https://druglandscape.com/drug/celsentri-tablets https://druglandscape.com/api/og?type=drug&title=CELSENTRI%C2%AE%20Tablets&subtitle=CELSENTRI%C2%AE%20Tablets%20%C2%B7%20ViiV%20Healthcare&badge=phase%202 CELSENTRI® Tablets CELSENTRI® Tablets · ViiV Healthcare https://druglandscape.com/drug/celz-201-administration https://druglandscape.com/api/og?type=drug&title=CELZ-201%20Administration&subtitle=CELZ-201%20Administration%20%C2%B7%20Creative%20Medical%20Technology%20Holdings%20Inc&badge=phase%201 CELZ-201 Administration CELZ-201 Administration · Creative Medical Technology Holdings Inc https://druglandscape.com/drug/cenicriviroc-in-mild-liver-impaired https://druglandscape.com/api/og?type=drug&title=Cenicriviroc%20in%20mild%20liver%20impaired&subtitle=Cenicriviroc%20in%20mild%20liver%20impaired%20%C2%B7%20Tobira%20Therapeutics%2C%20Inc.&badge=phase%201 Cenicriviroc in mild liver impaired Cenicriviroc in mild liver impaired · Tobira Therapeutics, Inc. https://druglandscape.com/drug/cenicriviroc-in-moderate-liver-impaired https://druglandscape.com/api/og?type=drug&title=Cenicriviroc%20in%20moderate%20liver%20impaired&subtitle=Cenicriviroc%20in%20moderate%20liver%20impaired%20%C2%B7%20Tobira%20Therapeutics%2C%20Inc.&badge=phase%201 Cenicriviroc in moderate liver impaired Cenicriviroc in moderate liver impaired · Tobira Therapeutics, Inc. https://druglandscape.com/drug/cenobamate-oral-suspension-fed https://druglandscape.com/api/og?type=drug&title=Cenobamate%20Oral%20Suspension%20Fed&subtitle=Cenobamate%20Oral%20Suspension%20Fed%20%C2%B7%20SK%20Life%20Science%2C%20Inc.&badge=phase%201 Cenobamate Oral Suspension Fed Cenobamate Oral Suspension Fed · SK Life Science, Inc. https://druglandscape.com/drug/cenobomate-oral-suspension-fasted https://druglandscape.com/api/og?type=drug&title=Cenobomate%20Oral%20Suspension%20Fasted&subtitle=Cenobomate%20Oral%20Suspension%20Fasted%20%C2%B7%20SK%20Life%20Science%2C%20Inc.&badge=phase%201 Cenobomate Oral Suspension Fasted Cenobomate Oral Suspension Fasted · SK Life Science, Inc. https://druglandscape.com/drug/centanafadine-qd-xr https://druglandscape.com/api/og?type=drug&title=Centanafadine%20QD%20XR&subtitle=Centanafadine%20QD%20XR%20%C2%B7%20Otsuka%20Pharmaceutical%20Development%20%26%20Commercialization%2C%20Inc.&badge=phase%201 Centanafadine QD XR Centanafadine QD XR · Otsuka Pharmaceutical Development & Commercialization, Inc. https://druglandscape.com/drug/cep-37247 https://druglandscape.com/api/og?type=drug&title=CEP-37247&subtitle=CEP-37247%20%C2%B7%20Cephalon&badge=phase%201 CEP-37247 CEP-37247 · Cephalon https://druglandscape.com/drug/cephalosporin-with-or-without-erythromycin https://druglandscape.com/api/og?type=drug&title=cephalosporin%20with%20or%20without%20erythromycin&subtitle=cephalosporin%20with%20or%20without%20erythromycin%20%C2%B7%20Universidad%20de%20Granada&badge=phase%201 cephalosporin with or without erythromycin cephalosporin with or without erythromycin · Universidad de Granada https://druglandscape.com/drug/ceramide-nanoliposome https://druglandscape.com/api/og?type=drug&title=Ceramide%20NanoLiposome&subtitle=Ceramide%20NanoLiposome%20%C2%B7%20Keystone%20Nano%2C%20Inc&badge=phase%201 Ceramide NanoLiposome Ceramide NanoLiposome · Keystone Nano, Inc https://druglandscape.com/drug/cerc-002 https://druglandscape.com/api/og?type=drug&title=CERC-002&subtitle=CERC-002%20%C2%B7%20Aevi%20Genomic%20Medicine%2C%20LLC%2C%20a%20Cerecor%20company&badge=phase%202 CERC-002 CERC-002 · Aevi Genomic Medicine, LLC, a Cerecor company https://druglandscape.com/drug/cerebral-dopamine-neurotrophic-factor https://druglandscape.com/api/og?type=drug&title=Cerebral%20Dopamine%20Neurotrophic%20Factor&subtitle=Cerebral%20Dopamine%20Neurotrophic%20Factor%20%C2%B7%20Herantis%20Pharma%20Plc.&badge=phase%201 Cerebral Dopamine Neurotrophic Factor Cerebral Dopamine Neurotrophic Factor · Herantis Pharma Plc. https://druglandscape.com/drug/cesol https://druglandscape.com/api/og?type=drug&title=Cesol%C2%AE&subtitle=Cesol%C2%AE%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 Cesol® Cesol® · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/cessation-of-somatostatin-analogues https://druglandscape.com/api/og?type=drug&title=Cessation%20of%20somatostatin%20analogues&subtitle=Cessation%20of%20somatostatin%20analogues%20%C2%B7%20Australasian%20Gastro-Intestinal%20Trials%20Group&badge=phase%202 Cessation of somatostatin analogues Cessation of somatostatin analogues · Australasian Gastro-Intestinal Trials Group https://druglandscape.com/drug/cetirizine-hcl-gummy https://druglandscape.com/api/og?type=drug&title=cetirizine%20HCl%20Gummy&subtitle=cetirizine%20HCl%20Gummy%20%C2%B7%20Seattle%20Gummy%20Company&badge=phase%201 cetirizine HCl Gummy cetirizine HCl Gummy · Seattle Gummy Company https://druglandscape.com/drug/cetrelimab-and-erdafitinib-combination https://druglandscape.com/api/og?type=drug&title=Cetrelimab%20and%20Erdafitinib%20combination&subtitle=Cetrelimab%20and%20Erdafitinib%20combination%20%C2%B7%20Spanish%20Oncology%20Genito-Urinary%20Group&badge=phase%202 Cetrelimab and Erdafitinib combination Cetrelimab and Erdafitinib combination · Spanish Oncology Genito-Urinary Group https://druglandscape.com/drug/cetuximab-c225 https://druglandscape.com/api/og?type=drug&title=cetuximab%20C225&subtitle=cetuximab%20C225%20%C2%B7%20Eastern%20Cooperative%20Oncology%20Group&badge=phase%202 cetuximab C225 cetuximab C225 · Eastern Cooperative Oncology Group https://druglandscape.com/drug/cetuximab-cohort-expansion https://druglandscape.com/api/og?type=drug&title=Cetuximab%20-%20Cohort%20Expansion&subtitle=Cetuximab%20-%20Cohort%20Expansion%20%C2%B7%20Wugen%2C%20Inc.&badge=phase%201 Cetuximab - Cohort Expansion Cetuximab - Cohort Expansion · Wugen, Inc. https://druglandscape.com/drug/cetuximab-dose-escalation https://druglandscape.com/api/og?type=drug&title=Cetuximab%20-%20Dose%20Escalation&subtitle=Cetuximab%20-%20Dose%20Escalation%20%C2%B7%20Wugen%2C%20Inc.&badge=phase%201 Cetuximab - Dose Escalation Cetuximab - Dose Escalation · Wugen, Inc. https://druglandscape.com/drug/cetuximab-irinotecan https://druglandscape.com/api/og?type=drug&title=Cetuximab%2C%20irinotecan&subtitle=Cetuximab%2C%20irinotecan%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 Cetuximab, irinotecan Cetuximab, irinotecan · Asan Medical Center https://druglandscape.com/drug/cetuximab-iv https://druglandscape.com/api/og?type=drug&title=cetuximab%20IV&subtitle=cetuximab%20IV%20%C2%B7%20Groupe%20Oncologie%20Radiotherapie%20Tete%20et%20Cou&badge=phase%202 cetuximab IV cetuximab IV · Groupe Oncologie Radiotherapie Tete et Cou https://druglandscape.com/drug/cetuximab-nanoparticles https://druglandscape.com/api/og?type=drug&title=Cetuximab%20nanoparticles&subtitle=Cetuximab%20nanoparticles%20%C2%B7%20Ahmed%20A.%20H.%20Abdellatif&badge=phase%201 Cetuximab nanoparticles Cetuximab nanoparticles · Ahmed A. H. Abdellatif https://druglandscape.com/drug/cetuximab-solution-for-infusion https://druglandscape.com/api/og?type=drug&title=Cetuximab%20Solution%20for%20infusion&subtitle=Cetuximab%20Solution%20for%20infusion%20%C2%B7%20Shanghai%20Junshi%20Bioscience%20Co.%2C%20Ltd.&badge=phase%201 Cetuximab Solution for infusion Cetuximab Solution for infusion · Shanghai Junshi Bioscience Co., Ltd. https://druglandscape.com/drug/cetuximab-zr-89 https://druglandscape.com/api/og?type=drug&title=Cetuximab-Zr.%2089&subtitle=Cetuximab-Zr.%2089%20%C2%B7%20Maastricht%20Radiation%20Oncology&badge=phase%201 Cetuximab-Zr. 89 Cetuximab-Zr. 89 · Maastricht Radiation Oncology https://druglandscape.com/drug/cf-102 https://druglandscape.com/api/og?type=drug&title=CF%20102&subtitle=CF%20102%20%C2%B7%20Can-Fite%20BioPharma&badge=phase%201 CF 102 CF 102 · Can-Fite BioPharma https://druglandscape.com/drug/cfi-402257 https://druglandscape.com/api/og?type=drug&title=CFI-402257&subtitle=CFI-402257%20%C2%B7%20Treadwell%20Therapeutics%2C%20Inc&badge=phase%201 CFI-402257 CFI-402257 · Treadwell Therapeutics, Inc https://druglandscape.com/drug/cfi-402411 https://druglandscape.com/api/og?type=drug&title=CFI-402411&subtitle=CFI-402411%20%C2%B7%20Treadwell%20Therapeutics%2C%20Inc&badge=phase%201 CFI-402411 CFI-402411 · Treadwell Therapeutics, Inc https://druglandscape.com/drug/cg-549 https://druglandscape.com/api/og?type=drug&title=CG-549&subtitle=CG-549%20%C2%B7%20CrystalGenomics%2C%20Inc.&badge=phase%201 CG-549 CG-549 · CrystalGenomics, Inc. https://druglandscape.com/drug/cg-p5-peptide https://druglandscape.com/api/og?type=drug&title=CG-P5%20peptide&subtitle=CG-P5%20peptide%20%C2%B7%20Caregen%20Co.%20Ltd.&badge=phase%201 CG-P5 peptide CG-P5 peptide · Caregen Co. Ltd. https://druglandscape.com/drug/cg001419 https://druglandscape.com/api/og?type=drug&title=CG001419&subtitle=CG001419%20%C2%B7%20Cullgen%20Australia%20Pty%20Ltd&badge=phase%201 CG001419 CG001419 · Cullgen Australia Pty Ltd https://druglandscape.com/drug/cg001419-tablets https://druglandscape.com/api/og?type=drug&title=CG001419%20tablets&subtitle=CG001419%20tablets%20%C2%B7%20Cullgen%20(Shanghai)%2CInc&badge=phase%201 CG001419 tablets CG001419 tablets · Cullgen (Shanghai),Inc https://druglandscape.com/drug/cg2001 https://druglandscape.com/api/og?type=drug&title=CG2001&subtitle=CG2001%20%C2%B7%20Beijing%20Dayspring%20Pharmaceutical%20Technology%20Co.%2C%20Ltd&badge=phase%201 CG2001 CG2001 · Beijing Dayspring Pharmaceutical Technology Co., Ltd https://druglandscape.com/drug/cg200745-ppa https://druglandscape.com/api/og?type=drug&title=CG200745%20PPA&subtitle=CG200745%20PPA%20%C2%B7%20CrystalGenomics%2C%20Inc.&badge=phase%201 CG200745 PPA CG200745 PPA · CrystalGenomics, Inc. https://druglandscape.com/drug/cgb-500-with-0-5-tofacitinib https://druglandscape.com/api/og?type=drug&title=CGB-500%20with%200.5%25%20tofacitinib&subtitle=CGB-500%20with%200.5%25%20tofacitinib%20%C2%B7%20CAGE%20Bio%20Inc.&badge=phase%202 CGB-500 with 0.5% tofacitinib CGB-500 with 0.5% tofacitinib · CAGE Bio Inc. https://druglandscape.com/drug/cgl1802 https://druglandscape.com/api/og?type=drug&title=CGL1802&subtitle=CGL1802%20%C2%B7%20CrystalGenomics%2C%20Inc.&badge=phase%201 CGL1802 CGL1802 · CrystalGenomics, Inc. https://druglandscape.com/drug/cgrp https://druglandscape.com/api/og?type=drug&title=CGRP&subtitle=CGRP%20%C2%B7%20Danish%20Headache%20Center&badge=phase%201 CGRP CGRP · Danish Headache Center https://druglandscape.com/drug/cgrp-infusion https://druglandscape.com/api/og?type=drug&title=CGRP%20infusion&subtitle=CGRP%20infusion%20%C2%B7%20Danish%20Headache%20Center&badge=phase%201 CGRP infusion CGRP infusion · Danish Headache Center https://druglandscape.com/drug/cgt4255 https://druglandscape.com/api/og?type=drug&title=CGT4255&subtitle=CGT4255%20%C2%B7%20Cogent%20Biosciences%2C%20Inc.&badge=phase%201 CGT4255 CGT4255 · Cogent Biosciences, Inc. https://druglandscape.com/drug/cgt4859 https://druglandscape.com/api/og?type=drug&title=CGT4859&subtitle=CGT4859%20%C2%B7%20Cogent%20Biosciences%2C%20Inc.&badge=phase%201 CGT4859 CGT4859 · Cogent Biosciences, Inc. https://druglandscape.com/drug/ch-mab7f9 https://druglandscape.com/api/og?type=drug&title=ch-mAb7f9&subtitle=ch-mAb7f9%20%C2%B7%20InterveXion%20Therapeutics%2C%20LLC&badge=phase%201 ch-mAb7f9 ch-mAb7f9 · InterveXion Therapeutics, LLC https://druglandscape.com/drug/ch6001 https://druglandscape.com/api/og?type=drug&title=CH6001&subtitle=CH6001%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%201 CH6001 CH6001 · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/chadox1-85a-aerosol https://druglandscape.com/api/og?type=drug&title=ChadOx1%2085A%20-%20aerosol&subtitle=ChadOx1%2085A%20-%20aerosol%20%C2%B7%20Fran%C3%A7ois%20Spertini&badge=phase%201 ChadOx1 85A - aerosol ChadOx1 85A - aerosol · François Spertini https://druglandscape.com/drug/chadox1-85a-im https://druglandscape.com/api/og?type=drug&title=ChadOx1%2085A%20-%20IM&subtitle=ChadOx1%2085A%20-%20IM%20%C2%B7%20Fran%C3%A7ois%20Spertini&badge=phase%201 ChadOx1 85A - IM ChadOx1 85A - IM · François Spertini https://druglandscape.com/drug/chamomile-topical-oral-gel https://druglandscape.com/api/og?type=drug&title=chamomile%20topical%20oral%20gel&subtitle=chamomile%20topical%20oral%20gel%20%C2%B7%20Hams%20Hamed%20Abdelrahman&badge=phase%202 chamomile topical oral gel chamomile topical oral gel · Hams Hamed Abdelrahman https://druglandscape.com/drug/chapstick-lip-moisturizer-black-cherry https://druglandscape.com/api/og?type=drug&title=ChapStick%20Lip%20Moisturizer%20Black%20Cherry&subtitle=ChapStick%20Lip%20Moisturizer%20Black%20Cherry%20%C2%B7%20HALEON&badge=phase%201 ChapStick Lip Moisturizer Black Cherry ChapStick Lip Moisturizer Black Cherry · HALEON https://druglandscape.com/drug/chapstick-lip-moisturizer-mint https://druglandscape.com/api/og?type=drug&title=ChapStick%20Lip%20Moisturizer%20Mint&subtitle=ChapStick%20Lip%20Moisturizer%20Mint%20%C2%B7%20HALEON&badge=phase%201 ChapStick Lip Moisturizer Mint ChapStick Lip Moisturizer Mint · HALEON https://druglandscape.com/drug/chapstick-lip-moisturizer-original https://druglandscape.com/api/og?type=drug&title=ChapStick%20Lip%20Moisturizer%20Original&subtitle=ChapStick%20Lip%20Moisturizer%20Original%20%C2%B7%20HALEON&badge=phase%201 ChapStick Lip Moisturizer Original ChapStick Lip Moisturizer Original · HALEON https://druglandscape.com/drug/chapstick-moisturizer-strawberry-flavor https://druglandscape.com/api/og?type=drug&title=ChapStick%20Moisturizer%2C%20Strawberry%20Flavor&subtitle=ChapStick%20Moisturizer%2C%20Strawberry%20Flavor%20%C2%B7%20GlaxoSmithKline&badge=phase%201 ChapStick Moisturizer, Strawberry Flavor ChapStick Moisturizer, Strawberry Flavor · GlaxoSmithKline https://druglandscape.com/drug/charcoal-and-symbicort-turbuhaler https://druglandscape.com/api/og?type=drug&title=Charcoal%20and%20Symbicort%20Turbuhaler&subtitle=Charcoal%20and%20Symbicort%20Turbuhaler%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 Charcoal and Symbicort Turbuhaler Charcoal and Symbicort Turbuhaler · Orion Corporation, Orion Pharma https://druglandscape.com/drug/checkpoint-inhibitor-immune https://druglandscape.com/api/og?type=drug&title=Checkpoint%20Inhibitor%2C%20Immune&subtitle=Checkpoint%20Inhibitor%2C%20Immune%20%C2%B7%20VastBiome&badge=phase%202 Checkpoint Inhibitor, Immune Checkpoint Inhibitor, Immune · VastBiome https://druglandscape.com/drug/chemotherapies-recommended-in-france https://druglandscape.com/api/og?type=drug&title=chemotherapies%20recommended%20in%20france&subtitle=chemotherapies%20recommended%20in%20france%20%C2%B7%20Pfizer&badge=phase%202 chemotherapies recommended in france chemotherapies recommended in france · Pfizer https://druglandscape.com/drug/chemotherapy-and-target-therapy https://druglandscape.com/api/og?type=drug&title=Chemotherapy%20and%20target%20therapy&subtitle=Chemotherapy%20and%20target%20therapy%20%C2%B7%20Haining%20Health-Coming%20Biotech%20Co.%2C%20Ltd.&badge=phase%202 Chemotherapy and target therapy Chemotherapy and target therapy · Haining Health-Coming Biotech Co., Ltd. https://druglandscape.com/drug/chemotherapy-by-investigator-s-choice https://druglandscape.com/api/og?type=drug&title=Chemotherapy%20by%20Investigator's%20choice&subtitle=Chemotherapy%20by%20Investigator's%20choice%20%C2%B7%20AIO-Studien-gGmbH&badge=phase%202 Chemotherapy by Investigator's choice Chemotherapy by Investigator's choice · AIO-Studien-gGmbH https://druglandscape.com/drug/chemotherapy-folfox-4 https://druglandscape.com/api/og?type=drug&title=chemotherapy%3A%20FOLFOX%204&subtitle=chemotherapy%3A%20FOLFOX%204%20%C2%B7%20Centre%20Georges%20Francois%20Leclerc&badge=phase%202 chemotherapy: FOLFOX 4 chemotherapy: FOLFOX 4 · Centre Georges Francois Leclerc https://druglandscape.com/drug/chemotherapy-for-colorectal-carcinoma https://druglandscape.com/api/og?type=drug&title=chemotherapy%20for%20colorectal%20carcinoma&subtitle=chemotherapy%20for%20colorectal%20carcinoma%20%C2%B7%20MyGenostics%20Inc.%2C%20Beijing&badge=phase%201 chemotherapy for colorectal carcinoma chemotherapy for colorectal carcinoma · MyGenostics Inc., Beijing https://druglandscape.com/drug/chemotherapy-pemetrexed https://druglandscape.com/api/og?type=drug&title=Chemotherapy%3A%20Pemetrexed&subtitle=Chemotherapy%3A%20Pemetrexed%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 Chemotherapy: Pemetrexed Chemotherapy: Pemetrexed · Janssen Research & Development, LLC https://druglandscape.com/drug/chemotherapy-prednisone https://druglandscape.com/api/og?type=drug&title=Chemotherapy%20Prednisone&subtitle=Chemotherapy%20Prednisone%20%C2%B7%20SciClone%20Pharmaceuticals&badge=phase%202 Chemotherapy Prednisone Chemotherapy Prednisone · SciClone Pharmaceuticals https://druglandscape.com/drug/chemotherapy-tip https://druglandscape.com/api/og?type=drug&title=Chemotherapy%20TIP&subtitle=Chemotherapy%20TIP%20%C2%B7%20UNICANCER&badge=phase%202 Chemotherapy TIP Chemotherapy TIP · UNICANCER https://druglandscape.com/drug/chemotherapy-treatment-called-gpoh https://druglandscape.com/api/og?type=drug&title=chemotherapy%20treatment%20called%20GPOH&subtitle=chemotherapy%20treatment%20called%20GPOH%20%C2%B7%20Princess%20Maxima%20Center%20for%20Pediatric%20Oncology&badge=phase%201 chemotherapy treatment called GPOH chemotherapy treatment called GPOH · Princess Maxima Center for Pediatric Oncology https://druglandscape.com/drug/chemotherapy-treatment-called-rapid-cojec https://druglandscape.com/api/og?type=drug&title=chemotherapy%20treatment%20called%20rapid%20COJEC&subtitle=chemotherapy%20treatment%20called%20rapid%20COJEC%20%C2%B7%20Princess%20Maxima%20Center%20for%20Pediatric%20Oncology&badge=phase%201 chemotherapy treatment called rapid COJEC chemotherapy treatment called rapid COJEC · Princess Maxima Center for Pediatric Oncology https://druglandscape.com/drug/chemotherapy-with-lmwh-enoxaparin https://druglandscape.com/api/og?type=drug&title=chemotherapy%20with%20LMWH%20-%20enoxaparin&subtitle=chemotherapy%20with%20LMWH%20-%20enoxaparin%20%C2%B7%20CONKO-Studiengruppe&badge=phase%202 chemotherapy with LMWH - enoxaparin chemotherapy with LMWH - enoxaparin · CONKO-Studiengruppe https://druglandscape.com/drug/chenodeoxycholic-acid-leadiant https://druglandscape.com/api/og?type=drug&title=Chenodeoxycholic%20acid%20leadiant&subtitle=Chenodeoxycholic%20acid%20leadiant%20%C2%B7%20Humanis%20Sagl%C4%B1k%20Anonim%20Sirketi&badge=phase%201 Chenodeoxycholic acid leadiant Chenodeoxycholic acid leadiant · Humanis Saglık Anonim Sirketi https://druglandscape.com/drug/chf-1531-pmdi https://druglandscape.com/api/og?type=drug&title=CHF%201531%20pMDI&subtitle=CHF%201531%20pMDI%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%202 CHF 1531 pMDI CHF 1531 pMDI · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/chf-5074 https://druglandscape.com/api/og?type=drug&title=CHF%205074&subtitle=CHF%205074%20%C2%B7%20CERESPIR&badge=phase%201 CHF 5074 CHF 5074 · CERESPIR https://druglandscape.com/drug/chf-5074-3x https://druglandscape.com/api/og?type=drug&title=CHF%205074%203x&subtitle=CHF%205074%203x%20%C2%B7%20CERESPIR&badge=phase%202 CHF 5074 3x CHF 5074 3x · CERESPIR https://druglandscape.com/drug/chf-5993-pmdi https://druglandscape.com/api/og?type=drug&title=CHF%205993%20pMDI&subtitle=CHF%205993%20pMDI%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%201 CHF 5993 pMDI CHF 5993 pMDI · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/chf-6001-dose1 https://druglandscape.com/api/og?type=drug&title=CHF%206001%20Dose1&subtitle=CHF%206001%20Dose1%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%202 CHF 6001 Dose1 CHF 6001 Dose1 · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/chf-6333 https://druglandscape.com/api/og?type=drug&title=CHF%206333&subtitle=CHF%206333%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%201 CHF 6333 CHF 6333 · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/chf1535-daily-dose https://druglandscape.com/api/og?type=drug&title=CHF1535%20daily%20dose&subtitle=CHF1535%20daily%20dose%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%202 CHF1535 daily dose CHF1535 daily dose · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/chf5259-and-chf6001 https://druglandscape.com/api/og?type=drug&title=CHF5259%20and%20CHF6001&subtitle=CHF5259%20and%20CHF6001%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%201 CHF5259 and CHF6001 CHF5259 and CHF6001 · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/chf5993-pmdi-with-hfa-152a https://druglandscape.com/api/og?type=drug&title=CHF5993%20pMDI%20with%20HFA-152a&subtitle=CHF5993%20pMDI%20with%20HFA-152a%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%202 CHF5993 pMDI with HFA-152a CHF5993 pMDI with HFA-152a · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/chf6366 https://druglandscape.com/api/og?type=drug&title=CHF6366&subtitle=CHF6366%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%201 CHF6366 CHF6366 · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/chf6467-active https://druglandscape.com/api/og?type=drug&title=CHF6467%20active&subtitle=CHF6467%20active%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%201 CHF6467 active CHF6467 active · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/chf6523 https://druglandscape.com/api/og?type=drug&title=CHF6523&subtitle=CHF6523%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%201 CHF6523 CHF6523 · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/chidamide-in-combination-with-ivonescimab https://druglandscape.com/api/og?type=drug&title=Chidamide%20in%20combination%20with%20Ivonescimab&subtitle=Chidamide%20in%20combination%20with%20Ivonescimab%20%C2%B7%20Guangdong%20Association%20of%20Clinical%20Trials&badge=phase%202 Chidamide in combination with Ivonescimab Chidamide in combination with Ivonescimab · Guangdong Association of Clinical Trials https://druglandscape.com/drug/children-s-mucinex-grape-flavor https://druglandscape.com/api/og?type=drug&title=Children's%20Mucinex%C2%AE%20Grape%20Flavor&subtitle=Children's%20Mucinex%C2%AE%20Grape%20Flavor%20%C2%B7%20Reckitt%20Benckiser%20LLC&badge=phase%201 Children's Mucinex® Grape Flavor Children's Mucinex® Grape Flavor · Reckitt Benckiser LLC https://druglandscape.com/drug/chimeric-anti-cd20-monoclonal-antibody https://druglandscape.com/api/og?type=drug&title=Chimeric%20anti-CD20%20monoclonal%20antibody&subtitle=Chimeric%20anti-CD20%20monoclonal%20antibody%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%201 Chimeric anti-CD20 monoclonal antibody Chimeric anti-CD20 monoclonal antibody · Sinocelltech Ltd. https://druglandscape.com/drug/chimerivax-je-vaccine https://druglandscape.com/api/og?type=drug&title=ChimeriVax%E2%84%A2-JE%20vaccine&subtitle=ChimeriVax%E2%84%A2-JE%20vaccine%20%C2%B7%20Sanofi&badge=phase%202 ChimeriVax™-JE vaccine ChimeriVax™-JE vaccine · Sanofi https://druglandscape.com/drug/china-crest-cavity-protection-toothpaste https://druglandscape.com/api/og?type=drug&title=China%20Crest%C2%AE%20Cavity%20Protection%20Toothpaste&subtitle=China%20Crest%C2%AE%20Cavity%20Protection%20Toothpaste%20%C2%B7%20Procter%20and%20Gamble&badge=phase%201 China Crest® Cavity Protection Toothpaste China Crest® Cavity Protection Toothpaste · Procter and Gamble https://druglandscape.com/drug/chitin-microparticles-by-nasal-route https://druglandscape.com/api/og?type=drug&title=Chitin%20microparticles%20by%20nasal%20route&subtitle=Chitin%20microparticles%20by%20nasal%20route%20%C2%B7%20CMP%20Therapeutics%20Ltd&badge=phase%201 Chitin microparticles by nasal route Chitin microparticles by nasal route · CMP Therapeutics Ltd https://druglandscape.com/drug/chlorhexidine-0-5 https://druglandscape.com/api/og?type=drug&title=Chlorhexidine%200.5%25&subtitle=Chlorhexidine%200.5%25%20%C2%B7%20Freya%20Biosciences%20ApS&badge=phase%202 Chlorhexidine 0.5% Chlorhexidine 0.5% · Freya Biosciences ApS https://druglandscape.com/drug/chlorhexidine-4-0 https://druglandscape.com/api/og?type=drug&title=Chlorhexidine%204.0%25&subtitle=Chlorhexidine%204.0%25%20%C2%B7%20Johns%20Hopkins%20Bloomberg%20School%20of%20Public%20Health&badge=phase%201 Chlorhexidine 4.0% Chlorhexidine 4.0% · Johns Hopkins Bloomberg School of Public Health https://druglandscape.com/drug/chlorhexidine-bath-and-nasal-mupirocin https://druglandscape.com/api/og?type=drug&title=Chlorhexidine%20bath%20and%20nasal%20mupirocin&subtitle=Chlorhexidine%20bath%20and%20nasal%20mupirocin%20%C2%B7%20Harvard%20Pilgrim%20Health%20Care&badge=phase%201 Chlorhexidine bath and nasal mupirocin Chlorhexidine bath and nasal mupirocin · Harvard Pilgrim Health Care https://druglandscape.com/drug/chlorhexidine-sol-4 https://druglandscape.com/api/og?type=drug&title=Chlorhexidine%20sol%204%25&subtitle=Chlorhexidine%20sol%204%25%20%C2%B7%20Lindenhofgruppe%20AG&badge=phase%201 Chlorhexidine sol 4% Chlorhexidine sol 4% · Lindenhofgruppe AG https://druglandscape.com/drug/chlorophyllin-sodium-copper-complex https://druglandscape.com/api/og?type=drug&title=Chlorophyllin%2C%20Sodium%20Copper%20Complex&subtitle=Chlorophyllin%2C%20Sodium%20Copper%20Complex%20%C2%B7%20Tata%20Memorial%20Centre&badge=phase%202 Chlorophyllin, Sodium Copper Complex Chlorophyllin, Sodium Copper Complex · Tata Memorial Centre https://druglandscape.com/drug/chloroquine-and-sulphadoxine-pyrimethamine https://druglandscape.com/api/og?type=drug&title=Chloroquine%20and%20sulphadoxine-pyrimethamine&subtitle=Chloroquine%20and%20sulphadoxine-pyrimethamine%20%C2%B7%20Menzies%20School%20of%20Health%20Research&badge=phase%201 Chloroquine and sulphadoxine-pyrimethamine Chloroquine and sulphadoxine-pyrimethamine · Menzies School of Health Research https://druglandscape.com/drug/chloroquine-chemoprophylaxis-alone https://druglandscape.com/api/og?type=drug&title=Chloroquine%20chemoprophylaxis%20alone&subtitle=Chloroquine%20chemoprophylaxis%20alone%20%C2%B7%20Sanaria%20Inc.&badge=phase%202 Chloroquine chemoprophylaxis alone Chloroquine chemoprophylaxis alone · Sanaria Inc. https://druglandscape.com/drug/chloroquine-p-vivax https://druglandscape.com/api/og?type=drug&title=Chloroquine-%20P.%20vivax&subtitle=Chloroquine-%20P.%20vivax%20%C2%B7%20Centers%20for%20Disease%20Control%20and%20Prevention&badge=phase%201 Chloroquine- P. vivax Chloroquine- P. vivax · Centers for Disease Control and Prevention https://druglandscape.com/drug/cho-a04 https://druglandscape.com/api/og?type=drug&title=CHO-A04&subtitle=CHO-A04%20%C2%B7%20Cho%20Pharma%20Inc.&badge=phase%201 CHO-A04 CHO-A04 · Cho Pharma Inc. https://druglandscape.com/drug/cho-h01-at-rp2d https://druglandscape.com/api/og?type=drug&title=CHO-H01%20at%20RP2D&subtitle=CHO-H01%20at%20RP2D%20%C2%B7%20Cho%20Pharma%20Inc.&badge=phase%201 CHO-H01 at RP2D CHO-H01 at RP2D · Cho Pharma Inc. https://druglandscape.com/drug/cholera-vaccination https://druglandscape.com/api/og?type=drug&title=Cholera%20vaccination&subtitle=Cholera%20vaccination%20%C2%B7%20NIZO%20Food%20Research&badge=phase%201 Cholera vaccination Cholera vaccination · NIZO Food Research https://druglandscape.com/drug/choline-alphoscerate https://druglandscape.com/api/og?type=drug&title=choline%20alphoscerate&subtitle=choline%20alphoscerate%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 choline alphoscerate choline alphoscerate · Samsung Medical Center https://druglandscape.com/drug/chong-kun-dang-tofacitinib-tablet https://druglandscape.com/api/og?type=drug&title=Chong%20Kun%20Dang%20Tofacitinib%20Tablet&subtitle=Chong%20Kun%20Dang%20Tofacitinib%20Tablet%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 Chong Kun Dang Tofacitinib Tablet Chong Kun Dang Tofacitinib Tablet · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/choriogonadotropin-alpha https://druglandscape.com/api/og?type=drug&title=Choriogonadotropin%20Alpha&subtitle=Choriogonadotropin%20Alpha%20%C2%B7%20Sports%20Medicine%20Research%20and%20Testing%20Laboratory&badge=phase%201 Choriogonadotropin Alpha Choriogonadotropin Alpha · Sports Medicine Research and Testing Laboratory https://druglandscape.com/drug/chort-1-of-m802 https://druglandscape.com/api/og?type=drug&title=Chort%201%20of%20M802&subtitle=Chort%201%20of%20M802%20%C2%B7%20Wuhan%20YZY%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 Chort 1 of M802 Chort 1 of M802 · Wuhan YZY Biopharma Co., Ltd. https://druglandscape.com/drug/chort-2-of-m802 https://druglandscape.com/api/og?type=drug&title=Chort%202%20of%20M802&subtitle=Chort%202%20of%20M802%20%C2%B7%20Wuhan%20YZY%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 Chort 2 of M802 Chort 2 of M802 · Wuhan YZY Biopharma Co., Ltd. https://druglandscape.com/drug/chr-2797 https://druglandscape.com/api/og?type=drug&title=CHR-2797&subtitle=CHR-2797%20%C2%B7%20CTI%20BioPharma&badge=phase%202 CHR-2797 CHR-2797 · CTI BioPharma https://druglandscape.com/drug/chronic-hormonal-treatment https://druglandscape.com/api/og?type=drug&title=Chronic%20hormonal%20treatment&subtitle=Chronic%20hormonal%20treatment%20%C2%B7%20Bayer&badge=phase%202 Chronic hormonal treatment Chronic hormonal treatment · Bayer https://druglandscape.com/drug/chrono-indocid https://druglandscape.com/api/og?type=drug&title=CHRONO-INDOCID&subtitle=CHRONO-INDOCID%20%C2%B7%20Genfit&badge=phase%201 CHRONO-INDOCID CHRONO-INDOCID · Genfit https://druglandscape.com/drug/chronocort-fasted https://druglandscape.com/api/og?type=drug&title=Chronocort%3A%20fasted&subtitle=Chronocort%3A%20fasted%20%C2%B7%20Neurocrine%20UK%20Limited&badge=phase%201 Chronocort: fasted Chronocort: fasted · Neurocrine UK Limited https://druglandscape.com/drug/chronseal https://druglandscape.com/api/og?type=drug&title=CHRONSEAL&subtitle=CHRONSEAL%20%C2%B7%20Kringle%20Pharma%20Europe%20AB&badge=phase%201 CHRONSEAL CHRONSEAL · Kringle Pharma Europe AB https://druglandscape.com/drug/chs-1000 https://druglandscape.com/api/og?type=drug&title=CHS-1000&subtitle=CHS-1000%20%C2%B7%20Coherus%20Oncology%2C%20Inc.&badge=phase%201 CHS-1000 CHS-1000 · Coherus Oncology, Inc. https://druglandscape.com/drug/chs-1701 https://druglandscape.com/api/og?type=drug&title=CHS-1701&subtitle=CHS-1701%20%C2%B7%20Coherus%20Oncology%2C%20Inc.&badge=phase%201 CHS-1701 CHS-1701 · Coherus Oncology, Inc. https://druglandscape.com/drug/cht-herbal-therapy https://druglandscape.com/api/og?type=drug&title=CHT%20-%20herbal%20therapy&subtitle=CHT%20-%20herbal%20therapy%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 CHT - herbal therapy CHT - herbal therapy · Hadassah Medical Organization https://druglandscape.com/drug/ci-8993 https://druglandscape.com/api/og?type=drug&title=CI-8993&subtitle=CI-8993%20%C2%B7%20Curis%2C%20Inc.&badge=phase%201 CI-8993 CI-8993 · Curis, Inc. https://druglandscape.com/drug/ciclesonide-inhalation-aerosol https://druglandscape.com/api/og?type=drug&title=Ciclesonide%20Inhalation%20Aerosol&subtitle=Ciclesonide%20Inhalation%20Aerosol%20%C2%B7%20Ola%20Blennow%2C%20MD%2C%20PhD&badge=phase%202 Ciclesonide Inhalation Aerosol Ciclesonide Inhalation Aerosol · Ola Blennow, MD, PhD https://druglandscape.com/drug/ciclopirox-olamine-topical-suspension https://druglandscape.com/api/og?type=drug&title=Ciclopirox%20Olamine%20Topical%20Suspension&subtitle=Ciclopirox%20Olamine%20Topical%20Suspension%20%C2%B7%20Padagis%20LLC&badge=phase%201 Ciclopirox Olamine Topical Suspension Ciclopirox Olamine Topical Suspension · Padagis LLC https://druglandscape.com/drug/cik-and-t https://druglandscape.com/api/og?type=drug&title=CIK%20and%20%CE%B3%CE%B4%20T&subtitle=CIK%20and%20%CE%B3%CE%B4%20T%20%C2%B7%20Beijing%20Doing%20Biomedical%20Co.%2C%20Ltd.&badge=phase%201 CIK and γδ T CIK and γδ T · Beijing Doing Biomedical Co., Ltd. https://druglandscape.com/drug/cilengitide-dose-escalation https://druglandscape.com/api/og?type=drug&title=Cilengitide%20dose%20escalation&subtitle=Cilengitide%20dose%20escalation%20%C2%B7%20Centre%20Oscar%20Lambret&badge=phase%201 Cilengitide dose escalation Cilengitide dose escalation · Centre Oscar Lambret https://druglandscape.com/drug/cimetidine-plus-chf5993-pmdi https://druglandscape.com/api/og?type=drug&title=Cimetidine%20plus%20CHF5993%20pMDI&subtitle=Cimetidine%20plus%20CHF5993%20pMDI%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%201 Cimetidine plus CHF5993 pMDI Cimetidine plus CHF5993 pMDI · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/cin-107 https://druglandscape.com/api/og?type=drug&title=CIN-107&subtitle=CIN-107%20%C2%B7%20AstraZeneca&badge=phase%202 CIN-107 CIN-107 · AstraZeneca https://druglandscape.com/drug/cinidipine-valsartan https://druglandscape.com/api/og?type=drug&title=cinidipine%2C%20valsartan&subtitle=cinidipine%2C%20valsartan%20%C2%B7%20IlDong%20Pharmaceutical%20Co%20Ltd&badge=phase%201 cinidipine, valsartan cinidipine, valsartan · IlDong Pharmaceutical Co Ltd https://druglandscape.com/drug/cinnamomum-verum-oil-extract https://druglandscape.com/api/og?type=drug&title=Cinnamomum%20Verum%20oil%20extract&subtitle=Cinnamomum%20Verum%20oil%20extract%20%C2%B7%20Universidad%20Nacional%20Autonoma%20de%20Honduras&badge=phase%202 Cinnamomum Verum oil extract Cinnamomum Verum oil extract · Universidad Nacional Autonoma de Honduras https://druglandscape.com/drug/cinryze-with-rhuph20 https://druglandscape.com/api/og?type=drug&title=CINRYZE%20with%20rHuPH20&subtitle=CINRYZE%20with%20rHuPH20%20%C2%B7%20Shire&badge=phase%202 CINRYZE with rHuPH20 CINRYZE with rHuPH20 · Shire https://druglandscape.com/drug/ciprofloxacin-reference-tablet https://druglandscape.com/api/og?type=drug&title=Ciprofloxacin%20reference%20tablet&subtitle=Ciprofloxacin%20reference%20tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Ciprofloxacin reference tablet Ciprofloxacin reference tablet · GlaxoSmithKline https://druglandscape.com/drug/cirmtuzumab-plus-ibrutinib https://druglandscape.com/api/og?type=drug&title=Cirmtuzumab%20plus%20ibrutinib&subtitle=Cirmtuzumab%20plus%20ibrutinib%20%C2%B7%20Oncternal%20Therapeutics%2C%20Inc&badge=phase%201 Cirmtuzumab plus ibrutinib Cirmtuzumab plus ibrutinib · Oncternal Therapeutics, Inc https://druglandscape.com/drug/cis-uca-ophthalmic-solution-1-0 https://druglandscape.com/api/og?type=drug&title=cis-UCA%20ophthalmic%20solution%201.0%25&subtitle=cis-UCA%20ophthalmic%20solution%201.0%25%20%C2%B7%20Herantis%20Pharma%20Plc.&badge=phase%202 cis-UCA ophthalmic solution 1.0% cis-UCA ophthalmic solution 1.0% · Herantis Pharma Plc. https://druglandscape.com/drug/cis-uca-ophthalmic-solution-2-5 https://druglandscape.com/api/og?type=drug&title=cis-UCA%20ophthalmic%20solution%202.5%25&subtitle=cis-UCA%20ophthalmic%20solution%202.5%25%20%C2%B7%20Herantis%20Pharma%20Plc.&badge=phase%202 cis-UCA ophthalmic solution 2.5% cis-UCA ophthalmic solution 2.5% · Herantis Pharma Plc. https://druglandscape.com/drug/cis-uca-solution https://druglandscape.com/api/og?type=drug&title=cis-UCA%20solution&subtitle=cis-UCA%20solution%20%C2%B7%20BioCis%20Pharma%20Ltd&badge=phase%201 cis-UCA solution cis-UCA solution · BioCis Pharma Ltd https://druglandscape.com/drug/cisplatin-5fu-afatinib https://druglandscape.com/api/og?type=drug&title=Cisplatin-5FU-Afatinib&subtitle=Cisplatin-5FU-Afatinib%20%C2%B7%20Hellenic%20Cooperative%20Oncology%20Group&badge=phase%202 Cisplatin-5FU-Afatinib Cisplatin-5FU-Afatinib · Hellenic Cooperative Oncology Group https://druglandscape.com/drug/cisplatin-and-5-fluorouracil https://druglandscape.com/api/og?type=drug&title=cisplatin%20and%205-fluorouracil&subtitle=cisplatin%20and%205-fluorouracil%20%C2%B7%20CbsBioscience&badge=phase%202 cisplatin and 5-fluorouracil cisplatin and 5-fluorouracil · CbsBioscience https://druglandscape.com/drug/cisplatin-based-neoadjuvant-chemotherapy https://druglandscape.com/api/og?type=drug&title=cisplatin%20based%20neoadjuvant%20chemotherapy&subtitle=cisplatin%20based%20neoadjuvant%20chemotherapy%20%C2%B7%20Regina%20Elena%20Cancer%20Institute&badge=phase%203 cisplatin based neoadjuvant chemotherapy cisplatin based neoadjuvant chemotherapy · Regina Elena Cancer Institute https://druglandscape.com/drug/cisplatin-combined-with-etoposide https://druglandscape.com/api/og?type=drug&title=Cisplatin%20combined%20with%20Etoposide&subtitle=Cisplatin%20combined%20with%20Etoposide%20%C2%B7%20Beijing%20Pearl%20Biotechnology%20Limited%20Liability%20Company&badge=phase%202 Cisplatin combined with Etoposide Cisplatin combined with Etoposide · Beijing Pearl Biotechnology Limited Liability Company https://druglandscape.com/drug/cisplatin-concurrent-chemotherapy https://druglandscape.com/api/og?type=drug&title=cisplatin%20concurrent%20chemotherapy&subtitle=cisplatin%20concurrent%20chemotherapy%20%C2%B7%20Sun%20Yat-sen%20University&badge=phase%203 cisplatin concurrent chemotherapy cisplatin concurrent chemotherapy · Sun Yat-sen University https://druglandscape.com/drug/cisplatin-dose-level-2 https://druglandscape.com/api/og?type=drug&title=Cisplatin%20-%20Dose%20Level%202&subtitle=Cisplatin%20-%20Dose%20Level%202%20%C2%B7%20Nebraska%20Methodist%20Health%20System&badge=phase%202 Cisplatin - Dose Level 2 Cisplatin - Dose Level 2 · Nebraska Methodist Health System https://druglandscape.com/drug/cisplatin-fluorouracil-chemotherapy https://druglandscape.com/api/og?type=drug&title=cisplatin-fluorouracil%20chemotherapy&subtitle=cisplatin-fluorouracil%20chemotherapy%20%C2%B7%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 cisplatin-fluorouracil chemotherapy cisplatin-fluorouracil chemotherapy · Simcere Pharmaceutical Co., Ltd https://druglandscape.com/drug/cisplatin-gemcitabine-panitumumab https://druglandscape.com/api/og?type=drug&title=Cisplatin%2C%20Gemcitabine%2C%20Panitumumab&subtitle=Cisplatin%2C%20Gemcitabine%2C%20Panitumumab%20%C2%B7%20Hannover%20Medical%20School&badge=phase%202 Cisplatin, Gemcitabine, Panitumumab Cisplatin, Gemcitabine, Panitumumab · Hannover Medical School https://druglandscape.com/drug/cisplatin-phase-1 https://druglandscape.com/api/og?type=drug&title=Cisplatin%20Phase%201&subtitle=Cisplatin%20Phase%201%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Cisplatin Phase 1 Cisplatin Phase 1 · Eli Lilly and Company https://druglandscape.com/drug/cisplatin-phase-2 https://druglandscape.com/api/og?type=drug&title=Cisplatin%20Phase%202&subtitle=Cisplatin%20Phase%202%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Cisplatin Phase 2 Cisplatin Phase 2 · Eli Lilly and Company https://druglandscape.com/drug/cisplatin-pleural-infusion https://druglandscape.com/api/og?type=drug&title=Cisplatin%20pleural%20infusion&subtitle=Cisplatin%20pleural%20infusion%20%C2%B7%20Wuhan%20YZY%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 Cisplatin pleural infusion Cisplatin pleural infusion · Wuhan YZY Biopharma Co., Ltd. https://druglandscape.com/drug/cisplatin-plus-radiotherapy https://druglandscape.com/api/og?type=drug&title=cisplatin%20plus%20radiotherapy&subtitle=cisplatin%20plus%20radiotherapy%20%C2%B7%20Grupo%20Espa%C3%B1ol%20de%20Tratamiento%20de%20Tumores%20de%20Cabeza%20y%20Cuello&badge=phase%201 cisplatin plus radiotherapy cisplatin plus radiotherapy · Grupo Español de Tratamiento de Tumores de Cabeza y Cuello https://druglandscape.com/drug/cisplatine-teva https://druglandscape.com/api/og?type=drug&title=Cisplatine%20Teva%C2%AE&subtitle=Cisplatine%20Teva%C2%AE%20%C2%B7%20Dr%20Jean%20Yannis%20PERENTES&badge=phase%201 Cisplatine Teva® Cisplatine Teva® · Dr Jean Yannis PERENTES https://druglandscape.com/drug/cita-rnpt https://druglandscape.com/api/og?type=drug&title=CITA-RNPT&subtitle=CITA-RNPT%20%C2%B7%20Hillel%20Yaffe%20Medical%20Center&badge=phase%201 CITA-RNPT CITA-RNPT · Hillel Yaffe Medical Center https://druglandscape.com/drug/citalopram-and-pindolol https://druglandscape.com/api/og?type=drug&title=Citalopram%20and%20Pindolol&subtitle=Citalopram%20and%20Pindolol%20%C2%B7%20Gitte%20Moos%20Knudsen&badge=phase%201 Citalopram and Pindolol Citalopram and Pindolol · Gitte Moos Knudsen https://druglandscape.com/drug/citalopram-p-o https://druglandscape.com/api/og?type=drug&title=Citalopram%20p.o&subtitle=Citalopram%20p.o%20%C2%B7%20Istituto%20Auxologico%20Italiano&badge=phase%202 Citalopram p.o Citalopram p.o · Istituto Auxologico Italiano https://druglandscape.com/drug/citrate-free-mirikizumab https://druglandscape.com/api/og?type=drug&title=Citrate-Free%20Mirikizumab&subtitle=Citrate-Free%20Mirikizumab%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Citrate-Free Mirikizumab Citrate-Free Mirikizumab · Eli Lilly and Company https://druglandscape.com/drug/cj-023-423 https://druglandscape.com/api/og?type=drug&title=CJ-023%2C423&subtitle=CJ-023%2C423%20%C2%B7%20Pfizer&badge=phase%201 CJ-023,423 CJ-023,423 · Pfizer https://druglandscape.com/drug/cj-12406 https://druglandscape.com/api/og?type=drug&title=CJ-12406&subtitle=CJ-12406%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 CJ-12406 CJ-12406 · HK inno.N Corporation https://druglandscape.com/drug/cj-12420 https://druglandscape.com/api/og?type=drug&title=CJ-12420&subtitle=CJ-12420%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%202 CJ-12420 CJ-12420 · HK inno.N Corporation https://druglandscape.com/drug/cj-30039 https://druglandscape.com/api/og?type=drug&title=CJ-30039&subtitle=CJ-30039%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 CJ-30039 CJ-30039 · HK inno.N Corporation https://druglandscape.com/drug/cj-30044 https://druglandscape.com/api/og?type=drug&title=CJ-30044&subtitle=CJ-30044%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 CJ-30044 CJ-30044 · HK inno.N Corporation https://druglandscape.com/drug/cj-30060 https://druglandscape.com/api/og?type=drug&title=CJ-30060&subtitle=CJ-30060%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 CJ-30060 CJ-30060 · HK inno.N Corporation https://druglandscape.com/drug/cj-40010-bivalent-vaccine-e-dose https://druglandscape.com/api/og?type=drug&title=CJ-40010%20Bivalent%20vaccine%20E%20dose&subtitle=CJ-40010%20Bivalent%20vaccine%20E%20dose%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 CJ-40010 Bivalent vaccine E dose CJ-40010 Bivalent vaccine E dose · HK inno.N Corporation https://druglandscape.com/drug/cj-40010-bivalent-vaccine-high-dose https://druglandscape.com/api/og?type=drug&title=CJ-40010%20Bivalent%20vaccine%20high%20dose&subtitle=CJ-40010%20Bivalent%20vaccine%20high%20dose%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 CJ-40010 Bivalent vaccine high dose CJ-40010 Bivalent vaccine high dose · HK inno.N Corporation https://druglandscape.com/drug/cj-40010-cva16-vaccine-d-dose https://druglandscape.com/api/og?type=drug&title=CJ-40010%20CVA16%20vaccine%20D%20dose&subtitle=CJ-40010%20CVA16%20vaccine%20D%20dose%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 CJ-40010 CVA16 vaccine D dose CJ-40010 CVA16 vaccine D dose · HK inno.N Corporation https://druglandscape.com/drug/cj-40010-ev71-vaccine-a-dose https://druglandscape.com/api/og?type=drug&title=CJ-40010%20EV71%20vaccine%20A%20dose&subtitle=CJ-40010%20EV71%20vaccine%20A%20dose%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 CJ-40010 EV71 vaccine A dose CJ-40010 EV71 vaccine A dose · HK inno.N Corporation https://druglandscape.com/drug/cj-40010-ev71-vaccine-b-dose https://druglandscape.com/api/og?type=drug&title=CJ-40010%20EV71%20vaccine%20B%20dose&subtitle=CJ-40010%20EV71%20vaccine%20B%20dose%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 CJ-40010 EV71 vaccine B dose CJ-40010 EV71 vaccine B dose · HK inno.N Corporation https://druglandscape.com/drug/cj-imatinib-mesylate-tablet https://druglandscape.com/api/og?type=drug&title=CJ%20Imatinib%20mesylate%20tablet&subtitle=CJ%20Imatinib%20mesylate%20tablet%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 CJ Imatinib mesylate tablet CJ Imatinib mesylate tablet · HK inno.N Corporation https://druglandscape.com/drug/cjrb-101 https://druglandscape.com/api/og?type=drug&title=CJRB-101&subtitle=CJRB-101%20%C2%B7%20CJ%20Bioscience%2C%20Inc.&badge=phase%201 CJRB-101 CJRB-101 · CJ Bioscience, Inc. https://druglandscape.com/drug/ck-101 https://druglandscape.com/api/og?type=drug&title=CK-101&subtitle=CK-101%20%C2%B7%20Checkpoint%20Therapeutics%2C%20Inc.&badge=phase%201 CK-101 CK-101 · Checkpoint Therapeutics, Inc. https://druglandscape.com/drug/ck-3773274-granules-in-capsule https://druglandscape.com/api/og?type=drug&title=CK-3773274%20-%20Granules%20in%20Capsule&subtitle=CK-3773274%20-%20Granules%20in%20Capsule%20%C2%B7%20Cytokinetics&badge=phase%201 CK-3773274 - Granules in Capsule CK-3773274 - Granules in Capsule · Cytokinetics https://druglandscape.com/drug/ck-3773274-tablets https://druglandscape.com/api/og?type=drug&title=CK-3773274%20-%20Tablets&subtitle=CK-3773274%20-%20Tablets%20%C2%B7%20Cytokinetics&badge=phase%201 CK-3773274 - Tablets CK-3773274 - Tablets · Cytokinetics https://druglandscape.com/drug/ck-4021586 https://druglandscape.com/api/og?type=drug&title=CK-4021586&subtitle=CK-4021586%20%C2%B7%20Cytokinetics&badge=phase%201 CK-4021586 CK-4021586 · Cytokinetics https://druglandscape.com/drug/ck0801 https://druglandscape.com/api/og?type=drug&title=CK0801&subtitle=CK0801%20%C2%B7%20Cellenkos%2C%20Inc.&badge=phase%201 CK0801 CK0801 · Cellenkos, Inc. https://druglandscape.com/drug/ck0802 https://druglandscape.com/api/og?type=drug&title=CK0802&subtitle=CK0802%20%C2%B7%20Cellenkos%2C%20Inc.&badge=phase%201 CK0802 CK0802 · Cellenkos, Inc. https://druglandscape.com/drug/ck0804 https://druglandscape.com/api/og?type=drug&title=CK0804&subtitle=CK0804%20%C2%B7%20Cellenkos%2C%20Inc.&badge=phase%201 CK0804 CK0804 · Cellenkos, Inc. https://druglandscape.com/drug/ckd-320-d012 https://druglandscape.com/api/og?type=drug&title=CKD-320%2C%20D012&subtitle=CKD-320%2C%20D012%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-320, D012 CKD-320, D012 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-330-1-tab-and-d085-1-tab https://druglandscape.com/api/og?type=drug&title=CKD-330%201%20Tab.%20and%20D085%201%20Tab.&subtitle=CKD-330%201%20Tab.%20and%20D085%201%20Tab.%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-330 1 Tab. and D085 1 Tab. CKD-330 1 Tab. and D085 1 Tab. · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-330-tab-and-d086-tab https://druglandscape.com/api/og?type=drug&title=CKD-330%20Tab.%20and%20D086%20Tab.&subtitle=CKD-330%20Tab.%20and%20D086%20Tab.%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-330 Tab. and D086 Tab. CKD-330 Tab. and D086 Tab. · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-330-tab-and-d090-tab https://druglandscape.com/api/og?type=drug&title=CKD-330%20Tab.%20and%20D090%20Tab.&subtitle=CKD-330%20Tab.%20and%20D090%20Tab.%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-330 Tab. and D090 Tab. CKD-330 Tab. and D090 Tab. · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-331-d337 https://druglandscape.com/api/og?type=drug&title=CKD-331%2C%20D337&subtitle=CKD-331%2C%20D337%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-331, D337 CKD-331, D337 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-333-1-tab https://druglandscape.com/api/og?type=drug&title=CKD-333%201%20Tab&subtitle=CKD-333%201%20Tab%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-333 1 Tab CKD-333 1 Tab · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-333-formula-i https://druglandscape.com/api/og?type=drug&title=CKD-333%2C%20formula%20I&subtitle=CKD-333%2C%20formula%20I%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-333, formula I CKD-333, formula I · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-337 https://druglandscape.com/api/og?type=drug&title=CKD-337&subtitle=CKD-337%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-337 CKD-337 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-341-d956 https://druglandscape.com/api/og?type=drug&title=CKD-341%2C%20D956&subtitle=CKD-341%2C%20D956%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-341, D956 CKD-341, D956 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-341-d958 https://druglandscape.com/api/og?type=drug&title=CKD-341%2C%20D958&subtitle=CKD-341%2C%20D958%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-341, D958 CKD-341, D958 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-344 https://druglandscape.com/api/og?type=drug&title=CKD-344&subtitle=CKD-344%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-344 CKD-344 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-348-f1-ckd-348-f2-ckd-828-d326-d337 https://druglandscape.com/api/og?type=drug&title=CKD-348%20F1%2C%20CKD-348%20F2%2C%20CKD-828%2C%20D326%2C%20D337&subtitle=CKD-348%20F1%2C%20CKD-348%20F2%2C%20CKD-828%2C%20D326%2C%20D337%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-348 F1, CKD-348 F2, CKD-828, D326, D337 CKD-348 F1, CKD-348 F2, CKD-828, D326, D337 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-348-t1-ckd-348-t2-ckd-828-d097-d337 https://druglandscape.com/api/og?type=drug&title=CKD-348%20T1%2C%20CKD-348%20T2%2C%20CKD-828%2C%20D097%2C%20D337%2C&subtitle=CKD-348%20T1%2C%20CKD-348%20T2%2C%20CKD-828%2C%20D097%2C%20D337%2C%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-348 T1, CKD-348 T2, CKD-828, D097, D337, CKD-348 T1, CKD-348 T2, CKD-828, D097, D337, · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-349 https://druglandscape.com/api/og?type=drug&title=CKD-349&subtitle=CKD-349%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-349 CKD-349 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-349-f1-tab https://druglandscape.com/api/og?type=drug&title=CKD-349%20F1%20Tab.&subtitle=CKD-349%20F1%20Tab.%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-349 F1 Tab. CKD-349 F1 Tab. · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-349-f2-tab https://druglandscape.com/api/og?type=drug&title=CKD-349%20F2%20Tab.&subtitle=CKD-349%20F2%20Tab.%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-349 F2 Tab. CKD-349 F2 Tab. · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-378-qd-po https://druglandscape.com/api/og?type=drug&title=CKD-378%2C%20QD%2C%20PO&subtitle=CKD-378%2C%20QD%2C%20PO%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-378, QD, PO CKD-378, QD, PO · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-378-qd-po-drug-d745-d150-qd-po https://druglandscape.com/api/og?type=drug&title=CKD-378%2C%20QD%2C%20PO%20Drug%3A%20D745%2C%20D150%2C%20QD%2C%20PO&subtitle=CKD-378%2C%20QD%2C%20PO%20Drug%3A%20D745%2C%20D150%2C%20QD%2C%20PO%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-378, QD, PO Drug: D745, D150, QD, PO CKD-378, QD, PO Drug: D745, D150, QD, PO · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-379-i https://druglandscape.com/api/og?type=drug&title=CKD-379%20I&subtitle=CKD-379%20I%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-379 I CKD-379 I · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-382-d860-d027 https://druglandscape.com/api/og?type=drug&title=CKD-382%2C%20D860%2C%20D027&subtitle=CKD-382%2C%20D860%2C%20D027%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-382, D860, D027 CKD-382, D860, D027 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-385 https://druglandscape.com/api/og?type=drug&title=CKD-385&subtitle=CKD-385%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-385 CKD-385 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-385-tab-1t https://druglandscape.com/api/og?type=drug&title=CKD-385%20Tab.%201T&subtitle=CKD-385%20Tab.%201T%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-385 Tab. 1T CKD-385 Tab. 1T · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-386 https://druglandscape.com/api/og?type=drug&title=CKD-386&subtitle=CKD-386%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-386 CKD-386 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-388-tab https://druglandscape.com/api/og?type=drug&title=CKD-388%20Tab.&subtitle=CKD-388%20Tab.%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-388 Tab. CKD-388 Tab. · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-391 https://druglandscape.com/api/og?type=drug&title=CKD-391&subtitle=CKD-391%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-391 CKD-391 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-393 https://druglandscape.com/api/og?type=drug&title=CKD-393&subtitle=CKD-393%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-393 CKD-393 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-393-formulation-i https://druglandscape.com/api/og?type=drug&title=CKD-393%20formulation%20I&subtitle=CKD-393%20formulation%20I%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-393 formulation I CKD-393 formulation I · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-393-formulation-ii https://druglandscape.com/api/og?type=drug&title=CKD-393%20formulation%20II&subtitle=CKD-393%20formulation%20II%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-393 formulation II CKD-393 formulation II · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-396 https://druglandscape.com/api/og?type=drug&title=CKD-396&subtitle=CKD-396%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-396 CKD-396 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-397 https://druglandscape.com/api/og?type=drug&title=CKD-397&subtitle=CKD-397%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-397 CKD-397 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-4101-tablet https://druglandscape.com/api/og?type=drug&title=CKD-4101%20tablet&subtitle=CKD-4101%20tablet%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-4101 tablet CKD-4101 tablet · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-501-amlodipine https://druglandscape.com/api/og?type=drug&title=CKD-501%20amlodipine&subtitle=CKD-501%20amlodipine%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-501 amlodipine CKD-501 amlodipine · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-501-and-d759 https://druglandscape.com/api/og?type=drug&title=CKD-501%20and%20D759&subtitle=CKD-501%20and%20D759%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-501 and D759 CKD-501 and D759 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-501-d744-d150 https://druglandscape.com/api/og?type=drug&title=CKD-501%2C%20D744%2C%20D150&subtitle=CKD-501%2C%20D744%2C%20D150%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-501, D744, D150 CKD-501, D744, D150 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-501-d745 https://druglandscape.com/api/og?type=drug&title=CKD-501%2C%20D745&subtitle=CKD-501%2C%20D745%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-501, D745 CKD-501, D745 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-501-d745-d150 https://druglandscape.com/api/og?type=drug&title=CKD-501%2C%20D745%2C%20D150&subtitle=CKD-501%2C%20D745%2C%20D150%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-501, D745, D150 CKD-501, D745, D150 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-501-d745-d150-d029 https://druglandscape.com/api/og?type=drug&title=CKD-501%2C%20D745%2C%20D150%2C%20D029&subtitle=CKD-501%2C%20D745%2C%20D150%2C%20D029%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-501, D745, D150, D029 CKD-501, D745, D150, D029 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-501-d759-d150 https://druglandscape.com/api/og?type=drug&title=CKD-501%2C%20D759%2C%20D150&subtitle=CKD-501%2C%20D759%2C%20D150%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-501, D759, D150 CKD-501, D759, D150 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-501-d759-d150-d029 https://druglandscape.com/api/og?type=drug&title=CKD-501%2C%20D759%2C%20D150%2C%20D029&subtitle=CKD-501%2C%20D759%2C%20D150%2C%20D029%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-501, D759, D150, D029 CKD-501, D759, D150, D029 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-501-ketoconazole https://druglandscape.com/api/og?type=drug&title=CKD-501%2C%20Ketoconazole&subtitle=CKD-501%2C%20Ketoconazole%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-501, Ketoconazole CKD-501, Ketoconazole · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-504 https://druglandscape.com/api/og?type=drug&title=CKD-504&subtitle=CKD-504%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-504 CKD-504 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-506 https://druglandscape.com/api/og?type=drug&title=CKD-506&subtitle=CKD-506%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%202 CKD-506 CKD-506 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-508-tablet https://druglandscape.com/api/og?type=drug&title=CKD-508%20Tablet&subtitle=CKD-508%20Tablet%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-508 Tablet CKD-508 Tablet · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-510-food-effect https://druglandscape.com/api/og?type=drug&title=CKD-510%20food%20effect&subtitle=CKD-510%20food%20effect%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-510 food effect CKD-510 food effect · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-510-multiple-dose https://druglandscape.com/api/og?type=drug&title=CKD-510%20multiple%20dose&subtitle=CKD-510%20multiple%20dose%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-510 multiple dose CKD-510 multiple dose · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-510-single-dose https://druglandscape.com/api/og?type=drug&title=CKD-510%20single%20dose&subtitle=CKD-510%20single%20dose%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-510 single dose CKD-510 single dose · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-512 https://druglandscape.com/api/og?type=drug&title=CKD-512&subtitle=CKD-512%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-512 CKD-512 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-516-inj https://druglandscape.com/api/og?type=drug&title=CKD-516%20inj&subtitle=CKD-516%20inj%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-516 inj CKD-516 inj · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-519 https://druglandscape.com/api/og?type=drug&title=CKD-519&subtitle=CKD-519%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-519 CKD-519 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-704 https://druglandscape.com/api/og?type=drug&title=CKD-704&subtitle=CKD-704%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-704 CKD-704 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-810-taxotere-inj https://druglandscape.com/api/og?type=drug&title=CKD-810%2C%20Taxotere%20inj.&subtitle=CKD-810%2C%20Taxotere%20inj.%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-810, Taxotere inj. CKD-810, Taxotere inj. · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-828-d064-d701 https://druglandscape.com/api/og?type=drug&title=CKD-828%2C%20D064%2C%20D701&subtitle=CKD-828%2C%20D064%2C%20D701%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-828, D064, D701 CKD-828, D064, D701 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-828-d064-d702 https://druglandscape.com/api/og?type=drug&title=CKD-828%2C%20D064%2C%20D702&subtitle=CKD-828%2C%20D064%2C%20D702%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-828, D064, D702 CKD-828, D064, D702 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-828-d097-d337 https://druglandscape.com/api/og?type=drug&title=CKD-828%2C%20D097%2C%20D337&subtitle=CKD-828%2C%20D097%2C%20D337%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-828, D097, D337 CKD-828, D097, D337 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-828-d097-d337-ckd-348-t1-ckd-348-t2 https://druglandscape.com/api/og?type=drug&title=CKD-828%2C%20D097%2C%20D337%2C%20CKD-348%20T1%2C%20CKD-348%20T2&subtitle=CKD-828%2C%20D097%2C%20D337%2C%20CKD-348%20T1%2C%20CKD-348%20T2%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-828, D097, D337, CKD-348 T1, CKD-348 T2 CKD-828, D097, D337, CKD-348 T1, CKD-348 T2 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-841 https://druglandscape.com/api/og?type=drug&title=CKD-841&subtitle=CKD-841%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-841 CKD-841 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-843-b https://druglandscape.com/api/og?type=drug&title=CKD-843%20B&subtitle=CKD-843%20B%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-843 B CKD-843 B · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-843-r https://druglandscape.com/api/og?type=drug&title=CKD-843-R&subtitle=CKD-843-R%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-843-R CKD-843-R · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-845 https://druglandscape.com/api/og?type=drug&title=CKD-845&subtitle=CKD-845%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-845 CKD-845 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckd-846 https://druglandscape.com/api/og?type=drug&title=CKD-846&subtitle=CKD-846%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 CKD-846 CKD-846 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/ckdb-501b https://druglandscape.com/api/og?type=drug&title=CKDB-501B&subtitle=CKDB-501B%20%C2%B7%20CKD%20Bio%20Corporation&badge=phase%201 CKDB-501B CKDB-501B · CKD Bio Corporation https://druglandscape.com/drug/ckr-051-dose-1 https://druglandscape.com/api/og?type=drug&title=CKR-051%20Dose%201&subtitle=CKR-051%20Dose%201%20%C2%B7%20CK%20Regeon%20Inc.&badge=phase%201 CKR-051 Dose 1 CKR-051 Dose 1 · CK Regeon Inc. https://druglandscape.com/drug/cl-sys-flavored-rinse https://druglandscape.com/api/og?type=drug&title=Cl%C5%8DSYS%C2%AE%20Flavored%20Rinse&subtitle=Cl%C5%8DSYS%C2%AE%20Flavored%20Rinse%20%C2%B7%20Rowpar%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ClōSYS® Flavored Rinse ClōSYS® Flavored Rinse · Rowpar Pharmaceuticals, Inc. https://druglandscape.com/drug/cl-sys-unflavored-rinse https://druglandscape.com/api/og?type=drug&title=Cl%C5%8DSYS%C2%AE%20Unflavored%20Rinse&subtitle=Cl%C5%8DSYS%C2%AE%20Unflavored%20Rinse%20%C2%B7%20Rowpar%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ClōSYS® Unflavored Rinse ClōSYS® Unflavored Rinse · Rowpar Pharmaceuticals, Inc. https://druglandscape.com/drug/clade-c-gp140-plus-adjuvant https://druglandscape.com/api/og?type=drug&title=Clade%20C%20gp140%20plus%20adjuvant&subtitle=Clade%20C%20gp140%20plus%20adjuvant%20%C2%B7%20Janssen%20Vaccines%20%26%20Prevention%20B.V.&badge=phase%201 Clade C gp140 plus adjuvant Clade C gp140 plus adjuvant · Janssen Vaccines & Prevention B.V. https://druglandscape.com/drug/clarithromycin-oral-high-dose https://druglandscape.com/api/og?type=drug&title=clarithromycin%2C%20oral%2C%20high%20dose&subtitle=clarithromycin%2C%20oral%2C%20high%20dose%20%C2%B7%20Andres%20J.%20M.%20Ferreri&badge=phase%202 clarithromycin, oral, high dose clarithromycin, oral, high dose · Andres J. M. Ferreri https://druglandscape.com/drug/classic-dmards-treatment-group https://druglandscape.com/api/og?type=drug&title=Classic%20DMARDs%20treatment%20group&subtitle=Classic%20DMARDs%20treatment%20group%20%C2%B7%20Zhang%2C%20Xiao%2C%20M.D.&badge=phase%201 Classic DMARDs treatment group Classic DMARDs treatment group · Zhang, Xiao, M.D. https://druglandscape.com/drug/claudin-18-2-car-t https://druglandscape.com/api/og?type=drug&title=Claudin%2018.2%20CAR-T&subtitle=Claudin%2018.2%20CAR-T%20%C2%B7%20Suzhou%20Immunofoco%20Biotechnology%20Co.%2C%20Ltd&badge=phase%201 Claudin 18.2 CAR-T Claudin 18.2 CAR-T · Suzhou Immunofoco Biotechnology Co., Ltd https://druglandscape.com/drug/claudin18-2-car-t https://druglandscape.com/api/og?type=drug&title=claudin18.2%20CAR-T&subtitle=claudin18.2%20CAR-T%20%C2%B7%20Chengdu%20Ucello%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 claudin18.2 CAR-T claudin18.2 CAR-T · Chengdu Ucello Biotechnology Co., Ltd. https://druglandscape.com/drug/clbs03-low-dose https://druglandscape.com/api/og?type=drug&title=CLBS03%20Low%20Dose&subtitle=CLBS03%20Low%20Dose%20%C2%B7%20Lisata%20Therapeutics%2C%20Inc.&badge=phase%202 CLBS03 Low Dose CLBS03 Low Dose · Lisata Therapeutics, Inc. https://druglandscape.com/drug/clbs201 https://druglandscape.com/api/og?type=drug&title=CLBS201&subtitle=CLBS201%20%C2%B7%20Lisata%20Therapeutics%2C%20Inc.&badge=phase%201 CLBS201 CLBS201 · Lisata Therapeutics, Inc. https://druglandscape.com/drug/cldn6-car-t https://druglandscape.com/api/og?type=drug&title=CLDN6%20CAR-T&subtitle=CLDN6%20CAR-T%20%C2%B7%20BioNTech%20Cell%20%26%20Gene%20Therapies%20GmbH&badge=phase%202 CLDN6 CAR-T CLDN6 CAR-T · BioNTech Cell & Gene Therapies GmbH https://druglandscape.com/drug/cle-400 https://druglandscape.com/api/og?type=drug&title=CLE-400&subtitle=CLE-400%20%C2%B7%20Clexio%20Biosciences%20Ltd.&badge=phase%202 CLE-400 CLE-400 · Clexio Biosciences Ltd. https://druglandscape.com/drug/clf065 https://druglandscape.com/api/og?type=drug&title=CLF065&subtitle=CLF065%20%C2%B7%20Calibr%2C%20a%20division%20of%20Scripps%20Research&badge=phase%202 CLF065 CLF065 · Calibr, a division of Scripps Research https://druglandscape.com/drug/clifutinib-with-fasted-state https://druglandscape.com/api/og?type=drug&title=Clifutinib%20with%20fasted%20state&subtitle=Clifutinib%20with%20fasted%20state%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 Clifutinib with fasted state Clifutinib with fasted state · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/clifutinib-with-fed-state https://druglandscape.com/api/og?type=drug&title=Clifutinib%20with%20fed%20state&subtitle=Clifutinib%20with%20fed%20state%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 Clifutinib with fed state Clifutinib with fed state · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/clindamycin-1-lotion-formulation https://druglandscape.com/api/og?type=drug&title=Clindamycin%201%25%20lotion%20formulation%3A&subtitle=Clindamycin%201%25%20lotion%20formulation%3A%20%C2%B7%20Centre%20for%20Human%20Drug%20Research%2C%20Netherlands&badge=phase%201 Clindamycin 1% lotion formulation: Clindamycin 1% lotion formulation: · Centre for Human Drug Research, Netherlands https://druglandscape.com/drug/clindamycin-1-topical-lotion https://druglandscape.com/api/og?type=drug&title=Clindamycin%201%20%25%20Topical%20Lotion&subtitle=Clindamycin%201%20%25%20Topical%20Lotion%20%C2%B7%20Erasmus%20Medical%20Center&badge=phase%201 Clindamycin 1 % Topical Lotion Clindamycin 1 % Topical Lotion · Erasmus Medical Center https://druglandscape.com/drug/clindamycin-2-in-hydrocortisone-1-lotion https://druglandscape.com/api/og?type=drug&title=Clindamycin%202%25%20in%20hydrocortisone%201%25%20lotion&subtitle=Clindamycin%202%25%20in%20hydrocortisone%201%25%20lotion%20%C2%B7%20British%20Columbia%20Cancer%20Agency&badge=phase%202 Clindamycin 2% in hydrocortisone 1% lotion Clindamycin 2% in hydrocortisone 1% lotion · British Columbia Cancer Agency https://druglandscape.com/drug/clindamycin-and-benzoyl-peroxide-gel-1-5 https://druglandscape.com/api/og?type=drug&title=Clindamycin%20and%20Benzoyl%20Peroxide%20Gel%201%255%25&subtitle=Clindamycin%20and%20Benzoyl%20Peroxide%20Gel%201%255%25%20%C2%B7%20Sun%20Pharmaceutical%20Industries%2C%20Inc.&badge=phase%201 Clindamycin and Benzoyl Peroxide Gel 1%5% Clindamycin and Benzoyl Peroxide Gel 1%5% · Sun Pharmaceutical Industries, Inc. https://druglandscape.com/drug/clindamycin-and-rifampicin-dosages https://druglandscape.com/api/og?type=drug&title=Clindamycin%20and%20rifampicin%20dosages&subtitle=Clindamycin%20and%20rifampicin%20dosages%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Clindamycin and rifampicin dosages Clindamycin and rifampicin dosages · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/clinic-and-neuropsychologic-evaluation https://druglandscape.com/api/og?type=drug&title=Clinic%20and%20neuropsychologic%20evaluation&subtitle=Clinic%20and%20neuropsychologic%20evaluation%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 Clinic and neuropsychologic evaluation Clinic and neuropsychologic evaluation · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/clinical-assessment https://druglandscape.com/api/og?type=drug&title=clinical%20assessment&subtitle=clinical%20assessment%20%C2%B7%20Poitiers%20University%20Hospital&badge=phase%203 clinical assessment clinical assessment · Poitiers University Hospital https://druglandscape.com/drug/cll-1-car-t-cells https://druglandscape.com/api/og?type=drug&title=CLL-1.CAR%20T%20cells&subtitle=CLL-1.CAR%20T%20cells%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 CLL-1.CAR T cells CLL-1.CAR T cells · Baylor College of Medicine https://druglandscape.com/drug/cll1-cd33-ccar-t-cells https://druglandscape.com/api/og?type=drug&title=CLL1-CD33%20cCAR%20T%20cells&subtitle=CLL1-CD33%20cCAR%20T%20cells%20%C2%B7%20iCell%20Gene%20Therapeutics&badge=phase%201 CLL1-CD33 cCAR T cells CLL1-CD33 cCAR T cells · iCell Gene Therapeutics https://druglandscape.com/drug/clls52 https://druglandscape.com/api/og?type=drug&title=CLLS52&subtitle=CLLS52%20%C2%B7%20Cellectis%20S.A.&badge=phase%201 CLLS52 CLLS52 · Cellectis S.A. https://druglandscape.com/drug/clm-original https://druglandscape.com/api/og?type=drug&title=CLM%20Original&subtitle=CLM%20Original%20%C2%B7%20HALEON&badge=phase%201 CLM Original CLM Original · HALEON https://druglandscape.com/drug/cln-049 https://druglandscape.com/api/og?type=drug&title=CLN-049&subtitle=CLN-049%20%C2%B7%20Cullinan%20Therapeutics%20Inc.&badge=phase%201 CLN-049 CLN-049 · Cullinan Therapeutics Inc. https://druglandscape.com/drug/cln-617 https://druglandscape.com/api/og?type=drug&title=CLN-617&subtitle=CLN-617%20%C2%B7%20Cullinan%20Therapeutics%20Inc.&badge=phase%201 CLN-617 CLN-617 · Cullinan Therapeutics Inc. https://druglandscape.com/drug/cln-619 https://druglandscape.com/api/og?type=drug&title=CLN-619&subtitle=CLN-619%20%C2%B7%20Cullinan%20Therapeutics%20Inc.&badge=phase%201 CLN-619 CLN-619 · Cullinan Therapeutics Inc. https://druglandscape.com/drug/clobetasol-propionate-0-05-lotion https://druglandscape.com/api/og?type=drug&title=Clobetasol%20Propionate%200.05%25%20Lotion&subtitle=Clobetasol%20Propionate%200.05%25%20Lotion%20%C2%B7%20MC2%20Therapeutics&badge=phase%201 Clobetasol Propionate 0.05% Lotion Clobetasol Propionate 0.05% Lotion · MC2 Therapeutics https://druglandscape.com/drug/clofarabine-cyclophosphamide https://druglandscape.com/api/og?type=drug&title=Clofarabine%2C%20Cyclophosphamide&subtitle=Clofarabine%2C%20Cyclophosphamide%20%C2%B7%20Gruppo%20Italiano%20Malattie%20EMatologiche%20dell'Adulto&badge=phase%202 Clofarabine, Cyclophosphamide Clofarabine, Cyclophosphamide · Gruppo Italiano Malattie EMatologiche dell'Adulto https://druglandscape.com/drug/clofarabine-cytarabine-idarubicin https://druglandscape.com/api/og?type=drug&title=clofarabine%2C%20cytarabine%2C%20idarubicin&subtitle=clofarabine%2C%20cytarabine%2C%20idarubicin%20%C2%B7%20Hannover%20Medical%20School&badge=phase%201 clofarabine, cytarabine, idarubicin clofarabine, cytarabine, idarubicin · Hannover Medical School https://druglandscape.com/drug/clofibrate-clofibrate https://druglandscape.com/api/og?type=drug&title=clofibrate%20clofibrate&subtitle=clofibrate%20clofibrate%20%C2%B7%20National%20Heart%2C%20Lung%2C%20and%20Blood%20Institute%20(NHLBI)&badge=phase%203 clofibrate clofibrate clofibrate clofibrate · National Heart, Lung, and Blood Institute (NHLBI) https://druglandscape.com/drug/clomid-respatio-and-ethinyl-estradiol https://druglandscape.com/api/og?type=drug&title=Clomid%2C%20Respatio%20and%20Ethinyl%20estradiol&subtitle=Clomid%2C%20Respatio%20and%20Ethinyl%20estradiol%20%C2%B7%20Nesreen%20Abdel%20Fattah%20Abdullah%20Shehata&badge=phase%201 Clomid, Respatio and Ethinyl estradiol Clomid, Respatio and Ethinyl estradiol · Nesreen Abdel Fattah Abdullah Shehata https://druglandscape.com/drug/clomiphene-and-clarithromycin https://druglandscape.com/api/og?type=drug&title=clomiphene%20and%20clarithromycin&subtitle=clomiphene%20and%20clarithromycin%20%C2%B7%20Robert%20Bosch%20Gesellschaft%20f%C3%BCr%20Medizinische%20Forschung%20mbH%20(RBMF)&badge=phase%201 clomiphene and clarithromycin clomiphene and clarithromycin · Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) https://druglandscape.com/drug/clomiphene-and-paroxetine https://druglandscape.com/api/og?type=drug&title=clomiphene%20and%20paroxetine&subtitle=clomiphene%20and%20paroxetine%20%C2%B7%20Robert%20Bosch%20Gesellschaft%20f%C3%BCr%20Medizinische%20Forschung%20mbH%20(RBMF)&badge=phase%201 clomiphene and paroxetine clomiphene and paroxetine · Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) https://druglandscape.com/drug/clomiphene-citrate-ufsh-arm https://druglandscape.com/api/og?type=drug&title=clomiphene%20citrate-uFSH%20arm&subtitle=clomiphene%20citrate-uFSH%20arm%20%C2%B7%20Mansoura%20Integrated%20Fertility%20Center&badge=phase%201 clomiphene citrate-uFSH arm clomiphene citrate-uFSH arm · Mansoura Integrated Fertility Center https://druglandscape.com/drug/clomiphine-citrate-plus-low-dose-ufsh https://druglandscape.com/api/og?type=drug&title=Clomiphine%20citrate%20plus%20low%20dose%20uFSH&subtitle=Clomiphine%20citrate%20plus%20low%20dose%20uFSH%20%C2%B7%20Mansoura%20Integrated%20Fertility%20Center&badge=phase%201 Clomiphine citrate plus low dose uFSH Clomiphine citrate plus low dose uFSH · Mansoura Integrated Fertility Center https://druglandscape.com/drug/clop-f1 https://druglandscape.com/api/og?type=drug&title=Clop%20F1&subtitle=Clop%20F1%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Clop F1 Clop F1 · GlaxoSmithKline https://druglandscape.com/drug/clop-f2 https://druglandscape.com/api/og?type=drug&title=Clop%20F2&subtitle=Clop%20F2%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Clop F2 Clop F2 · GlaxoSmithKline https://druglandscape.com/drug/clopidogrel-and-dexlansoprazole https://druglandscape.com/api/og?type=drug&title=Clopidogrel%20and%20Dexlansoprazole&subtitle=Clopidogrel%20and%20Dexlansoprazole%20%C2%B7%20Takeda&badge=phase%201 Clopidogrel and Dexlansoprazole Clopidogrel and Dexlansoprazole · Takeda https://druglandscape.com/drug/clopidogrel-and-esomeprazole https://druglandscape.com/api/og?type=drug&title=Clopidogrel%20and%20Esomeprazole&subtitle=Clopidogrel%20and%20Esomeprazole%20%C2%B7%20Takeda&badge=phase%201 Clopidogrel and Esomeprazole Clopidogrel and Esomeprazole · Takeda https://druglandscape.com/drug/clopidogrel-and-lansoprazole https://druglandscape.com/api/og?type=drug&title=Clopidogrel%20and%20Lansoprazole&subtitle=Clopidogrel%20and%20Lansoprazole%20%C2%B7%20Takeda&badge=phase%201 Clopidogrel and Lansoprazole Clopidogrel and Lansoprazole · Takeda https://druglandscape.com/drug/clopidogrel-and-omeprazole https://druglandscape.com/api/og?type=drug&title=Clopidogrel%20and%20Omeprazole&subtitle=Clopidogrel%20and%20Omeprazole%20%C2%B7%20Takeda&badge=phase%201 Clopidogrel and Omeprazole Clopidogrel and Omeprazole · Takeda https://druglandscape.com/drug/clorhexidine-dental-phb https://druglandscape.com/api/og?type=drug&title=Clorhexidine%20Dental%20PHB%C2%A9&subtitle=Clorhexidine%20Dental%20PHB%C2%A9%20%C2%B7%20Fundaci%C3%B3n%20para%20el%20Fomento%20de%20la%20Investigaci%C3%B3n%20Sanitaria%20y%20Biom%C3%A9dica%20de%20la&badge=phase%201 Clorhexidine Dental PHB© Clorhexidine Dental PHB© · Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana https://druglandscape.com/drug/clostridium-difficile-toxoid-vaccine https://druglandscape.com/api/og?type=drug&title=Clostridium%20difficile%20Toxoid%20Vaccine&subtitle=Clostridium%20difficile%20Toxoid%20Vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%202 Clostridium difficile Toxoid Vaccine Clostridium difficile Toxoid Vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/clotrimazole-varnish https://druglandscape.com/api/og?type=drug&title=Clotrimazole%20varnish&subtitle=Clotrimazole%20varnish%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%202 Clotrimazole varnish Clotrimazole varnish · Hadassah Medical Organization https://druglandscape.com/drug/clpg-topical-gel-1 https://druglandscape.com/api/og?type=drug&title=CLPG%20Topical%20Gel%201%25&subtitle=CLPG%20Topical%20Gel%201%25%20%C2%B7%20Sun%20Pharmaceutical%20Industries%2C%20Inc.&badge=phase%201 CLPG Topical Gel 1% CLPG Topical Gel 1% · Sun Pharmaceutical Industries, Inc. https://druglandscape.com/drug/clr-125 https://druglandscape.com/api/og?type=drug&title=CLR%20125&subtitle=CLR%20125%20%C2%B7%20Cellectar%20Biosciences%2C%20Inc.&badge=phase%201 CLR 125 CLR 125 · Cellectar Biosciences, Inc. https://druglandscape.com/drug/cls12311-high https://druglandscape.com/api/og?type=drug&title=CLS12311%20high&subtitle=CLS12311%20high%20%C2%B7%20Cellerys%20AG&badge=phase%201 CLS12311 high CLS12311 high · Cellerys AG https://druglandscape.com/drug/cls12311-low https://druglandscape.com/api/og?type=drug&title=CLS12311%20low&subtitle=CLS12311%20low%20%C2%B7%20Cellerys%20AG&badge=phase%201 CLS12311 low CLS12311 low · Cellerys AG https://druglandscape.com/drug/cls12311-medium https://druglandscape.com/api/og?type=drug&title=CLS12311%20medium&subtitle=CLS12311%20medium%20%C2%B7%20Cellerys%20AG&badge=phase%201 CLS12311 medium CLS12311 medium · Cellerys AG https://druglandscape.com/drug/clsp-1025 https://druglandscape.com/api/og?type=drug&title=CLSP-1025&subtitle=CLSP-1025%20%C2%B7%20Clasp%20Therapeutics%2C%20Inc.&badge=phase%201 CLSP-1025 CLSP-1025 · Clasp Therapeutics, Inc. https://druglandscape.com/drug/clusters-of-autologous-dermal-fibroblasts https://druglandscape.com/api/og?type=drug&title=Clusters%20of%20Autologous%20Dermal%20Fibroblasts&subtitle=Clusters%20of%20Autologous%20Dermal%20Fibroblasts%20%C2%B7%20S.Biomedics%20Co.%2C%20Ltd.&badge=phase%201 Clusters of Autologous Dermal Fibroblasts Clusters of Autologous Dermal Fibroblasts · S.Biomedics Co., Ltd. https://druglandscape.com/drug/clym116 https://druglandscape.com/api/og?type=drug&title=CLYM116&subtitle=CLYM116%20%C2%B7%20Climb%20Bio%2C%20Inc.&badge=phase%201 CLYM116 CLYM116 · Climb Bio, Inc. https://druglandscape.com/drug/cm-24-and-nivolumab-dose-escalation https://druglandscape.com/api/og?type=drug&title=CM-24%20and%20Nivolumab%20-%20Dose%20Escalation&subtitle=CM-24%20and%20Nivolumab%20-%20Dose%20Escalation%20%C2%B7%20Famewave%20Ltd.&badge=phase%201 CM-24 and Nivolumab - Dose Escalation CM-24 and Nivolumab - Dose Escalation · Famewave Ltd. https://druglandscape.com/drug/cm-cs1-t-cell-infusion https://druglandscape.com/api/og?type=drug&title=CM-CS1%20T-cell%20infusion&subtitle=CM-CS1%20T-cell%20infusion%20%C2%B7%20Celyad%20Oncology%20SA&badge=phase%201 CM-CS1 T-cell infusion CM-CS1 T-cell infusion · Celyad Oncology SA https://druglandscape.com/drug/cm082-plus-paclitaxel https://druglandscape.com/api/og?type=drug&title=CM082%20plus%20paclitaxel&subtitle=CM082%20plus%20paclitaxel%20%C2%B7%20AnewPharma&badge=phase%201 CM082 plus paclitaxel CM082 plus paclitaxel · AnewPharma https://druglandscape.com/drug/cm082-with-fed-or-fasting https://druglandscape.com/api/og?type=drug&title=CM082%20with%20fed%20or%20fasting&subtitle=CM082%20with%20fed%20or%20fasting%20%C2%B7%20AnewPharma&badge=phase%201 CM082 with fed or fasting CM082 with fed or fasting · AnewPharma https://druglandscape.com/drug/cm3-1-ac100 https://druglandscape.com/api/og?type=drug&title=CM3.1-AC100&subtitle=CM3.1-AC100%20%C2%B7%20CellMed%20AG%2C%20a%20subsidiary%20of%20BTG%20plc.&badge=phase%201 CM3.1-AC100 CM3.1-AC100 · CellMed AG, a subsidiary of BTG plc. https://druglandscape.com/drug/cm336-group-3a https://druglandscape.com/api/og?type=drug&title=CM336_group%203a&subtitle=CM336_group%203a%20%C2%B7%20Keymed%20Biosciences%20Co.Ltd&badge=phase%201 CM336_group 3a CM336_group 3a · Keymed Biosciences Co.Ltd https://druglandscape.com/drug/cm336-group-3b https://druglandscape.com/api/og?type=drug&title=CM336_group%203b&subtitle=CM336_group%203b%20%C2%B7%20Keymed%20Biosciences%20Co.Ltd&badge=phase%201 CM336_group 3b CM336_group 3b · Keymed Biosciences Co.Ltd https://druglandscape.com/drug/cm336-group-4a https://druglandscape.com/api/og?type=drug&title=CM336_group%204a&subtitle=CM336_group%204a%20%C2%B7%20Keymed%20Biosciences%20Co.Ltd&badge=phase%201 CM336_group 4a CM336_group 4a · Keymed Biosciences Co.Ltd https://druglandscape.com/drug/cm336-group-4b https://druglandscape.com/api/og?type=drug&title=CM336_group%204b&subtitle=CM336_group%204b%20%C2%B7%20Keymed%20Biosciences%20Co.Ltd&badge=phase%201 CM336_group 4b CM336_group 4b · Keymed Biosciences Co.Ltd https://druglandscape.com/drug/cm336-group-5 https://druglandscape.com/api/og?type=drug&title=CM336_group%205&subtitle=CM336_group%205%20%C2%B7%20Keymed%20Biosciences%20Co.Ltd&badge=phase%201 CM336_group 5 CM336_group 5 · Keymed Biosciences Co.Ltd https://druglandscape.com/drug/cm336-group-6a https://druglandscape.com/api/og?type=drug&title=CM336_group%206a&subtitle=CM336_group%206a%20%C2%B7%20Keymed%20Biosciences%20Co.Ltd&badge=phase%201 CM336_group 6a CM336_group 6a · Keymed Biosciences Co.Ltd https://druglandscape.com/drug/cm336-group-6b https://druglandscape.com/api/og?type=drug&title=CM336_group%206b&subtitle=CM336_group%206b%20%C2%B7%20Keymed%20Biosciences%20Co.Ltd&badge=phase%201 CM336_group 6b CM336_group 6b · Keymed Biosciences Co.Ltd https://druglandscape.com/drug/cm336-group-7 https://druglandscape.com/api/og?type=drug&title=CM336_group%207&subtitle=CM336_group%207%20%C2%B7%20Keymed%20Biosciences%20Co.Ltd&badge=phase%201 CM336_group 7 CM336_group 7 · Keymed Biosciences Co.Ltd https://druglandscape.com/drug/cm336-group-8b https://druglandscape.com/api/og?type=drug&title=CM336_group%208b&subtitle=CM336_group%208b%20%C2%B7%20Keymed%20Biosciences%20Co.Ltd&badge=phase%201 CM336_group 8b CM336_group 8b · Keymed Biosciences Co.Ltd https://druglandscape.com/drug/cm336-group-9 https://druglandscape.com/api/og?type=drug&title=CM336_group%209&subtitle=CM336_group%209%20%C2%B7%20Keymed%20Biosciences%20Co.Ltd&badge=phase%201 CM336_group 9 CM336_group 9 · Keymed Biosciences Co.Ltd https://druglandscape.com/drug/cm336-rp2d https://druglandscape.com/api/og?type=drug&title=CM336_RP2D&subtitle=CM336_RP2D%20%C2%B7%20Keymed%20Biosciences%20Co.Ltd&badge=phase%201 CM336_RP2D CM336_RP2D · Keymed Biosciences Co.Ltd https://druglandscape.com/drug/cm350-group1 https://druglandscape.com/api/og?type=drug&title=CM350%20group1&subtitle=CM350%20group1%20%C2%B7%20Keymed%20Biosciences%20Co.Ltd&badge=phase%201 CM350 group1 CM350 group1 · Keymed Biosciences Co.Ltd https://druglandscape.com/drug/cm369 https://druglandscape.com/api/og?type=drug&title=CM369&subtitle=CM369%20%C2%B7%20Beijing%20InnoCare%20Pharma%20Tech%20Co.%2C%20Ltd.&badge=phase%201 CM369 CM369 · Beijing InnoCare Pharma Tech Co., Ltd. https://druglandscape.com/drug/cm518d1 https://druglandscape.com/api/og?type=drug&title=CM518D1&subtitle=CM518D1%20%C2%B7%20Keymed%20Biosciences%20Co.Ltd&badge=phase%201 CM518D1 CM518D1 · Keymed Biosciences Co.Ltd https://druglandscape.com/drug/cm93 https://druglandscape.com/api/og?type=drug&title=CM93&subtitle=CM93%20%C2%B7%20Crimson%20Biopharm%20Inc.&badge=phase%201 CM93 CM93 · Crimson Biopharm Inc. https://druglandscape.com/drug/cmab017 https://druglandscape.com/api/og?type=drug&title=CMAB017&subtitle=CMAB017%20%C2%B7%20Taizhou%20Mabtech%20Pharmaceutical%20Co.%2CLtd&badge=phase%201 CMAB017 CMAB017 · Taizhou Mabtech Pharmaceutical Co.,Ltd https://druglandscape.com/drug/cmab809 https://druglandscape.com/api/og?type=drug&title=CMAB809&subtitle=CMAB809%20%C2%B7%20Taizhou%20Mabtech%20Pharmaceutical%20Co.%2CLtd&badge=phase%201 CMAB809 CMAB809 · Taizhou Mabtech Pharmaceutical Co.,Ltd https://druglandscape.com/drug/cmab818 https://druglandscape.com/api/og?type=drug&title=CMAB818&subtitle=CMAB818%20%C2%B7%20Shanghai%20Biomabs%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 CMAB818 CMAB818 · Shanghai Biomabs Pharmaceutical Co., Ltd. https://druglandscape.com/drug/cmp-cps-001 https://druglandscape.com/api/og?type=drug&title=CMP-CPS-001&subtitle=CMP-CPS-001%20%C2%B7%20CAMP4%20Therapeutics%20Corporation&badge=phase%201 CMP-CPS-001 CMP-CPS-001 · CAMP4 Therapeutics Corporation https://druglandscape.com/drug/cmr316 https://druglandscape.com/api/og?type=drug&title=CMR316&subtitle=CMR316%20%C2%B7%20Calibr%2C%20a%20division%20of%20Scripps%20Research&badge=phase%201 CMR316 CMR316 · Calibr, a division of Scripps Research https://druglandscape.com/drug/cms121 https://druglandscape.com/api/og?type=drug&title=CMS121&subtitle=CMS121%20%C2%B7%20Virogenics%2C%20Inc.&badge=phase%201 CMS121 CMS121 · Virogenics, Inc. https://druglandscape.com/drug/cmv-ctl-infusion https://druglandscape.com/api/og?type=drug&title=CMV%20CTL%20infusion&subtitle=CMV%20CTL%20infusion%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 CMV CTL infusion CMV CTL infusion · Baylor College of Medicine https://druglandscape.com/drug/cmv-dcs-with-gm-csf https://druglandscape.com/api/og?type=drug&title=CMV-DCs%20with%20GM-CSF&subtitle=CMV-DCs%20with%20GM-CSF%20%C2%B7%20Gary%20Archer%20Ph.D.&badge=phase%201 CMV-DCs with GM-CSF CMV-DCs with GM-CSF · Gary Archer Ph.D. https://druglandscape.com/drug/cn-avastin https://druglandscape.com/api/og?type=drug&title=CN-Avastin%C2%AE&subtitle=CN-Avastin%C2%AE%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 CN-Avastin® CN-Avastin® · Shanghai Henlius Biotech https://druglandscape.com/drug/cn-prolia https://druglandscape.com/api/og?type=drug&title=CN-Prolia%C2%AE&subtitle=CN-Prolia%C2%AE%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 CN-Prolia® CN-Prolia® · Shanghai Henlius Biotech https://druglandscape.com/drug/cn-sourced-darzalex https://druglandscape.com/api/og?type=drug&title=CN-sourced%20DARZALEX%C2%AE&subtitle=CN-sourced%20DARZALEX%C2%AE%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 CN-sourced DARZALEX® CN-sourced DARZALEX® · Shanghai Henlius Biotech https://druglandscape.com/drug/cn-sourced-ipilimumab https://druglandscape.com/api/og?type=drug&title=CN-sourced%20ipilimumab&subtitle=CN-sourced%20ipilimumab%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 CN-sourced ipilimumab CN-sourced ipilimumab · Shanghai Henlius Biotech https://druglandscape.com/drug/cn54env-dna https://druglandscape.com/api/og?type=drug&title=CN54ENV%20DNA&subtitle=CN54ENV%20DNA%20%C2%B7%20Imperial%20College%20London&badge=phase%201 CN54ENV DNA CN54ENV DNA · Imperial College London https://druglandscape.com/drug/cn54gp140-mixed-with-gla-af https://druglandscape.com/api/og?type=drug&title=CN54gp140%20mixed%20with%20GLA-AF&subtitle=CN54gp140%20mixed%20with%20GLA-AF%20%C2%B7%20Imperial%20College%20London&badge=phase%201 CN54gp140 mixed with GLA-AF CN54gp140 mixed with GLA-AF · Imperial College London https://druglandscape.com/drug/cn54rgp140 https://druglandscape.com/api/og?type=drug&title=CN54rgp140&subtitle=CN54rgp140%20%C2%B7%20Imperial%20College%20London&badge=phase%201 CN54rgp140 CN54rgp140 · Imperial College London https://druglandscape.com/drug/cna3103-1-5-x-10-8-cells https://druglandscape.com/api/og?type=drug&title=CNA3103%3A%201.5%20x%2010%5E8%20cells&subtitle=CNA3103%3A%201.5%20x%2010%5E8%20cells%20%C2%B7%20Carina%20Biotech%20Limited&badge=phase%201 CNA3103: 1.5 x 10^8 cells CNA3103: 1.5 x 10^8 cells · Carina Biotech Limited https://druglandscape.com/drug/cna3103-1-5-x-10-9-cells https://druglandscape.com/api/og?type=drug&title=CNA3103%3A%201.5%20x%2010%5E9%20cells&subtitle=CNA3103%3A%201.5%20x%2010%5E9%20cells%20%C2%B7%20Carina%20Biotech%20Limited&badge=phase%201 CNA3103: 1.5 x 10^9 cells CNA3103: 1.5 x 10^9 cells · Carina Biotech Limited https://druglandscape.com/drug/cna3103-4-5-x-10-8-cells https://druglandscape.com/api/og?type=drug&title=CNA3103%3A%204.5%20x%2010%5E8%20cells&subtitle=CNA3103%3A%204.5%20x%2010%5E8%20cells%20%C2%B7%20Carina%20Biotech%20Limited&badge=phase%201 CNA3103: 4.5 x 10^8 cells CNA3103: 4.5 x 10^8 cells · Carina Biotech Limited https://druglandscape.com/drug/cna3103-6-75-10-8-cells https://druglandscape.com/api/og?type=drug&title=CNA3103%3A%206.75%20%C3%97%2010%5E8%20cells&subtitle=CNA3103%3A%206.75%20%C3%97%2010%5E8%20cells%20%C2%B7%20Carina%20Biotech%20Limited&badge=phase%201 CNA3103: 6.75 × 10^8 cells CNA3103: 6.75 × 10^8 cells · Carina Biotech Limited https://druglandscape.com/drug/cndo-109-aank-cells https://druglandscape.com/api/og?type=drug&title=CNDO-109-AANK%20Cells&subtitle=CNDO-109-AANK%20Cells%20%C2%B7%20Coronado%20Biosciences%2C%20Inc.&badge=phase%201 CNDO-109-AANK Cells CNDO-109-AANK Cells · Coronado Biosciences, Inc. https://druglandscape.com/drug/cnf2024 https://druglandscape.com/api/og?type=drug&title=CNF2024&subtitle=CNF2024%20%C2%B7%20Biogen&badge=phase%201 CNF2024 CNF2024 · Biogen https://druglandscape.com/drug/cngrc-peptide-tnf-alpha-conjugate https://druglandscape.com/api/og?type=drug&title=CNGRC%20peptide-TNF%20alpha%20conjugate&subtitle=CNGRC%20peptide-TNF%20alpha%20conjugate%20%C2%B7%20European%20Organisation%20for%20Research%20and%20Treatment%20of%20Cancer%20-%20EOR&badge=phase%201 CNGRC peptide-TNF alpha conjugate CNGRC peptide-TNF alpha conjugate · European Organisation for Research and Treatment of Cancer - EORTC https://druglandscape.com/drug/cni-free-immunosuppression https://druglandscape.com/api/og?type=drug&title=CNI%20free%20immunosuppression&subtitle=CNI%20free%20immunosuppression%20%C2%B7%20Ospedale%20San%20Raffaele&badge=phase%201 CNI free immunosuppression CNI free immunosuppression · Ospedale San Raffaele https://druglandscape.com/drug/cnm-au8 https://druglandscape.com/api/og?type=drug&title=CNM-Au8&subtitle=CNM-Au8%20%C2%B7%20Merit%20E.%20Cudkowicz%2C%20MD&badge=phase%202 CNM-Au8 CNM-Au8 · Merit E. Cudkowicz, MD https://druglandscape.com/drug/cnp-103 https://druglandscape.com/api/og?type=drug&title=CNP-103&subtitle=CNP-103%20%C2%B7%20COUR%20Pharmaceutical%20Development%20Company%2C%20Inc.&badge=phase%201 CNP-103 CNP-103 · COUR Pharmaceutical Development Company, Inc. https://druglandscape.com/drug/cnp-104 https://druglandscape.com/api/og?type=drug&title=CNP-104&subtitle=CNP-104%20%C2%B7%20COUR%20Pharmaceutical%20Development%20Company%2C%20Inc.&badge=phase%201 CNP-104 CNP-104 · COUR Pharmaceutical Development Company, Inc. https://druglandscape.com/drug/cns10-npc-gdnf https://druglandscape.com/api/og?type=drug&title=CNS10-NPC-GDNF&subtitle=CNS10-NPC-GDNF%20%C2%B7%20Cedars-Sinai%20Medical%20Center&badge=phase%201 CNS10-NPC-GDNF CNS10-NPC-GDNF · Cedars-Sinai Medical Center https://druglandscape.com/drug/cns10-npc-implantation https://druglandscape.com/api/og?type=drug&title=CNS10-NPC%20implantation&subtitle=CNS10-NPC%20implantation%20%C2%B7%20Cedars-Sinai%20Medical%20Center&badge=phase%201 CNS10-NPC implantation CNS10-NPC implantation · Cedars-Sinai Medical Center https://druglandscape.com/drug/cnto-2476-3-0-x-10-5-cells https://druglandscape.com/api/og?type=drug&title=CNTO%202476%203.0%20x%2010%5E5%20cells&subtitle=CNTO%202476%203.0%20x%2010%5E5%20cells%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 CNTO 2476 3.0 x 10^5 cells CNTO 2476 3.0 x 10^5 cells · Janssen Research & Development, LLC https://druglandscape.com/drug/cnto-888 https://druglandscape.com/api/og?type=drug&title=CNTO%20888&subtitle=CNTO%20888%20%C2%B7%20Centocor%2C%20Inc.&badge=phase%201 CNTO 888 CNTO 888 · Centocor, Inc. https://druglandscape.com/drug/cnto-95-and-avastin https://druglandscape.com/api/og?type=drug&title=CNTO%2095%20and%20avastin&subtitle=CNTO%2095%20and%20avastin%20%C2%B7%20Herbert%20Hurwitz%2C%20MD&badge=phase%201 CNTO 95 and avastin CNTO 95 and avastin · Herbert Hurwitz, MD https://druglandscape.com/drug/cnto148 https://druglandscape.com/api/og?type=drug&title=CNTO148&subtitle=CNTO148%20%C2%B7%20Centocor%2C%20Inc.&badge=phase%202 CNTO148 CNTO148 · Centocor, Inc. https://druglandscape.com/drug/cnty-101 https://druglandscape.com/api/og?type=drug&title=CNTY-101&subtitle=CNTY-101%20%C2%B7%20Century%20Therapeutics%2C%20Inc.&badge=phase%201 CNTY-101 CNTY-101 · Century Therapeutics, Inc. https://druglandscape.com/drug/co-administration-of-ad-227a-and-ad-227b https://druglandscape.com/api/og?type=drug&title=Co-administration%20of%20AD-227A%20and%20AD-227B&subtitle=Co-administration%20of%20AD-227A%20and%20AD-227B%20%C2%B7%20Addpharma%20Inc.&badge=phase%201 Co-administration of AD-227A and AD-227B Co-administration of AD-227A and AD-227B · Addpharma Inc. https://druglandscape.com/drug/co-administration-of-olmetec-and-crestor https://druglandscape.com/api/og?type=drug&title=Co-administration%20of%20Olmetec%20and%20Crestor&subtitle=Co-administration%20of%20Olmetec%20and%20Crestor%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 Co-administration of Olmetec and Crestor Co-administration of Olmetec and Crestor · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/co-analgesic-therapy https://druglandscape.com/api/og?type=drug&title=Co-Analgesic%20Therapy&subtitle=Co-Analgesic%20Therapy%20%C2%B7%20VA%20Office%20of%20Research%20and%20Development&badge=phase%201 Co-Analgesic Therapy Co-Analgesic Therapy · VA Office of Research and Development https://druglandscape.com/drug/co-trimoxazole-tmp-smz https://druglandscape.com/api/og?type=drug&title=Co-Trimoxazole%3B%20TMP-SMZ&subtitle=Co-Trimoxazole%3B%20TMP-SMZ%20%C2%B7%20Johns%20Hopkins%20Bloomberg%20School%20of%20Public%20Health&badge=phase%201 Co-Trimoxazole; TMP-SMZ Co-Trimoxazole; TMP-SMZ · Johns Hopkins Bloomberg School of Public Health https://druglandscape.com/drug/coadministration-of-jp-1366-and-naproxen https://druglandscape.com/api/og?type=drug&title=coadministration%20of%20JP-1366%20and%20naproxen&subtitle=coadministration%20of%20JP-1366%20and%20naproxen%20%C2%B7%20Onconic%20Therapeutics%20Inc.&badge=phase%201 coadministration of JP-1366 and naproxen coadministration of JP-1366 and naproxen · Onconic Therapeutics Inc. https://druglandscape.com/drug/coartem-novartis https://druglandscape.com/api/og?type=drug&title=Coartem%C2%AE%2C%20Novartis&subtitle=Coartem%C2%AE%2C%20Novartis%20%C2%B7%20Epicentre&badge=phase%201 Coartem®, Novartis Coartem®, Novartis · Epicentre https://druglandscape.com/drug/coated-nifedipine-suppositories https://druglandscape.com/api/og?type=drug&title=Coated%20Nifedipine%20Suppositories&subtitle=Coated%20Nifedipine%20Suppositories%20%C2%B7%20RDD%20Pharma%20Ltd&badge=phase%201 Coated Nifedipine Suppositories Coated Nifedipine Suppositories · RDD Pharma Ltd https://druglandscape.com/drug/cobimetinib-dexamethasone-ixazomib-pomalidomide https://druglandscape.com/api/og?type=drug&title=Cobimetinib%2C%20dexamethasone%2C%20ixazomib%2C%20pomalidomide&subtitle=Cobimetinib%2C%20dexamethasone%2C%20ixazomib%2C%20pomalidomide%20%C2%B7%20Multiple%20Myeloma%20Research%20Consortium&badge=phase%201 Cobimetinib, dexamethasone, ixazomib, pomalidomide Cobimetinib, dexamethasone, ixazomib, pomalidomide · Multiple Myeloma Research Consortium https://druglandscape.com/drug/cocktail-of-5-already-approved-drugs https://druglandscape.com/api/og?type=drug&title=Cocktail%20of%205%20already%20approved%20drugs&subtitle=Cocktail%20of%205%20already%20approved%20drugs%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Cocktail of 5 already approved drugs Cocktail of 5 already approved drugs · Novo Nordisk A/S https://druglandscape.com/drug/cocktail-probe-drugs https://druglandscape.com/api/og?type=drug&title=cocktail%20probe%20drugs&subtitle=cocktail%20probe%20drugs%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 cocktail probe drugs cocktail probe drugs · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/cocs https://druglandscape.com/api/og?type=drug&title=COCs&subtitle=COCs%20%C2%B7%20FHI%20360&badge=phase%201 COCs COCs · FHI 360 https://druglandscape.com/drug/coda-vax-h1n1 https://druglandscape.com/api/og?type=drug&title=CODA-VAX%20H1N1&subtitle=CODA-VAX%20H1N1%20%C2%B7%20Codagenix%2C%20Inc&badge=phase%201 CODA-VAX H1N1 CODA-VAX H1N1 · Codagenix, Inc https://druglandscape.com/drug/codavax-h1n1 https://druglandscape.com/api/og?type=drug&title=CodaVax-H1N1&subtitle=CodaVax-H1N1%20%C2%B7%20Codagenix%2C%20Inc&badge=phase%201 CodaVax-H1N1 CodaVax-H1N1 · Codagenix, Inc https://druglandscape.com/drug/codavax-h1n1-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=CodaVax-H1N1%20influenza%20vaccine&subtitle=CodaVax-H1N1%20influenza%20vaccine%20%C2%B7%20Codagenix%2C%20Inc&badge=phase%201 CodaVax-H1N1 influenza vaccine CodaVax-H1N1 influenza vaccine · Codagenix, Inc https://druglandscape.com/drug/codavax-rsv https://druglandscape.com/api/og?type=drug&title=CodaVax-RSV&subtitle=CodaVax-RSV%20%C2%B7%20Codagenix%2C%20Inc&badge=phase%201 CodaVax-RSV CodaVax-RSV · Codagenix, Inc https://druglandscape.com/drug/code-ste https://druglandscape.com/api/og?type=drug&title=Code%20STE&subtitle=Code%20STE%20%C2%B7%20McNeil%20AB&badge=phase%201 Code STE Code STE · McNeil AB https://druglandscape.com/drug/codox-m https://druglandscape.com/api/og?type=drug&title=CODOX-M&subtitle=CODOX-M%20%C2%B7%20Cooperative%20Study%20Group%20A%20for%20Hematology&badge=phase%202 CODOX-M CODOX-M · Cooperative Study Group A for Hematology https://druglandscape.com/drug/cofactor https://druglandscape.com/api/og?type=drug&title=CoFactor&subtitle=CoFactor%20%C2%B7%20Mast%20Therapeutics%2C%20Inc.&badge=phase%202 CoFactor CoFactor · Mast Therapeutics, Inc. https://druglandscape.com/drug/cofactor-and-5fu https://druglandscape.com/api/og?type=drug&title=CoFactor%20and%205FU&subtitle=CoFactor%20and%205FU%20%C2%B7%20Mast%20Therapeutics%2C%20Inc.&badge=phase%202 CoFactor and 5FU CoFactor and 5FU · Mast Therapeutics, Inc. https://druglandscape.com/drug/cohort-1-ceplene-and-proleukin https://druglandscape.com/api/og?type=drug&title=Cohort%201%2C%20Ceplene%C2%AE%20and%20Proleukin%C2%AE&subtitle=Cohort%201%2C%20Ceplene%C2%AE%20and%20Proleukin%C2%AE%20%C2%B7%20Vastra%20Gotaland%20Region&badge=phase%201 Cohort 1, Ceplene® and Proleukin® Cohort 1, Ceplene® and Proleukin® · Vastra Gotaland Region https://druglandscape.com/drug/cohort-1-fp-045-oral-solution https://druglandscape.com/api/og?type=drug&title=Cohort%201%20-%20FP-045%20oral%20solution&subtitle=Cohort%201%20-%20FP-045%20oral%20solution%20%C2%B7%20Foresee%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 Cohort 1 - FP-045 oral solution Cohort 1 - FP-045 oral solution · Foresee Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/cohort-1-gnr-084 https://druglandscape.com/api/og?type=drug&title=Cohort%201%2C%20GNR-084&subtitle=Cohort%201%2C%20GNR-084%20%C2%B7%20AO%20GENERIUM&badge=phase%201 Cohort 1, GNR-084 Cohort 1, GNR-084 · AO GENERIUM https://druglandscape.com/drug/cohort-1-hl217-ophathalmic-solution-qd https://druglandscape.com/api/og?type=drug&title=Cohort%201%3A%20HL217%20Ophathalmic%20Solution%20QD&subtitle=Cohort%201%3A%20HL217%20Ophathalmic%20Solution%20QD%20%C2%B7%20Hanlim%20Pharm.%20Co.%2C%20Ltd.&badge=phase%201 Cohort 1: HL217 Ophathalmic Solution QD Cohort 1: HL217 Ophathalmic Solution QD · Hanlim Pharm. Co., Ltd. https://druglandscape.com/drug/cohort-1-jmkx003142-and-itraconazole https://druglandscape.com/api/og?type=drug&title=Cohort%201%3A%20JMKX003142%20and%20itraconazole&subtitle=Cohort%201%3A%20JMKX003142%20and%20itraconazole%20%C2%B7%20Jemincare&badge=phase%201 Cohort 1: JMKX003142 and itraconazole Cohort 1: JMKX003142 and itraconazole · Jemincare https://druglandscape.com/drug/cohort-1-of-m701 https://druglandscape.com/api/og?type=drug&title=Cohort%201%20of%20M701&subtitle=Cohort%201%20of%20M701%20%C2%B7%20Wuhan%20YZY%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 Cohort 1 of M701 Cohort 1 of M701 · Wuhan YZY Biopharma Co., Ltd. https://druglandscape.com/drug/cohort-1-of-y101d https://druglandscape.com/api/og?type=drug&title=Cohort%201%20of%20Y101D&subtitle=Cohort%201%20of%20Y101D%20%C2%B7%20Wuhan%20YZY%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 Cohort 1 of Y101D Cohort 1 of Y101D · Wuhan YZY Biopharma Co., Ltd. https://druglandscape.com/drug/cohort-1-tmp-301 https://druglandscape.com/api/og?type=drug&title=Cohort%201%20-%20TMP-301&subtitle=Cohort%201%20-%20TMP-301%20%C2%B7%20Tempero%20Bio%2C%20Inc.&badge=phase%201 Cohort 1 - TMP-301 Cohort 1 - TMP-301 · Tempero Bio, Inc. https://druglandscape.com/drug/cohort-2-hl217-ophathalmic-solution-bid https://druglandscape.com/api/og?type=drug&title=Cohort%202%3A%20HL217%20Ophathalmic%20Solution%20BID&subtitle=Cohort%202%3A%20HL217%20Ophathalmic%20Solution%20BID%20%C2%B7%20Hanlim%20Pharm.%20Co.%2C%20Ltd.&badge=phase%201 Cohort 2: HL217 Ophathalmic Solution BID Cohort 2: HL217 Ophathalmic Solution BID · Hanlim Pharm. Co., Ltd. https://druglandscape.com/drug/cohort-2-hl217-ophathalmic-solution-qid https://druglandscape.com/api/og?type=drug&title=Cohort%202%3A%20HL217%20Ophathalmic%20Solution%20QID&subtitle=Cohort%202%3A%20HL217%20Ophathalmic%20Solution%20QID%20%C2%B7%20Hanlim%20Pharm.%20Co.%2C%20Ltd.&badge=phase%201 Cohort 2: HL217 Ophathalmic Solution QID Cohort 2: HL217 Ophathalmic Solution QID · Hanlim Pharm. Co., Ltd. https://druglandscape.com/drug/cohort-2-jmkx003142-and-rifampicin https://druglandscape.com/api/og?type=drug&title=Cohort%202%3A%20JMKX003142%20and%20rifampicin&subtitle=Cohort%202%3A%20JMKX003142%20and%20rifampicin%20%C2%B7%20Jemincare&badge=phase%201 Cohort 2: JMKX003142 and rifampicin Cohort 2: JMKX003142 and rifampicin · Jemincare https://druglandscape.com/drug/cohort-3-hl217-ophthalmic-solution-qid https://druglandscape.com/api/og?type=drug&title=Cohort%203%3A%20HL217%20Ophthalmic%20Solution%20QID&subtitle=Cohort%203%3A%20HL217%20Ophthalmic%20Solution%20QID%20%C2%B7%20Hanlim%20Pharm.%20Co.%2C%20Ltd.&badge=phase%201 Cohort 3: HL217 Ophthalmic Solution QID Cohort 3: HL217 Ophthalmic Solution QID · Hanlim Pharm. Co., Ltd. https://druglandscape.com/drug/cohort-3-of-m802 https://druglandscape.com/api/og?type=drug&title=Cohort%203%20of%20M802&subtitle=Cohort%203%20of%20M802%20%C2%B7%20Wuhan%20YZY%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 Cohort 3 of M802 Cohort 3 of M802 · Wuhan YZY Biopharma Co., Ltd. https://druglandscape.com/drug/cohort-a-vilobelimab https://druglandscape.com/api/og?type=drug&title=Cohort%20A%3A%20vilobelimab&subtitle=Cohort%20A%3A%20vilobelimab%20%C2%B7%20PPD%20Development%2C%20LP&badge=phase%202 Cohort A: vilobelimab Cohort A: vilobelimab · PPD Development, LP https://druglandscape.com/drug/cohort-a1-a2-ktx-1001 https://druglandscape.com/api/og?type=drug&title=Cohort%20A1%20%26%20A2%3A%20KTX-1001&subtitle=Cohort%20A1%20%26%20A2%3A%20KTX-1001%20%C2%B7%20K36%20Therapeutics%2C%20Inc.&badge=phase%201 Cohort A1 & A2: KTX-1001 Cohort A1 & A2: KTX-1001 · K36 Therapeutics, Inc. https://druglandscape.com/drug/cohort-b-ormd-0801 https://druglandscape.com/api/og?type=drug&title=Cohort%20B%3A%20ORMD-0801&subtitle=Cohort%20B%3A%20ORMD-0801%20%C2%B7%20Oramed%2C%20Ltd.&badge=phase%202 Cohort B: ORMD-0801 Cohort B: ORMD-0801 · Oramed, Ltd. https://druglandscape.com/drug/cohort-b-paridiprubart https://druglandscape.com/api/og?type=drug&title=Cohort%20B%3A%20paridiprubart&subtitle=Cohort%20B%3A%20paridiprubart%20%C2%B7%20PPD%20Development%2C%20LP&badge=phase%202 Cohort B: paridiprubart Cohort B: paridiprubart · PPD Development, LP https://druglandscape.com/drug/cohort-b1-lu-ae58054 https://druglandscape.com/api/og?type=drug&title=Cohort%20B1%3A%20Lu%20AE58054&subtitle=Cohort%20B1%3A%20Lu%20AE58054%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Cohort B1: Lu AE58054 Cohort B1: Lu AE58054 · H. Lundbeck A/S https://druglandscape.com/drug/colchicine-sprinkle-capsules https://druglandscape.com/api/og?type=drug&title=colchicine%20sprinkle%20capsules&subtitle=colchicine%20sprinkle%20capsules%20%C2%B7%20Mutual%20Pharmaceutical%20Company%2C%20Inc.&badge=phase%201 colchicine sprinkle capsules colchicine sprinkle capsules · Mutual Pharmaceutical Company, Inc. https://druglandscape.com/drug/cold-fx https://druglandscape.com/api/og?type=drug&title=COLD-fX&subtitle=COLD-fX%20%C2%B7%20Afexa%20Life%20Sciences%20Inc&badge=phase%202 COLD-fX COLD-fX · Afexa Life Sciences Inc https://druglandscape.com/drug/cold-spray https://druglandscape.com/api/og?type=drug&title=Cold%20spray&subtitle=Cold%20spray%20%C2%B7%20Aynur%20Aytekin%20Ozdemir&badge=phase%201 Cold spray Cold spray · Aynur Aytekin Ozdemir https://druglandscape.com/drug/colgate-cavity-protection-dentifrice https://druglandscape.com/api/og?type=drug&title=Colgate%20Cavity%20Protection%20Dentifrice&subtitle=Colgate%20Cavity%20Protection%20Dentifrice%20%C2%B7%20HALEON&badge=phase%201 Colgate Cavity Protection Dentifrice Colgate Cavity Protection Dentifrice · HALEON https://druglandscape.com/drug/colgate-sensitive-prorelief https://druglandscape.com/api/og?type=drug&title=Colgate%20Sensitive%20ProRelief&subtitle=Colgate%20Sensitive%20ProRelief%20%C2%B7%20HALEON&badge=phase%201 Colgate Sensitive ProRelief Colgate Sensitive ProRelief · HALEON https://druglandscape.com/drug/colistin-and-meropenem https://druglandscape.com/api/og?type=drug&title=colistin%20and%20meropenem&subtitle=colistin%20and%20meropenem%20%C2%B7%20University%20of%20Michigan&badge=phase%203 colistin and meropenem colistin and meropenem · University of Michigan https://druglandscape.com/drug/collagen-punctal-plug https://druglandscape.com/api/og?type=drug&title=Collagen%20Punctal%20Plug&subtitle=Collagen%20Punctal%20Plug%20%C2%B7%20Ocular%20Therapeutix%2C%20Inc.&badge=phase%202 Collagen Punctal Plug Collagen Punctal Plug · Ocular Therapeutix, Inc. https://druglandscape.com/drug/collection-of-biological-parameters https://druglandscape.com/api/og?type=drug&title=Collection%20of%20biological%20parameters&subtitle=Collection%20of%20biological%20parameters%20%C2%B7%20Istituto%20Auxologico%20Italiano&badge=phase%201 Collection of biological parameters Collection of biological parameters · Istituto Auxologico Italiano https://druglandscape.com/drug/collection-of-samples https://druglandscape.com/api/og?type=drug&title=Collection%20of%20samples&subtitle=Collection%20of%20samples%20%C2%B7%20Emergent%20BioSolutions&badge=phase%202 Collection of samples Collection of samples · Emergent BioSolutions https://druglandscape.com/drug/collection-of-stool-and-serum-samples https://druglandscape.com/api/og?type=drug&title=Collection%20of%20stool%20and%20serum%20samples&subtitle=Collection%20of%20stool%20and%20serum%20samples%20%C2%B7%20Centre%20Georges%20Francois%20Leclerc&badge=phase%201 Collection of stool and serum samples Collection of stool and serum samples · Centre Georges Francois Leclerc https://druglandscape.com/drug/collection-of-vaginal-secretions https://druglandscape.com/api/og?type=drug&title=Collection%20of%20vaginal%20secretions&subtitle=Collection%20of%20vaginal%20secretions%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Collection of vaginal secretions Collection of vaginal secretions · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/colon-closed-as-of-may-2014 https://druglandscape.com/api/og?type=drug&title=Colon-%20Closed%20as%20of%20May%202014&subtitle=Colon-%20Closed%20as%20of%20May%202014%20%C2%B7%20howard%20safran&badge=phase%201 Colon- Closed as of May 2014 Colon- Closed as of May 2014 · howard safran https://druglandscape.com/drug/colon-kcc-heptapeptide https://druglandscape.com/api/og?type=drug&title=Colon%20KCC%20Heptapeptide&subtitle=Colon%20KCC%20Heptapeptide%20%C2%B7%20Danielle%20Kim%20Turgeon&badge=phase%201 Colon KCC Heptapeptide Colon KCC Heptapeptide · Danielle Kim Turgeon https://druglandscape.com/drug/colostrum-nasal-spray https://druglandscape.com/api/og?type=drug&title=Colostrum%20Nasal%20Spray&subtitle=Colostrum%20Nasal%20Spray%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 Colostrum Nasal Spray Colostrum Nasal Spray · Hadassah Medical Organization https://druglandscape.com/drug/combi-0-3-group https://druglandscape.com/api/og?type=drug&title=Combi%200.3%20group&subtitle=Combi%200.3%20group%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Combi 0.3 group Combi 0.3 group · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/combi-1-group https://druglandscape.com/api/og?type=drug&title=Combi%201%20group&subtitle=Combi%201%20group%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Combi 1 group Combi 1 group · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/combi-3-group https://druglandscape.com/api/og?type=drug&title=Combi%203%20group&subtitle=Combi%203%20group%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Combi 3 group Combi 3 group · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/combination-400 https://druglandscape.com/api/og?type=drug&title=Combination%20400&subtitle=Combination%20400%20%C2%B7%20Nuon%20Therapeutics%2C%20Inc.&badge=phase%202 Combination 400 Combination 400 · Nuon Therapeutics, Inc. https://druglandscape.com/drug/combination-agent-2 https://druglandscape.com/api/og?type=drug&title=Combination%20Agent%202&subtitle=Combination%20Agent%202%20%C2%B7%20Avenzo%20Therapeutics%2C%20Inc.&badge=phase%201 Combination Agent 2 Combination Agent 2 · Avenzo Therapeutics, Inc. https://druglandscape.com/drug/combination-drug-dw330sr-dw1030 https://druglandscape.com/api/og?type=drug&title=combination%20drug%3A%20DW330SR%2C%20DW1030&subtitle=combination%20drug%3A%20DW330SR%2C%20DW1030%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 combination drug: DW330SR, DW1030 combination drug: DW330SR, DW1030 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/combination-iodine-and-chlorhexidine https://druglandscape.com/api/og?type=drug&title=Combination%20iodine%20and%20chlorhexidine&subtitle=Combination%20iodine%20and%20chlorhexidine%20%C2%B7%20Montefiore%20Medical%20Center&badge=phase%201 Combination iodine and chlorhexidine Combination iodine and chlorhexidine · Montefiore Medical Center https://druglandscape.com/drug/combination-of-aswd-and-doxil https://druglandscape.com/api/og?type=drug&title=Combination%20of%20ASWD%20and%20DOXIL&subtitle=Combination%20of%20ASWD%20and%20DOXIL%20%C2%B7%20Sham%20Sunder%20Kakar&badge=phase%201 Combination of ASWD and DOXIL Combination of ASWD and DOXIL · Sham Sunder Kakar https://druglandscape.com/drug/combination-of-liposomal-doxorubicin https://druglandscape.com/api/og?type=drug&title=Combination%20of%20liposomal%20doxorubicin&subtitle=Combination%20of%20liposomal%20doxorubicin%20%C2%B7%20Mridula%20George%2C%20MD&badge=phase%202 Combination of liposomal doxorubicin Combination of liposomal doxorubicin · Mridula George, MD https://druglandscape.com/drug/combination-of-naproxen-and-pregabalin https://druglandscape.com/api/og?type=drug&title=Combination%20of%20Naproxen%20and%20Pregabalin&subtitle=Combination%20of%20Naproxen%20and%20Pregabalin%20%C2%B7%20Xgene%20Pharmaceutical%20Group&badge=phase%201 Combination of Naproxen and Pregabalin Combination of Naproxen and Pregabalin · Xgene Pharmaceutical Group https://druglandscape.com/drug/combination-of-sumatriptan-and-naproxen https://druglandscape.com/api/og?type=drug&title=combination%20of%20sumatriptan%20and%20naproxen&subtitle=combination%20of%20sumatriptan%20and%20naproxen%20%C2%B7%20IRCCS%20San%20Raffaele%20Roma&badge=phase%202 combination of sumatriptan and naproxen combination of sumatriptan and naproxen · IRCCS San Raffaele Roma https://druglandscape.com/drug/combination-of-tlc-d-99-and-ifosfamide https://druglandscape.com/api/og?type=drug&title=combination%20of%20TLC%20D-99%20and%20Ifosfamide&subtitle=combination%20of%20TLC%20D-99%20and%20Ifosfamide%20%C2%B7%20Istituto%20Clinico%20Humanitas&badge=phase%201 combination of TLC D-99 and Ifosfamide combination of TLC D-99 and Ifosfamide · Istituto Clinico Humanitas https://druglandscape.com/drug/combination-product-atezolizumab https://druglandscape.com/api/og?type=drug&title=Combination%20Product%3A%20Atezolizumab&subtitle=Combination%20Product%3A%20Atezolizumab%20%C2%B7%20TransThera%20Sciences%20(Nanjing)%2C%20Inc.&badge=phase%201 Combination Product: Atezolizumab Combination Product: Atezolizumab · TransThera Sciences (Nanjing), Inc. https://druglandscape.com/drug/combination-product-nab-paclitaxel https://druglandscape.com/api/og?type=drug&title=Combination%20Product%3A%20Nab-Paclitaxel&subtitle=Combination%20Product%3A%20Nab-Paclitaxel%20%C2%B7%20TransThera%20Sciences%20(Nanjing)%2C%20Inc.&badge=phase%201 Combination Product: Nab-Paclitaxel Combination Product: Nab-Paclitaxel · TransThera Sciences (Nanjing), Inc. https://druglandscape.com/drug/combination-product-nivolumab-with-pemetrexed https://druglandscape.com/api/og?type=drug&title=Combination%20Product%3A%20Nivolumab%20with%20Pemetrexed&subtitle=Combination%20Product%3A%20Nivolumab%20with%20Pemetrexed%20%C2%B7%20AHS%20Cancer%20Control%20Alberta&badge=phase%202 Combination Product: Nivolumab with Pemetrexed Combination Product: Nivolumab with Pemetrexed · AHS Cancer Control Alberta https://druglandscape.com/drug/combination-therapy-with-meki https://druglandscape.com/api/og?type=drug&title=combination%20therapy%20with%20MEKi.&subtitle=combination%20therapy%20with%20MEKi.%20%C2%B7%20Mandana%20Kamgar%2C%20MD&badge=phase%202 combination therapy with MEKi. combination therapy with MEKi. · Mandana Kamgar, MD https://druglandscape.com/drug/combination-therapy-with-meki-egfri https://druglandscape.com/api/og?type=drug&title=combination%20therapy%20with%20MEKi-EGFRi&subtitle=combination%20therapy%20with%20MEKi-EGFRi%20%C2%B7%20Mandana%20Kamgar%2C%20MD&badge=phase%202 combination therapy with MEKi-EGFRi combination therapy with MEKi-EGFRi · Mandana Kamgar, MD https://druglandscape.com/drug/combination-therapy-with-meki-hcq https://druglandscape.com/api/og?type=drug&title=combination%20therapy%20with%20MEKi-HCQ&subtitle=combination%20therapy%20with%20MEKi-HCQ%20%C2%B7%20Mandana%20Kamgar%2C%20MD&badge=phase%202 combination therapy with MEKi-HCQ combination therapy with MEKi-HCQ · Mandana Kamgar, MD https://druglandscape.com/drug/combination-tylenol-and-ibuprofen https://druglandscape.com/api/og?type=drug&title=Combination%20Tylenol%20and%20Ibuprofen&subtitle=Combination%20Tylenol%20and%20Ibuprofen%20%C2%B7%20Nova%20Scotia%20Health%20Authority&badge=phase%201 Combination Tylenol and Ibuprofen Combination Tylenol and Ibuprofen · Nova Scotia Health Authority https://druglandscape.com/drug/combined-nerve-blocks https://druglandscape.com/api/og?type=drug&title=Combined%20nerve%20blocks&subtitle=Combined%20nerve%20blocks%20%C2%B7%20Hillel%20Yaffe%20Medical%20Center&badge=phase%201 Combined nerve blocks Combined nerve blocks · Hillel Yaffe Medical Center https://druglandscape.com/drug/combined-therapy https://druglandscape.com/api/og?type=drug&title=Combined%20therapy&subtitle=Combined%20therapy%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 Combined therapy Combined therapy · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/combonox-tablets-single-dose https://druglandscape.com/api/og?type=drug&title=COMBONOX%C2%AE%20tablets%2C%20single%20dose&subtitle=COMBONOX%C2%AE%20tablets%2C%20single%20dose%20%C2%B7%20Actavis%20Inc.&badge=phase%201 COMBONOX® tablets, single dose COMBONOX® tablets, single dose · Actavis Inc. https://druglandscape.com/drug/comirnaty-omicron-xbb1-5 https://druglandscape.com/api/og?type=drug&title=Comirnaty%20Omicron%20XBB1.5&subtitle=Comirnaty%20Omicron%20XBB1.5%20%C2%B7%20Hipra%20Scientific%2C%20S.L.U&badge=phase%202 Comirnaty Omicron XBB1.5 Comirnaty Omicron XBB1.5 · Hipra Scientific, S.L.U https://druglandscape.com/drug/comm-fast https://druglandscape.com/api/og?type=drug&title=Comm-Fast&subtitle=Comm-Fast%20%C2%B7%20Pfizer&badge=phase%201 Comm-Fast Comm-Fast · Pfizer https://druglandscape.com/drug/comm-fed https://druglandscape.com/api/og?type=drug&title=Comm-Fed&subtitle=Comm-Fed%20%C2%B7%20Pfizer&badge=phase%201 Comm-Fed Comm-Fed · Pfizer https://druglandscape.com/drug/commercial-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=Commercial%20Influenza%20vaccine&subtitle=Commercial%20Influenza%20vaccine%20%C2%B7%20Aramis%20Biotechnologies%20Inc.&badge=phase%201 Commercial Influenza vaccine Commercial Influenza vaccine · Aramis Biotechnologies Inc. https://druglandscape.com/drug/commercial-nomac-e2 https://druglandscape.com/api/og?type=drug&title=Commercial%20NOMAC-E2&subtitle=Commercial%20NOMAC-E2%20%C2%B7%20Organon%20and%20Co&badge=phase%201 Commercial NOMAC-E2 Commercial NOMAC-E2 · Organon and Co https://druglandscape.com/drug/commercial-tablet-with-water https://druglandscape.com/api/og?type=drug&title=Commercial%20tablet%20with%20water&subtitle=Commercial%20tablet%20with%20water%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%201 Commercial tablet with water Commercial tablet with water · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/commercial-vaccine-1 https://druglandscape.com/api/og?type=drug&title=Commercial%20vaccine%201&subtitle=Commercial%20vaccine%201%20%C2%B7%20Crucell%20Holland%20BV&badge=phase%201 Commercial vaccine 1 Commercial vaccine 1 · Crucell Holland BV https://druglandscape.com/drug/commercial-vaccine-2 https://druglandscape.com/api/og?type=drug&title=Commercial%20vaccine%202&subtitle=Commercial%20vaccine%202%20%C2%B7%20Crucell%20Holland%20BV&badge=phase%201 Commercial vaccine 2 Commercial vaccine 2 · Crucell Holland BV https://druglandscape.com/drug/commercialized-ipv https://druglandscape.com/api/og?type=drug&title=Commercialized%20IPV&subtitle=Commercialized%20IPV%20%C2%B7%20Jiangsu%20Province%20Centers%20for%20Disease%20Control%20and%20Prevention&badge=phase%201 Commercialized IPV Commercialized IPV · Jiangsu Province Centers for Disease Control and Prevention https://druglandscape.com/drug/commercialized-sipv https://druglandscape.com/api/og?type=drug&title=Commercialized%20sIPV&subtitle=Commercialized%20sIPV%20%C2%B7%20Jiangsu%20Province%20Centers%20for%20Disease%20Control%20and%20Prevention&badge=phase%201 Commercialized sIPV Commercialized sIPV · Jiangsu Province Centers for Disease Control and Prevention https://druglandscape.com/drug/commercially-available-bcg-live-vaccine https://druglandscape.com/api/og?type=drug&title=Commercially%20available%20BCG%20live%20vaccine&subtitle=Commercially%20available%20BCG%20live%20vaccine%20%C2%B7%20Biofabri%2C%20S.L&badge=phase%201 Commercially available BCG live vaccine Commercially available BCG live vaccine · Biofabri, S.L https://druglandscape.com/drug/commercially-available-dutasteride https://druglandscape.com/api/og?type=drug&title=commercially%20available%20dutasteride&subtitle=commercially%20available%20dutasteride%20%C2%B7%20GlaxoSmithKline&badge=phase%202 commercially available dutasteride commercially available dutasteride · GlaxoSmithKline https://druglandscape.com/drug/commercially-available-live-vaccine-bcg https://druglandscape.com/api/og?type=drug&title=commercially%20available%20live%20vaccine%20BCG&subtitle=commercially%20available%20live%20vaccine%20BCG%20%C2%B7%20Serum%20Life%20Science%20Europe%20GmbH&badge=phase%201 commercially available live vaccine BCG commercially available live vaccine BCG · Serum Life Science Europe GmbH https://druglandscape.com/drug/comp02 https://druglandscape.com/api/og?type=drug&title=Comp02&subtitle=Comp02%20%C2%B7%20Promius%20Pharma%2C%20LLC&badge=phase%202 Comp02 Comp02 · Promius Pharma, LLC https://druglandscape.com/drug/compound-21 https://druglandscape.com/api/og?type=drug&title=Compound%2021&subtitle=Compound%2021%20%C2%B7%20Anna%20Stanhewicz%2C%20PhD&badge=phase%201 Compound 21 Compound 21 · Anna Stanhewicz, PhD https://druglandscape.com/drug/compound-pholcodine-oral-solution https://druglandscape.com/api/og?type=drug&title=compound%20pholcodine%20oral%20solution&subtitle=compound%20pholcodine%20oral%20solution%20%C2%B7%20Shanghai%20Children's%20Medical%20Center&badge=phase%201 compound pholcodine oral solution compound pholcodine oral solution · Shanghai Children's Medical Center https://druglandscape.com/drug/compound-vitamin-b12 https://druglandscape.com/api/og?type=drug&title=Compound%20Vitamin%20B12&subtitle=Compound%20Vitamin%20B12%20%C2%B7%20Wei%20LUO&badge=phase%202 Compound Vitamin B12 Compound Vitamin B12 · Wei LUO https://druglandscape.com/drug/comtan https://druglandscape.com/api/og?type=drug&title=Comtan%C2%AE&subtitle=Comtan%C2%AE%20%C2%B7%20Bial%20-%20Portela%20C%20S.A.&badge=phase%202 Comtan® Comtan® · Bial - Portela C S.A. https://druglandscape.com/drug/concentrate-of-red-blood-cells https://druglandscape.com/api/og?type=drug&title=concentrate%20of%20red%20blood%20cells&subtitle=concentrate%20of%20red%20blood%20cells%20%C2%B7%20Micha%C5%82%20Stasiowski&badge=phase%201 concentrate of red blood cells concentrate of red blood cells · Michał Stasiowski https://druglandscape.com/drug/concomitant-bevacizumab https://druglandscape.com/api/og?type=drug&title=Concomitant%20Bevacizumab&subtitle=Concomitant%20Bevacizumab%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Concomitant Bevacizumab Concomitant Bevacizumab · Hoffmann-La Roche https://druglandscape.com/drug/conditioned-media https://druglandscape.com/api/og?type=drug&title=Conditioned%20Media&subtitle=Conditioned%20Media%20%C2%B7%20Sukma%20Skin%20Treatment&badge=phase%201 Conditioned Media Conditioned Media · Sukma Skin Treatment https://druglandscape.com/drug/conditioned-medium https://druglandscape.com/api/og?type=drug&title=Conditioned%20Medium&subtitle=Conditioned%20Medium%20%C2%B7%20PT.%20Prodia%20Stem%20Cell%20Indonesia&badge=phase%201 Conditioned Medium Conditioned Medium · PT. Prodia Stem Cell Indonesia https://druglandscape.com/drug/conivaptan-and-furosemide https://druglandscape.com/api/og?type=drug&title=Conivaptan%20and%20furosemide&subtitle=Conivaptan%20and%20furosemide%20%C2%B7%20Hennepin%20County%20Medical%20Center%2C%20Minneapolis&badge=phase%201 Conivaptan and furosemide Conivaptan and furosemide · Hennepin County Medical Center, Minneapolis https://druglandscape.com/drug/conm-sosip https://druglandscape.com/api/og?type=drug&title=ConM%20SOSIP&subtitle=ConM%20SOSIP%20%C2%B7%20Imperial%20College%20London&badge=phase%201 ConM SOSIP ConM SOSIP · Imperial College London https://druglandscape.com/drug/connettivina-0-2-cream https://druglandscape.com/api/og?type=drug&title=Connettivina%200.2%25%20Cream&subtitle=Connettivina%200.2%25%20Cream%20%C2%B7%20Istituto%20Ganassini%20S.p.A.%20di%20Ricerche%20Biochimiche&badge=phase%201 Connettivina 0.2% Cream Connettivina 0.2% Cream · Istituto Ganassini S.p.A. di Ricerche Biochimiche https://druglandscape.com/drug/cons-ufo https://druglandscape.com/api/og?type=drug&title=ConS%20UFO&subtitle=ConS%20UFO%20%C2%B7%20Imperial%20College%20London&badge=phase%201 ConS UFO ConS UFO · Imperial College London https://druglandscape.com/drug/consolidation-5-fluorouracil https://druglandscape.com/api/og?type=drug&title=consolidation%205-fluorouracil&subtitle=consolidation%205-fluorouracil%20%C2%B7%20Radiation%20Therapy%20Oncology%20Group&badge=phase%202 consolidation 5-fluorouracil consolidation 5-fluorouracil · Radiation Therapy Oncology Group https://druglandscape.com/drug/consolidation-cisplatin https://druglandscape.com/api/og?type=drug&title=consolidation%20cisplatin&subtitle=consolidation%20cisplatin%20%C2%B7%20Radiation%20Therapy%20Oncology%20Group&badge=phase%202 consolidation cisplatin consolidation cisplatin · Radiation Therapy Oncology Group https://druglandscape.com/drug/consolidation-doublet-therapy https://druglandscape.com/api/og?type=drug&title=Consolidation%20Doublet%20Therapy%3A&subtitle=Consolidation%20Doublet%20Therapy%3A%20%C2%B7%20Inova%20Health%20Care%20Services&badge=phase%202 Consolidation Doublet Therapy: Consolidation Doublet Therapy: · Inova Health Care Services https://druglandscape.com/drug/consolidation-gemcitabine https://druglandscape.com/api/og?type=drug&title=consolidation%20gemcitabine&subtitle=consolidation%20gemcitabine%20%C2%B7%20Radiation%20Therapy%20Oncology%20Group&badge=phase%202 consolidation gemcitabine consolidation gemcitabine · Radiation Therapy Oncology Group https://druglandscape.com/drug/consolidation-vincristine-mecaptopurine-intrathecal-methotrexate https://druglandscape.com/api/og?type=drug&title=Consolidation%3A%20Vincristine%2C%20Mecaptopurine%2C%20Intrathecal%20Methotrexate&subtitle=Consolidation%3A%20Vincristine%2C%20Mecaptopurine%2C%20Intrathecal%20Methotrexate%20%C2%B7%20Hee%20Young%20Ju&badge=phase%202 Consolidation: Vincristine, Mecaptopurine, Intrathecal Methotrexate Consolidation: Vincristine, Mecaptopurine, Intrathecal Methotrexate · Hee Young Ju https://druglandscape.com/drug/continuation-of-somatostatin-analogues https://druglandscape.com/api/og?type=drug&title=Continuation%20of%20somatostatin%20analogues&subtitle=Continuation%20of%20somatostatin%20analogues%20%C2%B7%20Australasian%20Gastro-Intestinal%20Trials%20Group&badge=phase%202 Continuation of somatostatin analogues Continuation of somatostatin analogues · Australasian Gastro-Intestinal Trials Group https://druglandscape.com/drug/continuation-of-spironolactone https://druglandscape.com/api/og?type=drug&title=Continuation%20of%20spironolactone&subtitle=Continuation%20of%20spironolactone%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 Continuation of spironolactone Continuation of spironolactone · Asan Medical Center https://druglandscape.com/drug/continues-peripheral-block https://druglandscape.com/api/og?type=drug&title=Continues%20peripheral%20block&subtitle=Continues%20peripheral%20block%20%C2%B7%20Assaf-Harofeh%20Medical%20Center&badge=phase%201 Continues peripheral block Continues peripheral block · Assaf-Harofeh Medical Center https://druglandscape.com/drug/continuous-interscalene-brachial-plexus-block https://druglandscape.com/api/og?type=drug&title=continuous%20interscalene%20brachial%20plexus%20block&subtitle=continuous%20interscalene%20brachial%20plexus%20block%20%C2%B7%20Ciusss%20de%20L'Est%20de%20l'%C3%8Ele%20de%20Montr%C3%A9al&badge=phase%201 continuous interscalene brachial plexus block continuous interscalene brachial plexus block · Ciusss de L'Est de l'Île de Montréal https://druglandscape.com/drug/continuous-intra-femoral-thrombolysis-group https://druglandscape.com/api/og?type=drug&title=continuous%20intra-femoral%20thrombolysis%20group&subtitle=continuous%20intra-femoral%20thrombolysis%20group%20%C2%B7%20Xiang%20Guang-da&badge=phase%202 continuous intra-femoral thrombolysis group continuous intra-femoral thrombolysis group · Xiang Guang-da https://druglandscape.com/drug/continuous-iv-remifentanil https://druglandscape.com/api/og?type=drug&title=Continuous%20IV%20remifentanil&subtitle=Continuous%20IV%20remifentanil%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 Continuous IV remifentanil Continuous IV remifentanil · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/continuous-nebulization-of-salbutamol https://druglandscape.com/api/og?type=drug&title=Continuous%20Nebulization%20of%20Salbutamol&subtitle=Continuous%20Nebulization%20of%20Salbutamol%20%C2%B7%20Muhammad%20Aamir%20Latif&badge=phase%201 Continuous Nebulization of Salbutamol Continuous Nebulization of Salbutamol · Muhammad Aamir Latif https://druglandscape.com/drug/continuous-oral-cyclophosphamide-and-methotrexate https://druglandscape.com/api/og?type=drug&title=continuous%20oral%20cyclophosphamide%20and%20methotrexate&subtitle=continuous%20oral%20cyclophosphamide%20and%20methotrexate%20%C2%B7%20Grupo%20de%20Apoio%20ao%20Adolescente%20e%20a%20Crianca%20com%20Ca&badge=phase%202 continuous oral cyclophosphamide and methotrexate continuous oral cyclophosphamide and methotrexate · Grupo de Apoio ao Adolescente e a Crianca com Cancer https://druglandscape.com/drug/contraceptives-oral-combined https://druglandscape.com/api/og?type=drug&title=Contraceptives%2C%20Oral%2C%20Combined&subtitle=Contraceptives%2C%20Oral%2C%20Combined%20%C2%B7%20Bial%20-%20Portela%20C%20S.A.&badge=phase%202 Contraceptives, Oral, Combined Contraceptives, Oral, Combined · Bial - Portela C S.A. https://druglandscape.com/drug/contrast-media https://druglandscape.com/api/og?type=drug&title=Contrast%20Media&subtitle=Contrast%20Media%20%C2%B7%20Nextrast%2C%20Inc.&badge=phase%202 Contrast Media Contrast Media · Nextrast, Inc. https://druglandscape.com/drug/contrast-ultrasound https://druglandscape.com/api/og?type=drug&title=Contrast%20Ultrasound&subtitle=Contrast%20Ultrasound%20%C2%B7%20Rabih%20A.%20Chaer&badge=phase%202 Contrast Ultrasound Contrast Ultrasound · Rabih A. Chaer https://druglandscape.com/drug/control-cream-with-naloxone https://druglandscape.com/api/og?type=drug&title=Control%20Cream%20with%20Naloxone&subtitle=Control%20Cream%20with%20Naloxone%20%C2%B7%20Trustees%20of%20Dartmouth%20College&badge=phase%201 Control Cream with Naloxone Control Cream with Naloxone · Trustees of Dartmouth College https://druglandscape.com/drug/control-live-attenuated-varicella-vaccine https://druglandscape.com/api/og?type=drug&title=control%20live%20attenuated%20varicella%20vaccine&subtitle=control%20live%20attenuated%20varicella%20vaccine%20%C2%B7%20Sinovac%20(Dalian)%20Vaccine%20Technology%20Co.%2C%20Ltd.&badge=phase%201 control live attenuated varicella vaccine control live attenuated varicella vaccine · Sinovac (Dalian) Vaccine Technology Co., Ltd. https://druglandscape.com/drug/control-sodium-chloride-0-9 https://druglandscape.com/api/og?type=drug&title=Control%20Sodium%20Chloride%200.9%25&subtitle=Control%20Sodium%20Chloride%200.9%25%20%C2%B7%20Aeras&badge=phase%201 Control Sodium Chloride 0.9% Control Sodium Chloride 0.9% · Aeras https://druglandscape.com/drug/control-vaccine-older-adults https://druglandscape.com/api/og?type=drug&title=Control%20vaccine%20older%20adults&subtitle=Control%20vaccine%20older%20adults%20%C2%B7%20Arcturus%20Therapeutics%2C%20Inc.&badge=phase%201 Control vaccine older adults Control vaccine older adults · Arcturus Therapeutics, Inc. https://druglandscape.com/drug/control-vaccine-younger-adults https://druglandscape.com/api/og?type=drug&title=Control%20vaccine%20younger%20adults&subtitle=Control%20vaccine%20younger%20adults%20%C2%B7%20Arcturus%20Therapeutics%2C%20Inc.&badge=phase%201 Control vaccine younger adults Control vaccine younger adults · Arcturus Therapeutics, Inc. https://druglandscape.com/drug/control-zyrtec https://druglandscape.com/api/og?type=drug&title=Control%3A%20Zyrtec&subtitle=Control%3A%20Zyrtec%20%C2%B7%20JDP%20Therapeutics%2C%20Inc.&badge=phase%201 Control: Zyrtec Control: Zyrtec · JDP Therapeutics, Inc. https://druglandscape.com/drug/controlled-ovarian-stimulation https://druglandscape.com/api/og?type=drug&title=Controlled%20ovarian%20stimulation&subtitle=Controlled%20ovarian%20stimulation%20%C2%B7%20Istituto%20Clinico%20Humanitas&badge=phase%202 Controlled ovarian stimulation Controlled ovarian stimulation · Istituto Clinico Humanitas https://druglandscape.com/drug/convalescent-plasma-from-covid-19-donors https://druglandscape.com/api/og?type=drug&title=Convalescent%20Plasma%20from%20COVID-19%20donors&subtitle=Convalescent%20Plasma%20from%20COVID-19%20donors%20%C2%B7%20Fundacion%20Arturo%20Lopez%20Perez&badge=phase%202 Convalescent Plasma from COVID-19 donors Convalescent Plasma from COVID-19 donors · Fundacion Arturo Lopez Perez https://druglandscape.com/drug/convention-drugs https://druglandscape.com/api/og?type=drug&title=convention%20drugs&subtitle=convention%20drugs%20%C2%B7%20Hui%20ting%20Xu%EF%BC%8CMD&badge=phase%201 convention drugs convention drugs · Hui ting Xu，MD https://druglandscape.com/drug/conventional-controlled-ovarian-stimulation-proctol https://druglandscape.com/api/og?type=drug&title=Conventional%20controlled%20ovarian%20stimulation%20proctol&subtitle=Conventional%20controlled%20ovarian%20stimulation%20proctol%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Conventional controlled ovarian stimulation proctol Conventional controlled ovarian stimulation proctol · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/conventional-fviii-replacement-therapies https://druglandscape.com/api/og?type=drug&title=Conventional%20FVIII%20replacement%20therapies&subtitle=Conventional%20FVIII%20replacement%20therapies%20%C2%B7%20Bayer&badge=phase%202 Conventional FVIII replacement therapies Conventional FVIII replacement therapies · Bayer https://druglandscape.com/drug/conventional-mood-stabilizers https://druglandscape.com/api/og?type=drug&title=conventional%20mood%20stabilizers&subtitle=conventional%20mood%20stabilizers%20%C2%B7%20Shanghai%20Mental%20Health%20Center&badge=phase%202 conventional mood stabilizers conventional mood stabilizers · Shanghai Mental Health Center https://druglandscape.com/drug/conventional-oral-iron https://druglandscape.com/api/og?type=drug&title=conventional%20oral%20iron&subtitle=conventional%20oral%20iron%20%C2%B7%20Medeni%20%C5%9Eermet&badge=phase%201 conventional oral iron conventional oral iron · Medeni Şermet https://druglandscape.com/drug/conventional-pain-management https://druglandscape.com/api/og?type=drug&title=Conventional%20pain%20management&subtitle=Conventional%20pain%20management%20%C2%B7%20Eckehart%20SCH%C3%96LL&badge=phase%201 Conventional pain management Conventional pain management · Eckehart SCHÖLL https://druglandscape.com/drug/conventional-steroid-regimen https://druglandscape.com/api/og?type=drug&title=Conventional%20steroid%20regimen&subtitle=Conventional%20steroid%20regimen%20%C2%B7%20Centro%20de%20Investigaci%C3%B3n%20en.%20Enfermedades%20Infecciosas%2C%20Mexico&badge=phase%201 Conventional steroid regimen Conventional steroid regimen · Centro de Investigación en. Enfermedades Infecciosas, Mexico https://druglandscape.com/drug/conventional-therapy-plus-mensc-transplantation https://druglandscape.com/api/og?type=drug&title=conventional%20therapy%20plus%20MenSC%20transplantation&subtitle=conventional%20therapy%20plus%20MenSC%20transplantation%20%C2%B7%20S-Evans%20Biosciences%20Co.%2C%20Ltd.&badge=phase%201 conventional therapy plus MenSC transplantation conventional therapy plus MenSC transplantation · S-Evans Biosciences Co., Ltd. https://druglandscape.com/drug/conversion-from-cni-to-mmf https://druglandscape.com/api/og?type=drug&title=conversion%20from%20CNI%20to%20MMF&subtitle=conversion%20from%20CNI%20to%20MMF%20%C2%B7%20Pontificia%20Universidad%20Catolica%20de%20Chile&badge=phase%201 conversion from CNI to MMF conversion from CNI to MMF · Pontificia Universidad Catolica de Chile https://druglandscape.com/drug/cooperstown-cocktail https://druglandscape.com/api/og?type=drug&title=Cooperstown%20Cocktail&subtitle=Cooperstown%20Cocktail%20%C2%B7%20Tesaro%2C%20Inc.&badge=phase%201 Cooperstown Cocktail Cooperstown Cocktail · Tesaro, Inc. https://druglandscape.com/drug/copd-pharmacologic-substance https://druglandscape.com/api/og?type=drug&title=COPD%20Pharmacologic%20Substance&subtitle=COPD%20Pharmacologic%20Substance%20%C2%B7%20Elpen%20Pharmaceutical%20Co.%20Inc.&badge=phase%202 COPD Pharmacologic Substance COPD Pharmacologic Substance · Elpen Pharmaceutical Co. Inc. https://druglandscape.com/drug/copper-cu-64-dota-alendronate https://druglandscape.com/api/og?type=drug&title=Copper%20Cu-64-DOTA-alendronate&subtitle=Copper%20Cu-64-DOTA-alendronate%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%201 Copper Cu-64-DOTA-alendronate Copper Cu-64-DOTA-alendronate · City of Hope Medical Center https://druglandscape.com/drug/coppertone-bay1183345 https://druglandscape.com/api/og?type=drug&title=Coppertone%2C%20BAY1183345&subtitle=Coppertone%2C%20BAY1183345%20%C2%B7%20Bayer&badge=phase%201 Coppertone, BAY1183345 Coppertone, BAY1183345 · Bayer https://druglandscape.com/drug/cor-101 https://druglandscape.com/api/og?type=drug&title=COR-101&subtitle=COR-101%20%C2%B7%20Corat%20Therapeutics%20Gmbh&badge=phase%201 COR-101 COR-101 · Corat Therapeutics Gmbh https://druglandscape.com/drug/cord-blood-sampling https://druglandscape.com/api/og?type=drug&title=Cord%20blood%20sampling&subtitle=Cord%20blood%20sampling%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 Cord blood sampling Cord blood sampling · Hospices Civils de Lyon https://druglandscape.com/drug/cord-sampling https://druglandscape.com/api/og?type=drug&title=Cord%20sampling&subtitle=Cord%20sampling%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 Cord sampling Cord sampling · Hospices Civils de Lyon https://druglandscape.com/drug/cordstem-st https://druglandscape.com/api/og?type=drug&title=Cordstem-ST&subtitle=Cordstem-ST%20%C2%B7%20CHABiotech%20CO.%2C%20Ltd&badge=phase%201 Cordstem-ST Cordstem-ST · CHABiotech CO., Ltd https://druglandscape.com/drug/cordycepin-plus-pentostatin https://druglandscape.com/api/og?type=drug&title=Cordycepin%20plus%20Pentostatin&subtitle=Cordycepin%20plus%20Pentostatin%20%C2%B7%20OncoVista%2C%20Inc.&badge=phase%201 Cordycepin plus Pentostatin Cordycepin plus Pentostatin · OncoVista, Inc. https://druglandscape.com/drug/cort108297 https://druglandscape.com/api/og?type=drug&title=CORT108297&subtitle=CORT108297%20%C2%B7%20VA%20Office%20of%20Research%20and%20Development&badge=phase%202 CORT108297 CORT108297 · VA Office of Research and Development https://druglandscape.com/drug/cortexolone-17-propionate https://druglandscape.com/api/og?type=drug&title=cortexolone%2017%CE%B1-propionate&subtitle=cortexolone%2017%CE%B1-propionate%20%C2%B7%20Cassiopea%20SpA&badge=phase%202 cortexolone 17α-propionate cortexolone 17α-propionate · Cassiopea SpA https://druglandscape.com/drug/corticoid-acetonide-triamcinolone-0-2 https://druglandscape.com/api/og?type=drug&title=Corticoid%20Acetonide%20triamcinolone%200.2%25&subtitle=Corticoid%20Acetonide%20triamcinolone%200.2%25%20%C2%B7%20Pia%20Lopez%20Jornet&badge=phase%201 Corticoid Acetonide triamcinolone 0.2% Corticoid Acetonide triamcinolone 0.2% · Pia Lopez Jornet https://druglandscape.com/drug/corticosteroid-dexamethasone https://druglandscape.com/api/og?type=drug&title=Corticosteroid%3A%20Dexamethasone&subtitle=Corticosteroid%3A%20Dexamethasone%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 Corticosteroid: Dexamethasone Corticosteroid: Dexamethasone · Bristol-Myers Squibb https://druglandscape.com/drug/corticosteroid-fludrocortisone https://druglandscape.com/api/og?type=drug&title=Corticosteroid%3A%20Fludrocortisone&subtitle=Corticosteroid%3A%20Fludrocortisone%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 Corticosteroid: Fludrocortisone Corticosteroid: Fludrocortisone · Bristol-Myers Squibb https://druglandscape.com/drug/corticosteroid-hydrocortisone https://druglandscape.com/api/og?type=drug&title=Corticosteroid%3A%20Hydrocortisone&subtitle=Corticosteroid%3A%20Hydrocortisone%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 Corticosteroid: Hydrocortisone Corticosteroid: Hydrocortisone · Bristol-Myers Squibb https://druglandscape.com/drug/corticosteroids-and-immunosuppressants https://druglandscape.com/api/og?type=drug&title=corticosteroids%20and%20immunosuppressants&subtitle=corticosteroids%20and%20immunosuppressants%20%C2%B7%20Bausch%20%26%20Lomb%20Incorporated&badge=phase%202 corticosteroids and immunosuppressants corticosteroids and immunosuppressants · Bausch & Lomb Incorporated https://druglandscape.com/drug/corticosteroids-mycophenolate-mofetil https://druglandscape.com/api/og?type=drug&title=Corticosteroids%2C%20Mycophenolate%20mofetil&subtitle=Corticosteroids%2C%20Mycophenolate%20mofetil%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%201 Corticosteroids, Mycophenolate mofetil Corticosteroids, Mycophenolate mofetil · Samsung Medical Center https://druglandscape.com/drug/corticosteroids-triamcinolone-acetonide https://druglandscape.com/api/og?type=drug&title=Corticosteroids%20Triamcinolone%20Acetonide&subtitle=Corticosteroids%20Triamcinolone%20Acetonide%20%C2%B7%20%C5%9Eeyhmus%20KAPLAN&badge=phase%201 Corticosteroids Triamcinolone Acetonide Corticosteroids Triamcinolone Acetonide · Şeyhmus KAPLAN https://druglandscape.com/drug/cortisone-injectable https://druglandscape.com/api/og?type=drug&title=Cortisone%20Injectable&subtitle=Cortisone%20Injectable%20%C2%B7%20InGeneron%2C%20Inc.&badge=phase%201 Cortisone Injectable Cortisone Injectable · InGeneron, Inc. https://druglandscape.com/drug/cosentyx-secukinumab https://druglandscape.com/api/og?type=drug&title=Cosentyx%EF%BC%88Secukinumab%20%EF%BC%89&subtitle=Cosentyx%EF%BC%88Secukinumab%20%EF%BC%89%20%C2%B7%20BioRay%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Cosentyx（Secukinumab ） Cosentyx（Secukinumab ） · BioRay Pharmaceutical Co., Ltd. https://druglandscape.com/drug/cotadutide-300-micrograms https://druglandscape.com/api/og?type=drug&title=Cotadutide%20300%20micrograms&subtitle=Cotadutide%20300%20micrograms%20%C2%B7%20AstraZeneca&badge=phase%202 Cotadutide 300 micrograms Cotadutide 300 micrograms · AstraZeneca https://druglandscape.com/drug/covax-19 https://druglandscape.com/api/og?type=drug&title=Covax-19%E2%84%A2&subtitle=Covax-19%E2%84%A2%20%C2%B7%20GeneCure%20Biotechnologies&badge=phase%201 Covax-19™ Covax-19™ · GeneCure Biotechnologies https://druglandscape.com/drug/covi-vac https://druglandscape.com/api/og?type=drug&title=COVI-VAC&subtitle=COVI-VAC%20%C2%B7%20Codagenix%2C%20Inc&badge=phase%201 COVI-VAC COVI-VAC · Codagenix, Inc https://druglandscape.com/drug/covid-19-standard-therapy https://druglandscape.com/api/og?type=drug&title=COVID-19%20Standard%20Therapy&subtitle=COVID-19%20Standard%20Therapy%20%C2%B7%20Catalysis%20SL&badge=phase%201 COVID-19 Standard Therapy COVID-19 Standard Therapy · Catalysis SL https://druglandscape.com/drug/covid-19-vaccine-1 https://druglandscape.com/api/og?type=drug&title=COVID-19%20Vaccine%201&subtitle=COVID-19%20Vaccine%201%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 COVID-19 Vaccine 1 COVID-19 Vaccine 1 · ModernaTX, Inc. https://druglandscape.com/drug/covid-19-vaccine-2 https://druglandscape.com/api/og?type=drug&title=COVID-19%20Vaccine%202&subtitle=COVID-19%20Vaccine%202%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 COVID-19 Vaccine 2 COVID-19 Vaccine 2 · ModernaTX, Inc. https://druglandscape.com/drug/covid-19-vaccine-high-dose-level https://druglandscape.com/api/og?type=drug&title=COVID-19%20vaccine%2C%20high%20dose%20level&subtitle=COVID-19%20vaccine%2C%20high%20dose%20level%20%C2%B7%20Rokote%20Laboratories%20Finland%20Oy&badge=phase%201 COVID-19 vaccine, high dose level COVID-19 vaccine, high dose level · Rokote Laboratories Finland Oy https://druglandscape.com/drug/covid-globulin https://druglandscape.com/api/og?type=drug&title=COVID-globulin&subtitle=COVID-globulin%20%C2%B7%20Microgen&badge=phase%202 COVID-globulin COVID-globulin · Microgen https://druglandscape.com/drug/covid-hig https://druglandscape.com/api/og?type=drug&title=COVID-HIG&subtitle=COVID-HIG%20%C2%B7%20Emergent%20BioSolutions&badge=phase%201 COVID-HIG COVID-HIG · Emergent BioSolutions https://druglandscape.com/drug/covid-higiv https://druglandscape.com/api/og?type=drug&title=COVID-HIGIV&subtitle=COVID-HIGIV%20%C2%B7%20Emergent%20BioSolutions&badge=phase%201 COVID-HIGIV COVID-HIGIV · Emergent BioSolutions https://druglandscape.com/drug/covid-vaccination https://druglandscape.com/api/og?type=drug&title=COVID%20vaccination&subtitle=COVID%20vaccination%20%C2%B7%20King's%20College%20London&badge=phase%202 COVID vaccination COVID vaccination · King's College London https://druglandscape.com/drug/coxsackievirus-a21 https://druglandscape.com/api/og?type=drug&title=Coxsackievirus%20A21&subtitle=Coxsackievirus%20A21%20%C2%B7%20Viralytics&badge=phase%201 Coxsackievirus A21 Coxsackievirus A21 · Viralytics https://druglandscape.com/drug/cp-481-715 https://druglandscape.com/api/og?type=drug&title=CP-481%2C715&subtitle=CP-481%2C715%20%C2%B7%20Pfizer&badge=phase%201 CP-481,715 CP-481,715 · Pfizer https://druglandscape.com/drug/cp-533-536 https://druglandscape.com/api/og?type=drug&title=CP-533%2C%20536&subtitle=CP-533%2C%20536%20%C2%B7%20Pfizer&badge=phase%202 CP-533, 536 CP-533, 536 · Pfizer https://druglandscape.com/drug/cp-675-206-and-gemcitabine https://druglandscape.com/api/og?type=drug&title=CP-675%2C206%20and%20gemcitabine&subtitle=CP-675%2C206%20and%20gemcitabine%20%C2%B7%20AstraZeneca&badge=phase%201 CP-675,206 and gemcitabine CP-675,206 and gemcitabine · AstraZeneca https://druglandscape.com/drug/cp-690-550-and-cyclosporine https://druglandscape.com/api/og?type=drug&title=CP-%20690%2C550%20and%20Cyclosporine&subtitle=CP-%20690%2C550%20and%20Cyclosporine%20%C2%B7%20Pfizer&badge=phase%201 CP- 690,550 and Cyclosporine CP- 690,550 and Cyclosporine · Pfizer https://druglandscape.com/drug/cp-690-550-and-tacrolimus https://druglandscape.com/api/og?type=drug&title=CP-%20690%2C550%20and%20Tacrolimus&subtitle=CP-%20690%2C550%20and%20Tacrolimus%20%C2%B7%20Pfizer&badge=phase%201 CP- 690,550 and Tacrolimus CP- 690,550 and Tacrolimus · Pfizer https://druglandscape.com/drug/cp-70-429-and-pf-03709270 https://druglandscape.com/api/og?type=drug&title=CP-70%2C429%20and%20PF-03709270&subtitle=CP-70%2C429%20and%20PF-03709270%20%C2%B7%20Pfizer&badge=phase%201 CP-70,429 and PF-03709270 CP-70,429 and PF-03709270 · Pfizer https://druglandscape.com/drug/cp-866-087 https://druglandscape.com/api/og?type=drug&title=CP-866%2C087&subtitle=CP-866%2C087%20%C2%B7%20Pfizer&badge=phase%202 CP-866,087 CP-866,087 · Pfizer https://druglandscape.com/drug/cp-868-596 https://druglandscape.com/api/og?type=drug&title=CP-868%2C596&subtitle=CP-868%2C596%20%C2%B7%20Arog%20Pharmaceuticals%2C%20Inc.&badge=phase%201 CP-868,596 CP-868,596 · Arog Pharmaceuticals, Inc. https://druglandscape.com/drug/cp12 https://druglandscape.com/api/og?type=drug&title=cP12&subtitle=cP12%20%C2%B7%20Neomatrix%20Therapeutics%2C%20Inc.&badge=phase%202 cP12 cP12 · Neomatrix Therapeutics, Inc. https://druglandscape.com/drug/cpcb-rpe1 https://druglandscape.com/api/og?type=drug&title=CPCB-RPE1&subtitle=CPCB-RPE1%20%C2%B7%20Regenerative%20Patch%20Technologies%2C%20LLC&badge=phase%201 CPCB-RPE1 CPCB-RPE1 · Regenerative Patch Technologies, LLC https://druglandscape.com/drug/cpd-1061 https://druglandscape.com/api/og?type=drug&title=CPD-1061&subtitle=CPD-1061%20%C2%B7%20Centre%20for%20Probe%20Development%20and%20Commercialization&badge=phase%201 CPD-1061 CPD-1061 · Centre for Probe Development and Commercialization https://druglandscape.com/drug/cpert https://druglandscape.com/api/og?type=drug&title=CPERT&subtitle=CPERT%20%C2%B7%20AHS%20Cancer%20Control%20Alberta&badge=phase%201 CPERT CPERT · AHS Cancer Control Alberta https://druglandscape.com/drug/cpg-10104 https://druglandscape.com/api/og?type=drug&title=CpG%2010104&subtitle=CpG%2010104%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 CpG 10104 CpG 10104 · Baylor College of Medicine https://druglandscape.com/drug/cpg-1018 https://druglandscape.com/api/og?type=drug&title=CpG%201018%C2%AE&subtitle=CpG%201018%C2%AE%20%C2%B7%20Valneva%20Austria%20GmbH&badge=phase%201 CpG 1018® CpG 1018® · Valneva Austria GmbH https://druglandscape.com/drug/cpi-006 https://druglandscape.com/api/og?type=drug&title=CPI-006&subtitle=CPI-006%20%C2%B7%20Corvus%20Pharmaceuticals%2C%20Inc.&badge=phase%201 CPI-006 CPI-006 · Corvus Pharmaceuticals, Inc. https://druglandscape.com/drug/cpi-100 https://druglandscape.com/api/og?type=drug&title=CPI-100&subtitle=CPI-100%20%C2%B7%20Coordination%20Pharmaceuticals%2C%20Inc.&badge=phase%201 CPI-100 CPI-100 · Coordination Pharmaceuticals, Inc. https://druglandscape.com/drug/cpi-300 https://druglandscape.com/api/og?type=drug&title=CPI-300&subtitle=CPI-300%20%C2%B7%20Coordination%20Pharmaceuticals%2C%20Inc.&badge=phase%201 CPI-300 CPI-300 · Coordination Pharmaceuticals, Inc. https://druglandscape.com/drug/cpi-444 https://druglandscape.com/api/og?type=drug&title=CPI-444&subtitle=CPI-444%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 CPI-444 CPI-444 · Hoffmann-La Roche https://druglandscape.com/drug/cpi-444-capsules https://druglandscape.com/api/og?type=drug&title=CPI-444%20Capsules&subtitle=CPI-444%20Capsules%20%C2%B7%20Corvus%20Pharmaceuticals%2C%20Inc.&badge=phase%201 CPI-444 Capsules CPI-444 Capsules · Corvus Pharmaceuticals, Inc. https://druglandscape.com/drug/cpi-818 https://druglandscape.com/api/og?type=drug&title=CPI-818&subtitle=CPI-818%20%C2%B7%20Corvus%20Pharmaceuticals%2C%20Inc.&badge=phase%201 CPI-818 CPI-818 · Corvus Pharmaceuticals, Inc. https://druglandscape.com/drug/cpl304110 https://druglandscape.com/api/og?type=drug&title=CPL304110&subtitle=CPL304110%20%C2%B7%20Celon%20Pharma%20SA&badge=phase%201 CPL304110 CPL304110 · Celon Pharma SA https://druglandscape.com/drug/cpl500036-compound https://druglandscape.com/api/og?type=drug&title=CPL500036%20compound&subtitle=CPL500036%20compound%20%C2%B7%20Celon%20Pharma%20SA&badge=phase%201 CPL500036 compound CPL500036 compound · Celon Pharma SA https://druglandscape.com/drug/cpo-100 https://druglandscape.com/api/og?type=drug&title=CPO-100&subtitle=CPO-100%20%C2%B7%20Conjupro%20Biotherapeutics%2C%20Inc.&badge=phase%201 CPO-100 CPO-100 · Conjupro Biotherapeutics, Inc. https://druglandscape.com/drug/cpo301 https://druglandscape.com/api/og?type=drug&title=CPO301&subtitle=CPO301%20%C2%B7%20Conjupro%20Biotherapeutics%2C%20Inc.&badge=phase%201 CPO301 CPO301 · Conjupro Biotherapeutics, Inc. https://druglandscape.com/drug/cpt-11-and-ts-1 https://druglandscape.com/api/og?type=drug&title=CPT-11%20and%20TS-1&subtitle=CPT-11%20and%20TS-1%20%C2%B7%20Taiho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 CPT-11 and TS-1 CPT-11 and TS-1 · Taiho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/cpt31 https://druglandscape.com/api/og?type=drug&title=CPT31&subtitle=CPT31%20%C2%B7%20Navigen%2C%20Inc.&badge=phase%201 CPT31 CPT31 · Navigen, Inc. https://druglandscape.com/drug/cpv-104 https://druglandscape.com/api/og?type=drug&title=CPV-104&subtitle=CPV-104%20%C2%B7%20eleva%20GmbH&badge=phase%201 CPV-104 CPV-104 · eleva GmbH https://druglandscape.com/drug/cpx-351-in-cohort-a https://druglandscape.com/api/og?type=drug&title=CPX-351%20in%20cohort%20A&subtitle=CPX-351%20in%20cohort%20A%20%C2%B7%20Groupe%20Francophone%20des%20Myelodysplasies&badge=phase%201 CPX-351 in cohort A CPX-351 in cohort A · Groupe Francophone des Myelodysplasies https://druglandscape.com/drug/cpx-351-in-cohort-b https://druglandscape.com/api/og?type=drug&title=CPX-351%20in%20cohort%20B&subtitle=CPX-351%20in%20cohort%20B%20%C2%B7%20Groupe%20Francophone%20des%20Myelodysplasies&badge=phase%201 CPX-351 in cohort B CPX-351 in cohort B · Groupe Francophone des Myelodysplasies https://druglandscape.com/drug/cqss2 https://druglandscape.com/api/og?type=drug&title=CQSS2&subtitle=CQSS2%20%C2%B7%20Chrono%20Therapeutics%2C%20Inc.&badge=phase%202 CQSS2 CQSS2 · Chrono Therapeutics, Inc. https://druglandscape.com/drug/cr-3 https://druglandscape.com/api/og?type=drug&title=CR%203&subtitle=CR%203%20%C2%B7%20Pfizer&badge=phase%201 CR 3 CR 3 · Pfizer https://druglandscape.com/drug/cr002-liquid-api https://druglandscape.com/api/og?type=drug&title=CR002%20Liquid%20API&subtitle=CR002%20Liquid%20API%20%C2%B7%20CSL%20Behring&badge=phase%201 CR002 Liquid API CR002 Liquid API · CSL Behring https://druglandscape.com/drug/cr011-vcmmae https://druglandscape.com/api/og?type=drug&title=CR011-vcMMAE&subtitle=CR011-vcMMAE%20%C2%B7%20CuraGen%20Corporation&badge=phase%201 CR011-vcMMAE CR011-vcMMAE · CuraGen Corporation https://druglandscape.com/drug/cra-24781 https://druglandscape.com/api/og?type=drug&title=CRA-24781&subtitle=CRA-24781%20%C2%B7%20Pharmacyclics%20LLC.&badge=phase%201 CRA-24781 CRA-24781 · Pharmacyclics LLC. https://druglandscape.com/drug/cranberries-vaccinium-macrocarpon https://druglandscape.com/api/og?type=drug&title=Cranberries%20-%20Vaccinium%20macrocarpon&subtitle=Cranberries%20-%20Vaccinium%20macrocarpon%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 Cranberries - Vaccinium macrocarpon Cranberries - Vaccinium macrocarpon · Hadassah Medical Organization https://druglandscape.com/drug/crb-601-monoclonal-antibody https://druglandscape.com/api/og?type=drug&title=CRB-601%20monoclonal%20antibody&subtitle=CRB-601%20monoclonal%20antibody%20%C2%B7%20Corbus%20Pharmaceuticals%20Inc.&badge=phase%201 CRB-601 monoclonal antibody CRB-601 monoclonal antibody · Corbus Pharmaceuticals Inc. https://druglandscape.com/drug/crb-701 https://druglandscape.com/api/og?type=drug&title=CRB-701&subtitle=CRB-701%20%C2%B7%20Corbus%20Pharmaceuticals%20Inc.&badge=phase%201 CRB-701 CRB-701 · Corbus Pharmaceuticals Inc. https://druglandscape.com/drug/crb-913 https://druglandscape.com/api/og?type=drug&title=CRB-913&subtitle=CRB-913%20%C2%B7%20Corbus%20Pharmaceuticals%20Inc.&badge=phase%201 CRB-913 CRB-913 · Corbus Pharmaceuticals Inc. https://druglandscape.com/drug/crd-tmh-001 https://druglandscape.com/api/og?type=drug&title=CRD-TMH-001&subtitle=CRD-TMH-001%20%C2%B7%20Cure%20Rare%20Disease%2C%20Inc&badge=phase%201 CRD-TMH-001 CRD-TMH-001 · Cure Rare Disease, Inc https://druglandscape.com/drug/creatine-monohydrate-conjugated-linoleic-acid https://druglandscape.com/api/og?type=drug&title=Creatine%20Monohydrate%2C%20Conjugated%20Linoleic%20Acid&subtitle=Creatine%20Monohydrate%2C%20Conjugated%20Linoleic%20Acid%20%C2%B7%20Hamilton%20Health%20Sciences%20Corporation&badge=phase%201 Creatine Monohydrate, Conjugated Linoleic Acid Creatine Monohydrate, Conjugated Linoleic Acid · Hamilton Health Sciences Corporation https://druglandscape.com/drug/creation-of-a-serum-biobank https://druglandscape.com/api/og?type=drug&title=Creation%20of%20a%20serum%20biobank&subtitle=Creation%20of%20a%20serum%20biobank%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 Creation of a serum biobank Creation of a serum biobank · Hospices Civils de Lyon https://druglandscape.com/drug/crenezumab-dose-level-1 https://druglandscape.com/api/og?type=drug&title=Crenezumab%20dose%20level%201&subtitle=Crenezumab%20dose%20level%201%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 Crenezumab dose level 1 Crenezumab dose level 1 · Genentech, Inc. https://druglandscape.com/drug/crenezumab-dose-level-2 https://druglandscape.com/api/og?type=drug&title=Crenezumab%20dose%20level%202&subtitle=Crenezumab%20dose%20level%202%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 Crenezumab dose level 2 Crenezumab dose level 2 · Genentech, Inc. https://druglandscape.com/drug/crenezumb-dose-level-3 https://druglandscape.com/api/og?type=drug&title=Crenezumb%20dose%20level%203&subtitle=Crenezumb%20dose%20level%203%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 Crenezumb dose level 3 Crenezumb dose level 3 · Genentech, Inc. https://druglandscape.com/drug/crest-cavity-protection-fresh-lime https://druglandscape.com/api/og?type=drug&title=Crest%20Cavity%20Protection%20Fresh%20Lime&subtitle=Crest%20Cavity%20Protection%20Fresh%20Lime%20%C2%B7%20HALEON&badge=phase%201 Crest Cavity Protection Fresh Lime Crest Cavity Protection Fresh Lime · HALEON https://druglandscape.com/drug/crest-cavity-protection-toothpaste https://druglandscape.com/api/og?type=drug&title=Crest%20Cavity%20Protection%20Toothpaste&subtitle=Crest%20Cavity%20Protection%20Toothpaste%20%C2%B7%20HALEON&badge=phase%201 Crest Cavity Protection Toothpaste Crest Cavity Protection Toothpaste · HALEON https://druglandscape.com/drug/cresto-olmetec https://druglandscape.com/api/og?type=drug&title=Cresto%2C%20Olmetec&subtitle=Cresto%2C%20Olmetec%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 Cresto, Olmetec Cresto, Olmetec · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/cripec-docetaxel https://druglandscape.com/api/og?type=drug&title=Cripec%20Docetaxel&subtitle=Cripec%20Docetaxel%20%C2%B7%20Amsterdam%20UMC%2C%20location%20VUmc&badge=phase%201 Cripec Docetaxel Cripec Docetaxel · Amsterdam UMC, location VUmc https://druglandscape.com/drug/cris100 https://druglandscape.com/api/og?type=drug&title=CRIS100&subtitle=CRIS100%20%C2%B7%20Crist%C3%A1lia%20Produtos%20Qu%C3%ADmicos%20Farmac%C3%AAuticos%20Ltda.&badge=phase%201 CRIS100 CRIS100 · Cristália Produtos Químicos Farmacêuticos Ltda. https://druglandscape.com/drug/crispr-scd001 https://druglandscape.com/api/og?type=drug&title=CRISPR_SCD001&subtitle=CRISPR_SCD001%20%C2%B7%20Mark%20Walters%2C%20MD&badge=phase%201 CRISPR_SCD001 CRISPR_SCD001 · Mark Walters, MD https://druglandscape.com/drug/critical-care-patients-venofer https://druglandscape.com/api/og?type=drug&title=critical%20care%20patients%20venofer&subtitle=critical%20care%20patients%20venofer%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 critical care patients venofer critical care patients venofer · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/crizotinib-oral-solution https://druglandscape.com/api/og?type=drug&title=crizotinib%20oral%20solution&subtitle=crizotinib%20oral%20solution%20%C2%B7%20Pfizer&badge=phase%201 crizotinib oral solution crizotinib oral solution · Pfizer https://druglandscape.com/drug/crn01941-oral-solution https://druglandscape.com/api/og?type=drug&title=CRN01941%20Oral%20Solution&subtitle=CRN01941%20Oral%20Solution%20%C2%B7%20Crinetics%20Pharmaceuticals%20Inc.&badge=phase%201 CRN01941 Oral Solution CRN01941 Oral Solution · Crinetics Pharmaceuticals Inc. https://druglandscape.com/drug/crn04894-oral-solution https://druglandscape.com/api/og?type=drug&title=CRN04894%20Oral%20Solution&subtitle=CRN04894%20Oral%20Solution%20%C2%B7%20Crinetics%20Pharmaceuticals%20Inc.&badge=phase%201 CRN04894 Oral Solution CRN04894 Oral Solution · Crinetics Pharmaceuticals Inc. https://druglandscape.com/drug/crn09682 https://druglandscape.com/api/og?type=drug&title=CRN09682&subtitle=CRN09682%20%C2%B7%20Crinetics%20Pharmaceuticals%20Inc.&badge=phase%201 CRN09682 CRN09682 · Crinetics Pharmaceuticals Inc. https://druglandscape.com/drug/crocin-and-apigenin https://druglandscape.com/api/og?type=drug&title=Crocin%20and%20Apigenin&subtitle=Crocin%20and%20Apigenin%20%C2%B7%20Jinnah%20Postgraduate%20Medical%20Centre&badge=phase%201 Crocin and Apigenin Crocin and Apigenin · Jinnah Postgraduate Medical Centre https://druglandscape.com/drug/crofelemer-oral-product https://druglandscape.com/api/og?type=drug&title=Crofelemer%20Oral%20Product&subtitle=Crofelemer%20Oral%20Product%20%C2%B7%20Lindsey%20Russell%2C%20MD&badge=phase%201 Crofelemer Oral Product Crofelemer Oral Product · Lindsey Russell, MD https://druglandscape.com/drug/crs-mitigation-strategies https://druglandscape.com/api/og?type=drug&title=CRS%20Mitigation%20Strategies&subtitle=CRS%20Mitigation%20Strategies%20%C2%B7%20Amgen&badge=phase%201 CRS Mitigation Strategies CRS Mitigation Strategies · Amgen https://druglandscape.com/drug/crte7a2-01-tcr-t-cell https://druglandscape.com/api/og?type=drug&title=CRTE7A2-01%20TCR-T%20Cell&subtitle=CRTE7A2-01%20TCR-T%20Cell%20%C2%B7%20Corregene%20Biotechnology%20Co.%2C%20Ltd&badge=phase%201 CRTE7A2-01 TCR-T Cell CRTE7A2-01 TCR-T Cell · Corregene Biotechnology Co., Ltd https://druglandscape.com/drug/crte7a2-01-tcr-t-cell-therapy https://druglandscape.com/api/og?type=drug&title=CRTE7A2-01%20TCR-T%20cell%20therapy&subtitle=CRTE7A2-01%20TCR-T%20cell%20therapy%20%C2%B7%20Corregene%20Biotechnology%20Co.%2C%20Ltd&badge=phase%201 CRTE7A2-01 TCR-T cell therapy CRTE7A2-01 TCR-T cell therapy · Corregene Biotechnology Co., Ltd https://druglandscape.com/drug/crude-indigo-naturalis-ointment https://druglandscape.com/api/og?type=drug&title=crude%20indigo%20naturalis%20ointment&subtitle=crude%20indigo%20naturalis%20ointment%20%C2%B7%20Yin-ku%20Lin&badge=phase%202 crude indigo naturalis ointment crude indigo naturalis ointment · Yin-ku Lin https://druglandscape.com/drug/crushed-d-amphetamine-sulfate-ir-tablets https://druglandscape.com/api/og?type=drug&title=Crushed%20d-amphetamine%20sulfate%20IR%20tablets&subtitle=Crushed%20d-amphetamine%20sulfate%20IR%20tablets%20%C2%B7%20Vallon%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Crushed d-amphetamine sulfate IR tablets Crushed d-amphetamine sulfate IR tablets · Vallon Pharmaceuticals, Inc. https://druglandscape.com/drug/crv431 https://druglandscape.com/api/og?type=drug&title=CRV431&subtitle=CRV431%20%C2%B7%20Hepion%20Pharmaceuticals%2C%20Inc.&badge=phase%201 CRV431 CRV431 · Hepion Pharmaceuticals, Inc. https://druglandscape.com/drug/crx-191 https://druglandscape.com/api/og?type=drug&title=CRx-191&subtitle=CRx-191%20%C2%B7%20Zalicus&badge=phase%201 CRx-191 CRx-191 · Zalicus https://druglandscape.com/drug/crx100-suspension-for-infusion https://druglandscape.com/api/og?type=drug&title=CRX100%20suspension%20for%20infusion&subtitle=CRX100%20suspension%20for%20infusion%20%C2%B7%20BioEclipse%20Therapeutics&badge=phase%201 CRX100 suspension for infusion CRX100 suspension for infusion · BioEclipse Therapeutics https://druglandscape.com/drug/cryopreserved-devitalized-adipose-tissue-allograft https://druglandscape.com/api/og?type=drug&title=Cryopreserved%20Devitalized%20Adipose%20Tissue%20Allograft&subtitle=Cryopreserved%20Devitalized%20Adipose%20Tissue%20Allograft%20%C2%B7%20Britecyte&badge=phase%201 Cryopreserved Devitalized Adipose Tissue Allograft Cryopreserved Devitalized Adipose Tissue Allograft · Britecyte https://druglandscape.com/drug/cryopreserved-umbilical-cord-allograft https://druglandscape.com/api/og?type=drug&title=Cryopreserved%20Umbilical%20Cord%20Allograft&subtitle=Cryopreserved%20Umbilical%20Cord%20Allograft%20%C2%B7%20Hackensack%20Meridian%20Health&badge=phase%202 Cryopreserved Umbilical Cord Allograft Cryopreserved Umbilical Cord Allograft · Hackensack Meridian Health https://druglandscape.com/drug/cryotherapy-alone https://druglandscape.com/api/og?type=drug&title=Cryotherapy%20alone&subtitle=Cryotherapy%20alone%20%C2%B7%20Icahn%20School%20of%20Medicine%20at%20Mount%20Sinai&badge=phase%201 Cryotherapy alone Cryotherapy alone · Icahn School of Medicine at Mount Sinai https://druglandscape.com/drug/crystalloid-based-prime-solution https://druglandscape.com/api/og?type=drug&title=Crystalloid%20based%20prime%20solution&subtitle=Crystalloid%20based%20prime%20solution%20%C2%B7%20Vastra%20Gotaland%20Region&badge=phase%201 Crystalloid based prime solution Crystalloid based prime solution · Vastra Gotaland Region https://druglandscape.com/drug/crystalloid-cardioplegic-solution https://druglandscape.com/api/og?type=drug&title=Crystalloid%20Cardioplegic%20solution&subtitle=Crystalloid%20Cardioplegic%20solution%20%C2%B7%20mohamed&badge=phase%201 Crystalloid Cardioplegic solution Crystalloid Cardioplegic solution · mohamed https://druglandscape.com/drug/cs-002 https://druglandscape.com/api/og?type=drug&title=CS-002&subtitle=CS-002%20%C2%B7%20Applied%20Biology%2C%20Inc.&badge=phase%201 CS-002 CS-002 · Applied Biology, Inc. https://druglandscape.com/drug/cs-8958-formulated-as-dry-powder https://druglandscape.com/api/og?type=drug&title=CS-8958%20formulated%20as%20dry%20powder&subtitle=CS-8958%20formulated%20as%20dry%20powder%20%C2%B7%20Biota%20Scientific%20Management%20Pty%20Ltd&badge=phase%201 CS-8958 formulated as dry powder CS-8958 formulated as dry powder · Biota Scientific Management Pty Ltd https://druglandscape.com/drug/cs1-sodium-valproate https://druglandscape.com/api/og?type=drug&title=CS1-Sodium%20Valproate&subtitle=CS1-Sodium%20Valproate%20%C2%B7%20Cereno%20Scientific%20AB&badge=phase%201 CS1-Sodium Valproate CS1-Sodium Valproate · Cereno Scientific AB https://druglandscape.com/drug/cs1002 https://druglandscape.com/api/og?type=drug&title=CS1002&subtitle=CS1002%20%C2%B7%20CStone%20Pharmaceuticals&badge=phase%201 CS1002 CS1002 · CStone Pharmaceuticals https://druglandscape.com/drug/cs1003 https://druglandscape.com/api/og?type=drug&title=CS1003&subtitle=CS1003%20%C2%B7%20CStone%20Pharmaceuticals&badge=phase%201 CS1003 CS1003 · CStone Pharmaceuticals https://druglandscape.com/drug/cs1003-monoclonal-antibody https://druglandscape.com/api/og?type=drug&title=CS1003%20monoclonal%20antibody&subtitle=CS1003%20monoclonal%20antibody%20%C2%B7%20CStone%20Pharmaceuticals&badge=phase%201 CS1003 monoclonal antibody CS1003 monoclonal antibody · CStone Pharmaceuticals https://druglandscape.com/drug/cs10br05 https://druglandscape.com/api/og?type=drug&title=CS10BR05&subtitle=CS10BR05%20%C2%B7%20Corestemchemon%2C%20Inc.&badge=phase%201 CS10BR05 CS10BR05 · Corestemchemon, Inc. https://druglandscape.com/drug/cs12192-capsule https://druglandscape.com/api/og?type=drug&title=CS12192%20capsule&subtitle=CS12192%20capsule%20%C2%B7%20Chipscreen%20Biosciences%2C%20Ltd.&badge=phase%201 CS12192 capsule CS12192 capsule · Chipscreen Biosciences, Ltd. https://druglandscape.com/drug/cs19-expressing-etec-strain https://druglandscape.com/api/og?type=drug&title=CS19%20expressing%20ETEC%20strain&subtitle=CS19%20expressing%20ETEC%20strain%20%C2%B7%20Johns%20Hopkins%20Bloomberg%20School%20of%20Public%20Health&badge=phase%201 CS19 expressing ETEC strain CS19 expressing ETEC strain · Johns Hopkins Bloomberg School of Public Health https://druglandscape.com/drug/cs231295 https://druglandscape.com/api/og?type=drug&title=CS231295&subtitle=CS231295%20%C2%B7%20Chipscreen%20Biosciences%2C%20Ltd.&badge=phase%201 CS231295 CS231295 · Chipscreen Biosciences, Ltd. https://druglandscape.com/drug/cs3006 https://druglandscape.com/api/og?type=drug&title=CS3006&subtitle=CS3006%20%C2%B7%20CStone%20Pharmaceuticals&badge=phase%201 CS3006 CS3006 · CStone Pharmaceuticals https://druglandscape.com/drug/cs32582-capsule https://druglandscape.com/api/og?type=drug&title=CS32582%20capsule&subtitle=CS32582%20capsule%20%C2%B7%20Chipscreen%20Biosciences%2C%20Ltd.&badge=phase%201 CS32582 capsule CS32582 capsule · Chipscreen Biosciences, Ltd. https://druglandscape.com/drug/cs32582-capsule-high-dose https://druglandscape.com/api/og?type=drug&title=CS32582%20capsule%EF%BC%88high%20dose%EF%BC%89&subtitle=CS32582%20capsule%EF%BC%88high%20dose%EF%BC%89%20%C2%B7%20Chipscreen%20Biosciences%2C%20Ltd.&badge=phase%201 CS32582 capsule（high dose） CS32582 capsule（high dose） · Chipscreen Biosciences, Ltd. https://druglandscape.com/drug/cs32582-capsule-low-dose https://druglandscape.com/api/og?type=drug&title=CS32582%20capsule%EF%BC%88low%20dose%EF%BC%89&subtitle=CS32582%20capsule%EF%BC%88low%20dose%EF%BC%89%20%C2%B7%20Chipscreen%20Biosciences%2C%20Ltd.&badge=phase%201 CS32582 capsule（low dose） CS32582 capsule（low dose） · Chipscreen Biosciences, Ltd. https://druglandscape.com/drug/cs32582-capsule-medium-dose https://druglandscape.com/api/og?type=drug&title=CS32582%20capsule%EF%BC%88medium%20dose%EF%BC%89&subtitle=CS32582%20capsule%EF%BC%88medium%20dose%EF%BC%89%20%C2%B7%20Chipscreen%20Biosciences%2C%20Ltd.&badge=phase%201 CS32582 capsule（medium dose） CS32582 capsule（medium dose） · Chipscreen Biosciences, Ltd. https://druglandscape.com/drug/cs5001 https://druglandscape.com/api/og?type=drug&title=CS5001&subtitle=CS5001%20%C2%B7%20CStone%20Pharmaceuticals&badge=phase%201 CS5001 CS5001 · CStone Pharmaceuticals https://druglandscape.com/drug/csa-for-eye-emulsion https://druglandscape.com/api/og?type=drug&title=CsA%20for%20eye%20emulsion&subtitle=CsA%20for%20eye%20emulsion%20%C2%B7%20Zhaoke%20(Guangzhou)%20Ophthalmology%20Pharmaceutical%20Ltd.&badge=phase%202 CsA for eye emulsion CsA for eye emulsion · Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. https://druglandscape.com/drug/csaac https://druglandscape.com/api/og?type=drug&title=CSAAC&subtitle=CSAAC%20%C2%B7%20Universidade%20do%20Vale%20do%20Sapucai&badge=phase%201 CSAAC CSAAC · Universidade do Vale do Sapucai https://druglandscape.com/drug/csb-001-ophthalmic-solution-0-1 https://druglandscape.com/api/og?type=drug&title=CSB-001%20Ophthalmic%20Solution%200.1%25&subtitle=CSB-001%20Ophthalmic%20Solution%200.1%25%20%C2%B7%20Claris%20Biotherapeutics%2C%20Inc.&badge=phase%201 CSB-001 Ophthalmic Solution 0.1% CSB-001 Ophthalmic Solution 0.1% · Claris Biotherapeutics, Inc. https://druglandscape.com/drug/csb-111 https://druglandscape.com/api/og?type=drug&title=CSB-111&subtitle=CSB-111%20%C2%B7%20Cytosite%20Biopharma%20Inc.&badge=phase%201 CSB-111 CSB-111 · Cytosite Biopharma Inc. https://druglandscape.com/drug/csl040 https://druglandscape.com/api/og?type=drug&title=CSL040&subtitle=CSL040%20%C2%B7%20CSL%20Behring&badge=phase%201 CSL040 CSL040 · CSL Behring https://druglandscape.com/drug/cspcha131 https://druglandscape.com/api/og?type=drug&title=CSPCHA131&subtitle=CSPCHA131%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 CSPCHA131 CSPCHA131 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/csps-toothpaste https://druglandscape.com/api/og?type=drug&title=CSPS%20toothpaste&subtitle=CSPS%20toothpaste%20%C2%B7%20HALEON&badge=phase%201 CSPS toothpaste CSPS toothpaste · HALEON https://druglandscape.com/drug/cssba https://druglandscape.com/api/og?type=drug&title=CssBA&subtitle=CssBA%20%C2%B7%20PATH&badge=phase%202 CssBA CssBA · PATH https://druglandscape.com/drug/csti-500 https://druglandscape.com/api/og?type=drug&title=CSTI-500&subtitle=CSTI-500%20%C2%B7%20ConSynance%20Therapeutics&badge=phase%202 CSTI-500 CSTI-500 · ConSynance Therapeutics https://druglandscape.com/drug/csx-1004 https://druglandscape.com/api/og?type=drug&title=CSX-1004&subtitle=CSX-1004%20%C2%B7%20Cessation%20Therapeutics%2C%20Inc.&badge=phase%201 CSX-1004 CSX-1004 · Cessation Therapeutics, Inc. https://druglandscape.com/drug/ct-01 https://druglandscape.com/api/og?type=drug&title=CT-01&subtitle=CT-01%20%C2%B7%20Captor%20Therapeutics%20S.A.&badge=phase%201 CT-01 CT-01 · Captor Therapeutics S.A. https://druglandscape.com/drug/ct-044-hcl https://druglandscape.com/api/og?type=drug&title=CT-044%20HCl&subtitle=CT-044%20HCl%20%C2%B7%20Lotus%20Clinical%20Research%2C%20LLC&badge=phase%201 CT-044 HCl CT-044 HCl · Lotus Clinical Research, LLC https://druglandscape.com/drug/ct-0508 https://druglandscape.com/api/og?type=drug&title=CT-0508&subtitle=CT-0508%20%C2%B7%20Carisma%20Therapeutics%20Inc&badge=phase%201 CT-0508 CT-0508 · Carisma Therapeutics Inc https://druglandscape.com/drug/ct-0525 https://druglandscape.com/api/og?type=drug&title=CT-0525&subtitle=CT-0525%20%C2%B7%20Carisma%20Therapeutics%20Inc&badge=phase%201 CT-0525 CT-0525 · Carisma Therapeutics Inc https://druglandscape.com/drug/ct-707 https://druglandscape.com/api/og?type=drug&title=CT-707&subtitle=CT-707%20%C2%B7%20Shouyao%20Holdings%20(Beijing)%20Co.%20LTD&badge=phase%201 CT-707 CT-707 · Shouyao Holdings (Beijing) Co. LTD https://druglandscape.com/drug/ct-95 https://druglandscape.com/api/og?type=drug&title=CT-95&subtitle=CT-95%20%C2%B7%20Context%20Therapeutics%20Inc.&badge=phase%201 CT-95 CT-95 · Context Therapeutics Inc. https://druglandscape.com/drug/ct-996 https://druglandscape.com/api/og?type=drug&title=CT-996&subtitle=CT-996%20%C2%B7%20Carmot%20Australia%20First%20Pty%20Ltd&badge=phase%201 CT-996 CT-996 · Carmot Australia First Pty Ltd https://druglandscape.com/drug/ct-g11 https://druglandscape.com/api/og?type=drug&title=CT-G11&subtitle=CT-G11%20%C2%B7%20Celltrion&badge=phase%201 CT-G11 CT-G11 · Celltrion https://druglandscape.com/drug/ct-l01 https://druglandscape.com/api/og?type=drug&title=CT-L01&subtitle=CT-L01%20%C2%B7%20Celltrion&badge=phase%201 CT-L01 CT-L01 · Celltrion https://druglandscape.com/drug/ct-p13-sc-pre-filled-syringe https://druglandscape.com/api/og?type=drug&title=CT-P13%20SC%20Pre-filled%20Syringe&subtitle=CT-P13%20SC%20Pre-filled%20Syringe%20%C2%B7%20Celltrion&badge=phase%201 CT-P13 SC Pre-filled Syringe CT-P13 SC Pre-filled Syringe · Celltrion https://druglandscape.com/drug/ct-p52 https://druglandscape.com/api/og?type=drug&title=CT-P52&subtitle=CT-P52%20%C2%B7%20Celltrion&badge=phase%201 CT-P52 CT-P52 · Celltrion https://druglandscape.com/drug/ct041 https://druglandscape.com/api/og?type=drug&title=CT041&subtitle=CT041%20%C2%B7%20CARsgen%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 CT041 CT041 · CARsgen Therapeutics Co., Ltd. https://druglandscape.com/drug/ct071 https://druglandscape.com/api/og?type=drug&title=CT071&subtitle=CT071%20%C2%B7%20CARsgen%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 CT071 CT071 · CARsgen Therapeutics Co., Ltd. https://druglandscape.com/drug/ct3001 https://druglandscape.com/api/og?type=drug&title=CT3001&subtitle=CT3001%20%C2%B7%20Crossignal%20Therapeutics%2C%20Inc.&badge=phase%201 CT3001 CT3001 · Crossignal Therapeutics, Inc. https://druglandscape.com/drug/ct38 https://druglandscape.com/api/og?type=drug&title=CT38&subtitle=CT38%20%C2%B7%20LUCINDA%20BATEMAN%2C%20MD&badge=phase%201 CT38 CT38 · LUCINDA BATEMAN, MD https://druglandscape.com/drug/ct7001 https://druglandscape.com/api/og?type=drug&title=CT7001&subtitle=CT7001%20%C2%B7%20Carrick%20Therapeutics%20Limited&badge=phase%201 CT7001 CT7001 · Carrick Therapeutics Limited https://druglandscape.com/drug/cta-control https://druglandscape.com/api/og?type=drug&title=CTA%20control&subtitle=CTA%20control%20%C2%B7%20ImevaX&badge=phase%201 CTA control CTA control · ImevaX https://druglandscape.com/drug/ctdna-analysis https://druglandscape.com/api/og?type=drug&title=ctDNA%20analysis&subtitle=ctDNA%20analysis%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 ctDNA analysis ctDNA analysis · Hospices Civils de Lyon https://druglandscape.com/drug/cth-chronic-hepatitis-b https://druglandscape.com/api/og?type=drug&title=CTH%20Chronic%20Hepatitis%20B&subtitle=CTH%20Chronic%20Hepatitis%20B%20%C2%B7%20Nguyen%20Thi%20Trieu%2C%20MD&badge=phase%202 CTH Chronic Hepatitis B CTH Chronic Hepatitis B · Nguyen Thi Trieu, MD https://druglandscape.com/drug/cth120 https://druglandscape.com/api/og?type=drug&title=CTH120&subtitle=CTH120%20%C2%B7%20Connecta%20Therapeutics%2C%20S.L.&badge=phase%201 CTH120 CTH120 · Connecta Therapeutics, S.L. https://druglandscape.com/drug/ctim-76 https://druglandscape.com/api/og?type=drug&title=CTIM-76&subtitle=CTIM-76%20%C2%B7%20Context%20Therapeutics%20Inc.&badge=phase%201 CTIM-76 CTIM-76 · Context Therapeutics Inc. https://druglandscape.com/drug/ctl02 https://druglandscape.com/api/og?type=drug&title=CTL02&subtitle=CTL02%20%C2%B7%20Celltrion&badge=phase%201 CTL02 CTL02 · Celltrion https://druglandscape.com/drug/ctl0201 https://druglandscape.com/api/og?type=drug&title=CTL0201&subtitle=CTL0201%20%C2%B7%20Celltrion&badge=phase%201 CTL0201 CTL0201 · Celltrion https://druglandscape.com/drug/ctl0202 https://druglandscape.com/api/og?type=drug&title=CTL0202&subtitle=CTL0202%20%C2%B7%20Celltrion&badge=phase%201 CTL0202 CTL0202 · Celltrion https://druglandscape.com/drug/ctn-sr https://druglandscape.com/api/og?type=drug&title=CTN%20SR&subtitle=CTN%20SR%20%C2%B7%20Otsuka%20Pharmaceutical%20Development%20%26%20Commercialization%2C%20Inc.&badge=phase%202 CTN SR CTN SR · Otsuka Pharmaceutical Development & Commercialization, Inc. https://druglandscape.com/drug/cto-and-temodar https://druglandscape.com/api/og?type=drug&title=CTO%20and%20Temodar%C2%AE&subtitle=CTO%20and%20Temodar%C2%AE%20%C2%B7%20Tactical%20Therapeutics%2C%20Inc.&badge=phase%201 CTO and Temodar® CTO and Temodar® · Tactical Therapeutics, Inc. https://druglandscape.com/drug/cto-temodar-radiation-therapy https://druglandscape.com/api/og?type=drug&title=CTO%2C%20Temodar%C2%AE%2C%20Radiation%20therapy&subtitle=CTO%2C%20Temodar%C2%AE%2C%20Radiation%20therapy%20%C2%B7%20Tactical%20Therapeutics%2C%20Inc.&badge=phase%201 CTO, Temodar®, Radiation therapy CTO, Temodar®, Radiation therapy · Tactical Therapeutics, Inc. https://druglandscape.com/drug/cto0101 https://druglandscape.com/api/og?type=drug&title=CTO0101&subtitle=CTO0101%20%C2%B7%20Taejoon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 CTO0101 CTO0101 · Taejoon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/cto0303-c https://druglandscape.com/api/og?type=drug&title=CTO0303-C&subtitle=CTO0303-C%20%C2%B7%20Taejoon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 CTO0303-C CTO0303-C · Taejoon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/cts3497 https://druglandscape.com/api/og?type=drug&title=CTS3497&subtitle=CTS3497%20%C2%B7%20CytosinLab%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 CTS3497 CTS3497 · CytosinLab Therapeutics Co., Ltd. https://druglandscape.com/drug/ctt1057 https://druglandscape.com/api/og?type=drug&title=CTT1057&subtitle=CTT1057%20%C2%B7%20Cancer%20Targeted%20Technology&badge=phase%201 CTT1057 CTT1057 · Cancer Targeted Technology https://druglandscape.com/drug/cttq-dasatinib-tablet https://druglandscape.com/api/og?type=drug&title=CTTQ%20Dasatinib%20tablet&subtitle=CTTQ%20Dasatinib%20tablet%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 CTTQ Dasatinib tablet CTTQ Dasatinib tablet · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/ctx-712 https://druglandscape.com/api/og?type=drug&title=CTX-712&subtitle=CTX-712%20%C2%B7%20Chordia%20Therapeutics%2C%20Inc.&badge=phase%201 CTX-712 CTX-712 · Chordia Therapeutics, Inc. https://druglandscape.com/drug/ctx-dp https://druglandscape.com/api/og?type=drug&title=CTX%20DP&subtitle=CTX%20DP%20%C2%B7%20ReNeuron%20Limited&badge=phase%202 CTX DP CTX DP · ReNeuron Limited https://druglandscape.com/drug/ctx0e03-neural-stem-cells https://druglandscape.com/api/og?type=drug&title=CTX0E03%20neural%20stem%20cells&subtitle=CTX0E03%20neural%20stem%20cells%20%C2%B7%20ReNeuron%20Limited&badge=phase%201 CTX0E03 neural stem cells CTX0E03 neural stem cells · ReNeuron Limited https://druglandscape.com/drug/ctx112 https://druglandscape.com/api/og?type=drug&title=CTX112&subtitle=CTX112%20%C2%B7%20CRISPR%20Therapeutics&badge=phase%201 CTX112 CTX112 · CRISPR Therapeutics https://druglandscape.com/drug/ctx310 https://druglandscape.com/api/og?type=drug&title=CTX310&subtitle=CTX310%20%C2%B7%20CRISPR%20Therapeutics%20AG&badge=phase%201 CTX310 CTX310 · CRISPR Therapeutics AG https://druglandscape.com/drug/cu-10101 https://druglandscape.com/api/og?type=drug&title=CU-10101&subtitle=CU-10101%20%C2%B7%20Cutia%20Therapeutics%EF%BC%88Wuxi%EF%BC%89Co.%2CLtd&badge=phase%201 CU-10101 CU-10101 · Cutia Therapeutics（Wuxi）Co.,Ltd https://druglandscape.com/drug/cu-40101 https://druglandscape.com/api/og?type=drug&title=CU-40101&subtitle=CU-40101%20%C2%B7%20Cutia%20Therapeutics%EF%BC%88Wuxi%EF%BC%89Co.%2CLtd&badge=phase%201 CU-40101 CU-40101 · Cutia Therapeutics（Wuxi）Co.,Ltd https://druglandscape.com/drug/cu-64-sartate-and-cu-67-sartate https://druglandscape.com/api/og?type=drug&title=Cu-64%20SARTATE%20and%20Cu-67%20SARTATE&subtitle=Cu-64%20SARTATE%20and%20Cu-67%20SARTATE%20%C2%B7%20Clarity%20Pharmaceuticals%20Ltd&badge=phase%201 Cu-64 SARTATE and Cu-67 SARTATE Cu-64 SARTATE and Cu-67 SARTATE · Clarity Pharmaceuticals Ltd https://druglandscape.com/drug/cu01-1001 https://druglandscape.com/api/og?type=drug&title=CU01-1001&subtitle=CU01-1001%20%C2%B7%20Curacle%20Co.%2C%20Ltd.&badge=phase%202 CU01-1001 CU01-1001 · Curacle Co., Ltd. https://druglandscape.com/drug/cu06-1004-multiple-doses https://druglandscape.com/api/og?type=drug&title=CU06-1004%2C%20Multiple%20doses&subtitle=CU06-1004%2C%20Multiple%20doses%20%C2%B7%20Curacle%20Co.%2C%20Ltd.&badge=phase%201 CU06-1004, Multiple doses CU06-1004, Multiple doses · Curacle Co., Ltd. https://druglandscape.com/drug/cue-102 https://druglandscape.com/api/og?type=drug&title=CUE-102&subtitle=CUE-102%20%C2%B7%20David%20Reardon%2C%20MD&badge=phase%201 CUE-102 CUE-102 · David Reardon, MD https://druglandscape.com/drug/cug252 https://druglandscape.com/api/og?type=drug&title=CUG252&subtitle=CUG252%20%C2%B7%20Cugene%20Inc.&badge=phase%201 CUG252 CUG252 · Cugene Inc. https://druglandscape.com/drug/culture-with-growth-factors https://druglandscape.com/api/og?type=drug&title=Culture%20with%20growth%20factors&subtitle=Culture%20with%20growth%20factors%20%C2%B7%20Hillel%20Yaffe%20Medical%20Center&badge=phase%201 Culture with growth factors Culture with growth factors · Hillel Yaffe Medical Center https://druglandscape.com/drug/culture-with-progesterone https://druglandscape.com/api/og?type=drug&title=Culture%20with%20progesterone&subtitle=Culture%20with%20progesterone%20%C2%B7%20Hillel%20Yaffe%20Medical%20Center&badge=phase%201 Culture with progesterone Culture with progesterone · Hillel Yaffe Medical Center https://druglandscape.com/drug/culture-without-progesterone https://druglandscape.com/api/og?type=drug&title=Culture%20without%20progesterone&subtitle=Culture%20without%20progesterone%20%C2%B7%20Hillel%20Yaffe%20Medical%20Center&badge=phase%201 Culture without progesterone Culture without progesterone · Hillel Yaffe Medical Center https://druglandscape.com/drug/cultured-human-intestinal-microbiota https://druglandscape.com/api/og?type=drug&title=Cultured%20human%20intestinal%20microbiota&subtitle=Cultured%20human%20intestinal%20microbiota%20%C2%B7%20Per%20Hellstr%C3%B6m&badge=phase%202 Cultured human intestinal microbiota Cultured human intestinal microbiota · Per Hellström https://druglandscape.com/drug/cumulative-morphine-consumption https://druglandscape.com/api/og?type=drug&title=Cumulative%20morphine%20consumption&subtitle=Cumulative%20morphine%20consumption%20%C2%B7%20H%C3%B4pital%20Priv%C3%A9%20S%C3%A9vign%C3%A9&badge=phase%202 Cumulative morphine consumption Cumulative morphine consumption · Hôpital Privé Sévigné https://druglandscape.com/drug/cur-n399 https://druglandscape.com/api/og?type=drug&title=CUR-N399&subtitle=CUR-N399%20%C2%B7%20Curovir%20AB&badge=phase%201 CUR-N399 CUR-N399 · Curovir AB https://druglandscape.com/drug/cura-100 https://druglandscape.com/api/og?type=drug&title=Cura-100&subtitle=Cura-100%20%C2%B7%20Cura%20Biotech%20LLC&badge=phase%201 Cura-100 Cura-100 · Cura Biotech LLC https://druglandscape.com/drug/curcumin-phosphatidylcholine https://druglandscape.com/api/og?type=drug&title=Curcumin-phosphatidylcholine&subtitle=Curcumin-phosphatidylcholine%20%C2%B7%20Henry%20Ford%20Health%20System&badge=phase%201 Curcumin-phosphatidylcholine Curcumin-phosphatidylcholine · Henry Ford Health System https://druglandscape.com/drug/current-analgesic-strategy https://druglandscape.com/api/og?type=drug&title=current%20analgesic%20strategy&subtitle=current%20analgesic%20strategy%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 current analgesic strategy current analgesic strategy · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/current-formulation-of-oritavancin https://druglandscape.com/api/og?type=drug&title=Current%20Formulation%20of%20Oritavancin&subtitle=Current%20Formulation%20of%20Oritavancin%20%C2%B7%20Melinta%20Therapeutics%2C%20Inc.&badge=phase%201 Current Formulation of Oritavancin Current Formulation of Oritavancin · Melinta Therapeutics, Inc. https://druglandscape.com/drug/cusp06 https://druglandscape.com/api/og?type=drug&title=CUSP06&subtitle=CUSP06%20%C2%B7%20OnCusp%20Therapeutics%2C%20Inc.&badge=phase%201 CUSP06 CUSP06 · OnCusp Therapeutics, Inc. https://druglandscape.com/drug/custirsen-paclitaxel-and-carboplatin https://druglandscape.com/api/og?type=drug&title=Custirsen%2C%20paclitaxel%20and%20carboplatin&subtitle=Custirsen%2C%20paclitaxel%20and%20carboplatin%20%C2%B7%20Achieve%20Life%20Sciences&badge=phase%201 Custirsen, paclitaxel and carboplatin Custirsen, paclitaxel and carboplatin · Achieve Life Sciences https://druglandscape.com/drug/cutaneous-melanoma-biopsy https://druglandscape.com/api/og?type=drug&title=Cutaneous%20melanoma%20biopsy&subtitle=Cutaneous%20melanoma%20biopsy%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Cutaneous melanoma biopsy Cutaneous melanoma biopsy · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/cv-18c3 https://druglandscape.com/api/og?type=drug&title=CV-18C3&subtitle=CV-18C3%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 CV-18C3 CV-18C3 · Janssen Research & Development, LLC https://druglandscape.com/drug/cv0801-mrna-covid-19-vaccine https://druglandscape.com/api/og?type=drug&title=CV0801%20mRNA%20COVID-19%20Vaccine&subtitle=CV0801%20mRNA%20COVID-19%20Vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%202 CV0801 mRNA COVID-19 Vaccine CV0801 mRNA COVID-19 Vaccine · GlaxoSmithKline https://druglandscape.com/drug/cv7201-mrna https://druglandscape.com/api/og?type=drug&title=CV7201%20mRNA&subtitle=CV7201%20mRNA%20%C2%B7%20CureVac&badge=phase%201 CV7201 mRNA CV7201 mRNA · CureVac https://druglandscape.com/drug/cv8102 https://druglandscape.com/api/og?type=drug&title=CV8102&subtitle=CV8102%20%C2%B7%20CureVac&badge=phase%201 CV8102 CV8102 · CureVac https://druglandscape.com/drug/cv9201 https://druglandscape.com/api/og?type=drug&title=CV9201&subtitle=CV9201%20%C2%B7%20CureVac&badge=phase%201 CV9201 CV9201 · CureVac https://druglandscape.com/drug/cvd908ssb-txsvn https://druglandscape.com/api/og?type=drug&title=CVD908ssb-TXSVN&subtitle=CVD908ssb-TXSVN%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 CVD908ssb-TXSVN CVD908ssb-TXSVN · Baylor College of Medicine https://druglandscape.com/drug/cvl-231 https://druglandscape.com/api/og?type=drug&title=CVL-231&subtitle=CVL-231%20%C2%B7%20Cerevel%20Therapeutics%2C%20LLC&badge=phase%201 CVL-231 CVL-231 · Cerevel Therapeutics, LLC https://druglandscape.com/drug/cvl-354 https://druglandscape.com/api/og?type=drug&title=CVL-354&subtitle=CVL-354%20%C2%B7%20Cerevel%20Therapeutics%2C%20LLC&badge=phase%201 CVL-354 CVL-354 · Cerevel Therapeutics, LLC https://druglandscape.com/drug/cvl-751 https://druglandscape.com/api/og?type=drug&title=CVL-751&subtitle=CVL-751%20%C2%B7%20Cerevel%20Therapeutics%2C%20LLC&badge=phase%201 CVL-751 CVL-751 · Cerevel Therapeutics, LLC https://druglandscape.com/drug/cvl-865-high-dose https://druglandscape.com/api/og?type=drug&title=CVL-865%20High%20dose&subtitle=CVL-865%20High%20dose%20%C2%B7%20Cerevel%20Therapeutics%2C%20LLC&badge=phase%201 CVL-865 High dose CVL-865 High dose · Cerevel Therapeutics, LLC https://druglandscape.com/drug/cvl-865-low-dose https://druglandscape.com/api/og?type=drug&title=CVL-865%20low%20dose&subtitle=CVL-865%20low%20dose%20%C2%B7%20Cerevel%20Therapeutics%2C%20LLC&badge=phase%201 CVL-865 low dose CVL-865 low dose · Cerevel Therapeutics, LLC https://druglandscape.com/drug/cvl006-in-combination-with-ds-8201 https://druglandscape.com/api/og?type=drug&title=CVL006%20in%20combination%20with%20DS-8201&subtitle=CVL006%20in%20combination%20with%20DS-8201%20%C2%B7%20Convalife%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 CVL006 in combination with DS-8201 CVL006 in combination with DS-8201 · Convalife (Shanghai) Co., Ltd. https://druglandscape.com/drug/cvl006-in-combination-with-skb264 https://druglandscape.com/api/og?type=drug&title=CVL006%20in%20combination%20with%20SKB264&subtitle=CVL006%20in%20combination%20with%20SKB264%20%C2%B7%20Convalife%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 CVL006 in combination with SKB264 CVL006 in combination with SKB264 · Convalife (Shanghai) Co., Ltd. https://druglandscape.com/drug/cvm26 https://druglandscape.com/api/og?type=drug&title=CVM26&subtitle=CVM26%20%C2%B7%20CyanVac%20LLC&badge=phase%201 CVM26 CVM26 · CyanVac LLC https://druglandscape.com/drug/cvn058 https://druglandscape.com/api/og?type=drug&title=CVN058&subtitle=CVN058%20%C2%B7%20Cerevance%20Alpha%2C%20Inc.&badge=phase%201 CVN058 CVN058 · Cerevance Alpha, Inc. https://druglandscape.com/drug/cvn424 https://druglandscape.com/api/og?type=drug&title=CVN424&subtitle=CVN424%20%C2%B7%20Cerevance%20Beta%2C%20Inc.&badge=phase%201 CVN424 CVN424 · Cerevance Beta, Inc. https://druglandscape.com/drug/cvn424-low-dose https://druglandscape.com/api/og?type=drug&title=CVN424%20Low%20Dose&subtitle=CVN424%20Low%20Dose%20%C2%B7%20Cerevance%20Beta%2C%20Inc.&badge=phase%202 CVN424 Low Dose CVN424 Low Dose · Cerevance Beta, Inc. https://druglandscape.com/drug/cvn766 https://druglandscape.com/api/og?type=drug&title=CVN766&subtitle=CVN766%20%C2%B7%20Cerevance&badge=phase%201 CVN766 CVN766 · Cerevance https://druglandscape.com/drug/cvsqiv https://druglandscape.com/api/og?type=drug&title=CVSQIV&subtitle=CVSQIV%20%C2%B7%20CureVac&badge=phase%201 CVSQIV CVSQIV · CureVac https://druglandscape.com/drug/cvx-045 https://druglandscape.com/api/og?type=drug&title=CVX-045&subtitle=CVX-045%20%C2%B7%20Pfizer&badge=phase%201 CVX-045 CVX-045 · Pfizer https://druglandscape.com/drug/cvxga1-high-dose https://druglandscape.com/api/og?type=drug&title=CVXGA1%20high%20dose&subtitle=CVXGA1%20high%20dose%20%C2%B7%20CyanVac%20LLC&badge=phase%201 CVXGA1 high dose CVXGA1 high dose · CyanVac LLC https://druglandscape.com/drug/cvxga1-low-dose https://druglandscape.com/api/og?type=drug&title=CVXGA1%20low%20dose&subtitle=CVXGA1%20low%20dose%20%C2%B7%20CyanVac%20LLC&badge=phase%201 CVXGA1 low dose CVXGA1 low dose · CyanVac LLC https://druglandscape.com/drug/cx-011 https://druglandscape.com/api/og?type=drug&title=CX-011&subtitle=CX-011%20%C2%B7%20CarthroniX%2C%20Inc.&badge=phase%201 CX-011 CX-011 · CarthroniX, Inc. https://druglandscape.com/drug/cx-2051 https://druglandscape.com/api/og?type=drug&title=CX-2051&subtitle=CX-2051%20%C2%B7%20CytomX%20Therapeutics&badge=phase%201 CX-2051 CX-2051 · CytomX Therapeutics https://druglandscape.com/drug/cx5461 https://druglandscape.com/api/og?type=drug&title=CX5461&subtitle=CX5461%20%C2%B7%20Canadian%20Cancer%20Trials%20Group&badge=phase%201 CX5461 CX5461 · Canadian Cancer Trials Group https://druglandscape.com/drug/cxb722 https://druglandscape.com/api/og?type=drug&title=CXB722&subtitle=CXB722%20%C2%B7%20CeNeRx%20BioPharma%20Inc.&badge=phase%201 CXB722 CXB722 · CeNeRx BioPharma Inc. https://druglandscape.com/drug/cxd101-in-combination-with-nivolumab https://druglandscape.com/api/og?type=drug&title=CXD101%20in%20Combination%20With%20Nivolumab&subtitle=CXD101%20in%20Combination%20With%20Nivolumab%20%C2%B7%20Celleron%20Therapeutics%20Ltd.&badge=phase%201 CXD101 in Combination With Nivolumab CXD101 in Combination With Nivolumab · Celleron Therapeutics Ltd. https://druglandscape.com/drug/cxl-1020-dose-for-echo-cohort-a https://druglandscape.com/api/og?type=drug&title=CXL-1020%20Dose%20for%20Echo%20Cohort%20A&subtitle=CXL-1020%20Dose%20for%20Echo%20Cohort%20A%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 CXL-1020 Dose for Echo Cohort A CXL-1020 Dose for Echo Cohort A · Bristol-Myers Squibb https://druglandscape.com/drug/cxl-1020-doses-for-echo-cohort-b https://druglandscape.com/api/og?type=drug&title=CXL-1020%20Doses%20for%20Echo%20Cohort%20B&subtitle=CXL-1020%20Doses%20for%20Echo%20Cohort%20B%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 CXL-1020 Doses for Echo Cohort B CXL-1020 Doses for Echo Cohort B · Bristol-Myers Squibb https://druglandscape.com/drug/cxl-1427-ascending-dose https://druglandscape.com/api/og?type=drug&title=CXL-1427%20Ascending%20Dose&subtitle=CXL-1427%20Ascending%20Dose%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 CXL-1427 Ascending Dose CXL-1427 Ascending Dose · Bristol-Myers Squibb https://druglandscape.com/drug/cxl-1427-descending-dose https://druglandscape.com/api/og?type=drug&title=CXL-1427%20Descending%20Dose&subtitle=CXL-1427%20Descending%20Dose%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 CXL-1427 Descending Dose CXL-1427 Descending Dose · Bristol-Myers Squibb https://druglandscape.com/drug/cyad-02 https://druglandscape.com/api/og?type=drug&title=CYAD-02&subtitle=CYAD-02%20%C2%B7%20Celyad%20Oncology%20SA&badge=phase%201 CYAD-02 CYAD-02 · Celyad Oncology SA https://druglandscape.com/drug/cybis-10-25-thc-cbd-oil https://druglandscape.com/api/og?type=drug&title=Cybis%E2%84%A2%2010%3A25%20THC%3ACBD%20oil&subtitle=Cybis%E2%84%A2%2010%3A25%20THC%3ACBD%20oil%20%C2%B7%20Cymra%20Life%20Sciences&badge=phase%201 Cybis™ 10:25 THC:CBD oil Cybis™ 10:25 THC:CBD oil · Cymra Life Sciences https://druglandscape.com/drug/cyc065 https://druglandscape.com/api/og?type=drug&title=CYC065&subtitle=CYC065%20%C2%B7%20Cyclacel%20Pharmaceuticals%2C%20Inc.&badge=phase%201 CYC065 CYC065 · Cyclacel Pharmaceuticals, Inc. https://druglandscape.com/drug/cyclasol https://druglandscape.com/api/og?type=drug&title=CyclASol%C2%AE&subtitle=CyclASol%C2%AE%20%C2%B7%20Novaliq%20GmbH&badge=phase%201 CyclASol® CyclASol® · Novaliq GmbH https://druglandscape.com/drug/cycle-1-reference-drug https://druglandscape.com/api/og?type=drug&title=cycle%201%3A%20reference%20drug&subtitle=cycle%201%3A%20reference%20drug%20%C2%B7%20Shenzhen%20TargetRx%20Co.%2C%20Ltd.&badge=phase%201 cycle 1: reference drug cycle 1: reference drug · Shenzhen TargetRx Co., Ltd. https://druglandscape.com/drug/cycle-2-treatment-drug https://druglandscape.com/api/og?type=drug&title=cycle%202%3A%20treatment%20drug&subtitle=cycle%202%3A%20treatment%20drug%20%C2%B7%20Shenzhen%20TargetRx%20Co.%2C%20Ltd.&badge=phase%201 cycle 2: treatment drug cycle 2: treatment drug · Shenzhen TargetRx Co., Ltd. https://druglandscape.com/drug/cycle-3-early-consolidation https://druglandscape.com/api/og?type=drug&title=Cycle%203%20Early%20consolidation&subtitle=Cycle%203%20Early%20consolidation%20%C2%B7%20Gruppo%20Italiano%20Malattie%20EMatologiche%20dell'Adulto&badge=phase%202 Cycle 3 Early consolidation Cycle 3 Early consolidation · Gruppo Italiano Malattie EMatologiche dell'Adulto https://druglandscape.com/drug/cycle-3-reference-drug https://druglandscape.com/api/og?type=drug&title=cycle%203%3A%20reference%20drug&subtitle=cycle%203%3A%20reference%20drug%20%C2%B7%20Shenzhen%20TargetRx%20Co.%2C%20Ltd.&badge=phase%201 cycle 3: reference drug cycle 3: reference drug · Shenzhen TargetRx Co., Ltd. https://druglandscape.com/drug/cycle-3-treatment-drug https://druglandscape.com/api/og?type=drug&title=cycle%203%3A%20treatment%20drug&subtitle=cycle%203%3A%20treatment%20drug%20%C2%B7%20Shenzhen%20TargetRx%20Co.%2C%20Ltd.&badge=phase%201 cycle 3: treatment drug cycle 3: treatment drug · Shenzhen TargetRx Co., Ltd. https://druglandscape.com/drug/cycle-6-consolidation https://druglandscape.com/api/og?type=drug&title=Cycle%206%20Consolidation&subtitle=Cycle%206%20Consolidation%20%C2%B7%20Gruppo%20Italiano%20Malattie%20EMatologiche%20dell'Adulto&badge=phase%202 Cycle 6 Consolidation Cycle 6 Consolidation · Gruppo Italiano Malattie EMatologiche dell'Adulto https://druglandscape.com/drug/cycle-b https://druglandscape.com/api/og?type=drug&title=Cycle%20B&subtitle=Cycle%20B%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Cycle B Cycle B · Baylor College of Medicine https://druglandscape.com/drug/cyclobenzaprine-iv https://druglandscape.com/api/og?type=drug&title=Cyclobenzaprine%20IV&subtitle=Cyclobenzaprine%20IV%20%C2%B7%20Tonix%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Cyclobenzaprine IV Cyclobenzaprine IV · Tonix Pharmaceuticals, Inc. https://druglandscape.com/drug/cyclobenzaprine-tablets https://druglandscape.com/api/og?type=drug&title=Cyclobenzaprine%20tablets&subtitle=Cyclobenzaprine%20tablets%20%C2%B7%20Tonix%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Cyclobenzaprine tablets Cyclobenzaprine tablets · Tonix Pharmaceuticals, Inc. https://druglandscape.com/drug/cyclophosphamide-and-fludarabin https://druglandscape.com/api/og?type=drug&title=CYCLOPHOSPHAMIDE%20and%20FLUDARABIN&subtitle=CYCLOPHOSPHAMIDE%20and%20FLUDARABIN%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 CYCLOPHOSPHAMIDE and FLUDARABIN CYCLOPHOSPHAMIDE and FLUDARABIN · Hadassah Medical Organization https://druglandscape.com/drug/cyclophosphamide-doxorubicin-vincristine-prednisolone https://druglandscape.com/api/og?type=drug&title=Cyclophosphamide%2C%20Doxorubicin%2C%20Vincristine%2C%20Prednisolone.&subtitle=Cyclophosphamide%2C%20Doxorubicin%2C%20Vincristine%2C%20Prednisolone.%20%C2%B7%20Trans%20Tasman%20Radiation%20Oncology%20Group&badge=phase%201 Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone. Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone. · Trans Tasman Radiation Oncology Group https://druglandscape.com/drug/cyclophosphamide-fludarabine-and-antithymocyte-globulin https://druglandscape.com/api/og?type=drug&title=cyclophosphamide%2C%20fludarabine%2C%20and%20antithymocyte%20globulin&subtitle=cyclophosphamide%2C%20fludarabine%2C%20and%20antithymocyte%20globulin%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 cyclophosphamide, fludarabine, and antithymocyte globulin cyclophosphamide, fludarabine, and antithymocyte globulin · Asan Medical Center https://druglandscape.com/drug/cyclophosphamide-iv https://druglandscape.com/api/og?type=drug&title=Cyclophosphamide%20IV&subtitle=Cyclophosphamide%20IV%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Cyclophosphamide IV Cyclophosphamide IV · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/cyclophosphamide-methotrexate-and-fluorouracil https://druglandscape.com/api/og?type=drug&title=cyclophosphamide%2C%20methotrexate%2C%20and%20fluorouracil&subtitle=cyclophosphamide%2C%20methotrexate%2C%20and%20fluorouracil%20%C2%B7%20Taiho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%203 cyclophosphamide, methotrexate, and fluorouracil cyclophosphamide, methotrexate, and fluorouracil · Taiho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/cyclosporine-nova22007-0-1 https://druglandscape.com/api/og?type=drug&title=Cyclosporine%20NOVA22007%200.1%25&subtitle=Cyclosporine%20NOVA22007%200.1%25%20%C2%B7%20Santen%20SAS&badge=phase%202 Cyclosporine NOVA22007 0.1% Cyclosporine NOVA22007 0.1% · Santen SAS https://druglandscape.com/drug/cyclosporine-ophthalmic-emulsion-formulation-b https://druglandscape.com/api/og?type=drug&title=cyclosporine%20ophthalmic%20emulsion%20Formulation%20B&subtitle=cyclosporine%20ophthalmic%20emulsion%20Formulation%20B%20%C2%B7%20Allergan&badge=phase%201 cyclosporine ophthalmic emulsion Formulation B cyclosporine ophthalmic emulsion Formulation B · Allergan https://druglandscape.com/drug/cyclotron-produced-99mtc https://druglandscape.com/api/og?type=drug&title=Cyclotron-produced%2099mTc&subtitle=Cyclotron-produced%2099mTc%20%C2%B7%20British%20Columbia%20Cancer%20Agency&badge=phase%201 Cyclotron-produced 99mTc Cyclotron-produced 99mTc · British Columbia Cancer Agency https://druglandscape.com/drug/cyh33-for-tablet https://druglandscape.com/api/og?type=drug&title=CYH33%20for%20tablet&subtitle=CYH33%20for%20tablet%20%C2%B7%20Haihe%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 CYH33 for tablet CYH33 for tablet · Haihe Biopharma Co., Ltd. https://druglandscape.com/drug/cyp-and-transporter-probe-substrates https://druglandscape.com/api/og?type=drug&title=CYP%20and%20transporter%20probe%20substrates&subtitle=CYP%20and%20transporter%20probe%20substrates%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 CYP and transporter probe substrates CYP and transporter probe substrates · ViiV Healthcare https://druglandscape.com/drug/cyp-probe-cocktail https://druglandscape.com/api/og?type=drug&title=CYP%20Probe%20Cocktail&subtitle=CYP%20Probe%20Cocktail%20%C2%B7%20Min%20Kyu%20Park&badge=phase%201 CYP Probe Cocktail CYP Probe Cocktail · Min Kyu Park https://druglandscape.com/drug/cyp-substrates https://druglandscape.com/api/og?type=drug&title=CYP%20substrates&subtitle=CYP%20substrates%20%C2%B7%20Celgene&badge=phase%201 CYP substrates CYP substrates · Celgene https://druglandscape.com/drug/cyp3a4-probe https://druglandscape.com/api/og?type=drug&title=CYP3A4%20probe&subtitle=CYP3A4%20probe%20%C2%B7%20Repros%20Therapeutics%20Inc.&badge=phase%201 CYP3A4 probe CYP3A4 probe · Repros Therapeutics Inc. https://druglandscape.com/drug/cypep-1 https://druglandscape.com/api/og?type=drug&title=CyPep-1&subtitle=CyPep-1%20%C2%B7%20Cytovation%20AS&badge=phase%201 CyPep-1 CyPep-1 · Cytovation AS https://druglandscape.com/drug/cyt-0851 https://druglandscape.com/api/og?type=drug&title=CYT-0851&subtitle=CYT-0851%20%C2%B7%20Cyteir%20Therapeutics%2C%20Inc.&badge=phase%201 CYT-0851 CYT-0851 · Cyteir Therapeutics, Inc. https://druglandscape.com/drug/cyt-0851-in-combination-with-gemcitabine https://druglandscape.com/api/og?type=drug&title=CYT-0851%20in%20combination%20with%20gemcitabine&subtitle=CYT-0851%20in%20combination%20with%20gemcitabine%20%C2%B7%20Cyteir%20Therapeutics%2C%20Inc.&badge=phase%201 CYT-0851 in combination with gemcitabine CYT-0851 in combination with gemcitabine · Cyteir Therapeutics, Inc. https://druglandscape.com/drug/cyt-107 https://druglandscape.com/api/og?type=drug&title=CYT%20107&subtitle=CYT%20107%20%C2%B7%20Cytheris%20SA&badge=phase%201 CYT 107 CYT 107 · Cytheris SA https://druglandscape.com/drug/cyt002-nicqb https://druglandscape.com/api/og?type=drug&title=CYT002-NicQb&subtitle=CYT002-NicQb%20%C2%B7%20Cytos%20Biotechnology%20AG&badge=phase%202 CYT002-NicQb CYT002-NicQb · Cytos Biotechnology AG https://druglandscape.com/drug/cyt004-melqbg10 https://druglandscape.com/api/og?type=drug&title=CYT004-MelQbG10&subtitle=CYT004-MelQbG10%20%C2%B7%20Cytos%20Biotechnology%20AG&badge=phase%202 CYT004-MelQbG10 CYT004-MelQbG10 · Cytos Biotechnology AG https://druglandscape.com/drug/cyt005-allqbg10 https://druglandscape.com/api/og?type=drug&title=CYT005-AllQbG10&subtitle=CYT005-AllQbG10%20%C2%B7%20Cytos%20Biotechnology%20AG&badge=phase%201 CYT005-AllQbG10 CYT005-AllQbG10 · Cytos Biotechnology AG https://druglandscape.com/drug/cyt006-angqb https://druglandscape.com/api/og?type=drug&title=CYT006-AngQb&subtitle=CYT006-AngQb%20%C2%B7%20Cytos%20Biotechnology%20AG&badge=phase%202 CYT006-AngQb CYT006-AngQb · Cytos Biotechnology AG https://druglandscape.com/drug/cyt013-il1bqb https://druglandscape.com/api/og?type=drug&title=CYT013-IL1bQb&subtitle=CYT013-IL1bQb%20%C2%B7%20Cytos%20Biotechnology%20AG&badge=phase%201 CYT013-IL1bQb CYT013-IL1bQb · Cytos Biotechnology AG https://druglandscape.com/drug/cyt387 https://druglandscape.com/api/og?type=drug&title=CYT387&subtitle=CYT387%20%C2%B7%20Sierra%20Oncology%20LLC%20-%20a%20GSK%20company&badge=phase%201 CYT387 CYT387 · Sierra Oncology LLC - a GSK company https://druglandscape.com/drug/cytarabine-idarubicin-association https://druglandscape.com/api/og?type=drug&title=Cytarabine-Idarubicin%20Association&subtitle=Cytarabine-Idarubicin%20Association%20%C2%B7%20French%20Innovative%20Leukemia%20Organisation&badge=phase%202 Cytarabine-Idarubicin Association Cytarabine-Idarubicin Association · French Innovative Leukemia Organisation https://druglandscape.com/drug/cytarabine-it https://druglandscape.com/api/og?type=drug&title=Cytarabine%20IT&subtitle=Cytarabine%20IT%20%C2%B7%20C17%20Council&badge=phase%201 Cytarabine IT Cytarabine IT · C17 Council https://druglandscape.com/drug/cytokine-essays https://druglandscape.com/api/og?type=drug&title=cytokine%20essays&subtitle=cytokine%20essays%20%C2%B7%20Fondazione%20IRCCS%20Ca'%20Granda%2C%20Ospedale%20Maggiore%20Policlinico&badge=phase%202 cytokine essays cytokine essays · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico https://druglandscape.com/drug/cytokine-therapy https://druglandscape.com/api/og?type=drug&title=cytokine%20therapy&subtitle=cytokine%20therapy%20%C2%B7%20St.%20Luke's%20Medical%20Center&badge=phase%201 cytokine therapy cytokine therapy · St. Luke's Medical Center https://druglandscape.com/drug/cytomegalovirus-specific-t-lymphocytes https://druglandscape.com/api/og?type=drug&title=Cytomegalovirus%20Specific%20T-Lymphocytes&subtitle=Cytomegalovirus%20Specific%20T-Lymphocytes%20%C2%B7%20Jessie%20L.%20Alexander&badge=phase%201 Cytomegalovirus Specific T-Lymphocytes Cytomegalovirus Specific T-Lymphocytes · Jessie L. Alexander https://druglandscape.com/drug/cytovir-adv https://druglandscape.com/api/og?type=drug&title=Cytovir-ADV&subtitle=Cytovir-ADV%20%C2%B7%20Cell%20Medica%20Ltd&badge=phase%201 Cytovir-ADV Cytovir-ADV · Cell Medica Ltd https://druglandscape.com/drug/cz48 https://druglandscape.com/api/og?type=drug&title=CZ48&subtitle=CZ48%20%C2%B7%20Cao%20Pharmaceuticals%20Inc.&badge=phase%201 CZ48 CZ48 · Cao Pharmaceuticals Inc. https://druglandscape.com/drug/d-0120-in-combination-with-allopurinol https://druglandscape.com/api/og?type=drug&title=D-0120%20in%20combination%20with%20Allopurinol&subtitle=D-0120%20in%20combination%20with%20Allopurinol%20%C2%B7%20InventisBio%20Co.%2C%20Ltd&badge=phase%201 D-0120 in combination with Allopurinol D-0120 in combination with Allopurinol · InventisBio Co., Ltd https://druglandscape.com/drug/d-amphetamine https://druglandscape.com/api/og?type=drug&title=d-amphetamine&subtitle=d-amphetamine%20%C2%B7%20Biotie%20Therapies%20Inc.&badge=phase%202 d-amphetamine d-amphetamine · Biotie Therapies Inc. https://druglandscape.com/drug/d-amphetamine-transdermal-patch https://druglandscape.com/api/og?type=drug&title=d-Amphetamine%20Transdermal%20Patch&subtitle=d-Amphetamine%20Transdermal%20Patch%20%C2%B7%20Noven%20Pharmaceuticals%2C%20Inc.&badge=phase%202 d-Amphetamine Transdermal Patch d-Amphetamine Transdermal Patch · Noven Pharmaceuticals, Inc. https://druglandscape.com/drug/d-dose-as-cj-15314 https://druglandscape.com/api/og?type=drug&title=D%20dose%20as%20CJ-15314&subtitle=D%20dose%20as%20CJ-15314%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 D dose as CJ-15314 D dose as CJ-15314 · HK inno.N Corporation https://druglandscape.com/drug/d-gpei https://druglandscape.com/api/og?type=drug&title=D-GPEi&subtitle=D-GPEi%20%C2%B7%20Centers%20for%20Disease%20Control%20and%20Prevention%2C%20China&badge=phase%201 D-GPEi D-GPEi · Centers for Disease Control and Prevention, China https://druglandscape.com/drug/d-zolmitriptan-nasal-spray https://druglandscape.com/api/og?type=drug&title=D%3Azolmitriptan%20nasal%20spray&subtitle=D%3Azolmitriptan%20nasal%20spray%20%C2%B7%20Zosano%20Pharma%20Corporation&badge=phase%201 D:zolmitriptan nasal spray D:zolmitriptan nasal spray · Zosano Pharma Corporation https://druglandscape.com/drug/d012-d326-and-d337 https://druglandscape.com/api/og?type=drug&title=D012%2C%20D326%20and%20D337&subtitle=D012%2C%20D326%20and%20D337%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D012, D326 and D337 D012, D326 and D337 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d013-d326-and-d337 https://druglandscape.com/api/og?type=drug&title=D013%2C%20D326%20and%20D337&subtitle=D013%2C%20D326%20and%20D337%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D013, D326 and D337 D013, D326 and D337 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d026 https://druglandscape.com/api/og?type=drug&title=D026&subtitle=D026%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D026 D026 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d1000078 https://druglandscape.com/api/og?type=drug&title=D1000078&subtitle=D1000078%20%C2%B7%20AstraZeneca&badge=phase%201 D1000078 D1000078 · AstraZeneca https://druglandscape.com/drug/d1000082 https://druglandscape.com/api/og?type=drug&title=D1000082&subtitle=D1000082%20%C2%B7%20AstraZeneca&badge=phase%201 D1000082 D1000082 · AstraZeneca https://druglandscape.com/drug/d1000085 https://druglandscape.com/api/og?type=drug&title=D1000085&subtitle=D1000085%20%C2%B7%20AstraZeneca&badge=phase%201 D1000085 D1000085 · AstraZeneca https://druglandscape.com/drug/d14000136 https://druglandscape.com/api/og?type=drug&title=D14000136&subtitle=D14000136%20%C2%B7%20AstraZeneca&badge=phase%201 D14000136 D14000136 · AstraZeneca https://druglandscape.com/drug/d14000137 https://druglandscape.com/api/og?type=drug&title=D14000137&subtitle=D14000137%20%C2%B7%20AstraZeneca&badge=phase%201 D14000137 D14000137 · AstraZeneca https://druglandscape.com/drug/d308-ckd-501 https://druglandscape.com/api/og?type=drug&title=D308%2C%20CKD-501&subtitle=D308%2C%20CKD-501%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D308, CKD-501 D308, CKD-501 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d326-and-d337 https://druglandscape.com/api/og?type=drug&title=D326%20and%20D337&subtitle=D326%20and%20D337%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D326 and D337 D326 and D337 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d387 https://druglandscape.com/api/og?type=drug&title=D387&subtitle=D387%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D387 D387 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d390 https://druglandscape.com/api/og?type=drug&title=D390&subtitle=D390%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D390 D390 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d3l-001 https://druglandscape.com/api/og?type=drug&title=D3L-001&subtitle=D3L-001%20%C2%B7%20D3%20Bio%20(Wuxi)%20Co.%2C%20Ltd&badge=phase%201 D3L-001 D3L-001 · D3 Bio (Wuxi) Co., Ltd https://druglandscape.com/drug/d3s-002 https://druglandscape.com/api/og?type=drug&title=D3S-002&subtitle=D3S-002%20%C2%B7%20D3%20Bio%20(Wuxi)%20Co.%2C%20Ltd&badge=phase%201 D3S-002 D3S-002 · D3 Bio (Wuxi) Co., Ltd https://druglandscape.com/drug/d3s-003 https://druglandscape.com/api/og?type=drug&title=D3S-003&subtitle=D3S-003%20%C2%B7%20D3%20Bio%20(Wuxi)%20Co.%2C%20Ltd&badge=phase%201 D3S-003 D3S-003 · D3 Bio (Wuxi) Co., Ltd https://druglandscape.com/drug/d484 https://druglandscape.com/api/og?type=drug&title=D484&subtitle=D484%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D484 D484 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d501-d759-h053 https://druglandscape.com/api/og?type=drug&title=D501%2C%20D759%2C%20H053&subtitle=D501%2C%20D759%2C%20H053%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D501, D759, H053 D501, D759, H053 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d565 https://druglandscape.com/api/og?type=drug&title=D565&subtitle=D565%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D565 D565 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d569-tab https://druglandscape.com/api/og?type=drug&title=D569%20Tab.&subtitle=D569%20Tab.%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D569 Tab. D569 Tab. · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d5ns https://druglandscape.com/api/og?type=drug&title=D5NS&subtitle=D5NS%20%C2%B7%20MemorialCare&badge=phase%202 D5NS D5NS · MemorialCare https://druglandscape.com/drug/d635 https://druglandscape.com/api/og?type=drug&title=D635&subtitle=D635%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D635 D635 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d744 https://druglandscape.com/api/og?type=drug&title=D744&subtitle=D744%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D744 D744 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d745-d759-d150 https://druglandscape.com/api/og?type=drug&title=D745%2C%20D759%2C%20D150&subtitle=D745%2C%20D759%2C%20D150%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D745, D759, D150 D745, D759, D150 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d759-d150 https://druglandscape.com/api/og?type=drug&title=D759%2C%20D150&subtitle=D759%2C%20D150%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D759, D150 D759, D150 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d794 https://druglandscape.com/api/og?type=drug&title=D794&subtitle=D794%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D794 D794 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d797 https://druglandscape.com/api/og?type=drug&title=D797&subtitle=D797%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D797 D797 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/d935-cap-1t https://druglandscape.com/api/og?type=drug&title=D935%20Cap.%201T&subtitle=D935%20Cap.%201T%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 D935 Cap. 1T D935 Cap. 1T · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/da-020-and-hyperforin https://druglandscape.com/api/og?type=drug&title=DA-020%20and%20Hyperforin&subtitle=DA-020%20and%20Hyperforin%20%C2%B7%20Applied%20Biology%2C%20Inc.&badge=phase%201 DA-020 and Hyperforin DA-020 and Hyperforin · Applied Biology, Inc. https://druglandscape.com/drug/da-1229-01 https://druglandscape.com/api/og?type=drug&title=DA-1229_01&subtitle=DA-1229_01%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-1229_01 DA-1229_01 · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-1229-01-fast https://druglandscape.com/api/og?type=drug&title=DA-1229_01%20fast&subtitle=DA-1229_01%20fast%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-1229_01 fast DA-1229_01 fast · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-1229-01-fed https://druglandscape.com/api/og?type=drug&title=DA-1229_01%20fed&subtitle=DA-1229_01%20fed%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-1229_01 fed DA-1229_01 fed · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-1229-01-r https://druglandscape.com/api/og?type=drug&title=DA-1229_01-R&subtitle=DA-1229_01-R%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-1229_01-R DA-1229_01-R · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-1726 https://druglandscape.com/api/og?type=drug&title=DA-1726&subtitle=DA-1726%20%C2%B7%20NeuroBo%20Pharmaceuticals%20Inc.&badge=phase%201 DA-1726 DA-1726 · NeuroBo Pharmaceuticals Inc. https://druglandscape.com/drug/da-2803-tab https://druglandscape.com/api/og?type=drug&title=DA-2803%20Tab&subtitle=DA-2803%20Tab%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-2803 Tab DA-2803 Tab · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-2811-r https://druglandscape.com/api/og?type=drug&title=DA-2811-R&subtitle=DA-2811-R%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-2811-R DA-2811-R · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-2902-r https://druglandscape.com/api/og?type=drug&title=DA-2902-R&subtitle=DA-2902-R%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-2902-R DA-2902-R · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-3031 https://druglandscape.com/api/og?type=drug&title=DA-3031&subtitle=DA-3031%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-3031 DA-3031 · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-3501 https://druglandscape.com/api/og?type=drug&title=DA-3501&subtitle=DA-3501%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-3501 DA-3501 · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-4001-h https://druglandscape.com/api/og?type=drug&title=DA-4001%20H&subtitle=DA-4001%20H%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-4001 H DA-4001 H · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-5207-a https://druglandscape.com/api/og?type=drug&title=DA-5207%20A&subtitle=DA-5207%20A%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-5207 A DA-5207 A · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-5211 https://druglandscape.com/api/og?type=drug&title=DA-5211&subtitle=DA-5211%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-5211 DA-5211 · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-5215-r-tab https://druglandscape.com/api/og?type=drug&title=DA-5215-R%20Tab&subtitle=DA-5215-R%20Tab%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-5215-R Tab DA-5215-R Tab · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-5216 https://druglandscape.com/api/og?type=drug&title=DA-5216&subtitle=DA-5216%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-5216 DA-5216 · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-5221-01 https://druglandscape.com/api/og?type=drug&title=DA-5221_01&subtitle=DA-5221_01%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-5221_01 DA-5221_01 · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-5222-r1 https://druglandscape.com/api/og?type=drug&title=DA-5222-R1&subtitle=DA-5222-R1%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-5222-R1 DA-5222-R1 · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-5222-r2 https://druglandscape.com/api/og?type=drug&title=DA-5222-R2&subtitle=DA-5222-R2%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-5222-R2 DA-5222-R2 · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-5222-r3 https://druglandscape.com/api/og?type=drug&title=DA-5222-R3&subtitle=DA-5222-R3%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-5222-R3 DA-5222-R3 · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-5223 https://druglandscape.com/api/og?type=drug&title=DA-5223&subtitle=DA-5223%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-5223 DA-5223 · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-5223-r https://druglandscape.com/api/og?type=drug&title=DA-5223-R&subtitle=DA-5223-R%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-5223-R DA-5223-R · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-6034-3 https://druglandscape.com/api/og?type=drug&title=DA-6034%203%25&subtitle=DA-6034%203%25%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%202 DA-6034 3% DA-6034 3% · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-7503-multiple-dose https://druglandscape.com/api/og?type=drug&title=DA-7503%20Multiple%20dose&subtitle=DA-7503%20Multiple%20dose%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 DA-7503 Multiple dose DA-7503 Multiple dose · Dong-A ST Co., Ltd. https://druglandscape.com/drug/da-epoch-r-for-dlbcl-ptld-and-pmbcl https://druglandscape.com/api/og?type=drug&title=DA-EPOCH-R%20for%20DLBCL%2C%20PTLD%2C%20AND%20PMBCL&subtitle=DA-EPOCH-R%20for%20DLBCL%2C%20PTLD%2C%20AND%20PMBCL%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 DA-EPOCH-R for DLBCL, PTLD, AND PMBCL DA-EPOCH-R for DLBCL, PTLD, AND PMBCL · Baylor College of Medicine https://druglandscape.com/drug/da414-granules https://druglandscape.com/api/og?type=drug&title=DA414%20Granules&subtitle=DA414%20Granules%20%C2%B7%20Chendu%20DIAO%20Nine%20Hong%20Pharmaceutical%20Factory&badge=phase%201 DA414 Granules DA414 Granules · Chendu DIAO Nine Hong Pharmaceutical Factory https://druglandscape.com/drug/daa-treatment https://druglandscape.com/api/og?type=drug&title=DAA%20treatment&subtitle=DAA%20treatment%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 DAA treatment DAA treatment · Hospices Civils de Lyon https://druglandscape.com/drug/dacarbazine-or-dtic https://druglandscape.com/api/og?type=drug&title=dacarbazine%20or%20DTIC&subtitle=dacarbazine%20or%20DTIC%20%C2%B7%20Cellxpert%20Biotechnology%20Corp.&badge=phase%202 dacarbazine or DTIC dacarbazine or DTIC · Cellxpert Biotechnology Corp. https://druglandscape.com/drug/dacomitinib-intravenous https://druglandscape.com/api/og?type=drug&title=dacomitinib%20intravenous&subtitle=dacomitinib%20intravenous%20%C2%B7%20Pfizer&badge=phase%201 dacomitinib intravenous dacomitinib intravenous · Pfizer https://druglandscape.com/drug/daily-fluticasone-propionate https://druglandscape.com/api/og?type=drug&title=daily%20fluticasone%20propionate&subtitle=daily%20fluticasone%20propionate%20%C2%B7%20Milton%20S.%20Hershey%20Medical%20Center&badge=phase%203 daily fluticasone propionate daily fluticasone propionate · Milton S. Hershey Medical Center https://druglandscape.com/drug/daily-hgh https://druglandscape.com/api/og?type=drug&title=daily%20hGH&subtitle=daily%20hGH%20%C2%B7%20Visen%20Pharmaceuticals%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%203 daily hGH daily hGH · Visen Pharmaceuticals (Shanghai) Co., Ltd. https://druglandscape.com/drug/daily-tmz https://druglandscape.com/api/og?type=drug&title=Daily%20TMZ&subtitle=Daily%20TMZ%20%C2%B7%20Sunnybrook%20Health%20Sciences%20Centre&badge=phase%202 Daily TMZ Daily TMZ · Sunnybrook Health Sciences Centre https://druglandscape.com/drug/dalantercept-plus-sorafenib https://druglandscape.com/api/og?type=drug&title=Dalantercept%20plus%20sorafenib&subtitle=Dalantercept%20plus%20sorafenib%20%C2%B7%20Acceleron%20Pharma%2C%20Inc.%2C%20a%20wholly-owned%20subsidiary%20of%20Merck%20%26%20Co.%2C%20Inc.&badge=phase%201 Dalantercept plus sorafenib Dalantercept plus sorafenib · Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA https://druglandscape.com/drug/dan-222 https://druglandscape.com/api/og?type=drug&title=DAN-222&subtitle=DAN-222%20%C2%B7%20Dantari%2C%20Inc.&badge=phase%201 DAN-222 DAN-222 · Dantari, Inc. https://druglandscape.com/drug/danicopan-modified-release-prototype-1 https://druglandscape.com/api/og?type=drug&title=Danicopan%20Modified%20Release%20Prototype%201&subtitle=Danicopan%20Modified%20Release%20Prototype%201%20%C2%B7%20Alexion%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Danicopan Modified Release Prototype 1 Danicopan Modified Release Prototype 1 · Alexion Pharmaceuticals, Inc. https://druglandscape.com/drug/danicopan-powder-in-capsule-2 https://druglandscape.com/api/og?type=drug&title=Danicopan%3A%20Powder-In-Capsule%202&subtitle=Danicopan%3A%20Powder-In-Capsule%202%20%C2%B7%20Alexion%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Danicopan: Powder-In-Capsule 2 Danicopan: Powder-In-Capsule 2 · Alexion Pharmaceuticals, Inc. https://druglandscape.com/drug/danicopan-softgel https://druglandscape.com/api/og?type=drug&title=Danicopan%20-%20Softgel&subtitle=Danicopan%20-%20Softgel%20%C2%B7%20Alexion%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Danicopan - Softgel Danicopan - Softgel · Alexion Pharmaceuticals, Inc. https://druglandscape.com/drug/danicopan-tablet https://druglandscape.com/api/og?type=drug&title=Danicopan%20-%20Tablet&subtitle=Danicopan%20-%20Tablet%20%C2%B7%20Alexion%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Danicopan - Tablet Danicopan - Tablet · Alexion Pharmaceuticals, Inc. https://druglandscape.com/drug/dapagliflozin-and-sitagliptin https://druglandscape.com/api/og?type=drug&title=Dapagliflozin%20and%20Sitagliptin&subtitle=Dapagliflozin%20and%20Sitagliptin%20%C2%B7%20SK%20Chemicals%20Co.%2C%20Ltd.&badge=phase%201 Dapagliflozin and Sitagliptin Dapagliflozin and Sitagliptin · SK Chemicals Co., Ltd. https://druglandscape.com/drug/dapagliflozin-reference-product https://druglandscape.com/api/og?type=drug&title=Dapagliflozin-Reference%20product&subtitle=Dapagliflozin-Reference%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Dapagliflozin-Reference product Dapagliflozin-Reference product · Bio-innova Co., Ltd https://druglandscape.com/drug/dapagliflozin-test-product https://druglandscape.com/api/og?type=drug&title=Dapagliflozin-Test%20product&subtitle=Dapagliflozin-Test%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Dapagliflozin-Test product Dapagliflozin-Test product · Bio-innova Co., Ltd https://druglandscape.com/drug/dapsone-gel-verum https://druglandscape.com/api/og?type=drug&title=Dapsone%20gel%20-%20verum&subtitle=Dapsone%20gel%20-%20verum%20%C2%B7%20Cook%20County%20Health&badge=phase%201 Dapsone gel - verum Dapsone gel - verum · Cook County Health https://druglandscape.com/drug/dar-0100a https://druglandscape.com/api/og?type=drug&title=DAR-0100A&subtitle=DAR-0100A%20%C2%B7%20Larry%20J.%20Siever&badge=phase%202 DAR-0100A DAR-0100A · Larry J. Siever https://druglandscape.com/drug/dar-901 https://druglandscape.com/api/og?type=drug&title=DAR-901&subtitle=DAR-901%20%C2%B7%20Dartmouth-Hitchcock%20Medical%20Center&badge=phase%202 DAR-901 DAR-901 · Dartmouth-Hitchcock Medical Center https://druglandscape.com/drug/daratumumab-dexamethasone-ixazomib-pomalidomide https://druglandscape.com/api/og?type=drug&title=Daratumumab%2C%20dexamethasone%2C%20ixazomib%2C%20pomalidomide&subtitle=Daratumumab%2C%20dexamethasone%2C%20ixazomib%2C%20pomalidomide%20%C2%B7%20Multiple%20Myeloma%20Research%20Consortium&badge=phase%201 Daratumumab, dexamethasone, ixazomib, pomalidomide Daratumumab, dexamethasone, ixazomib, pomalidomide · Multiple Myeloma Research Consortium https://druglandscape.com/drug/daratumumab-dose-escalation https://druglandscape.com/api/og?type=drug&title=Daratumumab%20dose%20escalation&subtitle=Daratumumab%20dose%20escalation%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Daratumumab dose escalation Daratumumab dose escalation · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/daratumumab-full-dose https://druglandscape.com/api/og?type=drug&title=Daratumumab%20full%20dose&subtitle=Daratumumab%20full%20dose%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Daratumumab full dose Daratumumab full dose · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/darbepoetin-alfa-iv https://druglandscape.com/api/og?type=drug&title=Darbepoetin%20alfa%20IV&subtitle=Darbepoetin%20alfa%20IV%20%C2%B7%20Amgen&badge=phase%202 Darbepoetin alfa IV Darbepoetin alfa IV · Amgen https://druglandscape.com/drug/darbepoetin-alfa-sc https://druglandscape.com/api/og?type=drug&title=Darbepoetin%20alfa%20SC&subtitle=Darbepoetin%20alfa%20SC%20%C2%B7%20Amgen&badge=phase%202 Darbepoetin alfa SC Darbepoetin alfa SC · Amgen https://druglandscape.com/drug/dare-bv1 https://druglandscape.com/api/og?type=drug&title=DARE-BV1&subtitle=DARE-BV1%20%C2%B7%20Dar%C3%A9%20Bioscience%2C%20Inc.&badge=phase%201 DARE-BV1 DARE-BV1 · Daré Bioscience, Inc. https://druglandscape.com/drug/darolutamide-plus-adt-treatment https://druglandscape.com/api/og?type=drug&title=Darolutamide%20plus%20ADT%20treatment&subtitle=Darolutamide%20plus%20ADT%20treatment%20%C2%B7%20Bayer&badge=phase%202 Darolutamide plus ADT treatment Darolutamide plus ADT treatment · Bayer https://druglandscape.com/drug/darotamine-capsule https://druglandscape.com/api/og?type=drug&title=Darotamine%20Capsule&subtitle=Darotamine%20Capsule%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 Darotamine Capsule Darotamine Capsule · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/darunavir-monotherapy https://druglandscape.com/api/og?type=drug&title=darunavir%20monotherapy&subtitle=darunavir%20monotherapy%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%202 darunavir monotherapy darunavir monotherapy · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/das181-dry-powder-formulation-f02 https://druglandscape.com/api/og?type=drug&title=DAS181%20dry%20powder%2C%20formulation%20F02&subtitle=DAS181%20dry%20powder%2C%20formulation%20F02%20%C2%B7%20Ansun%20Biopharma%2C%20Inc.&badge=phase%202 DAS181 dry powder, formulation F02 DAS181 dry powder, formulation F02 · Ansun Biopharma, Inc. https://druglandscape.com/drug/das181-f02-formulation https://druglandscape.com/api/og?type=drug&title=DAS181-F02%20formulation&subtitle=DAS181-F02%20formulation%20%C2%B7%20Ansun%20Biopharma%2C%20Inc.&badge=phase%202 DAS181-F02 formulation DAS181-F02 formulation · Ansun Biopharma, Inc. https://druglandscape.com/drug/dasabuvir-8-weeks https://druglandscape.com/api/og?type=drug&title=dasabuvir%208%20weeks&subtitle=dasabuvir%208%20weeks%20%C2%B7%20Hepa%20C&badge=phase%202 dasabuvir 8 weeks dasabuvir 8 weeks · Hepa C https://druglandscape.com/drug/dasatinib-as-liquid https://druglandscape.com/api/og?type=drug&title=Dasatinib%20as%20liquid&subtitle=Dasatinib%20as%20liquid%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Dasatinib as liquid Dasatinib as liquid · Bristol-Myers Squibb https://druglandscape.com/drug/dasatinib-as-tablets https://druglandscape.com/api/og?type=drug&title=Dasatinib%20as%20tablets&subtitle=Dasatinib%20as%20tablets%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Dasatinib as tablets Dasatinib as tablets · Bristol-Myers Squibb https://druglandscape.com/drug/dasatinib-asd https://druglandscape.com/api/og?type=drug&title=Dasatinib%20ASD&subtitle=Dasatinib%20ASD%20%C2%B7%20Xspray%20Pharma%20AB&badge=phase%201 Dasatinib ASD Dasatinib ASD · Xspray Pharma AB https://druglandscape.com/drug/dat-2645-tablet https://druglandscape.com/api/og?type=drug&title=DAT-2645%20tablet&subtitle=DAT-2645%20tablet%20%C2%B7%20Danatlas%20Pharmaceuticals%20Co.%2C%20Ltd&badge=phase%201 DAT-2645 tablet DAT-2645 tablet · Danatlas Pharmaceuticals Co., Ltd https://druglandscape.com/drug/daxi-120-u https://druglandscape.com/api/og?type=drug&title=DAXI%20120%20U&subtitle=DAXI%20120%20U%20%C2%B7%20Revance%20Therapeutics%2C%20Inc.&badge=phase%202 DAXI 120 U DAXI 120 U · Revance Therapeutics, Inc. https://druglandscape.com/drug/daxi-80-u https://druglandscape.com/api/og?type=drug&title=DAXI%2080%20U&subtitle=DAXI%2080%20U%20%C2%B7%20Revance%20Therapeutics%2C%20Inc.&badge=phase%202 DAXI 80 U DAXI 80 U · Revance Therapeutics, Inc. https://druglandscape.com/drug/daxi-for-injection-500-u https://druglandscape.com/api/og?type=drug&title=DAXI%20for%20injection%20500%20U&subtitle=DAXI%20for%20injection%20500%20U%20%C2%B7%20Revance%20Therapeutics%2C%20Inc.&badge=phase%202 DAXI for injection 500 U DAXI for injection 500 U · Revance Therapeutics, Inc. https://druglandscape.com/drug/db-1202 https://druglandscape.com/api/og?type=drug&title=DB-1202&subtitle=DB-1202%20%C2%B7%20DualityBio%20Inc.&badge=phase%201 DB-1202 DB-1202 · DualityBio Inc. https://druglandscape.com/drug/db-1311 https://druglandscape.com/api/og?type=drug&title=DB-1311&subtitle=DB-1311%20%C2%B7%20DualityBio%20Inc.&badge=phase%201 DB-1311 DB-1311 · DualityBio Inc. https://druglandscape.com/drug/db-1317 https://druglandscape.com/api/og?type=drug&title=DB-1317&subtitle=DB-1317%20%C2%B7%20DualityBio%20Inc.&badge=phase%201 DB-1317 DB-1317 · DualityBio Inc. https://druglandscape.com/drug/db-3q https://druglandscape.com/api/og?type=drug&title=DB-3Q&subtitle=DB-3Q%20%C2%B7%20Direct%20Biologics%2C%20LLC&badge=phase%202 DB-3Q DB-3Q · Direct Biologics, LLC https://druglandscape.com/drug/dbi-002-probiotic-gel https://druglandscape.com/api/og?type=drug&title=DBI-002%20probiotic%20gel&subtitle=DBI-002%20probiotic%20gel%20%C2%B7%20DermBiont%2C%20Inc.&badge=phase%202 DBI-002 probiotic gel DBI-002 probiotic gel · DermBiont, Inc. https://druglandscape.com/drug/dbm-1152a-inhalation-solution https://druglandscape.com/api/og?type=drug&title=DBM-1152A%20Inhalation%20Solution&subtitle=DBM-1152A%20Inhalation%20Solution%20%C2%B7%20Joincare%20Pharmaceutical%20Group%20Industry%20Co.%2C%20Ltd&badge=phase%201 DBM-1152A Inhalation Solution DBM-1152A Inhalation Solution · Joincare Pharmaceutical Group Industry Co., Ltd https://druglandscape.com/drug/dbpr108-tablets https://druglandscape.com/api/og?type=drug&title=DBPR108%20tablets&subtitle=DBPR108%20tablets%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 DBPR108 tablets DBPR108 tablets · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/dc371739 https://druglandscape.com/api/og?type=drug&title=DC371739&subtitle=DC371739%20%C2%B7%20Guangzhou%20JOYO%20Pharma%20Co.%2C%20Ltd&badge=phase%201 DC371739 DC371739 · Guangzhou JOYO Pharma Co., Ltd https://druglandscape.com/drug/dcb-bo1301 https://druglandscape.com/api/og?type=drug&title=DCB-BO1301&subtitle=DCB-BO1301%20%C2%B7%20Chung%20Mei%20Biopharma%20Co.%2C%20Ltd&badge=phase%201 DCB-BO1301 DCB-BO1301 · Chung Mei Biopharma Co., Ltd https://druglandscape.com/drug/dcb-dm101 https://druglandscape.com/api/og?type=drug&title=DCB-DM101&subtitle=DCB-DM101%20%C2%B7%20VitNovo%2C%20Inc.&badge=phase%201 DCB-DM101 DCB-DM101 · VitNovo, Inc. https://druglandscape.com/drug/dcb-wh1-ointment https://druglandscape.com/api/og?type=drug&title=DCB-WH1%20ointment&subtitle=DCB-WH1%20ointment%20%C2%B7%20Oneness%20Biotech%20Co.%2C%20Ltd.&badge=phase%202 DCB-WH1 ointment DCB-WH1 ointment · Oneness Biotech Co., Ltd. https://druglandscape.com/drug/dcc-2812 https://druglandscape.com/api/og?type=drug&title=DCC-2812&subtitle=DCC-2812%20%C2%B7%20Deciphera%20Pharmaceuticals%2C%20LLC&badge=phase%201 DCC-2812 DCC-2812 · Deciphera Pharmaceuticals, LLC https://druglandscape.com/drug/dcdt2980s https://druglandscape.com/api/og?type=drug&title=DCDT2980S&subtitle=DCDT2980S%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 DCDT2980S DCDT2980S · Genentech, Inc. https://druglandscape.com/drug/dcll9718s https://druglandscape.com/api/og?type=drug&title=DCLL9718S&subtitle=DCLL9718S%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 DCLL9718S DCLL9718S · Genentech, Inc. https://druglandscape.com/drug/dcn01 https://druglandscape.com/api/og?type=drug&title=DCN01&subtitle=DCN01%20%C2%B7%20Deacon%20Biosciences%2C%20Inc.&badge=phase%202 DCN01 DCN01 · Deacon Biosciences, Inc. https://druglandscape.com/drug/dcr-hbvs https://druglandscape.com/api/og?type=drug&title=DCR-HBVS&subtitle=DCR-HBVS%20%C2%B7%20Dicerna%20Pharmaceuticals%2C%20Inc.%2C%20a%20Novo%20Nordisk%20company&badge=phase%201 DCR-HBVS DCR-HBVS · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company https://druglandscape.com/drug/dcr-pdl1 https://druglandscape.com/api/og?type=drug&title=DCR-PDL1&subtitle=DCR-PDL1%20%C2%B7%20Dicerna%20Pharmaceuticals%2C%20Inc.%2C%20a%20Novo%20Nordisk%20company&badge=phase%201 DCR-PDL1 DCR-PDL1 · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company https://druglandscape.com/drug/dcr-stat3 https://druglandscape.com/api/og?type=drug&title=DCR-STAT3&subtitle=DCR-STAT3%20%C2%B7%20Dicerna%20Pharmaceuticals%2C%20Inc.%2C%20a%20Novo%20Nordisk%20company&badge=phase%201 DCR-STAT3 DCR-STAT3 · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company https://druglandscape.com/drug/dcv-3daa-fdc https://druglandscape.com/api/og?type=drug&title=DCV%203DAA%20FDC&subtitle=DCV%203DAA%20FDC%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 DCV 3DAA FDC DCV 3DAA FDC · Bristol-Myers Squibb https://druglandscape.com/drug/dcv3 https://druglandscape.com/api/og?type=drug&title=DCV3&subtitle=DCV3%20%C2%B7%20Judit%20Pich%20Mart%C3%ADnez&badge=phase%201 DCV3 DCV3 · Judit Pich Martínez https://druglandscape.com/drug/dcv3-with-peg-inf https://druglandscape.com/api/og?type=drug&title=DCV3%20with%20PEG-INF&subtitle=DCV3%20with%20PEG-INF%20%C2%B7%20Judit%20Pich%20Mart%C3%ADnez&badge=phase%201 DCV3 with PEG-INF DCV3 with PEG-INF · Judit Pich Martínez https://druglandscape.com/drug/dcvac-add-on-to-soc https://druglandscape.com/api/og?type=drug&title=DCVAC%20add%20on%20to%20SOC&subtitle=DCVAC%20add%20on%20to%20SOC%20%C2%B7%20SOTIO%20a.s.&badge=phase%201 DCVAC add on to SOC DCVAC add on to SOC · SOTIO a.s. https://druglandscape.com/drug/dcvac-and-immune-enhancers-add-on-to-soc https://druglandscape.com/api/og?type=drug&title=DCVAC%20and%20immune%20enhancers%20add%20on%20to%20SOC&subtitle=DCVAC%20and%20immune%20enhancers%20add%20on%20to%20SOC%20%C2%B7%20SOTIO%20a.s.&badge=phase%201 DCVAC and immune enhancers add on to SOC DCVAC and immune enhancers add on to SOC · SOTIO a.s. https://druglandscape.com/drug/dd-cfdna-guided https://druglandscape.com/api/og?type=drug&title=dd-cfDNA-guided&subtitle=dd-cfDNA-guided%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 dd-cfDNA-guided dd-cfDNA-guided · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/dd-s052p https://druglandscape.com/api/og?type=drug&title=DD-S052P&subtitle=DD-S052P%20%C2%B7%20HLB%20Science&badge=phase%201 DD-S052P DD-S052P · HLB Science https://druglandscape.com/drug/dd01 https://druglandscape.com/api/og?type=drug&title=DD01&subtitle=DD01%20%C2%B7%20Neuraly%2C%20Inc.&badge=phase%202 DD01 DD01 · Neuraly, Inc. https://druglandscape.com/drug/ddo-3055-tablet https://druglandscape.com/api/og?type=drug&title=DDO-3055%20tablet&subtitle=DDO-3055%20tablet%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 DDO-3055 tablet DDO-3055 tablet · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/ddo-3055-tablets https://druglandscape.com/api/og?type=drug&title=DDO-3055%20tablets&subtitle=DDO-3055%20tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 DDO-3055 tablets DDO-3055 tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/de-104-high-concentration https://druglandscape.com/api/og?type=drug&title=DE-104%20high%20concentration&subtitle=DE-104%20high%20concentration%20%C2%B7%20Santen%20Inc.&badge=phase%201 DE-104 high concentration DE-104 high concentration · Santen Inc. https://druglandscape.com/drug/de-104-medium-concentration https://druglandscape.com/api/og?type=drug&title=DE-104%20medium%20concentration&subtitle=DE-104%20medium%20concentration%20%C2%B7%20Santen%20Inc.&badge=phase%201 DE-104 medium concentration DE-104 medium concentration · Santen Inc. https://druglandscape.com/drug/de-110-ophthalmic-suspension-high-dose https://druglandscape.com/api/og?type=drug&title=DE-110%20ophthalmic%20suspension%20high%20dose&subtitle=DE-110%20ophthalmic%20suspension%20high%20dose%20%C2%B7%20Santen%20Inc.&badge=phase%202 DE-110 ophthalmic suspension high dose DE-110 ophthalmic suspension high dose · Santen Inc. https://druglandscape.com/drug/de-117-and-0-0015-tafluprost https://druglandscape.com/api/og?type=drug&title=DE-117%20and%200.0015%25%20tafluprost&subtitle=DE-117%20and%200.0015%25%20tafluprost%20%C2%B7%20Santen%20Inc.&badge=phase%201 DE-117 and 0.0015% tafluprost DE-117 and 0.0015% tafluprost · Santen Inc. https://druglandscape.com/drug/de-117-ophthalmic-solution-low https://druglandscape.com/api/og?type=drug&title=DE-117%20ophthalmic%20solution%20low&subtitle=DE-117%20ophthalmic%20solution%20low%20%C2%B7%20Santen%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 DE-117 ophthalmic solution low DE-117 ophthalmic solution low · Santen Pharmaceutical Co., Ltd. https://druglandscape.com/drug/de-126-ophthalmic-solution-0-002-qd https://druglandscape.com/api/og?type=drug&title=DE-126%20Ophthalmic%20Solution%200.002%25%20QD&subtitle=DE-126%20Ophthalmic%20Solution%200.002%25%20QD%20%C2%B7%20Santen%20Inc.&badge=phase%202 DE-126 Ophthalmic Solution 0.002% QD DE-126 Ophthalmic Solution 0.002% QD · Santen Inc. https://druglandscape.com/drug/de-127-ophthalmic-solution-medium-dose https://druglandscape.com/api/og?type=drug&title=DE-127%20Ophthalmic%20Solution%20medium%20dose&subtitle=DE-127%20Ophthalmic%20Solution%20medium%20dose%20%C2%B7%20Santen%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 DE-127 Ophthalmic Solution medium dose DE-127 Ophthalmic Solution medium dose · Santen Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dead-sea-peloid-gel https://druglandscape.com/api/og?type=drug&title=Dead%20Sea%20Peloid%20Gel&subtitle=Dead%20Sea%20Peloid%20Gel%20%C2%B7%20Scientific%20Center%20for%20Family%20Health%20and%20Human%20Reproduction%20Problems%2C%20Russia&badge=phase%201 Dead Sea Peloid Gel Dead Sea Peloid Gel · Scientific Center for Family Health and Human Reproduction Problems, Russia https://druglandscape.com/drug/debio-0123-and-sacituzumab-govitecan https://druglandscape.com/api/og?type=drug&title=Debio%200123%20and%20Sacituzumab%20govitecan&subtitle=Debio%200123%20and%20Sacituzumab%20govitecan%20%C2%B7%20MedSIR&badge=phase%201 Debio 0123 and Sacituzumab govitecan Debio 0123 and Sacituzumab govitecan · MedSIR https://druglandscape.com/drug/debio1143 https://druglandscape.com/api/og?type=drug&title=DEBIO1143&subtitle=DEBIO1143%20%C2%B7%20Centre%20Leon%20Berard&badge=phase%201 DEBIO1143 DEBIO1143 · Centre Leon Berard https://druglandscape.com/drug/decellularized-allogeneic-human-amniotic-fluid https://druglandscape.com/api/og?type=drug&title=Decellularized%20allogeneic%20human%20amniotic%20fluid&subtitle=Decellularized%20allogeneic%20human%20amniotic%20fluid%20%C2%B7%20Restore%20Biologics%20Holdings%2C%20Inc.%20dba%20Xtress%C3%A9&badge=phase%201 Decellularized allogeneic human amniotic fluid Decellularized allogeneic human amniotic fluid · Restore Biologics Holdings, Inc. dba Xtressé https://druglandscape.com/drug/decitabine-and-cytarabine https://druglandscape.com/api/og?type=drug&title=decitabine%20and%20cytarabine&subtitle=decitabine%20and%20cytarabine%20%C2%B7%20Annie%20Im%2C%20M.D.&badge=phase%202 decitabine and cytarabine decitabine and cytarabine · Annie Im, M.D. https://druglandscape.com/drug/decitabine-and-r-gdp https://druglandscape.com/api/og?type=drug&title=Decitabine%20and%20R-GDP&subtitle=Decitabine%20and%20R-GDP%20%C2%B7%20Beijing%20Immunochina%20Medical%20Science%20%26%20Technology%20Co.%2C%20Ltd.&badge=phase%201 Decitabine and R-GDP Decitabine and R-GDP · Beijing Immunochina Medical Science & Technology Co., Ltd. https://druglandscape.com/drug/decitabine-cycle-1 https://druglandscape.com/api/og?type=drug&title=Decitabine%20cycle%201&subtitle=Decitabine%20cycle%201%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Decitabine cycle 1 Decitabine cycle 1 · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/decitabine-cycle-2 https://druglandscape.com/api/og?type=drug&title=Decitabine%20cycle%202&subtitle=Decitabine%20cycle%202%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Decitabine cycle 2 Decitabine cycle 2 · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/decitabine-cycle-3 https://druglandscape.com/api/og?type=drug&title=Decitabine%20cycle%203&subtitle=Decitabine%20cycle%203%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Decitabine cycle 3 Decitabine cycle 3 · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/decitabine-cycle-4 https://druglandscape.com/api/og?type=drug&title=Decitabine%20cycle%204&subtitle=Decitabine%20cycle%204%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Decitabine cycle 4 Decitabine cycle 4 · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/decitabine-thu https://druglandscape.com/api/og?type=drug&title=Decitabine-THU&subtitle=Decitabine-THU%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Decitabine-THU Decitabine-THU · Novo Nordisk A/S https://druglandscape.com/drug/decrease-per-dialytic-heparin-therapy https://druglandscape.com/api/og?type=drug&title=Decrease%20per-dialytic%20heparin%20therapy&subtitle=Decrease%20per-dialytic%20heparin%20therapy%20%C2%B7%20CHU%20de%20Reims&badge=phase%201 Decrease per-dialytic heparin therapy Decrease per-dialytic heparin therapy · CHU de Reims https://druglandscape.com/drug/dedn6526a https://druglandscape.com/api/og?type=drug&title=DEDN6526A&subtitle=DEDN6526A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 DEDN6526A DEDN6526A · Genentech, Inc. https://druglandscape.com/drug/deferiprone-delayed-release-tablet-formulation https://druglandscape.com/api/og?type=drug&title=Deferiprone%20delayed%20release%20tablet%20formulation&subtitle=Deferiprone%20delayed%20release%20tablet%20formulation%20%C2%B7%20ApoPharma&badge=phase%201 Deferiprone delayed release tablet formulation Deferiprone delayed release tablet formulation · ApoPharma https://druglandscape.com/drug/deferiprone-dose-level-1 https://druglandscape.com/api/og?type=drug&title=Deferiprone%2C%20dose%20level%201&subtitle=Deferiprone%2C%20dose%20level%201%20%C2%B7%20Consorzio%20per%20Valutazioni%20Biologiche%20e%20Farmacologiche&badge=phase%202 Deferiprone, dose level 1 Deferiprone, dose level 1 · Consorzio per Valutazioni Biologiche e Farmacologiche https://druglandscape.com/drug/deferiprone-sustained-release https://druglandscape.com/api/og?type=drug&title=Deferiprone%20sustained-release&subtitle=Deferiprone%20sustained-release%20%C2%B7%20ApoPharma&badge=phase%201 Deferiprone sustained-release Deferiprone sustained-release · ApoPharma https://druglandscape.com/drug/deflazacort-and-clarithromycin https://druglandscape.com/api/og?type=drug&title=Deflazacort%20and%20Clarithromycin&subtitle=Deflazacort%20and%20Clarithromycin%20%C2%B7%20PTC%20Therapeutics&badge=phase%201 Deflazacort and Clarithromycin Deflazacort and Clarithromycin · PTC Therapeutics https://druglandscape.com/drug/deflazacort-and-rifampin https://druglandscape.com/api/og?type=drug&title=Deflazacort%20and%20rifampin&subtitle=Deflazacort%20and%20rifampin%20%C2%B7%20PTC%20Therapeutics&badge=phase%201 Deflazacort and rifampin Deflazacort and rifampin · PTC Therapeutics https://druglandscape.com/drug/deflox https://druglandscape.com/api/og?type=drug&title=Deflox%C2%AE&subtitle=Deflox%C2%AE%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 Deflox® Deflox® · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/degludec-iv https://druglandscape.com/api/og?type=drug&title=Degludec%20IV&subtitle=Degludec%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Degludec IV Degludec IV · Eli Lilly and Company https://druglandscape.com/drug/delayed-primaquine https://druglandscape.com/api/og?type=drug&title=delayed%20primaquine&subtitle=delayed%20primaquine%20%C2%B7%20Menzies%20School%20of%20Health%20Research&badge=phase%201 delayed primaquine delayed primaquine · Menzies School of Health Research https://druglandscape.com/drug/delta-24-rgd-adenovirus https://druglandscape.com/api/og?type=drug&title=delta-24-RGD%20adenovirus&subtitle=delta-24-RGD%20adenovirus%20%C2%B7%20Erasmus%20Medical%20Center&badge=phase%201 delta-24-RGD adenovirus delta-24-RGD adenovirus · Erasmus Medical Center https://druglandscape.com/drug/delta-inulin https://druglandscape.com/api/og?type=drug&title=Delta-inulin&subtitle=Delta-inulin%20%C2%B7%20Central%20Adelaide%20Local%20Health%20Network%20Incorporated&badge=phase%201 Delta-inulin Delta-inulin · Central Adelaide Local Health Network Incorporated https://druglandscape.com/drug/den-vaccine-f17 https://druglandscape.com/api/og?type=drug&title=DEN%20vaccine%20F17&subtitle=DEN%20vaccine%20F17%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 DEN vaccine F17 DEN vaccine F17 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/dendritic-cell-tumor-fusion https://druglandscape.com/api/og?type=drug&title=Dendritic%20Cell%20Tumor%20Fusion&subtitle=Dendritic%20Cell%20Tumor%20Fusion%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%201 Dendritic Cell Tumor Fusion Dendritic Cell Tumor Fusion · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/dendritic-cells-pulsed-with-tumor-lysate https://druglandscape.com/api/og?type=drug&title=Dendritic%20cells%20pulsed%20with%20tumor%20lysate&subtitle=Dendritic%20cells%20pulsed%20with%20tumor%20lysate%20%C2%B7%20The%20Republican%20Research%20and%20Practical%20Center%20for%20Epidemio&badge=phase%201 Dendritic cells pulsed with tumor lysate Dendritic cells pulsed with tumor lysate · The Republican Research and Practical Center for Epidemiology and Microbiology https://druglandscape.com/drug/dental-pulp-mesenchymal-stem-cells https://druglandscape.com/api/og?type=drug&title=Dental%20pulp%20mesenchymal%20stem%20cells&subtitle=Dental%20pulp%20mesenchymal%20stem%20cells%20%C2%B7%20CAR-T%20(Shanghai)%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 Dental pulp mesenchymal stem cells Dental pulp mesenchymal stem cells · CAR-T (Shanghai) Biotechnology Co., Ltd. https://druglandscape.com/drug/denture-soaking-solution https://druglandscape.com/api/og?type=drug&title=Denture%20soaking%20solution&subtitle=Denture%20soaking%20solution%20%C2%B7%20Raphael%20Freitas%20de%20Souza&badge=phase%201 Denture soaking solution Denture soaking solution · Raphael Freitas de Souza https://druglandscape.com/drug/denv-1-piv-2-5-g https://druglandscape.com/api/og?type=drug&title=DENV-1%20PIV%2C%202.5%20%C2%B5g&subtitle=DENV-1%20PIV%2C%202.5%20%C2%B5g%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 DENV-1 PIV, 2.5 µg DENV-1 PIV, 2.5 µg · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/denv-1-piv-5-g https://druglandscape.com/api/og?type=drug&title=DENV-1%20PIV%2C%205%20%C2%B5g&subtitle=DENV-1%20PIV%2C%205%20%C2%B5g%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 DENV-1 PIV, 5 µg DENV-1 PIV, 5 µg · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/depakote-dr-tablets https://druglandscape.com/api/og?type=drug&title=Depakote%20DR%20Tablets&subtitle=Depakote%20DR%20Tablets%20%C2%B7%20Sandoz&badge=phase%201 Depakote DR Tablets Depakote DR Tablets · Sandoz https://druglandscape.com/drug/depleted-stem-cell-transplant https://druglandscape.com/api/og?type=drug&title=Depleted%20Stem%20Cell%20Transplant&subtitle=Depleted%20Stem%20Cell%20Transplant%20%C2%B7%20Porteus%2C%20Matthew%2C%20MD&badge=phase%201 Depleted Stem Cell Transplant Depleted Stem Cell Transplant · Porteus, Matthew, MD https://druglandscape.com/drug/depo-eligard https://druglandscape.com/api/og?type=drug&title=Depo-Eligard%C2%AE&subtitle=Depo-Eligard%C2%AE%20%C2%B7%20Astellas%20Pharma%20Europe%20B.V.&badge=phase%202 Depo-Eligard® Depo-Eligard® · Astellas Pharma Europe B.V. https://druglandscape.com/drug/depo-provera-ci https://druglandscape.com/api/og?type=drug&title=Depo-Provera%20CI&subtitle=Depo-Provera%20CI%20%C2%B7%20FHI%20360&badge=phase%201 Depo-Provera CI Depo-Provera CI · FHI 360 https://druglandscape.com/drug/depo-subq-104 https://druglandscape.com/api/og?type=drug&title=Depo-subQ%20104&subtitle=Depo-subQ%20104%20%C2%B7%20FHI%20360&badge=phase%201 Depo-subQ 104 Depo-subQ 104 · FHI 360 https://druglandscape.com/drug/depot-octreotide https://druglandscape.com/api/og?type=drug&title=depot%20octreotide&subtitle=depot%20octreotide%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 depot octreotide depot octreotide · Eli Lilly and Company https://druglandscape.com/drug/der-45-ev https://druglandscape.com/api/og?type=drug&title=DER%2045%20EV&subtitle=DER%2045%20EV%20%C2%B7%20Sol-Gel%20Technologies%2C%20Ltd.&badge=phase%202 DER 45 EV DER 45 EV · Sol-Gel Technologies, Ltd. https://druglandscape.com/drug/dermovate-cream https://druglandscape.com/api/og?type=drug&title=Dermovate%C2%AE%20cream&subtitle=Dermovate%C2%AE%20cream%20%C2%B7%20LEO%20Pharma&badge=phase%201 Dermovate® cream Dermovate® cream · LEO Pharma https://druglandscape.com/drug/dersalazine-sodium https://druglandscape.com/api/og?type=drug&title=Dersalazine%20sodium&subtitle=Dersalazine%20sodium%20%C2%B7%20Palau%20Pharma%20S.L.U.&badge=phase%202 Dersalazine sodium Dersalazine sodium · Palau Pharma S.L.U. https://druglandscape.com/drug/desacyl-ghrelin https://druglandscape.com/api/og?type=drug&title=Desacyl%20ghrelin&subtitle=Desacyl%20ghrelin%20%C2%B7%20Imperial%20College%20London&badge=phase%201 Desacyl ghrelin Desacyl ghrelin · Imperial College London https://druglandscape.com/drug/desogestrel-reference-product https://druglandscape.com/api/og?type=drug&title=Desogestrel-Reference%20product&subtitle=Desogestrel-Reference%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Desogestrel-Reference product Desogestrel-Reference product · Bio-innova Co., Ltd https://druglandscape.com/drug/determination-of-esr1-mutations https://druglandscape.com/api/og?type=drug&title=Determination%20of%20ESR1%20mutations&subtitle=Determination%20of%20ESR1%20mutations%20%C2%B7%20Centre%20Henri%20Becquerel&badge=phase%201 Determination of ESR1 mutations Determination of ESR1 mutations · Centre Henri Becquerel https://druglandscape.com/drug/deucrictibant-low-dose https://druglandscape.com/api/og?type=drug&title=Deucrictibant%20low%20dose&subtitle=Deucrictibant%20low%20dose%20%C2%B7%20Pharvaris%20Netherlands%20B.V.&badge=phase%202 Deucrictibant low dose Deucrictibant low dose · Pharvaris Netherlands B.V. https://druglandscape.com/drug/deuremidevir-hydrobromide-for-suspension https://druglandscape.com/api/og?type=drug&title=Deuremidevir%20Hydrobromide%20for%20Suspension&subtitle=Deuremidevir%20Hydrobromide%20for%20Suspension%20%C2%B7%20Vigonvita%20Life%20Sciences&badge=phase%202 Deuremidevir Hydrobromide for Suspension Deuremidevir Hydrobromide for Suspension · Vigonvita Life Sciences https://druglandscape.com/drug/deuremidevir-hydrobromide-tablets https://druglandscape.com/api/og?type=drug&title=Deuremidevir%20Hydrobromide%20Tablets&subtitle=Deuremidevir%20Hydrobromide%20Tablets%20%C2%B7%20Shanghai%20Vinnerna%20Biosciences%20Co.%2C%20Ltd.&badge=phase%201 Deuremidevir Hydrobromide Tablets Deuremidevir Hydrobromide Tablets · Shanghai Vinnerna Biosciences Co., Ltd. https://druglandscape.com/drug/deuterated-water https://druglandscape.com/api/og?type=drug&title=Deuterated%20Water&subtitle=Deuterated%20Water%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Deuterated Water Deuterated Water · GlaxoSmithKline https://druglandscape.com/drug/developmental-moisturizing-cream-1 https://druglandscape.com/api/og?type=drug&title=Developmental%20moisturizing%20cream%201&subtitle=Developmental%20moisturizing%20cream%201%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Developmental moisturizing cream 1 Developmental moisturizing cream 1 · GlaxoSmithKline https://druglandscape.com/drug/dexamethasone-700-intravitreal-implant https://druglandscape.com/api/og?type=drug&title=dexamethasone%20700%20%E3%8E%8D%20intravitreal%20implant&subtitle=dexamethasone%20700%20%E3%8E%8D%20intravitreal%20implant%20%C2%B7%20Allergan&badge=phase%202 dexamethasone 700 ㎍ intravitreal implant dexamethasone 700 ㎍ intravitreal implant · Allergan https://druglandscape.com/drug/dexamethasone-combined-with-ondansetron https://druglandscape.com/api/og?type=drug&title=dexamethasone%20combined%20with%20ondansetron&subtitle=dexamethasone%20combined%20with%20ondansetron%20%C2%B7%20AIPING%20ZHOU&badge=phase%202 dexamethasone combined with ondansetron dexamethasone combined with ondansetron · AIPING ZHOU https://druglandscape.com/drug/dexamethasone-or-equivalent-steroid https://druglandscape.com/api/og?type=drug&title=Dexamethasone%20or%20equivalent%20steroid&subtitle=Dexamethasone%20or%20equivalent%20steroid%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Dexamethasone or equivalent steroid Dexamethasone or equivalent steroid · Janssen Research & Development, LLC https://druglandscape.com/drug/dexamethasone-or-other-corticosteroid https://druglandscape.com/api/og?type=drug&title=Dexamethasone%20or%20other%20corticosteroid&subtitle=Dexamethasone%20or%20other%20corticosteroid%20%C2%B7%20NYU%20Langone%20Health&badge=phase%201 Dexamethasone or other corticosteroid Dexamethasone or other corticosteroid · NYU Langone Health https://druglandscape.com/drug/dexamethasone-premedication https://druglandscape.com/api/og?type=drug&title=Dexamethasone%20Premedication&subtitle=Dexamethasone%20Premedication%20%C2%B7%20Amgen&badge=phase%201 Dexamethasone Premedication Dexamethasone Premedication · Amgen https://druglandscape.com/drug/dexamethasone-steroid-oral https://druglandscape.com/api/og?type=drug&title=Dexamethasone%2C%20steroid%3B%20oral&subtitle=Dexamethasone%2C%20steroid%3B%20oral%20%C2%B7%20Pfizer&badge=phase%201 Dexamethasone, steroid; oral Dexamethasone, steroid; oral · Pfizer https://druglandscape.com/drug/dexamethasone-supplementation https://druglandscape.com/api/og?type=drug&title=Dexamethasone%20Supplementation&subtitle=Dexamethasone%20Supplementation%20%C2%B7%20Dr.%20Nils%20Gassen&badge=phase%201 Dexamethasone Supplementation Dexamethasone Supplementation · Dr. Nils Gassen https://druglandscape.com/drug/dexanabinol-dose-level-1 https://druglandscape.com/api/og?type=drug&title=Dexanabinol%20Dose%20Level%201&subtitle=Dexanabinol%20Dose%20Level%201%20%C2%B7%20e-Therapeutics%20PLC&badge=phase%201 Dexanabinol Dose Level 1 Dexanabinol Dose Level 1 · e-Therapeutics PLC https://druglandscape.com/drug/dexanabinol-dose-level-2 https://druglandscape.com/api/og?type=drug&title=Dexanabinol%20Dose%20Level%202&subtitle=Dexanabinol%20Dose%20Level%202%20%C2%B7%20e-Therapeutics%20PLC&badge=phase%201 Dexanabinol Dose Level 2 Dexanabinol Dose Level 2 · e-Therapeutics PLC https://druglandscape.com/drug/dexanabinol-dose-level-3 https://druglandscape.com/api/og?type=drug&title=Dexanabinol%20Dose%20Level%203&subtitle=Dexanabinol%20Dose%20Level%203%20%C2%B7%20e-Therapeutics%20PLC&badge=phase%201 Dexanabinol Dose Level 3 Dexanabinol Dose Level 3 · e-Therapeutics PLC https://druglandscape.com/drug/dexanabinol-dose-level-4 https://druglandscape.com/api/og?type=drug&title=Dexanabinol%20Dose%20Level%204&subtitle=Dexanabinol%20Dose%20Level%204%20%C2%B7%20e-Therapeutics%20PLC&badge=phase%201 Dexanabinol Dose Level 4 Dexanabinol Dose Level 4 · e-Therapeutics PLC https://druglandscape.com/drug/dexanabinol-dose-level-5 https://druglandscape.com/api/og?type=drug&title=Dexanabinol%20Dose%20Level%205&subtitle=Dexanabinol%20Dose%20Level%205%20%C2%B7%20e-Therapeutics%20PLC&badge=phase%201 Dexanabinol Dose Level 5 Dexanabinol Dose Level 5 · e-Therapeutics PLC https://druglandscape.com/drug/dexfadrostat-phosphate https://druglandscape.com/api/og?type=drug&title=dexfadrostat%20phosphate&subtitle=dexfadrostat%20phosphate%20%C2%B7%20Damian%20Pharma%20AG&badge=phase%202 dexfadrostat phosphate dexfadrostat phosphate · Damian Pharma AG https://druglandscape.com/drug/dexlansoprazole-delayed-release-capsules https://druglandscape.com/api/og?type=drug&title=Dexlansoprazole%20Delayed%20Release%20Capsules&subtitle=Dexlansoprazole%20Delayed%20Release%20Capsules%20%C2%B7%20Takeda&badge=phase%201 Dexlansoprazole Delayed Release Capsules Dexlansoprazole Delayed Release Capsules · Takeda https://druglandscape.com/drug/dexmedetomidine-hydrochloride-microneedles https://druglandscape.com/api/og?type=drug&title=Dexmedetomidine%20hydrochloride%20Microneedles&subtitle=Dexmedetomidine%20hydrochloride%20Microneedles%20%C2%B7%20Guangzhou%20Novaken%20Pharm%20Co.%2C%20Ltd.&badge=phase%202 Dexmedetomidine hydrochloride Microneedles Dexmedetomidine hydrochloride Microneedles · Guangzhou Novaken Pharm Co., Ltd. https://druglandscape.com/drug/dexmedetomidine-iv https://druglandscape.com/api/og?type=drug&title=Dexmedetomidine%20IV&subtitle=Dexmedetomidine%20IV%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 Dexmedetomidine IV Dexmedetomidine IV · Samsung Medical Center https://druglandscape.com/drug/dexmedetomidine-tramadol-and-flurbiprofen https://druglandscape.com/api/og?type=drug&title=dexmedetomidine%2C%20tramadol%20and%20flurbiprofen&subtitle=dexmedetomidine%2C%20tramadol%20and%20flurbiprofen%20%C2%B7%20Chinese%20Medical%20Association&badge=phase%201 dexmedetomidine, tramadol and flurbiprofen dexmedetomidine, tramadol and flurbiprofen · Chinese Medical Association https://druglandscape.com/drug/dextrin-2-sulfate https://druglandscape.com/api/og?type=drug&title=Dextrin%202-sulfate&subtitle=Dextrin%202-sulfate%20%C2%B7%20Steinhart%20Medical%20Associates&badge=phase%201 Dextrin 2-sulfate Dextrin 2-sulfate · Steinhart Medical Associates https://druglandscape.com/drug/dextrose-intraarticularly-administered https://druglandscape.com/api/og?type=drug&title=Dextrose%20intraarticularly%20administered&subtitle=Dextrose%20intraarticularly%20administered%20%C2%B7%20Universidad%20Nacional%20de%20Rosario&badge=phase%202 Dextrose intraarticularly administered Dextrose intraarticularly administered · Universidad Nacional de Rosario https://druglandscape.com/drug/dfd-04-ointment https://druglandscape.com/api/og?type=drug&title=DFD-04%20Ointment&subtitle=DFD-04%20Ointment%20%C2%B7%20Dr.%20Reddy's%20Laboratories%20Limited&badge=phase%202 DFD-04 Ointment DFD-04 Ointment · Dr. Reddy's Laboratories Limited https://druglandscape.com/drug/dfd-07-cream https://druglandscape.com/api/og?type=drug&title=DFD-07%20Cream&subtitle=DFD-07%20Cream%20%C2%B7%20Promius%20Pharma%2C%20LLC&badge=phase%202 DFD-07 Cream DFD-07 Cream · Promius Pharma, LLC https://druglandscape.com/drug/dfd05-cream https://druglandscape.com/api/og?type=drug&title=DFD05%20Cream&subtitle=DFD05%20Cream%20%C2%B7%20Dr.%20Reddys%20Laboratories%2C%20SA&badge=phase%202 DFD05 Cream DFD05 Cream · Dr. Reddys Laboratories, SA https://druglandscape.com/drug/dfmo https://druglandscape.com/api/og?type=drug&title=DFMO&subtitle=DFMO%20%C2%B7%20Aminex%20Therapeutics%2C%20Inc.&badge=phase%202 DFMO DFMO · Aminex Therapeutics, Inc. https://druglandscape.com/drug/dfp-14927 https://druglandscape.com/api/og?type=drug&title=DFP-14927&subtitle=DFP-14927%20%C2%B7%20Delta-Fly%20Pharma%2C%20Inc.&badge=phase%201 DFP-14927 DFP-14927 · Delta-Fly Pharma, Inc. https://druglandscape.com/drug/dfrf4539a https://druglandscape.com/api/og?type=drug&title=DFRF4539A&subtitle=DFRF4539A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 DFRF4539A DFRF4539A · Genentech, Inc. https://druglandscape.com/drug/dha-pq https://druglandscape.com/api/og?type=drug&title=DHA-PQ&subtitle=DHA-PQ%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%202 DHA-PQ DHA-PQ · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/dham https://druglandscape.com/api/og?type=drug&title=dHAM&subtitle=dHAM%20%C2%B7%20German%20Centre%20for%20Assessment%20and%20Evaluation%20of%20Innovative%20Techniques%20in%20Medicine&badge=phase%202 dHAM dHAM · German Centre for Assessment and Evaluation of Innovative Techniques in Medicine https://druglandscape.com/drug/dhes0815a https://druglandscape.com/api/og?type=drug&title=DHES0815A&subtitle=DHES0815A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 DHES0815A DHES0815A · Genentech, Inc. https://druglandscape.com/drug/dhp2302r1 https://druglandscape.com/api/og?type=drug&title=DHP2302R1&subtitle=DHP2302R1%20%C2%B7%20Daehwa%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DHP2302R1 DHP2302R1 · Daehwa Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dhp2302r2 https://druglandscape.com/api/og?type=drug&title=DHP2302R2&subtitle=DHP2302R2%20%C2%B7%20Daehwa%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DHP2302R2 DHP2302R2 · Daehwa Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dhp2306r1 https://druglandscape.com/api/og?type=drug&title=DHP2306R1&subtitle=DHP2306R1%20%C2%B7%20Daehwa%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DHP2306R1 DHP2306R1 · Daehwa Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dhp2306r2 https://druglandscape.com/api/og?type=drug&title=DHP2306R2&subtitle=DHP2306R2%20%C2%B7%20Daehwa%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DHP2306R2 DHP2306R2 · Daehwa Pharmaceutical Co., Ltd. https://druglandscape.com/drug/di-leu16-il2-immunocytokine https://druglandscape.com/api/og?type=drug&title=DI-Leu16-IL2%20immunocytokine&subtitle=DI-Leu16-IL2%20immunocytokine%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%201 DI-Leu16-IL2 immunocytokine DI-Leu16-IL2 immunocytokine · City of Hope Medical Center https://druglandscape.com/drug/diacerin-cream https://druglandscape.com/api/og?type=drug&title=Diacerin%20cream&subtitle=Diacerin%20cream%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%202 Diacerin cream Diacerin cream · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/diane-35-sugar-coated-tablet https://druglandscape.com/api/og?type=drug&title=Diane-35%20Sugar-coated%20tablet&subtitle=Diane-35%20Sugar-coated%20tablet%20%C2%B7%20PT%20Sydna%20Farma&badge=phase%201 Diane-35 Sugar-coated tablet Diane-35 Sugar-coated tablet · PT Sydna Farma https://druglandscape.com/drug/diazepam-nasal-spray-valtoco https://druglandscape.com/api/og?type=drug&title=Diazepam%20Nasal%20Spray%20%5BValtoco%5D&subtitle=Diazepam%20Nasal%20Spray%20%5BValtoco%5D%20%C2%B7%20Neurelis%2C%20Inc.&badge=phase%201 Diazepam Nasal Spray [Valtoco] Diazepam Nasal Spray [Valtoco] · Neurelis, Inc. https://druglandscape.com/drug/dic075v https://druglandscape.com/api/og?type=drug&title=DIC075V&subtitle=DIC075V%20%C2%B7%20Hospira%2C%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 DIC075V DIC075V · Hospira, now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/diclofenac-0-1-ophthalmic-susp https://druglandscape.com/api/og?type=drug&title=diclofenac%200.1%25%20ophthalmic%20susp.&subtitle=diclofenac%200.1%25%20ophthalmic%20susp.%20%C2%B7%20Nemocnice%20Kol%C3%ADn&badge=phase%201 diclofenac 0.1% ophthalmic susp. diclofenac 0.1% ophthalmic susp. · Nemocnice Kolín https://druglandscape.com/drug/diclofenac-only-gel https://druglandscape.com/api/og?type=drug&title=Diclofenac%20Only%20Gel&subtitle=Diclofenac%20Only%20Gel%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Diclofenac Only Gel Diclofenac Only Gel · GlaxoSmithKline https://druglandscape.com/drug/diclofenac-sodium-and-safinamide https://druglandscape.com/api/og?type=drug&title=Diclofenac%20sodium%20and%20safinamide&subtitle=Diclofenac%20sodium%20and%20safinamide%20%C2%B7%20Zambon%20SpA&badge=phase%201 Diclofenac sodium and safinamide Diclofenac sodium and safinamide · Zambon SpA https://druglandscape.com/drug/diet-a-group https://druglandscape.com/api/og?type=drug&title=Diet%20A%20group&subtitle=Diet%20A%20group%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 Diet A group Diet A group · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/diet-c-group https://druglandscape.com/api/og?type=drug&title=Diet%20C%20group&subtitle=Diet%20C%20group%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 Diet C group Diet C group · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/differing-iv-antibiotic-treatment https://druglandscape.com/api/og?type=drug&title=differing%20IV%20antibiotic%20treatment&subtitle=differing%20IV%20antibiotic%20treatment%20%C2%B7%20Methodist%20Health%20System&badge=phase%202 differing IV antibiotic treatment differing IV antibiotic treatment · Methodist Health System https://druglandscape.com/drug/digoxin-alone https://druglandscape.com/api/og?type=drug&title=Digoxin%20Alone&subtitle=Digoxin%20Alone%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Digoxin Alone Digoxin Alone · GlaxoSmithKline https://druglandscape.com/drug/digoxin-and-ivabradine https://druglandscape.com/api/og?type=drug&title=Digoxin%20and%20ivabradine&subtitle=Digoxin%20and%20ivabradine%20%C2%B7%20Cocco%2C%20Giuseppe%2C%20M.D.&badge=phase%202 Digoxin and ivabradine Digoxin and ivabradine · Cocco, Giuseppe, M.D. https://druglandscape.com/drug/digoxin-plus-albiglutide https://druglandscape.com/api/og?type=drug&title=digoxin%20plus%20albiglutide&subtitle=digoxin%20plus%20albiglutide%20%C2%B7%20GlaxoSmithKline&badge=phase%201 digoxin plus albiglutide digoxin plus albiglutide · GlaxoSmithKline https://druglandscape.com/drug/digoxin-tablets https://druglandscape.com/api/og?type=drug&title=Digoxin%20Tablets&subtitle=Digoxin%20Tablets%20%C2%B7%20Guangdong%20Raynovent%20Biotech%20Co.%2C%20Ltd&badge=phase%201 Digoxin Tablets Digoxin Tablets · Guangdong Raynovent Biotech Co., Ltd https://druglandscape.com/drug/digoxin-topical-gel https://druglandscape.com/api/og?type=drug&title=Digoxin%20Topical%20Gel&subtitle=Digoxin%20Topical%20Gel%20%C2%B7%20Maruho%20Co.%2C%20Ltd.&badge=phase%202 Digoxin Topical Gel Digoxin Topical Gel · Maruho Co., Ltd. https://druglandscape.com/drug/dihydroartemisinin-and-piperaquine https://druglandscape.com/api/og?type=drug&title=Dihydroartemisinin%20and%20piperaquine&subtitle=Dihydroartemisinin%20and%20piperaquine%20%C2%B7%20INDEPTH%20Network&badge=phase%202 Dihydroartemisinin and piperaquine Dihydroartemisinin and piperaquine · INDEPTH Network https://druglandscape.com/drug/dihydroartemisinin-piperaquine-plus-azithromycin https://druglandscape.com/api/og?type=drug&title=dihydroartemisinin-piperaquine%20plus%20azithromycin&subtitle=dihydroartemisinin-piperaquine%20plus%20azithromycin%20%C2%B7%20Liverpool%20School%20of%20Tropical%20Medicine&badge=phase%203 dihydroartemisinin-piperaquine plus azithromycin dihydroartemisinin-piperaquine plus azithromycin · Liverpool School of Tropical Medicine https://druglandscape.com/drug/dilatrend-sr-capsule https://druglandscape.com/api/og?type=drug&title=Dilatrend%20SR%20capsule&subtitle=Dilatrend%20SR%20capsule%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 Dilatrend SR capsule Dilatrend SR capsule · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/dilaudid-iv-scheduled https://druglandscape.com/api/og?type=drug&title=Dilaudid%20IV%20Scheduled&subtitle=Dilaudid%20IV%20Scheduled%20%C2%B7%20TriHealth%20Inc.&badge=phase%201 Dilaudid IV Scheduled Dilaudid IV Scheduled · TriHealth Inc. https://druglandscape.com/drug/dilaudid-pca https://druglandscape.com/api/og?type=drug&title=Dilaudid%20PCA&subtitle=Dilaudid%20PCA%20%C2%B7%20TriHealth%20Inc.&badge=phase%201 Dilaudid PCA Dilaudid PCA · TriHealth Inc. https://druglandscape.com/drug/diltiazem-hydrocholoride https://druglandscape.com/api/og?type=drug&title=Diltiazem%20hydrocholoride&subtitle=Diltiazem%20hydrocholoride%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Diltiazem hydrocholoride Diltiazem hydrocholoride · Merck Sharp & Dohme LLC https://druglandscape.com/drug/diluent-for-liq865 https://druglandscape.com/api/og?type=drug&title=Diluent%20for%20LIQ865&subtitle=Diluent%20for%20LIQ865%20%C2%B7%20Liquidia%20Technologies%2C%20Inc.&badge=phase%201 Diluent for LIQ865 Diluent for LIQ865 · Liquidia Technologies, Inc. https://druglandscape.com/drug/diluent-of-lyophilized-vaccine https://druglandscape.com/api/og?type=drug&title=diluent%20of%20lyophilized%20vaccine&subtitle=diluent%20of%20lyophilized%20vaccine%20%C2%B7%20Sinovac%20(Dalian)%20Vaccine%20Technology%20Co.%2C%20Ltd.&badge=phase%203 diluent of lyophilized vaccine diluent of lyophilized vaccine · Sinovac (Dalian) Vaccine Technology Co., Ltd. https://druglandscape.com/drug/diluted-intravenous-da-5217 https://druglandscape.com/api/og?type=drug&title=Diluted%20Intravenous%20DA-5217&subtitle=Diluted%20Intravenous%20DA-5217%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 Diluted Intravenous DA-5217 Diluted Intravenous DA-5217 · Dong-A ST Co., Ltd. https://druglandscape.com/drug/diluted-sodium-bicarbonate-2-1 https://druglandscape.com/api/og?type=drug&title=diluted%20sodium%20bicarbonate%202.1%25&subtitle=diluted%20sodium%20bicarbonate%202.1%25%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%202 diluted sodium bicarbonate 2.1% diluted sodium bicarbonate 2.1% · Sheba Medical Center https://druglandscape.com/drug/dimebon-ir https://druglandscape.com/api/og?type=drug&title=Dimebon%20IR&subtitle=Dimebon%20IR%20%C2%B7%20Pfizer&badge=phase%201 Dimebon IR Dimebon IR · Pfizer https://druglandscape.com/drug/dimebon-mr1 https://druglandscape.com/api/og?type=drug&title=Dimebon%20MR1&subtitle=Dimebon%20MR1%20%C2%B7%20Pfizer&badge=phase%201 Dimebon MR1 Dimebon MR1 · Pfizer https://druglandscape.com/drug/dimebon-mr2 https://druglandscape.com/api/og?type=drug&title=Dimebon%20MR2&subtitle=Dimebon%20MR2%20%C2%B7%20Pfizer&badge=phase%201 Dimebon MR2 Dimebon MR2 · Pfizer https://druglandscape.com/drug/dimebon-mr3 https://druglandscape.com/api/og?type=drug&title=Dimebon%20MR3&subtitle=Dimebon%20MR3%20%C2%B7%20Pfizer&badge=phase%201 Dimebon MR3 Dimebon MR3 · Pfizer https://druglandscape.com/drug/dimebon-mr4 https://druglandscape.com/api/og?type=drug&title=Dimebon%20MR4&subtitle=Dimebon%20MR4%20%C2%B7%20Pfizer&badge=phase%201 Dimebon MR4 Dimebon MR4 · Pfizer https://druglandscape.com/drug/dimebon-transdermal https://druglandscape.com/api/og?type=drug&title=Dimebon%20Transdermal&subtitle=Dimebon%20Transdermal%20%C2%B7%20Pfizer&badge=phase%201 Dimebon Transdermal Dimebon Transdermal · Pfizer https://druglandscape.com/drug/dimethyl-fumarate-test-form https://druglandscape.com/api/og?type=drug&title=dimethyl%20fumarate%20-%20Test%20form&subtitle=dimethyl%20fumarate%20-%20Test%20form%20%C2%B7%20Biogen&badge=phase%201 dimethyl fumarate - Test form dimethyl fumarate - Test form · Biogen https://druglandscape.com/drug/diosmin750 https://druglandscape.com/api/og?type=drug&title=Diosmin750&subtitle=Diosmin750%20%C2%B7%20Sergio%20Marques%20Borghi&badge=phase%201 Diosmin750 Diosmin750 · Sergio Marques Borghi https://druglandscape.com/drug/dipeptide-alanyl-glutamine https://druglandscape.com/api/og?type=drug&title=Dipeptide%20Alanyl-Glutamine&subtitle=Dipeptide%20Alanyl-Glutamine%20%C2%B7%20Medical%20Center%20Alkmaar&badge=phase%201 Dipeptide Alanyl-Glutamine Dipeptide Alanyl-Glutamine · Medical Center Alkmaar https://druglandscape.com/drug/diphenhydramine-hydrochloride-or-alternative-antihistamine https://druglandscape.com/api/og?type=drug&title=Diphenhydramine%20hydrochloride%20or%20alternative%20antihistamine&subtitle=Diphenhydramine%20hydrochloride%20or%20alternative%20antihistamine%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Diphenhydramine hydrochloride or alternative antihistamine Diphenhydramine hydrochloride or alternative antihistamine · Hoffmann-La Roche https://druglandscape.com/drug/diphtheria-tetanus-acellular-pertussis-vaccine https://druglandscape.com/api/og?type=drug&title=Diphtheria-tetanus-acellular%20pertussis%20vaccine&subtitle=Diphtheria-tetanus-acellular%20pertussis%20vaccine%20%C2%B7%20CanSino%20Biologics%20Inc.&badge=phase%201 Diphtheria-tetanus-acellular pertussis vaccine Diphtheria-tetanus-acellular pertussis vaccine · CanSino Biologics Inc. https://druglandscape.com/drug/diprosis-gel https://druglandscape.com/api/og?type=drug&title=Diprosis%20gel&subtitle=Diprosis%20gel%20%C2%B7%20Prism%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 Diprosis gel Diprosis gel · Prism Pharma Co., Ltd. https://druglandscape.com/drug/direct-boost-mrna https://druglandscape.com/api/og?type=drug&title=Direct%20boost%20mRNA&subtitle=Direct%20boost%20mRNA%20%C2%B7%20Erasmus%20Medical%20Center&badge=phase%201 Direct boost mRNA Direct boost mRNA · Erasmus Medical Center https://druglandscape.com/drug/direct-sodium-removal-infusate-2-0 https://druglandscape.com/api/og?type=drug&title=Direct%20Sodium%20Removal%20Infusate%202.0&subtitle=Direct%20Sodium%20Removal%20Infusate%202.0%20%C2%B7%20Sequana%20Medical%20N.V.&badge=phase%201 Direct Sodium Removal Infusate 2.0 Direct Sodium Removal Infusate 2.0 · Sequana Medical N.V. https://druglandscape.com/drug/disitamab-vedotin-injection-12-weeks https://druglandscape.com/api/og?type=drug&title=Disitamab%20Vedotin%20Injection%20%EF%BC%8812%20weeks%EF%BC%89&subtitle=Disitamab%20Vedotin%20Injection%20%EF%BC%8812%20weeks%EF%BC%89%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%202 Disitamab Vedotin Injection （12 weeks） Disitamab Vedotin Injection （12 weeks） · RemeGen Co., Ltd. https://druglandscape.com/drug/dispersion-of-6-bemt-in-petrolatum https://druglandscape.com/api/og?type=drug&title=Dispersion%20of%206%25%20BEMT%20in%20petrolatum&subtitle=Dispersion%20of%206%25%20BEMT%20in%20petrolatum%20%C2%B7%20dsm-firmenich%20Switzerland%20AG&badge=phase%202 Dispersion of 6% BEMT in petrolatum Dispersion of 6% BEMT in petrolatum · dsm-firmenich Switzerland AG https://druglandscape.com/drug/dissolved-n-acetylcystine https://druglandscape.com/api/og?type=drug&title=dissolved%20N-Acetylcystine&subtitle=dissolved%20N-Acetylcystine%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 dissolved N-Acetylcystine dissolved N-Acetylcystine · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/dkf-310 https://druglandscape.com/api/og?type=drug&title=DKF-310&subtitle=DKF-310%20%C2%B7%20Dongkook%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DKF-310 DKF-310 · Dongkook Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dlbs1442-200 https://druglandscape.com/api/og?type=drug&title=DLBS1442%20200&subtitle=DLBS1442%20200%20%C2%B7%20Dexa%20Medica%20Group&badge=phase%202 DLBS1442 200 DLBS1442 200 · Dexa Medica Group https://druglandscape.com/drug/dli-of-the-20-fraction-of-the-ucbt https://druglandscape.com/api/og?type=drug&title=DLI%20of%20the%2020%20fraction%20of%20the%20UCBT&subtitle=DLI%20of%20the%2020%20fraction%20of%20the%20UCBT%20%C2%B7%20Banc%20de%20Sang%20i%20Teixits&badge=phase%201 DLI of the 20 fraction of the UCBT DLI of the 20 fraction of the UCBT · Banc de Sang i Teixits https://druglandscape.com/drug/dlx105-dmp https://druglandscape.com/api/og?type=drug&title=DLX105-DMP&subtitle=DLX105-DMP%20%C2%B7%20DelArrivo%2C%20Inc.&badge=phase%201 DLX105-DMP DLX105-DMP · DelArrivo, Inc. https://druglandscape.com/drug/dlye5953a https://druglandscape.com/api/og?type=drug&title=DLYE5953A&subtitle=DLYE5953A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 DLYE5953A DLYE5953A · Genentech, Inc. https://druglandscape.com/drug/dm001 https://druglandscape.com/api/og?type=drug&title=DM001&subtitle=DM001%20%C2%B7%20Xadcera%20Biopharmaceutical%20(Suzhou)%20Co.%2C%20Ltd.&badge=phase%201 DM001 DM001 · Xadcera Biopharmaceutical (Suzhou) Co., Ltd. https://druglandscape.com/drug/dm005 https://druglandscape.com/api/og?type=drug&title=DM005&subtitle=DM005%20%C2%B7%20Doma%20Biopharmaceutical%EF%BC%88Suzhou%EF%BC%89Co.%2C%20Ltd.&badge=phase%201 DM005 DM005 · Doma Biopharmaceutical（Suzhou）Co., Ltd. https://druglandscape.com/drug/dm5167 https://druglandscape.com/api/og?type=drug&title=DM5167&subtitle=DM5167%20%C2%B7%20DIGMBIO&badge=phase%201 DM5167 DM5167 · DIGMBIO https://druglandscape.com/drug/dmb-3111 https://druglandscape.com/api/og?type=drug&title=DMB-3111&subtitle=DMB-3111%20%C2%B7%20Meiji%20Seika%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 DMB-3111 DMB-3111 · Meiji Seika Pharma Co., Ltd. https://druglandscape.com/drug/dmlt https://druglandscape.com/api/og?type=drug&title=dmLT&subtitle=dmLT%20%C2%B7%20PATH&badge=phase%202 dmLT dmLT · PATH https://druglandscape.com/drug/dmot4039a https://druglandscape.com/api/og?type=drug&title=DMOT4039A&subtitle=DMOT4039A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 DMOT4039A DMOT4039A · Genentech, Inc. https://druglandscape.com/drug/dmpa-104 https://druglandscape.com/api/og?type=drug&title=DMPA%20104&subtitle=DMPA%20104%20%C2%B7%20FHI%20360&badge=phase%201 DMPA 104 DMPA 104 · FHI 360 https://druglandscape.com/drug/dmpa-150 https://druglandscape.com/api/og?type=drug&title=DMPA%20150&subtitle=DMPA%20150%20%C2%B7%20FHI%20360&badge=phase%201 DMPA 150 DMPA 150 · FHI 360 https://druglandscape.com/drug/dmpa-300 https://druglandscape.com/api/og?type=drug&title=DMPA%20300&subtitle=DMPA%20300%20%C2%B7%20FHI%20360&badge=phase%201 DMPA 300 DMPA 300 · FHI 360 https://druglandscape.com/drug/dmsa-dimercaptosuccinic-acid https://druglandscape.com/api/og?type=drug&title=DMSA%20-%20dimercaptosuccinic%20acid&subtitle=DMSA%20-%20dimercaptosuccinic%20acid%20%C2%B7%20Southwest%20College%20of%20Naturopathic%20Medicine&badge=phase%201 DMSA - dimercaptosuccinic acid DMSA - dimercaptosuccinic acid · Southwest College of Naturopathic Medicine https://druglandscape.com/drug/dmt-medium-dose https://druglandscape.com/api/og?type=drug&title=DMT-Medium%20Dose&subtitle=DMT-Medium%20Dose%20%C2%B7%20Deepak%20C.%20D'Souza&badge=phase%201 DMT-Medium Dose DMT-Medium Dose · Deepak C. D'Souza https://druglandscape.com/drug/dmtn https://druglandscape.com/api/og?type=drug&title=DMTN&subtitle=DMTN%20%C2%B7%20Hans-Peter%20Landolt&badge=phase%201 DMTN DMTN · Hans-Peter Landolt https://druglandscape.com/drug/dmuc5754a https://druglandscape.com/api/og?type=drug&title=DMUC5754A&subtitle=DMUC5754A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 DMUC5754A DMUC5754A · Genentech, Inc. https://druglandscape.com/drug/dn-101 https://druglandscape.com/api/og?type=drug&title=DN-101&subtitle=DN-101%20%C2%B7%20Novacea&badge=phase%201 DN-101 DN-101 · Novacea https://druglandscape.com/drug/dn1508052-01 https://druglandscape.com/api/og?type=drug&title=DN1508052-01&subtitle=DN1508052-01%20%C2%B7%20Shanghai%20De%20Novo%20Pharmatech%20Co.%2C%20Ltd.&badge=phase%201 DN1508052-01 DN1508052-01 · Shanghai De Novo Pharmatech Co., Ltd. https://druglandscape.com/drug/dna-bank https://druglandscape.com/api/og?type=drug&title=DNA%20bank&subtitle=DNA%20bank%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 DNA bank DNA bank · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/dna-c-cn54env https://druglandscape.com/api/og?type=drug&title=DNA-C%20CN54ENV&subtitle=DNA-C%20CN54ENV%20%C2%B7%20Imperial%20College%20London&badge=phase%201 DNA-C CN54ENV DNA-C CN54ENV · Imperial College London https://druglandscape.com/drug/dna-vaccine-oc-007 https://druglandscape.com/api/og?type=drug&title=DNA%20vaccine%20OC-007&subtitle=DNA%20vaccine%20OC-007%20%C2%B7%20Matti%20S%C3%A4llberg&badge=phase%201 DNA vaccine OC-007 DNA vaccine OC-007 · Matti Sällberg https://druglandscape.com/drug/dna-vaccine-prime https://druglandscape.com/api/og?type=drug&title=DNA%20vaccine%20prime&subtitle=DNA%20vaccine%20prime%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 DNA vaccine prime DNA vaccine prime · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/dnl201 https://druglandscape.com/api/og?type=drug&title=DNL201&subtitle=DNL201%20%C2%B7%20Denali%20Therapeutics%20Inc.&badge=phase%201 DNL201 DNL201 · Denali Therapeutics Inc. https://druglandscape.com/drug/dnl919 https://druglandscape.com/api/og?type=drug&title=DNL919&subtitle=DNL919%20%C2%B7%20Denali%20Therapeutics%20Inc.&badge=phase%201 DNL919 DNL919 · Denali Therapeutics Inc. https://druglandscape.com/drug/dnp002 https://druglandscape.com/api/og?type=drug&title=DNP002&subtitle=DNP002%20%C2%B7%20Kumho%20HT%20Inc.&badge=phase%201 DNP002 DNP002 · Kumho HT Inc. https://druglandscape.com/drug/dnr-npc-specific-t-cells https://druglandscape.com/api/og?type=drug&title=DNR.NPC-specific%20T%20cells&subtitle=DNR.NPC-specific%20T%20cells%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 DNR.NPC-specific T cells DNR.NPC-specific T cells · Baylor College of Medicine https://druglandscape.com/drug/do-2 https://druglandscape.com/api/og?type=drug&title=DO-2&subtitle=DO-2%20%C2%B7%20DeuterOncology&badge=phase%201 DO-2 DO-2 · DeuterOncology https://druglandscape.com/drug/docetaxel-and-gemcitabine https://druglandscape.com/api/og?type=drug&title=Docetaxel%20and%20Gemcitabine&subtitle=Docetaxel%20and%20Gemcitabine%20%C2%B7%20Sanofi&badge=phase%202 Docetaxel and Gemcitabine Docetaxel and Gemcitabine · Sanofi https://druglandscape.com/drug/docetaxel-capecitabine-and-oxaliplatin https://druglandscape.com/api/og?type=drug&title=Docetaxel%2C%20Capecitabine%20and%20Oxaliplatin&subtitle=Docetaxel%2C%20Capecitabine%20and%20Oxaliplatin%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 Docetaxel, Capecitabine and Oxaliplatin Docetaxel, Capecitabine and Oxaliplatin · Asan Medical Center https://druglandscape.com/drug/docetaxel-capecitabine-cisplatin https://druglandscape.com/api/og?type=drug&title=docetaxel%2C%20capecitabine%2C%20cisplatin&subtitle=docetaxel%2C%20capecitabine%2C%20cisplatin%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 docetaxel, capecitabine, cisplatin docetaxel, capecitabine, cisplatin · Asan Medical Center https://druglandscape.com/drug/docetaxel-carboplatin-and-trastuzumab https://druglandscape.com/api/og?type=drug&title=Docetaxel%2C%20Carboplatin%20and%20Trastuzumab&subtitle=Docetaxel%2C%20Carboplatin%20and%20Trastuzumab%20%C2%B7%20Cancer%20Trials%20Ireland&badge=phase%202 Docetaxel, Carboplatin and Trastuzumab Docetaxel, Carboplatin and Trastuzumab · Cancer Trials Ireland https://druglandscape.com/drug/docetaxel-carboplatin-trastuzumab-and-lapatinib https://druglandscape.com/api/og?type=drug&title=Docetaxel%2C%20Carboplatin%2C%20Trastuzumab%20and%20Lapatinib&subtitle=Docetaxel%2C%20Carboplatin%2C%20Trastuzumab%20and%20Lapatinib%20%C2%B7%20Cancer%20Trials%20Ireland&badge=phase%202 Docetaxel, Carboplatin, Trastuzumab and Lapatinib Docetaxel, Carboplatin, Trastuzumab and Lapatinib · Cancer Trials Ireland https://druglandscape.com/drug/docetaxel-cisplatin-capecitabine-bevacizumab https://druglandscape.com/api/og?type=drug&title=Docetaxel%2C%20Cisplatin%2C%20Capecitabine%2C%20Bevacizumab&subtitle=Docetaxel%2C%20Cisplatin%2C%20Capecitabine%2C%20Bevacizumab%20%C2%B7%20Rabin%20Medical%20Center&badge=phase%201 Docetaxel, Cisplatin, Capecitabine, Bevacizumab Docetaxel, Cisplatin, Capecitabine, Bevacizumab · Rabin Medical Center https://druglandscape.com/drug/docetaxel-mitotic-inhibitor-intravenous https://druglandscape.com/api/og?type=drug&title=Docetaxel%2C%20mitotic%20inhibitor%3B%20intravenous&subtitle=Docetaxel%2C%20mitotic%20inhibitor%3B%20intravenous%20%C2%B7%20Array%20Biopharma%2C%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 Docetaxel, mitotic inhibitor; intravenous Docetaxel, mitotic inhibitor; intravenous · Array Biopharma, now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/docetaxel-nedaplatin-and-fluorouracil https://druglandscape.com/api/og?type=drug&title=docetaxel%2C%20nedaplatin%2C%20and%20fluorouracil&subtitle=docetaxel%2C%20nedaplatin%2C%20and%20fluorouracil%20%C2%B7%20Sun%20Yat-sen%20University&badge=phase%203 docetaxel, nedaplatin, and fluorouracil docetaxel, nedaplatin, and fluorouracil · Sun Yat-sen University https://druglandscape.com/drug/docetaxel-oxaliplatin-s-1-and-durvalumab https://druglandscape.com/api/og?type=drug&title=Docetaxel%2C%20Oxaliplatin%2C%20S-1%20and%20Durvalumab&subtitle=Docetaxel%2C%20Oxaliplatin%2C%20S-1%20and%20Durvalumab%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 Docetaxel, Oxaliplatin, S-1 and Durvalumab Docetaxel, Oxaliplatin, S-1 and Durvalumab · Asan Medical Center https://druglandscape.com/drug/docetaxel-plus-selumetinib https://druglandscape.com/api/og?type=drug&title=docetaxel%20plus%20selumetinib&subtitle=docetaxel%20plus%20selumetinib%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 docetaxel plus selumetinib docetaxel plus selumetinib · Samsung Medical Center https://druglandscape.com/drug/docetaxel-reolysin-and-prednisone https://druglandscape.com/api/og?type=drug&title=Docetaxel%2C%20Reolysin%20and%20Prednisone&subtitle=Docetaxel%2C%20Reolysin%20and%20Prednisone%20%C2%B7%20Canadian%20Cancer%20Trials%20Group&badge=phase%202 Docetaxel, Reolysin and Prednisone Docetaxel, Reolysin and Prednisone · Canadian Cancer Trials Group https://druglandscape.com/drug/docetaxel-trastuzumab https://druglandscape.com/api/og?type=drug&title=Docetaxel%2C%20trastuzumab&subtitle=Docetaxel%2C%20trastuzumab%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Docetaxel, trastuzumab Docetaxel, trastuzumab · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/dofequidar-fumarate https://druglandscape.com/api/og?type=drug&title=dofequidar%20fumarate&subtitle=dofequidar%20fumarate%20%C2%B7%20European%20Organisation%20for%20Research%20and%20Treatment%20of%20Cancer%20-%20EORTC&badge=phase%201 dofequidar fumarate dofequidar fumarate · European Organisation for Research and Treatment of Cancer - EORTC https://druglandscape.com/drug/dofetilide-and-diltiazem https://druglandscape.com/api/og?type=drug&title=Dofetilide%20and%20Diltiazem&subtitle=Dofetilide%20and%20Diltiazem%20%C2%B7%20Food%20and%20Drug%20Administration%20(FDA)&badge=phase%201 Dofetilide and Diltiazem Dofetilide and Diltiazem · Food and Drug Administration (FDA) https://druglandscape.com/drug/dolutegravir-dispersible-tablet https://druglandscape.com/api/og?type=drug&title=Dolutegravir%20dispersible%20tablet&subtitle=Dolutegravir%20dispersible%20tablet%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 Dolutegravir dispersible tablet Dolutegravir dispersible tablet · ViiV Healthcare https://druglandscape.com/drug/dolutegravir-elvitegravir-and-cobicistat https://druglandscape.com/api/og?type=drug&title=Dolutegravir%2C%20Elvitegravir%20and%20Cobicistat&subtitle=Dolutegravir%2C%20Elvitegravir%20and%20Cobicistat%20%C2%B7%20St%20Stephens%20Aids%20Trust&badge=phase%201 Dolutegravir, Elvitegravir and Cobicistat Dolutegravir, Elvitegravir and Cobicistat · St Stephens Aids Trust https://druglandscape.com/drug/dolutegravir-pediatric-granules https://druglandscape.com/api/og?type=drug&title=Dolutegravir%20Pediatric%20Granules&subtitle=Dolutegravir%20Pediatric%20Granules%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 Dolutegravir Pediatric Granules Dolutegravir Pediatric Granules · ViiV Healthcare https://druglandscape.com/drug/donafenib-tosilate-tablets https://druglandscape.com/api/og?type=drug&title=Donafenib%20Tosilate%20Tablets&subtitle=Donafenib%20Tosilate%20Tablets%20%C2%B7%20Suzhou%20Zelgen%20Biopharmaceuticals%20Co.%2CLtd&badge=phase%201 Donafenib Tosilate Tablets Donafenib Tosilate Tablets · Suzhou Zelgen Biopharmaceuticals Co.,Ltd https://druglandscape.com/drug/donepezil-hydrochloride-tablets https://druglandscape.com/api/og?type=drug&title=Donepezil%20hydrochloride%20tablets&subtitle=Donepezil%20hydrochloride%20tablets%20%C2%B7%20Wanbangde%20Pharmaceutical%20Group%20Co.%2C%20LTD&badge=phase%202 Donepezil hydrochloride tablets Donepezil hydrochloride tablets · Wanbangde Pharmaceutical Group Co., LTD https://druglandscape.com/drug/donepezil-tds https://druglandscape.com/api/og?type=drug&title=Donepezil%20TDS&subtitle=Donepezil%20TDS%20%C2%B7%20Corium%2C%20Inc.&badge=phase%201 Donepezil TDS Donepezil TDS · Corium, Inc. https://druglandscape.com/drug/donepezil-tds-version-a https://druglandscape.com/api/og?type=drug&title=Donepezil%20TDS%20Version%20A&subtitle=Donepezil%20TDS%20Version%20A%20%C2%B7%20Corium%2C%20Inc.&badge=phase%201 Donepezil TDS Version A Donepezil TDS Version A · Corium, Inc. https://druglandscape.com/drug/donepezil-tds-version-d https://druglandscape.com/api/og?type=drug&title=Donepezil%20TDS%20Version%20D&subtitle=Donepezil%20TDS%20Version%20D%20%C2%B7%20Corium%2C%20Inc.&badge=phase%201 Donepezil TDS Version D Donepezil TDS Version D · Corium, Inc. https://druglandscape.com/drug/donor-derived-cik-cells https://druglandscape.com/api/og?type=drug&title=donor-derived%20CIK%20cells&subtitle=donor-derived%20CIK%20cells%20%C2%B7%20A.O.%20Ospedale%20Papa%20Giovanni%20XXIII&badge=phase%201 donor-derived CIK cells donor-derived CIK cells · A.O. Ospedale Papa Giovanni XXIII https://druglandscape.com/drug/donor-derived-nk-cell-infusion https://druglandscape.com/api/og?type=drug&title=donor-derived%20NK%20cell%20infusion&subtitle=donor-derived%20NK%20cell%20infusion%20%C2%B7%20Precision%20Biotech%20Taiwan%20Corp.&badge=phase%201 donor-derived NK cell infusion donor-derived NK cell infusion · Precision Biotech Taiwan Corp. https://druglandscape.com/drug/donor-microbiota-applied-via-colonoscopy https://druglandscape.com/api/og?type=drug&title=Donor%20microbiota%20applied%20via%20colonoscopy.&subtitle=Donor%20microbiota%20applied%20via%20colonoscopy.%20%C2%B7%20Providence%20Holy%20Cross%20Medical%20Center&badge=phase%201 Donor microbiota applied via colonoscopy. Donor microbiota applied via colonoscopy. · Providence Holy Cross Medical Center https://druglandscape.com/drug/donor-specific-antibodies https://druglandscape.com/api/og?type=drug&title=Donor%20specific%20antibodies&subtitle=Donor%20specific%20antibodies%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Donor specific antibodies Donor specific antibodies · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/dopaminergic-medication https://druglandscape.com/api/og?type=drug&title=Dopaminergic%20medication&subtitle=Dopaminergic%20medication%20%C2%B7%20Universidad%20Francisco%20de%20Vitoria&badge=phase%201 Dopaminergic medication Dopaminergic medication · Universidad Francisco de Vitoria https://druglandscape.com/drug/dopasnap https://druglandscape.com/api/og?type=drug&title=DopaSnap%C2%AE&subtitle=DopaSnap%C2%AE%20%C2%B7%20Riverside%20Pharmacueticals%20Corporation&badge=phase%201 DopaSnap® DopaSnap® · Riverside Pharmacueticals Corporation https://druglandscape.com/drug/doravirine-tenofovir-lamivudine-blinded https://druglandscape.com/api/og?type=drug&title=Doravirine%2C%20Tenofovir%2C%20Lamivudine%20-%20Blinded&subtitle=Doravirine%2C%20Tenofovir%2C%20Lamivudine%20-%20Blinded%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Doravirine, Tenofovir, Lamivudine - Blinded Doravirine, Tenofovir, Lamivudine - Blinded · Merck Sharp & Dohme LLC https://druglandscape.com/drug/dorzolamide-2-timolol-0-5 https://druglandscape.com/api/og?type=drug&title=Dorzolamide%202%25-timolol%200.5%25&subtitle=Dorzolamide%202%25-timolol%200.5%25%20%C2%B7%20Massachusetts%20Eye%20and%20Ear%20Infirmary&badge=phase%201 Dorzolamide 2%-timolol 0.5% Dorzolamide 2%-timolol 0.5% · Massachusetts Eye and Ear Infirmary https://druglandscape.com/drug/dosage-of-cytokines https://druglandscape.com/api/og?type=drug&title=dosage%20of%20cytokines&subtitle=dosage%20of%20cytokines%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 dosage of cytokines dosage of cytokines · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/dose-1-group https://druglandscape.com/api/og?type=drug&title=dose-1%20group&subtitle=dose-1%20group%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 dose-1 group dose-1 group · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/dose-1-jkb-122 https://druglandscape.com/api/og?type=drug&title=Dose%201%20JKB-122&subtitle=Dose%201%20JKB-122%20%C2%B7%20TaiwanJ%20Pharmaceuticals%20Co.%2C%20Ltd&badge=phase%202 Dose 1 JKB-122 Dose 1 JKB-122 · TaiwanJ Pharmaceuticals Co., Ltd https://druglandscape.com/drug/dose-1-of-aluminum-adjuvant https://druglandscape.com/api/og?type=drug&title=Dose%201%20of%20Aluminum%20Adjuvant&subtitle=Dose%201%20of%20Aluminum%20Adjuvant%20%C2%B7%20Novavax&badge=phase%202 Dose 1 of Aluminum Adjuvant Dose 1 of Aluminum Adjuvant · Novavax https://druglandscape.com/drug/dose-2-group https://druglandscape.com/api/og?type=drug&title=dose-2%20group&subtitle=dose-2%20group%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 dose-2 group dose-2 group · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/dose-2-jtk-853 https://druglandscape.com/api/og?type=drug&title=Dose%202%20JTK-853&subtitle=Dose%202%20JTK-853%20%C2%B7%20Akros%20Pharma%20Inc.&badge=phase%201 Dose 2 JTK-853 Dose 2 JTK-853 · Akros Pharma Inc. https://druglandscape.com/drug/dose-2-of-glycopyrrolate-3-0-qd https://druglandscape.com/api/og?type=drug&title=Dose%202%20of%20glycopyrrolate%2C%203.0%25%20QD&subtitle=Dose%202%20of%20glycopyrrolate%2C%203.0%25%20QD%20%C2%B7%20Journey%20Medical%20Corporation&badge=phase%202 Dose 2 of glycopyrrolate, 3.0% QD Dose 2 of glycopyrrolate, 3.0% QD · Journey Medical Corporation https://druglandscape.com/drug/dose-3-group https://druglandscape.com/api/og?type=drug&title=dose-3%20group&subtitle=dose-3%20group%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 dose-3 group dose-3 group · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/dose-5-group https://druglandscape.com/api/og?type=drug&title=dose-5%20group&subtitle=dose-5%20group%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 dose-5 group dose-5 group · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/dose-adjusted-sk-1403 https://druglandscape.com/api/og?type=drug&title=Dose-adjusted%20SK-1403&subtitle=Dose-adjusted%20SK-1403%20%C2%B7%20Sanwa%20Kagaku%20Kenkyusho%20Co.%2C%20Ltd.&badge=phase%202 Dose-adjusted SK-1403 Dose-adjusted SK-1403 · Sanwa Kagaku Kenkyusho Co., Ltd. https://druglandscape.com/drug/dose-dense-abvd https://druglandscape.com/api/og?type=drug&title=dose%20dense%20ABVD&subtitle=dose%20dense%20ABVD%20%C2%B7%20Fondazione%20Italiana%20Linfomi%20-%20ETS&badge=phase%202 dose dense ABVD dose dense ABVD · Fondazione Italiana Linfomi - ETS https://druglandscape.com/drug/dose-escalated-selinexor-treatment https://druglandscape.com/api/og?type=drug&title=dose-escalated%20selinexor%20treatment&subtitle=dose-escalated%20selinexor%20treatment%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%201 dose-escalated selinexor treatment dose-escalated selinexor treatment · Sheba Medical Center https://druglandscape.com/drug/dose-escalation-of-sa030 https://druglandscape.com/api/og?type=drug&title=Dose%20escalation%20of%20SA030&subtitle=Dose%20escalation%20of%20SA030%20%C2%B7%20Suzhou%20Siran%20Biotechnology%20Co.%2CLtd.&badge=phase%201 Dose escalation of SA030 Dose escalation of SA030 · Suzhou Siran Biotechnology Co.,Ltd. https://druglandscape.com/drug/dose-escalation-stage https://druglandscape.com/api/og?type=drug&title=Dose-Escalation%20Stage&subtitle=Dose-Escalation%20Stage%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Dose-Escalation Stage Dose-Escalation Stage · Baylor College of Medicine https://druglandscape.com/drug/dose-expansion https://druglandscape.com/api/og?type=drug&title=Dose%20expansion&subtitle=Dose%20expansion%20%C2%B7%20Filamon%20LTD&badge=phase%201 Dose expansion Dose expansion · Filamon LTD https://druglandscape.com/drug/dose-expansion-of-sim0609-in-crc https://druglandscape.com/api/og?type=drug&title=dose%20expansion%20of%20SIM0609%20in%20CRC&subtitle=dose%20expansion%20of%20SIM0609%20in%20CRC%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 dose expansion of SIM0609 in CRC dose expansion of SIM0609 in CRC · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dose-expansion3 https://druglandscape.com/api/og?type=drug&title=Dose%20Expansion3&subtitle=Dose%20Expansion3%20%C2%B7%20GeneQuantum%20Healthcare%20(Suzhou)%20Co.%2C%20Ltd.&badge=phase%201 Dose Expansion3 Dose Expansion3 · GeneQuantum Healthcare (Suzhou) Co., Ltd. https://druglandscape.com/drug/dose-finding-comparison https://druglandscape.com/api/og?type=drug&title=Dose%20finding%20comparison&subtitle=Dose%20finding%20comparison%20%C2%B7%20Central%20Adelaide%20Local%20Health%20Network%20Incorporated&badge=phase%201 Dose finding comparison Dose finding comparison · Central Adelaide Local Health Network Incorporated https://druglandscape.com/drug/dose-given-at-day-0 https://druglandscape.com/api/og?type=drug&title=Dose%20given%20at%20Day%200&subtitle=Dose%20given%20at%20Day%200%20%C2%B7%20Medicago&badge=phase%201 Dose given at Day 0 Dose given at Day 0 · Medicago https://druglandscape.com/drug/dose-level-2-fixed-dose https://druglandscape.com/api/og?type=drug&title=Dose%20Level%202-%20Fixed%20Dose&subtitle=Dose%20Level%202-%20Fixed%20Dose%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Dose Level 2- Fixed Dose Dose Level 2- Fixed Dose · Baylor College of Medicine https://druglandscape.com/drug/dosing-1-atomoxetine https://druglandscape.com/api/og?type=drug&title=Dosing%201%3A%20Atomoxetine&subtitle=Dosing%201%3A%20Atomoxetine%20%C2%B7%20Apnimed&badge=phase%201 Dosing 1: Atomoxetine Dosing 1: Atomoxetine · Apnimed https://druglandscape.com/drug/dositinib-mesylate-tablets https://druglandscape.com/api/og?type=drug&title=Dositinib%20mesylate%20tablets&subtitle=Dositinib%20mesylate%20tablets%20%C2%B7%20Henan%20Genuine%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 Dositinib mesylate tablets Dositinib mesylate tablets · Henan Genuine Biotech Co., Ltd. https://druglandscape.com/drug/double-blinded-ivig https://druglandscape.com/api/og?type=drug&title=Double%20blinded%20IVIg&subtitle=Double%20blinded%20IVIg%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%202 Double blinded IVIg Double blinded IVIg · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/double-matched-sibling-transplantation https://druglandscape.com/api/og?type=drug&title=Double%20matched%20sibling%20transplantation&subtitle=Double%20matched%20sibling%20transplantation%20%C2%B7%20Rabin%20Medical%20Center&badge=phase%201 Double matched sibling transplantation Double matched sibling transplantation · Rabin Medical Center https://druglandscape.com/drug/doubled-therapy https://druglandscape.com/api/og?type=drug&title=doubled%20therapy&subtitle=doubled%20therapy%20%C2%B7%20University%20of%20Florence&badge=phase%203 doubled therapy doubled therapy · University of Florence https://druglandscape.com/drug/dovitinib-and-docetaxel https://druglandscape.com/api/og?type=drug&title=Dovitinib%20and%20docetaxel&subtitle=Dovitinib%20and%20docetaxel%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 Dovitinib and docetaxel Dovitinib and docetaxel · Asan Medical Center https://druglandscape.com/drug/dox-docetaxel-oxaliplatin-capecitabine https://druglandscape.com/api/og?type=drug&title=DOX%3A%20Docetaxel%2C%20oxaliplatin%2C%20Capecitabine&subtitle=DOX%3A%20Docetaxel%2C%20oxaliplatin%2C%20Capecitabine%20%C2%B7%20Spanish%20Cooperative%20Group%20for%20the%20Treatment%20of%20Digestive&badge=phase%202 DOX: Docetaxel, oxaliplatin, Capecitabine DOX: Docetaxel, oxaliplatin, Capecitabine · Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) https://druglandscape.com/drug/doxazosin-and-avanafil https://druglandscape.com/api/og?type=drug&title=Doxazosin%20and%20avanafil&subtitle=Doxazosin%20and%20avanafil%20%C2%B7%20VIVUS%20LLC&badge=phase%201 Doxazosin and avanafil Doxazosin and avanafil · VIVUS LLC https://druglandscape.com/drug/doxazosin-mesylate-gits https://druglandscape.com/api/og?type=drug&title=Doxazosin%20mesylate%20GITS&subtitle=Doxazosin%20mesylate%20GITS%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%202 Doxazosin mesylate GITS Doxazosin mesylate GITS · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/doxorubicin-cyclophosphamide-paclitaxel-trastuzumab https://druglandscape.com/api/og?type=drug&title=doxorubicin%2C%20cyclophosphamide%2C%20paclitaxel%2C%20trastuzumab&subtitle=doxorubicin%2C%20cyclophosphamide%2C%20paclitaxel%2C%20trastuzumab%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 doxorubicin, cyclophosphamide, paclitaxel, trastuzumab doxorubicin, cyclophosphamide, paclitaxel, trastuzumab · Merck Sharp & Dohme LLC https://druglandscape.com/drug/doxorubicin-docetaxel https://druglandscape.com/api/og?type=drug&title=doxorubicin%2C%20docetaxel&subtitle=doxorubicin%2C%20docetaxel%20%C2%B7%20GBG%20Forschungs%20GmbH&badge=phase%202 doxorubicin, docetaxel doxorubicin, docetaxel · GBG Forschungs GmbH https://druglandscape.com/drug/doxorubicin-docetaxel-tamoxifen https://druglandscape.com/api/og?type=drug&title=doxorubicin%2C%20docetaxel%2C%20tamoxifen&subtitle=doxorubicin%2C%20docetaxel%2C%20tamoxifen%20%C2%B7%20GBG%20Forschungs%20GmbH&badge=phase%202 doxorubicin, docetaxel, tamoxifen doxorubicin, docetaxel, tamoxifen · GBG Forschungs GmbH https://druglandscape.com/drug/doxorubicin-hcl-liposome-bevacizumab-carboplatin https://druglandscape.com/api/og?type=drug&title=doxorubicin%20HCL%20liposome%3B%20bevacizumab%3B%20carboplatin&subtitle=doxorubicin%20HCL%20liposome%3B%20bevacizumab%3B%20carboplatin%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Dev&badge=phase%202 doxorubicin HCL liposome; bevacizumab; carboplatin doxorubicin HCL liposome; bevacizumab; carboplatin · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/doxorubicin-pegylated https://druglandscape.com/api/og?type=drug&title=Doxorubicin%20pegylated&subtitle=Doxorubicin%20pegylated%20%C2%B7%20French%20Innovative%20Leukemia%20Organisation&badge=phase%202 Doxorubicin pegylated Doxorubicin pegylated · French Innovative Leukemia Organisation https://druglandscape.com/drug/doxorubicine-pegylated https://druglandscape.com/api/og?type=drug&title=Doxorubicine%20pegylated&subtitle=Doxorubicine%20pegylated%20%C2%B7%20French%20Innovative%20Leukemia%20Organisation&badge=phase%202 Doxorubicine pegylated Doxorubicine pegylated · French Innovative Leukemia Organisation https://druglandscape.com/drug/doxycycline-and-s-equol https://druglandscape.com/api/og?type=drug&title=Doxycycline%20and%20S-equol&subtitle=Doxycycline%20and%20S-equol%20%C2%B7%20Nexgen%20Dermatologics%2C%20Inc.&badge=phase%201 Doxycycline and S-equol Doxycycline and S-equol · Nexgen Dermatologics, Inc. https://druglandscape.com/drug/doxycycline-treatment https://druglandscape.com/api/og?type=drug&title=Doxycycline%20treatment&subtitle=Doxycycline%20treatment%20%C2%B7%20Centers%20for%20Disease%20Control%20and%20Prevention&badge=phase%202 Doxycycline treatment Doxycycline treatment · Centers for Disease Control and Prevention https://druglandscape.com/drug/dp-cd8-til https://druglandscape.com/api/og?type=drug&title=DP%20CD8%20TIL&subtitle=DP%20CD8%20TIL%20%C2%B7%20AgonOx%2C%20Inc.&badge=phase%201 DP CD8 TIL DP CD8 TIL · AgonOx, Inc. https://druglandscape.com/drug/dp-qb-mya-002 https://druglandscape.com/api/og?type=drug&title=DP-QB-MYA-002&subtitle=DP-QB-MYA-002%20%C2%B7%20Alberta%20Health%20services&badge=phase%201 DP-QB-MYA-002 DP-QB-MYA-002 · Alberta Health services https://druglandscape.com/drug/dp13 https://druglandscape.com/api/og?type=drug&title=DP13&subtitle=DP13%20%C2%B7%20Damian%20Pharma%20AG&badge=phase%201 DP13 DP13 · Damian Pharma AG https://druglandscape.com/drug/dpc-817 https://druglandscape.com/api/og?type=drug&title=DPC%20817&subtitle=DPC%20817%20%C2%B7%20Pharmasset&badge=phase%201 DPC 817 DPC 817 · Pharmasset https://druglandscape.com/drug/dpk-060-1-ointment https://druglandscape.com/api/og?type=drug&title=DPK-060%201%25%20ointment&subtitle=DPK-060%201%25%20ointment%20%C2%B7%20DermaGen%20AB&badge=phase%201 DPK-060 1% ointment DPK-060 1% ointment · DermaGen AB https://druglandscape.com/drug/dppg2-tsl-dox https://druglandscape.com/api/og?type=drug&title=DPPG2-TSL-DOX&subtitle=DPPG2-TSL-DOX%20%C2%B7%20Thermosome%20GmbH&badge=phase%201 DPPG2-TSL-DOX DPPG2-TSL-DOX · Thermosome GmbH https://druglandscape.com/drug/dpsg-7-5 https://druglandscape.com/api/og?type=drug&title=DPSG%207.5%25&subtitle=DPSG%207.5%25%20%C2%B7%20Sun%20Pharmaceutical%20Industries%2C%20Inc.&badge=phase%201 DPSG 7.5% DPSG 7.5% · Sun Pharmaceutical Industries, Inc. https://druglandscape.com/drug/dpv-001 https://druglandscape.com/api/og?type=drug&title=DPV-001&subtitle=DPV-001%20%C2%B7%20Providence%20Health%20%26%20Services&badge=phase%201 DPV-001 DPV-001 · Providence Health & Services https://druglandscape.com/drug/dpv-001-vaccine https://druglandscape.com/api/og?type=drug&title=DPV-001%20vaccine&subtitle=DPV-001%20vaccine%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 DPV-001 vaccine DPV-001 vaccine · Bristol-Myers Squibb https://druglandscape.com/drug/dr30206 https://druglandscape.com/api/og?type=drug&title=DR30206&subtitle=DR30206%20%C2%B7%20Zhejiang%20Doer%20Biologics%20Co.%2C%20Ltd.&badge=phase%201 DR30206 DR30206 · Zhejiang Doer Biologics Co., Ltd. https://druglandscape.com/drug/dribble-vaccine https://druglandscape.com/api/og?type=drug&title=DRibble%20vaccine&subtitle=DRibble%20vaccine%20%C2%B7%20Providence%20Health%20%26%20Services&badge=phase%202 DRibble vaccine DRibble vaccine · Providence Health & Services https://druglandscape.com/drug/drl-pg https://druglandscape.com/api/og?type=drug&title=DRL_PG&subtitle=DRL_PG%20%C2%B7%20Dr.%20Reddy's%20Laboratories%20Limited&badge=phase%201 DRL_PG DRL_PG · Dr. Reddy's Laboratories Limited https://druglandscape.com/drug/drl-ri https://druglandscape.com/api/og?type=drug&title=DRL_RI&subtitle=DRL_RI%20%C2%B7%20Dr.%20Reddy's%20Laboratories%20Limited&badge=phase%201 DRL_RI DRL_RI · Dr. Reddy's Laboratories Limited https://druglandscape.com/drug/dronedarone-hydrochloride-tablets https://druglandscape.com/api/og?type=drug&title=Dronedarone%20Hydrochloride%20Tablets&subtitle=Dronedarone%20Hydrochloride%20Tablets%20%C2%B7%20Shandong%20New%20Time%20Pharmaceutical%20Co.%2C%20LTD&badge=phase%201 Dronedarone Hydrochloride Tablets Dronedarone Hydrochloride Tablets · Shandong New Time Pharmaceutical Co., LTD https://druglandscape.com/drug/drug-18f-florbetaben https://druglandscape.com/api/og?type=drug&title=Drug%3A%20%5B18F%5Dflorbetaben&subtitle=Drug%3A%20%5B18F%5Dflorbetaben%20%C2%B7%20Sinotau%20Pharmaceutical%20Group&badge=phase%201 Drug: [18F]florbetaben Drug: [18F]florbetaben · Sinotau Pharmaceutical Group https://druglandscape.com/drug/drug-601 https://druglandscape.com/api/og?type=drug&title=Drug%20601&subtitle=Drug%20601%20%C2%B7%20Sunshine%20Guojian%20Pharmaceutical%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 Drug 601 Drug 601 · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. https://druglandscape.com/drug/drug-abbv-cls-484 https://druglandscape.com/api/og?type=drug&title=DRUG%3A%20ABBV-CLS-484&subtitle=DRUG%3A%20ABBV-CLS-484%20%C2%B7%20Calico%20Life%20Sciences%20LLC&badge=phase%202 DRUG: ABBV-CLS-484 DRUG: ABBV-CLS-484 · Calico Life Sciences LLC https://druglandscape.com/drug/drug-apixaban-sprinkle-capsules https://druglandscape.com/api/og?type=drug&title=Drug%3A%20Apixaban%20sprinkle%20capsules&subtitle=Drug%3A%20Apixaban%20sprinkle%20capsules%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Drug: Apixaban sprinkle capsules Drug: Apixaban sprinkle capsules · Bristol-Myers Squibb https://druglandscape.com/drug/drug-bg-t187 https://druglandscape.com/api/og?type=drug&title=Drug%3A%20BG-T187&subtitle=Drug%3A%20BG-T187%20%C2%B7%20BeiGene&badge=phase%201 Drug: BG-T187 Drug: BG-T187 · BeiGene https://druglandscape.com/drug/drug-cgb-600-gel-experimental-drug https://druglandscape.com/api/og?type=drug&title=Drug%3A%20CGB-600%20gel%2C%20experimental%20drug&subtitle=Drug%3A%20CGB-600%20gel%2C%20experimental%20drug%20%C2%B7%20CAGE%20Bio%20Inc.&badge=phase%201 Drug: CGB-600 gel, experimental drug Drug: CGB-600 gel, experimental drug · CAGE Bio Inc. https://druglandscape.com/drug/drug-ckd-391-qd-po https://druglandscape.com/api/og?type=drug&title=Drug%3A%20CKD-391%2C%20QD%2C%20PO&subtitle=Drug%3A%20CKD-391%2C%20QD%2C%20PO%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 Drug: CKD-391, QD, PO Drug: CKD-391, QD, PO · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/drug-cocktail https://druglandscape.com/api/og?type=drug&title=Drug%20Cocktail&subtitle=Drug%20Cocktail%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Drug Cocktail Drug Cocktail · Eli Lilly and Company https://druglandscape.com/drug/drug-covid19-0001-usr https://druglandscape.com/api/og?type=drug&title=Drug%20COVID19-0001-USR&subtitle=Drug%20COVID19-0001-USR%20%C2%B7%20United%20Medical%20Specialties&badge=phase%201 Drug COVID19-0001-USR Drug COVID19-0001-USR · United Medical Specialties https://druglandscape.com/drug/drug-e2609 https://druglandscape.com/api/og?type=drug&title=Drug%3A%20E2609&subtitle=Drug%3A%20E2609%20%C2%B7%20Eisai%20Inc.&badge=phase%201 Drug: E2609 Drug: E2609 · Eisai Inc. https://druglandscape.com/drug/drug-evp-6308 https://druglandscape.com/api/og?type=drug&title=Drug%3A%20EVP-6308&subtitle=Drug%3A%20EVP-6308%20%C2%B7%20FORUM%20Pharmaceuticals%20Inc&badge=phase%201 Drug: EVP-6308 Drug: EVP-6308 · FORUM Pharmaceuticals Inc https://druglandscape.com/drug/drug-fluoxetine https://druglandscape.com/api/og?type=drug&title=Drug%3A%20fluoxetine&subtitle=Drug%3A%20fluoxetine%20%C2%B7%20Shanghai%20Mental%20Health%20Center&badge=phase%201 Drug: fluoxetine Drug: fluoxetine · Shanghai Mental Health Center https://druglandscape.com/drug/drug-gc4419 https://druglandscape.com/api/og?type=drug&title=Drug%3A%20GC4419&subtitle=Drug%3A%20GC4419%20%C2%B7%20Galera%20Therapeutics%2C%20Inc.&badge=phase%202 Drug: GC4419 Drug: GC4419 · Galera Therapeutics, Inc. https://druglandscape.com/drug/drug-hs-10510 https://druglandscape.com/api/og?type=drug&title=Drug%EF%BC%9AHS-10510%EF%BC%9B&subtitle=Drug%EF%BC%9AHS-10510%EF%BC%9B%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Drug：HS-10510； Drug：HS-10510； · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/drug-icp-192 https://druglandscape.com/api/og?type=drug&title=Drug%20ICP-192&subtitle=Drug%20ICP-192%20%C2%B7%20Beijing%20InnoCare%20Pharma%20Tech%20Co.%2C%20Ltd.&badge=phase%201 Drug ICP-192 Drug ICP-192 · Beijing InnoCare Pharma Tech Co., Ltd. https://druglandscape.com/drug/drug-inm004-dose-1 https://druglandscape.com/api/og?type=drug&title=Drug%3A%20INM004%20Dose%201&subtitle=Drug%3A%20INM004%20Dose%201%20%C2%B7%20Inmunova%20S.A.&badge=phase%201 Drug: INM004 Dose 1 Drug: INM004 Dose 1 · Inmunova S.A. https://druglandscape.com/drug/drug-inm004-repeated-dose https://druglandscape.com/api/og?type=drug&title=Drug%3A%20INM004-%20Repeated%20dose&subtitle=Drug%3A%20INM004-%20Repeated%20dose%20%C2%B7%20Inmunova%20S.A.&badge=phase%201 Drug: INM004- Repeated dose Drug: INM004- Repeated dose · Inmunova S.A. https://druglandscape.com/drug/drug-lw402 https://druglandscape.com/api/og?type=drug&title=Drug%3A%20LW402&subtitle=Drug%3A%20LW402%20%C2%B7%20Shanghai%20Longwood%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 Drug: LW402 Drug: LW402 · Shanghai Longwood Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/drug-ly573636-sodium https://druglandscape.com/api/og?type=drug&title=Drug%3A%20LY573636-sodium&subtitle=Drug%3A%20LY573636-sodium%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Drug: LY573636-sodium Drug: LY573636-sodium · Eli Lilly and Company https://druglandscape.com/drug/drug-mediated-hyperemia https://druglandscape.com/api/og?type=drug&title=Drug-mediated%20hyperemia&subtitle=Drug-mediated%20hyperemia%20%C2%B7%20Fundaci%C3%B3n%20EPIC&badge=phase%201 Drug-mediated hyperemia Drug-mediated hyperemia · Fundación EPIC https://druglandscape.com/drug/drug-metabolizing-enzyme https://druglandscape.com/api/og?type=drug&title=Drug%20Metabolizing%20Enzyme&subtitle=Drug%20Metabolizing%20Enzyme%20%C2%B7%20OrsoBio%2C%20Inc&badge=phase%201 Drug Metabolizing Enzyme Drug Metabolizing Enzyme · OrsoBio, Inc https://druglandscape.com/drug/drug-monitoring https://druglandscape.com/api/og?type=drug&title=Drug%20Monitoring&subtitle=Drug%20Monitoring%20%C2%B7%20Fondation%20H%C3%B4pital%20Saint-Joseph&badge=phase%202 Drug Monitoring Drug Monitoring · Fondation Hôpital Saint-Joseph https://druglandscape.com/drug/drug-nv01-a02 https://druglandscape.com/api/og?type=drug&title=Drug%3A%20NV01-A02&subtitle=Drug%3A%20NV01-A02%20%C2%B7%20Neuroventi%20Inc.&badge=phase%202 Drug: NV01-A02 Drug: NV01-A02 · Neuroventi Inc. https://druglandscape.com/drug/drug-omega-3 https://druglandscape.com/api/og?type=drug&title=Drug%20Omega%203&subtitle=Drug%20Omega%203%20%C2%B7%20Matinas%20Biopharma%2C%20Inc&badge=phase%201 Drug Omega 3 Drug Omega 3 · Matinas Biopharma, Inc https://druglandscape.com/drug/drug-osimertinib https://druglandscape.com/api/og?type=drug&title=Drug%3A%20Osimertinib&subtitle=Drug%3A%20Osimertinib%20%C2%B7%20Revolution%20Medicines%2C%20Inc.&badge=phase%201 Drug: Osimertinib Drug: Osimertinib · Revolution Medicines, Inc. https://druglandscape.com/drug/drug-pf-07923568 https://druglandscape.com/api/og?type=drug&title=Drug%3A%20PF-07923568&subtitle=Drug%3A%20PF-07923568%20%C2%B7%20Pfizer&badge=phase%201 Drug: PF-07923568 Drug: PF-07923568 · Pfizer https://druglandscape.com/drug/drug-salmeterol-xinafoate https://druglandscape.com/api/og?type=drug&title=Drug%3A%20salmeterol%20xinafoate&subtitle=Drug%3A%20salmeterol%20xinafoate%20%C2%B7%20Neothetics%2C%20Inc&badge=phase%202 Drug: salmeterol xinafoate Drug: salmeterol xinafoate · Neothetics, Inc https://druglandscape.com/drug/drug-shr1459 https://druglandscape.com/api/og?type=drug&title=Drug%20-%20SHR1459&subtitle=Drug%20-%20SHR1459%20%C2%B7%20Reistone%20Biopharma%20Company%20Limited&badge=phase%202 Drug - SHR1459 Drug - SHR1459 · Reistone Biopharma Company Limited https://druglandscape.com/drug/drug-syha1801 https://druglandscape.com/api/og?type=drug&title=Drug%3A%20SYHA1801&subtitle=Drug%3A%20SYHA1801%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 Drug: SYHA1801 Drug: SYHA1801 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/drug-syha1805-tablets https://druglandscape.com/api/og?type=drug&title=Drug%3A%20SYHA1805%20tablets&subtitle=Drug%3A%20SYHA1805%20tablets%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 Drug: SYHA1805 tablets Drug: SYHA1805 tablets · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/drug-tagitanlimab-drug-capecitabine https://druglandscape.com/api/og?type=drug&title=Drug%3A%20Tagitanlimab%20Drug%3A%20Capecitabine&subtitle=Drug%3A%20Tagitanlimab%20Drug%3A%20Capecitabine%20%C2%B7%20Sichuan%20Kelun-Biotech%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Drug: Tagitanlimab Drug: Capecitabine Drug: Tagitanlimab Drug: Capecitabine · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/drug-therapy-for-heart-failure https://druglandscape.com/api/og?type=drug&title=Drug%20Therapy%20for%20Heart%20Failure&subtitle=Drug%20Therapy%20for%20Heart%20Failure%20%C2%B7%20King's%20College%20London&badge=phase%201 Drug Therapy for Heart Failure Drug Therapy for Heart Failure · King's College London https://druglandscape.com/drug/drug-topical-rapamycin https://druglandscape.com/api/og?type=drug&title=Drug%3A%20Topical%20Rapamycin&subtitle=Drug%3A%20Topical%20Rapamycin%20%C2%B7%20Clinica%20Universidad%20de%20Navarra%2C%20Universidad%20de%20Navarra&badge=phase%202 Drug: Topical Rapamycin Drug: Topical Rapamycin · Clinica Universidad de Navarra, Universidad de Navarra https://druglandscape.com/drug/drug-treatment-a https://druglandscape.com/api/og?type=drug&title=Drug%3A%20Treatment%20A&subtitle=Drug%3A%20Treatment%20A%20%C2%B7%20Celltrion&badge=phase%201 Drug: Treatment A Drug: Treatment A · Celltrion https://druglandscape.com/drug/drug-treatment-b https://druglandscape.com/api/og?type=drug&title=Drug%3A%20Treatment%20B&subtitle=Drug%3A%20Treatment%20B%20%C2%B7%20Celltrion&badge=phase%201 Drug: Treatment B Drug: Treatment B · Celltrion https://druglandscape.com/drug/drug-treatment-c https://druglandscape.com/api/og?type=drug&title=Drug%3A%20Treatment%20C&subtitle=Drug%3A%20Treatment%20C%20%C2%B7%20Celltrion&badge=phase%201 Drug: Treatment C Drug: Treatment C · Celltrion https://druglandscape.com/drug/drug-use-modafinil https://druglandscape.com/api/og?type=drug&title=Drug%20use%3A%20modafinil&subtitle=Drug%20use%3A%20modafinil%20%C2%B7%20K.%20Lieb&badge=phase%201 Drug use: modafinil Drug use: modafinil · K. Lieb https://druglandscape.com/drug/drug-xs-03 https://druglandscape.com/api/og?type=drug&title=Drug%3A%20XS-03&subtitle=Drug%3A%20XS-03%20%C2%B7%20NovaOnco%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 Drug: XS-03 Drug: XS-03 · NovaOnco Therapeutics Co., Ltd. https://druglandscape.com/drug/drugs-use-methylphenidate https://druglandscape.com/api/og?type=drug&title=Drugs%20use%3A%20methylphenidate&subtitle=Drugs%20use%3A%20methylphenidate%20%C2%B7%20K.%20Lieb&badge=phase%201 Drugs use: methylphenidate Drugs use: methylphenidate · K. Lieb https://druglandscape.com/drug/dry-powder-inhaled-mannitol https://druglandscape.com/api/og?type=drug&title=dry%20powder%20inhaled%20mannitol&subtitle=dry%20powder%20inhaled%20mannitol%20%C2%B7%20Syntara&badge=phase%201 dry powder inhaled mannitol dry powder inhaled mannitol · Syntara https://druglandscape.com/drug/ds-01 https://druglandscape.com/api/og?type=drug&title=DS-01&subtitle=DS-01%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%202 DS-01 DS-01 · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/ds-1123 https://druglandscape.com/api/og?type=drug&title=DS-1123&subtitle=DS-1123%20%C2%B7%20Daiichi%20Sankyo%20Co.%2C%20Ltd.&badge=phase%201 DS-1123 DS-1123 · Daiichi Sankyo Co., Ltd. https://druglandscape.com/drug/ds-6051b https://druglandscape.com/api/og?type=drug&title=DS-6051b&subtitle=DS-6051b%20%C2%B7%20Daiichi%20Sankyo%20Co.%2C%20Ltd.&badge=phase%201 DS-6051b DS-6051b · Daiichi Sankyo Co., Ltd. https://druglandscape.com/drug/ds-8895a https://druglandscape.com/api/og?type=drug&title=DS-8895a&subtitle=DS-8895a%20%C2%B7%20Daiichi%20Sankyo%20Co.%2C%20Ltd.&badge=phase%201 DS-8895a DS-8895a · Daiichi Sankyo Co., Ltd. https://druglandscape.com/drug/ds1040b https://druglandscape.com/api/og?type=drug&title=DS1040b&subtitle=DS1040b%20%C2%B7%20Daiichi%20Sankyo%20Co.%2C%20Ltd.&badge=phase%201 DS1040b DS1040b · Daiichi Sankyo Co., Ltd. https://druglandscape.com/drug/dsb2455 https://druglandscape.com/api/og?type=drug&title=DSB2455&subtitle=DSB2455%20%C2%B7%20Duke%20Street%20Bio%20Ltd&badge=phase%201 DSB2455 DSB2455 · Duke Street Bio Ltd https://druglandscape.com/drug/dsp-5336 https://druglandscape.com/api/og?type=drug&title=DSP-5336&subtitle=DSP-5336%20%C2%B7%20Sumitomo%20Pharma%20America%2C%20Inc.&badge=phase%201 DSP-5336 DSP-5336 · Sumitomo Pharma America, Inc. https://druglandscape.com/drug/dsp-8658 https://druglandscape.com/api/og?type=drug&title=DSP-8658&subtitle=DSP-8658%20%C2%B7%20Sumitomo%20Pharma%20America%2C%20Inc.&badge=phase%201 DSP-8658 DSP-8658 · Sumitomo Pharma America, Inc. https://druglandscape.com/drug/dsp-loaded-rbc-using-erydex-system https://druglandscape.com/api/og?type=drug&title=DSP%20loaded%20RBC%20using%20EryDex%20System&subtitle=DSP%20loaded%20RBC%20using%20EryDex%20System%20%C2%B7%20Quince%20Therapeutics%20S.p.A.&badge=phase%201 DSP loaded RBC using EryDex System DSP loaded RBC using EryDex System · Quince Therapeutics S.p.A. https://druglandscape.com/drug/dstp3086s https://druglandscape.com/api/og?type=drug&title=DSTP3086S&subtitle=DSTP3086S%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 DSTP3086S DSTP3086S · Genentech, Inc. https://druglandscape.com/drug/dt-216 https://druglandscape.com/api/og?type=drug&title=DT-216&subtitle=DT-216%20%C2%B7%20Design%20Therapeutics%2C%20Inc.&badge=phase%201 DT-216 DT-216 · Design Therapeutics, Inc. https://druglandscape.com/drug/dt-7012 https://druglandscape.com/api/og?type=drug&title=DT-7012&subtitle=DT-7012%20%C2%B7%20Domain%20Therapeutics%20Australia%20Pty%20Ltd&badge=phase%201 DT-7012 DT-7012 · Domain Therapeutics Australia Pty Ltd https://druglandscape.com/drug/dt-9081-dose-escalation https://druglandscape.com/api/og?type=drug&title=DT-9081%20-%20dose%20escalation&subtitle=DT-9081%20-%20dose%20escalation%20%C2%B7%20Domain%20Therapeutics%20SA&badge=phase%201 DT-9081 - dose escalation DT-9081 - dose escalation · Domain Therapeutics SA https://druglandscape.com/drug/dt-9081-expansion https://druglandscape.com/api/og?type=drug&title=DT-9081%20-%20expansion&subtitle=DT-9081%20-%20expansion%20%C2%B7%20Domain%20Therapeutics%20SA&badge=phase%201 DT-9081 - expansion DT-9081 - expansion · Domain Therapeutics SA https://druglandscape.com/drug/dt01 https://druglandscape.com/api/og?type=drug&title=DT01&subtitle=DT01%20%C2%B7%20DNA%20Therapeutics&badge=phase%201 DT01 DT01 · DNA Therapeutics https://druglandscape.com/drug/dt2216 https://druglandscape.com/api/og?type=drug&title=DT2216&subtitle=DT2216%20%C2%B7%20Dialectic%20Therapeutics%2C%20Inc&badge=phase%201 DT2216 DT2216 · Dialectic Therapeutics, Inc https://druglandscape.com/drug/dtap-hepb-ipv-hib-vaccine https://druglandscape.com/api/og?type=drug&title=DTap-HepB-IPV-Hib%20vaccine&subtitle=DTap-HepB-IPV-Hib%20vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%202 DTap-HepB-IPV-Hib vaccine DTap-HepB-IPV-Hib vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/dtcp-hib-mcv4 https://druglandscape.com/api/og?type=drug&title=DTcP-Hib-MCV4&subtitle=DTcP-Hib-MCV4%20%C2%B7%20CanSino%20Biologics%20Inc.&badge=phase%201 DTcP-Hib-MCV4 DTcP-Hib-MCV4 · CanSino Biologics Inc. https://druglandscape.com/drug/dtp-hepb-hib-vaccine-ipv https://druglandscape.com/api/og?type=drug&title=DTP-HepB-Hib%20vaccine%20%26%20IPV&subtitle=DTP-HepB-Hib%20vaccine%20%26%20IPV%20%C2%B7%20LG%20Chem&badge=phase%201 DTP-HepB-Hib vaccine & IPV DTP-HepB-Hib vaccine & IPV · LG Chem https://druglandscape.com/drug/dtp-hepb-ipv-hib-vaccine https://druglandscape.com/api/og?type=drug&title=DTP-HepB-IPV-Hib%20vaccine&subtitle=DTP-HepB-IPV-Hib%20vaccine%20%C2%B7%20LG%20Chem&badge=phase%201 DTP-HepB-IPV-Hib vaccine DTP-HepB-IPV-Hib vaccine · LG Chem https://druglandscape.com/drug/dtrm-505 https://druglandscape.com/api/og?type=drug&title=DTRM-505&subtitle=DTRM-505%20%C2%B7%20Zhejiang%20DTRM%20Biopharma&badge=phase%201 DTRM-505 DTRM-505 · Zhejiang DTRM Biopharma https://druglandscape.com/drug/dtrmwxhs-12 https://druglandscape.com/api/og?type=drug&title=DTRMWXHS-12&subtitle=DTRMWXHS-12%20%C2%B7%20Zhejiang%20DTRM%20Biopharma&badge=phase%201 DTRMWXHS-12 DTRMWXHS-12 · Zhejiang DTRM Biopharma https://druglandscape.com/drug/dtwp-hepb-sabin-ipv-hib https://druglandscape.com/api/og?type=drug&title=DTwP-HepB-Sabin%20IPV-Hib&subtitle=DTwP-HepB-Sabin%20IPV-Hib%20%C2%B7%20LG%20Chem&badge=phase%202 DTwP-HepB-Sabin IPV-Hib DTwP-HepB-Sabin IPV-Hib · LG Chem https://druglandscape.com/drug/dual-antidepressants https://druglandscape.com/api/og?type=drug&title=Dual%20antidepressants&subtitle=Dual%20antidepressants%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 Dual antidepressants Dual antidepressants · Eli Lilly and Company https://druglandscape.com/drug/dual-combination-therapy https://druglandscape.com/api/og?type=drug&title=Dual-combination%20therapy&subtitle=Dual-combination%20therapy%20%C2%B7%20Kyu%20Chang%20Won&badge=phase%201 Dual-combination therapy Dual-combination therapy · Kyu Chang Won https://druglandscape.com/drug/dual-integrin-antagonist https://druglandscape.com/api/og?type=drug&title=Dual%20Integrin%20Antagonist&subtitle=Dual%20Integrin%20Antagonist%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Dual Integrin Antagonist Dual Integrin Antagonist · Hoffmann-La Roche https://druglandscape.com/drug/dual-target-car-t-cell-therapy https://druglandscape.com/api/og?type=drug&title=dual%20target%20CAR-T%20cell%20therapy&subtitle=dual%20target%20CAR-T%20cell%20therapy%20%C2%B7%20YuLi&badge=phase%201 dual target CAR-T cell therapy dual target CAR-T cell therapy · YuLi https://druglandscape.com/drug/duoc-01 https://druglandscape.com/api/og?type=drug&title=DUOC-01&subtitle=DUOC-01%20%C2%B7%20Joanne%20Kurtzberg%2C%20MD&badge=phase%201 DUOC-01 DUOC-01 · Joanne Kurtzberg, MD https://druglandscape.com/drug/dupilumab-for-mad https://druglandscape.com/api/og?type=drug&title=Dupilumab%20for%20MAD&subtitle=Dupilumab%20for%20MAD%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 Dupilumab for MAD Dupilumab for MAD · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/durvalumab-and-vactosertib https://druglandscape.com/api/og?type=drug&title=durvalumab%20and%20vactosertib&subtitle=durvalumab%20and%20vactosertib%20%C2%B7%20Hark%20Kyun%20Kim&badge=phase%202 durvalumab and vactosertib durvalumab and vactosertib · Hark Kyun Kim https://druglandscape.com/drug/durvalumab-plus-tremelimumab https://druglandscape.com/api/og?type=drug&title=Durvalumab%20Plus%20Tremelimumab&subtitle=Durvalumab%20Plus%20Tremelimumab%20%C2%B7%20UNICANCER&badge=phase%202 Durvalumab Plus Tremelimumab Durvalumab Plus Tremelimumab · UNICANCER https://druglandscape.com/drug/durvalumab-tremelimumab-bevacizumab https://druglandscape.com/api/og?type=drug&title=durvalumab%2C%20tremelimumab%2C%20bevacizumab&subtitle=durvalumab%2C%20tremelimumab%2C%20bevacizumab%20%C2%B7%20Enrico%20De%20Toni&badge=phase%202 durvalumab, tremelimumab, bevacizumab durvalumab, tremelimumab, bevacizumab · Enrico De Toni https://druglandscape.com/drug/dust-mite-extract-fluticasone-methacholine https://druglandscape.com/api/og?type=drug&title=Dust%20mite%20extract%2C%20Fluticasone%2C%20Methacholine&subtitle=Dust%20mite%20extract%2C%20Fluticasone%2C%20Methacholine%20%C2%B7%20Novartis&badge=phase%201 Dust mite extract, Fluticasone, Methacholine Dust mite extract, Fluticasone, Methacholine · Novartis https://druglandscape.com/drug/dutasteride-and-tamsulosin https://druglandscape.com/api/og?type=drug&title=Dutasteride%20and%20Tamsulosin&subtitle=Dutasteride%20and%20Tamsulosin%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Dutasteride and Tamsulosin Dutasteride and Tamsulosin · GlaxoSmithKline https://druglandscape.com/drug/dutasteride-reference-product https://druglandscape.com/api/og?type=drug&title=Dutasteride-Reference%20product&subtitle=Dutasteride-Reference%20product%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Dutasteride-Reference product Dutasteride-Reference product · GlaxoSmithKline https://druglandscape.com/drug/duvax-200-g https://druglandscape.com/api/og?type=drug&title=DUVAX%20200%20%C2%B5g&subtitle=DUVAX%20200%20%C2%B5g%20%C2%B7%20Nuravax%2C%20Inc.&badge=phase%201 DUVAX 200 µg DUVAX 200 µg · Nuravax, Inc. https://druglandscape.com/drug/duvax-400-g https://druglandscape.com/api/og?type=drug&title=DUVAX%20400%20%C2%B5g&subtitle=DUVAX%20400%20%C2%B5g%20%C2%B7%20Nuravax%2C%20Inc.&badge=phase%201 DUVAX 400 µg DUVAX 400 µg · Nuravax, Inc. https://druglandscape.com/drug/dv-601 https://druglandscape.com/api/og?type=drug&title=DV-601&subtitle=DV-601%20%C2%B7%20Dynavax%20Technologies%20Corporation&badge=phase%201 DV-601 DV-601 · Dynavax Technologies Corporation https://druglandscape.com/drug/dv281 https://druglandscape.com/api/og?type=drug&title=DV281&subtitle=DV281%20%C2%B7%20Dynavax%20Technologies%20Corporation&badge=phase%201 DV281 DV281 · Dynavax Technologies Corporation https://druglandscape.com/drug/dw-0920 https://druglandscape.com/api/og?type=drug&title=DW-0920&subtitle=DW-0920%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW-0920 DW-0920 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw-3102 https://druglandscape.com/api/og?type=drug&title=DW-3102&subtitle=DW-3102%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 DW-3102 DW-3102 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw1809 https://druglandscape.com/api/og?type=drug&title=DW1809&subtitle=DW1809%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW1809 DW1809 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw1809-1 https://druglandscape.com/api/og?type=drug&title=DW1809-1&subtitle=DW1809-1%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW1809-1 DW1809-1 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw1903-r2 https://druglandscape.com/api/og?type=drug&title=DW1903-R2&subtitle=DW1903-R2%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW1903-R2 DW1903-R2 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw4421 https://druglandscape.com/api/og?type=drug&title=DW4421&subtitle=DW4421%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW4421 DW4421 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw4421-1 https://druglandscape.com/api/og?type=drug&title=DW4421-1&subtitle=DW4421-1%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW4421-1 DW4421-1 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw4421-2 https://druglandscape.com/api/og?type=drug&title=DW4421-2&subtitle=DW4421-2%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW4421-2 DW4421-2 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw4421-n1 https://druglandscape.com/api/og?type=drug&title=DW4421-N1&subtitle=DW4421-N1%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW4421-N1 DW4421-N1 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw4421-n2 https://druglandscape.com/api/og?type=drug&title=DW4421-N2&subtitle=DW4421-N2%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW4421-N2 DW4421-N2 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw4421-n3 https://druglandscape.com/api/og?type=drug&title=DW4421-N3&subtitle=DW4421-N3%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW4421-N3 DW4421-N3 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw4421-t1 https://druglandscape.com/api/og?type=drug&title=DW4421-T1&subtitle=DW4421-T1%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW4421-T1 DW4421-T1 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw4421s https://druglandscape.com/api/og?type=drug&title=DW4421S&subtitle=DW4421S%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW4421S DW4421S · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw4421s-t1 https://druglandscape.com/api/og?type=drug&title=DW4421S-T1&subtitle=DW4421S-T1%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW4421S-T1 DW4421S-T1 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw5124-r https://druglandscape.com/api/og?type=drug&title=DW5124-R&subtitle=DW5124-R%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW5124-R DW5124-R · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw5524 https://druglandscape.com/api/og?type=drug&title=DW5524&subtitle=DW5524%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW5524 DW5524 · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw5524-a https://druglandscape.com/api/og?type=drug&title=DW5524-A&subtitle=DW5524-A%20%C2%B7%20Daewon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 DW5524-A DW5524-A · Daewon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/dw6014 https://druglandscape.com/api/og?type=drug&title=DW6014&subtitle=DW6014%20%C2%B7%20Dong%20Wha%20Pharmaceutical%20Co.%20Ltd.&badge=phase%201 DW6014 DW6014 · Dong Wha Pharmaceutical Co. Ltd. https://druglandscape.com/drug/dwc20141 https://druglandscape.com/api/og?type=drug&title=DWC20141&subtitle=DWC20141%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC20141 DWC20141 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc20142 https://druglandscape.com/api/og?type=drug&title=DWC20142&subtitle=DWC20142%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC20142 DWC20142 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc20152 https://druglandscape.com/api/og?type=drug&title=DWC20152&subtitle=DWC20152%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC20152 DWC20152 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc20161 https://druglandscape.com/api/og?type=drug&title=DWC20161&subtitle=DWC20161%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC20161 DWC20161 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc20162 https://druglandscape.com/api/og?type=drug&title=DWC20162&subtitle=DWC20162%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC20162 DWC20162 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc20163 https://druglandscape.com/api/og?type=drug&title=DWC20163&subtitle=DWC20163%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC20163 DWC20163 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc201903 https://druglandscape.com/api/og?type=drug&title=DWC201903&subtitle=DWC201903%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC201903 DWC201903 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc202005-alone https://druglandscape.com/api/og?type=drug&title=DWC202005%2C%20alone&subtitle=DWC202005%2C%20alone%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC202005, alone DWC202005, alone · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc202101 https://druglandscape.com/api/og?type=drug&title=DWC202101&subtitle=DWC202101%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC202101 DWC202101 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc202203 https://druglandscape.com/api/og?type=drug&title=DWC202203&subtitle=DWC202203%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC202203 DWC202203 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc202213 https://druglandscape.com/api/og?type=drug&title=DWC202213&subtitle=DWC202213%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC202213 DWC202213 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc202215 https://druglandscape.com/api/og?type=drug&title=DWC202215&subtitle=DWC202215%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC202215 DWC202215 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc202216 https://druglandscape.com/api/og?type=drug&title=DWC202216&subtitle=DWC202216%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC202216 DWC202216 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc202307 https://druglandscape.com/api/og?type=drug&title=DWC202307&subtitle=DWC202307%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC202307 DWC202307 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc202310-and-dwc202311 https://druglandscape.com/api/og?type=drug&title=DWC202310%20and%20DWC202311&subtitle=DWC202310%20and%20DWC202311%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC202310 and DWC202311 DWC202310 and DWC202311 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc202312 https://druglandscape.com/api/og?type=drug&title=DWC202312&subtitle=DWC202312%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC202312 DWC202312 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc202314 https://druglandscape.com/api/og?type=drug&title=DWC202314&subtitle=DWC202314%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC202314 DWC202314 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc202511 https://druglandscape.com/api/og?type=drug&title=DWC202511&subtitle=DWC202511%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC202511 DWC202511 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwc202512 https://druglandscape.com/api/og?type=drug&title=DWC202512&subtitle=DWC202512%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWC202512 DWC202512 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwetr10 https://druglandscape.com/api/og?type=drug&title=DWETR10&subtitle=DWETR10%20%C2%B7%20Dong%20Wha%20Pharmaceutical%20Co.%20Ltd.&badge=phase%201 DWETR10 DWETR10 · Dong Wha Pharmaceutical Co. Ltd. https://druglandscape.com/drug/dwetr25 https://druglandscape.com/api/og?type=drug&title=DWETR25&subtitle=DWETR25%20%C2%B7%20Dong%20Wha%20Pharmaceutical%20Co.%20Ltd.&badge=phase%201 DWETR25 DWETR25 · Dong Wha Pharmaceutical Co. Ltd. https://druglandscape.com/drug/dwj1230 https://druglandscape.com/api/og?type=drug&title=DWJ1230&subtitle=DWJ1230%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1230 DWJ1230 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1351 https://druglandscape.com/api/og?type=drug&title=DWJ1351&subtitle=DWJ1351%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1351 DWJ1351 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1366-tab https://druglandscape.com/api/og?type=drug&title=DWJ1366%20Tab.&subtitle=DWJ1366%20Tab.%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1366 Tab. DWJ1366 Tab. · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1386-tab https://druglandscape.com/api/og?type=drug&title=DWJ1386%20Tab.&subtitle=DWJ1386%20Tab.%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1386 Tab. DWJ1386 Tab. · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1421 https://druglandscape.com/api/og?type=drug&title=DWJ1421&subtitle=DWJ1421%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1421 DWJ1421 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1439 https://druglandscape.com/api/og?type=drug&title=DWJ1439&subtitle=DWJ1439%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1439 DWJ1439 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1445 https://druglandscape.com/api/og?type=drug&title=DWJ1445&subtitle=DWJ1445%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1445 DWJ1445 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1451 https://druglandscape.com/api/og?type=drug&title=DWJ1451&subtitle=DWJ1451%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1451 DWJ1451 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1511 https://druglandscape.com/api/og?type=drug&title=DWJ1511&subtitle=DWJ1511%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1511 DWJ1511 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1521 https://druglandscape.com/api/og?type=drug&title=DWJ1521&subtitle=DWJ1521%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1521 DWJ1521 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1525 https://druglandscape.com/api/og?type=drug&title=DWJ1525&subtitle=DWJ1525%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1525 DWJ1525 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1543 https://druglandscape.com/api/og?type=drug&title=DWJ1543&subtitle=DWJ1543%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1543 DWJ1543 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1558 https://druglandscape.com/api/og?type=drug&title=DWJ1558&subtitle=DWJ1558%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1558 DWJ1558 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1563 https://druglandscape.com/api/og?type=drug&title=DWJ1563&subtitle=DWJ1563%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1563 DWJ1563 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1568 https://druglandscape.com/api/og?type=drug&title=DWJ1568&subtitle=DWJ1568%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1568 DWJ1568 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwj1622 https://druglandscape.com/api/og?type=drug&title=DWJ1622&subtitle=DWJ1622%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWJ1622 DWJ1622 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwp10292 https://druglandscape.com/api/og?type=drug&title=DWP10292&subtitle=DWP10292%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWP10292 DWP10292 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwp14012-bmg https://druglandscape.com/api/og?type=drug&title=DWP14012%20Bmg&subtitle=DWP14012%20Bmg%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWP14012 Bmg DWP14012 Bmg · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwp14012-tablet-b https://druglandscape.com/api/og?type=drug&title=DWP14012%20tablet%20B&subtitle=DWP14012%20tablet%20B%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWP14012 tablet B DWP14012 tablet B · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwp16001-drug-b https://druglandscape.com/api/og?type=drug&title=DWP16001%20drug%20B&subtitle=DWP16001%20drug%20B%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWP16001 drug B DWP16001 drug B · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwp16001-drug-c https://druglandscape.com/api/og?type=drug&title=DWP16001%20Drug%20C&subtitle=DWP16001%20Drug%20C%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWP16001 Drug C DWP16001 Drug C · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dwp712 https://druglandscape.com/api/og?type=drug&title=DWP712&subtitle=DWP712%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 DWP712 DWP712 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/dxc006 https://druglandscape.com/api/og?type=drug&title=DXC006&subtitle=DXC006%20%C2%B7%20Hangzhou%20DAC%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 DXC006 DXC006 · Hangzhou DAC Biotechnology Co., Ltd. https://druglandscape.com/drug/dxc014 https://druglandscape.com/api/og?type=drug&title=DXC014&subtitle=DXC014%20%C2%B7%20Hangzhou%20DAC%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 DXC014 DXC014 · Hangzhou DAC Biotechnology Co., Ltd. https://druglandscape.com/drug/dypiron-tramadol https://druglandscape.com/api/og?type=drug&title=dypiron%2C%20tramadol&subtitle=dypiron%2C%20tramadol%20%C2%B7%20HaEmek%20Medical%20Center%2C%20Israel&badge=phase%201 dypiron, tramadol dypiron, tramadol · HaEmek Medical Center, Israel https://druglandscape.com/drug/e-602 https://druglandscape.com/api/og?type=drug&title=E-602&subtitle=E-602%20%C2%B7%20Palleon%20Pharmaceuticals%2C%20Inc.&badge=phase%201 E-602 E-602 · Palleon Pharmaceuticals, Inc. https://druglandscape.com/drug/e-coli-bioconjugate-vaccine https://druglandscape.com/api/og?type=drug&title=E.coli%20bioconjugate%20vaccine&subtitle=E.coli%20bioconjugate%20vaccine%20%C2%B7%20GlycoVaxyn%20AG&badge=phase%201 E.coli bioconjugate vaccine E.coli bioconjugate vaccine · GlycoVaxyn AG https://druglandscape.com/drug/e-coli-h10407-and-buffer https://druglandscape.com/api/og?type=drug&title=E%20coli%20H10407%20and%20buffer&subtitle=E%20coli%20H10407%20and%20buffer%20%C2%B7%20Johns%20Hopkins%20Bloomberg%20School%20of%20Public%20Health&badge=phase%201 E coli H10407 and buffer E coli H10407 and buffer · Johns Hopkins Bloomberg School of Public Health https://druglandscape.com/drug/e-coli-strain-e1392-75-2a https://druglandscape.com/api/og?type=drug&title=E.%20coli%20strain%20E1392-75-2A&subtitle=E.%20coli%20strain%20E1392-75-2A%20%C2%B7%20NIZO%20Food%20Research&badge=phase%201 E. coli strain E1392-75-2A E. coli strain E1392-75-2A · NIZO Food Research https://druglandscape.com/drug/e-coli-strain-e1392-75-2a-dose-1e7-cfu https://druglandscape.com/api/og?type=drug&title=E.%20coli%20strain%20E1392-75-2A%20dose%201E7%20CFU&subtitle=E.%20coli%20strain%20E1392-75-2A%20dose%201E7%20CFU%20%C2%B7%20NIZO%20Food%20Research&badge=phase%201 E. coli strain E1392-75-2A dose 1E7 CFU E. coli strain E1392-75-2A dose 1E7 CFU · NIZO Food Research https://druglandscape.com/drug/e-coli-strain-e1392-75-2a-dose-1e9-cfu https://druglandscape.com/api/og?type=drug&title=E.%20coli%20strain%20E1392-75-2A%20dose%201E9%20CFU&subtitle=E.%20coli%20strain%20E1392-75-2A%20dose%201E9%20CFU%20%C2%B7%20NIZO%20Food%20Research&badge=phase%201 E. coli strain E1392-75-2A dose 1E9 CFU E. coli strain E1392-75-2A dose 1E9 CFU · NIZO Food Research https://druglandscape.com/drug/e-coli-strain-h10407-and-buffer https://druglandscape.com/api/og?type=drug&title=E%20coli%20strain%20H10407%20and%20buffer&subtitle=E%20coli%20strain%20H10407%20and%20buffer%20%C2%B7%20Johns%20Hopkins%20Bloomberg%20School%20of%20Public%20Health&badge=phase%201 E coli strain H10407 and buffer E coli strain H10407 and buffer · Johns Hopkins Bloomberg School of Public Health https://druglandscape.com/drug/e-edv-d682 https://druglandscape.com/api/og?type=drug&title=E-EDV-D682&subtitle=E-EDV-D682%20%C2%B7%20Engeneic%20Pty%20Limited&badge=phase%201 E-EDV-D682 E-EDV-D682 · Engeneic Pty Limited https://druglandscape.com/drug/e0302-ir https://druglandscape.com/api/og?type=drug&title=E0302%20IR&subtitle=E0302%20IR%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%201 E0302 IR E0302 IR · Eisai Co., Ltd. https://druglandscape.com/drug/e0302-sr1 https://druglandscape.com/api/og?type=drug&title=E0302%20SR1&subtitle=E0302%20SR1%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%201 E0302 SR1 E0302 SR1 · Eisai Co., Ltd. https://druglandscape.com/drug/e0302-sr2 https://druglandscape.com/api/og?type=drug&title=E0302%20SR2&subtitle=E0302%20SR2%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%201 E0302 SR2 E0302 SR2 · Eisai Co., Ltd. https://druglandscape.com/drug/e0302-sr3 https://druglandscape.com/api/og?type=drug&title=E0302%20SR3&subtitle=E0302%20SR3%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%201 E0302 SR3 E0302 SR3 · Eisai Co., Ltd. https://druglandscape.com/drug/e1-and-g1 https://druglandscape.com/api/og?type=drug&title=E1%20and%20G1&subtitle=E1%20and%20G1%20%C2%B7%20OPKO%20Health%2C%20Inc.&badge=phase%201 E1 and G1 E1 and G1 · OPKO Health, Inc. https://druglandscape.com/drug/e1018 https://druglandscape.com/api/og?type=drug&title=E1018&subtitle=E1018%20%C2%B7%20Eisai%20Inc.&badge=phase%201 E1018 E1018 · Eisai Inc. https://druglandscape.com/drug/e2006 https://druglandscape.com/api/og?type=drug&title=E2006&subtitle=E2006%20%C2%B7%20Eisai%20Inc.&badge=phase%202 E2006 E2006 · Eisai Inc. https://druglandscape.com/drug/e2022 https://druglandscape.com/api/og?type=drug&title=E2022&subtitle=E2022%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%201 E2022 E2022 · Eisai Co., Ltd. https://druglandscape.com/drug/e2022-current-formula-tape https://druglandscape.com/api/og?type=drug&title=E2022-%20Current%20Formula%20Tape&subtitle=E2022-%20Current%20Formula%20Tape%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%201 E2022- Current Formula Tape E2022- Current Formula Tape · Eisai Co., Ltd. https://druglandscape.com/drug/e2022-tape-formulation https://druglandscape.com/api/og?type=drug&title=E2022%20Tape%20Formulation&subtitle=E2022%20Tape%20Formulation%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%201 E2022 Tape Formulation E2022 Tape Formulation · Eisai Co., Ltd. https://druglandscape.com/drug/e2025 https://druglandscape.com/api/og?type=drug&title=E2025&subtitle=E2025%20%C2%B7%20Eisai%20Inc.&badge=phase%201 E2025 E2025 · Eisai Inc. https://druglandscape.com/drug/e2086 https://druglandscape.com/api/og?type=drug&title=E2086&subtitle=E2086%20%C2%B7%20Eisai%20Inc.&badge=phase%201 E2086 E2086 · Eisai Inc. https://druglandscape.com/drug/e2307 https://druglandscape.com/api/og?type=drug&title=E2307&subtitle=E2307%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%201 E2307 E2307 · Eisai Co., Ltd. https://druglandscape.com/drug/e2511 https://druglandscape.com/api/og?type=drug&title=E2511&subtitle=E2511%20%C2%B7%20Eisai%20Inc.&badge=phase%201 E2511 E2511 · Eisai Inc. https://druglandscape.com/drug/e3112 https://druglandscape.com/api/og?type=drug&title=E3112&subtitle=E3112%20%C2%B7%20EA%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 E3112 E3112 · EA Pharma Co., Ltd. https://druglandscape.com/drug/e3710 https://druglandscape.com/api/og?type=drug&title=E3710&subtitle=E3710%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%201 E3710 E3710 · Eisai Co., Ltd. https://druglandscape.com/drug/e39-peptide-vaccine https://druglandscape.com/api/og?type=drug&title=E39%20peptide%20vaccine&subtitle=E39%20peptide%20vaccine%20%C2%B7%20COL%20George%20Peoples%2C%20MD%2C%20FACS&badge=phase%201 E39 peptide vaccine E39 peptide vaccine · COL George Peoples, MD, FACS https://druglandscape.com/drug/e39-vaccine-then-j65-vaccine https://druglandscape.com/api/og?type=drug&title=E39%20vaccine%20then%20J65%20vaccine&subtitle=E39%20vaccine%20then%20J65%20vaccine%20%C2%B7%20COL%20George%20Peoples%2C%20MD%2C%20FACS&badge=phase%201 E39 vaccine then J65 vaccine E39 vaccine then J65 vaccine · COL George Peoples, MD, FACS https://druglandscape.com/drug/e5501 https://druglandscape.com/api/og?type=drug&title=E5501&subtitle=E5501%20%C2%B7%20Eisai%20Inc.&badge=phase%201 E5501 E5501 · Eisai Inc. https://druglandscape.com/drug/e6005-0-2 https://druglandscape.com/api/og?type=drug&title=E6005%200.2%25&subtitle=E6005%200.2%25%20%C2%B7%20Organon%20and%20Co&badge=phase%201 E6005 0.2% E6005 0.2% · Organon and Co https://druglandscape.com/drug/e6007 https://druglandscape.com/api/og?type=drug&title=E6007&subtitle=E6007%20%C2%B7%20Eisai%20Inc.&badge=phase%202 E6007 E6007 · Eisai Inc. https://druglandscape.com/drug/e6201-0-005 https://druglandscape.com/api/og?type=drug&title=E6201%200.005%25&subtitle=E6201%200.005%25%20%C2%B7%20Eisai%20Inc.&badge=phase%202 E6201 0.005% E6201 0.005% · Eisai Inc. https://druglandscape.com/drug/e6742 https://druglandscape.com/api/og?type=drug&title=E6742&subtitle=E6742%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%201 E6742 E6742 · Eisai Co., Ltd. https://druglandscape.com/drug/e7080-capsule https://druglandscape.com/api/og?type=drug&title=E7080%20capsule&subtitle=E7080%20capsule%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%202 E7080 capsule E7080 capsule · Eisai Co., Ltd. https://druglandscape.com/drug/e7130 https://druglandscape.com/api/og?type=drug&title=E7130&subtitle=E7130%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%201 E7130 E7130 · Eisai Co., Ltd. https://druglandscape.com/drug/e7386 https://druglandscape.com/api/og?type=drug&title=E7386&subtitle=E7386%20%C2%B7%20Eisai%20Inc.&badge=phase%201 E7386 E7386 · Eisai Inc. https://druglandscape.com/drug/e7389-21-day-cycle https://druglandscape.com/api/og?type=drug&title=E7389%2021%20Day%20Cycle&subtitle=E7389%2021%20Day%20Cycle%20%C2%B7%20Eisai%20Inc.&badge=phase%202 E7389 21 Day Cycle E7389 21 Day Cycle · Eisai Inc. https://druglandscape.com/drug/e7389-28-day-cycle https://druglandscape.com/api/og?type=drug&title=E7389%2028%20Day%20Cycle&subtitle=E7389%2028%20Day%20Cycle%20%C2%B7%20Eisai%20Inc.&badge=phase%202 E7389 28 Day Cycle E7389 28 Day Cycle · Eisai Inc. https://druglandscape.com/drug/e7389-lf https://druglandscape.com/api/og?type=drug&title=E7389-LF&subtitle=E7389-LF%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%201 E7389-LF E7389-LF · Eisai Co., Ltd. https://druglandscape.com/drug/e7974 https://druglandscape.com/api/og?type=drug&title=E7974&subtitle=E7974%20%C2%B7%20Eisai%20Inc.&badge=phase%201 E7974 E7974 · Eisai Inc. https://druglandscape.com/drug/e8001 https://druglandscape.com/api/og?type=drug&title=E8001&subtitle=E8001%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%201 E8001 E8001 · Eisai Co., Ltd. https://druglandscape.com/drug/ea1080 https://druglandscape.com/api/og?type=drug&title=EA1080&subtitle=EA1080%20%C2%B7%20EA%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 EA1080 EA1080 · EA Pharma Co., Ltd. https://druglandscape.com/drug/eapa115 https://druglandscape.com/api/og?type=drug&title=EAPA115&subtitle=EAPA115%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 EAPA115 EAPA115 · HK inno.N Corporation https://druglandscape.com/drug/early-antibiotic-cessation-alert https://druglandscape.com/api/og?type=drug&title=Early%20antibiotic%20cessation%20alert&subtitle=Early%20antibiotic%20cessation%20alert%20%C2%B7%20Peter%20MacCallum%20Cancer%20Centre%2C%20Australia&badge=phase%201 Early antibiotic cessation alert Early antibiotic cessation alert · Peter MacCallum Cancer Centre, Australia https://druglandscape.com/drug/early-combination-therapy https://druglandscape.com/api/og?type=drug&title=Early%20combination%20therapy&subtitle=Early%20combination%20therapy%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Early combination therapy Early combination therapy · GlaxoSmithKline https://druglandscape.com/drug/early-maintenance-treatment https://druglandscape.com/api/og?type=drug&title=Early%20maintenance%20treatment&subtitle=Early%20maintenance%20treatment%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Early maintenance treatment Early maintenance treatment · GlaxoSmithKline https://druglandscape.com/drug/early-rhythm-control-group https://druglandscape.com/api/og?type=drug&title=early%20rhythm%20control%20group&subtitle=early%20rhythm%20control%20group%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%201 early rhythm control group early rhythm control group · Samsung Medical Center https://druglandscape.com/drug/eb-001 https://druglandscape.com/api/og?type=drug&title=EB-001&subtitle=EB-001%20%C2%B7%20Bonti%2C%20Inc.&badge=phase%202 EB-001 EB-001 · Bonti, Inc. https://druglandscape.com/drug/eb-1020-ir https://druglandscape.com/api/og?type=drug&title=EB-1020%20IR&subtitle=EB-1020%20IR%20%C2%B7%20Neurovance%2C%20Inc.&badge=phase%201 EB-1020 IR EB-1020 IR · Neurovance, Inc. https://druglandscape.com/drug/eb-1020-sr1 https://druglandscape.com/api/og?type=drug&title=EB-1020%20SR1&subtitle=EB-1020%20SR1%20%C2%B7%20Neurovance%2C%20Inc.&badge=phase%201 EB-1020 SR1 EB-1020 SR1 · Neurovance, Inc. https://druglandscape.com/drug/eb-1020-sr2 https://druglandscape.com/api/og?type=drug&title=EB-1020%20SR2&subtitle=EB-1020%20SR2%20%C2%B7%20Neurovance%2C%20Inc.&badge=phase%201 EB-1020 SR2 EB-1020 SR2 · Neurovance, Inc. https://druglandscape.com/drug/eb-1020-sr3 https://druglandscape.com/api/og?type=drug&title=EB-1020%20SR3&subtitle=EB-1020%20SR3%20%C2%B7%20Neurovance%2C%20Inc.&badge=phase%201 EB-1020 SR3 EB-1020 SR3 · Neurovance, Inc. https://druglandscape.com/drug/eb-203 https://druglandscape.com/api/og?type=drug&title=EB-203&subtitle=EB-203%20%C2%B7%20EyebioKorea%2C%20Inc.&badge=phase%202 EB-203 EB-203 · EyebioKorea, Inc. https://druglandscape.com/drug/eb01-cream-0-2 https://druglandscape.com/api/og?type=drug&title=EB01%20Cream%200.2%25&subtitle=EB01%20Cream%200.2%25%20%C2%B7%20Edesa%20Biotech%20Inc.&badge=phase%202 EB01 Cream 0.2% EB01 Cream 0.2% · Edesa Biotech Inc. https://druglandscape.com/drug/eb01-cream-1-0 https://druglandscape.com/api/og?type=drug&title=EB01%20Cream%201.0%25&subtitle=EB01%20Cream%201.0%25%20%C2%B7%20Edesa%20Biotech%20Inc.&badge=phase%202 EB01 Cream 1.0% EB01 Cream 1.0% · Edesa Biotech Inc. https://druglandscape.com/drug/eb070 https://druglandscape.com/api/og?type=drug&title=EB070&subtitle=EB070%20%C2%B7%20Biotech%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 EB070 EB070 · Biotech Pharmaceutical Co., Ltd. https://druglandscape.com/drug/eb103 https://druglandscape.com/api/og?type=drug&title=EB103&subtitle=EB103%20%C2%B7%20Estrella%20Biopharma%2C%20Inc.&badge=phase%201 EB103 EB103 · Estrella Biopharma, Inc. https://druglandscape.com/drug/ebc-129 https://druglandscape.com/api/og?type=drug&title=EBC-129&subtitle=EBC-129%20%C2%B7%20EDDC%20(Experimental%20Drug%20Development%20Centre)%2C%20A*STAR%20Research%20Entities&badge=phase%201 EBC-129 EBC-129 · EDDC (Experimental Drug Development Centre), A*STAR Research Entities https://druglandscape.com/drug/ebfahf-2 https://druglandscape.com/api/og?type=drug&title=EBFAHF-2&subtitle=EBFAHF-2%20%C2%B7%20Icahn%20School%20of%20Medicine%20at%20Mount%20Sinai&badge=phase%201 EBFAHF-2 EBFAHF-2 · Icahn School of Medicine at Mount Sinai https://druglandscape.com/drug/ebola-vaccine-high-dose https://druglandscape.com/api/og?type=drug&title=Ebola%20Vaccine%20-%20high%20dose&subtitle=Ebola%20Vaccine%20-%20high%20dose%20%C2%B7%20Auro%20Vaccines%20LLC&badge=phase%201 Ebola Vaccine - high dose Ebola Vaccine - high dose · Auro Vaccines LLC https://druglandscape.com/drug/ebola-vaccine-low-dose https://druglandscape.com/api/og?type=drug&title=Ebola%20Vaccine%20-%20low%20dose&subtitle=Ebola%20Vaccine%20-%20low%20dose%20%C2%B7%20Auro%20Vaccines%20LLC&badge=phase%201 Ebola Vaccine - low dose Ebola Vaccine - low dose · Auro Vaccines LLC https://druglandscape.com/drug/ebola-vaccine-mid-dose https://druglandscape.com/api/og?type=drug&title=Ebola%20Vaccine%20-%20mid%20dose&subtitle=Ebola%20Vaccine%20-%20mid%20dose%20%C2%B7%20Auro%20Vaccines%20LLC&badge=phase%201 Ebola Vaccine - mid dose Ebola Vaccine - mid dose · Auro Vaccines LLC https://druglandscape.com/drug/ebp11 https://druglandscape.com/api/og?type=drug&title=EBP11&subtitle=EBP11%20%C2%B7%20Entera%20Bio%20Ltd.&badge=phase%201 EBP11 EBP11 · Entera Bio Ltd. https://druglandscape.com/drug/ebp11-f1 https://druglandscape.com/api/og?type=drug&title=EBP11-F1&subtitle=EBP11-F1%20%C2%B7%20Entera%20Bio%20Ltd.&badge=phase%201 EBP11-F1 EBP11-F1 · Entera Bio Ltd. https://druglandscape.com/drug/ebp11-f2 https://druglandscape.com/api/og?type=drug&title=EBP11-F2&subtitle=EBP11-F2%20%C2%B7%20Entera%20Bio%20Ltd.&badge=phase%201 EBP11-F2 EBP11-F2 · Entera Bio Ltd. https://druglandscape.com/drug/ebp11-f4 https://druglandscape.com/api/og?type=drug&title=EBP11-F4&subtitle=EBP11-F4%20%C2%B7%20Entera%20Bio%20Ltd.&badge=phase%201 EBP11-F4 EBP11-F4 · Entera Bio Ltd. https://druglandscape.com/drug/ebp11-f5 https://druglandscape.com/api/og?type=drug&title=EBP11-F5&subtitle=EBP11-F5%20%C2%B7%20Entera%20Bio%20Ltd.&badge=phase%201 EBP11-F5 EBP11-F5 · Entera Bio Ltd. https://druglandscape.com/drug/ebp22 https://druglandscape.com/api/og?type=drug&title=EBP22&subtitle=EBP22%20%C2%B7%20Entera%20Bio%20Ltd.&badge=phase%201 EBP22 EBP22 · Entera Bio Ltd. https://druglandscape.com/drug/ebt-101 https://druglandscape.com/api/og?type=drug&title=EBT-101&subtitle=EBT-101%20%C2%B7%20Excision%20BioTherapeutics&badge=phase%201 EBT-101 EBT-101 · Excision BioTherapeutics https://druglandscape.com/drug/ebv-specific-ctl-infusion https://druglandscape.com/api/og?type=drug&title=EBV%20specific%20CTL%20Infusion&subtitle=EBV%20specific%20CTL%20Infusion%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 EBV specific CTL Infusion EBV specific CTL Infusion · Baylor College of Medicine https://druglandscape.com/drug/ebv-specific-t-cells-a https://druglandscape.com/api/og?type=drug&title=EBV-specific%20T%20cells%3A%20A&subtitle=EBV-specific%20T%20cells%3A%20A%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 EBV-specific T cells: A EBV-specific T cells: A · Baylor College of Medicine https://druglandscape.com/drug/ebv-specific-t-cells-b https://druglandscape.com/api/og?type=drug&title=EBV-specific%20T%20cells%3A%20B&subtitle=EBV-specific%20T%20cells%3A%20B%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 EBV-specific T cells: B EBV-specific T cells: B · Baylor College of Medicine https://druglandscape.com/drug/ebvint-cell https://druglandscape.com/api/og?type=drug&title=EBViNT%20Cell&subtitle=EBViNT%20Cell%20%C2%B7%20Eutilex&badge=phase%201 EBViNT Cell EBViNT Cell · Eutilex https://druglandscape.com/drug/ebvst-cells https://druglandscape.com/api/og?type=drug&title=EBVST%20Cells&subtitle=EBVST%20Cells%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 EBVST Cells EBVST Cells · Baylor College of Medicine https://druglandscape.com/drug/ec-104-high-dose https://druglandscape.com/api/og?type=drug&title=EC-104%20high%20dose&subtitle=EC-104%20high%20dose%20%C2%B7%20Eclipse%20Life%20Sciences%2C%20Inc.&badge=phase%201 EC-104 high dose EC-104 high dose · Eclipse Life Sciences, Inc. https://druglandscape.com/drug/ec-104-low-dose https://druglandscape.com/api/og?type=drug&title=EC-104%20low%20dose&subtitle=EC-104%20low%20dose%20%C2%B7%20Eclipse%20Life%20Sciences%2C%20Inc.&badge=phase%201 EC-104 low dose EC-104 low dose · Eclipse Life Sciences, Inc. https://druglandscape.com/drug/ec-d-3263-hcl https://druglandscape.com/api/og?type=drug&title=EC%20D-3263%20HCl&subtitle=EC%20D-3263%20HCl%20%C2%B7%20Dendreon&badge=phase%201 EC D-3263 HCl EC D-3263 HCl · Dendreon https://druglandscape.com/drug/ec-esomeprazole https://druglandscape.com/api/og?type=drug&title=EC%20esomeprazole&subtitle=EC%20esomeprazole%20%C2%B7%20POZEN&badge=phase%201 EC esomeprazole EC esomeprazole · POZEN https://druglandscape.com/drug/ec-naproxen https://druglandscape.com/api/og?type=drug&title=EC%20naproxen&subtitle=EC%20naproxen%20%C2%B7%20POZEN&badge=phase%201 EC naproxen EC naproxen · POZEN https://druglandscape.com/drug/ec-naproxen-plus-ec-esomeprazole https://druglandscape.com/api/og?type=drug&title=EC%20naproxen%20plus%20EC%20esomeprazole&subtitle=EC%20naproxen%20plus%20EC%20esomeprazole%20%C2%B7%20POZEN&badge=phase%201 EC naproxen plus EC esomeprazole EC naproxen plus EC esomeprazole · POZEN https://druglandscape.com/drug/ec1169 https://druglandscape.com/api/og?type=drug&title=EC1169&subtitle=EC1169%20%C2%B7%20Endocyte&badge=phase%201 EC1169 EC1169 · Endocyte https://druglandscape.com/drug/ec1456 https://druglandscape.com/api/og?type=drug&title=EC1456&subtitle=EC1456%20%C2%B7%20Endocyte&badge=phase%201 EC1456 EC1456 · Endocyte https://druglandscape.com/drug/ec1456-and-ec20 https://druglandscape.com/api/og?type=drug&title=EC1456%20and%20EC20&subtitle=EC1456%20and%20EC20%20%C2%B7%20Endocyte&badge=phase%201 EC1456 and EC20 EC1456 and EC20 · Endocyte https://druglandscape.com/drug/ec5026-oral-tablet https://druglandscape.com/api/og?type=drug&title=EC5026%20oral%20tablet&subtitle=EC5026%20oral%20tablet%20%C2%B7%20EicOsis%20Human%20Health%20Inc.&badge=phase%201 EC5026 oral tablet EC5026 oral tablet · EicOsis Human Health Inc. https://druglandscape.com/drug/ec905 https://druglandscape.com/api/og?type=drug&title=EC905&subtitle=EC905%20%C2%B7%20Astellas%20Pharma%20Europe%20B.V.&badge=phase%201 EC905 EC905 · Astellas Pharma Europe B.V. https://druglandscape.com/drug/ecc4703-f0-formulation https://druglandscape.com/api/og?type=drug&title=ECC4703%20F0%20formulation&subtitle=ECC4703%20F0%20formulation%20%C2%B7%20Eccogene&badge=phase%201 ECC4703 F0 formulation ECC4703 F0 formulation · Eccogene https://druglandscape.com/drug/ecc4703-f1-formulation https://druglandscape.com/api/og?type=drug&title=ECC4703%20F1%20formulation&subtitle=ECC4703%20F1%20formulation%20%C2%B7%20Eccogene&badge=phase%201 ECC4703 F1 formulation ECC4703 F1 formulation · Eccogene https://druglandscape.com/drug/ecc4703-f2-formulation https://druglandscape.com/api/og?type=drug&title=ECC4703%20F2%20formulation&subtitle=ECC4703%20F2%20formulation%20%C2%B7%20Eccogene&badge=phase%201 ECC4703 F2 formulation ECC4703 F2 formulation · Eccogene https://druglandscape.com/drug/ecc4703-f3-formulation https://druglandscape.com/api/og?type=drug&title=ECC4703%20F3%20formulation&subtitle=ECC4703%20F3%20formulation%20%C2%B7%20Eccogene&badge=phase%201 ECC4703 F3 formulation ECC4703 F3 formulation · Eccogene https://druglandscape.com/drug/ecc5004 https://druglandscape.com/api/og?type=drug&title=ECC5004&subtitle=ECC5004%20%C2%B7%20Eccogene&badge=phase%201 ECC5004 ECC5004 · Eccogene https://druglandscape.com/drug/echinocandin-treatment https://druglandscape.com/api/og?type=drug&title=Echinocandin%20treatment&subtitle=Echinocandin%20treatment%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 Echinocandin treatment Echinocandin treatment · Hospices Civils de Lyon https://druglandscape.com/drug/ecnoglutide-tablets https://druglandscape.com/api/og?type=drug&title=ecnoglutide%20tablets&subtitle=ecnoglutide%20tablets%20%C2%B7%20Hangzhou%20Sciwind%20Biosciences%20Co.%2C%20Ltd.&badge=phase%201 ecnoglutide tablets ecnoglutide tablets · Hangzhou Sciwind Biosciences Co., Ltd. https://druglandscape.com/drug/ecopipam-immediate-release-form https://druglandscape.com/api/og?type=drug&title=Ecopipam%20immediate%20release%20form&subtitle=Ecopipam%20immediate%20release%20form%20%C2%B7%20Emalex%20Biosciences%20Inc.&badge=phase%201 Ecopipam immediate release form Ecopipam immediate release form · Emalex Biosciences Inc. https://druglandscape.com/drug/ecopipam-tablet https://druglandscape.com/api/og?type=drug&title=Ecopipam%20tablet&subtitle=Ecopipam%20tablet%20%C2%B7%20Emalex%20Biosciences%20Inc.&badge=phase%201 Ecopipam tablet Ecopipam tablet · Emalex Biosciences Inc. https://druglandscape.com/drug/ecp-019 https://druglandscape.com/api/og?type=drug&title=ECP-019&subtitle=ECP-019%20%C2%B7%20ColonaryConcepts%20LLC&badge=phase%202 ECP-019 ECP-019 · ColonaryConcepts LLC https://druglandscape.com/drug/ecp-1014 https://druglandscape.com/api/og?type=drug&title=ECP-1014&subtitle=ECP-1014%20%C2%B7%20Euclises%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ECP-1014 ECP-1014 · Euclises Pharmaceuticals, Inc. https://druglandscape.com/drug/ecp-methoxsalen https://druglandscape.com/api/og?type=drug&title=ECP%20Methoxsalen&subtitle=ECP%20Methoxsalen%20%C2%B7%20Mallinckrodt&badge=phase%201 ECP Methoxsalen ECP Methoxsalen · Mallinckrodt https://druglandscape.com/drug/ect-001-cb https://druglandscape.com/api/og?type=drug&title=ECT-001-CB&subtitle=ECT-001-CB%20%C2%B7%20Ciusss%20de%20L'Est%20de%20l'%C3%8Ele%20de%20Montr%C3%A9al&badge=phase%201 ECT-001-CB ECT-001-CB · Ciusss de L'Est de l'Île de Montréal https://druglandscape.com/drug/ect204-t-cells https://druglandscape.com/api/og?type=drug&title=ECT204%20T%20cells&subtitle=ECT204%20T%20cells%20%C2%B7%20Eureka%20Therapeutics%20Inc.&badge=phase%201 ECT204 T cells ECT204 T cells · Eureka Therapeutics Inc. https://druglandscape.com/drug/ecteinascidin-743 https://druglandscape.com/api/og?type=drug&title=ECTEINASCIDIN%20743&subtitle=ECTEINASCIDIN%20743%20%C2%B7%20Children's%20Oncology%20Group&badge=phase%201 ECTEINASCIDIN 743 ECTEINASCIDIN 743 · Children's Oncology Group https://druglandscape.com/drug/ectoin-mouth-wash https://druglandscape.com/api/og?type=drug&title=Ectoin%20Mouth%20Wash&subtitle=Ectoin%20Mouth%20Wash%20%C2%B7%20Bitop%20AG&badge=phase%201 Ectoin Mouth Wash Ectoin Mouth Wash · Bitop AG https://druglandscape.com/drug/edc-conm-sosip https://druglandscape.com/api/og?type=drug&title=EDC%20ConM%20SOSIP&subtitle=EDC%20ConM%20SOSIP%20%C2%B7%20Imperial%20College%20London&badge=phase%201 EDC ConM SOSIP EDC ConM SOSIP · Imperial College London https://druglandscape.com/drug/edg-15400 https://druglandscape.com/api/og?type=drug&title=EDG-15400&subtitle=EDG-15400%20%C2%B7%20Edgewise%20Therapeutics%2C%20Inc.&badge=phase%201 EDG-15400 EDG-15400 · Edgewise Therapeutics, Inc. https://druglandscape.com/drug/edg-5506 https://druglandscape.com/api/og?type=drug&title=EDG-5506&subtitle=EDG-5506%20%C2%B7%20Edgewise%20Therapeutics%2C%20Inc.&badge=phase%201 EDG-5506 EDG-5506 · Edgewise Therapeutics, Inc. https://druglandscape.com/drug/edit-101 https://druglandscape.com/api/og?type=drug&title=EDIT-101&subtitle=EDIT-101%20%C2%B7%20Editas%20Medicine%2C%20Inc.&badge=phase%201 EDIT-101 EDIT-101 · Editas Medicine, Inc. https://druglandscape.com/drug/edp-297 https://druglandscape.com/api/og?type=drug&title=EDP-297&subtitle=EDP-297%20%C2%B7%20Enanta%20Pharmaceuticals%2C%20Inc&badge=phase%201 EDP-297 EDP-297 · Enanta Pharmaceuticals, Inc https://druglandscape.com/drug/edp-305 https://druglandscape.com/api/og?type=drug&title=EDP-305&subtitle=EDP-305%20%C2%B7%20Enanta%20Pharmaceuticals%2C%20Inc&badge=phase%202 EDP-305 EDP-305 · Enanta Pharmaceuticals, Inc https://druglandscape.com/drug/edp-322 https://druglandscape.com/api/og?type=drug&title=EDP-322&subtitle=EDP-322%20%C2%B7%20Enanta%20Pharmaceuticals%2C%20Inc&badge=phase%201 EDP-322 EDP-322 · Enanta Pharmaceuticals, Inc https://druglandscape.com/drug/edp-323 https://druglandscape.com/api/og?type=drug&title=EDP-323&subtitle=EDP-323%20%C2%B7%20Enanta%20Pharmaceuticals%2C%20Inc&badge=phase%201 EDP-323 EDP-323 · Enanta Pharmaceuticals, Inc https://druglandscape.com/drug/edp1815-capsule-a https://druglandscape.com/api/og?type=drug&title=EDP1815%20capsule%20A&subtitle=EDP1815%20capsule%20A%20%C2%B7%20Evelo%20Biosciences%2C%20Inc.&badge=phase%201 EDP1815 capsule A EDP1815 capsule A · Evelo Biosciences, Inc. https://druglandscape.com/drug/edp1867 https://druglandscape.com/api/og?type=drug&title=EDP1867&subtitle=EDP1867%20%C2%B7%20Evelo%20Biosciences%2C%20Inc.&badge=phase%201 EDP1867 EDP1867 · Evelo Biosciences, Inc. https://druglandscape.com/drug/edp239 https://druglandscape.com/api/og?type=drug&title=EDP239&subtitle=EDP239%20%C2%B7%20Enanta%20Pharmaceuticals%2C%20Inc&badge=phase%201 EDP239 EDP239 · Enanta Pharmaceuticals, Inc https://druglandscape.com/drug/edp2939 https://druglandscape.com/api/og?type=drug&title=EDP2939&subtitle=EDP2939%20%C2%B7%20Evelo%20Biosciences%2C%20Inc.&badge=phase%201 EDP2939 EDP2939 · Evelo Biosciences, Inc. https://druglandscape.com/drug/edta-ophthalmic-solution-1-3 https://druglandscape.com/api/og?type=drug&title=EDTA%20Ophthalmic%20Solution%201.3%25&subtitle=EDTA%20Ophthalmic%20Solution%201.3%25%20%C2%B7%20Livionex%20Inc.&badge=phase%201 EDTA Ophthalmic Solution 1.3% EDTA Ophthalmic Solution 1.3% · Livionex Inc. https://druglandscape.com/drug/edta-ophthalmic-solution-2-6 https://druglandscape.com/api/og?type=drug&title=EDTA%20Ophthalmic%20Solution%202.6%25&subtitle=EDTA%20Ophthalmic%20Solution%202.6%25%20%C2%B7%20Livionex%20Inc.&badge=phase%201 EDTA Ophthalmic Solution 2.6% EDTA Ophthalmic Solution 2.6% · Livionex Inc. https://druglandscape.com/drug/edv-gc https://druglandscape.com/api/og?type=drug&title=EDV-GC&subtitle=EDV-GC%20%C2%B7%20Engeneic%20Pty%20Limited&badge=phase%201 EDV-GC EDV-GC · Engeneic Pty Limited https://druglandscape.com/drug/ef-m2 https://druglandscape.com/api/og?type=drug&title=EF-M2&subtitle=EF-M2%20%C2%B7%20S.LAB%20(SOLOWAYS)&badge=phase%201 EF-M2 EF-M2 · S.LAB (SOLOWAYS) https://druglandscape.com/drug/efavirenz-based-regimens https://druglandscape.com/api/og?type=drug&title=Efavirenz-based%20regimens&subtitle=Efavirenz-based%20regimens%20%C2%B7%20Funda%C3%A7%C3%A3o%20Bahiana%20de%20Infectologia&badge=phase%202 Efavirenz-based regimens Efavirenz-based regimens · Fundação Bahiana de Infectologia https://druglandscape.com/drug/efavirenz-containing-antiretroviral-regimen https://druglandscape.com/api/og?type=drug&title=efavirenz%20containing%20antiretroviral%20regimen&subtitle=efavirenz%20containing%20antiretroviral%20regimen%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 efavirenz containing antiretroviral regimen efavirenz containing antiretroviral regimen · Bristol-Myers Squibb https://druglandscape.com/drug/efavirenz-didanosine-ec-lamivudine https://druglandscape.com/api/og?type=drug&title=efavirenz%3B%20didanosine%20EC%3B%20lamivudine&subtitle=efavirenz%3B%20didanosine%20EC%3B%20lamivudine%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 efavirenz; didanosine EC; lamivudine efavirenz; didanosine EC; lamivudine · Bristol-Myers Squibb https://druglandscape.com/drug/efavirenz-tablet https://druglandscape.com/api/og?type=drug&title=Efavirenz%20tablet&subtitle=Efavirenz%20tablet%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Efavirenz tablet Efavirenz tablet · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/efavirenz-tenofovir-disoproxil-fumarate-telaprevir https://druglandscape.com/api/og?type=drug&title=Efavirenz%3B%20Tenofovir%20disoproxil%20fumarate%3B%20Telaprevir&subtitle=Efavirenz%3B%20Tenofovir%20disoproxil%20fumarate%3B%20Telaprevir%20%C2%B7%20Tibotec%20BVBA&badge=phase%201 Efavirenz; Tenofovir disoproxil fumarate; Telaprevir Efavirenz; Tenofovir disoproxil fumarate; Telaprevir · Tibotec BVBA https://druglandscape.com/drug/effects-of-anticholinergic-medication https://druglandscape.com/api/og?type=drug&title=Effects%20of%20anticholinergic%20medication&subtitle=Effects%20of%20anticholinergic%20medication%20%C2%B7%20Monash%20Medical%20Centre&badge=phase%202 Effects of anticholinergic medication Effects of anticholinergic medication · Monash Medical Centre https://druglandscape.com/drug/effervescent-ibuprofen-tablets https://druglandscape.com/api/og?type=drug&title=effervescent%20ibuprofen%20tablets&subtitle=effervescent%20ibuprofen%20tablets%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%203 effervescent ibuprofen tablets effervescent ibuprofen tablets · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/efgartigimod-ph20-sc-in-stage-b https://druglandscape.com/api/og?type=drug&title=efgartigimod%20PH20%20SC%20in%20stage%20B&subtitle=efgartigimod%20PH20%20SC%20in%20stage%20B%20%C2%B7%20argenx&badge=phase%202 efgartigimod PH20 SC in stage B efgartigimod PH20 SC in stage B · argenx https://druglandscape.com/drug/efluelda-tetra-pre-filled-syringe https://druglandscape.com/api/og?type=drug&title=Efluelda%20Tetra%20Pre-filled%20syringe&subtitle=Efluelda%20Tetra%20Pre-filled%20syringe%20%C2%B7%20Sanofi&badge=phase%202 Efluelda Tetra Pre-filled syringe Efluelda Tetra Pre-filled syringe · Sanofi https://druglandscape.com/drug/efrin-drops https://druglandscape.com/api/og?type=drug&title=Efrin%20drops&subtitle=Efrin%20drops%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%202 Efrin drops Efrin drops · Sheba Medical Center https://druglandscape.com/drug/eftilagimod-alpha https://druglandscape.com/api/og?type=drug&title=eftilagimod%20alpha&subtitle=eftilagimod%20alpha%20%C2%B7%20Immutep%20S.A.S.&badge=phase%202 eftilagimod alpha eftilagimod alpha · Immutep S.A.S. https://druglandscape.com/drug/eg-101 https://druglandscape.com/api/og?type=drug&title=EG-101&subtitle=EG-101%20%C2%B7%20Evergreen%20Therapeutics%2C%20Inc.&badge=phase%201 EG-101 EG-101 · Evergreen Therapeutics, Inc. https://druglandscape.com/drug/eg-covid-001 https://druglandscape.com/api/og?type=drug&title=EG-COVID-001&subtitle=EG-COVID-001%20%C2%B7%20EyeGene%20Inc.&badge=phase%201 EG-COVID-001 EG-COVID-001 · EyeGene Inc. https://druglandscape.com/drug/eg-covid-003 https://druglandscape.com/api/og?type=drug&title=EG-COVID-003&subtitle=EG-COVID-003%20%C2%B7%20EyeGene%20Inc.&badge=phase%201 EG-COVID-003 EG-COVID-003 · EyeGene Inc. https://druglandscape.com/drug/eg-covii https://druglandscape.com/api/og?type=drug&title=EG-COVII&subtitle=EG-COVII%20%C2%B7%20EyeGene%20Inc.&badge=phase%201 EG-COVII EG-COVII · EyeGene Inc. https://druglandscape.com/drug/eg110a https://druglandscape.com/api/og?type=drug&title=EG110A&subtitle=EG110A%20%C2%B7%20EG%20427&badge=phase%201 EG110A EG110A · EG 427 https://druglandscape.com/drug/egfr-monoclonal-antibody https://druglandscape.com/api/og?type=drug&title=EGFR%20Monoclonal%20antibody&subtitle=EGFR%20Monoclonal%20antibody%20%C2%B7%20Suzhou%20Genhouse%20Bio%20Co.%2C%20Ltd.&badge=phase%202 EGFR Monoclonal antibody EGFR Monoclonal antibody · Suzhou Genhouse Bio Co., Ltd. https://druglandscape.com/drug/egg-shell-nanoparticles https://druglandscape.com/api/og?type=drug&title=Egg%20Shell%20nanoparticles&subtitle=Egg%20Shell%20nanoparticles%20%C2%B7%20Egymedicalpedia&badge=phase%201 Egg Shell nanoparticles Egg Shell nanoparticles · Egymedicalpedia https://druglandscape.com/drug/ehp-101-liquid-multiple-doses https://druglandscape.com/api/og?type=drug&title=EHP-101%20Liquid%20multiple%20doses&subtitle=EHP-101%20Liquid%20multiple%20doses%20%C2%B7%20Emerald%20Health%20Pharmaceuticals&badge=phase%201 EHP-101 Liquid multiple doses EHP-101 Liquid multiple doses · Emerald Health Pharmaceuticals https://druglandscape.com/drug/ehp-101-liquid-single-dose https://druglandscape.com/api/og?type=drug&title=EHP-101%20Liquid%20single%20dose&subtitle=EHP-101%20Liquid%20single%20dose%20%C2%B7%20Emerald%20Health%20Pharmaceuticals&badge=phase%201 EHP-101 Liquid single dose EHP-101 Liquid single dose · Emerald Health Pharmaceuticals https://druglandscape.com/drug/ei-1071 https://druglandscape.com/api/og?type=drug&title=EI-1071&subtitle=EI-1071%20%C2%B7%20Elixiron%20Immunotherapeutics%20(Hong%20Kong)%20Ltd.&badge=phase%201 EI-1071 EI-1071 · Elixiron Immunotherapeutics (Hong Kong) Ltd. https://druglandscape.com/drug/eidd-2801 https://druglandscape.com/api/og?type=drug&title=EIDD-2801&subtitle=EIDD-2801%20%C2%B7%20Ridgeback%20Biotherapeutics%2C%20LP&badge=phase%202 EIDD-2801 EIDD-2801 · Ridgeback Biotherapeutics, LP https://druglandscape.com/drug/eis-12656 https://druglandscape.com/api/og?type=drug&title=EIS-12656&subtitle=EIS-12656%20%C2%B7%20Eisbach%20Bio%20GmbH&badge=phase%201 EIS-12656 EIS-12656 · Eisbach Bio GmbH https://druglandscape.com/drug/either-fentanyl-or-morphine https://druglandscape.com/api/og?type=drug&title=either%20fentanyl%20or%20morphine&subtitle=either%20fentanyl%20or%20morphine%20%C2%B7%20MetroHealth%20Medical%20Center&badge=phase%201 either fentanyl or morphine either fentanyl or morphine · MetroHealth Medical Center https://druglandscape.com/drug/ela026 https://druglandscape.com/api/og?type=drug&title=ELA026&subtitle=ELA026%20%C2%B7%20Electra%20Therapeutics%20Inc.&badge=phase%202 ELA026 ELA026 · Electra Therapeutics Inc. https://druglandscape.com/drug/elacestrant-dihydrochloride https://druglandscape.com/api/og?type=drug&title=Elacestrant%20dihydrochloride&subtitle=Elacestrant%20dihydrochloride%20%C2%B7%20Stemline%20Therapeutics%2C%20Inc.&badge=phase%201 Elacestrant dihydrochloride Elacestrant dihydrochloride · Stemline Therapeutics, Inc. https://druglandscape.com/drug/elb353 https://druglandscape.com/api/og?type=drug&title=ELB353&subtitle=ELB353%20%C2%B7%20Biotie%20Therapies%20Corp.&badge=phase%201 ELB353 ELB353 · Biotie Therapies Corp. https://druglandscape.com/drug/electrofusion-dc-vaccine https://druglandscape.com/api/og?type=drug&title=Electrofusion%20DC%20vaccine&subtitle=Electrofusion%20DC%20vaccine%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%201 Electrofusion DC vaccine Electrofusion DC vaccine · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/elemental-iron-and-vit-d https://druglandscape.com/api/og?type=drug&title=Elemental%20iron%20and%20Vit%20D&subtitle=Elemental%20iron%20and%20Vit%20D%20%C2%B7%20Nadirah%20Rasyid%20Ridha&badge=phase%201 Elemental iron and Vit D Elemental iron and Vit D · Nadirah Rasyid Ridha https://druglandscape.com/drug/eletriptan-commercial-tablet https://druglandscape.com/api/og?type=drug&title=Eletriptan%20commercial%20tablet&subtitle=Eletriptan%20commercial%20tablet%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%201 Eletriptan commercial tablet Eletriptan commercial tablet · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/elidel-1-topical-cream https://druglandscape.com/api/og?type=drug&title=Elidel%201%25%20Topical%20Cream&subtitle=Elidel%201%25%20Topical%20Cream%20%C2%B7%20MEDA%20PHARMA%20SPA%2C%20a%20Viatris%20company&badge=phase%202 Elidel 1% Topical Cream Elidel 1% Topical Cream · MEDA PHARMA SPA, a Viatris company https://druglandscape.com/drug/eliglustat-digoxin https://druglandscape.com/api/og?type=drug&title=eliglustat%3B%20digoxin&subtitle=eliglustat%3B%20digoxin%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%201 eliglustat; digoxin eliglustat; digoxin · Genzyme, a Sanofi Company https://druglandscape.com/drug/eliglustat-phase-3-capsule-formulation https://druglandscape.com/api/og?type=drug&title=Eliglustat%2C%20Phase%203%20capsule%20formulation&subtitle=Eliglustat%2C%20Phase%203%20capsule%20formulation%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%201 Eliglustat, Phase 3 capsule formulation Eliglustat, Phase 3 capsule formulation · Genzyme, a Sanofi Company https://druglandscape.com/drug/elocon-ointment https://druglandscape.com/api/og?type=drug&title=Elocon%20ointment&subtitle=Elocon%20ointment%20%C2%B7%20LEO%20Pharma&badge=phase%202 Elocon ointment Elocon ointment · LEO Pharma https://druglandscape.com/drug/eloralintide-and-tirzepatide https://druglandscape.com/api/og?type=drug&title=Eloralintide%20and%20Tirzepatide&subtitle=Eloralintide%20and%20Tirzepatide%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Eloralintide and Tirzepatide Eloralintide and Tirzepatide · Eli Lilly and Company https://druglandscape.com/drug/elpida https://druglandscape.com/api/og?type=drug&title=Elpida%C2%AE&subtitle=Elpida%C2%AE%20%C2%B7%20Viriom&badge=phase%201 Elpida® Elpida® · Viriom https://druglandscape.com/drug/elzsa-film-coated-tablet https://druglandscape.com/api/og?type=drug&title=Elzsa%20film-coated%20tablet&subtitle=Elzsa%20film-coated%20tablet%20%C2%B7%20PT%20Sydna%20Farma&badge=phase%201 Elzsa film-coated tablet Elzsa film-coated tablet · PT Sydna Farma https://druglandscape.com/drug/embryoglue-medium https://druglandscape.com/api/og?type=drug&title=EmbryoGlue%20Medium&subtitle=EmbryoGlue%20Medium%20%C2%B7%20ART%20Fertility%20Clinics%20LLC&badge=phase%201 EmbryoGlue Medium EmbryoGlue Medium · ART Fertility Clinics LLC https://druglandscape.com/drug/embryorp https://druglandscape.com/api/og?type=drug&title=EmbryORP%C2%AE&subtitle=EmbryORP%C2%AE%20%C2%B7%20Liliana%20Berenice%20Ram%C3%ADrez%20Dom%C3%ADnguez&badge=phase%201 EmbryORP® EmbryORP® · Liliana Berenice Ramírez Domínguez https://druglandscape.com/drug/emd-273066 https://druglandscape.com/api/og?type=drug&title=EMD%20273066&subtitle=EMD%20273066%20%C2%B7%20EMD%20Serono&badge=phase%201 EMD 273066 EMD 273066 · EMD Serono https://druglandscape.com/drug/emd-521873 https://druglandscape.com/api/og?type=drug&title=EMD%20521873&subtitle=EMD%20521873%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 EMD 521873 EMD 521873 · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/emd-525797 https://druglandscape.com/api/og?type=drug&title=EMD%20525797&subtitle=EMD%20525797%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%202 EMD 525797 EMD 525797 · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/emd525797 https://druglandscape.com/api/og?type=drug&title=EMD525797&subtitle=EMD525797%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 EMD525797 EMD525797 · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/emergency-department-initiated-oral-naltrexone https://druglandscape.com/api/og?type=drug&title=Emergency%20Department%20Initiated%20Oral%20Naltrexone&subtitle=Emergency%20Department%20Initiated%20Oral%20Naltrexone%20%C2%B7%20Icahn%20School%20of%20Medicine%20at%20Mount%20Sinai&badge=phase%201 Emergency Department Initiated Oral Naltrexone Emergency Department Initiated Oral Naltrexone · Icahn School of Medicine at Mount Sinai https://druglandscape.com/drug/emixustat-hcl-tablet https://druglandscape.com/api/og?type=drug&title=Emixustat%20HCl%20Tablet&subtitle=Emixustat%20HCl%20Tablet%20%C2%B7%20Kubota%20Vision%20Inc.&badge=phase%201 Emixustat HCl Tablet Emixustat HCl Tablet · Kubota Vision Inc. https://druglandscape.com/drug/emla-analgesic-cream https://druglandscape.com/api/og?type=drug&title=EMLA%20Analgesic%20Cream&subtitle=EMLA%20Analgesic%20Cream%20%C2%B7%20Hillel%20Yaffe%20Medical%20Center&badge=phase%201 EMLA Analgesic Cream EMLA Analgesic Cream · Hillel Yaffe Medical Center https://druglandscape.com/drug/emla-cream https://druglandscape.com/api/og?type=drug&title=Emla-cream&subtitle=Emla-cream%20%C2%B7%20Beatrice%20Olsson%20Duse&badge=phase%201 Emla-cream Emla-cream · Beatrice Olsson Duse https://druglandscape.com/drug/emla-creme https://druglandscape.com/api/og?type=drug&title=EMLA%20creme&subtitle=EMLA%20creme%20%C2%B7%20Rambam%20Health%20Care%20Campus&badge=phase%201 EMLA creme EMLA creme · Rambam Health Care Campus https://druglandscape.com/drug/emla-current-reference-patch https://druglandscape.com/api/og?type=drug&title=EMLA%20current%20reference%20patch&subtitle=EMLA%20current%20reference%20patch%20%C2%B7%20AstraZeneca&badge=phase%201 EMLA current reference patch EMLA current reference patch · AstraZeneca https://druglandscape.com/drug/emla-test-patch https://druglandscape.com/api/og?type=drug&title=EMLA%20test%20patch&subtitle=EMLA%20test%20patch%20%C2%B7%20AstraZeneca&badge=phase%201 EMLA test patch EMLA test patch · AstraZeneca https://druglandscape.com/drug/emp-16-vs-xenical https://druglandscape.com/api/og?type=drug&title=EMP%2016%20vs%20Xenical%C2%AE&subtitle=EMP%2016%20vs%20Xenical%C2%AE%20%C2%B7%20Empros%20Pharma%20AB&badge=phase%201 EMP 16 vs Xenical® EMP 16 vs Xenical® · Empros Pharma AB https://druglandscape.com/drug/emp-22-vs-xenical https://druglandscape.com/api/og?type=drug&title=EMP%2022%20vs%20Xenical%C2%AE&subtitle=EMP%2022%20vs%20Xenical%C2%AE%20%C2%B7%20Empros%20Pharma%20AB&badge=phase%201 EMP 22 vs Xenical® EMP 22 vs Xenical® · Empros Pharma AB https://druglandscape.com/drug/empagliflozin-film-coated-tablets https://druglandscape.com/api/og?type=drug&title=Empagliflozin%20film%20coated%20tablets&subtitle=Empagliflozin%20film%20coated%20tablets%20%C2%B7%20Humanis%20Sagl%C4%B1k%20Anonim%20Sirketi&badge=phase%201 Empagliflozin film coated tablets Empagliflozin film coated tablets · Humanis Saglık Anonim Sirketi https://druglandscape.com/drug/empagliflozin-reference-product https://druglandscape.com/api/og?type=drug&title=Empagliflozin-Reference%20product&subtitle=Empagliflozin-Reference%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Empagliflozin-Reference product Empagliflozin-Reference product · Bio-innova Co., Ltd https://druglandscape.com/drug/empagliflozin-test-product https://druglandscape.com/api/og?type=drug&title=Empagliflozin-Test%20product&subtitle=Empagliflozin-Test%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Empagliflozin-Test product Empagliflozin-Test product · Bio-innova Co., Ltd https://druglandscape.com/drug/empty-patch https://druglandscape.com/api/og?type=drug&title=Empty%20Patch&subtitle=Empty%20Patch%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Empty Patch Empty Patch · GlaxoSmithKline https://druglandscape.com/drug/emz702 https://druglandscape.com/api/og?type=drug&title=EMZ702&subtitle=EMZ702%20%C2%B7%20OPKO%20Health%2C%20Inc.&badge=phase%201 EMZ702 EMZ702 · OPKO Health, Inc. https://druglandscape.com/drug/en001 https://druglandscape.com/api/og?type=drug&title=EN001&subtitle=EN001%20%C2%B7%20ENCell&badge=phase%201 EN001 EN001 · ENCell https://druglandscape.com/drug/en41-fpa2-hiv-vaccine https://druglandscape.com/api/og?type=drug&title=EN41-FPA2%20HIV%20vaccine&subtitle=EN41-FPA2%20HIV%20vaccine%20%C2%B7%20PX'Therapeutics&badge=phase%201 EN41-FPA2 HIV vaccine EN41-FPA2 HIV vaccine · PX'Therapeutics https://druglandscape.com/drug/en41-ugr7c-hiv-vaccine https://druglandscape.com/api/og?type=drug&title=EN41-UGR7C%20HIV%20vaccine&subtitle=EN41-UGR7C%20HIV%20vaccine%20%C2%B7%20PX'Therapeutics&badge=phase%201 EN41-UGR7C HIV vaccine EN41-UGR7C HIV vaccine · PX'Therapeutics https://druglandscape.com/drug/enaoxaprin-sodium https://druglandscape.com/api/og?type=drug&title=Enaoxaprin%20sodium&subtitle=Enaoxaprin%20sodium%20%C2%B7%20The%20Egyptian%20IVF-ET%20Center&badge=phase%201 Enaoxaprin sodium Enaoxaprin sodium · The Egyptian IVF-ET Center https://druglandscape.com/drug/enasidenib-dexamethasone-ixazomib-pomalidomide https://druglandscape.com/api/og?type=drug&title=Enasidenib%2C%20dexamethasone%2C%20ixazomib%2C%20pomalidomide&subtitle=Enasidenib%2C%20dexamethasone%2C%20ixazomib%2C%20pomalidomide%20%C2%B7%20Multiple%20Myeloma%20Research%20Consortium&badge=phase%201 Enasidenib, dexamethasone, ixazomib, pomalidomide Enasidenib, dexamethasone, ixazomib, pomalidomide · Multiple Myeloma Research Consortium https://druglandscape.com/drug/enb003 https://druglandscape.com/api/og?type=drug&title=ENB003&subtitle=ENB003%20%C2%B7%20Canadian%20Cancer%20Trials%20Group&badge=phase%202 ENB003 ENB003 · Canadian Cancer Trials Group https://druglandscape.com/drug/enc1018-for-mad https://druglandscape.com/api/og?type=drug&title=ENC1018%20for%20MAD&subtitle=ENC1018%20for%20MAD%20%C2%B7%20EnnovaBio%20Australia%20Pharmaceuticals%20Pty%20Ltd&badge=phase%201 ENC1018 for MAD ENC1018 for MAD · EnnovaBio Australia Pharmaceuticals Pty Ltd https://druglandscape.com/drug/enc1018-for-sad https://druglandscape.com/api/og?type=drug&title=ENC1018%20for%20SAD&subtitle=ENC1018%20for%20SAD%20%C2%B7%20EnnovaBio%20Australia%20Pharmaceuticals%20Pty%20Ltd&badge=phase%201 ENC1018 for SAD ENC1018 for SAD · EnnovaBio Australia Pharmaceuticals Pty Ltd https://druglandscape.com/drug/encapsulated-benzoyl-peroxide-cream https://druglandscape.com/api/og?type=drug&title=Encapsulated%20Benzoyl%20Peroxide%20Cream&subtitle=Encapsulated%20Benzoyl%20Peroxide%20Cream%20%C2%B7%20Sol-Gel%20Technologies%2C%20Ltd.&badge=phase%201 Encapsulated Benzoyl Peroxide Cream Encapsulated Benzoyl Peroxide Cream · Sol-Gel Technologies, Ltd. https://druglandscape.com/drug/encorafenib-first-formulation https://druglandscape.com/api/og?type=drug&title=Encorafenib%20first%20formulation&subtitle=Encorafenib%20first%20formulation%20%C2%B7%20Pfizer&badge=phase%201 Encorafenib first formulation Encorafenib first formulation · Pfizer https://druglandscape.com/drug/encorafenib-oral-capsule https://druglandscape.com/api/og?type=drug&title=Encorafenib%20Oral%20Capsule&subtitle=Encorafenib%20Oral%20Capsule%20%C2%B7%20UNICANCER&badge=phase%202 Encorafenib Oral Capsule Encorafenib Oral Capsule · UNICANCER https://druglandscape.com/drug/encorafenib-second-formulation https://druglandscape.com/api/og?type=drug&title=Encorafenib%20second%20formulation&subtitle=Encorafenib%20second%20formulation%20%C2%B7%20Pfizer&badge=phase%201 Encorafenib second formulation Encorafenib second formulation · Pfizer https://druglandscape.com/drug/endocrinotherapy-doctor-s-choice https://druglandscape.com/api/og?type=drug&title=endocrinotherapy%EF%BC%88doctor's%20choice%EF%BC%89&subtitle=endocrinotherapy%EF%BC%88doctor's%20choice%EF%BC%89%20%C2%B7%20Biyun%20Wang%2C%20MD&badge=phase%201 endocrinotherapy（doctor's choice） endocrinotherapy（doctor's choice） · Biyun Wang, MD https://druglandscape.com/drug/endothelin-1 https://druglandscape.com/api/og?type=drug&title=Endothelin-1&subtitle=Endothelin-1%20%C2%B7%20Anna%20Stanhewicz%2C%20PhD&badge=phase%201 Endothelin-1 Endothelin-1 · Anna Stanhewicz, PhD https://druglandscape.com/drug/endoxana-ima901-leukine https://druglandscape.com/api/og?type=drug&title=Endoxana%2C%20IMA901%2C%20Leukine&subtitle=Endoxana%2C%20IMA901%2C%20Leukine%20%C2%B7%20Immatics%20Biotechnologies%20GmbH&badge=phase%202 Endoxana, IMA901, Leukine Endoxana, IMA901, Leukine · Immatics Biotechnologies GmbH https://druglandscape.com/drug/endoxana-leukine-ima910 https://druglandscape.com/api/og?type=drug&title=Endoxana%2C%20Leukine%2C%20IMA910&subtitle=Endoxana%2C%20Leukine%2C%20IMA910%20%C2%B7%20Immatics%20Biotechnologies%20GmbH&badge=phase%201 Endoxana, Leukine, IMA910 Endoxana, Leukine, IMA910 · Immatics Biotechnologies GmbH https://druglandscape.com/drug/endoxana-leukine-ima910-aldara https://druglandscape.com/api/og?type=drug&title=Endoxana%2C%20Leukine%2C%20IMA910%2C%20Aldara&subtitle=Endoxana%2C%20Leukine%2C%20IMA910%2C%20Aldara%20%C2%B7%20Immatics%20Biotechnologies%20GmbH&badge=phase%201 Endoxana, Leukine, IMA910, Aldara Endoxana, Leukine, IMA910, Aldara · Immatics Biotechnologies GmbH https://druglandscape.com/drug/engineering-tumor-infiltrating-lymphocytes https://druglandscape.com/api/og?type=drug&title=Engineering%20Tumor%20Infiltrating%20Lymphocytes&subtitle=Engineering%20Tumor%20Infiltrating%20Lymphocytes%20%C2%B7%20Shanghai%20Juncell%20Therapeutics&badge=phase%201 Engineering Tumor Infiltrating Lymphocytes Engineering Tumor Infiltrating Lymphocytes · Shanghai Juncell Therapeutics https://druglandscape.com/drug/enhanced-alpp-car-t-treatment https://druglandscape.com/api/og?type=drug&title=Enhanced%20ALPP%20CAR-T%20treatment&subtitle=Enhanced%20ALPP%20CAR-T%20treatment%20%C2%B7%20TCRCure%20Biopharma%20Ltd.&badge=phase%201 Enhanced ALPP CAR-T treatment Enhanced ALPP CAR-T treatment · TCRCure Biopharma Ltd. https://druglandscape.com/drug/enn0403-capsules-high-dose https://druglandscape.com/api/og?type=drug&title=ENN0403%20capsules%2C%20high%20dose&subtitle=ENN0403%20capsules%2C%20high%20dose%20%C2%B7%20EnnovaBio&badge=phase%202 ENN0403 capsules, high dose ENN0403 capsules, high dose · EnnovaBio https://druglandscape.com/drug/enoblituzumab-schedule-1 https://druglandscape.com/api/og?type=drug&title=Enoblituzumab%20Schedule%201&subtitle=Enoblituzumab%20Schedule%201%20%C2%B7%20MacroGenics&badge=phase%201 Enoblituzumab Schedule 1 Enoblituzumab Schedule 1 · MacroGenics https://druglandscape.com/drug/enp-501 https://druglandscape.com/api/og?type=drug&title=ENP-501&subtitle=ENP-501%20%C2%B7%20N-Fold%2C%20LLC&badge=phase%201 ENP-501 ENP-501 · N-Fold, LLC https://druglandscape.com/drug/enpatoran-high-dose https://druglandscape.com/api/og?type=drug&title=Enpatoran%20high%20dose&subtitle=Enpatoran%20high%20dose%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmsta&badge=phase%202 Enpatoran high dose Enpatoran high dose · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/enriched-avidekel-oil https://druglandscape.com/api/og?type=drug&title=Enriched%20Avidekel%20oil&subtitle=Enriched%20Avidekel%20oil%20%C2%B7%20Wolfson%20Medical%20Center&badge=phase%202 Enriched Avidekel oil Enriched Avidekel oil · Wolfson Medical Center https://druglandscape.com/drug/ensartinib-with-fed-or-fasting https://druglandscape.com/api/og?type=drug&title=Ensartinib%20with%20fed%20or%20fasting&subtitle=Ensartinib%20with%20fed%20or%20fasting%20%C2%B7%20Betta%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 Ensartinib with fed or fasting Ensartinib with fed or fasting · Betta Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/enso-16 https://druglandscape.com/api/og?type=drug&title=ENSO%2016&subtitle=ENSO%2016%20%C2%B7%20Alpha%20Republic%20GmbH&badge=phase%201 ENSO 16 ENSO 16 · Alpha Republic GmbH https://druglandscape.com/drug/enstilar-aerosol-foam https://druglandscape.com/api/og?type=drug&title=Enstilar%C2%AE%20aerosol%20foam&subtitle=Enstilar%C2%AE%20aerosol%20foam%20%C2%B7%20LEO%20Pharma&badge=phase%202 Enstilar® aerosol foam Enstilar® aerosol foam · LEO Pharma https://druglandscape.com/drug/ensure-enlive-advanced-nutrition-shake https://druglandscape.com/api/og?type=drug&title=Ensure%20Enlive%20Advanced%20Nutrition%20Shake&subtitle=Ensure%20Enlive%20Advanced%20Nutrition%20Shake%20%C2%B7%20Boston%20Medical%20Center&badge=phase%201 Ensure Enlive Advanced Nutrition Shake Ensure Enlive Advanced Nutrition Shake · Boston Medical Center https://druglandscape.com/drug/ensure-surgery-immunonutrition-shake https://druglandscape.com/api/og?type=drug&title=Ensure%20Surgery%20Immunonutrition%20Shake&subtitle=Ensure%20Surgery%20Immunonutrition%20Shake%20%C2%B7%20Boston%20Medical%20Center&badge=phase%201 Ensure Surgery Immunonutrition Shake Ensure Surgery Immunonutrition Shake · Boston Medical Center https://druglandscape.com/drug/ent-01 https://druglandscape.com/api/og?type=drug&title=ENT-01&subtitle=ENT-01%20%C2%B7%20Enterin%20Inc.&badge=phase%201 ENT-01 ENT-01 · Enterin Inc. https://druglandscape.com/drug/entacapone-propranolol https://druglandscape.com/api/og?type=drug&title=Entacapone%20%26%20Propranolol&subtitle=Entacapone%20%26%20Propranolol%20%C2%B7%20Satish%20R.%20Raj&badge=phase%201 Entacapone & Propranolol Entacapone & Propranolol · Satish R. Raj https://druglandscape.com/drug/enterovirus-type-71-vaccine https://druglandscape.com/api/og?type=drug&title=Enterovirus%20Type%2071%20Vaccine&subtitle=Enterovirus%20Type%2071%20Vaccine%20%C2%B7%20Beijing%20Zhifei%20Lvzhu%20Biopharmaceutical%20Co.%2C%20Ltd&badge=phase%202 Enterovirus Type 71 Vaccine Enterovirus Type 71 Vaccine · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd https://druglandscape.com/drug/entr-601-44 https://druglandscape.com/api/og?type=drug&title=ENTR-601-44&subtitle=ENTR-601-44%20%C2%B7%20Entrada%20Therapeutics%2C%20Inc.&badge=phase%201 ENTR-601-44 ENTR-601-44 · Entrada Therapeutics, Inc. https://druglandscape.com/drug/entr-601-45 https://druglandscape.com/api/og?type=drug&title=ENTR-601-45&subtitle=ENTR-601-45%20%C2%B7%20Entrada%20Therapeutics%2C%20Inc.&badge=phase%201 ENTR-601-45 ENTR-601-45 · Entrada Therapeutics, Inc. https://druglandscape.com/drug/entrectinib-form-c https://druglandscape.com/api/og?type=drug&title=Entrectinib%20Form%20C&subtitle=Entrectinib%20Form%20C%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 Entrectinib Form C Entrectinib Form C · Genentech, Inc. https://druglandscape.com/drug/envafolimab-with-old-manufacturing-process https://druglandscape.com/api/og?type=drug&title=Envafolimab%20with%20old%20manufacturing%20process&subtitle=Envafolimab%20with%20old%20manufacturing%20process%20%C2%B7%203D%20Medicines%20(Sichuan)%20Co.%2C%20Ltd.&badge=phase%201 Envafolimab with old manufacturing process Envafolimab with old manufacturing process · 3D Medicines (Sichuan) Co., Ltd. https://druglandscape.com/drug/enx-205 https://druglandscape.com/api/og?type=drug&title=ENX-205&subtitle=ENX-205%20%C2%B7%20Engrail%20Therapeutics%20INC&badge=phase%201 ENX-205 ENX-205 · Engrail Therapeutics INC https://druglandscape.com/drug/enzastaurin-hcl https://druglandscape.com/api/og?type=drug&title=Enzastaurin%20HCL&subtitle=Enzastaurin%20HCL%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 Enzastaurin HCL Enzastaurin HCL · Eli Lilly and Company https://druglandscape.com/drug/enzyme-replacement-therapy https://druglandscape.com/api/og?type=drug&title=Enzyme%20replacement%20therapy&subtitle=Enzyme%20replacement%20therapy%20%C2%B7%20Ulla%20Feldt-Rasmussen&badge=phase%202 Enzyme replacement therapy Enzyme replacement therapy · Ulla Feldt-Rasmussen https://druglandscape.com/drug/eo2002 https://druglandscape.com/api/og?type=drug&title=EO2002&subtitle=EO2002%20%C2%B7%20Emmecell&badge=phase%201 EO2002 EO2002 · Emmecell https://druglandscape.com/drug/eo2002-high-dose https://druglandscape.com/api/og?type=drug&title=EO2002%20high%20dose&subtitle=EO2002%20high%20dose%20%C2%B7%20Emmecell&badge=phase%201 EO2002 high dose EO2002 high dose · Emmecell https://druglandscape.com/drug/eo2002-low-dose https://druglandscape.com/api/og?type=drug&title=EO2002%20low%20dose&subtitle=EO2002%20low%20dose%20%C2%B7%20Emmecell&badge=phase%201 EO2002 low dose EO2002 low dose · Emmecell https://druglandscape.com/drug/eo2002-mid-dose https://druglandscape.com/api/og?type=drug&title=EO2002%20mid%20dose&subtitle=EO2002%20mid%20dose%20%C2%B7%20Emmecell&badge=phase%201 EO2002 mid dose EO2002 mid dose · Emmecell https://druglandscape.com/drug/eo2463 https://druglandscape.com/api/og?type=drug&title=EO2463&subtitle=EO2463%20%C2%B7%20Enterome&badge=phase%201 EO2463 EO2463 · Enterome https://druglandscape.com/drug/eoc237 https://druglandscape.com/api/og?type=drug&title=EOC237&subtitle=EOC237%20%C2%B7%20Shanghai%20Yiteng%20Jingang%20Bio-pharmaceutical%20Technology%20Co.%2C%20Ltd&badge=phase%201 EOC237 EOC237 · Shanghai Yiteng Jingang Bio-pharmaceutical Technology Co., Ltd https://druglandscape.com/drug/eoc317 https://druglandscape.com/api/og?type=drug&title=EOC317&subtitle=EOC317%20%C2%B7%20Taizhou%20EOC%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 EOC317 EOC317 · Taizhou EOC Pharma Co., Ltd. https://druglandscape.com/drug/eom613 https://druglandscape.com/api/og?type=drug&title=EOM613&subtitle=EOM613%20%C2%B7%20EOM%20Pharmaceuticals&badge=phase%201 EOM613 EOM613 · EOM Pharmaceuticals https://druglandscape.com/drug/eos-448 https://druglandscape.com/api/og?type=drug&title=EOS-448&subtitle=EOS-448%20%C2%B7%20iTeos%20Belgium%20SA&badge=phase%201 EOS-448 EOS-448 · iTeos Belgium SA https://druglandscape.com/drug/eos100850 https://druglandscape.com/api/og?type=drug&title=EOS100850&subtitle=EOS100850%20%C2%B7%20iTeos%20Therapeutics&badge=phase%201 EOS100850 EOS100850 · iTeos Therapeutics https://druglandscape.com/drug/eos301984 https://druglandscape.com/api/og?type=drug&title=EOS301984&subtitle=EOS301984%20%C2%B7%20iTeos%20Therapeutics&badge=phase%201 EOS301984 EOS301984 · iTeos Therapeutics https://druglandscape.com/drug/eosinophil-count https://druglandscape.com/api/og?type=drug&title=Eosinophil%20count&subtitle=Eosinophil%20count%20%C2%B7%20Centre%20d'Investigation%20Clinique%20et%20Technologique%20805&badge=phase%202 Eosinophil count Eosinophil count · Centre d'Investigation Clinique et Technologique 805 https://druglandscape.com/drug/ep-100 https://druglandscape.com/api/og?type=drug&title=EP-100&subtitle=EP-100%20%C2%B7%20Esperance%20Pharmaceuticals%20Inc&badge=phase%202 EP-100 EP-100 · Esperance Pharmaceuticals Inc https://druglandscape.com/drug/ep-104gi https://druglandscape.com/api/og?type=drug&title=EP-104GI&subtitle=EP-104GI%20%C2%B7%20Eupraxia%20Pharmaceuticals%20Inc.&badge=phase%201 EP-104GI EP-104GI · Eupraxia Pharmaceuticals Inc. https://druglandscape.com/drug/ep-104iar https://druglandscape.com/api/og?type=drug&title=EP-104IAR&subtitle=EP-104IAR%20%C2%B7%20Eupraxia%20Pharmaceuticals%20Inc.&badge=phase%201 EP-104IAR EP-104IAR · Eupraxia Pharmaceuticals Inc. https://druglandscape.com/drug/ep-2101 https://druglandscape.com/api/og?type=drug&title=EP-2101&subtitle=EP-2101%20%C2%B7%20Epimmune&badge=phase%202 EP-2101 EP-2101 · Epimmune https://druglandscape.com/drug/ep-7041 https://druglandscape.com/api/og?type=drug&title=EP%3D7041&subtitle=EP%3D7041%20%C2%B7%20eXIthera%20Pharmaceuticals&badge=phase%201 EP=7041 EP=7041 · eXIthera Pharmaceuticals https://druglandscape.com/drug/ep-9001a https://druglandscape.com/api/og?type=drug&title=EP-9001A&subtitle=EP-9001A%20%C2%B7%20Chengdu%20Easton%20Biopharmaceuticals%20Co%2CLtd&badge=phase%201 EP-9001A EP-9001A · Chengdu Easton Biopharmaceuticals Co,Ltd https://druglandscape.com/drug/ep1090 https://druglandscape.com/api/og?type=drug&title=EP1090&subtitle=EP1090%20%C2%B7%20Epimmune&badge=phase%201 EP1090 EP1090 · Epimmune https://druglandscape.com/drug/ep2101 https://druglandscape.com/api/og?type=drug&title=EP2101&subtitle=EP2101%20%C2%B7%20Epimmune&badge=phase%201 EP2101 EP2101 · Epimmune https://druglandscape.com/drug/ep31670 https://druglandscape.com/api/og?type=drug&title=EP31670&subtitle=EP31670%20%C2%B7%20Epigenetix%2C%20Inc.&badge=phase%201 EP31670 EP31670 · Epigenetix, Inc. https://druglandscape.com/drug/ep395 https://druglandscape.com/api/og?type=drug&title=EP395&subtitle=EP395%20%C2%B7%20EpiEndo%20Pharmaceuticals&badge=phase%202 EP395 EP395 · EpiEndo Pharmaceuticals https://druglandscape.com/drug/epamin-reference-drug https://druglandscape.com/api/og?type=drug&title=Epamin%3A%20Reference%20Drug&subtitle=Epamin%3A%20Reference%20Drug%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%201 Epamin: Reference Drug Epamin: Reference Drug · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/epaminurad-naproxen https://druglandscape.com/api/og?type=drug&title=Epaminurad%2C%20Naproxen&subtitle=Epaminurad%2C%20Naproxen%20%C2%B7%20JW%20Pharmaceutical&badge=phase%201 Epaminurad, Naproxen Epaminurad, Naproxen · JW Pharmaceutical https://druglandscape.com/drug/epc-treatment-group https://druglandscape.com/api/og?type=drug&title=EPC%20treatment%20group&subtitle=EPC%20treatment%20group%20%C2%B7%20Allife%20Medical%20Science%20and%20Technology%20Co.%2C%20Ltd.&badge=phase%201 EPC treatment group EPC treatment group · Allife Medical Science and Technology Co., Ltd. https://druglandscape.com/drug/epcam-targeted-car-t-cells https://druglandscape.com/api/og?type=drug&title=EPCAM-targeted%20CAR-T%20cells&subtitle=EPCAM-targeted%20CAR-T%20cells%20%C2%B7%20Sinobioway%20Cell%20Therapy%20Co.%2C%20Ltd.&badge=phase%201 EPCAM-targeted CAR-T cells EPCAM-targeted CAR-T cells · Sinobioway Cell Therapy Co., Ltd. https://druglandscape.com/drug/epcoritamab-lenalidomide-and-rituximab https://druglandscape.com/api/og?type=drug&title=Epcoritamab%2C%20lenalidomide%20and%20rituximab&subtitle=Epcoritamab%2C%20lenalidomide%20and%20rituximab%20%C2%B7%20Peter%20MacCallum%20Cancer%20Centre%2C%20Australia&badge=phase%202 Epcoritamab, lenalidomide and rituximab Epcoritamab, lenalidomide and rituximab · Peter MacCallum Cancer Centre, Australia https://druglandscape.com/drug/epcs https://druglandscape.com/api/og?type=drug&title=EPCs&subtitle=EPCs%20%C2%B7%20Allife%20Medical%20Science%20and%20Technology%20Co.%2C%20Ltd.&badge=phase%201 EPCs EPCs · Allife Medical Science and Technology Co., Ltd. https://druglandscape.com/drug/ephedrine-sulfate-with-caffeine https://druglandscape.com/api/og?type=drug&title=Ephedrine%20sulfate%20with%20caffeine&subtitle=Ephedrine%20sulfate%20with%20caffeine%20%C2%B7%20Oregon%20Weight%20Loss%20Surgery%2C%20LLC&badge=phase%201 Ephedrine sulfate with caffeine Ephedrine sulfate with caffeine · Oregon Weight Loss Surgery, LLC https://druglandscape.com/drug/epi-200 https://druglandscape.com/api/og?type=drug&title=Epi%20200&subtitle=Epi%20200%20%C2%B7%20Seoul%20Medical%20Center&badge=phase%201 Epi 200 Epi 200 · Seoul Medical Center https://druglandscape.com/drug/epicord https://druglandscape.com/api/og?type=drug&title=EpiCord&subtitle=EpiCord%20%C2%B7%20MiMedx%20Group%2C%20Inc.&badge=phase%201 EpiCord EpiCord · MiMedx Group, Inc. https://druglandscape.com/drug/epidural-fentanyl-via-pcea https://druglandscape.com/api/og?type=drug&title=epidural%20fentanyl%20via%20PCEA&subtitle=epidural%20fentanyl%20via%20PCEA%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 epidural fentanyl via PCEA epidural fentanyl via PCEA · Hadassah Medical Organization https://druglandscape.com/drug/epidural-methadone-via-pcea https://druglandscape.com/api/og?type=drug&title=epidural%20methadone%20via%20PCEA&subtitle=epidural%20methadone%20via%20PCEA%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 epidural methadone via PCEA epidural methadone via PCEA · Hadassah Medical Organization https://druglandscape.com/drug/epigallocatechin-3-gallate https://druglandscape.com/api/og?type=drug&title=Epigallocatechin-3-Gallate&subtitle=Epigallocatechin-3-Gallate%20%C2%B7%20Han%20Xi%20Zhao&badge=phase%201 Epigallocatechin-3-Gallate Epigallocatechin-3-Gallate · Han Xi Zhao https://druglandscape.com/drug/epikeia-coatings-with-aspirin https://druglandscape.com/api/og?type=drug&title=Epikeia%20coatings%20with%20aspirin&subtitle=Epikeia%20coatings%20with%20aspirin%20%C2%B7%20Biomedical%20Development%20Corporation&badge=phase%201 Epikeia coatings with aspirin Epikeia coatings with aspirin · Biomedical Development Corporation https://druglandscape.com/drug/epikeia-coatings-with-lidocaine https://druglandscape.com/api/og?type=drug&title=Epikeia%20coatings%20with%20lidocaine&subtitle=Epikeia%20coatings%20with%20lidocaine%20%C2%B7%20Biomedical%20Development%20Corporation&badge=phase%201 Epikeia coatings with lidocaine Epikeia coatings with lidocaine · Biomedical Development Corporation https://druglandscape.com/drug/epinastine-0-1 https://druglandscape.com/api/og?type=drug&title=epinastine%200.1%25&subtitle=epinastine%200.1%25%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 epinastine 0.1% epinastine 0.1% · Merck Sharp & Dohme LLC https://druglandscape.com/drug/epinastine-0-1-with-taste-masking-agent https://druglandscape.com/api/og?type=drug&title=epinastine%200.1%25%20with%20taste%20masking%20agent&subtitle=epinastine%200.1%25%20with%20taste%20masking%20agent%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 epinastine 0.1% with taste masking agent epinastine 0.1% with taste masking agent · Merck Sharp & Dohme LLC https://druglandscape.com/drug/epinastine-0-2 https://druglandscape.com/api/og?type=drug&title=epinastine%200.2%25&subtitle=epinastine%200.2%25%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 epinastine 0.2% epinastine 0.2% · Merck Sharp & Dohme LLC https://druglandscape.com/drug/epinastine-0-2-with-taste-masking-agent https://druglandscape.com/api/og?type=drug&title=epinastine%200.2%25%20with%20taste%20masking%20agent&subtitle=epinastine%200.2%25%20with%20taste%20masking%20agent%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 epinastine 0.2% with taste masking agent epinastine 0.2% with taste masking agent · Merck Sharp & Dohme LLC https://druglandscape.com/drug/epinephrine-100 https://druglandscape.com/api/og?type=drug&title=epinephrine%20100&subtitle=epinephrine%20100%20%C2%B7%20Seoul%20Medical%20Center&badge=phase%201 epinephrine 100 epinephrine 100 · Seoul Medical Center https://druglandscape.com/drug/epinephrine-50 https://druglandscape.com/api/og?type=drug&title=Epinephrine%2050&subtitle=Epinephrine%2050%20%C2%B7%20Seoul%20Medical%20Center&badge=phase%201 Epinephrine 50 Epinephrine 50 · Seoul Medical Center https://druglandscape.com/drug/epinephrine-inhalation-aerosol-hfa https://druglandscape.com/api/og?type=drug&title=Epinephrine%20Inhalation%20Aerosol%2C%20HFA&subtitle=Epinephrine%20Inhalation%20Aerosol%2C%20HFA%20%C2%B7%20Amphastar%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Epinephrine Inhalation Aerosol, HFA Epinephrine Inhalation Aerosol, HFA · Amphastar Pharmaceuticals, Inc. https://druglandscape.com/drug/episcleral-celecoxib https://druglandscape.com/api/og?type=drug&title=Episcleral%20Celecoxib&subtitle=Episcleral%20Celecoxib%20%C2%B7%20Targeted%20Therapy%20Technologies%2C%20LLC&badge=phase%201 Episcleral Celecoxib Episcleral Celecoxib · Targeted Therapy Technologies, LLC https://druglandscape.com/drug/episcleral-dexamethasone https://druglandscape.com/api/og?type=drug&title=Episcleral%20Dexamethasone&subtitle=Episcleral%20Dexamethasone%20%C2%B7%20Targeted%20Therapy%20Technologies%2C%20LLC&badge=phase%201 Episcleral Dexamethasone Episcleral Dexamethasone · Targeted Therapy Technologies, LLC https://druglandscape.com/drug/episcleral-topotecan https://druglandscape.com/api/og?type=drug&title=Episcleral%20Topotecan&subtitle=Episcleral%20Topotecan%20%C2%B7%20Targeted%20Therapy%20Technologies%2C%20LLC&badge=phase%201 Episcleral Topotecan Episcleral Topotecan · Targeted Therapy Technologies, LLC https://druglandscape.com/drug/epitinib-succinate https://druglandscape.com/api/og?type=drug&title=epitinib%20succinate&subtitle=epitinib%20succinate%20%C2%B7%20Hutchison%20Medipharma%20Limited&badge=phase%201 epitinib succinate epitinib succinate · Hutchison Medipharma Limited https://druglandscape.com/drug/epivir-retrovir-and-viramune https://druglandscape.com/api/og?type=drug&title=Epivir%C2%AE%2C%20Retrovir%C2%AE%20and%20Viramune%C2%AE&subtitle=Epivir%C2%AE%2C%20Retrovir%C2%AE%20and%20Viramune%C2%AE%20%C2%B7%20Elim%20Pediatric%20Pharmaceuticals%20Inc.&badge=phase%201 Epivir®, Retrovir® and Viramune® Epivir®, Retrovir® and Viramune® · Elim Pediatric Pharmaceuticals Inc. https://druglandscape.com/drug/eplerenone-tablets https://druglandscape.com/api/og?type=drug&title=Eplerenone%2C%20tablets&subtitle=Eplerenone%2C%20tablets%20%C2%B7%20AstraZeneca&badge=phase%201 Eplerenone, tablets Eplerenone, tablets · AstraZeneca https://druglandscape.com/drug/epo-018b https://druglandscape.com/api/og?type=drug&title=EPO-018B&subtitle=EPO-018B%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 EPO-018B EPO-018B · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/epoetin-hospira-mdv https://druglandscape.com/api/og?type=drug&title=Epoetin%20Hospira%20MDV&subtitle=Epoetin%20Hospira%20MDV%20%C2%B7%20Pfizer&badge=phase%201 Epoetin Hospira MDV Epoetin Hospira MDV · Pfizer https://druglandscape.com/drug/epratuzumab-iv https://druglandscape.com/api/og?type=drug&title=Epratuzumab%20iv&subtitle=Epratuzumab%20iv%20%C2%B7%20UCB%20Biopharma%20S.P.R.L.&badge=phase%201 Epratuzumab iv Epratuzumab iv · UCB Biopharma S.P.R.L. https://druglandscape.com/drug/epratuzumab-sc https://druglandscape.com/api/og?type=drug&title=Epratuzumab%20sc&subtitle=Epratuzumab%20sc%20%C2%B7%20UCB%20Biopharma%20S.P.R.L.&badge=phase%201 Epratuzumab sc Epratuzumab sc · UCB Biopharma S.P.R.L. https://druglandscape.com/drug/eptinezumab-mammalian-cell-line https://druglandscape.com/api/og?type=drug&title=Eptinezumab%20Mammalian%20Cell%20Line&subtitle=Eptinezumab%20Mammalian%20Cell%20Line%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Eptinezumab Mammalian Cell Line Eptinezumab Mammalian Cell Line · H. Lundbeck A/S https://druglandscape.com/drug/eptinezumab-yeast-cell-line https://druglandscape.com/api/og?type=drug&title=Eptinezumab%20Yeast%20Cell%20Line&subtitle=Eptinezumab%20Yeast%20Cell%20Line%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Eptinezumab Yeast Cell Line Eptinezumab Yeast Cell Line · H. Lundbeck A/S https://druglandscape.com/drug/epz-5676 https://druglandscape.com/api/og?type=drug&title=EPZ-5676&subtitle=EPZ-5676%20%C2%B7%20Epizyme%2C%20Inc.&badge=phase%201 EPZ-5676 EPZ-5676 · Epizyme, Inc. https://druglandscape.com/drug/eq101 https://druglandscape.com/api/og?type=drug&title=EQ101&subtitle=EQ101%20%C2%B7%20Equillium&badge=phase%202 EQ101 EQ101 · Equillium https://druglandscape.com/drug/er-oros-paliperidone-paliperidone-er https://druglandscape.com/api/og?type=drug&title=ER%20OROS%20paliperidone%2C%20paliperidone%20ER&subtitle=ER%20OROS%20paliperidone%2C%20paliperidone%20ER%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L&badge=phase%201 ER OROS paliperidone, paliperidone ER ER OROS paliperidone, paliperidone ER · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/er-tablet-under-fasted-conditions https://druglandscape.com/api/og?type=drug&title=ER%20Tablet%20under%20Fasted%20Conditions&subtitle=ER%20Tablet%20under%20Fasted%20Conditions%20%C2%B7%20Nexgen%20Pharma%2C%20Inc&badge=phase%201 ER Tablet under Fasted Conditions ER Tablet under Fasted Conditions · Nexgen Pharma, Inc https://druglandscape.com/drug/eras-0015 https://druglandscape.com/api/og?type=drug&title=ERAS-0015&subtitle=ERAS-0015%20%C2%B7%20Erasca%2C%20Inc.&badge=phase%201 ERAS-0015 ERAS-0015 · Erasca, Inc. https://druglandscape.com/drug/eras-0015-in-combination https://druglandscape.com/api/og?type=drug&title=ERAS-0015%20in%20combination&subtitle=ERAS-0015%20in%20combination%20%C2%B7%20Erasca%2C%20Inc.&badge=phase%201 ERAS-0015 in combination ERAS-0015 in combination · Erasca, Inc. https://druglandscape.com/drug/eras-007 https://druglandscape.com/api/og?type=drug&title=ERAS-007&subtitle=ERAS-007%20%C2%B7%20Erasca%2C%20Inc.&badge=phase%201 ERAS-007 ERAS-007 · Erasca, Inc. https://druglandscape.com/drug/eras-4001 https://druglandscape.com/api/og?type=drug&title=ERAS-4001&subtitle=ERAS-4001%20%C2%B7%20Erasca%2C%20Inc.&badge=phase%201 ERAS-4001 ERAS-4001 · Erasca, Inc. https://druglandscape.com/drug/eras-4001-in-combination https://druglandscape.com/api/og?type=drug&title=ERAS-4001%20in%20combination&subtitle=ERAS-4001%20in%20combination%20%C2%B7%20Erasca%2C%20Inc.&badge=phase%201 ERAS-4001 in combination ERAS-4001 in combination · Erasca, Inc. https://druglandscape.com/drug/erb-257 https://druglandscape.com/api/og?type=drug&title=ERB-257&subtitle=ERB-257%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 ERB-257 ERB-257 · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/erbitux-merck-serono https://druglandscape.com/api/og?type=drug&title=Erbitux%2Cmerck%20serono&subtitle=Erbitux%2Cmerck%20serono%20%C2%B7%20Rabin%20Medical%20Center&badge=phase%201 Erbitux,merck serono Erbitux,merck serono · Rabin Medical Center https://druglandscape.com/drug/erc1671 https://druglandscape.com/api/og?type=drug&title=ERC1671&subtitle=ERC1671%20%C2%B7%20Epitopoietic%20Research%20Corporation&badge=phase%202 ERC1671 ERC1671 · Epitopoietic Research Corporation https://druglandscape.com/drug/erenumab-pfs https://druglandscape.com/api/og?type=drug&title=Erenumab%20PFS&subtitle=Erenumab%20PFS%20%C2%B7%20Amgen&badge=phase%202 Erenumab PFS Erenumab PFS · Amgen https://druglandscape.com/drug/erlotinib-escalating-dose https://druglandscape.com/api/og?type=drug&title=Erlotinib%2C%20escalating%20dose&subtitle=Erlotinib%2C%20escalating%20dose%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Erlotinib, escalating dose Erlotinib, escalating dose · Hoffmann-La Roche https://druglandscape.com/drug/erlotinib-plus-docetaxel-or-pemetrexed https://druglandscape.com/api/og?type=drug&title=erlotinib%20plus%20docetaxel%20or%20pemetrexed&subtitle=erlotinib%20plus%20docetaxel%20or%20pemetrexed%20%C2%B7%20Dutch%20Society%20of%20Physicians%20for%20Pulmonology%20and%20Tuberculosi&badge=phase%202 erlotinib plus docetaxel or pemetrexed erlotinib plus docetaxel or pemetrexed · Dutch Society of Physicians for Pulmonology and Tuberculosis https://druglandscape.com/drug/ertugliflozin-oc-fast https://druglandscape.com/api/og?type=drug&title=Ertugliflozin%20OC%20Fast&subtitle=Ertugliflozin%20OC%20Fast%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Ertugliflozin OC Fast Ertugliflozin OC Fast · Merck Sharp & Dohme LLC https://druglandscape.com/drug/ertugliflozin-oc-slow https://druglandscape.com/api/og?type=drug&title=Ertugliflozin%20OC%20Slow&subtitle=Ertugliflozin%20OC%20Slow%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Ertugliflozin OC Slow Ertugliflozin OC Slow · Merck Sharp & Dohme LLC https://druglandscape.com/drug/erx-315 https://druglandscape.com/api/og?type=drug&title=ERX-315&subtitle=ERX-315%20%C2%B7%20EtiraRx%20Australia%20Pty%20Ltd&badge=phase%201 ERX-315 ERX-315 · EtiraRx Australia Pty Ltd https://druglandscape.com/drug/erx1000 https://druglandscape.com/api/og?type=drug&title=ERX1000&subtitle=ERX1000%20%C2%B7%20ERX%20Pharmaceuticals&badge=phase%201 ERX1000 ERX1000 · ERX Pharmaceuticals https://druglandscape.com/drug/erythrocyte-based-prime-solution https://druglandscape.com/api/og?type=drug&title=Erythrocyte%20based%20prime%20solution&subtitle=Erythrocyte%20based%20prime%20solution%20%C2%B7%20Vastra%20Gotaland%20Region&badge=phase%201 Erythrocyte based prime solution Erythrocyte based prime solution · Vastra Gotaland Region https://druglandscape.com/drug/erythropoiesis-stimulating-agents https://druglandscape.com/api/og?type=drug&title=Erythropoiesis-stimulating%20agents&subtitle=Erythropoiesis-stimulating%20agents%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 Erythropoiesis-stimulating agents Erythropoiesis-stimulating agents · Bristol-Myers Squibb https://druglandscape.com/drug/erythropoietin-and-early-iron-supplements https://druglandscape.com/api/og?type=drug&title=erythropoietin%20and%20early%20iron%20supplements&subtitle=erythropoietin%20and%20early%20iron%20supplements%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%202 erythropoietin and early iron supplements erythropoietin and early iron supplements · Sheba Medical Center https://druglandscape.com/drug/es009 https://druglandscape.com/api/og?type=drug&title=ES009&subtitle=ES009%20%C2%B7%20Elpiscience%20Biopharma%20Australia%20Pty.%20Ltd.&badge=phase%201 ES009 ES009 · Elpiscience Biopharma Australia Pty. Ltd. https://druglandscape.com/drug/es104 https://druglandscape.com/api/og?type=drug&title=ES104&subtitle=ES104%20%C2%B7%20Elpiscience%20(Suzhou)%20Biopharma%2C%20Ltd.&badge=phase%201 ES104 ES104 · Elpiscience (Suzhou) Biopharma, Ltd. https://druglandscape.com/drug/es2b-c001 https://druglandscape.com/api/og?type=drug&title=ES2B-C001&subtitle=ES2B-C001%20%C2%B7%20ExpreS2ion%20Biotechnologies&badge=phase%201 ES2B-C001 ES2B-C001 · ExpreS2ion Biotechnologies https://druglandscape.com/drug/esat6-cfp10 https://druglandscape.com/api/og?type=drug&title=ESAT6-CFP10&subtitle=ESAT6-CFP10%20%C2%B7%20Anhui%20Zhifei%20Longcom%20Biologic%20Pharmacy%20Co.%2C%20Ltd.&badge=phase%201 ESAT6-CFP10 ESAT6-CFP10 · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. https://druglandscape.com/drug/esba105 https://druglandscape.com/api/og?type=drug&title=ESBA105&subtitle=ESBA105%20%C2%B7%20ESBATech%20AG&badge=phase%202 ESBA105 ESBA105 · ESBATech AG https://druglandscape.com/drug/escitalopram-and-oxycodone https://druglandscape.com/api/og?type=drug&title=Escitalopram%20and%20Oxycodone&subtitle=Escitalopram%20and%20Oxycodone%20%C2%B7%20Food%20and%20Drug%20Administration%20(FDA)&badge=phase%201 Escitalopram and Oxycodone Escitalopram and Oxycodone · Food and Drug Administration (FDA) https://druglandscape.com/drug/escitalopram-oxalate-tablets https://druglandscape.com/api/og?type=drug&title=Escitalopram%20Oxalate%20Tablets&subtitle=Escitalopram%20Oxalate%20Tablets%20%C2%B7%20Torrent%20Pharmaceuticals%20Limited&badge=phase%201 Escitalopram Oxalate Tablets Escitalopram Oxalate Tablets · Torrent Pharmaceuticals Limited https://druglandscape.com/drug/esflurbiprofen-topical-system https://druglandscape.com/api/og?type=drug&title=Esflurbiprofen%20Topical%20System&subtitle=Esflurbiprofen%20Topical%20System%20%C2%B7%20Teikoku%20Seiyaku%20Co.%2C%20Ltd.&badge=phase%201 Esflurbiprofen Topical System Esflurbiprofen Topical System · Teikoku Seiyaku Co., Ltd. https://druglandscape.com/drug/esg406 https://druglandscape.com/api/og?type=drug&title=ESG406&subtitle=ESG406%20%C2%B7%20Shanghai%20Escugen%20Biotechnology%20Co.%2C%20Ltd&badge=phase%201 ESG406 ESG406 · Shanghai Escugen Biotechnology Co., Ltd https://druglandscape.com/drug/esketamine-dpi https://druglandscape.com/api/og?type=drug&title=Esketamine%20DPI&subtitle=Esketamine%20DPI%20%C2%B7%20Celon%20Pharma%20SA&badge=phase%201 Esketamine DPI Esketamine DPI · Celon Pharma SA https://druglandscape.com/drug/esketamine-dpi-high-dose https://druglandscape.com/api/og?type=drug&title=Esketamine%20DPI%20-%20high%20dose&subtitle=Esketamine%20DPI%20-%20high%20dose%20%C2%B7%20Celon%20Pharma%20SA&badge=phase%202 Esketamine DPI - high dose Esketamine DPI - high dose · Celon Pharma SA https://druglandscape.com/drug/esketamine-dpi-medium-dose https://druglandscape.com/api/og?type=drug&title=Esketamine%20DPI%20-%20medium%20dose&subtitle=Esketamine%20DPI%20-%20medium%20dose%20%C2%B7%20Celon%20Pharma%20SA&badge=phase%202 Esketamine DPI - medium dose Esketamine DPI - medium dose · Celon Pharma SA https://druglandscape.com/drug/esketamine-perfusion https://druglandscape.com/api/og?type=drug&title=Esketamine%20perfusion&subtitle=Esketamine%20perfusion%20%C2%B7%20Association%20pour%20la%20Formation%20l'Enseignement%20et%20la%20Recherche%20du%20Service%20de%20l'&badge=phase%202 Esketamine perfusion Esketamine perfusion · Association pour la Formation l'Enseignement et la Recherche du Service de l'Accueil des Urgences https://druglandscape.com/drug/esl-grape-taste https://druglandscape.com/api/og?type=drug&title=ESL%20Grape%20taste&subtitle=ESL%20Grape%20taste%20%C2%B7%20Bial%20-%20Portela%20C%20S.A.&badge=phase%202 ESL Grape taste ESL Grape taste · Bial - Portela C S.A. https://druglandscape.com/drug/eslicarbazepine-acetate-and-microginon https://druglandscape.com/api/og?type=drug&title=eslicarbazepine%20acetate%20and%20Microginon%C2%AE&subtitle=eslicarbazepine%20acetate%20and%20Microginon%C2%AE%20%C2%B7%20Bial%20-%20Portela%20C%20S.A.&badge=phase%201 eslicarbazepine acetate and Microginon® eslicarbazepine acetate and Microginon® · Bial - Portela C S.A. https://druglandscape.com/drug/esmeron https://druglandscape.com/api/og?type=drug&title=Esmeron%C2%AE&subtitle=Esmeron%C2%AE%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Esmeron® Esmeron® · Merck Sharp & Dohme LLC https://druglandscape.com/drug/esmolol-infusion https://druglandscape.com/api/og?type=drug&title=Esmolol%20infusion&subtitle=Esmolol%20infusion%20%C2%B7%20David%20N.%20Proctor%2C%20PhD&badge=phase%201 Esmolol infusion Esmolol infusion · David N. Proctor, PhD https://druglandscape.com/drug/eso-and-pritelivir https://druglandscape.com/api/og?type=drug&title=ESO%20and%20pritelivir&subtitle=ESO%20and%20pritelivir%20%C2%B7%20AiCuris%20Anti-infective%20Cures%20AG&badge=phase%201 ESO and pritelivir ESO and pritelivir · AiCuris Anti-infective Cures AG https://druglandscape.com/drug/esomeprazole-magnesium-dihydrate-reference-product https://druglandscape.com/api/og?type=drug&title=Esomeprazole%20magnesium%20dihydrate-Reference%20product&subtitle=Esomeprazole%20magnesium%20dihydrate-Reference%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Esomeprazole magnesium dihydrate-Reference product Esomeprazole magnesium dihydrate-Reference product · Bio-innova Co., Ltd https://druglandscape.com/drug/esomeprazole-magnesium-dihydrate-test-product https://druglandscape.com/api/og?type=drug&title=Esomeprazole%20magnesium%20dihydrate-Test%20product&subtitle=Esomeprazole%20magnesium%20dihydrate-Test%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Esomeprazole magnesium dihydrate-Test product Esomeprazole magnesium dihydrate-Test product · Bio-innova Co., Ltd https://druglandscape.com/drug/esr-114 https://druglandscape.com/api/og?type=drug&title=ESR-114&subtitle=ESR-114%20%C2%B7%20Escalier%20Biosciences%20B.V.&badge=phase%201 ESR-114 ESR-114 · Escalier Biosciences B.V. https://druglandscape.com/drug/estriol-0-1-vaginal-cream https://druglandscape.com/api/og?type=drug&title=Estriol%200.1%25%20vaginal%20cream&subtitle=Estriol%200.1%25%20vaginal%20cream%20%C2%B7%20Meir%20Medical%20Center&badge=phase%202 Estriol 0.1% vaginal cream Estriol 0.1% vaginal cream · Meir Medical Center https://druglandscape.com/drug/estrogen-receptor-antagonist https://druglandscape.com/api/og?type=drug&title=Estrogen%20Receptor%20Antagonist&subtitle=Estrogen%20Receptor%20Antagonist%20%C2%B7%20BeOne%20Medicines&badge=phase%201 Estrogen Receptor Antagonist Estrogen Receptor Antagonist · BeOne Medicines https://druglandscape.com/drug/estrogen-vaginal-use-form https://druglandscape.com/api/og?type=drug&title=Estrogen%20vaginal%20use%20form&subtitle=Estrogen%20vaginal%20use%20form%20%C2%B7%20Koru%20Health%20Groups&badge=phase%201 Estrogen vaginal use form Estrogen vaginal use form · Koru Health Groups https://druglandscape.com/drug/et-02 https://druglandscape.com/api/og?type=drug&title=ET-02&subtitle=ET-02%20%C2%B7%20EdiGene%20(GuangZhou)%20Inc.&badge=phase%201 ET-02 ET-02 · EdiGene (GuangZhou) Inc. https://druglandscape.com/drug/et-stem https://druglandscape.com/api/og?type=drug&title=ET-STEM&subtitle=ET-STEM%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%201 ET-STEM ET-STEM · Samsung Medical Center https://druglandscape.com/drug/et0038 https://druglandscape.com/api/og?type=drug&title=ET0038&subtitle=ET0038%20%C2%B7%20Etern%20BioPharma%20(Shanghai)%20Co.%2C%20Ltd&badge=phase%201 ET0038 ET0038 · Etern BioPharma (Shanghai) Co., Ltd https://druglandscape.com/drug/et0111 https://druglandscape.com/api/og?type=drug&title=ET0111&subtitle=ET0111%20%C2%B7%20Etern%20BioPharma%20(Shanghai)%20Co.%2C%20Ltd&badge=phase%201 ET0111 ET0111 · Etern BioPharma (Shanghai) Co., Ltd https://druglandscape.com/drug/et140203-t-cells https://druglandscape.com/api/og?type=drug&title=ET140203%20T%20Cells&subtitle=ET140203%20T%20Cells%20%C2%B7%20Eureka%20Therapeutics%20Inc.&badge=phase%201 ET140203 T Cells ET140203 T Cells · Eureka Therapeutics Inc. https://druglandscape.com/drug/et743 https://druglandscape.com/api/og?type=drug&title=ET743&subtitle=ET743%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%202 ET743 ET743 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/etanercept-given-by-perispinal-administration https://druglandscape.com/api/og?type=drug&title=etanercept%20given%20by%20perispinal%20administration&subtitle=etanercept%20given%20by%20perispinal%20administration%20%C2%B7%20Tobinick%2C%20Edward%20Lewis%2C%20M.D.&badge=phase%201 etanercept given by perispinal administration etanercept given by perispinal administration · Tobinick, Edward Lewis, M.D. https://druglandscape.com/drug/etbx-071 https://druglandscape.com/api/og?type=drug&title=ETBX-071&subtitle=ETBX-071%20%C2%B7%20ImmunityBio%2C%20Inc.&badge=phase%202 ETBX-071 ETBX-071 · ImmunityBio, Inc. https://druglandscape.com/drug/etd001 https://druglandscape.com/api/og?type=drug&title=ETD001&subtitle=ETD001%20%C2%B7%20Enterprise%20Therapeutics%20Ltd&badge=phase%202 ETD001 ETD001 · Enterprise Therapeutics Ltd https://druglandscape.com/drug/etd001-multiple-once-daily-doses https://druglandscape.com/api/og?type=drug&title=ETD001%20multiple%20once%20daily%20doses&subtitle=ETD001%20multiple%20once%20daily%20doses%20%C2%B7%20Enterprise%20Therapeutics%20Ltd&badge=phase%201 ETD001 multiple once daily doses ETD001 multiple once daily doses · Enterprise Therapeutics Ltd https://druglandscape.com/drug/etd002-14-day-repeat-dose https://druglandscape.com/api/og?type=drug&title=ETD002%20-%2014%20day%20repeat%20dose&subtitle=ETD002%20-%2014%20day%20repeat%20dose%20%C2%B7%20Enterprise%20Therapeutics%20Ltd&badge=phase%201 ETD002 - 14 day repeat dose ETD002 - 14 day repeat dose · Enterprise Therapeutics Ltd https://druglandscape.com/drug/etd002-7-day-repeat-dose https://druglandscape.com/api/og?type=drug&title=ETD002%20-%207%20day%20repeat%20dose&subtitle=ETD002%20-%207%20day%20repeat%20dose%20%C2%B7%20Enterprise%20Therapeutics%20Ltd&badge=phase%201 ETD002 - 7 day repeat dose ETD002 - 7 day repeat dose · Enterprise Therapeutics Ltd https://druglandscape.com/drug/etd002-single-dose https://druglandscape.com/api/og?type=drug&title=ETD002%20-%20single%20dose&subtitle=ETD002%20-%20single%20dose%20%C2%B7%20Enterprise%20Therapeutics%20Ltd&badge=phase%201 ETD002 - single dose ETD002 - single dose · Enterprise Therapeutics Ltd https://druglandscape.com/drug/eth-155008 https://druglandscape.com/api/og?type=drug&title=ETH-155008&subtitle=ETH-155008%20%C2%B7%20Shengke%20Pharmaceuticals%20Pty%20Ltd&badge=phase%201 ETH-155008 ETH-155008 · Shengke Pharmaceuticals Pty Ltd https://druglandscape.com/drug/ethanol-96-gel https://druglandscape.com/api/og?type=drug&title=Ethanol%2096%25%20Gel&subtitle=Ethanol%2096%25%20Gel%20%C2%B7%20Orfagen&badge=phase%202 Ethanol 96% Gel Ethanol 96% Gel · Orfagen https://druglandscape.com/drug/ethanol-98-solution https://druglandscape.com/api/og?type=drug&title=Ethanol%2098%25%20Solution&subtitle=Ethanol%2098%25%20Solution%20%C2%B7%20Orfagen&badge=phase%202 Ethanol 98% Solution Ethanol 98% Solution · Orfagen https://druglandscape.com/drug/ethinyl-estadiol https://druglandscape.com/api/og?type=drug&title=Ethinyl%20Estadiol&subtitle=Ethinyl%20Estadiol%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 Ethinyl Estadiol Ethinyl Estadiol · ViiV Healthcare https://druglandscape.com/drug/ethinyl-estradiol-and-levonorgestrel-exenatide https://druglandscape.com/api/og?type=drug&title=ethinyl%20estradiol%20and%20levonorgestrel%3B%20exenatide&subtitle=ethinyl%20estradiol%20and%20levonorgestrel%3B%20exenatide%20%C2%B7%20AstraZeneca&badge=phase%201 ethinyl estradiol and levonorgestrel; exenatide ethinyl estradiol and levonorgestrel; exenatide · AstraZeneca https://druglandscape.com/drug/ethinyl-estradiol-norethindrone-vi-0521 https://druglandscape.com/api/og?type=drug&title=ethinyl%20estradiol%2C%20norethindrone%2C%20VI-0521&subtitle=ethinyl%20estradiol%2C%20norethindrone%2C%20VI-0521%20%C2%B7%20VIVUS%20LLC&badge=phase%201 ethinyl estradiol, norethindrone, VI-0521 ethinyl estradiol, norethindrone, VI-0521 · VIVUS LLC https://druglandscape.com/drug/ethinylestradiol-and-levonorgestrel https://druglandscape.com/api/og?type=drug&title=Ethinylestradiol%20and%20Levonorgestrel&subtitle=Ethinylestradiol%20and%20Levonorgestrel%20%C2%B7%20Altimmune%2C%20Inc.&badge=phase%201 Ethinylestradiol and Levonorgestrel Ethinylestradiol and Levonorgestrel · Altimmune, Inc. https://druglandscape.com/drug/ethosomal-gel-bearing-losartan-5 https://druglandscape.com/api/og?type=drug&title=Ethosomal%20gel%20bearing%20losartan%205%25&subtitle=Ethosomal%20gel%20bearing%20losartan%205%25%20%C2%B7%20Yuni%20Eka%20Anggraini&badge=phase%201 Ethosomal gel bearing losartan 5% Ethosomal gel bearing losartan 5% · Yuni Eka Anggraini https://druglandscape.com/drug/ethyl-1-14c-idalopirdine https://druglandscape.com/api/og?type=drug&title=%5Bethyl-1-14C%5D-idalopirdine&subtitle=%5Bethyl-1-14C%5D-idalopirdine%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 [ethyl-1-14C]-idalopirdine [ethyl-1-14C]-idalopirdine · H. Lundbeck A/S https://druglandscape.com/drug/ethyl-chloride-topical-aerosol-anesthetic https://druglandscape.com/api/og?type=drug&title=Ethyl%20Chloride%20Topical%20Aerosol%20Anesthetic&subtitle=Ethyl%20Chloride%20Topical%20Aerosol%20Anesthetic%20%C2%B7%20Brooke%20Army%20Medical%20Center&badge=phase%201 Ethyl Chloride Topical Aerosol Anesthetic Ethyl Chloride Topical Aerosol Anesthetic · Brooke Army Medical Center https://druglandscape.com/drug/etiv-a https://druglandscape.com/api/og?type=drug&title=eTIV_a&subtitle=eTIV_a%20%C2%B7%20Novartis&badge=phase%202 eTIV_a eTIV_a · Novartis https://druglandscape.com/drug/etn101 https://druglandscape.com/api/og?type=drug&title=ETN101&subtitle=ETN101%20%C2%B7%20Etnova%20Therapeutics%20Corp.&badge=phase%201 ETN101 ETN101 · Etnova Therapeutics Corp. https://druglandscape.com/drug/etodalac-etoricoxib-and-dexamethasone https://druglandscape.com/api/og?type=drug&title=Etodalac%2C%20Etoricoxib%20and%20Dexamethasone&subtitle=Etodalac%2C%20Etoricoxib%20and%20Dexamethasone%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 Etodalac, Etoricoxib and Dexamethasone Etodalac, Etoricoxib and Dexamethasone · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/etonogestrel-with-testosterone-undecanoate https://druglandscape.com/api/og?type=drug&title=etonogestrel%20with%20testosterone%20undecanoate&subtitle=etonogestrel%20with%20testosterone%20undecanoate%20%C2%B7%20Organon%20and%20Co&badge=phase%202 etonogestrel with testosterone undecanoate etonogestrel with testosterone undecanoate · Organon and Co https://druglandscape.com/drug/etopcoxib-tablets https://druglandscape.com/api/og?type=drug&title=Etopcoxib%20Tablets&subtitle=Etopcoxib%20Tablets%20%C2%B7%20Sichuan%20Kelun%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 Etopcoxib Tablets Etopcoxib Tablets · Sichuan Kelun Pharmaceutical Co., Ltd https://druglandscape.com/drug/etoposide-cyclophosphamide-carboplatin https://druglandscape.com/api/og?type=drug&title=Etoposide%2C%20Cyclophosphamide%2C%20Carboplatin&subtitle=Etoposide%2C%20Cyclophosphamide%2C%20Carboplatin%20%C2%B7%20Xiaohua%20Wu%20MD&badge=phase%202 Etoposide, Cyclophosphamide, Carboplatin Etoposide, Cyclophosphamide, Carboplatin · Xiaohua Wu MD https://druglandscape.com/drug/etoposide-with-carboplatin-or-cisplatin https://druglandscape.com/api/og?type=drug&title=Etoposide%20with%20Carboplatin%20or%20Cisplatin&subtitle=Etoposide%20with%20Carboplatin%20or%20Cisplatin%20%C2%B7%20Trans%20Tasman%20Radiation%20Oncology%20Group&badge=phase%202 Etoposide with Carboplatin or Cisplatin Etoposide with Carboplatin or Cisplatin · Trans Tasman Radiation Oncology Group https://druglandscape.com/drug/etx-19477 https://druglandscape.com/api/og?type=drug&title=ETX-19477&subtitle=ETX-19477%20%C2%B7%20858%20Therapeutics%2C%20Inc.&badge=phase%201 ETX-19477 ETX-19477 · 858 Therapeutics, Inc. https://druglandscape.com/drug/etynodiol-diacetate https://druglandscape.com/api/og?type=drug&title=etynodiol%20diacetate&subtitle=etynodiol%20diacetate%20%C2%B7%20Pfizer&badge=phase%201 etynodiol diacetate etynodiol diacetate · Pfizer https://druglandscape.com/drug/eu-approved-herceptin-sc https://druglandscape.com/api/og?type=drug&title=EU-Approved%20Herceptin%20SC&subtitle=EU-Approved%20Herceptin%20SC%20%C2%B7%20Celltrion&badge=phase%201 EU-Approved Herceptin SC EU-Approved Herceptin SC · Celltrion https://druglandscape.com/drug/eu-approved-neulasta https://druglandscape.com/api/og?type=drug&title=EU-approved%20Neulasta&subtitle=EU-approved%20Neulasta%20%C2%B7%20Pfizer&badge=phase%201 EU-approved Neulasta EU-approved Neulasta · Pfizer https://druglandscape.com/drug/eu-approved-prolia https://druglandscape.com/api/og?type=drug&title=EU-approved%20Prolia&subtitle=EU-approved%20Prolia%20%C2%B7%20Celltrion&badge=phase%201 EU-approved Prolia EU-approved Prolia · Celltrion https://druglandscape.com/drug/eu-approved-stelara https://druglandscape.com/api/og?type=drug&title=EU-approved%20Stelara&subtitle=EU-approved%20Stelara%20%C2%B7%20Celltrion&badge=phase%201 EU-approved Stelara EU-approved Stelara · Celltrion https://druglandscape.com/drug/eu-dupixent https://druglandscape.com/api/og?type=drug&title=EU-Dupixent&subtitle=EU-Dupixent%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 EU-Dupixent EU-Dupixent · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/eu-erbitux https://druglandscape.com/api/og?type=drug&title=EU-Erbitux%C2%AE&subtitle=EU-Erbitux%C2%AE%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 EU-Erbitux® EU-Erbitux® · Shanghai Henlius Biotech https://druglandscape.com/drug/eu-herceptin https://druglandscape.com/api/og?type=drug&title=EU-Herceptin&subtitle=EU-Herceptin%20%C2%B7%20Prestige%20Biopharma%20Limited&badge=phase%201 EU-Herceptin EU-Herceptin · Prestige Biopharma Limited https://druglandscape.com/drug/eu-humalog https://druglandscape.com/api/og?type=drug&title=EU-Humalog%C2%AE&subtitle=EU-Humalog%C2%AE%20%C2%B7%20Xentria%2C%20Inc.&badge=phase%201 EU-Humalog® EU-Humalog® · Xentria, Inc. https://druglandscape.com/drug/eu-lantus https://druglandscape.com/api/og?type=drug&title=EU-Lantus%E2%84%A2&subtitle=EU-Lantus%E2%84%A2%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 EU-Lantus™ EU-Lantus™ · Merck Sharp & Dohme LLC https://druglandscape.com/drug/eu-licensed-herceptin https://druglandscape.com/api/og?type=drug&title=EU-licensed%20Herceptin&subtitle=EU-licensed%20Herceptin%20%C2%B7%20Alteogen%2C%20Inc.&badge=phase%201 EU-licensed Herceptin EU-licensed Herceptin · Alteogen, Inc. https://druglandscape.com/drug/eu-licensed-humira https://druglandscape.com/api/og?type=drug&title=EU-licensed%20Humira&subtitle=EU-licensed%20Humira%20%C2%B7%20Prestige%20Biopharma%20Limited&badge=phase%201 EU-licensed Humira EU-licensed Humira · Prestige Biopharma Limited https://druglandscape.com/drug/eu-neulasta https://druglandscape.com/api/og?type=drug&title=EU-Neulasta&subtitle=EU-Neulasta%20%C2%B7%20Mylan%20Inc.&badge=phase%201 EU-Neulasta EU-Neulasta · Mylan Inc. https://druglandscape.com/drug/eu-novorapid https://druglandscape.com/api/og?type=drug&title=EU-NovoRapid%C2%AE&subtitle=EU-NovoRapid%C2%AE%20%C2%B7%20Xentria%2C%20Inc.&badge=phase%201 EU-NovoRapid® EU-NovoRapid® · Xentria, Inc. https://druglandscape.com/drug/eu-source-enbrel https://druglandscape.com/api/og?type=drug&title=EU%20Source%20Enbrel&subtitle=EU%20Source%20Enbrel%20%C2%B7%20mAbxience%20Research%20S.L.&badge=phase%201 EU Source Enbrel EU Source Enbrel · mAbxience Research S.L. https://druglandscape.com/drug/eu-sourced-cerezyme https://druglandscape.com/api/og?type=drug&title=EU-sourced%20Cerezyme&subtitle=EU-sourced%20Cerezyme%20%C2%B7%20ISU%20Abxis%20Co.%2C%20Ltd.&badge=phase%201 EU-sourced Cerezyme EU-sourced Cerezyme · ISU Abxis Co., Ltd. https://druglandscape.com/drug/eu-sourced-darzalex https://druglandscape.com/api/og?type=drug&title=EU-sourced%20DARZALEX%C2%AE&subtitle=EU-sourced%20DARZALEX%C2%AE%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 EU-sourced DARZALEX® EU-sourced DARZALEX® · Shanghai Henlius Biotech https://druglandscape.com/drug/eu-sourced-enbrel https://druglandscape.com/api/og?type=drug&title=EU%20sourced%20Enbrel&subtitle=EU%20sourced%20Enbrel%20%C2%B7%20Samsung%20Bioepis%20Co.%2C%20Ltd.&badge=phase%201 EU sourced Enbrel EU sourced Enbrel · Samsung Bioepis Co., Ltd. https://druglandscape.com/drug/eu-sourced-herceptin https://druglandscape.com/api/og?type=drug&title=EU%20sourced%20Herceptin%C2%AE&subtitle=EU%20sourced%20Herceptin%C2%AE%20%C2%B7%20Samsung%20Bioepis%20Co.%2C%20Ltd.&badge=phase%201 EU sourced Herceptin® EU sourced Herceptin® · Samsung Bioepis Co., Ltd. https://druglandscape.com/drug/eu-sourced-humira https://druglandscape.com/api/og?type=drug&title=EU%20sourced%20Humira%C2%AE&subtitle=EU%20sourced%20Humira%C2%AE%20%C2%B7%20Samsung%20Bioepis%20Co.%2C%20Ltd.&badge=phase%201 EU sourced Humira® EU sourced Humira® · Samsung Bioepis Co., Ltd. https://druglandscape.com/drug/eu-sourced-ipilimumab-group https://druglandscape.com/api/og?type=drug&title=EU-sourced%20ipilimumab%20group&subtitle=EU-sourced%20ipilimumab%20group%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 EU-sourced ipilimumab group EU-sourced ipilimumab group · Shanghai Henlius Biotech https://druglandscape.com/drug/eu-sourced-orencia https://druglandscape.com/api/og?type=drug&title=EU-Sourced%20Orencia%C2%AE&subtitle=EU-Sourced%20Orencia%C2%AE%20%C2%B7%20Momenta%20Pharmaceuticals%2C%20Inc.&badge=phase%201 EU-Sourced Orencia® EU-Sourced Orencia® · Momenta Pharmaceuticals, Inc. https://druglandscape.com/drug/eu-sourced-prolia https://druglandscape.com/api/og?type=drug&title=EU%20Sourced%20Prolia&subtitle=EU%20Sourced%20Prolia%20%C2%B7%20Enzene%20Biosciences%20Ltd.&badge=phase%201 EU Sourced Prolia EU Sourced Prolia · Enzene Biosciences Ltd. https://druglandscape.com/drug/eu-synagis https://druglandscape.com/api/og?type=drug&title=EU-Synagis%C2%AE&subtitle=EU-Synagis%C2%AE%20%C2%B7%20mAbxience%20Research%20S.L.&badge=phase%201 EU-Synagis® EU-Synagis® · mAbxience Research S.L. https://druglandscape.com/drug/eu101 https://druglandscape.com/api/og?type=drug&title=EU101&subtitle=EU101%20%C2%B7%20Eutilex&badge=phase%201 EU101 EU101 · Eutilex https://druglandscape.com/drug/eu103 https://druglandscape.com/api/og?type=drug&title=EU103&subtitle=EU103%20%C2%B7%20Eutilex&badge=phase%201 EU103 EU103 · Eutilex https://druglandscape.com/drug/eu307-car-t-cell https://druglandscape.com/api/og?type=drug&title=EU307%20CAR-T%20Cell&subtitle=EU307%20CAR-T%20Cell%20%C2%B7%20Eutilex&badge=phase%201 EU307 CAR-T Cell EU307 CAR-T Cell · Eutilex https://druglandscape.com/drug/euglycemic-clamp-with-humalog https://druglandscape.com/api/og?type=drug&title=Euglycemic%20clamp%20with%20Humalog%C2%AE&subtitle=Euglycemic%20clamp%20with%20Humalog%C2%AE%20%C2%B7%20Adocia&badge=phase%201 Euglycemic clamp with Humalog® Euglycemic clamp with Humalog® · Adocia https://druglandscape.com/drug/euglycemic-clamp-with-humalog-and-lantus https://druglandscape.com/api/og?type=drug&title=Euglycemic%20clamp%20with%20Humalog%C2%AE%20and%20Lantus%C2%AE&subtitle=Euglycemic%20clamp%20with%20Humalog%C2%AE%20and%20Lantus%C2%AE%20%C2%B7%20Adocia&badge=phase%201 Euglycemic clamp with Humalog® and Lantus® Euglycemic clamp with Humalog® and Lantus® · Adocia https://druglandscape.com/drug/euglycemic-clamp-with-humalog-mix25 https://druglandscape.com/api/og?type=drug&title=Euglycemic%20clamp%20with%20Humalog%C2%AE%20Mix25&subtitle=Euglycemic%20clamp%20with%20Humalog%C2%AE%20Mix25%20%C2%B7%20Adocia&badge=phase%201 Euglycemic clamp with Humalog® Mix25 Euglycemic clamp with Humalog® Mix25 · Adocia https://druglandscape.com/drug/euglycemic-hyperinsulinemic-clamp https://druglandscape.com/api/og?type=drug&title=euglycemic%20hyperinsulinemic%20clamp&subtitle=euglycemic%20hyperinsulinemic%20clamp%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 euglycemic hyperinsulinemic clamp euglycemic hyperinsulinemic clamp · Hospices Civils de Lyon https://druglandscape.com/drug/eunmcv-5 https://druglandscape.com/api/og?type=drug&title=EuNmCV-5&subtitle=EuNmCV-5%20%C2%B7%20EuBiologics%20Co.%2CLtd&badge=phase%201 EuNmCV-5 EuNmCV-5 · EuBiologics Co.,Ltd https://druglandscape.com/drug/eupcv15 https://druglandscape.com/api/og?type=drug&title=EuPCV15&subtitle=EuPCV15%20%C2%B7%20EuBiologics%20Co.%2CLtd&badge=phase%201 EuPCV15 EuPCV15 · EuBiologics Co.,Ltd https://druglandscape.com/drug/eurartesim-film-coated-tablet https://druglandscape.com/api/og?type=drug&title=eurartesim%20film%20coated%20tablet&subtitle=eurartesim%20film%20coated%20tablet%20%C2%B7%20sigma-tau%20i.f.r.%20S.p.A.&badge=phase%202 eurartesim film coated tablet eurartesim film coated tablet · sigma-tau i.f.r. S.p.A. https://druglandscape.com/drug/european-taxotere https://druglandscape.com/api/og?type=drug&title=European%20Taxotere%C2%AE&subtitle=European%20Taxotere%C2%AE%20%C2%B7%20Hospira%2C%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 European Taxotere® European Taxotere® · Hospira, now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/eursv https://druglandscape.com/api/og?type=drug&title=EuRSV&subtitle=EuRSV%20%C2%B7%20EuBiologics%20Co.%2CLtd&badge=phase%201 EuRSV EuRSV · EuBiologics Co.,Ltd https://druglandscape.com/drug/eutirox https://druglandscape.com/api/og?type=drug&title=Eutirox%C2%AE&subtitle=Eutirox%C2%AE%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 Eutirox® Eutirox® · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/ev71-with-adjuvant-aluminium-phosphate https://druglandscape.com/api/og?type=drug&title=EV71%20with%20adjuvant%20aluminium%20phosphate&subtitle=EV71%20with%20adjuvant%20aluminium%20phosphate%20%C2%B7%20Medigen%20Vaccine%20Biologics%20Corp.&badge=phase%202 EV71 with adjuvant aluminium phosphate EV71 with adjuvant aluminium phosphate · Medigen Vaccine Biologics Corp. https://druglandscape.com/drug/evacetrapib-intravenous https://druglandscape.com/api/og?type=drug&title=Evacetrapib%20Intravenous&subtitle=Evacetrapib%20Intravenous%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Evacetrapib Intravenous Evacetrapib Intravenous · Eli Lilly and Company https://druglandscape.com/drug/evacetrapib-tablet https://druglandscape.com/api/og?type=drug&title=Evacetrapib%20Tablet&subtitle=Evacetrapib%20Tablet%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Evacetrapib Tablet Evacetrapib Tablet · Eli Lilly and Company https://druglandscape.com/drug/ever001 https://druglandscape.com/api/og?type=drug&title=EVER001&subtitle=EVER001%20%C2%B7%20Everest%20Medicines%20(China)%20Co.%2CLtd.&badge=phase%201 EVER001 EVER001 · Everest Medicines (China) Co.,Ltd. https://druglandscape.com/drug/ever4010001 https://druglandscape.com/api/og?type=drug&title=EVER4010001&subtitle=EVER4010001%20%C2%B7%20EverNov%20Medicines%20(Zhuhai%20Hengqin)%20Co.%2C%20Ltd&badge=phase%201 EVER4010001 EVER4010001 · EverNov Medicines (Zhuhai Hengqin) Co., Ltd https://druglandscape.com/drug/everolimus-and-exemestane https://druglandscape.com/api/og?type=drug&title=Everolimus%20and%20exemestane&subtitle=Everolimus%20and%20exemestane%20%C2%B7%20Novartis%20Healthcare%20A%2FS&badge=phase%202 Everolimus and exemestane Everolimus and exemestane · Novartis Healthcare A/S https://druglandscape.com/drug/everolimus-and-rituximab https://druglandscape.com/api/og?type=drug&title=Everolimus%20and%20rituximab&subtitle=Everolimus%20and%20rituximab%20%C2%B7%20The%20Lymphoma%20Academic%20Research%20Organisation&badge=phase%201 Everolimus and rituximab Everolimus and rituximab · The Lymphoma Academic Research Organisation https://druglandscape.com/drug/everolimus-eluting-coronary-stent-system https://druglandscape.com/api/og?type=drug&title=Everolimus%20Eluting%20Coronary%20Stent%20System&subtitle=Everolimus%20Eluting%20Coronary%20Stent%20System%20%C2%B7%20Spanish%20Society%20of%20Cardiology&badge=phase%202 Everolimus Eluting Coronary Stent System Everolimus Eluting Coronary Stent System · Spanish Society of Cardiology https://druglandscape.com/drug/everolimus-plus-exemestane https://druglandscape.com/api/og?type=drug&title=Everolimus%20plus%20Exemestane&subtitle=Everolimus%20plus%20Exemestane%20%C2%B7%20Amsterdam%20UMC%2C%20location%20VUmc&badge=phase%201 Everolimus plus Exemestane Everolimus plus Exemestane · Amsterdam UMC, location VUmc https://druglandscape.com/drug/evm14 https://druglandscape.com/api/og?type=drug&title=EVM14&subtitle=EVM14%20%C2%B7%20Everest%20Medicines%20(Beijing)%20Co.%2C%20Ltd.&badge=phase%201 EVM14 EVM14 · Everest Medicines (Beijing) Co., Ltd. https://druglandscape.com/drug/evobrutinib-mr-t-adapated https://druglandscape.com/api/og?type=drug&title=Evobrutinib%20MR-T%20adapated&subtitle=Evobrutinib%20MR-T%20adapated%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20D&badge=phase%201 Evobrutinib MR-T adapated Evobrutinib MR-T adapated · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/evobrutinib-mr-t1 https://druglandscape.com/api/og?type=drug&title=Evobrutinib%20MR-T1&subtitle=Evobrutinib%20MR-T1%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt&badge=phase%201 Evobrutinib MR-T1 Evobrutinib MR-T1 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/evobrutinib-mr-t2 https://druglandscape.com/api/og?type=drug&title=Evobrutinib%20MR-T2&subtitle=Evobrutinib%20MR-T2%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt&badge=phase%201 Evobrutinib MR-T2 Evobrutinib MR-T2 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/evobrutinib-mr-t3 https://druglandscape.com/api/og?type=drug&title=Evobrutinib%20MR-T3&subtitle=Evobrutinib%20MR-T3%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt&badge=phase%201 Evobrutinib MR-T3 Evobrutinib MR-T3 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/evobrutinib-mr-t4 https://druglandscape.com/api/og?type=drug&title=Evobrutinib%20MR-T4&subtitle=Evobrutinib%20MR-T4%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt&badge=phase%201 Evobrutinib MR-T4 Evobrutinib MR-T4 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/evobrutinib-mups-c1 https://druglandscape.com/api/og?type=drug&title=Evobrutinib%20MUPS-C1&subtitle=Evobrutinib%20MUPS-C1%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmsta&badge=phase%201 Evobrutinib MUPS-C1 Evobrutinib MUPS-C1 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/evobrutinib-mups-c2 https://druglandscape.com/api/og?type=drug&title=Evobrutinib%20MUPS-C2&subtitle=Evobrutinib%20MUPS-C2%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmsta&badge=phase%201 Evobrutinib MUPS-C2 Evobrutinib MUPS-C2 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/evobrutinib-mups-c3 https://druglandscape.com/api/og?type=drug&title=Evobrutinib%20MUPS-C3&subtitle=Evobrutinib%20MUPS-C3%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmsta&badge=phase%201 Evobrutinib MUPS-C3 Evobrutinib MUPS-C3 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/evobrutinib-mups-c4 https://druglandscape.com/api/og?type=drug&title=Evobrutinib%20MUPS-C4&subtitle=Evobrutinib%20MUPS-C4%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmsta&badge=phase%201 Evobrutinib MUPS-C4 Evobrutinib MUPS-C4 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/evolocumab-drug-substance-a https://druglandscape.com/api/og?type=drug&title=Evolocumab%20Drug%20Substance%20A&subtitle=Evolocumab%20Drug%20Substance%20A%20%C2%B7%20Amgen&badge=phase%201 Evolocumab Drug Substance A Evolocumab Drug Substance A · Amgen https://druglandscape.com/drug/evolocumab-drug-substance-b https://druglandscape.com/api/og?type=drug&title=Evolocumab%20Drug%20Substance%20B&subtitle=Evolocumab%20Drug%20Substance%20B%20%C2%B7%20Amgen&badge=phase%201 Evolocumab Drug Substance B Evolocumab Drug Substance B · Amgen https://druglandscape.com/drug/evolve104 https://druglandscape.com/api/og?type=drug&title=EVOLVE104&subtitle=EVOLVE104%20%C2%B7%20EvolveImmune%20United%2C%20Inc&badge=phase%201 EVOLVE104 EVOLVE104 · EvolveImmune United, Inc https://druglandscape.com/drug/evp-6308 https://druglandscape.com/api/og?type=drug&title=EVP-6308&subtitle=EVP-6308%20%C2%B7%20FORUM%20Pharmaceuticals%20Inc&badge=phase%201 EVP-6308 EVP-6308 · FORUM Pharmaceuticals Inc https://druglandscape.com/drug/evt-201 https://druglandscape.com/api/og?type=drug&title=EVT%20201&subtitle=EVT%20201%20%C2%B7%20Evotec%20Neurosciences%20GmbH&badge=phase%202 EVT 201 EVT 201 · Evotec Neurosciences GmbH https://druglandscape.com/drug/evt801 https://druglandscape.com/api/og?type=drug&title=EVT801&subtitle=EVT801%20%C2%B7%20Kazia%20Therapeutics%20Limited&badge=phase%201 EVT801 EVT801 · Kazia Therapeutics Limited https://druglandscape.com/drug/ex-9-infusion https://druglandscape.com/api/og?type=drug&title=Ex-9%20infusion&subtitle=Ex-9%20infusion%20%C2%B7%20David%20D'Alessio%2C%20M.D.&badge=phase%201 Ex-9 infusion Ex-9 infusion · David D'Alessio, M.D. https://druglandscape.com/drug/ex-vivo-activated-immune-cells https://druglandscape.com/api/og?type=drug&title=ex%20vivo%20Activated%20Immune%20Cells&subtitle=ex%20vivo%20Activated%20Immune%20Cells%20%C2%B7%20B%20%26%20Y%20Technologies&badge=phase%201 ex vivo Activated Immune Cells ex vivo Activated Immune Cells · B & Y Technologies https://druglandscape.com/drug/ex-vivo-expanded-effector-cells https://druglandscape.com/api/og?type=drug&title=Ex-vivo%20expanded%20effector%20cells&subtitle=Ex-vivo%20expanded%20effector%20cells%20%C2%B7%20Dartmouth-Hitchcock%20Medical%20Center&badge=phase%202 Ex-vivo expanded effector cells Ex-vivo expanded effector cells · Dartmouth-Hitchcock Medical Center https://druglandscape.com/drug/ex-vivo-immunotherapy https://druglandscape.com/api/og?type=drug&title=Ex%20vivo%20immunotherapy&subtitle=Ex%20vivo%20immunotherapy%20%C2%B7%20Shenzhen%20Zhongxing%20Yangfan%20Biotech%20Co.%20Ltd.&badge=phase%201 Ex vivo immunotherapy Ex vivo immunotherapy · Shenzhen Zhongxing Yangfan Biotech Co. Ltd. https://druglandscape.com/drug/ex5619 https://druglandscape.com/api/og?type=drug&title=EX5619&subtitle=EX5619%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 EX5619 EX5619 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/exe-346 https://druglandscape.com/api/og?type=drug&title=EXE-346&subtitle=EXE-346%20%C2%B7%20Exegi%20Pharma%2C%20LLC&badge=phase%201 EXE-346 EXE-346 · Exegi Pharma, LLC https://druglandscape.com/drug/exenatide-once-monthly-suspension https://druglandscape.com/api/og?type=drug&title=exenatide%20once%20monthly%20suspension&subtitle=exenatide%20once%20monthly%20suspension%20%C2%B7%20AstraZeneca&badge=phase%202 exenatide once monthly suspension exenatide once monthly suspension · AstraZeneca https://druglandscape.com/drug/exenatide-twice-daily https://druglandscape.com/api/og?type=drug&title=exenatide%20twice%20daily&subtitle=exenatide%20twice%20daily%20%C2%B7%20AstraZeneca&badge=phase%203 exenatide twice daily exenatide twice daily · AstraZeneca https://druglandscape.com/drug/exercise-under-inhalation-co2 https://druglandscape.com/api/og?type=drug&title=Exercise%20under%20inhalation%20CO2&subtitle=Exercise%20under%20inhalation%20CO2%20%C2%B7%20State%20Key%20Laboratory%20of%20Respiratory%20Disease&badge=phase%201 Exercise under inhalation CO2 Exercise under inhalation CO2 · State Key Laboratory of Respiratory Disease https://druglandscape.com/drug/exg34217 https://druglandscape.com/api/og?type=drug&title=EXG34217&subtitle=EXG34217%20%C2%B7%20Elixirgen%20Therapeutics%2C%20Inc.&badge=phase%201 EXG34217 EXG34217 · Elixirgen Therapeutics, Inc. https://druglandscape.com/drug/exhaled-breath-collection https://druglandscape.com/api/og?type=drug&title=exhaled%20breath%20collection&subtitle=exhaled%20breath%20collection%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 exhaled breath collection exhaled breath collection · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/existing-depression-medication-treatment https://druglandscape.com/api/og?type=drug&title=Existing%20depression%20medication%20treatment&subtitle=Existing%20depression%20medication%20treatment%20%C2%B7%20Centre%20for%20Addiction%20and%20Mental%20Health&badge=phase%201 Existing depression medication treatment Existing depression medication treatment · Centre for Addiction and Mental Health https://druglandscape.com/drug/existing-formulations-of-611 https://druglandscape.com/api/og?type=drug&title=existing%20formulations%20of%20611&subtitle=existing%20formulations%20of%20611%20%C2%B7%20Sunshine%20Guojian%20Pharmaceutical%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 existing formulations of 611 existing formulations of 611 · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. https://druglandscape.com/drug/exosome-preparation https://druglandscape.com/api/og?type=drug&title=Exosome%20Preparation&subtitle=Exosome%20Preparation%20%C2%B7%20Guangdong%20ProCapZoom%20Biosciences%20Co.%2C%20Ltd.&badge=phase%201 Exosome Preparation Exosome Preparation · Guangdong ProCapZoom Biosciences Co., Ltd. https://druglandscape.com/drug/exosome-therapy https://druglandscape.com/api/og?type=drug&title=Exosome%20Therapy&subtitle=Exosome%20Therapy%20%C2%B7%20Iffat%20Anwar%20Medical%20Complex&badge=phase%201 Exosome Therapy Exosome Therapy · Iffat Anwar Medical Complex https://druglandscape.com/drug/expec10v https://druglandscape.com/api/og?type=drug&title=ExPEC10V&subtitle=ExPEC10V%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 ExPEC10V ExPEC10V · Janssen Research & Development, LLC https://druglandscape.com/drug/expec4v https://druglandscape.com/api/og?type=drug&title=ExPEC4V&subtitle=ExPEC4V%20%C2%B7%20Janssen%20Pharmaceutical%20K.K.&badge=phase%202 ExPEC4V ExPEC4V · Janssen Pharmaceutical K.K. https://druglandscape.com/drug/experimental-antibiotics https://druglandscape.com/api/og?type=drug&title=Experimental%20Antibiotics&subtitle=Experimental%20Antibiotics%20%C2%B7%20Osteal%20Therapeutics%2C%20Inc.&badge=phase%202 Experimental Antibiotics Experimental Antibiotics · Osteal Therapeutics, Inc. https://druglandscape.com/drug/experimental-arm-imc-003 https://druglandscape.com/api/og?type=drug&title=experimental%20Arm%20IMC-003&subtitle=experimental%20Arm%20IMC-003%20%C2%B7%20ImmuneOnco%20Biopharmaceuticals%20(Shanghai)%20Inc.&badge=phase%201 experimental Arm IMC-003 experimental Arm IMC-003 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. https://druglandscape.com/drug/experimental-arm-tocosol-paclitaxel https://druglandscape.com/api/og?type=drug&title=Experimental%20Arm%3A%20TOCOSOL%20Paclitaxel&subtitle=Experimental%20Arm%3A%20TOCOSOL%20Paclitaxel%20%C2%B7%20Achieve%20Life%20Sciences&badge=phase%202 Experimental Arm: TOCOSOL Paclitaxel Experimental Arm: TOCOSOL Paclitaxel · Achieve Life Sciences https://druglandscape.com/drug/experimental-b244 https://druglandscape.com/api/og?type=drug&title=Experimental%3A%20B244&subtitle=Experimental%3A%20B244%20%C2%B7%20AOBiome%20LLC&badge=phase%201 Experimental: B244 Experimental: B244 · AOBiome LLC https://druglandscape.com/drug/experimental-bapineuzumab https://druglandscape.com/api/og?type=drug&title=Experimental%20Bapineuzumab&subtitle=Experimental%20Bapineuzumab%20%C2%B7%20JANSSEN%20Alzheimer%20Immunotherapy%20Research%20%26%20Development%2C%20LLC&badge=phase%202 Experimental Bapineuzumab Experimental Bapineuzumab · JANSSEN Alzheimer Immunotherapy Research & Development, LLC https://druglandscape.com/drug/experimental-bhvi2 https://druglandscape.com/api/og?type=drug&title=Experimental%20BHVI2&subtitle=Experimental%20BHVI2%20%C2%B7%20Hai%20Yen%20Eye%20Care&badge=phase%201 Experimental BHVI2 Experimental BHVI2 · Hai Yen Eye Care https://druglandscape.com/drug/experimental-cd07223-1-5-topical-gel-bid https://druglandscape.com/api/og?type=drug&title=Experimental%3A%20CD07223%201.5%20%25%20Topical%20Gel%20BID&subtitle=Experimental%3A%20CD07223%201.5%20%25%20Topical%20Gel%20BID%20%C2%B7%20NovaBay%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Experimental: CD07223 1.5 % Topical Gel BID Experimental: CD07223 1.5 % Topical Gel BID · NovaBay Pharmaceuticals, Inc. https://druglandscape.com/drug/experimental-cotadutide https://druglandscape.com/api/og?type=drug&title=Experimental%3A%20Cotadutide&subtitle=Experimental%3A%20Cotadutide%20%C2%B7%20AstraZeneca&badge=phase%201 Experimental: Cotadutide Experimental: Cotadutide · AstraZeneca https://druglandscape.com/drug/experimental-dentifrice https://druglandscape.com/api/og?type=drug&title=Experimental%20Dentifrice&subtitle=Experimental%20Dentifrice%20%C2%B7%20HALEON&badge=phase%201 Experimental Dentifrice Experimental Dentifrice · HALEON https://druglandscape.com/drug/experimental-dentifrice-1 https://druglandscape.com/api/og?type=drug&title=Experimental%20Dentifrice%201&subtitle=Experimental%20Dentifrice%201%20%C2%B7%20HALEON&badge=phase%201 Experimental Dentifrice 1 Experimental Dentifrice 1 · HALEON https://druglandscape.com/drug/experimental-drug-9mw1911 https://druglandscape.com/api/og?type=drug&title=Experimental%20drug%209MW1911&subtitle=Experimental%20drug%209MW1911%20%C2%B7%20Mabwell%20(Shanghai)%20Bioscience%20Co.%2C%20Ltd.&badge=phase%201 Experimental drug 9MW1911 Experimental drug 9MW1911 · Mabwell (Shanghai) Bioscience Co., Ltd. https://druglandscape.com/drug/experimental-evp-6124 https://druglandscape.com/api/og?type=drug&title=Experimental%3A%20EVP-6124&subtitle=Experimental%3A%20EVP-6124%20%C2%B7%20FORUM%20Pharmaceuticals%20Inc&badge=phase%201 Experimental: EVP-6124 Experimental: EVP-6124 · FORUM Pharmaceuticals Inc https://druglandscape.com/drug/experimental-las-41004-dosage-2 https://druglandscape.com/api/og?type=drug&title=Experimental%3A%20LAS%2041004%20dosage%202&subtitle=Experimental%3A%20LAS%2041004%20dosage%202%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%202 Experimental: LAS 41004 dosage 2 Experimental: LAS 41004 dosage 2 · Almirall, S.A. https://druglandscape.com/drug/experimental-las-41004-dosage-3 https://druglandscape.com/api/og?type=drug&title=Experimental%3A%20LAS%2041004%20dosage%203&subtitle=Experimental%3A%20LAS%2041004%20dosage%203%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%202 Experimental: LAS 41004 dosage 3 Experimental: LAS 41004 dosage 3 · Almirall, S.A. https://druglandscape.com/drug/experimental-mouth-rinse https://druglandscape.com/api/og?type=drug&title=Experimental%20Mouth%20Rinse&subtitle=Experimental%20Mouth%20Rinse%20%C2%B7%20Johnson%20%26%20Johnson%20Consumer%20and%20Personal%20Products%20Worldwide&badge=phase%201 Experimental Mouth Rinse Experimental Mouth Rinse · Johnson & Johnson Consumer and Personal Products Worldwide https://druglandscape.com/drug/experimental-mouthwash https://druglandscape.com/api/og?type=drug&title=Experimental%20Mouthwash&subtitle=Experimental%20Mouthwash%20%C2%B7%20HALEON&badge=phase%201 Experimental Mouthwash Experimental Mouthwash · HALEON https://druglandscape.com/drug/experimental-paxlovid-15-day-dosing https://druglandscape.com/api/og?type=drug&title=Experimental%3A%20Paxlovid%2015%20day%20dosing&subtitle=Experimental%3A%20Paxlovid%2015%20day%20dosing%20%C2%B7%20Kanecia%20Obie%20Zimmerman&badge=phase%202 Experimental: Paxlovid 15 day dosing Experimental: Paxlovid 15 day dosing · Kanecia Obie Zimmerman https://druglandscape.com/drug/experimental-product https://druglandscape.com/api/og?type=drug&title=Experimental%20Product&subtitle=Experimental%20Product%20%C2%B7%20Johnson%20%26%20Johnson%20Consumer%20Inc.%20(J%26JCI)&badge=phase%201 Experimental Product Experimental Product · Johnson & Johnson Consumer Inc. (J&JCI) https://druglandscape.com/drug/experimental-protesomal-vaccine-2-x-15-g https://druglandscape.com/api/og?type=drug&title=Experimental%3A%20Protesomal%20Vaccine%202%20x%2015%20%C2%B5g&subtitle=Experimental%3A%20Protesomal%20Vaccine%202%20x%2015%20%C2%B5g%20%C2%B7%20Hvivo&badge=phase%201 Experimental: Protesomal Vaccine 2 x 15 µg Experimental: Protesomal Vaccine 2 x 15 µg · Hvivo https://druglandscape.com/drug/experimental-protesomal-vaccine-2-x-30-g https://druglandscape.com/api/og?type=drug&title=Experimental%3A%20Protesomal%20Vaccine%202%20x%2030%20%C2%B5g&subtitle=Experimental%3A%20Protesomal%20Vaccine%202%20x%2030%20%C2%B5g%20%C2%B7%20Hvivo&badge=phase%201 Experimental: Protesomal Vaccine 2 x 30 µg Experimental: Protesomal Vaccine 2 x 30 µg · Hvivo https://druglandscape.com/drug/experimental-tazarotene-gel https://druglandscape.com/api/og?type=drug&title=Experimental%20Tazarotene%20Gel&subtitle=Experimental%20Tazarotene%20Gel%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%202 Experimental Tazarotene Gel Experimental Tazarotene Gel · Almirall, S.A. https://druglandscape.com/drug/exploratory-investigation https://druglandscape.com/api/og?type=drug&title=Exploratory%20investigation&subtitle=Exploratory%20investigation%20%C2%B7%20Centre%20Oscar%20Lambret&badge=phase%201 Exploratory investigation Exploratory investigation · Centre Oscar Lambret https://druglandscape.com/drug/exposed-group https://druglandscape.com/api/og?type=drug&title=Exposed%20group&subtitle=Exposed%20group%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Exposed group Exposed group · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/exposure-covid-19-severity https://druglandscape.com/api/og?type=drug&title=Exposure%3A%20COVID-19%20severity&subtitle=Exposure%3A%20COVID-19%20severity%20%C2%B7%20Pontificia%20Universidad%20Catolica%20de%20Chile&badge=phase%202 Exposure: COVID-19 severity Exposure: COVID-19 severity · Pontificia Universidad Catolica de Chile https://druglandscape.com/drug/exposure-to-ergot https://druglandscape.com/api/og?type=drug&title=Exposure%20to%20Ergot&subtitle=Exposure%20to%20Ergot%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%202 Exposure to Ergot Exposure to Ergot · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/exs21546-granule-in-capsule https://druglandscape.com/api/og?type=drug&title=EXS21546%20Granule%20in%20Capsule&subtitle=EXS21546%20Granule%20in%20Capsule%20%C2%B7%20Exscientia%20AI%20Limited&badge=phase%201 EXS21546 Granule in Capsule EXS21546 Granule in Capsule · Exscientia AI Limited https://druglandscape.com/drug/exs73565 https://druglandscape.com/api/og?type=drug&title=EXS73565&subtitle=EXS73565%20%C2%B7%20Exscientia%20AI%20Ltd.%2C%20a%20wholly%20owned%20subsidiary%20of%20Recursion%20Pharmaceuticals%2C%20Inc.&badge=phase%201 EXS73565 EXS73565 · Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. https://druglandscape.com/drug/ext608 https://druglandscape.com/api/og?type=drug&title=EXT608&subtitle=EXT608%20%C2%B7%20Extend%20Biosciences%20Inc.&badge=phase%202 EXT608 EXT608 · Extend Biosciences Inc. https://druglandscape.com/drug/extended-imipenem https://druglandscape.com/api/og?type=drug&title=Extended%20Imipenem&subtitle=Extended%20Imipenem%20%C2%B7%20Coordinaci%C3%B3n%20de%20Investigaci%C3%B3n%20en%20Salud%2C%20Mexico&badge=phase%201 Extended Imipenem Extended Imipenem · Coordinación de Investigación en Salud, Mexico https://druglandscape.com/drug/extended-letrozole-therapy https://druglandscape.com/api/og?type=drug&title=Extended%20Letrozole%20Therapy&subtitle=Extended%20Letrozole%20Therapy%20%C2%B7%20GABRIEL%20MONTEIRO%20PINHEIRO&badge=phase%201 Extended Letrozole Therapy Extended Letrozole Therapy · GABRIEL MONTEIRO PINHEIRO https://druglandscape.com/drug/extended-meropenem https://druglandscape.com/api/og?type=drug&title=Extended%20Meropenem&subtitle=Extended%20Meropenem%20%C2%B7%20Coordinaci%C3%B3n%20de%20Investigaci%C3%B3n%20en%20Salud%2C%20Mexico&badge=phase%201 Extended Meropenem Extended Meropenem · Coordinación de Investigación en Salud, Mexico https://druglandscape.com/drug/extended-release-of-octreotide https://druglandscape.com/api/og?type=drug&title=extended%20release%20of%20octreotide&subtitle=extended%20release%20of%20octreotide%20%C2%B7%20Chemi%20S.p.A.&badge=phase%202 extended release of octreotide extended release of octreotide · Chemi S.p.A. https://druglandscape.com/drug/extra-blood-draw https://druglandscape.com/api/og?type=drug&title=Extra%20Blood%20Draw&subtitle=Extra%20Blood%20Draw%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 Extra Blood Draw Extra Blood Draw · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/extract-of-green-and-black-tea https://druglandscape.com/api/og?type=drug&title=Extract%20of%20Green%20and%20Black%20Tea&subtitle=Extract%20of%20Green%20and%20Black%20Tea%20%C2%B7%20Dartmouth-Hitchcock%20Medical%20Center&badge=phase%202 Extract of Green and Black Tea Extract of Green and Black Tea · Dartmouth-Hitchcock Medical Center https://druglandscape.com/drug/extracted-capsules-13-cra https://druglandscape.com/api/og?type=drug&title=Extracted%20capsules%2013-CRA&subtitle=Extracted%20capsules%2013-CRA%20%C2%B7%20Nova%20Laboratories%20Limited&badge=phase%201 Extracted capsules 13-CRA Extracted capsules 13-CRA · Nova Laboratories Limited https://druglandscape.com/drug/exv-802 https://druglandscape.com/api/og?type=drug&title=EXV-802&subtitle=EXV-802%20%C2%B7%20Exciva%20GmbH&badge=phase%202 EXV-802 EXV-802 · Exciva GmbH https://druglandscape.com/drug/eye201 https://druglandscape.com/api/og?type=drug&title=EYE201&subtitle=EYE201%20%C2%B7%20EyeBiotech%20Ltd.&badge=phase%201 EYE201 EYE201 · EyeBiotech Ltd. https://druglandscape.com/drug/ezatiostat-hydrochlorine https://druglandscape.com/api/og?type=drug&title=Ezatiostat%20Hydrochlorine&subtitle=Ezatiostat%20Hydrochlorine%20%C2%B7%20Telik&badge=phase%201 Ezatiostat Hydrochlorine Ezatiostat Hydrochlorine · Telik https://druglandscape.com/drug/ezetimibe-and-raltegravir https://druglandscape.com/api/og?type=drug&title=Ezetimibe%20and%20raltegravir&subtitle=Ezetimibe%20and%20raltegravir%20%C2%B7%20St%20Stephens%20Aids%20Trust&badge=phase%201 Ezetimibe and raltegravir Ezetimibe and raltegravir · St Stephens Aids Trust https://druglandscape.com/drug/eziklen https://druglandscape.com/api/og?type=drug&title=Eziklen%C2%AE&subtitle=Eziklen%C2%AE%20%C2%B7%20Russian%20Society%20of%20Colorectal%20Surgeons&badge=phase%201 Eziklen® Eziklen® · Russian Society of Colorectal Surgeons https://druglandscape.com/drug/ezn-2208-cetuximab-and-irinotecan https://druglandscape.com/api/og?type=drug&title=EZN-2208%2C%20Cetuximab%20and%20Irinotecan&subtitle=EZN-2208%2C%20Cetuximab%20and%20Irinotecan%20%C2%B7%20Enzon%20Pharmaceuticals%2C%20Inc.&badge=phase%202 EZN-2208, Cetuximab and Irinotecan EZN-2208, Cetuximab and Irinotecan · Enzon Pharmaceuticals, Inc. https://druglandscape.com/drug/f-18-av-1451 https://druglandscape.com/api/og?type=drug&title=%5BF-18%5DAV-1451&subtitle=%5BF-18%5DAV-1451%20%C2%B7%20David%20Okonkwo%2C%20MD%2C%20PhD&badge=phase%202 [F-18]AV-1451 [F-18]AV-1451 · David Okonkwo, MD, PhD https://druglandscape.com/drug/f-18-fmiso https://druglandscape.com/api/og?type=drug&title=%5BF-18%5D%20FMISO&subtitle=%5BF-18%5D%20FMISO%20%C2%B7%20Siemens%20Molecular%20Imaging&badge=phase%201 [F-18] FMISO [F-18] FMISO · Siemens Molecular Imaging https://druglandscape.com/drug/f-18-hx4 https://druglandscape.com/api/og?type=drug&title=%5BF%2018%5DHX4&subtitle=%5BF%2018%5DHX4%20%C2%B7%20Siemens%20Molecular%20Imaging&badge=phase%202 [F 18]HX4 [F 18]HX4 · Siemens Molecular Imaging https://druglandscape.com/drug/f-18-rgd-k5 https://druglandscape.com/api/og?type=drug&title=%5BF-18%5DRGD-K5&subtitle=%5BF-18%5DRGD-K5%20%C2%B7%20Siemens%20Molecular%20Imaging&badge=phase%202 [F-18]RGD-K5 [F-18]RGD-K5 · Siemens Molecular Imaging https://druglandscape.com/drug/f-18-vm4-037 https://druglandscape.com/api/og?type=drug&title=%5BF-18%5D%20VM4-037&subtitle=%5BF-18%5D%20VM4-037%20%C2%B7%20Siemens%20Molecular%20Imaging&badge=phase%201 [F-18] VM4-037 [F-18] VM4-037 · Siemens Molecular Imaging https://druglandscape.com/drug/f-dose-as-cj-15314 https://druglandscape.com/api/og?type=drug&title=F%20dose%20as%20CJ-15314&subtitle=F%20dose%20as%20CJ-15314%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 F dose as CJ-15314 F dose as CJ-15314 · HK inno.N Corporation https://druglandscape.com/drug/f18-fddnp https://druglandscape.com/api/og?type=drug&title=%5BF18%5D-FDDNP&subtitle=%5BF18%5D-FDDNP%20%C2%B7%20Fundacion%20Clinic%20per%20a%20la%20Recerca%20Biom%C3%A9dica&badge=phase%201 [F18]-FDDNP [F18]-FDDNP · Fundacion Clinic per a la Recerca Biomédica https://druglandscape.com/drug/f182112 https://druglandscape.com/api/og?type=drug&title=F182112&subtitle=F182112%20%C2%B7%20Shandong%20New%20Time%20Pharmaceutical%20Co.%2C%20LTD&badge=phase%201 F182112 F182112 · Shandong New Time Pharmaceutical Co., LTD https://druglandscape.com/drug/f8il10 https://druglandscape.com/api/og?type=drug&title=F8IL10&subtitle=F8IL10%20%C2%B7%20Philogen%20S.p.A.&badge=phase%202 F8IL10 F8IL10 · Philogen S.p.A. https://druglandscape.com/drug/f901318-dose-level-a-oral https://druglandscape.com/api/og?type=drug&title=F901318%20Dose%20level%20A%20oral&subtitle=F901318%20Dose%20level%20A%20oral%20%C2%B7%20F2G%20Biotech%20GmbH&badge=phase%201 F901318 Dose level A oral F901318 Dose level A oral · F2G Biotech GmbH https://druglandscape.com/drug/f901318-dose-level-b-oral https://druglandscape.com/api/og?type=drug&title=F901318%20Dose%20level%20B%20oral&subtitle=F901318%20Dose%20level%20B%20oral%20%C2%B7%20F2G%20Biotech%20GmbH&badge=phase%201 F901318 Dose level B oral F901318 Dose level B oral · F2G Biotech GmbH https://druglandscape.com/drug/f901318-dose-level-c-oral https://druglandscape.com/api/og?type=drug&title=F901318%20Dose%20level%20C%20oral&subtitle=F901318%20Dose%20level%20C%20oral%20%C2%B7%20F2G%20Biotech%20GmbH&badge=phase%201 F901318 Dose level C oral F901318 Dose level C oral · F2G Biotech GmbH https://druglandscape.com/drug/f901318-ir-fasting https://druglandscape.com/api/og?type=drug&title=F901318%20IR%20Fasting&subtitle=F901318%20IR%20Fasting%20%C2%B7%20F2G%20Biotech%20GmbH&badge=phase%201 F901318 IR Fasting F901318 IR Fasting · F2G Biotech GmbH https://druglandscape.com/drug/f901318-ir-fed https://druglandscape.com/api/og?type=drug&title=F901318%20IR%20Fed&subtitle=F901318%20IR%20Fed%20%C2%B7%20F2G%20Biotech%20GmbH&badge=phase%201 F901318 IR Fed F901318 IR Fed · F2G Biotech GmbH https://druglandscape.com/drug/f901318-pharmacokinetics https://druglandscape.com/api/og?type=drug&title=F901318%20pharmacokinetics&subtitle=F901318%20pharmacokinetics%20%C2%B7%20F2G%20Biotech%20GmbH&badge=phase%201 F901318 pharmacokinetics F901318 pharmacokinetics · F2G Biotech GmbH https://druglandscape.com/drug/f901318-safety https://druglandscape.com/api/og?type=drug&title=F901318%20safety&subtitle=F901318%20safety%20%C2%B7%20F2G%20Biotech%20GmbH&badge=phase%201 F901318 safety F901318 safety · F2G Biotech GmbH https://druglandscape.com/drug/f901318-tolerability https://druglandscape.com/api/og?type=drug&title=F901318%20tolerability&subtitle=F901318%20tolerability%20%C2%B7%20F2G%20Biotech%20GmbH&badge=phase%201 F901318 tolerability F901318 tolerability · F2G Biotech GmbH https://druglandscape.com/drug/fab117-hc https://druglandscape.com/api/og?type=drug&title=FAB117-HC&subtitle=FAB117-HC%20%C2%B7%20Ferrer%20Internacional%20S.A.&badge=phase%201 FAB117-HC FAB117-HC · Ferrer Internacional S.A. https://druglandscape.com/drug/fact-complex-targeting-curaxin-cbl0137 https://druglandscape.com/api/og?type=drug&title=FACT%20Complex-targeting%20Curaxin%20CBL0137&subtitle=FACT%20Complex-targeting%20Curaxin%20CBL0137%20%C2%B7%20Children's%20Oncology%20Group&badge=phase%201 FACT Complex-targeting Curaxin CBL0137 FACT Complex-targeting Curaxin CBL0137 · Children's Oncology Group https://druglandscape.com/drug/factor-xiia-antagonist-monoclonal-antibody https://druglandscape.com/api/og?type=drug&title=Factor%20XIIa%20antagonist%20monoclonal%20antibody&subtitle=Factor%20XIIa%20antagonist%20monoclonal%20antibody%20%C2%B7%20CSL%20Behring&badge=phase%202 Factor XIIa antagonist monoclonal antibody Factor XIIa antagonist monoclonal antibody · CSL Behring https://druglandscape.com/drug/faecal-sampling https://druglandscape.com/api/og?type=drug&title=Faecal%20sampling&subtitle=Faecal%20sampling%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Faecal sampling Faecal sampling · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/fak-inhibitor-gsk2256098 https://druglandscape.com/api/og?type=drug&title=FAK%20Inhibitor%20GSK2256098&subtitle=FAK%20Inhibitor%20GSK2256098%20%C2%B7%20Alliance%20for%20Clinical%20Trials%20in%20Oncology&badge=phase%202 FAK Inhibitor GSK2256098 FAK Inhibitor GSK2256098 · Alliance for Clinical Trials in Oncology https://druglandscape.com/drug/famitinib-capsule https://druglandscape.com/api/og?type=drug&title=Famitinib%20capsule&subtitle=Famitinib%20capsule%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Famitinib capsule Famitinib capsule · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/famitinib-malate-capsules https://druglandscape.com/api/og?type=drug&title=Famitinib%20Malate%20Capsules&subtitle=Famitinib%20Malate%20Capsules%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Famitinib Malate Capsules Famitinib Malate Capsules · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/famitinib-po https://druglandscape.com/api/og?type=drug&title=famitinib%20po&subtitle=famitinib%20po%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 famitinib po famitinib po · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/famotidine-combinations https://druglandscape.com/api/og?type=drug&title=famotidine%20combinations&subtitle=famotidine%20combinations%20%C2%B7%20Canadian%20Network%20for%20Observational%20Drug%20Effect%20Studies%2C%20CNODES&badge=phase%202 famotidine combinations famotidine combinations · Canadian Network for Observational Drug Effect Studies, CNODES https://druglandscape.com/drug/famotidine-ct https://druglandscape.com/api/og?type=drug&title=Famotidine%20CT&subtitle=Famotidine%20CT%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Famotidine CT Famotidine CT · Merck Sharp & Dohme LLC https://druglandscape.com/drug/famotidine-fct https://druglandscape.com/api/og?type=drug&title=Famotidine%20FCT&subtitle=Famotidine%20FCT%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Famotidine FCT Famotidine FCT · Merck Sharp & Dohme LLC https://druglandscape.com/drug/farletuzumab-carboplatin-and-pld https://druglandscape.com/api/og?type=drug&title=Farletuzumab%2C%20Carboplatin%2C%20and%20PLD&subtitle=Farletuzumab%2C%20Carboplatin%2C%20and%20PLD%20%C2%B7%20Morphotek&badge=phase%201 Farletuzumab, Carboplatin, and PLD Farletuzumab, Carboplatin, and PLD · Morphotek https://druglandscape.com/drug/faropenem-high-dose-group https://druglandscape.com/api/og?type=drug&title=Faropenem%EF%BC%88high%20dose%20group%EF%BC%89&subtitle=Faropenem%EF%BC%88high%20dose%20group%EF%BC%89%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 Faropenem（high dose group） Faropenem（high dose group） · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/fasted-cohort-pbt2 https://druglandscape.com/api/og?type=drug&title=Fasted%20Cohort%20PBT2&subtitle=Fasted%20Cohort%20PBT2%20%C2%B7%20Prana%20Biotechnology%20Limited&badge=phase%201 Fasted Cohort PBT2 Fasted Cohort PBT2 · Prana Biotechnology Limited https://druglandscape.com/drug/fasted-treatment-axl1717 https://druglandscape.com/api/og?type=drug&title=Fasted%20treatment%3A%20AXL1717&subtitle=Fasted%20treatment%3A%20AXL1717%20%C2%B7%20Axelar%20AB&badge=phase%201 Fasted treatment: AXL1717 Fasted treatment: AXL1717 · Axelar AB https://druglandscape.com/drug/fasudil-hydrochloride-combined-with-immunotherapy https://druglandscape.com/api/og?type=drug&title=Fasudil%20hydrochloride%20combined%20with%20immunotherapy&subtitle=Fasudil%20hydrochloride%20combined%20with%20immunotherapy%20%C2%B7%20baotai%20Liang&badge=phase%202 Fasudil hydrochloride combined with immunotherapy Fasudil hydrochloride combined with immunotherapy · baotai Liang https://druglandscape.com/drug/fat-degeneration-of-supraspinatus-muscle https://druglandscape.com/api/og?type=drug&title=Fat%20degeneration%20of%20supraspinatus%20muscle&subtitle=Fat%20degeneration%20of%20supraspinatus%20muscle%20%C2%B7%20Applied%20Biologics%2C%20LLC&badge=phase%201 Fat degeneration of supraspinatus muscle Fat degeneration of supraspinatus muscle · Applied Biologics, LLC https://druglandscape.com/drug/fat-emulsion-20 https://druglandscape.com/api/og?type=drug&title=Fat%20Emulsion%2020%25&subtitle=Fat%20Emulsion%2020%25%20%C2%B7%20Abbott&badge=phase%201 Fat Emulsion 20% Fat Emulsion 20% · Abbott https://druglandscape.com/drug/favorable-outcome https://druglandscape.com/api/og?type=drug&title=favorable%20outcome&subtitle=favorable%20outcome%20%C2%B7%20Centre%20d'Investigation%20Clinique%20et%20Technologique%20805&badge=phase%202 favorable outcome favorable outcome · Centre d'Investigation Clinique et Technologique 805 https://druglandscape.com/drug/fb-001 https://druglandscape.com/api/og?type=drug&title=FB-001&subtitle=FB-001%20%C2%B7%20Federation%20Bio%20Inc.&badge=phase%201 FB-001 FB-001 · Federation Bio Inc. https://druglandscape.com/drug/fb-101 https://druglandscape.com/api/og?type=drug&title=FB-101&subtitle=FB-101%20%C2%B7%201ST%20Biotherapeutics%2C%20Inc.&badge=phase%201 FB-101 FB-101 · 1ST Biotherapeutics, Inc. https://druglandscape.com/drug/fb-1603 https://druglandscape.com/api/og?type=drug&title=FB-1603&subtitle=FB-1603%20%C2%B7%20Febico%20Biomedical%20Corp.&badge=phase%201 FB-1603 FB-1603 · Febico Biomedical Corp. https://druglandscape.com/drug/fb-pmt https://druglandscape.com/api/og?type=drug&title=fb-PMT&subtitle=fb-PMT%20%C2%B7%20NanoPharmaceuticals%20LLC&badge=phase%201 fb-PMT fb-PMT · NanoPharmaceuticals LLC https://druglandscape.com/drug/fb2001-for-inhalation https://druglandscape.com/api/og?type=drug&title=FB2001%20for%20inhalation&subtitle=FB2001%20for%20inhalation%20%C2%B7%20Frontier%20Biotechnologies%20Inc.&badge=phase%201 FB2001 for inhalation FB2001 for inhalation · Frontier Biotechnologies Inc. https://druglandscape.com/drug/fb418 https://druglandscape.com/api/og?type=drug&title=FB418&subtitle=FB418%20%C2%B7%201ST%20Biotherapeutics%2C%20Inc.&badge=phase%201 FB418 FB418 · 1ST Biotherapeutics, Inc. https://druglandscape.com/drug/fb704a https://druglandscape.com/api/og?type=drug&title=FB704A&subtitle=FB704A%20%C2%B7%20Fountain%20Biopharma%20Inc.&badge=phase%202 FB704A FB704A · Fountain Biopharma Inc. https://druglandscape.com/drug/fb825-in-intravenous-route https://druglandscape.com/api/og?type=drug&title=FB825%20in%20intravenous%20route&subtitle=FB825%20in%20intravenous%20route%20%C2%B7%20Oneness%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 FB825 in intravenous route FB825 in intravenous route · Oneness Biotech Co., Ltd. https://druglandscape.com/drug/fbf001 https://druglandscape.com/api/og?type=drug&title=FBF001&subtitle=FBF001%20%C2%B7%20Fab'entech&badge=phase%201 FBF001 FBF001 · Fab'entech https://druglandscape.com/drug/fbl-mtx https://druglandscape.com/api/og?type=drug&title=FBL-MTX&subtitle=FBL-MTX%20%C2%B7%20SOLFARCOS%20-%20Pharmaceutical%20and%20Cosmetic%20Solutions%20Ltd&badge=phase%202 FBL-MTX FBL-MTX · SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd https://druglandscape.com/drug/fbs0701 https://druglandscape.com/api/og?type=drug&title=FBS0701&subtitle=FBS0701%20%C2%B7%20FerroKin%20BioSciences%2C%20Inc.&badge=phase%201 FBS0701 FBS0701 · FerroKin BioSciences, Inc. https://druglandscape.com/drug/fbx-101 https://druglandscape.com/api/og?type=drug&title=FBX-101&subtitle=FBX-101%20%C2%B7%20Forge%20Biologics%2C%20Inc&badge=phase%202 FBX-101 FBX-101 · Forge Biologics, Inc https://druglandscape.com/drug/fc-12738 https://druglandscape.com/api/og?type=drug&title=FC-12738&subtitle=FC-12738%20%C2%B7%20Neurodegenerative%20Disease%20Research%20Inc&badge=phase%201 FC-12738 FC-12738 · Neurodegenerative Disease Research Inc https://druglandscape.com/drug/fc084csa-tablets https://druglandscape.com/api/og?type=drug&title=FC084CSA%20tablets&subtitle=FC084CSA%20tablets%20%C2%B7%20FindCure%20Biosciences%20(ZhongShan)%20Co.%2C%20Ltd.&badge=phase%201 FC084CSA tablets FC084CSA tablets · FindCure Biosciences (ZhongShan) Co., Ltd. https://druglandscape.com/drug/fcfd4514s https://druglandscape.com/api/og?type=drug&title=FCFD4514S&subtitle=FCFD4514S%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 FCFD4514S FCFD4514S · Genentech, Inc. https://druglandscape.com/drug/fcn-011 https://druglandscape.com/api/og?type=drug&title=FCN-011&subtitle=FCN-011%20%C2%B7%20Fochon%20Pharmaceuticals%2C%20Ltd.&badge=phase%201 FCN-011 FCN-011 · Fochon Pharmaceuticals, Ltd. https://druglandscape.com/drug/fcn-338 https://druglandscape.com/api/og?type=drug&title=FCN-338&subtitle=FCN-338%20%C2%B7%20Fochon%20Pharmaceuticals%2C%20Ltd.&badge=phase%201 FCN-338 FCN-338 · Fochon Pharmaceuticals, Ltd. https://druglandscape.com/drug/fcn-411-dose-escalation https://druglandscape.com/api/og?type=drug&title=FCN-411%20Dose-escalation&subtitle=FCN-411%20Dose-escalation%20%C2%B7%20Ahon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 FCN-411 Dose-escalation FCN-411 Dose-escalation · Ahon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/fcn-437 https://druglandscape.com/api/og?type=drug&title=FCN-437&subtitle=FCN-437%20%C2%B7%20Fochon%20Pharmaceuticals%2C%20Ltd.&badge=phase%201 FCN-437 FCN-437 · Fochon Pharmaceuticals, Ltd. https://druglandscape.com/drug/fcn-437c https://druglandscape.com/api/og?type=drug&title=FCN-437c&subtitle=FCN-437c%20%C2%B7%20Ahon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 FCN-437c FCN-437c · Ahon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/fcr-blocker-of-autoantibodies https://druglandscape.com/api/og?type=drug&title=Fcr%20blocker%20of%20autoantibodies&subtitle=Fcr%20blocker%20of%20autoantibodies%20%C2%B7%20IRCCS%20Ospedale%20San%20Raffaele&badge=phase%202 Fcr blocker of autoantibodies Fcr blocker of autoantibodies · IRCCS Ospedale San Raffaele https://druglandscape.com/drug/fd-001 https://druglandscape.com/api/og?type=drug&title=FD-001&subtitle=FD-001%20%C2%B7%20Chengdu%20FenDi%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 FD-001 FD-001 · Chengdu FenDi Pharmaceutical Co., Ltd. https://druglandscape.com/drug/fda-approved-mrna-vaccines https://druglandscape.com/api/og?type=drug&title=FDA%20approved%20mRNA%20vaccines&subtitle=FDA%20approved%20mRNA%20vaccines%20%C2%B7%20Biomedical%20Advanced%20Research%20and%20Development%20Authority&badge=phase%202 FDA approved mRNA vaccines FDA approved mRNA vaccines · Biomedical Advanced Research and Development Authority https://druglandscape.com/drug/fda022-bb05 https://druglandscape.com/api/og?type=drug&title=FDA022-BB05&subtitle=FDA022-BB05%20%C2%B7%20Shanghai%20Fudan-Zhangjiang%20Bio-Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 FDA022-BB05 FDA022-BB05 · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. https://druglandscape.com/drug/fdl176-fdl169-coadministration https://druglandscape.com/api/og?type=drug&title=FDL176%20%26%20FDL169%20coadministration&subtitle=FDL176%20%26%20FDL169%20coadministration%20%C2%B7%20Flatley%20Discovery%20Lab%20LLC&badge=phase%201 FDL176 & FDL169 coadministration FDL176 & FDL169 coadministration · Flatley Discovery Lab LLC https://druglandscape.com/drug/fe203799 https://druglandscape.com/api/og?type=drug&title=FE203799&subtitle=FE203799%20%C2%B7%20GlyPharma%20Therapeutics&badge=phase%201 FE203799 FE203799 · GlyPharma Therapeutics https://druglandscape.com/drug/fe203799-glp-2-analogue https://druglandscape.com/api/og?type=drug&title=FE203799%20GLP-2%20analogue&subtitle=FE203799%20GLP-2%20analogue%20%C2%B7%20GlyPharma%20Therapeutics&badge=phase%201 FE203799 GLP-2 analogue FE203799 GLP-2 analogue · GlyPharma Therapeutics https://druglandscape.com/drug/feburic https://druglandscape.com/api/og?type=drug&title=Feburic%C2%AE&subtitle=Feburic%C2%AE%20%C2%B7%20SK%20Chemicals%20Co.%2C%20Ltd.&badge=phase%201 Feburic® Feburic® · SK Chemicals Co., Ltd. https://druglandscape.com/drug/febuxostat-reference-product https://druglandscape.com/api/og?type=drug&title=Febuxostat-Reference%20product&subtitle=Febuxostat-Reference%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Febuxostat-Reference product Febuxostat-Reference product · Bio-innova Co., Ltd https://druglandscape.com/drug/febuxostat-test-product https://druglandscape.com/api/og?type=drug&title=Febuxostat-Test%20product&subtitle=Febuxostat-Test%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Febuxostat-Test product Febuxostat-Test product · Bio-innova Co., Ltd https://druglandscape.com/drug/fec100 https://druglandscape.com/api/og?type=drug&title=FEC100&subtitle=FEC100%20%C2%B7%20UNICANCER&badge=phase%202 FEC100 FEC100 · UNICANCER https://druglandscape.com/drug/fecal-calprotectin-concentration https://druglandscape.com/api/og?type=drug&title=fecal%20calprotectin%20concentration&subtitle=fecal%20calprotectin%20concentration%20%C2%B7%20CHU%20de%20Reims&badge=phase%201 fecal calprotectin concentration fecal calprotectin concentration · CHU de Reims https://druglandscape.com/drug/fecal-microbial-transplant-capsules https://druglandscape.com/api/og?type=drug&title=Fecal%20Microbial%20transplant%20Capsules&subtitle=Fecal%20Microbial%20transplant%20Capsules%20%C2%B7%20VA%20Office%20of%20Research%20and%20Development&badge=phase%201 Fecal Microbial transplant Capsules Fecal Microbial transplant Capsules · VA Office of Research and Development https://druglandscape.com/drug/fecal-microbial-transplant-enema https://druglandscape.com/api/og?type=drug&title=Fecal%20Microbial%20Transplant%20Enema&subtitle=Fecal%20Microbial%20Transplant%20Enema%20%C2%B7%20VA%20Office%20of%20Research%20and%20Development&badge=phase%201 Fecal Microbial Transplant Enema Fecal Microbial Transplant Enema · VA Office of Research and Development https://druglandscape.com/drug/fecal-microbial-transplantation-by-capsules https://druglandscape.com/api/og?type=drug&title=Fecal%20Microbial%20Transplantation%20by%20capsules&subtitle=Fecal%20Microbial%20Transplantation%20by%20capsules%20%C2%B7%20Ella%20Therapeutics%20Ltd&badge=phase%201 Fecal Microbial Transplantation by capsules Fecal Microbial Transplantation by capsules · Ella Therapeutics Ltd https://druglandscape.com/drug/fecal-microbiome https://druglandscape.com/api/og?type=drug&title=Fecal%20microbiome&subtitle=Fecal%20microbiome%20%C2%B7%20Fondazione%20IRCCS%20Ca'%20Granda%2C%20Ospedale%20Maggiore%20Policlinico&badge=phase%202 Fecal microbiome Fecal microbiome · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico https://druglandscape.com/drug/fecal-microbiota-transfer https://druglandscape.com/api/og?type=drug&title=fecal%20microbiota%20transfer&subtitle=fecal%20microbiota%20transfer%20%C2%B7%20MaaT%20Pharma&badge=phase%202 fecal microbiota transfer fecal microbiota transfer · MaaT Pharma https://druglandscape.com/drug/fecal-microbiota-transplant-vancomycin https://druglandscape.com/api/og?type=drug&title=Fecal%20Microbiota%20Transplant%3B%20Vancomycin&subtitle=Fecal%20Microbiota%20Transplant%3B%20Vancomycin%20%C2%B7%20ProgenaBiome&badge=phase%202 Fecal Microbiota Transplant; Vancomycin Fecal Microbiota Transplant; Vancomycin · ProgenaBiome https://druglandscape.com/drug/feces-sample https://druglandscape.com/api/og?type=drug&title=FECES%20SAMPLE&subtitle=FECES%20SAMPLE%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 FECES SAMPLE FECES SAMPLE · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/feces-sampling https://druglandscape.com/api/og?type=drug&title=Feces%20sampling&subtitle=Feces%20sampling%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Feces sampling Feces sampling · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/fed-cohort-pbt2 https://druglandscape.com/api/og?type=drug&title=Fed%20Cohort%20PBT2&subtitle=Fed%20Cohort%20PBT2%20%C2%B7%20Prana%20Biotechnology%20Limited&badge=phase%201 Fed Cohort PBT2 Fed Cohort PBT2 · Prana Biotechnology Limited https://druglandscape.com/drug/fed-treatment-axl1717 https://druglandscape.com/api/og?type=drug&title=Fed%20treatment%3A%20AXL1717&subtitle=Fed%20treatment%3A%20AXL1717%20%C2%B7%20Axelar%20AB&badge=phase%201 Fed treatment: AXL1717 Fed treatment: AXL1717 · Axelar AB https://druglandscape.com/drug/femja-transplatation https://druglandscape.com/api/og?type=drug&title=FEMJA%20transplatation&subtitle=FEMJA%20transplatation%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 FEMJA transplatation FEMJA transplatation · Hospices Civils de Lyon https://druglandscape.com/drug/femoral-group https://druglandscape.com/api/og?type=drug&title=femoral%20group&subtitle=femoral%20group%20%C2%B7%20ASST%20Gaetano%20Pini-CTO&badge=phase%201 femoral group femoral group · ASST Gaetano Pini-CTO https://druglandscape.com/drug/fen164 https://druglandscape.com/api/og?type=drug&title=FEN164&subtitle=FEN164%20%C2%B7%20Fenix%20Innovation%20Group&badge=phase%201 FEN164 FEN164 · Fenix Innovation Group https://druglandscape.com/drug/fendrix-or-hbvaxpro-40 https://druglandscape.com/api/og?type=drug&title=Fendrix%20or%20HBVAXPRO%2040&subtitle=Fendrix%20or%20HBVAXPRO%2040%20%C2%B7%20Corporacion%20Parc%20Tauli&badge=phase%201 Fendrix or HBVAXPRO 40 Fendrix or HBVAXPRO 40 · Corporacion Parc Tauli https://druglandscape.com/drug/fenfluramine-hcl https://druglandscape.com/api/og?type=drug&title=fenfluramine%20HCl&subtitle=fenfluramine%20HCl%20%C2%B7%20UCB%20BIOSCIENCES%2C%20Inc.&badge=phase%201 fenfluramine HCl fenfluramine HCl · UCB BIOSCIENCES, Inc. https://druglandscape.com/drug/fentanyl-400-g-sublingual-spray https://druglandscape.com/api/og?type=drug&title=Fentanyl%20400%20%C2%B5g%20sublingual%20spray&subtitle=Fentanyl%20400%20%C2%B5g%20sublingual%20spray%20%C2%B7%20INSYS%20Therapeutics%20Inc&badge=phase%201 Fentanyl 400 µg sublingual spray Fentanyl 400 µg sublingual spray · INSYS Therapeutics Inc https://druglandscape.com/drug/fentanyl-and-midazolam-infusion https://druglandscape.com/api/og?type=drug&title=Fentanyl%20and%20Midazolam%20infusion&subtitle=Fentanyl%20and%20Midazolam%20infusion%20%C2%B7%20Cl%C3%ADnica%20de%20Los%20Andes%20IPS&badge=phase%201 Fentanyl and Midazolam infusion Fentanyl and Midazolam infusion · Clínica de Los Andes IPS https://druglandscape.com/drug/fentanyl-based-sedation https://druglandscape.com/api/og?type=drug&title=fentanyl-based%20sedation&subtitle=fentanyl-based%20sedation%20%C2%B7%20Meir%20Medical%20Center&badge=phase%201 fentanyl-based sedation fentanyl-based sedation · Meir Medical Center https://druglandscape.com/drug/fentanyl-buprenorphine-naloxone https://druglandscape.com/api/og?type=drug&title=Fentanyl%3B%20Buprenorphine%3B%20Naloxone&subtitle=Fentanyl%3B%20Buprenorphine%3B%20Naloxone%20%C2%B7%20Janssen-Cilag%20A.G.%2C%20Switzerland&badge=phase%201 Fentanyl; Buprenorphine; Naloxone Fentanyl; Buprenorphine; Naloxone · Janssen-Cilag A.G., Switzerland https://druglandscape.com/drug/fentanyl-citrate-naltrexone-naloxone https://druglandscape.com/api/og?type=drug&title=Fentanyl%20citrate%3B%20Naltrexone%3B%20Naloxone&subtitle=Fentanyl%20citrate%3B%20Naltrexone%3B%20Naloxone%20%C2%B7%20Alza%20Corporation%2C%20DE%2C%20USA&badge=phase%201 Fentanyl citrate; Naltrexone; Naloxone Fentanyl citrate; Naltrexone; Naloxone · Alza Corporation, DE, USA https://druglandscape.com/drug/fentanyl-naltrexone https://druglandscape.com/api/og?type=drug&title=fentanyl%3B%20naltrexone&subtitle=fentanyl%3B%20naltrexone%20%C2%B7%20Alza%20Corporation%2C%20DE%2C%20USA&badge=phase%202 fentanyl; naltrexone fentanyl; naltrexone · Alza Corporation, DE, USA https://druglandscape.com/drug/fentanyl-pectin https://druglandscape.com/api/og?type=drug&title=Fentanyl%20pectin&subtitle=Fentanyl%20pectin%20%C2%B7%20Richard%20C%20Reznichek%2C%20MD&badge=phase%201 Fentanyl pectin Fentanyl pectin · Richard C Reznichek, MD https://druglandscape.com/drug/fentanyl-push-first https://druglandscape.com/api/og?type=drug&title=Fentanyl%20Push%20First&subtitle=Fentanyl%20Push%20First%20%C2%B7%20MemorialCare%20Health%20System&badge=phase%201 Fentanyl Push First Fentanyl Push First · MemorialCare Health System https://druglandscape.com/drug/fenugreek-seed-meal https://druglandscape.com/api/og?type=drug&title=Fenugreek%20seed%20meal&subtitle=Fenugreek%20seed%20meal%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 Fenugreek seed meal Fenugreek seed meal · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/ferinject-or-cosmofer https://druglandscape.com/api/og?type=drug&title=Ferinject%20or%20CosmoFer&subtitle=Ferinject%20or%20CosmoFer%20%C2%B7%20Imperial%20College%20London&badge=phase%202 Ferinject or CosmoFer Ferinject or CosmoFer · Imperial College London https://druglandscape.com/drug/ferric-carboxymaltose-infusion https://druglandscape.com/api/og?type=drug&title=Ferric%20carboxymaltose%20infusion&subtitle=Ferric%20carboxymaltose%20infusion%20%C2%B7%20NYU%20Langone%20Health&badge=phase%201 Ferric carboxymaltose infusion Ferric carboxymaltose infusion · NYU Langone Health https://druglandscape.com/drug/ferric-carboxymaltose-injectable-product https://druglandscape.com/api/og?type=drug&title=Ferric%20Carboxymaltose%20Injectable%20Product&subtitle=Ferric%20Carboxymaltose%20Injectable%20Product%20%C2%B7%20Royal%20Centre%20for%20Defence%20Medicine&badge=phase%201 Ferric Carboxymaltose Injectable Product Ferric Carboxymaltose Injectable Product · Royal Centre for Defence Medicine https://druglandscape.com/drug/ferumoxytol-intravenous https://druglandscape.com/api/og?type=drug&title=Ferumoxytol%20intravenous&subtitle=Ferumoxytol%20intravenous%20%C2%B7%20Auerbach%20Hematology%20Oncology%20Associates%20P%20C&badge=phase%202 Ferumoxytol intravenous Ferumoxytol intravenous · Auerbach Hematology Oncology Associates P C https://druglandscape.com/drug/fesoterodine-plus-fluconazole https://druglandscape.com/api/og?type=drug&title=fesoterodine%20plus%20fluconazole&subtitle=fesoterodine%20plus%20fluconazole%20%C2%B7%20Pfizer&badge=phase%201 fesoterodine plus fluconazole fesoterodine plus fluconazole · Pfizer https://druglandscape.com/drug/fetal-porcine-cells-neurocell-pd https://druglandscape.com/api/og?type=drug&title=Fetal%20porcine%20cells%2C%20Neurocell-PD&subtitle=Fetal%20porcine%20cells%2C%20Neurocell-PD%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%202 Fetal porcine cells, Neurocell-PD Fetal porcine cells, Neurocell-PD · Genzyme, a Sanofi Company https://druglandscape.com/drug/fexofenadine-hcl-new-formulation-tablet https://druglandscape.com/api/og?type=drug&title=Fexofenadine%20HCl%20New%20Formulation%20Tablet&subtitle=Fexofenadine%20HCl%20New%20Formulation%20Tablet%20%C2%B7%20Opella%20Healthcare%20Group%20SAS%2C%20a%20Sanofi%20Company&badge=phase%201 Fexofenadine HCl New Formulation Tablet Fexofenadine HCl New Formulation Tablet · Opella Healthcare Group SAS, a Sanofi Company https://druglandscape.com/drug/fexofenadine-tablet-dosing https://druglandscape.com/api/og?type=drug&title=Fexofenadine%20tablet%20dosing&subtitle=Fexofenadine%20tablet%20dosing%20%C2%B7%20AstraZeneca&badge=phase%201 Fexofenadine tablet dosing Fexofenadine tablet dosing · AstraZeneca https://druglandscape.com/drug/fexuprazan-injection-part-2 https://druglandscape.com/api/og?type=drug&title=Fexuprazan%20Injection_part%202&subtitle=Fexuprazan%20Injection_part%202%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 Fexuprazan Injection_part 2 Fexuprazan Injection_part 2 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/fezolinetant-reference-formulation https://druglandscape.com/api/og?type=drug&title=fezolinetant%20-%20reference%20formulation&subtitle=fezolinetant%20-%20reference%20formulation%20%C2%B7%20Shehzad%20Basaria%2C%20M.D.&badge=phase%202 fezolinetant - reference formulation fezolinetant - reference formulation · Shehzad Basaria, M.D. https://druglandscape.com/drug/fezolinetant-test-formulation https://druglandscape.com/api/og?type=drug&title=fezolinetant%20-%20test%20formulation&subtitle=fezolinetant%20-%20test%20formulation%20%C2%B7%20Astellas%20Pharma%20Global%20Development%2C%20Inc.&badge=phase%201 fezolinetant - test formulation fezolinetant - test formulation · Astellas Pharma Global Development, Inc. https://druglandscape.com/drug/ff-3-dry-powder https://druglandscape.com/api/og?type=drug&title=FF-3%20dry%20powder&subtitle=FF-3%20dry%20powder%20%C2%B7%20Autoimmune%20Technologies%2C%20LLC&badge=phase%202 FF-3 dry powder FF-3 dry powder · Autoimmune Technologies, LLC https://druglandscape.com/drug/ff-ud-dpi https://druglandscape.com/api/og?type=drug&title=FF%20UD-DPI&subtitle=FF%20UD-DPI%20%C2%B7%20GlaxoSmithKline&badge=phase%201 FF UD-DPI FF UD-DPI · GlaxoSmithKline https://druglandscape.com/drug/ff21101 https://druglandscape.com/api/og?type=drug&title=FF21101&subtitle=FF21101%20%C2%B7%20Fujifilm%20Pharmaceuticals%20U.S.A.%2C%20Inc.&badge=phase%201 FF21101 FF21101 · Fujifilm Pharmaceuticals U.S.A., Inc. https://druglandscape.com/drug/fgf-1 https://druglandscape.com/api/og?type=drug&title=FGF-1&subtitle=FGF-1%20%C2%B7%20CardioVascular%20BioTherapeutics%2C%20Inc.&badge=phase%201 FGF-1 FGF-1 · CardioVascular BioTherapeutics, Inc. https://druglandscape.com/drug/fgf-receptor https://druglandscape.com/api/og?type=drug&title=FGF%20Receptor&subtitle=FGF%20Receptor%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 FGF Receptor FGF Receptor · Eli Lilly and Company https://druglandscape.com/drug/fh-006 https://druglandscape.com/api/og?type=drug&title=FH-006&subtitle=FH-006%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 FH-006 FH-006 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/fhd-286 https://druglandscape.com/api/og?type=drug&title=FHD-286&subtitle=FHD-286%20%C2%B7%20Foghorn%20Therapeutics%20Inc.&badge=phase%201 FHD-286 FHD-286 · Foghorn Therapeutics Inc. https://druglandscape.com/drug/fhnd6091 https://druglandscape.com/api/og?type=drug&title=FHND6091&subtitle=FHND6091%20%C2%B7%20Jiangsu%20Chia%20Tai%20Fenghai%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 FHND6091 FHND6091 · Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. https://druglandscape.com/drug/fiblast-gelatin-sponge-fibrin-glue https://druglandscape.com/api/og?type=drug&title=fiblast%2Cgelatin%20sponge%2Cfibrin%20glue&subtitle=fiblast%2Cgelatin%20sponge%2Cfibrin%20glue%20%C2%B7%20Translational%20Research%20Center%20for%20Medical%20Innovation%2C%20Kobe%2C%20Hyo&badge=phase%203 fiblast,gelatin sponge,fibrin glue fiblast,gelatin sponge,fibrin glue · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan https://druglandscape.com/drug/fibrinogen-infusion https://druglandscape.com/api/og?type=drug&title=fibrinogen%20infusion&subtitle=fibrinogen%20infusion%20%C2%B7%20Azienda%20Usl%20di%20Bologna&badge=phase%203 fibrinogen infusion fibrinogen infusion · Azienda Usl di Bologna https://druglandscape.com/drug/ficb-block https://druglandscape.com/api/og?type=drug&title=FICB%20Block&subtitle=FICB%20Block%20%C2%B7%20Pain%20Medicine%20Department&badge=phase%202 FICB Block FICB Block · Pain Medicine Department https://druglandscape.com/drug/fid-022 https://druglandscape.com/api/og?type=drug&title=FID-022&subtitle=FID-022%20%C2%B7%20Fulgent%20Pharma%20LLC.&badge=phase%201 FID-022 FID-022 · Fulgent Pharma LLC. https://druglandscape.com/drug/filgrastim-hospira https://druglandscape.com/api/og?type=drug&title=Filgrastim%20Hospira&subtitle=Filgrastim%20Hospira%20%C2%B7%20Pfizer&badge=phase%201 Filgrastim Hospira Filgrastim Hospira · Pfizer https://druglandscape.com/drug/filgrastim-megalabs https://druglandscape.com/api/og?type=drug&title=Filgrastim%20Megalabs&subtitle=Filgrastim%20Megalabs%20%C2%B7%20Megalabs&badge=phase%201 Filgrastim Megalabs Filgrastim Megalabs · Megalabs https://druglandscape.com/drug/filgrastim-reference https://druglandscape.com/api/og?type=drug&title=Filgrastim%20reference&subtitle=Filgrastim%20reference%20%C2%B7%20Bio-ker%20S.r.l.&badge=phase%201 Filgrastim reference Filgrastim reference · Bio-ker S.r.l. https://druglandscape.com/drug/filgrastim-tbo-filgrastim-or-pegfilgrastim https://druglandscape.com/api/og?type=drug&title=filgrastim%2C%20TBO-filgrastim%20or%20pegfilgrastim&subtitle=filgrastim%2C%20TBO-filgrastim%20or%20pegfilgrastim%20%C2%B7%20Biologics%20%26%20Biosimilars%20Collective%20Intelligence%20Consor&badge=phase%202 filgrastim, TBO-filgrastim or pegfilgrastim filgrastim, TBO-filgrastim or pegfilgrastim · Biologics & Biosimilars Collective Intelligence Consortium https://druglandscape.com/drug/filgrastim-test https://druglandscape.com/api/og?type=drug&title=Filgrastim%20test&subtitle=Filgrastim%20test%20%C2%B7%20Bio-ker%20S.r.l.&badge=phase%201 Filgrastim test Filgrastim test · Bio-ker S.r.l. https://druglandscape.com/drug/fimasartan-atorvastatin https://druglandscape.com/api/og?type=drug&title=Fimasartan%2C%20Atorvastatin&subtitle=Fimasartan%2C%20Atorvastatin%20%C2%B7%20Boryung%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 Fimasartan, Atorvastatin Fimasartan, Atorvastatin · Boryung Pharmaceutical Co., Ltd https://druglandscape.com/drug/fimasartan-ketoconazole-rifampicin https://druglandscape.com/api/og?type=drug&title=Fimasartan%2C%20Ketoconazole%2C%20Rifampicin&subtitle=Fimasartan%2C%20Ketoconazole%2C%20Rifampicin%20%C2%B7%20Boryung%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 Fimasartan, Ketoconazole, Rifampicin Fimasartan, Ketoconazole, Rifampicin · Boryung Pharmaceutical Co., Ltd https://druglandscape.com/drug/fimasartan-warfarin https://druglandscape.com/api/og?type=drug&title=fimasartan%2C%20warfarin&subtitle=fimasartan%2C%20warfarin%20%C2%B7%20Boryung%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 fimasartan, warfarin fimasartan, warfarin · Boryung Pharmaceutical Co., Ltd https://druglandscape.com/drug/finafloxacin-hydrochloride https://druglandscape.com/api/og?type=drug&title=Finafloxacin%20hydrochloride&subtitle=Finafloxacin%20hydrochloride%20%C2%B7%20MerLion%20Pharmaceuticals%20GmbH&badge=phase%201 Finafloxacin hydrochloride Finafloxacin hydrochloride · MerLion Pharmaceuticals GmbH https://druglandscape.com/drug/finamine-tablets https://druglandscape.com/api/og?type=drug&title=Finamine%20tablets&subtitle=Finamine%20tablets%20%C2%B7%20Yiling%20Pharmaceutical%20Inc.&badge=phase%201 Finamine tablets Finamine tablets · Yiling Pharmaceutical Inc. https://druglandscape.com/drug/fingolimod-reference-formulation https://druglandscape.com/api/og?type=drug&title=Fingolimod%20Reference%20Formulation&subtitle=Fingolimod%20Reference%20Formulation%20%C2%B7%20Asofarma%20S.A.I.%20y%20C.&badge=phase%201 Fingolimod Reference Formulation Fingolimod Reference Formulation · Asofarma S.A.I. y C. https://druglandscape.com/drug/fingolimod-test-formulation https://druglandscape.com/api/og?type=drug&title=Fingolimod%20Test%20Formulation&subtitle=Fingolimod%20Test%20Formulation%20%C2%B7%20Asofarma%20S.A.I.%20y%20C.&badge=phase%201 Fingolimod Test Formulation Fingolimod Test Formulation · Asofarma S.A.I. y C. https://druglandscape.com/drug/fipamezole-odt https://druglandscape.com/api/og?type=drug&title=Fipamezole%20ODT&subtitle=Fipamezole%20ODT%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%202 Fipamezole ODT Fipamezole ODT · Bausch Health Americas, Inc. https://druglandscape.com/drug/firategrast-gastro-retentive-solution https://druglandscape.com/api/og?type=drug&title=Firategrast%20gastro-retentive%20solution&subtitle=Firategrast%20gastro-retentive%20solution%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Firategrast gastro-retentive solution Firategrast gastro-retentive solution · GlaxoSmithKline https://druglandscape.com/drug/firategrast-immediate-release-tablet https://druglandscape.com/api/og?type=drug&title=Firategrast%20immediate%20release%20tablet&subtitle=Firategrast%20immediate%20release%20tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Firategrast immediate release tablet Firategrast immediate release tablet · GlaxoSmithKline https://druglandscape.com/drug/first-generation-butrans-patch https://druglandscape.com/api/og?type=drug&title=First%20generation%20BuTrans%20patch&subtitle=First%20generation%20BuTrans%20patch%20%C2%B7%20Mundipharma%20Research%20Limited&badge=phase%201 First generation BuTrans patch First generation BuTrans patch · Mundipharma Research Limited https://druglandscape.com/drug/first-line-chemotherapy https://druglandscape.com/api/og?type=drug&title=First%20line%20chemotherapy&subtitle=First%20line%20chemotherapy%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 First line chemotherapy First line chemotherapy · Hoffmann-La Roche https://druglandscape.com/drug/fish-oil-containing-lipid-emulsion https://druglandscape.com/api/og?type=drug&title=fish%20oil%20containing%20lipid%20emulsion&subtitle=fish%20oil%20containing%20lipid%20emulsion%20%C2%B7%20B.%20Braun%20Melsungen%20AG&badge=phase%203 fish oil containing lipid emulsion fish oil containing lipid emulsion · B. Braun Melsungen AG https://druglandscape.com/drug/fispemifene-once-daily-for-4-weeks https://druglandscape.com/api/og?type=drug&title=Fispemifene%20once%20daily%20for%204%20weeks&subtitle=Fispemifene%20once%20daily%20for%204%20weeks%20%C2%B7%20QuatRx%20Pharmaceuticals%20Company&badge=phase%202 Fispemifene once daily for 4 weeks Fispemifene once daily for 4 weeks · QuatRx Pharmaceuticals Company https://druglandscape.com/drug/fisrt-period-twlo https://druglandscape.com/api/og?type=drug&title=Fisrt%20period%20TWLO&subtitle=Fisrt%20period%20TWLO%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 Fisrt period TWLO Fisrt period TWLO · Dong-A ST Co., Ltd. https://druglandscape.com/drug/fisrt-period-twlo-c https://druglandscape.com/api/og?type=drug&title=Fisrt%20period%20TWLO_C&subtitle=Fisrt%20period%20TWLO_C%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 Fisrt period TWLO_C Fisrt period TWLO_C · Dong-A ST Co., Ltd. https://druglandscape.com/drug/fk50 https://druglandscape.com/api/og?type=drug&title=FK50&subtitle=FK50%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 FK50 FK50 · Baylor College of Medicine https://druglandscape.com/drug/fk506-gp11046-gp11511 https://druglandscape.com/api/og?type=drug&title=FK506%2C%20GP11046%2C%20GP11511&subtitle=FK506%2C%20GP11046%2C%20GP11511%20%C2%B7%20Hordinsky%2C%20Maria%20K.%2C%20MD&badge=phase%201 FK506, GP11046, GP11511 FK506, GP11046, GP11511 · Hordinsky, Maria K., MD https://druglandscape.com/drug/fk614 https://druglandscape.com/api/og?type=drug&title=FK614&subtitle=FK614%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%202 FK614 FK614 · Astellas Pharma Inc https://druglandscape.com/drug/fk788 https://druglandscape.com/api/og?type=drug&title=FK788&subtitle=FK788%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%202 FK788 FK788 · Astellas Pharma Inc https://druglandscape.com/drug/fl058 https://druglandscape.com/api/og?type=drug&title=FL058&subtitle=FL058%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 FL058 FL058 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/fl058-1000mg-iv-120min https://druglandscape.com/api/og?type=drug&title=FL058%201000mg%EF%BC%88%20IV%20120min%EF%BC%89&subtitle=FL058%201000mg%EF%BC%88%20IV%20120min%EF%BC%89%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 FL058 1000mg（ IV 120min） FL058 1000mg（ IV 120min） · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/fl115 https://druglandscape.com/api/og?type=drug&title=FL115&subtitle=FL115%20%C2%B7%20Suzhou%20Forlong%20Biotechnology%20Co.%2C%20Ltd&badge=phase%201 FL115 FL115 · Suzhou Forlong Biotechnology Co., Ltd https://druglandscape.com/drug/flamsa https://druglandscape.com/api/og?type=drug&title=FLAMSA&subtitle=FLAMSA%20%C2%B7%20Hannover%20Medical%20School&badge=phase%202 FLAMSA FLAMSA · Hannover Medical School https://druglandscape.com/drug/flecainide-and-verapamil https://druglandscape.com/api/og?type=drug&title=Flecainide%20and%20verapamil&subtitle=Flecainide%20and%20verapamil%20%C2%B7%20Maatschap%20Cardiologie%20Zwolle&badge=phase%201 Flecainide and verapamil Flecainide and verapamil · Maatschap Cardiologie Zwolle https://druglandscape.com/drug/flecainide-iv https://druglandscape.com/api/og?type=drug&title=flecainide%20iv&subtitle=flecainide%20iv%20%C2%B7%20NYU%20Langone%20Health&badge=phase%202 flecainide iv flecainide iv · NYU Langone Health https://druglandscape.com/drug/flexyn2a-plus-adjuvant https://druglandscape.com/api/og?type=drug&title=Flexyn2a%20plus%20adjuvant&subtitle=Flexyn2a%20plus%20adjuvant%20%C2%B7%20LimmaTech%20Biologics%20AG&badge=phase%201 Flexyn2a plus adjuvant Flexyn2a plus adjuvant · LimmaTech Biologics AG https://druglandscape.com/drug/florbetapir-f-18-pet-scan https://druglandscape.com/api/og?type=drug&title=Florbetapir%20F%2018%20PET%20Scan&subtitle=Florbetapir%20F%2018%20PET%20Scan%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 Florbetapir F 18 PET Scan Florbetapir F 18 PET Scan · Eli Lilly and Company https://druglandscape.com/drug/floseal-application https://druglandscape.com/api/og?type=drug&title=FloSeal%20application&subtitle=FloSeal%20application%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 FloSeal application FloSeal application · Asan Medical Center https://druglandscape.com/drug/flp-dose-escalation-mtd https://druglandscape.com/api/og?type=drug&title=FLP%2Cdose%20escalation%2CMTD&subtitle=FLP%2Cdose%20escalation%2CMTD%20%C2%B7%20Acea%20Bio%20(Hangzhou)%20Co.%2C%20Ltd.&badge=phase%201 FLP,dose escalation,MTD FLP,dose escalation,MTD · Acea Bio (Hangzhou) Co., Ltd. https://druglandscape.com/drug/flq-101 https://druglandscape.com/api/og?type=drug&title=FLQ-101&subtitle=FLQ-101%20%C2%B7%20FELIQS%20INC.&badge=phase%201 FLQ-101 FLQ-101 · FELIQS INC. https://druglandscape.com/drug/flt3l https://druglandscape.com/api/og?type=drug&title=Flt3L&subtitle=Flt3L%20%C2%B7%20Icahn%20School%20of%20Medicine%20at%20Mount%20Sinai&badge=phase%201 Flt3L Flt3L · Icahn School of Medicine at Mount Sinai https://druglandscape.com/drug/flu-igiv https://druglandscape.com/api/og?type=drug&title=FLU-IGIV&subtitle=FLU-IGIV%20%C2%B7%20Emergent%20BioSolutions&badge=phase%202 FLU-IGIV FLU-IGIV · Emergent BioSolutions https://druglandscape.com/drug/flu-matrix-peptide-p58-66 https://druglandscape.com/api/og?type=drug&title=flu%20matrix%20peptide%20p58-66&subtitle=flu%20matrix%20peptide%20p58-66%20%C2%B7%20Baylor%20Health%20Care%20System&badge=phase%201 flu matrix peptide p58-66 flu matrix peptide p58-66 · Baylor Health Care System https://druglandscape.com/drug/flu-pandemic-mrna-dose-level-3 https://druglandscape.com/api/og?type=drug&title=Flu%20Pandemic%20mRNA_%20Dose%20level%203.&subtitle=Flu%20Pandemic%20mRNA_%20Dose%20level%203.%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Flu Pandemic mRNA_ Dose level 3. Flu Pandemic mRNA_ Dose level 3. · GlaxoSmithKline https://druglandscape.com/drug/flu-pandemic-mrna-dose-level-4 https://druglandscape.com/api/og?type=drug&title=Flu%20Pandemic%20mRNA_%20Dose%20level%204&subtitle=Flu%20Pandemic%20mRNA_%20Dose%20level%204%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Flu Pandemic mRNA_ Dose level 4 Flu Pandemic mRNA_ Dose level 4 · GlaxoSmithKline https://druglandscape.com/drug/flu-pandemic-mrna-dose-level-6 https://druglandscape.com/api/og?type=drug&title=Flu%20Pandemic%20mRNA_Dose%20level%206&subtitle=Flu%20Pandemic%20mRNA_Dose%20level%206%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Flu Pandemic mRNA_Dose level 6 Flu Pandemic mRNA_Dose level 6 · GlaxoSmithKline https://druglandscape.com/drug/flu-q-pan-h5n8-375-a https://druglandscape.com/api/og?type=drug&title=FLU%20Q-PAN%20H5N8%20375_A&subtitle=FLU%20Q-PAN%20H5N8%20375_A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 FLU Q-PAN H5N8 375_A FLU Q-PAN H5N8 375_A · GlaxoSmithKline https://druglandscape.com/drug/flu-q-pan-h5n8-375-b https://druglandscape.com/api/og?type=drug&title=FLU%20Q-PAN%20H5N8%20375_B&subtitle=FLU%20Q-PAN%20H5N8%20375_B%20%C2%B7%20GlaxoSmithKline&badge=phase%201 FLU Q-PAN H5N8 375_B FLU Q-PAN H5N8 375_B · GlaxoSmithKline https://druglandscape.com/drug/flu-q-pan-h5n8-750-a https://druglandscape.com/api/og?type=drug&title=FLU%20Q-PAN%20H5N8%20750_A&subtitle=FLU%20Q-PAN%20H5N8%20750_A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 FLU Q-PAN H5N8 750_A FLU Q-PAN H5N8 750_A · GlaxoSmithKline https://druglandscape.com/drug/flu-q-pan-h5n8-750-b https://druglandscape.com/api/og?type=drug&title=FLU%20Q-PAN%20H5N8%20750_B&subtitle=FLU%20Q-PAN%20H5N8%20750_B%20%C2%B7%20GlaxoSmithKline&badge=phase%201 FLU Q-PAN H5N8 750_B FLU Q-PAN H5N8 750_B · GlaxoSmithKline https://druglandscape.com/drug/flu-v-control https://druglandscape.com/api/og?type=drug&title=FLU-v%20Control&subtitle=FLU-v%20Control%20%C2%B7%20PepTcell%20Limited&badge=phase%201 FLU-v Control FLU-v Control · PepTcell Limited https://druglandscape.com/drug/fluarix-as01b https://druglandscape.com/api/og?type=drug&title=Fluarix-AS01B&subtitle=Fluarix-AS01B%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Fluarix-AS01B Fluarix-AS01B · GlaxoSmithKline https://druglandscape.com/drug/fluarix-as01e https://druglandscape.com/api/og?type=drug&title=Fluarix-AS01E&subtitle=Fluarix-AS01E%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Fluarix-AS01E Fluarix-AS01E · GlaxoSmithKline https://druglandscape.com/drug/fluarix-as50 https://druglandscape.com/api/og?type=drug&title=Fluarix-AS50&subtitle=Fluarix-AS50%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Fluarix-AS50 Fluarix-AS50 · GlaxoSmithKline https://druglandscape.com/drug/flubhpve6e7 https://druglandscape.com/api/og?type=drug&title=FluBHPVE6E7&subtitle=FluBHPVE6E7%20%C2%B7%20BlueSky%20Immunotherapies%20GmbH&badge=phase%201 FluBHPVE6E7 FluBHPVE6E7 · BlueSky Immunotherapies GmbH https://druglandscape.com/drug/flublok-quadrivalent-influenza-vaccine-riv4 https://druglandscape.com/api/og?type=drug&title=Flublok%20Quadrivalent%20influenza%20vaccine%20RIV4&subtitle=Flublok%20Quadrivalent%20influenza%20vaccine%20RIV4%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%202 Flublok Quadrivalent influenza vaccine RIV4 Flublok Quadrivalent influenza vaccine RIV4 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/flucelvax-quad https://druglandscape.com/api/og?type=drug&title=Flucelvax%20Quad&subtitle=Flucelvax%20Quad%20%C2%B7%20Codagenix%2C%20Inc&badge=phase%201 Flucelvax Quad Flucelvax Quad · Codagenix, Inc https://druglandscape.com/drug/fluconazole-capsules https://druglandscape.com/api/og?type=drug&title=Fluconazole%20Capsules&subtitle=Fluconazole%20Capsules%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Fluconazole Capsules Fluconazole Capsules · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/fludarabine-cyclophosphamide-rituximab-lenalidomide https://druglandscape.com/api/og?type=drug&title=Fludarabine%2C%20Cyclophosphamide%2C%20Rituximab%2C%20Lenalidomide&subtitle=Fludarabine%2C%20Cyclophosphamide%2C%20Rituximab%2C%20Lenalidomide%20%C2%B7%20Hackensack%20Meridian%20Health&badge=phase%202 Fludarabine, Cyclophosphamide, Rituximab, Lenalidomide Fludarabine, Cyclophosphamide, Rituximab, Lenalidomide · Hackensack Meridian Health https://druglandscape.com/drug/fludarabine-methotrexate-mercaptopurine https://druglandscape.com/api/og?type=drug&title=fludarabine%2C%20methotrexate%2C%20mercaptopurine&subtitle=fludarabine%2C%20methotrexate%2C%20mercaptopurine%20%C2%B7%20St.%20Jude%20Children's%20Research%20Hospital&badge=phase%203 fludarabine, methotrexate, mercaptopurine fludarabine, methotrexate, mercaptopurine · St. Jude Children's Research Hospital https://druglandscape.com/drug/fludarabine-mitoxantrone-cyclophosphamide-and-alemtuzumab https://druglandscape.com/api/og?type=drug&title=Fludarabine%2C%20Mitoxantrone%2C%20Cyclophosphamide%20and%20Alemtuzumab&subtitle=Fludarabine%2C%20Mitoxantrone%2C%20Cyclophosphamide%20and%20Alemtuzumab%20%C2%B7%20German%20CLL%20Study%20Group&badge=phase%202 Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab · German CLL Study Group https://druglandscape.com/drug/fludarabine-phosphate-busulfan https://druglandscape.com/api/og?type=drug&title=fludarabine%20phosphate%2C%20busulfan&subtitle=fludarabine%20phosphate%2C%20busulfan%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 fludarabine phosphate, busulfan fludarabine phosphate, busulfan · Samsung Medical Center https://druglandscape.com/drug/fludeoxyglucose-pet-mri https://druglandscape.com/api/og?type=drug&title=Fludeoxyglucose%20PET%20MRI&subtitle=Fludeoxyglucose%20PET%20MRI%20%C2%B7%20Michael%20C%20Roarke%2C%20MD&badge=phase%202 Fludeoxyglucose PET MRI Fludeoxyglucose PET MRI · Michael C Roarke, MD https://druglandscape.com/drug/flufirvitide-3 https://druglandscape.com/api/og?type=drug&title=Flufirvitide%203&subtitle=Flufirvitide%203%20%C2%B7%20Autoimmune%20Technologies%2C%20LLC&badge=phase%201 Flufirvitide 3 Flufirvitide 3 · Autoimmune Technologies, LLC https://druglandscape.com/drug/fluid-administration https://druglandscape.com/api/og?type=drug&title=fluid%20administration&subtitle=fluid%20administration%20%C2%B7%20Fondazione%20Poliambulanza%20Istituto%20Ospedaliero&badge=phase%202 fluid administration fluid administration · Fondazione Poliambulanza Istituto Ospedaliero https://druglandscape.com/drug/fluimucil-2-solution https://druglandscape.com/api/og?type=drug&title=Fluimucil%C2%AE%202%25%20solution&subtitle=Fluimucil%C2%AE%202%25%20solution%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Fluimucil® 2% solution Fluimucil® 2% solution · GlaxoSmithKline https://druglandscape.com/drug/fluor-varnish https://druglandscape.com/api/og?type=drug&title=Fluor%20varnish&subtitle=Fluor%20varnish%20%C2%B7%20Universidad%20Autonoma%20de%20San%20Luis%20Potos%C3%AD&badge=phase%202 Fluor varnish Fluor varnish · Universidad Autonoma de San Luis Potosí https://druglandscape.com/drug/fluor-varnish-with-nanoparticles https://druglandscape.com/api/og?type=drug&title=Fluor%20varnish%20with%20nanoparticles&subtitle=Fluor%20varnish%20with%20nanoparticles%20%C2%B7%20Universidad%20Autonoma%20de%20San%20Luis%20Potos%C3%AD&badge=phase%202 Fluor varnish with nanoparticles Fluor varnish with nanoparticles · Universidad Autonoma de San Luis Potosí https://druglandscape.com/drug/fluoride-neutral-naf-gel-2 https://druglandscape.com/api/og?type=drug&title=Fluoride%20neutral%20NaF%20gel%202%20%25&subtitle=Fluoride%20neutral%20NaF%20gel%202%20%25%20%C2%B7%20Universidade%20Federal%20de%20Santa%20Maria&badge=phase%202 Fluoride neutral NaF gel 2 % Fluoride neutral NaF gel 2 % · Universidade Federal de Santa Maria https://druglandscape.com/drug/fluoro-uracil https://druglandscape.com/api/og?type=drug&title=Fluoro%20Uracil&subtitle=Fluoro%20Uracil%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%202 Fluoro Uracil Fluoro Uracil · City of Hope Medical Center https://druglandscape.com/drug/fluorometholone-1-topical-ocular-steroid https://druglandscape.com/api/og?type=drug&title=Fluorometholone%201%25%20topical%20ocular%20steroid&subtitle=Fluorometholone%201%25%20topical%20ocular%20steroid%20%C2%B7%20United%20States%20Naval%20Medical%20Center%2C%20San%20Diego&badge=phase%202 Fluorometholone 1% topical ocular steroid Fluorometholone 1% topical ocular steroid · United States Naval Medical Center, San Diego https://druglandscape.com/drug/fluorothymidine-f-18 https://druglandscape.com/api/og?type=drug&title=fluorothymidine%20F%2018&subtitle=fluorothymidine%20F%2018%20%C2%B7%20John%20M.%20Buatti&badge=phase%202 fluorothymidine F 18 fluorothymidine F 18 · John M. Buatti https://druglandscape.com/drug/flurbiprofen-10 https://druglandscape.com/api/og?type=drug&title=Flurbiprofen%2010%25&subtitle=Flurbiprofen%2010%25%20%C2%B7%20Express%20Specialty%20Pharmacy&badge=phase%202 Flurbiprofen 10% Flurbiprofen 10% · Express Specialty Pharmacy https://druglandscape.com/drug/fluticasone-foroate https://druglandscape.com/api/og?type=drug&title=Fluticasone%20foroate&subtitle=Fluticasone%20foroate%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Fluticasone foroate Fluticasone foroate · GlaxoSmithKline https://druglandscape.com/drug/fluticasone-mono https://druglandscape.com/api/og?type=drug&title=Fluticasone%20mono&subtitle=Fluticasone%20mono%20%C2%B7%20MEDA%20Pharma%20GmbH%20%26%20Co.%20KG&badge=phase%201 Fluticasone mono Fluticasone mono · MEDA Pharma GmbH & Co. KG https://druglandscape.com/drug/fluticasone-monotherapy https://druglandscape.com/api/og?type=drug&title=Fluticasone%20monotherapy&subtitle=Fluticasone%20monotherapy%20%C2%B7%20Sanofi&badge=phase%202 Fluticasone monotherapy Fluticasone monotherapy · Sanofi https://druglandscape.com/drug/fluticasone-propionate-hfa-220 https://druglandscape.com/api/og?type=drug&title=Fluticasone%20propionate%20HFA%20220&subtitle=Fluticasone%20propionate%20HFA%20220%20%C2%B7%20NYU%20Langone%20Health&badge=phase%202 Fluticasone propionate HFA 220 Fluticasone propionate HFA 220 · NYU Langone Health https://druglandscape.com/drug/fluzone-hd-day-0 https://druglandscape.com/api/og?type=drug&title=Fluzone%20HD%20-%20Day%200&subtitle=Fluzone%20HD%20-%20Day%200%20%C2%B7%20Novavax&badge=phase%201 Fluzone HD - Day 0 Fluzone HD - Day 0 · Novavax https://druglandscape.com/drug/fluzone-hd-day-21 https://druglandscape.com/api/og?type=drug&title=Fluzone%20HD%20-%20Day%2021&subtitle=Fluzone%20HD%20-%20Day%2021%20%C2%B7%20Novavax&badge=phase%201 Fluzone HD - Day 21 Fluzone HD - Day 21 · Novavax https://druglandscape.com/drug/fluzone-hd-iiv https://druglandscape.com/api/og?type=drug&title=Fluzone%20HD%20IIV&subtitle=Fluzone%20HD%20IIV%20%C2%B7%20FluGen%20Inc&badge=phase%201 Fluzone HD IIV Fluzone HD IIV · FluGen Inc https://druglandscape.com/drug/fluzone-hd-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=Fluzone%20HD%20influenza%20vaccine&subtitle=Fluzone%20HD%20influenza%20vaccine%20%C2%B7%20Cidara%20Therapeutics%20Inc.&badge=phase%201 Fluzone HD influenza vaccine Fluzone HD influenza vaccine · Cidara Therapeutics Inc. https://druglandscape.com/drug/fluzone-in https://druglandscape.com/api/og?type=drug&title=Fluzone%20IN&subtitle=Fluzone%20IN%20%C2%B7%20NanoBio%20Corporation&badge=phase%201 Fluzone IN Fluzone IN · NanoBio Corporation https://druglandscape.com/drug/fluzone-vaccine https://druglandscape.com/api/og?type=drug&title=Fluzone%20vaccine&subtitle=Fluzone%20vaccine%20%C2%B7%20Colby%20Pharmaceutical%20Company&badge=phase%201 Fluzone vaccine Fluzone vaccine · Colby Pharmaceutical Company https://druglandscape.com/drug/fluzone-vaccine-with-jvrs-100-adjuvant https://druglandscape.com/api/og?type=drug&title=Fluzone%20vaccine%20with%20JVRS-100%20adjuvant&subtitle=Fluzone%20vaccine%20with%20JVRS-100%20adjuvant%20%C2%B7%20Colby%20Pharmaceutical%20Company&badge=phase%201 Fluzone vaccine with JVRS-100 adjuvant Fluzone vaccine with JVRS-100 adjuvant · Colby Pharmaceutical Company https://druglandscape.com/drug/fm-601 https://druglandscape.com/api/og?type=drug&title=FM-601&subtitle=FM-601%20%C2%B7%20C.B.%20Fleet%20Company%2C%20Inc.&badge=phase%202 FM-601 FM-601 · C.B. Fleet Company, Inc. https://druglandscape.com/drug/fmc-376 https://druglandscape.com/api/og?type=drug&title=FMC-376&subtitle=FMC-376%20%C2%B7%20Frontier%20Medicines%20Corporation&badge=phase%201 FMC-376 FMC-376 · Frontier Medicines Corporation https://druglandscape.com/drug/fmp012-with-as01b-adjuvant-system https://druglandscape.com/api/og?type=drug&title=FMP012%20with%20AS01B%20adjuvant%20system&subtitle=FMP012%20with%20AS01B%20adjuvant%20system%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 FMP012 with AS01B adjuvant system FMP012 with AS01B adjuvant system · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/fmp013 https://druglandscape.com/api/og?type=drug&title=FMP013&subtitle=FMP013%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 FMP013 FMP013 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/fmt-c https://druglandscape.com/api/og?type=drug&title=FMT-c&subtitle=FMT-c%20%C2%B7%20Universidad%20Autonoma%20de%20Nuevo%20Leon&badge=phase%201 FMT-c FMT-c · Universidad Autonoma de Nuevo Leon https://druglandscape.com/drug/fmt-c-lactobacillus https://druglandscape.com/api/og?type=drug&title=FMT-c%20Lactobacillus&subtitle=FMT-c%20Lactobacillus%20%C2%B7%20Universidad%20Autonoma%20de%20Nuevo%20Leon&badge=phase%201 FMT-c Lactobacillus FMT-c Lactobacillus · Universidad Autonoma de Nuevo Leon https://druglandscape.com/drug/fmtn https://druglandscape.com/api/og?type=drug&title=FMTN&subtitle=FMTN%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 FMTN FMTN · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/fmx101-minocycline-4-foam https://druglandscape.com/api/og?type=drug&title=FMX101%2C%20Minocycline%204%25%20foam&subtitle=FMX101%2C%20Minocycline%204%25%20foam%20%C2%B7%20Vyne%20Therapeutics%20Inc.&badge=phase%201 FMX101, Minocycline 4% foam FMX101, Minocycline 4% foam · Vyne Therapeutics Inc. https://druglandscape.com/drug/fog-001 https://druglandscape.com/api/og?type=drug&title=FOG-001&subtitle=FOG-001%20%C2%B7%20Parabilis%20Medicines%2C%20Inc.&badge=phase%201 FOG-001 FOG-001 · Parabilis Medicines, Inc. https://druglandscape.com/drug/folfiri-and-cetuximab https://druglandscape.com/api/og?type=drug&title=FOLFIRI%20and%20cetuximab&subtitle=FOLFIRI%20and%20cetuximab%20%C2%B7%20UNICANCER&badge=phase%202 FOLFIRI and cetuximab FOLFIRI and cetuximab · UNICANCER https://druglandscape.com/drug/folfiri-target-agent https://druglandscape.com/api/og?type=drug&title=FOLFIRI%2C%20target%20agent&subtitle=FOLFIRI%2C%20target%20agent%20%C2%B7%20Joong%20Bae%20Ahn&badge=phase%202 FOLFIRI, target agent FOLFIRI, target agent · Joong Bae Ahn https://druglandscape.com/drug/folfirinox-bevacizumab https://druglandscape.com/api/og?type=drug&title=FOLFIRINOX%20Bevacizumab&subtitle=FOLFIRINOX%20Bevacizumab%20%C2%B7%20Centre%20Georges%20Francois%20Leclerc&badge=phase%201 FOLFIRINOX Bevacizumab FOLFIRINOX Bevacizumab · Centre Georges Francois Leclerc https://druglandscape.com/drug/folfirninox https://druglandscape.com/api/og?type=drug&title=FOLFIRNINOX&subtitle=FOLFIRNINOX%20%C2%B7%20Colin%20D.%20Weekes%2C%20M.D.%2C%20PhD&badge=phase%202 FOLFIRNINOX FOLFIRNINOX · Colin D. Weekes, M.D., PhD https://druglandscape.com/drug/folforinox https://druglandscape.com/api/og?type=drug&title=FOLFORINOX&subtitle=FOLFORINOX%20%C2%B7%20Federation%20Francophone%20de%20Cancerologie%20Digestive&badge=phase%202 FOLFORINOX FOLFORINOX · Federation Francophone de Cancerologie Digestive https://druglandscape.com/drug/follicular-lymphoma https://druglandscape.com/api/og?type=drug&title=Follicular%20Lymphoma&subtitle=Follicular%20Lymphoma%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Follicular Lymphoma Follicular Lymphoma · GlaxoSmithKline https://druglandscape.com/drug/follitropin-delta-recombinant https://druglandscape.com/api/og?type=drug&title=Follitropin%20Delta%2C%20Recombinant&subtitle=Follitropin%20Delta%2C%20Recombinant%20%C2%B7%20IVI%20Madrid&badge=phase%202 Follitropin Delta, Recombinant Follitropin Delta, Recombinant · IVI Madrid https://druglandscape.com/drug/food-flour-allergens https://druglandscape.com/api/og?type=drug&title=Food%20Flour%20Allergens&subtitle=Food%20Flour%20Allergens%20%C2%B7%20Kari%20Christine%20Nadeau%2C%20MD%20PhD&badge=phase%202 Food Flour Allergens Food Flour Allergens · Kari Christine Nadeau, MD PhD https://druglandscape.com/drug/food-flour-buildup https://druglandscape.com/api/og?type=drug&title=Food%20Flour%20Buildup&subtitle=Food%20Flour%20Buildup%20%C2%B7%20Kari%20Christine%20Nadeau&badge=phase%202 Food Flour Buildup Food Flour Buildup · Kari Christine Nadeau https://druglandscape.com/drug/for-6219 https://druglandscape.com/api/og?type=drug&title=FOR-6219&subtitle=FOR-6219%20%C2%B7%20Forendo%20Pharma%20Ltd&badge=phase%201 FOR-6219 FOR-6219 · Forendo Pharma Ltd https://druglandscape.com/drug/for46 https://druglandscape.com/api/og?type=drug&title=FOR46&subtitle=FOR46%20%C2%B7%20Fortis%20Therapeutics%2C%20Inc.&badge=phase%201 FOR46 FOR46 · Fortis Therapeutics, Inc. https://druglandscape.com/drug/foradil-aerolizer https://druglandscape.com/api/og?type=drug&title=Foradil%20Aerolizer&subtitle=Foradil%20Aerolizer%20%C2%B7%20Dey&badge=phase%202 Foradil Aerolizer Foradil Aerolizer · Dey https://druglandscape.com/drug/form-1-of-azd5718-tablets https://druglandscape.com/api/og?type=drug&title=Form%201%20of%20AZD5718%20tablets&subtitle=Form%201%20of%20AZD5718%20tablets%20%C2%B7%20AstraZeneca&badge=phase%201 Form 1 of AZD5718 tablets Form 1 of AZD5718 tablets · AstraZeneca https://druglandscape.com/drug/form-2-of-azd5718-tablets https://druglandscape.com/api/og?type=drug&title=Form%202%20of%20AZD5718%20tablets&subtitle=Form%202%20of%20AZD5718%20tablets%20%C2%B7%20AstraZeneca&badge=phase%201 Form 2 of AZD5718 tablets Form 2 of AZD5718 tablets · AstraZeneca https://druglandscape.com/drug/form-4-of-azd5718-tablets https://druglandscape.com/api/og?type=drug&title=Form%204%20of%20AZD5718%20tablets&subtitle=Form%204%20of%20AZD5718%20tablets%20%C2%B7%20AstraZeneca&badge=phase%201 Form 4 of AZD5718 tablets Form 4 of AZD5718 tablets · AstraZeneca https://druglandscape.com/drug/form-5-of-azd5718-tablets https://druglandscape.com/api/og?type=drug&title=Form%205%20of%20AZD5718%20tablets&subtitle=Form%205%20of%20AZD5718%20tablets%20%C2%B7%20AstraZeneca&badge=phase%201 Form 5 of AZD5718 tablets Form 5 of AZD5718 tablets · AstraZeneca https://druglandscape.com/drug/formatris-24-g https://druglandscape.com/api/og?type=drug&title=Formatris%2024%C2%B5g&subtitle=Formatris%2024%C2%B5g%20%C2%B7%20MEDA%20Pharma%20GmbH%20%26%20Co.%20KG&badge=phase%202 Formatris 24µg Formatris 24µg · MEDA Pharma GmbH & Co. KG https://druglandscape.com/drug/formoterol-fumarate-dpi https://druglandscape.com/api/og?type=drug&title=Formoterol%20Fumarate%20DPI&subtitle=Formoterol%20Fumarate%20DPI%20%C2%B7%20Organon%20and%20Co&badge=phase%202 Formoterol Fumarate DPI Formoterol Fumarate DPI · Organon and Co https://druglandscape.com/drug/formoterol-inhalant-powder https://druglandscape.com/api/og?type=drug&title=Formoterol%20Inhalant%20Powder&subtitle=Formoterol%20Inhalant%20Powder%20%C2%B7%20Imperial%20College%20London&badge=phase%201 Formoterol Inhalant Powder Formoterol Inhalant Powder · Imperial College London https://druglandscape.com/drug/formula-or-breast-milk https://druglandscape.com/api/og?type=drug&title=Formula%20or%20breast%20milk&subtitle=Formula%20or%20breast%20milk%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%201 Formula or breast milk Formula or breast milk · Sheba Medical Center https://druglandscape.com/drug/formulation-00b https://druglandscape.com/api/og?type=drug&title=Formulation%2000B&subtitle=Formulation%2000B%20%C2%B7%20ISDIN&badge=phase%201 Formulation 00B Formulation 00B · ISDIN https://druglandscape.com/drug/formulation-4 https://druglandscape.com/api/og?type=drug&title=Formulation%204&subtitle=Formulation%204%20%C2%B7%20Bayer&badge=phase%201 Formulation 4 Formulation 4 · Bayer https://druglandscape.com/drug/formulation-a-gs-248 https://druglandscape.com/api/og?type=drug&title=Formulation%20A%20GS-248&subtitle=Formulation%20A%20GS-248%20%C2%B7%20Gesynta%20Pharma%20AB&badge=phase%201 Formulation A GS-248 Formulation A GS-248 · Gesynta Pharma AB https://druglandscape.com/drug/formulation-a-onabotulinumtoxina https://druglandscape.com/api/og?type=drug&title=Formulation%20A%3A%20OnabotulinumtoxinA&subtitle=Formulation%20A%3A%20OnabotulinumtoxinA%20%C2%B7%20Allergan&badge=phase%202 Formulation A: OnabotulinumtoxinA Formulation A: OnabotulinumtoxinA · Allergan https://druglandscape.com/drug/formulation-b-gs-248 https://druglandscape.com/api/og?type=drug&title=Formulation%20B%20GS-248&subtitle=Formulation%20B%20GS-248%20%C2%B7%20Gesynta%20Pharma%20AB&badge=phase%201 Formulation B GS-248 Formulation B GS-248 · Gesynta Pharma AB https://druglandscape.com/drug/formulation-b-onabotulinumtoxina https://druglandscape.com/api/og?type=drug&title=Formulation%20B%3A%20OnabotulinumtoxinA&subtitle=Formulation%20B%3A%20OnabotulinumtoxinA%20%C2%B7%20Allergan&badge=phase%202 Formulation B: OnabotulinumtoxinA Formulation B: OnabotulinumtoxinA · Allergan https://druglandscape.com/drug/formulation-e1-of-l-ppds https://druglandscape.com/api/og?type=drug&title=Formulation%20E1%20of%20L-PPDS&subtitle=Formulation%20E1%20of%20L-PPDS%20%C2%B7%20Mati%20Therapeutics%20Inc.&badge=phase%202 Formulation E1 of L-PPDS Formulation E1 of L-PPDS · Mati Therapeutics Inc. https://druglandscape.com/drug/formulation-e2-of-l-ppds https://druglandscape.com/api/og?type=drug&title=Formulation%20E2%20of%20L-PPDS&subtitle=Formulation%20E2%20of%20L-PPDS%20%C2%B7%20Mati%20Therapeutics%20Inc.&badge=phase%202 Formulation E2 of L-PPDS Formulation E2 of L-PPDS · Mati Therapeutics Inc. https://druglandscape.com/drug/formulation-g https://druglandscape.com/api/og?type=drug&title=Formulation%20G&subtitle=Formulation%20G%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Formulation G Formulation G · GlaxoSmithKline https://druglandscape.com/drug/formulation-m1 https://druglandscape.com/api/og?type=drug&title=Formulation%20M1&subtitle=Formulation%20M1%20%C2%B7%20Janssen%20Sciences%20Ireland%20UC&badge=phase%201 Formulation M1 Formulation M1 · Janssen Sciences Ireland UC https://druglandscape.com/drug/formulation-m2 https://druglandscape.com/api/og?type=drug&title=Formulation%20M2&subtitle=Formulation%20M2%20%C2%B7%20Janssen%20Sciences%20Ireland%20UC&badge=phase%201 Formulation M2 Formulation M2 · Janssen Sciences Ireland UC https://druglandscape.com/drug/formulation-m3 https://druglandscape.com/api/og?type=drug&title=Formulation%20M3&subtitle=Formulation%20M3%20%C2%B7%20Janssen%20Sciences%20Ireland%20UC&badge=phase%201 Formulation M3 Formulation M3 · Janssen Sciences Ireland UC https://druglandscape.com/drug/formulation-n1 https://druglandscape.com/api/og?type=drug&title=Formulation%20N1&subtitle=Formulation%20N1%20%C2%B7%20Janssen%20Sciences%20Ireland%20UC&badge=phase%201 Formulation N1 Formulation N1 · Janssen Sciences Ireland UC https://druglandscape.com/drug/formulation-n2 https://druglandscape.com/api/og?type=drug&title=Formulation%20N2&subtitle=Formulation%20N2%20%C2%B7%20Janssen%20Sciences%20Ireland%20UC&badge=phase%201 Formulation N2 Formulation N2 · Janssen Sciences Ireland UC https://druglandscape.com/drug/formulation-n3 https://druglandscape.com/api/og?type=drug&title=Formulation%20N3&subtitle=Formulation%20N3%20%C2%B7%20Janssen%20Sciences%20Ireland%20UC&badge=phase%201 Formulation N3 Formulation N3 · Janssen Sciences Ireland UC https://druglandscape.com/drug/forodesine-hcl https://druglandscape.com/api/og?type=drug&title=forodesine%20HCl&subtitle=forodesine%20HCl%20%C2%B7%20BioCryst%20Pharmaceuticals&badge=phase%202 forodesine HCl forodesine HCl · BioCryst Pharmaceuticals https://druglandscape.com/drug/fortified-oral-rehydration-therapy https://druglandscape.com/api/og?type=drug&title=Fortified%20Oral%20Rehydration%20Therapy&subtitle=Fortified%20Oral%20Rehydration%20Therapy%20%C2%B7%20Paul%20A%20Breslin&badge=phase%201 Fortified Oral Rehydration Therapy Fortified Oral Rehydration Therapy · Paul A Breslin https://druglandscape.com/drug/forx-428 https://druglandscape.com/api/og?type=drug&title=FORX-428&subtitle=FORX-428%20%C2%B7%20FoRx%20Therapeutics%20AG&badge=phase%201 FORX-428 FORX-428 · FoRx Therapeutics AG https://druglandscape.com/drug/fosinopril-and-losartan https://druglandscape.com/api/og?type=drug&title=Fosinopril%20and%20Losartan&subtitle=Fosinopril%20and%20Losartan%20%C2%B7%20Shanghai%20Municipal%20Health%20Bureau&badge=phase%201 Fosinopril and Losartan Fosinopril and Losartan · Shanghai Municipal Health Bureau https://druglandscape.com/drug/fosmidomycin-piperaquine https://druglandscape.com/api/og?type=drug&title=Fosmidomycin-Piperaquine&subtitle=Fosmidomycin-Piperaquine%20%C2%B7%20Jomaa%20Pharma%20GmbH&badge=phase%202 Fosmidomycin-Piperaquine Fosmidomycin-Piperaquine · Jomaa Pharma GmbH https://druglandscape.com/drug/fostamatin https://druglandscape.com/api/og?type=drug&title=FOSTAMATIN&subtitle=FOSTAMATIN%20%C2%B7%20AstraZeneca&badge=phase%201 FOSTAMATIN FOSTAMATIN · AstraZeneca https://druglandscape.com/drug/fp-02-2-vaccine https://druglandscape.com/api/og?type=drug&title=FP-02.2%20Vaccine&subtitle=FP-02.2%20Vaccine%20%C2%B7%20Altimmune%2C%20Inc.&badge=phase%201 FP-02.2 Vaccine FP-02.2 Vaccine · Altimmune, Inc. https://druglandscape.com/drug/fp-020 https://druglandscape.com/api/og?type=drug&title=FP-020&subtitle=FP-020%20%C2%B7%20Foresee%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 FP-020 FP-020 · Foresee Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/fp-025 https://druglandscape.com/api/og?type=drug&title=FP-025&subtitle=FP-025%20%C2%B7%20Foresee%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 FP-025 FP-025 · Foresee Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/fp-100 https://druglandscape.com/api/og?type=drug&title=FP%20100&subtitle=FP%20100%20%C2%B7%20GlaxoSmithKline&badge=phase%202 FP 100 FP 100 · GlaxoSmithKline https://druglandscape.com/drug/fp9-cs https://druglandscape.com/api/og?type=drug&title=FP9%20CS&subtitle=FP9%20CS%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%201 FP9 CS FP9 CS · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/fp9-me-trap https://druglandscape.com/api/og?type=drug&title=FP9%20ME-TRAP&subtitle=FP9%20ME-TRAP%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%201 FP9 ME-TRAP FP9 ME-TRAP · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/fpi-2053 https://druglandscape.com/api/og?type=drug&title=FPI-2053&subtitle=FPI-2053%20%C2%B7%20AstraZeneca&badge=phase%201 FPI-2053 FPI-2053 · AstraZeneca https://druglandscape.com/drug/fractionated-iced https://druglandscape.com/api/og?type=drug&title=fractionated%20ICED&subtitle=fractionated%20ICED%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 fractionated ICED fractionated ICED · Samsung Medical Center https://druglandscape.com/drug/free-of-charge https://druglandscape.com/api/og?type=drug&title=Free%20of%20charge&subtitle=Free%20of%20charge%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 Free of charge Free of charge · Hadassah Medical Organization https://druglandscape.com/drug/freeze-dried-pergoveris https://druglandscape.com/api/og?type=drug&title=Freeze-dried%20pergoveris&subtitle=Freeze-dried%20pergoveris%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 Freeze-dried pergoveris Freeze-dried pergoveris · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/frequency-of-treg-and-teffs https://druglandscape.com/api/og?type=drug&title=Frequency%20of%20Treg%20and%20Teffs&subtitle=Frequency%20of%20Treg%20and%20Teffs%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Frequency of Treg and Teffs Frequency of Treg and Teffs · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/fresubin-supportan https://druglandscape.com/api/og?type=drug&title=Fresubin%20Supportan&subtitle=Fresubin%20Supportan%20%C2%B7%20Anna%20Arthur%2C%20PhD&badge=phase%201 Fresubin Supportan Fresubin Supportan · Anna Arthur, PhD https://druglandscape.com/drug/frio-mouth-rinse https://druglandscape.com/api/og?type=drug&title=Frio%20Mouth%20Rinse&subtitle=Frio%20Mouth%20Rinse%20%C2%B7%20Biomedical%20Development%20Corporation&badge=phase%201 Frio Mouth Rinse Frio Mouth Rinse · Biomedical Development Corporation https://druglandscape.com/drug/frio-oral-rinse https://druglandscape.com/api/og?type=drug&title=Frio%20Oral%20Rinse&subtitle=Frio%20Oral%20Rinse%20%C2%B7%20Biomedical%20Development%20Corporation&badge=phase%202 Frio Oral Rinse Frio Oral Rinse · Biomedical Development Corporation https://druglandscape.com/drug/frm-0334 https://druglandscape.com/api/og?type=drug&title=FRM-0334&subtitle=FRM-0334%20%C2%B7%20FORUM%20Pharmaceuticals%20Inc&badge=phase%202 FRM-0334 FRM-0334 · FORUM Pharmaceuticals Inc https://druglandscape.com/drug/fs-1502 https://druglandscape.com/api/og?type=drug&title=FS-1502&subtitle=FS-1502%20%C2%B7%20Shanghai%20Fosun%20Pharmaceutical%20Industrial%20Development%20Co.%20Ltd.&badge=phase%201 FS-1502 FS-1502 · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. https://druglandscape.com/drug/fs102 https://druglandscape.com/api/og?type=drug&title=FS102&subtitle=FS102%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 FS102 FS102 · Bristol-Myers Squibb https://druglandscape.com/drug/fsh-gex https://druglandscape.com/api/og?type=drug&title=FSH-GEX%E2%84%A2&subtitle=FSH-GEX%E2%84%A2%20%C2%B7%20Glycotope%20GmbH&badge=phase%201 FSH-GEX™ FSH-GEX™ · Glycotope GmbH https://druglandscape.com/drug/fsp-peptides https://druglandscape.com/api/og?type=drug&title=FSP%20peptides&subtitle=FSP%20peptides%20%C2%B7%20Oryx%20GmbH%20%26%20Co.%20KG&badge=phase%201 FSP peptides FSP peptides · Oryx GmbH & Co. KG https://druglandscape.com/drug/fsr-peptide-100-m https://druglandscape.com/api/og?type=drug&title=FSR%20Peptide%20100%CE%BCM&subtitle=FSR%20Peptide%20100%CE%BCM%20%C2%B7%20Xequel%20Bio%2C%20Inc.&badge=phase%201 FSR Peptide 100μM FSR Peptide 100μM · Xequel Bio, Inc. https://druglandscape.com/drug/fsr-peptide-20-m https://druglandscape.com/api/og?type=drug&title=FSR%20Peptide%2020%CE%BCM&subtitle=FSR%20Peptide%2020%CE%BCM%20%C2%B7%20Xequel%20Bio%2C%20Inc.&badge=phase%201 FSR Peptide 20μM FSR Peptide 20μM · Xequel Bio, Inc. https://druglandscape.com/drug/fsr-peptide-200-m https://druglandscape.com/api/og?type=drug&title=FSR%20Peptide%20200%CE%BCM&subtitle=FSR%20Peptide%20200%CE%BCM%20%C2%B7%20Xequel%20Bio%2C%20Inc.&badge=phase%201 FSR Peptide 200μM FSR Peptide 200μM · Xequel Bio, Inc. https://druglandscape.com/drug/fsr-peptide-50-m https://druglandscape.com/api/og?type=drug&title=FSR%20Peptide%2050%CE%BCM&subtitle=FSR%20Peptide%2050%CE%BCM%20%C2%B7%20Xequel%20Bio%2C%20Inc.&badge=phase%201 FSR Peptide 50μM FSR Peptide 50μM · Xequel Bio, Inc. https://druglandscape.com/drug/ft-1101 https://druglandscape.com/api/og?type=drug&title=FT-1101&subtitle=FT-1101%20%C2%B7%20Forma%20Therapeutics%2C%20Inc.&badge=phase%201 FT-1101 FT-1101 · Forma Therapeutics, Inc. https://druglandscape.com/drug/ft-2102 https://druglandscape.com/api/og?type=drug&title=FT-2102&subtitle=FT-2102%20%C2%B7%20Forma%20Therapeutics%2C%20Inc.&badge=phase%201 FT-2102 FT-2102 · Forma Therapeutics, Inc. https://druglandscape.com/drug/ftl001 https://druglandscape.com/api/og?type=drug&title=FTL001&subtitle=FTL001%20%C2%B7%20Sound%20Biopharmaceuticals%20Ltd.&badge=phase%201 FTL001 FTL001 · Sound Biopharmaceuticals Ltd. https://druglandscape.com/drug/ftl008-16 https://druglandscape.com/api/og?type=drug&title=FTL008.16&subtitle=FTL008.16%20%C2%B7%20Sound%20Biopharmaceuticals%20Ltd.&badge=phase%201 FTL008.16 FTL008.16 · Sound Biopharmaceuticals Ltd. https://druglandscape.com/drug/ftp-198-multiple-doses https://druglandscape.com/api/og?type=drug&title=FTP-198%2C%20multiple%20doses&subtitle=FTP-198%2C%20multiple%20doses%20%C2%B7%20Sichuan%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd&badge=phase%201 FTP-198, multiple doses FTP-198, multiple doses · Sichuan Haisco Pharmaceutical Group Co., Ltd https://druglandscape.com/drug/ftp-198-single-dose https://druglandscape.com/api/og?type=drug&title=FTP-198%2C%20single%20dose&subtitle=FTP-198%2C%20single%20dose%20%C2%B7%20Sichuan%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd&badge=phase%201 FTP-198, single dose FTP-198, single dose · Sichuan Haisco Pharmaceutical Group Co., Ltd https://druglandscape.com/drug/fucosylated-msc-for-osteoporosis https://druglandscape.com/api/og?type=drug&title=Fucosylated%20MSC%20for%20Osteoporosis&subtitle=Fucosylated%20MSC%20for%20Osteoporosis%20%C2%B7%20Red%20de%20Terapia%20Celular&badge=phase%201 Fucosylated MSC for Osteoporosis Fucosylated MSC for Osteoporosis · Red de Terapia Celular https://druglandscape.com/drug/fuling-yunhua-granules https://druglandscape.com/api/og?type=drug&title=Fuling%20Yunhua%20Granules&subtitle=Fuling%20Yunhua%20Granules%20%C2%B7%20Beijing%20Supreme%20Life%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%202 Fuling Yunhua Granules Fuling Yunhua Granules · Beijing Supreme Life Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/furestem-cd-inj https://druglandscape.com/api/og?type=drug&title=FURESTEM-CD%20Inj.&subtitle=FURESTEM-CD%20Inj.%20%C2%B7%20Kang%20Stem%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 FURESTEM-CD Inj. FURESTEM-CD Inj. · Kang Stem Biotech Co., Ltd. https://druglandscape.com/drug/furestem-ra-inj https://druglandscape.com/api/og?type=drug&title=FURESTEM-RA%20Inj.&subtitle=FURESTEM-RA%20Inj.%20%C2%B7%20Kang%20Stem%20Biotech%20Co.%2C%20Ltd.&badge=phase%202 FURESTEM-RA Inj. FURESTEM-RA Inj. · Kang Stem Biotech Co., Ltd. https://druglandscape.com/drug/furmonertini-mesilate https://druglandscape.com/api/og?type=drug&title=Furmonertini%20Mesilate&subtitle=Furmonertini%20Mesilate%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Furmonertini Mesilate Furmonertini Mesilate · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/furmonertinib-mesilate-tablets-monotherapy https://druglandscape.com/api/og?type=drug&title=Furmonertinib%20Mesilate%20Tablets%20Monotherapy&subtitle=Furmonertinib%20Mesilate%20Tablets%20Monotherapy%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%202 Furmonertinib Mesilate Tablets Monotherapy Furmonertinib Mesilate Tablets Monotherapy · RemeGen Co., Ltd. https://druglandscape.com/drug/furosemide-first-then-acetazolamide https://druglandscape.com/api/og?type=drug&title=Furosemide%20first%2C%20then%20Acetazolamide&subtitle=Furosemide%20first%2C%20then%20Acetazolamide%20%C2%B7%20Rabin%20Medical%20Center&badge=phase%201 Furosemide first, then Acetazolamide Furosemide first, then Acetazolamide · Rabin Medical Center https://druglandscape.com/drug/furosemide-plus-albumin https://druglandscape.com/api/og?type=drug&title=Furosemide%20plus%20albumin&subtitle=Furosemide%20plus%20albumin%20%C2%B7%20Jose%20J%20Zaragoza%2C%20MD%20MSc&badge=phase%201 Furosemide plus albumin Furosemide plus albumin · Jose J Zaragoza, MD MSc https://druglandscape.com/drug/fwd1509-msoh https://druglandscape.com/api/og?type=drug&title=FWD1509%20MsOH&subtitle=FWD1509%20MsOH%20%C2%B7%20Forward%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 FWD1509 MsOH FWD1509 MsOH · Forward Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/fx-1006a https://druglandscape.com/api/og?type=drug&title=Fx-1006A&subtitle=Fx-1006A%20%C2%B7%20Pfizer&badge=phase%202 Fx-1006A Fx-1006A · Pfizer https://druglandscape.com/drug/fx005 https://druglandscape.com/api/og?type=drug&title=FX005&subtitle=FX005%20%C2%B7%20Pacira%20Pharmaceuticals%2C%20Inc&badge=phase%201 FX005 FX005 · Pacira Pharmaceuticals, Inc https://druglandscape.com/drug/fx06 https://druglandscape.com/api/og?type=drug&title=FX06&subtitle=FX06%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 FX06 FX06 · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/fx301 https://druglandscape.com/api/og?type=drug&title=FX301&subtitle=FX301%20%C2%B7%20Pacira%20Pharmaceuticals%2C%20Inc&badge=phase%201 FX301 FX301 · Pacira Pharmaceuticals, Inc https://druglandscape.com/drug/fxs887 https://druglandscape.com/api/og?type=drug&title=FXS887&subtitle=FXS887%20%C2%B7%20Shanghai%20Fosun%20Pharmaceutical%20Industrial%20Development%20Co.%20Ltd.&badge=phase%201 FXS887 FXS887 · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. https://druglandscape.com/drug/fz-ad004 https://druglandscape.com/api/og?type=drug&title=FZ-AD004&subtitle=FZ-AD004%20%C2%B7%20Shanghai%20Fudan-Zhangjiang%20Bio-Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 FZ-AD004 FZ-AD004 · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. https://druglandscape.com/drug/fz-ad005 https://druglandscape.com/api/og?type=drug&title=FZ-AD005&subtitle=FZ-AD005%20%C2%B7%20Shanghai%20Fudan-Zhangjiang%20Bio-Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 FZ-AD005 FZ-AD005 · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. https://druglandscape.com/drug/fzj-003 https://druglandscape.com/api/og?type=drug&title=FZJ-003&subtitle=FZJ-003%20%C2%B7%20Shanghai%20Fudan-Zhangjiang%20Bio-Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 FZJ-003 FZJ-003 · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. https://druglandscape.com/drug/g-cospe-tablets https://druglandscape.com/api/og?type=drug&title=G-COSPE%C2%AE%20tablets&subtitle=G-COSPE%C2%AE%20tablets%20%C2%B7%20Emzor%20Pharmaceutical%20Industries%20Limited&badge=phase%201 G-COSPE® tablets G-COSPE® tablets · Emzor Pharmaceutical Industries Limited https://druglandscape.com/drug/g-csf-or-peg-gcsf https://druglandscape.com/api/og?type=drug&title=G-CSF%20or%20Peg-GCSF&subtitle=G-CSF%20or%20Peg-GCSF%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%202 G-CSF or Peg-GCSF G-CSF or Peg-GCSF · Baylor College of Medicine https://druglandscape.com/drug/g03-52-01 https://druglandscape.com/api/og?type=drug&title=G03-52-01&subtitle=G03-52-01%20%C2%B7%20Alachua%20Government%20Services%2C%20Inc.&badge=phase%202 G03-52-01 G03-52-01 · Alachua Government Services, Inc. https://druglandscape.com/drug/g04cb02 https://druglandscape.com/api/og?type=drug&title=G04CB02&subtitle=G04CB02%20%C2%B7%20Fundaci%C3%B3n%20Universidad%20Cat%C3%B3lica%20de%20Valencia%20San%20Vicente%20M%C3%A1rtir&badge=phase%202 G04CB02 G04CB02 · Fundación Universidad Católica de Valencia San Vicente Mártir https://druglandscape.com/drug/g1t38 https://druglandscape.com/api/og?type=drug&title=G1T38&subtitle=G1T38%20%C2%B7%20G1%20Therapeutics%2C%20Inc.&badge=phase%201 G1T38 G1T38 · G1 Therapeutics, Inc. https://druglandscape.com/drug/g1t48 https://druglandscape.com/api/og?type=drug&title=G1T48&subtitle=G1T48%20%C2%B7%20G1%20Therapeutics%2C%20Inc.&badge=phase%201 G1T48 G1T48 · G1 Therapeutics, Inc. https://druglandscape.com/drug/g207 https://druglandscape.com/api/og?type=drug&title=G207&subtitle=G207%20%C2%B7%20Gregory%20K.%20Friedman%2C%20MD&badge=phase%201 G207 G207 · Gregory K. Friedman, MD https://druglandscape.com/drug/g207-an-oncolytic-virus https://druglandscape.com/api/og?type=drug&title=G207%2C%20an%20oncolytic%20virus&subtitle=G207%2C%20an%20oncolytic%20virus%20%C2%B7%20MediGene&badge=phase%201 G207, an oncolytic virus G207, an oncolytic virus · MediGene https://druglandscape.com/drug/g3041 https://druglandscape.com/api/og?type=drug&title=G3041&subtitle=G3041%20%C2%B7%20Dong-A%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 G3041 G3041 · Dong-A Pharmaceutical Co., Ltd. https://druglandscape.com/drug/g3215 https://druglandscape.com/api/og?type=drug&title=G3215&subtitle=G3215%20%C2%B7%20Imperial%20College%20London&badge=phase%201 G3215 G3215 · Imperial College London https://druglandscape.com/drug/ga-68-ngul https://druglandscape.com/api/og?type=drug&title=Ga-68-NGUL&subtitle=Ga-68-NGUL%20%C2%B7%20Cellbion%20Co.%2C%20Ltd.&badge=phase%201 Ga-68-NGUL Ga-68-NGUL · Cellbion Co., Ltd. https://druglandscape.com/drug/ga-68-psma-hbed-cc-pet https://druglandscape.com/api/og?type=drug&title=Ga-68%20PSMA-HBED-CC%20PET&subtitle=Ga-68%20PSMA-HBED-CC%20PET%20%C2%B7%20Michael%20Graham%20PhD%2C%20MD&badge=phase%202 Ga-68 PSMA-HBED-CC PET Ga-68 PSMA-HBED-CC PET · Michael Graham PhD, MD https://druglandscape.com/drug/ga-fapi-46 https://druglandscape.com/api/og?type=drug&title=%E2%81%B6%E2%81%B8Ga-FAPI-46&subtitle=%E2%81%B6%E2%81%B8Ga-FAPI-46%20%C2%B7%20Erasmus%20Medical%20Center&badge=phase%201 ⁶⁸Ga-FAPI-46 ⁶⁸Ga-FAPI-46 · Erasmus Medical Center https://druglandscape.com/drug/ga-fc516 https://druglandscape.com/api/og?type=drug&title=%E2%81%B6%E2%81%B8Ga-FC516&subtitle=%E2%81%B6%E2%81%B8Ga-FC516%20%C2%B7%20FindCure%20Biosciences%20(ZhongShan)%20Co.%2C%20Ltd.&badge=phase%201 ⁶⁸Ga-FC516 ⁶⁸Ga-FC516 · FindCure Biosciences (ZhongShan) Co., Ltd. https://druglandscape.com/drug/ga-gcb https://druglandscape.com/api/og?type=drug&title=GA-GCB&subtitle=GA-GCB%20%C2%B7%20Shire&badge=phase%201 GA-GCB GA-GCB · Shire https://druglandscape.com/drug/gabapentin-higher-dose https://druglandscape.com/api/og?type=drug&title=Gabapentin%20higher%20dose&subtitle=Gabapentin%20higher%20dose%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Gabapentin higher dose Gabapentin higher dose · GlaxoSmithKline https://druglandscape.com/drug/gabapentin-lower-dose https://druglandscape.com/api/og?type=drug&title=Gabapentin%20lower%20dose&subtitle=Gabapentin%20lower%20dose%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Gabapentin lower dose Gabapentin lower dose · GlaxoSmithKline https://druglandscape.com/drug/gabapentin-oral-solution-neurontin https://druglandscape.com/api/og?type=drug&title=Gabapentin%20Oral%20Solution%20%5BNeurontin%5D&subtitle=Gabapentin%20Oral%20Solution%20%5BNeurontin%5D%20%C2%B7%20Kuwait%20Specialized%20Eye%20Center&badge=phase%201 Gabapentin Oral Solution [Neurontin] Gabapentin Oral Solution [Neurontin] · Kuwait Specialized Eye Center https://druglandscape.com/drug/gad-209-fsp-high-dose https://druglandscape.com/api/og?type=drug&title=GAd-209-FSP%20high%20dose&subtitle=GAd-209-FSP%20high%20dose%20%C2%B7%20Nouscom%20SRL&badge=phase%201 GAd-209-FSP high dose GAd-209-FSP high dose · Nouscom SRL https://druglandscape.com/drug/gad-209-fsp-low-dose https://druglandscape.com/api/og?type=drug&title=GAd-209-FSP%20low%20dose&subtitle=GAd-209-FSP%20low%20dose%20%C2%B7%20Nouscom%20SRL&badge=phase%201 GAd-209-FSP low dose GAd-209-FSP low dose · Nouscom SRL https://druglandscape.com/drug/gadolinium-dtpa https://druglandscape.com/api/og?type=drug&title=Gadolinium%20DTPA&subtitle=Gadolinium%20DTPA%20%C2%B7%20Michael%20Vogelbaum%2C%20MD%2C%20PhD&badge=phase%201 Gadolinium DTPA Gadolinium DTPA · Michael Vogelbaum, MD, PhD https://druglandscape.com/drug/gadolinium-for-abdomen https://druglandscape.com/api/og?type=drug&title=Gadolinium%20For%20abdomen&subtitle=Gadolinium%20For%20abdomen%20%C2%B7%20ASIS%20Corporation&badge=phase%201 Gadolinium For abdomen Gadolinium For abdomen · ASIS Corporation https://druglandscape.com/drug/gadolinium-for-lower-back https://druglandscape.com/api/og?type=drug&title=Gadolinium%20For%20lower%20back&subtitle=Gadolinium%20For%20lower%20back%20%C2%B7%20ASIS%20Corporation&badge=phase%201 Gadolinium For lower back Gadolinium For lower back · ASIS Corporation https://druglandscape.com/drug/gal-101 https://druglandscape.com/api/og?type=drug&title=GAL-101&subtitle=GAL-101%20%C2%B7%20Galimedix%20Therapeutics%20Inc&badge=phase%202 GAL-101 GAL-101 · Galimedix Therapeutics Inc https://druglandscape.com/drug/gan-lee-insulin-aspart https://druglandscape.com/api/og?type=drug&title=Gan%20%26%20Lee%20Insulin%20Aspart&subtitle=Gan%20%26%20Lee%20Insulin%20Aspart%20%C2%B7%20Gan%20and%20Lee%20Pharmaceuticals%2C%20USA&badge=phase%201 Gan & Lee Insulin Aspart Gan & Lee Insulin Aspart · Gan and Lee Pharmaceuticals, USA https://druglandscape.com/drug/gap-134 https://druglandscape.com/api/og?type=drug&title=GAP-134&subtitle=GAP-134%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 GAP-134 GAP-134 · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/gastric-bypass https://druglandscape.com/api/og?type=drug&title=gastric%20bypass&subtitle=gastric%20bypass%20%C2%B7%20Imperial%20College%20London&badge=phase%201 gastric bypass gastric bypass · Imperial College London https://druglandscape.com/drug/gatifloxacin-and-moxifloxacin https://druglandscape.com/api/og?type=drug&title=gatifloxacin%20and%20moxifloxacin&subtitle=gatifloxacin%20and%20moxifloxacin%20%C2%B7%20Donnenfeld%2C%20Eric%2C%20M.D.&badge=phase%202 gatifloxacin and moxifloxacin gatifloxacin and moxifloxacin · Donnenfeld, Eric, M.D. https://druglandscape.com/drug/gb-5001 https://druglandscape.com/api/og?type=drug&title=GB-5001&subtitle=GB-5001%20%C2%B7%20G2GBio%2C%20Inc.&badge=phase%201 GB-5001 GB-5001 · G2GBio, Inc. https://druglandscape.com/drug/gb-5001d https://druglandscape.com/api/og?type=drug&title=GB-5001D&subtitle=GB-5001D%20%C2%B7%20G2GBio%2C%20Inc.&badge=phase%201 GB-5001D GB-5001D · G2GBio, Inc. https://druglandscape.com/drug/gb-6002 https://druglandscape.com/api/og?type=drug&title=GB-6002&subtitle=GB-6002%20%C2%B7%20G2GBio%2C%20Inc.&badge=phase%201 GB-6002 GB-6002 · G2GBio, Inc. https://druglandscape.com/drug/gb001 https://druglandscape.com/api/og?type=drug&title=GB001&subtitle=GB001%20%C2%B7%20GB001%2C%20Inc%2C%20a%20wholly%20owned%20subsidiary%20of%20Gossamer%20Bio%2C%20Inc.&badge=phase%202 GB001 GB001 · GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc. https://druglandscape.com/drug/gb002 https://druglandscape.com/api/og?type=drug&title=GB002&subtitle=GB002%20%C2%B7%20GB002%2C%20Inc.%2C%20a%20wholly%20owned%20subsidiary%20of%20Gossamer%20Bio%2C%20Inc.&badge=phase%201 GB002 GB002 · GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. https://druglandscape.com/drug/gb10 https://druglandscape.com/api/og?type=drug&title=GB10&subtitle=GB10%20%C2%B7%20Shenzhen%20Kexing%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GB10 GB10 · Shenzhen Kexing Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gb1211 https://druglandscape.com/api/og?type=drug&title=GB1211&subtitle=GB1211%20%C2%B7%20Galecto%20Biotech%20AB&badge=phase%202 GB1211 GB1211 · Galecto Biotech AB https://druglandscape.com/drug/gb2064 https://druglandscape.com/api/og?type=drug&title=GB2064&subtitle=GB2064%20%C2%B7%20Galecto%20Biotech%20AB&badge=phase%202 GB2064 GB2064 · Galecto Biotech AB https://druglandscape.com/drug/gb222 https://druglandscape.com/api/og?type=drug&title=GB222&subtitle=GB222%20%C2%B7%20Genor%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 GB222 GB222 · Genor Biopharma Co., Ltd. https://druglandscape.com/drug/gb226 https://druglandscape.com/api/og?type=drug&title=GB226&subtitle=GB226%20%C2%B7%20Genor%20Biopharma%20Co.%2C%20Ltd.&badge=phase%202 GB226 GB226 · Genor Biopharma Co., Ltd. https://druglandscape.com/drug/gb241 https://druglandscape.com/api/og?type=drug&title=GB241&subtitle=GB241%20%C2%B7%20Nanjing%20Yoko%20Biomedical%20Co.%2C%20Ltd.&badge=phase%201 GB241 GB241 · Nanjing Yoko Biomedical Co., Ltd. https://druglandscape.com/drug/gb261 https://druglandscape.com/api/og?type=drug&title=GB261&subtitle=GB261%20%C2%B7%20Genor%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 GB261 GB261 · Genor Biopharma Co., Ltd. https://druglandscape.com/drug/gb263t https://druglandscape.com/api/og?type=drug&title=GB263T&subtitle=GB263T%20%C2%B7%20Genor%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 GB263T GB263T · Genor Biopharma Co., Ltd. https://druglandscape.com/drug/gb3226 https://druglandscape.com/api/og?type=drug&title=GB3226&subtitle=GB3226%20%C2%B7%20Galecto%20Biotech%20AB&badge=phase%201 GB3226 GB3226 · Galecto Biotech AB https://druglandscape.com/drug/gbp560-a https://druglandscape.com/api/og?type=drug&title=GBP560-A&subtitle=GBP560-A%20%C2%B7%20SK%20Bioscience%20Co.%2C%20Ltd.&badge=phase%201 GBP560-A GBP560-A · SK Bioscience Co., Ltd. https://druglandscape.com/drug/gbr-900 https://druglandscape.com/api/og?type=drug&title=GBR%20900&subtitle=GBR%20900%20%C2%B7%20Glenmark%20Pharmaceuticals%20Ltd.%20India&badge=phase%201 GBR 900 GBR 900 · Glenmark Pharmaceuticals Ltd. India https://druglandscape.com/drug/gbs-nn-vaccine https://druglandscape.com/api/og?type=drug&title=GBS-NN%20vaccine&subtitle=GBS-NN%20vaccine%20%C2%B7%20Minervax%20ApS&badge=phase%201 GBS-NN vaccine GBS-NN vaccine · Minervax ApS https://druglandscape.com/drug/gc101til https://druglandscape.com/api/og?type=drug&title=GC101TIL&subtitle=GC101TIL%20%C2%B7%20Shanghai%20Juncell%20Therapeutics&badge=phase%201 GC101TIL GC101TIL · Shanghai Juncell Therapeutics https://druglandscape.com/drug/gc1102 https://druglandscape.com/api/og?type=drug&title=GC1102&subtitle=GC1102%20%C2%B7%20Green%20Cross%20Corporation&badge=phase%202 GC1102 GC1102 · Green Cross Corporation https://druglandscape.com/drug/gc1113 https://druglandscape.com/api/og?type=drug&title=GC1113&subtitle=GC1113%20%C2%B7%20Green%20Cross%20Corporation&badge=phase%201 GC1113 GC1113 · Green Cross Corporation https://druglandscape.com/drug/gc1119 https://druglandscape.com/api/og?type=drug&title=GC1119&subtitle=GC1119%20%C2%B7%20Green%20Cross%20Corporation&badge=phase%201 GC1119 GC1119 · Green Cross Corporation https://druglandscape.com/drug/gc1123 https://druglandscape.com/api/og?type=drug&title=GC1123&subtitle=GC1123%20%C2%B7%20GC%20Biopharma%20Corp&badge=phase%201 GC1123 GC1123 · GC Biopharma Corp https://druglandscape.com/drug/gc1130a https://druglandscape.com/api/og?type=drug&title=GC1130A&subtitle=GC1130A%20%C2%B7%20GC%20Biopharma%20Corp&badge=phase%201 GC1130A GC1130A · GC Biopharma Corp https://druglandscape.com/drug/gc203-til https://druglandscape.com/api/og?type=drug&title=GC203%20TIL&subtitle=GC203%20TIL%20%C2%B7%20Shanghai%20Juncell%20Therapeutics&badge=phase%201 GC203 TIL GC203 TIL · Shanghai Juncell Therapeutics https://druglandscape.com/drug/gc3111b https://druglandscape.com/api/og?type=drug&title=GC3111B&subtitle=GC3111B%20%C2%B7%20GC%20Biopharma%20Corp&badge=phase%201 GC3111B GC3111B · GC Biopharma Corp https://druglandscape.com/drug/gc3114 https://druglandscape.com/api/og?type=drug&title=GC3114&subtitle=GC3114%20%C2%B7%20Green%20Cross%20Corporation&badge=phase%202 GC3114 GC3114 · Green Cross Corporation https://druglandscape.com/drug/gc4702-dry-powder https://druglandscape.com/api/og?type=drug&title=GC4702%20dry%20powder&subtitle=GC4702%20dry%20powder%20%C2%B7%20Galera%20Therapeutics%2C%20Inc.&badge=phase%201 GC4702 dry powder GC4702 dry powder · Galera Therapeutics, Inc. https://druglandscape.com/drug/gc4702-lipid-suspension-part-2 https://druglandscape.com/api/og?type=drug&title=GC4702%20lipid%20suspension%20-%20Part%202&subtitle=GC4702%20lipid%20suspension%20-%20Part%202%20%C2%B7%20Galera%20Therapeutics%2C%20Inc.&badge=phase%201 GC4702 lipid suspension - Part 2 GC4702 lipid suspension - Part 2 · Galera Therapeutics, Inc. https://druglandscape.com/drug/gc4711-oral-capsule-g-101 https://druglandscape.com/api/og?type=drug&title=GC4711%20Oral%20Capsule%20G-101&subtitle=GC4711%20Oral%20Capsule%20G-101%20%C2%B7%20Galera%20Therapeutics%2C%20Inc.&badge=phase%201 GC4711 Oral Capsule G-101 GC4711 Oral Capsule G-101 · Galera Therapeutics, Inc. https://druglandscape.com/drug/gc4711-oral-capsule-g-111 https://druglandscape.com/api/og?type=drug&title=GC4711%20Oral%20Capsule%20G-111&subtitle=GC4711%20Oral%20Capsule%20G-111%20%C2%B7%20Galera%20Therapeutics%2C%20Inc.&badge=phase%201 GC4711 Oral Capsule G-111 GC4711 Oral Capsule G-111 · Galera Therapeutics, Inc. https://druglandscape.com/drug/gc4711-oral-capsule-g-112 https://druglandscape.com/api/og?type=drug&title=GC4711%20Oral%20Capsule%20G-112&subtitle=GC4711%20Oral%20Capsule%20G-112%20%C2%B7%20Galera%20Therapeutics%2C%20Inc.&badge=phase%201 GC4711 Oral Capsule G-112 GC4711 Oral Capsule G-112 · Galera Therapeutics, Inc. https://druglandscape.com/drug/gc4711-oral-capsule-g-119 https://druglandscape.com/api/og?type=drug&title=GC4711%20Oral%20Capsule%20G-119&subtitle=GC4711%20Oral%20Capsule%20G-119%20%C2%B7%20Galera%20Therapeutics%2C%20Inc.&badge=phase%201 GC4711 Oral Capsule G-119 GC4711 Oral Capsule G-119 · Galera Therapeutics, Inc. https://druglandscape.com/drug/gc4711-oral-capsule-g-125 https://druglandscape.com/api/og?type=drug&title=GC4711%20Oral%20Capsule%20G-125&subtitle=GC4711%20Oral%20Capsule%20G-125%20%C2%B7%20Galera%20Therapeutics%2C%20Inc.&badge=phase%201 GC4711 Oral Capsule G-125 GC4711 Oral Capsule G-125 · Galera Therapeutics, Inc. https://druglandscape.com/drug/gcc-4401 https://druglandscape.com/api/og?type=drug&title=GCC-4401&subtitle=GCC-4401%20%C2%B7%20Green%20Cross%20Corporation&badge=phase%201 GCC-4401 GCC-4401 · Green Cross Corporation https://druglandscape.com/drug/gcc19cart https://druglandscape.com/api/og?type=drug&title=GCC19CART&subtitle=GCC19CART%20%C2%B7%20Lyell%20Immunopharma%2C%20Inc.&badge=phase%201 GCC19CART GCC19CART · Lyell Immunopharma, Inc. https://druglandscape.com/drug/gcc2005 https://druglandscape.com/api/og?type=drug&title=GCC2005&subtitle=GCC2005%20%C2%B7%20GC%20Cell%20Corporation&badge=phase%201 GCC2005 GCC2005 · GC Cell Corporation https://druglandscape.com/drug/gcmaf https://druglandscape.com/api/og?type=drug&title=GcMAF&subtitle=GcMAF%20%C2%B7%20S.LAB%20(SOLOWAYS)&badge=phase%201 GcMAF GcMAF · S.LAB (SOLOWAYS) https://druglandscape.com/drug/gd-ca https://druglandscape.com/api/og?type=drug&title=Gd-CA&subtitle=Gd-CA%20%C2%B7%20Catharina%20Ziekenhuis%20Eindhoven&badge=phase%201 Gd-CA Gd-CA · Catharina Ziekenhuis Eindhoven https://druglandscape.com/drug/gd2-sada-177lu-dota-complex https://druglandscape.com/api/og?type=drug&title=GD2-SADA%3A177Lu-DOTA%20Complex&subtitle=GD2-SADA%3A177Lu-DOTA%20Complex%20%C2%B7%20Y-mAbs%20Therapeutics&badge=phase%201 GD2-SADA:177Lu-DOTA Complex GD2-SADA:177Lu-DOTA Complex · Y-mAbs Therapeutics https://druglandscape.com/drug/gd2-targeted-car-t-cells https://druglandscape.com/api/og?type=drug&title=GD2-targeted%20CAR-T%20cells&subtitle=GD2-targeted%20CAR-T%20cells%20%C2%B7%20Sinobioway%20Cell%20Therapy%20Co.%2C%20Ltd.&badge=phase%201 GD2-targeted CAR-T cells GD2-targeted CAR-T cells · Sinobioway Cell Therapy Co., Ltd. https://druglandscape.com/drug/gdc-0032-tablet https://druglandscape.com/api/og?type=drug&title=GDC-0032%20Tablet&subtitle=GDC-0032%20Tablet%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-0032 Tablet GDC-0032 Tablet · Genentech, Inc. https://druglandscape.com/drug/gdc-0134-f09-formulation https://druglandscape.com/api/og?type=drug&title=GDC-0134%20F09%20Formulation&subtitle=GDC-0134%20F09%20Formulation%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-0134 F09 Formulation GDC-0134 F09 Formulation · Genentech, Inc. https://druglandscape.com/drug/gdc-0134-f15-formulation https://druglandscape.com/api/og?type=drug&title=GDC-0134%20F15%20Formulation&subtitle=GDC-0134%20F15%20Formulation%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-0134 F15 Formulation GDC-0134 F15 Formulation · Genentech, Inc. https://druglandscape.com/drug/gdc-0349 https://druglandscape.com/api/og?type=drug&title=GDC-0349&subtitle=GDC-0349%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-0349 GDC-0349 · Genentech, Inc. https://druglandscape.com/drug/gdc-0425 https://druglandscape.com/api/og?type=drug&title=GDC-0425&subtitle=GDC-0425%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-0425 GDC-0425 · Genentech, Inc. https://druglandscape.com/drug/gdc-0575 https://druglandscape.com/api/og?type=drug&title=GDC-0575&subtitle=GDC-0575%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-0575 GDC-0575 · Genentech, Inc. https://druglandscape.com/drug/gdc-0623 https://druglandscape.com/api/og?type=drug&title=GDC-0623&subtitle=GDC-0623%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-0623 GDC-0623 · Genentech, Inc. https://druglandscape.com/drug/gdc-0810-phase-ii-tablet https://druglandscape.com/api/og?type=drug&title=GDC-0810%20Phase%20II%20Tablet&subtitle=GDC-0810%20Phase%20II%20Tablet%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-0810 Phase II Tablet GDC-0810 Phase II Tablet · Genentech, Inc. https://druglandscape.com/drug/gdc-0853-and-itraconazole https://druglandscape.com/api/og?type=drug&title=GDC-0853%20and%20itraconazole&subtitle=GDC-0853%20and%20itraconazole%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-0853 and itraconazole GDC-0853 and itraconazole · Genentech, Inc. https://druglandscape.com/drug/gdc-0973 https://druglandscape.com/api/og?type=drug&title=GDC-0973&subtitle=GDC-0973%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-0973 GDC-0973 · Genentech, Inc. https://druglandscape.com/drug/gdc-0973-iv-infusion https://druglandscape.com/api/og?type=drug&title=GDC-0973%20IV%20Infusion&subtitle=GDC-0973%20IV%20Infusion%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-0973 IV Infusion GDC-0973 IV Infusion · Genentech, Inc. https://druglandscape.com/drug/gdc-0973-oral-capsules https://druglandscape.com/api/og?type=drug&title=GDC-0973%20Oral%20Capsules&subtitle=GDC-0973%20Oral%20Capsules%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-0973 Oral Capsules GDC-0973 Oral Capsules · Genentech, Inc. https://druglandscape.com/drug/gdc-0980 https://druglandscape.com/api/og?type=drug&title=GDC-0980&subtitle=GDC-0980%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 GDC-0980 GDC-0980 · Genentech, Inc. https://druglandscape.com/drug/gdc-6036 https://druglandscape.com/api/og?type=drug&title=GDC-6036&subtitle=GDC-6036%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-6036 GDC-6036 · Genentech, Inc. https://druglandscape.com/drug/gdc-6988 https://druglandscape.com/api/og?type=drug&title=GDC-6988&subtitle=GDC-6988%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-6988 GDC-6988 · Genentech, Inc. https://druglandscape.com/drug/gdc-9545 https://druglandscape.com/api/og?type=drug&title=GDC-9545&subtitle=GDC-9545%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-9545 GDC-9545 · Genentech, Inc. https://druglandscape.com/drug/gdc-9545-capsule-fed-treatment-c https://druglandscape.com/api/og?type=drug&title=GDC-9545%20Capsule%2C%20Fed%3A%20Treatment%20C&subtitle=GDC-9545%20Capsule%2C%20Fed%3A%20Treatment%20C%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-9545 Capsule, Fed: Treatment C GDC-9545 Capsule, Fed: Treatment C · Genentech, Inc. https://druglandscape.com/drug/gdc-9545-solution-for-infusion https://druglandscape.com/api/og?type=drug&title=GDC-9545%20Solution%20for%20Infusion&subtitle=GDC-9545%20Solution%20for%20Infusion%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-9545 Solution for Infusion GDC-9545 Solution for Infusion · Genentech, Inc. https://druglandscape.com/drug/gdc-9545-tablet-fasted-treatment-a https://druglandscape.com/api/og?type=drug&title=GDC-9545%20Tablet%2C%20Fasted%3A%20Treatment%20A&subtitle=GDC-9545%20Tablet%2C%20Fasted%3A%20Treatment%20A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 GDC-9545 Tablet, Fasted: Treatment A GDC-9545 Tablet, Fasted: Treatment A · Genentech, Inc. https://druglandscape.com/drug/gec255-tablets https://druglandscape.com/api/og?type=drug&title=GEC255%20tablets&subtitle=GEC255%20tablets%20%C2%B7%20GenEros%20Biopharma%20Hangzhou%20Ltd&badge=phase%201 GEC255 tablets GEC255 tablets · GenEros Biopharma Hangzhou Ltd https://druglandscape.com/drug/gecacitinib-hydrochloride-tablets https://druglandscape.com/api/og?type=drug&title=Gecacitinib%20Hydrochloride%20Tablets&subtitle=Gecacitinib%20Hydrochloride%20Tablets%20%C2%B7%20Suzhou%20Zelgen%20Biopharmaceuticals%20Co.%2CLtd&badge=phase%201 Gecacitinib Hydrochloride Tablets Gecacitinib Hydrochloride Tablets · Suzhou Zelgen Biopharmaceuticals Co.,Ltd https://druglandscape.com/drug/gefitinib-and-capecitabine https://druglandscape.com/api/og?type=drug&title=Gefitinib%20and%20capecitabine&subtitle=Gefitinib%20and%20capecitabine%20%C2%B7%20AstraZeneca&badge=phase%201 Gefitinib and capecitabine Gefitinib and capecitabine · AstraZeneca https://druglandscape.com/drug/gefitinib-and-fulvestrant https://druglandscape.com/api/og?type=drug&title=gefitinib%20and%20fulvestrant&subtitle=gefitinib%20and%20fulvestrant%20%C2%B7%20AstraZeneca&badge=phase%202 gefitinib and fulvestrant gefitinib and fulvestrant · AstraZeneca https://druglandscape.com/drug/gefitinib-combined-with-apatinib https://druglandscape.com/api/og?type=drug&title=gefitinib%20combined%20with%20apatinib&subtitle=gefitinib%20combined%20with%20apatinib%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 gefitinib combined with apatinib gefitinib combined with apatinib · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gefitinib-radiotherapy https://druglandscape.com/api/og?type=drug&title=Gefitinib%2C%20radiotherapy&subtitle=Gefitinib%2C%20radiotherapy%20%C2%B7%20AstraZeneca&badge=phase%201 Gefitinib, radiotherapy Gefitinib, radiotherapy · AstraZeneca https://druglandscape.com/drug/gefitinib-single-agent https://druglandscape.com/api/og?type=drug&title=gefitinib%20single%20agent&subtitle=gefitinib%20single%20agent%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 gefitinib single agent gefitinib single agent · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gefurulimab-ai https://druglandscape.com/api/og?type=drug&title=Gefurulimab%20AI&subtitle=Gefurulimab%20AI%20%C2%B7%20Alexion%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Gefurulimab AI Gefurulimab AI · Alexion Pharmaceuticals, Inc. https://druglandscape.com/drug/gefurulimab-pfs-sd https://druglandscape.com/api/og?type=drug&title=Gefurulimab%20PFS-SD&subtitle=Gefurulimab%20PFS-SD%20%C2%B7%20Alexion%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Gefurulimab PFS-SD Gefurulimab PFS-SD · Alexion Pharmaceuticals, Inc. https://druglandscape.com/drug/gel-one https://druglandscape.com/api/og?type=drug&title=Gel-One&subtitle=Gel-One%20%C2%B7%20Cale%20Jacobs%2C%20PhD&badge=phase%201 Gel-One Gel-One · Cale Jacobs, PhD https://druglandscape.com/drug/gel-pkb171 https://druglandscape.com/api/og?type=drug&title=Gel%20PKB171&subtitle=Gel%20PKB171%20%C2%B7%20Prokrea%20BCN%2C%20S.L.&badge=phase%201 Gel PKB171 Gel PKB171 · Prokrea BCN, S.L. https://druglandscape.com/drug/gel-with-10-peel-powder-of-unripe-banana https://druglandscape.com/api/og?type=drug&title=Gel%20with%2010%25%20peel%20powder%20of%20unripe%20banana&subtitle=Gel%20with%2010%25%20peel%20powder%20of%20unripe%20banana%20%C2%B7%20Universidade%20do%20Vale%20do%20Sapucai&badge=phase%201 Gel with 10% peel powder of unripe banana Gel with 10% peel powder of unripe banana · Universidade do Vale do Sapucai https://druglandscape.com/drug/gel-xerostomia https://druglandscape.com/api/og?type=drug&title=gel%20xerostomia&subtitle=gel%20xerostomia%20%C2%B7%20Universidad%20de%20Murcia&badge=phase%201 gel xerostomia gel xerostomia · Universidad de Murcia https://druglandscape.com/drug/gelofusine-b-braun https://druglandscape.com/api/og?type=drug&title=Gelofusine%C2%AE%20B.%20Braun&subtitle=Gelofusine%C2%AE%20B.%20Braun%20%C2%B7%20Kratochvil%20Milan%2C%20MD&badge=phase%201 Gelofusine® B. Braun Gelofusine® B. Braun · Kratochvil Milan, MD https://druglandscape.com/drug/gem-231 https://druglandscape.com/api/og?type=drug&title=GEM%20231&subtitle=GEM%20231%20%C2%B7%20Montefiore%20Medical%20Center&badge=phase%201 GEM 231 GEM 231 · Montefiore Medical Center https://druglandscape.com/drug/gem-cis-or-gem-carbo https://druglandscape.com/api/og?type=drug&title=Gem-Cis%20or%20Gem-Carbo&subtitle=Gem-Cis%20or%20Gem-Carbo%20%C2%B7%20Robert%20C.%20Martin&badge=phase%202 Gem-Cis or Gem-Carbo Gem-Cis or Gem-Carbo · Robert C. Martin https://druglandscape.com/drug/gemcitabe-and-abraxane https://druglandscape.com/api/og?type=drug&title=Gemcitabe%20and%20Abraxane&subtitle=Gemcitabe%20and%20Abraxane%20%C2%B7%20Judith%20Dixon-Hughes&badge=phase%202 Gemcitabe and Abraxane Gemcitabe and Abraxane · Judith Dixon-Hughes https://druglandscape.com/drug/gemcitabina-cisplatino https://druglandscape.com/api/og?type=drug&title=Gemcitabina%2C%20Cisplatino&subtitle=Gemcitabina%2C%20Cisplatino%20%C2%B7%20Gruppo%20Italiano%20per%20lo%20studio%20dei%20Carcinomi%20dell'Apparato%20Digerente&badge=phase%202 Gemcitabina, Cisplatino Gemcitabina, Cisplatino · Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente https://druglandscape.com/drug/gemcitabine-and-plitidepsin https://druglandscape.com/api/og?type=drug&title=Gemcitabine%20and%20Plitidepsin&subtitle=Gemcitabine%20and%20Plitidepsin%20%C2%B7%20PharmaMar&badge=phase%201 Gemcitabine and Plitidepsin Gemcitabine and Plitidepsin · PharmaMar https://druglandscape.com/drug/gemcitabine-cisplatin-and-tislelizumab https://druglandscape.com/api/og?type=drug&title=gemcitabine%2C%20cisplatin%20and%20tislelizumab&subtitle=gemcitabine%2C%20cisplatin%20and%20tislelizumab%20%C2%B7%20Stichting%20Hemato-Oncologie%20voor%20Volwassenen%20Nederland&badge=phase%202 gemcitabine, cisplatin and tislelizumab gemcitabine, cisplatin and tislelizumab · Stichting Hemato-Oncologie voor Volwassenen Nederland https://druglandscape.com/drug/gemcitabine-cisplatin-or-carboplatin-erlotinib https://druglandscape.com/api/og?type=drug&title=gemcitabine%3B%20cisplatin%20or%20carboplatin%3B%20erlotinib&subtitle=gemcitabine%3B%20cisplatin%20or%20carboplatin%3B%20erlotinib%20%C2%B7%20Xinjiang%20Medical%20University&badge=phase%203 gemcitabine; cisplatin or carboplatin; erlotinib gemcitabine; cisplatin or carboplatin; erlotinib · Xinjiang Medical University https://druglandscape.com/drug/gemcitabine-docetaxel-and-bevacizumab https://druglandscape.com/api/og?type=drug&title=Gemcitabine%2C%20Docetaxel%20and%20Bevacizumab&subtitle=Gemcitabine%2C%20Docetaxel%20and%20Bevacizumab%20%C2%B7%20New%20Mexico%20Cancer%20Research%20Alliance&badge=phase%201 Gemcitabine, Docetaxel and Bevacizumab Gemcitabine, Docetaxel and Bevacizumab · New Mexico Cancer Research Alliance https://druglandscape.com/drug/gemcitabine-docetaxel-doxorubicin https://druglandscape.com/api/og?type=drug&title=gemcitabine%2C%20docetaxel%2C%20doxorubicin&subtitle=gemcitabine%2C%20docetaxel%2C%20doxorubicin%20%C2%B7%20Sarcoma%20Alliance%20for%20Research%20through%20Collaboration&badge=phase%202 gemcitabine, docetaxel, doxorubicin gemcitabine, docetaxel, doxorubicin · Sarcoma Alliance for Research through Collaboration https://druglandscape.com/drug/gemcitabine-etoposide https://druglandscape.com/api/og?type=drug&title=Gemcitabine%2C%20Etoposide&subtitle=Gemcitabine%2C%20Etoposide%20%C2%B7%20Corewell%20Health%20West&badge=phase%202 Gemcitabine, Etoposide Gemcitabine, Etoposide · Corewell Health West https://druglandscape.com/drug/gemcitabine-folinic-acid-5-fu https://druglandscape.com/api/og?type=drug&title=gemcitabine%2C%20folinic%20acid%2C%205-FU&subtitle=gemcitabine%2C%20folinic%20acid%2C%205-FU%20%C2%B7%20CONKO-Studiengruppe&badge=phase%202 gemcitabine, folinic acid, 5-FU gemcitabine, folinic acid, 5-FU · CONKO-Studiengruppe https://druglandscape.com/drug/gemcitabine-ifosfamide-cisplatin-g-csf https://druglandscape.com/api/og?type=drug&title=gemcitabine%2C%20ifosfamide%2C%20cisplatin%2C%20G-CSF&subtitle=gemcitabine%2C%20ifosfamide%2C%20cisplatin%2C%20G-CSF%20%C2%B7%20Gustave%20Roussy%2C%20Cancer%20Campus%2C%20Grand%20Paris&badge=phase%202 gemcitabine, ifosfamide, cisplatin, G-CSF gemcitabine, ifosfamide, cisplatin, G-CSF · Gustave Roussy, Cancer Campus, Grand Paris https://druglandscape.com/drug/gemcitabine-lapatinib https://druglandscape.com/api/og?type=drug&title=Gemcitabine%20Lapatinib&subtitle=Gemcitabine%20Lapatinib%20%C2%B7%20Latin%20American%20Cooperative%20Oncology%20Group&badge=phase%202 Gemcitabine Lapatinib Gemcitabine Lapatinib · Latin American Cooperative Oncology Group https://druglandscape.com/drug/gemcitabine-local-delivery https://druglandscape.com/api/og?type=drug&title=Gemcitabine%2C%20local%20delivery&subtitle=Gemcitabine%2C%20local%20delivery%20%C2%B7%20RenovoRx&badge=phase%201 Gemcitabine, local delivery Gemcitabine, local delivery · RenovoRx https://druglandscape.com/drug/gemcitabine-nucleoside-analogue-intravenous https://druglandscape.com/api/og?type=drug&title=Gemcitabine%2C%20nucleoside%20analogue%3B%20intravenous&subtitle=Gemcitabine%2C%20nucleoside%20analogue%3B%20intravenous%20%C2%B7%20Array%20BioPharma&badge=phase%201 Gemcitabine, nucleoside analogue; intravenous Gemcitabine, nucleoside analogue; intravenous · Array BioPharma https://druglandscape.com/drug/gemcitabine-plus-carboplatin https://druglandscape.com/api/og?type=drug&title=Gemcitabine%20plus%20carboplatin&subtitle=Gemcitabine%20plus%20carboplatin%20%C2%B7%20Chinese%20Society%20of%20Lung%20Cancer&badge=phase%202 Gemcitabine plus carboplatin Gemcitabine plus carboplatin · Chinese Society of Lung Cancer https://druglandscape.com/drug/gemcitabine-plus-oxaliplatin https://druglandscape.com/api/og?type=drug&title=gemcitabine%20plus%20oxaliplatin&subtitle=gemcitabine%20plus%20oxaliplatin%20%C2%B7%20Kyowa%20Kirin%2C%20Inc.&badge=phase%202 gemcitabine plus oxaliplatin gemcitabine plus oxaliplatin · Kyowa Kirin, Inc. https://druglandscape.com/drug/gemcitabine-plus-rapamycin https://druglandscape.com/api/og?type=drug&title=Gemcitabine%20plus%20rapamycin&subtitle=Gemcitabine%20plus%20rapamycin%20%C2%B7%20Broto%2C%20Javier%20Mart%C3%ADn%2C%20M.D.&badge=phase%202 Gemcitabine plus rapamycin Gemcitabine plus rapamycin · Broto, Javier Martín, M.D. https://druglandscape.com/drug/gemdox https://druglandscape.com/api/og?type=drug&title=GemDOx&subtitle=GemDOx%20%C2%B7%20Cooperative%20Study%20Group%20A%20for%20Hematology&badge=phase%202 GemDOx GemDOx · Cooperative Study Group A for Hematology https://druglandscape.com/drug/gemigliptin-and-glimepiride https://druglandscape.com/api/og?type=drug&title=Gemigliptin%20and%20Glimepiride&subtitle=Gemigliptin%20and%20Glimepiride%20%C2%B7%20LG%20Life%20Sciences&badge=phase%201 Gemigliptin and Glimepiride Gemigliptin and Glimepiride · LG Life Sciences https://druglandscape.com/drug/gemigliptin-and-rosuvastatin https://druglandscape.com/api/og?type=drug&title=gemigliptin%20and%20rosuvastatin&subtitle=gemigliptin%20and%20rosuvastatin%20%C2%B7%20LG%20Life%20Sciences&badge=phase%201 gemigliptin and rosuvastatin gemigliptin and rosuvastatin · LG Life Sciences https://druglandscape.com/drug/gemigliptin-only https://druglandscape.com/api/og?type=drug&title=gemigliptin%20only&subtitle=gemigliptin%20only%20%C2%B7%20LG%20Life%20Sciences&badge=phase%201 gemigliptin only gemigliptin only · LG Life Sciences https://druglandscape.com/drug/gemigliptin-tartrate-sesquihydrate-and-metformin https://druglandscape.com/api/og?type=drug&title=Gemigliptin%20tartrate%20sesquihydrate%20and%20metformin&subtitle=Gemigliptin%20tartrate%20sesquihydrate%20and%20metformin%20%C2%B7%20LG%20Chem&badge=phase%201 Gemigliptin tartrate sesquihydrate and metformin Gemigliptin tartrate sesquihydrate and metformin · LG Chem https://druglandscape.com/drug/gemox-cetuximab https://druglandscape.com/api/og?type=drug&title=Gemox%2C%20Cetuximab&subtitle=Gemox%2C%20Cetuximab%20%C2%B7%20Gustave%20Roussy%2C%20Cancer%20Campus%2C%20Grand%20Paris&badge=phase%202 Gemox, Cetuximab Gemox, Cetuximab · Gustave Roussy, Cancer Campus, Grand Paris https://druglandscape.com/drug/gen-003-with-matrix-m-2 https://druglandscape.com/api/og?type=drug&title=GEN-003%20with%20Matrix%20M-2&subtitle=GEN-003%20with%20Matrix%20M-2%20%C2%B7%20Genocea%20Biosciences%2C%20Inc.&badge=phase%201 GEN-003 with Matrix M-2 GEN-003 with Matrix M-2 · Genocea Biosciences, Inc. https://druglandscape.com/drug/gen-004-high-dose https://druglandscape.com/api/og?type=drug&title=GEN-004%20High%20Dose&subtitle=GEN-004%20High%20Dose%20%C2%B7%20Genocea%20Biosciences%2C%20Inc.&badge=phase%201 GEN-004 High Dose GEN-004 High Dose · Genocea Biosciences, Inc. https://druglandscape.com/drug/gen-004-low-dose https://druglandscape.com/api/og?type=drug&title=GEN-004%20Low%20Dose&subtitle=GEN-004%20Low%20Dose%20%C2%B7%20Genocea%20Biosciences%2C%20Inc.&badge=phase%201 GEN-004 Low Dose GEN-004 Low Dose · Genocea Biosciences, Inc. https://druglandscape.com/drug/gen-009-adjuvanted-vaccine https://druglandscape.com/api/og?type=drug&title=GEN-009%20Adjuvanted%20Vaccine&subtitle=GEN-009%20Adjuvanted%20Vaccine%20%C2%B7%20Genocea%20Biosciences%2C%20Inc.&badge=phase%201 GEN-009 Adjuvanted Vaccine GEN-009 Adjuvanted Vaccine · Genocea Biosciences, Inc. https://druglandscape.com/drug/gen-725-tablets https://druglandscape.com/api/og?type=drug&title=GEN-725%20tablets&subtitle=GEN-725%20tablets%20%C2%B7%20Henan%20Genuine%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 GEN-725 tablets GEN-725 tablets · Henan Genuine Biotech Co., Ltd. https://druglandscape.com/drug/gen1042 https://druglandscape.com/api/og?type=drug&title=GEN1042&subtitle=GEN1042%20%C2%B7%20Genmab&badge=phase%201 GEN1042 GEN1042 · Genmab https://druglandscape.com/drug/gen1056 https://druglandscape.com/api/og?type=drug&title=GEN1056&subtitle=GEN1056%20%C2%B7%20Genmab&badge=phase%201 GEN1056 GEN1056 · Genmab https://druglandscape.com/drug/gen1057 https://druglandscape.com/api/og?type=drug&title=GEN1057&subtitle=GEN1057%20%C2%B7%20Genmab&badge=phase%201 GEN1057 GEN1057 · Genmab https://druglandscape.com/drug/gen1106 https://druglandscape.com/api/og?type=drug&title=GEN1106&subtitle=GEN1106%20%C2%B7%20Genmab&badge=phase%201 GEN1106 GEN1106 · Genmab https://druglandscape.com/drug/gen1286 https://druglandscape.com/api/og?type=drug&title=GEN1286&subtitle=GEN1286%20%C2%B7%20Genmab&badge=phase%201 GEN1286 GEN1286 · Genmab https://druglandscape.com/drug/gen3018 https://druglandscape.com/api/og?type=drug&title=GEN3018&subtitle=GEN3018%20%C2%B7%20Genmab&badge=phase%201 GEN3018 GEN3018 · Genmab https://druglandscape.com/drug/gender-affirming-hormone-therapy https://druglandscape.com/api/og?type=drug&title=gender%20affirming%20hormone%20therapy&subtitle=gender%20affirming%20hormone%20therapy%20%C2%B7%20Celia%20Ba%C3%B1uls&badge=phase%202 gender affirming hormone therapy gender affirming hormone therapy · Celia Bañuls https://druglandscape.com/drug/gene-modified-autologous-fibroblasts https://druglandscape.com/api/og?type=drug&title=Gene-modified%20autologous%20fibroblasts&subtitle=Gene-modified%20autologous%20fibroblasts%20%C2%B7%20King's%20College%20London&badge=phase%201 Gene-modified autologous fibroblasts Gene-modified autologous fibroblasts · King's College London https://druglandscape.com/drug/gene-modified-cell-therapy https://druglandscape.com/api/og?type=drug&title=Gene-Modified%20Cell%20Therapy&subtitle=Gene-Modified%20Cell%20Therapy%20%C2%B7%20Sorrento%20Therapeutics%2C%20Inc.&badge=phase%202 Gene-Modified Cell Therapy Gene-Modified Cell Therapy · Sorrento Therapeutics, Inc. https://druglandscape.com/drug/gene-therapy-product-mco-010 https://druglandscape.com/api/og?type=drug&title=Gene%20Therapy%20Product-MCO-010&subtitle=Gene%20Therapy%20Product-MCO-010%20%C2%B7%20Nanoscope%20Therapeutics%20Inc.&badge=phase%202 Gene Therapy Product-MCO-010 Gene Therapy Product-MCO-010 · Nanoscope Therapeutics Inc. https://druglandscape.com/drug/gene-therapy-product-vmco-i https://druglandscape.com/api/og?type=drug&title=Gene%20Therapy%20product%3AvMCO-I&subtitle=Gene%20Therapy%20product%3AvMCO-I%20%C2%B7%20Nanoscope%20Therapeutics%20Inc.&badge=phase%202 Gene Therapy product:vMCO-I Gene Therapy product:vMCO-I · Nanoscope Therapeutics Inc. https://druglandscape.com/drug/general-anesthesia-and-epidural-analgesia https://druglandscape.com/api/og?type=drug&title=General%20anesthesia%20and%20epidural%20analgesia&subtitle=General%20anesthesia%20and%20epidural%20analgesia%20%C2%B7%20Ziekenhuis%20Oost-Limburg&badge=phase%201 General anesthesia and epidural analgesia General anesthesia and epidural analgesia · Ziekenhuis Oost-Limburg https://druglandscape.com/drug/general-practice https://druglandscape.com/api/og?type=drug&title=General%20practice&subtitle=General%20practice%20%C2%B7%20Center%20of%20Personalized%20Medicine%2C%20Pirogova&badge=phase%201 General practice General practice · Center of Personalized Medicine, Pirogova https://druglandscape.com/drug/generator-produced-99mtc https://druglandscape.com/api/og?type=drug&title=Generator-produced%2099mTc&subtitle=Generator-produced%2099mTc%20%C2%B7%20British%20Columbia%20Cancer%20Agency&badge=phase%201 Generator-produced 99mTc Generator-produced 99mTc · British Columbia Cancer Agency https://druglandscape.com/drug/generic-escitalopram https://druglandscape.com/api/og?type=drug&title=Generic%20Escitalopram&subtitle=Generic%20Escitalopram%20%C2%B7%20Shanghai%20Mental%20Health%20Center&badge=phase%202 Generic Escitalopram Generic Escitalopram · Shanghai Mental Health Center https://druglandscape.com/drug/generic-loteprednol-etabonate https://druglandscape.com/api/og?type=drug&title=Generic%20Loteprednol%20Etabonate&subtitle=Generic%20Loteprednol%20Etabonate%20%C2%B7%20Sandoz&badge=phase%201 Generic Loteprednol Etabonate Generic Loteprednol Etabonate · Sandoz https://druglandscape.com/drug/genetically-modified-ctls https://druglandscape.com/api/og?type=drug&title=Genetically%20modified%20CTLs&subtitle=Genetically%20modified%20CTLs%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Genetically modified CTLs Genetically modified CTLs · Baylor College of Medicine https://druglandscape.com/drug/geneticure-panel-for-htn-therapy https://druglandscape.com/api/og?type=drug&title=Geneticure%20Panel%20for%20HTN%20therapy&subtitle=Geneticure%20Panel%20for%20HTN%20therapy%20%C2%B7%20Geneticure%2C%20LLC&badge=phase%202 Geneticure Panel for HTN therapy Geneticure Panel for HTN therapy · Geneticure, LLC https://druglandscape.com/drug/genevax-il-12-dna https://druglandscape.com/api/og?type=drug&title=GENEVAX%C2%AE%20IL-12%20DNA&subtitle=GENEVAX%C2%AE%20IL-12%20DNA%20%C2%B7%20Imperial%20College%20London&badge=phase%201 GENEVAX® IL-12 DNA GENEVAX® IL-12 DNA · Imperial College London https://druglandscape.com/drug/genotropin-pen https://druglandscape.com/api/og?type=drug&title=Genotropin%20Pen%C2%AE&subtitle=Genotropin%20Pen%C2%AE%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Genotropin Pen® Genotropin Pen® · Novo Nordisk A/S https://druglandscape.com/drug/gensci098 https://druglandscape.com/api/og?type=drug&title=GenSci098&subtitle=GenSci098%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GenSci098 GenSci098 · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gensci120 https://druglandscape.com/api/og?type=drug&title=GenSci120&subtitle=GenSci120%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GenSci120 GenSci120 · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gensci128-tablets https://druglandscape.com/api/og?type=drug&title=GenSci128%20tablets&subtitle=GenSci128%20tablets%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GenSci128 tablets GenSci128 tablets · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gensci134 https://druglandscape.com/api/og?type=drug&title=GenSci134&subtitle=GenSci134%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GenSci134 GenSci134 · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gensci136 https://druglandscape.com/api/og?type=drug&title=GenSci136&subtitle=GenSci136%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GenSci136 GenSci136 · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gensci139 https://druglandscape.com/api/og?type=drug&title=GenSci139&subtitle=GenSci139%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GenSci139 GenSci139 · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gensci142 https://druglandscape.com/api/og?type=drug&title=GenSci142&subtitle=GenSci142%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GenSci142 GenSci142 · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gensci145-tablets https://druglandscape.com/api/og?type=drug&title=GenSci145%20tablets&subtitle=GenSci145%20tablets%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GenSci145 tablets GenSci145 tablets · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gensci161 https://druglandscape.com/api/og?type=drug&title=GenSci161&subtitle=GenSci161%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GenSci161 GenSci161 · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gentamicin-amoxicillin-x-7days https://druglandscape.com/api/og?type=drug&title=Gentamicin%20%26%20Amoxicillin%20x%207days&subtitle=Gentamicin%20%26%20Amoxicillin%20x%207days%20%C2%B7%20Johns%20Hopkins%20Bloomberg%20School%20of%20Public%20Health&badge=phase%201 Gentamicin & Amoxicillin x 7days Gentamicin & Amoxicillin x 7days · Johns Hopkins Bloomberg School of Public Health https://druglandscape.com/drug/gentamicin-and-piperacillin-tazobactam https://druglandscape.com/api/og?type=drug&title=gentamicin%20and%20Piperacillin-%20tazobactam&subtitle=gentamicin%20and%20Piperacillin-%20tazobactam%20%C2%B7%20Michael%20Cohen-Wolkowiez&badge=phase%202 gentamicin and Piperacillin- tazobactam gentamicin and Piperacillin- tazobactam · Michael Cohen-Wolkowiez https://druglandscape.com/drug/genz-112638 https://druglandscape.com/api/og?type=drug&title=Genz-112638&subtitle=Genz-112638%20%C2%B7%20Sanofi&badge=phase%201 Genz-112638 Genz-112638 · Sanofi https://druglandscape.com/drug/genz-682452 https://druglandscape.com/api/og?type=drug&title=Genz-682452&subtitle=Genz-682452%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%201 Genz-682452 Genz-682452 · Genzyme, a Sanofi Company https://druglandscape.com/drug/geographical-region-2-entyvio https://druglandscape.com/api/og?type=drug&title=Geographical%20region%202%20Entyvio&subtitle=Geographical%20region%202%20Entyvio%20%C2%B7%20Alvotech%20Swiss%20AG&badge=phase%201 Geographical region 2 Entyvio Geographical region 2 Entyvio · Alvotech Swiss AG https://druglandscape.com/drug/gepotidacin-capsule https://druglandscape.com/api/og?type=drug&title=Gepotidacin%20Capsule&subtitle=Gepotidacin%20Capsule%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Gepotidacin Capsule Gepotidacin Capsule · GlaxoSmithKline https://druglandscape.com/drug/gepotidacin-hswg-tablet https://druglandscape.com/api/og?type=drug&title=Gepotidacin%20HSWG%20Tablet&subtitle=Gepotidacin%20HSWG%20Tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Gepotidacin HSWG Tablet Gepotidacin HSWG Tablet · GlaxoSmithKline https://druglandscape.com/drug/gepotidacin-rc-tablet https://druglandscape.com/api/og?type=drug&title=Gepotidacin%20RC%20Tablet&subtitle=Gepotidacin%20RC%20Tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Gepotidacin RC Tablet Gepotidacin RC Tablet · GlaxoSmithKline https://druglandscape.com/drug/geptanolimab-injection-280mg-q3w https://druglandscape.com/api/og?type=drug&title=Geptanolimab%20Injection%20280mg%2C%20q3w&subtitle=Geptanolimab%20Injection%20280mg%2C%20q3w%20%C2%B7%20Genor%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 Geptanolimab Injection 280mg, q3w Geptanolimab Injection 280mg, q3w · Genor Biopharma Co., Ltd. https://druglandscape.com/drug/gf-cart01 https://druglandscape.com/api/og?type=drug&title=GF-CART01&subtitle=GF-CART01%20%C2%B7%20GenomeFrontier%20Therapeutics%20TW%20Co.%2C%20Ltd.&badge=phase%201 GF-CART01 GF-CART01 · GenomeFrontier Therapeutics TW Co., Ltd. https://druglandscape.com/drug/gfb-024 https://druglandscape.com/api/og?type=drug&title=GFB-024&subtitle=GFB-024%20%C2%B7%20Goldfinch%20Bio%2C%20Inc.&badge=phase%201 GFB-024 GFB-024 · Goldfinch Bio, Inc. https://druglandscape.com/drug/gff-inhalation-aerosphere https://druglandscape.com/api/og?type=drug&title=GFF%20Inhalation%20Aerosphere&subtitle=GFF%20Inhalation%20Aerosphere%20%C2%B7%20ShiYue%20Li&badge=phase%201 GFF Inhalation Aerosphere GFF Inhalation Aerosphere · ShiYue Li https://druglandscape.com/drug/gfh009 https://druglandscape.com/api/og?type=drug&title=GFH009&subtitle=GFH009%20%C2%B7%20Genfleet%20Therapeutics%20(Shanghai)%20Inc.&badge=phase%201 GFH009 GFH009 · Genfleet Therapeutics (Shanghai) Inc. https://druglandscape.com/drug/gfh276 https://druglandscape.com/api/og?type=drug&title=GFH276&subtitle=GFH276%20%C2%B7%20Genfleet%20Therapeutics%20(Shanghai)%20Inc.&badge=phase%201 GFH276 GFH276 · Genfleet Therapeutics (Shanghai) Inc. https://druglandscape.com/drug/gfh925 https://druglandscape.com/api/og?type=drug&title=GFH925&subtitle=GFH925%20%C2%B7%20Genfleet%20Therapeutics%20(Shanghai)%20Inc.&badge=phase%201 GFH925 GFH925 · Genfleet Therapeutics (Shanghai) Inc. https://druglandscape.com/drug/gft505 https://druglandscape.com/api/og?type=drug&title=GFT505&subtitle=GFT505%20%C2%B7%20Genfit&badge=phase%201 GFT505 GFT505 · Genfit https://druglandscape.com/drug/gh21-d-1553 https://druglandscape.com/api/og?type=drug&title=GH21%EF%BC%8CD-1553&subtitle=GH21%EF%BC%8CD-1553%20%C2%B7%20Suzhou%20Genhouse%20Bio%20Co.%2C%20Ltd.&badge=phase%202 GH21，D-1553 GH21，D-1553 · Suzhou Genhouse Bio Co., Ltd. https://druglandscape.com/drug/gh2616-tablets https://druglandscape.com/api/og?type=drug&title=GH2616%20Tablets&subtitle=GH2616%20Tablets%20%C2%B7%20Suzhou%20Genhouse%20Bio%20Co.%2C%20Ltd.&badge=phase%201 GH2616 Tablets GH2616 Tablets · Suzhou Genhouse Bio Co., Ltd. https://druglandscape.com/drug/gh35-tablet https://druglandscape.com/api/og?type=drug&title=GH35%20Tablet&subtitle=GH35%20Tablet%20%C2%B7%20Suzhou%20Genhouse%20Bio%20Co.%2C%20Ltd.&badge=phase%201 GH35 Tablet GH35 Tablet · Suzhou Genhouse Bio Co., Ltd. https://druglandscape.com/drug/gh509 https://druglandscape.com/api/og?type=drug&title=GH509&subtitle=GH509%20%C2%B7%201Globe%20Biomedical%20Co.%2C%20Ltd.&badge=phase%201 GH509 GH509 · 1Globe Biomedical Co., Ltd. https://druglandscape.com/drug/gh55 https://druglandscape.com/api/og?type=drug&title=GH55&subtitle=GH55%20%C2%B7%20Suzhou%20Genhouse%20Bio%20Co.%2C%20Ltd.&badge=phase%201 GH55 GH55 · Suzhou Genhouse Bio Co., Ltd. https://druglandscape.com/drug/gh56-capsule https://druglandscape.com/api/og?type=drug&title=GH56%20Capsule&subtitle=GH56%20Capsule%20%C2%B7%20Suzhou%20Genhouse%20Bio%20Co.%2C%20Ltd.&badge=phase%201 GH56 Capsule GH56 Capsule · Suzhou Genhouse Bio Co., Ltd. https://druglandscape.com/drug/ghb04l1 https://druglandscape.com/api/og?type=drug&title=GHB04L1&subtitle=GHB04L1%20%C2%B7%20AVIR%20Green%20Hills%20Biotechnology%20AG&badge=phase%201 GHB04L1 GHB04L1 · AVIR Green Hills Biotechnology AG https://druglandscape.com/drug/ghb16l2 https://druglandscape.com/api/og?type=drug&title=GHB16L2&subtitle=GHB16L2%20%C2%B7%20AVIR%20Green%20Hills%20Biotechnology%20AG&badge=phase%201 GHB16L2 GHB16L2 · AVIR Green Hills Biotechnology AG https://druglandscape.com/drug/gi-101a https://druglandscape.com/api/og?type=drug&title=GI-101A&subtitle=GI-101A%20%C2%B7%20GI%20Innovation%2C%20Inc.&badge=phase%201 GI-101A GI-101A · GI Innovation, Inc. https://druglandscape.com/drug/gi-102 https://druglandscape.com/api/og?type=drug&title=GI-102&subtitle=GI-102%20%C2%B7%20GI%20Innovation%2C%20Inc.&badge=phase%201 GI-102 GI-102 · GI Innovation, Inc. https://druglandscape.com/drug/gi-108 https://druglandscape.com/api/og?type=drug&title=GI-108&subtitle=GI-108%20%C2%B7%20GI%20Innovation%2C%20Inc.&badge=phase%201 GI-108 GI-108 · GI Innovation, Inc. https://druglandscape.com/drug/gi198745 https://druglandscape.com/api/og?type=drug&title=GI198745&subtitle=GI198745%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GI198745 GI198745 · GlaxoSmithKline https://druglandscape.com/drug/gi267119 https://druglandscape.com/api/og?type=drug&title=GI267119&subtitle=GI267119%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GI267119 GI267119 · GlaxoSmithKline https://druglandscape.com/drug/gic-1001 https://druglandscape.com/api/og?type=drug&title=GIC-1001&subtitle=GIC-1001%20%C2%B7%20gicare%20Pharma%20Inc.&badge=phase%202 GIC-1001 GIC-1001 · gicare Pharma Inc. https://druglandscape.com/drug/giga-564 https://druglandscape.com/api/og?type=drug&title=GIGA-564&subtitle=GIGA-564%20%C2%B7%20GigaGen%2C%20Inc.&badge=phase%201 GIGA-564 GIGA-564 · GigaGen, Inc. https://druglandscape.com/drug/gilteritinib-exposure https://druglandscape.com/api/og?type=drug&title=Gilteritinib%20Exposure&subtitle=Gilteritinib%20Exposure%20%C2%B7%20Astellas%20Pharma%20Korea%2C%20Inc.&badge=phase%202 Gilteritinib Exposure Gilteritinib Exposure · Astellas Pharma Korea, Inc. https://druglandscape.com/drug/gilteritinib-mini-tablet https://druglandscape.com/api/og?type=drug&title=gilteritinib%20mini%20tablet&subtitle=gilteritinib%20mini%20tablet%20%C2%B7%20Astellas%20Pharma%20Global%20Development%2C%20Inc.&badge=phase%201 gilteritinib mini tablet gilteritinib mini tablet · Astellas Pharma Global Development, Inc. https://druglandscape.com/drug/gilteritinib-oral-tablet https://druglandscape.com/api/og?type=drug&title=Gilteritinib%20Oral%20Tablet&subtitle=Gilteritinib%20Oral%20Tablet%20%C2%B7%20Oryzon%20Genomics%20S.A.&badge=phase%201 Gilteritinib Oral Tablet Gilteritinib Oral Tablet · Oryzon Genomics S.A. https://druglandscape.com/drug/gingilacer-enc-as-delicadas-colutorio https://druglandscape.com/api/og?type=drug&title=Gingilacer%20Enc%C3%ADas%20Delicadas%20Colutorio&subtitle=Gingilacer%20Enc%C3%ADas%20Delicadas%20Colutorio%20%C2%B7%20Fundaci%C3%B3n%20para%20el%20Fomento%20de%20la%20Investigaci%C3%B3n%20Sanitaria%20y%20Bi&badge=phase%201 Gingilacer Encías Delicadas Colutorio Gingilacer Encías Delicadas Colutorio · Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana https://druglandscape.com/drug/ginsenoside-h-dripping-pills https://druglandscape.com/api/og?type=drug&title=Ginsenoside%20H%20dripping%20pills&subtitle=Ginsenoside%20H%20dripping%20pills%20%C2%B7%20Tasly%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Ginsenoside H dripping pills Ginsenoside H dripping pills · Tasly Pharmaceuticals, Inc. https://druglandscape.com/drug/gip-3-30-nh2 https://druglandscape.com/api/og?type=drug&title=GIP%5B3-30%5DNH2&subtitle=GIP%5B3-30%5DNH2%20%C2%B7%20Frederikke%20Koefoed-Hansen&badge=phase%201 GIP[3-30]NH2 GIP[3-30]NH2 · Frederikke Koefoed-Hansen https://druglandscape.com/drug/gip-bolus https://druglandscape.com/api/og?type=drug&title=GIP%20Bolus&subtitle=GIP%20Bolus%20%C2%B7%20Diabeteszentrum%20Bad%20Lauterberg%20im%20Harz&badge=phase%201 GIP Bolus GIP Bolus · Diabeteszentrum Bad Lauterberg im Harz https://druglandscape.com/drug/gip-infusion https://druglandscape.com/api/og?type=drug&title=GIP%20infusion&subtitle=GIP%20infusion%20%C2%B7%20David%20D'Alessio%2C%20M.D.&badge=phase%201 GIP infusion GIP infusion · David D'Alessio, M.D. https://druglandscape.com/drug/gk02 https://druglandscape.com/api/og?type=drug&title=GK02&subtitle=GK02%20%C2%B7%20Beijing%20Geekgene%20Technology%20Co.%2C%20LTD&badge=phase%201 GK02 GK02 · Beijing Geekgene Technology Co., LTD https://druglandscape.com/drug/gkl-006 https://druglandscape.com/api/og?type=drug&title=GKL-006&subtitle=GKL-006%20%C2%B7%20Beijing%20Gene%20Key%20Life%20Technology%20Co.%2C%20Ltd&badge=phase%202 GKL-006 GKL-006 · Beijing Gene Key Life Technology Co., Ltd https://druglandscape.com/drug/gkt137831 https://druglandscape.com/api/og?type=drug&title=GKT137831&subtitle=GKT137831%20%C2%B7%20Calliditas%20Therapeutics%20AB&badge=phase%202 GKT137831 GKT137831 · Calliditas Therapeutics AB https://druglandscape.com/drug/gl-0719 https://druglandscape.com/api/og?type=drug&title=GL-0719&subtitle=GL-0719%20%C2%B7%20Gliknik%20Inc.&badge=phase%201 GL-0719 GL-0719 · Gliknik Inc. https://druglandscape.com/drug/gl0034 https://druglandscape.com/api/og?type=drug&title=GL0034&subtitle=GL0034%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%201 GL0034 GL0034 · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/gl0034-dose-level-1 https://druglandscape.com/api/og?type=drug&title=GL0034%20Dose%20Level%201&subtitle=GL0034%20Dose%20Level%201%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%202 GL0034 Dose Level 1 GL0034 Dose Level 1 · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/gl0034-dose-level-3 https://druglandscape.com/api/og?type=drug&title=GL0034%20Dose%20Level%203&subtitle=GL0034%20Dose%20Level%203%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%202 GL0034 Dose Level 3 GL0034 Dose Level 3 · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/gl0034-dose-level-5 https://druglandscape.com/api/og?type=drug&title=GL0034%20Dose%20Level%205&subtitle=GL0034%20Dose%20Level%205%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%202 GL0034 Dose Level 5 GL0034 Dose Level 5 · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/gl2907 https://druglandscape.com/api/og?type=drug&title=GL2907&subtitle=GL2907%20%C2%B7%20GL%20Pharm%20Tech%20Corporation&badge=phase%201 GL2907 GL2907 · GL Pharm Tech Corporation https://druglandscape.com/drug/glasdegib-oral-tablet https://druglandscape.com/api/og?type=drug&title=Glasdegib%20Oral%20Tablet&subtitle=Glasdegib%20Oral%20Tablet%20%C2%B7%20Pfizer&badge=phase%201 Glasdegib Oral Tablet Glasdegib Oral Tablet · Pfizer https://druglandscape.com/drug/glasdegib-supra-therapeutic-exposure https://druglandscape.com/api/og?type=drug&title=Glasdegib%20Supra-therapeutic%20Exposure&subtitle=Glasdegib%20Supra-therapeutic%20Exposure%20%C2%B7%20Pfizer&badge=phase%201 Glasdegib Supra-therapeutic Exposure Glasdegib Supra-therapeutic Exposure · Pfizer https://druglandscape.com/drug/glatiramer-acetate-n-acetylcysteine https://druglandscape.com/api/og?type=drug&title=Glatiramer%20Acetate%2C%20N-Acetylcysteine&subtitle=Glatiramer%20Acetate%2C%20N-Acetylcysteine%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%202 Glatiramer Acetate, N-Acetylcysteine Glatiramer Acetate, N-Acetylcysteine · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/glatiramer-acetate-with-minocycline https://druglandscape.com/api/og?type=drug&title=glatiramer%20acetate%20with%20minocycline&subtitle=glatiramer%20acetate%20with%20minocycline%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%202 glatiramer acetate with minocycline glatiramer acetate with minocycline · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/glb-001 https://druglandscape.com/api/og?type=drug&title=GLB-001&subtitle=GLB-001%20%C2%B7%20GluBio%20Therapeutics%20Inc.&badge=phase%201 GLB-001 GLB-001 · GluBio Therapeutics Inc. https://druglandscape.com/drug/glb-002 https://druglandscape.com/api/og?type=drug&title=GLB-002&subtitle=GLB-002%20%C2%B7%20Hangzhou%20GluBio%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GLB-002 GLB-002 · Hangzhou GluBio Pharmaceutical Co., Ltd. https://druglandscape.com/drug/glcnac-glcn https://druglandscape.com/api/og?type=drug&title=GlcNAc-GlcN&subtitle=GlcNAc-GlcN%20%C2%B7%20Eva%20Morava-Kozicz&badge=phase%202 GlcNAc-GlcN GlcNAc-GlcN · Eva Morava-Kozicz https://druglandscape.com/drug/glix1 https://druglandscape.com/api/og?type=drug&title=GLIX1&subtitle=GLIX1%20%C2%B7%20Tetragon%20Biosciences%20Ltd&badge=phase%201 GLIX1 GLIX1 · Tetragon Biosciences Ltd https://druglandscape.com/drug/globulina-antilinfocitaria https://druglandscape.com/api/og?type=drug&title=Globulina%20antilinfocitaria&subtitle=Globulina%20antilinfocitaria%20%C2%B7%20Gruppo%20Italiano%20Trapianto%20di%20Midollo%20Osseo&badge=phase%202 Globulina antilinfocitaria Globulina antilinfocitaria · Gruppo Italiano Trapianto di Midollo Osseo https://druglandscape.com/drug/glp-1-receptor-antagonist https://druglandscape.com/api/og?type=drug&title=GLP-1%20receptor%20antagonist&subtitle=GLP-1%20receptor%20antagonist%20%C2%B7%20Amsterdam%20UMC%2C%20location%20VUmc&badge=phase%201 GLP-1 receptor antagonist GLP-1 receptor antagonist · Amsterdam UMC, location VUmc https://druglandscape.com/drug/glp-1-therapy https://druglandscape.com/api/og?type=drug&title=GLP-1%20therapy&subtitle=GLP-1%20therapy%20%C2%B7%20Albany%20College%20of%20Pharmacy%20and%20Health%20Sciences&badge=phase%202 GLP-1 therapy GLP-1 therapy · Albany College of Pharmacy and Health Sciences https://druglandscape.com/drug/glpg0187 https://druglandscape.com/api/og?type=drug&title=GLPG0187&subtitle=GLPG0187%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG0187 GLPG0187 · Galapagos NV https://druglandscape.com/drug/glpg0259 https://druglandscape.com/api/og?type=drug&title=GLPG0259&subtitle=GLPG0259%20%C2%B7%20Galapagos%20NV&badge=phase%202 GLPG0259 GLPG0259 · Galapagos NV https://druglandscape.com/drug/glpg0555 https://druglandscape.com/api/og?type=drug&title=GLPG0555&subtitle=GLPG0555%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG0555 GLPG0555 · Galapagos NV https://druglandscape.com/drug/glpg0555-aqueous https://druglandscape.com/api/og?type=drug&title=GLPG0555%20aqueous&subtitle=GLPG0555%20aqueous%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG0555 aqueous GLPG0555 aqueous · Galapagos NV https://druglandscape.com/drug/glpg0555-nanosuspension https://druglandscape.com/api/og?type=drug&title=GLPG0555%20nanosuspension&subtitle=GLPG0555%20nanosuspension%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG0555 nanosuspension GLPG0555 nanosuspension · Galapagos NV https://druglandscape.com/drug/glpg0555-solid-dispersion https://druglandscape.com/api/og?type=drug&title=GLPG0555%20solid%20dispersion&subtitle=GLPG0555%20solid%20dispersion%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG0555 solid dispersion GLPG0555 solid dispersion · Galapagos NV https://druglandscape.com/drug/glpg0634 https://druglandscape.com/api/og?type=drug&title=GLPG0634&subtitle=GLPG0634%20%C2%B7%20Galapagos%20NV&badge=phase%202 GLPG0634 GLPG0634 · Galapagos NV https://druglandscape.com/drug/glpg1205-capsules https://druglandscape.com/api/og?type=drug&title=GLPG1205%20capsules&subtitle=GLPG1205%20capsules%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG1205 capsules GLPG1205 capsules · Galapagos NV https://druglandscape.com/drug/glpg1690-film-coated-tablets https://druglandscape.com/api/og?type=drug&title=GLPG1690%20film-coated%20tablets&subtitle=GLPG1690%20film-coated%20tablets%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG1690 film-coated tablets GLPG1690 film-coated tablets · Galapagos NV https://druglandscape.com/drug/glpg1837-dose-1 https://druglandscape.com/api/og?type=drug&title=GLPG1837%20dose%201&subtitle=GLPG1837%20dose%201%20%C2%B7%20Galapagos%20NV&badge=phase%202 GLPG1837 dose 1 GLPG1837 dose 1 · Galapagos NV https://druglandscape.com/drug/glpg1972-a https://druglandscape.com/api/og?type=drug&title=GLPG1972%20-%20A&subtitle=GLPG1972%20-%20A%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG1972 - A GLPG1972 - A · Galapagos NV https://druglandscape.com/drug/glpg1972-b https://druglandscape.com/api/og?type=drug&title=GLPG1972%20-%20B&subtitle=GLPG1972%20-%20B%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG1972 - B GLPG1972 - B · Galapagos NV https://druglandscape.com/drug/glpg1972-c https://druglandscape.com/api/og?type=drug&title=GLPG1972%20-%20C&subtitle=GLPG1972%20-%20C%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG1972 - C GLPG1972 - C · Galapagos NV https://druglandscape.com/drug/glpg2222 https://druglandscape.com/api/og?type=drug&title=GLPG2222&subtitle=GLPG2222%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG2222 GLPG2222 · Galapagos NV https://druglandscape.com/drug/glpg2222-multiple-doses https://druglandscape.com/api/og?type=drug&title=GLPG2222%20multiple%20doses&subtitle=GLPG2222%20multiple%20doses%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG2222 multiple doses GLPG2222 multiple doses · Galapagos NV https://druglandscape.com/drug/glpg2451-dose-regimen-b https://druglandscape.com/api/og?type=drug&title=GLPG2451%20dose%20regimen%20B&subtitle=GLPG2451%20dose%20regimen%20B%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG2451 dose regimen B GLPG2451 dose regimen B · Galapagos NV https://druglandscape.com/drug/glpg2451-multiple-dose https://druglandscape.com/api/og?type=drug&title=GLPG2451%20multiple%20dose&subtitle=GLPG2451%20multiple%20dose%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG2451 multiple dose GLPG2451 multiple dose · Galapagos NV https://druglandscape.com/drug/glpg2451-single-dose https://druglandscape.com/api/og?type=drug&title=GLPG2451%20single%20dose&subtitle=GLPG2451%20single%20dose%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG2451 single dose GLPG2451 single dose · Galapagos NV https://druglandscape.com/drug/glpg2737-multiple-dose https://druglandscape.com/api/og?type=drug&title=GLPG2737%20multiple%20dose&subtitle=GLPG2737%20multiple%20dose%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG2737 multiple dose GLPG2737 multiple dose · Galapagos NV https://druglandscape.com/drug/glpg2737-single-dose https://druglandscape.com/api/og?type=drug&title=GLPG2737%20single%20dose&subtitle=GLPG2737%20single%20dose%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG2737 single dose GLPG2737 single dose · Galapagos NV https://druglandscape.com/drug/glpg3067-oral-suspension https://druglandscape.com/api/og?type=drug&title=GLPG3067%20oral%20suspension&subtitle=GLPG3067%20oral%20suspension%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG3067 oral suspension GLPG3067 oral suspension · Galapagos NV https://druglandscape.com/drug/glpg3067-single-dose https://druglandscape.com/api/og?type=drug&title=GLPG3067%20single%20dose&subtitle=GLPG3067%20single%20dose%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG3067 single dose GLPG3067 single dose · Galapagos NV https://druglandscape.com/drug/glpg3121 https://druglandscape.com/api/og?type=drug&title=GLPG3121&subtitle=GLPG3121%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG3121 GLPG3121 · Galapagos NV https://druglandscape.com/drug/glpg3121-mad https://druglandscape.com/api/og?type=drug&title=GLPG3121%20MAD&subtitle=GLPG3121%20MAD%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG3121 MAD GLPG3121 MAD · Galapagos NV https://druglandscape.com/drug/glpg3121-sad https://druglandscape.com/api/og?type=drug&title=GLPG3121%20SAD&subtitle=GLPG3121%20SAD%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG3121 SAD GLPG3121 SAD · Galapagos NV https://druglandscape.com/drug/glpg3312-fe-mr https://druglandscape.com/api/og?type=drug&title=GLPG3312%20FE%20MR&subtitle=GLPG3312%20FE%20MR%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG3312 FE MR GLPG3312 FE MR · Galapagos NV https://druglandscape.com/drug/glpg3312-ir https://druglandscape.com/api/og?type=drug&title=GLPG3312%20IR&subtitle=GLPG3312%20IR%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG3312 IR GLPG3312 IR · Galapagos NV https://druglandscape.com/drug/glpg3312-mr https://druglandscape.com/api/og?type=drug&title=GLPG3312%20MR&subtitle=GLPG3312%20MR%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG3312 MR GLPG3312 MR · Galapagos NV https://druglandscape.com/drug/glpg3667 https://druglandscape.com/api/og?type=drug&title=GLPG3667&subtitle=GLPG3667%20%C2%B7%20Galapagos%20NV&badge=phase%202 GLPG3667 GLPG3667 · Galapagos NV https://druglandscape.com/drug/glpg4399-capsules https://druglandscape.com/api/og?type=drug&title=GLPG4399%20capsules&subtitle=GLPG4399%20capsules%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG4399 capsules GLPG4399 capsules · Galapagos NV https://druglandscape.com/drug/glpg4399-oral-suspension https://druglandscape.com/api/og?type=drug&title=GLPG4399%20oral%20suspension&subtitle=GLPG4399%20oral%20suspension%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG4399 oral suspension GLPG4399 oral suspension · Galapagos NV https://druglandscape.com/drug/glpg4716 https://druglandscape.com/api/og?type=drug&title=GLPG4716&subtitle=GLPG4716%20%C2%B7%20Galapagos%20NV&badge=phase%201 GLPG4716 GLPG4716 · Galapagos NV https://druglandscape.com/drug/glr2007 https://druglandscape.com/api/og?type=drug&title=GLR2007&subtitle=GLR2007%20%C2%B7%20Gan%20and%20Lee%20Pharmaceuticals%2C%20USA&badge=phase%201 GLR2007 GLR2007 · Gan and Lee Pharmaceuticals, USA https://druglandscape.com/drug/glr2037 https://druglandscape.com/api/og?type=drug&title=GLR2037&subtitle=GLR2037%20%C2%B7%20Gan%20%26%20Lee%20Pharmaceuticals.&badge=phase%201 GLR2037 GLR2037 · Gan & Lee Pharmaceuticals. https://druglandscape.com/drug/gls-012 https://druglandscape.com/api/og?type=drug&title=GLS-012&subtitle=GLS-012%20%C2%B7%20Guangzhou%20Gloria%20Biosciences%20Co.%2C%20Ltd.&badge=phase%201 GLS-012 GLS-012 · Guangzhou Gloria Biosciences Co., Ltd. https://druglandscape.com/drug/gls-5130 https://druglandscape.com/api/og?type=drug&title=GLS-5130&subtitle=GLS-5130%20%C2%B7%20GeneOne%20Life%20Science%2C%20Inc.&badge=phase%201 GLS-5130 GLS-5130 · GeneOne Life Science, Inc. https://druglandscape.com/drug/gls-5300 https://druglandscape.com/api/og?type=drug&title=GLS-5300&subtitle=GLS-5300%20%C2%B7%20GeneOne%20Life%20Science%2C%20Inc.&badge=phase%201 GLS-5300 GLS-5300 · GeneOne Life Science, Inc. https://druglandscape.com/drug/gls-5700 https://druglandscape.com/api/og?type=drug&title=GLS-5700&subtitle=GLS-5700%20%C2%B7%20GeneOne%20Life%20Science%2C%20Inc.&badge=phase%201 GLS-5700 GLS-5700 · GeneOne Life Science, Inc. https://druglandscape.com/drug/glucocorticoid-agent https://druglandscape.com/api/og?type=drug&title=Glucocorticoid%20Agent&subtitle=Glucocorticoid%20Agent%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Glucocorticoid Agent Glucocorticoid Agent · Hoffmann-La Roche https://druglandscape.com/drug/glucokinase-activator https://druglandscape.com/api/og?type=drug&title=glucokinase%20activator&subtitle=glucokinase%20activator%20%C2%B7%20PegBio%20Co.%2C%20Ltd.&badge=phase%201 glucokinase activator glucokinase activator · PegBio Co., Ltd. https://druglandscape.com/drug/glucophage-xr-rm-test https://druglandscape.com/api/og?type=drug&title=Glucophage%C2%AE%20XR%20RM%20Test&subtitle=Glucophage%C2%AE%20XR%20RM%20Test%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darm&badge=phase%201 Glucophage® XR RM Test Glucophage® XR RM Test · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/glucophagexr https://druglandscape.com/api/og?type=drug&title=GLUCOPHAGE%C2%AEXR&subtitle=GLUCOPHAGE%C2%AEXR%20%C2%B7%20IPCA%20Laboratories%20Ltd.&badge=phase%201 GLUCOPHAGE®XR GLUCOPHAGE®XR · IPCA Laboratories Ltd. https://druglandscape.com/drug/glucose-dependent-insulinotropic-peptide https://druglandscape.com/api/og?type=drug&title=glucose-dependent%20insulinotropic%20peptide&subtitle=glucose-dependent%20insulinotropic%20peptide%20%C2%B7%20Steno%20Diabetes%20Center%20Copenhagen&badge=phase%201 glucose-dependent insulinotropic peptide glucose-dependent insulinotropic peptide · Steno Diabetes Center Copenhagen https://druglandscape.com/drug/glucose-lowering-therapy https://druglandscape.com/api/og?type=drug&title=Glucose%20lowering%20therapy&subtitle=Glucose%20lowering%20therapy%20%C2%B7%20Peter%20G%C3%A6de&badge=phase%201 Glucose lowering therapy Glucose lowering therapy · Peter Gæde https://druglandscape.com/drug/glucose-solution-and-insulin https://druglandscape.com/api/og?type=drug&title=glucose%20solution%20and%20Insulin&subtitle=glucose%20solution%20and%20Insulin%20%C2%B7%20HaEmek%20Medical%20Center%2C%20Israel&badge=phase%201 glucose solution and Insulin glucose solution and Insulin · HaEmek Medical Center, Israel https://druglandscape.com/drug/glucose-solution-only https://druglandscape.com/api/og?type=drug&title=glucose%20solution%20only&subtitle=glucose%20solution%20only%20%C2%B7%20HaEmek%20Medical%20Center%2C%20Israel&badge=phase%201 glucose solution only glucose solution only · HaEmek Medical Center, Israel https://druglandscape.com/drug/glucosidase-alfa https://druglandscape.com/api/og?type=drug&title=glucosidase%20alfa&subtitle=glucosidase%20alfa%20%C2%B7%20LMU%20Klinikum&badge=phase%202 glucosidase alfa glucosidase alfa · LMU Klinikum https://druglandscape.com/drug/glutathione-supplementation https://druglandscape.com/api/og?type=drug&title=Glutathione%20supplementation&subtitle=Glutathione%20supplementation%20%C2%B7%20Milton%20S.%20Hershey%20Medical%20Center&badge=phase%201 Glutathione supplementation Glutathione supplementation · Milton S. Hershey Medical Center https://druglandscape.com/drug/gluthathione-peroxidases https://druglandscape.com/api/og?type=drug&title=Gluthathione%20peroxidases&subtitle=Gluthathione%20peroxidases%20%C2%B7%20Milton%20S.%20Hershey%20Medical%20Center&badge=phase%201 Gluthathione peroxidases Gluthathione peroxidases · Milton S. Hershey Medical Center https://druglandscape.com/drug/gly-200 https://druglandscape.com/api/og?type=drug&title=GLY-200&subtitle=GLY-200%20%C2%B7%20Glyscend%2C%20Inc.&badge=phase%202 GLY-200 GLY-200 · Glyscend, Inc. https://druglandscape.com/drug/glyceryl-tribenzoate https://druglandscape.com/api/og?type=drug&title=Glyceryl%20Tribenzoate&subtitle=Glyceryl%20Tribenzoate%20%C2%B7%20Forest%20Hills%20Lab&badge=phase%201 Glyceryl Tribenzoate Glyceryl Tribenzoate · Forest Hills Lab https://druglandscape.com/drug/glyceryl-trinitrate-azetazolamide https://druglandscape.com/api/og?type=drug&title=Glyceryl%20trinitrate%2C%20azetazolamide&subtitle=Glyceryl%20trinitrate%2C%20azetazolamide%20%C2%B7%20Danish%20Headache%20Center&badge=phase%201 Glyceryl trinitrate, azetazolamide Glyceryl trinitrate, azetazolamide · Danish Headache Center https://druglandscape.com/drug/glyconjugate-klebsiella-pneumoniae-bivalent-vaccine https://druglandscape.com/api/og?type=drug&title=Glyconjugate%20Klebsiella%20pneumoniae%20bivalent%20vaccine&subtitle=Glyconjugate%20Klebsiella%20pneumoniae%20bivalent%20vaccine%20%C2%B7%20Cho%20Pharma%20Inc.&badge=phase%201 Glyconjugate Klebsiella pneumoniae bivalent vaccine Glyconjugate Klebsiella pneumoniae bivalent vaccine · Cho Pharma Inc. https://druglandscape.com/drug/glycopyrrolate-1-0 https://druglandscape.com/api/og?type=drug&title=glycopyrrolate%2C%201.0%25&subtitle=glycopyrrolate%2C%201.0%25%20%C2%B7%20Journey%20Medical%20Corporation&badge=phase%202 glycopyrrolate, 1.0% glycopyrrolate, 1.0% · Journey Medical Corporation https://druglandscape.com/drug/glycopyrrolate-2-0 https://druglandscape.com/api/og?type=drug&title=glycopyrrolate%2C%202.0%25&subtitle=glycopyrrolate%2C%202.0%25%20%C2%B7%20Journey%20Medical%20Corporation&badge=phase%202 glycopyrrolate, 2.0% glycopyrrolate, 2.0% · Journey Medical Corporation https://druglandscape.com/drug/glycopyrrolate-3-0 https://druglandscape.com/api/og?type=drug&title=glycopyrrolate%2C%203.0%25&subtitle=glycopyrrolate%2C%203.0%25%20%C2%B7%20Journey%20Medical%20Corporation&badge=phase%202 glycopyrrolate, 3.0% glycopyrrolate, 3.0% · Journey Medical Corporation https://druglandscape.com/drug/glycopyrrolate-4-0 https://druglandscape.com/api/og?type=drug&title=glycopyrrolate%2C%204.0%25&subtitle=glycopyrrolate%2C%204.0%25%20%C2%B7%20Journey%20Medical%20Corporation&badge=phase%202 glycopyrrolate, 4.0% glycopyrrolate, 4.0% · Journey Medical Corporation https://druglandscape.com/drug/glycopyrronium-cloth-2-4 https://druglandscape.com/api/og?type=drug&title=Glycopyrronium%20cloth%2C%202.4%25&subtitle=Glycopyrronium%20cloth%2C%202.4%25%20%C2%B7%20Journey%20Medical%20Corporation&badge=phase%202 Glycopyrronium cloth, 2.4% Glycopyrronium cloth, 2.4% · Journey Medical Corporation https://druglandscape.com/drug/glycopyrronium-mdi-28-8-micrograms https://druglandscape.com/api/og?type=drug&title=Glycopyrronium%20MDI%2028.8%20micrograms&subtitle=Glycopyrronium%20MDI%2028.8%20micrograms%20%C2%B7%20Pearl%20Therapeutics%2C%20Inc.&badge=phase%202 Glycopyrronium MDI 28.8 micrograms Glycopyrronium MDI 28.8 micrograms · Pearl Therapeutics, Inc. https://druglandscape.com/drug/glycovax-002 https://druglandscape.com/api/og?type=drug&title=Glycovax-002&subtitle=Glycovax-002%20%C2%B7%20Glycovax%20Pharma%20Inc.&badge=phase%201 Glycovax-002 Glycovax-002 · Glycovax Pharma Inc. https://druglandscape.com/drug/gm-60106 https://druglandscape.com/api/og?type=drug&title=GM-60106&subtitle=GM-60106%20%C2%B7%20JD%20Bioscience%20Inc.&badge=phase%201 GM-60106 GM-60106 · JD Bioscience Inc. https://druglandscape.com/drug/gm-xantho-onitment https://druglandscape.com/api/og?type=drug&title=GM-XANTHO%20onitment&subtitle=GM-XANTHO%20onitment%20%C2%B7%20Xantho%20Biotechnology%20Co.%2C%20LTD&badge=phase%201 GM-XANTHO onitment GM-XANTHO onitment · Xantho Biotechnology Co., LTD https://druglandscape.com/drug/gm102-escalating-doses https://druglandscape.com/api/og?type=drug&title=GM102%20escalating%20doses&subtitle=GM102%20escalating%20doses%20%C2%B7%20GamaMabs%20Pharma&badge=phase%201 GM102 escalating doses GM102 escalating doses · GamaMabs Pharma https://druglandscape.com/drug/gm608 https://druglandscape.com/api/og?type=drug&title=GM608&subtitle=GM608%20%C2%B7%20Genervon%20Biopharmaceuticals%2C%20LLC&badge=phase%202 GM608 GM608 · Genervon Biopharmaceuticals, LLC https://druglandscape.com/drug/gnc-035 https://druglandscape.com/api/og?type=drug&title=GNC-035&subtitle=GNC-035%20%C2%B7%20Sichuan%20Baili%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GNC-035 GNC-035 · Sichuan Baili Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gnc-038 https://druglandscape.com/api/og?type=drug&title=GNC-038&subtitle=GNC-038%20%C2%B7%20Sichuan%20Baili%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GNC-038 GNC-038 · Sichuan Baili Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gnc-039 https://druglandscape.com/api/og?type=drug&title=GNC-039&subtitle=GNC-039%20%C2%B7%20Sichuan%20Baili%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GNC-039 GNC-039 · Sichuan Baili Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gnc-077 https://druglandscape.com/api/og?type=drug&title=GNC-077&subtitle=GNC-077%20%C2%B7%20Sichuan%20Baili%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GNC-077 GNC-077 · Sichuan Baili Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gnr-051 https://druglandscape.com/api/og?type=drug&title=GNR-051&subtitle=GNR-051%20%C2%B7%20AO%20GENERIUM&badge=phase%201 GNR-051 GNR-051 · AO GENERIUM https://druglandscape.com/drug/gnrh-a-goserelin https://druglandscape.com/api/og?type=drug&title=GNRH-A%20Goserelin&subtitle=GNRH-A%20Goserelin%20%C2%B7%20Praful%20Ravi%2C%20MB%20BCHir%2C%20MRCP&badge=phase%201 GNRH-A Goserelin GNRH-A Goserelin · Praful Ravi, MB BCHir, MRCP https://druglandscape.com/drug/gnrh-a-leuprolide-acetate https://druglandscape.com/api/og?type=drug&title=GNRH-A%20Leuprolide%20Acetate&subtitle=GNRH-A%20Leuprolide%20Acetate%20%C2%B7%20Praful%20Ravi%2C%20MB%20BCHir%2C%20MRCP&badge=phase%201 GNRH-A Leuprolide Acetate GNRH-A Leuprolide Acetate · Praful Ravi, MB BCHir, MRCP https://druglandscape.com/drug/gnrh-analog-and-recombinant-human-fsh https://druglandscape.com/api/og?type=drug&title=GnRH%20analog%20and%20recombinant%20human%20FSH&subtitle=GnRH%20analog%20and%20recombinant%20human%20FSH%20%C2%B7%20Fondazione%20IRCCS%20Ca'%20Granda%2C%20Ospedale%20Maggiore%20Policlinico&badge=phase%201 GnRH analog and recombinant human FSH GnRH analog and recombinant human FSH · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico https://druglandscape.com/drug/gnrh-antagonist-depot-degarelix https://druglandscape.com/api/og?type=drug&title=GnRH%20antagonist%20depot%20Degarelix&subtitle=GnRH%20antagonist%20depot%20Degarelix%20%C2%B7%20Bioroma&badge=phase%202 GnRH antagonist depot Degarelix GnRH antagonist depot Degarelix · Bioroma https://druglandscape.com/drug/gnt0003 https://druglandscape.com/api/og?type=drug&title=GNT0003&subtitle=GNT0003%20%C2%B7%20Genethon&badge=phase%202 GNT0003 GNT0003 · Genethon https://druglandscape.com/drug/go306 https://druglandscape.com/api/og?type=drug&title=GO306&subtitle=GO306%20%C2%B7%20GeneSail%20Biotech%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 GO306 GO306 · GeneSail Biotech (Shanghai) Co., Ltd. https://druglandscape.com/drug/gp-2250 https://druglandscape.com/api/og?type=drug&title=GP-2250&subtitle=GP-2250%20%C2%B7%20Geistlich%20Pharma%20AG&badge=phase%201 GP-2250 GP-2250 · Geistlich Pharma AG https://druglandscape.com/drug/gp-40081 https://druglandscape.com/api/og?type=drug&title=GP-40081&subtitle=GP-40081%20%C2%B7%20Geropharm&badge=phase%201 GP-40081 GP-40081 · Geropharm https://druglandscape.com/drug/gp140-dp-high-dose https://druglandscape.com/api/og?type=drug&title=gp140%20DP%20High-dose&subtitle=gp140%20DP%20High-dose%20%C2%B7%20Janssen%20Vaccines%20%26%20Prevention%20B.V.&badge=phase%201 gp140 DP High-dose gp140 DP High-dose · Janssen Vaccines & Prevention B.V. https://druglandscape.com/drug/gp140-dp-low-dose https://druglandscape.com/api/og?type=drug&title=gp140%20DP%20Low-dose&subtitle=gp140%20DP%20Low-dose%20%C2%B7%20Janssen%20Vaccines%20%26%20Prevention%20B.V.&badge=phase%201 gp140 DP Low-dose gp140 DP Low-dose · Janssen Vaccines & Prevention B.V. https://druglandscape.com/drug/gp140-hiv-bivalent-vaccine https://druglandscape.com/api/og?type=drug&title=gp140%20HIV%20Bivalent%20Vaccine&subtitle=gp140%20HIV%20Bivalent%20Vaccine%20%C2%B7%20Janssen%20Vaccines%20%26%20Prevention%20B.V.&badge=phase%201 gp140 HIV Bivalent Vaccine gp140 HIV Bivalent Vaccine · Janssen Vaccines & Prevention B.V. https://druglandscape.com/drug/gp30101 https://druglandscape.com/api/og?type=drug&title=GP30101&subtitle=GP30101%20%C2%B7%20Geropharm&badge=phase%201 GP30101 GP30101 · Geropharm https://druglandscape.com/drug/gp40141 https://druglandscape.com/api/og?type=drug&title=GP40141&subtitle=GP40141%20%C2%B7%20Geropharm&badge=phase%201 GP40141 GP40141 · Geropharm https://druglandscape.com/drug/gp75-dna-vaccine https://druglandscape.com/api/og?type=drug&title=gp75%20DNA%20vaccine&subtitle=gp75%20DNA%20vaccine%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 gp75 DNA vaccine gp75 DNA vaccine · Eli Lilly and Company https://druglandscape.com/drug/gp96 https://druglandscape.com/api/og?type=drug&title=gp96&subtitle=gp96%20%C2%B7%20Cure%26Sure%20Biotech%20Co.%2C%20LTD&badge=phase%202 gp96 gp96 · Cure&Sure Biotech Co., LTD https://druglandscape.com/drug/gpa-trimar-t https://druglandscape.com/api/og?type=drug&title=GPA-TriMAR-T&subtitle=GPA-TriMAR-T%20%C2%B7%20Timmune%20Biotech%20Inc.&badge=phase%201 GPA-TriMAR-T GPA-TriMAR-T · Timmune Biotech Inc. https://druglandscape.com/drug/gpc-100 https://druglandscape.com/api/og?type=drug&title=GPC-100&subtitle=GPC-100%20%C2%B7%20GPCR%20Therapeutics%2C%20Inc.&badge=phase%202 GPC-100 GPC-100 · GPCR Therapeutics, Inc. https://druglandscape.com/drug/gpo-ritonavir-versus-norvir https://druglandscape.com/api/og?type=drug&title=GPO%20ritonavir%20versus%20Norvir&subtitle=GPO%20ritonavir%20versus%20Norvir%20%C2%B7%20The%20HIV%20Netherlands%20Australia%20Thailand%20Research%20Collaboration&badge=phase%201 GPO ritonavir versus Norvir GPO ritonavir versus Norvir · The HIV Netherlands Australia Thailand Research Collaboration https://druglandscape.com/drug/gprc5d-car-t-cell-intravenous-infusion https://druglandscape.com/api/og?type=drug&title=GPRC5D%20CAR-T%20cell%20intravenous%20infusion&subtitle=GPRC5D%20CAR-T%20cell%20intravenous%20infusion%20%C2%B7%20Qi%20deng&badge=phase%201 GPRC5D CAR-T cell intravenous infusion GPRC5D CAR-T cell intravenous infusion · Qi deng https://druglandscape.com/drug/gq1001 https://druglandscape.com/api/og?type=drug&title=GQ1001&subtitle=GQ1001%20%C2%B7%20GeneQuantum%20Healthcare%20(Suzhou)%20Co.%2C%20Ltd.&badge=phase%201 GQ1001 GQ1001 · GeneQuantum Healthcare (Suzhou) Co., Ltd. https://druglandscape.com/drug/gq1005 https://druglandscape.com/api/og?type=drug&title=GQ1005&subtitle=GQ1005%20%C2%B7%20GeneQuantum%20Healthcare%20(Suzhou)%20Co.%2C%20Ltd.&badge=phase%201 GQ1005 GQ1005 · GeneQuantum Healthcare (Suzhou) Co., Ltd. https://druglandscape.com/drug/gr121167-solution https://druglandscape.com/api/og?type=drug&title=GR121167%20Solution&subtitle=GR121167%20Solution%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GR121167 Solution GR121167 Solution · GlaxoSmithKline https://druglandscape.com/drug/gr37547-tablet https://druglandscape.com/api/og?type=drug&title=GR37547%20tablet&subtitle=GR37547%20tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GR37547 tablet GR37547 tablet · GlaxoSmithKline https://druglandscape.com/drug/graft-intracerebral-of-foetal-neurons https://druglandscape.com/api/og?type=drug&title=graft%20intracerebral%20of%20foetal%20neurons&subtitle=graft%20intracerebral%20of%20foetal%20neurons%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 graft intracerebral of foetal neurons graft intracerebral of foetal neurons · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/gralb https://druglandscape.com/api/og?type=drug&title=GRALB&subtitle=GRALB%20%C2%B7%20Centro%20Pediatrico%20Albina%20de%20Patino&badge=phase%201 GRALB GRALB · Centro Pediatrico Albina de Patino https://druglandscape.com/drug/grammidin-a-metered-dose-topical-spray https://druglandscape.com/api/og?type=drug&title=Grammidin%2C%20a%20metered%20dose%20topical%20spray&subtitle=Grammidin%2C%20a%20metered%20dose%20topical%20spray%20%C2%B7%20Valenta%20Pharm%20JSC&badge=phase%201 Grammidin, a metered dose topical spray Grammidin, a metered dose topical spray · Valenta Pharm JSC https://druglandscape.com/drug/grammidin-neo https://druglandscape.com/api/og?type=drug&title=Grammidin%20neo&subtitle=Grammidin%20neo%20%C2%B7%20Valenta%20Pharm%20JSC&badge=phase%201 Grammidin neo Grammidin neo · Valenta Pharm JSC https://druglandscape.com/drug/grammidin-with-anesthetic https://druglandscape.com/api/og?type=drug&title=Grammidin%20with%20anesthetic&subtitle=Grammidin%20with%20anesthetic%20%C2%B7%20Valenta%20Pharm%20JSC&badge=phase%202 Grammidin with anesthetic Grammidin with anesthetic · Valenta Pharm JSC https://druglandscape.com/drug/grammidin-with-anesthetic-neo https://druglandscape.com/api/og?type=drug&title=Grammidin%20with%20anesthetic%20neo&subtitle=Grammidin%20with%20anesthetic%20neo%20%C2%B7%20Valenta%20Pharm%20JSC&badge=phase%201 Grammidin with anesthetic neo Grammidin with anesthetic neo · Valenta Pharm JSC https://druglandscape.com/drug/granexin-gel-100-m https://druglandscape.com/api/og?type=drug&title=Granexin%C2%AE%20gel%20100%20%CE%BCM&subtitle=Granexin%C2%AE%20gel%20100%20%CE%BCM%20%C2%B7%20Xequel%20Bio%2C%20Inc.&badge=phase%202 Granexin® gel 100 μM Granexin® gel 100 μM · Xequel Bio, Inc. https://druglandscape.com/drug/granisetron-plus-dexamethasone https://druglandscape.com/api/og?type=drug&title=Granisetron%20plus%20dexamethasone&subtitle=Granisetron%20plus%20dexamethasone%20%C2%B7%20Shanghai%20Children's%20Medical%20Center&badge=phase%201 Granisetron plus dexamethasone Granisetron plus dexamethasone · Shanghai Children's Medical Center https://druglandscape.com/drug/gras-cream https://druglandscape.com/api/og?type=drug&title=GRAS%20cream&subtitle=GRAS%20cream%20%C2%B7%20East%20Suburban%20Ob%20Gyn&badge=phase%201 GRAS cream GRAS cream · East Suburban Ob Gyn https://druglandscape.com/drug/graspa https://druglandscape.com/api/og?type=drug&title=GRASPA&subtitle=GRASPA%20%C2%B7%20ERYtech%20Pharma&badge=phase%202 GRASPA GRASPA · ERYtech Pharma https://druglandscape.com/drug/grazoprevir-oral-granules https://druglandscape.com/api/og?type=drug&title=Grazoprevir%20Oral%20Granules&subtitle=Grazoprevir%20Oral%20Granules%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Grazoprevir Oral Granules Grazoprevir Oral Granules · Merck Sharp & Dohme LLC https://druglandscape.com/drug/grc-27864 https://druglandscape.com/api/og?type=drug&title=GRC%2027864&subtitle=GRC%2027864%20%C2%B7%20Glenmark%20Pharmaceuticals%20Ltd.%20India&badge=phase%201 GRC 27864 GRC 27864 · Glenmark Pharmaceuticals Ltd. India https://druglandscape.com/drug/grc-54276 https://druglandscape.com/api/og?type=drug&title=GRC%2054276&subtitle=GRC%2054276%20%C2%B7%20Glenmark%20Specialty%20S.A.&badge=phase%201 GRC 54276 GRC 54276 · Glenmark Specialty S.A. https://druglandscape.com/drug/grdf-furosemide https://druglandscape.com/api/og?type=drug&title=GRDF%20furosemide&subtitle=GRDF%20furosemide%20%C2%B7%20LTS%20Lohmann%20Therapie-Systeme%20AG&badge=phase%201 GRDF furosemide GRDF furosemide · LTS Lohmann Therapie-Systeme AG https://druglandscape.com/drug/grf6019 https://druglandscape.com/api/og?type=drug&title=GRF6019&subtitle=GRF6019%20%C2%B7%20Alkahest%2C%20Inc.&badge=phase%202 GRF6019 GRF6019 · Alkahest, Inc. https://druglandscape.com/drug/grf6021 https://druglandscape.com/api/og?type=drug&title=GRF6021&subtitle=GRF6021%20%C2%B7%20Alkahest%2C%20Inc.&badge=phase%202 GRF6021 GRF6021 · Alkahest, Inc. https://druglandscape.com/drug/grippol-quadri https://druglandscape.com/api/og?type=drug&title=Grippol%C2%AE%20Quadri&subtitle=Grippol%C2%AE%20Quadri%20%C2%B7%20NPO%20Petrovax&badge=phase%202 Grippol® Quadri Grippol® Quadri · NPO Petrovax https://druglandscape.com/drug/grn-1201 https://druglandscape.com/api/og?type=drug&title=GRN-1201&subtitle=GRN-1201%20%C2%B7%20BrightPath%20Biotherapeutics&badge=phase%201 GRN-1201 GRN-1201 · BrightPath Biotherapeutics https://druglandscape.com/drug/grnvac1 https://druglandscape.com/api/og?type=drug&title=GRNVAC1&subtitle=GRNVAC1%20%C2%B7%20Asterias%20Biotherapeutics%2C%20Inc.&badge=phase%202 GRNVAC1 GRNVAC1 · Asterias Biotherapeutics, Inc. https://druglandscape.com/drug/group-3-0-2-chlorhexidine https://druglandscape.com/api/og?type=drug&title=Group%203%3A%200.2%25%20Chlorhexidine&subtitle=Group%203%3A%200.2%25%20Chlorhexidine%20%C2%B7%20Dr%20Meru%20S&badge=phase%201 Group 3: 0.2% Chlorhexidine Group 3: 0.2% Chlorhexidine · Dr Meru S https://druglandscape.com/drug/group-3-dsl101-high-dose https://druglandscape.com/api/og?type=drug&title=Group%203%3A%20DSL101%20High%20dose&subtitle=Group%203%3A%20DSL101%20High%20dose%20%C2%B7%20DSciLab%20Co.%2C%20Ltd.&badge=phase%201 Group 3: DSL101 High dose Group 3: DSL101 High dose · DSciLab Co., Ltd. https://druglandscape.com/drug/group-r-rasagiline https://druglandscape.com/api/og?type=drug&title=Group%20R%20Rasagiline&subtitle=Group%20R%20Rasagiline%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%202 Group R Rasagiline Group R Rasagiline · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/grt-r902 https://druglandscape.com/api/og?type=drug&title=GRT-R902&subtitle=GRT-R902%20%C2%B7%20Seattle%20Project%20Corporation&badge=phase%202 GRT-R902 GRT-R902 · Seattle Project Corporation https://druglandscape.com/drug/grt-r904 https://druglandscape.com/api/og?type=drug&title=GRT-R904&subtitle=GRT-R904%20%C2%B7%20Gritstone%20bio%2C%20Inc.&badge=phase%201 GRT-R904 GRT-R904 · Gritstone bio, Inc. https://druglandscape.com/drug/grt-r910 https://druglandscape.com/api/og?type=drug&title=GRT-R910&subtitle=GRT-R910%20%C2%B7%20Gritstone%20bio%2C%20Inc.&badge=phase%201 GRT-R910 GRT-R910 · Gritstone bio, Inc. https://druglandscape.com/drug/grt-r912-samrna-spikebeta-tce11 https://druglandscape.com/api/og?type=drug&title=GRT-R912%2C%20samRNA-Spikebeta-TCE11&subtitle=GRT-R912%2C%20samRNA-Spikebeta-TCE11%20%C2%B7%20Gritstone%20bio%2C%20Inc.&badge=phase%201 GRT-R912, samRNA-Spikebeta-TCE11 GRT-R912, samRNA-Spikebeta-TCE11 · Gritstone bio, Inc. https://druglandscape.com/drug/grt-r914-samrna-spikebeta-tce9 https://druglandscape.com/api/og?type=drug&title=GRT-R914%2C%20samRNA-Spikebeta-TCE9&subtitle=GRT-R914%2C%20samRNA-Spikebeta-TCE9%20%C2%B7%20Gritstone%20bio%2C%20Inc.&badge=phase%201 GRT-R914, samRNA-Spikebeta-TCE9 GRT-R914, samRNA-Spikebeta-TCE9 · Gritstone bio, Inc. https://druglandscape.com/drug/grt6019 https://druglandscape.com/api/og?type=drug&title=GRT6019&subtitle=GRT6019%20%C2%B7%20Gr%C3%BCnenthal%20GmbH&badge=phase%201 GRT6019 GRT6019 · Grünenthal GmbH https://druglandscape.com/drug/grt7041-sad https://druglandscape.com/api/og?type=drug&title=GRT7041%20SAD&subtitle=GRT7041%20SAD%20%C2%B7%20Gr%C3%BCnenthal%20GmbH&badge=phase%201 GRT7041 SAD GRT7041 SAD · Grünenthal GmbH https://druglandscape.com/drug/grt9906-pr-tablet https://druglandscape.com/api/og?type=drug&title=GRT9906%20PR%20tablet&subtitle=GRT9906%20PR%20tablet%20%C2%B7%20Gr%C3%BCnenthal%20GmbH&badge=phase%201 GRT9906 PR tablet GRT9906 PR tablet · Grünenthal GmbH https://druglandscape.com/drug/gs1-144 https://druglandscape.com/api/og?type=drug&title=GS1-144&subtitle=GS1-144%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 GS1-144 GS1-144 · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gs3-007-oral-liquid https://druglandscape.com/api/og?type=drug&title=GS3-007%20oral%20liquid&subtitle=GS3-007%20oral%20liquid%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GS3-007 oral liquid GS3-007 oral liquid · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gs3-007a-for-suspension https://druglandscape.com/api/og?type=drug&title=GS3-007a%20for%20Suspension&subtitle=GS3-007a%20for%20Suspension%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 GS3-007a for Suspension GS3-007a for Suspension · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/gsc-loaded-autologous-dendritic-cells https://druglandscape.com/api/og?type=drug&title=GSC-loaded%20autologous%20dendritic%20cells&subtitle=GSC-loaded%20autologous%20dendritic%20cells%20%C2%B7%20Fondazione%20I.R.C.C.S.%20Istituto%20Neurologico%20Carlo%20Besta&badge=phase%201 GSC-loaded autologous dendritic cells GSC-loaded autologous dendritic cells · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta https://druglandscape.com/drug/gsi-953 https://druglandscape.com/api/og?type=drug&title=GSI-953&subtitle=GSI-953%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 GSI-953 GSI-953 · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/gsk-249553-vaccine https://druglandscape.com/api/og?type=drug&title=GSK%20249553%20vaccine&subtitle=GSK%20249553%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK 249553 vaccine GSK 249553 vaccine · GlaxoSmithKline https://druglandscape.com/drug/gsk-257049 https://druglandscape.com/api/og?type=drug&title=GSK%20257049&subtitle=GSK%20257049%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK 257049 GSK 257049 · GlaxoSmithKline https://druglandscape.com/drug/gsk-bio-s-influenza-vaccine-gsk576389a https://druglandscape.com/api/og?type=drug&title=GSK%20Bio's%20Influenza%20Vaccine%20GSK576389A&subtitle=GSK%20Bio's%20Influenza%20Vaccine%20GSK576389A%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK Bio's Influenza Vaccine GSK576389A GSK Bio's Influenza Vaccine GSK576389A · GlaxoSmithKline https://druglandscape.com/drug/gsk-biologicals-719125 https://druglandscape.com/api/og?type=drug&title=GSK%20Biologicals'%20719125&subtitle=GSK%20Biologicals'%20719125%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK Biologicals' 719125 GSK Biologicals' 719125 · GlaxoSmithKline https://druglandscape.com/drug/gsk-biologicals-flulaval https://druglandscape.com/api/og?type=drug&title=GSK%20Biologicals'%20FluLaval%C2%AE&subtitle=GSK%20Biologicals'%20FluLaval%C2%AE%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK Biologicals' FluLaval® GSK Biologicals' FluLaval® · GlaxoSmithKline https://druglandscape.com/drug/gsk-biologicals-gsk2340272a https://druglandscape.com/api/og?type=drug&title=GSK%20Biologicals'%20-%20GSK2340272A&subtitle=GSK%20Biologicals'%20-%20GSK2340272A%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK Biologicals' - GSK2340272A GSK Biologicals' - GSK2340272A · GlaxoSmithKline https://druglandscape.com/drug/gsk-biologicals-influenza-vaccine-gsk1557482a https://druglandscape.com/api/og?type=drug&title=GSK%20Biologicals'%20influenza%20vaccine%20GSK1557482A&subtitle=GSK%20Biologicals'%20influenza%20vaccine%20GSK1557482A%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK Biologicals' influenza vaccine GSK1557482A GSK Biologicals' influenza vaccine GSK1557482A · GlaxoSmithKline https://druglandscape.com/drug/gsk-biologicals-investigational-vaccine-gsk2340273a https://druglandscape.com/api/og?type=drug&title=GSK%20Biologicals'%20investigational%20vaccine%20GSK2340273A&subtitle=GSK%20Biologicals'%20investigational%20vaccine%20GSK2340273A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK Biologicals' investigational vaccine GSK2340273A GSK Biologicals' investigational vaccine GSK2340273A · GlaxoSmithKline https://druglandscape.com/drug/gsk-biologicals-investigational-vaccine-gsk2340274a https://druglandscape.com/api/og?type=drug&title=GSK%20Biologicals'%20investigational%20vaccine%20GSK2340274A&subtitle=GSK%20Biologicals'%20investigational%20vaccine%20GSK2340274A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK Biologicals' investigational vaccine GSK2340274A GSK Biologicals' investigational vaccine GSK2340274A · GlaxoSmithKline https://druglandscape.com/drug/gsk-biologicals-investigational-vaccine-gsk2590066a https://druglandscape.com/api/og?type=drug&title=GSK%20Biologicals'%20investigational%20vaccine%20GSK2590066A&subtitle=GSK%20Biologicals'%20investigational%20vaccine%20GSK2590066A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK Biologicals' investigational vaccine GSK2590066A GSK Biologicals' investigational vaccine GSK2590066A · GlaxoSmithKline https://druglandscape.com/drug/gsk-biologicals-investigational-vaccine-gsk2592984a https://druglandscape.com/api/og?type=drug&title=GSK%20Biologicals'%20investigational%20vaccine%20GSK2592984A&subtitle=GSK%20Biologicals'%20investigational%20vaccine%20GSK2592984A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK Biologicals' investigational vaccine GSK2592984A GSK Biologicals' investigational vaccine GSK2592984A · GlaxoSmithKline https://druglandscape.com/drug/gsk-biologicals-quadrivalent-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=GSK%20Biologicals'%20quadrivalent%20influenza%20vaccine&subtitle=GSK%20Biologicals'%20quadrivalent%20influenza%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK Biologicals' quadrivalent influenza vaccine GSK Biologicals' quadrivalent influenza vaccine · GlaxoSmithKline https://druglandscape.com/drug/gsk-hiv-vaccine-732462 https://druglandscape.com/api/og?type=drug&title=GSK%20HIV%20vaccine%20732462&subtitle=GSK%20HIV%20vaccine%20732462%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK HIV vaccine 732462 GSK HIV vaccine 732462 · GlaxoSmithKline https://druglandscape.com/drug/gsk-s-investigational-vaccine-692342 https://druglandscape.com/api/og?type=drug&title=GSK's%20investigational%20vaccine%20692342&subtitle=GSK's%20investigational%20vaccine%20692342%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK's investigational vaccine 692342 GSK's investigational vaccine 692342 · GlaxoSmithKline https://druglandscape.com/drug/gsk1004723 https://druglandscape.com/api/og?type=drug&title=GSK1004723&subtitle=GSK1004723%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1004723 GSK1004723 · GlaxoSmithKline https://druglandscape.com/drug/gsk1014802 https://druglandscape.com/api/og?type=drug&title=GSK1014802&subtitle=GSK1014802%20%C2%B7%20Biogen&badge=phase%201 GSK1014802 GSK1014802 · Biogen https://druglandscape.com/drug/gsk1018921 https://druglandscape.com/api/og?type=drug&title=GSK1018921&subtitle=GSK1018921%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1018921 GSK1018921 · GlaxoSmithKline https://druglandscape.com/drug/gsk1034702 https://druglandscape.com/api/og?type=drug&title=GSK1034702&subtitle=GSK1034702%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1034702 GSK1034702 · GlaxoSmithKline https://druglandscape.com/drug/gsk1120212-plus-everolimus https://druglandscape.com/api/og?type=drug&title=GSK1120212%20plus%20everolimus&subtitle=GSK1120212%20plus%20everolimus%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1120212 plus everolimus GSK1120212 plus everolimus · GlaxoSmithKline https://druglandscape.com/drug/gsk1120212b https://druglandscape.com/api/og?type=drug&title=GSK1120212B&subtitle=GSK1120212B%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1120212B GSK1120212B · GlaxoSmithKline https://druglandscape.com/drug/gsk1144814 https://druglandscape.com/api/og?type=drug&title=GSK1144814&subtitle=GSK1144814%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1144814 GSK1144814 · GlaxoSmithKline https://druglandscape.com/drug/gsk1160724 https://druglandscape.com/api/og?type=drug&title=GSK1160724&subtitle=GSK1160724%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1160724 GSK1160724 · GlaxoSmithKline https://druglandscape.com/drug/gsk1247446a https://druglandscape.com/api/og?type=drug&title=GSK1247446A&subtitle=GSK1247446A%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK1247446A GSK1247446A · GlaxoSmithKline https://druglandscape.com/drug/gsk1265744 https://druglandscape.com/api/og?type=drug&title=GSK1265744&subtitle=GSK1265744%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1265744 GSK1265744 · GlaxoSmithKline https://druglandscape.com/drug/gsk1265744-free-acid-micronized-capsules https://druglandscape.com/api/og?type=drug&title=GSK1265744%20Free%20Acid%20Micronized%20Capsules&subtitle=GSK1265744%20Free%20Acid%20Micronized%20Capsules%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 GSK1265744 Free Acid Micronized Capsules GSK1265744 Free Acid Micronized Capsules · ViiV Healthcare https://druglandscape.com/drug/gsk1265744-free-acid-nanomilled-capsules https://druglandscape.com/api/og?type=drug&title=GSK1265744%20Free%20Acid%20Nanomilled%20Capsules&subtitle=GSK1265744%20Free%20Acid%20Nanomilled%20Capsules%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 GSK1265744 Free Acid Nanomilled Capsules GSK1265744 Free Acid Nanomilled Capsules · ViiV Healthcare https://druglandscape.com/drug/gsk1265744-na-salt-tablets https://druglandscape.com/api/og?type=drug&title=GSK1265744%20Na%20Salt%20Tablets&subtitle=GSK1265744%20Na%20Salt%20Tablets%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 GSK1265744 Na Salt Tablets GSK1265744 Na Salt Tablets · ViiV Healthcare https://druglandscape.com/drug/gsk1265744-reference-formulation https://druglandscape.com/api/og?type=drug&title=GSK1265744%20Reference%20formulation&subtitle=GSK1265744%20Reference%20formulation%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 GSK1265744 Reference formulation GSK1265744 Reference formulation · ViiV Healthcare https://druglandscape.com/drug/gsk1322888 https://druglandscape.com/api/og?type=drug&title=GSK1322888&subtitle=GSK1322888%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1322888 GSK1322888 · GlaxoSmithKline https://druglandscape.com/drug/gsk1349572-and-maaloxadvanced-maximum-strength https://druglandscape.com/api/og?type=drug&title=GSK1349572%20and%20MaaloxAdvanced%20Maximum%20Strength&subtitle=GSK1349572%20and%20MaaloxAdvanced%20Maximum%20Strength%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1349572 and MaaloxAdvanced Maximum Strength GSK1349572 and MaaloxAdvanced Maximum Strength · GlaxoSmithKline https://druglandscape.com/drug/gsk1349572-and-one-a-day https://druglandscape.com/api/og?type=drug&title=GSK1349572%20and%20One%20A%20Day&subtitle=GSK1349572%20and%20One%20A%20Day%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1349572 and One A Day GSK1349572 and One A Day · GlaxoSmithKline https://druglandscape.com/drug/gsk1349572-and-tenofovir https://druglandscape.com/api/og?type=drug&title=GSK1349572%20and%20tenofovir&subtitle=GSK1349572%20and%20tenofovir%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1349572 and tenofovir GSK1349572 and tenofovir · GlaxoSmithKline https://druglandscape.com/drug/gsk1349572-formulation-aw https://druglandscape.com/api/og?type=drug&title=GSK1349572%20formulation%20AW&subtitle=GSK1349572%20formulation%20AW%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 GSK1349572 formulation AW GSK1349572 formulation AW · ViiV Healthcare https://druglandscape.com/drug/gsk1349572-formulation-ax https://druglandscape.com/api/og?type=drug&title=GSK1349572%20formulation%20AX&subtitle=GSK1349572%20formulation%20AX%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 GSK1349572 formulation AX GSK1349572 formulation AX · ViiV Healthcare https://druglandscape.com/drug/gsk1363089 https://druglandscape.com/api/og?type=drug&title=GSK1363089&subtitle=GSK1363089%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1363089 GSK1363089 · GlaxoSmithKline https://druglandscape.com/drug/gsk149203a https://druglandscape.com/api/og?type=drug&title=GSK149203A&subtitle=GSK149203A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK149203A GSK149203A · GlaxoSmithKline https://druglandscape.com/drug/gsk1550188-iv https://druglandscape.com/api/og?type=drug&title=GSK1550188%20IV&subtitle=GSK1550188%20IV%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1550188 IV GSK1550188 IV · GlaxoSmithKline https://druglandscape.com/drug/gsk1550188-sc https://druglandscape.com/api/og?type=drug&title=GSK1550188%20SC&subtitle=GSK1550188%20SC%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1550188 SC GSK1550188 SC · GlaxoSmithKline https://druglandscape.com/drug/gsk159797 https://druglandscape.com/api/og?type=drug&title=GSK159797&subtitle=GSK159797%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK159797 GSK159797 · GlaxoSmithKline https://druglandscape.com/drug/gsk1605786-chemocentryx-formulation-a https://druglandscape.com/api/og?type=drug&title=GSK1605786%20ChemoCentryx%3A%20formulation%20A&subtitle=GSK1605786%20ChemoCentryx%3A%20formulation%20A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1605786 ChemoCentryx: formulation A GSK1605786 ChemoCentryx: formulation A · GlaxoSmithKline https://druglandscape.com/drug/gsk1605786-gsk-direct-fill-formulation-c https://druglandscape.com/api/og?type=drug&title=GSK1605786%20GSK%20direct-fill%3A%20formulation%20C&subtitle=GSK1605786%20GSK%20direct-fill%3A%20formulation%20C%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1605786 GSK direct-fill: formulation C GSK1605786 GSK direct-fill: formulation C · GlaxoSmithKline https://druglandscape.com/drug/gsk1605786-gsk-formulation-b https://druglandscape.com/api/og?type=drug&title=GSK1605786%20GSK%3A%20formulation%20B&subtitle=GSK1605786%20GSK%3A%20formulation%20B%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1605786 GSK: formulation B GSK1605786 GSK: formulation B · GlaxoSmithKline https://druglandscape.com/drug/gsk1614235 https://druglandscape.com/api/og?type=drug&title=GSK1614235&subtitle=GSK1614235%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1614235 GSK1614235 · GlaxoSmithKline https://druglandscape.com/drug/gsk163090-capsule-fasted https://druglandscape.com/api/og?type=drug&title=GSK163090%20capsule%2C%20fasted&subtitle=GSK163090%20capsule%2C%20fasted%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK163090 capsule, fasted GSK163090 capsule, fasted · GlaxoSmithKline https://druglandscape.com/drug/gsk163090-tablet-fed https://druglandscape.com/api/og?type=drug&title=GSK163090%20Tablet%2C%20fed&subtitle=GSK163090%20Tablet%2C%20fed%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK163090 Tablet, fed GSK163090 Tablet, fed · GlaxoSmithKline https://druglandscape.com/drug/gsk1795091 https://druglandscape.com/api/og?type=drug&title=GSK1795091&subtitle=GSK1795091%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1795091 GSK1795091 · GlaxoSmithKline https://druglandscape.com/drug/gsk1827771 https://druglandscape.com/api/og?type=drug&title=GSK1827771&subtitle=GSK1827771%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1827771 GSK1827771 · GlaxoSmithKline https://druglandscape.com/drug/gsk1838262 https://druglandscape.com/api/og?type=drug&title=GSK1838262&subtitle=GSK1838262%20%C2%B7%20XenoPort%2C%20Inc.&badge=phase%202 GSK1838262 GSK1838262 · XenoPort, Inc. https://druglandscape.com/drug/gsk189075a https://druglandscape.com/api/og?type=drug&title=GSK189075A&subtitle=GSK189075A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK189075A GSK189075A · GlaxoSmithKline https://druglandscape.com/drug/gsk1995057-single-dose https://druglandscape.com/api/og?type=drug&title=GSK1995057%20single%20dose&subtitle=GSK1995057%20single%20dose%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK1995057 single dose GSK1995057 single dose · GlaxoSmithKline https://druglandscape.com/drug/gsk2018682 https://druglandscape.com/api/og?type=drug&title=GSK2018682&subtitle=GSK2018682%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2018682 GSK2018682 · GlaxoSmithKline https://druglandscape.com/drug/gsk2036874a-vaccine https://druglandscape.com/api/og?type=drug&title=GSK2036874A%20vaccine&subtitle=GSK2036874A%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK2036874A vaccine GSK2036874A vaccine · GlaxoSmithKline https://druglandscape.com/drug/gsk206136 https://druglandscape.com/api/og?type=drug&title=GSK206136&subtitle=GSK206136%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK206136 GSK206136 · GlaxoSmithKline https://druglandscape.com/drug/gsk2110183-gelatin-capsule https://druglandscape.com/api/og?type=drug&title=GSK2110183%20Gelatin%20Capsule&subtitle=GSK2110183%20Gelatin%20Capsule%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2110183 Gelatin Capsule GSK2110183 Gelatin Capsule · GlaxoSmithKline https://druglandscape.com/drug/gsk2110183-ir-tablet https://druglandscape.com/api/og?type=drug&title=GSK2110183%20IR%20Tablet&subtitle=GSK2110183%20IR%20Tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2110183 IR Tablet GSK2110183 IR Tablet · GlaxoSmithKline https://druglandscape.com/drug/gsk21110183 https://druglandscape.com/api/og?type=drug&title=GSK21110183&subtitle=GSK21110183%20%C2%B7%20Accenture&badge=phase%201 GSK21110183 GSK21110183 · Accenture https://druglandscape.com/drug/gsk2140944-capsules https://druglandscape.com/api/og?type=drug&title=GSK2140944%20Capsules&subtitle=GSK2140944%20Capsules%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK2140944 Capsules GSK2140944 Capsules · GlaxoSmithKline https://druglandscape.com/drug/gsk2190915 https://druglandscape.com/api/og?type=drug&title=GSK2190915&subtitle=GSK2190915%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK2190915 GSK2190915 · GlaxoSmithKline https://druglandscape.com/drug/gsk2190915-micronised-tablet https://druglandscape.com/api/og?type=drug&title=GSK2190915%20Micronised%20Tablet&subtitle=GSK2190915%20Micronised%20Tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2190915 Micronised Tablet GSK2190915 Micronised Tablet · GlaxoSmithKline https://druglandscape.com/drug/gsk2190915-milled-tablet https://druglandscape.com/api/og?type=drug&title=GSK2190915%20Milled%20Tablet&subtitle=GSK2190915%20Milled%20Tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2190915 Milled Tablet GSK2190915 Milled Tablet · GlaxoSmithKline https://druglandscape.com/drug/gsk2190915-solution https://druglandscape.com/api/og?type=drug&title=GSK2190915%20Solution.&subtitle=GSK2190915%20Solution.%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2190915 Solution. GSK2190915 Solution. · GlaxoSmithKline https://druglandscape.com/drug/gsk2212836 https://druglandscape.com/api/og?type=drug&title=GSK2212836&subtitle=GSK2212836%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2212836 GSK2212836 · GlaxoSmithKline https://druglandscape.com/drug/gsk2230672 https://druglandscape.com/api/og?type=drug&title=GSK2230672&subtitle=GSK2230672%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2230672 GSK2230672 · GlaxoSmithKline https://druglandscape.com/drug/gsk2239633 https://druglandscape.com/api/og?type=drug&title=GSK2239633&subtitle=GSK2239633%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2239633 GSK2239633 · GlaxoSmithKline https://druglandscape.com/drug/gsk2248761-formulation-2-or-4 https://druglandscape.com/api/og?type=drug&title=GSK2248761%20formulation%202%20or%204&subtitle=GSK2248761%20formulation%202%20or%204%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 GSK2248761 formulation 2 or 4 GSK2248761 formulation 2 or 4 · ViiV Healthcare https://druglandscape.com/drug/gsk2248761-reference-formulation https://druglandscape.com/api/og?type=drug&title=GSK2248761%20reference%20formulation&subtitle=GSK2248761%20reference%20formulation%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 GSK2248761 reference formulation GSK2248761 reference formulation · ViiV Healthcare https://druglandscape.com/drug/gsk2248761-wbm-capsule https://druglandscape.com/api/og?type=drug&title=GSK2248761%20WBM%20Capsule&subtitle=GSK2248761%20WBM%20Capsule%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 GSK2248761 WBM Capsule GSK2248761 WBM Capsule · ViiV Healthcare https://druglandscape.com/drug/gsk2269557-500-g https://druglandscape.com/api/og?type=drug&title=GSK2269557%20500%20%C2%B5g&subtitle=GSK2269557%20500%20%C2%B5g%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2269557 500 µg GSK2269557 500 µg · GlaxoSmithKline https://druglandscape.com/drug/gsk2269557-750-g https://druglandscape.com/api/og?type=drug&title=GSK2269557%20750%20%C2%B5g&subtitle=GSK2269557%20750%20%C2%B5g%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2269557 750 µg GSK2269557 750 µg · GlaxoSmithKline https://druglandscape.com/drug/gsk2269557-dpi https://druglandscape.com/api/og?type=drug&title=GSK2269557%20DPI&subtitle=GSK2269557%20DPI%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK2269557 DPI GSK2269557 DPI · GlaxoSmithKline https://druglandscape.com/drug/gsk2269557-ellipta-dpi https://druglandscape.com/api/og?type=drug&title=GSK2269557%20ELLIPTA%20DPI&subtitle=GSK2269557%20ELLIPTA%20DPI%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2269557 ELLIPTA DPI GSK2269557 ELLIPTA DPI · GlaxoSmithKline https://druglandscape.com/drug/gsk2269557-via-dpi https://druglandscape.com/api/og?type=drug&title=GSK2269557%20via%20DPI&subtitle=GSK2269557%20via%20DPI%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2269557 via DPI GSK2269557 via DPI · GlaxoSmithKline https://druglandscape.com/drug/gsk2315698 https://druglandscape.com/api/og?type=drug&title=GSK2315698&subtitle=GSK2315698%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2315698 GSK2315698 · GlaxoSmithKline https://druglandscape.com/drug/gsk2336805 https://druglandscape.com/api/og?type=drug&title=GSK2336805&subtitle=GSK2336805%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK2336805 GSK2336805 · GlaxoSmithKline https://druglandscape.com/drug/gsk233705-and-gw642444 https://druglandscape.com/api/og?type=drug&title=GSK233705%20and%20GW642444&subtitle=GSK233705%20and%20GW642444%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK233705 and GW642444 GSK233705 and GW642444 · GlaxoSmithKline https://druglandscape.com/drug/gsk2376497 https://druglandscape.com/api/og?type=drug&title=GSK2376497&subtitle=GSK2376497%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2376497 GSK2376497 · GlaxoSmithKline https://druglandscape.com/drug/gsk2398852 https://druglandscape.com/api/og?type=drug&title=GSK2398852&subtitle=GSK2398852%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2398852 GSK2398852 · GlaxoSmithKline https://druglandscape.com/drug/gsk249320a https://druglandscape.com/api/og?type=drug&title=GSK249320A&subtitle=GSK249320A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK249320A GSK249320A · GlaxoSmithKline https://druglandscape.com/drug/gsk256073 https://druglandscape.com/api/og?type=drug&title=GSK256073&subtitle=GSK256073%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK256073 GSK256073 · GlaxoSmithKline https://druglandscape.com/drug/gsk256073a-tablets https://druglandscape.com/api/og?type=drug&title=GSK256073A%20tablets&subtitle=GSK256073A%20tablets%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK256073A tablets GSK256073A tablets · GlaxoSmithKline https://druglandscape.com/drug/gsk257049-dosage-1 https://druglandscape.com/api/og?type=drug&title=GSK257049%20Dosage%201&subtitle=GSK257049%20Dosage%201%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK257049 Dosage 1 GSK257049 Dosage 1 · GlaxoSmithKline https://druglandscape.com/drug/gsk2585823 https://druglandscape.com/api/og?type=drug&title=GSK2585823&subtitle=GSK2585823%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2585823 GSK2585823 · GlaxoSmithKline https://druglandscape.com/drug/gsk2586184-new-formulation https://druglandscape.com/api/og?type=drug&title=GSK2586184%20new%20formulation&subtitle=GSK2586184%20new%20formulation%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2586184 new formulation GSK2586184 new formulation · GlaxoSmithKline https://druglandscape.com/drug/gsk2636771 https://druglandscape.com/api/og?type=drug&title=GSK2636771&subtitle=GSK2636771%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2636771 GSK2636771 · GlaxoSmithKline https://druglandscape.com/drug/gsk2646264-1-topical-cream https://druglandscape.com/api/og?type=drug&title=GSK2646264%201%25%20topical%20cream&subtitle=GSK2646264%201%25%20topical%20cream%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2646264 1% topical cream GSK2646264 1% topical cream · GlaxoSmithKline https://druglandscape.com/drug/gsk2831781 https://druglandscape.com/api/og?type=drug&title=GSK2831781&subtitle=GSK2831781%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2831781 GSK2831781 · GlaxoSmithKline https://druglandscape.com/drug/gsk2838232-ir1 https://druglandscape.com/api/og?type=drug&title=GSK2838232%20IR1&subtitle=GSK2838232%20IR1%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2838232 IR1 GSK2838232 IR1 · GlaxoSmithKline https://druglandscape.com/drug/gsk2838232-ir2 https://druglandscape.com/api/og?type=drug&title=GSK2838232%20IR2&subtitle=GSK2838232%20IR2%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2838232 IR2 GSK2838232 IR2 · GlaxoSmithKline https://druglandscape.com/drug/gsk2838232-pib https://druglandscape.com/api/og?type=drug&title=GSK2838232%20PIB&subtitle=GSK2838232%20PIB%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2838232 PIB GSK2838232 PIB · GlaxoSmithKline https://druglandscape.com/drug/gsk2838510 https://druglandscape.com/api/og?type=drug&title=GSK2838510&subtitle=GSK2838510%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2838510 GSK2838510 · GlaxoSmithKline https://druglandscape.com/drug/gsk2857916 https://druglandscape.com/api/og?type=drug&title=GSK2857916&subtitle=GSK2857916%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2857916 GSK2857916 · GlaxoSmithKline https://druglandscape.com/drug/gsk2878175 https://druglandscape.com/api/og?type=drug&title=GSK2878175&subtitle=GSK2878175%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2878175 GSK2878175 · GlaxoSmithKline https://druglandscape.com/drug/gsk2894512-topical-cream https://druglandscape.com/api/og?type=drug&title=GSK2894512%20Topical%20Cream&subtitle=GSK2894512%20Topical%20Cream%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2894512 Topical Cream GSK2894512 Topical Cream · GlaxoSmithKline https://druglandscape.com/drug/gsk2944404-fdc https://druglandscape.com/api/og?type=drug&title=GSK2944404%20FDC&subtitle=GSK2944404%20FDC%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2944404 FDC GSK2944404 FDC · GlaxoSmithKline https://druglandscape.com/drug/gsk2981278-0-03 https://druglandscape.com/api/og?type=drug&title=GSK2981278%200.03%25&subtitle=GSK2981278%200.03%25%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2981278 0.03% GSK2981278 0.03% · GlaxoSmithKline https://druglandscape.com/drug/gsk2981278-0-1 https://druglandscape.com/api/og?type=drug&title=GSK2981278%200.1%25&subtitle=GSK2981278%200.1%25%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2981278 0.1% GSK2981278 0.1% · GlaxoSmithKline https://druglandscape.com/drug/gsk2981278-ointment https://druglandscape.com/api/og?type=drug&title=GSK2981278%20ointment&subtitle=GSK2981278%20ointment%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2981278 ointment GSK2981278 ointment · GlaxoSmithKline https://druglandscape.com/drug/gsk2981710 https://druglandscape.com/api/og?type=drug&title=GSK2981710&subtitle=GSK2981710%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2981710 GSK2981710 · GlaxoSmithKline https://druglandscape.com/drug/gsk2982772-modified-release https://druglandscape.com/api/og?type=drug&title=GSK2982772%20Modified%20Release&subtitle=GSK2982772%20Modified%20Release%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK2982772 Modified Release GSK2982772 Modified Release · GlaxoSmithKline https://druglandscape.com/drug/gsk3008356 https://druglandscape.com/api/og?type=drug&title=GSK3008356&subtitle=GSK3008356%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3008356 GSK3008356 · GlaxoSmithKline https://druglandscape.com/drug/gsk3052230 https://druglandscape.com/api/og?type=drug&title=GSK3052230&subtitle=GSK3052230%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3052230 GSK3052230 · GlaxoSmithKline https://druglandscape.com/drug/gsk3074477-fdc-1 https://druglandscape.com/api/og?type=drug&title=GSK3074477%20FDC%20-%201&subtitle=GSK3074477%20FDC%20-%201%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3074477 FDC - 1 GSK3074477 FDC - 1 · GlaxoSmithKline https://druglandscape.com/drug/gsk3074477-fdc-2 https://druglandscape.com/api/og?type=drug&title=GSK3074477%20FDC%20-%202&subtitle=GSK3074477%20FDC%20-%202%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3074477 FDC - 2 GSK3074477 FDC - 2 · GlaxoSmithKline https://druglandscape.com/drug/gsk3152314a https://druglandscape.com/api/og?type=drug&title=GSK3152314A&subtitle=GSK3152314A%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK3152314A GSK3152314A · GlaxoSmithKline https://druglandscape.com/drug/gsk3179106 https://druglandscape.com/api/og?type=drug&title=GSK3179106&subtitle=GSK3179106%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3179106 GSK3179106 · GlaxoSmithKline https://druglandscape.com/drug/gsk3196165 https://druglandscape.com/api/og?type=drug&title=GSK3196165&subtitle=GSK3196165%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK3196165 GSK3196165 · GlaxoSmithKline https://druglandscape.com/drug/gsk3228836 https://druglandscape.com/api/og?type=drug&title=GSK3228836&subtitle=GSK3228836%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK3228836 GSK3228836 · GlaxoSmithKline https://druglandscape.com/drug/gsk3359609 https://druglandscape.com/api/og?type=drug&title=GSK3359609&subtitle=GSK3359609%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3359609 GSK3359609 · GlaxoSmithKline https://druglandscape.com/drug/gsk3389245a-hd-group https://druglandscape.com/api/og?type=drug&title=GSK3389245A_HD%20GROUP&subtitle=GSK3389245A_HD%20GROUP%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3389245A_HD GROUP GSK3389245A_HD GROUP · GlaxoSmithKline https://druglandscape.com/drug/gsk3389245a-ld-group https://druglandscape.com/api/og?type=drug&title=GSK3389245A_LD%20GROUP&subtitle=GSK3389245A_LD%20GROUP%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3389245A_LD GROUP GSK3389245A_LD GROUP · GlaxoSmithKline https://druglandscape.com/drug/gsk3439171a https://druglandscape.com/api/og?type=drug&title=GSK3439171A&subtitle=GSK3439171A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3439171A GSK3439171A · GlaxoSmithKline https://druglandscape.com/drug/gsk3494245 https://druglandscape.com/api/og?type=drug&title=GSK3494245&subtitle=GSK3494245%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3494245 GSK3494245 · GlaxoSmithKline https://druglandscape.com/drug/gsk3640254-bis-hydrochloride-salt-capsule https://druglandscape.com/api/og?type=drug&title=GSK3640254%20bis-hydrochloride%20salt%20capsule&subtitle=GSK3640254%20bis-hydrochloride%20salt%20capsule%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 GSK3640254 bis-hydrochloride salt capsule GSK3640254 bis-hydrochloride salt capsule · ViiV Healthcare https://druglandscape.com/drug/gsk3640254-mesylate-salt-capsule https://druglandscape.com/api/og?type=drug&title=GSK3640254%20Mesylate%20Salt%20Capsule&subtitle=GSK3640254%20Mesylate%20Salt%20Capsule%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 GSK3640254 Mesylate Salt Capsule GSK3640254 Mesylate Salt Capsule · ViiV Healthcare https://druglandscape.com/drug/gsk364735-oral-solution-and-oral-tablets https://druglandscape.com/api/og?type=drug&title=GSK364735%20oral%20solution%20and%20oral%20tablets&subtitle=GSK364735%20oral%20solution%20and%20oral%20tablets%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK364735 oral solution and oral tablets GSK364735 oral solution and oral tablets · GlaxoSmithKline https://druglandscape.com/drug/gsk369796 https://druglandscape.com/api/og?type=drug&title=GSK369796&subtitle=GSK369796%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK369796 GSK369796 · GlaxoSmithKline https://druglandscape.com/drug/gsk372475 https://druglandscape.com/api/og?type=drug&title=GSK372475&subtitle=GSK372475%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK372475 GSK372475 · GlaxoSmithKline https://druglandscape.com/drug/gsk3745417 https://druglandscape.com/api/og?type=drug&title=GSK3745417&subtitle=GSK3745417%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3745417 GSK3745417 · GlaxoSmithKline https://druglandscape.com/drug/gsk376501 https://druglandscape.com/api/og?type=drug&title=GSK376501&subtitle=GSK376501%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK376501 GSK376501 · GlaxoSmithKline https://druglandscape.com/drug/gsk3810109a https://druglandscape.com/api/og?type=drug&title=GSK3810109A&subtitle=GSK3810109A%20%C2%B7%20ViiV%20Healthcare&badge=phase%202 GSK3810109A GSK3810109A · ViiV Healthcare https://druglandscape.com/drug/gsk3858279-iv https://druglandscape.com/api/og?type=drug&title=GSK3858279%20IV&subtitle=GSK3858279%20IV%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3858279 IV GSK3858279 IV · GlaxoSmithKline https://druglandscape.com/drug/gsk3858279-sc https://druglandscape.com/api/og?type=drug&title=GSK3858279%20SC&subtitle=GSK3858279%20SC%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3858279 SC GSK3858279 SC · GlaxoSmithKline https://druglandscape.com/drug/gsk3882347 https://druglandscape.com/api/og?type=drug&title=GSK3882347&subtitle=GSK3882347%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3882347 GSK3882347 · GlaxoSmithKline https://druglandscape.com/drug/gsk3888130b https://druglandscape.com/api/og?type=drug&title=GSK3888130B&subtitle=GSK3888130B%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3888130B GSK3888130B · GlaxoSmithKline https://druglandscape.com/drug/gsk3923868 https://druglandscape.com/api/og?type=drug&title=GSK3923868&subtitle=GSK3923868%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK3923868 GSK3923868 · GlaxoSmithKline https://druglandscape.com/drug/gsk4024484c https://druglandscape.com/api/og?type=drug&title=GSK4024484C&subtitle=GSK4024484C%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4024484C GSK4024484C · GlaxoSmithKline https://druglandscape.com/drug/gsk4382276a-dose-level-1 https://druglandscape.com/api/og?type=drug&title=GSK4382276A%20Dose%20level%201&subtitle=GSK4382276A%20Dose%20level%201%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4382276A Dose level 1 GSK4382276A Dose level 1 · GlaxoSmithKline https://druglandscape.com/drug/gsk4382276a-dose-level-10 https://druglandscape.com/api/og?type=drug&title=GSK4382276A%20Dose%20level%2010&subtitle=GSK4382276A%20Dose%20level%2010%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4382276A Dose level 10 GSK4382276A Dose level 10 · GlaxoSmithKline https://druglandscape.com/drug/gsk4382276a-dose-level-2 https://druglandscape.com/api/og?type=drug&title=GSK4382276A%20Dose%20level%202&subtitle=GSK4382276A%20Dose%20level%202%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4382276A Dose level 2 GSK4382276A Dose level 2 · GlaxoSmithKline https://druglandscape.com/drug/gsk4382276a-dose-level-3 https://druglandscape.com/api/og?type=drug&title=GSK4382276A%20Dose%20level%203&subtitle=GSK4382276A%20Dose%20level%203%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4382276A Dose level 3 GSK4382276A Dose level 3 · GlaxoSmithKline https://druglandscape.com/drug/gsk4382276a-dose-level-4 https://druglandscape.com/api/og?type=drug&title=GSK4382276A%20Dose%20level%204&subtitle=GSK4382276A%20Dose%20level%204%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4382276A Dose level 4 GSK4382276A Dose level 4 · GlaxoSmithKline https://druglandscape.com/drug/gsk4382276a-dose-level-5 https://druglandscape.com/api/og?type=drug&title=GSK4382276A%20Dose%20level%205&subtitle=GSK4382276A%20Dose%20level%205%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4382276A Dose level 5 GSK4382276A Dose level 5 · GlaxoSmithKline https://druglandscape.com/drug/gsk4382276a-dose-level-6 https://druglandscape.com/api/og?type=drug&title=GSK4382276A%20Dose%20level%206&subtitle=GSK4382276A%20Dose%20level%206%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4382276A Dose level 6 GSK4382276A Dose level 6 · GlaxoSmithKline https://druglandscape.com/drug/gsk4382276a-dose-level-7 https://druglandscape.com/api/og?type=drug&title=GSK4382276A%20Dose%20level%207&subtitle=GSK4382276A%20Dose%20level%207%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4382276A Dose level 7 GSK4382276A Dose level 7 · GlaxoSmithKline https://druglandscape.com/drug/gsk4382276a-dose-level-8 https://druglandscape.com/api/og?type=drug&title=GSK4382276A%20Dose%20level%208&subtitle=GSK4382276A%20Dose%20level%208%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4382276A Dose level 8 GSK4382276A Dose level 8 · GlaxoSmithKline https://druglandscape.com/drug/gsk4382276a-dose-level-9 https://druglandscape.com/api/og?type=drug&title=GSK4382276A%20Dose%20level%209&subtitle=GSK4382276A%20Dose%20level%209%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4382276A Dose level 9 GSK4382276A Dose level 9 · GlaxoSmithKline https://druglandscape.com/drug/gsk4524101 https://druglandscape.com/api/og?type=drug&title=GSK4524101&subtitle=GSK4524101%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4524101 GSK4524101 · GlaxoSmithKline https://druglandscape.com/drug/gsk4527226 https://druglandscape.com/api/og?type=drug&title=GSK4527226&subtitle=GSK4527226%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK4527226 GSK4527226 · GlaxoSmithKline https://druglandscape.com/drug/gsk4527363 https://druglandscape.com/api/og?type=drug&title=GSK4527363&subtitle=GSK4527363%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4527363 GSK4527363 · GlaxoSmithKline https://druglandscape.com/drug/gsk4528287 https://druglandscape.com/api/og?type=drug&title=GSK4528287&subtitle=GSK4528287%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4528287 GSK4528287 · GlaxoSmithKline https://druglandscape.com/drug/gsk461364 https://druglandscape.com/api/og?type=drug&title=GSK461364&subtitle=GSK461364%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK461364 GSK461364 · GlaxoSmithKline https://druglandscape.com/drug/gsk4771261 https://druglandscape.com/api/og?type=drug&title=GSK4771261&subtitle=GSK4771261%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK4771261 GSK4771261 · GlaxoSmithKline https://druglandscape.com/drug/gsk5458514 https://druglandscape.com/api/og?type=drug&title=GSK5458514&subtitle=GSK5458514%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK5458514 GSK5458514 · GlaxoSmithKline https://druglandscape.com/drug/gsk5460025 https://druglandscape.com/api/og?type=drug&title=GSK5460025&subtitle=GSK5460025%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK5460025 GSK5460025 · GlaxoSmithKline https://druglandscape.com/drug/gsk5464714-camlipixant https://druglandscape.com/api/og?type=drug&title=GSK5464714-%20Camlipixant&subtitle=GSK5464714-%20Camlipixant%20%C2%B7%20Bellus%20Health%20Inc.%20-%20a%20GSK%20company&badge=phase%201 GSK5464714- Camlipixant GSK5464714- Camlipixant · Bellus Health Inc. - a GSK company https://druglandscape.com/drug/gsk5471713 https://druglandscape.com/api/og?type=drug&title=GSK5471713&subtitle=GSK5471713%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK5471713 GSK5471713 · GlaxoSmithKline https://druglandscape.com/drug/gsk557296 https://druglandscape.com/api/og?type=drug&title=GSK557296&subtitle=GSK557296%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK557296 GSK557296 · GlaxoSmithKline https://druglandscape.com/drug/gsk561679-tablet-or-solution https://druglandscape.com/api/og?type=drug&title=GSK561679%20tablet%20or%20solution&subtitle=GSK561679%20tablet%20or%20solution%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK561679 tablet or solution GSK561679 tablet or solution · GlaxoSmithKline https://druglandscape.com/drug/gsk573179 https://druglandscape.com/api/og?type=drug&title=GSK573179&subtitle=GSK573179%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK573179 GSK573179 · GlaxoSmithKline https://druglandscape.com/drug/gsk5784283 https://druglandscape.com/api/og?type=drug&title=GSK5784283&subtitle=GSK5784283%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK5784283 GSK5784283 · GlaxoSmithKline https://druglandscape.com/drug/gsk5800544a https://druglandscape.com/api/og?type=drug&title=GSK5800544A&subtitle=GSK5800544A%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK5800544A GSK5800544A · GlaxoSmithKline https://druglandscape.com/drug/gsk580416 https://druglandscape.com/api/og?type=drug&title=GSK580416&subtitle=GSK580416%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK580416 GSK580416 · GlaxoSmithKline https://druglandscape.com/drug/gsk586529-capsules https://druglandscape.com/api/og?type=drug&title=GSK586529%20capsules&subtitle=GSK586529%20capsules%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK586529 capsules GSK586529 capsules · GlaxoSmithKline https://druglandscape.com/drug/gsk586529-tablets https://druglandscape.com/api/og?type=drug&title=GSK586529%20tablets&subtitle=GSK586529%20tablets%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK586529 tablets GSK586529 tablets · GlaxoSmithKline https://druglandscape.com/drug/gsk587323 https://druglandscape.com/api/og?type=drug&title=GSK587323&subtitle=GSK587323%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK587323 GSK587323 · GlaxoSmithKline https://druglandscape.com/drug/gsk5926371 https://druglandscape.com/api/og?type=drug&title=GSK5926371&subtitle=GSK5926371%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK5926371 GSK5926371 · GlaxoSmithKline https://druglandscape.com/drug/gsk598809-capsules https://druglandscape.com/api/og?type=drug&title=GSK598809%20Capsules&subtitle=GSK598809%20Capsules%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK598809 Capsules GSK598809 Capsules · GlaxoSmithKline https://druglandscape.com/drug/gsk598809-new-formulation https://druglandscape.com/api/og?type=drug&title=GSK598809%20new%20formulation&subtitle=GSK598809%20new%20formulation%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK598809 new formulation GSK598809 new formulation · GlaxoSmithKline https://druglandscape.com/drug/gsk598809-old-formulation https://druglandscape.com/api/og?type=drug&title=GSK598809%20old%20formulation&subtitle=GSK598809%20old%20formulation%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK598809 old formulation GSK598809 old formulation · GlaxoSmithKline https://druglandscape.com/drug/gsk6097608 https://druglandscape.com/api/og?type=drug&title=GSK6097608&subtitle=GSK6097608%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK6097608 GSK6097608 · GlaxoSmithKline https://druglandscape.com/drug/gsk610677 https://druglandscape.com/api/og?type=drug&title=GSK610677&subtitle=GSK610677%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK610677 GSK610677 · GlaxoSmithKline https://druglandscape.com/drug/gsk615915a https://druglandscape.com/api/og?type=drug&title=GSK615915A&subtitle=GSK615915A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK615915A GSK615915A · GlaxoSmithKline https://druglandscape.com/drug/gsk618334 https://druglandscape.com/api/og?type=drug&title=GSK618334&subtitle=GSK618334%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK618334 GSK618334 · GlaxoSmithKline https://druglandscape.com/drug/gsk618334-high-dose https://druglandscape.com/api/og?type=drug&title=GSK618334%20High%20Dose&subtitle=GSK618334%20High%20Dose%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK618334 High Dose GSK618334 High Dose · GlaxoSmithKline https://druglandscape.com/drug/gsk618334-low-dose https://druglandscape.com/api/og?type=drug&title=GSK618334%20Low%20Dose&subtitle=GSK618334%20Low%20Dose%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK618334 Low Dose GSK618334 Low Dose · GlaxoSmithKline https://druglandscape.com/drug/gsk618334-medium-dose https://druglandscape.com/api/og?type=drug&title=GSK618334%20Medium%20Dose&subtitle=GSK618334%20Medium%20Dose%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK618334 Medium Dose GSK618334 Medium Dose · GlaxoSmithKline https://druglandscape.com/drug/gsk618334-pet-subjects https://druglandscape.com/api/og?type=drug&title=GSK618334%20PET%20subjects&subtitle=GSK618334%20PET%20subjects%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK618334 PET subjects GSK618334 PET subjects · GlaxoSmithKline https://druglandscape.com/drug/gsk704838 https://druglandscape.com/api/og?type=drug&title=GSK704838&subtitle=GSK704838%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK704838 GSK704838 · GlaxoSmithKline https://druglandscape.com/drug/gsk706769-kaletra https://druglandscape.com/api/og?type=drug&title=GSK706769%20%26%20KALETRA&subtitle=GSK706769%20%26%20KALETRA%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK706769 & KALETRA GSK706769 & KALETRA · GlaxoSmithKline https://druglandscape.com/drug/gsk716155-subcutaneous-injections https://druglandscape.com/api/og?type=drug&title=GSK716155%20subcutaneous%20injections&subtitle=GSK716155%20subcutaneous%20injections%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK716155 subcutaneous injections GSK716155 subcutaneous injections · GlaxoSmithKline https://druglandscape.com/drug/gsk729327 https://druglandscape.com/api/og?type=drug&title=GSK729327&subtitle=GSK729327%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK729327 GSK729327 · GlaxoSmithKline https://druglandscape.com/drug/gsk835726 https://druglandscape.com/api/og?type=drug&title=GSK835726&subtitle=GSK835726%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK835726 GSK835726 · GlaxoSmithKline https://druglandscape.com/drug/gsk923295 https://druglandscape.com/api/og?type=drug&title=GSK923295&subtitle=GSK923295%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK923295 GSK923295 · GlaxoSmithKline https://druglandscape.com/drug/gsk933776-for-im-administration https://druglandscape.com/api/og?type=drug&title=GSK933776%20for%20IM%20administration&subtitle=GSK933776%20for%20IM%20administration%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK933776 for IM administration GSK933776 for IM administration · GlaxoSmithKline https://druglandscape.com/drug/gsk933776-for-iv-administration https://druglandscape.com/api/og?type=drug&title=GSK933776%20for%20IV%20administration&subtitle=GSK933776%20for%20IV%20administration%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK933776 for IV administration GSK933776 for IV administration · GlaxoSmithKline https://druglandscape.com/drug/gsk933776-for-sq-administration https://druglandscape.com/api/og?type=drug&title=GSK933776%20for%20SQ%20administration&subtitle=GSK933776%20for%20SQ%20administration%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK933776 for SQ administration GSK933776 for SQ administration · GlaxoSmithKline https://druglandscape.com/drug/gsk958108 https://druglandscape.com/api/og?type=drug&title=GSK958108&subtitle=GSK958108%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK958108 GSK958108 · GlaxoSmithKline https://druglandscape.com/drug/gsk961081 https://druglandscape.com/api/og?type=drug&title=GSK961081&subtitle=GSK961081%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GSK961081 GSK961081 · GlaxoSmithKline https://druglandscape.com/drug/gsk961081-800-microgram-dose https://druglandscape.com/api/og?type=drug&title=GSK961081%20800%20microgram%20dose&subtitle=GSK961081%20800%20microgram%20dose%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK961081 800 microgram dose GSK961081 800 microgram dose · GlaxoSmithKline https://druglandscape.com/drug/gsk962040 https://druglandscape.com/api/og?type=drug&title=GSK962040&subtitle=GSK962040%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GSK962040 GSK962040 · GlaxoSmithKline https://druglandscape.com/drug/gst-hg121-tablets https://druglandscape.com/api/og?type=drug&title=GST-HG121%20tablets&subtitle=GST-HG121%20tablets%20%C2%B7%20Fujian%20Akeylink%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 GST-HG121 tablets GST-HG121 tablets · Fujian Akeylink Biotechnology Co., Ltd. https://druglandscape.com/drug/gst-hg131-tablets https://druglandscape.com/api/og?type=drug&title=GST-HG131%20tablets&subtitle=GST-HG131%20tablets%20%C2%B7%20Fujian%20Cosunter%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 GST-HG131 tablets GST-HG131 tablets · Fujian Cosunter Pharmaceutical Co. Ltd https://druglandscape.com/drug/gst-hg141-tablets https://druglandscape.com/api/og?type=drug&title=GST-HG141%20tablets&subtitle=GST-HG141%20tablets%20%C2%B7%20Fujian%20Cosunter%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 GST-HG141 tablets GST-HG141 tablets · Fujian Cosunter Pharmaceutical Co. Ltd https://druglandscape.com/drug/gst-hg151 https://druglandscape.com/api/og?type=drug&title=GST-HG151&subtitle=GST-HG151%20%C2%B7%20Fujian%20Cosunter%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 GST-HG151 GST-HG151 · Fujian Cosunter Pharmaceutical Co. Ltd https://druglandscape.com/drug/gst-hg161 https://druglandscape.com/api/og?type=drug&title=GST-HG161&subtitle=GST-HG161%20%C2%B7%20Fujian%20Cosunter%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 GST-HG161 GST-HG161 · Fujian Cosunter Pharmaceutical Co. Ltd https://druglandscape.com/drug/gst-hg171 https://druglandscape.com/api/og?type=drug&title=GST-HG171&subtitle=GST-HG171%20%C2%B7%20Fujian%20Akeylink%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 GST-HG171 GST-HG171 · Fujian Akeylink Biotechnology Co., Ltd. https://druglandscape.com/drug/gst-hg171-tablets https://druglandscape.com/api/og?type=drug&title=GST-HG171%20Tablets&subtitle=GST-HG171%20Tablets%20%C2%B7%20Fujian%20Akeylink%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 GST-HG171 Tablets GST-HG171 Tablets · Fujian Akeylink Biotechnology Co., Ltd. https://druglandscape.com/drug/gstd-igad https://druglandscape.com/api/og?type=drug&title=GSTD%E2%86%92IGAD&subtitle=GSTD%E2%86%92IGAD%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 GSTD→IGAD GSTD→IGAD · Dong-A ST Co., Ltd. https://druglandscape.com/drug/gt-001 https://druglandscape.com/api/og?type=drug&title=GT-001&subtitle=GT-001%20%C2%B7%20Gila%20Therapeutics%2C%20Inc.&badge=phase%201 GT-001 GT-001 · Gila Therapeutics, Inc. https://druglandscape.com/drug/gt-002 https://druglandscape.com/api/og?type=drug&title=GT-002&subtitle=GT-002%20%C2%B7%20Gabather%20AB&badge=phase%201 GT-002 GT-002 · Gabather AB https://druglandscape.com/drug/gt-02287 https://druglandscape.com/api/og?type=drug&title=GT-02287&subtitle=GT-02287%20%C2%B7%20Gain%20Therapeutics%2C%20Inc.&badge=phase%201 GT-02287 GT-02287 · Gain Therapeutics, Inc. https://druglandscape.com/drug/gt-220f-capsule https://druglandscape.com/api/og?type=drug&title=GT-220F%20capsule&subtitle=GT-220F%20capsule%20%C2%B7%20Geode%20Therapeutics%20Inc.&badge=phase%201 GT-220F capsule GT-220F capsule · Geode Therapeutics Inc. https://druglandscape.com/drug/gt160-246 https://druglandscape.com/api/og?type=drug&title=GT160-246&subtitle=GT160-246%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%202 GT160-246 GT160-246 · Genzyme, a Sanofi Company https://druglandscape.com/drug/gt20029-gel https://druglandscape.com/api/og?type=drug&title=GT20029%20Gel&subtitle=GT20029%20Gel%20%C2%B7%20Suzhou%20Kintor%20Pharmaceutical%20Inc%2C&badge=phase%201 GT20029 Gel GT20029 Gel · Suzhou Kintor Pharmaceutical Inc, https://druglandscape.com/drug/gt300 https://druglandscape.com/api/og?type=drug&title=GT300&subtitle=GT300%20%C2%B7%20Generian%20Pharmaceuticals%2C%20Inc.&badge=phase%201 GT300 GT300 · Generian Pharmaceuticals, Inc. https://druglandscape.com/drug/gt90001-and-nivolumab https://druglandscape.com/api/og?type=drug&title=GT90001%20and%20Nivolumab&subtitle=GT90001%20and%20Nivolumab%20%C2%B7%20Suzhou%20Kintor%20Pharmaceutical%20Inc%2C&badge=phase%201 GT90001 and Nivolumab GT90001 and Nivolumab · Suzhou Kintor Pharmaceutical Inc, https://druglandscape.com/drug/gta-glyceryl-triacetate https://druglandscape.com/api/og?type=drug&title=GTA%20glyceryl%20triacetate&subtitle=GTA%20glyceryl%20triacetate%20%C2%B7%20Shaare%20Zedek%20Medical%20Center&badge=phase%201 GTA glyceryl triacetate GTA glyceryl triacetate · Shaare Zedek Medical Center https://druglandscape.com/drug/gtaexs617 https://druglandscape.com/api/og?type=drug&title=GTAEXS617&subtitle=GTAEXS617%20%C2%B7%20Exscientia%20AI%20Ltd.%2C%20a%20wholly%20owned%20subsidiary%20of%20Recursion%20Pharmaceuticals%2C%20Inc.&badge=phase%201 GTAEXS617 GTAEXS617 · Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. https://druglandscape.com/drug/gtn-diamox https://druglandscape.com/api/og?type=drug&title=GTN%2C%20Diamox&subtitle=GTN%2C%20Diamox%20%C2%B7%20Danish%20Headache%20Center&badge=phase%201 GTN, Diamox GTN, Diamox · Danish Headache Center https://druglandscape.com/drug/gtu-multihiv-b-clade https://druglandscape.com/api/og?type=drug&title=GTU%C2%AE-multiHIV%20B%20clade&subtitle=GTU%C2%AE-multiHIV%20B%20clade%20%C2%B7%20Imperial%20College%20London&badge=phase%201 GTU®-multiHIV B clade GTU®-multiHIV B clade · Imperial College London https://druglandscape.com/drug/gtx-101 https://druglandscape.com/api/og?type=drug&title=GTX-101&subtitle=GTX-101%20%C2%B7%20Grace%20Therapeutics%20Inc.&badge=phase%201 GTX-101 GTX-101 · Grace Therapeutics Inc. https://druglandscape.com/drug/gtx-b001 https://druglandscape.com/api/og?type=drug&title=GTX-B001&subtitle=GTX-B001%20%C2%B7%20Granular%20Therapeutics%20Limited&badge=phase%201 GTX-B001 GTX-B001 · Granular Therapeutics Limited https://druglandscape.com/drug/guaran https://druglandscape.com/api/og?type=drug&title=Guaran%C3%A1&subtitle=Guaran%C3%A1%20%C2%B7%20Faculdade%20de%20Medicina%20do%20ABC&badge=phase%202 Guaraná Guaraná · Faculdade de Medicina do ABC https://druglandscape.com/drug/gub014295 https://druglandscape.com/api/og?type=drug&title=GUB014295&subtitle=GUB014295%20%C2%B7%20AbbVie&badge=phase%201 GUB014295 GUB014295 · AbbVie https://druglandscape.com/drug/gucy2c-cart-cells https://druglandscape.com/api/og?type=drug&title=gucy2c%20cart%20cells&subtitle=gucy2c%20cart%20cells%20%C2%B7%20Innovative%20Cellular%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 gucy2c cart cells gucy2c cart cells · Innovative Cellular Therapeutics Co., Ltd. https://druglandscape.com/drug/guduchi-ghan-vati https://druglandscape.com/api/og?type=drug&title=Guduchi%20Ghan%20Vati&subtitle=Guduchi%20Ghan%20Vati%20%C2%B7%20Aarogyam%20UK&badge=phase%202 Guduchi Ghan Vati Guduchi Ghan Vati · Aarogyam UK https://druglandscape.com/drug/gum-chewing https://druglandscape.com/api/og?type=drug&title=gum%20chewing&subtitle=gum%20chewing%20%C2%B7%20Guangxi%20Medical%20University&badge=phase%203 gum chewing gum chewing · Guangxi Medical University https://druglandscape.com/drug/gumarontinib-tablets https://druglandscape.com/api/og?type=drug&title=Gumarontinib%20Tablets&subtitle=Gumarontinib%20Tablets%20%C2%B7%20Haihe%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 Gumarontinib Tablets Gumarontinib Tablets · Haihe Biopharma Co., Ltd. https://druglandscape.com/drug/gut-microbial-transplantation https://druglandscape.com/api/og?type=drug&title=Gut%20Microbial%20Transplantation&subtitle=Gut%20Microbial%20Transplantation%20%C2%B7%20Corewell%20Health%20West&badge=phase%201 Gut Microbial Transplantation Gut Microbial Transplantation · Corewell Health West https://druglandscape.com/drug/gv101 https://druglandscape.com/api/og?type=drug&title=GV101&subtitle=GV101%20%C2%B7%20Graviton%20Bioscience%20Corporation&badge=phase%202 GV101 GV101 · Graviton Bioscience Corporation https://druglandscape.com/drug/gv20-0251-and-pembrolizumab-keytruda https://druglandscape.com/api/og?type=drug&title=GV20-0251%20and%20Pembrolizumab%20%5BKEYTRUDA%C2%AE%5D&subtitle=GV20-0251%20and%20Pembrolizumab%20%5BKEYTRUDA%C2%AE%5D%20%C2%B7%20GV20%20Therapeutics&badge=phase%201 GV20-0251 and Pembrolizumab [KEYTRUDA®] GV20-0251 and Pembrolizumab [KEYTRUDA®] · GV20 Therapeutics https://druglandscape.com/drug/gvax-pancreas https://druglandscape.com/api/og?type=drug&title=GVAX%20Pancreas&subtitle=GVAX%20Pancreas%20%C2%B7%20Aduro%20Biotech%2C%20Inc.&badge=phase%202 GVAX Pancreas GVAX Pancreas · Aduro Biotech, Inc. https://druglandscape.com/drug/gvb-2001-low-dose https://druglandscape.com/api/og?type=drug&title=GVB-2001-low%20dose&subtitle=GVB-2001-low%20dose%20%C2%B7%20IVIEW%20Therapeutics%20Inc.&badge=phase%201 GVB-2001-low dose GVB-2001-low dose · IVIEW Therapeutics Inc. https://druglandscape.com/drug/gw117-odt https://druglandscape.com/api/og?type=drug&title=GW117%20ODT&subtitle=GW117%20ODT%20%C2%B7%20Beijing%20Greatway%20Pharmaceutical%20Technology%20Co.%2CLtd.&badge=phase%201 GW117 ODT GW117 ODT · Beijing Greatway Pharmaceutical Technology Co.,Ltd. https://druglandscape.com/drug/gw427353 https://druglandscape.com/api/og?type=drug&title=GW427353&subtitle=GW427353%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GW427353 GW427353 · GlaxoSmithKline https://druglandscape.com/drug/gw597599b https://druglandscape.com/api/og?type=drug&title=GW597599B&subtitle=GW597599B%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GW597599B GW597599B · GlaxoSmithKline https://druglandscape.com/drug/gw642444m https://druglandscape.com/api/og?type=drug&title=GW642444M&subtitle=GW642444M%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GW642444M GW642444M · GlaxoSmithKline https://druglandscape.com/drug/gw642444m-for-14-days https://druglandscape.com/api/og?type=drug&title=GW642444M%20for%2014%20days&subtitle=GW642444M%20for%2014%20days%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GW642444M for 14 days GW642444M for 14 days · GlaxoSmithKline https://druglandscape.com/drug/gw685698x-gw642444m https://druglandscape.com/api/og?type=drug&title=GW685698X%20%26%20GW642444M&subtitle=GW685698X%20%26%20GW642444M%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GW685698X & GW642444M GW685698X & GW642444M · GlaxoSmithKline https://druglandscape.com/drug/gw766944 https://druglandscape.com/api/og?type=drug&title=GW766944&subtitle=GW766944%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GW766944 GW766944 · GlaxoSmithKline https://druglandscape.com/drug/gw784568x https://druglandscape.com/api/og?type=drug&title=GW784568X&subtitle=GW784568X%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GW784568X GW784568X · GlaxoSmithKline https://druglandscape.com/drug/gw786034-iv https://druglandscape.com/api/og?type=drug&title=GW786034%2C%20IV&subtitle=GW786034%2C%20IV%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GW786034, IV GW786034, IV · GlaxoSmithKline https://druglandscape.com/drug/gw786034-oral https://druglandscape.com/api/og?type=drug&title=GW786034%2C%20oral&subtitle=GW786034%2C%20oral%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GW786034, oral GW786034, oral · GlaxoSmithKline https://druglandscape.com/drug/gw786034-radiolabeled-oral https://druglandscape.com/api/og?type=drug&title=GW786034%2C%20radiolabeled%20oral&subtitle=GW786034%2C%20radiolabeled%20oral%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GW786034, radiolabeled oral GW786034, radiolabeled oral · GlaxoSmithKline https://druglandscape.com/drug/gw823296-tablet https://druglandscape.com/api/og?type=drug&title=GW823296%20tablet&subtitle=GW823296%20tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 GW823296 tablet GW823296 tablet · GlaxoSmithKline https://druglandscape.com/drug/gw842470x-cream https://druglandscape.com/api/og?type=drug&title=GW842470X%20cream&subtitle=GW842470X%20cream%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GW842470X cream GW842470X cream · GlaxoSmithKline https://druglandscape.com/drug/gw869682 https://druglandscape.com/api/og?type=drug&title=GW869682&subtitle=GW869682%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GW869682 GW869682 · GlaxoSmithKline https://druglandscape.com/drug/gw869682-oral-tablets https://druglandscape.com/api/og?type=drug&title=GW869682%20oral%20tablets&subtitle=GW869682%20oral%20tablets%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GW869682 oral tablets GW869682 oral tablets · GlaxoSmithKline https://druglandscape.com/drug/gw870086x https://druglandscape.com/api/og?type=drug&title=GW870086X&subtitle=GW870086X%20%C2%B7%20GlaxoSmithKline&badge=phase%202 GW870086X GW870086X · GlaxoSmithKline https://druglandscape.com/drug/gx-051 https://druglandscape.com/api/og?type=drug&title=GX-051&subtitle=GX-051%20%C2%B7%20Genexine%2C%20Inc.&badge=phase%201 GX-051 GX-051 · Genexine, Inc. https://druglandscape.com/drug/gx-e2 https://druglandscape.com/api/og?type=drug&title=GX-E2&subtitle=GX-E2%20%C2%B7%20Genexine%2C%20Inc.&badge=phase%202 GX-E2 GX-E2 · Genexine, Inc. https://druglandscape.com/drug/gx-h9 https://druglandscape.com/api/og?type=drug&title=GX-H9&subtitle=GX-H9%20%C2%B7%20Genexine%2C%20Inc.&badge=phase%202 GX-H9 GX-H9 · Genexine, Inc. https://druglandscape.com/drug/gx15-070ms https://druglandscape.com/api/og?type=drug&title=GX15-070MS&subtitle=GX15-070MS%20%C2%B7%20Gemin%20X&badge=phase%201 GX15-070MS GX15-070MS · Gemin X https://druglandscape.com/drug/gxcpc1 https://druglandscape.com/api/og?type=drug&title=GXCPC1&subtitle=GXCPC1%20%C2%B7%20Gwo%20Xi%20Stem%20Cell%20Applied%20Technology%20Co.%2C%20Ltd.&badge=phase%201 GXCPC1 GXCPC1 · Gwo Xi Stem Cell Applied Technology Co., Ltd. https://druglandscape.com/drug/gynazole-1-vaginal-cream https://druglandscape.com/api/og?type=drug&title=Gynazole%201%20vaginal%20cream&subtitle=Gynazole%201%20vaginal%20cream%20%C2%B7%20Padagis%20LLC&badge=phase%201 Gynazole 1 vaginal cream Gynazole 1 vaginal cream · Padagis LLC https://druglandscape.com/drug/gyno-daktarin https://druglandscape.com/api/og?type=drug&title=Gyno-Daktarin&subtitle=Gyno-Daktarin%20%C2%B7%20Bayer&badge=phase%201 Gyno-Daktarin Gyno-Daktarin · Bayer https://druglandscape.com/drug/gynomunal-gel-treatment https://druglandscape.com/api/og?type=drug&title=Gynomunal%20gel%20treatment&subtitle=Gynomunal%20gel%20treatment%20%C2%B7%20Lumenis%20Be%20Ltd.&badge=phase%201 Gynomunal gel treatment Gynomunal gel treatment · Lumenis Be Ltd. https://druglandscape.com/drug/gz17-6-02 https://druglandscape.com/api/og?type=drug&title=GZ17-6.02&subtitle=GZ17-6.02%20%C2%B7%20Genzada%20Pharmaceuticals%20USA%2C%20Inc.&badge=phase%201 GZ17-6.02 GZ17-6.02 · Genzada Pharmaceuticals USA, Inc. https://druglandscape.com/drug/gz21t https://druglandscape.com/api/og?type=drug&title=GZ21T&subtitle=GZ21T%20%C2%B7%20Genzada%20Pharmaceuticals%20USA%2C%20Inc.&badge=phase%201 GZ21T GZ21T · Genzada Pharmaceuticals USA, Inc. https://druglandscape.com/drug/gz402668 https://druglandscape.com/api/og?type=drug&title=GZ402668&subtitle=GZ402668%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%201 GZ402668 GZ402668 · Genzyme, a Sanofi Company https://druglandscape.com/drug/gzr-33 https://druglandscape.com/api/og?type=drug&title=GZR-33&subtitle=GZR-33%20%C2%B7%20Gan%20and%20Lee%20Pharmaceuticals%2C%20USA&badge=phase%201 GZR-33 GZR-33 · Gan and Lee Pharmaceuticals, USA https://druglandscape.com/drug/gzr101-80 https://druglandscape.com/api/og?type=drug&title=GZR101-80&subtitle=GZR101-80%20%C2%B7%20Gan%20%26%20Lee%20Pharmaceuticals.&badge=phase%202 GZR101-80 GZR101-80 · Gan & Lee Pharmaceuticals. https://druglandscape.com/drug/gzr18-and-metformin https://druglandscape.com/api/og?type=drug&title=GZR18%20and%20metformin&subtitle=GZR18%20and%20metformin%20%C2%B7%20Gan%20and%20Lee%20Pharmaceuticals%2C%20USA&badge=phase%201 GZR18 and metformin GZR18 and metformin · Gan and Lee Pharmaceuticals, USA https://druglandscape.com/drug/gzr18-injection-b https://druglandscape.com/api/og?type=drug&title=GZR18%20injection%20B&subtitle=GZR18%20injection%20B%20%C2%B7%20Gan%20%26%20Lee%20Pharmaceuticals.&badge=phase%201 GZR18 injection B GZR18 injection B · Gan & Lee Pharmaceuticals. https://druglandscape.com/drug/h-pylori-eradication-scheme-a https://druglandscape.com/api/og?type=drug&title=H.%20pylori%20eradication%20scheme%20A&subtitle=H.%20pylori%20eradication%20scheme%20A%20%C2%B7%20Unidade%20Local%20de%20Sa%C3%BAde%20de%20Coimbra%2C%20EPE&badge=phase%201 H. pylori eradication scheme A H. pylori eradication scheme A · Unidade Local de Saúde de Coimbra, EPE https://druglandscape.com/drug/h-pylori-eradication-scheme-b https://druglandscape.com/api/og?type=drug&title=H.%20pylori%20eradication%20scheme%20B&subtitle=H.%20pylori%20eradication%20scheme%20B%20%C2%B7%20Unidade%20Local%20de%20Sa%C3%BAde%20de%20Coimbra%2C%20EPE&badge=phase%201 H. pylori eradication scheme B H. pylori eradication scheme B · Unidade Local de Saúde de Coimbra, EPE https://druglandscape.com/drug/h-pylori-eradication-scheme-c https://druglandscape.com/api/og?type=drug&title=H.%20pylori%20eradication%20scheme%20C&subtitle=H.%20pylori%20eradication%20scheme%20C%20%C2%B7%20Unidade%20Local%20de%20Sa%C3%BAde%20de%20Coimbra%2C%20EPE&badge=phase%201 H. pylori eradication scheme C H. pylori eradication scheme C · Unidade Local de Saúde de Coimbra, EPE https://druglandscape.com/drug/h-pylori-eradication-scheme-d https://druglandscape.com/api/og?type=drug&title=H.%20pylori%20eradication%20scheme%20D&subtitle=H.%20pylori%20eradication%20scheme%20D%20%C2%B7%20Unidade%20Local%20de%20Sa%C3%BAde%20de%20Coimbra%2C%20EPE&badge=phase%201 H. pylori eradication scheme D H. pylori eradication scheme D · Unidade Local de Saúde de Coimbra, EPE https://druglandscape.com/drug/h-pylori-eradication-scheme-e https://druglandscape.com/api/og?type=drug&title=H.%20pylori%20eradication%20scheme%20E&subtitle=H.%20pylori%20eradication%20scheme%20E%20%C2%B7%20Unidade%20Local%20de%20Sa%C3%BAde%20de%20Coimbra%2C%20EPE&badge=phase%201 H. pylori eradication scheme E H. pylori eradication scheme E · Unidade Local de Saúde de Coimbra, EPE https://druglandscape.com/drug/h002-capsule https://druglandscape.com/api/og?type=drug&title=H002%20capsule&subtitle=H002%20capsule%20%C2%B7%20RedCloud%20Bio&badge=phase%201 H002 capsule H002 capsule · RedCloud Bio https://druglandscape.com/drug/h008 https://druglandscape.com/api/og?type=drug&title=H008&subtitle=H008%20%C2%B7%20Jiangsu%20Carephar%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 H008 H008 · Jiangsu Carephar Pharmaceutical Co., Ltd. https://druglandscape.com/drug/h021 https://druglandscape.com/api/og?type=drug&title=H021&subtitle=H021%20%C2%B7%20Jiangsu%20Carephar%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 H021 H021 · Jiangsu Carephar Pharmaceutical Co., Ltd. https://druglandscape.com/drug/h10407 https://druglandscape.com/api/og?type=drug&title=H10407&subtitle=H10407%20%C2%B7%20Johns%20Hopkins%20Bloomberg%20School%20of%20Public%20Health&badge=phase%201 H10407 H10407 · Johns Hopkins Bloomberg School of Public Health https://druglandscape.com/drug/h10407-challenge-strain https://druglandscape.com/api/og?type=drug&title=H10407%20challenge%20strain&subtitle=H10407%20challenge%20strain%20%C2%B7%20PATH&badge=phase%201 H10407 challenge strain H10407 challenge strain · PATH https://druglandscape.com/drug/h2rb https://druglandscape.com/api/og?type=drug&title=H2RB&subtitle=H2RB%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%201 H2RB H2RB · Samsung Medical Center https://druglandscape.com/drug/h4-ic31 https://druglandscape.com/api/og?type=drug&title=H4%3AIC31&subtitle=H4%3AIC31%20%C2%B7%20Aeras&badge=phase%201 H4:IC31 H4:IC31 · Aeras https://druglandscape.com/drug/h5-vlp-pandemic-influenza-vaccine-10-g https://druglandscape.com/api/og?type=drug&title=H5%20VLP%20pandemic%20influenza%20vaccine%2010%20%C2%B5g&subtitle=H5%20VLP%20pandemic%20influenza%20vaccine%2010%20%C2%B5g%20%C2%B7%20Medicago&badge=phase%201 H5 VLP pandemic influenza vaccine 10 µg H5 VLP pandemic influenza vaccine 10 µg · Medicago https://druglandscape.com/drug/h5n1-antigen-combined-with-mf59-adjuvant https://druglandscape.com/api/og?type=drug&title=H5N1%20antigen%20combined%20with%20MF59%20adjuvant&subtitle=H5N1%20antigen%20combined%20with%20MF59%20adjuvant%20%C2%B7%20Seqirus&badge=phase%202 H5N1 antigen combined with MF59 adjuvant H5N1 antigen combined with MF59 adjuvant · Seqirus https://druglandscape.com/drug/h5n1-iiv-im https://druglandscape.com/api/og?type=drug&title=H5N1%20IIV%20-%20IM&subtitle=H5N1%20IIV%20-%20IM%20%C2%B7%20BlueWillow%20Biologics&badge=phase%201 H5N1 IIV - IM H5N1 IIV - IM · BlueWillow Biologics https://druglandscape.com/drug/h5n1-pandemic-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=H5N1%20pandemic%20influenza%20vaccine&subtitle=H5N1%20pandemic%20influenza%20vaccine%20%C2%B7%20Seqirus&badge=phase%202 H5N1 pandemic influenza vaccine H5N1 pandemic influenza vaccine · Seqirus https://druglandscape.com/drug/h5n1-vlp-vaccine https://druglandscape.com/api/og?type=drug&title=H5N1%20VLP%20Vaccine&subtitle=H5N1%20VLP%20Vaccine%20%C2%B7%20Novavax&badge=phase%201 H5N1 VLP Vaccine H5N1 VLP Vaccine · Novavax https://druglandscape.com/drug/ha121-28-tablet-a https://druglandscape.com/api/og?type=drug&title=HA121-28%20tablet%20A&subtitle=HA121-28%20tablet%20A%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 HA121-28 tablet A HA121-28 tablet A · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/ha121-28-tablet-b https://druglandscape.com/api/og?type=drug&title=HA121-28%20tablet%20B&subtitle=HA121-28%20tablet%20B%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 HA121-28 tablet B HA121-28 tablet B · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/ha131 https://druglandscape.com/api/og?type=drug&title=HA131&subtitle=HA131%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 HA131 HA131 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/haart-treatment https://druglandscape.com/api/og?type=drug&title=HAART%20Treatment&subtitle=HAART%20Treatment%20%C2%B7%20ViiV%20Healthcare&badge=phase%202 HAART Treatment HAART Treatment · ViiV Healthcare https://druglandscape.com/drug/hac1-vaccine https://druglandscape.com/api/og?type=drug&title=HAC1%20Vaccine&subtitle=HAC1%20Vaccine%20%C2%B7%20Fraunhofer%2C%20Center%20for%20Molecular%20Biotechnology&badge=phase%201 HAC1 Vaccine HAC1 Vaccine · Fraunhofer, Center for Molecular Biotechnology https://druglandscape.com/drug/haemocomplettan-p-or-riastaptm https://druglandscape.com/api/og?type=drug&title=Haemocomplettan%C2%AE%20P%20or%20RiaSTAPTM&subtitle=Haemocomplettan%C2%AE%20P%20or%20RiaSTAPTM%20%C2%B7%20Octapharma&badge=phase%202 Haemocomplettan® P or RiaSTAPTM Haemocomplettan® P or RiaSTAPTM · Octapharma https://druglandscape.com/drug/haemostasis-tests https://druglandscape.com/api/og?type=drug&title=Haemostasis%20tests&subtitle=Haemostasis%20tests%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Haemostasis tests Haemostasis tests · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/hai-05-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=HAI-05%20Influenza%20Vaccine&subtitle=HAI-05%20Influenza%20Vaccine%20%C2%B7%20Fraunhofer%2C%20Center%20for%20Molecular%20Biotechnology&badge=phase%201 HAI-05 Influenza Vaccine HAI-05 Influenza Vaccine · Fraunhofer, Center for Molecular Biotechnology https://druglandscape.com/drug/hai-conventional-chemotherapy https://druglandscape.com/api/og?type=drug&title=HAI%20conventional%20chemotherapy&subtitle=HAI%20conventional%20chemotherapy%20%C2%B7%20Association%20pour%20la%20Recherche%20sur%20le%20Temps%20Biologique%20et%20la%20Chronoth&badge=phase%202 HAI conventional chemotherapy HAI conventional chemotherapy · Association pour la Recherche sur le Temps Biologique et la Chronothérapie https://druglandscape.com/drug/hair-sampling https://druglandscape.com/api/og?type=drug&title=hair%20sampling&subtitle=hair%20sampling%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 hair sampling hair sampling · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/hal-5-with-illumination https://druglandscape.com/api/og?type=drug&title=HAL%205%25%20with%20illumination&subtitle=HAL%205%25%20with%20illumination%20%C2%B7%20Photocure&badge=phase%202 HAL 5% with illumination HAL 5% with illumination · Photocure https://druglandscape.com/drug/hal-mpe1 https://druglandscape.com/api/og?type=drug&title=HAL-MPE1&subtitle=HAL-MPE1%20%C2%B7%20HAL%20Allergy&badge=phase%201 HAL-MPE1 HAL-MPE1 · HAL Allergy https://druglandscape.com/drug/hal-mre1 https://druglandscape.com/api/og?type=drug&title=HAL-MRE1&subtitle=HAL-MRE1%20%C2%B7%20HAL%20Allergy&badge=phase%201 HAL-MRE1 HAL-MRE1 · HAL Allergy https://druglandscape.com/drug/half-dose-of-mrna-1273 https://druglandscape.com/api/og?type=drug&title=Half%20dose%20of%20mRNA-1273&subtitle=Half%20dose%20of%20mRNA-1273%20%C2%B7%20Medigen%20Vaccine%20Biologics%20Corp.&badge=phase%202 Half dose of mRNA-1273 Half dose of mRNA-1273 · Medigen Vaccine Biologics Corp. https://druglandscape.com/drug/hallux-terbinafine-subungual-gel https://druglandscape.com/api/og?type=drug&title=Hallux%20Terbinafine%20Subungual%20Gel&subtitle=Hallux%20Terbinafine%20Subungual%20Gel%20%C2%B7%20Hallux%2C%20Inc.&badge=phase%202 Hallux Terbinafine Subungual Gel Hallux Terbinafine Subungual Gel · Hallux, Inc. https://druglandscape.com/drug/halobetasol-propionate-lotion-0-05 https://druglandscape.com/api/og?type=drug&title=Halobetasol%20Propionate%20Lotion%200.05%25&subtitle=Halobetasol%20Propionate%20Lotion%200.05%25%20%C2%B7%20Therapeutics%2C%20Inc.&badge=phase%202 Halobetasol Propionate Lotion 0.05% Halobetasol Propionate Lotion 0.05% · Therapeutics, Inc. https://druglandscape.com/drug/halobetasol-proprionate-cream-0-05 https://druglandscape.com/api/og?type=drug&title=Halobetasol%20Proprionate%20Cream%200.05%25&subtitle=Halobetasol%20Proprionate%20Cream%200.05%25%20%C2%B7%20Therapeutics%2C%20Inc.&badge=phase%202 Halobetasol Proprionate Cream 0.05% Halobetasol Proprionate Cream 0.05% · Therapeutics, Inc. https://druglandscape.com/drug/halobetasol-proprionate-lotion-0-05 https://druglandscape.com/api/og?type=drug&title=Halobetasol%20Proprionate%20Lotion%200.05%25&subtitle=Halobetasol%20Proprionate%20Lotion%200.05%25%20%C2%B7%20Therapeutics%2C%20Inc.&badge=phase%202 Halobetasol Proprionate Lotion 0.05% Halobetasol Proprionate Lotion 0.05% · Therapeutics, Inc. https://druglandscape.com/drug/halometasone-cream https://druglandscape.com/api/og?type=drug&title=Halometasone%20Cream&subtitle=Halometasone%20Cream%20%C2%B7%20xjpfW&badge=phase%201 Halometasone Cream Halometasone Cream · xjpfW https://druglandscape.com/drug/haloperidol-pet https://druglandscape.com/api/og?type=drug&title=haloperidol%2C%20PET&subtitle=haloperidol%2C%20PET%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 haloperidol, PET haloperidol, PET · Asan Medical Center https://druglandscape.com/drug/haloperidol-pimozide-olanzapine-risperidone-amisulpride https://druglandscape.com/api/og?type=drug&title=haloperidol%2C%20pimozide%2C%20olanzapine%2C%20risperidone%2C%20amisulpride&subtitle=haloperidol%2C%20pimozide%2C%20olanzapine%2C%20risperidone%2C%20amisulpride%20%C2%B7%20Fundaci%C3%B3n%20P%C3%BAblica%20Andaluza%20para%20la%20ges&badge=phase%202 haloperidol, pimozide, olanzapine, risperidone, amisulpride haloperidol, pimozide, olanzapine, risperidone, amisulpride · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla https://druglandscape.com/drug/haloperidol-tablets-cycle-pharmaceuticals-ltd https://druglandscape.com/api/og?type=drug&title=Haloperidol%20Tablets%2C%20Cycle%20Pharmaceuticals%20Ltd&subtitle=Haloperidol%20Tablets%2C%20Cycle%20Pharmaceuticals%20Ltd%20%C2%B7%20Cycle%20Pharmaceuticals%20Ltd.&badge=phase%201 Haloperidol Tablets, Cycle Pharmaceuticals Ltd Haloperidol Tablets, Cycle Pharmaceuticals Ltd · Cycle Pharmaceuticals Ltd. https://druglandscape.com/drug/hamsa-1-tl-118 https://druglandscape.com/api/og?type=drug&title=Hamsa-1%E2%84%A2%20TL-118&subtitle=Hamsa-1%E2%84%A2%20TL-118%20%C2%B7%20Tiltan%20Pharma%20Ltd.&badge=phase%202 Hamsa-1™ TL-118 Hamsa-1™ TL-118 · Tiltan Pharma Ltd. https://druglandscape.com/drug/hanmi-tams-capsule https://druglandscape.com/api/og?type=drug&title=Hanmi%20Tams%C2%AE%20Capsule&subtitle=Hanmi%20Tams%C2%AE%20Capsule%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%202 Hanmi Tams® Capsule Hanmi Tams® Capsule · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hantaan-vaccine https://druglandscape.com/api/og?type=drug&title=Hantaan%20Vaccine%3A&subtitle=Hantaan%20Vaccine%3A%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 Hantaan Vaccine: Hantaan Vaccine: · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/haploid-allogeneic-nk-cell-therapy https://druglandscape.com/api/og?type=drug&title=haploid%20allogeneic%20NK%20cell%20therapy&subtitle=haploid%20allogeneic%20NK%20cell%20therapy%20%C2%B7%20Shanghai%20iCELL%20Biotechnology%20Co.%2C%20Ltd%2C%20Shanghai%2C%20China&badge=phase%201 haploid allogeneic NK cell therapy haploid allogeneic NK cell therapy · Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China https://druglandscape.com/drug/harnal-d-tab https://druglandscape.com/api/og?type=drug&title=Harnal-D%20Tab.&subtitle=Harnal-D%20Tab.%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 Harnal-D Tab. Harnal-D Tab. · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/hav-implantation https://druglandscape.com/api/og?type=drug&title=HAV%20implantation&subtitle=HAV%20implantation%20%C2%B7%20Humacyte%2C%20Inc.&badge=phase%202 HAV implantation HAV implantation · Humacyte, Inc. https://druglandscape.com/drug/havg https://druglandscape.com/api/og?type=drug&title=HAVG&subtitle=HAVG%20%C2%B7%20Humacyte%2C%20Inc.&badge=phase%201 HAVG HAVG · Humacyte, Inc. https://druglandscape.com/drug/hb-101-vaccine https://druglandscape.com/api/og?type=drug&title=HB-101%20vaccine&subtitle=HB-101%20vaccine%20%C2%B7%20Hookipa%20Biotech%20GmbH&badge=phase%202 HB-101 vaccine HB-101 vaccine · Hookipa Biotech GmbH https://druglandscape.com/drug/hb-201-intravenous-administration https://druglandscape.com/api/og?type=drug&title=HB-201%20intravenous%20administration.&subtitle=HB-201%20intravenous%20administration.%20%C2%B7%20Hookipa%20Biotech%20GmbH&badge=phase%201 HB-201 intravenous administration. HB-201 intravenous administration. · Hookipa Biotech GmbH https://druglandscape.com/drug/hb-2121 https://druglandscape.com/api/og?type=drug&title=HB-2121&subtitle=HB-2121%20%C2%B7%20Nielsen%20Fernandez-Becker&badge=phase%201 HB-2121 HB-2121 · Nielsen Fernandez-Becker https://druglandscape.com/drug/hb0017 https://druglandscape.com/api/og?type=drug&title=HB0017&subtitle=HB0017%20%C2%B7%20Huabo%20Biopharm%20Co.%2C%20Ltd.&badge=phase%202 HB0017 HB0017 · Huabo Biopharm Co., Ltd. https://druglandscape.com/drug/hb002-1m https://druglandscape.com/api/og?type=drug&title=HB002.1M&subtitle=HB002.1M%20%C2%B7%20Huabo%20Biopharm%20Co.%2C%20Ltd.&badge=phase%201 HB002.1M HB002.1M · Huabo Biopharm Co., Ltd. https://druglandscape.com/drug/hb002-1t https://druglandscape.com/api/og?type=drug&title=HB002.1T&subtitle=HB002.1T%20%C2%B7%20Huabo%20Biopharm%20Co.%2C%20Ltd.&badge=phase%201 HB002.1T HB002.1T · Huabo Biopharm Co., Ltd. https://druglandscape.com/drug/hb0028 https://druglandscape.com/api/og?type=drug&title=HB0028&subtitle=HB0028%20%C2%B7%20Shanghai%20Huaota%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HB0028 HB0028 · Shanghai Huaota Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/hb0034 https://druglandscape.com/api/og?type=drug&title=HB0034&subtitle=HB0034%20%C2%B7%20Shanghai%20Huaota%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 HB0034 HB0034 · Shanghai Huaota Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/hb0036 https://druglandscape.com/api/og?type=drug&title=HB0036&subtitle=HB0036%20%C2%B7%20Shanghai%20Huaota%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HB0036 HB0036 · Shanghai Huaota Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/hb0043 https://druglandscape.com/api/og?type=drug&title=HB0043&subtitle=HB0043%20%C2%B7%20Shanghai%20Huaota%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HB0043 HB0043 · Shanghai Huaota Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/hb0045-drug-product https://druglandscape.com/api/og?type=drug&title=HB0045%20Drug%20Product&subtitle=HB0045%20Drug%20Product%20%C2%B7%20Shanghai%20Huaota%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HB0045 Drug Product HB0045 Drug Product · Shanghai Huaota Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/hb0056 https://druglandscape.com/api/og?type=drug&title=HB0056&subtitle=HB0056%20%C2%B7%20Shanghai%20Huaota%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HB0056 HB0056 · Shanghai Huaota Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/hbi-002 https://druglandscape.com/api/og?type=drug&title=HBI-002&subtitle=HBI-002%20%C2%B7%20Hillhurst%20Biopharmaceuticals%2C%20Inc.&badge=phase%202 HBI-002 HBI-002 · Hillhurst Biopharmaceuticals, Inc. https://druglandscape.com/drug/hbi-0201-eso-tcrt https://druglandscape.com/api/og?type=drug&title=HBI%200201-ESO%20TCRT&subtitle=HBI%200201-ESO%20TCRT%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 HBI 0201-ESO TCRT HBI 0201-ESO TCRT · Hadassah Medical Organization https://druglandscape.com/drug/hbm1020 https://druglandscape.com/api/og?type=drug&title=HBM1020&subtitle=HBM1020%20%C2%B7%20Harbour%20BioMed%20US%2C%20Inc.&badge=phase%201 HBM1020 HBM1020 · Harbour BioMed US, Inc. https://druglandscape.com/drug/hbm4003 https://druglandscape.com/api/og?type=drug&title=HBM4003&subtitle=HBM4003%20%C2%B7%20Harbour%20BioMed%20(Guangzhou)%20Co.%20Ltd.&badge=phase%201 HBM4003 HBM4003 · Harbour BioMed (Guangzhou) Co. Ltd. https://druglandscape.com/drug/hbm4003-and-triprilimab https://druglandscape.com/api/og?type=drug&title=HBM4003%20and%20Triprilimab&subtitle=HBM4003%20and%20Triprilimab%20%C2%B7%20Harbour%20BioMed%20(Guangzhou)%20Co.%20Ltd.&badge=phase%201 HBM4003 and Triprilimab HBM4003 and Triprilimab · Harbour BioMed (Guangzhou) Co. Ltd. https://druglandscape.com/drug/hbm9161-dose-a https://druglandscape.com/api/og?type=drug&title=HBM9161%20Dose%20A&subtitle=HBM9161%20Dose%20A%20%C2%B7%20Harbour%20BioMed%20(Guangzhou)%20Co.%20Ltd.&badge=phase%202 HBM9161 Dose A HBM9161 Dose A · Harbour BioMed (Guangzhou) Co. Ltd. https://druglandscape.com/drug/hbm9161-dose-b https://druglandscape.com/api/og?type=drug&title=HBM9161%20Dose%20B&subtitle=HBM9161%20Dose%20B%20%C2%B7%20Harbour%20BioMed%20(Guangzhou)%20Co.%20Ltd.&badge=phase%202 HBM9161 Dose B HBM9161 Dose B · Harbour BioMed (Guangzhou) Co. Ltd. https://druglandscape.com/drug/hbmmsc https://druglandscape.com/api/og?type=drug&title=hBMMSC&subtitle=hBMMSC%20%C2%B7%20Jiuzhitang%20Maker%20(Beijing)%20Cell%20Technology%20Co.%2CLtd.&badge=phase%201 hBMMSC hBMMSC · Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd. https://druglandscape.com/drug/hbn-1 https://druglandscape.com/api/og?type=drug&title=HBN-1&subtitle=HBN-1%20%C2%B7%20Hibernaid%2C%20Inc&badge=phase%201 HBN-1 HBN-1 · Hibernaid, Inc https://druglandscape.com/drug/hbot https://druglandscape.com/api/og?type=drug&title=HBOT&subtitle=HBOT%20%C2%B7%20Assaf-Harofeh%20Medical%20Center&badge=phase%202 HBOT HBOT · Assaf-Harofeh Medical Center https://druglandscape.com/drug/hbsag-vaccine-with-entecavir https://druglandscape.com/api/og?type=drug&title=HBsAg%20vaccine%20with%20Entecavir&subtitle=HBsAg%20vaccine%20with%20Entecavir%20%C2%B7%20Genexine%2C%20Inc.&badge=phase%201 HBsAg vaccine with Entecavir HBsAg vaccine with Entecavir · Genexine, Inc. https://druglandscape.com/drug/hbt-708 https://druglandscape.com/api/og?type=drug&title=HBT-708&subtitle=HBT-708%20%C2%B7%20Shenyang%20Sunshine%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%201 HBT-708 HBT-708 · Shenyang Sunshine Pharmaceutical Co., LTD. https://druglandscape.com/drug/hbv-mpl-vaccine-formulation-b https://druglandscape.com/api/og?type=drug&title=HBV-MPL%20vaccine%20Formulation%20B&subtitle=HBV-MPL%20vaccine%20Formulation%20B%20%C2%B7%20GlaxoSmithKline&badge=phase%202 HBV-MPL vaccine Formulation B HBV-MPL vaccine Formulation B · GlaxoSmithKline https://druglandscape.com/drug/hby-097 https://druglandscape.com/api/og?type=drug&title=HBY%20097&subtitle=HBY%20097%20%C2%B7%20Hoechst%20Marion%20Roussel&badge=phase%202 HBY 097 HBY 097 · Hoechst Marion Roussel https://druglandscape.com/drug/hc-5404-fu https://druglandscape.com/api/og?type=drug&title=HC-5404-FU&subtitle=HC-5404-FU%20%C2%B7%20HiberCell%2C%20Inc.&badge=phase%201 HC-5404-FU HC-5404-FU · HiberCell, Inc. https://druglandscape.com/drug/hc-7366 https://druglandscape.com/api/og?type=drug&title=HC-7366&subtitle=HC-7366%20%C2%B7%20HiberCell%2C%20Inc.&badge=phase%201 HC-7366 HC-7366 · HiberCell, Inc. https://druglandscape.com/drug/hc002-mad https://druglandscape.com/api/og?type=drug&title=HC002%20MAD&subtitle=HC002%20MAD%20%C2%B7%20Holoclara%20Aus%20Pty%20Ltd&badge=phase%201 HC002 MAD HC002 MAD · Holoclara Aus Pty Ltd https://druglandscape.com/drug/hc002-sad https://druglandscape.com/api/og?type=drug&title=HC002%20SAD&subtitle=HC002%20SAD%20%C2%B7%20Holoclara%20Aus%20Pty%20Ltd&badge=phase%201 HC002 SAD HC002 SAD · Holoclara Aus Pty Ltd https://druglandscape.com/drug/hc006 https://druglandscape.com/api/og?type=drug&title=HC006&subtitle=HC006%20%C2%B7%20HC%20Biopharma%20Inc.&badge=phase%201 HC006 HC006 · HC Biopharma Inc. https://druglandscape.com/drug/hc022 https://druglandscape.com/api/og?type=drug&title=HC022&subtitle=HC022%20%C2%B7%20HC%20Biopharma%20Inc.&badge=phase%201 HC022 HC022 · HC Biopharma Inc. https://druglandscape.com/drug/hc1119 https://druglandscape.com/api/og?type=drug&title=HC1119&subtitle=HC1119%20%C2%B7%20Hinova%20Pharmaceuticals%20Inc.&badge=phase%201 HC1119 HC1119 · Hinova Pharmaceuticals Inc. https://druglandscape.com/drug/hcb301 https://druglandscape.com/api/og?type=drug&title=HCB301&subtitle=HCB301%20%C2%B7%20FBD%20Biologics%20Limited&badge=phase%201 HCB301 HCB301 · FBD Biologics Limited https://druglandscape.com/drug/hcd19-il15-car-inkt https://druglandscape.com/api/og?type=drug&title=hCD19.IL15.CAR-iNKT&subtitle=hCD19.IL15.CAR-iNKT%20%C2%B7%20Kai%20Lin%20Xu%3B%20Jun%20Nian%20Zheng&badge=phase%201 hCD19.IL15.CAR-iNKT hCD19.IL15.CAR-iNKT · Kai Lin Xu; Jun Nian Zheng https://druglandscape.com/drug/hcg-administration-before-embryo-transfer https://druglandscape.com/api/og?type=drug&title=hCG%20administration%20before%20embryo%20transfer&subtitle=hCG%20administration%20before%20embryo%20transfer%20%C2%B7%20Istituto%20Clinico%20Humanitas&badge=phase%202 hCG administration before embryo transfer hCG administration before embryo transfer · Istituto Clinico Humanitas https://druglandscape.com/drug/hcg-hormone https://druglandscape.com/api/og?type=drug&title=hcg%20hormone&subtitle=hcg%20hormone%20%C2%B7%20mostafa%20gomaa%20hamid%20halawa&badge=phase%202 hcg hormone hcg hormone · mostafa gomaa hamid halawa https://druglandscape.com/drug/hcg-is-introduced https://druglandscape.com/api/og?type=drug&title=HCG%20is%20introduced&subtitle=HCG%20is%20introduced%20%C2%B7%20Servy%20Massey%20Fertility%20Insititute&badge=phase%201 HCG is introduced HCG is introduced · Servy Massey Fertility Insititute https://druglandscape.com/drug/hcg-luteal-support https://druglandscape.com/api/og?type=drug&title=hCG%20luteal%20support&subtitle=hCG%20luteal%20support%20%C2%B7%20Meir%20Medical%20Center&badge=phase%201 hCG luteal support hCG luteal support · Meir Medical Center https://druglandscape.com/drug/hcp0816 https://druglandscape.com/api/og?type=drug&title=HCP0816&subtitle=HCP0816%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP0816 HCP0816 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp0918 https://druglandscape.com/api/og?type=drug&title=HCP0918&subtitle=HCP0918%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP0918 HCP0918 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp1007 https://druglandscape.com/api/og?type=drug&title=HCP1007&subtitle=HCP1007%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP1007 HCP1007 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp1201-fed-followed-by-fasted https://druglandscape.com/api/og?type=drug&title=HCP1201%2C%20Fed%20followed%20by%20fasted&subtitle=HCP1201%2C%20Fed%20followed%20by%20fasted%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP1201, Fed followed by fasted HCP1201, Fed followed by fasted · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp1303 https://druglandscape.com/api/og?type=drug&title=HCP1303&subtitle=HCP1303%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP1303 HCP1303 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp1306 https://druglandscape.com/api/og?type=drug&title=HCP1306&subtitle=HCP1306%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP1306 HCP1306 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp1704 https://druglandscape.com/api/og?type=drug&title=HCP1704&subtitle=HCP1704%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP1704 HCP1704 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp1801 https://druglandscape.com/api/og?type=drug&title=HCP1801&subtitle=HCP1801%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP1801 HCP1801 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp1803 https://druglandscape.com/api/og?type=drug&title=HCP1803&subtitle=HCP1803%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%202 HCP1803 HCP1803 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp1805 https://druglandscape.com/api/og?type=drug&title=HCP1805&subtitle=HCP1805%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP1805 HCP1805 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp1902 https://druglandscape.com/api/og?type=drug&title=HCP1902&subtitle=HCP1902%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP1902 HCP1902 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp2001 https://druglandscape.com/api/og?type=drug&title=HCP2001&subtitle=HCP2001%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP2001 HCP2001 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp2201 https://druglandscape.com/api/og?type=drug&title=HCP2201&subtitle=HCP2201%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP2201 HCP2201 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp2202 https://druglandscape.com/api/og?type=drug&title=HCP2202&subtitle=HCP2202%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP2202 HCP2202 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hcp2303 https://druglandscape.com/api/og?type=drug&title=HCP2303&subtitle=HCP2303%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HCP2303 HCP2303 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hct-msc https://druglandscape.com/api/og?type=drug&title=hCT-MSC&subtitle=hCT-MSC%20%C2%B7%20Joanne%20Kurtzberg%2C%20MD&badge=phase%201 hCT-MSC hCT-MSC · Joanne Kurtzberg, MD https://druglandscape.com/drug/hcv-treatment https://druglandscape.com/api/og?type=drug&title=HCV%20treatment&subtitle=HCV%20treatment%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 HCV treatment HCV treatment · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/hcvax https://druglandscape.com/api/og?type=drug&title=HCVax&subtitle=HCVax%20%C2%B7%20GeneCure%20Biotechnologies&badge=phase%201 HCVax HCVax · GeneCure Biotechnologies https://druglandscape.com/drug/hcw9302-an-il-2-fusion-protein https://druglandscape.com/api/og?type=drug&title=HCW9302%2C%20an%20IL-2%20fusion%20protein&subtitle=HCW9302%2C%20an%20IL-2%20fusion%20protein%20%C2%B7%20HCW%20Biologics&badge=phase%201 HCW9302, an IL-2 fusion protein HCW9302, an IL-2 fusion protein · HCW Biologics https://druglandscape.com/drug/hd-p023 https://druglandscape.com/api/og?type=drug&title=HD-P023&subtitle=HD-P023%20%C2%B7%20Handok%20Inc.&badge=phase%201 HD-P023 HD-P023 · Handok Inc. https://druglandscape.com/drug/hd-pepgnp-covid19 https://druglandscape.com/api/og?type=drug&title=HD%20PepGNP-Covid19&subtitle=HD%20PepGNP-Covid19%20%C2%B7%20Gylden%20Pharma%20Ltd&badge=phase%201 HD PepGNP-Covid19 HD PepGNP-Covid19 · Gylden Pharma Ltd https://druglandscape.com/drug/hd-universal-influenza-vaccine-uniflu https://druglandscape.com/api/og?type=drug&title=HD%20Universal%20Influenza%20Vaccine%20Uniflu&subtitle=HD%20Universal%20Influenza%20Vaccine%20Uniflu%20%C2%B7%20VA%20Pharma%20Limited%20Liability%20Company&badge=phase%201 HD Universal Influenza Vaccine Uniflu HD Universal Influenza Vaccine Uniflu · VA Pharma Limited Liability Company https://druglandscape.com/drug/hddo-1756 https://druglandscape.com/api/og?type=drug&title=HDDO-1756&subtitle=HDDO-1756%20%C2%B7%20Hyundai%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%201 HDDO-1756 HDDO-1756 · Hyundai Pharmaceutical Co., LTD. https://druglandscape.com/drug/hdfscs-exo https://druglandscape.com/api/og?type=drug&title=hDFSCs-Exo&subtitle=hDFSCs-Exo%20%C2%B7%20Zigong%20Mental%20Health%20Center&badge=phase%201 hDFSCs-Exo hDFSCs-Exo · Zigong Mental Health Center https://druglandscape.com/drug/hdit101 https://druglandscape.com/api/og?type=drug&title=HDIT101&subtitle=HDIT101%20%C2%B7%20Heidelberg%20ImmunoTherapeutics%20GmbH&badge=phase%202 HDIT101 HDIT101 · Heidelberg ImmunoTherapeutics GmbH https://druglandscape.com/drug/hdm1002 https://druglandscape.com/api/og?type=drug&title=HDM1002&subtitle=HDM1002%20%C2%B7%20Hangzhou%20Zhongmei%20Huadong%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HDM1002 HDM1002 · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hdm1002-and-itraconazole https://druglandscape.com/api/og?type=drug&title=HDM1002%20and%20itraconazole&subtitle=HDM1002%20and%20itraconazole%20%C2%B7%20Hangzhou%20Zhongmei%20Huadong%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HDM1002 and itraconazole HDM1002 and itraconazole · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hdm1002-and-rifampicin https://druglandscape.com/api/og?type=drug&title=HDM1002%20and%20rifampicin&subtitle=HDM1002%20and%20rifampicin%20%C2%B7%20Hangzhou%20Zhongmei%20Huadong%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HDM1002 and rifampicin HDM1002 and rifampicin · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hdm1005-4 https://druglandscape.com/api/og?type=drug&title=HDM1005%204&subtitle=HDM1005%204%20%C2%B7%20Hangzhou%20Zhongmei%20Huadong%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 HDM1005 4 HDM1005 4 · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hdm2005 https://druglandscape.com/api/og?type=drug&title=HDM2005&subtitle=HDM2005%20%C2%B7%20Hangzhou%20Zhongmei%20Huadong%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HDM2005 HDM2005 · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hdm2006 https://druglandscape.com/api/og?type=drug&title=HDM2006&subtitle=HDM2006%20%C2%B7%20Hangzhou%20Zhongmei%20Huadong%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HDM2006 HDM2006 · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hdm201 https://druglandscape.com/api/og?type=drug&title=HDM201&subtitle=HDM201%20%C2%B7%20Centre%20Leon%20Berard&badge=phase%202 HDM201 HDM201 · Centre Leon Berard https://druglandscape.com/drug/hdm2012 https://druglandscape.com/api/og?type=drug&title=HDM2012&subtitle=HDM2012%20%C2%B7%20Hangzhou%20Zhongmei%20Huadong%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HDM2012 HDM2012 · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hdm2017 https://druglandscape.com/api/og?type=drug&title=HDM2017&subtitle=HDM2017%20%C2%B7%20Hangzhou%20Zhongmei%20Huadong%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HDM2017 HDM2017 · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hdm2020 https://druglandscape.com/api/og?type=drug&title=HDM2020&subtitle=HDM2020%20%C2%B7%20Hangzhou%20Zhongmei%20Huadong%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HDM2020 HDM2020 · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hdnagr-therapy https://druglandscape.com/api/og?type=drug&title=hDNAgr%20Therapy&subtitle=hDNAgr%20Therapy%20%C2%B7%20S.LAB%20(SOLOWAYS)&badge=phase%201 hDNAgr Therapy hDNAgr Therapy · S.LAB (SOLOWAYS) https://druglandscape.com/drug/hdp-101 https://druglandscape.com/api/og?type=drug&title=HDP-101&subtitle=HDP-101%20%C2%B7%20Heidelberg%20Pharma%20AG&badge=phase%201 HDP-101 HDP-101 · Heidelberg Pharma AG https://druglandscape.com/drug/head-and-neck https://druglandscape.com/api/og?type=drug&title=Head%20and%20neck&subtitle=Head%20and%20neck%20%C2%B7%20howard%20safran&badge=phase%201 Head and neck Head and neck · howard safran https://druglandscape.com/drug/healthy-subjects https://druglandscape.com/api/og?type=drug&title=Healthy%20subjects&subtitle=Healthy%20subjects%20%C2%B7%20Nadia%20Bouzidi%2C%20PhD&badge=phase%202 Healthy subjects Healthy subjects · Nadia Bouzidi, PhD https://druglandscape.com/drug/hearing-aid-with-nr-4 https://druglandscape.com/api/og?type=drug&title=Hearing%20Aid%20with%20NR_4&subtitle=Hearing%20Aid%20with%20NR_4%20%C2%B7%20Sonova%20AG&badge=phase%201 Hearing Aid with NR_4 Hearing Aid with NR_4 · Sonova AG https://druglandscape.com/drug/heated-lidocaine-and-tetracaine-patch https://druglandscape.com/api/og?type=drug&title=Heated%20Lidocaine%20and%20Tetracaine%20Patch&subtitle=Heated%20Lidocaine%20and%20Tetracaine%20Patch%20%C2%B7%20ZARS%20Pharma%20Inc.&badge=phase%202 Heated Lidocaine and Tetracaine Patch Heated Lidocaine and Tetracaine Patch · ZARS Pharma Inc. https://druglandscape.com/drug/hec-68498 https://druglandscape.com/api/og?type=drug&title=HEC%2068498&subtitle=HEC%2068498%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC 68498 HEC 68498 · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec-glargine https://druglandscape.com/api/og?type=drug&title=HEC-Glargine&subtitle=HEC-Glargine%20%C2%B7%20Lannett%20Company%2C%20Inc.&badge=phase%201 HEC-Glargine HEC-Glargine · Lannett Company, Inc. https://druglandscape.com/drug/hec110114 https://druglandscape.com/api/og?type=drug&title=HEC110114&subtitle=HEC110114%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC110114 HEC110114 · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec113995 https://druglandscape.com/api/og?type=drug&title=HEC113995&subtitle=HEC113995%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC113995 HEC113995 · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec113995-pa-h2o-tablets https://druglandscape.com/api/og?type=drug&title=HEC113995%20PA%E2%80%A2H2O%20tablets&subtitle=HEC113995%20PA%E2%80%A2H2O%20tablets%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC113995 PA•H2O tablets HEC113995 PA•H2O tablets · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec113995pa-h2o-tablet https://druglandscape.com/api/og?type=drug&title=HEC113995PA%E2%80%A2H2O%20tablet&subtitle=HEC113995PA%E2%80%A2H2O%20tablet%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC113995PA•H2O tablet HEC113995PA•H2O tablet · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec116094 https://druglandscape.com/api/og?type=drug&title=HEC116094&subtitle=HEC116094%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC116094 HEC116094 · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec122505msoh https://druglandscape.com/api/og?type=drug&title=HEC122505MsOH&subtitle=HEC122505MsOH%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC122505MsOH HEC122505MsOH · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec169096 https://druglandscape.com/api/og?type=drug&title=HEC169096&subtitle=HEC169096%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC169096 HEC169096 · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec169584-capsule https://druglandscape.com/api/og?type=drug&title=HEC169584%20capsule&subtitle=HEC169584%20capsule%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC169584 capsule HEC169584 capsule · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec30654acoh-capsule https://druglandscape.com/api/og?type=drug&title=HEC30654AcOH%20capsule&subtitle=HEC30654AcOH%20capsule%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC30654AcOH capsule HEC30654AcOH capsule · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec53856 https://druglandscape.com/api/og?type=drug&title=HEC53856&subtitle=HEC53856%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC53856 HEC53856 · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec585-dose-b https://druglandscape.com/api/og?type=drug&title=HEC585%20dose%20B&subtitle=HEC585%20dose%20B%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%202 HEC585 dose B HEC585 dose B · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec73077-tablets https://druglandscape.com/api/og?type=drug&title=HEC73077%20tablets&subtitle=HEC73077%20tablets%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC73077 tablets HEC73077 tablets · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec74647 https://druglandscape.com/api/og?type=drug&title=HEC74647&subtitle=HEC74647%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC74647 HEC74647 · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec74647pa-capsule https://druglandscape.com/api/og?type=drug&title=HEC74647PA%20capsule&subtitle=HEC74647PA%20capsule%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC74647PA capsule HEC74647PA capsule · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec83518-tablets https://druglandscape.com/api/og?type=drug&title=HEC83518%20tablets&subtitle=HEC83518%20tablets%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC83518 tablets HEC83518 tablets · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec93077 https://druglandscape.com/api/og?type=drug&title=HEC93077&subtitle=HEC93077%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC93077 HEC93077 · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/hec96719-tablets https://druglandscape.com/api/og?type=drug&title=HEC96719%20tablets&subtitle=HEC96719%20tablets%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 HEC96719 tablets HEC96719 tablets · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/height-adjusted-dose-of-bupivacaine https://druglandscape.com/api/og?type=drug&title=Height-adjusted%20dose%20of%20bupivacaine&subtitle=Height-adjusted%20dose%20of%20bupivacaine%20%C2%B7%20Bartosz%20Horosz%2C%20MD&badge=phase%201 Height-adjusted dose of bupivacaine Height-adjusted dose of bupivacaine · Bartosz Horosz, MD https://druglandscape.com/drug/hemamax https://druglandscape.com/api/og?type=drug&title=HemaMax&subtitle=HemaMax%20%C2%B7%20Neumedicines%20Inc.&badge=phase%202 HemaMax HemaMax · Neumedicines Inc. https://druglandscape.com/drug/hematologic-drug https://druglandscape.com/api/og?type=drug&title=Hematologic%20Drug&subtitle=Hematologic%20Drug%20%C2%B7%20Maite%20Antonio%2C%20MD%2C%20Phd&badge=phase%201 Hematologic Drug Hematologic Drug · Maite Antonio, MD, Phd https://druglandscape.com/drug/hematological-indicators https://druglandscape.com/api/og?type=drug&title=Hematological%20indicators&subtitle=Hematological%20indicators%20%C2%B7%20Ya-Wei%20Xu&badge=phase%202 Hematological indicators Hematological indicators · Ya-Wei Xu https://druglandscape.com/drug/hematopoietic-cell-transplantation-conditioning-regimen https://druglandscape.com/api/og?type=drug&title=Hematopoietic%20Cell%20Transplantation%20Conditioning%20Regimen&subtitle=Hematopoietic%20Cell%20Transplantation%20Conditioning%20Regimen%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%202 Hematopoietic Cell Transplantation Conditioning Regimen Hematopoietic Cell Transplantation Conditioning Regimen · City of Hope Medical Center https://druglandscape.com/drug/hematopoietic-factor https://druglandscape.com/api/og?type=drug&title=Hematopoietic%20Factor&subtitle=Hematopoietic%20Factor%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%202 Hematopoietic Factor Hematopoietic Factor · Baylor College of Medicine https://druglandscape.com/drug/hemay005-tablets https://druglandscape.com/api/og?type=drug&title=Hemay005%20tablets&subtitle=Hemay005%20tablets%20%C2%B7%20Ganzhou%20Hemay%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 Hemay005 tablets Hemay005 tablets · Ganzhou Hemay Pharmaceutical Co., Ltd https://druglandscape.com/drug/hemay102 https://druglandscape.com/api/og?type=drug&title=Hemay102&subtitle=Hemay102%20%C2%B7%20Tianjin%20Hemay%20Oncology%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 Hemay102 Hemay102 · Tianjin Hemay Oncology Pharmaceutical Co., Ltd https://druglandscape.com/drug/hemay181 https://druglandscape.com/api/og?type=drug&title=Hemay181&subtitle=Hemay181%20%C2%B7%20Ganzhou%20Hemay%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 Hemay181 Hemay181 · Ganzhou Hemay Pharmaceutical Co., Ltd https://druglandscape.com/drug/heme-arginate-administration https://druglandscape.com/api/og?type=drug&title=heme%20arginate%20administration&subtitle=heme%20arginate%20administration%20%C2%B7%20MWolzt&badge=phase%202 heme arginate administration heme arginate administration · MWolzt https://druglandscape.com/drug/hemp-based-cbd https://druglandscape.com/api/og?type=drug&title=Hemp-based%20CBD&subtitle=Hemp-based%20CBD%20%C2%B7%20Main%20Line%20Health&badge=phase%202 Hemp-based CBD Hemp-based CBD · Main Line Health https://druglandscape.com/drug/hepatic-derived-surgical-matrix https://druglandscape.com/api/og?type=drug&title=Hepatic%20derived%20surgical%20matrix&subtitle=Hepatic%20derived%20surgical%20matrix%20%C2%B7%20Miromatrix%20Medical%20Inc.&badge=phase%202 Hepatic derived surgical matrix Hepatic derived surgical matrix · Miromatrix Medical Inc. https://druglandscape.com/drug/hepatitis-b-control-vaccine https://druglandscape.com/api/og?type=drug&title=Hepatitis%20B%20control%20vaccine&subtitle=Hepatitis%20B%20control%20vaccine%20%C2%B7%20African%20Malaria%20Network%20Trust&badge=phase%201 Hepatitis B control vaccine Hepatitis B control vaccine · African Malaria Network Trust https://druglandscape.com/drug/hepatitis-b-vaccine-experimental-formulation https://druglandscape.com/api/og?type=drug&title=Hepatitis%20B%20vaccine%2C%20experimental%20formulation&subtitle=Hepatitis%20B%20vaccine%2C%20experimental%20formulation%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Hepatitis B vaccine, experimental formulation Hepatitis B vaccine, experimental formulation · GlaxoSmithKline https://druglandscape.com/drug/hepatitis-b-vaccines https://druglandscape.com/api/og?type=drug&title=hepatitis%20B%20vaccines&subtitle=hepatitis%20B%20vaccines%20%C2%B7%20National%20Heart%2C%20Lung%2C%20and%20Blood%20Institute%20(NHLBI)&badge=phase%203 hepatitis B vaccines hepatitis B vaccines · National Heart, Lung, and Blood Institute (NHLBI) https://druglandscape.com/drug/hepatitis-e-serology https://druglandscape.com/api/og?type=drug&title=Hepatitis%20E%20serology&subtitle=Hepatitis%20E%20serology%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 Hepatitis E serology Hepatitis E serology · Hospices Civils de Lyon https://druglandscape.com/drug/hepenofovir-fumarate-tablets-dose4 https://druglandscape.com/api/og?type=drug&title=Hepenofovir%20Fumarate%20Tablets%20Dose4&subtitle=Hepenofovir%20Fumarate%20Tablets%20Dose4%20%C2%B7%20Xi'an%20Xintong%20Pharmaceutical%20Research%20Co.%2CLtd.&badge=phase%201 Hepenofovir Fumarate Tablets Dose4 Hepenofovir Fumarate Tablets Dose4 · Xi'an Xintong Pharmaceutical Research Co.,Ltd. https://druglandscape.com/drug/hepenofovir-fumarate-tablets-single-dose https://druglandscape.com/api/og?type=drug&title=Hepenofovir%20Fumarate%20Tablets%20Single%20Dose&subtitle=Hepenofovir%20Fumarate%20Tablets%20Single%20Dose%20%C2%B7%20Xi'an%20Xintong%20Pharmaceutical%20Research%20Co.%2CLtd.&badge=phase%201 Hepenofovir Fumarate Tablets Single Dose Hepenofovir Fumarate Tablets Single Dose · Xi'an Xintong Pharmaceutical Research Co.,Ltd. https://druglandscape.com/drug/her-096 https://druglandscape.com/api/og?type=drug&title=HER-096&subtitle=HER-096%20%C2%B7%20Herantis%20Pharma%20Plc.&badge=phase%201 HER-096 HER-096 · Herantis Pharma Plc. https://druglandscape.com/drug/her-car-cmv-specific-ctls https://druglandscape.com/api/og?type=drug&title=HER.CAR%20CMV-specific%20CTLs&subtitle=HER.CAR%20CMV-specific%20CTLs%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 HER.CAR CMV-specific CTLs HER.CAR CMV-specific CTLs · Baylor College of Medicine https://druglandscape.com/drug/her2-e-cart-cells https://druglandscape.com/api/og?type=drug&title=HER2-E-CART%20cells&subtitle=HER2-E-CART%20cells%20%C2%B7%20su%20haichuan&badge=phase%201 HER2-E-CART cells HER2-E-CART cells · su haichuan https://druglandscape.com/drug/her2-specific-car-t-cell https://druglandscape.com/api/og?type=drug&title=HER2%20Specific%20CAR%20T%20Cell&subtitle=HER2%20Specific%20CAR%20T%20Cell%20%C2%B7%20Children's%20Oncology%20Group&badge=phase%201 HER2 Specific CAR T Cell HER2 Specific CAR T Cell · Children's Oncology Group https://druglandscape.com/drug/her2-vaccine https://druglandscape.com/api/og?type=drug&title=HER2%20Vaccine&subtitle=HER2%20Vaccine%20%C2%B7%20Pravin%20T.P%20Kaumaya&badge=phase%201 HER2 Vaccine HER2 Vaccine · Pravin T.P Kaumaya https://druglandscape.com/drug/herbal-api https://druglandscape.com/api/og?type=drug&title=Herbal%20API&subtitle=Herbal%20API%20%C2%B7%20Shaare%20Zedek%20Medical%20Center&badge=phase%201 Herbal API Herbal API · Shaare Zedek Medical Center https://druglandscape.com/drug/herbmed-plus https://druglandscape.com/api/og?type=drug&title=Herbmed%20plus&subtitle=Herbmed%20plus%20%C2%B7%20Dr%20.S.B.PATANKAR&badge=phase%202 Herbmed plus Herbmed plus · Dr .S.B.PATANKAR https://druglandscape.com/drug/herceptin-eu https://druglandscape.com/api/og?type=drug&title=Herceptin%20EU&subtitle=Herceptin%20EU%20%C2%B7%20Mylan%20Pharmaceuticals%20Inc&badge=phase%201 Herceptin EU Herceptin EU · Mylan Pharmaceuticals Inc https://druglandscape.com/drug/herpes-simplex-virus-containing-gd-alum https://druglandscape.com/api/og?type=drug&title=Herpes%20simplex%20virus%20containing%20gD-Alum&subtitle=Herpes%20simplex%20virus%20containing%20gD-Alum%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Herpes simplex virus containing gD-Alum Herpes simplex virus containing gD-Alum · GlaxoSmithKline https://druglandscape.com/drug/herpes-zoster-vaccine-1437173a https://druglandscape.com/api/og?type=drug&title=Herpes%20Zoster%20Vaccine%201437173A&subtitle=Herpes%20Zoster%20Vaccine%201437173A%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Herpes Zoster Vaccine 1437173A Herpes Zoster Vaccine 1437173A · GlaxoSmithKline https://druglandscape.com/drug/hetrombopag-olamine-tablet https://druglandscape.com/api/og?type=drug&title=Hetrombopag%20Olamine%20Tablet&subtitle=Hetrombopag%20Olamine%20Tablet%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Hetrombopag Olamine Tablet Hetrombopag Olamine Tablet · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hetrombopag-olamine-tablets https://druglandscape.com/api/og?type=drug&title=Hetrombopag%20Olamine%20Tablets&subtitle=Hetrombopag%20Olamine%20Tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Hetrombopag Olamine Tablets Hetrombopag Olamine Tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hev-sg-v https://druglandscape.com/api/og?type=drug&title=HeV-sG-V&subtitle=HeV-sG-V%20%C2%B7%20Auro%20Vaccines%20LLC&badge=phase%201 HeV-sG-V HeV-sG-V · Auro Vaccines LLC https://druglandscape.com/drug/hexell-2020 https://druglandscape.com/api/og?type=drug&title=HeXell-2020&subtitle=HeXell-2020%20%C2%B7%20Hexun%20Biosciences%20Co.%2C%20LTD.&badge=phase%201 HeXell-2020 HeXell-2020 · Hexun Biosciences Co., LTD. https://druglandscape.com/drug/hexylaminolaevulinate-cream https://druglandscape.com/api/og?type=drug&title=Hexylaminolaevulinate%20cream&subtitle=Hexylaminolaevulinate%20cream%20%C2%B7%20Joint%20Authority%20for%20P%C3%A4ij%C3%A4t-H%C3%A4me%20Social%20and%20Health%20Care&badge=phase%201 Hexylaminolaevulinate cream Hexylaminolaevulinate cream · Joint Authority for Päijät-Häme Social and Health Care https://druglandscape.com/drug/hezkue-sildenafil-oral-suspension https://druglandscape.com/api/og?type=drug&title=Hezkue%20Sildenafil%20Oral%20Suspension&subtitle=Hezkue%20Sildenafil%20Oral%20Suspension%20%C2%B7%20Aspargo%20Labs%2C%20Inc&badge=phase%202 Hezkue Sildenafil Oral Suspension Hezkue Sildenafil Oral Suspension · Aspargo Labs, Inc https://druglandscape.com/drug/hf1020 https://druglandscape.com/api/og?type=drug&title=HF1020&subtitle=HF1020%20%C2%B7%20Trident%20Pharmaceuticals%20Inc&badge=phase%201 HF1020 HF1020 · Trident Pharmaceuticals Inc https://druglandscape.com/drug/hf1k16 https://druglandscape.com/api/og?type=drug&title=HF1K16&subtitle=HF1K16%20%C2%B7%20HighField%20Biopharmaceuticals%20Corporation&badge=phase%201 HF1K16 HF1K16 · HighField Biopharmaceuticals Corporation https://druglandscape.com/drug/hfa-134a-propellant https://druglandscape.com/api/og?type=drug&title=HFA-134A%20propellant&subtitle=HFA-134A%20propellant%20%C2%B7%20GlaxoSmithKline&badge=phase%201 HFA-134A propellant HFA-134A propellant · GlaxoSmithKline https://druglandscape.com/drug/hfa-152a-propellant https://druglandscape.com/api/og?type=drug&title=HFA-152A%20propellant&subtitle=HFA-152A%20propellant%20%C2%B7%20GlaxoSmithKline&badge=phase%201 HFA-152A propellant HFA-152A propellant · GlaxoSmithKline https://druglandscape.com/drug/hfb200301 https://druglandscape.com/api/og?type=drug&title=HFB200301&subtitle=HFB200301%20%C2%B7%20HiFiBiO%20Therapeutics&badge=phase%201 HFB200301 HFB200301 · HiFiBiO Therapeutics https://druglandscape.com/drug/hfb200603 https://druglandscape.com/api/og?type=drug&title=HFB200603&subtitle=HFB200603%20%C2%B7%20HiFiBiO%20Therapeutics&badge=phase%201 HFB200603 HFB200603 · HiFiBiO Therapeutics https://druglandscape.com/drug/hfb30132a https://druglandscape.com/api/og?type=drug&title=HFB30132A&subtitle=HFB30132A%20%C2%B7%20HiFiBiO%20Therapeutics&badge=phase%201 HFB30132A HFB30132A · HiFiBiO Therapeutics https://druglandscape.com/drug/hg004 https://druglandscape.com/api/og?type=drug&title=HG004&subtitle=HG004%20%C2%B7%20HuidaGene%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 HG004 HG004 · HuidaGene Therapeutics Co., Ltd. https://druglandscape.com/drug/hg146 https://druglandscape.com/api/og?type=drug&title=HG146&subtitle=HG146%20%C2%B7%20HitGen%20Inc.&badge=phase%202 HG146 HG146 · HitGen Inc. https://druglandscape.com/drug/hg381 https://druglandscape.com/api/og?type=drug&title=HG381&subtitle=HG381%20%C2%B7%20HitGen%20Inc.&badge=phase%201 HG381 HG381 · HitGen Inc. https://druglandscape.com/drug/hgf-plasmid https://druglandscape.com/api/og?type=drug&title=HGF%20Plasmid&subtitle=HGF%20Plasmid%20%C2%B7%20AnGes%20USA%2C%20Inc.&badge=phase%202 HGF Plasmid HGF Plasmid · AnGes USA, Inc. https://druglandscape.com/drug/hgp0904-and-hgp1201-co-administraion https://druglandscape.com/api/og?type=drug&title=HGP0904%20and%20HGP1201%20co-administraion&subtitle=HGP0904%20and%20HGP1201%20co-administraion%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP0904 and HGP1201 co-administraion HGP0904 and HGP1201 co-administraion · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgp0918 https://druglandscape.com/api/og?type=drug&title=HGP0918&subtitle=HGP0918%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP0918 HGP0918 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgp1103 https://druglandscape.com/api/og?type=drug&title=HGP1103&subtitle=HGP1103%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP1103 HGP1103 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgp1206 https://druglandscape.com/api/og?type=drug&title=HGP1206&subtitle=HGP1206%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP1206 HGP1206 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgp1404 https://druglandscape.com/api/og?type=drug&title=HGP1404&subtitle=HGP1404%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP1404 HGP1404 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgp1405 https://druglandscape.com/api/og?type=drug&title=HGP1405&subtitle=HGP1405%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP1405 HGP1405 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgp1406 https://druglandscape.com/api/og?type=drug&title=HGP1406&subtitle=HGP1406%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP1406 HGP1406 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgp1501 https://druglandscape.com/api/og?type=drug&title=HGP1501&subtitle=HGP1501%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP1501 HGP1501 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgp1602 https://druglandscape.com/api/og?type=drug&title=HGP1602&subtitle=HGP1602%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP1602 HGP1602 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgp1607 https://druglandscape.com/api/og?type=drug&title=HGP1607&subtitle=HGP1607%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP1607 HGP1607 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgp1809 https://druglandscape.com/api/og?type=drug&title=HGP1809&subtitle=HGP1809%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP1809 HGP1809 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgp1810 https://druglandscape.com/api/og?type=drug&title=HGP1810&subtitle=HGP1810%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP1810 HGP1810 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgp1812 https://druglandscape.com/api/og?type=drug&title=HGP1812&subtitle=HGP1812%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP1812 HGP1812 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgp2001 https://druglandscape.com/api/og?type=drug&title=HGP2001&subtitle=HGP2001%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HGP2001 HGP2001 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hgr4113 https://druglandscape.com/api/og?type=drug&title=HGR4113&subtitle=HGR4113%20%C2%B7%20Glaceum&badge=phase%201 HGR4113 HGR4113 · Glaceum https://druglandscape.com/drug/hh2853-tablets https://druglandscape.com/api/og?type=drug&title=HH2853%20Tablets&subtitle=HH2853%20Tablets%20%C2%B7%20Haihe%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 HH2853 Tablets HH2853 Tablets · Haihe Biopharma Co., Ltd. https://druglandscape.com/drug/hi-con1-150-l https://druglandscape.com/api/og?type=drug&title=hI-con1%E2%84%A2%20150%C2%B5l&subtitle=hI-con1%E2%84%A2%20150%C2%B5l%20%C2%B7%20Iconic%20Therapeutics%2C%20Inc.&badge=phase%201 hI-con1™ 150µl hI-con1™ 150µl · Iconic Therapeutics, Inc. https://druglandscape.com/drug/hi-con1-300-l https://druglandscape.com/api/og?type=drug&title=hI-con1%E2%84%A2%20300%C2%B5l&subtitle=hI-con1%E2%84%A2%20300%C2%B5l%20%C2%B7%20Iconic%20Therapeutics%2C%20Inc.&badge=phase%201 hI-con1™ 300µl hI-con1™ 300µl · Iconic Therapeutics, Inc. https://druglandscape.com/drug/hi-con1-60-l https://druglandscape.com/api/og?type=drug&title=hI-con1%E2%84%A2%2060%C2%B5l&subtitle=hI-con1%E2%84%A2%2060%C2%B5l%20%C2%B7%20Iconic%20Therapeutics%2C%20Inc.&badge=phase%201 hI-con1™ 60µl hI-con1™ 60µl · Iconic Therapeutics, Inc. https://druglandscape.com/drug/hib210 https://druglandscape.com/api/og?type=drug&title=HIB210&subtitle=HIB210%20%C2%B7%20HI-Bio%2C%20A%20Biogen%20Company&badge=phase%201 HIB210 HIB210 · HI-Bio, A Biogen Company https://druglandscape.com/drug/high-cbd-cannabis https://druglandscape.com/api/og?type=drug&title=High%20CBD%20cannabis&subtitle=High%20CBD%20cannabis%20%C2%B7%20Multidisciplinary%20Association%20for%20Psychedelic%20Studies&badge=phase%202 High CBD cannabis High CBD cannabis · Multidisciplinary Association for Psychedelic Studies https://druglandscape.com/drug/high-clonidine-concentration https://druglandscape.com/api/og?type=drug&title=high%20Clonidine%20concentration&subtitle=high%20Clonidine%20concentration%20%C2%B7%20Universidade%20Federal%20do%20Rio%20de%20Janeiro&badge=phase%202 high Clonidine concentration high Clonidine concentration · Universidade Federal do Rio de Janeiro https://druglandscape.com/drug/high-metformin https://druglandscape.com/api/og?type=drug&title=High%20Metformin&subtitle=High%20Metformin%20%C2%B7%20NuSirt%20Biopharma&badge=phase%202 High Metformin High Metformin · NuSirt Biopharma https://druglandscape.com/drug/high-price https://druglandscape.com/api/og?type=drug&title=High%20price&subtitle=High%20price%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 High price High price · Hadassah Medical Organization https://druglandscape.com/drug/high-sodium-diet https://druglandscape.com/api/og?type=drug&title=high%20sodium%20diet&subtitle=high%20sodium%20diet%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 high sodium diet high sodium diet · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/high-strength-idp-107 https://druglandscape.com/api/og?type=drug&title=High%20Strength%20IDP-107&subtitle=High%20Strength%20IDP-107%20%C2%B7%20Dow%20Pharmaceutical%20Sciences&badge=phase%202 High Strength IDP-107 High Strength IDP-107 · Dow Pharmaceutical Sciences https://druglandscape.com/drug/high-strength-idp-108-under-occlusion https://druglandscape.com/api/og?type=drug&title=High%20Strength%20IDP-108%20under%20occlusion&subtitle=High%20Strength%20IDP-108%20under%20occlusion%20%C2%B7%20Dow%20Pharmaceutical%20Sciences&badge=phase%202 High Strength IDP-108 under occlusion High Strength IDP-108 under occlusion · Dow Pharmaceutical Sciences https://druglandscape.com/drug/high-thc-cannabis https://druglandscape.com/api/og?type=drug&title=High%20THC%20cannabis&subtitle=High%20THC%20cannabis%20%C2%B7%20Multidisciplinary%20Association%20for%20Psychedelic%20Studies&badge=phase%202 High THC cannabis High THC cannabis · Multidisciplinary Association for Psychedelic Studies https://druglandscape.com/drug/high-titre-influenza-virus https://druglandscape.com/api/og?type=drug&title=High%20Titre%20Influenza%20virus&subtitle=High%20Titre%20Influenza%20virus%20%C2%B7%20Hvivo&badge=phase%201 High Titre Influenza virus High Titre Influenza virus · Hvivo https://druglandscape.com/drug/higher-dose-icotinib https://druglandscape.com/api/og?type=drug&title=Higher%20dose%20icotinib&subtitle=Higher%20dose%20icotinib%20%C2%B7%20Betta%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 Higher dose icotinib Higher dose icotinib · Betta Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/higher-dose-marketed-paracetamol https://druglandscape.com/api/og?type=drug&title=Higher%20dose%20marketed%20paracetamol&subtitle=Higher%20dose%20marketed%20paracetamol%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Higher dose marketed paracetamol Higher dose marketed paracetamol · GlaxoSmithKline https://druglandscape.com/drug/highly-selective-fgfr1-3-inhibitor https://druglandscape.com/api/og?type=drug&title=Highly%20selective%20FGFR1-3%20inhibitor&subtitle=Highly%20selective%20FGFR1-3%20inhibitor%20%C2%B7%203D%20Medicines%20(Beijing)%20Co.%2C%20Ltd.&badge=phase%201 Highly selective FGFR1-3 inhibitor Highly selective FGFR1-3 inhibitor · 3D Medicines (Beijing) Co., Ltd. https://druglandscape.com/drug/hiltonol-and-autologous-dendritic-cells https://druglandscape.com/api/og?type=drug&title=Hiltonol%20and%20autologous%20dendritic%20cells&subtitle=Hiltonol%20and%20autologous%20dendritic%20cells%20%C2%B7%20Clinica%20Universidad%20de%20Navarra%2C%20Universidad%20de%20Navarra&badge=phase%202 Hiltonol and autologous dendritic cells Hiltonol and autologous dendritic cells · Clinica Universidad de Navarra, Universidad de Navarra https://druglandscape.com/drug/hip0908 https://druglandscape.com/api/og?type=drug&title=HIP0908&subtitle=HIP0908%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HIP0908 HIP0908 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hip1302 https://druglandscape.com/api/og?type=drug&title=HIP1302&subtitle=HIP1302%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HIP1302 HIP1302 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hip1403 https://druglandscape.com/api/og?type=drug&title=HIP1403&subtitle=HIP1403%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HIP1403 HIP1403 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hip1503 https://druglandscape.com/api/og?type=drug&title=HIP1503&subtitle=HIP1503%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HIP1503 HIP1503 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hip1701 https://druglandscape.com/api/og?type=drug&title=HIP1701&subtitle=HIP1701%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HIP1701 HIP1701 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hip1802 https://druglandscape.com/api/og?type=drug&title=HIP1802&subtitle=HIP1802%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HIP1802 HIP1802 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hip2001 https://druglandscape.com/api/og?type=drug&title=HIP2001&subtitle=HIP2001%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HIP2001 HIP2001 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hip2105 https://druglandscape.com/api/og?type=drug&title=HIP2105&subtitle=HIP2105%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HIP2105 HIP2105 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hip2503 https://druglandscape.com/api/og?type=drug&title=HIP2503&subtitle=HIP2503%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HIP2503 HIP2503 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hip2b https://druglandscape.com/api/og?type=drug&title=HIP2B&subtitle=HIP2B%20%C2%B7%20CureDM&badge=phase%201 HIP2B HIP2B · CureDM https://druglandscape.com/drug/histology-based-chemotherapy-doublet https://druglandscape.com/api/og?type=drug&title=Histology-Based%20Chemotherapy%20Doublet&subtitle=Histology-Based%20Chemotherapy%20Doublet%20%C2%B7%20BeiGene&badge=phase%201 Histology-Based Chemotherapy Doublet Histology-Based Chemotherapy Doublet · BeiGene https://druglandscape.com/drug/hiv-lfn-p24 https://druglandscape.com/api/og?type=drug&title=HIV%20LFn-p24&subtitle=HIV%20LFn-p24%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 HIV LFn-p24 HIV LFn-p24 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/hiv-vaccine-732461 https://druglandscape.com/api/og?type=drug&title=HIV%20vaccine%20732461&subtitle=HIV%20vaccine%20732461%20%C2%B7%20GlaxoSmithKline&badge=phase%202 HIV vaccine 732461 HIV vaccine 732461 · GlaxoSmithKline https://druglandscape.com/drug/hiv-vaccine-732462 https://druglandscape.com/api/og?type=drug&title=HIV%20Vaccine%20732462&subtitle=HIV%20Vaccine%20732462%20%C2%B7%20GlaxoSmithKline&badge=phase%201 HIV Vaccine 732462 HIV Vaccine 732462 · GlaxoSmithKline https://druglandscape.com/drug/hivax https://druglandscape.com/api/og?type=drug&title=HIVAX&subtitle=HIVAX%20%C2%B7%20GeneCure%20Biotechnologies&badge=phase%201 HIVAX HIVAX · GeneCure Biotechnologies https://druglandscape.com/drug/hk-001 https://druglandscape.com/api/og?type=drug&title=HK-001&subtitle=HK-001%20%C2%B7%20Everfront%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 HK-001 HK-001 · Everfront Biotech Co., Ltd. https://druglandscape.com/drug/hk-660s https://druglandscape.com/api/og?type=drug&title=HK-660S&subtitle=HK-660S%20%C2%B7%20CuromeBiosciences&badge=phase%202 HK-660S HK-660S · CuromeBiosciences https://druglandscape.com/drug/hl-003-tablet-placeco https://druglandscape.com/api/og?type=drug&title=HL-003%20tablet%20Placeco&subtitle=HL-003%20tablet%20Placeco%20%C2%B7%20Shanghai%20Kechow%20Pharma%2C%20Inc.&badge=phase%201 HL-003 tablet Placeco HL-003 tablet Placeco · Shanghai Kechow Pharma, Inc. https://druglandscape.com/drug/hl-085 https://druglandscape.com/api/og?type=drug&title=HL-085&subtitle=HL-085%20%C2%B7%20Shanghai%20Kechow%20Pharma%2C%20Inc.&badge=phase%202 HL-085 HL-085 · Shanghai Kechow Pharma, Inc. https://druglandscape.com/drug/hl-1186 https://druglandscape.com/api/og?type=drug&title=HL-1186&subtitle=HL-1186%20%C2%B7%20Shanghai%20Yidian%20Pharmaceutical%20Technology%20Development%20Co.%2C%20Ltd.&badge=phase%202 HL-1186 HL-1186 · Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. https://druglandscape.com/drug/hl036 https://druglandscape.com/api/og?type=drug&title=HL036&subtitle=HL036%20%C2%B7%20HanAll%20BioPharma%20Co.%2C%20Ltd.&badge=phase%201 HL036 HL036 · HanAll BioPharma Co., Ltd. https://druglandscape.com/drug/hl040xc https://druglandscape.com/api/og?type=drug&title=HL040XC&subtitle=HL040XC%20%C2%B7%20HanAll%20BioPharma%20Co.%2C%20Ltd.&badge=phase%201 HL040XC HL040XC · HanAll BioPharma Co., Ltd. https://druglandscape.com/drug/hla-g-car-bite-allogeneic-t-cells https://druglandscape.com/api/og?type=drug&title=HLA-G-CAR.BiTE%20allogeneic%20%CE%B3%CE%B4%20T%20cells&subtitle=HLA-G-CAR.BiTE%20allogeneic%20%CE%B3%CE%B4%20T%20cells%20%C2%B7%20Ever%20Supreme%20Bio%20Technology%20Co.%2C%20Ltd.&badge=phase%201 HLA-G-CAR.BiTE allogeneic γδ T cells HLA-G-CAR.BiTE allogeneic γδ T cells · Ever Supreme Bio Technology Co., Ltd. https://druglandscape.com/drug/hla-matched-vsts https://druglandscape.com/api/og?type=drug&title=HLA-matched%20VSTs&subtitle=HLA-matched%20VSTs%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 HLA-matched VSTs HLA-matched VSTs · Baylor College of Medicine https://druglandscape.com/drug/hlb-001 https://druglandscape.com/api/og?type=drug&title=hLB-001&subtitle=hLB-001%20%C2%B7%20Alexion%20Pharmaceuticals%2C%20Inc.&badge=phase%202 hLB-001 hLB-001 · Alexion Pharmaceuticals, Inc. https://druglandscape.com/drug/hlb3-002 https://druglandscape.com/api/og?type=drug&title=HLB3-002&subtitle=HLB3-002%20%C2%B7%20Huonslab%20Co.%2C%20Ltd.&badge=phase%201 HLB3-002 HLB3-002 · Huonslab Co., Ltd. https://druglandscape.com/drug/hld-0915 https://druglandscape.com/api/og?type=drug&title=HLD-0915&subtitle=HLD-0915%20%C2%B7%20Halda%20Therapeutics%20OpCo%2C%20Inc.&badge=phase%201 HLD-0915 HLD-0915 · Halda Therapeutics OpCo, Inc. https://druglandscape.com/drug/hld100 https://druglandscape.com/api/og?type=drug&title=HLD100&subtitle=HLD100%20%C2%B7%20Ironshore%20Pharmaceuticals%20and%20Development%2C%20Inc&badge=phase%202 HLD100 HLD100 · Ironshore Pharmaceuticals and Development, Inc https://druglandscape.com/drug/hld100-b https://druglandscape.com/api/og?type=drug&title=HLD100-B&subtitle=HLD100-B%20%C2%B7%20Ironshore%20Pharmaceuticals%20and%20Development%2C%20Inc&badge=phase%201 HLD100-B HLD100-B · Ironshore Pharmaceuticals and Development, Inc https://druglandscape.com/drug/hld100-e https://druglandscape.com/api/og?type=drug&title=HLD100-E&subtitle=HLD100-E%20%C2%B7%20Ironshore%20Pharmaceuticals%20and%20Development%2C%20Inc&badge=phase%201 HLD100-E HLD100-E · Ironshore Pharmaceuticals and Development, Inc https://druglandscape.com/drug/hlx05 https://druglandscape.com/api/og?type=drug&title=HLX05&subtitle=HLX05%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 HLX05 HLX05 · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx07 https://druglandscape.com/api/og?type=drug&title=HLX07&subtitle=HLX07%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%202 HLX07 HLX07 · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx15 https://druglandscape.com/api/og?type=drug&title=HLX15&subtitle=HLX15%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 HLX15 HLX15 · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx15-sc-rd https://druglandscape.com/api/og?type=drug&title=HLX15-SC-Rd&subtitle=HLX15-SC-Rd%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 HLX15-SC-Rd HLX15-SC-Rd · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx20 https://druglandscape.com/api/og?type=drug&title=HLX20&subtitle=HLX20%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 HLX20 HLX20 · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx35 https://druglandscape.com/api/og?type=drug&title=HLX35&subtitle=HLX35%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 HLX35 HLX35 · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx37 https://druglandscape.com/api/og?type=drug&title=HLX37&subtitle=HLX37%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 HLX37 HLX37 · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx3901 https://druglandscape.com/api/og?type=drug&title=HLX3901&subtitle=HLX3901%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 HLX3901 HLX3901 · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx42 https://druglandscape.com/api/og?type=drug&title=HLX42&subtitle=HLX42%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 HLX42 HLX42 · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx43-dose-1-in-2l-tnbc https://druglandscape.com/api/og?type=drug&title=HLX43%20DOSE%201%20IN%20%E2%89%A52L%20TNBC&subtitle=HLX43%20DOSE%201%20IN%20%E2%89%A52L%20TNBC%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%202 HLX43 DOSE 1 IN ≥2L TNBC HLX43 DOSE 1 IN ≥2L TNBC · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx43-dose1-in-1l-tnbc https://druglandscape.com/api/og?type=drug&title=HLX43%20DOSE1%20IN%201L%20TNBC&subtitle=HLX43%20DOSE1%20IN%201L%20TNBC%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%202 HLX43 DOSE1 IN 1L TNBC HLX43 DOSE1 IN 1L TNBC · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx51 https://druglandscape.com/api/og?type=drug&title=HLX51&subtitle=HLX51%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 HLX51 HLX51 · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx53 https://druglandscape.com/api/og?type=drug&title=HLX53&subtitle=HLX53%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 HLX53 HLX53 · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx55 https://druglandscape.com/api/og?type=drug&title=HLX55&subtitle=HLX55%20%C2%B7%20Henlix%2C%20Inc&badge=phase%201 HLX55 HLX55 · Henlix, Inc https://druglandscape.com/drug/hlx60-combined-with-hlx10 https://druglandscape.com/api/og?type=drug&title=HLX60%20combined%20with%20HLX10&subtitle=HLX60%20combined%20with%20HLX10%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 HLX60 combined with HLX10 HLX60 combined with HLX10 · Shanghai Henlius Biotech https://druglandscape.com/drug/hlx71 https://druglandscape.com/api/og?type=drug&title=HLX71&subtitle=HLX71%20%C2%B7%20Hengenix%20Biotech%20Inc&badge=phase%201 HLX71 HLX71 · Hengenix Biotech Inc https://druglandscape.com/drug/hlx97 https://druglandscape.com/api/og?type=drug&title=HLX97&subtitle=HLX97%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 HLX97 HLX97 · Shanghai Henlius Biotech https://druglandscape.com/drug/hm12470 https://druglandscape.com/api/og?type=drug&title=HM12470&subtitle=HM12470%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HM12470 HM12470 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hm15275 https://druglandscape.com/api/og?type=drug&title=HM15275&subtitle=HM15275%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%202 HM15275 HM15275 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hm15912-active https://druglandscape.com/api/og?type=drug&title=HM15912%20Active&subtitle=HM15912%20Active%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%202 HM15912 Active HM15912 Active · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hm16390 https://druglandscape.com/api/og?type=drug&title=HM16390&subtitle=HM16390%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HM16390 HM16390 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hm17321 https://druglandscape.com/api/og?type=drug&title=HM17321&subtitle=HM17321%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HM17321 HM17321 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hm71224-food-effect https://druglandscape.com/api/og?type=drug&title=HM71224%20food%20effect&subtitle=HM71224%20food%20effect%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HM71224 food effect HM71224 food effect · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hm71224-single-ascending-dose https://druglandscape.com/api/og?type=drug&title=HM71224%20single%20ascending%20dose&subtitle=HM71224%20single%20ascending%20dose%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HM71224 single ascending dose HM71224 single ascending dose · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hm97662 https://druglandscape.com/api/og?type=drug&title=HM97662&subtitle=HM97662%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 HM97662 HM97662 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hmb-plus-vitamin-d https://druglandscape.com/api/og?type=drug&title=HMB%20plus%20Vitamin%20D&subtitle=HMB%20plus%20Vitamin%20D%20%C2%B7%20Metabolic%20Technologies%20Inc.&badge=phase%201 HMB plus Vitamin D HMB plus Vitamin D · Metabolic Technologies Inc. https://druglandscape.com/drug/hmbd-001-and-enzalutamide https://druglandscape.com/api/og?type=drug&title=HMBD-001%20and%20enzalutamide&subtitle=HMBD-001%20and%20enzalutamide%20%C2%B7%20Cancer%20Research%20UK&badge=phase%201 HMBD-001 and enzalutamide HMBD-001 and enzalutamide · Cancer Research UK https://druglandscape.com/drug/hmpl-004-high-dose https://druglandscape.com/api/og?type=drug&title=HMPL-004%20high%20dose&subtitle=HMPL-004%20high%20dose%20%C2%B7%20Hutchison%20Medipharma%20Limited&badge=phase%202 HMPL-004 high dose HMPL-004 high dose · Hutchison Medipharma Limited https://druglandscape.com/drug/hmpl-004-low-dose https://druglandscape.com/api/og?type=drug&title=HMPL-004%20low%20dose&subtitle=HMPL-004%20low%20dose%20%C2%B7%20Hutchison%20Medipharma%20Limited&badge=phase%202 HMPL-004 low dose HMPL-004 low dose · Hutchison Medipharma Limited https://druglandscape.com/drug/hmpl-011-capsules https://druglandscape.com/api/og?type=drug&title=HMPL-011%20capsules&subtitle=HMPL-011%20capsules%20%C2%B7%20Hutchison%20Medipharma%20Limited&badge=phase%201 HMPL-011 capsules HMPL-011 capsules · Hutchison Medipharma Limited https://druglandscape.com/drug/hmpl-011-tablets https://druglandscape.com/api/og?type=drug&title=HMPL-011%20tablets&subtitle=HMPL-011%20tablets%20%C2%B7%20Hutchison%20Medipharma%20Limited&badge=phase%201 HMPL-011 tablets HMPL-011 tablets · Hutchison Medipharma Limited https://druglandscape.com/drug/hmpl-415s1 https://druglandscape.com/api/og?type=drug&title=HMPL-415S1&subtitle=HMPL-415S1%20%C2%B7%20Hutchmed&badge=phase%201 HMPL-415S1 HMPL-415S1 · Hutchmed https://druglandscape.com/drug/hmpl-a251 https://druglandscape.com/api/og?type=drug&title=HMPL-A251&subtitle=HMPL-A251%20%C2%B7%20Hutchmed&badge=phase%201 HMPL-A251 HMPL-A251 · Hutchmed https://druglandscape.com/drug/hmsc https://druglandscape.com/api/og?type=drug&title=hMSC&subtitle=hMSC%20%C2%B7%20Bernard%20(Barry)%20Baumel&badge=phase%202 hMSC hMSC · Bernard (Barry) Baumel https://druglandscape.com/drug/hnc042-multiple-ascending-doses https://druglandscape.com/api/og?type=drug&title=HNC042%20multiple%20ascending%20doses&subtitle=HNC042%20multiple%20ascending%20doses%20%C2%B7%20Guangzhou%20Henovcom%20Bioscience%20Co.%20Ltd.&badge=phase%201 HNC042 multiple ascending doses HNC042 multiple ascending doses · Guangzhou Henovcom Bioscience Co. Ltd. https://druglandscape.com/drug/hnc042-single-dose https://druglandscape.com/api/og?type=drug&title=HNC042%20single%20dose&subtitle=HNC042%20single%20dose%20%C2%B7%20Guangzhou%20Henovcom%20Bioscience%20Co.%20Ltd.&badge=phase%201 HNC042 single dose HNC042 single dose · Guangzhou Henovcom Bioscience Co. Ltd. https://druglandscape.com/drug/hnc1058-capsules https://druglandscape.com/api/og?type=drug&title=HNC1058%20Capsules&subtitle=HNC1058%20Capsules%20%C2%B7%20Guangzhou%20Henovcom%20Bioscience%20Co.%20Ltd.&badge=phase%201 HNC1058 Capsules HNC1058 Capsules · Guangzhou Henovcom Bioscience Co. Ltd. https://druglandscape.com/drug/hnc364 https://druglandscape.com/api/og?type=drug&title=HNC364&subtitle=HNC364%20%C2%B7%20Guangzhou%20Henovcom%20Bioscience%20Co.%20Ltd.&badge=phase%201 HNC364 HNC364 · Guangzhou Henovcom Bioscience Co. Ltd. https://druglandscape.com/drug/hnc364-injectable-suspension https://druglandscape.com/api/og?type=drug&title=HNC364%20Injectable%20Suspension&subtitle=HNC364%20Injectable%20Suspension%20%C2%B7%20Guangzhou%20Henovcom%20Bioscience%20Co.%20Ltd.&badge=phase%201 HNC364 Injectable Suspension HNC364 Injectable Suspension · Guangzhou Henovcom Bioscience Co. Ltd. https://druglandscape.com/drug/hnc664-capsules-fed https://druglandscape.com/api/og?type=drug&title=HNC664%20capsules%20FED&subtitle=HNC664%20capsules%20FED%20%C2%B7%20Guangzhou%20Henovcom%20Bioscience%20Co.%20Ltd.&badge=phase%201 HNC664 capsules FED HNC664 capsules FED · Guangzhou Henovcom Bioscience Co. Ltd. https://druglandscape.com/drug/hnc664-capsules-single-dose https://druglandscape.com/api/og?type=drug&title=HNC664%20capsules%20Single%20dose&subtitle=HNC664%20capsules%20Single%20dose%20%C2%B7%20Guangzhou%20Henovcom%20Bioscience%20Co.%20Ltd.&badge=phase%201 HNC664 capsules Single dose HNC664 capsules Single dose · Guangzhou Henovcom Bioscience Co. Ltd. https://druglandscape.com/drug/hneo-t https://druglandscape.com/api/og?type=drug&title=hNeo-T&subtitle=hNeo-T%20%C2%B7%20BGI%2C%20China&badge=phase%201 hNeo-T hNeo-T · BGI, China https://druglandscape.com/drug/hno-donor https://druglandscape.com/api/og?type=drug&title=HNO%20Donor&subtitle=HNO%20Donor%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 HNO Donor HNO Donor · Bristol-Myers Squibb https://druglandscape.com/drug/hnpc01 https://druglandscape.com/api/og?type=drug&title=hNPC01&subtitle=hNPC01%20%C2%B7%20Hopstem%20Biotechnology%20Inc.&badge=phase%201 hNPC01 hNPC01 · Hopstem Biotechnology Inc. https://druglandscape.com/drug/hoat-huyet-nhat-nhat https://druglandscape.com/api/og?type=drug&title=Hoat%20Huyet%20Nhat%20Nhat&subtitle=Hoat%20Huyet%20Nhat%20Nhat%20%C2%B7%20Nhat%20Nhat%20Pharmaceutical%20Company&badge=phase%202 Hoat Huyet Nhat Nhat Hoat Huyet Nhat Nhat · Nhat Nhat Pharmaceutical Company https://druglandscape.com/drug/hold-acei-or-arb https://druglandscape.com/api/og?type=drug&title=Hold%20ACEI%20or%20ARB&subtitle=Hold%20ACEI%20or%20ARB%20%C2%B7%20Hamilton%20Health%20Sciences%20Corporation&badge=phase%202 Hold ACEI or ARB Hold ACEI or ARB · Hamilton Health Sciences Corporation https://druglandscape.com/drug/homeo-gh https://druglandscape.com/api/og?type=drug&title=Homeo-GH&subtitle=Homeo-GH%20%C2%B7%20HomeoTherapy%20Co.%2C%20Ltd&badge=phase%201 Homeo-GH Homeo-GH · HomeoTherapy Co., Ltd https://druglandscape.com/drug/homeopathy-and-nutritional-oriented-diet https://druglandscape.com/api/og?type=drug&title=Homeopathy%20and%20Nutritional%20oriented%20diet&subtitle=Homeopathy%20and%20Nutritional%20oriented%20diet%20%C2%B7%20Edgard%20Costa%20de%20Vilhena&badge=phase%202 Homeopathy and Nutritional oriented diet Homeopathy and Nutritional oriented diet · Edgard Costa de Vilhena https://druglandscape.com/drug/homsc200 https://druglandscape.com/api/og?type=drug&title=hOMSC200&subtitle=hOMSC200%20%C2%B7%20Cytora%20Ltd.&badge=phase%201 hOMSC200 hOMSC200 · Cytora Ltd. https://druglandscape.com/drug/homsc300 https://druglandscape.com/api/og?type=drug&title=hOMSC300&subtitle=hOMSC300%20%C2%B7%20Cytora%20Ltd.&badge=phase%201 hOMSC300 hOMSC300 · Cytora Ltd. https://druglandscape.com/drug/hormonal-profile https://druglandscape.com/api/og?type=drug&title=Hormonal%20profile&subtitle=Hormonal%20profile%20%C2%B7%20Monica%20Levy%20Andersen&badge=phase%201 Hormonal profile Hormonal profile · Monica Levy Andersen https://druglandscape.com/drug/hormone-and-radiation-therapy https://druglandscape.com/api/og?type=drug&title=Hormone%20and%20radiation%20therapy&subtitle=Hormone%20and%20radiation%20therapy%20%C2%B7%20Spanish%20Oncology%20Genito-Urinary%20Group&badge=phase%202 Hormone and radiation therapy Hormone and radiation therapy · Spanish Oncology Genito-Urinary Group https://druglandscape.com/drug/hormone-replacement-treatment https://druglandscape.com/api/og?type=drug&title=hormone%20replacement%20treatment&subtitle=hormone%20replacement%20treatment%20%C2%B7%20Li-jun%20Ding&badge=phase%201 hormone replacement treatment hormone replacement treatment · Li-jun Ding https://druglandscape.com/drug/hormone-suppressors https://druglandscape.com/api/og?type=drug&title=Hormone%20Suppressors&subtitle=Hormone%20Suppressors%20%C2%B7%20NYU%20Langone%20Health&badge=phase%201 Hormone Suppressors Hormone Suppressors · NYU Langone Health https://druglandscape.com/drug/hot-1030 https://druglandscape.com/api/og?type=drug&title=HOT-1030&subtitle=HOT-1030%20%C2%B7%20Huabo%20Biopharm%20Co.%2C%20Ltd.&badge=phase%201 HOT-1030 HOT-1030 · Huabo Biopharm Co., Ltd. https://druglandscape.com/drug/hp-1050-patch https://druglandscape.com/api/og?type=drug&title=HP-1050%20Patch&subtitle=HP-1050%20Patch%20%C2%B7%20Noven%20Pharmaceuticals%2C%20Inc.&badge=phase%201 HP-1050 Patch HP-1050 Patch · Noven Pharmaceuticals, Inc. https://druglandscape.com/drug/hp-5000-topical-patch https://druglandscape.com/api/og?type=drug&title=HP-5000%20Topical%20Patch&subtitle=HP-5000%20Topical%20Patch%20%C2%B7%20Noven%20Pharmaceuticals%2C%20Inc.&badge=phase%201 HP-5000 Topical Patch HP-5000 Topical Patch · Noven Pharmaceuticals, Inc. https://druglandscape.com/drug/hp-monad-lotion https://druglandscape.com/api/og?type=drug&title=HP%20Monad%20Lotion&subtitle=HP%20Monad%20Lotion%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%201 HP Monad Lotion HP Monad Lotion · Bausch Health Americas, Inc. https://druglandscape.com/drug/hp184 https://druglandscape.com/api/og?type=drug&title=HP184&subtitle=HP184%20%C2%B7%20Sanofi&badge=phase%202 HP184 HP184 · Sanofi https://druglandscape.com/drug/hp518-dose-escalation https://druglandscape.com/api/og?type=drug&title=HP518%20-%20Dose%20Escalation&subtitle=HP518%20-%20Dose%20Escalation%20%C2%B7%20Hinova%20Pharmaceuticals%20Aus%20Pty%20Ltd&badge=phase%201 HP518 - Dose Escalation HP518 - Dose Escalation · Hinova Pharmaceuticals Aus Pty Ltd https://druglandscape.com/drug/hp518-dose-expansion https://druglandscape.com/api/og?type=drug&title=HP518%20-%20Dose%20expansion&subtitle=HP518%20-%20Dose%20expansion%20%C2%B7%20Hinova%20Pharmaceuticals%20Aus%20Pty%20Ltd&badge=phase%201 HP518 - Dose expansion HP518 - Dose expansion · Hinova Pharmaceuticals Aus Pty Ltd https://druglandscape.com/drug/hpb-092-tablet https://druglandscape.com/api/og?type=drug&title=HPB-092%20tablet&subtitle=HPB-092%20tablet%20%C2%B7%20Hangzhou%20Polymed%20Biopharmaceuticals%2C%20Inc.&badge=phase%201 HPB-092 tablet HPB-092 tablet · Hangzhou Polymed Biopharmaceuticals, Inc. https://druglandscape.com/drug/hpfsh-hmg https://druglandscape.com/api/og?type=drug&title=HPFSH%20%26%20HMG&subtitle=HPFSH%20%26%20HMG%20%C2%B7%20Alaa%20Fouli%20Gaber%20Ebrahim&badge=phase%202 HPFSH & HMG HPFSH & HMG · Alaa Fouli Gaber Ebrahim https://druglandscape.com/drug/hpg1860 https://druglandscape.com/api/og?type=drug&title=HPG1860&subtitle=HPG1860%20%C2%B7%20Hepagene%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%202 HPG1860 HPG1860 · Hepagene (Shanghai) Co., Ltd. https://druglandscape.com/drug/hpp2005 https://druglandscape.com/api/og?type=drug&title=HPP2005&subtitle=HPP2005%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%202 HPP2005 HPP2005 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/hpp737 https://druglandscape.com/api/og?type=drug&title=HPP737&subtitle=HPP737%20%C2%B7%20Newsoara%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 HPP737 HPP737 · Newsoara Biopharma Co., Ltd. https://druglandscape.com/drug/hpv-t https://druglandscape.com/api/og?type=drug&title=HPV-T&subtitle=HPV-T%20%C2%B7%20BGI%2C%20China&badge=phase%201 HPV-T HPV-T · BGI, China https://druglandscape.com/drug/hpv-vaccinations https://druglandscape.com/api/og?type=drug&title=HPV%20Vaccinations&subtitle=HPV%20Vaccinations%20%C2%B7%20UbiVac&badge=phase%201 HPV Vaccinations HPV Vaccinations · UbiVac https://druglandscape.com/drug/hpv16-ct-dna-dosing https://druglandscape.com/api/og?type=drug&title=HPV16%20Ct-DNA%20dosing&subtitle=HPV16%20Ct-DNA%20dosing%20%C2%B7%20UNICANCER&badge=phase%202 HPV16 Ct-DNA dosing HPV16 Ct-DNA dosing · UNICANCER https://druglandscape.com/drug/hpv19-mab https://druglandscape.com/api/og?type=drug&title=hPV19%20mAb&subtitle=hPV19%20mAb%20%C2%B7%20SuZhou%20Stainwei%20Biotech%20Inc.&badge=phase%201 hPV19 mAb hPV19 mAb · SuZhou Stainwei Biotech Inc. https://druglandscape.com/drug/hpv9-high-formulation https://druglandscape.com/api/og?type=drug&title=HPV9%20High%20formulation&subtitle=HPV9%20High%20formulation%20%C2%B7%20GlaxoSmithKline&badge=phase%201 HPV9 High formulation HPV9 High formulation · GlaxoSmithKline https://druglandscape.com/drug/hpv9-low-formulation https://druglandscape.com/api/og?type=drug&title=HPV9%20Low%20formulation&subtitle=HPV9%20Low%20formulation%20%C2%B7%20GlaxoSmithKline&badge=phase%201 HPV9 Low formulation HPV9 Low formulation · GlaxoSmithKline https://druglandscape.com/drug/hqp1351 https://druglandscape.com/api/og?type=drug&title=HQP1351&subtitle=HQP1351%20%C2%B7%20Ascentage%20Pharma%20Group%20Inc.&badge=phase%202 HQP1351 HQP1351 · Ascentage Pharma Group Inc. https://druglandscape.com/drug/hr011408-injection-novorapid https://druglandscape.com/api/og?type=drug&title=HR011408%20injection%3B%20NovoRapid%C2%AE&subtitle=HR011408%20injection%3B%20NovoRapid%C2%AE%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HR011408 injection; NovoRapid® HR011408 injection; NovoRapid® · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hr091506-tablet https://druglandscape.com/api/og?type=drug&title=HR091506%20tablet&subtitle=HR091506%20tablet%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HR091506 tablet HR091506 tablet · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hr18042 https://druglandscape.com/api/og?type=drug&title=HR18042&subtitle=HR18042%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 HR18042 HR18042 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hr19024 https://druglandscape.com/api/og?type=drug&title=HR19024&subtitle=HR19024%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HR19024 HR19024 · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hr19042-capsule-tarpeyo-budenofalk https://druglandscape.com/api/og?type=drug&title=HR19042%20Capsule%2C%20Tarpeyo%C2%AE%2C%20Budenofalk%C2%AE&subtitle=HR19042%20Capsule%2C%20Tarpeyo%C2%AE%2C%20Budenofalk%C2%AE%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HR19042 Capsule, Tarpeyo®, Budenofalk® HR19042 Capsule, Tarpeyo®, Budenofalk® · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hr20013-for-injection-dexamethason https://druglandscape.com/api/og?type=drug&title=HR20013%20for%20injection%EF%BC%9Bdexamethason&subtitle=HR20013%20for%20injection%EF%BC%9Bdexamethason%20%C2%B7%20Fujian%20Shengdi%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HR20013 for injection；dexamethason HR20013 for injection；dexamethason · Fujian Shengdi Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hr20031-fdc https://druglandscape.com/api/og?type=drug&title=HR20031%20FDC&subtitle=HR20031%20FDC%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HR20031 FDC HR20031 FDC · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hr20033-tablets https://druglandscape.com/api/og?type=drug&title=HR20033%20tablets&subtitle=HR20033%20tablets%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HR20033 tablets HR20033 tablets · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrbmp4 https://druglandscape.com/api/og?type=drug&title=hrBMP4&subtitle=hrBMP4%20%C2%B7%20Stemgen&badge=phase%201 hrBMP4 hrBMP4 · Stemgen https://druglandscape.com/drug/hrescap https://druglandscape.com/api/og?type=drug&title=hRESCAP&subtitle=hRESCAP%20%C2%B7%20TNO&badge=phase%201 hRESCAP hRESCAP · TNO https://druglandscape.com/drug/hrf2105-patch https://druglandscape.com/api/og?type=drug&title=HRF2105%20patch&subtitle=HRF2105%20patch%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 HRF2105 patch HRF2105 patch · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrg2010-capsule-sinemet-madopar https://druglandscape.com/api/og?type=drug&title=HRG2010%20Capsule%2C%20Sinemet%C2%AE%2C%20Madopar%C2%AE&subtitle=HRG2010%20Capsule%2C%20Sinemet%C2%AE%2C%20Madopar%C2%AE%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRG2010 Capsule, Sinemet®, Madopar® HRG2010 Capsule, Sinemet®, Madopar® · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrpc https://druglandscape.com/api/og?type=drug&title=hRPC&subtitle=hRPC%20%C2%B7%20ReNeuron%20Limited&badge=phase%201 hRPC hRPC · ReNeuron Limited https://druglandscape.com/drug/hrs-1167-tablets https://druglandscape.com/api/og?type=drug&title=HRS-1167%20tablets&subtitle=HRS-1167%20tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-1167 tablets HRS-1167 tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-1167-tablets-rifampicin https://druglandscape.com/api/og?type=drug&title=HRS-1167%20tablets%3B%20rifampicin&subtitle=HRS-1167%20tablets%3B%20rifampicin%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-1167 tablets; rifampicin HRS-1167 tablets; rifampicin · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-1301-tablet https://druglandscape.com/api/og?type=drug&title=HRS-1301%20Tablet&subtitle=HRS-1301%20Tablet%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 HRS-1301 Tablet HRS-1301 Tablet · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-1301-tablets https://druglandscape.com/api/og?type=drug&title=HRS-1301%20Tablets&subtitle=HRS-1301%20Tablets%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-1301 Tablets HRS-1301 Tablets · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-1780 https://druglandscape.com/api/og?type=drug&title=HRS-1780&subtitle=HRS-1780%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-1780 HRS-1780 · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-1893 https://druglandscape.com/api/og?type=drug&title=HRS-1893&subtitle=HRS-1893%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 HRS-1893 HRS-1893 · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-1893-tablet-a https://druglandscape.com/api/og?type=drug&title=HRS-1893%20tablet%20A&subtitle=HRS-1893%20tablet%20A%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-1893 tablet A HRS-1893 tablet A · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-1893-tablet-b https://druglandscape.com/api/og?type=drug&title=HRS-1893%20tablet%20B&subtitle=HRS-1893%20tablet%20B%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-1893 tablet B HRS-1893 tablet B · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-2129 https://druglandscape.com/api/og?type=drug&title=HRS-2129&subtitle=HRS-2129%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-2129 HRS-2129 · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-2129-tablets https://druglandscape.com/api/og?type=drug&title=HRS-2129%20Tablets&subtitle=HRS-2129%20Tablets%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 HRS-2129 Tablets HRS-2129 Tablets · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-2162 https://druglandscape.com/api/og?type=drug&title=HRS-2162&subtitle=HRS-2162%20%C2%B7%20Fujian%20Shengdi%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HRS-2162 HRS-2162 · Fujian Shengdi Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hrs-2183 https://druglandscape.com/api/og?type=drug&title=HRS-2183&subtitle=HRS-2183%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-2183 HRS-2183 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-2189-tablets https://druglandscape.com/api/og?type=drug&title=HRS-2189%20Tablets&subtitle=HRS-2189%20Tablets%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-2189 Tablets HRS-2189 Tablets · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-2329-tablet https://druglandscape.com/api/og?type=drug&title=HRS-2329%20Tablet&subtitle=HRS-2329%20Tablet%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-2329 Tablet HRS-2329 Tablet · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-3095-tablet https://druglandscape.com/api/og?type=drug&title=HRS-3095%20Tablet&subtitle=HRS-3095%20Tablet%20%C2%B7%20Chengdu%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-3095 Tablet HRS-3095 Tablet · Chengdu Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-3738 https://druglandscape.com/api/og?type=drug&title=HRS-3738&subtitle=HRS-3738%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-3738 HRS-3738 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-3802 https://druglandscape.com/api/og?type=drug&title=HRS-3802&subtitle=HRS-3802%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-3802 HRS-3802 · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-4029 https://druglandscape.com/api/og?type=drug&title=HRS-4029&subtitle=HRS-4029%20%C2%B7%20Beijing%20Suncadia%20Pharmaceuticals%20Co.%2C%20Ltd&badge=phase%201 HRS-4029 HRS-4029 · Beijing Suncadia Pharmaceuticals Co., Ltd https://druglandscape.com/drug/hrs-4642 https://druglandscape.com/api/og?type=drug&title=HRS-4642&subtitle=HRS-4642%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 HRS-4642 HRS-4642 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-4642-nab-paclitaxel-gemcitabine https://druglandscape.com/api/og?type=drug&title=HRS-4642%3Bnab-paclitaxel%3B%20gemcitabine&subtitle=HRS-4642%3Bnab-paclitaxel%3B%20gemcitabine%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HRS-4642;nab-paclitaxel; gemcitabine HRS-4642;nab-paclitaxel; gemcitabine · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hrs-5041-dose-level-1 https://druglandscape.com/api/og?type=drug&title=HRS-5041%20dose%20level%201&subtitle=HRS-5041%20dose%20level%201%20%C2%B7%20Atridia%20Pty%20Ltd.&badge=phase%201 HRS-5041 dose level 1 HRS-5041 dose level 1 · Atridia Pty Ltd. https://druglandscape.com/drug/hrs-5041-dose-level-2 https://druglandscape.com/api/og?type=drug&title=HRS-5041%20dose%20level%202&subtitle=HRS-5041%20dose%20level%202%20%C2%B7%20Atridia%20Pty%20Ltd.&badge=phase%201 HRS-5041 dose level 2 HRS-5041 dose level 2 · Atridia Pty Ltd. https://druglandscape.com/drug/hrs-5346-tablets https://druglandscape.com/api/og?type=drug&title=HRS-5346%20tablets&subtitle=HRS-5346%20tablets%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-5346 tablets HRS-5346 tablets · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-5965-capsules https://druglandscape.com/api/og?type=drug&title=HRS-5965%20Capsules&subtitle=HRS-5965%20Capsules%20%C2%B7%20Chengdu%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 HRS-5965 Capsules HRS-5965 Capsules · Chengdu Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-5965-tablets-hrs-5965-capsules https://druglandscape.com/api/og?type=drug&title=HRS-5965%20tablets%EF%BC%9BHRS-5965%20capsules&subtitle=HRS-5965%20tablets%EF%BC%9BHRS-5965%20capsules%20%C2%B7%20Chengdu%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-5965 tablets；HRS-5965 capsules HRS-5965 tablets；HRS-5965 capsules · Chengdu Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-6093 https://druglandscape.com/api/og?type=drug&title=HRS-6093&subtitle=HRS-6093%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-6093 HRS-6093 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-6208 https://druglandscape.com/api/og?type=drug&title=HRS-6208&subtitle=HRS-6208%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-6208 HRS-6208 · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-6209 https://druglandscape.com/api/og?type=drug&title=HRS-6209&subtitle=HRS-6209%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-6209 HRS-6209 · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-6209-capsules https://druglandscape.com/api/og?type=drug&title=HRS-6209%20Capsules&subtitle=HRS-6209%20Capsules%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-6209 Capsules HRS-6209 Capsules · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-6209-in-combination-with-fulvestrant https://druglandscape.com/api/og?type=drug&title=HRS-6209%20in%20Combination%20with%20Fulvestrant&subtitle=HRS-6209%20in%20Combination%20with%20Fulvestrant%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-6209 in Combination with Fulvestrant HRS-6209 in Combination with Fulvestrant · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-6209-in-combination-with-hrs-1358 https://druglandscape.com/api/og?type=drug&title=HRS-6209%20in%20Combination%20with%20HRS-1358&subtitle=HRS-6209%20in%20Combination%20with%20HRS-1358%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-6209 in Combination with HRS-1358 HRS-6209 in Combination with HRS-1358 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-6209-in-combination-with-hrs-8080 https://druglandscape.com/api/og?type=drug&title=HRS-6209%20in%20Combination%20with%20HRS-8080&subtitle=HRS-6209%20in%20Combination%20with%20HRS-8080%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-6209 in Combination with HRS-8080 HRS-6209 in Combination with HRS-8080 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-6213 https://druglandscape.com/api/og?type=drug&title=HRS-6213&subtitle=HRS-6213%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-6213 HRS-6213 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-6768 https://druglandscape.com/api/og?type=drug&title=HRS-6768&subtitle=HRS-6768%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-6768 HRS-6768 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-7085-simulant https://druglandscape.com/api/og?type=drug&title=HRS-7085%20simulant&subtitle=HRS-7085%20simulant%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-7085 simulant HRS-7085 simulant · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-7085-tablets https://druglandscape.com/api/og?type=drug&title=HRS-7085%20tablets&subtitle=HRS-7085%20tablets%20%C2%B7%20Atridia%20Pty%20Ltd.&badge=phase%201 HRS-7085 tablets HRS-7085 tablets · Atridia Pty Ltd. https://druglandscape.com/drug/hrs-7172-tablets https://druglandscape.com/api/og?type=drug&title=HRS-7172%20Tablets&subtitle=HRS-7172%20Tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-7172 Tablets HRS-7172 Tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-7249-injection-set https://druglandscape.com/api/og?type=drug&title=HRS-7249%20injection%20set&subtitle=HRS-7249%20injection%20set%20%C2%B7%20Fujian%20Shengdi%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 HRS-7249 injection set HRS-7249 injection set · Fujian Shengdi Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hrs-7535-c-tablets https://druglandscape.com/api/og?type=drug&title=HRS-7535%EF%BC%88C%EF%BC%89Tablets&subtitle=HRS-7535%EF%BC%88C%EF%BC%89Tablets%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-7535（C）Tablets HRS-7535（C）Tablets · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-7535-d-tablets https://druglandscape.com/api/og?type=drug&title=HRS-7535%EF%BC%88D%EF%BC%89Tablets&subtitle=HRS-7535%EF%BC%88D%EF%BC%89Tablets%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-7535（D）Tablets HRS-7535（D）Tablets · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-7535-tables https://druglandscape.com/api/og?type=drug&title=HRS-7535%20Tables&subtitle=HRS-7535%20Tables%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-7535 Tables HRS-7535 Tables · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-8080-dalpiciclib-isethionate-tablets https://druglandscape.com/api/og?type=drug&title=HRS-8080%3B%20Dalpiciclib%20Isethionate%20Tablets&subtitle=HRS-8080%3B%20Dalpiciclib%20Isethionate%20Tablets%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-8080; Dalpiciclib Isethionate Tablets HRS-8080; Dalpiciclib Isethionate Tablets · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-8080-shr-a1811 https://druglandscape.com/api/og?type=drug&title=HRS-8080%3B%20SHR-A1811&subtitle=HRS-8080%3B%20SHR-A1811%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-8080; SHR-A1811 HRS-8080; SHR-A1811 · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-8080-shr-a2009 https://druglandscape.com/api/og?type=drug&title=HRS-8080%3B%20SHR-A2009&subtitle=HRS-8080%3B%20SHR-A2009%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-8080; SHR-A2009 HRS-8080; SHR-A2009 · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrs-8364-tablet https://druglandscape.com/api/og?type=drug&title=HRS-8364%20Tablet&subtitle=HRS-8364%20Tablet%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-8364 Tablet HRS-8364 Tablet · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-8427-injection-plus-furosemide https://druglandscape.com/api/og?type=drug&title=HRS-8427%20injection%20plus%20furosemide&subtitle=HRS-8427%20injection%20plus%20furosemide%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS-8427 injection plus furosemide HRS-8427 injection plus furosemide · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-9057 https://druglandscape.com/api/og?type=drug&title=HRS-9057&subtitle=HRS-9057%20%C2%B7%20Fujian%20Shengdi%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HRS-9057 HRS-9057 · Fujian Shengdi Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hrs-9190 https://druglandscape.com/api/og?type=drug&title=HRS-9190&subtitle=HRS-9190%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 HRS-9190 HRS-9190 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-9190-under-intravenous-anesthesia https://druglandscape.com/api/og?type=drug&title=HRS-9190%3B%20under%20Intravenous%20Anesthesia&subtitle=HRS-9190%3B%20under%20Intravenous%20Anesthesia%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 HRS-9190; under Intravenous Anesthesia HRS-9190; under Intravenous Anesthesia · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs-9531-tablet https://druglandscape.com/api/og?type=drug&title=HRS-9531%20Tablet&subtitle=HRS-9531%20Tablet%20%C2%B7%20Fujian%20Shengdi%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HRS-9531 Tablet HRS-9531 Tablet · Fujian Shengdi Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hrs-9813-capsule https://druglandscape.com/api/og?type=drug&title=HRS-9813%20Capsule&subtitle=HRS-9813%20Capsule%20%C2%B7%20Guangdong%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 HRS-9813 Capsule HRS-9813 Capsule · Guangdong Hengrui Pharmaceutical Co., Ltd https://druglandscape.com/drug/hrs-9813-capsule-mimetic https://druglandscape.com/api/og?type=drug&title=HRS-9813%20capsule%20mimetic&subtitle=HRS-9813%20capsule%20mimetic%20%C2%B7%20Guangdong%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 HRS-9813 capsule mimetic HRS-9813 capsule mimetic · Guangdong Hengrui Pharmaceutical Co., Ltd https://druglandscape.com/drug/hrs-9821 https://druglandscape.com/api/og?type=drug&title=HRS-9821&subtitle=HRS-9821%20%C2%B7%20Guangdong%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 HRS-9821 HRS-9821 · Guangdong Hengrui Pharmaceutical Co., Ltd https://druglandscape.com/drug/hrs2398-tablets https://druglandscape.com/api/og?type=drug&title=HRS2398%20Tablets&subtitle=HRS2398%20Tablets%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HRS2398 Tablets HRS2398 Tablets · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hrs3797 https://druglandscape.com/api/og?type=drug&title=HRS3797&subtitle=HRS3797%20%C2%B7%20Fujian%20Shengdi%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HRS3797 HRS3797 · Fujian Shengdi Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hrs4800 https://druglandscape.com/api/og?type=drug&title=HRS4800&subtitle=HRS4800%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS4800 HRS4800 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs5091 https://druglandscape.com/api/og?type=drug&title=HRS5091&subtitle=HRS5091%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS5091 HRS5091 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs5091-tablets https://druglandscape.com/api/og?type=drug&title=HRS5091%20Tablets&subtitle=HRS5091%20Tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS5091 Tablets HRS5091 Tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs7415 https://druglandscape.com/api/og?type=drug&title=HRS7415&subtitle=HRS7415%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS7415 HRS7415 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs8179 https://druglandscape.com/api/og?type=drug&title=HRS8179&subtitle=HRS8179%20%C2%B7%20Beijing%20Suncadia%20Pharmaceuticals%20Co.%2C%20Ltd&badge=phase%202 HRS8179 HRS8179 · Beijing Suncadia Pharmaceuticals Co., Ltd https://druglandscape.com/drug/hrs8807-shr6390 https://druglandscape.com/api/og?type=drug&title=HRS8807%E3%80%81SHR6390&subtitle=HRS8807%E3%80%81SHR6390%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HRS8807、SHR6390 HRS8807、SHR6390 · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hrs9531-tablets https://druglandscape.com/api/og?type=drug&title=HRS9531%20tablets&subtitle=HRS9531%20tablets%20%C2%B7%20Fujian%20Shengdi%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HRS9531 tablets HRS9531 tablets · Fujian Shengdi Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hrs9950 https://druglandscape.com/api/og?type=drug&title=HRS9950&subtitle=HRS9950%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HRS9950 HRS9950 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hrs9950-tablets https://druglandscape.com/api/og?type=drug&title=HRS9950%20tablets&subtitle=HRS9950%20tablets%20%C2%B7%20Chengdu%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 HRS9950 tablets HRS9950 tablets · Chengdu Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrv-vaccine https://druglandscape.com/api/og?type=drug&title=HRV%20vaccine&subtitle=HRV%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%202 HRV vaccine HRV vaccine · GlaxoSmithKline https://druglandscape.com/drug/hrx0701-tablets https://druglandscape.com/api/og?type=drug&title=hrx0701%20tablets&subtitle=hrx0701%20tablets%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 hrx0701 tablets hrx0701 tablets · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/hrx215-capsules https://druglandscape.com/api/og?type=drug&title=HRX215%20capsules&subtitle=HRX215%20capsules%20%C2%B7%20HepaRegeniX%20GmbH&badge=phase%201 HRX215 capsules HRX215 capsules · HepaRegeniX GmbH https://druglandscape.com/drug/hryz-t101-tcr-t-cell https://druglandscape.com/api/og?type=drug&title=HRYZ-T101%20TCR-T%20Cell&subtitle=HRYZ-T101%20TCR-T%20Cell%20%C2%B7%20HRYZ%20Biotech%20Co.&badge=phase%201 HRYZ-T101 TCR-T Cell HRYZ-T101 TCR-T Cell · HRYZ Biotech Co. https://druglandscape.com/drug/hrze-plus-alpe500 https://druglandscape.com/api/og?type=drug&title=HRZE%20plus%20AlpE500&subtitle=HRZE%20plus%20AlpE500%20%C2%B7%20BioVersys%20AG&badge=phase%202 HRZE plus AlpE500 HRZE plus AlpE500 · BioVersys AG https://druglandscape.com/drug/hs-001-cs https://druglandscape.com/api/og?type=drug&title=HS-001%20CS&subtitle=HS-001%20CS%20%C2%B7%20Heartseed%20Inc.&badge=phase%201 HS-001 CS HS-001 CS · Heartseed Inc. https://druglandscape.com/drug/hs-10241 https://druglandscape.com/api/og?type=drug&title=HS-10241&subtitle=HS-10241%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10241 HS-10241 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10342 https://druglandscape.com/api/og?type=drug&title=HS-10342&subtitle=HS-10342%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 HS-10342 HS-10342 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10352 https://druglandscape.com/api/og?type=drug&title=HS-10352&subtitle=HS-10352%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10352 HS-10352 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10365 https://druglandscape.com/api/og?type=drug&title=HS-10365&subtitle=HS-10365%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10365 HS-10365 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10365-capsules https://druglandscape.com/api/og?type=drug&title=HS-10365%20capsules&subtitle=HS-10365%20capsules%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 HS-10365 capsules HS-10365 capsules · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10370 https://druglandscape.com/api/og?type=drug&title=HS-10370&subtitle=HS-10370%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10370 HS-10370 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10374 https://druglandscape.com/api/og?type=drug&title=HS-10374&subtitle=HS-10374%20%C2%B7%20Hansoh%20BioMedical%20R%26D%20Company&badge=phase%202 HS-10374 HS-10374 · Hansoh BioMedical R&D Company https://druglandscape.com/drug/hs-10374-tablets https://druglandscape.com/api/og?type=drug&title=HS-10374%20tablets&subtitle=HS-10374%20tablets%20%C2%B7%20Hansoh%20BioMedical%20R%26D%20Company&badge=phase%201 HS-10374 tablets HS-10374 tablets · Hansoh BioMedical R&D Company https://druglandscape.com/drug/hs-10375 https://druglandscape.com/api/og?type=drug&title=HS-10375&subtitle=HS-10375%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10375 HS-10375 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10381 https://druglandscape.com/api/og?type=drug&title=HS-10381&subtitle=HS-10381%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10381 HS-10381 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10384-tablet-dose-1 https://druglandscape.com/api/og?type=drug&title=HS-10384%20tablet%20Dose%201&subtitle=HS-10384%20tablet%20Dose%201%20%C2%B7%20Hansoh%20BioMedical%20R%26D%20Company&badge=phase%202 HS-10384 tablet Dose 1 HS-10384 tablet Dose 1 · Hansoh BioMedical R&D Company https://druglandscape.com/drug/hs-10384-tablets https://druglandscape.com/api/og?type=drug&title=HS-10384%20tablets&subtitle=HS-10384%20tablets%20%C2%B7%20Hansoh%20BioMedical%20R%26D%20Company&badge=phase%201 HS-10384 tablets HS-10384 tablets · Hansoh BioMedical R&D Company https://druglandscape.com/drug/hs-10386 https://druglandscape.com/api/og?type=drug&title=HS-10386&subtitle=HS-10386%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10386 HS-10386 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10398 https://druglandscape.com/api/og?type=drug&title=HS-10398&subtitle=HS-10398%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10398 HS-10398 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10501-tablet https://druglandscape.com/api/og?type=drug&title=HS-10501%20tablet&subtitle=HS-10501%20tablet%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10501 tablet HS-10501 tablet · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10502 https://druglandscape.com/api/og?type=drug&title=HS-10502&subtitle=HS-10502%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10502 HS-10502 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10504 https://druglandscape.com/api/og?type=drug&title=HS-10504&subtitle=HS-10504%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10504 HS-10504 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10509 https://druglandscape.com/api/og?type=drug&title=HS-10509&subtitle=HS-10509%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10509 HS-10509 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10511-tablets https://druglandscape.com/api/og?type=drug&title=HS-10511%20Tablets&subtitle=HS-10511%20Tablets%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10511 Tablets HS-10511 Tablets · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10517-dose-1 https://druglandscape.com/api/og?type=drug&title=HS-10517%20Dose%201&subtitle=HS-10517%20Dose%201%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10517 Dose 1 HS-10517 Dose 1 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10518 https://druglandscape.com/api/og?type=drug&title=HS-10518&subtitle=HS-10518%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10518 HS-10518 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10529 https://druglandscape.com/api/og?type=drug&title=HS-10529&subtitle=HS-10529%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10529 HS-10529 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10542 https://druglandscape.com/api/og?type=drug&title=HS-10542&subtitle=HS-10542%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10542 HS-10542 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10542-high-dose https://druglandscape.com/api/og?type=drug&title=HS-10542%20High%20Dose&subtitle=HS-10542%20High%20Dose%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 HS-10542 High Dose HS-10542 High Dose · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10561 https://druglandscape.com/api/og?type=drug&title=HS-10561&subtitle=HS-10561%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10561 HS-10561 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-10566 https://druglandscape.com/api/og?type=drug&title=HS-10566&subtitle=HS-10566%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-10566 HS-10566 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-20004 https://druglandscape.com/api/og?type=drug&title=HS-20004&subtitle=HS-20004%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 HS-20004 HS-20004 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hs-20090 https://druglandscape.com/api/og?type=drug&title=HS-20090&subtitle=HS-20090%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-20090 HS-20090 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-20090-2 https://druglandscape.com/api/og?type=drug&title=HS-20090-2&subtitle=HS-20090-2%20%C2%B7%20Shanghai%20Hansoh%20Biomedical%20Co.%2C%20Ltd&badge=phase%201 HS-20090-2 HS-20090-2 · Shanghai Hansoh Biomedical Co., Ltd https://druglandscape.com/drug/hs-20094-ai-pen https://druglandscape.com/api/og?type=drug&title=HS-20094%20AI%20pen%3B&subtitle=HS-20094%20AI%20pen%3B%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-20094 AI pen; HS-20094 AI pen; · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-20094-mdv-pen https://druglandscape.com/api/og?type=drug&title=HS-20094%20MDV%20pen&subtitle=HS-20094%20MDV%20pen%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-20094 MDV pen HS-20094 MDV pen · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-20105 https://druglandscape.com/api/og?type=drug&title=HS-20105&subtitle=HS-20105%20%C2%B7%20Hansoh%20BioMedical%20R%26D%20Company&badge=phase%201 HS-20105 HS-20105 · Hansoh BioMedical R&D Company https://druglandscape.com/drug/hs-20106 https://druglandscape.com/api/og?type=drug&title=HS-20106&subtitle=HS-20106%20%C2%B7%20Hansoh%20BioMedical%20R%26D%20Company&badge=phase%202 HS-20106 HS-20106 · Hansoh BioMedical R&D Company https://druglandscape.com/drug/hs-20108-monotherapy https://druglandscape.com/api/og?type=drug&title=HS-20108%20Monotherapy&subtitle=HS-20108%20Monotherapy%20%C2%B7%20Hansoh%20BioMedical%20R%26D%20Company&badge=phase%201 HS-20108 Monotherapy HS-20108 Monotherapy · Hansoh BioMedical R&D Company https://druglandscape.com/drug/hs-20117 https://druglandscape.com/api/og?type=drug&title=HS-20117&subtitle=HS-20117%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 HS-20117 HS-20117 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-20117-combined-hs-20093 https://druglandscape.com/api/og?type=drug&title=HS-20117%20combined%20HS-20093&subtitle=HS-20117%20combined%20HS-20093%20%C2%B7%20Hansoh%20BioMedical%20R%26D%20Company&badge=phase%201 HS-20117 combined HS-20093 HS-20117 combined HS-20093 · Hansoh BioMedical R&D Company https://druglandscape.com/drug/hs-20117-combined-hs-20093-and-5-fu https://druglandscape.com/api/og?type=drug&title=HS-20117%20combined%20HS-20093%20and%205-FU&subtitle=HS-20117%20combined%20HS-20093%20and%205-FU%20%C2%B7%20Hansoh%20BioMedical%20R%26D%20Company&badge=phase%201 HS-20117 combined HS-20093 and 5-FU HS-20117 combined HS-20093 and 5-FU · Hansoh BioMedical R&D Company https://druglandscape.com/drug/hs-20118 https://druglandscape.com/api/og?type=drug&title=HS-20118&subtitle=HS-20118%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-20118 HS-20118 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-20122 https://druglandscape.com/api/og?type=drug&title=HS-20122&subtitle=HS-20122%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HS-20122 HS-20122 · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/hs-it101-monotherapy https://druglandscape.com/api/og?type=drug&title=HS-IT101%20monotherapy&subtitle=HS-IT101%20monotherapy%20%C2%B7%20Qingdao%20Sino-Cell%20Biomedicine%20Co.%2C%20Ltd.&badge=phase%201 HS-IT101 monotherapy HS-IT101 monotherapy · Qingdao Sino-Cell Biomedicine Co., Ltd. https://druglandscape.com/drug/hs235 https://druglandscape.com/api/og?type=drug&title=HS235&subtitle=HS235%20%C2%B7%2035Pharma%20Inc&badge=phase%201 HS235 HS235 · 35Pharma Inc https://druglandscape.com/drug/hs248-pieces https://druglandscape.com/api/og?type=drug&title=HS248%20pieces&subtitle=HS248%20pieces%20%C2%B7%20Hanhui%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 HS248 pieces HS248 pieces · Hanhui Pharmaceutical Co., Ltd https://druglandscape.com/drug/hs269 https://druglandscape.com/api/og?type=drug&title=HS269&subtitle=HS269%20%C2%B7%20Zhejiang%20Hisun%20Pharmaceutical%20Co.%20Ltd.&badge=phase%201 HS269 HS269 · Zhejiang Hisun Pharmaceutical Co. Ltd. https://druglandscape.com/drug/hs387 https://druglandscape.com/api/og?type=drug&title=HS387&subtitle=HS387%20%C2%B7%20Zhejiang%20Hisun%20Pharmaceutical%20Co.%20Ltd.&badge=phase%201 HS387 HS387 · Zhejiang Hisun Pharmaceutical Co. Ltd. https://druglandscape.com/drug/hsk16149 https://druglandscape.com/api/og?type=drug&title=HSK16149&subtitle=HSK16149%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 HSK16149 HSK16149 · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk16149-probenecid-cimetidine https://druglandscape.com/api/og?type=drug&title=HSK16149%EF%BC%8Cprobenecid%2C%20cimetidine&subtitle=HSK16149%EF%BC%8Cprobenecid%2C%20cimetidine%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 HSK16149，probenecid, cimetidine HSK16149，probenecid, cimetidine · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk21542-dose-level-2 https://druglandscape.com/api/og?type=drug&title=HSK21542%20dose%20level%202&subtitle=HSK21542%20dose%20level%202%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 HSK21542 dose level 2 HSK21542 dose level 2 · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk29116 https://druglandscape.com/api/og?type=drug&title=HSK29116&subtitle=HSK29116%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 HSK29116 HSK29116 · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk31679 https://druglandscape.com/api/og?type=drug&title=HSK31679&subtitle=HSK31679%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 HSK31679 HSK31679 · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk31679-high-dose https://druglandscape.com/api/og?type=drug&title=HSK31679%20high%20dose&subtitle=HSK31679%20high%20dose%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 HSK31679 high dose HSK31679 high dose · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk31679-low-dose https://druglandscape.com/api/og?type=drug&title=HSK31679%20low%20dose&subtitle=HSK31679%20low%20dose%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 HSK31679 low dose HSK31679 low dose · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk31679-medium-dose https://druglandscape.com/api/og?type=drug&title=HSK31679%20medium%20dose&subtitle=HSK31679%20medium%20dose%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 HSK31679 medium dose HSK31679 medium dose · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk31858-tablets-and-itraconazole-capsules https://druglandscape.com/api/og?type=drug&title=HSK31858%20Tablets%20and%20Itraconazole%20Capsules&subtitle=HSK31858%20Tablets%20and%20Itraconazole%20Capsules%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 HSK31858 Tablets and Itraconazole Capsules HSK31858 Tablets and Itraconazole Capsules · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk36273 https://druglandscape.com/api/og?type=drug&title=HSK36273&subtitle=HSK36273%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 HSK36273 HSK36273 · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk39004 https://druglandscape.com/api/og?type=drug&title=HSK39004&subtitle=HSK39004%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 HSK39004 HSK39004 · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk39004-dry-powder-inhaler-simulant https://druglandscape.com/api/og?type=drug&title=HSK39004%20Dry%20Powder%20Inhaler%20Simulant&subtitle=HSK39004%20Dry%20Powder%20Inhaler%20Simulant%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 HSK39004 Dry Powder Inhaler Simulant HSK39004 Dry Powder Inhaler Simulant · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk39004-in-copd https://druglandscape.com/api/og?type=drug&title=HSK39004%20in%20COPD&subtitle=HSK39004%20in%20COPD%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 HSK39004 in COPD HSK39004 in COPD · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk39004-in-healthy https://druglandscape.com/api/og?type=drug&title=HSK39004%20in%20healthy&subtitle=HSK39004%20in%20healthy%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 HSK39004 in healthy HSK39004 in healthy · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk39004-inhalation-suspension https://druglandscape.com/api/og?type=drug&title=HSK39004%20inhalation%20suspension&subtitle=HSK39004%20inhalation%20suspension%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 HSK39004 inhalation suspension HSK39004 inhalation suspension · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk39297-200mgqd https://druglandscape.com/api/og?type=drug&title=HSK39297%20200mgQD&subtitle=HSK39297%20200mgQD%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 HSK39297 200mgQD HSK39297 200mgQD · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk39297-300mgqd https://druglandscape.com/api/og?type=drug&title=HSK39297%20300mgQD&subtitle=HSK39297%20300mgQD%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 HSK39297 300mgQD HSK39297 300mgQD · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk39297-50mgbid https://druglandscape.com/api/og?type=drug&title=HSK39297%2050mgBID&subtitle=HSK39297%2050mgBID%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 HSK39297 50mgBID HSK39297 50mgBID · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk39775-monotherapy https://druglandscape.com/api/og?type=drug&title=HSK39775%20Monotherapy&subtitle=HSK39775%20Monotherapy%20%C2%B7%20Xizang%20Haisco%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 HSK39775 Monotherapy HSK39775 Monotherapy · Xizang Haisco Pharmaceutical Co., Ltd https://druglandscape.com/drug/hsk40118 https://druglandscape.com/api/og?type=drug&title=HSK40118&subtitle=HSK40118%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 HSK40118 HSK40118 · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk42360 https://druglandscape.com/api/og?type=drug&title=HSK42360&subtitle=HSK42360%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 HSK42360 HSK42360 · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk44459 https://druglandscape.com/api/og?type=drug&title=HSK44459&subtitle=HSK44459%20%C2%B7%20Xizang%20Haisco%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 HSK44459 HSK44459 · Xizang Haisco Pharmaceutical Co., Ltd https://druglandscape.com/drug/hsk44459-dose-level-2 https://druglandscape.com/api/og?type=drug&title=HSK44459%20dose%20level%202&subtitle=HSK44459%20dose%20level%202%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 HSK44459 dose level 2 HSK44459 dose level 2 · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk46575 https://druglandscape.com/api/og?type=drug&title=HSK46575&subtitle=HSK46575%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 HSK46575 HSK46575 · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk47977 https://druglandscape.com/api/og?type=drug&title=HSK47977&subtitle=HSK47977%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 HSK47977 HSK47977 · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk7653 https://druglandscape.com/api/og?type=drug&title=HSK7653&subtitle=HSK7653%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 HSK7653 HSK7653 · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsk7653-tablets https://druglandscape.com/api/og?type=drug&title=HSK7653%20tablets&subtitle=HSK7653%20tablets%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 HSK7653 tablets HSK7653 tablets · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/hsp-130 https://druglandscape.com/api/og?type=drug&title=HSP-130&subtitle=HSP-130%20%C2%B7%20Pfizer&badge=phase%202 HSP-130 HSP-130 · Pfizer https://druglandscape.com/drug/hsp90-inhibitor-auy-922 https://druglandscape.com/api/og?type=drug&title=Hsp90%20Inhibitor%20AUY%20922&subtitle=Hsp90%20Inhibitor%20AUY%20922%20%C2%B7%20SCRI%20Development%20Innovations%2C%20LLC&badge=phase%201 Hsp90 Inhibitor AUY 922 Hsp90 Inhibitor AUY 922 · SCRI Development Innovations, LLC https://druglandscape.com/drug/hspe7-and-poly-iclc https://druglandscape.com/api/og?type=drug&title=HspE7%20and%20Poly-ICLC&subtitle=HspE7%20and%20Poly-ICLC%20%C2%B7%20Nventa%20Biopharmaceuticals%20Corporation&badge=phase%201 HspE7 and Poly-ICLC HspE7 and Poly-ICLC · Nventa Biopharmaceuticals Corporation https://druglandscape.com/drug/hst-001 https://druglandscape.com/api/og?type=drug&title=HST%20001&subtitle=HST%20001%20%C2%B7%20Histogen&badge=phase%201 HST 001 HST 001 · Histogen https://druglandscape.com/drug/hst-1011 https://druglandscape.com/api/og?type=drug&title=HST-1011&subtitle=HST-1011%20%C2%B7%20HotSpot%20Therapeutics%2C%20Inc&badge=phase%201 HST-1011 HST-1011 · HotSpot Therapeutics, Inc https://druglandscape.com/drug/hst101 https://druglandscape.com/api/og?type=drug&title=HST101&subtitle=HST101%20%C2%B7%20Hasten%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 HST101 HST101 · Hasten Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/hstc810 https://druglandscape.com/api/og?type=drug&title=hSTC810&subtitle=hSTC810%20%C2%B7%20STCube%2C%20Inc.&badge=phase%201 hSTC810 hSTC810 · STCube, Inc. https://druglandscape.com/drug/hsv-formulation-1-with-adjuvant-1 https://druglandscape.com/api/og?type=drug&title=HSV%20formulation%201%20with%20adjuvant%201&subtitle=HSV%20formulation%201%20with%20adjuvant%201%20%C2%B7%20GlaxoSmithKline&badge=phase%201 HSV formulation 1 with adjuvant 1 HSV formulation 1 with adjuvant 1 · GlaxoSmithKline https://druglandscape.com/drug/hsv-formulation-1-with-adjuvant-2 https://druglandscape.com/api/og?type=drug&title=HSV%20formulation%201%20with%20adjuvant%202&subtitle=HSV%20formulation%201%20with%20adjuvant%202%20%C2%B7%20GlaxoSmithKline&badge=phase%201 HSV formulation 1 with adjuvant 2 HSV formulation 1 with adjuvant 2 · GlaxoSmithKline https://druglandscape.com/drug/hsv-formulation-2-with-adjuvant-1 https://druglandscape.com/api/og?type=drug&title=HSV%20formulation%202%20with%20adjuvant%201&subtitle=HSV%20formulation%202%20with%20adjuvant%201%20%C2%B7%20GlaxoSmithKline&badge=phase%201 HSV formulation 2 with adjuvant 1 HSV formulation 2 with adjuvant 1 · GlaxoSmithKline https://druglandscape.com/drug/hsv-formulation-2-with-adjuvant-2 https://druglandscape.com/api/og?type=drug&title=HSV%20formulation%202%20with%20adjuvant%202&subtitle=HSV%20formulation%202%20with%20adjuvant%202%20%C2%B7%20GlaxoSmithKline&badge=phase%201 HSV formulation 2 with adjuvant 2 HSV formulation 2 with adjuvant 2 · GlaxoSmithKline https://druglandscape.com/drug/hsv-formulation-3-with-adjuvant-1 https://druglandscape.com/api/og?type=drug&title=HSV%20formulation%203%20with%20adjuvant%201&subtitle=HSV%20formulation%203%20with%20adjuvant%201%20%C2%B7%20GlaxoSmithKline&badge=phase%201 HSV formulation 3 with adjuvant 1 HSV formulation 3 with adjuvant 1 · GlaxoSmithKline https://druglandscape.com/drug/hsv-formulation-3-with-adjuvant-2 https://druglandscape.com/api/og?type=drug&title=HSV%20formulation%203%20with%20adjuvant%202&subtitle=HSV%20formulation%203%20with%20adjuvant%202%20%C2%B7%20GlaxoSmithKline&badge=phase%201 HSV formulation 3 with adjuvant 2 HSV formulation 3 with adjuvant 2 · GlaxoSmithKline https://druglandscape.com/drug/hsvti-f1 https://druglandscape.com/api/og?type=drug&title=HSVTI_F1&subtitle=HSVTI_F1%20%C2%B7%20GlaxoSmithKline&badge=phase%201 HSVTI_F1 HSVTI_F1 · GlaxoSmithKline https://druglandscape.com/drug/ht-001-0-5-topical-gel https://druglandscape.com/api/og?type=drug&title=HT-001%200.5%25%20Topical%20Gel&subtitle=HT-001%200.5%25%20Topical%20Gel%20%C2%B7%20Hoth%20Therapeutics%2C%20Inc.&badge=phase%202 HT-001 0.5% Topical Gel HT-001 0.5% Topical Gel · Hoth Therapeutics, Inc. https://druglandscape.com/drug/ht-001-1-topical-gel https://druglandscape.com/api/og?type=drug&title=HT-001%201%25%20Topical%20Gel&subtitle=HT-001%201%25%20Topical%20Gel%20%C2%B7%20Hoth%20Therapeutics%2C%20Inc.&badge=phase%202 HT-001 1% Topical Gel HT-001 1% Topical Gel · Hoth Therapeutics, Inc. https://druglandscape.com/drug/ht-001-2-topical-gel https://druglandscape.com/api/og?type=drug&title=HT-001%202%25%20Topical%20Gel&subtitle=HT-001%202%25%20Topical%20Gel%20%C2%B7%20Hoth%20Therapeutics%2C%20Inc.&badge=phase%202 HT-001 2% Topical Gel HT-001 2% Topical Gel · Hoth Therapeutics, Inc. https://druglandscape.com/drug/ht-002-01 https://druglandscape.com/api/og?type=drug&title=HT-002-01&subtitle=HT-002-01%20%C2%B7%20Hyundai%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%201 HT-002-01 HT-002-01 · Hyundai Pharmaceutical Co., LTD. https://druglandscape.com/drug/ht-6184 https://druglandscape.com/api/og?type=drug&title=HT-6184&subtitle=HT-6184%20%C2%B7%20Halia%20Therapeutics%2C%20Inc.&badge=phase%202 HT-6184 HT-6184 · Halia Therapeutics, Inc. https://druglandscape.com/drug/ht31-1 https://druglandscape.com/api/og?type=drug&title=HT31-1&subtitle=HT31-1%20%C2%B7%20HTIC%2C%20Inc&badge=phase%201 HT31-1 HT31-1 · HTIC, Inc https://druglandscape.com/drug/htbz https://druglandscape.com/api/og?type=drug&title=HTBZ&subtitle=HTBZ%20%C2%B7%20Kirk%20A.%20Frey&badge=phase%201 HTBZ HTBZ · Kirk A. Frey https://druglandscape.com/drug/htd4010 https://druglandscape.com/api/og?type=drug&title=HTD4010&subtitle=HTD4010%20%C2%B7%20HighTide%20Biopharma%20Pty%20Ltd&badge=phase%201 HTD4010 HTD4010 · HighTide Biopharma Pty Ltd https://druglandscape.com/drug/hti-1066-dose-level-1 https://druglandscape.com/api/og?type=drug&title=HTI-1066%20dose%20level%201&subtitle=HTI-1066%20dose%20level%201%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HTI-1066 dose level 1 HTI-1066 dose level 1 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hti-1066-dose-level-2 https://druglandscape.com/api/og?type=drug&title=HTI-1066%20dose%20level%202&subtitle=HTI-1066%20dose%20level%202%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HTI-1066 dose level 2 HTI-1066 dose level 2 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hti-1066-dose-level-3 https://druglandscape.com/api/og?type=drug&title=HTI-1066%20dose%20level%203&subtitle=HTI-1066%20dose%20level%203%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HTI-1066 dose level 3 HTI-1066 dose level 3 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hti-1066-dose-level-4 https://druglandscape.com/api/og?type=drug&title=HTI-1066%20dose%20level%204&subtitle=HTI-1066%20dose%20level%204%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 HTI-1066 dose level 4 HTI-1066 dose level 4 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/htl0009936-modified-release https://druglandscape.com/api/og?type=drug&title=HTL0009936%20modified%20release&subtitle=HTL0009936%20modified%20release%20%C2%B7%20Nxera%20Pharma%20UK%20Limited&badge=phase%201 HTL0009936 modified release HTL0009936 modified release · Nxera Pharma UK Limited https://druglandscape.com/drug/htl0014242 https://druglandscape.com/api/og?type=drug&title=HTL0014242&subtitle=HTL0014242%20%C2%B7%20Nxera%20Pharma%20UK%20Limited&badge=phase%201 HTL0014242 HTL0014242 · Nxera Pharma UK Limited https://druglandscape.com/drug/htl0016878 https://druglandscape.com/api/og?type=drug&title=HTL0016878&subtitle=HTL0016878%20%C2%B7%20Nxera%20Pharma%20UK%20Limited&badge=phase%201 HTL0016878 HTL0016878 · Nxera Pharma UK Limited https://druglandscape.com/drug/htl0030310 https://druglandscape.com/api/og?type=drug&title=HTL0030310&subtitle=HTL0030310%20%C2%B7%20Nxera%20Pharma%20UK%20Limited&badge=phase%201 HTL0030310 HTL0030310 · Nxera Pharma UK Limited https://druglandscape.com/drug/htl0039732-capsules https://druglandscape.com/api/og?type=drug&title=HTL0039732%20Capsules&subtitle=HTL0039732%20Capsules%20%C2%B7%20Cancer%20Research%20UK&badge=phase%201 HTL0039732 Capsules HTL0039732 Capsules · Cancer Research UK https://druglandscape.com/drug/htmc0435 https://druglandscape.com/api/og?type=drug&title=HTMC0435&subtitle=HTMC0435%20%C2%B7%20Shanghai%20Yidian%20Pharmaceutical%20Technology%20Development%20Co.%2C%20Ltd.&badge=phase%201 HTMC0435 HTMC0435 · Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. https://druglandscape.com/drug/htmc0658 https://druglandscape.com/api/og?type=drug&title=HTMC0658&subtitle=HTMC0658%20%C2%B7%20Shanghai%20Yidian%20Pharmaceutical%20Technology%20Development%20Co.%2C%20Ltd.&badge=phase%202 HTMC0658 HTMC0658 · Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. https://druglandscape.com/drug/hts-519-insert https://druglandscape.com/api/og?type=drug&title=HTS-519%20Insert&subtitle=HTS-519%20Insert%20%C2%B7%20Hallux%2C%20Inc.&badge=phase%202 HTS-519 Insert HTS-519 Insert · Hallux, Inc. https://druglandscape.com/drug/htu-520-patch https://druglandscape.com/api/og?type=drug&title=HTU-520%20Patch&subtitle=HTU-520%20Patch%20%C2%B7%20Hisamitsu%20Pharmaceutical%20Co.%2C%20Inc.&badge=phase%202 HTU-520 Patch HTU-520 Patch · Hisamitsu Pharmaceutical Co., Inc. https://druglandscape.com/drug/hu-hydroxyurea https://druglandscape.com/api/og?type=drug&title=HU%20-%20Hydroxyurea&subtitle=HU%20-%20Hydroxyurea%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 HU - Hydroxyurea HU - Hydroxyurea · Novo Nordisk A/S https://druglandscape.com/drug/hu14-18-il2-fusion-protein https://druglandscape.com/api/og?type=drug&title=hu14.18-IL2%20fusion%20protein&subtitle=hu14.18-IL2%20fusion%20protein%20%C2%B7%20Children's%20Oncology%20Group&badge=phase%202 hu14.18-IL2 fusion protein hu14.18-IL2 fusion protein · Children's Oncology Group https://druglandscape.com/drug/hu14-18-interleukin-2-fusion-protein https://druglandscape.com/api/og?type=drug&title=hu14.18-Interleukin-2%20fusion%20protein&subtitle=hu14.18-Interleukin-2%20fusion%20protein%20%C2%B7%20Children's%20Oncology%20Group&badge=phase%202 hu14.18-Interleukin-2 fusion protein hu14.18-Interleukin-2 fusion protein · Children's Oncology Group https://druglandscape.com/drug/huang-qi-gui-zhi-wu-wu-granule https://druglandscape.com/api/og?type=drug&title=Huang%20qi%20gui%20zhi%20wu%20wu%20granule&subtitle=Huang%20qi%20gui%20zhi%20wu%20wu%20granule%20%C2%B7%20Cui%20xuejun&badge=phase%202 Huang qi gui zhi wu wu granule Huang qi gui zhi wu wu granule · Cui xuejun https://druglandscape.com/drug/huangkui-capsule https://druglandscape.com/api/og?type=drug&title=HuangKui%20Capsule&subtitle=HuangKui%20Capsule%20%C2%B7%20Jiangsu%20Famous%20Medical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 HuangKui Capsule HuangKui Capsule · Jiangsu Famous Medical Technology Co., Ltd. https://druglandscape.com/drug/huashibaidu-granule https://druglandscape.com/api/og?type=drug&title=Huashibaidu%20granule&subtitle=Huashibaidu%20granule%20%C2%B7%20Shanghai%20Children's%20Medical%20Center&badge=phase%201 Huashibaidu granule Huashibaidu granule · Shanghai Children's Medical Center https://druglandscape.com/drug/huc-msc https://druglandscape.com/api/og?type=drug&title=hUC-MSC&subtitle=hUC-MSC%20%C2%B7%20Guangzhou%20Women%20and%20Children's%20Medical%20Center&badge=phase%202 hUC-MSC hUC-MSC · Guangzhou Women and Children's Medical Center https://druglandscape.com/drug/huc-mscs-treatment-double-dose https://druglandscape.com/api/og?type=drug&title=hUC-MSCs%20treatment%20%EF%BC%88Double%20dose%EF%BC%89&subtitle=hUC-MSCs%20treatment%20%EF%BC%88Double%20dose%EF%BC%89%20%C2%B7%20Shenzhen%20Beike%20Bio-Technology%20Co.%2C%20Ltd.&badge=phase%201 hUC-MSCs treatment （Double dose） hUC-MSCs treatment （Double dose） · Shenzhen Beike Bio-Technology Co., Ltd. https://druglandscape.com/drug/huc2-344 https://druglandscape.com/api/og?type=drug&title=HUC2-344&subtitle=HUC2-344%20%C2%B7%20Huons%20Co.%2C%20Ltd.&badge=phase%201 HUC2-344 HUC2-344 · Huons Co., Ltd. https://druglandscape.com/drug/huc2-344-r1-huc2-344-r2 https://druglandscape.com/api/og?type=drug&title=HUC2-344-R1%2C%20HUC2-344-R2&subtitle=HUC2-344-R1%2C%20HUC2-344-R2%20%C2%B7%20Huons%20Co.%2C%20Ltd.&badge=phase%201 HUC2-344-R1, HUC2-344-R2 HUC2-344-R1, HUC2-344-R2 · Huons Co., Ltd. https://druglandscape.com/drug/huc2-565-a-huc2-565-a-and-huc2-565-b https://druglandscape.com/api/og?type=drug&title=HUC2-565-A%2C%20HUC2-565-A%20and%20HUC2-565-B&subtitle=HUC2-565-A%2C%20HUC2-565-A%20and%20HUC2-565-B%20%C2%B7%20Huons%20Co.%2C%20Ltd.&badge=phase%201 HUC2-565-A, HUC2-565-A and HUC2-565-B HUC2-565-A, HUC2-565-A and HUC2-565-B · Huons Co., Ltd. https://druglandscape.com/drug/huc2-676 https://druglandscape.com/api/og?type=drug&title=HUC2-676&subtitle=HUC2-676%20%C2%B7%20Huons%20Co.%2C%20Ltd.&badge=phase%201 HUC2-676 HUC2-676 · Huons Co., Ltd. https://druglandscape.com/drug/huc2-676-r https://druglandscape.com/api/og?type=drug&title=HUC2-676-R&subtitle=HUC2-676-R%20%C2%B7%20Huons%20Co.%2C%20Ltd.&badge=phase%201 HUC2-676-R HUC2-676-R · Huons Co., Ltd. https://druglandscape.com/drug/hucmscs-and-hcbmncs https://druglandscape.com/api/og?type=drug&title=hUCMSCs%20and%20hCBMNCs&subtitle=hUCMSCs%20and%20hCBMNCs%20%C2%B7%20Shenzhen%20Beike%20Bio-Technology%20Co.%2C%20Ltd.&badge=phase%201 hUCMSCs and hCBMNCs hUCMSCs and hCBMNCs · Shenzhen Beike Bio-Technology Co., Ltd. https://druglandscape.com/drug/hucns-sc-transplant-in-the-lead-in-phase https://druglandscape.com/api/og?type=drug&title=HuCNS-SC%20transplant%20in%20the%20lead-in%20phase&subtitle=HuCNS-SC%20transplant%20in%20the%20lead-in%20phase%20%C2%B7%20StemCells%2C%20Inc.&badge=phase%202 HuCNS-SC transplant in the lead-in phase HuCNS-SC transplant in the lead-in phase · StemCells, Inc. https://druglandscape.com/drug/hug186 https://druglandscape.com/api/og?type=drug&title=HUG186&subtitle=HUG186%20%C2%B7%20Huons%20Co.%2C%20Ltd.&badge=phase%201 HUG186 HUG186 · Huons Co., Ltd. https://druglandscape.com/drug/hug186-b-and-hug186-d https://druglandscape.com/api/og?type=drug&title=HUG186-B%20and%20HUG186-D&subtitle=HUG186-B%20and%20HUG186-D%20%C2%B7%20Huons%20Co.%2C%20Ltd.&badge=phase%201 HUG186-B and HUG186-D HUG186-B and HUG186-D · Huons Co., Ltd. https://druglandscape.com/drug/huhuanglianzonggan-capsule https://druglandscape.com/api/og?type=drug&title=HuHuangLianzonggan%20capsule&subtitle=HuHuangLianzonggan%20capsule%20%C2%B7%20Tasly%20Pharmaceutical%20Group%20Co.%2C%20Ltd&badge=phase%202 HuHuangLianzonggan capsule HuHuangLianzonggan capsule · Tasly Pharmaceutical Group Co., Ltd https://druglandscape.com/drug/hul001 https://druglandscape.com/api/og?type=drug&title=HuL001&subtitle=HuL001%20%C2%B7%20HuniLife%20Biotechnology%2C%20Inc.&badge=phase%201 HuL001 HuL001 · HuniLife Biotechnology, Inc. https://druglandscape.com/drug/humab-ox40l https://druglandscape.com/api/og?type=drug&title=huMAb%20OX40L&subtitle=huMAb%20OX40L%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 huMAb OX40L huMAb OX40L · Genentech, Inc. https://druglandscape.com/drug/humalog-diluent https://druglandscape.com/api/og?type=drug&title=Humalog%20diluent&subtitle=Humalog%20diluent%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Humalog diluent Humalog diluent · Eli Lilly and Company https://druglandscape.com/drug/humalog-mix-25 https://druglandscape.com/api/og?type=drug&title=Humalog%C2%AE%20Mix%2025&subtitle=Humalog%C2%AE%20Mix%2025%20%C2%B7%20Geropharm&badge=phase%201 Humalog® Mix 25 Humalog® Mix 25 · Geropharm https://druglandscape.com/drug/humalog-with-100-basal-rate-reduction https://druglandscape.com/api/og?type=drug&title=Humalog%20with%20100%25%20basal%20rate%20reduction&subtitle=Humalog%20with%20100%25%20basal%20rate%20reduction%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Humalog with 100% basal rate reduction Humalog with 100% basal rate reduction · Eli Lilly and Company https://druglandscape.com/drug/humalog-with-50-basal-rate-reduction https://druglandscape.com/api/og?type=drug&title=Humalog%20with%2050%25%20basal%20rate%20reduction&subtitle=Humalog%20with%2050%25%20basal%20rate%20reduction%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Humalog with 50% basal rate reduction Humalog with 50% basal rate reduction · Eli Lilly and Company https://druglandscape.com/drug/human-adme https://druglandscape.com/api/og?type=drug&title=Human%20ADME&subtitle=Human%20ADME%20%C2%B7%20Trius%20Therapeutics%20LLC%2C%20a%20subsidiary%20of%20Merck%20%26%20Co.%2C%20Inc.%20(Rahway%2C%20New%20Jersey%20USA)&badge=phase%201 Human ADME Human ADME · Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) https://druglandscape.com/drug/human-biphasic-insulin https://druglandscape.com/api/og?type=drug&title=human%20biphasic%20insulin&subtitle=human%20biphasic%20insulin%20%C2%B7%20Julphar%20Gulf%20Pharmaceutical%20Industries&badge=phase%201 human biphasic insulin human biphasic insulin · Julphar Gulf Pharmaceutical Industries https://druglandscape.com/drug/human-biphasic-insulin-reference https://druglandscape.com/api/og?type=drug&title=human%20biphasic%20insulin%2C%20reference&subtitle=human%20biphasic%20insulin%2C%20reference%20%C2%B7%20Julphar%20Gulf%20Pharmaceutical%20Industries&badge=phase%201 human biphasic insulin, reference human biphasic insulin, reference · Julphar Gulf Pharmaceutical Industries https://druglandscape.com/drug/human-cadaver-allograft https://druglandscape.com/api/og?type=drug&title=Human%20Cadaver%20Allograft&subtitle=Human%20Cadaver%20Allograft%20%C2%B7%20XenoTherapeutics%2C%20Inc.&badge=phase%201 Human Cadaver Allograft Human Cadaver Allograft · XenoTherapeutics, Inc. https://druglandscape.com/drug/human-cord-blood-mononuclear-cells https://druglandscape.com/api/og?type=drug&title=human%20cord%20blood%20mononuclear%20cells&subtitle=human%20cord%20blood%20mononuclear%20cells%20%C2%B7%20Shenzhen%20Beike%20Bio-Technology%20Co.%2C%20Ltd.&badge=phase%201 human cord blood mononuclear cells human cord blood mononuclear cells · Shenzhen Beike Bio-Technology Co., Ltd. https://druglandscape.com/drug/human-fgf-1 https://druglandscape.com/api/og?type=drug&title=Human%20FGF-1&subtitle=Human%20FGF-1%20%C2%B7%20Zhittya%20Genesis%20Medicine%2C%20Inc.&badge=phase%201 Human FGF-1 Human FGF-1 · Zhittya Genesis Medicine, Inc. https://druglandscape.com/drug/human-heterologous-liver-cells https://druglandscape.com/api/og?type=drug&title=Human%20Heterologous%20Liver%20Cells&subtitle=Human%20Heterologous%20Liver%20Cells%20%C2%B7%20Cytonet%20GmbH%20%26%20Co.%20KG&badge=phase%202 Human Heterologous Liver Cells Human Heterologous Liver Cells · Cytonet GmbH & Co. KG https://druglandscape.com/drug/human-menopausal-gonadotropins https://druglandscape.com/api/og?type=drug&title=Human%20Menopausal%20Gonadotropins&subtitle=Human%20Menopausal%20Gonadotropins%20%C2%B7%20Miao%20benyu&badge=phase%201 Human Menopausal Gonadotropins Human Menopausal Gonadotropins · Miao benyu https://druglandscape.com/drug/human-mesenchymal-stromal-cells https://druglandscape.com/api/og?type=drug&title=Human%20Mesenchymal%20Stromal%20Cells&subtitle=Human%20Mesenchymal%20Stromal%20Cells%20%C2%B7%20Michael%20A.%20Matthay&badge=phase%202 Human Mesenchymal Stromal Cells Human Mesenchymal Stromal Cells · Michael A. Matthay https://druglandscape.com/drug/human-neural-stem-cells https://druglandscape.com/api/og?type=drug&title=Human%20Neural%20Stem%20Cells&subtitle=Human%20Neural%20Stem%20Cells%20%C2%B7%20Casa%20Sollievo%20della%20Sofferenza%20IRCCS&badge=phase%201 Human Neural Stem Cells Human Neural Stem Cells · Casa Sollievo della Sofferenza IRCCS https://druglandscape.com/drug/human-pancreatic-islet https://druglandscape.com/api/og?type=drug&title=Human%20pancreatic%20islet&subtitle=Human%20pancreatic%20islet%20%C2%B7%20Ospedale%20San%20Raffaele&badge=phase%202 Human pancreatic islet Human pancreatic islet · Ospedale San Raffaele https://druglandscape.com/drug/human-pancreatic-islet-transplantation https://druglandscape.com/api/og?type=drug&title=Human%20Pancreatic%20Islet%20Transplantation&subtitle=Human%20Pancreatic%20Islet%20Transplantation%20%C2%B7%20Midhat%20H.%20Abdulreda&badge=phase%201 Human Pancreatic Islet Transplantation Human Pancreatic Islet Transplantation · Midhat H. Abdulreda https://druglandscape.com/drug/human-papillomavirus-16-e7-peptide https://druglandscape.com/api/og?type=drug&title=human%20papillomavirus%2016%20E7%20peptide&subtitle=human%20papillomavirus%2016%20E7%20peptide%20%C2%B7%20European%20Organisation%20for%20Research%20and%20Treatment%20of%20Cancer%20-%20EO&badge=phase%202 human papillomavirus 16 E7 peptide human papillomavirus 16 E7 peptide · European Organisation for Research and Treatment of Cancer - EORTC https://druglandscape.com/drug/human-plasma-derived-fibrinogen-concentrate https://druglandscape.com/api/og?type=drug&title=Human%20Plasma-Derived%20Fibrinogen%20Concentrate&subtitle=Human%20Plasma-Derived%20Fibrinogen%20Concentrate%20%C2%B7%20Grifols%20Therapeutics%20LLC&badge=phase%201 Human Plasma-Derived Fibrinogen Concentrate Human Plasma-Derived Fibrinogen Concentrate · Grifols Therapeutics LLC https://druglandscape.com/drug/human-platelets https://druglandscape.com/api/og?type=drug&title=Human%20platelets&subtitle=Human%20platelets%20%C2%B7%20Cellphire%20Therapeutics%2C%20Inc.&badge=phase%202 Human platelets Human platelets · Cellphire Therapeutics, Inc. https://druglandscape.com/drug/human-recombinant-epidermal-growth-factor https://druglandscape.com/api/og?type=drug&title=Human%20recombinant%20epidermal%20growth%20factor&subtitle=Human%20recombinant%20epidermal%20growth%20factor%20%C2%B7%20Ennar%20Pharmaceuticals%20AF&badge=phase%201 Human recombinant epidermal growth factor Human recombinant epidermal growth factor · Ennar Pharmaceuticals AF https://druglandscape.com/drug/human-retinal-progenitor-cells https://druglandscape.com/api/og?type=drug&title=human%20retinal%20progenitor%20cells&subtitle=human%20retinal%20progenitor%20cells%20%C2%B7%20jCyte%2C%20Inc&badge=phase%202 human retinal progenitor cells human retinal progenitor cells · jCyte, Inc https://druglandscape.com/drug/human-spinal-cord-stem-cells https://druglandscape.com/api/og?type=drug&title=Human%20spinal%20cord%20stem%20cells.&subtitle=Human%20spinal%20cord%20stem%20cells.%20%C2%B7%20Neuralstem%20Inc.&badge=phase%201 Human spinal cord stem cells. Human spinal cord stem cells. · Neuralstem Inc. https://druglandscape.com/drug/human-treated-dentin-matrix https://druglandscape.com/api/og?type=drug&title=human%20treated%20dentin%20matrix&subtitle=human%20treated%20dentin%20matrix%20%C2%B7%20nora%20mostafa%20mohammed%20abo%20shanady&badge=phase%201 human treated dentin matrix human treated dentin matrix · nora mostafa mohammed abo shanady https://druglandscape.com/drug/human-umbilical-cord-blood-plasma https://druglandscape.com/api/og?type=drug&title=Human%20Umbilical%20Cord%20Blood%20Plasma&subtitle=Human%20Umbilical%20Cord%20Blood%20Plasma%20%C2%B7%20Hexagon%20Therapies%2C%20LLC&badge=phase%201 Human Umbilical Cord Blood Plasma Human Umbilical Cord Blood Plasma · Hexagon Therapies, LLC https://druglandscape.com/drug/humanized-anti-her2-antibody https://druglandscape.com/api/og?type=drug&title=humanized%20anti-HER2%20antibody&subtitle=humanized%20anti-HER2%20antibody%20%C2%B7%20Shanghai%20CP%20Guojian%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 humanized anti-HER2 antibody humanized anti-HER2 antibody · Shanghai CP Guojian Pharmaceutical Co., Ltd. https://druglandscape.com/drug/humanized-tnf-monoclonal-antibody https://druglandscape.com/api/og?type=drug&title=Humanized%20TNF%CE%B1%20monoclonal%20antibody&subtitle=Humanized%20TNF%CE%B1%20monoclonal%20antibody%20%C2%B7%20Shenyang%20Sunshine%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%201 Humanized TNFα monoclonal antibody Humanized TNFα monoclonal antibody · Shenyang Sunshine Pharmaceutical Co., LTD. https://druglandscape.com/drug/humax-il8 https://druglandscape.com/api/og?type=drug&title=HuMax-IL8&subtitle=HuMax-IL8%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 HuMax-IL8 HuMax-IL8 · Bristol-Myers Squibb https://druglandscape.com/drug/humibid https://druglandscape.com/api/og?type=drug&title=Humibid%C2%AE&subtitle=Humibid%C2%AE%20%C2%B7%20Reckitt%20Benckiser%20LLC&badge=phase%201 Humibid® Humibid® · Reckitt Benckiser LLC https://druglandscape.com/drug/humibid-and-hydrocodone-bitartrate-tablet https://druglandscape.com/api/og?type=drug&title=Humibid%C2%AE%20and%20Hydrocodone%20Bitartrate%20tablet&subtitle=Humibid%C2%AE%20and%20Hydrocodone%20Bitartrate%20tablet%20%C2%B7%20Reckitt%20Benckiser%20LLC&badge=phase%201 Humibid® and Hydrocodone Bitartrate tablet Humibid® and Hydrocodone Bitartrate tablet · Reckitt Benckiser LLC https://druglandscape.com/drug/huminsulin-normal https://druglandscape.com/api/og?type=drug&title=Huminsulin%C2%AE%20Normal&subtitle=Huminsulin%C2%AE%20Normal%20%C2%B7%20Adocia&badge=phase%201 Huminsulin® Normal Huminsulin® Normal · Adocia https://druglandscape.com/drug/humulin-m3 https://druglandscape.com/api/og?type=drug&title=Humulin%C2%AE%20M3&subtitle=Humulin%C2%AE%20M3%20%C2%B7%20Geropharm&badge=phase%201 Humulin® M3 Humulin® M3 · Geropharm https://druglandscape.com/drug/humulin-nph https://druglandscape.com/api/og?type=drug&title=Humulin%20NPH&subtitle=Humulin%20NPH%20%C2%B7%20Geropharm&badge=phase%201 Humulin NPH Humulin NPH · Geropharm https://druglandscape.com/drug/humulin-regular https://druglandscape.com/api/og?type=drug&title=Humulin%C2%AE%20Regular&subtitle=Humulin%C2%AE%20Regular%20%C2%B7%20Geropharm&badge=phase%201 Humulin® Regular Humulin® Regular · Geropharm https://druglandscape.com/drug/huyps-1-nine-tablets https://druglandscape.com/api/og?type=drug&title=HUYPS-1%20nine%20tablets&subtitle=HUYPS-1%20nine%20tablets%20%C2%B7%20Sinew%20Pharma%20Inc.&badge=phase%201 HUYPS-1 nine tablets HUYPS-1 nine tablets · Sinew Pharma Inc. https://druglandscape.com/drug/huyps-1-one-tablet https://druglandscape.com/api/og?type=drug&title=HUYPS-1%20one%20tablet&subtitle=HUYPS-1%20one%20tablet%20%C2%B7%20Sinew%20Pharma%20Inc.&badge=phase%201 HUYPS-1 one tablet HUYPS-1 one tablet · Sinew Pharma Inc. https://druglandscape.com/drug/hw071021-tablets https://druglandscape.com/api/og?type=drug&title=HW071021%20Tablets&subtitle=HW071021%20Tablets%20%C2%B7%20Wuhan%20Humanwell%20Innovative%20Drug%20Research%20and%20Development%20Center%20Limited%20Company&badge=phase%201 HW071021 Tablets HW071021 Tablets · Wuhan Humanwell Innovative Drug Research and Development Center Limited Company https://druglandscape.com/drug/hw201877-capsules https://druglandscape.com/api/og?type=drug&title=HW201877%20capsules&subtitle=HW201877%20capsules%20%C2%B7%20Wuhan%20Humanwell%20Innovative%20Drug%20Research%20and%20Development%20Center%20Limited%20Company&badge=phase%201 HW201877 capsules HW201877 capsules · Wuhan Humanwell Innovative Drug Research and Development Center Limited Company https://druglandscape.com/drug/hwk-007 https://druglandscape.com/api/og?type=drug&title=HWK-007&subtitle=HWK-007%20%C2%B7%20Whitehawk%20Therapeutics%2C%20Inc.&badge=phase%201 HWK-007 HWK-007 · Whitehawk Therapeutics, Inc. https://druglandscape.com/drug/hwk-016-mucin-16-targeted-adc https://druglandscape.com/api/og?type=drug&title=HWK-016%2C%20MUCIN-16-targeted%20ADC&subtitle=HWK-016%2C%20MUCIN-16-targeted%20ADC%20%C2%B7%20Whitehawk%20Therapeutics%2C%20Inc.&badge=phase%201 HWK-016, MUCIN-16-targeted ADC HWK-016, MUCIN-16-targeted ADC · Whitehawk Therapeutics, Inc. https://druglandscape.com/drug/hx044 https://druglandscape.com/api/og?type=drug&title=HX044&subtitle=HX044%20%C2%B7%20Hanx%20Biopharmaceuticals%20(Wuhan)%20Co.%2C%20Ltd.&badge=phase%201 HX044 HX044 · Hanx Biopharmaceuticals (Wuhan) Co., Ltd. https://druglandscape.com/drug/hx301 https://druglandscape.com/api/og?type=drug&title=HX301&subtitle=HX301%20%C2%B7%20Hangzhou%20Hanx%20Biopharmaceuticals%2C%20Ltd.&badge=phase%201 HX301 HX301 · Hangzhou Hanx Biopharmaceuticals, Ltd. https://druglandscape.com/drug/hxn6005 https://druglandscape.com/api/og?type=drug&title=HXN6005&subtitle=HXN6005%20%C2%B7%20Helixon%20Biotechnology%20(Suzhou)%20Co.%2C%20Ltd&badge=phase%201 HXN6005 HXN6005 · Helixon Biotechnology (Suzhou) Co., Ltd https://druglandscape.com/drug/hy-0102 https://druglandscape.com/api/og?type=drug&title=HY-0102&subtitle=HY-0102%20%C2%B7%20Shanghai%20YingLi%20Pharmaceutical%20Co.%20Ltd.&badge=phase%201 HY-0102 HY-0102 · Shanghai YingLi Pharmaceutical Co. Ltd. https://druglandscape.com/drug/hy-209 https://druglandscape.com/api/og?type=drug&title=HY-209&subtitle=HY-209%20%C2%B7%20Kukjeon%20Pharmaceutical%20Co.%2CLtd.&badge=phase%201 HY-209 HY-209 · Kukjeon Pharmaceutical Co.,Ltd. https://druglandscape.com/drug/hy01 https://druglandscape.com/api/og?type=drug&title=HY01&subtitle=HY01%20%C2%B7%20Heyu%20(Suzhou)%20Pharmaceutical%20Technology%20Co.%2C%20Ltd&badge=phase%201 HY01 HY01 · Heyu (Suzhou) Pharmaceutical Technology Co., Ltd https://druglandscape.com/drug/hy1272 https://druglandscape.com/api/og?type=drug&title=HY1272&subtitle=HY1272%20%C2%B7%20Newsoara%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 HY1272 HY1272 · Newsoara Biopharma Co., Ltd. https://druglandscape.com/drug/hy209 https://druglandscape.com/api/og?type=drug&title=HY209&subtitle=HY209%20%C2%B7%20Shaperon&badge=phase%201 HY209 HY209 · Shaperon https://druglandscape.com/drug/hy209-0-3 https://druglandscape.com/api/og?type=drug&title=HY209%200.3%25&subtitle=HY209%200.3%25%20%C2%B7%20Shaperon&badge=phase%202 HY209 0.3% HY209 0.3% · Shaperon https://druglandscape.com/drug/hy209gel-active https://druglandscape.com/api/og?type=drug&title=HY209GEL%20Active&subtitle=HY209GEL%20Active%20%C2%B7%20Shaperon&badge=phase%202 HY209GEL Active HY209GEL Active · Shaperon https://druglandscape.com/drug/hy6725 https://druglandscape.com/api/og?type=drug&title=HY6725&subtitle=HY6725%20%C2%B7%20Newsoara%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 HY6725 HY6725 · Newsoara Biopharma Co., Ltd. https://druglandscape.com/drug/hy8931 https://druglandscape.com/api/og?type=drug&title=HY8931&subtitle=HY8931%20%C2%B7%20Newsoara%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 HY8931 HY8931 · Newsoara Biopharma Co., Ltd. https://druglandscape.com/drug/hyaluronic-acid-vaginal-gel https://druglandscape.com/api/og?type=drug&title=Hyaluronic%20acid%20vaginal%20gel&subtitle=Hyaluronic%20acid%20vaginal%20gel%20%C2%B7%20Koru%20Health%20Groups&badge=phase%201 Hyaluronic acid vaginal gel Hyaluronic acid vaginal gel · Koru Health Groups https://druglandscape.com/drug/hyaluronic-acid-with-mannitol https://druglandscape.com/api/og?type=drug&title=hyaluronic%20acid%20with%20mannitol&subtitle=hyaluronic%20acid%20with%20mannitol%20%C2%B7%20Brigitte%20Jolles%2C%20MD&badge=phase%202 hyaluronic acid with mannitol hyaluronic acid with mannitol · Brigitte Jolles, MD https://druglandscape.com/drug/hyaluronic-acid-with-sorbitol https://druglandscape.com/api/og?type=drug&title=hyaluronic%20acid%20with%20sorbitol&subtitle=hyaluronic%20acid%20with%20sorbitol%20%C2%B7%20Brigitte%20Jolles%2C%20MD&badge=phase%202 hyaluronic acid with sorbitol hyaluronic acid with sorbitol · Brigitte Jolles, MD https://druglandscape.com/drug/hydrochlorothiazide-henagliflozin-proline https://druglandscape.com/api/og?type=drug&title=Hydrochlorothiazide%E3%80%81Henagliflozin%20Proline&subtitle=Hydrochlorothiazide%E3%80%81Henagliflozin%20Proline%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Hydrochlorothiazide、Henagliflozin Proline Hydrochlorothiazide、Henagliflozin Proline · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/hydrocodon-bitartrate-acetaminophen-arm-1 https://druglandscape.com/api/og?type=drug&title=Hydrocodon%20bitartrate-acetaminophen%20arm%201&subtitle=Hydrocodon%20bitartrate-acetaminophen%20arm%201%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 Hydrocodon bitartrate-acetaminophen arm 1 Hydrocodon bitartrate-acetaminophen arm 1 · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/hydrocodone-bitartrate-extended-release-tablet https://druglandscape.com/api/og?type=drug&title=Hydrocodone%20bitartrate%20extended-release%20tablet&subtitle=Hydrocodone%20bitartrate%20extended-release%20tablet%20%C2%B7%20Cephalon&badge=phase%201 Hydrocodone bitartrate extended-release tablet Hydrocodone bitartrate extended-release tablet · Cephalon https://druglandscape.com/drug/hydrocortisone-and-fludrocortisone https://druglandscape.com/api/og?type=drug&title=Hydrocortisone%20and%20fludrocortisone&subtitle=Hydrocortisone%20and%20fludrocortisone%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Hydrocortisone and fludrocortisone Hydrocortisone and fludrocortisone · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/hydrocortisone-high-dose https://druglandscape.com/api/og?type=drug&title=Hydrocortisone%20High%20Dose&subtitle=Hydrocortisone%20High%20Dose%20%C2%B7%20Cedars-Sinai%20Medical%20Center&badge=phase%201 Hydrocortisone High Dose Hydrocortisone High Dose · Cedars-Sinai Medical Center https://druglandscape.com/drug/hydrocortisone-low-dose https://druglandscape.com/api/og?type=drug&title=Hydrocortisone%20Low%20Dose&subtitle=Hydrocortisone%20Low%20Dose%20%C2%B7%20Cedars-Sinai%20Medical%20Center&badge=phase%201 Hydrocortisone Low Dose Hydrocortisone Low Dose · Cedars-Sinai Medical Center https://druglandscape.com/drug/hydrofluoroalkane-beclomethasone-metred-dose-inhaler https://druglandscape.com/api/og?type=drug&title=Hydrofluoroalkane%20beclomethasone%20metred%20dose%20inhaler&subtitle=Hydrofluoroalkane%20beclomethasone%20metred%20dose%20inhaler%20%C2%B7%20Research%20in%20Real-Life%20Ltd&badge=phase%202 Hydrofluoroalkane beclomethasone metred dose inhaler Hydrofluoroalkane beclomethasone metred dose inhaler · Research in Real-Life Ltd https://druglandscape.com/drug/hydrogel-treatment https://druglandscape.com/api/og?type=drug&title=Hydrogel%20treatment&subtitle=Hydrogel%20treatment%20%C2%B7%20Carlos%20E%20Salas&badge=phase%202 Hydrogel treatment Hydrogel treatment · Carlos E Salas https://druglandscape.com/drug/hydrolyzed-guar-gum https://druglandscape.com/api/og?type=drug&title=hydrolyzed%20guar%20gum&subtitle=hydrolyzed%20guar%20gum%20%C2%B7%20IRCCS%20San%20Raffaele%20Roma&badge=phase%202 hydrolyzed guar gum hydrolyzed guar gum · IRCCS San Raffaele Roma https://druglandscape.com/drug/hydromorphone-hydrochloride-4-milligrams https://druglandscape.com/api/og?type=drug&title=Hydromorphone%20hydrochloride%204%20milligrams&subtitle=Hydromorphone%20hydrochloride%204%20milligrams%20%C2%B7%20Tris%20Pharma%2C%20Inc.&badge=phase%201 Hydromorphone hydrochloride 4 milligrams Hydromorphone hydrochloride 4 milligrams · Tris Pharma, Inc. https://druglandscape.com/drug/hydronidone-capsules-entecavir-capsules https://druglandscape.com/api/og?type=drug&title=Hydronidone%20capsules%26%20Entecavir%20capsules&subtitle=Hydronidone%20capsules%26%20Entecavir%20capsules%20%C2%B7%20Beijing%20Continent%20Pharmaceutical%20Co%2C%20Ltd.&badge=phase%201 Hydronidone capsules& Entecavir capsules Hydronidone capsules& Entecavir capsules · Beijing Continent Pharmaceutical Co, Ltd. https://druglandscape.com/drug/hydrovax-002-yfv https://druglandscape.com/api/og?type=drug&title=HydroVax-002%20YFV&subtitle=HydroVax-002%20YFV%20%C2%B7%20Najit%20Technologies%2C%20Inc.&badge=phase%201 HydroVax-002 YFV HydroVax-002 YFV · Najit Technologies, Inc. https://druglandscape.com/drug/hydrovax-005-chikv https://druglandscape.com/api/og?type=drug&title=HydroVax-005%20CHIKV&subtitle=HydroVax-005%20CHIKV%20%C2%B7%20Najit%20Technologies%2C%20Inc.&badge=phase%201 HydroVax-005 CHIKV HydroVax-005 CHIKV · Najit Technologies, Inc. https://druglandscape.com/drug/hydroxycarbamide-dispersible-tablets https://druglandscape.com/api/og?type=drug&title=Hydroxycarbamide%20dispersible%20tablets&subtitle=Hydroxycarbamide%20dispersible%20tablets%20%C2%B7%20Theravia&badge=phase%201 Hydroxycarbamide dispersible tablets Hydroxycarbamide dispersible tablets · Theravia https://druglandscape.com/drug/hydroxycarbamide-film-coated-tablet https://druglandscape.com/api/og?type=drug&title=Hydroxycarbamide%20film-coated%20tablet&subtitle=Hydroxycarbamide%20film-coated%20tablet%20%C2%B7%20Theravia&badge=phase%201 Hydroxycarbamide film-coated tablet Hydroxycarbamide film-coated tablet · Theravia https://druglandscape.com/drug/hydroxychloroquin-with-azithromycin https://druglandscape.com/api/og?type=drug&title=Hydroxychloroquin%20with%20Azithromycin&subtitle=Hydroxychloroquin%20with%20Azithromycin%20%C2%B7%20Alkarkh%20Health%20Directorate-Baghdad&badge=phase%201 Hydroxychloroquin with Azithromycin Hydroxychloroquin with Azithromycin · Alkarkh Health Directorate-Baghdad https://druglandscape.com/drug/hydroxyethylcellulose-0-19 https://druglandscape.com/api/og?type=drug&title=Hydroxyethylcellulose%200.19%25&subtitle=Hydroxyethylcellulose%200.19%25%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%201 Hydroxyethylcellulose 0.19% Hydroxyethylcellulose 0.19% · Sheba Medical Center https://druglandscape.com/drug/hydroxyurea-or-interferon-based-therapy https://druglandscape.com/api/og?type=drug&title=Hydroxyurea%20or%20Interferon-based%20therapy&subtitle=Hydroxyurea%20or%20Interferon-based%20therapy%20%C2%B7%20Ascentage%20Pharma%20Group%20Inc.&badge=phase%202 Hydroxyurea or Interferon-based therapy Hydroxyurea or Interferon-based therapy · Ascentage Pharma Group Inc. https://druglandscape.com/drug/hyml-122 https://druglandscape.com/api/og?type=drug&title=HYML-122&subtitle=HYML-122%20%C2%B7%20Tarapeutics%20Science%20Inc.&badge=phase%202 HYML-122 HYML-122 · Tarapeutics Science Inc. https://druglandscape.com/drug/hynr-cs-inj https://druglandscape.com/api/og?type=drug&title=HYNR-CS%20inj&subtitle=HYNR-CS%20inj%20%C2%B7%20Corestemchemon%2C%20Inc.&badge=phase%201 HYNR-CS inj HYNR-CS inj · Corestemchemon, Inc. https://druglandscape.com/drug/hyperacute-melanoma-vaccine https://druglandscape.com/api/og?type=drug&title=HyperAcute-Melanoma%20Vaccine&subtitle=HyperAcute-Melanoma%20Vaccine%20%C2%B7%20NewLink%20Genetics%20Corporation&badge=phase%201 HyperAcute-Melanoma Vaccine HyperAcute-Melanoma Vaccine · NewLink Genetics Corporation https://druglandscape.com/drug/hyperacute-pancreatic-cancer-vaccine https://druglandscape.com/api/og?type=drug&title=HyperAcute-Pancreatic%20Cancer%20Vaccine&subtitle=HyperAcute-Pancreatic%20Cancer%20Vaccine%20%C2%B7%20NewLink%20Genetics%20Corporation&badge=phase%201 HyperAcute-Pancreatic Cancer Vaccine HyperAcute-Pancreatic Cancer Vaccine · NewLink Genetics Corporation https://druglandscape.com/drug/hypercholesterolemic-diet https://druglandscape.com/api/og?type=drug&title=Hypercholesterolemic%20diet&subtitle=Hypercholesterolemic%20diet%20%C2%B7%20Universidad%20Miguel%20Hernandez%20de%20Elche&badge=phase%201 Hypercholesterolemic diet Hypercholesterolemic diet · Universidad Miguel Hernandez de Elche https://druglandscape.com/drug/hyperimmune-plasma https://druglandscape.com/api/og?type=drug&title=Hyperimmune%20plasma&subtitle=Hyperimmune%20plasma%20%C2%B7%20Andalusian%20Network%20for%20Design%20and%20Translation%20of%20Advanced%20Therapies&badge=phase%201 Hyperimmune plasma Hyperimmune plasma · Andalusian Network for Design and Translation of Advanced Therapies https://druglandscape.com/drug/hyperpolarized-13c-urea https://druglandscape.com/api/og?type=drug&title=Hyperpolarized%2013C-Urea&subtitle=Hyperpolarized%2013C-Urea%20%C2%B7%20Michael%20Ohliger%2C%20MD%20PhD&badge=phase%202 Hyperpolarized 13C-Urea Hyperpolarized 13C-Urea · Michael Ohliger, MD PhD https://druglandscape.com/drug/hyperpolarized-c13 https://druglandscape.com/api/og?type=drug&title=Hyperpolarized%20C13&subtitle=Hyperpolarized%20C13%20%C2%B7%20Ivan%20de%20Kouchkovsky%2C%20MD&badge=phase%202 Hyperpolarized C13 Hyperpolarized C13 · Ivan de Kouchkovsky, MD https://druglandscape.com/drug/hzn-1116 https://druglandscape.com/api/og?type=drug&title=HZN-1116&subtitle=HZN-1116%20%C2%B7%20Amgen&badge=phase%202 HZN-1116 HZN-1116 · Amgen https://druglandscape.com/drug/hzn-457 https://druglandscape.com/api/og?type=drug&title=HZN-457&subtitle=HZN-457%20%C2%B7%20Horizon%20Therapeutics%20Ireland%20DAC&badge=phase%201 HZN-457 HZN-457 · Horizon Therapeutics Ireland DAC https://druglandscape.com/drug/i-020201 https://druglandscape.com/api/og?type=drug&title=I-020201&subtitle=I-020201%20%C2%B7%20Kuros%20Biosurgery%20AG&badge=phase%202 I-020201 I-020201 · Kuros Biosurgery AG https://druglandscape.com/drug/i-131-clr1404 https://druglandscape.com/api/og?type=drug&title=I-131-CLR1404&subtitle=I-131-CLR1404%20%C2%B7%20Cellectar%20Biosciences%2C%20Inc.&badge=phase%202 I-131-CLR1404 I-131-CLR1404 · Cellectar Biosciences, Inc. https://druglandscape.com/drug/i-v-drug-based-multimodal-approach https://druglandscape.com/api/og?type=drug&title=I.V%20drug%20based%20multimodal%20approach&subtitle=I.V%20drug%20based%20multimodal%20approach%20%C2%B7%20Eslam%20Ayman%20Mohamed%20Shawki&badge=phase%201 I.V drug based multimodal approach I.V drug based multimodal approach · Eslam Ayman Mohamed Shawki https://druglandscape.com/drug/i-v-fentanyl https://druglandscape.com/api/og?type=drug&title=i.v.%20fentanyl&subtitle=i.v.%20fentanyl%20%C2%B7%20YM%20BioSciences&badge=phase%201 i.v. fentanyl i.v. fentanyl · YM BioSciences https://druglandscape.com/drug/i-v-fentanyl-aerolef https://druglandscape.com/api/og?type=drug&title=i.v%20fentanyl%2C%20AeroLEF&subtitle=i.v%20fentanyl%2C%20AeroLEF%20%C2%B7%20YM%20BioSciences&badge=phase%201 i.v fentanyl, AeroLEF i.v fentanyl, AeroLEF · YM BioSciences https://druglandscape.com/drug/i-v-fentanyl-and-aerolef https://druglandscape.com/api/og?type=drug&title=i.v.%20fentanyl%20and%20AeroLEF&subtitle=i.v.%20fentanyl%20and%20AeroLEF%20%C2%B7%20YM%20BioSciences&badge=phase%201 i.v. fentanyl and AeroLEF i.v. fentanyl and AeroLEF · YM BioSciences https://druglandscape.com/drug/i-v-nnc-0113-0987 https://druglandscape.com/api/og?type=drug&title=I.v.%20NNC%200113-0987&subtitle=I.v.%20NNC%200113-0987%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 I.v. NNC 0113-0987 I.v. NNC 0113-0987 · Novo Nordisk A/S https://druglandscape.com/drug/i004 https://druglandscape.com/api/og?type=drug&title=I004&subtitle=I004%20%C2%B7%20Amphastar%20Pharmaceuticals%2C%20Inc.&badge=phase%202 I004 I004 · Amphastar Pharmaceuticals, Inc. https://druglandscape.com/drug/ia-session https://druglandscape.com/api/og?type=drug&title=IA%20session&subtitle=IA%20session%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 IA session IA session · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/iae0972 https://druglandscape.com/api/og?type=drug&title=IAE0972&subtitle=IAE0972%20%C2%B7%20SUNHO%EF%BC%88China%EF%BC%89BioPharmaceutical%20CO.%2C%20Ltd.&badge=phase%201 IAE0972 IAE0972 · SUNHO（China）BioPharmaceutical CO., Ltd. https://druglandscape.com/drug/iah0968 https://druglandscape.com/api/og?type=drug&title=IAH0968&subtitle=IAH0968%20%C2%B7%20SUNHO%EF%BC%88China%EF%BC%89BioPharmaceutical%20CO.%2C%20Ltd.&badge=phase%202 IAH0968 IAH0968 · SUNHO（China）BioPharmaceutical CO., Ltd. https://druglandscape.com/drug/iam1363 https://druglandscape.com/api/og?type=drug&title=IAM1363&subtitle=IAM1363%20%C2%B7%20Iambic%20Therapeutics%2C%20Inc&badge=phase%201 IAM1363 IAM1363 · Iambic Therapeutics, Inc https://druglandscape.com/drug/iama-6 https://druglandscape.com/api/og?type=drug&title=IAMA-6&subtitle=IAMA-6%20%C2%B7%20Iama%20Therapeutics%20S.r.l.&badge=phase%201 IAMA-6 IAMA-6 · Iama Therapeutics S.r.l. https://druglandscape.com/drug/iap0971 https://druglandscape.com/api/og?type=drug&title=IAP0971&subtitle=IAP0971%20%C2%B7%20SUNHO%EF%BC%88China%EF%BC%89BioPharmaceutical%20CO.%2C%20Ltd.&badge=phase%201 IAP0971 IAP0971 · SUNHO（China）BioPharmaceutical CO., Ltd. https://druglandscape.com/drug/ib-001 https://druglandscape.com/api/og?type=drug&title=IB-001&subtitle=IB-001%20%C2%B7%20IntegerBio&badge=phase%201 IB-001 IB-001 · IntegerBio https://druglandscape.com/drug/ibb0979 https://druglandscape.com/api/og?type=drug&title=IBB0979&subtitle=IBB0979%20%C2%B7%20SUNHO%EF%BC%88China%EF%BC%89BioPharmaceutical%20CO.%2C%20Ltd.&badge=phase%202 IBB0979 IBB0979 · SUNHO（China）BioPharmaceutical CO., Ltd. https://druglandscape.com/drug/ibc0966 https://druglandscape.com/api/og?type=drug&title=IBC0966&subtitle=IBC0966%20%C2%B7%20SUNHO%EF%BC%88China%EF%BC%89BioPharmaceutical%20CO.%2C%20Ltd.&badge=phase%201 IBC0966 IBC0966 · SUNHO（China）BioPharmaceutical CO., Ltd. https://druglandscape.com/drug/ibd0333 https://druglandscape.com/api/og?type=drug&title=IBD0333&subtitle=IBD0333%20%C2%B7%20SUNHO%EF%BC%88China%EF%BC%89BioPharmaceutical%20CO.%2C%20Ltd.&badge=phase%201 IBD0333 IBD0333 · SUNHO（China）BioPharmaceutical CO., Ltd. https://druglandscape.com/drug/ibd98-m https://druglandscape.com/api/og?type=drug&title=IBD98-M%3A&subtitle=IBD98-M%3A%20%C2%B7%20Holy%20Stone%20Healthcare%20Co.%2C%20Ltd&badge=phase%201 IBD98-M: IBD98-M: · Holy Stone Healthcare Co., Ltd https://druglandscape.com/drug/ibd98-m-without-ha https://druglandscape.com/api/og?type=drug&title=IBD98-M%20without%20HA&subtitle=IBD98-M%20without%20HA%20%C2%B7%20Holy%20Stone%20Healthcare%20Co.%2C%20Ltd&badge=phase%201 IBD98-M without HA IBD98-M without HA · Holy Stone Healthcare Co., Ltd https://druglandscape.com/drug/iberogast https://druglandscape.com/api/og?type=drug&title=Iberogast%C2%AE&subtitle=Iberogast%C2%AE%20%C2%B7%20Bayer&badge=phase%202 Iberogast® Iberogast® · Bayer https://druglandscape.com/drug/ibi-360-injection-sintilimab https://druglandscape.com/api/og?type=drug&title=IBI%20360%20Injection%20Sintilimab&subtitle=IBI%20360%20Injection%20Sintilimab%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI 360 Injection Sintilimab IBI 360 Injection Sintilimab · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi110 https://druglandscape.com/api/og?type=drug&title=IBI110&subtitle=IBI110%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI110 IBI110 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi110-plus-sintilimab https://druglandscape.com/api/og?type=drug&title=IBI110%20plus%20sintilimab&subtitle=IBI110%20plus%20sintilimab%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI110 plus sintilimab IBI110 plus sintilimab · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi129 https://druglandscape.com/api/og?type=drug&title=IBI129&subtitle=IBI129%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI129 IBI129 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi130 https://druglandscape.com/api/og?type=drug&title=IBI130&subtitle=IBI130%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI130 IBI130 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi133 https://druglandscape.com/api/og?type=drug&title=IBI133&subtitle=IBI133%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI133 IBI133 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi3001 https://druglandscape.com/api/og?type=drug&title=IBI3001&subtitle=IBI3001%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI3001 IBI3001 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi3003 https://druglandscape.com/api/og?type=drug&title=IBI3003&subtitle=IBI3003%20%C2%B7%20Fortvita%20Biologics%20(USA)Inc.&badge=phase%201 IBI3003 IBI3003 · Fortvita Biologics (USA)Inc. https://druglandscape.com/drug/ibi3005 https://druglandscape.com/api/og?type=drug&title=IBI3005&subtitle=IBI3005%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI3005 IBI3005 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi3009 https://druglandscape.com/api/og?type=drug&title=IBI3009&subtitle=IBI3009%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI3009 IBI3009 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi3011 https://druglandscape.com/api/og?type=drug&title=IBI3011&subtitle=IBI3011%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI3011 IBI3011 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi3014 https://druglandscape.com/api/og?type=drug&title=IBI3014&subtitle=IBI3014%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI3014 IBI3014 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi3016 https://druglandscape.com/api/og?type=drug&title=IBI3016&subtitle=IBI3016%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%202 IBI3016 IBI3016 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi3026 https://druglandscape.com/api/og?type=drug&title=IBI3026&subtitle=IBI3026%20%C2%B7%20Innovent%20Biologics%20Technology%20Limited%20(Shanghai%20R%26D%20Center)&badge=phase%201 IBI3026 IBI3026 · Innovent Biologics Technology Limited (Shanghai R&D Center) https://druglandscape.com/drug/ibi3032 https://druglandscape.com/api/og?type=drug&title=IBI3032&subtitle=IBI3032%20%C2%B7%20Innovent%20Biologics%20Technology%20Limited%20(Shanghai%20R%26D%20Center)&badge=phase%201 IBI3032 IBI3032 · Innovent Biologics Technology Limited (Shanghai R&D Center) https://druglandscape.com/drug/ibi3032-tablets https://druglandscape.com/api/og?type=drug&title=IBI3032%20tablets&subtitle=IBI3032%20tablets%20%C2%B7%20Innovent%20Biologics%20Technology%20Limited%20(Shanghai%20R%26D%20Center)&badge=phase%201 IBI3032 tablets IBI3032 tablets · Innovent Biologics Technology Limited (Shanghai R&D Center) https://druglandscape.com/drug/ibi3033 https://druglandscape.com/api/og?type=drug&title=IBI3033&subtitle=IBI3033%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI3033 IBI3033 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi308-cisplatin-gemcitabine https://druglandscape.com/api/og?type=drug&title=IBI308%5Ccisplatin%5Cgemcitabine&subtitle=IBI308%5Ccisplatin%5Cgemcitabine%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI308\cisplatin\gemcitabine IBI308\cisplatin\gemcitabine · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi308-etoposide-cisplatin https://druglandscape.com/api/og?type=drug&title=IBI308%5Cetoposide%5Ccisplatin&subtitle=IBI308%5Cetoposide%5Ccisplatin%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI308\etoposide\cisplatin IBI308\etoposide\cisplatin · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi308-irinotecan-5-fu https://druglandscape.com/api/og?type=drug&title=IBI308%5Cirinotecan%5C5-FU&subtitle=IBI308%5Cirinotecan%5C5-FU%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI308\irinotecan\5-FU IBI308\irinotecan\5-FU · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi308-oxaliplatin-capecitabine https://druglandscape.com/api/og?type=drug&title=IBI308%5Coxaliplatin%5Ccapecitabine&subtitle=IBI308%5Coxaliplatin%5Ccapecitabine%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI308\oxaliplatin\capecitabine IBI308\oxaliplatin\capecitabine · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi315 https://druglandscape.com/api/og?type=drug&title=IBI315&subtitle=IBI315%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI315 IBI315 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi319 https://druglandscape.com/api/og?type=drug&title=IBI319&subtitle=IBI319%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI319 IBI319 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi321 https://druglandscape.com/api/og?type=drug&title=IBI321&subtitle=IBI321%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI321 IBI321 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi323 https://druglandscape.com/api/og?type=drug&title=IBI323&subtitle=IBI323%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI323 IBI323 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi324 https://druglandscape.com/api/og?type=drug&title=IBI324&subtitle=IBI324%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI324 IBI324 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi325 https://druglandscape.com/api/og?type=drug&title=IBI325&subtitle=IBI325%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI325 IBI325 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi333 https://druglandscape.com/api/og?type=drug&title=IBI333&subtitle=IBI333%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI333 IBI333 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi334 https://druglandscape.com/api/og?type=drug&title=IBI334&subtitle=IBI334%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI334 IBI334 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi345 https://druglandscape.com/api/og?type=drug&title=IBI345&subtitle=IBI345%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI345 IBI345 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi351 https://druglandscape.com/api/og?type=drug&title=IBI351&subtitle=IBI351%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI351 IBI351 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi351-combined-with-cetuximab https://druglandscape.com/api/og?type=drug&title=IBI351%20combined%20with%20cetuximab%20%CE%B2&subtitle=IBI351%20combined%20with%20cetuximab%20%CE%B2%20%C2%B7%20Guangdong%20Association%20of%20Clinical%20Trials&badge=phase%202 IBI351 combined with cetuximab β IBI351 combined with cetuximab β · Guangdong Association of Clinical Trials https://druglandscape.com/drug/ibi355 https://druglandscape.com/api/og?type=drug&title=IBI355&subtitle=IBI355%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI355 IBI355 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi356-for-mad https://druglandscape.com/api/og?type=drug&title=IBI356%20for%20MAD&subtitle=IBI356%20for%20MAD%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI356 for MAD IBI356 for MAD · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi356-for-sad https://druglandscape.com/api/og?type=drug&title=IBI356%20for%20SAD&subtitle=IBI356%20for%20SAD%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI356 for SAD IBI356 for SAD · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi362-liquid-formulation https://druglandscape.com/api/og?type=drug&title=IBI362%20liquid%20formulation&subtitle=IBI362%20liquid%20formulation%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI362 liquid formulation IBI362 liquid formulation · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi362-lyophilized-powder https://druglandscape.com/api/og?type=drug&title=IBI362%20lyophilized%20powder&subtitle=IBI362%20lyophilized%20powder%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI362 lyophilized powder IBI362 lyophilized powder · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibi939 https://druglandscape.com/api/og?type=drug&title=IBI939&subtitle=IBI939%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%201 IBI939 IBI939 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/ibio-600 https://druglandscape.com/api/og?type=drug&title=IBIO-600&subtitle=IBIO-600%20%C2%B7%20iBio%2C%20Inc.&badge=phase%201 IBIO-600 IBIO-600 · iBio, Inc. https://druglandscape.com/drug/ibio123 https://druglandscape.com/api/og?type=drug&title=IBIO123&subtitle=IBIO123%20%C2%B7%20Immune%20Biosolutions%20Inc&badge=phase%202 IBIO123 IBIO123 · Immune Biosolutions Inc https://druglandscape.com/drug/ibrutinib-acalabrutinib-zanubrutinib https://druglandscape.com/api/og?type=drug&title=Ibrutinib%2C%20Acalabrutinib%2C%20Zanubrutinib&subtitle=Ibrutinib%2C%20Acalabrutinib%2C%20Zanubrutinib%20%C2%B7%20VA%20Office%20of%20Research%20and%20Development&badge=phase%202 Ibrutinib, Acalabrutinib, Zanubrutinib Ibrutinib, Acalabrutinib, Zanubrutinib · VA Office of Research and Development https://druglandscape.com/drug/ibrutinib-alone https://druglandscape.com/api/og?type=drug&title=Ibrutinib%20alone&subtitle=Ibrutinib%20alone%20%C2%B7%20Oncternal%20Therapeutics%2C%20Inc&badge=phase%201 Ibrutinib alone Ibrutinib alone · Oncternal Therapeutics, Inc https://druglandscape.com/drug/ibrutinib-venetoclax https://druglandscape.com/api/og?type=drug&title=ibrutinib%2C%20venetoclax&subtitle=ibrutinib%2C%20venetoclax%20%C2%B7%20Stichting%20Hemato-Oncologie%20voor%20Volwassenen%20Nederland&badge=phase%202 ibrutinib, venetoclax ibrutinib, venetoclax · Stichting Hemato-Oncologie voor Volwassenen Nederland https://druglandscape.com/drug/ibrutinib-venetoclax-obinutuzumab https://druglandscape.com/api/og?type=drug&title=ibrutinib%2C%20venetoclax%2C%20obinutuzumab&subtitle=ibrutinib%2C%20venetoclax%2C%20obinutuzumab%20%C2%B7%20Stichting%20Hemato-Oncologie%20voor%20Volwassenen%20Nederland&badge=phase%202 ibrutinib, venetoclax, obinutuzumab ibrutinib, venetoclax, obinutuzumab · Stichting Hemato-Oncologie voor Volwassenen Nederland https://druglandscape.com/drug/ibrx-042 https://druglandscape.com/api/og?type=drug&title=IBRX-042&subtitle=IBRX-042%20%C2%B7%20ImmunityBio%2C%20Inc.&badge=phase%201 IBRX-042 IBRX-042 · ImmunityBio, Inc. https://druglandscape.com/drug/ibuflex https://druglandscape.com/api/og?type=drug&title=Ibuflex%C2%AE&subtitle=Ibuflex%C2%AE%20%C2%B7%20Apsen%20Farmaceutica%20S.A.&badge=phase%202 Ibuflex® Ibuflex® · Apsen Farmaceutica S.A. https://druglandscape.com/drug/ibuprofen-brimonidine-latanoprost https://druglandscape.com/api/og?type=drug&title=Ibuprofen%2C%20brimonidine%2C%20latanoprost&subtitle=Ibuprofen%2C%20brimonidine%2C%20latanoprost%20%C2%B7%20Philadelphia%20Eye%20Associates&badge=phase%201 Ibuprofen, brimonidine, latanoprost Ibuprofen, brimonidine, latanoprost · Philadelphia Eye Associates https://druglandscape.com/drug/ibuprofen-latanoprost-brimonidine https://druglandscape.com/api/og?type=drug&title=ibuprofen%2C%20latanoprost%2C%20brimonidine&subtitle=ibuprofen%2C%20latanoprost%2C%20brimonidine%20%C2%B7%20Philadelphia%20Eye%20Associates&badge=phase%201 ibuprofen, latanoprost, brimonidine ibuprofen, latanoprost, brimonidine · Philadelphia Eye Associates https://druglandscape.com/drug/ibuprofen-ldh https://druglandscape.com/api/og?type=drug&title=Ibuprofen-LDH&subtitle=Ibuprofen-LDH%20%C2%B7%20Oxford%20Pharmascience%20Ltd&badge=phase%201 Ibuprofen-LDH Ibuprofen-LDH · Oxford Pharmascience Ltd https://druglandscape.com/drug/ibuprofen-liquid-capsules https://druglandscape.com/api/og?type=drug&title=Ibuprofen%20Liquid%20Capsules&subtitle=Ibuprofen%20Liquid%20Capsules%20%C2%B7%20Reckitt%20Benckiser%20Healthcare%20(UK)%20Limited&badge=phase%201 Ibuprofen Liquid Capsules Ibuprofen Liquid Capsules · Reckitt Benckiser Healthcare (UK) Limited https://druglandscape.com/drug/ibuprofen-pc https://druglandscape.com/api/og?type=drug&title=Ibuprofen-PC&subtitle=Ibuprofen-PC%20%C2%B7%20PLx%20Pharma&badge=phase%202 Ibuprofen-PC Ibuprofen-PC · PLx Pharma https://druglandscape.com/drug/ic43 https://druglandscape.com/api/og?type=drug&title=IC43&subtitle=IC43%20%C2%B7%20Valneva%20Austria%20GmbH&badge=phase%202 IC43 IC43 · Valneva Austria GmbH https://druglandscape.com/drug/ic47 https://druglandscape.com/api/og?type=drug&title=IC47&subtitle=IC47%20%C2%B7%20Valneva%20Austria%20GmbH&badge=phase%201 IC47 IC47 · Valneva Austria GmbH https://druglandscape.com/drug/ic84 https://druglandscape.com/api/og?type=drug&title=IC84&subtitle=IC84%20%C2%B7%20Valneva%20Austria%20GmbH&badge=phase%201 IC84 IC84 · Valneva Austria GmbH https://druglandscape.com/drug/ica07-therapy https://druglandscape.com/api/og?type=drug&title=ICA07%20therapy&subtitle=ICA07%20therapy%20%C2%B7%20iCamuno%20Biotherapeutics%20Ltd.&badge=phase%201 ICA07 therapy ICA07 therapy · iCamuno Biotherapeutics Ltd. https://druglandscape.com/drug/icar19-car-t-cells https://druglandscape.com/api/og?type=drug&title=ICAR19%20CAR-T%20cells&subtitle=ICAR19%20CAR-T%20cells%20%C2%B7%20Immune%20Cell%2C%20Inc.&badge=phase%201 ICAR19 CAR-T cells ICAR19 CAR-T cells · Immune Cell, Inc. https://druglandscape.com/drug/icar30-t-cells https://druglandscape.com/api/og?type=drug&title=ICAR30%20T%20cells&subtitle=ICAR30%20T%20cells%20%C2%B7%20Immune%20Cell%2C%20Inc.&badge=phase%201 ICAR30 T cells ICAR30 T cells · Immune Cell, Inc. https://druglandscape.com/drug/icaspase9-transduced-t-cells https://druglandscape.com/api/og?type=drug&title=iCaspase9-transduced%20T%20cells&subtitle=iCaspase9-transduced%20T%20cells%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 iCaspase9-transduced T cells iCaspase9-transduced T cells · Baylor College of Medicine https://druglandscape.com/drug/ice-chemotherapy-regimen https://druglandscape.com/api/og?type=drug&title=ICE%20chemotherapy%20regimen&subtitle=ICE%20chemotherapy%20regimen%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 ICE chemotherapy regimen ICE chemotherapy regimen · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/icm20 https://druglandscape.com/api/og?type=drug&title=ICM20&subtitle=ICM20%20%C2%B7%20IC-MedTech%20Corporation&badge=phase%201 ICM20 ICM20 · IC-MedTech Corporation https://druglandscape.com/drug/icon-remineralization https://druglandscape.com/api/og?type=drug&title=ICON%20Remineralization&subtitle=ICON%20Remineralization%20%C2%B7%20Riyadh%20Colleges%20of%20Dentistry%20and%20Pharmacy&badge=phase%201 ICON Remineralization ICON Remineralization · Riyadh Colleges of Dentistry and Pharmacy https://druglandscape.com/drug/icovamenib-hpmc https://druglandscape.com/api/og?type=drug&title=Icovamenib%20HPMC&subtitle=Icovamenib%20HPMC%20%C2%B7%20Biomea%20Fusion%20Inc.&badge=phase%201 Icovamenib HPMC Icovamenib HPMC · Biomea Fusion Inc. https://druglandscape.com/drug/icp-033-tablet https://druglandscape.com/api/og?type=drug&title=ICP-033%20tablet&subtitle=ICP-033%20tablet%20%C2%B7%20Beijing%20InnoCare%20Pharma%20Tech%20Co.%2C%20Ltd.&badge=phase%201 ICP-033 tablet ICP-033 tablet · Beijing InnoCare Pharma Tech Co., Ltd. https://druglandscape.com/drug/icp-105 https://druglandscape.com/api/og?type=drug&title=ICP-105&subtitle=ICP-105%20%C2%B7%20Beijing%20InnoCare%20Pharma%20Tech%20Co.%2C%20Ltd.&badge=phase%201 ICP-105 ICP-105 · Beijing InnoCare Pharma Tech Co., Ltd. https://druglandscape.com/drug/icp-192 https://druglandscape.com/api/og?type=drug&title=ICP-192&subtitle=ICP-192%20%C2%B7%20Beijing%20InnoCare%20Pharma%20Tech%20Co.%2C%20Ltd.&badge=phase%202 ICP-192 ICP-192 · Beijing InnoCare Pharma Tech Co., Ltd. https://druglandscape.com/drug/icp-248 https://druglandscape.com/api/og?type=drug&title=ICP-248&subtitle=ICP-248%20%C2%B7%20Beijing%20InnoCare%20Pharma%20Tech%20Co.%2C%20Ltd.&badge=phase%202 ICP-248 ICP-248 · Beijing InnoCare Pharma Tech Co., Ltd. https://druglandscape.com/drug/icp-490 https://druglandscape.com/api/og?type=drug&title=ICP-490&subtitle=ICP-490%20%C2%B7%20Beijing%20InnoCare%20Pharma%20Tech%20Co.%2C%20Ltd.&badge=phase%201 ICP-490 ICP-490 · Beijing InnoCare Pharma Tech Co., Ltd. https://druglandscape.com/drug/icp-723 https://druglandscape.com/api/og?type=drug&title=ICP-723&subtitle=ICP-723%20%C2%B7%20Beijing%20InnoCare%20Pharma%20Tech%20Co.%2C%20Ltd.&badge=phase%201 ICP-723 ICP-723 · Beijing InnoCare Pharma Tech Co., Ltd. https://druglandscape.com/drug/icp-b794 https://druglandscape.com/api/og?type=drug&title=ICP-B794&subtitle=ICP-B794%20%C2%B7%20Beijing%20InnoCare%20Pharma%20Tech%20Co.%2C%20Ltd.&badge=phase%201 ICP-B794 ICP-B794 · Beijing InnoCare Pharma Tech Co., Ltd. https://druglandscape.com/drug/ict01 https://druglandscape.com/api/og?type=drug&title=ICT01&subtitle=ICT01%20%C2%B7%20ImCheck%20Therapeutics&badge=phase%201 ICT01 ICT01 · ImCheck Therapeutics https://druglandscape.com/drug/icvax https://druglandscape.com/api/og?type=drug&title=ICVAX&subtitle=ICVAX%20%C2%B7%20Immuno%20Cure%20Holding%20(HK)%20Limited&badge=phase%201 ICVAX ICVAX · Immuno Cure Holding (HK) Limited https://druglandscape.com/drug/icvt-topical-gel https://druglandscape.com/api/og?type=drug&title=ICVT%20Topical%20Gel&subtitle=ICVT%20Topical%20Gel%20%C2%B7%20Maruho%20Co.%2C%20Ltd.&badge=phase%202 ICVT Topical Gel ICVT Topical Gel · Maruho Co., Ltd. https://druglandscape.com/drug/id-085 https://druglandscape.com/api/og?type=drug&title=ID-085&subtitle=ID-085%20%C2%B7%20Idorsia%20Pharmaceuticals%20Ltd.&badge=phase%201 ID-085 ID-085 · Idorsia Pharmaceuticals Ltd. https://druglandscape.com/drug/id-klh https://druglandscape.com/api/og?type=drug&title=Id-KLH&subtitle=Id-KLH%20%C2%B7%20Favrille&badge=phase%202 Id-KLH Id-KLH · Favrille https://druglandscape.com/drug/id120040002 https://druglandscape.com/api/og?type=drug&title=ID120040002&subtitle=ID120040002%20%C2%B7%20IlDong%20Pharmaceutical%20Co%20Ltd&badge=phase%201 ID120040002 ID120040002 · IlDong Pharmaceutical Co Ltd https://druglandscape.com/drug/id1201 https://druglandscape.com/api/og?type=drug&title=ID1201&subtitle=ID1201%20%C2%B7%20IlDong%20Pharmaceutical%20Co%20Ltd&badge=phase%202 ID1201 ID1201 · IlDong Pharmaceutical Co Ltd https://druglandscape.com/drug/idct https://druglandscape.com/api/og?type=drug&title=IDCT&subtitle=IDCT%20%C2%B7%20DiscGenics%2C%20Inc.&badge=phase%201 IDCT IDCT · DiscGenics, Inc. https://druglandscape.com/drug/ide161 https://druglandscape.com/api/og?type=drug&title=IDE161&subtitle=IDE161%20%C2%B7%20IDEAYA%20Biosciences&badge=phase%201 IDE161 IDE161 · IDEAYA Biosciences https://druglandscape.com/drug/ide397 https://druglandscape.com/api/og?type=drug&title=IDE397&subtitle=IDE397%20%C2%B7%20IDEAYA%20Biosciences&badge=phase%201 IDE397 IDE397 · IDEAYA Biosciences https://druglandscape.com/drug/ide849 https://druglandscape.com/api/og?type=drug&title=IDE849&subtitle=IDE849%20%C2%B7%20IDEAYA%20Biosciences&badge=phase%201 IDE849 IDE849 · IDEAYA Biosciences https://druglandscape.com/drug/ide892 https://druglandscape.com/api/og?type=drug&title=IDE892&subtitle=IDE892%20%C2%B7%20IDEAYA%20Biosciences&badge=phase%201 IDE892 IDE892 · IDEAYA Biosciences https://druglandscape.com/drug/idea-070 https://druglandscape.com/api/og?type=drug&title=IDEA-070&subtitle=IDEA-070%20%C2%B7%20IDEA%20AG&badge=phase%202 IDEA-070 IDEA-070 · IDEA AG https://druglandscape.com/drug/idec-114 https://druglandscape.com/api/og?type=drug&title=IDEC-114&subtitle=IDEC-114%20%C2%B7%20Biogen&badge=phase%201 IDEC-114 IDEC-114 · Biogen https://druglandscape.com/drug/idec-152 https://druglandscape.com/api/og?type=drug&title=IDEC-152&subtitle=IDEC-152%20%C2%B7%20Biogen&badge=phase%201 IDEC-152 IDEC-152 · Biogen https://druglandscape.com/drug/idelalisib-and-rituximab https://druglandscape.com/api/og?type=drug&title=idelalisib%20and%20rituximab&subtitle=idelalisib%20and%20rituximab%20%C2%B7%20Gruppo%20Italiano%20Malattie%20EMatologiche%20dell'Adulto&badge=phase%202 idelalisib and rituximab idelalisib and rituximab · Gruppo Italiano Malattie EMatologiche dell'Adulto https://druglandscape.com/drug/identification-of-circulating-tumor-cells https://druglandscape.com/api/og?type=drug&title=Identification%20of%20Circulating%20Tumor%20Cells&subtitle=Identification%20of%20Circulating%20Tumor%20Cells%20%C2%B7%20Fondation%20H%C3%B4pital%20Saint-Joseph&badge=phase%201 Identification of Circulating Tumor Cells Identification of Circulating Tumor Cells · Fondation Hôpital Saint-Joseph https://druglandscape.com/drug/ides https://druglandscape.com/api/og?type=drug&title=IdeS&subtitle=IdeS%20%C2%B7%20Hansa%20Biopharma%20AB&badge=phase%202 IdeS IdeS · Hansa Biopharma AB https://druglandscape.com/drug/ido-peptide-vaccination https://druglandscape.com/api/og?type=drug&title=IDO%20peptide%20vaccination&subtitle=IDO%20peptide%20vaccination%20%C2%B7%20Inge%20Marie%20Svane&badge=phase%201 IDO peptide vaccination IDO peptide vaccination · Inge Marie Svane https://druglandscape.com/drug/idp-023 https://druglandscape.com/api/og?type=drug&title=IDP-023&subtitle=IDP-023%20%C2%B7%20Indapta%20Therapeutics%2C%20INC.&badge=phase%201 IDP-023 IDP-023 · Indapta Therapeutics, INC. https://druglandscape.com/drug/idp-118-high-strength https://druglandscape.com/api/og?type=drug&title=IDP-118%20High%20Strength&subtitle=IDP-118%20High%20Strength%20%C2%B7%20Dow%20Pharmaceutical%20Sciences&badge=phase%201 IDP-118 High Strength IDP-118 High Strength · Dow Pharmaceutical Sciences https://druglandscape.com/drug/idp-118-low-strength https://druglandscape.com/api/og?type=drug&title=IDP-118%20Low%20Strength&subtitle=IDP-118%20Low%20Strength%20%C2%B7%20Dow%20Pharmaceutical%20Sciences&badge=phase%201 IDP-118 Low Strength IDP-118 Low Strength · Dow Pharmaceutical Sciences https://druglandscape.com/drug/idp-118-monad-hp-lotion https://druglandscape.com/api/og?type=drug&title=IDP-118%20Monad%20HP%20Lotion&subtitle=IDP-118%20Monad%20HP%20Lotion%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%202 IDP-118 Monad HP Lotion IDP-118 Monad HP Lotion · Bausch Health Americas, Inc. https://druglandscape.com/drug/idp-120-component-a-gel https://druglandscape.com/api/og?type=drug&title=IDP%20120%20Component%20A%20Gel&subtitle=IDP%20120%20Component%20A%20Gel%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%202 IDP 120 Component A Gel IDP 120 Component A Gel · Bausch Health Americas, Inc. https://druglandscape.com/drug/idp-120-component-b-gel https://druglandscape.com/api/og?type=drug&title=IDP%20120%20Component%20B%20Gel&subtitle=IDP%20120%20Component%20B%20Gel%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%202 IDP 120 Component B Gel IDP 120 Component B Gel · Bausch Health Americas, Inc. https://druglandscape.com/drug/idp-121 https://druglandscape.com/api/og?type=drug&title=IDP-121&subtitle=IDP-121%20%C2%B7%20IDP%20Discovery%20Pharma%20S.L.&badge=phase%201 IDP-121 IDP-121 · IDP Discovery Pharma S.L. https://druglandscape.com/drug/idp-126-component-a https://druglandscape.com/api/og?type=drug&title=IDP-126%20Component%20A&subtitle=IDP-126%20Component%20A%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%202 IDP-126 Component A IDP-126 Component A · Bausch Health Americas, Inc. https://druglandscape.com/drug/idp-126-component-b https://druglandscape.com/api/og?type=drug&title=IDP-126%20Component%20B&subtitle=IDP-126%20Component%20B%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%202 IDP-126 Component B IDP-126 Component B · Bausch Health Americas, Inc. https://druglandscape.com/drug/idp-126-component-c https://druglandscape.com/api/og?type=drug&title=IDP-126%20Component%20C&subtitle=IDP-126%20Component%20C%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%202 IDP-126 Component C IDP-126 Component C · Bausch Health Americas, Inc. https://druglandscape.com/drug/idursulfase-it https://druglandscape.com/api/og?type=drug&title=Idursulfase-IT&subtitle=Idursulfase-IT%20%C2%B7%20Shire&badge=phase%202 Idursulfase-IT Idursulfase-IT · Shire https://druglandscape.com/drug/idx-1197 https://druglandscape.com/api/og?type=drug&title=IDX-1197&subtitle=IDX-1197%20%C2%B7%20Idience%20Co.%2C%20Ltd.&badge=phase%201 IDX-1197 IDX-1197 · Idience Co., Ltd. https://druglandscape.com/drug/idx320 https://druglandscape.com/api/og?type=drug&title=IDX320&subtitle=IDX320%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 IDX320 IDX320 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/idx719 https://druglandscape.com/api/og?type=drug&title=IDX719&subtitle=IDX719%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 IDX719 IDX719 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/iepcs https://druglandscape.com/api/og?type=drug&title=iEPCs&subtitle=iEPCs%20%C2%B7%20Allife%20Medical%20Science%20and%20Technology%20Co.%2C%20Ltd.&badge=phase%201 iEPCs iEPCs · Allife Medical Science and Technology Co., Ltd. https://druglandscape.com/drug/ifn https://druglandscape.com/api/og?type=drug&title=%CE%B1-IFN&subtitle=%CE%B1-IFN%20%C2%B7%20Sun%20Yat-sen%20University&badge=phase%203 α-IFN α-IFN · Sun Yat-sen University https://druglandscape.com/drug/ifn-k https://druglandscape.com/api/og?type=drug&title=IFN-K&subtitle=IFN-K%20%C2%B7%20Neovacs&badge=phase%201 IFN-K IFN-K · Neovacs https://druglandscape.com/drug/ifosfamide-gemcitabine-vinorelbine https://druglandscape.com/api/og?type=drug&title=Ifosfamide%2C%20Gemcitabine%2C%20Vinorelbine&subtitle=Ifosfamide%2C%20Gemcitabine%2C%20Vinorelbine%20%C2%B7%20Istituto%20Clinico%20Humanitas&badge=phase%202 Ifosfamide, Gemcitabine, Vinorelbine Ifosfamide, Gemcitabine, Vinorelbine · Istituto Clinico Humanitas https://druglandscape.com/drug/ifosphamide-etoposide-methotrexate-vincristine-prednisone https://druglandscape.com/api/og?type=drug&title=Ifosphamide%2C%20Etoposide%2C%20Methotrexate%2C%20Vincristine%2C%20Prednisone&subtitle=Ifosphamide%2C%20Etoposide%2C%20Methotrexate%2C%20Vincristine%2C%20Prednisone%20%C2%B7%20Children's%20Cancer%20Group%2C%20China&badge=phase%202 Ifosphamide, Etoposide, Methotrexate, Vincristine, Prednisone Ifosphamide, Etoposide, Methotrexate, Vincristine, Prednisone · Children's Cancer Group, China https://druglandscape.com/drug/ifx-1 https://druglandscape.com/api/og?type=drug&title=IFX-1&subtitle=IFX-1%20%C2%B7%20InflaRx%20GmbH&badge=phase%202 IFX-1 IFX-1 · InflaRx GmbH https://druglandscape.com/drug/ig-001 https://druglandscape.com/api/og?type=drug&title=IG-001&subtitle=IG-001%20%C2%B7%20Sorrento%20Therapeutics%2C%20Inc.&badge=phase%201 IG-001 IG-001 · Sorrento Therapeutics, Inc. https://druglandscape.com/drug/ig3018 https://druglandscape.com/api/og?type=drug&title=IG3018&subtitle=IG3018%20%C2%B7%20Intelligem%20Therapeutics%20Australia%20Pty%20Ltd.&badge=phase%201 IG3018 IG3018 · Intelligem Therapeutics Australia Pty Ltd. https://druglandscape.com/drug/igad-gstd https://druglandscape.com/api/og?type=drug&title=IGAD%E2%86%92GSTD&subtitle=IGAD%E2%86%92GSTD%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 IGAD→GSTD IGAD→GSTD · Dong-A ST Co., Ltd. https://druglandscape.com/drug/igc-ad1 https://druglandscape.com/api/og?type=drug&title=IGC%20AD1&subtitle=IGC%20AD1%20%C2%B7%20IGC%20Pharma%2C%20LLC&badge=phase%201 IGC AD1 IGC AD1 · IGC Pharma, LLC https://druglandscape.com/drug/igc-ad1-active https://druglandscape.com/api/og?type=drug&title=IGC-AD1-Active&subtitle=IGC-AD1-Active%20%C2%B7%20IGC%20Pharma%2C%20LLC&badge=phase%202 IGC-AD1-Active IGC-AD1-Active · IGC Pharma, LLC https://druglandscape.com/drug/ige-1 https://druglandscape.com/api/og?type=drug&title=IGE-1&subtitle=IGE-1%20%C2%B7%20Pfizer&badge=phase%201 IGE-1 IGE-1 · Pfizer https://druglandscape.com/drug/ige-2 https://druglandscape.com/api/og?type=drug&title=IGE-2&subtitle=IGE-2%20%C2%B7%20Pfizer&badge=phase%201 IGE-2 IGE-2 · Pfizer https://druglandscape.com/drug/igf-methotrexate-conjugate https://druglandscape.com/api/og?type=drug&title=IGF-Methotrexate%20conjugate&subtitle=IGF-Methotrexate%20conjugate%20%C2%B7%20IGF%20Oncology%2C%20LLC&badge=phase%201 IGF-Methotrexate conjugate IGF-Methotrexate conjugate · IGF Oncology, LLC https://druglandscape.com/drug/igf1r-antibody-mk0646 https://druglandscape.com/api/og?type=drug&title=IGF1R%20antibody%20MK0646&subtitle=IGF1R%20antibody%20MK0646%20%C2%B7%20Hillel%20Yaffe%20Medical%20Center&badge=phase%202 IGF1R antibody MK0646 IGF1R antibody MK0646 · Hillel Yaffe Medical Center https://druglandscape.com/drug/igm-7354 https://druglandscape.com/api/og?type=drug&title=IGM-7354&subtitle=IGM-7354%20%C2%B7%20IGM%20Biosciences%2C%20Inc.&badge=phase%201 IGM-7354 IGM-7354 · IGM Biosciences, Inc. https://druglandscape.com/drug/ign-es001 https://druglandscape.com/api/og?type=drug&title=IGN-ES001&subtitle=IGN-ES001%20%C2%B7%20IgNova%20GmbH&badge=phase%201 IGN-ES001 IGN-ES001 · IgNova GmbH https://druglandscape.com/drug/ignx001 https://druglandscape.com/api/og?type=drug&title=IGNX001&subtitle=IGNX001%20%C2%B7%20IgGenix%20Australia%20Pty%20Ltd&badge=phase%201 IGNX001 IGNX001 · IgGenix Australia Pty Ltd https://druglandscape.com/drug/igt-303 https://druglandscape.com/api/og?type=drug&title=IGT-303&subtitle=IGT-303%20%C2%B7%20Ingenia%20Therapeutics%20INC&badge=phase%201 IGT-303 IGT-303 · Ingenia Therapeutics INC https://druglandscape.com/drug/ih-chadox1-vzv https://druglandscape.com/api/og?type=drug&title=IH%20ChAdOx1-VZV&subtitle=IH%20ChAdOx1-VZV%20%C2%B7%20CanSino%20Biologics%20Inc.&badge=phase%201 IH ChAdOx1-VZV IH ChAdOx1-VZV · CanSino Biologics Inc. https://druglandscape.com/drug/ih-peg-ifn-2a https://druglandscape.com/api/og?type=drug&title=ih%20PEG-IFN%20%CE%B1-2a&subtitle=ih%20PEG-IFN%20%CE%B1-2a%20%C2%B7%20Ascletis%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 ih PEG-IFN α-2a ih PEG-IFN α-2a · Ascletis Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/ihl-42x-low-dose https://druglandscape.com/api/og?type=drug&title=IHL-42X%20Low%20Dose&subtitle=IHL-42X%20Low%20Dose%20%C2%B7%20Incannex%20Healthcare%20Ltd&badge=phase%202 IHL-42X Low Dose IHL-42X Low Dose · Incannex Healthcare Ltd https://druglandscape.com/drug/ihl42x https://druglandscape.com/api/og?type=drug&title=IHL42X&subtitle=IHL42X%20%C2%B7%20Incannex%20Healthcare%20Ltd&badge=phase%201 IHL42X IHL42X · Incannex Healthcare Ltd https://druglandscape.com/drug/ihscs-treatment-group https://druglandscape.com/api/og?type=drug&title=iHSCs%20treatment%20group&subtitle=iHSCs%20treatment%20group%20%C2%B7%20Allife%20Medical%20Science%20and%20Technology%20Co.%2C%20Ltd.&badge=phase%201 iHSCs treatment group iHSCs treatment group · Allife Medical Science and Technology Co., Ltd. https://druglandscape.com/drug/iiv-hd https://druglandscape.com/api/og?type=drug&title=IIV-HD&subtitle=IIV-HD%20%C2%B7%20Sanofi&badge=phase%201 IIV-HD IIV-HD · Sanofi https://druglandscape.com/drug/iiv4c https://druglandscape.com/api/og?type=drug&title=IIV4c&subtitle=IIV4c%20%C2%B7%20Seqirus&badge=phase%202 IIV4c IIV4c · Seqirus https://druglandscape.com/drug/iks014 https://druglandscape.com/api/og?type=drug&title=IKS014&subtitle=IKS014%20%C2%B7%20Iksuda%20Therapeutics%20Ltd.&badge=phase%201 IKS014 IKS014 · Iksuda Therapeutics Ltd. https://druglandscape.com/drug/iks03 https://druglandscape.com/api/og?type=drug&title=IKS03&subtitle=IKS03%20%C2%B7%20Iksuda%20Therapeutics%20Ltd.&badge=phase%201 IKS03 IKS03 · Iksuda Therapeutics Ltd. https://druglandscape.com/drug/ikt-148009 https://druglandscape.com/api/og?type=drug&title=IkT-148009&subtitle=IkT-148009%20%C2%B7%20ABLi%20Therapeutics%2C%20Inc.&badge=phase%201 IkT-148009 IkT-148009 · ABLi Therapeutics, Inc. https://druglandscape.com/drug/il-1ra-kineret https://druglandscape.com/api/og?type=drug&title=IL-1Ra%20Kineret%C2%AE&subtitle=IL-1Ra%20Kineret%C2%AE%20%C2%B7%20Adrian%20Parry-Jones&badge=phase%202 IL-1Ra Kineret® IL-1Ra Kineret® · Adrian Parry-Jones https://druglandscape.com/drug/il-yang-flu-vaccine https://druglandscape.com/api/og?type=drug&title=IL-YANG%20FLU%20Vaccine&subtitle=IL-YANG%20FLU%20Vaccine%20%C2%B7%20Il-Yang%20Pharm.%20Co.%2C%20Ltd.&badge=phase%201 IL-YANG FLU Vaccine IL-YANG FLU Vaccine · Il-Yang Pharm. Co., Ltd. https://druglandscape.com/drug/il12-l19l19 https://druglandscape.com/api/og?type=drug&title=IL12-L19L19&subtitle=IL12-L19L19%20%C2%B7%20Philogen%20S.p.A.&badge=phase%201 IL12-L19L19 IL12-L19L19 · Philogen S.p.A. https://druglandscape.com/drug/il28b-polymorphism https://druglandscape.com/api/og?type=drug&title=IL28B%20Polymorphism&subtitle=IL28B%20Polymorphism%20%C2%B7%20Dr.Waleed%20Samir&badge=phase%201 IL28B Polymorphism IL28B Polymorphism · Dr.Waleed Samir https://druglandscape.com/drug/ilb-202 https://druglandscape.com/api/og?type=drug&title=ILB-202&subtitle=ILB-202%20%C2%B7%20ILIAS%20Biologics%20Inc.&badge=phase%201 ILB-202 ILB-202 · ILIAS Biologics Inc. https://druglandscape.com/drug/ileocolonic-biopsies https://druglandscape.com/api/og?type=drug&title=Ileocolonic%20biopsies&subtitle=Ileocolonic%20biopsies%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 Ileocolonic biopsies Ileocolonic biopsies · Hospices Civils de Lyon https://druglandscape.com/drug/ilkn421h https://druglandscape.com/api/og?type=drug&title=ILKN421H&subtitle=ILKN421H%20%C2%B7%20iLeukon%20Therapeutics%2C%20Inc.&badge=phase%202 ILKN421H ILKN421H · iLeukon Therapeutics, Inc. https://druglandscape.com/drug/illuccix-68ga-psma-11-total-body-pet-ct https://druglandscape.com/api/og?type=drug&title=illuccix%2068Ga-PSMA-11%20Total%20Body%20PET-CT&subtitle=illuccix%2068Ga-PSMA-11%20Total%20Body%20PET-CT%20%C2%B7%20BAMF%20Health&badge=phase%201 illuccix 68Ga-PSMA-11 Total Body PET-CT illuccix 68Ga-PSMA-11 Total Body PET-CT · BAMF Health https://druglandscape.com/drug/iloprost-infusion https://druglandscape.com/api/og?type=drug&title=Iloprost%20infusion&subtitle=Iloprost%20infusion%20%C2%B7%20Amsterdam%20UMC%2C%20location%20VUmc&badge=phase%201 Iloprost infusion Iloprost infusion · Amsterdam UMC, location VUmc https://druglandscape.com/drug/ilt101 https://druglandscape.com/api/og?type=drug&title=ILT101&subtitle=ILT101%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 ILT101 ILT101 · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/ilv-095 https://druglandscape.com/api/og?type=drug&title=ILV-095&subtitle=ILV-095%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 ILV-095 ILV-095 · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/ily101 https://druglandscape.com/api/og?type=drug&title=ILY101&subtitle=ILY101%20%C2%B7%20Ilypsa&badge=phase%202 ILY101 ILY101 · Ilypsa https://druglandscape.com/drug/im-01 https://druglandscape.com/api/og?type=drug&title=IM-01&subtitle=IM-01%20%C2%B7%20ImmuniMed%20Inc.&badge=phase%202 IM-01 IM-01 · ImmuniMed Inc. https://druglandscape.com/drug/im-101-part-a https://druglandscape.com/api/og?type=drug&title=IM-101%20Part%20A&subtitle=IM-101%20Part%20A%20%C2%B7%20ImmunAbs%20Inc.&badge=phase%201 IM-101 Part A IM-101 Part A · ImmunAbs Inc. https://druglandscape.com/drug/im-101-part-b https://druglandscape.com/api/og?type=drug&title=IM-101%20Part%20B&subtitle=IM-101%20Part%20B%20%C2%B7%20ImmunAbs%20Inc.&badge=phase%201 IM-101 Part B IM-101 Part B · ImmunAbs Inc. https://druglandscape.com/drug/im-1021 https://druglandscape.com/api/og?type=drug&title=IM-1021&subtitle=IM-1021%20%C2%B7%20Immunome%2C%20Inc.&badge=phase%201 IM-1021 IM-1021 · Immunome, Inc. https://druglandscape.com/drug/im-glucagon https://druglandscape.com/api/og?type=drug&title=IM%20Glucagon&subtitle=IM%20Glucagon%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 IM Glucagon IM Glucagon · Eli Lilly and Company https://druglandscape.com/drug/im156 https://druglandscape.com/api/og?type=drug&title=IM156&subtitle=IM156%20%C2%B7%20ImmunoMet%20Therapeutics%2C%20Inc.&badge=phase%201 IM156 IM156 · ImmunoMet Therapeutics, Inc. https://druglandscape.com/drug/im19 https://druglandscape.com/api/og?type=drug&title=IM19&subtitle=IM19%20%C2%B7%20Beijing%20Immunochina%20Medical%20Science%20%26%20Technology%20Co.%2C%20Ltd.&badge=phase%201 IM19 IM19 · Beijing Immunochina Medical Science & Technology Co., Ltd. https://druglandscape.com/drug/im19-car-t https://druglandscape.com/api/og?type=drug&title=IM19%20CAR-T&subtitle=IM19%20CAR-T%20%C2%B7%20Beijing%20Immunochina%20Medical%20Science%20%26%20Technology%20Co.%2C%20Ltd.&badge=phase%201 IM19 CAR-T IM19 CAR-T · Beijing Immunochina Medical Science & Technology Co., Ltd. https://druglandscape.com/drug/im19-car-t-cells https://druglandscape.com/api/og?type=drug&title=IM19%20CAR-T%20cells&subtitle=IM19%20CAR-T%20cells%20%C2%B7%20Beijing%20Immunochina%20Medical%20Science%20%26%20Technology%20Co.%2C%20Ltd.&badge=phase%201 IM19 CAR-T cells IM19 CAR-T cells · Beijing Immunochina Medical Science & Technology Co., Ltd. https://druglandscape.com/drug/im23 https://druglandscape.com/api/og?type=drug&title=IM23&subtitle=IM23%20%C2%B7%20Beijing%20Immunochina%20Medical%20Science%20%26%20Technology%20Co.%2C%20Ltd.&badge=phase%201 IM23 IM23 · Beijing Immunochina Medical Science & Technology Co., Ltd. https://druglandscape.com/drug/im83-car-t-cells https://druglandscape.com/api/og?type=drug&title=IM83%20CAR-T%20Cells&subtitle=IM83%20CAR-T%20Cells%20%C2%B7%20Beijing%20Immunochina%20Medical%20Science%20%26%20Technology%20Co.%2C%20Ltd.&badge=phase%201 IM83 CAR-T Cells IM83 CAR-T Cells · Beijing Immunochina Medical Science & Technology Co., Ltd. https://druglandscape.com/drug/im92-car-t-cells https://druglandscape.com/api/og?type=drug&title=IM92%20CAR-T%20cells&subtitle=IM92%20CAR-T%20cells%20%C2%B7%20Beijing%20Immunochina%20Medical%20Science%20%26%20Technology%20Co.%2C%20Ltd.&badge=phase%201 IM92 CAR-T cells IM92 CAR-T cells · Beijing Immunochina Medical Science & Technology Co., Ltd. https://druglandscape.com/drug/im96-car-t-cells https://druglandscape.com/api/og?type=drug&title=IM96%20CAR-T%20Cells&subtitle=IM96%20CAR-T%20Cells%20%C2%B7%20Beijing%20Immunochina%20Medical%20Science%20%26%20Technology%20Co.%2C%20Ltd.&badge=phase%201 IM96 CAR-T Cells IM96 CAR-T Cells · Beijing Immunochina Medical Science & Technology Co., Ltd. https://druglandscape.com/drug/ima-638 https://druglandscape.com/api/og?type=drug&title=IMA-638&subtitle=IMA-638%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%202 IMA-638 IMA-638 · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/ima-638-is-a-biologic https://druglandscape.com/api/og?type=drug&title=IMA-638%20is%20a%20biologic&subtitle=IMA-638%20is%20a%20biologic%20%C2%B7%20Pfizer&badge=phase%202 IMA-638 is a biologic IMA-638 is a biologic · Pfizer https://druglandscape.com/drug/ima101-product https://druglandscape.com/api/og?type=drug&title=IMA101%20product&subtitle=IMA101%20product%20%C2%B7%20Immatics%20US%2C%20Inc.&badge=phase%201 IMA101 product IMA101 product · Immatics US, Inc. https://druglandscape.com/drug/ima201-product https://druglandscape.com/api/og?type=drug&title=IMA201%20Product&subtitle=IMA201%20Product%20%C2%B7%20Immatics%20US%2C%20Inc.&badge=phase%201 IMA201 Product IMA201 Product · Immatics US, Inc. https://druglandscape.com/drug/ima202-product https://druglandscape.com/api/og?type=drug&title=IMA202%20Product&subtitle=IMA202%20Product%20%C2%B7%20Immatics%20US%2C%20Inc.&badge=phase%201 IMA202 Product IMA202 Product · Immatics US, Inc. https://druglandscape.com/drug/ima203-product-flat-dose https://druglandscape.com/api/og?type=drug&title=IMA203%20product-%20flat%20dose&subtitle=IMA203%20product-%20flat%20dose%20%C2%B7%20Immatics%20US%2C%20Inc.&badge=phase%201 IMA203 product- flat dose IMA203 product- flat dose · Immatics US, Inc. https://druglandscape.com/drug/ima901-and-leukine https://druglandscape.com/api/og?type=drug&title=IMA901%20and%20Leukine&subtitle=IMA901%20and%20Leukine%20%C2%B7%20Immatics%20Biotechnologies%20GmbH&badge=phase%202 IMA901 and Leukine IMA901 and Leukine · Immatics Biotechnologies GmbH https://druglandscape.com/drug/imab027 https://druglandscape.com/api/og?type=drug&title=IMAB027&subtitle=IMAB027%20%C2%B7%20Ganymed%20Pharmaceuticals%20GmbH&badge=phase%201 IMAB027 IMAB027 · Ganymed Pharmaceuticals GmbH https://druglandscape.com/drug/imab362 https://druglandscape.com/api/og?type=drug&title=IMAB362&subtitle=IMAB362%20%C2%B7%20Astellas%20Pharma%20Global%20Development%2C%20Inc.&badge=phase%202 IMAB362 IMAB362 · Astellas Pharma Global Development, Inc. https://druglandscape.com/drug/imatinib-dasatinib-or-nilotinib https://druglandscape.com/api/og?type=drug&title=Imatinib%2C%20Dasatinib%20or%20Nilotinib&subtitle=Imatinib%2C%20Dasatinib%20or%20Nilotinib%20%C2%B7%20Ascentage%20Pharma%20Group%20Inc.&badge=phase%202 Imatinib, Dasatinib or Nilotinib Imatinib, Dasatinib or Nilotinib · Ascentage Pharma Group Inc. https://druglandscape.com/drug/imatinib-mesylate-plus-gemcitabine https://druglandscape.com/api/og?type=drug&title=Imatinib%20mesylate%20plus%20Gemcitabine&subtitle=Imatinib%20mesylate%20plus%20Gemcitabine%20%C2%B7%20Gruppo%20Italiano%20MEsotelioma&badge=phase%202 Imatinib mesylate plus Gemcitabine Imatinib mesylate plus Gemcitabine · Gruppo Italiano MEsotelioma https://druglandscape.com/drug/imatinib-treatment https://druglandscape.com/api/og?type=drug&title=Imatinib%20treatment&subtitle=Imatinib%20treatment%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Imatinib treatment Imatinib treatment · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/imc-001 https://druglandscape.com/api/og?type=drug&title=IMC-001&subtitle=IMC-001%20%C2%B7%20ImmuneOncia%20Therapeutics%20Inc.&badge=phase%202 IMC-001 IMC-001 · ImmuneOncia Therapeutics Inc. https://druglandscape.com/drug/imc-002 https://druglandscape.com/api/og?type=drug&title=IMC-002&subtitle=IMC-002%20%C2%B7%20ImmuneOncia%20Therapeutics%20Inc.&badge=phase%201 IMC-002 IMC-002 · ImmuneOncia Therapeutics Inc. https://druglandscape.com/drug/imc-11f8 https://druglandscape.com/api/og?type=drug&title=IMC-11F8&subtitle=IMC-11F8%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 IMC-11F8 IMC-11F8 · Eli Lilly and Company https://druglandscape.com/drug/imc-11f8-i-v https://druglandscape.com/api/og?type=drug&title=IMC-11F8%20I.V.&subtitle=IMC-11F8%20I.V.%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 IMC-11F8 I.V. IMC-11F8 I.V. · Eli Lilly and Company https://druglandscape.com/drug/imc-3g3 https://druglandscape.com/api/og?type=drug&title=IMC-3G3&subtitle=IMC-3G3%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 IMC-3G3 IMC-3G3 · Eli Lilly and Company https://druglandscape.com/drug/imc-ron8 https://druglandscape.com/api/og?type=drug&title=IMC-RON8&subtitle=IMC-RON8%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 IMC-RON8 IMC-RON8 · Eli Lilly and Company https://druglandscape.com/drug/imc-tr1 https://druglandscape.com/api/og?type=drug&title=IMC-TR1&subtitle=IMC-TR1%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 IMC-TR1 IMC-TR1 · Eli Lilly and Company https://druglandscape.com/drug/imcy-0141 https://druglandscape.com/api/og?type=drug&title=IMCY-0141&subtitle=IMCY-0141%20%C2%B7%20Imcyse%20SA&badge=phase%201 IMCY-0141 IMCY-0141 · Imcyse SA https://druglandscape.com/drug/imexon-in-combination-with-gemcitabine https://druglandscape.com/api/og?type=drug&title=imexon%20in%20combination%20with%20gemcitabine&subtitle=imexon%20in%20combination%20with%20gemcitabine%20%C2%B7%20AmpliMed%20Corporation&badge=phase%202 imexon in combination with gemcitabine imexon in combination with gemcitabine · AmpliMed Corporation https://druglandscape.com/drug/imf-001 https://druglandscape.com/api/og?type=drug&title=IMF-001&subtitle=IMF-001%20%C2%B7%20ImmunoFrontier%2C%20Inc.&badge=phase%201 IMF-001 IMF-001 · ImmunoFrontier, Inc. https://druglandscape.com/drug/imgc936 https://druglandscape.com/api/og?type=drug&title=IMGC936&subtitle=IMGC936%20%C2%B7%20ImmunoGen%2C%20Inc.&badge=phase%201 IMGC936 IMGC936 · ImmunoGen, Inc. https://druglandscape.com/drug/imgn151 https://druglandscape.com/api/og?type=drug&title=IMGN151&subtitle=IMGN151%20%C2%B7%20AbbVie&badge=phase%202 IMGN151 IMGN151 · AbbVie https://druglandscape.com/drug/imgn388 https://druglandscape.com/api/og?type=drug&title=IMGN388&subtitle=IMGN388%20%C2%B7%20ImmunoGen%2C%20Inc.&badge=phase%201 IMGN388 IMGN388 · ImmunoGen, Inc. https://druglandscape.com/drug/imgn632 https://druglandscape.com/api/og?type=drug&title=IMGN632&subtitle=IMGN632%20%C2%B7%20AbbVie&badge=phase%201 IMGN632 IMGN632 · AbbVie https://druglandscape.com/drug/imgn779 https://druglandscape.com/api/og?type=drug&title=IMGN779&subtitle=IMGN779%20%C2%B7%20ImmunoGen%2C%20Inc.&badge=phase%201 IMGN779 IMGN779 · ImmunoGen, Inc. https://druglandscape.com/drug/imgs-001 https://druglandscape.com/api/og?type=drug&title=IMGS-001&subtitle=IMGS-001%20%C2%B7%20ImmunoGenesis&badge=phase%201 IMGS-001 IMGS-001 · ImmunoGenesis https://druglandscape.com/drug/imitrex-oral-product https://druglandscape.com/api/og?type=drug&title=Imitrex%20Oral%20Product&subtitle=Imitrex%20Oral%20Product%20%C2%B7%20Targia%20Pharmaceuticals%20Ltd.&badge=phase%201 Imitrex Oral Product Imitrex Oral Product · Targia Pharmaceuticals Ltd. https://druglandscape.com/drug/imm-h014 https://druglandscape.com/api/og?type=drug&title=IMM-H014&subtitle=IMM-H014%20%C2%B7%20Changchun%20Intellicrown%20Pharmaceutical%20Co.%20LTD&badge=phase%201 IMM-H014 IMM-H014 · Changchun Intellicrown Pharmaceutical Co. LTD https://druglandscape.com/drug/imm01-stem https://druglandscape.com/api/og?type=drug&title=IMM01-STEM&subtitle=IMM01-STEM%20%C2%B7%20Immunis%2C%20Inc.&badge=phase%202 IMM01-STEM IMM01-STEM · Immunis, Inc. https://druglandscape.com/drug/imm2510 https://druglandscape.com/api/og?type=drug&title=IMM2510&subtitle=IMM2510%20%C2%B7%20ImmuneOnco%20Biopharmaceuticals%20(Shanghai)%20Inc.&badge=phase%202 IMM2510 IMM2510 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. https://druglandscape.com/drug/imm27m https://druglandscape.com/api/og?type=drug&title=IMM27M&subtitle=IMM27M%20%C2%B7%20ImmuneOnco%20Biopharmaceuticals%20(Shanghai)%20Inc.&badge=phase%201 IMM27M IMM27M · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. https://druglandscape.com/drug/imm40h https://druglandscape.com/api/og?type=drug&title=IMM40H&subtitle=IMM40H%20%C2%B7%20ImmuneOnco%20Biopharmaceuticals%20(Shanghai)%20Inc.&badge=phase%201 IMM40H IMM40H · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. https://druglandscape.com/drug/imm47 https://druglandscape.com/api/og?type=drug&title=IMM47&subtitle=IMM47%20%C2%B7%20ImmuneOnco%20Biopharmaceuticals%20(Shanghai)%20Inc.&badge=phase%201 IMM47 IMM47 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. https://druglandscape.com/drug/immediate-release-amphetamine-salt https://druglandscape.com/api/og?type=drug&title=Immediate%20Release%20Amphetamine%20Salt&subtitle=Immediate%20Release%20Amphetamine%20Salt%20%C2%B7%20Shire&badge=phase%202 Immediate Release Amphetamine Salt Immediate Release Amphetamine Salt · Shire https://druglandscape.com/drug/immediate-release-guanfacine-hydrochloride https://druglandscape.com/api/og?type=drug&title=immediate%20release%20guanfacine%20hydrochloride&subtitle=immediate%20release%20guanfacine%20hydrochloride%20%C2%B7%20Shire&badge=phase%201 immediate release guanfacine hydrochloride immediate release guanfacine hydrochloride · Shire https://druglandscape.com/drug/immediate-release-hydrocortisone-fasted https://druglandscape.com/api/og?type=drug&title=Immediate%20release%20hydrocortisone%3A%20fasted&subtitle=Immediate%20release%20hydrocortisone%3A%20fasted%20%C2%B7%20Neurocrine%20UK%20Limited&badge=phase%201 Immediate release hydrocortisone: fasted Immediate release hydrocortisone: fasted · Neurocrine UK Limited https://druglandscape.com/drug/immediate-release-metronidazole https://druglandscape.com/api/og?type=drug&title=Immediate-release%20metronidazole&subtitle=Immediate-release%20metronidazole%20%C2%B7%20Gateway%20Pharmaceutical%20LLC&badge=phase%201 Immediate-release metronidazole Immediate-release metronidazole · Gateway Pharmaceutical LLC https://druglandscape.com/drug/immediate-release-reference-drug https://druglandscape.com/api/og?type=drug&title=Immediate-release%20reference%20drug&subtitle=Immediate-release%20reference%20drug%20%C2%B7%20Pfizer&badge=phase%202 Immediate-release reference drug Immediate-release reference drug · Pfizer https://druglandscape.com/drug/immucin-hgm-csf https://druglandscape.com/api/og?type=drug&title=ImMucin%2C%20hGM-CSF&subtitle=ImMucin%2C%20hGM-CSF%20%C2%B7%20Vaxil%20Therapeutics%20Ltd.&badge=phase%201 ImMucin, hGM-CSF ImMucin, hGM-CSF · Vaxil Therapeutics Ltd. https://druglandscape.com/drug/immune-attractant https://druglandscape.com/api/og?type=drug&title=Immune-attractant&subtitle=Immune-attractant%20%C2%B7%20UNICANCER&badge=phase%202 Immune-attractant Immune-attractant · UNICANCER https://druglandscape.com/drug/immune-evaluation https://druglandscape.com/api/og?type=drug&title=immune%20evaluation&subtitle=immune%20evaluation%20%C2%B7%20Istituto%20Clinico%20Humanitas&badge=phase%201 immune evaluation immune evaluation · Istituto Clinico Humanitas https://druglandscape.com/drug/immune-inhibitors https://druglandscape.com/api/og?type=drug&title=Immune%20inhibitors&subtitle=Immune%20inhibitors%20%C2%B7%20Hrain%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 Immune inhibitors Immune inhibitors · Hrain Biotechnology Co., Ltd. https://druglandscape.com/drug/immune-plasma https://druglandscape.com/api/og?type=drug&title=immune%20plasma&subtitle=immune%20plasma%20%C2%B7%20Azienda%20USL%20Toscana%20Nord%20Ovest&badge=phase%202 immune plasma immune plasma · Azienda USL Toscana Nord Ovest https://druglandscape.com/drug/immune-system-activator https://druglandscape.com/api/og?type=drug&title=Immune%20System%20Activator&subtitle=Immune%20System%20Activator%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Immune System Activator Immune System Activator · H. Lundbeck A/S https://druglandscape.com/drug/immunnotherapy-group https://druglandscape.com/api/og?type=drug&title=Immunnotherapy%20group&subtitle=Immunnotherapy%20group%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 Immunnotherapy group Immunnotherapy group · Samsung Medical Center https://druglandscape.com/drug/immunological-and-tumour-characterization https://druglandscape.com/api/og?type=drug&title=Immunological%20and%20tumour%20characterization&subtitle=Immunological%20and%20tumour%20characterization%20%C2%B7%20Centre%20Leon%20Berard&badge=phase%202 Immunological and tumour characterization Immunological and tumour characterization · Centre Leon Berard https://druglandscape.com/drug/immunose-flu-1 https://druglandscape.com/api/og?type=drug&title=Immunose%E2%84%A2%20FLU%201%25&subtitle=Immunose%E2%84%A2%20FLU%201%25%20%C2%B7%20Eurocine%20Vaccines%20AB&badge=phase%201 Immunose™ FLU 1% Immunose™ FLU 1% · Eurocine Vaccines AB https://druglandscape.com/drug/immunose-flu-2-200-l https://druglandscape.com/api/og?type=drug&title=Immunose%E2%84%A2%20FLU%202%25%2C%20200%20%CE%BCl&subtitle=Immunose%E2%84%A2%20FLU%202%25%2C%20200%20%CE%BCl%20%C2%B7%20Eurocine%20Vaccines%20AB&badge=phase%201 Immunose™ FLU 2%, 200 μl Immunose™ FLU 2%, 200 μl · Eurocine Vaccines AB https://druglandscape.com/drug/immunose-flu-2-300-l https://druglandscape.com/api/og?type=drug&title=Immunose%E2%84%A2%20FLU%202%25%2C%20300%20%CE%BCl&subtitle=Immunose%E2%84%A2%20FLU%202%25%2C%20300%20%CE%BCl%20%C2%B7%20Eurocine%20Vaccines%20AB&badge=phase%201 Immunose™ FLU 2%, 300 μl Immunose™ FLU 2%, 300 μl · Eurocine Vaccines AB https://druglandscape.com/drug/immunotherapeutic-gsk2302025a-different-formulations https://druglandscape.com/api/og?type=drug&title=Immunotherapeutic%20GSK2302025A%2C%20different%20formulations&subtitle=Immunotherapeutic%20GSK2302025A%2C%20different%20formulations%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Immunotherapeutic GSK2302025A, different formulations Immunotherapeutic GSK2302025A, different formulations · GlaxoSmithKline https://druglandscape.com/drug/immunotherapy-pd-1-blocker https://druglandscape.com/api/og?type=drug&title=Immunotherapy%20-%20PD-1%20Blocker&subtitle=Immunotherapy%20-%20PD-1%20Blocker%20%C2%B7%20Liza%20Villaruz%2C%20MD&badge=phase%202 Immunotherapy - PD-1 Blocker Immunotherapy - PD-1 Blocker · Liza Villaruz, MD https://druglandscape.com/drug/imnn-001 https://druglandscape.com/api/og?type=drug&title=IMNN-001&subtitle=IMNN-001%20%C2%B7%20Imunon&badge=phase%201 IMNN-001 IMNN-001 · Imunon https://druglandscape.com/drug/imnn-101 https://druglandscape.com/api/og?type=drug&title=IMNN-101&subtitle=IMNN-101%20%C2%B7%20Imunon&badge=phase%201 IMNN-101 IMNN-101 · Imunon https://druglandscape.com/drug/imnovid https://druglandscape.com/api/og?type=drug&title=IMNOVID&subtitle=IMNOVID%20%C2%B7%20Celgene&badge=phase%202 IMNOVID IMNOVID · Celgene https://druglandscape.com/drug/imo-8400-regimen-1 https://druglandscape.com/api/og?type=drug&title=IMO-8400%20Regimen%201&subtitle=IMO-8400%20Regimen%201%20%C2%B7%20Idera%20Pharmaceuticals%2C%20Inc.&badge=phase%202 IMO-8400 Regimen 1 IMO-8400 Regimen 1 · Idera Pharmaceuticals, Inc. https://druglandscape.com/drug/imo-8400-regimen-3 https://druglandscape.com/api/og?type=drug&title=IMO-8400%20Regimen%203&subtitle=IMO-8400%20Regimen%203%20%C2%B7%20Idera%20Pharmaceuticals%2C%20Inc.&badge=phase%202 IMO-8400 Regimen 3 IMO-8400 Regimen 3 · Idera Pharmaceuticals, Inc. https://druglandscape.com/drug/imo-8400-regimen-4 https://druglandscape.com/api/og?type=drug&title=IMO-8400%20Regimen%204&subtitle=IMO-8400%20Regimen%204%20%C2%B7%20Idera%20Pharmaceuticals%2C%20Inc.&badge=phase%202 IMO-8400 Regimen 4 IMO-8400 Regimen 4 · Idera Pharmaceuticals, Inc. https://druglandscape.com/drug/imovax-rabies-vaccine https://druglandscape.com/api/og?type=drug&title=Imovax%20Rabies%20vaccine&subtitle=Imovax%20Rabies%20vaccine%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 Imovax Rabies vaccine Imovax Rabies vaccine · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/imp-08p2002f0 https://druglandscape.com/api/og?type=drug&title=IMP%2008P2002F0&subtitle=IMP%2008P2002F0%20%C2%B7%20Unither%20Pharmaceuticals%2C%20France&badge=phase%201 IMP 08P2002F0 IMP 08P2002F0 · Unither Pharmaceuticals, France https://druglandscape.com/drug/imp-application-km-001 https://druglandscape.com/api/og?type=drug&title=IMP%20Application%20KM-001&subtitle=IMP%20Application%20KM-001%20%C2%B7%20Kamari%20Pharma%20Ltd&badge=phase%201 IMP Application KM-001 IMP Application KM-001 · Kamari Pharma Ltd https://druglandscape.com/drug/imp-cells https://druglandscape.com/api/og?type=drug&title=iMP%20cells&subtitle=iMP%20cells%20%C2%B7%20Cell%20Therapy%20Ltd.&badge=phase%202 iMP cells iMP cells · Cell Therapy Ltd. https://druglandscape.com/drug/imp321 https://druglandscape.com/api/og?type=drug&title=IMP321&subtitle=IMP321%20%C2%B7%20Immutep%20S.A.S.&badge=phase%201 IMP321 IMP321 · Immutep S.A.S. https://druglandscape.com/drug/imp4297 https://druglandscape.com/api/og?type=drug&title=IMP4297&subtitle=IMP4297%20%C2%B7%20Impact%20Therapeutics%2C%20Inc.&badge=phase%202 IMP4297 IMP4297 · Impact Therapeutics, Inc. https://druglandscape.com/drug/imp7068 https://druglandscape.com/api/og?type=drug&title=IMP7068&subtitle=IMP7068%20%C2%B7%20Impact%20Therapeutics%2C%20Inc.&badge=phase%201 IMP7068 IMP7068 · Impact Therapeutics, Inc. https://druglandscape.com/drug/imp761 https://druglandscape.com/api/og?type=drug&title=IMP761&subtitle=IMP761%20%C2%B7%20Immutep%20S.A.S.&badge=phase%201 IMP761 IMP761 · Immutep S.A.S. https://druglandscape.com/drug/imp9064 https://druglandscape.com/api/og?type=drug&title=IMP9064&subtitle=IMP9064%20%C2%B7%20Impact%20Therapeutics%2C%20Inc.&badge=phase%201 IMP9064 IMP9064 · Impact Therapeutics, Inc. https://druglandscape.com/drug/ims001 https://druglandscape.com/api/og?type=drug&title=IMS001&subtitle=IMS001%20%C2%B7%20ImStem%20Biotechnology&badge=phase%201 IMS001 IMS001 · ImStem Biotechnology https://druglandscape.com/drug/imsb301 https://druglandscape.com/api/og?type=drug&title=IMSB301&subtitle=IMSB301%20%C2%B7%20ImmuneSensor%20Therapeutics%20Inc.&badge=phase%201 IMSB301 IMSB301 · ImmuneSensor Therapeutics Inc. https://druglandscape.com/drug/imu-838 https://druglandscape.com/api/og?type=drug&title=IMU-838&subtitle=IMU-838%20%C2%B7%20Immunic%20AG&badge=phase%202 IMU-838 IMU-838 · Immunic AG https://druglandscape.com/drug/imv101-treatment https://druglandscape.com/api/og?type=drug&title=IMV101%20treatment&subtitle=IMV101%20treatment%20%C2%B7%20Suzhou%20Immunofoco%20Biotechnology%20Co.%2C%20Ltd&badge=phase%201 IMV101 treatment IMV101 treatment · Suzhou Immunofoco Biotechnology Co., Ltd https://druglandscape.com/drug/imx-110 https://druglandscape.com/api/og?type=drug&title=Imx-110&subtitle=Imx-110%20%C2%B7%20Immix%20Biopharma%20Australia%20Pty%20Ltd&badge=phase%201 Imx-110 Imx-110 · Immix Biopharma Australia Pty Ltd https://druglandscape.com/drug/imx101-vaccine https://druglandscape.com/api/og?type=drug&title=IMX101%20vaccine&subtitle=IMX101%20vaccine%20%C2%B7%20ImevaX&badge=phase%201 IMX101 vaccine IMX101 vaccine · ImevaX https://druglandscape.com/drug/in-115314-ointment-3 https://druglandscape.com/api/og?type=drug&title=IN-115314%20Ointment%203%25&subtitle=IN-115314%20Ointment%203%25%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%202 IN-115314 Ointment 3% IN-115314 Ointment 3% · HK inno.N Corporation https://druglandscape.com/drug/in-a001-y-mg https://druglandscape.com/api/og?type=drug&title=IN-A001%20Y%20mg&subtitle=IN-A001%20Y%20mg%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-A001 Y mg IN-A001 Y mg · HK inno.N Corporation https://druglandscape.com/drug/in-a002-ointment-1 https://druglandscape.com/api/og?type=drug&title=IN-A002%20Ointment%201%25&subtitle=IN-A002%20Ointment%201%25%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-A002 Ointment 1% IN-A002 Ointment 1% · HK inno.N Corporation https://druglandscape.com/drug/in-b001-ev71-a-dose https://druglandscape.com/api/og?type=drug&title=IN-B001%20EV71%20A%20dose&subtitle=IN-B001%20EV71%20A%20dose%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-B001 EV71 A dose IN-B001 EV71 A dose · HK inno.N Corporation https://druglandscape.com/drug/in-c004 https://druglandscape.com/api/og?type=drug&title=IN-C004&subtitle=IN-C004%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-C004 IN-C004 · HK inno.N Corporation https://druglandscape.com/drug/in-c004-with-water https://druglandscape.com/api/og?type=drug&title=IN-C004%20with%20water&subtitle=IN-C004%20with%20water%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-C004 with water IN-C004 with water · HK inno.N Corporation https://druglandscape.com/drug/in-c005-dose-a https://druglandscape.com/api/og?type=drug&title=IN-C005%20dose%20A&subtitle=IN-C005%20dose%20A%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-C005 dose A IN-C005 dose A · HK inno.N Corporation https://druglandscape.com/drug/in-c005-dose-b https://druglandscape.com/api/og?type=drug&title=IN-C005%20dose%20B&subtitle=IN-C005%20dose%20B%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-C005 dose B IN-C005 dose B · HK inno.N Corporation https://druglandscape.com/drug/in-c005-dose-c https://druglandscape.com/api/og?type=drug&title=IN-C005%20dose%20C&subtitle=IN-C005%20dose%20C%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-C005 dose C IN-C005 dose C · HK inno.N Corporation https://druglandscape.com/drug/in-c005-dose-d https://druglandscape.com/api/og?type=drug&title=IN-C005%20dose%20D&subtitle=IN-C005%20dose%20D%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-C005 dose D IN-C005 dose D · HK inno.N Corporation https://druglandscape.com/drug/in-c005-dose-e https://druglandscape.com/api/og?type=drug&title=IN-C005%20dose%20E&subtitle=IN-C005%20dose%20E%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-C005 dose E IN-C005 dose E · HK inno.N Corporation https://druglandscape.com/drug/in-c005-dose-f https://druglandscape.com/api/og?type=drug&title=IN-C005%20dose%20F&subtitle=IN-C005%20dose%20F%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-C005 dose F IN-C005 dose F · HK inno.N Corporation https://druglandscape.com/drug/in-c005-x-mg https://druglandscape.com/api/og?type=drug&title=IN-C005%20X%20mg&subtitle=IN-C005%20X%20mg%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-C005 X mg IN-C005 X mg · HK inno.N Corporation https://druglandscape.com/drug/in-c005-y-mg https://druglandscape.com/api/og?type=drug&title=IN-C005%20Y%20mg&subtitle=IN-C005%20Y%20mg%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-C005 Y mg IN-C005 Y mg · HK inno.N Corporation https://druglandscape.com/drug/in-c005-z-mg https://druglandscape.com/api/og?type=drug&title=IN-C005%20Z%20mg&subtitle=IN-C005%20Z%20mg%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-C005 Z mg IN-C005 Z mg · HK inno.N Corporation https://druglandscape.com/drug/in-g00002 https://druglandscape.com/api/og?type=drug&title=IN-G00002&subtitle=IN-G00002%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-G00002 IN-G00002 · HK inno.N Corporation https://druglandscape.com/drug/in-m00002 https://druglandscape.com/api/og?type=drug&title=IN-M00002&subtitle=IN-M00002%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-M00002 IN-M00002 · HK inno.N Corporation https://druglandscape.com/drug/in-m00007 https://druglandscape.com/api/og?type=drug&title=IN-M00007&subtitle=IN-M00007%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-M00007 IN-M00007 · HK inno.N Corporation https://druglandscape.com/drug/in-r00002 https://druglandscape.com/api/og?type=drug&title=IN-R00002&subtitle=IN-R00002%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 IN-R00002 IN-R00002 · HK inno.N Corporation https://druglandscape.com/drug/in-situ-immunotherapy https://druglandscape.com/api/og?type=drug&title=In%20situ%20immunotherapy&subtitle=In%20situ%20immunotherapy%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 In situ immunotherapy In situ immunotherapy · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/in-stent-restenosis https://druglandscape.com/api/og?type=drug&title=In-stent%20restenosis&subtitle=In-stent%20restenosis%20%C2%B7%20Silesian%20Centre%20for%20Heart%20Diseases&badge=phase%201 In-stent restenosis In-stent restenosis · Silesian Centre for Heart Diseases https://druglandscape.com/drug/in-vitro-fertilization https://druglandscape.com/api/og?type=drug&title=IN%20VITRO%20FERTILIZATION&subtitle=IN%20VITRO%20FERTILIZATION%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 IN VITRO FERTILIZATION IN VITRO FERTILIZATION · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/in10018 https://druglandscape.com/api/og?type=drug&title=IN10018&subtitle=IN10018%20%C2%B7%20InxMed%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%202 IN10018 IN10018 · InxMed (Shanghai) Co., Ltd. https://druglandscape.com/drug/in10018-ifebemtinib https://druglandscape.com/api/og?type=drug&title=IN10018%EF%BC%88Ifebemtinib%EF%BC%89&subtitle=IN10018%EF%BC%88Ifebemtinib%EF%BC%89%20%C2%B7%20InxMed%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 IN10018（Ifebemtinib） IN10018（Ifebemtinib） · InxMed (Shanghai) Co., Ltd. https://druglandscape.com/drug/in10018-in-combination-with-pld https://druglandscape.com/api/og?type=drug&title=IN10018%20in%20combination%20with%20PLD&subtitle=IN10018%20in%20combination%20with%20PLD%20%C2%B7%20InxMed%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 IN10018 in combination with PLD IN10018 in combination with PLD · InxMed (Shanghai) Co., Ltd. https://druglandscape.com/drug/in10018-in-combination-with-rnk08954 https://druglandscape.com/api/og?type=drug&title=IN10018%20in%20combination%20with%20RNK08954&subtitle=IN10018%20in%20combination%20with%20RNK08954%20%C2%B7%20InxMed%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 IN10018 in combination with RNK08954 IN10018 in combination with RNK08954 · InxMed (Shanghai) Co., Ltd. https://druglandscape.com/drug/in1011-n17 https://druglandscape.com/api/og?type=drug&title=iN1011-N17&subtitle=iN1011-N17%20%C2%B7%20iN%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 iN1011-N17 iN1011-N17 · iN Therapeutics Co., Ltd. https://druglandscape.com/drug/inactivated-enterovirus-type-71-vaccine https://druglandscape.com/api/og?type=drug&title=Inactivated%20Enterovirus%20Type%2071%20Vaccine&subtitle=Inactivated%20Enterovirus%20Type%2071%20Vaccine%20%C2%B7%20Sinovac%20Biotech%20Co.%2C%20Ltd&badge=phase%201 Inactivated Enterovirus Type 71 Vaccine Inactivated Enterovirus Type 71 Vaccine · Sinovac Biotech Co., Ltd https://druglandscape.com/drug/inactivated-influenza-vaccine-of-gsk https://druglandscape.com/api/og?type=drug&title=Inactivated%20Influenza%20Vaccine%20of%20GSK&subtitle=Inactivated%20Influenza%20Vaccine%20of%20GSK%20%C2%B7%20Hualan%20Biological%20Engineering%2C%20Inc.&badge=phase%201 Inactivated Influenza Vaccine of GSK Inactivated Influenza Vaccine of GSK · Hualan Biological Engineering, Inc. https://druglandscape.com/drug/inactive-marijuana https://druglandscape.com/api/og?type=drug&title=Inactive%20marijuana&subtitle=Inactive%20marijuana%20%C2%B7%20Shanna%20Babalonis%2C%20PhD&badge=phase%201 Inactive marijuana Inactive marijuana · Shanna Babalonis, PhD https://druglandscape.com/drug/inbrx-106 https://druglandscape.com/api/og?type=drug&title=INBRX-106&subtitle=INBRX-106%20%C2%B7%20Providence%20Health%20%26%20Services&badge=phase%202 INBRX-106 INBRX-106 · Providence Health & Services https://druglandscape.com/drug/inbrx-109 https://druglandscape.com/api/og?type=drug&title=INBRX-109&subtitle=INBRX-109%20%C2%B7%20Inhibrx%20Biosciences%2C%20Inc&badge=phase%202 INBRX-109 INBRX-109 · Inhibrx Biosciences, Inc https://druglandscape.com/drug/incidence-of-acute-kidney-injury https://druglandscape.com/api/og?type=drug&title=Incidence%20of%20acute%20kidney%20injury&subtitle=Incidence%20of%20acute%20kidney%20injury%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 Incidence of acute kidney injury Incidence of acute kidney injury · Hospices Civils de Lyon https://druglandscape.com/drug/incobotulinum-toxin-a https://druglandscape.com/api/og?type=drug&title=Incobotulinum%20Toxin%20A&subtitle=Incobotulinum%20Toxin%20A%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%202 Incobotulinum Toxin A Incobotulinum Toxin A · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/indium-111-pentreotide https://druglandscape.com/api/og?type=drug&title=Indium-111%20Pentreotide&subtitle=Indium-111%20Pentreotide%20%C2%B7%20Marcelo%20F.%20Di%20Carli%2C%20MD%2C%20FACC&badge=phase%201 Indium-111 Pentreotide Indium-111 Pentreotide · Marcelo F. Di Carli, MD, FACC https://druglandscape.com/drug/indium-in-111-dota-basiliximab https://druglandscape.com/api/og?type=drug&title=Indium%20In%20111-DOTA-Basiliximab&subtitle=Indium%20In%20111-DOTA-Basiliximab%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%201 Indium In 111-DOTA-Basiliximab Indium In 111-DOTA-Basiliximab · City of Hope Medical Center https://druglandscape.com/drug/indocyaine-green https://druglandscape.com/api/og?type=drug&title=Indocyaine%20Green&subtitle=Indocyaine%20Green%20%C2%B7%20Corewell%20Health%20West&badge=phase%202 Indocyaine Green Indocyaine Green · Corewell Health West https://druglandscape.com/drug/indocyanine-green-retention-test https://druglandscape.com/api/og?type=drug&title=Indocyanine%20Green%20Retention%20test&subtitle=Indocyanine%20Green%20Retention%20test%20%C2%B7%20VA%20Connecticut%20Healthcare%20System&badge=phase%201 Indocyanine Green Retention test Indocyanine Green Retention test · VA Connecticut Healthcare System https://druglandscape.com/drug/indomethacin-capsules-low-dose https://druglandscape.com/api/og?type=drug&title=Indomethacin%20Capsules%20low%20dose&subtitle=Indomethacin%20Capsules%20low%20dose%20%C2%B7%20Iroko%20Pharmaceuticals%2C%20LLC&badge=phase%202 Indomethacin Capsules low dose Indomethacin Capsules low dose · Iroko Pharmaceuticals, LLC https://druglandscape.com/drug/indoximod-base-formulation https://druglandscape.com/api/og?type=drug&title=Indoximod%20base%20formulation&subtitle=Indoximod%20base%20formulation%20%C2%B7%20NewLink%20Genetics%20Corporation&badge=phase%201 Indoximod base formulation Indoximod base formulation · NewLink Genetics Corporation https://druglandscape.com/drug/indoximod-freebase https://druglandscape.com/api/og?type=drug&title=Indoximod%20Freebase&subtitle=Indoximod%20Freebase%20%C2%B7%20NewLink%20Genetics%20Corporation&badge=phase%201 Indoximod Freebase Indoximod Freebase · NewLink Genetics Corporation https://druglandscape.com/drug/indoximod-hcl-f1 https://druglandscape.com/api/og?type=drug&title=Indoximod%20HCL%20F1&subtitle=Indoximod%20HCL%20F1%20%C2%B7%20NewLink%20Genetics%20Corporation&badge=phase%201 Indoximod HCL F1 Indoximod HCL F1 · NewLink Genetics Corporation https://druglandscape.com/drug/induction-5-fluorouracil https://druglandscape.com/api/og?type=drug&title=induction%205-fluorouracil&subtitle=induction%205-fluorouracil%20%C2%B7%20Radiation%20Therapy%20Oncology%20Group&badge=phase%202 induction 5-fluorouracil induction 5-fluorouracil · Radiation Therapy Oncology Group https://druglandscape.com/drug/induction-carboplatin https://druglandscape.com/api/og?type=drug&title=Induction%20Carboplatin&subtitle=Induction%20Carboplatin%20%C2%B7%20Radiation%20Therapy%20Oncology%20Group&badge=phase%202 Induction Carboplatin Induction Carboplatin · Radiation Therapy Oncology Group https://druglandscape.com/drug/induction-chemotherapy-arm-a https://druglandscape.com/api/og?type=drug&title=Induction%20Chemotherapy%20arm%20A&subtitle=Induction%20Chemotherapy%20arm%20A%20%C2%B7%20Prof.%20Dr.%20med.%20Claus%20R%C3%B6del&badge=phase%202 Induction Chemotherapy arm A Induction Chemotherapy arm A · Prof. Dr. med. Claus Rödel https://druglandscape.com/drug/induction-chemotherapy-triplet-therapy https://druglandscape.com/api/og?type=drug&title=Induction%20Chemotherapy%20Triplet%20Therapy&subtitle=Induction%20Chemotherapy%20Triplet%20Therapy%20%C2%B7%20Inova%20Health%20Care%20Services&badge=phase%202 Induction Chemotherapy Triplet Therapy Induction Chemotherapy Triplet Therapy · Inova Health Care Services https://druglandscape.com/drug/induction-gemcitabine https://druglandscape.com/api/og?type=drug&title=induction%20gemcitabine&subtitle=induction%20gemcitabine%20%C2%B7%20Radiation%20Therapy%20Oncology%20Group&badge=phase%202 induction gemcitabine induction gemcitabine · Radiation Therapy Oncology Group https://druglandscape.com/drug/induction-phase https://druglandscape.com/api/og?type=drug&title=Induction%20Phase&subtitle=Induction%20Phase%20%C2%B7%20Andres%20J.%20M.%20Ferreri&badge=phase%202 Induction Phase Induction Phase · Andres J. M. Ferreri https://druglandscape.com/drug/indv-6001 https://druglandscape.com/api/og?type=drug&title=INDV-6001&subtitle=INDV-6001%20%C2%B7%20Indivior%20Inc.&badge=phase%202 INDV-6001 INDV-6001 · Indivior Inc. https://druglandscape.com/drug/indv-6200 https://druglandscape.com/api/og?type=drug&title=INDV-6200&subtitle=INDV-6200%20%C2%B7%20Indivior%20Inc.&badge=phase%201 INDV-6200 INDV-6200 · Indivior Inc. https://druglandscape.com/drug/inert-alcoholic-solution https://druglandscape.com/api/og?type=drug&title=Inert%20alcoholic%20solution&subtitle=Inert%20alcoholic%20solution%20%C2%B7%20Casa%20Espirita%20Terra%20de%20Ismael&badge=phase%201 Inert alcoholic solution Inert alcoholic solution · Casa Espirita Terra de Ismael https://druglandscape.com/drug/inert-ingredients-oral-product https://druglandscape.com/api/og?type=drug&title=Inert%20Ingredients%20Oral%20Product&subtitle=Inert%20Ingredients%20Oral%20Product%20%C2%B7%20Xenon%20Pharmaceuticals%20Inc.&badge=phase%201 Inert Ingredients Oral Product Inert Ingredients Oral Product · Xenon Pharmaceuticals Inc. https://druglandscape.com/drug/infanrix-hexa-vaccine https://druglandscape.com/api/og?type=drug&title=Infanrix%20hexa%20Vaccine&subtitle=Infanrix%20hexa%20Vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Infanrix hexa Vaccine Infanrix hexa Vaccine · GlaxoSmithKline https://druglandscape.com/drug/infected-group https://druglandscape.com/api/og?type=drug&title=infected%20group&subtitle=infected%20group%20%C2%B7%20Ahmed%20A.%20H.%20Abdellatif&badge=phase%201 infected group infected group · Ahmed A. H. Abdellatif https://druglandscape.com/drug/infective-mosquito-bite https://druglandscape.com/api/og?type=drug&title=Infective%20mosquito%20bite&subtitle=Infective%20mosquito%20bite%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 Infective mosquito bite Infective mosquito bite · Medicines for Malaria Venture https://druglandscape.com/drug/inferior-alveolar-nerve-block https://druglandscape.com/api/og?type=drug&title=Inferior%20Alveolar%20Nerve%20Block&subtitle=Inferior%20Alveolar%20Nerve%20Block%20%C2%B7%20CIMS%20Dental%20College&badge=phase%201 Inferior Alveolar Nerve Block Inferior Alveolar Nerve Block · CIMS Dental College https://druglandscape.com/drug/infiltration-of-papaverine https://druglandscape.com/api/og?type=drug&title=Infiltration%20of%20papaverine&subtitle=Infiltration%20of%20papaverine%20%C2%B7%20US%20Neuropathy%20Centers&badge=phase%201 Infiltration of papaverine Infiltration of papaverine · US Neuropathy Centers https://druglandscape.com/drug/infiltrative-treatment-with-cb-prp https://druglandscape.com/api/og?type=drug&title=Infiltrative%20treatment%20with%20CB-PRP&subtitle=Infiltrative%20treatment%20with%20CB-PRP%20%C2%B7%20Fondazione%20IRCCS%20Ca'%20Granda%2C%20Ospedale%20Maggiore%20Policlinico&badge=phase%201 Infiltrative treatment with CB-PRP Infiltrative treatment with CB-PRP · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico https://druglandscape.com/drug/inflammatory-profile https://druglandscape.com/api/og?type=drug&title=Inflammatory%20profile&subtitle=Inflammatory%20profile%20%C2%B7%20Monica%20Levy%20Andersen&badge=phase%201 Inflammatory profile Inflammatory profile · Monica Levy Andersen https://druglandscape.com/drug/infliximab-etanercept https://druglandscape.com/api/og?type=drug&title=infliximab%2C%20etanercept&subtitle=infliximab%2C%20etanercept%20%C2%B7%20Centocor%20Ortho%20Biotech%20Services%2C%20L.L.C.&badge=phase%203 infliximab, etanercept infliximab, etanercept · Centocor Ortho Biotech Services, L.L.C. https://druglandscape.com/drug/influenza-a-vaccine-acam-flu-a https://druglandscape.com/api/og?type=drug&title=Influenza%20A%20Vaccine%3A%20ACAM%20FLU-A&subtitle=Influenza%20A%20Vaccine%3A%20ACAM%20FLU-A%20%C2%B7%20Sanofi&badge=phase%201 Influenza A Vaccine: ACAM FLU-A Influenza A Vaccine: ACAM FLU-A · Sanofi https://druglandscape.com/drug/influenza-challenge-virus https://druglandscape.com/api/og?type=drug&title=Influenza%20challenge%20virus&subtitle=Influenza%20challenge%20virus%20%C2%B7%20Imperial%20College%20London&badge=phase%201 Influenza challenge virus Influenza challenge virus · Imperial College London https://druglandscape.com/drug/influenza-g1-mha https://druglandscape.com/api/og?type=drug&title=INFLUENZA%20G1%20mHA&subtitle=INFLUENZA%20G1%20mHA%20%C2%B7%20Janssen%20Vaccines%20%26%20Prevention%20B.V.&badge=phase%201 INFLUENZA G1 mHA INFLUENZA G1 mHA · Janssen Vaccines & Prevention B.V. https://druglandscape.com/drug/influenza-ha-vaccine-biken-ha https://druglandscape.com/api/og?type=drug&title=Influenza%20HA%20vaccine%20%22Biken%20HA%22&subtitle=Influenza%20HA%20vaccine%20%22Biken%20HA%22%20%C2%B7%20Nitto%20Denko%20Corporation&badge=phase%201 Influenza HA vaccine "Biken HA" Influenza HA vaccine "Biken HA" · Nitto Denko Corporation https://druglandscape.com/drug/influenza-hemagglutinin-mrna-vaccine https://druglandscape.com/api/og?type=drug&title=Influenza%20Hemagglutinin%20mRNA%20vaccine&subtitle=Influenza%20Hemagglutinin%20mRNA%20vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Influenza Hemagglutinin mRNA vaccine Influenza Hemagglutinin mRNA vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/influenza-trivalent-inactivated-vaccines https://druglandscape.com/api/og?type=drug&title=Influenza%20Trivalent%20Inactivated%20vaccines&subtitle=Influenza%20Trivalent%20Inactivated%20vaccines%20%C2%B7%20Novartis&badge=phase%202 Influenza Trivalent Inactivated vaccines Influenza Trivalent Inactivated vaccines · Novartis https://druglandscape.com/drug/influenza-vaccine-bk01-adjuvnat https://druglandscape.com/api/og?type=drug&title=influenza%20vaccine%EF%BC%88BK01%20adjuvnat%EF%BC%89&subtitle=influenza%20vaccine%EF%BC%88BK01%20adjuvnat%EF%BC%89%20%C2%B7%20Changchun%20BCHT%20Biotechnology%20Co.&badge=phase%201 influenza vaccine（BK01 adjuvnat） influenza vaccine（BK01 adjuvnat） · Changchun BCHT Biotechnology Co. https://druglandscape.com/drug/influenza-vaccine-gsk1247446a https://druglandscape.com/api/og?type=drug&title=Influenza%20Vaccine%20GSK1247446A&subtitle=Influenza%20Vaccine%20GSK1247446A%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Influenza Vaccine GSK1247446A Influenza Vaccine GSK1247446A · GlaxoSmithKline https://druglandscape.com/drug/influenza-vaccine-recombinant-hemagglutinin https://druglandscape.com/api/og?type=drug&title=Influenza%20Vaccine%2C%20recombinant%20Hemagglutinin&subtitle=Influenza%20Vaccine%2C%20recombinant%20Hemagglutinin%20%C2%B7%20Protein%20Sciences%20Corporation&badge=phase%202 Influenza Vaccine, recombinant Hemagglutinin Influenza Vaccine, recombinant Hemagglutinin · Protein Sciences Corporation https://druglandscape.com/drug/influenza-virus-vaccine-live-intranasal https://druglandscape.com/api/og?type=drug&title=Influenza%20Virus%20Vaccine%20Live%2C%20Intranasal&subtitle=Influenza%20Virus%20Vaccine%20Live%2C%20Intranasal%20%C2%B7%20Tufts%20Medical%20Center&badge=phase%201 Influenza Virus Vaccine Live, Intranasal Influenza Virus Vaccine Live, Intranasal · Tufts Medical Center https://druglandscape.com/drug/influenza-vlp-vaccine https://druglandscape.com/api/og?type=drug&title=Influenza%20VLP%20Vaccine&subtitle=Influenza%20VLP%20Vaccine%20%C2%B7%20Novavax&badge=phase%202 Influenza VLP Vaccine Influenza VLP Vaccine · Novavax https://druglandscape.com/drug/infudopa-i-v https://druglandscape.com/api/og?type=drug&title=Infudopa%20i.v.&subtitle=Infudopa%20i.v.%20%C2%B7%20Vastra%20Gotaland%20Region&badge=phase%201 Infudopa i.v. Infudopa i.v. · Vastra Gotaland Region https://druglandscape.com/drug/infudopa-s-c https://druglandscape.com/api/og?type=drug&title=Infudopa%20s.c.&subtitle=Infudopa%20s.c.%20%C2%B7%20Vastra%20Gotaland%20Region&badge=phase%201 Infudopa s.c. Infudopa s.c. · Vastra Gotaland Region https://druglandscape.com/drug/infusion-of-hct-msc https://druglandscape.com/api/og?type=drug&title=Infusion%20of%20hCT-MSC&subtitle=Infusion%20of%20hCT-MSC%20%C2%B7%20Joanne%20Kurtzberg%2C%20MD&badge=phase%201 Infusion of hCT-MSC Infusion of hCT-MSC · Joanne Kurtzberg, MD https://druglandscape.com/drug/infusion-of-msc https://druglandscape.com/api/og?type=drug&title=Infusion%20of%20MSC&subtitle=Infusion%20of%20MSC%20%C2%B7%20Andalusian%20Initiative%20for%20Advanced%20Therapies%20-%20Fundaci%C3%B3n%20P%C3%BAblica%20Andaluza%20Progreso&badge=phase%201 Infusion of MSC Infusion of MSC · Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud https://druglandscape.com/drug/infusion-of-mscs https://druglandscape.com/api/og?type=drug&title=Infusion%20of%20MSCs&subtitle=Infusion%20of%20MSCs%20%C2%B7%20Joanne%20Kurtzberg%2C%20MD&badge=phase%201 Infusion of MSCs Infusion of MSCs · Joanne Kurtzberg, MD https://druglandscape.com/drug/infusion-of-nexi-001-t-cells https://druglandscape.com/api/og?type=drug&title=Infusion%20of%20NEXI-001%20T%20Cells&subtitle=Infusion%20of%20NEXI-001%20T%20Cells%20%C2%B7%20NexImmune%20Inc.&badge=phase%201 Infusion of NEXI-001 T Cells Infusion of NEXI-001 T Cells · NexImmune Inc. https://druglandscape.com/drug/infusion-without-ald518 https://druglandscape.com/api/og?type=drug&title=Infusion%20without%20ALD518'&subtitle=Infusion%20without%20ALD518'%20%C2%B7%20CSL%20Behring&badge=phase%202 Infusion without ALD518' Infusion without ALD518' · CSL Behring https://druglandscape.com/drug/inh-139-u https://druglandscape.com/api/og?type=drug&title=INH%20139%20U&subtitle=INH%20139%20U%20%C2%B7%20Dance%20Biopharm%20Inc.&badge=phase%201 INH 139 U INH 139 U · Dance Biopharm Inc. https://druglandscape.com/drug/inh-208-u https://druglandscape.com/api/og?type=drug&title=INH%20208%20U&subtitle=INH%20208%20U%20%C2%B7%20Dance%20Biopharm%20Inc.&badge=phase%201 INH 208 U INH 208 U · Dance Biopharm Inc. https://druglandscape.com/drug/inhalation-of-afatinib-dimaleate https://druglandscape.com/api/og?type=drug&title=inhalation%20of%20afatinib%20dimaleate&subtitle=inhalation%20of%20afatinib%20dimaleate%20%C2%B7%20Petrov%2C%20Andrey&badge=phase%201 inhalation of afatinib dimaleate inhalation of afatinib dimaleate · Petrov, Andrey https://druglandscape.com/drug/initiation-of-letrozole https://druglandscape.com/api/og?type=drug&title=Initiation%20of%20letrozole&subtitle=Initiation%20of%20letrozole%20%C2%B7%20Shirley%20Vichy%20Wang&badge=phase%202 Initiation of letrozole Initiation of letrozole · Shirley Vichy Wang https://druglandscape.com/drug/inj-bupivicain https://druglandscape.com/api/og?type=drug&title=inj%20bupivicain&subtitle=inj%20bupivicain%20%C2%B7%20Sheikh%20Zayed%20Medical%20College&badge=phase%203 inj bupivicain inj bupivicain · Sheikh Zayed Medical College https://druglandscape.com/drug/injected-bupivacaine-post-operatively https://druglandscape.com/api/og?type=drug&title=Injected%20bupivacaine%20post-operatively&subtitle=Injected%20bupivacaine%20post-operatively%20%C2%B7%20Pinnacle%20Health%20System&badge=phase%202 Injected bupivacaine post-operatively Injected bupivacaine post-operatively · Pinnacle Health System https://druglandscape.com/drug/injected-lidocaine https://druglandscape.com/api/og?type=drug&title=Injected%20lidocaine&subtitle=Injected%20lidocaine%20%C2%B7%20PhenoSolve%2C%20LLC&badge=phase%201 Injected lidocaine Injected lidocaine · PhenoSolve, LLC https://druglandscape.com/drug/injecting-indocyanine-green https://druglandscape.com/api/og?type=drug&title=Injecting%20indocyanine%20green&subtitle=Injecting%20indocyanine%20green%20%C2%B7%20LI%20XIN-XIANG&badge=phase%202 Injecting indocyanine green Injecting indocyanine green · LI XIN-XIANG https://druglandscape.com/drug/injection-cu-20401 https://druglandscape.com/api/og?type=drug&title=injection%20%EF%BC%8CCU-20401&subtitle=injection%20%EF%BC%8CCU-20401%20%C2%B7%20Cutia%20Therapeutics%EF%BC%88Wuxi%EF%BC%89Co.%2CLtd&badge=phase%201 injection ，CU-20401 injection ，CU-20401 · Cutia Therapeutics（Wuxi）Co.,Ltd https://druglandscape.com/drug/injection-of-allogeneic-neuroblastoma-cells https://druglandscape.com/api/og?type=drug&title=Injection%20of%20allogeneic%20neuroblastoma%20cells&subtitle=Injection%20of%20allogeneic%20neuroblastoma%20cells%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Injection of allogeneic neuroblastoma cells Injection of allogeneic neuroblastoma cells · Baylor College of Medicine https://druglandscape.com/drug/injection-of-pegfilgrastim https://druglandscape.com/api/og?type=drug&title=Injection%20of%20Pegfilgrastim&subtitle=Injection%20of%20Pegfilgrastim%20%C2%B7%20Centre%20Leon%20Berard&badge=phase%202 Injection of Pegfilgrastim Injection of Pegfilgrastim · Centre Leon Berard https://druglandscape.com/drug/injection-sekucinumab https://druglandscape.com/api/og?type=drug&title=injection%20Sekucinumab&subtitle=injection%20Sekucinumab%20%C2%B7%20Jinnah%20Postgraduate%20Medical%20Centre&badge=phase%202 injection Sekucinumab injection Sekucinumab · Jinnah Postgraduate Medical Centre https://druglandscape.com/drug/inkt https://druglandscape.com/api/og?type=drug&title=INKT&subtitle=INKT%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%201 INKT INKT · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/inm005 https://druglandscape.com/api/og?type=drug&title=INM005&subtitle=INM005%20%C2%B7%20Inmunova%20S.A.&badge=phase%202 INM005 INM005 · Inmunova S.A. https://druglandscape.com/drug/inmunocem https://druglandscape.com/api/og?type=drug&title=INMUNOCEM&subtitle=INMUNOCEM%20%C2%B7%20GUSTAVO%20SALGUERO&badge=phase%202 INMUNOCEM INMUNOCEM · GUSTAVO SALGUERO https://druglandscape.com/drug/inn805 https://druglandscape.com/api/og?type=drug&title=INN805&subtitle=INN805%20%C2%B7%20FindCure%20Biosciences%20(ZhongShan)%20Co.%2C%20Ltd.&badge=phase%201 INN805 INN805 · FindCure Biosciences (ZhongShan) Co., Ltd. https://druglandscape.com/drug/innocell-autologous-cellular-immunotherapy https://druglandscape.com/api/og?type=drug&title=Innocell%20Autologous%20Cellular%20Immunotherapy&subtitle=Innocell%20Autologous%20Cellular%20Immunotherapy%20%C2%B7%20PhotonPharma%2C%20Inc.&badge=phase%201 Innocell Autologous Cellular Immunotherapy Innocell Autologous Cellular Immunotherapy · PhotonPharma, Inc. https://druglandscape.com/drug/innovative-valganciclovir https://druglandscape.com/api/og?type=drug&title=Innovative%20Valganciclovir&subtitle=Innovative%20Valganciclovir%20%C2%B7%20Luis%20Eduardo%20Morales%20Buenrostro&badge=phase%201 Innovative Valganciclovir Innovative Valganciclovir · Luis Eduardo Morales Buenrostro https://druglandscape.com/drug/inorpha-solution https://druglandscape.com/api/og?type=drug&title=InOrpha%20Solution&subtitle=InOrpha%20Solution%20%C2%B7%20Georg%20K%C3%A4gi%2C%20MD&badge=phase%202 InOrpha Solution InOrpha Solution · Georg Kägi, MD https://druglandscape.com/drug/inp12 https://druglandscape.com/api/og?type=drug&title=INP12&subtitle=INP12%20%C2%B7%20InnoUp%20Farma%20S.L.&badge=phase%201 INP12 INP12 · InnoUp Farma S.L. https://druglandscape.com/drug/ins018-055 https://druglandscape.com/api/og?type=drug&title=INS018_055&subtitle=INS018_055%20%C2%B7%20InSilico%20Medicine%20Hong%20Kong%20Limited&badge=phase%202 INS018_055 INS018_055 · InSilico Medicine Hong Kong Limited https://druglandscape.com/drug/ins117548 https://druglandscape.com/api/og?type=drug&title=INS117548&subtitle=INS117548%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 INS117548 INS117548 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/ins19-car-t-cells https://druglandscape.com/api/og?type=drug&title=INS19%20CAR-T%20Cells&subtitle=INS19%20CAR-T%20Cells%20%C2%B7%20Beijing%20Immunochina%20Medical%20Science%20%26%20Technology%20Co.%2C%20Ltd.&badge=phase%201 INS19 CAR-T Cells INS19 CAR-T Cells · Beijing Immunochina Medical Science & Technology Co., Ltd. https://druglandscape.com/drug/ins37217-nasal-spray https://druglandscape.com/api/og?type=drug&title=INS37217%20Nasal%20Spray&subtitle=INS37217%20Nasal%20Spray%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 INS37217 Nasal Spray INS37217 Nasal Spray · Merck Sharp & Dohme LLC https://druglandscape.com/drug/instiladrin https://druglandscape.com/api/og?type=drug&title=INSTILADRIN&subtitle=INSTILADRIN%20%C2%B7%20FKD%20Therapies%20Oy&badge=phase%202 INSTILADRIN INSTILADRIN · FKD Therapies Oy https://druglandscape.com/drug/instillation-of-cyclopentolate https://druglandscape.com/api/og?type=drug&title=Instillation%20of%20cyclopentolate&subtitle=Instillation%20of%20cyclopentolate%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Instillation of cyclopentolate Instillation of cyclopentolate · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/instramuscular-vaccine https://druglandscape.com/api/og?type=drug&title=Instramuscular%20vaccine&subtitle=Instramuscular%20vaccine%20%C2%B7%20Medicago&badge=phase%201 Instramuscular vaccine Instramuscular vaccine · Medicago https://druglandscape.com/drug/insulin-287 https://druglandscape.com/api/og?type=drug&title=insulin%20287&subtitle=insulin%20287%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 insulin 287 insulin 287 · Novo Nordisk A/S https://druglandscape.com/drug/insulin-320 https://druglandscape.com/api/og?type=drug&title=Insulin%20320&subtitle=Insulin%20320%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Insulin 320 Insulin 320 · Novo Nordisk A/S https://druglandscape.com/drug/insulin-338 https://druglandscape.com/api/og?type=drug&title=Insulin%20338&subtitle=Insulin%20338%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Insulin 338 Insulin 338 · Novo Nordisk A/S https://druglandscape.com/drug/insulin-analogue https://druglandscape.com/api/og?type=drug&title=insulin%20analogue&subtitle=insulin%20analogue%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 insulin analogue insulin analogue · Novo Nordisk A/S https://druglandscape.com/drug/insulin-degludec-injection-rd15003 https://druglandscape.com/api/og?type=drug&title=Insulin%20degludec%20injection%2C%20RD15003&subtitle=Insulin%20degludec%20injection%2C%20RD15003%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 Insulin degludec injection, RD15003 Insulin degludec injection, RD15003 · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/insulin-degludec-iv https://druglandscape.com/api/og?type=drug&title=Insulin%20Degludec%20-%20IV&subtitle=Insulin%20Degludec%20-%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Insulin Degludec - IV Insulin Degludec - IV · Eli Lilly and Company https://druglandscape.com/drug/insulin-degludec-sc https://druglandscape.com/api/og?type=drug&title=Insulin%20Degludec%20-%20SC&subtitle=Insulin%20Degludec%20-%20SC%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Insulin Degludec - SC Insulin Degludec - SC · Eli Lilly and Company https://druglandscape.com/drug/insulin-degludec-tresiba https://druglandscape.com/api/og?type=drug&title=Insulin%20degludec%2C%20Tresiba&subtitle=Insulin%20degludec%2C%20Tresiba%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 Insulin degludec, Tresiba Insulin degludec, Tresiba · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/insulin-glargine-and-insulin-aspart https://druglandscape.com/api/og?type=drug&title=insulin%20glargine%20and%20insulin%20aspart&subtitle=insulin%20glargine%20and%20insulin%20aspart%20%C2%B7%20Dr.%20Muhammad%20Abdulghani&badge=phase%201 insulin glargine and insulin aspart insulin glargine and insulin aspart · Dr. Muhammad Abdulghani https://druglandscape.com/drug/insulin-glargine-treatment https://druglandscape.com/api/og?type=drug&title=insulin%20glargine%20treatment&subtitle=insulin%20glargine%20treatment%20%C2%B7%20Amsterdam%20UMC%2C%20location%20VUmc&badge=phase%201 insulin glargine treatment insulin glargine treatment · Amsterdam UMC, location VUmc https://druglandscape.com/drug/insulin-glargine-u200-hoe901 https://druglandscape.com/api/og?type=drug&title=insulin%20glargine%20U200%20HOE901&subtitle=insulin%20glargine%20U200%20HOE901%20%C2%B7%20Sanofi&badge=phase%201 insulin glargine U200 HOE901 insulin glargine U200 HOE901 · Sanofi https://druglandscape.com/drug/insulin-glargine-u500-hoe901 https://druglandscape.com/api/og?type=drug&title=insulin%20glargine%20U500%20HOE901&subtitle=insulin%20glargine%20U500%20HOE901%20%C2%B7%20Sanofi&badge=phase%201 insulin glargine U500 HOE901 insulin glargine U500 HOE901 · Sanofi https://druglandscape.com/drug/insulin-iontophoresis https://druglandscape.com/api/og?type=drug&title=Insulin%20iontophoresis&subtitle=Insulin%20iontophoresis%20%C2%B7%20James%20J.%20Peters%20Veterans%20Affairs%20Medical%20Center&badge=phase%201 Insulin iontophoresis Insulin iontophoresis · James J. Peters Veterans Affairs Medical Center https://druglandscape.com/drug/insulin-lispro-cartridge https://druglandscape.com/api/og?type=drug&title=Insulin%20Lispro%20Cartridge&subtitle=Insulin%20Lispro%20Cartridge%20%C2%B7%20Inreda%20Diabetic%20B.V.&badge=phase%201 Insulin Lispro Cartridge Insulin Lispro Cartridge · Inreda Diabetic B.V. https://druglandscape.com/drug/insulin-lispro-cartridge-lyumjev https://druglandscape.com/api/og?type=drug&title=Insulin%20Lispro%20Cartridge%20%5BLyumjev%5D&subtitle=Insulin%20Lispro%20Cartridge%20%5BLyumjev%5D%20%C2%B7%20Inreda%20Diabetic%20B.V.&badge=phase%201 Insulin Lispro Cartridge [Lyumjev] Insulin Lispro Cartridge [Lyumjev] · Inreda Diabetic B.V. https://druglandscape.com/drug/insulin-lispro-sar342434 https://druglandscape.com/api/og?type=drug&title=Insulin%20Lispro%20SAR342434&subtitle=Insulin%20Lispro%20SAR342434%20%C2%B7%20Sanofi&badge=phase%201 Insulin Lispro SAR342434 Insulin Lispro SAR342434 · Sanofi https://druglandscape.com/drug/intanza-15 https://druglandscape.com/api/og?type=drug&title=INTANZA%C2%AE%2015&subtitle=INTANZA%C2%AE%2015%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 INTANZA® 15 INTANZA® 15 · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/intanza-15-t https://druglandscape.com/api/og?type=drug&title=INTANZA%C2%AE%2015%20T&subtitle=INTANZA%C2%AE%2015%20T%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 INTANZA® 15 T INTANZA® 15 T · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/intellicap https://druglandscape.com/api/og?type=drug&title=IntelliCap&subtitle=IntelliCap%20%C2%B7%20AstraZeneca&badge=phase%201 IntelliCap IntelliCap · AstraZeneca https://druglandscape.com/drug/intensive-dosage-orofacial-exercises https://druglandscape.com/api/og?type=drug&title=Intensive%20dosage%20orofacial%20exercises&subtitle=Intensive%20dosage%20orofacial%20exercises%20%C2%B7%20Universidad%20Autonoma%20de%20Madrid&badge=phase%201 Intensive dosage orofacial exercises Intensive dosage orofacial exercises · Universidad Autonoma de Madrid https://druglandscape.com/drug/intensive-lipid-lowering-strategy https://druglandscape.com/api/og?type=drug&title=Intensive%20lipid-lowering%20strategy&subtitle=Intensive%20lipid-lowering%20strategy%20%C2%B7%20Liu%20yong&badge=phase%201 Intensive lipid-lowering strategy Intensive lipid-lowering strategy · Liu yong https://druglandscape.com/drug/intercoat-administration https://druglandscape.com/api/og?type=drug&title=INTERCOAT%20administration&subtitle=INTERCOAT%20administration%20%C2%B7%20Carmel%20Medical%20Center&badge=phase%201 INTERCOAT administration INTERCOAT administration · Carmel Medical Center https://druglandscape.com/drug/interferon-1 https://druglandscape.com/api/og?type=drug&title=Interferon-%CE%B2-1&subtitle=Interferon-%CE%B2-1%20%C2%B7%20Sanofi&badge=phase%202 Interferon-β-1 Interferon-β-1 · Sanofi https://druglandscape.com/drug/interferon-5 https://druglandscape.com/api/og?type=drug&title=Interferon%20%CE%B1-5&subtitle=Interferon%20%CE%B1-5%20%C2%B7%20Digna%20Biotech%20S.L.&badge=phase%201 Interferon α-5 Interferon α-5 · Digna Biotech S.L. https://druglandscape.com/drug/interferon-5-plus-interferon-2b https://druglandscape.com/api/og?type=drug&title=Interferon-%CE%B15%20plus%20Interferon-%CE%B1%202b&subtitle=Interferon-%CE%B15%20plus%20Interferon-%CE%B1%202b%20%C2%B7%20Digna%20Biotech%20S.L.&badge=phase%201 Interferon-α5 plus Interferon-α 2b Interferon-α5 plus Interferon-α 2b · Digna Biotech S.L. https://druglandscape.com/drug/interferon-alpha2b https://druglandscape.com/api/og?type=drug&title=Interferon-Alpha2B&subtitle=Interferon-Alpha2B%20%C2%B7%20Pontificia%20Universidad%20Catolica%20de%20Chile&badge=phase%202 Interferon-Alpha2B Interferon-Alpha2B · Pontificia Universidad Catolica de Chile https://druglandscape.com/drug/interferon-beta-1a-44-microgram https://druglandscape.com/api/og?type=drug&title=Interferon-beta-1a%2C%2044%20microgram&subtitle=Interferon-beta-1a%2C%2044%20microgram%20%C2%B7%20EMD%20Serono&badge=phase%202 Interferon-beta-1a, 44 microgram Interferon-beta-1a, 44 microgram · EMD Serono https://druglandscape.com/drug/interferon-beta-1a-66-microgram https://druglandscape.com/api/og?type=drug&title=Interferon-beta-1a%2C%2066%20microgram&subtitle=Interferon-beta-1a%2C%2066%20microgram%20%C2%B7%20EMD%20Serono&badge=phase%202 Interferon-beta-1a, 66 microgram Interferon-beta-1a, 66 microgram · EMD Serono https://druglandscape.com/drug/interferon-beta-1b-and-tacrolimus https://druglandscape.com/api/og?type=drug&title=Interferon%20beta-1b%20and%20Tacrolimus&subtitle=Interferon%20beta-1b%20and%20Tacrolimus%20%C2%B7%20Clinique%20de%20scl%C3%A9rose%20en%20plaques%20et%20neuromusculaire%20de%20l'Outaouai&badge=phase%202 Interferon beta-1b and Tacrolimus Interferon beta-1b and Tacrolimus · Clinique de sclérose en plaques et neuromusculaire de l'Outaouais https://druglandscape.com/drug/interferon-beta-therapy https://druglandscape.com/api/og?type=drug&title=Interferon%20Beta%20Therapy&subtitle=Interferon%20Beta%20Therapy%20%C2%B7%20Biogen&badge=phase%202 Interferon Beta Therapy Interferon Beta Therapy · Biogen https://druglandscape.com/drug/interferon-inoculation https://druglandscape.com/api/og?type=drug&title=Interferon%20Inoculation&subtitle=Interferon%20Inoculation%20%C2%B7%20BriaCell%20Therapeutics%20Corporation&badge=phase%201 Interferon Inoculation Interferon Inoculation · BriaCell Therapeutics Corporation https://druglandscape.com/drug/interleukin-2-sa https://druglandscape.com/api/og?type=drug&title=Interleukin-2%20SA&subtitle=Interleukin-2%20SA%20%C2%B7%20Bayer&badge=phase%201 Interleukin-2 SA Interleukin-2 SA · Bayer https://druglandscape.com/drug/intermittent-dosing-of-azd5363 https://druglandscape.com/api/og?type=drug&title=Intermittent%20dosing%20of%20AZD5363&subtitle=Intermittent%20dosing%20of%20AZD5363%20%C2%B7%20AstraZeneca&badge=phase%201 Intermittent dosing of AZD5363 Intermittent dosing of AZD5363 · AstraZeneca https://druglandscape.com/drug/intermittent-imipenem https://druglandscape.com/api/og?type=drug&title=Intermittent%20Imipenem&subtitle=Intermittent%20Imipenem%20%C2%B7%20Coordinaci%C3%B3n%20de%20Investigaci%C3%B3n%20en%20Salud%2C%20Mexico&badge=phase%201 Intermittent Imipenem Intermittent Imipenem · Coordinación de Investigación en Salud, Mexico https://druglandscape.com/drug/intermittent-meropenem https://druglandscape.com/api/og?type=drug&title=Intermittent%20Meropenem&subtitle=Intermittent%20Meropenem%20%C2%B7%20Coordinaci%C3%B3n%20de%20Investigaci%C3%B3n%20en%20Salud%2C%20Mexico&badge=phase%201 Intermittent Meropenem Intermittent Meropenem · Coordinación de Investigación en Salud, Mexico https://druglandscape.com/drug/intermittent-nebulization-of-salbutamol https://druglandscape.com/api/og?type=drug&title=Intermittent%20Nebulization%20of%20Salbutamol&subtitle=Intermittent%20Nebulization%20of%20Salbutamol%20%C2%B7%20Muhammad%20Aamir%20Latif&badge=phase%201 Intermittent Nebulization of Salbutamol Intermittent Nebulization of Salbutamol · Muhammad Aamir Latif https://druglandscape.com/drug/intermittent-parasite-clearance https://druglandscape.com/api/og?type=drug&title=Intermittent%20parasite%20clearance&subtitle=Intermittent%20parasite%20clearance%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%201 Intermittent parasite clearance Intermittent parasite clearance · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/intra-arterial-administration-of-tenecteplase https://druglandscape.com/api/og?type=drug&title=Intra-arterial%20administration%20of%20tenecteplase&subtitle=Intra-arterial%20administration%20of%20tenecteplase%20%C2%B7%20Hui-Sheng%20Chen&badge=phase%201 Intra-arterial administration of tenecteplase Intra-arterial administration of tenecteplase · Hui-Sheng Chen https://druglandscape.com/drug/intra-arterial-cocktail-therapy https://druglandscape.com/api/og?type=drug&title=intra-arterial%20cocktail%20therapy&subtitle=intra-arterial%20cocktail%20therapy%20%C2%B7%20Hui-Sheng%20Chen&badge=phase%201 intra-arterial cocktail therapy intra-arterial cocktail therapy · Hui-Sheng Chen https://druglandscape.com/drug/intra-arterial-injection-of-melphalan https://druglandscape.com/api/og?type=drug&title=Intra-arterial%20injection%20of%20melphalan&subtitle=Intra-arterial%20injection%20of%20melphalan%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 Intra-arterial injection of melphalan Intra-arterial injection of melphalan · Hadassah Medical Organization https://druglandscape.com/drug/intra-arterial-tenecteplase https://druglandscape.com/api/og?type=drug&title=intra-arterial%20tenecteplase&subtitle=intra-arterial%20tenecteplase%20%C2%B7%20ProMedica%20Health%20System&badge=phase%202 intra-arterial tenecteplase intra-arterial tenecteplase · ProMedica Health System https://druglandscape.com/drug/intra-articular-secretome-injection-therapy https://druglandscape.com/api/og?type=drug&title=Intra-articular%20secretome%20injection%20therapy&subtitle=Intra-articular%20secretome%20injection%20therapy%20%C2%B7%20Kementerian%20Riset%20dan%20Teknologi%20%2F%20Badan%20Riset%20dan%20Inov&badge=phase%201 Intra-articular secretome injection therapy Intra-articular secretome injection therapy · Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia https://druglandscape.com/drug/intra-lesional-mmr-immunotherapy https://druglandscape.com/api/og?type=drug&title=Intra-Lesional%20MMR%20Immunotherapy&subtitle=Intra-Lesional%20MMR%20Immunotherapy%20%C2%B7%20Abeer%20Mohamed%20Abdelaziz%20Elkholy&badge=phase%201 Intra-Lesional MMR Immunotherapy Intra-Lesional MMR Immunotherapy · Abeer Mohamed Abdelaziz Elkholy https://druglandscape.com/drug/intra-lisional-pentostam https://druglandscape.com/api/og?type=drug&title=intra-lisional%20pentostam&subtitle=intra-lisional%20pentostam%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 intra-lisional pentostam intra-lisional pentostam · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/intra-lymphatic-allergenic-extract https://druglandscape.com/api/og?type=drug&title=Intra-lymphatic%20allergenic%20extract&subtitle=Intra-lymphatic%20allergenic%20extract%20%C2%B7%20Christopher%20Thompson%2C%20MD&badge=phase%202 Intra-lymphatic allergenic extract Intra-lymphatic allergenic extract · Christopher Thompson, MD https://druglandscape.com/drug/intra-operative-5-fu-chemotherapy https://druglandscape.com/api/og?type=drug&title=intra-operative%205-FU%20chemotherapy&subtitle=intra-operative%205-FU%20chemotherapy%20%C2%B7%20Sun%20Yat-sen%20University&badge=phase%203 intra-operative 5-FU chemotherapy intra-operative 5-FU chemotherapy · Sun Yat-sen University https://druglandscape.com/drug/intra-tympanic-injection-of-drugs https://druglandscape.com/api/og?type=drug&title=Intra-tympanic%20injection%20of%20drugs&subtitle=Intra-tympanic%20injection%20of%20drugs%20%C2%B7%20saad%20elzayat&badge=phase%201 Intra-tympanic injection of drugs Intra-tympanic injection of drugs · saad elzayat https://druglandscape.com/drug/intra-venous-fluid https://druglandscape.com/api/og?type=drug&title=Intra%20venous%20fluid&subtitle=Intra%20venous%20fluid%20%C2%B7%20King's%20College%20London&badge=phase%201 Intra venous fluid Intra venous fluid · King's College London https://druglandscape.com/drug/intra-vitreal-anti-vegf-drug https://druglandscape.com/api/og?type=drug&title=Intra-vitreal%20Anti-VEGF%20Drug&subtitle=Intra-vitreal%20Anti-VEGF%20Drug%20%C2%B7%20Retina%20Vitreous%20Associates%20of%20Florida&badge=phase%201 Intra-vitreal Anti-VEGF Drug Intra-vitreal Anti-VEGF Drug · Retina Vitreous Associates of Florida https://druglandscape.com/drug/intraanal-nrl001-gel-2-strengths https://druglandscape.com/api/og?type=drug&title=Intraanal%20NRL001%20Gel%202%20strengths&subtitle=Intraanal%20NRL001%20Gel%202%20strengths%20%C2%B7%20Norgine&badge=phase%201 Intraanal NRL001 Gel 2 strengths Intraanal NRL001 Gel 2 strengths · Norgine https://druglandscape.com/drug/intraarticular-injections-of-platelet-lysate https://druglandscape.com/api/og?type=drug&title=intraarticular%20injections%20of%20platelet%20lysate&subtitle=intraarticular%20injections%20of%20platelet%20lysate%20%C2%B7%20Fondazione%20IRCCS%20Policlinico%20San%20Matteo%20di%20Pavia&badge=phase%202 intraarticular injections of platelet lysate intraarticular injections of platelet lysate · Fondazione IRCCS Policlinico San Matteo di Pavia https://druglandscape.com/drug/intracavernous-platelet-rich-plasma-therapy https://druglandscape.com/api/og?type=drug&title=intracavernous%20platelet%20rich%20plasma%20therapy&subtitle=intracavernous%20platelet%20rich%20plasma%20therapy%20%C2%B7%20Bakirkoy%20Dr.%20Sadi%20Konuk%20Research%20and%20Training%20Hospital&badge=phase%203 intracavernous platelet rich plasma therapy intracavernous platelet rich plasma therapy · Bakirkoy Dr. Sadi Konuk Research and Training Hospital https://druglandscape.com/drug/intracochlear-application-of-vsf1-01 https://druglandscape.com/api/og?type=drug&title=Intracochlear%20application%20of%20VSF1.01&subtitle=Intracochlear%20application%20of%20VSF1.01%20%C2%B7%20Hannover%20Medical%20School&badge=phase%201 Intracochlear application of VSF1.01 Intracochlear application of VSF1.01 · Hannover Medical School https://druglandscape.com/drug/intracoronary-infusion-of-acetylcholine https://druglandscape.com/api/og?type=drug&title=intracoronary%20infusion%20of%20acetylcholine&subtitle=intracoronary%20infusion%20of%20acetylcholine%20%C2%B7%20Azienda%20Ospedaliera%20San%20Camillo%20Forlanini&badge=phase%201 intracoronary infusion of acetylcholine intracoronary infusion of acetylcholine · Azienda Ospedaliera San Camillo Forlanini https://druglandscape.com/drug/intradermal-avotermin https://druglandscape.com/api/og?type=drug&title=Intradermal%20avotermin&subtitle=Intradermal%20avotermin%20%C2%B7%20Renovo&badge=phase%201 Intradermal avotermin Intradermal avotermin · Renovo https://druglandscape.com/drug/intradermal-hbv-1-course https://druglandscape.com/api/og?type=drug&title=Intradermal%20HBV%201%20course&subtitle=Intradermal%20HBV%201%20course%20%C2%B7%20The%20HIV%20Netherlands%20Australia%20Thailand%20Research%20Collaboration&badge=phase%202 Intradermal HBV 1 course Intradermal HBV 1 course · The HIV Netherlands Australia Thailand Research Collaboration https://druglandscape.com/drug/intradermal-microinjections-of-tranexamic-acid https://druglandscape.com/api/og?type=drug&title=Intradermal%20microinjections%20of%20tranexamic%20acid&subtitle=Intradermal%20microinjections%20of%20tranexamic%20acid%20%C2%B7%20Hayat%20Abad%20Medical%20Complex%2C%20Peshawar&badge=phase%201 Intradermal microinjections of tranexamic acid Intradermal microinjections of tranexamic acid · Hayat Abad Medical Complex, Peshawar https://druglandscape.com/drug/intradiscal-rhgdf-5 https://druglandscape.com/api/og?type=drug&title=Intradiscal%20rhGDF-5&subtitle=Intradiscal%20rhGDF-5%20%C2%B7%20DePuy%20Spine&badge=phase%202 Intradiscal rhGDF-5 Intradiscal rhGDF-5 · DePuy Spine https://druglandscape.com/drug/intralesional-rituximab https://druglandscape.com/api/og?type=drug&title=intralesional%20rituximab&subtitle=intralesional%20rituximab%20%C2%B7%20Andres%20J.%20M.%20Ferreri&badge=phase%202 intralesional rituximab intralesional rituximab · Andres J. M. Ferreri https://druglandscape.com/drug/intralipids https://druglandscape.com/api/og?type=drug&title=INTRALIPIDS&subtitle=INTRALIPIDS%20%C2%B7%20OSF%20Healthcare%20System&badge=phase%201 INTRALIPIDS INTRALIPIDS · OSF Healthcare System https://druglandscape.com/drug/intramuscular-botulinum-toxin https://druglandscape.com/api/og?type=drug&title=intramuscular%20Botulinum%20Toxin&subtitle=intramuscular%20Botulinum%20Toxin%20%C2%B7%20Yassir%20R.%20Al-khannaq&badge=phase%201 intramuscular Botulinum Toxin intramuscular Botulinum Toxin · Yassir R. Al-khannaq https://druglandscape.com/drug/intramuscular-dmpa https://druglandscape.com/api/og?type=drug&title=Intramuscular%20DMPA&subtitle=Intramuscular%20DMPA%20%C2%B7%20Johns%20Hopkins%20Bloomberg%20School%20of%20Public%20Health&badge=phase%201 Intramuscular DMPA Intramuscular DMPA · Johns Hopkins Bloomberg School of Public Health https://druglandscape.com/drug/intramuscular-hbv-i-course https://druglandscape.com/api/og?type=drug&title=Intramuscular%20HBV%20I%20course&subtitle=Intramuscular%20HBV%20I%20course%20%C2%B7%20The%20HIV%20Netherlands%20Australia%20Thailand%20Research%20Collaboration&badge=phase%202 Intramuscular HBV I course Intramuscular HBV I course · The HIV Netherlands Australia Thailand Research Collaboration https://druglandscape.com/drug/intramuscular-injection-of-dexamethasone https://druglandscape.com/api/og?type=drug&title=Intramuscular%20Injection%20of%20Dexamethasone&subtitle=Intramuscular%20Injection%20of%20Dexamethasone%20%C2%B7%20Ashraf%20elanzy&badge=phase%201 Intramuscular Injection of Dexamethasone Intramuscular Injection of Dexamethasone · Ashraf elanzy https://druglandscape.com/drug/intramuscular-levosulpiride https://druglandscape.com/api/og?type=drug&title=Intramuscular%20Levosulpiride&subtitle=Intramuscular%20Levosulpiride%20%C2%B7%20Shanghai%20Mental%20Health%20Center&badge=phase%202 Intramuscular Levosulpiride Intramuscular Levosulpiride · Shanghai Mental Health Center https://druglandscape.com/drug/intramuscular-mode-of-administration https://druglandscape.com/api/og?type=drug&title=Intramuscular%20mode%20of%20administration&subtitle=Intramuscular%20mode%20of%20administration%20%C2%B7%20Objectif%20Recherche%20Vaccins%20SIDA&badge=phase%201 Intramuscular mode of administration Intramuscular mode of administration · Objectif Recherche Vaccins SIDA https://druglandscape.com/drug/intraocular-injections-of-bevacizumab https://druglandscape.com/api/og?type=drug&title=intraocular%20injections%20of%20bevacizumab&subtitle=intraocular%20injections%20of%20bevacizumab%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 intraocular injections of bevacizumab intraocular injections of bevacizumab · Samsung Medical Center https://druglandscape.com/drug/intraocular-triamcinolone-and-gatifloxicin https://druglandscape.com/api/og?type=drug&title=intraocular%20triamcinolone%20and%20gatifloxicin&subtitle=intraocular%20triamcinolone%20and%20gatifloxicin%20%C2%B7%20Dean%20Health%20System&badge=phase%201 intraocular triamcinolone and gatifloxicin intraocular triamcinolone and gatifloxicin · Dean Health System https://druglandscape.com/drug/intraperitoneal-and-port-sites-infiltration https://druglandscape.com/api/og?type=drug&title=Intraperitoneal%20and%20port%20sites%20infiltration&subtitle=Intraperitoneal%20and%20port%20sites%20infiltration%20%C2%B7%20medina%20medical%20center&badge=phase%201 Intraperitoneal and port sites infiltration Intraperitoneal and port sites infiltration · medina medical center https://druglandscape.com/drug/intraperitoneal-infiltration-to-liver https://druglandscape.com/api/og?type=drug&title=Intraperitoneal%20infiltration%20to%20liver&subtitle=Intraperitoneal%20infiltration%20to%20liver%20%C2%B7%20Royal%20College%20of%20Surgeons%2C%20Ireland&badge=phase%201 Intraperitoneal infiltration to liver Intraperitoneal infiltration to liver · Royal College of Surgeons, Ireland https://druglandscape.com/drug/intrarectal-nrl001-gel https://druglandscape.com/api/og?type=drug&title=Intrarectal%20NRL001%20Gel&subtitle=Intrarectal%20NRL001%20Gel%20%C2%B7%20Norgine&badge=phase%201 Intrarectal NRL001 Gel Intrarectal NRL001 Gel · Norgine https://druglandscape.com/drug/intrathecal-cytarabine https://druglandscape.com/api/og?type=drug&title=Intrathecal%20cytarabine&subtitle=Intrathecal%20cytarabine%20%C2%B7%20SWOG%20Cancer%20Research%20Network&badge=phase%202 Intrathecal cytarabine Intrathecal cytarabine · SWOG Cancer Research Network https://druglandscape.com/drug/intrathecal-local-anesthesia https://druglandscape.com/api/og?type=drug&title=Intrathecal%20local%20anesthesia&subtitle=Intrathecal%20local%20anesthesia%20%C2%B7%20Milton%20S.%20Hershey%20Medical%20Center&badge=phase%202 Intrathecal local anesthesia Intrathecal local anesthesia · Milton S. Hershey Medical Center https://druglandscape.com/drug/intrathecal-mafosfamide https://druglandscape.com/api/og?type=drug&title=Intrathecal%20Mafosfamide&subtitle=Intrathecal%20Mafosfamide%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Intrathecal Mafosfamide Intrathecal Mafosfamide · Baylor College of Medicine https://druglandscape.com/drug/intrathecal-triple-chemotherapy https://druglandscape.com/api/og?type=drug&title=Intrathecal%20triple%20chemotherapy&subtitle=Intrathecal%20triple%20chemotherapy%20%C2%B7%20The%20Korean%20Society%20of%20Pediatric%20Hematology%20Oncology&badge=phase%202 Intrathecal triple chemotherapy Intrathecal triple chemotherapy · The Korean Society of Pediatric Hematology Oncology https://druglandscape.com/drug/intraumbilical-vein-injection-oxytocin https://druglandscape.com/api/og?type=drug&title=Intraumbilical%20vein%20injection%20oxytocin&subtitle=Intraumbilical%20vein%20injection%20oxytocin%20%C2%B7%20Eslam%20Mohammed%20Abbas&badge=phase%202 Intraumbilical vein injection oxytocin Intraumbilical vein injection oxytocin · Eslam Mohammed Abbas https://druglandscape.com/drug/intravenous-administration-of-acmp https://druglandscape.com/api/og?type=drug&title=intravenous%20administration%20of%20ACMP&subtitle=intravenous%20administration%20of%20ACMP%20%C2%B7%20Alenka%20Spindler-Vesel&badge=phase%202 intravenous administration of ACMP intravenous administration of ACMP · Alenka Spindler-Vesel https://druglandscape.com/drug/intravenous-aon-d21 https://druglandscape.com/api/og?type=drug&title=Intravenous%20AON-D21&subtitle=Intravenous%20AON-D21%20%C2%B7%20Aptarion%20Biotech%20AG&badge=phase%201 Intravenous AON-D21 Intravenous AON-D21 · Aptarion Biotech AG https://druglandscape.com/drug/intravenous-bolus-furosemide https://druglandscape.com/api/og?type=drug&title=Intravenous%20Bolus%20Furosemide&subtitle=Intravenous%20Bolus%20Furosemide%20%C2%B7%20Momentum%20Research%2C%20Inc.&badge=phase%201 Intravenous Bolus Furosemide Intravenous Bolus Furosemide · Momentum Research, Inc. https://druglandscape.com/drug/intravenous-brivaracetam https://druglandscape.com/api/og?type=drug&title=Intravenous%20brivaracetam&subtitle=Intravenous%20brivaracetam%20%C2%B7%20Muhammad%20Aamir%20Latif&badge=phase%201 Intravenous brivaracetam Intravenous brivaracetam · Muhammad Aamir Latif https://druglandscape.com/drug/intravenous-carbamazepine https://druglandscape.com/api/og?type=drug&title=Intravenous%20Carbamazepine&subtitle=Intravenous%20Carbamazepine%20%C2%B7%20Lundbeck%20LLC&badge=phase%201 Intravenous Carbamazepine Intravenous Carbamazepine · Lundbeck LLC https://druglandscape.com/drug/intravenous-deferiprone https://druglandscape.com/api/og?type=drug&title=Intravenous%20deferiprone&subtitle=Intravenous%20deferiprone%20%C2%B7%20ApoPharma&badge=phase%201 Intravenous deferiprone Intravenous deferiprone · ApoPharma https://druglandscape.com/drug/intravenous-fluid https://druglandscape.com/api/og?type=drug&title=Intravenous%20fluid&subtitle=Intravenous%20fluid%20%C2%B7%20Christiana%20Care%20Health%20Services&badge=phase%201 Intravenous fluid Intravenous fluid · Christiana Care Health Services https://druglandscape.com/drug/intravenous-formulation-of-pd-0332991 https://druglandscape.com/api/og?type=drug&title=Intravenous%20Formulation%20of%20PD-0332991&subtitle=Intravenous%20Formulation%20of%20PD-0332991%20%C2%B7%20Pfizer&badge=phase%201 Intravenous Formulation of PD-0332991 Intravenous Formulation of PD-0332991 · Pfizer https://druglandscape.com/drug/intravenous-gemini https://druglandscape.com/api/og?type=drug&title=Intravenous%20Gemini&subtitle=Intravenous%20Gemini%20%C2%B7%20Revelation%20Biosciences%2C%20Inc&badge=phase%201 Intravenous Gemini Intravenous Gemini · Revelation Biosciences, Inc https://druglandscape.com/drug/intravenous-glucose-tolerance-test https://druglandscape.com/api/og?type=drug&title=intravenous%20glucose%20tolerance%20test&subtitle=intravenous%20glucose%20tolerance%20test%20%C2%B7%20German%20Diabetes%20Center&badge=phase%201 intravenous glucose tolerance test intravenous glucose tolerance test · German Diabetes Center https://druglandscape.com/drug/intravenous-gr270773-phospholipid-emulsion https://druglandscape.com/api/og?type=drug&title=Intravenous%20GR270773-%20Phospholipid%20Emulsion&subtitle=Intravenous%20GR270773-%20Phospholipid%20Emulsion%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Intravenous GR270773- Phospholipid Emulsion Intravenous GR270773- Phospholipid Emulsion · GlaxoSmithKline https://druglandscape.com/drug/intravenous-graniseton https://druglandscape.com/api/og?type=drug&title=intravenous%20graniseton&subtitle=intravenous%20graniseton%20%C2%B7%20Mohamed%20Youssef%20Mohamed&badge=phase%201 intravenous graniseton intravenous graniseton · Mohamed Youssef Mohamed https://druglandscape.com/drug/intravenous-human-immunoglobulin https://druglandscape.com/api/og?type=drug&title=Intravenous%20human%20immunoglobulin&subtitle=Intravenous%20human%20immunoglobulin%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 Intravenous human immunoglobulin Intravenous human immunoglobulin · Hospices Civils de Lyon https://druglandscape.com/drug/intravenous-infusion-of-bosutinib https://druglandscape.com/api/og?type=drug&title=Intravenous%20infusion%20of%20bosutinib&subtitle=Intravenous%20infusion%20of%20bosutinib%20%C2%B7%20Pfizer&badge=phase%201 Intravenous infusion of bosutinib Intravenous infusion of bosutinib · Pfizer https://druglandscape.com/drug/intravenous-injection-of-labeled-crbc https://druglandscape.com/api/og?type=drug&title=intravenous%20injection%20of%20labeled%20cRBC&subtitle=intravenous%20injection%20of%20labeled%20cRBC%20%C2%B7%20Etablissement%20Fran%C3%A7ais%20du%20Sang&badge=phase%201 intravenous injection of labeled cRBC intravenous injection of labeled cRBC · Etablissement Français du Sang https://druglandscape.com/drug/intravenous-levetiracetam https://druglandscape.com/api/og?type=drug&title=Intravenous%20levetiracetam&subtitle=Intravenous%20levetiracetam%20%C2%B7%20Muhammad%20Aamir%20Latif&badge=phase%202 Intravenous levetiracetam Intravenous levetiracetam · Muhammad Aamir Latif https://druglandscape.com/drug/intravenous-morphine-titration https://druglandscape.com/api/og?type=drug&title=intravenous%20morphine%20titration&subtitle=intravenous%20morphine%20titration%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 intravenous morphine titration intravenous morphine titration · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/intravenous-morphine-via-pca https://druglandscape.com/api/og?type=drug&title=intravenous%20morphine%20via%20PCA&subtitle=intravenous%20morphine%20via%20PCA%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 intravenous morphine via PCA intravenous morphine via PCA · Hadassah Medical Organization https://druglandscape.com/drug/intravenous-neostigmine-and-glycopyrrolate https://druglandscape.com/api/og?type=drug&title=Intravenous%20Neostigmine%20and%20Glycopyrrolate&subtitle=Intravenous%20Neostigmine%20and%20Glycopyrrolate%20%C2%B7%20James%20J.%20Peters%20Veterans%20Affairs%20Medical%20Center&badge=phase%201 Intravenous Neostigmine and Glycopyrrolate Intravenous Neostigmine and Glycopyrrolate · James J. Peters Veterans Affairs Medical Center https://druglandscape.com/drug/intravenous-racemic-ketamine https://druglandscape.com/api/og?type=drug&title=Intravenous%20racemic%20ketamine&subtitle=Intravenous%20racemic%20ketamine%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Intravenous racemic ketamine Intravenous racemic ketamine · Janssen Research & Development, LLC https://druglandscape.com/drug/intravenous-rescue-urapidil-administration https://druglandscape.com/api/og?type=drug&title=intravenous%20rescue%20urapidil%20administration&subtitle=intravenous%20rescue%20urapidil%20administration%20%C2%B7%20Micha%C5%82%20Stasiowski&badge=phase%201 intravenous rescue urapidil administration intravenous rescue urapidil administration · Michał Stasiowski https://druglandscape.com/drug/intravenous-ribavirin https://druglandscape.com/api/og?type=drug&title=Intravenous%20ribavirin&subtitle=Intravenous%20ribavirin%20%C2%B7%20Arisan%20Therapeutics%2C%20Inc.&badge=phase%202 Intravenous ribavirin Intravenous ribavirin · Arisan Therapeutics, Inc. https://druglandscape.com/drug/intravenous-sodium-valproate https://druglandscape.com/api/og?type=drug&title=Intravenous%20Sodium%20Valproate&subtitle=Intravenous%20Sodium%20Valproate%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Intravenous Sodium Valproate Intravenous Sodium Valproate · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/intravenous-thiamine https://druglandscape.com/api/og?type=drug&title=intravenous%20Thiamine&subtitle=intravenous%20Thiamine%20%C2%B7%20Meir%20Medical%20Center&badge=phase%202 intravenous Thiamine intravenous Thiamine · Meir Medical Center https://druglandscape.com/drug/intravenous14c-odm-201 https://druglandscape.com/api/og?type=drug&title=intravenous14C-ODM-201&subtitle=intravenous14C-ODM-201%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 intravenous14C-ODM-201 intravenous14C-ODM-201 · Orion Corporation, Orion Pharma https://druglandscape.com/drug/intravesical-gemcitabine-and-docetaxel https://druglandscape.com/api/og?type=drug&title=Intravesical%20Gemcitabine%20and%20Docetaxel&subtitle=Intravesical%20Gemcitabine%20and%20Docetaxel%20%C2%B7%20Michael%20A.%20O'Donnell&badge=phase%202 Intravesical Gemcitabine and Docetaxel Intravesical Gemcitabine and Docetaxel · Michael A. O'Donnell https://druglandscape.com/drug/intravitreal-adalimumab https://druglandscape.com/api/og?type=drug&title=Intravitreal%20Adalimumab&subtitle=Intravitreal%20Adalimumab%20%C2%B7%20Centro%20de%20Pesquisa%20Rubens%20Siqueira&badge=phase%201 Intravitreal Adalimumab Intravitreal Adalimumab · Centro de Pesquisa Rubens Siqueira https://druglandscape.com/drug/intravitreal-implant-in-applicator https://druglandscape.com/api/og?type=drug&title=Intravitreal%20Implant%20in%20Applicator&subtitle=Intravitreal%20Implant%20in%20Applicator%20%C2%B7%20Uptown%20Eye%20Specialists&badge=phase%201 Intravitreal Implant in Applicator Intravitreal Implant in Applicator · Uptown Eye Specialists https://druglandscape.com/drug/intravitreal-injection-of-rc28-e https://druglandscape.com/api/og?type=drug&title=intravitreal%20injection%20of%20RC28-E&subtitle=intravitreal%20injection%20of%20RC28-E%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%202 intravitreal injection of RC28-E intravitreal injection of RC28-E · RemeGen Co., Ltd. https://druglandscape.com/drug/intravitreal-injection-of-triamcinolone-acetonide https://druglandscape.com/api/og?type=drug&title=intravitreal%20injection%20of%20triamcinolone%20acetonide&subtitle=intravitreal%20injection%20of%20triamcinolone%20acetonide%20%C2%B7%20Retina%20Associates%20of%20Florida%2C%20P.A.&badge=phase%202 intravitreal injection of triamcinolone acetonide intravitreal injection of triamcinolone acetonide · Retina Associates of Florida, P.A. https://druglandscape.com/drug/intravitreal-injections-of-ziv-aflibercept https://druglandscape.com/api/og?type=drug&title=Intravitreal%20injections%20of%20ziv-aflibercept&subtitle=Intravitreal%20injections%20of%20ziv-aflibercept%20%C2%B7%20Retina%20Clinic%2C%20Sao%20Paulo%2C%20Brazil&badge=phase%201 Intravitreal injections of ziv-aflibercept Intravitreal injections of ziv-aflibercept · Retina Clinic, Sao Paulo, Brazil https://druglandscape.com/drug/intravitreal-triamcinolone-acetonide https://druglandscape.com/api/og?type=drug&title=intravitreal%20triamcinolone%20acetonide&subtitle=intravitreal%20triamcinolone%20acetonide%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%201 intravitreal triamcinolone acetonide intravitreal triamcinolone acetonide · Samsung Medical Center https://druglandscape.com/drug/intravitreous-injection-of-ranibizumab https://druglandscape.com/api/og?type=drug&title=Intravitreous%20injection%20of%20ranibizumab&subtitle=Intravitreous%20injection%20of%20ranibizumab%20%C2%B7%20Jos%C3%A9%20Cunha-Vaz&badge=phase%202 Intravitreous injection of ranibizumab Intravitreous injection of ranibizumab · José Cunha-Vaz https://druglandscape.com/drug/intrinsic-heart-rate https://druglandscape.com/api/og?type=drug&title=Intrinsic%20Heart%20Rate&subtitle=Intrinsic%20Heart%20Rate%20%C2%B7%20Satish%20R.%20Raj&badge=phase%201 Intrinsic Heart Rate Intrinsic Heart Rate · Satish R. Raj https://druglandscape.com/drug/ints-gmma-dose-a https://druglandscape.com/api/og?type=drug&title=iNTS-GMMA%20Dose%20A&subtitle=iNTS-GMMA%20Dose%20A%20%C2%B7%20GlaxoSmithKline&badge=phase%202 iNTS-GMMA Dose A iNTS-GMMA Dose A · GlaxoSmithKline https://druglandscape.com/drug/ints-gmma-dose-b https://druglandscape.com/api/og?type=drug&title=iNTS-GMMA%20Dose%20B&subtitle=iNTS-GMMA%20Dose%20B%20%C2%B7%20GlaxoSmithKline&badge=phase%202 iNTS-GMMA Dose B iNTS-GMMA Dose B · GlaxoSmithKline https://druglandscape.com/drug/ints-gmma-dose-c https://druglandscape.com/api/og?type=drug&title=iNTS-GMMA%20Dose%20C&subtitle=iNTS-GMMA%20Dose%20C%20%C2%B7%20GlaxoSmithKline&badge=phase%202 iNTS-GMMA Dose C iNTS-GMMA Dose C · GlaxoSmithKline https://druglandscape.com/drug/inv-001 https://druglandscape.com/api/og?type=drug&title=INV-001&subtitle=INV-001%20%C2%B7%20Innovo%20Therapeutics%2C%20Inc.&badge=phase%202 INV-001 INV-001 · Innovo Therapeutics, Inc. https://druglandscape.com/drug/inv-101 https://druglandscape.com/api/og?type=drug&title=INV-101&subtitle=INV-101%20%C2%B7%20Innovo%20Therapeutics%2C%20Inc.&badge=phase%201 INV-101 INV-101 · Innovo Therapeutics, Inc. https://druglandscape.com/drug/inv-1120 https://druglandscape.com/api/og?type=drug&title=INV-1120&subtitle=INV-1120%20%C2%B7%20Shenzhen%20Ionova%20Life%20Sciences%20Co.%2C%20Ltd.&badge=phase%201 INV-1120 INV-1120 · Shenzhen Ionova Life Sciences Co., Ltd. https://druglandscape.com/drug/inv-144 https://druglandscape.com/api/og?type=drug&title=INV-144&subtitle=INV-144%20%C2%B7%20InVasc%20Therapeutics%2C%20Inc.&badge=phase%202 INV-144 INV-144 · InVasc Therapeutics, Inc. https://druglandscape.com/drug/inv-347 https://druglandscape.com/api/og?type=drug&title=INV-347&subtitle=INV-347%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 INV-347 INV-347 · Novo Nordisk A/S https://druglandscape.com/drug/inv-9956 https://druglandscape.com/api/og?type=drug&title=INV-9956&subtitle=INV-9956%20%C2%B7%20Shenzhen%20Ionova%20Life%20Sciences%20Co.%2C%20Ltd.&badge=phase%201 INV-9956 INV-9956 · Shenzhen Ionova Life Sciences Co., Ltd. https://druglandscape.com/drug/inv21-high-dose https://druglandscape.com/api/og?type=drug&title=INV21%20High%20Dose&subtitle=INV21%20High%20Dose%20%C2%B7%20Inviragen%20Inc.&badge=phase%201 INV21 High Dose INV21 High Dose · Inviragen Inc. https://druglandscape.com/drug/inv21-low-dose https://druglandscape.com/api/og?type=drug&title=INV21%20Low%20Dose&subtitle=INV21%20Low%20Dose%20%C2%B7%20Inviragen%20Inc.&badge=phase%201 INV21 Low Dose INV21 Low Dose · Inviragen Inc. https://druglandscape.com/drug/invaplex-ar-detox https://druglandscape.com/api/og?type=drug&title=Invaplex%5BAR-DETOX%5D&subtitle=Invaplex%5BAR-DETOX%5D%20%C2%B7%20PATH&badge=phase%201 Invaplex[AR-DETOX] Invaplex[AR-DETOX] · PATH https://druglandscape.com/drug/investigational-aiiv4c https://druglandscape.com/api/og?type=drug&title=Investigational%20aIIV4c&subtitle=Investigational%20aIIV4c%20%C2%B7%20Seqirus&badge=phase%202 Investigational aIIV4c Investigational aIIV4c · Seqirus https://druglandscape.com/drug/investigational-cancer-drug https://druglandscape.com/api/og?type=drug&title=Investigational%20Cancer%20Drug&subtitle=Investigational%20Cancer%20Drug%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Investigational Cancer Drug Investigational Cancer Drug · GlaxoSmithKline https://druglandscape.com/drug/investigational-covid-19-vaccine-1 https://druglandscape.com/api/og?type=drug&title=Investigational%20COVID-19%20Vaccine%201&subtitle=Investigational%20COVID-19%20Vaccine%201%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 Investigational COVID-19 Vaccine 1 Investigational COVID-19 Vaccine 1 · ModernaTX, Inc. https://druglandscape.com/drug/investigational-h7n9-vaccine-gsk3206640a https://druglandscape.com/api/og?type=drug&title=Investigational%20H7N9%20vaccine%20GSK3206640A&subtitle=Investigational%20H7N9%20vaccine%20GSK3206640A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Investigational H7N9 vaccine GSK3206640A Investigational H7N9 vaccine GSK3206640A · GlaxoSmithKline https://druglandscape.com/drug/investigational-h9n2-vaccine-gsk2654909a https://druglandscape.com/api/og?type=drug&title=Investigational%20H9N2%20vaccine%20GSK2654909A&subtitle=Investigational%20H9N2%20vaccine%20GSK2654909A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Investigational H9N2 vaccine GSK2654909A Investigational H9N2 vaccine GSK2654909A · GlaxoSmithKline https://druglandscape.com/drug/investigational-h9n2-vaccine-gsk2654911a https://druglandscape.com/api/og?type=drug&title=Investigational%20H9N2%20vaccine%20GSK2654911A&subtitle=Investigational%20H9N2%20vaccine%20GSK2654911A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Investigational H9N2 vaccine GSK2654911A Investigational H9N2 vaccine GSK2654911A · GlaxoSmithKline https://druglandscape.com/drug/investigational-influenza-vaccine-2 https://druglandscape.com/api/og?type=drug&title=Investigational%20Influenza%20Vaccine%202&subtitle=Investigational%20Influenza%20Vaccine%202%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 Investigational Influenza Vaccine 2 Investigational Influenza Vaccine 2 · ModernaTX, Inc. https://druglandscape.com/drug/investigational-rsv-vaccine-1 https://druglandscape.com/api/og?type=drug&title=Investigational%20RSV%20vaccine%201&subtitle=Investigational%20RSV%20vaccine%201%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Investigational RSV vaccine 1 Investigational RSV vaccine 1 · GlaxoSmithKline https://druglandscape.com/drug/investigational-rsv-vaccine-4 https://druglandscape.com/api/og?type=drug&title=Investigational%20RSV%20vaccine%204&subtitle=Investigational%20RSV%20vaccine%204%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Investigational RSV vaccine 4 Investigational RSV vaccine 4 · GlaxoSmithKline https://druglandscape.com/drug/investigational-rsv-vaccine-5 https://druglandscape.com/api/og?type=drug&title=Investigational%20RSV%20vaccine%205&subtitle=Investigational%20RSV%20vaccine%205%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Investigational RSV vaccine 5 Investigational RSV vaccine 5 · GlaxoSmithKline https://druglandscape.com/drug/investigational-rsv-vaccine-6 https://druglandscape.com/api/og?type=drug&title=Investigational%20RSV%20vaccine%206&subtitle=Investigational%20RSV%20vaccine%206%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Investigational RSV vaccine 6 Investigational RSV vaccine 6 · GlaxoSmithKline https://druglandscape.com/drug/investigational-varicella-vaccine-high-potency https://druglandscape.com/api/og?type=drug&title=Investigational%20varicella%20vaccine%20high%20potency&subtitle=Investigational%20varicella%20vaccine%20high%20potency%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Investigational varicella vaccine high potency Investigational varicella vaccine high potency · GlaxoSmithKline https://druglandscape.com/drug/investigational-varicella-vaccine-medium-potency https://druglandscape.com/api/og?type=drug&title=Investigational%20varicella%20vaccine%20medium%20potency&subtitle=Investigational%20varicella%20vaccine%20medium%20potency%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Investigational varicella vaccine medium potency Investigational varicella vaccine medium potency · GlaxoSmithKline https://druglandscape.com/drug/investigator-choice-of-standard-therapy https://druglandscape.com/api/og?type=drug&title=Investigator%20choice%20of%20standard%20therapy&subtitle=Investigator%20choice%20of%20standard%20therapy%20%C2%B7%20iOnctura&badge=phase%202 Investigator choice of standard therapy Investigator choice of standard therapy · iOnctura https://druglandscape.com/drug/investigator-s-choice-of-soc https://druglandscape.com/api/og?type=drug&title=Investigator's%20choice%20of%20SOC&subtitle=Investigator's%20choice%20of%20SOC%20%C2%B7%20CSPC%20Megalith%20Biopharmaceutical%20Co.%2CLtd.&badge=phase%202 Investigator's choice of SOC Investigator's choice of SOC · CSPC Megalith Biopharmaceutical Co.,Ltd. https://druglandscape.com/drug/investigator-s-choice-treatment https://druglandscape.com/api/og?type=drug&title=Investigator's%20Choice%20Treatment&subtitle=Investigator's%20Choice%20Treatment%20%C2%B7%20Shanghai%20Runshi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd&badge=phase%202 Investigator's Choice Treatment Investigator's Choice Treatment · Shanghai Runshi Pharmaceutical Technology Co., Ltd https://druglandscape.com/drug/inxn-4001 https://druglandscape.com/api/og?type=drug&title=INXN-4001&subtitle=INXN-4001%20%C2%B7%20Triple-Gene%2C%20LLC&badge=phase%201 INXN-4001 INXN-4001 · Triple-Gene, LLC https://druglandscape.com/drug/io-202 https://druglandscape.com/api/og?type=drug&title=IO-202&subtitle=IO-202%20%C2%B7%20Immune-Onc%20Therapeutics&badge=phase%201 IO-202 IO-202 · Immune-Onc Therapeutics https://druglandscape.com/drug/io-202-and-azacitidine https://druglandscape.com/api/og?type=drug&title=IO-202%20and%20Azacitidine&subtitle=IO-202%20and%20Azacitidine%20%C2%B7%20Immune-Onc%20Therapeutics&badge=phase%201 IO-202 and Azacitidine IO-202 and Azacitidine · Immune-Onc Therapeutics https://druglandscape.com/drug/ioa-244 https://druglandscape.com/api/og?type=drug&title=IOA-244&subtitle=IOA-244%20%C2%B7%20iOnctura&badge=phase%201 IOA-244 IOA-244 · iOnctura https://druglandscape.com/drug/ioa-289 https://druglandscape.com/api/og?type=drug&title=IOA-289&subtitle=IOA-289%20%C2%B7%20iOnctura&badge=phase%201 IOA-289 IOA-289 · iOnctura https://druglandscape.com/drug/iobitridol-350 https://druglandscape.com/api/og?type=drug&title=Iobitridol%20350&subtitle=Iobitridol%20350%20%C2%B7%20Azienda%20Sanitaria%20Locale%209%2C%20Grosseto&badge=phase%201 Iobitridol 350 Iobitridol 350 · Azienda Sanitaria Locale 9, Grosseto https://druglandscape.com/drug/iocide-oral-rinse https://druglandscape.com/api/og?type=drug&title=Iocide%20Oral%20Rinse&subtitle=Iocide%20Oral%20Rinse%20%C2%B7%20Biomedical%20Development%20Corporation&badge=phase%202 Iocide Oral Rinse Iocide Oral Rinse · Biomedical Development Corporation https://druglandscape.com/drug/iodinated-contrast-agent https://druglandscape.com/api/og?type=drug&title=iodinated%20contrast%20agent&subtitle=iodinated%20contrast%20agent%20%C2%B7%20Bracco%20Diagnostics%2C%20Inc&badge=phase%202 iodinated contrast agent iodinated contrast agent · Bracco Diagnostics, Inc https://druglandscape.com/drug/iodinated-contrast-dye https://druglandscape.com/api/og?type=drug&title=iodinated%20contrast%20dye&subtitle=iodinated%20contrast%20dye%20%C2%B7%20American%20College%20of%20Radiology%20Imaging%20Network&badge=phase%202 iodinated contrast dye iodinated contrast dye · American College of Radiology Imaging Network https://druglandscape.com/drug/iodine-i-124-monoclonal-antibody-m5a https://druglandscape.com/api/og?type=drug&title=Iodine%20I%20124%20Monoclonal%20Antibody%20M5A&subtitle=Iodine%20I%20124%20Monoclonal%20Antibody%20M5A%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%201 Iodine I 124 Monoclonal Antibody M5A Iodine I 124 Monoclonal Antibody M5A · City of Hope Medical Center https://druglandscape.com/drug/ion224 https://druglandscape.com/api/og?type=drug&title=ION224&subtitle=ION224%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 ION224 ION224 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ion251 https://druglandscape.com/api/og?type=drug&title=ION251&subtitle=ION251%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ION251 ION251 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ion356 https://druglandscape.com/api/og?type=drug&title=ION356&subtitle=ION356%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ION356 ION356 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ion440 https://druglandscape.com/api/og?type=drug&title=ION440&subtitle=ION440%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ION440 ION440 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ion464 https://druglandscape.com/api/og?type=drug&title=ION464&subtitle=ION464%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ION464 ION464 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ion537 https://druglandscape.com/api/og?type=drug&title=ION537&subtitle=ION537%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ION537 ION537 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ion547 https://druglandscape.com/api/og?type=drug&title=ION547&subtitle=ION547%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ION547 ION547 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ion717 https://druglandscape.com/api/og?type=drug&title=ION717&subtitle=ION717%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ION717 ION717 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ion904 https://druglandscape.com/api/og?type=drug&title=ION904&subtitle=ION904%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 ION904 ION904 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ionis-agt-lrx https://druglandscape.com/api/og?type=drug&title=IONIS-AGT-LRx&subtitle=IONIS-AGT-LRx%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 IONIS-AGT-LRx IONIS-AGT-LRx · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ionis-enacrx https://druglandscape.com/api/og?type=drug&title=IONIS-ENaCRx&subtitle=IONIS-ENaCRx%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 IONIS-ENaCRx IONIS-ENaCRx · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ionis-fxi-lrx https://druglandscape.com/api/og?type=drug&title=IONIS%20FXI-LRx&subtitle=IONIS%20FXI-LRx%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 IONIS FXI-LRx IONIS FXI-LRx · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ionis-hbvrx https://druglandscape.com/api/og?type=drug&title=IONIS-HBVRx&subtitle=IONIS-HBVRx%20%C2%B7%20GlaxoSmithKline&badge=phase%202 IONIS-HBVRx IONIS-HBVRx · GlaxoSmithKline https://druglandscape.com/drug/ionis-maptrx https://druglandscape.com/api/og?type=drug&title=IONIS%20MAPTRx&subtitle=IONIS%20MAPTRx%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 IONIS MAPTRx IONIS MAPTRx · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ionis-stat3rx https://druglandscape.com/api/og?type=drug&title=IONIS-STAT3Rx&subtitle=IONIS-STAT3Rx%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 IONIS-STAT3Rx IONIS-STAT3Rx · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/ios-1002 https://druglandscape.com/api/og?type=drug&title=IOS-1002&subtitle=IOS-1002%20%C2%B7%20ImmunOs%20Therapeutics%20AG&badge=phase%201 IOS-1002 IOS-1002 · ImmunOs Therapeutics AG https://druglandscape.com/drug/iov-4001 https://druglandscape.com/api/og?type=drug&title=IOV-4001&subtitle=IOV-4001%20%C2%B7%20Iovance%20Biotherapeutics%2C%20Inc.&badge=phase%201 IOV-4001 IOV-4001 · Iovance Biotherapeutics, Inc. https://druglandscape.com/drug/ip-001 https://druglandscape.com/api/og?type=drug&title=IP-001&subtitle=IP-001%20%C2%B7%20M.R.%20Meijerink&badge=phase%201 IP-001 IP-001 · M.R. Meijerink https://druglandscape.com/drug/ip10-c8 https://druglandscape.com/api/og?type=drug&title=IP10.C8&subtitle=IP10.C8%20%C2%B7%20Immune%20Technologies%20%26%20Medicine%20GmbH&badge=phase%202 IP10.C8 IP10.C8 · Immune Technologies & Medicine GmbH https://druglandscape.com/drug/ipaq https://druglandscape.com/api/og?type=drug&title=IPAQ&subtitle=IPAQ%20%C2%B7%20UPECLIN%20HC%20FM%20Botucatu%20Unesp&badge=phase%201 IPAQ IPAQ · UPECLIN HC FM Botucatu Unesp https://druglandscape.com/drug/ipg1094 https://druglandscape.com/api/og?type=drug&title=IPG1094&subtitle=IPG1094%20%C2%B7%20Nanjing%20Immunophage%20Biotech%20Co.%2C%20Ltd&badge=phase%201 IPG1094 IPG1094 · Nanjing Immunophage Biotech Co., Ltd https://druglandscape.com/drug/ipg11406 https://druglandscape.com/api/og?type=drug&title=IPG11406&subtitle=IPG11406%20%C2%B7%20Nanjing%20Immunophage%20Biotech%20Co.%2C%20Ltd&badge=phase%201 IPG11406 IPG11406 · Nanjing Immunophage Biotech Co., Ltd https://druglandscape.com/drug/ipg7236 https://druglandscape.com/api/og?type=drug&title=IPG7236&subtitle=IPG7236%20%C2%B7%20Nanjing%20Immunophage%20Biotech%20Co.%2C%20Ltd&badge=phase%201 IPG7236 IPG7236 · Nanjing Immunophage Biotech Co., Ltd https://druglandscape.com/drug/iph5201 https://druglandscape.com/api/og?type=drug&title=IPH5201&subtitle=IPH5201%20%C2%B7%20MedImmune%20LLC&badge=phase%201 IPH5201 IPH5201 · MedImmune LLC https://druglandscape.com/drug/ipi-145-a-pi3k-inhibitor https://druglandscape.com/api/og?type=drug&title=IPI-145%2C%20a%20PI3K%20Inhibitor&subtitle=IPI-145%2C%20a%20PI3K%20Inhibitor%20%C2%B7%20SecuraBio&badge=phase%202 IPI-145, a PI3K Inhibitor IPI-145, a PI3K Inhibitor · SecuraBio https://druglandscape.com/drug/ipi-504-docetaxel https://druglandscape.com/api/og?type=drug&title=IPI-504%2C%20docetaxel&subtitle=IPI-504%2C%20docetaxel%20%C2%B7%20Infinity%20Pharmaceuticals%2C%20Inc.&badge=phase%201 IPI-504, docetaxel IPI-504, docetaxel · Infinity Pharmaceuticals, Inc. https://druglandscape.com/drug/ipi-504-plus-docetaxel https://druglandscape.com/api/og?type=drug&title=IPI%20504%20plus%20Docetaxel&subtitle=IPI%20504%20plus%20Docetaxel%20%C2%B7%20Infinity%20Pharmaceuticals%2C%20Inc.&badge=phase%202 IPI 504 plus Docetaxel IPI 504 plus Docetaxel · Infinity Pharmaceuticals, Inc. https://druglandscape.com/drug/ipi-926 https://druglandscape.com/api/og?type=drug&title=IPI-926&subtitle=IPI-926%20%C2%B7%20Infinity%20Pharmaceuticals%2C%20Inc.&badge=phase%202 IPI-926 IPI-926 · Infinity Pharmaceuticals, Inc. https://druglandscape.com/drug/ipi-926-plus-gemcitabine https://druglandscape.com/api/og?type=drug&title=IPI-926%20plus%20gemcitabine&subtitle=IPI-926%20plus%20gemcitabine%20%C2%B7%20Infinity%20Pharmaceuticals%2C%20Inc.&badge=phase%201 IPI-926 plus gemcitabine IPI-926 plus gemcitabine · Infinity Pharmaceuticals, Inc. https://druglandscape.com/drug/ipilimumab-and-fotemustine https://druglandscape.com/api/og?type=drug&title=Ipilimumab%20and%20Fotemustine&subtitle=Ipilimumab%20and%20Fotemustine%20%C2%B7%20Italian%20Network%20for%20Tumor%20Biotherapy&badge=phase%202 Ipilimumab and Fotemustine Ipilimumab and Fotemustine · Italian Network for Tumor Biotherapy https://druglandscape.com/drug/ipilimumab-it https://druglandscape.com/api/og?type=drug&title=Ipilimumab%20IT&subtitle=Ipilimumab%20IT%20%C2%B7%20Gustave%20Roussy%2C%20Cancer%20Campus%2C%20Grand%20Paris&badge=phase%201 Ipilimumab IT Ipilimumab IT · Gustave Roussy, Cancer Campus, Grand Paris https://druglandscape.com/drug/ipilimumab-iv https://druglandscape.com/api/og?type=drug&title=Ipilimumab%20IV&subtitle=Ipilimumab%20IV%20%C2%B7%20Gustave%20Roussy%2C%20Cancer%20Campus%2C%20Grand%20Paris&badge=phase%201 Ipilimumab IV Ipilimumab IV · Gustave Roussy, Cancer Campus, Grand Paris https://druglandscape.com/drug/ipm514 https://druglandscape.com/api/og?type=drug&title=IPM514&subtitle=IPM514%20%C2%B7%20Beijing%20Immupeutics%20Medicine%20Technology%20Limited&badge=phase%201 IPM514 IPM514 · Beijing Immupeutics Medicine Technology Limited https://druglandscape.com/drug/ipn01195 https://druglandscape.com/api/og?type=drug&title=IPN01195&subtitle=IPN01195%20%C2%B7%20Ipsen&badge=phase%201 IPN01195 IPN01195 · Ipsen https://druglandscape.com/drug/ipn01203 https://druglandscape.com/api/og?type=drug&title=IPN01203&subtitle=IPN01203%20%C2%B7%20Ipsen&badge=phase%201 IPN01203 IPN01203 · Ipsen https://druglandscape.com/drug/ipn10200-dose-a https://druglandscape.com/api/og?type=drug&title=IPN10200%20dose%20A&subtitle=IPN10200%20dose%20A%20%C2%B7%20Ipsen&badge=phase%202 IPN10200 dose A IPN10200 dose A · Ipsen https://druglandscape.com/drug/ipn60130 https://druglandscape.com/api/og?type=drug&title=IPN60130&subtitle=IPN60130%20%C2%B7%20Clementia%20Pharmaceuticals%20Inc.&badge=phase%202 IPN60130 IPN60130 · Clementia Pharmaceuticals Inc. https://druglandscape.com/drug/ipn60300 https://druglandscape.com/api/og?type=drug&title=IPN60300&subtitle=IPN60300%20%C2%B7%20Ipsen&badge=phase%201 IPN60300 IPN60300 · Ipsen https://druglandscape.com/drug/ipratropium-bromide-0-03-spray https://druglandscape.com/api/og?type=drug&title=ipratropium%20bromide%200.03%25%20spray&subtitle=ipratropium%20bromide%200.03%25%20spray%20%C2%B7%20Centre%20for%20Addiction%20and%20Mental%20Health&badge=phase%201 ipratropium bromide 0.03% spray ipratropium bromide 0.03% spray · Centre for Addiction and Mental Health https://druglandscape.com/drug/ipsc-cl https://druglandscape.com/api/og?type=drug&title=iPSC-CL&subtitle=iPSC-CL%20%C2%B7%20HeartWorks%2C%20Inc.&badge=phase%201 iPSC-CL iPSC-CL · HeartWorks, Inc. https://druglandscape.com/drug/ipt803 https://druglandscape.com/api/og?type=drug&title=IPT803&subtitle=IPT803%20%C2%B7%20Tools4Patient&badge=phase%201 IPT803 IPT803 · Tools4Patient https://druglandscape.com/drug/ipti-mefloquine https://druglandscape.com/api/og?type=drug&title=IPTi%20mefloquine&subtitle=IPTi%20mefloquine%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%202 IPTi mefloquine IPTi mefloquine · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/ipv-vaccine https://druglandscape.com/api/og?type=drug&title=IPV%20Vaccine&subtitle=IPV%20Vaccine%20%C2%B7%20PT%20Bio%20Farma&badge=phase%202 IPV Vaccine IPV Vaccine · PT Bio Farma https://druglandscape.com/drug/ipx056 https://druglandscape.com/api/og?type=drug&title=IPX056&subtitle=IPX056%20%C2%B7%20Impax%20Laboratories%2C%20LLC&badge=phase%202 IPX056 IPX056 · Impax Laboratories, LLC https://druglandscape.com/drug/iq-007 https://druglandscape.com/api/og?type=drug&title=iQ-007&subtitle=iQ-007%20%C2%B7%20iQure%20Australia%20Pty%20Ltd&badge=phase%201 iQ-007 iQ-007 · iQure Australia Pty Ltd https://druglandscape.com/drug/ir-cpi-dose-1 https://druglandscape.com/api/og?type=drug&title=Ir-CPI%20-%20Dose%201&subtitle=Ir-CPI%20-%20Dose%201%20%C2%B7%20Bioxodes%20S.A.&badge=phase%201 Ir-CPI - Dose 1 Ir-CPI - Dose 1 · Bioxodes S.A. https://druglandscape.com/drug/ir-morphine-sulphate https://druglandscape.com/api/og?type=drug&title=IR%20morphine%20sulphate&subtitle=IR%20morphine%20sulphate%20%C2%B7%20Mundipharma%20Research%20Limited&badge=phase%201 IR morphine sulphate IR morphine sulphate · Mundipharma Research Limited https://druglandscape.com/drug/ir-tablet-under-fasted-conditions https://druglandscape.com/api/og?type=drug&title=IR%20Tablet%20under%20Fasted%20conditions&subtitle=IR%20Tablet%20under%20Fasted%20conditions%20%C2%B7%20Nexgen%20Pharma%2C%20Inc&badge=phase%201 IR Tablet under Fasted conditions IR Tablet under Fasted conditions · Nexgen Pharma, Inc https://druglandscape.com/drug/ir-viloxazine https://druglandscape.com/api/og?type=drug&title=IR%20Viloxazine&subtitle=IR%20Viloxazine%20%C2%B7%20Supernus%20Pharmaceuticals%2C%20Inc.&badge=phase%201 IR Viloxazine IR Viloxazine · Supernus Pharmaceuticals, Inc. https://druglandscape.com/drug/irbesartan-high https://druglandscape.com/api/og?type=drug&title=Irbesartan%20High&subtitle=Irbesartan%20High%20%C2%B7%20Handok%20Inc.&badge=phase%201 Irbesartan High Irbesartan High · Handok Inc. https://druglandscape.com/drug/irbesartan-tablets https://druglandscape.com/api/og?type=drug&title=irbesartan%20tablets&subtitle=irbesartan%20tablets%20%C2%B7%20Jiangsu%20Famous%20Medical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 irbesartan tablets irbesartan tablets · Jiangsu Famous Medical Technology Co., Ltd. https://druglandscape.com/drug/irct https://druglandscape.com/api/og?type=drug&title=IRCT&subtitle=IRCT%20%C2%B7%20Pneumoflex%20Systems%2C%20LLC&badge=phase%202 IRCT IRCT · Pneumoflex Systems, LLC https://druglandscape.com/drug/irinotecan-capecitabine-oxaliplatin https://druglandscape.com/api/og?type=drug&title=Irinotecan-Capecitabine-Oxaliplatin&subtitle=Irinotecan-Capecitabine-Oxaliplatin%20%C2%B7%20AHS%20Cancer%20Control%20Alberta&badge=phase%202 Irinotecan-Capecitabine-Oxaliplatin Irinotecan-Capecitabine-Oxaliplatin · AHS Cancer Control Alberta https://druglandscape.com/drug/irinotecan-eluting-beads https://druglandscape.com/api/og?type=drug&title=Irinotecan-Eluting%20Beads&subtitle=Irinotecan-Eluting%20Beads%20%C2%B7%20Federation%20Francophone%20de%20Cancerologie%20Digestive&badge=phase%202 Irinotecan-Eluting Beads Irinotecan-Eluting Beads · Federation Francophone de Cancerologie Digestive https://druglandscape.com/drug/irinotecan-hydrochloride-injection-campto https://druglandscape.com/api/og?type=drug&title=Irinotecan%20Hydrochloride%20Injection%EF%BC%88CAMPTO%C2%AE%EF%BC%89&subtitle=Irinotecan%20Hydrochloride%20Injection%EF%BC%88CAMPTO%C2%AE%EF%BC%89%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 Irinotecan Hydrochloride Injection（CAMPTO®） Irinotecan Hydrochloride Injection（CAMPTO®） · Luye Pharma Group Ltd. https://druglandscape.com/drug/irinotecan-liposoma https://druglandscape.com/api/og?type=drug&title=Irinotecan%20liposoma&subtitle=Irinotecan%20liposoma%20%C2%B7%20Dai%2C%20Guanghai&badge=phase%201 Irinotecan liposoma Irinotecan liposoma · Dai, Guanghai https://druglandscape.com/drug/irinotecan-liposome-combined-with-bevacizumab https://druglandscape.com/api/og?type=drug&title=Irinotecan%20liposome%20combined%20with%20bevacizumab&subtitle=Irinotecan%20liposome%20combined%20with%20bevacizumab%20%C2%B7%20Zhifeng%20Tian%2CMD&badge=phase%202 Irinotecan liposome combined with bevacizumab Irinotecan liposome combined with bevacizumab · Zhifeng Tian,MD https://druglandscape.com/drug/irinotecan-only-and-sequential-cmab009 https://druglandscape.com/api/og?type=drug&title=Irinotecan-only%20and%20sequential-CMAB009&subtitle=Irinotecan-only%20and%20sequential-CMAB009%20%C2%B7%20Shanghai%20Zhangjiang%20Biotechnology%20Limited%20Company&badge=phase%202 Irinotecan-only and sequential-CMAB009 Irinotecan-only and sequential-CMAB009 · Shanghai Zhangjiang Biotechnology Limited Company https://druglandscape.com/drug/irinotecan-oxaliplatin-and-cetuximab https://druglandscape.com/api/og?type=drug&title=Irinotecan%2C%20oxaliplatin%2C%20and%20cetuximab&subtitle=Irinotecan%2C%20oxaliplatin%2C%20and%20cetuximab%20%C2%B7%20New%20Mexico%20Cancer%20Research%20Alliance&badge=phase%202 Irinotecan, oxaliplatin, and cetuximab Irinotecan, oxaliplatin, and cetuximab · New Mexico Cancer Research Alliance https://druglandscape.com/drug/irinotecan-plus-lobaplatin https://druglandscape.com/api/og?type=drug&title=irinotecan%20plus%20lobaplatin&subtitle=irinotecan%20plus%20lobaplatin%20%C2%B7%20ShengFa%20Su&badge=phase%202 irinotecan plus lobaplatin irinotecan plus lobaplatin · ShengFa Su https://druglandscape.com/drug/irl757 https://druglandscape.com/api/og?type=drug&title=IRL757&subtitle=IRL757%20%C2%B7%20Integrative%20Research%20Laboratories%20AB&badge=phase%201 IRL757 IRL757 · Integrative Research Laboratories AB https://druglandscape.com/drug/irl790 https://druglandscape.com/api/og?type=drug&title=IRL790&subtitle=IRL790%20%C2%B7%20Integrative%20Research%20Laboratories%20AB&badge=phase%201 IRL790 IRL790 · Integrative Research Laboratories AB https://druglandscape.com/drug/iron-folic-acid-supplement https://druglandscape.com/api/og?type=drug&title=Iron-folic%20acid%20supplement&subtitle=Iron-folic%20acid%20supplement%20%C2%B7%20Johns%20Hopkins%20Bloomberg%20School%20of%20Public%20Health&badge=phase%201 Iron-folic acid supplement Iron-folic acid supplement · Johns Hopkins Bloomberg School of Public Health https://druglandscape.com/drug/iron-preparation https://druglandscape.com/api/og?type=drug&title=Iron%20preparation&subtitle=Iron%20preparation%20%C2%B7%20HaEmek%20Medical%20Center%2C%20Israel&badge=phase%201 Iron preparation Iron preparation · HaEmek Medical Center, Israel https://druglandscape.com/drug/iron-sucrose-azad https://druglandscape.com/api/og?type=drug&title=Iron%20Sucrose%20Azad&subtitle=Iron%20Sucrose%20Azad%20%C2%B7%20Azad%20Pharma%20AG&badge=phase%201 Iron Sucrose Azad Iron Sucrose Azad · Azad Pharma AG https://druglandscape.com/drug/is-5-mn-r https://druglandscape.com/api/og?type=drug&title=IS-5-MN%20R&subtitle=IS-5-MN%20R%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 IS-5-MN R IS-5-MN R · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/is-5-mn-t1 https://druglandscape.com/api/og?type=drug&title=IS-5-MN%20T1&subtitle=IS-5-MN%20T1%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 IS-5-MN T1 IS-5-MN T1 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/isa104 https://druglandscape.com/api/og?type=drug&title=ISA104&subtitle=ISA104%20%C2%B7%20Erasmus%20Medical%20Center&badge=phase%201 ISA104 ISA104 · Erasmus Medical Center https://druglandscape.com/drug/isatuximab-dexamethasone https://druglandscape.com/api/og?type=drug&title=Isatuximab-dexamethasone&subtitle=Isatuximab-dexamethasone%20%C2%B7%20EMN%20Trial%20Office%20S.r.l.%20Impresa%20Sociale&badge=phase%202 Isatuximab-dexamethasone Isatuximab-dexamethasone · EMN Trial Office S.r.l. Impresa Sociale https://druglandscape.com/drug/isatuximab-sar650984-sc https://druglandscape.com/api/og?type=drug&title=isatuximab%20SAR650984%20SC&subtitle=isatuximab%20SAR650984%20SC%20%C2%B7%20Sanofi&badge=phase%201 isatuximab SAR650984 SC isatuximab SAR650984 SC · Sanofi https://druglandscape.com/drug/isatuximab-sc-obds https://druglandscape.com/api/og?type=drug&title=Isatuximab%20SC-OBDS&subtitle=Isatuximab%20SC-OBDS%20%C2%B7%20Sanofi&badge=phase%202 Isatuximab SC-OBDS Isatuximab SC-OBDS · Sanofi https://druglandscape.com/drug/isavuconazonium-sulfate-capsules https://druglandscape.com/api/og?type=drug&title=Isavuconazonium%20sulfate%20capsules&subtitle=Isavuconazonium%20sulfate%20capsules%20%C2%B7%20Astellas%20Pharma%20Global%20Development%2C%20Inc.&badge=phase%201 Isavuconazonium sulfate capsules Isavuconazonium sulfate capsules · Astellas Pharma Global Development, Inc. https://druglandscape.com/drug/isavuconazonium-sulfate-intravenous https://druglandscape.com/api/og?type=drug&title=isavuconazonium%20sulfate%20-%20intravenous&subtitle=isavuconazonium%20sulfate%20-%20intravenous%20%C2%B7%20Astellas%20Pharma%20Global%20Development%2C%20Inc.&badge=phase%201 isavuconazonium sulfate - intravenous isavuconazonium sulfate - intravenous · Astellas Pharma Global Development, Inc. https://druglandscape.com/drug/isavuconazonium-sulfate-iv https://druglandscape.com/api/og?type=drug&title=Isavuconazonium%20sulfate%20IV&subtitle=Isavuconazonium%20sulfate%20IV%20%C2%B7%20Astellas%20Pharma%20Global%20Development%2C%20Inc.&badge=phase%201 Isavuconazonium sulfate IV Isavuconazonium sulfate IV · Astellas Pharma Global Development, Inc. https://druglandscape.com/drug/isb-2001 https://druglandscape.com/api/og?type=drug&title=ISB%202001&subtitle=ISB%202001%20%C2%B7%20Ichnos%20Sciences%20SA&badge=phase%201 ISB 2001 ISB 2001 · Ichnos Sciences SA https://druglandscape.com/drug/isc-hpnsc https://druglandscape.com/api/og?type=drug&title=ISC-hpNSC&subtitle=ISC-hpNSC%20%C2%B7%20Cyto%20Therapeutics%20Pty%20Limited&badge=phase%201 ISC-hpNSC ISC-hpNSC · Cyto Therapeutics Pty Limited https://druglandscape.com/drug/iscador-p https://druglandscape.com/api/og?type=drug&title=Iscador*P&subtitle=Iscador*P%20%C2%B7%20Hackensack%20Meridian%20Health&badge=phase%202 Iscador*P Iscador*P · Hackensack Meridian Health https://druglandscape.com/drug/iscomatrix https://druglandscape.com/api/og?type=drug&title=ISCOMATRIX%E2%84%A2&subtitle=ISCOMATRIX%E2%84%A2%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 ISCOMATRIX™ ISCOMATRIX™ · Merck Sharp & Dohme LLC https://druglandscape.com/drug/isis-104838 https://druglandscape.com/api/og?type=drug&title=ISIS%20104838&subtitle=ISIS%20104838%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 ISIS 104838 ISIS 104838 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/isis-14803 https://druglandscape.com/api/og?type=drug&title=ISIS%2014803&subtitle=ISIS%2014803%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 ISIS 14803 ISIS 14803 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/isis-14803-peginterferon-alfa-ribavirin https://druglandscape.com/api/og?type=drug&title=ISIS%2014803%2C%20peginterferon%20alfa%2C%20ribavirin&subtitle=ISIS%2014803%2C%20peginterferon%20alfa%2C%20ribavirin%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ISIS 14803, peginterferon alfa, ribavirin ISIS 14803, peginterferon alfa, ribavirin · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/isis-325568 https://druglandscape.com/api/og?type=drug&title=ISIS%20325568&subtitle=ISIS%20325568%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ISIS 325568 ISIS 325568 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/isis-353512 https://druglandscape.com/api/og?type=drug&title=ISIS%20353512&subtitle=ISIS%20353512%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ISIS 353512 ISIS 353512 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/isis-388626 https://druglandscape.com/api/og?type=drug&title=ISIS%20388626&subtitle=ISIS%20388626%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ISIS 388626 ISIS 388626 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/isis-416858 https://druglandscape.com/api/og?type=drug&title=ISIS%20416858&subtitle=ISIS%20416858%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 ISIS 416858 ISIS 416858 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/isis-5132 https://druglandscape.com/api/og?type=drug&title=ISIS%205132&subtitle=ISIS%205132%20%C2%B7%20NCIC%20Clinical%20Trials%20Group&badge=phase%202 ISIS 5132 ISIS 5132 · NCIC Clinical Trials Group https://druglandscape.com/drug/isis-757456 https://druglandscape.com/api/og?type=drug&title=ISIS%20757456&subtitle=ISIS%20757456%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 ISIS 757456 ISIS 757456 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/isis-crp-rx https://druglandscape.com/api/og?type=drug&title=ISIS%20CRP%20Rx&subtitle=ISIS%20CRP%20Rx%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 ISIS CRP Rx ISIS CRP Rx · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/isis-eif4e-rx https://druglandscape.com/api/og?type=drug&title=ISIS%20EIF4E%20Rx&subtitle=ISIS%20EIF4E%20Rx%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ISIS EIF4E Rx ISIS EIF4E Rx · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/isis-fxirx-dose-3 https://druglandscape.com/api/og?type=drug&title=ISIS-FXIRx%20Dose%20%233&subtitle=ISIS-FXIRx%20Dose%20%233%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 ISIS-FXIRx Dose #3 ISIS-FXIRx Dose #3 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/isis-gcgrrx-dose-level-1 https://druglandscape.com/api/og?type=drug&title=ISIS-GCGRRx%20-%20Dose%20Level%201&subtitle=ISIS-GCGRRx%20-%20Dose%20Level%201%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 ISIS-GCGRRx - Dose Level 1 ISIS-GCGRRx - Dose Level 1 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/isis-gcgrrx-dose-level-2 https://druglandscape.com/api/og?type=drug&title=ISIS-GCGRRx%20-%20Dose%20Level%202&subtitle=ISIS-GCGRRx%20-%20Dose%20Level%202%20%C2%B7%20Ionis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 ISIS-GCGRRx - Dose Level 2 ISIS-GCGRRx - Dose Level 2 · Ionis Pharmaceuticals, Inc. https://druglandscape.com/drug/islet-body https://druglandscape.com/api/og?type=drug&title=islet%20body&subtitle=islet%20body%20%C2%B7%20Allife%20Medical%20Science%20and%20Technology%20Co.%2C%20Ltd.&badge=phase%201 islet body islet body · Allife Medical Science and Technology Co., Ltd. https://druglandscape.com/drug/ism3412 https://druglandscape.com/api/og?type=drug&title=ISM3412&subtitle=ISM3412%20%C2%B7%20InSilico%20Medicine%20Hong%20Kong%20Limited&badge=phase%201 ISM3412 ISM3412 · InSilico Medicine Hong Kong Limited https://druglandscape.com/drug/ism4808 https://druglandscape.com/api/og?type=drug&title=ISM4808&subtitle=ISM4808%20%C2%B7%20TaiGen%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 ISM4808 ISM4808 · TaiGen Biotechnology Co., Ltd. https://druglandscape.com/drug/ism5411 https://druglandscape.com/api/og?type=drug&title=ISM5411&subtitle=ISM5411%20%C2%B7%20InSilico%20Medicine%20Hong%20Kong%20Limited&badge=phase%201 ISM5411 ISM5411 · InSilico Medicine Hong Kong Limited https://druglandscape.com/drug/ism6331 https://druglandscape.com/api/og?type=drug&title=ISM6331&subtitle=ISM6331%20%C2%B7%20InSilico%20Medicine%20Hong%20Kong%20Limited&badge=phase%201 ISM6331 ISM6331 · InSilico Medicine Hong Kong Limited https://druglandscape.com/drug/ism8207 https://druglandscape.com/api/og?type=drug&title=ISM8207&subtitle=ISM8207%20%C2%B7%20InSilico%20Medicine%20Hong%20Kong%20Limited&badge=phase%201 ISM8207 ISM8207 · InSilico Medicine Hong Kong Limited https://druglandscape.com/drug/isobaric-ropivacaine https://druglandscape.com/api/og?type=drug&title=Isobaric%20ropivacaine&subtitle=Isobaric%20ropivacaine%20%C2%B7%20Mohamed%20Sayed%20Mohamed%20Abbas&badge=phase%201 Isobaric ropivacaine Isobaric ropivacaine · Mohamed Sayed Mohamed Abbas https://druglandscape.com/drug/isoflavone-supplement https://druglandscape.com/api/og?type=drug&title=Isoflavone%20supplement&subtitle=Isoflavone%20supplement%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%202 Isoflavone supplement Isoflavone supplement · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/isoflavones-enriched-foods https://druglandscape.com/api/og?type=drug&title=Isoflavones-enriched%20foods&subtitle=Isoflavones-enriched%20foods%20%C2%B7%20TNO&badge=phase%201 Isoflavones-enriched foods Isoflavones-enriched foods · TNO https://druglandscape.com/drug/isoflurane-inhal-soln https://druglandscape.com/api/og?type=drug&title=Isoflurane%20Inhal%20Soln&subtitle=Isoflurane%20Inhal%20Soln%20%C2%B7%20A.O.U.%20Citt%C3%A0%20della%20Salute%20e%20della%20Scienza&badge=phase%202 Isoflurane Inhal Soln Isoflurane Inhal Soln · A.O.U. Città della Salute e della Scienza https://druglandscape.com/drug/isoglycemic-clamp https://druglandscape.com/api/og?type=drug&title=Isoglycemic%20Clamp&subtitle=Isoglycemic%20Clamp%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Isoglycemic Clamp Isoglycemic Clamp · Merck Sharp & Dohme LLC https://druglandscape.com/drug/isolation-of-multipotent-cells https://druglandscape.com/api/og?type=drug&title=Isolation%20of%20multipotent%20cells&subtitle=Isolation%20of%20multipotent%20cells%20%C2%B7%20I.R.C.C.S%20Ospedale%20Galeazzi-Sant'Ambrogio&badge=phase%202 Isolation of multipotent cells Isolation of multipotent cells · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio https://druglandscape.com/drug/isonep https://druglandscape.com/api/og?type=drug&title=iSONEP&subtitle=iSONEP%20%C2%B7%20Lpath%2C%20Inc.&badge=phase%201 iSONEP iSONEP · Lpath, Inc. https://druglandscape.com/drug/isoniazid-treatment https://druglandscape.com/api/og?type=drug&title=Isoniazid%20treatment&subtitle=Isoniazid%20treatment%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 Isoniazid treatment Isoniazid treatment · Asan Medical Center https://druglandscape.com/drug/isoniazid-with-huexc030-and-rze https://druglandscape.com/api/og?type=drug&title=Isoniazid%20with%20HUEXC030%20and%20RZE&subtitle=Isoniazid%20with%20HUEXC030%20and%20RZE%20%C2%B7%20Orient%20Pharma%20Co.%2C%20Ltd.&badge=phase%202 Isoniazid with HUEXC030 and RZE Isoniazid with HUEXC030 and RZE · Orient Pharma Co., Ltd. https://druglandscape.com/drug/isoquercetin-or-quercetin https://druglandscape.com/api/og?type=drug&title=isoquercetin%20or%20quercetin&subtitle=isoquercetin%20or%20quercetin%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%201 isoquercetin or quercetin isoquercetin or quercetin · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/isosorbide-oral-solution https://druglandscape.com/api/og?type=drug&title=Isosorbide%20oral%20solution&subtitle=Isosorbide%20oral%20solution%20%C2%B7%20Lunan%20Better%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%202 Isosorbide oral solution Isosorbide oral solution · Lunan Better Pharmaceutical Co., LTD. https://druglandscape.com/drug/isoton-sodium-chloride https://druglandscape.com/api/og?type=drug&title=Isoton%20sodium%20chloride&subtitle=Isoton%20sodium%20chloride%20%C2%B7%20Danish%20Headache%20Center&badge=phase%201 Isoton sodium chloride Isoton sodium chloride · Danish Headache Center https://druglandscape.com/drug/isotretinoin-reference-medication-1 https://druglandscape.com/api/og?type=drug&title=Isotretinoin%3A%20Reference%20Medication%201&subtitle=Isotretinoin%3A%20Reference%20Medication%201%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Isotretinoin: Reference Medication 1 Isotretinoin: Reference Medication 1 · GlaxoSmithKline https://druglandscape.com/drug/isotretinoin-reference-medication-2 https://druglandscape.com/api/og?type=drug&title=Isotretinoin%3A%20Reference%20Medication%202&subtitle=Isotretinoin%3A%20Reference%20Medication%202%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Isotretinoin: Reference Medication 2 Isotretinoin: Reference Medication 2 · GlaxoSmithKline https://druglandscape.com/drug/isotretinoin-test-medication https://druglandscape.com/api/og?type=drug&title=Isotretinoin%3A%20Test%20Medication&subtitle=Isotretinoin%3A%20Test%20Medication%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Isotretinoin: Test Medication Isotretinoin: Test Medication · GlaxoSmithKline https://druglandscape.com/drug/ista-tears https://druglandscape.com/api/og?type=drug&title=ISTA%20Tears&subtitle=ISTA%20Tears%20%C2%B7%20Bausch%20%26%20Lomb%20Incorporated&badge=phase%201 ISTA Tears ISTA Tears · Bausch & Lomb Incorporated https://druglandscape.com/drug/isu104 https://druglandscape.com/api/og?type=drug&title=ISU104&subtitle=ISU104%20%C2%B7%20ISU%20Abxis%20Co.%2C%20Ltd.&badge=phase%201 ISU104 ISU104 · ISU Abxis Co., Ltd. https://druglandscape.com/drug/it-pil12-ep https://druglandscape.com/api/og?type=drug&title=IT-pIL12-EP&subtitle=IT-pIL12-EP%20%C2%B7%20OncoSec%20Medical%20Incorporated&badge=phase%201 IT-pIL12-EP IT-pIL12-EP · OncoSec Medical Incorporated https://druglandscape.com/drug/itc-6146ro https://druglandscape.com/api/og?type=drug&title=ITC-6146RO&subtitle=ITC-6146RO%20%C2%B7%20IntoCell%2C%20Inc&badge=phase%201 ITC-6146RO ITC-6146RO · IntoCell, Inc https://druglandscape.com/drug/itepekimab-ai https://druglandscape.com/api/og?type=drug&title=Itepekimab%20AI&subtitle=Itepekimab%20AI%20%C2%B7%20Sanofi&badge=phase%201 Itepekimab AI Itepekimab AI · Sanofi https://druglandscape.com/drug/itepekimab-pfs https://druglandscape.com/api/og?type=drug&title=Itepekimab%20PFS&subtitle=Itepekimab%20PFS%20%C2%B7%20Sanofi&badge=phase%201 Itepekimab PFS Itepekimab PFS · Sanofi https://druglandscape.com/drug/iti-1001 https://druglandscape.com/api/og?type=drug&title=ITI-1001&subtitle=ITI-1001%20%C2%B7%20Immunomic%20Therapeutics%2C%20Inc.&badge=phase%201 ITI-1001 ITI-1001 · Immunomic Therapeutics, Inc. https://druglandscape.com/drug/iti-214 https://druglandscape.com/api/og?type=drug&title=ITI-214&subtitle=ITI-214%20%C2%B7%20Intra-Cellular%20Therapies%2C%20Inc.&badge=phase%201 ITI-214 ITI-214 · Intra-Cellular Therapies, Inc. https://druglandscape.com/drug/iti-333 https://druglandscape.com/api/og?type=drug&title=ITI-333&subtitle=ITI-333%20%C2%B7%20Intra-Cellular%20Therapies%2C%20Inc.&badge=phase%201 ITI-333 ITI-333 · Intra-Cellular Therapies, Inc. https://druglandscape.com/drug/itolizumab-bmab-600 https://druglandscape.com/api/og?type=drug&title=Itolizumab%20%5BBmab%20600%5D&subtitle=Itolizumab%20%5BBmab%20600%5D%20%C2%B7%20Equillium&badge=phase%201 Itolizumab [Bmab 600] Itolizumab [Bmab 600] · Equillium https://druglandscape.com/drug/itraconazole-capsules https://druglandscape.com/api/og?type=drug&title=Itraconazole%20Capsules&subtitle=Itraconazole%20Capsules%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Itraconazole Capsules Itraconazole Capsules · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/itraconazole-oral-product https://druglandscape.com/api/og?type=drug&title=Itraconazole%20Oral%20Product&subtitle=Itraconazole%20Oral%20Product%20%C2%B7%20Gynaecologisch%20Oncologisch%20Centrum%20Zuid&badge=phase%202 Itraconazole Oral Product Itraconazole Oral Product · Gynaecologisch Oncologisch Centrum Zuid https://druglandscape.com/drug/itraconazole-shr0302-tablets https://druglandscape.com/api/og?type=drug&title=itraconazole%E3%80%81%20SHR0302%20tablets&subtitle=itraconazole%E3%80%81%20SHR0302%20tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 itraconazole、 SHR0302 tablets itraconazole、 SHR0302 tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/iv-14c-labeled-pf-06700841 https://druglandscape.com/api/og?type=drug&title=IV%2014C-labeled%20PF-06700841&subtitle=IV%2014C-labeled%20PF-06700841%20%C2%B7%20Pfizer&badge=phase%201 IV 14C-labeled PF-06700841 IV 14C-labeled PF-06700841 · Pfizer https://druglandscape.com/drug/iv-antibiotic-treatment-from-prior https://druglandscape.com/api/og?type=drug&title=IV%20antibiotic%20treatment%20from%20prior&subtitle=IV%20antibiotic%20treatment%20from%20prior%20%C2%B7%20Methodist%20Health%20System&badge=phase%202 IV antibiotic treatment from prior IV antibiotic treatment from prior · Methodist Health System https://druglandscape.com/drug/iv-baclofen https://druglandscape.com/api/og?type=drug&title=IV%20Baclofen&subtitle=IV%20Baclofen%20%C2%B7%20Allaysis%2C%20LLC&badge=phase%201 IV Baclofen IV Baclofen · Allaysis, LLC https://druglandscape.com/drug/iv-bisphosphonate-q-4-weeks https://druglandscape.com/api/og?type=drug&title=IV%20Bisphosphonate%20q%204%20weeks&subtitle=IV%20Bisphosphonate%20q%204%20weeks%20%C2%B7%20Amgen&badge=phase%202 IV Bisphosphonate q 4 weeks IV Bisphosphonate q 4 weeks · Amgen https://druglandscape.com/drug/iv-bisphosphonates https://druglandscape.com/api/og?type=drug&title=IV%20Bisphosphonates&subtitle=IV%20Bisphosphonates%20%C2%B7%20Amgen&badge=phase%202 IV Bisphosphonates IV Bisphosphonates · Amgen https://druglandscape.com/drug/iv-bolus-etoposide https://druglandscape.com/api/og?type=drug&title=IV%20Bolus%20Etoposide&subtitle=IV%20Bolus%20Etoposide%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%202 IV Bolus Etoposide IV Bolus Etoposide · Baylor College of Medicine https://druglandscape.com/drug/iv-dexamethasone-therapy https://druglandscape.com/api/og?type=drug&title=IV%20Dexamethasone%20Therapy&subtitle=IV%20Dexamethasone%20Therapy%20%C2%B7%20Hillel%20Yaffe%20Medical%20Center&badge=phase%201 IV Dexamethasone Therapy IV Dexamethasone Therapy · Hillel Yaffe Medical Center https://druglandscape.com/drug/iv-dhe https://druglandscape.com/api/og?type=drug&title=IV%20DHE&subtitle=IV%20DHE%20%C2%B7%20Allergan&badge=phase%201 IV DHE IV DHE · Allergan https://druglandscape.com/drug/iv-diuretic https://druglandscape.com/api/og?type=drug&title=IV%20diuretic&subtitle=IV%20diuretic%20%C2%B7%20Nuwellis%2C%20Inc.&badge=phase%201 IV diuretic IV diuretic · Nuwellis, Inc. https://druglandscape.com/drug/iv-durvalumab https://druglandscape.com/api/og?type=drug&title=IV%20durvalumab&subtitle=IV%20durvalumab%20%C2%B7%20AstraZeneca&badge=phase%201 IV durvalumab IV durvalumab · AstraZeneca https://druglandscape.com/drug/iv-fludarabine https://druglandscape.com/api/og?type=drug&title=IV%20Fludarabine&subtitle=IV%20Fludarabine%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 IV Fludarabine IV Fludarabine · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/iv-fluorescein-administration https://druglandscape.com/api/og?type=drug&title=IV%20fluorescein%20administration&subtitle=IV%20fluorescein%20administration%20%C2%B7%20IHU%20Strasbourg&badge=phase%201 IV fluorescein administration IV fluorescein administration · IHU Strasbourg https://druglandscape.com/drug/iv-gc4419 https://druglandscape.com/api/og?type=drug&title=IV%20GC4419&subtitle=IV%20GC4419%20%C2%B7%20Galera%20Therapeutics%2C%20Inc.&badge=phase%201 IV GC4419 IV GC4419 · Galera Therapeutics, Inc. https://druglandscape.com/drug/iv-gc4711 https://druglandscape.com/api/og?type=drug&title=IV%20GC4711&subtitle=IV%20GC4711%20%C2%B7%20Galera%20Therapeutics%2C%20Inc.&badge=phase%201 IV GC4711 IV GC4711 · Galera Therapeutics, Inc. https://druglandscape.com/drug/iv-glucose-5 https://druglandscape.com/api/og?type=drug&title=IV%20glucose%205%25&subtitle=IV%20glucose%205%25%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 IV glucose 5% IV glucose 5% · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/iv-ict01 https://druglandscape.com/api/og?type=drug&title=IV%20ICT01&subtitle=IV%20ICT01%20%C2%B7%20ImCheck%20Therapeutics&badge=phase%201 IV ICT01 IV ICT01 · ImCheck Therapeutics https://druglandscape.com/drug/iv-insulin-drip https://druglandscape.com/api/og?type=drug&title=IV%20Insulin%20drip&subtitle=IV%20Insulin%20drip%20%C2%B7%20American%20Heart%20Association&badge=phase%201 IV Insulin drip IV Insulin drip · American Heart Association https://druglandscape.com/drug/iv-iron-dextran https://druglandscape.com/api/og?type=drug&title=IV%20iron%20dextran&subtitle=IV%20iron%20dextran%20%C2%B7%20Amgen&badge=phase%202 IV iron dextran IV iron dextran · Amgen https://druglandscape.com/drug/iv-meperidine https://druglandscape.com/api/og?type=drug&title=IV%20Meperidine&subtitle=IV%20Meperidine%20%C2%B7%20HaEmek%20Medical%20Center%2C%20Israel&badge=phase%201 IV Meperidine IV Meperidine · HaEmek Medical Center, Israel https://druglandscape.com/drug/iv-methylnaltrexone https://druglandscape.com/api/og?type=drug&title=IV%20Methylnaltrexone&subtitle=IV%20Methylnaltrexone%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%202 IV Methylnaltrexone IV Methylnaltrexone · Bausch Health Americas, Inc. https://druglandscape.com/drug/iv-methylprednisolone-pulses https://druglandscape.com/api/og?type=drug&title=IV%20Methylprednisolone%20pulses&subtitle=IV%20Methylprednisolone%20pulses%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 IV Methylprednisolone pulses IV Methylprednisolone pulses · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/iv-sodium-chloride-0-9 https://druglandscape.com/api/og?type=drug&title=IV%20Sodium%20Chloride%200.9%20%25&subtitle=IV%20Sodium%20Chloride%200.9%20%25%20%C2%B7%20Pr.%20Nicolas%20GIRERD&badge=phase%202 IV Sodium Chloride 0.9 % IV Sodium Chloride 0.9 % · Pr. Nicolas GIRERD https://druglandscape.com/drug/iv-tedizolid-phosphate https://druglandscape.com/api/og?type=drug&title=IV%20Tedizolid%20Phosphate&subtitle=IV%20Tedizolid%20Phosphate%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 IV Tedizolid Phosphate IV Tedizolid Phosphate · Merck Sharp & Dohme LLC https://druglandscape.com/drug/iv-thyroxin https://druglandscape.com/api/og?type=drug&title=IV%20thyroxin&subtitle=IV%20thyroxin%20%C2%B7%20Rambam%20Health%20Care%20Campus&badge=phase%201 IV thyroxin IV thyroxin · Rambam Health Care Campus https://druglandscape.com/drug/iv-wck771 https://druglandscape.com/api/og?type=drug&title=IV%20WCK771&subtitle=IV%20WCK771%20%C2%B7%20Wockhardt&badge=phase%201 IV WCK771 IV WCK771 · Wockhardt https://druglandscape.com/drug/ivac-w-bre1-uid https://druglandscape.com/api/og?type=drug&title=IVAC_W_bre1_uID&subtitle=IVAC_W_bre1_uID%20%C2%B7%20BioNTech%20SE&badge=phase%201 IVAC_W_bre1_uID IVAC_W_bre1_uID · BioNTech SE https://druglandscape.com/drug/ivacflu https://druglandscape.com/api/og?type=drug&title=IVACFLU&subtitle=IVACFLU%20%C2%B7%20PATH&badge=phase%201 IVACFLU IVACFLU · PATH https://druglandscape.com/drug/ivermectin-and-doxycyline https://druglandscape.com/api/og?type=drug&title=Ivermectin%20and%20Doxycyline&subtitle=Ivermectin%20and%20Doxycyline%20%C2%B7%20Alkarkh%20Health%20Directorate-Baghdad&badge=phase%201 Ivermectin and Doxycyline Ivermectin and Doxycyline · Alkarkh Health Directorate-Baghdad https://druglandscape.com/drug/ivermectin-treatment-conditioner https://druglandscape.com/api/og?type=drug&title=ivermectin%20treatment%20conditioner&subtitle=ivermectin%20treatment%20conditioner%20%C2%B7%20Topaz%20Pharmaceuticals%20Inc&badge=phase%202 ivermectin treatment conditioner ivermectin treatment conditioner · Topaz Pharmaceuticals Inc https://druglandscape.com/drug/ivl3001 https://druglandscape.com/api/og?type=drug&title=IVL3001&subtitle=IVL3001%20%C2%B7%20Inventage%20Lab.%2C%20Inc.&badge=phase%201 IVL3001 IVL3001 · Inventage Lab., Inc. https://druglandscape.com/drug/ivl3003 https://druglandscape.com/api/og?type=drug&title=IVL3003&subtitle=IVL3003%20%C2%B7%20Inventage%20Lab.%2C%20Inc.&badge=phase%201 IVL3003 IVL3003 · Inventage Lab., Inc. https://druglandscape.com/drug/ivl4002 https://druglandscape.com/api/og?type=drug&title=IVL4002&subtitle=IVL4002%20%C2%B7%20Inventage%20Lab.%2C%20Inc.&badge=phase%201 IVL4002 IVL4002 · Inventage Lab., Inc. https://druglandscape.com/drug/ivmed-85 https://druglandscape.com/api/og?type=drug&title=IVMED%2085&subtitle=IVMED%2085%20%C2%B7%20iVeena%20Delivery%20Systems%2C%20Inc.&badge=phase%201 IVMED 85 IVMED 85 · iVeena Delivery Systems, Inc. https://druglandscape.com/drug/ivosidenib-and-nivolumab https://druglandscape.com/api/og?type=drug&title=ivosidenib%20and%20nivolumab&subtitle=ivosidenib%20and%20nivolumab%20%C2%B7%20Jason%20J.%20Luke%2C%20MD&badge=phase%202 ivosidenib and nivolumab ivosidenib and nivolumab · Jason J. Luke, MD https://druglandscape.com/drug/ivt-gbs-06 https://druglandscape.com/api/og?type=drug&title=IVT%20GBS-06&subtitle=IVT%20GBS-06%20%C2%B7%20Inventprise%20Inc.&badge=phase%201 IVT GBS-06 IVT GBS-06 · Inventprise Inc. https://druglandscape.com/drug/ivt-pcv-25 https://druglandscape.com/api/og?type=drug&title=IVT%20PCV-25&subtitle=IVT%20PCV-25%20%C2%B7%20Inventprise%20Inc.&badge=phase%201 IVT PCV-25 IVT PCV-25 · Inventprise Inc. https://druglandscape.com/drug/ivt-pcv-25-formulation-a https://druglandscape.com/api/og?type=drug&title=IVT%20PCV-25%20Formulation%20A&subtitle=IVT%20PCV-25%20Formulation%20A%20%C2%B7%20Inventprise%20Inc.&badge=phase%202 IVT PCV-25 Formulation A IVT PCV-25 Formulation A · Inventprise Inc. https://druglandscape.com/drug/ivt-pcv-25-formulation-b https://druglandscape.com/api/og?type=drug&title=IVT%20PCV-25%20Formulation%20B&subtitle=IVT%20PCV-25%20Formulation%20B%20%C2%B7%20Inventprise%20Inc.&badge=phase%202 IVT PCV-25 Formulation B IVT PCV-25 Formulation B · Inventprise Inc. https://druglandscape.com/drug/ivt-shigella-04 https://druglandscape.com/api/og?type=drug&title=IVT%20Shigella-04&subtitle=IVT%20Shigella-04%20%C2%B7%20Inventprise%20Inc.&badge=phase%201 IVT Shigella-04 IVT Shigella-04 · Inventprise Inc. https://druglandscape.com/drug/ivw-1001-ophthalmic-eyelid-wipe https://druglandscape.com/api/og?type=drug&title=IVW-1001%20Ophthalmic%20Eyelid%20Wipe&subtitle=IVW-1001%20Ophthalmic%20Eyelid%20Wipe%20%C2%B7%20IVIEW%20Therapeutics%20Inc.&badge=phase%202 IVW-1001 Ophthalmic Eyelid Wipe IVW-1001 Ophthalmic Eyelid Wipe · IVIEW Therapeutics Inc. https://druglandscape.com/drug/ivw-1001-ophthalmic-eyelid-wipe-0-1 https://druglandscape.com/api/og?type=drug&title=IVW-1001%20Ophthalmic%20Eyelid%20Wipe%200.1%25&subtitle=IVW-1001%20Ophthalmic%20Eyelid%20Wipe%200.1%25%20%C2%B7%20IVIEW%20Therapeutics%20Inc.&badge=phase%201 IVW-1001 Ophthalmic Eyelid Wipe 0.1% IVW-1001 Ophthalmic Eyelid Wipe 0.1% · IVIEW Therapeutics Inc. https://druglandscape.com/drug/ivx-121 https://druglandscape.com/api/og?type=drug&title=IVX-121&subtitle=IVX-121%20%C2%B7%20Icosavax%2C%20Inc.&badge=phase%201 IVX-121 IVX-121 · Icosavax, Inc. https://druglandscape.com/drug/ivx-241 https://druglandscape.com/api/og?type=drug&title=IVX-241&subtitle=IVX-241%20%C2%B7%20Icosavax%2C%20Inc.&badge=phase%201 IVX-241 IVX-241 · Icosavax, Inc. https://druglandscape.com/drug/ivx-a12 https://druglandscape.com/api/og?type=drug&title=IVX-A12&subtitle=IVX-A12%20%C2%B7%20Icosavax%2C%20Inc.&badge=phase%202 IVX-A12 IVX-A12 · Icosavax, Inc. https://druglandscape.com/drug/ivx037 https://druglandscape.com/api/og?type=drug&title=IVX037&subtitle=IVX037%20%C2%B7%20ImmVirx%20Pty%20Ltd&badge=phase%201 IVX037 IVX037 · ImmVirx Pty Ltd https://druglandscape.com/drug/iw-3300 https://druglandscape.com/api/og?type=drug&title=IW-3300&subtitle=IW-3300%20%C2%B7%20Ironwood%20Pharmaceuticals%2C%20Inc.&badge=phase%201 IW-3300 IW-3300 · Ironwood Pharmaceuticals, Inc. https://druglandscape.com/drug/iw001 https://druglandscape.com/api/og?type=drug&title=IW001&subtitle=IW001%20%C2%B7%20ImmuneWorks&badge=phase%201 IW001 IW001 · ImmuneWorks https://druglandscape.com/drug/ixabepilone-25-mg-with-famotidine https://druglandscape.com/api/og?type=drug&title=Ixabepilone%2C%2025%20mg%2C%20with%20famotidine&subtitle=Ixabepilone%2C%2025%20mg%2C%20with%20famotidine%20%C2%B7%20R-Pharm&badge=phase%201 Ixabepilone, 25 mg, with famotidine Ixabepilone, 25 mg, with famotidine · R-Pharm https://druglandscape.com/drug/ixabepilone-25-mg-with-food https://druglandscape.com/api/og?type=drug&title=Ixabepilone%2C%2025%20mg%2C%20with%20food&subtitle=Ixabepilone%2C%2025%20mg%2C%20with%20food%20%C2%B7%20R-Pharm&badge=phase%201 Ixabepilone, 25 mg, with food Ixabepilone, 25 mg, with food · R-Pharm https://druglandscape.com/drug/iy-828026a https://druglandscape.com/api/og?type=drug&title=IY-828026A&subtitle=IY-828026A%20%C2%B7%20Il-Yang%20Pharm.%20Co.%2C%20Ltd.&badge=phase%201 IY-828026A IY-828026A · Il-Yang Pharm. Co., Ltd. https://druglandscape.com/drug/iy-hcr21 https://druglandscape.com/api/og?type=drug&title=IY-HCR21&subtitle=IY-HCR21%20%C2%B7%20Il-Yang%20Pharm.%20Co.%2C%20Ltd.&badge=phase%201 IY-HCR21 IY-HCR21 · Il-Yang Pharm. Co., Ltd. https://druglandscape.com/drug/iy-mic https://druglandscape.com/api/og?type=drug&title=IY-MIC&subtitle=IY-MIC%20%C2%B7%20Il-Yang%20Pharm.%20Co.%2C%20Ltd.&badge=phase%201 IY-MIC IY-MIC · Il-Yang Pharm. Co., Ltd. https://druglandscape.com/drug/iy-ns250 https://druglandscape.com/api/og?type=drug&title=IY-NS250&subtitle=IY-NS250%20%C2%B7%20Il-Yang%20Pharm.%20Co.%2C%20Ltd.&badge=phase%201 IY-NS250 IY-NS250 · Il-Yang Pharm. Co., Ltd. https://druglandscape.com/drug/iy-nt-r https://druglandscape.com/api/og?type=drug&title=IY-NT-R&subtitle=IY-NT-R%20%C2%B7%20Il-Yang%20Pharm.%20Co.%2C%20Ltd.&badge=phase%201 IY-NT-R IY-NT-R · Il-Yang Pharm. Co., Ltd. https://druglandscape.com/drug/izd334 https://druglandscape.com/api/og?type=drug&title=IZD334&subtitle=IZD334%20%C2%B7%20Inflazome%20UK%20Ltd&badge=phase%201 IZD334 IZD334 · Inflazome UK Ltd https://druglandscape.com/drug/izn-6d4-gel https://druglandscape.com/api/og?type=drug&title=IZN-6D4%20Gel&subtitle=IZN-6D4%20Gel%20%C2%B7%20Izun%20Pharma%20Ltd&badge=phase%202 IZN-6D4 Gel IZN-6D4 Gel · Izun Pharma Ltd https://druglandscape.com/drug/izn-6n4 https://druglandscape.com/api/og?type=drug&title=IZN-6N4&subtitle=IZN-6N4%20%C2%B7%20Izun%20Pharma%20Ltd&badge=phase%202 IZN-6N4 IZN-6N4 · Izun Pharma Ltd https://druglandscape.com/drug/izn-6nvs-cream https://druglandscape.com/api/og?type=drug&title=IZN-6NVS%20Cream&subtitle=IZN-6NVS%20Cream%20%C2%B7%20Izun%20Pharma%20Ltd&badge=phase%201 IZN-6NVS Cream IZN-6NVS Cream · Izun Pharma Ltd https://druglandscape.com/drug/j65-vaccine-then-e39-vaccine https://druglandscape.com/api/og?type=drug&title=J65%20vaccine%20then%20E39%20vaccine&subtitle=J65%20vaccine%20then%20E39%20vaccine%20%C2%B7%20COL%20George%20Peoples%2C%20MD%2C%20FACS&badge=phase%201 J65 vaccine then E39 vaccine J65 vaccine then E39 vaccine · COL George Peoples, MD, FACS https://druglandscape.com/drug/jab-23e73 https://druglandscape.com/api/og?type=drug&title=JAB-23E73&subtitle=JAB-23E73%20%C2%B7%20Jacobio%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 JAB-23E73 JAB-23E73 · Jacobio Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/jab-30355 https://druglandscape.com/api/og?type=drug&title=JAB-30355&subtitle=JAB-30355%20%C2%B7%20Jacobio%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 JAB-30355 JAB-30355 · Jacobio Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/jab-8263 https://druglandscape.com/api/og?type=drug&title=JAB-8263&subtitle=JAB-8263%20%C2%B7%20Jacobio%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 JAB-8263 JAB-8263 · Jacobio Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/jaci-35-054 https://druglandscape.com/api/og?type=drug&title=JACI-35.054&subtitle=JACI-35.054%20%C2%B7%20AC%20Immune%20SA&badge=phase%201 JACI-35.054 JACI-35.054 · AC Immune SA https://druglandscape.com/drug/jade101 https://druglandscape.com/api/og?type=drug&title=JADE101&subtitle=JADE101%20%C2%B7%20Jade%20Biosciences%2C%20Inc.&badge=phase%201 JADE101 JADE101 · Jade Biosciences, Inc. https://druglandscape.com/drug/jak-2-inhibitor https://druglandscape.com/api/og?type=drug&title=JAK-2%20inhibitor&subtitle=JAK-2%20inhibitor%20%C2%B7%20Pi%20Research%20Consultancy%20Center%2C%20Bangladesh&badge=phase%201 JAK-2 inhibitor JAK-2 inhibitor · Pi Research Consultancy Center, Bangladesh https://druglandscape.com/drug/jaki https://druglandscape.com/api/og?type=drug&title=JAKi&subtitle=JAKi%20%C2%B7%20Marie%20Hudson%2C%20MD&badge=phase%201 JAKi JAKi · Marie Hudson, MD https://druglandscape.com/drug/jaktinib-hydrochloride-tablets https://druglandscape.com/api/og?type=drug&title=Jaktinib%20Hydrochloride%20Tablets&subtitle=Jaktinib%20Hydrochloride%20Tablets%20%C2%B7%20Suzhou%20Zelgen%20Biopharmaceuticals%20Co.%2CLtd&badge=phase%202 Jaktinib Hydrochloride Tablets Jaktinib Hydrochloride Tablets · Suzhou Zelgen Biopharmaceuticals Co.,Ltd https://druglandscape.com/drug/janssen-ad26-cov2-s https://druglandscape.com/api/og?type=drug&title=Janssen%20Ad26.COV2.S&subtitle=Janssen%20Ad26.COV2.S%20%C2%B7%20Alvea%20Holdings%2C%20LLC&badge=phase%201 Janssen Ad26.COV2.S Janssen Ad26.COV2.S · Alvea Holdings, LLC https://druglandscape.com/drug/janthinobacterium-lividum https://druglandscape.com/api/og?type=drug&title=Janthinobacterium%20lividum&subtitle=Janthinobacterium%20lividum%20%C2%B7%20DermBiont%2C%20Inc.&badge=phase%202 Janthinobacterium lividum Janthinobacterium lividum · DermBiont, Inc. https://druglandscape.com/drug/jardiance-film-coated-tablets https://druglandscape.com/api/og?type=drug&title=Jardiance%20film-coated%20tablets&subtitle=Jardiance%20film-coated%20tablets%20%C2%B7%20Humanis%20Sagl%C4%B1k%20Anonim%20Sirketi&badge=phase%201 Jardiance film-coated tablets Jardiance film-coated tablets · Humanis Saglık Anonim Sirketi https://druglandscape.com/drug/jbz-001 https://druglandscape.com/api/og?type=drug&title=JBZ-001&subtitle=JBZ-001%20%C2%B7%20Jabez%20Bioscience%2C%20Inc&badge=phase%201 JBZ-001 JBZ-001 · Jabez Bioscience, Inc https://druglandscape.com/drug/jc-013 https://druglandscape.com/api/og?type=drug&title=JC-013&subtitle=JC-013%20%C2%B7%20Jeil%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 JC-013 JC-013 · Jeil Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jcm-16021 https://druglandscape.com/api/og?type=drug&title=JCM-16021&subtitle=JCM-16021%20%C2%B7%20ZhaoXiang%20Bian&badge=phase%202 JCM-16021 JCM-16021 · ZhaoXiang Bian https://druglandscape.com/drug/jcxh-105 https://druglandscape.com/api/og?type=drug&title=JCXH-105&subtitle=JCXH-105%20%C2%B7%20Immorna%20Biotherapeutics%2C%20Inc.&badge=phase%202 JCXH-105 JCXH-105 · Immorna Biotherapeutics, Inc. https://druglandscape.com/drug/jcxh-108 https://druglandscape.com/api/og?type=drug&title=JCXH-108&subtitle=JCXH-108%20%C2%B7%20Immorna%20Biotherapeutics%2C%20Inc.&badge=phase%201 JCXH-108 JCXH-108 · Immorna Biotherapeutics, Inc. https://druglandscape.com/drug/jcxh-221 https://druglandscape.com/api/og?type=drug&title=JCXH-221&subtitle=JCXH-221%20%C2%B7%20Immorna%20Biotherapeutics%2C%20Inc.&badge=phase%201 JCXH-221 JCXH-221 · Immorna Biotherapeutics, Inc. https://druglandscape.com/drug/jdp-205-im https://druglandscape.com/api/og?type=drug&title=JDP-205%20IM&subtitle=JDP-205%20IM%20%C2%B7%20JDP%20Therapeutics%2C%20Inc.&badge=phase%201 JDP-205 IM JDP-205 IM · JDP Therapeutics, Inc. https://druglandscape.com/drug/jdp-205-iv-high-dose https://druglandscape.com/api/og?type=drug&title=JDP-205%20IV%20high%20dose&subtitle=JDP-205%20IV%20high%20dose%20%C2%B7%20JDP%20Therapeutics%2C%20Inc.&badge=phase%201 JDP-205 IV high dose JDP-205 IV high dose · JDP Therapeutics, Inc. https://druglandscape.com/drug/jdp-205-iv-low-dose https://druglandscape.com/api/og?type=drug&title=JDP-205%20IV%20low%20dose&subtitle=JDP-205%20IV%20low%20dose%20%C2%B7%20JDP%20Therapeutics%2C%20Inc.&badge=phase%201 JDP-205 IV low dose JDP-205 IV low dose · JDP Therapeutics, Inc. https://druglandscape.com/drug/je-vax-vaccine https://druglandscape.com/api/og?type=drug&title=JE-VAX%C2%AE%20vaccine&subtitle=JE-VAX%C2%AE%20vaccine%20%C2%B7%20Sanofi&badge=phase%202 JE-VAX® vaccine JE-VAX® vaccine · Sanofi https://druglandscape.com/drug/jhl1149 https://druglandscape.com/api/og?type=drug&title=JHL1149&subtitle=JHL1149%20%C2%B7%20JHL%20Biotech%2C%20Inc.&badge=phase%201 JHL1149 JHL1149 · JHL Biotech, Inc. https://druglandscape.com/drug/jhl1922 https://druglandscape.com/api/og?type=drug&title=JHL1922&subtitle=JHL1922%20%C2%B7%20JHL%20Biotech%2C%20Inc.&badge=phase%201 JHL1922 JHL1922 · JHL Biotech, Inc. https://druglandscape.com/drug/jhm03 https://druglandscape.com/api/og?type=drug&title=JHM03&subtitle=JHM03%20%C2%B7%20JHM%20BioPharma%20(Tonghua)%20Co.%20%2C%20Ltd.&badge=phase%201 JHM03 JHM03 · JHM BioPharma (Tonghua) Co. , Ltd. https://druglandscape.com/drug/jiashen-tablets https://druglandscape.com/api/og?type=drug&title=Jiashen%20Tablets&subtitle=Jiashen%20Tablets%20%C2%B7%20Tasly%20Pharmaceutical%20Group%20Co.%2C%20Ltd&badge=phase%201 Jiashen Tablets Jiashen Tablets · Tasly Pharmaceutical Group Co., Ltd https://druglandscape.com/drug/jin-a02 https://druglandscape.com/api/og?type=drug&title=JIN-A02&subtitle=JIN-A02%20%C2%B7%20J%20Ints%20Bio&badge=phase%201 JIN-A02 JIN-A02 · J Ints Bio https://druglandscape.com/drug/jincaopian-tablets-low-dose https://druglandscape.com/api/og?type=drug&title=Jincaopian%20Tablets%20low%20dose&subtitle=Jincaopian%20Tablets%20low%20dose%20%C2%B7%20Beijing%20Konruns%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Jincaopian Tablets low dose Jincaopian Tablets low dose · Beijing Konruns Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jintrolong-high-dose-group https://druglandscape.com/api/og?type=drug&title=Jintrolong%C2%AE%20high%20dose%20group&subtitle=Jintrolong%C2%AE%20high%20dose%20group%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Jintrolong® high dose group Jintrolong® high dose group · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jintrolong-low-dose-group https://druglandscape.com/api/og?type=drug&title=Jintrolong%C2%AE%20low%20dose%20group&subtitle=Jintrolong%C2%AE%20low%20dose%20group%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Jintrolong® low dose group Jintrolong® low dose group · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jintropin-aq https://druglandscape.com/api/og?type=drug&title=Jintropin%20AQ&subtitle=Jintropin%20AQ%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Jintropin AQ Jintropin AQ · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jinzhen-granules-for-oral-solution https://druglandscape.com/api/og?type=drug&title=JINZHEN%20Granules%20for%20Oral%20Solution&subtitle=JINZHEN%20Granules%20for%20Oral%20Solution%20%C2%B7%20Lianyungang%20Kanion%20Group%2C%20Ltd.&badge=phase%201 JINZHEN Granules for Oral Solution JINZHEN Granules for Oral Solution · Lianyungang Kanion Group, Ltd. https://druglandscape.com/drug/jk06 https://druglandscape.com/api/og?type=drug&title=JK06&subtitle=JK06%20%C2%B7%20Salubris%20Biotherapeutics%20Inc&badge=phase%201 JK06 JK06 · Salubris Biotherapeutics Inc https://druglandscape.com/drug/jk07 https://druglandscape.com/api/og?type=drug&title=JK07&subtitle=JK07%20%C2%B7%20Salubris%20Biotherapeutics%20Inc&badge=phase%202 JK07 JK07 · Salubris Biotherapeutics Inc https://druglandscape.com/drug/jkb-122-in-capsule-or-tablet-form https://druglandscape.com/api/og?type=drug&title=JKB-122%20in%20capsule%20or%20tablet%20form&subtitle=JKB-122%20in%20capsule%20or%20tablet%20form%20%C2%B7%20TaiwanJ%20Pharmaceuticals%20Co.%2C%20Ltd&badge=phase%201 JKB-122 in capsule or tablet form JKB-122 in capsule or tablet form · TaiwanJ Pharmaceuticals Co., Ltd https://druglandscape.com/drug/jkn2304-inhalation-solution https://druglandscape.com/api/og?type=drug&title=JKN2304%20Inhalation%20Solution&subtitle=JKN2304%20Inhalation%20Solution%20%C2%B7%20Joincare%20Pharmaceutical%20Group%20Industry%20Co.%2C%20Ltd&badge=phase%202 JKN2304 Inhalation Solution JKN2304 Inhalation Solution · Joincare Pharmaceutical Group Industry Co., Ltd https://druglandscape.com/drug/jkn2306 https://druglandscape.com/api/og?type=drug&title=JKN2306&subtitle=JKN2306%20%C2%B7%20Joincare%20Pharmaceutical%20Group%20Industry%20Co.%2C%20Ltd&badge=phase%201 JKN2306 JKN2306 · Joincare Pharmaceutical Group Industry Co., Ltd https://druglandscape.com/drug/jkn24011 https://druglandscape.com/api/og?type=drug&title=JKN24011&subtitle=JKN24011%20%C2%B7%20Joincare%20Pharmaceutical%20Group%20Industry%20Co.%2C%20Ltd&badge=phase%202 JKN24011 JKN24011 · Joincare Pharmaceutical Group Industry Co., Ltd https://druglandscape.com/drug/jkn2501 https://druglandscape.com/api/og?type=drug&title=JKN2501&subtitle=JKN2501%20%C2%B7%20Joincare%20Pharmaceutical%20Group%20Industry%20Co.%2C%20Ltd&badge=phase%201 JKN2501 JKN2501 · Joincare Pharmaceutical Group Industry Co., Ltd https://druglandscape.com/drug/jl18008 https://druglandscape.com/api/og?type=drug&title=JL18008&subtitle=JL18008%20%C2%B7%20Jecho%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 JL18008 JL18008 · Jecho Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/jlp-1207 https://druglandscape.com/api/og?type=drug&title=JLP-1207&subtitle=JLP-1207%20%C2%B7%20Jeil%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 JLP-1207 JLP-1207 · Jeil Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jlp-1310 https://druglandscape.com/api/og?type=drug&title=JLP-1310&subtitle=JLP-1310%20%C2%B7%20Jeil%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 JLP-1310 JLP-1310 · Jeil Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jlp-1310-fed-followed-by-fasted https://druglandscape.com/api/og?type=drug&title=JLP-1310%2C%20Fed%20followed%20by%20fasted&subtitle=JLP-1310%2C%20Fed%20followed%20by%20fasted%20%C2%B7%20Jeil%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 JLP-1310, Fed followed by fasted JLP-1310, Fed followed by fasted · Jeil Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jlp-1901 https://druglandscape.com/api/og?type=drug&title=JLP-1901&subtitle=JLP-1901%20%C2%B7%20Jeil%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 JLP-1901 JLP-1901 · Jeil Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jlp-2004 https://druglandscape.com/api/og?type=drug&title=JLP-2004&subtitle=JLP-2004%20%C2%B7%20Jeil%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 JLP-2004 JLP-2004 · Jeil Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jlp-2004-qd https://druglandscape.com/api/og?type=drug&title=JLP-2004%20qd&subtitle=JLP-2004%20qd%20%C2%B7%20Jeil%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 JLP-2004 qd JLP-2004 qd · Jeil Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jlp-2302 https://druglandscape.com/api/og?type=drug&title=JLP-2302&subtitle=JLP-2302%20%C2%B7%20Onconic%20Therapeutics%20Inc.&badge=phase%201 JLP-2302 JLP-2302 · Onconic Therapeutics Inc. https://druglandscape.com/drug/jm-4 https://druglandscape.com/api/og?type=drug&title=JM-4&subtitle=JM-4%20%C2%B7%20Cook%2C%20Stuart%2C%20MD&badge=phase%201 JM-4 JM-4 · Cook, Stuart, MD https://druglandscape.com/drug/jmi-001 https://druglandscape.com/api/og?type=drug&title=JMI-001&subtitle=JMI-001%20%C2%B7%20Sen-Jam%20Pharmaceutical&badge=phase%201 JMI-001 JMI-001 · Sen-Jam Pharmaceutical https://druglandscape.com/drug/jmkx000189 https://druglandscape.com/api/og?type=drug&title=JMKX000189&subtitle=JMKX000189%20%C2%B7%20Jemincare&badge=phase%202 JMKX000189 JMKX000189 · Jemincare https://druglandscape.com/drug/jmkx000197 https://druglandscape.com/api/og?type=drug&title=JMKX000197&subtitle=JMKX000197%20%C2%B7%20Jemincare&badge=phase%201 JMKX000197 JMKX000197 · Jemincare https://druglandscape.com/drug/jmkx000623 https://druglandscape.com/api/og?type=drug&title=JMKX000623&subtitle=JMKX000623%20%C2%B7%20Jemincare&badge=phase%202 JMKX000623 JMKX000623 · Jemincare https://druglandscape.com/drug/jmkx003002-will-be-administered-orally https://druglandscape.com/api/og?type=drug&title=JMKX003002%20will%20be%20administered%20orally&subtitle=JMKX003002%20will%20be%20administered%20orally%20%C2%B7%20Jemincare&badge=phase%202 JMKX003002 will be administered orally JMKX003002 will be administered orally · Jemincare https://druglandscape.com/drug/jmkx003142-will-be-administered-orally https://druglandscape.com/api/og?type=drug&title=JMKX003142%20will%20be%20administered%20orally&subtitle=JMKX003142%20will%20be%20administered%20orally%20%C2%B7%20Jemincare&badge=phase%202 JMKX003142 will be administered orally JMKX003142 will be administered orally · Jemincare https://druglandscape.com/drug/jmkx003801 https://druglandscape.com/api/og?type=drug&title=JMKX003801&subtitle=JMKX003801%20%C2%B7%20Jemincare&badge=phase%201 JMKX003801 JMKX003801 · Jemincare https://druglandscape.com/drug/jmkx003948 https://druglandscape.com/api/og?type=drug&title=JMKX003948&subtitle=JMKX003948%20%C2%B7%20Jemincare&badge=phase%201 JMKX003948 JMKX003948 · Jemincare https://druglandscape.com/drug/jmkx003948-ophthalmic-suspension https://druglandscape.com/api/og?type=drug&title=JMKX003948%20Ophthalmic%20Suspension&subtitle=JMKX003948%20Ophthalmic%20Suspension%20%C2%B7%20Jemincare&badge=phase%201 JMKX003948 Ophthalmic Suspension JMKX003948 Ophthalmic Suspension · Jemincare https://druglandscape.com/drug/jmkx005425 https://druglandscape.com/api/og?type=drug&title=JMKX005425&subtitle=JMKX005425%20%C2%B7%20Jemincare&badge=phase%201 JMKX005425 JMKX005425 · Jemincare https://druglandscape.com/drug/jmt202 https://druglandscape.com/api/og?type=drug&title=JMT202&subtitle=JMT202%20%C2%B7%20Shanghai%20JMT-Bio%20Inc.&badge=phase%201 JMT202 JMT202 · Shanghai JMT-Bio Inc. https://druglandscape.com/drug/jmt206 https://druglandscape.com/api/og?type=drug&title=JMT206&subtitle=JMT206%20%C2%B7%20Shanghai%20JMT-Bio%20Inc.&badge=phase%201 JMT206 JMT206 · Shanghai JMT-Bio Inc. https://druglandscape.com/drug/jmt601 https://druglandscape.com/api/og?type=drug&title=JMT601&subtitle=JMT601%20%C2%B7%20Shanghai%20JMT-Bio%20Inc.&badge=phase%202 JMT601 JMT601 · Shanghai JMT-Bio Inc. https://druglandscape.com/drug/jnj-10229570-aaa-1-2 https://druglandscape.com/api/og?type=drug&title=JNJ%2010229570-AAA%201.2%25&subtitle=JNJ%2010229570-AAA%201.2%25%20%C2%B7%20Janssen%20Pharmaceutical%20K.K.&badge=phase%201 JNJ 10229570-AAA 1.2% JNJ 10229570-AAA 1.2% · Janssen Pharmaceutical K.K. https://druglandscape.com/drug/jnj-10229570-aaa-2-4-cream https://druglandscape.com/api/og?type=drug&title=JNJ%2010229570-AAA%202.4%25%20cream&subtitle=JNJ%2010229570-AAA%202.4%25%20cream%20%C2%B7%20Janssen%20Pharmaceutical%20K.K.&badge=phase%201 JNJ 10229570-AAA 2.4% cream JNJ 10229570-AAA 2.4% cream · Janssen Pharmaceutical K.K. https://druglandscape.com/drug/jnj-10229570-aaa-3-6 https://druglandscape.com/api/og?type=drug&title=JNJ%2010229570-AAA%203.6%25&subtitle=JNJ%2010229570-AAA%203.6%25%20%C2%B7%20Janssen%20Pharmaceutical%20K.K.&badge=phase%201 JNJ 10229570-AAA 3.6% JNJ 10229570-AAA 3.6% · Janssen Pharmaceutical K.K. https://druglandscape.com/drug/jnj-212082 https://druglandscape.com/api/og?type=drug&title=JNJ-212082&subtitle=JNJ-212082%20%C2%B7%20Janssen%20Pharmaceutical%20K.K.&badge=phase%201 JNJ-212082 JNJ-212082 · Janssen Pharmaceutical K.K. https://druglandscape.com/drug/jnj-26528398 https://druglandscape.com/api/og?type=drug&title=JNJ-26528398&subtitle=JNJ-26528398%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-26528398 JNJ-26528398 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-26854165 https://druglandscape.com/api/og?type=drug&title=JNJ-26854165&subtitle=JNJ-26854165%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 JNJ-26854165 JNJ-26854165 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/jnj-28431754 https://druglandscape.com/api/og?type=drug&title=JNJ%2028431754&subtitle=JNJ%2028431754%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 JNJ 28431754 JNJ 28431754 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/jnj-31001074-ketoconazole https://druglandscape.com/api/og?type=drug&title=JNJ-31001074%3B%20ketoconazole&subtitle=JNJ-31001074%3B%20ketoconazole%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 JNJ-31001074; ketoconazole JNJ-31001074; ketoconazole · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/jnj-35684-aaa-023-size-1-small-patch https://druglandscape.com/api/og?type=drug&title=JNJ-35684-AAA-023%3A%20Size%201%3B%20small%20patch&subtitle=JNJ-35684-AAA-023%3A%20Size%201%3B%20small%20patch%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-35684-AAA-023: Size 1; small patch JNJ-35684-AAA-023: Size 1; small patch · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-35684-aaa-023-size-2-large-patch https://druglandscape.com/api/og?type=drug&title=JNJ-35684-AAA-023%3A%20Size%202%3B%20large%20patch&subtitle=JNJ-35684-AAA-023%3A%20Size%202%3B%20large%20patch%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-35684-AAA-023: Size 2; large patch JNJ-35684-AAA-023: Size 2; large patch · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-38431055-dose-1 https://druglandscape.com/api/og?type=drug&title=JNJ-38431055%20Dose%201&subtitle=JNJ-38431055%20Dose%201%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 JNJ-38431055 Dose 1 JNJ-38431055 Dose 1 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/jnj-38877618-part-1a https://druglandscape.com/api/og?type=drug&title=JNJ-38877618%3A%20Part%201a&subtitle=JNJ-38877618%3A%20Part%201a%20%C2%B7%20Janssen%20Cilag%20N.V.%2FS.A.&badge=phase%201 JNJ-38877618: Part 1a JNJ-38877618: Part 1a · Janssen Cilag N.V./S.A. https://druglandscape.com/drug/jnj-38877618-part-1b https://druglandscape.com/api/og?type=drug&title=JNJ-38877618%3A%20Part%201b&subtitle=JNJ-38877618%3A%20Part%201b%20%C2%B7%20Janssen%20Cilag%20N.V.%2FS.A.&badge=phase%201 JNJ-38877618: Part 1b JNJ-38877618: Part 1b · Janssen Cilag N.V./S.A. https://druglandscape.com/drug/jnj-38877618-part-2 https://druglandscape.com/api/og?type=drug&title=JNJ-38877618%3A%20Part%202&subtitle=JNJ-38877618%3A%20Part%202%20%C2%B7%20Janssen%20Cilag%20N.V.%2FS.A.&badge=phase%201 JNJ-38877618: Part 2 JNJ-38877618: Part 2 · Janssen Cilag N.V./S.A. https://druglandscape.com/drug/jnj-39439335 https://druglandscape.com/api/og?type=drug&title=JNJ-39439335&subtitle=JNJ-39439335%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-39439335 JNJ-39439335 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-39823277 https://druglandscape.com/api/og?type=drug&title=JNJ-39823277&subtitle=JNJ-39823277%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 JNJ-39823277 JNJ-39823277 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/jnj-40411813-formulation-a https://druglandscape.com/api/og?type=drug&title=JNJ-40411813%3A%20Formulation%20A&subtitle=JNJ-40411813%3A%20Formulation%20A%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 JNJ-40411813: Formulation A JNJ-40411813: Formulation A · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/jnj-40411813-formulation-b https://druglandscape.com/api/og?type=drug&title=JNJ-40411813%3A%20Formulation%20B&subtitle=JNJ-40411813%3A%20Formulation%20B%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 JNJ-40411813: Formulation B JNJ-40411813: Formulation B · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/jnj-40411813-formulation-c https://druglandscape.com/api/og?type=drug&title=JNJ-40411813%3A%20Formulation%20C&subtitle=JNJ-40411813%3A%20Formulation%20C%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 JNJ-40411813: Formulation C JNJ-40411813: Formulation C · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/jnj-42847922 https://druglandscape.com/api/og?type=drug&title=JNJ-42847922&subtitle=JNJ-42847922%20%C2%B7%20Janssen%20Cilag%20N.V.%2FS.A.&badge=phase%202 JNJ-42847922 JNJ-42847922 · Janssen Cilag N.V./S.A. https://druglandscape.com/drug/jnj-440 https://druglandscape.com/api/og?type=drug&title=JNJ-440&subtitle=JNJ-440%20%C2%B7%20Alios%20Biopharma%20Inc.&badge=phase%201 JNJ-440 JNJ-440 · Alios Biopharma Inc. https://druglandscape.com/drug/jnj-54135419 https://druglandscape.com/api/og?type=drug&title=JNJ-54135419&subtitle=JNJ-54135419%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-54135419 JNJ-54135419 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-54179060 https://druglandscape.com/api/og?type=drug&title=JNJ-54179060&subtitle=JNJ-54179060%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-54179060 JNJ-54179060 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-54861911-supratherapeutic-dose https://druglandscape.com/api/og?type=drug&title=JNJ-54861911%20-%20Supratherapeutic%20Dose&subtitle=JNJ-54861911%20-%20Supratherapeutic%20Dose%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-54861911 - Supratherapeutic Dose JNJ-54861911 - Supratherapeutic Dose · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-54861911-tbd https://druglandscape.com/api/og?type=drug&title=JNJ-54861911%20tbd&subtitle=JNJ-54861911%20tbd%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-54861911 tbd JNJ-54861911 tbd · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-55375515 https://druglandscape.com/api/og?type=drug&title=JNJ-55375515&subtitle=JNJ-55375515%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-55375515 JNJ-55375515 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-55375515-dose-level-1 https://druglandscape.com/api/og?type=drug&title=JNJ-55375515%20Dose%20Level%201&subtitle=JNJ-55375515%20Dose%20Level%201%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-55375515 Dose Level 1 JNJ-55375515 Dose Level 1 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-55375515-dose-level-2 https://druglandscape.com/api/og?type=drug&title=JNJ-55375515%20Dose%20Level%202&subtitle=JNJ-55375515%20Dose%20Level%202%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-55375515 Dose Level 2 JNJ-55375515 Dose Level 2 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-55375515-dose-level-3 https://druglandscape.com/api/og?type=drug&title=JNJ-55375515%20Dose%20Level%203&subtitle=JNJ-55375515%20Dose%20Level%203%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-55375515 Dose Level 3 JNJ-55375515 Dose Level 3 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-55375515-dose-level-4 https://druglandscape.com/api/og?type=drug&title=JNJ-55375515%20Dose%20Level%204&subtitle=JNJ-55375515%20Dose%20Level%204%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-55375515 Dose Level 4 JNJ-55375515 Dose Level 4 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-55375515-dose-level-6 https://druglandscape.com/api/og?type=drug&title=JNJ-55375515%20Dose%20Level%206&subtitle=JNJ-55375515%20Dose%20Level%206%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-55375515 Dose Level 6 JNJ-55375515 Dose Level 6 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-55920839 https://druglandscape.com/api/og?type=drug&title=JNJ-55920839&subtitle=JNJ-55920839%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-55920839 JNJ-55920839 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-56021927 https://druglandscape.com/api/og?type=drug&title=JNJ%2056021927&subtitle=JNJ%2056021927%20%C2%B7%20Aragon%20Pharmaceuticals%2C%20Inc.&badge=phase%201 JNJ 56021927 JNJ 56021927 · Aragon Pharmaceuticals, Inc. https://druglandscape.com/drug/jnj-56021927-120-milligram https://druglandscape.com/api/og?type=drug&title=JNJ-56021927%20120%20Milligram&subtitle=JNJ-56021927%20120%20Milligram%20%C2%B7%20Janssen%20Pharmaceutical%20K.K.&badge=phase%201 JNJ-56021927 120 Milligram JNJ-56021927 120 Milligram · Janssen Pharmaceutical K.K. https://druglandscape.com/drug/jnj-56021927-60-milligram https://druglandscape.com/api/og?type=drug&title=JNJ-56021927%2060%20Milligram&subtitle=JNJ-56021927%2060%20Milligram%20%C2%B7%20Janssen%20Pharmaceutical%20K.K.&badge=phase%201 JNJ-56021927 60 Milligram JNJ-56021927 60 Milligram · Janssen Pharmaceutical K.K. https://druglandscape.com/drug/jnj-56021927-capsule https://druglandscape.com/api/og?type=drug&title=JNJ-56021927%20capsule&subtitle=JNJ-56021927%20capsule%20%C2%B7%20Aragon%20Pharmaceuticals%2C%20Inc.&badge=phase%201 JNJ-56021927 capsule JNJ-56021927 capsule · Aragon Pharmaceuticals, Inc. https://druglandscape.com/drug/jnj-61178104-intravenous https://druglandscape.com/api/og?type=drug&title=JNJ-61178104%20Intravenous&subtitle=JNJ-61178104%20Intravenous%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-61178104 Intravenous JNJ-61178104 Intravenous · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-61178104-subcutaneous https://druglandscape.com/api/og?type=drug&title=JNJ-61178104%20Subcutaneous&subtitle=JNJ-61178104%20Subcutaneous%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-61178104 Subcutaneous JNJ-61178104 Subcutaneous · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-61818549 https://druglandscape.com/api/og?type=drug&title=JNJ-61818549&subtitle=JNJ-61818549%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-61818549 JNJ-61818549 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-63623872 https://druglandscape.com/api/og?type=drug&title=JNJ-63623872&subtitle=JNJ-63623872%20%C2%B7%20Janssen%20Cilag%20N.V.%2FS.A.&badge=phase%202 JNJ-63623872 JNJ-63623872 · Janssen Cilag N.V./S.A. https://druglandscape.com/drug/jnj-63709178 https://druglandscape.com/api/og?type=drug&title=JNJ-63709178&subtitle=JNJ-63709178%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-63709178 JNJ-63709178 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-63733657 https://druglandscape.com/api/og?type=drug&title=JNJ-63733657&subtitle=JNJ-63733657%20%C2%B7%20Janssen%20Pharmaceutical%20K.K.&badge=phase%202 JNJ-63733657 JNJ-63733657 · Janssen Pharmaceutical K.K. https://druglandscape.com/drug/jnj-63898081 https://druglandscape.com/api/og?type=drug&title=JNJ-63898081&subtitle=JNJ-63898081%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-63898081 JNJ-63898081 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-64232025-iv https://druglandscape.com/api/og?type=drug&title=JNJ-64232025%20IV&subtitle=JNJ-64232025%20IV%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-64232025 IV JNJ-64232025 IV · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-64232025-sc https://druglandscape.com/api/og?type=drug&title=JNJ-64232025%20SC&subtitle=JNJ-64232025%20SC%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-64232025 SC JNJ-64232025 SC · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-64251330 https://druglandscape.com/api/og?type=drug&title=JNJ-64251330&subtitle=JNJ-64251330%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-64251330 JNJ-64251330 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-64457107 https://druglandscape.com/api/og?type=drug&title=JNJ-64457107&subtitle=JNJ-64457107%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-64457107 JNJ-64457107 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-64619178 https://druglandscape.com/api/og?type=drug&title=JNJ-64619178&subtitle=JNJ-64619178%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-64619178 JNJ-64619178 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-64991524-dose-level-1 https://druglandscape.com/api/og?type=drug&title=JNJ-64991524%20Dose%20Level%201&subtitle=JNJ-64991524%20Dose%20Level%201%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-64991524 Dose Level 1 JNJ-64991524 Dose Level 1 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-64991524-dose-level-2 https://druglandscape.com/api/og?type=drug&title=JNJ-64991524%20Dose%20Level%202&subtitle=JNJ-64991524%20Dose%20Level%202%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-64991524 Dose Level 2 JNJ-64991524 Dose Level 2 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-64991524-dose-level-3 https://druglandscape.com/api/og?type=drug&title=JNJ-64991524%20Dose%20Level%203&subtitle=JNJ-64991524%20Dose%20Level%203%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-64991524 Dose Level 3 JNJ-64991524 Dose Level 3 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-64991524-dose-level-4 https://druglandscape.com/api/og?type=drug&title=JNJ-64991524%20Dose%20Level%204&subtitle=JNJ-64991524%20Dose%20Level%204%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-64991524 Dose Level 4 JNJ-64991524 Dose Level 4 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-64991524-dose-level-5 https://druglandscape.com/api/og?type=drug&title=JNJ-64991524%20Dose%20Level%205&subtitle=JNJ-64991524%20Dose%20Level%205%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-64991524 Dose Level 5 JNJ-64991524 Dose Level 5 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-64991524-dose-level-6 https://druglandscape.com/api/og?type=drug&title=JNJ-64991524%20Dose%20Level%206&subtitle=JNJ-64991524%20Dose%20Level%206%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-64991524 Dose Level 6 JNJ-64991524 Dose Level 6 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-64991524-dose-level-7 https://druglandscape.com/api/og?type=drug&title=JNJ-64991524%20Dose%20Level%207&subtitle=JNJ-64991524%20Dose%20Level%207%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-64991524 Dose Level 7 JNJ-64991524 Dose Level 7 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-64991524-dose-level-9 https://druglandscape.com/api/og?type=drug&title=JNJ-64991524%20Dose%20Level%209&subtitle=JNJ-64991524%20Dose%20Level%209%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-64991524 Dose Level 9 JNJ-64991524 Dose Level 9 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-67484703 https://druglandscape.com/api/og?type=drug&title=JNJ-67484703&subtitle=JNJ-67484703%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-67484703 JNJ-67484703 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-67856633 https://druglandscape.com/api/og?type=drug&title=JNJ-67856633&subtitle=JNJ-67856633%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-67856633 JNJ-67856633 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-68179280 https://druglandscape.com/api/og?type=drug&title=JNJ-68179280&subtitle=JNJ-68179280%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-68179280 JNJ-68179280 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-69086420 https://druglandscape.com/api/og?type=drug&title=JNJ-69086420&subtitle=JNJ-69086420%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-69086420 JNJ-69086420 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-70033093 https://druglandscape.com/api/og?type=drug&title=JNJ-70033093&subtitle=JNJ-70033093%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-70033093 JNJ-70033093 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-70218902 https://druglandscape.com/api/og?type=drug&title=JNJ-70218902&subtitle=JNJ-70218902%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-70218902 JNJ-70218902 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-72537634 https://druglandscape.com/api/og?type=drug&title=JNJ-72537634&subtitle=JNJ-72537634%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-72537634 JNJ-72537634 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-74699157 https://druglandscape.com/api/og?type=drug&title=JNJ-74699157&subtitle=JNJ-74699157%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-74699157 JNJ-74699157 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-74856665 https://druglandscape.com/api/og?type=drug&title=JNJ-74856665&subtitle=JNJ-74856665%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-74856665 JNJ-74856665 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-75229414 https://druglandscape.com/api/og?type=drug&title=JNJ-75229414&subtitle=JNJ-75229414%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-75229414 JNJ-75229414 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-75348780 https://druglandscape.com/api/og?type=drug&title=JNJ-75348780&subtitle=JNJ-75348780%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-75348780 JNJ-75348780 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-78306358 https://druglandscape.com/api/og?type=drug&title=JNJ-78306358&subtitle=JNJ-78306358%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-78306358 JNJ-78306358 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-79032421 https://druglandscape.com/api/og?type=drug&title=JNJ-79032421&subtitle=JNJ-79032421%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-79032421 JNJ-79032421 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-80038114 https://druglandscape.com/api/og?type=drug&title=JNJ-80038114&subtitle=JNJ-80038114%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-80038114 JNJ-80038114 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-80948543 https://druglandscape.com/api/og?type=drug&title=JNJ-80948543&subtitle=JNJ-80948543%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-80948543 JNJ-80948543 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-81201887 https://druglandscape.com/api/og?type=drug&title=JNJ-81201887&subtitle=JNJ-81201887%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 JNJ-81201887 JNJ-81201887 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-86974680 https://druglandscape.com/api/og?type=drug&title=JNJ-86974680&subtitle=JNJ-86974680%20%C2%B7%20Johnson%20%26%20Johnson%20Enterprise%20Innovation%20Inc.&badge=phase%201 JNJ-86974680 JNJ-86974680 · Johnson & Johnson Enterprise Innovation Inc. https://druglandscape.com/drug/jnj-87189401 https://druglandscape.com/api/og?type=drug&title=JNJ-87189401&subtitle=JNJ-87189401%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-87189401 JNJ-87189401 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-87562761 https://druglandscape.com/api/og?type=drug&title=JNJ-87562761&subtitle=JNJ-87562761%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-87562761 JNJ-87562761 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-87704916 https://druglandscape.com/api/og?type=drug&title=JNJ-87704916&subtitle=JNJ-87704916%20%C2%B7%20Johnson%20%26%20Johnson%20Enterprise%20Innovation%20Inc.&badge=phase%201 JNJ-87704916 JNJ-87704916 · Johnson & Johnson Enterprise Innovation Inc. https://druglandscape.com/drug/jnj-87801493 https://druglandscape.com/api/og?type=drug&title=JNJ-87801493&subtitle=JNJ-87801493%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-87801493 JNJ-87801493 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-87890387 https://druglandscape.com/api/og?type=drug&title=JNJ-87890387&subtitle=JNJ-87890387%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-87890387 JNJ-87890387 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-88260237 https://druglandscape.com/api/og?type=drug&title=JNJ-88260237&subtitle=JNJ-88260237%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-88260237 JNJ-88260237 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-88545223 https://druglandscape.com/api/og?type=drug&title=JNJ-88545223&subtitle=JNJ-88545223%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 JNJ-88545223 JNJ-88545223 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-88549968 https://druglandscape.com/api/og?type=drug&title=JNJ-88549968&subtitle=JNJ-88549968%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-88549968 JNJ-88549968 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-88998377 https://druglandscape.com/api/og?type=drug&title=JNJ-88998377&subtitle=JNJ-88998377%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-88998377 JNJ-88998377 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-89402638 https://druglandscape.com/api/og?type=drug&title=JNJ-89402638&subtitle=JNJ-89402638%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-89402638 JNJ-89402638 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-89495120 https://druglandscape.com/api/og?type=drug&title=JNJ-89495120&subtitle=JNJ-89495120%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 JNJ-89495120 JNJ-89495120 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-89862175 https://druglandscape.com/api/og?type=drug&title=JNJ-89862175&subtitle=JNJ-89862175%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-89862175 JNJ-89862175 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-90009530 https://druglandscape.com/api/og?type=drug&title=JNJ-90009530&subtitle=JNJ-90009530%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-90009530 JNJ-90009530 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-90189892 https://druglandscape.com/api/og?type=drug&title=JNJ-90189892&subtitle=JNJ-90189892%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-90189892 JNJ-90189892 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-90301900 https://druglandscape.com/api/og?type=drug&title=JNJ-90301900&subtitle=JNJ-90301900%20%C2%B7%20Johnson%20%26%20Johnson%20Enterprise%20Innovation%20Inc.&badge=phase%202 JNJ-90301900 JNJ-90301900 · Johnson & Johnson Enterprise Innovation Inc. https://druglandscape.com/drug/jnj-95437446 https://druglandscape.com/api/og?type=drug&title=JNJ-95437446&subtitle=JNJ-95437446%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-95437446 JNJ-95437446 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-95566692 https://druglandscape.com/api/og?type=drug&title=JNJ-95566692&subtitle=JNJ-95566692%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 JNJ-95566692 JNJ-95566692 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj-95597528 https://druglandscape.com/api/og?type=drug&title=JNJ-95597528&subtitle=JNJ-95597528%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 JNJ-95597528 JNJ-95597528 · Janssen Research & Development, LLC https://druglandscape.com/drug/jnj38224342 https://druglandscape.com/api/og?type=drug&title=JNJ38224342&subtitle=JNJ38224342%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 JNJ38224342 JNJ38224342 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/jnj39758979 https://druglandscape.com/api/og?type=drug&title=JNJ39758979&subtitle=JNJ39758979%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%202 JNJ39758979 JNJ39758979 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/jns002 https://druglandscape.com/api/og?type=drug&title=JNS002&subtitle=JNS002%20%C2%B7%20Janssen%20Pharmaceutical%20K.K.&badge=phase%201 JNS002 JNS002 · Janssen Pharmaceutical K.K. https://druglandscape.com/drug/jp-1366-and-apixaban https://druglandscape.com/api/og?type=drug&title=JP-1366%20and%20apixaban&subtitle=JP-1366%20and%20apixaban%20%C2%B7%20Onconic%20Therapeutics%20Inc.&badge=phase%201 JP-1366 and apixaban JP-1366 and apixaban · Onconic Therapeutics Inc. https://druglandscape.com/drug/jp-1366-and-aspirin https://druglandscape.com/api/og?type=drug&title=JP-1366%20and%20aspirin&subtitle=JP-1366%20and%20aspirin%20%C2%B7%20Onconic%20Therapeutics%20Inc.&badge=phase%201 JP-1366 and aspirin JP-1366 and aspirin · Onconic Therapeutics Inc. https://druglandscape.com/drug/jp-1366-and-atorvastatin https://druglandscape.com/api/og?type=drug&title=JP-1366%20and%20atorvastatin&subtitle=JP-1366%20and%20atorvastatin%20%C2%B7%20Onconic%20Therapeutics%20Inc.&badge=phase%201 JP-1366 and atorvastatin JP-1366 and atorvastatin · Onconic Therapeutics Inc. https://druglandscape.com/drug/jp-2266 https://druglandscape.com/api/og?type=drug&title=JP-2266&subtitle=JP-2266%20%C2%B7%20Jeil%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 JP-2266 JP-2266 · Jeil Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jpi-289 https://druglandscape.com/api/og?type=drug&title=JPI-289&subtitle=JPI-289%20%C2%B7%20Jeil%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 JPI-289 JPI-289 · Jeil Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jpi-547 https://druglandscape.com/api/og?type=drug&title=JPI-547&subtitle=JPI-547%20%C2%B7%20Onconic%20Therapeutics%20Inc.&badge=phase%202 JPI-547 JPI-547 · Onconic Therapeutics Inc. https://druglandscape.com/drug/jr-441 https://druglandscape.com/api/og?type=drug&title=JR-441&subtitle=JR-441%20%C2%B7%20JCR%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 JR-441 JR-441 · JCR Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/jr8603 https://druglandscape.com/api/og?type=drug&title=JR8603&subtitle=JR8603%20%C2%B7%20JiaRay%20Group&badge=phase%201 JR8603 JR8603 · JiaRay Group https://druglandscape.com/drug/js005 https://druglandscape.com/api/og?type=drug&title=JS005&subtitle=JS005%20%C2%B7%20Shanghai%20Junshi%20Bioscience%20Co.%2C%20Ltd.&badge=phase%202 JS005 JS005 · Shanghai Junshi Bioscience Co., Ltd. https://druglandscape.com/drug/js006-as-monotherapy https://druglandscape.com/api/og?type=drug&title=JS006%20as%20Monotherapy&subtitle=JS006%20as%20Monotherapy%20%C2%B7%20Shanghai%20Junshi%20Bioscience%20Co.%2C%20Ltd.&badge=phase%201 JS006 as Monotherapy JS006 as Monotherapy · Shanghai Junshi Bioscience Co., Ltd. https://druglandscape.com/drug/js006-in-combination-with-toripalimab https://druglandscape.com/api/og?type=drug&title=JS006%20in%20combination%20with%20Toripalimab&subtitle=JS006%20in%20combination%20with%20Toripalimab%20%C2%B7%20Shanghai%20Junshi%20Bioscience%20Co.%2C%20Ltd.&badge=phase%201 JS006 in combination with Toripalimab JS006 in combination with Toripalimab · Shanghai Junshi Bioscience Co., Ltd. https://druglandscape.com/drug/js019 https://druglandscape.com/api/og?type=drug&title=JS019&subtitle=JS019%20%C2%B7%20Suzhou%20Kebo%20Ruijun%20Biotechnology%20Co.%2C%20Ltd&badge=phase%201 JS019 JS019 · Suzhou Kebo Ruijun Biotechnology Co., Ltd https://druglandscape.com/drug/js1-1-01-low-dose-group https://druglandscape.com/api/og?type=drug&title=JS1-1-01%20low-dose%20group&subtitle=JS1-1-01%20low-dose%20group%20%C2%B7%20Tasly%20Pharmaceutical%20Group%20Co.%2C%20Ltd&badge=phase%202 JS1-1-01 low-dose group JS1-1-01 low-dose group · Tasly Pharmaceutical Group Co., Ltd https://druglandscape.com/drug/js201 https://druglandscape.com/api/og?type=drug&title=JS201&subtitle=JS201%20%C2%B7%20Shanghai%20Junshi%20Bioscience%20Co.%2C%20Ltd.&badge=phase%201 JS201 JS201 · Shanghai Junshi Bioscience Co., Ltd. https://druglandscape.com/drug/js207 https://druglandscape.com/api/og?type=drug&title=JS207&subtitle=JS207%20%C2%B7%20Shanghai%20Junshi%20Bioscience%20Co.%2C%20Ltd.&badge=phase%202 JS207 JS207 · Shanghai Junshi Bioscience Co., Ltd. https://druglandscape.com/drug/js401 https://druglandscape.com/api/og?type=drug&title=JS401&subtitle=JS401%20%C2%B7%20Shanghai%20Junshi%20Bioscience%20Co.%2C%20Ltd.&badge=phase%201 JS401 JS401 · Shanghai Junshi Bioscience Co., Ltd. https://druglandscape.com/drug/js7-plasmid-dna-and-mva62b-vaccine https://druglandscape.com/api/og?type=drug&title=JS7%20plasmid%20DNA%20and%20MVA62B%20vaccine&subtitle=JS7%20plasmid%20DNA%20and%20MVA62B%20vaccine%20%C2%B7%20GeoVax%2C%20Inc.&badge=phase%201 JS7 plasmid DNA and MVA62B vaccine JS7 plasmid DNA and MVA62B vaccine · GeoVax, Inc. https://druglandscape.com/drug/jskn016-q2w https://druglandscape.com/api/og?type=drug&title=JSKN016%20Q2W&subtitle=JSKN016%20Q2W%20%C2%B7%20Jiangsu%20Alphamab%20Biopharmaceuticals%20Co.%2C%20Ltd&badge=phase%201 JSKN016 Q2W JSKN016 Q2W · Jiangsu Alphamab Biopharmaceuticals Co., Ltd https://druglandscape.com/drug/jskn016-q3w https://druglandscape.com/api/og?type=drug&title=JSKN016%20Q3W&subtitle=JSKN016%20Q3W%20%C2%B7%20Jiangsu%20Alphamab%20Biopharmaceuticals%20Co.%2C%20Ltd&badge=phase%201 JSKN016 Q3W JSKN016 Q3W · Jiangsu Alphamab Biopharmaceuticals Co., Ltd https://druglandscape.com/drug/jskn016hc https://druglandscape.com/api/og?type=drug&title=JSKN016HC&subtitle=JSKN016HC%20%C2%B7%20Jiangsu%20Alphamab%20Biopharmaceuticals%20Co.%2C%20Ltd&badge=phase%201 JSKN016HC JSKN016HC · Jiangsu Alphamab Biopharmaceuticals Co., Ltd https://druglandscape.com/drug/jskn022 https://druglandscape.com/api/og?type=drug&title=JSKN022&subtitle=JSKN022%20%C2%B7%20Jiangsu%20Alphamab%20Biopharmaceuticals%20Co.%2C%20Ltd&badge=phase%201 JSKN022 JSKN022 · Jiangsu Alphamab Biopharmaceuticals Co., Ltd https://druglandscape.com/drug/jskn027 https://druglandscape.com/api/og?type=drug&title=JSKN027&subtitle=JSKN027%20%C2%B7%20Jiangsu%20Alphamab%20Biopharmaceuticals%20Co.%2C%20Ltd&badge=phase%201 JSKN027 JSKN027 · Jiangsu Alphamab Biopharmaceuticals Co., Ltd https://druglandscape.com/drug/jsp191 https://druglandscape.com/api/og?type=drug&title=JSP191&subtitle=JSP191%20%C2%B7%20Porteus%2C%20Matthew%2C%20MD&badge=phase%201 JSP191 JSP191 · Porteus, Matthew, MD https://druglandscape.com/drug/jte-162 https://druglandscape.com/api/og?type=drug&title=JTE-162&subtitle=JTE-162%20%C2%B7%20Akros%20Pharma%20Inc.&badge=phase%201 JTE-162 JTE-162 · Akros Pharma Inc. https://druglandscape.com/drug/jte-451 https://druglandscape.com/api/og?type=drug&title=JTE-451&subtitle=JTE-451%20%C2%B7%20Akros%20Pharma%20Inc.&badge=phase%201 JTE-451 JTE-451 · Akros Pharma Inc. https://druglandscape.com/drug/jtm104 https://druglandscape.com/api/og?type=drug&title=JTM104&subtitle=JTM104%20%C2%B7%20Jetema%20Co.%2C%20Ltd.&badge=phase%201 JTM104 JTM104 · Jetema Co., Ltd. https://druglandscape.com/drug/jtm201 https://druglandscape.com/api/og?type=drug&title=JTM201&subtitle=JTM201%20%C2%B7%20Jetema%20USA%20Inc.&badge=phase%202 JTM201 JTM201 · Jetema USA Inc. https://druglandscape.com/drug/jtr-161 https://druglandscape.com/api/og?type=drug&title=JTR-161&subtitle=JTR-161%20%C2%B7%20Teijin%20Pharma%20Limited&badge=phase%201 JTR-161 JTR-161 · Teijin Pharma Limited https://druglandscape.com/drug/jtt-130 https://druglandscape.com/api/og?type=drug&title=JTT-130&subtitle=JTT-130%20%C2%B7%20Akros%20Pharma%20Inc.&badge=phase%202 JTT-130 JTT-130 · Akros Pharma Inc. https://druglandscape.com/drug/jtt-302 https://druglandscape.com/api/og?type=drug&title=JTT-302&subtitle=JTT-302%20%C2%B7%20Akros%20Pharma%20Inc.&badge=phase%202 JTT-302 JTT-302 · Akros Pharma Inc. https://druglandscape.com/drug/jtt-851 https://druglandscape.com/api/og?type=drug&title=JTT-851&subtitle=JTT-851%20%C2%B7%20Akros%20Pharma%20Inc.&badge=phase%202 JTT-851 JTT-851 · Akros Pharma Inc. https://druglandscape.com/drug/jtx-2011 https://druglandscape.com/api/og?type=drug&title=JTX-2011&subtitle=JTX-2011%20%C2%B7%20Jounce%20Therapeutics%2C%20Inc.&badge=phase%201 JTX-2011 JTX-2011 · Jounce Therapeutics, Inc. https://druglandscape.com/drug/jtx-4014 https://druglandscape.com/api/og?type=drug&title=JTX-4014&subtitle=JTX-4014%20%C2%B7%20Jounce%20Therapeutics%2C%20Inc.&badge=phase%201 JTX-4014 JTX-4014 · Jounce Therapeutics, Inc. https://druglandscape.com/drug/jtx-8064 https://druglandscape.com/api/og?type=drug&title=JTX-8064&subtitle=JTX-8064%20%C2%B7%20Jounce%20Therapeutics%2C%20Inc.&badge=phase%201 JTX-8064 JTX-8064 · Jounce Therapeutics, Inc. https://druglandscape.com/drug/jtz-951-14c-jtz-951 https://druglandscape.com/api/og?type=drug&title=JTZ-951%2C%2014C-JTZ-951&subtitle=JTZ-951%2C%2014C-JTZ-951%20%C2%B7%20Akros%20Pharma%20Inc.&badge=phase%201 JTZ-951, 14C-JTZ-951 JTZ-951, 14C-JTZ-951 · Akros Pharma Inc. https://druglandscape.com/drug/juanbi-pill https://druglandscape.com/api/og?type=drug&title=Juanbi%20pill&subtitle=Juanbi%20pill%20%C2%B7%20Cui%20xuejun&badge=phase%202 Juanbi pill Juanbi pill · Cui xuejun https://druglandscape.com/drug/juvederm-ultra-plus-xc https://druglandscape.com/api/og?type=drug&title=Juvederm%C2%AE%20ULTRA%20PLUS%20XC&subtitle=Juvederm%C2%AE%20ULTRA%20PLUS%20XC%20%C2%B7%20Jetema%20Co.%2C%20Ltd.&badge=phase%201 Juvederm® ULTRA PLUS XC Juvederm® ULTRA PLUS XC · Jetema Co., Ltd. https://druglandscape.com/drug/jvs-100 https://druglandscape.com/api/og?type=drug&title=JVS-100&subtitle=JVS-100%20%C2%B7%20Juventas%20Therapeutics%2C%20Inc.&badge=phase%202 JVS-100 JVS-100 · Juventas Therapeutics, Inc. https://druglandscape.com/drug/jw2286 https://druglandscape.com/api/og?type=drug&title=JW2286&subtitle=JW2286%20%C2%B7%20JW%20Pharmaceutical&badge=phase%201 JW2286 JW2286 · JW Pharmaceutical https://druglandscape.com/drug/jx09 https://druglandscape.com/api/og?type=drug&title=JX09&subtitle=JX09%20%C2%B7%20Ji%20Xing%20Pharmaceuticals%20Australia%20Pty%20Ltd&badge=phase%201 JX09 JX09 · Ji Xing Pharmaceuticals Australia Pty Ltd https://druglandscape.com/drug/jx11502ma https://druglandscape.com/api/og?type=drug&title=JX11502MA&subtitle=JX11502MA%20%C2%B7%20Zhejiang%20Jingxin%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 JX11502MA JX11502MA · Zhejiang Jingxin Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jx2105 https://druglandscape.com/api/og?type=drug&title=JX2105&subtitle=JX2105%20%C2%B7%20Zhejiang%20Jingxin%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 JX2105 JX2105 · Zhejiang Jingxin Pharmaceutical Co., Ltd. https://druglandscape.com/drug/jy09 https://druglandscape.com/api/og?type=drug&title=JY09&subtitle=JY09%20%C2%B7%20Beijing%20Dongfang%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 JY09 JY09 · Beijing Dongfang Biotech Co., Ltd. https://druglandscape.com/drug/jyp0035-experimental-drug-treatment https://druglandscape.com/api/og?type=drug&title=JYP0035%20Experimental%20Drug%20Treatment&subtitle=JYP0035%20Experimental%20Drug%20Treatment%20%C2%B7%20Chengdu%20JOYO%20pharma%20Co.%2C%20Ltd.&badge=phase%201 JYP0035 Experimental Drug Treatment JYP0035 Experimental Drug Treatment · Chengdu JOYO pharma Co., Ltd. https://druglandscape.com/drug/jyp0061 https://druglandscape.com/api/og?type=drug&title=JYP0061&subtitle=JYP0061%20%C2%B7%20Guangzhou%20JOYO%20Pharma%20Co.%2C%20Ltd&badge=phase%202 JYP0061 JYP0061 · Guangzhou JOYO Pharma Co., Ltd https://druglandscape.com/drug/jzoloft https://druglandscape.com/api/og?type=drug&title=JZoloft&subtitle=JZoloft%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%201 JZoloft JZoloft · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/k-757 https://druglandscape.com/api/og?type=drug&title=K-757&subtitle=K-757%20%C2%B7%20Kallyope%20Inc.&badge=phase%201 K-757 K-757 · Kallyope Inc. https://druglandscape.com/drug/k-757-and-k-833 https://druglandscape.com/api/og?type=drug&title=K-757%20and%20K-833&subtitle=K-757%20and%20K-833%20%C2%B7%20Kallyope%20Inc.&badge=phase%201 K-757 and K-833 K-757 and K-833 · Kallyope Inc. https://druglandscape.com/drug/k-757-and-open-label-sitagliptin https://druglandscape.com/api/og?type=drug&title=K-757%20and%20open-label%20sitagliptin&subtitle=K-757%20and%20open-label%20sitagliptin%20%C2%B7%20Kallyope%20Inc.&badge=phase%201 K-757 and open-label sitagliptin K-757 and open-label sitagliptin · Kallyope Inc. https://druglandscape.com/drug/k-cab-tab-with-water https://druglandscape.com/api/og?type=drug&title=K-CAB%20tab.%20with%20water&subtitle=K-CAB%20tab.%20with%20water%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 K-CAB tab. with water K-CAB tab. with water · HK inno.N Corporation https://druglandscape.com/drug/k1-70-intramuscular-or-k1-70-intravenous https://druglandscape.com/api/og?type=drug&title=K1-70%20intramuscular%20or%20K1-70%20intravenous&subtitle=K1-70%20intramuscular%20or%20K1-70%20intravenous%20%C2%B7%20AV7%20Limited&badge=phase%201 K1-70 intramuscular or K1-70 intravenous K1-70 intramuscular or K1-70 intravenous · AV7 Limited https://druglandscape.com/drug/k40b https://druglandscape.com/api/og?type=drug&title=K40b&subtitle=K40b%20%C2%B7%20Moberg%20Pharma%20AB&badge=phase%202 K40b K40b · Moberg Pharma AB https://druglandscape.com/drug/ka2237 https://druglandscape.com/api/og?type=drug&title=KA2237&subtitle=KA2237%20%C2%B7%20Karus%20Therapeutics%20Limited&badge=phase%201 KA2237 KA2237 · Karus Therapeutics Limited https://druglandscape.com/drug/ka34 https://druglandscape.com/api/og?type=drug&title=KA34&subtitle=KA34%20%C2%B7%20Calibr%2C%20a%20division%20of%20Scripps%20Research&badge=phase%201 KA34 KA34 · Calibr, a division of Scripps Research https://druglandscape.com/drug/kai-7535 https://druglandscape.com/api/og?type=drug&title=KAI-7535&subtitle=KAI-7535%20%C2%B7%20Kailera&badge=phase%201 KAI-7535 KAI-7535 · Kailera https://druglandscape.com/drug/kamada-aat-for-inhalation https://druglandscape.com/api/og?type=drug&title=Kamada%20AAT%20for%20inhalation&subtitle=Kamada%20AAT%20for%20inhalation%20%C2%B7%20Kamada%2C%20Ltd.&badge=phase%202 Kamada AAT for inhalation Kamada AAT for inhalation · Kamada, Ltd. https://druglandscape.com/drug/kamada-anti-sars-cov-2 https://druglandscape.com/api/og?type=drug&title=Kamada%20Anti-SARS-CoV-2&subtitle=Kamada%20Anti-SARS-CoV-2%20%C2%B7%20Kamada%2C%20Ltd.&badge=phase%201 Kamada Anti-SARS-CoV-2 Kamada Anti-SARS-CoV-2 · Kamada, Ltd. https://druglandscape.com/drug/kamada-api https://druglandscape.com/api/og?type=drug&title=Kamada-API&subtitle=Kamada-API%20%C2%B7%20Kamada%2C%20Ltd.&badge=phase%202 Kamada-API Kamada-API · Kamada, Ltd. https://druglandscape.com/drug/kamuvudine-9 https://druglandscape.com/api/og?type=drug&title=Kamuvudine-9&subtitle=Kamuvudine-9%20%C2%B7%20Michelle%20Abou-Jaoude&badge=phase%201 Kamuvudine-9 Kamuvudine-9 · Michelle Abou-Jaoude https://druglandscape.com/drug/kamuvudine-k9 https://druglandscape.com/api/og?type=drug&title=Kamuvudine%20K9&subtitle=Kamuvudine%20K9%20%C2%B7%20Dr.%20Bryan%20Strelow&badge=phase%201 Kamuvudine K9 Kamuvudine K9 · Dr. Bryan Strelow https://druglandscape.com/drug/kand145 https://druglandscape.com/api/og?type=drug&title=KAND145&subtitle=KAND145%20%C2%B7%20Novakand%20Pharma%20AB&badge=phase%201 KAND145 KAND145 · Novakand Pharma AB https://druglandscape.com/drug/kangdaprevir-sodium-tablet https://druglandscape.com/api/og?type=drug&title=Kangdaprevir%20Sodium%20Tablet&subtitle=Kangdaprevir%20Sodium%20Tablet%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 Kangdaprevir Sodium Tablet Kangdaprevir Sodium Tablet · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/kanglaite-injection-plus-gemcitabine https://druglandscape.com/api/og?type=drug&title=Kanglaite%20Injection%20plus%20gemcitabine&subtitle=Kanglaite%20Injection%20plus%20gemcitabine%20%C2%B7%20KangLaiTe%20USA&badge=phase%202 Kanglaite Injection plus gemcitabine Kanglaite Injection plus gemcitabine · KangLaiTe USA https://druglandscape.com/drug/kanion-capsule https://druglandscape.com/api/og?type=drug&title=Kanion%20Capsule&subtitle=Kanion%20Capsule%20%C2%B7%20Lianyungang%20Kanion%20Group%2C%20Ltd.&badge=phase%202 Kanion Capsule Kanion Capsule · Lianyungang Kanion Group, Ltd. https://druglandscape.com/drug/kappa-cd28-t-cells https://druglandscape.com/api/og?type=drug&title=Kappa%20CD28%20T%20cells&subtitle=Kappa%20CD28%20T%20cells%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Kappa CD28 T cells Kappa CD28 T cells · Baylor College of Medicine https://druglandscape.com/drug/kareniticin-and-cyclophosphamide https://druglandscape.com/api/og?type=drug&title=Kareniticin%20and%20cyclophosphamide&subtitle=Kareniticin%20and%20cyclophosphamide%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Kareniticin and cyclophosphamide Kareniticin and cyclophosphamide · Baylor College of Medicine https://druglandscape.com/drug/kb-gdt-01 https://druglandscape.com/api/og?type=drug&title=KB-GDT-01&subtitle=KB-GDT-01%20%C2%B7%20Kiromic%20BioPharma%20Inc.&badge=phase%201 KB-GDT-01 KB-GDT-01 · Kiromic BioPharma Inc. https://druglandscape.com/drug/kb001 https://druglandscape.com/api/og?type=drug&title=KB001&subtitle=KB001%20%C2%B7%20Humanigen%2C%20Inc.&badge=phase%201 KB001 KB001 · Humanigen, Inc. https://druglandscape.com/drug/kb001-a https://druglandscape.com/api/og?type=drug&title=KB001-A&subtitle=KB001-A%20%C2%B7%20Humanigen%2C%20Inc.&badge=phase%202 KB001-A KB001-A · Humanigen, Inc. https://druglandscape.com/drug/kb15a-vaginal-film https://druglandscape.com/api/og?type=drug&title=KB15A%20Vaginal%20Film&subtitle=KB15A%20Vaginal%20Film%20%C2%B7%20ZabBio%20Inc.&badge=phase%201 KB15A Vaginal Film KB15A Vaginal Film · ZabBio Inc. https://druglandscape.com/drug/kb2115 https://druglandscape.com/api/og?type=drug&title=KB2115&subtitle=KB2115%20%C2%B7%20Karo%20Bio%20AB&badge=phase%202 KB2115 KB2115 · Karo Bio AB https://druglandscape.com/drug/kb304 https://druglandscape.com/api/og?type=drug&title=KB304&subtitle=KB304%20%C2%B7%20Krystal%20Biotech%2C%20Inc.&badge=phase%201 KB304 KB304 · Krystal Biotech, Inc. https://druglandscape.com/drug/kb707 https://druglandscape.com/api/og?type=drug&title=KB707&subtitle=KB707%20%C2%B7%20Krystal%20Biotech%2C%20Inc.&badge=phase%201 KB707 KB707 · Krystal Biotech, Inc. https://druglandscape.com/drug/kb801 https://druglandscape.com/api/og?type=drug&title=KB801&subtitle=KB801%20%C2%B7%20Krystal%20Biotech%2C%20Inc.&badge=phase%201 KB801 KB801 · Krystal Biotech, Inc. https://druglandscape.com/drug/kba1412 https://druglandscape.com/api/og?type=drug&title=KBA1412&subtitle=KBA1412%20%C2%B7%20Kling%20Biotherapeutics%20B.V.&badge=phase%201 KBA1412 KBA1412 · Kling Biotherapeutics B.V. https://druglandscape.com/drug/kbl693 https://druglandscape.com/api/og?type=drug&title=KBL693&subtitle=KBL693%20%C2%B7%20KoBioLabs&badge=phase%201 KBL693 KBL693 · KoBioLabs https://druglandscape.com/drug/kbp-5209 https://druglandscape.com/api/og?type=drug&title=KBP-5209&subtitle=KBP-5209%20%C2%B7%20Sihuan%20Pharmaceutical%20Holdings%20Group%20Ltd.&badge=phase%201 KBP-5209 KBP-5209 · Sihuan Pharmaceutical Holdings Group Ltd. https://druglandscape.com/drug/kbp-7072 https://druglandscape.com/api/og?type=drug&title=KBP-7072&subtitle=KBP-7072%20%C2%B7%20KBP%20Biosciences&badge=phase%201 KBP-7072 KBP-7072 · KBP Biosciences https://druglandscape.com/drug/kbsa301 https://druglandscape.com/api/og?type=drug&title=KBSA301&subtitle=KBSA301%20%C2%B7%20Aridis%20Pharmaceuticals%2C%20Inc.&badge=phase%201 KBSA301 KBSA301 · Aridis Pharmaceuticals, Inc. https://druglandscape.com/drug/kc1086 https://druglandscape.com/api/og?type=drug&title=KC1086&subtitle=KC1086%20%C2%B7%20Beijing%20Konruns%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 KC1086 KC1086 · Beijing Konruns Pharmaceutical Co., Ltd. https://druglandscape.com/drug/kcentra-a-4-factor-pcc https://druglandscape.com/api/og?type=drug&title=Kcentra%2C%20a%204-factor%20PCC&subtitle=Kcentra%2C%20a%204-factor%20PCC%20%C2%B7%20Janssen%20Scientific%20Affairs%2C%20LLC&badge=phase%201 Kcentra, a 4-factor PCC Kcentra, a 4-factor PCC · Janssen Scientific Affairs, LLC https://druglandscape.com/drug/kd-025 https://druglandscape.com/api/og?type=drug&title=KD-025&subtitle=KD-025%20%C2%B7%20jianming%20xu&badge=phase%201 KD-025 KD-025 · jianming xu https://druglandscape.com/drug/kd025 https://druglandscape.com/api/og?type=drug&title=KD025&subtitle=KD025%20%C2%B7%20Kadmon%2C%20a%20Sanofi%20Company&badge=phase%202 KD025 KD025 · Kadmon, a Sanofi Company https://druglandscape.com/drug/kd6005 https://druglandscape.com/api/og?type=drug&title=KD6005&subtitle=KD6005%20%C2%B7%20Shanghai%20Kanda%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 KD6005 KD6005 · Shanghai Kanda Biotechnology Co., Ltd. https://druglandscape.com/drug/kdr2-2 https://druglandscape.com/api/og?type=drug&title=KDR2-2&subtitle=KDR2-2%20%C2%B7%20Guangzhou%20HuiBoRui%20Biological%20Pharmaceutical%20Technology%20Co.%20Ltd&badge=phase%201 KDR2-2 KDR2-2 · Guangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd https://druglandscape.com/drug/kds2010 https://druglandscape.com/api/og?type=drug&title=KDS2010&subtitle=KDS2010%20%C2%B7%20NeuroBiogen%20Co.%2C%20Ltd&badge=phase%202 KDS2010 KDS2010 · NeuroBiogen Co., Ltd https://druglandscape.com/drug/kdstem-inj https://druglandscape.com/api/og?type=drug&title=KDSTEM%20Inj.&subtitle=KDSTEM%20Inj.%20%C2%B7%20EHL%20Bio%20Co.%2C%20Ltd.&badge=phase%201 KDSTEM Inj. KDSTEM Inj. · EHL Bio Co., Ltd. https://druglandscape.com/drug/kdt-3594 https://druglandscape.com/api/og?type=drug&title=KDT-3594&subtitle=KDT-3594%20%C2%B7%20Kissei%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 KDT-3594 KDT-3594 · Kissei Pharmaceutical Co., Ltd. https://druglandscape.com/drug/keli-101 https://druglandscape.com/api/og?type=drug&title=KELI-101&subtitle=KELI-101%20%C2%B7%20Kelifarma&badge=phase%201 KELI-101 KELI-101 · Kelifarma https://druglandscape.com/drug/kenacort-in-orabase https://druglandscape.com/api/og?type=drug&title=Kenacort%20in%20orabase&subtitle=Kenacort%20in%20orabase%20%C2%B7%20Hams%20Hamed%20Abdelrahman&badge=phase%201 Kenacort in orabase Kenacort in orabase · Hams Hamed Abdelrahman https://druglandscape.com/drug/ketamine-effect-on-intracranial-pressure https://druglandscape.com/api/og?type=drug&title=Ketamine%2C%20effect%20on%20intracranial%20pressure&subtitle=Ketamine%2C%20effect%20on%20intracranial%20pressure%20%C2%B7%20Rambam%20Health%20Care%20Campus&badge=phase%201 Ketamine, effect on intracranial pressure Ketamine, effect on intracranial pressure · Rambam Health Care Campus https://druglandscape.com/drug/ketamine-enhanced-prolonged-exposure https://druglandscape.com/api/og?type=drug&title=ketamine-enhanced%20prolonged%20exposure&subtitle=ketamine-enhanced%20prolonged%20exposure%20%C2%B7%20Minneapolis%20Veterans%20Affairs%20Medical%20Center&badge=phase%201 ketamine-enhanced prolonged exposure ketamine-enhanced prolonged exposure · Minneapolis Veterans Affairs Medical Center https://druglandscape.com/drug/ketoconazole-pill https://druglandscape.com/api/og?type=drug&title=Ketoconazole%20Pill&subtitle=Ketoconazole%20Pill%20%C2%B7%20Peter%20y.%20Liu&badge=phase%202 Ketoconazole Pill Ketoconazole Pill · Peter y. Liu https://druglandscape.com/drug/ketoconozole-tablets https://druglandscape.com/api/og?type=drug&title=Ketoconozole%20tablets&subtitle=Ketoconozole%20tablets%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Ketoconozole tablets Ketoconozole tablets · GlaxoSmithKline https://druglandscape.com/drug/ketoprofen-oral-product https://druglandscape.com/api/og?type=drug&title=Ketoprofen%20Oral%20Product&subtitle=Ketoprofen%20Oral%20Product%20%C2%B7%20Aziende%20Chimiche%20Riunite%20Angelini%20Francesco%20S.p.A&badge=phase%201 Ketoprofen Oral Product Ketoprofen Oral Product · Aziende Chimiche Riunite Angelini Francesco S.p.A https://druglandscape.com/drug/ketotifen-4-0-patch https://druglandscape.com/api/og?type=drug&title=Ketotifen%204.0%25%20Patch&subtitle=Ketotifen%204.0%25%20Patch%20%C2%B7%20Senju%20USA%2C%20Inc.&badge=phase%202 Ketotifen 4.0% Patch Ketotifen 4.0% Patch · Senju USA, Inc. https://druglandscape.com/drug/ketotifen-fumarate-0-25-cream https://druglandscape.com/api/og?type=drug&title=Ketotifen%20Fumarate%200.25%25%20Cream&subtitle=Ketotifen%20Fumarate%200.25%25%20Cream%20%C2%B7%20Center%20for%20Vulvovaginal%20Disorders&badge=phase%202 Ketotifen Fumarate 0.25% Cream Ketotifen Fumarate 0.25% Cream · Center for Vulvovaginal Disorders https://druglandscape.com/drug/keytruda-us https://druglandscape.com/api/og?type=drug&title=Keytruda%20-%20US&subtitle=Keytruda%20-%20US%20%C2%B7%20Sandoz&badge=phase%201 Keytruda - US Keytruda - US · Sandoz https://druglandscape.com/drug/kgx101-and-envafolimab https://druglandscape.com/api/og?type=drug&title=KGX101%20and%20Envafolimab&subtitle=KGX101%20and%20Envafolimab%20%C2%B7%20Kangabio%20AUSTRALIA%20LTD%20PTY&badge=phase%201 KGX101 and Envafolimab KGX101 and Envafolimab · Kangabio AUSTRALIA LTD PTY https://druglandscape.com/drug/kh001 https://druglandscape.com/api/og?type=drug&title=KH001&subtitle=KH001%20%C2%B7%20Byoung-Moo%20Seo&badge=phase%202 KH001 KH001 · Byoung-Moo Seo https://druglandscape.com/drug/kh176 https://druglandscape.com/api/og?type=drug&title=KH176&subtitle=KH176%20%C2%B7%20Khondrion%20BV&badge=phase%202 KH176 KH176 · Khondrion BV https://druglandscape.com/drug/kh607-tablets https://druglandscape.com/api/og?type=drug&title=KH607%20tablets&subtitle=KH607%20tablets%20%C2%B7%20Chengdu%20Kanghong%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 KH607 tablets KH607 tablets · Chengdu Kanghong Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/kh631 https://druglandscape.com/api/og?type=drug&title=KH631&subtitle=KH631%20%C2%B7%20Chengdu%20Origen%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 KH631 KH631 · Chengdu Origen Biotechnology Co., Ltd. https://druglandscape.com/drug/kh658 https://druglandscape.com/api/og?type=drug&title=KH658&subtitle=KH658%20%C2%B7%20Chengdu%20Origen%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 KH658 KH658 · Chengdu Origen Biotechnology Co., Ltd. https://druglandscape.com/drug/kh801 https://druglandscape.com/api/og?type=drug&title=KH801&subtitle=KH801%20%C2%B7%20Beijing%20Kanghong%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 KH801 KH801 · Beijing Kanghong Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/kh902 https://druglandscape.com/api/og?type=drug&title=KH902&subtitle=KH902%20%C2%B7%20Chengdu%20Kanghong%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 KH902 KH902 · Chengdu Kanghong Biotech Co., Ltd. https://druglandscape.com/drug/khat-leaves https://druglandscape.com/api/og?type=drug&title=Khat%20leaves&subtitle=Khat%20leaves%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%201 Khat leaves Khat leaves · Sheba Medical Center https://druglandscape.com/drug/khk2375 https://druglandscape.com/api/og?type=drug&title=KHK2375&subtitle=KHK2375%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%201 KHK2375 KHK2375 · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/khk4563 https://druglandscape.com/api/og?type=drug&title=KHK4563&subtitle=KHK4563%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%202 KHK4563 KHK4563 · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/khk4951 https://druglandscape.com/api/og?type=drug&title=KHK4951&subtitle=KHK4951%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%202 KHK4951 KHK4951 · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/khk6188 https://druglandscape.com/api/og?type=drug&title=KHK6188&subtitle=KHK6188%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%202 KHK6188 KHK6188 · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/khk7580-high-dose https://druglandscape.com/api/og?type=drug&title=KHK7580%20high%20dose&subtitle=KHK7580%20high%20dose%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%202 KHK7580 high dose KHK7580 high dose · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/khk7580-low-dose https://druglandscape.com/api/og?type=drug&title=KHK7580%20low%20dose&subtitle=KHK7580%20low%20dose%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%202 KHK7580 low dose KHK7580 low dose · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/khk7580-middle-dose https://druglandscape.com/api/og?type=drug&title=KHK7580%20middle%20dose&subtitle=KHK7580%20middle%20dose%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%202 KHK7580 middle dose KHK7580 middle dose · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/khn702 https://druglandscape.com/api/og?type=drug&title=KHN702&subtitle=KHN702%20%C2%B7%20Chengdu%20Kanghong%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 KHN702 KHN702 · Chengdu Kanghong Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/kin-2787 https://druglandscape.com/api/og?type=drug&title=KIN-2787&subtitle=KIN-2787%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%201 KIN-2787 KIN-2787 · Pierre Fabre Medicament https://druglandscape.com/drug/kin-2787-and-binimetinib https://druglandscape.com/api/og?type=drug&title=KIN-2787%20and%20binimetinib&subtitle=KIN-2787%20and%20binimetinib%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%201 KIN-2787 and binimetinib KIN-2787 and binimetinib · Pierre Fabre Medicament https://druglandscape.com/drug/kine-101 https://druglandscape.com/api/og?type=drug&title=KINE-101&subtitle=KINE-101%20%C2%B7%20Kine%20Sciences%20Co.%2C%20Ltd.&badge=phase%201 KINE-101 KINE-101 · Kine Sciences Co., Ltd. https://druglandscape.com/drug/kio-104 https://druglandscape.com/api/og?type=drug&title=KIO-104&subtitle=KIO-104%20%C2%B7%20Kiora%20Pharmaceuticals%2C%20Inc.&badge=phase%202 KIO-104 KIO-104 · Kiora Pharmaceuticals, Inc. https://druglandscape.com/drug/kirim-kongo-vax https://druglandscape.com/api/og?type=drug&title=KIRIM-KONGO-VAX&subtitle=KIRIM-KONGO-VAX%20%C2%B7%20The%20Scientific%20and%20Technological%20Research%20Council%20of%20Turkey&badge=phase%201 KIRIM-KONGO-VAX KIRIM-KONGO-VAX · The Scientific and Technological Research Council of Turkey https://druglandscape.com/drug/kisspeptin-112-121 https://druglandscape.com/api/og?type=drug&title=Kisspeptin%20112-121&subtitle=Kisspeptin%20112-121%20%C2%B7%20Stephanie%20B.%20Seminara%2C%20MD&badge=phase%202 Kisspeptin 112-121 Kisspeptin 112-121 · Stephanie B. Seminara, MD https://druglandscape.com/drug/kit2014 https://druglandscape.com/api/og?type=drug&title=KIT2014&subtitle=KIT2014%20%C2%B7%20Kither%20Biotech%20Srl&badge=phase%201 KIT2014 KIT2014 · Kither Biotech Srl https://druglandscape.com/drug/kivu-107 https://druglandscape.com/api/og?type=drug&title=KIVU-107&subtitle=KIVU-107%20%C2%B7%20Kivu%20Bioscience%20Inc.&badge=phase%201 KIVU-107 KIVU-107 · Kivu Bioscience Inc. https://druglandscape.com/drug/kj101 https://druglandscape.com/api/og?type=drug&title=KJ101&subtitle=KJ101%20%C2%B7%20Shanghai%20Bao%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 KJ101 KJ101 · Shanghai Bao Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/kj103 https://druglandscape.com/api/og?type=drug&title=KJ103&subtitle=KJ103%20%C2%B7%20Shanghai%20Bao%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 KJ103 KJ103 · Shanghai Bao Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/kk2223 https://druglandscape.com/api/og?type=drug&title=KK2223&subtitle=KK2223%20%C2%B7%20Kyowa%20Kirin%2C%20Inc.&badge=phase%201 KK2223 KK2223 · Kyowa Kirin, Inc. https://druglandscape.com/drug/kk2260 https://druglandscape.com/api/og?type=drug&title=KK2260&subtitle=KK2260%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%201 KK2260 KK2260 · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/kk2269 https://druglandscape.com/api/og?type=drug&title=KK2269&subtitle=KK2269%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%201 KK2269 KK2269 · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/kk2845-2 https://druglandscape.com/api/og?type=drug&title=KK2845_2&subtitle=KK2845_2%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%201 KK2845_2 KK2845_2 · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/kk2845-4 https://druglandscape.com/api/og?type=drug&title=KK2845_4&subtitle=KK2845_4%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%201 KK2845_4 KK2845_4 · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/kk2845-5 https://druglandscape.com/api/og?type=drug&title=KK2845_5&subtitle=KK2845_5%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%201 KK2845_5 KK2845_5 · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/kk3910 https://druglandscape.com/api/og?type=drug&title=KK3910&subtitle=KK3910%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%201 KK3910 KK3910 · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/kk4277 https://druglandscape.com/api/og?type=drug&title=KK4277&subtitle=KK4277%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%201 KK4277 KK4277 · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/kk8123 https://druglandscape.com/api/og?type=drug&title=KK8123&subtitle=KK8123%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%201 KK8123 KK8123 · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/kl003-cell-injection-drug-product https://druglandscape.com/api/og?type=drug&title=KL003%20Cell%20Injection%20Drug%20Product&subtitle=KL003%20Cell%20Injection%20Drug%20Product%20%C2%B7%20Kanglin%20Biotechnology%20(Hangzhou)%20Co.%2C%20Ltd.&badge=phase%201 KL003 Cell Injection Drug Product KL003 Cell Injection Drug Product · Kanglin Biotechnology (Hangzhou) Co., Ltd. https://druglandscape.com/drug/kl590586-capsule https://druglandscape.com/api/og?type=drug&title=KL590586%20Capsule&subtitle=KL590586%20Capsule%20%C2%B7%20Sichuan%20Kelun-Biotech%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 KL590586 Capsule KL590586 Capsule · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/kla478 https://druglandscape.com/api/og?type=drug&title=KLA478&subtitle=KLA478%20%C2%B7%20Hunan%20Kelun%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 KLA478 KLA478 · Hunan Kelun Pharmaceutical Co., Ltd. https://druglandscape.com/drug/kleb4v-target-dose https://druglandscape.com/api/og?type=drug&title=Kleb4V%20target%20dose&subtitle=Kleb4V%20target%20dose%20%C2%B7%20LimmaTech%20Biologics%20AG&badge=phase%201 Kleb4V target dose Kleb4V target dose · LimmaTech Biologics AG https://druglandscape.com/drug/klh-day-1 https://druglandscape.com/api/og?type=drug&title=KLH%20Day%201&subtitle=KLH%20Day%201%20%C2%B7%20Providence%20Health%20%26%20Services&badge=phase%201 KLH Day 1 KLH Day 1 · Providence Health & Services https://druglandscape.com/drug/klh-day-29 https://druglandscape.com/api/og?type=drug&title=KLH%20Day%2029&subtitle=KLH%20Day%2029%20%C2%B7%20Providence%20Health%20%26%20Services&badge=phase%201 KLH Day 29 KLH Day 29 · Providence Health & Services https://druglandscape.com/drug/klh-ono-4685 https://druglandscape.com/api/og?type=drug&title=KLH%2C%20ONO-4685&subtitle=KLH%2C%20ONO-4685%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 KLH, ONO-4685 KLH, ONO-4685 · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/klh-peptides-dendritic-cells https://druglandscape.com/api/og?type=drug&title=KLH%3B%20Peptides%3B%20Dendritic%20Cells&subtitle=KLH%3B%20Peptides%3B%20Dendritic%20Cells%20%C2%B7%20Dr.%20Nina%20Bhardwaj&badge=phase%201 KLH; Peptides; Dendritic Cells KLH; Peptides; Dendritic Cells · Dr. Nina Bhardwaj https://druglandscape.com/drug/klh-peptides-plus-montanide https://druglandscape.com/api/og?type=drug&title=KLH%2C%20peptides%20plus%20Montanide&subtitle=KLH%2C%20peptides%20plus%20Montanide%20%C2%B7%20Dr.%20Nina%20Bhardwaj&badge=phase%201 KLH, peptides plus Montanide KLH, peptides plus Montanide · Dr. Nina Bhardwaj https://druglandscape.com/drug/kln-1010 https://druglandscape.com/api/og?type=drug&title=KLN-1010&subtitle=KLN-1010%20%C2%B7%20Kelonia%20Therapeutics%2C%20Inc.&badge=phase%201 KLN-1010 KLN-1010 · Kelonia Therapeutics, Inc. https://druglandscape.com/drug/klonopin-wafers https://druglandscape.com/api/og?type=drug&title=Klonopin%20Wafers&subtitle=Klonopin%20Wafers%20%C2%B7%20Par%20Pharmaceutical%2C%20Inc.&badge=phase%201 Klonopin Wafers Klonopin Wafers · Par Pharmaceutical, Inc. https://druglandscape.com/drug/kls-0611 https://druglandscape.com/api/og?type=drug&title=KLS-0611&subtitle=KLS-0611%20%C2%B7%20Kissei%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 KLS-0611 KLS-0611 · Kissei Pharmaceutical Co., Ltd. https://druglandscape.com/drug/km-001-1-cream-12-weeks-treatment https://druglandscape.com/api/og?type=drug&title=KM-001%201%25%20cream%2012%20weeks%20treatment&subtitle=KM-001%201%25%20cream%2012%20weeks%20treatment%20%C2%B7%20Kamari%20Pharma%20Ltd&badge=phase%201 KM-001 1% cream 12 weeks treatment KM-001 1% cream 12 weeks treatment · Kamari Pharma Ltd https://druglandscape.com/drug/km-001-1-cream-16-weeks-treatment https://druglandscape.com/api/og?type=drug&title=KM-001%201%25%20cream%2016%20weeks%20treatment&subtitle=KM-001%201%25%20cream%2016%20weeks%20treatment%20%C2%B7%20Kamari%20Pharma%20Ltd&badge=phase%201 KM-001 1% cream 16 weeks treatment KM-001 1% cream 16 weeks treatment · Kamari Pharma Ltd https://druglandscape.com/drug/km-001-cream-1-12-weeks-treatment https://druglandscape.com/api/og?type=drug&title=KM-001%20cream%201%25%2012%20weeks%20treatment.&subtitle=KM-001%20cream%201%25%2012%20weeks%20treatment.%20%C2%B7%20Kamari%20Pharma%20Ltd&badge=phase%201 KM-001 cream 1% 12 weeks treatment. KM-001 cream 1% 12 weeks treatment. · Kamari Pharma Ltd https://druglandscape.com/drug/km-001-cream-1-16-weeks-treatment https://druglandscape.com/api/og?type=drug&title=KM-001%20cream%201%25%2016%20weeks%20treatment.&subtitle=KM-001%20cream%201%25%2016%20weeks%20treatment.%20%C2%B7%20Kamari%20Pharma%20Ltd&badge=phase%201 KM-001 cream 1% 16 weeks treatment. KM-001 cream 1% 16 weeks treatment. · Kamari Pharma Ltd https://druglandscape.com/drug/km-023 https://druglandscape.com/api/og?type=drug&title=KM-023&subtitle=KM-023%20%C2%B7%20Kainos%20Medicine%20Inc.&badge=phase%201 KM-023 KM-023 · Kainos Medicine Inc. https://druglandscape.com/drug/km-819 https://druglandscape.com/api/og?type=drug&title=KM-819&subtitle=KM-819%20%C2%B7%20FAScinate%20Therapeutics%20Inc.&badge=phase%202 KM-819 KM-819 · FAScinate Therapeutics Inc. https://druglandscape.com/drug/km257-bispecific-antibody https://druglandscape.com/api/og?type=drug&title=KM257%20Bispecific%20antibody&subtitle=KM257%20Bispecific%20antibody%20%C2%B7%20Xuanzhu%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 KM257 Bispecific antibody KM257 Bispecific antibody · Xuanzhu Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/km501 https://druglandscape.com/api/og?type=drug&title=KM501&subtitle=KM501%20%C2%B7%20Xuanzhu%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 KM501 KM501 · Xuanzhu Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/km602 https://druglandscape.com/api/og?type=drug&title=KM602&subtitle=KM602%20%C2%B7%20Xuanzhu%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 KM602 KM602 · Xuanzhu Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/kmy-tablets https://druglandscape.com/api/og?type=drug&title=KMY%20Tablets&subtitle=KMY%20Tablets%20%C2%B7%20Lei%20Yunshang%20Group&badge=phase%201 KMY Tablets KMY Tablets · Lei Yunshang Group https://druglandscape.com/drug/kn-002 https://druglandscape.com/api/og?type=drug&title=KN-002&subtitle=KN-002%20%C2%B7%20Kinaset%20Therapeutics%20Inc&badge=phase%201 KN-002 KN-002 · Kinaset Therapeutics Inc https://druglandscape.com/drug/kn015 https://druglandscape.com/api/og?type=drug&title=KN015&subtitle=KN015%20%C2%B7%20Alphamab%20Jilin%20Co.%2C%20Ltd.&badge=phase%201 KN015 KN015 · Alphamab Jilin Co., Ltd. https://druglandscape.com/drug/kn026-monotherapy https://druglandscape.com/api/og?type=drug&title=KN026%20monotherapy&subtitle=KN026%20monotherapy%20%C2%B7%20Jiangsu%20Alphamab%20Biopharmaceuticals%20Co.%2C%20Ltd&badge=phase%202 KN026 monotherapy KN026 monotherapy · Jiangsu Alphamab Biopharmaceuticals Co., Ltd https://druglandscape.com/drug/kn035 https://druglandscape.com/api/og?type=drug&title=KN035&subtitle=KN035%20%C2%B7%203D%20Medicines%20(Sichuan)%20Co.%2C%20Ltd.&badge=phase%202 KN035 KN035 · 3D Medicines (Sichuan) Co., Ltd. https://druglandscape.com/drug/kn044 https://druglandscape.com/api/og?type=drug&title=KN044&subtitle=KN044%20%C2%B7%20Changchun%20Intellicrown%20Pharmaceutical%20Co.%20LTD&badge=phase%201 KN044 KN044 · Changchun Intellicrown Pharmaceutical Co. LTD https://druglandscape.com/drug/kn060 https://druglandscape.com/api/og?type=drug&title=KN060&subtitle=KN060%20%C2%B7%20Suzhou%20Alphamab%20Co.%2C%20Ltd.&badge=phase%201 KN060 KN060 · Suzhou Alphamab Co., Ltd. https://druglandscape.com/drug/kn060-middle https://druglandscape.com/api/og?type=drug&title=KN060%20Middle&subtitle=KN060%20Middle%20%C2%B7%20Suzhou%20Alphamab%20Co.%2C%20Ltd.&badge=phase%202 KN060 Middle KN060 Middle · Suzhou Alphamab Co., Ltd. https://druglandscape.com/drug/kn069 https://druglandscape.com/api/og?type=drug&title=KN069&subtitle=KN069%20%C2%B7%20Suzhou%20Alphamab%20Co.%2C%20Ltd.&badge=phase%201 KN069 KN069 · Suzhou Alphamab Co., Ltd. https://druglandscape.com/drug/knt-0916 https://druglandscape.com/api/og?type=drug&title=KNT-0916&subtitle=KNT-0916%20%C2%B7%20KinoTeck%20Therapeutics%20Co.%2C%20Ltd&badge=phase%201 KNT-0916 KNT-0916 · KinoTeck Therapeutics Co., Ltd https://druglandscape.com/drug/knx100 https://druglandscape.com/api/og?type=drug&title=KNX100&subtitle=KNX100%20%C2%B7%20Kinoxis%20Therapeutics%20Pty%20Ltd&badge=phase%201 KNX100 KNX100 · Kinoxis Therapeutics Pty Ltd https://druglandscape.com/drug/kogenate-fs https://druglandscape.com/api/og?type=drug&title=Kogenate%20FS&subtitle=Kogenate%20FS%20%C2%B7%20Octapharma&badge=phase%202 Kogenate FS Kogenate FS · Octapharma https://druglandscape.com/drug/kp001 https://druglandscape.com/api/og?type=drug&title=KP001&subtitle=KP001%20%C2%B7%20Kokua%20Pharma%20Inc.&badge=phase%201 KP001 KP001 · Kokua Pharma Inc. https://druglandscape.com/drug/kpcxm18 https://druglandscape.com/api/og?type=drug&title=KPCXM18&subtitle=KPCXM18%20%C2%B7%20Kunming%20Pharmaceuticals%2C%20Inc.&badge=phase%201 KPCXM18 KPCXM18 · Kunming Pharmaceuticals, Inc. https://druglandscape.com/drug/kpg-818 https://druglandscape.com/api/og?type=drug&title=KPG-818&subtitle=KPG-818%20%C2%B7%20Kangpu%20Biopharmaceuticals%2C%20Ltd.&badge=phase%201 KPG-818 KPG-818 · Kangpu Biopharmaceuticals, Ltd. https://druglandscape.com/drug/kpg-818-high-dose https://druglandscape.com/api/og?type=drug&title=KPG-818%20high%20dose&subtitle=KPG-818%20high%20dose%20%C2%B7%20Kangpu%20Biopharmaceuticals%2C%20Ltd.&badge=phase%201 KPG-818 high dose KPG-818 high dose · Kangpu Biopharmaceuticals, Ltd. https://druglandscape.com/drug/kpi-121 https://druglandscape.com/api/og?type=drug&title=KPI-121&subtitle=KPI-121%20%C2%B7%20Kala%20Pharmaceuticals%2C%20Inc.&badge=phase%202 KPI-121 KPI-121 · Kala Pharmaceuticals, Inc. https://druglandscape.com/drug/kpi-121-1-0-ophthalmic-suspension https://druglandscape.com/api/og?type=drug&title=KPI-121%201.0%25%20Ophthalmic%20Suspension&subtitle=KPI-121%201.0%25%20Ophthalmic%20Suspension%20%C2%B7%20Kala%20Pharmaceuticals%2C%20Inc.&badge=phase%201 KPI-121 1.0% Ophthalmic Suspension KPI-121 1.0% Ophthalmic Suspension · Kala Pharmaceuticals, Inc. https://druglandscape.com/drug/kq-2003-car-t-cells https://druglandscape.com/api/og?type=drug&title=KQ-2003%20CAR%20T-cells&subtitle=KQ-2003%20CAR%20T-cells%20%C2%B7%20Novatim%20Immune%20Therapeutics%20(Zhejiang)%20Co.%2C%20Ltd.&badge=phase%201 KQ-2003 CAR T-cells KQ-2003 CAR T-cells · Novatim Immune Therapeutics (Zhejiang) Co., Ltd. https://druglandscape.com/drug/kq-791 https://druglandscape.com/api/og?type=drug&title=KQ-791&subtitle=KQ-791%20%C2%B7%20Kaneq%20Bioscience%20Limited&badge=phase%201 KQ-791 KQ-791 · Kaneq Bioscience Limited https://druglandscape.com/drug/kqb168 https://druglandscape.com/api/og?type=drug&title=KQB168&subtitle=KQB168%20%C2%B7%20Kumquat%20Biosciences%20Inc.&badge=phase%201 KQB168 KQB168 · Kumquat Biosciences Inc. https://druglandscape.com/drug/kqb365 https://druglandscape.com/api/og?type=drug&title=KQB365&subtitle=KQB365%20%C2%B7%20Kumquat%20Biosciences%20Inc.&badge=phase%201 KQB365 KQB365 · Kumquat Biosciences Inc. https://druglandscape.com/drug/kqb548 https://druglandscape.com/api/og?type=drug&title=KQB548&subtitle=KQB548%20%C2%B7%20Kumquat%20Biosciences%20Inc.&badge=phase%201 KQB548 KQB548 · Kumquat Biosciences Inc. https://druglandscape.com/drug/kr-uterblut https://druglandscape.com/api/og?type=drug&title=Kr%C3%A4uterblut&subtitle=Kr%C3%A4uterblut%20%C2%B7%20Northern%20Orthopaedic%20Division%2C%20Denmark&badge=phase%201 Kräuterblut Kräuterblut · Northern Orthopaedic Division, Denmark https://druglandscape.com/drug/kr230109-cream-0-05 https://druglandscape.com/api/og?type=drug&title=KR230109%20cream%200.05%25&subtitle=KR230109%20cream%200.05%25%20%C2%B7%20Jiangxi%20Kvvit%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 KR230109 cream 0.05% KR230109 cream 0.05% · Jiangxi Kvvit Pharmaceutical Co., Ltd. https://druglandscape.com/drug/kr23343 https://druglandscape.com/api/og?type=drug&title=KR23343&subtitle=KR23343%20%C2%B7%20Jiangxi%20Kvvit%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 KR23343 KR23343 · Jiangxi Kvvit Pharmaceutical Co., Ltd. https://druglandscape.com/drug/krc-01 https://druglandscape.com/api/og?type=drug&title=KRC-01&subtitle=KRC-01%20%C2%B7%20Kortuc%2C%20Inc.&badge=phase%201 KRC-01 KRC-01 · Kortuc, Inc. https://druglandscape.com/drug/krp-104 https://druglandscape.com/api/og?type=drug&title=KRP-104&subtitle=KRP-104%20%C2%B7%20ActivX%20Biosciences%2C%20Inc.&badge=phase%202 KRP-104 KRP-104 · ActivX Biosciences, Inc. https://druglandscape.com/drug/krp-a218 https://druglandscape.com/api/og?type=drug&title=KRP-A218&subtitle=KRP-A218%20%C2%B7%20Kyorin%20Pharmaceutical%20Co.%2CLtd&badge=phase%201 KRP-A218 KRP-A218 · Kyorin Pharmaceutical Co.,Ltd https://druglandscape.com/drug/krro-110 https://druglandscape.com/api/og?type=drug&title=KRRO-110&subtitle=KRRO-110%20%C2%B7%20Korro%20Bio%2C%20Inc.&badge=phase%201 KRRO-110 KRRO-110 · Korro Bio, Inc. https://druglandscape.com/drug/ksd-101 https://druglandscape.com/api/og?type=drug&title=KSD-101&subtitle=KSD-101%20%C2%B7%20Kousai%20Bio%20Co.%2C%20Ltd.&badge=phase%201 KSD-101 KSD-101 · Kousai Bio Co., Ltd. https://druglandscape.com/drug/ksd-201 https://druglandscape.com/api/og?type=drug&title=KSD-201&subtitle=KSD-201%20%C2%B7%20Kousai%20Bio%20Co.%2C%20Ltd.&badge=phase%201 KSD-201 KSD-201 · Kousai Bio Co., Ltd. https://druglandscape.com/drug/kshn001034 https://druglandscape.com/api/og?type=drug&title=KSHN001034&subtitle=KSHN001034%20%C2%B7%20Kashiv%20BioSciences%2C%20LLC&badge=phase%201 KSHN001034 KSHN001034 · Kashiv BioSciences, LLC https://druglandscape.com/drug/kso-0400 https://druglandscape.com/api/og?type=drug&title=KSO-0400&subtitle=KSO-0400%20%C2%B7%20Kissei%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 KSO-0400 KSO-0400 · Kissei Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ksp-0243 https://druglandscape.com/api/og?type=drug&title=KSP-0243&subtitle=KSP-0243%20%C2%B7%20Kissei%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 KSP-0243 KSP-0243 · Kissei Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ksp-1007 https://druglandscape.com/api/og?type=drug&title=KSP-1007&subtitle=KSP-1007%20%C2%B7%20Sumitovant%20Biopharma%2C%20Inc.&badge=phase%201 KSP-1007 KSP-1007 · Sumitovant Biopharma, Inc. https://druglandscape.com/drug/kst-6051 https://druglandscape.com/api/og?type=drug&title=KST-6051&subtitle=KST-6051%20%C2%B7%20Kestrel%20Therapeutics%2C%20Inc.&badge=phase%201 KST-6051 KST-6051 · Kestrel Therapeutics, Inc. https://druglandscape.com/drug/kt-253 https://druglandscape.com/api/og?type=drug&title=KT-253&subtitle=KT-253%20%C2%B7%20Kymera%20Therapeutics%2C%20Inc.&badge=phase%201 KT-253 KT-253 · Kymera Therapeutics, Inc. https://druglandscape.com/drug/kt-333 https://druglandscape.com/api/og?type=drug&title=KT-333&subtitle=KT-333%20%C2%B7%20Kymera%20Therapeutics%2C%20Inc.&badge=phase%201 KT-333 KT-333 · Kymera Therapeutics, Inc. https://druglandscape.com/drug/kt-413 https://druglandscape.com/api/og?type=drug&title=KT-413&subtitle=KT-413%20%C2%B7%20Kymera%20Therapeutics%2C%20Inc.&badge=phase%201 KT-413 KT-413 · Kymera Therapeutics, Inc. https://druglandscape.com/drug/kt-579 https://druglandscape.com/api/og?type=drug&title=KT-579&subtitle=KT-579%20%C2%B7%20Kymera%20Therapeutics%2C%20Inc.&badge=phase%201 KT-579 KT-579 · Kymera Therapeutics, Inc. https://druglandscape.com/drug/kt-621 https://druglandscape.com/api/og?type=drug&title=KT-621&subtitle=KT-621%20%C2%B7%20Kymera%20Therapeutics%2C%20Inc.&badge=phase%202 KT-621 KT-621 · Kymera Therapeutics, Inc. https://druglandscape.com/drug/kt07-capsule https://druglandscape.com/api/og?type=drug&title=KT07%20Capsule&subtitle=KT07%20Capsule%20%C2%B7%20Yiling%20Pharmaceutical%20Inc.&badge=phase%202 KT07 Capsule KT07 Capsule · Yiling Pharmaceutical Inc. https://druglandscape.com/drug/kt501 https://druglandscape.com/api/og?type=drug&title=KT501&subtitle=KT501%20%C2%B7%20Kali%20Therapeutics%2C%20Inc.&badge=phase%201 KT501 KT501 · Kali Therapeutics, Inc. https://druglandscape.com/drug/kte-c19 https://druglandscape.com/api/og?type=drug&title=KTE-C19&subtitle=KTE-C19%20%C2%B7%20Kite%2C%20A%20Gilead%20Company&badge=phase%201 KTE-C19 KTE-C19 · Kite, A Gilead Company https://druglandscape.com/drug/ktp-001 https://druglandscape.com/api/og?type=drug&title=KTP-001&subtitle=KTP-001%20%C2%B7%20Teijin%20America%2C%20Inc.&badge=phase%201 KTP-001 KTP-001 · Teijin America, Inc. https://druglandscape.com/drug/ktx-2001 https://druglandscape.com/api/og?type=drug&title=KTX-2001&subtitle=KTX-2001%20%C2%B7%20K36%20Therapeutics%2C%20Inc.&badge=phase%201 KTX-2001 KTX-2001 · K36 Therapeutics, Inc. https://druglandscape.com/drug/kukoamine-b-mesilate https://druglandscape.com/api/og?type=drug&title=Kukoamine%20B%20Mesilate&subtitle=Kukoamine%20B%20Mesilate%20%C2%B7%20Tianjin%20Chasesun%20Pharmaceutical%20Co.%2C%20LTD&badge=phase%201 Kukoamine B Mesilate Kukoamine B Mesilate · Tianjin Chasesun Pharmaceutical Co., LTD https://druglandscape.com/drug/kur-101 https://druglandscape.com/api/og?type=drug&title=KUR-101&subtitle=KUR-101%20%C2%B7%20Kures%2C%20Inc.&badge=phase%201 KUR-101 KUR-101 · Kures, Inc. https://druglandscape.com/drug/kus121-high-dose https://druglandscape.com/api/og?type=drug&title=KUS121%20high%20dose&subtitle=KUS121%20high%20dose%20%C2%B7%20Kyoto%20Drug%20Discovery%20and%20Development%20Co.%2C%20Ltd.&badge=phase%202 KUS121 high dose KUS121 high dose · Kyoto Drug Discovery and Development Co., Ltd. https://druglandscape.com/drug/kus121-low-dose https://druglandscape.com/api/og?type=drug&title=KUS121%20low%20dose&subtitle=KUS121%20low%20dose%20%C2%B7%20Kyoto%20Drug%20Discovery%20and%20Development%20Co.%2C%20Ltd.&badge=phase%202 KUS121 low dose KUS121 low dose · Kyoto Drug Discovery and Development Co., Ltd. https://druglandscape.com/drug/kva12123-dose-expansion https://druglandscape.com/api/og?type=drug&title=KVA12123%20-%20Dose%20Expansion&subtitle=KVA12123%20-%20Dose%20Expansion%20%C2%B7%20Kineta%20Inc.&badge=phase%201 KVA12123 - Dose Expansion KVA12123 - Dose Expansion · Kineta Inc. https://druglandscape.com/drug/kva12123-plus-pembrolizumab-dose-escalation https://druglandscape.com/api/og?type=drug&title=KVA12123%20Plus%20Pembrolizumab%20-%20Dose%20Escalation&subtitle=KVA12123%20Plus%20Pembrolizumab%20-%20Dose%20Escalation%20%C2%B7%20Kineta%20Inc.&badge=phase%201 KVA12123 Plus Pembrolizumab - Dose Escalation KVA12123 Plus Pembrolizumab - Dose Escalation · Kineta Inc. https://druglandscape.com/drug/kva12123-plus-pembrolizumab-dose-expansion https://druglandscape.com/api/og?type=drug&title=KVA12123%20Plus%20Pembrolizumab%20-%20Dose%20Expansion&subtitle=KVA12123%20Plus%20Pembrolizumab%20-%20Dose%20Expansion%20%C2%B7%20Kineta%20Inc.&badge=phase%201 KVA12123 Plus Pembrolizumab - Dose Expansion KVA12123 Plus Pembrolizumab - Dose Expansion · Kineta Inc. https://druglandscape.com/drug/kvd824-immediate-release-capsule https://druglandscape.com/api/og?type=drug&title=KVD824%20Immediate-Release%20Capsule&subtitle=KVD824%20Immediate-Release%20Capsule%20%C2%B7%20KalVista%20Pharmaceuticals%2C%20Ltd.&badge=phase%201 KVD824 Immediate-Release Capsule KVD824 Immediate-Release Capsule · KalVista Pharmaceuticals, Ltd. https://druglandscape.com/drug/kvd900 https://druglandscape.com/api/og?type=drug&title=KVD900&subtitle=KVD900%20%C2%B7%20KalVista%20Pharmaceuticals%2C%20Ltd.&badge=phase%202 KVD900 KVD900 · KalVista Pharmaceuticals, Ltd. https://druglandscape.com/drug/kw-6356 https://druglandscape.com/api/og?type=drug&title=KW-6356&subtitle=KW-6356%20%C2%B7%20Kyowa%20Kirin%2C%20Inc.&badge=phase%202 KW-6356 KW-6356 · Kyowa Kirin, Inc. https://druglandscape.com/drug/kw-6356-high-dose https://druglandscape.com/api/og?type=drug&title=KW-6356%20High%20Dose&subtitle=KW-6356%20High%20Dose%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%201 KW-6356 High Dose KW-6356 High Dose · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/kw-6356-low-dose https://druglandscape.com/api/og?type=drug&title=KW-6356%20Low%20Dose&subtitle=KW-6356%20Low%20Dose%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%201 KW-6356 Low Dose KW-6356 Low Dose · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/kw-6356-y-dose https://druglandscape.com/api/og?type=drug&title=KW-6356%20Y%20Dose&subtitle=KW-6356%20Y%20Dose%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%201 KW-6356 Y Dose KW-6356 Y Dose · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/kx-826-0-5-bid https://druglandscape.com/api/og?type=drug&title=KX-826%200.5%25%20BID&subtitle=KX-826%200.5%25%20BID%20%C2%B7%20Suzhou%20Kintor%20Pharmaceutical%20Inc%2C&badge=phase%202 KX-826 0.5% BID KX-826 0.5% BID · Suzhou Kintor Pharmaceutical Inc, https://druglandscape.com/drug/kx0826 https://druglandscape.com/api/og?type=drug&title=KX0826&subtitle=KX0826%20%C2%B7%20Suzhou%20Kintor%20Pharmaceutical%20Inc%2C&badge=phase%201 KX0826 KX0826 · Suzhou Kintor Pharmaceutical Inc, https://druglandscape.com/drug/kx2-391 https://druglandscape.com/api/og?type=drug&title=KX2-391&subtitle=KX2-391%20%C2%B7%20Athenex%2C%20Inc.&badge=phase%202 KX2-391 KX2-391 · Athenex, Inc. https://druglandscape.com/drug/kx2-391-and-paclitaxel https://druglandscape.com/api/og?type=drug&title=KX2-391%20and%20Paclitaxel&subtitle=KX2-391%20and%20Paclitaxel%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 KX2-391 and Paclitaxel KX2-391 and Paclitaxel · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/ky-0118 https://druglandscape.com/api/og?type=drug&title=KY-0118&subtitle=KY-0118%20%C2%B7%20Novatim%20Immune%20Therapeutics%20(Zhejiang)%20Co.%2C%20Ltd.&badge=phase%201 KY-0118 KY-0118 · Novatim Immune Therapeutics (Zhejiang) Co., Ltd. https://druglandscape.com/drug/ky-0301 https://druglandscape.com/api/og?type=drug&title=KY-0301&subtitle=KY-0301%20%C2%B7%20Novatim%20Immune%20Therapeutics%20(Zhejiang)%20Co.%2C%20Ltd.&badge=phase%201 KY-0301 KY-0301 · Novatim Immune Therapeutics (Zhejiang) Co., Ltd. https://druglandscape.com/drug/ky100001 https://druglandscape.com/api/og?type=drug&title=KY100001&subtitle=KY100001%20%C2%B7%20Kunming%20Pharmaceuticals%2C%20Inc.&badge=phase%201 KY100001 KY100001 · Kunming Pharmaceuticals, Inc. https://druglandscape.com/drug/kylo-0603-capsule https://druglandscape.com/api/og?type=drug&title=Kylo-0603%20capsule&subtitle=Kylo-0603%20capsule%20%C2%B7%20Kylonova%20(Xiamen)%20Biopharma%20co.%2C%20LTD.&badge=phase%201 Kylo-0603 capsule Kylo-0603 capsule · Kylonova (Xiamen) Biopharma co., LTD. https://druglandscape.com/drug/kylo-11 https://druglandscape.com/api/og?type=drug&title=Kylo-11&subtitle=Kylo-11%20%C2%B7%20Kylonova%20(Xiamen)%20Biopharma%20co.%2C%20LTD.&badge=phase%201 Kylo-11 Kylo-11 · Kylonova (Xiamen) Biopharma co., LTD. https://druglandscape.com/drug/kylo-12 https://druglandscape.com/api/og?type=drug&title=Kylo-12&subtitle=Kylo-12%20%C2%B7%20Kylonova%20(Xiamen)%20Biopharma%20co.%2C%20LTD.&badge=phase%201 Kylo-12 Kylo-12 · Kylonova (Xiamen) Biopharma co., LTD. https://druglandscape.com/drug/kyn-5356 https://druglandscape.com/api/og?type=drug&title=KYN-5356&subtitle=KYN-5356%20%C2%B7%20Kynexis%20B.V.&badge=phase%201 KYN-5356 KYN-5356 · Kynexis B.V. https://druglandscape.com/drug/kyn-5356-high-dose https://druglandscape.com/api/og?type=drug&title=KYN-5356%20High%20Dose&subtitle=KYN-5356%20High%20Dose%20%C2%B7%20Kynexis%20B.V.&badge=phase%202 KYN-5356 High Dose KYN-5356 High Dose · Kynexis B.V. https://druglandscape.com/drug/kyn-5356-low-dose https://druglandscape.com/api/og?type=drug&title=KYN-5356%20low%20dose&subtitle=KYN-5356%20low%20dose%20%C2%B7%20Kynexis%20B.V.&badge=phase%202 KYN-5356 low dose KYN-5356 low dose · Kynexis B.V. https://druglandscape.com/drug/l-697-661 https://druglandscape.com/api/og?type=drug&title=L-697%2C661&subtitle=L-697%2C661%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 L-697,661 L-697,661 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/l-bcl-2-antisense-oligonucleotide https://druglandscape.com/api/og?type=drug&title=L-Bcl-2%20antisense%20oligonucleotide&subtitle=L-Bcl-2%20antisense%20oligonucleotide%20%C2%B7%20Bio-Path%20Holdings%2C%20Inc.&badge=phase%201 L-Bcl-2 antisense oligonucleotide L-Bcl-2 antisense oligonucleotide · Bio-Path Holdings, Inc. https://druglandscape.com/drug/l-boronophenylalanine-intravenous-administration https://druglandscape.com/api/og?type=drug&title=L-Boronophenylalanine%20intravenous%20administration&subtitle=L-Boronophenylalanine%20intravenous%20administration%20%C2%B7%20Neutron%20Therapeutics%2C%20LLC&badge=phase%201 L-Boronophenylalanine intravenous administration L-Boronophenylalanine intravenous administration · Neutron Therapeutics, LLC https://druglandscape.com/drug/l-lv https://druglandscape.com/api/og?type=drug&title=l-LV&subtitle=l-LV%20%C2%B7%20EPS%20Corporation&badge=phase%202 l-LV l-LV · EPS Corporation https://druglandscape.com/drug/l-m-x-4-cream https://druglandscape.com/api/og?type=drug&title=L.M.X.4.%C2%AE%20cream&subtitle=L.M.X.4.%C2%AE%20cream%20%C2%B7%20Ulthera%2C%20Inc&badge=phase%201 L.M.X.4.® cream L.M.X.4.® cream · Ulthera, Inc https://druglandscape.com/drug/l-ohp https://druglandscape.com/api/og?type=drug&title=L-OHP&subtitle=L-OHP%20%C2%B7%20EPS%20Corporation&badge=phase%202 L-OHP L-OHP · EPS Corporation https://druglandscape.com/drug/l-pzq-odt https://druglandscape.com/api/og?type=drug&title=L-PZQ%20ODT&subtitle=L-PZQ%20ODT%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 L-PZQ ODT L-PZQ ODT · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/l03rd1 https://druglandscape.com/api/og?type=drug&title=L03RD1&subtitle=L03RD1%20%C2%B7%20Celltrion&badge=phase%201 L03RD1 L03RD1 · Celltrion https://druglandscape.com/drug/l03rd2 https://druglandscape.com/api/og?type=drug&title=L03RD2&subtitle=L03RD2%20%C2%B7%20Celltrion&badge=phase%201 L03RD2 L03RD2 · Celltrion https://druglandscape.com/drug/l04rd1 https://druglandscape.com/api/og?type=drug&title=L04RD1&subtitle=L04RD1%20%C2%B7%20Celltrion&badge=phase%201 L04RD1 L04RD1 · Celltrion https://druglandscape.com/drug/l04td1 https://druglandscape.com/api/og?type=drug&title=L04TD1&subtitle=L04TD1%20%C2%B7%20Celltrion&badge=phase%201 L04TD1 L04TD1 · Celltrion https://druglandscape.com/drug/l04td2 https://druglandscape.com/api/og?type=drug&title=L04TD2&subtitle=L04TD2%20%C2%B7%20Celltrion&badge=phase%201 L04TD2 L04TD2 · Celltrion https://druglandscape.com/drug/l04td3 https://druglandscape.com/api/og?type=drug&title=L04TD3&subtitle=L04TD3%20%C2%B7%20Celltrion&badge=phase%201 L04TD3 L04TD3 · Celltrion https://druglandscape.com/drug/l1-79 https://druglandscape.com/api/og?type=drug&title=L1-79&subtitle=L1-79%20%C2%B7%20Yamo%20Pharmaceuticals%20LLC&badge=phase%202 L1-79 L1-79 · Yamo Pharmaceuticals LLC https://druglandscape.com/drug/l19il2-at-rd-ph-ii https://druglandscape.com/api/og?type=drug&title=L19IL2%20at%20RD%20-%20Ph%20II&subtitle=L19IL2%20at%20RD%20-%20Ph%20II%20%C2%B7%20Philogen%20S.p.A.&badge=phase%201 L19IL2 at RD - Ph II L19IL2 at RD - Ph II · Philogen S.p.A. https://druglandscape.com/drug/l19il2-ph-i https://druglandscape.com/api/og?type=drug&title=L19IL2%20-%20Ph%20I&subtitle=L19IL2%20-%20Ph%20I%20%C2%B7%20Philogen%20S.p.A.&badge=phase%201 L19IL2 - Ph I L19IL2 - Ph I · Philogen S.p.A. https://druglandscape.com/drug/l19tnf https://druglandscape.com/api/og?type=drug&title=L19TNF&subtitle=L19TNF%20%C2%B7%20Philogen%20S.p.A.&badge=phase%202 L19TNF L19TNF · Philogen S.p.A. https://druglandscape.com/drug/l19tnf-and-ccnu https://druglandscape.com/api/og?type=drug&title=L19TNF%20and%20CCNU&subtitle=L19TNF%20and%20CCNU%20%C2%B7%20Philogen%20S.p.A.&badge=phase%202 L19TNF and CCNU L19TNF and CCNU · Philogen S.p.A. https://druglandscape.com/drug/l19tnf-and-tmz-in-recurrent-astrocytoma https://druglandscape.com/api/og?type=drug&title=L19TNF%20and%20TMZ%20in%20recurrent%20astrocytoma&subtitle=L19TNF%20and%20TMZ%20in%20recurrent%20astrocytoma%20%C2%B7%20Philogen%20S.p.A.&badge=phase%202 L19TNF and TMZ in recurrent astrocytoma L19TNF and TMZ in recurrent astrocytoma · Philogen S.p.A. https://druglandscape.com/drug/l19tnf-monotherapy https://druglandscape.com/api/og?type=drug&title=L19TNF%20monotherapy&subtitle=L19TNF%20monotherapy%20%C2%B7%20Philogen%20S.p.A.&badge=phase%202 L19TNF monotherapy L19TNF monotherapy · Philogen S.p.A. https://druglandscape.com/drug/l19tnf-monothery-in-recurrent-oligodendroglioma https://druglandscape.com/api/og?type=drug&title=L19TNF%20monothery%20in%20recurrent%20oligodendroglioma&subtitle=L19TNF%20monothery%20in%20recurrent%20oligodendroglioma%20%C2%B7%20Philogen%20S.p.A.&badge=phase%202 L19TNF monothery in recurrent oligodendroglioma L19TNF monothery in recurrent oligodendroglioma · Philogen S.p.A. https://druglandscape.com/drug/l608-inhalation-solution https://druglandscape.com/api/og?type=drug&title=L608%20Inhalation%20Solution&subtitle=L608%20Inhalation%20Solution%20%C2%B7%20Pharmosa%20Biopharm%20Inc.&badge=phase%201 L608 Inhalation Solution L608 Inhalation Solution · Pharmosa Biopharm Inc. https://druglandscape.com/drug/l608-liposomal-inhalation-suspension https://druglandscape.com/api/og?type=drug&title=L608%20Liposomal%20inhalation%20suspension&subtitle=L608%20Liposomal%20inhalation%20suspension%20%C2%B7%20Pharmosa%20Biopharm%20Inc.&badge=phase%201 L608 Liposomal inhalation suspension L608 Liposomal inhalation suspension · Pharmosa Biopharm Inc. https://druglandscape.com/drug/lab4 https://druglandscape.com/api/og?type=drug&title=LAB4&subtitle=LAB4%20%C2%B7%20Fondazione%20IRCCS%20Ca'%20Granda%2C%20Ospedale%20Maggiore%20Policlinico&badge=phase%201 LAB4 LAB4 · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico https://druglandscape.com/drug/lacer-clorhexidina-colutorio https://druglandscape.com/api/og?type=drug&title=Lacer%20Clorhexidina%20Colutorio&subtitle=Lacer%20Clorhexidina%20Colutorio%20%C2%B7%20Fundaci%C3%B3n%20para%20el%20Fomento%20de%20la%20Investigaci%C3%B3n%20Sanitaria%20y%20Biom%C3%A9dica%20d&badge=phase%201 Lacer Clorhexidina Colutorio Lacer Clorhexidina Colutorio · Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana https://druglandscape.com/drug/lacer-clorhexidine-0-20-colutorio https://druglandscape.com/api/og?type=drug&title=Lacer%20Clorhexidine%200.20%25%20Colutorio&subtitle=Lacer%20Clorhexidine%200.20%25%20Colutorio%20%C2%B7%20Fundaci%C3%B3n%20para%20el%20Fomento%20de%20la%20Investigaci%C3%B3n%20Sanitaria%20y%20Biom%C3%A9&badge=phase%201 Lacer Clorhexidine 0.20% Colutorio Lacer Clorhexidine 0.20% Colutorio · Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana https://druglandscape.com/drug/lacosamide-infusion https://druglandscape.com/api/og?type=drug&title=Lacosamide%20infusion&subtitle=Lacosamide%20infusion%20%C2%B7%20UCB%20Pharma%20SA&badge=phase%201 Lacosamide infusion Lacosamide infusion · UCB Pharma SA https://druglandscape.com/drug/lacosamide-tablets https://druglandscape.com/api/og?type=drug&title=Lacosamide%20Tablets&subtitle=Lacosamide%20Tablets%20%C2%B7%20Overseas%20Pharmaceuticals%2C%20Ltd.&badge=phase%201 Lacosamide Tablets Lacosamide Tablets · Overseas Pharmaceuticals, Ltd. https://druglandscape.com/drug/lactalbumin-vaccine https://druglandscape.com/api/og?type=drug&title=%CE%B1-lactalbumin%20vaccine&subtitle=%CE%B1-lactalbumin%20vaccine%20%C2%B7%20George%20T.%20Budd&badge=phase%201 α-lactalbumin vaccine α-lactalbumin vaccine · George T. Budd https://druglandscape.com/drug/lactobacillus-farciminis https://druglandscape.com/api/og?type=drug&title=Lactobacillus%20farciminis&subtitle=Lactobacillus%20farciminis%20%C2%B7%20Lallemand%20SAS&badge=phase%201 Lactobacillus farciminis Lactobacillus farciminis · Lallemand SAS https://druglandscape.com/drug/lactobacillus-gasseri-bgp345a https://druglandscape.com/api/og?type=drug&title=Lactobacillus%20gasseri%20BGP345A&subtitle=Lactobacillus%20gasseri%20BGP345A%20%C2%B7%20BioGaia%20Pharma%20AB&badge=phase%202 Lactobacillus gasseri BGP345A Lactobacillus gasseri BGP345A · BioGaia Pharma AB https://druglandscape.com/drug/lactobacillus-reuteri-cr20 https://druglandscape.com/api/og?type=drug&title=Lactobacillus%20reuteri%20CR20&subtitle=Lactobacillus%20reuteri%20CR20%20%C2%B7%20Universidad%20Complutense%20de%20Madrid&badge=phase%202 Lactobacillus reuteri CR20 Lactobacillus reuteri CR20 · Universidad Complutense de Madrid https://druglandscape.com/drug/lactobacillus-rhamnosus-x253 https://druglandscape.com/api/og?type=drug&title=Lactobacillus%20rhamnosus%20X253&subtitle=Lactobacillus%20rhamnosus%20X253%20%C2%B7%20Junlebao%20Dairy%20Group%20Co.%2C%20Ltd.&badge=phase%201 Lactobacillus rhamnosus X253 Lactobacillus rhamnosus X253 · Junlebao Dairy Group Co., Ltd. https://druglandscape.com/drug/lactobacillus-salivarius-cect5713 https://druglandscape.com/api/og?type=drug&title=Lactobacillus%20salivarius%20CECT5713&subtitle=Lactobacillus%20salivarius%20CECT5713%20%C2%B7%20Universidad%20Complutense%20de%20Madrid&badge=phase%202 Lactobacillus salivarius CECT5713 Lactobacillus salivarius CECT5713 · Universidad Complutense de Madrid https://druglandscape.com/drug/lactobacillus-salivarius-hn6 https://druglandscape.com/api/og?type=drug&title=Lactobacillus%20salivarius%20HN6&subtitle=Lactobacillus%20salivarius%20HN6%20%C2%B7%20Universidad%20Complutense%20de%20Madrid&badge=phase%202 Lactobacillus salivarius HN6 Lactobacillus salivarius HN6 · Universidad Complutense de Madrid https://druglandscape.com/drug/lactobacillus-salivarius-ps2 https://druglandscape.com/api/og?type=drug&title=Lactobacillus%20salivarius%20PS2&subtitle=Lactobacillus%20salivarius%20PS2%20%C2%B7%20Universidad%20Complutense%20de%20Madrid&badge=phase%201 Lactobacillus salivarius PS2 Lactobacillus salivarius PS2 · Universidad Complutense de Madrid https://druglandscape.com/drug/lactose-free-memantine https://druglandscape.com/api/og?type=drug&title=Lactose-free%20memantine&subtitle=Lactose-free%20memantine%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Lactose-free memantine Lactose-free memantine · H. Lundbeck A/S https://druglandscape.com/drug/lacudy https://druglandscape.com/api/og?type=drug&title=LACUDY&subtitle=LACUDY%20%C2%B7%20Gun%20Oh%20Chong&badge=phase%201 LACUDY LACUDY · Gun Oh Chong https://druglandscape.com/drug/lad106 https://druglandscape.com/api/og?type=drug&title=LAD106&subtitle=LAD106%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%201 LAD106 LAD106 · Almirall, S.A. https://druglandscape.com/drug/lad191 https://druglandscape.com/api/og?type=drug&title=LAD191&subtitle=LAD191%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%202 LAD191 LAD191 · Almirall, S.A. https://druglandscape.com/drug/ladostigil-hemitartrate https://druglandscape.com/api/og?type=drug&title=ladostigil%20hemitartrate&subtitle=ladostigil%20hemitartrate%20%C2%B7%20Avraham%20Pharmaceuticals%20Ltd&badge=phase%202 ladostigil hemitartrate ladostigil hemitartrate · Avraham Pharmaceuticals Ltd https://druglandscape.com/drug/laennec https://druglandscape.com/api/og?type=drug&title=LAENNEC&subtitle=LAENNEC%20%C2%B7%20Green%20Cross%20Wellbeing&badge=phase%201 LAENNEC LAENNEC · Green Cross Wellbeing https://druglandscape.com/drug/laiv-h5n2 https://druglandscape.com/api/og?type=drug&title=LAIV%20H5N2&subtitle=LAIV%20H5N2%20%C2%B7%20PATH&badge=phase%201 LAIV H5N2 LAIV H5N2 · PATH https://druglandscape.com/drug/laiv-h7n3 https://druglandscape.com/api/og?type=drug&title=LAIV%20H7N3&subtitle=LAIV%20H7N3%20%C2%B7%20PATH&badge=phase%201 LAIV H7N3 LAIV H7N3 · PATH https://druglandscape.com/drug/lam-001 https://druglandscape.com/api/og?type=drug&title=LAM-001&subtitle=LAM-001%20%C2%B7%20OrphAI%20Therapeutics&badge=phase%202 LAM-001 LAM-001 · OrphAI Therapeutics https://druglandscape.com/drug/lam-002a https://druglandscape.com/api/og?type=drug&title=LAM-002A&subtitle=LAM-002A%20%C2%B7%20OrphAI%20Therapeutics&badge=phase%202 LAM-002A LAM-002A · OrphAI Therapeutics https://druglandscape.com/drug/lamisil-once https://druglandscape.com/api/og?type=drug&title=Lamisil%20Once&subtitle=Lamisil%20Once%20%C2%B7%20Bayer&badge=phase%202 Lamisil Once Lamisil Once · Bayer https://druglandscape.com/drug/lamivudine-zidovudine-and-nevirapine https://druglandscape.com/api/og?type=drug&title=Lamivudine%2C%20Zidovudine%20and%20nevirapine&subtitle=Lamivudine%2C%20Zidovudine%20and%20nevirapine%20%C2%B7%20Elim%20Pediatric%20Pharmaceuticals%20Inc.&badge=phase%201 Lamivudine, Zidovudine and nevirapine Lamivudine, Zidovudine and nevirapine · Elim Pediatric Pharmaceuticals Inc. https://druglandscape.com/drug/lamivudine-zidovudine-nevirapine https://druglandscape.com/api/og?type=drug&title=Lamivudine%2C%20zidovudine%2C%20nevirapine&subtitle=Lamivudine%2C%20zidovudine%2C%20nevirapine%20%C2%B7%20Elim%20Pediatric%20Pharmaceuticals%20Inc.&badge=phase%201 Lamivudine, zidovudine, nevirapine Lamivudine, zidovudine, nevirapine · Elim Pediatric Pharmaceuticals Inc. https://druglandscape.com/drug/lamotrigine-caplet https://druglandscape.com/api/og?type=drug&title=Lamotrigine%20caplet&subtitle=Lamotrigine%20caplet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Lamotrigine caplet Lamotrigine caplet · GlaxoSmithKline https://druglandscape.com/drug/lamotrigine-compressed-tablet https://druglandscape.com/api/og?type=drug&title=Lamotrigine%20Compressed%20tablet&subtitle=Lamotrigine%20Compressed%20tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Lamotrigine Compressed tablet Lamotrigine Compressed tablet · GlaxoSmithKline https://druglandscape.com/drug/lamotrigine-ir-tablets https://druglandscape.com/api/og?type=drug&title=Lamotrigine%20IR%20tablets&subtitle=Lamotrigine%20IR%20tablets%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Lamotrigine IR tablets Lamotrigine IR tablets · GlaxoSmithKline https://druglandscape.com/drug/lamotrigine-monotherapy https://druglandscape.com/api/og?type=drug&title=Lamotrigine%20monotherapy&subtitle=Lamotrigine%20monotherapy%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Lamotrigine monotherapy Lamotrigine monotherapy · GlaxoSmithKline https://druglandscape.com/drug/lamotrigine-odt-tablets https://druglandscape.com/api/og?type=drug&title=Lamotrigine%20ODT%20tablets&subtitle=Lamotrigine%20ODT%20tablets%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Lamotrigine ODT tablets Lamotrigine ODT tablets · GlaxoSmithKline https://druglandscape.com/drug/lamotrigine-polytherapy-including-valproate https://druglandscape.com/api/og?type=drug&title=Lamotrigine%20polytherapy%20including%20valproate&subtitle=Lamotrigine%20polytherapy%20including%20valproate%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Lamotrigine polytherapy including valproate Lamotrigine polytherapy including valproate · GlaxoSmithKline https://druglandscape.com/drug/lamotrigine-polytherapy-without-valproate https://druglandscape.com/api/og?type=drug&title=Lamotrigine%20polytherapy%20without%20valproate&subtitle=Lamotrigine%20polytherapy%20without%20valproate%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Lamotrigine polytherapy without valproate Lamotrigine polytherapy without valproate · GlaxoSmithKline https://druglandscape.com/drug/lamotrigine-use https://druglandscape.com/api/og?type=drug&title=Lamotrigine%20use&subtitle=Lamotrigine%20use%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Lamotrigine use Lamotrigine use · GlaxoSmithKline https://druglandscape.com/drug/lanreotide-and-metformin https://druglandscape.com/api/og?type=drug&title=Lanreotide%20and%20Metformin&subtitle=Lanreotide%20and%20Metformin%20%C2%B7%20Fondazione%20IRCCS%20Istituto%20Nazionale%20dei%20Tumori%2C%20Milano&badge=phase%201 Lanreotide and Metformin Lanreotide and Metformin · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano https://druglandscape.com/drug/lanreotide-prf https://druglandscape.com/api/og?type=drug&title=Lanreotide%20PRF&subtitle=Lanreotide%20PRF%20%C2%B7%20Ipsen&badge=phase%201 Lanreotide PRF Lanreotide PRF · Ipsen https://druglandscape.com/drug/lanthanum-carbonate-granule-formulation https://druglandscape.com/api/og?type=drug&title=Lanthanum%20carbonate%20Granule%20Formulation&subtitle=Lanthanum%20carbonate%20Granule%20Formulation%20%C2%B7%20Shire&badge=phase%201 Lanthanum carbonate Granule Formulation Lanthanum carbonate Granule Formulation · Shire https://druglandscape.com/drug/lanthanum-carbonate-hydrate https://druglandscape.com/api/og?type=drug&title=Lanthanum%20carbonate%20hydrate&subtitle=Lanthanum%20carbonate%20hydrate%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%201 Lanthanum carbonate hydrate Lanthanum carbonate hydrate · Astellas Pharma Inc https://druglandscape.com/drug/lanthanum-polystyrene-sulphonate-powder https://druglandscape.com/api/og?type=drug&title=Lanthanum%20Polystyrene%20Sulphonate%20Powder&subtitle=Lanthanum%20Polystyrene%20Sulphonate%20Powder%20%C2%B7%20Grand%20Life%20Science%20(Liaoning)%20Co.%2C%20Ltd.&badge=phase%201 Lanthanum Polystyrene Sulphonate Powder Lanthanum Polystyrene Sulphonate Powder · Grand Life Science (Liaoning) Co., Ltd. https://druglandscape.com/drug/lapaquistat-acetate-and-fenofibrate https://druglandscape.com/api/og?type=drug&title=Lapaquistat%20acetate%20and%20fenofibrate&subtitle=Lapaquistat%20acetate%20and%20fenofibrate%20%C2%B7%20Takeda&badge=phase%202 Lapaquistat acetate and fenofibrate Lapaquistat acetate and fenofibrate · Takeda https://druglandscape.com/drug/laparoscopical-l-cuff-closure https://druglandscape.com/api/og?type=drug&title=laparoscopical%20l%20cuff%20closure&subtitle=laparoscopical%20l%20cuff%20closure%20%C2%B7%20El-Galaa%20Military%20Medical%20Complex&badge=phase%201 laparoscopical l cuff closure laparoscopical l cuff closure · El-Galaa Military Medical Complex https://druglandscape.com/drug/lapatinib-and-ixempra https://druglandscape.com/api/og?type=drug&title=Lapatinib%20and%20ixempra&subtitle=Lapatinib%20and%20ixempra%20%C2%B7%20Hung-Hsueh%20Chou&badge=phase%201 Lapatinib and ixempra Lapatinib and ixempra · Hung-Hsueh Chou https://druglandscape.com/drug/lapatinib-and-sorafenib https://druglandscape.com/api/og?type=drug&title=Lapatinib%20and%20Sorafenib&subtitle=Lapatinib%20and%20Sorafenib%20%C2%B7%20Istituto%20Clinico%20Humanitas&badge=phase%201 Lapatinib and Sorafenib Lapatinib and Sorafenib · Istituto Clinico Humanitas https://druglandscape.com/drug/lapatinib-and-vinorelbine https://druglandscape.com/api/og?type=drug&title=lapatinib%20and%20Vinorelbine&subtitle=lapatinib%20and%20Vinorelbine%20%C2%B7%20GlaxoSmithKline&badge=phase%202 lapatinib and Vinorelbine lapatinib and Vinorelbine · GlaxoSmithKline https://druglandscape.com/drug/lapatinib-oral-tablets https://druglandscape.com/api/og?type=drug&title=Lapatinib%20oral%20tablets&subtitle=Lapatinib%20oral%20tablets%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Lapatinib oral tablets Lapatinib oral tablets · GlaxoSmithKline https://druglandscape.com/drug/lapatinib-plus-esomeprazole https://druglandscape.com/api/og?type=drug&title=lapatinib%20plus%20esomeprazole&subtitle=lapatinib%20plus%20esomeprazole%20%C2%B7%20GlaxoSmithKline&badge=phase%201 lapatinib plus esomeprazole lapatinib plus esomeprazole · GlaxoSmithKline https://druglandscape.com/drug/laroprovstat-dose-x-stp https://druglandscape.com/api/og?type=drug&title=Laroprovstat%20Dose%20X%20STP&subtitle=Laroprovstat%20Dose%20X%20STP%20%C2%B7%20AstraZeneca&badge=phase%201 Laroprovstat Dose X STP Laroprovstat Dose X STP · AstraZeneca https://druglandscape.com/drug/las-41004 https://druglandscape.com/api/og?type=drug&title=LAS%2041004&subtitle=LAS%2041004%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%202 LAS 41004 LAS 41004 · Almirall, S.A. https://druglandscape.com/drug/las-41004-dosage-6 https://druglandscape.com/api/og?type=drug&title=LAS%2041004%20dosage%206&subtitle=LAS%2041004%20dosage%206%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%202 LAS 41004 dosage 6 LAS 41004 dosage 6 · Almirall, S.A. https://druglandscape.com/drug/las189961 https://druglandscape.com/api/og?type=drug&title=LAS189961&subtitle=LAS189961%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%202 LAS189961 LAS189961 · Almirall, S.A. https://druglandscape.com/drug/las189962 https://druglandscape.com/api/og?type=drug&title=LAS189962&subtitle=LAS189962%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%202 LAS189962 LAS189962 · Almirall, S.A. https://druglandscape.com/drug/las190792-dose-1 https://druglandscape.com/api/og?type=drug&title=LAS190792%20Dose%201&subtitle=LAS190792%20Dose%201%20%C2%B7%20AstraZeneca&badge=phase%201 LAS190792 Dose 1 LAS190792 Dose 1 · AstraZeneca https://druglandscape.com/drug/las40468 https://druglandscape.com/api/og?type=drug&title=LAS40468&subtitle=LAS40468%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%201 LAS40468 LAS40468 · Almirall, S.A. https://druglandscape.com/drug/las41004 https://druglandscape.com/api/og?type=drug&title=LAS41004&subtitle=LAS41004%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%202 LAS41004 LAS41004 · Almirall, S.A. https://druglandscape.com/drug/las41004-imp1 https://druglandscape.com/api/og?type=drug&title=LAS41004-IMP1&subtitle=LAS41004-IMP1%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%201 LAS41004-IMP1 LAS41004-IMP1 · Almirall, S.A. https://druglandscape.com/drug/las41004-imp2 https://druglandscape.com/api/og?type=drug&title=LAS41004%20IMP2&subtitle=LAS41004%20IMP2%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%201 LAS41004 IMP2 LAS41004 IMP2 · Almirall, S.A. https://druglandscape.com/drug/las41004-imp4 https://druglandscape.com/api/og?type=drug&title=LAS41004%20IMP4&subtitle=LAS41004%20IMP4%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%201 LAS41004 IMP4 LAS41004 IMP4 · Almirall, S.A. https://druglandscape.com/drug/las41004-imp5 https://druglandscape.com/api/og?type=drug&title=LAS41004%20IMP5&subtitle=LAS41004%20IMP5%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%201 LAS41004 IMP5 LAS41004 IMP5 · Almirall, S.A. https://druglandscape.com/drug/las41004-imp6 https://druglandscape.com/api/og?type=drug&title=LAS41004%20IMP6&subtitle=LAS41004%20IMP6%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%201 LAS41004 IMP6 LAS41004 IMP6 · Almirall, S.A. https://druglandscape.com/drug/las41007-b-i-d https://druglandscape.com/api/og?type=drug&title=LAS41007%20b.i.d.&subtitle=LAS41007%20b.i.d.%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%202 LAS41007 b.i.d. LAS41007 b.i.d. · Almirall, S.A. https://druglandscape.com/drug/las41007-o-d https://druglandscape.com/api/og?type=drug&title=LAS41007%20o.d.&subtitle=LAS41007%20o.d.%20%C2%B7%20Almirall%2C%20S.A.&badge=phase%202 LAS41007 o.d. LAS41007 o.d. · Almirall, S.A. https://druglandscape.com/drug/lasn01 https://druglandscape.com/api/og?type=drug&title=LASN01&subtitle=LASN01%20%C2%B7%20Lassen%20Therapeutics%201%20PTY%20LTD&badge=phase%202 LASN01 LASN01 · Lassen Therapeutics 1 PTY LTD https://druglandscape.com/drug/last-5-amino-acids-of-glp-1 https://druglandscape.com/api/og?type=drug&title=Last%205%20amino%20acids%20of%20GLP-1&subtitle=Last%205%20amino%20acids%20of%20GLP-1%20%C2%B7%20Elahi%2C%20Dariush%2C%20PhD&badge=phase%201 Last 5 amino acids of GLP-1 Last 5 amino acids of GLP-1 · Elahi, Dariush, PhD https://druglandscape.com/drug/lat010 https://druglandscape.com/api/og?type=drug&title=LAT010&subtitle=LAT010%20%C2%B7%20Latticon%20Antibody%20Therapeutics%2C%20Inc&badge=phase%201 LAT010 LAT010 · Latticon Antibody Therapeutics, Inc https://druglandscape.com/drug/lat8881 https://druglandscape.com/api/og?type=drug&title=LAT8881&subtitle=LAT8881%20%C2%B7%20Lateral%20Pharma%20Pty%20Ltd&badge=phase%202 LAT8881 LAT8881 · Lateral Pharma Pty Ltd https://druglandscape.com/drug/latanoprost-0-0025-qd https://druglandscape.com/api/og?type=drug&title=latanoprost%200.0025%25%20QD&subtitle=latanoprost%200.0025%25%20QD%20%C2%B7%20Inotek%20Pharmaceuticals%20Corporation&badge=phase%202 latanoprost 0.0025% QD latanoprost 0.0025% QD · Inotek Pharmaceuticals Corporation https://druglandscape.com/drug/latanoprost-0-005-qd https://druglandscape.com/api/og?type=drug&title=latanoprost%200.005%25%20QD&subtitle=latanoprost%200.005%25%20QD%20%C2%B7%20Inotek%20Pharmaceuticals%20Corporation&badge=phase%202 latanoprost 0.005% QD latanoprost 0.005% QD · Inotek Pharmaceuticals Corporation https://druglandscape.com/drug/latanoprost-punctal-plug https://druglandscape.com/api/og?type=drug&title=Latanoprost%20punctal%20plug&subtitle=Latanoprost%20punctal%20plug%20%C2%B7%20Mati%20Therapeutics%20Inc.&badge=phase%202 Latanoprost punctal plug Latanoprost punctal plug · Mati Therapeutics Inc. https://druglandscape.com/drug/late-boost-cd40-adjuvanted https://druglandscape.com/api/og?type=drug&title=Late%20boost%20CD40%20adjuvanted&subtitle=Late%20boost%20CD40%20adjuvanted%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Late boost CD40 adjuvanted Late boost CD40 adjuvanted · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/late-boost-cd40-alone https://druglandscape.com/api/og?type=drug&title=Late%20boost%20CD40%20alone&subtitle=Late%20boost%20CD40%20alone%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Late boost CD40 alone Late boost CD40 alone · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/lavior-diabetic-wound-gel https://druglandscape.com/api/og?type=drug&title=Lavior%20Diabetic%20Wound%20Gel&subtitle=Lavior%20Diabetic%20Wound%20Gel%20%C2%B7%20Lavior%20Pharma%20Inc.&badge=phase%202 Lavior Diabetic Wound Gel Lavior Diabetic Wound Gel · Lavior Pharma Inc. https://druglandscape.com/drug/lb-100-plus-doxorrubicin https://druglandscape.com/api/og?type=drug&title=LB-100%20plus%20Doxorrubicin&subtitle=LB-100%20plus%20Doxorrubicin%20%C2%B7%20Grupo%20Espanol%20de%20Investigacion%20en%20Sarcomas&badge=phase%201 LB-100 plus Doxorrubicin LB-100 plus Doxorrubicin · Grupo Espanol de Investigacion en Sarcomas https://druglandscape.com/drug/lb-p6 https://druglandscape.com/api/og?type=drug&title=LB-P6&subtitle=LB-P6%20%C2%B7%20LISCure%20Biosciences&badge=phase%201 LB-P6 LB-P6 · LISCure Biosciences https://druglandscape.com/drug/lb-p8 https://druglandscape.com/api/og?type=drug&title=LB-P8&subtitle=LB-P8%20%C2%B7%20LISCure%20Biosciences&badge=phase%201 LB-P8 LB-P8 · LISCure Biosciences https://druglandscape.com/drug/lb-p8-high-dose https://druglandscape.com/api/og?type=drug&title=LB-P8%20high-dose&subtitle=LB-P8%20high-dose%20%C2%B7%20LISCure%20Biosciences&badge=phase%202 LB-P8 high-dose LB-P8 high-dose · LISCure Biosciences https://druglandscape.com/drug/lb-p8-low-dose https://druglandscape.com/api/og?type=drug&title=LB-P8%20low-dose&subtitle=LB-P8%20low-dose%20%C2%B7%20LISCure%20Biosciences&badge=phase%202 LB-P8 low-dose LB-P8 low-dose · LISCure Biosciences https://druglandscape.com/drug/lb1901 https://druglandscape.com/api/og?type=drug&title=LB1901&subtitle=LB1901%20%C2%B7%20Legend%20Biotech%20USA%20Inc&badge=phase%201 LB1901 LB1901 · Legend Biotech USA Inc https://druglandscape.com/drug/lb1908 https://druglandscape.com/api/og?type=drug&title=LB1908&subtitle=LB1908%20%C2%B7%20Legend%20Biotech%20USA%20Inc&badge=phase%201 LB1908 LB1908 · Legend Biotech USA Inc https://druglandscape.com/drug/lb2102 https://druglandscape.com/api/og?type=drug&title=LB2102&subtitle=LB2102%20%C2%B7%20Legend%20Biotech%20USA%20Inc&badge=phase%201 LB2102 LB2102 · Legend Biotech USA Inc https://druglandscape.com/drug/lb64640 https://druglandscape.com/api/og?type=drug&title=LB64640&subtitle=LB64640%20%C2%B7%20LG%20Chem&badge=phase%201 LB64640 LB64640 · LG Chem https://druglandscape.com/drug/lb80380-free-base https://druglandscape.com/api/og?type=drug&title=LB80380%20free%20base&subtitle=LB80380%20free%20base%20%C2%B7%20LG%20Life%20Sciences&badge=phase%201 LB80380 free base LB80380 free base · LG Life Sciences https://druglandscape.com/drug/lb80380-maleate-salt https://druglandscape.com/api/og?type=drug&title=LB80380%20maleate%20salt&subtitle=LB80380%20maleate%20salt%20%C2%B7%20LG%20Life%20Sciences&badge=phase%201 LB80380 maleate salt LB80380 maleate salt · LG Life Sciences https://druglandscape.com/drug/lbl-015-for-injections https://druglandscape.com/api/og?type=drug&title=LBL-015%20for%20Injections&subtitle=LBL-015%20for%20Injections%20%C2%B7%20Nanjing%20Leads%20Biolabs%20Co.%2CLtd&badge=phase%201 LBL-015 for Injections LBL-015 for Injections · Nanjing Leads Biolabs Co.,Ltd https://druglandscape.com/drug/lbr-101-high-dose https://druglandscape.com/api/og?type=drug&title=LBR-101%20High%20Dose&subtitle=LBR-101%20High%20Dose%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%202 LBR-101 High Dose LBR-101 High Dose · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/lbr-101-iv https://druglandscape.com/api/og?type=drug&title=LBR-101%20IV&subtitle=LBR-101%20IV%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%201 LBR-101 IV LBR-101 IV · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/lbr-101-sc https://druglandscape.com/api/og?type=drug&title=LBR-101%20SC&subtitle=LBR-101%20SC%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%201 LBR-101 SC LBR-101 SC · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/lbs-007 https://druglandscape.com/api/og?type=drug&title=LBS-007&subtitle=LBS-007%20%C2%B7%20Lin%20BioScience%2C%20Inc&badge=phase%201 LBS-007 LBS-007 · Lin BioScience, Inc https://druglandscape.com/drug/lbs-008 https://druglandscape.com/api/og?type=drug&title=LBS-008&subtitle=LBS-008%20%C2%B7%20RBP4%20Pty%20Ltd&badge=phase%201 LBS-008 LBS-008 · RBP4 Pty Ltd https://druglandscape.com/drug/lbt-3627 https://druglandscape.com/api/og?type=drug&title=LBT-3627&subtitle=LBT-3627%20%C2%B7%20Longevity%20Biotech%20Australia%20Pty%20Ltd%20(subsidiary)&badge=phase%201 LBT-3627 LBT-3627 · Longevity Biotech Australia Pty Ltd (subsidiary) https://druglandscape.com/drug/lbvd https://druglandscape.com/api/og?type=drug&title=LBVD&subtitle=LBVD%20%C2%B7%20LG%20Chem&badge=phase%202 LBVD LBVD · LG Chem https://druglandscape.com/drug/lbve01 https://druglandscape.com/api/og?type=drug&title=LBVE01&subtitle=LBVE01%20%C2%B7%20LG%20Chem&badge=phase%201 LBVE01 LBVE01 · LG Chem https://druglandscape.com/drug/lbve02 https://druglandscape.com/api/og?type=drug&title=LBVE02&subtitle=LBVE02%20%C2%B7%20LG%20Chem&badge=phase%201 LBVE02 LBVE02 · LG Chem https://druglandscape.com/drug/lc15-0444 https://druglandscape.com/api/og?type=drug&title=LC15-0444&subtitle=LC15-0444%20%C2%B7%20LG%20Life%20Sciences&badge=phase%201 LC15-0444 LC15-0444 · LG Life Sciences https://druglandscape.com/drug/lc15-0444-pioglitazone https://druglandscape.com/api/og?type=drug&title=LC15-0444%2C%20Pioglitazone&subtitle=LC15-0444%2C%20Pioglitazone%20%C2%B7%20LG%20Life%20Sciences&badge=phase%201 LC15-0444, Pioglitazone LC15-0444, Pioglitazone · LG Life Sciences https://druglandscape.com/drug/lc16m8-smallpox-vaccine https://druglandscape.com/api/og?type=drug&title=LC16m8%20Smallpox%20Vaccine&subtitle=LC16m8%20Smallpox%20Vaccine%20%C2%B7%20VaxGen&badge=phase%201 LC16m8 Smallpox Vaccine LC16m8 Smallpox Vaccine · VaxGen https://druglandscape.com/drug/lc28-0126 https://druglandscape.com/api/og?type=drug&title=LC28-0126&subtitle=LC28-0126%20%C2%B7%20LG%20Chem&badge=phase%201 LC28-0126 LC28-0126 · LG Chem https://druglandscape.com/drug/lc28-0126-dose-a https://druglandscape.com/api/og?type=drug&title=LC28-0126%20Dose%20A&subtitle=LC28-0126%20Dose%20A%20%C2%B7%20LG%20Life%20Sciences&badge=phase%202 LC28-0126 Dose A LC28-0126 Dose A · LG Life Sciences https://druglandscape.com/drug/lc28-0126-dose-b https://druglandscape.com/api/og?type=drug&title=LC28-0126%20Dose%20B&subtitle=LC28-0126%20Dose%20B%20%C2%B7%20LG%20Life%20Sciences&badge=phase%202 LC28-0126 Dose B LC28-0126 Dose B · LG Life Sciences https://druglandscape.com/drug/lc350189-formulated-capsule https://druglandscape.com/api/og?type=drug&title=LC350189%20formulated%20capsule&subtitle=LC350189%20formulated%20capsule%20%C2%B7%20LG%20Chem&badge=phase%202 LC350189 formulated capsule LC350189 formulated capsule · LG Chem https://druglandscape.com/drug/lc350189-tablet https://druglandscape.com/api/og?type=drug&title=LC350189%20Tablet&subtitle=LC350189%20Tablet%20%C2%B7%20LG%20Chem&badge=phase%201 LC350189 Tablet LC350189 Tablet · LG Chem https://druglandscape.com/drug/lc542019 https://druglandscape.com/api/og?type=drug&title=LC542019&subtitle=LC542019%20%C2%B7%20LG%20Chem&badge=phase%201 LC542019 LC542019 · LG Chem https://druglandscape.com/drug/lcar-aio-t-cells https://druglandscape.com/api/og?type=drug&title=LCAR-AIO%20T%20cells&subtitle=LCAR-AIO%20T%20cells%20%C2%B7%20Nanjing%20Legend%20Biotech%20Co.&badge=phase%201 LCAR-AIO T cells LCAR-AIO T cells · Nanjing Legend Biotech Co. https://druglandscape.com/drug/lcar-f33s-cells-intravenous-infusion https://druglandscape.com/api/og?type=drug&title=LCAR-%20F33S%20cells%20intravenous%20infusion&subtitle=LCAR-%20F33S%20cells%20intravenous%20infusion%20%C2%B7%20Nanjing%20Legend%20Biotech%20Co.&badge=phase%201 LCAR- F33S cells intravenous infusion LCAR- F33S cells intravenous infusion · Nanjing Legend Biotech Co. https://druglandscape.com/drug/lcb01-0371-1200mg-qd https://druglandscape.com/api/og?type=drug&title=LCB01-0371%201200mg%2C%20QD&subtitle=LCB01-0371%201200mg%2C%20QD%20%C2%B7%20LigaChem%20Biosciences%2C%20Inc.&badge=phase%202 LCB01-0371 1200mg, QD LCB01-0371 1200mg, QD · LigaChem Biosciences, Inc. https://druglandscape.com/drug/lcb01-0371-400mg-bid https://druglandscape.com/api/og?type=drug&title=LCB01-0371%20400mg%2C%20BID&subtitle=LCB01-0371%20400mg%2C%20BID%20%C2%B7%20LigaChem%20Biosciences%2C%20Inc.&badge=phase%202 LCB01-0371 400mg, BID LCB01-0371 400mg, BID · LigaChem Biosciences, Inc. https://druglandscape.com/drug/lcb01-0371-800mg-qd https://druglandscape.com/api/og?type=drug&title=LCB01-0371%20800mg%2C%20QD&subtitle=LCB01-0371%20800mg%2C%20QD%20%C2%B7%20LigaChem%20Biosciences%2C%20Inc.&badge=phase%202 LCB01-0371 800mg, QD LCB01-0371 800mg, QD · LigaChem Biosciences, Inc. https://druglandscape.com/drug/lcb02a https://druglandscape.com/api/og?type=drug&title=LCB02A&subtitle=LCB02A%20%C2%B7%20LigaChem%20Biosciences%2C%20Inc.&badge=phase%201 LCB02A LCB02A · LigaChem Biosciences, Inc. https://druglandscape.com/drug/lcb84 https://druglandscape.com/api/og?type=drug&title=LCB84&subtitle=LCB84%20%C2%B7%20LigaChem%20Biosciences%2C%20Inc.&badge=phase%201 LCB84 LCB84 · LigaChem Biosciences, Inc. https://druglandscape.com/drug/lcig https://druglandscape.com/api/og?type=drug&title=LCIG&subtitle=LCIG%20%C2%B7%20NeuroDerm%20Ltd.&badge=phase%201 LCIG LCIG · NeuroDerm Ltd. https://druglandscape.com/drug/lcr-restituo-sachet https://druglandscape.com/api/og?type=drug&title=Lcr%20restituo%C2%AE%20sachet&subtitle=Lcr%20restituo%C2%AE%20sachet%20%C2%B7%20Biose&badge=phase%202 Lcr restituo® sachet Lcr restituo® sachet · Biose https://druglandscape.com/drug/ld-aminopterin-oral-capsule https://druglandscape.com/api/og?type=drug&title=LD-Aminopterin%20oral%20capsule&subtitle=LD-Aminopterin%20oral%20capsule%20%C2%B7%20Syntrix%20Biosystems%2C%20Inc.&badge=phase%202 LD-Aminopterin oral capsule LD-Aminopterin oral capsule · Syntrix Biosystems, Inc. https://druglandscape.com/drug/ld-bris10-m2sr-h3n2-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=LD%20Bris10%20M2SR%20H3N2%20influenza%20vaccine&subtitle=LD%20Bris10%20M2SR%20H3N2%20influenza%20vaccine%20%C2%B7%20FluGen%20Inc&badge=phase%201 LD Bris10 M2SR H3N2 influenza vaccine LD Bris10 M2SR H3N2 influenza vaccine · FluGen Inc https://druglandscape.com/drug/ld-pepgnp-covid19 https://druglandscape.com/api/og?type=drug&title=LD%20PepGNP-Covid19&subtitle=LD%20PepGNP-Covid19%20%C2%B7%20Gylden%20Pharma%20Ltd&badge=phase%201 LD PepGNP-Covid19 LD PepGNP-Covid19 · Gylden Pharma Ltd https://druglandscape.com/drug/ld-pepgnp-dengue https://druglandscape.com/api/og?type=drug&title=LD%20PepGNP-Dengue&subtitle=LD%20PepGNP-Dengue%20%C2%B7%20Gylden%20Pharma%20Ltd&badge=phase%201 LD PepGNP-Dengue LD PepGNP-Dengue · Gylden Pharma Ltd https://druglandscape.com/drug/ld-sing2016-m2sr-h3n2-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=LD%20Sing2016%20M2SR%20H3N2%20influenza%20vaccine&subtitle=LD%20Sing2016%20M2SR%20H3N2%20influenza%20vaccine%20%C2%B7%20FluGen%20Inc&badge=phase%201 LD Sing2016 M2SR H3N2 influenza vaccine LD Sing2016 M2SR H3N2 influenza vaccine · FluGen Inc https://druglandscape.com/drug/ld-universal-influenza-vaccine-uniflu https://druglandscape.com/api/og?type=drug&title=LD%20Universal%20Influenza%20Vaccine%20Uniflu&subtitle=LD%20Universal%20Influenza%20Vaccine%20Uniflu%20%C2%B7%20VA%20Pharma%20Limited%20Liability%20Company&badge=phase%201 LD Universal Influenza Vaccine Uniflu LD Universal Influenza Vaccine Uniflu · VA Pharma Limited Liability Company https://druglandscape.com/drug/ld02gifro https://druglandscape.com/api/og?type=drug&title=LD02GIFRO&subtitle=LD02GIFRO%20%C2%B7%20LG%20Life%20Sciences&badge=phase%202 LD02GIFRO LD02GIFRO · LG Life Sciences https://druglandscape.com/drug/ldla202 https://druglandscape.com/api/og?type=drug&title=LDLA202&subtitle=LDLA202%20%C2%B7%20AOP%20Orphan%20Pharmaceuticals%20AG&badge=phase%201 LDLA202 LDLA202 · AOP Orphan Pharmaceuticals AG https://druglandscape.com/drug/ldll600 https://druglandscape.com/api/og?type=drug&title=LDLL600&subtitle=LDLL600%20%C2%B7%20AOP%20Orphan%20Pharmaceuticals%20AG&badge=phase%201 LDLL600 LDLL600 · AOP Orphan Pharmaceuticals AG https://druglandscape.com/drug/ldp-02 https://druglandscape.com/api/og?type=drug&title=LDP-02&subtitle=LDP-02%20%C2%B7%20Millennium%20Pharmaceuticals%2C%20Inc.&badge=phase%202 LDP-02 LDP-02 · Millennium Pharmaceuticals, Inc. https://druglandscape.com/drug/le-dt https://druglandscape.com/api/og?type=drug&title=LE-DT&subtitle=LE-DT%20%C2%B7%20INSYS%20Therapeutics%20Inc&badge=phase%201 LE-DT LE-DT · INSYS Therapeutics Inc https://druglandscape.com/drug/le-gel https://druglandscape.com/api/og?type=drug&title=LE%20Gel&subtitle=LE%20Gel%20%C2%B7%20Bausch%20%26%20Lomb%20Incorporated&badge=phase%201 LE Gel LE Gel · Bausch & Lomb Incorporated https://druglandscape.com/drug/lecanemab-treatment-group https://druglandscape.com/api/og?type=drug&title=Lecanemab%20treatment%20group&subtitle=Lecanemab%20treatment%20group%20%C2%B7%20Cuibai%20Wei%EF%BC%8CClinical%20Professor&badge=phase%202 Lecanemab treatment group Lecanemab treatment group · Cuibai Wei，Clinical Professor https://druglandscape.com/drug/lecozotan-sr https://druglandscape.com/api/og?type=drug&title=lecozotan%20SR&subtitle=lecozotan%20SR%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%202 lecozotan SR lecozotan SR · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/lee-011 https://druglandscape.com/api/og?type=drug&title=LEE-011&subtitle=LEE-011%20%C2%B7%20Melissa%20K%20Accordino&badge=phase%202 LEE-011 LEE-011 · Melissa K Accordino https://druglandscape.com/drug/leflutrozole-dose-1 https://druglandscape.com/api/og?type=drug&title=Leflutrozole%2C%20Dose%201&subtitle=Leflutrozole%2C%20Dose%201%20%C2%B7%20ReproNovo%20Aps&badge=phase%202 Leflutrozole, Dose 1 Leflutrozole, Dose 1 · ReproNovo Aps https://druglandscape.com/drug/lem-mr203 https://druglandscape.com/api/og?type=drug&title=LEM-mR203&subtitle=LEM-mR203%20%C2%B7%20Lemonex&badge=phase%201 LEM-mR203 LEM-mR203 · Lemonex https://druglandscape.com/drug/lem-s401 https://druglandscape.com/api/og?type=drug&title=LEM-S401&subtitle=LEM-S401%20%C2%B7%20Lemonex%20Inc.&badge=phase%201 LEM-S401 LEM-S401 · Lemonex Inc. https://druglandscape.com/drug/lem10 https://druglandscape.com/api/og?type=drug&title=LEM10&subtitle=LEM10%20%C2%B7%20Eisai%20Inc.&badge=phase%201 LEM10 LEM10 · Eisai Inc. https://druglandscape.com/drug/lem5 https://druglandscape.com/api/og?type=drug&title=LEM5&subtitle=LEM5%20%C2%B7%20Eisai%20Inc.&badge=phase%201 LEM5 LEM5 · Eisai Inc. https://druglandscape.com/drug/lemonaid-health-sildenafil https://druglandscape.com/api/og?type=drug&title=Lemonaid%20Health%20Sildenafil&subtitle=Lemonaid%20Health%20Sildenafil%20%C2%B7%20Aspargo%20Labs%2C%20Inc&badge=phase%202 Lemonaid Health Sildenafil Lemonaid Health Sildenafil · Aspargo Labs, Inc https://druglandscape.com/drug/lenalidomide-and-dexametasone https://druglandscape.com/api/og?type=drug&title=Lenalidomide%20and%20Dexametasone&subtitle=Lenalidomide%20and%20Dexametasone%20%C2%B7%20Fondazione%20Italiana%20Linfomi%20-%20ETS&badge=phase%202 Lenalidomide and Dexametasone Lenalidomide and Dexametasone · Fondazione Italiana Linfomi - ETS https://druglandscape.com/drug/lenalidomide-and-ga101 https://druglandscape.com/api/og?type=drug&title=Lenalidomide%20and%20GA101&subtitle=Lenalidomide%20and%20GA101%20%C2%B7%20The%20Lymphoma%20Academic%20Research%20Organisation&badge=phase%201 Lenalidomide and GA101 Lenalidomide and GA101 · The Lymphoma Academic Research Organisation https://druglandscape.com/drug/lenalidomide-and-r-chop https://druglandscape.com/api/og?type=drug&title=Lenalidomide%20and%20R-CHOP&subtitle=Lenalidomide%20and%20R-CHOP%20%C2%B7%20The%20Lymphoma%20Academic%20Research%20Organisation&badge=phase%202 Lenalidomide and R-CHOP Lenalidomide and R-CHOP · The Lymphoma Academic Research Organisation https://druglandscape.com/drug/lenalidomide-and-rituximab https://druglandscape.com/api/og?type=drug&title=Lenalidomide%20and%20Rituximab&subtitle=Lenalidomide%20and%20Rituximab%20%C2%B7%20Chronic%20Lymphocytic%20Leukemia%20Research%20Consortium&badge=phase%202 Lenalidomide and Rituximab Lenalidomide and Rituximab · Chronic Lymphocytic Leukemia Research Consortium https://druglandscape.com/drug/lenalidomide-endoxan-prednisone https://druglandscape.com/api/og?type=drug&title=Lenalidomide%2C%20endoxan%2C%20prednisone&subtitle=Lenalidomide%2C%20endoxan%2C%20prednisone%20%C2%B7%20UMC%20Utrecht&badge=phase%201 Lenalidomide, endoxan, prednisone Lenalidomide, endoxan, prednisone · UMC Utrecht https://druglandscape.com/drug/lenalidomide-plus-dexamethasone https://druglandscape.com/api/og?type=drug&title=lenalidomide%20plus%20dexamethasone&subtitle=lenalidomide%20plus%20dexamethasone%20%C2%B7%20Austrian%20Forum%20Against%20Cancer&badge=phase%202 lenalidomide plus dexamethasone lenalidomide plus dexamethasone · Austrian Forum Against Cancer https://druglandscape.com/drug/lenvatinib-mesilate-capsules https://druglandscape.com/api/og?type=drug&title=Lenvatinib%20Mesilate%20Capsules&subtitle=Lenvatinib%20Mesilate%20Capsules%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 Lenvatinib Mesilate Capsules Lenvatinib Mesilate Capsules · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/leo-124249-ointment https://druglandscape.com/api/og?type=drug&title=LEO%20124249%20ointment&subtitle=LEO%20124249%20ointment%20%C2%B7%20LEO%20Pharma&badge=phase%202 LEO 124249 ointment LEO 124249 ointment · LEO Pharma https://druglandscape.com/drug/leo-130852a-gel-1 https://druglandscape.com/api/og?type=drug&title=LEO%20130852A%20gel%201%25&subtitle=LEO%20130852A%20gel%201%25%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 130852A gel 1% LEO 130852A gel 1% · LEO Pharma https://druglandscape.com/drug/leo-134310 https://druglandscape.com/api/og?type=drug&title=LEO%20134310&subtitle=LEO%20134310%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 134310 LEO 134310 · LEO Pharma https://druglandscape.com/drug/leo-138559 https://druglandscape.com/api/og?type=drug&title=LEO%20138559&subtitle=LEO%20138559%20%C2%B7%20LEO%20Pharma&badge=phase%202 LEO 138559 LEO 138559 · LEO Pharma https://druglandscape.com/drug/leo-152020-tablet https://druglandscape.com/api/og?type=drug&title=LEO%20152020%20Tablet&subtitle=LEO%20152020%20Tablet%20%C2%B7%20JW%20Pharmaceutical&badge=phase%202 LEO 152020 Tablet LEO 152020 Tablet · JW Pharmaceutical https://druglandscape.com/drug/leo-153339 https://druglandscape.com/api/og?type=drug&title=LEO%20153339&subtitle=LEO%20153339%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 153339 LEO 153339 · LEO Pharma https://druglandscape.com/drug/leo-158968 https://druglandscape.com/api/og?type=drug&title=LEO%20158968&subtitle=LEO%20158968%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 158968 LEO 158968 · LEO Pharma https://druglandscape.com/drug/leo-22811 https://druglandscape.com/api/og?type=drug&title=LEO%2022811&subtitle=LEO%2022811%20%C2%B7%20LEO%20Pharma&badge=phase%202 LEO 22811 LEO 22811 · LEO Pharma https://druglandscape.com/drug/leo-27847 https://druglandscape.com/api/og?type=drug&title=LEO%2027847&subtitle=LEO%2027847%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 27847 LEO 27847 · LEO Pharma https://druglandscape.com/drug/leo-27989-ointment https://druglandscape.com/api/og?type=drug&title=LEO%2027989%20ointment&subtitle=LEO%2027989%20ointment%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 27989 ointment LEO 27989 ointment · LEO Pharma https://druglandscape.com/drug/leo-32731-api-hard-capsule https://druglandscape.com/api/og?type=drug&title=LEO%2032731%20API%2C%20hard%20capsule&subtitle=LEO%2032731%20API%2C%20hard%20capsule%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 32731 API, hard capsule LEO 32731 API, hard capsule · LEO Pharma https://druglandscape.com/drug/leo-32731-blend-hard-capsule https://druglandscape.com/api/og?type=drug&title=LEO%2032731%20blend%2C%20hard%20capsule&subtitle=LEO%2032731%20blend%2C%20hard%20capsule%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 32731 blend, hard capsule LEO 32731 blend, hard capsule · LEO Pharma https://druglandscape.com/drug/leo-32731-gastro-resistant-capsule https://druglandscape.com/api/og?type=drug&title=LEO%2032731%20gastro-resistant%20capsule&subtitle=LEO%2032731%20gastro-resistant%20capsule%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 32731 gastro-resistant capsule LEO 32731 gastro-resistant capsule · LEO Pharma https://druglandscape.com/drug/leo-32731-modified-release-tablet https://druglandscape.com/api/og?type=drug&title=LEO%2032731%20modified%20release%20tablet&subtitle=LEO%2032731%20modified%20release%20tablet%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 32731 modified release tablet LEO 32731 modified release tablet · LEO Pharma https://druglandscape.com/drug/leo-32731-soft-capsule https://druglandscape.com/api/og?type=drug&title=LEO%2032731%20soft%20capsule&subtitle=LEO%2032731%20soft%20capsule%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 32731 soft capsule LEO 32731 soft capsule · LEO Pharma https://druglandscape.com/drug/leo-39652-cream https://druglandscape.com/api/og?type=drug&title=LEO%2039652%20cream&subtitle=LEO%2039652%20cream%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 39652 cream LEO 39652 cream · LEO Pharma https://druglandscape.com/drug/leo-43204-formulation-1-dose-x https://druglandscape.com/api/og?type=drug&title=LEO%2043204%20Formulation%201%20Dose%20X&subtitle=LEO%2043204%20Formulation%201%20Dose%20X%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 43204 Formulation 1 Dose X LEO 43204 Formulation 1 Dose X · LEO Pharma https://druglandscape.com/drug/leo-43204-formulation-1-dose-y https://druglandscape.com/api/og?type=drug&title=LEO%2043204%20Formulation%201%20Dose%20Y&subtitle=LEO%2043204%20Formulation%201%20Dose%20Y%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 43204 Formulation 1 Dose Y LEO 43204 Formulation 1 Dose Y · LEO Pharma https://druglandscape.com/drug/leo-43204-formulation-2-dose-xx https://druglandscape.com/api/og?type=drug&title=LEO%2043204%20Formulation%202%20Dose%20XX&subtitle=LEO%2043204%20Formulation%202%20Dose%20XX%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 43204 Formulation 2 Dose XX LEO 43204 Formulation 2 Dose XX · LEO Pharma https://druglandscape.com/drug/leo-43204-formulation-2-dose-yy https://druglandscape.com/api/og?type=drug&title=LEO%2043204%20Formulation%202%20Dose%20YY&subtitle=LEO%2043204%20Formulation%202%20Dose%20YY%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 43204 Formulation 2 Dose YY LEO 43204 Formulation 2 Dose YY · LEO Pharma https://druglandscape.com/drug/leo-43204-gel-0-018 https://druglandscape.com/api/og?type=drug&title=LEO%2043204%20gel%200.018%25&subtitle=LEO%2043204%20gel%200.018%25%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 43204 gel 0.018% LEO 43204 gel 0.018% · LEO Pharma https://druglandscape.com/drug/leo-43204-gel-0-037 https://druglandscape.com/api/og?type=drug&title=LEO%2043204%20Gel%2C%200.037%25&subtitle=LEO%2043204%20Gel%2C%200.037%25%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 43204 Gel, 0.037% LEO 43204 Gel, 0.037% · LEO Pharma https://druglandscape.com/drug/leo-43204-gel-0-1 https://druglandscape.com/api/og?type=drug&title=LEO%2043204%20gel%200.1%25&subtitle=LEO%2043204%20gel%200.1%25%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 43204 gel 0.1% LEO 43204 gel 0.1% · LEO Pharma https://druglandscape.com/drug/leo-90105 https://druglandscape.com/api/og?type=drug&title=LEO%2090105&subtitle=LEO%2090105%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO 90105 LEO 90105 · LEO Pharma https://druglandscape.com/drug/leo32731 https://druglandscape.com/api/og?type=drug&title=LEO32731&subtitle=LEO32731%20%C2%B7%20LEO%20Pharma&badge=phase%201 LEO32731 LEO32731 · LEO Pharma https://druglandscape.com/drug/leo90100-cutaneous-spray-ointment https://druglandscape.com/api/og?type=drug&title=LEO90100%20cutaneous%20spray%2C%20ointment&subtitle=LEO90100%20cutaneous%20spray%2C%20ointment%20%C2%B7%20LEO%20Pharma&badge=phase%202 LEO90100 cutaneous spray, ointment LEO90100 cutaneous spray, ointment · LEO Pharma https://druglandscape.com/drug/lepidium-meyenii-walp https://druglandscape.com/api/og?type=drug&title=Lepidium%20Meyenii%20Walp&subtitle=Lepidium%20Meyenii%20Walp%20%C2%B7%20Universidade%20do%20Vale%20do%20Sapucai&badge=phase%201 Lepidium Meyenii Walp Lepidium Meyenii Walp · Universidade do Vale do Sapucai https://druglandscape.com/drug/leptin-human https://druglandscape.com/api/og?type=drug&title=Leptin%20Human&subtitle=Leptin%20Human%20%C2%B7%20Hafiz%20Muhammad%20Asif&badge=phase%202 Leptin Human Leptin Human · Hafiz Muhammad Asif https://druglandscape.com/drug/lerafaon https://druglandscape.com/api/og?type=drug&title=LErafAON&subtitle=LErafAON%20%C2%B7%20INSYS%20Therapeutics%20Inc&badge=phase%201 LErafAON LErafAON · INSYS Therapeutics Inc https://druglandscape.com/drug/lerafaon-etu https://druglandscape.com/api/og?type=drug&title=LErafAON-ETU&subtitle=LErafAON-ETU%20%C2%B7%20INSYS%20Therapeutics%20Inc&badge=phase%201 LErafAON-ETU LErafAON-ETU · INSYS Therapeutics Inc https://druglandscape.com/drug/lercanidipine-or-valsartan https://druglandscape.com/api/og?type=drug&title=Lercanidipine%20or%20Valsartan&subtitle=Lercanidipine%20or%20Valsartan%20%C2%B7%20LG%20Life%20Sciences&badge=phase%202 Lercanidipine or Valsartan Lercanidipine or Valsartan · LG Life Sciences https://druglandscape.com/drug/letrozole-gonadotropins https://druglandscape.com/api/og?type=drug&title=Letrozole%2C%20Gonadotropins&subtitle=Letrozole%2C%20Gonadotropins%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%201 Letrozole, Gonadotropins Letrozole, Gonadotropins · Sheba Medical Center https://druglandscape.com/drug/letrozole-ism https://druglandscape.com/api/og?type=drug&title=Letrozole%20ISM&subtitle=Letrozole%20ISM%20%C2%B7%20Rovi%20Pharmaceuticals%20Laboratories&badge=phase%201 Letrozole ISM Letrozole ISM · Rovi Pharmaceuticals Laboratories https://druglandscape.com/drug/letrozole-lapatinib https://druglandscape.com/api/og?type=drug&title=Letrozole%2C%20Lapatinib&subtitle=Letrozole%2C%20Lapatinib%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 Letrozole, Lapatinib Letrozole, Lapatinib · Asan Medical Center https://druglandscape.com/drug/letrozole-or-anastrozole-or-fulvestrant https://druglandscape.com/api/og?type=drug&title=Letrozole%20or%20anastrozole%20or%20Fulvestrant&subtitle=Letrozole%20or%20anastrozole%20or%20Fulvestrant%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Letrozole or anastrozole or Fulvestrant Letrozole or anastrozole or Fulvestrant · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/letrozole-pd-0332991 https://druglandscape.com/api/og?type=drug&title=Letrozole%2C%20PD%200332991&subtitle=Letrozole%2C%20PD%200332991%20%C2%B7%20Organisation%20for%20Oncology%20and%20Translational%20Research&badge=phase%202 Letrozole, PD 0332991 Letrozole, PD 0332991 · Organisation for Oncology and Translational Research https://druglandscape.com/drug/leu-met-sil-1-0 https://druglandscape.com/api/og?type=drug&title=Leu-Met-Sil%201.0&subtitle=Leu-Met-Sil%201.0%20%C2%B7%20NuSirt%20Biopharma&badge=phase%202 Leu-Met-Sil 1.0 Leu-Met-Sil 1.0 · NuSirt Biopharma https://druglandscape.com/drug/leucostim https://druglandscape.com/api/og?type=drug&title=Leucostim%C2%AE&subtitle=Leucostim%C2%AE%20%C2%B7%20Biocad&badge=phase%201 Leucostim® Leucostim® · Biocad https://druglandscape.com/drug/leuplin-inj https://druglandscape.com/api/og?type=drug&title=Leuplin%E2%93%A1Inj&subtitle=Leuplin%E2%93%A1Inj%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 LeuplinⓡInj LeuplinⓡInj · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/leuporelin-acetate https://druglandscape.com/api/og?type=drug&title=Leuporelin%20acetate&subtitle=Leuporelin%20acetate%20%C2%B7%20Palleos%20Healthcare%20GmbH&badge=phase%202 Leuporelin acetate Leuporelin acetate · Palleos Healthcare GmbH https://druglandscape.com/drug/leuprolide-acetate-and-bicalutamide https://druglandscape.com/api/og?type=drug&title=leuprolide%20acetate%20and%20bicalutamide&subtitle=leuprolide%20acetate%20and%20bicalutamide%20%C2%B7%20AstraZeneca&badge=phase%201 leuprolide acetate and bicalutamide leuprolide acetate and bicalutamide · AstraZeneca https://druglandscape.com/drug/leuprolide-acetate-fluidcrystal-injection-depot https://druglandscape.com/api/og?type=drug&title=leuprolide%20acetate%20FluidCrystal%C2%AE%20injection%20depot&subtitle=leuprolide%20acetate%20FluidCrystal%C2%AE%20injection%20depot%20%C2%B7%20Camurus%20AB&badge=phase%202 leuprolide acetate FluidCrystal® injection depot leuprolide acetate FluidCrystal® injection depot · Camurus AB https://druglandscape.com/drug/leuprolide-degarelix-or-relugolix https://druglandscape.com/api/og?type=drug&title=Leuprolide%2C%20Degarelix%20or%20Relugolix&subtitle=Leuprolide%2C%20Degarelix%20or%20Relugolix%20%C2%B7%20NYU%20Langone%20Health&badge=phase%202 Leuprolide, Degarelix or Relugolix Leuprolide, Degarelix or Relugolix · NYU Langone Health https://druglandscape.com/drug/leuprolide-oral-tablet-10-mg-bid https://druglandscape.com/api/og?type=drug&title=Leuprolide%20Oral%20Tablet%2010-mg%20BID&subtitle=Leuprolide%20Oral%20Tablet%2010-mg%20BID%20%C2%B7%20Enteris%20BioPharma%20Inc.&badge=phase%202 Leuprolide Oral Tablet 10-mg BID Leuprolide Oral Tablet 10-mg BID · Enteris BioPharma Inc. https://druglandscape.com/drug/leuprolide-oral-tablet-4-mg-bid https://druglandscape.com/api/og?type=drug&title=Leuprolide%20Oral%20Tablet%204-mg%20BID&subtitle=Leuprolide%20Oral%20Tablet%204-mg%20BID%20%C2%B7%20Enteris%20BioPharma%20Inc.&badge=phase%202 Leuprolide Oral Tablet 4-mg BID Leuprolide Oral Tablet 4-mg BID · Enteris BioPharma Inc. https://druglandscape.com/drug/leuprolide-oral-tablet-4-mg-qd https://druglandscape.com/api/og?type=drug&title=Leuprolide%20Oral%20Tablet%204-mg%20QD&subtitle=Leuprolide%20Oral%20Tablet%204-mg%20QD%20%C2%B7%20Enteris%20BioPharma%20Inc.&badge=phase%202 Leuprolide Oral Tablet 4-mg QD Leuprolide Oral Tablet 4-mg QD · Enteris BioPharma Inc. https://druglandscape.com/drug/leuprorelin-acetate-depot https://druglandscape.com/api/og?type=drug&title=Leuprorelin%20Acetate%20Depot&subtitle=Leuprorelin%20Acetate%20Depot%20%C2%B7%20AbbVie&badge=phase%202 Leuprorelin Acetate Depot Leuprorelin Acetate Depot · AbbVie https://druglandscape.com/drug/lev102-1-0 https://druglandscape.com/api/og?type=drug&title=LEV102%201.0%25&subtitle=LEV102%201.0%25%20%C2%B7%20Levation%20Pharma%2C%20Ltd.&badge=phase%201 LEV102 1.0% LEV102 1.0% · Levation Pharma, Ltd. https://druglandscape.com/drug/lev102-2-0 https://druglandscape.com/api/og?type=drug&title=LEV102%202.0%25&subtitle=LEV102%202.0%25%20%C2%B7%20Levation%20Pharma%2C%20Ltd.&badge=phase%201 LEV102 2.0% LEV102 2.0% · Levation Pharma, Ltd. https://druglandscape.com/drug/levamlodipine-amlodipine https://druglandscape.com/api/og?type=drug&title=Levamlodipine%2C%20Amlodipine&subtitle=Levamlodipine%2C%20Amlodipine%20%C2%B7%20Conjupro%20Biotherapeutics%2C%20Inc.&badge=phase%201 Levamlodipine, Amlodipine Levamlodipine, Amlodipine · Conjupro Biotherapeutics, Inc. https://druglandscape.com/drug/level-2-analgesic-treatments https://druglandscape.com/api/og?type=drug&title=Level%202%20Analgesic%20Treatments&subtitle=Level%202%20Analgesic%20Treatments%20%C2%B7%20Sublimed&badge=phase%201 Level 2 Analgesic Treatments Level 2 Analgesic Treatments · Sublimed https://druglandscape.com/drug/levetiracetam-pill https://druglandscape.com/api/og?type=drug&title=Levetiracetam%20Pill&subtitle=Levetiracetam%20Pill%20%C2%B7%20NYU%20Langone%20Health&badge=phase%202 Levetiracetam Pill Levetiracetam Pill · NYU Langone Health https://druglandscape.com/drug/levetiracetam-tablets https://druglandscape.com/api/og?type=drug&title=Levetiracetam%20Tablets&subtitle=Levetiracetam%20Tablets%20%C2%B7%20Gitte%20Moos%20Knudsen&badge=phase%202 Levetiracetam Tablets Levetiracetam Tablets · Gitte Moos Knudsen https://druglandscape.com/drug/levo-bupivacaine-0-25 https://druglandscape.com/api/og?type=drug&title=Levo-bupivacaine%200.25&subtitle=Levo-bupivacaine%200.25%20%C2%B7%20Egymedicalpedia&badge=phase%201 Levo-bupivacaine 0.25 Levo-bupivacaine 0.25 · Egymedicalpedia https://druglandscape.com/drug/levo-phencynonate-hydrochloride https://druglandscape.com/api/og?type=drug&title=levo%20phencynonate%20hydrochloride&subtitle=levo%20phencynonate%20hydrochloride%20%C2%B7%20Sihuan%20Pharmaceutical%20Holdings%20Group%20Ltd.&badge=phase%202 levo phencynonate hydrochloride levo phencynonate hydrochloride · Sihuan Pharmaceutical Holdings Group Ltd. https://druglandscape.com/drug/levo-praziquantel-odt https://druglandscape.com/api/og?type=drug&title=Levo%20Praziquantel%20ODT&subtitle=Levo%20Praziquantel%20ODT%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%202 Levo Praziquantel ODT Levo Praziquantel ODT · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/levocetirizine-dihcl https://druglandscape.com/api/og?type=drug&title=Levocetirizine%20DiHCl&subtitle=Levocetirizine%20DiHCl%20%C2%B7%20Dr.%20Reddy's%20Laboratories%20Limited&badge=phase%201 Levocetirizine DiHCl Levocetirizine DiHCl · Dr. Reddy's Laboratories Limited https://druglandscape.com/drug/levodopa-carbidopa-immediate-release https://druglandscape.com/api/og?type=drug&title=Levodopa-Carbidopa%20Immediate%20Release&subtitle=Levodopa-Carbidopa%20Immediate%20Release%20%C2%B7%20Nimble%20Science%20Ltd.&badge=phase%202 Levodopa-Carbidopa Immediate Release Levodopa-Carbidopa Immediate Release · Nimble Science Ltd. https://druglandscape.com/drug/levodopa-carbidopa-immediate-release-tablets https://druglandscape.com/api/og?type=drug&title=Levodopa%20Carbidopa%20immediate%20release%20tablets&subtitle=Levodopa%20Carbidopa%20immediate%20release%20tablets%20%C2%B7%20Desitin%20Arzneimittel%20GmbH&badge=phase%201 Levodopa Carbidopa immediate release tablets Levodopa Carbidopa immediate release tablets · Desitin Arzneimittel GmbH https://druglandscape.com/drug/levodopa-carbidopa-odm-104 https://druglandscape.com/api/og?type=drug&title=Levodopa%2C%20carbidopa%2C%20ODM-104&subtitle=Levodopa%2C%20carbidopa%2C%20ODM-104%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 Levodopa, carbidopa, ODM-104 Levodopa, carbidopa, ODM-104 · Orion Corporation, Orion Pharma https://druglandscape.com/drug/levodopa-mr https://druglandscape.com/api/og?type=drug&title=levodopa%20MR&subtitle=levodopa%20MR%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%202 levodopa MR levodopa MR · Orion Corporation, Orion Pharma https://druglandscape.com/drug/levodopa-tablet https://druglandscape.com/api/og?type=drug&title=Levodopa%20tablet&subtitle=Levodopa%20tablet%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%202 Levodopa tablet Levodopa tablet · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/levonorgestrel-0-15-milligram https://druglandscape.com/api/og?type=drug&title=Levonorgestrel%200.15%20milligram&subtitle=Levonorgestrel%200.15%20milligram%20%C2%B7%20InnovaGyn%2C%20Inc.&badge=phase%202 Levonorgestrel 0.15 milligram Levonorgestrel 0.15 milligram · InnovaGyn, Inc. https://druglandscape.com/drug/levonorgestrel-and-ethynilestradiol https://druglandscape.com/api/og?type=drug&title=levonorgestrel%20and%20ethynilestradiol&subtitle=levonorgestrel%20and%20ethynilestradiol%20%C2%B7%20IVI%20Madrid&badge=phase%201 levonorgestrel and ethynilestradiol levonorgestrel and ethynilestradiol · IVI Madrid https://druglandscape.com/drug/levonorgestrel-iud-or-copper-iud https://druglandscape.com/api/og?type=drug&title=Levonorgestrel%20IUD%20or%20Copper%20IUD&subtitle=Levonorgestrel%20IUD%20or%20Copper%20IUD%20%C2%B7%20Bayer&badge=phase%202 Levonorgestrel IUD or Copper IUD Levonorgestrel IUD or Copper IUD · Bayer https://druglandscape.com/drug/levothyroxine-oral-tablet-synthroid https://druglandscape.com/api/og?type=drug&title=Levothyroxine%20Oral%20Tablet%20%5BSynthroid%5D&subtitle=Levothyroxine%20Oral%20Tablet%20%5BSynthroid%5D%20%C2%B7%20AHS%20Cancer%20Control%20Alberta&badge=phase%202 Levothyroxine Oral Tablet [Synthroid] Levothyroxine Oral Tablet [Synthroid] · AHS Cancer Control Alberta https://druglandscape.com/drug/levothyroxine-propylthiouracile https://druglandscape.com/api/og?type=drug&title=Levothyroxine%2C%20Propylthiouracile&subtitle=Levothyroxine%2C%20Propylthiouracile%20%C2%B7%20Ospedale%20V.%20Fazzi&badge=phase%201 Levothyroxine, Propylthiouracile Levothyroxine, Propylthiouracile · Ospedale V. Fazzi https://druglandscape.com/drug/ley-car-t-cells https://druglandscape.com/api/og?type=drug&title=LeY%20CAR%20T%20cells&subtitle=LeY%20CAR%20T%20cells%20%C2%B7%20Peter%20MacCallum%20Cancer%20Centre%2C%20Australia&badge=phase%201 LeY CAR T cells LeY CAR T cells · Peter MacCallum Cancer Centre, Australia https://druglandscape.com/drug/lf-gm-090-capsule https://druglandscape.com/api/og?type=drug&title=LF%20GM-090%20capsule&subtitle=LF%20GM-090%20capsule%20%C2%B7%20GenMont%20Biotech%20Incorporation&badge=phase%201 LF GM-090 capsule LF GM-090 capsule · GenMont Biotech Incorporation https://druglandscape.com/drug/lf-pb https://druglandscape.com/api/og?type=drug&title=LF-PB&subtitle=LF-PB%20%C2%B7%20Chemi%20S.p.A.&badge=phase%202 LF-PB LF-PB · Chemi S.p.A. https://druglandscape.com/drug/lfd-200 https://druglandscape.com/api/og?type=drug&title=LFD-200&subtitle=LFD-200%20%C2%B7%20Lifordi%20Immunotherapeutics%2C%20Inc.&badge=phase%201 LFD-200 LFD-200 · Lifordi Immunotherapeutics, Inc. https://druglandscape.com/drug/lg002 https://druglandscape.com/api/og?type=drug&title=LG002&subtitle=LG002%20%C2%B7%20Zhen-Yu%20Ding&badge=phase%201 LG002 LG002 · Zhen-Yu Ding https://druglandscape.com/drug/lgw16-03 https://druglandscape.com/api/og?type=drug&title=LGW16-03&subtitle=LGW16-03%20%C2%B7%20Eric%20R.%20Henderson&badge=phase%201 LGW16-03 LGW16-03 · Eric R. Henderson https://druglandscape.com/drug/lh-001 https://druglandscape.com/api/og?type=drug&title=LH-001&subtitle=LH-001%20%C2%B7%20Chien-Liang%20Lin&badge=phase%201 LH-001 LH-001 · Chien-Liang Lin https://druglandscape.com/drug/lh-8 https://druglandscape.com/api/og?type=drug&title=LH-8&subtitle=LH-8%20%C2%B7%20Legacy%20Healthcare%20SA&badge=phase%202 LH-8 LH-8 · Legacy Healthcare SA https://druglandscape.com/drug/lhp588 https://druglandscape.com/api/og?type=drug&title=LHP588&subtitle=LHP588%20%C2%B7%20Lighthouse%20Pharmaceuticals%2C%20Inc.&badge=phase%202 LHP588 LHP588 · Lighthouse Pharmaceuticals, Inc. https://druglandscape.com/drug/lhrh-analogues https://druglandscape.com/api/og?type=drug&title=LHRH%20analogues&subtitle=LHRH%20analogues%20%C2%B7%20Ipsen&badge=phase%202 LHRH analogues LHRH analogues · Ipsen https://druglandscape.com/drug/lib-01 https://druglandscape.com/api/og?type=drug&title=LIB-01&subtitle=LIB-01%20%C2%B7%20Dicot%20AB&badge=phase%202 LIB-01 LIB-01 · Dicot AB https://druglandscape.com/drug/lib003 https://druglandscape.com/api/og?type=drug&title=LIB003&subtitle=LIB003%20%C2%B7%20LIB%20Therapeutics%20LLC&badge=phase%202 LIB003 LIB003 · LIB Therapeutics LLC https://druglandscape.com/drug/liberal-blood-pressure-management https://druglandscape.com/api/og?type=drug&title=Liberal%20blood%20pressure%20management&subtitle=Liberal%20blood%20pressure%20management%20%C2%B7%20Miodrag%20Filipovic%2C%20Prof.%20Dr.%20med.&badge=phase%201 Liberal blood pressure management Liberal blood pressure management · Miodrag Filipovic, Prof. Dr. med. https://druglandscape.com/drug/liberal-fluid-administration https://druglandscape.com/api/og?type=drug&title=liberal%20fluid%20administration&subtitle=liberal%20fluid%20administration%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 liberal fluid administration liberal fluid administration · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/libertal-a-phospholipid-mixture https://druglandscape.com/api/og?type=drug&title=LIBERTAL-%20a%20phospholipid%20mixture&subtitle=LIBERTAL-%20a%20phospholipid%20mixture%20%C2%B7%20Kaplan%20Medical%20Center&badge=phase%202 LIBERTAL- a phospholipid mixture LIBERTAL- a phospholipid mixture · Kaplan Medical Center https://druglandscape.com/drug/licensed-dtap https://druglandscape.com/api/og?type=drug&title=Licensed%20DTaP&subtitle=Licensed%20DTaP%20%C2%B7%20BioNet-Asia%20Co.%2C%20Ltd.&badge=phase%202 Licensed DTaP Licensed DTaP · BioNet-Asia Co., Ltd. https://druglandscape.com/drug/licensed-mrna-vaccine https://druglandscape.com/api/og?type=drug&title=Licensed%20mRNA%20vaccine&subtitle=Licensed%20mRNA%20vaccine%20%C2%B7%20AstraZeneca&badge=phase%201 Licensed mRNA vaccine Licensed mRNA vaccine · AstraZeneca https://druglandscape.com/drug/licensed-tdap-vaccine https://druglandscape.com/api/og?type=drug&title=Licensed%20Tdap%20vaccine&subtitle=Licensed%20Tdap%20vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Licensed Tdap vaccine Licensed Tdap vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/licensed-varicella-vaccine-lot-1 https://druglandscape.com/api/og?type=drug&title=Licensed%20varicella%20vaccine%20Lot%201&subtitle=Licensed%20varicella%20vaccine%20Lot%201%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Licensed varicella vaccine Lot 1 Licensed varicella vaccine Lot 1 · GlaxoSmithKline https://druglandscape.com/drug/licensed-varicella-vaccine-lot-2 https://druglandscape.com/api/og?type=drug&title=Licensed%20varicella%20vaccine%20Lot%202&subtitle=Licensed%20varicella%20vaccine%20Lot%202%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Licensed varicella vaccine Lot 2 Licensed varicella vaccine Lot 2 · GlaxoSmithKline https://druglandscape.com/drug/lidocain-hydrochloride-2-with-epinephrine https://druglandscape.com/api/og?type=drug&title=Lidocain%20hydrochloride%202%20%25%20with%20epinephrine&subtitle=Lidocain%20hydrochloride%202%20%25%20with%20epinephrine%20%C2%B7%20Mahmoud%20Ahmed%20Mahmoud&badge=phase%201 Lidocain hydrochloride 2 % with epinephrine Lidocain hydrochloride 2 % with epinephrine · Mahmoud Ahmed Mahmoud https://druglandscape.com/drug/lidocaine-2-topical-cream https://druglandscape.com/api/og?type=drug&title=Lidocaine%202%20%25%20Topical%20Cream&subtitle=Lidocaine%202%20%25%20Topical%20Cream%20%C2%B7%20Universidade%20do%20Vale%20do%20Sapucai&badge=phase%201 Lidocaine 2 % Topical Cream Lidocaine 2 % Topical Cream · Universidade do Vale do Sapucai https://druglandscape.com/drug/lidocaine-2-with-1-100-000-epinephrine https://druglandscape.com/api/og?type=drug&title=Lidocaine%202%25%20with%201%3A100%20000%20epinephrine&subtitle=Lidocaine%202%25%20with%201%3A100%20000%20epinephrine%20%C2%B7%20St.%20Joseph's%20Healthcare%20Hamilton&badge=phase%202 Lidocaine 2% with 1:100 000 epinephrine Lidocaine 2% with 1:100 000 epinephrine · St. Joseph's Healthcare Hamilton https://druglandscape.com/drug/lidocaine-3-6-menthol-1-25 https://druglandscape.com/api/og?type=drug&title=lidocaine%203.6%25%2C%20menthol%201.25%25&subtitle=lidocaine%203.6%25%2C%20menthol%201.25%25%20%C2%B7%20J.A.R.%20Laboratories&badge=phase%201 lidocaine 3.6%, menthol 1.25% lidocaine 3.6%, menthol 1.25% · J.A.R. Laboratories https://druglandscape.com/drug/lidocaine-a-local-anaesthetic https://druglandscape.com/api/og?type=drug&title=Lidocaine%2C%20a%20local%20anaesthetic.&subtitle=Lidocaine%2C%20a%20local%20anaesthetic.%20%C2%B7%20Oman%20Medical%20Speciality%20Board&badge=phase%201 Lidocaine, a local anaesthetic. Lidocaine, a local anaesthetic. · Oman Medical Speciality Board https://druglandscape.com/drug/lidocaine-adhesive-tape https://druglandscape.com/api/og?type=drug&title=Lidocaine%20adhesive%20tape&subtitle=Lidocaine%20adhesive%20tape%20%C2%B7%20Northern%20Orthopaedic%20Division%2C%20Denmark&badge=phase%201 Lidocaine adhesive tape Lidocaine adhesive tape · Northern Orthopaedic Division, Denmark https://druglandscape.com/drug/lidocaine-aguettant https://druglandscape.com/api/og?type=drug&title=lidocaine%20aguettant&subtitle=lidocaine%20aguettant%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%203 lidocaine aguettant lidocaine aguettant · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/lidocaine-and-adrenalin https://druglandscape.com/api/og?type=drug&title=lidocaine%20and%20adrenalin&subtitle=lidocaine%20and%20adrenalin%20%C2%B7%20Uri%20farkash&badge=phase%201 lidocaine and adrenalin lidocaine and adrenalin · Uri farkash https://druglandscape.com/drug/lidocaine-and-arterial-blockage https://druglandscape.com/api/og?type=drug&title=lidocaine%20and%20arterial%20blockage&subtitle=lidocaine%20and%20arterial%20blockage%20%C2%B7%20Uri%20farkash&badge=phase%201 lidocaine and arterial blockage lidocaine and arterial blockage · Uri farkash https://druglandscape.com/drug/lidocaine-epinephrine-added-gadoterate-meglumine https://druglandscape.com/api/og?type=drug&title=Lidocaine-epinephrine%20added%20gadoterate%20meglumine&subtitle=Lidocaine-epinephrine%20added%20gadoterate%20meglumine%20%C2%B7%20Thomas%20F.%20Bendtsen&badge=phase%202 Lidocaine-epinephrine added gadoterate meglumine Lidocaine-epinephrine added gadoterate meglumine · Thomas F. Bendtsen https://druglandscape.com/drug/lidocaine-medicated-plaster-5 https://druglandscape.com/api/og?type=drug&title=Lidocaine%20medicated%20plaster%205%25&subtitle=Lidocaine%20medicated%20plaster%205%25%20%C2%B7%20Scilex%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Lidocaine medicated plaster 5% Lidocaine medicated plaster 5% · Scilex Pharmaceuticals, Inc. https://druglandscape.com/drug/lidocaine-paracervical-block https://druglandscape.com/api/og?type=drug&title=Lidocaine%20paracervical%20block&subtitle=Lidocaine%20paracervical%20block%20%C2%B7%20Montefiore%20Medical%20Center&badge=phase%202 Lidocaine paracervical block Lidocaine paracervical block · Montefiore Medical Center https://druglandscape.com/drug/lidocaine-topical-system-1-8 https://druglandscape.com/api/og?type=drug&title=Lidocaine%20topical%20system%201.8%25&subtitle=Lidocaine%20topical%20system%201.8%25%20%C2%B7%20Scilex%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Lidocaine topical system 1.8% Lidocaine topical system 1.8% · Scilex Pharmaceuticals, Inc. https://druglandscape.com/drug/lidodyn https://druglandscape.com/api/og?type=drug&title=LidoDyn&subtitle=LidoDyn%20%C2%B7%20Rambam%20Health%20Care%20Campus&badge=phase%201 LidoDyn LidoDyn · Rambam Health Care Campus https://druglandscape.com/drug/life-001 https://druglandscape.com/api/og?type=drug&title=LIFE-001&subtitle=LIFE-001%20%C2%B7%20LifeMine%20Therapeutics&badge=phase%201 LIFE-001 LIFE-001 · LifeMine Therapeutics https://druglandscape.com/drug/life-001-mad https://druglandscape.com/api/og?type=drug&title=LIFE-001%20MAD&subtitle=LIFE-001%20MAD%20%C2%B7%20LifeMine%20Therapeutics&badge=phase%201 LIFE-001 MAD LIFE-001 MAD · LifeMine Therapeutics https://druglandscape.com/drug/life-cycle-pharma-tacrolimus https://druglandscape.com/api/og?type=drug&title=Life-Cycle%20Pharma%20Tacrolimus&subtitle=Life-Cycle%20Pharma%20Tacrolimus%20%C2%B7%20Chiesi%20SAS&badge=phase%202 Life-Cycle Pharma Tacrolimus Life-Cycle Pharma Tacrolimus · Chiesi SAS https://druglandscape.com/drug/ligilactobacillus-salivarius-mp101 https://druglandscape.com/api/og?type=drug&title=Ligilactobacillus%20salivarius%20MP101&subtitle=Ligilactobacillus%20salivarius%20MP101%20%C2%B7%20Universidad%20Complutense%20de%20Madrid&badge=phase%201 Ligilactobacillus salivarius MP101 Ligilactobacillus salivarius MP101 · Universidad Complutense de Madrid https://druglandscape.com/drug/lim-0705-and-tacrolimus https://druglandscape.com/api/og?type=drug&title=LIM-0705%20and%20tacrolimus&subtitle=LIM-0705%20and%20tacrolimus%20%C2%B7%20Limerick%20BioPharma&badge=phase%201 LIM-0705 and tacrolimus LIM-0705 and tacrolimus · Limerick BioPharma https://druglandscape.com/drug/linaprazan-glurate-capsules https://druglandscape.com/api/og?type=drug&title=Linaprazan%20Glurate%20Capsules&subtitle=Linaprazan%20Glurate%20Capsules%20%C2%B7%20Jiangsu%20Sinorda%20Biomedicine%20Co.%2C%20Ltd&badge=phase%201 Linaprazan Glurate Capsules Linaprazan Glurate Capsules · Jiangsu Sinorda Biomedicine Co., Ltd https://druglandscape.com/drug/linerixibat-tablet https://druglandscape.com/api/og?type=drug&title=Linerixibat%20tablet&subtitle=Linerixibat%20tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Linerixibat tablet Linerixibat tablet · GlaxoSmithKline https://druglandscape.com/drug/linperlisib-rituximab https://druglandscape.com/api/og?type=drug&title=Linperlisib%20%EF%BC%9B%20Rituximab&subtitle=Linperlisib%20%EF%BC%9B%20Rituximab%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Linperlisib ； Rituximab Linperlisib ； Rituximab · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/linperlisib-tablet https://druglandscape.com/api/og?type=drug&title=Linperlisib%20Tablet&subtitle=Linperlisib%20Tablet%20%C2%B7%20Shanghai%20YingLi%20Pharmaceutical%20Co.%20Ltd.&badge=phase%201 Linperlisib Tablet Linperlisib Tablet · Shanghai YingLi Pharmaceutical Co. Ltd. https://druglandscape.com/drug/liocyx-m https://druglandscape.com/api/og?type=drug&title=LioCyx-M&subtitle=LioCyx-M%20%C2%B7%20Lion%20TCR%20Pte.%20Ltd.&badge=phase%202 LioCyx-M LioCyx-M · Lion TCR Pte. Ltd. https://druglandscape.com/drug/lipidem-20 https://druglandscape.com/api/og?type=drug&title=Lipidem%2020%25&subtitle=Lipidem%2020%25%20%C2%B7%20B.%20Braun%20Melsungen%20AG&badge=phase%202 Lipidem 20% Lipidem 20% · B. Braun Melsungen AG https://druglandscape.com/drug/lipidomic-analyses https://druglandscape.com/api/og?type=drug&title=Lipidomic%20analyses&subtitle=Lipidomic%20analyses%20%C2%B7%20Centre%20Georges%20Francois%20Leclerc&badge=phase%202 Lipidomic analyses Lipidomic analyses · Centre Georges Francois Leclerc https://druglandscape.com/drug/lipo-102-low https://druglandscape.com/api/og?type=drug&title=LIPO-102%20Low&subtitle=LIPO-102%20Low%20%C2%B7%20Neothetics%2C%20Inc&badge=phase%202 LIPO-102 Low LIPO-102 Low · Neothetics, Inc https://druglandscape.com/drug/lipo-merit https://druglandscape.com/api/og?type=drug&title=Lipo-MERIT&subtitle=Lipo-MERIT%20%C2%B7%20BioNTech%20SE&badge=phase%201 Lipo-MERIT Lipo-MERIT · BioNTech SE https://druglandscape.com/drug/liposomal-alendronate https://druglandscape.com/api/og?type=drug&title=Liposomal%20Alendronate&subtitle=Liposomal%20Alendronate%20%C2%B7%20BIOrest%20Ltd.&badge=phase%202 Liposomal Alendronate Liposomal Alendronate · BIOrest Ltd. https://druglandscape.com/drug/liposomal-bupivacaine-13-3 https://druglandscape.com/api/og?type=drug&title=Liposomal%20Bupivacaine%2013.3&subtitle=Liposomal%20Bupivacaine%2013.3%20%C2%B7%20Pacira%20Pharmaceuticals%2C%20Inc&badge=phase%201 Liposomal Bupivacaine 13.3 Liposomal Bupivacaine 13.3 · Pacira Pharmaceuticals, Inc https://druglandscape.com/drug/liposomal-interleukin-2 https://druglandscape.com/api/og?type=drug&title=liposomal%20interleukin-2&subtitle=liposomal%20interleukin-2%20%C2%B7%20NYU%20Langone%20Health&badge=phase%202 liposomal interleukin-2 liposomal interleukin-2 · NYU Langone Health https://druglandscape.com/drug/liposomal-irinotecan-monotherapy https://druglandscape.com/api/og?type=drug&title=liposomal%20irinotecan%20monotherapy&subtitle=liposomal%20irinotecan%20monotherapy%20%C2%B7%20Dong%20sheng%20Zhang&badge=phase%201 liposomal irinotecan monotherapy liposomal irinotecan monotherapy · Dong sheng Zhang https://druglandscape.com/drug/liposomal-lurtotecan https://druglandscape.com/api/og?type=drug&title=liposomal%20lurtotecan&subtitle=liposomal%20lurtotecan%20%C2%B7%20European%20Organisation%20for%20Research%20and%20Treatment%20of%20Cancer%20-%20EORTC&badge=phase%202 liposomal lurtotecan liposomal lurtotecan · European Organisation for Research and Treatment of Cancer - EORTC https://druglandscape.com/drug/liposomal-nddp https://druglandscape.com/api/og?type=drug&title=liposomal%20NDDP&subtitle=liposomal%20NDDP%20%C2%B7%20NYU%20Langone%20Health&badge=phase%202 liposomal NDDP liposomal NDDP · NYU Langone Health https://druglandscape.com/drug/liposomal-paclitaxel-and-capecitabine https://druglandscape.com/api/og?type=drug&title=Liposomal%20paclitaxel%20and%20capecitabine&subtitle=Liposomal%20paclitaxel%20and%20capecitabine%20%C2%B7%20Nanjing%20Sike%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Liposomal paclitaxel and capecitabine Liposomal paclitaxel and capecitabine · Nanjing Sike Pharmaceutical Co., Ltd. https://druglandscape.com/drug/liposomal-paclitaxel-plus-capecitabine https://druglandscape.com/api/og?type=drug&title=Liposomal%20paclitaxel%20plus%20capecitabine&subtitle=Liposomal%20paclitaxel%20plus%20capecitabine%20%C2%B7%20Nanjing%20Sike%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Liposomal paclitaxel plus capecitabine Liposomal paclitaxel plus capecitabine · Nanjing Sike Pharmaceutical Co., Ltd. https://druglandscape.com/drug/liposome-dispersion https://druglandscape.com/api/og?type=drug&title=liposome%20dispersion&subtitle=liposome%20dispersion%20%C2%B7%20Crist%C3%A1lia%20Produtos%20Qu%C3%ADmicos%20Farmac%C3%AAuticos%20Ltda.&badge=phase%201 liposome dispersion liposome dispersion · Cristália Produtos Químicos Farmacêuticos Ltda. https://druglandscape.com/drug/liposome-encapsulated-sn38 https://druglandscape.com/api/og?type=drug&title=Liposome-encapsulated%20SN38&subtitle=Liposome-encapsulated%20SN38%20%C2%B7%20INSYS%20Therapeutics%20Inc&badge=phase%201 Liposome-encapsulated SN38 Liposome-encapsulated SN38 · INSYS Therapeutics Inc https://druglandscape.com/drug/liposome-mitoxantrone https://druglandscape.com/api/og?type=drug&title=Liposome%20mitoxantrone&subtitle=Liposome%20mitoxantrone%20%C2%B7%20BGI%2C%20China&badge=phase%201 Liposome mitoxantrone Liposome mitoxantrone · BGI, China https://druglandscape.com/drug/liposomeal-curcumin https://druglandscape.com/api/og?type=drug&title=Liposomeal%20curcumin&subtitle=Liposomeal%20curcumin%20%C2%B7%20SignPath%20Pharma%2C%20Inc.&badge=phase%201 Liposomeal curcumin Liposomeal curcumin · SignPath Pharma, Inc. https://druglandscape.com/drug/lipovaxin-mm https://druglandscape.com/api/og?type=drug&title=Lipovaxin-MM&subtitle=Lipovaxin-MM%20%C2%B7%20Lipotek%20Pty%20Ltd&badge=phase%201 Lipovaxin-MM Lipovaxin-MM · Lipotek Pty Ltd https://druglandscape.com/drug/liprostin-liposomal-prostaglandin-e1 https://druglandscape.com/api/og?type=drug&title=Liprostin%20%5Bliposomal%20Prostaglandin%20E1%5D&subtitle=Liprostin%20%5Bliposomal%20Prostaglandin%20E1%5D%20%C2%B7%20Endovasc&badge=phase%202 Liprostin [liposomal Prostaglandin E1] Liprostin [liposomal Prostaglandin E1] · Endovasc https://druglandscape.com/drug/liq-avexitide https://druglandscape.com/api/og?type=drug&title=Liq%20avexitide&subtitle=Liq%20avexitide%20%C2%B7%20Tracey%20McLaughlin&badge=phase%202 Liq avexitide Liq avexitide · Tracey McLaughlin https://druglandscape.com/drug/liq861 https://druglandscape.com/api/og?type=drug&title=LIQ861&subtitle=LIQ861%20%C2%B7%20Liquidia%20Technologies%2C%20Inc.&badge=phase%202 LIQ861 LIQ861 · Liquidia Technologies, Inc. https://druglandscape.com/drug/liq865a-bupivacaine-formulation https://druglandscape.com/api/og?type=drug&title=LIQ865A%20bupivacaine%20formulation&subtitle=LIQ865A%20bupivacaine%20formulation%20%C2%B7%20Liquidia%20Technologies%2C%20Inc.&badge=phase%201 LIQ865A bupivacaine formulation LIQ865A bupivacaine formulation · Liquidia Technologies, Inc. https://druglandscape.com/drug/liq865b-bupivacaine-formulation https://druglandscape.com/api/og?type=drug&title=LIQ865B%20bupivacaine%20formulation&subtitle=LIQ865B%20bupivacaine%20formulation%20%C2%B7%20Liquidia%20Technologies%2C%20Inc.&badge=phase%201 LIQ865B bupivacaine formulation LIQ865B bupivacaine formulation · Liquidia Technologies, Inc. https://druglandscape.com/drug/liquid-13-cis-retinoic-acid https://druglandscape.com/api/og?type=drug&title=Liquid%2013-Cis%20Retinoic%20Acid&subtitle=Liquid%2013-Cis%20Retinoic%20Acid%20%C2%B7%20Nova%20Laboratories%20Limited&badge=phase%201 Liquid 13-Cis Retinoic Acid Liquid 13-Cis Retinoic Acid · Nova Laboratories Limited https://druglandscape.com/drug/liquid-alpha-pi https://druglandscape.com/api/og?type=drug&title=Liquid%20Alpha%E2%82%81-PI&subtitle=Liquid%20Alpha%E2%82%81-PI%20%C2%B7%20Grifols%20Therapeutics%20LLC&badge=phase%202 Liquid Alpha₁-PI Liquid Alpha₁-PI · Grifols Therapeutics LLC https://druglandscape.com/drug/liquid-nitrogen-and-cantharidin https://druglandscape.com/api/og?type=drug&title=Liquid%20nitrogen%20and%20cantharidin&subtitle=Liquid%20nitrogen%20and%20cantharidin%20%C2%B7%20North%20Idaho%20Dermatology&badge=phase%201 Liquid nitrogen and cantharidin Liquid nitrogen and cantharidin · North Idaho Dermatology https://druglandscape.com/drug/liquid-pergoveris https://druglandscape.com/api/og?type=drug&title=Liquid%20pergoveris&subtitle=Liquid%20pergoveris%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 Liquid pergoveris Liquid pergoveris · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/liraglutide-3h https://druglandscape.com/api/og?type=drug&title=liraglutide%20%5B3H%5D&subtitle=liraglutide%20%5B3H%5D%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 liraglutide [3H] liraglutide [3H] · Novo Nordisk A/S https://druglandscape.com/drug/liraglutide-injection-rd12014 https://druglandscape.com/api/og?type=drug&title=Liraglutide%20injection%2CRD12014&subtitle=Liraglutide%20injection%2CRD12014%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 Liraglutide injection,RD12014 Liraglutide injection,RD12014 · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/liraglutide-treatment-12-weeks https://druglandscape.com/api/og?type=drug&title=Liraglutide%20treatment%2012%20weeks&subtitle=Liraglutide%20treatment%2012%20weeks%20%C2%B7%20Amsterdam%20UMC%2C%20location%20VUmc&badge=phase%201 Liraglutide treatment 12 weeks Liraglutide treatment 12 weeks · Amsterdam UMC, location VUmc https://druglandscape.com/drug/liris https://druglandscape.com/api/og?type=drug&title=LiRIS%C2%AE&subtitle=LiRIS%C2%AE%20%C2%B7%20Allergan&badge=phase%202 LiRIS® LiRIS® · Allergan https://druglandscape.com/drug/liris-low-dose-and-liris-high-dose https://druglandscape.com/api/og?type=drug&title=LiRIS%20low%20dose%20and%20LiRIS%20high%20dose&subtitle=LiRIS%20low%20dose%20and%20LiRIS%20high%20dose%20%C2%B7%20Allergan&badge=phase%201 LiRIS low dose and LiRIS high dose LiRIS low dose and LiRIS high dose · Allergan https://druglandscape.com/drug/lis-18-u https://druglandscape.com/api/og?type=drug&title=LIS%2018%20U&subtitle=LIS%2018%20U%20%C2%B7%20Dance%20Biopharm%20Inc.&badge=phase%201 LIS 18 U LIS 18 U · Dance Biopharm Inc. https://druglandscape.com/drug/lis1 https://druglandscape.com/api/og?type=drug&title=LIS1&subtitle=LIS1%20%C2%B7%20Xenothera%20SAS&badge=phase%201 LIS1 LIS1 · Xenothera SAS https://druglandscape.com/drug/lisinopril-losartan-and-atorvastatin https://druglandscape.com/api/og?type=drug&title=Lisinopril%2C%20losartan%2C%20and%20atorvastatin&subtitle=Lisinopril%2C%20losartan%2C%20and%20atorvastatin%20%C2%B7%20NYU%20Langone%20Health&badge=phase%202 Lisinopril, losartan, and atorvastatin Lisinopril, losartan, and atorvastatin · NYU Langone Health https://druglandscape.com/drug/lispro-insulin-and-glargine-insulin https://druglandscape.com/api/og?type=drug&title=Lispro%20Insulin%20and%20glargine%20insulin&subtitle=Lispro%20Insulin%20and%20glargine%20insulin%20%C2%B7%20Diabetes%20Care%20Center&badge=phase%201 Lispro Insulin and glargine insulin Lispro Insulin and glargine insulin · Diabetes Care Center https://druglandscape.com/drug/lispro-insulin-u-100 https://druglandscape.com/api/og?type=drug&title=Lispro%20insulin%20U-100&subtitle=Lispro%20insulin%20U-100%20%C2%B7%20AstraZeneca&badge=phase%201 Lispro insulin U-100 Lispro insulin U-100 · AstraZeneca https://druglandscape.com/drug/lispro-sc https://druglandscape.com/api/og?type=drug&title=Lispro%20SC&subtitle=Lispro%20SC%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Lispro SC Lispro SC · Eli Lilly and Company https://druglandscape.com/drug/lit-00814 https://druglandscape.com/api/og?type=drug&title=LIT-00814&subtitle=LIT-00814%20%C2%B7%20LittDD%20Medicines%20Ltd&badge=phase%201 LIT-00814 LIT-00814 · LittDD Medicines Ltd https://druglandscape.com/drug/litapiprant-tablet https://druglandscape.com/api/og?type=drug&title=Litapiprant%20Tablet&subtitle=Litapiprant%20Tablet%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 Litapiprant Tablet Litapiprant Tablet · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/liv001 https://druglandscape.com/api/og?type=drug&title=LIV001&subtitle=LIV001%20%C2%B7%20Liveome%20Inc.&badge=phase%201 LIV001 LIV001 · Liveome Inc. https://druglandscape.com/drug/livalo-fixed-combination-drug https://druglandscape.com/api/og?type=drug&title=Livalo%C2%AE%20fixed%20combination%20drug&subtitle=Livalo%C2%AE%20fixed%20combination%20drug%20%C2%B7%20JW%20Pharmaceutical&badge=phase%201 Livalo® fixed combination drug Livalo® fixed combination drug · JW Pharmaceutical https://druglandscape.com/drug/live-attenuated-japanese-encephalitis-virus https://druglandscape.com/api/og?type=drug&title=Live%20attenuated%20Japanese%20encephalitis%20virus&subtitle=Live%20attenuated%20Japanese%20encephalitis%20virus%20%C2%B7%20Sanofi&badge=phase%202 Live attenuated Japanese encephalitis virus Live attenuated Japanese encephalitis virus · Sanofi https://druglandscape.com/drug/live-attenuated-rotavirus-vaccine https://druglandscape.com/api/og?type=drug&title=Live%20attenuated%20rotavirus%20vaccine&subtitle=Live%20attenuated%20rotavirus%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Live attenuated rotavirus vaccine Live attenuated rotavirus vaccine · GlaxoSmithKline https://druglandscape.com/drug/live-attenuated-tetravalent-dengue-vaccine https://druglandscape.com/api/og?type=drug&title=Live%20attenuated%20tetravalent%20dengue%20vaccine&subtitle=Live%20attenuated%20tetravalent%20dengue%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Live attenuated tetravalent dengue vaccine Live attenuated tetravalent dengue vaccine · GlaxoSmithKline https://druglandscape.com/drug/live-francisella-tularensis-vaccine https://druglandscape.com/api/og?type=drug&title=Live%20Francisella%20Tularensis%20Vaccine&subtitle=Live%20Francisella%20Tularensis%20Vaccine%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%202 Live Francisella Tularensis Vaccine Live Francisella Tularensis Vaccine · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/liverpearls-irinotecan https://druglandscape.com/api/og?type=drug&title=LIVERPEARLS-Irinotecan&subtitle=LIVERPEARLS-Irinotecan%20%C2%B7%20Grupo%20Espanol%20Multidisciplinario%20del%20Cancer%20Digestivo&badge=phase%202 LIVERPEARLS-Irinotecan LIVERPEARLS-Irinotecan · Grupo Espanol Multidisciplinario del Cancer Digestivo https://druglandscape.com/drug/livitol-70 https://druglandscape.com/api/og?type=drug&title=Livitol-70&subtitle=Livitol-70%20%C2%B7%20Composite%20Interceptive%20Med%20Science&badge=phase%201 Livitol-70 Livitol-70 · Composite Interceptive Med Science https://druglandscape.com/drug/ll-bmt1 https://druglandscape.com/api/og?type=drug&title=LL-BMT1&subtitle=LL-BMT1%20%C2%B7%20MediPrint%20Ophthalmics%2C%20Inc.&badge=phase%202 LL-BMT1 LL-BMT1 · MediPrint Ophthalmics, Inc. https://druglandscape.com/drug/llp2a-alendronate https://druglandscape.com/api/og?type=drug&title=LLP2A-ALENDRONATE&subtitle=LLP2A-ALENDRONATE%20%C2%B7%20Nancy%20E.%20Lane%2C%20MD&badge=phase%201 LLP2A-ALENDRONATE LLP2A-ALENDRONATE · Nancy E. Lane, MD https://druglandscape.com/drug/llx-424 https://druglandscape.com/api/og?type=drug&title=LLX-424&subtitle=LLX-424%20%C2%B7%20Lilac%20Therapeutics%2C%20Inc.&badge=phase%202 LLX-424 LLX-424 · Lilac Therapeutics, Inc. https://druglandscape.com/drug/lm-108 https://druglandscape.com/api/og?type=drug&title=LM-108&subtitle=LM-108%20%C2%B7%20LaNova%20Medicines%20Limited&badge=phase%202 LM-108 LM-108 · LaNova Medicines Limited https://druglandscape.com/drug/lm-168 https://druglandscape.com/api/og?type=drug&title=LM-168&subtitle=LM-168%20%C2%B7%20LaNova%20Medicines%20Limited&badge=phase%201 LM-168 LM-168 · LaNova Medicines Limited https://druglandscape.com/drug/lm-2417 https://druglandscape.com/api/og?type=drug&title=LM-2417&subtitle=LM-2417%20%C2%B7%20LaNova%20Medicines%20Limited&badge=phase%201 LM-2417 LM-2417 · LaNova Medicines Limited https://druglandscape.com/drug/lm-24c5 https://druglandscape.com/api/og?type=drug&title=LM-24C5&subtitle=LM-24C5%20%C2%B7%20LaNova%20Medicines%20Limited&badge=phase%202 LM-24C5 LM-24C5 · LaNova Medicines Limited https://druglandscape.com/drug/lm-299 https://druglandscape.com/api/og?type=drug&title=LM-299&subtitle=LM-299%20%C2%B7%20LaNova%20Medicines%20Limited&badge=phase%201 LM-299 LM-299 · LaNova Medicines Limited https://druglandscape.com/drug/lm001 https://druglandscape.com/api/og?type=drug&title=LM001&subtitle=LM001%20%C2%B7%20Alphamab%20Jilin%20Co.%2C%20Ltd.&badge=phase%201 LM001 LM001 · Alphamab Jilin Co., Ltd. https://druglandscape.com/drug/lm101 https://druglandscape.com/api/og?type=drug&title=LM101&subtitle=LM101%20%C2%B7%20LaNova%20Medicines%20Limited&badge=phase%201 LM101 LM101 · LaNova Medicines Limited https://druglandscape.com/drug/lm103 https://druglandscape.com/api/og?type=drug&title=LM103&subtitle=LM103%20%C2%B7%20Suzhou%20BlueHorse%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 LM103 LM103 · Suzhou BlueHorse Therapeutics Co., Ltd. https://druglandscape.com/drug/lm303 https://druglandscape.com/api/og?type=drug&title=LM303&subtitle=LM303%20%C2%B7%20Suzhou%20BlueHorse%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 LM303 LM303 · Suzhou BlueHorse Therapeutics Co., Ltd. https://druglandscape.com/drug/lmi-1195-101 https://druglandscape.com/api/og?type=drug&title=LMI%201195-101&subtitle=LMI%201195-101%20%C2%B7%20Lantheus%20Medical%20Imaging&badge=phase%201 LMI 1195-101 LMI 1195-101 · Lantheus Medical Imaging https://druglandscape.com/drug/lmn-201 https://druglandscape.com/api/og?type=drug&title=LMN-201&subtitle=LMN-201%20%C2%B7%20Lumen%20Bioscience%2C%20Inc.&badge=phase%202 LMN-201 LMN-201 · Lumen Bioscience, Inc. https://druglandscape.com/drug/lmn-201-anti-toxin-b-vhh-1 https://druglandscape.com/api/og?type=drug&title=LMN-201%20Anti-toxin%20B%20VHH-1&subtitle=LMN-201%20Anti-toxin%20B%20VHH-1%20%C2%B7%20Lumen%20Bioscience%2C%20Inc.&badge=phase%201 LMN-201 Anti-toxin B VHH-1 LMN-201 Anti-toxin B VHH-1 · Lumen Bioscience, Inc. https://druglandscape.com/drug/lmn-201-anti-toxin-b-vhh-1-vhh-2-vhh-3 https://druglandscape.com/api/og?type=drug&title=LMN-201%20Anti-toxin%20B%20VHH-1%2C%20VHH-2%2C%20VHH-3&subtitle=LMN-201%20Anti-toxin%20B%20VHH-1%2C%20VHH-2%2C%20VHH-3%20%C2%B7%20Lumen%20Bioscience%2C%20Inc.&badge=phase%201 LMN-201 Anti-toxin B VHH-1, VHH-2, VHH-3 LMN-201 Anti-toxin B VHH-1, VHH-2, VHH-3 · Lumen Bioscience, Inc. https://druglandscape.com/drug/lmn-201-anti-toxin-b-vhh-2 https://druglandscape.com/api/og?type=drug&title=LMN-201%20Anti-toxin%20B%20VHH-2&subtitle=LMN-201%20Anti-toxin%20B%20VHH-2%20%C2%B7%20Lumen%20Bioscience%2C%20Inc.&badge=phase%201 LMN-201 Anti-toxin B VHH-2 LMN-201 Anti-toxin B VHH-2 · Lumen Bioscience, Inc. https://druglandscape.com/drug/lmn-201-anti-toxin-b-vhh-3 https://druglandscape.com/api/og?type=drug&title=LMN-201%20Anti-toxin%20B%20VHH-3&subtitle=LMN-201%20Anti-toxin%20B%20VHH-3%20%C2%B7%20Lumen%20Bioscience%2C%20Inc.&badge=phase%201 LMN-201 Anti-toxin B VHH-3 LMN-201 Anti-toxin B VHH-3 · Lumen Bioscience, Inc. https://druglandscape.com/drug/lmn-301 https://druglandscape.com/api/og?type=drug&title=LMN-301&subtitle=LMN-301%20%C2%B7%20Lumen%20Bioscience%2C%20Inc.&badge=phase%201 LMN-301 LMN-301 · Lumen Bioscience, Inc. https://druglandscape.com/drug/lmn-401 https://druglandscape.com/api/og?type=drug&title=LMN-401&subtitle=LMN-401%20%C2%B7%20Lumen%20Bioscience%2C%20Inc.&badge=phase%201 LMN-401 LMN-401 · Lumen Bioscience, Inc. https://druglandscape.com/drug/lmp-specific-t-cells https://druglandscape.com/api/og?type=drug&title=LMP%20specific%20T%20cells&subtitle=LMP%20specific%20T%20cells%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 LMP specific T cells LMP specific T cells · Baylor College of Medicine https://druglandscape.com/drug/lmt503 https://druglandscape.com/api/og?type=drug&title=LMT503&subtitle=LMT503%20%C2%B7%20Lmito%20Therapeutics%20Inc.&badge=phase%201 LMT503 LMT503 · Lmito Therapeutics Inc. https://druglandscape.com/drug/lmwh-and-phenprocoumon https://druglandscape.com/api/og?type=drug&title=LMWH%20and%20Phenprocoumon&subtitle=LMWH%20and%20Phenprocoumon%20%C2%B7%20Bayer&badge=phase%202 LMWH and Phenprocoumon LMWH and Phenprocoumon · Bayer https://druglandscape.com/drug/ln-145 https://druglandscape.com/api/og?type=drug&title=LN-145&subtitle=LN-145%20%C2%B7%20Karam%20Khaddour%2C%20MD%2C%20MS&badge=phase%202 LN-145 LN-145 · Karam Khaddour, MD, MS https://druglandscape.com/drug/ln-145-s1 https://druglandscape.com/api/og?type=drug&title=LN-145-S1&subtitle=LN-145-S1%20%C2%B7%20Iovance%20Biotherapeutics%2C%20Inc.&badge=phase%202 LN-145-S1 LN-145-S1 · Iovance Biotherapeutics, Inc. https://druglandscape.com/drug/lncb74 https://druglandscape.com/api/og?type=drug&title=LNCB74&subtitle=LNCB74%20%C2%B7%20NextCure%2C%20Inc.&badge=phase%201 LNCB74 LNCB74 · NextCure, Inc. https://druglandscape.com/drug/lnf2007 https://druglandscape.com/api/og?type=drug&title=LNF2007&subtitle=LNF2007%20%C2%B7%20Shandong%20New%20Time%20Pharmaceutical%20Co.%2C%20LTD&badge=phase%201 LNF2007 LNF2007 · Shandong New Time Pharmaceutical Co., LTD https://druglandscape.com/drug/lnk-754 https://druglandscape.com/api/og?type=drug&title=LNK-754&subtitle=LNK-754%20%C2%B7%20Link%20Medicine%20Corporation&badge=phase%201 LNK-754 LNK-754 · Link Medicine Corporation https://druglandscape.com/drug/lnk01001-dose-a https://druglandscape.com/api/og?type=drug&title=LNK01001%20Dose%20A&subtitle=LNK01001%20Dose%20A%20%C2%B7%20Lynk%20Pharmaceuticals%20Co.%2C%20Ltd&badge=phase%202 LNK01001 Dose A LNK01001 Dose A · Lynk Pharmaceuticals Co., Ltd https://druglandscape.com/drug/lnk01001-dose-b https://druglandscape.com/api/og?type=drug&title=LNK01001%20Dose%20B&subtitle=LNK01001%20Dose%20B%20%C2%B7%20Lynk%20Pharmaceuticals%20Co.%2C%20Ltd&badge=phase%202 LNK01001 Dose B LNK01001 Dose B · Lynk Pharmaceuticals Co., Ltd https://druglandscape.com/drug/lnk01004-ointment-0-3 https://druglandscape.com/api/og?type=drug&title=LNK01004%20ointment%200.3%25&subtitle=LNK01004%20ointment%200.3%25%20%C2%B7%20Lynk%20Pharmaceuticals%20Co.%2C%20Ltd&badge=phase%202 LNK01004 ointment 0.3% LNK01004 ointment 0.3% · Lynk Pharmaceuticals Co., Ltd https://druglandscape.com/drug/lnk01004-ointment-1-5 https://druglandscape.com/api/og?type=drug&title=LNK01004%20ointment%201.5%25&subtitle=LNK01004%20ointment%201.5%25%20%C2%B7%20Lynk%20Pharmaceuticals%20Co.%2C%20Ltd&badge=phase%201 LNK01004 ointment 1.5% LNK01004 ointment 1.5% · Lynk Pharmaceuticals Co., Ltd https://druglandscape.com/drug/lnp-ncov-sarna-02-vaccine https://druglandscape.com/api/og?type=drug&title=LNP-nCOV%20saRNA-02%20Vaccine&subtitle=LNP-nCOV%20saRNA-02%20Vaccine%20%C2%B7%20MRC%2FUVRI%20and%20LSHTM%20Uganda%20Research%20Unit&badge=phase%201 LNP-nCOV saRNA-02 Vaccine LNP-nCOV saRNA-02 Vaccine · MRC/UVRI and LSHTM Uganda Research Unit https://druglandscape.com/drug/lnp1892 https://druglandscape.com/api/og?type=drug&title=LNP1892&subtitle=LNP1892%20%C2%B7%20Lupin%20Ltd.&badge=phase%201 LNP1892 LNP1892 · Lupin Ltd. https://druglandscape.com/drug/lnp3794 https://druglandscape.com/api/og?type=drug&title=LNP3794&subtitle=LNP3794%20%C2%B7%20Lupin%20Ltd.&badge=phase%201 LNP3794 LNP3794 · Lupin Ltd. https://druglandscape.com/drug/lnth2403-phase-1-dose https://druglandscape.com/api/og?type=drug&title=LNTH2403%20Phase%201%20dose&subtitle=LNTH2403%20Phase%201%20dose%20%C2%B7%20Lantheus%20Medical%20Imaging&badge=phase%201 LNTH2403 Phase 1 dose LNTH2403 Phase 1 dose · Lantheus Medical Imaging https://druglandscape.com/drug/lo2a https://druglandscape.com/api/og?type=drug&title=LO2A&subtitle=LO2A%20%C2%B7%20Ocuwize%20LTD&badge=phase%202 LO2A LO2A · Ocuwize LTD https://druglandscape.com/drug/load703 https://druglandscape.com/api/og?type=drug&title=LOAd703&subtitle=LOAd703%20%C2%B7%20Lokon%20Pharma%20AB&badge=phase%201 LOAd703 LOAd703 · Lokon Pharma AB https://druglandscape.com/drug/local-anaesthesia https://druglandscape.com/api/og?type=drug&title=Local%20anaesthesia&subtitle=Local%20anaesthesia%20%C2%B7%20Northern%20Orthopaedic%20Division%2C%20Denmark&badge=phase%201 Local anaesthesia Local anaesthesia · Northern Orthopaedic Division, Denmark https://druglandscape.com/drug/local-anesthesia-using-2-lidocaine https://druglandscape.com/api/og?type=drug&title=local%20anesthesia%20using%202%25%20lidocaine&subtitle=local%20anesthesia%20using%202%25%20lidocaine%20%C2%B7%20Op%C4%87a%20%C5%BEupanijska%20bolnica%20Po%C5%BEega&badge=phase%201 local anesthesia using 2% lidocaine local anesthesia using 2% lidocaine · Opća županijska bolnica Požega https://druglandscape.com/drug/local-anesthetics-procaine https://druglandscape.com/api/og?type=drug&title=Local%20Anesthetics%20Procaine&subtitle=Local%20Anesthetics%20Procaine%20%C2%B7%20Gihan%20M%20Abuelniel%20%2CPhD&badge=phase%202 Local Anesthetics Procaine Local Anesthetics Procaine · Gihan M Abuelniel ,PhD https://druglandscape.com/drug/local-application-pentostam https://druglandscape.com/api/og?type=drug&title=Local%20application%20pentostam&subtitle=Local%20application%20pentostam%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 Local application pentostam Local application pentostam · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/local-steroid https://druglandscape.com/api/og?type=drug&title=Local%20Steroid&subtitle=Local%20Steroid%20%C2%B7%20AbbVie&badge=phase%202 Local Steroid Local Steroid · AbbVie https://druglandscape.com/drug/loceryl-5 https://druglandscape.com/api/og?type=drug&title=Loceryl%205%25&subtitle=Loceryl%205%25%20%C2%B7%20Oystershell%20NV&badge=phase%201 Loceryl 5% Loceryl 5% · Oystershell NV https://druglandscape.com/drug/locoid-lipocream https://druglandscape.com/api/og?type=drug&title=Locoid%20Lipocream&subtitle=Locoid%20Lipocream%20%C2%B7%20Icahn%20School%20of%20Medicine%20at%20Mount%20Sinai&badge=phase%201 Locoid Lipocream Locoid Lipocream · Icahn School of Medicine at Mount Sinai https://druglandscape.com/drug/lodinet https://druglandscape.com/api/og?type=drug&title=LodineT&subtitle=LodineT%20%C2%B7%20Hanlim%20Pharm.%20Co.%2C%20Ltd.&badge=phase%201 LodineT LodineT · Hanlim Pharm. Co., Ltd. https://druglandscape.com/drug/lofexidine-matching-sugar-pill https://druglandscape.com/api/og?type=drug&title=Lofexidine-matching%20sugar%20pill&subtitle=Lofexidine-matching%20sugar%20pill%20%C2%B7%20USWM%2C%20LLC%20(dba%20US%20WorldMeds)&badge=phase%201 Lofexidine-matching sugar pill Lofexidine-matching sugar pill · USWM, LLC (dba US WorldMeds) https://druglandscape.com/drug/lon002 https://druglandscape.com/api/og?type=drug&title=LON002&subtitle=LON002%20%C2%B7%20LondonPharma%20Ltd.&badge=phase%201 LON002 LON002 · LondonPharma Ltd. https://druglandscape.com/drug/long-acting-blockers https://druglandscape.com/api/og?type=drug&title=Long%20acting%20%CE%B2-blockers&subtitle=Long%20acting%20%CE%B2-blockers%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Long acting β-blockers Long acting β-blockers · GlaxoSmithKline https://druglandscape.com/drug/long-and-intermediate-acting-insulins https://druglandscape.com/api/og?type=drug&title=Long-%20and%20intermediate-%20acting%20insulins&subtitle=Long-%20and%20intermediate-%20acting%20insulins%20%C2%B7%20Biologics%20%26%20Biosimilars%20Collective%20Intelligence%20Consortium&badge=phase%202 Long- and intermediate- acting insulins Long- and intermediate- acting insulins · Biologics & Biosimilars Collective Intelligence Consortium https://druglandscape.com/drug/long-gnrh-agonist https://druglandscape.com/api/og?type=drug&title=Long%20GnRH%20agonist&subtitle=Long%20GnRH%20agonist%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%202 Long GnRH agonist Long GnRH agonist · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/long-term-dosing-cohort https://druglandscape.com/api/og?type=drug&title=Long-term%20Dosing%20Cohort&subtitle=Long-term%20Dosing%20Cohort%20%C2%B7%20Shaanxi%20Micot%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%202 Long-term Dosing Cohort Long-term Dosing Cohort · Shaanxi Micot Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/long-term-follow-up https://druglandscape.com/api/og?type=drug&title=Long%20Term%20Follow-Up&subtitle=Long%20Term%20Follow-Up%20%C2%B7%20Sentynl%20Therapeutics%2C%20Inc.&badge=phase%202 Long Term Follow-Up Long Term Follow-Up · Sentynl Therapeutics, Inc. https://druglandscape.com/drug/long-term-on-q https://druglandscape.com/api/og?type=drug&title=Long-term%20ON-Q&subtitle=Long-term%20ON-Q%20%C2%B7%20AdventHealth&badge=phase%201 Long-term ON-Q Long-term ON-Q · AdventHealth https://druglandscape.com/drug/long-term-safety-follow-up https://druglandscape.com/api/og?type=drug&title=Long-Term%20Safety%20Follow-up&subtitle=Long-Term%20Safety%20Follow-up%20%C2%B7%20Sollis%20Therapeutics%2C%20Inc.&badge=phase%202 Long-Term Safety Follow-up Long-Term Safety Follow-up · Sollis Therapeutics, Inc. https://druglandscape.com/drug/long-tirofiban https://druglandscape.com/api/og?type=drug&title=Long%20Tirofiban&subtitle=Long%20Tirofiban%20%C2%B7%20Medicure&badge=phase%202 Long Tirofiban Long Tirofiban · Medicure https://druglandscape.com/drug/longeveron-mesenchymal-stem-cells https://druglandscape.com/api/og?type=drug&title=Longeveron%20Mesenchymal%20Stem%20Cells&subtitle=Longeveron%20Mesenchymal%20Stem%20Cells%20%C2%B7%20Longeveron%20Inc.&badge=phase%201 Longeveron Mesenchymal Stem Cells Longeveron Mesenchymal Stem Cells · Longeveron Inc. https://druglandscape.com/drug/lor-253-hcl https://druglandscape.com/api/og?type=drug&title=LOR-253%20HCl&subtitle=LOR-253%20HCl%20%C2%B7%20Aptose%20Biosciences%20Inc.&badge=phase%201 LOR-253 HCl LOR-253 HCl · Aptose Biosciences Inc. https://druglandscape.com/drug/loratadine-oral-solution https://druglandscape.com/api/og?type=drug&title=Loratadine%20oral%20solution&subtitle=Loratadine%20oral%20solution%20%C2%B7%20Bayer&badge=phase%201 Loratadine oral solution Loratadine oral solution · Bayer https://druglandscape.com/drug/lorazepam-ci https://druglandscape.com/api/og?type=drug&title=Lorazepam%20CI&subtitle=Lorazepam%20CI%20%C2%B7%20The%20Emmes%20Company%2C%20LLC&badge=phase%202 Lorazepam CI Lorazepam CI · The Emmes Company, LLC https://druglandscape.com/drug/lorcaserin-dose-1 https://druglandscape.com/api/og?type=drug&title=Lorcaserin%20Dose%20%231&subtitle=Lorcaserin%20Dose%20%231%20%C2%B7%20Eisai%20Inc.&badge=phase%201 Lorcaserin Dose #1 Lorcaserin Dose #1 · Eisai Inc. https://druglandscape.com/drug/lorcaserin-dose-3 https://druglandscape.com/api/og?type=drug&title=Lorcaserin%20Dose%20%233&subtitle=Lorcaserin%20Dose%20%233%20%C2%B7%20Eisai%20Inc.&badge=phase%201 Lorcaserin Dose #3 Lorcaserin Dose #3 · Eisai Inc. https://druglandscape.com/drug/lorcaserin-manufactured-at-kawashima https://druglandscape.com/api/og?type=drug&title=Lorcaserin%20manufactured%20at%20Kawashima&subtitle=Lorcaserin%20manufactured%20at%20Kawashima%20%C2%B7%20Eisai%20Inc.&badge=phase%201 Lorcaserin manufactured at Kawashima Lorcaserin manufactured at Kawashima · Eisai Inc. https://druglandscape.com/drug/losartan-potassium-and-hydrochlorothiazide-tablets https://druglandscape.com/api/og?type=drug&title=Losartan%20Potassium%20and%20Hydrochlorothiazide%20Tablets&subtitle=Losartan%20Potassium%20and%20Hydrochlorothiazide%20Tablets%20%C2%B7%20Torrent%20Pharmaceuticals%20Limited&badge=phase%201 Losartan Potassium and Hydrochlorothiazide Tablets Losartan Potassium and Hydrochlorothiazide Tablets · Torrent Pharmaceuticals Limited https://druglandscape.com/drug/losartan-tablets-qingremoshen-granule https://druglandscape.com/api/og?type=drug&title=Losartan%20Tablets%20%26%20QingReMoShen%20Granule&subtitle=Losartan%20Tablets%20%26%20QingReMoShen%20Granule%20%C2%B7%20wanglin&badge=phase%201 Losartan Tablets & QingReMoShen Granule Losartan Tablets & QingReMoShen Granule · wanglin https://druglandscape.com/drug/losmapimod-for-repeat-dose https://druglandscape.com/api/og?type=drug&title=Losmapimod%20for%20repeat%20dose&subtitle=Losmapimod%20for%20repeat%20dose%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Losmapimod for repeat dose Losmapimod for repeat dose · GlaxoSmithKline https://druglandscape.com/drug/losmapimod-for-single-dose https://druglandscape.com/api/og?type=drug&title=Losmapimod%20for%20single%20dose&subtitle=Losmapimod%20for%20single%20dose%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Losmapimod for single dose Losmapimod for single dose · GlaxoSmithKline https://druglandscape.com/drug/loteprednol-etabonate-suspension https://druglandscape.com/api/og?type=drug&title=Loteprednol%20etabonate%20suspension&subtitle=Loteprednol%20etabonate%20suspension%20%C2%B7%20Bausch%20%26%20Lomb%20Incorporated&badge=phase%202 Loteprednol etabonate suspension Loteprednol etabonate suspension · Bausch & Lomb Incorporated https://druglandscape.com/drug/loteprendol-etabonate-0-5 https://druglandscape.com/api/og?type=drug&title=Loteprendol%20etabonate%200.5%25&subtitle=Loteprendol%20etabonate%200.5%25%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 Loteprendol etabonate 0.5% Loteprendol etabonate 0.5% · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/lotilaner-gel-2-0 https://druglandscape.com/api/og?type=drug&title=Lotilaner%20Gel%2C%202.0%25&subtitle=Lotilaner%20Gel%2C%202.0%25%20%C2%B7%20Tarsus%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Lotilaner Gel, 2.0% Lotilaner Gel, 2.0% · Tarsus Pharmaceuticals, Inc. https://druglandscape.com/drug/low-bpv-regimen https://druglandscape.com/api/og?type=drug&title=Low%20BPV%20Regimen&subtitle=Low%20BPV%20Regimen%20%C2%B7%20Cedars-Sinai%20Medical%20Center&badge=phase%201 Low BPV Regimen Low BPV Regimen · Cedars-Sinai Medical Center https://druglandscape.com/drug/low-clonidine-concentration https://druglandscape.com/api/og?type=drug&title=low%20clonidine%20concentration&subtitle=low%20clonidine%20concentration%20%C2%B7%20Universidade%20Federal%20do%20Rio%20de%20Janeiro&badge=phase%202 low clonidine concentration low clonidine concentration · Universidade Federal do Rio de Janeiro https://druglandscape.com/drug/low-hla-group-cbu-infusion https://druglandscape.com/api/og?type=drug&title=Low%20HLA%20group%20CBU%20infusion&subtitle=Low%20HLA%20group%20CBU%20infusion%20%C2%B7%20State-Financed%20Health%20Facility%20%22Samara%20Regional%20Medical%20Center%20Dinasty%22&badge=phase%202 Low HLA group CBU infusion Low HLA group CBU infusion · State-Financed Health Facility "Samara Regional Medical Center Dinasty" https://druglandscape.com/drug/low-level-laser-therapy https://druglandscape.com/api/og?type=drug&title=Low%20Level%20Laser%20Therapy&subtitle=Low%20Level%20Laser%20Therapy%20%C2%B7%20Universidade%20Federal%20do%20Para&badge=phase%201 Low Level Laser Therapy Low Level Laser Therapy · Universidade Federal do Para https://druglandscape.com/drug/low-metformin https://druglandscape.com/api/og?type=drug&title=Low%20Metformin&subtitle=Low%20Metformin%20%C2%B7%20NuSirt%20Biopharma&badge=phase%202 Low Metformin Low Metformin · NuSirt Biopharma https://druglandscape.com/drug/low-or-upper-respiratory-tract-sample https://druglandscape.com/api/og?type=drug&title=Low%20or%20upper%20respiratory%20tract%20sample&subtitle=Low%20or%20upper%20respiratory%20tract%20sample%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 Low or upper respiratory tract sample Low or upper respiratory tract sample · Hospices Civils de Lyon https://druglandscape.com/drug/low-pressure-hyperbaric-oxygen-therapy https://druglandscape.com/api/og?type=drug&title=Low%20pressure%20hyperbaric%20oxygen%20therapy&subtitle=Low%20pressure%20hyperbaric%20oxygen%20therapy%20%C2%B7%20Paul%20G.%20Harch%2C%20M.D.&badge=phase%201 Low pressure hyperbaric oxygen therapy Low pressure hyperbaric oxygen therapy · Paul G. Harch, M.D. https://druglandscape.com/drug/low-price https://druglandscape.com/api/og?type=drug&title=Low%20price&subtitle=Low%20price%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 Low price Low price · Hadassah Medical Organization https://druglandscape.com/drug/low-price-participants-aware-paying-part https://druglandscape.com/api/og?type=drug&title=Low%20price%20participants%20aware%20paying%20part&subtitle=Low%20price%20participants%20aware%20paying%20part%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 Low price participants aware paying part Low price participants aware paying part · Hadassah Medical Organization https://druglandscape.com/drug/low-sodium-diet https://druglandscape.com/api/og?type=drug&title=low%20sodium%20diet&subtitle=low%20sodium%20diet%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 low sodium diet low sodium diet · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/low-strength-idp-108 https://druglandscape.com/api/og?type=drug&title=Low%20Strength%20IDP-108&subtitle=Low%20Strength%20IDP-108%20%C2%B7%20Dow%20Pharmaceutical%20Sciences&badge=phase%202 Low Strength IDP-108 Low Strength IDP-108 · Dow Pharmaceutical Sciences https://druglandscape.com/drug/low-titre https://druglandscape.com/api/og?type=drug&title=Low%20titre&subtitle=Low%20titre%20%C2%B7%20Hvivo&badge=phase%201 Low titre Low titre · Hvivo https://druglandscape.com/drug/lower-dose-kyg0395 https://druglandscape.com/api/og?type=drug&title=lower%20dose%20KYG0395&subtitle=lower%20dose%20KYG0395%20%C2%B7%20Jiangsu%20Kanion%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 lower dose KYG0395 lower dose KYG0395 · Jiangsu Kanion Pharmaceutical Co., Ltd https://druglandscape.com/drug/loxo-260 https://druglandscape.com/api/og?type=drug&title=LOXO-260&subtitle=LOXO-260%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LOXO-260 LOXO-260 · Eli Lilly and Company https://druglandscape.com/drug/loxo-292 https://druglandscape.com/api/og?type=drug&title=LOXO-292&subtitle=LOXO-292%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LOXO-292 LOXO-292 · Eli Lilly and Company https://druglandscape.com/drug/loxo-338 https://druglandscape.com/api/og?type=drug&title=LOXO-338&subtitle=LOXO-338%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LOXO-338 LOXO-338 · Eli Lilly and Company https://druglandscape.com/drug/loxo-435 https://druglandscape.com/api/og?type=drug&title=LOXO-435&subtitle=LOXO-435%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LOXO-435 LOXO-435 · Eli Lilly and Company https://druglandscape.com/drug/loxoprofen-pain-patch https://druglandscape.com/api/og?type=drug&title=Loxoprofen%20Pain%20Patch&subtitle=Loxoprofen%20Pain%20Patch%20%C2%B7%20Lead%20Chemical%20Co.%2C%20Ltd.&badge=phase%202 Loxoprofen Pain Patch Loxoprofen Pain Patch · Lead Chemical Co., Ltd. https://druglandscape.com/drug/lp-10 https://druglandscape.com/api/og?type=drug&title=LP-10&subtitle=LP-10%20%C2%B7%20Lipella%20Pharmaceuticals%2C%20Inc.&badge=phase%202 LP-10 LP-10 · Lipella Pharmaceuticals, Inc. https://druglandscape.com/drug/lp-108 https://druglandscape.com/api/og?type=drug&title=LP-108&subtitle=LP-108%20%C2%B7%20Guangzhou%20Lupeng%20Pharmaceutical%20Company%20LTD.&badge=phase%201 LP-108 LP-108 · Guangzhou Lupeng Pharmaceutical Company LTD. https://druglandscape.com/drug/lp-108-and-azacitidine https://druglandscape.com/api/og?type=drug&title=LP-108%20and%20azacitidine&subtitle=LP-108%20and%20azacitidine%20%C2%B7%20Newave%20Pharmaceutical%20Inc&badge=phase%201 LP-108 and azacitidine LP-108 and azacitidine · Newave Pharmaceutical Inc https://druglandscape.com/drug/lp-168-tablet https://druglandscape.com/api/og?type=drug&title=LP-168%20tablet&subtitle=LP-168%20tablet%20%C2%B7%20Guangzhou%20Lupeng%20Pharmaceutical%20Company%20LTD.&badge=phase%202 LP-168 tablet LP-168 tablet · Guangzhou Lupeng Pharmaceutical Company LTD. https://druglandscape.com/drug/lp-284 https://druglandscape.com/api/og?type=drug&title=LP-284&subtitle=LP-284%20%C2%B7%20Lantern%20Pharma%20Inc.&badge=phase%201 LP-284 LP-284 · Lantern Pharma Inc. https://druglandscape.com/drug/lp-300 https://druglandscape.com/api/og?type=drug&title=LP-300&subtitle=LP-300%20%C2%B7%20Lantern%20Pharma%20Inc.&badge=phase%202 LP-300 LP-300 · Lantern Pharma Inc. https://druglandscape.com/drug/lp-gmnl-133-capsule https://druglandscape.com/api/og?type=drug&title=LP%20GMNL-133%20capsule&subtitle=LP%20GMNL-133%20capsule%20%C2%B7%20GenMont%20Biotech%20Incorporation&badge=phase%201 LP GMNL-133 capsule LP GMNL-133 capsule · GenMont Biotech Incorporation https://druglandscape.com/drug/lpcn-1144 https://druglandscape.com/api/og?type=drug&title=LPCN%201144&subtitle=LPCN%201144%20%C2%B7%20Lipocine%20Inc.&badge=phase%202 LPCN 1144 LPCN 1144 · Lipocine Inc. https://druglandscape.com/drug/lpcn-1144-formulation-a https://druglandscape.com/api/og?type=drug&title=LPCN%201144%20Formulation%20A&subtitle=LPCN%201144%20Formulation%20A%20%C2%B7%20Lipocine%20Inc.&badge=phase%202 LPCN 1144 Formulation A LPCN 1144 Formulation A · Lipocine Inc. https://druglandscape.com/drug/lpcn-1148 https://druglandscape.com/api/og?type=drug&title=LPCN%201148&subtitle=LPCN%201148%20%C2%B7%20Lipocine%20Inc.&badge=phase%202 LPCN 1148 LPCN 1148 · Lipocine Inc. https://druglandscape.com/drug/lph-5 https://druglandscape.com/api/og?type=drug&title=LPH-5&subtitle=LPH-5%20%C2%B7%20Lophora&badge=phase%201 LPH-5 LPH-5 · Lophora https://druglandscape.com/drug/lpm3480226 https://druglandscape.com/api/og?type=drug&title=LPM3480226&subtitle=LPM3480226%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LPM3480226 LPM3480226 · Luye Pharma Group Ltd. https://druglandscape.com/drug/lpm3770164-sustained-release-tablet https://druglandscape.com/api/og?type=drug&title=LPM3770164%20sustained%20release%20tablet&subtitle=LPM3770164%20sustained%20release%20tablet%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LPM3770164 sustained release tablet LPM3770164 sustained release tablet · Luye Pharma Group Ltd. https://druglandscape.com/drug/lpm3770164-sustained-release-tablet-simulant https://druglandscape.com/api/og?type=drug&title=LPM3770164%20sustained%20release%20tablet%20simulant&subtitle=LPM3770164%20sustained%20release%20tablet%20simulant%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LPM3770164 sustained release tablet simulant LPM3770164 sustained release tablet simulant · Luye Pharma Group Ltd. https://druglandscape.com/drug/lpm6690176 https://druglandscape.com/api/og?type=drug&title=LPM6690176&subtitle=LPM6690176%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LPM6690176 LPM6690176 · Luye Pharma Group Ltd. https://druglandscape.com/drug/lpx-ti641 https://druglandscape.com/api/og?type=drug&title=LPX-TI641&subtitle=LPX-TI641%20%C2%B7%20LAPIX%20Therapeutics%20Inc.&badge=phase%201 LPX-TI641 LPX-TI641 · LAPIX Therapeutics Inc. https://druglandscape.com/drug/lr-chop21 https://druglandscape.com/api/og?type=drug&title=LR-CHOP21&subtitle=LR-CHOP21%20%C2%B7%20Fondazione%20Italiana%20Linfomi%20-%20ETS&badge=phase%202 LR-CHOP21 LR-CHOP21 · Fondazione Italiana Linfomi - ETS https://druglandscape.com/drug/lr20062 https://druglandscape.com/api/og?type=drug&title=LR20062&subtitle=LR20062%20%C2%B7%20LG%20Chem&badge=phase%202 LR20062 LR20062 · LG Chem https://druglandscape.com/drug/lsc2 https://druglandscape.com/api/og?type=drug&title=LSC2&subtitle=LSC2%20%C2%B7%20RHEACELL%20GmbH%20%26%20Co.%20KG&badge=phase%201 LSC2 LSC2 · RHEACELL GmbH & Co. KG https://druglandscape.com/drug/lsp-5415 https://druglandscape.com/api/og?type=drug&title=LSP-5415&subtitle=LSP-5415%20%C2%B7%20Lupin%20Research%20Inc&badge=phase%202 LSP-5415 LSP-5415 · Lupin Research Inc https://druglandscape.com/drug/lt-002-158-tablets https://druglandscape.com/api/og?type=drug&title=LT-002-158%20Tablets&subtitle=LT-002-158%20Tablets%20%C2%B7%20Leadingtac%20Pharmaceutical%20(Shaoxing)%20Co.%2C%20Ltd.&badge=phase%201 LT-002-158 Tablets LT-002-158 Tablets · Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. https://druglandscape.com/drug/lt3001-drug-high-dose https://druglandscape.com/api/og?type=drug&title=LT3001%20Drug%3Ahigh%20dose&subtitle=LT3001%20Drug%3Ahigh%20dose%20%C2%B7%20Shanghai%20Pharmaceuticals%20Holding%20Co.%2C%20Ltd&badge=phase%202 LT3001 Drug:high dose LT3001 Drug:high dose · Shanghai Pharmaceuticals Holding Co., Ltd https://druglandscape.com/drug/lt3001-drug-product https://druglandscape.com/api/og?type=drug&title=LT3001%20Drug%20Product&subtitle=LT3001%20Drug%20Product%20%C2%B7%20Lumosa%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%202 LT3001 Drug Product LT3001 Drug Product · Lumosa Therapeutics Co., Ltd. https://druglandscape.com/drug/ltb-sa7 https://druglandscape.com/api/og?type=drug&title=LTB-SA7&subtitle=LTB-SA7%20%C2%B7%20LimmaTech%20Biologics%20AG&badge=phase%201 LTB-SA7 LTB-SA7 · LimmaTech Biologics AG https://druglandscape.com/drug/ltb4 https://druglandscape.com/api/og?type=drug&title=LTB4&subtitle=LTB4%20%C2%B7%20LTB4%20Sweden%20AB&badge=phase%202 LTB4 LTB4 · LTB4 Sweden AB https://druglandscape.com/drug/ltc004 https://druglandscape.com/api/og?type=drug&title=LTC004&subtitle=LTC004%20%C2%B7%20Letolab&badge=phase%201 LTC004 LTC004 · Letolab https://druglandscape.com/drug/ltx-109-2 https://druglandscape.com/api/og?type=drug&title=LTX-109%202%20%25&subtitle=LTX-109%202%20%25%20%C2%B7%20Lytix%20Biopharma%20AS&badge=phase%202 LTX-109 2 % LTX-109 2 % · Lytix Biopharma AS https://druglandscape.com/drug/ltx-109-gel-3 https://druglandscape.com/api/og?type=drug&title=LTX-109%20gel%2C%203%25&subtitle=LTX-109%20gel%2C%203%25%20%C2%B7%20Pharma%20Holdings%20AS&badge=phase%202 LTX-109 gel, 3% LTX-109 gel, 3% · Pharma Holdings AS https://druglandscape.com/drug/ltx-315 https://druglandscape.com/api/og?type=drug&title=LTX-315&subtitle=LTX-315%20%C2%B7%20Lytix%20Biopharma%20AS&badge=phase%201 LTX-315 LTX-315 · Lytix Biopharma AS https://druglandscape.com/drug/ltx-315-consecutive-lesions https://druglandscape.com/api/og?type=drug&title=LTX-315%20consecutive%20lesions&subtitle=LTX-315%20consecutive%20lesions%20%C2%B7%20Lytix%20Biopharma%20AS&badge=phase%201 LTX-315 consecutive lesions LTX-315 consecutive lesions · Lytix Biopharma AS https://druglandscape.com/drug/ltz-301 https://druglandscape.com/api/og?type=drug&title=LTZ-301&subtitle=LTZ-301%20%C2%B7%20LTZ%20Therapeutics%2C%20Inc.&badge=phase%201 LTZ-301 LTZ-301 · LTZ Therapeutics, Inc. https://druglandscape.com/drug/lu-17-psma-617 https://druglandscape.com/api/og?type=drug&title=Lu-17-PSMA-617&subtitle=Lu-17-PSMA-617%20%C2%B7%20Hackensack%20Meridian%20Health&badge=phase%202 Lu-17-PSMA-617 Lu-17-PSMA-617 · Hackensack Meridian Health https://druglandscape.com/drug/lu-177-dgul https://druglandscape.com/api/og?type=drug&title=Lu-177-DGUL&subtitle=Lu-177-DGUL%20%C2%B7%20Cellbion%20Co.%2C%20Ltd.&badge=phase%201 Lu-177-DGUL Lu-177-DGUL · Cellbion Co., Ltd. https://druglandscape.com/drug/lu-177-dota-octreotide https://druglandscape.com/api/og?type=drug&title=Lu-177-DOTA-Octreotide&subtitle=Lu-177-DOTA-Octreotide%20%C2%B7%20Tine%20Gregersen%2C%20MD&badge=phase%202 Lu-177-DOTA-Octreotide Lu-177-DOTA-Octreotide · Tine Gregersen, MD https://druglandscape.com/drug/lu-177-itg-psma-1 https://druglandscape.com/api/og?type=drug&title=Lu-177-ITG-PSMA-1&subtitle=Lu-177-ITG-PSMA-1%20%C2%B7%20John%20O.%20Prior&badge=phase%201 Lu-177-ITG-PSMA-1 Lu-177-ITG-PSMA-1 · John O. Prior https://druglandscape.com/drug/lu-aa24493 https://druglandscape.com/api/og?type=drug&title=Lu%20AA24493&subtitle=Lu%20AA24493%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%202 Lu AA24493 Lu AA24493 · H. Lundbeck A/S https://druglandscape.com/drug/lu-ae58054 https://druglandscape.com/api/og?type=drug&title=Lu%20AE58054&subtitle=Lu%20AE58054%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%202 Lu AE58054 Lu AE58054 · H. Lundbeck A/S https://druglandscape.com/drug/lu-af28996 https://druglandscape.com/api/og?type=drug&title=Lu%20AF28996&subtitle=Lu%20AF28996%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Lu AF28996 Lu AF28996 · H. Lundbeck A/S https://druglandscape.com/drug/lu-af76432 https://druglandscape.com/api/og?type=drug&title=Lu%20AF76432&subtitle=Lu%20AF76432%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Lu AF76432 Lu AF76432 · H. Lundbeck A/S https://druglandscape.com/drug/lu-af82422 https://druglandscape.com/api/og?type=drug&title=Lu%20AF82422&subtitle=Lu%20AF82422%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%202 Lu AF82422 Lu AF82422 · H. Lundbeck A/S https://druglandscape.com/drug/lu-af87908 https://druglandscape.com/api/og?type=drug&title=Lu%20AF87908&subtitle=Lu%20AF87908%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Lu AF87908 Lu AF87908 · H. Lundbeck A/S https://druglandscape.com/drug/lu-af88434 https://druglandscape.com/api/og?type=drug&title=Lu%20AF88434&subtitle=Lu%20AF88434%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Lu AF88434 Lu AF88434 · H. Lundbeck A/S https://druglandscape.com/drug/lu-ag13909 https://druglandscape.com/api/og?type=drug&title=Lu%20AG13909&subtitle=Lu%20AG13909%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%202 Lu AG13909 Lu AG13909 · H. Lundbeck A/S https://druglandscape.com/drug/lu-ag22515 https://druglandscape.com/api/og?type=drug&title=Lu%20AG22515&subtitle=Lu%20AG22515%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Lu AG22515 Lu AG22515 · H. Lundbeck A/S https://druglandscape.com/drug/lu-psma https://druglandscape.com/api/og?type=drug&title=Lu-PSMA&subtitle=Lu-PSMA%20%C2%B7%20Australian%20and%20New%20Zealand%20Urogenital%20and%20Prostate%20Cancer%20Trials%20Group&badge=phase%202 Lu-PSMA Lu-PSMA · Australian and New Zealand Urogenital and Prostate Cancer Trials Group https://druglandscape.com/drug/lucar-dks1-nk-cells https://druglandscape.com/api/og?type=drug&title=LUCAR-DKS1%20NK%20cells&subtitle=LUCAR-DKS1%20NK%20cells%20%C2%B7%20Nanjing%20Legend%20Biotech%20Co.&badge=phase%201 LUCAR-DKS1 NK cells LUCAR-DKS1 NK cells · Nanjing Legend Biotech Co. https://druglandscape.com/drug/lucar-g79-t-cells https://druglandscape.com/api/og?type=drug&title=LUCAR-G79%20T%20cells&subtitle=LUCAR-G79%20T%20cells%20%C2%B7%20Nanjing%20Legend%20Biotech%20Co.&badge=phase%201 LUCAR-G79 T cells LUCAR-G79 T cells · Nanjing Legend Biotech Co. https://druglandscape.com/drug/lucar-g79d-t-cells https://druglandscape.com/api/og?type=drug&title=LUCAR-G79D%20T%20cells&subtitle=LUCAR-G79D%20T%20cells%20%C2%B7%20Nanjing%20Legend%20Biotech%20Co.&badge=phase%201 LUCAR-G79D T cells LUCAR-G79D T cells · Nanjing Legend Biotech Co. https://druglandscape.com/drug/luitpold-azacitidine https://druglandscape.com/api/og?type=drug&title=Luitpold%20Azacitidine&subtitle=Luitpold%20Azacitidine%20%C2%B7%20American%20Regent%2C%20Inc.&badge=phase%201 Luitpold Azacitidine Luitpold Azacitidine · American Regent, Inc. https://druglandscape.com/drug/lum015 https://druglandscape.com/api/og?type=drug&title=LUM015&subtitle=LUM015%20%C2%B7%20Lumicell%2C%20Inc.&badge=phase%202 LUM015 LUM015 · Lumicell, Inc. https://druglandscape.com/drug/lumacaftor-ivacaftor-drug-combination https://druglandscape.com/api/og?type=drug&title=Lumacaftor%2C%20Ivacaftor%20Drug%20Combination&subtitle=Lumacaftor%2C%20Ivacaftor%20Drug%20Combination%20%C2%B7%20Carmel%20Medical%20Center&badge=phase%202 Lumacaftor, Ivacaftor Drug Combination Lumacaftor, Ivacaftor Drug Combination · Carmel Medical Center https://druglandscape.com/drug/lumateperone-capsule https://druglandscape.com/api/og?type=drug&title=Lumateperone%20Capsule&subtitle=Lumateperone%20Capsule%20%C2%B7%20Intra-Cellular%20Therapies%2C%20Inc.&badge=phase%201 Lumateperone Capsule Lumateperone Capsule · Intra-Cellular Therapies, Inc. https://druglandscape.com/drug/lumateperone-lai https://druglandscape.com/api/og?type=drug&title=Lumateperone%20LAI&subtitle=Lumateperone%20LAI%20%C2%B7%20Intra-Cellular%20Therapies%2C%20Inc.&badge=phase%201 Lumateperone LAI Lumateperone LAI · Intra-Cellular Therapies, Inc. https://druglandscape.com/drug/lumateperone-long-acting-injectable https://druglandscape.com/api/og?type=drug&title=Lumateperone%20Long-Acting%20Injectable&subtitle=Lumateperone%20Long-Acting%20Injectable%20%C2%B7%20Intra-Cellular%20Therapies%2C%20Inc.&badge=phase%201 Lumateperone Long-Acting Injectable Lumateperone Long-Acting Injectable · Intra-Cellular Therapies, Inc. https://druglandscape.com/drug/lumbar-interbody-fusion-with-autograft https://druglandscape.com/api/og?type=drug&title=Lumbar%20Interbody%20Fusion%20with%20Autograft&subtitle=Lumbar%20Interbody%20Fusion%20with%20Autograft%20%C2%B7%20Mesoblast%2C%20Ltd.&badge=phase%202 Lumbar Interbody Fusion with Autograft Lumbar Interbody Fusion with Autograft · Mesoblast, Ltd. https://druglandscape.com/drug/lumbar-interbody-fusion-with-neofuse https://druglandscape.com/api/og?type=drug&title=Lumbar%20Interbody%20Fusion%20with%20NeoFuse&subtitle=Lumbar%20Interbody%20Fusion%20with%20NeoFuse%20%C2%B7%20Mesoblast%2C%20Ltd.&badge=phase%202 Lumbar Interbody Fusion with NeoFuse Lumbar Interbody Fusion with NeoFuse · Mesoblast, Ltd. https://druglandscape.com/drug/lumentin-44-powder-for-oral-foam https://druglandscape.com/api/og?type=drug&title=Lumentin%C2%AE%2044%20Powder%20for%20oral%20foam&subtitle=Lumentin%C2%AE%2044%20Powder%20for%20oral%20foam%20%C2%B7%20Lument%20AB&badge=phase%202 Lumentin® 44 Powder for oral foam Lumentin® 44 Powder for oral foam · Lument AB https://druglandscape.com/drug/lumiliximab-with-fcr https://druglandscape.com/api/og?type=drug&title=Lumiliximab%20with%20FCR&subtitle=Lumiliximab%20with%20FCR%20%C2%B7%20Biogen&badge=phase%201 Lumiliximab with FCR Lumiliximab with FCR · Biogen https://druglandscape.com/drug/lunasin-regimen https://druglandscape.com/api/og?type=drug&title=Lunasin%20Regimen&subtitle=Lunasin%20Regimen%20%C2%B7%20Richard%20Bedlack%2C%20M.D.%2C%20Ph.D.&badge=phase%202 Lunasin Regimen Lunasin Regimen · Richard Bedlack, M.D., Ph.D. https://druglandscape.com/drug/lung-cancer-cohort https://druglandscape.com/api/og?type=drug&title=Lung%20cancer%20cohort&subtitle=Lung%20cancer%20cohort%20%C2%B7%20Centre%20Leon%20Berard&badge=phase%202 Lung cancer cohort Lung cancer cohort · Centre Leon Berard https://druglandscape.com/drug/lurbinectedin-alone https://druglandscape.com/api/og?type=drug&title=Lurbinectedin%20alone&subtitle=Lurbinectedin%20alone%20%C2%B7%20PharmaMar&badge=phase%201 Lurbinectedin alone Lurbinectedin alone · PharmaMar https://druglandscape.com/drug/lurtotecan-liposome https://druglandscape.com/api/og?type=drug&title=lurtotecan%20liposome&subtitle=lurtotecan%20liposome%20%C2%B7%20NCIC%20Clinical%20Trials%20Group&badge=phase%202 lurtotecan liposome lurtotecan liposome · NCIC Clinical Trials Group https://druglandscape.com/drug/lutetium-177-dotaga-iac https://druglandscape.com/api/og?type=drug&title=Lutetium-177-DOTAGA-IAC&subtitle=Lutetium-177-DOTAGA-IAC%20%C2%B7%20Advanced%20Imaging%20Projects%2C%20LLC&badge=phase%201 Lutetium-177-DOTAGA-IAC Lutetium-177-DOTAGA-IAC · Advanced Imaging Projects, LLC https://druglandscape.com/drug/lutetium-177lu-bl-arc001 https://druglandscape.com/api/og?type=drug&title=Lutetium%20%5B177Lu%5D%20BL-ARC001&subtitle=Lutetium%20%5B177Lu%5D%20BL-ARC001%20%C2%B7%20Sichuan%20Baili%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Lutetium [177Lu] BL-ARC001 Lutetium [177Lu] BL-ARC001 · Sichuan Baili Pharmaceutical Co., Ltd. https://druglandscape.com/drug/lutetium-lu-177-psma-617 https://druglandscape.com/api/og?type=drug&title=Lutetium%20Lu%20177-PSMA-617&subtitle=Lutetium%20Lu%20177-PSMA-617%20%C2%B7%20Vadim%20S%20Koshkin&badge=phase%201 Lutetium Lu 177-PSMA-617 Lutetium Lu 177-PSMA-617 · Vadim S Koshkin https://druglandscape.com/drug/lutikizumab-dose-a https://druglandscape.com/api/og?type=drug&title=Lutikizumab%20Dose%20A&subtitle=Lutikizumab%20Dose%20A%20%C2%B7%20AbbVie&badge=phase%201 Lutikizumab Dose A Lutikizumab Dose A · AbbVie https://druglandscape.com/drug/lutikizumab-dose-b https://druglandscape.com/api/og?type=drug&title=Lutikizumab%20Dose%20B&subtitle=Lutikizumab%20Dose%20B%20%C2%B7%20AbbVie&badge=phase%201 Lutikizumab Dose B Lutikizumab Dose B · AbbVie https://druglandscape.com/drug/luvometinib-tablets https://druglandscape.com/api/og?type=drug&title=Luvometinib%20Tablets&subtitle=Luvometinib%20Tablets%20%C2%B7%20Shanghai%20Fosun%20Pharmaceutical%20Industrial%20Development%20Co.%20Ltd.&badge=phase%201 Luvometinib Tablets Luvometinib Tablets · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. https://druglandscape.com/drug/luz11 https://druglandscape.com/api/og?type=drug&title=LUZ11&subtitle=LUZ11%20%C2%B7%20Luzitin%20SA&badge=phase%201 LUZ11 LUZ11 · Luzitin SA https://druglandscape.com/drug/lv009-injection-infusion https://druglandscape.com/api/og?type=drug&title=LV009%20Injection%20Infusion&subtitle=LV009%20Injection%20Infusion%20%C2%B7%20PersonGen%20BioTherapeutics%20(Suzhou)%20Co.%2C%20Ltd.&badge=phase%201 LV009 Injection Infusion LV009 Injection Infusion · PersonGen BioTherapeutics (Suzhou) Co., Ltd. https://druglandscape.com/drug/lv232 https://druglandscape.com/api/og?type=drug&title=LV232&subtitle=LV232%20%C2%B7%20Vigonvita%20Life%20Sciences&badge=phase%201 LV232 LV232 · Vigonvita Life Sciences https://druglandscape.com/drug/lvgn7409 https://druglandscape.com/api/og?type=drug&title=LVGN7409&subtitle=LVGN7409%20%C2%B7%20Lyvgen%20Biopharma%20Holdings%20Limited&badge=phase%201 LVGN7409 LVGN7409 · Lyvgen Biopharma Holdings Limited https://druglandscape.com/drug/lvt-001 https://druglandscape.com/api/og?type=drug&title=LVT-001&subtitle=LVT-001%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 LVT-001 LVT-001 · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/lw231 https://druglandscape.com/api/og?type=drug&title=LW231&subtitle=LW231%20%C2%B7%20Shanghai%20Longwood%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 LW231 LW231 · Shanghai Longwood Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/lw231-tablets https://druglandscape.com/api/og?type=drug&title=LW231%20tablets&subtitle=LW231%20tablets%20%C2%B7%20Shanghai%20Longwood%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 LW231 tablets LW231 tablets · Shanghai Longwood Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/lwp779 https://druglandscape.com/api/og?type=drug&title=LWP779&subtitle=LWP779%20%C2%B7%20Longwood%20Pharmaceuticals%20(Hangzhou)%20Co.%2C%20Ltd.&badge=phase%201 LWP779 LWP779 · Longwood Pharmaceuticals (Hangzhou) Co., Ltd. https://druglandscape.com/drug/lx-039-tablets https://druglandscape.com/api/og?type=drug&title=LX-039%20tablets&subtitle=LX-039%20tablets%20%C2%B7%20Shandong%20Luoxin%20Pharmaceutical%20Group%20Stock%20Co.%2C%20Ltd.&badge=phase%201 LX-039 tablets LX-039 tablets · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. https://druglandscape.com/drug/lx22001-for-injeciton https://druglandscape.com/api/og?type=drug&title=LX22001%20for%20Injeciton&subtitle=LX22001%20for%20Injeciton%20%C2%B7%20Shandong%20Luoxin%20Pharmaceutical%20Group%20Stock%20Co.%2C%20Ltd.&badge=phase%201 LX22001 for Injeciton LX22001 for Injeciton · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. https://druglandscape.com/drug/lxr015-1 https://druglandscape.com/api/og?type=drug&title=LXR015-1&subtitle=LXR015-1%20%C2%B7%20LXR%20Biotechnology&badge=phase%201 LXR015-1 LXR015-1 · LXR Biotechnology https://druglandscape.com/drug/ly-covmab https://druglandscape.com/api/og?type=drug&title=LY-CovMab&subtitle=LY-CovMab%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LY-CovMab LY-CovMab · Luye Pharma Group Ltd. https://druglandscape.com/drug/ly007 https://druglandscape.com/api/og?type=drug&title=LY007&subtitle=LY007%20%C2%B7%20Shanghai%20Longyao%20Biotechnology%20Inc.%2C%20Ltd.&badge=phase%201 LY007 LY007 · Shanghai Longyao Biotechnology Inc., Ltd. https://druglandscape.com/drug/ly01021 https://druglandscape.com/api/og?type=drug&title=LY01021&subtitle=LY01021%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%202 LY01021 LY01021 · Luye Pharma Group Ltd. https://druglandscape.com/drug/ly010616 https://druglandscape.com/api/og?type=drug&title=LY010616&subtitle=LY010616%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LY010616 LY010616 · Luye Pharma Group Ltd. https://druglandscape.com/drug/ly011 https://druglandscape.com/api/og?type=drug&title=LY011&subtitle=LY011%20%C2%B7%20Shanghai%20Longyao%20Biotechnology%20Inc.%2C%20Ltd.&badge=phase%201 LY011 LY011 · Shanghai Longyao Biotechnology Inc., Ltd. https://druglandscape.com/drug/ly03003 https://druglandscape.com/api/og?type=drug&title=LY03003&subtitle=LY03003%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LY03003 LY03003 · Luye Pharma Group Ltd. https://druglandscape.com/drug/ly03004 https://druglandscape.com/api/og?type=drug&title=LY03004&subtitle=LY03004%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LY03004 LY03004 · Luye Pharma Group Ltd. https://druglandscape.com/drug/ly03009-f1 https://druglandscape.com/api/og?type=drug&title=LY03009%20F1&subtitle=LY03009%20F1%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LY03009 F1 LY03009 F1 · Luye Pharma Group Ltd. https://druglandscape.com/drug/ly03009-f2 https://druglandscape.com/api/og?type=drug&title=LY03009%20F2&subtitle=LY03009%20F2%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LY03009 F2 LY03009 F2 · Luye Pharma Group Ltd. https://druglandscape.com/drug/ly03009-f3 https://druglandscape.com/api/og?type=drug&title=LY03009%20F3&subtitle=LY03009%20F3%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LY03009 F3 LY03009 F3 · Luye Pharma Group Ltd. https://druglandscape.com/drug/ly03010 https://druglandscape.com/api/og?type=drug&title=LY03010&subtitle=LY03010%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LY03010 LY03010 · Luye Pharma Group Ltd. https://druglandscape.com/drug/ly03010-paliperidone-palmitate https://druglandscape.com/api/og?type=drug&title=LY03010%3B%20paliperidone%20palmitate&subtitle=LY03010%3B%20paliperidone%20palmitate%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LY03010; paliperidone palmitate LY03010; paliperidone palmitate · Luye Pharma Group Ltd. https://druglandscape.com/drug/ly03017 https://druglandscape.com/api/og?type=drug&title=LY03017&subtitle=LY03017%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LY03017 LY03017 · Luye Pharma Group Ltd. https://druglandscape.com/drug/ly03020 https://druglandscape.com/api/og?type=drug&title=LY03020&subtitle=LY03020%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%202 LY03020 LY03020 · Luye Pharma Group Ltd. https://druglandscape.com/drug/ly03021 https://druglandscape.com/api/og?type=drug&title=LY03021&subtitle=LY03021%20%C2%B7%20Luye%20Pharma%20Group%20Ltd.&badge=phase%201 LY03021 LY03021 · Luye Pharma Group Ltd. https://druglandscape.com/drug/ly110140 https://druglandscape.com/api/og?type=drug&title=LY110140&subtitle=LY110140%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY110140 LY110140 · Eli Lilly and Company https://druglandscape.com/drug/ly2140023-reference-form https://druglandscape.com/api/og?type=drug&title=LY2140023%20Reference%20form&subtitle=LY2140023%20Reference%20form%20%C2%B7%20Denovo%20Biopharma%20LLC&badge=phase%201 LY2140023 Reference form LY2140023 Reference form · Denovo Biopharma LLC https://druglandscape.com/drug/ly2140023-test-high https://druglandscape.com/api/og?type=drug&title=LY2140023%20Test-High&subtitle=LY2140023%20Test-High%20%C2%B7%20Denovo%20Biopharma%20LLC&badge=phase%201 LY2140023 Test-High LY2140023 Test-High · Denovo Biopharma LLC https://druglandscape.com/drug/ly2140023-test-low https://druglandscape.com/api/og?type=drug&title=LY2140023%20Test-Low&subtitle=LY2140023%20Test-Low%20%C2%B7%20Denovo%20Biopharma%20LLC&badge=phase%201 LY2140023 Test-Low LY2140023 Test-Low · Denovo Biopharma LLC https://druglandscape.com/drug/ly2140023-test-medium https://druglandscape.com/api/og?type=drug&title=LY2140023%20Test-Medium&subtitle=LY2140023%20Test-Medium%20%C2%B7%20Denovo%20Biopharma%20LLC&badge=phase%201 LY2140023 Test-Medium LY2140023 Test-Medium · Denovo Biopharma LLC https://druglandscape.com/drug/ly2157299 https://druglandscape.com/api/og?type=drug&title=LY2157299&subtitle=LY2157299%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY2157299 LY2157299 · Eli Lilly and Company https://druglandscape.com/drug/ly2189102 https://druglandscape.com/api/og?type=drug&title=LY2189102&subtitle=LY2189102%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY2189102 LY2189102 · Eli Lilly and Company https://druglandscape.com/drug/ly2334737 https://druglandscape.com/api/og?type=drug&title=LY2334737&subtitle=LY2334737%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2334737 LY2334737 · Eli Lilly and Company https://druglandscape.com/drug/ly2393910 https://druglandscape.com/api/og?type=drug&title=LY2393910&subtitle=LY2393910%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2393910 LY2393910 · Eli Lilly and Company https://druglandscape.com/drug/ly2405319 https://druglandscape.com/api/og?type=drug&title=LY2405319&subtitle=LY2405319%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2405319 LY2405319 · Eli Lilly and Company https://druglandscape.com/drug/ly2428757 https://druglandscape.com/api/og?type=drug&title=LY2428757&subtitle=LY2428757%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY2428757 LY2428757 · Eli Lilly and Company https://druglandscape.com/drug/ly2439821 https://druglandscape.com/api/og?type=drug&title=LY2439821&subtitle=LY2439821%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY2439821 LY2439821 · Eli Lilly and Company https://druglandscape.com/drug/ly2484595 https://druglandscape.com/api/og?type=drug&title=LY2484595&subtitle=LY2484595%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY2484595 LY2484595 · Eli Lilly and Company https://druglandscape.com/drug/ly2495655 https://druglandscape.com/api/og?type=drug&title=LY2495655&subtitle=LY2495655%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY2495655 LY2495655 · Eli Lilly and Company https://druglandscape.com/drug/ly2503029 https://druglandscape.com/api/og?type=drug&title=LY2503029&subtitle=LY2503029%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY2503029 LY2503029 · Eli Lilly and Company https://druglandscape.com/drug/ly2541546 https://druglandscape.com/api/og?type=drug&title=LY2541546&subtitle=LY2541546%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY2541546 LY2541546 · Eli Lilly and Company https://druglandscape.com/drug/ly2541546-iv https://druglandscape.com/api/og?type=drug&title=LY2541546%20-%20IV&subtitle=LY2541546%20-%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2541546 - IV LY2541546 - IV · Eli Lilly and Company https://druglandscape.com/drug/ly2608204-reference https://druglandscape.com/api/og?type=drug&title=LY2608204%20Reference&subtitle=LY2608204%20Reference%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2608204 Reference LY2608204 Reference · Eli Lilly and Company https://druglandscape.com/drug/ly2608204-test https://druglandscape.com/api/og?type=drug&title=LY2608204%20Test&subtitle=LY2608204%20Test%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2608204 Test LY2608204 Test · Eli Lilly and Company https://druglandscape.com/drug/ly2624587 https://druglandscape.com/api/og?type=drug&title=LY2624587&subtitle=LY2624587%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2624587 LY2624587 · Eli Lilly and Company https://druglandscape.com/drug/ly2624803-capsules https://druglandscape.com/api/og?type=drug&title=LY2624803%20-%20Capsules&subtitle=LY2624803%20-%20Capsules%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2624803 - Capsules LY2624803 - Capsules · Eli Lilly and Company https://druglandscape.com/drug/ly2624803-solution https://druglandscape.com/api/og?type=drug&title=LY2624803%20-%20Solution&subtitle=LY2624803%20-%20Solution%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2624803 - Solution LY2624803 - Solution · Eli Lilly and Company https://druglandscape.com/drug/ly2775240 https://druglandscape.com/api/og?type=drug&title=LY2775240&subtitle=LY2775240%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2775240 LY2775240 · Eli Lilly and Company https://druglandscape.com/drug/ly2780301 https://druglandscape.com/api/og?type=drug&title=LY2780301&subtitle=LY2780301%20%C2%B7%20Gustave%20Roussy%2C%20Cancer%20Campus%2C%20Grand%20Paris&badge=phase%201 LY2780301 LY2780301 · Gustave Roussy, Cancer Campus, Grand Paris https://druglandscape.com/drug/ly2784544 https://druglandscape.com/api/og?type=drug&title=LY2784544&subtitle=LY2784544%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2784544 LY2784544 · Eli Lilly and Company https://druglandscape.com/drug/ly2801653 https://druglandscape.com/api/og?type=drug&title=LY2801653&subtitle=LY2801653%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2801653 LY2801653 · Eli Lilly and Company https://druglandscape.com/drug/ly2811376 https://druglandscape.com/api/og?type=drug&title=LY2811376&subtitle=LY2811376%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2811376 LY2811376 · Eli Lilly and Company https://druglandscape.com/drug/ly2835219 https://druglandscape.com/api/og?type=drug&title=LY2835219&subtitle=LY2835219%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2835219 LY2835219 · Eli Lilly and Company https://druglandscape.com/drug/ly2874455 https://druglandscape.com/api/og?type=drug&title=LY2874455&subtitle=LY2874455%20%C2%B7%20Jacqueline%20Garcia%2C%20MD&badge=phase%201 LY2874455 LY2874455 · Jacqueline Garcia, MD https://druglandscape.com/drug/ly2875358 https://druglandscape.com/api/og?type=drug&title=LY2875358&subtitle=LY2875358%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY2875358 LY2875358 · Eli Lilly and Company https://druglandscape.com/drug/ly2875358-at-part-a-highest-dose https://druglandscape.com/api/og?type=drug&title=LY2875358%20at%20Part%20A%20highest%20dose&subtitle=LY2875358%20at%20Part%20A%20highest%20dose%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2875358 at Part A highest dose LY2875358 at Part A highest dose · Eli Lilly and Company https://druglandscape.com/drug/ly2880070 https://druglandscape.com/api/og?type=drug&title=LY2880070&subtitle=LY2880070%20%C2%B7%20Esperas%20Pharma%20Inc.&badge=phase%202 LY2880070 LY2880070 · Esperas Pharma Inc. https://druglandscape.com/drug/ly2886721-in-a-capsule https://druglandscape.com/api/og?type=drug&title=LY2886721%20in%20a%20Capsule&subtitle=LY2886721%20in%20a%20Capsule%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2886721 in a Capsule LY2886721 in a Capsule · Eli Lilly and Company https://druglandscape.com/drug/ly2922083 https://druglandscape.com/api/og?type=drug&title=LY2922083&subtitle=LY2922083%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2922083 LY2922083 · Eli Lilly and Company https://druglandscape.com/drug/ly2922470 https://druglandscape.com/api/og?type=drug&title=LY2922470&subtitle=LY2922470%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2922470 LY2922470 · Eli Lilly and Company https://druglandscape.com/drug/ly2928057 https://druglandscape.com/api/og?type=drug&title=LY2928057&subtitle=LY2928057%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY2928057 LY2928057 · Eli Lilly and Company https://druglandscape.com/drug/ly293111 https://druglandscape.com/api/og?type=drug&title=LY293111&subtitle=LY293111%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY293111 LY293111 · Eli Lilly and Company https://druglandscape.com/drug/ly3000328 https://druglandscape.com/api/og?type=drug&title=LY3000328&subtitle=LY3000328%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3000328 LY3000328 · Eli Lilly and Company https://druglandscape.com/drug/ly3002813 https://druglandscape.com/api/og?type=drug&title=LY3002813&subtitle=LY3002813%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3002813 LY3002813 · Eli Lilly and Company https://druglandscape.com/drug/ly3002813-iv https://druglandscape.com/api/og?type=drug&title=LY3002813-IV&subtitle=LY3002813-IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3002813-IV LY3002813-IV · Eli Lilly and Company https://druglandscape.com/drug/ly3002813-sc https://druglandscape.com/api/og?type=drug&title=LY3002813-SC&subtitle=LY3002813-SC%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3002813-SC LY3002813-SC · Eli Lilly and Company https://druglandscape.com/drug/ly3007113 https://druglandscape.com/api/og?type=drug&title=LY3007113&subtitle=LY3007113%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3007113 LY3007113 · Eli Lilly and Company https://druglandscape.com/drug/ly3009104 https://druglandscape.com/api/og?type=drug&title=LY3009104&subtitle=LY3009104%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3009104 LY3009104 · Eli Lilly and Company https://druglandscape.com/drug/ly3009385 https://druglandscape.com/api/og?type=drug&title=LY3009385&subtitle=LY3009385%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3009385 LY3009385 · Eli Lilly and Company https://druglandscape.com/drug/ly3015014 https://druglandscape.com/api/og?type=drug&title=LY3015014&subtitle=LY3015014%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3015014 LY3015014 · Eli Lilly and Company https://druglandscape.com/drug/ly3015014-iv https://druglandscape.com/api/og?type=drug&title=LY3015014%20IV&subtitle=LY3015014%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3015014 IV LY3015014 IV · Eli Lilly and Company https://druglandscape.com/drug/ly3015014-sc https://druglandscape.com/api/og?type=drug&title=LY3015014%20SC&subtitle=LY3015014%20SC%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3015014 SC LY3015014 SC · Eli Lilly and Company https://druglandscape.com/drug/ly3016859-intravenous https://druglandscape.com/api/og?type=drug&title=LY3016859%20intravenous&subtitle=LY3016859%20intravenous%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3016859 intravenous LY3016859 intravenous · Eli Lilly and Company https://druglandscape.com/drug/ly3016859-isa https://druglandscape.com/api/og?type=drug&title=LY3016859%20ISA&subtitle=LY3016859%20ISA%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3016859 ISA LY3016859 ISA · Eli Lilly and Company https://druglandscape.com/drug/ly3016859-subcutaneous https://druglandscape.com/api/og?type=drug&title=LY3016859%20subcutaneous&subtitle=LY3016859%20subcutaneous%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3016859 subcutaneous LY3016859 subcutaneous · Eli Lilly and Company https://druglandscape.com/drug/ly3022855 https://druglandscape.com/api/og?type=drug&title=LY3022855&subtitle=LY3022855%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3022855 LY3022855 · Eli Lilly and Company https://druglandscape.com/drug/ly3023414-reference-fasted https://druglandscape.com/api/og?type=drug&title=LY3023414%20Reference%20Fasted&subtitle=LY3023414%20Reference%20Fasted%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3023414 Reference Fasted LY3023414 Reference Fasted · Eli Lilly and Company https://druglandscape.com/drug/ly3023414-test-fasted https://druglandscape.com/api/og?type=drug&title=LY3023414%20Test%20Fasted&subtitle=LY3023414%20Test%20Fasted%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3023414 Test Fasted LY3023414 Test Fasted · Eli Lilly and Company https://druglandscape.com/drug/ly3023414-test-fed https://druglandscape.com/api/og?type=drug&title=LY3023414%20Test%20Fed&subtitle=LY3023414%20Test%20Fed%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3023414 Test Fed LY3023414 Test Fed · Eli Lilly and Company https://druglandscape.com/drug/ly3023703 https://druglandscape.com/api/og?type=drug&title=LY3023703&subtitle=LY3023703%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3023703 LY3023703 · Eli Lilly and Company https://druglandscape.com/drug/ly3025876 https://druglandscape.com/api/og?type=drug&title=LY3025876&subtitle=LY3025876%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3025876 LY3025876 · Eli Lilly and Company https://druglandscape.com/drug/ly3045697 https://druglandscape.com/api/og?type=drug&title=LY3045697&subtitle=LY3045697%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3045697 LY3045697 · Eli Lilly and Company https://druglandscape.com/drug/ly3050258 https://druglandscape.com/api/og?type=drug&title=LY3050258&subtitle=LY3050258%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3050258 LY3050258 · Eli Lilly and Company https://druglandscape.com/drug/ly3074828 https://druglandscape.com/api/og?type=drug&title=LY3074828&subtitle=LY3074828%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3074828 LY3074828 · Eli Lilly and Company https://druglandscape.com/drug/ly3076226 https://druglandscape.com/api/og?type=drug&title=LY3076226&subtitle=LY3076226%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3076226 LY3076226 · Eli Lilly and Company https://druglandscape.com/drug/ly3079514 https://druglandscape.com/api/og?type=drug&title=LY3079514&subtitle=LY3079514%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3079514 LY3079514 · Eli Lilly and Company https://druglandscape.com/drug/ly3084077 https://druglandscape.com/api/og?type=drug&title=LY3084077&subtitle=LY3084077%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3084077 LY3084077 · Eli Lilly and Company https://druglandscape.com/drug/ly3090106 https://druglandscape.com/api/og?type=drug&title=LY3090106&subtitle=LY3090106%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3090106 LY3090106 · Eli Lilly and Company https://druglandscape.com/drug/ly3090106-iv https://druglandscape.com/api/og?type=drug&title=LY3090106%20-%20IV&subtitle=LY3090106%20-%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3090106 - IV LY3090106 - IV · Eli Lilly and Company https://druglandscape.com/drug/ly3090106-sq https://druglandscape.com/api/og?type=drug&title=LY3090106%20-%20SQ&subtitle=LY3090106%20-%20SQ%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3090106 - SQ LY3090106 - SQ · Eli Lilly and Company https://druglandscape.com/drug/ly3108743-capsule https://druglandscape.com/api/og?type=drug&title=LY3108743%20-%20Capsule&subtitle=LY3108743%20-%20Capsule%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3108743 - Capsule LY3108743 - Capsule · Eli Lilly and Company https://druglandscape.com/drug/ly3113593 https://druglandscape.com/api/og?type=drug&title=LY3113593&subtitle=LY3113593%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3113593 LY3113593 · Eli Lilly and Company https://druglandscape.com/drug/ly3114062-iv https://druglandscape.com/api/og?type=drug&title=LY3114062%20IV&subtitle=LY3114062%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3114062 IV LY3114062 IV · Eli Lilly and Company https://druglandscape.com/drug/ly3114062-sc https://druglandscape.com/api/og?type=drug&title=LY3114062%20SC&subtitle=LY3114062%20SC%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3114062 SC LY3114062 SC · Eli Lilly and Company https://druglandscape.com/drug/ly3127760 https://druglandscape.com/api/og?type=drug&title=LY3127760&subtitle=LY3127760%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3127760 LY3127760 · Eli Lilly and Company https://druglandscape.com/drug/ly3143921-hydrate https://druglandscape.com/api/og?type=drug&title=LY3143921%20hydrate&subtitle=LY3143921%20hydrate%20%C2%B7%20Cancer%20Research%20UK&badge=phase%201 LY3143921 hydrate LY3143921 hydrate · Cancer Research UK https://druglandscape.com/drug/ly3154207 https://druglandscape.com/api/og?type=drug&title=LY3154207&subtitle=LY3154207%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3154207 LY3154207 · Eli Lilly and Company https://druglandscape.com/drug/ly3164530 https://druglandscape.com/api/og?type=drug&title=LY3164530&subtitle=LY3164530%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3164530 LY3164530 · Eli Lilly and Company https://druglandscape.com/drug/ly317615 https://druglandscape.com/api/og?type=drug&title=LY317615&subtitle=LY317615%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY317615 LY317615 · Eli Lilly and Company https://druglandscape.com/drug/ly3185643 https://druglandscape.com/api/og?type=drug&title=LY3185643&subtitle=LY3185643%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3185643 LY3185643 · Eli Lilly and Company https://druglandscape.com/drug/ly3192767 https://druglandscape.com/api/og?type=drug&title=LY3192767&subtitle=LY3192767%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3192767 LY3192767 · Eli Lilly and Company https://druglandscape.com/drug/ly3200882 https://druglandscape.com/api/og?type=drug&title=LY3200882&subtitle=LY3200882%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3200882 LY3200882 · Eli Lilly and Company https://druglandscape.com/drug/ly3202328 https://druglandscape.com/api/og?type=drug&title=LY3202328&subtitle=LY3202328%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3202328 LY3202328 · Eli Lilly and Company https://druglandscape.com/drug/ly3295668 https://druglandscape.com/api/og?type=drug&title=LY3295668&subtitle=LY3295668%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3295668 LY3295668 · Eli Lilly and Company https://druglandscape.com/drug/ly3295668-erbumine https://druglandscape.com/api/og?type=drug&title=LY3295668%20Erbumine&subtitle=LY3295668%20Erbumine%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3295668 Erbumine LY3295668 Erbumine · Eli Lilly and Company https://druglandscape.com/drug/ly3300054 https://druglandscape.com/api/og?type=drug&title=LY3300054&subtitle=LY3300054%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3300054 LY3300054 · Eli Lilly and Company https://druglandscape.com/drug/ly3303560-iv https://druglandscape.com/api/og?type=drug&title=LY3303560%20-%20IV&subtitle=LY3303560%20-%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3303560 - IV LY3303560 - IV · Eli Lilly and Company https://druglandscape.com/drug/ly3303560-sc https://druglandscape.com/api/og?type=drug&title=LY3303560%20-%20SC&subtitle=LY3303560%20-%20SC%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3303560 - SC LY3303560 - SC · Eli Lilly and Company https://druglandscape.com/drug/ly3305677 https://druglandscape.com/api/og?type=drug&title=LY3305677&subtitle=LY3305677%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3305677 LY3305677 · Eli Lilly and Company https://druglandscape.com/drug/ly3316531 https://druglandscape.com/api/og?type=drug&title=LY3316531&subtitle=LY3316531%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3316531 LY3316531 · Eli Lilly and Company https://druglandscape.com/drug/ly3316531-iv https://druglandscape.com/api/og?type=drug&title=LY3316531%20-%20IV&subtitle=LY3316531%20-%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3316531 - IV LY3316531 - IV · Eli Lilly and Company https://druglandscape.com/drug/ly3316531-sc https://druglandscape.com/api/og?type=drug&title=LY3316531%20-%20SC&subtitle=LY3316531%20-%20SC%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3316531 - SC LY3316531 - SC · Eli Lilly and Company https://druglandscape.com/drug/ly3321367 https://druglandscape.com/api/og?type=drug&title=LY3321367&subtitle=LY3321367%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3321367 LY3321367 · Eli Lilly and Company https://druglandscape.com/drug/ly3323795 https://druglandscape.com/api/og?type=drug&title=LY3323795&subtitle=LY3323795%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3323795 LY3323795 · Eli Lilly and Company https://druglandscape.com/drug/ly3325656 https://druglandscape.com/api/og?type=drug&title=LY3325656&subtitle=LY3325656%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3325656 LY3325656 · Eli Lilly and Company https://druglandscape.com/drug/ly333334 https://druglandscape.com/api/og?type=drug&title=LY333334&subtitle=LY333334%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY333334 LY333334 · Eli Lilly and Company https://druglandscape.com/drug/ly333531 https://druglandscape.com/api/og?type=drug&title=LY333531&subtitle=LY333531%20%C2%B7%20Chromaderm%2C%20Inc.&badge=phase%202 LY333531 LY333531 · Chromaderm, Inc. https://druglandscape.com/drug/ly3361237-iv https://druglandscape.com/api/og?type=drug&title=LY3361237%20-%20IV&subtitle=LY3361237%20-%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3361237 - IV LY3361237 - IV · Eli Lilly and Company https://druglandscape.com/drug/ly3361237-sc https://druglandscape.com/api/og?type=drug&title=LY3361237%20-%20SC&subtitle=LY3361237%20-%20SC%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3361237 - SC LY3361237 - SC · Eli Lilly and Company https://druglandscape.com/drug/ly3372689 https://druglandscape.com/api/og?type=drug&title=LY3372689&subtitle=LY3372689%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3372689 LY3372689 · Eli Lilly and Company https://druglandscape.com/drug/ly3372993 https://druglandscape.com/api/og?type=drug&title=LY3372993&subtitle=LY3372993%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3372993 LY3372993 · Eli Lilly and Company https://druglandscape.com/drug/ly3374849-iv https://druglandscape.com/api/og?type=drug&title=LY3374849%20-%20IV&subtitle=LY3374849%20-%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3374849 - IV LY3374849 - IV · Eli Lilly and Company https://druglandscape.com/drug/ly3375880-iv https://druglandscape.com/api/og?type=drug&title=LY3375880%20IV&subtitle=LY3375880%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3375880 IV LY3375880 IV · Eli Lilly and Company https://druglandscape.com/drug/ly3375880-sc https://druglandscape.com/api/og?type=drug&title=LY3375880%20SC&subtitle=LY3375880%20SC%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3375880 SC LY3375880 SC · Eli Lilly and Company https://druglandscape.com/drug/ly3410738 https://druglandscape.com/api/og?type=drug&title=LY3410738&subtitle=LY3410738%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3410738 LY3410738 · Eli Lilly and Company https://druglandscape.com/drug/ly3437943 https://druglandscape.com/api/og?type=drug&title=LY3437943&subtitle=LY3437943%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3437943 LY3437943 · Eli Lilly and Company https://druglandscape.com/drug/ly3451838 https://druglandscape.com/api/og?type=drug&title=LY3451838&subtitle=LY3451838%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3451838 LY3451838 · Eli Lilly and Company https://druglandscape.com/drug/ly3461767-iv https://druglandscape.com/api/og?type=drug&title=LY3461767%20-%20IV&subtitle=LY3461767%20-%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3461767 - IV LY3461767 - IV · Eli Lilly and Company https://druglandscape.com/drug/ly3461767-sc https://druglandscape.com/api/og?type=drug&title=LY3461767%20-%20SC&subtitle=LY3461767%20-%20SC%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3461767 - SC LY3461767 - SC · Eli Lilly and Company https://druglandscape.com/drug/ly3462817 https://druglandscape.com/api/og?type=drug&title=LY3462817&subtitle=LY3462817%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3462817 LY3462817 · Eli Lilly and Company https://druglandscape.com/drug/ly3473329 https://druglandscape.com/api/og?type=drug&title=LY3473329&subtitle=LY3473329%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3473329 LY3473329 · Eli Lilly and Company https://druglandscape.com/drug/ly3475070 https://druglandscape.com/api/og?type=drug&title=LY3475070&subtitle=LY3475070%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3475070 LY3475070 · Eli Lilly and Company https://druglandscape.com/drug/ly3475766-iv https://druglandscape.com/api/og?type=drug&title=LY3475766%20-%20IV&subtitle=LY3475766%20-%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3475766 - IV LY3475766 - IV · Eli Lilly and Company https://druglandscape.com/drug/ly3475766-sc https://druglandscape.com/api/og?type=drug&title=LY3475766%20-%20SC&subtitle=LY3475766%20-%20SC%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3475766 - SC LY3475766 - SC · Eli Lilly and Company https://druglandscape.com/drug/ly3478045 https://druglandscape.com/api/og?type=drug&title=LY3478045&subtitle=LY3478045%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3478045 LY3478045 · Eli Lilly and Company https://druglandscape.com/drug/ly3484356 https://druglandscape.com/api/og?type=drug&title=LY3484356&subtitle=LY3484356%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3484356 LY3484356 · Eli Lilly and Company https://druglandscape.com/drug/ly3493269-iv https://druglandscape.com/api/og?type=drug&title=LY3493269%20-%20IV&subtitle=LY3493269%20-%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3493269 - IV LY3493269 - IV · Eli Lilly and Company https://druglandscape.com/drug/ly3493269-sc https://druglandscape.com/api/og?type=drug&title=LY3493269%20-%20SC&subtitle=LY3493269%20-%20SC%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3493269 - SC LY3493269 - SC · Eli Lilly and Company https://druglandscape.com/drug/ly3522348 https://druglandscape.com/api/og?type=drug&title=LY3522348&subtitle=LY3522348%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3522348 LY3522348 · Eli Lilly and Company https://druglandscape.com/drug/ly3526318-isa https://druglandscape.com/api/og?type=drug&title=LY3526318%20ISA&subtitle=LY3526318%20ISA%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3526318 ISA LY3526318 ISA · Eli Lilly and Company https://druglandscape.com/drug/ly3532226 https://druglandscape.com/api/og?type=drug&title=LY3532226&subtitle=LY3532226%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3532226 LY3532226 · Eli Lilly and Company https://druglandscape.com/drug/ly3537021 https://druglandscape.com/api/og?type=drug&title=LY3537021&subtitle=LY3537021%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3537021 LY3537021 · Eli Lilly and Company https://druglandscape.com/drug/ly3541105 https://druglandscape.com/api/og?type=drug&title=LY3541105&subtitle=LY3541105%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3541105 LY3541105 · Eli Lilly and Company https://druglandscape.com/drug/ly3541860 https://druglandscape.com/api/og?type=drug&title=LY3541860&subtitle=LY3541860%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3541860 LY3541860 · Eli Lilly and Company https://druglandscape.com/drug/ly3556050-isa https://druglandscape.com/api/og?type=drug&title=LY3556050%20ISA&subtitle=LY3556050%20ISA%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3556050 ISA LY3556050 ISA · Eli Lilly and Company https://druglandscape.com/drug/ly3561774 https://druglandscape.com/api/og?type=drug&title=LY3561774&subtitle=LY3561774%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3561774 LY3561774 · Eli Lilly and Company https://druglandscape.com/drug/ly3841136 https://druglandscape.com/api/og?type=drug&title=LY3841136&subtitle=LY3841136%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3841136 LY3841136 · Eli Lilly and Company https://druglandscape.com/drug/ly3847429 https://druglandscape.com/api/og?type=drug&title=LY3847429&subtitle=LY3847429%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3847429 LY3847429 · Eli Lilly and Company https://druglandscape.com/drug/ly3849891 https://druglandscape.com/api/og?type=drug&title=LY3849891&subtitle=LY3849891%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3849891 LY3849891 · Eli Lilly and Company https://druglandscape.com/drug/ly3853113 https://druglandscape.com/api/og?type=drug&title=LY3853113&subtitle=LY3853113%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3853113 LY3853113 · Eli Lilly and Company https://druglandscape.com/drug/ly3857210-isa https://druglandscape.com/api/og?type=drug&title=LY3857210%20ISA&subtitle=LY3857210%20ISA%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3857210 ISA LY3857210 ISA · Eli Lilly and Company https://druglandscape.com/drug/ly3866288 https://druglandscape.com/api/og?type=drug&title=LY3866288&subtitle=LY3866288%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3866288 LY3866288 · Eli Lilly and Company https://druglandscape.com/drug/ly3871801 https://druglandscape.com/api/og?type=drug&title=LY3871801&subtitle=LY3871801%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3871801 LY3871801 · Eli Lilly and Company https://druglandscape.com/drug/ly3873862 https://druglandscape.com/api/og?type=drug&title=LY3873862&subtitle=LY3873862%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3873862 LY3873862 · Eli Lilly and Company https://druglandscape.com/drug/ly3876602 https://druglandscape.com/api/og?type=drug&title=LY3876602&subtitle=LY3876602%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3876602 LY3876602 · Eli Lilly and Company https://druglandscape.com/drug/ly3938577 https://druglandscape.com/api/og?type=drug&title=LY3938577&subtitle=LY3938577%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3938577 LY3938577 · Eli Lilly and Company https://druglandscape.com/drug/ly3954068 https://druglandscape.com/api/og?type=drug&title=LY3954068&subtitle=LY3954068%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3954068 LY3954068 · Eli Lilly and Company https://druglandscape.com/drug/ly3971297 https://druglandscape.com/api/og?type=drug&title=LY3971297&subtitle=LY3971297%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3971297 LY3971297 · Eli Lilly and Company https://druglandscape.com/drug/ly3971297-iv https://druglandscape.com/api/og?type=drug&title=LY3971297%20IV&subtitle=LY3971297%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3971297 IV LY3971297 IV · Eli Lilly and Company https://druglandscape.com/drug/ly3972406 https://druglandscape.com/api/og?type=drug&title=LY3972406&subtitle=LY3972406%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY3972406 LY3972406 · Eli Lilly and Company https://druglandscape.com/drug/ly3985297 https://druglandscape.com/api/og?type=drug&title=LY3985297&subtitle=LY3985297%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3985297 LY3985297 · Eli Lilly and Company https://druglandscape.com/drug/ly3985863 https://druglandscape.com/api/og?type=drug&title=LY3985863&subtitle=LY3985863%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY3985863 LY3985863 · Eli Lilly and Company https://druglandscape.com/drug/ly4005130 https://druglandscape.com/api/og?type=drug&title=LY4005130&subtitle=LY4005130%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4005130 LY4005130 · Eli Lilly and Company https://druglandscape.com/drug/ly4006895 https://druglandscape.com/api/og?type=drug&title=LY4006895&subtitle=LY4006895%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4006895 LY4006895 · Eli Lilly and Company https://druglandscape.com/drug/ly4006896 https://druglandscape.com/api/og?type=drug&title=LY4006896&subtitle=LY4006896%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4006896 LY4006896 · Eli Lilly and Company https://druglandscape.com/drug/ly4050784 https://druglandscape.com/api/og?type=drug&title=LY4050784&subtitle=LY4050784%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4050784 LY4050784 · Eli Lilly and Company https://druglandscape.com/drug/ly4057996-sc https://druglandscape.com/api/og?type=drug&title=LY4057996%20SC&subtitle=LY4057996%20SC%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4057996 SC LY4057996 SC · Eli Lilly and Company https://druglandscape.com/drug/ly4060874 https://druglandscape.com/api/og?type=drug&title=LY4060874&subtitle=LY4060874%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4060874 LY4060874 · Eli Lilly and Company https://druglandscape.com/drug/ly4064809-reference-formulation https://druglandscape.com/api/og?type=drug&title=LY4064809%20Reference%20Formulation&subtitle=LY4064809%20Reference%20Formulation%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4064809 Reference Formulation LY4064809 Reference Formulation · Eli Lilly and Company https://druglandscape.com/drug/ly4064809-test-formulation https://druglandscape.com/api/og?type=drug&title=LY4064809%20Test%20Formulation&subtitle=LY4064809%20Test%20Formulation%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4064809 Test Formulation LY4064809 Test Formulation · Eli Lilly and Company https://druglandscape.com/drug/ly4066434 https://druglandscape.com/api/og?type=drug&title=LY4066434.&subtitle=LY4066434.%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4066434. LY4066434. · Eli Lilly and Company https://druglandscape.com/drug/ly4066708 https://druglandscape.com/api/og?type=drug&title=LY4066708&subtitle=LY4066708%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4066708 LY4066708 · Eli Lilly and Company https://druglandscape.com/drug/ly4086940 https://druglandscape.com/api/og?type=drug&title=LY4086940&subtitle=LY4086940%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4086940 LY4086940 · Eli Lilly and Company https://druglandscape.com/drug/ly4088044 https://druglandscape.com/api/og?type=drug&title=LY4088044&subtitle=LY4088044%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4088044 LY4088044 · Eli Lilly and Company https://druglandscape.com/drug/ly4101174 https://druglandscape.com/api/og?type=drug&title=LY4101174&subtitle=LY4101174%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4101174 LY4101174 · Eli Lilly and Company https://druglandscape.com/drug/ly4152199-iv https://druglandscape.com/api/og?type=drug&title=LY4152199%20-%20IV&subtitle=LY4152199%20-%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4152199 - IV LY4152199 - IV · Eli Lilly and Company https://druglandscape.com/drug/ly4167586 https://druglandscape.com/api/og?type=drug&title=LY4167586&subtitle=LY4167586%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4167586 LY4167586 · Eli Lilly and Company https://druglandscape.com/drug/ly4170156 https://druglandscape.com/api/og?type=drug&title=LY4170156&subtitle=LY4170156%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4170156 LY4170156 · Eli Lilly and Company https://druglandscape.com/drug/ly4213663 https://druglandscape.com/api/og?type=drug&title=LY4213663&subtitle=LY4213663%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4213663 LY4213663 · Eli Lilly and Company https://druglandscape.com/drug/ly4214835 https://druglandscape.com/api/og?type=drug&title=LY4214835&subtitle=LY4214835%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4214835 LY4214835 · Eli Lilly and Company https://druglandscape.com/drug/ly4256984 https://druglandscape.com/api/og?type=drug&title=LY4256984&subtitle=LY4256984%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4256984 LY4256984 · Eli Lilly and Company https://druglandscape.com/drug/ly4268989 https://druglandscape.com/api/og?type=drug&title=LY4268989&subtitle=LY4268989%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY4268989 LY4268989 · Eli Lilly and Company https://druglandscape.com/drug/ly4292009 https://druglandscape.com/api/og?type=drug&title=LY4292009&subtitle=LY4292009%20%C2%B7%20Morphic%20Therapeutic%2C%20Inc.%20(A%20Wholly%20Owned%20Subsidiary%20of%20Eli%20Lilly%20and%20Company)&badge=phase%201 LY4292009 LY4292009 · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) https://druglandscape.com/drug/ly4298445 https://druglandscape.com/api/og?type=drug&title=LY4298445&subtitle=LY4298445%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4298445 LY4298445 · Eli Lilly and Company https://druglandscape.com/drug/ly4337713 https://druglandscape.com/api/og?type=drug&title=LY4337713&subtitle=LY4337713%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4337713 LY4337713 · Eli Lilly and Company https://druglandscape.com/drug/ly4395089 https://druglandscape.com/api/og?type=drug&title=LY4395089&subtitle=LY4395089%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY4395089 LY4395089 · Eli Lilly and Company https://druglandscape.com/drug/ly4515100-via-mad https://druglandscape.com/api/og?type=drug&title=LY4515100%20via%20MAD&subtitle=LY4515100%20via%20MAD%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4515100 via MAD LY4515100 via MAD · Eli Lilly and Company https://druglandscape.com/drug/ly4515100-via-sad https://druglandscape.com/api/og?type=drug&title=LY4515100%20via%20SAD&subtitle=LY4515100%20via%20SAD%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4515100 via SAD LY4515100 via SAD · Eli Lilly and Company https://druglandscape.com/drug/ly4584180 https://druglandscape.com/api/og?type=drug&title=LY4584180&subtitle=LY4584180%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY4584180 LY4584180 · Eli Lilly and Company https://druglandscape.com/drug/ly517717 https://druglandscape.com/api/og?type=drug&title=LY517717&subtitle=LY517717%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY517717 LY517717 · Eli Lilly and Company https://druglandscape.com/drug/ly686017 https://druglandscape.com/api/og?type=drug&title=LY686017&subtitle=LY686017%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 LY686017 LY686017 · Eli Lilly and Company https://druglandscape.com/drug/ly900010 https://druglandscape.com/api/og?type=drug&title=LY900010&subtitle=LY900010%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY900010 LY900010 · Eli Lilly and Company https://druglandscape.com/drug/ly900014-u-100 https://druglandscape.com/api/og?type=drug&title=LY900014%20U-100&subtitle=LY900014%20U-100%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY900014 U-100 LY900014 U-100 · Eli Lilly and Company https://druglandscape.com/drug/ly900014-u-200 https://druglandscape.com/api/og?type=drug&title=LY900014%20U-200&subtitle=LY900014%20U-200%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY900014 U-200 LY900014 U-200 · Eli Lilly and Company https://druglandscape.com/drug/ly900014-u100 https://druglandscape.com/api/og?type=drug&title=LY900014-U100&subtitle=LY900014-U100%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY900014-U100 LY900014-U100 · Eli Lilly and Company https://druglandscape.com/drug/ly900020 https://druglandscape.com/api/og?type=drug&title=LY900020&subtitle=LY900020%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY900020 LY900020 · Eli Lilly and Company https://druglandscape.com/drug/ly900021 https://druglandscape.com/api/og?type=drug&title=LY900021&subtitle=LY900021%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 LY900021 LY900021 · Eli Lilly and Company https://druglandscape.com/drug/lyb001 https://druglandscape.com/api/og?type=drug&title=LYB001&subtitle=LYB001%20%C2%B7%20Yantai%20Patronus%20Biotech%20Co.%2C%20Ltd.&badge=phase%202 LYB001 LYB001 · Yantai Patronus Biotech Co., Ltd. https://druglandscape.com/drug/lyb002ca https://druglandscape.com/api/og?type=drug&title=LYB002CA&subtitle=LYB002CA%20%C2%B7%20Guangzhou%20Patronus%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 LYB002CA LYB002CA · Guangzhou Patronus Biotech Co., Ltd. https://druglandscape.com/drug/lyb002v14 https://druglandscape.com/api/og?type=drug&title=LYB002V14&subtitle=LYB002V14%20%C2%B7%20Guangzhou%20Patronus%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 LYB002V14 LYB002V14 · Guangzhou Patronus Biotech Co., Ltd. https://druglandscape.com/drug/lyb002v14a https://druglandscape.com/api/og?type=drug&title=LYB002V14A&subtitle=LYB002V14A%20%C2%B7%20Guangzhou%20Patronus%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 LYB002V14A LYB002V14A · Guangzhou Patronus Biotech Co., Ltd. https://druglandscape.com/drug/lyb004-25-g https://druglandscape.com/api/og?type=drug&title=LYB004%2025%C2%B5g&subtitle=LYB004%2025%C2%B5g%20%C2%B7%20Guangzhou%20Patronus%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 LYB004 25µg LYB004 25µg · Guangzhou Patronus Biotech Co., Ltd. https://druglandscape.com/drug/lyb004-50-g https://druglandscape.com/api/og?type=drug&title=LYB004%2050%C2%B5g&subtitle=LYB004%2050%C2%B5g%20%C2%B7%20Guangzhou%20Patronus%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 LYB004 50µg LYB004 50µg · Guangzhou Patronus Biotech Co., Ltd. https://druglandscape.com/drug/lyb005-high-dose-with-adjuvant https://druglandscape.com/api/og?type=drug&title=LYB005%20high%20dose%20with%20adjuvant&subtitle=LYB005%20high%20dose%20with%20adjuvant%20%C2%B7%20Guangzhou%20Patronus%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 LYB005 high dose with adjuvant LYB005 high dose with adjuvant · Guangzhou Patronus Biotech Co., Ltd. https://druglandscape.com/drug/lyb005-high-dose-without-adjuvant https://druglandscape.com/api/og?type=drug&title=LYB005%20high%20dose%20without%20adjuvant&subtitle=LYB005%20high%20dose%20without%20adjuvant%20%C2%B7%20Guangzhou%20Patronus%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 LYB005 high dose without adjuvant LYB005 high dose without adjuvant · Guangzhou Patronus Biotech Co., Ltd. https://druglandscape.com/drug/lyb005-low-dose-with-adjuvant https://druglandscape.com/api/og?type=drug&title=LYB005%20low%20dose%20with%20adjuvant&subtitle=LYB005%20low%20dose%20with%20adjuvant%20%C2%B7%20Guangzhou%20Patronus%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 LYB005 low dose with adjuvant LYB005 low dose with adjuvant · Guangzhou Patronus Biotech Co., Ltd. https://druglandscape.com/drug/lyb005-low-dose-without-adjuvant https://druglandscape.com/api/og?type=drug&title=LYB005%20low%20dose%20without%20adjuvant&subtitle=LYB005%20low%20dose%20without%20adjuvant%20%C2%B7%20Guangzhou%20Patronus%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 LYB005 low dose without adjuvant LYB005 low dose without adjuvant · Guangzhou Patronus Biotech Co., Ltd. https://druglandscape.com/drug/lyb005-middle-dose-with-adjuvant https://druglandscape.com/api/og?type=drug&title=LYB005%20middle%20dose%20with%20adjuvant&subtitle=LYB005%20middle%20dose%20with%20adjuvant%20%C2%B7%20Guangzhou%20Patronus%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 LYB005 middle dose with adjuvant LYB005 middle dose with adjuvant · Guangzhou Patronus Biotech Co., Ltd. https://druglandscape.com/drug/lyb005-middle-dose-without-adjuvant https://druglandscape.com/api/og?type=drug&title=LYB005%20middle%20dose%20without%20adjuvant&subtitle=LYB005%20middle%20dose%20without%20adjuvant%20%C2%B7%20Guangzhou%20Patronus%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 LYB005 middle dose without adjuvant LYB005 middle dose without adjuvant · Guangzhou Patronus Biotech Co., Ltd. https://druglandscape.com/drug/lyc-30937 https://druglandscape.com/api/og?type=drug&title=LYC-30937&subtitle=LYC-30937%20%C2%B7%20Lycera%20Corp.&badge=phase%201 LYC-30937 LYC-30937 · Lycera Corp. https://druglandscape.com/drug/lyc-55716 https://druglandscape.com/api/og?type=drug&title=LYC-55716&subtitle=LYC-55716%20%C2%B7%20Lycera%20Corp.&badge=phase%201 LYC-55716 LYC-55716 · Lycera Corp. https://druglandscape.com/drug/lyg-liv0001 https://druglandscape.com/api/og?type=drug&title=LYG-LIV0001&subtitle=LYG-LIV0001%20%C2%B7%20LyGenesis%2C%20Inc.&badge=phase%202 LYG-LIV0001 LYG-LIV0001 · LyGenesis, Inc. https://druglandscape.com/drug/lyl314 https://druglandscape.com/api/og?type=drug&title=LYL314&subtitle=LYL314%20%C2%B7%20Lyell%20Immunopharma%2C%20Inc.&badge=phase%201 LYL314 LYL314 · Lyell Immunopharma, Inc. https://druglandscape.com/drug/lymphocytes-immunophenotyping https://druglandscape.com/api/og?type=drug&title=lymphocytes%20immunophenotyping&subtitle=lymphocytes%20immunophenotyping%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 lymphocytes immunophenotyping lymphocytes immunophenotyping · Hospices Civils de Lyon https://druglandscape.com/drug/lymphodepletion-chemotherapy https://druglandscape.com/api/og?type=drug&title=Lymphodepletion%20Chemotherapy&subtitle=Lymphodepletion%20Chemotherapy%20%C2%B7%20Marcela%20V.%20Maus%2C%20M.D.%2CPh.D.&badge=phase%202 Lymphodepletion Chemotherapy Lymphodepletion Chemotherapy · Marcela V. Maus, M.D.,Ph.D. https://druglandscape.com/drug/lymphoseek-and-vbd-sln-dissection https://druglandscape.com/api/og?type=drug&title=Lymphoseek%20and%20VBD%20Sln%20dissection&subtitle=Lymphoseek%20and%20VBD%20Sln%20dissection%20%C2%B7%20Maimonides%20Medical%20Center&badge=phase%202 Lymphoseek and VBD Sln dissection Lymphoseek and VBD Sln dissection · Maimonides Medical Center https://druglandscape.com/drug/lyn-057 https://druglandscape.com/api/og?type=drug&title=LYN-057&subtitle=LYN-057%20%C2%B7%20Lyndra%20Inc.&badge=phase%201 LYN-057 LYN-057 · Lyndra Inc. https://druglandscape.com/drug/lyn101 https://druglandscape.com/api/og?type=drug&title=LYN101&subtitle=LYN101%20%C2%B7%20Shanghai%20TTM-Bio%20Technology%20Co.%2C%20Ltd&badge=phase%201 LYN101 LYN101 · Shanghai TTM-Bio Technology Co., Ltd https://druglandscape.com/drug/lyndiol https://druglandscape.com/api/og?type=drug&title=Lyndiol%C2%AE&subtitle=Lyndiol%C2%AE%20%C2%B7%20Organon%20and%20Co&badge=phase%201 Lyndiol® Lyndiol® · Organon and Co https://druglandscape.com/drug/lyophilized-fecal-microbiota-transplantation https://druglandscape.com/api/og?type=drug&title=Lyophilized%20Fecal%20Microbiota%20Transplantation&subtitle=Lyophilized%20Fecal%20Microbiota%20Transplantation%20%C2%B7%20Vancouver%20Island%20Health%20Authority&badge=phase%201 Lyophilized Fecal Microbiota Transplantation Lyophilized Fecal Microbiota Transplantation · Vancouver Island Health Authority https://druglandscape.com/drug/lyral https://druglandscape.com/api/og?type=drug&title=Lyral%C2%AE&subtitle=Lyral%C2%AE%20%C2%B7%20Allerderm&badge=phase%202 Lyral® Lyral® · Allerderm https://druglandscape.com/drug/lys-saf302 https://druglandscape.com/api/og?type=drug&title=LYS-SAF302&subtitle=LYS-SAF302%20%C2%B7%20LYSOGENE&badge=phase%202 LYS-SAF302 LYS-SAF302 · LYSOGENE https://druglandscape.com/drug/lysate-of-tumor https://druglandscape.com/api/og?type=drug&title=Lysate%20of%20Tumor&subtitle=Lysate%20of%20Tumor%20%C2%B7%20Macarena%20De%20La%20Fuente%2C%20MD&badge=phase%201 Lysate of Tumor Lysate of Tumor · Macarena De La Fuente, MD https://druglandscape.com/drug/lyt-200 https://druglandscape.com/api/og?type=drug&title=LYT-200&subtitle=LYT-200%20%C2%B7%20PureTech&badge=phase%201 LYT-200 LYT-200 · PureTech https://druglandscape.com/drug/lyt-300 https://druglandscape.com/api/og?type=drug&title=LYT-300&subtitle=LYT-300%20%C2%B7%20PureTech&badge=phase%201 LYT-300 LYT-300 · PureTech https://druglandscape.com/drug/lyumjev-u-100-insulin https://druglandscape.com/api/og?type=drug&title=Lyumjev%20U-100%20Insulin&subtitle=Lyumjev%20U-100%20Insulin%20%C2%B7%20Portal%20Diabetes%2C%20Inc.&badge=phase%201 Lyumjev U-100 Insulin Lyumjev U-100 Insulin · Portal Diabetes, Inc. https://druglandscape.com/drug/lyumjev-with-100-basal-rate-reduction https://druglandscape.com/api/og?type=drug&title=Lyumjev%20with%20100%25%20basal%20rate%20reduction&subtitle=Lyumjev%20with%20100%25%20basal%20rate%20reduction%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Lyumjev with 100% basal rate reduction Lyumjev with 100% basal rate reduction · Eli Lilly and Company https://druglandscape.com/drug/lyumjev-with-50-basal-rate-reduction https://druglandscape.com/api/og?type=drug&title=Lyumjev%20with%2050%25%20basal%20rate%20reduction&subtitle=Lyumjev%20with%2050%25%20basal%20rate%20reduction%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Lyumjev with 50% basal rate reduction Lyumjev with 50% basal rate reduction · Eli Lilly and Company https://druglandscape.com/drug/m-folfox https://druglandscape.com/api/og?type=drug&title=m-FOLFOX&subtitle=m-FOLFOX%20%C2%B7%20Spanish%20Cooperative%20Group%20for%20the%20Treatment%20of%20Digestive%20Tumours%20(TTD)&badge=phase%201 m-FOLFOX m-FOLFOX · Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) https://druglandscape.com/drug/m-folfox-6-regimen https://druglandscape.com/api/og?type=drug&title=m-FOLFOX-6%20regimen&subtitle=m-FOLFOX-6%20regimen%20%C2%B7%20Arcus%20Biosciences%2C%20Inc.&badge=phase%201 m-FOLFOX-6 regimen m-FOLFOX-6 regimen · Arcus Biosciences, Inc. https://druglandscape.com/drug/m-gpe https://druglandscape.com/api/og?type=drug&title=M-GPE&subtitle=M-GPE%20%C2%B7%20Centers%20for%20Disease%20Control%20and%20Prevention%2C%20China&badge=phase%201 M-GPE M-GPE · Centers for Disease Control and Prevention, China https://druglandscape.com/drug/m-ipv-hd https://druglandscape.com/api/og?type=drug&title=m-IPV%20HD&subtitle=m-IPV%20HD%20%C2%B7%20Vaxtrials%20S.A.&badge=phase%202 m-IPV HD m-IPV HD · Vaxtrials S.A. https://druglandscape.com/drug/m-opv2 https://druglandscape.com/api/og?type=drug&title=m-OPV2&subtitle=m-OPV2%20%C2%B7%20Vaxtrials%20S.A.&badge=phase%202 m-OPV2 m-OPV2 · Vaxtrials S.A. https://druglandscape.com/drug/m-vac https://druglandscape.com/api/og?type=drug&title=M-Vac%E2%84%A2&subtitle=M-Vac%E2%84%A2%20%C2%B7%20GlaxoSmithKline&badge=phase%202 M-Vac™ M-Vac™ · GlaxoSmithKline https://druglandscape.com/drug/m0002 https://druglandscape.com/api/og?type=drug&title=M0002&subtitle=M0002%20%C2%B7%20Movetis&badge=phase%202 M0002 M0002 · Movetis https://druglandscape.com/drug/m1-pram-p037 https://druglandscape.com/api/og?type=drug&title=M1%20Pram%20P037&subtitle=M1%20Pram%20P037%20%C2%B7%20Adocia&badge=phase%202 M1 Pram P037 M1 Pram P037 · Adocia https://druglandscape.com/drug/m108 https://druglandscape.com/api/og?type=drug&title=M108&subtitle=M108%20%C2%B7%20FutureGen%20Biopharmaceutical%20(Beijing)%20Co.%2C%20Ltd&badge=phase%201 M108 M108 · FutureGen Biopharmaceutical (Beijing) Co., Ltd https://druglandscape.com/drug/m118 https://druglandscape.com/api/og?type=drug&title=M118&subtitle=M118%20%C2%B7%20Momenta%20Pharmaceuticals%2C%20Inc.&badge=phase%202 M118 M118 · Momenta Pharmaceuticals, Inc. https://druglandscape.com/drug/m281 https://druglandscape.com/api/og?type=drug&title=M281&subtitle=M281%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 M281 M281 · Janssen Research & Development, LLC https://druglandscape.com/drug/m2951-high-dose https://druglandscape.com/api/og?type=drug&title=M2951%20High%20Dose&subtitle=M2951%20High%20Dose%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt%2C%20&badge=phase%201 M2951 High Dose M2951 High Dose · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/m2951-low-dose https://druglandscape.com/api/og?type=drug&title=M2951%20Low%20Dose&subtitle=M2951%20Low%20Dose%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt%2C%20G&badge=phase%201 M2951 Low Dose M2951 Low Dose · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/m2rlab-001 https://druglandscape.com/api/og?type=drug&title=M2RLAB%20001&subtitle=M2RLAB%20001%20%C2%B7%20M2RLAB%20SL&badge=phase%202 M2RLAB 001 M2RLAB 001 · M2RLAB SL https://druglandscape.com/drug/m366 https://druglandscape.com/api/og?type=drug&title=M366&subtitle=M366%20%C2%B7%20Charleston%20Laboratories%2C%20Inc&badge=phase%201 M366 M366 · Charleston Laboratories, Inc https://druglandscape.com/drug/m3t01 https://druglandscape.com/api/og?type=drug&title=M3T01&subtitle=M3T01%20%C2%B7%20Providence%20Health%20%26%20Services&badge=phase%201 M3T01 M3T01 · Providence Health & Services https://druglandscape.com/drug/m5049-low-dose https://druglandscape.com/api/og?type=drug&title=M5049%20low%20dose&subtitle=M5049%20low%20dose%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt%2C%20G&badge=phase%202 M5049 low dose M5049 low dose · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/m5049-medium-dose https://druglandscape.com/api/og?type=drug&title=M5049%20medium%20dose&subtitle=M5049%20medium%20dose%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt&badge=phase%202 M5049 medium dose M5049 medium dose · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/m516102 https://druglandscape.com/api/og?type=drug&title=M516102&subtitle=M516102%20%C2%B7%20Maruho%20Co.%2C%20Ltd.&badge=phase%202 M516102 M516102 · Maruho Co., Ltd. https://druglandscape.com/drug/m5542 https://druglandscape.com/api/og?type=drug&title=M5542&subtitle=M5542%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 M5542 M5542 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/m5717 https://druglandscape.com/api/og?type=drug&title=M5717&subtitle=M5717%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 M5717 M5717 · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/m6229 https://druglandscape.com/api/og?type=drug&title=M6229&subtitle=M6229%20%C2%B7%20A.P.J.%20Vlaar&badge=phase%201 M6229 M6229 · A.P.J. Vlaar https://druglandscape.com/drug/m6495 https://druglandscape.com/api/og?type=drug&title=M6495&subtitle=M6495%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 M6495 M6495 · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/m7583 https://druglandscape.com/api/og?type=drug&title=M7583&subtitle=M7583%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 M7583 M7583 · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/m834 https://druglandscape.com/api/og?type=drug&title=M834&subtitle=M834%20%C2%B7%20Momenta%20Pharmaceuticals%2C%20Inc.&badge=phase%201 M834 M834 · Momenta Pharmaceuticals, Inc. https://druglandscape.com/drug/m9140 https://druglandscape.com/api/og?type=drug&title=M9140&subtitle=M9140%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 M9140 M9140 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/ma-0211 https://druglandscape.com/api/og?type=drug&title=MA-0211&subtitle=MA-0211%20%C2%B7%20Astellas%20Pharma%20Global%20Development%2C%20Inc.&badge=phase%201 MA-0211 MA-0211 · Astellas Pharma Global Development, Inc. https://druglandscape.com/drug/maalox-advance-regular-strength-liquid https://druglandscape.com/api/og?type=drug&title=Maalox%20Advance%20Regular%20Strength%20liquid&subtitle=Maalox%20Advance%20Regular%20Strength%20liquid%20%C2%B7%20Takeda&badge=phase%201 Maalox Advance Regular Strength liquid Maalox Advance Regular Strength liquid · Takeda https://druglandscape.com/drug/maat033-capsule https://druglandscape.com/api/og?type=drug&title=MaaT033%20capsule&subtitle=MaaT033%20capsule%20%C2%B7%20Gustave%20Roussy%2C%20Cancer%20Campus%2C%20Grand%20Paris&badge=phase%202 MaaT033 capsule MaaT033 capsule · Gustave Roussy, Cancer Campus, Grand Paris https://druglandscape.com/drug/mabel-ctls https://druglandscape.com/api/og?type=drug&title=MABEL%20CTLs&subtitle=MABEL%20CTLs%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 MABEL CTLs MABEL CTLs · Baylor College of Medicine https://druglandscape.com/drug/mabp1 https://druglandscape.com/api/og?type=drug&title=MABp1&subtitle=MABp1%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 MABp1 MABp1 · Janssen Research & Development, LLC https://druglandscape.com/drug/mabt5102a https://druglandscape.com/api/og?type=drug&title=MABT5102A&subtitle=MABT5102A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 MABT5102A MABT5102A · Genentech, Inc. https://druglandscape.com/drug/mac-321 https://druglandscape.com/api/og?type=drug&title=MAC-321&subtitle=MAC-321%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%202 MAC-321 MAC-321 · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/mad-apx-115 https://druglandscape.com/api/og?type=drug&title=MAD%3A%20APX-115&subtitle=MAD%3A%20APX-115%20%C2%B7%20Aptabio%20Therapeutics%2C%20Inc.&badge=phase%201 MAD: APX-115 MAD: APX-115 · Aptabio Therapeutics, Inc. https://druglandscape.com/drug/mad-nd003-dose-1 https://druglandscape.com/api/og?type=drug&title=MAD_ND003_Dose%201&subtitle=MAD_ND003_Dose%201%20%C2%B7%20Shenzhen%20NewDEL%20Biotech%2C%20Co.%2C%20Ltd&badge=phase%201 MAD_ND003_Dose 1 MAD_ND003_Dose 1 · Shenzhen NewDEL Biotech, Co., Ltd https://druglandscape.com/drug/mad-nd003-dose-3 https://druglandscape.com/api/og?type=drug&title=MAD_ND003_Dose%203&subtitle=MAD_ND003_Dose%203%20%C2%B7%20Shenzhen%20NewDEL%20Biotech%2C%20Co.%2C%20Ltd&badge=phase%201 MAD_ND003_Dose 3 MAD_ND003_Dose 3 · Shenzhen NewDEL Biotech, Co., Ltd https://druglandscape.com/drug/madopar-125 https://druglandscape.com/api/og?type=drug&title=Madopar%C2%AE%20125&subtitle=Madopar%C2%AE%20125%20%C2%B7%20Bial%20-%20Portela%20C%20S.A.&badge=phase%201 Madopar® 125 Madopar® 125 · Bial - Portela C S.A. https://druglandscape.com/drug/madopar-250 https://druglandscape.com/api/og?type=drug&title=Madopar%C2%AE%20250&subtitle=Madopar%C2%AE%20250%20%C2%B7%20Bial%20-%20Portela%20C%20S.A.&badge=phase%201 Madopar® 250 Madopar® 250 · Bial - Portela C S.A. https://druglandscape.com/drug/madopar-hbs https://druglandscape.com/api/og?type=drug&title=Madopar%C2%AE%20HBS&subtitle=Madopar%C2%AE%20HBS%20%C2%B7%20Bial%20-%20Portela%20C%20S.A.&badge=phase%201 Madopar® HBS Madopar® HBS · Bial - Portela C S.A. https://druglandscape.com/drug/madopar-hbs-125 https://druglandscape.com/api/og?type=drug&title=Madopar%C2%AE%20HBS%20125&subtitle=Madopar%C2%AE%20HBS%20125%20%C2%B7%20Bial%20-%20Portela%20C%20S.A.&badge=phase%201 Madopar® HBS 125 Madopar® HBS 125 · Bial - Portela C S.A. https://druglandscape.com/drug/maekmoondong-tang https://druglandscape.com/api/og?type=drug&title=Maekmoondong-tang&subtitle=Maekmoondong-tang%20%C2%B7%20Seong-Gyu%20Ko&badge=phase%202 Maekmoondong-tang Maekmoondong-tang · Seong-Gyu Ko https://druglandscape.com/drug/magne-b6-new-formulation-tablet https://druglandscape.com/api/og?type=drug&title=MAGNE-B6%20New%20Formulation%20Tablet&subtitle=MAGNE-B6%20New%20Formulation%20Tablet%20%C2%B7%20Opella%20Healthcare%20Group%20SAS%2C%20a%20Sanofi%20Company&badge=phase%201 MAGNE-B6 New Formulation Tablet MAGNE-B6 New Formulation Tablet · Opella Healthcare Group SAS, a Sanofi Company https://druglandscape.com/drug/magne-b6-oral-solution https://druglandscape.com/api/og?type=drug&title=MAGNE-B6%20Oral%20Solution&subtitle=MAGNE-B6%20Oral%20Solution%20%C2%B7%20Opella%20Healthcare%20Group%20SAS%2C%20a%20Sanofi%20Company&badge=phase%201 MAGNE-B6 Oral Solution MAGNE-B6 Oral Solution · Opella Healthcare Group SAS, a Sanofi Company https://druglandscape.com/drug/magnetic-resonance-imaging-with-contrast https://druglandscape.com/api/og?type=drug&title=Magnetic%20Resonance%20Imaging%20with%20Contrast&subtitle=Magnetic%20Resonance%20Imaging%20with%20Contrast%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Magnetic Resonance Imaging with Contrast Magnetic Resonance Imaging with Contrast · Bristol-Myers Squibb https://druglandscape.com/drug/magtrace-only https://druglandscape.com/api/og?type=drug&title=MagTrace%20only&subtitle=MagTrace%20only%20%C2%B7%20Vastra%20Gotaland%20Region&badge=phase%201 MagTrace only MagTrace only · Vastra Gotaland Region https://druglandscape.com/drug/maintenance-of-ult https://druglandscape.com/api/og?type=drug&title=Maintenance%20of%20ULT&subtitle=Maintenance%20of%20ULT%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Maintenance of ULT Maintenance of ULT · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/maintenance-venetoclax https://druglandscape.com/api/og?type=drug&title=Maintenance%20Venetoclax&subtitle=Maintenance%20Venetoclax%20%C2%B7%20PrECOG%2C%20LLC.&badge=phase%202 Maintenance Venetoclax Maintenance Venetoclax · PrECOG, LLC. https://druglandscape.com/drug/maldox-tablets https://druglandscape.com/api/og?type=drug&title=Maldox%20tablets&subtitle=Maldox%20tablets%20%C2%B7%20Emzor%20Pharmaceutical%20Industries%20Limited&badge=phase%201 Maldox tablets Maldox tablets · Emzor Pharmaceutical Industries Limited https://druglandscape.com/drug/mannitol-based-38-drug-loaded-tablet https://druglandscape.com/api/og?type=drug&title=Mannitol-based%2038%25%20drug-loaded%20tablet&subtitle=Mannitol-based%2038%25%20drug-loaded%20tablet%20%C2%B7%20AstraZeneca&badge=phase%201 Mannitol-based 38% drug-loaded tablet Mannitol-based 38% drug-loaded tablet · AstraZeneca https://druglandscape.com/drug/manufactured-anti-bcma-car-t-cells https://druglandscape.com/api/og?type=drug&title=Manufactured%20Anti-BCMA%20CAR-T%20cells&subtitle=Manufactured%20Anti-BCMA%20CAR-T%20cells%20%C2%B7%20Thomas%20Martin%2C%20MD&badge=phase%201 Manufactured Anti-BCMA CAR-T cells Manufactured Anti-BCMA CAR-T cells · Thomas Martin, MD https://druglandscape.com/drug/manuka-honey-in-liquid-form https://druglandscape.com/api/og?type=drug&title=Manuka%20honey%20in%20liquid%20form&subtitle=Manuka%20honey%20in%20liquid%20form%20%C2%B7%20Radiation%20Therapy%20Oncology%20Group&badge=phase%202 Manuka honey in liquid form Manuka honey in liquid form · Radiation Therapy Oncology Group https://druglandscape.com/drug/manuka-honey-in-lozenge-form https://druglandscape.com/api/og?type=drug&title=Manuka%20honey%20in%20lozenge%20form&subtitle=Manuka%20honey%20in%20lozenge%20form%20%C2%B7%20Radiation%20Therapy%20Oncology%20Group&badge=phase%202 Manuka honey in lozenge form Manuka honey in lozenge form · Radiation Therapy Oncology Group https://druglandscape.com/drug/map0010-high-dose https://druglandscape.com/api/og?type=drug&title=MAP0010%20high%20dose&subtitle=MAP0010%20high%20dose%20%C2%B7%20Allergan&badge=phase%202 MAP0010 high dose MAP0010 high dose · Allergan https://druglandscape.com/drug/map0010-intermediate-dose https://druglandscape.com/api/og?type=drug&title=MAP0010%20intermediate%20dose&subtitle=MAP0010%20intermediate%20dose%20%C2%B7%20Allergan&badge=phase%201 MAP0010 intermediate dose MAP0010 intermediate dose · Allergan https://druglandscape.com/drug/map0010-low-dose https://druglandscape.com/api/og?type=drug&title=MAP0010%20low%20dose&subtitle=MAP0010%20low%20dose%20%C2%B7%20Allergan&badge=phase%202 MAP0010 low dose MAP0010 low dose · Allergan https://druglandscape.com/drug/maq-001 https://druglandscape.com/api/og?type=drug&title=MAQ-001&subtitle=MAQ-001%20%C2%B7%20MabQuest%20SA&badge=phase%201 MAQ-001 MAQ-001 · MabQuest SA https://druglandscape.com/drug/maraviroc-experimental-group https://druglandscape.com/api/og?type=drug&title=Maraviroc%20experimental%20group&subtitle=Maraviroc%20experimental%20group%20%C2%B7%20Fundaci%C3%B3n%20P%C3%BAblica%20Andaluza%20para%20la%20gesti%C3%B3n%20de%20la%20Investigaci%C3%B3n%20en%20Sev&badge=phase%202 Maraviroc experimental group Maraviroc experimental group · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla https://druglandscape.com/drug/marcaine-0-25-infiltration https://druglandscape.com/api/og?type=drug&title=Marcaine%200.25%25%20infiltration&subtitle=Marcaine%200.25%25%20infiltration%20%C2%B7%20Innocoll&badge=phase%201 Marcaine 0.25% infiltration Marcaine 0.25% infiltration · Innocoll https://druglandscape.com/drug/marcaine-0-5-injectable-solution https://druglandscape.com/api/og?type=drug&title=Marcaine%200.5%20%25%20Injectable%20Solution&subtitle=Marcaine%200.5%20%25%20Injectable%20Solution%20%C2%B7%20Barzilai%20Medical%20Center&badge=phase%201 Marcaine 0.5 % Injectable Solution Marcaine 0.5 % Injectable Solution · Barzilai Medical Center https://druglandscape.com/drug/margetuximab-margetuximab-iv https://druglandscape.com/api/og?type=drug&title=Margetuximab%20Margetuximab-IV&subtitle=Margetuximab%20Margetuximab-IV%20%C2%B7%20Zai%20Lab%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 Margetuximab Margetuximab-IV Margetuximab Margetuximab-IV · Zai Lab (Shanghai) Co., Ltd. https://druglandscape.com/drug/maribavir-commercial-tablet-formulation https://druglandscape.com/api/og?type=drug&title=Maribavir%20Commercial%20Tablet%20Formulation&subtitle=Maribavir%20Commercial%20Tablet%20Formulation%20%C2%B7%20Takeda&badge=phase%201 Maribavir Commercial Tablet Formulation Maribavir Commercial Tablet Formulation · Takeda https://druglandscape.com/drug/marine-liquid-and-fluids https://druglandscape.com/api/og?type=drug&title=Marine%20liquid%20and%20fluids&subtitle=Marine%20liquid%20and%20fluids%20%C2%B7%20Universidade%20do%20Porto&badge=phase%202 Marine liquid and fluids Marine liquid and fluids · Universidade do Porto https://druglandscape.com/drug/market-approved-oac https://druglandscape.com/api/og?type=drug&title=Market-approved%20OAC&subtitle=Market-approved%20OAC%20%C2%B7%20Boston%20Scientific%20Corporation&badge=phase%201 Market-approved OAC Market-approved OAC · Boston Scientific Corporation https://druglandscape.com/drug/marketed-analgesic https://druglandscape.com/api/og?type=drug&title=marketed%20analgesic&subtitle=marketed%20analgesic%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 marketed analgesic marketed analgesic · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/marketed-antagonists https://druglandscape.com/api/og?type=drug&title=Marketed%20antagonists&subtitle=Marketed%20antagonists%20%C2%B7%20Teva%20Pharmaceuticals%20Europe&badge=phase%202 Marketed antagonists Marketed antagonists · Teva Pharmaceuticals Europe https://druglandscape.com/drug/marketed-bowel-cleanser https://druglandscape.com/api/og?type=drug&title=Marketed%20Bowel%20Cleanser&subtitle=Marketed%20Bowel%20Cleanser%20%C2%B7%20C.B.%20Fleet%20Company%2C%20Inc.&badge=phase%202 Marketed Bowel Cleanser Marketed Bowel Cleanser · C.B. Fleet Company, Inc. https://druglandscape.com/drug/marketed-enteric-coated-naproxen-formulation https://druglandscape.com/api/og?type=drug&title=Marketed%20enteric-coated%20naproxen%20formulation&subtitle=Marketed%20enteric-coated%20naproxen%20formulation%20%C2%B7%20AstraZeneca&badge=phase%201 Marketed enteric-coated naproxen formulation Marketed enteric-coated naproxen formulation · AstraZeneca https://druglandscape.com/drug/marketed-flavored-dentifrice https://druglandscape.com/api/og?type=drug&title=Marketed%20Flavored%20Dentifrice&subtitle=Marketed%20Flavored%20Dentifrice%20%C2%B7%20Procter%20and%20Gamble&badge=phase%201 Marketed Flavored Dentifrice Marketed Flavored Dentifrice · Procter and Gamble https://druglandscape.com/drug/marketed-nicotine-lozenge https://druglandscape.com/api/og?type=drug&title=Marketed%20Nicotine%20Lozenge&subtitle=Marketed%20Nicotine%20Lozenge%20%C2%B7%20McNeil%20AB&badge=phase%201 Marketed Nicotine Lozenge Marketed Nicotine Lozenge · McNeil AB https://druglandscape.com/drug/marketed-nicotine-tablet https://druglandscape.com/api/og?type=drug&title=Marketed%20Nicotine%20Tablet&subtitle=Marketed%20Nicotine%20Tablet%20%C2%B7%20McNeil%20AB&badge=phase%201 Marketed Nicotine Tablet Marketed Nicotine Tablet · McNeil AB https://druglandscape.com/drug/marketed-oxycodone-hydrochloride https://druglandscape.com/api/og?type=drug&title=marketed%20oxycodone%20hydrochloride&subtitle=marketed%20oxycodone%20hydrochloride%20%C2%B7%20Pfizer&badge=phase%201 marketed oxycodone hydrochloride marketed oxycodone hydrochloride · Pfizer https://druglandscape.com/drug/marketed-scopolamine-patch https://druglandscape.com/api/og?type=drug&title=Marketed%20scopolamine%20patch&subtitle=Marketed%20scopolamine%20patch%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Marketed scopolamine patch Marketed scopolamine patch · GlaxoSmithKline https://druglandscape.com/drug/marketed-topical-nsaid https://druglandscape.com/api/og?type=drug&title=marketed%20topical%20NSAID&subtitle=marketed%20topical%20NSAID%20%C2%B7%20LEO%20Pharma&badge=phase%202 marketed topical NSAID marketed topical NSAID · LEO Pharma https://druglandscape.com/drug/marketed-topical-retinoid https://druglandscape.com/api/og?type=drug&title=marketed%20topical%20retinoid&subtitle=marketed%20topical%20retinoid%20%C2%B7%20LEO%20Pharma&badge=phase%202 marketed topical retinoid marketed topical retinoid · LEO Pharma https://druglandscape.com/drug/masct-i https://druglandscape.com/api/og?type=drug&title=MASCT-I&subtitle=MASCT-I%20%C2%B7%20HRYZ%20Biotech%20Co.&badge=phase%202 MASCT-I MASCT-I · HRYZ Biotech Co. https://druglandscape.com/drug/matrix-m-adjuvant https://druglandscape.com/api/og?type=drug&title=Matrix-M%20Adjuvant&subtitle=Matrix-M%20Adjuvant%20%C2%B7%20Novavax&badge=phase%201 Matrix-M Adjuvant Matrix-M Adjuvant · Novavax https://druglandscape.com/drug/mavacamten-capsule-1 https://druglandscape.com/api/og?type=drug&title=Mavacamten%20Capsule%201&subtitle=Mavacamten%20Capsule%201%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Mavacamten Capsule 1 Mavacamten Capsule 1 · Bristol-Myers Squibb https://druglandscape.com/drug/mavacamten-capsule-2 https://druglandscape.com/api/og?type=drug&title=Mavacamten%20Capsule%202&subtitle=Mavacamten%20Capsule%202%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Mavacamten Capsule 2 Mavacamten Capsule 2 · Bristol-Myers Squibb https://druglandscape.com/drug/mavacamten-capsule-3 https://druglandscape.com/api/og?type=drug&title=Mavacamten%20Capsule%203&subtitle=Mavacamten%20Capsule%203%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Mavacamten Capsule 3 Mavacamten Capsule 3 · Bristol-Myers Squibb https://druglandscape.com/drug/max-40070 https://druglandscape.com/api/og?type=drug&title=MAX-40070&subtitle=MAX-40070%20%C2%B7%20Maxinovel%20Pty.%2C%20Ltd.&badge=phase%201 MAX-40070 MAX-40070 · Maxinovel Pty., Ltd. https://druglandscape.com/drug/max-40279 https://druglandscape.com/api/og?type=drug&title=MAX-40279&subtitle=MAX-40279%20%C2%B7%20Maxinovel%20Pty.%2C%20Ltd.&badge=phase%202 MAX-40279 MAX-40279 · Maxinovel Pty., Ltd. https://druglandscape.com/drug/max-40279-01 https://druglandscape.com/api/og?type=drug&title=MAX-40279-01&subtitle=MAX-40279-01%20%C2%B7%20Maxinovel%20Pty.%2C%20Ltd.&badge=phase%202 MAX-40279-01 MAX-40279-01 · Maxinovel Pty., Ltd. https://druglandscape.com/drug/maxmarvil https://druglandscape.com/api/og?type=drug&title=Maxmarvil%C2%AE&subtitle=Maxmarvil%C2%AE%20%C2%B7%20Yuyu%20Pharma%2C%20Inc.&badge=phase%201 Maxmarvil® Maxmarvil® · Yuyu Pharma, Inc. https://druglandscape.com/drug/mayne-glucagon https://druglandscape.com/api/og?type=drug&title=Mayne%20Glucagon&subtitle=Mayne%20Glucagon%20%C2%B7%20Hospira%2C%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 Mayne Glucagon Mayne Glucagon · Hospira, now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/mb-105 https://druglandscape.com/api/og?type=drug&title=MB-105&subtitle=MB-105%20%C2%B7%20March%20Biosciences%20Inc&badge=phase%202 MB-105 MB-105 · March Biosciences Inc https://druglandscape.com/drug/mb-110 https://druglandscape.com/api/og?type=drug&title=MB-110&subtitle=MB-110%20%C2%B7%20Microbio%20Co%20Ltd&badge=phase%201 MB-110 MB-110 · Microbio Co Ltd https://druglandscape.com/drug/mb-6 https://druglandscape.com/api/og?type=drug&title=MB-6&subtitle=MB-6%20%C2%B7%20Microbio%20Co%20Ltd&badge=phase%202 MB-6 MB-6 · Microbio Co Ltd https://druglandscape.com/drug/mb-cart19-1 https://druglandscape.com/api/og?type=drug&title=MB-CART19.1&subtitle=MB-CART19.1%20%C2%B7%20Miltenyi%20Biomedicine%20GmbH&badge=phase%202 MB-CART19.1 MB-CART19.1 · Miltenyi Biomedicine GmbH https://druglandscape.com/drug/mb-cart20-1 https://druglandscape.com/api/og?type=drug&title=MB-CART20.1&subtitle=MB-CART20.1%20%C2%B7%20Miltenyi%20Biomedicine%20GmbH&badge=phase%201 MB-CART20.1 MB-CART20.1 · Miltenyi Biomedicine GmbH https://druglandscape.com/drug/mb-cart2019-1-dose-level-1 https://druglandscape.com/api/og?type=drug&title=MB-CART2019.1%20Dose%20level%201&subtitle=MB-CART2019.1%20Dose%20level%201%20%C2%B7%20Miltenyi%20Biomedicine%20GmbH&badge=phase%201 MB-CART2019.1 Dose level 1 MB-CART2019.1 Dose level 1 · Miltenyi Biomedicine GmbH https://druglandscape.com/drug/mb-cart2019-1-dose-level-2 https://druglandscape.com/api/og?type=drug&title=MB-CART2019.1%20Dose%20level%202&subtitle=MB-CART2019.1%20Dose%20level%202%20%C2%B7%20Miltenyi%20Biomedicine%20GmbH&badge=phase%201 MB-CART2019.1 Dose level 2 MB-CART2019.1 Dose level 2 · Miltenyi Biomedicine GmbH https://druglandscape.com/drug/mb-dnpm1-tcr-1 https://druglandscape.com/api/og?type=drug&title=MB-dNPM1-TCR.1&subtitle=MB-dNPM1-TCR.1%20%C2%B7%20Miltenyi%20Biomedicine%20GmbH&badge=phase%201 MB-dNPM1-TCR.1 MB-dNPM1-TCR.1 · Miltenyi Biomedicine GmbH https://druglandscape.com/drug/mb-imp https://druglandscape.com/api/og?type=drug&title=MB-IMP&subtitle=MB-IMP%20%C2%B7%20Southwest%20Autism%20Research%20%26%20Resource%20Center&badge=phase%202 MB-IMP MB-IMP · Southwest Autism Research & Resource Center https://druglandscape.com/drug/mb02 https://druglandscape.com/api/og?type=drug&title=MB02&subtitle=MB02%20%C2%B7%20mAbxience%20Research%20S.L.&badge=phase%201 MB02 MB02 · mAbxience Research S.L. https://druglandscape.com/drug/mb02-dm https://druglandscape.com/api/og?type=drug&title=MB02-DM&subtitle=MB02-DM%20%C2%B7%20mAbxience%20Research%20S.L.&badge=phase%201 MB02-DM MB02-DM · mAbxience Research S.L. https://druglandscape.com/drug/mb02-sp https://druglandscape.com/api/og?type=drug&title=MB02-SP&subtitle=MB02-SP%20%C2%B7%20mAbxience%20Research%20S.L.&badge=phase%201 MB02-SP MB02-SP · mAbxience Research S.L. https://druglandscape.com/drug/mb04 https://druglandscape.com/api/og?type=drug&title=MB04&subtitle=MB04%20%C2%B7%20mAbxience%20Research%20S.L.&badge=phase%201 MB04 MB04 · mAbxience Research S.L. https://druglandscape.com/drug/mb07133 https://druglandscape.com/api/og?type=drug&title=MB07133&subtitle=MB07133%20%C2%B7%20Xi'an%20Xintong%20Pharmaceutical%20Research%20Co.%2CLtd.&badge=phase%202 MB07133 MB07133 · Xi'an Xintong Pharmaceutical Research Co.,Ltd. https://druglandscape.com/drug/mb09 https://druglandscape.com/api/og?type=drug&title=MB09&subtitle=MB09%20%C2%B7%20mAbxience%20Research%20S.L.&badge=phase%201 MB09 MB09 · mAbxience Research S.L. https://druglandscape.com/drug/mb12066 https://druglandscape.com/api/og?type=drug&title=MB12066&subtitle=MB12066%20%C2%B7%20Yungjin%20Pharm.%20Co.%2C%20Ltd.&badge=phase%201 MB12066 MB12066 · Yungjin Pharm. Co., Ltd. https://druglandscape.com/drug/mb66 https://druglandscape.com/api/og?type=drug&title=MB66&subtitle=MB66%20%C2%B7%20KBio%20Inc&badge=phase%201 MB66 MB66 · KBio Inc https://druglandscape.com/drug/mbf-118-oral-capsules https://druglandscape.com/api/og?type=drug&title=MBF-118%20oral%20capsules&subtitle=MBF-118%20oral%20capsules%20%C2%B7%20Medibiofarma%20S.L.&badge=phase%202 MBF-118 oral capsules MBF-118 oral capsules · Medibiofarma S.L. https://druglandscape.com/drug/mbf-362 https://druglandscape.com/api/og?type=drug&title=MBF-362&subtitle=MBF-362%20%C2%B7%20Medibiofarma%20S.L.&badge=phase%201 MBF-362 MBF-362 · Medibiofarma S.L. https://druglandscape.com/drug/mbi-226-acne-solutions https://druglandscape.com/api/og?type=drug&title=MBI%20226%20Acne%20Solutions&subtitle=MBI%20226%20Acne%20Solutions%20%C2%B7%20BioWest%20Therapeutics%20Inc&badge=phase%202 MBI 226 Acne Solutions MBI 226 Acne Solutions · BioWest Therapeutics Inc https://druglandscape.com/drug/mbm-01 https://druglandscape.com/api/og?type=drug&title=MBM-01&subtitle=MBM-01%20%C2%B7%20Matrix%20Biomed%2C%20Inc.&badge=phase%202 MBM-01 MBM-01 · Matrix Biomed, Inc. https://druglandscape.com/drug/mbp-426 https://druglandscape.com/api/og?type=drug&title=MBP-426&subtitle=MBP-426%20%C2%B7%20Mebiopharm%20Co.%2C%20Ltd&badge=phase%201 MBP-426 MBP-426 · Mebiopharm Co., Ltd https://druglandscape.com/drug/mbs-cov https://druglandscape.com/api/og?type=drug&title=MBS-COV&subtitle=MBS-COV%20%C2%B7%20Oneness%20Biotech%20Co.%2C%20Ltd.&badge=phase%202 MBS-COV MBS-COV · Oneness Biotech Co., Ltd. https://druglandscape.com/drug/mbs2320 https://druglandscape.com/api/og?type=drug&title=MBS2320&subtitle=MBS2320%20%C2%B7%20Modern%20Biosciences%20Ltd&badge=phase%202 MBS2320 MBS2320 · Modern Biosciences Ltd https://druglandscape.com/drug/mbs303 https://druglandscape.com/api/og?type=drug&title=MBS303&subtitle=MBS303%20%C2%B7%20Beijing%20Mabworks%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 MBS303 MBS303 · Beijing Mabworks Biotech Co., Ltd. https://druglandscape.com/drug/mbx-2109 https://druglandscape.com/api/og?type=drug&title=MBX%202109&subtitle=MBX%202109%20%C2%B7%20MBX%20Biosciences&badge=phase%202 MBX 2109 MBX 2109 · MBX Biosciences https://druglandscape.com/drug/mbx-400 https://druglandscape.com/api/og?type=drug&title=MBX-400&subtitle=MBX-400%20%C2%B7%20Microbiotix%2C%20Inc.&badge=phase%201 MBX-400 MBX-400 · Microbiotix, Inc. https://druglandscape.com/drug/mbx-4291 https://druglandscape.com/api/og?type=drug&title=MBX%204291&subtitle=MBX%204291%20%C2%B7%20MBX%20Biosciences&badge=phase%201 MBX 4291 MBX 4291 · MBX Biosciences https://druglandscape.com/drug/mc-1-50 https://druglandscape.com/api/og?type=drug&title=MC-1-50&subtitle=MC-1-50%20%C2%B7%20Chongqing%20Precision%20Biotech%20Co.%2C%20Ltd&badge=phase%201 MC-1-50 MC-1-50 · Chongqing Precision Biotech Co., Ltd https://druglandscape.com/drug/mc2-01-cream-irradiation https://druglandscape.com/api/og?type=drug&title=MC2-01%20Cream%2C%20irradiation&subtitle=MC2-01%20Cream%2C%20irradiation%20%C2%B7%20MC2%20Therapeutics&badge=phase%201 MC2-01 Cream, irradiation MC2-01 Cream, irradiation · MC2 Therapeutics https://druglandscape.com/drug/mc2-01-cream-no-irradiation https://druglandscape.com/api/og?type=drug&title=MC2-01%20Cream%2C%20no%20irradiation&subtitle=MC2-01%20Cream%2C%20no%20irradiation%20%C2%B7%20MC2%20Therapeutics&badge=phase%201 MC2-01 Cream, no irradiation MC2-01 Cream, no irradiation · MC2 Therapeutics https://druglandscape.com/drug/mcaf5352a https://druglandscape.com/api/og?type=drug&title=MCAF5352A&subtitle=MCAF5352A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 MCAF5352A MCAF5352A · Genentech, Inc. https://druglandscape.com/drug/mcc-135 https://druglandscape.com/api/og?type=drug&title=MCC-135&subtitle=MCC-135%20%C2%B7%20Takeda&badge=phase%202 MCC-135 MCC-135 · Takeda https://druglandscape.com/drug/mcc-257 https://druglandscape.com/api/og?type=drug&title=MCC-257&subtitle=MCC-257%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MCC-257 MCC-257 · Tanabe Pharma Corporation https://druglandscape.com/drug/mcc-based-13-drug-loaded-tablets https://druglandscape.com/api/og?type=drug&title=MCC-based%2013%25%20drug%20loaded%20tablets&subtitle=MCC-based%2013%25%20drug%20loaded%20tablets%20%C2%B7%20AstraZeneca&badge=phase%201 MCC-based 13% drug loaded tablets MCC-based 13% drug loaded tablets · AstraZeneca https://druglandscape.com/drug/mcla-128 https://druglandscape.com/api/og?type=drug&title=MCLA-128&subtitle=MCLA-128%20%C2%B7%20Merus%20B.V.&badge=phase%202 MCLA-128 MCLA-128 · Merus B.V. https://druglandscape.com/drug/mcla-129 https://druglandscape.com/api/og?type=drug&title=MCLA-129&subtitle=MCLA-129%20%C2%B7%20Betta%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 MCLA-129 MCLA-129 · Betta Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/mcla-145 https://druglandscape.com/api/og?type=drug&title=MCLA-145&subtitle=MCLA-145%20%C2%B7%20Merus%20B.V.&badge=phase%201 MCLA-145 MCLA-145 · Merus B.V. https://druglandscape.com/drug/mcla-158 https://druglandscape.com/api/og?type=drug&title=MCLA-158&subtitle=MCLA-158%20%C2%B7%20Merus%20B.V.&badge=phase%201 MCLA-158 MCLA-158 · Merus B.V. https://druglandscape.com/drug/mcmv3068a https://druglandscape.com/api/og?type=drug&title=MCMV3068A&subtitle=MCMV3068A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 MCMV3068A MCMV3068A · Genentech, Inc. https://druglandscape.com/drug/mcmv5322a https://druglandscape.com/api/og?type=drug&title=MCMV5322A&subtitle=MCMV5322A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 MCMV5322A MCMV5322A · Genentech, Inc. https://druglandscape.com/drug/mcs-2-soft-gel-capsule https://druglandscape.com/api/og?type=drug&title=MCS-2%20soft-gel%20capsule&subtitle=MCS-2%20soft-gel%20capsule%20%C2%B7%20Health%20Ever%20Bio-Tech%20Co.%2C%20Ltd.&badge=phase%201 MCS-2 soft-gel capsule MCS-2 soft-gel capsule · Health Ever Bio-Tech Co., Ltd. https://druglandscape.com/drug/md-0727 https://druglandscape.com/api/og?type=drug&title=MD-0727&subtitle=MD-0727%20%C2%B7%20Ironwood%20Pharmaceuticals%2C%20Inc.&badge=phase%202 MD-0727 MD-0727 · Ironwood Pharmaceuticals, Inc. https://druglandscape.com/drug/md-18 https://druglandscape.com/api/og?type=drug&title=MD-18&subtitle=MD-18%20%C2%B7%20Cohen%20Global%2C%20Ltd.&badge=phase%201 MD-18 MD-18 · Cohen Global, Ltd. https://druglandscape.com/drug/md-7246 https://druglandscape.com/api/og?type=drug&title=MD-7246&subtitle=MD-7246%20%C2%B7%20Ironwood%20Pharmaceuticals%2C%20Inc.&badge=phase%202 MD-7246 MD-7246 · Ironwood Pharmaceuticals, Inc. https://druglandscape.com/drug/md05 https://druglandscape.com/api/og?type=drug&title=MD05&subtitle=MD05%20%C2%B7%20Scil%20Technology%20GmbH&badge=phase%202 MD05 MD05 · Scil Technology GmbH https://druglandscape.com/drug/md05-and-open-flap-debridement https://druglandscape.com/api/og?type=drug&title=MD05%20and%20open%20flap%20debridement&subtitle=MD05%20and%20open%20flap%20debridement%20%C2%B7%20Scil%20Technology%20GmbH&badge=phase%202 MD05 and open flap debridement MD05 and open flap debridement · Scil Technology GmbH https://druglandscape.com/drug/mdcf https://druglandscape.com/api/og?type=drug&title=mDCF&subtitle=mDCF%20%C2%B7%20GERCOR%20-%20Multidisciplinary%20Oncology%20Cooperative%20Group&badge=phase%202 mDCF mDCF · GERCOR - Multidisciplinary Oncology Cooperative Group https://druglandscape.com/drug/mdco-157 https://druglandscape.com/api/og?type=drug&title=MDCO-157&subtitle=MDCO-157%20%C2%B7%20The%20Medicines%20Company&badge=phase%201 MDCO-157 MDCO-157 · The Medicines Company https://druglandscape.com/drug/mdco-2010 https://druglandscape.com/api/og?type=drug&title=MDCO-2010&subtitle=MDCO-2010%20%C2%B7%20The%20Medicines%20Company&badge=phase%202 MDCO-2010 MDCO-2010 · The Medicines Company https://druglandscape.com/drug/mdco-216 https://druglandscape.com/api/og?type=drug&title=MDCO-216&subtitle=MDCO-216%20%C2%B7%20The%20Medicines%20Company&badge=phase%201 MDCO-216 MDCO-216 · The Medicines Company https://druglandscape.com/drug/mdi-2517 https://druglandscape.com/api/og?type=drug&title=MDI-2517&subtitle=MDI-2517%20%C2%B7%20MDI%20Therapeutics%2C%20Inc.&badge=phase%201 MDI-2517 MDI-2517 · MDI Therapeutics, Inc. https://druglandscape.com/drug/mdma-assisted-psychotherapy https://druglandscape.com/api/og?type=drug&title=MDMA%20assisted%20psychotherapy&subtitle=MDMA%20assisted%20psychotherapy%20%C2%B7%20Remedy&badge=phase%202 MDMA assisted psychotherapy MDMA assisted psychotherapy · Remedy https://druglandscape.com/drug/mdna55 https://druglandscape.com/api/og?type=drug&title=MDNA55&subtitle=MDNA55%20%C2%B7%20Medicenna%20Therapeutics%2C%20Inc.&badge=phase%202 MDNA55 MDNA55 · Medicenna Therapeutics, Inc. https://druglandscape.com/drug/mdt-15 https://druglandscape.com/api/og?type=drug&title=MDT-15&subtitle=MDT-15%20%C2%B7%20Medtronic%20Spinal%20and%20Biologics&badge=phase%202 MDT-15 MDT-15 · Medtronic Spinal and Biologics https://druglandscape.com/drug/mdt-637 https://druglandscape.com/api/og?type=drug&title=MDT-637&subtitle=MDT-637%20%C2%B7%20MicroDose%20Therapeutx%2C%20Inc&badge=phase%201 MDT-637 MDT-637 · MicroDose Therapeutx, Inc https://druglandscape.com/drug/mdx-1100 https://druglandscape.com/api/og?type=drug&title=MDX-1100&subtitle=MDX-1100%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 MDX-1100 MDX-1100 · Bristol-Myers Squibb https://druglandscape.com/drug/mdx-1106 https://druglandscape.com/api/og?type=drug&title=MDX-1106&subtitle=MDX-1106%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 MDX-1106 MDX-1106 · Bristol-Myers Squibb https://druglandscape.com/drug/mdx-1203 https://druglandscape.com/api/og?type=drug&title=MDX-1203&subtitle=MDX-1203%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 MDX-1203 MDX-1203 · Bristol-Myers Squibb https://druglandscape.com/drug/mdx1106-02 https://druglandscape.com/api/og?type=drug&title=MDX1106-02&subtitle=MDX1106-02%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 MDX1106-02 MDX1106-02 · Bristol-Myers Squibb https://druglandscape.com/drug/mdx1303 https://druglandscape.com/api/og?type=drug&title=MDX1303&subtitle=MDX1303%20%C2%B7%20PharmAthene%2C%20Inc.&badge=phase%201 MDX1303 MDX1303 · PharmAthene, Inc. https://druglandscape.com/drug/mdx2001 https://druglandscape.com/api/og?type=drug&title=MDX2001&subtitle=MDX2001%20%C2%B7%20ModeX%20Therapeutics%2C%20An%20OPKO%20Health%20Company&badge=phase%201 MDX2001 MDX2001 · ModeX Therapeutics, An OPKO Health Company https://druglandscape.com/drug/mdx2003 https://druglandscape.com/api/og?type=drug&title=MDX2003&subtitle=MDX2003%20%C2%B7%20ModeX%20Therapeutics%2C%20An%20OPKO%20Health%20Company&badge=phase%201 MDX2003 MDX2003 · ModeX Therapeutics, An OPKO Health Company https://druglandscape.com/drug/mdx2004 https://druglandscape.com/api/og?type=drug&title=MDX2004&subtitle=MDX2004%20%C2%B7%20ModeX%20Therapeutics%2C%20An%20OPKO%20Health%20Company&badge=phase%201 MDX2004 MDX2004 · ModeX Therapeutics, An OPKO Health Company https://druglandscape.com/drug/mdx2301 https://druglandscape.com/api/og?type=drug&title=MDX2301&subtitle=MDX2301%20%C2%B7%20ModeX%20Therapeutics%2C%20An%20OPKO%20Health%20Company&badge=phase%201 MDX2301 MDX2301 · ModeX Therapeutics, An OPKO Health Company https://druglandscape.com/drug/me-143 https://druglandscape.com/api/og?type=drug&title=ME-143&subtitle=ME-143%20%C2%B7%20MEI%20Pharma%2C%20Inc.&badge=phase%201 ME-143 ME-143 · MEI Pharma, Inc. https://druglandscape.com/drug/me-401 https://druglandscape.com/api/og?type=drug&title=ME-401&subtitle=ME-401%20%C2%B7%20Kyowa%20Kirin%20Co.%2C%20Ltd.&badge=phase%202 ME-401 ME-401 · Kyowa Kirin Co., Ltd. https://druglandscape.com/drug/me1100-inhalation-solution https://druglandscape.com/api/og?type=drug&title=ME1100%20inhalation%20solution&subtitle=ME1100%20inhalation%20solution%20%C2%B7%20Meiji%20Seika%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 ME1100 inhalation solution ME1100 inhalation solution · Meiji Seika Pharma Co., Ltd. https://druglandscape.com/drug/me1111-solution https://druglandscape.com/api/og?type=drug&title=ME1111%20solution&subtitle=ME1111%20solution%20%C2%B7%20Meiji%20Seika%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 ME1111 solution ME1111 solution · Meiji Seika Pharma Co., Ltd. https://druglandscape.com/drug/me1111-solution-high-strength https://druglandscape.com/api/og?type=drug&title=ME1111%20Solution%2C%20High%20strength&subtitle=ME1111%20Solution%2C%20High%20strength%20%C2%B7%20Meiji%20Seika%20Pharma%20Co.%2C%20Ltd.&badge=phase%202 ME1111 Solution, High strength ME1111 Solution, High strength · Meiji Seika Pharma Co., Ltd. https://druglandscape.com/drug/me1111-solution-low-strength https://druglandscape.com/api/og?type=drug&title=ME1111%20Solution%2C%20Low%20strength&subtitle=ME1111%20Solution%2C%20Low%20strength%20%C2%B7%20Meiji%20Seika%20Pharma%20Co.%2C%20Ltd.&badge=phase%202 ME1111 Solution, Low strength ME1111 Solution, Low strength · Meiji Seika Pharma Co., Ltd. https://druglandscape.com/drug/me3183 https://druglandscape.com/api/og?type=drug&title=ME3183&subtitle=ME3183%20%C2%B7%20Meiji%20Pharma%20USA%20Inc.&badge=phase%202 ME3183 ME3183 · Meiji Pharma USA Inc. https://druglandscape.com/drug/me3241 https://druglandscape.com/api/og?type=drug&title=ME3241&subtitle=ME3241%20%C2%B7%20Meiji%20Pharma%20USA%20Inc.&badge=phase%201 ME3241 ME3241 · Meiji Pharma USA Inc. https://druglandscape.com/drug/measles-vaccine-at-18-months-of-age https://druglandscape.com/api/og?type=drug&title=Measles%20Vaccine%20at%2018%20months%20of%20age&subtitle=Measles%20Vaccine%20at%2018%20months%20of%20age%20%C2%B7%20Medical%20Research%20Council%20Unit%2C%20The%20Gambia&badge=phase%201 Measles Vaccine at 18 months of age Measles Vaccine at 18 months of age · Medical Research Council Unit, The Gambia https://druglandscape.com/drug/meb-1170 https://druglandscape.com/api/og?type=drug&title=MEB-1170&subtitle=MEB-1170%20%C2%B7%20Mebias%20Discovery%2C%20Inc&badge=phase%201 MEB-1170 MEB-1170 · Mebias Discovery, Inc https://druglandscape.com/drug/mechlorethamine-topical-gel https://druglandscape.com/api/og?type=drug&title=Mechlorethamine%20Topical%20Gel&subtitle=Mechlorethamine%20Topical%20Gel%20%C2%B7%20Soligenix&badge=phase%202 Mechlorethamine Topical Gel Mechlorethamine Topical Gel · Soligenix https://druglandscape.com/drug/mechnicov-probiotics https://druglandscape.com/api/og?type=drug&title=Mechnicov%20probiotics&subtitle=Mechnicov%20probiotics%20%C2%B7%20Kye%20Bong-Hyeon&badge=phase%201 Mechnicov probiotics Mechnicov probiotics · Kye Bong-Hyeon https://druglandscape.com/drug/medi-4166 https://druglandscape.com/api/og?type=drug&title=MEDI-4166&subtitle=MEDI-4166%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI-4166 MEDI-4166 · MedImmune LLC https://druglandscape.com/drug/medi-493 https://druglandscape.com/api/og?type=drug&title=MEDI-493&subtitle=MEDI-493%20%C2%B7%20MedImmune%20LLC&badge=phase%202 MEDI-493 MEDI-493 · MedImmune LLC https://druglandscape.com/drug/medi-517 https://druglandscape.com/api/og?type=drug&title=MEDI%20517&subtitle=MEDI%20517%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI 517 MEDI 517 · MedImmune LLC https://druglandscape.com/drug/medi-522 https://druglandscape.com/api/og?type=drug&title=MEDI--522&subtitle=MEDI--522%20%C2%B7%20MedImmune%20LLC&badge=phase%202 MEDI--522 MEDI--522 · MedImmune LLC https://druglandscape.com/drug/medi-524 https://druglandscape.com/api/og?type=drug&title=Medi-524&subtitle=Medi-524%20%C2%B7%20MedImmune%20LLC&badge=phase%201 Medi-524 Medi-524 · MedImmune LLC https://druglandscape.com/drug/medi-534 https://druglandscape.com/api/og?type=drug&title=MEDI-534&subtitle=MEDI-534%20%C2%B7%20MedImmune%20LLC&badge=phase%202 MEDI-534 MEDI-534 · MedImmune LLC https://druglandscape.com/drug/medi-551 https://druglandscape.com/api/og?type=drug&title=MEDI-551&subtitle=MEDI-551%20%C2%B7%20MedImmune%20LLC&badge=phase%202 MEDI-551 MEDI-551 · MedImmune LLC https://druglandscape.com/drug/medi-551-100-mg-iv https://druglandscape.com/api/og?type=drug&title=MEDI-551%20100%20MG-IV&subtitle=MEDI-551%20100%20MG-IV%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI-551 100 MG-IV MEDI-551 100 MG-IV · MedImmune LLC https://druglandscape.com/drug/medi-551-30-mg-iv https://druglandscape.com/api/og?type=drug&title=MEDI-551%2030%20MG-IV&subtitle=MEDI-551%2030%20MG-IV%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI-551 30 MG-IV MEDI-551 30 MG-IV · MedImmune LLC https://druglandscape.com/drug/medi-551-300-mg-sc https://druglandscape.com/api/og?type=drug&title=MEDI-551%20300%20MG-SC&subtitle=MEDI-551%20300%20MG-SC%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI-551 300 MG-SC MEDI-551 300 MG-SC · MedImmune LLC https://druglandscape.com/drug/medi-551-60-mg-sc https://druglandscape.com/api/og?type=drug&title=MEDI-551%2060%20MG-SC&subtitle=MEDI-551%2060%20MG-SC%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI-551 60 MG-SC MEDI-551 60 MG-SC · MedImmune LLC https://druglandscape.com/drug/medi-551-600-mg-iv https://druglandscape.com/api/og?type=drug&title=MEDI-551%20600%20MG-IV&subtitle=MEDI-551%20600%20MG-IV%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI-551 600 MG-IV MEDI-551 600 MG-IV · MedImmune LLC https://druglandscape.com/drug/medi-559 https://druglandscape.com/api/og?type=drug&title=MEDI-559&subtitle=MEDI-559%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI-559 MEDI-559 · MedImmune LLC https://druglandscape.com/drug/medi-563 https://druglandscape.com/api/og?type=drug&title=MEDI-563&subtitle=MEDI-563%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI-563 MEDI-563 · MedImmune LLC https://druglandscape.com/drug/medi-573 https://druglandscape.com/api/og?type=drug&title=MEDI-573&subtitle=MEDI-573%20%C2%B7%20MedImmune%20LLC&badge=phase%202 MEDI-573 MEDI-573 · MedImmune LLC https://druglandscape.com/drug/medi0382 https://druglandscape.com/api/og?type=drug&title=MEDI0382&subtitle=MEDI0382%20%C2%B7%20MedImmune%20LLC&badge=phase%202 MEDI0382 MEDI0382 · MedImmune LLC https://druglandscape.com/drug/medi0382-high-dose https://druglandscape.com/api/og?type=drug&title=MEDI0382%20high%20dose&subtitle=MEDI0382%20high%20dose%20%C2%B7%20AstraZeneca&badge=phase%202 MEDI0382 high dose MEDI0382 high dose · AstraZeneca https://druglandscape.com/drug/medi0382-low-dose https://druglandscape.com/api/og?type=drug&title=MEDI0382%20low%20dose&subtitle=MEDI0382%20low%20dose%20%C2%B7%20AstraZeneca&badge=phase%202 MEDI0382 low dose MEDI0382 low dose · AstraZeneca https://druglandscape.com/drug/medi0382-mid-dose https://druglandscape.com/api/og?type=drug&title=MEDI0382%20mid%20dose&subtitle=MEDI0382%20mid%20dose%20%C2%B7%20AstraZeneca&badge=phase%202 MEDI0382 mid dose MEDI0382 mid dose · AstraZeneca https://druglandscape.com/drug/medi0562 https://druglandscape.com/api/og?type=drug&title=MEDI0562&subtitle=MEDI0562%20%C2%B7%20Providence%20Health%20%26%20Services&badge=phase%201 MEDI0562 MEDI0562 · Providence Health & Services https://druglandscape.com/drug/medi0618 https://druglandscape.com/api/og?type=drug&title=MEDI0618&subtitle=MEDI0618%20%C2%B7%20AstraZeneca&badge=phase%202 MEDI0618 MEDI0618 · AstraZeneca https://druglandscape.com/drug/medi0680 https://druglandscape.com/api/og?type=drug&title=MEDI0680&subtitle=MEDI0680%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI0680 MEDI0680 · MedImmune LLC https://druglandscape.com/drug/medi1191 https://druglandscape.com/api/og?type=drug&title=MEDI1191&subtitle=MEDI1191%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI1191 MEDI1191 · MedImmune LLC https://druglandscape.com/drug/medi1341 https://druglandscape.com/api/og?type=drug&title=MEDI1341&subtitle=MEDI1341%20%C2%B7%20AstraZeneca&badge=phase%201 MEDI1341 MEDI1341 · AstraZeneca https://druglandscape.com/drug/medi1873 https://druglandscape.com/api/og?type=drug&title=MEDI1873&subtitle=MEDI1873%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI1873 MEDI1873 · MedImmune LLC https://druglandscape.com/drug/medi2070 https://druglandscape.com/api/og?type=drug&title=MEDI2070&subtitle=MEDI2070%20%C2%B7%20AstraZeneca&badge=phase%202 MEDI2070 MEDI2070 · AstraZeneca https://druglandscape.com/drug/medi2338 https://druglandscape.com/api/og?type=drug&title=MEDI2338&subtitle=MEDI2338%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI2338 MEDI2338 · MedImmune LLC https://druglandscape.com/drug/medi3617 https://druglandscape.com/api/og?type=drug&title=MEDI3617&subtitle=MEDI3617%20%C2%B7%20F.%20Stephen%20Hodi%2C%20MD&badge=phase%201 MEDI3617 MEDI3617 · F. Stephen Hodi, MD https://druglandscape.com/drug/medi3726-enzalutamide-combo https://druglandscape.com/api/og?type=drug&title=MEDI3726%20%26%20Enzalutamide%20Combo&subtitle=MEDI3726%20%26%20Enzalutamide%20Combo%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI3726 & Enzalutamide Combo MEDI3726 & Enzalutamide Combo · MedImmune LLC https://druglandscape.com/drug/medi3726-post-chemo https://druglandscape.com/api/og?type=drug&title=MEDI3726%20Post-Chemo&subtitle=MEDI3726%20Post-Chemo%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI3726 Post-Chemo MEDI3726 Post-Chemo · MedImmune LLC https://druglandscape.com/drug/medi3726-pre-chemo https://druglandscape.com/api/og?type=drug&title=MEDI3726%20Pre-Chemo&subtitle=MEDI3726%20Pre-Chemo%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI3726 Pre-Chemo MEDI3726 Pre-Chemo · MedImmune LLC https://druglandscape.com/drug/medi3902 https://druglandscape.com/api/og?type=drug&title=MEDI3902&subtitle=MEDI3902%20%C2%B7%20MedImmune%20LLC&badge=phase%202 MEDI3902 MEDI3902 · MedImmune LLC https://druglandscape.com/drug/medi3902-dose-1 https://druglandscape.com/api/og?type=drug&title=MEDI3902%20-%20Dose%201&subtitle=MEDI3902%20-%20Dose%201%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI3902 - Dose 1 MEDI3902 - Dose 1 · MedImmune LLC https://druglandscape.com/drug/medi4276 https://druglandscape.com/api/og?type=drug&title=MEDI4276&subtitle=MEDI4276%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI4276 MEDI4276 · MedImmune LLC https://druglandscape.com/drug/medi4736-evaluate-medi4736-in-mds https://druglandscape.com/api/og?type=drug&title=MEDI4736%20Evaluate%20MEDI4736%20in%20MDS&subtitle=MEDI4736%20Evaluate%20MEDI4736%20in%20MDS%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI4736 Evaluate MEDI4736 in MDS MEDI4736 Evaluate MEDI4736 in MDS · MedImmune LLC https://druglandscape.com/drug/medi4736-in-combination-with-azd5069 https://druglandscape.com/api/og?type=drug&title=MEDI4736%20in%20combination%20with%20AZD5069&subtitle=MEDI4736%20in%20combination%20with%20AZD5069%20%C2%B7%20AstraZeneca&badge=phase%201 MEDI4736 in combination with AZD5069 MEDI4736 in combination with AZD5069 · AstraZeneca https://druglandscape.com/drug/medi4736-monotherapy https://druglandscape.com/api/og?type=drug&title=MEDI4736%20monotherapy&subtitle=MEDI4736%20monotherapy%20%C2%B7%20AstraZeneca&badge=phase%202 MEDI4736 monotherapy MEDI4736 monotherapy · AstraZeneca https://druglandscape.com/drug/medi5083-monotherapy https://druglandscape.com/api/og?type=drug&title=MEDI5083%20monotherapy&subtitle=MEDI5083%20monotherapy%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI5083 monotherapy MEDI5083 monotherapy · MedImmune LLC https://druglandscape.com/drug/medi5083-with-durvalumab-and-docetaxel https://druglandscape.com/api/og?type=drug&title=Medi5083%20with%20Durvalumab%20and%20Docetaxel&subtitle=Medi5083%20with%20Durvalumab%20and%20Docetaxel%20%C2%B7%20MedImmune%20LLC&badge=phase%201 Medi5083 with Durvalumab and Docetaxel Medi5083 with Durvalumab and Docetaxel · MedImmune LLC https://druglandscape.com/drug/medi5752 https://druglandscape.com/api/og?type=drug&title=MEDI5752&subtitle=MEDI5752%20%C2%B7%20AstraZeneca&badge=phase%202 MEDI5752 MEDI5752 · AstraZeneca https://druglandscape.com/drug/medi5884 https://druglandscape.com/api/og?type=drug&title=MEDI5884&subtitle=MEDI5884%20%C2%B7%20MedImmune%20LLC&badge=phase%202 MEDI5884 MEDI5884 · MedImmune LLC https://druglandscape.com/drug/medi6012-iv-push https://druglandscape.com/api/og?type=drug&title=MEDI6012%20IV%20Push&subtitle=MEDI6012%20IV%20Push%20%C2%B7%20MedImmune%20LLC&badge=phase%202 MEDI6012 IV Push MEDI6012 IV Push · MedImmune LLC https://druglandscape.com/drug/medi6383 https://druglandscape.com/api/og?type=drug&title=MEDI6383&subtitle=MEDI6383%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI6383 MEDI6383 · MedImmune LLC https://druglandscape.com/drug/medi6383-and-medi4736 https://druglandscape.com/api/og?type=drug&title=MEDI6383%20and%20MEDI4736&subtitle=MEDI6383%20and%20MEDI4736%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI6383 and MEDI4736 MEDI6383 and MEDI4736 · MedImmune LLC https://druglandscape.com/drug/medi6570 https://druglandscape.com/api/og?type=drug&title=MEDI6570&subtitle=MEDI6570%20%C2%B7%20AstraZeneca&badge=phase%202 MEDI6570 MEDI6570 · AstraZeneca https://druglandscape.com/drug/medi7183-high-dose https://druglandscape.com/api/og?type=drug&title=MEDI7183%20high%20dose&subtitle=MEDI7183%20high%20dose%20%C2%B7%20AstraZeneca&badge=phase%202 MEDI7183 high dose MEDI7183 high dose · AstraZeneca https://druglandscape.com/drug/medi7183-low-dose https://druglandscape.com/api/og?type=drug&title=MEDI7183%20low%20dose&subtitle=MEDI7183%20low%20dose%20%C2%B7%20AstraZeneca&badge=phase%202 MEDI7183 low dose MEDI7183 low dose · AstraZeneca https://druglandscape.com/drug/medi7183-medium-dose https://druglandscape.com/api/og?type=drug&title=MEDI7183%20medium%20dose&subtitle=MEDI7183%20medium%20dose%20%C2%B7%20AstraZeneca&badge=phase%202 MEDI7183 medium dose MEDI7183 medium dose · AstraZeneca https://druglandscape.com/drug/medi7247 https://druglandscape.com/api/og?type=drug&title=MEDI7247&subtitle=MEDI7247%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI7247 MEDI7247 · MedImmune LLC https://druglandscape.com/drug/medi7352-for-iv-infusion https://druglandscape.com/api/og?type=drug&title=MEDI7352%20for%20IV%20infusion&subtitle=MEDI7352%20for%20IV%20infusion%20%C2%B7%20AstraZeneca&badge=phase%201 MEDI7352 for IV infusion MEDI7352 for IV infusion · AstraZeneca https://druglandscape.com/drug/medi7734 https://druglandscape.com/api/og?type=drug&title=MEDI7734&subtitle=MEDI7734%20%C2%B7%20Amgen&badge=phase%201 MEDI7734 MEDI7734 · Amgen https://druglandscape.com/drug/medi7836-dose-1 https://druglandscape.com/api/og?type=drug&title=MEDI7836%20Dose%201&subtitle=MEDI7836%20Dose%201%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI7836 Dose 1 MEDI7836 Dose 1 · MedImmune LLC https://druglandscape.com/drug/medi8111 https://druglandscape.com/api/og?type=drug&title=MEDI8111&subtitle=MEDI8111%20%C2%B7%20AstraZeneca&badge=phase%201 MEDI8111 MEDI8111 · AstraZeneca https://druglandscape.com/drug/medi8367 https://druglandscape.com/api/og?type=drug&title=MEDI8367&subtitle=MEDI8367%20%C2%B7%20AstraZeneca&badge=phase%201 MEDI8367 MEDI8367 · AstraZeneca https://druglandscape.com/drug/medi8897-intramuscular https://druglandscape.com/api/og?type=drug&title=MEDI8897%20Intramuscular&subtitle=MEDI8897%20Intramuscular%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI8897 Intramuscular MEDI8897 Intramuscular · MedImmune LLC https://druglandscape.com/drug/medi8897-intravenous https://druglandscape.com/api/og?type=drug&title=MEDI8897%20Intravenous&subtitle=MEDI8897%20Intravenous%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI8897 Intravenous MEDI8897 Intravenous · MedImmune LLC https://druglandscape.com/drug/medi9090 https://druglandscape.com/api/og?type=drug&title=MEDI9090&subtitle=MEDI9090%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI9090 MEDI9090 · MedImmune LLC https://druglandscape.com/drug/medi9314 https://druglandscape.com/api/og?type=drug&title=MEDI9314&subtitle=MEDI9314%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEDI9314 MEDI9314 · MedImmune LLC https://druglandscape.com/drug/medi9929 https://druglandscape.com/api/og?type=drug&title=MEDI9929&subtitle=MEDI9929%20%C2%B7%20AstraZeneca&badge=phase%202 MEDI9929 MEDI9929 · AstraZeneca https://druglandscape.com/drug/medialipide-20-perfusion https://druglandscape.com/api/og?type=drug&title=Medialipide%2020%25%20perfusion&subtitle=Medialipide%2020%25%20perfusion%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 Medialipide 20% perfusion Medialipide 20% perfusion · Hospices Civils de Lyon https://druglandscape.com/drug/median-dose-prt042-nasal-spray https://druglandscape.com/api/og?type=drug&title=median%20Dose%20PRT042%20nasal%20spray&subtitle=median%20Dose%20PRT042%20nasal%20spray%20%C2%B7%20Sichuan%20Purity%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%202 median Dose PRT042 nasal spray median Dose PRT042 nasal spray · Sichuan Purity Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/median-dose-vc004-capsules https://druglandscape.com/api/og?type=drug&title=Median%20Dose%20VC004%20Capsules&subtitle=Median%20Dose%20VC004%20Capsules%20%C2%B7%20Jiangsu%20vcare%20pharmaceutical%20technology%20co.%2C%20LTD&badge=phase%201 Median Dose VC004 Capsules Median Dose VC004 Capsules · Jiangsu vcare pharmaceutical technology co., LTD https://druglandscape.com/drug/medical-glaucoma-treatment https://druglandscape.com/api/og?type=drug&title=MEDICAL%20GLAUCOMA%20TREATMENT&subtitle=MEDICAL%20GLAUCOMA%20TREATMENT%20%C2%B7%20Xerencia%20de%20Xesti%C3%B3n%20Integrada%20de%20Ferrol&badge=phase%201 MEDICAL GLAUCOMA TREATMENT MEDICAL GLAUCOMA TREATMENT · Xerencia de Xestión Integrada de Ferrol https://druglandscape.com/drug/medical-management https://druglandscape.com/api/og?type=drug&title=Medical%20Management&subtitle=Medical%20Management%20%C2%B7%20CVRx%2C%20Inc.&badge=phase%202 Medical Management Medical Management · CVRx, Inc. https://druglandscape.com/drug/medical-standard-treatment https://druglandscape.com/api/og?type=drug&title=Medical%20standard%20treatment&subtitle=Medical%20standard%20treatment%20%C2%B7%20Universidad%20de%20Granada&badge=phase%201 Medical standard treatment Medical standard treatment · Universidad de Granada https://druglandscape.com/drug/medical-treatment-alone https://druglandscape.com/api/og?type=drug&title=Medical%20treatment%20alone&subtitle=Medical%20treatment%20alone%20%C2%B7%20Barts%20%26%20The%20London%20NHS%20Trust&badge=phase%201 Medical treatment alone Medical treatment alone · Barts & The London NHS Trust https://druglandscape.com/drug/medicated-2-atorvastatin-dentifrice https://druglandscape.com/api/og?type=drug&title=Medicated%202%25%20atorvastatin%20dentifrice&subtitle=Medicated%202%25%20atorvastatin%20dentifrice%20%C2%B7%20Universidad%20de%20los%20Andes%2C%20Chile&badge=phase%202 Medicated 2% atorvastatin dentifrice Medicated 2% atorvastatin dentifrice · Universidad de los Andes, Chile https://druglandscape.com/drug/medication-other https://druglandscape.com/api/og?type=drug&title=Medication%20Other&subtitle=Medication%20Other%20%C2%B7%20Praxis%20f%C3%BCr%20kleine%20und%20grosse%20Leute&badge=phase%202 Medication Other Medication Other · Praxis für kleine und grosse Leute https://druglandscape.com/drug/medication-review-and-deprescribing https://druglandscape.com/api/og?type=drug&title=medication%20review%20and%20deprescribing&subtitle=medication%20review%20and%20deprescribing%20%C2%B7%20Regione%20del%20Veneto%20-%20AULSS%20n.%207%20Pedemontana&badge=phase%202 medication review and deprescribing medication review and deprescribing · Regione del Veneto - AULSS n. 7 Pedemontana https://druglandscape.com/drug/medication-use-during-pregnancy https://druglandscape.com/api/og?type=drug&title=Medication%20use%20during%20pregnancy&subtitle=Medication%20use%20during%20pregnancy%20%C2%B7%20KU%20Leuven&badge=phase%202 Medication use during pregnancy Medication use during pregnancy · KU Leuven https://druglandscape.com/drug/medications-used-in-addition-to-hypnosis https://druglandscape.com/api/og?type=drug&title=Medications%20used%20in%20addition%20to%20hypnosis&subtitle=Medications%20used%20in%20addition%20to%20hypnosis%20%C2%B7%20Fondation%20H%C3%B4pital%20Saint-Joseph&badge=phase%201 Medications used in addition to hypnosis Medications used in addition to hypnosis · Fondation Hôpital Saint-Joseph https://druglandscape.com/drug/medium-dose-for-15-hpv-vaccine https://druglandscape.com/api/og?type=drug&title=Medium%20dose%20for%2015-HPV%20vaccine&subtitle=Medium%20dose%20for%2015-HPV%20vaccine%20%C2%B7%20Shanghai%20Bovax%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%202 Medium dose for 15-HPV vaccine Medium dose for 15-HPV vaccine · Shanghai Bovax Biotechnology Co., Ltd. https://druglandscape.com/drug/medium-dose-grt6005 https://druglandscape.com/api/og?type=drug&title=Medium%20Dose%20GRT6005&subtitle=Medium%20Dose%20GRT6005%20%C2%B7%20Tris%20Pharma%2C%20Inc.&badge=phase%202 Medium Dose GRT6005 Medium Dose GRT6005 · Tris Pharma, Inc. https://druglandscape.com/drug/medium-dose-hsk55718 https://druglandscape.com/api/og?type=drug&title=Medium%20Dose%20HSK55718&subtitle=Medium%20Dose%20HSK55718%20%C2%B7%20Yingyong%20Zhou%2CMD%2CPhD&badge=phase%202 Medium Dose HSK55718 Medium Dose HSK55718 · Yingyong Zhou,MD,PhD https://druglandscape.com/drug/medium-dose-lactin-v-applicator https://druglandscape.com/api/og?type=drug&title=Medium%20dose%20LACTIN-V%20applicator&subtitle=Medium%20dose%20LACTIN-V%20applicator%20%C2%B7%20Osel%2C%20Inc.&badge=phase%201 Medium dose LACTIN-V applicator Medium dose LACTIN-V applicator · Osel, Inc. https://druglandscape.com/drug/medium-dose-of-quadrivalent-vlp-vaccine https://druglandscape.com/api/og?type=drug&title=Medium%20dose%20of%20quadrivalent%20VLP%20vaccine&subtitle=Medium%20dose%20of%20quadrivalent%20VLP%20vaccine%20%C2%B7%20Medicago&badge=phase%202 Medium dose of quadrivalent VLP vaccine Medium dose of quadrivalent VLP vaccine · Medicago https://druglandscape.com/drug/medium-dose-strep-a-alum https://druglandscape.com/api/og?type=drug&title=Medium%20dose%20Strep%20A%20Alum&subtitle=Medium%20dose%20Strep%20A%20Alum%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Medium dose Strep A Alum Medium dose Strep A Alum · GlaxoSmithKline https://druglandscape.com/drug/medium-dose-strep-a-as37 https://druglandscape.com/api/og?type=drug&title=Medium%20dose%20Strep%20A%20AS37&subtitle=Medium%20dose%20Strep%20A%20AS37%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Medium dose Strep A AS37 Medium dose Strep A AS37 · GlaxoSmithKline https://druglandscape.com/drug/medium-dose-tbs-2 https://druglandscape.com/api/og?type=drug&title=Medium%20dose%20TBS-2&subtitle=Medium%20dose%20TBS-2%20%C2%B7%20Acerus%20Pharmaceuticals%20Corporation&badge=phase%202 Medium dose TBS-2 Medium dose TBS-2 · Acerus Pharmaceuticals Corporation https://druglandscape.com/drug/medium-dose-tso https://druglandscape.com/api/og?type=drug&title=Medium%20dose%20TSO&subtitle=Medium%20dose%20TSO%20%C2%B7%20Dr.%20Falk%20Pharma%20GmbH&badge=phase%202 Medium dose TSO Medium dose TSO · Dr. Falk Pharma GmbH https://druglandscape.com/drug/medium-dose-vis649 https://druglandscape.com/api/og?type=drug&title=Medium%20Dose-VIS649&subtitle=Medium%20Dose-VIS649%20%C2%B7%20Visterra%2C%20Inc.&badge=phase%202 Medium Dose-VIS649 Medium Dose-VIS649 · Visterra, Inc. https://druglandscape.com/drug/medium-high-influenza-virus https://druglandscape.com/api/og?type=drug&title=Medium%20-%20High%20Influenza%20virus&subtitle=Medium%20-%20High%20Influenza%20virus%20%C2%B7%20Hvivo&badge=phase%201 Medium - High Influenza virus Medium - High Influenza virus · Hvivo https://druglandscape.com/drug/medium-low-titre-influenza-virus https://druglandscape.com/api/og?type=drug&title=Medium%20Low%20Titre%20Influenza%20virus&subtitle=Medium%20Low%20Titre%20Influenza%20virus%20%C2%B7%20Hvivo&badge=phase%201 Medium Low Titre Influenza virus Medium Low Titre Influenza virus · Hvivo https://druglandscape.com/drug/mee-hu-medicus https://druglandscape.com/api/og?type=drug&title=MEE-HU%20Medicus&subtitle=MEE-HU%20Medicus%20%C2%B7%20Dr.%20Ahmed%20Ismail&badge=phase%202 MEE-HU Medicus MEE-HU Medicus · Dr. Ahmed Ismail https://druglandscape.com/drug/mefanamic-acid https://druglandscape.com/api/og?type=drug&title=Mefanamic%20Acid&subtitle=Mefanamic%20Acid%20%C2%B7%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 Mefanamic Acid Mefanamic Acid · Haisco Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/megace-f https://druglandscape.com/api/og?type=drug&title=Megace%20F&subtitle=Megace%20F%20%C2%B7%20Boryung%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 Megace F Megace F · Boryung Pharmaceutical Co., Ltd https://druglandscape.com/drug/megace-os https://druglandscape.com/api/og?type=drug&title=Megace%20OS&subtitle=Megace%20OS%20%C2%B7%20Boryung%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 Megace OS Megace OS · Boryung Pharmaceutical Co., Ltd https://druglandscape.com/drug/megf0444a https://druglandscape.com/api/og?type=drug&title=MEGF0444A&subtitle=MEGF0444A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 MEGF0444A MEGF0444A · Genentech, Inc. https://druglandscape.com/drug/meglumine-sodium-succinate https://druglandscape.com/api/og?type=drug&title=Meglumine%20Sodium%20Succinate&subtitle=Meglumine%20Sodium%20Succinate%20%C2%B7%20POLYSAN%20Scientific%20%26%20Technological%20Pharmaceutical%20Company&badge=phase%202 Meglumine Sodium Succinate Meglumine Sodium Succinate · POLYSAN Scientific & Technological Pharmaceutical Company https://druglandscape.com/drug/mehd7945a https://druglandscape.com/api/og?type=drug&title=MEHD7945A&subtitle=MEHD7945A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 MEHD7945A MEHD7945A · Genentech, Inc. https://druglandscape.com/drug/meid5083-with-durvalumab-or-tremelimumab https://druglandscape.com/api/og?type=drug&title=MEID5083%20with%20Durvalumab%20or%20Tremelimumab&subtitle=MEID5083%20with%20Durvalumab%20or%20Tremelimumab%20%C2%B7%20MedImmune%20LLC&badge=phase%201 MEID5083 with Durvalumab or Tremelimumab MEID5083 with Durvalumab or Tremelimumab · MedImmune LLC https://druglandscape.com/drug/mejoral-500-tablets https://druglandscape.com/api/og?type=drug&title=Mejoral%C2%AE%20500%20Tablets&subtitle=Mejoral%C2%AE%20500%20Tablets%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Mejoral® 500 Tablets Mejoral® 500 Tablets · GlaxoSmithKline https://druglandscape.com/drug/mek-inhibitor https://druglandscape.com/api/og?type=drug&title=MEK%20inhibitor&subtitle=MEK%20inhibitor%20%C2%B7%20Craig%20L%20Slingluff%2C%20Jr&badge=phase%202 MEK inhibitor MEK inhibitor · Craig L Slingluff, Jr https://druglandscape.com/drug/melan-a-vlp-vaccine-imp321-adjuvant https://druglandscape.com/api/og?type=drug&title=Melan-A%20VLP%20vaccine%2C%20IMP321%20adjuvant&subtitle=Melan-A%20VLP%20vaccine%2C%20IMP321%20adjuvant%20%C2%B7%20Prof.%20Serge%20Leyvraz&badge=phase%201 Melan-A VLP vaccine, IMP321 adjuvant Melan-A VLP vaccine, IMP321 adjuvant · Prof. Serge Leyvraz https://druglandscape.com/drug/melanoma-helper-peptide-vaccine https://druglandscape.com/api/og?type=drug&title=melanoma%20helper%20peptide%20vaccine&subtitle=melanoma%20helper%20peptide%20vaccine%20%C2%B7%20Craig%20L%20Slingluff%2C%20Jr&badge=phase%202 melanoma helper peptide vaccine melanoma helper peptide vaccine · Craig L Slingluff, Jr https://druglandscape.com/drug/melatonin-intravenous https://druglandscape.com/api/og?type=drug&title=Melatonin%20intravenous&subtitle=Melatonin%20intravenous%20%C2%B7%20Pharmamel%20S.L.&badge=phase%202 Melatonin intravenous Melatonin intravenous · Pharmamel S.L. https://druglandscape.com/drug/meloxicam-0-09 https://druglandscape.com/api/og?type=drug&title=Meloxicam%200.09%25&subtitle=Meloxicam%200.09%25%20%C2%B7%20Express%20Specialty%20Pharmacy&badge=phase%202 Meloxicam 0.09% Meloxicam 0.09% · Express Specialty Pharmacy https://druglandscape.com/drug/meloxicam-15-milligram https://druglandscape.com/api/og?type=drug&title=Meloxicam%2015%20milligram&subtitle=Meloxicam%2015%20milligram%20%C2%B7%20InnovaGyn%2C%20Inc.&badge=phase%202 Meloxicam 15 milligram Meloxicam 15 milligram · InnovaGyn, Inc. https://druglandscape.com/drug/melperone-hcl https://druglandscape.com/api/og?type=drug&title=Melperone%20HCl&subtitle=Melperone%20HCl%20%C2%B7%20Lundbeck%20LLC&badge=phase%202 Melperone HCl Melperone HCl · Lundbeck LLC https://druglandscape.com/drug/melphalan-thalidomide-and-dexamethasone https://druglandscape.com/api/og?type=drug&title=melphalan%2C%20thalidomide%20and%20dexamethasone&subtitle=melphalan%2C%20thalidomide%20and%20dexamethasone%20%C2%B7%20FDA%20Office%20of%20Orphan%20Products%20Development&badge=phase%202 melphalan, thalidomide and dexamethasone melphalan, thalidomide and dexamethasone · FDA Office of Orphan Products Development https://druglandscape.com/drug/membrane-bound-cytokine-modified-til https://druglandscape.com/api/og?type=drug&title=Membrane%20Bound%20Cytokine%20Modified%20TIL&subtitle=Membrane%20Bound%20Cytokine%20Modified%20TIL%20%C2%B7%20Shanghai%20Juncell%20Therapeutics&badge=phase%201 Membrane Bound Cytokine Modified TIL Membrane Bound Cytokine Modified TIL · Shanghai Juncell Therapeutics https://druglandscape.com/drug/memp1972a https://druglandscape.com/api/og?type=drug&title=MEMP1972A&subtitle=MEMP1972A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 MEMP1972A MEMP1972A · Genentech, Inc. https://druglandscape.com/drug/men2312 https://druglandscape.com/api/og?type=drug&title=MEN2312&subtitle=MEN2312%20%C2%B7%20Stemline%20Therapeutics%2C%20Inc.&badge=phase%201 MEN2312 MEN2312 · Stemline Therapeutics, Inc. https://druglandscape.com/drug/menabcyw-conjugate-vaccine https://druglandscape.com/api/og?type=drug&title=MenABCYW%20conjugate%20vaccine&subtitle=MenABCYW%20conjugate%20vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 MenABCYW conjugate vaccine MenABCYW conjugate vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/menactra-meningococcal-polysaccharide-diphtheria-conjugate https://druglandscape.com/api/og?type=drug&title=Menactra%C2%AE%3A%20Meningococcal%20Polysaccharide%20Diphtheria%20Conjugate&subtitle=Menactra%C2%AE%3A%20Meningococcal%20Polysaccharide%20Diphtheria%20Conjugate%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%202 Menactra®: Meningococcal Polysaccharide Diphtheria Conjugate Menactra®: Meningococcal Polysaccharide Diphtheria Conjugate · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/menactra-polysaccharide-diphtheria-toxoid-conjugate https://druglandscape.com/api/og?type=drug&title=Menactra%C2%AE%3A%20Polysaccharide%20Diphtheria%20Toxoid%20Conjugate&subtitle=Menactra%C2%AE%3A%20Polysaccharide%20Diphtheria%20Toxoid%20Conjugate%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Menactra®: Polysaccharide Diphtheria Toxoid Conjugate Menactra®: Polysaccharide Diphtheria Toxoid Conjugate · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/menacwy-liquid https://druglandscape.com/api/og?type=drug&title=MenACWY%20liquid&subtitle=MenACWY%20liquid%20%C2%B7%20GlaxoSmithKline&badge=phase%202 MenACWY liquid MenACWY liquid · GlaxoSmithKline https://druglandscape.com/drug/menc-crm-emv https://druglandscape.com/api/og?type=drug&title=MenC-CRM%20EMV&subtitle=MenC-CRM%20EMV%20%C2%B7%20Novartis&badge=phase%202 MenC-CRM EMV MenC-CRM EMV · Novartis https://druglandscape.com/drug/menc-crm-liq https://druglandscape.com/api/og?type=drug&title=MenC-CRM%20LIQ&subtitle=MenC-CRM%20LIQ%20%C2%B7%20Novartis&badge=phase%202 MenC-CRM LIQ MenC-CRM LIQ · Novartis https://druglandscape.com/drug/menc-crm-ros https://druglandscape.com/api/og?type=drug&title=MenC-CRM%20ROS&subtitle=MenC-CRM%20ROS%20%C2%B7%20Novartis&badge=phase%202 MenC-CRM ROS MenC-CRM ROS · Novartis https://druglandscape.com/drug/menc-tt https://druglandscape.com/api/og?type=drug&title=MenC-TT&subtitle=MenC-TT%20%C2%B7%20GlaxoSmithKline&badge=phase%202 MenC-TT MenC-TT · GlaxoSmithKline https://druglandscape.com/drug/meningococcal-abcwy https://druglandscape.com/api/og?type=drug&title=Meningococcal%20ABCWY&subtitle=Meningococcal%20ABCWY%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Meningococcal ABCWY Meningococcal ABCWY · GlaxoSmithKline https://druglandscape.com/drug/meningococcal-abcwy-vaccine https://druglandscape.com/api/og?type=drug&title=Meningococcal%20ABCWY%20Vaccine&subtitle=Meningococcal%20ABCWY%20Vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Meningococcal ABCWY Vaccine Meningococcal ABCWY Vaccine · GlaxoSmithKline https://druglandscape.com/drug/meningococcal-b-recombinant-vaccine https://druglandscape.com/api/og?type=drug&title=Meningococcal%20B%20Recombinant%20vaccine&subtitle=Meningococcal%20B%20Recombinant%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Meningococcal B Recombinant vaccine Meningococcal B Recombinant vaccine · GlaxoSmithKline https://druglandscape.com/drug/meningococcal-b-vaccine-nz https://druglandscape.com/api/og?type=drug&title=Meningococcal%20B%20Vaccine%20NZ&subtitle=Meningococcal%20B%20Vaccine%20NZ%20%C2%B7%20Public%20Health%20England&badge=phase%202 Meningococcal B Vaccine NZ Meningococcal B Vaccine NZ · Public Health England https://druglandscape.com/drug/meningococcal-polysaccharide-tetanus-protein-conjugate https://druglandscape.com/api/og?type=drug&title=Meningococcal%20Polysaccharide%20Tetanus%20Protein%20Conjugate&subtitle=Meningococcal%20Polysaccharide%20Tetanus%20Protein%20Conjugate%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Meningococcal Polysaccharide Tetanus Protein Conjugate Meningococcal Polysaccharide Tetanus Protein Conjugate · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/meningococcal-vaccine-134612 https://druglandscape.com/api/og?type=drug&title=Meningococcal%20vaccine%20134612&subtitle=Meningococcal%20vaccine%20134612%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Meningococcal vaccine 134612 Meningococcal vaccine 134612 · GlaxoSmithKline https://druglandscape.com/drug/menisc-t https://druglandscape.com/api/og?type=drug&title=MENISC-T&subtitle=MENISC-T%20%C2%B7%20TBF%20Genie%20Tissulaire&badge=phase%202 MENISC-T MENISC-T · TBF Genie Tissulaire https://druglandscape.com/drug/menscs-transplantation https://druglandscape.com/api/og?type=drug&title=MenSCs%20transplantation&subtitle=MenSCs%20transplantation%20%C2%B7%20S-Evans%20Biosciences%20Co.%2C%20Ltd.&badge=phase%201 MenSCs transplantation MenSCs transplantation · S-Evans Biosciences Co., Ltd. https://druglandscape.com/drug/menstrual-blood-stem-cells https://druglandscape.com/api/og?type=drug&title=Menstrual%20blood%20stem%20cells&subtitle=Menstrual%20blood%20stem%20cells%20%C2%B7%20S-Evans%20Biosciences%20Co.%2C%20Ltd.&badge=phase%201 Menstrual blood stem cells Menstrual blood stem cells · S-Evans Biosciences Co., Ltd. https://druglandscape.com/drug/menthol-nf-5-00 https://druglandscape.com/api/og?type=drug&title=Menthol%2C%20NF%205.00%20%25&subtitle=Menthol%2C%20NF%205.00%20%25%20%C2%B7%20Express%20Specialty%20Pharmacy&badge=phase%202 Menthol, NF 5.00 % Menthol, NF 5.00 % · Express Specialty Pharmacy https://druglandscape.com/drug/menthol-only-gel https://druglandscape.com/api/og?type=drug&title=Menthol%20Only%20Gel&subtitle=Menthol%20Only%20Gel%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Menthol Only Gel Menthol Only Gel · GlaxoSmithKline https://druglandscape.com/drug/mephedrone-and-alcohol https://druglandscape.com/api/og?type=drug&title=Mephedrone%20and%20alcohol&subtitle=Mephedrone%20and%20alcohol%20%C2%B7%20Parc%20de%20Salut%20Mar&badge=phase%201 Mephedrone and alcohol Mephedrone and alcohol · Parc de Salut Mar https://druglandscape.com/drug/mepolizumab-75 https://druglandscape.com/api/og?type=drug&title=Mepolizumab%2075&subtitle=Mepolizumab%2075%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Mepolizumab 75 Mepolizumab 75 · GlaxoSmithKline https://druglandscape.com/drug/mepolizumab-750 https://druglandscape.com/api/og?type=drug&title=Mepolizumab%20750&subtitle=Mepolizumab%20750%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Mepolizumab 750 Mepolizumab 750 · GlaxoSmithKline https://druglandscape.com/drug/meropenem-fl058 https://druglandscape.com/api/og?type=drug&title=Meropenem-%20FL058&subtitle=Meropenem-%20FL058%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Meropenem- FL058 Meropenem- FL058 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/meropenem-pralubactam https://druglandscape.com/api/og?type=drug&title=Meropenem-Pralubactam&subtitle=Meropenem-Pralubactam%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Meropenem-Pralubactam Meropenem-Pralubactam · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/mesalamine-enema https://druglandscape.com/api/og?type=drug&title=Mesalamine%20Enema&subtitle=Mesalamine%20Enema%20%C2%B7%20Altheus%20Therapeutics%2C%20Inc.&badge=phase%202 Mesalamine Enema Mesalamine Enema · Altheus Therapeutics, Inc. https://druglandscape.com/drug/mesalamine-oral-product https://druglandscape.com/api/og?type=drug&title=Mesalamine%20Oral%20Product&subtitle=Mesalamine%20Oral%20Product%20%C2%B7%20Dr.%20Falk%20Pharma%20GmbH&badge=phase%202 Mesalamine Oral Product Mesalamine Oral Product · Dr. Falk Pharma GmbH https://druglandscape.com/drug/mesenchymal-progenitor-cells https://druglandscape.com/api/og?type=drug&title=Mesenchymal%20progenitor%20cells&subtitle=Mesenchymal%20progenitor%20cells%20%C2%B7%20Shanghai%20AbelZeta%20Ltd.&badge=phase%202 Mesenchymal progenitor cells Mesenchymal progenitor cells · Shanghai AbelZeta Ltd. https://druglandscape.com/drug/mesenchymal-stem-cell-therapy https://druglandscape.com/api/og?type=drug&title=Mesenchymal%20stem%20cell%20therapy&subtitle=Mesenchymal%20stem%20cell%20therapy%20%C2%B7%20UNICEF&badge=phase%201 Mesenchymal stem cell therapy Mesenchymal stem cell therapy · UNICEF https://druglandscape.com/drug/mesenchymal-stem-cells-high-dose-group https://druglandscape.com/api/og?type=drug&title=Mesenchymal%20stem%20cells%20high-dose%20group&subtitle=Mesenchymal%20stem%20cells%20high-dose%20group%20%C2%B7%20Shanghai%20AbelZeta%20Ltd.&badge=phase%201 Mesenchymal stem cells high-dose group Mesenchymal stem cells high-dose group · Shanghai AbelZeta Ltd. https://druglandscape.com/drug/mesenchymal-stem-cells-mid-dose-group https://druglandscape.com/api/og?type=drug&title=Mesenchymal%20stem%20cells%20mid-dose%20group&subtitle=Mesenchymal%20stem%20cells%20mid-dose%20group%20%C2%B7%20Shanghai%20AbelZeta%20Ltd.&badge=phase%201 Mesenchymal stem cells mid-dose group Mesenchymal stem cells mid-dose group · Shanghai AbelZeta Ltd. https://druglandscape.com/drug/mesenchymal-stem-cells-with-ocn-19 https://druglandscape.com/api/og?type=drug&title=mesenchymal%20stem%20cells%20with%20OCN-19&subtitle=mesenchymal%20stem%20cells%20with%20OCN-19%20%C2%B7%20Lu%20jin%20%EF%BC%8CMD&badge=phase%202 mesenchymal stem cells with OCN-19 mesenchymal stem cells with OCN-19 · Lu jin ，MD https://druglandscape.com/drug/mesenchymal-stromal-cell-therapy https://druglandscape.com/api/og?type=drug&title=Mesenchymal%20stromal%20cell%20therapy&subtitle=Mesenchymal%20stromal%20cell%20therapy%20%C2%B7%20R.P.Herrmann&badge=phase%202 Mesenchymal stromal cell therapy Mesenchymal stromal cell therapy · R.P.Herrmann https://druglandscape.com/drug/mesenchymoangioblast-derived-mesenchymal-stem-cells https://druglandscape.com/api/og?type=drug&title=Mesenchymoangioblast-derived%20mesenchymal%20stem%20cells&subtitle=Mesenchymoangioblast-derived%20mesenchymal%20stem%20cells%20%C2%B7%20Cynata%20Therapeutics%20Limited&badge=phase%201 Mesenchymoangioblast-derived mesenchymal stem cells Mesenchymoangioblast-derived mesenchymal stem cells · Cynata Therapeutics Limited https://druglandscape.com/drug/mesocancervac https://druglandscape.com/api/og?type=drug&title=MesoCancerVac&subtitle=MesoCancerVac%20%C2%B7%20Erasmus%20Medical%20Center&badge=phase%201 MesoCancerVac MesoCancerVac · Erasmus Medical Center https://druglandscape.com/drug/mesopher https://druglandscape.com/api/og?type=drug&title=MesoPher&subtitle=MesoPher%20%C2%B7%20Joachim%20Aerts%2C%20MD%20PhD&badge=phase%202 MesoPher MesoPher · Joachim Aerts, MD PhD https://druglandscape.com/drug/met-3 https://druglandscape.com/api/og?type=drug&title=MET-3&subtitle=MET-3%20%C2%B7%20NuBiyota&badge=phase%201 MET-3 MET-3 · NuBiyota https://druglandscape.com/drug/met409-active https://druglandscape.com/api/og?type=drug&title=MET409%20Active&subtitle=MET409%20Active%20%C2%B7%20Metacrine%2C%20Inc.&badge=phase%202 MET409 Active MET409 Active · Metacrine, Inc. https://druglandscape.com/drug/met642 https://druglandscape.com/api/og?type=drug&title=MET642&subtitle=MET642%20%C2%B7%20Metacrine%2C%20Inc.&badge=phase%202 MET642 MET642 · Metacrine, Inc. https://druglandscape.com/drug/metabolic-profile https://druglandscape.com/api/og?type=drug&title=Metabolic%20profile&subtitle=Metabolic%20profile%20%C2%B7%20Monica%20Levy%20Andersen&badge=phase%201 Metabolic profile Metabolic profile · Monica Levy Andersen https://druglandscape.com/drug/metal-allergen-epicutaneous-patch https://druglandscape.com/api/og?type=drug&title=Metal%20Allergen%20Epicutaneous%20Patch&subtitle=Metal%20Allergen%20Epicutaneous%20Patch%20%C2%B7%20Allerderm&badge=phase%202 Metal Allergen Epicutaneous Patch Metal Allergen Epicutaneous Patch · Allerderm https://druglandscape.com/drug/metatinib-tromethamine https://druglandscape.com/api/og?type=drug&title=Metatinib%20Tromethamine&subtitle=Metatinib%20Tromethamine%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Metatinib Tromethamine Metatinib Tromethamine · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/metenkephalin-ogf-opioid-growth-factor https://druglandscape.com/api/og?type=drug&title=metenkephalin%2C%20OGF-opioid%20growth%20factor&subtitle=metenkephalin%2C%20OGF-opioid%20growth%20factor%20%C2%B7%20Milton%20S.%20Hershey%20Medical%20Center&badge=phase%202 metenkephalin, OGF-opioid growth factor metenkephalin, OGF-opioid growth factor · Milton S. Hershey Medical Center https://druglandscape.com/drug/metformin-and-evogliptin https://druglandscape.com/api/og?type=drug&title=Metformin%20and%20Evogliptin&subtitle=Metformin%20and%20Evogliptin%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%202 Metformin and Evogliptin Metformin and Evogliptin · Dong-A ST Co., Ltd. https://druglandscape.com/drug/metformin-and-melatonin-gel https://druglandscape.com/api/og?type=drug&title=Metformin%20and%20melatonin%20gel&subtitle=Metformin%20and%20melatonin%20gel%20%C2%B7%20Amira%20ragab&badge=phase%202 Metformin and melatonin gel Metformin and melatonin gel · Amira ragab https://druglandscape.com/drug/metformin-and-rosuvastatin https://druglandscape.com/api/og?type=drug&title=Metformin%20and%20Rosuvastatin&subtitle=Metformin%20and%20Rosuvastatin%20%C2%B7%20Jeil%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Metformin and Rosuvastatin Metformin and Rosuvastatin · Jeil Pharmaceutical Co., Ltd. https://druglandscape.com/drug/metformin-and-rosuvastatin-seperately https://druglandscape.com/api/og?type=drug&title=%22Metformin%22%20and%20%22Rosuvastatin%22%20seperately&subtitle=%22Metformin%22%20and%20%22Rosuvastatin%22%20seperately%20%C2%B7%20Jeil%20Pharmaceutical%20Co.%2C%20Ltd.&badge=Marketed "Metformin" and "Rosuvastatin" seperately "Metformin" and "Rosuvastatin" seperately · Jeil Pharmaceutical Co., Ltd. https://druglandscape.com/drug/metformin-and-sulfonylurea https://druglandscape.com/api/og?type=drug&title=Metformin%20and%20Sulfonylurea&subtitle=Metformin%20and%20Sulfonylurea%20%C2%B7%20PhaseBio%20Pharmaceuticals%20Inc.&badge=phase%202 Metformin and Sulfonylurea Metformin and Sulfonylurea · PhaseBio Pharmaceuticals Inc. https://druglandscape.com/drug/metformin-eicosapentaenoate https://druglandscape.com/api/og?type=drug&title=Metformin%20Eicosapentaenoate&subtitle=Metformin%20Eicosapentaenoate%20%C2%B7%20Thetis%20Pharmaceuticals%20LLC&badge=phase%201 Metformin Eicosapentaenoate Metformin Eicosapentaenoate · Thetis Pharmaceuticals LLC https://druglandscape.com/drug/metformin-entecavir https://druglandscape.com/api/og?type=drug&title=Metformin%20%26%20Entecavir&subtitle=Metformin%20%26%20Entecavir%20%C2%B7%20Fu-Sheng%20Wang&badge=phase%201 Metformin & Entecavir Metformin & Entecavir · Fu-Sheng Wang https://druglandscape.com/drug/metformin-gel-30 https://druglandscape.com/api/og?type=drug&title=Metformin%20gel%2C%2030%25&subtitle=Metformin%20gel%2C%2030%25%20%C2%B7%20Jinnah%20Postgraduate%20Medical%20Centre&badge=phase%201 Metformin gel, 30% Metformin gel, 30% · Jinnah Postgraduate Medical Centre https://druglandscape.com/drug/metformin-hydrochloride-prolonged-release https://druglandscape.com/api/og?type=drug&title=Metformin%20hydrochloride%20prolonged%20release&subtitle=Metformin%20hydrochloride%20prolonged%20release%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Metformin hydrochloride prolonged release Metformin hydrochloride prolonged release · GlaxoSmithKline https://druglandscape.com/drug/metformin-immediate-release-tablet https://druglandscape.com/api/og?type=drug&title=Metformin%20Immediate-Release%20Tablet&subtitle=Metformin%20Immediate-Release%20Tablet%20%C2%B7%20Aspargo%20Labs%2C%20Inc&badge=phase%201 Metformin Immediate-Release Tablet Metformin Immediate-Release Tablet · Aspargo Labs, Inc https://druglandscape.com/drug/metformin-ir-tablets https://druglandscape.com/api/og?type=drug&title=Metformin%20IR%20tablets&subtitle=Metformin%20IR%20tablets%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Metformin IR tablets Metformin IR tablets · Janssen Research & Development, LLC https://druglandscape.com/drug/metformin-plus-chemotherapy https://druglandscape.com/api/og?type=drug&title=Metformin%20plus%20chemotherapy&subtitle=Metformin%20plus%20chemotherapy%20%C2%B7%20Hager%20salah%20el%20din&badge=phase%202 Metformin plus chemotherapy Metformin plus chemotherapy · Hager salah el din https://druglandscape.com/drug/metformin-s-707106-plus-metformin https://druglandscape.com/api/og?type=drug&title=Metformin%2C%20S-707106%20plus%20metformin&subtitle=Metformin%2C%20S-707106%20plus%20metformin%20%C2%B7%20Shionogi&badge=phase%201 Metformin, S-707106 plus metformin Metformin, S-707106 plus metformin · Shionogi https://druglandscape.com/drug/metformin-vi-0521-sitagliptan-probenecid https://druglandscape.com/api/og?type=drug&title=Metformin%2C%20VI-0521%2C%20Sitagliptan%2C%20Probenecid&subtitle=Metformin%2C%20VI-0521%2C%20Sitagliptan%2C%20Probenecid%20%C2%B7%20VIVUS%20LLC&badge=phase%201 Metformin, VI-0521, Sitagliptan, Probenecid Metformin, VI-0521, Sitagliptan, Probenecid · VIVUS LLC https://druglandscape.com/drug/methadone-pca https://druglandscape.com/api/og?type=drug&title=Methadone%20PCA&subtitle=Methadone%20PCA%20%C2%B7%20Fondazione%20IRCCS%20Istituto%20Nazionale%20dei%20Tumori%2C%20Milano&badge=phase%201 Methadone PCA Methadone PCA · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano https://druglandscape.com/drug/methotrexate-amneal https://druglandscape.com/api/og?type=drug&title=Methotrexate%20-%20Amneal&subtitle=Methotrexate%20-%20Amneal%20%C2%B7%20Amneal%20Pharmaceuticals%2C%20LLC&badge=phase%201 Methotrexate - Amneal Methotrexate - Amneal · Amneal Pharmaceuticals, LLC https://druglandscape.com/drug/methotrexate-and-temozolomide https://druglandscape.com/api/og?type=drug&title=Methotrexate%20and%20temozolomide&subtitle=Methotrexate%20and%20temozolomide%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Methotrexate and temozolomide Methotrexate and temozolomide · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/methotrexate-biodim https://druglandscape.com/api/og?type=drug&title=Methotrexate%20Biodim%C2%AE&subtitle=Methotrexate%20Biodim%C2%AE%20%C2%B7%20Crossject&badge=phase%201 Methotrexate Biodim® Methotrexate Biodim® · Crossject https://druglandscape.com/drug/methotrexate-dava https://druglandscape.com/api/og?type=drug&title=Methotrexate%20-%20DAVA&subtitle=Methotrexate%20-%20DAVA%20%C2%B7%20Amneal%20Pharmaceuticals%2C%20LLC&badge=phase%201 Methotrexate - DAVA Methotrexate - DAVA · Amneal Pharmaceuticals, LLC https://druglandscape.com/drug/methotrexate-leucovorin-and-bms-986142 https://druglandscape.com/api/og?type=drug&title=Methotrexate%2C%20Leucovorin%20and%20BMS-986142&subtitle=Methotrexate%2C%20Leucovorin%20and%20BMS-986142%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Methotrexate, Leucovorin and BMS-986142 Methotrexate, Leucovorin and BMS-986142 · Bristol-Myers Squibb https://druglandscape.com/drug/methotrexate-plus-folinic-acid-alone https://druglandscape.com/api/og?type=drug&title=Methotrexate%20plus%20folinic%20acid%20alone&subtitle=Methotrexate%20plus%20folinic%20acid%20alone%20%C2%B7%20Maher%20elesawi%20kamel%20elesawi&badge=phase%202 Methotrexate plus folinic acid alone Methotrexate plus folinic acid alone · Maher elesawi kamel elesawi https://druglandscape.com/drug/methotrexate-prefilled-pen https://druglandscape.com/api/og?type=drug&title=methotrexate%20prefilled%20pen&subtitle=methotrexate%20prefilled%20pen%20%C2%B7%20medac%20GmbH&badge=phase%203 methotrexate prefilled pen methotrexate prefilled pen · medac GmbH https://druglandscape.com/drug/methotrexate-procarbazine-vincristine-cytarabine https://druglandscape.com/api/og?type=drug&title=Methotrexate%20%2C%20procarbazine%20%2Cvincristine%20%2Ccytarabine&subtitle=Methotrexate%20%2C%20procarbazine%20%2Cvincristine%20%2Ccytarabine%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Methotrexate , procarbazine ,vincristine ,cytarabine Methotrexate , procarbazine ,vincristine ,cytarabine · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/methoxy-polyethylene-glycol-ep-mircera https://druglandscape.com/api/og?type=drug&title=methoxy%20polyethylene%20glycol-ep%20%5BMircera%5D&subtitle=methoxy%20polyethylene%20glycol-ep%20%5BMircera%5D%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 methoxy polyethylene glycol-ep [Mircera] methoxy polyethylene glycol-ep [Mircera] · Hoffmann-La Roche https://druglandscape.com/drug/methoxy-polyethyleneglycol-epoetin-beta https://druglandscape.com/api/og?type=drug&title=Methoxy-polyethyleneglycol%20epoetin%20beta&subtitle=Methoxy-polyethyleneglycol%20epoetin%20beta%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Methoxy-polyethyleneglycol epoetin beta Methoxy-polyethyleneglycol epoetin beta · Hoffmann-La Roche https://druglandscape.com/drug/methoxyethyl-etomidate-hydrochloride https://druglandscape.com/api/og?type=drug&title=Methoxyethyl%20Etomidate%20Hydrochloride&subtitle=Methoxyethyl%20Etomidate%20Hydrochloride%20%C2%B7%20Ahon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Methoxyethyl Etomidate Hydrochloride Methoxyethyl Etomidate Hydrochloride · Ahon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/methyl-donor https://druglandscape.com/api/og?type=drug&title=methyl%20donor&subtitle=methyl%20donor%20%C2%B7%20Harvard%20School%20of%20Public%20Health%20(HSPH)&badge=phase%201 methyl donor methyl donor · Harvard School of Public Health (HSPH) https://druglandscape.com/drug/methyl-p-plus-gwi-nutrient-formula https://druglandscape.com/api/og?type=drug&title=Methyl-P%20plus%20GWI%20Nutrient%20Formula&subtitle=Methyl-P%20plus%20GWI%20Nutrient%20Formula%20%C2%B7%20K-PAX%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Methyl-P plus GWI Nutrient Formula Methyl-P plus GWI Nutrient Formula · K-PAX Pharmaceuticals, Inc. https://druglandscape.com/drug/methyl-p-plus-nutrient-formula https://druglandscape.com/api/og?type=drug&title=Methyl-P%20plus%20Nutrient%20Formula&subtitle=Methyl-P%20plus%20Nutrient%20Formula%20%C2%B7%20K-PAX%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Methyl-P plus Nutrient Formula Methyl-P plus Nutrient Formula · K-PAX Pharmaceuticals, Inc. https://druglandscape.com/drug/methylaminolaevulinate-cream https://druglandscape.com/api/og?type=drug&title=Methylaminolaevulinate%20cream&subtitle=Methylaminolaevulinate%20cream%20%C2%B7%20Joint%20Authority%20for%20P%C3%A4ij%C3%A4t-H%C3%A4me%20Social%20and%20Health%20Care&badge=phase%201 Methylaminolaevulinate cream Methylaminolaevulinate cream · Joint Authority for Päijät-Häme Social and Health Care https://druglandscape.com/drug/methylene-blue-mmx-tablets https://druglandscape.com/api/og?type=drug&title=Methylene%20Blue%20MMX%20tablets&subtitle=Methylene%20Blue%20MMX%20tablets%20%C2%B7%20Cosmo%20Technologies%20Ltd&badge=phase%202 Methylene Blue MMX tablets Methylene Blue MMX tablets · Cosmo Technologies Ltd https://druglandscape.com/drug/methylenedioxymethamphetamine https://druglandscape.com/api/og?type=drug&title=methylenedioxymethamphetamine&subtitle=methylenedioxymethamphetamine%20%C2%B7%20HaEmek%20Medical%20Center%2C%20Israel&badge=phase%202 methylenedioxymethamphetamine methylenedioxymethamphetamine · HaEmek Medical Center, Israel https://druglandscape.com/drug/methylnaltrexone-treatment https://druglandscape.com/api/og?type=drug&title=Methylnaltrexone%20treatment&subtitle=Methylnaltrexone%20treatment%20%C2%B7%20Asbj%C3%B8rn%20Mohr%20Drewes&badge=phase%202 Methylnaltrexone treatment Methylnaltrexone treatment · Asbjørn Mohr Drewes https://druglandscape.com/drug/methylphenidate-pill https://druglandscape.com/api/og?type=drug&title=Methylphenidate%20Pill&subtitle=Methylphenidate%20Pill%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%202 Methylphenidate Pill Methylphenidate Pill · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/methylprednisolon-lidocaine https://druglandscape.com/api/og?type=drug&title=Methylprednisolon%2C%20Lidocaine&subtitle=Methylprednisolon%2C%20Lidocaine%20%C2%B7%20Satasairaala&badge=phase%201 Methylprednisolon, Lidocaine Methylprednisolon, Lidocaine · Satasairaala https://druglandscape.com/drug/methylprednisolone-iv https://druglandscape.com/api/og?type=drug&title=methylprednisolone%20IV&subtitle=methylprednisolone%20IV%20%C2%B7%20Rennes%20University%20Hospital&badge=phase%203 methylprednisolone IV methylprednisolone IV · Rennes University Hospital https://druglandscape.com/drug/metmab https://druglandscape.com/api/og?type=drug&title=MetMAb&subtitle=MetMAb%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 MetMAb MetMAb · Genentech, Inc. https://druglandscape.com/drug/metoprolol-and-pyronaridine-artesunate https://druglandscape.com/api/og?type=drug&title=Metoprolol%20and%20pyronaridine-artesunate&subtitle=Metoprolol%20and%20pyronaridine-artesunate%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 Metoprolol and pyronaridine-artesunate Metoprolol and pyronaridine-artesunate · Medicines for Malaria Venture https://druglandscape.com/drug/metoprolol-lopressor https://druglandscape.com/api/og?type=drug&title=Metoprolol-%20Lopressor&subtitle=Metoprolol-%20Lopressor%20%C2%B7%20AstraZeneca&badge=phase%201 Metoprolol- Lopressor Metoprolol- Lopressor · AstraZeneca https://druglandscape.com/drug/metoprolol-toprol-xl https://druglandscape.com/api/og?type=drug&title=Metoprolol-%20Toprol%20XL&subtitle=Metoprolol-%20Toprol%20XL%20%C2%B7%20AstraZeneca&badge=phase%201 Metoprolol- Toprol XL Metoprolol- Toprol XL · AstraZeneca https://druglandscape.com/drug/metoprolol-vs-diltiazem https://druglandscape.com/api/og?type=drug&title=Metoprolol%20vs%20Diltiazem&subtitle=Metoprolol%20vs%20Diltiazem%20%C2%B7%20RaeAnn%20Hirschy&badge=phase%202 Metoprolol vs Diltiazem Metoprolol vs Diltiazem · RaeAnn Hirschy https://druglandscape.com/drug/metronidazole-1-cream-top https://druglandscape.com/api/og?type=drug&title=Metronidazole%201%25%20Cream%2CTop&subtitle=Metronidazole%201%25%20Cream%2CTop%20%C2%B7%20Dr.dr.Irma%20Bernadette%2C%20SpKK%20(K)&badge=phase%201 Metronidazole 1% Cream,Top Metronidazole 1% Cream,Top · Dr.dr.Irma Bernadette, SpKK (K) https://druglandscape.com/drug/metronidazole-10-ointment https://druglandscape.com/api/og?type=drug&title=Metronidazole%2010%25%20ointment&subtitle=Metronidazole%2010%25%20ointment%20%C2%B7%20S.L.A.%20Pharma%20AG&badge=phase%202 Metronidazole 10% ointment Metronidazole 10% ointment · S.L.A. Pharma AG https://druglandscape.com/drug/metronidazole-actavis https://druglandscape.com/api/og?type=drug&title=Metronidazole%20Actavis&subtitle=Metronidazole%20Actavis%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Metronidazole Actavis Metronidazole Actavis · Hoffmann-La Roche https://druglandscape.com/drug/metronidazole-active-phase https://druglandscape.com/api/og?type=drug&title=Metronidazole%20active%20phase&subtitle=Metronidazole%20active%20phase%20%C2%B7%20Bel%C3%A9n%20Retamal-Valdes&badge=phase%201 Metronidazole active phase Metronidazole active phase · Belén Retamal-Valdes https://druglandscape.com/drug/metronidazole-after-srp https://druglandscape.com/api/og?type=drug&title=Metronidazole%20after%20SRP&subtitle=Metronidazole%20after%20SRP%20%C2%B7%20Bel%C3%A9n%20Retamal-Valdes&badge=phase%201 Metronidazole after SRP Metronidazole after SRP · Belén Retamal-Valdes https://druglandscape.com/drug/metronidazole-benzoate-oral-granules https://druglandscape.com/api/og?type=drug&title=Metronidazole%20benzoate%20oral%20granules&subtitle=Metronidazole%20benzoate%20oral%20granules%20%C2%B7%20Verisfield%20UK%20Ltd.%20Greek%20Branch&badge=phase%202 Metronidazole benzoate oral granules Metronidazole benzoate oral granules · Verisfield UK Ltd. Greek Branch https://druglandscape.com/drug/metronidazole-clindamycin-or-piperacillin-tazobactam https://druglandscape.com/api/og?type=drug&title=metronidazole%2C%20clindamycin%2C%20or%20piperacillin-tazobactam&subtitle=metronidazole%2C%20clindamycin%2C%20or%20piperacillin-tazobactam%20%C2%B7%20Michael%20Cohen-Wolkowiez&badge=phase%202 metronidazole, clindamycin, or piperacillin-tazobactam metronidazole, clindamycin, or piperacillin-tazobactam · Michael Cohen-Wolkowiez https://druglandscape.com/drug/metronidazole-drf1 https://druglandscape.com/api/og?type=drug&title=Metronidazole-DRF1&subtitle=Metronidazole-DRF1%20%C2%B7%20Dr.%20Reddy's%20Laboratories%20Limited&badge=phase%202 Metronidazole-DRF1 Metronidazole-DRF1 · Dr. Reddy's Laboratories Limited https://druglandscape.com/drug/metronidazole-drf2 https://druglandscape.com/api/og?type=drug&title=Metronidazole-DRF2&subtitle=Metronidazole-DRF2%20%C2%B7%20Dr.%20Reddy's%20Laboratories%20Limited&badge=phase%202 Metronidazole-DRF2 Metronidazole-DRF2 · Dr. Reddy's Laboratories Limited https://druglandscape.com/drug/metronidazole-during-srp https://druglandscape.com/api/og?type=drug&title=Metronidazole%20during%20SRP&subtitle=Metronidazole%20during%20SRP%20%C2%B7%20Bel%C3%A9n%20Retamal-Valdes&badge=phase%201 Metronidazole during SRP Metronidazole during SRP · Belén Retamal-Valdes https://druglandscape.com/drug/metronidazole-emulsion https://druglandscape.com/api/og?type=drug&title=Metronidazole%20Emulsion&subtitle=Metronidazole%20Emulsion%20%C2%B7%20LEO%20Pharma&badge=phase%202 Metronidazole Emulsion Metronidazole Emulsion · LEO Pharma https://druglandscape.com/drug/metronidazole-healing-phase https://druglandscape.com/api/og?type=drug&title=Metronidazole%20healing%20phase&subtitle=Metronidazole%20healing%20phase%20%C2%B7%20Bel%C3%A9n%20Retamal-Valdes&badge=phase%201 Metronidazole healing phase Metronidazole healing phase · Belén Retamal-Valdes https://druglandscape.com/drug/metronidazole-lotion https://druglandscape.com/api/og?type=drug&title=Metronidazole%20Lotion&subtitle=Metronidazole%20Lotion%20%C2%B7%20LEO%20Pharma&badge=phase%202 Metronidazole Lotion Metronidazole Lotion · LEO Pharma https://druglandscape.com/drug/metronidazole-topical-gel-1 https://druglandscape.com/api/og?type=drug&title=Metronidazole%20Topical%20Gel%201%25&subtitle=Metronidazole%20Topical%20Gel%201%25%20%C2%B7%20Sun%20Pharmaceutical%20Industries%2C%20Inc.&badge=phase%201 Metronidazole Topical Gel 1% Metronidazole Topical Gel 1% · Sun Pharmaceutical Industries, Inc. https://druglandscape.com/drug/metvixia-cream https://druglandscape.com/api/og?type=drug&title=METVIXIA%20Cream&subtitle=METVIXIA%20Cream%20%C2%B7%20Galderma%20R%26D&badge=phase%201 METVIXIA Cream METVIXIA Cream · Galderma R&D https://druglandscape.com/drug/metyrapone-capsules https://druglandscape.com/api/og?type=drug&title=Metyrapone%20Capsules&subtitle=Metyrapone%20Capsules%20%C2%B7%20Istituto%20Auxologico%20Italiano&badge=phase%202 Metyrapone Capsules Metyrapone Capsules · Istituto Auxologico Italiano https://druglandscape.com/drug/metyrapone-oxazepam https://druglandscape.com/api/og?type=drug&title=metyrapone%20%26%20oxazepam&subtitle=metyrapone%20%26%20oxazepam%20%C2%B7%20Embera%20NeuroTherapeutics%2C%20Inc.&badge=phase%201 metyrapone & oxazepam metyrapone & oxazepam · Embera NeuroTherapeutics, Inc. https://druglandscape.com/drug/mf59 https://druglandscape.com/api/og?type=drug&title=MF59&subtitle=MF59%20%C2%B7%20Ab%26B%20Bio-tech%20Co.%2C%20Ltd.JS&badge=phase%202 MF59 MF59 · Ab&B Bio-tech Co., Ltd.JS https://druglandscape.com/drug/mf59-eh5n1 https://druglandscape.com/api/og?type=drug&title=MF59-eH5N1&subtitle=MF59-eH5N1%20%C2%B7%20Novartis&badge=phase%202 MF59-eH5N1 MF59-eH5N1 · Novartis https://druglandscape.com/drug/mfolfox6-3-6-month https://druglandscape.com/api/og?type=drug&title=mFOLFOX6%203-6%20month&subtitle=mFOLFOX6%203-6%20month%20%C2%B7%20NRG%20Oncology&badge=phase%202 mFOLFOX6 3-6 month mFOLFOX6 3-6 month · NRG Oncology https://druglandscape.com/drug/mfolfoxiri https://druglandscape.com/api/og?type=drug&title=mFOLFOXIRI&subtitle=mFOLFOXIRI%20%C2%B7%20Sun%20Yat-sen%20University&badge=phase%203 mFOLFOXIRI mFOLFOXIRI · Sun Yat-sen University https://druglandscape.com/drug/mg-1 https://druglandscape.com/api/og?type=drug&title=MG-1&subtitle=MG-1%20%C2%B7%20PharmaKing&badge=phase%202 MG-1 MG-1 · PharmaKing https://druglandscape.com/drug/mg-98 https://druglandscape.com/api/og?type=drug&title=MG%2098&subtitle=MG%2098%20%C2%B7%20NCIC%20Clinical%20Trials%20Group&badge=phase%201 MG 98 MG 98 · NCIC Clinical Trials Group https://druglandscape.com/drug/mg-o-1002 https://druglandscape.com/api/og?type=drug&title=MG-O-1002&subtitle=MG-O-1002%20%C2%B7%20Theratocular%20Biotek%20Co.&badge=phase%202 MG-O-1002 MG-O-1002 · Theratocular Biotek Co. https://druglandscape.com/drug/mg005 https://druglandscape.com/api/og?type=drug&title=MG005&subtitle=MG005%20%C2%B7%20Metagone%20Biotech%20Inc.&badge=phase%201 MG005 MG005 · Metagone Biotech Inc. https://druglandscape.com/drug/mg01ci-extended-release-tablet https://druglandscape.com/api/og?type=drug&title=MG01CI%20extended-release%20tablet&subtitle=MG01CI%20extended-release%20tablet%20%C2%B7%20Alcobra%20Ltd.&badge=phase%202 MG01CI extended-release tablet MG01CI extended-release tablet · Alcobra Ltd. https://druglandscape.com/drug/mg1111 https://druglandscape.com/api/og?type=drug&title=MG1111&subtitle=MG1111%20%C2%B7%20GC%20Biopharma%20Corp&badge=phase%201 MG1111 MG1111 · GC Biopharma Corp https://druglandscape.com/drug/mg1113 https://druglandscape.com/api/og?type=drug&title=MG1113&subtitle=MG1113%20%C2%B7%20Green%20Cross%20Corporation&badge=phase%201 MG1113 MG1113 · Green Cross Corporation https://druglandscape.com/drug/mg1ma3 https://druglandscape.com/api/og?type=drug&title=MG1MA3&subtitle=MG1MA3%20%C2%B7%20Canadian%20Cancer%20Trials%20Group&badge=phase%201 MG1MA3 MG1MA3 · Canadian Cancer Trials Group https://druglandscape.com/drug/mg4101 https://druglandscape.com/api/og?type=drug&title=MG4101&subtitle=MG4101%20%C2%B7%20GC%20Cell%20Corporation&badge=phase%202 MG4101 MG4101 · GC Cell Corporation https://druglandscape.com/drug/mg56-mannosylated-1000-subcutaneous https://druglandscape.com/api/og?type=drug&title=MG56%20Mannosylated%201000%20subcutaneous&subtitle=MG56%20Mannosylated%201000%20subcutaneous%20%C2%B7%20Inmunotek%20S.L.&badge=phase%202 MG56 Mannosylated 1000 subcutaneous MG56 Mannosylated 1000 subcutaneous · Inmunotek S.L. https://druglandscape.com/drug/mg56-mannosylated-3000-subcutaneous https://druglandscape.com/api/og?type=drug&title=MG56%20Mannosylated%203000%20subcutaneous&subtitle=MG56%20Mannosylated%203000%20subcutaneous%20%C2%B7%20Inmunotek%20S.L.&badge=phase%202 MG56 Mannosylated 3000 subcutaneous MG56 Mannosylated 3000 subcutaneous · Inmunotek S.L. https://druglandscape.com/drug/mg56-mannosylated-500-sublingual https://druglandscape.com/api/og?type=drug&title=MG56%20Mannosylated%20500%20sublingual&subtitle=MG56%20Mannosylated%20500%20sublingual%20%C2%B7%20Inmunotek%20S.L.&badge=phase%202 MG56 Mannosylated 500 sublingual MG56 Mannosylated 500 sublingual · Inmunotek S.L. https://druglandscape.com/drug/mg56-mannosylated-5000-sublingual https://druglandscape.com/api/og?type=drug&title=MG56%20Mannosylated%205000%20sublingual&subtitle=MG56%20Mannosylated%205000%20sublingual%20%C2%B7%20Inmunotek%20S.L.&badge=phase%202 MG56 Mannosylated 5000 sublingual MG56 Mannosylated 5000 sublingual · Inmunotek S.L. https://druglandscape.com/drug/mgc026-dose-escalation https://druglandscape.com/api/og?type=drug&title=MGC026%20Dose%20Escalation&subtitle=MGC026%20Dose%20Escalation%20%C2%B7%20MacroGenics&badge=phase%201 MGC026 Dose Escalation MGC026 Dose Escalation · MacroGenics https://druglandscape.com/drug/mgc026-dose-for-expansion https://druglandscape.com/api/og?type=drug&title=MGC026%20Dose%20for%20Expansion&subtitle=MGC026%20Dose%20for%20Expansion%20%C2%B7%20MacroGenics&badge=phase%201 MGC026 Dose for Expansion MGC026 Dose for Expansion · MacroGenics https://druglandscape.com/drug/mgcd265 https://druglandscape.com/api/og?type=drug&title=MGCD265&subtitle=MGCD265%20%C2%B7%20Mirati%20Therapeutics%20Inc.&badge=phase%202 MGCD265 MGCD265 · Mirati Therapeutics Inc. https://druglandscape.com/drug/mgd007 https://druglandscape.com/api/og?type=drug&title=MGD007&subtitle=MGD007%20%C2%B7%20MacroGenics&badge=phase%201 MGD007 MGD007 · MacroGenics https://druglandscape.com/drug/mgd024 https://druglandscape.com/api/og?type=drug&title=MGD024&subtitle=MGD024%20%C2%B7%20MacroGenics&badge=phase%201 MGD024 MGD024 · MacroGenics https://druglandscape.com/drug/mgmtp140k-encoding-retroviral-vector https://druglandscape.com/api/og?type=drug&title=MGMTP140K-encoding%20retroviral%20vector&subtitle=MGMTP140K-encoding%20retroviral%20vector%20%C2%B7%20Stanton%20Gerson%20MD&badge=phase%201 MGMTP140K-encoding retroviral vector MGMTP140K-encoding retroviral vector · Stanton Gerson MD https://druglandscape.com/drug/mgn1601 https://druglandscape.com/api/og?type=drug&title=MGN1601&subtitle=MGN1601%20%C2%B7%20Mologen%20AG&badge=phase%201 MGN1601 MGN1601 · Mologen AG https://druglandscape.com/drug/mgr001 https://druglandscape.com/api/og?type=drug&title=MGR001&subtitle=MGR001%20%C2%B7%20Mylan%20Pharma%20UK%20Ltd.&badge=phase%201 MGR001 MGR001 · Mylan Pharma UK Ltd. https://druglandscape.com/drug/mgta-456 https://druglandscape.com/api/og?type=drug&title=MGTA-456&subtitle=MGTA-456%20%C2%B7%20Magenta%20Therapeutics%2C%20Inc.&badge=phase%202 MGTA-456 MGTA-456 · Magenta Therapeutics, Inc. https://druglandscape.com/drug/mh004-0-3-ointment https://druglandscape.com/api/og?type=drug&title=MH004%200.3%25%20Ointment&subtitle=MH004%200.3%25%20Ointment%20%C2%B7%20Minghui%20Pharmaceutical%20(Hangzhou)%20Ltd&badge=phase%201 MH004 0.3% Ointment MH004 0.3% Ointment · Minghui Pharmaceutical (Hangzhou) Ltd https://druglandscape.com/drug/mh048 https://druglandscape.com/api/og?type=drug&title=MH048&subtitle=MH048%20%C2%B7%20Minghui%20Pharmaceutical%20(Shanghai)%20LTD&badge=phase%201 MH048 MH048 · Minghui Pharmaceutical (Shanghai) LTD https://druglandscape.com/drug/mhaa4549a https://druglandscape.com/api/og?type=drug&title=MHAA4549A&subtitle=MHAA4549A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 MHAA4549A MHAA4549A · Genentech, Inc. https://druglandscape.com/drug/mhaa549a https://druglandscape.com/api/og?type=drug&title=MHAA549A&subtitle=MHAA549A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 MHAA549A MHAA549A · Genentech, Inc. https://druglandscape.com/drug/mhacmb https://druglandscape.com/api/og?type=drug&title=mHACMb&subtitle=mHACMb%20%C2%B7%20Applied%20Biologics%2C%20LLC&badge=phase%202 mHACMb mHACMb · Applied Biologics, LLC https://druglandscape.com/drug/mhb036c https://druglandscape.com/api/og?type=drug&title=MHB036C&subtitle=MHB036C%20%C2%B7%20Minghui%20Pharmaceutical%20(Hangzhou)%20Ltd&badge=phase%201 MHB036C MHB036C · Minghui Pharmaceutical (Hangzhou) Ltd https://druglandscape.com/drug/mhb046c https://druglandscape.com/api/og?type=drug&title=MHB046C&subtitle=MHB046C%20%C2%B7%20Minghui%20Pharmaceutical%20(Hangzhou)%20Ltd&badge=phase%201 MHB046C MHB046C · Minghui Pharmaceutical (Hangzhou) Ltd https://druglandscape.com/drug/mhs-1031 https://druglandscape.com/api/og?type=drug&title=MHS-1031&subtitle=MHS-1031%20%C2%B7%20Microbiome%20Health%20Sciences&badge=phase%202 MHS-1031 MHS-1031 · Microbiome Health Sciences https://druglandscape.com/drug/mi078 https://druglandscape.com/api/og?type=drug&title=MI078&subtitle=MI078%20%C2%B7%20Nanjing%20Minova%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 MI078 MI078 · Nanjing Minova Pharmaceutical Co., Ltd. https://druglandscape.com/drug/mianhuahua-flavonoids-tablets https://druglandscape.com/api/og?type=drug&title=Mianhuahua%20Flavonoids%20Tablets&subtitle=Mianhuahua%20Flavonoids%20Tablets%20%C2%B7%20Xinjiang%20Uygur%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Mianhuahua Flavonoids Tablets Mianhuahua Flavonoids Tablets · Xinjiang Uygur Pharmaceutical Co., Ltd. https://druglandscape.com/drug/mibefradil-with-radiation https://druglandscape.com/api/og?type=drug&title=Mibefradil%20with%20Radiation&subtitle=Mibefradil%20with%20Radiation%20%C2%B7%20Cavion%2C%20Inc.&badge=phase%201 Mibefradil with Radiation Mibefradil with Radiation · Cavion, Inc. https://druglandscape.com/drug/miconaz-oral-gel https://druglandscape.com/api/og?type=drug&title=Miconaz%20oral%20gel&subtitle=Miconaz%20oral%20gel%20%C2%B7%20Hams%20Hamed%20Abdelrahman&badge=phase%202 Miconaz oral gel Miconaz oral gel · Hams Hamed Abdelrahman https://druglandscape.com/drug/miconazole-2-oil https://druglandscape.com/api/og?type=drug&title=miconazole%202%25%20oil&subtitle=miconazole%202%25%20oil%20%C2%B7%20Hill%20Dermaceuticals%2C%20Inc.&badge=phase%202 miconazole 2% oil miconazole 2% oil · Hill Dermaceuticals, Inc. https://druglandscape.com/drug/miconazole-oral-gel https://druglandscape.com/api/og?type=drug&title=Miconazole%20Oral%20gel&subtitle=Miconazole%20Oral%20gel%20%C2%B7%20Hams%20Hamed%20Abdelrahman&badge=phase%201 Miconazole Oral gel Miconazole Oral gel · Hams Hamed Abdelrahman https://druglandscape.com/drug/miconazole-topical-gel https://druglandscape.com/api/og?type=drug&title=Miconazole%20Topical%20Gel&subtitle=Miconazole%20Topical%20Gel%20%C2%B7%20Hams%20Hamed%20Abdelrahman&badge=phase%202 Miconazole Topical Gel Miconazole Topical Gel · Hams Hamed Abdelrahman https://druglandscape.com/drug/microarray-patch-a https://druglandscape.com/api/og?type=drug&title=Microarray%20patch%20A&subtitle=Microarray%20patch%20A%20%C2%B7%20LEO%20Pharma&badge=phase%201 Microarray patch A Microarray patch A · LEO Pharma https://druglandscape.com/drug/microarray-patch-b https://druglandscape.com/api/og?type=drug&title=Microarray%20patch%20B&subtitle=Microarray%20patch%20B%20%C2%B7%20LEO%20Pharma&badge=phase%201 Microarray patch B Microarray patch B · LEO Pharma https://druglandscape.com/drug/microbiome-restoration-fmt https://druglandscape.com/api/og?type=drug&title=Microbiome%20restoration%20-%20FMT&subtitle=Microbiome%20restoration%20-%20FMT%20%C2%B7%20Professor%20Klaus%20B%C3%B8nnelykke&badge=phase%201 Microbiome restoration - FMT Microbiome restoration - FMT · Professor Klaus Bønnelykke https://druglandscape.com/drug/microbiome-therapeutic-lp-51 https://druglandscape.com/api/og?type=drug&title=Microbiome%20Therapeutic%20LP-51&subtitle=Microbiome%20Therapeutic%20LP-51%20%C2%B7%20Ho-Yeon%20Song&badge=phase%201 Microbiome Therapeutic LP-51 Microbiome Therapeutic LP-51 · Ho-Yeon Song https://druglandscape.com/drug/microcrystalline-cellulose-capsules https://druglandscape.com/api/og?type=drug&title=microcrystalline%20cellulose%20capsules&subtitle=microcrystalline%20cellulose%20capsules%20%C2%B7%20Neuralstem%20Inc.&badge=phase%201 microcrystalline cellulose capsules microcrystalline cellulose capsules · Neuralstem Inc. https://druglandscape.com/drug/microcrystalline-methylcellulose https://druglandscape.com/api/og?type=drug&title=Microcrystalline%20Methylcellulose&subtitle=Microcrystalline%20Methylcellulose%20%C2%B7%20Dr.%20Rachel%20Holden&badge=phase%202 Microcrystalline Methylcellulose Microcrystalline Methylcellulose · Dr. Rachel Holden https://druglandscape.com/drug/microginon https://druglandscape.com/api/og?type=drug&title=Microginon%C2%AE&subtitle=Microginon%C2%AE%20%C2%B7%20Bial%20-%20Portela%20C%20S.A.&badge=phase%201 Microginon® Microginon® · Bial - Portela C S.A. https://druglandscape.com/drug/microgyn https://druglandscape.com/api/og?type=drug&title=Microgyn%C2%AE&subtitle=Microgyn%C2%AE%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Microgyn® Microgyn® · Novo Nordisk A/S https://druglandscape.com/drug/microtracer-14c-acp-196 https://druglandscape.com/api/og?type=drug&title=Microtracer%20%5B14C%5DACP-196&subtitle=Microtracer%20%5B14C%5DACP-196%20%C2%B7%20Acerta%20Pharma%20BV&badge=phase%201 Microtracer [14C]ACP-196 Microtracer [14C]ACP-196 · Acerta Pharma BV https://druglandscape.com/drug/mid-dose-anavex2-73 https://druglandscape.com/api/og?type=drug&title=Mid%20dose%20ANAVEX2-73&subtitle=Mid%20dose%20ANAVEX2-73%20%C2%B7%20Anavex%20Life%20Sciences%20Corp.&badge=phase%202 Mid dose ANAVEX2-73 Mid dose ANAVEX2-73 · Anavex Life Sciences Corp. https://druglandscape.com/drug/mid-dose-cohort https://druglandscape.com/api/og?type=drug&title=Mid-Dose%20Cohort&subtitle=Mid-Dose%20Cohort%20%C2%B7%20Changchun%20BCHT%20Biotechnology%20Co.&badge=phase%201 Mid-Dose Cohort Mid-Dose Cohort · Changchun BCHT Biotechnology Co. https://druglandscape.com/drug/mid-dose-okn-007-tid https://druglandscape.com/api/og?type=drug&title=Mid-dose%20OKN-007%2C%20TID&subtitle=Mid-dose%20OKN-007%2C%20TID%20%C2%B7%20Oblato%2C%20Inc.&badge=phase%201 Mid-dose OKN-007, TID Mid-dose OKN-007, TID · Oblato, Inc. https://druglandscape.com/drug/mid-dose-pf-03635659 https://druglandscape.com/api/og?type=drug&title=Mid%20Dose%20PF-03635659&subtitle=Mid%20Dose%20PF-03635659%20%C2%B7%20Pfizer&badge=phase%202 Mid Dose PF-03635659 Mid Dose PF-03635659 · Pfizer https://druglandscape.com/drug/mid-metformin https://druglandscape.com/api/og?type=drug&title=Mid%20Metformin&subtitle=Mid%20Metformin%20%C2%B7%20NuSirt%20Biopharma&badge=phase%202 Mid Metformin Mid Metformin · NuSirt Biopharma https://druglandscape.com/drug/midazolam-alone https://druglandscape.com/api/og?type=drug&title=midazolam%20alone&subtitle=midazolam%20alone%20%C2%B7%20Greg%20S%20Cohen%20MD%20LLC&badge=phase%202 midazolam alone midazolam alone · Greg S Cohen MD LLC https://druglandscape.com/drug/midazolam-and-gdc-0853 https://druglandscape.com/api/og?type=drug&title=Midazolam%20and%20GDC-0853&subtitle=Midazolam%20and%20GDC-0853%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 Midazolam and GDC-0853 Midazolam and GDC-0853 · Genentech, Inc. https://druglandscape.com/drug/midazolam-and-jnj-38518168 https://druglandscape.com/api/og?type=drug&title=Midazolam%20and%20JNJ-38518168&subtitle=Midazolam%20and%20JNJ-38518168%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Midazolam and JNJ-38518168 Midazolam and JNJ-38518168 · Janssen Research & Development, LLC https://druglandscape.com/drug/midazolam-and-ketamine https://druglandscape.com/api/og?type=drug&title=Midazolam%20and%20Ketamine&subtitle=Midazolam%20and%20Ketamine%20%C2%B7%20Universidade%20Federal%20de%20Goias&badge=phase%202 Midazolam and Ketamine Midazolam and Ketamine · Universidade Federal de Goias https://druglandscape.com/drug/midazolam-and-lidocaine https://druglandscape.com/api/og?type=drug&title=midazolam%20and%20lidocaine&subtitle=midazolam%20and%20lidocaine%20%C2%B7%20Amany%20Ahmed%20Eissa&badge=phase%201 midazolam and lidocaine midazolam and lidocaine · Amany Ahmed Eissa https://druglandscape.com/drug/midazolam-and-qualaquin-at-steady-state https://druglandscape.com/api/og?type=drug&title=Midazolam%20and%20Qualaquin%20at%20steady%20state&subtitle=Midazolam%20and%20Qualaquin%20at%20steady%20state%20%C2%B7%20Mutual%20Pharmaceutical%20Company%2C%20Inc.&badge=phase%201 Midazolam and Qualaquin at steady state Midazolam and Qualaquin at steady state · Mutual Pharmaceutical Company, Inc. https://druglandscape.com/drug/midazolam-based-sedation https://druglandscape.com/api/og?type=drug&title=midazolam-based%20sedation&subtitle=midazolam-based%20sedation%20%C2%B7%20Meir%20Medical%20Center&badge=phase%201 midazolam-based sedation midazolam-based sedation · Meir Medical Center https://druglandscape.com/drug/midazolam-iv https://druglandscape.com/api/og?type=drug&title=Midazolam%2C%20IV&subtitle=Midazolam%2C%20IV%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 Midazolam, IV Midazolam, IV · Hoffmann-La Roche https://druglandscape.com/drug/midazolam-ketamine-and-sevoflurane https://druglandscape.com/api/og?type=drug&title=Midazolam%2C%20Ketamine%20and%20Sevoflurane&subtitle=Midazolam%2C%20Ketamine%20and%20Sevoflurane%20%C2%B7%20Universidade%20Federal%20de%20Goias&badge=phase%202 Midazolam, Ketamine and Sevoflurane Midazolam, Ketamine and Sevoflurane · Universidade Federal de Goias https://druglandscape.com/drug/midazolam-ketamine-arm https://druglandscape.com/api/og?type=drug&title=Midazolam%20Ketamine%20arm&subtitle=Midazolam%20Ketamine%20arm%20%C2%B7%20Azienda%20Sanitaria%20dell'Alto%20Adige&badge=phase%201 Midazolam Ketamine arm Midazolam Ketamine arm · Azienda Sanitaria dell'Alto Adige https://druglandscape.com/drug/midazolam-maleate-tablets https://druglandscape.com/api/og?type=drug&title=Midazolam%20Maleate%20Tablets&subtitle=Midazolam%20Maleate%20Tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Midazolam Maleate Tablets Midazolam Maleate Tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/midazolam-rosuvastatin-calcium-and-digoxin https://druglandscape.com/api/og?type=drug&title=Midazolam%20%2C%20Rosuvastatin%20calcium%20and%20digoxin&subtitle=Midazolam%20%2C%20Rosuvastatin%20calcium%20and%20digoxin%20%C2%B7%20Allist%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Midazolam , Rosuvastatin calcium and digoxin Midazolam , Rosuvastatin calcium and digoxin · Allist Pharmaceuticals, Inc. https://druglandscape.com/drug/middle-dose https://druglandscape.com/api/og?type=drug&title=Middle%20Dose&subtitle=Middle%20Dose%20%C2%B7%20Beijing%20Northland%20Biotech.%20Co.%2C%20Ltd.&badge=phase%202 Middle Dose Middle Dose · Beijing Northland Biotech. Co., Ltd. https://druglandscape.com/drug/middle-dose-of-lvrna009 https://druglandscape.com/api/og?type=drug&title=Middle-dose%20of%20LVRNA009&subtitle=Middle-dose%20of%20LVRNA009%20%C2%B7%20AIM%20Vaccine%20Co.%2C%20Ltd.&badge=phase%201 Middle-dose of LVRNA009 Middle-dose of LVRNA009 · AIM Vaccine Co., Ltd. https://druglandscape.com/drug/middle-dose-of-mrm-3379 https://druglandscape.com/api/og?type=drug&title=Middle%20Dose%20of%20MRM-3379&subtitle=Middle%20Dose%20of%20MRM-3379%20%C2%B7%20Mirum%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Middle Dose of MRM-3379 Middle Dose of MRM-3379 · Mirum Pharmaceuticals, Inc. https://druglandscape.com/drug/mif-pristone-versus-misoprostol https://druglandscape.com/api/og?type=drug&title=Mif%C3%A9pristone%20versus%20Misoprostol&subtitle=Mif%C3%A9pristone%20versus%20Misoprostol%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 Mifépristone versus Misoprostol Mifépristone versus Misoprostol · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/mifamurtide-arm https://druglandscape.com/api/og?type=drug&title=Mifamurtide%20arm&subtitle=Mifamurtide%20arm%20%C2%B7%20Italian%20Sarcoma%20Group&badge=phase%202 Mifamurtide arm Mifamurtide arm · Italian Sarcoma Group https://druglandscape.com/drug/mifepristone-misoprostol-treatment https://druglandscape.com/api/og?type=drug&title=mifepristone-misoprostol%20treatment&subtitle=mifepristone-misoprostol%20treatment%20%C2%B7%20Gynuity%20Health%20Projects&badge=phase%201 mifepristone-misoprostol treatment mifepristone-misoprostol treatment · Gynuity Health Projects https://druglandscape.com/drug/mifepristone-oral-tablet-korlym https://druglandscape.com/api/og?type=drug&title=Mifepristone%20Oral%20Tablet%20%5BKorlym%5D&subtitle=Mifepristone%20Oral%20Tablet%20%5BKorlym%5D%20%C2%B7%20VA%20Office%20of%20Research%20and%20Development&badge=phase%202 Mifepristone Oral Tablet [Korlym] Mifepristone Oral Tablet [Korlym] · VA Office of Research and Development https://druglandscape.com/drug/mifepristone-vaginal-tablets https://druglandscape.com/api/og?type=drug&title=mifepristone%20vaginal%20tablets&subtitle=mifepristone%20vaginal%20tablets%20%C2%B7%20BioPro%20Medical%20Ltd&badge=phase%202 mifepristone vaginal tablets mifepristone vaginal tablets · BioPro Medical Ltd https://druglandscape.com/drug/mil116 https://druglandscape.com/api/og?type=drug&title=MIL116&subtitle=MIL116%20%C2%B7%20Beijing%20Mabworks%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 MIL116 MIL116 · Beijing Mabworks Biotech Co., Ltd. https://druglandscape.com/drug/milk-powder https://druglandscape.com/api/og?type=drug&title=Milk%20powder&subtitle=Milk%20powder%20%C2%B7%20Hugh%20A%20Sampson%2C%20MD&badge=phase%202 Milk powder Milk powder · Hugh A Sampson, MD https://druglandscape.com/drug/miltefosine-meglumine-antimoniate https://druglandscape.com/api/og?type=drug&title=Miltefosine%20%2C%20meglumine%20antimoniate&subtitle=Miltefosine%20%2C%20meglumine%20antimoniate%20%C2%B7%20Centro%20de%20Investigaciones%20Biocl%C3%ADnicas%20de%20la%20Fundaci%C3%B3n%20Fader&badge=phase%202 Miltefosine , meglumine antimoniate Miltefosine , meglumine antimoniate · Centro de Investigaciones Bioclínicas de la Fundación Fader https://druglandscape.com/drug/miltefosine-oral-capsule https://druglandscape.com/api/og?type=drug&title=Miltefosine%20Oral%20Capsule&subtitle=Miltefosine%20Oral%20Capsule%20%C2%B7%20Fundacion%20Nacional%20de%20Dermatologia&badge=phase%202 Miltefosine Oral Capsule Miltefosine Oral Capsule · Fundacion Nacional de Dermatologia https://druglandscape.com/drug/mimedx-amniofix https://druglandscape.com/api/og?type=drug&title=MiMedx%20AmnioFix&subtitle=MiMedx%20AmnioFix%20%C2%B7%20Choon%20Hyuck%20David%20Kwon&badge=phase%202 MiMedx AmnioFix MiMedx AmnioFix · Choon Hyuck David Kwon https://druglandscape.com/drug/min-102 https://druglandscape.com/api/og?type=drug&title=MIN-102&subtitle=MIN-102%20%C2%B7%20Minoryx%20Therapeutics%2C%20S.L.&badge=phase%202 MIN-102 MIN-102 · Minoryx Therapeutics, S.L. https://druglandscape.com/drug/miniderm-20-cream https://druglandscape.com/api/og?type=drug&title=Miniderm%C2%AE%2020%25%20cream&subtitle=Miniderm%C2%AE%2020%25%20cream%20%C2%B7%20ACO%20Hud%20Nordic%20AB&badge=phase%202 Miniderm® 20% cream Miniderm® 20% cream · ACO Hud Nordic AB https://druglandscape.com/drug/miniderm-cream https://druglandscape.com/api/og?type=drug&title=Miniderm%20cream&subtitle=Miniderm%20cream%20%C2%B7%20Beatrice%20Olsson%20Duse&badge=phase%201 Miniderm cream Miniderm cream · Beatrice Olsson Duse https://druglandscape.com/drug/minnelide-001 https://druglandscape.com/api/og?type=drug&title=Minnelide%E2%84%A2%20001&subtitle=Minnelide%E2%84%A2%20001%20%C2%B7%20Minneamrita%20Therapeutics%20LLC&badge=phase%201 Minnelide™ 001 Minnelide™ 001 · Minneamrita Therapeutics LLC https://druglandscape.com/drug/minnelidecapsules https://druglandscape.com/api/og?type=drug&title=Minnelide%E2%84%A2Capsules&subtitle=Minnelide%E2%84%A2Capsules%20%C2%B7%20Minneamrita%20Therapeutics%20LLC&badge=phase%201 Minnelide™Capsules Minnelide™Capsules · Minneamrita Therapeutics LLC https://druglandscape.com/drug/minocycline-iv https://druglandscape.com/api/og?type=drug&title=Minocycline%20IV&subtitle=Minocycline%20IV%20%C2%B7%20Rempex%20(a%20wholly%20owned%20subsidiary%20of%20Melinta%20Therapeutics%2C%20Inc.)&badge=phase%202 Minocycline IV Minocycline IV · Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) https://druglandscape.com/drug/minocycline-topical-gel https://druglandscape.com/api/og?type=drug&title=minocycline%20topical%20gel&subtitle=minocycline%20topical%20gel%20%C2%B7%20BioPharmX%2C%20Inc.&badge=phase%202 minocycline topical gel minocycline topical gel · BioPharmX, Inc. https://druglandscape.com/drug/minoxidil-2-only https://druglandscape.com/api/og?type=drug&title=Minoxidil%202%25%20only&subtitle=Minoxidil%202%25%20only%20%C2%B7%20Merz%20Pharmaceuticals%20GmbH&badge=phase%202 Minoxidil 2% only Minoxidil 2% only · Merz Pharmaceuticals GmbH https://druglandscape.com/drug/mint1526a https://druglandscape.com/api/og?type=drug&title=MINT1526A&subtitle=MINT1526A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 MINT1526A MINT1526A · Genentech, Inc. https://druglandscape.com/drug/mipomersen-sodium-warfarin-sodium https://druglandscape.com/api/og?type=drug&title=mipomersen%20sodium%3B%20warfarin%20sodium&subtitle=mipomersen%20sodium%3B%20warfarin%20sodium%20%C2%B7%20Kastle%20Therapeutics%2C%20LLC&badge=phase%201 mipomersen sodium; warfarin sodium mipomersen sodium; warfarin sodium · Kastle Therapeutics, LLC https://druglandscape.com/drug/mir-126-inhibitor-miristen https://druglandscape.com/api/og?type=drug&title=miR-126%20Inhibitor%20miRisten&subtitle=miR-126%20Inhibitor%20miRisten%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%201 miR-126 Inhibitor miRisten miR-126 Inhibitor miRisten · City of Hope Medical Center https://druglandscape.com/drug/mirabegron-ocas https://druglandscape.com/api/og?type=drug&title=mirabegron%20OCAS&subtitle=mirabegron%20OCAS%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%201 mirabegron OCAS mirabegron OCAS · Astellas Pharma Inc https://druglandscape.com/drug/miracle-fruit https://druglandscape.com/api/og?type=drug&title=Miracle%20Fruit&subtitle=Miracle%20Fruit%20%C2%B7%20Mt.%20Sinai%20Medical%20Center%2C%20Miami&badge=phase%201 Miracle Fruit Miracle Fruit · Mt. Sinai Medical Center, Miami https://druglandscape.com/drug/miracle-mouthwash-plus-hydrocortisone https://druglandscape.com/api/og?type=drug&title=Miracle%20Mouthwash%20Plus%20Hydrocortisone&subtitle=Miracle%20Mouthwash%20Plus%20Hydrocortisone%20%C2%B7%20US%20Oncology%20Research&badge=phase%202 Miracle Mouthwash Plus Hydrocortisone Miracle Mouthwash Plus Hydrocortisone · US Oncology Research https://druglandscape.com/drug/miravirsen-sodium https://druglandscape.com/api/og?type=drug&title=Miravirsen%20sodium&subtitle=Miravirsen%20sodium%20%C2%B7%20Santaris%20Pharma%20A%2FS&badge=phase%202 Miravirsen sodium Miravirsen sodium · Santaris Pharma A/S https://druglandscape.com/drug/mirdametinib-and-carbamazepine https://druglandscape.com/api/og?type=drug&title=Mirdametinib%20and%20Carbamazepine&subtitle=Mirdametinib%20and%20Carbamazepine%20%C2%B7%20SpringWorks%20Therapeutics%2C%20Inc.&badge=phase%201 Mirdametinib and Carbamazepine Mirdametinib and Carbamazepine · SpringWorks Therapeutics, Inc. https://druglandscape.com/drug/mirikizumab-autoinjector https://druglandscape.com/api/og?type=drug&title=Mirikizumab%20Autoinjector&subtitle=Mirikizumab%20Autoinjector%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Mirikizumab Autoinjector Mirikizumab Autoinjector · Eli Lilly and Company https://druglandscape.com/drug/mirikizumab-prefilled-syringe https://druglandscape.com/api/og?type=drug&title=Mirikizumab%20Prefilled%20Syringe&subtitle=Mirikizumab%20Prefilled%20Syringe%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Mirikizumab Prefilled Syringe Mirikizumab Prefilled Syringe · Eli Lilly and Company https://druglandscape.com/drug/mirikizumab-test https://druglandscape.com/api/og?type=drug&title=Mirikizumab%20Test&subtitle=Mirikizumab%20Test%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Mirikizumab Test Mirikizumab Test · Eli Lilly and Company https://druglandscape.com/drug/mirna-quantification https://druglandscape.com/api/og?type=drug&title=miRNA%20quantification&subtitle=miRNA%20quantification%20%C2%B7%20Dr.Waleed%20Samir&badge=phase%201 miRNA quantification miRNA quantification · Dr.Waleed Samir https://druglandscape.com/drug/misaver https://druglandscape.com/api/og?type=drug&title=MiSaver&subtitle=MiSaver%20%C2%B7%20Honya%20Medical%20Inc&badge=phase%202 MiSaver MiSaver · Honya Medical Inc https://druglandscape.com/drug/misoprostol-25-g-vaginal https://druglandscape.com/api/og?type=drug&title=Misoprostol%2025%20%C2%B5g%20Vaginal&subtitle=Misoprostol%2025%20%C2%B5g%20Vaginal%20%C2%B7%20Raid%20M.%20Al-Ani&badge=phase%201 Misoprostol 25 µg Vaginal Misoprostol 25 µg Vaginal · Raid M. Al-Ani https://druglandscape.com/drug/misoprostol-vaginal-insert https://druglandscape.com/api/og?type=drug&title=Misoprostol%20vaginal%20insert&subtitle=Misoprostol%20vaginal%20insert%20%C2%B7%20Asklepios%20Kliniken%20Hamburg%20GmbH&badge=phase%202 Misoprostol vaginal insert Misoprostol vaginal insert · Asklepios Kliniken Hamburg GmbH https://druglandscape.com/drug/mit-001 https://druglandscape.com/api/og?type=drug&title=MIT-001&subtitle=MIT-001%20%C2%B7%20MitoImmune%20Therapeutics&badge=phase%202 MIT-001 MIT-001 · MitoImmune Therapeutics https://druglandscape.com/drug/mit-001-plus-ccrt https://druglandscape.com/api/og?type=drug&title=MIT-001%20plus%20CCRT&subtitle=MIT-001%20plus%20CCRT%20%C2%B7%20MitoImmune%20Therapeutics&badge=phase%202 MIT-001 plus CCRT MIT-001 plus CCRT · MitoImmune Therapeutics https://druglandscape.com/drug/mitapivat-coated-granules https://druglandscape.com/api/og?type=drug&title=Mitapivat%20coated%20granules&subtitle=Mitapivat%20coated%20granules%20%C2%B7%20Agios%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Mitapivat coated granules Mitapivat coated granules · Agios Pharmaceuticals, Inc. https://druglandscape.com/drug/mitapivat-tablet https://druglandscape.com/api/og?type=drug&title=Mitapivat%20tablet&subtitle=Mitapivat%20tablet%20%C2%B7%20Agios%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Mitapivat tablet Mitapivat tablet · Agios Pharmaceuticals, Inc. https://druglandscape.com/drug/mitapivat-tablets https://druglandscape.com/api/og?type=drug&title=Mitapivat%20tablets&subtitle=Mitapivat%20tablets%20%C2%B7%20Agios%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Mitapivat tablets Mitapivat tablets · Agios Pharmaceuticals, Inc. https://druglandscape.com/drug/mitiglinide-and-metformin https://druglandscape.com/api/og?type=drug&title=mitiglinide%20and%20metformin&subtitle=mitiglinide%20and%20metformin%20%C2%B7%20JW%20Pharmaceutical&badge=phase%201 mitiglinide and metformin mitiglinide and metformin · JW Pharmaceutical https://druglandscape.com/drug/mitiglinide-calcium-hydrate https://druglandscape.com/api/og?type=drug&title=Mitiglinide%20calcium%20hydrate&subtitle=Mitiglinide%20calcium%20hydrate%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%201 Mitiglinide calcium hydrate Mitiglinide calcium hydrate · Astellas Pharma Inc https://druglandscape.com/drug/mitizodone-phosphate-tablets https://druglandscape.com/api/og?type=drug&title=Mitizodone%20Phosphate%20tablets&subtitle=Mitizodone%20Phosphate%20tablets%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%202 Mitizodone Phosphate tablets Mitizodone Phosphate tablets · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/mitomycin-c-capecitabine-bevacizumab https://druglandscape.com/api/og?type=drug&title=Mitomycin%20C%3B%20Capecitabine%3B%20Bevacizumab&subtitle=Mitomycin%20C%3B%20Capecitabine%3B%20Bevacizumab%20%C2%B7%20Australasian%20Gastro-Intestinal%20Trials%20Group&badge=phase%202 Mitomycin C; Capecitabine; Bevacizumab Mitomycin C; Capecitabine; Bevacizumab · Australasian Gastro-Intestinal Trials Group https://druglandscape.com/drug/mitomycin-fluorouracil https://druglandscape.com/api/og?type=drug&title=mitomycin%2C%20Fluorouracil&subtitle=mitomycin%2C%20Fluorouracil%20%C2%B7%20Shenzhen%20Kangzhe%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 mitomycin, Fluorouracil mitomycin, Fluorouracil · Shenzhen Kangzhe Pharmaceutical Co., Ltd. https://druglandscape.com/drug/mitoq-compound https://druglandscape.com/api/og?type=drug&title=MitoQ%20Compound&subtitle=MitoQ%20Compound%20%C2%B7%20Imperial%20College%20London&badge=phase%202 MitoQ Compound MitoQ Compound · Imperial College London https://druglandscape.com/drug/mix-of-allert1-t2-t3 https://druglandscape.com/api/og?type=drug&title=mix%20of%20AllerT1-T2-T3&subtitle=mix%20of%20AllerT1-T2-T3%20%C2%B7%20Anergis&badge=phase%201 mix of AllerT1-T2-T3 mix of AllerT1-T2-T3 · Anergis https://druglandscape.com/drug/mix-of-allert4-t5 https://druglandscape.com/api/og?type=drug&title=mix%20of%20AllerT4-T5&subtitle=mix%20of%20AllerT4-T5%20%C2%B7%20Anergis&badge=phase%201 mix of AllerT4-T5 mix of AllerT4-T5 · Anergis https://druglandscape.com/drug/mk-0472 https://druglandscape.com/api/og?type=drug&title=MK-0472&subtitle=MK-0472%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-0472 MK-0472 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-0476-montelukast-sodium https://druglandscape.com/api/og?type=drug&title=MK-0476%2C%20montelukast%20sodium&subtitle=MK-0476%2C%20montelukast%20sodium%20%C2%B7%20Organon%20and%20Co&badge=phase%202 MK-0476, montelukast sodium MK-0476, montelukast sodium · Organon and Co https://druglandscape.com/drug/mk-0482 https://druglandscape.com/api/og?type=drug&title=MK-0482&subtitle=MK-0482%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK-0482 MK-0482 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-0616 https://druglandscape.com/api/og?type=drug&title=MK-0616&subtitle=MK-0616%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-0616 MK-0616 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-0616a https://druglandscape.com/api/og?type=drug&title=MK-0616A&subtitle=MK-0616A%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-0616A MK-0616A · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-0822 https://druglandscape.com/api/og?type=drug&title=MK-0822&subtitle=MK-0822%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-0822 MK-0822 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-0873-patch https://druglandscape.com/api/og?type=drug&title=MK-0873%20Patch&subtitle=MK-0873%20Patch%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-0873 Patch MK-0873 Patch · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-0974-12mo5c https://druglandscape.com/api/og?type=drug&title=MK-0974%2012Mo5C&subtitle=MK-0974%2012Mo5C%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-0974 12Mo5C MK-0974 12Mo5C · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-1006-dfc https://druglandscape.com/api/og?type=drug&title=MK-1006%20DFC&subtitle=MK-1006%20DFC%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-1006 DFC MK-1006 DFC · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-1006-fct https://druglandscape.com/api/og?type=drug&title=MK-1006%20FCT&subtitle=MK-1006%20FCT%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-1006 FCT MK-1006 FCT · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-1045 https://druglandscape.com/api/og?type=drug&title=MK-1045&subtitle=MK-1045%20%C2%B7%20MSD%20R%26D%20(China)%20Co.%2C%20Ltd.&badge=phase%201 MK-1045 MK-1045 · MSD R&D (China) Co., Ltd. https://druglandscape.com/drug/mk-1075 https://druglandscape.com/api/og?type=drug&title=MK-1075&subtitle=MK-1075%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-1075 MK-1075 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-1200 https://druglandscape.com/api/og?type=drug&title=MK-1200&subtitle=MK-1200%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-1200 MK-1200 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-1484 https://druglandscape.com/api/og?type=drug&title=MK-1484&subtitle=MK-1484%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-1484 MK-1484 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-1602 https://druglandscape.com/api/og?type=drug&title=MK-1602&subtitle=MK-1602%20%C2%B7%20Allergan&badge=phase%202 MK-1602 MK-1602 · Allergan https://druglandscape.com/drug/mk-1708 https://druglandscape.com/api/og?type=drug&title=MK-1708&subtitle=MK-1708%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-1708 MK-1708 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-2206-with-or-without-trastuzumab https://druglandscape.com/api/og?type=drug&title=MK-2206%20with%20or%20without%20Trastuzumab&subtitle=MK-2206%20with%20or%20without%20Trastuzumab%20%C2%B7%20QuantumLeap%20Healthcare%20Collaborative&badge=phase%202 MK-2206 with or without Trastuzumab MK-2206 with or without Trastuzumab · QuantumLeap Healthcare Collaborative https://druglandscape.com/drug/mk-2214 https://druglandscape.com/api/og?type=drug&title=MK-2214&subtitle=MK-2214%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK-2214 MK-2214 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-2248 https://druglandscape.com/api/og?type=drug&title=MK-2248&subtitle=MK-2248%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-2248 MK-2248 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-2828 https://druglandscape.com/api/og?type=drug&title=MK-2828&subtitle=MK-2828%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-2828 MK-2828 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-3102 https://druglandscape.com/api/og?type=drug&title=MK-3102&subtitle=MK-3102%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-3102 MK-3102 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-3614 https://druglandscape.com/api/og?type=drug&title=MK-3614&subtitle=MK-3614%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-3614 MK-3614 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-3795 https://druglandscape.com/api/og?type=drug&title=MK-3795&subtitle=MK-3795%20%C2%B7%20Peloton%20Therapeutics%2C%20Inc.%2C%20a%20subsidiary%20of%20Merck%20%26%20Co.%2C%20Inc.%20(Rahway%2C%20New%20Jersey%20USA)&badge=phase%202 MK-3795 MK-3795 · Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) https://druglandscape.com/drug/mk-4002 https://druglandscape.com/api/og?type=drug&title=MK-4002&subtitle=MK-4002%20%C2%B7%20Harpoon%20Therapeutics%2C%20Inc.%2C%20a%20subsidiary%20of%20Merck%20%26%20Co.%2C%20Inc.%20(Rahway%2C%20New%20Jersey%20USA)&badge=phase%201 MK-4002 MK-4002 · Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) https://druglandscape.com/drug/mk-4082 https://druglandscape.com/api/og?type=drug&title=MK-4082&subtitle=MK-4082%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-4082 MK-4082 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-4166 https://druglandscape.com/api/og?type=drug&title=MK-4166&subtitle=MK-4166%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-4166 MK-4166 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-4250 https://druglandscape.com/api/og?type=drug&title=MK-4250&subtitle=MK-4250%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-4250 MK-4250 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-4318 https://druglandscape.com/api/og?type=drug&title=MK-4318&subtitle=MK-4318%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-4318 MK-4318 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-4464 https://druglandscape.com/api/og?type=drug&title=MK-4464&subtitle=MK-4464%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-4464 MK-4464 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-4482 https://druglandscape.com/api/og?type=drug&title=MK-4482&subtitle=MK-4482%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-4482 MK-4482 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-4618 https://druglandscape.com/api/og?type=drug&title=MK-4618&subtitle=MK-4618%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-4618 MK-4618 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-4646 https://druglandscape.com/api/og?type=drug&title=MK-4646&subtitle=MK-4646%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-4646 MK-4646 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-4700 https://druglandscape.com/api/og?type=drug&title=MK-4700&subtitle=MK-4700%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-4700 MK-4700 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-4716 https://druglandscape.com/api/og?type=drug&title=MK-4716&subtitle=MK-4716%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-4716 MK-4716 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-4830a https://druglandscape.com/api/og?type=drug&title=MK-4830A&subtitle=MK-4830A%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-4830A MK-4830A · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-5478 https://druglandscape.com/api/og?type=drug&title=MK-5478&subtitle=MK-5478%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-5478 MK-5478 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-5684 https://druglandscape.com/api/og?type=drug&title=MK-5684&subtitle=MK-5684%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-5684 MK-5684 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-5720 https://druglandscape.com/api/og?type=drug&title=MK-5720&subtitle=MK-5720%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-5720 MK-5720 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-6096 https://druglandscape.com/api/og?type=drug&title=MK-6096&subtitle=MK-6096%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK-6096 MK-6096 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-6183 https://druglandscape.com/api/og?type=drug&title=MK-6183&subtitle=MK-6183%20%C2%B7%20Cubist%20Pharmaceuticals%20LLC%2C%20a%20subsidiary%20of%20Merck%20%26%20Co.%2C%20Inc.%20(Rahway%2C%20New%20Jersey%20USA)&badge=phase%201 MK-6183 MK-6183 · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) https://druglandscape.com/drug/mk-6213 https://druglandscape.com/api/og?type=drug&title=MK-6213&subtitle=MK-6213%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK-6213 MK-6213 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-6240 https://druglandscape.com/api/og?type=drug&title=MK%206240&subtitle=MK%206240%20%C2%B7%20Tammie%20L.%20S.%20Benzinger%2C%20MD%2C%20PhD&badge=phase%202 MK 6240 MK 6240 · Tammie L. S. Benzinger, MD, PhD https://druglandscape.com/drug/mk-6598 https://druglandscape.com/api/og?type=drug&title=MK-6598&subtitle=MK-6598%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-6598 MK-6598 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-6837 https://druglandscape.com/api/og?type=drug&title=MK-6837&subtitle=MK-6837%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-6837 MK-6837 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-6916 https://druglandscape.com/api/og?type=drug&title=MK-6916&subtitle=MK-6916%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-6916 MK-6916 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-7162 https://druglandscape.com/api/og?type=drug&title=MK-7162&subtitle=MK-7162%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-7162 MK-7162 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-7252 https://druglandscape.com/api/og?type=drug&title=MK-7252&subtitle=MK-7252%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-7252 MK-7252 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-7602 https://druglandscape.com/api/og?type=drug&title=MK-7602&subtitle=MK-7602%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-7602 MK-7602 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-7655 https://druglandscape.com/api/og?type=drug&title=MK-7655&subtitle=MK-7655%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-7655 MK-7655 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-7680 https://druglandscape.com/api/og?type=drug&title=MK-7680&subtitle=MK-7680%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-7680 MK-7680 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8150 https://druglandscape.com/api/og?type=drug&title=MK-8150&subtitle=MK-8150%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-8150 MK-8150 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8237 https://druglandscape.com/api/og?type=drug&title=MK-8237&subtitle=MK-8237%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-8237 MK-8237 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8237-12-du https://druglandscape.com/api/og?type=drug&title=MK-8237%2012%20DU&subtitle=MK-8237%2012%20DU%20%C2%B7%20ALK-Abell%C3%B3%20A%2FS&badge=phase%202 MK-8237 12 DU MK-8237 12 DU · ALK-Abelló A/S https://druglandscape.com/drug/mk-8237-6-du https://druglandscape.com/api/og?type=drug&title=MK-8237%206%20DU&subtitle=MK-8237%206%20DU%20%C2%B7%20ALK-Abell%C3%B3%20A%2FS&badge=phase%202 MK-8237 6 DU MK-8237 6 DU · ALK-Abelló A/S https://druglandscape.com/drug/mk-8266 https://druglandscape.com/api/og?type=drug&title=MK-8266&subtitle=MK-8266%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-8266 MK-8266 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8291 https://druglandscape.com/api/og?type=drug&title=MK-8291&subtitle=MK-8291%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-8291 MK-8291 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8294 https://druglandscape.com/api/og?type=drug&title=MK-8294&subtitle=MK-8294%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-8294 MK-8294 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8504 https://druglandscape.com/api/og?type=drug&title=MK-8504&subtitle=MK-8504%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-8504 MK-8504 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8507 https://druglandscape.com/api/og?type=drug&title=MK-8507&subtitle=MK-8507%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-8507 MK-8507 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8558 https://druglandscape.com/api/og?type=drug&title=MK-8558&subtitle=MK-8558%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-8558 MK-8558 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8583 https://druglandscape.com/api/og?type=drug&title=MK-8583&subtitle=MK-8583%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-8583 MK-8583 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8616 https://druglandscape.com/api/og?type=drug&title=MK-8616&subtitle=MK-8616%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK-8616 MK-8616 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8655 https://druglandscape.com/api/og?type=drug&title=MK-8655&subtitle=MK-8655%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-8655 MK-8655 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8690 https://druglandscape.com/api/og?type=drug&title=MK-8690&subtitle=MK-8690%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK-8690 MK-8690 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8723 https://druglandscape.com/api/og?type=drug&title=MK-8723&subtitle=MK-8723%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-8723 MK-8723 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8931 https://druglandscape.com/api/og?type=drug&title=MK-8931&subtitle=MK-8931%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK-8931 MK-8931 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk-8998 https://druglandscape.com/api/og?type=drug&title=MK-8998&subtitle=MK-8998%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK-8998 MK-8998 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0359 https://druglandscape.com/api/og?type=drug&title=MK0359&subtitle=MK0359%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK0359 MK0359 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0364 https://druglandscape.com/api/og?type=drug&title=MK0364&subtitle=MK0364%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK0364 MK0364 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0429 https://druglandscape.com/api/og?type=drug&title=MK0429&subtitle=MK0429%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK0429 MK0429 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0493 https://druglandscape.com/api/og?type=drug&title=MK0493&subtitle=MK0493%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK0493 MK0493 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0518 https://druglandscape.com/api/og?type=drug&title=MK0518&subtitle=MK0518%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK0518 MK0518 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0524 https://druglandscape.com/api/og?type=drug&title=MK0524&subtitle=MK0524%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK0524 MK0524 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0594 https://druglandscape.com/api/og?type=drug&title=MK0594&subtitle=MK0594%20%C2%B7%20Vyne%20Therapeutics%20Inc.&badge=phase%202 MK0594 MK0594 · Vyne Therapeutics Inc. https://druglandscape.com/drug/mk0657 https://druglandscape.com/api/og?type=drug&title=MK0657&subtitle=MK0657%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK0657 MK0657 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0731 https://druglandscape.com/api/og?type=drug&title=MK0731&subtitle=MK0731%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK0731 MK0731 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0736 https://druglandscape.com/api/og?type=drug&title=MK0736&subtitle=MK0736%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK0736 MK0736 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0752 https://druglandscape.com/api/og?type=drug&title=MK0752&subtitle=MK0752%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK0752 MK0752 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0822a https://druglandscape.com/api/og?type=drug&title=MK0822A&subtitle=MK0822A%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK0822A MK0822A · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0916 https://druglandscape.com/api/og?type=drug&title=MK0916&subtitle=MK0916%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK0916 MK0916 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0941 https://druglandscape.com/api/og?type=drug&title=MK0941&subtitle=MK0941%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK0941 MK0941 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0974-ethanolate-formulation https://druglandscape.com/api/og?type=drug&title=MK0974%20Ethanolate%20formulation&subtitle=MK0974%20Ethanolate%20formulation%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK0974 Ethanolate formulation MK0974 Ethanolate formulation · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0974-tablet https://druglandscape.com/api/og?type=drug&title=MK0974%20tablet&subtitle=MK0974%20tablet%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK0974 tablet MK0974 tablet · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk0999 https://druglandscape.com/api/og?type=drug&title=MK0999&subtitle=MK0999%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK0999 MK0999 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk1006 https://druglandscape.com/api/og?type=drug&title=MK1006&subtitle=MK1006%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK1006 MK1006 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk1809 https://druglandscape.com/api/og?type=drug&title=MK1809&subtitle=MK1809%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK1809 MK1809 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk1903 https://druglandscape.com/api/og?type=drug&title=MK1903&subtitle=MK1903%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK1903 MK1903 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk2206-every-other-day https://druglandscape.com/api/og?type=drug&title=MK2206%20every%20other%20day&subtitle=MK2206%20every%20other%20day%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK2206 every other day MK2206 every other day · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk2206-once-weekly https://druglandscape.com/api/og?type=drug&title=MK2206%20once%20weekly&subtitle=MK2206%20once%20weekly%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK2206 once weekly MK2206 once weekly · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk2295 https://druglandscape.com/api/og?type=drug&title=MK2295&subtitle=MK2295%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK2295 MK2295 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk2461 https://druglandscape.com/api/og?type=drug&title=MK2461&subtitle=MK2461%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK2461 MK2461 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk2637 https://druglandscape.com/api/og?type=drug&title=MK2637&subtitle=MK2637%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK2637 MK2637 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk3134 https://druglandscape.com/api/og?type=drug&title=MK3134&subtitle=MK3134%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK3134 MK3134 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk3475 https://druglandscape.com/api/og?type=drug&title=MK3475&subtitle=MK3475%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 MK3475 MK3475 · Samsung Medical Center https://druglandscape.com/drug/mk5757 https://druglandscape.com/api/og?type=drug&title=MK5757&subtitle=MK5757%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK5757 MK5757 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk633 https://druglandscape.com/api/og?type=drug&title=MK633&subtitle=MK633%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK633 MK633 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk8141 https://druglandscape.com/api/og?type=drug&title=MK8141&subtitle=MK8141%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 MK8141 MK8141 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mk8245 https://druglandscape.com/api/og?type=drug&title=MK8245&subtitle=MK8245%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 MK8245 MK8245 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/mkp10241 https://druglandscape.com/api/og?type=drug&title=MKP10241&subtitle=MKP10241%20%C2%B7%20Mankind%20Pharma%20Limited&badge=phase%202 MKP10241 MKP10241 · Mankind Pharma Limited https://druglandscape.com/drug/ml-007c-ma https://druglandscape.com/api/og?type=drug&title=ML-007C-MA&subtitle=ML-007C-MA%20%C2%B7%20MapLight%20Therapeutics&badge=phase%202 ML-007C-MA ML-007C-MA · MapLight Therapeutics https://druglandscape.com/drug/ml-007c-ma-bid https://druglandscape.com/api/og?type=drug&title=ML-007C-MA%20BID&subtitle=ML-007C-MA%20BID%20%C2%B7%20MapLight%20Therapeutics&badge=phase%202 ML-007C-MA BID ML-007C-MA BID · MapLight Therapeutics https://druglandscape.com/drug/ml-007c-ma-qd https://druglandscape.com/api/og?type=drug&title=ML-007C-MA%20QD&subtitle=ML-007C-MA%20QD%20%C2%B7%20MapLight%20Therapeutics&badge=phase%202 ML-007C-MA QD ML-007C-MA QD · MapLight Therapeutics https://druglandscape.com/drug/ml261 https://druglandscape.com/api/og?type=drug&title=ML261&subtitle=ML261%20%C2%B7%20Moonlight%20Bio%2C%20Inc&badge=phase%201 ML261 ML261 · Moonlight Bio, Inc https://druglandscape.com/drug/mlc1501 https://druglandscape.com/api/og?type=drug&title=MLC1501&subtitle=MLC1501%20%C2%B7%20Moleac%20Pte%20Ltd.&badge=phase%202 MLC1501 MLC1501 · Moleac Pte Ltd. https://druglandscape.com/drug/mln2480 https://druglandscape.com/api/og?type=drug&title=MLN2480&subtitle=MLN2480%20%C2%B7%20Millennium%20Pharmaceuticals%2C%20Inc.&badge=phase%201 MLN2480 MLN2480 · Millennium Pharmaceuticals, Inc. https://druglandscape.com/drug/mln8237 https://druglandscape.com/api/og?type=drug&title=MLN8237&subtitle=MLN8237%20%C2%B7%20New%20Approaches%20to%20Neuroblastoma%20Therapy%20Consortium&badge=phase%202 MLN8237 MLN8237 · New Approaches to Neuroblastoma Therapy Consortium https://druglandscape.com/drug/mlta3698a https://druglandscape.com/api/og?type=drug&title=MLTA3698A&subtitle=MLTA3698A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 MLTA3698A MLTA3698A · Genentech, Inc. https://druglandscape.com/drug/mm-ii-dose-ii https://druglandscape.com/api/og?type=drug&title=MM-II%20dose%20II&subtitle=MM-II%20dose%20II%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%202 MM-II dose II MM-II dose II · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/mm-ii-dose-iii https://druglandscape.com/api/og?type=drug&title=MM-II%20dose%20III&subtitle=MM-II%20dose%20III%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%202 MM-II dose III MM-II dose III · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/mm09-mannosylated-10-000-sublingual https://druglandscape.com/api/og?type=drug&title=MM09%20Mannosylated%2010.000%20sublingual&subtitle=MM09%20Mannosylated%2010.000%20sublingual%20%C2%B7%20Inmunotek%20S.L.&badge=phase%202 MM09 Mannosylated 10.000 sublingual MM09 Mannosylated 10.000 sublingual · Inmunotek S.L. https://druglandscape.com/drug/mm09-mannosylated-30-000-subcutaneous https://druglandscape.com/api/og?type=drug&title=MM09%20Mannosylated%2030.000%20subcutaneous&subtitle=MM09%20Mannosylated%2030.000%20subcutaneous%20%C2%B7%20Inmunotek%20S.L.&badge=phase%202 MM09 Mannosylated 30.000 subcutaneous MM09 Mannosylated 30.000 subcutaneous · Inmunotek S.L. https://druglandscape.com/drug/mm09-mannosylated-30-000-sublingual https://druglandscape.com/api/og?type=drug&title=MM09%20Mannosylated%2030.000%20sublingual&subtitle=MM09%20Mannosylated%2030.000%20sublingual%20%C2%B7%20Inmunotek%20S.L.&badge=phase%202 MM09 Mannosylated 30.000 sublingual MM09 Mannosylated 30.000 sublingual · Inmunotek S.L. https://druglandscape.com/drug/mm09-mannosylated-5-000-subcutaneous https://druglandscape.com/api/og?type=drug&title=MM09%20Mannosylated%205.000%20subcutaneous&subtitle=MM09%20Mannosylated%205.000%20subcutaneous%20%C2%B7%20Inmunotek%20S.L.&badge=phase%202 MM09 Mannosylated 5.000 subcutaneous MM09 Mannosylated 5.000 subcutaneous · Inmunotek S.L. https://druglandscape.com/drug/mm09-mannosylated-5-000-sublingual https://druglandscape.com/api/og?type=drug&title=MM09%20Mannosylated%205.000%20sublingual&subtitle=MM09%20Mannosylated%205.000%20sublingual%20%C2%B7%20Inmunotek%20S.L.&badge=phase%202 MM09 Mannosylated 5.000 sublingual MM09 Mannosylated 5.000 sublingual · Inmunotek S.L. https://druglandscape.com/drug/mm09-mannosylated-50-000-subcutaneous https://druglandscape.com/api/og?type=drug&title=MM09%20Mannosylated%2050.000%20subcutaneous&subtitle=MM09%20Mannosylated%2050.000%20subcutaneous%20%C2%B7%20Inmunotek%20S.L.&badge=phase%202 MM09 Mannosylated 50.000 subcutaneous MM09 Mannosylated 50.000 subcutaneous · Inmunotek S.L. https://druglandscape.com/drug/mm09-mannosylated-50-000-sublingual https://druglandscape.com/api/og?type=drug&title=MM09%20Mannosylated%2050.000%20sublingual&subtitle=MM09%20Mannosylated%2050.000%20sublingual%20%C2%B7%20Inmunotek%20S.L.&badge=phase%202 MM09 Mannosylated 50.000 sublingual MM09 Mannosylated 50.000 sublingual · Inmunotek S.L. https://druglandscape.com/drug/mm120 https://druglandscape.com/api/og?type=drug&title=MM120&subtitle=MM120%20%C2%B7%20Definium%20Therapeutics%20US%2C%20Inc.&badge=phase%202 MM120 MM120 · Definium Therapeutics US, Inc. https://druglandscape.com/drug/mm36-topical-ointment-1 https://druglandscape.com/api/og?type=drug&title=MM36%20topical%20ointment%2C%201%25&subtitle=MM36%20topical%20ointment%2C%201%25%20%C2%B7%20Medimetriks%20Pharmaceuticals%2C%20Inc&badge=phase%202 MM36 topical ointment, 1% MM36 topical ointment, 1% · Medimetriks Pharmaceuticals, Inc https://druglandscape.com/drug/mmb4-dms https://druglandscape.com/api/og?type=drug&title=MMB4%20DMS&subtitle=MMB4%20DMS%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 MMB4 DMS MMB4 DMS · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/mmv055-dose-1 https://druglandscape.com/api/og?type=drug&title=MMV055%20Dose%201&subtitle=MMV055%20Dose%201%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 MMV055 Dose 1 MMV055 Dose 1 · Medicines for Malaria Venture https://druglandscape.com/drug/mmv367 https://druglandscape.com/api/og?type=drug&title=MMV367&subtitle=MMV367%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 MMV367 MMV367 · Medicines for Malaria Venture https://druglandscape.com/drug/mmv371-lai https://druglandscape.com/api/og?type=drug&title=MMV371%20LAI&subtitle=MMV371%20LAI%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 MMV371 LAI MMV371 LAI · Medicines for Malaria Venture https://druglandscape.com/drug/mmv390048-dose-to-be-determined-mg https://druglandscape.com/api/og?type=drug&title=MMV390048%20dose%20to%20be%20determined%20mg&subtitle=MMV390048%20dose%20to%20be%20determined%20mg%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 MMV390048 dose to be determined mg MMV390048 dose to be determined mg · Medicines for Malaria Venture https://druglandscape.com/drug/mmv390048-formulation-b https://druglandscape.com/api/og?type=drug&title=MMV390048%20formulation%20B&subtitle=MMV390048%20formulation%20B%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 MMV390048 formulation B MMV390048 formulation B · Medicines for Malaria Venture https://druglandscape.com/drug/mmv688533 https://druglandscape.com/api/og?type=drug&title=MMV688533&subtitle=MMV688533%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 MMV688533 MMV688533 · Medicines for Malaria Venture https://druglandscape.com/drug/mn-001 https://druglandscape.com/api/og?type=drug&title=MN-001&subtitle=MN-001%20%C2%B7%20MediciNova&badge=phase%202 MN-001 MN-001 · MediciNova https://druglandscape.com/drug/mn-166 https://druglandscape.com/api/og?type=drug&title=MN-166&subtitle=MN-166%20%C2%B7%20MediciNova&badge=phase%202 MN-166 MN-166 · MediciNova https://druglandscape.com/drug/mn-221 https://druglandscape.com/api/og?type=drug&title=MN-221&subtitle=MN-221%20%C2%B7%20MediciNova&badge=phase%202 MN-221 MN-221 · MediciNova https://druglandscape.com/drug/mnb-rlp2086 https://druglandscape.com/api/og?type=drug&title=MnB%20rLP2086&subtitle=MnB%20rLP2086%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 MnB rLP2086 MnB rLP2086 · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/mnb-vaccine-rlp8026 https://druglandscape.com/api/og?type=drug&title=MnB%20vaccine%20rLP8026&subtitle=MnB%20vaccine%20rLP8026%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 MnB vaccine rLP8026 MnB vaccine rLP8026 · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/mnk6106 https://druglandscape.com/api/og?type=drug&title=MNK6106&subtitle=MNK6106%20%C2%B7%20Mallinckrodt&badge=phase%202 MNK6106 MNK6106 · Mallinckrodt https://druglandscape.com/drug/mnrp1685a https://druglandscape.com/api/og?type=drug&title=MNRP1685A&subtitle=MNRP1685A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 MNRP1685A MNRP1685A · Genentech, Inc. https://druglandscape.com/drug/mnsod-mimetic-bmx-001 https://druglandscape.com/api/og?type=drug&title=MnSOD%20Mimetic%20BMX-001&subtitle=MnSOD%20Mimetic%20BMX-001%20%C2%B7%20NRG%20Oncology&badge=phase%202 MnSOD Mimetic BMX-001 MnSOD Mimetic BMX-001 · NRG Oncology https://druglandscape.com/drug/mnv-201 https://druglandscape.com/api/og?type=drug&title=MNV-201&subtitle=MNV-201%20%C2%B7%20Minovia%20Therapeutics%20Ltd.&badge=phase%202 MNV-201 MNV-201 · Minovia Therapeutics Ltd. https://druglandscape.com/drug/moap https://druglandscape.com/api/og?type=drug&title=MOAP&subtitle=MOAP%20%C2%B7%20Han%20weidong&badge=phase%201 MOAP MOAP · Han weidong https://druglandscape.com/drug/mob015 https://druglandscape.com/api/og?type=drug&title=MOB015&subtitle=MOB015%20%C2%B7%20Moberg%20Pharma%20AB&badge=phase%202 MOB015 MOB015 · Moberg Pharma AB https://druglandscape.com/drug/mobile-clinic https://druglandscape.com/api/og?type=drug&title=Mobile%20Clinic&subtitle=Mobile%20Clinic%20%C2%B7%20Cedars-Sinai%20Medical%20Center&badge=phase%201 Mobile Clinic Mobile Clinic · Cedars-Sinai Medical Center https://druglandscape.com/drug/mobilization-with-g-csf-and-mozobil https://druglandscape.com/api/og?type=drug&title=Mobilization%20with%20G-CSF%20and%20Mozobil&subtitle=Mobilization%20with%20G-CSF%20and%20Mozobil%20%C2%B7%20Proteonomix%2C%20Inc.&badge=phase%201 Mobilization with G-CSF and Mozobil Mobilization with G-CSF and Mozobil · Proteonomix, Inc. https://druglandscape.com/drug/mobilization-with-movement https://druglandscape.com/api/og?type=drug&title=Mobilization%20with%20movement&subtitle=Mobilization%20with%20movement%20%C2%B7%20Eleuterio%20Atanasio%20S%C3%A1nchez%20Romero&badge=phase%201 Mobilization with movement Mobilization with movement · Eleuterio Atanasio Sánchez Romero https://druglandscape.com/drug/mod-5014 https://druglandscape.com/api/og?type=drug&title=MOD-5014&subtitle=MOD-5014%20%C2%B7%20OPKO%20Health%2C%20Inc.&badge=phase%201 MOD-5014 MOD-5014 · OPKO Health, Inc. https://druglandscape.com/drug/mod-6031 https://druglandscape.com/api/og?type=drug&title=MOD-6031&subtitle=MOD-6031%20%C2%B7%20OPKO%20Health%2C%20Inc.&badge=phase%201 MOD-6031 MOD-6031 · OPKO Health, Inc. https://druglandscape.com/drug/modafinil-and-escitalopram https://druglandscape.com/api/og?type=drug&title=Modafinil%20and%20Escitalopram&subtitle=Modafinil%20and%20Escitalopram%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Modafinil and Escitalopram Modafinil and Escitalopram · Baylor College of Medicine https://druglandscape.com/drug/modafinil-propranolol https://druglandscape.com/api/og?type=drug&title=Modafinil%20%26%20Propranolol&subtitle=Modafinil%20%26%20Propranolol%20%C2%B7%20Satish%20R.%20Raj&badge=phase%201 Modafinil & Propranolol Modafinil & Propranolol · Satish R. Raj https://druglandscape.com/drug/modafinilnicotine-replacement-therapy https://druglandscape.com/api/og?type=drug&title=ModafinilNicotine%20Replacement%20Therapy&subtitle=ModafinilNicotine%20Replacement%20Therapy%20%C2%B7%20Catherine%20Martin%2C%20MD&badge=phase%201 ModafinilNicotine Replacement Therapy ModafinilNicotine Replacement Therapy · Catherine Martin, MD https://druglandscape.com/drug/mode-of-gonadotropin-administration https://druglandscape.com/api/og?type=drug&title=mode%20of%20gonadotropin%20administration&subtitle=mode%20of%20gonadotropin%20administration%20%C2%B7%20Genesis%20Center%20for%20Fertility%20%26%20Human%20Pre-Implantation%20Genetics&badge=phase%202 mode of gonadotropin administration mode of gonadotropin administration · Genesis Center for Fertility & Human Pre-Implantation Genetics https://druglandscape.com/drug/moderate-doses-of-thiamine-y-biotin https://druglandscape.com/api/og?type=drug&title=Moderate%20doses%20of%20Thiamine%20y%20Biotin&subtitle=Moderate%20doses%20of%20Thiamine%20y%20Biotin%20%C2%B7%20Fundaci%C3%B3n%20P%C3%BAblica%20Andaluza%20para%20la%20gesti%C3%B3n%20de%20la%20Investigaci%C3%B3n&badge=phase%202 Moderate doses of Thiamine y Biotin Moderate doses of Thiamine y Biotin · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla https://druglandscape.com/drug/moderate-intensity-statin-monotherapy https://druglandscape.com/api/og?type=drug&title=Moderate-intensity%20statin%20monotherapy&subtitle=Moderate-intensity%20statin%20monotherapy%20%C2%B7%20Sin%20Gon%20Kim&badge=phase%201 Moderate-intensity statin monotherapy Moderate-intensity statin monotherapy · Sin Gon Kim https://druglandscape.com/drug/moderate-nmb-using-rocuronium https://druglandscape.com/api/og?type=drug&title=Moderate%20NMB%20using%20rocuronium&subtitle=Moderate%20NMB%20using%20rocuronium%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 Moderate NMB using rocuronium Moderate NMB using rocuronium · Asan Medical Center https://druglandscape.com/drug/moderna-covid-19-mrna-vaccine https://druglandscape.com/api/og?type=drug&title=Moderna%20COVID-19%20mRNA%20vaccine&subtitle=Moderna%20COVID-19%20mRNA%20vaccine%20%C2%B7%20Methodist%20Health%20System&badge=phase%202 Moderna COVID-19 mRNA vaccine Moderna COVID-19 mRNA vaccine · Methodist Health System https://druglandscape.com/drug/moderna-mrna-1273-222 https://druglandscape.com/api/og?type=drug&title=Moderna%20mRNA-1273.222&subtitle=Moderna%20mRNA-1273.222%20%C2%B7%20COVID-19%20Prevention%20Network&badge=phase%202 Moderna mRNA-1273.222 Moderna mRNA-1273.222 · COVID-19 Prevention Network https://druglandscape.com/drug/moderna-mrna1273-222-booster https://druglandscape.com/api/og?type=drug&title=Moderna%20mRNA1273.222%20Booster&subtitle=Moderna%20mRNA1273.222%20Booster%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 Moderna mRNA1273.222 Booster Moderna mRNA1273.222 Booster · ModernaTX, Inc. https://druglandscape.com/drug/modified-folfiri https://druglandscape.com/api/og?type=drug&title=Modified%20FOLFIRI&subtitle=Modified%20FOLFIRI%20%C2%B7%20AbbVie&badge=phase%202 Modified FOLFIRI Modified FOLFIRI · AbbVie https://druglandscape.com/drug/modified-measles-virus https://druglandscape.com/api/og?type=drug&title=Modified%20Measles%20Virus&subtitle=Modified%20Measles%20Virus%20%C2%B7%20Sabine%20Mueller%2C%20MD%2C%20PhD&badge=phase%201 Modified Measles Virus Modified Measles Virus · Sabine Mueller, MD, PhD https://druglandscape.com/drug/modified-measles-virus-lumbar-puncture https://druglandscape.com/api/og?type=drug&title=Modified%20Measles%20Virus%20Lumbar%20Puncture&subtitle=Modified%20Measles%20Virus%20Lumbar%20Puncture%20%C2%B7%20Sabine%20Mueller%2C%20MD%2C%20PhD&badge=phase%201 Modified Measles Virus Lumbar Puncture Modified Measles Virus Lumbar Puncture · Sabine Mueller, MD, PhD https://druglandscape.com/drug/modified-peritoneal-equilibration-test https://druglandscape.com/api/og?type=drug&title=modified%20Peritoneal%20Equilibration%20test&subtitle=modified%20Peritoneal%20Equilibration%20test%20%C2%B7%20CHU%20de%20Reims&badge=phase%201 modified Peritoneal Equilibration test modified Peritoneal Equilibration test · CHU de Reims https://druglandscape.com/drug/modified-release-morphine https://druglandscape.com/api/og?type=drug&title=Modified-release%20morphine&subtitle=Modified-release%20morphine%20%C2%B7%20Icahn%20School%20of%20Medicine%20at%20Mount%20Sinai&badge=phase%202 Modified-release morphine Modified-release morphine · Icahn School of Medicine at Mount Sinai https://druglandscape.com/drug/modified-release-rhtsh https://druglandscape.com/api/og?type=drug&title=Modified%20Release%20rhTSH&subtitle=Modified%20Release%20rhTSH%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%201 Modified Release rhTSH Modified Release rhTSH · Genzyme, a Sanofi Company https://druglandscape.com/drug/modulation-of-fio2 https://druglandscape.com/api/og?type=drug&title=Modulation%20of%20FiO2&subtitle=Modulation%20of%20FiO2%20%C2%B7%20Amsterdam%20UMC%2C%20location%20VUmc&badge=phase%201 Modulation of FiO2 Modulation of FiO2 · Amsterdam UMC, location VUmc https://druglandscape.com/drug/moisturizer-a-f-9155-005 https://druglandscape.com/api/og?type=drug&title=Moisturizer%20A%2C%20F%239155-005&subtitle=Moisturizer%20A%2C%20F%239155-005%20%C2%B7%20Johnson%20%26%20Johnson%20Consumer%20Inc.%20(J%26JCI)&badge=phase%201 Moisturizer A, F#9155-005 Moisturizer A, F#9155-005 · Johnson & Johnson Consumer Inc. (J&JCI) https://druglandscape.com/drug/mol4239 https://druglandscape.com/api/og?type=drug&title=MOL4239&subtitle=MOL4239%20%C2%B7%20Moleculin%2C%20LLC&badge=phase%202 MOL4239 MOL4239 · Moleculin, LLC https://druglandscape.com/drug/molecular-detection-of-antibiotic-resistance https://druglandscape.com/api/og?type=drug&title=Molecular%20detection%20of%20antibiotic%20resistance&subtitle=Molecular%20detection%20of%20antibiotic%20resistance%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Molecular detection of antibiotic resistance Molecular detection of antibiotic resistance · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/molgramostim-nebulizer-solution https://druglandscape.com/api/og?type=drug&title=Molgramostim%20nebulizer%20solution&subtitle=Molgramostim%20nebulizer%20solution%20%C2%B7%20Savara%20Inc.&badge=phase%202 Molgramostim nebulizer solution Molgramostim nebulizer solution · Savara Inc. https://druglandscape.com/drug/moli1901 https://druglandscape.com/api/og?type=drug&title=Moli1901&subtitle=Moli1901%20%C2%B7%20AOP%20Orphan%20Pharmaceuticals%20AG&badge=phase%202 Moli1901 Moli1901 · AOP Orphan Pharmaceuticals AG https://druglandscape.com/drug/moma-313 https://druglandscape.com/api/og?type=drug&title=MOMA-313&subtitle=MOMA-313%20%C2%B7%20MOMA%20Therapeutics&badge=phase%201 MOMA-313 MOMA-313 · MOMA Therapeutics https://druglandscape.com/drug/moma-341 https://druglandscape.com/api/og?type=drug&title=MOMA-341&subtitle=MOMA-341%20%C2%B7%20MOMA%20Therapeutics&badge=phase%201 MOMA-341 MOMA-341 · MOMA Therapeutics https://druglandscape.com/drug/momelotinib-treatment https://druglandscape.com/api/og?type=drug&title=Momelotinib%20treatment&subtitle=Momelotinib%20treatment%20%C2%B7%20Groupe%20Francophone%20des%20Myelodysplasies&badge=phase%202 Momelotinib treatment Momelotinib treatment · Groupe Francophone des Myelodysplasies https://druglandscape.com/drug/mometasone-furoate-dpi https://druglandscape.com/api/og?type=drug&title=Mometasone%20Furoate%20DPI&subtitle=Mometasone%20Furoate%20DPI%20%C2%B7%20Organon%20and%20Co&badge=phase%202 Mometasone Furoate DPI Mometasone Furoate DPI · Organon and Co https://druglandscape.com/drug/momordica-charantia-extract https://druglandscape.com/api/og?type=drug&title=Momordica%20Charantia%20Extract&subtitle=Momordica%20Charantia%20Extract%20%C2%B7%20Syamsudin%20Abdillah%2CPh.D%2C%20Pharm%20D&badge=phase%202 Momordica Charantia Extract Momordica Charantia Extract · Syamsudin Abdillah,Ph.D, Pharm D https://druglandscape.com/drug/monad-1 https://druglandscape.com/api/og?type=drug&title=Monad%201&subtitle=Monad%201%20%C2%B7%20Citius%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Monad 1 Monad 1 · Citius Pharmaceuticals, Inc. https://druglandscape.com/drug/monad-2 https://druglandscape.com/api/og?type=drug&title=Monad%202&subtitle=Monad%202%20%C2%B7%20Citius%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Monad 2 Monad 2 · Citius Pharmaceuticals, Inc. https://druglandscape.com/drug/monad-3 https://druglandscape.com/api/og?type=drug&title=Monad%203&subtitle=Monad%203%20%C2%B7%20Citius%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Monad 3 Monad 3 · Citius Pharmaceuticals, Inc. https://druglandscape.com/drug/monoclonal-antibody-11d10-anti-idiotype https://druglandscape.com/api/og?type=drug&title=monoclonal%20antibody%2011D10%20anti-idiotype&subtitle=monoclonal%20antibody%2011D10%20anti-idiotype%20%C2%B7%20Alliance%20for%20Clinical%20Trials%20in%20Oncology&badge=phase%202 monoclonal antibody 11D10 anti-idiotype monoclonal antibody 11D10 anti-idiotype · Alliance for Clinical Trials in Oncology https://druglandscape.com/drug/monoclonal-antibody-3h1-alu-gel https://druglandscape.com/api/og?type=drug&title=monoclonal%20antibody%203H1%20Alu%20Gel&subtitle=monoclonal%20antibody%203H1%20Alu%20Gel%20%C2%B7%20Alliance%20for%20Clinical%20Trials%20in%20Oncology&badge=phase%202 monoclonal antibody 3H1 Alu Gel monoclonal antibody 3H1 Alu Gel · Alliance for Clinical Trials in Oncology https://druglandscape.com/drug/monoclonal-antibody-bat6026 https://druglandscape.com/api/og?type=drug&title=Monoclonal%20antibody%20BAT6026&subtitle=Monoclonal%20antibody%20BAT6026%20%C2%B7%20Bio-Thera%20Solutions&badge=phase%201 Monoclonal antibody BAT6026 Monoclonal antibody BAT6026 · Bio-Thera Solutions https://druglandscape.com/drug/monoclonal-antibody-hefi-1 https://druglandscape.com/api/og?type=drug&title=monoclonal%20antibody%20HeFi-1&subtitle=monoclonal%20antibody%20HeFi-1%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%201 monoclonal antibody HeFi-1 monoclonal antibody HeFi-1 · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/monoclonal-antibody-j591 https://druglandscape.com/api/og?type=drug&title=Monoclonal%20Antibody%20J591&subtitle=Monoclonal%20Antibody%20J591%20%C2%B7%20BZL%20Biologics&badge=phase%202 Monoclonal Antibody J591 Monoclonal Antibody J591 · BZL Biologics https://druglandscape.com/drug/monoclonal-antibody-jst-010 https://druglandscape.com/api/og?type=drug&title=Monoclonal%20antibody%20JST-010&subtitle=Monoclonal%20antibody%20JST-010%20%C2%B7%20Just-Evotec%20Biologics&badge=phase%201 Monoclonal antibody JST-010 Monoclonal antibody JST-010 · Just-Evotec Biologics https://druglandscape.com/drug/monoclonal-antibody-rav12 https://druglandscape.com/api/og?type=drug&title=monoclonal%20antibody%20RAV12&subtitle=monoclonal%20antibody%20RAV12%20%C2%B7%20MacroGenics&badge=phase%201 monoclonal antibody RAV12 monoclonal antibody RAV12 · MacroGenics https://druglandscape.com/drug/monolayer-group https://druglandscape.com/api/og?type=drug&title=Monolayer%20group&subtitle=Monolayer%20group%20%C2%B7%20LG%20Chem&badge=phase%201 Monolayer group Monolayer group · LG Chem https://druglandscape.com/drug/monolithic-zirconia https://druglandscape.com/api/og?type=drug&title=Monolithic%20zirconia&subtitle=Monolithic%20zirconia%20%C2%B7%20Universidad%20Complutense%20de%20Madrid&badge=phase%201 Monolithic zirconia Monolithic zirconia · Universidad Complutense de Madrid https://druglandscape.com/drug/monotherapy-chemotherapy https://druglandscape.com/api/og?type=drug&title=monotherapy%20chemotherapy&subtitle=monotherapy%20chemotherapy%20%C2%B7%20CSPC%20Megalith%20Biopharmaceutical%20Co.%2CLtd.&badge=phase%201 monotherapy chemotherapy monotherapy chemotherapy · CSPC Megalith Biopharmaceutical Co.,Ltd. https://druglandscape.com/drug/monovalent-rsv-vaccine https://druglandscape.com/api/og?type=drug&title=Monovalent%20RSV%20Vaccine&subtitle=Monovalent%20RSV%20Vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Monovalent RSV Vaccine Monovalent RSV Vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/monovalent-subvirion-h5n1-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=Monovalent%20subvirion%20H5N1%20influenza%20vaccine&subtitle=Monovalent%20subvirion%20H5N1%20influenza%20vaccine%20%C2%B7%20Sanofi&badge=phase%201 Monovalent subvirion H5N1 influenza vaccine Monovalent subvirion H5N1 influenza vaccine · Sanofi https://druglandscape.com/drug/montelukast-and-levocetirizine-fdc https://druglandscape.com/api/og?type=drug&title=montelukast%20and%20levocetirizine%20FDC&subtitle=montelukast%20and%20levocetirizine%20FDC%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 montelukast and levocetirizine FDC montelukast and levocetirizine FDC · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/montelukast-buccal-film https://druglandscape.com/api/og?type=drug&title=Montelukast%20buccal%20film&subtitle=Montelukast%20buccal%20film%20%C2%B7%20IntelGenx%20Corp.&badge=phase%202 Montelukast buccal film Montelukast buccal film · IntelGenx Corp. https://druglandscape.com/drug/montelukast-in-treatment-of-enl-reaction https://druglandscape.com/api/og?type=drug&title=montelukast%20in%20treatment%20of%20ENL%20reaction&subtitle=montelukast%20in%20treatment%20of%20ENL%20reaction%20%C2%B7%20The%20Leprosy%20Mission%20Bangladesh&badge=phase%201 montelukast in treatment of ENL reaction montelukast in treatment of ENL reaction · The Leprosy Mission Bangladesh https://druglandscape.com/drug/monthly-ranibizumab https://druglandscape.com/api/og?type=drug&title=Monthly%20Ranibizumab&subtitle=Monthly%20Ranibizumab%20%C2%B7%20Brian%20Burke%2C%20MPH&badge=phase%201 Monthly Ranibizumab Monthly Ranibizumab · Brian Burke, MPH https://druglandscape.com/drug/montmorillonite-power https://druglandscape.com/api/og?type=drug&title=Montmorillonite%20Power&subtitle=Montmorillonite%20Power%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Montmorillonite Power Montmorillonite Power · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/mor03087 https://druglandscape.com/api/og?type=drug&title=MOR03087&subtitle=MOR03087%20%C2%B7%20MorphoSys%20AG&badge=phase%201 MOR03087 MOR03087 · MorphoSys AG https://druglandscape.com/drug/mor03087-phase-1-dose-escalation https://druglandscape.com/api/og?type=drug&title=MOR03087%20phase%201%20dose%20escalation&subtitle=MOR03087%20phase%201%20dose%20escalation%20%C2%B7%20MorphoSys%20AG&badge=phase%201 MOR03087 phase 1 dose escalation MOR03087 phase 1 dose escalation · MorphoSys AG https://druglandscape.com/drug/mor103 https://druglandscape.com/api/og?type=drug&title=MOR103&subtitle=MOR103%20%C2%B7%20MorphoSys%20AG&badge=phase%201 MOR103 MOR103 · MorphoSys AG https://druglandscape.com/drug/mor106-multiple-ascending-doses-intravenous https://druglandscape.com/api/og?type=drug&title=MOR106%20multiple%20ascending%20doses%2C%20intravenous&subtitle=MOR106%20multiple%20ascending%20doses%2C%20intravenous%20%C2%B7%20Galapagos%20NV&badge=phase%201 MOR106 multiple ascending doses, intravenous MOR106 multiple ascending doses, intravenous · Galapagos NV https://druglandscape.com/drug/mor106-single-ascending-doses-intravenous https://druglandscape.com/api/og?type=drug&title=MOR106%20single%20ascending%20doses%2C%20intravenous&subtitle=MOR106%20single%20ascending%20doses%2C%20intravenous%20%C2%B7%20Galapagos%20NV&badge=phase%201 MOR106 single ascending doses, intravenous MOR106 single ascending doses, intravenous · Galapagos NV https://druglandscape.com/drug/mor202 https://druglandscape.com/api/og?type=drug&title=MOR202&subtitle=MOR202%20%C2%B7%20HI-Bio%2C%20A%20Biogen%20Company&badge=phase%202 MOR202 MOR202 · HI-Bio, A Biogen Company https://druglandscape.com/drug/morab-009 https://druglandscape.com/api/og?type=drug&title=MORAb-009&subtitle=MORAb-009%20%C2%B7%20Morphotek&badge=phase%202 MORAb-009 MORAb-009 · Morphotek https://druglandscape.com/drug/morab-022 https://druglandscape.com/api/og?type=drug&title=MORAb-022&subtitle=MORAb-022%20%C2%B7%20Morphotek&badge=phase%201 MORAb-022 MORAb-022 · Morphotek https://druglandscape.com/drug/morab-066 https://druglandscape.com/api/og?type=drug&title=MORAb-066&subtitle=MORAb-066%20%C2%B7%20Morphotek&badge=phase%201 MORAb-066 MORAb-066 · Morphotek https://druglandscape.com/drug/morf-057 https://druglandscape.com/api/og?type=drug&title=MORF-057&subtitle=MORF-057%20%C2%B7%20Morphic%20Therapeutic%2C%20Inc.%20(A%20Wholly%20Owned%20Subsidiary%20of%20Eli%20Lilly%20and%20Company)&badge=phase%202 MORF-057 MORF-057 · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) https://druglandscape.com/drug/morphine-hi https://druglandscape.com/api/og?type=drug&title=Morphine%20Hi&subtitle=Morphine%20Hi%20%C2%B7%20mads%20u%20werner&badge=phase%201 Morphine Hi Morphine Hi · mads u werner https://druglandscape.com/drug/morphine-infusion https://druglandscape.com/api/og?type=drug&title=Morphine%20infusion&subtitle=Morphine%20infusion%20%C2%B7%20Cl%C3%ADnica%20de%20Los%20Andes%20IPS&badge=phase%202 Morphine infusion Morphine infusion · Clínica de Los Andes IPS https://druglandscape.com/drug/morphine-ketamine https://druglandscape.com/api/og?type=drug&title=morphine%20ketamine&subtitle=morphine%20ketamine%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 morphine ketamine morphine ketamine · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/morphine-lo https://druglandscape.com/api/og?type=drug&title=morphine%20LO&subtitle=morphine%20LO%20%C2%B7%20mads%20u%20werner&badge=phase%201 morphine LO morphine LO · mads u werner https://druglandscape.com/drug/morphine-plus-nalbuphine https://druglandscape.com/api/og?type=drug&title=Morphine%20plus%20Nalbuphine&subtitle=Morphine%20plus%20Nalbuphine%20%C2%B7%20Abdelrady%20S%20Ibrahim%2C%20MD&badge=phase%202 Morphine plus Nalbuphine Morphine plus Nalbuphine · Abdelrady S Ibrahim, MD https://druglandscape.com/drug/morphine-sulfate-cr-crushed https://druglandscape.com/api/og?type=drug&title=morphine%20sulfate%20CR%20crushed.&subtitle=morphine%20sulfate%20CR%20crushed.%20%C2%B7%20Pfizer&badge=phase%201 morphine sulfate CR crushed. morphine sulfate CR crushed. · Pfizer https://druglandscape.com/drug/morphine-sulfate-sustained-release-capsules https://druglandscape.com/api/og?type=drug&title=morphine%20sulfate%20sustained-release%20capsules&subtitle=morphine%20sulfate%20sustained-release%20capsules%20%C2%B7%20Actavis%20Inc.&badge=phase%201 morphine sulfate sustained-release capsules morphine sulfate sustained-release capsules · Actavis Inc. https://druglandscape.com/drug/mosaic-sosips https://druglandscape.com/api/og?type=drug&title=Mosaic%20SOSIPs&subtitle=Mosaic%20SOSIPs%20%C2%B7%20Imperial%20College%20London&badge=phase%201 Mosaic SOSIPs Mosaic SOSIPs · Imperial College London https://druglandscape.com/drug/mosquito-bite-chmi https://druglandscape.com/api/og?type=drug&title=Mosquito-bite%20CHMI&subtitle=Mosquito-bite%20CHMI%20%C2%B7%20Sanaria%20Inc.&badge=phase%201 Mosquito-bite CHMI Mosquito-bite CHMI · Sanaria Inc. https://druglandscape.com/drug/mosunetuzumab-in-combination-with-zanubrutinib https://druglandscape.com/api/og?type=drug&title=Mosunetuzumab%20in%20combination%20with%20Zanubrutinib&subtitle=Mosunetuzumab%20in%20combination%20with%20Zanubrutinib%20%C2%B7%20Fondazione%20Italiana%20Linfomi%20-%20ETS&badge=phase%202 Mosunetuzumab in combination with Zanubrutinib Mosunetuzumab in combination with Zanubrutinib · Fondazione Italiana Linfomi - ETS https://druglandscape.com/drug/motavizumab-palivizumab https://druglandscape.com/api/og?type=drug&title=Motavizumab%2C%20palivizumab&subtitle=Motavizumab%2C%20palivizumab%20%C2%B7%20MedImmune%20LLC&badge=phase%202 Motavizumab, palivizumab Motavizumab, palivizumab · MedImmune LLC https://druglandscape.com/drug/mouth-washing https://druglandscape.com/api/og?type=drug&title=Mouth%20washing&subtitle=Mouth%20washing%20%C2%B7%20Ameritek%20USA&badge=phase%201 Mouth washing Mouth washing · Ameritek USA https://druglandscape.com/drug/mov18-ige https://druglandscape.com/api/og?type=drug&title=MOv18%20IgE&subtitle=MOv18%20IgE%20%C2%B7%20Cancer%20Research%20UK&badge=phase%201 MOv18 IgE MOv18 IgE · Cancer Research UK https://druglandscape.com/drug/moxidectin-oral-product https://druglandscape.com/api/og?type=drug&title=Moxidectin%20Oral%20Product&subtitle=Moxidectin%20Oral%20Product%20%C2%B7%20Medicines%20Development%20for%20Global%20Health&badge=phase%202 Moxidectin Oral Product Moxidectin Oral Product · Medicines Development for Global Health https://druglandscape.com/drug/moxifloxacin-and-cobicistat https://druglandscape.com/api/og?type=drug&title=Moxifloxacin%20and%20Cobicistat&subtitle=Moxifloxacin%20and%20Cobicistat%20%C2%B7%20Food%20and%20Drug%20Administration%20(FDA)&badge=phase%201 Moxifloxacin and Cobicistat Moxifloxacin and Cobicistat · Food and Drug Administration (FDA) https://druglandscape.com/drug/moxifloxacin-infusion https://druglandscape.com/api/og?type=drug&title=Moxifloxacin%20infusion&subtitle=Moxifloxacin%20infusion%20%C2%B7%20UCB%20Pharma&badge=phase%201 Moxifloxacin infusion Moxifloxacin infusion · UCB Pharma https://druglandscape.com/drug/moxifloxacin-treatment-c https://druglandscape.com/api/og?type=drug&title=Moxifloxacin%20Treatment%20C&subtitle=Moxifloxacin%20Treatment%20C%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 Moxifloxacin Treatment C Moxifloxacin Treatment C · Hoffmann-La Roche https://druglandscape.com/drug/moxifloxacin-treatment-d https://druglandscape.com/api/og?type=drug&title=Moxifloxacin%20Treatment%20D&subtitle=Moxifloxacin%20Treatment%20D%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 Moxifloxacin Treatment D Moxifloxacin Treatment D · Hoffmann-La Roche https://druglandscape.com/drug/mp-214 https://druglandscape.com/api/og?type=drug&title=MP-214&subtitle=MP-214%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MP-214 MP-214 · Tanabe Pharma Corporation https://druglandscape.com/drug/mp-3180 https://druglandscape.com/api/og?type=drug&title=MP-3180&subtitle=MP-3180%20%C2%B7%20MediBeacon&badge=phase%201 MP-3180 MP-3180 · MediBeacon https://druglandscape.com/drug/mp-376 https://druglandscape.com/api/og?type=drug&title=MP-376&subtitle=MP-376%20%C2%B7%20Amgen&badge=phase%202 MP-376 MP-376 · Amgen https://druglandscape.com/drug/mp-470 https://druglandscape.com/api/og?type=drug&title=MP-470&subtitle=MP-470%20%C2%B7%20Astex%20Pharmaceuticals%2C%20Inc.&badge=phase%201 MP-470 MP-470 · Astex Pharmaceuticals, Inc. https://druglandscape.com/drug/mp-513-high-dose-and-metformin https://druglandscape.com/api/og?type=drug&title=MP-513%20High%20Dose%20and%20Metformin&subtitle=MP-513%20High%20Dose%20and%20Metformin%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MP-513 High Dose and Metformin MP-513 High Dose and Metformin · Tanabe Pharma Corporation https://druglandscape.com/drug/mp-513-low-dose-and-metformin https://druglandscape.com/api/og?type=drug&title=MP-513%20Low%20Dose%20and%20Metformin&subtitle=MP-513%20Low%20Dose%20and%20Metformin%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MP-513 Low Dose and Metformin MP-513 Low Dose and Metformin · Tanabe Pharma Corporation https://druglandscape.com/drug/mp-513-lowest-dose-and-metformin https://druglandscape.com/api/og?type=drug&title=MP-513%20Lowest%20Dose%20and%20Metformin&subtitle=MP-513%20Lowest%20Dose%20and%20Metformin%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MP-513 Lowest Dose and Metformin MP-513 Lowest Dose and Metformin · Tanabe Pharma Corporation https://druglandscape.com/drug/mp-513-medium-dose-and-metformin https://druglandscape.com/api/og?type=drug&title=MP-513%20Medium%20Dose%20and%20Metformin&subtitle=MP-513%20Medium%20Dose%20and%20Metformin%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MP-513 Medium Dose and Metformin MP-513 Medium Dose and Metformin · Tanabe Pharma Corporation https://druglandscape.com/drug/mp0250 https://druglandscape.com/api/og?type=drug&title=MP0250&subtitle=MP0250%20%C2%B7%20Molecular%20Partners%20AG&badge=phase%201 MP0250 MP0250 · Molecular Partners AG https://druglandscape.com/drug/mp0274 https://druglandscape.com/api/og?type=drug&title=MP0274&subtitle=MP0274%20%C2%B7%20Molecular%20Partners%20AG&badge=phase%201 MP0274 MP0274 · Molecular Partners AG https://druglandscape.com/drug/mp0310 https://druglandscape.com/api/og?type=drug&title=MP0310&subtitle=MP0310%20%C2%B7%20Molecular%20Partners%20AG&badge=phase%201 MP0310 MP0310 · Molecular Partners AG https://druglandscape.com/drug/mp0533-with-obinutuzumab-pretreatment https://druglandscape.com/api/og?type=drug&title=MP0533%20with%20Obinutuzumab%20pretreatment&subtitle=MP0533%20with%20Obinutuzumab%20pretreatment%20%C2%B7%20Molecular%20Partners%20AG&badge=phase%201 MP0533 with Obinutuzumab pretreatment MP0533 with Obinutuzumab pretreatment · Molecular Partners AG https://druglandscape.com/drug/mp1032 https://druglandscape.com/api/og?type=drug&title=MP1032&subtitle=MP1032%20%C2%B7%20MetrioPharm%20AG&badge=phase%202 MP1032 MP1032 · MetrioPharm AG https://druglandscape.com/drug/mpb-1734 https://druglandscape.com/api/og?type=drug&title=MPB-1734&subtitle=MPB-1734%20%C2%B7%20MegaPro%20Biomedical%20Co.%20Ltd.&badge=phase%201 MPB-1734 MPB-1734 · MegaPro Biomedical Co. Ltd. https://druglandscape.com/drug/mpc-6827 https://druglandscape.com/api/og?type=drug&title=MPC-6827&subtitle=MPC-6827%20%C2%B7%20Myrexis%20Inc.&badge=phase%201 MPC-6827 MPC-6827 · Myrexis Inc. https://druglandscape.com/drug/mpff https://druglandscape.com/api/og?type=drug&title=MPFF&subtitle=MPFF%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%202 MPFF MPFF · Pierre Fabre Medicament https://druglandscape.com/drug/mpnc-control https://druglandscape.com/api/og?type=drug&title=mPnC%20control&subtitle=mPnC%20control%20%C2%B7%20Pfizer&badge=phase%202 mPnC control mPnC control · Pfizer https://druglandscape.com/drug/mpsk3169a https://druglandscape.com/api/og?type=drug&title=MPSK3169A&subtitle=MPSK3169A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 MPSK3169A MPSK3169A · Genentech, Inc. https://druglandscape.com/drug/mpt-0118 https://druglandscape.com/api/og?type=drug&title=MPT-0118&subtitle=MPT-0118%20%C2%B7%20Monopteros%20Therapeutics%20Inc.&badge=phase%201 MPT-0118 MPT-0118 · Monopteros Therapeutics Inc. https://druglandscape.com/drug/mqx-503 https://druglandscape.com/api/og?type=drug&title=MQX-503&subtitle=MQX-503%20%C2%B7%20MediQuest%20Therapeutics&badge=phase%202 MQX-503 MQX-503 · MediQuest Therapeutics https://druglandscape.com/drug/mr-107a-01 https://druglandscape.com/api/og?type=drug&title=MR-107A-01&subtitle=MR-107A-01%20%C2%B7%20Mylan%20Inc.&badge=phase%202 MR-107A-01 MR-107A-01 · Mylan Inc. https://druglandscape.com/drug/mr-130a-01-transdermal-patch https://druglandscape.com/api/og?type=drug&title=MR-130A-01%20Transdermal%20patch&subtitle=MR-130A-01%20Transdermal%20patch%20%C2%B7%20Mylan%20Pharmaceuticals%20Inc&badge=phase%202 MR-130A-01 Transdermal patch MR-130A-01 Transdermal patch · Mylan Pharmaceuticals Inc https://druglandscape.com/drug/mr-mc-01 https://druglandscape.com/api/og?type=drug&title=MR-MC-01&subtitle=MR-MC-01%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 MR-MC-01 MR-MC-01 · Asan Medical Center https://druglandscape.com/drug/mr-vaccine-sii https://druglandscape.com/api/og?type=drug&title=MR%20Vaccine%20SII&subtitle=MR%20Vaccine%20SII%20%C2%B7%20PT%20Bio%20Farma&badge=phase%202 MR Vaccine SII MR Vaccine SII · PT Bio Farma https://druglandscape.com/drug/mr1817 https://druglandscape.com/api/og?type=drug&title=MR1817&subtitle=MR1817%20%C2%B7%20Mochida%20Pharmaceutical%20Company%2C%20Ltd.&badge=phase%201 MR1817 MR1817 · Mochida Pharmaceutical Company, Ltd. https://druglandscape.com/drug/mr1xxx https://druglandscape.com/api/og?type=drug&title=MR1XXX&subtitle=MR1XXX%20%C2%B7%20Mundipharma%20Research%20Limited&badge=phase%201 MR1XXX MR1XXX · Mundipharma Research Limited https://druglandscape.com/drug/mr2xxx https://druglandscape.com/api/og?type=drug&title=MR2XXX&subtitle=MR2XXX%20%C2%B7%20Mundipharma%20Research%20Limited&badge=phase%201 MR2XXX MR2XXX · Mundipharma Research Limited https://druglandscape.com/drug/mr3xxx https://druglandscape.com/api/og?type=drug&title=MR3XXX&subtitle=MR3XXX%20%C2%B7%20Mundipharma%20Research%20Limited&badge=phase%201 MR3XXX MR3XXX · Mundipharma Research Limited https://druglandscape.com/drug/mr902 https://druglandscape.com/api/og?type=drug&title=MR902&subtitle=MR902%20%C2%B7%20Mundipharma%20Research%20Limited&badge=phase%201 MR902 MR902 · Mundipharma Research Limited https://druglandscape.com/drug/mrcp001 https://druglandscape.com/api/og?type=drug&title=MRCP001&subtitle=MRCP001%20%C2%B7%20Aurora%20Cannabis%20Inc&badge=phase%202 MRCP001 MRCP001 · Aurora Cannabis Inc https://druglandscape.com/drug/mrg-001 https://druglandscape.com/api/og?type=drug&title=MRG-001&subtitle=MRG-001%20%C2%B7%20MedRegen%20LLC&badge=phase%202 MRG-001 MRG-001 · MedRegen LLC https://druglandscape.com/drug/mrg-110 https://druglandscape.com/api/og?type=drug&title=MRG-110&subtitle=MRG-110%20%C2%B7%20miRagen%20Therapeutics%2C%20Inc.&badge=phase%201 MRG-110 MRG-110 · miRagen Therapeutics, Inc. https://druglandscape.com/drug/mrg-201 https://druglandscape.com/api/og?type=drug&title=MRG-201&subtitle=MRG-201%20%C2%B7%20miRagen%20Therapeutics%2C%20Inc.&badge=phase%201 MRG-201 MRG-201 · miRagen Therapeutics, Inc. https://druglandscape.com/drug/mrg001 https://druglandscape.com/api/og?type=drug&title=MRG001&subtitle=MRG001%20%C2%B7%20Shanghai%20Miracogen%20Inc.&badge=phase%201 MRG001 MRG001 · Shanghai Miracogen Inc. https://druglandscape.com/drug/mrg006a https://druglandscape.com/api/og?type=drug&title=MRG006A&subtitle=MRG006A%20%C2%B7%20Lepu%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 MRG006A MRG006A · Lepu Biopharma Co., Ltd. https://druglandscape.com/drug/mrg007 https://druglandscape.com/api/og?type=drug&title=MRG007&subtitle=MRG007%20%C2%B7%20ArriVent%20BioPharma%2C%20Inc.&badge=phase%201 MRG007 MRG007 · ArriVent BioPharma, Inc. https://druglandscape.com/drug/mri-tracer https://druglandscape.com/api/og?type=drug&title=MRI%20Tracer&subtitle=MRI%20Tracer%20%C2%B7%20NYU%20Langone%20Health&badge=phase%202 MRI Tracer MRI Tracer · NYU Langone Health https://druglandscape.com/drug/mrna-1010-2 https://druglandscape.com/api/og?type=drug&title=mRNA-1010.2&subtitle=mRNA-1010.2%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1010.2 mRNA-1010.2 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1010-3 https://druglandscape.com/api/og?type=drug&title=mRNA-1010.3&subtitle=mRNA-1010.3%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1010.3 mRNA-1010.3 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1010-4 https://druglandscape.com/api/og?type=drug&title=mRNA-1010.4&subtitle=mRNA-1010.4%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1010.4 mRNA-1010.4 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1010-6 https://druglandscape.com/api/og?type=drug&title=mRNA-1010.6&subtitle=mRNA-1010.6%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1010.6 mRNA-1010.6 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1011-1 https://druglandscape.com/api/og?type=drug&title=mRNA-1011.1&subtitle=mRNA-1011.1%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1011.1 mRNA-1011.1 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1011-2 https://druglandscape.com/api/og?type=drug&title=mRNA-1011.2&subtitle=mRNA-1011.2%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1011.2 mRNA-1011.2 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1012-1 https://druglandscape.com/api/og?type=drug&title=mRNA-1012.1&subtitle=mRNA-1012.1%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1012.1 mRNA-1012.1 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1018-for-h5-only https://druglandscape.com/api/og?type=drug&title=mRNA-1018%20for%20H5%20Only&subtitle=mRNA-1018%20for%20H5%20Only%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1018 for H5 Only mRNA-1018 for H5 Only · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1018-for-h5-only-cg https://druglandscape.com/api/og?type=drug&title=mRNA-1018%20for%20H5%20Only-CG&subtitle=mRNA-1018%20for%20H5%20Only-CG%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1018 for H5 Only-CG mRNA-1018 for H5 Only-CG · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1018-for-h5n8 https://druglandscape.com/api/og?type=drug&title=mRNA-1018%20for%20H5N8&subtitle=mRNA-1018%20for%20H5N8%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1018 for H5N8 mRNA-1018 for H5N8 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1018-for-h7-only https://druglandscape.com/api/og?type=drug&title=mRNA-1018%20for%20H7%20Only&subtitle=mRNA-1018%20for%20H7%20Only%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1018 for H7 Only mRNA-1018 for H7 Only · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1018-for-h7n9 https://druglandscape.com/api/og?type=drug&title=mRNA-1018%20for%20H7N9&subtitle=mRNA-1018%20for%20H7N9%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1018 for H7N9 mRNA-1018 for H7N9 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1030 https://druglandscape.com/api/og?type=drug&title=mRNA-1030&subtitle=mRNA-1030%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1030 mRNA-1030 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1045 https://druglandscape.com/api/og?type=drug&title=mRNA-1045&subtitle=mRNA-1045%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1045 mRNA-1045 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1073 https://druglandscape.com/api/og?type=drug&title=mRNA-1073&subtitle=mRNA-1073%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1073 mRNA-1073 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1083-2 https://druglandscape.com/api/og?type=drug&title=mRNA-1083.2&subtitle=mRNA-1083.2%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1083.2 mRNA-1083.2 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1083-3 https://druglandscape.com/api/og?type=drug&title=mRNA-1083.3&subtitle=mRNA-1083.3%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1083.3 mRNA-1083.3 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1083-composition-1-dose-a-lot-a https://druglandscape.com/api/og?type=drug&title=mRNA-1083%20Composition%201%20Dose%20A%20Lot%20A&subtitle=mRNA-1083%20Composition%201%20Dose%20A%20Lot%20A%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1083 Composition 1 Dose A Lot A mRNA-1083 Composition 1 Dose A Lot A · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1083-composition-1-dose-a-lot-b https://druglandscape.com/api/og?type=drug&title=mRNA-1083%20Composition%201%20Dose%20A%20Lot%20B&subtitle=mRNA-1083%20Composition%201%20Dose%20A%20Lot%20B%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1083 Composition 1 Dose A Lot B mRNA-1083 Composition 1 Dose A Lot B · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1083-composition-1-dose-b https://druglandscape.com/api/og?type=drug&title=mRNA-1083%20Composition%201%20Dose%20B&subtitle=mRNA-1083%20Composition%201%20Dose%20B%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1083 Composition 1 Dose B mRNA-1083 Composition 1 Dose B · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1083-composition-1-dose-c https://druglandscape.com/api/og?type=drug&title=mRNA-1083%20Composition%201%20Dose%20C&subtitle=mRNA-1083%20Composition%201%20Dose%20C%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1083 Composition 1 Dose C mRNA-1083 Composition 1 Dose C · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1083-composition-2-dose-a https://druglandscape.com/api/og?type=drug&title=mRNA-1083%20Composition%202%20Dose%20A&subtitle=mRNA-1083%20Composition%202%20Dose%20A%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1083 Composition 2 Dose A mRNA-1083 Composition 2 Dose A · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1083-composition-2-dose-b https://druglandscape.com/api/og?type=drug&title=mRNA-1083%20Composition%202%20Dose%20B&subtitle=mRNA-1083%20Composition%202%20Dose%20B%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1083 Composition 2 Dose B mRNA-1083 Composition 2 Dose B · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1083-composition-3-dose-a https://druglandscape.com/api/og?type=drug&title=mRNA-1083%20Composition%203%20Dose%20A&subtitle=mRNA-1083%20Composition%203%20Dose%20A%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1083 Composition 3 Dose A mRNA-1083 Composition 3 Dose A · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1083-composition-3-dose-b https://druglandscape.com/api/og?type=drug&title=mRNA-1083%20Composition%203%20Dose%20B&subtitle=mRNA-1083%20Composition%203%20Dose%20B%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1083 Composition 3 Dose B mRNA-1083 Composition 3 Dose B · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1189 https://druglandscape.com/api/og?type=drug&title=mRNA-1189&subtitle=mRNA-1189%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1189 mRNA-1189 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1195 https://druglandscape.com/api/og?type=drug&title=mRNA-1195&subtitle=mRNA-1195%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1195 mRNA-1195 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1195-1 https://druglandscape.com/api/og?type=drug&title=mRNA-1195.1&subtitle=mRNA-1195.1%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1195.1 mRNA-1195.1 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1195-2 https://druglandscape.com/api/og?type=drug&title=mRNA-1195.2&subtitle=mRNA-1195.2%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1195.2 mRNA-1195.2 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1273-213 https://druglandscape.com/api/og?type=drug&title=mRNA-1273.213&subtitle=mRNA-1273.213%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1273.213 mRNA-1273.213 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1273-214-vaccine https://druglandscape.com/api/og?type=drug&title=mRNA-1273.214%20Vaccine&subtitle=mRNA-1273.214%20Vaccine%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%202 mRNA-1273.214 Vaccine mRNA-1273.214 Vaccine · Sheba Medical Center https://druglandscape.com/drug/mrna-1273-222 https://druglandscape.com/api/og?type=drug&title=mRNA-1273.222&subtitle=mRNA-1273.222%20%C2%B7%20National%20Institute%20of%20Allergy%20and%20Infectious%20Diseases%20(NIAID)&badge=phase%203 mRNA-1273.222 mRNA-1273.222 · National Institute of Allergy and Infectious Diseases (NIAID) https://druglandscape.com/drug/mrna-1273-222-vaccine https://druglandscape.com/api/og?type=drug&title=MRNA-1273.222%20Vaccine&subtitle=MRNA-1273.222%20Vaccine%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%202 MRNA-1273.222 Vaccine MRNA-1273.222 Vaccine · Sheba Medical Center https://druglandscape.com/drug/mrna-1273-231 https://druglandscape.com/api/og?type=drug&title=mRNA-1273.231&subtitle=mRNA-1273.231%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1273.231 mRNA-1273.231 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1273-529 https://druglandscape.com/api/og?type=drug&title=mRNA-1273.529&subtitle=mRNA-1273.529%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1273.529 mRNA-1273.529 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1273-815 https://druglandscape.com/api/og?type=drug&title=mRNA-1273.815&subtitle=mRNA-1273.815%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%203 mRNA-1273.815 mRNA-1273.815 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1273-sars-cov-2-vaccine https://druglandscape.com/api/og?type=drug&title=mRNA-1273%20SARS-CoV-2%20vaccine&subtitle=mRNA-1273%20SARS-CoV-2%20vaccine%20%C2%B7%20Canadian%20Immunization%20Research%20Network&badge=phase%202 mRNA-1273 SARS-CoV-2 vaccine mRNA-1273 SARS-CoV-2 vaccine · Canadian Immunization Research Network https://druglandscape.com/drug/mrna-1283-211 https://druglandscape.com/api/og?type=drug&title=mRNA-1283.211&subtitle=mRNA-1283.211%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1283.211 mRNA-1283.211 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1283-529 https://druglandscape.com/api/og?type=drug&title=mRNA-1283.529&subtitle=mRNA-1283.529%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-1283.529 mRNA-1283.529 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1325 https://druglandscape.com/api/og?type=drug&title=mRNA-1325&subtitle=mRNA-1325%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1325 mRNA-1325 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1365 https://druglandscape.com/api/og?type=drug&title=mRNA-1365&subtitle=mRNA-1365%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1365 mRNA-1365 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1405 https://druglandscape.com/api/og?type=drug&title=mRNA-1405&subtitle=mRNA-1405%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1405 mRNA-1405 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1443 https://druglandscape.com/api/og?type=drug&title=mRNA-1443&subtitle=mRNA-1443%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1443 mRNA-1443 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1468 https://druglandscape.com/api/og?type=drug&title=mRNA-1468&subtitle=mRNA-1468%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1468 mRNA-1468 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1608 https://druglandscape.com/api/og?type=drug&title=mRNA-1608&subtitle=mRNA-1608%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1608 mRNA-1608 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1653 https://druglandscape.com/api/og?type=drug&title=mRNA-1653&subtitle=mRNA-1653%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1653 mRNA-1653 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1944 https://druglandscape.com/api/og?type=drug&title=mRNA-1944&subtitle=mRNA-1944%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1944 mRNA-1944 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1975 https://druglandscape.com/api/og?type=drug&title=mRNA-1975&subtitle=mRNA-1975%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1975 mRNA-1975 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-1982 https://druglandscape.com/api/og?type=drug&title=mRNA-1982&subtitle=mRNA-1982%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-1982 mRNA-1982 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-2752 https://druglandscape.com/api/og?type=drug&title=mRNA-2752&subtitle=mRNA-2752%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-2752 mRNA-2752 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-2808 https://druglandscape.com/api/og?type=drug&title=mRNA-2808&subtitle=mRNA-2808%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-2808 mRNA-2808 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-3705 https://druglandscape.com/api/og?type=drug&title=mRNA-3705&subtitle=mRNA-3705%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-3705 mRNA-3705 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-3745 https://druglandscape.com/api/og?type=drug&title=mRNA-3745&subtitle=mRNA-3745%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-3745 mRNA-3745 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-4106 https://druglandscape.com/api/og?type=drug&title=mRNA-4106&subtitle=mRNA-4106%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-4106 mRNA-4106 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-4157 https://druglandscape.com/api/og?type=drug&title=mRNA-4157&subtitle=mRNA-4157%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 mRNA-4157 mRNA-4157 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-4203 https://druglandscape.com/api/og?type=drug&title=mRNA-4203&subtitle=mRNA-4203%20%C2%B7%20Immatics%20US%2C%20Inc.&badge=phase%201 mRNA-4203 mRNA-4203 · Immatics US, Inc. https://druglandscape.com/drug/mrna-4359 https://druglandscape.com/api/og?type=drug&title=mRNA-4359&subtitle=mRNA-4359%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-4359 mRNA-4359 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-6231 https://druglandscape.com/api/og?type=drug&title=mRNA-6231&subtitle=mRNA-6231%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 mRNA-6231 mRNA-6231 · ModernaTX, Inc. https://druglandscape.com/drug/mrna-na-vaccine https://druglandscape.com/api/og?type=drug&title=mRNA%20NA%20vaccine&subtitle=mRNA%20NA%20vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 mRNA NA vaccine mRNA NA vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/mrna-transfected-dendritic-cell https://druglandscape.com/api/og?type=drug&title=mRNA%20transfected%20dendritic%20cell&subtitle=mRNA%20transfected%20dendritic%20cell%20%C2%B7%20Inge%20Marie%20Svane&badge=phase%202 mRNA transfected dendritic cell mRNA transfected dendritic cell · Inge Marie Svane https://druglandscape.com/drug/mrna1273-vaccine https://druglandscape.com/api/og?type=drug&title=mRNA1273%20vaccine&subtitle=mRNA1273%20vaccine%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%203 mRNA1273 vaccine mRNA1273 vaccine · Sheba Medical Center https://druglandscape.com/drug/mrrhtsh https://druglandscape.com/api/og?type=drug&title=MRrhTSH&subtitle=MRrhTSH%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%202 MRrhTSH MRrhTSH · Genzyme, a Sanofi Company https://druglandscape.com/drug/mrt-6160 https://druglandscape.com/api/og?type=drug&title=MRT-6160&subtitle=MRT-6160%20%C2%B7%20Monte%20Rosa%20Therapeutics%2C%20Inc&badge=phase%201 MRT-6160 MRT-6160 · Monte Rosa Therapeutics, Inc https://druglandscape.com/drug/mrt-8102 https://druglandscape.com/api/og?type=drug&title=MRT-8102&subtitle=MRT-8102%20%C2%B7%20Monte%20Rosa%20Therapeutics%2C%20Inc&badge=phase%201 MRT-8102 MRT-8102 · Monte Rosa Therapeutics, Inc https://druglandscape.com/drug/mrt5005 https://druglandscape.com/api/og?type=drug&title=MRT5005&subtitle=MRT5005%20%C2%B7%20Sanofi&badge=phase%201 MRT5005 MRT5005 · Sanofi https://druglandscape.com/drug/mrtx1719 https://druglandscape.com/api/og?type=drug&title=MRTX1719&subtitle=MRTX1719%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 MRTX1719 MRTX1719 · Bristol-Myers Squibb https://druglandscape.com/drug/mrx-4-co-administered-with-omeprazole https://druglandscape.com/api/og?type=drug&title=MRX-4%20co-administered%20with%20omeprazole&subtitle=MRX-4%20co-administered%20with%20omeprazole%20%C2%B7%20MicuRx&badge=phase%201 MRX-4 co-administered with omeprazole MRX-4 co-administered with omeprazole · MicuRx https://druglandscape.com/drug/mrx-8 https://druglandscape.com/api/og?type=drug&title=MRX-8&subtitle=MRX-8%20%C2%B7%20MicuRx&badge=phase%201 MRX-8 MRX-8 · MicuRx https://druglandscape.com/drug/mrx-i https://druglandscape.com/api/og?type=drug&title=MRX-I&subtitle=MRX-I%20%C2%B7%20MicuRx&badge=phase%202 MRX-I MRX-I · MicuRx https://druglandscape.com/drug/mrx0518-capsules https://druglandscape.com/api/og?type=drug&title=MRx0518%20Capsules&subtitle=MRx0518%20Capsules%20%C2%B7%20Imperial%20College%20London&badge=phase%201 MRx0518 Capsules MRx0518 Capsules · Imperial College London https://druglandscape.com/drug/mrx2843 https://druglandscape.com/api/og?type=drug&title=MRX2843&subtitle=MRX2843%20%C2%B7%20Betta%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 MRX2843 MRX2843 · Betta Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/mrxxx https://druglandscape.com/api/og?type=drug&title=MRXXX&subtitle=MRXXX%20%C2%B7%20Mundipharma%20Research%20Limited&badge=phase%201 MRXXX MRXXX · Mundipharma Research Limited https://druglandscape.com/drug/mrxxx-and-mr1xxx https://druglandscape.com/api/og?type=drug&title=MRXXX%20and%20MR1XXX&subtitle=MRXXX%20and%20MR1XXX%20%C2%B7%20Mundipharma%20Research%20Limited&badge=phase%201 MRXXX and MR1XXX MRXXX and MR1XXX · Mundipharma Research Limited https://druglandscape.com/drug/ms-553 https://druglandscape.com/api/og?type=drug&title=MS-553&subtitle=MS-553%20%C2%B7%20MingSight%20Pharmaceuticals%2C%20Inc&badge=phase%201 MS-553 MS-553 · MingSight Pharmaceuticals, Inc https://druglandscape.com/drug/ms-553-ds1 https://druglandscape.com/api/og?type=drug&title=MS-553%2C%20DS1&subtitle=MS-553%2C%20DS1%20%C2%B7%20MingSight%20Pharmaceuticals%2C%20Inc&badge=phase%201 MS-553, DS1 MS-553, DS1 · MingSight Pharmaceuticals, Inc https://druglandscape.com/drug/ms-553-ds2 https://druglandscape.com/api/og?type=drug&title=MS-553%2C%20DS2&subtitle=MS-553%2C%20DS2%20%C2%B7%20MingSight%20Pharmaceuticals%2C%20Inc&badge=phase%201 MS-553, DS2 MS-553, DS2 · MingSight Pharmaceuticals, Inc https://druglandscape.com/drug/ms-continus https://druglandscape.com/api/og?type=drug&title=MS%20Continus%C2%AE&subtitle=MS%20Continus%C2%AE%20%C2%B7%20Tris%20Pharma%2C%20Inc.&badge=phase%202 MS Continus® MS Continus® · Tris Pharma, Inc. https://druglandscape.com/drug/ms1819-sd https://druglandscape.com/api/og?type=drug&title=MS1819-SD&subtitle=MS1819-SD%20%C2%B7%20AzurRx%20SAS&badge=phase%202 MS1819-SD MS1819-SD · AzurRx SAS https://druglandscape.com/drug/msb-car001-combined-with-hyaluronan https://druglandscape.com/api/og?type=drug&title=MSB-CAR001%20Combined%20With%20Hyaluronan&subtitle=MSB-CAR001%20Combined%20With%20Hyaluronan%20%C2%B7%20Mesoblast%2C%20Ltd.&badge=phase%201 MSB-CAR001 Combined With Hyaluronan MSB-CAR001 Combined With Hyaluronan · Mesoblast, Ltd. https://druglandscape.com/drug/msb0010841 https://druglandscape.com/api/og?type=drug&title=MSB0010841&subtitle=MSB0010841%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 MSB0010841 MSB0010841 · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/msb0011359c https://druglandscape.com/api/og?type=drug&title=MSB0011359C&subtitle=MSB0011359C%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%202 MSB0011359C MSB0011359C · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/msb11455 https://druglandscape.com/api/og?type=drug&title=MSB11455&subtitle=MSB11455%20%C2%B7%20Fresenius%20Kabi%20SwissBioSim%20GmbH&badge=phase%201 MSB11455 MSB11455 · Fresenius Kabi SwissBioSim GmbH https://druglandscape.com/drug/msc-1 https://druglandscape.com/api/og?type=drug&title=MSC-1&subtitle=MSC-1%20%C2%B7%20AstraZeneca&badge=phase%201 MSC-1 MSC-1 · AstraZeneca https://druglandscape.com/drug/msc-construct-for-osteonecrosis https://druglandscape.com/api/og?type=drug&title=MSC%20construct%20for%20Osteonecrosis&subtitle=MSC%20construct%20for%20Osteonecrosis%20%C2%B7%20Red%20de%20Terapia%20Celular&badge=phase%201 MSC construct for Osteonecrosis MSC construct for Osteonecrosis · Red de Terapia Celular https://druglandscape.com/drug/msc-plga https://druglandscape.com/api/og?type=drug&title=MSC-PLGA&subtitle=MSC-PLGA%20%C2%B7%20Sophia%20Al-Adwan&badge=phase%201 MSC-PLGA MSC-PLGA · Sophia Al-Adwan https://druglandscape.com/drug/msc-treatment https://druglandscape.com/api/og?type=drug&title=MSC%20treatment&subtitle=MSC%20treatment%20%C2%B7%20Universidad%20de%20los%20Andes%2C%20Chile&badge=phase%202 MSC treatment MSC treatment · Universidad de los Andes, Chile https://druglandscape.com/drug/msc1936369b https://druglandscape.com/api/og?type=drug&title=MSC1936369B&subtitle=MSC1936369B%20%C2%B7%20Sanofi&badge=phase%201 MSC1936369B MSC1936369B · Sanofi https://druglandscape.com/drug/msc2156119j https://druglandscape.com/api/og?type=drug&title=MSC2156119J&subtitle=MSC2156119J%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 MSC2156119J MSC2156119J · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/msc2363318a https://druglandscape.com/api/og?type=drug&title=MSC2363318A&subtitle=MSC2363318A%20%C2%B7%20EMD%20Serono&badge=phase%201 MSC2363318A MSC2363318A · EMD Serono https://druglandscape.com/drug/msc2363318a-plus-tamoxifen https://druglandscape.com/api/og?type=drug&title=MSC2363318A%20plus%20Tamoxifen&subtitle=MSC2363318A%20plus%20Tamoxifen%20%C2%B7%20EMD%20Serono&badge=phase%201 MSC2363318A plus Tamoxifen MSC2363318A plus Tamoxifen · EMD Serono https://druglandscape.com/drug/msc2363318a-plus-trastuzumab https://druglandscape.com/api/og?type=drug&title=MSC2363318A%20plus%20Trastuzumab&subtitle=MSC2363318A%20plus%20Trastuzumab%20%C2%B7%20EMD%20Serono&badge=phase%201 MSC2363318A plus Trastuzumab MSC2363318A plus Trastuzumab · EMD Serono https://druglandscape.com/drug/msc2499550a https://druglandscape.com/api/og?type=drug&title=MSC2499550A&subtitle=MSC2499550A%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 MSC2499550A MSC2499550A · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/mscohi-o-lenses https://druglandscape.com/api/og?type=drug&title=MSCohi-O%20Lenses&subtitle=MSCohi-O%20Lenses%20%C2%B7%20Guangdong%20ProCapZoom%20Biosciences%20Co.%2C%20Ltd.&badge=phase%201 MSCohi-O Lenses MSCohi-O Lenses · Guangdong ProCapZoom Biosciences Co., Ltd. https://druglandscape.com/drug/msctc-0010 https://druglandscape.com/api/og?type=drug&title=MSCTC-0010&subtitle=MSCTC-0010%20%C2%B7%20IMAC%20Holdings%2C%20Inc.&badge=phase%201 MSCTC-0010 MSCTC-0010 · IMAC Holdings, Inc. https://druglandscape.com/drug/msd-001 https://druglandscape.com/api/og?type=drug&title=MSD-001&subtitle=MSD-001%20%C2%B7%20Mindstate%20Design%20Labs&badge=phase%201 MSD-001 MSD-001 · Mindstate Design Labs https://druglandscape.com/drug/msdc-0160 https://druglandscape.com/api/og?type=drug&title=MSDC-0160&subtitle=MSDC-0160%20%C2%B7%20Metabolic%20Solutions%20Development%20Company&badge=phase%202 MSDC-0160 MSDC-0160 · Metabolic Solutions Development Company https://druglandscape.com/drug/msi-195 https://druglandscape.com/api/og?type=drug&title=MSI-195&subtitle=MSI-195%20%C2%B7%20MSI%20Methylation%20Sciences%2C%20Inc.&badge=phase%202 MSI-195 MSI-195 · MSI Methylation Sciences, Inc. https://druglandscape.com/drug/msir https://druglandscape.com/api/og?type=drug&title=MSIR&subtitle=MSIR%20%C2%B7%20Pfizer&badge=phase%201 MSIR MSIR · Pfizer https://druglandscape.com/drug/msl-109 https://druglandscape.com/api/og?type=drug&title=MSL-109&subtitle=MSL-109%20%C2%B7%20Johns%20Hopkins%20Bloomberg%20School%20of%20Public%20Health&badge=phase%202 MSL-109 MSL-109 · Johns Hopkins Bloomberg School of Public Health https://druglandscape.com/drug/msp-2020 https://druglandscape.com/api/og?type=drug&title=MSP-2020&subtitle=MSP-2020%20%C2%B7%20Otsuka%20Pharmaceutical%20Development%20%26%20Commercialization%2C%20Inc.&badge=phase%201 MSP-2020 MSP-2020 · Otsuka Pharmaceutical Development & Commercialization, Inc. https://druglandscape.com/drug/msp-3-long-synthetic-peptide https://druglandscape.com/api/og?type=drug&title=MSP%203%20Long%20Synthetic%20Peptide&subtitle=MSP%203%20Long%20Synthetic%20Peptide%20%C2%B7%20African%20Malaria%20Network%20Trust&badge=phase%201 MSP 3 Long Synthetic Peptide MSP 3 Long Synthetic Peptide · African Malaria Network Trust https://druglandscape.com/drug/msp008-22 https://druglandscape.com/api/og?type=drug&title=MSP008-22&subtitle=MSP008-22%20%C2%B7%20Godavari%20Biorefineries%20Limited&badge=phase%201 MSP008-22 MSP008-22 · Godavari Biorefineries Limited https://druglandscape.com/drug/msp3-candidate-vaccine https://druglandscape.com/api/og?type=drug&title=MSP3%20candidate%20vaccine&subtitle=MSP3%20candidate%20vaccine%20%C2%B7%20African%20Malaria%20Network%20Trust&badge=phase%201 MSP3 candidate vaccine MSP3 candidate vaccine · African Malaria Network Trust https://druglandscape.com/drug/msp3-vaccine https://druglandscape.com/api/og?type=drug&title=MSP3%20vaccine&subtitle=MSP3%20vaccine%20%C2%B7%20African%20Malaria%20Network%20Trust&badge=phase%201 MSP3 vaccine MSP3 vaccine · African Malaria Network Trust https://druglandscape.com/drug/msv-treatment https://druglandscape.com/api/og?type=drug&title=MSV%20treatment&subtitle=MSV%20treatment%20%C2%B7%20Red%20de%20Terapia%20Celular&badge=phase%201 MSV treatment MSV treatment · Red de Terapia Celular https://druglandscape.com/drug/mt-125 https://druglandscape.com/api/og?type=drug&title=MT-125&subtitle=MT-125%20%C2%B7%20Myosin%20Therapeutics%20Inc.&badge=phase%201 MT-125 MT-125 · Myosin Therapeutics Inc. https://druglandscape.com/drug/mt-1303 https://druglandscape.com/api/og?type=drug&title=MT-1303&subtitle=MT-1303%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%202 MT-1303 MT-1303 · Bausch Health Americas, Inc. https://druglandscape.com/drug/mt-1303-forma https://druglandscape.com/api/og?type=drug&title=MT-1303-FormA&subtitle=MT-1303-FormA%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%201 MT-1303-FormA MT-1303-FormA · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-1303-formb https://druglandscape.com/api/og?type=drug&title=MT-1303-FormB&subtitle=MT-1303-FormB%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%201 MT-1303-FormB MT-1303-FormB · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-1303-high https://druglandscape.com/api/og?type=drug&title=MT-1303-High&subtitle=MT-1303-High%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MT-1303-High MT-1303-High · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-1303-high-dose https://druglandscape.com/api/og?type=drug&title=MT-1303%20High%20dose&subtitle=MT-1303%20High%20dose%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%201 MT-1303 High dose MT-1303 High dose · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-1303-low https://druglandscape.com/api/og?type=drug&title=MT-1303-Low&subtitle=MT-1303-Low%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MT-1303-Low MT-1303-Low · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-1303-low-dose https://druglandscape.com/api/og?type=drug&title=MT-1303%20Low%20dose&subtitle=MT-1303%20Low%20dose%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%201 MT-1303 Low dose MT-1303 Low dose · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-1303-middle https://druglandscape.com/api/og?type=drug&title=MT-1303-Middle&subtitle=MT-1303-Middle%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MT-1303-Middle MT-1303-Middle · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-201 https://druglandscape.com/api/og?type=drug&title=MT-201&subtitle=MT-201%20%C2%B7%20Mirador%20Therapeutics%2C%20Inc.&badge=phase%202 MT-201 MT-201 · Mirador Therapeutics, Inc. https://druglandscape.com/drug/mt-2111 https://druglandscape.com/api/og?type=drug&title=MT-2111&subtitle=MT-2111%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%201 MT-2111 MT-2111 · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-251 https://druglandscape.com/api/og?type=drug&title=MT-251&subtitle=MT-251%20%C2%B7%20Mirador%20Therapeutics%2C%20Inc.&badge=phase%201 MT-251 MT-251 · Mirador Therapeutics, Inc. https://druglandscape.com/drug/mt-2990 https://druglandscape.com/api/og?type=drug&title=MT-2990&subtitle=MT-2990%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MT-2990 MT-2990 · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-3534 https://druglandscape.com/api/og?type=drug&title=MT-3534&subtitle=MT-3534%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%201 MT-3534 MT-3534 · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-3921 https://druglandscape.com/api/og?type=drug&title=MT-3921&subtitle=MT-3921%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MT-3921 MT-3921 · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-3921-low-dose https://druglandscape.com/api/og?type=drug&title=MT-3921%20Low%20dose&subtitle=MT-3921%20Low%20dose%20%C2%B7%20Tanabe%20Pharma%20America%2C%20Inc.&badge=phase%201 MT-3921 Low dose MT-3921 Low dose · Tanabe Pharma America, Inc. https://druglandscape.com/drug/mt-3995-high https://druglandscape.com/api/og?type=drug&title=MT-3995%20High&subtitle=MT-3995%20High%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MT-3995 High MT-3995 High · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-3995-middle https://druglandscape.com/api/og?type=drug&title=MT-3995%20Middle&subtitle=MT-3995%20Middle%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MT-3995 Middle MT-3995 Middle · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-4129 https://druglandscape.com/api/og?type=drug&title=MT-4129&subtitle=MT-4129%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%201 MT-4129 MT-4129 · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-4561 https://druglandscape.com/api/og?type=drug&title=MT-4561&subtitle=MT-4561%20%C2%B7%20Tanabe%20Pharma%20America%2C%20Inc.&badge=phase%201 MT-4561 MT-4561 · Tanabe Pharma America, Inc. https://druglandscape.com/drug/mt-501 https://druglandscape.com/api/og?type=drug&title=MT-501&subtitle=MT-501%20%C2%B7%20Mirador%20Therapeutics%2C%20Inc.&badge=phase%202 MT-501 MT-501 · Mirador Therapeutics, Inc. https://druglandscape.com/drug/mt-5199 https://druglandscape.com/api/og?type=drug&title=MT-5199&subtitle=MT-5199%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MT-5199 MT-5199 · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-5547 https://druglandscape.com/api/og?type=drug&title=MT-5547&subtitle=MT-5547%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MT-5547 MT-5547 · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-5625-high-dose https://druglandscape.com/api/og?type=drug&title=MT-5625%20high%20dose&subtitle=MT-5625%20high%20dose%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%201 MT-5625 high dose MT-5625 high dose · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-5625-middle-dose https://druglandscape.com/api/og?type=drug&title=MT-5625%20middle%20dose&subtitle=MT-5625%20middle%20dose%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%201 MT-5625 middle dose MT-5625 middle dose · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-601 https://druglandscape.com/api/og?type=drug&title=MT-601&subtitle=MT-601%20%C2%B7%20Marker%20Therapeutics%2C%20Inc.&badge=phase%201 MT-601 MT-601 · Marker Therapeutics, Inc. https://druglandscape.com/drug/mt-701 https://druglandscape.com/api/og?type=drug&title=MT-701&subtitle=MT-701%20%C2%B7%20Mirador%20Therapeutics%2C%20Inc.&badge=phase%201 MT-701 MT-701 · Mirador Therapeutics, Inc. https://druglandscape.com/drug/mt-8554 https://druglandscape.com/api/og?type=drug&title=MT-8554&subtitle=MT-8554%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MT-8554 MT-8554 · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-8554-low-dose https://druglandscape.com/api/og?type=drug&title=MT-8554%20low%20dose&subtitle=MT-8554%20low%20dose%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MT-8554 low dose MT-8554 low dose · Tanabe Pharma Corporation https://druglandscape.com/drug/mt-8554-middle-dose https://druglandscape.com/api/og?type=drug&title=MT-8554%20middle%20dose&subtitle=MT-8554%20middle%20dose%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 MT-8554 middle dose MT-8554 middle dose · Tanabe Pharma Corporation https://druglandscape.com/drug/mt027-cells-suspension https://druglandscape.com/api/og?type=drug&title=MT027%20cells%20suspension&subtitle=MT027%20cells%20suspension%20%C2%B7%20Suzhou%20Maximum%20Bio-tech%20Co.%2C%20Ltd.&badge=phase%201 MT027 cells suspension MT027 cells suspension · Suzhou Maximum Bio-tech Co., Ltd. https://druglandscape.com/drug/mt101-5 https://druglandscape.com/api/og?type=drug&title=MT101-5&subtitle=MT101-5%20%C2%B7%20Mthera%20Pharma%20Co.%2C%20Ltd.&badge=phase%202 MT101-5 MT101-5 · Mthera Pharma Co., Ltd. https://druglandscape.com/drug/mt1011 https://druglandscape.com/api/og?type=drug&title=MT1011&subtitle=MT1011%20%C2%B7%20Shaanxi%20Micot%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 MT1011 MT1011 · Shaanxi Micot Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/mt110 https://druglandscape.com/api/og?type=drug&title=MT110&subtitle=MT110%20%C2%B7%20Amgen%20Research%20(Munich)%20GmbH&badge=phase%201 MT110 MT110 · Amgen Research (Munich) GmbH https://druglandscape.com/drug/mt1980 https://druglandscape.com/api/og?type=drug&title=MT1980&subtitle=MT1980%20%C2%B7%20Monument%20Therapeutics%20Limited&badge=phase%201 MT1980 MT1980 · Monument Therapeutics Limited https://druglandscape.com/drug/mt1988 https://druglandscape.com/api/og?type=drug&title=MT1988&subtitle=MT1988%20%C2%B7%20Monument%20Therapeutics%20Limited&badge=phase%201 MT1988 MT1988 · Monument Therapeutics Limited https://druglandscape.com/drug/mt1988-high-dose https://druglandscape.com/api/og?type=drug&title=MT1988%20High%20Dose&subtitle=MT1988%20High%20Dose%20%C2%B7%20Monument%20Therapeutics%20Limited&badge=phase%201 MT1988 High Dose MT1988 High Dose · Monument Therapeutics Limited https://druglandscape.com/drug/mt2004 https://druglandscape.com/api/og?type=drug&title=MT2004&subtitle=MT2004%20%C2%B7%20Xi'an%20Biocare%20Pharma%20Ltd.&badge=phase%202 MT2004 MT2004 · Xi'an Biocare Pharma Ltd. https://druglandscape.com/drug/mt200605 https://druglandscape.com/api/og?type=drug&title=MT200605&subtitle=MT200605%20%C2%B7%20Shaanxi%20Micot%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%202 MT200605 MT200605 · Shaanxi Micot Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/mt400 https://druglandscape.com/api/og?type=drug&title=MT400&subtitle=MT400%20%C2%B7%20GlaxoSmithKline&badge=phase%201 MT400 MT400 · GlaxoSmithKline https://druglandscape.com/drug/mtb-9655 https://druglandscape.com/api/og?type=drug&title=MTB-9655&subtitle=MTB-9655%20%C2%B7%20MetaboMed%20Inc&badge=phase%201 MTB-9655 MTB-9655 · MetaboMed Inc https://druglandscape.com/drug/mtbvac-live-vaccine https://druglandscape.com/api/og?type=drug&title=MTBVAC%20live%20vaccine&subtitle=MTBVAC%20live%20vaccine%20%C2%B7%20Biofabri%2C%20S.L&badge=phase%201 MTBVAC live vaccine MTBVAC live vaccine · Biofabri, S.L https://druglandscape.com/drug/mtc-01 https://druglandscape.com/api/og?type=drug&title=MTC%2001&subtitle=MTC%2001%20%C2%B7%20Icahn%20School%20of%20Medicine%20at%20Mount%20Sinai&badge=phase%201 MTC 01 MTC 01 · Icahn School of Medicine at Mount Sinai https://druglandscape.com/drug/mtc896-gel https://druglandscape.com/api/og?type=drug&title=MTC896%20Gel&subtitle=MTC896%20Gel%20%C2%B7%20Mimetica%20Pty%20Limited&badge=phase%202 MTC896 Gel MTC896 Gel · Mimetica Pty Limited https://druglandscape.com/drug/mtg201 https://druglandscape.com/api/og?type=drug&title=MTG201&subtitle=MTG201%20%C2%B7%20Momotaro-Gene%20Inc.&badge=phase%202 MTG201 MTG201 · Momotaro-Gene Inc. https://druglandscape.com/drug/mtl-cebpa https://druglandscape.com/api/og?type=drug&title=MTL-CEBPA&subtitle=MTL-CEBPA%20%C2%B7%20Mina%20Alpha%20Limited&badge=phase%202 MTL-CEBPA MTL-CEBPA · Mina Alpha Limited https://druglandscape.com/drug/mtp-101-c-encapsulated-microbiota https://druglandscape.com/api/og?type=drug&title=MTP-101-C%20encapsulated%20Microbiota&subtitle=MTP-101-C%20encapsulated%20Microbiota%20%C2%B7%20Melana%20Yuzefpolskaya%2C%20MD&badge=phase%201 MTP-101-C encapsulated Microbiota MTP-101-C encapsulated Microbiota · Melana Yuzefpolskaya, MD https://druglandscape.com/drug/mtr107 https://druglandscape.com/api/og?type=drug&title=MTR107&subtitle=MTR107%20%C2%B7%20Wolfson%20Medical%20Center&badge=phase%202 MTR107 MTR107 · Wolfson Medical Center https://druglandscape.com/drug/mtx-101 https://druglandscape.com/api/og?type=drug&title=MTX-101&subtitle=MTX-101%20%C2%B7%20Mozart%20Therapeutics%20Australia%20Pty%20Ltd&badge=phase%201 MTX-101 MTX-101 · Mozart Therapeutics Australia Pty Ltd https://druglandscape.com/drug/mtx-covab36 https://druglandscape.com/api/og?type=drug&title=MTx-COVAB36&subtitle=MTx-COVAB36%20%C2%B7%20Memo%20Therapeutics%20AG&badge=phase%201 MTx-COVAB36 MTx-COVAB36 · Memo Therapeutics AG https://druglandscape.com/drug/mtx-mvd-via https://druglandscape.com/api/og?type=drug&title=MTX%2C%20MVD%2C%20VIA&subtitle=MTX%2C%20MVD%2C%20VIA%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 MTX, MVD, VIA MTX, MVD, VIA · Samsung Medical Center https://druglandscape.com/drug/muc1-gene-dc-ctl https://druglandscape.com/api/og?type=drug&title=MUC1-gene-DC-CTL&subtitle=MUC1-gene-DC-CTL%20%C2%B7%20Beijing%20Doing%20Biomedical%20Co.%2C%20Ltd.&badge=phase%201 MUC1-gene-DC-CTL MUC1-gene-DC-CTL · Beijing Doing Biomedical Co., Ltd. https://druglandscape.com/drug/muc1-peptide-dc-ctl https://druglandscape.com/api/og?type=drug&title=MUC1-peptide-DC-CTL&subtitle=MUC1-peptide-DC-CTL%20%C2%B7%20Beijing%20Doing%20Biomedical%20Co.%2C%20Ltd.&badge=phase%201 MUC1-peptide-DC-CTL MUC1-peptide-DC-CTL · Beijing Doing Biomedical Co., Ltd. https://druglandscape.com/drug/muc1-peptide-poly-iclc-adjuvant-vaccine https://druglandscape.com/api/og?type=drug&title=MUC1%20peptide-poly-ICLC%20adjuvant%20vaccine&subtitle=MUC1%20peptide-poly-ICLC%20adjuvant%20vaccine%20%C2%B7%20Joseph%20Baar%2C%20MD%2C%20PhD&badge=phase%201 MUC1 peptide-poly-ICLC adjuvant vaccine MUC1 peptide-poly-ICLC adjuvant vaccine · Joseph Baar, MD, PhD https://druglandscape.com/drug/muc1-peptide-vaccine https://druglandscape.com/api/og?type=drug&title=MUC1%20Peptide%20Vaccine&subtitle=MUC1%20Peptide%20Vaccine%20%C2%B7%20Finn%2C%20Olivera%2C%20PhD&badge=phase%201 MUC1 Peptide Vaccine MUC1 Peptide Vaccine · Finn, Olivera, PhD https://druglandscape.com/drug/mucopolysaccharide-polysulfate-cream https://druglandscape.com/api/og?type=drug&title=Mucopolysaccharide%20Polysulfate%20Cream&subtitle=Mucopolysaccharide%20Polysulfate%20Cream%20%C2%B7%20Shenzhen%20Kangzhe%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Mucopolysaccharide Polysulfate Cream Mucopolysaccharide Polysulfate Cream · Shenzhen Kangzhe Pharmaceutical Co., Ltd. https://druglandscape.com/drug/multi-epitope-melanoma-peptide-vaccine https://druglandscape.com/api/og?type=drug&title=multi-epitope%20melanoma%20peptide%20vaccine&subtitle=multi-epitope%20melanoma%20peptide%20vaccine%20%C2%B7%20Craig%20L%20Slingluff%2C%20Jr&badge=phase%202 multi-epitope melanoma peptide vaccine multi-epitope melanoma peptide vaccine · Craig L Slingluff, Jr https://druglandscape.com/drug/multi-modality-pain-management https://druglandscape.com/api/og?type=drug&title=multi-modality%20pain%20management&subtitle=multi-modality%20pain%20management%20%C2%B7%20AppliedVR%20Inc.&badge=phase%201 multi-modality pain management multi-modality pain management · AppliedVR Inc. https://druglandscape.com/drug/multi-oit https://druglandscape.com/api/og?type=drug&title=Multi%20OIT&subtitle=Multi%20OIT%20%C2%B7%20Xiu-Min%20Li&badge=phase%202 Multi OIT Multi OIT · Xiu-Min Li https://druglandscape.com/drug/multi-target-therapy https://druglandscape.com/api/og?type=drug&title=Multi-target%20therapy&subtitle=Multi-target%20therapy%20%C2%B7%20Zhi-Hong%20Liu%2C%20M.D.&badge=phase%201 Multi-target therapy Multi-target therapy · Zhi-Hong Liu, M.D. https://druglandscape.com/drug/multi-virus-specific-t-cells https://druglandscape.com/api/og?type=drug&title=Multi-virus%20Specific%20T%20cells&subtitle=Multi-virus%20Specific%20T%20cells%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Multi-virus Specific T cells Multi-virus Specific T cells · Baylor College of Medicine https://druglandscape.com/drug/multi-vitamins https://druglandscape.com/api/og?type=drug&title=multi-vitamins&subtitle=multi-vitamins%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 multi-vitamins multi-vitamins · Eli Lilly and Company https://druglandscape.com/drug/multigene-screening-for-single-snps https://druglandscape.com/api/og?type=drug&title=MULTIGENE%20SCREENING%20FOR%20SINGLE%20SNPS&subtitle=MULTIGENE%20SCREENING%20FOR%20SINGLE%20SNPS%20%C2%B7%20Fondazione%20C.N.R.%2FRegione%20Toscana%20%22G.%20Monasterio%22%2C%20Pisa%2C%20Italy&badge=phase%202 MULTIGENE SCREENING FOR SINGLE SNPS MULTIGENE SCREENING FOR SINGLE SNPS · Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy https://druglandscape.com/drug/multigeneangio https://druglandscape.com/api/og?type=drug&title=MultiGeneAngio&subtitle=MultiGeneAngio%20%C2%B7%20MultiGene%20Vascular%20Systems%20Ltd.&badge=phase%201 MultiGeneAngio MultiGeneAngio · MultiGene Vascular Systems Ltd. https://druglandscape.com/drug/multikinase-inhibitor-at9283 https://druglandscape.com/api/og?type=drug&title=multikinase%20inhibitor%20AT9283&subtitle=multikinase%20inhibitor%20AT9283%20%C2%B7%20Cancer%20Research%20UK&badge=phase%201 multikinase inhibitor AT9283 multikinase inhibitor AT9283 · Cancer Research UK https://druglandscape.com/drug/multiple-administration-amg-dose-group https://druglandscape.com/api/og?type=drug&title=Multiple%20administration%20Amg%20dose%20group&subtitle=Multiple%20administration%20Amg%20dose%20group%20%C2%B7%20J2H%20Biotech&badge=phase%201 Multiple administration Amg dose group Multiple administration Amg dose group · J2H Biotech https://druglandscape.com/drug/multiple-administration-bmg-dose-group https://druglandscape.com/api/og?type=drug&title=Multiple%20administration%20Bmg%20dose%20group&subtitle=Multiple%20administration%20Bmg%20dose%20group%20%C2%B7%20J2H%20Biotech&badge=phase%201 Multiple administration Bmg dose group Multiple administration Bmg dose group · J2H Biotech https://druglandscape.com/drug/multiple-administration-cmg-dose-group https://druglandscape.com/api/og?type=drug&title=Multiple%20administration%20Cmg%20dose%20group&subtitle=Multiple%20administration%20Cmg%20dose%20group%20%C2%B7%20J2H%20Biotech&badge=phase%201 Multiple administration Cmg dose group Multiple administration Cmg dose group · J2H Biotech https://druglandscape.com/drug/multiple-administration-dmg-dose-group https://druglandscape.com/api/og?type=drug&title=Multiple%20administration%20Dmg%20dose%20group&subtitle=Multiple%20administration%20Dmg%20dose%20group%20%C2%B7%20J2H%20Biotech&badge=phase%201 Multiple administration Dmg dose group Multiple administration Dmg dose group · J2H Biotech https://druglandscape.com/drug/multiple-administration-emg-dose-group https://druglandscape.com/api/og?type=drug&title=Multiple%20administration%20Emg%20dose%20group&subtitle=Multiple%20administration%20Emg%20dose%20group%20%C2%B7%20J2H%20Biotech&badge=phase%201 Multiple administration Emg dose group Multiple administration Emg dose group · J2H Biotech https://druglandscape.com/drug/multiple-ascending-dose-of-x842 https://druglandscape.com/api/og?type=drug&title=Multiple%20ascending%20dose%20of%20X842&subtitle=Multiple%20ascending%20dose%20of%20X842%20%C2%B7%20Cinclus%20Pharma%20AG&badge=phase%201 Multiple ascending dose of X842 Multiple ascending dose of X842 · Cinclus Pharma AG https://druglandscape.com/drug/multiple-ascending-dose-sc https://druglandscape.com/api/og?type=drug&title=Multiple%20Ascending%20Dose%20SC&subtitle=Multiple%20Ascending%20Dose%20SC%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Multiple Ascending Dose SC Multiple Ascending Dose SC · Bristol-Myers Squibb https://druglandscape.com/drug/multiple-ascending-doses-of-eb8018 https://druglandscape.com/api/og?type=drug&title=Multiple%20Ascending%20Doses%20of%20EB8018&subtitle=Multiple%20Ascending%20Doses%20of%20EB8018%20%C2%B7%20Enterome&badge=phase%201 Multiple Ascending Doses of EB8018 Multiple Ascending Doses of EB8018 · Enterome https://druglandscape.com/drug/multiple-ascending-doses-of-mt1013 https://druglandscape.com/api/og?type=drug&title=Multiple%20ascending%20doses%20of%20MT1013&subtitle=Multiple%20ascending%20doses%20of%20MT1013%20%C2%B7%20Shaanxi%20Micot%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%202 Multiple ascending doses of MT1013 Multiple ascending doses of MT1013 · Shaanxi Micot Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/multiple-ascending-doses-of-qrl-201 https://druglandscape.com/api/og?type=drug&title=Multiple%20ascending%20doses%20of%20QRL-201&subtitle=Multiple%20ascending%20doses%20of%20QRL-201%20%C2%B7%20QurAlis%20Corporation&badge=phase%201 Multiple ascending doses of QRL-201 Multiple ascending doses of QRL-201 · QurAlis Corporation https://druglandscape.com/drug/multiple-ascending-doses-sul-238 https://druglandscape.com/api/og?type=drug&title=Multiple%20ascending%20doses%20SUL-238&subtitle=Multiple%20ascending%20doses%20SUL-238%20%C2%B7%20GEN%20%C4%B0la%C3%A7%20ve%20Sa%C4%9Fl%C4%B1k%20%C3%9Cr%C3%BCnleri%20A.%C5%9E.&badge=phase%201 Multiple ascending doses SUL-238 Multiple ascending doses SUL-238 · GEN İlaç ve Sağlık Ürünleri A.Ş. https://druglandscape.com/drug/multiple-dose-azd2014 https://druglandscape.com/api/og?type=drug&title=Multiple%20dose%20AZD2014&subtitle=Multiple%20dose%20AZD2014%20%C2%B7%20AstraZeneca&badge=phase%201 Multiple dose AZD2014 Multiple dose AZD2014 · AstraZeneca https://druglandscape.com/drug/multiple-dose-insulin-injections https://druglandscape.com/api/og?type=drug&title=Multiple%20dose%20insulin%20injections&subtitle=Multiple%20dose%20insulin%20injections%20%C2%B7%20Castilla-La%20Mancha%20Health%20Service&badge=phase%202 Multiple dose insulin injections Multiple dose insulin injections · Castilla-La Mancha Health Service https://druglandscape.com/drug/multiple-dose-of-eo2401 https://druglandscape.com/api/og?type=drug&title=Multiple%20dose%20of%20EO2401&subtitle=Multiple%20dose%20of%20EO2401%20%C2%B7%20Enterome&badge=phase%201 Multiple dose of EO2401 Multiple dose of EO2401 · Enterome https://druglandscape.com/drug/multiple-doses-of-sucrose https://druglandscape.com/api/og?type=drug&title=multiple%20doses%20of%20sucrose&subtitle=multiple%20doses%20of%20sucrose%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%201 multiple doses of sucrose multiple doses of sucrose · Sheba Medical Center https://druglandscape.com/drug/multiple-dosing-of-g1090n https://druglandscape.com/api/og?type=drug&title=Multiple%20dosing%20of%20G1090N&subtitle=Multiple%20dosing%20of%20G1090N%20%C2%B7%20Genfit&badge=phase%201 Multiple dosing of G1090N Multiple dosing of G1090N · Genfit https://druglandscape.com/drug/multiple-intravenous-doses-of-mrx-4 https://druglandscape.com/api/og?type=drug&title=Multiple%20intravenous%20doses%20of%20MRX-4&subtitle=Multiple%20intravenous%20doses%20of%20MRX-4%20%C2%B7%20MicuRx&badge=phase%201 Multiple intravenous doses of MRX-4 Multiple intravenous doses of MRX-4 · MicuRx https://druglandscape.com/drug/multiple-low-dose-cyclophosphamide https://druglandscape.com/api/og?type=drug&title=Multiple%20low%20dose%20cyclophosphamide&subtitle=Multiple%20low%20dose%20cyclophosphamide%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%202 Multiple low dose cyclophosphamide Multiple low dose cyclophosphamide · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/multiple-oral-dose-of https://druglandscape.com/api/og?type=drug&title=Multiple%20Oral%20Dose%20of&subtitle=Multiple%20Oral%20Dose%20of%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 Multiple Oral Dose of Multiple Oral Dose of · Asan Medical Center https://druglandscape.com/drug/multiple-shot-antibiotic-prophylaxis https://druglandscape.com/api/og?type=drug&title=Multiple%20shot%20antibiotic%20prophylaxis&subtitle=Multiple%20shot%20antibiotic%20prophylaxis%20%C2%B7%20Onze%20Lieve%20Vrouwe%20Gasthuis&badge=phase%202 Multiple shot antibiotic prophylaxis Multiple shot antibiotic prophylaxis · Onze Lieve Vrouwe Gasthuis https://druglandscape.com/drug/multipotent-stromal-cells https://druglandscape.com/api/og?type=drug&title=Multipotent%20Stromal%20Cells&subtitle=Multipotent%20Stromal%20Cells%20%C2%B7%20AlloCure%20Inc.&badge=phase%201 Multipotent Stromal Cells Multipotent Stromal Cells · AlloCure Inc. https://druglandscape.com/drug/multistem-high-dose https://druglandscape.com/api/og?type=drug&title=MultiStem%20high%20dose&subtitle=MultiStem%20high%20dose%20%C2%B7%20Pfizer&badge=phase%202 MultiStem high dose MultiStem high dose · Pfizer https://druglandscape.com/drug/multistem-low-dose https://druglandscape.com/api/og?type=drug&title=MultiStem%20low%20dose&subtitle=MultiStem%20low%20dose%20%C2%B7%20Pfizer&badge=phase%202 MultiStem low dose MultiStem low dose · Pfizer https://druglandscape.com/drug/multitaa-specific-t-cells https://druglandscape.com/api/og?type=drug&title=MultiTAA-specific%20T%20cells&subtitle=MultiTAA-specific%20T%20cells%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 MultiTAA-specific T cells MultiTAA-specific T cells · Baylor College of Medicine https://druglandscape.com/drug/multivalent-plain-polysaccharide-vaccine https://druglandscape.com/api/og?type=drug&title=Multivalent%20plain%20polysaccharide%20vaccine&subtitle=Multivalent%20plain%20polysaccharide%20vaccine%20%C2%B7%20LimmaTech%20Biologics%20AG&badge=phase%201 Multivalent plain polysaccharide vaccine Multivalent plain polysaccharide vaccine · LimmaTech Biologics AG https://druglandscape.com/drug/multivirus-specific-t-cells https://druglandscape.com/api/og?type=drug&title=Multivirus%20Specific%20T%20cells&subtitle=Multivirus%20Specific%20T%20cells%20%C2%B7%20AlloVir&badge=phase%201 Multivirus Specific T cells Multivirus Specific T cells · AlloVir https://druglandscape.com/drug/multivirus-specific-t-cells-dose-level-2 https://druglandscape.com/api/og?type=drug&title=Multivirus-specific%20T%20cells%20Dose%20Level%202&subtitle=Multivirus-specific%20T%20cells%20Dose%20Level%202%20%C2%B7%20AlloVir&badge=phase%201 Multivirus-specific T cells Dose Level 2 Multivirus-specific T cells Dose Level 2 · AlloVir https://druglandscape.com/drug/multivirus-specific-t-cells-dose-level-3 https://druglandscape.com/api/og?type=drug&title=Multivirus-specific%20T%20cells%20Dose%20Level%203&subtitle=Multivirus-specific%20T%20cells%20Dose%20Level%203%20%C2%B7%20AlloVir&badge=phase%201 Multivirus-specific T cells Dose Level 3 Multivirus-specific T cells Dose Level 3 · AlloVir https://druglandscape.com/drug/munc-cd34 https://druglandscape.com/api/og?type=drug&title=MUNC-CD34&subtitle=MUNC-CD34%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 MUNC-CD34 MUNC-CD34 · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/munc-t3 https://druglandscape.com/api/og?type=drug&title=MUNC-T3&subtitle=MUNC-T3%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 MUNC-T3 MUNC-T3 · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/mupirocin-2-nasal-ointement https://druglandscape.com/api/og?type=drug&title=Mupirocin%202%25%20nasal%20ointement&subtitle=Mupirocin%202%25%20nasal%20ointement%20%C2%B7%20Lindenhofgruppe%20AG&badge=phase%201 Mupirocin 2% nasal ointement Mupirocin 2% nasal ointement · Lindenhofgruppe AG https://druglandscape.com/drug/murine-cart19 https://druglandscape.com/api/og?type=drug&title=Murine%20CART19&subtitle=Murine%20CART19%20%C2%B7%20Stephan%20Grupp%20MD%20PhD&badge=phase%202 Murine CART19 Murine CART19 · Stephan Grupp MD PhD https://druglandscape.com/drug/mutant-pro-urokinase https://druglandscape.com/api/og?type=drug&title=mutant%20pro-urokinase&subtitle=mutant%20pro-urokinase%20%C2%B7%20Erasmus%20Medical%20Center&badge=phase%202 mutant pro-urokinase mutant pro-urokinase · Erasmus Medical Center https://druglandscape.com/drug/mv-012-968 https://druglandscape.com/api/og?type=drug&title=MV-012-968&subtitle=MV-012-968%20%C2%B7%20Meissa%20Vaccines%2C%20Inc.&badge=phase%202 MV-012-968 MV-012-968 · Meissa Vaccines, Inc. https://druglandscape.com/drug/mv-140 https://druglandscape.com/api/og?type=drug&title=MV-140&subtitle=MV-140%20%C2%B7%20Unidade%20Local%20de%20Sa%C3%BAde%20Santa%20Maria&badge=phase%202 MV-140 MV-140 · Unidade Local de Saúde Santa Maria https://druglandscape.com/drug/mv-chik https://druglandscape.com/api/og?type=drug&title=MV-CHIK&subtitle=MV-CHIK%20%C2%B7%20Themis%20Bioscience%20GmbH&badge=phase%202 MV-CHIK MV-CHIK · Themis Bioscience GmbH https://druglandscape.com/drug/mv-chik-low-dose https://druglandscape.com/api/og?type=drug&title=MV-CHIK%20low%20dose&subtitle=MV-CHIK%20low%20dose%20%C2%B7%20Themis%20Bioscience%20GmbH&badge=phase%202 MV-CHIK low dose MV-CHIK low dose · Themis Bioscience GmbH https://druglandscape.com/drug/mv-chik-lyophilised-formulation-low-dose https://druglandscape.com/api/og?type=drug&title=MV-CHIK%20lyophilised%20formulation%2C%20low%20dose&subtitle=MV-CHIK%20lyophilised%20formulation%2C%20low%20dose%20%C2%B7%20Themis%20Bioscience%20GmbH&badge=phase%202 MV-CHIK lyophilised formulation, low dose MV-CHIK lyophilised formulation, low dose · Themis Bioscience GmbH https://druglandscape.com/drug/mv-chik-sps-formulation-low-dose https://druglandscape.com/api/og?type=drug&title=MV-CHIK%20SPS%C2%AE%20formulation%2C%20low%20dose&subtitle=MV-CHIK%20SPS%C2%AE%20formulation%2C%20low%20dose%20%C2%B7%20Themis%20Bioscience%20GmbH&badge=phase%202 MV-CHIK SPS® formulation, low dose MV-CHIK SPS® formulation, low dose · Themis Bioscience GmbH https://druglandscape.com/drug/mv-lasv https://druglandscape.com/api/og?type=drug&title=MV-LASV&subtitle=MV-LASV%20%C2%B7%20Themis%20Bioscience%20GmbH&badge=phase%201 MV-LASV MV-LASV · Themis Bioscience GmbH https://druglandscape.com/drug/mv-zika https://druglandscape.com/api/og?type=drug&title=MV-ZIKA&subtitle=MV-ZIKA%20%C2%B7%20Themis%20Bioscience%20GmbH&badge=phase%201 MV-ZIKA MV-ZIKA · Themis Bioscience GmbH https://druglandscape.com/drug/mv130 https://druglandscape.com/api/og?type=drug&title=MV130&subtitle=MV130%20%C2%B7%20Inmunotek%20S.L.&badge=phase%202 MV130 MV130 · Inmunotek S.L. https://druglandscape.com/drug/mva-209-fsp-high-dose https://druglandscape.com/api/og?type=drug&title=MVA-209-FSP%20high%20dose&subtitle=MVA-209-FSP%20high%20dose%20%C2%B7%20Nouscom%20SRL&badge=phase%201 MVA-209-FSP high dose MVA-209-FSP high dose · Nouscom SRL https://druglandscape.com/drug/mva-209-fsp-low-dose https://druglandscape.com/api/og?type=drug&title=MVA-209-FSP%20low%20dose&subtitle=MVA-209-FSP%20low%20dose%20%C2%B7%20Nouscom%20SRL&badge=phase%201 MVA-209-FSP low dose MVA-209-FSP low dose · Nouscom SRL https://druglandscape.com/drug/mva-209-fsp-rp2d https://druglandscape.com/api/og?type=drug&title=MVA-209-FSP%2C%20RP2D&subtitle=MVA-209-FSP%2C%20RP2D%20%C2%B7%20Nouscom%20SRL&badge=phase%201 MVA-209-FSP, RP2D MVA-209-FSP, RP2D · Nouscom SRL https://druglandscape.com/drug/mva-b https://druglandscape.com/api/og?type=drug&title=MVA-B&subtitle=MVA-B%20%C2%B7%20Juan%20A.%20Arnaiz&badge=phase%201 MVA-B MVA-B · Juan A. Arnaiz https://druglandscape.com/drug/mva-c https://druglandscape.com/api/og?type=drug&title=MVA-C&subtitle=MVA-C%20%C2%B7%20Imperial%20College%20London&badge=phase%201 MVA-C MVA-C · Imperial College London https://druglandscape.com/drug/mva-cn54 https://druglandscape.com/api/og?type=drug&title=MVA-CN54&subtitle=MVA-CN54%20%C2%B7%20Imperial%20College%20London&badge=phase%201 MVA-CN54 MVA-CN54 · Imperial College London https://druglandscape.com/drug/mva-cs https://druglandscape.com/api/og?type=drug&title=MVA%20CS&subtitle=MVA%20CS%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%201 MVA CS MVA CS · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/mva-fcu1-flucytosine https://druglandscape.com/api/og?type=drug&title=MVA-FCU1%2C%20flucytosine&subtitle=MVA-FCU1%2C%20flucytosine%20%C2%B7%20Transgene&badge=phase%201 MVA-FCU1, flucytosine MVA-FCU1, flucytosine · Transgene https://druglandscape.com/drug/mva-hiva https://druglandscape.com/api/og?type=drug&title=MVA.HIVA&subtitle=MVA.HIVA%20%C2%B7%20Medical%20Research%20Council&badge=phase%202 MVA.HIVA MVA.HIVA · Medical Research Council https://druglandscape.com/drug/mva-hivconsv-vaccine https://druglandscape.com/api/og?type=drug&title=MVA.HIVconsv%20vaccine&subtitle=MVA.HIVconsv%20vaccine%20%C2%B7%20IrsiCaixa&badge=phase%201 MVA.HIVconsv vaccine MVA.HIVconsv vaccine · IrsiCaixa https://druglandscape.com/drug/mva-me-trap https://druglandscape.com/api/og?type=drug&title=MVA%20ME-TRAP&subtitle=MVA%20ME-TRAP%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%201 MVA ME-TRAP MVA ME-TRAP · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/mva-mosaic https://druglandscape.com/api/og?type=drug&title=MVA%20Mosaic&subtitle=MVA%20Mosaic%20%C2%B7%20Crucell%20Holland%20BV&badge=phase%201 MVA Mosaic MVA Mosaic · Crucell Holland BV https://druglandscape.com/drug/mva-nsmut https://druglandscape.com/api/og?type=drug&title=MVA-NSmut&subtitle=MVA-NSmut%20%C2%B7%20ReiThera%20Srl&badge=phase%201 MVA-NSmut MVA-NSmut · ReiThera Srl https://druglandscape.com/drug/mvi-and-lactated-ringers https://druglandscape.com/api/og?type=drug&title=MVI%20and%20lactated%20ringers&subtitle=MVI%20and%20lactated%20ringers%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%202 MVI and lactated ringers MVI and lactated ringers · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/mvp005 https://druglandscape.com/api/og?type=drug&title=MVP005&subtitle=MVP005%20%C2%B7%20Mitovie%20Pharma%20Ltd&badge=phase%201 MVP005 MVP005 · Mitovie Pharma Ltd https://druglandscape.com/drug/mvt-100 https://druglandscape.com/api/og?type=drug&title=MVT-100&subtitle=MVT-100%20%C2%B7%20Microvascular%20Therapeutics%2C%20LLC&badge=phase%201 MVT-100 MVT-100 · Microvascular Therapeutics, LLC https://druglandscape.com/drug/mvx01 https://druglandscape.com/api/og?type=drug&title=MVX01&subtitle=MVX01%20%C2%B7%20Matrivax%20Research%20and%20Development%20Corporation&badge=phase%201 MVX01 MVX01 · Matrivax Research and Development Corporation https://druglandscape.com/drug/mw02 https://druglandscape.com/api/og?type=drug&title=MW02&subtitle=MW02%20%C2%B7%20Mabwell%20(Shanghai)%20Bioscience%20Co.%2C%20Ltd.&badge=phase%202 MW02 MW02 · Mabwell (Shanghai) Bioscience Co., Ltd. https://druglandscape.com/drug/mw05 https://druglandscape.com/api/og?type=drug&title=MW05&subtitle=MW05%20%C2%B7%20Mabwell%20(Shanghai)%20Bioscience%20Co.%2C%20Ltd.&badge=phase%202 MW05 MW05 · Mabwell (Shanghai) Bioscience Co., Ltd. https://druglandscape.com/drug/mw151 https://druglandscape.com/api/og?type=drug&title=MW151&subtitle=MW151%20%C2%B7%20ImmunoChem%20Therapeutics%2C%20LLC&badge=phase%201 MW151 MW151 · ImmunoChem Therapeutics, LLC https://druglandscape.com/drug/mwn109-tablet https://druglandscape.com/api/og?type=drug&title=MWN109%20tablet&subtitle=MWN109%20tablet%20%C2%B7%20Shanghai%20Minwei%20Biotechnology%20Co.%2C%20Ltd&badge=phase%201 MWN109 tablet MWN109 tablet · Shanghai Minwei Biotechnology Co., Ltd https://druglandscape.com/drug/my006-high-dose https://druglandscape.com/api/og?type=drug&title=MY006%20High%20Dose&subtitle=MY006%20High%20Dose%20%C2%B7%20Mabylon%20AG&badge=phase%201 MY006 High Dose MY006 High Dose · Mabylon AG https://druglandscape.com/drug/my006-low-dose https://druglandscape.com/api/og?type=drug&title=MY006%20Low%20Dose&subtitle=MY006%20Low%20Dose%20%C2%B7%20Mabylon%20AG&badge=phase%201 MY006 Low Dose MY006 Low Dose · Mabylon AG https://druglandscape.com/drug/my006-mid-dose https://druglandscape.com/api/og?type=drug&title=MY006%20Mid%20Dose&subtitle=MY006%20Mid%20Dose%20%C2%B7%20Mabylon%20AG&badge=phase%201 MY006 Mid Dose MY006 Mid Dose · Mabylon AG https://druglandscape.com/drug/my006-selected-dose https://druglandscape.com/api/og?type=drug&title=MY006%20Selected%20Dose&subtitle=MY006%20Selected%20Dose%20%C2%B7%20Mabylon%20AG&badge=phase%201 MY006 Selected Dose MY006 Selected Dose · Mabylon AG https://druglandscape.com/drug/mycobacteriophage-muddy-hrmn0052 https://druglandscape.com/api/og?type=drug&title=Mycobacteriophage%20Muddy_HRMN0052&subtitle=Mycobacteriophage%20Muddy_HRMN0052%20%C2%B7%20Vancouver%20Coastal%20Health&badge=phase%201 Mycobacteriophage Muddy_HRMN0052 Mycobacteriophage Muddy_HRMN0052 · Vancouver Coastal Health https://druglandscape.com/drug/mycobacterium-obuense https://druglandscape.com/api/og?type=drug&title=Mycobacterium%20obuense&subtitle=Mycobacterium%20obuense%20%C2%B7%20Immodulon%20Therapeutics%20Ltd&badge=phase%202 Mycobacterium obuense Mycobacterium obuense · Immodulon Therapeutics Ltd https://druglandscape.com/drug/mycograb-docetaxel https://druglandscape.com/api/og?type=drug&title=Mycograb%2C%20Docetaxel&subtitle=Mycograb%2C%20Docetaxel%20%C2%B7%20NeuTec%20Pharma&badge=phase%201 Mycograb, Docetaxel Mycograb, Docetaxel · NeuTec Pharma https://druglandscape.com/drug/mycophenolate-mofetil-corticosteroids https://druglandscape.com/api/og?type=drug&title=Mycophenolate%20mofetil%2C%20Corticosteroids&subtitle=Mycophenolate%20mofetil%2C%20Corticosteroids%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%201 Mycophenolate mofetil, Corticosteroids Mycophenolate mofetil, Corticosteroids · Samsung Medical Center https://druglandscape.com/drug/mycophenolic-acid-0-1 https://druglandscape.com/api/og?type=drug&title=Mycophenolic%20Acid%200.1%25&subtitle=Mycophenolic%20Acid%200.1%25%20%C2%B7%20Surface%20Ophthalmics%2C%20Inc.&badge=phase%202 Mycophenolic Acid 0.1% Mycophenolic Acid 0.1% · Surface Ophthalmics, Inc. https://druglandscape.com/drug/mycophenolic-acid-0-3 https://druglandscape.com/api/og?type=drug&title=Mycophenolic%20Acid%200.3%25&subtitle=Mycophenolic%20Acid%200.3%25%20%C2%B7%20Surface%20Ophthalmics%2C%20Inc.&badge=phase%202 Mycophenolic Acid 0.3% Mycophenolic Acid 0.3% · Surface Ophthalmics, Inc. https://druglandscape.com/drug/mydriacyl-ophthalmic-product https://druglandscape.com/api/og?type=drug&title=Mydriacyl%20Ophthalmic%20Product&subtitle=Mydriacyl%20Ophthalmic%20Product%20%C2%B7%20Mantis%20Photonics%20AB&badge=phase%201 Mydriacyl Ophthalmic Product Mydriacyl Ophthalmic Product · Mantis Photonics AB https://druglandscape.com/drug/mydriasert-insert https://druglandscape.com/api/og?type=drug&title=Mydriasert%C2%AE%20insert&subtitle=Mydriasert%C2%AE%20insert%20%C2%B7%20Unither%20Pharmaceuticals%2C%20France&badge=phase%201 Mydriasert® insert Mydriasert® insert · Unither Pharmaceuticals, France https://druglandscape.com/drug/mydriatic-agent https://druglandscape.com/api/og?type=drug&title=Mydriatic%20Agent&subtitle=Mydriatic%20Agent%20%C2%B7%20Eyenuk%2C%20Inc.&badge=phase%202 Mydriatic Agent Mydriatic Agent · Eyenuk, Inc. https://druglandscape.com/drug/mydriatics-agent https://druglandscape.com/api/og?type=drug&title=Mydriatics%20Agent&subtitle=Mydriatics%20Agent%20%C2%B7%20RETINA-AI%20Health%2C%20Inc.&badge=phase%202 Mydriatics Agent Mydriatics Agent · RETINA-AI Health, Inc. https://druglandscape.com/drug/myelo001 https://druglandscape.com/api/og?type=drug&title=Myelo001&subtitle=Myelo001%20%C2%B7%20Myelo%20Therapeutics%20GmbH&badge=phase%202 Myelo001 Myelo001 · Myelo Therapeutics GmbH https://druglandscape.com/drug/myk-491 https://druglandscape.com/api/og?type=drug&title=MYK-491&subtitle=MYK-491%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 MYK-491 MYK-491 · Bristol-Myers Squibb https://druglandscape.com/drug/myl-1402o https://druglandscape.com/api/og?type=drug&title=MYL-1402O&subtitle=MYL-1402O%20%C2%B7%20Mylan%20Inc.&badge=phase%201 MYL-1402O MYL-1402O · Mylan Inc. https://druglandscape.com/drug/mymd-1 https://druglandscape.com/api/og?type=drug&title=MYMD-1&subtitle=MYMD-1%20%C2%B7%20TNF%20Pharmaceuticals%2C%20Inc.&badge=phase%201 MYMD-1 MYMD-1 · TNF Pharmaceuticals, Inc. https://druglandscape.com/drug/mymd1 https://druglandscape.com/api/og?type=drug&title=MyMD1&subtitle=MyMD1%20%C2%B7%20TNF%20Pharmaceuticals%2C%20Inc.&badge=phase%201 MyMD1 MyMD1 · TNF Pharmaceuticals, Inc. https://druglandscape.com/drug/myo-029 https://druglandscape.com/api/og?type=drug&title=MYO-029&subtitle=MYO-029%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 MYO-029 MYO-029 · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/myocell https://druglandscape.com/api/og?type=drug&title=MyoCell&subtitle=MyoCell%20%C2%B7%20Bioheart%2C%20Inc.&badge=phase%202 MyoCell MyoCell · Bioheart, Inc. https://druglandscape.com/drug/myocell-autologous-myoblasts https://druglandscape.com/api/og?type=drug&title=MyoCell%E2%84%A2%20Autologous%20Myoblasts&subtitle=MyoCell%E2%84%A2%20Autologous%20Myoblasts%20%C2%B7%20Bioheart%2C%20Inc.&badge=phase%201 MyoCell™ Autologous Myoblasts MyoCell™ Autologous Myoblasts · Bioheart, Inc. https://druglandscape.com/drug/myrin-p-forte https://druglandscape.com/api/og?type=drug&title=Myrin%20P%20Forte&subtitle=Myrin%20P%20Forte%20%C2%B7%20Pfizer&badge=phase%201 Myrin P Forte Myrin P Forte · Pfizer https://druglandscape.com/drug/n-3-pufa https://druglandscape.com/api/og?type=drug&title=n-3%20PUFA&subtitle=n-3%20PUFA%20%C2%B7%20Gruppo%20di%20Ricerca%20GISSI&badge=phase%203 n-3 PUFA n-3 PUFA · Gruppo di Ricerca GISSI https://druglandscape.com/drug/n-803-and-bcg https://druglandscape.com/api/og?type=drug&title=N-803%20and%20BCG&subtitle=N-803%20and%20BCG%20%C2%B7%20ImmunityBio%2C%20Inc.&badge=phase%202 N-803 and BCG N-803 and BCG · ImmunityBio, Inc. https://druglandscape.com/drug/n-803-and-gemcitabine https://druglandscape.com/api/og?type=drug&title=N-803%20and%20Gemcitabine&subtitle=N-803%20and%20Gemcitabine%20%C2%B7%20ImmunityBio%2C%20Inc.&badge=phase%202 N-803 and Gemcitabine N-803 and Gemcitabine · ImmunityBio, Inc. https://druglandscape.com/drug/n-acetylcysteine-and-deferoxamine https://druglandscape.com/api/og?type=drug&title=N-acetylcysteine%20and%20deferoxamine&subtitle=N-acetylcysteine%20and%20deferoxamine%20%C2%B7%20Universidade%20do%20Extremo%20Sul%20Catarinense%20-%20Unidade%20Academica%20de%20C&badge=phase%202 N-acetylcysteine and deferoxamine N-acetylcysteine and deferoxamine · Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude https://druglandscape.com/drug/n-ip-00001-inhalation-solution https://druglandscape.com/api/og?type=drug&title=N-IP-00001%20inhalation%20solution&subtitle=N-IP-00001%20inhalation%20solution%20%C2%B7%20NeoTrials%20Pty%20Ltd&badge=phase%201 N-IP-00001 inhalation solution N-IP-00001 inhalation solution · NeoTrials Pty Ltd https://druglandscape.com/drug/n-methyl-pyrrolidone https://druglandscape.com/api/og?type=drug&title=N-methyl-pyrrolidone&subtitle=N-methyl-pyrrolidone%20%C2%B7%20Peter%20MacCallum%20Cancer%20Centre%2C%20Australia&badge=phase%201 N-methyl-pyrrolidone N-methyl-pyrrolidone · Peter MacCallum Cancer Centre, Australia https://druglandscape.com/drug/n17350 https://druglandscape.com/api/og?type=drug&title=N17350&subtitle=N17350%20%C2%B7%20Onchilles%20Pharma%20Inc&badge=phase%201 N17350 N17350 · Onchilles Pharma Inc https://druglandscape.com/drug/n9-gp https://druglandscape.com/api/og?type=drug&title=N9-GP&subtitle=N9-GP%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 N9-GP N9-GP · Novo Nordisk A/S https://druglandscape.com/drug/n91115 https://druglandscape.com/api/og?type=drug&title=N91115&subtitle=N91115%20%C2%B7%20Nivalis%20Therapeutics%2C%20Inc.&badge=phase%201 N91115 N91115 · Nivalis Therapeutics, Inc. https://druglandscape.com/drug/na-931 https://druglandscape.com/api/og?type=drug&title=NA-931&subtitle=NA-931%20%C2%B7%20Biomed%20Industries%2C%20Inc.&badge=phase%202 NA-931 NA-931 · Biomed Industries, Inc. https://druglandscape.com/drug/na-931-dose-1-daily-and-orally https://druglandscape.com/api/og?type=drug&title=NA-931%2C%20dose%201%2C%20daily%20and%20orally&subtitle=NA-931%2C%20dose%201%2C%20daily%20and%20orally%20%C2%B7%20Biomed%20Industries%2C%20Inc.&badge=phase%202 NA-931, dose 1, daily and orally NA-931, dose 1, daily and orally · Biomed Industries, Inc. https://druglandscape.com/drug/na-931-dose-3-daily-and-orally https://druglandscape.com/api/og?type=drug&title=NA-931%20dose%203%2C%20daily%20and%20orally&subtitle=NA-931%20dose%203%2C%20daily%20and%20orally%20%C2%B7%20Biomed%20Industries%2C%20Inc.&badge=phase%202 NA-931 dose 3, daily and orally NA-931 dose 3, daily and orally · Biomed Industries, Inc. https://druglandscape.com/drug/na-gst-1 https://druglandscape.com/api/og?type=drug&title=Na-GST-1&subtitle=Na-GST-1%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Na-GST-1 Na-GST-1 · Baylor College of Medicine https://druglandscape.com/drug/na-picosulfate-magnesium-citrate https://druglandscape.com/api/og?type=drug&title=NA%20picosulfate%20magnesium%20citrate&subtitle=NA%20picosulfate%20magnesium%20citrate%20%C2%B7%20Norgine&badge=phase%202 NA picosulfate magnesium citrate NA picosulfate magnesium citrate · Norgine https://druglandscape.com/drug/nab-paclitaxel-iv https://druglandscape.com/api/og?type=drug&title=nab-paclitaxel%20IV&subtitle=nab-paclitaxel%20IV%20%C2%B7%20Celgene&badge=phase%202 nab-paclitaxel IV nab-paclitaxel IV · Celgene https://druglandscape.com/drug/nab-placlitaxel https://druglandscape.com/api/og?type=drug&title=Nab-placlitaxel&subtitle=Nab-placlitaxel%20%C2%B7%20BioNTech%20SE&badge=phase%202 Nab-placlitaxel Nab-placlitaxel · BioNTech SE https://druglandscape.com/drug/nab-sirolimus https://druglandscape.com/api/og?type=drug&title=nab-sirolimus&subtitle=nab-sirolimus%20%C2%B7%20Aadi%20Bioscience%2C%20Inc.&badge=phase%202 nab-sirolimus nab-sirolimus · Aadi Bioscience, Inc. https://druglandscape.com/drug/nacl-0-9-ns https://druglandscape.com/api/og?type=drug&title=NaCl%200.9%25%20NS&subtitle=NaCl%200.9%25%20NS%20%C2%B7%20Ahmed%20Mohamed%20ELbadawy&badge=phase%201 NaCl 0.9% NS NaCl 0.9% NS · Ahmed Mohamed ELbadawy https://druglandscape.com/drug/nacl-3-hs https://druglandscape.com/api/og?type=drug&title=NaCl%203%25%20HS&subtitle=NaCl%203%25%20HS%20%C2%B7%20Ahmed%20Mohamed%20ELbadawy&badge=phase%201 NaCl 3% HS NaCl 3% HS · Ahmed Mohamed ELbadawy https://druglandscape.com/drug/nacl-9 https://druglandscape.com/api/og?type=drug&title=NaCl%209%25&subtitle=NaCl%209%25%20%C2%B7%20Helse%20M%C3%B8re%20og%20Romsdal%20HF&badge=phase%202 NaCl 9% NaCl 9% · Helse Møre og Romsdal HF https://druglandscape.com/drug/nadroparine-calcium https://druglandscape.com/api/og?type=drug&title=nadroparine%20calcium&subtitle=nadroparine%20calcium%20%C2%B7%20University%20Hospital%2C%20Geneva&badge=phase%203 nadroparine calcium nadroparine calcium · University Hospital, Geneva https://druglandscape.com/drug/naf-dentifrice https://druglandscape.com/api/og?type=drug&title=NaF%20Dentifrice&subtitle=NaF%20Dentifrice%20%C2%B7%20GlaxoSmithKline&badge=phase%202 NaF Dentifrice NaF Dentifrice · GlaxoSmithKline https://druglandscape.com/drug/naf-pet-ct https://druglandscape.com/api/og?type=drug&title=NaF%20PET-CT&subtitle=NaF%20PET-CT%20%C2%B7%20Atlantic%20Health%20System&badge=phase%201 NaF PET-CT NaF PET-CT · Atlantic Health System https://druglandscape.com/drug/naftifine-hcl-cream-1 https://druglandscape.com/api/og?type=drug&title=Naftifine%20HCl%20Cream%201%25&subtitle=Naftifine%20HCl%20Cream%201%25%20%C2%B7%20Sun%20Pharmaceutical%20Industries%2C%20Inc.&badge=phase%201 Naftifine HCl Cream 1% Naftifine HCl Cream 1% · Sun Pharmaceutical Industries, Inc. https://druglandscape.com/drug/naftin-gel-2 https://druglandscape.com/api/og?type=drug&title=Naftin%C2%AE%20Gel%202%25&subtitle=Naftin%C2%AE%20Gel%202%25%20%C2%B7%20Sun%20Pharmaceutical%20Industries%2C%20Inc.&badge=phase%201 Naftin® Gel 2% Naftin® Gel 2% · Sun Pharmaceutical Industries, Inc. https://druglandscape.com/drug/naive-hbi0101-car-t https://druglandscape.com/api/og?type=drug&title=Naive%20HBI0101%20CAR-T&subtitle=Naive%20HBI0101%20CAR-T%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 Naive HBI0101 CAR-T Naive HBI0101 CAR-T · Hadassah Medical Organization https://druglandscape.com/drug/nalfurafine-hydrochloride-orally-disintegrating-tablets https://druglandscape.com/api/og?type=drug&title=Nalfurafine%20Hydrochloride%20Orally%20Disintegrating%20Tablets&subtitle=Nalfurafine%20Hydrochloride%20Orally%20Disintegrating%20Tablets%20%C2%B7%20Shandong%20New%20Time%20Pharmaceutical%20Co.%2C%20LTD&badge=phase%201 Nalfurafine Hydrochloride Orally Disintegrating Tablets Nalfurafine Hydrochloride Orally Disintegrating Tablets · Shandong New Time Pharmaceutical Co., LTD https://druglandscape.com/drug/nalmefene-hydrochloride-hydrate https://druglandscape.com/api/og?type=drug&title=Nalmefene%20Hydrochloride%20Hydrate&subtitle=Nalmefene%20Hydrochloride%20Hydrate%20%C2%B7%20Otsuka%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Nalmefene Hydrochloride Hydrate Nalmefene Hydrochloride Hydrate · Otsuka Pharmaceutical Co., Ltd. https://druglandscape.com/drug/naloxone-hcl-intranasal https://druglandscape.com/api/og?type=drug&title=Naloxone%20HCl%20intranasal&subtitle=Naloxone%20HCl%20intranasal%20%C2%B7%20Purdue%20Pharma%20LP&badge=phase%202 Naloxone HCl intranasal Naloxone HCl intranasal · Purdue Pharma LP https://druglandscape.com/drug/naloxone-nasal-swab https://druglandscape.com/api/og?type=drug&title=Naloxone%20Nasal%20Swab&subtitle=Naloxone%20Nasal%20Swab%20%C2%B7%20Pocket%20Naloxone%20Corp&badge=phase%201 Naloxone Nasal Swab Naloxone Nasal Swab · Pocket Naloxone Corp https://druglandscape.com/drug/nalrinox-combination https://druglandscape.com/api/og?type=drug&title=NALRINOX%20combination&subtitle=NALRINOX%20combination%20%C2%B7%20Fundaci%C3%B3n%20de%20investigaci%C3%B3n%20HM&badge=phase%202 NALRINOX combination NALRINOX combination · Fundación de investigación HM https://druglandscape.com/drug/naltrexone-and-acetaminophen-high-dose https://druglandscape.com/api/og?type=drug&title=Naltrexone%20and%20Acetaminophen-High%20Dose&subtitle=Naltrexone%20and%20Acetaminophen-High%20Dose%20%C2%B7%20Allodynic%20Therapeutics%2C%20Inc&badge=phase%202 Naltrexone and Acetaminophen-High Dose Naltrexone and Acetaminophen-High Dose · Allodynic Therapeutics, Inc https://druglandscape.com/drug/naltrexone-and-clonidine-combination https://druglandscape.com/api/og?type=drug&title=Naltrexone%20and%20Clonidine%20Combination&subtitle=Naltrexone%20and%20Clonidine%20Combination%20%C2%B7%20Annette%20C.%20Toledano%20MD&badge=phase%202 Naltrexone and Clonidine Combination Naltrexone and Clonidine Combination · Annette C. Toledano MD https://druglandscape.com/drug/naltrexone-immediate-release-oral-capsules https://druglandscape.com/api/og?type=drug&title=Naltrexone%20immediate%20release%20oral%20capsules&subtitle=Naltrexone%20immediate%20release%20oral%20capsules%20%C2%B7%20Scilex%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Naltrexone immediate release oral capsules Naltrexone immediate release oral capsules · Scilex Pharmaceuticals, Inc. https://druglandscape.com/drug/naltrexone-implant https://druglandscape.com/api/og?type=drug&title=naltrexone%20implant&subtitle=naltrexone%20implant%20%C2%B7%20Go%20Medical%20Industries%20Pty%20Ltd&badge=phase%202 naltrexone implant naltrexone implant · Go Medical Industries Pty Ltd https://druglandscape.com/drug/naltrexone-implant-14-4-grams https://druglandscape.com/api/og?type=drug&title=Naltrexone%20implant%2C%2014.4%20grams&subtitle=Naltrexone%20implant%2C%2014.4%20grams%20%C2%B7%20Akyso%20Therapeutics%2C%20LLC&badge=phase%201 Naltrexone implant, 14.4 grams Naltrexone implant, 14.4 grams · Akyso Therapeutics, LLC https://druglandscape.com/drug/naltrexone-implant-9-6-grams https://druglandscape.com/api/og?type=drug&title=Naltrexone%20implant%2C%209.6%20grams&subtitle=Naltrexone%20implant%2C%209.6%20grams%20%C2%B7%20Akyso%20Therapeutics%2C%20LLC&badge=phase%201 Naltrexone implant, 9.6 grams Naltrexone implant, 9.6 grams · Akyso Therapeutics, LLC https://druglandscape.com/drug/nangibotide-high-dose https://druglandscape.com/api/og?type=drug&title=nangibotide%20high%20dose&subtitle=nangibotide%20high%20dose%20%C2%B7%20Inotrem&badge=phase%202 nangibotide high dose nangibotide high dose · Inotrem https://druglandscape.com/drug/nangibotide-low-dose https://druglandscape.com/api/og?type=drug&title=nangibotide%20low%20dose&subtitle=nangibotide%20low%20dose%20%C2%B7%20Inotrem&badge=phase%202 nangibotide low dose nangibotide low dose · Inotrem https://druglandscape.com/drug/nano2tm https://druglandscape.com/api/og?type=drug&title=NanO2TM&subtitle=NanO2TM%20%C2%B7%20NHS%20Greater%20Glasgow%20and%20Clyde&badge=phase%202 NanO2TM NanO2TM · NHS Greater Glasgow and Clyde https://druglandscape.com/drug/nanoliposomal-irinotecan https://druglandscape.com/api/og?type=drug&title=Nanoliposomal%20Irinotecan&subtitle=Nanoliposomal%20Irinotecan%20%C2%B7%20PharmaEngine&badge=phase%202 Nanoliposomal Irinotecan Nanoliposomal Irinotecan · PharmaEngine https://druglandscape.com/drug/nanolithium-np03 https://druglandscape.com/api/og?type=drug&title=NanoLithium%C2%AE%20NP03&subtitle=NanoLithium%C2%AE%20NP03%20%C2%B7%20Medesis%20Pharma%20SA&badge=phase%202 NanoLithium® NP03 NanoLithium® NP03 · Medesis Pharma SA https://druglandscape.com/drug/nanomilled-dutasteride https://druglandscape.com/api/og?type=drug&title=Nanomilled%20dutasteride&subtitle=Nanomilled%20dutasteride%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Nanomilled dutasteride Nanomilled dutasteride · GlaxoSmithKline https://druglandscape.com/drug/nanopac https://druglandscape.com/api/og?type=drug&title=NanoPac%C2%AE&subtitle=NanoPac%C2%AE%20%C2%B7%20NanOlogy%2C%20LLC&badge=phase%202 NanoPac® NanoPac® · NanOlogy, LLC https://druglandscape.com/drug/nanoparticulate-paclitaxel https://druglandscape.com/api/og?type=drug&title=nanoparticulate%20paclitaxel&subtitle=nanoparticulate%20paclitaxel%20%C2%B7%20CritiTech%2C%20Inc.&badge=phase%201 nanoparticulate paclitaxel nanoparticulate paclitaxel · CritiTech, Inc. https://druglandscape.com/drug/naproxcinod-750-bid https://druglandscape.com/api/og?type=drug&title=naproxcinod%20750%20bid&subtitle=naproxcinod%20750%20bid%20%C2%B7%20NicOx&badge=phase%201 naproxcinod 750 bid naproxcinod 750 bid · NicOx https://druglandscape.com/drug/naproxen-and-lidocaine-gel https://druglandscape.com/api/og?type=drug&title=Naproxen%20and%20lidocaine%20gel&subtitle=Naproxen%20and%20lidocaine%20gel%20%C2%B7%20Sultan%20%C3%87E%C3%87EN&badge=phase%201 Naproxen and lidocaine gel Naproxen and lidocaine gel · Sultan ÇEÇEN https://druglandscape.com/drug/naproxen-test https://druglandscape.com/api/og?type=drug&title=Naproxen%20Test&subtitle=Naproxen%20Test%20%C2%B7%20Iroko%20Pharmaceuticals%2C%20LLC&badge=phase%202 Naproxen Test Naproxen Test · Iroko Pharmaceuticals, LLC https://druglandscape.com/drug/naquinate https://druglandscape.com/api/og?type=drug&title=NaQuinate&subtitle=NaQuinate%20%C2%B7%20Haoma%20Medica%20Limited&badge=phase%201 NaQuinate NaQuinate · Haoma Medica Limited https://druglandscape.com/drug/naratriptan-pill https://druglandscape.com/api/og?type=drug&title=Naratriptan%20Pill&subtitle=Naratriptan%20Pill%20%C2%B7%20Hartford%20HealthCare&badge=phase%201 Naratriptan Pill Naratriptan Pill · Hartford HealthCare https://druglandscape.com/drug/narcan-nasal-product https://druglandscape.com/api/og?type=drug&title=Narcan%20Nasal%20Product&subtitle=Narcan%20Nasal%20Product%20%C2%B7%20Johns%20Hopkins%20Bloomberg%20School%20of%20Public%20Health&badge=phase%201 Narcan Nasal Product Narcan Nasal Product · Johns Hopkins Bloomberg School of Public Health https://druglandscape.com/drug/nardostachys-jatamansi https://druglandscape.com/api/og?type=drug&title=Nardostachys%20jatamansi&subtitle=Nardostachys%20jatamansi%20%C2%B7%20Q.Mundewadi%20Ayurvedic%20Research%20%26%20Charitable%20Trust&badge=phase%202 Nardostachys jatamansi Nardostachys jatamansi · Q.Mundewadi Ayurvedic Research & Charitable Trust https://druglandscape.com/drug/narmafotinib-ascending-doses https://druglandscape.com/api/og?type=drug&title=narmafotinib%20ascending%20doses&subtitle=narmafotinib%20ascending%20doses%20%C2%B7%20Amplia%20Therapeutics%20Limited&badge=phase%201 narmafotinib ascending doses narmafotinib ascending doses · Amplia Therapeutics Limited https://druglandscape.com/drug/nas-monotherapy-group https://druglandscape.com/api/og?type=drug&title=NAs%20monotherapy%20group&subtitle=NAs%20monotherapy%20group%20%C2%B7%20Qing%20XIe&badge=phase%201 NAs monotherapy group NAs monotherapy group · Qing XIe https://druglandscape.com/drug/nasal-co2 https://druglandscape.com/api/og?type=drug&title=Nasal%20CO2&subtitle=Nasal%20CO2%20%C2%B7%20Capnia%2C%20Inc.&badge=phase%202 Nasal CO2 Nasal CO2 · Capnia, Inc. https://druglandscape.com/drug/nasal-dexamethasone https://druglandscape.com/api/og?type=drug&title=Nasal%20Dexamethasone&subtitle=Nasal%20Dexamethasone%20%C2%B7%20Edda%20Sciutto%20Conde&badge=phase%202 Nasal Dexamethasone Nasal Dexamethasone · Edda Sciutto Conde https://druglandscape.com/drug/nasal-mupirocin https://druglandscape.com/api/og?type=drug&title=nasal%20mupirocin&subtitle=nasal%20mupirocin%20%C2%B7%20Natividad%20Medical%20Center&badge=phase%201 nasal mupirocin nasal mupirocin · Natividad Medical Center https://druglandscape.com/drug/nasapaque-nasal-solution https://druglandscape.com/api/og?type=drug&title=Nasapaque%20Nasal%20Solution&subtitle=Nasapaque%20Nasal%20Solution%20%C2%B7%203E%20Therapeutics%20Corporation&badge=phase%201 Nasapaque Nasal Solution Nasapaque Nasal Solution · 3E Therapeutics Corporation https://druglandscape.com/drug/nasobol https://druglandscape.com/api/og?type=drug&title=Nasobol%C2%AE&subtitle=Nasobol%C2%AE%20%C2%B7%20Acerus%20Pharmaceuticals%20Corporation&badge=phase%202 Nasobol® Nasobol® · Acerus Pharmaceuticals Corporation https://druglandscape.com/drug/nasopharyngeal-swab https://druglandscape.com/api/og?type=drug&title=nasopharyngeal%20swab&subtitle=nasopharyngeal%20swab%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 nasopharyngeal swab nasopharyngeal swab · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/nasoshield https://druglandscape.com/api/og?type=drug&title=NasoShield&subtitle=NasoShield%20%C2%B7%20Altimmune%2C%20Inc.&badge=phase%201 NasoShield NasoShield · Altimmune, Inc. https://druglandscape.com/drug/natalizumab-iv https://druglandscape.com/api/og?type=drug&title=natalizumab%20IV&subtitle=natalizumab%20IV%20%C2%B7%20Biogen&badge=phase%202 natalizumab IV natalizumab IV · Biogen https://druglandscape.com/drug/natalizumab-sc https://druglandscape.com/api/og?type=drug&title=natalizumab%20SC&subtitle=natalizumab%20SC%20%C2%B7%20Biogen&badge=phase%202 natalizumab SC natalizumab SC · Biogen https://druglandscape.com/drug/natalizumab-treatment https://druglandscape.com/api/og?type=drug&title=natalizumab%20treatment&subtitle=natalizumab%20treatment%20%C2%B7%20Biogen&badge=phase%201 natalizumab treatment natalizumab treatment · Biogen https://druglandscape.com/drug/natesto-testosterone-intranasal-gel https://druglandscape.com/api/og?type=drug&title=Natesto%20testosterone%20intranasal%20gel&subtitle=Natesto%20testosterone%20intranasal%20gel%20%C2%B7%20VA%20Office%20of%20Research%20and%20Development&badge=phase%201 Natesto testosterone intranasal gel Natesto testosterone intranasal gel · VA Office of Research and Development https://druglandscape.com/drug/native-l-asparaginase https://druglandscape.com/api/og?type=drug&title=native%20L%20asparaginase&subtitle=native%20L%20asparaginase%20%C2%B7%20ERYtech%20Pharma&badge=phase%201 native L asparaginase native L asparaginase · ERYtech Pharma https://druglandscape.com/drug/natriuretic-peptides https://druglandscape.com/api/og?type=drug&title=Natriuretic%20peptides&subtitle=Natriuretic%20peptides%20%C2%B7%20Danish%20Headache%20Center&badge=phase%201 Natriuretic peptides Natriuretic peptides · Danish Headache Center https://druglandscape.com/drug/natrosol-4-gel https://druglandscape.com/api/og?type=drug&title=Natrosol%204%25%20Gel&subtitle=Natrosol%204%25%20Gel%20%C2%B7%20Universidade%20Federal%20do%20Para&badge=phase%201 Natrosol 4% Gel Natrosol 4% Gel · Universidade Federal do Para https://druglandscape.com/drug/natrova-creme-rinse-1 https://druglandscape.com/api/og?type=drug&title=NatrOVA%20Creme%20Rinse%20-%201%25&subtitle=NatrOVA%20Creme%20Rinse%20-%201%25%20%C2%B7%20ParaPRO%20LLC&badge=phase%202 NatrOVA Creme Rinse - 1% NatrOVA Creme Rinse - 1% · ParaPRO LLC https://druglandscape.com/drug/natrunixtm https://druglandscape.com/api/og?type=drug&title=NatrunixTM&subtitle=NatrunixTM%20%C2%B7%20XBiotech%2C%20Inc.&badge=phase%201 NatrunixTM NatrunixTM · XBiotech, Inc. https://druglandscape.com/drug/nature-s-tears-sterile-water https://druglandscape.com/api/og?type=drug&title=Nature's%20Tears%20Sterile%20Water&subtitle=Nature's%20Tears%20Sterile%20Water%20%C2%B7%20Brooke%20Army%20Medical%20Center&badge=phase%201 Nature's Tears Sterile Water Nature's Tears Sterile Water · Brooke Army Medical Center https://druglandscape.com/drug/nav-240 https://druglandscape.com/api/og?type=drug&title=NAV-240&subtitle=NAV-240%20%C2%B7%20Navigator%20Medicines%2C%20Inc.&badge=phase%202 NAV-240 NAV-240 · Navigator Medicines, Inc. https://druglandscape.com/drug/navicixizumab-monotherapy https://druglandscape.com/api/og?type=drug&title=navicixizumab%20monotherapy&subtitle=navicixizumab%20monotherapy%20%C2%B7%20OncXerna%20Theraputics%2C%20Inc.&badge=phase%202 navicixizumab monotherapy navicixizumab monotherapy · OncXerna Theraputics, Inc. https://druglandscape.com/drug/navx-010 https://druglandscape.com/api/og?type=drug&title=NAVX-010&subtitle=NAVX-010%20%C2%B7%20Algenis%20SpA&badge=phase%201 NAVX-010 NAVX-010 · Algenis SpA https://druglandscape.com/drug/naxredy https://druglandscape.com/api/og?type=drug&title=NaxRedy%20%E2%84%A2&subtitle=NaxRedy%20%E2%84%A2%20%C2%B7%20Pfizer&badge=phase%201 NaxRedy ™ NaxRedy ™ · Pfizer https://druglandscape.com/drug/nb-002 https://druglandscape.com/api/og?type=drug&title=NB-002&subtitle=NB-002%20%C2%B7%20NanoBio%20Corporation&badge=phase%202 NB-002 NB-002 · NanoBio Corporation https://druglandscape.com/drug/nb-1008 https://druglandscape.com/api/og?type=drug&title=NB-1008&subtitle=NB-1008%20%C2%B7%20NanoBio%20Corporation&badge=phase%201 NB-1008 NB-1008 · NanoBio Corporation https://druglandscape.com/drug/nb002 https://druglandscape.com/api/og?type=drug&title=NB002&subtitle=NB002%20%C2%B7%20Suzhou%20Neologics%20Bioscience%20Co.%2C%20Ltd.&badge=phase%201 NB002 NB002 · Suzhou Neologics Bioscience Co., Ltd. https://druglandscape.com/drug/nb003 https://druglandscape.com/api/og?type=drug&title=NB003&subtitle=NB003%20%C2%B7%20Ningbo%20Newbay%20Technology%20Development%20Co.%2C%20Ltd&badge=phase%202 NB003 NB003 · Ningbo Newbay Technology Development Co., Ltd https://druglandscape.com/drug/nb003-tablets https://druglandscape.com/api/og?type=drug&title=NB003%20tablets&subtitle=NB003%20tablets%20%C2%B7%20Ningbo%20Newbay%20Technology%20Development%20Co.%2C%20Ltd&badge=phase%201 NB003 tablets NB003 tablets · Ningbo Newbay Technology Development Co., Ltd https://druglandscape.com/drug/nb01 https://druglandscape.com/api/og?type=drug&title=NB01&subtitle=NB01%20%C2%B7%20Naked%20Biome%2C%20Inc.&badge=phase%201 NB01 NB01 · Naked Biome, Inc. https://druglandscape.com/drug/nbf-006 https://druglandscape.com/api/og?type=drug&title=NBF-006&subtitle=NBF-006%20%C2%B7%20Nitto%20BioPharma%2C%20Inc.&badge=phase%201 NBF-006 NBF-006 · Nitto BioPharma, Inc. https://druglandscape.com/drug/nbl-028 https://druglandscape.com/api/og?type=drug&title=NBL-028&subtitle=NBL-028%20%C2%B7%20NovaRock%20Biotherapeutics%2C%20Ltd&badge=phase%201 NBL-028 NBL-028 · NovaRock Biotherapeutics, Ltd https://druglandscape.com/drug/nbm-bmx-capsule https://druglandscape.com/api/og?type=drug&title=NBM-BMX%20Capsule&subtitle=NBM-BMX%20Capsule%20%C2%B7%20Novelwise%20Pharmaceutical%20Corporation&badge=phase%201 NBM-BMX Capsule NBM-BMX Capsule · Novelwise Pharmaceutical Corporation https://druglandscape.com/drug/nbm-bmx-softgel-capsules https://druglandscape.com/api/og?type=drug&title=NBM-BMX%20softgel%20capsules&subtitle=NBM-BMX%20softgel%20capsules%20%C2%B7%20NatureWise%20Biotech%20%26%20Medicals%20Corporation&badge=phase%201 NBM-BMX softgel capsules NBM-BMX softgel capsules · NatureWise Biotech & Medicals Corporation https://druglandscape.com/drug/nbmi https://druglandscape.com/api/og?type=drug&title=NBMI&subtitle=NBMI%20%C2%B7%20EmeraMed&badge=phase%202 NBMI NBMI · EmeraMed https://druglandscape.com/drug/nbp-softgel-capsules https://druglandscape.com/api/og?type=drug&title=NBP%20Softgel%20Capsules&subtitle=NBP%20Softgel%20Capsules%20%C2%B7%20Conjupro%20Biotherapeutics%2C%20Inc.&badge=phase%202 NBP Softgel Capsules NBP Softgel Capsules · Conjupro Biotherapeutics, Inc. https://druglandscape.com/drug/nbp607qiv https://druglandscape.com/api/og?type=drug&title=NBP607QIV&subtitle=NBP607QIV%20%C2%B7%20SK%20Chemicals%20Co.%2C%20Ltd.&badge=phase%201 NBP607QIV NBP607QIV · SK Chemicals Co., Ltd. https://druglandscape.com/drug/nbp6081 https://druglandscape.com/api/og?type=drug&title=NBP6081&subtitle=NBP6081%20%C2%B7%20SK%20Chemicals%20Co.%2C%20Ltd.&badge=phase%201 NBP6081 NBP6081 · SK Chemicals Co., Ltd. https://druglandscape.com/drug/nbp6082 https://druglandscape.com/api/og?type=drug&title=NBP6082&subtitle=NBP6082%20%C2%B7%20SK%20Chemicals%20Co.%2C%20Ltd.&badge=phase%201 NBP6082 NBP6082 · SK Chemicals Co., Ltd. https://druglandscape.com/drug/nbp6083 https://druglandscape.com/api/og?type=drug&title=NBP6083&subtitle=NBP6083%20%C2%B7%20SK%20Chemicals%20Co.%2C%20Ltd.&badge=phase%201 NBP6083 NBP6083 · SK Chemicals Co., Ltd. https://druglandscape.com/drug/nbp615 https://druglandscape.com/api/og?type=drug&title=NBP615&subtitle=NBP615%20%C2%B7%20SK%20Bioscience%20Co.%2C%20Ltd.&badge=phase%201 NBP615 NBP615 · SK Bioscience Co., Ltd. https://druglandscape.com/drug/nbq72s https://druglandscape.com/api/og?type=drug&title=NBQ72S&subtitle=NBQ72S%20%C2%B7%20Nantong%20Bencao%20Quadriga%20Medical%20Technology%20Co.%20Ltd.&badge=phase%202 NBQ72S NBQ72S · Nantong Bencao Quadriga Medical Technology Co. Ltd. https://druglandscape.com/drug/nbs10 https://druglandscape.com/api/og?type=drug&title=NBS10&subtitle=NBS10%20%C2%B7%20Lisata%20Therapeutics%2C%20Inc.&badge=phase%202 NBS10 NBS10 · Lisata Therapeutics, Inc. https://druglandscape.com/drug/nbtx-001 https://druglandscape.com/api/og?type=drug&title=NBTX-001&subtitle=NBTX-001%20%C2%B7%20Nobilis%20Therapeutics%20Inc.&badge=phase%201 NBTX-001 NBTX-001 · Nobilis Therapeutics Inc. https://druglandscape.com/drug/nbtxr3 https://druglandscape.com/api/og?type=drug&title=NBTXR3&subtitle=NBTXR3%20%C2%B7%20Nanobiotix&badge=phase%201 NBTXR3 NBTXR3 · Nanobiotix https://druglandscape.com/drug/nc-001 https://druglandscape.com/api/og?type=drug&title=nC-001&subtitle=nC-001%20%C2%B7%20nephCentric&badge=phase%202 nC-001 nC-001 · nephCentric https://druglandscape.com/drug/nc-4016 https://druglandscape.com/api/og?type=drug&title=NC-4016&subtitle=NC-4016%20%C2%B7%20NanoCarrier%20Co.%2C%20Ltd.&badge=phase%201 NC-4016 NC-4016 · NanoCarrier Co., Ltd. https://druglandscape.com/drug/nc-6300 https://druglandscape.com/api/og?type=drug&title=NC%206300&subtitle=NC%206300%20%C2%B7%20NanoCarrier%20Co.%2C%20Ltd.&badge=phase%201 NC 6300 NC 6300 · NanoCarrier Co., Ltd. https://druglandscape.com/drug/ncaf2-primer https://druglandscape.com/api/og?type=drug&title=nCaF2%20primer&subtitle=nCaF2%20primer%20%C2%B7%20University%20of%20Baghdad&badge=phase%203 nCaF2 primer nCaF2 primer · University of Baghdad https://druglandscape.com/drug/nco-48-fumarate https://druglandscape.com/api/og?type=drug&title=NCO-48%20Fumarate&subtitle=NCO-48%20Fumarate%20%C2%B7%20Nucorion%20Pharmaceuticals%2C%20Inc.&badge=phase%201 NCO-48 Fumarate NCO-48 Fumarate · Nucorion Pharmaceuticals, Inc. https://druglandscape.com/drug/ncp112 https://druglandscape.com/api/og?type=drug&title=NCP112&subtitle=NCP112%20%C2%B7%20Huons%20Co.%2C%20Ltd.&badge=phase%201 NCP112 NCP112 · Huons Co., Ltd. https://druglandscape.com/drug/ncr100 https://druglandscape.com/api/og?type=drug&title=NCR100&subtitle=NCR100%20%C2%B7%20Nuwacell%20Biotechnologies%20Co.%2C%20Ltd.&badge=phase%201 NCR100 NCR100 · Nuwacell Biotechnologies Co., Ltd. https://druglandscape.com/drug/ncs-01 https://druglandscape.com/api/og?type=drug&title=NCS-01&subtitle=NCS-01%20%C2%B7%20NC%20Medial%20Research%20Inc&badge=phase%201 NCS-01 NCS-01 · NC Medial Research Inc https://druglandscape.com/drug/ncx-4251 https://druglandscape.com/api/og?type=drug&title=NCX%204251&subtitle=NCX%204251%20%C2%B7%20Nicox%20Ophthalmics%2C%20Inc.&badge=phase%202 NCX 4251 NCX 4251 · Nicox Ophthalmics, Inc. https://druglandscape.com/drug/ncx-470 https://druglandscape.com/api/og?type=drug&title=NCX%20470&subtitle=NCX%20470%20%C2%B7%20Nicox%20Ophthalmics%2C%20Inc.&badge=phase%202 NCX 470 NCX 470 · Nicox Ophthalmics, Inc. https://druglandscape.com/drug/nd-003-tablets https://druglandscape.com/api/og?type=drug&title=ND-003%20tablets&subtitle=ND-003%20tablets%20%C2%B7%20Shenzhen%20NewDEL%20Biotech%2C%20Co.%2C%20Ltd&badge=phase%201 ND-003 tablets ND-003 tablets · Shenzhen NewDEL Biotech, Co., Ltd https://druglandscape.com/drug/nd0611 https://druglandscape.com/api/og?type=drug&title=ND0611&subtitle=ND0611%20%C2%B7%20NeuroDerm%20Ltd.&badge=phase%201 ND0611 ND0611 · NeuroDerm Ltd. https://druglandscape.com/drug/nd1-1 https://druglandscape.com/api/og?type=drug&title=ND1.1&subtitle=ND1.1%20%C2%B7%20Vaxart&badge=phase%201 ND1.1 ND1.1 · Vaxart https://druglandscape.com/drug/ndc-002 https://druglandscape.com/api/og?type=drug&title=NDC-002&subtitle=NDC-002%20%C2%B7%20Dr.%20Noah%20Biotech%20Inc.&badge=phase%201 NDC-002 NDC-002 · Dr. Noah Biotech Inc. https://druglandscape.com/drug/ndec-oral-decitabine-tetrahydrouridine https://druglandscape.com/api/og?type=drug&title=NDec%20-%20oral%20decitabine-tetrahydrouridine&subtitle=NDec%20-%20oral%20decitabine-tetrahydrouridine%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 NDec - oral decitabine-tetrahydrouridine NDec - oral decitabine-tetrahydrouridine · Novo Nordisk A/S https://druglandscape.com/drug/ndi-034858 https://druglandscape.com/api/og?type=drug&title=NDI-034858&subtitle=NDI-034858%20%C2%B7%20Takeda&badge=phase%202 NDI-034858 NDI-034858 · Takeda https://druglandscape.com/drug/ndi-101150 https://druglandscape.com/api/og?type=drug&title=NDI-101150&subtitle=NDI-101150%20%C2%B7%20Nimbus%20Saturn%2C%20Inc.&badge=phase%201 NDI-101150 NDI-101150 · Nimbus Saturn, Inc. https://druglandscape.com/drug/ndi-219216 https://druglandscape.com/api/og?type=drug&title=NDI-219216&subtitle=NDI-219216%20%C2%B7%20Nimbus%20Wadjet%2C%20Inc.&badge=phase%201 NDI-219216 NDI-219216 · Nimbus Wadjet, Inc. https://druglandscape.com/drug/ndv-3 https://druglandscape.com/api/og?type=drug&title=NDV-3&subtitle=NDV-3%20%C2%B7%20NovaDigm%20Therapeutics%2C%20Inc.&badge=phase%201 NDV-3 NDV-3 · NovaDigm Therapeutics, Inc. https://druglandscape.com/drug/ndv-3-investigational-vaccine https://druglandscape.com/api/og?type=drug&title=NDV-3%20investigational%20vaccine&subtitle=NDV-3%20investigational%20vaccine%20%C2%B7%20NovaDigm%20Therapeutics%2C%20Inc.&badge=phase%201 NDV-3 investigational vaccine NDV-3 investigational vaccine · NovaDigm Therapeutics, Inc. https://druglandscape.com/drug/ndv-3-vaccine-with-alum-im https://druglandscape.com/api/og?type=drug&title=NDV-3%20vaccine%20with%20alum%20IM&subtitle=NDV-3%20vaccine%20with%20alum%20IM%20%C2%B7%20NovaDigm%20Therapeutics%2C%20Inc.&badge=phase%201 NDV-3 vaccine with alum IM NDV-3 vaccine with alum IM · NovaDigm Therapeutics, Inc. https://druglandscape.com/drug/ndv-3-vaccine-without-alum-im https://druglandscape.com/api/og?type=drug&title=NDV-3%20vaccine%20without%20alum%20IM&subtitle=NDV-3%20vaccine%20without%20alum%20IM%20%C2%B7%20NovaDigm%20Therapeutics%2C%20Inc.&badge=phase%201 NDV-3 vaccine without alum IM NDV-3 vaccine without alum IM · NovaDigm Therapeutics, Inc. https://druglandscape.com/drug/ndv-hxp-s-kp-2 https://druglandscape.com/api/og?type=drug&title=NDV-HXP-S-KP.2&subtitle=NDV-HXP-S-KP.2%20%C2%B7%20CastleVax%20Inc.&badge=phase%202 NDV-HXP-S-KP.2 NDV-HXP-S-KP.2 · CastleVax Inc. https://druglandscape.com/drug/ndx-1017 https://druglandscape.com/api/og?type=drug&title=NDX-1017&subtitle=NDX-1017%20%C2%B7%20LeonaBio&badge=phase%201 NDX-1017 NDX-1017 · LeonaBio https://druglandscape.com/drug/ndx-3315-and-ndx-3324 https://druglandscape.com/api/og?type=drug&title=NDX-3315%20and%20NDX-3324&subtitle=NDX-3315%20and%20NDX-3324%20%C2%B7%20NexEos%20Diagnostics%2C%20Inc.&badge=phase%202 NDX-3315 and NDX-3324 NDX-3315 and NDX-3324 · NexEos Diagnostics, Inc. https://druglandscape.com/drug/ne-58095-ir https://druglandscape.com/api/og?type=drug&title=NE-58095%20IR&subtitle=NE-58095%20IR%20%C2%B7%20Takeda&badge=phase%202 NE-58095 IR NE-58095 IR · Takeda https://druglandscape.com/drug/nebivolol-ophthalmic-suspension-1-percent https://druglandscape.com/api/og?type=drug&title=Nebivolol%20Ophthalmic%20Suspension%201%20Percent&subtitle=Nebivolol%20Ophthalmic%20Suspension%201%20Percent%20%C2%B7%20Betaliq%2C%20Inc.&badge=phase%202 Nebivolol Ophthalmic Suspension 1 Percent Nebivolol Ophthalmic Suspension 1 Percent · Betaliq, Inc. https://druglandscape.com/drug/nebivolol-reference-product https://druglandscape.com/api/og?type=drug&title=Nebivolol-Reference%20product&subtitle=Nebivolol-Reference%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Nebivolol-Reference product Nebivolol-Reference product · Bio-innova Co., Ltd https://druglandscape.com/drug/nebivolol-test-product https://druglandscape.com/api/og?type=drug&title=Nebivolol-Test%20product&subtitle=Nebivolol-Test%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Nebivolol-Test product Nebivolol-Test product · Bio-innova Co., Ltd https://druglandscape.com/drug/nebulised-liposomal-amphotericin-b https://druglandscape.com/api/og?type=drug&title=nebulised%20liposomal%20amphotericin%20B&subtitle=nebulised%20liposomal%20amphotericin%20B%20%C2%B7%20Erasmus%20Medical%20Center&badge=phase%202 nebulised liposomal amphotericin B nebulised liposomal amphotericin B · Erasmus Medical Center https://druglandscape.com/drug/nebulized-ivx-0142 https://druglandscape.com/api/og?type=drug&title=Nebulized%20IVX-0142&subtitle=Nebulized%20IVX-0142%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%202 Nebulized IVX-0142 Nebulized IVX-0142 · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/nebulized-midazolam https://druglandscape.com/api/og?type=drug&title=Nebulized%20Midazolam&subtitle=Nebulized%20Midazolam%20%C2%B7%20Nourhan%20M.Aly&badge=phase%202 Nebulized Midazolam Nebulized Midazolam · Nourhan M.Aly https://druglandscape.com/drug/necator-americanus-hookworm-larvae https://druglandscape.com/api/og?type=drug&title=Necator%20americanus%20Hookworm%20Larvae&subtitle=Necator%20americanus%20Hookworm%20Larvae%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Necator americanus Hookworm Larvae Necator americanus Hookworm Larvae · Baylor College of Medicine https://druglandscape.com/drug/nectero-east-system https://druglandscape.com/api/og?type=drug&title=Nectero%20EAST%20System&subtitle=Nectero%20EAST%20System%20%C2%B7%20Nectero%20Medical%2C%20Inc.&badge=phase%202 Nectero EAST System Nectero EAST System · Nectero Medical, Inc. https://druglandscape.com/drug/necvax-neo1 https://druglandscape.com/api/og?type=drug&title=NECVAX-NEO1&subtitle=NECVAX-NEO1%20%C2%B7%20NEC%20Bio%20B.V&badge=phase%201 NECVAX-NEO1 NECVAX-NEO1 · NEC Bio B.V https://druglandscape.com/drug/nedaplatin-and-docetaxel https://druglandscape.com/api/og?type=drug&title=nedaplatin%20and%20docetaxel&subtitle=nedaplatin%20and%20docetaxel%20%C2%B7%20Guangxi%20Medical%20University&badge=phase%203 nedaplatin and docetaxel nedaplatin and docetaxel · Guangxi Medical University https://druglandscape.com/drug/negative-control-dentifrice https://druglandscape.com/api/og?type=drug&title=Negative%20control%20dentifrice&subtitle=Negative%20control%20dentifrice%20%C2%B7%20Procter%20and%20Gamble&badge=phase%202 Negative control dentifrice Negative control dentifrice · Procter and Gamble https://druglandscape.com/drug/nelmastobart-and-docetaxel https://druglandscape.com/api/og?type=drug&title=Nelmastobart%20and%20Docetaxel&subtitle=Nelmastobart%20and%20Docetaxel%20%C2%B7%20STCube%2C%20Inc.&badge=phase%202 Nelmastobart and Docetaxel Nelmastobart and Docetaxel · STCube, Inc. https://druglandscape.com/drug/nemonoxacin-3-tablets https://druglandscape.com/api/og?type=drug&title=Nemonoxacin%203%20tablets&subtitle=Nemonoxacin%203%20tablets%20%C2%B7%20TaiGen%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%202 Nemonoxacin 3 tablets Nemonoxacin 3 tablets · TaiGen Biotechnology Co., Ltd. https://druglandscape.com/drug/nemonoxacin-malate-sodium-chloride https://druglandscape.com/api/og?type=drug&title=Nemonoxacin%20Malate%20Sodium%20Chloride&subtitle=Nemonoxacin%20Malate%20Sodium%20Chloride%20%C2%B7%20TaiGen%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 Nemonoxacin Malate Sodium Chloride Nemonoxacin Malate Sodium Chloride · TaiGen Biotechnology Co., Ltd. https://druglandscape.com/drug/neo-811 https://druglandscape.com/api/og?type=drug&title=NEO-811&subtitle=NEO-811%20%C2%B7%20Neomorph%2C%20Inc&badge=phase%201 NEO-811 NEO-811 · Neomorph, Inc https://druglandscape.com/drug/neo-antigen-pulsed-dendritic-cell https://druglandscape.com/api/og?type=drug&title=Neo-antigen%20pulsed%20Dendritic%20cell&subtitle=Neo-antigen%20pulsed%20Dendritic%20cell%20%C2%B7%20Universidad%20Nacional%20de%20Colombia&badge=phase%201 Neo-antigen pulsed Dendritic cell Neo-antigen pulsed Dendritic cell · Universidad Nacional de Colombia https://druglandscape.com/drug/neo-t https://druglandscape.com/api/og?type=drug&title=Neo-T&subtitle=Neo-T%20%C2%B7%20BGI%2C%20China&badge=phase%201 Neo-T Neo-T · BGI, China https://druglandscape.com/drug/neo100 https://druglandscape.com/api/og?type=drug&title=NEO100&subtitle=NEO100%20%C2%B7%20Neonc%20Technologies%2C%20Inc.&badge=phase%202 NEO100 NEO100 · Neonc Technologies, Inc. https://druglandscape.com/drug/neo212-oral-capsule https://druglandscape.com/api/og?type=drug&title=NEO212%20Oral%20Capsule&subtitle=NEO212%20Oral%20Capsule%20%C2%B7%20Neonc%20Technologies%2C%20Inc.&badge=phase%201 NEO212 Oral Capsule NEO212 Oral Capsule · Neonc Technologies, Inc. https://druglandscape.com/drug/neoadjuvant-and-adjuvant-immunotherapy https://druglandscape.com/api/og?type=drug&title=Neoadjuvant%20and%20Adjuvant%20Immunotherapy&subtitle=Neoadjuvant%20and%20Adjuvant%20Immunotherapy%20%C2%B7%20Xiwei%20XU&badge=phase%202 Neoadjuvant and Adjuvant Immunotherapy Neoadjuvant and Adjuvant Immunotherapy · Xiwei XU https://druglandscape.com/drug/neoadjuvant-bevacizumab https://druglandscape.com/api/og?type=drug&title=Neoadjuvant%20Bevacizumab&subtitle=Neoadjuvant%20Bevacizumab%20%C2%B7%20Si-Yu%20Wang&badge=phase%202 Neoadjuvant Bevacizumab Neoadjuvant Bevacizumab · Si-Yu Wang https://druglandscape.com/drug/neoadjuvant-epigenetic-therapy https://druglandscape.com/api/og?type=drug&title=Neoadjuvant%20Epigenetic%20Therapy&subtitle=Neoadjuvant%20Epigenetic%20Therapy%20%C2%B7%20Edwin%20Posadas%2C%20MD&badge=phase%201 Neoadjuvant Epigenetic Therapy Neoadjuvant Epigenetic Therapy · Edwin Posadas, MD https://druglandscape.com/drug/neoadjuvant-olaparib-monotherapy-group https://druglandscape.com/api/og?type=drug&title=Neoadjuvant%20Olaparib%20monotherapy%20group&subtitle=Neoadjuvant%20Olaparib%20monotherapy%20group%20%C2%B7%20AstraZeneca&badge=phase%202 Neoadjuvant Olaparib monotherapy group Neoadjuvant Olaparib monotherapy group · AstraZeneca https://druglandscape.com/drug/neoag-mbraf https://druglandscape.com/api/og?type=drug&title=NeoAg-mBRAF&subtitle=NeoAg-mBRAF%20%C2%B7%20Craig%20L%20Slingluff%2C%20Jr&badge=phase%201 NeoAg-mBRAF NeoAg-mBRAF · Craig L Slingluff, Jr https://druglandscape.com/drug/neofuse https://druglandscape.com/api/og?type=drug&title=NeoFuse&subtitle=NeoFuse%20%C2%B7%20Mesoblast%2C%20Ltd.&badge=phase%202 NeoFuse NeoFuse · Mesoblast, Ltd. https://druglandscape.com/drug/neomycin-colistin-nystatin-vancomycin https://druglandscape.com/api/og?type=drug&title=Neomycin%20Colistin%20Nystatin%20Vancomycin&subtitle=Neomycin%20Colistin%20Nystatin%20Vancomycin%20%C2%B7%20Rambam%20Health%20Care%20Campus&badge=phase%202 Neomycin Colistin Nystatin Vancomycin Neomycin Colistin Nystatin Vancomycin · Rambam Health Care Campus https://druglandscape.com/drug/neoquine-cream-2 https://druglandscape.com/api/og?type=drug&title=Neoquine%20Cream%202%25&subtitle=Neoquine%20Cream%202%25%20%C2%B7%20CynosureLutronic&badge=phase%201 Neoquine Cream 2% Neoquine Cream 2% · CynosureLutronic https://druglandscape.com/drug/neosynephrine-10-collyrium https://druglandscape.com/api/og?type=drug&title=Neosynephrine%2010%25%20collyrium&subtitle=Neosynephrine%2010%25%20collyrium%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Neosynephrine 10% collyrium Neosynephrine 10% collyrium · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/neovax https://druglandscape.com/api/og?type=drug&title=NeoVax&subtitle=NeoVax%20%C2%B7%20Patrick%20Ott%2C%20MD%2C%20PhD&badge=phase%201 NeoVax NeoVax · Patrick Ott, MD, PhD https://druglandscape.com/drug/nephrocheck-test https://druglandscape.com/api/og?type=drug&title=Nephrocheck%20test&subtitle=Nephrocheck%20test%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 Nephrocheck test Nephrocheck test · Hospices Civils de Lyon https://druglandscape.com/drug/neratinib-tablets https://druglandscape.com/api/og?type=drug&title=Neratinib%20tablets&subtitle=Neratinib%20tablets%20%C2%B7%20Convalife%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%202 Neratinib tablets Neratinib tablets · Convalife (Shanghai) Co., Ltd. https://druglandscape.com/drug/nesinaact-tablet https://druglandscape.com/api/og?type=drug&title=NesinaAct%C2%AE%20Tablet&subtitle=NesinaAct%C2%AE%20Tablet%20%C2%B7%20Takeda&badge=phase%202 NesinaAct® Tablet NesinaAct® Tablet · Takeda https://druglandscape.com/drug/nesp-novel-erythropoiesis-stimulating-protein https://druglandscape.com/api/og?type=drug&title=NESP%20-%20Novel%20Erythropoiesis%20Stimulating%20Protein&subtitle=NESP%20-%20Novel%20Erythropoiesis%20Stimulating%20Protein%20%C2%B7%20Mirhashemi%2C%20Ramin%2C%20M.D.&badge=phase%202 NESP - Novel Erythropoiesis Stimulating Protein NESP - Novel Erythropoiesis Stimulating Protein · Mirhashemi, Ramin, M.D. https://druglandscape.com/drug/neu-111 https://druglandscape.com/api/og?type=drug&title=NEU-111&subtitle=NEU-111%20%C2%B7%20Neuron23%20Inc.&badge=phase%201 NEU-111 NEU-111 · Neuron23 Inc. https://druglandscape.com/drug/neu-411 https://druglandscape.com/api/og?type=drug&title=NEU-411&subtitle=NEU-411%20%C2%B7%20Neuron23%20Inc.&badge=phase%202 NEU-411 NEU-411 · Neuron23 Inc. https://druglandscape.com/drug/neu2000kwl-high-does-group https://druglandscape.com/api/og?type=drug&title=Neu2000KWL%20High-does%20group&subtitle=Neu2000KWL%20High-does%20group%20%C2%B7%20GNT%20Pharma&badge=phase%202 Neu2000KWL High-does group Neu2000KWL High-does group · GNT Pharma https://druglandscape.com/drug/neu2000kwl-high-dose-group https://druglandscape.com/api/og?type=drug&title=Neu2000KWL%20High-dose%20group&subtitle=Neu2000KWL%20High-dose%20group%20%C2%B7%20GNT%20Pharma&badge=phase%202 Neu2000KWL High-dose group Neu2000KWL High-dose group · GNT Pharma https://druglandscape.com/drug/neu2000kwl-low-does-group https://druglandscape.com/api/og?type=drug&title=Neu2000KWL%20Low-does%20group&subtitle=Neu2000KWL%20Low-does%20group%20%C2%B7%20GNT%20Pharma&badge=phase%202 Neu2000KWL Low-does group Neu2000KWL Low-does group · GNT Pharma https://druglandscape.com/drug/neu2000kwl-low-dose-group https://druglandscape.com/api/og?type=drug&title=Neu2000KWL%20Low-dose%20group&subtitle=Neu2000KWL%20Low-dose%20group%20%C2%B7%20GNT%20Pharma&badge=phase%202 Neu2000KWL Low-dose group Neu2000KWL Low-dose group · GNT Pharma https://druglandscape.com/drug/neucavis https://druglandscape.com/api/og?type=drug&title=NeuCaVis&subtitle=NeuCaVis%20%C2%B7%20Yellowbird%20Diagnostics%20Inc&badge=phase%201 NeuCaVis NeuCaVis · Yellowbird Diagnostics Inc https://druglandscape.com/drug/neural-stem-cells https://druglandscape.com/api/og?type=drug&title=Neural%20Stem%20Cells&subtitle=Neural%20Stem%20Cells%20%C2%B7%20Gary%20Steinberg%2C%20MD%2C%20PhD&badge=phase%201 Neural Stem Cells Neural Stem Cells · Gary Steinberg, MD, PhD https://druglandscape.com/drug/neural-stem-cells-expressing-crad-s-pk7 https://druglandscape.com/api/og?type=drug&title=Neural%20Stem%20Cells-expressing%20CRAd-S-pk7&subtitle=Neural%20Stem%20Cells-expressing%20CRAd-S-pk7%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%201 Neural Stem Cells-expressing CRAd-S-pk7 Neural Stem Cells-expressing CRAd-S-pk7 · City of Hope Medical Center https://druglandscape.com/drug/neurapas-balance https://druglandscape.com/api/og?type=drug&title=Neurapas%20balance&subtitle=Neurapas%20balance%20%C2%B7%20Pascoe%20Pharmazeutische%20Praeparate%20GmbH&badge=phase%201 Neurapas balance Neurapas balance · Pascoe Pharmazeutische Praeparate GmbH https://druglandscape.com/drug/neurexan https://druglandscape.com/api/og?type=drug&title=Neurexan%C2%AE&subtitle=Neurexan%C2%AE%20%C2%B7%20Biologische%20Heilmittel%20Heel%20GmbH&badge=phase%202 Neurexan® Neurexan® · Biologische Heilmittel Heel GmbH https://druglandscape.com/drug/neuro-cells https://druglandscape.com/api/og?type=drug&title=Neuro-Cells&subtitle=Neuro-Cells%20%C2%B7%20Neuroplast&badge=phase%202 Neuro-Cells Neuro-Cells · Neuroplast https://druglandscape.com/drug/neurokinin-1-receptor-antagonist https://druglandscape.com/api/og?type=drug&title=Neurokinin-1%20receptor%20antagonist&subtitle=Neurokinin-1%20receptor%20antagonist%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Neurokinin-1 receptor antagonist Neurokinin-1 receptor antagonist · Merck Sharp & Dohme LLC https://druglandscape.com/drug/neuroleptanalgesic-treatment https://druglandscape.com/api/og?type=drug&title=Neuroleptanalgesic%20treatment&subtitle=Neuroleptanalgesic%20treatment%20%C2%B7%20GCS%20Ramsay%20Sant%C3%A9%20pour%20l'Enseignement%20et%20la%20Recherche&badge=phase%201 Neuroleptanalgesic treatment Neuroleptanalgesic treatment · GCS Ramsay Santé pour l'Enseignement et la Recherche https://druglandscape.com/drug/neuroncell-ex https://druglandscape.com/api/og?type=drug&title=Neuroncell-EX&subtitle=Neuroncell-EX%20%C2%B7%20Cytopeutics%20Sdn.%20Bhd.&badge=phase%202 Neuroncell-EX Neuroncell-EX · Cytopeutics Sdn. Bhd. https://druglandscape.com/drug/neurostem-ad https://druglandscape.com/api/og?type=drug&title=NEUROSTEM%C2%AE-AD&subtitle=NEUROSTEM%C2%AE-AD%20%C2%B7%20Duk%20Lyul%20Na&badge=phase%202 NEUROSTEM®-AD NEUROSTEM®-AD · Duk Lyul Na https://druglandscape.com/drug/neurosteroid-enantiomer https://druglandscape.com/api/og?type=drug&title=Neurosteroid%20enantiomer&subtitle=Neurosteroid%20enantiomer%20%C2%B7%20Oragenics%2C%20Inc.&badge=phase%202 Neurosteroid enantiomer Neurosteroid enantiomer · Oragenics, Inc. https://druglandscape.com/drug/neurovax https://druglandscape.com/api/og?type=drug&title=NeuroVax&subtitle=NeuroVax%20%C2%B7%20Immune%20Response%20BioPharma%2C%20Inc.&badge=phase%202 NeuroVax NeuroVax · Immune Response BioPharma, Inc. https://druglandscape.com/drug/neutral-pills-with-no-medicinal-effect https://druglandscape.com/api/og?type=drug&title=Neutral%20pills%20with%20no%20medicinal%20effect&subtitle=Neutral%20pills%20with%20no%20medicinal%20effect%20%C2%B7%20Mid-Atlantic%20Retina%20Consultations%2C%20Inc.&badge=phase%201 Neutral pills with no medicinal effect Neutral pills with no medicinal effect · Mid-Atlantic Retina Consultations, Inc. https://druglandscape.com/drug/nev801 https://druglandscape.com/api/og?type=drug&title=NEV801&subtitle=NEV801%20%C2%B7%20Neovia%20Oncology%20Ltd.&badge=phase%201 NEV801 NEV801 · Neovia Oncology Ltd. https://druglandscape.com/drug/nevirapine-efavirenz https://druglandscape.com/api/og?type=drug&title=Nevirapine%2C%20Efavirenz&subtitle=Nevirapine%2C%20Efavirenz%20%C2%B7%20The%20HIV%20Netherlands%20Australia%20Thailand%20Research%20Collaboration&badge=phase%202 Nevirapine, Efavirenz Nevirapine, Efavirenz · The HIV Netherlands Australia Thailand Research Collaboration https://druglandscape.com/drug/new-antiviral-therapy https://druglandscape.com/api/og?type=drug&title=new%20antiviral%20therapy&subtitle=new%20antiviral%20therapy%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 new antiviral therapy new antiviral therapy · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/new-formulation-adalimumab https://druglandscape.com/api/og?type=drug&title=New%20formulation%20adalimumab&subtitle=New%20formulation%20adalimumab%20%C2%B7%20AbbVie%20(prior%20sponsor%2C%20Abbott)&badge=phase%202 New formulation adalimumab New formulation adalimumab · AbbVie (prior sponsor, Abbott) https://druglandscape.com/drug/new-formulation-emb-001 https://druglandscape.com/api/og?type=drug&title=New%20formulation%20EMB-001&subtitle=New%20formulation%20EMB-001%20%C2%B7%20Embera%20NeuroTherapeutics%2C%20Inc.&badge=phase%201 New formulation EMB-001 New formulation EMB-001 · Embera NeuroTherapeutics, Inc. https://druglandscape.com/drug/new-formulation-of-cab-la https://druglandscape.com/api/og?type=drug&title=New%20formulation%20of%20CAB%20LA&subtitle=New%20formulation%20of%20CAB%20LA%20%C2%B7%20ViiV%20Healthcare&badge=phase%202 New formulation of CAB LA New formulation of CAB LA · ViiV Healthcare https://druglandscape.com/drug/new-formulations-of-611 https://druglandscape.com/api/og?type=drug&title=new%20formulations%20of%20611&subtitle=new%20formulations%20of%20611%20%C2%B7%20Sunshine%20Guojian%20Pharmaceutical%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 new formulations of 611 new formulations of 611 · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. https://druglandscape.com/drug/new-mexico-honey https://druglandscape.com/api/og?type=drug&title=New%20Mexico%20Honey&subtitle=New%20Mexico%20Honey%20%C2%B7%20R.%20Stephen%20Rankin%2C%20M.D.&badge=phase%202 New Mexico Honey New Mexico Honey · R. Stephen Rankin, M.D. https://druglandscape.com/drug/new-teta-4hcl-formulation https://druglandscape.com/api/og?type=drug&title=New%20TETA%204HCl%20Formulation&subtitle=New%20TETA%204HCl%20Formulation%20%C2%B7%20Orphalan&badge=phase%202 New TETA 4HCl Formulation New TETA 4HCl Formulation · Orphalan https://druglandscape.com/drug/nex-20a https://druglandscape.com/api/og?type=drug&title=NEX-20A&subtitle=NEX-20A%20%C2%B7%20Nanexa%20AB&badge=phase%201 NEX-20A NEX-20A · Nanexa AB https://druglandscape.com/drug/nexagon-high-dose https://druglandscape.com/api/og?type=drug&title=Nexagon%C2%AE%20High%20Dose&subtitle=Nexagon%C2%AE%20High%20Dose%20%C2%B7%20OcuNexus%20Therapeutics%2C%20Inc.&badge=phase%202 Nexagon® High Dose Nexagon® High Dose · OcuNexus Therapeutics, Inc. https://druglandscape.com/drug/nexagon-low-dose https://druglandscape.com/api/og?type=drug&title=Nexagon%C2%AE%20Low%20Dose&subtitle=Nexagon%C2%AE%20Low%20Dose%20%C2%B7%20OcuNexus%20Therapeutics%2C%20Inc.&badge=phase%202 Nexagon® Low Dose Nexagon® Low Dose · OcuNexus Therapeutics, Inc. https://druglandscape.com/drug/nexagon-medium-dose https://druglandscape.com/api/og?type=drug&title=Nexagon%C2%AE%20Medium%20Dose&subtitle=Nexagon%C2%AE%20Medium%20Dose%20%C2%B7%20OcuNexus%20Therapeutics%2C%20Inc.&badge=phase%202 Nexagon® Medium Dose Nexagon® Medium Dose · OcuNexus Therapeutics, Inc. https://druglandscape.com/drug/nexavar-tab https://druglandscape.com/api/og?type=drug&title=Nexavar%20tab&subtitle=Nexavar%20tab%20%C2%B7%20Samyang%20Biopharmaceuticals%20Corporation&badge=phase%201 Nexavar tab Nexavar tab · Samyang Biopharmaceuticals Corporation https://druglandscape.com/drug/nexi-003-t-cells https://druglandscape.com/api/og?type=drug&title=NEXI-003%20T%20cells&subtitle=NEXI-003%20T%20cells%20%C2%B7%20NexImmune%20Inc.&badge=phase%201 NEXI-003 T cells NEXI-003 T cells · NexImmune Inc. https://druglandscape.com/drug/nexvax2 https://druglandscape.com/api/og?type=drug&title=Nexvax2&subtitle=Nexvax2%20%C2%B7%20ImmusanT%2C%20Inc.&badge=phase%202 Nexvax2 Nexvax2 · ImmusanT, Inc. https://druglandscape.com/drug/nezavist-sdd https://druglandscape.com/api/og?type=drug&title=Nezavist%20SDD&subtitle=Nezavist%20SDD%20%C2%B7%20Lohocla%20Research%20Corporation&badge=phase%201 Nezavist SDD Nezavist SDD · Lohocla Research Corporation https://druglandscape.com/drug/nf-kappab-decoy https://druglandscape.com/api/og?type=drug&title=NF-kappaB%20Decoy&subtitle=NF-kappaB%20Decoy%20%C2%B7%20Anesiva%2C%20Inc.&badge=phase%201 NF-kappaB Decoy NF-kappaB Decoy · Anesiva, Inc. https://druglandscape.com/drug/nfc-1 https://druglandscape.com/api/og?type=drug&title=NFC-1&subtitle=NFC-1%20%C2%B7%20Aevi%20Genomic%20Medicine%2C%20LLC%2C%20a%20Cerecor%20company&badge=phase%202 NFC-1 NFC-1 · Aevi Genomic Medicine, LLC, a Cerecor company https://druglandscape.com/drug/nfl-101 https://druglandscape.com/api/og?type=drug&title=NFL-101&subtitle=NFL-101%20%C2%B7%20NFL%20Biosciences%20SAS&badge=phase%202 NFL-101 NFL-101 · NFL Biosciences SAS https://druglandscape.com/drug/nfx-179-gel https://druglandscape.com/api/og?type=drug&title=NFX-179%20Gel&subtitle=NFX-179%20Gel%20%C2%B7%20NFlection%20Therapeutics%2C%20Inc.&badge=phase%202 NFX-179 Gel NFX-179 Gel · NFlection Therapeutics, Inc. https://druglandscape.com/drug/nfx88-1 https://druglandscape.com/api/og?type=drug&title=NFX88%20-%201&subtitle=NFX88%20-%201%20%C2%B7%20Neurofix%20S.L.&badge=phase%202 NFX88 - 1 NFX88 - 1 · Neurofix S.L. https://druglandscape.com/drug/nfx88-2 https://druglandscape.com/api/og?type=drug&title=NFX88%20-%202&subtitle=NFX88%20-%202%20%C2%B7%20Neurofix%20S.L.&badge=phase%202 NFX88 - 2 NFX88 - 2 · Neurofix S.L. https://druglandscape.com/drug/nfx88-3 https://druglandscape.com/api/og?type=drug&title=NFX88%20-%203&subtitle=NFX88%20-%203%20%C2%B7%20Neurofix%20S.L.&badge=phase%202 NFX88 - 3 NFX88 - 3 · Neurofix S.L. https://druglandscape.com/drug/ng-monomethyl-l-arginine https://druglandscape.com/api/og?type=drug&title=NG-Monomethyl-L-Arginine&subtitle=NG-Monomethyl-L-Arginine%20%C2%B7%20VA%20Office%20of%20Research%20and%20Development&badge=phase%202 NG-Monomethyl-L-Arginine NG-Monomethyl-L-Arginine · VA Office of Research and Development https://druglandscape.com/drug/ng004 https://druglandscape.com/api/og?type=drug&title=NG004&subtitle=NG004%20%C2%B7%20NovaGo%20Therapeutics%20AG&badge=phase%201 NG004 NG004 · NovaGo Therapeutics AG https://druglandscape.com/drug/ng101 https://druglandscape.com/api/og?type=drug&title=NG101&subtitle=NG101%20%C2%B7%20Neurogastrx%2C%20Inc.&badge=phase%202 NG101 NG101 · Neurogastrx, Inc. https://druglandscape.com/drug/ng101m https://druglandscape.com/api/og?type=drug&title=NG101m&subtitle=NG101m%20%C2%B7%20NeuGATE%20Theranostics&badge=phase%201 NG101m NG101m · NeuGATE Theranostics https://druglandscape.com/drug/ng11-2 https://druglandscape.com/api/og?type=drug&title=NG11-2&subtitle=NG11-2%20%C2%B7%20VasoDynamics%20Ltd&badge=phase%201 NG11-2 NG11-2 · VasoDynamics Ltd https://druglandscape.com/drug/ngg-below-htd-investigational-vaccine https://druglandscape.com/api/og?type=drug&title=NgG%20below%20HTD%20investigational%20vaccine&subtitle=NgG%20below%20HTD%20investigational%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%201 NgG below HTD investigational vaccine NgG below HTD investigational vaccine · GlaxoSmithKline https://druglandscape.com/drug/ngg-high-dose-investigational-vaccine https://druglandscape.com/api/og?type=drug&title=NgG%20high%20dose%20investigational%20vaccine&subtitle=NgG%20high%20dose%20investigational%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%201 NgG high dose investigational vaccine NgG high dose investigational vaccine · GlaxoSmithKline https://druglandscape.com/drug/ngg-htd-investigational-vaccine https://druglandscape.com/api/og?type=drug&title=NgG%20HTD%20investigational%20vaccine&subtitle=NgG%20HTD%20investigational%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%201 NgG HTD investigational vaccine NgG HTD investigational vaccine · GlaxoSmithKline https://druglandscape.com/drug/ngg-low-dose-investigational-vaccine https://druglandscape.com/api/og?type=drug&title=NgG%20low%20dose%20investigational%20vaccine&subtitle=NgG%20low%20dose%20investigational%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%201 NgG low dose investigational vaccine NgG low dose investigational vaccine · GlaxoSmithKline https://druglandscape.com/drug/ngg-medium-dose-investigational-vaccine https://druglandscape.com/api/og?type=drug&title=NgG%20medium%20dose%20investigational%20vaccine&subtitle=NgG%20medium%20dose%20investigational%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%201 NgG medium dose investigational vaccine NgG medium dose investigational vaccine · GlaxoSmithKline https://druglandscape.com/drug/nggt001 https://druglandscape.com/api/og?type=drug&title=NGGT001&subtitle=NGGT001%20%C2%B7%20NGGT%20(Suzhou)%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 NGGT001 NGGT001 · NGGT (Suzhou) Biotechnology Co., Ltd. https://druglandscape.com/drug/ngm120-q4w https://druglandscape.com/api/og?type=drug&title=NGM120%20Q4W&subtitle=NGM120%20Q4W%20%C2%B7%20NGM%20Biopharmaceuticals%2C%20Inc&badge=phase%202 NGM120 Q4W NGM120 Q4W · NGM Biopharmaceuticals, Inc https://druglandscape.com/drug/ngm120-q8w https://druglandscape.com/api/og?type=drug&title=NGM120%20Q8W&subtitle=NGM120%20Q8W%20%C2%B7%20NGM%20Biopharmaceuticals%2C%20Inc&badge=phase%202 NGM120 Q8W NGM120 Q8W · NGM Biopharmaceuticals, Inc https://druglandscape.com/drug/ngm282 https://druglandscape.com/api/og?type=drug&title=NGM282&subtitle=NGM282%20%C2%B7%20NGM%20Biopharmaceuticals%2C%20Inc&badge=phase%202 NGM282 NGM282 · NGM Biopharmaceuticals, Inc https://druglandscape.com/drug/ngm313 https://druglandscape.com/api/og?type=drug&title=NGM313&subtitle=NGM313%20%C2%B7%20NGM%20Biopharmaceuticals%2C%20Inc&badge=phase%201 NGM313 NGM313 · NGM Biopharmaceuticals, Inc https://druglandscape.com/drug/ngm395 https://druglandscape.com/api/og?type=drug&title=NGM395&subtitle=NGM395%20%C2%B7%20NGM%20Biopharmaceuticals%2C%20Inc&badge=phase%201 NGM395 NGM395 · NGM Biopharmaceuticals, Inc https://druglandscape.com/drug/ngm438 https://druglandscape.com/api/og?type=drug&title=NGM438&subtitle=NGM438%20%C2%B7%20NGM%20Biopharmaceuticals%2C%20Inc&badge=phase%201 NGM438 NGM438 · NGM Biopharmaceuticals, Inc https://druglandscape.com/drug/ngm707 https://druglandscape.com/api/og?type=drug&title=NGM707&subtitle=NGM707%20%C2%B7%20NGM%20Biopharmaceuticals%2C%20Inc&badge=phase%201 NGM707 NGM707 · NGM Biopharmaceuticals, Inc https://druglandscape.com/drug/ngm831 https://druglandscape.com/api/og?type=drug&title=NGM831&subtitle=NGM831%20%C2%B7%20NGM%20Biopharmaceuticals%2C%20Inc&badge=phase%201 NGM831 NGM831 · NGM Biopharmaceuticals, Inc https://druglandscape.com/drug/ngp-555 https://druglandscape.com/api/og?type=drug&title=NGP%20555&subtitle=NGP%20555%20%C2%B7%20NeuroGenetic%20Pharmaceuticals%20Inc&badge=phase%201 NGP 555 NGP 555 · NeuroGenetic Pharmaceuticals Inc https://druglandscape.com/drug/ngr-htnf https://druglandscape.com/api/og?type=drug&title=NGR-hTNF&subtitle=NGR-hTNF%20%C2%B7%20AGC%20Biologics%20S.p.A.&badge=phase%202 NGR-hTNF NGR-hTNF · AGC Biologics S.p.A. https://druglandscape.com/drug/ngx-1998 https://druglandscape.com/api/og?type=drug&title=NGX-1998&subtitle=NGX-1998%20%C2%B7%20NeurogesX&badge=phase%202 NGX-1998 NGX-1998 · NeurogesX https://druglandscape.com/drug/ngx267 https://druglandscape.com/api/og?type=drug&title=NGX267&subtitle=NGX267%20%C2%B7%20TorreyPines%20Therapeutics&badge=phase%202 NGX267 NGX267 · TorreyPines Therapeutics https://druglandscape.com/drug/nh004-tropicamide https://druglandscape.com/api/og?type=drug&title=NH004%20tropicamide&subtitle=NH004%20tropicamide%20%C2%B7%20NeuroHealing%20Pharmaceuticals%20Inc.&badge=phase%202 NH004 tropicamide NH004 tropicamide · NeuroHealing Pharmaceuticals Inc. https://druglandscape.com/drug/nh102 https://druglandscape.com/api/og?type=drug&title=NH102&subtitle=NH102%20%C2%B7%20Jiangsu%20Nhwa%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 NH102 NH102 · Jiangsu Nhwa Pharmaceutical Co., Ltd. https://druglandscape.com/drug/nh280105-mad https://druglandscape.com/api/og?type=drug&title=NH280105-%20MAD&subtitle=NH280105-%20MAD%20%C2%B7%20Jiangsu%20Nhwa%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 NH280105- MAD NH280105- MAD · Jiangsu Nhwa Pharmaceutical Co., Ltd. https://druglandscape.com/drug/nh280105-sad https://druglandscape.com/api/og?type=drug&title=NH280105-%20SAD&subtitle=NH280105-%20SAD%20%C2%B7%20Jiangsu%20Nhwa%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 NH280105- SAD NH280105- SAD · Jiangsu Nhwa Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ni-0101 https://druglandscape.com/api/og?type=drug&title=NI-0101&subtitle=NI-0101%20%C2%B7%20Light%20Chain%20Bioscience%20-%20Novimmune%20SA&badge=phase%202 NI-0101 NI-0101 · Light Chain Bioscience - Novimmune SA https://druglandscape.com/drug/ni-03 https://druglandscape.com/api/og?type=drug&title=NI-03&subtitle=NI-03%20%C2%B7%20Kangen%20Pharmaceuticals%2C%20Inc&badge=phase%201 NI-03 NI-03 · Kangen Pharmaceuticals, Inc https://druglandscape.com/drug/ni-0401 https://druglandscape.com/api/og?type=drug&title=NI-0401&subtitle=NI-0401%20%C2%B7%20Light%20Chain%20Bioscience%20-%20Novimmune%20SA&badge=phase%201 NI-0401 NI-0401 · Light Chain Bioscience - Novimmune SA https://druglandscape.com/drug/ni-0501 https://druglandscape.com/api/og?type=drug&title=NI-0501&subtitle=NI-0501%20%C2%B7%20Swedish%20Orphan%20Biovitrum&badge=phase%202 NI-0501 NI-0501 · Swedish Orphan Biovitrum https://druglandscape.com/drug/ni-0701 https://druglandscape.com/api/og?type=drug&title=NI-0701&subtitle=NI-0701%20%C2%B7%20Light%20Chain%20Bioscience%20-%20Novimmune%20SA&badge=phase%201 NI-0701 NI-0701 · Light Chain Bioscience - Novimmune SA https://druglandscape.com/drug/ni-1801-in-combination-with-paclitaxel https://druglandscape.com/api/og?type=drug&title=NI-1801%20in%20combination%20with%20paclitaxel&subtitle=NI-1801%20in%20combination%20with%20paclitaxel%20%C2%B7%20Light%20Chain%20Bioscience%20-%20Novimmune%20SA&badge=phase%201 NI-1801 in combination with paclitaxel NI-1801 in combination with paclitaxel · Light Chain Bioscience - Novimmune SA https://druglandscape.com/drug/ni006 https://druglandscape.com/api/og?type=drug&title=NI006&subtitle=NI006%20%C2%B7%20Neurimmune%20AG&badge=phase%201 NI006 NI006 · Neurimmune AG https://druglandscape.com/drug/niacin-and-aspirin https://druglandscape.com/api/og?type=drug&title=Niacin%20and%20aspirin&subtitle=Niacin%20and%20aspirin%20%C2%B7%20Eastern%20Virginia%20Medical%20School&badge=phase%202 Niacin and aspirin Niacin and aspirin · Eastern Virginia Medical School https://druglandscape.com/drug/niagenplus https://druglandscape.com/api/og?type=drug&title=Niagen%C2%AEPlus&subtitle=Niagen%C2%AEPlus%20%C2%B7%20ChromaDex%2C%20Inc.&badge=phase%201 Niagen®Plus Niagen®Plus · ChromaDex, Inc. https://druglandscape.com/drug/nic002 https://druglandscape.com/api/og?type=drug&title=NIC002&subtitle=NIC002%20%C2%B7%20Novartis&badge=phase%202 NIC002 NIC002 · Novartis https://druglandscape.com/drug/nic5-15 https://druglandscape.com/api/og?type=drug&title=NIC5-15&subtitle=NIC5-15%20%C2%B7%20VA%20Office%20of%20Research%20and%20Development&badge=phase%202 NIC5-15 NIC5-15 · VA Office of Research and Development https://druglandscape.com/drug/nic7-001 https://druglandscape.com/api/og?type=drug&title=NIC7-001&subtitle=NIC7-001%20%C2%B7%20Pfizer&badge=phase%201 NIC7-001 NIC7-001 · Pfizer https://druglandscape.com/drug/nic7-003 https://druglandscape.com/api/og?type=drug&title=NIC7-003&subtitle=NIC7-003%20%C2%B7%20Pfizer&badge=phase%201 NIC7-003 NIC7-003 · Pfizer https://druglandscape.com/drug/nicergoline-from-china https://druglandscape.com/api/og?type=drug&title=Nicergoline%20from%20China&subtitle=Nicergoline%20from%20China%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%201 Nicergoline from China Nicergoline from China · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/nicergoline-from-italy https://druglandscape.com/api/og?type=drug&title=Nicergoline%20from%20Italy&subtitle=Nicergoline%20from%20Italy%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%201 Nicergoline from Italy Nicergoline from Italy · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/niclosamide-inhalation-powder https://druglandscape.com/api/og?type=drug&title=Niclosamide%20Inhalation%20Powder&subtitle=Niclosamide%20Inhalation%20Powder%20%C2%B7%20TFF%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Niclosamide Inhalation Powder Niclosamide Inhalation Powder · TFF Pharmaceuticals, Inc. https://druglandscape.com/drug/nicord https://druglandscape.com/api/og?type=drug&title=NiCord&subtitle=NiCord%20%C2%B7%20Gamida%20Cell%20ltd&badge=phase%201 NiCord NiCord · Gamida Cell ltd https://druglandscape.com/drug/nicorette-inhalator https://druglandscape.com/api/og?type=drug&title=Nicorette%20Inhalator&subtitle=Nicorette%20Inhalator%20%C2%B7%20NJOY%2C%20Inc.&badge=phase%201 Nicorette Inhalator Nicorette Inhalator · NJOY, Inc. https://druglandscape.com/drug/nicorette-microtab https://druglandscape.com/api/og?type=drug&title=Nicorette%20Microtab&subtitle=Nicorette%20Microtab%20%C2%B7%20McNeil%20AB&badge=phase%201 Nicorette Microtab Nicorette Microtab · McNeil AB https://druglandscape.com/drug/nicorette-mini-lozenge https://druglandscape.com/api/og?type=drug&title=Nicorette%20Mini%20Lozenge&subtitle=Nicorette%20Mini%20Lozenge%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Nicorette Mini Lozenge Nicorette Mini Lozenge · GlaxoSmithKline https://druglandscape.com/drug/nicotine-film https://druglandscape.com/api/og?type=drug&title=Nicotine%20Film&subtitle=Nicotine%20Film%20%C2%B7%20Milton%20S.%20Hershey%20Medical%20Center&badge=phase%201 Nicotine Film Nicotine Film · Milton S. Hershey Medical Center https://druglandscape.com/drug/nicotine-gum-and-patch https://druglandscape.com/api/og?type=drug&title=Nicotine%20Gum%20and%20Patch&subtitle=Nicotine%20Gum%20and%20Patch%20%C2%B7%20Fundacio%20d'Investigacio%20en%20Atencio%20Primaria%20Jordi%20Gol%20i%20Gurina&badge=phase%201 Nicotine Gum and Patch Nicotine Gum and Patch · Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina https://druglandscape.com/drug/nicotine-higher-dose https://druglandscape.com/api/og?type=drug&title=Nicotine%20higher%20dose&subtitle=Nicotine%20higher%20dose%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Nicotine higher dose Nicotine higher dose · GlaxoSmithKline https://druglandscape.com/drug/nicotine-lower-dose https://druglandscape.com/api/og?type=drug&title=Nicotine%20lower%20dose&subtitle=Nicotine%20lower%20dose%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Nicotine lower dose Nicotine lower dose · GlaxoSmithKline https://druglandscape.com/drug/nicotine-medicated-gum https://druglandscape.com/api/og?type=drug&title=Nicotine%20Medicated%20Gum&subtitle=Nicotine%20Medicated%20Gum%20%C2%B7%20McNeil%20AB&badge=phase%201 Nicotine Medicated Gum Nicotine Medicated Gum · McNeil AB https://druglandscape.com/drug/nicotine-prototype-mini-lozenge https://druglandscape.com/api/og?type=drug&title=Nicotine%20Prototype%20Mini%20lozenge&subtitle=Nicotine%20Prototype%20Mini%20lozenge%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Nicotine Prototype Mini lozenge Nicotine Prototype Mini lozenge · GlaxoSmithKline https://druglandscape.com/drug/nicotine-replacement-products https://druglandscape.com/api/og?type=drug&title=Nicotine%20Replacement%20Products&subtitle=Nicotine%20Replacement%20Products%20%C2%B7%20Joseph%20Valentino%2C%20MD&badge=phase%202 Nicotine Replacement Products Nicotine Replacement Products · Joseph Valentino, MD https://druglandscape.com/drug/nido-361 https://druglandscape.com/api/og?type=drug&title=NIDO-361&subtitle=NIDO-361%20%C2%B7%20Nido%20Biosciences%2C%20Inc.&badge=phase%202 NIDO-361 NIDO-361 · Nido Biosciences, Inc. https://druglandscape.com/drug/nifedipine-coated-suppositories https://druglandscape.com/api/og?type=drug&title=Nifedipine%20coated%20suppositories&subtitle=Nifedipine%20coated%20suppositories%20%C2%B7%20RDD%20Pharma%20Ltd&badge=phase%201 Nifedipine coated suppositories Nifedipine coated suppositories · RDD Pharma Ltd https://druglandscape.com/drug/nifedipine-soft-gelatine-capsules https://druglandscape.com/api/og?type=drug&title=Nifedipine%20soft%20gelatine%20capsules&subtitle=Nifedipine%20soft%20gelatine%20capsules%20%C2%B7%20Reig%20Jofre%20Group&badge=phase%201 Nifedipine soft gelatine capsules Nifedipine soft gelatine capsules · Reig Jofre Group https://druglandscape.com/drug/nifedipine-sustained-release-tablets https://druglandscape.com/api/og?type=drug&title=Nifedipine%20Sustained%20-release%20Tablets&subtitle=Nifedipine%20Sustained%20-release%20Tablets%20%C2%B7%20Hasten%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Nifedipine Sustained -release Tablets Nifedipine Sustained -release Tablets · Hasten Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/nim-1324 https://druglandscape.com/api/og?type=drug&title=NIM-1324&subtitle=NIM-1324%20%C2%B7%20NImmune%20Biopharma&badge=phase%201 NIM-1324 NIM-1324 · NImmune Biopharma https://druglandscape.com/drug/nimodipine-capsules https://druglandscape.com/api/og?type=drug&title=Nimodipine%20Capsules&subtitle=Nimodipine%20Capsules%20%C2%B7%20Grace%20Therapeutics%20Inc.&badge=phase%201 Nimodipine Capsules Nimodipine Capsules · Grace Therapeutics Inc. https://druglandscape.com/drug/nimodipine-microparticles https://druglandscape.com/api/og?type=drug&title=Nimodipine%20Microparticles&subtitle=Nimodipine%20Microparticles%20%C2%B7%20Edge%20Therapeutics%20Inc&badge=phase%201 Nimodipine Microparticles Nimodipine Microparticles · Edge Therapeutics Inc https://druglandscape.com/drug/nintedanib-nivolumab-combination-therapy https://druglandscape.com/api/og?type=drug&title=nintedanib-nivolumab%20combination%20therapy&subtitle=nintedanib-nivolumab%20combination%20therapy%20%C2%B7%20AIO-Studien-gGmbH&badge=phase%201 nintedanib-nivolumab combination therapy nintedanib-nivolumab combination therapy · AIO-Studien-gGmbH https://druglandscape.com/drug/nintedanib-soft-capsules https://druglandscape.com/api/og?type=drug&title=Nintedanib%20Soft%20Capsules&subtitle=Nintedanib%20Soft%20Capsules%20%C2%B7%20Guangdong%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 Nintedanib Soft Capsules Nintedanib Soft Capsules · Guangdong Hengrui Pharmaceutical Co., Ltd https://druglandscape.com/drug/niquitintm-nicotine-lozenge https://druglandscape.com/api/og?type=drug&title=NiQuitinTM%20Nicotine%20Lozenge&subtitle=NiQuitinTM%20Nicotine%20Lozenge%20%C2%B7%20McNeil%20AB&badge=phase%201 NiQuitinTM Nicotine Lozenge NiQuitinTM Nicotine Lozenge · McNeil AB https://druglandscape.com/drug/niraparib-oral-tablets https://druglandscape.com/api/og?type=drug&title=Niraparib%20oral%20tablets&subtitle=Niraparib%20oral%20tablets%20%C2%B7%20MedSIR&badge=phase%202 Niraparib oral tablets Niraparib oral tablets · MedSIR https://druglandscape.com/drug/nirogacestat-and-famotidine https://druglandscape.com/api/og?type=drug&title=Nirogacestat%20and%20Famotidine&subtitle=Nirogacestat%20and%20Famotidine%20%C2%B7%20SpringWorks%20Therapeutics%2C%20Inc.&badge=phase%201 Nirogacestat and Famotidine Nirogacestat and Famotidine · SpringWorks Therapeutics, Inc. https://druglandscape.com/drug/nirogacestat-and-rabeprazole https://druglandscape.com/api/og?type=drug&title=Nirogacestat%20and%20Rabeprazole&subtitle=Nirogacestat%20and%20Rabeprazole%20%C2%B7%20SpringWorks%20Therapeutics%2C%20Inc.&badge=phase%201 Nirogacestat and Rabeprazole Nirogacestat and Rabeprazole · SpringWorks Therapeutics, Inc. https://druglandscape.com/drug/nitazoxanide-and-cicl-sonide https://druglandscape.com/api/og?type=drug&title=Nitazoxanide%20and%20Cicl%C3%A9sonide&subtitle=Nitazoxanide%20and%20Cicl%C3%A9sonide%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%202 Nitazoxanide and Ciclésonide Nitazoxanide and Ciclésonide · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/nitazoxanide-plus-peginterferon-alfa-2b https://druglandscape.com/api/og?type=drug&title=Nitazoxanide%20plus%20peginterferon%20alfa-2b&subtitle=Nitazoxanide%20plus%20peginterferon%20alfa-2b%20%C2%B7%20Romark%20Laboratories%20L.C.&badge=phase%202 Nitazoxanide plus peginterferon alfa-2b Nitazoxanide plus peginterferon alfa-2b · Romark Laboratories L.C. https://druglandscape.com/drug/nitisinone-baked-tablet https://druglandscape.com/api/og?type=drug&title=Nitisinone%20Baked%20Tablet&subtitle=Nitisinone%20Baked%20Tablet%20%C2%B7%20Cycle%20Pharmaceuticals%20Ltd.&badge=phase%201 Nitisinone Baked Tablet Nitisinone Baked Tablet · Cycle Pharmaceuticals Ltd. https://druglandscape.com/drug/nitisinone-capsule https://druglandscape.com/api/og?type=drug&title=Nitisinone%2C%20capsule&subtitle=Nitisinone%2C%20capsule%20%C2%B7%20Swedish%20Orphan%20Biovitrum&badge=phase%201 Nitisinone, capsule Nitisinone, capsule · Swedish Orphan Biovitrum https://druglandscape.com/drug/nitisinone-in-arm-a https://druglandscape.com/api/og?type=drug&title=Nitisinone%20in%20Arm%20A&subtitle=Nitisinone%20in%20Arm%20A%20%C2%B7%20Swedish%20Orphan%20Biovitrum&badge=phase%201 Nitisinone in Arm A Nitisinone in Arm A · Swedish Orphan Biovitrum https://druglandscape.com/drug/nitisinone-in-arm-b https://druglandscape.com/api/og?type=drug&title=Nitisinone%20in%20Arm%20B&subtitle=Nitisinone%20in%20Arm%20B%20%C2%B7%20Swedish%20Orphan%20Biovitrum&badge=phase%201 Nitisinone in Arm B Nitisinone in Arm B · Swedish Orphan Biovitrum https://druglandscape.com/drug/nitric-oxide-100-000-ppm https://druglandscape.com/api/og?type=drug&title=Nitric%20Oxide%20100%2C000%20ppm&subtitle=Nitric%20Oxide%20100%2C000%20ppm%20%C2%B7%20Beyond%20Air%20Inc.&badge=phase%201 Nitric Oxide 100,000 ppm Nitric Oxide 100,000 ppm · Beyond Air Inc. https://druglandscape.com/drug/nitric-oxide-25-000-ppm https://druglandscape.com/api/og?type=drug&title=Nitric%20Oxide%2025%2C000%20ppm&subtitle=Nitric%20Oxide%2025%2C000%20ppm%20%C2%B7%20Beyond%20Air%20Inc.&badge=phase%201 Nitric Oxide 25,000 ppm Nitric Oxide 25,000 ppm · Beyond Air Inc. https://druglandscape.com/drug/nitric-oxide-50-000-ppm https://druglandscape.com/api/og?type=drug&title=Nitric%20Oxide%2050%2C000%20ppm&subtitle=Nitric%20Oxide%2050%2C000%20ppm%20%C2%B7%20Beyond%20Air%20Inc.&badge=phase%201 Nitric Oxide 50,000 ppm Nitric Oxide 50,000 ppm · Beyond Air Inc. https://druglandscape.com/drug/nitric-oxide-by-inhalation-inomax https://druglandscape.com/api/og?type=drug&title=Nitric%20oxide%20by%20inhalation%20INOMAX&subtitle=Nitric%20oxide%20by%20inhalation%20INOMAX%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Nitric oxide by inhalation INOMAX Nitric oxide by inhalation INOMAX · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/nitric-oxide-releasing-solution https://druglandscape.com/api/og?type=drug&title=Nitric%20Oxide%20Releasing%20Solution&subtitle=Nitric%20Oxide%20Releasing%20Solution%20%C2%B7%20Sanotize%20Research%20and%20Development%20corp.&badge=phase%202 Nitric Oxide Releasing Solution Nitric Oxide Releasing Solution · Sanotize Research and Development corp. https://druglandscape.com/drug/nitro-pohl https://druglandscape.com/api/og?type=drug&title=Nitro%20Pohl&subtitle=Nitro%20Pohl%20%C2%B7%20Futura%20Medical%20Developments%20Ltd.&badge=phase%201 Nitro Pohl Nitro Pohl · Futura Medical Developments Ltd. https://druglandscape.com/drug/nitroderm-patch https://druglandscape.com/api/og?type=drug&title=Nitroderm%20patch&subtitle=Nitroderm%20patch%20%C2%B7%20Rabin%20Medical%20Center&badge=phase%201 Nitroderm patch Nitroderm patch · Rabin Medical Center https://druglandscape.com/drug/nitrofurantoin-capsules https://druglandscape.com/api/og?type=drug&title=Nitrofurantoin%20capsules&subtitle=Nitrofurantoin%20capsules%20%C2%B7%20Paratek%20Pharmaceuticals%20Inc&badge=phase%202 Nitrofurantoin capsules Nitrofurantoin capsules · Paratek Pharmaceuticals Inc https://druglandscape.com/drug/nitroglycerin-iv https://druglandscape.com/api/og?type=drug&title=nitroglycerin%20iv&subtitle=nitroglycerin%20iv%20%C2%B7%20Frisius%20Medisch%20Centrum&badge=phase%203 nitroglycerin iv nitroglycerin iv · Frisius Medisch Centrum https://druglandscape.com/drug/nitroglycerin-ointment-2-usp https://druglandscape.com/api/og?type=drug&title=Nitroglycerin%20ointment%202%25%2C%20USP&subtitle=Nitroglycerin%20ointment%202%25%2C%20USP%20%C2%B7%20MediQuest%20Therapeutics&badge=phase%201 Nitroglycerin ointment 2%, USP Nitroglycerin ointment 2%, USP · MediQuest Therapeutics https://druglandscape.com/drug/nitroglycerin-topical-product https://druglandscape.com/api/og?type=drug&title=Nitroglycerin%20Topical%20Product&subtitle=Nitroglycerin%20Topical%20Product%20%C2%B7%20Deborah%20Heart%20and%20Lung%20Center&badge=phase%202 Nitroglycerin Topical Product Nitroglycerin Topical Product · Deborah Heart and Lung Center https://druglandscape.com/drug/nitrous-oxide-no https://druglandscape.com/api/og?type=drug&title=Nitrous%20Oxide%20NO&subtitle=Nitrous%20Oxide%20NO%20%C2%B7%20Universidade%20Federal%20Fluminense&badge=phase%201 Nitrous Oxide NO Nitrous Oxide NO · Universidade Federal Fluminense https://druglandscape.com/drug/nivolumab-daratumumab https://druglandscape.com/api/og?type=drug&title=nivolumab-daratumumab&subtitle=nivolumab-daratumumab%20%C2%B7%20Amsterdam%20UMC%2C%20location%20VUmc&badge=phase%202 nivolumab-daratumumab nivolumab-daratumumab · Amsterdam UMC, location VUmc https://druglandscape.com/drug/nivolumab-docetaxel-cisplatin-group https://druglandscape.com/api/og?type=drug&title=nivolumab%2C%20docetaxel%2C%20cisplatin%20Group&subtitle=nivolumab%2C%20docetaxel%2C%20cisplatin%20Group%20%C2%B7%20Myung-Ju%20Ahn&badge=phase%202 nivolumab, docetaxel, cisplatin Group nivolumab, docetaxel, cisplatin Group · Myung-Ju Ahn https://druglandscape.com/drug/nivolumab-fixed-dose https://druglandscape.com/api/og?type=drug&title=Nivolumab%2C%20fixed%20dose&subtitle=Nivolumab%2C%20fixed%20dose%20%C2%B7%20Philogen%20S.p.A.&badge=phase%201 Nivolumab, fixed dose Nivolumab, fixed dose · Philogen S.p.A. https://druglandscape.com/drug/nivolumab-injectable-product https://druglandscape.com/api/og?type=drug&title=Nivolumab%20Injectable%20Product&subtitle=Nivolumab%20Injectable%20Product%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%202 Nivolumab Injectable Product Nivolumab Injectable Product · Baylor College of Medicine https://druglandscape.com/drug/nivolumab-injection-opdivo https://druglandscape.com/api/og?type=drug&title=Nivolumab%20Injection%20%5BOpdivo%5D&subtitle=Nivolumab%20Injection%20%5BOpdivo%5D%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%202 Nivolumab Injection [Opdivo] Nivolumab Injection [Opdivo] · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/nivolumab-iv https://druglandscape.com/api/og?type=drug&title=Nivolumab%20IV&subtitle=Nivolumab%20IV%20%C2%B7%20Gustave%20Roussy%2C%20Cancer%20Campus%2C%20Grand%20Paris&badge=phase%201 Nivolumab IV Nivolumab IV · Gustave Roussy, Cancer Campus, Grand Paris https://druglandscape.com/drug/nivolumab-low-dose-cyclophosphamide https://druglandscape.com/api/og?type=drug&title=Nivolumab%2Clow%20dose%20cyclophosphamide&subtitle=Nivolumab%2Clow%20dose%20cyclophosphamide%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 Nivolumab,low dose cyclophosphamide Nivolumab,low dose cyclophosphamide · Hadassah Medical Organization https://druglandscape.com/drug/nivolumab-plus-relatlimab-fdc https://druglandscape.com/api/og?type=drug&title=Nivolumab%20plus%20Relatlimab%20FDC&subtitle=Nivolumab%20plus%20Relatlimab%20FDC%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 Nivolumab plus Relatlimab FDC Nivolumab plus Relatlimab FDC · Bristol-Myers Squibb https://druglandscape.com/drug/nivolumab-starting-at-day-1 https://druglandscape.com/api/og?type=drug&title=Nivolumab%20starting%20at%20day%20-1&subtitle=Nivolumab%20starting%20at%20day%20-1%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Nivolumab starting at day -1 Nivolumab starting at day -1 · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/nix-cr-me https://druglandscape.com/api/og?type=drug&title=Nix%20Cr%C3%A8me&subtitle=Nix%20Cr%C3%A8me%20%C2%B7%20Oystershell%20NV&badge=phase%201 Nix Crème Nix Crème · Oystershell NV https://druglandscape.com/drug/nix-creme-rinse-1-permethrin https://druglandscape.com/api/og?type=drug&title=NIX%20Creme%20Rinse%20-%201%25%20permethrin&subtitle=NIX%20Creme%20Rinse%20-%201%25%20permethrin%20%C2%B7%20ParaPRO%20LLC&badge=phase%202 NIX Creme Rinse - 1% permethrin NIX Creme Rinse - 1% permethrin · ParaPRO LLC https://druglandscape.com/drug/njoy-e-cigarette https://druglandscape.com/api/og?type=drug&title=NJOY%20e-cigarette&subtitle=NJOY%20e-cigarette%20%C2%B7%20Milton%20S.%20Hershey%20Medical%20Center&badge=phase%201 NJOY e-cigarette NJOY e-cigarette · Milton S. Hershey Medical Center https://druglandscape.com/drug/nk-cell-preparation https://druglandscape.com/api/og?type=drug&title=NK%20cell%20preparation&subtitle=NK%20cell%20preparation%20%C2%B7%20Guangzhou%20Xiling%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 NK cell preparation NK cell preparation · Guangzhou Xiling Biotechnology Co., Ltd. https://druglandscape.com/drug/nk012 https://druglandscape.com/api/og?type=drug&title=NK012&subtitle=NK012%20%C2%B7%20Nippon%20Kayaku%20Co.%2C%20Ltd.&badge=phase%202 NK012 NK012 · Nippon Kayaku Co., Ltd. https://druglandscape.com/drug/nk012-and-5-fu https://druglandscape.com/api/og?type=drug&title=NK012%20and%205-FU&subtitle=NK012%20and%205-FU%20%C2%B7%20Nippon%20Kayaku%20Co.%2C%20Ltd.&badge=phase%201 NK012 and 5-FU NK012 and 5-FU · Nippon Kayaku Co., Ltd. https://druglandscape.com/drug/nk012-and-carboplatin https://druglandscape.com/api/og?type=drug&title=NK012%20and%20carboplatin&subtitle=NK012%20and%20carboplatin%20%C2%B7%20Nippon%20Kayaku%20Co.%2C%20Ltd.&badge=phase%201 NK012 and carboplatin NK012 and carboplatin · Nippon Kayaku Co., Ltd. https://druglandscape.com/drug/nk042 https://druglandscape.com/api/og?type=drug&title=NK042&subtitle=NK042%20%C2%B7%20Shanghai%20NK%20Cell%20Technology%20Co.%2C%20LTD&badge=phase%201 NK042 NK042 · Shanghai NK Cell Technology Co., LTD https://druglandscape.com/drug/nk1-antagonist https://druglandscape.com/api/og?type=drug&title=NK1%20Antagonist&subtitle=NK1%20Antagonist%20%C2%B7%20St.%20Joseph's%20Healthcare%20Hamilton&badge=phase%201 NK1 Antagonist NK1 Antagonist · St. Joseph's Healthcare Hamilton https://druglandscape.com/drug/nk3r-antagonist-azd4901 https://druglandscape.com/api/og?type=drug&title=NK3R%20antagonist%20-%20AZD4901&subtitle=NK3R%20antagonist%20-%20AZD4901%20%C2%B7%20Imperial%20College%20London&badge=phase%202 NK3R antagonist - AZD4901 NK3R antagonist - AZD4901 · Imperial College London https://druglandscape.com/drug/nk510 https://druglandscape.com/api/og?type=drug&title=NK510&subtitle=NK510%20%C2%B7%20Base%20Therapeutics%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 NK510 NK510 · Base Therapeutics (Shanghai) Co., Ltd. https://druglandscape.com/drug/nk510-allogeneic-genetic-modified-nk https://druglandscape.com/api/og?type=drug&title=NK510%20%3A%20allogeneic%20genetic%20modified%20NK&subtitle=NK510%20%3A%20allogeneic%20genetic%20modified%20NK%20%C2%B7%20Base%20Therapeutics%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 NK510 : allogeneic genetic modified NK NK510 : allogeneic genetic modified NK · Base Therapeutics (Shanghai) Co., Ltd. https://druglandscape.com/drug/nk520 https://druglandscape.com/api/og?type=drug&title=NK520&subtitle=NK520%20%C2%B7%20Base%20Therapeutics%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 NK520 NK520 · Base Therapeutics (Shanghai) Co., Ltd. https://druglandscape.com/drug/nkg2d-car-nk https://druglandscape.com/api/og?type=drug&title=NKG2D%20CAR-NK&subtitle=NKG2D%20CAR-NK%20%C2%B7%20Hangzhou%20Cheetah%20Cell%20Therapeutics%20Co.%2C%20Ltd&badge=phase%201 NKG2D CAR-NK NKG2D CAR-NK · Hangzhou Cheetah Cell Therapeutics Co., Ltd https://druglandscape.com/drug/nkg2d-car-t https://druglandscape.com/api/og?type=drug&title=NKG2D%20CAR-T&subtitle=NKG2D%20CAR-T%20%C2%B7%20UWELL%20Biopharma&badge=phase%201 NKG2D CAR-T NKG2D CAR-T · UWELL Biopharma https://druglandscape.com/drug/nkp-1339 https://druglandscape.com/api/og?type=drug&title=NKP-1339&subtitle=NKP-1339%20%C2%B7%20Niiki%20Pharma%20Inc.&badge=phase%201 NKP-1339 NKP-1339 · Niiki Pharma Inc. https://druglandscape.com/drug/nkr-2 https://druglandscape.com/api/og?type=drug&title=NKR-2&subtitle=NKR-2%20%C2%B7%20Celyad%20Oncology%20SA&badge=phase%201 NKR-2 NKR-2 · Celyad Oncology SA https://druglandscape.com/drug/nkt3964 https://druglandscape.com/api/og?type=drug&title=NKT3964&subtitle=NKT3964%20%C2%B7%20NiKang%20Therapeutics%2C%20Inc.&badge=phase%201 NKT3964 NKT3964 · NiKang Therapeutics, Inc. https://druglandscape.com/drug/nktr118-formulation-1a https://druglandscape.com/api/og?type=drug&title=NKTR118%20Formulation%201a&subtitle=NKTR118%20Formulation%201a%20%C2%B7%20AstraZeneca&badge=phase%201 NKTR118 Formulation 1a NKTR118 Formulation 1a · AstraZeneca https://druglandscape.com/drug/nktr118-formulation-3a https://druglandscape.com/api/og?type=drug&title=NKTR118%20Formulation%203a&subtitle=NKTR118%20Formulation%203a%20%C2%B7%20AstraZeneca&badge=phase%201 NKTR118 Formulation 3a NKTR118 Formulation 3a · AstraZeneca https://druglandscape.com/drug/nktr118-group1 https://druglandscape.com/api/og?type=drug&title=NKTR118%20Group1&subtitle=NKTR118%20Group1%20%C2%B7%20AstraZeneca&badge=phase%201 NKTR118 Group1 NKTR118 Group1 · AstraZeneca https://druglandscape.com/drug/nktt120 https://druglandscape.com/api/og?type=drug&title=NKTT120&subtitle=NKTT120%20%C2%B7%20NKT%20Therapeutics&badge=phase%201 NKTT120 NKTT120 · NKT Therapeutics https://druglandscape.com/drug/nkx019 https://druglandscape.com/api/og?type=drug&title=NKX019&subtitle=NKX019%20%C2%B7%20Nkarta%2C%20Inc.&badge=phase%201 NKX019 NKX019 · Nkarta, Inc. https://druglandscape.com/drug/nl-201 https://druglandscape.com/api/og?type=drug&title=NL-201&subtitle=NL-201%20%C2%B7%20Neurogene%20Inc.&badge=phase%201 NL-201 NL-201 · Neurogene Inc. https://druglandscape.com/drug/nl-saa1-01 https://druglandscape.com/api/og?type=drug&title=nL-SAA1-01&subtitle=nL-SAA1-01%20%C2%B7%20Nelson%20Leung%2C%20MD&badge=phase%201 nL-SAA1-01 nL-SAA1-01 · Nelson Leung, MD https://druglandscape.com/drug/nl005-high-dose https://druglandscape.com/api/og?type=drug&title=NL005%20High%20Dose&subtitle=NL005%20High%20Dose%20%C2%B7%20Beijing%20Northland%20Biotech.%20Co.%2C%20Ltd.&badge=phase%202 NL005 High Dose NL005 High Dose · Beijing Northland Biotech. Co., Ltd. https://druglandscape.com/drug/nl005-middle-dose https://druglandscape.com/api/og?type=drug&title=NL005%20Middle%20Dose&subtitle=NL005%20Middle%20Dose%20%C2%B7%20Beijing%20Northland%20Biotech.%20Co.%2C%20Ltd.&badge=phase%202 NL005 Middle Dose NL005 Middle Dose · Beijing Northland Biotech. Co., Ltd. https://druglandscape.com/drug/nls-133 https://druglandscape.com/api/og?type=drug&title=NLS-133&subtitle=NLS-133%20%C2%B7%20Next%20Life%20Sciences&badge=phase%202 NLS-133 NLS-133 · Next Life Sciences https://druglandscape.com/drug/nlx-112 https://druglandscape.com/api/og?type=drug&title=NLX-112&subtitle=NLX-112%20%C2%B7%20Neurolixis%20SAS&badge=phase%202 NLX-112 NLX-112 · Neurolixis SAS https://druglandscape.com/drug/nly01 https://druglandscape.com/api/og?type=drug&title=NLY01&subtitle=NLY01%20%C2%B7%20Neuraly%2C%20Inc.&badge=phase%202 NLY01 NLY01 · Neuraly, Inc. https://druglandscape.com/drug/nm-002 https://druglandscape.com/api/og?type=drug&title=NM-002&subtitle=NM-002%20%C2%B7%209%20Meters%20Biopharma%2C%20Inc.&badge=phase%201 NM-002 NM-002 · 9 Meters Biopharma, Inc. https://druglandscape.com/drug/nm-101 https://druglandscape.com/api/og?type=drug&title=NM-101&subtitle=NM-101%20%C2%B7%20Neuramedy%20Co.%20Ltd.&badge=phase%201 NM-101 NM-101 · Neuramedy Co. Ltd. https://druglandscape.com/drug/nm-3 https://druglandscape.com/api/og?type=drug&title=NM-3&subtitle=NM-3%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%201 NM-3 NM-3 · Genzyme, a Sanofi Company https://druglandscape.com/drug/nm-il-12-and-tsebt https://druglandscape.com/api/og?type=drug&title=NM-IL-12%20and%20TSEBT&subtitle=NM-IL-12%20and%20TSEBT%20%C2%B7%20Neumedicines%20Inc.&badge=phase%202 NM-IL-12 and TSEBT NM-IL-12 and TSEBT · Neumedicines Inc. https://druglandscape.com/drug/nm283-plus-peg-ifn-2a https://druglandscape.com/api/og?type=drug&title=NM283%20plus%20Peg-IFN%CE%B1-2a&subtitle=NM283%20plus%20Peg-IFN%CE%B1-2a%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 NM283 plus Peg-IFNα-2a NM283 plus Peg-IFNα-2a · Merck Sharp & Dohme LLC https://druglandscape.com/drug/nm504 https://druglandscape.com/api/og?type=drug&title=NM504%3A&subtitle=NM504%3A%20%C2%B7%20NuMe%20Health&badge=phase%201 NM504: NM504: · NuMe Health https://druglandscape.com/drug/nm6603 https://druglandscape.com/api/og?type=drug&title=NM6603&subtitle=NM6603%20%C2%B7%20NucMito%20Pharmaceuticals%20Co.%20Ltd.&badge=phase%201 NM6603 NM6603 · NucMito Pharmaceuticals Co. Ltd. https://druglandscape.com/drug/nm8074 https://druglandscape.com/api/og?type=drug&title=NM8074&subtitle=NM8074%20%C2%B7%20NovelMed%20Therapeutics&badge=phase%202 NM8074 NM8074 · NovelMed Therapeutics https://druglandscape.com/drug/nmbas https://druglandscape.com/api/og?type=drug&title=NMBAs&subtitle=NMBAs%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 NMBAs NMBAs · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/nmd670 https://druglandscape.com/api/og?type=drug&title=NMD670&subtitle=NMD670%20%C2%B7%20NMD%20Pharma%20A%2FS&badge=phase%202 NMD670 NMD670 · NMD Pharma A/S https://druglandscape.com/drug/nmk89 https://druglandscape.com/api/og?type=drug&title=NMK89&subtitle=NMK89%20%C2%B7%20Nihon%20Medi-Physics%20Co.%2C%20Ltd.&badge=phase%201 NMK89 NMK89 · Nihon Medi-Physics Co., Ltd. https://druglandscape.com/drug/nmra-323511 https://druglandscape.com/api/og?type=drug&title=NMRA-323511&subtitle=NMRA-323511%20%C2%B7%20Neumora%20Therapeutics%2C%20Inc.&badge=phase%201 NMRA-323511 NMRA-323511 · Neumora Therapeutics, Inc. https://druglandscape.com/drug/nmrc-m3v-ad-pfca https://druglandscape.com/api/og?type=drug&title=NMRC-M3V-Ad-PfCA&subtitle=NMRC-M3V-Ad-PfCA%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 NMRC-M3V-Ad-PfCA NMRC-M3V-Ad-PfCA · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/nmrc-mv-ad-pfc-nmrc-m3v-ad-pfca https://druglandscape.com/api/og?type=drug&title=NMRC-MV-Ad-PfC%2C%20NMRC-M3V-Ad-PfCA&subtitle=NMRC-MV-Ad-PfC%2C%20NMRC-M3V-Ad-PfCA%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/nms-03305293 https://druglandscape.com/api/og?type=drug&title=NMS-03305293&subtitle=NMS-03305293%20%C2%B7%20Nerviano%20Medical%20Sciences&badge=phase%201 NMS-03305293 NMS-03305293 · Nerviano Medical Sciences https://druglandscape.com/drug/nms-1286937 https://druglandscape.com/api/og?type=drug&title=NMS-1286937&subtitle=NMS-1286937%20%C2%B7%20Nerviano%20Medical%20Sciences&badge=phase%201 NMS-1286937 NMS-1286937 · Nerviano Medical Sciences https://druglandscape.com/drug/nn1218 https://druglandscape.com/api/og?type=drug&title=NN1218&subtitle=NN1218%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NN1218 NN1218 · Novo Nordisk A/S https://druglandscape.com/drug/nn1952 https://druglandscape.com/api/og?type=drug&title=NN1952&subtitle=NN1952%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NN1952 NN1952 · Novo Nordisk A/S https://druglandscape.com/drug/nn3201 https://druglandscape.com/api/og?type=drug&title=NN3201&subtitle=NN3201%20%C2%B7%20Novelty%20Nobility%2C%20Inc.&badge=phase%201 NN3201 NN3201 · Novelty Nobility, Inc. https://druglandscape.com/drug/nn414 https://druglandscape.com/api/og?type=drug&title=NN414&subtitle=NN414%20%C2%B7%20Danish%20Headache%20Center&badge=phase%201 NN414 NN414 · Danish Headache Center https://druglandscape.com/drug/nnc-0123-0000-0338 https://druglandscape.com/api/og?type=drug&title=NNC%200123-0000-0338&subtitle=NNC%200123-0000-0338%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC 0123-0000-0338 NNC 0123-0000-0338 · Novo Nordisk A/S https://druglandscape.com/drug/nnc-0128-0000-2011 https://druglandscape.com/api/og?type=drug&title=NNC%200128-0000-2011&subtitle=NNC%200128-0000-2011%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC 0128-0000-2011 NNC 0128-0000-2011 · Novo Nordisk A/S https://druglandscape.com/drug/nnc-0128-0000-2021 https://druglandscape.com/api/og?type=drug&title=NNC%200128-0000-2021&subtitle=NNC%200128-0000-2021%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC 0128-0000-2021 NNC 0128-0000-2021 · Novo Nordisk A/S https://druglandscape.com/drug/nnc-0142-0000-0002 https://druglandscape.com/api/og?type=drug&title=NNC%200142-0000-0002&subtitle=NNC%200142-0000-0002%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 NNC 0142-0000-0002 NNC 0142-0000-0002 · Janssen Research & Development, LLC https://druglandscape.com/drug/nnc-0148-0000-0362 https://druglandscape.com/api/og?type=drug&title=NNC%200148-0000-0362&subtitle=NNC%200148-0000-0362%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC 0148-0000-0362 NNC 0148-0000-0362 · Novo Nordisk A/S https://druglandscape.com/drug/nnc-0172-0000-2021 https://druglandscape.com/api/og?type=drug&title=NNC%200172-0000-2021&subtitle=NNC%200172-0000-2021%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC 0172-0000-2021 NNC 0172-0000-2021 · Novo Nordisk A/S https://druglandscape.com/drug/nnc-55-0414 https://druglandscape.com/api/og?type=drug&title=NNC%2055-0414&subtitle=NNC%2055-0414%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC 55-0414 NNC 55-0414 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0090-2746 https://druglandscape.com/api/og?type=drug&title=NNC0090-2746&subtitle=NNC0090-2746%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 NNC0090-2746 NNC0090-2746 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0113-2023 https://druglandscape.com/api/og?type=drug&title=NNC0113-2023&subtitle=NNC0113-2023%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0113-2023 NNC0113-2023 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0113-6856 https://druglandscape.com/api/og?type=drug&title=NNC0113-6856&subtitle=NNC0113-6856%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0113-6856 NNC0113-6856 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0113-6860 https://druglandscape.com/api/og?type=drug&title=NNC0113-6860&subtitle=NNC0113-6860%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0113-6860 NNC0113-6860 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0113-6861 https://druglandscape.com/api/og?type=drug&title=NNC0113-6861&subtitle=NNC0113-6861%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0113-6861 NNC0113-6861 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0113-6891 https://druglandscape.com/api/og?type=drug&title=NNC0113-6891&subtitle=NNC0113-6891%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0113-6891 NNC0113-6891 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0114-0000-0005 https://druglandscape.com/api/og?type=drug&title=NNC0114-0000-0005&subtitle=NNC0114-0000-0005%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0114-0000-0005 NNC0114-0000-0005 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0142-0002 https://druglandscape.com/api/og?type=drug&title=NNC0142-0002&subtitle=NNC0142-0002%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 NNC0142-0002 NNC0142-0002 · Janssen Research & Development, LLC https://druglandscape.com/drug/nnc0143-0406 https://druglandscape.com/api/og?type=drug&title=NNC0143-0406&subtitle=NNC0143-0406%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0143-0406 NNC0143-0406 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0148-0287 https://druglandscape.com/api/og?type=drug&title=NNC0148-0287&subtitle=NNC0148-0287%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0148-0287 NNC0148-0287 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0148-0287sema https://druglandscape.com/api/og?type=drug&title=NNC0148-0287sema&subtitle=NNC0148-0287sema%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0148-0287sema NNC0148-0287sema · Novo Nordisk A/S https://druglandscape.com/drug/nnc0165-1562 https://druglandscape.com/api/og?type=drug&title=NNC0165-1562&subtitle=NNC0165-1562%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0165-1562 NNC0165-1562 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0165-1875 https://druglandscape.com/api/og?type=drug&title=NNC0165-1875&subtitle=NNC0165-1875%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0165-1875 NNC0165-1875 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0174-0833 https://druglandscape.com/api/og?type=drug&title=NNC0174-0833&subtitle=NNC0174-0833%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 NNC0174-0833 NNC0174-0833 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0174-1213-a https://druglandscape.com/api/og?type=drug&title=NNC0174-1213%20A&subtitle=NNC0174-1213%20A%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0174-1213 A NNC0174-1213 A · Novo Nordisk A/S https://druglandscape.com/drug/nnc0215-0384 https://druglandscape.com/api/og?type=drug&title=NNC0215-0384&subtitle=NNC0215-0384%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0215-0384 NNC0215-0384 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0247-0829 https://druglandscape.com/api/og?type=drug&title=NNC0247-0829&subtitle=NNC0247-0829%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0247-0829 NNC0247-0829 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0268-0965 https://druglandscape.com/api/og?type=drug&title=NNC0268-0965&subtitle=NNC0268-0965%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0268-0965 NNC0268-0965 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0363-0845 https://druglandscape.com/api/og?type=drug&title=NNC0363-0845&subtitle=NNC0363-0845%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0363-0845 NNC0363-0845 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0363-1063 https://druglandscape.com/api/og?type=drug&title=NNC0363-1063&subtitle=NNC0363-1063%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0363-1063 NNC0363-1063 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0385-0434-b https://druglandscape.com/api/og?type=drug&title=NNC0385-0434%20B&subtitle=NNC0385-0434%20B%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0385-0434 B NNC0385-0434 B · Novo Nordisk A/S https://druglandscape.com/drug/nnc0385-0434-d https://druglandscape.com/api/og?type=drug&title=NNC0385-0434%20D&subtitle=NNC0385-0434%20D%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0385-0434 D NNC0385-0434 D · Novo Nordisk A/S https://druglandscape.com/drug/nnc0385-0434-e https://druglandscape.com/api/og?type=drug&title=NNC0385-0434%20E&subtitle=NNC0385-0434%20E%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0385-0434 E NNC0385-0434 E · Novo Nordisk A/S https://druglandscape.com/drug/nnc0385-0434-f https://druglandscape.com/api/og?type=drug&title=NNC0385-0434%20F&subtitle=NNC0385-0434%20F%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0385-0434 F NNC0385-0434 F · Novo Nordisk A/S https://druglandscape.com/drug/nnc0442-0344-a https://druglandscape.com/api/og?type=drug&title=NNC0442-0344%20A&subtitle=NNC0442-0344%20A%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0442-0344 A NNC0442-0344 A · Novo Nordisk A/S https://druglandscape.com/drug/nnc0471-0119 https://druglandscape.com/api/og?type=drug&title=NNC0471-0119&subtitle=NNC0471-0119%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0471-0119 NNC0471-0119 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0471-0119-a https://druglandscape.com/api/og?type=drug&title=NNC0471-0119%20A&subtitle=NNC0471-0119%20A%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0471-0119 A NNC0471-0119 A · Novo Nordisk A/S https://druglandscape.com/drug/nnc0471-0119-b https://druglandscape.com/api/og?type=drug&title=NNC0471-0119%20B&subtitle=NNC0471-0119%20B%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0471-0119 B NNC0471-0119 B · Novo Nordisk A/S https://druglandscape.com/drug/nnc0471-0119-h https://druglandscape.com/api/og?type=drug&title=NNC0471-0119%20H&subtitle=NNC0471-0119%20H%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0471-0119 H NNC0471-0119 H · Novo Nordisk A/S https://druglandscape.com/drug/nnc0472-0147 https://druglandscape.com/api/og?type=drug&title=NNC0472-0147&subtitle=NNC0472-0147%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0472-0147 NNC0472-0147 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0480-0389 https://druglandscape.com/api/og?type=drug&title=NNC0480-0389&subtitle=NNC0480-0389%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 NNC0480-0389 NNC0480-0389 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0487-0111-a https://druglandscape.com/api/og?type=drug&title=NNC0487-0111%20A&subtitle=NNC0487-0111%20A%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0487-0111 A NNC0487-0111 A · Novo Nordisk A/S https://druglandscape.com/drug/nnc0487-0111-b https://druglandscape.com/api/og?type=drug&title=NNC0487-0111%20B&subtitle=NNC0487-0111%20B%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0487-0111 B NNC0487-0111 B · Novo Nordisk A/S https://druglandscape.com/drug/nnc0487-0111-c https://druglandscape.com/api/og?type=drug&title=NNC0487-0111%20C&subtitle=NNC0487-0111%20C%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0487-0111 C NNC0487-0111 C · Novo Nordisk A/S https://druglandscape.com/drug/nnc0487-0111-subcutanous https://druglandscape.com/api/og?type=drug&title=NNC0487-0111%20subcutanous&subtitle=NNC0487-0111%20subcutanous%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 NNC0487-0111 subcutanous NNC0487-0111 subcutanous · Novo Nordisk A/S https://druglandscape.com/drug/nnc0491-6075 https://druglandscape.com/api/og?type=drug&title=NNC0491-6075&subtitle=NNC0491-6075%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0491-6075 NNC0491-6075 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0519-0130 https://druglandscape.com/api/og?type=drug&title=NNC0519-0130&subtitle=NNC0519-0130%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 NNC0519-0130 NNC0519-0130 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0519-0130-b https://druglandscape.com/api/og?type=drug&title=NNC0519-0130%20B&subtitle=NNC0519-0130%20B%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0519-0130 B NNC0519-0130 B · Novo Nordisk A/S https://druglandscape.com/drug/nnc0519-0130-c https://druglandscape.com/api/og?type=drug&title=NNC0519-0130%20C&subtitle=NNC0519-0130%20C%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0519-0130 C NNC0519-0130 C · Novo Nordisk A/S https://druglandscape.com/drug/nnc0537-1482 https://druglandscape.com/api/og?type=drug&title=NNC0537-1482&subtitle=NNC0537-1482%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0537-1482 NNC0537-1482 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0560-0004 https://druglandscape.com/api/og?type=drug&title=NNC0560-0004&subtitle=NNC0560-0004%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0560-0004 NNC0560-0004 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0581-0001 https://druglandscape.com/api/og?type=drug&title=NNC0581-0001&subtitle=NNC0581-0001%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0581-0001 NNC0581-0001 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0582-0001 https://druglandscape.com/api/og?type=drug&title=NNC0582-0001&subtitle=NNC0582-0001%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0582-0001 NNC0582-0001 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0638-0355 https://druglandscape.com/api/og?type=drug&title=NNC0638-0355&subtitle=NNC0638-0355%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0638-0355 NNC0638-0355 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0650-0013-a https://druglandscape.com/api/og?type=drug&title=NNC0650-0013%20A&subtitle=NNC0650-0013%20A%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0650-0013 A NNC0650-0013 A · Novo Nordisk A/S https://druglandscape.com/drug/nnc0662-0419 https://druglandscape.com/api/og?type=drug&title=NNC0662-0419&subtitle=NNC0662-0419%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 NNC0662-0419 NNC0662-0419 · Novo Nordisk A/S https://druglandscape.com/drug/nnc0705-0001 https://druglandscape.com/api/og?type=drug&title=NNC0705-0001&subtitle=NNC0705-0001%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC0705-0001 NNC0705-0001 · Novo Nordisk A/S https://druglandscape.com/drug/nnc109-0012 https://druglandscape.com/api/og?type=drug&title=NNC109-0012&subtitle=NNC109-0012%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 NNC109-0012 NNC109-0012 · Novo Nordisk A/S https://druglandscape.com/drug/nnc126-0083 https://druglandscape.com/api/og?type=drug&title=NNC126-0083&subtitle=NNC126-0083%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 NNC126-0083 NNC126-0083 · Novo Nordisk A/S https://druglandscape.com/drug/nnc4005-001 https://druglandscape.com/api/og?type=drug&title=NNC4005-001&subtitle=NNC4005-001%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC4005-001 NNC4005-001 · Novo Nordisk A/S https://druglandscape.com/drug/nnc6022-0001 https://druglandscape.com/api/og?type=drug&title=NNC6022-0001&subtitle=NNC6022-0001%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC6022-0001 NNC6022-0001 · Novo Nordisk A/S https://druglandscape.com/drug/nnc9204-0530 https://druglandscape.com/api/og?type=drug&title=NNC9204-0530&subtitle=NNC9204-0530%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC9204-0530 NNC9204-0530 · Novo Nordisk A/S https://druglandscape.com/drug/nnc9204-1177 https://druglandscape.com/api/og?type=drug&title=NNC9204-1177&subtitle=NNC9204-1177%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC9204-1177 NNC9204-1177 · Novo Nordisk A/S https://druglandscape.com/drug/nnc9204-1513 https://druglandscape.com/api/og?type=drug&title=NNC9204-1513&subtitle=NNC9204-1513%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC9204-1513 NNC9204-1513 · Novo Nordisk A/S https://druglandscape.com/drug/nnc9204-1706 https://druglandscape.com/api/og?type=drug&title=NNC9204-1706&subtitle=NNC9204-1706%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC9204-1706 NNC9204-1706 · Novo Nordisk A/S https://druglandscape.com/drug/nnc9204-1706-a https://druglandscape.com/api/og?type=drug&title=NNC9204-1706%20A&subtitle=NNC9204-1706%20A%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC9204-1706 A NNC9204-1706 A · Novo Nordisk A/S https://druglandscape.com/drug/nnc9733-0001 https://druglandscape.com/api/og?type=drug&title=NNC9733-0001&subtitle=NNC9733-0001%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 NNC9733-0001 NNC9733-0001 · Novo Nordisk A/S https://druglandscape.com/drug/nni-362 https://druglandscape.com/api/og?type=drug&title=NNI-362&subtitle=NNI-362%20%C2%B7%20Neuronascent%2C%20Inc.&badge=phase%201 NNI-362 NNI-362 · Neuronascent, Inc. https://druglandscape.com/drug/no-adt https://druglandscape.com/api/og?type=drug&title=No%20ADT&subtitle=No%20ADT%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 No ADT No ADT · Asan Medical Center https://druglandscape.com/drug/no-anti-epileptic-drug-exposure https://druglandscape.com/api/og?type=drug&title=No%20anti-epileptic%20drug%20exposure&subtitle=No%20anti-epileptic%20drug%20exposure%20%C2%B7%20GlaxoSmithKline&badge=phase%202 No anti-epileptic drug exposure No anti-epileptic drug exposure · GlaxoSmithKline https://druglandscape.com/drug/no-antiplatelet-treatment https://druglandscape.com/api/og?type=drug&title=No%20antiplatelet%20treatment&subtitle=No%20antiplatelet%20treatment%20%C2%B7%20Fundaci%C3%B3n%20P%C3%BAblica%20Andaluza%20para%20la%20gesti%C3%B3n%20de%20la%20Investigaci%C3%B3n%20en%20Sevill&badge=phase%202 No antiplatelet treatment No antiplatelet treatment · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla https://druglandscape.com/drug/no-basiliximab https://druglandscape.com/api/og?type=drug&title=No%20basiliximab&subtitle=No%20basiliximab%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 No basiliximab No basiliximab · Asan Medical Center https://druglandscape.com/drug/no-biologics https://druglandscape.com/api/og?type=drug&title=No%20Biologics&subtitle=No%20Biologics%20%C2%B7%20Janssen%20Biotech%2C%20Inc.&badge=phase%202 No Biologics No Biologics · Janssen Biotech, Inc. https://druglandscape.com/drug/no-cytoreductive-vs-cytoreductive-drugs https://druglandscape.com/api/og?type=drug&title=No%20cytoreductive%20vs%20cytoreductive%20drugs&subtitle=No%20cytoreductive%20vs%20cytoreductive%20drugs%20%C2%B7%20Dr%20Yan%20Beauverd&badge=phase%202 No cytoreductive vs cytoreductive drugs No cytoreductive vs cytoreductive drugs · Dr Yan Beauverd https://druglandscape.com/drug/no-dham https://druglandscape.com/api/og?type=drug&title=No%20dHAM&subtitle=No%20dHAM%20%C2%B7%20German%20Centre%20for%20Assessment%20and%20Evaluation%20of%20Innovative%20Techniques%20in%20Medicine&badge=phase%202 No dHAM No dHAM · German Centre for Assessment and Evaluation of Innovative Techniques in Medicine https://druglandscape.com/drug/no-dmts https://druglandscape.com/api/og?type=drug&title=No%20DMTs&subtitle=No%20DMTs%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 No DMTs No DMTs · Bristol-Myers Squibb https://druglandscape.com/drug/no-domperidone https://druglandscape.com/api/og?type=drug&title=No%20domperidone&subtitle=No%20domperidone%20%C2%B7%20Canadian%20Network%20for%20Observational%20Drug%20Effect%20Studies%2C%20CNODES&badge=phase%202 No domperidone No domperidone · Canadian Network for Observational Drug Effect Studies, CNODES https://druglandscape.com/drug/no-hp802-treatment https://druglandscape.com/api/og?type=drug&title=No%20HP802%20Treatment&subtitle=No%20HP802%20Treatment%20%C2%B7%20Healthpoint&badge=phase%202 No HP802 Treatment No HP802 Treatment · Healthpoint https://druglandscape.com/drug/no-imid-treatment https://druglandscape.com/api/og?type=drug&title=No%20IMiD%20treatment&subtitle=No%20IMiD%20treatment%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 No IMiD treatment No IMiD treatment · Bristol-Myers Squibb https://druglandscape.com/drug/no-immunosuppressive https://druglandscape.com/api/og?type=drug&title=NO-Immunosuppressive&subtitle=NO-Immunosuppressive%20%C2%B7%20Spanish%20Network%20for%20Research%20in%20Infectious%20Diseases&badge=phase%202 NO-Immunosuppressive NO-Immunosuppressive · Spanish Network for Research in Infectious Diseases https://druglandscape.com/drug/no-maintenance-vitamin-d https://druglandscape.com/api/og?type=drug&title=No%20maintenance%20Vitamin%20D&subtitle=No%20maintenance%20Vitamin%20D%20%C2%B7%20Amany%20Keruakous%2C%20MD%2C%20MS.&badge=phase%201 No maintenance Vitamin D No maintenance Vitamin D · Amany Keruakous, MD, MS. https://druglandscape.com/drug/no-mesenchymal-progenitor-cells https://druglandscape.com/api/og?type=drug&title=No%20mesenchymal%20progenitor%20cells&subtitle=No%20mesenchymal%20progenitor%20cells%20%C2%B7%20Shanghai%20AbelZeta%20Ltd.&badge=phase%202 No mesenchymal progenitor cells No mesenchymal progenitor cells · Shanghai AbelZeta Ltd. https://druglandscape.com/drug/no-patch-control https://druglandscape.com/api/og?type=drug&title=No%20Patch%20Control&subtitle=No%20Patch%20Control%20%C2%B7%20McNeil%20AB&badge=phase%201 No Patch Control No Patch Control · McNeil AB https://druglandscape.com/drug/no-price https://druglandscape.com/api/og?type=drug&title=No%20price&subtitle=No%20price%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 No price No price · Hadassah Medical Organization https://druglandscape.com/drug/noac-apixaban https://druglandscape.com/api/og?type=drug&title=NOAC%3A%20Apixaban&subtitle=NOAC%3A%20Apixaban%20%C2%B7%20Bayer&badge=phase%202 NOAC: Apixaban NOAC: Apixaban · Bayer https://druglandscape.com/drug/noac-dabigatran-etexilate https://druglandscape.com/api/og?type=drug&title=NOAC%3A%20Dabigatran%20etexilate&subtitle=NOAC%3A%20Dabigatran%20etexilate%20%C2%B7%20Bayer&badge=phase%202 NOAC: Dabigatran etexilate NOAC: Dabigatran etexilate · Bayer https://druglandscape.com/drug/noac-edoxaban https://druglandscape.com/api/og?type=drug&title=NOAC%3A%20Edoxaban&subtitle=NOAC%3A%20Edoxaban%20%C2%B7%20Bayer&badge=phase%202 NOAC: Edoxaban NOAC: Edoxaban · Bayer https://druglandscape.com/drug/noac-lixiana https://druglandscape.com/api/og?type=drug&title=NOAC%3A%20Lixiana&subtitle=NOAC%3A%20Lixiana%20%C2%B7%20Bayer&badge=phase%202 NOAC: Lixiana NOAC: Lixiana · Bayer https://druglandscape.com/drug/noe-105 https://druglandscape.com/api/og?type=drug&title=NOE-105&subtitle=NOE-105%20%C2%B7%20Noema%20Pharma%20AG&badge=phase%202 NOE-105 NOE-105 · Noema Pharma AG https://druglandscape.com/drug/noe-115 https://druglandscape.com/api/og?type=drug&title=NOE-115&subtitle=NOE-115%20%C2%B7%20Noema%20Pharma%20AG&badge=phase%202 NOE-115 NOE-115 · Noema Pharma AG https://druglandscape.com/drug/nomac https://druglandscape.com/api/og?type=drug&title=NOMAC&subtitle=NOMAC%20%C2%B7%20Theramex&badge=phase%202 NOMAC NOMAC · Theramex https://druglandscape.com/drug/nomegestrol-acetate-and-estradiol https://druglandscape.com/api/og?type=drug&title=nomegestrol%20acetate%20and%20estradiol&subtitle=nomegestrol%20acetate%20and%20estradiol%20%C2%B7%20Organon%20and%20Co&badge=phase%201 nomegestrol acetate and estradiol nomegestrol acetate and estradiol · Organon and Co https://druglandscape.com/drug/non-active-base-from-azelaic-acid-15-gel https://druglandscape.com/api/og?type=drug&title=Non-active%20base%20from%20azelaic%20acid%2015%25%20gel&subtitle=Non-active%20base%20from%20azelaic%20acid%2015%25%20gel%20%C2%B7%20LEO%20Pharma&badge=phase%202 Non-active base from azelaic acid 15% gel Non-active base from azelaic acid 15% gel · LEO Pharma https://druglandscape.com/drug/non-adherent-to-5ari-therapy https://druglandscape.com/api/og?type=drug&title=Non-adherent%20to%205ARI%20therapy&subtitle=Non-adherent%20to%205ARI%20therapy%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Non-adherent to 5ARI therapy Non-adherent to 5ARI therapy · GlaxoSmithKline https://druglandscape.com/drug/non-alcoholic-beverage https://druglandscape.com/api/og?type=drug&title=non-alcoholic%20beverage&subtitle=non-alcoholic%20beverage%20%C2%B7%20Centre%20for%20Addiction%20and%20Mental%20Health&badge=phase%201 non-alcoholic beverage non-alcoholic beverage · Centre for Addiction and Mental Health https://druglandscape.com/drug/non-anti-tnf-biologics https://druglandscape.com/api/og?type=drug&title=non-anti-TNF%20biologics&subtitle=non-anti-TNF%20biologics%20%C2%B7%20Janssen%20Biotech%2C%20Inc.&badge=phase%202 non-anti-TNF biologics non-anti-TNF biologics · Janssen Biotech, Inc. https://druglandscape.com/drug/non-antipsychotic-medication https://druglandscape.com/api/og?type=drug&title=Non-antipsychotic%20medication&subtitle=Non-antipsychotic%20medication%20%C2%B7%20Icahn%20School%20of%20Medicine%20at%20Mount%20Sinai&badge=phase%202 Non-antipsychotic medication Non-antipsychotic medication · Icahn School of Medicine at Mount Sinai https://druglandscape.com/drug/non-biologic-anti-rheumatic-drugs https://druglandscape.com/api/og?type=drug&title=non-biologic%20anti-rheumatic%20drugs&subtitle=non-biologic%20anti-rheumatic%20drugs%20%C2%B7%20Pfizer&badge=phase%202 non-biologic anti-rheumatic drugs non-biologic anti-rheumatic drugs · Pfizer https://druglandscape.com/drug/non-chemotherapy https://druglandscape.com/api/og?type=drug&title=Non%20Chemotherapy&subtitle=Non%20Chemotherapy%20%C2%B7%20Haining%20Health-Coming%20Biotech%20Co.%2C%20Ltd.&badge=phase%202 Non Chemotherapy Non Chemotherapy · Haining Health-Coming Biotech Co., Ltd. https://druglandscape.com/drug/non-enteric-coated-chewable-aspirin https://druglandscape.com/api/og?type=drug&title=non-enteric-coated%20chewable%20aspirin&subtitle=non-enteric-coated%20chewable%20aspirin%20%C2%B7%20Vectura%2C%20Inc.&badge=phase%201 non-enteric-coated chewable aspirin non-enteric-coated chewable aspirin · Vectura, Inc. https://druglandscape.com/drug/non-macrolides-antibiotics https://druglandscape.com/api/og?type=drug&title=non-macrolides%20antibiotics&subtitle=non-macrolides%20antibiotics%20%C2%B7%20Shanghai%20Children's%20Medical%20Center&badge=phase%202 non-macrolides antibiotics non-macrolides antibiotics · Shanghai Children's Medical Center https://druglandscape.com/drug/non-mavacamten-symptomatic-ohcm-therapy https://druglandscape.com/api/og?type=drug&title=Non-mavacamten%20symptomatic%20oHCM%20therapy&subtitle=Non-mavacamten%20symptomatic%20oHCM%20therapy%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 Non-mavacamten symptomatic oHCM therapy Non-mavacamten symptomatic oHCM therapy · Bristol-Myers Squibb https://druglandscape.com/drug/non-medicated-dentifrice https://druglandscape.com/api/og?type=drug&title=Non-medicated%20dentifrice&subtitle=Non-medicated%20dentifrice%20%C2%B7%20Universidad%20de%20los%20Andes%2C%20Chile&badge=phase%202 Non-medicated dentifrice Non-medicated dentifrice · Universidad de los Andes, Chile https://druglandscape.com/drug/non-myeloablative-stem-cell-transplantation https://druglandscape.com/api/og?type=drug&title=Non-myeloablative%20Stem%20Cell%20Transplantation&subtitle=Non-myeloablative%20Stem%20Cell%20Transplantation%20%C2%B7%20David%20Rizzieri%2C%20MD&badge=phase%202 Non-myeloablative Stem Cell Transplantation Non-myeloablative Stem Cell Transplantation · David Rizzieri, MD https://druglandscape.com/drug/non-nephrotoxic-antibiotics https://druglandscape.com/api/og?type=drug&title=Non-nephrotoxic%20antibiotics&subtitle=Non-nephrotoxic%20antibiotics%20%C2%B7%20Shaare%20Zedek%20Medical%20Center&badge=phase%202 Non-nephrotoxic antibiotics Non-nephrotoxic antibiotics · Shaare Zedek Medical Center https://druglandscape.com/drug/non-pamora https://druglandscape.com/api/og?type=drug&title=non-PAMORA&subtitle=non-PAMORA%20%C2%B7%20Valinor%20Pharma%20LLC&badge=phase%202 non-PAMORA non-PAMORA · Valinor Pharma LLC https://druglandscape.com/drug/non-pegylated-interferon https://druglandscape.com/api/og?type=drug&title=non-pegylated%20interferon&subtitle=non-pegylated%20interferon%20%C2%B7%20Biogen&badge=phase%202 non-pegylated interferon non-pegylated interferon · Biogen https://druglandscape.com/drug/non-phenacetin-containing-analgesics https://druglandscape.com/api/og?type=drug&title=non-phenacetin%20containing%20analgesics&subtitle=non-phenacetin%20containing%20analgesics%20%C2%B7%20Center%20for%20Epidemiology%20and%20Health%20Research%2C%20Germany&badge=phase%202 non-phenacetin containing analgesics non-phenacetin containing analgesics · Center for Epidemiology and Health Research, Germany https://druglandscape.com/drug/non-preserved-ocular-lubricants https://druglandscape.com/api/og?type=drug&title=Non%20preserved%20ocular%20lubricants&subtitle=Non%20preserved%20ocular%20lubricants%20%C2%B7%20Abilion%20Medical%20Systems%20AB&badge=phase%201 Non preserved ocular lubricants Non preserved ocular lubricants · Abilion Medical Systems AB https://druglandscape.com/drug/non-racemic-mixture-of-methadone-hcl https://druglandscape.com/api/og?type=drug&title=Non-racemic%20mixture%20of%20methadone%20HCl&subtitle=Non-racemic%20mixture%20of%20methadone%20HCl%20%C2%B7%20MetaPharm%2C%20Inc.&badge=phase%202 Non-racemic mixture of methadone HCl Non-racemic mixture of methadone HCl · MetaPharm, Inc. https://druglandscape.com/drug/non-selective-beta-blocker-propranolol https://druglandscape.com/api/og?type=drug&title=Non%20selective%20beta%20blocker%20-%20Propranolol&subtitle=Non%20selective%20beta%20blocker%20-%20Propranolol%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%202 Non selective beta blocker - Propranolol Non selective beta blocker - Propranolol · Hadassah Medical Organization https://druglandscape.com/drug/non-selective-beta-blockers https://druglandscape.com/api/og?type=drug&title=Non-selective%20beta-blockers&subtitle=Non-selective%20beta-blockers%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 Non-selective beta-blockers Non-selective beta-blockers · Samsung Medical Center https://druglandscape.com/drug/non-ssri-treated-group https://druglandscape.com/api/og?type=drug&title=non-SSRI%20treated%20group&subtitle=non-SSRI%20treated%20group%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%201 non-SSRI treated group non-SSRI treated group · Samsung Medical Center https://druglandscape.com/drug/non-steroidal-anti-inflammatory-drug https://druglandscape.com/api/og?type=drug&title=Non-steroidal%20anti-inflammatory%20drug&subtitle=Non-steroidal%20anti-inflammatory%20drug%20%C2%B7%20Sucampo%20Pharma%20Americas%2C%20LLC&badge=phase%202 Non-steroidal anti-inflammatory drug Non-steroidal anti-inflammatory drug · Sucampo Pharma Americas, LLC https://druglandscape.com/drug/non-target-drug https://druglandscape.com/api/og?type=drug&title=non-target%20drug&subtitle=non-target%20drug%20%C2%B7%20OmicsWay%20Corp.&badge=phase%202 non-target drug non-target drug · OmicsWay Corp. https://druglandscape.com/drug/non-tkis https://druglandscape.com/api/og?type=drug&title=Non-TKIs&subtitle=Non-TKIs%20%C2%B7%20Bayer&badge=phase%202 Non-TKIs Non-TKIs · Bayer https://druglandscape.com/drug/non-tnfi-biologic-class https://druglandscape.com/api/og?type=drug&title=non-TNFi-biologic%20class&subtitle=non-TNFi-biologic%20class%20%C2%B7%20University%20of%20Alabama%20at%20Birmingham&badge=phase%203 non-TNFi-biologic class non-TNFi-biologic class · University of Alabama at Birmingham https://druglandscape.com/drug/non-transabdominal-plane-block https://druglandscape.com/api/og?type=drug&title=Non%20Transabdominal%20Plane%20Block&subtitle=Non%20Transabdominal%20Plane%20Block%20%C2%B7%20Icahn%20School%20of%20Medicine%20at%20Mount%20Sinai&badge=phase%202 Non Transabdominal Plane Block Non Transabdominal Plane Block · Icahn School of Medicine at Mount Sinai https://druglandscape.com/drug/non-vagifem-ldve-estradiol https://druglandscape.com/api/og?type=drug&title=Non-Vagifem%C2%AE%20LDVE%2C%20Estradiol&subtitle=Non-Vagifem%C2%AE%20LDVE%2C%20Estradiol%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 Non-Vagifem® LDVE, Estradiol Non-Vagifem® LDVE, Estradiol · Novo Nordisk A/S https://druglandscape.com/drug/non-vitamin-k-oral-antagonists https://druglandscape.com/api/og?type=drug&title=Non-Vitamin%20K%20Oral%20Antagonists&subtitle=Non-Vitamin%20K%20Oral%20Antagonists%20%C2%B7%20Abbott%20Medical%20Devices&badge=phase%201 Non-Vitamin K Oral Antagonists Non-Vitamin K Oral Antagonists · Abbott Medical Devices https://druglandscape.com/drug/non-vitamin-k-oral-anticoagulant https://druglandscape.com/api/og?type=drug&title=Non-Vitamin%20K%20Oral%20Anticoagulant&subtitle=Non-Vitamin%20K%20Oral%20Anticoagulant%20%C2%B7%20Boston%20Scientific%20Corporation&badge=phase%201 Non-Vitamin K Oral Anticoagulant Non-Vitamin K Oral Anticoagulant · Boston Scientific Corporation https://druglandscape.com/drug/noncarbonated-water https://druglandscape.com/api/og?type=drug&title=Noncarbonated%20Water&subtitle=Noncarbonated%20Water%20%C2%B7%20Takeda&badge=phase%201 Noncarbonated Water Noncarbonated Water · Takeda https://druglandscape.com/drug/nonconforming-idecabtagene-vicleucel https://druglandscape.com/api/og?type=drug&title=Nonconforming%20idecabtagene%20vicleucel&subtitle=Nonconforming%20idecabtagene%20vicleucel%20%C2%B7%20Celgene&badge=phase%202 Nonconforming idecabtagene vicleucel Nonconforming idecabtagene vicleucel · Celgene https://druglandscape.com/drug/nonconforming-lisocabtagene-maraleucel https://druglandscape.com/api/og?type=drug&title=Nonconforming%20Lisocabtagene%20Maraleucel&subtitle=Nonconforming%20Lisocabtagene%20Maraleucel%20%C2%B7%20Juno%20Therapeutics%2C%20a%20Subsidiary%20of%20Celgene&badge=phase%202 Nonconforming Lisocabtagene Maraleucel Nonconforming Lisocabtagene Maraleucel · Juno Therapeutics, a Subsidiary of Celgene https://druglandscape.com/drug/noninvasive-core-temperature-thermistor https://druglandscape.com/api/og?type=drug&title=Noninvasive%20core%20temperature%20thermistor&subtitle=Noninvasive%20core%20temperature%20thermistor%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%201 Noninvasive core temperature thermistor Noninvasive core temperature thermistor · Sheba Medical Center https://druglandscape.com/drug/nonmyeloablative-stem-cell-transplant https://druglandscape.com/api/og?type=drug&title=nonmyeloablative%20stem%20cell%20transplant&subtitle=nonmyeloablative%20stem%20cell%20transplant%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%201 nonmyeloablative stem cell transplant nonmyeloablative stem cell transplant · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/nor-adrenaline https://druglandscape.com/api/og?type=drug&title=Nor-Adrenaline&subtitle=Nor-Adrenaline%20%C2%B7%20Ahmed%20talaat%20ahmed%20aly&badge=phase%202 Nor-Adrenaline Nor-Adrenaline · Ahmed talaat ahmed aly https://druglandscape.com/drug/nora520-dose-1 https://druglandscape.com/api/og?type=drug&title=NORA520%20Dose%201&subtitle=NORA520%20Dose%201%20%C2%B7%20DuKang%20Pharmaceuticals%2C%20Inc.&badge=phase%202 NORA520 Dose 1 NORA520 Dose 1 · DuKang Pharmaceuticals, Inc. https://druglandscape.com/drug/norditropin-flexpro https://druglandscape.com/api/og?type=drug&title=Norditropin%C2%AE%20FlexPro%C2%AE&subtitle=Norditropin%C2%AE%20FlexPro%C2%AE%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 Norditropin® FlexPro® Norditropin® FlexPro® · Novo Nordisk A/S https://druglandscape.com/drug/norditropin-flexpro-pen https://druglandscape.com/api/og?type=drug&title=Norditropin%C2%AE%20FlexPro%C2%AE%20pen&subtitle=Norditropin%C2%AE%20FlexPro%C2%AE%20pen%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 Norditropin® FlexPro® pen Norditropin® FlexPro® pen · Novo Nordisk A/S https://druglandscape.com/drug/norditropin-nordiflex https://druglandscape.com/api/og?type=drug&title=Norditropin%20NordiFlex%C2%AE&subtitle=Norditropin%20NordiFlex%C2%AE%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 Norditropin NordiFlex® Norditropin NordiFlex® · Novo Nordisk A/S https://druglandscape.com/drug/norditropin-pen https://druglandscape.com/api/og?type=drug&title=Norditropin%20pen&subtitle=Norditropin%20pen%20%C2%B7%20Gulhane%20School%20of%20Medicine&badge=phase%202 Norditropin pen Norditropin pen · Gulhane School of Medicine https://druglandscape.com/drug/norditropin-simplexx https://druglandscape.com/api/og?type=drug&title=Norditropin%C2%AE%20SimpleXx%C2%AE&subtitle=Norditropin%C2%AE%20SimpleXx%C2%AE%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Norditropin® SimpleXx® Norditropin® SimpleXx® · Novo Nordisk A/S https://druglandscape.com/drug/norethindrone-acetate-ethinyl-estradiol https://druglandscape.com/api/og?type=drug&title=Norethindrone%20Acetate-Ethinyl%20Estradiol&subtitle=Norethindrone%20Acetate-Ethinyl%20Estradiol%20%C2%B7%20Elizabeth%20Austen%20Lawson&badge=phase%201 Norethindrone Acetate-Ethinyl Estradiol Norethindrone Acetate-Ethinyl Estradiol · Elizabeth Austen Lawson https://druglandscape.com/drug/norgestimate-ethinyl-estradiol-folic-acid https://druglandscape.com/api/og?type=drug&title=Norgestimate%3B%20Ethinyl%20Estradiol%3B%20Folic%20acid&subtitle=Norgestimate%3B%20Ethinyl%20Estradiol%3B%20Folic%20acid%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Developmen&badge=phase%201 Norgestimate; Ethinyl Estradiol; Folic acid Norgestimate; Ethinyl Estradiol; Folic acid · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/normal-control https://druglandscape.com/api/og?type=drug&title=Normal%20control&subtitle=Normal%20control%20%C2%B7%20Janssen%20Korea%2C%20Ltd.%2C%20Korea&badge=phase%202 Normal control Normal control · Janssen Korea, Ltd., Korea https://druglandscape.com/drug/normal-medication-positive-control https://druglandscape.com/api/og?type=drug&title=Normal%20Medication%20Positive%20Control&subtitle=Normal%20Medication%20Positive%20Control%20%C2%B7%20Endocrine%20Research%20Society&badge=phase%201 Normal Medication Positive Control Normal Medication Positive Control · Endocrine Research Society https://druglandscape.com/drug/normoxic-allogenic-ucmsc https://druglandscape.com/api/og?type=drug&title=Normoxic%20Allogenic%20UCMSC&subtitle=Normoxic%20Allogenic%20UCMSC%20%C2%B7%20Kementerian%20Riset%20dan%20Teknologi%20%2F%20Badan%20Riset%20dan%20Inovasi%20Nasional%2C%20Indon&badge=phase%202 Normoxic Allogenic UCMSC Normoxic Allogenic UCMSC · Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia https://druglandscape.com/drug/norovirus-bivalent-vaccine https://druglandscape.com/api/og?type=drug&title=Norovirus%20Bivalent%20Vaccine&subtitle=Norovirus%20Bivalent%20Vaccine%20%C2%B7%20Takeda&badge=phase%201 Norovirus Bivalent Vaccine Norovirus Bivalent Vaccine · Takeda https://druglandscape.com/drug/norovirus-bivalent-vlp-vaccine https://druglandscape.com/api/og?type=drug&title=Norovirus%20Bivalent%20VLP%20Vaccine&subtitle=Norovirus%20Bivalent%20VLP%20Vaccine%20%C2%B7%20Takeda&badge=phase%202 Norovirus Bivalent VLP Vaccine Norovirus Bivalent VLP Vaccine · Takeda https://druglandscape.com/drug/norovirus-gi-1-norwalk-virus-inoculum https://druglandscape.com/api/og?type=drug&title=Norovirus%20GI.1%20Norwalk%20Virus%20Inoculum&subtitle=Norovirus%20GI.1%20Norwalk%20Virus%20Inoculum%20%C2%B7%20Vaxart&badge=phase%201 Norovirus GI.1 Norwalk Virus Inoculum Norovirus GI.1 Norwalk Virus Inoculum · Vaxart https://druglandscape.com/drug/norudca https://druglandscape.com/api/og?type=drug&title=norUDCA&subtitle=norUDCA%20%C2%B7%20Dr.%20Falk%20Pharma%20GmbH&badge=phase%202 norUDCA norUDCA · Dr. Falk Pharma GmbH https://druglandscape.com/drug/norwalk-gi-1-virus https://druglandscape.com/api/og?type=drug&title=Norwalk%20GI.1%20Virus&subtitle=Norwalk%20GI.1%20Virus%20%C2%B7%20WCCT%20Global&badge=phase%201 Norwalk GI.1 Virus Norwalk GI.1 Virus · WCCT Global https://druglandscape.com/drug/notch-signaling-pathway-inhibitor-mk0752 https://druglandscape.com/api/og?type=drug&title=Notch%20signaling%20pathway%20inhibitor%20MK0752&subtitle=Notch%20signaling%20pathway%20inhibitor%20MK0752%20%C2%B7%20Cancer%20Research%20UK&badge=phase%201 Notch signaling pathway inhibitor MK0752 Notch signaling pathway inhibitor MK0752 · Cancer Research UK https://druglandscape.com/drug/nov-205 https://druglandscape.com/api/og?type=drug&title=NOV-205&subtitle=NOV-205%20%C2%B7%20Cellectar%20Biosciences%2C%20Inc.&badge=phase%202 NOV-205 NOV-205 · Cellectar Biosciences, Inc. https://druglandscape.com/drug/nov-vaccine https://druglandscape.com/api/og?type=drug&title=NoV%20Vaccine&subtitle=NoV%20Vaccine%20%C2%B7%20Takeda&badge=phase%202 NoV Vaccine NoV Vaccine · Takeda https://druglandscape.com/drug/nova22007-cyclosporine https://druglandscape.com/api/og?type=drug&title=NOVA22007%20''Cyclosporine''&subtitle=NOVA22007%20''Cyclosporine''%20%C2%B7%20Santen%20SAS&badge=phase%202 NOVA22007 ''Cyclosporine'' NOVA22007 ''Cyclosporine'' · Santen SAS https://druglandscape.com/drug/novavax-quadrivalent-vaccine https://druglandscape.com/api/og?type=drug&title=Novavax%20Quadrivalent%20vaccine&subtitle=Novavax%20Quadrivalent%20vaccine%20%C2%B7%20Novavax&badge=phase%202 Novavax Quadrivalent vaccine Novavax Quadrivalent vaccine · Novavax https://druglandscape.com/drug/novavax-trivalent-vaccine https://druglandscape.com/api/og?type=drug&title=Novavax%20Trivalent%20vaccine&subtitle=Novavax%20Trivalent%20vaccine%20%C2%B7%20Novavax&badge=phase%202 Novavax Trivalent vaccine Novavax Trivalent vaccine · Novavax https://druglandscape.com/drug/novel-formulation https://druglandscape.com/api/og?type=drug&title=Novel%20formulation&subtitle=Novel%20formulation%20%C2%B7%20King's%20College%20London&badge=phase%201 Novel formulation Novel formulation · King's College London https://druglandscape.com/drug/novel-opv2-candidate-1 https://druglandscape.com/api/og?type=drug&title=Novel%20OPV2%20candidate%201&subtitle=Novel%20OPV2%20candidate%201%20%C2%B7%20Pierre%20Van%20Damme&badge=phase%202 Novel OPV2 candidate 1 Novel OPV2 candidate 1 · Pierre Van Damme https://druglandscape.com/drug/novel-opv2-candidate-2 https://druglandscape.com/api/og?type=drug&title=Novel%20OPV2%20candidate%202&subtitle=Novel%20OPV2%20candidate%202%20%C2%B7%20Pierre%20Van%20Damme&badge=phase%202 Novel OPV2 candidate 2 Novel OPV2 candidate 2 · Pierre Van Damme https://druglandscape.com/drug/novo-methylphenidate-er-c https://druglandscape.com/api/og?type=drug&title=Novo-Methylphenidate%20ER-C&subtitle=Novo-Methylphenidate%20ER-C%20%C2%B7%20Janssen-Ortho%20Inc.%2C%20Canada&badge=phase%201 Novo-Methylphenidate ER-C Novo-Methylphenidate ER-C · Janssen-Ortho Inc., Canada https://druglandscape.com/drug/novo-rapid https://druglandscape.com/api/og?type=drug&title=Novo%20Rapid&subtitle=Novo%20Rapid%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Novo Rapid Novo Rapid · Novo Nordisk A/S https://druglandscape.com/drug/novocart-disc-plus https://druglandscape.com/api/og?type=drug&title=NOVOCART%C2%AE%20Disc%20plus&subtitle=NOVOCART%C2%AE%20Disc%20plus%20%C2%B7%20Tetec%20AG&badge=phase%201 NOVOCART® Disc plus NOVOCART® Disc plus · Tetec AG https://druglandscape.com/drug/novomix-30-penfill https://druglandscape.com/api/og?type=drug&title=NovoMix%C2%AE%2030%20Penfill%C2%AE&subtitle=NovoMix%C2%AE%2030%20Penfill%C2%AE%20%C2%B7%20Geropharm&badge=phase%201 NovoMix® 30 Penfill® NovoMix® 30 Penfill® · Geropharm https://druglandscape.com/drug/nowarta110 https://druglandscape.com/api/og?type=drug&title=Nowarta110&subtitle=Nowarta110%20%C2%B7%20Nowarta%20Biopharma%20Inc&badge=phase%201 Nowarta110 Nowarta110 · Nowarta Biopharma Inc https://druglandscape.com/drug/nox-a12 https://druglandscape.com/api/og?type=drug&title=NOX-A12&subtitle=NOX-A12%20%C2%B7%20TME%20Pharma%20AG&badge=phase%202 NOX-A12 NOX-A12 · TME Pharma AG https://druglandscape.com/drug/nox-a12-in-combination-with-filgrastim https://druglandscape.com/api/og?type=drug&title=NOX-A12%20in%20combination%20with%20Filgrastim&subtitle=NOX-A12%20in%20combination%20with%20Filgrastim%20%C2%B7%20TME%20Pharma%20AG&badge=phase%201 NOX-A12 in combination with Filgrastim NOX-A12 in combination with Filgrastim · TME Pharma AG https://druglandscape.com/drug/nox-e36 https://druglandscape.com/api/og?type=drug&title=NOX-E36&subtitle=NOX-E36%20%C2%B7%20TME%20Pharma%20AG&badge=phase%202 NOX-E36 NOX-E36 · TME Pharma AG https://druglandscape.com/drug/nox-h94 https://druglandscape.com/api/og?type=drug&title=NOX-H94&subtitle=NOX-H94%20%C2%B7%20TME%20Pharma%20AG&badge=phase%202 NOX-H94 NOX-H94 · TME Pharma AG https://druglandscape.com/drug/nox1416-and-soc https://druglandscape.com/api/og?type=drug&title=NOX1416%20and%20SOC&subtitle=NOX1416%20and%20SOC%20%C2%B7%20NOxy%20Health%20Products%2C%20LLC&badge=phase%201 NOX1416 and SOC NOX1416 and SOC · NOxy Health Products, LLC https://druglandscape.com/drug/np-015 https://druglandscape.com/api/og?type=drug&title=NP-015&subtitle=NP-015%20%C2%B7%20Emergent%20BioSolutions&badge=phase%201 NP-015 NP-015 · Emergent BioSolutions https://druglandscape.com/drug/np-g2-044-combination-therapy https://druglandscape.com/api/og?type=drug&title=NP-G2-044%20Combination%20therapy&subtitle=NP-G2-044%20Combination%20therapy%20%C2%B7%20Novita%20Pharmaceuticals%2C%20Inc.&badge=phase%201 NP-G2-044 Combination therapy NP-G2-044 Combination therapy · Novita Pharmaceuticals, Inc. https://druglandscape.com/drug/np-g2-044-monotherapy https://druglandscape.com/api/og?type=drug&title=NP-G2-044%20Monotherapy&subtitle=NP-G2-044%20Monotherapy%20%C2%B7%20Novita%20Pharmaceuticals%2C%20Inc.&badge=phase%201 NP-G2-044 Monotherapy NP-G2-044 Monotherapy · Novita Pharmaceuticals, Inc. https://druglandscape.com/drug/np000888 https://druglandscape.com/api/og?type=drug&title=NP000888&subtitle=NP000888%20%C2%B7%20Galderma%20R%26D&badge=phase%202 NP000888 NP000888 · Galderma R&D https://druglandscape.com/drug/np10679 https://druglandscape.com/api/og?type=drug&title=NP10679&subtitle=NP10679%20%C2%B7%20Neurop%20Inc.&badge=phase%201 NP10679 NP10679 · Neurop Inc. https://druglandscape.com/drug/np137 https://druglandscape.com/api/og?type=drug&title=NP137&subtitle=NP137%20%C2%B7%20Centre%20Leon%20Berard&badge=phase%202 NP137 NP137 · Centre Leon Berard https://druglandscape.com/drug/np202 https://druglandscape.com/api/og?type=drug&title=NP202&subtitle=NP202%20%C2%B7%20Armaron%20Bio%20Pty%20Ltd&badge=phase%202 NP202 NP202 · Armaron Bio Pty Ltd https://druglandscape.com/drug/npc-08 https://druglandscape.com/api/og?type=drug&title=NPC-08&subtitle=NPC-08%20%C2%B7%20Nobelpharma&badge=phase%201 NPC-08 NPC-08 · Nobelpharma https://druglandscape.com/drug/npc-15-granules-higher-dose https://druglandscape.com/api/og?type=drug&title=NPC-15%20Granules%20Higher%20Dose&subtitle=NPC-15%20Granules%20Higher%20Dose%20%C2%B7%20Nobelpharma&badge=phase%202 NPC-15 Granules Higher Dose NPC-15 Granules Higher Dose · Nobelpharma https://druglandscape.com/drug/npc-15-granules-lower-dose https://druglandscape.com/api/og?type=drug&title=NPC-15%20Granules%20Lower%20Dose&subtitle=NPC-15%20Granules%20Lower%20Dose%20%C2%B7%20Nobelpharma&badge=phase%202 NPC-15 Granules Lower Dose NPC-15 Granules Lower Dose · Nobelpharma https://druglandscape.com/drug/npc-21-high-dose https://druglandscape.com/api/og?type=drug&title=NPC-21%20High%20dose&subtitle=NPC-21%20High%20dose%20%C2%B7%20Nobelpharma&badge=phase%202 NPC-21 High dose NPC-21 High dose · Nobelpharma https://druglandscape.com/drug/npc-21-low-dose https://druglandscape.com/api/og?type=drug&title=NPC-21%20Low%20dose&subtitle=NPC-21%20Low%20dose%20%C2%B7%20Nobelpharma&badge=phase%202 NPC-21 Low dose NPC-21 Low dose · Nobelpharma https://druglandscape.com/drug/npc-22 https://druglandscape.com/api/og?type=drug&title=NPC-22&subtitle=NPC-22%20%C2%B7%20Nobelpharma&badge=phase%201 NPC-22 NPC-22 · Nobelpharma https://druglandscape.com/drug/npep https://druglandscape.com/api/og?type=drug&title=nPEP&subtitle=nPEP%20%C2%B7%20Unity%20Health%20Toronto&badge=phase%202 nPEP nPEP · Unity Health Toronto https://druglandscape.com/drug/npf-08 https://druglandscape.com/api/og?type=drug&title=NPF-08&subtitle=NPF-08%20%C2%B7%20Nihon%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 NPF-08 NPF-08 · Nihon Pharmaceutical Co., Ltd https://druglandscape.com/drug/npi-001 https://druglandscape.com/api/og?type=drug&title=NPI-001&subtitle=NPI-001%20%C2%B7%20Nacuity%20Pharmaceuticals%2C%20Inc.&badge=phase%201 NPI-001 NPI-001 · Nacuity Pharmaceuticals, Inc. https://druglandscape.com/drug/npi-002-intravitreal-implant https://druglandscape.com/api/og?type=drug&title=NPI-002%20Intravitreal%20Implant&subtitle=NPI-002%20Intravitreal%20Implant%20%C2%B7%20Nacuity%20Pharmaceuticals%2C%20Inc.&badge=phase%201 NPI-002 Intravitreal Implant NPI-002 Intravitreal Implant · Nacuity Pharmaceuticals, Inc. https://druglandscape.com/drug/npi-0052 https://druglandscape.com/api/og?type=drug&title=NPI-0052&subtitle=NPI-0052%20%C2%B7%20Celgene&badge=phase%201 NPI-0052 NPI-0052 · Celgene https://druglandscape.com/drug/npi-0052-on-days-1-8-15-every-28-days https://druglandscape.com/api/og?type=drug&title=NPI-0052%20on%20Days%201%2C%208%2C%2015%20every%2028%20days&subtitle=NPI-0052%20on%20Days%201%2C%208%2C%2015%20every%2028%20days%20%C2%B7%20Celgene&badge=phase%201 NPI-0052 on Days 1, 8, 15 every 28 days NPI-0052 on Days 1, 8, 15 every 28 days · Celgene https://druglandscape.com/drug/npl-2009 https://druglandscape.com/api/og?type=drug&title=NPL-2009&subtitle=NPL-2009%20%C2%B7%20Neuropharm&badge=phase%201 NPL-2009 NPL-2009 · Neuropharm https://druglandscape.com/drug/npmw-peptide-vaccine https://druglandscape.com/api/og?type=drug&title=NPMW-peptide%20vaccine&subtitle=NPMW-peptide%20vaccine%20%C2%B7%20Daniel%20El%20Fassi&badge=phase%201 NPMW-peptide vaccine NPMW-peptide vaccine · Daniel El Fassi https://druglandscape.com/drug/npo-13 https://druglandscape.com/api/og?type=drug&title=NPO-13&subtitle=NPO-13%20%C2%B7%20Nihon%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 NPO-13 NPO-13 · Nihon Pharmaceutical Co., Ltd https://druglandscape.com/drug/npo-13-l-menthol https://druglandscape.com/api/og?type=drug&title=NPO-13%3A%20l-menthol&subtitle=NPO-13%3A%20l-menthol%20%C2%B7%20Nihon%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 NPO-13: l-menthol NPO-13: l-menthol · Nihon Pharmaceutical Co., Ltd https://druglandscape.com/drug/npsp795 https://druglandscape.com/api/og?type=drug&title=NPSP795&subtitle=NPSP795%20%C2%B7%20Shire&badge=phase%202 NPSP795 NPSP795 · Shire https://druglandscape.com/drug/npt-2042 https://druglandscape.com/api/og?type=drug&title=NPT%202042&subtitle=NPT%202042%20%C2%B7%20NeuroPro%20Therapeutics%2C%20Inc.&badge=phase%202 NPT 2042 NPT 2042 · NeuroPro Therapeutics, Inc. https://druglandscape.com/drug/npt088 https://druglandscape.com/api/og?type=drug&title=NPT088&subtitle=NPT088%20%C2%B7%20Proclara%20Biosciences%2C%20Inc.&badge=phase%201 NPT088 NPT088 · Proclara Biosciences, Inc. https://druglandscape.com/drug/npt200-11 https://druglandscape.com/api/og?type=drug&title=NPT200-11&subtitle=NPT200-11%20%C2%B7%20Neuropore%20Therapies%20Inc.&badge=phase%201 NPT200-11 NPT200-11 · Neuropore Therapies Inc. https://druglandscape.com/drug/npx887 https://druglandscape.com/api/og?type=drug&title=NPX887&subtitle=NPX887%20%C2%B7%20NextPoint%20Therapeutics%2C%20Inc.&badge=phase%201 NPX887 NPX887 · NextPoint Therapeutics, Inc. https://druglandscape.com/drug/nrct-101-sr https://druglandscape.com/api/og?type=drug&title=NRCT-101-SR&subtitle=NRCT-101-SR%20%C2%B7%20Neurocentria%2C%20Inc.&badge=phase%202 NRCT-101-SR NRCT-101-SR · Neurocentria, Inc. https://druglandscape.com/drug/nrd135se-1 https://druglandscape.com/api/og?type=drug&title=NRD135SE.1&subtitle=NRD135SE.1%20%C2%B7%20James%20P.%20Rathmell%2C%20MD&badge=phase%202 NRD135SE.1 NRD135SE.1 · James P. Rathmell, MD https://druglandscape.com/drug/nrl001 https://druglandscape.com/api/og?type=drug&title=NRL001&subtitle=NRL001%20%C2%B7%20Norgine&badge=phase%201 NRL001 NRL001 · Norgine https://druglandscape.com/drug/nrl0706 https://druglandscape.com/api/og?type=drug&title=NRL0706&subtitle=NRL0706%20%C2%B7%20Norgine&badge=phase%202 NRL0706 NRL0706 · Norgine https://druglandscape.com/drug/nrl994 https://druglandscape.com/api/og?type=drug&title=NRL994&subtitle=NRL994%20%C2%B7%20Norgine&badge=phase%202 NRL994 NRL994 · Norgine https://druglandscape.com/drug/nrm-823 https://druglandscape.com/api/og?type=drug&title=NRM-823&subtitle=NRM-823%20%C2%B7%20Normunity%20AccelCo%2C%20Inc.&badge=phase%201 NRM-823 NRM-823 · Normunity AccelCo, Inc. https://druglandscape.com/drug/nrx-195183-soft-gelatin-capsule https://druglandscape.com/api/og?type=drug&title=NRX%20195183%20Soft%20Gelatin%20Capsule&subtitle=NRX%20195183%20Soft%20Gelatin%20Capsule%20%C2%B7%20NuRx%20Pharmaceuticals%2C%20Inc.&badge=phase%202 NRX 195183 Soft Gelatin Capsule NRX 195183 Soft Gelatin Capsule · NuRx Pharmaceuticals, Inc. https://druglandscape.com/drug/nrx194204 https://druglandscape.com/api/og?type=drug&title=NRX194204&subtitle=NRX194204%20%C2%B7%20NuRx%20Pharmaceuticals%2C%20Inc.&badge=phase%202 NRX194204 NRX194204 · NuRx Pharmaceuticals, Inc. https://druglandscape.com/drug/ns-136-tablet https://druglandscape.com/api/og?type=drug&title=NS-136%20tablet&subtitle=NS-136%20tablet%20%C2%B7%20NeuShen%20Therapeutics&badge=phase%201 NS-136 tablet NS-136 tablet · NeuShen Therapeutics https://druglandscape.com/drug/ns-229 https://druglandscape.com/api/og?type=drug&title=NS-229&subtitle=NS-229%20%C2%B7%20NS%20Pharma%2C%20Inc.&badge=phase%202 NS-229 NS-229 · NS Pharma, Inc. https://druglandscape.com/drug/ns-863-high-dose https://druglandscape.com/api/og?type=drug&title=NS-863%20High%20Dose&subtitle=NS-863%20High%20Dose%20%C2%B7%20NS%20Pharma%2C%20Inc.&badge=phase%202 NS-863 High Dose NS-863 High Dose · NS Pharma, Inc. https://druglandscape.com/drug/ns-863-low-dose https://druglandscape.com/api/og?type=drug&title=NS-863%20Low%20Dose&subtitle=NS-863%20Low%20Dose%20%C2%B7%20NS%20Pharma%2C%20Inc.&badge=phase%202 NS-863 Low Dose NS-863 Low Dose · NS Pharma, Inc. https://druglandscape.com/drug/ns-9-poly-i-poly-c https://druglandscape.com/api/og?type=drug&title=NS-9%20%5BPoly%20I%3A%20Poly%20C%5D&subtitle=NS-9%20%5BPoly%20I%3A%20Poly%20C%5D%20%C2%B7%20NS%20Pharma%2C%20Inc.&badge=phase%201 NS-9 [Poly I: Poly C] NS-9 [Poly I: Poly C] · NS Pharma, Inc. https://druglandscape.com/drug/ns101 https://druglandscape.com/api/og?type=drug&title=NS101&subtitle=NS101%20%C2%B7%20Neuracle%20Science%20Co.%2C%20LTD.&badge=phase%201 NS101 NS101 · Neuracle Science Co., LTD. https://druglandscape.com/drug/ns101-iv-infusion https://druglandscape.com/api/og?type=drug&title=NS101%20IV%20infusion&subtitle=NS101%20IV%20infusion%20%C2%B7%20Neuracle%20Science%20Co.%2C%20LTD.&badge=phase%202 NS101 IV infusion NS101 IV infusion · Neuracle Science Co., LTD. https://druglandscape.com/drug/nsc001 https://druglandscape.com/api/og?type=drug&title=NSC001&subtitle=NSC001%20%C2%B7%20NSC-Therapeutics&badge=phase%201 NSC001 NSC001 · NSC-Therapeutics https://druglandscape.com/drug/nse-cerebral-biomarker-testing https://druglandscape.com/api/og?type=drug&title=NSE%20cerebral%20biomarker%20testing&subtitle=NSE%20cerebral%20biomarker%20testing%20%C2%B7%20Rabin%20Medical%20Center&badge=phase%201 NSE cerebral biomarker testing NSE cerebral biomarker testing · Rabin Medical Center https://druglandscape.com/drug/nsho-101 https://druglandscape.com/api/og?type=drug&title=NSHO-101&subtitle=NSHO-101%20%C2%B7%20Ensho%20Therapeutics%2C%20Inc.&badge=phase%201 NSHO-101 NSHO-101 · Ensho Therapeutics, Inc. https://druglandscape.com/drug/nsi-566 https://druglandscape.com/api/og?type=drug&title=NSI-566&subtitle=NSI-566%20%C2%B7%20Suzhou%20Neuralstem%20Biopharmaceuticals&badge=phase%201 NSI-566 NSI-566 · Suzhou Neuralstem Biopharmaceuticals https://druglandscape.com/drug/nsi-8226 https://druglandscape.com/api/og?type=drug&title=NSI-8226&subtitle=NSI-8226%20%C2%B7%20Uniquity%20One%20(UNI)&badge=phase%202 NSI-8226 NSI-8226 · Uniquity One (UNI) https://druglandscape.com/drug/nst-1024 https://druglandscape.com/api/og?type=drug&title=NST-1024&subtitle=NST-1024%20%C2%B7%20NorthSea%20Therapeutics%20B.V.&badge=phase%202 NST-1024 NST-1024 · NorthSea Therapeutics B.V. https://druglandscape.com/drug/nst-6179-part-a https://druglandscape.com/api/og?type=drug&title=NST-6179%20Part%20A&subtitle=NST-6179%20Part%20A%20%C2%B7%20NorthSea%20Therapeutics%20B.V.&badge=phase%202 NST-6179 Part A NST-6179 Part A · NorthSea Therapeutics B.V. https://druglandscape.com/drug/nst-6179-part-b https://druglandscape.com/api/og?type=drug&title=NST-6179%20Part%20B&subtitle=NST-6179%20Part%20B%20%C2%B7%20NorthSea%20Therapeutics%20B.V.&badge=phase%202 NST-6179 Part B NST-6179 Part B · NorthSea Therapeutics B.V. https://druglandscape.com/drug/nst-628 https://druglandscape.com/api/og?type=drug&title=NST-628&subtitle=NST-628%20%C2%B7%20Nested%20Therapeutics%2C%20Inc&badge=phase%201 NST-628 NST-628 · Nested Therapeutics, Inc https://druglandscape.com/drug/nsv0001 https://druglandscape.com/api/og?type=drug&title=NSV0001&subtitle=NSV0001%20%C2%B7%20Nitto%20Denko%20Corporation&badge=phase%201 NSV0001 NSV0001 · Nitto Denko Corporation https://druglandscape.com/drug/nt-101-low-dose https://druglandscape.com/api/og?type=drug&title=NT-101%20Low%20Dose&subtitle=NT-101%20Low%20Dose%20%C2%B7%20NexThera%20Co.%2C%20Ltd.&badge=phase%201 NT-101 Low Dose NT-101 Low Dose · NexThera Co., Ltd. https://druglandscape.com/drug/nt-501-cntf-implant https://druglandscape.com/api/og?type=drug&title=NT-501%20CNTF%20Implant&subtitle=NT-501%20CNTF%20Implant%20%C2%B7%20Jeffrey%20L%20Goldberg&badge=phase%201 NT-501 CNTF Implant NT-501 CNTF Implant · Jeffrey L Goldberg https://druglandscape.com/drug/nt100 https://druglandscape.com/api/og?type=drug&title=NT100&subtitle=NT100%20%C2%B7%20Nora%20Therapeutics%2C%20Inc.&badge=phase%202 NT100 NT100 · Nora Therapeutics, Inc. https://druglandscape.com/drug/nt219-and-erbitux-dose-escalation https://druglandscape.com/api/og?type=drug&title=NT219%20and%20ERBITUX%C2%AE%20-%20Dose%20Escalation&subtitle=NT219%20and%20ERBITUX%C2%AE%20-%20Dose%20Escalation%20%C2%B7%20TyrNovo%20Ltd.&badge=phase%201 NT219 and ERBITUX® - Dose Escalation NT219 and ERBITUX® - Dose Escalation · TyrNovo Ltd. https://druglandscape.com/drug/nt219-and-erbitux-expansion https://druglandscape.com/api/og?type=drug&title=NT219%20and%20ERBITUX%C2%AE%20-%20Expansion&subtitle=NT219%20and%20ERBITUX%C2%AE%20-%20Expansion%20%C2%B7%20TyrNovo%20Ltd.&badge=phase%201 NT219 and ERBITUX® - Expansion NT219 and ERBITUX® - Expansion · TyrNovo Ltd. https://druglandscape.com/drug/ntb003 https://druglandscape.com/api/og?type=drug&title=NTB003&subtitle=NTB003%20%C2%B7%20Nanjing%20Chia-tai%20Tianqing%20Pharmaceutical&badge=phase%201 NTB003 NTB003 · Nanjing Chia-tai Tianqing Pharmaceutical https://druglandscape.com/drug/ntcell-implantation https://druglandscape.com/api/og?type=drug&title=NTCELL%20Implantation&subtitle=NTCELL%20Implantation%20%C2%B7%20Living%20Cell%20Technologies&badge=phase%202 NTCELL Implantation NTCELL Implantation · Living Cell Technologies https://druglandscape.com/drug/nthi-10-as01e https://druglandscape.com/api/og?type=drug&title=NTHi-10-AS01E&subtitle=NTHi-10-AS01E%20%C2%B7%20GlaxoSmithKline&badge=phase%202 NTHi-10-AS01E NTHi-10-AS01E · GlaxoSmithKline https://druglandscape.com/drug/ntp42-kva4-capsule https://druglandscape.com/api/og?type=drug&title=NTP42%3AKVA4%20Capsule&subtitle=NTP42%3AKVA4%20Capsule%20%C2%B7%20ATXA%20Therapeutics%20Limited&badge=phase%201 NTP42:KVA4 Capsule NTP42:KVA4 Capsule · ATXA Therapeutics Limited https://druglandscape.com/drug/ntp42-kva4-liquid https://druglandscape.com/api/og?type=drug&title=NTP42%3AKVA4%20Liquid&subtitle=NTP42%3AKVA4%20Liquid%20%C2%B7%20ATXA%20Therapeutics%20Limited&badge=phase%201 NTP42:KVA4 Liquid NTP42:KVA4 Liquid · ATXA Therapeutics Limited https://druglandscape.com/drug/ntq1062 https://druglandscape.com/api/og?type=drug&title=NTQ1062&subtitle=NTQ1062%20%C2%B7%20Nanjing%20Chia-tai%20Tianqing%20Pharmaceutical&badge=phase%201 NTQ1062 NTQ1062 · Nanjing Chia-tai Tianqing Pharmaceutical https://druglandscape.com/drug/ntq1062-with-fulvestrant https://druglandscape.com/api/og?type=drug&title=NTQ1062%20with%20Fulvestrant&subtitle=NTQ1062%20with%20Fulvestrant%20%C2%B7%20Nanjing%20Chia-tai%20Tianqing%20Pharmaceutical&badge=phase%201 NTQ1062 with Fulvestrant NTQ1062 with Fulvestrant · Nanjing Chia-tai Tianqing Pharmaceutical https://druglandscape.com/drug/ntq2494-tablet https://druglandscape.com/api/og?type=drug&title=NTQ2494%20tablet&subtitle=NTQ2494%20tablet%20%C2%B7%20Nanjing%20Chia-tai%20Tianqing%20Pharmaceutical&badge=phase%201 NTQ2494 tablet NTQ2494 tablet · Nanjing Chia-tai Tianqing Pharmaceutical https://druglandscape.com/drug/ntq5082-capsule https://druglandscape.com/api/og?type=drug&title=NTQ5082%20capsule&subtitle=NTQ5082%20capsule%20%C2%B7%20Nanjing%20Chia-tai%20Tianqing%20Pharmaceutical&badge=phase%201 NTQ5082 capsule NTQ5082 capsule · Nanjing Chia-tai Tianqing Pharmaceutical https://druglandscape.com/drug/ntr1011 https://druglandscape.com/api/og?type=drug&title=NTR1011&subtitle=NTR1011%20%C2%B7%20Neutrolis&badge=phase%201 NTR1011 NTR1011 · Neutrolis https://druglandscape.com/drug/ntrx-07 https://druglandscape.com/api/og?type=drug&title=NTRX-07&subtitle=NTRX-07%20%C2%B7%20NeuroTherapia%2C%20Inc.&badge=phase%202 NTRX-07 NTRX-07 · NeuroTherapia, Inc. https://druglandscape.com/drug/nts-104-tris https://druglandscape.com/api/og?type=drug&title=NTS-104%20TRIS&subtitle=NTS-104%20TRIS%20%C2%B7%20NeuroTrauma%20Sciences%2C%20LLC&badge=phase%201 NTS-104 TRIS NTS-104 TRIS · NeuroTrauma Sciences, LLC https://druglandscape.com/drug/nts071 https://druglandscape.com/api/og?type=drug&title=NTS071&subtitle=NTS071%20%C2%B7%20Nutshell%20Therapeutics%20(Shanghai)%20Co.%2C%20LTD.&badge=phase%201 NTS071 NTS071 · Nutshell Therapeutics (Shanghai) Co., LTD. https://druglandscape.com/drug/ntx-101 https://druglandscape.com/api/og?type=drug&title=NTX-101&subtitle=NTX-101%20%C2%B7%20Pinotbio%2C%20Inc.&badge=phase%201 NTX-101 NTX-101 · Pinotbio, Inc. https://druglandscape.com/drug/ntx-1472 https://druglandscape.com/api/og?type=drug&title=NTX-1472&subtitle=NTX-1472%20%C2%B7%20Newleos%20Therapeutics%2C%20Inc.&badge=phase%202 NTX-1472 NTX-1472 · Newleos Therapeutics, Inc. https://druglandscape.com/drug/ntx-253 https://druglandscape.com/api/og?type=drug&title=NTX-253&subtitle=NTX-253%20%C2%B7%20Neurosterix&badge=phase%201 NTX-253 NTX-253 · Neurosterix https://druglandscape.com/drug/ntx-301 https://druglandscape.com/api/og?type=drug&title=NTX-301&subtitle=NTX-301%20%C2%B7%20Xennials%20Therapeutics%20Australia%20Pty%20Ltd&badge=phase%201 NTX-301 NTX-301 · Xennials Therapeutics Australia Pty Ltd https://druglandscape.com/drug/nu172 https://druglandscape.com/api/og?type=drug&title=NU172&subtitle=NU172%20%C2%B7%20ARCA%20Biopharma%2C%20Inc.&badge=phase%202 NU172 NU172 · ARCA Biopharma, Inc. https://druglandscape.com/drug/nu300 https://druglandscape.com/api/og?type=drug&title=NU300&subtitle=NU300%20%C2%B7%20Nuron%20Biotech%20Inc.&badge=phase%202 NU300 NU300 · Nuron Biotech Inc. https://druglandscape.com/drug/nuberol-forte https://druglandscape.com/api/og?type=drug&title=Nuberol%20Forte&subtitle=Nuberol%20Forte%20%C2%B7%20The%20Searle%20Company%20Limited%20Pakistan&badge=phase%202 Nuberol Forte Nuberol Forte · The Searle Company Limited Pakistan https://druglandscape.com/drug/nuc-1031-and-carboplatin https://druglandscape.com/api/og?type=drug&title=Nuc-1031%20and%20Carboplatin&subtitle=Nuc-1031%20and%20Carboplatin%20%C2%B7%20Imperial%20College%20Healthcare%20NHS%20Trust&badge=phase%201 Nuc-1031 and Carboplatin Nuc-1031 and Carboplatin · Imperial College Healthcare NHS Trust https://druglandscape.com/drug/nuc-7738 https://druglandscape.com/api/og?type=drug&title=NUC-7738&subtitle=NUC-7738%20%C2%B7%20NuCana%20plc&badge=phase%201 NUC-7738 NUC-7738 · NuCana plc https://druglandscape.com/drug/nucleoside-analogues-or-interferon https://druglandscape.com/api/og?type=drug&title=nucleoside%20analogues%20or%20interferon&subtitle=nucleoside%20analogues%20or%20interferon%20%C2%B7%20Wen-hong%20Zhang&badge=phase%202 nucleoside analogues or interferon nucleoside analogues or interferon · Wen-hong Zhang https://druglandscape.com/drug/nucleotide-drugs-control-group https://druglandscape.com/api/og?type=drug&title=Nucleotide%20drugs%20Control%20group&subtitle=Nucleotide%20drugs%20Control%20group%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 Nucleotide drugs Control group Nucleotide drugs Control group · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/nufiri https://druglandscape.com/api/og?type=drug&title=NUFIRI&subtitle=NUFIRI%20%C2%B7%20NuCana%20plc&badge=phase%201 NUFIRI NUFIRI · NuCana plc https://druglandscape.com/drug/nufox https://druglandscape.com/api/og?type=drug&title=NUFOX&subtitle=NUFOX%20%C2%B7%20NuCana%20plc&badge=phase%201 NUFOX NUFOX · NuCana plc https://druglandscape.com/drug/numeta-g16-e https://druglandscape.com/api/og?type=drug&title=Numeta%20G16%25E&subtitle=Numeta%20G16%25E%20%C2%B7%20Baxter%20Healthcare%20Corporation&badge=phase%201 Numeta G16%E Numeta G16%E · Baxter Healthcare Corporation https://druglandscape.com/drug/nur-isterate https://druglandscape.com/api/og?type=drug&title=Nur-Isterate&subtitle=Nur-Isterate%20%C2%B7%20Desmond%20Tutu%20HIV%20Centre&badge=phase%201 Nur-Isterate Nur-Isterate · Desmond Tutu HIV Centre https://druglandscape.com/drug/nurigra-chewable-tablet https://druglandscape.com/api/og?type=drug&title=Nurigra%20Chewable%20tablet&subtitle=Nurigra%20Chewable%20tablet%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 Nurigra Chewable tablet Nurigra Chewable tablet · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/nurofen-for-children https://druglandscape.com/api/og?type=drug&title=Nurofen%20for%20Children%C2%AE&subtitle=Nurofen%20for%20Children%C2%AE%20%C2%B7%20Reckitt%20Benckiser%20Healthcare%20(UK)%20Limited&badge=phase%201 Nurofen for Children® Nurofen for Children® · Reckitt Benckiser Healthcare (UK) Limited https://druglandscape.com/drug/nutraceutical-topical https://druglandscape.com/api/og?type=drug&title=Nutraceutical%20Topical&subtitle=Nutraceutical%20Topical%20%C2%B7%20Medical%20Life%20Care%20Planners%2C%20LLC&badge=phase%201 Nutraceutical Topical Nutraceutical Topical · Medical Life Care Planners, LLC https://druglandscape.com/drug/nutriceutical-oral-capsule https://druglandscape.com/api/og?type=drug&title=Nutriceutical%20Oral%20Capsule%2C&subtitle=Nutriceutical%20Oral%20Capsule%2C%20%C2%B7%20Villa%20dei%20Gerani&badge=phase%202 Nutriceutical Oral Capsule, Nutriceutical Oral Capsule, · Villa dei Gerani https://druglandscape.com/drug/nuv-1511 https://druglandscape.com/api/og?type=drug&title=NUV-1511&subtitle=NUV-1511%20%C2%B7%20Nuvation%20Bio%20Inc.&badge=phase%201 NUV-1511 NUV-1511 · Nuvation Bio Inc. https://druglandscape.com/drug/nuvaring-vaginal-ring https://druglandscape.com/api/og?type=drug&title=NuvaRing%20Vaginal%20Ring&subtitle=NuvaRing%20Vaginal%20Ring%20%C2%B7%20Lupin%20Research%20Inc&badge=phase%202 NuvaRing Vaginal Ring NuvaRing Vaginal Ring · Lupin Research Inc https://druglandscape.com/drug/nuz-001 https://druglandscape.com/api/og?type=drug&title=NUZ-001&subtitle=NUZ-001%20%C2%B7%20Merit%20E.%20Cudkowicz%2C%20MD&badge=phase%202 NUZ-001 NUZ-001 · Merit E. Cudkowicz, MD https://druglandscape.com/drug/nv1020 https://druglandscape.com/api/og?type=drug&title=NV1020&subtitle=NV1020%20%C2%B7%20MediGene&badge=phase%201 NV1020 NV1020 · MediGene https://druglandscape.com/drug/nv701 https://druglandscape.com/api/og?type=drug&title=NV701&subtitle=NV701%20%C2%B7%20Novus%20Vision%20LLC&badge=phase%201 NV701 NV701 · Novus Vision LLC https://druglandscape.com/drug/nva237-100-g https://druglandscape.com/api/og?type=drug&title=NVA237%20100%20%C2%B5g&subtitle=NVA237%20100%20%C2%B5g%20%C2%B7%20Novartis&badge=phase%202 NVA237 100 µg NVA237 100 µg · Novartis https://druglandscape.com/drug/nvc-422-solution-0-3 https://druglandscape.com/api/og?type=drug&title=NVC-422%20Solution%2C%200.3%25&subtitle=NVC-422%20Solution%2C%200.3%25%20%C2%B7%20NovaBay%20Pharmaceuticals%2C%20Inc.&badge=phase%202 NVC-422 Solution, 0.3% NVC-422 Solution, 0.3% · NovaBay Pharmaceuticals, Inc. https://druglandscape.com/drug/nvg-111 https://druglandscape.com/api/og?type=drug&title=NVG-111&subtitle=NVG-111%20%C2%B7%20NovalGen%20Ltd.&badge=phase%201 NVG-111 NVG-111 · NovalGen Ltd. https://druglandscape.com/drug/nvg-291 https://druglandscape.com/api/og?type=drug&title=NVG-291&subtitle=NVG-291%20%C2%B7%20NervGen%20Pharma&badge=phase%201 NVG-291 NVG-291 · NervGen Pharma https://druglandscape.com/drug/nvgh-vi-crm197 https://druglandscape.com/api/og?type=drug&title=NVGH%20Vi-CRM197&subtitle=NVGH%20Vi-CRM197%20%C2%B7%20Novartis&badge=phase%202 NVGH Vi-CRM197 NVGH Vi-CRM197 · Novartis https://druglandscape.com/drug/nvl-330 https://druglandscape.com/api/og?type=drug&title=NVL-330&subtitle=NVL-330%20%C2%B7%20Nuvalent%20Inc.&badge=phase%201 NVL-330 NVL-330 · Nuvalent Inc. https://druglandscape.com/drug/nvl-655 https://druglandscape.com/api/og?type=drug&title=NVL-655&subtitle=NVL-655%20%C2%B7%20Nuvalent%20Inc.&badge=phase%202 NVL-655 NVL-655 · Nuvalent Inc. https://druglandscape.com/drug/nvn1000 https://druglandscape.com/api/og?type=drug&title=NVN1000&subtitle=NVN1000%20%C2%B7%20Novan%2C%20Inc.&badge=phase%201 NVN1000 NVN1000 · Novan, Inc. https://druglandscape.com/drug/nvn1000-1-gel https://druglandscape.com/api/og?type=drug&title=NVN1000%201%25%20Gel&subtitle=NVN1000%201%25%20Gel%20%C2%B7%20Novan%2C%20Inc.&badge=phase%202 NVN1000 1% Gel NVN1000 1% Gel · Novan, Inc. https://druglandscape.com/drug/nvn1000-16 https://druglandscape.com/api/og?type=drug&title=NVN1000%2016%25&subtitle=NVN1000%2016%25%20%C2%B7%20Novan%2C%20Inc.&badge=phase%202 NVN1000 16% NVN1000 16% · Novan, Inc. https://druglandscape.com/drug/nvn1000-4-gel https://druglandscape.com/api/og?type=drug&title=NVN1000%204%25%20Gel&subtitle=NVN1000%204%25%20Gel%20%C2%B7%20Novan%2C%20Inc.&badge=phase%202 NVN1000 4% Gel NVN1000 4% Gel · Novan, Inc. https://druglandscape.com/drug/nvn1000-8-gel https://druglandscape.com/api/og?type=drug&title=NVN1000%208%25%20Gel&subtitle=NVN1000%208%25%20Gel%20%C2%B7%20Novan%2C%20Inc.&badge=phase%202 NVN1000 8% Gel NVN1000 8% Gel · Novan, Inc. https://druglandscape.com/drug/nvp-1203-r1 https://druglandscape.com/api/og?type=drug&title=NVP-1203-R1&subtitle=NVP-1203-R1%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-1203-R1 NVP-1203-R1 · NVP Healthcare https://druglandscape.com/drug/nvp-1203-r1-and-nvp-1203-r2 https://druglandscape.com/api/og?type=drug&title=NVP-1203-R1%20and%20NVP-1203-R2&subtitle=NVP-1203-R1%20and%20NVP-1203-R2%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-1203-R1 and NVP-1203-R2 NVP-1203-R1 and NVP-1203-R2 · NVP Healthcare https://druglandscape.com/drug/nvp-1203-r2 https://druglandscape.com/api/og?type=drug&title=NVP-1203-R2&subtitle=NVP-1203-R2%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-1203-R2 NVP-1203-R2 · NVP Healthcare https://druglandscape.com/drug/nvp-1205 https://druglandscape.com/api/og?type=drug&title=NVP-1205&subtitle=NVP-1205%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-1205 NVP-1205 · NVP Healthcare https://druglandscape.com/drug/nvp-1402 https://druglandscape.com/api/og?type=drug&title=NVP-1402&subtitle=NVP-1402%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-1402 NVP-1402 · NVP Healthcare https://druglandscape.com/drug/nvp-1402r https://druglandscape.com/api/og?type=drug&title=NVP-1402R&subtitle=NVP-1402R%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-1402R NVP-1402R · NVP Healthcare https://druglandscape.com/drug/nvp-1705 https://druglandscape.com/api/og?type=drug&title=NVP-1705&subtitle=NVP-1705%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-1705 NVP-1705 · NVP Healthcare https://druglandscape.com/drug/nvp-1705-r https://druglandscape.com/api/og?type=drug&title=NVP-1705-R&subtitle=NVP-1705-R%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-1705-R NVP-1705-R · NVP Healthcare https://druglandscape.com/drug/nvp-1805 https://druglandscape.com/api/og?type=drug&title=NVP-1805&subtitle=NVP-1805%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-1805 NVP-1805 · NVP Healthcare https://druglandscape.com/drug/nvp-1805-r1 https://druglandscape.com/api/og?type=drug&title=NVP-1805-R1&subtitle=NVP-1805-R1%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-1805-R1 NVP-1805-R1 · NVP Healthcare https://druglandscape.com/drug/nvp-1805-r1-and-nvp-1805-r2 https://druglandscape.com/api/og?type=drug&title=NVP-1805-R1%20and%20NVP-1805-R2&subtitle=NVP-1805-R1%20and%20NVP-1805-R2%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-1805-R1 and NVP-1805-R2 NVP-1805-R1 and NVP-1805-R2 · NVP Healthcare https://druglandscape.com/drug/nvp-1805-r1and-nvp-1805-r2 https://druglandscape.com/api/og?type=drug&title=NVP-1805-R1and%20NVP-1805-R2&subtitle=NVP-1805-R1and%20NVP-1805-R2%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-1805-R1and NVP-1805-R2 NVP-1805-R1and NVP-1805-R2 · NVP Healthcare https://druglandscape.com/drug/nvp-1805-r2 https://druglandscape.com/api/og?type=drug&title=NVP-1805-R2&subtitle=NVP-1805-R2%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-1805-R2 NVP-1805-R2 · NVP Healthcare https://druglandscape.com/drug/nvp-2102 https://druglandscape.com/api/og?type=drug&title=NVP-2102&subtitle=NVP-2102%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-2102 NVP-2102 · NVP Healthcare https://druglandscape.com/drug/nvp-2102-r https://druglandscape.com/api/og?type=drug&title=NVP-2102-R&subtitle=NVP-2102-R%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-2102-R NVP-2102-R · NVP Healthcare https://druglandscape.com/drug/nvp-2203-r https://druglandscape.com/api/og?type=drug&title=NVP-2203-R&subtitle=NVP-2203-R%20%C2%B7%20NVP%20Healthcare&badge=phase%201 NVP-2203-R NVP-2203-R · NVP Healthcare https://druglandscape.com/drug/nvp-vak694 https://druglandscape.com/api/og?type=drug&title=NVP-VAK694&subtitle=NVP-VAK694%20%C2%B7%20Novartis&badge=phase%201 NVP-VAK694 NVP-VAK694 · Novartis https://druglandscape.com/drug/nvr-3-778 https://druglandscape.com/api/og?type=drug&title=NVR%203-778&subtitle=NVR%203-778%20%C2%B7%20Novira%20Therapeutics%2C%20Inc.&badge=phase%201 NVR 3-778 NVR 3-778 · Novira Therapeutics, Inc. https://druglandscape.com/drug/nvx-108 https://druglandscape.com/api/og?type=drug&title=NVX-108&subtitle=NVX-108%20%C2%B7%20NuvOx%20LLC&badge=phase%201 NVX-108 NVX-108 · NuvOx LLC https://druglandscape.com/drug/nvxt-topical https://druglandscape.com/api/og?type=drug&title=NVXT%20topical&subtitle=NVXT%20topical%20%C2%B7%20Sun%20Pharmaceutical%20Industries%2C%20Inc.&badge=phase%202 NVXT topical NVXT topical · Sun Pharmaceutical Industries, Inc. https://druglandscape.com/drug/nw-3509a https://druglandscape.com/api/og?type=drug&title=NW-3509a&subtitle=NW-3509a%20%C2%B7%20Newron%20Pharmaceuticals%20SPA&badge=phase%202 NW-3509a NW-3509a · Newron Pharmaceuticals SPA https://druglandscape.com/drug/nwrd06-administered-by-electroporation https://druglandscape.com/api/og?type=drug&title=NWRD06%20administered%20by%20electroporation&subtitle=NWRD06%20administered%20by%20electroporation%20%C2%B7%20Newish%20Technology%20(Beijing)%20Co.%2C%20Ltd.&badge=phase%202 NWRD06 administered by electroporation NWRD06 administered by electroporation · Newish Technology (Beijing) Co., Ltd. https://druglandscape.com/drug/nwrd08 https://druglandscape.com/api/og?type=drug&title=NWRD08&subtitle=NWRD08%20%C2%B7%20Newish%20Technology%20(Beijing)%20Co.%2C%20Ltd.&badge=phase%201 NWRD08 NWRD08 · Newish Technology (Beijing) Co., Ltd. https://druglandscape.com/drug/nwrd08-administered-by-electroporation https://druglandscape.com/api/og?type=drug&title=NWRD08%20administered%20by%20electroporation&subtitle=NWRD08%20administered%20by%20electroporation%20%C2%B7%20Newish%20Biotech%20(Wuxi)%20Co.%2C%20Ltd.&badge=phase%202 NWRD08 administered by electroporation NWRD08 administered by electroporation · Newish Biotech (Wuxi) Co., Ltd. https://druglandscape.com/drug/nwy001 https://druglandscape.com/api/og?type=drug&title=NWY001&subtitle=NWY001%20%C2%B7%20Chipscreen%20Biosciences%2C%20Ltd.&badge=phase%201 NWY001 NWY001 · Chipscreen Biosciences, Ltd. https://druglandscape.com/drug/nx-019 https://druglandscape.com/api/og?type=drug&title=NX-019&subtitle=NX-019%20%C2%B7%20Nalo%20Therapeutics%20Inc.&badge=phase%201 NX-019 NX-019 · Nalo Therapeutics Inc. https://druglandscape.com/drug/nx-1607 https://druglandscape.com/api/og?type=drug&title=NX-1607&subtitle=NX-1607%20%C2%B7%20Nurix%20Therapeutics%2C%20Inc.&badge=phase%201 NX-1607 NX-1607 · Nurix Therapeutics, Inc. https://druglandscape.com/drug/nx-2127 https://druglandscape.com/api/og?type=drug&title=NX-2127&subtitle=NX-2127%20%C2%B7%20Nurix%20Therapeutics%2C%20Inc.&badge=phase%201 NX-2127 NX-2127 · Nurix Therapeutics, Inc. https://druglandscape.com/drug/nx-cp105 https://druglandscape.com/api/og?type=drug&title=NX-CP105&subtitle=NX-CP105%20%C2%B7%20Neuronyx&badge=phase%201 NX-CP105 NX-CP105 · Neuronyx https://druglandscape.com/drug/nx9-oral-contrast-agent https://druglandscape.com/api/og?type=drug&title=NX9%20Oral%20Contrast%20Agent&subtitle=NX9%20Oral%20Contrast%20Agent%20%C2%B7%20Nextrast%2C%20Inc.&badge=phase%202 NX9 Oral Contrast Agent NX9 Oral Contrast Agent · Nextrast, Inc. https://druglandscape.com/drug/nxc-201-car-t https://druglandscape.com/api/og?type=drug&title=NXC-201%20CAR-T&subtitle=NXC-201%20CAR-T%20%C2%B7%20Nexcella%20Inc.&badge=phase%201 NXC-201 CAR-T NXC-201 CAR-T · Nexcella Inc. https://druglandscape.com/drug/nxc736 https://druglandscape.com/api/og?type=drug&title=NXC736&subtitle=NXC736%20%C2%B7%20NEXTGEN%20Bioscience&badge=phase%202 NXC736 NXC736 · NEXTGEN Bioscience https://druglandscape.com/drug/nxl104 https://druglandscape.com/api/og?type=drug&title=NXL104&subtitle=NXL104%20%C2%B7%20Pfizer&badge=phase%201 NXL104 NXL104 · Pfizer https://druglandscape.com/drug/nxn-188 https://druglandscape.com/api/og?type=drug&title=NXN-188&subtitle=NXN-188%20%C2%B7%20NeurAxon%20Inc.&badge=phase%202 NXN-188 NXN-188 · NeurAxon Inc. https://druglandscape.com/drug/nxn-462 https://druglandscape.com/api/og?type=drug&title=NXN-462&subtitle=NXN-462%20%C2%B7%20NeurAxon%20Inc.&badge=phase%202 NXN-462 NXN-462 · NeurAxon Inc. https://druglandscape.com/drug/nxp800 https://druglandscape.com/api/og?type=drug&title=NXP800&subtitle=NXP800%20%C2%B7%20Nuvectis%20Pharma%2C%20Inc.&badge=phase%201 NXP800 NXP800 · Nuvectis Pharma, Inc. https://druglandscape.com/drug/nxp900 https://druglandscape.com/api/og?type=drug&title=NXP900&subtitle=NXP900%20%C2%B7%20Nuvectis%20Pharma%2C%20Inc.&badge=phase%201 NXP900 NXP900 · Nuvectis Pharma, Inc. https://druglandscape.com/drug/nxt007 https://druglandscape.com/api/og?type=drug&title=NXT007&subtitle=NXT007%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 NXT007 NXT007 · Hoffmann-La Roche https://druglandscape.com/drug/nyeso-1c259-t-cells https://druglandscape.com/api/og?type=drug&title=NYESO-1c259%20T%20cells&subtitle=NYESO-1c259%20T%20cells%20%C2%B7%20Adaptimmune&badge=phase%201 NYESO-1c259 T cells NYESO-1c259 T cells · Adaptimmune https://druglandscape.com/drug/nyh100p https://druglandscape.com/api/og?type=drug&title=NYH100P&subtitle=NYH100P%20%C2%B7%20Haim%20Bio%20Co.%2C%20Ltd.&badge=phase%201 NYH100P NYH100P · Haim Bio Co., Ltd. https://druglandscape.com/drug/nyr-bi03 https://druglandscape.com/api/og?type=drug&title=NYR-BI03&subtitle=NYR-BI03%20%C2%B7%20Nyrada%20Pty%20Ltd&badge=phase%201 NYR-BI03 NYR-BI03 · Nyrada Pty Ltd https://druglandscape.com/drug/nyvac-b https://druglandscape.com/api/og?type=drug&title=NYVAC-B&subtitle=NYVAC-B%20%C2%B7%20HIV%20Vaccine%20Trials%20Network&badge=phase%201 NYVAC-B NYVAC-B · HIV Vaccine Trials Network https://druglandscape.com/drug/nyx-458 https://druglandscape.com/api/og?type=drug&title=NYX-458&subtitle=NYX-458%20%C2%B7%20Aptinyx&badge=phase%202 NYX-458 NYX-458 · Aptinyx https://druglandscape.com/drug/oa-sys https://druglandscape.com/api/og?type=drug&title=OA-SYS&subtitle=OA-SYS%20%C2%B7%20Ageless%20Biotech%2C%20Inc.&badge=phase%202 OA-SYS OA-SYS · Ageless Biotech, Inc. https://druglandscape.com/drug/oap-189 https://druglandscape.com/api/og?type=drug&title=OAP-189&subtitle=OAP-189%20%C2%B7%20Pfizer&badge=phase%201 OAP-189 OAP-189 · Pfizer https://druglandscape.com/drug/oatd-01 https://druglandscape.com/api/og?type=drug&title=OATD-01&subtitle=OATD-01%20%C2%B7%20Molecure%20S.A.&badge=phase%202 OATD-01 OATD-01 · Molecure S.A. https://druglandscape.com/drug/oatd-02 https://druglandscape.com/api/og?type=drug&title=OATD-02&subtitle=OATD-02%20%C2%B7%20Molecure%20S.A.&badge=phase%201 OATD-02 OATD-02 · Molecure S.A. https://druglandscape.com/drug/ob318-capsule https://druglandscape.com/api/og?type=drug&title=OB318%20capsule&subtitle=OB318%20capsule%20%C2%B7%20Oneness%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 OB318 capsule OB318 capsule · Oneness Biotech Co., Ltd. https://druglandscape.com/drug/obe022 https://druglandscape.com/api/og?type=drug&title=OBE022&subtitle=OBE022%20%C2%B7%20ObsEva%20SA&badge=phase%202 OBE022 OBE022 · ObsEva SA https://druglandscape.com/drug/obi-902 https://druglandscape.com/api/og?type=drug&title=OBI-902&subtitle=OBI-902%20%C2%B7%20OBI%20Pharma%2C%20Inc&badge=phase%201 OBI-902 OBI-902 · OBI Pharma, Inc https://druglandscape.com/drug/obi-992 https://druglandscape.com/api/og?type=drug&title=OBI-992&subtitle=OBI-992%20%C2%B7%20OBI%20Pharma%2C%20Inc&badge=phase%201 OBI-992 OBI-992 · OBI Pharma, Inc https://druglandscape.com/drug/oc-10x https://druglandscape.com/api/og?type=drug&title=OC-10X&subtitle=OC-10X%20%C2%B7%20OcuCure%20Therapeutics%2C%20Inc.&badge=phase%201 OC-10X OC-10X · OcuCure Therapeutics, Inc. https://druglandscape.com/drug/oc-containing-ee-and-net https://druglandscape.com/api/og?type=drug&title=OC%20containing%20EE%20and%20NET&subtitle=OC%20containing%20EE%20and%20NET%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 OC containing EE and NET OC containing EE and NET · Bristol-Myers Squibb https://druglandscape.com/drug/oce-205 https://druglandscape.com/api/og?type=drug&title=OCE-205&subtitle=OCE-205%20%C2%B7%20Ocelot%20Bio%2C%20Inc&badge=phase%202 OCE-205 OCE-205 · Ocelot Bio, Inc https://druglandscape.com/drug/ocimum-sanctum https://druglandscape.com/api/og?type=drug&title=Ocimum%20Sanctum&subtitle=Ocimum%20Sanctum%20%C2%B7%20Composite%20Interceptive%20Med%20Science&badge=phase%201 Ocimum Sanctum Ocimum Sanctum · Composite Interceptive Med Science https://druglandscape.com/drug/ocr-002-ir-oral-tablet https://druglandscape.com/api/og?type=drug&title=OCR-002%20IR%20Oral%20Tablet&subtitle=OCR-002%20IR%20Oral%20Tablet%20%C2%B7%20Ocera%20Therapeutics%2C%20Inc.&badge=phase%201 OCR-002 IR Oral Tablet OCR-002 IR Oral Tablet · Ocera Therapeutics, Inc. https://druglandscape.com/drug/ocrelizumab-reference-formulation https://druglandscape.com/api/og?type=drug&title=Ocrelizumab%20Reference%20Formulation&subtitle=Ocrelizumab%20Reference%20Formulation%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Ocrelizumab Reference Formulation Ocrelizumab Reference Formulation · Hoffmann-La Roche https://druglandscape.com/drug/ocrelizumab-test-formulation https://druglandscape.com/api/og?type=drug&title=Ocrelizumab%20Test%20Formulation&subtitle=Ocrelizumab%20Test%20Formulation%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Ocrelizumab Test Formulation Ocrelizumab Test Formulation · Hoffmann-La Roche https://druglandscape.com/drug/ocriplasmin-25-g https://druglandscape.com/api/og?type=drug&title=Ocriplasmin%2025%C2%B5g&subtitle=Ocriplasmin%2025%C2%B5g%20%C2%B7%20ThromboGenics&badge=phase%202 Ocriplasmin 25µg Ocriplasmin 25µg · ThromboGenics https://druglandscape.com/drug/ocriplasmin-75-g https://druglandscape.com/api/og?type=drug&title=Ocriplasmin%2075%C2%B5g&subtitle=Ocriplasmin%2075%C2%B5g%20%C2%B7%20ThromboGenics&badge=phase%202 Ocriplasmin 75µg Ocriplasmin 75µg · ThromboGenics https://druglandscape.com/drug/oct-598 https://druglandscape.com/api/og?type=drug&title=OCT-598&subtitle=OCT-598%20%C2%B7%20Oscotec%20Inc.&badge=phase%201 OCT-598 OCT-598 · Oscotec Inc. https://druglandscape.com/drug/oct-clear https://druglandscape.com/api/og?type=drug&title=OCT%20-%20clear&subtitle=OCT%20-%20clear%20%C2%B7%20Becton%2C%20Dickinson%20and%20Company&badge=phase%202 OCT - clear OCT - clear · Becton, Dickinson and Company https://druglandscape.com/drug/oct-tinted https://druglandscape.com/api/og?type=drug&title=OCT-%20tinted&subtitle=OCT-%20tinted%20%C2%B7%20Becton%2C%20Dickinson%20and%20Company&badge=phase%202 OCT- tinted OCT- tinted · Becton, Dickinson and Company https://druglandscape.com/drug/octagam-5 https://druglandscape.com/api/og?type=drug&title=Octagam%205%25&subtitle=Octagam%205%25%20%C2%B7%20Octapharma&badge=phase%202 Octagam 5% Octagam 5% · Octapharma https://druglandscape.com/drug/octagam-ivig-5-or-10 https://druglandscape.com/api/og?type=drug&title=Octagam%20IVIG%205%25%20or%2010%25&subtitle=Octagam%20IVIG%205%25%20or%2010%25%20%C2%B7%20Octapharma&badge=phase%202 Octagam IVIG 5% or 10% Octagam IVIG 5% or 10% · Octapharma https://druglandscape.com/drug/octaplas-lg https://druglandscape.com/api/og?type=drug&title=Octaplas%20LG&subtitle=Octaplas%20LG%20%C2%B7%20Octapharma&badge=phase%202 Octaplas LG Octaplas LG · Octapharma https://druglandscape.com/drug/octaplas-sd https://druglandscape.com/api/og?type=drug&title=Octaplas%20SD&subtitle=Octaplas%20SD%20%C2%B7%20Octapharma&badge=phase%201 Octaplas SD Octaplas SD · Octapharma https://druglandscape.com/drug/octenidine-dihydrocloride-in-aqueous-solution https://druglandscape.com/api/og?type=drug&title=Octenidine%20Dihydrocloride%20in%20aqueous%20solution&subtitle=Octenidine%20Dihydrocloride%20in%20aqueous%20solution%20%C2%B7%20Becton%2C%20Dickinson%20and%20Company&badge=phase%202 Octenidine Dihydrocloride in aqueous solution Octenidine Dihydrocloride in aqueous solution · Becton, Dickinson and Company https://druglandscape.com/drug/octohydroaminoacridine-succinate-tablets https://druglandscape.com/api/og?type=drug&title=Octohydroaminoacridine%20Succinate%20Tablets&subtitle=Octohydroaminoacridine%20Succinate%20Tablets%20%C2%B7%20Changchun%20Huayang%20High-tech%20Co.%2C%20Ltd&badge=phase%202 Octohydroaminoacridine Succinate Tablets Octohydroaminoacridine Succinate Tablets · Changchun Huayang High-tech Co., Ltd https://druglandscape.com/drug/octreotide-fluidcrystal-injection-depot https://druglandscape.com/api/og?type=drug&title=octreotide%20FluidCrystal%C2%AE%20injection%20depot&subtitle=octreotide%20FluidCrystal%C2%AE%20injection%20depot%20%C2%B7%20Camurus%20AB&badge=phase%202 octreotide FluidCrystal® injection depot octreotide FluidCrystal® injection depot · Camurus AB https://druglandscape.com/drug/ocu200 https://druglandscape.com/api/og?type=drug&title=OCU200&subtitle=OCU200%20%C2%B7%20Ocugen&badge=phase%201 OCU200 OCU200 · Ocugen https://druglandscape.com/drug/ocu400 https://druglandscape.com/api/og?type=drug&title=OCU400&subtitle=OCU400%20%C2%B7%20Ocugen&badge=phase%202 OCU400 OCU400 · Ocugen https://druglandscape.com/drug/ocu400-low-dose https://druglandscape.com/api/og?type=drug&title=OCU400%20Low%20Dose&subtitle=OCU400%20Low%20Dose%20%C2%B7%20Ocugen&badge=phase%201 OCU400 Low Dose OCU400 Low Dose · Ocugen https://druglandscape.com/drug/ocu400-med-dose https://druglandscape.com/api/og?type=drug&title=OCU400%20Med%20Dose&subtitle=OCU400%20Med%20Dose%20%C2%B7%20Ocugen&badge=phase%201 OCU400 Med Dose OCU400 Med Dose · Ocugen https://druglandscape.com/drug/ocu400-second-eye-dosing https://druglandscape.com/api/og?type=drug&title=OCU400%20Second%20Eye%20Dosing&subtitle=OCU400%20Second%20Eye%20Dosing%20%C2%B7%20Ocugen&badge=phase%201 OCU400 Second Eye Dosing OCU400 Second Eye Dosing · Ocugen https://druglandscape.com/drug/ocu410st https://druglandscape.com/api/og?type=drug&title=OCU410ST&subtitle=OCU410ST%20%C2%B7%20Ocugen&badge=phase%202 OCU410ST OCU410ST · Ocugen https://druglandscape.com/drug/ocular-gel https://druglandscape.com/api/og?type=drug&title=Ocular%20gel&subtitle=Ocular%20gel%20%C2%B7%20Sintetica%20SA&badge=phase%202 Ocular gel Ocular gel · Sintetica SA https://druglandscape.com/drug/ocv-103-and-ocv-104 https://druglandscape.com/api/og?type=drug&title=OCV-103%20and%20OCV-104&subtitle=OCV-103%20and%20OCV-104%20%C2%B7%20Otsuka%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 OCV-103 and OCV-104 OCV-103 and OCV-104 · Otsuka Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ocv-501 https://druglandscape.com/api/og?type=drug&title=OCV-501&subtitle=OCV-501%20%C2%B7%20Otsuka%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 OCV-501 OCV-501 · Otsuka Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ocv-vaccine https://druglandscape.com/api/og?type=drug&title=OCV%20Vaccine&subtitle=OCV%20Vaccine%20%C2%B7%20Centre%20for%20Infectious%20Disease%20Research%20in%20Zambia&badge=phase%201 OCV Vaccine OCV Vaccine · Centre for Infectious Disease Research in Zambia https://druglandscape.com/drug/ocz103-os https://druglandscape.com/api/og?type=drug&title=OCZ103-OS&subtitle=OCZ103-OS%20%C2%B7%20Oncozyme%20Pharma%20Inc.&badge=phase%202 OCZ103-OS OCZ103-OS · Oncozyme Pharma Inc. https://druglandscape.com/drug/od-dual-release-hydrocortisone https://druglandscape.com/api/og?type=drug&title=OD%20dual-release%20Hydrocortisone&subtitle=OD%20dual-release%20Hydrocortisone%20%C2%B7%20Vastra%20Gotaland%20Region&badge=phase%201 OD dual-release Hydrocortisone OD dual-release Hydrocortisone · Vastra Gotaland Region https://druglandscape.com/drug/odc-il2 https://druglandscape.com/api/og?type=drug&title=ODC-IL2&subtitle=ODC-IL2%20%C2%B7%20Trutino%20Biosciences%20Inc.&badge=phase%201 ODC-IL2 ODC-IL2 · Trutino Biosciences Inc. https://druglandscape.com/drug/odm-104 https://druglandscape.com/api/og?type=drug&title=ODM-104&subtitle=ODM-104%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 ODM-104 ODM-104 · Orion Corporation, Orion Pharma https://druglandscape.com/drug/odm-106 https://druglandscape.com/api/og?type=drug&title=ODM-106&subtitle=ODM-106%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 ODM-106 ODM-106 · Orion Corporation, Orion Pharma https://druglandscape.com/drug/odm-109 https://druglandscape.com/api/og?type=drug&title=ODM-109&subtitle=ODM-109%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%202 ODM-109 ODM-109 · Orion Corporation, Orion Pharma https://druglandscape.com/drug/odm-201-capsule-formulation https://druglandscape.com/api/og?type=drug&title=ODM-201%20capsule%20formulation&subtitle=ODM-201%20capsule%20formulation%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%202 ODM-201 capsule formulation ODM-201 capsule formulation · Orion Corporation, Orion Pharma https://druglandscape.com/drug/odm-203 https://druglandscape.com/api/og?type=drug&title=ODM%20203&subtitle=ODM%20203%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 ODM 203 ODM 203 · Orion Corporation, Orion Pharma https://druglandscape.com/drug/odm-208 https://druglandscape.com/api/og?type=drug&title=ODM-208&subtitle=ODM-208%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 ODM-208 ODM-208 · Orion Corporation, Orion Pharma https://druglandscape.com/drug/odm-209 https://druglandscape.com/api/og?type=drug&title=ODM-209&subtitle=ODM-209%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 ODM-209 ODM-209 · Orion Corporation, Orion Pharma https://druglandscape.com/drug/odm103 https://druglandscape.com/api/og?type=drug&title=ODM103&subtitle=ODM103%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 ODM103 ODM103 · Orion Corporation, Orion Pharma https://druglandscape.com/drug/odt-1-with-water https://druglandscape.com/api/og?type=drug&title=ODT%20%231%20with%20water&subtitle=ODT%20%231%20with%20water%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%201 ODT #1 with water ODT #1 with water · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/odt-1-without-water https://druglandscape.com/api/og?type=drug&title=ODT%20%231%20without%20water&subtitle=ODT%20%231%20without%20water%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%201 ODT #1 without water ODT #1 without water · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/odt-2-with-water https://druglandscape.com/api/og?type=drug&title=ODT%20%232%20with%20water&subtitle=ODT%20%232%20with%20water%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%201 ODT #2 with water ODT #2 with water · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/odt-2-without-water https://druglandscape.com/api/og?type=drug&title=ODT%20%232%20without%20water&subtitle=ODT%20%232%20without%20water%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%201 ODT #2 without water ODT #2 without water · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/odt-pzq https://druglandscape.com/api/og?type=drug&title=ODT-PZQ&subtitle=ODT-PZQ%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 ODT-PZQ ODT-PZQ · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/ofatumumab-100 https://druglandscape.com/api/og?type=drug&title=Ofatumumab%20100&subtitle=Ofatumumab%20100%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Ofatumumab 100 Ofatumumab 100 · GlaxoSmithKline https://druglandscape.com/drug/ofatumumab-300 https://druglandscape.com/api/og?type=drug&title=Ofatumumab%20300&subtitle=Ofatumumab%20300%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Ofatumumab 300 Ofatumumab 300 · GlaxoSmithKline https://druglandscape.com/drug/ofatumumab-700 https://druglandscape.com/api/og?type=drug&title=Ofatumumab%20700&subtitle=Ofatumumab%20700%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Ofatumumab 700 Ofatumumab 700 · GlaxoSmithKline https://druglandscape.com/drug/ofatumumab-combined-with-sb-485232 https://druglandscape.com/api/og?type=drug&title=Ofatumumab%20combined%20with%20SB-485232&subtitle=Ofatumumab%20combined%20with%20SB-485232%20%C2%B7%20Michael%20John%20Robertson&badge=phase%201 Ofatumumab combined with SB-485232 Ofatumumab combined with SB-485232 · Michael John Robertson https://druglandscape.com/drug/off-in-experimental-arm https://druglandscape.com/api/og?type=drug&title=OFF%20in%20experimental%20arm&subtitle=OFF%20in%20experimental%20arm%20%C2%B7%20CONKO-Studiengruppe&badge=phase%202 OFF in experimental arm OFF in experimental arm · CONKO-Studiengruppe https://druglandscape.com/drug/off-metformin https://druglandscape.com/api/og?type=drug&title=Off%20Metformin&subtitle=Off%20Metformin%20%C2%B7%20German%20Diabetes%20Center&badge=phase%201 Off Metformin Off Metformin · German Diabetes Center https://druglandscape.com/drug/off-site-methadone-or-no-agonist https://druglandscape.com/api/og?type=drug&title=Off-site%20-%20methadone%20or%20no%20agonist&subtitle=Off-site%20-%20methadone%20or%20no%20agonist%20%C2%B7%20Ruth%20M.%20Rothstein%20CORE%20Center&badge=phase%202 Off-site - methadone or no agonist Off-site - methadone or no agonist · Ruth M. Rothstein CORE Center https://druglandscape.com/drug/og-6219 https://druglandscape.com/api/og?type=drug&title=OG-6219&subtitle=OG-6219%20%C2%B7%20Organon%20and%20Co&badge=phase%202 OG-6219 OG-6219 · Organon and Co https://druglandscape.com/drug/ogtt https://druglandscape.com/api/og?type=drug&title=OGTT&subtitle=OGTT%20%C2%B7%20Haugaard%2C%20Steen%20Bendix%2C%20M.D.%2C%20DMSc&badge=phase%202 OGTT OGTT · Haugaard, Steen Bendix, M.D., DMSc https://druglandscape.com/drug/oh2-oncolytic-virus https://druglandscape.com/api/og?type=drug&title=OH2%20oncolytic%20virus&subtitle=OH2%20oncolytic%20virus%20%C2%B7%20Taizhou%20HoudeAoke%20Biomedical%20Co.%2C%20Ltd.&badge=phase%201 OH2 oncolytic virus OH2 oncolytic virus · Taizhou HoudeAoke Biomedical Co., Ltd. https://druglandscape.com/drug/ohb-607 https://druglandscape.com/api/og?type=drug&title=OHB-607&subtitle=OHB-607%20%C2%B7%20OHB%20Neonatology%20Ltd.&badge=phase%202 OHB-607 OHB-607 · OHB Neonatology Ltd. https://druglandscape.com/drug/oil-special-107-and-mygliol-810 https://druglandscape.com/api/og?type=drug&title=Oil%20special%20107%20and%20MYGLIOL%20810&subtitle=Oil%20special%20107%20and%20MYGLIOL%20810%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Oil special 107 and MYGLIOL 810 Oil special 107 and MYGLIOL 810 · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/ointment-synthomycine https://druglandscape.com/api/og?type=drug&title=ointment%20Synthomycine&subtitle=ointment%20Synthomycine%20%C2%B7%20Rabin%20Medical%20Center&badge=phase%202 ointment Synthomycine ointment Synthomycine · Rabin Medical Center https://druglandscape.com/drug/ojp-2028 https://druglandscape.com/api/og?type=drug&title=OJP-2028&subtitle=OJP-2028%20%C2%B7%20Jeil%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 OJP-2028 OJP-2028 · Jeil Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ok-101 https://druglandscape.com/api/og?type=drug&title=OK-101&subtitle=OK-101%20%C2%B7%20Okyo%20Pharma%20Ltd&badge=phase%202 OK-101 OK-101 · Okyo Pharma Ltd https://druglandscape.com/drug/ok432 https://druglandscape.com/api/og?type=drug&title=OK432&subtitle=OK432%20%C2%B7%20Richard%20JH%20Smith&badge=phase%202 OK432 OK432 · Richard JH Smith https://druglandscape.com/drug/okg-0301 https://druglandscape.com/api/og?type=drug&title=OKG-0301&subtitle=OKG-0301%20%C2%B7%20Okogen&badge=phase%202 OKG-0301 OKG-0301 · Okogen https://druglandscape.com/drug/oki-179 https://druglandscape.com/api/og?type=drug&title=OKI-179&subtitle=OKI-179%20%C2%B7%20OnKure%2C%20Inc.&badge=phase%201 OKI-179 OKI-179 · OnKure, Inc. https://druglandscape.com/drug/oki-219 https://druglandscape.com/api/og?type=drug&title=OKI-219&subtitle=OKI-219%20%C2%B7%20OnKure%2C%20Inc.&badge=phase%201 OKI-219 OKI-219 · OnKure, Inc. https://druglandscape.com/drug/okn4395 https://druglandscape.com/api/og?type=drug&title=OKN4395&subtitle=OKN4395%20%C2%B7%20Epkin&badge=phase%201 OKN4395 OKN4395 · Epkin https://druglandscape.com/drug/okt3-gc https://druglandscape.com/api/og?type=drug&title=OKT3%2C%20GC&subtitle=OKT3%2C%20GC%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 OKT3, GC OKT3, GC · Hadassah Medical Organization https://druglandscape.com/drug/olanzapine-and-vitamin-d-and-vitamin-e https://druglandscape.com/api/og?type=drug&title=Olanzapine%20and%20Vitamin%20D%20and%20Vitamin%20E&subtitle=Olanzapine%20and%20Vitamin%20D%20and%20Vitamin%20E%20%C2%B7%20Dr%20Rabia%20Arshad&badge=phase%201 Olanzapine and Vitamin D and Vitamin E Olanzapine and Vitamin D and Vitamin E · Dr Rabia Arshad https://druglandscape.com/drug/olanzapine-immediate-release https://druglandscape.com/api/og?type=drug&title=Olanzapine%20Immediate%20Release&subtitle=Olanzapine%20Immediate%20Release%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%20LLC&badge=phase%201 Olanzapine Immediate Release Olanzapine Immediate Release · Teva Branded Pharmaceutical Products R&D LLC https://druglandscape.com/drug/olanzapine-oral-formulation https://druglandscape.com/api/og?type=drug&title=Olanzapine%2C%20oral%20formulation&subtitle=Olanzapine%2C%20oral%20formulation%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Olanzapine, oral formulation Olanzapine, oral formulation · Janssen Research & Development, LLC https://druglandscape.com/drug/olanzapine-raim https://druglandscape.com/api/og?type=drug&title=olanzapine-RAIM&subtitle=olanzapine-RAIM%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 olanzapine-RAIM olanzapine-RAIM · Eli Lilly and Company https://druglandscape.com/drug/olaparib-177lu-dotatate https://druglandscape.com/api/og?type=drug&title=Olaparib%3B%20177Lu-DOTATATE&subtitle=Olaparib%3B%20177Lu-DOTATATE%20%C2%B7%20Fundaci%C3%B3n%20de%20investigaci%C3%B3n%20HM&badge=phase%202 Olaparib; 177Lu-DOTATATE Olaparib; 177Lu-DOTATATE · Fundación de investigación HM https://druglandscape.com/drug/olaparib-durvalumab-tremelimumab https://druglandscape.com/api/og?type=drug&title=olaparib%2C%20durvalumab%2C%20tremelimumab&subtitle=olaparib%2C%20durvalumab%2C%20tremelimumab%20%C2%B7%20Centre%20Georges%20Francois%20Leclerc&badge=phase%202 olaparib, durvalumab, tremelimumab olaparib, durvalumab, tremelimumab · Centre Georges Francois Leclerc https://druglandscape.com/drug/olaparib-tablet-dosing https://druglandscape.com/api/og?type=drug&title=Olaparib%20tablet%20dosing&subtitle=Olaparib%20tablet%20dosing%20%C2%B7%20AstraZeneca&badge=phase%201 Olaparib tablet dosing Olaparib tablet dosing · AstraZeneca https://druglandscape.com/drug/olaparib-tablets https://druglandscape.com/api/og?type=drug&title=Olaparib%20tablets&subtitle=Olaparib%20tablets%20%C2%B7%20AstraZeneca&badge=phase%202 Olaparib tablets Olaparib tablets · AstraZeneca https://druglandscape.com/drug/olaparib-treatment-a https://druglandscape.com/api/og?type=drug&title=Olaparib%20Treatment%20A&subtitle=Olaparib%20Treatment%20A%20%C2%B7%20AstraZeneca&badge=phase%201 Olaparib Treatment A Olaparib Treatment A · AstraZeneca https://druglandscape.com/drug/olaparib-treatment-c https://druglandscape.com/api/og?type=drug&title=Olaparib%20Treatment%20C&subtitle=Olaparib%20Treatment%20C%20%C2%B7%20AstraZeneca&badge=phase%201 Olaparib Treatment C Olaparib Treatment C · AstraZeneca https://druglandscape.com/drug/olaptesed-pegol-monotherapy https://druglandscape.com/api/og?type=drug&title=Olaptesed%20pegol%20-%20Monotherapy&subtitle=Olaptesed%20pegol%20-%20Monotherapy%20%C2%B7%20TME%20Pharma%20AG&badge=phase%201 Olaptesed pegol - Monotherapy Olaptesed pegol - Monotherapy · TME Pharma AG https://druglandscape.com/drug/olaratumab-and-trabectedin https://druglandscape.com/api/og?type=drug&title=Olaratumab%20and%20Trabectedin&subtitle=Olaratumab%20and%20Trabectedin%20%C2%B7%20Grupo%20Espanol%20de%20Investigacion%20en%20Sarcomas&badge=phase%201 Olaratumab and Trabectedin Olaratumab and Trabectedin · Grupo Espanol de Investigacion en Sarcomas https://druglandscape.com/drug/oln324 https://druglandscape.com/api/og?type=drug&title=OLN324&subtitle=OLN324%20%C2%B7%20Ollin%20Biosciences%2C%20Inc.&badge=phase%201 OLN324 OLN324 · Ollin Biosciences, Inc. https://druglandscape.com/drug/olostar-tab https://druglandscape.com/api/og?type=drug&title=Olostar%20Tab.&subtitle=Olostar%20Tab.%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 Olostar Tab. Olostar Tab. · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/olp-1002 https://druglandscape.com/api/og?type=drug&title=OLP-1002&subtitle=OLP-1002%20%C2%B7%20OliPass%20Corporation&badge=phase%202 OLP-1002 OLP-1002 · OliPass Corporation https://druglandscape.com/drug/olt1177-capsules https://druglandscape.com/api/og?type=drug&title=OLT1177%20Capsules&subtitle=OLT1177%20Capsules%20%C2%B7%20Olatec%20Therapeutics%20LLC&badge=phase%201 OLT1177 Capsules OLT1177 Capsules · Olatec Therapeutics LLC https://druglandscape.com/drug/olt1177-gel https://druglandscape.com/api/og?type=drug&title=OLT1177%20Gel&subtitle=OLT1177%20Gel%20%C2%B7%20Olatec%20Therapeutics%20LLC&badge=phase%202 OLT1177 Gel OLT1177 Gel · Olatec Therapeutics LLC https://druglandscape.com/drug/olumacostat-glasaretil-gel-7-5 https://druglandscape.com/api/og?type=drug&title=Olumacostat%20Glasaretil%20Gel%2C%207.5%25&subtitle=Olumacostat%20Glasaretil%20Gel%2C%207.5%25%20%C2%B7%20Dermira%2C%20Inc.&badge=phase%201 Olumacostat Glasaretil Gel, 7.5% Olumacostat Glasaretil Gel, 7.5% · Dermira, Inc. https://druglandscape.com/drug/olvi-vec https://druglandscape.com/api/og?type=drug&title=Olvi-Vec&subtitle=Olvi-Vec%20%C2%B7%20Newsoara%20HYK%20Biopharmaceutical%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 Olvi-Vec Olvi-Vec · Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd. https://druglandscape.com/drug/olx-07010-active https://druglandscape.com/api/og?type=drug&title=OLX-07010%20Active&subtitle=OLX-07010%20Active%20%C2%B7%20Oligomerix%2C%20Inc&badge=phase%201 OLX-07010 Active OLX-07010 Active · Oligomerix, Inc https://druglandscape.com/drug/olx10010 https://druglandscape.com/api/og?type=drug&title=OLX10010&subtitle=OLX10010%20%C2%B7%20Olix%20Pharmaceuticals%2C%20Inc.&badge=phase%202 OLX10010 OLX10010 · Olix Pharmaceuticals, Inc. https://druglandscape.com/drug/olx72021 https://druglandscape.com/api/og?type=drug&title=OLX72021&subtitle=OLX72021%20%C2%B7%20Olix%20Pharmaceuticals%2C%20Inc.&badge=phase%201 OLX72021 OLX72021 · Olix Pharmaceuticals, Inc. https://druglandscape.com/drug/om-85-in https://druglandscape.com/api/og?type=drug&title=OM-85-IN&subtitle=OM-85-IN%20%C2%B7%20OM%20Pharma%20SA&badge=phase%201 OM-85-IN OM-85-IN · OM Pharma SA https://druglandscape.com/drug/omadacycline-tablets https://druglandscape.com/api/og?type=drug&title=Omadacycline%20tablets&subtitle=Omadacycline%20tablets%20%C2%B7%20Paratek%20Pharmaceuticals%20Inc&badge=phase%202 Omadacycline tablets Omadacycline tablets · Paratek Pharmaceuticals Inc https://druglandscape.com/drug/omarco-and-crestor https://druglandscape.com/api/og?type=drug&title=Omarco%20and%20Crestor&subtitle=Omarco%20and%20Crestor%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 Omarco and Crestor Omarco and Crestor · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/omaveloxolone-lotion-0-5 https://druglandscape.com/api/og?type=drug&title=Omaveloxolone%20Lotion%200.5%25&subtitle=Omaveloxolone%20Lotion%200.5%25%20%C2%B7%20Biogen&badge=phase%202 Omaveloxolone Lotion 0.5% Omaveloxolone Lotion 0.5% · Biogen https://druglandscape.com/drug/omaveloxolone-lotion-3 https://druglandscape.com/api/og?type=drug&title=Omaveloxolone%20Lotion%203%25&subtitle=Omaveloxolone%20Lotion%203%25%20%C2%B7%20Biogen&badge=phase%202 Omaveloxolone Lotion 3% Omaveloxolone Lotion 3% · Biogen https://druglandscape.com/drug/omaveloxolone-ophthalmic-suspension-0-5 https://druglandscape.com/api/og?type=drug&title=Omaveloxolone%20Ophthalmic%20Suspension%200.5%25&subtitle=Omaveloxolone%20Ophthalmic%20Suspension%200.5%25%20%C2%B7%20Biogen&badge=phase%202 Omaveloxolone Ophthalmic Suspension 0.5% Omaveloxolone Ophthalmic Suspension 0.5% · Biogen https://druglandscape.com/drug/omaveloxolone-ophthalmic-suspension-1 https://druglandscape.com/api/og?type=drug&title=Omaveloxolone%20Ophthalmic%20Suspension%201%25&subtitle=Omaveloxolone%20Ophthalmic%20Suspension%201%25%20%C2%B7%20Biogen&badge=phase%202 Omaveloxolone Ophthalmic Suspension 1% Omaveloxolone Ophthalmic Suspension 1% · Biogen https://druglandscape.com/drug/omaveloxolone-ophthalmic-suspension-1-0 https://druglandscape.com/api/og?type=drug&title=Omaveloxolone%20Ophthalmic%20Suspension%201.0%25&subtitle=Omaveloxolone%20Ophthalmic%20Suspension%201.0%25%20%C2%B7%20Biogen&badge=phase%202 Omaveloxolone Ophthalmic Suspension 1.0% Omaveloxolone Ophthalmic Suspension 1.0% · Biogen https://druglandscape.com/drug/omaveloxolone-opthalmic-suspension-0-5 https://druglandscape.com/api/og?type=drug&title=Omaveloxolone%20Opthalmic%20Suspension%200.5%25&subtitle=Omaveloxolone%20Opthalmic%20Suspension%200.5%25%20%C2%B7%20Biogen&badge=phase%202 Omaveloxolone Opthalmic Suspension 0.5% Omaveloxolone Opthalmic Suspension 0.5% · Biogen https://druglandscape.com/drug/ombitasvir-mini-tablet https://druglandscape.com/api/og?type=drug&title=Ombitasvir%20mini%20tablet&subtitle=Ombitasvir%20mini%20tablet%20%C2%B7%20AbbVie&badge=phase%202 Ombitasvir mini tablet Ombitasvir mini tablet · AbbVie https://druglandscape.com/drug/omburtamab-i-131 https://druglandscape.com/api/og?type=drug&title=Omburtamab%20I-131&subtitle=Omburtamab%20I-131%20%C2%B7%20Pediatric%20Brain%20Tumor%20Consortium&badge=phase%202 Omburtamab I-131 Omburtamab I-131 · Pediatric Brain Tumor Consortium https://druglandscape.com/drug/omecamtiv-mecarbil-matrix-f1-formulation https://druglandscape.com/api/og?type=drug&title=Omecamtiv%20Mecarbil%20Matrix%20F1%20Formulation&subtitle=Omecamtiv%20Mecarbil%20Matrix%20F1%20Formulation%20%C2%B7%20Cytokinetics&badge=phase%202 Omecamtiv Mecarbil Matrix F1 Formulation Omecamtiv Mecarbil Matrix F1 Formulation · Cytokinetics https://druglandscape.com/drug/omecamtiv-mecarbil-matrix-f2-formulation https://druglandscape.com/api/og?type=drug&title=Omecamtiv%20Mecarbil%20Matrix%20F2%20Formulation&subtitle=Omecamtiv%20Mecarbil%20Matrix%20F2%20Formulation%20%C2%B7%20Cytokinetics&badge=phase%202 Omecamtiv Mecarbil Matrix F2 Formulation Omecamtiv Mecarbil Matrix F2 Formulation · Cytokinetics https://druglandscape.com/drug/omega-3-carboxylic-acid https://druglandscape.com/api/og?type=drug&title=Omega-3%20carboxylic%20acid&subtitle=Omega-3%20carboxylic%20acid%20%C2%B7%20AstraZeneca&badge=phase%202 Omega-3 carboxylic acid Omega-3 carboxylic acid · AstraZeneca https://druglandscape.com/drug/omega-3-efa-supplement https://druglandscape.com/api/og?type=drug&title=Omega-3%20EFA%20Supplement&subtitle=Omega-3%20EFA%20Supplement%20%C2%B7%20Asbell%2C%20Penny%2C%20M.D.&badge=phase%202 Omega-3 EFA Supplement Omega-3 EFA Supplement · Asbell, Penny, M.D. https://druglandscape.com/drug/omega-3-fatty-acid-supplement https://druglandscape.com/api/og?type=drug&title=Omega-3%20Fatty%20Acid%20Supplement&subtitle=Omega-3%20Fatty%20Acid%20Supplement%20%C2%B7%20Icahn%20School%20of%20Medicine%20at%20Mount%20Sinai&badge=phase%202 Omega-3 Fatty Acid Supplement Omega-3 Fatty Acid Supplement · Icahn School of Medicine at Mount Sinai https://druglandscape.com/drug/omega-3-pentaenoic-acid https://druglandscape.com/api/og?type=drug&title=Omega%203%20pentaenoic%20acid&subtitle=Omega%203%20pentaenoic%20acid%20%C2%B7%20Matinas%20BioPharma%20Nanotechnologies%2C%20Inc.&badge=phase%202 Omega 3 pentaenoic acid Omega 3 pentaenoic acid · Matinas BioPharma Nanotechnologies, Inc. https://druglandscape.com/drug/omega-dek https://druglandscape.com/api/og?type=drug&title=Omega-DEK&subtitle=Omega-DEK%20%C2%B7%20Claudia%20R.%20Morris&badge=phase%202 Omega-DEK Omega-DEK · Claudia R. Morris https://druglandscape.com/drug/omegaven-therapy https://druglandscape.com/api/og?type=drug&title=Omegaven%20Therapy&subtitle=Omegaven%20Therapy%20%C2%B7%20Amarnath%2C%20Rathna%2C%20M.D.&badge=phase%202 Omegaven Therapy Omegaven Therapy · Amarnath, Rathna, M.D. https://druglandscape.com/drug/omeprazole-and-bortezomib https://druglandscape.com/api/og?type=drug&title=omeprazole%20and%20bortezomib&subtitle=omeprazole%20and%20bortezomib%20%C2%B7%20Millennium%20Pharmaceuticals%2C%20Inc.&badge=phase%201 omeprazole and bortezomib omeprazole and bortezomib · Millennium Pharmaceuticals, Inc. https://druglandscape.com/drug/omeprazole-caffeine-flurbiprofen-rosiglitazone https://druglandscape.com/api/og?type=drug&title=omeprazole%2C%20caffeine%2C%20flurbiprofen%2C%20rosiglitazone&subtitle=omeprazole%2C%20caffeine%2C%20flurbiprofen%2C%20rosiglitazone%20%C2%B7%20GlaxoSmithKline&badge=phase%201 omeprazole, caffeine, flurbiprofen, rosiglitazone omeprazole, caffeine, flurbiprofen, rosiglitazone · GlaxoSmithKline https://druglandscape.com/drug/omeprazole-enteric-capsules https://druglandscape.com/api/og?type=drug&title=Omeprazole%20Enteric%20Capsules&subtitle=Omeprazole%20Enteric%20Capsules%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Omeprazole Enteric Capsules Omeprazole Enteric Capsules · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/omeprazole-enteric-coated-capsules https://druglandscape.com/api/og?type=drug&title=Omeprazole%20Enteric-coated%20Capsules&subtitle=Omeprazole%20Enteric-coated%20Capsules%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Omeprazole Enteric-coated Capsules Omeprazole Enteric-coated Capsules · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/omeprazole-pill https://druglandscape.com/api/og?type=drug&title=Omeprazole%20Pill&subtitle=Omeprazole%20Pill%20%C2%B7%20SK%20Life%20Science%2C%20Inc.&badge=phase%201 Omeprazole Pill Omeprazole Pill · SK Life Science, Inc. https://druglandscape.com/drug/omeprazole-tablet-dosing https://druglandscape.com/api/og?type=drug&title=Omeprazole%20tablet%20dosing&subtitle=Omeprazole%20tablet%20dosing%20%C2%B7%20AstraZeneca&badge=phase%201 Omeprazole tablet dosing Omeprazole tablet dosing · AstraZeneca https://druglandscape.com/drug/omexa-sublingual-sumatriptan-tablet https://druglandscape.com/api/og?type=drug&title=Omexa%20Sublingual%20Sumatriptan%20tablet&subtitle=Omexa%20Sublingual%20Sumatriptan%20tablet%20%C2%B7%20Targia%20Pharmaceuticals%20Ltd.&badge=phase%201 Omexa Sublingual Sumatriptan tablet Omexa Sublingual Sumatriptan tablet · Targia Pharmaceuticals Ltd. https://druglandscape.com/drug/omicron-vaccine https://druglandscape.com/api/og?type=drug&title=Omicron%20Vaccine&subtitle=Omicron%20Vaccine%20%C2%B7%20Pontificia%20Universidad%20Catolica%20de%20Chile&badge=phase%202 Omicron Vaccine Omicron Vaccine · Pontificia Universidad Catolica de Chile https://druglandscape.com/drug/omics-identity-card https://druglandscape.com/api/og?type=drug&title=omics%20identity%20card&subtitle=omics%20identity%20card%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 omics identity card omics identity card · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/omiganan-2-5-and-imiquimod https://druglandscape.com/api/og?type=drug&title=Omiganan%202.5%25%20and%20Imiquimod&subtitle=Omiganan%202.5%25%20and%20Imiquimod%20%C2%B7%20Maruho%20Co.%2C%20Ltd.&badge=phase%201 Omiganan 2.5% and Imiquimod Omiganan 2.5% and Imiquimod · Maruho Co., Ltd. https://druglandscape.com/drug/omix-ocas https://druglandscape.com/api/og?type=drug&title=Omix%20Ocas&subtitle=Omix%20Ocas%20%C2%B7%20GL%20Pharm%20Tech%20Corporation&badge=phase%201 Omix Ocas Omix Ocas · GL Pharm Tech Corporation https://druglandscape.com/drug/omn6 https://druglandscape.com/api/og?type=drug&title=OMN6&subtitle=OMN6%20%C2%B7%20Omnix%20Medical%20Ltd&badge=phase%202 OMN6 OMN6 · Omnix Medical Ltd https://druglandscape.com/drug/omnihib https://druglandscape.com/api/og?type=drug&title=OmniHIB&subtitle=OmniHIB%20%C2%B7%20GlaxoSmithKline&badge=phase%202 OmniHIB OmniHIB · GlaxoSmithKline https://druglandscape.com/drug/omnimmune https://druglandscape.com/api/og?type=drug&title=OmnImmune%C2%AE&subtitle=OmnImmune%C2%AE%20%C2%B7%20TC%20Biopharm&badge=phase%201 OmnImmune® OmnImmune® · TC Biopharm https://druglandscape.com/drug/omnimsc-ami https://druglandscape.com/api/og?type=drug&title=OmniMSC-AMI&subtitle=OmniMSC-AMI%20%C2%B7%20Taiwan%20Bio%20Therapeutics%20Inc.&badge=phase%201 OmniMSC-AMI OmniMSC-AMI · Taiwan Bio Therapeutics Inc. https://druglandscape.com/drug/omnitram-oral-tablet https://druglandscape.com/api/og?type=drug&title=Omnitram%20Oral%20Tablet&subtitle=Omnitram%20Oral%20Tablet%20%C2%B7%20Syntrix%20Biosystems%2C%20Inc.&badge=phase%202 Omnitram Oral Tablet Omnitram Oral Tablet · Syntrix Biosystems, Inc. https://druglandscape.com/drug/omo-103 https://druglandscape.com/api/og?type=drug&title=OMO-103&subtitle=OMO-103%20%C2%B7%20Peptomyc%20S.L.&badge=phase%202 OMO-103 OMO-103 · Peptomyc S.L. https://druglandscape.com/drug/omp-18r5 https://druglandscape.com/api/og?type=drug&title=OMP-18R5&subtitle=OMP-18R5%20%C2%B7%20OncoMed%20Pharmaceuticals%2C%20Inc.&badge=phase%201 OMP-18R5 OMP-18R5 · OncoMed Pharmaceuticals, Inc. https://druglandscape.com/drug/omp-21m18 https://druglandscape.com/api/og?type=drug&title=OMP-21M18&subtitle=OMP-21M18%20%C2%B7%20OncoMed%20Pharmaceuticals%2C%20Inc.&badge=phase%201 OMP-21M18 OMP-21M18 · OncoMed Pharmaceuticals, Inc. https://druglandscape.com/drug/omp-52m51 https://druglandscape.com/api/og?type=drug&title=OMP-52M51&subtitle=OMP-52M51%20%C2%B7%20OncoMed%20Pharmaceuticals%2C%20Inc.&badge=phase%201 OMP-52M51 OMP-52M51 · OncoMed Pharmaceuticals, Inc. https://druglandscape.com/drug/omp-54f28 https://druglandscape.com/api/og?type=drug&title=OMP-54F28&subtitle=OMP-54F28%20%C2%B7%20OncoMed%20Pharmaceuticals%2C%20Inc.&badge=phase%201 OMP-54F28 OMP-54F28 · OncoMed Pharmaceuticals, Inc. https://druglandscape.com/drug/omp-54f28-nab-paclitaxel-and-gemcitabine https://druglandscape.com/api/og?type=drug&title=OMP-54F28%2C%20Nab-Paclitaxel%20and%20Gemcitabine&subtitle=OMP-54F28%2C%20Nab-Paclitaxel%20and%20Gemcitabine%20%C2%B7%20OncoMed%20Pharmaceuticals%2C%20Inc.&badge=phase%201 OMP-54F28, Nab-Paclitaxel and Gemcitabine OMP-54F28, Nab-Paclitaxel and Gemcitabine · OncoMed Pharmaceuticals, Inc. https://druglandscape.com/drug/omp-54f28-paclitaxel-and-carboplatin https://druglandscape.com/api/og?type=drug&title=OMP-54F28%2C%20Paclitaxel%20and%20Carboplatin&subtitle=OMP-54F28%2C%20Paclitaxel%20and%20Carboplatin%20%C2%B7%20OncoMed%20Pharmaceuticals%2C%20Inc.&badge=phase%201 OMP-54F28, Paclitaxel and Carboplatin OMP-54F28, Paclitaxel and Carboplatin · OncoMed Pharmaceuticals, Inc. https://druglandscape.com/drug/omp-54f28-with-sorafenib https://druglandscape.com/api/og?type=drug&title=OMP-54F28%20with%20Sorafenib&subtitle=OMP-54F28%20with%20Sorafenib%20%C2%B7%20OncoMed%20Pharmaceuticals%2C%20Inc.&badge=phase%201 OMP-54F28 with Sorafenib OMP-54F28 with Sorafenib · OncoMed Pharmaceuticals, Inc. https://druglandscape.com/drug/omt-111 https://druglandscape.com/api/og?type=drug&title=OMT-111&subtitle=OMT-111%20%C2%B7%20MetiMedi%20Pharmaceuticals&badge=phase%202 OMT-111 OMT-111 · MetiMedi Pharmaceuticals https://druglandscape.com/drug/omt-28 https://druglandscape.com/api/og?type=drug&title=OMT-28&subtitle=OMT-28%20%C2%B7%20Omeicos%20Therapeutics%20GmbH&badge=phase%202 OMT-28 OMT-28 · Omeicos Therapeutics GmbH https://druglandscape.com/drug/omtx705 https://druglandscape.com/api/og?type=drug&title=OMTX705&subtitle=OMTX705%20%C2%B7%20Oncomatryx%20Biopharma%20S.L.&badge=phase%201 OMTX705 OMTX705 · Oncomatryx Biopharma S.L. https://druglandscape.com/drug/on-01910-na-and-irinotecan https://druglandscape.com/api/og?type=drug&title=ON%2001910.Na%20and%20irinotecan&subtitle=ON%2001910.Na%20and%20irinotecan%20%C2%B7%20Traws%20Pharma%2C%20Inc.&badge=phase%201 ON 01910.Na and irinotecan ON 01910.Na and irinotecan · Traws Pharma, Inc. https://druglandscape.com/drug/on-01910-na-and-oxaliplatin https://druglandscape.com/api/og?type=drug&title=ON%2001910.Na%20and%20oxaliplatin&subtitle=ON%2001910.Na%20and%20oxaliplatin%20%C2%B7%20Traws%20Pharma%2C%20Inc.&badge=phase%201 ON 01910.Na and oxaliplatin ON 01910.Na and oxaliplatin · Traws Pharma, Inc. https://druglandscape.com/drug/on-demand-nsaid-administration https://druglandscape.com/api/og?type=drug&title=On-Demand%20NSAID%20Administration&subtitle=On-Demand%20NSAID%20Administration%20%C2%B7%20Le%20Thi%20Kieu%20Trang&badge=phase%201 On-Demand NSAID Administration On-Demand NSAID Administration · Le Thi Kieu Trang https://druglandscape.com/drug/on-ibalizumab-treatment https://druglandscape.com/api/og?type=drug&title=On%20ibalizumab%20treatment&subtitle=On%20ibalizumab%20treatment%20%C2%B7%20Theratechnologies&badge=phase%202 On ibalizumab treatment On ibalizumab treatment · Theratechnologies https://druglandscape.com/drug/on-metformin https://druglandscape.com/api/og?type=drug&title=On%20Metformin&subtitle=On%20Metformin%20%C2%B7%20German%20Diabetes%20Center&badge=phase%201 On Metformin On Metformin · German Diabetes Center https://druglandscape.com/drug/on123300 https://druglandscape.com/api/og?type=drug&title=ON123300&subtitle=ON123300%20%C2%B7%20Traws%20Pharma%2C%20Inc.&badge=phase%201 ON123300 ON123300 · Traws Pharma, Inc. https://druglandscape.com/drug/onabotulinumtoxina-and-hydrogel-admixture https://druglandscape.com/api/og?type=drug&title=OnabotulinumtoxinA%20and%20Hydrogel%20admixture&subtitle=OnabotulinumtoxinA%20and%20Hydrogel%20admixture%20%C2%B7%20Allergan&badge=phase%202 OnabotulinumtoxinA and Hydrogel admixture OnabotulinumtoxinA and Hydrogel admixture · Allergan https://druglandscape.com/drug/onabotulinumtoxina-at-a-depth-of-2mm https://druglandscape.com/api/og?type=drug&title=onabotulinumtoxinA%20at%20a%20depth%20of%202mm&subtitle=onabotulinumtoxinA%20at%20a%20depth%20of%202mm%20%C2%B7%20Henry%20Ford%20Health%20System&badge=phase%201 onabotulinumtoxinA at a depth of 2mm onabotulinumtoxinA at a depth of 2mm · Henry Ford Health System https://druglandscape.com/drug/onabotulinumtoxina-at-a-depth-of-4mm https://druglandscape.com/api/og?type=drug&title=onabotulinumtoxinA%20at%20a%20depth%20of%204mm&subtitle=onabotulinumtoxinA%20at%20a%20depth%20of%204mm%20%C2%B7%20Henry%20Ford%20Health%20System&badge=phase%201 onabotulinumtoxinA at a depth of 4mm onabotulinumtoxinA at a depth of 4mm · Henry Ford Health System https://druglandscape.com/drug/onabotulinumtoxina-x https://druglandscape.com/api/og?type=drug&title=OnabotulinumtoxinA%20X&subtitle=OnabotulinumtoxinA%20X%20%C2%B7%20Allergan&badge=phase%202 OnabotulinumtoxinA X OnabotulinumtoxinA X · Allergan https://druglandscape.com/drug/onc-392-high https://druglandscape.com/api/og?type=drug&title=ONC-392%20high&subtitle=ONC-392%20high%20%C2%B7%20OncoC4%2C%20Inc.&badge=phase%201 ONC-392 high ONC-392 high · OncoC4, Inc. https://druglandscape.com/drug/onc-392-low https://druglandscape.com/api/og?type=drug&title=ONC-392%20low&subtitle=ONC-392%20low%20%C2%B7%20OncoC4%2C%20Inc.&badge=phase%201 ONC-392 low ONC-392 low · OncoC4, Inc. https://druglandscape.com/drug/onc-783 https://druglandscape.com/api/og?type=drug&title=ONC-783&subtitle=ONC-783%20%C2%B7%20OncoC4%2C%20Inc.&badge=phase%201 ONC-783 ONC-783 · OncoC4, Inc. https://druglandscape.com/drug/onc-841 https://druglandscape.com/api/og?type=drug&title=ONC-841&subtitle=ONC-841%20%C2%B7%20OncoC4%2C%20Inc.&badge=phase%201 ONC-841 ONC-841 · OncoC4, Inc. https://druglandscape.com/drug/onc1-0013b https://druglandscape.com/api/og?type=drug&title=ONC1-0013B&subtitle=ONC1-0013B%20%C2%B7%20Avionco%20LLC&badge=phase%201 ONC1-0013B ONC1-0013B · Avionco LLC https://druglandscape.com/drug/onc206 https://druglandscape.com/api/og?type=drug&title=ONC206&subtitle=ONC206%20%C2%B7%20Sabine%20Mueller%2C%20MD%2C%20PhD&badge=phase%202 ONC206 ONC206 · Sabine Mueller, MD, PhD https://druglandscape.com/drug/oncocare https://druglandscape.com/api/og?type=drug&title=OncoCare&subtitle=OncoCare%20%C2%B7%20MyGenostics%20Inc.%2C%20Beijing&badge=phase%201 OncoCare OncoCare · MyGenostics Inc., Beijing https://druglandscape.com/drug/oncofid-p-b https://druglandscape.com/api/og?type=drug&title=Oncofid-P-B&subtitle=Oncofid-P-B%20%C2%B7%20Fidia%20Farmaceutici%20s.p.a.&badge=phase%202 Oncofid-P-B Oncofid-P-B · Fidia Farmaceutici s.p.a. https://druglandscape.com/drug/oncoquest-cll-vaccine https://druglandscape.com/api/og?type=drug&title=Oncoquest-CLL%20vaccine&subtitle=Oncoquest-CLL%20vaccine%20%C2%B7%20XEME%20Biopharma%20Inc.&badge=phase%201 Oncoquest-CLL vaccine Oncoquest-CLL vaccine · XEME Biopharma Inc. https://druglandscape.com/drug/oncoquest-l-vaccine https://druglandscape.com/api/og?type=drug&title=Oncoquest-L%20vaccine&subtitle=Oncoquest-L%20vaccine%20%C2%B7%20XEME%20Biopharma%20Inc.&badge=phase%202 Oncoquest-L vaccine Oncoquest-L vaccine · XEME Biopharma Inc. https://druglandscape.com/drug/ondansetron-marketed-formulation https://druglandscape.com/api/og?type=drug&title=ondansetron%20marketed%20formulation&subtitle=ondansetron%20marketed%20formulation%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 ondansetron marketed formulation ondansetron marketed formulation · Merck Sharp & Dohme LLC https://druglandscape.com/drug/ondansetron-oral-membrane https://druglandscape.com/api/og?type=drug&title=Ondansetron%20oral%20membrane&subtitle=Ondansetron%20oral%20membrane%20%C2%B7%20Shanghai%20Children's%20Medical%20Center&badge=phase%201 Ondansetron oral membrane Ondansetron oral membrane · Shanghai Children's Medical Center https://druglandscape.com/drug/ondansetron-with1-1-ora-sweet https://druglandscape.com/api/og?type=drug&title=Ondansetron%20with1%3A1%20ORA%20-%20sweet.&subtitle=Ondansetron%20with1%3A1%20ORA%20-%20sweet.%20%C2%B7%20Hamad%20Medical%20Corporation&badge=phase%201 Ondansetron with1:1 ORA - sweet. Ondansetron with1:1 ORA - sweet. · Hamad Medical Corporation https://druglandscape.com/drug/one-dose-diclofenac https://druglandscape.com/api/og?type=drug&title=One%20dose%20Diclofenac&subtitle=One%20dose%20Diclofenac%20%C2%B7%20Universidad%20Autonoma%20de%20Baja%20California&badge=phase%201 One dose Diclofenac One dose Diclofenac · Universidad Autonoma de Baja California https://druglandscape.com/drug/one-dose-of-control-vaccine https://druglandscape.com/api/og?type=drug&title=One%20dose%20of%20control%20vaccine&subtitle=One%20dose%20of%20control%20vaccine%20%C2%B7%20Sinovac%20Biotech%20Co.%2C%20Ltd&badge=phase%201 One dose of control vaccine One dose of control vaccine · Sinovac Biotech Co., Ltd https://druglandscape.com/drug/one-dose-of-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=one%20dose%20of%20Influenza%20Vaccine&subtitle=one%20dose%20of%20Influenza%20Vaccine%20%C2%B7%20Beijing%20Chaoyang%20District%20Centre%20for%20Disease%20Control%20and%20Prevention&badge=phase%201 one dose of Influenza Vaccine one dose of Influenza Vaccine · Beijing Chaoyang District Centre for Disease Control and Prevention https://druglandscape.com/drug/one-dose-of-investigational-vaccine https://druglandscape.com/api/og?type=drug&title=One%20dose%20of%20investigational%20vaccine&subtitle=One%20dose%20of%20investigational%20vaccine%20%C2%B7%20Sinovac%20Biotech%20Co.%2C%20Ltd&badge=phase%201 One dose of investigational vaccine One dose of investigational vaccine · Sinovac Biotech Co., Ltd https://druglandscape.com/drug/one-dose-of-pcv13a-vaccine https://druglandscape.com/api/og?type=drug&title=One%20dose%20of%20PCV13a%20vaccine&subtitle=One%20dose%20of%20PCV13a%20vaccine%20%C2%B7%20Beijing%20Chaoyang%20District%20Centre%20for%20Disease%20Control%20and%20Prevention&badge=phase%201 One dose of PCV13a vaccine One dose of PCV13a vaccine · Beijing Chaoyang District Centre for Disease Control and Prevention https://druglandscape.com/drug/one-im-injection-lenti-hpv-07 https://druglandscape.com/api/og?type=drug&title=One%20IM%20injection%20Lenti-HPV-07&subtitle=One%20IM%20injection%20Lenti-HPV-07%20%C2%B7%20Theravectys%20S.A.&badge=phase%201 One IM injection Lenti-HPV-07 One IM injection Lenti-HPV-07 · Theravectys S.A. https://druglandscape.com/drug/one-pomx-capsule-daily https://druglandscape.com/api/og?type=drug&title=One%20POMx%20capsule%20daily&subtitle=One%20POMx%20capsule%20daily%20%C2%B7%20POM%20Wonderful%20LLC&badge=phase%202 One POMx capsule daily One POMx capsule daily · POM Wonderful LLC https://druglandscape.com/drug/onkord https://druglandscape.com/api/og?type=drug&title=oNKord%C2%AE&subtitle=oNKord%C2%AE%20%C2%B7%20Glycostem%20Therapeutics%20BV&badge=phase%202 oNKord® oNKord® · Glycostem Therapeutics BV https://druglandscape.com/drug/onl1204 https://druglandscape.com/api/og?type=drug&title=ONL1204&subtitle=ONL1204%20%C2%B7%20ONL%20Therapeutics&badge=phase%201 ONL1204 ONL1204 · ONL Therapeutics https://druglandscape.com/drug/onl1204-opthalmic-solution https://druglandscape.com/api/og?type=drug&title=ONL1204%20Opthalmic%20solution&subtitle=ONL1204%20Opthalmic%20solution%20%C2%B7%20ONL%20Therapeutics&badge=phase%202 ONL1204 Opthalmic solution ONL1204 Opthalmic solution · ONL Therapeutics https://druglandscape.com/drug/onlife https://druglandscape.com/api/og?type=drug&title=OnLife%C2%AE&subtitle=OnLife%C2%AE%20%C2%B7%20Centre%20Georges%20Francois%20Leclerc&badge=phase%202 OnLife® OnLife® · Centre Georges Francois Leclerc https://druglandscape.com/drug/only-chemotherapy https://druglandscape.com/api/og?type=drug&title=only%20chemotherapy&subtitle=only%20chemotherapy%20%C2%B7%20CONKO-Studiengruppe&badge=phase%202 only chemotherapy only chemotherapy · CONKO-Studiengruppe https://druglandscape.com/drug/only-emla-cream https://druglandscape.com/api/og?type=drug&title=Only%20EMLA%20cream&subtitle=Only%20EMLA%20cream%20%C2%B7%20IRCCS%20Burlo%20Garofolo&badge=phase%201 Only EMLA cream Only EMLA cream · IRCCS Burlo Garofolo https://druglandscape.com/drug/only-standard-treatment https://druglandscape.com/api/og?type=drug&title=Only%20Standard%20Treatment&subtitle=Only%20Standard%20Treatment%20%C2%B7%20Bangladesh%20Medical%20Research%20Council%20(BMRC)&badge=phase%202 Only Standard Treatment Only Standard Treatment · Bangladesh Medical Research Council (BMRC) https://druglandscape.com/drug/onm-100 https://druglandscape.com/api/og?type=drug&title=ONM-100&subtitle=ONM-100%20%C2%B7%20OncoNano%20Medicine%2C%20Inc.&badge=phase%202 ONM-100 ONM-100 · OncoNano Medicine, Inc. https://druglandscape.com/drug/onm-501 https://druglandscape.com/api/og?type=drug&title=ONM-501&subtitle=ONM-501%20%C2%B7%20OncoNano%20Medicine%2C%20Inc.&badge=phase%201 ONM-501 ONM-501 · OncoNano Medicine, Inc. https://druglandscape.com/drug/ono-1110 https://druglandscape.com/api/og?type=drug&title=ONO-1110&subtitle=ONO-1110%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%202 ONO-1110 ONO-1110 · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-2020 https://druglandscape.com/api/og?type=drug&title=ONO-2020&subtitle=ONO-2020%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%202 ONO-2020 ONO-2020 · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-2333ms-experimental-1 https://druglandscape.com/api/og?type=drug&title=ONO-2333Ms%20Experimental%201&subtitle=ONO-2333Ms%20Experimental%201%20%C2%B7%20Ono%20Pharma%20USA%20Inc&badge=phase%202 ONO-2333Ms Experimental 1 ONO-2333Ms Experimental 1 · Ono Pharma USA Inc https://druglandscape.com/drug/ono-2333ms-experimental-2 https://druglandscape.com/api/og?type=drug&title=ONO-2333Ms%20Experimental%202&subtitle=ONO-2333Ms%20Experimental%202%20%C2%B7%20Ono%20Pharma%20USA%20Inc&badge=phase%202 ONO-2333Ms Experimental 2 ONO-2333Ms Experimental 2 · Ono Pharma USA Inc https://druglandscape.com/drug/ono-2506po https://druglandscape.com/api/og?type=drug&title=ONO-2506PO&subtitle=ONO-2506PO%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%202 ONO-2506PO ONO-2506PO · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-2808 https://druglandscape.com/api/og?type=drug&title=ONO-2808&subtitle=ONO-2808%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%202 ONO-2808 ONO-2808 · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-4474-part-a1 https://druglandscape.com/api/og?type=drug&title=ONO-4474%20Part%20A1&subtitle=ONO-4474%20Part%20A1%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 ONO-4474 Part A1 ONO-4474 Part A1 · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-4474-part-a2 https://druglandscape.com/api/og?type=drug&title=ONO-4474%20Part%20A2&subtitle=ONO-4474%20Part%20A2%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 ONO-4474 Part A2 ONO-4474 Part A2 · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-4474-part-b https://druglandscape.com/api/og?type=drug&title=ONO-4474%20Part%20B&subtitle=ONO-4474%20Part%20B%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 ONO-4474 Part B ONO-4474 Part B · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-4474-part-c https://druglandscape.com/api/og?type=drug&title=ONO-4474%20Part%20C&subtitle=ONO-4474%20Part%20C%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 ONO-4474 Part C ONO-4474 Part C · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-4474-part-d https://druglandscape.com/api/og?type=drug&title=ONO-4474%20Part%20D&subtitle=ONO-4474%20Part%20D%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 ONO-4474 Part D ONO-4474 Part D · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-4538hsc https://druglandscape.com/api/og?type=drug&title=ONO-4538HSC&subtitle=ONO-4538HSC%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 ONO-4538HSC ONO-4538HSC · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-4578 https://druglandscape.com/api/og?type=drug&title=ONO-4578&subtitle=ONO-4578%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%202 ONO-4578 ONO-4578 · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-4685 https://druglandscape.com/api/og?type=drug&title=ONO-4685&subtitle=ONO-4685%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 ONO-4685 ONO-4685 · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-5046na https://druglandscape.com/api/og?type=drug&title=ONO-5046Na&subtitle=ONO-5046Na%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%202 ONO-5046Na ONO-5046Na · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-5129 https://druglandscape.com/api/og?type=drug&title=ONO-5129&subtitle=ONO-5129%20%C2%B7%20Ono%20Pharma%20USA%20Inc&badge=phase%202 ONO-5129 ONO-5129 · Ono Pharma USA Inc https://druglandscape.com/drug/ono-6950 https://druglandscape.com/api/og?type=drug&title=ONO-6950&subtitle=ONO-6950%20%C2%B7%20Ono%20Pharma%20USA%20Inc&badge=phase%202 ONO-6950 ONO-6950 · Ono Pharma USA Inc https://druglandscape.com/drug/ono-7018 https://druglandscape.com/api/og?type=drug&title=ONO-7018&subtitle=ONO-7018%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 ONO-7018 ONO-7018 · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-7428 https://druglandscape.com/api/og?type=drug&title=ONO-7428&subtitle=ONO-7428%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 ONO-7428 ONO-7428 · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-7436 https://druglandscape.com/api/og?type=drug&title=ONO-7436&subtitle=ONO-7436%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%202 ONO-7436 ONO-7436 · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-7913 https://druglandscape.com/api/og?type=drug&title=ONO-7913&subtitle=ONO-7913%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 ONO-7913 ONO-7913 · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-8577 https://druglandscape.com/api/og?type=drug&title=ONO-8577&subtitle=ONO-8577%20%C2%B7%20Ono%20Pharmaceutical%20Co.%20Ltd&badge=phase%202 ONO-8577 ONO-8577 · Ono Pharmaceutical Co. Ltd https://druglandscape.com/drug/ono-9054 https://druglandscape.com/api/og?type=drug&title=ONO-9054&subtitle=ONO-9054%20%C2%B7%20Ono%20Pharma%20USA%20Inc&badge=phase%202 ONO-9054 ONO-9054 · Ono Pharma USA Inc https://druglandscape.com/drug/ono-ldl50 https://druglandscape.com/api/og?type=drug&title=ONO%20LDL50&subtitle=ONO%20LDL50%20%C2%B7%20AOP%20Orphan%20Pharmaceuticals%20AG&badge=phase%201 ONO LDL50 ONO LDL50 · AOP Orphan Pharmaceuticals AG https://druglandscape.com/drug/ont-10 https://druglandscape.com/api/og?type=drug&title=ONT-10&subtitle=ONT-10%20%C2%B7%20Cascadian%20Therapeutics%20Inc.&badge=phase%201 ONT-10 ONT-10 · Cascadian Therapeutics Inc. https://druglandscape.com/drug/ont-10-varlilumab-combination https://druglandscape.com/api/og?type=drug&title=ONT-10%2C%20Varlilumab%20combination&subtitle=ONT-10%2C%20Varlilumab%20combination%20%C2%B7%20Cascadian%20Therapeutics%20Inc.&badge=phase%201 ONT-10, Varlilumab combination ONT-10, Varlilumab combination · Cascadian Therapeutics Inc. https://druglandscape.com/drug/oos-amtagvi https://druglandscape.com/api/og?type=drug&title=OOS%20AMTAGVI&subtitle=OOS%20AMTAGVI%20%C2%B7%20Iovance%20Biotherapeutics%2C%20Inc.&badge=phase%202 OOS AMTAGVI OOS AMTAGVI · Iovance Biotherapeutics, Inc. https://druglandscape.com/drug/op-1250 https://druglandscape.com/api/og?type=drug&title=OP-1250&subtitle=OP-1250%20%C2%B7%20Olema%20Pharmaceuticals%2C%20Inc.&badge=phase%201 OP-1250 OP-1250 · Olema Pharmaceuticals, Inc. https://druglandscape.com/drug/op-3136 https://druglandscape.com/api/og?type=drug&title=OP-3136&subtitle=OP-3136%20%C2%B7%20Olema%20Pharmaceuticals%2C%20Inc.&badge=phase%201 OP-3136 OP-3136 · Olema Pharmaceuticals, Inc. https://druglandscape.com/drug/op-724 https://druglandscape.com/api/og?type=drug&title=OP-724&subtitle=OP-724%20%C2%B7%20Kiminori%20Kimura%2C%20MD&badge=phase%201 OP-724 OP-724 · Kiminori Kimura, MD https://druglandscape.com/drug/op0595 https://druglandscape.com/api/og?type=drug&title=OP0595&subtitle=OP0595%20%C2%B7%20Meiji%20Seika%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 OP0595 OP0595 · Meiji Seika Pharma Co., Ltd. https://druglandscape.com/drug/opa-6566 https://druglandscape.com/api/og?type=drug&title=OPA-6566&subtitle=OPA-6566%20%C2%B7%20Kubota%20Vision%20Inc.&badge=phase%201 OPA-6566 OPA-6566 · Kubota Vision Inc. https://druglandscape.com/drug/opb-101 https://druglandscape.com/api/og?type=drug&title=OPB-101&subtitle=OPB-101%20%C2%B7%20Outpace%20Bio%2C%20Inc.&badge=phase%201 OPB-101 OPB-101 · Outpace Bio, Inc. https://druglandscape.com/drug/opb-111077 https://druglandscape.com/api/og?type=drug&title=OPB-111077&subtitle=OPB-111077%20%C2%B7%20Otsuka%20Pharmaceutical%20Development%20%26%20Commercialization%2C%20Inc.&badge=phase%202 OPB-111077 OPB-111077 · Otsuka Pharmaceutical Development & Commercialization, Inc. https://druglandscape.com/drug/opb-31121-phase2 https://druglandscape.com/api/og?type=drug&title=OPB-31121%20phase2&subtitle=OPB-31121%20phase2%20%C2%B7%20Otsuka%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 OPB-31121 phase2 OPB-31121 phase2 · Otsuka Pharmaceutical Co., Ltd. https://druglandscape.com/drug/opc-131461 https://druglandscape.com/api/og?type=drug&title=OPC-131461&subtitle=OPC-131461%20%C2%B7%20Otsuka%20Pharmaceutical%20Development%20%26%20Commercialization%2C%20Inc.&badge=phase%202 OPC-131461 OPC-131461 · Otsuka Pharmaceutical Development & Commercialization, Inc. https://druglandscape.com/drug/opc-14597-imd https://druglandscape.com/api/og?type=drug&title=OPC-14597%20IMD&subtitle=OPC-14597%20IMD%20%C2%B7%20Otsuka%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 OPC-14597 IMD OPC-14597 IMD · Otsuka Pharmaceutical Co., Ltd. https://druglandscape.com/drug/opc-18 https://druglandscape.com/api/og?type=drug&title=OPC-18&subtitle=OPC-18%20%C2%B7%20Otsuka%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 OPC-18 OPC-18 · Otsuka Pharmaceutical Co., Ltd. https://druglandscape.com/drug/opc-214870 https://druglandscape.com/api/og?type=drug&title=OPC-214870&subtitle=OPC-214870%20%C2%B7%20Otsuka%20Pharmaceutical%20Development%20%26%20Commercialization%2C%20Inc.&badge=phase%201 OPC-214870 OPC-214870 · Otsuka Pharmaceutical Development & Commercialization, Inc. https://druglandscape.com/drug/opc-249 https://druglandscape.com/api/og?type=drug&title=OPC-249&subtitle=OPC-249%20%C2%B7%20Otsuka%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 OPC-249 OPC-249 · Otsuka Pharmaceutical Co., Ltd. https://druglandscape.com/drug/opc-415 https://druglandscape.com/api/og?type=drug&title=OPC-415&subtitle=OPC-415%20%C2%B7%20Otsuka%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 OPC-415 OPC-415 · Otsuka Pharmaceutical Co., Ltd. https://druglandscape.com/drug/opc-64005 https://druglandscape.com/api/og?type=drug&title=OPC-64005&subtitle=OPC-64005%20%C2%B7%20Otsuka%20Pharmaceutical%20Development%20%26%20Commercialization%2C%20Inc.&badge=phase%202 OPC-64005 OPC-64005 · Otsuka Pharmaceutical Development & Commercialization, Inc. https://druglandscape.com/drug/opc1 https://druglandscape.com/api/og?type=drug&title=OPC1&subtitle=OPC1%20%C2%B7%20Lineage%20Cell%20Therapeutics%2C%20Inc.&badge=phase%201 OPC1 OPC1 · Lineage Cell Therapeutics, Inc. https://druglandscape.com/drug/opct-001 https://druglandscape.com/api/og?type=drug&title=OpCT-001&subtitle=OpCT-001%20%C2%B7%20BlueRock%20Therapeutics&badge=phase%201 OpCT-001 OpCT-001 · BlueRock Therapeutics https://druglandscape.com/drug/opdc-34712 https://druglandscape.com/api/og?type=drug&title=OPDC-34712&subtitle=OPDC-34712%20%C2%B7%20Otsuka%20Pharmaceutical%20Development%20%26%20Commercialization%2C%20Inc.&badge=phase%202 OPDC-34712 OPDC-34712 · Otsuka Pharmaceutical Development & Commercialization, Inc. https://druglandscape.com/drug/opdivo-injectable-product https://druglandscape.com/api/og?type=drug&title=Opdivo%20Injectable%20Product&subtitle=Opdivo%20Injectable%20Product%20%C2%B7%20Rampart%20Health%2C%20L.L.C.&badge=phase%202 Opdivo Injectable Product Opdivo Injectable Product · Rampart Health, L.L.C. https://druglandscape.com/drug/open-label-cbp-307 https://druglandscape.com/api/og?type=drug&title=Open-label%20CBP-307&subtitle=Open-label%20CBP-307%20%C2%B7%20Connect%20Biopharm%20LLC&badge=phase%202 Open-label CBP-307 Open-label CBP-307 · Connect Biopharm LLC https://druglandscape.com/drug/open-label-lam-003 https://druglandscape.com/api/og?type=drug&title=Open%20Label%20LAM-003&subtitle=Open%20Label%20LAM-003%20%C2%B7%20OrphAI%20Therapeutics&badge=phase%201 Open Label LAM-003 Open Label LAM-003 · OrphAI Therapeutics https://druglandscape.com/drug/open-label-tenofovir-tablet https://druglandscape.com/api/og?type=drug&title=Open%20label%20tenofovir%20tablet&subtitle=Open%20label%20tenofovir%20tablet%20%C2%B7%20CONRAD&badge=phase%201 Open label tenofovir tablet Open label tenofovir tablet · CONRAD https://druglandscape.com/drug/open-label-treatment-access-maraviroc https://druglandscape.com/api/og?type=drug&title=Open%20Label%20Treatment%20Access%3A%20Maraviroc&subtitle=Open%20Label%20Treatment%20Access%3A%20Maraviroc%20%C2%B7%20ViiV%20Healthcare&badge=phase%202 Open Label Treatment Access: Maraviroc Open Label Treatment Access: Maraviroc · ViiV Healthcare https://druglandscape.com/drug/open-labeled https://druglandscape.com/api/og?type=drug&title=Open%20labeled&subtitle=Open%20labeled%20%C2%B7%20Clinica%20Universidad%20de%20Navarra%2C%20Universidad%20de%20Navarra&badge=phase%202 Open labeled Open labeled · Clinica Universidad de Navarra, Universidad de Navarra https://druglandscape.com/drug/opiate-based-pain-regimen https://druglandscape.com/api/og?type=drug&title=Opiate%20based%20pain%20regimen.&subtitle=Opiate%20based%20pain%20regimen.%20%C2%B7%20Inova%20Health%20Care%20Services&badge=phase%202 Opiate based pain regimen. Opiate based pain regimen. · Inova Health Care Services https://druglandscape.com/drug/opiate-with-bolus https://druglandscape.com/api/og?type=drug&title=opiate%20with%20bolus&subtitle=opiate%20with%20bolus%20%C2%B7%20Swiss%20Paraplegic%20Research%2C%20Nottwil&badge=phase%202 opiate with bolus opiate with bolus · Swiss Paraplegic Research, Nottwil https://druglandscape.com/drug/opiates-exposure-treated-with-bpn https://druglandscape.com/api/og?type=drug&title=Opiates%20exposure%20treated%20with%20BPN&subtitle=Opiates%20exposure%20treated%20with%20BPN%20%C2%B7%20Gauda%2C%20Estelle%20B.%2C%20M.D.&badge=phase%201 Opiates exposure treated with BPN Opiates exposure treated with BPN · Gauda, Estelle B., M.D. https://druglandscape.com/drug/opioid-analgesics https://druglandscape.com/api/og?type=drug&title=Opioid%20Analgesics&subtitle=Opioid%20Analgesics%20%C2%B7%20VA%20Office%20of%20Research%20and%20Development&badge=phase%202 Opioid Analgesics Opioid Analgesics · VA Office of Research and Development https://druglandscape.com/drug/opioid-receptor-kappa-antagonist https://druglandscape.com/api/og?type=drug&title=opioid%20receptor%20kappa%20antagonist&subtitle=opioid%20receptor%20kappa%20antagonist%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 opioid receptor kappa antagonist opioid receptor kappa antagonist · Eli Lilly and Company https://druglandscape.com/drug/opk-88003 https://druglandscape.com/api/og?type=drug&title=OPK-88003&subtitle=OPK-88003%20%C2%B7%20OPKO%20Health%2C%20Inc.&badge=phase%202 OPK-88003 OPK-88003 · OPKO Health, Inc. https://druglandscape.com/drug/opl-002 https://druglandscape.com/api/og?type=drug&title=OPL-002&subtitle=OPL-002%20%C2%B7%20Oppilan%20Pharma%20Ltd&badge=phase%201 OPL-002 OPL-002 · Oppilan Pharma Ltd https://druglandscape.com/drug/opl-0401-dose-1 https://druglandscape.com/api/og?type=drug&title=OPL-0401%20Dose%201&subtitle=OPL-0401%20Dose%201%20%C2%B7%20Valo%20Health%2C%20Inc.&badge=phase%202 OPL-0401 Dose 1 OPL-0401 Dose 1 · Valo Health, Inc. https://druglandscape.com/drug/opm-101 https://druglandscape.com/api/og?type=drug&title=OPM-101&subtitle=OPM-101%20%C2%B7%20Oncodesign%20Precision%20Medicine&badge=phase%201 OPM-101 OPM-101 · Oncodesign Precision Medicine https://druglandscape.com/drug/opn-305 https://druglandscape.com/api/og?type=drug&title=OPN-305&subtitle=OPN-305%20%C2%B7%20Opsona%20Therapeutics%20Ltd.&badge=phase%202 OPN-305 OPN-305 · Opsona Therapeutics Ltd. https://druglandscape.com/drug/opregen https://druglandscape.com/api/og?type=drug&title=OpRegen&subtitle=OpRegen%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 OpRegen OpRegen · Genentech, Inc. https://druglandscape.com/drug/oprx-106 https://druglandscape.com/api/og?type=drug&title=OPRX-106&subtitle=OPRX-106%20%C2%B7%20Protalix&badge=phase%202 OPRX-106 OPRX-106 · Protalix https://druglandscape.com/drug/opscf https://druglandscape.com/api/og?type=drug&title=OpSCF&subtitle=OpSCF%20%C2%B7%20Opsidio%2C%20LLC&badge=phase%202 OpSCF OpSCF · Opsidio, LLC https://druglandscape.com/drug/opt-821 https://druglandscape.com/api/og?type=drug&title=OPT-821&subtitle=OPT-821%20%C2%B7%20MabVax%20Therapeutics%2C%20Inc.&badge=phase%202 OPT-821 OPT-821 · MabVax Therapeutics, Inc. https://druglandscape.com/drug/opt101 https://druglandscape.com/api/og?type=drug&title=OPT101&subtitle=OPT101%20%C2%B7%20Op-T%20LLC&badge=phase%202 OPT101 OPT101 · Op-T LLC https://druglandscape.com/drug/optimark https://druglandscape.com/api/og?type=drug&title=Optimark%C2%AE&subtitle=Optimark%C2%AE%20%C2%B7%20Daniel%20S.%20Berman&badge=phase%201 Optimark® Optimark® · Daniel S. Berman https://druglandscape.com/drug/optimized-background-arv-therapy https://druglandscape.com/api/og?type=drug&title=Optimized%20background%20ARV%20therapy&subtitle=Optimized%20background%20ARV%20therapy%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Optimized background ARV therapy Optimized background ARV therapy · Hoffmann-La Roche https://druglandscape.com/drug/optimized-background-arvs https://druglandscape.com/api/og?type=drug&title=Optimized%20Background%20ARVs&subtitle=Optimized%20Background%20ARVs%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Optimized Background ARVs Optimized Background ARVs · Hoffmann-La Roche https://druglandscape.com/drug/optimized-background-therapy https://druglandscape.com/api/og?type=drug&title=optimized%20background%20therapy&subtitle=optimized%20background%20therapy%20%C2%B7%20ViiV%20Healthcare&badge=phase%202 optimized background therapy optimized background therapy · ViiV Healthcare https://druglandscape.com/drug/optimized-mmc https://druglandscape.com/api/og?type=drug&title=optimized%20MMC&subtitle=optimized%20MMC%20%C2%B7%20Turku%20University%20Hospital&badge=phase%203 optimized MMC optimized MMC · Turku University Hospital https://druglandscape.com/drug/optimized-prophylactic-im-therapy https://druglandscape.com/api/og?type=drug&title=Optimized%20Prophylactic%20IM%20Therapy&subtitle=Optimized%20Prophylactic%20IM%20Therapy%20%C2%B7%20Ultragenyx%20Pharmaceutical%20Inc&badge=phase%202 Optimized Prophylactic IM Therapy Optimized Prophylactic IM Therapy · Ultragenyx Pharmaceutical Inc https://druglandscape.com/drug/optimized-tcs-treatment https://druglandscape.com/api/og?type=drug&title=Optimized%20TCS%20treatment&subtitle=Optimized%20TCS%20treatment%20%C2%B7%20Association%20pour%20la%20Recherche%20Clinique%20et%20Immunologique&badge=phase%201 Optimized TCS treatment Optimized TCS treatment · Association pour la Recherche Clinique et Immunologique https://druglandscape.com/drug/optinose-fluticasone https://druglandscape.com/api/og?type=drug&title=OPTINOSE%E2%84%A2%20FLUTICASONE&subtitle=OPTINOSE%E2%84%A2%20FLUTICASONE%20%C2%B7%20Optinose%20US%20Inc.&badge=phase%201 OPTINOSE™ FLUTICASONE OPTINOSE™ FLUTICASONE · Optinose US Inc. https://druglandscape.com/drug/optional-rescue-medication-corticosteroids-methylprednisolone https://druglandscape.com/api/og?type=drug&title=Optional%20Rescue%20medication%20-%20Corticosteroids%3A%20Methylprednisolone&subtitle=Optional%20Rescue%20medication%20-%20Corticosteroids%3A%20Methylprednisolone%20%C2%B7%20Vector%20Y%20Therapeutics&badge=phase%201 Optional Rescue medication - Corticosteroids: Methylprednisolone Optional Rescue medication - Corticosteroids: Methylprednisolone · Vector Y Therapeutics https://druglandscape.com/drug/opv-plus-bcg https://druglandscape.com/api/og?type=drug&title=OPV%20plus%20BCG&subtitle=OPV%20plus%20BCG%20%C2%B7%20Bandim%20Health%20Project&badge=phase%201 OPV plus BCG OPV plus BCG · Bandim Health Project https://druglandscape.com/drug/oql011 https://druglandscape.com/api/og?type=drug&title=OQL011&subtitle=OQL011%20%C2%B7%20OnQuality%20Pharmaceuticals%20(USA)%20LLC&badge=phase%202 OQL011 OQL011 · OnQuality Pharmaceuticals (USA) LLC https://druglandscape.com/drug/or2805 https://druglandscape.com/api/og?type=drug&title=OR2805&subtitle=OR2805%20%C2%B7%20OncoResponse%2C%20Inc.&badge=phase%201 OR2805 OR2805 · OncoResponse, Inc. https://druglandscape.com/drug/or502 https://druglandscape.com/api/og?type=drug&title=OR502&subtitle=OR502%20%C2%B7%20OncoResponse%2C%20Inc.&badge=phase%201 OR502 OR502 · OncoResponse, Inc. https://druglandscape.com/drug/ora-sweet https://druglandscape.com/api/og?type=drug&title=Ora%20Sweet&subtitle=Ora%20Sweet%20%C2%B7%20IWK%20Health%20Centre&badge=phase%201 Ora Sweet Ora Sweet · IWK Health Centre https://druglandscape.com/drug/ora102-and-avastin https://druglandscape.com/api/og?type=drug&title=ORA102%20and%20Avastin&subtitle=ORA102%20and%20Avastin%20%C2%B7%20Ora%20Bio%20Ltd.&badge=phase%201 ORA102 and Avastin ORA102 and Avastin · Ora Bio Ltd. https://druglandscape.com/drug/oracure-gel https://druglandscape.com/api/og?type=drug&title=Oracure%20gel&subtitle=Oracure%20gel%20%C2%B7%20Hams%20Hamed%20Abdelrahman&badge=phase%202 Oracure gel Oracure gel · Hams Hamed Abdelrahman https://druglandscape.com/drug/oraplus https://druglandscape.com/api/og?type=drug&title=OraPlus&subtitle=OraPlus%20%C2%B7%20Forbes%20Porter%2C%20M.D.&badge=phase%202 OraPlus OraPlus · Forbes Porter, M.D. https://druglandscape.com/drug/oraqix-gel https://druglandscape.com/api/og?type=drug&title=Oraqix%C2%AE%20gel&subtitle=Oraqix%C2%AE%20gel%20%C2%B7%20Joanneum%20Research%20Forschungsgesellschaft%20mbH&badge=phase%201 Oraqix® gel Oraqix® gel · Joanneum Research Forschungsgesellschaft mbH https://druglandscape.com/drug/oratecan-and-capecitabine https://druglandscape.com/api/og?type=drug&title=Oratecan%20and%20Capecitabine&subtitle=Oratecan%20and%20Capecitabine%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 Oratecan and Capecitabine Oratecan and Capecitabine · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/orb-011 https://druglandscape.com/api/og?type=drug&title=ORB-011&subtitle=ORB-011%20%C2%B7%20Orionis%20Biosciences%20Inc&badge=phase%201 ORB-011 ORB-011 · Orionis Biosciences Inc https://druglandscape.com/drug/orb-021 https://druglandscape.com/api/og?type=drug&title=ORB-021&subtitle=ORB-021%20%C2%B7%20Orionis%20Biosciences%20Inc&badge=phase%201 ORB-021 ORB-021 · Orionis Biosciences Inc https://druglandscape.com/drug/orca-010 https://druglandscape.com/api/og?type=drug&title=ORCA-010&subtitle=ORCA-010%20%C2%B7%20Orca%20Therapeutics%20B.V.&badge=phase%201 ORCA-010 ORCA-010 · Orca Therapeutics B.V. https://druglandscape.com/drug/ore001 https://druglandscape.com/api/og?type=drug&title=ORE001&subtitle=ORE001%20%C2%B7%20Orexa%20BV&badge=phase%202 ORE001 ORE001 · Orexa BV https://druglandscape.com/drug/ore1001 https://druglandscape.com/api/og?type=drug&title=ORE1001&subtitle=ORE1001%20%C2%B7%20Ore%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ORE1001 ORE1001 · Ore Pharmaceuticals, Inc. https://druglandscape.com/drug/orelabrutinib-high-dose https://druglandscape.com/api/og?type=drug&title=Orelabrutinib%20High%20dose&subtitle=Orelabrutinib%20High%20dose%20%C2%B7%20InnoCare%20Pharma%20Inc.&badge=phase%202 Orelabrutinib High dose Orelabrutinib High dose · InnoCare Pharma Inc. https://druglandscape.com/drug/orelabrutinib-low-dose https://druglandscape.com/api/og?type=drug&title=Orelabrutinib%20Low%20dose&subtitle=Orelabrutinib%20Low%20dose%20%C2%B7%20InnoCare%20Pharma%20Inc.&badge=phase%202 Orelabrutinib Low dose Orelabrutinib Low dose · InnoCare Pharma Inc. https://druglandscape.com/drug/orelabrutinib-tablets https://druglandscape.com/api/og?type=drug&title=Orelabrutinib%20Tablets&subtitle=Orelabrutinib%20Tablets%20%C2%B7%20Beijing%20InnoCare%20Pharma%20Tech%20Co.%2C%20Ltd.&badge=phase%201 Orelabrutinib Tablets Orelabrutinib Tablets · Beijing InnoCare Pharma Tech Co., Ltd. https://druglandscape.com/drug/orexine-a https://druglandscape.com/api/og?type=drug&title=Orexine%20A&subtitle=Orexine%20A%20%C2%B7%20Zentrum%20f%C3%BCr%20Integrative%20Psychiatrie&badge=phase%201 Orexine A Orexine A · Zentrum für Integrative Psychiatrie https://druglandscape.com/drug/org-36286 https://druglandscape.com/api/og?type=drug&title=Org%2036286&subtitle=Org%2036286%20%C2%B7%20Organon%20and%20Co&badge=phase%202 Org 36286 Org 36286 · Organon and Co https://druglandscape.com/drug/org101-experimental-1 https://druglandscape.com/api/og?type=drug&title=ORG101%20-%20Experimental%201&subtitle=ORG101%20-%20Experimental%201%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 ORG101 - Experimental 1 ORG101 - Experimental 1 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/organ-i-nr-tablet https://druglandscape.com/api/og?type=drug&title=Organ-I-%20NR%20tablet&subtitle=Organ-I-%20NR%20tablet%20%C2%B7%20Reckitt%20Benckiser%20Inc.&badge=phase%201 Organ-I- NR tablet Organ-I- NR tablet · Reckitt Benckiser Inc. https://druglandscape.com/drug/organogel-of-naftifine-2 https://druglandscape.com/api/og?type=drug&title=Organogel%20of%20naftifine%2C%202%25&subtitle=Organogel%20of%20naftifine%2C%202%25%20%C2%B7%20MediQuest%20Therapeutics&badge=phase%202 Organogel of naftifine, 2% Organogel of naftifine, 2% · MediQuest Therapeutics https://druglandscape.com/drug/organogel-of-naftifine-6 https://druglandscape.com/api/og?type=drug&title=Organogel%20of%20naftifine%2C%206%25&subtitle=Organogel%20of%20naftifine%2C%206%25%20%C2%B7%20MediQuest%20Therapeutics&badge=phase%202 Organogel of naftifine, 6% Organogel of naftifine, 6% · MediQuest Therapeutics https://druglandscape.com/drug/organogel-of-terbinafine-2 https://druglandscape.com/api/og?type=drug&title=Organogel%20of%20terbinafine%2C%202%25&subtitle=Organogel%20of%20terbinafine%2C%202%25%20%C2%B7%20MediQuest%20Therapeutics&badge=phase%202 Organogel of terbinafine, 2% Organogel of terbinafine, 2% · MediQuest Therapeutics https://druglandscape.com/drug/organogel-of-terbinafine-6 https://druglandscape.com/api/og?type=drug&title=Organogel%20of%20terbinafine%2C%206%25&subtitle=Organogel%20of%20terbinafine%2C%206%25%20%C2%B7%20MediQuest%20Therapeutics&badge=phase%202 Organogel of terbinafine, 6% Organogel of terbinafine, 6% · MediQuest Therapeutics https://druglandscape.com/drug/orh-2014 https://druglandscape.com/api/og?type=drug&title=ORH-2014&subtitle=ORH-2014%20%C2%B7%20Orsenix%20LLC&badge=phase%201 ORH-2014 ORH-2014 · Orsenix LLC https://druglandscape.com/drug/ori-c101 https://druglandscape.com/api/og?type=drug&title=Ori-C101&subtitle=Ori-C101%20%C2%B7%20OriCell%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 Ori-C101 Ori-C101 · OriCell Therapeutics Co., Ltd. https://druglandscape.com/drug/oric-114 https://druglandscape.com/api/og?type=drug&title=ORIC-114&subtitle=ORIC-114%20%C2%B7%20ORIC%20Pharmaceuticals&badge=phase%201 ORIC-114 ORIC-114 · ORIC Pharmaceuticals https://druglandscape.com/drug/oric-533 https://druglandscape.com/api/og?type=drug&title=ORIC-533&subtitle=ORIC-533%20%C2%B7%20ORIC%20Pharmaceuticals&badge=phase%201 ORIC-533 ORIC-533 · ORIC Pharmaceuticals https://druglandscape.com/drug/oric-944 https://druglandscape.com/api/og?type=drug&title=ORIC-944&subtitle=ORIC-944%20%C2%B7%20ORIC%20Pharmaceuticals&badge=phase%201 ORIC-944 ORIC-944 · ORIC Pharmaceuticals https://druglandscape.com/drug/oricar-017 https://druglandscape.com/api/og?type=drug&title=OriCAR-017&subtitle=OriCAR-017%20%C2%B7%20OriCell%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 OriCAR-017 OriCAR-017 · OriCell Therapeutics Co., Ltd. https://druglandscape.com/drug/orienx010 https://druglandscape.com/api/og?type=drug&title=OrienX010&subtitle=OrienX010%20%C2%B7%20OrienGene%20Biotechnology%20Ltd.&badge=phase%202 OrienX010 OrienX010 · OrienGene Biotechnology Ltd. https://druglandscape.com/drug/original-formulation-emb-001 https://druglandscape.com/api/og?type=drug&title=Original%20formulation%20EMB-001&subtitle=Original%20formulation%20EMB-001%20%C2%B7%20Embera%20NeuroTherapeutics%2C%20Inc.&badge=phase%201 Original formulation EMB-001 Original formulation EMB-001 · Embera NeuroTherapeutics, Inc. https://druglandscape.com/drug/original-ointment https://druglandscape.com/api/og?type=drug&title=Original%20Ointment&subtitle=Original%20Ointment%20%C2%B7%20Johnson%20%26%20Johnson%20Consumer%20and%20Personal%20Products%20Worldwide&badge=phase%201 Original Ointment Original Ointment · Johnson & Johnson Consumer and Personal Products Worldwide https://druglandscape.com/drug/orismilast-modified-release-tablets https://druglandscape.com/api/og?type=drug&title=Orismilast%20modified%20release%20tablets&subtitle=Orismilast%20modified%20release%20tablets%20%C2%B7%20UNION%20therapeutics&badge=phase%202 Orismilast modified release tablets Orismilast modified release tablets · UNION therapeutics https://druglandscape.com/drug/orka-001 https://druglandscape.com/api/og?type=drug&title=ORKA-001&subtitle=ORKA-001%20%C2%B7%20Oruka%20Therapeutics%2C%20Inc.&badge=phase%202 ORKA-001 ORKA-001 · Oruka Therapeutics, Inc. https://druglandscape.com/drug/orka-001-induction-dose https://druglandscape.com/api/og?type=drug&title=ORKA-001%20Induction%20Dose&subtitle=ORKA-001%20Induction%20Dose%20%C2%B7%20Oruka%20Therapeutics%2C%20Inc.&badge=phase%202 ORKA-001 Induction Dose ORKA-001 Induction Dose · Oruka Therapeutics, Inc. https://druglandscape.com/drug/orka-001-maintenance-dose https://druglandscape.com/api/og?type=drug&title=ORKA-001%20Maintenance%20Dose&subtitle=ORKA-001%20Maintenance%20Dose%20%C2%B7%20Oruka%20Therapeutics%2C%20Inc.&badge=phase%202 ORKA-001 Maintenance Dose ORKA-001 Maintenance Dose · Oruka Therapeutics, Inc. https://druglandscape.com/drug/orka-002 https://druglandscape.com/api/og?type=drug&title=ORKA-002&subtitle=ORKA-002%20%C2%B7%20Oruka%20Therapeutics%2C%20Inc.&badge=phase%202 ORKA-002 ORKA-002 · Oruka Therapeutics, Inc. https://druglandscape.com/drug/orlistat-120 https://druglandscape.com/api/og?type=drug&title=Orlistat%20120&subtitle=Orlistat%20120%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Orlistat 120 Orlistat 120 · GlaxoSmithKline https://druglandscape.com/drug/orlistat-60 https://druglandscape.com/api/og?type=drug&title=Orlistat%2060&subtitle=Orlistat%2060%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Orlistat 60 Orlistat 60 · GlaxoSmithKline https://druglandscape.com/drug/orlistat-experimental-dose https://druglandscape.com/api/og?type=drug&title=orlistat%20experimental%20dose&subtitle=orlistat%20experimental%20dose%20%C2%B7%20GlaxoSmithKline&badge=phase%201 orlistat experimental dose orlistat experimental dose · GlaxoSmithKline https://druglandscape.com/drug/orm-12741-ir https://druglandscape.com/api/og?type=drug&title=ORM-12741%20IR&subtitle=ORM-12741%20IR%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 ORM-12741 IR ORM-12741 IR · Orion Corporation, Orion Pharma https://druglandscape.com/drug/orm-12741-mr-a https://druglandscape.com/api/og?type=drug&title=ORM-12741%20MR%20A&subtitle=ORM-12741%20MR%20A%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 ORM-12741 MR A ORM-12741 MR A · Orion Corporation, Orion Pharma https://druglandscape.com/drug/orm-12741-mr-b https://druglandscape.com/api/og?type=drug&title=ORM-12741%20MR%20B&subtitle=ORM-12741%20MR%20B%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 ORM-12741 MR B ORM-12741 MR B · Orion Corporation, Orion Pharma https://druglandscape.com/drug/orm-14540 https://druglandscape.com/api/og?type=drug&title=ORM-14540&subtitle=ORM-14540%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 ORM-14540 ORM-14540 · Orion Corporation, Orion Pharma https://druglandscape.com/drug/ormd-0801-capsules https://druglandscape.com/api/og?type=drug&title=ORMD-0801%20Capsules&subtitle=ORMD-0801%20Capsules%20%C2%B7%20Oramed%2C%20Ltd.&badge=phase%202 ORMD-0801 Capsules ORMD-0801 Capsules · Oramed, Ltd. https://druglandscape.com/drug/ormd-0801-dose-1 https://druglandscape.com/api/og?type=drug&title=ORMD-0801%20Dose%20%23%201&subtitle=ORMD-0801%20Dose%20%23%201%20%C2%B7%20Oramed%2C%20Ltd.&badge=phase%202 ORMD-0801 Dose # 1 ORMD-0801 Dose # 1 · Oramed, Ltd. https://druglandscape.com/drug/ormd-0801-treatment-a https://druglandscape.com/api/og?type=drug&title=ORMD-0801%20Treatment%20A&subtitle=ORMD-0801%20Treatment%20A%20%C2%B7%20Oramed%2C%20Ltd.&badge=phase%202 ORMD-0801 Treatment A ORMD-0801 Treatment A · Oramed, Ltd. https://druglandscape.com/drug/ormd-0801-treatment-b https://druglandscape.com/api/og?type=drug&title=ORMD-0801%20Treatment%20B&subtitle=ORMD-0801%20Treatment%20B%20%C2%B7%20Oramed%2C%20Ltd.&badge=phase%202 ORMD-0801 Treatment B ORMD-0801 Treatment B · Oramed, Ltd. https://druglandscape.com/drug/orn252 https://druglandscape.com/api/og?type=drug&title=ORN252&subtitle=ORN252%20%C2%B7%20Orna%20Therapeutics%2C%20Inc.&badge=phase%201 ORN252 ORN252 · Orna Therapeutics, Inc. https://druglandscape.com/drug/orshsa https://druglandscape.com/api/og?type=drug&title=OrsHSA&subtitle=OrsHSA%20%C2%B7%20Healthgen%20Biotechnology%20Corp.&badge=phase%202 OrsHSA OrsHSA · Healthgen Biotechnology Corp. https://druglandscape.com/drug/ort247 https://druglandscape.com/api/og?type=drug&title=ORT247&subtitle=ORT247%20%C2%B7%20Orthogonal%20Neuroscience%20Inc.&badge=phase%201 ORT247 ORT247 · Orthogonal Neuroscience Inc. https://druglandscape.com/drug/orx489-tablets https://druglandscape.com/api/og?type=drug&title=ORX489%20Tablets&subtitle=ORX489%20Tablets%20%C2%B7%20Centessa%20Pharmaceuticals%20(UK)%20Limited&badge=phase%201 ORX489 Tablets ORX489 Tablets · Centessa Pharmaceuticals (UK) Limited https://druglandscape.com/drug/ory-2001-high-dose https://druglandscape.com/api/og?type=drug&title=ORY-2001%20High%20dose&subtitle=ORY-2001%20High%20dose%20%C2%B7%20Oryzon%20Genomics%20S.A.&badge=phase%202 ORY-2001 High dose ORY-2001 High dose · Oryzon Genomics S.A. https://druglandscape.com/drug/ory-2001-low-dose https://druglandscape.com/api/og?type=drug&title=ORY-2001%20Low%20dose&subtitle=ORY-2001%20Low%20dose%20%C2%B7%20Oryzon%20Genomics%20S.A.&badge=phase%202 ORY-2001 Low dose ORY-2001 Low dose · Oryzon Genomics S.A. https://druglandscape.com/drug/ose-127 https://druglandscape.com/api/og?type=drug&title=OSE-127&subtitle=OSE-127%20%C2%B7%20OSE%20Immunotherapeutics&badge=phase%202 OSE-127 OSE-127 · OSE Immunotherapeutics https://druglandscape.com/drug/oseltamivir-3-days https://druglandscape.com/api/og?type=drug&title=Oseltamivir%203%20days&subtitle=Oseltamivir%203%20days%20%C2%B7%20Centre%20of%20Postgraduate%20Medical%20Education&badge=phase%201 Oseltamivir 3 days Oseltamivir 3 days · Centre of Postgraduate Medical Education https://druglandscape.com/drug/oseltamivir-7-days https://druglandscape.com/api/og?type=drug&title=Oseltamivir%207%20days&subtitle=Oseltamivir%207%20days%20%C2%B7%20Centre%20of%20Postgraduate%20Medical%20Education&badge=phase%201 Oseltamivir 7 days Oseltamivir 7 days · Centre of Postgraduate Medical Education https://druglandscape.com/drug/oshadi-d https://druglandscape.com/api/og?type=drug&title=Oshadi%20D&subtitle=Oshadi%20D%20%C2%B7%20Oshadi%20Drug%20Administration&badge=phase%201 Oshadi D Oshadi D · Oshadi Drug Administration https://druglandscape.com/drug/oshadi-oral-insulin https://druglandscape.com/api/og?type=drug&title=Oshadi%20Oral%20Insulin&subtitle=Oshadi%20Oral%20Insulin%20%C2%B7%20Oshadi%20Drug%20Administration&badge=phase%201 Oshadi Oral Insulin Oshadi Oral Insulin · Oshadi Drug Administration https://druglandscape.com/drug/osi-461 https://druglandscape.com/api/og?type=drug&title=OSI-461&subtitle=OSI-461%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%202 OSI-461 OSI-461 · Astellas Pharma Inc https://druglandscape.com/drug/osi-7904l https://druglandscape.com/api/og?type=drug&title=OSI%207904L&subtitle=OSI%207904L%20%C2%B7%20OSI%20Pharmaceuticals&badge=phase%202 OSI 7904L OSI 7904L · OSI Pharmaceuticals https://druglandscape.com/drug/osi-930-and-erlotinib https://druglandscape.com/api/og?type=drug&title=OSI-930%20and%20erlotinib&subtitle=OSI-930%20and%20erlotinib%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%201 OSI-930 and erlotinib OSI-930 and erlotinib · Astellas Pharma Inc https://druglandscape.com/drug/osimertinib-azd9291 https://druglandscape.com/api/og?type=drug&title=Osimertinib%3B%20AZD9291&subtitle=Osimertinib%3B%20AZD9291%20%C2%B7%20AstraZeneca&badge=phase%201 Osimertinib; AZD9291 Osimertinib; AZD9291 · AstraZeneca https://druglandscape.com/drug/osimertinib-oral-and-bevazizumab-intravenously https://druglandscape.com/api/og?type=drug&title=osimertinib%20oral%20and%20bevazizumab%20intravenously&subtitle=osimertinib%20oral%20and%20bevazizumab%20intravenously%20%C2%B7%20Qingdao%20Central%20Hospital&badge=phase%203 osimertinib oral and bevazizumab intravenously osimertinib oral and bevazizumab intravenously · Qingdao Central Hospital https://druglandscape.com/drug/osimertininb-tablet-dosing https://druglandscape.com/api/og?type=drug&title=Osimertininb%20tablet%20dosing&subtitle=Osimertininb%20tablet%20dosing%20%C2%B7%20AstraZeneca&badge=phase%201 Osimertininb tablet dosing Osimertininb tablet dosing · AstraZeneca https://druglandscape.com/drug/osiris-phleum-pratense https://druglandscape.com/api/og?type=drug&title=Osiris%20Phleum%20pratense&subtitle=Osiris%20Phleum%20pratense%20%C2%B7%20ALK-Abell%C3%B3%20A%2FS&badge=phase%202 Osiris Phleum pratense Osiris Phleum pratense · ALK-Abelló A/S https://druglandscape.com/drug/ost-122 https://druglandscape.com/api/og?type=drug&title=OST-122&subtitle=OST-122%20%C2%B7%20Oncostellae%20S.L&badge=phase%201 OST-122 OST-122 · Oncostellae S.L https://druglandscape.com/drug/ost31-164 https://druglandscape.com/api/og?type=drug&title=OST31-164&subtitle=OST31-164%20%C2%B7%20Emerald%20Clinical%20Inc.&badge=phase%202 OST31-164 OST31-164 · Emerald Clinical Inc. https://druglandscape.com/drug/ostenil-plus https://druglandscape.com/api/og?type=drug&title=Ostenil%20plus&subtitle=Ostenil%20plus%20%C2%B7%20TRB%20Chemedica&badge=phase%202 Ostenil plus Ostenil plus · TRB Chemedica https://druglandscape.com/drug/osteoanabolic-therapy https://druglandscape.com/api/og?type=drug&title=osteoanabolic%20therapy&subtitle=osteoanabolic%20therapy%20%C2%B7%20University%20of%20Zurich&badge=phase%203 osteoanabolic therapy osteoanabolic therapy · University of Zurich https://druglandscape.com/drug/osteocel-plus https://druglandscape.com/api/og?type=drug&title=Osteocel%20Plus&subtitle=Osteocel%20Plus%20%C2%B7%20NuVasive&badge=phase%202 Osteocel Plus Osteocel Plus · NuVasive https://druglandscape.com/drug/osu-6162 https://druglandscape.com/api/og?type=drug&title=OSU%206162&subtitle=OSU%206162%20%C2%B7%20Arvid%20Carlsson%20Research%20AB&badge=phase%202 OSU 6162 OSU 6162 · Arvid Carlsson Research AB https://druglandscape.com/drug/osvaren-film-coated-tablets https://druglandscape.com/api/og?type=drug&title=Osvaren%20film-coated%20tablets&subtitle=Osvaren%20film-coated%20tablets%20%C2%B7%20Fresenius%20Medical%20Care%20Deutschland%20GmbH&badge=phase%202 Osvaren film-coated tablets Osvaren film-coated tablets · Fresenius Medical Care Deutschland GmbH https://druglandscape.com/drug/osvaren-granules https://druglandscape.com/api/og?type=drug&title=Osvaren%20Granules&subtitle=Osvaren%20Granules%20%C2%B7%20Fresenius%20Medical%20Care%20Deutschland%20GmbH&badge=phase%202 Osvaren Granules Osvaren Granules · Fresenius Medical Care Deutschland GmbH https://druglandscape.com/drug/ot-101 https://druglandscape.com/api/og?type=drug&title=OT-101&subtitle=OT-101%20%C2%B7%20Oncotelic%20Inc.&badge=phase%202 OT-101 OT-101 · Oncotelic Inc. https://druglandscape.com/drug/ot-82-dose-escalation https://druglandscape.com/api/og?type=drug&title=OT-82%20Dose%20Escalation&subtitle=OT-82%20Dose%20Escalation%20%C2%B7%20Oncotartis%2C%20Inc.&badge=phase%201 OT-82 Dose Escalation OT-82 Dose Escalation · Oncotartis, Inc. https://druglandscape.com/drug/ot-82-dose-expansion https://druglandscape.com/api/og?type=drug&title=OT-82%20Dose%20Expansion&subtitle=OT-82%20Dose%20Expansion%20%C2%B7%20Oncotartis%2C%20Inc.&badge=phase%201 OT-82 Dose Expansion OT-82 Dose Expansion · Oncotartis, Inc. https://druglandscape.com/drug/ot202-conc-0-1 https://druglandscape.com/api/og?type=drug&title=OT202%20conc%200.1%25&subtitle=OT202%20conc%200.1%25%20%C2%B7%20Ocumension%20Therapeutics%20(Shanghai)%20Co.%2C%20Ltd&badge=phase%202 OT202 conc 0.1% OT202 conc 0.1% · Ocumension Therapeutics (Shanghai) Co., Ltd https://druglandscape.com/drug/otc-eczema-moisturizer-regimen https://druglandscape.com/api/og?type=drug&title=OTC%20Eczema%20Moisturizer%20Regimen&subtitle=OTC%20Eczema%20Moisturizer%20Regimen%20%C2%B7%20Johnson%20%26%20Johnson%20Consumer%20Products%20Company%20Division%20of%20Johnson%20%26%20J&badge=phase%201 OTC Eczema Moisturizer Regimen OTC Eczema Moisturizer Regimen · Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc. https://druglandscape.com/drug/otf-1 https://druglandscape.com/api/og?type=drug&title=OTF%201&subtitle=OTF%201%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 OTF 1 OTF 1 · Janssen Research & Development, LLC https://druglandscape.com/drug/otf-2 https://druglandscape.com/api/og?type=drug&title=OTF%202&subtitle=OTF%202%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 OTF 2 OTF 2 · Janssen Research & Development, LLC https://druglandscape.com/drug/otf-3 https://druglandscape.com/api/og?type=drug&title=OTF%203&subtitle=OTF%203%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 OTF 3 OTF 3 · Janssen Research & Development, LLC https://druglandscape.com/drug/otf-4 https://druglandscape.com/api/og?type=drug&title=OTF%204&subtitle=OTF%204%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 OTF 4 OTF 4 · Janssen Research & Development, LLC https://druglandscape.com/drug/other-anti-hbv-medication https://druglandscape.com/api/og?type=drug&title=Other%20anti-HBV%20medication&subtitle=Other%20anti-HBV%20medication%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 Other anti-HBV medication Other anti-HBV medication · Bristol-Myers Squibb https://druglandscape.com/drug/other-anti-psoriatic-systemic-treatments https://druglandscape.com/api/og?type=drug&title=Other%20anti-psoriatic%20systemic%20treatments&subtitle=Other%20anti-psoriatic%20systemic%20treatments%20%C2%B7%20Swiss%20Dermatology%20Network%20for%20Targeted%20Therapies&badge=phase%202 Other anti-psoriatic systemic treatments Other anti-psoriatic systemic treatments · Swiss Dermatology Network for Targeted Therapies https://druglandscape.com/drug/other-anti-retroviral-therapy https://druglandscape.com/api/og?type=drug&title=Other%20Anti-Retroviral%20Therapy&subtitle=Other%20Anti-Retroviral%20Therapy%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Other Anti-Retroviral Therapy Other Anti-Retroviral Therapy · Merck Sharp & Dohme LLC https://druglandscape.com/drug/other-anti-vegfs https://druglandscape.com/api/og?type=drug&title=Other%20anti-VEGFs&subtitle=Other%20anti-VEGFs%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Other anti-VEGFs Other anti-VEGFs · GlaxoSmithKline https://druglandscape.com/drug/other-antibiotics https://druglandscape.com/api/og?type=drug&title=Other%20Antibiotics&subtitle=Other%20Antibiotics%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 Other Antibiotics Other Antibiotics · Janssen Research & Development, LLC https://druglandscape.com/drug/other-antidiabetic-therapies https://druglandscape.com/api/og?type=drug&title=Other%20antidiabetic%20therapies&subtitle=Other%20antidiabetic%20therapies%20%C2%B7%20AstraZeneca&badge=phase%202 Other antidiabetic therapies Other antidiabetic therapies · AstraZeneca https://druglandscape.com/drug/other-antipsychotics-new-starts https://druglandscape.com/api/og?type=drug&title=Other%20Antipsychotics%20-%20New%20Starts&subtitle=Other%20Antipsychotics%20-%20New%20Starts%20%C2%B7%20Janssen%20Scientific%20Affairs%2C%20LLC&badge=phase%202 Other Antipsychotics - New Starts Other Antipsychotics - New Starts · Janssen Scientific Affairs, LLC https://druglandscape.com/drug/other-antiretroviral-medications https://druglandscape.com/api/og?type=drug&title=Other%20antiretroviral%20medications&subtitle=Other%20antiretroviral%20medications%20%C2%B7%20Janssen%20Inc.&badge=phase%202 Other antiretroviral medications Other antiretroviral medications · Janssen Inc. https://druglandscape.com/drug/other-approved-anti-cancer-therapy https://druglandscape.com/api/og?type=drug&title=Other%20approved%20anti-cancer%20therapy&subtitle=Other%20approved%20anti-cancer%20therapy%20%C2%B7%20Riboscience%2C%20LLC.&badge=phase%201 Other approved anti-cancer therapy Other approved anti-cancer therapy · Riboscience, LLC. https://druglandscape.com/drug/other-biologic-therapies https://druglandscape.com/api/og?type=drug&title=Other%20Biologic%20Therapies&subtitle=Other%20Biologic%20Therapies%20%C2%B7%20Janssen%20Scientific%20Affairs%2C%20LLC&badge=phase%202 Other Biologic Therapies Other Biologic Therapies · Janssen Scientific Affairs, LLC https://druglandscape.com/drug/other-biological-agent https://druglandscape.com/api/og?type=drug&title=Other%20Biological%20Agent&subtitle=Other%20Biological%20Agent%20%C2%B7%20Takeda&badge=phase%202 Other Biological Agent Other Biological Agent · Takeda https://druglandscape.com/drug/other-biological-sample-collection https://druglandscape.com/api/og?type=drug&title=Other%20biological%20sample%20collection&subtitle=Other%20biological%20sample%20collection%20%C2%B7%20Direction%20Centrale%20du%20Service%20de%20Sant%C3%A9%20des%20Arm%C3%A9es&badge=phase%202 Other biological sample collection Other biological sample collection · Direction Centrale du Service de Santé des Armées https://druglandscape.com/drug/other-combined-oral-contraceptives https://druglandscape.com/api/og?type=drug&title=Other%20combined%20oral%20contraceptives&subtitle=Other%20combined%20oral%20contraceptives%20%C2%B7%20Bayer&badge=phase%202 Other combined oral contraceptives Other combined oral contraceptives · Bayer https://druglandscape.com/drug/other-copd-medication https://druglandscape.com/api/og?type=drug&title=Other%20COPD%20medication&subtitle=Other%20COPD%20medication%20%C2%B7%20AstraZeneca&badge=phase%202 Other COPD medication Other COPD medication · AstraZeneca https://druglandscape.com/drug/other-cox-2-inhibitor https://druglandscape.com/api/og?type=drug&title=Other%20COX-2%20inhibitor&subtitle=Other%20COX-2%20inhibitor%20%C2%B7%20Organon%20and%20Co&badge=phase%202 Other COX-2 inhibitor Other COX-2 inhibitor · Organon and Co https://druglandscape.com/drug/other-cox-2-inhibitors https://druglandscape.com/api/og?type=drug&title=Other%20Cox-2%20inhibitors&subtitle=Other%20Cox-2%20inhibitors%20%C2%B7%20Organon%20and%20Co&badge=phase%202 Other Cox-2 inhibitors Other Cox-2 inhibitors · Organon and Co https://druglandscape.com/drug/other-doacs https://druglandscape.com/api/og?type=drug&title=other%20DOACs&subtitle=other%20DOACs%20%C2%B7%20Bayer&badge=phase%202 other DOACs other DOACs · Bayer https://druglandscape.com/drug/other-dtap-vaccines https://druglandscape.com/api/og?type=drug&title=Other%20DTap%20Vaccines&subtitle=Other%20DTap%20Vaccines%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%202 Other DTap Vaccines Other DTap Vaccines · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/other-individualized-treatments https://druglandscape.com/api/og?type=drug&title=Other%20individualized%20treatments&subtitle=Other%20individualized%20treatments%20%C2%B7%20Shanghai%20Minimally%20Invasive%20Surgery%20Center&badge=phase%201 Other individualized treatments Other individualized treatments · Shanghai Minimally Invasive Surgery Center https://druglandscape.com/drug/other-injectable-antidiabetic-treatment-regimens https://druglandscape.com/api/og?type=drug&title=other%20injectable%20antidiabetic%20treatment%20regimens&subtitle=other%20injectable%20antidiabetic%20treatment%20regimens%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 other injectable antidiabetic treatment regimens other injectable antidiabetic treatment regimens · Novo Nordisk A/S https://druglandscape.com/drug/other-marketed-ivig-product https://druglandscape.com/api/og?type=drug&title=Other%20marketed%20IVIG%20product&subtitle=Other%20marketed%20IVIG%20product%20%C2%B7%20Octapharma&badge=phase%202 Other marketed IVIG product Other marketed IVIG product · Octapharma https://druglandscape.com/drug/other-multikinase-inhibitors https://druglandscape.com/api/og?type=drug&title=Other%20Multikinase%20inhibitors&subtitle=Other%20Multikinase%20inhibitors%20%C2%B7%20Bayer&badge=phase%202 Other Multikinase inhibitors Other Multikinase inhibitors · Bayer https://druglandscape.com/drug/other-noacs https://druglandscape.com/api/og?type=drug&title=other%20NOACs&subtitle=other%20NOACs%20%C2%B7%20Bayer&badge=phase%202 other NOACs other NOACs · Bayer https://druglandscape.com/drug/other-non-selective-nsaids https://druglandscape.com/api/og?type=drug&title=Other%20Non-selective%20NSAIDs&subtitle=Other%20Non-selective%20NSAIDs%20%C2%B7%20Organon%20and%20Co&badge=phase%202 Other Non-selective NSAIDs Other Non-selective NSAIDs · Organon and Co https://druglandscape.com/drug/other-oral-mucolytic-drugs https://druglandscape.com/api/og?type=drug&title=Other%20oral%20mucolytic%20drugs&subtitle=Other%20oral%20mucolytic%20drugs%20%C2%B7%20Beijing%20Grand%20Johamu%20Pharmaceutical%20Company%2C%20Ltd.&badge=phase%202 Other oral mucolytic drugs Other oral mucolytic drugs · Beijing Grand Johamu Pharmaceutical Company, Ltd. https://druglandscape.com/drug/other-oral-triptans https://druglandscape.com/api/og?type=drug&title=other%20oral%20triptans&subtitle=other%20oral%20triptans%20%C2%B7%20GlaxoSmithKline&badge=phase%202 other oral triptans other oral triptans · GlaxoSmithKline https://druglandscape.com/drug/other-parenteral-antifungal-drugs https://druglandscape.com/api/og?type=drug&title=Other%20parenteral%20antifungal%20drugs&subtitle=Other%20parenteral%20antifungal%20drugs%20%C2%B7%20Astellas%20Pharma%20Europe%20B.V.&badge=phase%202 Other parenteral antifungal drugs Other parenteral antifungal drugs · Astellas Pharma Europe B.V. https://druglandscape.com/drug/other-parkinson-s-disease-treatments https://druglandscape.com/api/og?type=drug&title=Other%20Parkinson's%20Disease%20treatments&subtitle=Other%20Parkinson's%20Disease%20treatments%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Other Parkinson's Disease treatments Other Parkinson's Disease treatments · Merck Sharp & Dohme LLC https://druglandscape.com/drug/other-pertussis-vaccines https://druglandscape.com/api/og?type=drug&title=Other%20Pertussis%20Vaccines&subtitle=Other%20Pertussis%20Vaccines%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%202 Other Pertussis Vaccines Other Pertussis Vaccines · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/other-progestin-containing-oral-contraceptive https://druglandscape.com/api/og?type=drug&title=Other%20progestin%20containing%20oral%20contraceptive&subtitle=Other%20progestin%20containing%20oral%20contraceptive%20%C2%B7%20Center%20for%20Epidemiology%20and%20Health%20Research%2C%20Germany&badge=phase%202 Other progestin containing oral contraceptive Other progestin containing oral contraceptive · Center for Epidemiology and Health Research, Germany https://druglandscape.com/drug/other-standard-care https://druglandscape.com/api/og?type=drug&title=Other%20standard%20care&subtitle=Other%20standard%20care%20%C2%B7%20Bayer&badge=phase%202 Other standard care Other standard care · Bayer https://druglandscape.com/drug/other-subcutaneous-immunoglobulins https://druglandscape.com/api/og?type=drug&title=Other%20Subcutaneous%20Immunoglobulins&subtitle=Other%20Subcutaneous%20Immunoglobulins%20%C2%B7%20Octapharma&badge=phase%202 Other Subcutaneous Immunoglobulins Other Subcutaneous Immunoglobulins · Octapharma https://druglandscape.com/drug/other-systemic-treatments-for-pso https://druglandscape.com/api/og?type=drug&title=Other%20systemic%20treatments%20for%20PsO&subtitle=Other%20systemic%20treatments%20for%20PsO%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 Other systemic treatments for PsO Other systemic treatments for PsO · Bristol-Myers Squibb https://druglandscape.com/drug/other-therapeutic-agents https://druglandscape.com/api/og?type=drug&title=Other%20Therapeutic%20Agents&subtitle=Other%20Therapeutic%20Agents%20%C2%B7%20BeiGene&badge=phase%201 Other Therapeutic Agents Other Therapeutic Agents · BeiGene https://druglandscape.com/drug/other-tkis https://druglandscape.com/api/og?type=drug&title=Other%20TKIs&subtitle=Other%20TKIs%20%C2%B7%20Bayer&badge=phase%202 Other TKIs Other TKIs · Bayer https://druglandscape.com/drug/other-topical https://druglandscape.com/api/og?type=drug&title=Other%20topical&subtitle=Other%20topical%20%C2%B7%20LEO%20Pharma&badge=phase%202 Other topical Other topical · LEO Pharma https://druglandscape.com/drug/other-treatment-combinations https://druglandscape.com/api/og?type=drug&title=Other%20treatment%20combinations&subtitle=Other%20treatment%20combinations%20%C2%B7%20Canadian%20Network%20for%20Observational%20Drug%20Effect%20Studies%2C%20CNODES&badge=phase%202 Other treatment combinations Other treatment combinations · Canadian Network for Observational Drug Effect Studies, CNODES https://druglandscape.com/drug/other-treatments https://druglandscape.com/api/og?type=drug&title=Other%20treatments&subtitle=Other%20treatments%20%C2%B7%20Parc%20de%20Salut%20Mar&badge=phase%202 Other treatments Other treatments · Parc de Salut Mar https://druglandscape.com/drug/others-except-finerenone https://druglandscape.com/api/og?type=drug&title=Others%20except%20finerenone&subtitle=Others%20except%20finerenone%20%C2%B7%20Bayer&badge=phase%202 Others except finerenone Others except finerenone · Bayer https://druglandscape.com/drug/oto-313 https://druglandscape.com/api/og?type=drug&title=OTO-313&subtitle=OTO-313%20%C2%B7%20Otonomy%2C%20Inc.&badge=phase%202 OTO-313 OTO-313 · Otonomy, Inc. https://druglandscape.com/drug/oto-413 https://druglandscape.com/api/og?type=drug&title=OTO-413&subtitle=OTO-413%20%C2%B7%20Otonomy%2C%20Inc.&badge=phase%201 OTO-413 OTO-413 · Otonomy, Inc. https://druglandscape.com/drug/otp-01 https://druglandscape.com/api/og?type=drug&title=OTP-01&subtitle=OTP-01%20%C2%B7%20Ottimo%20Pharma%20Limited&badge=phase%201 OTP-01 OTP-01 · Ottimo Pharma Limited https://druglandscape.com/drug/ots-412 https://druglandscape.com/api/og?type=drug&title=OTS-412&subtitle=OTS-412%20%C2%B7%20Bionoxx%20Inc.&badge=phase%201 OTS-412 OTS-412 · Bionoxx Inc. https://druglandscape.com/drug/ots167po https://druglandscape.com/api/og?type=drug&title=OTS167PO&subtitle=OTS167PO%20%C2%B7%20OncoTherapy%20Science%2C%20Inc.&badge=phase%201 OTS167PO OTS167PO · OncoTherapy Science, Inc. https://druglandscape.com/drug/ott166 https://druglandscape.com/api/og?type=drug&title=OTT166&subtitle=OTT166%20%C2%B7%20OcuTerra%20Therapeutics%2C%20Inc.&badge=phase%202 OTT166 OTT166 · OcuTerra Therapeutics, Inc. https://druglandscape.com/drug/otx-101-0-05 https://druglandscape.com/api/og?type=drug&title=OTX-101%200.05%25&subtitle=OTX-101%200.05%25%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%202 OTX-101 0.05% OTX-101 0.05% · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/otx-ded https://druglandscape.com/api/og?type=drug&title=OTX-DED&subtitle=OTX-DED%20%C2%B7%20Ocular%20Therapeutix%2C%20Inc.&badge=phase%202 OTX-DED OTX-DED · Ocular Therapeutix, Inc. https://druglandscape.com/drug/otx-tic https://druglandscape.com/api/og?type=drug&title=OTX-TIC&subtitle=OTX-TIC%20%C2%B7%20Ocular%20Therapeutix%2C%20Inc.&badge=phase%201 OTX-TIC OTX-TIC · Ocular Therapeutix, Inc. https://druglandscape.com/drug/otx-tp https://druglandscape.com/api/og?type=drug&title=OTX-TP&subtitle=OTX-TP%20%C2%B7%20Ocular%20Therapeutix%2C%20Inc.&badge=phase%202 OTX-TP OTX-TP · Ocular Therapeutix, Inc. https://druglandscape.com/drug/otx008 https://druglandscape.com/api/og?type=drug&title=OTX008&subtitle=OTX008%20%C2%B7%20Oncoethix%20GmbH%2C%20a%20subsidiary%20of%20Merck%20%26%20Co.%2C%20Inc.%20(Rahway%2C%20New%20Jersey%20USA)&badge=phase%201 OTX008 OTX008 · Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) https://druglandscape.com/drug/ov101-regimen-1 https://druglandscape.com/api/og?type=drug&title=OV101%20Regimen%201&subtitle=OV101%20Regimen%201%20%C2%B7%20Healx%20AI&badge=phase%202 OV101 Regimen 1 OV101 Regimen 1 · Healx AI https://druglandscape.com/drug/ov101-regimen-2 https://druglandscape.com/api/og?type=drug&title=OV101%20regimen%202&subtitle=OV101%20regimen%202%20%C2%B7%20Healx%20AI&badge=phase%202 OV101 regimen 2 OV101 regimen 2 · Healx AI https://druglandscape.com/drug/ovaleap https://druglandscape.com/api/og?type=drug&title=Ovaleap%C2%AE&subtitle=Ovaleap%C2%AE%20%C2%B7%20Teva%20Pharma%20GmbH&badge=phase%202 Ovaleap® Ovaleap® · Teva Pharma GmbH https://druglandscape.com/drug/ovcon-35-fe https://druglandscape.com/api/og?type=drug&title=Ovcon%C2%AE%2035%20Fe&subtitle=Ovcon%C2%AE%2035%20Fe%20%C2%B7%20Teva%20Pharmaceuticals%20USA&badge=phase%201 Ovcon® 35 Fe Ovcon® 35 Fe · Teva Pharmaceuticals USA https://druglandscape.com/drug/over-encapsulated-oseltamivir https://druglandscape.com/api/og?type=drug&title=over-encapsulated%20oseltamivir&subtitle=over-encapsulated%20oseltamivir%20%C2%B7%20GlaxoSmithKline&badge=phase%201 over-encapsulated oseltamivir over-encapsulated oseltamivir · GlaxoSmithKline https://druglandscape.com/drug/ovihd https://druglandscape.com/api/og?type=drug&title=OVIHD&subtitle=OVIHD%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 OVIHD OVIHD · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/ovm-200 https://druglandscape.com/api/og?type=drug&title=OVM-200&subtitle=OVM-200%20%C2%B7%20Oxford%20Vacmedix%20UK%20Ltd.&badge=phase%201 OVM-200 OVM-200 · Oxford Vacmedix UK Ltd. https://druglandscape.com/drug/ovx033 https://druglandscape.com/api/og?type=drug&title=OVX033&subtitle=OVX033%20%C2%B7%20Osivax&badge=phase%201 OVX033 OVX033 · Osivax https://druglandscape.com/drug/ovx836 https://druglandscape.com/api/og?type=drug&title=OVX836&subtitle=OVX836%20%C2%B7%20Osivax&badge=phase%202 OVX836 OVX836 · Osivax https://druglandscape.com/drug/ovx836-003 https://druglandscape.com/api/og?type=drug&title=OVX836-003&subtitle=OVX836-003%20%C2%B7%20Osivax&badge=phase%202 OVX836-003 OVX836-003 · Osivax https://druglandscape.com/drug/ovx836-480-g https://druglandscape.com/api/og?type=drug&title=OVX836%20480%C2%B5g&subtitle=OVX836%20480%C2%B5g%20%C2%B7%20Osivax&badge=phase%202 OVX836 480µg OVX836 480µg · Osivax https://druglandscape.com/drug/ovx836-shot https://druglandscape.com/api/og?type=drug&title=OVX836%20shot&subtitle=OVX836%20shot%20%C2%B7%20Osivax&badge=phase%202 OVX836 shot OVX836 shot · Osivax https://druglandscape.com/drug/owc-control-cream https://druglandscape.com/api/og?type=drug&title=OWC%20Control%20Cream&subtitle=OWC%20Control%20Cream%20%C2%B7%20One%20World%20Cannabis%20Ltd.&badge=phase%201 OWC Control Cream OWC Control Cream · One World Cannabis Ltd. https://druglandscape.com/drug/owc-mgc-cream https://druglandscape.com/api/og?type=drug&title=OWC%20MGC%20cream&subtitle=OWC%20MGC%20cream%20%C2%B7%20One%20World%20Cannabis%20Ltd.&badge=phase%201 OWC MGC cream OWC MGC cream · One World Cannabis Ltd. https://druglandscape.com/drug/owcp-orally-disintegrating-tablet https://druglandscape.com/api/og?type=drug&title=OWCP%20Orally%20Disintegrating%20Tablet&subtitle=OWCP%20Orally%20Disintegrating%20Tablet%20%C2%B7%20One%20World%20Cannabis%20Ltd.&badge=phase%201 OWCP Orally Disintegrating Tablet OWCP Orally Disintegrating Tablet · One World Cannabis Ltd. https://druglandscape.com/drug/oxabact-oc5-capsules https://druglandscape.com/api/og?type=drug&title=Oxabact%20OC5%20capsules&subtitle=Oxabact%20OC5%20capsules%20%C2%B7%20OxThera&badge=phase%201 Oxabact OC5 capsules Oxabact OC5 capsules · OxThera https://druglandscape.com/drug/oxaliplatin-5-fluorouracil https://druglandscape.com/api/og?type=drug&title=Oxaliplatin%2C%205-Fluorouracil&subtitle=Oxaliplatin%2C%205-Fluorouracil%20%C2%B7%20Sanofi&badge=phase%202 Oxaliplatin, 5-Fluorouracil Oxaliplatin, 5-Fluorouracil · Sanofi https://druglandscape.com/drug/oxaliplatin-5-fluorouracil-leucovorin-panitumumab https://druglandscape.com/api/og?type=drug&title=Oxaliplatin%2C%205-fluorouracil%2Cleucovorin%2Cpanitumumab&subtitle=Oxaliplatin%2C%205-fluorouracil%2Cleucovorin%2Cpanitumumab%20%C2%B7%20Fondazione%20IRCCS%20Istituto%20Nazionale%20dei%20Tumori%2C&badge=phase%202 Oxaliplatin, 5-fluorouracil,leucovorin,panitumumab Oxaliplatin, 5-fluorouracil,leucovorin,panitumumab · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano https://druglandscape.com/drug/oxaliplatin-5-fu https://druglandscape.com/api/og?type=drug&title=Oxaliplatin%2C%205-FU&subtitle=Oxaliplatin%2C%205-FU%20%C2%B7%20Sanofi&badge=phase%202 Oxaliplatin, 5-FU Oxaliplatin, 5-FU · Sanofi https://druglandscape.com/drug/oxaliplatin-and-on-01910-na https://druglandscape.com/api/og?type=drug&title=oxaliplatin%20and%20ON%2001910.Na&subtitle=oxaliplatin%20and%20ON%2001910.Na%20%C2%B7%20Traws%20Pharma%2C%20Inc.&badge=phase%201 oxaliplatin and ON 01910.Na oxaliplatin and ON 01910.Na · Traws Pharma, Inc. https://druglandscape.com/drug/oxaliplatin-capecitabine-radiotherapy https://druglandscape.com/api/og?type=drug&title=Oxaliplatin%2C%20capecitabine%2C%20radiotherapy&subtitle=Oxaliplatin%2C%20capecitabine%2C%20radiotherapy%20%C2%B7%20Sanofi&badge=phase%202 Oxaliplatin, capecitabine, radiotherapy Oxaliplatin, capecitabine, radiotherapy · Sanofi https://druglandscape.com/drug/oxaliplatin-gemcitabine-bevacizumab https://druglandscape.com/api/og?type=drug&title=oxaliplatin%2C%20gemcitabine%2C%20bevacizumab&subtitle=oxaliplatin%2C%20gemcitabine%2C%20bevacizumab%20%C2%B7%20Mt.%20Sinai%20Medical%20Center%2C%20Miami&badge=phase%202 oxaliplatin, gemcitabine, bevacizumab oxaliplatin, gemcitabine, bevacizumab · Mt. Sinai Medical Center, Miami https://druglandscape.com/drug/oxaliplatin-irinotecan-bevacizumab-docetaxel https://druglandscape.com/api/og?type=drug&title=Oxaliplatin%2C%20Irinotecan%2C%20Bevacizumab%2C%20Docetaxel&subtitle=Oxaliplatin%2C%20Irinotecan%2C%20Bevacizumab%2C%20Docetaxel%20%C2%B7%20Arbeitsgemeinschaft%20medikamentoese%20Tumortherapie&badge=phase%202 Oxaliplatin, Irinotecan, Bevacizumab, Docetaxel Oxaliplatin, Irinotecan, Bevacizumab, Docetaxel · Arbeitsgemeinschaft medikamentoese Tumortherapie https://druglandscape.com/drug/oxaliplatin-iv https://druglandscape.com/api/og?type=drug&title=Oxaliplatin%20IV&subtitle=Oxaliplatin%20IV%20%C2%B7%20Gustave%20Roussy%2C%20Cancer%20Campus%2C%20Grand%20Paris&badge=phase%202 Oxaliplatin IV Oxaliplatin IV · Gustave Roussy, Cancer Campus, Grand Paris https://druglandscape.com/drug/oxaliplatin-paclitaxel https://druglandscape.com/api/og?type=drug&title=Oxaliplatin%2C%20Paclitaxel&subtitle=Oxaliplatin%2C%20Paclitaxel%20%C2%B7%20Sanofi&badge=phase%202 Oxaliplatin, Paclitaxel Oxaliplatin, Paclitaxel · Sanofi https://druglandscape.com/drug/oxaluria-evolution https://druglandscape.com/api/og?type=drug&title=Oxaluria%20evolution.&subtitle=Oxaluria%20evolution.%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 Oxaluria evolution. Oxaluria evolution. · Hospices Civils de Lyon https://druglandscape.com/drug/oxfendazole-single-dose https://druglandscape.com/api/og?type=drug&title=Oxfendazole%20single%20dose&subtitle=Oxfendazole%20single%20dose%20%C2%B7%20Universidad%20Peruana%20Cayetano%20Heredia&badge=phase%202 Oxfendazole single dose Oxfendazole single dose · Universidad Peruana Cayetano Heredia https://druglandscape.com/drug/oxfendazole-three-doses https://druglandscape.com/api/og?type=drug&title=Oxfendazole%20three%20doses&subtitle=Oxfendazole%20three%20doses%20%C2%B7%20Universidad%20Peruana%20Cayetano%20Heredia&badge=phase%202 Oxfendazole three doses Oxfendazole three doses · Universidad Peruana Cayetano Heredia https://druglandscape.com/drug/oxiconazole-nitrate-cream-1 https://druglandscape.com/api/og?type=drug&title=Oxiconazole%20Nitrate%20Cream%201%25&subtitle=Oxiconazole%20Nitrate%20Cream%201%25%20%C2%B7%20Sun%20Pharmaceutical%20Industries%2C%20Inc.&badge=phase%201 Oxiconazole Nitrate Cream 1% Oxiconazole Nitrate Cream 1% · Sun Pharmaceutical Industries, Inc. https://druglandscape.com/drug/oximen-3 https://druglandscape.com/api/og?type=drug&title=Oximen%C2%AE%203%25&subtitle=Oximen%C2%AE%203%25%20%C2%B7%20Fundaci%C3%B3n%20para%20el%20Fomento%20de%20la%20Investigaci%C3%B3n%20Sanitaria%20y%20Biom%C3%A9dica%20de%20la%20Comunitat%20Val&badge=phase%201 Oximen® 3% Oximen® 3% · Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana https://druglandscape.com/drug/oxn-pr-followed-by-oxypr-tablets https://druglandscape.com/api/og?type=drug&title=OXN%20PR%20followed%20by%20OxyPR%20tablets&subtitle=OXN%20PR%20followed%20by%20OxyPR%20tablets%20%C2%B7%20Mundipharma%20Research%20GmbH%20%26%20Co%20KG&badge=phase%202 OXN PR followed by OxyPR tablets OXN PR followed by OxyPR tablets · Mundipharma Research GmbH & Co KG https://druglandscape.com/drug/oxo-001 https://druglandscape.com/api/og?type=drug&title=OXO-001&subtitle=OXO-001%20%C2%B7%20OXOLIFE&badge=phase%202 OXO-001 OXO-001 · OXOLIFE https://druglandscape.com/drug/oxoisoindolin-14c-arv-471 https://druglandscape.com/api/og?type=drug&title=%5Boxoisoindolin-14C%5DARV-471&subtitle=%5Boxoisoindolin-14C%5DARV-471%20%C2%B7%20Pfizer&badge=phase%201 [oxoisoindolin-14C]ARV-471 [oxoisoindolin-14C]ARV-471 · Pfizer https://druglandscape.com/drug/oxp005 https://druglandscape.com/api/og?type=drug&title=OXP005&subtitle=OXP005%20%C2%B7%20Oxford%20Pharmascience%20Ltd&badge=phase%201 OXP005 OXP005 · Oxford Pharmascience Ltd https://druglandscape.com/drug/oxybutinin-fesoterodine-solifenacin-propiverin-trospium https://druglandscape.com/api/og?type=drug&title=Oxybutinin%2C%20Fesoterodine%2C%20Solifenacin%2C%20Propiverin%2C%20Trospium&subtitle=Oxybutinin%2C%20Fesoterodine%2C%20Solifenacin%2C%20Propiverin%2C%20Trospium%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%201 Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospium Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospium · Samsung Medical Center https://druglandscape.com/drug/oxybutynin-pill https://druglandscape.com/api/og?type=drug&title=Oxybutynin%20Pill&subtitle=Oxybutynin%20Pill%20%C2%B7%20Universidad%20de%20Valparaiso&badge=phase%201 Oxybutynin Pill Oxybutynin Pill · Universidad de Valparaiso https://druglandscape.com/drug/oxycodone-and-midazolam https://druglandscape.com/api/og?type=drug&title=Oxycodone%20and%20Midazolam&subtitle=Oxycodone%20and%20Midazolam%20%C2%B7%20Food%20and%20Drug%20Administration%20(FDA)&badge=phase%201 Oxycodone and Midazolam Oxycodone and Midazolam · Food and Drug Administration (FDA) https://druglandscape.com/drug/oxycodone-api-powder https://druglandscape.com/api/og?type=drug&title=Oxycodone%20API%20powder&subtitle=Oxycodone%20API%20powder%20%C2%B7%20Gr%C3%BCnenthal%20GmbH&badge=phase%201 Oxycodone API powder Oxycodone API powder · Grünenthal GmbH https://druglandscape.com/drug/oxycodone-controlled-release-test-formulation https://druglandscape.com/api/og?type=drug&title=Oxycodone%20controlled-release%20test%20formulation&subtitle=Oxycodone%20controlled-release%20test%20formulation%20%C2%B7%20Pfizer&badge=phase%202 Oxycodone controlled-release test formulation Oxycodone controlled-release test formulation · Pfizer https://druglandscape.com/drug/oxycodone-in https://druglandscape.com/api/og?type=drug&title=Oxycodone%20IN&subtitle=Oxycodone%20IN%20%C2%B7%20Parc%20de%20Salut%20Mar&badge=phase%201 Oxycodone IN Oxycodone IN · Parc de Salut Mar https://druglandscape.com/drug/oxycodone-ir-adf https://druglandscape.com/api/og?type=drug&title=Oxycodone%20IR%20ADF&subtitle=Oxycodone%20IR%20ADF%20%C2%B7%20Gr%C3%BCnenthal%20GmbH&badge=phase%201 Oxycodone IR ADF Oxycodone IR ADF · Grünenthal GmbH https://druglandscape.com/drug/oxycodone-paroxetine-and-quetiapine https://druglandscape.com/api/og?type=drug&title=Oxycodone%2C%20Paroxetine%2C%20and%20Quetiapine&subtitle=Oxycodone%2C%20Paroxetine%2C%20and%20Quetiapine%20%C2%B7%20Food%20and%20Drug%20Administration%20(FDA)&badge=phase%201 Oxycodone, Paroxetine, and Quetiapine Oxycodone, Paroxetine, and Quetiapine · Food and Drug Administration (FDA) https://druglandscape.com/drug/oxycodone-part-b https://druglandscape.com/api/og?type=drug&title=Oxycodone%20-%20Part%20B&subtitle=Oxycodone%20-%20Part%20B%20%C2%B7%20Indivior%20Inc.&badge=phase%201 Oxycodone - Part B Oxycodone - Part B · Indivior Inc. https://druglandscape.com/drug/oxycodone-prolonged-release-tablet https://druglandscape.com/api/og?type=drug&title=oxycodone%20prolonged%20release%20tablet&subtitle=oxycodone%20prolonged%20release%20tablet%20%C2%B7%20Mundipharma%20Research%20GmbH%20%26%20Co%20KG&badge=phase%203 oxycodone prolonged release tablet oxycodone prolonged release tablet · Mundipharma Research GmbH & Co KG https://druglandscape.com/drug/oxycodone-tamper-resistant https://druglandscape.com/api/og?type=drug&title=Oxycodone%20Tamper%20Resistant&subtitle=Oxycodone%20Tamper%20Resistant%20%C2%B7%20Mundipharma%20(China)%20Pharmaceutical%20Co.%20Ltd&badge=phase%201 Oxycodone Tamper Resistant Oxycodone Tamper Resistant · Mundipharma (China) Pharmaceutical Co. Ltd https://druglandscape.com/drug/oxyhydrogen-nanobubble-infusion https://druglandscape.com/api/og?type=drug&title=oxyhydrogen%20nanobubble%20infusion&subtitle=oxyhydrogen%20nanobubble%20infusion%20%C2%B7%20dr.%20Siti%20Nurlaela%2C%20SpN&badge=phase%202 oxyhydrogen nanobubble infusion oxyhydrogen nanobubble infusion · dr. Siti Nurlaela, SpN https://druglandscape.com/drug/oxymetazoline-hcl-0-025 https://druglandscape.com/api/og?type=drug&title=Oxymetazoline%20HCl%200.025%25&subtitle=Oxymetazoline%20HCl%200.025%25%20%C2%B7%20Eye%20Therapies%2C%20LLC&badge=phase%202 Oxymetazoline HCl 0.025% Oxymetazoline HCl 0.025% · Eye Therapies, LLC https://druglandscape.com/drug/oxypr-followed-by-oxn-pr-tablets https://druglandscape.com/api/og?type=drug&title=OxyPR%20followed%20by%20OXN%20PR%20tablets&subtitle=OxyPR%20followed%20by%20OXN%20PR%20tablets%20%C2%B7%20Mundipharma%20Research%20GmbH%20%26%20Co%20KG&badge=phase%202 OxyPR followed by OXN PR tablets OxyPR followed by OXN PR tablets · Mundipharma Research GmbH & Co KG https://druglandscape.com/drug/oxytocin-100-i-u https://druglandscape.com/api/og?type=drug&title=Oxytocin%20100%20i.u.&subtitle=Oxytocin%20100%20i.u.%20%C2%B7%20PepTonic%20Medical%20AB&badge=phase%202 Oxytocin 100 i.u. Oxytocin 100 i.u. · PepTonic Medical AB https://druglandscape.com/drug/oxytocin-400-i-u https://druglandscape.com/api/og?type=drug&title=Oxytocin%20400%20i.u.&subtitle=Oxytocin%20400%20i.u.%20%C2%B7%20PepTonic%20Medical%20AB&badge=phase%202 Oxytocin 400 i.u. Oxytocin 400 i.u. · PepTonic Medical AB https://druglandscape.com/drug/oxytocin-and-misoprostol https://druglandscape.com/api/og?type=drug&title=oxytocin%20and%20misoprostol&subtitle=oxytocin%20and%20misoprostol%20%C2%B7%20Jhpiego&badge=phase%201 oxytocin and misoprostol oxytocin and misoprostol · Jhpiego https://druglandscape.com/drug/oxytocin-iv https://druglandscape.com/api/og?type=drug&title=Oxytocin%20IV&subtitle=Oxytocin%20IV%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%201 Oxytocin IV Oxytocin IV · Sheba Medical Center https://druglandscape.com/drug/oxytocin-only https://druglandscape.com/api/og?type=drug&title=Oxytocin%20only&subtitle=Oxytocin%20only%20%C2%B7%20Darlington-Peter%20Chibuzor%20Ugoji&badge=phase%201 Oxytocin only Oxytocin only · Darlington-Peter Chibuzor Ugoji https://druglandscape.com/drug/oxytocin-tranexamic-acid-and-ethamsylate https://druglandscape.com/api/og?type=drug&title=Oxytocin%20%2CTranexamic%20acid%20and%20Ethamsylate&subtitle=Oxytocin%20%2CTranexamic%20acid%20and%20Ethamsylate%20%C2%B7%20Egymedicalpedia&badge=phase%201 Oxytocin ,Tranexamic acid and Ethamsylate Oxytocin ,Tranexamic acid and Ethamsylate · Egymedicalpedia https://druglandscape.com/drug/oz439-prototype-1 https://druglandscape.com/api/og?type=drug&title=OZ439%20Prototype%201&subtitle=OZ439%20Prototype%201%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 OZ439 Prototype 1 OZ439 Prototype 1 · Medicines for Malaria Venture https://druglandscape.com/drug/oz439-prototype-3 https://druglandscape.com/api/og?type=drug&title=OZ439%20Prototype%203&subtitle=OZ439%20Prototype%203%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 OZ439 Prototype 3 OZ439 Prototype 3 · Medicines for Malaria Venture https://druglandscape.com/drug/ozon-treatment https://druglandscape.com/api/og?type=drug&title=Ozon%20treatment&subtitle=Ozon%20treatment%20%C2%B7%20Yunus%20Burak%20Bay%C4%B1r&badge=phase%201 Ozon treatment Ozon treatment · Yunus Burak Bayır https://druglandscape.com/drug/ozone-therapy https://druglandscape.com/api/og?type=drug&title=Ozone%20therapy&subtitle=Ozone%20therapy%20%C2%B7%20Bernardino%20Clavo%2C%20MD%2C%20PhD&badge=phase%202 Ozone therapy Ozone therapy · Bernardino Clavo, MD, PhD https://druglandscape.com/drug/ozone-treatment https://druglandscape.com/api/og?type=drug&title=Ozone%20treatment&subtitle=Ozone%20treatment%20%C2%B7%20Ekrem%20Bilal%20Karaayvaz&badge=phase%201 Ozone treatment Ozone treatment · Ekrem Bilal Karaayvaz https://druglandscape.com/drug/p-cd19cd20-allo1 https://druglandscape.com/api/og?type=drug&title=P-CD19CD20-ALLO1&subtitle=P-CD19CD20-ALLO1%20%C2%B7%20Poseida%20Therapeutics%2C%20Inc.&badge=phase%201 P-CD19CD20-ALLO1 P-CD19CD20-ALLO1 · Poseida Therapeutics, Inc. https://druglandscape.com/drug/p-cd19cd20-allo1-cells https://druglandscape.com/api/og?type=drug&title=P-CD19CD20-ALLO1%20Cells&subtitle=P-CD19CD20-ALLO1%20Cells%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 P-CD19CD20-ALLO1 Cells P-CD19CD20-ALLO1 Cells · Genentech, Inc. https://druglandscape.com/drug/p-falciparum-ibsm-infection https://druglandscape.com/api/og?type=drug&title=P.%20falciparum%20IBSM%20infection&subtitle=P.%20falciparum%20IBSM%20infection%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 P. falciparum IBSM infection P. falciparum IBSM infection · Medicines for Malaria Venture https://druglandscape.com/drug/p-gp-victim-drug https://druglandscape.com/api/og?type=drug&title=P-gp%20victim%20drug&subtitle=P-gp%20victim%20drug%20%C2%B7%20Kadmon%2C%20a%20Sanofi%20Company&badge=phase%201 P-gp victim drug P-gp victim drug · Kadmon, a Sanofi Company https://druglandscape.com/drug/p-pnl-thc-cbd-soft-gelatin-capsule https://druglandscape.com/api/og?type=drug&title=P-PNL-THC%3ACBD%20soft%20gelatin%20capsule&subtitle=P-PNL-THC%3ACBD%20soft%20gelatin%20capsule%20%C2%B7%20PhytoTech%20Therapeutics%2C%20Ltd.&badge=phase%201 P-PNL-THC:CBD soft gelatin capsule P-PNL-THC:CBD soft gelatin capsule · PhytoTech Therapeutics, Ltd. https://druglandscape.com/drug/p-tabletten-wei https://druglandscape.com/api/og?type=drug&title=P-Tabletten%20wei%C3%9F&subtitle=P-Tabletten%20wei%C3%9F%20%C2%B7%20Pascoe%20Pharmazeutische%20Praeparate%20GmbH&badge=phase%201 P-Tabletten weiß P-Tabletten weiß · Pascoe Pharmazeutische Praeparate GmbH https://druglandscape.com/drug/p-tev https://druglandscape.com/api/og?type=drug&title=P-TEV&subtitle=P-TEV%20%C2%B7%20Verigraft%20AB&badge=phase%201 P-TEV P-TEV · Verigraft AB https://druglandscape.com/drug/p-vivax-infected-mosquito-bites https://druglandscape.com/api/og?type=drug&title=P.%20vivax%20infected%20mosquito%20bites&subtitle=P.%20vivax%20infected%20mosquito%20bites%20%C2%B7%20Socrates%20Herrera%20Valencia&badge=phase%201 P. vivax infected mosquito bites P. vivax infected mosquito bites · Socrates Herrera Valencia https://druglandscape.com/drug/p03277 https://druglandscape.com/api/og?type=drug&title=P03277&subtitle=P03277%20%C2%B7%20Guerbet&badge=phase%202 P03277 P03277 · Guerbet https://druglandscape.com/drug/p1101-180-g-q1w-48-doses https://druglandscape.com/api/og?type=drug&title=P1101%20180%20%C2%B5g%20Q1W%2C%2048%20doses&subtitle=P1101%20180%20%C2%B5g%20Q1W%2C%2048%20doses%20%C2%B7%20PharmaEssentia&badge=phase%202 P1101 180 µg Q1W, 48 doses P1101 180 µg Q1W, 48 doses · PharmaEssentia https://druglandscape.com/drug/p1101-270-g-q1w-48-doses https://druglandscape.com/api/og?type=drug&title=P1101%20270%C2%B5g%20Q1W%2C%2048%20doses&subtitle=P1101%20270%C2%B5g%20Q1W%2C%2048%20doses%20%C2%B7%20PharmaEssentia&badge=phase%202 P1101 270µg Q1W, 48 doses P1101 270µg Q1W, 48 doses · PharmaEssentia https://druglandscape.com/drug/p11187 https://druglandscape.com/api/og?type=drug&title=P11187&subtitle=P11187%20%C2%B7%20Piramal%20Enterprises%20Limited&badge=phase%201 P11187 P11187 · Piramal Enterprises Limited https://druglandscape.com/drug/p144-cream https://druglandscape.com/api/og?type=drug&title=P144%20cream&subtitle=P144%20cream%20%C2%B7%20ISDIN&badge=phase%202 P144 cream P144 cream · ISDIN https://druglandscape.com/drug/p16-37-63 https://druglandscape.com/api/og?type=drug&title=P16_37-63&subtitle=P16_37-63%20%C2%B7%20Oryx%20GmbH%20%26%20Co.%20KG&badge=phase%201 P16_37-63 P16_37-63 · Oryx GmbH & Co. KG https://druglandscape.com/drug/p2-vp8-subunit-rotavirus-vaccine https://druglandscape.com/api/og?type=drug&title=P2-VP8%20subunit%20rotavirus%20vaccine&subtitle=P2-VP8%20subunit%20rotavirus%20vaccine%20%C2%B7%20PATH&badge=phase%201 P2-VP8 subunit rotavirus vaccine P2-VP8 subunit rotavirus vaccine · PATH https://druglandscape.com/drug/p3-fast https://druglandscape.com/api/og?type=drug&title=P3-Fast&subtitle=P3-Fast%20%C2%B7%20Pfizer&badge=phase%201 P3-Fast P3-Fast · Pfizer https://druglandscape.com/drug/p501-as15-vaccine https://druglandscape.com/api/og?type=drug&title=P501-AS15%20vaccine&subtitle=P501-AS15%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%201 P501-AS15 vaccine P501-AS15 vaccine · GlaxoSmithKline https://druglandscape.com/drug/p53-gene https://druglandscape.com/api/og?type=drug&title=p53%20gene&subtitle=p53%20gene%20%C2%B7%20Shenzhen%20SiBiono%20GeneTech%20Co.%2CLtd&badge=phase%202 p53 gene p53 gene · Shenzhen SiBiono GeneTech Co.,Ltd https://druglandscape.com/drug/pa-111a https://druglandscape.com/api/og?type=drug&title=PA-111A&subtitle=PA-111A%20%C2%B7%20Addpharma%20Inc.&badge=phase%201 PA-111A PA-111A · Addpharma Inc. https://druglandscape.com/drug/pa1010 https://druglandscape.com/api/og?type=drug&title=PA1010&subtitle=PA1010%20%C2%B7%20Zhejiang%20Palo%20Alto%20Pharmaceuticals%2C%20Inc.&badge=phase%201 PA1010 PA1010 · Zhejiang Palo Alto Pharmaceuticals, Inc. https://druglandscape.com/drug/pa32540-and-celecoxib https://druglandscape.com/api/og?type=drug&title=PA32540%20and%20celecoxib&subtitle=PA32540%20and%20celecoxib%20%C2%B7%20POZEN&badge=phase%201 PA32540 and celecoxib PA32540 and celecoxib · POZEN https://druglandscape.com/drug/pa3670 https://druglandscape.com/api/og?type=drug&title=PA3670&subtitle=PA3670%20%C2%B7%20Zhejiang%20Palo%20Alto%20Pharmaceuticals%2C%20Inc.&badge=phase%201 PA3670 PA3670 · Zhejiang Palo Alto Pharmaceuticals, Inc. https://druglandscape.com/drug/pa5108 https://druglandscape.com/api/og?type=drug&title=PA5108&subtitle=PA5108%20%C2%B7%20PolyActiva%20Pty%20Ltd&badge=phase%201 PA5108 PA5108 · PolyActiva Pty Ltd https://druglandscape.com/drug/pa5108-latanoprost-fa-sr-ocular-implant https://druglandscape.com/api/og?type=drug&title=PA5108%20Latanoprost%20FA%20SR%20Ocular%20Implant&subtitle=PA5108%20Latanoprost%20FA%20SR%20Ocular%20Implant%20%C2%B7%20PolyActiva%20Pty%20Ltd&badge=phase%201 PA5108 Latanoprost FA SR Ocular Implant PA5108 Latanoprost FA SR Ocular Implant · PolyActiva Pty Ltd https://druglandscape.com/drug/pa83-fhcmb https://druglandscape.com/api/og?type=drug&title=PA83-FhCMB&subtitle=PA83-FhCMB%20%C2%B7%20Fraunhofer%2C%20Center%20for%20Molecular%20Biotechnology&badge=phase%201 PA83-FhCMB PA83-FhCMB · Fraunhofer, Center for Molecular Biotechnology https://druglandscape.com/drug/pac-cb https://druglandscape.com/api/og?type=drug&title=Pac-CB&subtitle=Pac-CB%20%C2%B7%20Calithera%20Biosciences%2C%20Inc&badge=phase%201 Pac-CB Pac-CB · Calithera Biosciences, Inc https://druglandscape.com/drug/pac113 https://druglandscape.com/api/og?type=drug&title=PAC113&subtitle=PAC113%20%C2%B7%20Pacgen%20Biopharmaceuticals%20Corporation&badge=phase%202 PAC113 PAC113 · Pacgen Biopharmaceuticals Corporation https://druglandscape.com/drug/pacap https://druglandscape.com/api/og?type=drug&title=PACAP&subtitle=PACAP%20%C2%B7%20Danish%20Headache%20Center&badge=phase%201 PACAP PACAP · Danish Headache Center https://druglandscape.com/drug/pacap-38 https://druglandscape.com/api/og?type=drug&title=PACAP-38&subtitle=PACAP-38%20%C2%B7%20Danish%20Headache%20Center&badge=phase%201 PACAP-38 PACAP-38 · Danish Headache Center https://druglandscape.com/drug/pacap-38-challenge-agent https://druglandscape.com/api/og?type=drug&title=PACAP-38%20Challenge%20Agent&subtitle=PACAP-38%20Challenge%20Agent%20%C2%B7%20Amgen&badge=phase%201 PACAP-38 Challenge Agent PACAP-38 Challenge Agent · Amgen https://druglandscape.com/drug/pacap27 https://druglandscape.com/api/og?type=drug&title=PACAP27&subtitle=PACAP27%20%C2%B7%20Danish%20Headache%20Center&badge=phase%201 PACAP27 PACAP27 · Danish Headache Center https://druglandscape.com/drug/pacap38 https://druglandscape.com/api/og?type=drug&title=PACAP38&subtitle=PACAP38%20%C2%B7%20Danish%20Headache%20Center&badge=phase%201 PACAP38 PACAP38 · Danish Headache Center https://druglandscape.com/drug/pacemaker-and-defibrillator https://druglandscape.com/api/og?type=drug&title=Pacemaker%20and%20defibrillator&subtitle=Pacemaker%20and%20defibrillator%20%C2%B7%20Deutsches%20Herzzentrum%20Muenchen&badge=phase%202 Pacemaker and defibrillator Pacemaker and defibrillator · Deutsches Herzzentrum Muenchen https://druglandscape.com/drug/packed-red-blood-cells-transfusion https://druglandscape.com/api/og?type=drug&title=packed%20red%20blood%20cells%20transfusion&subtitle=packed%20red%20blood%20cells%20transfusion%20%C2%B7%20Rania%20Ali%20El-Farrash&badge=phase%201 packed red blood cells transfusion packed red blood cells transfusion · Rania Ali El-Farrash https://druglandscape.com/drug/paclitaxel-and-platinum https://druglandscape.com/api/og?type=drug&title=paclitaxel%20and%20platinum&subtitle=paclitaxel%20and%20platinum%20%C2%B7%20Women's%20Hospital%20School%20Of%20Medicine%20Zhejiang%20University&badge=phase%203 paclitaxel and platinum paclitaxel and platinum · Women's Hospital School Of Medicine Zhejiang University https://druglandscape.com/drug/paclitaxel-and-ramucirumab https://druglandscape.com/api/og?type=drug&title=Paclitaxel%20and%20ramucirumab&subtitle=Paclitaxel%20and%20ramucirumab%20%C2%B7%20Hellenic%20Cooperative%20Oncology%20Group&badge=phase%202 Paclitaxel and ramucirumab Paclitaxel and ramucirumab · Hellenic Cooperative Oncology Group https://druglandscape.com/drug/paclitaxel-and-sorafenib https://druglandscape.com/api/og?type=drug&title=Paclitaxel%20and%20Sorafenib&subtitle=Paclitaxel%20and%20Sorafenib%20%C2%B7%20Gesellschaft%20fur%20Medizinische%20Innovation%20-%20Hamatologie%20und%20Onkologie%20mbH&badge=phase%202 Paclitaxel and Sorafenib Paclitaxel and Sorafenib · Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH https://druglandscape.com/drug/paclitaxel-bound-albumine https://druglandscape.com/api/og?type=drug&title=Paclitaxel%20bound%20albumine&subtitle=Paclitaxel%20bound%20albumine%20%C2%B7%20Gruppo%20Oncologico%20Italiano%20di%20Ricerca%20Clinica&badge=phase%201 Paclitaxel bound albumine Paclitaxel bound albumine · Gruppo Oncologico Italiano di Ricerca Clinica https://druglandscape.com/drug/paclitaxel-carboplatin-and-bevacizumab https://druglandscape.com/api/og?type=drug&title=paclitaxel%2C%20carboplatin%20and%20bevacizumab&subtitle=paclitaxel%2C%20carboplatin%20and%20bevacizumab%20%C2%B7%20Spanish%20Lung%20Cancer%20Group&badge=phase%202 paclitaxel, carboplatin and bevacizumab paclitaxel, carboplatin and bevacizumab · Spanish Lung Cancer Group https://druglandscape.com/drug/paclitaxel-carboplatin-pembrolizumab https://druglandscape.com/api/og?type=drug&title=Paclitaxel%2C%20Carboplatin%2C%20Pembrolizumab&subtitle=Paclitaxel%2C%20Carboplatin%2C%20Pembrolizumab%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 Paclitaxel, Carboplatin, Pembrolizumab Paclitaxel, Carboplatin, Pembrolizumab · Samsung Medical Center https://druglandscape.com/drug/paclitaxel-cationic-liposomes https://druglandscape.com/api/og?type=drug&title=paclitaxel%20cationic%20liposomes&subtitle=paclitaxel%20cationic%20liposomes%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 paclitaxel cationic liposomes paclitaxel cationic liposomes · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/paclitaxel-docetaxel-taxane https://druglandscape.com/api/og?type=drug&title=paclitaxel%2C%20docetaxel%2C%20taxane&subtitle=paclitaxel%2C%20docetaxel%2C%20taxane%20%C2%B7%20New%20Mexico%20Cancer%20Research%20Alliance&badge=phase%203 paclitaxel, docetaxel, taxane paclitaxel, docetaxel, taxane · New Mexico Cancer Research Alliance https://druglandscape.com/drug/paclitaxel-dose-escalation https://druglandscape.com/api/og?type=drug&title=Paclitaxel%20dose%20escalation&subtitle=Paclitaxel%20dose%20escalation%20%C2%B7%20Centre%20Oscar%20Lambret&badge=phase%201 Paclitaxel dose escalation Paclitaxel dose escalation · Centre Oscar Lambret https://druglandscape.com/drug/paclitaxel-liposome-injection-plus-cisplatin https://druglandscape.com/api/og?type=drug&title=paclitaxel%20liposome%20injection%20plus%20cisplatin&subtitle=paclitaxel%20liposome%20injection%20plus%20cisplatin%20%C2%B7%20Nanjing%20Luye%20Sike%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 paclitaxel liposome injection plus cisplatin paclitaxel liposome injection plus cisplatin · Nanjing Luye Sike Pharmaceutical Co., Ltd. https://druglandscape.com/drug/paclitaxel-mitotic-inhibitor-intravenous https://druglandscape.com/api/og?type=drug&title=Paclitaxel%2C%20mitotic%20inhibitor%3B%20intravenous&subtitle=Paclitaxel%2C%20mitotic%20inhibitor%3B%20intravenous%20%C2%B7%20Array%20Biopharma%2C%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfize&badge=phase%201 Paclitaxel, mitotic inhibitor; intravenous Paclitaxel, mitotic inhibitor; intravenous · Array Biopharma, now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/paclitaxel-nanoparticle-albumin-bound https://druglandscape.com/api/og?type=drug&title=Paclitaxel%20Nanoparticle%20Albumin%20Bound&subtitle=Paclitaxel%20Nanoparticle%20Albumin%20Bound%20%C2%B7%20Celgene&badge=phase%202 Paclitaxel Nanoparticle Albumin Bound Paclitaxel Nanoparticle Albumin Bound · Celgene https://druglandscape.com/drug/paclitaxel-or-nab-paclitaxel https://druglandscape.com/api/og?type=drug&title=Paclitaxel%20or%20Nab-Paclitaxel&subtitle=Paclitaxel%20or%20Nab-Paclitaxel%20%C2%B7%20MedImmune%20LLC&badge=phase%202 Paclitaxel or Nab-Paclitaxel Paclitaxel or Nab-Paclitaxel · MedImmune LLC https://druglandscape.com/drug/paclitaxel-plus-trastuzumab https://druglandscape.com/api/og?type=drug&title=paclitaxel%20plus%20trastuzumab&subtitle=paclitaxel%20plus%20trastuzumab%20%C2%B7%20WiSP%20Wissenschaftlicher%20Service%20Pharma%20GmbH&badge=phase%202 paclitaxel plus trastuzumab paclitaxel plus trastuzumab · WiSP Wissenschaftlicher Service Pharma GmbH https://druglandscape.com/drug/paclitaxel-poliglumex-pemetrexed https://druglandscape.com/api/og?type=drug&title=paclitaxel%20poliglumex%2C%20pemetrexed&subtitle=paclitaxel%20poliglumex%2C%20pemetrexed%20%C2%B7%20Dartmouth-Hitchcock%20Medical%20Center&badge=phase%202 paclitaxel poliglumex, pemetrexed paclitaxel poliglumex, pemetrexed · Dartmouth-Hitchcock Medical Center https://druglandscape.com/drug/paclitaxel-trastzumab https://druglandscape.com/api/og?type=drug&title=Paclitaxel-trastzumab&subtitle=Paclitaxel-trastzumab%20%C2%B7%20Amsterdam%20UMC%2C%20location%20VUmc&badge=phase%202 Paclitaxel-trastzumab Paclitaxel-trastzumab · Amsterdam UMC, location VUmc https://druglandscape.com/drug/paclitaxel-vinorelbine-cisplatin https://druglandscape.com/api/og?type=drug&title=Paclitaxel%2C%20vinorelbine%2C%20cisplatin&subtitle=Paclitaxel%2C%20vinorelbine%2C%20cisplatin%20%C2%B7%20Intergroupe%20Francophone%20de%20Cancerologie%20Thoracique&badge=phase%202 Paclitaxel, vinorelbine, cisplatin Paclitaxel, vinorelbine, cisplatin · Intergroupe Francophone de Cancerologie Thoracique https://druglandscape.com/drug/pacritinib-and-clarithromycin https://druglandscape.com/api/og?type=drug&title=Pacritinib%20and%20Clarithromycin&subtitle=Pacritinib%20and%20Clarithromycin%20%C2%B7%20CTI%20BioPharma&badge=phase%201 Pacritinib and Clarithromycin Pacritinib and Clarithromycin · CTI BioPharma https://druglandscape.com/drug/pacritinib-and-rifampin https://druglandscape.com/api/og?type=drug&title=Pacritinib%20and%20Rifampin&subtitle=Pacritinib%20and%20Rifampin%20%C2%B7%20CTI%20BioPharma&badge=phase%201 Pacritinib and Rifampin Pacritinib and Rifampin · CTI BioPharma https://druglandscape.com/drug/pad-induction https://druglandscape.com/api/og?type=drug&title=PAD%20induction&subtitle=PAD%20induction%20%C2%B7%20Janssen-Cilag%20Pty%20Ltd&badge=phase%202 PAD induction PAD induction · Janssen-Cilag Pty Ltd https://druglandscape.com/drug/padre-cmv-fusion-peptide-vaccine https://druglandscape.com/api/og?type=drug&title=PADRE-CMV%20fusion%20peptide%20vaccine&subtitle=PADRE-CMV%20fusion%20peptide%20vaccine%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%201 PADRE-CMV fusion peptide vaccine PADRE-CMV fusion peptide vaccine · City of Hope Medical Center https://druglandscape.com/drug/pah-medication https://druglandscape.com/api/og?type=drug&title=PAH%20medication&subtitle=PAH%20medication%20%C2%B7%20Bayer&badge=phase%202 PAH medication PAH medication · Bayer https://druglandscape.com/drug/pain-relief-medication https://druglandscape.com/api/og?type=drug&title=Pain-Relief%20Medication&subtitle=Pain-Relief%20Medication%20%C2%B7%20Parc%20de%20Salut%20Mar&badge=phase%202 Pain-Relief Medication Pain-Relief Medication · Parc de Salut Mar https://druglandscape.com/drug/palbociclib-administered-fasted https://druglandscape.com/api/og?type=drug&title=Palbociclib%20administered%20Fasted&subtitle=Palbociclib%20administered%20Fasted%20%C2%B7%20Pfizer&badge=phase%201 Palbociclib administered Fasted Palbociclib administered Fasted · Pfizer https://druglandscape.com/drug/palbociclib-administered-fed-high-calorie https://druglandscape.com/api/og?type=drug&title=Palbociclib%20administered%20Fed%20high%20calorie&subtitle=Palbociclib%20administered%20Fed%20high%20calorie%20%C2%B7%20Pfizer&badge=phase%201 Palbociclib administered Fed high calorie Palbociclib administered Fed high calorie · Pfizer https://druglandscape.com/drug/palbociclib-administered-fed-low-calorie https://druglandscape.com/api/og?type=drug&title=Palbociclib%20administered%20Fed%20low%20calorie&subtitle=Palbociclib%20administered%20Fed%20low%20calorie%20%C2%B7%20Pfizer&badge=phase%201 Palbociclib administered Fed low calorie Palbociclib administered Fed low calorie · Pfizer https://druglandscape.com/drug/palbociclib-administered-fed-moderate-calorie https://druglandscape.com/api/og?type=drug&title=Palbociclib%20administered%20Fed%20moderate%20calorie&subtitle=Palbociclib%20administered%20Fed%20moderate%20calorie%20%C2%B7%20Pfizer&badge=phase%201 Palbociclib administered Fed moderate calorie Palbociclib administered Fed moderate calorie · Pfizer https://druglandscape.com/drug/palbociclib-alone https://druglandscape.com/api/og?type=drug&title=Palbociclib%20alone&subtitle=Palbociclib%20alone%20%C2%B7%20Pfizer&badge=phase%201 Palbociclib alone Palbociclib alone · Pfizer https://druglandscape.com/drug/palbociclib-capsule-ich https://druglandscape.com/api/og?type=drug&title=Palbociclib%20capsule%3A%20ICH&subtitle=Palbociclib%20capsule%3A%20ICH%20%C2%B7%20Pfizer&badge=phase%201 Palbociclib capsule: ICH Palbociclib capsule: ICH · Pfizer https://druglandscape.com/drug/palbociclib-commercial-free-base https://druglandscape.com/api/og?type=drug&title=palbociclib%20commercial%20free%20base&subtitle=palbociclib%20commercial%20free%20base%20%C2%B7%20Pfizer&badge=phase%201 palbociclib commercial free base palbociclib commercial free base · Pfizer https://druglandscape.com/drug/palbociclib-formulation-reference https://druglandscape.com/api/og?type=drug&title=Palbociclib%20Formulation%20Reference&subtitle=Palbociclib%20Formulation%20Reference%20%C2%B7%20Pfizer&badge=phase%201 Palbociclib Formulation Reference Palbociclib Formulation Reference · Pfizer https://druglandscape.com/drug/palbociclib-formulation-test https://druglandscape.com/api/og?type=drug&title=Palbociclib%20Formulation%20Test&subtitle=Palbociclib%20Formulation%20Test%20%C2%B7%20Pfizer&badge=phase%201 Palbociclib Formulation Test Palbociclib Formulation Test · Pfizer https://druglandscape.com/drug/palbociclib-plus-an-aromatase-inhibitor https://druglandscape.com/api/og?type=drug&title=Palbociclib%20plus%20an%20aromatase%20inhibitor&subtitle=Palbociclib%20plus%20an%20aromatase%20inhibitor%20%C2%B7%20Pfizer&badge=phase%202 Palbociclib plus an aromatase inhibitor Palbociclib plus an aromatase inhibitor · Pfizer https://druglandscape.com/drug/palbociclib-plus-itraconazole https://druglandscape.com/api/og?type=drug&title=Palbociclib%20plus%20itraconazole&subtitle=Palbociclib%20plus%20itraconazole%20%C2%B7%20Pfizer&badge=phase%201 Palbociclib plus itraconazole Palbociclib plus itraconazole · Pfizer https://druglandscape.com/drug/palbociclib-plus-modafinil https://druglandscape.com/api/og?type=drug&title=Palbociclib%20plus%20Modafinil&subtitle=Palbociclib%20plus%20Modafinil%20%C2%B7%20Pfizer&badge=phase%201 Palbociclib plus Modafinil Palbociclib plus Modafinil · Pfizer https://druglandscape.com/drug/palbociclib-plus-pioglitazone https://druglandscape.com/api/og?type=drug&title=Palbociclib%20plus%20pioglitazone&subtitle=Palbociclib%20plus%20pioglitazone%20%C2%B7%20Pfizer&badge=phase%201 Palbociclib plus pioglitazone Palbociclib plus pioglitazone · Pfizer https://druglandscape.com/drug/palbociclib-tablet https://druglandscape.com/api/og?type=drug&title=Palbociclib%20tablet&subtitle=Palbociclib%20tablet%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 Palbociclib tablet Palbociclib tablet · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/palingen-flow-amniotic-tissue-allograft https://druglandscape.com/api/og?type=drug&title=PalinGen%20Flow%20Amniotic%20Tissue%20Allograft&subtitle=PalinGen%20Flow%20Amniotic%20Tissue%20Allograft%20%C2%B7%20Amnio%20Technology%2C%20LLC&badge=phase%202 PalinGen Flow Amniotic Tissue Allograft PalinGen Flow Amniotic Tissue Allograft · Amnio Technology, LLC https://druglandscape.com/drug/paliperidone-er-carbamazepine https://druglandscape.com/api/og?type=drug&title=paliperidone%20ER%3B%20Carbamazepine&subtitle=paliperidone%20ER%3B%20Carbamazepine%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 paliperidone ER; Carbamazepine paliperidone ER; Carbamazepine · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/paliperidone-lai https://druglandscape.com/api/og?type=drug&title=Paliperidone%2C%20LAI&subtitle=Paliperidone%2C%20LAI%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Paliperidone, LAI Paliperidone, LAI · Janssen Research & Development, LLC https://druglandscape.com/drug/paliperidone-palmitate-f016 https://druglandscape.com/api/og?type=drug&title=Paliperidone%20palmitate%20F016&subtitle=Paliperidone%20palmitate%20F016%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Paliperidone palmitate F016 Paliperidone palmitate F016 · Janssen Research & Development, LLC https://druglandscape.com/drug/paliperidone-palmitate-treatment-a https://druglandscape.com/api/og?type=drug&title=Paliperidone%20palmitate%20Treatment%20A&subtitle=Paliperidone%20palmitate%20Treatment%20A%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 Paliperidone palmitate Treatment A Paliperidone palmitate Treatment A · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/paliperidone-palmitate-treatment-b https://druglandscape.com/api/og?type=drug&title=Paliperidone%20palmitate%20Treatment%20B&subtitle=Paliperidone%20palmitate%20Treatment%20B%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 Paliperidone palmitate Treatment B Paliperidone palmitate Treatment B · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/palivizumab-motavizumab https://druglandscape.com/api/og?type=drug&title=Palivizumab%2C%20motavizumab&subtitle=Palivizumab%2C%20motavizumab%20%C2%B7%20MedImmune%20LLC&badge=phase%202 Palivizumab, motavizumab Palivizumab, motavizumab · MedImmune LLC https://druglandscape.com/drug/palliative-care https://druglandscape.com/api/og?type=drug&title=palliative%20care&subtitle=palliative%20care%20%C2%B7%20OmicsWay%20Corp.&badge=phase%202 palliative care palliative care · OmicsWay Corp. https://druglandscape.com/drug/pallov-cc https://druglandscape.com/api/og?type=drug&title=PalloV-CC&subtitle=PalloV-CC%20%C2%B7%20George%20E.%20Peoples&badge=phase%201 PalloV-CC PalloV-CC · George E. Peoples https://druglandscape.com/drug/palonosetron-dexamethasone-carboplatin-paclitaxel-olanzapine https://druglandscape.com/api/og?type=drug&title=Palonosetron%2C%20Dexamethasone%2C%20Carboplatin%2C%20Paclitaxel%2C%20Olanzapine&subtitle=Palonosetron%2C%20Dexamethasone%2C%20Carboplatin%2C%20Paclitaxel%2C%20Olanzapine%20%C2%B7%20Fondazione%20IRCCS%20Istituto%20Naziona&badge=phase%202 Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine Palonosetron, Dexamethasone, Carboplatin, Paclitaxel, Olanzapine · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano https://druglandscape.com/drug/palovarotene-dose-level-1 https://druglandscape.com/api/og?type=drug&title=Palovarotene%20dose%20level%201&subtitle=Palovarotene%20dose%20level%201%20%C2%B7%20Clementia%20Pharmaceuticals%20Inc.&badge=phase%202 Palovarotene dose level 1 Palovarotene dose level 1 · Clementia Pharmaceuticals Inc. https://druglandscape.com/drug/palovarotene-dose-level-2 https://druglandscape.com/api/og?type=drug&title=Palovarotene%20dose%20level%202&subtitle=Palovarotene%20dose%20level%202%20%C2%B7%20Clementia%20Pharmaceuticals%20Inc.&badge=phase%202 Palovarotene dose level 2 Palovarotene dose level 2 · Clementia Pharmaceuticals Inc. https://druglandscape.com/drug/palovarotene-dose-level-3 https://druglandscape.com/api/og?type=drug&title=Palovarotene%20dose%20level%203&subtitle=Palovarotene%20dose%20level%203%20%C2%B7%20Clementia%20Pharmaceuticals%20Inc.&badge=phase%202 Palovarotene dose level 3 Palovarotene dose level 3 · Clementia Pharmaceuticals Inc. https://druglandscape.com/drug/palovarotene-dose-level-4 https://druglandscape.com/api/og?type=drug&title=Palovarotene%20dose%20level%204&subtitle=Palovarotene%20dose%20level%204%20%C2%B7%20Clementia%20Pharmaceuticals%20Inc.&badge=phase%202 Palovarotene dose level 4 Palovarotene dose level 4 · Clementia Pharmaceuticals Inc. https://druglandscape.com/drug/palovarotene-high-dose https://druglandscape.com/api/og?type=drug&title=palovarotene%20high-dose&subtitle=palovarotene%20high-dose%20%C2%B7%20Clementia%20Pharmaceuticals%20Inc.&badge=phase%201 palovarotene high-dose palovarotene high-dose · Clementia Pharmaceuticals Inc. https://druglandscape.com/drug/palovarotene-low-dose https://druglandscape.com/api/og?type=drug&title=palovarotene%20low-dose&subtitle=palovarotene%20low-dose%20%C2%B7%20Clementia%20Pharmaceuticals%20Inc.&badge=phase%201 palovarotene low-dose palovarotene low-dose · Clementia Pharmaceuticals Inc. https://druglandscape.com/drug/pan-301-1 https://druglandscape.com/api/og?type=drug&title=PAN-301-1&subtitle=PAN-301-1%20%C2%B7%20Sensei%20Biotherapeutics%2C%20Inc.&badge=phase%201 PAN-301-1 PAN-301-1 · Sensei Biotherapeutics, Inc. https://druglandscape.com/drug/panadol-film-coated-tablet https://druglandscape.com/api/og?type=drug&title=Panadol%20film-coated%20Tablet&subtitle=Panadol%20film-coated%20Tablet%20%C2%B7%20HALEON&badge=phase%201 Panadol film-coated Tablet Panadol film-coated Tablet · HALEON https://druglandscape.com/drug/panchol https://druglandscape.com/api/og?type=drug&title=PanChol&subtitle=PanChol%20%C2%B7%20Centre%20for%20Infectious%20Disease%20Research%20in%20Zambia&badge=phase%201 PanChol PanChol · Centre for Infectious Disease Research in Zambia https://druglandscape.com/drug/pancreatic-adenocarcinoma https://druglandscape.com/api/og?type=drug&title=Pancreatic%20adenocarcinoma&subtitle=Pancreatic%20adenocarcinoma%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Pancreatic adenocarcinoma Pancreatic adenocarcinoma · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/pancreatic-clamp https://druglandscape.com/api/og?type=drug&title=Pancreatic%20Clamp&subtitle=Pancreatic%20Clamp%20%C2%B7%20Albert%20Einstein%20College%20of%20Medicine&badge=phase%202 Pancreatic Clamp Pancreatic Clamp · Albert Einstein College of Medicine https://druglandscape.com/drug/pancreatic-neuroendocrine-tumor https://druglandscape.com/api/og?type=drug&title=Pancreatic%20neuroendocrine%20tumor&subtitle=Pancreatic%20neuroendocrine%20tumor%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Pancreatic neuroendocrine tumor Pancreatic neuroendocrine tumor · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/pancrelipase-microtablets https://druglandscape.com/api/og?type=drug&title=Pancrelipase%20microtablets&subtitle=Pancrelipase%20microtablets%20%C2%B7%20McNeil%20Consumer%20%26%20Specialty%20Pharmaceuticals%2C%20a%20Division%20of%20McNeil-PPC%2C%20I&badge=phase%202 Pancrelipase microtablets Pancrelipase microtablets · McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. https://druglandscape.com/drug/pancytovir https://druglandscape.com/api/og?type=drug&title=PanCytoVir%E2%84%A2&subtitle=PanCytoVir%E2%84%A2%20%C2%B7%20TrippBio%2C%20Inc.&badge=phase%201 PanCytoVir™ PanCytoVir™ · TrippBio, Inc. https://druglandscape.com/drug/pandemic-flu-h5-mrna-vaccine https://druglandscape.com/api/og?type=drug&title=Pandemic%20flu%20H5%20mRNA%20vaccine&subtitle=Pandemic%20flu%20H5%20mRNA%20vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Pandemic flu H5 mRNA vaccine Pandemic flu H5 mRNA vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/pandemrix https://druglandscape.com/api/og?type=drug&title=Pandemrix%20%E2%84%A2&subtitle=Pandemrix%20%E2%84%A2%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Pandemrix ™ Pandemrix ™ · GlaxoSmithKline https://druglandscape.com/drug/pangramin-plus-d-pteronyssinus https://druglandscape.com/api/og?type=drug&title=Pangramin%20Plus%20D.%20pteronyssinus&subtitle=Pangramin%20Plus%20D.%20pteronyssinus%20%C2%B7%20Miguel%20Blanca%20Gomez&badge=phase%202 Pangramin Plus D. pteronyssinus Pangramin Plus D. pteronyssinus · Miguel Blanca Gomez https://druglandscape.com/drug/panitumumab-and-cpt-11 https://druglandscape.com/api/og?type=drug&title=Panitumumab%20and%20CPT-11&subtitle=Panitumumab%20and%20CPT-11%20%C2%B7%20Spanish%20Cooperative%20Group%20for%20the%20Treatment%20of%20Digestive%20Tumours%20(TTD)&badge=phase%202 Panitumumab and CPT-11 Panitumumab and CPT-11 · Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) https://druglandscape.com/drug/panitumumab-mytomicin-c-5-fu-radiation https://druglandscape.com/api/og?type=drug&title=panitumumab%2C%20mytomicin%20C%2C%205-FU%2C%20radiation&subtitle=panitumumab%2C%20mytomicin%20C%2C%205-FU%2C%20radiation%20%C2%B7%20Grupo%20Espanol%20Multidisciplinario%20del%20Cancer%20Digestivo&badge=phase%202 panitumumab, mytomicin C, 5-FU, radiation panitumumab, mytomicin C, 5-FU, radiation · Grupo Espanol Multidisciplinario del Cancer Digestivo https://druglandscape.com/drug/panitumumab-plus-gemox-chemotherapy https://druglandscape.com/api/og?type=drug&title=Panitumumab%20plus%20GEMOX%20chemotherapy&subtitle=Panitumumab%20plus%20GEMOX%20chemotherapy%20%C2%B7%20Prof.%20Massimo%20Aglietta&badge=phase%202 Panitumumab plus GEMOX chemotherapy Panitumumab plus GEMOX chemotherapy · Prof. Massimo Aglietta https://druglandscape.com/drug/pankomab-gex https://druglandscape.com/api/og?type=drug&title=PankoMab-GEX%E2%84%A2&subtitle=PankoMab-GEX%E2%84%A2%20%C2%B7%20Glycotope%20GmbH&badge=phase%202 PankoMab-GEX™ PankoMab-GEX™ · Glycotope GmbH https://druglandscape.com/drug/panobinostat-nanoparticle-formulation-mtx110 https://druglandscape.com/api/og?type=drug&title=Panobinostat%20Nanoparticle%20Formulation%20MTX110&subtitle=Panobinostat%20Nanoparticle%20Formulation%20MTX110%20%C2%B7%20Sabine%20Mueller%2C%20MD%2C%20PhD&badge=phase%201 Panobinostat Nanoparticle Formulation MTX110 Panobinostat Nanoparticle Formulation MTX110 · Sabine Mueller, MD, PhD https://druglandscape.com/drug/pantoprazole-20 https://druglandscape.com/api/og?type=drug&title=Pantoprazole_20&subtitle=Pantoprazole_20%20%C2%B7%20Ahn-Gook%20Pharmaceuticals%20Co.%2CLtd&badge=phase%201 Pantoprazole_20 Pantoprazole_20 · Ahn-Gook Pharmaceuticals Co.,Ltd https://druglandscape.com/drug/pantoprazole-40 https://druglandscape.com/api/og?type=drug&title=Pantoprazole_40&subtitle=Pantoprazole_40%20%C2%B7%20Ahn-Gook%20Pharmaceuticals%20Co.%2CLtd&badge=phase%201 Pantoprazole_40 Pantoprazole_40 · Ahn-Gook Pharmaceuticals Co.,Ltd https://druglandscape.com/drug/panzem-nanocrystal-colloidal-dispersion https://druglandscape.com/api/og?type=drug&title=Panzem%20Nanocrystal%20Colloidal%20Dispersion&subtitle=Panzem%20Nanocrystal%20Colloidal%20Dispersion%20%C2%B7%20CASI%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Panzem Nanocrystal Colloidal Dispersion Panzem Nanocrystal Colloidal Dispersion · CASI Pharmaceuticals, Inc. https://druglandscape.com/drug/panzem-ncd https://druglandscape.com/api/og?type=drug&title=Panzem%C2%AE%20NCD&subtitle=Panzem%C2%AE%20NCD%20%C2%B7%20CASI%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Panzem® NCD Panzem® NCD · CASI Pharmaceuticals, Inc. https://druglandscape.com/drug/papaya-1-extract-ointment https://druglandscape.com/api/og?type=drug&title=papaya%201%25%20extract%20ointment&subtitle=papaya%201%25%20extract%20ointment%20%C2%B7%20Philippine%20Dermatological%20Society&badge=phase%201 papaya 1% extract ointment papaya 1% extract ointment · Philippine Dermatological Society https://druglandscape.com/drug/para-aminohippurate-infusion https://druglandscape.com/api/og?type=drug&title=Para-aminohippurate%20infusion&subtitle=Para-aminohippurate%20infusion%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 Para-aminohippurate infusion Para-aminohippurate infusion · ViiV Healthcare https://druglandscape.com/drug/paracetamol-3 https://druglandscape.com/api/og?type=drug&title=Paracetamol%203%25&subtitle=Paracetamol%203%25%20%C2%B7%20Sintetica%20SA&badge=phase%201 Paracetamol 3% Paracetamol 3% · Sintetica SA https://druglandscape.com/drug/paracetamol-fast-dissolution-suspension https://druglandscape.com/api/og?type=drug&title=Paracetamol%20fast%20dissolution%20suspension&subtitle=Paracetamol%20fast%20dissolution%20suspension%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Paracetamol fast dissolution suspension Paracetamol fast dissolution suspension · GlaxoSmithKline https://druglandscape.com/drug/paracetamol-odt https://druglandscape.com/api/og?type=drug&title=Paracetamol%20ODT&subtitle=Paracetamol%20ODT%20%C2%B7%20HALEON&badge=phase%201 Paracetamol ODT Paracetamol ODT · HALEON https://druglandscape.com/drug/paracetamol-slow-dissolution-suspension https://druglandscape.com/api/og?type=drug&title=Paracetamol%20slow%20dissolution%20suspension&subtitle=Paracetamol%20slow%20dissolution%20suspension%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Paracetamol slow dissolution suspension Paracetamol slow dissolution suspension · GlaxoSmithKline https://druglandscape.com/drug/paracetamol-tablets https://druglandscape.com/api/og?type=drug&title=Paracetamol%20tablets&subtitle=Paracetamol%20tablets%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Paracetamol tablets Paracetamol tablets · GlaxoSmithKline https://druglandscape.com/drug/paracetamol-the-group-p https://druglandscape.com/api/og?type=drug&title=paracetamol%2C%20the%20group%20P&subtitle=paracetamol%2C%20the%20group%20P%20%C2%B7%20Aga%20Khan%20University&badge=phase%203 paracetamol, the group P paracetamol, the group P · Aga Khan University https://druglandscape.com/drug/parenteral-anticoagulant https://druglandscape.com/api/og?type=drug&title=Parenteral%20anticoagulant&subtitle=Parenteral%20anticoagulant%20%C2%B7%20Pfizer&badge=phase%202 Parenteral anticoagulant Parenteral anticoagulant · Pfizer https://druglandscape.com/drug/paritaprevir-mini-tablet https://druglandscape.com/api/og?type=drug&title=Paritaprevir%20mini%20tablet&subtitle=Paritaprevir%20mini%20tablet%20%C2%B7%20AbbVie&badge=phase%202 Paritaprevir mini tablet Paritaprevir mini tablet · AbbVie https://druglandscape.com/drug/paromomycin-sulfate-fasted-state https://druglandscape.com/api/og?type=drug&title=Paromomycin%20Sulfate%20Fasted%20State&subtitle=Paromomycin%20Sulfate%20Fasted%20State%20%C2%B7%20KU%20Leuven&badge=phase%201 Paromomycin Sulfate Fasted State Paromomycin Sulfate Fasted State · KU Leuven https://druglandscape.com/drug/paromomycin-sulfate-fed-state https://druglandscape.com/api/og?type=drug&title=Paromomycin%20Sulfate%20Fed%20State&subtitle=Paromomycin%20Sulfate%20Fed%20State%20%C2%B7%20KU%20Leuven&badge=phase%201 Paromomycin Sulfate Fed State Paromomycin Sulfate Fed State · KU Leuven https://druglandscape.com/drug/paroxetine-12-5-milligrams-tablet https://druglandscape.com/api/og?type=drug&title=Paroxetine%2012.5%20milligrams%20tablet&subtitle=Paroxetine%2012.5%20milligrams%20tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Paroxetine 12.5 milligrams tablet Paroxetine 12.5 milligrams tablet · GlaxoSmithKline https://druglandscape.com/drug/paroxetine-alone https://druglandscape.com/api/og?type=drug&title=Paroxetine%20alone&subtitle=Paroxetine%20alone%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Paroxetine alone Paroxetine alone · GlaxoSmithKline https://druglandscape.com/drug/paroxetine-and-oxycodone https://druglandscape.com/api/og?type=drug&title=Paroxetine%20and%20Oxycodone&subtitle=Paroxetine%20and%20Oxycodone%20%C2%B7%20Food%20and%20Drug%20Administration%20(FDA)&badge=phase%201 Paroxetine and Oxycodone Paroxetine and Oxycodone · Food and Drug Administration (FDA) https://druglandscape.com/drug/paroxetine-controlled-release-tablet https://druglandscape.com/api/og?type=drug&title=Paroxetine%20controlled%20release%20tablet&subtitle=Paroxetine%20controlled%20release%20tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Paroxetine controlled release tablet Paroxetine controlled release tablet · GlaxoSmithKline https://druglandscape.com/drug/paroxetine-cr-and-paroxetine-ir https://druglandscape.com/api/og?type=drug&title=Paroxetine%20CR%20and%20Paroxetine%20IR&subtitle=Paroxetine%20CR%20and%20Paroxetine%20IR%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Paroxetine CR and Paroxetine IR Paroxetine CR and Paroxetine IR · GlaxoSmithKline https://druglandscape.com/drug/paroxetine-duloxetine-fluoxetine-or-venlafaxine https://druglandscape.com/api/og?type=drug&title=paroxetine%2C%20duloxetine%2C%20fluoxetine%20or%20venlafaxine&subtitle=paroxetine%2C%20duloxetine%2C%20fluoxetine%20or%20venlafaxine%20%C2%B7%20prof.%20Peter%20de%20Jonge&badge=phase%202 paroxetine, duloxetine, fluoxetine or venlafaxine paroxetine, duloxetine, fluoxetine or venlafaxine · prof. Peter de Jonge https://druglandscape.com/drug/paroxetine-ir-tablets-a https://druglandscape.com/api/og?type=drug&title=Paroxetine%20IR%20tablets%20A&subtitle=Paroxetine%20IR%20tablets%20A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Paroxetine IR tablets A Paroxetine IR tablets A · GlaxoSmithKline https://druglandscape.com/drug/paroxetine-ir-tablets-b https://druglandscape.com/api/og?type=drug&title=Paroxetine%20IR%20tablets%20B&subtitle=Paroxetine%20IR%20tablets%20B%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Paroxetine IR tablets B Paroxetine IR tablets B · GlaxoSmithKline https://druglandscape.com/drug/paroxetine-treatment-during-8-weeks https://druglandscape.com/api/og?type=drug&title=Paroxetine%20treatment%20during%208%20weeks&subtitle=Paroxetine%20treatment%20during%208%20weeks%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Paroxetine treatment during 8 weeks Paroxetine treatment during 8 weeks · GlaxoSmithKline https://druglandscape.com/drug/part-1-1-idg-16177 https://druglandscape.com/api/og?type=drug&title=%5BPart%201.1%5D%20IDG-16177&subtitle=%5BPart%201.1%5D%20IDG-16177%20%C2%B7%20IlDong%20Pharmaceutical%20Co%20Ltd&badge=phase%201 [Part 1.1] IDG-16177 [Part 1.1] IDG-16177 · IlDong Pharmaceutical Co Ltd https://druglandscape.com/drug/part-1-cnto-7160 https://druglandscape.com/api/og?type=drug&title=Part%201%3A%20CNTO%207160&subtitle=Part%201%3A%20CNTO%207160%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Part 1: CNTO 7160 Part 1: CNTO 7160 · Janssen Research & Development, LLC https://druglandscape.com/drug/part-1-daratumumab https://druglandscape.com/api/og?type=drug&title=Part%201%3A%20Daratumumab&subtitle=Part%201%3A%20Daratumumab%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 Part 1: Daratumumab Part 1: Daratumumab · Janssen Research & Development, LLC https://druglandscape.com/drug/part-1-es002023 https://druglandscape.com/api/og?type=drug&title=Part%201%20ES002023&subtitle=Part%201%20ES002023%20%C2%B7%20Elpiscience%20Biopharma%2C%20Ltd.&badge=phase%201 Part 1 ES002023 Part 1 ES002023 · Elpiscience Biopharma, Ltd. https://druglandscape.com/drug/part-1-jnj-42756493 https://druglandscape.com/api/og?type=drug&title=Part%201%3A%20JNJ-42756493&subtitle=Part%201%3A%20JNJ-42756493%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Part 1: JNJ-42756493 Part 1: JNJ-42756493 · Janssen Research & Development, LLC https://druglandscape.com/drug/part-1-ks101 https://druglandscape.com/api/og?type=drug&title=Part%201%20KS101&subtitle=Part%201%20KS101%20%C2%B7%20Klotho%20Sciences%20Australia%20Pty%20Ltd.&badge=phase%201 Part 1 KS101 Part 1 KS101 · Klotho Sciences Australia Pty Ltd. https://druglandscape.com/drug/part-1-levulan-surface-application-twice https://druglandscape.com/api/og?type=drug&title=Part%201%20Levulan%20surface%20application%20twice&subtitle=Part%201%20Levulan%20surface%20application%20twice%20%C2%B7%20Harry%20T%20Whelan%2C%20MD&badge=phase%201 Part 1 Levulan surface application twice Part 1 Levulan surface application twice · Harry T Whelan, MD https://druglandscape.com/drug/part-1-lotion https://druglandscape.com/api/og?type=drug&title=Part%201%3A%20Lotion&subtitle=Part%201%3A%20Lotion%20%C2%B7%20Food%20and%20Drug%20Administration%20(FDA)&badge=phase%201 Part 1: Lotion Part 1: Lotion · Food and Drug Administration (FDA) https://druglandscape.com/drug/part-1-sad-ro7033877 https://druglandscape.com/api/og?type=drug&title=Part%201%3A%20SAD%20RO7033877&subtitle=Part%201%3A%20SAD%20RO7033877%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 Part 1: SAD RO7033877 Part 1: SAD RO7033877 · Hoffmann-La Roche https://druglandscape.com/drug/part-1-spray-1 https://druglandscape.com/api/og?type=drug&title=Part%201%3A%20Spray%201&subtitle=Part%201%3A%20Spray%201%20%C2%B7%20Food%20and%20Drug%20Administration%20(FDA)&badge=phase%201 Part 1: Spray 1 Part 1: Spray 1 · Food and Drug Administration (FDA) https://druglandscape.com/drug/part-2-aerosol-spray https://druglandscape.com/api/og?type=drug&title=Part%202%3A%20Aerosol%20Spray&subtitle=Part%202%3A%20Aerosol%20Spray%20%C2%B7%20Food%20and%20Drug%20Administration%20(FDA)&badge=phase%201 Part 2: Aerosol Spray Part 2: Aerosol Spray · Food and Drug Administration (FDA) https://druglandscape.com/drug/part-2-azd2423 https://druglandscape.com/api/og?type=drug&title=Part%202%20-%20AZD2423&subtitle=Part%202%20-%20AZD2423%20%C2%B7%20AstraZeneca&badge=phase%201 Part 2 - AZD2423 Part 2 - AZD2423 · AstraZeneca https://druglandscape.com/drug/part-2-idg-16177 https://druglandscape.com/api/og?type=drug&title=%5BPart%202%5D%20IDG-16177&subtitle=%5BPart%202%5D%20IDG-16177%20%C2%B7%20IlDong%20Pharmaceutical%20Co%20Ltd&badge=phase%201 [Part 2] IDG-16177 [Part 2] IDG-16177 · IlDong Pharmaceutical Co Ltd https://druglandscape.com/drug/part-2-nonaerosol-spray https://druglandscape.com/api/og?type=drug&title=Part%202%3A%20Nonaerosol%20Spray&subtitle=Part%202%3A%20Nonaerosol%20Spray%20%C2%B7%20Food%20and%20Drug%20Administration%20(FDA)&badge=phase%201 Part 2: Nonaerosol Spray Part 2: Nonaerosol Spray · Food and Drug Administration (FDA) https://druglandscape.com/drug/part-2-pump-spray https://druglandscape.com/api/og?type=drug&title=Part%202%3A%20Pump%20Spray&subtitle=Part%202%3A%20Pump%20Spray%20%C2%B7%20Food%20and%20Drug%20Administration%20(FDA)&badge=phase%201 Part 2: Pump Spray Part 2: Pump Spray · Food and Drug Administration (FDA) https://druglandscape.com/drug/part-2-sitagliptin https://druglandscape.com/api/og?type=drug&title=%5BPart%202%5D%20Sitagliptin&subtitle=%5BPart%202%5D%20Sitagliptin%20%C2%B7%20IlDong%20Pharmaceutical%20Co%20Ltd&badge=phase%201 [Part 2] Sitagliptin [Part 2] Sitagliptin · IlDong Pharmaceutical Co Ltd https://druglandscape.com/drug/part-2-treatment-a-ro7033877 https://druglandscape.com/api/og?type=drug&title=Part%202%3A%20Treatment%20A%2C%20RO7033877&subtitle=Part%202%3A%20Treatment%20A%2C%20RO7033877%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 Part 2: Treatment A, RO7033877 Part 2: Treatment A, RO7033877 · Hoffmann-La Roche https://druglandscape.com/drug/part-2-treatment-b-ro7033877 https://druglandscape.com/api/og?type=drug&title=Part%202%3A%20Treatment%20B%2C%20RO7033877&subtitle=Part%202%3A%20Treatment%20B%2C%20RO7033877%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 Part 2: Treatment B, RO7033877 Part 2: Treatment B, RO7033877 · Hoffmann-La Roche https://druglandscape.com/drug/part-2-treatment-c-moxifloxacin https://druglandscape.com/api/og?type=drug&title=Part%202%3A%20Treatment%20C%2C%20moxifloxacin&subtitle=Part%202%3A%20Treatment%20C%2C%20moxifloxacin%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 Part 2: Treatment C, moxifloxacin Part 2: Treatment C, moxifloxacin · Hoffmann-La Roche https://druglandscape.com/drug/part-2-with-food https://druglandscape.com/api/og?type=drug&title=Part%202%20with%20Food&subtitle=Part%202%20with%20Food%20%C2%B7%20Klotho%20Sciences%20Australia%20Pty%20Ltd.&badge=phase%201 Part 2 with Food Part 2 with Food · Klotho Sciences Australia Pty Ltd. https://druglandscape.com/drug/part-a-absk201-and-itraconazole https://druglandscape.com/api/og?type=drug&title=Part%20A%20ABSK201%20and%20Itraconazole&subtitle=Part%20A%20ABSK201%20and%20Itraconazole%20%C2%B7%20Abbisko%20Therapeutics%20Co%2C%20Ltd&badge=phase%201 Part A ABSK201 and Itraconazole Part A ABSK201 and Itraconazole · Abbisko Therapeutics Co, Ltd https://druglandscape.com/drug/part-a-absk201-and-rifampicin https://druglandscape.com/api/og?type=drug&title=Part%20A%20ABSK201%20and%20Rifampicin&subtitle=Part%20A%20ABSK201%20and%20Rifampicin%20%C2%B7%20Abbisko%20Therapeutics%20Co%2C%20Ltd&badge=phase%201 Part A ABSK201 and Rifampicin Part A ABSK201 and Rifampicin · Abbisko Therapeutics Co, Ltd https://druglandscape.com/drug/part-a-assessing-gsk1521498 https://druglandscape.com/api/og?type=drug&title=Part%20A%20Assessing%20GSK1521498&subtitle=Part%20A%20Assessing%20GSK1521498%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Part A Assessing GSK1521498 Part A Assessing GSK1521498 · GlaxoSmithKline https://druglandscape.com/drug/part-a-azd8186-monotherapy https://druglandscape.com/api/og?type=drug&title=Part%20A%3A%20AZD8186%20monotherapy&subtitle=Part%20A%3A%20AZD8186%20monotherapy%20%C2%B7%20AstraZeneca&badge=phase%201 Part A: AZD8186 monotherapy Part A: AZD8186 monotherapy · AstraZeneca https://druglandscape.com/drug/part-a-azd8233 https://druglandscape.com/api/og?type=drug&title=Part%20A%3AAZD8233&subtitle=Part%20A%3AAZD8233%20%C2%B7%20AstraZeneca&badge=phase%201 Part A:AZD8233 Part A:AZD8233 · AstraZeneca https://druglandscape.com/drug/part-a-dose-escalation-of-cantrixil https://druglandscape.com/api/og?type=drug&title=Part%20A%3A%20Dose%20Escalation%20of%20Cantrixil&subtitle=Part%20A%3A%20Dose%20Escalation%20of%20Cantrixil%20%C2%B7%20Kazia%20Therapeutics%20Limited&badge=phase%201 Part A: Dose Escalation of Cantrixil Part A: Dose Escalation of Cantrixil · Kazia Therapeutics Limited https://druglandscape.com/drug/part-a-lu-af35700 https://druglandscape.com/api/og?type=drug&title=Part%20A%3A%20Lu%20AF35700&subtitle=Part%20A%3A%20Lu%20AF35700%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Part A: Lu AF35700 Part A: Lu AF35700 · H. Lundbeck A/S https://druglandscape.com/drug/part-a-rpl554 https://druglandscape.com/api/og?type=drug&title=Part%20A%3A%20RPL554&subtitle=Part%20A%3A%20RPL554%20%C2%B7%20Verona%20Pharma%20plc&badge=phase%202 Part A: RPL554 Part A: RPL554 · Verona Pharma plc https://druglandscape.com/drug/part-a-single-rising-dose-1 https://druglandscape.com/api/og?type=drug&title=Part%20A%20-%20single%20rising%20dose%201&subtitle=Part%20A%20-%20single%20rising%20dose%201%20%C2%B7%20Brilliant%20Inspiration%20Biotherapeutics&badge=phase%201 Part A - single rising dose 1 Part A - single rising dose 1 · Brilliant Inspiration Biotherapeutics https://druglandscape.com/drug/part-b-assessing-gsk1521498 https://druglandscape.com/api/og?type=drug&title=Part%20B%20Assessing%20GSK1521498&subtitle=Part%20B%20Assessing%20GSK1521498%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Part B Assessing GSK1521498 Part B Assessing GSK1521498 · GlaxoSmithKline https://druglandscape.com/drug/part-b-azd8186-monotherapy https://druglandscape.com/api/og?type=drug&title=Part%20B%3A%20AZD8186%20monotherapy&subtitle=Part%20B%3A%20AZD8186%20monotherapy%20%C2%B7%20AstraZeneca&badge=phase%201 Part B: AZD8186 monotherapy Part B: AZD8186 monotherapy · AstraZeneca https://druglandscape.com/drug/part-b-azd8233 https://druglandscape.com/api/og?type=drug&title=Part%20B%3AAZD8233&subtitle=Part%20B%3AAZD8233%20%C2%B7%20AstraZeneca&badge=phase%201 Part B:AZD8233 Part B:AZD8233 · AstraZeneca https://druglandscape.com/drug/part-b-expansion-cohort-of-cantrixil https://druglandscape.com/api/og?type=drug&title=Part%20B%3A%20Expansion%20Cohort%20of%20Cantrixil&subtitle=Part%20B%3A%20Expansion%20Cohort%20of%20Cantrixil%20%C2%B7%20Kazia%20Therapeutics%20Limited&badge=phase%201 Part B: Expansion Cohort of Cantrixil Part B: Expansion Cohort of Cantrixil · Kazia Therapeutics Limited https://druglandscape.com/drug/part-b-lu-af35700 https://druglandscape.com/api/og?type=drug&title=Part%20B%3A%20Lu%20AF35700&subtitle=Part%20B%3A%20Lu%20AF35700%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Part B: Lu AF35700 Part B: Lu AF35700 · H. Lundbeck A/S https://druglandscape.com/drug/part-b-mutiple-rising-dose-1 https://druglandscape.com/api/og?type=drug&title=Part%20B%20-%20mutiple%20rising%20dose%201&subtitle=Part%20B%20-%20mutiple%20rising%20dose%201%20%C2%B7%20Brilliant%20Inspiration%20Biotherapeutics&badge=phase%201 Part B - mutiple rising dose 1 Part B - mutiple rising dose 1 · Brilliant Inspiration Biotherapeutics https://druglandscape.com/drug/part-b-rpl554 https://druglandscape.com/api/og?type=drug&title=Part%20B%3A%20RPL554&subtitle=Part%20B%3A%20RPL554%20%C2%B7%20Verona%20Pharma%20plc&badge=phase%202 Part B: RPL554 Part B: RPL554 · Verona Pharma plc https://druglandscape.com/drug/part-c-assessing-naltrexone https://druglandscape.com/api/og?type=drug&title=Part%20C%20Assessing%20Naltrexone&subtitle=Part%20C%20Assessing%20Naltrexone%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Part C Assessing Naltrexone Part C Assessing Naltrexone · GlaxoSmithKline https://druglandscape.com/drug/part-c-azd8233 https://druglandscape.com/api/og?type=drug&title=Part%20C%3A%20AZD8233&subtitle=Part%20C%3A%20AZD8233%20%C2%B7%20AstraZeneca&badge=phase%201 Part C: AZD8233 Part C: AZD8233 · AstraZeneca https://druglandscape.com/drug/part-d1-azd2014-combination-with-azd8186 https://druglandscape.com/api/og?type=drug&title=Part%20D1%3A%20AZD2014%20combination%20with%20AZD8186&subtitle=Part%20D1%3A%20AZD2014%20combination%20with%20AZD8186%20%C2%B7%20AstraZeneca&badge=phase%201 Part D1: AZD2014 combination with AZD8186 Part D1: AZD2014 combination with AZD8186 · AstraZeneca https://druglandscape.com/drug/part-d2-azd2014-combination-with-azd8186 https://druglandscape.com/api/og?type=drug&title=Part%20D2%20AZD2014%20combination%20with%20AZD8186&subtitle=Part%20D2%20AZD2014%20combination%20with%20AZD8186%20%C2%B7%20AstraZeneca&badge=phase%201 Part D2 AZD2014 combination with AZD8186 Part D2 AZD2014 combination with AZD8186 · AstraZeneca https://druglandscape.com/drug/part1-ops-2071 https://druglandscape.com/api/og?type=drug&title=Part1%20%3A%20OPS-2071&subtitle=Part1%20%3A%20OPS-2071%20%C2%B7%20Korea%20Otsuka%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Part1 : OPS-2071 Part1 : OPS-2071 · Korea Otsuka Pharmaceutical Co., Ltd. https://druglandscape.com/drug/part2-covid-19-vaccine-mrna https://druglandscape.com/api/og?type=drug&title=Part2%3A%20COVID-19%20Vaccine%2C%20mRNA&subtitle=Part2%3A%20COVID-19%20Vaccine%2C%20mRNA%20%C2%B7%20Jiangsu%20Rec-Biotechnology%20Co.%2C%20Ltd.&badge=phase%202 Part2: COVID-19 Vaccine, mRNA Part2: COVID-19 Vaccine, mRNA · Jiangsu Rec-Biotechnology Co., Ltd. https://druglandscape.com/drug/particulated-juvenile-cartilage-allograft https://druglandscape.com/api/og?type=drug&title=Particulated%20Juvenile%20Cartilage%20Allograft&subtitle=Particulated%20Juvenile%20Cartilage%20Allograft%20%C2%B7%20Zimmer%20Orthobiologics%2C%20Inc.&badge=phase%202 Particulated Juvenile Cartilage Allograft Particulated Juvenile Cartilage Allograft · Zimmer Orthobiologics, Inc. https://druglandscape.com/drug/pas-004-tablets https://druglandscape.com/api/og?type=drug&title=PAS-004%20Tablets&subtitle=PAS-004%20Tablets%20%C2%B7%20Pasithea%20Therapeutics%20Corp.&badge=phase%201 PAS-004 Tablets PAS-004 Tablets · Pasithea Therapeutics Corp. https://druglandscape.com/drug/pasireotide-ampule-with-syringe https://druglandscape.com/api/og?type=drug&title=Pasireotide%20ampule%20with%20syringe&subtitle=Pasireotide%20ampule%20with%20syringe%20%C2%B7%20RECORDATI%20GROUP&badge=phase%201 Pasireotide ampule with syringe Pasireotide ampule with syringe · RECORDATI GROUP https://druglandscape.com/drug/pasturlized-cow-milk https://druglandscape.com/api/og?type=drug&title=Pasturlized%20cow%20milk&subtitle=Pasturlized%20cow%20milk%20%C2%B7%20HaEmek%20Medical%20Center%2C%20Israel&badge=phase%201 Pasturlized cow milk Pasturlized cow milk · HaEmek Medical Center, Israel https://druglandscape.com/drug/pat-001-0-1 https://druglandscape.com/api/og?type=drug&title=PAT-001%2C%200.1%25&subtitle=PAT-001%2C%200.1%25%20%C2%B7%20Patagonia%20Pharmaceuticals%2C%20LLC&badge=phase%202 PAT-001, 0.1% PAT-001, 0.1% · Patagonia Pharmaceuticals, LLC https://druglandscape.com/drug/pat-001-0-2 https://druglandscape.com/api/og?type=drug&title=PAT-001%2C%200.2%25&subtitle=PAT-001%2C%200.2%25%20%C2%B7%20Patagonia%20Pharmaceuticals%2C%20LLC&badge=phase%202 PAT-001, 0.2% PAT-001, 0.2% · Patagonia Pharmaceuticals, LLC https://druglandscape.com/drug/pat-1251 https://druglandscape.com/api/og?type=drug&title=PAT-1251&subtitle=PAT-1251%20%C2%B7%20PharmAkea%2C%20Inc.&badge=phase%201 PAT-1251 PAT-1251 · PharmAkea, Inc. https://druglandscape.com/drug/patanase-nasal-spray https://druglandscape.com/api/og?type=drug&title=PATANASE%20nasal%20spray&subtitle=PATANASE%20nasal%20spray%20%C2%B7%20Glenmark%20Pharmaceuticals%20Ltd.%20India&badge=phase%202 PATANASE nasal spray PATANASE nasal spray · Glenmark Pharmaceuticals Ltd. India https://druglandscape.com/drug/patas-trifluoroacetate https://druglandscape.com/api/og?type=drug&title=PATAS%20Trifluoroacetate&subtitle=PATAS%20Trifluoroacetate%20%C2%B7%20AdipoPharma%20LLC&badge=phase%201 PATAS Trifluoroacetate PATAS Trifluoroacetate · AdipoPharma LLC https://druglandscape.com/drug/patentex-oval https://druglandscape.com/api/og?type=drug&title=Patentex%20oval&subtitle=Patentex%20oval%20%C2%B7%20Bayer&badge=phase%201 Patentex oval Patentex oval · Bayer https://druglandscape.com/drug/path-wsp https://druglandscape.com/api/og?type=drug&title=PATH-wSP&subtitle=PATH-wSP%20%C2%B7%20PATH&badge=phase%201 PATH-wSP PATH-wSP · PATH https://druglandscape.com/drug/pathogen-reduced-platelet-concentrates https://druglandscape.com/api/og?type=drug&title=Pathogen-Reduced%20Platelet%20Concentrates&subtitle=Pathogen-Reduced%20Platelet%20Concentrates%20%C2%B7%20Deutsches%20Rotes%20Kreuz%20DRK-Blutspendedienst%20Baden-Wurttember&badge=phase%202 Pathogen-Reduced Platelet Concentrates Pathogen-Reduced Platelet Concentrates · Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen https://druglandscape.com/drug/patient-controlled-analgesics https://druglandscape.com/api/og?type=drug&title=Patient%20controlled%20analgesics&subtitle=Patient%20controlled%20analgesics%20%C2%B7%20Hopital%20de%20l'Enfant-Jesus&badge=phase%201 Patient controlled analgesics Patient controlled analgesics · Hopital de l'Enfant-Jesus https://druglandscape.com/drug/patients-treated-with-esketamine https://druglandscape.com/api/og?type=drug&title=Patients%20treated%20with%20Esketamine&subtitle=Patients%20treated%20with%20Esketamine%20%C2%B7%20Neuronetics&badge=phase%202 Patients treated with Esketamine Patients treated with Esketamine · Neuronetics https://druglandscape.com/drug/patritumab-and-trastuzumab https://druglandscape.com/api/og?type=drug&title=Patritumab%20and%20Trastuzumab&subtitle=Patritumab%20and%20Trastuzumab%20%C2%B7%20QuantumLeap%20Healthcare%20Collaborative&badge=phase%202 Patritumab and Trastuzumab Patritumab and Trastuzumab · QuantumLeap Healthcare Collaborative https://druglandscape.com/drug/paullinia-cupana https://druglandscape.com/api/og?type=drug&title=Paullinia%20cupana&subtitle=Paullinia%20cupana%20%C2%B7%20Faculdade%20de%20Medicina%20do%20ABC&badge=phase%201 Paullinia cupana Paullinia cupana · Faculdade de Medicina do ABC https://druglandscape.com/drug/paxerol-dose-level-1 https://druglandscape.com/api/og?type=drug&title=Paxerol%20-%20Dose%20Level%201&subtitle=Paxerol%20-%20Dose%20Level%201%20%C2%B7%20Wellesley%20Pharmaceuticals%2C%20LLC&badge=phase%202 Paxerol - Dose Level 1 Paxerol - Dose Level 1 · Wellesley Pharmaceuticals, LLC https://druglandscape.com/drug/paxerol-dose-level-2 https://druglandscape.com/api/og?type=drug&title=Paxerol%20-%20Dose%20Level%202&subtitle=Paxerol%20-%20Dose%20Level%202%20%C2%B7%20Wellesley%20Pharmaceuticals%2C%20LLC&badge=phase%202 Paxerol - Dose Level 2 Paxerol - Dose Level 2 · Wellesley Pharmaceuticals, LLC https://druglandscape.com/drug/paxerol-dose-level-3 https://druglandscape.com/api/og?type=drug&title=Paxerol%20-%20Dose%20Level%203&subtitle=Paxerol%20-%20Dose%20Level%203%20%C2%B7%20Wellesley%20Pharmaceuticals%2C%20LLC&badge=phase%202 Paxerol - Dose Level 3 Paxerol - Dose Level 3 · Wellesley Pharmaceuticals, LLC https://druglandscape.com/drug/paxlovid-15-day-dosing https://druglandscape.com/api/og?type=drug&title=Paxlovid%2015%20day%20dosing&subtitle=Paxlovid%2015%20day%20dosing%20%C2%B7%20Kanecia%20Obie%20Zimmerman&badge=phase%202 Paxlovid 15 day dosing Paxlovid 15 day dosing · Kanecia Obie Zimmerman https://druglandscape.com/drug/paxlovid-25-day-dosing https://druglandscape.com/api/og?type=drug&title=Paxlovid%2025%20day%20dosing&subtitle=Paxlovid%2025%20day%20dosing%20%C2%B7%20Kanecia%20Obie%20Zimmerman&badge=phase%202 Paxlovid 25 day dosing Paxlovid 25 day dosing · Kanecia Obie Zimmerman https://druglandscape.com/drug/pazopanib-3-week https://druglandscape.com/api/og?type=drug&title=Pazopanib%203%20week&subtitle=Pazopanib%203%20week%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Pazopanib 3 week Pazopanib 3 week · GlaxoSmithKline https://druglandscape.com/drug/pazopanib-and-pemetrexed https://druglandscape.com/api/og?type=drug&title=pazopanib%20and%20pemetrexed&subtitle=pazopanib%20and%20pemetrexed%20%C2%B7%20GlaxoSmithKline&badge=phase%202 pazopanib and pemetrexed pazopanib and pemetrexed · GlaxoSmithKline https://druglandscape.com/drug/pazopanib-and-th-302 https://druglandscape.com/api/og?type=drug&title=Pazopanib%20and%20TH-302&subtitle=Pazopanib%20and%20TH-302%20%C2%B7%20Herbert%20Hurwitz%2C%20MD&badge=phase%201 Pazopanib and TH-302 Pazopanib and TH-302 · Herbert Hurwitz, MD https://druglandscape.com/drug/pazopanib-as-add-on-to-vinflunine https://druglandscape.com/api/og?type=drug&title=Pazopanib%20as%20add-on%20to%20vinflunine&subtitle=Pazopanib%20as%20add-on%20to%20vinflunine%20%C2%B7%20Prof.%20Dr.%20Thomas%20Otto&badge=phase%201 Pazopanib as add-on to vinflunine Pazopanib as add-on to vinflunine · Prof. Dr. Thomas Otto https://druglandscape.com/drug/pazopanib-monotherapy https://druglandscape.com/api/og?type=drug&title=pazopanib%20monotherapy&subtitle=pazopanib%20monotherapy%20%C2%B7%20GlaxoSmithKline&badge=phase%202 pazopanib monotherapy pazopanib monotherapy · GlaxoSmithKline https://druglandscape.com/drug/pazopanib-plus-capecitabine https://druglandscape.com/api/og?type=drug&title=Pazopanib%20plus%20capecitabine&subtitle=Pazopanib%20plus%20capecitabine%20%C2%B7%20GBG%20Forschungs%20GmbH&badge=phase%201 Pazopanib plus capecitabine Pazopanib plus capecitabine · GBG Forschungs GmbH https://druglandscape.com/drug/pazopanib-plus-gemcitabine https://druglandscape.com/api/og?type=drug&title=Pazopanib%20plus%20Gemcitabine&subtitle=Pazopanib%20plus%20Gemcitabine%20%C2%B7%20North%20Eastern%20German%20Society%20of%20Gynaecological%20Oncology&badge=phase%202 Pazopanib plus Gemcitabine Pazopanib plus Gemcitabine · North Eastern German Society of Gynaecological Oncology https://druglandscape.com/drug/pazopanib-use https://druglandscape.com/api/og?type=drug&title=Pazopanib%20use&subtitle=Pazopanib%20use%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Pazopanib use Pazopanib use · GlaxoSmithKline https://druglandscape.com/drug/pazufloxacin-mesilate-ear-drops https://druglandscape.com/api/og?type=drug&title=Pazufloxacin%20Mesilate%20ear%20drops&subtitle=Pazufloxacin%20Mesilate%20ear%20drops%20%C2%B7%20Lee's%20Pharmaceutical%20Limited&badge=phase%201 Pazufloxacin Mesilate ear drops Pazufloxacin Mesilate ear drops · Lee's Pharmaceutical Limited https://druglandscape.com/drug/pb-718 https://druglandscape.com/api/og?type=drug&title=PB%20718&subtitle=PB%20718%20%C2%B7%20PegBio%20Co.%2C%20Ltd.&badge=phase%201 PB 718 PB 718 · PegBio Co., Ltd. https://druglandscape.com/drug/pb-dotam-grpr1 https://druglandscape.com/api/og?type=drug&title=%C2%B2%C2%B9%C2%B2Pb-DOTAM-GRPR1&subtitle=%C2%B2%C2%B9%C2%B2Pb-DOTAM-GRPR1%20%C2%B7%20Orano%20Med%20LLC&badge=phase%201 ²¹²Pb-DOTAM-GRPR1 ²¹²Pb-DOTAM-GRPR1 · Orano Med LLC https://druglandscape.com/drug/pb119 https://druglandscape.com/api/og?type=drug&title=PB119&subtitle=PB119%20%C2%B7%20PegBio%20Co.%2C%20Ltd.&badge=phase%201 PB119 PB119 · PegBio Co., Ltd. https://druglandscape.com/drug/pb2452-infusion https://druglandscape.com/api/og?type=drug&title=PB2452%20Infusion&subtitle=PB2452%20Infusion%20%C2%B7%20SFJ%20Pharmaceuticals%2C%20Inc.&badge=phase%202 PB2452 Infusion PB2452 Infusion · SFJ Pharmaceuticals, Inc. https://druglandscape.com/drug/pba-0111 https://druglandscape.com/api/og?type=drug&title=PBA-0111&subtitle=PBA-0111%20%C2%B7%20Pure%20Biologics%20S.A.&badge=phase%201 PBA-0111 PBA-0111 · Pure Biologics S.A. https://druglandscape.com/drug/pba-0405 https://druglandscape.com/api/og?type=drug&title=PBA-0405&subtitle=PBA-0405%20%C2%B7%20Pure%20Biologics%20S.A.&badge=phase%201 PBA-0405 PBA-0405 · Pure Biologics S.A. https://druglandscape.com/drug/pbcar3-phosphopeptide https://druglandscape.com/api/og?type=drug&title=pBCAR3-phosphopeptide&subtitle=pBCAR3-phosphopeptide%20%C2%B7%20Craig%20L%20Slingluff%2C%20Jr&badge=phase%201 pBCAR3-phosphopeptide pBCAR3-phosphopeptide · Craig L Slingluff, Jr https://druglandscape.com/drug/pbf-1650-oral-capsules https://druglandscape.com/api/og?type=drug&title=PBF-1650%20oral%20capsules&subtitle=PBF-1650%20oral%20capsules%20%C2%B7%20Palobiofarma%20SL&badge=phase%201 PBF-1650 oral capsules PBF-1650 oral capsules · Palobiofarma SL https://druglandscape.com/drug/pbf-677 https://druglandscape.com/api/og?type=drug&title=PBF-677&subtitle=PBF-677%20%C2%B7%20Palobiofarma%20SL&badge=phase%202 PBF-677 PBF-677 · Palobiofarma SL https://druglandscape.com/drug/pbft02 https://druglandscape.com/api/og?type=drug&title=PBFT02&subtitle=PBFT02%20%C2%B7%20Passage%20Bio%2C%20Inc.&badge=phase%201 PBFT02 PBFT02 · Passage Bio, Inc. https://druglandscape.com/drug/pbi-0451-dose-1 https://druglandscape.com/api/og?type=drug&title=PBI-0451%20Dose%201&subtitle=PBI-0451%20Dose%201%20%C2%B7%20Pardes%20Biosciences%2C%20Inc.&badge=phase%201 PBI-0451 Dose 1 PBI-0451 Dose 1 · Pardes Biosciences, Inc. https://druglandscape.com/drug/pbi-4050-and-midazolam https://druglandscape.com/api/og?type=drug&title=PBI-4050%20and%20midazolam&subtitle=PBI-4050%20and%20midazolam%20%C2%B7%20Liminal%20BioSciences%20Ltd.&badge=phase%201 PBI-4050 and midazolam PBI-4050 and midazolam · Liminal BioSciences Ltd. https://druglandscape.com/drug/pbi-shrna-stmn1-lp https://druglandscape.com/api/og?type=drug&title=pbi-shRNA%20STMN1%20LP&subtitle=pbi-shRNA%20STMN1%20LP%20%C2%B7%20Gradalis%2C%20Inc.&badge=phase%201 pbi-shRNA STMN1 LP pbi-shRNA STMN1 LP · Gradalis, Inc. https://druglandscape.com/drug/pbk-1801 https://druglandscape.com/api/og?type=drug&title=PBK-1801&subtitle=PBK-1801%20%C2%B7%20Pharmbio%20Korea%20Co.%2C%20Ltd.&badge=phase%201 PBK-1801 PBK-1801 · Pharmbio Korea Co., Ltd. https://druglandscape.com/drug/pbl-1427-capsules https://druglandscape.com/api/og?type=drug&title=PBL%201427%20capsules&subtitle=PBL%201427%20capsules%20%C2%B7%20Panacea%20Biotec%20Ltd&badge=phase%201 PBL 1427 capsules PBL 1427 capsules · Panacea Biotec Ltd https://druglandscape.com/drug/pbp1502 https://druglandscape.com/api/og?type=drug&title=PBP1502&subtitle=PBP1502%20%C2%B7%20Prestige%20Biopharma%20Limited&badge=phase%201 PBP1502 PBP1502 · Prestige Biopharma Limited https://druglandscape.com/drug/pbpv https://druglandscape.com/api/og?type=drug&title=PBPV&subtitle=PBPV%20%C2%B7%20CanSino%20Biologics%20Inc.&badge=phase%201 PBPV PBPV · CanSino Biologics Inc. https://druglandscape.com/drug/pbs-and-tiv-15 https://druglandscape.com/api/og?type=drug&title=PBS%20and%20TIV%2015%25&subtitle=PBS%20and%20TIV%2015%25%20%C2%B7%20BiondVax%20Pharmaceuticals%20ltd.&badge=phase%202 PBS and TIV 15% PBS and TIV 15% · BiondVax Pharmaceuticals ltd. https://druglandscape.com/drug/pbs-and-tiv-50 https://druglandscape.com/api/og?type=drug&title=PBS%20and%20TIV%2050%25&subtitle=PBS%20and%20TIV%2050%25%20%C2%B7%20BiondVax%20Pharmaceuticals%20ltd.&badge=phase%202 PBS and TIV 50% PBS and TIV 50% · BiondVax Pharmaceuticals ltd. https://druglandscape.com/drug/pbt2 https://druglandscape.com/api/og?type=drug&title=PBT2&subtitle=PBT2%20%C2%B7%20Prana%20Biotechnology%20Limited&badge=phase%202 PBT2 PBT2 · Prana Biotechnology Limited https://druglandscape.com/drug/pbtz169-ncp https://druglandscape.com/api/og?type=drug&title=PBTZ169%20NCP&subtitle=PBTZ169%20NCP%20%C2%B7%20Innovative%20Medicines%20for%20Tuberculosis&badge=phase%201 PBTZ169 NCP PBTZ169 NCP · Innovative Medicines for Tuberculosis https://druglandscape.com/drug/pc-sod https://druglandscape.com/api/og?type=drug&title=PC-SOD&subtitle=PC-SOD%20%C2%B7%20Beijing%20Tide%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 PC-SOD PC-SOD · Beijing Tide Pharmaceutical Co., Ltd https://druglandscape.com/drug/pc14586 https://druglandscape.com/api/og?type=drug&title=PC14586&subtitle=PC14586%20%C2%B7%20PMV%20Pharmaceuticals%2C%20Inc&badge=phase%201 PC14586 PC14586 · PMV Pharmaceuticals, Inc https://druglandscape.com/drug/pca-mo-only https://druglandscape.com/api/og?type=drug&title=PCA%20MO%20only&subtitle=PCA%20MO%20only%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 PCA MO only PCA MO only · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/pca-morphine https://druglandscape.com/api/og?type=drug&title=PCA%20Morphine&subtitle=PCA%20Morphine%20%C2%B7%20IRCCS%20San%20Raffaele&badge=phase%201 PCA Morphine PCA Morphine · IRCCS San Raffaele https://druglandscape.com/drug/pca-pump https://druglandscape.com/api/og?type=drug&title=PCA-pump&subtitle=PCA-pump%20%C2%B7%20Kai%20Henrik%20Wiborg%20Lange&badge=phase%201 PCA-pump PCA-pump · Kai Henrik Wiborg Lange https://druglandscape.com/drug/pcar-19b-cells https://druglandscape.com/api/og?type=drug&title=pCAR-19B%20cells&subtitle=pCAR-19B%20cells%20%C2%B7%20Chongqing%20Precision%20Biotech%20Co.%2C%20Ltd&badge=phase%202 pCAR-19B cells pCAR-19B cells · Chongqing Precision Biotech Co., Ltd https://druglandscape.com/drug/pcec-rabies-vaccine-administered-intramuscularly https://druglandscape.com/api/og?type=drug&title=PCEC%20rabies%20vaccine%20administered%20intramuscularly&subtitle=PCEC%20rabies%20vaccine%20administered%20intramuscularly%20%C2%B7%20Centers%20for%20Disease%20Control%20and%20Prevention&badge=phase%201 PCEC rabies vaccine administered intramuscularly PCEC rabies vaccine administered intramuscularly · Centers for Disease Control and Prevention https://druglandscape.com/drug/pcec-rabies-vaccine-given-intradermally https://druglandscape.com/api/og?type=drug&title=PCEC%20rabies%20vaccine%20given%20intradermally&subtitle=PCEC%20rabies%20vaccine%20given%20intradermally%20%C2%B7%20Centers%20for%20Disease%20Control%20and%20Prevention&badge=phase%201 PCEC rabies vaccine given intradermally PCEC rabies vaccine given intradermally · Centers for Disease Control and Prevention https://druglandscape.com/drug/pcna-inhibitor-aoh1996 https://druglandscape.com/api/og?type=drug&title=PCNA%20Inhibitor%20AOH1996&subtitle=PCNA%20Inhibitor%20AOH1996%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%201 PCNA Inhibitor AOH1996 PCNA Inhibitor AOH1996 · City of Hope Medical Center https://druglandscape.com/drug/pcr-multiplex-by-filmarray https://druglandscape.com/api/og?type=drug&title=PCR%20multiplex%20by%20FilmArray&subtitle=PCR%20multiplex%20by%20FilmArray%20%C2%B7%20CHU%20de%20Reims&badge=phase%202 PCR multiplex by FilmArray PCR multiplex by FilmArray · CHU de Reims https://druglandscape.com/drug/pcsk9-antibody-pcsk9-enzyme https://druglandscape.com/api/og?type=drug&title=PCSK9%20Antibody%2C%20PCSK9%20Enzyme&subtitle=PCSK9%20Antibody%2C%20PCSK9%20Enzyme%20%C2%B7%20LifeBridge%20Health&badge=phase%202 PCSK9 Antibody, PCSK9 Enzyme PCSK9 Antibody, PCSK9 Enzyme · LifeBridge Health https://druglandscape.com/drug/pcv-10 https://druglandscape.com/api/og?type=drug&title=PCV-10&subtitle=PCV-10%20%C2%B7%20Westat&badge=phase%202 PCV-10 PCV-10 · Westat https://druglandscape.com/drug/pcv-lite https://druglandscape.com/api/og?type=drug&title=PCV-LITE&subtitle=PCV-LITE%20%C2%B7%20LiteVax%20BV&badge=phase%201 PCV-LITE PCV-LITE · LiteVax BV https://druglandscape.com/drug/pcx-12 https://druglandscape.com/api/og?type=drug&title=PCX-12&subtitle=PCX-12%20%C2%B7%20Haoming%20(Carl)%20Qiu&badge=phase%201 PCX-12 PCX-12 · Haoming (Carl) Qiu https://druglandscape.com/drug/pd-0332991-alone https://druglandscape.com/api/og?type=drug&title=PD-0332991%20alone&subtitle=PD-0332991%20alone%20%C2%B7%20Pfizer&badge=phase%201 PD-0332991 alone PD-0332991 alone · Pfizer https://druglandscape.com/drug/pd-0348292 https://druglandscape.com/api/og?type=drug&title=PD%200348292&subtitle=PD%200348292%20%C2%B7%20Pfizer&badge=phase%202 PD 0348292 PD 0348292 · Pfizer https://druglandscape.com/drug/pd-1-and-ace2-knockout-t-cells https://druglandscape.com/api/og?type=drug&title=PD-1%20and%20ACE2%20Knockout%20T%20Cells&subtitle=PD-1%20and%20ACE2%20Knockout%20T%20Cells%20%C2%B7%20Mahmoud%20Ramadan%20mohamed%20Elkazzaz&badge=phase%201 PD-1 and ACE2 Knockout T Cells PD-1 and ACE2 Knockout T Cells · Mahmoud Ramadan mohamed Elkazzaz https://druglandscape.com/drug/pd-1-and-dc-cik-cells https://druglandscape.com/api/og?type=drug&title=pd-1%20and%20dc-cik%20cells&subtitle=pd-1%20and%20dc-cik%20cells%20%C2%B7%20Allife%20Medical%20Science%20and%20Technology%20Co.%2C%20Ltd.&badge=phase%201 pd-1 and dc-cik cells pd-1 and dc-cik cells · Allife Medical Science and Technology Co., Ltd. https://druglandscape.com/drug/pd-1-and-dc-nk-cells https://druglandscape.com/api/og?type=drug&title=pd-1%20and%20DC-NK%20cells&subtitle=pd-1%20and%20DC-NK%20cells%20%C2%B7%20Allife%20Medical%20Science%20and%20Technology%20Co.%2C%20Ltd.&badge=phase%201 pd-1 and DC-NK cells pd-1 and DC-NK cells · Allife Medical Science and Technology Co., Ltd. https://druglandscape.com/drug/pd-1-m1-nk-cells https://druglandscape.com/api/og?type=drug&title=PD-1-M1-NK%20Cells&subtitle=PD-1-M1-NK%20Cells%20%C2%B7%20jiuwei%20cui&badge=phase%201 PD-1-M1-NK Cells PD-1-M1-NK Cells · jiuwei cui https://druglandscape.com/drug/pd-l1-t-hank https://druglandscape.com/api/og?type=drug&title=PD-L1%20t-haNK&subtitle=PD-L1%20t-haNK%20%C2%B7%20Glenn%20J.%20Hanna&badge=phase%202 PD-L1 t-haNK PD-L1 t-haNK · Glenn J. Hanna https://druglandscape.com/drug/pd-l2-and-pd-l1-peptide https://druglandscape.com/api/og?type=drug&title=PD-L2%20and%20PD-L1%20peptide&subtitle=PD-L2%20and%20PD-L1%20peptide%20%C2%B7%20Lars%20M%C3%B8ller%20Pedersen&badge=phase%201 PD-L2 and PD-L1 peptide PD-L2 and PD-L1 peptide · Lars Møller Pedersen https://druglandscape.com/drug/pd-l2-peptide https://druglandscape.com/api/og?type=drug&title=PD-L2%20peptide&subtitle=PD-L2%20peptide%20%C2%B7%20Lars%20M%C3%B8ller%20Pedersen&badge=phase%201 PD-L2 peptide PD-L2 peptide · Lars Møller Pedersen https://druglandscape.com/drug/pd-p-506-a https://druglandscape.com/api/og?type=drug&title=PD%20P%20506%20A&subtitle=PD%20P%20506%20A%20%C2%B7%20photonamic%20GmbH%20%26%20Co.%20KG&badge=phase%202 PD P 506 A PD P 506 A · photonamic GmbH & Co. KG https://druglandscape.com/drug/pd-solution-containing-glucose https://druglandscape.com/api/og?type=drug&title=PD%20solution%20containing%20glucose&subtitle=PD%20solution%20containing%20glucose%20%C2%B7%20Iperboreal%20Pharma%20Srl&badge=phase%202 PD solution containing glucose PD solution containing glucose · Iperboreal Pharma Srl https://druglandscape.com/drug/pd5k3 https://druglandscape.com/api/og?type=drug&title=PD5K3&subtitle=PD5K3%20%C2%B7%20Chongqing%20Peg-Bio%20Biopharm%20Co.%2C%20Ltd.&badge=phase%201 PD5K3 PD5K3 · Chongqing Peg-Bio Biopharm Co., Ltd. https://druglandscape.com/drug/pdc-1421-capsule https://druglandscape.com/api/og?type=drug&title=PDC-1421%20Capsule&subtitle=PDC-1421%20Capsule%20%C2%B7%20BioLite%2C%20Inc.&badge=phase%202 PDC-1421 Capsule PDC-1421 Capsule · BioLite, Inc. https://druglandscape.com/drug/pdc-748 https://druglandscape.com/api/og?type=drug&title=PDC-748&subtitle=PDC-748%20%C2%B7%20PhytoHealth%20Corporation&badge=phase%202 PDC-748 PDC-748 · PhytoHealth Corporation https://druglandscape.com/drug/pdc-apb https://druglandscape.com/api/og?type=drug&title=PDC-APB&subtitle=PDC-APB%20%C2%B7%20Hapten%20Sciences%2C%20Inc.&badge=phase%201 PDC-APB PDC-APB · Hapten Sciences, Inc. https://druglandscape.com/drug/pdc-lung01 https://druglandscape.com/api/og?type=drug&title=PDC*lung01&subtitle=PDC*lung01%20%C2%B7%20PDC*line%20Pharma%20SAS&badge=phase%201 PDC*lung01 PDC*lung01 · PDC*line Pharma SAS https://druglandscape.com/drug/pdc31 https://druglandscape.com/api/og?type=drug&title=PDC31&subtitle=PDC31%20%C2%B7%20PDC%20Biotech%20GmbH&badge=phase%201 PDC31 PDC31 · PDC Biotech GmbH https://druglandscape.com/drug/pde9i https://druglandscape.com/api/og?type=drug&title=PDE9i&subtitle=PDE9i%20%C2%B7%20Pfizer&badge=phase%201 PDE9i PDE9i · Pfizer https://druglandscape.com/drug/pdfe-2304-topical-solution https://druglandscape.com/api/og?type=drug&title=PDFE-2304%20Topical%20Solution&subtitle=PDFE-2304%20Topical%20Solution%20%C2%B7%20PDFE%20Pharma%20Innovations%20FZCO&badge=phase%202 PDFE-2304 Topical Solution PDFE-2304 Topical Solution · PDFE Pharma Innovations FZCO https://druglandscape.com/drug/pdi-320 https://druglandscape.com/api/og?type=drug&title=PDI-320&subtitle=PDI-320%20%C2%B7%20PreCision%20Dermatology%2C%20Inc.&badge=phase%202 PDI-320 PDI-320 · PreCision Dermatology, Inc. https://druglandscape.com/drug/pdi-320-monad-1 https://druglandscape.com/api/og?type=drug&title=PDI-320%20Monad%20%231&subtitle=PDI-320%20Monad%20%231%20%C2%B7%20PreCision%20Dermatology%2C%20Inc.&badge=phase%202 PDI-320 Monad #1 PDI-320 Monad #1 · PreCision Dermatology, Inc. https://druglandscape.com/drug/pdi-320-monad-2 https://druglandscape.com/api/og?type=drug&title=PDI-320%20Monad%20%232&subtitle=PDI-320%20Monad%20%232%20%C2%B7%20PreCision%20Dermatology%2C%20Inc.&badge=phase%202 PDI-320 Monad #2 PDI-320 Monad #2 · PreCision Dermatology, Inc. https://druglandscape.com/drug/pdl192 https://druglandscape.com/api/og?type=drug&title=PDL192&subtitle=PDL192%20%C2%B7%20Abbott&badge=phase%201 PDL192 PDL192 · Abbott https://druglandscape.com/drug/pdlla https://druglandscape.com/api/og?type=drug&title=PDLLA&subtitle=PDLLA%20%C2%B7%20Jin%20Cheol%20Kim&badge=phase%201 PDLLA PDLLA · Jin Cheol Kim https://druglandscape.com/drug/pdm08 https://druglandscape.com/api/og?type=drug&title=PDM08&subtitle=PDM08%20%C2%B7%20Prodimed%20S.A.&badge=phase%201 PDM08 PDM08 · Prodimed S.A. https://druglandscape.com/drug/pdm608 https://druglandscape.com/api/og?type=drug&title=PDM608&subtitle=PDM608%20%C2%B7%20Calibr%2C%20a%20division%20of%20Scripps%20Research&badge=phase%201 PDM608 PDM608 · Calibr, a division of Scripps Research https://druglandscape.com/drug/pdo-group https://druglandscape.com/api/og?type=drug&title=PDO%20group&subtitle=PDO%20group%20%C2%B7%20Shanghai%20Minimally%20Invasive%20Surgery%20Center&badge=phase%202 PDO group PDO group · Shanghai Minimally Invasive Surgery Center https://druglandscape.com/drug/pdr001-imatinib https://druglandscape.com/api/og?type=drug&title=PDR001%2C%20Imatinib&subtitle=PDR001%2C%20Imatinib%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 PDR001, Imatinib PDR001, Imatinib · Asan Medical Center https://druglandscape.com/drug/pe0116 https://druglandscape.com/api/og?type=drug&title=PE0116&subtitle=PE0116%20%C2%B7%20Shanghai%20HyaMab%20Biotech%20Co.%2CLtd.&badge=phase%201 PE0116 PE0116 · Shanghai HyaMab Biotech Co.,Ltd. https://druglandscape.com/drug/pe0116-pe0105 https://druglandscape.com/api/og?type=drug&title=PE0116%26PE0105&subtitle=PE0116%26PE0105%20%C2%B7%20Shanghai%20HyaMab%20Biotech%20Co.%2CLtd.&badge=phase%201 PE0116&PE0105 PE0116&PE0105 · Shanghai HyaMab Biotech Co.,Ltd. https://druglandscape.com/drug/peanut-slit-tablet https://druglandscape.com/api/og?type=drug&title=Peanut%20SLIT-tablet&subtitle=Peanut%20SLIT-tablet%20%C2%B7%20ALK-Abell%C3%B3%20A%2FS&badge=phase%201 Peanut SLIT-tablet Peanut SLIT-tablet · ALK-Abelló A/S https://druglandscape.com/drug/pediatric-hav-vaccine https://druglandscape.com/api/og?type=drug&title=Pediatric%20HAV%20vaccine&subtitle=Pediatric%20HAV%20vaccine%20%C2%B7%20Pfizer&badge=phase%202 Pediatric HAV vaccine Pediatric HAV vaccine · Pfizer https://druglandscape.com/drug/pediatric-multitaa-t-cells-stage https://druglandscape.com/api/og?type=drug&title=Pediatric%20multiTAA%20T%20cells%20Stage&subtitle=Pediatric%20multiTAA%20T%20cells%20Stage%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Pediatric multiTAA T cells Stage Pediatric multiTAA T cells Stage · Baylor College of Medicine https://druglandscape.com/drug/peflutren-lipid-microsphere-injectable-suspension https://druglandscape.com/api/og?type=drug&title=Peflutren%20Lipid%20Microsphere%20Injectable%20Suspension&subtitle=Peflutren%20Lipid%20Microsphere%20Injectable%20Suspension%20%C2%B7%20Lantheus%20Medical%20Imaging&badge=phase%202 Peflutren Lipid Microsphere Injectable Suspension Peflutren Lipid Microsphere Injectable Suspension · Lantheus Medical Imaging https://druglandscape.com/drug/peg-3350-without-electrolytes https://druglandscape.com/api/og?type=drug&title=PEG%203350%20without%20electrolytes&subtitle=PEG%203350%20without%20electrolytes%20%C2%B7%20Norgine&badge=phase%201 PEG 3350 without electrolytes PEG 3350 without electrolytes · Norgine https://druglandscape.com/drug/peg-hirudin https://druglandscape.com/api/og?type=drug&title=PEG-hirudin&subtitle=PEG-hirudin%20%C2%B7%20Speedel%20Pharma%20Ltd.&badge=phase%202 PEG-hirudin PEG-hirudin · Speedel Pharma Ltd. https://druglandscape.com/drug/peg-ifn-alpha-2a https://druglandscape.com/api/og?type=drug&title=peg-IFN%20alpha%20-2a&subtitle=peg-IFN%20alpha%20-2a%20%C2%B7%20French%20Innovative%20Leukemia%20Organisation&badge=phase%201 peg-IFN alpha -2a peg-IFN alpha -2a · French Innovative Leukemia Organisation https://druglandscape.com/drug/peg-ifnalfa2a https://druglandscape.com/api/og?type=drug&title=PEG-IFNalfa2a&subtitle=PEG-IFNalfa2a%20%C2%B7%20Human%20Genome%20Sciences%20Inc.&badge=phase%202 PEG-IFNalfa2a PEG-IFNalfa2a · Human Genome Sciences Inc. https://druglandscape.com/drug/peg-interleukin-2 https://druglandscape.com/api/og?type=drug&title=PEG-interleukin-2&subtitle=PEG-interleukin-2%20%C2%B7%20Icahn%20School%20of%20Medicine%20at%20Mount%20Sinai&badge=phase%201 PEG-interleukin-2 PEG-interleukin-2 · Icahn School of Medicine at Mount Sinai https://druglandscape.com/drug/peg-methug-csf https://druglandscape.com/api/og?type=drug&title=PEG-MetHuG-CSF&subtitle=PEG-MetHuG-CSF%20%C2%B7%20PharmaEssentia&badge=phase%201 PEG-MetHuG-CSF PEG-MetHuG-CSF · PharmaEssentia https://druglandscape.com/drug/peg-rhgh-high-dose https://druglandscape.com/api/og?type=drug&title=PEG-rhGH%20high%20dose&subtitle=PEG-rhGH%20high%20dose%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 PEG-rhGH high dose PEG-rhGH high dose · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/peg-rhgh-low-dose https://druglandscape.com/api/og?type=drug&title=PEG-rhGH%20low%20dose&subtitle=PEG-rhGH%20low%20dose%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 PEG-rhGH low dose PEG-rhGH low dose · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/peg-rhgh-with-new-preparation https://druglandscape.com/api/og?type=drug&title=PEG-rhGH%20with%20new%20preparation&subtitle=PEG-rhGH%20with%20new%20preparation%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 PEG-rhGH with new preparation PEG-rhGH with new preparation · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/peg-rhgh-with-present-preparation https://druglandscape.com/api/og?type=drug&title=PEG-rhGH%20with%20present%20preparation&subtitle=PEG-rhGH%20with%20present%20preparation%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 PEG-rhGH with present preparation PEG-rhGH with present preparation · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/peg-ril-29 https://druglandscape.com/api/og?type=drug&title=PEG-rIL-29&subtitle=PEG-rIL-29%20%C2%B7%20ZymoGenetics&badge=phase%202 PEG-rIL-29 PEG-rIL-29 · ZymoGenetics https://druglandscape.com/drug/pegasys-180-g-q1w https://druglandscape.com/api/og?type=drug&title=PEGASYS%20180%20%C2%B5g%20Q1W&subtitle=PEGASYS%20180%20%C2%B5g%20Q1W%20%C2%B7%20PharmaEssentia&badge=phase%202 PEGASYS 180 µg Q1W PEGASYS 180 µg Q1W · PharmaEssentia https://druglandscape.com/drug/pegfilgastim-amgen https://druglandscape.com/api/og?type=drug&title=Pegfilgastim%20Amgen&subtitle=Pegfilgastim%20Amgen%20%C2%B7%20Megalabs&badge=phase%201 Pegfilgastim Amgen Pegfilgastim Amgen · Megalabs https://druglandscape.com/drug/pegfilgastrim-megalabs https://druglandscape.com/api/og?type=drug&title=Pegfilgastrim%20Megalabs&subtitle=Pegfilgastrim%20Megalabs%20%C2%B7%20Megalabs&badge=phase%201 Pegfilgastrim Megalabs Pegfilgastrim Megalabs · Megalabs https://druglandscape.com/drug/pegfilgrastim-form-a https://druglandscape.com/api/og?type=drug&title=Pegfilgrastim%20Form%20A&subtitle=Pegfilgrastim%20Form%20A%20%C2%B7%20Dr.%20Reddy's%20Laboratories%20Limited&badge=phase%201 Pegfilgrastim Form A Pegfilgrastim Form A · Dr. Reddy's Laboratories Limited https://druglandscape.com/drug/pegfilgrastim-form-b https://druglandscape.com/api/og?type=drug&title=Pegfilgrastim%20Form%20B&subtitle=Pegfilgrastim%20Form%20B%20%C2%B7%20Dr.%20Reddy's%20Laboratories%20Limited&badge=phase%201 Pegfilgrastim Form B Pegfilgrastim Form B · Dr. Reddy's Laboratories Limited https://druglandscape.com/drug/pegfilgrastim-hospira https://druglandscape.com/api/og?type=drug&title=Pegfilgrastim%20Hospira&subtitle=Pegfilgrastim%20Hospira%20%C2%B7%20Hospira%2C%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 Pegfilgrastim Hospira Pegfilgrastim Hospira · Hospira, now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/pegfn https://druglandscape.com/api/og?type=drug&title=PegFN&subtitle=PegFN%20%C2%B7%20Janssen%20R%26D%20Ireland&badge=phase%201 PegFN PegFN · Janssen R&D Ireland https://druglandscape.com/drug/pegifn https://druglandscape.com/api/og?type=drug&title=pegIFN&subtitle=pegIFN%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 pegIFN pegIFN · Bristol-Myers Squibb https://druglandscape.com/drug/pegifn-2a https://druglandscape.com/api/og?type=drug&title=PegIFN%CE%B1-2a&subtitle=PegIFN%CE%B1-2a%20%C2%B7%20Janssen%20Pharmaceutical%20K.K.&badge=phase%202 PegIFNα-2a PegIFNα-2a · Janssen Pharmaceutical K.K. https://druglandscape.com/drug/pegifn-alpha2a https://druglandscape.com/api/og?type=drug&title=PegIFN-alpha2a&subtitle=PegIFN-alpha2a%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 PegIFN-alpha2a PegIFN-alpha2a · Janssen Research & Development, LLC https://druglandscape.com/drug/pegifn-lambda https://druglandscape.com/api/og?type=drug&title=PegIFN%20lambda&subtitle=PegIFN%20lambda%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 PegIFN lambda PegIFN lambda · Bristol-Myers Squibb https://druglandscape.com/drug/peginterferon-alpha https://druglandscape.com/api/og?type=drug&title=Peginterferon%20alpha&subtitle=Peginterferon%20alpha%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Peginterferon alpha Peginterferon alpha · Merck Sharp & Dohme LLC https://druglandscape.com/drug/peginterferon-and-ribavirin https://druglandscape.com/api/og?type=drug&title=peginterferon%20and%20ribavirin&subtitle=peginterferon%20and%20ribavirin%20%C2%B7%20Casa%20Sollievo%20della%20Sofferenza%20IRCCS&badge=phase%202 peginterferon and ribavirin peginterferon and ribavirin · Casa Sollievo della Sofferenza IRCCS https://druglandscape.com/drug/pegliposomal-doxorubicin https://druglandscape.com/api/og?type=drug&title=PegLiposomal%20Doxorubicin&subtitle=PegLiposomal%20Doxorubicin%20%C2%B7%20AGO%20Study%20Group&badge=phase%202 PegLiposomal Doxorubicin PegLiposomal Doxorubicin · AGO Study Group https://druglandscape.com/drug/pegylated-formula-interferon-alpha-2b https://druglandscape.com/api/og?type=drug&title=pegylated%20formula%20Interferon-alpha%202b&subtitle=pegylated%20formula%20Interferon-alpha%202b%20%C2%B7%20European%20Mantle%20Cell%20Lymphoma%20Network&badge=phase%203 pegylated formula Interferon-alpha 2b pegylated formula Interferon-alpha 2b · European Mantle Cell Lymphoma Network https://druglandscape.com/drug/pegylated-ifna2b https://druglandscape.com/api/og?type=drug&title=pegylated%20IFNa2b&subtitle=pegylated%20IFNa2b%20%C2%B7%20Biolex%20Therapeutics%2C%20Inc.&badge=phase%201 pegylated IFNa2b pegylated IFNa2b · Biolex Therapeutics, Inc. https://druglandscape.com/drug/pegylated-interferon-2b https://druglandscape.com/api/og?type=drug&title=Pegylated%20Interferon-%CE%B12b&subtitle=Pegylated%20Interferon-%CE%B12b%20%C2%B7%20Zydus%20Lifesciences%20Limited&badge=phase%202 Pegylated Interferon-α2b Pegylated Interferon-α2b · Zydus Lifesciences Limited https://druglandscape.com/drug/pegylated-interferon-conventional-interferon-ribavirin https://druglandscape.com/api/og?type=drug&title=pegylated-interferon%2C%20conventional-interferon%2C%20ribavirin&subtitle=pegylated-interferon%2C%20conventional-interferon%2C%20ribavirin%20%C2%B7%20UPECLIN%20HC%20FM%20Botucatu%20Unesp&badge=phase%202 pegylated-interferon, conventional-interferon, ribavirin pegylated-interferon, conventional-interferon, ribavirin · UPECLIN HC FM Botucatu Unesp https://druglandscape.com/drug/pegylated-liposomal-doxorubicin-and-carboplatin https://druglandscape.com/api/og?type=drug&title=Pegylated%20Liposomal%20Doxorubicin%20and%20Carboplatin&subtitle=Pegylated%20Liposomal%20Doxorubicin%20and%20Carboplatin%20%C2%B7%20AGO%20Study%20Group&badge=phase%202 Pegylated Liposomal Doxorubicin and Carboplatin Pegylated Liposomal Doxorubicin and Carboplatin · AGO Study Group https://druglandscape.com/drug/pegylated-lyposomal-doxorubicin https://druglandscape.com/api/og?type=drug&title=Pegylated%20Lyposomal%20Doxorubicin&subtitle=Pegylated%20Lyposomal%20Doxorubicin%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Pegylated Lyposomal Doxorubicin Pegylated Lyposomal Doxorubicin · Merck Sharp & Dohme LLC https://druglandscape.com/drug/pegylated-recombinant-candida-urate-oxidase https://druglandscape.com/api/og?type=drug&title=PEGylated%20recombinant%20candida%20urate%20oxidase&subtitle=PEGylated%20recombinant%20candida%20urate%20oxidase%20%C2%B7%20Shenyang%20Sunshine%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%201 PEGylated recombinant candida urate oxidase PEGylated recombinant candida urate oxidase · Shenyang Sunshine Pharmaceutical Co., LTD. https://druglandscape.com/drug/pegylated-recombinant-human-g-csf https://druglandscape.com/api/og?type=drug&title=Pegylated%20Recombinant%20Human%20G-CSF&subtitle=Pegylated%20Recombinant%20Human%20G-CSF%20%C2%B7%20Jiangsu%20T-Mab%20Biopharma%20Co.%2CLtd&badge=phase%201 Pegylated Recombinant Human G-CSF Pegylated Recombinant Human G-CSF · Jiangsu T-Mab Biopharma Co.,Ltd https://druglandscape.com/drug/pegylated-rhepo https://druglandscape.com/api/og?type=drug&title=Pegylated%20rhEPO&subtitle=Pegylated%20rhEPO%20%C2%B7%20Xiamen%20Amoytop%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 Pegylated rhEPO Pegylated rhEPO · Xiamen Amoytop Biotech Co., Ltd. https://druglandscape.com/drug/pegylated-somatropin https://druglandscape.com/api/og?type=drug&title=pegylated%20Somatropin&subtitle=pegylated%20Somatropin%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 pegylated Somatropin pegylated Somatropin · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/pek-fusion-protein-vaccine https://druglandscape.com/api/og?type=drug&title=PEK%20Fusion%20Protein%20Vaccine&subtitle=PEK%20Fusion%20Protein%20Vaccine%20%C2%B7%20HealthBanks%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 PEK Fusion Protein Vaccine PEK Fusion Protein Vaccine · HealthBanks Biotech Co., Ltd. https://druglandscape.com/drug/pembrolizumab-4-cycle https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20-%204%20cycle&subtitle=Pembrolizumab%20-%204%20cycle%20%C2%B7%20QuantumLeap%20Healthcare%20Collaborative&badge=phase%202 Pembrolizumab - 4 cycle Pembrolizumab - 4 cycle · QuantumLeap Healthcare Collaborative https://druglandscape.com/drug/pembrolizumab-adjuvant https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20adjuvant&subtitle=Pembrolizumab%20adjuvant%20%C2%B7%20Gustave%20Roussy%2C%20Cancer%20Campus%2C%20Grand%20Paris&badge=phase%202 Pembrolizumab adjuvant Pembrolizumab adjuvant · Gustave Roussy, Cancer Campus, Grand Paris https://druglandscape.com/drug/pembrolizumab-alone https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20alone&subtitle=Pembrolizumab%20alone%20%C2%B7%20Precigen%2C%20Inc&badge=phase%202 Pembrolizumab alone Pembrolizumab alone · Precigen, Inc https://druglandscape.com/drug/pembrolizumab-and-cetuximab https://druglandscape.com/api/og?type=drug&title=pembrolizumab%20and%20cetuximab&subtitle=pembrolizumab%20and%20cetuximab%20%C2%B7%20Commonwealth%20Healthcare%20Corporation&badge=phase%202 pembrolizumab and cetuximab pembrolizumab and cetuximab · Commonwealth Healthcare Corporation https://druglandscape.com/drug/pembrolizumab-and-lenvatinib https://druglandscape.com/api/og?type=drug&title=pembrolizumab%20and%20lenvatinib&subtitle=pembrolizumab%20and%20lenvatinib%20%C2%B7%20Prof.%20Dr.%20Remi%20A.%20Nout&badge=phase%202 pembrolizumab and lenvatinib pembrolizumab and lenvatinib · Prof. Dr. Remi A. Nout https://druglandscape.com/drug/pembrolizumab-before-randomization https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20before%20randomization&subtitle=Pembrolizumab%20before%20randomization%20%C2%B7%20Intergroupe%20Francophone%20de%20Cancerologie%20Thoracique&badge=phase%202 Pembrolizumab before randomization Pembrolizumab before randomization · Intergroupe Francophone de Cancerologie Thoracique https://druglandscape.com/drug/pembrolizumab-dose-a https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20Dose%20A&subtitle=Pembrolizumab%20Dose%20A%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Pembrolizumab Dose A Pembrolizumab Dose A · Merck Sharp & Dohme LLC https://druglandscape.com/drug/pembrolizumab-dose-b https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20Dose%20B&subtitle=Pembrolizumab%20Dose%20B%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Pembrolizumab Dose B Pembrolizumab Dose B · Merck Sharp & Dohme LLC https://druglandscape.com/drug/pembrolizumab-dose-c https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20Dose%20C&subtitle=Pembrolizumab%20Dose%20C%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Pembrolizumab Dose C Pembrolizumab Dose C · Merck Sharp & Dohme LLC https://druglandscape.com/drug/pembrolizumab-dose-d https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20Dose%20D&subtitle=Pembrolizumab%20Dose%20D%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Pembrolizumab Dose D Pembrolizumab Dose D · Merck Sharp & Dohme LLC https://druglandscape.com/drug/pembrolizumab-etoposide-cisplatin-or-carboplatin https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%2C%20Etoposide%2C%20Cisplatin%20or%20Carboplatin&subtitle=Pembrolizumab%2C%20Etoposide%2C%20Cisplatin%20or%20Carboplatin%20%C2%B7%20Fondazione%20IRCCS%20Istituto%20Nazionale%20dei%20Tumori%2C&badge=phase%202 Pembrolizumab, Etoposide, Cisplatin or Carboplatin Pembrolizumab, Etoposide, Cisplatin or Carboplatin · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano https://druglandscape.com/drug/pembrolizumab-injectable-product https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20Injectable%20Product&subtitle=Pembrolizumab%20Injectable%20Product%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%202 Pembrolizumab Injectable Product Pembrolizumab Injectable Product · Baylor College of Medicine https://druglandscape.com/drug/pembrolizumab-injectable-product-chemotherapy-bevacizumab https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20Injectable%20Product%20-%20Chemotherapy%20-%20Bevacizumab&subtitle=Pembrolizumab%20Injectable%20Product%20-%20Chemotherapy%20-%20Bevacizumab%20%C2%B7%20ARCAGY%2F%20GINECO%20GROUP&badge=phase%202 Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab · ARCAGY/ GINECO GROUP https://druglandscape.com/drug/pembrolizumab-injection-keytruda https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20Injection%20%5BKeytruda%5D&subtitle=Pembrolizumab%20Injection%20%5BKeytruda%5D%20%C2%B7%20SMT%20bio%20Co.%2C%20Ltd.&badge=phase%202 Pembrolizumab Injection [Keytruda] Pembrolizumab Injection [Keytruda] · SMT bio Co., Ltd. https://druglandscape.com/drug/pembrolizumab-or-nivolumab https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20or%20Nivolumab&subtitle=Pembrolizumab%20or%20Nivolumab%20%C2%B7%20Intergruppo%20Melanoma%20Italiano&badge=phase%202 Pembrolizumab or Nivolumab Pembrolizumab or Nivolumab · Intergruppo Melanoma Italiano https://druglandscape.com/drug/pembrolizumab-plus-chemotherapy https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20plus%20chemotherapy&subtitle=Pembrolizumab%20plus%20chemotherapy%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 Pembrolizumab plus chemotherapy Pembrolizumab plus chemotherapy · Samsung Medical Center https://druglandscape.com/drug/pembrolizumab-plus-denosumab https://druglandscape.com/api/og?type=drug&title=Pembrolizumab%20plus%20denosumab&subtitle=Pembrolizumab%20plus%20denosumab%20%C2%B7%20Australian%20and%20New%20Zealand%20Urogenital%20and%20Prostate%20Cancer%20Trials%20Grou&badge=phase%202 Pembrolizumab plus denosumab Pembrolizumab plus denosumab · Australian and New Zealand Urogenital and Prostate Cancer Trials Group https://druglandscape.com/drug/pembrolizumab-plus-ramucirumab https://druglandscape.com/api/og?type=drug&title=pembrolizumab%20plus%20ramucirumab&subtitle=pembrolizumab%20plus%20ramucirumab%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 pembrolizumab plus ramucirumab pembrolizumab plus ramucirumab · Samsung Medical Center https://druglandscape.com/drug/pembrolizumab-vorinostat https://druglandscape.com/api/og?type=drug&title=pembrolizumab%3B%20vorinostat&subtitle=pembrolizumab%3B%20vorinostat%20%C2%B7%20UNICANCER&badge=phase%202 pembrolizumab; vorinostat pembrolizumab; vorinostat · UNICANCER https://druglandscape.com/drug/pembrort https://druglandscape.com/api/og?type=drug&title=PembroRT&subtitle=PembroRT%20%C2%B7%20Albert%20Einstein%20College%20of%20Medicine&badge=phase%202 PembroRT PembroRT · Albert Einstein College of Medicine https://druglandscape.com/drug/pemetrexed-and-gemcitabine-plus-bevacizumab https://druglandscape.com/api/og?type=drug&title=Pemetrexed%20and%20Gemcitabine%20plus%20Bevacizumab&subtitle=Pemetrexed%20and%20Gemcitabine%20plus%20Bevacizumab%20%C2%B7%20Accelerated%20Community%20Oncology%20Research%20Network&badge=phase%202 Pemetrexed and Gemcitabine plus Bevacizumab Pemetrexed and Gemcitabine plus Bevacizumab · Accelerated Community Oncology Research Network https://druglandscape.com/drug/pemetrexed-carboplatin-pembrolizumab https://druglandscape.com/api/og?type=drug&title=Pemetrexed%2C%20Carboplatin%2C%20Pembrolizumab&subtitle=Pemetrexed%2C%20Carboplatin%2C%20Pembrolizumab%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 Pemetrexed, Carboplatin, Pembrolizumab Pemetrexed, Carboplatin, Pembrolizumab · Samsung Medical Center https://druglandscape.com/drug/pemetrexed-cisplatin-and-cbp501 https://druglandscape.com/api/og?type=drug&title=pemetrexed%2C%20cisplatin%20and%20CBP501&subtitle=pemetrexed%2C%20cisplatin%20and%20CBP501%20%C2%B7%20CanBas%20Co.%20Ltd.&badge=phase%201 pemetrexed, cisplatin and CBP501 pemetrexed, cisplatin and CBP501 · CanBas Co. Ltd. https://druglandscape.com/drug/pemetrexed-docetaxel-or-gemcitabine https://druglandscape.com/api/og?type=drug&title=Pemetrexed%2C%20docetaxel%20or%20gemcitabine&subtitle=Pemetrexed%2C%20docetaxel%20or%20gemcitabine%20%C2%B7%20ArQule%2C%20Inc.%2C%20a%20subsidiary%20of%20Merck%20Sharp%20%26%20Dohme%20LLC%2C%20a%20subs&badge=phase%202 Pemetrexed, docetaxel or gemcitabine Pemetrexed, docetaxel or gemcitabine · ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) https://druglandscape.com/drug/pemetrexed-phase-1 https://druglandscape.com/api/og?type=drug&title=Pemetrexed%20-%20Phase%201&subtitle=Pemetrexed%20-%20Phase%201%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Pemetrexed - Phase 1 Pemetrexed - Phase 1 · Eli Lilly and Company https://druglandscape.com/drug/pemetrexed-plus-carboplatin https://druglandscape.com/api/og?type=drug&title=Pemetrexed%20plus%20carboplatin&subtitle=Pemetrexed%20plus%20carboplatin%20%C2%B7%20Gruppo%20Oncologico%20Italiano%20di%20Ricerca%20Clinica&badge=phase%202 Pemetrexed plus carboplatin Pemetrexed plus carboplatin · Gruppo Oncologico Italiano di Ricerca Clinica https://druglandscape.com/drug/pen-of-sb5 https://druglandscape.com/api/og?type=drug&title=Pen%20of%20SB5&subtitle=Pen%20of%20SB5%20%C2%B7%20Samsung%20Bioepis%20Co.%2C%20Ltd.&badge=phase%201 Pen of SB5 Pen of SB5 · Samsung Bioepis Co., Ltd. https://druglandscape.com/drug/pentavalent-meningococcal-abcyw-vaccine https://druglandscape.com/api/og?type=drug&title=Pentavalent%20Meningococcal%20ABCYW%20vaccine&subtitle=Pentavalent%20Meningococcal%20ABCYW%20vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Pentavalent Meningococcal ABCYW vaccine Pentavalent Meningococcal ABCYW vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/pentavalent-vaccine-and-salk-ipv https://druglandscape.com/api/og?type=drug&title=Pentavalent%20vaccine%20and%20Salk%20IPV&subtitle=Pentavalent%20vaccine%20and%20Salk%20IPV%20%C2%B7%20LG%20Chem&badge=phase%202 Pentavalent vaccine and Salk IPV Pentavalent vaccine and Salk IPV · LG Chem https://druglandscape.com/drug/pentosan-polysulfate-sodium-fixed-dose https://druglandscape.com/api/og?type=drug&title=Pentosan%20Polysulfate%20Sodium%20Fixed%20Dose&subtitle=Pentosan%20Polysulfate%20Sodium%20Fixed%20Dose%20%C2%B7%20Paradigm%20Biopharmaceuticals%20USA%20(INC)&badge=phase%202 Pentosan Polysulfate Sodium Fixed Dose Pentosan Polysulfate Sodium Fixed Dose · Paradigm Biopharmaceuticals USA (INC) https://druglandscape.com/drug/pentosan-polysulfate-sodium-once-weekly https://druglandscape.com/api/og?type=drug&title=Pentosan%20Polysulfate%20Sodium%20once%20weekly&subtitle=Pentosan%20Polysulfate%20Sodium%20once%20weekly%20%C2%B7%20Paradigm%20Biopharmaceuticals%20USA%20(INC)&badge=phase%202 Pentosan Polysulfate Sodium once weekly Pentosan Polysulfate Sodium once weekly · Paradigm Biopharmaceuticals USA (INC) https://druglandscape.com/drug/pentosan-polysulphate-sodium https://druglandscape.com/api/og?type=drug&title=Pentosan%20Polysulphate%20Sodium&subtitle=Pentosan%20Polysulphate%20Sodium%20%C2%B7%20Paradigm%20Biopharmaceuticals%20Ltd.&badge=phase%202 Pentosan Polysulphate Sodium Pentosan Polysulphate Sodium · Paradigm Biopharmaceuticals Ltd. https://druglandscape.com/drug/pentoxifylline-plus-chemotherapy https://druglandscape.com/api/og?type=drug&title=Pentoxifylline%20Plus%20Chemotherapy&subtitle=Pentoxifylline%20Plus%20Chemotherapy%20%C2%B7%20Ram%C3%B3n%20%C3%93scar%20Gonz%C3%A1lez-Ramella%2C%20Ph.D&badge=phase%202 Pentoxifylline Plus Chemotherapy Pentoxifylline Plus Chemotherapy · Ramón Óscar González-Ramella, Ph.D https://druglandscape.com/drug/pep005-topical-gel https://druglandscape.com/api/og?type=drug&title=PEP005%20Topical%20Gel&subtitle=PEP005%20Topical%20Gel%20%C2%B7%20Peplin&badge=phase%202 PEP005 Topical Gel PEP005 Topical Gel · Peplin https://druglandscape.com/drug/pep02 https://druglandscape.com/api/og?type=drug&title=PEP02&subtitle=PEP02%20%C2%B7%20PharmaEngine&badge=phase%202 PEP02 PEP02 · PharmaEngine https://druglandscape.com/drug/pep03 https://druglandscape.com/api/og?type=drug&title=PEP03&subtitle=PEP03%20%C2%B7%20PharmaEngine&badge=phase%202 PEP03 PEP03 · PharmaEngine https://druglandscape.com/drug/pep07 https://druglandscape.com/api/og?type=drug&title=PEP07&subtitle=PEP07%20%C2%B7%20PharmaEngine&badge=phase%201 PEP07 PEP07 · PharmaEngine https://druglandscape.com/drug/pep08 https://druglandscape.com/api/og?type=drug&title=PEP08&subtitle=PEP08%20%C2%B7%20PharmaEngine&badge=phase%201 PEP08 PEP08 · PharmaEngine https://druglandscape.com/drug/pep2dia https://druglandscape.com/api/og?type=drug&title=pep2dia&subtitle=pep2dia%20%C2%B7%20Muhamed%20Ahmed%20Abdelmoaty%20Muhamed%20Alhagrasy&badge=phase%201 pep2dia pep2dia · Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy https://druglandscape.com/drug/pepidh1m-vaccine https://druglandscape.com/api/og?type=drug&title=PEPIDH1M%20vaccine&subtitle=PEPIDH1M%20vaccine%20%C2%B7%20Katy%20Peters%2C%20MD%2C%20PhD&badge=phase%201 PEPIDH1M vaccine PEPIDH1M vaccine · Katy Peters, MD, PhD https://druglandscape.com/drug/pepticrad-1 https://druglandscape.com/api/og?type=drug&title=PeptiCRAd-1&subtitle=PeptiCRAd-1%20%C2%B7%20Valo%20Therapeutics%20Oy&badge=phase%201 PeptiCRAd-1 PeptiCRAd-1 · Valo Therapeutics Oy https://druglandscape.com/drug/peptide-cancer-vaccine https://druglandscape.com/api/og?type=drug&title=Peptide%20cancer%20vaccine&subtitle=Peptide%20cancer%20vaccine%20%C2%B7%20zeinab%20ahmed%20yousif%20hasan%20ashour&badge=phase%201 Peptide cancer vaccine Peptide cancer vaccine · zeinab ahmed yousif hasan ashour https://druglandscape.com/drug/peptide-construction-3-synthetic https://druglandscape.com/api/og?type=drug&title=Peptide%20Construction%203%2C%20Synthetic&subtitle=Peptide%20Construction%203%2C%20Synthetic%20%C2%B7%20Columbia%20Research%20Laboratories&badge=phase%201 Peptide Construction 3, Synthetic Peptide Construction 3, Synthetic · Columbia Research Laboratories https://druglandscape.com/drug/peptide-pulsed-dendritic-cell https://druglandscape.com/api/og?type=drug&title=Peptide%20pulsed%20Dendritic%20cell&subtitle=Peptide%20pulsed%20Dendritic%20cell%20%C2%B7%20Universidad%20Nacional%20de%20Colombia&badge=phase%201 Peptide pulsed Dendritic cell Peptide pulsed Dendritic cell · Universidad Nacional de Colombia https://druglandscape.com/drug/peptide-yy3-36 https://druglandscape.com/api/og?type=drug&title=Peptide%20YY3-36&subtitle=Peptide%20YY3-36%20%C2%B7%20Pfizer&badge=phase%201 Peptide YY3-36 Peptide YY3-36 · Pfizer https://druglandscape.com/drug/per-001-intravitreal-implant-high-dose https://druglandscape.com/api/og?type=drug&title=PER-001%20Intravitreal%20Implant%20-%20High%20Dose&subtitle=PER-001%20Intravitreal%20Implant%20-%20High%20Dose%20%C2%B7%20Perfuse%20Therapeutics%2C%20Inc.&badge=phase%202 PER-001 Intravitreal Implant - High Dose PER-001 Intravitreal Implant - High Dose · Perfuse Therapeutics, Inc. https://druglandscape.com/drug/per-001-intravitreal-implant-low-dose https://druglandscape.com/api/og?type=drug&title=PER-001%20Intravitreal%20Implant%20-%20Low%20Dose&subtitle=PER-001%20Intravitreal%20Implant%20-%20Low%20Dose%20%C2%B7%20Perfuse%20Therapeutics%2C%20Inc.&badge=phase%202 PER-001 Intravitreal Implant - Low Dose PER-001 Intravitreal Implant - Low Dose · Perfuse Therapeutics, Inc. https://druglandscape.com/drug/per977 https://druglandscape.com/api/og?type=drug&title=PER977&subtitle=PER977%20%C2%B7%20Perosphere%20Pharmaceuticals%20Inc%2C%20a%20wholly%20owned%20subsidiary%20of%20AMAG%20Pharmaceuticals%2C%20Inc.&badge=phase%202 PER977 PER977 · Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. https://druglandscape.com/drug/perampanel-and-microgynon-30 https://druglandscape.com/api/og?type=drug&title=Perampanel%20and%20Microgynon-30&subtitle=Perampanel%20and%20Microgynon-30%20%C2%B7%20Eisai%20Inc.&badge=phase%201 Perampanel and Microgynon-30 Perampanel and Microgynon-30 · Eisai Inc. https://druglandscape.com/drug/pergoveris-fd https://druglandscape.com/api/og?type=drug&title=Pergoveris%20FD&subtitle=Pergoveris%20FD%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt%2C%20Ge&badge=phase%201 Pergoveris FD Pergoveris FD · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/pergoveris-liquid https://druglandscape.com/api/og?type=drug&title=Pergoveris%20Liquid&subtitle=Pergoveris%20Liquid%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt&badge=phase%201 Pergoveris Liquid Pergoveris Liquid · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/peri-urethral-and-clitoral-injections https://druglandscape.com/api/og?type=drug&title=Peri-urethral%20and%20clitoral%20injections&subtitle=Peri-urethral%20and%20clitoral%20injections%20%C2%B7%20Center%20for%20Vulvovaginal%20Disorders&badge=phase%202 Peri-urethral and clitoral injections Peri-urethral and clitoral injections · Center for Vulvovaginal Disorders https://druglandscape.com/drug/perianal-nrl001-gel-3-strengths https://druglandscape.com/api/og?type=drug&title=Perianal%20NRL001%20Gel%203%20strengths&subtitle=Perianal%20NRL001%20Gel%203%20strengths%20%C2%B7%20Norgine&badge=phase%201 Perianal NRL001 Gel 3 strengths Perianal NRL001 Gel 3 strengths · Norgine https://druglandscape.com/drug/perindopril-tert-butylamine-tablets-acertil https://druglandscape.com/api/og?type=drug&title=Perindopril%20tert-Butylamine%20tablets%EF%BC%88ACERTIL%C2%AE%EF%BC%89&subtitle=Perindopril%20tert-Butylamine%20tablets%EF%BC%88ACERTIL%C2%AE%EF%BC%89%20%C2%B7%20Sichuan%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd&badge=phase%201 Perindopril tert-Butylamine tablets（ACERTIL®） Perindopril tert-Butylamine tablets（ACERTIL®） · Sichuan Haisco Pharmaceutical Group Co., Ltd https://druglandscape.com/drug/perineural-incobotulinumtoxin-a-200-u https://druglandscape.com/api/og?type=drug&title=Perineural%20Incobotulinumtoxin-A%20200%20U&subtitle=Perineural%20Incobotulinumtoxin-A%20200%20U%20%C2%B7%20Bo%20Biering-Soerensen&badge=phase%201 Perineural Incobotulinumtoxin-A 200 U Perineural Incobotulinumtoxin-A 200 U · Bo Biering-Soerensen https://druglandscape.com/drug/period-1 https://druglandscape.com/api/og?type=drug&title=Period%201&subtitle=Period%201%20%C2%B7%20Pfizer&badge=phase%202 Period 1 Period 1 · Pfizer https://druglandscape.com/drug/period-1-abiraterone https://druglandscape.com/api/og?type=drug&title=Period%201%3A%20Abiraterone&subtitle=Period%201%3A%20Abiraterone%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Period 1: Abiraterone Period 1: Abiraterone · Janssen Research & Development, LLC https://druglandscape.com/drug/period-1-day-1-pf-04965842-administered https://druglandscape.com/api/og?type=drug&title=Period%201%20-%20Day%201%3A%20PF-04965842%20administered&subtitle=Period%201%20-%20Day%201%3A%20PF-04965842%20administered%20%C2%B7%20Pfizer&badge=phase%201 Period 1 - Day 1: PF-04965842 administered Period 1 - Day 1: PF-04965842 administered · Pfizer https://druglandscape.com/drug/period-1-gx-30-period-2-thyrogen https://druglandscape.com/api/og?type=drug&title=Period%201%20GX-30%2C%20Period%202%20THYROGEN%C2%AE&subtitle=Period%201%20GX-30%2C%20Period%202%20THYROGEN%C2%AE%20%C2%B7%20Genexine%2C%20Inc.&badge=phase%201 Period 1 GX-30, Period 2 THYROGEN® Period 1 GX-30, Period 2 THYROGEN® · Genexine, Inc. https://druglandscape.com/drug/period-1-thyrogen-period-2-gx-30 https://druglandscape.com/api/og?type=drug&title=Period%201%20THYROGEN%C2%AE%2C%20Period%202%20GX-30&subtitle=Period%201%20THYROGEN%C2%AE%2C%20Period%202%20GX-30%20%C2%B7%20Genexine%2C%20Inc.&badge=phase%201 Period 1 THYROGEN®, Period 2 GX-30 Period 1 THYROGEN®, Period 2 GX-30 · Genexine, Inc. https://druglandscape.com/drug/period-1-treatment https://druglandscape.com/api/og?type=drug&title=Period%201%20treatment&subtitle=Period%201%20treatment%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 Period 1 treatment Period 1 treatment · Genentech, Inc. https://druglandscape.com/drug/period-1-treatment-sequence-ab https://druglandscape.com/api/og?type=drug&title=Period%201%20-%20Treatment%20Sequence%20AB&subtitle=Period%201%20-%20Treatment%20Sequence%20AB%20%C2%B7%20Theriva%20Biologics%2C%20Inc.&badge=phase%201 Period 1 - Treatment Sequence AB Period 1 - Treatment Sequence AB · Theriva Biologics, Inc. https://druglandscape.com/drug/period-1-treatment-sequence-ac https://druglandscape.com/api/og?type=drug&title=Period%201%20-%20Treatment%20Sequence%20AC&subtitle=Period%201%20-%20Treatment%20Sequence%20AC%20%C2%B7%20Theriva%20Biologics%2C%20Inc.&badge=phase%201 Period 1 - Treatment Sequence AC Period 1 - Treatment Sequence AC · Theriva Biologics, Inc. https://druglandscape.com/drug/period-2 https://druglandscape.com/api/og?type=drug&title=Period%202&subtitle=Period%202%20%C2%B7%20Pfizer&badge=phase%202 Period 2 Period 2 · Pfizer https://druglandscape.com/drug/period-2-carbamazepine https://druglandscape.com/api/og?type=drug&title=Period%202%3A%20carbamazepine&subtitle=Period%202%3A%20carbamazepine%20%C2%B7%20Atea%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Period 2: carbamazepine Period 2: carbamazepine · Atea Pharmaceuticals, Inc. https://druglandscape.com/drug/period-2-ibi112-dose-3 https://druglandscape.com/api/og?type=drug&title=Period%202%20IBI112%20dose%203&subtitle=Period%202%20IBI112%20dose%203%20%C2%B7%20Innovent%20Biologics%20(Suzhou)%20Co.%20Ltd.&badge=phase%202 Period 2 IBI112 dose 3 Period 2 IBI112 dose 3 · Innovent Biologics (Suzhou) Co. Ltd. https://druglandscape.com/drug/period-2-treatment https://druglandscape.com/api/og?type=drug&title=Period%202%20treatment&subtitle=Period%202%20treatment%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 Period 2 treatment Period 2 treatment · Genentech, Inc. https://druglandscape.com/drug/period-2-treatment-sequence-ab https://druglandscape.com/api/og?type=drug&title=Period%202%20-%20Treatment%20Sequence%20AB&subtitle=Period%202%20-%20Treatment%20Sequence%20AB%20%C2%B7%20Theriva%20Biologics%2C%20Inc.&badge=phase%201 Period 2 - Treatment Sequence AB Period 2 - Treatment Sequence AB · Theriva Biologics, Inc. https://druglandscape.com/drug/period-2-treatment-sequence-ac https://druglandscape.com/api/og?type=drug&title=Period%202%20-%20Treatment%20Sequence%20AC&subtitle=Period%202%20-%20Treatment%20Sequence%20AC%20%C2%B7%20Theriva%20Biologics%2C%20Inc.&badge=phase%201 Period 2 - Treatment Sequence AC Period 2 - Treatment Sequence AC · Theriva Biologics, Inc. https://druglandscape.com/drug/period-3 https://druglandscape.com/api/og?type=drug&title=Period%203&subtitle=Period%203%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 Period 3 Period 3 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/period-4 https://druglandscape.com/api/og?type=drug&title=Period%204&subtitle=Period%204%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%201 Period 4 Period 4 · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/period-c https://druglandscape.com/api/og?type=drug&title=Period%20C&subtitle=Period%20C%20%C2%B7%20Apnimed&badge=phase%202 Period C Period C · Apnimed https://druglandscape.com/drug/perioperative-diclofenac-eye-drops-administration https://druglandscape.com/api/og?type=drug&title=Perioperative%20Diclofenac%20eye-drops%20administration&subtitle=Perioperative%20Diclofenac%20eye-drops%20administration%20%C2%B7%20Eye%20Clinic%20Medic%20Zuljan%20Jukic&badge=phase%201 Perioperative Diclofenac eye-drops administration Perioperative Diclofenac eye-drops administration · Eye Clinic Medic Zuljan Jukic https://druglandscape.com/drug/perioperative-treatment https://druglandscape.com/api/og?type=drug&title=perioperative%20treatment&subtitle=perioperative%20treatment%20%C2%B7%20Centre%20Francois%20Baclesse&badge=phase%202 perioperative treatment perioperative treatment · Centre Francois Baclesse https://druglandscape.com/drug/peripheral-blood-puncture https://druglandscape.com/api/og?type=drug&title=Peripheral%20blood%20puncture&subtitle=Peripheral%20blood%20puncture%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Peripheral blood puncture Peripheral blood puncture · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/peripheral-blood-stem-cell-infusion https://druglandscape.com/api/og?type=drug&title=Peripheral%20Blood%20Stem%20Cell%20Infusion&subtitle=Peripheral%20Blood%20Stem%20Cell%20Infusion%20%C2%B7%20Cedars-Sinai%20Medical%20Center&badge=phase%201 Peripheral Blood Stem Cell Infusion Peripheral Blood Stem Cell Infusion · Cedars-Sinai Medical Center https://druglandscape.com/drug/peripheral-iv https://druglandscape.com/api/og?type=drug&title=Peripheral%20iv&subtitle=Peripheral%20iv%20%C2%B7%20Sclnow%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 Peripheral iv Peripheral iv · Sclnow Biotechnology Co., Ltd. https://druglandscape.com/drug/periurethral-application-of-estradiol-cream https://druglandscape.com/api/og?type=drug&title=Periurethral%20application%20of%20estradiol%20cream&subtitle=Periurethral%20application%20of%20estradiol%20cream%20%C2%B7%20Stephanie%20Wang%20Zuo&badge=phase%202 Periurethral application of estradiol cream Periurethral application of estradiol cream · Stephanie Wang Zuo https://druglandscape.com/drug/perjeta-injectable-product https://druglandscape.com/api/og?type=drug&title=Perjeta%20Injectable%20Product&subtitle=Perjeta%20Injectable%20Product%20%C2%B7%20Palleos%20Healthcare%20GmbH&badge=phase%202 Perjeta Injectable Product Perjeta Injectable Product · Palleos Healthcare GmbH https://druglandscape.com/drug/perla-cold-preservation-solution https://druglandscape.com/api/og?type=drug&title=Perla%C2%AE%20Cold%20Preservation%20solution&subtitle=Perla%C2%AE%20Cold%20Preservation%20solution%20%C2%B7%20Advanced%20Life%20Solutions&badge=phase%201 Perla® Cold Preservation solution Perla® Cold Preservation solution · Advanced Life Solutions https://druglandscape.com/drug/permethrin-5-lotion https://druglandscape.com/api/og?type=drug&title=Permethrin%205%25%20lotion&subtitle=Permethrin%205%25%20lotion%20%C2%B7%20Edward%20Via%20Virginia%20College%20of%20Osteopathic%20Medicine&badge=phase%201 Permethrin 5% lotion Permethrin 5% lotion · Edward Via Virginia College of Osteopathic Medicine https://druglandscape.com/drug/permethrin-foam-4 https://druglandscape.com/api/og?type=drug&title=Permethrin%20Foam%204%25&subtitle=Permethrin%20Foam%204%25%20%C2%B7%20Mylan%20Inc.&badge=phase%202 Permethrin Foam 4% Permethrin Foam 4% · Mylan Inc. https://druglandscape.com/drug/permethrin-foam-5 https://druglandscape.com/api/og?type=drug&title=Permethrin%20Foam%205%25&subtitle=Permethrin%20Foam%205%25%20%C2%B7%20Mylan%20Inc.&badge=phase%202 Permethrin Foam 5% Permethrin Foam 5% · Mylan Inc. https://druglandscape.com/drug/peroperative-infiltration-of-local-anesthetics https://druglandscape.com/api/og?type=drug&title=peroperative%20infiltration%20of%20local%20anesthetics&subtitle=peroperative%20infiltration%20of%20local%20anesthetics%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%203 peroperative infiltration of local anesthetics peroperative infiltration of local anesthetics · Hospices Civils de Lyon https://druglandscape.com/drug/personalized-neoantigen-peptide-vaccine https://druglandscape.com/api/og?type=drug&title=Personalized%20Neoantigen%20Peptide%20Vaccine&subtitle=Personalized%20Neoantigen%20Peptide%20Vaccine%20%C2%B7%20Seqker%20Biosciences%2C%20Inc.&badge=phase%201 Personalized Neoantigen Peptide Vaccine Personalized Neoantigen Peptide Vaccine · Seqker Biosciences, Inc. https://druglandscape.com/drug/personalized-neoantigen-vaccine https://druglandscape.com/api/og?type=drug&title=Personalized%20neoantigen%20vaccine&subtitle=Personalized%20neoantigen%20vaccine%20%C2%B7%20Anda%20Biopharmaceutical%20Development%20(Shenzhen)%20Co.%2C%20Ltd.&badge=phase%201 Personalized neoantigen vaccine Personalized neoantigen vaccine · Anda Biopharmaceutical Development (Shenzhen) Co., Ltd. https://druglandscape.com/drug/pert-at-discharge https://druglandscape.com/api/og?type=drug&title=PERT%20at%20discharge&subtitle=PERT%20at%20discharge%20%C2%B7%20Sunnybrook%20Health%20Sciences%20Centre&badge=phase%201 PERT at discharge PERT at discharge · Sunnybrook Health Sciences Centre https://druglandscape.com/drug/pertubation-with-lidocain-solution https://druglandscape.com/api/og?type=drug&title=Pertubation%20with%20Lidocain%20Solution&subtitle=Pertubation%20with%20Lidocain%20Solution%20%C2%B7%20Isifer%20AB&badge=phase%202 Pertubation with Lidocain Solution Pertubation with Lidocain Solution · Isifer AB https://druglandscape.com/drug/pertuzumab-and-trastuzumab-fdc-subcutaneous https://druglandscape.com/api/og?type=drug&title=Pertuzumab%20and%20trastuzumab%20FDC%20subcutaneous&subtitle=Pertuzumab%20and%20trastuzumab%20FDC%20subcutaneous%20%C2%B7%20David%20Garcia%20Cinca&badge=phase%202 Pertuzumab and trastuzumab FDC subcutaneous Pertuzumab and trastuzumab FDC subcutaneous · David Garcia Cinca https://druglandscape.com/drug/pertuzumab-trastuzumab-emtansine https://druglandscape.com/api/og?type=drug&title=Pertuzumab%2C%20trastuzumab-emtansine&subtitle=Pertuzumab%2C%20trastuzumab-emtansine%20%C2%B7%20Fondazione%20del%20Piemonte%20per%20l'Oncologia&badge=phase%202 Pertuzumab, trastuzumab-emtansine Pertuzumab, trastuzumab-emtansine · Fondazione del Piemonte per l'Oncologia https://druglandscape.com/drug/pet-scan-with-pf-03654746 https://druglandscape.com/api/og?type=drug&title=PET%20Scan%20with%20PF-03654746&subtitle=PET%20Scan%20with%20PF-03654746%20%C2%B7%20Pfizer&badge=phase%201 PET Scan with PF-03654746 PET Scan with PF-03654746 · Pfizer https://druglandscape.com/drug/pet-with-11c-flumazenil https://druglandscape.com/api/og?type=drug&title=PET%20with%2011C-Flumazenil&subtitle=PET%20with%2011C-Flumazenil%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 PET with 11C-Flumazenil PET with 11C-Flumazenil · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/pethidin-hydrochlorid-midazolam https://druglandscape.com/api/og?type=drug&title=pethidin%20hydrochlorid%2C%20midazolam&subtitle=pethidin%20hydrochlorid%2C%20midazolam%20%C2%B7%20Kantonsspital%20M%C3%BCnsterlingen&badge=phase%202 pethidin hydrochlorid, midazolam pethidin hydrochlorid, midazolam · Kantonsspital Münsterlingen https://druglandscape.com/drug/pev-001 https://druglandscape.com/api/og?type=drug&title=PEV-001&subtitle=PEV-001%20%C2%B7%20POSVAX&badge=phase%201 PEV-001 PEV-001 · POSVAX https://druglandscape.com/drug/pev2a-pev2b https://druglandscape.com/api/og?type=drug&title=PEV2A%20PEV2B&subtitle=PEV2A%20PEV2B%20%C2%B7%20Pevion%20Biotech%20Ltd&badge=phase%201 PEV2A PEV2B PEV2A PEV2B · Pevion Biotech Ltd https://druglandscape.com/drug/pev7b1 https://druglandscape.com/api/og?type=drug&title=PEV7B1&subtitle=PEV7B1%20%C2%B7%20Pevion%20Biotech%20Ltd&badge=phase%201 PEV7B1 PEV7B1 · Pevion Biotech Ltd https://druglandscape.com/drug/pev7b2 https://druglandscape.com/api/og?type=drug&title=PEV7B2&subtitle=PEV7B2%20%C2%B7%20Pevion%20Biotech%20Ltd&badge=phase%201 PEV7B2 PEV7B2 · Pevion Biotech Ltd https://druglandscape.com/drug/pev7c1 https://druglandscape.com/api/og?type=drug&title=PEV7C1&subtitle=PEV7C1%20%C2%B7%20Pevion%20Biotech%20Ltd&badge=phase%201 PEV7C1 PEV7C1 · Pevion Biotech Ltd https://druglandscape.com/drug/pev7c9 https://druglandscape.com/api/og?type=drug&title=PEV7C9&subtitle=PEV7C9%20%C2%B7%20Pevion%20Biotech%20Ltd&badge=phase%201 PEV7C9 PEV7C9 · Pevion Biotech Ltd https://druglandscape.com/drug/pex168 https://druglandscape.com/api/og?type=drug&title=PEX168&subtitle=PEX168%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 PEX168 PEX168 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/pexa-vec-combined-with-zkab001 https://druglandscape.com/api/og?type=drug&title=Pexa-Vec%20combined%20with%20ZKAB001&subtitle=Pexa-Vec%20combined%20with%20ZKAB001%20%C2%B7%20Lee's%20Pharmaceutical%20Limited&badge=phase%201 Pexa-Vec combined with ZKAB001 Pexa-Vec combined with ZKAB001 · Lee's Pharmaceutical Limited https://druglandscape.com/drug/peys606 https://druglandscape.com/api/og?type=drug&title=pEYS606&subtitle=pEYS606%20%C2%B7%20Eyevensys&badge=phase%201 pEYS606 pEYS606 · Eyevensys https://druglandscape.com/drug/pf-00184562 https://druglandscape.com/api/og?type=drug&title=PF-00184562&subtitle=PF-00184562%20%C2%B7%20Pfizer&badge=phase%201 PF-00184562 PF-00184562 · Pfizer https://druglandscape.com/drug/pf-00232798 https://druglandscape.com/api/og?type=drug&title=PF-00232798&subtitle=PF-00232798%20%C2%B7%20Pfizer&badge=phase%202 PF-00232798 PF-00232798 · Pfizer https://druglandscape.com/drug/pf-00547659 https://druglandscape.com/api/og?type=drug&title=PF-00547659&subtitle=PF-00547659%20%C2%B7%20Shire&badge=phase%202 PF-00547659 PF-00547659 · Shire https://druglandscape.com/drug/pf-00592379 https://druglandscape.com/api/og?type=drug&title=PF-00592379&subtitle=PF-00592379%20%C2%B7%20Pfizer&badge=phase%202 PF-00592379 PF-00592379 · Pfizer https://druglandscape.com/drug/pf-00868554 https://druglandscape.com/api/og?type=drug&title=PF-00868554&subtitle=PF-00868554%20%C2%B7%20Pfizer&badge=phase%202 PF-00868554 PF-00868554 · Pfizer https://druglandscape.com/drug/pf-03187207 https://druglandscape.com/api/og?type=drug&title=PF-03187207&subtitle=PF-03187207%20%C2%B7%20Bausch%20%26%20Lomb%20Incorporated&badge=phase%202 PF-03187207 PF-03187207 · Bausch & Lomb Incorporated https://druglandscape.com/drug/pf-03526299 https://druglandscape.com/api/og?type=drug&title=PF-03526299&subtitle=PF-03526299%20%C2%B7%20Pfizer&badge=phase%201 PF-03526299 PF-03526299 · Pfizer https://druglandscape.com/drug/pf-03716539 https://druglandscape.com/api/og?type=drug&title=PF-03716539&subtitle=PF-03716539%20%C2%B7%20Pfizer&badge=phase%201 PF-03716539 PF-03716539 · Pfizer https://druglandscape.com/drug/pf-03893787 https://druglandscape.com/api/og?type=drug&title=PF-03893787&subtitle=PF-03893787%20%C2%B7%20Pfizer&badge=phase%201 PF-03893787 PF-03893787 · Pfizer https://druglandscape.com/drug/pf-04217329 https://druglandscape.com/api/og?type=drug&title=PF-04217329&subtitle=PF-04217329%20%C2%B7%20Pfizer&badge=phase%202 PF-04217329 PF-04217329 · Pfizer https://druglandscape.com/drug/pf-04217329-high-dose https://druglandscape.com/api/og?type=drug&title=PF-04217329%20-%20High%20Dose&subtitle=PF-04217329%20-%20High%20Dose%20%C2%B7%20Pfizer&badge=phase%202 PF-04217329 - High Dose PF-04217329 - High Dose · Pfizer https://druglandscape.com/drug/pf-04217329-high-middle-dose https://druglandscape.com/api/og?type=drug&title=PF-04217329%20-%20High%20Middle%20Dose&subtitle=PF-04217329%20-%20High%20Middle%20Dose%20%C2%B7%20Pfizer&badge=phase%202 PF-04217329 - High Middle Dose PF-04217329 - High Middle Dose · Pfizer https://druglandscape.com/drug/pf-04217329-low-dose https://druglandscape.com/api/og?type=drug&title=PF-04217329%20-%20Low%20Dose&subtitle=PF-04217329%20-%20Low%20Dose%20%C2%B7%20Pfizer&badge=phase%202 PF-04217329 - Low Dose PF-04217329 - Low Dose · Pfizer https://druglandscape.com/drug/pf-04217329-lowest-dose https://druglandscape.com/api/og?type=drug&title=PF-04217329%20-%20Lowest%20Dose&subtitle=PF-04217329%20-%20Lowest%20Dose%20%C2%B7%20Pfizer&badge=phase%202 PF-04217329 - Lowest Dose PF-04217329 - Lowest Dose · Pfizer https://druglandscape.com/drug/pf-04217329-middle-dose https://druglandscape.com/api/og?type=drug&title=PF-04217329%20-%20Middle%20Dose&subtitle=PF-04217329%20-%20Middle%20Dose%20%C2%B7%20Pfizer&badge=phase%202 PF-04217329 - Middle Dose PF-04217329 - Middle Dose · Pfizer https://druglandscape.com/drug/pf-04236921 https://druglandscape.com/api/og?type=drug&title=PF-04236921&subtitle=PF-04236921%20%C2%B7%20Pfizer&badge=phase%202 PF-04236921 PF-04236921 · Pfizer https://druglandscape.com/drug/pf-04308515 https://druglandscape.com/api/og?type=drug&title=PF-04308515&subtitle=PF-04308515%20%C2%B7%20Pfizer&badge=phase%201 PF-04308515 PF-04308515 · Pfizer https://druglandscape.com/drug/pf-04360365 https://druglandscape.com/api/og?type=drug&title=PF-04360365&subtitle=PF-04360365%20%C2%B7%20Pfizer&badge=phase%201 PF-04360365 PF-04360365 · Pfizer https://druglandscape.com/drug/pf-04449913-ketoconazole https://druglandscape.com/api/og?type=drug&title=PF-04449913%2C%20ketoconazole&subtitle=PF-04449913%2C%20ketoconazole%20%C2%B7%20Pfizer&badge=phase%201 PF-04449913, ketoconazole PF-04449913, ketoconazole · Pfizer https://druglandscape.com/drug/pf-04457845-faah-inhibitor https://druglandscape.com/api/og?type=drug&title=PF-04457845%2C%20FAAH%20inhibitor&subtitle=PF-04457845%2C%20FAAH%20inhibitor%20%C2%B7%20Pfizer&badge=phase%201 PF-04457845, FAAH inhibitor PF-04457845, FAAH inhibitor · Pfizer https://druglandscape.com/drug/pf-04494700 https://druglandscape.com/api/og?type=drug&title=PF-04494700&subtitle=PF-04494700%20%C2%B7%20Pfizer&badge=phase%202 PF-04494700 PF-04494700 · Pfizer https://druglandscape.com/drug/pf-04494700-high-dose-arm https://druglandscape.com/api/og?type=drug&title=PF-04494700%20-%20High%20Dose%20Arm&subtitle=PF-04494700%20-%20High%20Dose%20Arm%20%C2%B7%20Pfizer&badge=phase%202 PF-04494700 - High Dose Arm PF-04494700 - High Dose Arm · Pfizer https://druglandscape.com/drug/pf-04518600-plus-pf-05082566 https://druglandscape.com/api/og?type=drug&title=PF-04518600%20plus%20PF-05082566&subtitle=PF-04518600%20plus%20PF-05082566%20%C2%B7%20Pfizer&badge=phase%201 PF-04518600 plus PF-05082566 PF-04518600 plus PF-05082566 · Pfizer https://druglandscape.com/drug/pf-04554878 https://druglandscape.com/api/og?type=drug&title=PF-04554878&subtitle=PF-04554878%20%C2%B7%20Verastem%2C%20Inc.&badge=phase%201 PF-04554878 PF-04554878 · Verastem, Inc. https://druglandscape.com/drug/pf-04629991 https://druglandscape.com/api/og?type=drug&title=PF-04629991&subtitle=PF-04629991%20%C2%B7%20Pfizer&badge=phase%201 PF-04629991 PF-04629991 · Pfizer https://druglandscape.com/drug/pf-04856883 https://druglandscape.com/api/og?type=drug&title=PF-04856883&subtitle=PF-04856883%20%C2%B7%20Pfizer&badge=phase%201 PF-04856883 PF-04856883 · Pfizer https://druglandscape.com/drug/pf-04937319 https://druglandscape.com/api/og?type=drug&title=PF-04937319&subtitle=PF-04937319%20%C2%B7%20Pfizer&badge=phase%201 PF-04937319 PF-04937319 · Pfizer https://druglandscape.com/drug/pf-04937319-high-dose https://druglandscape.com/api/og?type=drug&title=PF-04937319%20high%20dose&subtitle=PF-04937319%20high%20dose%20%C2%B7%20Pfizer&badge=phase%201 PF-04937319 high dose PF-04937319 high dose · Pfizer https://druglandscape.com/drug/pf-04937319-ir-mst https://druglandscape.com/api/og?type=drug&title=PF-04937319%20IR%20MST&subtitle=PF-04937319%20IR%20MST%20%C2%B7%20Pfizer&badge=phase%201 PF-04937319 IR MST PF-04937319 IR MST · Pfizer https://druglandscape.com/drug/pf-04937319-low-dose https://druglandscape.com/api/og?type=drug&title=PF-04937319%20low%20dose&subtitle=PF-04937319%20low%20dose%20%C2%B7%20Pfizer&badge=phase%201 PF-04937319 low dose PF-04937319 low dose · Pfizer https://druglandscape.com/drug/pf-04937319-mr-1 https://druglandscape.com/api/og?type=drug&title=PF-04937319%20MR%201&subtitle=PF-04937319%20MR%201%20%C2%B7%20Pfizer&badge=phase%201 PF-04937319 MR 1 PF-04937319 MR 1 · Pfizer https://druglandscape.com/drug/pf-04937319-mr-2 https://druglandscape.com/api/og?type=drug&title=PF-04937319%20MR%202&subtitle=PF-04937319%20MR%202%20%C2%B7%20Pfizer&badge=phase%201 PF-04937319 MR 2 PF-04937319 MR 2 · Pfizer https://druglandscape.com/drug/pf-04937319-mr-3 https://druglandscape.com/api/og?type=drug&title=PF-04937319%20MR%203&subtitle=PF-04937319%20MR%203%20%C2%B7%20Pfizer&badge=phase%201 PF-04937319 MR 3 PF-04937319 MR 3 · Pfizer https://druglandscape.com/drug/pf-04937319-once-daily https://druglandscape.com/api/og?type=drug&title=PF-04937319%20once-daily&subtitle=PF-04937319%20once-daily%20%C2%B7%20Pfizer&badge=phase%201 PF-04937319 once-daily PF-04937319 once-daily · Pfizer https://druglandscape.com/drug/pf-04937319-split-dose https://druglandscape.com/api/og?type=drug&title=PF-04937319%20split-dose&subtitle=PF-04937319%20split-dose%20%C2%B7%20Pfizer&badge=phase%201 PF-04937319 split-dose PF-04937319 split-dose · Pfizer https://druglandscape.com/drug/pf-04950615 https://druglandscape.com/api/og?type=drug&title=PF-04950615&subtitle=PF-04950615%20%C2%B7%20Pfizer&badge=phase%202 PF-04950615 PF-04950615 · Pfizer https://druglandscape.com/drug/pf-04950615-dose-a https://druglandscape.com/api/og?type=drug&title=PF-04950615%20Dose%20A&subtitle=PF-04950615%20Dose%20A%20%C2%B7%20Pfizer&badge=phase%201 PF-04950615 Dose A PF-04950615 Dose A · Pfizer https://druglandscape.com/drug/pf-0499132 https://druglandscape.com/api/og?type=drug&title=PF-0499132&subtitle=PF-0499132%20%C2%B7%20Pfizer&badge=phase%201 PF-0499132 PF-0499132 · Pfizer https://druglandscape.com/drug/pf-04991532-alone https://druglandscape.com/api/og?type=drug&title=PF-04991532%20alone&subtitle=PF-04991532%20alone%20%C2%B7%20Pfizer&badge=phase%201 PF-04991532 alone PF-04991532 alone · Pfizer https://druglandscape.com/drug/pf-05212365 https://druglandscape.com/api/og?type=drug&title=PF-05212365&subtitle=PF-05212365%20%C2%B7%20Pfizer&badge=phase%201 PF-05212365 PF-05212365 · Pfizer https://druglandscape.com/drug/pf-05221304-administered-day-1-14 https://druglandscape.com/api/og?type=drug&title=PF-05221304%20administered%20Day%201-14&subtitle=PF-05221304%20administered%20Day%201-14%20%C2%B7%20Pfizer&badge=phase%201 PF-05221304 administered Day 1-14 PF-05221304 administered Day 1-14 · Pfizer https://druglandscape.com/drug/pf-05221304-administered-day-7-14 https://druglandscape.com/api/og?type=drug&title=PF-05221304%20administered%20Day%207-14&subtitle=PF-05221304%20administered%20Day%207-14%20%C2%B7%20Pfizer&badge=phase%201 PF-05221304 administered Day 7-14 PF-05221304 administered Day 7-14 · Pfizer https://druglandscape.com/drug/pf-05221304-and-pf-06865571-combination https://druglandscape.com/api/og?type=drug&title=PF-05221304%20and%20PF-06865571%20Combination&subtitle=PF-05221304%20and%20PF-06865571%20Combination%20%C2%B7%20Pfizer&badge=phase%202 PF-05221304 and PF-06865571 Combination PF-05221304 and PF-06865571 Combination · Pfizer https://druglandscape.com/drug/pf-05221304-formulation-b https://druglandscape.com/api/og?type=drug&title=PF-05221304%20Formulation%20B&subtitle=PF-05221304%20Formulation%20B%20%C2%B7%20Pfizer&badge=phase%201 PF-05221304 Formulation B PF-05221304 Formulation B · Pfizer https://druglandscape.com/drug/pf-05221304-monotherapy https://druglandscape.com/api/og?type=drug&title=PF-05221304%20Monotherapy&subtitle=PF-05221304%20Monotherapy%20%C2%B7%20Pfizer&badge=phase%202 PF-05221304 Monotherapy PF-05221304 Monotherapy · Pfizer https://druglandscape.com/drug/pf-05230905 https://druglandscape.com/api/og?type=drug&title=PF-05230905&subtitle=PF-05230905%20%C2%B7%20Ablynx%2C%20a%20Sanofi%20company&badge=phase%201 PF-05230905 PF-05230905 · Ablynx, a Sanofi company https://druglandscape.com/drug/pf-05231023 https://druglandscape.com/api/og?type=drug&title=PF-05231023&subtitle=PF-05231023%20%C2%B7%20Pfizer&badge=phase%201 PF-05231023 PF-05231023 · Pfizer https://druglandscape.com/drug/pf-05335810-dose-a https://druglandscape.com/api/og?type=drug&title=PF-05335810%20Dose%20A&subtitle=PF-05335810%20Dose%20A%20%C2%B7%20Pfizer&badge=phase%201 PF-05335810 Dose A PF-05335810 Dose A · Pfizer https://druglandscape.com/drug/pf-05335810-dose-b https://druglandscape.com/api/og?type=drug&title=PF-05335810%20Dose%20B&subtitle=PF-05335810%20Dose%20B%20%C2%B7%20Pfizer&badge=phase%201 PF-05335810 Dose B PF-05335810 Dose B · Pfizer https://druglandscape.com/drug/pf-05335810-dose-c https://druglandscape.com/api/og?type=drug&title=PF-05335810%20Dose%20C&subtitle=PF-05335810%20Dose%20C%20%C2%B7%20Pfizer&badge=phase%201 PF-05335810 Dose C PF-05335810 Dose C · Pfizer https://druglandscape.com/drug/pf-05335810-dose-d https://druglandscape.com/api/og?type=drug&title=PF-05335810%20Dose%20D&subtitle=PF-05335810%20Dose%20D%20%C2%B7%20Pfizer&badge=phase%201 PF-05335810 Dose D PF-05335810 Dose D · Pfizer https://druglandscape.com/drug/pf-05335810-dose-e https://druglandscape.com/api/og?type=drug&title=PF-05335810%20Dose%20E&subtitle=PF-05335810%20Dose%20E%20%C2%B7%20Pfizer&badge=phase%201 PF-05335810 Dose E PF-05335810 Dose E · Pfizer https://druglandscape.com/drug/pf-06252161 https://druglandscape.com/api/og?type=drug&title=PF-06252161&subtitle=PF-06252161%20%C2%B7%20Pfizer&badge=phase%201 PF-06252161 PF-06252161 · Pfizer https://druglandscape.com/drug/pf-06263726 https://druglandscape.com/api/og?type=drug&title=PF-06263726&subtitle=PF-06263726%20%C2%B7%20Pfizer&badge=phase%201 PF-06263726 PF-06263726 · Pfizer https://druglandscape.com/drug/pf-06266047 https://druglandscape.com/api/og?type=drug&title=PF-06266047&subtitle=PF-06266047%20%C2%B7%20Pfizer&badge=phase%201 PF-06266047 PF-06266047 · Pfizer https://druglandscape.com/drug/pf-06273588 https://druglandscape.com/api/og?type=drug&title=PF-06273588&subtitle=PF-06273588%20%C2%B7%20Pfizer&badge=phase%201 PF-06273588 PF-06273588 · Pfizer https://druglandscape.com/drug/pf-06293620 https://druglandscape.com/api/og?type=drug&title=PF-06293620&subtitle=PF-06293620%20%C2%B7%20Pfizer&badge=phase%201 PF-06293620 PF-06293620 · Pfizer https://druglandscape.com/drug/pf-06342674-dose-a https://druglandscape.com/api/og?type=drug&title=PF-06342674%20Dose%20A&subtitle=PF-06342674%20Dose%20A%20%C2%B7%20Pfizer&badge=phase%201 PF-06342674 Dose A PF-06342674 Dose A · Pfizer https://druglandscape.com/drug/pf-06342674-dose-b https://druglandscape.com/api/og?type=drug&title=PF-06342674%20Dose%20B&subtitle=PF-06342674%20Dose%20B%20%C2%B7%20Pfizer&badge=phase%201 PF-06342674 Dose B PF-06342674 Dose B · Pfizer https://druglandscape.com/drug/pf-06342674-dose-c https://druglandscape.com/api/og?type=drug&title=PF-06342674%20Dose%20C&subtitle=PF-06342674%20Dose%20C%20%C2%B7%20Pfizer&badge=phase%201 PF-06342674 Dose C PF-06342674 Dose C · Pfizer https://druglandscape.com/drug/pf-06342674-dose-e https://druglandscape.com/api/og?type=drug&title=PF-06342674%20Dose%20E&subtitle=PF-06342674%20Dose%20E%20%C2%B7%20Pfizer&badge=phase%201 PF-06342674 Dose E PF-06342674 Dose E · Pfizer https://druglandscape.com/drug/pf-06342674-dose-f https://druglandscape.com/api/og?type=drug&title=PF-06342674%20Dose%20F&subtitle=PF-06342674%20Dose%20F%20%C2%B7%20Pfizer&badge=phase%201 PF-06342674 Dose F PF-06342674 Dose F · Pfizer https://druglandscape.com/drug/pf-06342674-dose-g https://druglandscape.com/api/og?type=drug&title=PF-06342674%20Dose%20G&subtitle=PF-06342674%20Dose%20G%20%C2%B7%20Pfizer&badge=phase%201 PF-06342674 Dose G PF-06342674 Dose G · Pfizer https://druglandscape.com/drug/pf-06342674-dose-h https://druglandscape.com/api/og?type=drug&title=PF-06342674%20Dose%20H&subtitle=PF-06342674%20Dose%20H%20%C2%B7%20Pfizer&badge=phase%201 PF-06342674 Dose H PF-06342674 Dose H · Pfizer https://druglandscape.com/drug/pf-06342674-dose-i https://druglandscape.com/api/og?type=drug&title=PF-06342674%20Dose%20I&subtitle=PF-06342674%20Dose%20I%20%C2%B7%20Pfizer&badge=phase%201 PF-06342674 Dose I PF-06342674 Dose I · Pfizer https://druglandscape.com/drug/pf-06342674-dose-j https://druglandscape.com/api/og?type=drug&title=PF-06342674%20Dose%20J&subtitle=PF-06342674%20Dose%20J%20%C2%B7%20Pfizer&badge=phase%201 PF-06342674 Dose J PF-06342674 Dose J · Pfizer https://druglandscape.com/drug/pf-06412562-tbd-mg https://druglandscape.com/api/og?type=drug&title=PF-06412562%20TBD%20mg&subtitle=PF-06412562%20TBD%20mg%20%C2%B7%20Pfizer&badge=phase%201 PF-06412562 TBD mg PF-06412562 TBD mg · Pfizer https://druglandscape.com/drug/pf-06427878 https://druglandscape.com/api/og?type=drug&title=PF-06427878&subtitle=PF-06427878%20%C2%B7%20Pfizer&badge=phase%201 PF-06427878 PF-06427878 · Pfizer https://druglandscape.com/drug/pf-06439535 https://druglandscape.com/api/og?type=drug&title=PF-06439535&subtitle=PF-06439535%20%C2%B7%20Pfizer&badge=phase%201 PF-06439535 PF-06439535 · Pfizer https://druglandscape.com/drug/pf-06480605 https://druglandscape.com/api/og?type=drug&title=PF-06480605&subtitle=PF-06480605%20%C2%B7%20Telavant%2C%20Inc.&badge=phase%202 PF-06480605 PF-06480605 · Telavant, Inc. https://druglandscape.com/drug/pf-06647020-combined-with-avelumab https://druglandscape.com/api/og?type=drug&title=PF-06647020%20combined%20with%20Avelumab&subtitle=PF-06647020%20combined%20with%20Avelumab%20%C2%B7%20Pfizer&badge=phase%201 PF-06647020 combined with Avelumab PF-06647020 combined with Avelumab · Pfizer https://druglandscape.com/drug/pf-06647020-q2w https://druglandscape.com/api/og?type=drug&title=PF-06647020%20Q2W&subtitle=PF-06647020%20Q2W%20%C2%B7%20Pfizer&badge=phase%201 PF-06647020 Q2W PF-06647020 Q2W · Pfizer https://druglandscape.com/drug/pf-06647020-q3w https://druglandscape.com/api/og?type=drug&title=PF-06647020%20Q3W&subtitle=PF-06647020%20Q3W%20%C2%B7%20Pfizer&badge=phase%201 PF-06647020 Q3W PF-06647020 Q3W · Pfizer https://druglandscape.com/drug/pf-06648671 https://druglandscape.com/api/og?type=drug&title=PF-06648671&subtitle=PF-06648671%20%C2%B7%20Pfizer&badge=phase%201 PF-06648671 PF-06648671 · Pfizer https://druglandscape.com/drug/pf-06650833-alone https://druglandscape.com/api/og?type=drug&title=PF-06650833%20alone&subtitle=PF-06650833%20alone%20%C2%B7%20Pfizer&badge=phase%201 PF-06650833 alone PF-06650833 alone · Pfizer https://druglandscape.com/drug/pf-06650833-together-with-pf-06651600 https://druglandscape.com/api/og?type=drug&title=PF-06650833%20together%20with%20PF-06651600&subtitle=PF-06650833%20together%20with%20PF-06651600%20%C2%B7%20Pfizer&badge=phase%201 PF-06650833 together with PF-06651600 PF-06650833 together with PF-06651600 · Pfizer https://druglandscape.com/drug/pf-06651600-alone https://druglandscape.com/api/og?type=drug&title=PF-06651600%20alone&subtitle=PF-06651600%20alone%20%C2%B7%20Pfizer&badge=phase%201 PF-06651600 alone PF-06651600 alone · Pfizer https://druglandscape.com/drug/pf-06651600-induction-dose https://druglandscape.com/api/og?type=drug&title=PF-06651600%20Induction%20Dose&subtitle=PF-06651600%20Induction%20Dose%20%C2%B7%20Pfizer&badge=phase%202 PF-06651600 Induction Dose PF-06651600 Induction Dose · Pfizer https://druglandscape.com/drug/pf-06651600-maintenance-dose-1 https://druglandscape.com/api/og?type=drug&title=PF-06651600%20Maintenance%20Dose%20%231&subtitle=PF-06651600%20Maintenance%20Dose%20%231%20%C2%B7%20Pfizer&badge=phase%202 PF-06651600 Maintenance Dose #1 PF-06651600 Maintenance Dose #1 · Pfizer https://druglandscape.com/drug/pf-06651600-maintenance-dose-2 https://druglandscape.com/api/og?type=drug&title=PF-06651600%20Maintenance%20Dose%20%232&subtitle=PF-06651600%20Maintenance%20Dose%20%232%20%C2%B7%20Pfizer&badge=phase%202 PF-06651600 Maintenance Dose #2 PF-06651600 Maintenance Dose #2 · Pfizer https://druglandscape.com/drug/pf-06651600-maintenance-dose-3 https://druglandscape.com/api/og?type=drug&title=PF-06651600%20Maintenance%20Dose%20%233&subtitle=PF-06651600%20Maintenance%20Dose%20%233%20%C2%B7%20Pfizer&badge=phase%202 PF-06651600 Maintenance Dose #3 PF-06651600 Maintenance Dose #3 · Pfizer https://druglandscape.com/drug/pf-06667272 https://druglandscape.com/api/og?type=drug&title=PF-06667272&subtitle=PF-06667272%20%C2%B7%20Pfizer&badge=phase%201 PF-06667272 PF-06667272 · Pfizer https://druglandscape.com/drug/pf-06669571 https://druglandscape.com/api/og?type=drug&title=PF-06669571&subtitle=PF-06669571%20%C2%B7%20Pfizer&badge=phase%201 PF-06669571 PF-06669571 · Pfizer https://druglandscape.com/drug/pf-06678552 https://druglandscape.com/api/og?type=drug&title=PF-06678552&subtitle=PF-06678552%20%C2%B7%20Pfizer&badge=phase%201 PF-06678552 PF-06678552 · Pfizer https://druglandscape.com/drug/pf-06700841-immediate-release-tablets https://druglandscape.com/api/og?type=drug&title=PF-06700841%20Immediate%20release%20tablets&subtitle=PF-06700841%20Immediate%20release%20tablets%20%C2%B7%20Pfizer&badge=phase%201 PF-06700841 Immediate release tablets PF-06700841 Immediate release tablets · Pfizer https://druglandscape.com/drug/pf-06700841-ir https://druglandscape.com/api/og?type=drug&title=PF-06700841%20IR&subtitle=PF-06700841%20IR%20%C2%B7%20Pfizer&badge=phase%201 PF-06700841 IR PF-06700841 IR · Pfizer https://druglandscape.com/drug/pf-06700841-modified-release-tablets https://druglandscape.com/api/og?type=drug&title=PF-06700841%20Modified%20release%20tablets&subtitle=PF-06700841%20Modified%20release%20tablets%20%C2%B7%20Pfizer&badge=phase%201 PF-06700841 Modified release tablets PF-06700841 Modified release tablets · Pfizer https://druglandscape.com/drug/pf-06700841-mr1 https://druglandscape.com/api/og?type=drug&title=PF-06700841%20MR1&subtitle=PF-06700841%20MR1%20%C2%B7%20Pfizer&badge=phase%201 PF-06700841 MR1 PF-06700841 MR1 · Pfizer https://druglandscape.com/drug/pf-06700841-mr2 https://druglandscape.com/api/og?type=drug&title=PF-06700841%20MR2&subtitle=PF-06700841%20MR2%20%C2%B7%20Pfizer&badge=phase%201 PF-06700841 MR2 PF-06700841 MR2 · Pfizer https://druglandscape.com/drug/pf-06700841-mr3 https://druglandscape.com/api/og?type=drug&title=PF-06700841%20MR3&subtitle=PF-06700841%20MR3%20%C2%B7%20Pfizer&badge=phase%201 PF-06700841 MR3 PF-06700841 MR3 · Pfizer https://druglandscape.com/drug/pf-06751979-multiple-ascending-dose https://druglandscape.com/api/og?type=drug&title=PF-06751979%20multiple%20ascending%20dose&subtitle=PF-06751979%20multiple%20ascending%20dose%20%C2%B7%20Pfizer&badge=phase%201 PF-06751979 multiple ascending dose PF-06751979 multiple ascending dose · Pfizer https://druglandscape.com/drug/pf-06751979-multiple-dose https://druglandscape.com/api/og?type=drug&title=PF-06751979%20multiple%20dose&subtitle=PF-06751979%20multiple%20dose%20%C2%B7%20Pfizer&badge=phase%201 PF-06751979 multiple dose PF-06751979 multiple dose · Pfizer https://druglandscape.com/drug/pf-06751979-single-ascending-dose https://druglandscape.com/api/og?type=drug&title=PF-06751979%20single%20ascending%20dose&subtitle=PF-06751979%20single%20ascending%20dose%20%C2%B7%20Pfizer&badge=phase%201 PF-06751979 single ascending dose PF-06751979 single ascending dose · Pfizer https://druglandscape.com/drug/pf-06751979-single-dose https://druglandscape.com/api/og?type=drug&title=PF-06751979%20single%20dose&subtitle=PF-06751979%20single%20dose%20%C2%B7%20Pfizer&badge=phase%201 PF-06751979 single dose PF-06751979 single dose · Pfizer https://druglandscape.com/drug/pf-06763809 https://druglandscape.com/api/og?type=drug&title=PF-06763809&subtitle=PF-06763809%20%C2%B7%20Pfizer&badge=phase%201 PF-06763809 PF-06763809 · Pfizer https://druglandscape.com/drug/pf-06823859-high https://druglandscape.com/api/og?type=drug&title=PF-06823859%20high&subtitle=PF-06823859%20high%20%C2%B7%20Pfizer&badge=phase%202 PF-06823859 high PF-06823859 high · Pfizer https://druglandscape.com/drug/pf-06826647 https://druglandscape.com/api/og?type=drug&title=PF-06826647&subtitle=PF-06826647%20%C2%B7%20Pfizer&badge=phase%202 PF-06826647 PF-06826647 · Pfizer https://druglandscape.com/drug/pf-06835919-high-dose https://druglandscape.com/api/og?type=drug&title=PF-06835919%20High%20Dose&subtitle=PF-06835919%20High%20Dose%20%C2%B7%20Pfizer&badge=phase%202 PF-06835919 High Dose PF-06835919 High Dose · Pfizer https://druglandscape.com/drug/pf-06835919-low-dose https://druglandscape.com/api/og?type=drug&title=PF-06835919%20Low%20Dose&subtitle=PF-06835919%20Low%20Dose%20%C2%B7%20Pfizer&badge=phase%202 PF-06835919 Low Dose PF-06835919 Low Dose · Pfizer https://druglandscape.com/drug/pf-06852231 https://druglandscape.com/api/og?type=drug&title=PF-06852231&subtitle=PF-06852231%20%C2%B7%20Pfizer&badge=phase%201 PF-06852231 PF-06852231 · Pfizer https://druglandscape.com/drug/pf-06865571-administered-day-1-14 https://druglandscape.com/api/og?type=drug&title=PF-06865571%20administered%20Day%201-14&subtitle=PF-06865571%20administered%20Day%201-14%20%C2%B7%20Pfizer&badge=phase%201 PF-06865571 administered Day 1-14 PF-06865571 administered Day 1-14 · Pfizer https://druglandscape.com/drug/pf-06865571-administered-day-7-14 https://druglandscape.com/api/og?type=drug&title=PF-06865571%20administered%20Day%207-14&subtitle=PF-06865571%20administered%20Day%207-14%20%C2%B7%20Pfizer&badge=phase%201 PF-06865571 administered Day 7-14 PF-06865571 administered Day 7-14 · Pfizer https://druglandscape.com/drug/pf-06865571-fast-release-mr-tablets https://druglandscape.com/api/og?type=drug&title=PF-06865571%20Fast%20release%20MR%20tablets&subtitle=PF-06865571%20Fast%20release%20MR%20tablets%20%C2%B7%20Pfizer&badge=phase%201 PF-06865571 Fast release MR tablets PF-06865571 Fast release MR tablets · Pfizer https://druglandscape.com/drug/pf-06865571-immediate-release-suspension https://druglandscape.com/api/og?type=drug&title=PF-06865571%20Immediate%20release%20suspension&subtitle=PF-06865571%20Immediate%20release%20suspension%20%C2%B7%20Pfizer&badge=phase%201 PF-06865571 Immediate release suspension PF-06865571 Immediate release suspension · Pfizer https://druglandscape.com/drug/pf-06865571-monotherapy https://druglandscape.com/api/og?type=drug&title=PF-06865571%20Monotherapy&subtitle=PF-06865571%20Monotherapy%20%C2%B7%20Pfizer&badge=phase%202 PF-06865571 Monotherapy PF-06865571 Monotherapy · Pfizer https://druglandscape.com/drug/pf-06865571-slow-release-mr-tablets https://druglandscape.com/api/og?type=drug&title=PF-06865571%20Slow%20release%20MR%20tablets&subtitle=PF-06865571%20Slow%20release%20MR%20tablets%20%C2%B7%20Pfizer&badge=phase%201 PF-06865571 Slow release MR tablets PF-06865571 Slow release MR tablets · Pfizer https://druglandscape.com/drug/pf-06881894 https://druglandscape.com/api/og?type=drug&title=PF-06881894&subtitle=PF-06881894%20%C2%B7%20Pfizer&badge=phase%201 PF-06881894 PF-06881894 · Pfizer https://druglandscape.com/drug/pf-06882961-immediate-release-tablet https://druglandscape.com/api/og?type=drug&title=PF-06882961%20Immediate%20Release%20Tablet&subtitle=PF-06882961%20Immediate%20Release%20Tablet%20%C2%B7%20Pfizer&badge=phase%201 PF-06882961 Immediate Release Tablet PF-06882961 Immediate Release Tablet · Pfizer https://druglandscape.com/drug/pf-06946860 https://druglandscape.com/api/og?type=drug&title=PF-06946860&subtitle=PF-06946860%20%C2%B7%20Pfizer&badge=phase%201 PF-06946860 PF-06946860 · Pfizer https://druglandscape.com/drug/pf-07038124-ointment https://druglandscape.com/api/og?type=drug&title=PF-07038124%20ointment&subtitle=PF-07038124%20ointment%20%C2%B7%20Pfizer&badge=phase%202 PF-07038124 ointment PF-07038124 ointment · Pfizer https://druglandscape.com/drug/pf-07209326 https://druglandscape.com/api/og?type=drug&title=PF-07209326&subtitle=PF-07209326%20%C2%B7%20Pfizer&badge=phase%201 PF-07209326 PF-07209326 · Pfizer https://druglandscape.com/drug/pf-07242813 https://druglandscape.com/api/og?type=drug&title=PF-07242813&subtitle=PF-07242813%20%C2%B7%20Pfizer&badge=phase%201 PF-07242813 PF-07242813 · Pfizer https://druglandscape.com/drug/pf-07257876 https://druglandscape.com/api/og?type=drug&title=PF-07257876&subtitle=PF-07257876%20%C2%B7%20Pfizer&badge=phase%201 PF-07257876 PF-07257876 · Pfizer https://druglandscape.com/drug/pf-07284890-treatment-a https://druglandscape.com/api/og?type=drug&title=PF-07284890%20Treatment%20A&subtitle=PF-07284890%20Treatment%20A%20%C2%B7%20Pfizer&badge=phase%201 PF-07284890 Treatment A PF-07284890 Treatment A · Pfizer https://druglandscape.com/drug/pf-07284890-treatment-b https://druglandscape.com/api/og?type=drug&title=PF-07284890%20Treatment%20B&subtitle=PF-07284890%20Treatment%20B%20%C2%B7%20Pfizer&badge=phase%201 PF-07284890 Treatment B PF-07284890 Treatment B · Pfizer https://druglandscape.com/drug/pf-07284890-treatment-c https://druglandscape.com/api/og?type=drug&title=PF-07284890%20Treatment%20C&subtitle=PF-07284890%20Treatment%20C%20%C2%B7%20Pfizer&badge=phase%201 PF-07284890 Treatment C PF-07284890 Treatment C · Pfizer https://druglandscape.com/drug/pf-07940367 https://druglandscape.com/api/og?type=drug&title=PF-07940367&subtitle=PF-07940367%20%C2%B7%20Pfizer&badge=phase%201 PF-07940367 PF-07940367 · Pfizer https://druglandscape.com/drug/pf-114 https://druglandscape.com/api/og?type=drug&title=PF-114&subtitle=PF-114%20%C2%B7%20Fusion%20Pharma%20LLC&badge=phase%201 PF-114 PF-114 · Fusion Pharma LLC https://druglandscape.com/drug/pf-4217329-highest-dose https://druglandscape.com/api/og?type=drug&title=PF-4217329%20-%20Highest%20Dose&subtitle=PF-4217329%20-%20Highest%20Dose%20%C2%B7%20Pfizer&badge=phase%202 PF-4217329 - Highest Dose PF-4217329 - Highest Dose · Pfizer https://druglandscape.com/drug/pf-610-355 https://druglandscape.com/api/og?type=drug&title=PF-610%2C355&subtitle=PF-610%2C355%20%C2%B7%20Pfizer&badge=phase%202 PF-610,355 PF-610,355 · Pfizer https://druglandscape.com/drug/pf-868554 https://druglandscape.com/api/og?type=drug&title=PF-868554&subtitle=PF-868554%20%C2%B7%20Pfizer&badge=phase%201 PF-868554 PF-868554 · Pfizer https://druglandscape.com/drug/pf00562271 https://druglandscape.com/api/og?type=drug&title=PF00562271&subtitle=PF00562271%20%C2%B7%20Verastem%2C%20Inc.&badge=phase%201 PF00562271 PF00562271 · Verastem, Inc. https://druglandscape.com/drug/pf03446962 https://druglandscape.com/api/og?type=drug&title=PF03446962&subtitle=PF03446962%20%C2%B7%20Fondazione%20IRCCS%20Istituto%20Nazionale%20dei%20Tumori%2C%20Milano&badge=phase%202 PF03446962 PF03446962 · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano https://druglandscape.com/drug/pf03635659 https://druglandscape.com/api/og?type=drug&title=PF03635659&subtitle=PF03635659%20%C2%B7%20Pfizer&badge=phase%201 PF03635659 PF03635659 · Pfizer https://druglandscape.com/drug/pf06263276 https://druglandscape.com/api/og?type=drug&title=PF06263276&subtitle=PF06263276%20%C2%B7%20Pfizer&badge=phase%201 PF06263276 PF06263276 · Pfizer https://druglandscape.com/drug/pf06649751-itraconazole https://druglandscape.com/api/og?type=drug&title=PF06649751%2C%20Itraconazole&subtitle=PF06649751%2C%20Itraconazole%20%C2%B7%20Pfizer&badge=phase%201 PF06649751, Itraconazole PF06649751, Itraconazole · Pfizer https://druglandscape.com/drug/pf06700841 https://druglandscape.com/api/og?type=drug&title=PF06700841&subtitle=PF06700841%20%C2%B7%20Pfizer&badge=phase%202 PF06700841 PF06700841 · Pfizer https://druglandscape.com/drug/pf582 https://druglandscape.com/api/og?type=drug&title=PF582&subtitle=PF582%20%C2%B7%20Pfenex%2C%20Inc&badge=phase%201 PF582 PF582 · Pfenex, Inc https://druglandscape.com/drug/pfizer-biontech-covid-19-vaccine https://druglandscape.com/api/og?type=drug&title=Pfizer-BioNTech%20COVID-19%20vaccine&subtitle=Pfizer-BioNTech%20COVID-19%20vaccine%20%C2%B7%20Respiralab&badge=phase%202 Pfizer-BioNTech COVID-19 vaccine Pfizer-BioNTech COVID-19 vaccine · Respiralab https://druglandscape.com/drug/pfizer-comirnaty-vaccine https://druglandscape.com/api/og?type=drug&title=Pfizer%20Comirnaty%20vaccine&subtitle=Pfizer%20Comirnaty%20vaccine%20%C2%B7%20Italian%20Group%20for%20the%20study%20of%20Inflammatory%20Bowel%20Disease%20(IG-IBD)&badge=phase%202 Pfizer Comirnaty vaccine Pfizer Comirnaty vaccine · Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) https://druglandscape.com/drug/pfizer-viagra https://druglandscape.com/api/og?type=drug&title=Pfizer%20Viagra&subtitle=Pfizer%20Viagra%20%C2%B7%20Aspargo%20Labs%2C%20Inc&badge=phase%202 Pfizer Viagra Pfizer Viagra · Aspargo Labs, Inc https://druglandscape.com/drug/pfras https://druglandscape.com/api/og?type=drug&title=PfRAS&subtitle=PfRAS%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 PfRAS PfRAS · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/pfs-of-sb5 https://druglandscape.com/api/og?type=drug&title=PFS%20of%20SB5&subtitle=PFS%20of%20SB5%20%C2%B7%20Samsung%20Bioepis%20Co.%2C%20Ltd.&badge=phase%201 PFS of SB5 PFS of SB5 · Samsung Bioepis Co., Ltd. https://druglandscape.com/drug/pfs25-vlp-fhcmb https://druglandscape.com/api/og?type=drug&title=Pfs25%20VLP-%20FhCMB&subtitle=Pfs25%20VLP-%20FhCMB%20%C2%B7%20Fraunhofer%2C%20Center%20for%20Molecular%20Biotechnology&badge=phase%201 Pfs25 VLP- FhCMB Pfs25 VLP- FhCMB · Fraunhofer, Center for Molecular Biotechnology https://druglandscape.com/drug/pfspz-dvi-challenge https://druglandscape.com/api/og?type=drug&title=PfSPZ-DVI%20Challenge&subtitle=PfSPZ-DVI%20Challenge%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 PfSPZ-DVI Challenge PfSPZ-DVI Challenge · Medicines for Malaria Venture https://druglandscape.com/drug/pfspz-ga1-vaccine https://druglandscape.com/api/og?type=drug&title=PfSPZ-GA1%20Vaccine&subtitle=PfSPZ-GA1%20Vaccine%20%C2%B7%20Sanaria%20Inc.&badge=phase%201 PfSPZ-GA1 Vaccine PfSPZ-GA1 Vaccine · Sanaria Inc. https://druglandscape.com/drug/pfspz-larc2-vaccine https://druglandscape.com/api/og?type=drug&title=PfSPZ-LARC2%20Vaccine&subtitle=PfSPZ-LARC2%20Vaccine%20%C2%B7%20Sanaria%20Inc.&badge=phase%201 PfSPZ-LARC2 Vaccine PfSPZ-LARC2 Vaccine · Sanaria Inc. https://druglandscape.com/drug/pfspz-vaccine https://druglandscape.com/api/og?type=drug&title=PfSPZ%20Vaccine&subtitle=PfSPZ%20Vaccine%20%C2%B7%20Sanaria%20Inc.&badge=phase%202 PfSPZ Vaccine PfSPZ Vaccine · Sanaria Inc. https://druglandscape.com/drug/pg-033 https://druglandscape.com/api/og?type=drug&title=PG-033&subtitle=PG-033%20%C2%B7%20Prime%20Gene%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 PG-033 PG-033 · Prime Gene Therapeutics Co., Ltd. https://druglandscape.com/drug/pg101 https://druglandscape.com/api/og?type=drug&title=PG101&subtitle=PG101%20%C2%B7%20Rhodes%20Pharmaceuticals%2C%20L.P.&badge=phase%201 PG101 PG101 · Rhodes Pharmaceuticals, L.P. https://druglandscape.com/drug/pg110 https://druglandscape.com/api/og?type=drug&title=PG110&subtitle=PG110%20%C2%B7%20Abbott&badge=phase%201 PG110 PG110 · Abbott https://druglandscape.com/drug/pge1-tablet https://druglandscape.com/api/og?type=drug&title=PGE1%20tablet&subtitle=PGE1%20tablet%20%C2%B7%20Hillel%20Yaffe%20Medical%20Center&badge=phase%202 PGE1 tablet PGE1 tablet · Hillel Yaffe Medical Center https://druglandscape.com/drug/pgl5001 https://druglandscape.com/api/og?type=drug&title=PGL5001&subtitle=PGL5001%20%C2%B7%20PregLem%20SA&badge=phase%202 PGL5001 PGL5001 · PregLem SA https://druglandscape.com/drug/pgn-edodm1 https://druglandscape.com/api/og?type=drug&title=PGN-EDODM1&subtitle=PGN-EDODM1%20%C2%B7%20PepGen%20Inc&badge=phase%202 PGN-EDODM1 PGN-EDODM1 · PepGen Inc https://druglandscape.com/drug/pgn-edodm1-for-infusion https://druglandscape.com/api/og?type=drug&title=PGN-EDODM1%20for%20infusion&subtitle=PGN-EDODM1%20for%20infusion%20%C2%B7%20PepGen%20Inc&badge=phase%201 PGN-EDODM1 for infusion PGN-EDODM1 for infusion · PepGen Inc https://druglandscape.com/drug/pgrf https://druglandscape.com/api/og?type=drug&title=PGRF&subtitle=PGRF%20%C2%B7%20Meir%20Medical%20Center&badge=phase%201 PGRF PGRF · Meir Medical Center https://druglandscape.com/drug/pgv-001 https://druglandscape.com/api/og?type=drug&title=PGV-001&subtitle=PGV-001%20%C2%B7%20Ashutosh%20Kumar%20Tewari&badge=phase%201 PGV-001 PGV-001 · Ashutosh Kumar Tewari https://druglandscape.com/drug/ph-762 https://druglandscape.com/api/og?type=drug&title=PH-762&subtitle=PH-762%20%C2%B7%20Phio%20Pharmaceuticals%20Inc.&badge=phase%201 PH-762 PH-762 · Phio Pharmaceuticals Inc. https://druglandscape.com/drug/ph-797804-material-sparing-tablet https://druglandscape.com/api/og?type=drug&title=PH-797804%20material%20sparing%20tablet&subtitle=PH-797804%20material%20sparing%20tablet%20%C2%B7%20Pfizer&badge=phase%201 PH-797804 material sparing tablet PH-797804 material sparing tablet · Pfizer https://druglandscape.com/drug/ph-fdc-sc https://druglandscape.com/api/og?type=drug&title=PH%20FDC%20SC&subtitle=PH%20FDC%20SC%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 PH FDC SC PH FDC SC · Hoffmann-La Roche https://druglandscape.com/drug/ph009-1-tablet https://druglandscape.com/api/og?type=drug&title=PH009-1%20tablet&subtitle=PH009-1%20tablet%20%C2%B7%20Suzhou%20Puhe%20Pharmaceutical%20Technology%20Co.%2C%20LTD&badge=phase%201 PH009-1 tablet PH009-1 tablet · Suzhou Puhe Pharmaceutical Technology Co., LTD https://druglandscape.com/drug/ph94b-intranasal-spray https://druglandscape.com/api/og?type=drug&title=PH94B%20intranasal%20spray&subtitle=PH94B%20intranasal%20spray%20%C2%B7%20Pherin%20Pharmaceuticals%2C%20Inc.&badge=phase%202 PH94B intranasal spray PH94B intranasal spray · Pherin Pharmaceuticals, Inc. https://druglandscape.com/drug/pha-848125ac https://druglandscape.com/api/og?type=drug&title=PHA-848125AC&subtitle=PHA-848125AC%20%C2%B7%20Nerviano%20Medical%20Sciences&badge=phase%201 PHA-848125AC PHA-848125AC · Nerviano Medical Sciences https://druglandscape.com/drug/pharm-pal2 https://druglandscape.com/api/og?type=drug&title=PHARM-PAL2&subtitle=PHARM-PAL2%20%C2%B7%20Henry%20Ford%20Health%20System&badge=phase%201 PHARM-PAL2 PHARM-PAL2 · Henry Ford Health System https://druglandscape.com/drug/pharmacogenetic-algorithm https://druglandscape.com/api/og?type=drug&title=pharmacogenetic%20algorithm&subtitle=pharmacogenetic%20algorithm%20%C2%B7%20University%20of%20Pernambuco&badge=phase%203 pharmacogenetic algorithm pharmacogenetic algorithm · University of Pernambuco https://druglandscape.com/drug/pharmacokinetics-blood-sample-assessment https://druglandscape.com/api/og?type=drug&title=pharmacokinetics%20blood%20sample%20assessment&subtitle=pharmacokinetics%20blood%20sample%20assessment%20%C2%B7%20Centre%20Henri%20Becquerel&badge=phase%201 pharmacokinetics blood sample assessment pharmacokinetics blood sample assessment · Centre Henri Becquerel https://druglandscape.com/drug/pharmacokinetics-of-certolizumab-pegol https://druglandscape.com/api/og?type=drug&title=Pharmacokinetics%20of%20certolizumab%20pegol&subtitle=Pharmacokinetics%20of%20certolizumab%20pegol%20%C2%B7%20UCB%20Biopharma%20SRL&badge=phase%201 Pharmacokinetics of certolizumab pegol Pharmacokinetics of certolizumab pegol · UCB Biopharma SRL https://druglandscape.com/drug/pharmacologic-stress-agent https://druglandscape.com/api/og?type=drug&title=Pharmacologic%20Stress%20Agent&subtitle=Pharmacologic%20Stress%20Agent%20%C2%B7%20Cedars-Sinai%20Medical%20Center&badge=phase%202 Pharmacologic Stress Agent Pharmacologic Stress Agent · Cedars-Sinai Medical Center https://druglandscape.com/drug/pharmacological-ascorbate https://druglandscape.com/api/og?type=drug&title=Pharmacological%20ascorbate&subtitle=Pharmacological%20ascorbate%20%C2%B7%20Joseph%20J.%20Cullen&badge=phase%202 Pharmacological ascorbate Pharmacological ascorbate · Joseph J. Cullen https://druglandscape.com/drug/pharmacological-prophylaxis https://druglandscape.com/api/og?type=drug&title=Pharmacological%20prophylaxis&subtitle=Pharmacological%20prophylaxis%20%C2%B7%20Fondazione%20I.R.C.C.S.%20Istituto%20Neurologico%20Carlo%20Besta&badge=phase%201 Pharmacological prophylaxis Pharmacological prophylaxis · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta https://druglandscape.com/drug/pharyngeal-swab https://druglandscape.com/api/og?type=drug&title=Pharyngeal%20swab&subtitle=Pharyngeal%20swab%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 Pharyngeal swab Pharyngeal swab · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/phase-1a-lb-lr1109 https://druglandscape.com/api/og?type=drug&title=Phase%201a%3A%20LB-LR1109&subtitle=Phase%201a%3A%20LB-LR1109%20%C2%B7%20LG%20Chem&badge=phase%201 Phase 1a: LB-LR1109 Phase 1a: LB-LR1109 · LG Chem https://druglandscape.com/drug/phase-1a-oct-980-capsule https://druglandscape.com/api/og?type=drug&title=Phase%201a%3A%20OCT-980%20Capsule&subtitle=Phase%201a%3A%20OCT-980%20Capsule%20%C2%B7%20Octant%2C%20Inc.&badge=phase%201 Phase 1a: OCT-980 Capsule Phase 1a: OCT-980 Capsule · Octant, Inc. https://druglandscape.com/drug/phase-1b-cwp232291-lenalidomide-dexamethasone https://druglandscape.com/api/og?type=drug&title=Phase%201b%3A%20CWP232291%2C%20Lenalidomide%2C%20Dexamethasone&subtitle=Phase%201b%3A%20CWP232291%2C%20Lenalidomide%2C%20Dexamethasone%20%C2%B7%20JW%20Pharmaceutical&badge=phase%201 Phase 1b: CWP232291, Lenalidomide, Dexamethasone Phase 1b: CWP232291, Lenalidomide, Dexamethasone · JW Pharmaceutical https://druglandscape.com/drug/phase-2-high-dose-myobloc https://druglandscape.com/api/og?type=drug&title=Phase%202%3B%20High%20Dose%20MYOBLOC&subtitle=Phase%202%3B%20High%20Dose%20MYOBLOC%20%C2%B7%20Supernus%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Phase 2; High Dose MYOBLOC Phase 2; High Dose MYOBLOC · Supernus Pharmaceuticals, Inc. https://druglandscape.com/drug/phase-2-low-dose-myobloc https://druglandscape.com/api/og?type=drug&title=Phase%202%3B%20Low%20Dose%20MYOBLOC&subtitle=Phase%202%3B%20Low%20Dose%20MYOBLOC%20%C2%B7%20Supernus%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Phase 2; Low Dose MYOBLOC Phase 2; Low Dose MYOBLOC · Supernus Pharmaceuticals, Inc. https://druglandscape.com/drug/phase-3-myobloc https://druglandscape.com/api/og?type=drug&title=Phase%203%3B%20MYOBLOC&subtitle=Phase%203%3B%20MYOBLOC%20%C2%B7%20Supernus%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Phase 3; MYOBLOC Phase 3; MYOBLOC · Supernus Pharmaceuticals, Inc. https://druglandscape.com/drug/phase-3-nomac-e2-batch-b https://druglandscape.com/api/og?type=drug&title=Phase%203%20NOMAC-E2%20%22Batch%20B%22&subtitle=Phase%203%20NOMAC-E2%20%22Batch%20B%22%20%C2%B7%20Organon%20and%20Co&badge=phase%201 Phase 3 NOMAC-E2 "Batch B" Phase 3 NOMAC-E2 "Batch B" · Organon and Co https://druglandscape.com/drug/phase-i-arm-a https://druglandscape.com/api/og?type=drug&title=Phase%20I%20Arm%20A&subtitle=Phase%20I%20Arm%20A%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 Phase I Arm A Phase I Arm A · Genentech, Inc. https://druglandscape.com/drug/phase-i-arm-b https://druglandscape.com/api/og?type=drug&title=Phase%20I%20Arm%20B&subtitle=Phase%20I%20Arm%20B%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 Phase I Arm B Phase I Arm B · Genentech, Inc. https://druglandscape.com/drug/phase-i-dose-expansion https://druglandscape.com/api/og?type=drug&title=Phase%20I%3A%20Dose%20Expansion&subtitle=Phase%20I%3A%20Dose%20Expansion%20%C2%B7%20Suzhou%20Genhouse%20Bio%20Co.%2C%20Ltd.&badge=phase%201 Phase I: Dose Expansion Phase I: Dose Expansion · Suzhou Genhouse Bio Co., Ltd. https://druglandscape.com/drug/phase-i-mirdametinib-level-1 https://druglandscape.com/api/og?type=drug&title=Phase%20I%20-%20Mirdametinib%20-%20Level%201&subtitle=Phase%20I%20-%20Mirdametinib%20-%20Level%201%20%C2%B7%20Centre%20Georges%20Francois%20Leclerc&badge=phase%201 Phase I - Mirdametinib - Level 1 Phase I - Mirdametinib - Level 1 · Centre Georges Francois Leclerc https://druglandscape.com/drug/phase-i-mirdametinib-level-2 https://druglandscape.com/api/og?type=drug&title=Phase%20I%20-%20Mirdametinib%20-%20Level%202&subtitle=Phase%20I%20-%20Mirdametinib%20-%20Level%202%20%C2%B7%20Centre%20Georges%20Francois%20Leclerc&badge=phase%201 Phase I - Mirdametinib - Level 2 Phase I - Mirdametinib - Level 2 · Centre Georges Francois Leclerc https://druglandscape.com/drug/phase-i-mirdametinib-level-3 https://druglandscape.com/api/og?type=drug&title=Phase%20I%20-%20Mirdametinib%20-%20Level%203&subtitle=Phase%20I%20-%20Mirdametinib%20-%20Level%203%20%C2%B7%20Centre%20Georges%20Francois%20Leclerc&badge=phase%201 Phase I - Mirdametinib - Level 3 Phase I - Mirdametinib - Level 3 · Centre Georges Francois Leclerc https://druglandscape.com/drug/phase-i-mirdametinib-level-4 https://druglandscape.com/api/og?type=drug&title=Phase%20I%20-%20Mirdametinib%20-%20Level%204&subtitle=Phase%20I%20-%20Mirdametinib%20-%20Level%204%20%C2%B7%20Centre%20Georges%20Francois%20Leclerc&badge=phase%201 Phase I - Mirdametinib - Level 4 Phase I - Mirdametinib - Level 4 · Centre Georges Francois Leclerc https://druglandscape.com/drug/phase-ii-advanced-melanoma https://druglandscape.com/api/og?type=drug&title=Phase%20II-Advanced%20melanoma&subtitle=Phase%20II-Advanced%20melanoma%20%C2%B7%20Tyligand%20Bioscience%20(Shanghai)%20Limited&badge=phase%201 Phase II-Advanced melanoma Phase II-Advanced melanoma · Tyligand Bioscience (Shanghai) Limited https://druglandscape.com/drug/phase-ii-hnscc https://druglandscape.com/api/og?type=drug&title=Phase%20II-HNSCC&subtitle=Phase%20II-HNSCC%20%C2%B7%20Tyligand%20Bioscience%20(Shanghai)%20Limited&badge=phase%201 Phase II-HNSCC Phase II-HNSCC · Tyligand Bioscience (Shanghai) Limited https://druglandscape.com/drug/phase-ii-mirdametinib https://druglandscape.com/api/og?type=drug&title=Phase%20II%20-%20Mirdametinib&subtitle=Phase%20II%20-%20Mirdametinib%20%C2%B7%20Centre%20Georges%20Francois%20Leclerc&badge=phase%201 Phase II - Mirdametinib Phase II - Mirdametinib · Centre Georges Francois Leclerc https://druglandscape.com/drug/phase-ii-ntc015-high-dose https://druglandscape.com/api/og?type=drug&title=Phase%20II%3A%20NTC015%20high%20dose&subtitle=Phase%20II%3A%20NTC015%20high%20dose%20%C2%B7%20NTC%20srl&badge=phase%202 Phase II: NTC015 high dose Phase II: NTC015 high dose · NTC srl https://druglandscape.com/drug/phase-ii-ntc015-low-dose https://druglandscape.com/api/og?type=drug&title=Phase%20II%3A%20NTC015%20low%20dose&subtitle=Phase%20II%3A%20NTC015%20low%20dose%20%C2%B7%20NTC%20srl&badge=phase%202 Phase II: NTC015 low dose Phase II: NTC015 low dose · NTC srl https://druglandscape.com/drug/phase-ii-ntc015-medium-dose https://druglandscape.com/api/og?type=drug&title=Phase%20II%3A%20NTC015%20medium%20dose&subtitle=Phase%20II%3A%20NTC015%20medium%20dose%20%C2%B7%20NTC%20srl&badge=phase%202 Phase II: NTC015 medium dose Phase II: NTC015 medium dose · NTC srl https://druglandscape.com/drug/phase-iib-formulation https://druglandscape.com/api/og?type=drug&title=Phase%20IIb%20formulation&subtitle=Phase%20IIb%20formulation%20%C2%B7%20AstraZeneca&badge=phase%201 Phase IIb formulation Phase IIb formulation · AstraZeneca https://druglandscape.com/drug/phase-iii-ntc015-selected-dose https://druglandscape.com/api/og?type=drug&title=Phase%20III%3A%20NTC015%20selected%20dose&subtitle=Phase%20III%3A%20NTC015%20selected%20dose%20%C2%B7%20NTC%20srl&badge=phase%202 Phase III: NTC015 selected dose Phase III: NTC015 selected dose · NTC srl https://druglandscape.com/drug/phenlarmide-tablets https://druglandscape.com/api/og?type=drug&title=Phenlarmide%20Tablets&subtitle=Phenlarmide%20Tablets%20%C2%B7%20Yiling%20Pharmaceutical%20Inc.&badge=phase%201 Phenlarmide Tablets Phenlarmide Tablets · Yiling Pharmaceutical Inc. https://druglandscape.com/drug/phenotype-of-treg-and-teffs https://druglandscape.com/api/og?type=drug&title=Phenotype%20of%20Treg%20and%20Teffs&subtitle=Phenotype%20of%20Treg%20and%20Teffs%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Phenotype of Treg and Teffs Phenotype of Treg and Teffs · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/phenotypical-approach https://druglandscape.com/api/og?type=drug&title=phenotypical%20approach&subtitle=phenotypical%20approach%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 phenotypical approach phenotypical approach · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/phentermine-and-b12 https://druglandscape.com/api/og?type=drug&title=Phentermine%20and%20B12&subtitle=Phentermine%20and%20B12%20%C2%B7%20Dr.%20Michael%20Lang&badge=phase%201 Phentermine and B12 Phentermine and B12 · Dr. Michael Lang https://druglandscape.com/drug/phenyl-14c-arv-471 https://druglandscape.com/api/og?type=drug&title=%5Bphenyl-14C%5DARV-471&subtitle=%5Bphenyl-14C%5DARV-471%20%C2%B7%20Pfizer&badge=phase%201 [phenyl-14C]ARV-471 [phenyl-14C]ARV-471 · Pfizer https://druglandscape.com/drug/phenylephrine-10-eyedrop https://druglandscape.com/api/og?type=drug&title=Phenylephrine%2010%25%20Eyedrop&subtitle=Phenylephrine%2010%25%20Eyedrop%20%C2%B7%20Eyenovia%20Inc.&badge=phase%202 Phenylephrine 10% Eyedrop Phenylephrine 10% Eyedrop · Eyenovia Inc. https://druglandscape.com/drug/phenylephrine-2-5-eyedrop https://druglandscape.com/api/og?type=drug&title=Phenylephrine%202.5%25%20Eyedrop&subtitle=Phenylephrine%202.5%25%20Eyedrop%20%C2%B7%20Eyenovia%20Inc.&badge=phase%202 Phenylephrine 2.5% Eyedrop Phenylephrine 2.5% Eyedrop · Eyenovia Inc. https://druglandscape.com/drug/phenylephrine-hcl-immediate-release https://druglandscape.com/api/og?type=drug&title=Phenylephrine%20HCl%20Immediate%20Release&subtitle=Phenylephrine%20HCl%20Immediate%20Release%20%C2%B7%20Bayer&badge=phase%201 Phenylephrine HCl Immediate Release Phenylephrine HCl Immediate Release · Bayer https://druglandscape.com/drug/phh-1v81 https://druglandscape.com/api/og?type=drug&title=PHH-1V81&subtitle=PHH-1V81%20%C2%B7%20Hipra%20Scientific%2C%20S.L.U&badge=phase%202 PHH-1V81 PHH-1V81 · Hipra Scientific, S.L.U https://druglandscape.com/drug/phitah https://druglandscape.com/api/og?type=drug&title=PHITAH&subtitle=PHITAH%20%C2%B7%20Andalusian%20Network%20for%20Design%20and%20Translation%20of%20Advanced%20Therapies&badge=phase%202 PHITAH PHITAH · Andalusian Network for Design and Translation of Advanced Therapies https://druglandscape.com/drug/phosphate-binder-agents https://druglandscape.com/api/og?type=drug&title=Phosphate%20Binder%20Agents&subtitle=Phosphate%20Binder%20Agents%20%C2%B7%20Ardelyx&badge=phase%202 Phosphate Binder Agents Phosphate Binder Agents · Ardelyx https://druglandscape.com/drug/phosphate-binders https://druglandscape.com/api/og?type=drug&title=Phosphate%20Binders&subtitle=Phosphate%20Binders%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 Phosphate Binders Phosphate Binders · Eli Lilly and Company https://druglandscape.com/drug/photocil-for-atopic-dermatitis https://druglandscape.com/api/og?type=drug&title=Photocil%20for%20Atopic%20Dermatitis&subtitle=Photocil%20for%20Atopic%20Dermatitis%20%C2%B7%20Applied%20Biology%2C%20Inc.&badge=phase%201 Photocil for Atopic Dermatitis Photocil for Atopic Dermatitis · Applied Biology, Inc. https://druglandscape.com/drug/photocil-for-vitiligo https://druglandscape.com/api/og?type=drug&title=Photocil%20for%20Vitiligo&subtitle=Photocil%20for%20Vitiligo%20%C2%B7%20Applied%20Biology%2C%20Inc.&badge=phase%201 Photocil for Vitiligo Photocil for Vitiligo · Applied Biology, Inc. https://druglandscape.com/drug/phox2b-pc-car-t-cells https://druglandscape.com/api/og?type=drug&title=PHOX2B%20PC-CAR%20T%20Cells&subtitle=PHOX2B%20PC-CAR%20T%20Cells%20%C2%B7%20Stephan%20Grupp%20MD%20PhD&badge=phase%201 PHOX2B PC-CAR T Cells PHOX2B PC-CAR T Cells · Stephan Grupp MD PhD https://druglandscape.com/drug/phox430 https://druglandscape.com/api/og?type=drug&title=PhOx430&subtitle=PhOx430%20%C2%B7%20Phost'In%20Therapeutics&badge=phase%201 PhOx430 PhOx430 · Phost'In Therapeutics https://druglandscape.com/drug/php-303 https://druglandscape.com/api/og?type=drug&title=PHP-303&subtitle=PHP-303%20%C2%B7%20pH%20Pharma&badge=phase%201 PHP-303 PHP-303 · pH Pharma https://druglandscape.com/drug/phv01 https://druglandscape.com/api/og?type=drug&title=PHV01&subtitle=PHV01%20%C2%B7%20Public%20Health%20Vaccines%20LLC&badge=phase%201 PHV01 PHV01 · Public Health Vaccines LLC https://druglandscape.com/drug/phv02 https://druglandscape.com/api/og?type=drug&title=PHV02&subtitle=PHV02%20%C2%B7%20Public%20Health%20Vaccines%20LLC&badge=phase%201 PHV02 PHV02 · Public Health Vaccines LLC https://druglandscape.com/drug/phx1149 https://druglandscape.com/api/og?type=drug&title=PHX1149&subtitle=PHX1149%20%C2%B7%20Phenomix&badge=phase%202 PHX1149 PHX1149 · Phenomix https://druglandscape.com/drug/physician-s-choice-treatments-group https://druglandscape.com/api/og?type=drug&title=Physician's%20choice%20treatments%20group&subtitle=Physician's%20choice%20treatments%20group%20%C2%B7%20Yeon%20Hee%20Park&badge=phase%202 Physician's choice treatments group Physician's choice treatments group · Yeon Hee Park https://druglandscape.com/drug/physician-standard-of-care https://druglandscape.com/api/og?type=drug&title=Physician%20standard-of-care&subtitle=Physician%20standard-of-care%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Physician standard-of-care Physician standard-of-care · Merck Sharp & Dohme LLC https://druglandscape.com/drug/physiological-nacl-solution https://druglandscape.com/api/og?type=drug&title=Physiological%20NaCL%20solution&subtitle=Physiological%20NaCL%20solution%20%C2%B7%20Ostergotland%20County%20Council%2C%20Sweden&badge=phase%201 Physiological NaCL solution Physiological NaCL solution · Ostergotland County Council, Sweden https://druglandscape.com/drug/physiopathology-endpoint-classification https://druglandscape.com/api/og?type=drug&title=Physiopathology%20Endpoint%20Classification&subtitle=Physiopathology%20Endpoint%20Classification%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Physiopathology Endpoint Classification Physiopathology Endpoint Classification · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/pi-88-and-dacarbazine https://druglandscape.com/api/og?type=drug&title=PI-88%20and%20dacarbazine&subtitle=PI-88%20and%20dacarbazine%20%C2%B7%20Cellxpert%20Biotechnology%20Corp.&badge=phase%202 PI-88 and dacarbazine PI-88 and dacarbazine · Cellxpert Biotechnology Corp. https://druglandscape.com/drug/pi3k-inhibitor https://druglandscape.com/api/og?type=drug&title=PI3K%20inhibitor&subtitle=PI3K%20inhibitor%20%C2%B7%20SecuraBio&badge=phase%202 PI3K inhibitor PI3K inhibitor · SecuraBio https://druglandscape.com/drug/pi3k-inhibitor-bkm120 https://druglandscape.com/api/og?type=drug&title=PI3K%20inhibitor%20BKM120&subtitle=PI3K%20inhibitor%20BKM120%20%C2%B7%20Kami%20Maddocks%2C%20MD&badge=phase%201 PI3K inhibitor BKM120 PI3K inhibitor BKM120 · Kami Maddocks, MD https://druglandscape.com/drug/piece-of-kidney-removal https://druglandscape.com/api/og?type=drug&title=Piece%20of%20kidney%20removal&subtitle=Piece%20of%20kidney%20removal%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Piece of kidney removal Piece of kidney removal · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/piflufolastat-f-18 https://druglandscape.com/api/og?type=drug&title=piflufolastat%20F%2018&subtitle=piflufolastat%20F%2018%20%C2%B7%20Lantheus%20Medical%20Imaging&badge=phase%202 piflufolastat F 18 piflufolastat F 18 · Lantheus Medical Imaging https://druglandscape.com/drug/pigment-solution-program https://druglandscape.com/api/og?type=drug&title=Pigment%20Solution%20Program&subtitle=Pigment%20Solution%20Program%20%C2%B7%20Dr.dr.Irma%20Bernadette%2C%20SpKK%20(K)&badge=phase%201 Pigment Solution Program Pigment Solution Program · Dr.dr.Irma Bernadette, SpKK (K) https://druglandscape.com/drug/pika-covid-19-vaccine https://druglandscape.com/api/og?type=drug&title=PIKA%20COVID-19%20vaccine&subtitle=PIKA%20COVID-19%20vaccine%20%C2%B7%20Yisheng%20Biopharma%20(Singapore)%20Pte.%20Ltd.&badge=phase%202 PIKA COVID-19 vaccine PIKA COVID-19 vaccine · Yisheng Biopharma (Singapore) Pte. Ltd. https://druglandscape.com/drug/pika-rabies-vaccine https://druglandscape.com/api/og?type=drug&title=PIKA%20rabies%20vaccine&subtitle=PIKA%20rabies%20vaccine%20%C2%B7%20Yisheng%20Biopharma%20(Singapore)%20Pte.%20Ltd.&badge=phase%202 PIKA rabies vaccine PIKA rabies vaccine · Yisheng Biopharma (Singapore) Pte. Ltd. https://druglandscape.com/drug/pilocarpine-nitrate-5 https://druglandscape.com/api/og?type=drug&title=Pilocarpine%20Nitrate%205%25&subtitle=Pilocarpine%20Nitrate%205%25%20%C2%B7%20Richard%20Barry%20Moss&badge=phase%201 Pilocarpine Nitrate 5% Pilocarpine Nitrate 5% · Richard Barry Moss https://druglandscape.com/drug/pimasertib-once-daily https://druglandscape.com/api/og?type=drug&title=Pimasertib%20once%20daily&subtitle=Pimasertib%20once%20daily%20%C2%B7%20EMD%20Serono&badge=phase%202 Pimasertib once daily Pimasertib once daily · EMD Serono https://druglandscape.com/drug/pimasertib-twice-daily https://druglandscape.com/api/og?type=drug&title=Pimasertib%20twice%20daily&subtitle=Pimasertib%20twice%20daily%20%C2%B7%20EMD%20Serono&badge=phase%202 Pimasertib twice daily Pimasertib twice daily · EMD Serono https://druglandscape.com/drug/pimecrolimus-1-top-cream https://druglandscape.com/api/og?type=drug&title=Pimecrolimus%201%25%20Top%20Cream&subtitle=Pimecrolimus%201%25%20Top%20Cream%20%C2%B7%20Mylan%20Inc.&badge=phase%202 Pimecrolimus 1% Top Cream Pimecrolimus 1% Top Cream · Mylan Inc. https://druglandscape.com/drug/pimecrolimus-and-clobetasol https://druglandscape.com/api/og?type=drug&title=pimecrolimus%20and%20clobetasol&subtitle=pimecrolimus%20and%20clobetasol%20%C2%B7%20Center%20for%20Vulvovaginal%20Disorders&badge=phase%202 pimecrolimus and clobetasol pimecrolimus and clobetasol · Center for Vulvovaginal Disorders https://druglandscape.com/drug/pimicotinib-capsule https://druglandscape.com/api/og?type=drug&title=Pimicotinib%20capsule&subtitle=Pimicotinib%20capsule%20%C2%B7%20Abbisko%20Therapeutics%20Co%2C%20Ltd&badge=phase%201 Pimicotinib capsule Pimicotinib capsule · Abbisko Therapeutics Co, Ltd https://druglandscape.com/drug/pimicotinib-capsules https://druglandscape.com/api/og?type=drug&title=pimicotinib%20capsules&subtitle=pimicotinib%20capsules%20%C2%B7%20Abbisko%20Therapeutics%20Co%2C%20Ltd&badge=phase%201 pimicotinib capsules pimicotinib capsules · Abbisko Therapeutics Co, Ltd https://druglandscape.com/drug/pin201104 https://druglandscape.com/api/og?type=drug&title=PIN201104&subtitle=PIN201104%20%C2%B7%20Peptinnovate&badge=phase%201 PIN201104 PIN201104 · Peptinnovate https://druglandscape.com/drug/pioglitazone-and-atorvastatin https://druglandscape.com/api/og?type=drug&title=Pioglitazone%20and%20atorvastatin&subtitle=Pioglitazone%20and%20atorvastatin%20%C2%B7%20Takeda&badge=phase%202 Pioglitazone and atorvastatin Pioglitazone and atorvastatin · Takeda https://druglandscape.com/drug/pioglitazone-and-ramipril https://druglandscape.com/api/og?type=drug&title=Pioglitazone%20and%20ramipril&subtitle=Pioglitazone%20and%20ramipril%20%C2%B7%20Takeda&badge=phase%202 Pioglitazone and ramipril Pioglitazone and ramipril · Takeda https://druglandscape.com/drug/pioglitazone-and-sulphonylurea https://druglandscape.com/api/og?type=drug&title=Pioglitazone%20and%20sulphonylurea&subtitle=Pioglitazone%20and%20sulphonylurea%20%C2%B7%20Takeda&badge=phase%202 Pioglitazone and sulphonylurea Pioglitazone and sulphonylurea · Takeda https://druglandscape.com/drug/pioglitazone-and-tretinoin https://druglandscape.com/api/og?type=drug&title=Pioglitazone%20and%20Tretinoin&subtitle=Pioglitazone%20and%20Tretinoin%20%C2%B7%20Phoenix%20Neurological%20Associates%2C%20LTD&badge=phase%201 Pioglitazone and Tretinoin Pioglitazone and Tretinoin · Phoenix Neurological Associates, LTD https://druglandscape.com/drug/pioglitazone-or-metformin https://druglandscape.com/api/og?type=drug&title=Pioglitazone%20or%20metformin&subtitle=Pioglitazone%20or%20metformin%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%202 Pioglitazone or metformin Pioglitazone or metformin · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/pipac https://druglandscape.com/api/og?type=drug&title=PIPAC&subtitle=PIPAC%20%C2%B7%20Michael%20Bau%20Mortensen&badge=phase%202 PIPAC PIPAC · Michael Bau Mortensen https://druglandscape.com/drug/pipac-with-systemic-chemotherapy https://druglandscape.com/api/og?type=drug&title=PIPAC%20with%20systemic%20chemotherapy&subtitle=PIPAC%20with%20systemic%20chemotherapy%20%C2%B7%20Association%20Francaise%20de%20Chirurgie&badge=phase%202 PIPAC with systemic chemotherapy PIPAC with systemic chemotherapy · Association Francaise de Chirurgie https://druglandscape.com/drug/piperacillin-i-v https://druglandscape.com/api/og?type=drug&title=Piperacillin%20i.v.&subtitle=Piperacillin%20i.v.%20%C2%B7%20Allecra&badge=phase%201 Piperacillin i.v. Piperacillin i.v. · Allecra https://druglandscape.com/drug/piperaquine-tetraphosphate-dispersible-granules https://druglandscape.com/api/og?type=drug&title=Piperaquine%20Tetraphosphate%20dispersible%20granules&subtitle=Piperaquine%20Tetraphosphate%20dispersible%20granules%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 Piperaquine Tetraphosphate dispersible granules Piperaquine Tetraphosphate dispersible granules · Medicines for Malaria Venture https://druglandscape.com/drug/piperaquine-tetraphosphate-uncoated-tablets https://druglandscape.com/api/og?type=drug&title=Piperaquine%20Tetraphosphate%20uncoated%20tablets&subtitle=Piperaquine%20Tetraphosphate%20uncoated%20tablets%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 Piperaquine Tetraphosphate uncoated tablets Piperaquine Tetraphosphate uncoated tablets · Medicines for Malaria Venture https://druglandscape.com/drug/pirfenidone-capsules-0mg https://druglandscape.com/api/og?type=drug&title=Pirfenidone%20Capsules%EF%BC%880mg%EF%BC%89&subtitle=Pirfenidone%20Capsules%EF%BC%880mg%EF%BC%89%20%C2%B7%20Beijing%20Continent%20Pharmaceutical%20Co%2C%20Ltd.&badge=phase%202 Pirfenidone Capsules（0mg） Pirfenidone Capsules（0mg） · Beijing Continent Pharmaceutical Co, Ltd. https://druglandscape.com/drug/pirfenidone-capsules-400-mg https://druglandscape.com/api/og?type=drug&title=Pirfenidone%20Capsules%20%EF%BC%88400%20mg%EF%BC%89&subtitle=Pirfenidone%20Capsules%20%EF%BC%88400%20mg%EF%BC%89%20%C2%B7%20Beijing%20Continent%20Pharmaceutical%20Co%2C%20Ltd.&badge=phase%202 Pirfenidone Capsules （400 mg） Pirfenidone Capsules （400 mg） · Beijing Continent Pharmaceutical Co, Ltd. https://druglandscape.com/drug/pirfenidone-modified-release-tablets https://druglandscape.com/api/og?type=drug&title=Pirfenidone%20Modified-Release%20Tablets&subtitle=Pirfenidone%20Modified-Release%20Tablets%20%C2%B7%20Overseas%20Pharmaceuticals%2C%20Ltd.&badge=phase%201 Pirfenidone Modified-Release Tablets Pirfenidone Modified-Release Tablets · Overseas Pharmaceuticals, Ltd. https://druglandscape.com/drug/pirfenidone-tablets https://druglandscape.com/api/og?type=drug&title=Pirfenidone%20Tablets&subtitle=Pirfenidone%20Tablets%20%C2%B7%20Overseas%20Pharmaceuticals%2C%20Ltd.&badge=phase%201 Pirfenidone Tablets Pirfenidone Tablets · Overseas Pharmaceuticals, Ltd. https://druglandscape.com/drug/pirs2-phosphopeptide https://druglandscape.com/api/og?type=drug&title=pIRS2-phosphopeptide&subtitle=pIRS2-phosphopeptide%20%C2%B7%20Craig%20L%20Slingluff%2C%20Jr&badge=phase%201 pIRS2-phosphopeptide pIRS2-phosphopeptide · Craig L Slingluff, Jr https://druglandscape.com/drug/pirtobrutinib-and-rituximab https://druglandscape.com/api/og?type=drug&title=Pirtobrutinib%20and%20rituximab&subtitle=Pirtobrutinib%20and%20rituximab%20%C2%B7%20Grupo%20Espa%C3%B1ol%20de%20Linfomas%20y%20Transplante%20Aut%C3%B3logo%20de%20M%C3%A9dula%20%C3%93sea&badge=phase%202 Pirtobrutinib and rituximab Pirtobrutinib and rituximab · Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea https://druglandscape.com/drug/pitavastatin-and-levothyroxine https://druglandscape.com/api/og?type=drug&title=Pitavastatin%20and%20levothyroxine&subtitle=Pitavastatin%20and%20levothyroxine%20%C2%B7%20Shaochun.Li&badge=phase%201 Pitavastatin and levothyroxine Pitavastatin and levothyroxine · Shaochun.Li https://druglandscape.com/drug/pitavastatin-valsartan https://druglandscape.com/api/og?type=drug&title=Pitavastatin%2C%20Valsartan&subtitle=Pitavastatin%2C%20Valsartan%20%C2%B7%20JW%20Pharmaceutical&badge=phase%201 Pitavastatin, Valsartan Pitavastatin, Valsartan · JW Pharmaceutical https://druglandscape.com/drug/pitocin-injectable-product https://druglandscape.com/api/og?type=drug&title=Pitocin%20Injectable%20Product&subtitle=Pitocin%20Injectable%20Product%20%C2%B7%20Rambam%20Health%20Care%20Campus&badge=phase%201 Pitocin Injectable Product Pitocin Injectable Product · Rambam Health Care Campus https://druglandscape.com/drug/pitolisant-oral-tablets https://druglandscape.com/api/og?type=drug&title=Pitolisant%20oral%20tablets&subtitle=Pitolisant%20oral%20tablets%20%C2%B7%20Harmony%20Biosciences%20Management%2C%20Inc.&badge=phase%202 Pitolisant oral tablets Pitolisant oral tablets · Harmony Biosciences Management, Inc. https://druglandscape.com/drug/pizv https://druglandscape.com/api/og?type=drug&title=PIZV&subtitle=PIZV%20%C2%B7%20Takeda&badge=phase%201 PIZV PIZV · Takeda https://druglandscape.com/drug/pk101-001-pk101-002 https://druglandscape.com/api/og?type=drug&title=PK101-001%2C%20PK101-002&subtitle=PK101-001%2C%20PK101-002%20%C2%B7%20PMG%20Pharm%20Co.%2C%20Ltd&badge=phase%201 PK101-001, PK101-002 PK101-001, PK101-002 · PMG Pharm Co., Ltd https://druglandscape.com/drug/pl2200 https://druglandscape.com/api/og?type=drug&title=PL2200&subtitle=PL2200%20%C2%B7%20PLx%20Pharma&badge=phase%202 PL2200 PL2200 · PLx Pharma https://druglandscape.com/drug/pl2200-fasted https://druglandscape.com/api/og?type=drug&title=PL2200%20fasted&subtitle=PL2200%20fasted%20%C2%B7%20PLx%20Pharma&badge=phase%201 PL2200 fasted PL2200 fasted · PLx Pharma https://druglandscape.com/drug/pl2200-fed https://druglandscape.com/api/og?type=drug&title=PL2200%20fed&subtitle=PL2200%20fed%20%C2%B7%20PLx%20Pharma&badge=phase%201 PL2200 fed PL2200 fed · PLx Pharma https://druglandscape.com/drug/pl3100 https://druglandscape.com/api/og?type=drug&title=PL3100&subtitle=PL3100%20%C2%B7%20PLx%20Pharma&badge=phase%202 PL3100 PL3100 · PLx Pharma https://druglandscape.com/drug/pl3994 https://druglandscape.com/api/og?type=drug&title=PL3994&subtitle=PL3994%20%C2%B7%20Palatin%20Technologies%2C%20Inc&badge=phase%202 PL3994 PL3994 · Palatin Technologies, Inc https://druglandscape.com/drug/pla-pru-pla-pru https://druglandscape.com/api/og?type=drug&title=PLA-PRU-PLA-PRU&subtitle=PLA-PRU-PLA-PRU%20%C2%B7%20Movetis&badge=phase%202 PLA-PRU-PLA-PRU PLA-PRU-PLA-PRU · Movetis https://druglandscape.com/drug/pla-pru-pru-pla https://druglandscape.com/api/og?type=drug&title=PLA-PRU-PRU-PLA&subtitle=PLA-PRU-PRU-PLA%20%C2%B7%20Movetis&badge=phase%202 PLA-PRU-PRU-PLA PLA-PRU-PRU-PLA · Movetis https://druglandscape.com/drug/plactebo-to-match https://druglandscape.com/api/og?type=drug&title=Plactebo%20To%20Match&subtitle=Plactebo%20To%20Match%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Plactebo To Match Plactebo To Match · GlaxoSmithKline https://druglandscape.com/drug/plain-patch https://druglandscape.com/api/og?type=drug&title=Plain%20patch&subtitle=Plain%20patch%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Plain patch Plain patch · Merck Sharp & Dohme LLC https://druglandscape.com/drug/plasma-citrulline https://druglandscape.com/api/og?type=drug&title=Plasma%20citrulline&subtitle=Plasma%20citrulline%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 Plasma citrulline Plasma citrulline · Asan Medical Center https://druglandscape.com/drug/plasma-collection https://druglandscape.com/api/og?type=drug&title=Plasma%20collection&subtitle=Plasma%20collection%20%C2%B7%20Fondazione%20IRCCS%20Istituto%20Nazionale%20dei%20Tumori%2C%20Milano&badge=phase%202 Plasma collection Plasma collection · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano https://druglandscape.com/drug/plasma-derived-at-iii-concentrate https://druglandscape.com/api/og?type=drug&title=Plasma-derived%20AT-III%20concentrate&subtitle=Plasma-derived%20AT-III%20concentrate%20%C2%B7%20Grifols%20Biologicals%2C%20LLC&badge=phase%202 Plasma-derived AT-III concentrate Plasma-derived AT-III concentrate · Grifols Biologicals, LLC https://druglandscape.com/drug/plasma-derived-fix-pdfix https://druglandscape.com/api/og?type=drug&title=Plasma%20derived%20FIX%20%5BpdFIX%5D&subtitle=Plasma%20derived%20FIX%20%5BpdFIX%5D%20%C2%B7%20CSL%20Behring&badge=phase%201 Plasma derived FIX [pdFIX] Plasma derived FIX [pdFIX] · CSL Behring https://druglandscape.com/drug/plasma-exchanges-and-intravenous-immunoglobulins https://druglandscape.com/api/og?type=drug&title=Plasma%20exchanges%20and%20intravenous%20immunoglobulins&subtitle=Plasma%20exchanges%20and%20intravenous%20immunoglobulins%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Plasma exchanges and intravenous immunoglobulins Plasma exchanges and intravenous immunoglobulins · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/plasma-film https://druglandscape.com/api/og?type=drug&title=Plasma%20Film&subtitle=Plasma%20Film%20%C2%B7%20Vitruvian%20Medical%20Devices%2C%20Inc.&badge=phase%201 Plasma Film Plasma Film · Vitruvian Medical Devices, Inc. https://druglandscape.com/drug/plasma-sample https://druglandscape.com/api/og?type=drug&title=Plasma%20Sample&subtitle=Plasma%20Sample%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 Plasma Sample Plasma Sample · Hospices Civils de Lyon https://druglandscape.com/drug/plasminogen-activator https://druglandscape.com/api/og?type=drug&title=Plasminogen%20Activator&subtitle=Plasminogen%20Activator%20%C2%B7%20Grifols%20Therapeutics%20LLC&badge=phase%202 Plasminogen Activator Plasminogen Activator · Grifols Therapeutics LLC https://druglandscape.com/drug/plasmodium-falciparum-malaria-parasite https://druglandscape.com/api/og?type=drug&title=Plasmodium%20falciparum%20malaria%20parasite&subtitle=Plasmodium%20falciparum%20malaria%20parasite%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 Plasmodium falciparum malaria parasite Plasmodium falciparum malaria parasite · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/plasmodium-falciparum-sporozoite-challenge https://druglandscape.com/api/og?type=drug&title=Plasmodium%20falciparum%20sporozoite%20challenge&subtitle=Plasmodium%20falciparum%20sporozoite%20challenge%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 Plasmodium falciparum sporozoite challenge Plasmodium falciparum sporozoite challenge · Medicines for Malaria Venture https://druglandscape.com/drug/platelet-antiaggregant https://druglandscape.com/api/og?type=drug&title=Platelet%20Antiaggregant&subtitle=Platelet%20Antiaggregant%20%C2%B7%20Jaime%20Daniel%20Mondragon&badge=phase%202 Platelet Antiaggregant Platelet Antiaggregant · Jaime Daniel Mondragon https://druglandscape.com/drug/platelet-derived-repairing-factors https://druglandscape.com/api/og?type=drug&title=platelet-derived%20repairing%20factors&subtitle=platelet-derived%20repairing%20factors%20%C2%B7%20Fondazione%20IRCCS%20Policlinico%20San%20Matteo%20di%20Pavia&badge=phase%202 platelet-derived repairing factors platelet-derived repairing factors · Fondazione IRCCS Policlinico San Matteo di Pavia https://druglandscape.com/drug/platelet-rich-fibrin-matrix https://druglandscape.com/api/og?type=drug&title=Platelet%20rich%20fibrin%20matrix&subtitle=Platelet%20rich%20fibrin%20matrix%20%C2%B7%20The%20New%20York%20Eye%20%26%20Ear%20Infirmary&badge=phase%201 Platelet rich fibrin matrix Platelet rich fibrin matrix · The New York Eye & Ear Infirmary https://druglandscape.com/drug/platelet-rich-plasma-and-fibrin-glue https://druglandscape.com/api/og?type=drug&title=Platelet-Rich%20Plasma%20and%20Fibrin%20Glue&subtitle=Platelet-Rich%20Plasma%20and%20Fibrin%20Glue%20%C2%B7%20Daryoush%20Hamidi%20Alamdari%2C%20PhD&badge=phase%202 Platelet-Rich Plasma and Fibrin Glue Platelet-Rich Plasma and Fibrin Glue · Daryoush Hamidi Alamdari, PhD https://druglandscape.com/drug/platelet-rich-plasma-dressing https://druglandscape.com/api/og?type=drug&title=Platelet%20Rich%20Plasma%20Dressing&subtitle=Platelet%20Rich%20Plasma%20Dressing%20%C2%B7%20Multan%20Medical%20And%20Dental%20College&badge=phase%201 Platelet Rich Plasma Dressing Platelet Rich Plasma Dressing · Multan Medical And Dental College https://druglandscape.com/drug/platelets-rich-plasma https://druglandscape.com/api/og?type=drug&title=platelets%20rich%20plasma&subtitle=platelets%20rich%20plasma%20%C2%B7%20Aya%20abdelnasser%20hassani&badge=phase%201 platelets rich plasma platelets rich plasma · Aya abdelnasser hassani https://druglandscape.com/drug/platinum-analogues https://druglandscape.com/api/og?type=drug&title=Platinum%20analogues&subtitle=Platinum%20analogues%20%C2%B7%20Daiichi%20Sankyo%20Co.%2C%20Ltd.&badge=phase%202 Platinum analogues Platinum analogues · Daiichi Sankyo Co., Ltd. https://druglandscape.com/drug/platinum-based-agent https://druglandscape.com/api/og?type=drug&title=Platinum-based%20agent&subtitle=Platinum-based%20agent%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Platinum-based agent Platinum-based agent · Merck Sharp & Dohme LLC https://druglandscape.com/drug/platinum-based-chemotherapies https://druglandscape.com/api/og?type=drug&title=Platinum%20based%20chemotherapies&subtitle=Platinum%20based%20chemotherapies%20%C2%B7%20UNICANCER&badge=phase%202 Platinum based chemotherapies Platinum based chemotherapies · UNICANCER https://druglandscape.com/drug/platinum-based-chemotherapy-plus-nivolumab https://druglandscape.com/api/og?type=drug&title=Platinum-based%20chemotherapy%20plus%20Nivolumab&subtitle=Platinum-based%20chemotherapy%20plus%20Nivolumab%20%C2%B7%20Fondazione%20Ricerca%20Traslazionale&badge=phase%202 Platinum-based chemotherapy plus Nivolumab Platinum-based chemotherapy plus Nivolumab · Fondazione Ricerca Traslazionale https://druglandscape.com/drug/platinum-doublet https://druglandscape.com/api/og?type=drug&title=Platinum%20Doublet&subtitle=Platinum%20Doublet%20%C2%B7%20Montefiore%20Medical%20Center&badge=phase%202 Platinum Doublet Platinum Doublet · Montefiore Medical Center https://druglandscape.com/drug/platinum-doublet-chemotherapy https://druglandscape.com/api/og?type=drug&title=Platinum%20doublet%20chemotherapy&subtitle=Platinum%20doublet%20chemotherapy%20%C2%B7%20Fondazione%20Ricerca%20Traslazionale&badge=phase%202 Platinum doublet chemotherapy Platinum doublet chemotherapy · Fondazione Ricerca Traslazionale https://druglandscape.com/drug/plavix-and-pa32540 https://druglandscape.com/api/og?type=drug&title=Plavix%C2%AE%20and%20PA32540&subtitle=Plavix%C2%AE%20and%20PA32540%20%C2%B7%20POZEN&badge=phase%201 Plavix® and PA32540 Plavix® and PA32540 · POZEN https://druglandscape.com/drug/plb-002 https://druglandscape.com/api/og?type=drug&title=PLB-002&subtitle=PLB-002%20%C2%B7%20Primelink%20BioTherapeitics(ShenZhen)%20Limited&badge=phase%201 PLB-002 PLB-002 · Primelink BioTherapeitics(ShenZhen) Limited https://druglandscape.com/drug/plb-1001 https://druglandscape.com/api/og?type=drug&title=PLB-1001&subtitle=PLB-1001%20%C2%B7%20Apollomics%20Inc.&badge=phase%201 PLB-1001 PLB-1001 · Apollomics Inc. https://druglandscape.com/drug/pld-cyclophosphamide-trastuzumab-paclitaxel https://druglandscape.com/api/og?type=drug&title=PLD%2C%20cyclophosphamide%2C%20trastuzumab%2C%20paclitaxel&subtitle=PLD%2C%20cyclophosphamide%2C%20trastuzumab%2C%20paclitaxel%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 PLD, cyclophosphamide, trastuzumab, paclitaxel PLD, cyclophosphamide, trastuzumab, paclitaxel · Merck Sharp & Dohme LLC https://druglandscape.com/drug/plendil https://druglandscape.com/api/og?type=drug&title=PLENDIL%C2%AE&subtitle=PLENDIL%C2%AE%20%C2%B7%20Ranbaxy%20Laboratories%20Limited&badge=phase%201 PLENDIL® PLENDIL® · Ranbaxy Laboratories Limited https://druglandscape.com/drug/plenvu-powder-for-oral-solution https://druglandscape.com/api/og?type=drug&title=PLENVU%20powder%20for%20oral%20solution&subtitle=PLENVU%20powder%20for%20oral%20solution%20%C2%B7%20Norgine&badge=phase%201 PLENVU powder for oral solution PLENVU powder for oral solution · Norgine https://druglandscape.com/drug/plerixafor-gz316455 https://druglandscape.com/api/og?type=drug&title=plerixafor%20GZ316455&subtitle=plerixafor%20GZ316455%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%202 plerixafor GZ316455 plerixafor GZ316455 · Genzyme, a Sanofi Company https://druglandscape.com/drug/plg0206 https://druglandscape.com/api/og?type=drug&title=PLG0206&subtitle=PLG0206%20%C2%B7%20Peptilogics&badge=phase%202 PLG0206 PLG0206 · Peptilogics https://druglandscape.com/drug/plitidepsin-and-sorafenib https://druglandscape.com/api/og?type=drug&title=Plitidepsin%20and%20Sorafenib&subtitle=Plitidepsin%20and%20Sorafenib%20%C2%B7%20PharmaMar&badge=phase%201 Plitidepsin and Sorafenib Plitidepsin and Sorafenib · PharmaMar https://druglandscape.com/drug/pln-101095 https://druglandscape.com/api/og?type=drug&title=PLN-101095&subtitle=PLN-101095%20%C2%B7%20Pliant%20Therapeutics%2C%20Inc.&badge=phase%201 PLN-101095 PLN-101095 · Pliant Therapeutics, Inc. https://druglandscape.com/drug/plt012 https://druglandscape.com/api/og?type=drug&title=PLT012&subtitle=PLT012%20%C2%B7%20Pilatus%20Biosciences%20Inc&badge=phase%201 PLT012 PLT012 · Pilatus Biosciences Inc https://druglandscape.com/drug/plt101 https://druglandscape.com/api/og?type=drug&title=PLT101&subtitle=PLT101%20%C2%B7%20PhytoTech%20Therapeutics%2C%20Ltd.&badge=phase%202 PLT101 PLT101 · PhytoTech Therapeutics, Ltd. https://druglandscape.com/drug/plurogel-n https://druglandscape.com/api/og?type=drug&title=PluroGel%20N&subtitle=PluroGel%20N%20%C2%B7%20PluroGen%20Therapeutics%2C%20Inc&badge=phase%202 PluroGel N PluroGel N · PluroGen Therapeutics, Inc https://druglandscape.com/drug/plx-61639 https://druglandscape.com/api/og?type=drug&title=PLX-61639&subtitle=PLX-61639%20%C2%B7%20Plexium%2C%20Inc.&badge=phase%201 PLX-61639 PLX-61639 · Plexium, Inc. https://druglandscape.com/drug/plx-pad-high-doses https://druglandscape.com/api/og?type=drug&title=PLX-PAD%20high%20doses&subtitle=PLX-PAD%20high%20doses%20%C2%B7%20Pluristem%20Ltd.&badge=phase%202 PLX-PAD high doses PLX-PAD high doses · Pluristem Ltd. https://druglandscape.com/drug/plx-pad-low-dose https://druglandscape.com/api/og?type=drug&title=PLX-PAD%20Low%20dose&subtitle=PLX-PAD%20Low%20dose%20%C2%B7%20Pluristem%20Ltd.&badge=phase%202 PLX-PAD Low dose PLX-PAD Low dose · Pluristem Ltd. https://druglandscape.com/drug/plx-r18 https://druglandscape.com/api/og?type=drug&title=PLX-R18&subtitle=PLX-R18%20%C2%B7%20Pluristem%20Ltd.&badge=phase%201 PLX-R18 PLX-R18 · Pluristem Ltd. https://druglandscape.com/drug/plx038 https://druglandscape.com/api/og?type=drug&title=PLX038&subtitle=PLX038%20%C2%B7%20ProLynx%20LLC&badge=phase%202 PLX038 PLX038 · ProLynx LLC https://druglandscape.com/drug/plx3397 https://druglandscape.com/api/og?type=drug&title=PLX3397&subtitle=PLX3397%20%C2%B7%20Daiichi%20Sankyo%20Co.%2C%20Ltd.&badge=phase%202 PLX3397 PLX3397 · Daiichi Sankyo Co., Ltd. https://druglandscape.com/drug/plx4032 https://druglandscape.com/api/og?type=drug&title=PLX4032&subtitle=PLX4032%20%C2%B7%20Plexxikon&badge=phase%201 PLX4032 PLX4032 · Plexxikon https://druglandscape.com/drug/plx5622 https://druglandscape.com/api/og?type=drug&title=PLX5622&subtitle=PLX5622%20%C2%B7%20Plexxikon&badge=phase%201 PLX5622 PLX5622 · Plexxikon https://druglandscape.com/drug/pm01183 https://druglandscape.com/api/og?type=drug&title=PM01183&subtitle=PM01183%20%C2%B7%20PharmaMar&badge=phase%202 PM01183 PM01183 · PharmaMar https://druglandscape.com/drug/pm012 https://druglandscape.com/api/og?type=drug&title=PM012&subtitle=PM012%20%C2%B7%20VTBIO%20Co.%20LTD&badge=phase%202 PM012 PM012 · VTBIO Co. LTD https://druglandscape.com/drug/pm02734-and-erlotinib https://druglandscape.com/api/og?type=drug&title=PM02734%20and%20erlotinib&subtitle=PM02734%20and%20erlotinib%20%C2%B7%20PharmaMar&badge=phase%201 PM02734 and erlotinib PM02734 and erlotinib · PharmaMar https://druglandscape.com/drug/pm1022 https://druglandscape.com/api/og?type=drug&title=PM1022&subtitle=PM1022%20%C2%B7%20Biotheus%20Inc.&badge=phase%201 PM1022 PM1022 · Biotheus Inc. https://druglandscape.com/drug/pm14 https://druglandscape.com/api/og?type=drug&title=PM14&subtitle=PM14%20%C2%B7%20PharmaMar&badge=phase%201 PM14 PM14 · PharmaMar https://druglandscape.com/drug/pm359 https://druglandscape.com/api/og?type=drug&title=PM359&subtitle=PM359%20%C2%B7%20Prime%20Medicine%2C%20Inc.&badge=phase%201 PM359 PM359 · Prime Medicine, Inc. https://druglandscape.com/drug/pm534 https://druglandscape.com/api/og?type=drug&title=PM534&subtitle=PM534%20%C2%B7%20PharmaMar&badge=phase%201 PM534 PM534 · PharmaMar https://druglandscape.com/drug/pm54 https://druglandscape.com/api/og?type=drug&title=PM54&subtitle=PM54%20%C2%B7%20PharmaMar&badge=phase%201 PM54 PM54 · PharmaMar https://druglandscape.com/drug/pmc-309-dose-expansion https://druglandscape.com/api/og?type=drug&title=PMC-309%20Dose%20Expansion&subtitle=PMC-309%20Dose%20Expansion%20%C2%B7%20PharmAbcine&badge=phase%201 PMC-309 Dose Expansion PMC-309 Dose Expansion · PharmAbcine https://druglandscape.com/drug/pmc-309-monotherapy https://druglandscape.com/api/og?type=drug&title=PMC-309%20monotherapy&subtitle=PMC-309%20monotherapy%20%C2%B7%20PharmAbcine&badge=phase%201 PMC-309 monotherapy PMC-309 monotherapy · PharmAbcine https://druglandscape.com/drug/pmc-403 https://druglandscape.com/api/og?type=drug&title=PMC-403&subtitle=PMC-403%20%C2%B7%20PharmAbcine&badge=phase%201 PMC-403 PMC-403 · PharmAbcine https://druglandscape.com/drug/pmdi-standard-actuator https://druglandscape.com/api/og?type=drug&title=pMDI%20standard%20actuator&subtitle=pMDI%20standard%20actuator%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%201 pMDI standard actuator pMDI standard actuator · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/pmg1015-dose-1 https://druglandscape.com/api/og?type=drug&title=PMG1015%20Dose%201&subtitle=PMG1015%20Dose%201%20%C2%B7%20Pulmongene%20Ltd.&badge=phase%201 PMG1015 Dose 1 PMG1015 Dose 1 · Pulmongene Ltd. https://druglandscape.com/drug/pmk-s005 https://druglandscape.com/api/og?type=drug&title=PMK-S005&subtitle=PMK-S005%20%C2%B7%20PharmaKing&badge=phase%201 PMK-S005 PMK-S005 · PharmaKing https://druglandscape.com/drug/pmk-s005-1 https://druglandscape.com/api/og?type=drug&title=PMK-S005%201&subtitle=PMK-S005%201%20%C2%B7%20PharmaKing&badge=phase%202 PMK-S005 1 PMK-S005 1 · PharmaKing https://druglandscape.com/drug/pmk-s005-2 https://druglandscape.com/api/og?type=drug&title=PMK-S005%202&subtitle=PMK-S005%202%20%C2%B7%20PharmaKing&badge=phase%202 PMK-S005 2 PMK-S005 2 · PharmaKing https://druglandscape.com/drug/pmk-s005-3 https://druglandscape.com/api/og?type=drug&title=PMK-S005%203&subtitle=PMK-S005%203%20%C2%B7%20PharmaKing&badge=phase%202 PMK-S005 3 PMK-S005 3 · PharmaKing https://druglandscape.com/drug/pmn310 https://druglandscape.com/api/og?type=drug&title=PMN310&subtitle=PMN310%20%C2%B7%20ProMis%20Neurosciences%2C%20Inc&badge=phase%201 PMN310 PMN310 · ProMis Neurosciences, Inc https://druglandscape.com/drug/pmx-30063-investigational-drug https://druglandscape.com/api/og?type=drug&title=PMX-30063-investigational%20drug&subtitle=PMX-30063-investigational%20drug%20%C2%B7%20PolyMedix%2C%20Inc.&badge=phase%202 PMX-30063-investigational drug PMX-30063-investigational drug · PolyMedix, Inc. https://druglandscape.com/drug/pmz-1620-along-with-standard-treatment https://druglandscape.com/api/og?type=drug&title=PMZ-1620%20along%20with%20standard%20treatment&subtitle=PMZ-1620%20along%20with%20standard%20treatment%20%C2%B7%20Pharmazz%2C%20Inc.&badge=phase%202 PMZ-1620 along with standard treatment PMZ-1620 along with standard treatment · Pharmazz, Inc. https://druglandscape.com/drug/pn-101 https://druglandscape.com/api/og?type=drug&title=PN-101&subtitle=PN-101%20%C2%B7%20Paean%20Biotechnology%20Inc.&badge=phase%202 PN-101 PN-101 · Paean Biotechnology Inc. https://druglandscape.com/drug/pn-232 https://druglandscape.com/api/og?type=drug&title=PN-232&subtitle=PN-232%20%C2%B7%20Protagonist%20Therapeutics%2C%20Inc.&badge=phase%201 PN-232 PN-232 · Protagonist Therapeutics, Inc. https://druglandscape.com/drug/pn-235 https://druglandscape.com/api/og?type=drug&title=PN-235&subtitle=PN-235%20%C2%B7%20Protagonist%20Therapeutics%2C%20Inc.&badge=phase%201 PN-235 PN-235 · Protagonist Therapeutics, Inc. https://druglandscape.com/drug/pn-400 https://druglandscape.com/api/og?type=drug&title=PN%20400&subtitle=PN%20400%20%C2%B7%20POZEN&badge=phase%201 PN 400 PN 400 · POZEN https://druglandscape.com/drug/pn-881-oral-solution https://druglandscape.com/api/og?type=drug&title=PN-881%20Oral%20Solution&subtitle=PN-881%20Oral%20Solution%20%C2%B7%20Protagonist%20Therapeutics%2C%20Inc.&badge=phase%201 PN-881 Oral Solution PN-881 Oral Solution · Protagonist Therapeutics, Inc. https://druglandscape.com/drug/pn-943 https://druglandscape.com/api/og?type=drug&title=PN-943&subtitle=PN-943%20%C2%B7%20Protagonist%20Therapeutics%2C%20Inc.&badge=phase%202 PN-943 PN-943 · Protagonist Therapeutics, Inc. https://druglandscape.com/drug/pn-maps30plus https://druglandscape.com/api/og?type=drug&title=Pn-MAPS30plus&subtitle=Pn-MAPS30plus%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Pn-MAPS30plus Pn-MAPS30plus · GlaxoSmithKline https://druglandscape.com/drug/pn20 https://druglandscape.com/api/og?type=drug&title=PN20&subtitle=PN20%20%C2%B7%20Chongqing%20Peg-Bio%20Biopharm%20Co.%2C%20Ltd.&badge=phase%201 PN20 PN20 · Chongqing Peg-Bio Biopharm Co., Ltd. https://druglandscape.com/drug/pn20-treatment https://druglandscape.com/api/og?type=drug&title=PN20%20treatment&subtitle=PN20%20treatment%20%C2%B7%20Chongqing%20Peg-Bio%20Biopharm%20Co.%2C%20Ltd.&badge=phase%201 PN20 treatment PN20 treatment · Chongqing Peg-Bio Biopharm Co., Ltd. https://druglandscape.com/drug/pn400 https://druglandscape.com/api/og?type=drug&title=PN400&subtitle=PN400%20%C2%B7%20POZEN&badge=phase%201 PN400 PN400 · POZEN https://druglandscape.com/drug/pneumo-23-0-1 https://druglandscape.com/api/og?type=drug&title=Pneumo%2023%C2%AE%200%2C1&subtitle=Pneumo%2023%C2%AE%200%2C1%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Pneumo 23® 0,1 Pneumo 23® 0,1 · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/pneumo-23-0-5 https://druglandscape.com/api/og?type=drug&title=Pneumo%2023%C2%AE%200%2C5&subtitle=Pneumo%2023%C2%AE%200%2C5%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Pneumo 23® 0,5 Pneumo 23® 0,5 · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/pneumococal-vaccination https://druglandscape.com/api/og?type=drug&title=Pneumococal%20vaccination&subtitle=Pneumococal%20vaccination%20%C2%B7%20Castilla-La%20Mancha%20Health%20Service&badge=phase%202 Pneumococal vaccination Pneumococal vaccination · Castilla-La Mancha Health Service https://druglandscape.com/drug/pneumococcal-conjugate-vaccine-gsk2830929a https://druglandscape.com/api/og?type=drug&title=Pneumococcal%20conjugate%20vaccine%20GSK2830929A&subtitle=Pneumococcal%20conjugate%20vaccine%20GSK2830929A%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Pneumococcal conjugate vaccine GSK2830929A Pneumococcal conjugate vaccine GSK2830929A · GlaxoSmithKline https://druglandscape.com/drug/pneumococcal-conjugate-vaccine-gsk2830930a https://druglandscape.com/api/og?type=drug&title=Pneumococcal%20conjugate%20vaccine%20GSK2830930A&subtitle=Pneumococcal%20conjugate%20vaccine%20GSK2830930A%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Pneumococcal conjugate vaccine GSK2830930A Pneumococcal conjugate vaccine GSK2830930A · GlaxoSmithKline https://druglandscape.com/drug/pneumococcal-disease-prevention https://druglandscape.com/api/og?type=drug&title=pneumococcal%20disease%20prevention&subtitle=pneumococcal%20disease%20prevention%20%C2%B7%20Beijing%20Minhai%20Biotechnology%20Co.%2C%20Ltd&badge=phase%203 pneumococcal disease prevention pneumococcal disease prevention · Beijing Minhai Biotechnology Co., Ltd https://druglandscape.com/drug/pneumococcal-pneumonia-vaccine https://druglandscape.com/api/og?type=drug&title=Pneumococcal%20Pneumonia%20vaccine&subtitle=Pneumococcal%20Pneumonia%20vaccine%20%C2%B7%20Boston%20Medical%20Center&badge=phase%202 Pneumococcal Pneumonia vaccine Pneumococcal Pneumonia vaccine · Boston Medical Center https://druglandscape.com/drug/pneumococcal-polysaccharide-conjugate-vaccine https://druglandscape.com/api/og?type=drug&title=Pneumococcal%20Polysaccharide%20Conjugate%20Vaccine&subtitle=Pneumococcal%20Polysaccharide%20Conjugate%20Vaccine%20%C2%B7%20PATH&badge=phase%202 Pneumococcal Polysaccharide Conjugate Vaccine Pneumococcal Polysaccharide Conjugate Vaccine · PATH https://druglandscape.com/drug/pneumococcal-vaccine-gsk2189241a https://druglandscape.com/api/og?type=drug&title=Pneumococcal%20vaccine%20GSK2189241A&subtitle=Pneumococcal%20vaccine%20GSK2189241A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Pneumococcal vaccine GSK2189241A Pneumococcal vaccine GSK2189241A · GlaxoSmithKline https://druglandscape.com/drug/pneumococcal-vaccine-gsk2189242a https://druglandscape.com/api/og?type=drug&title=Pneumococcal%20vaccine%20GSK2189242A&subtitle=Pneumococcal%20vaccine%20GSK2189242A%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Pneumococcal vaccine GSK2189242A Pneumococcal vaccine GSK2189242A · GlaxoSmithKline https://druglandscape.com/drug/pneumococcal-vaccine-gsk2830930a https://druglandscape.com/api/og?type=drug&title=Pneumococcal%20vaccine%20GSK2830930A&subtitle=Pneumococcal%20vaccine%20GSK2830930A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Pneumococcal vaccine GSK2830930A Pneumococcal vaccine GSK2830930A · GlaxoSmithKline https://druglandscape.com/drug/pneumococcal-vaccine-gsk513026 https://druglandscape.com/api/og?type=drug&title=Pneumococcal%20vaccine%20GSK513026&subtitle=Pneumococcal%20vaccine%20GSK513026%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Pneumococcal vaccine GSK513026 Pneumococcal vaccine GSK513026 · GlaxoSmithKline https://druglandscape.com/drug/pneumoniae-bacteremia-therapy https://druglandscape.com/api/og?type=drug&title=pneumoniae%20bacteremia%20therapy&subtitle=pneumoniae%20bacteremia%20therapy%20%C2%B7%20Methodist%20Health%20System&badge=phase%202 pneumoniae bacteremia therapy pneumoniae bacteremia therapy · Methodist Health System https://druglandscape.com/drug/pnl-thc-cbd-soft-gelatin-capsule https://druglandscape.com/api/og?type=drug&title=PNL-THC%3ACBD%20soft%20gelatin%20capsule&subtitle=PNL-THC%3ACBD%20soft%20gelatin%20capsule%20%C2%B7%20PhytoTech%20Therapeutics%2C%20Ltd.&badge=phase%201 PNL-THC:CBD soft gelatin capsule PNL-THC:CBD soft gelatin capsule · PhytoTech Therapeutics, Ltd. https://druglandscape.com/drug/pnu-100480 https://druglandscape.com/api/og?type=drug&title=PNU-100480&subtitle=PNU-100480%20%C2%B7%20Sequella%2C%20Inc.&badge=phase%202 PNU-100480 PNU-100480 · Sequella, Inc. https://druglandscape.com/drug/pnubiovax https://druglandscape.com/api/og?type=drug&title=PnuBioVax&subtitle=PnuBioVax%20%C2%B7%20ImmunoBiology%20Limited&badge=phase%201 PnuBioVax PnuBioVax · ImmunoBiology Limited https://druglandscape.com/drug/polb-001 https://druglandscape.com/api/og?type=drug&title=POLB%20001&subtitle=POLB%20001%20%C2%B7%20Poolbeg%20Pharma%20plc&badge=phase%201 POLB 001 POLB 001 · Poolbeg Pharma plc https://druglandscape.com/drug/polidocanol-endovenous-microfoam-0-125 https://druglandscape.com/api/og?type=drug&title=Polidocanol%20Endovenous%20Microfoam%200.125%25&subtitle=Polidocanol%20Endovenous%20Microfoam%200.125%25%20%C2%B7%20Boston%20Scientific%20Corporation&badge=phase%202 Polidocanol Endovenous Microfoam 0.125% Polidocanol Endovenous Microfoam 0.125% · Boston Scientific Corporation https://druglandscape.com/drug/polidocanol-foam-sclerotherapy https://druglandscape.com/api/og?type=drug&title=Polidocanol%20foam%20sclerotherapy&subtitle=Polidocanol%20foam%20sclerotherapy%20%C2%B7%20Universidade%20do%20Porto&badge=phase%202 Polidocanol foam sclerotherapy Polidocanol foam sclerotherapy · Universidade do Porto https://druglandscape.com/drug/polidocanol-injectable-foam https://druglandscape.com/api/og?type=drug&title=Polidocanol%20Injectable%20Foam&subtitle=Polidocanol%20Injectable%20Foam%20%C2%B7%20Universidade%20do%20Porto&badge=phase%202 Polidocanol Injectable Foam Polidocanol Injectable Foam · Universidade do Porto https://druglandscape.com/drug/polidocanol-injectable-foam-0-125 https://druglandscape.com/api/og?type=drug&title=polidocanol%20injectable%20foam%2C%200.125%25&subtitle=polidocanol%20injectable%20foam%2C%200.125%25%20%C2%B7%20Boston%20Scientific%20Corporation&badge=phase%203 polidocanol injectable foam, 0.125% polidocanol injectable foam, 0.125% · Boston Scientific Corporation https://druglandscape.com/drug/polmacoxib-and-tramadol-combination https://druglandscape.com/api/og?type=drug&title=Polmacoxib%20and%20Tramadol%20combination&subtitle=Polmacoxib%20and%20Tramadol%20combination%20%C2%B7%20CrystalGenomics%2C%20Inc.&badge=phase%201 Polmacoxib and Tramadol combination Polmacoxib and Tramadol combination · CrystalGenomics, Inc. https://druglandscape.com/drug/poly-gamma-glutamic-acid https://druglandscape.com/api/og?type=drug&title=Poly-gamma%20Glutamic%20Acid&subtitle=Poly-gamma%20Glutamic%20Acid%20%C2%B7%20BioLeaders%20Corporation&badge=phase%202 Poly-gamma Glutamic Acid Poly-gamma Glutamic Acid · BioLeaders Corporation https://druglandscape.com/drug/polyherbal-capsule-coccinia-bougainvillea-catharanthus https://druglandscape.com/api/og?type=drug&title=Polyherbal%20capsule%20coccinia%2C%20bougainvillea%2C%20catharanthus&subtitle=Polyherbal%20capsule%20coccinia%2C%20bougainvillea%2C%20catharanthus%20%C2%B7%20Composite%20Interceptive%20Med%20Science&badge=phase%201 Polyherbal capsule coccinia, bougainvillea, catharanthus Polyherbal capsule coccinia, bougainvillea, catharanthus · Composite Interceptive Med Science https://druglandscape.com/drug/polyherbal-formulation https://druglandscape.com/api/og?type=drug&title=polyherbal%20formulation&subtitle=polyherbal%20formulation%20%C2%B7%20Composite%20Interceptive%20Med%20Science&badge=phase%201 polyherbal formulation polyherbal formulation · Composite Interceptive Med Science https://druglandscape.com/drug/polyiclc https://druglandscape.com/api/og?type=drug&title=polyICLC&subtitle=polyICLC%20%C2%B7%20Craig%20L%20Slingluff%2C%20Jr&badge=phase%201 polyICLC polyICLC · Craig L Slingluff, Jr https://druglandscape.com/drug/polypepi1018 https://druglandscape.com/api/og?type=drug&title=PolyPEPI1018&subtitle=PolyPEPI1018%20%C2%B7%20Treos%20Bio%20Limited&badge=phase%202 PolyPEPI1018 PolyPEPI1018 · Treos Bio Limited https://druglandscape.com/drug/polypepi1018-crc-vaccine https://druglandscape.com/api/og?type=drug&title=PolyPEPI1018%20CRC%20Vaccine&subtitle=PolyPEPI1018%20CRC%20Vaccine%20%C2%B7%20Treos%20Bio%20Zrt&badge=phase%201 PolyPEPI1018 CRC Vaccine PolyPEPI1018 CRC Vaccine · Treos Bio Zrt https://druglandscape.com/drug/polypodium-leucotomos https://druglandscape.com/api/og?type=drug&title=Polypodium%20Leucotomos&subtitle=Polypodium%20Leucotomos%20%C2%B7%20Henry%20Ford%20Health%20System&badge=phase%202 Polypodium Leucotomos Polypodium Leucotomos · Henry Ford Health System https://druglandscape.com/drug/polysaccharide-diphtheria-conjugate-vaccine https://druglandscape.com/api/og?type=drug&title=Polysaccharide%20Diphtheria%20Conjugate%20Vaccine&subtitle=Polysaccharide%20Diphtheria%20Conjugate%20Vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%202 Polysaccharide Diphtheria Conjugate Vaccine Polysaccharide Diphtheria Conjugate Vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/polysaccharide-diphtheria-toxoid-conjugate-vaccine https://druglandscape.com/api/og?type=drug&title=Polysaccharide%20Diphtheria%20Toxoid%20Conjugate%20Vaccine&subtitle=Polysaccharide%20Diphtheria%20Toxoid%20Conjugate%20Vaccine%20%C2%B7%20Sanofi&badge=phase%202 Polysaccharide Diphtheria Toxoid Conjugate Vaccine Polysaccharide Diphtheria Toxoid Conjugate Vaccine · Sanofi https://druglandscape.com/drug/polyvalent-melanoma-vaccine https://druglandscape.com/api/og?type=drug&title=polyvalent%20melanoma%20vaccine&subtitle=polyvalent%20melanoma%20vaccine%20%C2%B7%20NYU%20Langone%20Health&badge=phase%202 polyvalent melanoma vaccine polyvalent melanoma vaccine · NYU Langone Health https://druglandscape.com/drug/polyvinylpyrrolidone-sodium-hyaluronate-gel https://druglandscape.com/api/og?type=drug&title=polyvinylpyrrolidone-sodium%20hyaluronate%20gel&subtitle=polyvinylpyrrolidone-sodium%20hyaluronate%20gel%20%C2%B7%20Children's%20Cancer%20and%20Leukaemia%20Group&badge=phase%201 polyvinylpyrrolidone-sodium hyaluronate gel polyvinylpyrrolidone-sodium hyaluronate gel · Children's Cancer and Leukaemia Group https://druglandscape.com/drug/pom3 https://druglandscape.com/api/og?type=drug&title=POM3&subtitle=POM3%20%C2%B7%20Provident%20Clinical%20Research&badge=phase%201 POM3 POM3 · Provident Clinical Research https://druglandscape.com/drug/pomalidomide-and-dexamethasone https://druglandscape.com/api/og?type=drug&title=Pomalidomide%20and%20Dexamethasone&subtitle=Pomalidomide%20and%20Dexamethasone%20%C2%B7%20Fondazione%20IRCCS%20Policlinico%20San%20Matteo%20di%20Pavia&badge=phase%202 Pomalidomide and Dexamethasone Pomalidomide and Dexamethasone · Fondazione IRCCS Policlinico San Matteo di Pavia https://druglandscape.com/drug/pomalidomide-cyclophosphamide-prednisone https://druglandscape.com/api/og?type=drug&title=Pomalidomide%2C%20Cyclophosphamide%2C%20Prednisone&subtitle=Pomalidomide%2C%20Cyclophosphamide%2C%20Prednisone%20%C2%B7%20Fondazione%20EMN%20Italy%20Onlus&badge=phase%201 Pomalidomide, Cyclophosphamide, Prednisone Pomalidomide, Cyclophosphamide, Prednisone · Fondazione EMN Italy Onlus https://druglandscape.com/drug/pomegrante-and-ginkgo-biloba-group https://druglandscape.com/api/og?type=drug&title=Pomegrante%20and%20Ginkgo%20biloba%20group&subtitle=Pomegrante%20and%20Ginkgo%20biloba%20group%20%C2%B7%20Ahmed%20A.%20H.%20Abdellatif&badge=phase%201 Pomegrante and Ginkgo biloba group Pomegrante and Ginkgo biloba group · Ahmed A. H. Abdellatif https://druglandscape.com/drug/ponesimod-i-v https://druglandscape.com/api/og?type=drug&title=Ponesimod%20i.v.&subtitle=Ponesimod%20i.v.%20%C2%B7%20Actelion&badge=phase%201 Ponesimod i.v. Ponesimod i.v. · Actelion https://druglandscape.com/drug/port-77 https://druglandscape.com/api/og?type=drug&title=PORT-77&subtitle=PORT-77%20%C2%B7%20Portal%20Therapeutics%2C%20Inc.&badge=phase%202 PORT-77 PORT-77 · Portal Therapeutics, Inc. https://druglandscape.com/drug/posaconazole-iv https://druglandscape.com/api/og?type=drug&title=Posaconazole%20IV&subtitle=Posaconazole%20IV%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Posaconazole IV Posaconazole IV · Merck Sharp & Dohme LLC https://druglandscape.com/drug/posaconazole-pfs https://druglandscape.com/api/og?type=drug&title=Posaconazole%20PFS&subtitle=Posaconazole%20PFS%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Posaconazole PFS Posaconazole PFS · Merck Sharp & Dohme LLC https://druglandscape.com/drug/posaconazole-powder-for-oral-suspension https://druglandscape.com/api/og?type=drug&title=Posaconazole%20powder%20for%20oral%20suspension&subtitle=Posaconazole%20powder%20for%20oral%20suspension%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Posaconazole powder for oral suspension Posaconazole powder for oral suspension · Merck Sharp & Dohme LLC https://druglandscape.com/drug/positive-comparative-patch https://druglandscape.com/api/og?type=drug&title=positive%20comparative%20patch&subtitle=positive%20comparative%20patch%20%C2%B7%20Frontier%20Biotechnologies%20Inc.&badge=phase%201 positive comparative patch positive comparative patch · Frontier Biotechnologies Inc. https://druglandscape.com/drug/positive-control-na-laurylsulfat-solution https://druglandscape.com/api/og?type=drug&title=Positive%20control%2C%20Na-laurylsulfat-solution&subtitle=Positive%20control%2C%20Na-laurylsulfat-solution%20%C2%B7%20Bayer&badge=phase%201 Positive control, Na-laurylsulfat-solution Positive control, Na-laurylsulfat-solution · Bayer https://druglandscape.com/drug/post-change-cmab807 https://druglandscape.com/api/og?type=drug&title=Post-change%20CMAB807&subtitle=Post-change%20CMAB807%20%C2%B7%20Taizhou%20Mabtech%20Pharmaceutical%20Co.%2CLtd&badge=phase%201 Post-change CMAB807 Post-change CMAB807 · Taizhou Mabtech Pharmaceutical Co.,Ltd https://druglandscape.com/drug/post-closure-local-anesthetic https://druglandscape.com/api/og?type=drug&title=Post-Closure%20Local%20Anesthetic&subtitle=Post-Closure%20Local%20Anesthetic%20%C2%B7%20Valley%20Anesthesiology%20Consultants&badge=phase%201 Post-Closure Local Anesthetic Post-Closure Local Anesthetic · Valley Anesthesiology Consultants https://druglandscape.com/drug/post-dosing-with-nt100 https://druglandscape.com/api/og?type=drug&title=Post%20dosing%20with%20NT100&subtitle=Post%20dosing%20with%20NT100%20%C2%B7%20Nora%20Therapeutics%2C%20Inc.&badge=phase%202 Post dosing with NT100 Post dosing with NT100 · Nora Therapeutics, Inc. https://druglandscape.com/drug/post-op-pregabalin https://druglandscape.com/api/og?type=drug&title=Post-Op%20pregabalin&subtitle=Post-Op%20pregabalin%20%C2%B7%20Nevakar%2C%20Inc.&badge=phase%202 Post-Op pregabalin Post-Op pregabalin · Nevakar, Inc. https://druglandscape.com/drug/post-operative-care https://druglandscape.com/api/og?type=drug&title=Post-operative%20care&subtitle=Post-operative%20care%20%C2%B7%20Renato%20Correa%20Viana%20Casarin&badge=phase%201 Post-operative care Post-operative care · Renato Correa Viana Casarin https://druglandscape.com/drug/post-poned-boost-adeno https://druglandscape.com/api/og?type=drug&title=Post-poned%20boost%20adeno&subtitle=Post-poned%20boost%20adeno%20%C2%B7%20Erasmus%20Medical%20Center&badge=phase%201 Post-poned boost adeno Post-poned boost adeno · Erasmus Medical Center https://druglandscape.com/drug/post-poned-boost-mrna https://druglandscape.com/api/og?type=drug&title=Post-poned%20boost%20mRNA&subtitle=Post-poned%20boost%20mRNA%20%C2%B7%20Erasmus%20Medical%20Center&badge=phase%201 Post-poned boost mRNA Post-poned boost mRNA · Erasmus Medical Center https://druglandscape.com/drug/post-radiation-temozolomide https://druglandscape.com/api/og?type=drug&title=post-radiation%20temozolomide&subtitle=post-radiation%20temozolomide%20%C2%B7%20Radiation%20Therapy%20Oncology%20Group&badge=phase%201 post-radiation temozolomide post-radiation temozolomide · Radiation Therapy Oncology Group https://druglandscape.com/drug/post-radiation-therapy-temozolomide https://druglandscape.com/api/og?type=drug&title=post-radiation%20therapy%20temozolomide&subtitle=post-radiation%20therapy%20temozolomide%20%C2%B7%20Radiation%20Therapy%20Oncology%20Group&badge=phase%201 post-radiation therapy temozolomide post-radiation therapy temozolomide · Radiation Therapy Oncology Group https://druglandscape.com/drug/post-remission https://druglandscape.com/api/og?type=drug&title=Post-Remission&subtitle=Post-Remission%20%C2%B7%20SWOG%20Cancer%20Research%20Network&badge=phase%202 Post-Remission Post-Remission · SWOG Cancer Research Network https://druglandscape.com/drug/post-transfection-f17 https://druglandscape.com/api/og?type=drug&title=Post-transfection%20F17&subtitle=Post-transfection%20F17%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%202 Post-transfection F17 Post-transfection F17 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/post-transfection-f19 https://druglandscape.com/api/og?type=drug&title=Post-transfection%20F19&subtitle=Post-transfection%20F19%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%202 Post-transfection F19 Post-transfection F19 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/postoperative-dosage-of-released-troponin https://druglandscape.com/api/og?type=drug&title=Postoperative%20dosage%20of%20released%20troponin&subtitle=Postoperative%20dosage%20of%20released%20troponin%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 Postoperative dosage of released troponin Postoperative dosage of released troponin · Hospices Civils de Lyon https://druglandscape.com/drug/postoperative-epidural-morphine https://druglandscape.com/api/og?type=drug&title=Postoperative%20epidural%20morphine&subtitle=Postoperative%20epidural%20morphine%20%C2%B7%20Northern%20Orthopaedic%20Division%2C%20Denmark&badge=phase%201 Postoperative epidural morphine Postoperative epidural morphine · Northern Orthopaedic Division, Denmark https://druglandscape.com/drug/postperative-analgesia https://druglandscape.com/api/og?type=drug&title=Postperative%20analgesia&subtitle=Postperative%20analgesia%20%C2%B7%20Ospedale%20di%20Circolo%20-%20Fondazione%20Macchi&badge=phase%201 Postperative analgesia Postperative analgesia · Ospedale di Circolo - Fondazione Macchi https://druglandscape.com/drug/pot-4 https://druglandscape.com/api/og?type=drug&title=POT-4&subtitle=POT-4%20%C2%B7%20Potentia%20Pharmaceuticals%2C%20Inc.&badge=phase%201 POT-4 POT-4 · Potentia Pharmaceuticals, Inc. https://druglandscape.com/drug/potassium-canrenoate https://druglandscape.com/api/og?type=drug&title=Potassium%20Canrenoate&subtitle=Potassium%20Canrenoate%20%C2%B7%20Fondazione%20IRCCS%20Ca'%20Granda%2C%20Ospedale%20Maggiore%20Policlinico&badge=phase%202 Potassium Canrenoate Potassium Canrenoate · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico https://druglandscape.com/drug/povidone-iodine-0-4-ni https://druglandscape.com/api/og?type=drug&title=Povidone-Iodine%200.4%25%20NI&subtitle=Povidone-Iodine%200.4%25%20NI%20%C2%B7%20DR.%20MALA%20KHAN&badge=phase%202 Povidone-Iodine 0.4% NI Povidone-Iodine 0.4% NI · DR. MALA KHAN https://druglandscape.com/drug/povidone-iodine-0-5-ni https://druglandscape.com/api/og?type=drug&title=Povidone-Iodine%200.5%25%20NI&subtitle=Povidone-Iodine%200.5%25%20NI%20%C2%B7%20DR.%20MALA%20KHAN&badge=phase%202 Povidone-Iodine 0.5% NI Povidone-Iodine 0.5% NI · DR. MALA KHAN https://druglandscape.com/drug/povidone-iodine-0-5-ns https://druglandscape.com/api/og?type=drug&title=Povidone-Iodine%200.5%25%20NS&subtitle=Povidone-Iodine%200.5%25%20NS%20%C2%B7%20DR.%20MALA%20KHAN&badge=phase%202 Povidone-Iodine 0.5% NS Povidone-Iodine 0.5% NS · DR. MALA KHAN https://druglandscape.com/drug/povidone-iodine-0-6-ns https://druglandscape.com/api/og?type=drug&title=Povidone-Iodine%200.6%25%20NS&subtitle=Povidone-Iodine%200.6%25%20NS%20%C2%B7%20DR.%20MALA%20KHAN&badge=phase%202 Povidone-Iodine 0.6% NS Povidone-Iodine 0.6% NS · DR. MALA KHAN https://druglandscape.com/drug/povidone-iodine-1-topical-solution https://druglandscape.com/api/og?type=drug&title=Povidone-Iodine%201%20%25%20Topical%20Solution&subtitle=Povidone-Iodine%201%20%25%20Topical%20Solution%20%C2%B7%20Shaare%20Zedek%20Medical%20Center&badge=phase%201 Povidone-Iodine 1 % Topical Solution Povidone-Iodine 1 % Topical Solution · Shaare Zedek Medical Center https://druglandscape.com/drug/pp-001 https://druglandscape.com/api/og?type=drug&title=PP-001&subtitle=PP-001%20%C2%B7%20Panoptes%20Pharma%20GmbH&badge=phase%201 PP-001 PP-001 · Panoptes Pharma GmbH https://druglandscape.com/drug/pp-1420 https://druglandscape.com/api/og?type=drug&title=PP%201420&subtitle=PP%201420%20%C2%B7%20Imperial%20College%20London&badge=phase%201 PP 1420 PP 1420 · Imperial College London https://druglandscape.com/drug/pp110-gel https://druglandscape.com/api/og?type=drug&title=PP110%20Gel&subtitle=PP110%20Gel%20%C2%B7%20Peritech%20Pharma%20Ltd.&badge=phase%202 PP110 Gel PP110 Gel · Peritech Pharma Ltd. https://druglandscape.com/drug/pp110-medicated-wipes https://druglandscape.com/api/og?type=drug&title=PP110%20Medicated%20wipes&subtitle=PP110%20Medicated%20wipes%20%C2%B7%20Peritech%20Pharma%20Ltd.&badge=phase%202 PP110 Medicated wipes PP110 Medicated wipes · Peritech Pharma Ltd. https://druglandscape.com/drug/pp353 https://druglandscape.com/api/og?type=drug&title=PP353&subtitle=PP353%20%C2%B7%20Persica%20Pharmaceuticals%20Ltd&badge=phase%201 PP353 PP353 · Persica Pharmaceuticals Ltd https://druglandscape.com/drug/pp4001 https://druglandscape.com/api/og?type=drug&title=PP4001&subtitle=PP4001%20%C2%B7%20Pinnacle%20Pharmaceuticals%2C%20Inc.&badge=phase%202 PP4001 PP4001 · Pinnacle Pharmaceuticals, Inc. https://druglandscape.com/drug/pp405-0-05-topical-gel https://druglandscape.com/api/og?type=drug&title=PP405%200.05%25%20Topical%20Gel&subtitle=PP405%200.05%25%20Topical%20Gel%20%C2%B7%20Pelage%20Pharmaceuticals%2C%20Inc.&badge=phase%202 PP405 0.05% Topical Gel PP405 0.05% Topical Gel · Pelage Pharmaceuticals, Inc. https://druglandscape.com/drug/ppc-5650 https://druglandscape.com/api/og?type=drug&title=PPC-5650&subtitle=PPC-5650%20%C2%B7%20Aros%20Pharma%20ApS&badge=phase%201 PPC-5650 PPC-5650 · Aros Pharma ApS https://druglandscape.com/drug/ppd10558 https://druglandscape.com/api/og?type=drug&title=PPD10558&subtitle=PPD10558%20%C2%B7%20Furiex%20Pharmaceuticals%2C%20Inc&badge=phase%202 PPD10558 PPD10558 · Furiex Pharmaceuticals, Inc https://druglandscape.com/drug/ppdpsc18-administered-by-pmed https://druglandscape.com/api/og?type=drug&title=ppdpSC18%20administered%20by%20PMED&subtitle=ppdpSC18%20administered%20by%20PMED%20%C2%B7%20PowderMed&badge=phase%201 ppdpSC18 administered by PMED ppdpSC18 administered by PMED · PowderMed https://druglandscape.com/drug/ppi-383 https://druglandscape.com/api/og?type=drug&title=PPI-383&subtitle=PPI-383%20%C2%B7%20Presidio%20Pharmaceuticals%2C%20Inc.&badge=phase%201 PPI-383 PPI-383 · Presidio Pharmaceuticals, Inc. https://druglandscape.com/drug/ppi-461 https://druglandscape.com/api/og?type=drug&title=PPI-461&subtitle=PPI-461%20%C2%B7%20Presidio%20Pharmaceuticals%2C%20Inc.&badge=phase%201 PPI-461 PPI-461 · Presidio Pharmaceuticals, Inc. https://druglandscape.com/drug/ppi-668 https://druglandscape.com/api/og?type=drug&title=PPI-668&subtitle=PPI-668%20%C2%B7%20Presidio%20Pharmaceuticals%2C%20Inc.&badge=phase%202 PPI-668 PPI-668 · Presidio Pharmaceuticals, Inc. https://druglandscape.com/drug/ppjv7630-administered-by-pmed https://druglandscape.com/api/og?type=drug&title=pPJV7630%20administered%20by%20PMED&subtitle=pPJV7630%20administered%20by%20PMED%20%C2%B7%20PowderMed&badge=phase%201 pPJV7630 administered by PMED pPJV7630 administered by PMED · PowderMed https://druglandscape.com/drug/ppp001 https://druglandscape.com/api/og?type=drug&title=PPP001&subtitle=PPP001%20%C2%B7%20Tetra%20Bio-Pharma&badge=phase%202 PPP001 PPP001 · Tetra Bio-Pharma https://druglandscape.com/drug/pps-vaccine https://druglandscape.com/api/og?type=drug&title=PPS%20vaccine&subtitle=PPS%20vaccine%20%C2%B7%20Sanofi&badge=phase%202 PPS vaccine PPS vaccine · Sanofi https://druglandscape.com/drug/ppv-06 https://druglandscape.com/api/og?type=drug&title=PPV-06&subtitle=PPV-06%20%C2%B7%20Peptinov%20SAS&badge=phase%202 PPV-06 PPV-06 · Peptinov SAS https://druglandscape.com/drug/ppv-23 https://druglandscape.com/api/og?type=drug&title=PPV-23&subtitle=PPV-23%20%C2%B7%20Westat&badge=phase%202 PPV-23 PPV-23 · Westat https://druglandscape.com/drug/pq203 https://druglandscape.com/api/og?type=drug&title=PQ203&subtitle=PQ203%20%C2%B7%20ProteinQure%20Inc.&badge=phase%201 PQ203 PQ203 · ProteinQure Inc. https://druglandscape.com/drug/pq912-oral https://druglandscape.com/api/og?type=drug&title=PQ912%20oral&subtitle=PQ912%20oral%20%C2%B7%20Vivoryon%20Therapeutics%20N.V.&badge=phase%202 PQ912 oral PQ912 oral · Vivoryon Therapeutics N.V. https://druglandscape.com/drug/pqr-309 https://druglandscape.com/api/og?type=drug&title=PQR%20309&subtitle=PQR%20309%20%C2%B7%20PIQUR%20Therapeutics%20AG&badge=phase%201 PQR 309 PQR 309 · PIQUR Therapeutics AG https://druglandscape.com/drug/pr022 https://druglandscape.com/api/og?type=drug&title=PR022&subtitle=PR022%20%C2%B7%20Realm%20Therapeutics%2C%20Inc.&badge=phase%202 PR022 PR022 · Realm Therapeutics, Inc. https://druglandscape.com/drug/pra-216 https://druglandscape.com/api/og?type=drug&title=PRA-216&subtitle=PRA-216%20%C2%B7%20Prana%20Therapies%20Inc&badge=phase%201 PRA-216 PRA-216 · Prana Therapies Inc https://druglandscape.com/drug/pra023 https://druglandscape.com/api/og?type=drug&title=PRA023&subtitle=PRA023%20%C2%B7%20Prometheus%20Biosciences%2C%20Inc.%2C%20a%20subsidiary%20of%20Merck%20%26%20Co.%2C%20Inc.%20(Rahway%2C%20New%20Jersey%20USA)&badge=phase%201 PRA023 PRA023 · Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) https://druglandscape.com/drug/pra023-iv https://druglandscape.com/api/og?type=drug&title=PRA023%20IV&subtitle=PRA023%20IV%20%C2%B7%20Prometheus%20Biosciences%2C%20Inc.%2C%20a%20subsidiary%20of%20Merck%20%26%20Co.%2C%20Inc.%20(Rahway%2C%20New%20Jersey%20USA)&badge=phase%202 PRA023 IV PRA023 IV · Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) https://druglandscape.com/drug/pra023-iv-low-dose https://druglandscape.com/api/og?type=drug&title=PRA023%20IV%20Low%20Dose&subtitle=PRA023%20IV%20Low%20Dose%20%C2%B7%20Prometheus%20Biosciences%2C%20Inc.%2C%20a%20subsidiary%20of%20Merck%20%26%20Co.%2C%20Inc.%20(Rahway%2C%20New%20Je&badge=phase%201 PRA023 IV Low Dose PRA023 IV Low Dose · Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) https://druglandscape.com/drug/pra023-sc https://druglandscape.com/api/og?type=drug&title=PRA023%20SC&subtitle=PRA023%20SC%20%C2%B7%20Prometheus%20Biosciences%2C%20Inc.%2C%20a%20subsidiary%20of%20Merck%20%26%20Co.%2C%20Inc.%20(Rahway%2C%20New%20Jersey%20USA)&badge=phase%201 PRA023 SC PRA023 SC · Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) https://druglandscape.com/drug/pra052 https://druglandscape.com/api/og?type=drug&title=PRA052&subtitle=PRA052%20%C2%B7%20Prometheus%20Biosciences%2C%20Inc.%2C%20a%20subsidiary%20of%20Merck%20%26%20Co.%2C%20Inc.%20(Rahway%2C%20New%20Jersey%20USA)&badge=phase%201 PRA052 PRA052 · Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) https://druglandscape.com/drug/prabotulinumtoxina https://druglandscape.com/api/og?type=drug&title=prabotulinumtoxinA&subtitle=prabotulinumtoxinA%20%C2%B7%20Evolus%2C%20Inc.&badge=phase%202 prabotulinumtoxinA prabotulinumtoxinA · Evolus, Inc. https://druglandscape.com/drug/pramipexole-amisulpride https://druglandscape.com/api/og?type=drug&title=Pramipexole%2C%20Amisulpride&subtitle=Pramipexole%2C%20Amisulpride%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Pramipexole, Amisulpride Pramipexole, Amisulpride · GlaxoSmithKline https://druglandscape.com/drug/pramipexole-boehringer-ingelheim-pharma https://druglandscape.com/api/og?type=drug&title=Pramipexole%20Boehringer%20Ingelheim%20Pharma&subtitle=Pramipexole%20Boehringer%20Ingelheim%20Pharma%20%C2%B7%20Dexa%20Medica%20Group&badge=phase%201 Pramipexole Boehringer Ingelheim Pharma Pramipexole Boehringer Ingelheim Pharma · Dexa Medica Group https://druglandscape.com/drug/pramipexole-dexa-medica https://druglandscape.com/api/og?type=drug&title=Pramipexole%20Dexa%20Medica&subtitle=Pramipexole%20Dexa%20Medica%20%C2%B7%20Dexa%20Medica%20Group&badge=phase%201 Pramipexole Dexa Medica Pramipexole Dexa Medica · Dexa Medica Group https://druglandscape.com/drug/pramipexole-hydrochloride-sustained-release-tablets https://druglandscape.com/api/og?type=drug&title=pramipexole%20hydrochloride%20sustained-release%20tablets&subtitle=pramipexole%20hydrochloride%20sustained-release%20tablets%20%C2%B7%20Hunan%20Kelun%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 pramipexole hydrochloride sustained-release tablets pramipexole hydrochloride sustained-release tablets · Hunan Kelun Pharmaceutical Co., Ltd. https://druglandscape.com/drug/pramlintide-and-metreleptin https://druglandscape.com/api/og?type=drug&title=Pramlintide%20and%20Metreleptin&subtitle=Pramlintide%20and%20Metreleptin%20%C2%B7%20AstraZeneca&badge=phase%202 Pramlintide and Metreleptin Pramlintide and Metreleptin · AstraZeneca https://druglandscape.com/drug/prasugrel-odt1-tablet https://druglandscape.com/api/og?type=drug&title=Prasugrel%20ODT1%20-%20Tablet&subtitle=Prasugrel%20ODT1%20-%20Tablet%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Prasugrel ODT1 - Tablet Prasugrel ODT1 - Tablet · Eli Lilly and Company https://druglandscape.com/drug/pravachol https://druglandscape.com/api/og?type=drug&title=Pravachol%C2%AE&subtitle=Pravachol%C2%AE%20%C2%B7%20Teva%20Pharmaceuticals%20USA&badge=phase%201 Pravachol® Pravachol® · Teva Pharmaceuticals USA https://druglandscape.com/drug/pravastatin-alone https://druglandscape.com/api/og?type=drug&title=Pravastatin%20alone&subtitle=Pravastatin%20alone%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Pravastatin alone Pravastatin alone · GlaxoSmithKline https://druglandscape.com/drug/pravastatin-and-paroxetine-combined https://druglandscape.com/api/og?type=drug&title=Pravastatin%20and%20paroxetine%20combined&subtitle=Pravastatin%20and%20paroxetine%20combined%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Pravastatin and paroxetine combined Pravastatin and paroxetine combined · GlaxoSmithKline https://druglandscape.com/drug/prax-222-initial-ascending-doses https://druglandscape.com/api/og?type=drug&title=PRAX-222%20-%20Initial%20Ascending%20Doses&subtitle=PRAX-222%20-%20Initial%20Ascending%20Doses%20%C2%B7%20Praxis%20Precision%20Medicines&badge=phase%201 PRAX-222 - Initial Ascending Doses PRAX-222 - Initial Ascending Doses · Praxis Precision Medicines https://druglandscape.com/drug/prax-222-initial-dose https://druglandscape.com/api/og?type=drug&title=PRAX-222%20-%20Initial%20Dose&subtitle=PRAX-222%20-%20Initial%20Dose%20%C2%B7%20Praxis%20Precision%20Medicines&badge=phase%201 PRAX-222 - Initial Dose PRAX-222 - Initial Dose · Praxis Precision Medicines https://druglandscape.com/drug/prax-222-optional-ascending-doses https://druglandscape.com/api/og?type=drug&title=PRAX-222%20-%20Optional%20Ascending%20Doses&subtitle=PRAX-222%20-%20Optional%20Ascending%20Doses%20%C2%B7%20Praxis%20Precision%20Medicines&badge=phase%201 PRAX-222 - Optional Ascending Doses PRAX-222 - Optional Ascending Doses · Praxis Precision Medicines https://druglandscape.com/drug/prax-562 https://druglandscape.com/api/og?type=drug&title=PRAX-562&subtitle=PRAX-562%20%C2%B7%20Praxis%20Precision%20Medicines&badge=phase%202 PRAX-562 PRAX-562 · Praxis Precision Medicines https://druglandscape.com/drug/prcl-02 https://druglandscape.com/api/og?type=drug&title=PRCL-02&subtitle=PRCL-02%20%C2%B7%20PRCL%20Research%20Inc.&badge=phase%202 PRCL-02 PRCL-02 · PRCL Research Inc. https://druglandscape.com/drug/prd001 https://druglandscape.com/api/og?type=drug&title=PRD001&subtitle=PRD001%20%C2%B7%20PRD%20Therapeutics%2C%20Inc.&badge=phase%201 PRD001 PRD001 · PRD Therapeutics, Inc. https://druglandscape.com/drug/pre-emptive-skin-treatment https://druglandscape.com/api/og?type=drug&title=Pre-emptive%20Skin%20Treatment&subtitle=Pre-emptive%20Skin%20Treatment%20%C2%B7%20Amgen&badge=phase%202 Pre-emptive Skin Treatment Pre-emptive Skin Treatment · Amgen https://druglandscape.com/drug/pre-incisional-local-anesthetic https://druglandscape.com/api/og?type=drug&title=Pre%20Incisional%20Local%20Anesthetic&subtitle=Pre%20Incisional%20Local%20Anesthetic%20%C2%B7%20Valley%20Anesthesiology%20Consultants&badge=phase%201 Pre Incisional Local Anesthetic Pre Incisional Local Anesthetic · Valley Anesthesiology Consultants https://druglandscape.com/drug/pre-op-pregabalin https://druglandscape.com/api/og?type=drug&title=Pre-Op%20pregabalin&subtitle=Pre-Op%20pregabalin%20%C2%B7%20Nevakar%2C%20Inc.&badge=phase%202 Pre-Op pregabalin Pre-Op pregabalin · Nevakar, Inc. https://druglandscape.com/drug/pre-radiation-temozolomide https://druglandscape.com/api/og?type=drug&title=Pre-radiation%20temozolomide.&subtitle=Pre-radiation%20temozolomide.%20%C2%B7%20The%20Cooper%20Health%20System&badge=phase%202 Pre-radiation temozolomide. Pre-radiation temozolomide. · The Cooper Health System https://druglandscape.com/drug/pre-surgical-chemotherapy https://druglandscape.com/api/og?type=drug&title=pre-surgical%20chemotherapy&subtitle=pre-surgical%20chemotherapy%20%C2%B7%20National%20Cancer%20Institute%20(NCI)&badge=phase%203 pre-surgical chemotherapy pre-surgical chemotherapy · National Cancer Institute (NCI) https://druglandscape.com/drug/pre-transfection-f17 https://druglandscape.com/api/og?type=drug&title=Pre-transfection%20F17&subtitle=Pre-transfection%20F17%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%202 Pre-transfection F17 Pre-transfection F17 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/precision-dose-ibuprofen-oral-suspension https://druglandscape.com/api/og?type=drug&title=Precision%20Dose%20-%20Ibuprofen%20oral%20suspension&subtitle=Precision%20Dose%20-%20Ibuprofen%20oral%20suspension%20%C2%B7%20Hamilton%20Health%20Sciences%20Corporation&badge=phase%202 Precision Dose - Ibuprofen oral suspension Precision Dose - Ibuprofen oral suspension · Hamilton Health Sciences Corporation https://druglandscape.com/drug/predetermined-treatment-duration https://druglandscape.com/api/og?type=drug&title=Predetermined%20treatment%20duration&subtitle=Predetermined%20treatment%20duration%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Predetermined treatment duration Predetermined treatment duration · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/predimenol-tablet https://druglandscape.com/api/og?type=drug&title=Predimenol%20tablet&subtitle=Predimenol%20tablet%20%C2%B7%20Dexa%20Medica%20Group&badge=phase%202 Predimenol tablet Predimenol tablet · Dexa Medica Group https://druglandscape.com/drug/prednicarbate-0-25-ointment https://druglandscape.com/api/og?type=drug&title=Prednicarbate%200.25%25%20ointment&subtitle=Prednicarbate%200.25%25%20ointment%20%C2%B7%20Bayer&badge=phase%201 Prednicarbate 0.25% ointment Prednicarbate 0.25% ointment · Bayer https://druglandscape.com/drug/prednisolone-acetate1 https://druglandscape.com/api/og?type=drug&title=Prednisolone%20acetate1%25%2C&subtitle=Prednisolone%20acetate1%25%2C%20%C2%B7%20Aravind%20Eye%20Care%20System&badge=phase%201 Prednisolone acetate1%, Prednisolone acetate1%, · Aravind Eye Care System https://druglandscape.com/drug/prednisolone-acetate1-cyclosporine-2 https://druglandscape.com/api/og?type=drug&title=Prednisolone%20acetate1%25%2C%20cyclosporine%202%25&subtitle=Prednisolone%20acetate1%25%2C%20cyclosporine%202%25%20%C2%B7%20Aravind%20Eye%20Care%20System&badge=phase%201 Prednisolone acetate1%, cyclosporine 2% Prednisolone acetate1%, cyclosporine 2% · Aravind Eye Care System https://druglandscape.com/drug/prednisolone-and-tacrolimus https://druglandscape.com/api/og?type=drug&title=prednisolone%20and%20tacrolimus&subtitle=prednisolone%20and%20tacrolimus%20%C2%B7%20Hospital%20Authority%2C%20Hong%20Kong&badge=phase%203 prednisolone and tacrolimus prednisolone and tacrolimus · Hospital Authority, Hong Kong https://druglandscape.com/drug/prednisolone-prednisone-or-equivalent https://druglandscape.com/api/og?type=drug&title=Prednisolone%2C%20Prednisone%20or%20equivalent&subtitle=Prednisolone%2C%20Prednisone%20or%20equivalent%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Prednisolone, Prednisone or equivalent Prednisolone, Prednisone or equivalent · GlaxoSmithKline https://druglandscape.com/drug/prednisolone-treatment https://druglandscape.com/api/og?type=drug&title=Prednisolone%20treatment&subtitle=Prednisolone%20treatment%20%C2%B7%20Barz%20IVF%20Center%20for%20Infertility%20Treatment%20and%20Embryo%20Research&badge=phase%201 Prednisolone treatment Prednisolone treatment · Barz IVF Center for Infertility Treatment and Embryo Research https://druglandscape.com/drug/prednison-and-sirolimus https://druglandscape.com/api/og?type=drug&title=prednison%20and%20Sirolimus&subtitle=prednison%20and%20Sirolimus%20%C2%B7%20Shanghai%20Children's%20Medical%20Center&badge=phase%201 prednison and Sirolimus prednison and Sirolimus · Shanghai Children's Medical Center https://druglandscape.com/drug/prednisone-acetate-tablets https://druglandscape.com/api/og?type=drug&title=prednisone%20acetate%20tablets&subtitle=prednisone%20acetate%20tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 prednisone acetate tablets prednisone acetate tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/prednisone-in-full-dose https://druglandscape.com/api/og?type=drug&title=Prednisone%20in%20full%20dose&subtitle=Prednisone%20in%20full%20dose%20%C2%B7%20Zhi-Hong%20Liu%2C%20M.D.&badge=phase%201 Prednisone in full dose Prednisone in full dose · Zhi-Hong Liu, M.D. https://druglandscape.com/drug/prednisone-low-dose-rituximab https://druglandscape.com/api/og?type=drug&title=prednisone%2C%20low%20dose%20rituximab&subtitle=prednisone%2C%20low%20dose%20rituximab%20%C2%B7%20Fondazione%20IRCCS%20Ca'%20Granda%2C%20Ospedale%20Maggiore%20Policlinico&badge=phase%202 prednisone, low dose rituximab prednisone, low dose rituximab · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico https://druglandscape.com/drug/prednisone-treatment https://druglandscape.com/api/og?type=drug&title=prednisone%20treatment&subtitle=prednisone%20treatment%20%C2%B7%20Centre%20Hospitalier%20Universitaire%20Dijon&badge=phase%203 prednisone treatment prednisone treatment · Centre Hospitalier Universitaire Dijon https://druglandscape.com/drug/prednisone-valacyclovir https://druglandscape.com/api/og?type=drug&title=prednisone-%20valacyclovir&subtitle=prednisone-%20valacyclovir%20%C2%B7%20Universidad%20de%20la%20Republica&badge=phase%201 prednisone- valacyclovir prednisone- valacyclovir · Universidad de la Republica https://druglandscape.com/drug/prednisone-vincristine-cyclophosphamide https://druglandscape.com/api/og?type=drug&title=Prednisone%2CVincristine%2C%20Cyclophosphamide&subtitle=Prednisone%2CVincristine%2C%20Cyclophosphamide%20%C2%B7%20Children's%20Cancer%20Group%2C%20China&badge=phase%202 Prednisone,Vincristine, Cyclophosphamide Prednisone,Vincristine, Cyclophosphamide · Children's Cancer Group, China https://druglandscape.com/drug/pregabalin-sustained-release-tablets https://druglandscape.com/api/og?type=drug&title=pregabalin%20sustained-release%20tablets&subtitle=pregabalin%20sustained-release%20tablets%20%C2%B7%20CSPC%20Ouyi%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%203 pregabalin sustained-release tablets pregabalin sustained-release tablets · CSPC Ouyi Pharmaceutical Co., Ltd. https://druglandscape.com/drug/pregnant-women-exposed-to-tildrakizumab https://druglandscape.com/api/og?type=drug&title=Pregnant%20women%20exposed%20to%20tildrakizumab&subtitle=Pregnant%20women%20exposed%20to%20tildrakizumab%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%202 Pregnant women exposed to tildrakizumab Pregnant women exposed to tildrakizumab · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/prehabilitation-group-deuterated-water https://druglandscape.com/api/og?type=drug&title=Prehabilitation%20Group%20Deuterated%20Water&subtitle=Prehabilitation%20Group%20Deuterated%20Water%20%C2%B7%20Universidad%20de%20La%20Frontera&badge=phase%201 Prehabilitation Group Deuterated Water Prehabilitation Group Deuterated Water · Universidad de La Frontera https://druglandscape.com/drug/premarin-oral-tablets https://druglandscape.com/api/og?type=drug&title=Premarin%C2%AE%20oral%20tablets&subtitle=Premarin%C2%AE%20oral%20tablets%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 Premarin® oral tablets Premarin® oral tablets · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/preoperative-statin-use https://druglandscape.com/api/og?type=drug&title=Preoperative%20Statin%20Use&subtitle=Preoperative%20Statin%20Use%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 Preoperative Statin Use Preoperative Statin Use · Asan Medical Center https://druglandscape.com/drug/prep-for-participants-without-hiv https://druglandscape.com/api/og?type=drug&title=PrEP%20for%20participants%20without%20HIV&subtitle=PrEP%20for%20participants%20without%20HIV%20%C2%B7%20HIV%20Prevention%20Trials%20Network&badge=phase%201 PrEP for participants without HIV PrEP for participants without HIV · HIV Prevention Trials Network https://druglandscape.com/drug/prep-with-truvada https://druglandscape.com/api/og?type=drug&title=PrEP%20with%20Truvada%C2%AE&subtitle=PrEP%20with%20Truvada%C2%AE%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 PrEP with Truvada® PrEP with Truvada® · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/preparation-h-cream https://druglandscape.com/api/og?type=drug&title=Preparation-H%20Cream&subtitle=Preparation-H%20Cream%20%C2%B7%20Peritech%20Pharma%20Ltd.&badge=phase%202 Preparation-H Cream Preparation-H Cream · Peritech Pharma Ltd. https://druglandscape.com/drug/pres-hbsag https://druglandscape.com/api/og?type=drug&title=PreS%20HBsAg&subtitle=PreS%20HBsAg%20%C2%B7%20Vaxine%20Pty%20Ltd&badge=phase%201 PreS HBsAg PreS HBsAg · Vaxine Pty Ltd https://druglandscape.com/drug/prescription-drugs-with-known-hepatotoxicity https://druglandscape.com/api/og?type=drug&title=Prescription%20drugs%20with%20known%20hepatotoxicity&subtitle=Prescription%20drugs%20with%20known%20hepatotoxicity%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Prescription drugs with known hepatotoxicity Prescription drugs with known hepatotoxicity · GlaxoSmithKline https://druglandscape.com/drug/prescription-psychotropic-medications https://druglandscape.com/api/og?type=drug&title=Prescription%20Psychotropic%20Medications&subtitle=Prescription%20Psychotropic%20Medications%20%C2%B7%20Gaize&badge=phase%202 Prescription Psychotropic Medications Prescription Psychotropic Medications · Gaize https://druglandscape.com/drug/preset-increase-in-frusemide-dose https://druglandscape.com/api/og?type=drug&title=Preset%20increase%20in%20frusemide%20dose&subtitle=Preset%20increase%20in%20frusemide%20dose%20%C2%B7%20Barts%20%26%20The%20London%20NHS%20Trust&badge=phase%201 Preset increase in frusemide dose Preset increase in frusemide dose · Barts & The London NHS Trust https://druglandscape.com/drug/prestarium-a-tablet https://druglandscape.com/api/og?type=drug&title=Prestarium%C2%AE%20A%20tablet&subtitle=Prestarium%C2%AE%20A%20tablet%20%C2%B7%20Pharmtechnology%20LLC&badge=phase%201 Prestarium® A tablet Prestarium® A tablet · Pharmtechnology LLC https://druglandscape.com/drug/prevascar-100ng https://druglandscape.com/api/og?type=drug&title=Prevascar%20100ng&subtitle=Prevascar%20100ng%20%C2%B7%20Renovo&badge=phase%201 Prevascar 100ng Prevascar 100ng · Renovo https://druglandscape.com/drug/prevascar-250ng https://druglandscape.com/api/og?type=drug&title=Prevascar%20250ng&subtitle=Prevascar%20250ng%20%C2%B7%20Renovo&badge=phase%201 Prevascar 250ng Prevascar 250ng · Renovo https://druglandscape.com/drug/prevascar-25ng https://druglandscape.com/api/og?type=drug&title=Prevascar%2025ng&subtitle=Prevascar%2025ng%20%C2%B7%20Renovo&badge=phase%201 Prevascar 25ng Prevascar 25ng · Renovo https://druglandscape.com/drug/prevascar-5ng https://druglandscape.com/api/og?type=drug&title=Prevascar%205ng&subtitle=Prevascar%205ng%20%C2%B7%20Renovo&badge=phase%201 Prevascar 5ng Prevascar 5ng · Renovo https://druglandscape.com/drug/prevenar13-0-5 https://druglandscape.com/api/og?type=drug&title=Prevenar13%C2%AE%200%2C5&subtitle=Prevenar13%C2%AE%200%2C5%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Prevenar13® 0,5 Prevenar13® 0,5 · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/prevention-of-gvhd https://druglandscape.com/api/og?type=drug&title=Prevention%20of%20GVHD&subtitle=Prevention%20of%20GVHD%20%C2%B7%20Association%20for%20Training%2C%20Education%2C%20and%20Research%20in%20Hematology%2C%20Immunology%2C%20an&badge=phase%201 Prevention of GVHD Prevention of GVHD · Association for Training, Education, and Research in Hematology, Immunology, and Transplantation https://druglandscape.com/drug/preventive-antibiotic-treatment-cephalexin https://druglandscape.com/api/og?type=drug&title=Preventive%20antibiotic%20treatment-%20CEPHALEXIN&subtitle=Preventive%20antibiotic%20treatment-%20CEPHALEXIN%20%C2%B7%20HaEmek%20Medical%20Center%2C%20Israel&badge=phase%201 Preventive antibiotic treatment- CEPHALEXIN Preventive antibiotic treatment- CEPHALEXIN · HaEmek Medical Center, Israel https://druglandscape.com/drug/preventive-antibiotic-treatment-nitrofurantoin https://druglandscape.com/api/og?type=drug&title=Preventive%20antibiotic%20treatment-%20NITROFURANTOIN&subtitle=Preventive%20antibiotic%20treatment-%20NITROFURANTOIN%20%C2%B7%20HaEmek%20Medical%20Center%2C%20Israel&badge=phase%201 Preventive antibiotic treatment- NITROFURANTOIN Preventive antibiotic treatment- NITROFURANTOIN · HaEmek Medical Center, Israel https://druglandscape.com/drug/preventive-treatment-amoxicillin https://druglandscape.com/api/og?type=drug&title=PREVENTIVE%20TREATMENT-%20AMOXICILLIN&subtitle=PREVENTIVE%20TREATMENT-%20AMOXICILLIN%20%C2%B7%20HaEmek%20Medical%20Center%2C%20Israel&badge=phase%201 PREVENTIVE TREATMENT- AMOXICILLIN PREVENTIVE TREATMENT- AMOXICILLIN · HaEmek Medical Center, Israel https://druglandscape.com/drug/preventive-treatment-cefuroxime https://druglandscape.com/api/og?type=drug&title=PREVENTIVE%20TREATMENT-%20CEFUROXIME&subtitle=PREVENTIVE%20TREATMENT-%20CEFUROXIME%20%C2%B7%20HaEmek%20Medical%20Center%2C%20Israel&badge=phase%201 PREVENTIVE TREATMENT- CEFUROXIME PREVENTIVE TREATMENT- CEFUROXIME · HaEmek Medical Center, Israel https://druglandscape.com/drug/preventive-treatment-sulfamethoxazole-and-trimethoprim https://druglandscape.com/api/og?type=drug&title=PREVENTIVE%20TREATMENT%20SULFAMETHOXAZOLE%20AND%20TRIMETHOPRIM&subtitle=PREVENTIVE%20TREATMENT%20SULFAMETHOXAZOLE%20AND%20TRIMETHOPRIM%20%C2%B7%20HaEmek%20Medical%20Center%2C%20Israel&badge=phase%201 PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM · HaEmek Medical Center, Israel https://druglandscape.com/drug/previous-denosumab https://druglandscape.com/api/og?type=drug&title=Previous%20denosumab&subtitle=Previous%20denosumab%20%C2%B7%20Amgen&badge=phase%202 Previous denosumab Previous denosumab · Amgen https://druglandscape.com/drug/prevnar20 https://druglandscape.com/api/og?type=drug&title=Prevnar20&subtitle=Prevnar20%20%C2%B7%20Inventprise%20Inc.&badge=phase%202 Prevnar20 Prevnar20 · Inventprise Inc. https://druglandscape.com/drug/prf-108 https://druglandscape.com/api/og?type=drug&title=PRF-108&subtitle=PRF-108%20%C2%B7%20PainReform%20LTD&badge=phase%201 PRF-108 PRF-108 · PainReform LTD https://druglandscape.com/drug/prf-110 https://druglandscape.com/api/og?type=drug&title=PRF-110&subtitle=PRF-110%20%C2%B7%20PainReform%20LTD&badge=phase%201 PRF-110 PRF-110 · PainReform LTD https://druglandscape.com/drug/prf110 https://druglandscape.com/api/og?type=drug&title=PRF110&subtitle=PRF110%20%C2%B7%20PainReform%20LTD&badge=phase%202 PRF110 PRF110 · PainReform LTD https://druglandscape.com/drug/prgf-in-candidates-for-sperm-donors https://druglandscape.com/api/og?type=drug&title=PRGF%20in%20candidates%20for%20sperm%20donors&subtitle=PRGF%20in%20candidates%20for%20sperm%20donors%20%C2%B7%20IVI%20Bilbao&badge=phase%202 PRGF in candidates for sperm donors PRGF in candidates for sperm donors · IVI Bilbao https://druglandscape.com/drug/prgn-2009-plus-pembrolizumab https://druglandscape.com/api/og?type=drug&title=PRGN-2009%20plus%20Pembrolizumab&subtitle=PRGN-2009%20plus%20Pembrolizumab%20%C2%B7%20Precigen%2C%20Inc&badge=phase%202 PRGN-2009 plus Pembrolizumab PRGN-2009 plus Pembrolizumab · Precigen, Inc https://druglandscape.com/drug/prgn-2012-phase-i-dose-level-1 https://druglandscape.com/api/og?type=drug&title=PRGN-2012%20-%20Phase%20I%3B%20Dose%20Level%201&subtitle=PRGN-2012%20-%20Phase%20I%3B%20Dose%20Level%201%20%C2%B7%20Precigen%2C%20Inc&badge=phase%201 PRGN-2012 - Phase I; Dose Level 1 PRGN-2012 - Phase I; Dose Level 1 · Precigen, Inc https://druglandscape.com/drug/prgn-2012-phase-i-dose-level-2 https://druglandscape.com/api/og?type=drug&title=PRGN-2012%20-%20Phase%20I%3B%20Dose%20Level%202&subtitle=PRGN-2012%20-%20Phase%20I%3B%20Dose%20Level%202%20%C2%B7%20Precigen%2C%20Inc&badge=phase%201 PRGN-2012 - Phase I; Dose Level 2 PRGN-2012 - Phase I; Dose Level 2 · Precigen, Inc https://druglandscape.com/drug/prgn-2012-phase-ii-dose-level-2 https://druglandscape.com/api/og?type=drug&title=PRGN-2012%20-%20Phase%20II%3B%20Dose%20Level%202&subtitle=PRGN-2012%20-%20Phase%20II%3B%20Dose%20Level%202%20%C2%B7%20Precigen%2C%20Inc&badge=phase%201 PRGN-2012 - Phase II; Dose Level 2 PRGN-2012 - Phase II; Dose Level 2 · Precigen, Inc https://druglandscape.com/drug/prgn-3005-ultracar-t-cells https://druglandscape.com/api/og?type=drug&title=PRGN-3005%20UltraCAR-T%20cells&subtitle=PRGN-3005%20UltraCAR-T%20cells%20%C2%B7%20Precigen%2C%20Inc&badge=phase%201 PRGN-3005 UltraCAR-T cells PRGN-3005 UltraCAR-T cells · Precigen, Inc https://druglandscape.com/drug/prgn-3006-t-cells https://druglandscape.com/api/og?type=drug&title=PRGN-3006%20T%20Cells&subtitle=PRGN-3006%20T%20Cells%20%C2%B7%20Precigen%2C%20Inc&badge=phase%201 PRGN-3006 T Cells PRGN-3006 T Cells · Precigen, Inc https://druglandscape.com/drug/pri-002 https://druglandscape.com/api/og?type=drug&title=PRI-002&subtitle=PRI-002%20%C2%B7%20PRInnovation%20GmbH&badge=phase%202 PRI-002 PRI-002 · PRInnovation GmbH https://druglandscape.com/drug/prilocaine-chlorhydrate https://druglandscape.com/api/og?type=drug&title=Prilocaine%20Chlorhydrate&subtitle=Prilocaine%20Chlorhydrate%20%C2%B7%20Astes&badge=phase%202 Prilocaine Chlorhydrate Prilocaine Chlorhydrate · Astes https://druglandscape.com/drug/primaquine-diphosphate https://druglandscape.com/api/og?type=drug&title=Primaquine%20Diphosphate&subtitle=Primaquine%20Diphosphate%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%202 Primaquine Diphosphate Primaquine Diphosphate · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/prime-boost-pneumococcal-immunization https://druglandscape.com/api/og?type=drug&title=Prime-boost%20pneumococcal%20immunization&subtitle=Prime-boost%20pneumococcal%20immunization%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Prime-boost pneumococcal immunization Prime-boost pneumococcal immunization · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/primepro https://druglandscape.com/api/og?type=drug&title=PrimePro&subtitle=PrimePro%20%C2%B7%20Thomas%20Advanced%20Medical%20LLC&badge=phase%201 PrimePro PrimePro · Thomas Advanced Medical LLC https://druglandscape.com/drug/prismasol-2 https://druglandscape.com/api/og?type=drug&title=Prismasol%202&subtitle=Prismasol%202%20%C2%B7%20Vantive%20Health%20LLC&badge=phase%202 Prismasol 2 Prismasol 2 · Vantive Health LLC https://druglandscape.com/drug/pritchard-regimen https://druglandscape.com/api/og?type=drug&title=Pritchard%20regimen&subtitle=Pritchard%20regimen%20%C2%B7%20Adebayo%20Joshua%20Adeniyi&badge=phase%201 Pritchard regimen Pritchard regimen · Adebayo Joshua Adeniyi https://druglandscape.com/drug/prj1-3024 https://druglandscape.com/api/og?type=drug&title=PRJ1-3024&subtitle=PRJ1-3024%20%C2%B7%20Zhuhai%20Yufan%20Biotechnologies%20Co.%2C%20Ltd&badge=phase%201 PRJ1-3024 PRJ1-3024 · Zhuhai Yufan Biotechnologies Co., Ltd https://druglandscape.com/drug/prl3-zumab https://druglandscape.com/api/og?type=drug&title=PRL3-ZUMAB&subtitle=PRL3-ZUMAB%20%C2%B7%20Intra-IMMUSG%20Pte%20Ltd&badge=phase%202 PRL3-ZUMAB PRL3-ZUMAB · Intra-IMMUSG Pte Ltd https://druglandscape.com/drug/prm-151 https://druglandscape.com/api/og?type=drug&title=PRM-151&subtitle=PRM-151%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 PRM-151 PRM-151 · Hoffmann-La Roche https://druglandscape.com/drug/prn1008 https://druglandscape.com/api/og?type=drug&title=PRN1008&subtitle=PRN1008%20%C2%B7%20Principia%20Biopharma%2C%20a%20Sanofi%20Company&badge=phase%202 PRN1008 PRN1008 · Principia Biopharma, a Sanofi Company https://druglandscape.com/drug/pro-bone https://druglandscape.com/api/og?type=drug&title=Pro-Bone&subtitle=Pro-Bone%20%C2%B7%20OsteoBuild%20Ltd.&badge=phase%201 Pro-Bone Pro-Bone · OsteoBuild Ltd. https://druglandscape.com/drug/pro-care-gel-remineralizing-agent https://druglandscape.com/api/og?type=drug&title=pro%20care%20gel%20remineralizing%20agent&subtitle=pro%20care%20gel%20remineralizing%20agent%20%C2%B7%20Roya%20mohamed%20Hamad%20Elmaghrbi&badge=phase%201 pro care gel remineralizing agent pro care gel remineralizing agent · Roya mohamed Hamad Elmaghrbi https://druglandscape.com/drug/pro-ocular-gel https://druglandscape.com/api/og?type=drug&title=Pro-ocular%20gel&subtitle=Pro-ocular%20gel%20%C2%B7%20SIFI%20SpA&badge=phase%202 Pro-ocular gel Pro-ocular gel · SIFI SpA https://druglandscape.com/drug/pro-ocular-topical-gel https://druglandscape.com/api/og?type=drug&title=Pro-ocular%E2%84%A2%20topical%20gel&subtitle=Pro-ocular%E2%84%A2%20topical%20gel%20%C2%B7%20Glia%2C%20LLC&badge=phase%202 Pro-ocular™ topical gel Pro-ocular™ topical gel · Glia, LLC https://druglandscape.com/drug/pro-ocular-topical-gel-1 https://druglandscape.com/api/og?type=drug&title=Pro-ocular%E2%84%A2%20Topical%20Gel%201%25&subtitle=Pro-ocular%E2%84%A2%20Topical%20Gel%201%25%20%C2%B7%20Glia%2C%20LLC&badge=phase%202 Pro-ocular™ Topical Gel 1% Pro-ocular™ Topical Gel 1% · Glia, LLC https://druglandscape.com/drug/pro044-iv https://druglandscape.com/api/og?type=drug&title=PRO044%20IV&subtitle=PRO044%20IV%20%C2%B7%20BioMarin%20Pharmaceutical&badge=phase%201 PRO044 IV PRO044 IV · BioMarin Pharmaceutical https://druglandscape.com/drug/pro044-sc https://druglandscape.com/api/og?type=drug&title=PRO044%20SC&subtitle=PRO044%20SC%20%C2%B7%20BioMarin%20Pharmaceutical&badge=phase%201 PRO044 SC PRO044 SC · BioMarin Pharmaceutical https://druglandscape.com/drug/pro283698 https://druglandscape.com/api/og?type=drug&title=PRO283698&subtitle=PRO283698%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 PRO283698 PRO283698 · Genentech, Inc. https://druglandscape.com/drug/proagio-dose-expansion https://druglandscape.com/api/og?type=drug&title=ProAgio%20Dose%20Expansion&subtitle=ProAgio%20Dose%20Expansion%20%C2%B7%20ProDa%20BioTech%2C%20LLC&badge=phase%201 ProAgio Dose Expansion ProAgio Dose Expansion · ProDa BioTech, LLC https://druglandscape.com/drug/proagio-dose-levels-4a-5a-6a https://druglandscape.com/api/og?type=drug&title=ProAgio%20Dose%20Levels%204a%2C5a%2C6a&subtitle=ProAgio%20Dose%20Levels%204a%2C5a%2C6a%20%C2%B7%20ProDa%20BioTech%2C%20LLC&badge=phase%201 ProAgio Dose Levels 4a,5a,6a ProAgio Dose Levels 4a,5a,6a · ProDa BioTech, LLC https://druglandscape.com/drug/proalgazyme https://druglandscape.com/api/og?type=drug&title=ProAlgaZyme&subtitle=ProAlgaZyme%20%C2%B7%20Health%20Enhancement%20Products%2C%20Inc.&badge=phase%201 ProAlgaZyme ProAlgaZyme · Health Enhancement Products, Inc. https://druglandscape.com/drug/probe-drug-cocktail https://druglandscape.com/api/og?type=drug&title=Probe%20Drug%20Cocktail&subtitle=Probe%20Drug%20Cocktail%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Probe Drug Cocktail Probe Drug Cocktail · Eli Lilly and Company https://druglandscape.com/drug/probiotics-bio-plus https://druglandscape.com/api/og?type=drug&title=Probiotics-Bio-plus&subtitle=Probiotics-Bio-plus%20%C2%B7%20Meir%20Medical%20Center&badge=phase%201 Probiotics-Bio-plus Probiotics-Bio-plus · Meir Medical Center https://druglandscape.com/drug/procervix https://druglandscape.com/api/og?type=drug&title=ProCervix&subtitle=ProCervix%20%C2%B7%20Genticel&badge=phase%202 ProCervix ProCervix · Genticel https://druglandscape.com/drug/process-c-belatacept https://druglandscape.com/api/og?type=drug&title=Process%20C%20Belatacept&subtitle=Process%20C%20Belatacept%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Process C Belatacept Process C Belatacept · Bristol-Myers Squibb https://druglandscape.com/drug/process-changed-cmab007 https://druglandscape.com/api/og?type=drug&title=Process-Changed%20CMAB007&subtitle=Process-Changed%20CMAB007%20%C2%B7%20Taizhou%20Mabtech%20Pharmaceutical%20Co.%2CLtd&badge=phase%201 Process-Changed CMAB007 Process-Changed CMAB007 · Taizhou Mabtech Pharmaceutical Co.,Ltd https://druglandscape.com/drug/process-e-belatacept https://druglandscape.com/api/og?type=drug&title=Process%20E%20Belatacept&subtitle=Process%20E%20Belatacept%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Process E Belatacept Process E Belatacept · Bristol-Myers Squibb https://druglandscape.com/drug/proellex-formulation-a https://druglandscape.com/api/og?type=drug&title=Proellex%20Formulation%20A&subtitle=Proellex%20Formulation%20A%20%C2%B7%20Repros%20Therapeutics%20Inc.&badge=phase%201 Proellex Formulation A Proellex Formulation A · Repros Therapeutics Inc. https://druglandscape.com/drug/proellex-formulation-b https://druglandscape.com/api/og?type=drug&title=Proellex%20Formulation%20B&subtitle=Proellex%20Formulation%20B%20%C2%B7%20Repros%20Therapeutics%20Inc.&badge=phase%201 Proellex Formulation B Proellex Formulation B · Repros Therapeutics Inc. https://druglandscape.com/drug/prof-001 https://druglandscape.com/api/og?type=drug&title=Prof-001&subtitle=Prof-001%20%C2%B7%20ProFem%20GmbH&badge=phase%202 Prof-001 Prof-001 · ProFem GmbH https://druglandscape.com/drug/profile-of-csf-biomarkers-of-ad https://druglandscape.com/api/og?type=drug&title=profile%20of%20CSF%20biomarkers%20of%20AD&subtitle=profile%20of%20CSF%20biomarkers%20of%20AD%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 profile of CSF biomarkers of AD profile of CSF biomarkers of AD · Hospices Civils de Lyon https://druglandscape.com/drug/profilnine-sd https://druglandscape.com/api/og?type=drug&title=Profilnine%20SD&subtitle=Profilnine%20SD%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Profilnine SD Profilnine SD · Janssen Research & Development, LLC https://druglandscape.com/drug/proflavine-high-resolution-imaging https://druglandscape.com/api/og?type=drug&title=Proflavine%2C%20high%20resolution%20imaging&subtitle=Proflavine%2C%20high%20resolution%20imaging%20%C2%B7%20Anandasabapathy%2C%20Sharmila%2C%20M.D.&badge=phase%202 Proflavine, high resolution imaging Proflavine, high resolution imaging · Anandasabapathy, Sharmila, M.D. https://druglandscape.com/drug/progesterone-only-hormone-replacement-therapy https://druglandscape.com/api/og?type=drug&title=Progesterone%20Only%20Hormone%20Replacement%20Therapy&subtitle=Progesterone%20Only%20Hormone%20Replacement%20Therapy%20%C2%B7%20New%20Mexico%20Cancer%20Research%20Alliance&badge=phase%202 Progesterone Only Hormone Replacement Therapy Progesterone Only Hormone Replacement Therapy · New Mexico Cancer Research Alliance https://druglandscape.com/drug/progesterone-vaginal-gel-8 https://druglandscape.com/api/og?type=drug&title=Progesterone%20Vaginal%20Gel%208%25&subtitle=Progesterone%20Vaginal%20Gel%208%25%20%C2%B7%20Eastern%20Virginia%20Medical%20School&badge=phase%202 Progesterone Vaginal Gel 8% Progesterone Vaginal Gel 8% · Eastern Virginia Medical School https://druglandscape.com/drug/progestin-only-pills https://druglandscape.com/api/og?type=drug&title=Progestin%20Only%20Pills&subtitle=Progestin%20Only%20Pills%20%C2%B7%20Bayer&badge=phase%202 Progestin Only Pills Progestin Only Pills · Bayer https://druglandscape.com/drug/prolectin-m https://druglandscape.com/api/og?type=drug&title=Prolectin-M&subtitle=Prolectin-M%20%C2%B7%20Bioxytran%20Inc.&badge=phase%202 Prolectin-M Prolectin-M · Bioxytran Inc. https://druglandscape.com/drug/proleukin-injectable-product https://druglandscape.com/api/og?type=drug&title=Proleukin%20Injectable%20Product&subtitle=Proleukin%20Injectable%20Product%20%C2%B7%20ImCheck%20Therapeutics&badge=phase%201 Proleukin Injectable Product Proleukin Injectable Product · ImCheck Therapeutics https://druglandscape.com/drug/prolonged-perioperative-antibiotics https://druglandscape.com/api/og?type=drug&title=Prolonged%20perioperative%20antibiotics&subtitle=Prolonged%20perioperative%20antibiotics%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 Prolonged perioperative antibiotics Prolonged perioperative antibiotics · Asan Medical Center https://druglandscape.com/drug/prolopa https://druglandscape.com/api/og?type=drug&title=Prolopa%C2%AE&subtitle=Prolopa%C2%AE%20%C2%B7%20Bial%20-%20Portela%20C%20S.A.&badge=phase%201 Prolopa® Prolopa® · Bial - Portela C S.A. https://druglandscape.com/drug/promilk-85 https://druglandscape.com/api/og?type=drug&title=ProMilk%2085&subtitle=ProMilk%2085%20%C2%B7%20Johns%20Hopkins%20Bloomberg%20School%20of%20Public%20Health&badge=phase%201 ProMilk 85 ProMilk 85 · Johns Hopkins Bloomberg School of Public Health https://druglandscape.com/drug/proparacaine-drops-0-05 https://druglandscape.com/api/og?type=drug&title=Proparacaine%20drops%200.05%25&subtitle=Proparacaine%20drops%200.05%25%20%C2%B7%20London%20Health%20Sciences%20Centre&badge=phase%201 Proparacaine drops 0.05% Proparacaine drops 0.05% · London Health Sciences Centre https://druglandscape.com/drug/proparacaine-hcl-0-5 https://druglandscape.com/api/og?type=drug&title=proparacaine%20HCL%200.5%25&subtitle=proparacaine%20HCL%200.5%25%20%C2%B7%20Illinois%20Retina%20Associates&badge=phase%203 proparacaine HCL 0.5% proparacaine HCL 0.5% · Illinois Retina Associates https://druglandscape.com/drug/proparacaine-hydrochloride-0-5-drop https://druglandscape.com/api/og?type=drug&title=Proparacaine%20Hydrochloride%200.5%25%20Drop&subtitle=Proparacaine%20Hydrochloride%200.5%25%20Drop%20%C2%B7%20Retina%20Vitreous%20Associates%20of%20Florida&badge=phase%201 Proparacaine Hydrochloride 0.5% Drop Proparacaine Hydrochloride 0.5% Drop · Retina Vitreous Associates of Florida https://druglandscape.com/drug/prophylactic-corticosteroid-taper-regimen https://druglandscape.com/api/og?type=drug&title=Prophylactic%20Corticosteroid%20Taper%20Regimen&subtitle=Prophylactic%20Corticosteroid%20Taper%20Regimen%20%C2%B7%20Ultragenyx%20Pharmaceutical%20Inc&badge=phase%201 Prophylactic Corticosteroid Taper Regimen Prophylactic Corticosteroid Taper Regimen · Ultragenyx Pharmaceutical Inc https://druglandscape.com/drug/prophylactic-growth-factors-subcutaneous https://druglandscape.com/api/og?type=drug&title=Prophylactic%20growth%20factors%3B%20subcutaneous&subtitle=Prophylactic%20growth%20factors%3B%20subcutaneous%20%C2%B7%20Array%20Biopharma%2C%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 Prophylactic growth factors; subcutaneous Prophylactic growth factors; subcutaneous · Array Biopharma, now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/prophylactic-loperamide https://druglandscape.com/api/og?type=drug&title=Prophylactic%20Loperamide&subtitle=Prophylactic%20Loperamide%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 Prophylactic Loperamide Prophylactic Loperamide · Eli Lilly and Company https://druglandscape.com/drug/prophylactic-nsaid-administration https://druglandscape.com/api/og?type=drug&title=Prophylactic%20NSAID%20Administration&subtitle=Prophylactic%20NSAID%20Administration%20%C2%B7%20Le%20Thi%20Kieu%20Trang&badge=phase%201 Prophylactic NSAID Administration Prophylactic NSAID Administration · Le Thi Kieu Trang https://druglandscape.com/drug/prophylaxis-a https://druglandscape.com/api/og?type=drug&title=Prophylaxis%20A&subtitle=Prophylaxis%20A%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 Prophylaxis A Prophylaxis A · Janssen Research & Development, LLC https://druglandscape.com/drug/prophylaxis-b https://druglandscape.com/api/og?type=drug&title=Prophylaxis%20B&subtitle=Prophylaxis%20B%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 Prophylaxis B Prophylaxis B · Janssen Research & Development, LLC https://druglandscape.com/drug/prophylaxis-c https://druglandscape.com/api/og?type=drug&title=Prophylaxis%20C&subtitle=Prophylaxis%20C%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%202 Prophylaxis C Prophylaxis C · Janssen Research & Development, LLC https://druglandscape.com/drug/prophylaxis-plus-azythromycin https://druglandscape.com/api/og?type=drug&title=Prophylaxis%20plus%20azythromycin&subtitle=Prophylaxis%20plus%20azythromycin%20%C2%B7%20Universidad%20de%20Antioquia&badge=phase%201 Prophylaxis plus azythromycin Prophylaxis plus azythromycin · Universidad de Antioquia https://druglandscape.com/drug/propionyl-l-carnitine-hydrochloride https://druglandscape.com/api/og?type=drug&title=Propionyl%20L-carnitine%20Hydrochloride&subtitle=Propionyl%20L-carnitine%20Hydrochloride%20%C2%B7%20Lee's%20Pharmaceutical%20Limited&badge=phase%201 Propionyl L-carnitine Hydrochloride Propionyl L-carnitine Hydrochloride · Lee's Pharmaceutical Limited https://druglandscape.com/drug/propofol-hsk3486 https://druglandscape.com/api/og?type=drug&title=Propofol%20HSK3486&subtitle=Propofol%20HSK3486%20%C2%B7%20Sichuan%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd&badge=phase%202 Propofol HSK3486 Propofol HSK3486 · Sichuan Haisco Pharmaceutical Group Co., Ltd https://druglandscape.com/drug/propofol-remifentanil-sevoflurane https://druglandscape.com/api/og?type=drug&title=propofol%2C%20remifentanil%2C%20sevoflurane&subtitle=propofol%2C%20remifentanil%2C%20sevoflurane%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 propofol, remifentanil, sevoflurane propofol, remifentanil, sevoflurane · Asan Medical Center https://druglandscape.com/drug/propofol-tci-kataria https://druglandscape.com/api/og?type=drug&title=Propofol%20%3A%20TCI%20Kataria&subtitle=Propofol%20%3A%20TCI%20Kataria%20%C2%B7%20Pr%20Isabelle%20CONSTANT&badge=phase%201 Propofol : TCI Kataria Propofol : TCI Kataria · Pr Isabelle CONSTANT https://druglandscape.com/drug/propofol-tci-schnider https://druglandscape.com/api/og?type=drug&title=Propofol%20%3A%20TCI%20Schnider&subtitle=Propofol%20%3A%20TCI%20Schnider%20%C2%B7%20Pr%20Isabelle%20CONSTANT&badge=phase%201 Propofol : TCI Schnider Propofol : TCI Schnider · Pr Isabelle CONSTANT https://druglandscape.com/drug/propolis-tablet-to-limit-dental-biofilm https://druglandscape.com/api/og?type=drug&title=Propolis%20tablet%20to%20limit%20dental%20biofilm&subtitle=Propolis%20tablet%20to%20limit%20dental%20biofilm%20%C2%B7%20Universidade%20Federal%20do%20Rio%20de%20Janeiro&badge=phase%202 Propolis tablet to limit dental biofilm Propolis tablet to limit dental biofilm · Universidade Federal do Rio de Janeiro https://druglandscape.com/drug/propranolol-etodolac https://druglandscape.com/api/og?type=drug&title=Propranolol%2C%20etodolac&subtitle=Propranolol%2C%20etodolac%20%C2%B7%20Kaplan%20Medical%20Center&badge=phase%201 Propranolol, etodolac Propranolol, etodolac · Kaplan Medical Center https://druglandscape.com/drug/propsynvi-film-coated-tablets https://druglandscape.com/api/og?type=drug&title=PrOpsynvi%C2%AE%20Film-Coated%20Tablets&subtitle=PrOpsynvi%C2%AE%20Film-Coated%20Tablets%20%C2%B7%20Humanis%20Sagl%C4%B1k%20Anonim%20Sirketi&badge=phase%201 PrOpsynvi® Film-Coated Tablets PrOpsynvi® Film-Coated Tablets · Humanis Saglık Anonim Sirketi https://druglandscape.com/drug/prostacyclin-receptor-agonist https://druglandscape.com/api/og?type=drug&title=Prostacyclin%20Receptor%20Agonist&subtitle=Prostacyclin%20Receptor%20Agonist%20%C2%B7%20Actelion&badge=phase%201 Prostacyclin Receptor Agonist Prostacyclin Receptor Agonist · Actelion https://druglandscape.com/drug/prostaglandin-e1-analogue https://druglandscape.com/api/og?type=drug&title=prostaglandin%20E1%20analogue&subtitle=prostaglandin%20E1%20analogue%20%C2%B7%20Nwali%20Matthew%20Igwe&badge=phase%201 prostaglandin E1 analogue prostaglandin E1 analogue · Nwali Matthew Igwe https://druglandscape.com/drug/prostaglandin-f2alpha https://druglandscape.com/api/og?type=drug&title=Prostaglandin%20F2alpha&subtitle=Prostaglandin%20F2alpha%20%C2%B7%20Danish%20Headache%20Center&badge=phase%201 Prostaglandin F2alpha Prostaglandin F2alpha · Danish Headache Center https://druglandscape.com/drug/prostaglandin-i2-analogue https://druglandscape.com/api/og?type=drug&title=prostaglandin%20I2%20analogue&subtitle=prostaglandin%20I2%20analogue%20%C2%B7%20Seoul%20National%20University%20Hospital&badge=phase%203 prostaglandin I2 analogue prostaglandin I2 analogue · Seoul National University Hospital https://druglandscape.com/drug/prostate-cancer-vaccine-ony-p1 https://druglandscape.com/api/og?type=drug&title=prostate%20cancer%20vaccine%20ONY-P1&subtitle=prostate%20cancer%20vaccine%20ONY-P1%20%C2%B7%20Kael-GemVax%20Co.%2C%20Ltd.&badge=phase%202 prostate cancer vaccine ONY-P1 prostate cancer vaccine ONY-P1 · Kael-GemVax Co., Ltd. https://druglandscape.com/drug/prot-001 https://druglandscape.com/api/og?type=drug&title=PROT-001&subtitle=PROT-001%20%C2%B7%20Protego%20Biopharma%20Pty%20Ltd&badge=phase%201 PROT-001 PROT-001 · Protego Biopharma Pty Ltd https://druglandscape.com/drug/prot-cl-np101-015-01 https://druglandscape.com/api/og?type=drug&title=PROT-CL-NP101-015.01&subtitle=PROT-CL-NP101-015.01%20%C2%B7%20NuPathe%20Inc.&badge=phase%201 PROT-CL-NP101-015.01 PROT-CL-NP101-015.01 · NuPathe Inc. https://druglandscape.com/drug/protein-phosphatase-2a-inhibitor-lb-100 https://druglandscape.com/api/og?type=drug&title=Protein%20Phosphatase%202A%20Inhibitor%20LB-100&subtitle=Protein%20Phosphatase%202A%20Inhibitor%20LB-100%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%201 Protein Phosphatase 2A Inhibitor LB-100 Protein Phosphatase 2A Inhibitor LB-100 · City of Hope Medical Center https://druglandscape.com/drug/protheracytes https://druglandscape.com/api/og?type=drug&title=PROTHERACYTES&subtitle=PROTHERACYTES%20%C2%B7%20CellProthera&badge=phase%202 PROTHERACYTES PROTHERACYTES · CellProthera https://druglandscape.com/drug/prothrombin-complex-concentrates https://druglandscape.com/api/og?type=drug&title=Prothrombin%20Complex%20Concentrates&subtitle=Prothrombin%20Complex%20Concentrates%20%C2%B7%20Angel%20Augusto%20Perez%20Calatayud&badge=phase%201 Prothrombin Complex Concentrates Prothrombin Complex Concentrates · Angel Augusto Perez Calatayud https://druglandscape.com/drug/prototype-bms-986165 https://druglandscape.com/api/og?type=drug&title=Prototype%20BMS-986165&subtitle=Prototype%20BMS-986165%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Prototype BMS-986165 Prototype BMS-986165 · Bristol-Myers Squibb https://druglandscape.com/drug/protracted-oral-etoposide https://druglandscape.com/api/og?type=drug&title=Protracted%20Oral%20Etoposide&subtitle=Protracted%20Oral%20Etoposide%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%202 Protracted Oral Etoposide Protracted Oral Etoposide · Baylor College of Medicine https://druglandscape.com/drug/protrans https://druglandscape.com/api/og?type=drug&title=ProTrans&subtitle=ProTrans%20%C2%B7%20NextCell%20Pharma%20Ab&badge=phase%201 ProTrans ProTrans · NextCell Pharma Ab https://druglandscape.com/drug/protrans-allogeneic-transplantation-with-wjmscs https://druglandscape.com/api/og?type=drug&title=ProTrans%3A%20Allogeneic%20transplantation%20with%20WJMSCs&subtitle=ProTrans%3A%20Allogeneic%20transplantation%20with%20WJMSCs%20%C2%B7%20NextCell%20Pharma%20Ab&badge=phase%201 ProTrans: Allogeneic transplantation with WJMSCs ProTrans: Allogeneic transplantation with WJMSCs · NextCell Pharma Ab https://druglandscape.com/drug/proventil-mdi https://druglandscape.com/api/og?type=drug&title=Proventil%C2%AE%20MDI&subtitle=Proventil%C2%AE%20MDI%20%C2%B7%20Amphastar%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Proventil® MDI Proventil® MDI · Amphastar Pharmaceuticals, Inc. https://druglandscape.com/drug/provodine-topical-cream https://druglandscape.com/api/og?type=drug&title=Provodine%20Topical%20Cream&subtitle=Provodine%20Topical%20Cream%20%C2%B7%20Henry%20Ford%20Health%20System&badge=phase%201 Provodine Topical Cream Provodine Topical Cream · Henry Ford Health System https://druglandscape.com/drug/prozac-weekly https://druglandscape.com/api/og?type=drug&title=PROZAC%20WEEKLY%C2%AE&subtitle=PROZAC%20WEEKLY%C2%AE%20%C2%B7%20Teva%20Pharmaceuticals%20USA&badge=phase%201 PROZAC WEEKLY® PROZAC WEEKLY® · Teva Pharmaceuticals USA https://druglandscape.com/drug/prp-and-ppp https://druglandscape.com/api/og?type=drug&title=PRP%20and%20PPP&subtitle=PRP%20and%20PPP%20%C2%B7%20Gary%20M.%20Kiebzak%2C%20Ph.D.&badge=phase%201 PRP and PPP PRP and PPP · Gary M. Kiebzak, Ph.D. https://druglandscape.com/drug/prp-concentrate-arm-1 https://druglandscape.com/api/og?type=drug&title=PRP%20Concentrate%20Arm%201&subtitle=PRP%20Concentrate%20Arm%201%20%C2%B7%20Healeon%20Medical%20Inc&badge=phase%201 PRP Concentrate Arm 1 PRP Concentrate Arm 1 · Healeon Medical Inc https://druglandscape.com/drug/prp-plasma-rich-platelets https://druglandscape.com/api/og?type=drug&title=PRP%20plasma%20rich%20platelets&subtitle=PRP%20plasma%20rich%20platelets%20%C2%B7%20Anita%20Syla%20Lokaj&badge=phase%201 PRP plasma rich platelets PRP plasma rich platelets · Anita Syla Lokaj https://druglandscape.com/drug/prp-prolotherapy https://druglandscape.com/api/og?type=drug&title=PRP%20prolotherapy&subtitle=PRP%20prolotherapy%20%C2%B7%20Abdelrahman%20Soliman%20Alateyh&badge=phase%201 PRP prolotherapy PRP prolotherapy · Abdelrahman Soliman Alateyh https://druglandscape.com/drug/prrt-every-5-weeks https://druglandscape.com/api/og?type=drug&title=PRRT%20every%205%20weeks&subtitle=PRRT%20every%205%20weeks%20%C2%B7%20Istituto%20Romagnolo%20per%20lo%20Studio%20dei%20Tumori%20Dino%20Amadori%20IRST%20S.r.l.%20IRCCS&badge=phase%202 PRRT every 5 weeks PRRT every 5 weeks · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS https://druglandscape.com/drug/prrt-every-8-10-weeks https://druglandscape.com/api/og?type=drug&title=PRRT%20every%208-10%20weeks&subtitle=PRRT%20every%208-10%20weeks%20%C2%B7%20Istituto%20Romagnolo%20per%20lo%20Studio%20dei%20Tumori%20Dino%20Amadori%20IRST%20S.r.l.%20IRCCS&badge=phase%202 PRRT every 8-10 weeks PRRT every 8-10 weeks · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS https://druglandscape.com/drug/prs-060 https://druglandscape.com/api/og?type=drug&title=PRS-060&subtitle=PRS-060%20%C2%B7%20Pieris%20Australia%20Pty%20Ltd&badge=phase%201 PRS-060 PRS-060 · Pieris Australia Pty Ltd https://druglandscape.com/drug/prs-080-022-dp https://druglandscape.com/api/og?type=drug&title=PRS-080%23022-DP&subtitle=PRS-080%23022-DP%20%C2%B7%20Pieris%20Pharmaceuticals%20GmbH&badge=phase%201 PRS-080#022-DP PRS-080#022-DP · Pieris Pharmaceuticals GmbH https://druglandscape.com/drug/prs-343 https://druglandscape.com/api/og?type=drug&title=PRS-343&subtitle=PRS-343%20%C2%B7%20Pieris%20Pharmaceuticals%2C%20Inc.&badge=phase%201 PRS-343 PRS-343 · Pieris Pharmaceuticals, Inc. https://druglandscape.com/drug/prs-343-in-combination-with-atezolizumab https://druglandscape.com/api/og?type=drug&title=PRS-343%20in%20Combination%20with%20Atezolizumab&subtitle=PRS-343%20in%20Combination%20with%20Atezolizumab%20%C2%B7%20Pieris%20Pharmaceuticals%2C%20Inc.&badge=phase%201 PRS-343 in Combination with Atezolizumab PRS-343 in Combination with Atezolizumab · Pieris Pharmaceuticals, Inc. https://druglandscape.com/drug/prs-ck-storm https://druglandscape.com/api/og?type=drug&title=PRS%20CK%20STORM&subtitle=PRS%20CK%20STORM%20%C2%B7%20PEACHES%20BIOTECH&badge=phase%201 PRS CK STORM PRS CK STORM · PEACHES BIOTECH https://druglandscape.com/drug/prt-064040-nasal-spray https://druglandscape.com/api/og?type=drug&title=PRT-064040%20nasal%20spray&subtitle=PRT-064040%20nasal%20spray%20%C2%B7%20Sichuan%20Purity%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%202 PRT-064040 nasal spray PRT-064040 nasal spray · Sichuan Purity Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/prt-2761-0 https://druglandscape.com/api/og?type=drug&title=PRT-2761%200%25&subtitle=PRT-2761%200%25%20%C2%B7%20ORA%2C%20Inc.&badge=phase%202 PRT-2761 0% PRT-2761 0% · ORA, Inc. https://druglandscape.com/drug/prt-2761-0-5 https://druglandscape.com/api/og?type=drug&title=PRT-2761%200.5%25&subtitle=PRT-2761%200.5%25%20%C2%B7%20ORA%2C%20Inc.&badge=phase%202 PRT-2761 0.5% PRT-2761 0.5% · ORA, Inc. https://druglandscape.com/drug/prt-2761-1 https://druglandscape.com/api/og?type=drug&title=PRT-2761%201%25&subtitle=PRT-2761%201%25%20%C2%B7%20ORA%2C%20Inc.&badge=phase%202 PRT-2761 1% PRT-2761 1% · ORA, Inc. https://druglandscape.com/drug/pru-pla-pla-pru https://druglandscape.com/api/og?type=drug&title=PRU-PLA-PLA-PRU&subtitle=PRU-PLA-PLA-PRU%20%C2%B7%20Movetis&badge=phase%202 PRU-PLA-PLA-PRU PRU-PLA-PLA-PRU · Movetis https://druglandscape.com/drug/pru-pla-pru-pla https://druglandscape.com/api/og?type=drug&title=PRU-PLA-PRU-PLA&subtitle=PRU-PLA-PRU-PLA%20%C2%B7%20Movetis&badge=phase%202 PRU-PLA-PRU-PLA PRU-PLA-PRU-PLA · Movetis https://druglandscape.com/drug/prv-015 https://druglandscape.com/api/og?type=drug&title=PRV-015&subtitle=PRV-015%20%C2%B7%20Provention%20Bio%2C%20a%20Sanofi%20Company&badge=phase%202 PRV-015 PRV-015 · Provention Bio, a Sanofi Company https://druglandscape.com/drug/prv-101 https://druglandscape.com/api/og?type=drug&title=PRV-101&subtitle=PRV-101%20%C2%B7%20Provention%20Bio%2C%20Inc.&badge=phase%201 PRV-101 PRV-101 · Provention Bio, Inc. https://druglandscape.com/drug/prv-300 https://druglandscape.com/api/og?type=drug&title=PRV-300&subtitle=PRV-300%20%C2%B7%20Provention%20Bio%2C%20Inc.&badge=phase%201 PRV-300 PRV-300 · Provention Bio, Inc. https://druglandscape.com/drug/prv-6527 https://druglandscape.com/api/og?type=drug&title=PRV-6527&subtitle=PRV-6527%20%C2%B7%20Provention%20Bio%2C%20Inc.&badge=phase%202 PRV-6527 PRV-6527 · Provention Bio, Inc. https://druglandscape.com/drug/prx-100 https://druglandscape.com/api/og?type=drug&title=PRX-100&subtitle=PRX-100%20%C2%B7%20LENZ%20Therapeutics%2C%20Inc&badge=phase%202 PRX-100 PRX-100 · LENZ Therapeutics, Inc https://druglandscape.com/drug/prx-105 https://druglandscape.com/api/og?type=drug&title=PRX-105&subtitle=PRX-105%20%C2%B7%20Protalix&badge=phase%201 PRX-105 PRX-105 · Protalix https://druglandscape.com/drug/prx-112 https://druglandscape.com/api/og?type=drug&title=PRX-112&subtitle=PRX-112%20%C2%B7%20Protalix&badge=phase%202 PRX-112 PRX-112 · Protalix https://druglandscape.com/drug/prx-115 https://druglandscape.com/api/og?type=drug&title=PRX-115&subtitle=PRX-115%20%C2%B7%20Protalix&badge=phase%202 PRX-115 PRX-115 · Protalix https://druglandscape.com/drug/prx002 https://druglandscape.com/api/og?type=drug&title=PRX002&subtitle=PRX002%20%C2%B7%20Prothena%20Biosciences%20Limited&badge=phase%201 PRX002 PRX002 · Prothena Biosciences Limited https://druglandscape.com/drug/prx003 https://druglandscape.com/api/og?type=drug&title=PRX003&subtitle=PRX003%20%C2%B7%20Prothena%20Biosciences%20Limited&badge=phase%201 PRX003 PRX003 · Prothena Biosciences Limited https://druglandscape.com/drug/prx019 https://druglandscape.com/api/og?type=drug&title=PRX019&subtitle=PRX019%20%C2%B7%20Prothena%20Biosciences%20Ltd.&badge=phase%201 PRX019 PRX019 · Prothena Biosciences Ltd. https://druglandscape.com/drug/psa-activated-psa-pah1 https://druglandscape.com/api/og?type=drug&title=PSA-Activated%20PSA-PAH1&subtitle=PSA-Activated%20PSA-PAH1%20%C2%B7%20Sophiris%20Bio%20Corp&badge=phase%201 PSA-Activated PSA-PAH1 PSA-Activated PSA-PAH1 · Sophiris Bio Corp https://druglandscape.com/drug/psb202 https://druglandscape.com/api/og?type=drug&title=PSB202&subtitle=PSB202%20%C2%B7%20Qilu%20Puget%20Sound%20Biotherapeutics%20(dba%20Sound%20Biologics)&badge=phase%201 PSB202 PSB202 · Qilu Puget Sound Biotherapeutics (dba Sound Biologics) https://druglandscape.com/drug/psb205 https://druglandscape.com/api/og?type=drug&title=PSB205&subtitle=PSB205%20%C2%B7%20Qilu%20Puget%20Sound%20Biotherapeutics%20(dba%20Sound%20Biologics)&badge=phase%201 PSB205 PSB205 · Qilu Puget Sound Biotherapeutics (dba Sound Biologics) https://druglandscape.com/drug/psc-01 https://druglandscape.com/api/og?type=drug&title=PSC-01&subtitle=PSC-01%20%C2%B7%20Personalized%20Stem%20Cells%2C%20Inc.&badge=phase%201 PSC-01 PSC-01 · Personalized Stem Cells, Inc. https://druglandscape.com/drug/psc-04 https://druglandscape.com/api/og?type=drug&title=PSC-04&subtitle=PSC-04%20%C2%B7%20Sorrento%20Therapeutics%2C%20Inc.&badge=phase%201 PSC-04 PSC-04 · Sorrento Therapeutics, Inc. https://druglandscape.com/drug/psd502 https://druglandscape.com/api/og?type=drug&title=PSD502&subtitle=PSD502%20%C2%B7%20Plethora%20Solutions%20Ltd&badge=phase%202 PSD502 PSD502 · Plethora Solutions Ltd https://druglandscape.com/drug/pseudoephedrine-pill https://druglandscape.com/api/og?type=drug&title=Pseudoephedrine%20Pill&subtitle=Pseudoephedrine%20Pill%20%C2%B7%20John%20Muir%20Health&badge=phase%201 Pseudoephedrine Pill Pseudoephedrine Pill · John Muir Health https://druglandscape.com/drug/psilocybin-and-d-serine https://druglandscape.com/api/og?type=drug&title=Psilocybin%20and%20D-Serine&subtitle=Psilocybin%20and%20D-Serine%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 Psilocybin and D-Serine Psilocybin and D-Serine · Hadassah Medical Organization https://druglandscape.com/drug/psilocybin-therapy-with-zolpidem https://druglandscape.com/api/og?type=drug&title=Psilocybin%20therapy%20with%20Zolpidem&subtitle=Psilocybin%20therapy%20with%20Zolpidem%20%C2%B7%20Joshua%20Woolley%2C%20MD%2C%20PhD&badge=phase%201 Psilocybin therapy with Zolpidem Psilocybin therapy with Zolpidem · Joshua Woolley, MD, PhD https://druglandscape.com/drug/psma-adc https://druglandscape.com/api/og?type=drug&title=PSMA%20ADC&subtitle=PSMA%20ADC%20%C2%B7%20Progenics%20Pharmaceuticals%2C%20Inc.&badge=phase%202 PSMA ADC PSMA ADC · Progenics Pharmaceuticals, Inc. https://druglandscape.com/drug/psma-radionuclide-therapy https://druglandscape.com/api/og?type=drug&title=PSMA%20radionuclide%20therapy&subtitle=PSMA%20radionuclide%20therapy%20%C2%B7%20Methodist%20Health%20System&badge=phase%202 PSMA radionuclide therapy PSMA radionuclide therapy · Methodist Health System https://druglandscape.com/drug/psn821 https://druglandscape.com/api/og?type=drug&title=PSN821&subtitle=PSN821%20%C2%B7%20Prosidion%20Ltd.&badge=phase%202 PSN821 PSN821 · Prosidion Ltd. https://druglandscape.com/drug/psp-neuro-serum https://druglandscape.com/api/og?type=drug&title=PSP%20NEURO%20SERUM&subtitle=PSP%20NEURO%20SERUM%20%C2%B7%20Algenis%20SpA&badge=phase%201 PSP NEURO SERUM PSP NEURO SERUM · Algenis SpA https://druglandscape.com/drug/pst-611 https://druglandscape.com/api/og?type=drug&title=PST-611&subtitle=PST-611%20%C2%B7%20Eyevensys&badge=phase%201 PST-611 PST-611 · Eyevensys https://druglandscape.com/drug/psychiatric-drugs https://druglandscape.com/api/og?type=drug&title=Psychiatric%20Drugs&subtitle=Psychiatric%20Drugs%20%C2%B7%20Mark%20Weiser%2C%20MD%2C%20Principal%20Investigator&badge=phase%202 Psychiatric Drugs Psychiatric Drugs · Mark Weiser, MD, Principal Investigator https://druglandscape.com/drug/psychiatric-treatment-with-escitalopram https://druglandscape.com/api/og?type=drug&title=Psychiatric%20treatment%20with%20escitalopram&subtitle=Psychiatric%20treatment%20with%20escitalopram%20%C2%B7%20Klini%C4%8Dki%20Bolni%C4%8Dki%20Centar%20Zagreb&badge=phase%201 Psychiatric treatment with escitalopram Psychiatric treatment with escitalopram · Klinički Bolnički Centar Zagreb https://druglandscape.com/drug/psychiatric-treatment-with-sertraline https://druglandscape.com/api/og?type=drug&title=Psychiatric%20treatment%20with%20sertraline&subtitle=Psychiatric%20treatment%20with%20sertraline%20%C2%B7%20Klini%C4%8Dki%20Bolni%C4%8Dki%20Centar%20Zagreb&badge=phase%201 Psychiatric treatment with sertraline Psychiatric treatment with sertraline · Klinički Bolnički Centar Zagreb https://druglandscape.com/drug/pt-112 https://druglandscape.com/api/og?type=drug&title=PT-112&subtitle=PT-112%20%C2%B7%20Promontory%20Therapeutics%20Inc.&badge=phase%202 PT-112 PT-112 · Promontory Therapeutics Inc. https://druglandscape.com/drug/pt001-mdi https://druglandscape.com/api/og?type=drug&title=PT001%20MDI&subtitle=PT001%20MDI%20%C2%B7%20Pearl%20Therapeutics%2C%20Inc.&badge=phase%202 PT001 MDI PT001 MDI · Pearl Therapeutics, Inc. https://druglandscape.com/drug/pt003 https://druglandscape.com/api/og?type=drug&title=PT003&subtitle=PT003%20%C2%B7%20Pearl%20Therapeutics%2C%20Inc.&badge=phase%202 PT003 PT003 · Pearl Therapeutics, Inc. https://druglandscape.com/drug/pt003-mdi https://druglandscape.com/api/og?type=drug&title=PT003%20MDI&subtitle=PT003%20MDI%20%C2%B7%20Pearl%20Therapeutics%2C%20Inc.&badge=phase%202 PT003 MDI PT003 MDI · Pearl Therapeutics, Inc. https://druglandscape.com/drug/pt005 https://druglandscape.com/api/og?type=drug&title=PT005&subtitle=PT005%20%C2%B7%20Pearl%20Therapeutics%2C%20Inc.&badge=phase%202 PT005 PT005 · Pearl Therapeutics, Inc. https://druglandscape.com/drug/pt005-mdi https://druglandscape.com/api/og?type=drug&title=PT005%20MDI&subtitle=PT005%20MDI%20%C2%B7%20Pearl%20Therapeutics%2C%20Inc.&badge=phase%202 PT005 MDI PT005 MDI · Pearl Therapeutics, Inc. https://druglandscape.com/drug/pt009 https://druglandscape.com/api/og?type=drug&title=PT009&subtitle=PT009%20%C2%B7%20Pearl%20Therapeutics%2C%20Inc.&badge=phase%201 PT009 PT009 · Pearl Therapeutics, Inc. https://druglandscape.com/drug/pt010 https://druglandscape.com/api/og?type=drug&title=PT010&subtitle=PT010%20%C2%B7%20Pearl%20Therapeutics%2C%20Inc.&badge=phase%201 PT010 PT010 · Pearl Therapeutics, Inc. https://druglandscape.com/drug/pt0253 https://druglandscape.com/api/og?type=drug&title=PT0253&subtitle=PT0253%20%C2%B7%20PAQ%20Therapeutics%2C%20Inc.&badge=phase%201 PT0253 PT0253 · PAQ Therapeutics, Inc. https://druglandscape.com/drug/pt0511 https://druglandscape.com/api/og?type=drug&title=PT0511&subtitle=PT0511%20%C2%B7%20PAQ%20Therapeutics%2C%20Inc.&badge=phase%201 PT0511 PT0511 · PAQ Therapeutics, Inc. https://druglandscape.com/drug/pt2385 https://druglandscape.com/api/og?type=drug&title=PT2385&subtitle=PT2385%20%C2%B7%20Peloton%20Therapeutics%2C%20Inc.%2C%20a%20subsidiary%20of%20Merck%20%26%20Co.%2C%20Inc.%20(Rahway%2C%20New%20Jersey%20USA)&badge=phase%201 PT2385 PT2385 · Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) https://druglandscape.com/drug/ptc-589 https://druglandscape.com/api/og?type=drug&title=PTC-589&subtitle=PTC-589%20%C2%B7%20Edison%20Pharmaceuticals%20Inc&badge=phase%202 PTC-589 PTC-589 · Edison Pharmaceuticals Inc https://druglandscape.com/drug/ptc124 https://druglandscape.com/api/og?type=drug&title=PTC124&subtitle=PTC124%20%C2%B7%20PTC%20Therapeutics&badge=phase%202 PTC124 PTC124 · PTC Therapeutics https://druglandscape.com/drug/ptc596 https://druglandscape.com/api/og?type=drug&title=PTC596&subtitle=PTC596%20%C2%B7%20PTC%20Therapeutics&badge=phase%201 PTC596 PTC596 · PTC Therapeutics https://druglandscape.com/drug/ptg-300 https://druglandscape.com/api/og?type=drug&title=PTG-300&subtitle=PTG-300%20%C2%B7%20Protagonist%20Therapeutics%2C%20Inc.&badge=phase%202 PTG-300 PTG-300 · Protagonist Therapeutics, Inc. https://druglandscape.com/drug/pth-analog https://druglandscape.com/api/og?type=drug&title=PTH%20analog&subtitle=PTH%20analog%20%C2%B7%20Unigene%20Laboratories%20Inc.&badge=phase%202 PTH analog PTH analog · Unigene Laboratories Inc. https://druglandscape.com/drug/pth134 https://druglandscape.com/api/og?type=drug&title=PTH134&subtitle=PTH134%20%C2%B7%20Novartis&badge=phase%201 PTH134 PTH134 · Novartis https://druglandscape.com/drug/pti-428 https://druglandscape.com/api/og?type=drug&title=PTI-428&subtitle=PTI-428%20%C2%B7%20Proteostasis%20Therapeutics%2C%20Inc.&badge=phase%202 PTI-428 PTI-428 · Proteostasis Therapeutics, Inc. https://druglandscape.com/drug/pti-808 https://druglandscape.com/api/og?type=drug&title=PTI-808&subtitle=PTI-808%20%C2%B7%20Proteostasis%20Therapeutics%2C%20Inc.&badge=phase%201 PTI-808 PTI-808 · Proteostasis Therapeutics, Inc. https://druglandscape.com/drug/ptl201 https://druglandscape.com/api/og?type=drug&title=PTL201&subtitle=PTL201%20%C2%B7%20PhytoTech%20Therapeutics%2C%20Ltd.&badge=phase%202 PTL201 PTL201 · PhytoTech Therapeutics, Ltd. https://druglandscape.com/drug/ptm-101 https://druglandscape.com/api/og?type=drug&title=PTM-101&subtitle=PTM-101%20%C2%B7%20PanTher%20Therapeutics&badge=phase%201 PTM-101 PTM-101 · PanTher Therapeutics https://druglandscape.com/drug/ptp-001 https://druglandscape.com/api/og?type=drug&title=PTP-001&subtitle=PTP-001%20%C2%B7%20Bioventus%20LLC&badge=phase%202 PTP-001 PTP-001 · Bioventus LLC https://druglandscape.com/drug/ptr-01 https://druglandscape.com/api/og?type=drug&title=PTR-01&subtitle=PTR-01%20%C2%B7%20Phoenix%20Tissue%20Repair%2C%20Inc.&badge=phase%202 PTR-01 PTR-01 · Phoenix Tissue Repair, Inc. https://druglandscape.com/drug/ptt-936 https://druglandscape.com/api/og?type=drug&title=PTT-936&subtitle=PTT-936%20%C2%B7%20Pyrotech%20Therapeutics%2C%20Inc.&badge=phase%201 PTT-936 PTT-936 · Pyrotech Therapeutics, Inc. https://druglandscape.com/drug/pttl https://druglandscape.com/api/og?type=drug&title=pTTL&subtitle=pTTL%20%C2%B7%20Neogap%20Therapeutics%20AB&badge=phase%201 pTTL pTTL · Neogap Therapeutics AB https://druglandscape.com/drug/ptx-100 https://druglandscape.com/api/og?type=drug&title=PTX-100&subtitle=PTX-100%20%C2%B7%20Prescient%20Therapeutics%2C%20Ltd.&badge=phase%202 PTX-100 PTX-100 · Prescient Therapeutics, Ltd. https://druglandscape.com/drug/ptx-200 https://druglandscape.com/api/og?type=drug&title=PTX-200&subtitle=PTX-200%20%C2%B7%20Prescient%20Therapeutics%2C%20Ltd.&badge=phase%201 PTX-200 PTX-200 · Prescient Therapeutics, Ltd. https://druglandscape.com/drug/ptx-912 https://druglandscape.com/api/og?type=drug&title=PTX-912&subtitle=PTX-912%20%C2%B7%20Proviva%20Therapeutics%2C%20Inc.&badge=phase%201 PTX-912 PTX-912 · Proviva Therapeutics, Inc. https://druglandscape.com/drug/pucotenlimab-combined-with-mrg002 https://druglandscape.com/api/og?type=drug&title=Pucotenlimab%20combined%20with%20MRG002&subtitle=Pucotenlimab%20combined%20with%20MRG002%20%C2%B7%20Zhiguo%20Luo%2C%20MD%2C%20PhD&badge=phase%202 Pucotenlimab combined with MRG002 Pucotenlimab combined with MRG002 · Zhiguo Luo, MD, PhD https://druglandscape.com/drug/pul-042 https://druglandscape.com/api/og?type=drug&title=PUL-042&subtitle=PUL-042%20%C2%B7%20Pulmotect%2C%20Inc.&badge=phase%202 PUL-042 PUL-042 · Pulmotect, Inc. https://druglandscape.com/drug/pul-042-inhalation-solution https://druglandscape.com/api/og?type=drug&title=PUL-042%20Inhalation%20Solution&subtitle=PUL-042%20Inhalation%20Solution%20%C2%B7%20Pulmotect%2C%20Inc.&badge=phase%202 PUL-042 Inhalation Solution PUL-042 Inhalation Solution · Pulmotect, Inc. https://druglandscape.com/drug/pulmicort-pmdi-hfa https://druglandscape.com/api/og?type=drug&title=Pulmicort%20pMDI%20HFA&subtitle=Pulmicort%20pMDI%20HFA%20%C2%B7%20AstraZeneca&badge=phase%201 Pulmicort pMDI HFA Pulmicort pMDI HFA · AstraZeneca https://druglandscape.com/drug/pulmicort-repulses https://druglandscape.com/api/og?type=drug&title=Pulmicort%20Repulses&subtitle=Pulmicort%20Repulses%20%C2%B7%20AstraZeneca&badge=phase%201 Pulmicort Repulses Pulmicort Repulses · AstraZeneca https://druglandscape.com/drug/pulmicort-turbohaler https://druglandscape.com/api/og?type=drug&title=Pulmicort%20Turbohaler&subtitle=Pulmicort%20Turbohaler%20%C2%B7%20AstraZeneca&badge=phase%201 Pulmicort Turbohaler Pulmicort Turbohaler · AstraZeneca https://druglandscape.com/drug/pulmonary-hypertension-specific-therapy https://druglandscape.com/api/og?type=drug&title=Pulmonary%20hypertension-specific%20therapy&subtitle=Pulmonary%20hypertension-specific%20therapy%20%C2%B7%20Irina%20E.%20Chazova&badge=phase%202 Pulmonary hypertension-specific therapy Pulmonary hypertension-specific therapy · Irina E. Chazova https://druglandscape.com/drug/pulmonary-surfactant https://druglandscape.com/api/og?type=drug&title=pulmonary%20surfactant&subtitle=pulmonary%20surfactant%20%C2%B7%20National%20Heart%2C%20Lung%2C%20and%20Blood%20Institute%20(NHLBI)&badge=phase%203 pulmonary surfactant pulmonary surfactant · National Heart, Lung, and Blood Institute (NHLBI) https://druglandscape.com/drug/pulse-bolus-corticosteroids https://druglandscape.com/api/og?type=drug&title=Pulse%20bolus%20corticosteroids&subtitle=Pulse%20bolus%20corticosteroids%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Pulse bolus corticosteroids Pulse bolus corticosteroids · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/pulse-bolus-corticosteroids-and-ivig https://druglandscape.com/api/og?type=drug&title=Pulse%20bolus%20corticosteroids%20and%20IVIG&subtitle=Pulse%20bolus%20corticosteroids%20and%20IVIG%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Pulse bolus corticosteroids and IVIG Pulse bolus corticosteroids and IVIG · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/pumarix https://druglandscape.com/api/og?type=drug&title=Pumarix%E2%84%A2&subtitle=Pumarix%E2%84%A2%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Pumarix™ Pumarix™ · GlaxoSmithKline https://druglandscape.com/drug/pumecitinib-nasal-spray-0-3 https://druglandscape.com/api/og?type=drug&title=Pumecitinib%20Nasal%20Spray%200.3%25&subtitle=Pumecitinib%20Nasal%20Spray%200.3%25%20%C2%B7%20Prime%20Gene%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%202 Pumecitinib Nasal Spray 0.3% Pumecitinib Nasal Spray 0.3% · Prime Gene Therapeutics Co., Ltd. https://druglandscape.com/drug/pumecitinib-nasal-spray-0-6 https://druglandscape.com/api/og?type=drug&title=Pumecitinib%20Nasal%20Spray%200.6%25&subtitle=Pumecitinib%20Nasal%20Spray%200.6%25%20%C2%B7%20Prime%20Gene%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%202 Pumecitinib Nasal Spray 0.6% Pumecitinib Nasal Spray 0.6% · Prime Gene Therapeutics Co., Ltd. https://druglandscape.com/drug/pur001 https://druglandscape.com/api/og?type=drug&title=PUR001&subtitle=PUR001%20%C2%B7%20Purinomia%20Biotech%2C%20Inc.&badge=phase%201 PUR001 PUR001 · Purinomia Biotech, Inc. https://druglandscape.com/drug/pur003 https://druglandscape.com/api/og?type=drug&title=PUR003&subtitle=PUR003%20%C2%B7%20Pulmatrix%20Inc.&badge=phase%201 PUR003 PUR003 · Pulmatrix Inc. https://druglandscape.com/drug/pur0200 https://druglandscape.com/api/og?type=drug&title=PUR0200&subtitle=PUR0200%20%C2%B7%20Pulmatrix%20Inc.&badge=phase%201 PUR0200 PUR0200 · Pulmatrix Inc. https://druglandscape.com/drug/pur118 https://druglandscape.com/api/og?type=drug&title=PUR118&subtitle=PUR118%20%C2%B7%20Pulmatrix%20Inc.&badge=phase%201 PUR118 PUR118 · Pulmatrix Inc. https://druglandscape.com/drug/pur3100 https://druglandscape.com/api/og?type=drug&title=PUR3100&subtitle=PUR3100%20%C2%B7%20Pulmatrix%20Inc.&badge=phase%201 PUR3100 PUR3100 · Pulmatrix Inc. https://druglandscape.com/drug/puran-t4 https://druglandscape.com/api/og?type=drug&title=Puran%20T4%C2%AE&subtitle=Puran%20T4%C2%AE%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt%2C%20German&badge=phase%201 Puran T4® Puran T4® · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/putative-phase-iii-formulation https://druglandscape.com/api/og?type=drug&title=Putative%20phase%20III%20formulation&subtitle=Putative%20phase%20III%20formulation%20%C2%B7%20AstraZeneca&badge=phase%201 Putative phase III formulation Putative phase III formulation · AstraZeneca https://druglandscape.com/drug/puumala-vaccine https://druglandscape.com/api/og?type=drug&title=Puumala%20Vaccine&subtitle=Puumala%20Vaccine%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 Puumala Vaccine Puumala Vaccine · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/pv-001 https://druglandscape.com/api/og?type=drug&title=PV-001&subtitle=PV-001%20%C2%B7%20POSVAX&badge=phase%201 PV-001 PV-001 · POSVAX https://druglandscape.com/drug/pv-001-dc https://druglandscape.com/api/og?type=drug&title=PV-001-DC&subtitle=PV-001-DC%20%C2%B7%20PrimeVax%20Immuno-Oncology%20Inc.&badge=phase%201 PV-001-DC PV-001-DC · PrimeVax Immuno-Oncology Inc. https://druglandscape.com/drug/pvs-10200 https://druglandscape.com/api/og?type=drug&title=PVS-10200&subtitle=PVS-10200%20%C2%B7%20Shire&badge=phase%201 PVS-10200 PVS-10200 · Shire https://druglandscape.com/drug/pvt-1 https://druglandscape.com/api/og?type=drug&title=PVT-1&subtitle=PVT-1%20%C2%B7%20PlusVitech%20S.L.&badge=phase%202 PVT-1 PVT-1 · PlusVitech S.L. https://druglandscape.com/drug/pvt401 https://druglandscape.com/api/og?type=drug&title=PVT401&subtitle=PVT401%20%C2%B7%20Parvus%20Therapeutics%2C%20Inc.&badge=phase%201 PVT401 PVT401 · Parvus Therapeutics, Inc. https://druglandscape.com/drug/pvx-108 https://druglandscape.com/api/og?type=drug&title=PVX-108&subtitle=PVX-108%20%C2%B7%20Aravax%20Pty%20Ltd&badge=phase%202 PVX-108 PVX-108 · Aravax Pty Ltd https://druglandscape.com/drug/pvx-410 https://druglandscape.com/api/og?type=drug&title=PVX-410&subtitle=PVX-410%20%C2%B7%20OncoPep%2C%20Inc.&badge=phase%202 PVX-410 PVX-410 · OncoPep, Inc. https://druglandscape.com/drug/pwcb https://druglandscape.com/api/og?type=drug&title=PwCb&subtitle=PwCb%20%C2%B7%20GBG%20Forschungs%20GmbH&badge=phase%202 PwCb PwCb · GBG Forschungs GmbH https://druglandscape.com/drug/pwt-143 https://druglandscape.com/api/og?type=drug&title=PWT-143&subtitle=PWT-143%20%C2%B7%20MEI%20Pharma%2C%20Inc.&badge=phase%201 PWT-143 PWT-143 · MEI Pharma, Inc. https://druglandscape.com/drug/pwt33597-mesylate https://druglandscape.com/api/og?type=drug&title=PWT33597%20mesylate&subtitle=PWT33597%20mesylate%20%C2%B7%20Pathway%20Therapeutics%2C%20Inc.&badge=phase%201 PWT33597 mesylate PWT33597 mesylate · Pathway Therapeutics, Inc. https://druglandscape.com/drug/px-104 https://druglandscape.com/api/og?type=drug&title=Px-104&subtitle=Px-104%20%C2%B7%20Phenex%20Pharmaceuticals%20AG&badge=phase%202 Px-104 Px-104 · Phenex Pharmaceuticals AG https://druglandscape.com/drug/pxl01 https://druglandscape.com/api/og?type=drug&title=PXL01&subtitle=PXL01%20%C2%B7%20PharmaSurgics%20AB&badge=phase%202 PXL01 PXL01 · PharmaSurgics AB https://druglandscape.com/drug/pxs-5382a https://druglandscape.com/api/og?type=drug&title=PXS-5382A&subtitle=PXS-5382A%20%C2%B7%20Syntara&badge=phase%201 PXS-5382A PXS-5382A · Syntara https://druglandscape.com/drug/pxt00864 https://druglandscape.com/api/og?type=drug&title=PXT00864&subtitle=PXT00864%20%C2%B7%20Pharnext%20S.C.A.&badge=phase%202 PXT00864 PXT00864 · Pharnext S.C.A. https://druglandscape.com/drug/pxt3003-high-dose https://druglandscape.com/api/og?type=drug&title=PXT3003%20High%20Dose&subtitle=PXT3003%20High%20Dose%20%C2%B7%20Pharnext%20S.C.A.&badge=phase%202 PXT3003 High Dose PXT3003 High Dose · Pharnext S.C.A. https://druglandscape.com/drug/pxt3003-low-dose https://druglandscape.com/api/og?type=drug&title=PXT3003%20Low%20dose&subtitle=PXT3003%20Low%20dose%20%C2%B7%20Pharnext%20S.C.A.&badge=phase%202 PXT3003 Low dose PXT3003 Low dose · Pharnext S.C.A. https://druglandscape.com/drug/pyc-001 https://druglandscape.com/api/og?type=drug&title=PYC-001&subtitle=PYC-001%20%C2%B7%20PYC%20Therapeutics&badge=phase%201 PYC-001 PYC-001 · PYC Therapeutics https://druglandscape.com/drug/pyc-003 https://druglandscape.com/api/og?type=drug&title=PYC-003&subtitle=PYC-003%20%C2%B7%20PYC%20Therapeutics&badge=phase%201 PYC-003 PYC-003 · PYC Therapeutics https://druglandscape.com/drug/pylorex-plus https://druglandscape.com/api/og?type=drug&title=Pylorex%20plus&subtitle=Pylorex%20plus%20%C2%B7%20Hafiz%20Muhammad%20Asif&badge=phase%202 Pylorex plus Pylorex plus · Hafiz Muhammad Asif https://druglandscape.com/drug/pym50028 https://druglandscape.com/api/og?type=drug&title=PYM50028&subtitle=PYM50028%20%C2%B7%20Phytopharm&badge=phase%202 PYM50028 PYM50028 · Phytopharm https://druglandscape.com/drug/pyridinylmethyl-14c-labeled-isavuconazonium-sulfate https://druglandscape.com/api/og?type=drug&title=Pyridinylmethyl-14C-labeled%20isavuconazonium%20sulfate&subtitle=Pyridinylmethyl-14C-labeled%20isavuconazonium%20sulfate%20%C2%B7%20Astellas%20Pharma%20Global%20Development%2C%20Inc.&badge=phase%201 Pyridinylmethyl-14C-labeled isavuconazonium sulfate Pyridinylmethyl-14C-labeled isavuconazonium sulfate · Astellas Pharma Global Development, Inc. https://druglandscape.com/drug/pyridostigmine-prednisone-tacrolimus https://druglandscape.com/api/og?type=drug&title=Pyridostigmine%2C%20Prednisone%2C%20Tacrolimus&subtitle=Pyridostigmine%2C%20Prednisone%2C%20Tacrolimus%20%C2%B7%20Da%2C%20Yuwei%2C%20M.D.&badge=phase%202 Pyridostigmine, Prednisone, Tacrolimus Pyridostigmine, Prednisone, Tacrolimus · Da, Yuwei, M.D. https://druglandscape.com/drug/pyridostigmine-tacrolimus https://druglandscape.com/api/og?type=drug&title=Pyridostigmine%2C%20Tacrolimus&subtitle=Pyridostigmine%2C%20Tacrolimus%20%C2%B7%20Da%2C%20Yuwei%2C%20M.D.&badge=phase%202 Pyridostigmine, Tacrolimus Pyridostigmine, Tacrolimus · Da, Yuwei, M.D. https://druglandscape.com/drug/pyroglutamate-rongliflozin-capsules https://druglandscape.com/api/og?type=drug&title=pyroglutamate%20rongliflozin%20capsules&subtitle=pyroglutamate%20rongliflozin%20capsules%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 pyroglutamate rongliflozin capsules pyroglutamate rongliflozin capsules · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/pyronaridine-artesunate-tablets https://druglandscape.com/api/og?type=drug&title=Pyronaridine-artesunate%20tablets&subtitle=Pyronaridine-artesunate%20tablets%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 Pyronaridine-artesunate tablets Pyronaridine-artesunate tablets · Medicines for Malaria Venture https://druglandscape.com/drug/pyrotinib-fluconazole https://druglandscape.com/api/og?type=drug&title=Pyrotinib%EF%BC%9BFluconazole&subtitle=Pyrotinib%EF%BC%9BFluconazole%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Pyrotinib；Fluconazole Pyrotinib；Fluconazole · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/pyrotinib-tablet https://druglandscape.com/api/og?type=drug&title=pyrotinib%20tablet&subtitle=pyrotinib%20tablet%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 pyrotinib tablet pyrotinib tablet · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/pyx-106 https://druglandscape.com/api/og?type=drug&title=PYX-106&subtitle=PYX-106%20%C2%B7%20Pyxis%20Oncology%2C%20Inc&badge=phase%201 PYX-106 PYX-106 · Pyxis Oncology, Inc https://druglandscape.com/drug/pyx-201 https://druglandscape.com/api/og?type=drug&title=PYX-201&subtitle=PYX-201%20%C2%B7%20Pyxis%20Oncology%2C%20Inc&badge=phase%201 PYX-201 PYX-201 · Pyxis Oncology, Inc https://druglandscape.com/drug/pz-601 https://druglandscape.com/api/og?type=drug&title=PZ-601&subtitle=PZ-601%20%C2%B7%20Protez%20Pharmaceuticals%2C%20Inc.&badge=phase%202 PZ-601 PZ-601 · Protez Pharmaceuticals, Inc. https://druglandscape.com/drug/pz01-car-t-cells https://druglandscape.com/api/og?type=drug&title=PZ01%20CAR-T%20cells&subtitle=PZ01%20CAR-T%20cells%20%C2%B7%20Pinze%20Lifetechnology%20Co.%20Ltd.&badge=phase%201 PZ01 CAR-T cells PZ01 CAR-T cells · Pinze Lifetechnology Co. Ltd. https://druglandscape.com/drug/q-1802 https://druglandscape.com/api/og?type=drug&title=Q-1802&subtitle=Q-1802%20%C2%B7%20QureBio%20Ltd.&badge=phase%201 Q-1802 Q-1802 · QureBio Ltd. https://druglandscape.com/drug/q203 https://druglandscape.com/api/og?type=drug&title=Q203&subtitle=Q203%20%C2%B7%20Qurient%20Co.%2C%20Ltd.&badge=phase%201 Q203 Q203 · Qurient Co., Ltd. https://druglandscape.com/drug/q901 https://druglandscape.com/api/og?type=drug&title=Q901&subtitle=Q901%20%C2%B7%20Qurient%20Co.%2C%20Ltd.&badge=phase%201 Q901 Q901 · Qurient Co., Ltd. https://druglandscape.com/drug/qa102 https://druglandscape.com/api/og?type=drug&title=QA102&subtitle=QA102%20%C2%B7%20Smilebiotek%20Zhuhai%20Limited&badge=phase%202 QA102 QA102 · Smilebiotek Zhuhai Limited https://druglandscape.com/drug/qat370 https://druglandscape.com/api/og?type=drug&title=QAT370&subtitle=QAT370%20%C2%B7%20Novartis&badge=phase%201 QAT370 QAT370 · Novartis https://druglandscape.com/drug/qax028 https://druglandscape.com/api/og?type=drug&title=QAX028&subtitle=QAX028%20%C2%B7%20Novartis&badge=phase%202 QAX028 QAX028 · Novartis https://druglandscape.com/drug/qbeco https://druglandscape.com/api/og?type=drug&title=QBECO&subtitle=QBECO%20%C2%B7%20Sunnybrook%20Health%20Sciences%20Centre&badge=phase%202 QBECO QBECO · Sunnybrook Health Sciences Centre https://druglandscape.com/drug/qbkpn-ssi https://druglandscape.com/api/og?type=drug&title=QBKPN%20SSI&subtitle=QBKPN%20SSI%20%C2%B7%20Qu%20Biologics%20Inc.&badge=phase%202 QBKPN SSI QBKPN SSI · Qu Biologics Inc. https://druglandscape.com/drug/qbs10072s https://druglandscape.com/api/og?type=drug&title=QBS10072S&subtitle=QBS10072S%20%C2%B7%20Patrick%20Wen%2C%20MD&badge=phase%202 QBS10072S QBS10072S · Patrick Wen, MD https://druglandscape.com/drug/qel-001 https://druglandscape.com/api/og?type=drug&title=QEL-001&subtitle=QEL-001%20%C2%B7%20Quell%20Therapeutics%20Limited&badge=phase%201 QEL-001 QEL-001 · Quell Therapeutics Limited https://druglandscape.com/drug/qel-005 https://druglandscape.com/api/og?type=drug&title=QEL-005&subtitle=QEL-005%20%C2%B7%20Quell%20Therapeutics%20Limited&badge=phase%201 QEL-005 QEL-005 · Quell Therapeutics Limited https://druglandscape.com/drug/qftb-g-and-t-spot-tb-tests https://druglandscape.com/api/og?type=drug&title=QFTB-G%20and%20T-SPOT.TB%20tests&subtitle=QFTB-G%20and%20T-SPOT.TB%20tests%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 QFTB-G and T-SPOT.TB tests QFTB-G and T-SPOT.TB tests · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/qg101-23-0-capsules https://druglandscape.com/api/og?type=drug&title=QG101-23-0%20capsules&subtitle=QG101-23-0%20capsules%20%C2%B7%20Amckaus%20PTY%20LTD.&badge=phase%201 QG101-23-0 capsules QG101-23-0 capsules · Amckaus PTY LTD. https://druglandscape.com/drug/qhrd107-capsule-venclexta-and-azacitidine https://druglandscape.com/api/og?type=drug&title=QHRD107%20capsule%EF%BC%8CVenclexta%20and%20Azacitidine&subtitle=QHRD107%20capsule%EF%BC%8CVenclexta%20and%20Azacitidine%20%C2%B7%20Changzhou%20Qianhong%20Bio-pharma%20Co.%2C%20Ltd.&badge=phase%202 QHRD107 capsule，Venclexta and Azacitidine QHRD107 capsule，Venclexta and Azacitidine · Changzhou Qianhong Bio-pharma Co., Ltd. https://druglandscape.com/drug/qinqiao-yanshu-granules https://druglandscape.com/api/og?type=drug&title=Qinqiao%20Yanshu%20Granules&subtitle=Qinqiao%20Yanshu%20Granules%20%C2%B7%20Jianmin%20Pharmaceutical%20Group%20Co.%2C%20LTD.&badge=phase%202 Qinqiao Yanshu Granules Qinqiao Yanshu Granules · Jianmin Pharmaceutical Group Co., LTD. https://druglandscape.com/drug/qishenyiqi-dripping-pills-12-bags https://druglandscape.com/api/og?type=drug&title=Qishenyiqi%20dripping%20pills%2C%2012%20bags&subtitle=Qishenyiqi%20dripping%20pills%2C%2012%20bags%20%C2%B7%20Tasly%20Pharmaceutical%20Group%20Co.%2C%20Ltd&badge=phase%201 Qishenyiqi dripping pills, 12 bags Qishenyiqi dripping pills, 12 bags · Tasly Pharmaceutical Group Co., Ltd https://druglandscape.com/drug/qishenyiqi-dripping-pills-6-bags https://druglandscape.com/api/og?type=drug&title=Qishenyiqi%20dripping%20pills%2C%206%20bags&subtitle=Qishenyiqi%20dripping%20pills%2C%206%20bags%20%C2%B7%20Tasly%20Pharmaceutical%20Group%20Co.%2C%20Ltd&badge=phase%201 Qishenyiqi dripping pills, 6 bags Qishenyiqi dripping pills, 6 bags · Tasly Pharmaceutical Group Co., Ltd https://druglandscape.com/drug/qishenyiqi-dripping-pills-9-bags https://druglandscape.com/api/og?type=drug&title=Qishenyiqi%20dripping%20pills%2C%209%20bags&subtitle=Qishenyiqi%20dripping%20pills%2C%209%20bags%20%C2%B7%20Tasly%20Pharmaceutical%20Group%20Co.%2C%20Ltd&badge=phase%201 Qishenyiqi dripping pills, 9 bags Qishenyiqi dripping pills, 9 bags · Tasly Pharmaceutical Group Co., Ltd https://druglandscape.com/drug/qiv-booster https://druglandscape.com/api/og?type=drug&title=QIV%20Booster&subtitle=QIV%20Booster%20%C2%B7%20Canadian%20Immunization%20Research%20Network&badge=phase%202 QIV Booster QIV Booster · Canadian Immunization Research Network https://druglandscape.com/drug/qiv-hd-by-im https://druglandscape.com/api/og?type=drug&title=QIV-HD%20by%20IM&subtitle=QIV-HD%20by%20IM%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 QIV-HD by IM QIV-HD by IM · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/qiv-hd-by-sc https://druglandscape.com/api/og?type=drug&title=QIV-HD%20by%20SC&subtitle=QIV-HD%20by%20SC%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 QIV-HD by SC QIV-HD by SC · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/qiv-primer https://druglandscape.com/api/og?type=drug&title=QIV%20Primer&subtitle=QIV%20Primer%20%C2%B7%20Canadian%20Immunization%20Research%20Network&badge=phase%202 QIV Primer QIV Primer · Canadian Immunization Research Network https://druglandscape.com/drug/ql0605 https://druglandscape.com/api/og?type=drug&title=QL0605&subtitle=QL0605%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QL0605 QL0605 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ql1012d https://druglandscape.com/api/og?type=drug&title=QL1012D&subtitle=QL1012D%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QL1012D QL1012D · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ql1205 https://druglandscape.com/api/og?type=drug&title=QL1205&subtitle=QL1205%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QL1205 QL1205 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ql1706-iv-infusion https://druglandscape.com/api/og?type=drug&title=QL1706%2C%20IV%20infusion&subtitle=QL1706%2C%20IV%20infusion%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QL1706, IV infusion QL1706, IV infusion · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ql1706-plus-lenvatinib https://druglandscape.com/api/og?type=drug&title=QL1706%20Plus%20Lenvatinib&subtitle=QL1706%20Plus%20Lenvatinib%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 QL1706 Plus Lenvatinib QL1706 Plus Lenvatinib · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ql1706h https://druglandscape.com/api/og?type=drug&title=QL1706H&subtitle=QL1706H%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QL1706H QL1706H · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ql2106 https://druglandscape.com/api/og?type=drug&title=QL2106&subtitle=QL2106%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QL2106 QL2106 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ql2109-or-daratumumab https://druglandscape.com/api/og?type=drug&title=QL2109%20or%20Daratumumab&subtitle=QL2109%20or%20Daratumumab%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 QL2109 or Daratumumab QL2109 or Daratumumab · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ql2302 https://druglandscape.com/api/og?type=drug&title=QL2302&subtitle=QL2302%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QL2302 QL2302 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ql2401 https://druglandscape.com/api/og?type=drug&title=QL2401&subtitle=QL2401%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QL2401 QL2401 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qlc1101 https://druglandscape.com/api/og?type=drug&title=QLC1101&subtitle=QLC1101%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLC1101 QLC1101 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qlc1401 https://druglandscape.com/api/og?type=drug&title=QLC1401&subtitle=QLC1401%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLC1401 QLC1401 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qlc5513-iv-infusion https://druglandscape.com/api/og?type=drug&title=QLC5513%20IV%20infusion&subtitle=QLC5513%20IV%20infusion%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLC5513 IV infusion QLC5513 IV infusion · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qlf3108 https://druglandscape.com/api/og?type=drug&title=QLF3108&subtitle=QLF3108%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLF3108 QLF3108 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qlf31907 https://druglandscape.com/api/og?type=drug&title=QLF31907&subtitle=QLF31907%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 QLF31907 QLF31907 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qlf32004 https://druglandscape.com/api/og?type=drug&title=QLF32004&subtitle=QLF32004%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLF32004 QLF32004 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qlf32101 https://druglandscape.com/api/og?type=drug&title=QLF32101&subtitle=QLF32101%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLF32101 QLF32101 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qlh11811 https://druglandscape.com/api/og?type=drug&title=QLH11811&subtitle=QLH11811%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLH11811 QLH11811 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qlh11906 https://druglandscape.com/api/og?type=drug&title=QLH11906&subtitle=QLH11906%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLH11906 QLH11906 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qlh12016 https://druglandscape.com/api/og?type=drug&title=QLH12016&subtitle=QLH12016%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLH12016 QLH12016 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qlh2405 https://druglandscape.com/api/og?type=drug&title=QLH2405&subtitle=QLH2405%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLH2405 QLH2405 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qlm2011 https://druglandscape.com/api/og?type=drug&title=QLM2011&subtitle=QLM2011%20%C2%B7%20Qilu%20Pharmaceutical%20(Hainan)%20Co.%2C%20Ltd.&badge=phase%201 QLM2011 QLM2011 · Qilu Pharmaceutical (Hainan) Co., Ltd. https://druglandscape.com/drug/qlp2117 https://druglandscape.com/api/og?type=drug&title=QLP2117&subtitle=QLP2117%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLP2117 QLP2117 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls-101 https://druglandscape.com/api/og?type=drug&title=QLS-101&subtitle=QLS-101%20%C2%B7%20Qlaris%20Bio%2C%20Inc.&badge=phase%202 QLS-101 QLS-101 · Qlaris Bio, Inc. https://druglandscape.com/drug/qls-101-ophthalmic-solution-2-0 https://druglandscape.com/api/og?type=drug&title=QLS-101%20ophthalmic%20solution%2C%202.0%20%25&subtitle=QLS-101%20ophthalmic%20solution%2C%202.0%20%25%20%C2%B7%20Qlaris%20Bio%2C%20Inc.&badge=phase%202 QLS-101 ophthalmic solution, 2.0 % QLS-101 ophthalmic solution, 2.0 % · Qlaris Bio, Inc. https://druglandscape.com/drug/qls-101ophthalmic-solution-1 https://druglandscape.com/api/og?type=drug&title=QLS-101ophthalmic%20solution%201%25&subtitle=QLS-101ophthalmic%20solution%201%25%20%C2%B7%20Qlaris%20Bio%2C%20Inc.&badge=phase%202 QLS-101ophthalmic solution 1% QLS-101ophthalmic solution 1% · Qlaris Bio, Inc. https://druglandscape.com/drug/qls-101ophthalmic-solution-2 https://druglandscape.com/api/og?type=drug&title=QLS-101ophthalmic%20solution%202%25&subtitle=QLS-101ophthalmic%20solution%202%25%20%C2%B7%20Qlaris%20Bio%2C%20Inc.&badge=phase%202 QLS-101ophthalmic solution 2% QLS-101ophthalmic solution 2% · Qlaris Bio, Inc. https://druglandscape.com/drug/qls-111-0-015 https://druglandscape.com/api/og?type=drug&title=QLS-111%2C%200.015%25&subtitle=QLS-111%2C%200.015%25%20%C2%B7%20Qlaris%20Bio%2C%20Inc.&badge=phase%202 QLS-111, 0.015% QLS-111, 0.015% · Qlaris Bio, Inc. https://druglandscape.com/drug/qls-111-0-030 https://druglandscape.com/api/og?type=drug&title=QLS-111%2C%200.030%25&subtitle=QLS-111%2C%200.030%25%20%C2%B7%20Qlaris%20Bio%2C%20Inc.&badge=phase%202 QLS-111, 0.030% QLS-111, 0.030% · Qlaris Bio, Inc. https://druglandscape.com/drug/qls-111-0-075 https://druglandscape.com/api/og?type=drug&title=QLS-111%2C%200.075%25&subtitle=QLS-111%2C%200.075%25%20%C2%B7%20Qlaris%20Bio%2C%20Inc.&badge=phase%202 QLS-111, 0.075% QLS-111, 0.075% · Qlaris Bio, Inc. https://druglandscape.com/drug/qls1103 https://druglandscape.com/api/og?type=drug&title=QLS1103&subtitle=QLS1103%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS1103 QLS1103 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls1128-a-dose-1-5-and-ritonavir https://druglandscape.com/api/og?type=drug&title=QLS1128%20A-Dose%201~5%20and%20Ritonavir&subtitle=QLS1128%20A-Dose%201~5%20and%20Ritonavir%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS1128 A-Dose 1~5 and Ritonavir QLS1128 A-Dose 1~5 and Ritonavir · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls1128-c-dose-1-3-and-ritonavir https://druglandscape.com/api/og?type=drug&title=QLS1128%20C-Dose%201~3%20and%20Ritonavir&subtitle=QLS1128%20C-Dose%201~3%20and%20Ritonavir%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS1128 C-Dose 1~3 and Ritonavir QLS1128 C-Dose 1~3 and Ritonavir · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls1128-d-dose-1-and-ritonavir https://druglandscape.com/api/og?type=drug&title=QLS1128%20D-Dose%201%20and%20Ritonavir&subtitle=QLS1128%20D-Dose%201%20and%20Ritonavir%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS1128 D-Dose 1 and Ritonavir QLS1128 D-Dose 1 and Ritonavir · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls12004 https://druglandscape.com/api/og?type=drug&title=QLS12004&subtitle=QLS12004%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS12004 QLS12004 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls12010 https://druglandscape.com/api/og?type=drug&title=QLS12010&subtitle=QLS12010%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 QLS12010 QLS12010 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls1209 https://druglandscape.com/api/og?type=drug&title=QLS1209&subtitle=QLS1209%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS1209 QLS1209 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls1410 https://druglandscape.com/api/og?type=drug&title=QLS1410&subtitle=QLS1410%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS1410 QLS1410 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls2309 https://druglandscape.com/api/og?type=drug&title=QLS2309&subtitle=QLS2309%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS2309 QLS2309 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls2313 https://druglandscape.com/api/og?type=drug&title=QLS2313&subtitle=QLS2313%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS2313 QLS2313 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls31901 https://druglandscape.com/api/og?type=drug&title=QLS31901&subtitle=QLS31901%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS31901 QLS31901 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls31903 https://druglandscape.com/api/og?type=drug&title=QLS31903&subtitle=QLS31903%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS31903 QLS31903 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls31904 https://druglandscape.com/api/og?type=drug&title=QLS31904&subtitle=QLS31904%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS31904 QLS31904 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls5132 https://druglandscape.com/api/og?type=drug&title=QLS5132&subtitle=QLS5132%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS5132 QLS5132 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls5132-bevacizumab https://druglandscape.com/api/og?type=drug&title=QLS5132%3B%20Bevacizumab&subtitle=QLS5132%3B%20Bevacizumab%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS5132; Bevacizumab QLS5132; Bevacizumab · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls5132-olaparib-bevacizumab https://druglandscape.com/api/og?type=drug&title=QLS5132%3B%20Olaparib%3B%20Bevacizumab&subtitle=QLS5132%3B%20Olaparib%3B%20Bevacizumab%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS5132; Olaparib; Bevacizumab QLS5132; Olaparib; Bevacizumab · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls5132-ql1706-ql2107 https://druglandscape.com/api/og?type=drug&title=QLS5132%3B%20QL1706%3B%20QL2107&subtitle=QLS5132%3B%20QL1706%3B%20QL2107%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS5132; QL1706; QL2107 QLS5132; QL1706; QL2107 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls5133 https://druglandscape.com/api/og?type=drug&title=QLS5133&subtitle=QLS5133%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS5133 QLS5133 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls5212 https://druglandscape.com/api/og?type=drug&title=QLS5212&subtitle=QLS5212%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS5212 QLS5212 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls5308-iv-infusion https://druglandscape.com/api/og?type=drug&title=QLS5308%20IV%20infusion&subtitle=QLS5308%20IV%20infusion%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS5308 IV infusion QLS5308 IV infusion · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qls5316 https://druglandscape.com/api/og?type=drug&title=QLS5316&subtitle=QLS5316%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 QLS5316 QLS5316 · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/qlt0074 https://druglandscape.com/api/og?type=drug&title=QLT0074&subtitle=QLT0074%20%C2%B7%20QLT%20Inc.&badge=phase%201 QLT0074 QLT0074 · QLT Inc. https://druglandscape.com/drug/qniv-vaccine-with-matrix-m-adjuvant https://druglandscape.com/api/og?type=drug&title=qNIV%20Vaccine%20with%20Matrix-M%20Adjuvant&subtitle=qNIV%20Vaccine%20with%20Matrix-M%20Adjuvant%20%C2%B7%20Novavax&badge=phase%202 qNIV Vaccine with Matrix-M Adjuvant qNIV Vaccine with Matrix-M Adjuvant · Novavax https://druglandscape.com/drug/qpx2014 https://druglandscape.com/api/og?type=drug&title=QPX2014&subtitle=QPX2014%20%C2%B7%20Qpex%20Biopharma%2C%20Inc.&badge=phase%201 QPX2014 QPX2014 · Qpex Biopharma, Inc. https://druglandscape.com/drug/qpx2015 https://druglandscape.com/api/og?type=drug&title=QPX2015&subtitle=QPX2015%20%C2%B7%20Qpex%20Biopharma%2C%20Inc.&badge=phase%201 QPX2015 QPX2015 · Qpex Biopharma, Inc. https://druglandscape.com/drug/qpx7728 https://druglandscape.com/api/og?type=drug&title=QPX7728&subtitle=QPX7728%20%C2%B7%20Qpex%20Biopharma%2C%20Inc.&badge=phase%201 QPX7728 QPX7728 · Qpex Biopharma, Inc. https://druglandscape.com/drug/qpx7831 https://druglandscape.com/api/og?type=drug&title=QPX7831&subtitle=QPX7831%20%C2%B7%20Qpex%20Biopharma%2C%20Inc.&badge=phase%201 QPX7831 QPX7831 · Qpex Biopharma, Inc. https://druglandscape.com/drug/qpx9003-for-iv-infusion https://druglandscape.com/api/og?type=drug&title=QPX9003%20for%20IV%20Infusion&subtitle=QPX9003%20for%20IV%20Infusion%20%C2%B7%20Qpex%20Biopharma%2C%20Inc.&badge=phase%201 QPX9003 for IV Infusion QPX9003 for IV Infusion · Qpex Biopharma, Inc. https://druglandscape.com/drug/qr-1123 https://druglandscape.com/api/og?type=drug&title=QR-1123&subtitle=QR-1123%20%C2%B7%20ProQR%20Therapeutics&badge=phase%201 QR-1123 QR-1123 · ProQR Therapeutics https://druglandscape.com/drug/qrl-101 https://druglandscape.com/api/og?type=drug&title=QRL-101&subtitle=QRL-101%20%C2%B7%20QurAlis%20Corporation&badge=phase%201 QRL-101 QRL-101 · QurAlis Corporation https://druglandscape.com/drug/qrl-101-dose-b https://druglandscape.com/api/og?type=drug&title=QRL-101%20Dose%20B&subtitle=QRL-101%20Dose%20B%20%C2%B7%20QurAlis%20Corporation&badge=phase%201 QRL-101 Dose B QRL-101 Dose B · QurAlis Corporation https://druglandscape.com/drug/qrl-201 https://druglandscape.com/api/og?type=drug&title=QRL-201&subtitle=QRL-201%20%C2%B7%20QurAlis%20Corporation&badge=phase%201 QRL-201 QRL-201 · QurAlis Corporation https://druglandscape.com/drug/qrx-3 https://druglandscape.com/api/og?type=drug&title=QRX-3&subtitle=QRX-3%20%C2%B7%20Ebima%20Clifford%20Okundaye&badge=phase%202 QRX-3 QRX-3 · Ebima Clifford Okundaye https://druglandscape.com/drug/quadrivalent-inactivated-influenza-high-dose https://druglandscape.com/api/og?type=drug&title=Quadrivalent%20Inactivated%20Influenza%20High%20Dose&subtitle=Quadrivalent%20Inactivated%20Influenza%20High%20Dose%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%202 Quadrivalent Inactivated Influenza High Dose Quadrivalent Inactivated Influenza High Dose · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/quadrivalent-influenza-high-dose-vaccine https://druglandscape.com/api/og?type=drug&title=Quadrivalent%20Influenza%20High-Dose%20Vaccine&subtitle=Quadrivalent%20Influenza%20High-Dose%20Vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Quadrivalent Influenza High-Dose Vaccine Quadrivalent Influenza High-Dose Vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/quadrivalent-influenza-mrna-vaccine-mrt5407 https://druglandscape.com/api/og?type=drug&title=Quadrivalent%20Influenza%20mRNA%20Vaccine%20MRT5407&subtitle=Quadrivalent%20Influenza%20mRNA%20Vaccine%20MRT5407%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Quadrivalent Influenza mRNA Vaccine MRT5407 Quadrivalent Influenza mRNA Vaccine MRT5407 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/quadrivalent-influenza-mrna-vaccine-mrt5410 https://druglandscape.com/api/og?type=drug&title=Quadrivalent%20Influenza%20mRNA%20Vaccine%20MRT5410&subtitle=Quadrivalent%20Influenza%20mRNA%20Vaccine%20MRT5410%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Quadrivalent Influenza mRNA Vaccine MRT5410 Quadrivalent Influenza mRNA Vaccine MRT5410 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/quadrivalent-influenza-mrna-vaccine-mrt5413 https://druglandscape.com/api/og?type=drug&title=Quadrivalent%20Influenza%20mRNA%20Vaccine%20MRT5413&subtitle=Quadrivalent%20Influenza%20mRNA%20Vaccine%20MRT5413%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Quadrivalent Influenza mRNA Vaccine MRT5413 Quadrivalent Influenza mRNA Vaccine MRT5413 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/quadrivalent-influenza-mrna-vaccine-mrt5421 https://druglandscape.com/api/og?type=drug&title=Quadrivalent%20Influenza%20mRNA%20Vaccine%20MRT5421&subtitle=Quadrivalent%20Influenza%20mRNA%20Vaccine%20MRT5421%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Quadrivalent Influenza mRNA Vaccine MRT5421 Quadrivalent Influenza mRNA Vaccine MRT5421 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/quadrivalent-influenza-mrna-vaccine-mrt5424 https://druglandscape.com/api/og?type=drug&title=Quadrivalent%20Influenza%20mRNA%20Vaccine%20MRT5424&subtitle=Quadrivalent%20Influenza%20mRNA%20Vaccine%20MRT5424%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Quadrivalent Influenza mRNA Vaccine MRT5424 Quadrivalent Influenza mRNA Vaccine MRT5424 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/quadrivalent-influenza-mrna-vaccine-mrt5429 https://druglandscape.com/api/og?type=drug&title=Quadrivalent%20Influenza%20mRNA%20Vaccine%20MRT5429&subtitle=Quadrivalent%20Influenza%20mRNA%20Vaccine%20MRT5429%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Quadrivalent Influenza mRNA Vaccine MRT5429 Quadrivalent Influenza mRNA Vaccine MRT5429 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/quadrivalent-influenza-split-vaccine https://druglandscape.com/api/og?type=drug&title=quadrivalent%20influenza%20split%20vaccine&subtitle=quadrivalent%20influenza%20split%20vaccine%20%C2%B7%20Jiangsu%20Province%20Centers%20for%20Disease%20Control%20and%20Prevention&badge=phase%201 quadrivalent influenza split vaccine quadrivalent influenza split vaccine · Jiangsu Province Centers for Disease Control and Prevention https://druglandscape.com/drug/quadrivalent-influenza-standard-dose-vaccine https://druglandscape.com/api/og?type=drug&title=Quadrivalent%20Influenza%20Standard%20Dose%20Vaccine&subtitle=Quadrivalent%20Influenza%20Standard%20Dose%20Vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Quadrivalent Influenza Standard Dose Vaccine Quadrivalent Influenza Standard Dose Vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/quadrivalent-riv-with-h3-strain-1 https://druglandscape.com/api/og?type=drug&title=Quadrivalent%20RIV%20with%20H3%20strain%201&subtitle=Quadrivalent%20RIV%20with%20H3%20strain%201%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Quadrivalent RIV with H3 strain 1 Quadrivalent RIV with H3 strain 1 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/quadrivalent-riv-with-h3-strain-2 https://druglandscape.com/api/og?type=drug&title=Quadrivalent%20RIV%20with%20H3%20strain%202&subtitle=Quadrivalent%20RIV%20with%20H3%20strain%202%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Quadrivalent RIV with H3 strain 2 Quadrivalent RIV with H3 strain 2 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/quadrivalent-riv-with-h3-strain-3 https://druglandscape.com/api/og?type=drug&title=Quadrivalent%20RIV%20with%20H3%20strain%203&subtitle=Quadrivalent%20RIV%20with%20H3%20strain%203%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Quadrivalent RIV with H3 strain 3 Quadrivalent RIV with H3 strain 3 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/quadrivalent-riv-with-h3-strain-4 https://druglandscape.com/api/og?type=drug&title=Quadrivalent%20RIV%20with%20H3%20strain%204&subtitle=Quadrivalent%20RIV%20with%20H3%20strain%204%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Quadrivalent RIV with H3 strain 4 Quadrivalent RIV with H3 strain 4 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/quadrivalent-subunit-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=quadrivalent%20subunit%20influenza%20vaccine&subtitle=quadrivalent%20subunit%20influenza%20vaccine%20%C2%B7%20Ab%26B%20Bio-tech%20Co.%2C%20Ltd.JS&badge=phase%202 quadrivalent subunit influenza vaccine quadrivalent subunit influenza vaccine · Ab&B Bio-tech Co., Ltd.JS https://druglandscape.com/drug/quadruple-allopathic-therapy https://druglandscape.com/api/og?type=drug&title=Quadruple%20Allopathic%20therapy&subtitle=Quadruple%20Allopathic%20therapy%20%C2%B7%20Hafiz%20Muhammad%20Asif&badge=phase%202 Quadruple Allopathic therapy Quadruple Allopathic therapy · Hafiz Muhammad Asif https://druglandscape.com/drug/quetiapine-and-vitamin-d-and-vitamin-e https://druglandscape.com/api/og?type=drug&title=Quetiapine%20and%20Vitamin%20D%20and%20Vitamin%20E&subtitle=Quetiapine%20and%20Vitamin%20D%20and%20Vitamin%20E%20%C2%B7%20Dr%20Rabia%20Arshad&badge=phase%201 Quetiapine and Vitamin D and Vitamin E Quetiapine and Vitamin D and Vitamin E · Dr Rabia Arshad https://druglandscape.com/drug/quetiapine-fumarate-tablets https://druglandscape.com/api/og?type=drug&title=quetiapine%20fumarate%20tablets&subtitle=quetiapine%20fumarate%20tablets%20%C2%B7%20AstraZeneca&badge=phase%203 quetiapine fumarate tablets quetiapine fumarate tablets · AstraZeneca https://druglandscape.com/drug/quetiapine-oral-formulation https://druglandscape.com/api/og?type=drug&title=Quetiapine%2C%20oral%20formulation&subtitle=Quetiapine%2C%20oral%20formulation%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Quetiapine, oral formulation Quetiapine, oral formulation · Janssen Research & Development, LLC https://druglandscape.com/drug/quinacrine-dihydrochloride-extension-dose https://druglandscape.com/api/og?type=drug&title=quinacrine%20dihydrochloride%20-%20Extension%20dose&subtitle=quinacrine%20dihydrochloride%20-%20Extension%20dose%20%C2%B7%20Neelesh%20Sharma%20MD%20PhD&badge=phase%201 quinacrine dihydrochloride - Extension dose quinacrine dihydrochloride - Extension dose · Neelesh Sharma MD PhD https://druglandscape.com/drug/qutenza-exposure https://druglandscape.com/api/og?type=drug&title=Qutenza%20exposure&subtitle=Qutenza%20exposure%20%C2%B7%20Astellas%20Pharma%20Europe%20Ltd.&badge=phase%202 Qutenza exposure Qutenza exposure · Astellas Pharma Europe Ltd. https://druglandscape.com/drug/r-2487 https://druglandscape.com/api/og?type=drug&title=R-2487&subtitle=R-2487%20%C2%B7%20Rise%20Therapeutics%20LLC&badge=phase%201 R-2487 R-2487 · Rise Therapeutics LLC https://druglandscape.com/drug/r-3750 https://druglandscape.com/api/og?type=drug&title=R-3750&subtitle=R-3750%20%C2%B7%20Rise%20Therapeutics%20LLC&badge=phase%201 R-3750 R-3750 · Rise Therapeutics LLC https://druglandscape.com/drug/r-5280 https://druglandscape.com/api/og?type=drug&title=R-5280&subtitle=R-5280%20%C2%B7%20Rise%20Therapeutics%20LLC&badge=phase%201 R-5280 R-5280 · Rise Therapeutics LLC https://druglandscape.com/drug/r-albuterol-s-albuterol https://druglandscape.com/api/og?type=drug&title=R-albuterol%2C%20S-albuterol&subtitle=R-albuterol%2C%20S-albuterol%20%C2%B7%20Hamilton%20Health%20Sciences%20Corporation&badge=phase%202 R-albuterol, S-albuterol R-albuterol, S-albuterol · Hamilton Health Sciences Corporation https://druglandscape.com/drug/r-chop14-induction-regimen https://druglandscape.com/api/og?type=drug&title=R-CHOP14%20induction%20regimen&subtitle=R-CHOP14%20induction%20regimen%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 R-CHOP14 induction regimen R-CHOP14 induction regimen · Hospices Civils de Lyon https://druglandscape.com/drug/r-dxd https://druglandscape.com/api/og?type=drug&title=R-DXd&subtitle=R-DXd%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 R-DXd R-DXd · Merck Sharp & Dohme LLC https://druglandscape.com/drug/r-epoch-and-cart https://druglandscape.com/api/og?type=drug&title=R-EPOCH%20and%20cART&subtitle=R-EPOCH%20and%20cART%20%C2%B7%20Ontario%20Clinical%20Oncology%20Group%20(OCOG)&badge=phase%202 R-EPOCH and cART R-EPOCH and cART · Ontario Clinical Oncology Group (OCOG) https://druglandscape.com/drug/r-hfsh-and-r-hlh https://druglandscape.com/api/og?type=drug&title=r-hFSH%20and%20r-hLH&subtitle=r-hFSH%20and%20r-hLH%20%C2%B7%20Reproductive%20Medicine%20Associates%20of%20New%20Jersey&badge=phase%201 r-hFSH and r-hLH r-hFSH and r-hLH · Reproductive Medicine Associates of New Jersey https://druglandscape.com/drug/r-licarbazepine https://druglandscape.com/api/og?type=drug&title=R-licarbazepine&subtitle=R-licarbazepine%20%C2%B7%20Bial%20-%20Portela%20C%20S.A.&badge=phase%201 R-licarbazepine R-licarbazepine · Bial - Portela C S.A. https://druglandscape.com/drug/r-megachop https://druglandscape.com/api/og?type=drug&title=R-MEGACHOP&subtitle=R-MEGACHOP%20%C2%B7%20Grupo%20Espa%C3%B1ol%20de%20Linfomas%20y%20Transplante%20Aut%C3%B3logo%20de%20M%C3%A9dula%20%C3%93sea&badge=phase%202 R-MEGACHOP R-MEGACHOP · Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea https://druglandscape.com/drug/r-methuleptin https://druglandscape.com/api/og?type=drug&title=r-metHuLeptin&subtitle=r-metHuLeptin%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%202 r-metHuLeptin r-metHuLeptin · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/r-oxybutynin https://druglandscape.com/api/og?type=drug&title=R-oxybutynin&subtitle=R-oxybutynin%20%C2%B7%20Apnimed&badge=phase%202 R-oxybutynin R-oxybutynin · Apnimed https://druglandscape.com/drug/r-star001 https://druglandscape.com/api/og?type=drug&title=R-Star001&subtitle=R-Star001%20%C2%B7%20changjianhua&badge=phase%201 R-Star001 R-Star001 · changjianhua https://druglandscape.com/drug/r-tm123 https://druglandscape.com/api/og?type=drug&title=R-TM123&subtitle=R-TM123%20%C2%B7%20AvenCell%20Europe%20GmbH&badge=phase%201 R-TM123 R-TM123 · AvenCell Europe GmbH https://druglandscape.com/drug/r092670 https://druglandscape.com/api/og?type=drug&title=R092670&subtitle=R092670%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%202 R092670 R092670 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/r115777 https://druglandscape.com/api/og?type=drug&title=R115777&subtitle=R115777%20%C2%B7%20SWOG%20Cancer%20Research%20Network&badge=phase%202 R115777 R115777 · SWOG Cancer Research Network https://druglandscape.com/drug/r209130 https://druglandscape.com/api/og?type=drug&title=R209130&subtitle=R209130%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%202 R209130 R209130 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/r228060 https://druglandscape.com/api/og?type=drug&title=R228060&subtitle=R228060%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%202 R228060 R228060 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/r256918 https://druglandscape.com/api/og?type=drug&title=R256918&subtitle=R256918%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%202 R256918 R256918 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/r2r01 https://druglandscape.com/api/og?type=drug&title=R2R01&subtitle=R2R01%20%C2%B7%20River%202%20Renal%20Corp.&badge=phase%202 R2R01 R2R01 · River 2 Renal Corp. https://druglandscape.com/drug/r306465 https://druglandscape.com/api/og?type=drug&title=R306465&subtitle=R306465%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 R306465 R306465 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/r713r https://druglandscape.com/api/og?type=drug&title=R713R&subtitle=R713R%20%C2%B7%20AJU%20Pharm%20Co.%2C%20Ltd.&badge=phase%201 R713R R713R · AJU Pharm Co., Ltd. https://druglandscape.com/drug/raav-hcnga3 https://druglandscape.com/api/og?type=drug&title=rAAV.hCNGA3&subtitle=rAAV.hCNGA3%20%C2%B7%20STZ%20eyetrial&badge=phase%201 rAAV.hCNGA3 rAAV.hCNGA3 · STZ eyetrial https://druglandscape.com/drug/raav-olig001-aspa https://druglandscape.com/api/og?type=drug&title=rAAV-Olig001-ASPA&subtitle=rAAV-Olig001-ASPA%20%C2%B7%20Myrtelle%20Inc.&badge=phase%201 rAAV-Olig001-ASPA rAAV-Olig001-ASPA · Myrtelle Inc. https://druglandscape.com/drug/raavrh74-mhck7-dysf-dv https://druglandscape.com/api/og?type=drug&title=rAAVrh74.MHCK7.DYSF.DV&subtitle=rAAVrh74.MHCK7.DYSF.DV%20%C2%B7%20Sarepta%20Therapeutics%2C%20Inc.&badge=phase%201 rAAVrh74.MHCK7.DYSF.DV rAAVrh74.MHCK7.DYSF.DV · Sarepta Therapeutics, Inc. https://druglandscape.com/drug/rab001-high-dose https://druglandscape.com/api/og?type=drug&title=RAB001%20high%20dose&subtitle=RAB001%20high%20dose%20%C2%B7%20ZhongShan%20LaiBo%20RuiChen%20BioMedicine%20Co.%2CLtd.&badge=phase%202 RAB001 high dose RAB001 high dose · ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. https://druglandscape.com/drug/rab001-medium-dose https://druglandscape.com/api/og?type=drug&title=RAB001%20medium%20dose&subtitle=RAB001%20medium%20dose%20%C2%B7%20ZhongShan%20LaiBo%20RuiChen%20BioMedicine%20Co.%2CLtd.&badge=phase%202 RAB001 medium dose RAB001 medium dose · ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. https://druglandscape.com/drug/rabeprazole-delayed-release-tablet https://druglandscape.com/api/og?type=drug&title=Rabeprazole%2C%20Delayed-release%20tablet&subtitle=Rabeprazole%2C%20Delayed-release%20tablet%20%C2%B7%20AstraZeneca&badge=phase%201 Rabeprazole, Delayed-release tablet Rabeprazole, Delayed-release tablet · AstraZeneca https://druglandscape.com/drug/rabeprazole-sodium-treatment-b https://druglandscape.com/api/og?type=drug&title=Rabeprazole%20sodium%3A%20Treatment%20B&subtitle=Rabeprazole%20sodium%3A%20Treatment%20B%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 Rabeprazole sodium: Treatment B Rabeprazole sodium: Treatment B · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/rabeprazole-sodium-treatment-c https://druglandscape.com/api/og?type=drug&title=Rabeprazole%20sodium%3A%20Treatment%20C&subtitle=Rabeprazole%20sodium%3A%20Treatment%20C%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 Rabeprazole sodium: Treatment C Rabeprazole sodium: Treatment C · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/rabeprazole-sodium-treatment-d https://druglandscape.com/api/og?type=drug&title=Rabeprazole%20sodium%3A%20Treatment%20D&subtitle=Rabeprazole%20sodium%3A%20Treatment%20D%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 Rabeprazole sodium: Treatment D Rabeprazole sodium: Treatment D · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/rabeprazole-sodium-treatment-e https://druglandscape.com/api/og?type=drug&title=Rabeprazole%20sodium%3A%20Treatment%20E&subtitle=Rabeprazole%20sodium%3A%20Treatment%20E%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 Rabeprazole sodium: Treatment E Rabeprazole sodium: Treatment E · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/rabies-mrna-vaccine-cv7202 https://druglandscape.com/api/og?type=drug&title=Rabies%20mRNA%20vaccine%20CV7202&subtitle=Rabies%20mRNA%20vaccine%20CV7202%20%C2%B7%20CureVac&badge=phase%201 Rabies mRNA vaccine CV7202 Rabies mRNA vaccine CV7202 · CureVac https://druglandscape.com/drug/rabies-virus-specific-monoclonal-antibodies https://druglandscape.com/api/og?type=drug&title=Rabies%20virus-specific%20monoclonal%20antibodies&subtitle=Rabies%20virus-specific%20monoclonal%20antibodies%20%C2%B7%20Crucell%20Holland%20BV&badge=phase%202 Rabies virus-specific monoclonal antibodies Rabies virus-specific monoclonal antibodies · Crucell Holland BV https://druglandscape.com/drug/rac-pzq-odt https://druglandscape.com/api/og?type=drug&title=Rac-PZQ%20ODT&subtitle=Rac-PZQ%20ODT%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 Rac-PZQ ODT Rac-PZQ ODT · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/racecadotril-suspension https://druglandscape.com/api/og?type=drug&title=Racecadotril%20suspension&subtitle=Racecadotril%20suspension%20%C2%B7%20Bioprojet&badge=phase%201 Racecadotril suspension Racecadotril suspension · Bioprojet https://druglandscape.com/drug/racemate-praziquantel-odt https://druglandscape.com/api/og?type=drug&title=Racemate%20Praziquantel%20ODT&subtitle=Racemate%20Praziquantel%20ODT%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%202 Racemate Praziquantel ODT Racemate Praziquantel ODT · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/racemic-formoterol https://druglandscape.com/api/og?type=drug&title=Racemic%20formoterol&subtitle=Racemic%20formoterol%20%C2%B7%20Sumitomo%20Pharma%20America%2C%20Inc.&badge=phase%202 Racemic formoterol Racemic formoterol · Sumitomo Pharma America, Inc. https://druglandscape.com/drug/rad-p53 https://druglandscape.com/api/og?type=drug&title=rAd-p53&subtitle=rAd-p53%20%C2%B7%20Shenzhen%20SiBiono%20GeneTech%20Co.%2CLtd&badge=phase%202 rAd-p53 rAd-p53 · Shenzhen SiBiono GeneTech Co.,Ltd https://druglandscape.com/drug/rad001-capecitabine-oxaliplatin https://druglandscape.com/api/og?type=drug&title=RAD001%2C%20Capecitabine%2C%20Oxaliplatin&subtitle=RAD001%2C%20Capecitabine%2C%20Oxaliplatin%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 RAD001, Capecitabine, Oxaliplatin RAD001, Capecitabine, Oxaliplatin · Asan Medical Center https://druglandscape.com/drug/rad140 https://druglandscape.com/api/og?type=drug&title=RAD140&subtitle=RAD140%20%C2%B7%20Stemline%20Therapeutics%2C%20Inc.&badge=phase%201 RAD140 RAD140 · Stemline Therapeutics, Inc. https://druglandscape.com/drug/rad5 https://druglandscape.com/api/og?type=drug&title=rAd5&subtitle=rAd5%20%C2%B7%20HIV%20Vaccine%20Trials%20Network&badge=phase%201 rAd5 rAd5 · HIV Vaccine Trials Network https://druglandscape.com/drug/radiation-131i-mibg https://druglandscape.com/api/og?type=drug&title=Radiation%3A%20131I-MIBG&subtitle=Radiation%3A%20131I-MIBG%20%C2%B7%20New%20Approaches%20to%20Neuroblastoma%20Therapy%20Consortium&badge=phase%202 Radiation: 131I-MIBG Radiation: 131I-MIBG · New Approaches to Neuroblastoma Therapy Consortium https://druglandscape.com/drug/radio-labeled-osi-906 https://druglandscape.com/api/og?type=drug&title=radio-labeled%20OSI-906&subtitle=radio-labeled%20OSI-906%20%C2%B7%20Astellas%20Pharma%20Global%20Development%2C%20Inc.&badge=phase%201 radio-labeled OSI-906 radio-labeled OSI-906 · Astellas Pharma Global Development, Inc. https://druglandscape.com/drug/radio-labelled-s-770108 https://druglandscape.com/api/og?type=drug&title=Radio-labelled%20S-770108&subtitle=Radio-labelled%20S-770108%20%C2%B7%20Shionogi&badge=phase%201 Radio-labelled S-770108 Radio-labelled S-770108 · Shionogi https://druglandscape.com/drug/radiochemotherapy-combination-cetuximab-folfox https://druglandscape.com/api/og?type=drug&title=radiochemotherapy%2Ccombination%20Cetuximab-FOLFOX&subtitle=radiochemotherapy%2Ccombination%20Cetuximab-FOLFOX%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 radiochemotherapy,combination Cetuximab-FOLFOX radiochemotherapy,combination Cetuximab-FOLFOX · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/radioiodine-therapy https://druglandscape.com/api/og?type=drug&title=Radioiodine%20therapy&subtitle=Radioiodine%20therapy%20%C2%B7%20Fabricio%20Lopes%20da%20Fonseca&badge=phase%201 Radioiodine therapy Radioiodine therapy · Fabricio Lopes da Fonseca https://druglandscape.com/drug/radiolabeled-edg-5506-intravenous https://druglandscape.com/api/og?type=drug&title=Radiolabeled%20EDG-5506%20Intravenous&subtitle=Radiolabeled%20EDG-5506%20Intravenous%20%C2%B7%20Edgewise%20Therapeutics%2C%20Inc.&badge=phase%201 Radiolabeled EDG-5506 Intravenous Radiolabeled EDG-5506 Intravenous · Edgewise Therapeutics, Inc. https://druglandscape.com/drug/radiolabeled-prucalopride-succinate https://druglandscape.com/api/og?type=drug&title=Radiolabeled%20Prucalopride%20Succinate&subtitle=Radiolabeled%20Prucalopride%20Succinate%20%C2%B7%20Shire&badge=phase%201 Radiolabeled Prucalopride Succinate Radiolabeled Prucalopride Succinate · Shire https://druglandscape.com/drug/radiolabeled-spd557 https://druglandscape.com/api/og?type=drug&title=Radiolabeled%20SPD557&subtitle=Radiolabeled%20SPD557%20%C2%B7%20Shire&badge=phase%201 Radiolabeled SPD557 Radiolabeled SPD557 · Shire https://druglandscape.com/drug/radiolabelled-cb307 https://druglandscape.com/api/og?type=drug&title=Radiolabelled%20CB307&subtitle=Radiolabelled%20CB307%20%C2%B7%20Crescendo%20Biologics%20Ltd.&badge=phase%201 Radiolabelled CB307 Radiolabelled CB307 · Crescendo Biologics Ltd. https://druglandscape.com/drug/radiolabelled-diclofenac-tablet-c https://druglandscape.com/api/og?type=drug&title=Radiolabelled%20Diclofenac%20tablet%20C&subtitle=Radiolabelled%20Diclofenac%20tablet%20C%20%C2%B7%20BDD%20Pharma%20Ltd&badge=phase%201 Radiolabelled Diclofenac tablet C Radiolabelled Diclofenac tablet C · BDD Pharma Ltd https://druglandscape.com/drug/radiolabelled-gsk189075 https://druglandscape.com/api/og?type=drug&title=Radiolabelled%20GSK189075&subtitle=Radiolabelled%20GSK189075%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Radiolabelled GSK189075 Radiolabelled GSK189075 · GlaxoSmithKline https://druglandscape.com/drug/radiolabelled-t4-tablet https://druglandscape.com/api/og?type=drug&title=Radiolabelled%20T4%20Tablet&subtitle=Radiolabelled%20T4%20Tablet%20%C2%B7%20BDD%20Pharma%20Ltd&badge=phase%201 Radiolabelled T4 Tablet Radiolabelled T4 Tablet · BDD Pharma Ltd https://druglandscape.com/drug/radiolabelled-t6-tablet https://druglandscape.com/api/og?type=drug&title=Radiolabelled%20T6%20Tablet&subtitle=Radiolabelled%20T6%20Tablet%20%C2%B7%20BDD%20Pharma%20Ltd&badge=phase%201 Radiolabelled T6 Tablet Radiolabelled T6 Tablet · BDD Pharma Ltd https://druglandscape.com/drug/radioligand-11c-az12713580 https://druglandscape.com/api/og?type=drug&title=radioligand%20%5B11C%5D%20AZ12713580&subtitle=radioligand%20%5B11C%5D%20AZ12713580%20%C2%B7%20AstraZeneca&badge=phase%201 radioligand [11C] AZ12713580 radioligand [11C] AZ12713580 · AstraZeneca https://druglandscape.com/drug/radioligand-18f-azd4694 https://druglandscape.com/api/og?type=drug&title=radioligand%20%5B18F%5DAZD4694&subtitle=radioligand%20%5B18F%5DAZD4694%20%C2%B7%20AstraZeneca&badge=phase%201 radioligand [18F]AZD4694 radioligand [18F]AZD4694 · AstraZeneca https://druglandscape.com/drug/radiosensitive-therapy https://druglandscape.com/api/og?type=drug&title=Radiosensitive%20therapy&subtitle=Radiosensitive%20therapy%20%C2%B7%20Istituto%20Clinico%20Humanitas&badge=phase%201 Radiosensitive therapy Radiosensitive therapy · Istituto Clinico Humanitas https://druglandscape.com/drug/radium-223-and-enzalutamide https://druglandscape.com/api/og?type=drug&title=Radium-223%20and%20enzalutamide&subtitle=Radium-223%20and%20enzalutamide%20%C2%B7%20Cancer%20Trials%20Ireland&badge=phase%202 Radium-223 and enzalutamide Radium-223 and enzalutamide · Cancer Trials Ireland https://druglandscape.com/drug/radp53-plus-cisplatin https://druglandscape.com/api/og?type=drug&title=rAdp53%20plus%20cisplatin&subtitle=rAdp53%20plus%20cisplatin%20%C2%B7%20Shenzhen%20SiBiono%20GeneTech%20Co.%2CLtd&badge=phase%202 rAdp53 plus cisplatin rAdp53 plus cisplatin · Shenzhen SiBiono GeneTech Co.,Ltd https://druglandscape.com/drug/radprotect https://druglandscape.com/api/og?type=drug&title=RadProtect%C2%AE&subtitle=RadProtect%C2%AE%20%C2%B7%20Original%20BioMedicals%20Co.%20Ltd.&badge=phase%201 RadProtect® RadProtect® · Original BioMedicals Co. Ltd. https://druglandscape.com/drug/rag-01 https://druglandscape.com/api/og?type=drug&title=RAG-01&subtitle=RAG-01%20%C2%B7%20Ractigen%20Therapeutics.&badge=phase%201 RAG-01 RAG-01 · Ractigen Therapeutics. https://druglandscape.com/drug/rahf-pfm https://druglandscape.com/api/og?type=drug&title=rAHF-PFM&subtitle=rAHF-PFM%20%C2%B7%20Baxalta%20now%20part%20of%20Shire&badge=phase%202 rAHF-PFM rAHF-PFM · Baxalta now part of Shire https://druglandscape.com/drug/ral-or-egv-based-regimens-without-abc https://druglandscape.com/api/og?type=drug&title=RAL%20or%20EGV%20based%20regimens%20without%20ABC&subtitle=RAL%20or%20EGV%20based%20regimens%20without%20ABC%20%C2%B7%20ViiV%20Healthcare&badge=phase%202 RAL or EGV based regimens without ABC RAL or EGV based regimens without ABC · ViiV Healthcare https://druglandscape.com/drug/raloxifene-usual https://druglandscape.com/api/og?type=drug&title=Raloxifene%20-%20Usual&subtitle=Raloxifene%20-%20Usual%20%C2%B7%20Han%20Xu%2C%20M.D.%2C%20Ph.D.%2C%20FAPCR%2C%20Sponsor-Investigator%2C%20IRB%20Chair&badge=phase%202 Raloxifene - Usual Raloxifene - Usual · Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair https://druglandscape.com/drug/raltegravir-and-etravirine https://druglandscape.com/api/og?type=drug&title=raltegravir%20and%20etravirine&subtitle=raltegravir%20and%20etravirine%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%202 raltegravir and etravirine raltegravir and etravirine · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/raltegravir-and-ezetimibe https://druglandscape.com/api/og?type=drug&title=Raltegravir%20and%20ezetimibe&subtitle=Raltegravir%20and%20ezetimibe%20%C2%B7%20St%20Stephens%20Aids%20Trust&badge=phase%201 Raltegravir and ezetimibe Raltegravir and ezetimibe · St Stephens Aids Trust https://druglandscape.com/drug/raltegravir-chewable-tablet https://druglandscape.com/api/og?type=drug&title=Raltegravir%20Chewable%20Tablet&subtitle=Raltegravir%20Chewable%20Tablet%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Raltegravir Chewable Tablet Raltegravir Chewable Tablet · Merck Sharp & Dohme LLC https://druglandscape.com/drug/ramelteon-and-doxepin https://druglandscape.com/api/og?type=drug&title=Ramelteon%20and%20doxepin&subtitle=Ramelteon%20and%20doxepin%20%C2%B7%20Takeda&badge=phase%202 Ramelteon and doxepin Ramelteon and doxepin · Takeda https://druglandscape.com/drug/ramelteon-and-gabapentin https://druglandscape.com/api/og?type=drug&title=Ramelteon%20and%20gabapentin&subtitle=Ramelteon%20and%20gabapentin%20%C2%B7%20Takeda&badge=phase%202 Ramelteon and gabapentin Ramelteon and gabapentin · Takeda https://druglandscape.com/drug/ramipril-amlodipine-and-atorvastatin https://druglandscape.com/api/og?type=drug&title=Ramipril%2C%20Amlodipine%20and%20Atorvastatin&subtitle=Ramipril%2C%20Amlodipine%20and%20Atorvastatin%20%C2%B7%20Midas%20Pharma%20GmbH&badge=phase%201 Ramipril, Amlodipine and Atorvastatin Ramipril, Amlodipine and Atorvastatin · Midas Pharma GmbH https://druglandscape.com/drug/ramucirumab-injection-cyramza https://druglandscape.com/api/og?type=drug&title=Ramucirumab%20Injection%20%5BCyramza%5D&subtitle=Ramucirumab%20Injection%20%5BCyramza%5D%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 Ramucirumab Injection [Cyramza] Ramucirumab Injection [Cyramza] · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/ramucirumab-iv https://druglandscape.com/api/og?type=drug&title=Ramucirumab%20-%20IV&subtitle=Ramucirumab%20-%20IV%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Ramucirumab - IV Ramucirumab - IV · Eli Lilly and Company https://druglandscape.com/drug/ranibizumab-verteporfin https://druglandscape.com/api/og?type=drug&title=Ranibizumab%3B%20Verteporfin&subtitle=Ranibizumab%3B%20Verteporfin%20%C2%B7%20Fondazione%20G.B.%20Bietti%2C%20IRCCS&badge=phase%202 Ranibizumab; Verteporfin Ranibizumab; Verteporfin · Fondazione G.B. Bietti, IRCCS https://druglandscape.com/drug/rap-219 https://druglandscape.com/api/og?type=drug&title=RAP-219&subtitle=RAP-219%20%C2%B7%20Rapport%20Therapeutics%20Inc.&badge=phase%202 RAP-219 RAP-219 · Rapport Therapeutics Inc. https://druglandscape.com/drug/rapa-201-autologous-t-cells https://druglandscape.com/api/og?type=drug&title=RAPA-201%20Autologous%20T%20cells&subtitle=RAPA-201%20Autologous%20T%20cells%20%C2%B7%20Rapa%20Therapeutics%20LLC&badge=phase%202 RAPA-201 Autologous T cells RAPA-201 Autologous T cells · Rapa Therapeutics LLC https://druglandscape.com/drug/rapa-201-rapamycin-resistant-t-cells https://druglandscape.com/api/og?type=drug&title=RAPA-201%20Rapamycin%20Resistant%20T%20Cells&subtitle=RAPA-201%20Rapamycin%20Resistant%20T%20Cells%20%C2%B7%20Rapa%20Therapeutics%20LLC&badge=phase%202 RAPA-201 Rapamycin Resistant T Cells RAPA-201 Rapamycin Resistant T Cells · Rapa Therapeutics LLC https://druglandscape.com/drug/rapa-501-autologous-t-stem-cells https://druglandscape.com/api/og?type=drug&title=RAPA-501%20Autologous%20T%20stem%20cells&subtitle=RAPA-501%20Autologous%20T%20stem%20cells%20%C2%B7%20Rapa%20Therapeutics%20LLC&badge=phase%202 RAPA-501 Autologous T stem cells RAPA-501 Autologous T stem cells · Rapa Therapeutics LLC https://druglandscape.com/drug/rapa113 https://druglandscape.com/api/og?type=drug&title=RAPA113&subtitle=RAPA113%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 RAPA113 RAPA113 · HK inno.N Corporation https://druglandscape.com/drug/rapa114 https://druglandscape.com/api/og?type=drug&title=RAPA114&subtitle=RAPA114%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 RAPA114 RAPA114 · HK inno.N Corporation https://druglandscape.com/drug/rapa115 https://druglandscape.com/api/og?type=drug&title=RAPA115&subtitle=RAPA115%20%C2%B7%20HK%20inno.N%20Corporation&badge=phase%201 RAPA115 RAPA115 · HK inno.N Corporation https://druglandscape.com/drug/rapid-optimized-analgesic-strategy https://druglandscape.com/api/og?type=drug&title=Rapid%20optimized%20analgesic%20strategy&subtitle=Rapid%20optimized%20analgesic%20strategy%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Rapid optimized analgesic strategy Rapid optimized analgesic strategy · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/rar-gamma https://druglandscape.com/api/og?type=drug&title=RAR%20Gamma&subtitle=RAR%20Gamma%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RAR Gamma RAR Gamma · Hoffmann-La Roche https://druglandscape.com/drug/rasagiline-tablets https://druglandscape.com/api/og?type=drug&title=Rasagiline%20Tablets&subtitle=Rasagiline%20Tablets%20%C2%B7%20Guangzhou%20Henovcom%20Bioscience%20Co.%20Ltd.&badge=phase%201 Rasagiline Tablets Rasagiline Tablets · Guangzhou Henovcom Bioscience Co. Ltd. https://druglandscape.com/drug/ravpal-peg https://druglandscape.com/api/og?type=drug&title=rAvPAL-PEG&subtitle=rAvPAL-PEG%20%C2%B7%20BioMarin%20Pharmaceutical&badge=phase%202 rAvPAL-PEG rAvPAL-PEG · BioMarin Pharmaceutical https://druglandscape.com/drug/ray1216-dose-4-ritonavir https://druglandscape.com/api/og?type=drug&title=RAY1216%20dose%204%20%26ritonavir&subtitle=RAY1216%20dose%204%20%26ritonavir%20%C2%B7%20Guangdong%20Raynovent%20Biotech%20Co.%2C%20Ltd&badge=phase%201 RAY1216 dose 4 &ritonavir RAY1216 dose 4 &ritonavir · Guangdong Raynovent Biotech Co., Ltd https://druglandscape.com/drug/rbcg-n-hrsv-full-dose https://druglandscape.com/api/og?type=drug&title=rBCG-N-hRSV%20full%20dose&subtitle=rBCG-N-hRSV%20full%20dose%20%C2%B7%20Pontificia%20Universidad%20Catolica%20de%20Chile&badge=phase%201 rBCG-N-hRSV full dose rBCG-N-hRSV full dose · Pontificia Universidad Catolica de Chile https://druglandscape.com/drug/rbd1016 https://druglandscape.com/api/og?type=drug&title=RBD1016&subtitle=RBD1016%20%C2%B7%20Ribocure%20Pharmaceuticals%20AB&badge=phase%202 RBD1016 RBD1016 · Ribocure Pharmaceuticals AB https://druglandscape.com/drug/rbd1119 https://druglandscape.com/api/og?type=drug&title=RBD1119&subtitle=RBD1119%20%C2%B7%20Suzhou%20Ribo%20Life%20Science%20Co.%20Ltd.&badge=phase%201 RBD1119 RBD1119 · Suzhou Ribo Life Science Co. Ltd. https://druglandscape.com/drug/rbd4059 https://druglandscape.com/api/og?type=drug&title=RBD4059&subtitle=RBD4059%20%C2%B7%20Suzhou%20Ribo%20Life%20Science%20Co.%20Ltd.&badge=phase%202 RBD4059 RBD4059 · Suzhou Ribo Life Science Co. Ltd. https://druglandscape.com/drug/rbd5044 https://druglandscape.com/api/og?type=drug&title=RBD5044&subtitle=RBD5044%20%C2%B7%20Ribocure%20Pharmaceuticals%20AB&badge=phase%202 RBD5044 RBD5044 · Ribocure Pharmaceuticals AB https://druglandscape.com/drug/rbet-v1-fv https://druglandscape.com/api/og?type=drug&title=rBet%20v1-FV&subtitle=rBet%20v1-FV%20%C2%B7%20Allergopharma%20GmbH%20%26%20Co.%20KG&badge=phase%202 rBet v1-FV rBet v1-FV · Allergopharma GmbH & Co. KG https://druglandscape.com/drug/rbm-001 https://druglandscape.com/api/og?type=drug&title=RBM-001&subtitle=RBM-001%20%C2%B7%20Rock%20BioMedical%2C%20Inc.&badge=phase%201 RBM-001 RBM-001 · Rock BioMedical, Inc. https://druglandscape.com/drug/rbm-007 https://druglandscape.com/api/og?type=drug&title=RBM-007&subtitle=RBM-007%20%C2%B7%20Ribomic%20USA%20Inc&badge=phase%202 RBM-007 RBM-007 · Ribomic USA Inc https://druglandscape.com/drug/rbm-007-injectable-solution https://druglandscape.com/api/og?type=drug&title=RBM-007%20Injectable%20Solution&subtitle=RBM-007%20Injectable%20Solution%20%C2%B7%20Ribomic%20USA%20Inc&badge=phase%202 RBM-007 Injectable Solution RBM-007 Injectable Solution · Ribomic USA Inc https://druglandscape.com/drug/rbmrna-176 https://druglandscape.com/api/og?type=drug&title=RBMRNA-176&subtitle=RBMRNA-176%20%C2%B7%20Argorna%20Pharmaceuticals%20Co.%2C%20LTD&badge=phase%201 RBMRNA-176 RBMRNA-176 · Argorna Pharmaceuticals Co., LTD https://druglandscape.com/drug/rbn-2397 https://druglandscape.com/api/og?type=drug&title=RBN-2397&subtitle=RBN-2397%20%C2%B7%20Ribon%20Therapeutics%2C%20Inc.&badge=phase%201 RBN-2397 RBN-2397 · Ribon Therapeutics, Inc. https://druglandscape.com/drug/rbn-3143 https://druglandscape.com/api/og?type=drug&title=RBN-3143&subtitle=RBN-3143%20%C2%B7%20Ribon%20Therapeutics%2C%20Inc.&badge=phase%201 RBN-3143 RBN-3143 · Ribon Therapeutics, Inc. https://druglandscape.com/drug/rbp-6300 https://druglandscape.com/api/og?type=drug&title=RBP-6300&subtitle=RBP-6300%20%C2%B7%20Indivior%20Inc.&badge=phase%202 RBP-6300 RBP-6300 · Indivior Inc. https://druglandscape.com/drug/rbs2418 https://druglandscape.com/api/og?type=drug&title=RBS2418&subtitle=RBS2418%20%C2%B7%20Riboscience%2C%20LLC.&badge=phase%202 RBS2418 RBS2418 · Riboscience, LLC. https://druglandscape.com/drug/rbt-3 https://druglandscape.com/api/og?type=drug&title=RBT-3&subtitle=RBT-3%20%C2%B7%20Renibus%20Therapeutics%2C%20Inc.&badge=phase%201 RBT-3 RBT-3 · Renibus Therapeutics, Inc. https://druglandscape.com/drug/rc-1291 https://druglandscape.com/api/og?type=drug&title=RC-1291&subtitle=RC-1291%20%C2%B7%20Helsinn%20Therapeutics%20(U.S.)%2C%20Inc&badge=phase%202 RC-1291 RC-1291 · Helsinn Therapeutics (U.S.), Inc https://druglandscape.com/drug/rc108 https://druglandscape.com/api/og?type=drug&title=RC108&subtitle=RC108%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%202 RC108 RC108 · RemeGen Co., Ltd. https://druglandscape.com/drug/rc118 https://druglandscape.com/api/og?type=drug&title=RC118&subtitle=RC118%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%201 RC118 RC118 · RemeGen Co., Ltd. https://druglandscape.com/drug/rc118-adc https://druglandscape.com/api/og?type=drug&title=RC118-ADC&subtitle=RC118-ADC%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%201 RC118-ADC RC118-ADC · RemeGen Co., Ltd. https://druglandscape.com/drug/rc1416 https://druglandscape.com/api/og?type=drug&title=RC1416&subtitle=RC1416%20%C2%B7%20Nanjing%20RegeneCore%20Biotech%20Co.%2C%20Ltd.&badge=phase%202 RC1416 RC1416 · Nanjing RegeneCore Biotech Co., Ltd. https://druglandscape.com/drug/rc148 https://druglandscape.com/api/og?type=drug&title=RC148&subtitle=RC148%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%202 RC148 RC148 · RemeGen Co., Ltd. https://druglandscape.com/drug/rc220 https://druglandscape.com/api/og?type=drug&title=RC220&subtitle=RC220%20%C2%B7%20Race%20Oncology%20Ltd&badge=phase%201 RC220 RC220 · Race Oncology Ltd https://druglandscape.com/drug/rc278 https://druglandscape.com/api/og?type=drug&title=RC278&subtitle=RC278%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%201 RC278 RC278 · RemeGen Co., Ltd. https://druglandscape.com/drug/rc48-adc-in-combination-with-gemcitabine https://druglandscape.com/api/og?type=drug&title=RC48-ADC%20in%20Combination%20with%20gemcitabine&subtitle=RC48-ADC%20in%20Combination%20with%20gemcitabine%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%202 RC48-ADC in Combination with gemcitabine RC48-ADC in Combination with gemcitabine · RemeGen Co., Ltd. https://druglandscape.com/drug/rc88 https://druglandscape.com/api/og?type=drug&title=RC88&subtitle=RC88%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%202 RC88 RC88 · RemeGen Co., Ltd. https://druglandscape.com/drug/rc98 https://druglandscape.com/api/og?type=drug&title=RC98&subtitle=RC98%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%201 RC98 RC98 · RemeGen Co., Ltd. https://druglandscape.com/drug/rchop https://druglandscape.com/api/og?type=drug&title=RCHOP&subtitle=RCHOP%20%C2%B7%20Grupo%20Espa%C3%B1ol%20de%20Linfomas%20y%20Transplante%20Aut%C3%B3logo%20de%20M%C3%A9dula%20%C3%93sea&badge=phase%202 RCHOP RCHOP · Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea https://druglandscape.com/drug/rcomp https://druglandscape.com/api/og?type=drug&title=RCOMP&subtitle=RCOMP%20%C2%B7%20Grupo%20Espa%C3%B1ol%20de%20Linfomas%20y%20Transplante%20Aut%C3%B3logo%20de%20M%C3%A9dula%20%C3%93sea&badge=phase%202 RCOMP RCOMP · Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea https://druglandscape.com/drug/rcs-01 https://druglandscape.com/api/og?type=drug&title=RCS-01&subtitle=RCS-01%20%C2%B7%20RepliCel%20Life%20Sciences%2C%20Inc.&badge=phase%201 RCS-01 RCS-01 · RepliCel Life Sciences, Inc. https://druglandscape.com/drug/rct1100 https://druglandscape.com/api/og?type=drug&title=RCT1100&subtitle=RCT1100%20%C2%B7%20ReCode%20Therapeutics&badge=phase%201 RCT1100 RCT1100 · ReCode Therapeutics https://druglandscape.com/drug/rd01 https://druglandscape.com/api/og?type=drug&title=RD01&subtitle=RD01%20%C2%B7%20Shengzhen%20Sciprogen%20Bio-pharmaceutical%20Co.%20Ltd&badge=phase%202 RD01 RD01 · Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd https://druglandscape.com/drug/rdc-0313 https://druglandscape.com/api/og?type=drug&title=RDC-0313&subtitle=RDC-0313%20%C2%B7%20Alkermes%2C%20Inc.&badge=phase%201 RDC-0313 RDC-0313 · Alkermes, Inc. https://druglandscape.com/drug/rdea119 https://druglandscape.com/api/og?type=drug&title=RDEA119&subtitle=RDEA119%20%C2%B7%20Bayer&badge=phase%201 RDEA119 RDEA119 · Bayer https://druglandscape.com/drug/rdea3170 https://druglandscape.com/api/og?type=drug&title=RDEA3170&subtitle=RDEA3170%20%C2%B7%20Ardea%20Biosciences%2C%20Inc.&badge=phase%202 RDEA3170 RDEA3170 · Ardea Biosciences, Inc. https://druglandscape.com/drug/rdea594 https://druglandscape.com/api/og?type=drug&title=RDEA594&subtitle=RDEA594%20%C2%B7%20Ardea%20Biosciences%2C%20Inc.&badge=phase%202 RDEA594 RDEA594 · Ardea Biosciences, Inc. https://druglandscape.com/drug/rdea806 https://druglandscape.com/api/og?type=drug&title=RDEA806&subtitle=RDEA806%20%C2%B7%20Ardea%20Biosciences%2C%20Inc.&badge=phase%202 RDEA806 RDEA806 · Ardea Biosciences, Inc. https://druglandscape.com/drug/rdl-of-cd-ld https://druglandscape.com/api/og?type=drug&title=RDL%20of%20CD-LD&subtitle=RDL%20of%20CD-LD%20%C2%B7%20Riverside%20Pharmacueticals%20Corporation&badge=phase%201 RDL of CD-LD RDL of CD-LD · Riverside Pharmacueticals Corporation https://druglandscape.com/drug/rdn-929-tbd-dose https://druglandscape.com/api/og?type=drug&title=RDN-929%20TBD%20dose&subtitle=RDN-929%20TBD%20dose%20%C2%B7%20Alkermes%2C%20Inc.&badge=phase%201 RDN-929 TBD dose RDN-929 TBD dose · Alkermes, Inc. https://druglandscape.com/drug/rdx013 https://druglandscape.com/api/og?type=drug&title=RDX013&subtitle=RDX013%20%C2%B7%20Ardelyx&badge=phase%202 RDX013 RDX013 · Ardelyx https://druglandscape.com/drug/rdx5791 https://druglandscape.com/api/og?type=drug&title=RDX5791&subtitle=RDX5791%20%C2%B7%20Ardelyx&badge=phase%202 RDX5791 RDX5791 · Ardelyx https://druglandscape.com/drug/re-induction-phase https://druglandscape.com/api/og?type=drug&title=Re-Induction%20Phase&subtitle=Re-Induction%20Phase%20%C2%B7%20SWOG%20Cancer%20Research%20Network&badge=phase%202 Re-Induction Phase Re-Induction Phase · SWOG Cancer Research Network https://druglandscape.com/drug/reactive-skin-treatment https://druglandscape.com/api/og?type=drug&title=Reactive%20Skin%20Treatment&subtitle=Reactive%20Skin%20Treatment%20%C2%B7%20Amgen&badge=phase%202 Reactive Skin Treatment Reactive Skin Treatment · Amgen https://druglandscape.com/drug/reamberin-solution-for-infusion-1-5 https://druglandscape.com/api/og?type=drug&title=Reamberin%C2%AE%20solution%20for%20infusion%2C%201.5%20%25&subtitle=Reamberin%C2%AE%20solution%20for%20infusion%2C%201.5%20%25%20%C2%B7%20POLYSAN%20Scientific%20%26%20Technological%20Pharmaceutical%20Company&badge=phase%202 Reamberin® solution for infusion, 1.5 % Reamberin® solution for infusion, 1.5 % · POLYSAN Scientific & Technological Pharmaceutical Company https://druglandscape.com/drug/reb-blood-cell-transfusion https://druglandscape.com/api/og?type=drug&title=Reb%20blood%20cell%20transfusion&subtitle=Reb%20blood%20cell%20transfusion%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 Reb blood cell transfusion Reb blood cell transfusion · Bristol-Myers Squibb https://druglandscape.com/drug/rebamipide-effervescent-granules https://druglandscape.com/api/og?type=drug&title=Rebamipide%20effervescent%20granules&subtitle=Rebamipide%20effervescent%20granules%20%C2%B7%20Biolab%20Sanus%20Farmaceutica&badge=phase%201 Rebamipide effervescent granules Rebamipide effervescent granules · Biolab Sanus Farmaceutica https://druglandscape.com/drug/rebif-new-formulation https://druglandscape.com/api/og?type=drug&title=Rebif%C2%AE%20New%20Formulation&subtitle=Rebif%C2%AE%20New%20Formulation%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%202 Rebif® New Formulation Rebif® New Formulation · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/rec-4881 https://druglandscape.com/api/og?type=drug&title=REC-4881&subtitle=REC-4881%20%C2%B7%20Recursion%20Pharmaceuticals%20Inc.&badge=phase%202 REC-4881 REC-4881 · Recursion Pharmaceuticals Inc. https://druglandscape.com/drug/rec-994 https://druglandscape.com/api/og?type=drug&title=REC-994&subtitle=REC-994%20%C2%B7%20Recursion%20Pharmaceuticals%20Inc.&badge=phase%202 REC-994 REC-994 · Recursion Pharmaceuticals Inc. https://druglandscape.com/drug/rec610 https://druglandscape.com/api/og?type=drug&title=REC610&subtitle=REC610%20%C2%B7%20Jiangsu%20Rec-Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 REC610 REC610 · Jiangsu Rec-Biotechnology Co., Ltd. https://druglandscape.com/drug/recombinant-adamts13 https://druglandscape.com/api/og?type=drug&title=Recombinant%20ADAMTS13&subtitle=Recombinant%20ADAMTS13%20%C2%B7%20Takeda&badge=phase%202 Recombinant ADAMTS13 Recombinant ADAMTS13 · Takeda https://druglandscape.com/drug/recombinant-anti-egfr-antibody https://druglandscape.com/api/og?type=drug&title=Recombinant%20Anti-EGFr%20Antibody&subtitle=Recombinant%20Anti-EGFr%20Antibody%20%C2%B7%20Sichuan%20Kelun%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 Recombinant Anti-EGFr Antibody Recombinant Anti-EGFr Antibody · Sichuan Kelun Pharmaceutical Co., Ltd https://druglandscape.com/drug/recombinant-anti-egfr-monoclonal-antibody https://druglandscape.com/api/og?type=drug&title=recombinant%20anti-EGFR%20monoclonal%20antibody&subtitle=recombinant%20anti-EGFR%20monoclonal%20antibody%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%201 recombinant anti-EGFR monoclonal antibody recombinant anti-EGFR monoclonal antibody · Sinocelltech Ltd. https://druglandscape.com/drug/recombinant-chimeric-monoclonal-antibody https://druglandscape.com/api/og?type=drug&title=Recombinant%20Chimeric%20Monoclonal%20Antibody&subtitle=Recombinant%20Chimeric%20Monoclonal%20Antibody%20%C2%B7%20ICOS%20Corporation&badge=phase%202 Recombinant Chimeric Monoclonal Antibody Recombinant Chimeric Monoclonal Antibody · ICOS Corporation https://druglandscape.com/drug/recombinant-ephb4-hsa-fusion-protein https://druglandscape.com/api/og?type=drug&title=Recombinant%20EphB4-HSA%20Fusion%20Protein&subtitle=Recombinant%20EphB4-HSA%20Fusion%20Protein%20%C2%B7%20AIDS%20Malignancy%20Consortium&badge=phase%202 Recombinant EphB4-HSA Fusion Protein Recombinant EphB4-HSA Fusion Protein · AIDS Malignancy Consortium https://druglandscape.com/drug/recombinant-erythropoietin-stimulating-protein https://druglandscape.com/api/og?type=drug&title=Recombinant%20erythropoietin%20stimulating%20protein&subtitle=Recombinant%20erythropoietin%20stimulating%20protein%20%C2%B7%20Shenyang%20Sunshine%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%201 Recombinant erythropoietin stimulating protein Recombinant erythropoietin stimulating protein · Shenyang Sunshine Pharmaceutical Co., LTD. https://druglandscape.com/drug/recombinant-factor-viii https://druglandscape.com/api/og?type=drug&title=recombinant%20Factor%20VIII&subtitle=recombinant%20Factor%20VIII%20%C2%B7%20Octapharma&badge=phase%203 recombinant Factor VIII recombinant Factor VIII · Octapharma https://druglandscape.com/drug/recombinant-fimbrial-adhesin-dsccfae https://druglandscape.com/api/og?type=drug&title=Recombinant%20fimbrial%20adhesin%20dscCfaE&subtitle=Recombinant%20fimbrial%20adhesin%20dscCfaE%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 Recombinant fimbrial adhesin dscCfaE Recombinant fimbrial adhesin dscCfaE · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/recombinant-fsh-or-hmg https://druglandscape.com/api/og?type=drug&title=recombinant%20FSH%20or%20hMG&subtitle=recombinant%20FSH%20or%20hMG%20%C2%B7%20Yazd%20Research%20%26%20Clinical%20Center%20for%20Infertility&badge=phase%201 recombinant FSH or hMG recombinant FSH or hMG · Yazd Research & Clinical Center for Infertility https://druglandscape.com/drug/recombinant-hiv-1-tat-protein https://druglandscape.com/api/og?type=drug&title=recombinant%20HIV-1%20Tat%20protein&subtitle=recombinant%20HIV-1%20Tat%20protein%20%C2%B7%20Istituto%20Superiore%20di%20Sanit%C3%A0&badge=phase%201 recombinant HIV-1 Tat protein recombinant HIV-1 Tat protein · Istituto Superiore di Sanità https://druglandscape.com/drug/recombinant-human-acid-sphingomyelinase https://druglandscape.com/api/og?type=drug&title=Recombinant%20human%20acid%20sphingomyelinase&subtitle=Recombinant%20human%20acid%20sphingomyelinase%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%201 Recombinant human acid sphingomyelinase Recombinant human acid sphingomyelinase · Genzyme, a Sanofi Company https://druglandscape.com/drug/recombinant-human-alpha-b-crystallin https://druglandscape.com/api/og?type=drug&title=recombinant%20human%20alpha%20B-crystallin&subtitle=recombinant%20human%20alpha%20B-crystallin%20%C2%B7%20Delta%20Crystallon%20BV&badge=phase%202 recombinant human alpha B-crystallin recombinant human alpha B-crystallin · Delta Crystallon BV https://druglandscape.com/drug/recombinant-human-angiostatin-protein https://druglandscape.com/api/og?type=drug&title=recombinant%20human%20Angiostatin%20protein&subtitle=recombinant%20human%20Angiostatin%20protein%20%C2%B7%20CASI%20Pharmaceuticals%2C%20Inc.&badge=phase%202 recombinant human Angiostatin protein recombinant human Angiostatin protein · CASI Pharmaceuticals, Inc. https://druglandscape.com/drug/recombinant-human-arylsulfatase-a https://druglandscape.com/api/og?type=drug&title=Recombinant%20human%20arylsulfatase%20A&subtitle=Recombinant%20human%20arylsulfatase%20A%20%C2%B7%20Shire&badge=phase%201 Recombinant human arylsulfatase A Recombinant human arylsulfatase A · Shire https://druglandscape.com/drug/recombinant-human-c1-esterase-inhibitor https://druglandscape.com/api/og?type=drug&title=Recombinant%20human%20C1%20esterase%20inhibitor&subtitle=Recombinant%20human%20C1%20esterase%20inhibitor%20%C2%B7%20Shire&badge=phase%201 Recombinant human C1 esterase inhibitor Recombinant human C1 esterase inhibitor · Shire https://druglandscape.com/drug/recombinant-human-cardiotrophin-1 https://druglandscape.com/api/og?type=drug&title=recombinant%20human%20cardiotrophin-1&subtitle=recombinant%20human%20cardiotrophin-1%20%C2%B7%20Digna%20Biotech%20S.L.&badge=phase%201 recombinant human cardiotrophin-1 recombinant human cardiotrophin-1 · Digna Biotech S.L. https://druglandscape.com/drug/recombinant-human-erythropoietin-rhepo https://druglandscape.com/api/og?type=drug&title=recombinant%20human%20erythropoietin%2C%20rhEpo&subtitle=recombinant%20human%20erythropoietin%2C%20rhEpo%20%C2%B7%20Claudia%20Sue%20Robertson&badge=phase%202 recombinant human erythropoietin, rhEpo recombinant human erythropoietin, rhEpo · Claudia Sue Robertson https://druglandscape.com/drug/recombinant-human-interleukin-21 https://druglandscape.com/api/og?type=drug&title=recombinant%20human%20interleukin-21&subtitle=recombinant%20human%20interleukin-21%20%C2%B7%20NCIC%20Clinical%20Trials%20Group&badge=phase%202 recombinant human interleukin-21 recombinant human interleukin-21 · NCIC Clinical Trials Group https://druglandscape.com/drug/recombinant-human-lactoferrin https://druglandscape.com/api/og?type=drug&title=Recombinant%20Human%20Lactoferrin&subtitle=Recombinant%20Human%20Lactoferrin%20%C2%B7%20Agennix&badge=phase%202 Recombinant Human Lactoferrin Recombinant Human Lactoferrin · Agennix https://druglandscape.com/drug/recombinant-human-luteinizing-hormone https://druglandscape.com/api/og?type=drug&title=Recombinant%20Human%20Luteinizing%20Hormone&subtitle=Recombinant%20Human%20Luteinizing%20Hormone%20%C2%B7%20Peter%20y.%20Liu&badge=phase%201 Recombinant Human Luteinizing Hormone Recombinant Human Luteinizing Hormone · Peter y. Liu https://druglandscape.com/drug/recombinant-human-plasma-gelsolin https://druglandscape.com/api/og?type=drug&title=Recombinant%20Human%20Plasma%20Gelsolin&subtitle=Recombinant%20Human%20Plasma%20Gelsolin%20%C2%B7%20BioAegis%20Therapeutics%20Inc.&badge=phase%201 Recombinant Human Plasma Gelsolin Recombinant Human Plasma Gelsolin · BioAegis Therapeutics Inc. https://druglandscape.com/drug/recombinant-human-proteoglycan-4 https://druglandscape.com/api/og?type=drug&title=Recombinant%20Human%20Proteoglycan%204&subtitle=Recombinant%20Human%20Proteoglycan%204%20%C2%B7%20Lubris%20Bio%20Pty%20Ltd&badge=phase%202 Recombinant Human Proteoglycan 4 Recombinant Human Proteoglycan 4 · Lubris Bio Pty Ltd https://druglandscape.com/drug/recombinant-human-thymosin-4 https://druglandscape.com/api/og?type=drug&title=Recombinant%20Human%20Thymosin%20%CE%B24&subtitle=Recombinant%20Human%20Thymosin%20%CE%B24%20%C2%B7%20Beijing%20Northland%20Biotech.%20Co.%2C%20Ltd.&badge=phase%201 Recombinant Human Thymosin β4 Recombinant Human Thymosin β4 · Beijing Northland Biotech. Co., Ltd. https://druglandscape.com/drug/recombinant-human-tissue-kallikrein https://druglandscape.com/api/og?type=drug&title=Recombinant%20human%20tissue%20kallikrein&subtitle=Recombinant%20human%20tissue%20kallikrein%20%C2%B7%20DiaMedica%20Therapeutics%20Inc&badge=phase%202 Recombinant human tissue kallikrein Recombinant human tissue kallikrein · DiaMedica Therapeutics Inc https://druglandscape.com/drug/recombinant-humanized-monoclonal-antibody-mil93 https://druglandscape.com/api/og?type=drug&title=Recombinant%20Humanized%20Monoclonal%20Antibody%20MIL93&subtitle=Recombinant%20Humanized%20Monoclonal%20Antibody%20MIL93%20%C2%B7%20Beijing%20Mabworks%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 Recombinant Humanized Monoclonal Antibody MIL93 Recombinant Humanized Monoclonal Antibody MIL93 · Beijing Mabworks Biotech Co., Ltd. https://druglandscape.com/drug/recombinant-humanized-monoclonal-antibody-mil95 https://druglandscape.com/api/og?type=drug&title=Recombinant%20Humanized%20Monoclonal%20Antibody%20MIL95&subtitle=Recombinant%20Humanized%20Monoclonal%20Antibody%20MIL95%20%C2%B7%20Beijing%20Mabworks%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 Recombinant Humanized Monoclonal Antibody MIL95 Recombinant Humanized Monoclonal Antibody MIL95 · Beijing Mabworks Biotech Co., Ltd. https://druglandscape.com/drug/recombinant-interferon-alfa-2a https://druglandscape.com/api/og?type=drug&title=Recombinant%20Interferon%20Alfa%202a&subtitle=Recombinant%20Interferon%20Alfa%202a%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Recombinant Interferon Alfa 2a Recombinant Interferon Alfa 2a · Hoffmann-La Roche https://druglandscape.com/drug/recombinant-interferon-alpha-2a https://druglandscape.com/api/og?type=drug&title=recombinant%20interferon%20alpha-2a&subtitle=recombinant%20interferon%20alpha-2a%20%C2%B7%20Mount%20Vernon%20Cancer%20Centre%20at%20Mount%20Vernon%20Hospital&badge=phase%203 recombinant interferon alpha-2a recombinant interferon alpha-2a · Mount Vernon Cancer Centre at Mount Vernon Hospital https://druglandscape.com/drug/recombinant-somatropin https://druglandscape.com/api/og?type=drug&title=recombinant%20somatropin&subtitle=recombinant%20somatropin%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%202 recombinant somatropin recombinant somatropin · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/rectal-diclofenac https://druglandscape.com/api/og?type=drug&title=Rectal%20Diclofenac&subtitle=Rectal%20Diclofenac%20%C2%B7%20Assumpta%20Nnenna%20Nweke&badge=phase%201 Rectal Diclofenac Rectal Diclofenac · Assumpta Nnenna Nweke https://druglandscape.com/drug/rectal-swab https://druglandscape.com/api/og?type=drug&title=rectal%20swab&subtitle=rectal%20swab%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 rectal swab rectal swab · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/recurring-blood-sample https://druglandscape.com/api/og?type=drug&title=Recurring%20blood%20sample&subtitle=Recurring%20blood%20sample%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 Recurring blood sample Recurring blood sample · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/red-blood-cells-autotransfusion https://druglandscape.com/api/og?type=drug&title=red%20blood%20cells%20autotransfusion&subtitle=red%20blood%20cells%20autotransfusion%20%C2%B7%20Micha%C5%82%20Stasiowski&badge=phase%201 red blood cells autotransfusion red blood cells autotransfusion · Michał Stasiowski https://druglandscape.com/drug/red-blood-cells-concentrate https://druglandscape.com/api/og?type=drug&title=Red%20blood%20cells%20concentrate&subtitle=Red%20blood%20cells%20concentrate%20%C2%B7%20Banc%20de%20Sang%20i%20Teixits&badge=phase%201 Red blood cells concentrate Red blood cells concentrate · Banc de Sang i Teixits https://druglandscape.com/drug/red-blood-cells-unit-age-14-days-or-less https://druglandscape.com/api/og?type=drug&title=Red%20blood%20cells%20unit%20age%2014%20days%20or%20less&subtitle=Red%20blood%20cells%20unit%20age%2014%20days%20or%20less%20%C2%B7%20Abdelrady%20S%20Ibrahim%2C%20MD&badge=phase%202 Red blood cells unit age 14 days or less Red blood cells unit age 14 days or less · Abdelrady S Ibrahim, MD https://druglandscape.com/drug/red-blood-transfusion https://druglandscape.com/api/og?type=drug&title=red%20blood%20transfusion&subtitle=red%20blood%20transfusion%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 red blood transfusion red blood transfusion · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/red-wine-beer-ethanol https://druglandscape.com/api/og?type=drug&title=red%20wine%2C%20beer%2C%20ethanol&subtitle=red%20wine%2C%20beer%2C%20ethanol%20%C2%B7%20European%20Research%20Advisory%20Board&badge=phase%201 red wine, beer, ethanol red wine, beer, ethanol · European Research Advisory Board https://druglandscape.com/drug/reduced-dose-hht https://druglandscape.com/api/og?type=drug&title=Reduced-dose%20HHT&subtitle=Reduced-dose%20HHT%20%C2%B7%20Ascentage%20Pharma%20Group%20Inc.&badge=phase%201 Reduced-dose HHT Reduced-dose HHT · Ascentage Pharma Group Inc. https://druglandscape.com/drug/reduced-nicotine-content-cigarettes https://druglandscape.com/api/og?type=drug&title=Reduced%20Nicotine%20Content%20Cigarettes&subtitle=Reduced%20Nicotine%20Content%20Cigarettes%20%C2%B7%20Milton%20S.%20Hershey%20Medical%20Center&badge=phase%201 Reduced Nicotine Content Cigarettes Reduced Nicotine Content Cigarettes · Milton S. Hershey Medical Center https://druglandscape.com/drug/ref-08-038 https://druglandscape.com/api/og?type=drug&title=Ref-08-038&subtitle=Ref-08-038%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 Ref-08-038 Ref-08-038 · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/reference-dentifrice https://druglandscape.com/api/og?type=drug&title=Reference%20Dentifrice&subtitle=Reference%20Dentifrice%20%C2%B7%20HALEON&badge=phase%201 Reference Dentifrice Reference Dentifrice · HALEON https://druglandscape.com/drug/reference-dextromethorphan https://druglandscape.com/api/og?type=drug&title=reference%20%5Bdextromethorphan%5D&subtitle=reference%20%5Bdextromethorphan%5D%20%C2%B7%20Pfizer&badge=phase%201 reference [dextromethorphan] reference [dextromethorphan] · Pfizer https://druglandscape.com/drug/reference-drug https://druglandscape.com/api/og?type=drug&title=Reference%20drug&subtitle=Reference%20drug%20%C2%B7%20Pfizer&badge=phase%202 Reference drug Reference drug · Pfizer https://druglandscape.com/drug/reference-drug-or-test-drug https://druglandscape.com/api/og?type=drug&title=Reference%20Drug%20or%20Test%20Drug&subtitle=Reference%20Drug%20or%20Test%20Drug%20%C2%B7%20JW%20Pharmaceutical&badge=phase%201 Reference Drug or Test Drug Reference Drug or Test Drug · JW Pharmaceutical https://druglandscape.com/drug/reference-drugs https://druglandscape.com/api/og?type=drug&title=reference%20drugs&subtitle=reference%20drugs%20%C2%B7%20Pfizer&badge=phase%201 reference drugs reference drugs · Pfizer https://druglandscape.com/drug/reference-formulation-b https://druglandscape.com/api/og?type=drug&title=Reference%20formulation%20B&subtitle=Reference%20formulation%20B%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Reference formulation B Reference formulation B · GlaxoSmithKline https://druglandscape.com/drug/reference-glucophage-xr https://druglandscape.com/api/og?type=drug&title=Reference%20Glucophage%C2%AE%20XR&subtitle=Reference%20Glucophage%C2%AE%20XR%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Da&badge=phase%201 Reference Glucophage® XR Reference Glucophage® XR · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/reference-gxr https://druglandscape.com/api/og?type=drug&title=Reference%20GXR&subtitle=Reference%20GXR%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 Reference GXR Reference GXR · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/reference-medicinal-product https://druglandscape.com/api/og?type=drug&title=Reference%20Medicinal%20Product&subtitle=Reference%20Medicinal%20Product%20%C2%B7%20Dr.%20Reddy's%20Laboratories%20Limited&badge=phase%201 Reference Medicinal Product Reference Medicinal Product · Dr. Reddy's Laboratories Limited https://druglandscape.com/drug/reference-montelukast https://druglandscape.com/api/og?type=drug&title=Reference%20Montelukast&subtitle=Reference%20Montelukast%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Reference Montelukast Reference Montelukast · GlaxoSmithKline https://druglandscape.com/drug/reference-standard https://druglandscape.com/api/og?type=drug&title=Reference%20standard&subtitle=Reference%20standard%20%C2%B7%20JHP%20Pharmaceuticals%20LLC&badge=phase%202 Reference standard Reference standard · JHP Pharmaceuticals LLC https://druglandscape.com/drug/reference-toothpaste https://druglandscape.com/api/og?type=drug&title=Reference%20Toothpaste&subtitle=Reference%20Toothpaste%20%C2%B7%20HALEON&badge=phase%201 Reference Toothpaste Reference Toothpaste · HALEON https://druglandscape.com/drug/reference-treatment-bms-986165-01 https://druglandscape.com/api/og?type=drug&title=Reference%20Treatment-%20BMS-986165-01&subtitle=Reference%20Treatment-%20BMS-986165-01%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Reference Treatment- BMS-986165-01 Reference Treatment- BMS-986165-01 · Bristol-Myers Squibb https://druglandscape.com/drug/reference-treatment-iv-fosaprepitant-infusion https://druglandscape.com/api/og?type=drug&title=Reference%20Treatment%3A%20IV%20fosaprepitant%20infusion&subtitle=Reference%20Treatment%3A%20IV%20fosaprepitant%20infusion%20%C2%B7%20Helsinn%20Healthcare%20SA&badge=phase%202 Reference Treatment: IV fosaprepitant infusion Reference Treatment: IV fosaprepitant infusion · Helsinn Healthcare SA https://druglandscape.com/drug/reference-treatment-nicotine-transdermal-patch https://druglandscape.com/api/og?type=drug&title=Reference%20treatment%20%3A%20Nicotine%20transdermal%20patch&subtitle=Reference%20treatment%20%3A%20Nicotine%20transdermal%20patch%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%201 Reference treatment : Nicotine transdermal patch Reference treatment : Nicotine transdermal patch · Pierre Fabre Medicament https://druglandscape.com/drug/reference001-hydrocodone https://druglandscape.com/api/og?type=drug&title=Reference001%20-%20Hydrocodone&subtitle=Reference001%20-%20Hydrocodone%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 Reference001 - Hydrocodone Reference001 - Hydrocodone · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/reference001-type-ii https://druglandscape.com/api/og?type=drug&title=Reference001%20type%20II&subtitle=Reference001%20type%20II%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 Reference001 type II Reference001 type II · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/reference147609 https://druglandscape.com/api/og?type=drug&title=Reference147609&subtitle=Reference147609%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 Reference147609 Reference147609 · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/reference147709 https://druglandscape.com/api/og?type=drug&title=Reference147709&subtitle=Reference147709%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 Reference147709 Reference147709 · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/reference1613 https://druglandscape.com/api/og?type=drug&title=Reference1613&subtitle=Reference1613%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 Reference1613 Reference1613 · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/refixia https://druglandscape.com/api/og?type=drug&title=Refixia%C2%AE&subtitle=Refixia%C2%AE%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 Refixia® Refixia® · Novo Nordisk A/S https://druglandscape.com/drug/refrigeration-free-latanoprost https://druglandscape.com/api/og?type=drug&title=refrigeration%20free%20latanoprost&subtitle=refrigeration%20free%20latanoprost%20%C2%B7%20Aurolab&badge=phase%201 refrigeration free latanoprost refrigeration free latanoprost · Aurolab https://druglandscape.com/drug/reg1 https://druglandscape.com/api/og?type=drug&title=REG1&subtitle=REG1%20%C2%B7%20Regado%20Biosciences%2C%20Inc.&badge=phase%202 REG1 REG1 · Regado Biosciences, Inc. https://druglandscape.com/drug/regadenoson-infusion https://druglandscape.com/api/og?type=drug&title=Regadenoson%20infusion&subtitle=Regadenoson%20infusion%20%C2%B7%20Christine%20Lau%2C%20MD&badge=phase%201 Regadenoson infusion Regadenoson infusion · Christine Lau, MD https://druglandscape.com/drug/regan-tangjiang https://druglandscape.com/api/og?type=drug&title=Regan%20Tangjiang&subtitle=Regan%20Tangjiang%20%C2%B7%20Beijing%20Da-an%20Bio-technology%20Co.%2C%20Ltd.&badge=phase%202 Regan Tangjiang Regan Tangjiang · Beijing Da-an Bio-technology Co., Ltd. https://druglandscape.com/drug/rege-pro-dressing https://druglandscape.com/api/og?type=drug&title=REGE%20pro%20dressing&subtitle=REGE%20pro%20dressing%20%C2%B7%20Egyptian%20Atomic%20Energy%20Authority&badge=phase%201 REGE pro dressing REGE pro dressing · Egyptian Atomic Energy Authority https://druglandscape.com/drug/regimen-1-course-2 https://druglandscape.com/api/og?type=drug&title=Regimen%201%2C%20Course%202&subtitle=Regimen%201%2C%20Course%202%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Regimen 1, Course 2 Regimen 1, Course 2 · Baylor College of Medicine https://druglandscape.com/drug/regimen-1-course-2-it-mafosfamide https://druglandscape.com/api/og?type=drug&title=Regimen%201%20Course%202%2C%20IT%20mafosfamide&subtitle=Regimen%201%20Course%202%2C%20IT%20mafosfamide%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Regimen 1 Course 2, IT mafosfamide Regimen 1 Course 2, IT mafosfamide · Baylor College of Medicine https://druglandscape.com/drug/regimen-2-course-1 https://druglandscape.com/api/og?type=drug&title=Regimen%202%2C%20Course%201&subtitle=Regimen%202%2C%20Course%201%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Regimen 2, Course 1 Regimen 2, Course 1 · Baylor College of Medicine https://druglandscape.com/drug/regimen-2-course-2 https://druglandscape.com/api/og?type=drug&title=Regimen%202%2C%20Course%202&subtitle=Regimen%202%2C%20Course%202%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Regimen 2, Course 2 Regimen 2, Course 2 · Baylor College of Medicine https://druglandscape.com/drug/reglan-odt https://druglandscape.com/api/og?type=drug&title=Reglan%20ODT&subtitle=Reglan%20ODT%20%C2%B7%20UCB%20Pharma&badge=phase%201 Reglan ODT Reglan ODT · UCB Pharma https://druglandscape.com/drug/regorafenib-pill https://druglandscape.com/api/og?type=drug&title=Regorafenib%20Pill&subtitle=Regorafenib%20Pill%20%C2%B7%20Teclison%20Ltd.&badge=phase%202 Regorafenib Pill Regorafenib Pill · Teclison Ltd. https://druglandscape.com/drug/regorafenib-tablets https://druglandscape.com/api/og?type=drug&title=Regorafenib%20Tablets&subtitle=Regorafenib%20Tablets%20%C2%B7%20Zhejiang%20Hisun%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 Regorafenib Tablets Regorafenib Tablets · Zhejiang Hisun Pharmaceutical Co. Ltd. https://druglandscape.com/drug/regstem https://druglandscape.com/api/og?type=drug&title=RegStem&subtitle=RegStem%20%C2%B7%20EMO%20Biomedicine%20Corporation&badge=phase%201 RegStem RegStem · EMO Biomedicine Corporation https://druglandscape.com/drug/regular-insulin-u-100 https://druglandscape.com/api/og?type=drug&title=Regular%20insulin%20U-100&subtitle=Regular%20insulin%20U-100%20%C2%B7%20AstraZeneca&badge=phase%201 Regular insulin U-100 Regular insulin U-100 · AstraZeneca https://druglandscape.com/drug/regular-use-of-any-other-antidepressant https://druglandscape.com/api/og?type=drug&title=Regular%20use%20of%20any%20other%20antidepressant&subtitle=Regular%20use%20of%20any%20other%20antidepressant%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Regular use of any other antidepressant Regular use of any other antidepressant · GlaxoSmithKline https://druglandscape.com/drug/rejointm https://druglandscape.com/api/og?type=drug&title=ReJoinTM&subtitle=ReJoinTM%20%C2%B7%20Shanghai%20AbelZeta%20Ltd.&badge=phase%202 ReJoinTM ReJoinTM · Shanghai AbelZeta Ltd. https://druglandscape.com/drug/rejuveinix-high-dose https://druglandscape.com/api/og?type=drug&title=Rejuveinix%20High%20Dose&subtitle=Rejuveinix%20High%20Dose%20%C2%B7%20Reven%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Rejuveinix High Dose Rejuveinix High Dose · Reven Pharmaceuticals, Inc. https://druglandscape.com/drug/rejuveinix-low-dose https://druglandscape.com/api/og?type=drug&title=Rejuveinix%20Low%20Dose&subtitle=Rejuveinix%20Low%20Dose%20%C2%B7%20Reven%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Rejuveinix Low Dose Rejuveinix Low Dose · Reven Pharmaceuticals, Inc. https://druglandscape.com/drug/relative-bioavailability https://druglandscape.com/api/og?type=drug&title=Relative%20Bioavailability&subtitle=Relative%20Bioavailability%20%C2%B7%20Pfizer&badge=phase%201 Relative Bioavailability Relative Bioavailability · Pfizer https://druglandscape.com/drug/relestat-ophthalmic-solution-0-05 https://druglandscape.com/api/og?type=drug&title=Relestat%20Ophthalmic%20Solution%200.05%25&subtitle=Relestat%20Ophthalmic%20Solution%200.05%25%20%C2%B7%20Allergan&badge=phase%202 Relestat Ophthalmic Solution 0.05% Relestat Ophthalmic Solution 0.05% · Allergan https://druglandscape.com/drug/relief-pro-rectal-suppositories https://druglandscape.com/api/og?type=drug&title=Relief%20Pro%20rectal%20suppositories&subtitle=Relief%20Pro%20rectal%20suppositories%20%C2%B7%20Bayer&badge=phase%202 Relief Pro rectal suppositories Relief Pro rectal suppositories · Bayer https://druglandscape.com/drug/relistor-injectable-product https://druglandscape.com/api/og?type=drug&title=Relistor%20Injectable%20Product&subtitle=Relistor%20Injectable%20Product%20%C2%B7%20Methodist%20Health%20System&badge=phase%202 Relistor Injectable Product Relistor Injectable Product · Methodist Health System https://druglandscape.com/drug/relugolix-containing-product https://druglandscape.com/api/og?type=drug&title=Relugolix-Containing%20Product&subtitle=Relugolix-Containing%20Product%20%C2%B7%20Sumitomo%20Pharma%20Switzerland%20GmbH&badge=phase%202 Relugolix-Containing Product Relugolix-Containing Product · Sumitomo Pharma Switzerland GmbH https://druglandscape.com/drug/relvar-100-ellipta https://druglandscape.com/api/og?type=drug&title=RELVAR%20100%20ELLIPTA&subtitle=RELVAR%20100%20ELLIPTA%20%C2%B7%20GlaxoSmithKline&badge=phase%202 RELVAR 100 ELLIPTA RELVAR 100 ELLIPTA · GlaxoSmithKline https://druglandscape.com/drug/rem0046127 https://druglandscape.com/api/og?type=drug&title=REM0046127&subtitle=REM0046127%20%C2%B7%20reMYND&badge=phase%201 REM0046127 REM0046127 · reMYND https://druglandscape.com/drug/remifentanil-manual https://druglandscape.com/api/og?type=drug&title=Remifentanil%20manual&subtitle=Remifentanil%20manual%20%C2%B7%20Centre%20Clinical%2C%20France&badge=phase%201 Remifentanil manual Remifentanil manual · Centre Clinical, France https://druglandscape.com/drug/remifentanil-tci https://druglandscape.com/api/og?type=drug&title=Remifentanil%20TCI&subtitle=Remifentanil%20TCI%20%C2%B7%20Scarlata%2C%20Simone%2C%20M.D.&badge=phase%201 Remifentanil TCI Remifentanil TCI · Scarlata, Simone, M.D. https://druglandscape.com/drug/remitch https://druglandscape.com/api/og?type=drug&title=Remitch%C2%AE&subtitle=Remitch%C2%AE%20%C2%B7%20Shandong%20New%20Time%20Pharmaceutical%20Co.%2C%20LTD&badge=phase%201 Remitch® Remitch® · Shandong New Time Pharmaceutical Co., LTD https://druglandscape.com/drug/remsima-iv https://druglandscape.com/api/og?type=drug&title=Remsima%20IV&subtitle=Remsima%20IV%20%C2%B7%20Celltrion&badge=phase%202 Remsima IV Remsima IV · Celltrion https://druglandscape.com/drug/remsima-sc https://druglandscape.com/api/og?type=drug&title=Remsima%20SC&subtitle=Remsima%20SC%20%C2%B7%20Celltrion&badge=phase%202 Remsima SC Remsima SC · Celltrion https://druglandscape.com/drug/ren-1654 https://druglandscape.com/api/og?type=drug&title=REN-1654&subtitle=REN-1654%20%C2%B7%20Renovis&badge=phase%202 REN-1654 REN-1654 · Renovis https://druglandscape.com/drug/renexin https://druglandscape.com/api/og?type=drug&title=Renexin%C2%AE&subtitle=Renexin%C2%AE%20%C2%B7%20SK%20Chemicals%20Co.%2C%20Ltd.&badge=phase%201 Renexin® Renexin® · SK Chemicals Co., Ltd. https://druglandscape.com/drug/reopro https://druglandscape.com/api/og?type=drug&title=ReoPro%C2%AE&subtitle=ReoPro%C2%AE%20%C2%B7%20Ablynx%2C%20a%20Sanofi%20company&badge=phase%202 ReoPro® ReoPro® · Ablynx, a Sanofi company https://druglandscape.com/drug/rep-2055 https://druglandscape.com/api/og?type=drug&title=REP%202055&subtitle=REP%202055%20%C2%B7%20Replicor%20Inc.&badge=phase%201 REP 2055 REP 2055 · Replicor Inc. https://druglandscape.com/drug/rep-2139-mg https://druglandscape.com/api/og?type=drug&title=REP%202139-Mg&subtitle=REP%202139-Mg%20%C2%B7%20Replicor%20Inc.&badge=phase%202 REP 2139-Mg REP 2139-Mg · Replicor Inc. https://druglandscape.com/drug/rep-2165-mg https://druglandscape.com/api/og?type=drug&title=REP%202165-Mg&subtitle=REP%202165-Mg%20%C2%B7%20Replicor%20Inc.&badge=phase%202 REP 2165-Mg REP 2165-Mg · Replicor Inc. https://druglandscape.com/drug/repaglinide-bupropion-and-shr3680 https://druglandscape.com/api/og?type=drug&title=Repaglinide%2C%20Bupropion%20and%20SHR3680&subtitle=Repaglinide%2C%20Bupropion%20and%20SHR3680%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Repaglinide, Bupropion and SHR3680 Repaglinide, Bupropion and SHR3680 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/repaglinide-midazolam-shr4640 https://druglandscape.com/api/og?type=drug&title=repaglinide%3B%20midazolam%3B%20SHR4640&subtitle=repaglinide%3B%20midazolam%3B%20SHR4640%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 repaglinide; midazolam; SHR4640 repaglinide; midazolam; SHR4640 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/repaglinide-tablets https://druglandscape.com/api/og?type=drug&title=Repaglinide%20Tablets&subtitle=Repaglinide%20Tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Repaglinide Tablets Repaglinide Tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/reparixin-continuous-infusion https://druglandscape.com/api/og?type=drug&title=Reparixin%20continuous%20infusion&subtitle=Reparixin%20continuous%20infusion%20%C2%B7%20Domp%C3%A9%20Farmaceutici%20S.p.A&badge=phase%202 Reparixin continuous infusion Reparixin continuous infusion · Dompé Farmaceutici S.p.A https://druglandscape.com/drug/repeat-iv-dose-of-gsk2862277 https://druglandscape.com/api/og?type=drug&title=Repeat%20IV%20dose%20of%20GSK2862277&subtitle=Repeat%20IV%20dose%20of%20GSK2862277%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Repeat IV dose of GSK2862277 Repeat IV dose of GSK2862277 · GlaxoSmithKline https://druglandscape.com/drug/repo-a https://druglandscape.com/api/og?type=drug&title=REPO-A&subtitle=REPO-A%20%C2%B7%20LG%20Life%20Sciences&badge=phase%201 REPO-A REPO-A · LG Life Sciences https://druglandscape.com/drug/rescap https://druglandscape.com/api/og?type=drug&title=RESCAP%C2%AE&subtitle=RESCAP%C2%AE%20%C2%B7%20Alloksys%20Life%20Sciences%20B.V.&badge=phase%202 RESCAP® RESCAP® · Alloksys Life Sciences B.V. https://druglandscape.com/drug/resin-modified-glass-ionomer-cement https://druglandscape.com/api/og?type=drug&title=Resin%20modified%20glass%20ionomer%20cement&subtitle=Resin%20modified%20glass%20ionomer%20cement%20%C2%B7%20Nourhan%20M.Aly&badge=phase%202 Resin modified glass ionomer cement Resin modified glass ionomer cement · Nourhan M.Aly https://druglandscape.com/drug/resiquimod-0-01 https://druglandscape.com/api/og?type=drug&title=Resiquimod%200.01%25&subtitle=Resiquimod%200.01%25%20%C2%B7%20Spirig%20Pharma%20Ltd.&badge=phase%202 Resiquimod 0.01% Resiquimod 0.01% · Spirig Pharma Ltd. https://druglandscape.com/drug/resiquimod-0-03 https://druglandscape.com/api/og?type=drug&title=Resiquimod%200.03%25&subtitle=Resiquimod%200.03%25%20%C2%B7%20Spirig%20Pharma%20Ltd.&badge=phase%202 Resiquimod 0.03% Resiquimod 0.03% · Spirig Pharma Ltd. https://druglandscape.com/drug/resistant-potato-starch https://druglandscape.com/api/og?type=drug&title=Resistant%20Potato%20Starch&subtitle=Resistant%20Potato%20Starch%20%C2%B7%20VA%20Office%20of%20Research%20and%20Development&badge=phase%202 Resistant Potato Starch Resistant Potato Starch · VA Office of Research and Development https://druglandscape.com/drug/reslizumab-iv https://druglandscape.com/api/og?type=drug&title=Reslizumab%20IV&subtitle=Reslizumab%20IV%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%201 Reslizumab IV Reslizumab IV · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/reslizumab-sc https://druglandscape.com/api/og?type=drug&title=Reslizumab%20SC&subtitle=Reslizumab%20SC%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%201 Reslizumab SC Reslizumab SC · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/resp302 https://druglandscape.com/api/og?type=drug&title=RESP302&subtitle=RESP302%20%C2%B7%20Thirty%20Respiratory%20Limited&badge=phase%201 RESP302 RESP302 · Thirty Respiratory Limited https://druglandscape.com/drug/resp303 https://druglandscape.com/api/og?type=drug&title=RESP303&subtitle=RESP303%20%C2%B7%20Thirty%20Respiratory%20Limited&badge=phase%201 RESP303 RESP303 · Thirty Respiratory Limited https://druglandscape.com/drug/resp30tb https://druglandscape.com/api/og?type=drug&title=RESP30TB&subtitle=RESP30TB%20%C2%B7%20Thirty%20Respiratory%20Limited&badge=phase%202 RESP30TB RESP30TB · Thirty Respiratory Limited https://druglandscape.com/drug/restrictive-fluid-administration https://druglandscape.com/api/og?type=drug&title=restrictive%20fluid%20administration&subtitle=restrictive%20fluid%20administration%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 restrictive fluid administration restrictive fluid administration · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/restylane-line-of-injectables https://druglandscape.com/api/og?type=drug&title=Restylane%20line%20of%20injectables&subtitle=Restylane%20line%20of%20injectables%20%C2%B7%20Erevna%20Innovations%20Inc.&badge=phase%201 Restylane line of injectables Restylane line of injectables · Erevna Innovations Inc. https://druglandscape.com/drug/restylane-lyft https://druglandscape.com/api/og?type=drug&title=Restylane%C2%AE%20Lyft&subtitle=Restylane%C2%AE%20Lyft%20%C2%B7%20DeNova%20Research&badge=phase%201 Restylane® Lyft Restylane® Lyft · DeNova Research https://druglandscape.com/drug/restylane-volyme https://druglandscape.com/api/og?type=drug&title=Restylane%20Volyme&subtitle=Restylane%20Volyme%20%C2%B7%20Chongqing%20Jinsaixing%20Medical%20Technology%20Co.%2C%20Ltd&badge=phase%201 Restylane Volyme Restylane Volyme · Chongqing Jinsaixing Medical Technology Co., Ltd https://druglandscape.com/drug/retagliptin-phosphate-tablet https://druglandscape.com/api/og?type=drug&title=Retagliptin%20Phosphate%20Tablet&subtitle=Retagliptin%20Phosphate%20Tablet%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Retagliptin Phosphate Tablet Retagliptin Phosphate Tablet · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/retapamulin-microdialysis https://druglandscape.com/api/og?type=drug&title=Retapamulin%20Microdialysis&subtitle=Retapamulin%20Microdialysis%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Retapamulin Microdialysis Retapamulin Microdialysis · GlaxoSmithKline https://druglandscape.com/drug/retin-a-0-1-cream https://druglandscape.com/api/og?type=drug&title=Retin-A%C2%AE%200.1%25%20Cream&subtitle=Retin-A%C2%AE%200.1%25%20Cream%20%C2%B7%20Sol-Gel%20Technologies%2C%20Ltd.&badge=phase%201 Retin-A® 0.1% Cream Retin-A® 0.1% Cream · Sol-Gel Technologies, Ltd. https://druglandscape.com/drug/retin-a-and-microdermabrasion https://druglandscape.com/api/og?type=drug&title=Retin-A%20and%20microdermabrasion&subtitle=Retin-A%20and%20microdermabrasion%20%C2%B7%20ConBio%2C%20a%20Cynosure%20Company&badge=phase%201 Retin-A and microdermabrasion Retin-A and microdermabrasion · ConBio, a Cynosure Company https://druglandscape.com/drug/retin-a-micro-0-04-facial-acne-treatment https://druglandscape.com/api/og?type=drug&title=Retin-A%20Micro%200.04%25%20facial%20acne%20treatment&subtitle=Retin-A%20Micro%200.04%25%20facial%20acne%20treatment%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%202 Retin-A Micro 0.04% facial acne treatment Retin-A Micro 0.04% facial acne treatment · Bausch Health Americas, Inc. https://druglandscape.com/drug/retinostat https://druglandscape.com/api/og?type=drug&title=RetinoStat&subtitle=RetinoStat%20%C2%B7%20Oxford%20BioMedica&badge=phase%201 RetinoStat RetinoStat · Oxford BioMedica https://druglandscape.com/drug/retisert-implant https://druglandscape.com/api/og?type=drug&title=Retisert%20Implant&subtitle=Retisert%20Implant%20%C2%B7%20Control%20Delivery%20Systems&badge=phase%202 Retisert Implant Retisert Implant · Control Delivery Systems https://druglandscape.com/drug/review-medication https://druglandscape.com/api/og?type=drug&title=review%20medication&subtitle=review%20medication%20%C2%B7%20Parc%20Sanitari%20Pere%20Virgili&badge=phase%201 review medication review medication · Parc Sanitari Pere Virgili https://druglandscape.com/drug/revlimid-cap https://druglandscape.com/api/og?type=drug&title=Revlimid%20cap&subtitle=Revlimid%20cap%20%C2%B7%20Samyang%20Biopharmaceuticals%20Corporation&badge=phase%201 Revlimid cap Revlimid cap · Samyang Biopharmaceuticals Corporation https://druglandscape.com/drug/revlimid-melphalan-prednisone-thalidomide https://druglandscape.com/api/og?type=drug&title=Revlimid%2C%20Melphalan%2C%20Prednisone%2C%20Thalidomide&subtitle=Revlimid%2C%20Melphalan%2C%20Prednisone%2C%20Thalidomide%20%C2%B7%20Fondazione%20EMN%20Italy%20Onlus&badge=phase%202 Revlimid, Melphalan, Prednisone, Thalidomide Revlimid, Melphalan, Prednisone, Thalidomide · Fondazione EMN Italy Onlus https://druglandscape.com/drug/revm10-gene https://druglandscape.com/api/og?type=drug&title=RevM10%20gene&subtitle=RevM10%20gene%20%C2%B7%20Systemix&badge=phase%201 RevM10 gene RevM10 gene · Systemix https://druglandscape.com/drug/rexenatide-4 https://druglandscape.com/api/og?type=drug&title=rExenatide-4&subtitle=rExenatide-4%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%202 rExenatide-4 rExenatide-4 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/reyataz-atazanavir https://druglandscape.com/api/og?type=drug&title=Reyataz%20Atazanavir&subtitle=Reyataz%20Atazanavir%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%201 Reyataz Atazanavir Reyataz Atazanavir · Bristol-Myers Squibb https://druglandscape.com/drug/rf1-and-rv-protein-antigens https://druglandscape.com/api/og?type=drug&title=rF1%20and%20rV%20protein%20antigens&subtitle=rF1%20and%20rV%20protein%20antigens%20%C2%B7%20PharmAthene%20UK%20Limited&badge=phase%201 rF1 and rV protein antigens rF1 and rV protein antigens · PharmAthene UK Limited https://druglandscape.com/drug/rf1v-1018 https://druglandscape.com/api/og?type=drug&title=rF1V-1018&subtitle=rF1V-1018%20%C2%B7%20Dynavax%20Technologies%20Corporation&badge=phase%202 rF1V-1018 rF1V-1018 · Dynavax Technologies Corporation https://druglandscape.com/drug/rf1v-vaccine https://druglandscape.com/api/og?type=drug&title=rF1V%20vaccine&subtitle=rF1V%20vaccine%20%C2%B7%20DynPort%20Vaccine%20Company%20LLC%2C%20A%20GDIT%20Company&badge=phase%202 rF1V vaccine rF1V vaccine · DynPort Vaccine Company LLC, A GDIT Company https://druglandscape.com/drug/rfiv-vaccine https://druglandscape.com/api/og?type=drug&title=rFIV%20vaccine&subtitle=rFIV%20vaccine%20%C2%B7%20DynPort%20Vaccine%20Company%20LLC%2C%20A%20GDIT%20Company&badge=phase%202 rFIV vaccine rFIV vaccine · DynPort Vaccine Company LLC, A GDIT Company https://druglandscape.com/drug/rg012 https://druglandscape.com/api/og?type=drug&title=RG012&subtitle=RG012%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%201 RG012 RG012 · Genzyme, a Sanofi Company https://druglandscape.com/drug/rg1511 https://druglandscape.com/api/og?type=drug&title=RG1511&subtitle=RG1511%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RG1511 RG1511 · Hoffmann-La Roche https://druglandscape.com/drug/rg1530 https://druglandscape.com/api/og?type=drug&title=RG1530&subtitle=RG1530%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RG1530 RG1530 · Hoffmann-La Roche https://druglandscape.com/drug/rg1662 https://druglandscape.com/api/og?type=drug&title=RG1662&subtitle=RG1662%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RG1662 RG1662 · Hoffmann-La Roche https://druglandscape.com/drug/rg1671 https://druglandscape.com/api/og?type=drug&title=RG1671&subtitle=RG1671%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RG1671 RG1671 · Hoffmann-La Roche https://druglandscape.com/drug/rg4733 https://druglandscape.com/api/og?type=drug&title=RG4733&subtitle=RG4733%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RG4733 RG4733 · Hoffmann-La Roche https://druglandscape.com/drug/rg547 https://druglandscape.com/api/og?type=drug&title=RG547&subtitle=RG547%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RG547 RG547 · Hoffmann-La Roche https://druglandscape.com/drug/rg7314 https://druglandscape.com/api/og?type=drug&title=RG7314&subtitle=RG7314%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RG7314 RG7314 · Hoffmann-La Roche https://druglandscape.com/drug/rg7625 https://druglandscape.com/api/og?type=drug&title=RG7625&subtitle=RG7625%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RG7625 RG7625 · Hoffmann-La Roche https://druglandscape.com/drug/rg7667 https://druglandscape.com/api/og?type=drug&title=RG7667&subtitle=RG7667%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 RG7667 RG7667 · Genentech, Inc. https://druglandscape.com/drug/rg7774 https://druglandscape.com/api/og?type=drug&title=RG7774&subtitle=RG7774%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RG7774 RG7774 · Hoffmann-La Roche https://druglandscape.com/drug/rgb-03 https://druglandscape.com/api/og?type=drug&title=RGB-03&subtitle=RGB-03%20%C2%B7%20Gedeon%20Richter%20Plc.&badge=phase%201 RGB-03 RGB-03 · Gedeon Richter Plc. https://druglandscape.com/drug/rgb-10 https://druglandscape.com/api/og?type=drug&title=RGB-10&subtitle=RGB-10%20%C2%B7%20Gedeon%20Richter%20Plc.&badge=phase%201 RGB-10 RGB-10 · Gedeon Richter Plc. https://druglandscape.com/drug/rgb-5088 https://druglandscape.com/api/og?type=drug&title=RGB-5088&subtitle=RGB-5088%20%C2%B7%20Hangzhou%20Reprogenix%20Bioscience%2C%20Inc&badge=phase%201 RGB-5088 RGB-5088 · Hangzhou Reprogenix Bioscience, Inc https://druglandscape.com/drug/rgh-706 https://druglandscape.com/api/og?type=drug&title=RGH-706&subtitle=RGH-706%20%C2%B7%20Gedeon%20Richter%20Plc.&badge=phase%202 RGH-706 RGH-706 · Gedeon Richter Plc. https://druglandscape.com/drug/rgls8429 https://druglandscape.com/api/og?type=drug&title=RGLS8429&subtitle=RGLS8429%20%C2%B7%20Regulus%20Therapeutics%20Inc.&badge=phase%201 RGLS8429 RGLS8429 · Regulus Therapeutics Inc. https://druglandscape.com/drug/rglucagon https://druglandscape.com/api/og?type=drug&title=rGlucagon&subtitle=rGlucagon%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 rGlucagon rGlucagon · Eli Lilly and Company https://druglandscape.com/drug/rgt-61159 https://druglandscape.com/api/og?type=drug&title=RGT-61159&subtitle=RGT-61159%20%C2%B7%20Rgenta%20Therapeutics%20Inc&badge=phase%201 RGT-61159 RGT-61159 · Rgenta Therapeutics Inc https://druglandscape.com/drug/rgt001-075 https://druglandscape.com/api/og?type=drug&title=RGT001-075&subtitle=RGT001-075%20%C2%B7%20Regor%20Pharmaceuticals%20Inc.&badge=phase%202 RGT001-075 RGT001-075 · Regor Pharmaceuticals Inc. https://druglandscape.com/drug/rgx-104 https://druglandscape.com/api/og?type=drug&title=RGX-104&subtitle=RGX-104%20%C2%B7%20Inspirna%2C%20Inc.&badge=phase%201 RGX-104 RGX-104 · Inspirna, Inc. https://druglandscape.com/drug/rh324 https://druglandscape.com/api/og?type=drug&title=RH324&subtitle=RH324%20%C2%B7%20ReHeva%20Biosciences%2CInc.&badge=phase%201 RH324 RH324 · ReHeva Biosciences,Inc. https://druglandscape.com/drug/rha-adjuvant https://druglandscape.com/api/og?type=drug&title=rHA%20adjuvant&subtitle=rHA%20adjuvant%20%C2%B7%20Protein%20Sciences%20Corporation&badge=phase%201 rHA adjuvant rHA adjuvant · Protein Sciences Corporation https://druglandscape.com/drug/rhasa-dose-level-3 https://druglandscape.com/api/og?type=drug&title=rhASA%20-%20Dose%20Level%203&subtitle=rhASA%20-%20Dose%20Level%203%20%C2%B7%20Shire&badge=phase%201 rhASA - Dose Level 3 rhASA - Dose Level 3 · Shire https://druglandscape.com/drug/rhbmp-2-placement https://druglandscape.com/api/og?type=drug&title=rhBMP-2%20placement&subtitle=rhBMP-2%20placement%20%C2%B7%20Aya%20Adil%20Saeed&badge=phase%201 rhBMP-2 placement rhBMP-2 placement · Aya Adil Saeed https://druglandscape.com/drug/rhbssl https://druglandscape.com/api/og?type=drug&title=rhBSSL&subtitle=rhBSSL%20%C2%B7%20Swedish%20Orphan%20Biovitrum&badge=phase%202 rhBSSL rhBSSL · Swedish Orphan Biovitrum https://druglandscape.com/drug/rhc1inh https://druglandscape.com/api/og?type=drug&title=rhC1INH&subtitle=rhC1INH%20%C2%B7%20University%20of%20Wisconsin%2C%20Madison&badge=phase%203 rhC1INH rhC1INH · University of Wisconsin, Madison https://druglandscape.com/drug/rhc1inh-or-pdc1inh https://druglandscape.com/api/og?type=drug&title=rhC1INH%20or%20pdC1INH&subtitle=rhC1INH%20or%20pdC1INH%20%C2%B7%20Pharming%20Technologies%20B.V.&badge=phase%202 rhC1INH or pdC1INH rhC1INH or pdC1INH · Pharming Technologies B.V. https://druglandscape.com/drug/rhdl https://druglandscape.com/api/og?type=drug&title=rHDL&subtitle=rHDL%20%C2%B7%20CSL%20Limited&badge=phase%202 rHDL rHDL · CSL Limited https://druglandscape.com/drug/rhez https://druglandscape.com/api/og?type=drug&title=RHEZ&subtitle=RHEZ%20%C2%B7%20Otsuka%20Pharmaceutical%20Development%20%26%20Commercialization%2C%20Inc.&badge=phase%202 RHEZ RHEZ · Otsuka Pharmaceutical Development & Commercialization, Inc. https://druglandscape.com/drug/rhfviia https://druglandscape.com/api/og?type=drug&title=rhFVIIa&subtitle=rhFVIIa%20%C2%B7%20rEVO%20Biologics&badge=phase%201 rhFVIIa rhFVIIa · rEVO Biologics https://druglandscape.com/drug/rhinovirus-a-16-infection https://druglandscape.com/api/og?type=drug&title=Rhinovirus%20A-16%20Infection&subtitle=Rhinovirus%20A-16%20Infection%20%C2%B7%20Imperial%20College%20London&badge=phase%201 Rhinovirus A-16 Infection Rhinovirus A-16 Infection · Imperial College London https://druglandscape.com/drug/rhngf https://druglandscape.com/api/og?type=drug&title=rhNGF&subtitle=rhNGF%20%C2%B7%20Domp%C3%A9%20Farmaceutici%20S.p.A&badge=phase%202 rhNGF rhNGF · Dompé Farmaceutici S.p.A https://druglandscape.com/drug/rho-11 https://druglandscape.com/api/og?type=drug&title=Rho-11&subtitle=Rho-11%20%C2%B7%20Rhoshan%20Pharmaceuticals%20Inc&badge=phase%201 Rho-11 Rho-11 · Rhoshan Pharmaceuticals Inc https://druglandscape.com/drug/rhu-pgelsolin https://druglandscape.com/api/og?type=drug&title=rhu-pGelsolin&subtitle=rhu-pGelsolin%20%C2%B7%20Critical%20Biologics%20Corporation&badge=phase%201 rhu-pGelsolin rhu-pGelsolin · Critical Biologics Corporation https://druglandscape.com/drug/rhu-pgsn https://druglandscape.com/api/og?type=drug&title=Rhu-pGSN&subtitle=Rhu-pGSN%20%C2%B7%20BioAegis%20Therapeutics%20Inc.&badge=phase%202 Rhu-pGSN Rhu-pGSN · BioAegis Therapeutics Inc. https://druglandscape.com/drug/rhugm-csf https://druglandscape.com/api/og?type=drug&title=rhuGM-CSF&subtitle=rhuGM-CSF%20%C2%B7%20Bionor%20Immuno%20AS&badge=phase%202 rhuGM-CSF rhuGM-CSF · Bionor Immuno AS https://druglandscape.com/drug/rhumab https://druglandscape.com/api/og?type=drug&title=rhuMAb&subtitle=rhuMAb%20%C2%B7%20Alliance%20for%20Clinical%20Trials%20in%20Oncology&badge=phase%201 rhuMAb rhuMAb · Alliance for Clinical Trials in Oncology https://druglandscape.com/drug/rhumab-2c4 https://druglandscape.com/api/og?type=drug&title=rhuMAb%202C4&subtitle=rhuMAb%202C4%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 rhuMAb 2C4 rhuMAb 2C4 · Genentech, Inc. https://druglandscape.com/drug/rhumab-beta7 https://druglandscape.com/api/og?type=drug&title=rhuMAb%20Beta7&subtitle=rhuMAb%20Beta7%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 rhuMAb Beta7 rhuMAb Beta7 · Genentech, Inc. https://druglandscape.com/drug/rhumab-ifnalpha https://druglandscape.com/api/og?type=drug&title=rhuMAb%20IFNalpha&subtitle=rhuMAb%20IFNalpha%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 rhuMAb IFNalpha rhuMAb IFNalpha · Genentech, Inc. https://druglandscape.com/drug/rhuph20 https://druglandscape.com/api/og?type=drug&title=rHuPH20&subtitle=rHuPH20%20%C2%B7%20ViiV%20Healthcare&badge=phase%203 rHuPH20 rHuPH20 · ViiV Healthcare https://druglandscape.com/drug/rhustoxicodendron-30 https://druglandscape.com/api/og?type=drug&title=Rhustoxicodendron%2030&subtitle=Rhustoxicodendron%2030%20%C2%B7%20Healthcare%20Homoeo%20Charitable%20Society&badge=phase%202 Rhustoxicodendron 30 Rhustoxicodendron 30 · Healthcare Homoeo Charitable Society https://druglandscape.com/drug/rhze https://druglandscape.com/api/og?type=drug&title=RHZE&subtitle=RHZE%20%C2%B7%20Sequella%2C%20Inc.&badge=phase%202 RHZE RHZE · Sequella, Inc. https://druglandscape.com/drug/ri-001 https://druglandscape.com/api/og?type=drug&title=RI-001&subtitle=RI-001%20%C2%B7%20ADMA%20Biologics%2C%20Inc.&badge=phase%202 RI-001 RI-001 · ADMA Biologics, Inc. https://druglandscape.com/drug/riamet https://druglandscape.com/api/og?type=drug&title=Riamet%C2%AE&subtitle=Riamet%C2%AE%20%C2%B7%20sigma-tau%20i.f.r.%20S.p.A.&badge=phase%201 Riamet® Riamet® · sigma-tau i.f.r. S.p.A. https://druglandscape.com/drug/ribavirin-capsules https://druglandscape.com/api/og?type=drug&title=Ribavirin%20Capsules&subtitle=Ribavirin%20Capsules%20%C2%B7%20The%20Scientific%20and%20Technological%20Research%20Council%20of%20Turkey&badge=phase%202 Ribavirin Capsules Ribavirin Capsules · The Scientific and Technological Research Council of Turkey https://druglandscape.com/drug/ribavirin-usp https://druglandscape.com/api/og?type=drug&title=ribavirin%2C%20USP&subtitle=ribavirin%2C%20USP%20%C2%B7%20Medtronic%20Corporate%20Technologies%20and%20New%20Ventures&badge=phase%202 ribavirin, USP ribavirin, USP · Medtronic Corporate Technologies and New Ventures https://druglandscape.com/drug/ribociclib-plus-letrozole https://druglandscape.com/api/og?type=drug&title=Ribociclib%20plus%20letrozole&subtitle=Ribociclib%20plus%20letrozole%20%C2%B7%20Borstkanker%20Onderzoek%20Groep&badge=phase%202 Ribociclib plus letrozole Ribociclib plus letrozole · Borstkanker Onderzoek Groep https://druglandscape.com/drug/ribociclib-with-fulvestrant https://druglandscape.com/api/og?type=drug&title=Ribociclib%20with%20fulvestrant&subtitle=Ribociclib%20with%20fulvestrant%20%C2%B7%20Yeon%20Hee%20Park&badge=phase%202 Ribociclib with fulvestrant Ribociclib with fulvestrant · Yeon Hee Park https://druglandscape.com/drug/ribvd https://druglandscape.com/api/og?type=drug&title=RiBVD&subtitle=RiBVD%20%C2%B7%20French%20Innovative%20Leukemia%20Organisation&badge=phase%202 RiBVD RiBVD · French Innovative Leukemia Organisation https://druglandscape.com/drug/rifafour-e-275 https://druglandscape.com/api/og?type=drug&title=RIFAFOUR%20e-275&subtitle=RIFAFOUR%20e-275%20%C2%B7%20GlaxoSmithKline&badge=phase%202 RIFAFOUR e-275 RIFAFOUR e-275 · GlaxoSmithKline https://druglandscape.com/drug/rifafour-e275 https://druglandscape.com/api/og?type=drug&title=Rifafour%20e275&subtitle=Rifafour%20e275%20%C2%B7%20TASK%20Applied%20Science&badge=phase%202 Rifafour e275 Rifafour e275 · TASK Applied Science https://druglandscape.com/drug/rifalazil-25-milligram https://druglandscape.com/api/og?type=drug&title=Rifalazil%2025%20milligram&subtitle=Rifalazil%2025%20milligram%20%C2%B7%20ActivBiotics%20Pharma%2C%20LLC&badge=phase%202 Rifalazil 25 milligram Rifalazil 25 milligram · ActivBiotics Pharma, LLC https://druglandscape.com/drug/rifampicin-ask120067 https://druglandscape.com/api/og?type=drug&title=Rifampicin%3B%20ASK120067&subtitle=Rifampicin%3B%20ASK120067%20%C2%B7%20Jiangsu%20Aosaikang%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Rifampicin; ASK120067 Rifampicin; ASK120067 · Jiangsu Aosaikang Pharmaceutical Co., Ltd. https://druglandscape.com/drug/rifampicin-sy-004 https://druglandscape.com/api/og?type=drug&title=rifampicin%EF%BC%8CSY-004&subtitle=rifampicin%EF%BC%8CSY-004%20%C2%B7%20Suzhou%20Yabao%20Pharmaceutical%20R%26D%20Co.%2C%20Ltd.&badge=phase%201 rifampicin，SY-004 rifampicin，SY-004 · Suzhou Yabao Pharmaceutical R&D Co., Ltd. https://druglandscape.com/drug/rifampin-hsk3486 https://druglandscape.com/api/og?type=drug&title=rifampin%20%2C%20HSK3486&subtitle=rifampin%20%2C%20HSK3486%20%C2%B7%20Sichuan%20Haisco%20Pharmaceutical%20Group%20Co.%2C%20Ltd&badge=phase%201 rifampin , HSK3486 rifampin , HSK3486 · Sichuan Haisco Pharmaceutical Group Co., Ltd https://druglandscape.com/drug/rifampin-oral-capsules https://druglandscape.com/api/og?type=drug&title=Rifampin%20Oral%20Capsules&subtitle=Rifampin%20Oral%20Capsules%20%C2%B7%20Amgen&badge=phase%201 Rifampin Oral Capsules Rifampin Oral Capsules · Amgen https://druglandscape.com/drug/rifamycin-sv-mmx-600 https://druglandscape.com/api/og?type=drug&title=Rifamycin%20SV-MMX%C2%AE%20600&subtitle=Rifamycin%20SV-MMX%C2%AE%20600%20%C2%B7%20Cosmo%20Technologies%20Ltd&badge=phase%201 Rifamycin SV-MMX® 600 Rifamycin SV-MMX® 600 · Cosmo Technologies Ltd https://druglandscape.com/drug/rifaximin-novel-formulation https://druglandscape.com/api/og?type=drug&title=Rifaximin%20Novel%20Formulation&subtitle=Rifaximin%20Novel%20Formulation%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%201 Rifaximin Novel Formulation Rifaximin Novel Formulation · Bausch Health Americas, Inc. https://druglandscape.com/drug/rifinah-or-local-generics https://druglandscape.com/api/og?type=drug&title=Rifinah%20or%20local%20generics&subtitle=Rifinah%20or%20local%20generics%20%C2%B7%20St%20Stephens%20Aids%20Trust&badge=phase%201 Rifinah or local generics Rifinah or local generics · St Stephens Aids Trust https://druglandscape.com/drug/rig-c https://druglandscape.com/api/og?type=drug&title=RIG-C&subtitle=RIG-C%20%C2%B7%20Grifols%20Therapeutics%20LLC&badge=phase%201 RIG-C RIG-C · Grifols Therapeutics LLC https://druglandscape.com/drug/ril-21 https://druglandscape.com/api/og?type=drug&title=rIL-21&subtitle=rIL-21%20%C2%B7%20NCIC%20Clinical%20Trials%20Group&badge=phase%202 rIL-21 rIL-21 · NCIC Clinical Trials Group https://druglandscape.com/drug/ril-21-only https://druglandscape.com/api/og?type=drug&title=rIL-21%20only&subtitle=rIL-21%20only%20%C2%B7%20ZymoGenetics&badge=phase%201 rIL-21 only rIL-21 only · ZymoGenetics https://druglandscape.com/drug/rilpivirine-formulation-g002 https://druglandscape.com/api/og?type=drug&title=Rilpivirine%20formulation%20G002&subtitle=Rilpivirine%20formulation%20G002%20%C2%B7%20Janssen%20Sciences%20Ireland%20UC&badge=phase%201 Rilpivirine formulation G002 Rilpivirine formulation G002 · Janssen Sciences Ireland UC https://druglandscape.com/drug/rilpivirine-formulation-g007 https://druglandscape.com/api/og?type=drug&title=Rilpivirine%20formulation%20G007&subtitle=Rilpivirine%20formulation%20G007%20%C2%B7%20Janssen%20Sciences%20Ireland%20UC&badge=phase%201 Rilpivirine formulation G007 Rilpivirine formulation G007 · Janssen Sciences Ireland UC https://druglandscape.com/drug/rilpivirine-oral-tablet https://druglandscape.com/api/og?type=drug&title=Rilpivirine%20Oral%20Tablet&subtitle=Rilpivirine%20Oral%20Tablet%20%C2%B7%20Janssen%20Sciences%20Ireland%20UC&badge=phase%201 Rilpivirine Oral Tablet Rilpivirine Oral Tablet · Janssen Sciences Ireland UC https://druglandscape.com/drug/rilzabrutinib-amorphous-form https://druglandscape.com/api/og?type=drug&title=Rilzabrutinib%20amorphous%20form&subtitle=Rilzabrutinib%20amorphous%20form%20%C2%B7%20Sanofi&badge=phase%201 Rilzabrutinib amorphous form Rilzabrutinib amorphous form · Sanofi https://druglandscape.com/drug/rilzabrutinib-crystalline-form https://druglandscape.com/api/og?type=drug&title=Rilzabrutinib%20crystalline%20form&subtitle=Rilzabrutinib%20crystalline%20form%20%C2%B7%20Sanofi&badge=phase%201 Rilzabrutinib crystalline form Rilzabrutinib crystalline form · Sanofi https://druglandscape.com/drug/rilzabrutinib-dose-1 https://druglandscape.com/api/og?type=drug&title=Rilzabrutinib%20dose%201&subtitle=Rilzabrutinib%20dose%201%20%C2%B7%20Sanofi&badge=phase%202 Rilzabrutinib dose 1 Rilzabrutinib dose 1 · Sanofi https://druglandscape.com/drug/rilzabrutinib-sar444671 https://druglandscape.com/api/og?type=drug&title=rilzabrutinib%20SAR444671&subtitle=rilzabrutinib%20SAR444671%20%C2%B7%20Principia%20Biopharma%2C%20a%20Sanofi%20Company&badge=phase%201 rilzabrutinib SAR444671 rilzabrutinib SAR444671 · Principia Biopharma, a Sanofi Company https://druglandscape.com/drug/rimo-301 https://druglandscape.com/api/og?type=drug&title=RiMO-301&subtitle=RiMO-301%20%C2%B7%20Coordination%20Pharmaceuticals%2C%20Inc.&badge=phase%201 RiMO-301 RiMO-301 · Coordination Pharmaceuticals, Inc. https://druglandscape.com/drug/rin-150 https://druglandscape.com/api/og?type=drug&title=RIN%20150&subtitle=RIN%20150%20%C2%B7%20Pfizer&badge=phase%201 RIN 150 RIN 150 · Pfizer https://druglandscape.com/drug/ringer-lactate-and-norepinephrine-infusion https://druglandscape.com/api/og?type=drug&title=Ringer%20Lactate%20and%20Norepinephrine%20infusion&subtitle=Ringer%20Lactate%20and%20Norepinephrine%20infusion%20%C2%B7%20Tata%20Memorial%20Centre&badge=phase%201 Ringer Lactate and Norepinephrine infusion Ringer Lactate and Norepinephrine infusion · Tata Memorial Centre https://druglandscape.com/drug/ringerfundin-b-braun https://druglandscape.com/api/og?type=drug&title=Ringerfundin%20%C2%AE%20B.%20Braun&subtitle=Ringerfundin%20%C2%AE%20B.%20Braun%20%C2%B7%20Kratochvil%20Milan%2C%20MD&badge=phase%201 Ringerfundin ® B. Braun Ringerfundin ® B. Braun · Kratochvil Milan, MD https://druglandscape.com/drug/rinsulin-nph https://druglandscape.com/api/og?type=drug&title=Rinsulin%20NPH&subtitle=Rinsulin%20NPH%20%C2%B7%20Geropharm&badge=phase%201 Rinsulin NPH Rinsulin NPH · Geropharm https://druglandscape.com/drug/rinsulin-r https://druglandscape.com/api/og?type=drug&title=Rinsulin%C2%AE%20R&subtitle=Rinsulin%C2%AE%20R%20%C2%B7%20Geropharm&badge=phase%201 Rinsulin® R Rinsulin® R · Geropharm https://druglandscape.com/drug/riociguat-film-coated-tablets https://druglandscape.com/api/og?type=drug&title=Riociguat%20film%20coated%20tablets&subtitle=Riociguat%20film%20coated%20tablets%20%C2%B7%20Humanis%20Sagl%C4%B1k%20Anonim%20Sirketi&badge=phase%201 Riociguat film coated tablets Riociguat film coated tablets · Humanis Saglık Anonim Sirketi https://druglandscape.com/drug/ripk1-inhibitor https://druglandscape.com/api/og?type=drug&title=RIPK1%20inhibitor&subtitle=RIPK1%20inhibitor%20%C2%B7%20Sanofi&badge=phase%201 RIPK1 inhibitor RIPK1 inhibitor · Sanofi https://druglandscape.com/drug/risankizumab-dose-a https://druglandscape.com/api/og?type=drug&title=Risankizumab%20Dose%20A&subtitle=Risankizumab%20Dose%20A%20%C2%B7%20AbbVie&badge=phase%201 Risankizumab Dose A Risankizumab Dose A · AbbVie https://druglandscape.com/drug/risankizumab-dose-b https://druglandscape.com/api/og?type=drug&title=Risankizumab%20Dose%20B&subtitle=Risankizumab%20Dose%20B%20%C2%B7%20AbbVie&badge=phase%201 Risankizumab Dose B Risankizumab Dose B · AbbVie https://druglandscape.com/drug/risk-of-asthma-in-offspring https://druglandscape.com/api/og?type=drug&title=Risk%20of%20asthma%20in%20offspring&subtitle=Risk%20of%20asthma%20in%20offspring%20%C2%B7%20AstraZeneca&badge=phase%202 Risk of asthma in offspring Risk of asthma in offspring · AstraZeneca https://druglandscape.com/drug/risk-of-seizure https://druglandscape.com/api/og?type=drug&title=Risk%20of%20seizure&subtitle=Risk%20of%20seizure%20%C2%B7%20AstraZeneca&badge=phase%202 Risk of seizure Risk of seizure · AstraZeneca https://druglandscape.com/drug/risk-of-selected-safety-events https://druglandscape.com/api/og?type=drug&title=Risk%20of%20selected%20safety%20events&subtitle=Risk%20of%20selected%20safety%20events%20%C2%B7%20AstraZeneca&badge=phase%202 Risk of selected safety events Risk of selected safety events · AstraZeneca https://druglandscape.com/drug/risperidone-ir-and-lai-formulation https://druglandscape.com/api/og?type=drug&title=risperidone%20IR%20and%20LAI%20formulation&subtitle=risperidone%20IR%20and%20LAI%20formulation%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 risperidone IR and LAI formulation risperidone IR and LAI formulation · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/risperidone-ism https://druglandscape.com/api/og?type=drug&title=Risperidone%20ISM&subtitle=Risperidone%20ISM%20%C2%B7%20Rovi%20Pharmaceuticals%20Laboratories&badge=phase%202 Risperidone ISM Risperidone ISM · Rovi Pharmaceuticals Laboratories https://druglandscape.com/drug/risperidone-lai https://druglandscape.com/api/og?type=drug&title=Risperidone%2C%20LAI&subtitle=Risperidone%2C%20LAI%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Risperidone, LAI Risperidone, LAI · Janssen Research & Development, LLC https://druglandscape.com/drug/risperidone-oral-formulation https://druglandscape.com/api/og?type=drug&title=Risperidone%2C%20oral%20formulation&subtitle=Risperidone%2C%20oral%20formulation%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Risperidone, oral formulation Risperidone, oral formulation · Janssen Research & Development, LLC https://druglandscape.com/drug/risperidone-orally-disintegrating-tablets https://druglandscape.com/api/og?type=drug&title=Risperidone%20Orally%20Disintegrating%20Tablets&subtitle=Risperidone%20Orally%20Disintegrating%20Tablets%20%C2%B7%20Dr.%20Reddy's%20Laboratories%20Limited&badge=phase%201 Risperidone Orally Disintegrating Tablets Risperidone Orally Disintegrating Tablets · Dr. Reddy's Laboratories Limited https://druglandscape.com/drug/risperidone-saber https://druglandscape.com/api/og?type=drug&title=risperidone-SABER&subtitle=risperidone-SABER%20%C2%B7%20Zogenix%2C%20Inc.&badge=phase%201 risperidone-SABER risperidone-SABER · Zogenix, Inc. https://druglandscape.com/drug/ritalin-sr https://druglandscape.com/api/og?type=drug&title=Ritalin-SR&subtitle=Ritalin-SR%20%C2%B7%20Janssen-Ortho%20Inc.%2C%20Canada&badge=phase%201 Ritalin-SR Ritalin-SR · Janssen-Ortho Inc., Canada https://druglandscape.com/drug/ritonavir-and-pyramax https://druglandscape.com/api/og?type=drug&title=Ritonavir%20and%20Pyramax&subtitle=Ritonavir%20and%20Pyramax%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 Ritonavir and Pyramax Ritonavir and Pyramax · Medicines for Malaria Venture https://druglandscape.com/drug/ritonavir-and-saquinavir https://druglandscape.com/api/og?type=drug&title=ritonavir%20and%20saquinavir&subtitle=ritonavir%20and%20saquinavir%20%C2%B7%20The%20HIV%20Netherlands%20Australia%20Thailand%20Research%20Collaboration&badge=phase%201 ritonavir and saquinavir ritonavir and saquinavir · The HIV Netherlands Australia Thailand Research Collaboration https://druglandscape.com/drug/ritonavir-boosted-indinavir https://druglandscape.com/api/og?type=drug&title=Ritonavir-boosted%20indinavir&subtitle=Ritonavir-boosted%20indinavir%20%C2%B7%20Harvard%20School%20of%20Public%20Health%20(HSPH)&badge=phase%202 Ritonavir-boosted indinavir Ritonavir-boosted indinavir · Harvard School of Public Health (HSPH) https://druglandscape.com/drug/rituximab-and-bendamustine https://druglandscape.com/api/og?type=drug&title=Rituximab%20and%20Bendamustine&subtitle=Rituximab%20and%20Bendamustine%20%C2%B7%20Grupo%20Espa%C3%B1ol%20de%20Linfomas%20y%20Transplante%20Aut%C3%B3logo%20de%20M%C3%A9dula%20%C3%93sea&badge=phase%202 Rituximab and Bendamustine Rituximab and Bendamustine · Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea https://druglandscape.com/drug/rituximab-bendamustine-mitoxantrone-dexamethasone https://druglandscape.com/api/og?type=drug&title=Rituximab%2C%20Bendamustine%2C%20Mitoxantrone%2C%20Dexamethasone&subtitle=Rituximab%2C%20Bendamustine%2C%20Mitoxantrone%2C%20Dexamethasone%20%C2%B7%20Grupo%20Espa%C3%B1ol%20de%20Linfomas%20y%20Transplante%20Aut%C3%B3l&badge=phase%202 Rituximab, Bendamustine, Mitoxantrone, Dexamethasone Rituximab, Bendamustine, Mitoxantrone, Dexamethasone · Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea https://druglandscape.com/drug/rituximab-biosimilar-abp-798 https://druglandscape.com/api/og?type=drug&title=Rituximab%20Biosimilar%20ABP%20798&subtitle=Rituximab%20Biosimilar%20ABP%20798%20%C2%B7%20Istituto%20Giannina%20Gaslini&badge=phase%202 Rituximab Biosimilar ABP 798 Rituximab Biosimilar ABP 798 · Istituto Giannina Gaslini https://druglandscape.com/drug/rituximab-chop-plus-velcade https://druglandscape.com/api/og?type=drug&title=Rituximab%20-CHOP%20plus%20Velcade&subtitle=Rituximab%20-CHOP%20plus%20Velcade%20%C2%B7%20Lymphoma%20Study%20Association&badge=phase%202 Rituximab -CHOP plus Velcade Rituximab -CHOP plus Velcade · Lymphoma Study Association https://druglandscape.com/drug/rituximab-cmc544-gemcitabine-and-oxaliplatine https://druglandscape.com/api/og?type=drug&title=Rituximab%2C%20CMC544%2C%20Gemcitabine%20and%20Oxaliplatine&subtitle=Rituximab%2C%20CMC544%2C%20Gemcitabine%20and%20Oxaliplatine%20%C2%B7%20The%20Lymphoma%20Academic%20Research%20Organisation&badge=phase%201 Rituximab, CMC544, Gemcitabine and Oxaliplatine Rituximab, CMC544, Gemcitabine and Oxaliplatine · The Lymphoma Academic Research Organisation https://druglandscape.com/drug/rituximab-dexamethasone-lenalidomide https://druglandscape.com/api/og?type=drug&title=Rituximab-Dexamethasone-Lenalidomide&subtitle=Rituximab-Dexamethasone-Lenalidomide%20%C2%B7%20Fondazione%20Italiana%20Linfomi%20-%20ETS&badge=phase%202 Rituximab-Dexamethasone-Lenalidomide Rituximab-Dexamethasone-Lenalidomide · Fondazione Italiana Linfomi - ETS https://druglandscape.com/drug/rituximab-mitoxantrone-bendamustine https://druglandscape.com/api/og?type=drug&title=Rituximab%2C%20Mitoxantrone%2C%20Bendamustine&subtitle=Rituximab%2C%20Mitoxantrone%2C%20Bendamustine%20%C2%B7%20Fondazione%20Italiana%20Linfomi%20-%20ETS&badge=phase%202 Rituximab, Mitoxantrone, Bendamustine Rituximab, Mitoxantrone, Bendamustine · Fondazione Italiana Linfomi - ETS https://druglandscape.com/drug/rituximab-mtx-folic-acid https://druglandscape.com/api/og?type=drug&title=Rituximab%2C%20MTX%2C%20folic%20acid&subtitle=Rituximab%2C%20MTX%2C%20folic%20acid%20%C2%B7%20Celltrion&badge=phase%201 Rituximab, MTX, folic acid Rituximab, MTX, folic acid · Celltrion https://druglandscape.com/drug/rituximab-plus-chop-immunochemotherapy https://druglandscape.com/api/og?type=drug&title=Rituximab%20plus%20CHOP%20Immunochemotherapy&subtitle=Rituximab%20plus%20CHOP%20Immunochemotherapy%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 Rituximab plus CHOP Immunochemotherapy Rituximab plus CHOP Immunochemotherapy · Asan Medical Center https://druglandscape.com/drug/rituximab-sc-consolidation https://druglandscape.com/api/og?type=drug&title=Rituximab%20sc%20consolidation&subtitle=Rituximab%20sc%20consolidation%20%C2%B7%20Diako%20Ev.%20Diakonie-Krankenhaus%20gemeinn%C3%BCtzige%20GmbH&badge=phase%202 Rituximab sc consolidation Rituximab sc consolidation · Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH https://druglandscape.com/drug/rituximab-temsirolimus-dhap-intravenous https://druglandscape.com/api/og?type=drug&title=Rituximab%2C%20Temsirolimus%2C%20DHAP%2C%20intravenous&subtitle=Rituximab%2C%20Temsirolimus%2C%20DHAP%2C%20intravenous%20%C2%B7%20Mathias%20Witzens-Harig&badge=phase%202 Rituximab, Temsirolimus, DHAP, intravenous Rituximab, Temsirolimus, DHAP, intravenous · Mathias Witzens-Harig https://druglandscape.com/drug/riv3 https://druglandscape.com/api/og?type=drug&title=RIV3&subtitle=RIV3%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%202 RIV3 RIV3 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/riv4 https://druglandscape.com/api/og?type=drug&title=RIV4&subtitle=RIV4%20%C2%B7%20Seqirus&badge=phase%202 RIV4 RIV4 · Seqirus https://druglandscape.com/drug/rivaroxaban-granules-for-oral-suspension https://druglandscape.com/api/og?type=drug&title=Rivaroxaban%20granules%20for%20oral%20suspension&subtitle=Rivaroxaban%20granules%20for%20oral%20suspension%20%C2%B7%20Bayer&badge=phase%202 Rivaroxaban granules for oral suspension Rivaroxaban granules for oral suspension · Bayer https://druglandscape.com/drug/rivoceranib-mesylate-paclitaxel https://druglandscape.com/api/og?type=drug&title=Rivoceranib%20Mesylate%2C%20Paclitaxel&subtitle=Rivoceranib%20Mesylate%2C%20Paclitaxel%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 Rivoceranib Mesylate, Paclitaxel Rivoceranib Mesylate, Paclitaxel · Asan Medical Center https://druglandscape.com/drug/rj4287 https://druglandscape.com/api/og?type=drug&title=RJ4287&subtitle=RJ4287%20%C2%B7%20Nanjing%20Ruijie%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 RJ4287 RJ4287 · Nanjing Ruijie Pharma Co., Ltd. https://druglandscape.com/drug/rjk-rt2831-dose-escalation-phase-ia https://druglandscape.com/api/og?type=drug&title=RJK-RT2831%20dose-escalation%20phase%20Ia&subtitle=RJK-RT2831%20dose-escalation%20phase%20Ia%20%C2%B7%20Nanjing%20RegeneCore%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 RJK-RT2831 dose-escalation phase Ia RJK-RT2831 dose-escalation phase Ia · Nanjing RegeneCore Biotech Co., Ltd. https://druglandscape.com/drug/rjk-rt2831-dose-expansion-phase-ib https://druglandscape.com/api/og?type=drug&title=RJK-RT2831%20Dose%20Expansion%20Phase%20Ib&subtitle=RJK-RT2831%20Dose%20Expansion%20Phase%20Ib%20%C2%B7%20Nanjing%20RegeneCore%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 RJK-RT2831 Dose Expansion Phase Ib RJK-RT2831 Dose Expansion Phase Ib · Nanjing RegeneCore Biotech Co., Ltd. https://druglandscape.com/drug/rjv001 https://druglandscape.com/api/og?type=drug&title=RJV001&subtitle=RJV001%20%C2%B7%20Rejuven%20Dermaceutical%20Co.%2C%20Ltd.&badge=phase%201 RJV001 RJV001 · Rejuven Dermaceutical Co., Ltd. https://druglandscape.com/drug/rk-0202 https://druglandscape.com/api/og?type=drug&title=RK-0202&subtitle=RK-0202%20%C2%B7%20RxKinetix&badge=phase%202 RK-0202 RK-0202 · RxKinetix https://druglandscape.com/drug/rki983 https://druglandscape.com/api/og?type=drug&title=RKI983&subtitle=RKI983%20%C2%B7%20Novartis&badge=phase%201 RKI983 RKI983 · Novartis https://druglandscape.com/drug/rl-007 https://druglandscape.com/api/og?type=drug&title=RL-007&subtitle=RL-007%20%C2%B7%20Recognify%20Life%20Sciences&badge=phase%202 RL-007 RL-007 · Recognify Life Sciences https://druglandscape.com/drug/rld2003 https://druglandscape.com/api/og?type=drug&title=RLD2003&subtitle=RLD2003%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%202 RLD2003 RLD2003 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/rld2004 https://druglandscape.com/api/og?type=drug&title=RLD2004&subtitle=RLD2004%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%202 RLD2004 RLD2004 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/rld2005 https://druglandscape.com/api/og?type=drug&title=RLD2005&subtitle=RLD2005%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%202 RLD2005 RLD2005 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/rld2006 https://druglandscape.com/api/og?type=drug&title=RLD2006&subtitle=RLD2006%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 RLD2006 RLD2006 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/rld2007 https://druglandscape.com/api/og?type=drug&title=RLD2007&subtitle=RLD2007%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 RLD2007 RLD2007 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/rld2102 https://druglandscape.com/api/og?type=drug&title=RLD2102&subtitle=RLD2102%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 RLD2102 RLD2102 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/rld2104 https://druglandscape.com/api/og?type=drug&title=RLD2104&subtitle=RLD2104%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 RLD2104 RLD2104 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/rld2202 https://druglandscape.com/api/og?type=drug&title=RLD2202&subtitle=RLD2202%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 RLD2202 RLD2202 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/rld2203 https://druglandscape.com/api/og?type=drug&title=RLD2203&subtitle=RLD2203%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 RLD2203 RLD2203 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/rld2205 https://druglandscape.com/api/og?type=drug&title=RLD2205&subtitle=RLD2205%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 RLD2205 RLD2205 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/rld2206 https://druglandscape.com/api/og?type=drug&title=RLD2206&subtitle=RLD2206%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 RLD2206 RLD2206 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/rld2301 https://druglandscape.com/api/og?type=drug&title=RLD2301&subtitle=RLD2301%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 RLD2301 RLD2301 · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/rlf-od032 https://druglandscape.com/api/og?type=drug&title=RLF-OD032&subtitle=RLF-OD032%20%C2%B7%20APR%20Applied%20Pharma%20Research%20s.a.&badge=phase%201 RLF-OD032 RLF-OD032 · APR Applied Pharma Research s.a. https://druglandscape.com/drug/rlp2086-vaccine-or-control https://druglandscape.com/api/og?type=drug&title=rLP2086%20vaccine%20or%20control&subtitle=rLP2086%20vaccine%20or%20control%20%C2%B7%20Pfizer&badge=phase%201 rLP2086 vaccine or control rLP2086 vaccine or control · Pfizer https://druglandscape.com/drug/rls-0071 https://druglandscape.com/api/og?type=drug&title=RLS-0071&subtitle=RLS-0071%20%C2%B7%20ReAlta%20Life%20Sciences%2C%20Inc.&badge=phase%202 RLS-0071 RLS-0071 · ReAlta Life Sciences, Inc. https://druglandscape.com/drug/rly-1971 https://druglandscape.com/api/og?type=drug&title=RLY-1971&subtitle=RLY-1971%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RLY-1971 RLY-1971 · Hoffmann-La Roche https://druglandscape.com/drug/rmbcg https://druglandscape.com/api/og?type=drug&title=rMBCG&subtitle=rMBCG%20%C2%B7%20ImmunityBio%2C%20Inc.&badge=phase%202 rMBCG rMBCG · ImmunityBio, Inc. https://druglandscape.com/drug/rmc-4630 https://druglandscape.com/api/og?type=drug&title=RMC-4630&subtitle=RMC-4630%20%C2%B7%20Revolution%20Medicines%2C%20Inc.&badge=phase%202 RMC-4630 RMC-4630 · Revolution Medicines, Inc. https://druglandscape.com/drug/rmc-5127 https://druglandscape.com/api/og?type=drug&title=RMC-5127&subtitle=RMC-5127%20%C2%B7%20Revolution%20Medicines%2C%20Inc.&badge=phase%201 RMC-5127 RMC-5127 · Revolution Medicines, Inc. https://druglandscape.com/drug/rmp-a03-dose-1 https://druglandscape.com/api/og?type=drug&title=RMP-A03%20-%20Dose%201&subtitle=RMP-A03%20-%20Dose%201%20%C2%B7%20Suzhou%20Raymon%20Pharmaceuticals%20Company%2C%20Ltd.&badge=phase%202 RMP-A03 - Dose 1 RMP-A03 - Dose 1 · Suzhou Raymon Pharmaceuticals Company, Ltd. https://druglandscape.com/drug/rn0361 https://druglandscape.com/api/og?type=drug&title=RN0361&subtitle=RN0361%20%C2%B7%20Ikaria%20Bioscience%20Pty%20Ltd&badge=phase%201 RN0361 RN0361 · Ikaria Bioscience Pty Ltd https://druglandscape.com/drug/rn316 https://druglandscape.com/api/og?type=drug&title=RN316&subtitle=RN316%20%C2%B7%20Pfizer&badge=phase%201 RN316 RN316 · Pfizer https://druglandscape.com/drug/rn3161 https://druglandscape.com/api/og?type=drug&title=RN3161&subtitle=RN3161%20%C2%B7%20Ikaria%20Bioscience%20Pty%20Ltd&badge=phase%201 RN3161 RN3161 · Ikaria Bioscience Pty Ltd https://druglandscape.com/drug/rn5681 https://druglandscape.com/api/og?type=drug&title=RN5681&subtitle=RN5681%20%C2%B7%20Ikaria%20Bioscience%20Pty%20Ltd&badge=phase%201 RN5681 RN5681 · Ikaria Bioscience Pty Ltd https://druglandscape.com/drug/rn624 https://druglandscape.com/api/og?type=drug&title=RN624&subtitle=RN624%20%C2%B7%20Pfizer&badge=phase%202 RN624 RN624 · Pfizer https://druglandscape.com/drug/rna-loaded-dendritic-cell-vaccine https://druglandscape.com/api/og?type=drug&title=RNA-loaded%20dendritic%20cell%20vaccine&subtitle=RNA-loaded%20dendritic%20cell%20vaccine%20%C2%B7%20Gary%20Archer%20Ph.D.&badge=phase%201 RNA-loaded dendritic cell vaccine RNA-loaded dendritic cell vaccine · Gary Archer Ph.D. https://druglandscape.com/drug/rna-seq-analysis https://druglandscape.com/api/og?type=drug&title=RNA%20seq%20analysis&subtitle=RNA%20seq%20analysis%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 RNA seq analysis RNA seq analysis · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/rnapc2 https://druglandscape.com/api/og?type=drug&title=rNAPc2&subtitle=rNAPc2%20%C2%B7%20ARCA%20Biopharma%2C%20Inc.&badge=phase%202 rNAPc2 rNAPc2 · ARCA Biopharma, Inc. https://druglandscape.com/drug/rnk05047 https://druglandscape.com/api/og?type=drug&title=RNK05047&subtitle=RNK05047%20%C2%B7%20Ranok%20Therapeutics%20(Hangzhou)%20Co.%2C%20Ltd.&badge=phase%201 RNK05047 RNK05047 · Ranok Therapeutics (Hangzhou) Co., Ltd. https://druglandscape.com/drug/rnk08954 https://druglandscape.com/api/og?type=drug&title=RNK08954&subtitle=RNK08954%20%C2%B7%20Ranok%20Therapeutics%20(Hangzhou)%20Co.%2C%20Ltd.&badge=phase%202 RNK08954 RNK08954 · Ranok Therapeutics (Hangzhou) Co., Ltd. https://druglandscape.com/drug/rnk08954-01 https://druglandscape.com/api/og?type=drug&title=RNK08954-01&subtitle=RNK08954-01%20%C2%B7%20Ranok%20Therapeutics%20(Hangzhou)%20Co.%2C%20Ltd.&badge=phase%201 RNK08954-01 RNK08954-01 · Ranok Therapeutics (Hangzhou) Co., Ltd. https://druglandscape.com/drug/rnl-vascostem https://druglandscape.com/api/og?type=drug&title=RNL-Vascostem%C2%AE&subtitle=RNL-Vascostem%C2%AE%20%C2%B7%20R-Bio&badge=phase%201 RNL-Vascostem® RNL-Vascostem® · R-Bio https://druglandscape.com/drug/ro-14 https://druglandscape.com/api/og?type=drug&title=RO-14&subtitle=RO-14%20%C2%B7%20Rovi%20Pharmaceuticals%20Laboratories&badge=phase%201 RO-14 RO-14 · Rovi Pharmaceuticals Laboratories https://druglandscape.com/drug/ro-sparks https://druglandscape.com/api/og?type=drug&title=Ro%20Sparks&subtitle=Ro%20Sparks%20%C2%B7%20Aspargo%20Labs%2C%20Inc&badge=phase%202 Ro Sparks Ro Sparks · Aspargo Labs, Inc https://druglandscape.com/drug/ro4602522 https://druglandscape.com/api/og?type=drug&title=RO4602522&subtitle=RO4602522%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO4602522 RO4602522 · Hoffmann-La Roche https://druglandscape.com/drug/ro4876904 https://druglandscape.com/api/og?type=drug&title=RO4876904&subtitle=RO4876904%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO4876904 RO4876904 · Hoffmann-La Roche https://druglandscape.com/drug/ro4905417 https://druglandscape.com/api/og?type=drug&title=RO4905417&subtitle=RO4905417%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO4905417 RO4905417 · Hoffmann-La Roche https://druglandscape.com/drug/ro4917523 https://druglandscape.com/api/og?type=drug&title=RO4917523&subtitle=RO4917523%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO4917523 RO4917523 · Hoffmann-La Roche https://druglandscape.com/drug/ro4917838-and-rosuvastatin https://druglandscape.com/api/og?type=drug&title=RO4917838%20and%20Rosuvastatin&subtitle=RO4917838%20and%20Rosuvastatin%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO4917838 and Rosuvastatin RO4917838 and Rosuvastatin · Hoffmann-La Roche https://druglandscape.com/drug/ro4927838 https://druglandscape.com/api/og?type=drug&title=RO4927838&subtitle=RO4927838%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO4927838 RO4927838 · Hoffmann-La Roche https://druglandscape.com/drug/ro4987655 https://druglandscape.com/api/og?type=drug&title=RO4987655&subtitle=RO4987655%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO4987655 RO4987655 · Hoffmann-La Roche https://druglandscape.com/drug/ro4989991 https://druglandscape.com/api/og?type=drug&title=RO4989991&subtitle=RO4989991%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO4989991 RO4989991 · Hoffmann-La Roche https://druglandscape.com/drug/ro4998452 https://druglandscape.com/api/og?type=drug&title=RO4998452&subtitle=RO4998452%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO4998452 RO4998452 · Hoffmann-La Roche https://druglandscape.com/drug/ro5011232 https://druglandscape.com/api/og?type=drug&title=RO5011232&subtitle=RO5011232%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5011232 RO5011232 · Hoffmann-La Roche https://druglandscape.com/drug/ro5028442 https://druglandscape.com/api/og?type=drug&title=RO5028442&subtitle=RO5028442%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5028442 RO5028442 · Hoffmann-La Roche https://druglandscape.com/drug/ro5045337 https://druglandscape.com/api/og?type=drug&title=RO5045337&subtitle=RO5045337%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5045337 RO5045337 · Hoffmann-La Roche https://druglandscape.com/drug/ro5045377 https://druglandscape.com/api/og?type=drug&title=RO5045377&subtitle=RO5045377%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5045377 RO5045377 · Hoffmann-La Roche https://druglandscape.com/drug/ro5093151 https://druglandscape.com/api/og?type=drug&title=RO5093151&subtitle=RO5093151%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO5093151 RO5093151 · Hoffmann-La Roche https://druglandscape.com/drug/ro5095932 https://druglandscape.com/api/og?type=drug&title=RO5095932&subtitle=RO5095932%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5095932 RO5095932 · Hoffmann-La Roche https://druglandscape.com/drug/ro5126766 https://druglandscape.com/api/og?type=drug&title=RO5126766&subtitle=RO5126766%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5126766 RO5126766 · Hoffmann-La Roche https://druglandscape.com/drug/ro5185426 https://druglandscape.com/api/og?type=drug&title=RO5185426&subtitle=RO5185426%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO5185426 RO5185426 · Hoffmann-La Roche https://druglandscape.com/drug/ro5190591 https://druglandscape.com/api/og?type=drug&title=RO5190591&subtitle=RO5190591%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO5190591 RO5190591 · Hoffmann-La Roche https://druglandscape.com/drug/ro5217790 https://druglandscape.com/api/og?type=drug&title=RO5217790&subtitle=RO5217790%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO5217790 RO5217790 · Hoffmann-La Roche https://druglandscape.com/drug/ro5267683 https://druglandscape.com/api/og?type=drug&title=RO5267683&subtitle=RO5267683%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5267683 RO5267683 · Hoffmann-La Roche https://druglandscape.com/drug/ro5271983-mad https://druglandscape.com/api/og?type=drug&title=RO5271983%20-%20MAD&subtitle=RO5271983%20-%20MAD%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5271983 - MAD RO5271983 - MAD · Hoffmann-La Roche https://druglandscape.com/drug/ro5271983-sad https://druglandscape.com/api/og?type=drug&title=RO5271983%20-%20SAD&subtitle=RO5271983%20-%20SAD%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5271983 - SAD RO5271983 - SAD · Hoffmann-La Roche https://druglandscape.com/drug/ro5303253 https://druglandscape.com/api/og?type=drug&title=RO5303253&subtitle=RO5303253%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5303253 RO5303253 · Hoffmann-La Roche https://druglandscape.com/drug/ro5310074 https://druglandscape.com/api/og?type=drug&title=RO5310074&subtitle=RO5310074%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5310074 RO5310074 · Hoffmann-La Roche https://druglandscape.com/drug/ro5313534 https://druglandscape.com/api/og?type=drug&title=RO5313534&subtitle=RO5313534%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO5313534 RO5313534 · Hoffmann-La Roche https://druglandscape.com/drug/ro5323441 https://druglandscape.com/api/og?type=drug&title=RO5323441&subtitle=RO5323441%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5323441 RO5323441 · Hoffmann-La Roche https://druglandscape.com/drug/ro5424802 https://druglandscape.com/api/og?type=drug&title=RO5424802&subtitle=RO5424802%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5424802 RO5424802 · Hoffmann-La Roche https://druglandscape.com/drug/ro5428029 https://druglandscape.com/api/og?type=drug&title=RO5428029&subtitle=RO5428029%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5428029 RO5428029 · Hoffmann-La Roche https://druglandscape.com/drug/ro5458640 https://druglandscape.com/api/og?type=drug&title=RO5458640&subtitle=RO5458640%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5458640 RO5458640 · Hoffmann-La Roche https://druglandscape.com/drug/ro5466731 https://druglandscape.com/api/og?type=drug&title=RO5466731&subtitle=RO5466731%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO5466731 RO5466731 · Hoffmann-La Roche https://druglandscape.com/drug/ro5469754 https://druglandscape.com/api/og?type=drug&title=RO5469754&subtitle=RO5469754%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5469754 RO5469754 · Hoffmann-La Roche https://druglandscape.com/drug/ro5490258 https://druglandscape.com/api/og?type=drug&title=RO5490258&subtitle=RO5490258%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 RO5490258 RO5490258 · Genentech, Inc. https://druglandscape.com/drug/ro5503781 https://druglandscape.com/api/og?type=drug&title=RO5503781&subtitle=RO5503781%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5503781 RO5503781 · Hoffmann-La Roche https://druglandscape.com/drug/ro5503781-sdp https://druglandscape.com/api/og?type=drug&title=RO5503781%20SDP&subtitle=RO5503781%20SDP%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5503781 SDP RO5503781 SDP · Hoffmann-La Roche https://druglandscape.com/drug/ro5508887 https://druglandscape.com/api/og?type=drug&title=RO5508887&subtitle=RO5508887%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5508887 RO5508887 · Hoffmann-La Roche https://druglandscape.com/drug/ro5509554 https://druglandscape.com/api/og?type=drug&title=RO5509554&subtitle=RO5509554%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5509554 RO5509554 · Hoffmann-La Roche https://druglandscape.com/drug/ro5545965 https://druglandscape.com/api/og?type=drug&title=RO5545965&subtitle=RO5545965%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO5545965 RO5545965 · Hoffmann-La Roche https://druglandscape.com/drug/ro6799477 https://druglandscape.com/api/og?type=drug&title=RO6799477&subtitle=RO6799477%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO6799477 RO6799477 · Hoffmann-La Roche https://druglandscape.com/drug/ro6806127 https://druglandscape.com/api/og?type=drug&title=RO6806127&subtitle=RO6806127%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO6806127 RO6806127 · Hoffmann-La Roche https://druglandscape.com/drug/ro6836191 https://druglandscape.com/api/og?type=drug&title=RO6836191&subtitle=RO6836191%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO6836191 RO6836191 · Hoffmann-La Roche https://druglandscape.com/drug/ro6864018 https://druglandscape.com/api/og?type=drug&title=RO6864018&subtitle=RO6864018%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO6864018 RO6864018 · Hoffmann-La Roche https://druglandscape.com/drug/ro6867461 https://druglandscape.com/api/og?type=drug&title=RO6867461&subtitle=RO6867461%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO6867461 RO6867461 · Hoffmann-La Roche https://druglandscape.com/drug/ro6870868 https://druglandscape.com/api/og?type=drug&title=RO6870868&subtitle=RO6870868%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO6870868 RO6870868 · Hoffmann-La Roche https://druglandscape.com/drug/ro6874281 https://druglandscape.com/api/og?type=drug&title=RO6874281&subtitle=RO6874281%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO6874281 RO6874281 · Hoffmann-La Roche https://druglandscape.com/drug/ro6874813 https://druglandscape.com/api/og?type=drug&title=RO6874813&subtitle=RO6874813%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO6874813 RO6874813 · Hoffmann-La Roche https://druglandscape.com/drug/ro6895882 https://druglandscape.com/api/og?type=drug&title=RO6895882&subtitle=RO6895882%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO6895882 RO6895882 · Hoffmann-La Roche https://druglandscape.com/drug/ro6926496 https://druglandscape.com/api/og?type=drug&title=RO6926496&subtitle=RO6926496%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO6926496 RO6926496 · Hoffmann-La Roche https://druglandscape.com/drug/ro6958688 https://druglandscape.com/api/og?type=drug&title=RO6958688&subtitle=RO6958688%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO6958688 RO6958688 · Hoffmann-La Roche https://druglandscape.com/drug/ro7009789 https://druglandscape.com/api/og?type=drug&title=RO7009789&subtitle=RO7009789%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7009789 RO7009789 · Hoffmann-La Roche https://druglandscape.com/drug/ro7017773 https://druglandscape.com/api/og?type=drug&title=RO7017773&subtitle=RO7017773%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO7017773 RO7017773 · Hoffmann-La Roche https://druglandscape.com/drug/ro7017773-phase-i-capsule https://druglandscape.com/api/og?type=drug&title=RO7017773%20Phase%20I%20Capsule&subtitle=RO7017773%20Phase%20I%20Capsule%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7017773 Phase I Capsule RO7017773 Phase I Capsule · Hoffmann-La Roche https://druglandscape.com/drug/ro7017773-phase-ii-tablet-unflavored https://druglandscape.com/api/og?type=drug&title=RO7017773%20Phase%20II%20Tablet%20Unflavored&subtitle=RO7017773%20Phase%20II%20Tablet%20Unflavored%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7017773 Phase II Tablet Unflavored RO7017773 Phase II Tablet Unflavored · Hoffmann-La Roche https://druglandscape.com/drug/ro7020531 https://druglandscape.com/api/og?type=drug&title=RO7020531&subtitle=RO7020531%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7020531 RO7020531 · Hoffmann-La Roche https://druglandscape.com/drug/ro7033877 https://druglandscape.com/api/og?type=drug&title=RO7033877&subtitle=RO7033877%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7033877 RO7033877 · Hoffmann-La Roche https://druglandscape.com/drug/ro7046015 https://druglandscape.com/api/og?type=drug&title=RO7046015&subtitle=RO7046015%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO7046015 RO7046015 · Hoffmann-La Roche https://druglandscape.com/drug/ro7049389 https://druglandscape.com/api/og?type=drug&title=RO7049389&subtitle=RO7049389%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7049389 RO7049389 · Hoffmann-La Roche https://druglandscape.com/drug/ro7051790 https://druglandscape.com/api/og?type=drug&title=RO7051790&subtitle=RO7051790%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7051790 RO7051790 · Hoffmann-La Roche https://druglandscape.com/drug/ro7062931 https://druglandscape.com/api/og?type=drug&title=RO7062931&subtitle=RO7062931%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7062931 RO7062931 · Hoffmann-La Roche https://druglandscape.com/drug/ro7070179 https://druglandscape.com/api/og?type=drug&title=RO7070179&subtitle=RO7070179%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7070179 RO7070179 · Hoffmann-La Roche https://druglandscape.com/drug/ro7079901 https://druglandscape.com/api/og?type=drug&title=RO7079901&subtitle=RO7079901%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7079901 RO7079901 · Hoffmann-La Roche https://druglandscape.com/drug/ro7082859 https://druglandscape.com/api/og?type=drug&title=RO7082859&subtitle=RO7082859%20%C2%B7%20The%20Lymphoma%20Academic%20Research%20Organisation&badge=phase%202 RO7082859 RO7082859 · The Lymphoma Academic Research Organisation https://druglandscape.com/drug/ro7105705 https://druglandscape.com/api/og?type=drug&title=RO7105705&subtitle=RO7105705%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 RO7105705 RO7105705 · Genentech, Inc. https://druglandscape.com/drug/ro7119929 https://druglandscape.com/api/og?type=drug&title=RO7119929&subtitle=RO7119929%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7119929 RO7119929 · Hoffmann-La Roche https://druglandscape.com/drug/ro7121932-iv https://druglandscape.com/api/og?type=drug&title=RO7121932%20IV&subtitle=RO7121932%20IV%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7121932 IV RO7121932 IV · Hoffmann-La Roche https://druglandscape.com/drug/ro7122290 https://druglandscape.com/api/og?type=drug&title=RO7122290&subtitle=RO7122290%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7122290 RO7122290 · Hoffmann-La Roche https://druglandscape.com/drug/ro7171009 https://druglandscape.com/api/og?type=drug&title=RO7171009&subtitle=RO7171009%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 RO7171009 RO7171009 · Genentech, Inc. https://druglandscape.com/drug/ro7200220 https://druglandscape.com/api/og?type=drug&title=RO7200220&subtitle=RO7200220%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7200220 RO7200220 · Hoffmann-La Roche https://druglandscape.com/drug/ro7204239 https://druglandscape.com/api/og?type=drug&title=RO7204239&subtitle=RO7204239%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO7204239 RO7204239 · Hoffmann-La Roche https://druglandscape.com/drug/ro7223280 https://druglandscape.com/api/og?type=drug&title=RO7223280&subtitle=RO7223280%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7223280 RO7223280 · Hoffmann-La Roche https://druglandscape.com/drug/ro7247669 https://druglandscape.com/api/og?type=drug&title=RO7247669&subtitle=RO7247669%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO7247669 RO7247669 · Hoffmann-La Roche https://druglandscape.com/drug/ro7268489 https://druglandscape.com/api/og?type=drug&title=RO7268489&subtitle=RO7268489%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO7268489 RO7268489 · Hoffmann-La Roche https://druglandscape.com/drug/ro7269162 https://druglandscape.com/api/og?type=drug&title=RO7269162&subtitle=RO7269162%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO7269162 RO7269162 · Hoffmann-La Roche https://druglandscape.com/drug/ro7283420 https://druglandscape.com/api/og?type=drug&title=RO7283420&subtitle=RO7283420%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7283420 RO7283420 · Hoffmann-La Roche https://druglandscape.com/drug/ro7293583 https://druglandscape.com/api/og?type=drug&title=RO7293583&subtitle=RO7293583%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7293583 RO7293583 · Hoffmann-La Roche https://druglandscape.com/drug/ro7300490 https://druglandscape.com/api/og?type=drug&title=RO7300490&subtitle=RO7300490%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7300490 RO7300490 · Hoffmann-La Roche https://druglandscape.com/drug/ro7303359 https://druglandscape.com/api/og?type=drug&title=RO7303359&subtitle=RO7303359%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7303359 RO7303359 · Hoffmann-La Roche https://druglandscape.com/drug/ro7303509 https://druglandscape.com/api/og?type=drug&title=RO7303509&subtitle=RO7303509%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 RO7303509 RO7303509 · Genentech, Inc. https://druglandscape.com/drug/ro7446603 https://druglandscape.com/api/og?type=drug&title=RO7446603&subtitle=RO7446603%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 RO7446603 RO7446603 · Genentech, Inc. https://druglandscape.com/drug/ro7490677 https://druglandscape.com/api/og?type=drug&title=RO7490677&subtitle=RO7490677%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO7490677 RO7490677 · Hoffmann-La Roche https://druglandscape.com/drug/ro7496353 https://druglandscape.com/api/og?type=drug&title=RO7496353&subtitle=RO7496353%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 RO7496353 RO7496353 · Genentech, Inc. https://druglandscape.com/drug/ro7497372 https://druglandscape.com/api/og?type=drug&title=RO7497372&subtitle=RO7497372%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 RO7497372 RO7497372 · Genentech, Inc. https://druglandscape.com/drug/ro7502175 https://druglandscape.com/api/og?type=drug&title=RO7502175&subtitle=RO7502175%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 RO7502175 RO7502175 · Genentech, Inc. https://druglandscape.com/drug/ro7567132-and-atezolizumab https://druglandscape.com/api/og?type=drug&title=RO7567132%20and%20Atezolizumab&subtitle=RO7567132%20and%20Atezolizumab%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7567132 and Atezolizumab RO7567132 and Atezolizumab · Hoffmann-La Roche https://druglandscape.com/drug/ro7616789 https://druglandscape.com/api/og?type=drug&title=RO7616789&subtitle=RO7616789%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7616789 RO7616789 · Hoffmann-La Roche https://druglandscape.com/drug/ro7656594 https://druglandscape.com/api/og?type=drug&title=RO7656594&subtitle=RO7656594%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 RO7656594 RO7656594 · Genentech, Inc. https://druglandscape.com/drug/ro7669330 https://druglandscape.com/api/og?type=drug&title=RO7669330&subtitle=RO7669330%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7669330 RO7669330 · Hoffmann-La Roche https://druglandscape.com/drug/ro7673396 https://druglandscape.com/api/og?type=drug&title=RO7673396&subtitle=RO7673396%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7673396 RO7673396 · Hoffmann-La Roche https://druglandscape.com/drug/ro7771950 https://druglandscape.com/api/og?type=drug&title=RO7771950&subtitle=RO7771950%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO7771950 RO7771950 · Hoffmann-La Roche https://druglandscape.com/drug/ro7790121 https://druglandscape.com/api/og?type=drug&title=RO7790121&subtitle=RO7790121%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7790121 RO7790121 · Hoffmann-La Roche https://druglandscape.com/drug/ro7795081 https://druglandscape.com/api/og?type=drug&title=RO7795081&subtitle=RO7795081%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RO7795081 RO7795081 · Hoffmann-La Roche https://druglandscape.com/drug/ro7806881 https://druglandscape.com/api/og?type=drug&title=RO7806881&subtitle=RO7806881%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7806881 RO7806881 · Hoffmann-La Roche https://druglandscape.com/drug/ro7812653 https://druglandscape.com/api/og?type=drug&title=RO7812653&subtitle=RO7812653%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 RO7812653 RO7812653 · Hoffmann-La Roche https://druglandscape.com/drug/ro7823653 https://druglandscape.com/api/og?type=drug&title=RO7823653&subtitle=RO7823653%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 RO7823653 RO7823653 · Genentech, Inc. https://druglandscape.com/drug/ro7837195 https://druglandscape.com/api/og?type=drug&title=RO7837195&subtitle=RO7837195%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 RO7837195 RO7837195 · Genentech, Inc. https://druglandscape.com/drug/ro7875913 https://druglandscape.com/api/og?type=drug&title=RO7875913&subtitle=RO7875913%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 RO7875913 RO7875913 · Genentech, Inc. https://druglandscape.com/drug/rob-803 https://druglandscape.com/api/og?type=drug&title=Rob%20803&subtitle=Rob%20803%20%C2%B7%20OxyPharma&badge=phase%202 Rob 803 Rob 803 · OxyPharma https://druglandscape.com/drug/roc-101 https://druglandscape.com/api/og?type=drug&title=ROC-101&subtitle=ROC-101%20%C2%B7%20AllRock%20Bio%2C%20Inc.&badge=phase%202 ROC-101 ROC-101 · AllRock Bio, Inc. https://druglandscape.com/drug/rocbrutinib-tablets https://druglandscape.com/api/og?type=drug&title=Rocbrutinib%20tablets&subtitle=Rocbrutinib%20tablets%20%C2%B7%20Guangzhou%20Lupeng%20Pharmaceutical%20Company%20LTD.&badge=phase%201 Rocbrutinib tablets Rocbrutinib tablets · Guangzhou Lupeng Pharmaceutical Company LTD. https://druglandscape.com/drug/roflumilast-0-3-topical-foam https://druglandscape.com/api/og?type=drug&title=Roflumilast%200.3%25%20topical%20foam&subtitle=Roflumilast%200.3%25%20topical%20foam%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%202 Roflumilast 0.3% topical foam Roflumilast 0.3% topical foam · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/roflumilast-topical-0-3-foam https://druglandscape.com/api/og?type=drug&title=Roflumilast%20topical%200.3%25%20foam&subtitle=Roflumilast%20topical%200.3%25%20foam%20%C2%B7%20Derm%20Texas%2C%20PLLC&badge=phase%202 Roflumilast topical 0.3% foam Roflumilast topical 0.3% foam · Derm Texas, PLLC https://druglandscape.com/drug/rolapitant-dose-1 https://druglandscape.com/api/og?type=drug&title=Rolapitant%20Dose%201&subtitle=Rolapitant%20Dose%201%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Rolapitant Dose 1 Rolapitant Dose 1 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/rolapitant-iv https://druglandscape.com/api/og?type=drug&title=Rolapitant%20-%20IV&subtitle=Rolapitant%20-%20IV%20%C2%B7%20Tesaro%2C%20Inc.&badge=phase%201 Rolapitant - IV Rolapitant - IV · Tesaro, Inc. https://druglandscape.com/drug/rolapitant-oral https://druglandscape.com/api/og?type=drug&title=Rolapitant%20-%20Oral&subtitle=Rolapitant%20-%20Oral%20%C2%B7%20Tesaro%2C%20Inc.&badge=phase%201 Rolapitant - Oral Rolapitant - Oral · Tesaro, Inc. https://druglandscape.com/drug/romidepsin-and-chop https://druglandscape.com/api/og?type=drug&title=Romidepsin%20and%20CHOP&subtitle=Romidepsin%20and%20CHOP%20%C2%B7%20The%20Lymphoma%20Academic%20Research%20Organisation&badge=phase%201 Romidepsin and CHOP Romidepsin and CHOP · The Lymphoma Academic Research Organisation https://druglandscape.com/drug/romidepsin-cycle-1 https://druglandscape.com/api/og?type=drug&title=Romidepsin%20cycle%201&subtitle=Romidepsin%20cycle%201%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Romidepsin cycle 1 Romidepsin cycle 1 · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/romidepsin-cycle-3 https://druglandscape.com/api/og?type=drug&title=Romidepsin%20cycle%203&subtitle=Romidepsin%20cycle%203%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Romidepsin cycle 3 Romidepsin cycle 3 · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/romidepsin-cycle-4 https://druglandscape.com/api/og?type=drug&title=Romidepsin%20cycle%204&subtitle=Romidepsin%20cycle%204%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Romidepsin cycle 4 Romidepsin cycle 4 · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/ronkyla-plus https://druglandscape.com/api/og?type=drug&title=Ronkyla%20Plus&subtitle=Ronkyla%20Plus%20%C2%B7%20Glonova%20Pharma%20Co.%2C%20Ltd&badge=phase%201 Ronkyla Plus Ronkyla Plus · Glonova Pharma Co., Ltd https://druglandscape.com/drug/ropinirole-dosing-for-up-to-28-days https://druglandscape.com/api/og?type=drug&title=ropinirole%20dosing%20for%20up%20to%2028%20days&subtitle=ropinirole%20dosing%20for%20up%20to%2028%20days%20%C2%B7%20GlaxoSmithKline&badge=phase%201 ropinirole dosing for up to 28 days ropinirole dosing for up to 28 days · GlaxoSmithKline https://druglandscape.com/drug/ropivacaine-1 https://druglandscape.com/api/og?type=drug&title=Ropivacaine%201%25&subtitle=Ropivacaine%201%25%20%C2%B7%20Sunnybrook%20Health%20Sciences%20Centre&badge=phase%201 Ropivacaine 1% Ropivacaine 1% · Sunnybrook Health Sciences Centre https://druglandscape.com/drug/ropivacaine-and-midazolam-epidural-administration https://druglandscape.com/api/og?type=drug&title=ropivacaine%20and%20midazolam%20epidural%20administration&subtitle=ropivacaine%20and%20midazolam%20epidural%20administration%20%C2%B7%20Universidad%20Autonoma%20de%20Nuevo%20Leon&badge=phase%202 ropivacaine and midazolam epidural administration ropivacaine and midazolam epidural administration · Universidad Autonoma de Nuevo Leon https://druglandscape.com/drug/ropivacaine-hcl https://druglandscape.com/api/og?type=drug&title=ropivacaine%20HCl.&subtitle=ropivacaine%20HCl.%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 ropivacaine HCl. ropivacaine HCl. · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ropivacaine-ketorolac-and-epinephrine https://druglandscape.com/api/og?type=drug&title=ropivacaine%2C%20ketorolac%20and%20epinephrine&subtitle=ropivacaine%2C%20ketorolac%20and%20epinephrine%20%C2%B7%20Region%20%C3%96rebro%20County&badge=phase%201 ropivacaine, ketorolac and epinephrine ropivacaine, ketorolac and epinephrine · Region Örebro County https://druglandscape.com/drug/ropivacaine-plus-dexmedetomidine https://druglandscape.com/api/og?type=drug&title=Ropivacaine%20plus%20dexmedetomidine&subtitle=Ropivacaine%20plus%20dexmedetomidine%20%C2%B7%20Universidad%20Aut%C3%B3noma%20de%20Tamaulipas&badge=phase%201 Ropivacaine plus dexmedetomidine Ropivacaine plus dexmedetomidine · Universidad Autónoma de Tamaulipas https://druglandscape.com/drug/rosuvastatin-and-gdc-0853 https://druglandscape.com/api/og?type=drug&title=Rosuvastatin%20and%20GDC-0853&subtitle=Rosuvastatin%20and%20GDC-0853%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 Rosuvastatin and GDC-0853 Rosuvastatin and GDC-0853 · Genentech, Inc. https://druglandscape.com/drug/rosuvastatin-calcium-tablets https://druglandscape.com/api/og?type=drug&title=Rosuvastatin%20Calcium%20Tablets&subtitle=Rosuvastatin%20Calcium%20Tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Rosuvastatin Calcium Tablets Rosuvastatin Calcium Tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/rosuvastatin-dose-1-stp https://druglandscape.com/api/og?type=drug&title=Rosuvastatin%20Dose%201%20STP&subtitle=Rosuvastatin%20Dose%201%20STP%20%C2%B7%20AstraZeneca&badge=phase%201 Rosuvastatin Dose 1 STP Rosuvastatin Dose 1 STP · AstraZeneca https://druglandscape.com/drug/rosuvastatin-olmesartan-medoxomil https://druglandscape.com/api/og?type=drug&title=Rosuvastatin%2C%20Olmesartan%20Medoxomil&subtitle=Rosuvastatin%2C%20Olmesartan%20Medoxomil%20%C2%B7%20Daewoong%20Pharmaceutical%20Co.%20LTD.&badge=phase%202 Rosuvastatin, Olmesartan Medoxomil Rosuvastatin, Olmesartan Medoxomil · Daewoong Pharmaceutical Co. LTD. https://druglandscape.com/drug/rotigotine-nasal-spray https://druglandscape.com/api/og?type=drug&title=Rotigotine%20Nasal%20Spray&subtitle=Rotigotine%20Nasal%20Spray%20%C2%B7%20UCB%20Pharma&badge=phase%202 Rotigotine Nasal Spray Rotigotine Nasal Spray · UCB Pharma https://druglandscape.com/drug/rotigotine-patch https://druglandscape.com/api/og?type=drug&title=Rotigotine%20patch&subtitle=Rotigotine%20patch%20%C2%B7%20UCB%20Pharma&badge=phase%202 Rotigotine patch Rotigotine patch · UCB Pharma https://druglandscape.com/drug/rotigotine-period-1 https://druglandscape.com/api/og?type=drug&title=Rotigotine%2C%20Period%201&subtitle=Rotigotine%2C%20Period%201%20%C2%B7%20UCB%20Pharma&badge=phase%201 Rotigotine, Period 1 Rotigotine, Period 1 · UCB Pharma https://druglandscape.com/drug/rotigotine-period-2 https://druglandscape.com/api/og?type=drug&title=Rotigotine%2C%20Period%202&subtitle=Rotigotine%2C%20Period%202%20%C2%B7%20UCB%20Pharma&badge=phase%201 Rotigotine, Period 2 Rotigotine, Period 2 · UCB Pharma https://druglandscape.com/drug/rotigotine-pr-2-1-4 https://druglandscape.com/api/og?type=drug&title=Rotigotine%20PR%202.1.4&subtitle=Rotigotine%20PR%202.1.4%20%C2%B7%20UCB%20Pharma&badge=phase%201 Rotigotine PR 2.1.4 Rotigotine PR 2.1.4 · UCB Pharma https://druglandscape.com/drug/rotigotine-pr2-1-1 https://druglandscape.com/api/og?type=drug&title=Rotigotine%20PR2.1.1&subtitle=Rotigotine%20PR2.1.1%20%C2%B7%20UCB%20Pharma%20SA&badge=phase%201 Rotigotine PR2.1.1 Rotigotine PR2.1.1 · UCB Pharma SA https://druglandscape.com/drug/rotigotine-transdermal-system https://druglandscape.com/api/og?type=drug&title=Rotigotine%20Transdermal%20System&subtitle=Rotigotine%20Transdermal%20System%20%C2%B7%20Inflamax%20Research%20Incorporated&badge=phase%201 Rotigotine Transdermal System Rotigotine Transdermal System · Inflamax Research Incorporated https://druglandscape.com/drug/routine-biological-monitoring https://druglandscape.com/api/og?type=drug&title=Routine%20biological%20monitoring&subtitle=Routine%20biological%20monitoring%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Routine biological monitoring Routine biological monitoring · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/routine-deworming https://druglandscape.com/api/og?type=drug&title=Routine%20deworming&subtitle=Routine%20deworming%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%201 Routine deworming Routine deworming · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/routine-dose-icotinib https://druglandscape.com/api/og?type=drug&title=Routine%20dose%20icotinib&subtitle=Routine%20dose%20icotinib%20%C2%B7%20Betta%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 Routine dose icotinib Routine dose icotinib · Betta Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/routine-postoperative-calcium-and-calcitriol https://druglandscape.com/api/og?type=drug&title=routine%20postoperative%20calcium%20and%20calcitriol&subtitle=routine%20postoperative%20calcium%20and%20calcitriol%20%C2%B7%20Centro%20de%20Excelencia%20en%20Enfermedades%20de%20Cabeza%20y%20Cuel&badge=phase%201 routine postoperative calcium and calcitriol routine postoperative calcium and calcitriol · Centro de Excelencia en Enfermedades de Cabeza y Cuello https://druglandscape.com/drug/routine-use-of-p-cab-on-dapt https://druglandscape.com/api/og?type=drug&title=Routine%20use%20of%20P-CAB%20on%20DAPT&subtitle=Routine%20use%20of%20P-CAB%20on%20DAPT%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 Routine use of P-CAB on DAPT Routine use of P-CAB on DAPT · Samsung Medical Center https://druglandscape.com/drug/rouvax https://druglandscape.com/api/og?type=drug&title=Rouvax%E2%84%A2&subtitle=Rouvax%E2%84%A2%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Rouvax™ Rouvax™ · GlaxoSmithKline https://druglandscape.com/drug/rp-01 https://druglandscape.com/api/og?type=drug&title=RP%2001&subtitle=RP%2001%20%C2%B7%20Resistentia%20Pharmaceuticals%20AB&badge=phase%202 RP 01 RP 01 · Resistentia Pharmaceuticals AB https://druglandscape.com/drug/rp-3500 https://druglandscape.com/api/og?type=drug&title=RP-3500&subtitle=RP-3500%20%C2%B7%20Canadian%20Cancer%20Trials%20Group&badge=phase%202 RP-3500 RP-3500 · Canadian Cancer Trials Group https://druglandscape.com/drug/rp-a501 https://druglandscape.com/api/og?type=drug&title=RP-A501&subtitle=RP-A501%20%C2%B7%20Rocket%20Pharmaceuticals%20Inc.&badge=phase%201 RP-A501 RP-A501 · Rocket Pharmaceuticals Inc. https://druglandscape.com/drug/rp-followed-by-mpr https://druglandscape.com/api/og?type=drug&title=RP%20followed%20by%20MPR&subtitle=RP%20followed%20by%20MPR%20%C2%B7%20Fondazione%20EMN%20Italy%20Onlus&badge=phase%202 RP followed by MPR RP followed by MPR · Fondazione EMN Italy Onlus https://druglandscape.com/drug/rp-l102 https://druglandscape.com/api/og?type=drug&title=RP-L102&subtitle=RP-L102%20%C2%B7%20Rocket%20Pharmaceuticals%20Inc.&badge=phase%202 RP-L102 RP-L102 · Rocket Pharmaceuticals Inc. https://druglandscape.com/drug/rp12146 https://druglandscape.com/api/og?type=drug&title=RP12146&subtitle=RP12146%20%C2%B7%20Rhizen%20Pharmaceuticals%20SA&badge=phase%201 RP12146 RP12146 · Rhizen Pharmaceuticals SA https://druglandscape.com/drug/rp2-monotherapy https://druglandscape.com/api/og?type=drug&title=RP2%20Monotherapy&subtitle=RP2%20Monotherapy%20%C2%B7%20Replimune%20Inc.&badge=phase%202 RP2 Monotherapy RP2 Monotherapy · Replimune Inc. https://druglandscape.com/drug/rp6530 https://druglandscape.com/api/og?type=drug&title=RP6530&subtitle=RP6530%20%C2%B7%20Rhizen%20Pharmaceuticals%20SA&badge=phase%201 RP6530 RP6530 · Rhizen Pharmaceuticals SA https://druglandscape.com/drug/rp72 https://druglandscape.com/api/og?type=drug&title=RP72&subtitle=RP72%20%C2%B7%20Rise%20Biopharmaceuticals%2C%20Inc.&badge=phase%201 RP72 RP72 · Rise Biopharmaceuticals, Inc. https://druglandscape.com/drug/rp903 https://druglandscape.com/api/og?type=drug&title=RP903&subtitle=RP903%20%C2%B7%20Risen%20(Suzhou)%20Pharma%20Tech%20Co.%2C%20Ltd.&badge=phase%201 RP903 RP903 · Risen (Suzhou) Pharma Tech Co., Ltd. https://druglandscape.com/drug/rpa-vaccine-containing-alhydrogel https://druglandscape.com/api/og?type=drug&title=rPA%20vaccine%20containing%20alhydrogel&subtitle=rPA%20vaccine%20containing%20alhydrogel%20%C2%B7%20PharmAthene%20UK%20Limited&badge=phase%202 rPA vaccine containing alhydrogel rPA vaccine containing alhydrogel · PharmAthene UK Limited https://druglandscape.com/drug/rpa102 https://druglandscape.com/api/og?type=drug&title=rPA102&subtitle=rPA102%20%C2%B7%20VaxGen&badge=phase%202 rPA102 rPA102 · VaxGen https://druglandscape.com/drug/rpa102-vaccine https://druglandscape.com/api/og?type=drug&title=rPA102%20Vaccine&subtitle=rPA102%20Vaccine%20%C2%B7%20VaxGen&badge=phase%201 rPA102 Vaccine rPA102 Vaccine · VaxGen https://druglandscape.com/drug/rpesc-rpe-4w https://druglandscape.com/api/og?type=drug&title=RPESC-RPE-4W&subtitle=RPESC-RPE-4W%20%C2%B7%20Luxa%20Biotechnology%2C%20LLC&badge=phase%201 RPESC-RPE-4W RPESC-RPE-4W · Luxa Biotechnology, LLC https://druglandscape.com/drug/rphleum https://druglandscape.com/api/og?type=drug&title=rPhleum&subtitle=rPhleum%20%C2%B7%20Allergopharma%20GmbH%20%26%20Co.%20KG&badge=phase%202 rPhleum rPhleum · Allergopharma GmbH & Co. KG https://druglandscape.com/drug/rpl554 https://druglandscape.com/api/og?type=drug&title=RPL554&subtitle=RPL554%20%C2%B7%20Verona%20Pharma%20plc&badge=phase%202 RPL554 RPL554 · Verona Pharma plc https://druglandscape.com/drug/rptr-1-201 https://druglandscape.com/api/og?type=drug&title=RPTR-1-201&subtitle=RPTR-1-201%20%C2%B7%20Repertoire%20Immune%20Medicines&badge=phase%201 RPTR-1-201 RPTR-1-201 · Repertoire Immune Medicines https://druglandscape.com/drug/rpv-oral-tablets https://druglandscape.com/api/og?type=drug&title=RPV%20Oral%20Tablets&subtitle=RPV%20Oral%20Tablets%20%C2%B7%20ViiV%20Healthcare&badge=phase%202 RPV Oral Tablets RPV Oral Tablets · ViiV Healthcare https://druglandscape.com/drug/rpx2014 https://druglandscape.com/api/og?type=drug&title=RPX2014&subtitle=RPX2014%20%C2%B7%20Rempex%20Pharmaceuticals%20(a%20wholly%20owned%20subsidiary%20of%20The%20Medicines%20Company)&badge=phase%201 RPX2014 RPX2014 · Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) https://druglandscape.com/drug/rpx7009 https://druglandscape.com/api/og?type=drug&title=RPX7009&subtitle=RPX7009%20%C2%B7%20Rempex%20Pharmaceuticals%20(a%20wholly%20owned%20subsidiary%20of%20The%20Medicines%20Company)&badge=phase%201 RPX7009 RPX7009 · Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) https://druglandscape.com/drug/rq3013 https://druglandscape.com/api/og?type=drug&title=RQ3013&subtitle=RQ3013%20%C2%B7%20Walvax%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 RQ3013 RQ3013 · Walvax Biotechnology Co., Ltd. https://druglandscape.com/drug/rr001 https://druglandscape.com/api/og?type=drug&title=RR001&subtitle=RR001%20%C2%B7%20EIR%20Biotherapies%20s.r.l.&badge=phase%201 RR001 RR001 · EIR Biotherapies s.r.l. https://druglandscape.com/drug/rrg001 https://druglandscape.com/api/og?type=drug&title=RRG001&subtitle=RRG001%20%C2%B7%20Shanghai%20Refreshgene%20Technology%20Co.%2C%20Ltd.&badge=phase%201 RRG001 RRG001 · Shanghai Refreshgene Technology Co., Ltd. https://druglandscape.com/drug/rrx-001 https://druglandscape.com/api/og?type=drug&title=RRx-001&subtitle=RRx-001%20%C2%B7%20EpicentRx%2C%20Inc.&badge=phase%202 RRx-001 RRx-001 · EpicentRx, Inc. https://druglandscape.com/drug/rs1-aav-vector https://druglandscape.com/api/og?type=drug&title=RS1%20AAV%20Vector&subtitle=RS1%20AAV%20Vector%20%C2%B7%20VegaVect%2C%20Inc.&badge=phase%201 RS1 AAV Vector RS1 AAV Vector · VegaVect, Inc. https://druglandscape.com/drug/rsc-1255-dose-escalation https://druglandscape.com/api/og?type=drug&title=RSC-1255%20Dose%20Escalation&subtitle=RSC-1255%20Dose%20Escalation%20%C2%B7%20RasCal%20Therapeutics%2C%20Inc.&badge=phase%201 RSC-1255 Dose Escalation RSC-1255 Dose Escalation · RasCal Therapeutics, Inc. https://druglandscape.com/drug/rsifn-co-nasal-spray https://druglandscape.com/api/og?type=drug&title=rSIFN-co%20Nasal%20Spray&subtitle=rSIFN-co%20Nasal%20Spray%20%C2%B7%20Sichuan%20Huiyang%20Life%20Science%20and%20Technology%20Corporation&badge=phase%202 rSIFN-co Nasal Spray rSIFN-co Nasal Spray · Sichuan Huiyang Life Science and Technology Corporation https://druglandscape.com/drug/rso-021 https://druglandscape.com/api/og?type=drug&title=RSO-021&subtitle=RSO-021%20%C2%B7%20RS%20Oncology%20LLC&badge=phase%201 RSO-021 RSO-021 · RS Oncology LLC https://druglandscape.com/drug/rsp-1502 https://druglandscape.com/api/og?type=drug&title=RSP-1502&subtitle=RSP-1502%20%C2%B7%20Respirion%20Pharmaceuticals%20Pty%20Ltd&badge=phase%201 RSP-1502 RSP-1502 · Respirion Pharmaceuticals Pty Ltd https://druglandscape.com/drug/rss0343-tablets https://druglandscape.com/api/og?type=drug&title=RSS0343%20tablets&subtitle=RSS0343%20tablets%20%C2%B7%20Reistone%20Biopharma%20Company%20Limited&badge=phase%202 RSS0343 tablets RSS0343 tablets · Reistone Biopharma Company Limited https://druglandscape.com/drug/rss0393-ointment https://druglandscape.com/api/og?type=drug&title=RSS0393%20ointment&subtitle=RSS0393%20ointment%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 RSS0393 ointment RSS0393 ointment · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/rsv-a-memphis-37 https://druglandscape.com/api/og?type=drug&title=RSV%20A%20Memphis%2037&subtitle=RSV%20A%20Memphis%2037%20%C2%B7%20Imperial%20College%20London&badge=phase%201 RSV A Memphis 37 RSV A Memphis 37 · Imperial College London https://druglandscape.com/drug/rsv-vaccine-candidate https://druglandscape.com/api/og?type=drug&title=RSV%20vaccine%20candidate&subtitle=RSV%20vaccine%20candidate%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%202 RSV vaccine candidate RSV vaccine candidate · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/rsv-vaccine-formulation-4-dose https://druglandscape.com/api/og?type=drug&title=RSV%20vaccine%20formulation%204%20dose&subtitle=RSV%20vaccine%20formulation%204%20dose%20%C2%B7%20Sanofi&badge=phase%201 RSV vaccine formulation 4 dose RSV vaccine formulation 4 dose · Sanofi https://druglandscape.com/drug/rsv-vaccine-formulation-5-dose https://druglandscape.com/api/og?type=drug&title=RSV%20vaccine%20formulation%205%20dose&subtitle=RSV%20vaccine%20formulation%205%20dose%20%C2%B7%20Sanofi&badge=phase%201 RSV vaccine formulation 5 dose RSV vaccine formulation 5 dose · Sanofi https://druglandscape.com/drug/rsv-vaccine-formulation-6-dose https://druglandscape.com/api/og?type=drug&title=RSV%20vaccine%20formulation%206%20dose&subtitle=RSV%20vaccine%20formulation%206%20dose%20%C2%B7%20Sanofi&badge=phase%201 RSV vaccine formulation 6 dose RSV vaccine formulation 6 dose · Sanofi https://druglandscape.com/drug/rsv-vaccine-formulation-7-dose https://druglandscape.com/api/og?type=drug&title=RSV%20vaccine%20formulation%207%20dose&subtitle=RSV%20vaccine%20formulation%207%20dose%20%C2%B7%20Sanofi&badge=phase%201 RSV vaccine formulation 7 dose RSV vaccine formulation 7 dose · Sanofi https://druglandscape.com/drug/rsv-vaccine-formulation-8-dose https://druglandscape.com/api/og?type=drug&title=RSV%20vaccine%20formulation%208%20dose&subtitle=RSV%20vaccine%20formulation%208%20dose%20%C2%B7%20Sanofi&badge=phase%201 RSV vaccine formulation 8 dose RSV vaccine formulation 8 dose · Sanofi https://druglandscape.com/drug/rta-408-lotion-0-5-1-3 https://druglandscape.com/api/og?type=drug&title=RTA%20408%20Lotion%200.5%25%2C%201%25%2C%203%25&subtitle=RTA%20408%20Lotion%200.5%25%2C%201%25%2C%203%25%20%C2%B7%20Biogen&badge=phase%201 RTA 408 Lotion 0.5%, 1%, 3% RTA 408 Lotion 0.5%, 1%, 3% · Biogen https://druglandscape.com/drug/rtb101 https://druglandscape.com/api/og?type=drug&title=RTB101&subtitle=RTB101%20%C2%B7%20Restorbio%20Inc.&badge=phase%202 RTB101 RTB101 · Restorbio Inc. https://druglandscape.com/drug/rtp-026 https://druglandscape.com/api/og?type=drug&title=RTP-026&subtitle=RTP-026%20%C2%B7%20ResoTher%20Pharma&badge=phase%202 RTP-026 RTP-026 · ResoTher Pharma https://druglandscape.com/drug/rtsst-1-variant-candidate-vaccine https://druglandscape.com/api/og?type=drug&title=rTSST-1%20Variant%20Candidate%20Vaccine&subtitle=rTSST-1%20Variant%20Candidate%20Vaccine%20%C2%B7%20Biomedizinische%20Forschungs%20gmbH&badge=phase%201 rTSST-1 Variant Candidate Vaccine rTSST-1 Variant Candidate Vaccine · Biomedizinische Forschungs gmbH https://druglandscape.com/drug/rtsst-1v https://druglandscape.com/api/og?type=drug&title=rTSST-1v&subtitle=rTSST-1v%20%C2%B7%20Biomedizinische%20Forschungs%20gmbH&badge=phase%202 rTSST-1v rTSST-1v · Biomedizinische Forschungs gmbH https://druglandscape.com/drug/rtv-tablets https://druglandscape.com/api/og?type=drug&title=RTV%20tablets&subtitle=RTV%20tablets%20%C2%B7%20Ascletis%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 RTV tablets RTV tablets · Ascletis Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/rtx001 https://druglandscape.com/api/og?type=drug&title=RTX001&subtitle=RTX001%20%C2%B7%20Resolution%20Therapeutics%20Limited&badge=phase%201 RTX001 RTX001 · Resolution Therapeutics Limited https://druglandscape.com/drug/ru-101 https://druglandscape.com/api/og?type=drug&title=RU-101&subtitle=RU-101%20%C2%B7%20R-Tech%20Ueno%2C%20Ltd.&badge=phase%201 RU-101 RU-101 · R-Tech Ueno, Ltd. https://druglandscape.com/drug/ruc-4-compound https://druglandscape.com/api/og?type=drug&title=RUC-4%20Compound&subtitle=RUC-4%20Compound%20%C2%B7%20CeleCor%20Therapeutics&badge=phase%202 RUC-4 Compound RUC-4 Compound · CeleCor Therapeutics https://druglandscape.com/drug/rupture-of-membrane https://druglandscape.com/api/og?type=drug&title=rupture%20of%20membrane&subtitle=rupture%20of%20membrane%20%C2%B7%20sarah%20mohamed%20hassan&badge=phase%202 rupture of membrane rupture of membrane · sarah mohamed hassan https://druglandscape.com/drug/rurioctocog-alfa-pegol https://druglandscape.com/api/og?type=drug&title=rurioctocog%20alfa%20pegol&subtitle=rurioctocog%20alfa%20pegol%20%C2%B7%20Spanish%20Society%20of%20Thrombosis%20and%20Haemostasis&badge=phase%202 rurioctocog alfa pegol rurioctocog alfa pegol · Spanish Society of Thrombosis and Haemostasis https://druglandscape.com/drug/ruxolitinib-1-5-cream-qd https://druglandscape.com/api/og?type=drug&title=Ruxolitinib%201.5%25%20Cream%20QD&subtitle=Ruxolitinib%201.5%25%20Cream%20QD%20%C2%B7%20CAGE%20Bio%20Inc.&badge=phase%202 Ruxolitinib 1.5% Cream QD Ruxolitinib 1.5% Cream QD · CAGE Bio Inc. https://druglandscape.com/drug/ruxolitinib-plus-simvastatin https://druglandscape.com/api/og?type=drug&title=Ruxolitinib%20plus%20simvastatin&subtitle=Ruxolitinib%20plus%20simvastatin%20%C2%B7%20Fundaci%C3%B3n%20de%20investigaci%C3%B3n%20HM&badge=phase%202 Ruxolitinib plus simvastatin Ruxolitinib plus simvastatin · Fundación de investigación HM https://druglandscape.com/drug/rv001v https://druglandscape.com/api/og?type=drug&title=RV001V&subtitle=RV001V%20%C2%B7%20RhoVac%20APS&badge=phase%202 RV001V RV001V · RhoVac APS https://druglandscape.com/drug/rv16ub https://druglandscape.com/api/og?type=drug&title=RV16UB&subtitle=RV16UB%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 RV16UB RV16UB · Merck Sharp & Dohme LLC https://druglandscape.com/drug/rv3-bb https://druglandscape.com/api/og?type=drug&title=RV3-BB&subtitle=RV3-BB%20%C2%B7%20PATH&badge=phase%202 RV3-BB RV3-BB · PATH https://druglandscape.com/drug/rv3-bb-birth-dose https://druglandscape.com/api/og?type=drug&title=RV3-BB%20birth%20dose&subtitle=RV3-BB%20birth%20dose%20%C2%B7%20PATH&badge=phase%202 RV3-BB birth dose RV3-BB birth dose · PATH https://druglandscape.com/drug/rvf-mp-12 https://druglandscape.com/api/og?type=drug&title=RVF%20MP-12&subtitle=RVF%20MP-12%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%202 RVF MP-12 RVF MP-12 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/rvf-vaccine https://druglandscape.com/api/og?type=drug&title=RVF%20Vaccine&subtitle=RVF%20Vaccine%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%202 RVF Vaccine RVF Vaccine · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/rvsv-g-zebov https://druglandscape.com/api/og?type=drug&title=rVSV%CE%94G-ZEBOV&subtitle=rVSV%CE%94G-ZEBOV%20%C2%B7%20Centers%20for%20Disease%20Control%20and%20Prevention&badge=phase%202 rVSVΔG-ZEBOV rVSVΔG-ZEBOV · Centers for Disease Control and Prevention https://druglandscape.com/drug/rvwf https://druglandscape.com/api/og?type=drug&title=rVWF&subtitle=rVWF%20%C2%B7%20Baxalta%20now%20part%20of%20Shire&badge=phase%203 rVWF rVWF · Baxalta now part of Shire https://druglandscape.com/drug/rwj-445380 https://druglandscape.com/api/og?type=drug&title=RWJ-445380&subtitle=RWJ-445380%20%C2%B7%20Alza%20Corporation%2C%20DE%2C%20USA&badge=phase%202 RWJ-445380 RWJ-445380 · Alza Corporation, DE, USA https://druglandscape.com/drug/rx-0201-plus-gemcitabine https://druglandscape.com/api/og?type=drug&title=RX-0201%20plus%20Gemcitabine&subtitle=RX-0201%20plus%20Gemcitabine%20%C2%B7%20Rexahn%20Pharmaceuticals%2C%20Inc.&badge=phase%202 RX-0201 plus Gemcitabine RX-0201 plus Gemcitabine · Rexahn Pharmaceuticals, Inc. https://druglandscape.com/drug/rx-10001 https://druglandscape.com/api/og?type=drug&title=RX-10001&subtitle=RX-10001%20%C2%B7%20Resolvyx%20Pharmaceuticals%2C%20Inc&badge=phase%201 RX-10001 RX-10001 · Resolvyx Pharmaceuticals, Inc https://druglandscape.com/drug/rx-10045 https://druglandscape.com/api/og?type=drug&title=RX-10045&subtitle=RX-10045%20%C2%B7%20C.T.%20Development%20America%2C%20Inc.&badge=phase%202 RX-10045 RX-10045 · C.T. Development America, Inc. https://druglandscape.com/drug/rx-10100 https://druglandscape.com/api/og?type=drug&title=RX-10100&subtitle=RX-10100%20%C2%B7%20Rexahn%20Pharmaceuticals%2C%20Inc.&badge=phase%202 RX-10100 RX-10100 · Rexahn Pharmaceuticals, Inc. https://druglandscape.com/drug/rx001 https://druglandscape.com/api/og?type=drug&title=RX001&subtitle=RX001%20%C2%B7%20GeneCraft%20Inc.&badge=phase%201 RX001 RX001 · GeneCraft Inc. https://druglandscape.com/drug/rx0041 https://druglandscape.com/api/og?type=drug&title=RX0041&subtitle=RX0041%20%C2%B7%20Pharmaceutical%20Project%20Solutions%2C%20Inc.&badge=phase%201 RX0041 RX0041 · Pharmaceutical Project Solutions, Inc. https://druglandscape.com/drug/rx0041-2 https://druglandscape.com/api/og?type=drug&title=RX0041-2&subtitle=RX0041-2%20%C2%B7%20Pharmaceutical%20Project%20Solutions%2C%20Inc.&badge=phase%201 RX0041-2 RX0041-2 · Pharmaceutical Project Solutions, Inc. https://druglandscape.com/drug/rx108 https://druglandscape.com/api/og?type=drug&title=RX108&subtitle=RX108%20%C2%B7%20NeuPharma%2C%20Inc.&badge=phase%201 RX108 RX108 · NeuPharma, Inc. https://druglandscape.com/drug/rxc007 https://druglandscape.com/api/og?type=drug&title=RXC007&subtitle=RXC007%20%C2%B7%20Redx%20Pharma%20Ltd&badge=phase%202 RXC007 RXC007 · Redx Pharma Ltd https://druglandscape.com/drug/rxdx-105 https://druglandscape.com/api/og?type=drug&title=RXDX-105&subtitle=RXDX-105%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 RXDX-105 RXDX-105 · Hoffmann-La Roche https://druglandscape.com/drug/rxi-109 https://druglandscape.com/api/og?type=drug&title=RXI-109&subtitle=RXI-109%20%C2%B7%20RXi%20Pharmaceuticals%2C%20Corp.&badge=phase%202 RXI-109 RXI-109 · RXi Pharmaceuticals, Corp. https://druglandscape.com/drug/rxrg001 https://druglandscape.com/api/og?type=drug&title=RXRG001&subtitle=RXRG001%20%C2%B7%20RiboX%20Therapeutics%20Ltd.&badge=phase%201 RXRG001 RXRG001 · RiboX Therapeutics Ltd. https://druglandscape.com/drug/rxulti-film-coated-tablet https://druglandscape.com/api/og?type=drug&title=RXULTI%20film%20coated%20tablet&subtitle=RXULTI%20film%20coated%20tablet%20%C2%B7%20Humanis%20Sagl%C4%B1k%20Anonim%20Sirketi&badge=phase%201 RXULTI film coated tablet RXULTI film coated tablet · Humanis Saglık Anonim Sirketi https://druglandscape.com/drug/ryi-018 https://druglandscape.com/api/og?type=drug&title=RYI-018&subtitle=RYI-018%20%C2%B7%20Bird%20Rock%20Bio%2C%20Inc.&badge=phase%201 RYI-018 RYI-018 · Bird Rock Bio, Inc. https://druglandscape.com/drug/ryz101-dose-level-1 https://druglandscape.com/api/og?type=drug&title=RYZ101%20Dose%20Level%20-1&subtitle=RYZ101%20Dose%20Level%20-1%20%C2%B7%20RayzeBio%2C%20Inc.&badge=phase%201 RYZ101 Dose Level -1 RYZ101 Dose Level -1 · RayzeBio, Inc. https://druglandscape.com/drug/ryz101-dose-level-2 https://druglandscape.com/api/og?type=drug&title=RYZ101%20Dose%20Level%202&subtitle=RYZ101%20Dose%20Level%202%20%C2%B7%20RayzeBio%2C%20Inc.&badge=phase%201 RYZ101 Dose Level 2 RYZ101 Dose Level 2 · RayzeBio, Inc. https://druglandscape.com/drug/ryz401 https://druglandscape.com/api/og?type=drug&title=RYZ401&subtitle=RYZ401%20%C2%B7%20RayzeBio%2C%20Inc.&badge=phase%201 RYZ401 RYZ401 · RayzeBio, Inc. https://druglandscape.com/drug/ryzodeg https://druglandscape.com/api/og?type=drug&title=Ryzodeg%C2%AE&subtitle=Ryzodeg%C2%AE%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%202 Ryzodeg® Ryzodeg® · Novo Nordisk A/S https://druglandscape.com/drug/rz-001 https://druglandscape.com/api/og?type=drug&title=RZ-001&subtitle=RZ-001%20%C2%B7%20Rznomics%2C%20Inc.&badge=phase%202 RZ-001 RZ-001 · Rznomics, Inc. https://druglandscape.com/drug/rzl-012 https://druglandscape.com/api/og?type=drug&title=RZL-012&subtitle=RZL-012%20%C2%B7%20Raziel%20Therapeutics%20Ltd.&badge=phase%202 RZL-012 RZL-012 · Raziel Therapeutics Ltd. https://druglandscape.com/drug/s-1-bevacizumab https://druglandscape.com/api/og?type=drug&title=S-1%2C%20Bevacizumab&subtitle=S-1%2C%20Bevacizumab%20%C2%B7%20Taiho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 S-1, Bevacizumab S-1, Bevacizumab · Taiho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/s-1-de-escalation https://druglandscape.com/api/og?type=drug&title=S-1%20de-escalation&subtitle=S-1%20de-escalation%20%C2%B7%20AIO-Studien-gGmbH&badge=phase%202 S-1 de-escalation S-1 de-escalation · AIO-Studien-gGmbH https://druglandscape.com/drug/s-1-gemcitabine-cisplatin https://druglandscape.com/api/og?type=drug&title=S-1%2C%20Gemcitabine%2C%20Cisplatin&subtitle=S-1%2C%20Gemcitabine%2C%20Cisplatin%20%C2%B7%20Kansai%20Hepatobiliary%20Oncology%20Group&badge=phase%201 S-1, Gemcitabine, Cisplatin S-1, Gemcitabine, Cisplatin · Kansai Hepatobiliary Oncology Group https://druglandscape.com/drug/s-1117 https://druglandscape.com/api/og?type=drug&title=S-1117&subtitle=S-1117%20%C2%B7%20Seismic%20Therapeutic%20AU%20Pty%20Ltd&badge=phase%201 S-1117 S-1117 · Seismic Therapeutic AU Pty Ltd https://druglandscape.com/drug/s-309309 https://druglandscape.com/api/og?type=drug&title=S-309309&subtitle=S-309309%20%C2%B7%20Shionogi&badge=phase%202 S-309309 S-309309 · Shionogi https://druglandscape.com/drug/s-337395 https://druglandscape.com/api/og?type=drug&title=S-337395&subtitle=S-337395%20%C2%B7%20Shionogi&badge=phase%202 S-337395 S-337395 · Shionogi https://druglandscape.com/drug/s-4321 https://druglandscape.com/api/og?type=drug&title=S-4321&subtitle=S-4321%20%C2%B7%20Seismic%20Therapeutic%20AU%20Pty%20Ltd&badge=phase%201 S-4321 S-4321 · Seismic Therapeutic AU Pty Ltd https://druglandscape.com/drug/s-488210 https://druglandscape.com/api/og?type=drug&title=S-488210&subtitle=S-488210%20%C2%B7%20Shionogi&badge=phase%201 S-488210 S-488210 · Shionogi https://druglandscape.com/drug/s-488211 https://druglandscape.com/api/og?type=drug&title=S-488211&subtitle=S-488211%20%C2%B7%20Shionogi&badge=phase%201 S-488211 S-488211 · Shionogi https://druglandscape.com/drug/s-531011 https://druglandscape.com/api/og?type=drug&title=S-531011&subtitle=S-531011%20%C2%B7%20Shionogi&badge=phase%201 S-531011 S-531011 · Shionogi https://druglandscape.com/drug/s-555739-dose-1 https://druglandscape.com/api/og?type=drug&title=S-555739%20Dose%201&subtitle=S-555739%20Dose%201%20%C2%B7%20Shionogi&badge=phase%202 S-555739 Dose 1 S-555739 Dose 1 · Shionogi https://druglandscape.com/drug/s-600918 https://druglandscape.com/api/og?type=drug&title=S-600918&subtitle=S-600918%20%C2%B7%20Shionogi&badge=phase%202 S-600918 S-600918 · Shionogi https://druglandscape.com/drug/s-606001 https://druglandscape.com/api/og?type=drug&title=S-606001&subtitle=S-606001%20%C2%B7%20Shionogi&badge=phase%202 S-606001 S-606001 · Shionogi https://druglandscape.com/drug/s-648414 https://druglandscape.com/api/og?type=drug&title=S-648414&subtitle=S-648414%20%C2%B7%20Shionogi&badge=phase%201 S-648414 S-648414 · Shionogi https://druglandscape.com/drug/s-707106 https://druglandscape.com/api/og?type=drug&title=S-707106&subtitle=S-707106%20%C2%B7%20Shionogi&badge=phase%201 S-707106 S-707106 · Shionogi https://druglandscape.com/drug/s-707106-dose-a https://druglandscape.com/api/og?type=drug&title=S-707106%20Dose%20A&subtitle=S-707106%20Dose%20A%20%C2%B7%20Shionogi&badge=phase%202 S-707106 Dose A S-707106 Dose A · Shionogi https://druglandscape.com/drug/s-707106-dose-b https://druglandscape.com/api/og?type=drug&title=S-707106%20Dose%20B&subtitle=S-707106%20Dose%20B%20%C2%B7%20Shionogi&badge=phase%202 S-707106 Dose B S-707106 Dose B · Shionogi https://druglandscape.com/drug/s-707106-dose-c https://druglandscape.com/api/og?type=drug&title=S-707106%20Dose%20C&subtitle=S-707106%20Dose%20C%20%C2%B7%20Shionogi&badge=phase%202 S-707106 Dose C S-707106 Dose C · Shionogi https://druglandscape.com/drug/s-740792-suspension https://druglandscape.com/api/og?type=drug&title=S-740792%20Suspension&subtitle=S-740792%20Suspension%20%C2%B7%20Shionogi&badge=phase%201 S-740792 Suspension S-740792 Suspension · Shionogi https://druglandscape.com/drug/s-8184-paclitaxel-injectable-emulsion https://druglandscape.com/api/og?type=drug&title=S-8184%20Paclitaxel%20Injectable%20Emulsion&subtitle=S-8184%20Paclitaxel%20Injectable%20Emulsion%20%C2%B7%20Achieve%20Life%20Sciences&badge=phase%202 S-8184 Paclitaxel Injectable Emulsion S-8184 Paclitaxel Injectable Emulsion · Achieve Life Sciences https://druglandscape.com/drug/s-888711 https://druglandscape.com/api/og?type=drug&title=S-888711&subtitle=S-888711%20%C2%B7%20Shionogi&badge=phase%201 S-888711 S-888711 · Shionogi https://druglandscape.com/drug/s-892216 https://druglandscape.com/api/og?type=drug&title=S-892216&subtitle=S-892216%20%C2%B7%20Shionogi&badge=phase%202 S-892216 S-892216 · Shionogi https://druglandscape.com/drug/s-892216-lai https://druglandscape.com/api/og?type=drug&title=S-892216-LAI&subtitle=S-892216-LAI%20%C2%B7%20Shionogi&badge=phase%201 S-892216-LAI S-892216-LAI · Shionogi https://druglandscape.com/drug/s-892216-po https://druglandscape.com/api/og?type=drug&title=S-892216-PO&subtitle=S-892216-PO%20%C2%B7%20Shionogi&badge=phase%201 S-892216-PO S-892216-PO · Shionogi https://druglandscape.com/drug/s-amlodipine https://druglandscape.com/api/og?type=drug&title=S-amlodipine&subtitle=S-amlodipine%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%202 S-amlodipine S-amlodipine · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/s-amlodipine-telmisartan https://druglandscape.com/api/og?type=drug&title=S-Amlodipine%2C%20Telmisartan&subtitle=S-Amlodipine%2C%20Telmisartan%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%202 S-Amlodipine, Telmisartan S-Amlodipine, Telmisartan · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/s-equol https://druglandscape.com/api/og?type=drug&title=S-equol&subtitle=S-equol%20%C2%B7%20Ausio%20Pharmaceuticals%2C%20LLC&badge=phase%202 S-equol S-equol · Ausio Pharmaceuticals, LLC https://druglandscape.com/drug/s-ketamine-infusion-outpatient-setting https://druglandscape.com/api/og?type=drug&title=S-ketamine%20infusion%20outpatient%20setting&subtitle=S-ketamine%20infusion%20outpatient%20setting%20%C2%B7%20Erasmus%20Medical%20Center&badge=phase%201 S-ketamine infusion outpatient setting S-ketamine infusion outpatient setting · Erasmus Medical Center https://druglandscape.com/drug/s-licarbazepine https://druglandscape.com/api/og?type=drug&title=S-licarbazepine&subtitle=S-licarbazepine%20%C2%B7%20Bial%20-%20Portela%20C%20S.A.&badge=phase%201 S-licarbazepine S-licarbazepine · Bial - Portela C S.A. https://druglandscape.com/drug/s-lmwh https://druglandscape.com/api/og?type=drug&title=s-LMWH&subtitle=s-LMWH%20%C2%B7%20Huazhong%20University%20of%20Science%20and%20Technology&badge=phase%203 s-LMWH s-LMWH · Huazhong University of Science and Technology https://druglandscape.com/drug/s-s-reboxetine-monotherapy https://druglandscape.com/api/og?type=drug&title=%5BS%2CS%5D-reboxetine%20monotherapy&subtitle=%5BS%2CS%5D-reboxetine%20monotherapy%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%202 [S,S]-reboxetine monotherapy [S,S]-reboxetine monotherapy · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/s-salivarius https://druglandscape.com/api/og?type=drug&title=S%20salivarius&subtitle=S%20salivarius%20%C2%B7%20Universidade%20de%20Passo%20Fundo&badge=phase%202 S salivarius S salivarius · Universidade de Passo Fundo https://druglandscape.com/drug/s-sonnei-vaccine https://druglandscape.com/api/og?type=drug&title=S.sonnei%20vaccine&subtitle=S.sonnei%20vaccine%20%C2%B7%20GlaxoSmithKline&badge=phase%202 S.sonnei vaccine S.sonnei vaccine · GlaxoSmithKline https://druglandscape.com/drug/s095018 https://druglandscape.com/api/og?type=drug&title=S095018&subtitle=S095018%20%C2%B7%20Servier%20Bio-Innovation%20LLC&badge=phase%201 S095018 S095018 · Servier Bio-Innovation LLC https://druglandscape.com/drug/s095024 https://druglandscape.com/api/og?type=drug&title=S095024&subtitle=S095024%20%C2%B7%20Servier%20Bio-Innovation%20LLC&badge=phase%201 S095024 S095024 · Servier Bio-Innovation LLC https://druglandscape.com/drug/s095024-rde https://druglandscape.com/api/og?type=drug&title=S095024%20RDE&subtitle=S095024%20RDE%20%C2%B7%20Servier%20Bio-Innovation%20LLC&badge=phase%201 S095024 RDE S095024 RDE · Servier Bio-Innovation LLC https://druglandscape.com/drug/s095029 https://druglandscape.com/api/og?type=drug&title=S095029&subtitle=S095029%20%C2%B7%20Servier%20Bio-Innovation%20LLC&badge=phase%201 S095029 S095029 · Servier Bio-Innovation LLC https://druglandscape.com/drug/s095029-rde https://druglandscape.com/api/og?type=drug&title=S095029%20RDE&subtitle=S095029%20RDE%20%C2%B7%20Servier%20Bio-Innovation%20LLC&badge=phase%201 S095029 RDE S095029 RDE · Servier Bio-Innovation LLC https://druglandscape.com/drug/s095035 https://druglandscape.com/api/og?type=drug&title=S095035&subtitle=S095035%20%C2%B7%20Servier%20Bio-Innovation%20LLC&badge=phase%201 S095035 S095035 · Servier Bio-Innovation LLC https://druglandscape.com/drug/s1b-408 https://druglandscape.com/api/og?type=drug&title=S1B-408&subtitle=S1B-408%20%C2%B7%20S1%20Biopharma%2C%20Inc.&badge=phase%202 S1B-408 S1B-408 · S1 Biopharma, Inc. https://druglandscape.com/drug/s1b-509-high-dose https://druglandscape.com/api/og?type=drug&title=S1B-509%20High%20Dose&subtitle=S1B-509%20High%20Dose%20%C2%B7%20S1%20Biopharma%2C%20Inc.&badge=phase%202 S1B-509 High Dose S1B-509 High Dose · S1 Biopharma, Inc. https://druglandscape.com/drug/s1b-509-low-dose https://druglandscape.com/api/og?type=drug&title=S1B-509%20low%20dose&subtitle=S1B-509%20low%20dose%20%C2%B7%20S1%20Biopharma%2C%20Inc.&badge=phase%202 S1B-509 low dose S1B-509 low dose · S1 Biopharma, Inc. https://druglandscape.com/drug/s309309 https://druglandscape.com/api/og?type=drug&title=S309309&subtitle=S309309%20%C2%B7%20Shionogi&badge=phase%201 S309309 S309309 · Shionogi https://druglandscape.com/drug/s315 https://druglandscape.com/api/og?type=drug&title=S315&subtitle=S315%20%C2%B7%20MassBiologics&badge=phase%201 S315 S315 · MassBiologics https://druglandscape.com/drug/s410914-tablet https://druglandscape.com/api/og?type=drug&title=S410914%20tablet&subtitle=S410914%20tablet%20%C2%B7%20Jiangxi%20Qingfeng%20Pharmaceutical%20Co.%20Ltd.&badge=phase%201 S410914 tablet S410914 tablet · Jiangxi Qingfeng Pharmaceutical Co. Ltd. https://druglandscape.com/drug/s6g5t-1 https://druglandscape.com/api/og?type=drug&title=S6G5T-1&subtitle=S6G5T-1%20%C2%B7%20Sol-Gel%20Technologies%2C%20Ltd.&badge=phase%202 S6G5T-1 S6G5T-1 · Sol-Gel Technologies, Ltd. https://druglandscape.com/drug/s6g5t-5 https://druglandscape.com/api/og?type=drug&title=S6G5T-5&subtitle=S6G5T-5%20%C2%B7%20Sol-Gel%20Technologies%2C%20Ltd.&badge=phase%202 S6G5T-5 S6G5T-5 · Sol-Gel Technologies, Ltd. https://druglandscape.com/drug/s6g5t-6 https://druglandscape.com/api/og?type=drug&title=S6G5T-6&subtitle=S6G5T-6%20%C2%B7%20Sol-Gel%20Technologies%2C%20Ltd.&badge=phase%202 S6G5T-6 S6G5T-6 · Sol-Gel Technologies, Ltd. https://druglandscape.com/drug/s6g5t-7 https://druglandscape.com/api/og?type=drug&title=S6G5T-7&subtitle=S6G5T-7%20%C2%B7%20Sol-Gel%20Technologies%2C%20Ltd.&badge=phase%202 S6G5T-7 S6G5T-7 · Sol-Gel Technologies, Ltd. https://druglandscape.com/drug/sa-5ag-full-dose-non-adjuvanted https://druglandscape.com/api/og?type=drug&title=Sa-5Ag%20full%20dose%20non-adjuvanted&subtitle=Sa-5Ag%20full%20dose%20non-adjuvanted%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Sa-5Ag full dose non-adjuvanted Sa-5Ag full dose non-adjuvanted · GlaxoSmithKline https://druglandscape.com/drug/sa-5ag-half-dose-adjuvanted https://druglandscape.com/api/og?type=drug&title=Sa-5Ag%20half%20dose%20adjuvanted&subtitle=Sa-5Ag%20half%20dose%20adjuvanted%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Sa-5Ag half dose adjuvanted Sa-5Ag half dose adjuvanted · GlaxoSmithKline https://druglandscape.com/drug/sa-mrna-vaccine-dose-1 https://druglandscape.com/api/og?type=drug&title=sa-mRNA%20vaccine%20Dose%201&subtitle=sa-mRNA%20vaccine%20Dose%201%20%C2%B7%20Seqirus&badge=phase%201 sa-mRNA vaccine Dose 1 sa-mRNA vaccine Dose 1 · Seqirus https://druglandscape.com/drug/sa001-low-dose https://druglandscape.com/api/og?type=drug&title=SA001%20Low%20dose&subtitle=SA001%20Low%20dose%20%C2%B7%20Samjin%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 SA001 Low dose SA001 Low dose · Samjin Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sa001-mid-dose https://druglandscape.com/api/og?type=drug&title=SA001%20Mid%20dose&subtitle=SA001%20Mid%20dose%20%C2%B7%20Samjin%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 SA001 Mid dose SA001 Mid dose · Samjin Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sa09012-high-dose https://druglandscape.com/api/og?type=drug&title=SA09012%20High%20dose&subtitle=SA09012%20High%20dose%20%C2%B7%20SamA%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 SA09012 High dose SA09012 High dose · SamA Pharmaceutical Co., Ltd https://druglandscape.com/drug/sa09012-low-dose https://druglandscape.com/api/og?type=drug&title=SA09012%20Low%20dose&subtitle=SA09012%20Low%20dose%20%C2%B7%20SamA%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 SA09012 Low dose SA09012 Low dose · SamA Pharmaceutical Co., Ltd https://druglandscape.com/drug/sa3ag-vaccine https://druglandscape.com/api/og?type=drug&title=SA3Ag%20vaccine&subtitle=SA3Ag%20vaccine%20%C2%B7%20Pfizer&badge=phase%201 SA3Ag vaccine SA3Ag vaccine · Pfizer https://druglandscape.com/drug/sa3ag-with-no-booster-in-stage-2 https://druglandscape.com/api/og?type=drug&title=SA3Ag%20with%20no%20booster%20in%20stage%202&subtitle=SA3Ag%20with%20no%20booster%20in%20stage%202%20%C2%B7%20Pfizer&badge=phase%201 SA3Ag with no booster in stage 2 SA3Ag with no booster in stage 2 · Pfizer https://druglandscape.com/drug/sa4503-high https://druglandscape.com/api/og?type=drug&title=SA4503%20High&subtitle=SA4503%20High%20%C2%B7%20M's%20Science%20Corporation&badge=phase%202 SA4503 High SA4503 High · M's Science Corporation https://druglandscape.com/drug/sa4503-low https://druglandscape.com/api/og?type=drug&title=SA4503%20Low&subtitle=SA4503%20Low%20%C2%B7%20M's%20Science%20Corporation&badge=phase%202 SA4503 Low SA4503 Low · M's Science Corporation https://druglandscape.com/drug/sa4ag-vaccine-high-dose https://druglandscape.com/api/og?type=drug&title=SA4Ag%20vaccine%20high%20dose&subtitle=SA4Ag%20vaccine%20high%20dose%20%C2%B7%20Pfizer&badge=phase%201 SA4Ag vaccine high dose SA4Ag vaccine high dose · Pfizer https://druglandscape.com/drug/sa4ag-vaccine-mid-dose https://druglandscape.com/api/og?type=drug&title=SA4Ag%20vaccine%20mid%20dose&subtitle=SA4Ag%20vaccine%20mid%20dose%20%C2%B7%20Pfizer&badge=phase%201 SA4Ag vaccine mid dose SA4Ag vaccine mid dose · Pfizer https://druglandscape.com/drug/sa55-nasal-spray https://druglandscape.com/api/og?type=drug&title=SA55%20nasal%20spray&subtitle=SA55%20nasal%20spray%20%C2%B7%20Sinovac%20Life%20Sciences%20Co.%2C%20Ltd.&badge=phase%201 SA55 nasal spray SA55 nasal spray · Sinovac Life Sciences Co., Ltd. https://druglandscape.com/drug/sa58-nasal-spray https://druglandscape.com/api/og?type=drug&title=SA58%20Nasal%20Spray&subtitle=SA58%20Nasal%20Spray%20%C2%B7%20Sinovac%20Life%20Sciences%20Co.%2C%20Ltd.&badge=phase%201 SA58 Nasal Spray SA58 Nasal Spray · Sinovac Life Sciences Co., Ltd. https://druglandscape.com/drug/saber-bupivacaine-treatment-1a https://druglandscape.com/api/og?type=drug&title=SABER-Bupivacaine%20Treatment%201a&subtitle=SABER-Bupivacaine%20Treatment%201a%20%C2%B7%20Durect&badge=phase%202 SABER-Bupivacaine Treatment 1a SABER-Bupivacaine Treatment 1a · Durect https://druglandscape.com/drug/saber-bupivacaine-treatment-2a https://druglandscape.com/api/og?type=drug&title=SABER-Bupivacaine%20Treatment%202a&subtitle=SABER-Bupivacaine%20Treatment%202a%20%C2%B7%20Durect&badge=phase%202 SABER-Bupivacaine Treatment 2a SABER-Bupivacaine Treatment 2a · Durect https://druglandscape.com/drug/sacituzumab-govetican https://druglandscape.com/api/og?type=drug&title=Sacituzumab%20govetican&subtitle=Sacituzumab%20govetican%20%C2%B7%20Henry%20Ford%20Health%20System&badge=phase%201 Sacituzumab govetican Sacituzumab govetican · Henry Ford Health System https://druglandscape.com/drug/sacituzumab-govitecan-with-pegfilgrastim https://druglandscape.com/api/og?type=drug&title=Sacituzumab%20Govitecan%20with%20pegfilgrastim&subtitle=Sacituzumab%20Govitecan%20with%20pegfilgrastim%20%C2%B7%20Yeon%20Hee%20Park&badge=phase%202 Sacituzumab Govitecan with pegfilgrastim Sacituzumab Govitecan with pegfilgrastim · Yeon Hee Park https://druglandscape.com/drug/sacrosidase-oral-solution https://druglandscape.com/api/og?type=drug&title=Sacrosidase%20Oral%20Solution&subtitle=Sacrosidase%20Oral%20Solution%20%C2%B7%20QOL%20Medical%2C%20LLC&badge=phase%202 Sacrosidase Oral Solution Sacrosidase Oral Solution · QOL Medical, LLC https://druglandscape.com/drug/sacubitril-and-valsartan-reference-product https://druglandscape.com/api/og?type=drug&title=Sacubitril%20and%20Valsartan-Reference%20product&subtitle=Sacubitril%20and%20Valsartan-Reference%20product%20%C2%B7%20Humanis%20Sagl%C4%B1k%20Anonim%20Sirketi&badge=phase%201 Sacubitril and Valsartan-Reference product Sacubitril and Valsartan-Reference product · Humanis Saglık Anonim Sirketi https://druglandscape.com/drug/sad-apx-115 https://druglandscape.com/api/og?type=drug&title=SAD%3A%20APX-115&subtitle=SAD%3A%20APX-115%20%C2%B7%20Aptabio%20Therapeutics%2C%20Inc.&badge=phase%201 SAD: APX-115 SAD: APX-115 · Aptabio Therapeutics, Inc. https://druglandscape.com/drug/sad-shr-2004 https://druglandscape.com/api/og?type=drug&title=SAD%2C%20SHR-2004&subtitle=SAD%2C%20SHR-2004%20%C2%B7%20Beijing%20Suncadia%20Pharmaceuticals%20Co.%2C%20Ltd&badge=phase%201 SAD, SHR-2004 SAD, SHR-2004 · Beijing Suncadia Pharmaceuticals Co., Ltd https://druglandscape.com/drug/saf-189s https://druglandscape.com/api/og?type=drug&title=SAF-189s&subtitle=SAF-189s%20%C2%B7%20Shanghai%20Fosun%20Pharmaceutical%20Industrial%20Development%20Co.%20Ltd.&badge=phase%201 SAF-189s SAF-189s · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. https://druglandscape.com/drug/safestart https://druglandscape.com/api/og?type=drug&title=SAFEstart&subtitle=SAFEstart%20%C2%B7%20Intermountain%20Health%20Care%2C%20Inc.&badge=phase%202 SAFEstart SAFEstart · Intermountain Health Care, Inc. https://druglandscape.com/drug/safety-and-efficacy-assessments https://druglandscape.com/api/og?type=drug&title=Safety%20and%20efficacy%20assessments&subtitle=Safety%20and%20efficacy%20assessments%20%C2%B7%20Celgene&badge=phase%202 Safety and efficacy assessments Safety and efficacy assessments · Celgene https://druglandscape.com/drug/safety-assessment-of-ch1701 https://druglandscape.com/api/og?type=drug&title=Safety%20assessment%20of%20CH1701&subtitle=Safety%20assessment%20of%20CH1701%20%C2%B7%20Vietlife%20Healthcare%20Corporation&badge=phase%201 Safety assessment of CH1701 Safety assessment of CH1701 · Vietlife Healthcare Corporation https://druglandscape.com/drug/safety-group https://druglandscape.com/api/og?type=drug&title=Safety%20group&subtitle=Safety%20group%20%C2%B7%20Sinovac%20(Dalian)%20Vaccine%20Technology%20Co.%2C%20Ltd.&badge=phase%202 Safety group Safety group · Sinovac (Dalian) Vaccine Technology Co., Ltd. https://druglandscape.com/drug/sage-217-high-dose https://druglandscape.com/api/og?type=drug&title=SAGE-217%20high%20dose&subtitle=SAGE-217%20high%20dose%20%C2%B7%20Biogen&badge=phase%201 SAGE-217 high dose SAGE-217 high dose · Biogen https://druglandscape.com/drug/sahastara-remedy-extract https://druglandscape.com/api/og?type=drug&title=Sahastara%20remedy%20extract&subtitle=Sahastara%20remedy%20extract%20%C2%B7%20Mr%20NARIN%20KAKATUM&badge=phase%202 Sahastara remedy extract Sahastara remedy extract · Mr NARIN KAKATUM https://druglandscape.com/drug/saint-thomas-group https://druglandscape.com/api/og?type=drug&title=Saint-Thomas%20group&subtitle=Saint-Thomas%20group%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 Saint-Thomas group Saint-Thomas group · Hospices Civils de Lyon https://druglandscape.com/drug/sal0123 https://druglandscape.com/api/og?type=drug&title=SAL0123&subtitle=SAL0123%20%C2%B7%20Shenzhen%20Salubris%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 SAL0123 SAL0123 · Shenzhen Salubris Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/sal0133 https://druglandscape.com/api/og?type=drug&title=SAL0133&subtitle=SAL0133%20%C2%B7%20Shenzhen%20Salubris%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 SAL0133 SAL0133 · Shenzhen Salubris Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/sal0140 https://druglandscape.com/api/og?type=drug&title=SAL0140&subtitle=SAL0140%20%C2%B7%20Shenzhen%20Salubris%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 SAL0140 SAL0140 · Shenzhen Salubris Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/salbutamol-aerosol https://druglandscape.com/api/og?type=drug&title=Salbutamol%20Aerosol&subtitle=Salbutamol%20Aerosol%20%C2%B7%20snow&badge=phase%201 Salbutamol Aerosol Salbutamol Aerosol · snow https://druglandscape.com/drug/salbutamol-dose2 https://druglandscape.com/api/og?type=drug&title=Salbutamol%20-%20dose2&subtitle=Salbutamol%20-%20dose2%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Salbutamol - dose2 Salbutamol - dose2 · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/salbutamol-mdi https://druglandscape.com/api/og?type=drug&title=Salbutamol%20MDI&subtitle=Salbutamol%20MDI%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Salbutamol MDI Salbutamol MDI · GlaxoSmithKline https://druglandscape.com/drug/salbutamol-or-levosalbutamol https://druglandscape.com/api/og?type=drug&title=Salbutamol%20or%20levosalbutamol&subtitle=Salbutamol%20or%20levosalbutamol%20%C2%B7%20Sanofi&badge=phase%201 Salbutamol or levosalbutamol Salbutamol or levosalbutamol · Sanofi https://druglandscape.com/drug/salbutamol-plus-ipratropium-bromide https://druglandscape.com/api/og?type=drug&title=Salbutamol%20plus%20Ipratropium%20Bromide&subtitle=Salbutamol%20plus%20Ipratropium%20Bromide%20%C2%B7%20Hat%20Yai%20Medical%20Education%20Center&badge=phase%201 Salbutamol plus Ipratropium Bromide Salbutamol plus Ipratropium Bromide · Hat Yai Medical Education Center https://druglandscape.com/drug/salbutamol-sulfate-inhalation-aerosol https://druglandscape.com/api/og?type=drug&title=Salbutamol%20sulfate%20inhalation%20aerosol&subtitle=Salbutamol%20sulfate%20inhalation%20aerosol%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 Salbutamol sulfate inhalation aerosol Salbutamol sulfate inhalation aerosol · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/saliva-sample https://druglandscape.com/api/og?type=drug&title=saliva%20sample&subtitle=saliva%20sample%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%203 saliva sample saliva sample · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/saliva-sample-collection https://druglandscape.com/api/og?type=drug&title=Saliva%20sample%20collection&subtitle=Saliva%20sample%20collection%20%C2%B7%20Direction%20Centrale%20du%20Service%20de%20Sant%C3%A9%20des%20Arm%C3%A9es&badge=phase%202 Saliva sample collection Saliva sample collection · Direction Centrale du Service de Santé des Armées https://druglandscape.com/drug/saliva-samples https://druglandscape.com/api/og?type=drug&title=Saliva%20Samples&subtitle=Saliva%20Samples%20%C2%B7%20Unity%20Health%20Toronto&badge=phase%202 Saliva Samples Saliva Samples · Unity Health Toronto https://druglandscape.com/drug/saliva-sampling https://druglandscape.com/api/og?type=drug&title=Saliva%20sampling&subtitle=Saliva%20sampling%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 Saliva sampling Saliva sampling · Hospices Civils de Lyon https://druglandscape.com/drug/salivary-sample https://druglandscape.com/api/og?type=drug&title=salivary%20sample&subtitle=salivary%20sample%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 salivary sample salivary sample · Hospices Civils de Lyon https://druglandscape.com/drug/salmonella-il2 https://druglandscape.com/api/og?type=drug&title=Salmonella-IL2&subtitle=Salmonella-IL2%20%C2%B7%20Salspera%20LLC&badge=phase%202 Salmonella-IL2 Salmonella-IL2 · Salspera LLC https://druglandscape.com/drug/salmonella-typhi-vaccination https://druglandscape.com/api/og?type=drug&title=Salmonella%20typhi%20vaccination&subtitle=Salmonella%20typhi%20vaccination%20%C2%B7%20NHS%20Greater%20Glasgow%20and%20Clyde&badge=phase%201 Salmonella typhi vaccination Salmonella typhi vaccination · NHS Greater Glasgow and Clyde https://druglandscape.com/drug/salvage-iressa https://druglandscape.com/api/og?type=drug&title=salvage%20iressa&subtitle=salvage%20iressa%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%202 salvage iressa salvage iressa · Samsung Medical Center https://druglandscape.com/drug/sam-531 https://druglandscape.com/api/og?type=drug&title=SAM-531&subtitle=SAM-531%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%202 SAM-531 SAM-531 · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/sam-760 https://druglandscape.com/api/og?type=drug&title=SAM-760&subtitle=SAM-760%20%C2%B7%20Pfizer&badge=phase%201 SAM-760 SAM-760 · Pfizer https://druglandscape.com/drug/sam-e https://druglandscape.com/api/og?type=drug&title=SAM-e&subtitle=SAM-e%20%C2%B7%20NYU%20Langone%20Health&badge=phase%202 SAM-e SAM-e · NYU Langone Health https://druglandscape.com/drug/samarium-153 https://druglandscape.com/api/og?type=drug&title=Samarium%20153&subtitle=Samarium%20153%20%C2%B7%20Radiation%20Therapy%20Oncology%20Group&badge=phase%202 Samarium 153 Samarium 153 · Radiation Therapy Oncology Group https://druglandscape.com/drug/samatasvir-tablet https://druglandscape.com/api/og?type=drug&title=Samatasvir%20tablet&subtitle=Samatasvir%20tablet%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Samatasvir tablet Samatasvir tablet · Merck Sharp & Dohme LLC https://druglandscape.com/drug/same-nicotine-content-cigarettes https://druglandscape.com/api/og?type=drug&title=Same%20Nicotine%20Content%20Cigarettes&subtitle=Same%20Nicotine%20Content%20Cigarettes%20%C2%B7%20Milton%20S.%20Hershey%20Medical%20Center&badge=phase%201 Same Nicotine Content Cigarettes Same Nicotine Content Cigarettes · Milton S. Hershey Medical Center https://druglandscape.com/drug/samidorphan-iv https://druglandscape.com/api/og?type=drug&title=Samidorphan%20IV&subtitle=Samidorphan%20IV%20%C2%B7%20Alkermes%2C%20Inc.&badge=phase%201 Samidorphan IV Samidorphan IV · Alkermes, Inc. https://druglandscape.com/drug/san007-10-cream https://druglandscape.com/api/og?type=drug&title=SAN007%2010%25%20cream&subtitle=SAN007%2010%25%20cream%20%C2%B7%20Santalis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 SAN007 10% cream SAN007 10% cream · Santalis Pharmaceuticals, Inc. https://druglandscape.com/drug/san007-5-cream https://druglandscape.com/api/og?type=drug&title=SAN007%205%25%20cream&subtitle=SAN007%205%25%20cream%20%C2%B7%20Santalis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 SAN007 5% cream SAN007 5% cream · Santalis Pharmaceuticals, Inc. https://druglandscape.com/drug/san711 https://druglandscape.com/api/og?type=drug&title=SAN711&subtitle=SAN711%20%C2%B7%20Saniona&badge=phase%201 SAN711 SAN711 · Saniona https://druglandscape.com/drug/sancuso-part-1 https://druglandscape.com/api/og?type=drug&title=Sancuso%20-%20Part%201&subtitle=Sancuso%20-%20Part%201%20%C2%B7%20Kyowa%20Kirin%2C%20Inc.&badge=phase%201 Sancuso - Part 1 Sancuso - Part 1 · Kyowa Kirin, Inc. https://druglandscape.com/drug/sandostatine-lp https://druglandscape.com/api/og?type=drug&title=Sandostatine%20LP&subtitle=Sandostatine%20LP%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Sandostatine LP Sandostatine LP · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/sanfu-herbal-patch https://druglandscape.com/api/og?type=drug&title=Sanfu%20herbal%20patch&subtitle=Sanfu%20herbal%20patch%20%C2%B7%20Hubei%20Provincial%20Collaborative%20Innovation%20Center%20of%20Preventive%20Treatment%20by%20Acu&badge=phase%202 Sanfu herbal patch Sanfu herbal patch · Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust https://druglandscape.com/drug/sanfu-herbal-patch-and-moxibustion https://druglandscape.com/api/og?type=drug&title=Sanfu%20herbal%20patch%20and%20moxibustion&subtitle=Sanfu%20herbal%20patch%20and%20moxibustion%20%C2%B7%20Hubei%20Provincial%20Collaborative%20Innovation%20Center%20of%20Preventive%20&badge=phase%202 Sanfu herbal patch and moxibustion Sanfu herbal patch and moxibustion · Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust https://druglandscape.com/drug/sanfu-moxibustion https://druglandscape.com/api/og?type=drug&title=Sanfu%20moxibustion&subtitle=Sanfu%20moxibustion%20%C2%B7%20Hubei%20Provincial%20Collaborative%20Innovation%20Center%20of%20Preventive%20Treatment%20by%20Acup&badge=phase%202 Sanfu moxibustion Sanfu moxibustion · Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust https://druglandscape.com/drug/sap-001 https://druglandscape.com/api/og?type=drug&title=SAP-001&subtitle=SAP-001%20%C2%B7%20Shanton%20Pharma%20Pte.%20Ltd.&badge=phase%202 SAP-001 SAP-001 · Shanton Pharma Pte. Ltd. https://druglandscape.com/drug/sapacitabine-arm-a https://druglandscape.com/api/og?type=drug&title=Sapacitabine%2C%20Arm%20A&subtitle=Sapacitabine%2C%20Arm%20A%20%C2%B7%20Cyclacel%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Sapacitabine, Arm A Sapacitabine, Arm A · Cyclacel Pharmaceuticals, Inc. https://druglandscape.com/drug/sapacitabine-arm-b https://druglandscape.com/api/og?type=drug&title=Sapacitabine%2C%20Arm%20B&subtitle=Sapacitabine%2C%20Arm%20B%20%C2%B7%20Cyclacel%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Sapacitabine, Arm B Sapacitabine, Arm B · Cyclacel Pharmaceuticals, Inc. https://druglandscape.com/drug/sapacitabine-arm-c https://druglandscape.com/api/og?type=drug&title=Sapacitabine%2C%20Arm%20C&subtitle=Sapacitabine%2C%20Arm%20C%20%C2%B7%20Cyclacel%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Sapacitabine, Arm C Sapacitabine, Arm C · Cyclacel Pharmaceuticals, Inc. https://druglandscape.com/drug/sapacitabine-arm-d https://druglandscape.com/api/og?type=drug&title=Sapacitabine%2C%20Arm%20D&subtitle=Sapacitabine%2C%20Arm%20D%20%C2%B7%20Cyclacel%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Sapacitabine, Arm D Sapacitabine, Arm D · Cyclacel Pharmaceuticals, Inc. https://druglandscape.com/drug/sapacitabine-arm-e https://druglandscape.com/api/og?type=drug&title=sapacitabine%2C%20Arm%20E&subtitle=sapacitabine%2C%20Arm%20E%20%C2%B7%20Cyclacel%20Pharmaceuticals%2C%20Inc.&badge=phase%202 sapacitabine, Arm E sapacitabine, Arm E · Cyclacel Pharmaceuticals, Inc. https://druglandscape.com/drug/sapacitabine-arm-f https://druglandscape.com/api/og?type=drug&title=sapacitabine%2C%20Arm%20F&subtitle=sapacitabine%2C%20Arm%20F%20%C2%B7%20Cyclacel%20Pharmaceuticals%2C%20Inc.&badge=phase%202 sapacitabine, Arm F sapacitabine, Arm F · Cyclacel Pharmaceuticals, Inc. https://druglandscape.com/drug/sapacitabine-arm-g https://druglandscape.com/api/og?type=drug&title=Sapacitabine%2C%20Arm%20G&subtitle=Sapacitabine%2C%20Arm%20G%20%C2%B7%20Cyclacel%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Sapacitabine, Arm G Sapacitabine, Arm G · Cyclacel Pharmaceuticals, Inc. https://druglandscape.com/drug/sapacitabine-arm-h https://druglandscape.com/api/og?type=drug&title=Sapacitabine%2C%20Arm%20H&subtitle=Sapacitabine%2C%20Arm%20H%20%C2%B7%20Cyclacel%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Sapacitabine, Arm H Sapacitabine, Arm H · Cyclacel Pharmaceuticals, Inc. https://druglandscape.com/drug/sapacitabine-arm-i https://druglandscape.com/api/og?type=drug&title=Sapacitabine%2C%20Arm%20I&subtitle=Sapacitabine%2C%20Arm%20I%20%C2%B7%20Cyclacel%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Sapacitabine, Arm I Sapacitabine, Arm I · Cyclacel Pharmaceuticals, Inc. https://druglandscape.com/drug/saponin-based-immunoadjuvant-obi-821 https://druglandscape.com/api/og?type=drug&title=Saponin-based%20Immunoadjuvant%20OBI-821&subtitle=Saponin-based%20Immunoadjuvant%20OBI-821%20%C2%B7%20Gynecologic%20Oncology%20Group&badge=phase%202 Saponin-based Immunoadjuvant OBI-821 Saponin-based Immunoadjuvant OBI-821 · Gynecologic Oncology Group https://druglandscape.com/drug/sapropterin-dihydrochloride-and-vitamin-c https://druglandscape.com/api/og?type=drug&title=Sapropterin%20Dihydrochloride%20and%20Vitamin%20C&subtitle=Sapropterin%20Dihydrochloride%20and%20Vitamin%20C%20%C2%B7%20BioMarin%20Pharmaceutical&badge=phase%202 Sapropterin Dihydrochloride and Vitamin C Sapropterin Dihydrochloride and Vitamin C · BioMarin Pharmaceutical https://druglandscape.com/drug/sapu003 https://druglandscape.com/api/og?type=drug&title=Sapu003&subtitle=Sapu003%20%C2%B7%20SAPU%20NANO%20(US)%20LLC&badge=phase%201 Sapu003 Sapu003 · SAPU NANO (US) LLC https://druglandscape.com/drug/saquinavir-lopinavir-ritonavir https://druglandscape.com/api/og?type=drug&title=Saquinavir%2C%20lopinavir%2C%20ritonavir&subtitle=Saquinavir%2C%20lopinavir%2C%20ritonavir%20%C2%B7%20The%20HIV%20Netherlands%20Australia%20Thailand%20Research%20Collaboration&badge=phase%202 Saquinavir, lopinavir, ritonavir Saquinavir, lopinavir, ritonavir · The HIV Netherlands Australia Thailand Research Collaboration https://druglandscape.com/drug/sar100842 https://druglandscape.com/api/og?type=drug&title=SAR100842&subtitle=SAR100842%20%C2%B7%20Sanofi&badge=phase%202 SAR100842 SAR100842 · Sanofi https://druglandscape.com/drug/sar103168 https://druglandscape.com/api/og?type=drug&title=SAR103168&subtitle=SAR103168%20%C2%B7%20Sanofi&badge=phase%201 SAR103168 SAR103168 · Sanofi https://druglandscape.com/drug/sar110894 https://druglandscape.com/api/og?type=drug&title=SAR110894&subtitle=SAR110894%20%C2%B7%20Sanofi&badge=phase%202 SAR110894 SAR110894 · Sanofi https://druglandscape.com/drug/sar113945 https://druglandscape.com/api/og?type=drug&title=SAR113945&subtitle=SAR113945%20%C2%B7%20Sanofi&badge=phase%202 SAR113945 SAR113945 · Sanofi https://druglandscape.com/drug/sar153191-c1f3-drug-product https://druglandscape.com/api/og?type=drug&title=SAR153191-C1F3%20drug%20product&subtitle=SAR153191-C1F3%20drug%20product%20%C2%B7%20Sanofi&badge=phase%201 SAR153191-C1F3 drug product SAR153191-C1F3 drug product · Sanofi https://druglandscape.com/drug/sar153191-p2-drug-product https://druglandscape.com/api/og?type=drug&title=SAR153191-P2%20drug%20product&subtitle=SAR153191-P2%20drug%20product%20%C2%B7%20Sanofi&badge=phase%201 SAR153191-P2 drug product SAR153191-P2 drug product · Sanofi https://druglandscape.com/drug/sar153191-p3-drug-product https://druglandscape.com/api/og?type=drug&title=SAR153191-P3%20drug%20product&subtitle=SAR153191-P3%20drug%20product%20%C2%B7%20Sanofi&badge=phase%201 SAR153191-P3 drug product SAR153191-P3 drug product · Sanofi https://druglandscape.com/drug/sar156597 https://druglandscape.com/api/og?type=drug&title=SAR156597&subtitle=SAR156597%20%C2%B7%20Sanofi&badge=phase%202 SAR156597 SAR156597 · Sanofi https://druglandscape.com/drug/sar161271 https://druglandscape.com/api/og?type=drug&title=SAR161271&subtitle=SAR161271%20%C2%B7%20Sanofi&badge=phase%201 SAR161271 SAR161271 · Sanofi https://druglandscape.com/drug/sar228810 https://druglandscape.com/api/og?type=drug&title=SAR228810&subtitle=SAR228810%20%C2%B7%20Sanofi&badge=phase%201 SAR228810 SAR228810 · Sanofi https://druglandscape.com/drug/sar245408 https://druglandscape.com/api/og?type=drug&title=SAR245408&subtitle=SAR245408%20%C2%B7%20Sanofi&badge=phase%201 SAR245408 SAR245408 · Sanofi https://druglandscape.com/drug/sar245409 https://druglandscape.com/api/og?type=drug&title=SAR245409&subtitle=SAR245409%20%C2%B7%20Sanofi&badge=phase%202 SAR245409 SAR245409 · Sanofi https://druglandscape.com/drug/sar247799 https://druglandscape.com/api/og?type=drug&title=SAR247799&subtitle=SAR247799%20%C2%B7%20Sanofi&badge=phase%201 SAR247799 SAR247799 · Sanofi https://druglandscape.com/drug/sar260301 https://druglandscape.com/api/og?type=drug&title=SAR260301&subtitle=SAR260301%20%C2%B7%20Sanofi&badge=phase%201 SAR260301 SAR260301 · Sanofi https://druglandscape.com/drug/sar292833 https://druglandscape.com/api/og?type=drug&title=SAR292833&subtitle=SAR292833%20%C2%B7%20Sanofi&badge=phase%202 SAR292833 SAR292833 · Sanofi https://druglandscape.com/drug/sar341402 https://druglandscape.com/api/og?type=drug&title=SAR341402&subtitle=SAR341402%20%C2%B7%20Sanofi&badge=phase%201 SAR341402 SAR341402 · Sanofi https://druglandscape.com/drug/sar366234 https://druglandscape.com/api/og?type=drug&title=SAR366234&subtitle=SAR366234%20%C2%B7%20Sanofi&badge=phase%201 SAR366234 SAR366234 · Sanofi https://druglandscape.com/drug/sar402663 https://druglandscape.com/api/og?type=drug&title=SAR402663&subtitle=SAR402663%20%C2%B7%20Sanofi&badge=phase%201 SAR402663 SAR402663 · Sanofi https://druglandscape.com/drug/sar407899a https://druglandscape.com/api/og?type=drug&title=SAR407899A&subtitle=SAR407899A%20%C2%B7%20Sanofi&badge=phase%201 SAR407899A SAR407899A · Sanofi https://druglandscape.com/drug/sar428926 https://druglandscape.com/api/og?type=drug&title=SAR428926&subtitle=SAR428926%20%C2%B7%20Sanofi&badge=phase%201 SAR428926 SAR428926 · Sanofi https://druglandscape.com/drug/sar439459 https://druglandscape.com/api/og?type=drug&title=SAR439459&subtitle=SAR439459%20%C2%B7%20Sanofi&badge=phase%201 SAR439459 SAR439459 · Sanofi https://druglandscape.com/drug/sar440340 https://druglandscape.com/api/og?type=drug&title=SAR440340&subtitle=SAR440340%20%C2%B7%20Sanofi&badge=phase%202 SAR440340 SAR440340 · Sanofi https://druglandscape.com/drug/sar441255 https://druglandscape.com/api/og?type=drug&title=SAR441255&subtitle=SAR441255%20%C2%B7%20Sanofi&badge=phase%201 SAR441255 SAR441255 · Sanofi https://druglandscape.com/drug/sar441344 https://druglandscape.com/api/og?type=drug&title=SAR441344&subtitle=SAR441344%20%C2%B7%20Sanofi&badge=phase%202 SAR441344 SAR441344 · Sanofi https://druglandscape.com/drug/sar441344-sc https://druglandscape.com/api/og?type=drug&title=SAR441344%20SC&subtitle=SAR441344%20SC%20%C2%B7%20Sanofi&badge=phase%202 SAR441344 SC SAR441344 SC · Sanofi https://druglandscape.com/drug/sar441566 https://druglandscape.com/api/og?type=drug&title=SAR441566&subtitle=SAR441566%20%C2%B7%20Sanofi&badge=phase%202 SAR441566 SAR441566 · Sanofi https://druglandscape.com/drug/sar442085 https://druglandscape.com/api/og?type=drug&title=SAR442085&subtitle=SAR442085%20%C2%B7%20Sanofi&badge=phase%201 SAR442085 SAR442085 · Sanofi https://druglandscape.com/drug/sar442257 https://druglandscape.com/api/og?type=drug&title=SAR442257&subtitle=SAR442257%20%C2%B7%20Sanofi&badge=phase%201 SAR442257 SAR442257 · Sanofi https://druglandscape.com/drug/sar442970 https://druglandscape.com/api/og?type=drug&title=SAR442970&subtitle=SAR442970%20%C2%B7%20Sanofi&badge=phase%202 SAR442970 SAR442970 · Sanofi https://druglandscape.com/drug/sar443122 https://druglandscape.com/api/og?type=drug&title=SAR443122&subtitle=SAR443122%20%C2%B7%20Sanofi&badge=phase%202 SAR443122 SAR443122 · Sanofi https://druglandscape.com/drug/sar443765 https://druglandscape.com/api/og?type=drug&title=SAR443765&subtitle=SAR443765%20%C2%B7%20Sanofi&badge=phase%201 SAR443765 SAR443765 · Sanofi https://druglandscape.com/drug/sar444336 https://druglandscape.com/api/og?type=drug&title=SAR444336&subtitle=SAR444336%20%C2%B7%20Sanofi&badge=phase%202 SAR444336 SAR444336 · Sanofi https://druglandscape.com/drug/sar445399 https://druglandscape.com/api/og?type=drug&title=SAR445399&subtitle=SAR445399%20%C2%B7%20Sanofi&badge=phase%202 SAR445399 SAR445399 · Sanofi https://druglandscape.com/drug/sar446268 https://druglandscape.com/api/og?type=drug&title=SAR446268&subtitle=SAR446268%20%C2%B7%20Sanofi&badge=phase%201 SAR446268 SAR446268 · Sanofi https://druglandscape.com/drug/sar446523 https://druglandscape.com/api/og?type=drug&title=SAR446523&subtitle=SAR446523%20%C2%B7%20Sanofi&badge=phase%201 SAR446523 SAR446523 · Sanofi https://druglandscape.com/drug/sar446597 https://druglandscape.com/api/og?type=drug&title=SAR446597&subtitle=SAR446597%20%C2%B7%20Sanofi&badge=phase%201 SAR446597 SAR446597 · Sanofi https://druglandscape.com/drug/sar446959 https://druglandscape.com/api/og?type=drug&title=SAR446959&subtitle=SAR446959%20%C2%B7%20Sanofi&badge=phase%201 SAR446959 SAR446959 · Sanofi https://druglandscape.com/drug/sar447537 https://druglandscape.com/api/og?type=drug&title=SAR447537&subtitle=SAR447537%20%C2%B7%20Sanofi&badge=phase%202 SAR447537 SAR447537 · Sanofi https://druglandscape.com/drug/sarizotan-hcl https://druglandscape.com/api/og?type=drug&title=Sarizotan%20HCl&subtitle=Sarizotan%20HCl%20%C2%B7%20EMD%20Serono&badge=phase%202 Sarizotan HCl Sarizotan HCl · EMD Serono https://druglandscape.com/drug/saroglitazar-magnesium https://druglandscape.com/api/og?type=drug&title=Saroglitazar%20magnesium&subtitle=Saroglitazar%20magnesium%20%C2%B7%20Zydus%20Therapeutics%20Inc.&badge=phase%201 Saroglitazar magnesium Saroglitazar magnesium · Zydus Therapeutics Inc. https://druglandscape.com/drug/sars-cov-2-infection https://druglandscape.com/api/og?type=drug&title=Sars%20Cov%202%20infection&subtitle=Sars%20Cov%202%20infection%20%C2%B7%20Novafem&badge=phase%202 Sars Cov 2 infection Sars Cov 2 infection · Novafem https://druglandscape.com/drug/sars-cov-2-omicron-virus-dose-arm-1 https://druglandscape.com/api/og?type=drug&title=SARS-CoV-2%20omicron%20virus%20dose%20arm%201&subtitle=SARS-CoV-2%20omicron%20virus%20dose%20arm%201%20%C2%B7%20Hvivo&badge=phase%201 SARS-CoV-2 omicron virus dose arm 1 SARS-CoV-2 omicron virus dose arm 1 · Hvivo https://druglandscape.com/drug/sars-cov-2-virus-1x10-3-tcid50 https://druglandscape.com/api/og?type=drug&title=SARS-CoV-2%20Virus%201x10%5E3%20TCID50&subtitle=SARS-CoV-2%20Virus%201x10%5E3%20TCID50%20%C2%B7%20Imperial%20College%20London&badge=phase%201 SARS-CoV-2 Virus 1x10^3 TCID50 SARS-CoV-2 Virus 1x10^3 TCID50 · Imperial College London https://druglandscape.com/drug/sars-cov-2-virus-vaccines https://druglandscape.com/api/og?type=drug&title=SARS-CoV-2%20virus%20vaccines&subtitle=SARS-CoV-2%20virus%20vaccines%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%202 SARS-CoV-2 virus vaccines SARS-CoV-2 virus vaccines · Sheba Medical Center https://druglandscape.com/drug/sars-cov-2-vlp-vaccine https://druglandscape.com/api/og?type=drug&title=SARS-CoV-2%20VLP%20Vaccine&subtitle=SARS-CoV-2%20VLP%20Vaccine%20%C2%B7%20Ihsan%20GURSEL%2C%20PhD%2C%20Prof.&badge=phase%201 SARS-CoV-2 VLP Vaccine SARS-CoV-2 VLP Vaccine · Ihsan GURSEL, PhD, Prof. https://druglandscape.com/drug/sars-cov-2-vlp-vaccine-wuhan https://druglandscape.com/api/og?type=drug&title=SARS-CoV-2%20VLP%20Vaccine-Wuhan&subtitle=SARS-CoV-2%20VLP%20Vaccine-Wuhan%20%C2%B7%20Ihsan%20GURSEL%2C%20PhD%2C%20Prof.&badge=phase%202 SARS-CoV-2 VLP Vaccine-Wuhan SARS-CoV-2 VLP Vaccine-Wuhan · Ihsan GURSEL, PhD, Prof. https://druglandscape.com/drug/sarscov2-convalescent-plasma https://druglandscape.com/api/og?type=drug&title=SARSCoV2%20Convalescent%20Plasma&subtitle=SARSCoV2%20Convalescent%20Plasma%20%C2%B7%20AdventHealth&badge=phase%202 SARSCoV2 Convalescent Plasma SARSCoV2 Convalescent Plasma · AdventHealth https://druglandscape.com/drug/sass-001 https://druglandscape.com/api/og?type=drug&title=SASS-001&subtitle=SASS-001%20%C2%B7%20Shionogi%20Apnimed%20Sleep%20Science&badge=phase%202 SASS-001 SASS-001 · Shionogi Apnimed Sleep Science https://druglandscape.com/drug/sativex-buccal-spray https://druglandscape.com/api/og?type=drug&title=Sativex%20buccal%20spray&subtitle=Sativex%20buccal%20spray%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 Sativex buccal spray Sativex buccal spray · Hadassah Medical Organization https://druglandscape.com/drug/sativex-high-dose https://druglandscape.com/api/og?type=drug&title=Sativex%20High%20Dose&subtitle=Sativex%20High%20Dose%20%C2%B7%20GW%20Pharmaceuticals%20Ltd&badge=phase%202 Sativex High Dose Sativex High Dose · GW Pharmaceuticals Ltd https://druglandscape.com/drug/sativex-low-dose https://druglandscape.com/api/og?type=drug&title=Sativex%20Low%20Dose&subtitle=Sativex%20Low%20Dose%20%C2%B7%20GW%20Pharmaceuticals%20Ltd&badge=phase%202 Sativex Low Dose Sativex Low Dose · GW Pharmaceuticals Ltd https://druglandscape.com/drug/sativex-medium-dose https://druglandscape.com/api/og?type=drug&title=Sativex%20Medium%20Dose&subtitle=Sativex%20Medium%20Dose%20%C2%B7%20GW%20Pharmaceuticals%20Ltd&badge=phase%202 Sativex Medium Dose Sativex Medium Dose · GW Pharmaceuticals Ltd https://druglandscape.com/drug/sativex-oromucosal-spray https://druglandscape.com/api/og?type=drug&title=Sativex%20Oromucosal%20Spray&subtitle=Sativex%20Oromucosal%20Spray%20%C2%B7%20King's%20College%20London&badge=phase%201 Sativex Oromucosal Spray Sativex Oromucosal Spray · King's College London https://druglandscape.com/drug/satraplatin-in-combo-with-vinorelbine https://druglandscape.com/api/og?type=drug&title=Satraplatin%20in%20combo%20with%20vinorelbine&subtitle=Satraplatin%20in%20combo%20with%20vinorelbine%20%C2%B7%20Southern%20Europe%20New%20Drug%20Organization&badge=phase%201 Satraplatin in combo with vinorelbine Satraplatin in combo with vinorelbine · Southern Europe New Drug Organization https://druglandscape.com/drug/saturno-ii-association https://druglandscape.com/api/og?type=drug&title=SATURNO%20II%20association&subtitle=SATURNO%20II%20association%20%C2%B7%20EMS&badge=phase%202 SATURNO II association SATURNO II association · EMS https://druglandscape.com/drug/sav001-h https://druglandscape.com/api/og?type=drug&title=SAV001-H&subtitle=SAV001-H%20%C2%B7%20Sumagen&badge=phase%201 SAV001-H SAV001-H · Sumagen https://druglandscape.com/drug/savolitinib-reference-preparation https://druglandscape.com/api/og?type=drug&title=Savolitinib%20Reference%20Preparation&subtitle=Savolitinib%20Reference%20Preparation%20%C2%B7%20Hutchison%20Medipharma%20Limited&badge=phase%201 Savolitinib Reference Preparation Savolitinib Reference Preparation · Hutchison Medipharma Limited https://druglandscape.com/drug/savolitinib-test-preparation https://druglandscape.com/api/og?type=drug&title=Savolitinib%20Test%20Preparation&subtitle=Savolitinib%20Test%20Preparation%20%C2%B7%20Hutchison%20Medipharma%20Limited&badge=phase%201 Savolitinib Test Preparation Savolitinib Test Preparation · Hutchison Medipharma Limited https://druglandscape.com/drug/sb-11285 https://druglandscape.com/api/og?type=drug&title=SB%2011285&subtitle=SB%2011285%20%C2%B7%20invoX%20Pharma%20Limited&badge=phase%201 SB 11285 SB 11285 · invoX Pharma Limited https://druglandscape.com/drug/sb-121 https://druglandscape.com/api/og?type=drug&title=SB-121&subtitle=SB-121%20%C2%B7%20Scioto%20Biosciences%2C%20Inc.&badge=phase%201 SB-121 SB-121 · Scioto Biosciences, Inc. https://druglandscape.com/drug/sb-207266 https://druglandscape.com/api/og?type=drug&title=SB-207266&subtitle=SB-207266%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB-207266 SB-207266 · GlaxoSmithKline https://druglandscape.com/drug/sb-240563 https://druglandscape.com/api/og?type=drug&title=SB-240563&subtitle=SB-240563%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SB-240563 SB-240563 · GlaxoSmithKline https://druglandscape.com/drug/sb-424323 https://druglandscape.com/api/og?type=drug&title=SB-424323&subtitle=SB-424323%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB-424323 SB-424323 · GlaxoSmithKline https://druglandscape.com/drug/sb-480848 https://druglandscape.com/api/og?type=drug&title=SB-480848&subtitle=SB-480848%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB-480848 SB-480848 · GlaxoSmithKline https://druglandscape.com/drug/sb-480848-tablets https://druglandscape.com/api/og?type=drug&title=SB%20480848%2C%20tablets&subtitle=SB%20480848%2C%20tablets%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SB 480848, tablets SB 480848, tablets · GlaxoSmithKline https://druglandscape.com/drug/sb-485232 https://druglandscape.com/api/og?type=drug&title=SB-485232&subtitle=SB-485232%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB-485232 SB-485232 · GlaxoSmithKline https://druglandscape.com/drug/sb-497115-gr https://druglandscape.com/api/og?type=drug&title=SB-497115-GR&subtitle=SB-497115-GR%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB-497115-GR SB-497115-GR · GlaxoSmithKline https://druglandscape.com/drug/sb-568859 https://druglandscape.com/api/og?type=drug&title=SB-568859&subtitle=SB-568859%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SB-568859 SB-568859 · GlaxoSmithKline https://druglandscape.com/drug/sb-656933-aaa https://druglandscape.com/api/og?type=drug&title=SB-656933-AAA&subtitle=SB-656933-AAA%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SB-656933-AAA SB-656933-AAA · GlaxoSmithKline https://druglandscape.com/drug/sb-681323 https://druglandscape.com/api/og?type=drug&title=SB-681323&subtitle=SB-681323%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB-681323 SB-681323 · GlaxoSmithKline https://druglandscape.com/drug/sb-681323-oral-tablets https://druglandscape.com/api/og?type=drug&title=SB-681323%20oral%20tablets&subtitle=SB-681323%20oral%20tablets%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SB-681323 oral tablets SB-681323 oral tablets · GlaxoSmithKline https://druglandscape.com/drug/sb-715992 https://druglandscape.com/api/og?type=drug&title=SB-715992&subtitle=SB-715992%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SB-715992 SB-715992 · GlaxoSmithKline https://druglandscape.com/drug/sb-742457 https://druglandscape.com/api/og?type=drug&title=SB-742457&subtitle=SB-742457%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB-742457 SB-742457 · GlaxoSmithKline https://druglandscape.com/drug/sb-756050-immediate-release-capsule https://druglandscape.com/api/og?type=drug&title=SB-756050%20immediate%20release%20capsule&subtitle=SB-756050%20immediate%20release%20capsule%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SB-756050 immediate release capsule SB-756050 immediate release capsule · GlaxoSmithKline https://druglandscape.com/drug/sb-756050-modified-release-capsule https://druglandscape.com/api/og?type=drug&title=SB-756050%20modified%20release%20capsule&subtitle=SB-756050%20modified%20release%20capsule%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SB-756050 modified release capsule SB-756050 modified release capsule · GlaxoSmithKline https://druglandscape.com/drug/sb-9200 https://druglandscape.com/api/og?type=drug&title=SB%209200&subtitle=SB%209200%20%C2%B7%20F-star%20Therapeutics%2C%20Inc.&badge=phase%202 SB 9200 SB 9200 · F-star Therapeutics, Inc. https://druglandscape.com/drug/sb-as02b-adjuvant https://druglandscape.com/api/og?type=drug&title=SB-AS02B%20adjuvant&subtitle=SB-AS02B%20adjuvant%20%C2%B7%20SWOG%20Cancer%20Research%20Network&badge=phase%202 SB-AS02B adjuvant SB-AS02B adjuvant · SWOG Cancer Research Network https://druglandscape.com/drug/sb-as15-adjuvant https://druglandscape.com/api/og?type=drug&title=SB-AS15%20adjuvant&subtitle=SB-AS15%20adjuvant%20%C2%B7%20European%20Organisation%20for%20Research%20and%20Treatment%20of%20Cancer%20-%20EORTC&badge=phase%202 SB-AS15 adjuvant SB-AS15 adjuvant · European Organisation for Research and Treatment of Cancer - EORTC https://druglandscape.com/drug/sb-mdz https://druglandscape.com/api/og?type=drug&title=SB_MDZ&subtitle=SB_MDZ%20%C2%B7%20SPARK%20Biopharma&badge=phase%201 SB_MDZ SB_MDZ · SPARK Biopharma https://druglandscape.com/drug/sb010 https://druglandscape.com/api/og?type=drug&title=SB010&subtitle=SB010%20%C2%B7%20Sterna%20Biologicals%20GmbH%20%26%20Co.%20KG&badge=phase%202 SB010 SB010 · Sterna Biologicals GmbH & Co. KG https://druglandscape.com/drug/sb012 https://druglandscape.com/api/og?type=drug&title=SB012&subtitle=SB012%20%C2%B7%20Sterna%20Biologicals%20GmbH%20%26%20Co.%20KG&badge=phase%201 SB012 SB012 · Sterna Biologicals GmbH & Co. KG https://druglandscape.com/drug/sb17170 https://druglandscape.com/api/og?type=drug&title=SB17170&subtitle=SB17170%20%C2%B7%20SPARK%20Biopharma&badge=phase%202 SB17170 SB17170 · SPARK Biopharma https://druglandscape.com/drug/sb204 https://druglandscape.com/api/og?type=drug&title=SB204&subtitle=SB204%20%C2%B7%20Novan%2C%20Inc.&badge=phase%201 SB204 SB204 · Novan, Inc. https://druglandscape.com/drug/sb204-2 https://druglandscape.com/api/og?type=drug&title=SB204%202%25&subtitle=SB204%202%25%20%C2%B7%20Novan%2C%20Inc.&badge=phase%202 SB204 2% SB204 2% · Novan, Inc. https://druglandscape.com/drug/sb204-8-or-12 https://druglandscape.com/api/og?type=drug&title=SB204%208%25%20or%2012%25&subtitle=SB204%208%25%20or%2012%25%20%C2%B7%20Novan%2C%20Inc.&badge=phase%201 SB204 8% or 12% SB204 8% or 12% · Novan, Inc. https://druglandscape.com/drug/sb206-4 https://druglandscape.com/api/og?type=drug&title=SB206%204%25&subtitle=SB206%204%25%20%C2%B7%20Novan%2C%20Inc.&badge=phase%202 SB206 4% SB206 4% · Novan, Inc. https://druglandscape.com/drug/sb206-8 https://druglandscape.com/api/og?type=drug&title=SB206%208%25&subtitle=SB206%208%25%20%C2%B7%20Novan%2C%20Inc.&badge=phase%202 SB206 8% SB206 8% · Novan, Inc. https://druglandscape.com/drug/sb208-16 https://druglandscape.com/api/og?type=drug&title=SB208%2016%25&subtitle=SB208%2016%25%20%C2%B7%20Novan%2C%20Inc.&badge=phase%202 SB208 16% SB208 16% · Novan, Inc. https://druglandscape.com/drug/sb208-2 https://druglandscape.com/api/og?type=drug&title=SB208%202%25&subtitle=SB208%202%25%20%C2%B7%20Novan%2C%20Inc.&badge=phase%202 SB208 2% SB208 2% · Novan, Inc. https://druglandscape.com/drug/sb208-4 https://druglandscape.com/api/og?type=drug&title=SB208%204%25&subtitle=SB208%204%25%20%C2%B7%20Novan%2C%20Inc.&badge=phase%202 SB208 4% SB208 4% · Novan, Inc. https://druglandscape.com/drug/sb218352-15 https://druglandscape.com/api/og?type=drug&title=SB218352_15&subtitle=SB218352_15%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB218352_15 SB218352_15 · GlaxoSmithKline https://druglandscape.com/drug/sb218352-2 https://druglandscape.com/api/og?type=drug&title=SB218352_2&subtitle=SB218352_2%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB218352_2 SB218352_2 · GlaxoSmithKline https://druglandscape.com/drug/sb218352-2al https://druglandscape.com/api/og?type=drug&title=SB218352_2AL&subtitle=SB218352_2AL%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB218352_2AL SB218352_2AL · GlaxoSmithKline https://druglandscape.com/drug/sb218352-4 https://druglandscape.com/api/og?type=drug&title=SB218352_4&subtitle=SB218352_4%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB218352_4 SB218352_4 · GlaxoSmithKline https://druglandscape.com/drug/sb218352-4al https://druglandscape.com/api/og?type=drug&title=SB218352_4AL&subtitle=SB218352_4AL%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB218352_4AL SB218352_4AL · GlaxoSmithKline https://druglandscape.com/drug/sb26 https://druglandscape.com/api/og?type=drug&title=SB26&subtitle=SB26%20%C2%B7%20Samsung%20Bioepis%20Co.%2C%20Ltd.&badge=phase%201 SB26 SB26 · Samsung Bioepis Co., Ltd. https://druglandscape.com/drug/sb414-2 https://druglandscape.com/api/og?type=drug&title=SB414%202%25&subtitle=SB414%202%25%20%C2%B7%20Novan%2C%20Inc.&badge=phase%201 SB414 2% SB414 2% · Novan, Inc. https://druglandscape.com/drug/sb424323 https://druglandscape.com/api/og?type=drug&title=SB424323&subtitle=SB424323%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB424323 SB424323 · GlaxoSmithKline https://druglandscape.com/drug/sb497115 https://druglandscape.com/api/og?type=drug&title=SB497115&subtitle=SB497115%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB497115 SB497115 · GlaxoSmithKline https://druglandscape.com/drug/sb623 https://druglandscape.com/api/og?type=drug&title=SB623&subtitle=SB623%20%C2%B7%20SanBio%2C%20Inc.&badge=phase%201 SB623 SB623 · SanBio, Inc. https://druglandscape.com/drug/sb623-cells https://druglandscape.com/api/og?type=drug&title=SB623%20cells&subtitle=SB623%20cells%20%C2%B7%20SanBio%2C%20Inc.&badge=phase%202 SB623 cells SB623 cells · SanBio, Inc. https://druglandscape.com/drug/sb656933 https://druglandscape.com/api/og?type=drug&title=SB656933&subtitle=SB656933%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB656933 SB656933 · GlaxoSmithKline https://druglandscape.com/drug/sb659032 https://druglandscape.com/api/og?type=drug&title=SB659032&subtitle=SB659032%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SB659032 SB659032 · GlaxoSmithKline https://druglandscape.com/drug/sb681323 https://druglandscape.com/api/og?type=drug&title=SB681323&subtitle=SB681323%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB681323 SB681323 · GlaxoSmithKline https://druglandscape.com/drug/sb683699 https://druglandscape.com/api/og?type=drug&title=SB683699&subtitle=SB683699%20%C2%B7%20GlaxoSmithKline&badge=phase%202 SB683699 SB683699 · GlaxoSmithKline https://druglandscape.com/drug/sb705498 https://druglandscape.com/api/og?type=drug&title=SB705498&subtitle=SB705498%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SB705498 SB705498 · GlaxoSmithKline https://druglandscape.com/drug/sb751689 https://druglandscape.com/api/og?type=drug&title=SB751689&subtitle=SB751689%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SB751689 SB751689 · GlaxoSmithKline https://druglandscape.com/drug/sb756050 https://druglandscape.com/api/og?type=drug&title=SB756050&subtitle=SB756050%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SB756050 SB756050 · GlaxoSmithKline https://druglandscape.com/drug/sb773812 https://druglandscape.com/api/og?type=drug&title=SB773812&subtitle=SB773812%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SB773812 SB773812 · GlaxoSmithKline https://druglandscape.com/drug/sbi-100-ophthalmic-emulsion-0-5 https://druglandscape.com/api/og?type=drug&title=SBI-100%20Ophthalmic%20Emulsion%2C%200.5%25&subtitle=SBI-100%20Ophthalmic%20Emulsion%2C%200.5%25%20%C2%B7%20Skye%20Bioscience%2C%20Inc.&badge=phase%202 SBI-100 Ophthalmic Emulsion, 0.5% SBI-100 Ophthalmic Emulsion, 0.5% · Skye Bioscience, Inc. https://druglandscape.com/drug/sbi-101 https://druglandscape.com/api/og?type=drug&title=SBI-101&subtitle=SBI-101%20%C2%B7%20Sentien%20Biotechnologies%2C%20Inc.&badge=phase%201 SBI-101 SBI-101 · Sentien Biotechnologies, Inc. https://druglandscape.com/drug/sbp-101 https://druglandscape.com/api/og?type=drug&title=SBP-101&subtitle=SBP-101%20%C2%B7%20Panbela%20Therapeutics%2C%20Inc.&badge=phase%202 SBP-101 SBP-101 · Panbela Therapeutics, Inc. https://druglandscape.com/drug/sbp-9330 https://druglandscape.com/api/og?type=drug&title=SBP-9330&subtitle=SBP-9330%20%C2%B7%20Camino%20Pharma%2C%20LLC&badge=phase%201 SBP-9330 SBP-9330 · Camino Pharma, LLC https://druglandscape.com/drug/sbrt https://druglandscape.com/api/og?type=drug&title=SBRT&subtitle=SBRT%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 SBRT SBRT · Genentech, Inc. https://druglandscape.com/drug/sbs-1000 https://druglandscape.com/api/og?type=drug&title=SBS-1000&subtitle=SBS-1000%20%C2%B7%20Sparian%20Biosciences%2C%20Inc&badge=phase%201 SBS-1000 SBS-1000 · Sparian Biosciences, Inc https://druglandscape.com/drug/sbs-147 https://druglandscape.com/api/og?type=drug&title=SBS-147&subtitle=SBS-147%20%C2%B7%20Sparian%20Biosciences%2C%20Inc&badge=phase%201 SBS-147 SBS-147 · Sparian Biosciences, Inc https://druglandscape.com/drug/sbt115301 https://druglandscape.com/api/og?type=drug&title=SBT115301&subtitle=SBT115301%20%C2%B7%20Sonoma%20Biotherapeutics%2C%20Inc.&badge=phase%201 SBT115301 SBT115301 · Sonoma Biotherapeutics, Inc. https://druglandscape.com/drug/sbt777101 https://druglandscape.com/api/og?type=drug&title=SBT777101&subtitle=SBT777101%20%C2%B7%20Sonoma%20Biotherapeutics%2C%20Inc.&badge=phase%201 SBT777101 SBT777101 · Sonoma Biotherapeutics, Inc. https://druglandscape.com/drug/sc-101 https://druglandscape.com/api/og?type=drug&title=SC-101&subtitle=SC-101%20%C2%B7%20Tianjin%20ConjuStar%20Biologics%20Co.%2C%20Ltd.&badge=phase%202 SC-101 SC-101 · Tianjin ConjuStar Biologics Co., Ltd. https://druglandscape.com/drug/sc-ad6-1 https://druglandscape.com/api/og?type=drug&title=SC-Ad6-1&subtitle=SC-Ad6-1%20%C2%B7%20Moat%20Biotechnology%20Corporation&badge=phase%201 SC-Ad6-1 SC-Ad6-1 · Moat Biotechnology Corporation https://druglandscape.com/drug/sc-cls-ta https://druglandscape.com/api/og?type=drug&title=SC%20CLS-TA&subtitle=SC%20CLS-TA%20%C2%B7%20Clearside%20Biomedical%2C%20Inc.&badge=phase%202 SC CLS-TA SC CLS-TA · Clearside Biomedical, Inc. https://druglandscape.com/drug/sc-glucagon https://druglandscape.com/api/og?type=drug&title=SC%20Glucagon&subtitle=SC%20Glucagon%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 SC Glucagon SC Glucagon · Eli Lilly and Company https://druglandscape.com/drug/sc-hylenex-and-ceftriaxone https://druglandscape.com/api/og?type=drug&title=SC%20HYLENEX%20and%20Ceftriaxone&subtitle=SC%20HYLENEX%20and%20Ceftriaxone%20%C2%B7%20Baxter%20Healthcare%20Corporation&badge=phase%201 SC HYLENEX and Ceftriaxone SC HYLENEX and Ceftriaxone · Baxter Healthcare Corporation https://druglandscape.com/drug/sc-interferon-beta-1a https://druglandscape.com/api/og?type=drug&title=SC%20interferon%20beta-1a&subtitle=SC%20interferon%20beta-1a%20%C2%B7%20Biogen&badge=phase%202 SC interferon beta-1a SC interferon beta-1a · Biogen https://druglandscape.com/drug/sc-interferon-beta-1b https://druglandscape.com/api/og?type=drug&title=SC%20interferon%20beta-1b&subtitle=SC%20interferon%20beta-1b%20%C2%B7%20Biogen&badge=phase%202 SC interferon beta-1b SC interferon beta-1b · Biogen https://druglandscape.com/drug/sc-mntx https://druglandscape.com/api/og?type=drug&title=SC%20MNTX&subtitle=SC%20MNTX%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%202 SC MNTX SC MNTX · Bausch Health Americas, Inc. https://druglandscape.com/drug/sc-mosunetuzumab https://druglandscape.com/api/og?type=drug&title=SC%20Mosunetuzumab&subtitle=SC%20Mosunetuzumab%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 SC Mosunetuzumab SC Mosunetuzumab · Hoffmann-La Roche https://druglandscape.com/drug/sc-peg-e-coli-l-asparaginase https://druglandscape.com/api/og?type=drug&title=SC-PEG%20E.%20coli%20L-asparaginase&subtitle=SC-PEG%20E.%20coli%20L-asparaginase%20%C2%B7%20Children's%20Oncology%20Group&badge=phase%201 SC-PEG E. coli L-asparaginase SC-PEG E. coli L-asparaginase · Children's Oncology Group https://druglandscape.com/drug/sc-peginterferon-beta-1a https://druglandscape.com/api/og?type=drug&title=SC%20Peginterferon%20beta-1a&subtitle=SC%20Peginterferon%20beta-1a%20%C2%B7%20Biogen&badge=phase%202 SC Peginterferon beta-1a SC Peginterferon beta-1a · Biogen https://druglandscape.com/drug/sc-rilvegostomig https://druglandscape.com/api/og?type=drug&title=SC%20Rilvegostomig&subtitle=SC%20Rilvegostomig%20%C2%B7%20AstraZeneca&badge=phase%201 SC Rilvegostomig SC Rilvegostomig · AstraZeneca https://druglandscape.com/drug/sc0062-high-dose https://druglandscape.com/api/og?type=drug&title=SC0062%20high%20dose&subtitle=SC0062%20high%20dose%20%C2%B7%20Biocity%20Biopharmaceutics%20Co.%2C%20Ltd.&badge=phase%202 SC0062 high dose SC0062 high dose · Biocity Biopharmaceutics Co., Ltd. https://druglandscape.com/drug/sc0245 https://druglandscape.com/api/og?type=drug&title=SC0245&subtitle=SC0245%20%C2%B7%20Biocity%20Biopharmaceutics%20Co.%2C%20Ltd.&badge=phase%201 SC0245 SC0245 · Biocity Biopharmaceutics Co., Ltd. https://druglandscape.com/drug/sc1011 https://druglandscape.com/api/og?type=drug&title=SC1011&subtitle=SC1011%20%C2%B7%20Guangzhou%20JOYO%20Pharma%20Co.%2C%20Ltd&badge=phase%202 SC1011 SC1011 · Guangzhou JOYO Pharma Co., Ltd https://druglandscape.com/drug/scai-001-0-01-eyedrop https://druglandscape.com/api/og?type=drug&title=SCAI-001%200.01%25%20eyedrop&subtitle=SCAI-001%200.01%25%20eyedrop%20%C2%B7%20SCAI%20Therapeutics&badge=phase%202 SCAI-001 0.01% eyedrop SCAI-001 0.01% eyedrop · SCAI Therapeutics https://druglandscape.com/drug/scai-001-0-02-eyedrop https://druglandscape.com/api/og?type=drug&title=SCAI-001%200.02%25%20eyedrop&subtitle=SCAI-001%200.02%25%20eyedrop%20%C2%B7%20SCAI%20Therapeutics&badge=phase%202 SCAI-001 0.02% eyedrop SCAI-001 0.02% eyedrop · SCAI Therapeutics https://druglandscape.com/drug/scb-1019t https://druglandscape.com/api/og?type=drug&title=SCB-1019T&subtitle=SCB-1019T%20%C2%B7%20Clover%20Biopharmaceuticals%20AUS%20Pty&badge=phase%201 SCB-1019T SCB-1019T · Clover Biopharmaceuticals AUS Pty https://druglandscape.com/drug/scb-1022 https://druglandscape.com/api/og?type=drug&title=SCB-1022&subtitle=SCB-1022%20%C2%B7%20Clover%20Biopharmaceuticals%20AUS%20Pty&badge=phase%201 SCB-1022 SCB-1022 · Clover Biopharmaceuticals AUS Pty https://druglandscape.com/drug/scb-2019-vaccine https://druglandscape.com/api/og?type=drug&title=SCB-2019%20vaccine&subtitle=SCB-2019%20vaccine%20%C2%B7%20Clover%20Biopharmaceuticals%20AUS%20Pty&badge=phase%202 SCB-2019 vaccine SCB-2019 vaccine · Clover Biopharmaceuticals AUS Pty https://druglandscape.com/drug/scb-2019-with-alum-adjuvant https://druglandscape.com/api/og?type=drug&title=SCB-2019%20with%20Alum%20adjuvant&subtitle=SCB-2019%20with%20Alum%20adjuvant%20%C2%B7%20Clover%20Biopharmaceuticals%20AUS%20Pty&badge=phase%201 SCB-2019 with Alum adjuvant SCB-2019 with Alum adjuvant · Clover Biopharmaceuticals AUS Pty https://druglandscape.com/drug/scb-2019-with-as03-adjuvant https://druglandscape.com/api/og?type=drug&title=SCB-2019%20with%20AS03%20adjuvant&subtitle=SCB-2019%20with%20AS03%20adjuvant%20%C2%B7%20Clover%20Biopharmaceuticals%20AUS%20Pty&badge=phase%201 SCB-2019 with AS03 adjuvant SCB-2019 with AS03 adjuvant · Clover Biopharmaceuticals AUS Pty https://druglandscape.com/drug/scd-044-dose-2 https://druglandscape.com/api/og?type=drug&title=SCD-044_Dose%202&subtitle=SCD-044_Dose%202%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%202 SCD-044_Dose 2 SCD-044_Dose 2 · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/scd-044-dose-3 https://druglandscape.com/api/og?type=drug&title=SCD-044_Dose%203&subtitle=SCD-044_Dose%203%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%202 SCD-044_Dose 3 SCD-044_Dose 3 · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/scd-101 https://druglandscape.com/api/og?type=drug&title=SCD-101&subtitle=SCD-101%20%C2%B7%20Invenux%2C%20LLC&badge=phase%201 SCD-101 SCD-101 · Invenux, LLC https://druglandscape.com/drug/scg101 https://druglandscape.com/api/og?type=drug&title=SCG101&subtitle=SCG101%20%C2%B7%20SCG%20Cell%20Therapy%20Pte.%20Ltd.&badge=phase%201 SCG101 SCG101 · SCG Cell Therapy Pte. Ltd. https://druglandscape.com/drug/scg142 https://druglandscape.com/api/og?type=drug&title=SCG142&subtitle=SCG142%20%C2%B7%20SCG%20Cell%20Therapy%20Pte.%20Ltd.&badge=phase%201 SCG142 SCG142 · SCG Cell Therapy Pte. Ltd. https://druglandscape.com/drug/sch-1 https://druglandscape.com/api/og?type=drug&title=SCH-1&subtitle=SCH-1%20%C2%B7%20Sacsh&badge=phase%202 SCH-1 SCH-1 · Sacsh https://druglandscape.com/drug/sch-39641-12-amb-a-1-u https://druglandscape.com/api/og?type=drug&title=SCH%2039641%2012%20Amb%20a%201-U&subtitle=SCH%2039641%2012%20Amb%20a%201-U%20%C2%B7%20ALK-Abell%C3%B3%20A%2FS&badge=phase%202 SCH 39641 12 Amb a 1-U SCH 39641 12 Amb a 1-U · ALK-Abelló A/S https://druglandscape.com/drug/sch-497079 https://druglandscape.com/api/og?type=drug&title=SCH%20497079&subtitle=SCH%20497079%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 SCH 497079 SCH 497079 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/sch-530348 https://druglandscape.com/api/og?type=drug&title=SCH%20530348&subtitle=SCH%20530348%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 SCH 530348 SCH 530348 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/sch-56592 https://druglandscape.com/api/og?type=drug&title=SCH%2056592&subtitle=SCH%2056592%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 SCH 56592 SCH 56592 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/sch-900460 https://druglandscape.com/api/og?type=drug&title=SCH%20900460&subtitle=SCH%20900460%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 SCH 900460 SCH 900460 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/sch-900518 https://druglandscape.com/api/og?type=drug&title=SCH%20900518&subtitle=SCH%20900518%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 SCH 900518 SCH 900518 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/sch-900538 https://druglandscape.com/api/og?type=drug&title=SCH%20900538&subtitle=SCH%20900538%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 SCH 900538 SCH 900538 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/sci-110 https://druglandscape.com/api/og?type=drug&title=SCI%20-110&subtitle=SCI%20-110%20%C2%B7%20The%20Israeli%20Medical%20Center%20for%20Alzheimer's&badge=phase%202 SCI -110 SCI -110 · The Israeli Medical Center for Alzheimer's https://druglandscape.com/drug/scio-469 https://druglandscape.com/api/og?type=drug&title=SCIO-469&subtitle=SCIO-469%20%C2%B7%20Scios%2C%20Inc.&badge=phase%202 SCIO-469 SCIO-469 · Scios, Inc. https://druglandscape.com/drug/scit https://druglandscape.com/api/og?type=drug&title=SCIT&subtitle=SCIT%20%C2%B7%20United%20Allergy%20Services&badge=phase%201 SCIT SCIT · United Allergy Services https://druglandscape.com/drug/sclerfix-ip https://druglandscape.com/api/og?type=drug&title=SclerFIX-IP&subtitle=SclerFIX-IP%20%C2%B7%20TBF%20Genie%20Tissulaire&badge=phase%202 SclerFIX-IP SclerFIX-IP · TBF Genie Tissulaire https://druglandscape.com/drug/scm-agh https://druglandscape.com/api/og?type=drug&title=SCM-AGH&subtitle=SCM-AGH%20%C2%B7%20SCM%20Lifescience%20Co.%2C%20LTD.&badge=phase%201 SCM-AGH SCM-AGH · SCM Lifescience Co., LTD. https://druglandscape.com/drug/scm-cgh https://druglandscape.com/api/og?type=drug&title=SCM-CGH&subtitle=SCM-CGH%20%C2%B7%20SCM%20Lifescience%20Co.%2C%20LTD.&badge=phase%202 SCM-CGH SCM-CGH · SCM Lifescience Co., LTD. https://druglandscape.com/drug/sco-101 https://druglandscape.com/api/og?type=drug&title=SCO-101&subtitle=SCO-101%20%C2%B7%20Scandion%20Oncology%20A%2FS&badge=phase%201 SCO-101 SCO-101 · Scandion Oncology A/S https://druglandscape.com/drug/sco-120 https://druglandscape.com/api/og?type=drug&title=SCO-120&subtitle=SCO-120%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 SCO-120 SCO-120 · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/scp-111 https://druglandscape.com/api/og?type=drug&title=SCP-111&subtitle=SCP-111%20%C2%B7%20scPharmaceuticals%2C%20Inc.&badge=phase%201 SCP-111 SCP-111 · scPharmaceuticals, Inc. https://druglandscape.com/drug/scr-6920-capsule https://druglandscape.com/api/og?type=drug&title=SCR-6920%20capsule&subtitle=SCR-6920%20capsule%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SCR-6920 capsule SCR-6920 capsule · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/screening-platform https://druglandscape.com/api/og?type=drug&title=Screening%20Platform&subtitle=Screening%20Platform%20%C2%B7%20SWOG%20Cancer%20Research%20Network&badge=phase%202 Screening Platform Screening Platform · SWOG Cancer Research Network https://druglandscape.com/drug/sct-001-car-t-cells https://druglandscape.com/api/og?type=drug&title=SCT-001%20CAR-T%20cells&subtitle=SCT-001%20CAR-T%20cells%20%C2%B7%20Shanghai%20Gynecologic%20Oncology%20Group&badge=phase%201 SCT-001 CAR-T cells SCT-001 CAR-T cells · Shanghai Gynecologic Oncology Group https://druglandscape.com/drug/sct-i10a https://druglandscape.com/api/og?type=drug&title=SCT-I10A&subtitle=SCT-I10A%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCT-I10A SCT-I10A · Sinocelltech Ltd. https://druglandscape.com/drug/sct1000 https://druglandscape.com/api/og?type=drug&title=SCT1000&subtitle=SCT1000%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCT1000 SCT1000 · Sinocelltech Ltd. https://druglandscape.com/drug/sct200 https://druglandscape.com/api/og?type=drug&title=SCT200&subtitle=SCT200%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCT200 SCT200 · Sinocelltech Ltd. https://druglandscape.com/drug/sct520ff https://druglandscape.com/api/og?type=drug&title=SCT520FF&subtitle=SCT520FF%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%201 SCT520FF SCT520FF · Sinocelltech Ltd. https://druglandscape.com/drug/sct650c https://druglandscape.com/api/og?type=drug&title=SCT650C&subtitle=SCT650C%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCT650C SCT650C · Sinocelltech Ltd. https://druglandscape.com/drug/scta01 https://druglandscape.com/api/og?type=drug&title=SCTA01&subtitle=SCTA01%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCTA01 SCTA01 · Sinocelltech Ltd. https://druglandscape.com/drug/sctb39-1 https://druglandscape.com/api/og?type=drug&title=SCTB39-1&subtitle=SCTB39-1%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%201 SCTB39-1 SCTB39-1 · Sinocelltech Ltd. https://druglandscape.com/drug/sctb41 https://druglandscape.com/api/og?type=drug&title=SCTB41&subtitle=SCTB41%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%201 SCTB41 SCTB41 · Sinocelltech Ltd. https://druglandscape.com/drug/sctt11 https://druglandscape.com/api/og?type=drug&title=SCTT11&subtitle=SCTT11%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%201 SCTT11 SCTT11 · Sinocelltech Ltd. https://druglandscape.com/drug/sctv01e-1-on-d0 https://druglandscape.com/api/og?type=drug&title=SCTV01E-1%20on%20D0&subtitle=SCTV01E-1%20on%20D0%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCTV01E-1 on D0 SCTV01E-1 on D0 · Sinocelltech Ltd. https://druglandscape.com/drug/sctv01e-1-on-d120 https://druglandscape.com/api/og?type=drug&title=SCTV01E-1%20on%20D120&subtitle=SCTV01E-1%20on%20D120%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCTV01E-1 on D120 SCTV01E-1 on D120 · Sinocelltech Ltd. https://druglandscape.com/drug/sctv01e-1-on-d150 https://druglandscape.com/api/og?type=drug&title=SCTV01E-1%20on%20D150&subtitle=SCTV01E-1%20on%20D150%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCTV01E-1 on D150 SCTV01E-1 on D150 · Sinocelltech Ltd. https://druglandscape.com/drug/sctv01e-1-on-d28 https://druglandscape.com/api/og?type=drug&title=SCTV01E-1%20on%20D28&subtitle=SCTV01E-1%20on%20D28%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCTV01E-1 on D28 SCTV01E-1 on D28 · Sinocelltech Ltd. https://druglandscape.com/drug/sctv01e-2 https://druglandscape.com/api/og?type=drug&title=SCTV01E-2&subtitle=SCTV01E-2%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCTV01E-2 SCTV01E-2 · Sinocelltech Ltd. https://druglandscape.com/drug/sctv01e-on-d0 https://druglandscape.com/api/og?type=drug&title=SCTV01E%20on%20D0&subtitle=SCTV01E%20on%20D0%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCTV01E on D0 SCTV01E on D0 · Sinocelltech Ltd. https://druglandscape.com/drug/sctv01e-on-d120 https://druglandscape.com/api/og?type=drug&title=SCTV01E%20on%20D120&subtitle=SCTV01E%20on%20D120%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCTV01E on D120 SCTV01E on D120 · Sinocelltech Ltd. https://druglandscape.com/drug/sctv01e-on-d150 https://druglandscape.com/api/og?type=drug&title=SCTV01E%20on%20D150&subtitle=SCTV01E%20on%20D150%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCTV01E on D150 SCTV01E on D150 · Sinocelltech Ltd. https://druglandscape.com/drug/sctv01e-on-d28 https://druglandscape.com/api/og?type=drug&title=SCTV01E%20on%20D28&subtitle=SCTV01E%20on%20D28%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%202 SCTV01E on D28 SCTV01E on D28 · Sinocelltech Ltd. https://druglandscape.com/drug/sctv02 https://druglandscape.com/api/og?type=drug&title=SCTV02&subtitle=SCTV02%20%C2%B7%20Sinocelltech%20Ltd.&badge=phase%201 SCTV02 SCTV02 · Sinocelltech Ltd. https://druglandscape.com/drug/scv-07 https://druglandscape.com/api/og?type=drug&title=SCV-07&subtitle=SCV-07%20%C2%B7%20SciClone%20Pharmaceuticals&badge=phase%202 SCV-07 SCV-07 · SciClone Pharmaceuticals https://druglandscape.com/drug/scx-001 https://druglandscape.com/api/og?type=drug&title=SCX-001&subtitle=SCX-001%20%C2%B7%20ScarX%20Corp&badge=phase%201 SCX-001 SCX-001 · ScarX Corp https://druglandscape.com/drug/scy-078-plus-dab https://druglandscape.com/api/og?type=drug&title=SCY-078%20plus%20DAB&subtitle=SCY-078%20plus%20DAB%20%C2%B7%20Scynexis%2C%20Inc.&badge=phase%201 SCY-078 plus DAB SCY-078 plus DAB · Scynexis, Inc. https://druglandscape.com/drug/scyx-7158 https://druglandscape.com/api/og?type=drug&title=SCYX-7158&subtitle=SCYX-7158%20%C2%B7%20Drugs%20for%20Neglected%20Diseases&badge=phase%201 SCYX-7158 SCYX-7158 · Drugs for Neglected Diseases https://druglandscape.com/drug/sdx-105 https://druglandscape.com/api/og?type=drug&title=SDX-105&subtitle=SDX-105%20%C2%B7%20Cephalon&badge=phase%202 SDX-105 SDX-105 · Cephalon https://druglandscape.com/drug/sdx-7320 https://druglandscape.com/api/og?type=drug&title=SDX-7320&subtitle=SDX-7320%20%C2%B7%20SynDevRx%2C%20Inc.&badge=phase%202 SDX-7320 SDX-7320 · SynDevRx, Inc. https://druglandscape.com/drug/sea-cd40 https://druglandscape.com/api/og?type=drug&title=SEA-CD40&subtitle=SEA-CD40%20%C2%B7%20Seagen%20Inc.&badge=phase%202 SEA-CD40 SEA-CD40 · Seagen Inc. https://druglandscape.com/drug/seawater-eyedrops https://druglandscape.com/api/og?type=drug&title=Seawater%20eyedrops&subtitle=Seawater%20eyedrops%20%C2%B7%20American%20Society%20Of%20Thermalism%20And%20Climatology%20Inc&badge=phase%201 Seawater eyedrops Seawater eyedrops · American Society Of Thermalism And Climatology Inc https://druglandscape.com/drug/second-asthma-controller-medication https://druglandscape.com/api/og?type=drug&title=Second%20Asthma%20Controller%20Medication&subtitle=Second%20Asthma%20Controller%20Medication%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Second Asthma Controller Medication Second Asthma Controller Medication · Hoffmann-La Roche https://druglandscape.com/drug/second-generation-antipsychotic https://druglandscape.com/api/og?type=drug&title=Second%20generation%20antipsychotic&subtitle=Second%20generation%20antipsychotic%20%C2%B7%20Takeda&badge=phase%201 Second generation antipsychotic Second generation antipsychotic · Takeda https://druglandscape.com/drug/second-generation-btds-patch https://druglandscape.com/api/og?type=drug&title=Second%20generation%20BTDS%20patch&subtitle=Second%20generation%20BTDS%20patch%20%C2%B7%20Mundipharma%20Research%20Limited&badge=phase%201 Second generation BTDS patch Second generation BTDS patch · Mundipharma Research Limited https://druglandscape.com/drug/second-line-chemotherapy-agents https://druglandscape.com/api/og?type=drug&title=Second-Line%20Chemotherapy%20Agents&subtitle=Second-Line%20Chemotherapy%20Agents%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 Second-Line Chemotherapy Agents Second-Line Chemotherapy Agents · Genentech, Inc. https://druglandscape.com/drug/second-period-twlo https://druglandscape.com/api/og?type=drug&title=Second%20period%20TWLO&subtitle=Second%20period%20TWLO%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 Second period TWLO Second period TWLO · Dong-A ST Co., Ltd. https://druglandscape.com/drug/second-period-twlo-c https://druglandscape.com/api/og?type=drug&title=Second%20period%20TWLO_C&subtitle=Second%20period%20TWLO_C%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 Second period TWLO_C Second period TWLO_C · Dong-A ST Co., Ltd. https://druglandscape.com/drug/seebri-breezhaler https://druglandscape.com/api/og?type=drug&title=Seebri%C2%AE%20Breezhaler%C2%AE&subtitle=Seebri%C2%AE%20Breezhaler%C2%AE%20%C2%B7%20Sunovion%20Respiratory%20Development%20Inc.&badge=phase%201 Seebri® Breezhaler® Seebri® Breezhaler® · Sunovion Respiratory Development Inc. https://druglandscape.com/drug/segmental-allergen-challenge https://druglandscape.com/api/og?type=drug&title=Segmental%20allergen%20challenge&subtitle=Segmental%20allergen%20challenge%20%C2%B7%20JOSALYN%20CHO&badge=phase%202 Segmental allergen challenge Segmental allergen challenge · JOSALYN CHO https://druglandscape.com/drug/sel-068 https://druglandscape.com/api/og?type=drug&title=SEL-068&subtitle=SEL-068%20%C2%B7%20Selecta%20Biosciences%2C%20Inc.&badge=phase%201 SEL-068 SEL-068 · Selecta Biosciences, Inc. https://druglandscape.com/drug/sel-212 https://druglandscape.com/api/og?type=drug&title=SEL-212&subtitle=SEL-212%20%C2%B7%20Selecta%20Biosciences%2C%20Inc.&badge=phase%202 SEL-212 SEL-212 · Selecta Biosciences, Inc. https://druglandscape.com/drug/sela-070 https://druglandscape.com/api/og?type=drug&title=SELA-070&subtitle=SELA-070%20%C2%B7%20Selecta%20Biosciences%2C%20Inc.&badge=phase%201 SELA-070 SELA-070 · Selecta Biosciences, Inc. https://druglandscape.com/drug/select-dmts-other-than-ozanimod https://druglandscape.com/api/og?type=drug&title=Select%20DMTs%20other%20than%20ozanimod&subtitle=Select%20DMTs%20other%20than%20ozanimod%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 Select DMTs other than ozanimod Select DMTs other than ozanimod · Bristol-Myers Squibb https://druglandscape.com/drug/selection-of-anesthetic-induction-technique https://druglandscape.com/api/og?type=drug&title=Selection%20of%20anesthetic%20induction%20technique&subtitle=Selection%20of%20anesthetic%20induction%20technique%20%C2%B7%20Albert%20Einstein%20Healthcare%20Network&badge=phase%201 Selection of anesthetic induction technique Selection of anesthetic induction technique · Albert Einstein Healthcare Network https://druglandscape.com/drug/selexipag-encapsulated-pellets https://druglandscape.com/api/og?type=drug&title=Selexipag%20encapsulated%20pellets&subtitle=Selexipag%20encapsulated%20pellets%20%C2%B7%20Actelion&badge=phase%201 Selexipag encapsulated pellets Selexipag encapsulated pellets · Actelion https://druglandscape.com/drug/selexipag-for-intravenous-use https://druglandscape.com/api/og?type=drug&title=Selexipag%20for%20intravenous%20use&subtitle=Selexipag%20for%20intravenous%20use%20%C2%B7%20Actelion&badge=phase%201 Selexipag for intravenous use Selexipag for intravenous use · Actelion https://druglandscape.com/drug/selexipag-for-oral-use https://druglandscape.com/api/og?type=drug&title=Selexipag%20for%20oral%20use&subtitle=Selexipag%20for%20oral%20use%20%C2%B7%20Actelion&badge=phase%201 Selexipag for oral use Selexipag for oral use · Actelion https://druglandscape.com/drug/selexipag-matrix-tablet https://druglandscape.com/api/og?type=drug&title=Selexipag%20matrix%20tablet&subtitle=Selexipag%20matrix%20tablet%20%C2%B7%20Actelion&badge=phase%201 Selexipag matrix tablet Selexipag matrix tablet · Actelion https://druglandscape.com/drug/selg1 https://druglandscape.com/api/og?type=drug&title=SelG1&subtitle=SelG1%20%C2%B7%20Reprixys%20Pharmaceutical%20Corporation&badge=phase%202 SelG1 SelG1 · Reprixys Pharmaceutical Corporation https://druglandscape.com/drug/selinexor-dexamethasone-ixazomib-pomalidomide https://druglandscape.com/api/og?type=drug&title=Selinexor%2C%20dexamethasone%2C%20ixazomib%2C%20pomalidomide&subtitle=Selinexor%2C%20dexamethasone%2C%20ixazomib%2C%20pomalidomide%20%C2%B7%20Multiple%20Myeloma%20Research%20Consortium&badge=phase%201 Selinexor, dexamethasone, ixazomib, pomalidomide Selinexor, dexamethasone, ixazomib, pomalidomide · Multiple Myeloma Research Consortium https://druglandscape.com/drug/selk2 https://druglandscape.com/api/og?type=drug&title=SelK2&subtitle=SelK2%20%C2%B7%20Tetherex%20Pharmaceuticals%20Corporation&badge=phase%202 SelK2 SelK2 · Tetherex Pharmaceuticals Corporation https://druglandscape.com/drug/seltorexant-dose-1 https://druglandscape.com/api/og?type=drug&title=Seltorexant%20Dose%201&subtitle=Seltorexant%20Dose%201%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Seltorexant Dose 1 Seltorexant Dose 1 · Janssen Research & Development, LLC https://druglandscape.com/drug/seltorexant-high-dose https://druglandscape.com/api/og?type=drug&title=Seltorexant%20High%20Dose&subtitle=Seltorexant%20High%20Dose%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Seltorexant High Dose Seltorexant High Dose · Janssen Research & Development, LLC https://druglandscape.com/drug/seltorexant-low-dose https://druglandscape.com/api/og?type=drug&title=Seltorexant%20Low%20Dose&subtitle=Seltorexant%20Low%20Dose%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Seltorexant Low Dose Seltorexant Low Dose · Janssen Research & Development, LLC https://druglandscape.com/drug/selumetinib-granule-formulation https://druglandscape.com/api/og?type=drug&title=Selumetinib%20granule%20formulation&subtitle=Selumetinib%20granule%20formulation%20%C2%B7%20AstraZeneca&badge=phase%201 Selumetinib granule formulation Selumetinib granule formulation · AstraZeneca https://druglandscape.com/drug/semaglutide-administered-sc https://druglandscape.com/api/og?type=drug&title=Semaglutide%20Administered%20SC&subtitle=Semaglutide%20Administered%20SC%20%C2%B7%20BrightGene%20Bio-Medical%20Technology%20Co.%2C%20Ltd.&badge=phase%202 Semaglutide Administered SC Semaglutide Administered SC · BrightGene Bio-Medical Technology Co., Ltd. https://druglandscape.com/drug/semaglutide-c https://druglandscape.com/api/og?type=drug&title=Semaglutide%20C&subtitle=Semaglutide%20C%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Semaglutide C Semaglutide C · Novo Nordisk A/S https://druglandscape.com/drug/semaglutide-d https://druglandscape.com/api/og?type=drug&title=Semaglutide%20D&subtitle=Semaglutide%20D%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Semaglutide D Semaglutide D · Novo Nordisk A/S https://druglandscape.com/drug/semaglutide-h https://druglandscape.com/api/og?type=drug&title=Semaglutide%20H&subtitle=Semaglutide%20H%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Semaglutide H Semaglutide H · Novo Nordisk A/S https://druglandscape.com/drug/semaglutide-i https://druglandscape.com/api/og?type=drug&title=Semaglutide%20I&subtitle=Semaglutide%20I%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Semaglutide I Semaglutide I · Novo Nordisk A/S https://druglandscape.com/drug/semaglutide-m https://druglandscape.com/api/og?type=drug&title=Semaglutide%20M&subtitle=Semaglutide%20M%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Semaglutide M Semaglutide M · Novo Nordisk A/S https://druglandscape.com/drug/semaglutide-n https://druglandscape.com/api/og?type=drug&title=Semaglutide%20N&subtitle=Semaglutide%20N%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Semaglutide N Semaglutide N · Novo Nordisk A/S https://druglandscape.com/drug/semaglutide-nasal-spray https://druglandscape.com/api/og?type=drug&title=Semaglutide%20Nasal%20Spray&subtitle=Semaglutide%20Nasal%20Spray%20%C2%B7%20Shanghai%20World%20Leader%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Semaglutide Nasal Spray Semaglutide Nasal Spray · Shanghai World Leader Pharmaceutical Co., Ltd. https://druglandscape.com/drug/semaglutide-oral-product https://druglandscape.com/api/og?type=drug&title=Semaglutide%20Oral%20Product&subtitle=Semaglutide%20Oral%20Product%20%C2%B7%20Imperial%20College%20London&badge=phase%201 Semaglutide Oral Product Semaglutide Oral Product · Imperial College London https://druglandscape.com/drug/seminal-plasma https://druglandscape.com/api/og?type=drug&title=seminal%20plasma&subtitle=seminal%20plasma%20%C2%B7%20Ostergotland%20County%20Council%2C%20Sweden&badge=phase%201 seminal plasma seminal plasma · Ostergotland County Council, Sweden https://druglandscape.com/drug/sen0014196 https://druglandscape.com/api/og?type=drug&title=SEN0014196&subtitle=SEN0014196%20%C2%B7%20Siena%20Biotech%20S.p.A.&badge=phase%202 SEN0014196 SEN0014196 · Siena Biotech S.p.A. https://druglandscape.com/drug/senl-t7 https://druglandscape.com/api/og?type=drug&title=Senl-T7&subtitle=Senl-T7%20%C2%B7%20Hebei%20Senlang%20Biotechnology%20Inc.%2C%20Ltd.&badge=phase%201 Senl-T7 Senl-T7 · Hebei Senlang Biotechnology Inc., Ltd. https://druglandscape.com/drug/senl101 https://druglandscape.com/api/og?type=drug&title=SENL101&subtitle=SENL101%20%C2%B7%20Hebei%20Senlang%20Biotechnology%20Inc.%2C%20Ltd.&badge=phase%201 SENL101 SENL101 · Hebei Senlang Biotechnology Inc., Ltd. https://druglandscape.com/drug/senl103 https://druglandscape.com/api/og?type=drug&title=SENL103&subtitle=SENL103%20%C2%B7%20Hebei%20Senlang%20Biotechnology%20Inc.%2C%20Ltd.&badge=phase%201 SENL103 SENL103 · Hebei Senlang Biotechnology Inc., Ltd. https://druglandscape.com/drug/sensipar-after-post-transplant https://druglandscape.com/api/og?type=drug&title=Sensipar%20after%20Post%20Transplant&subtitle=Sensipar%20after%20Post%20Transplant%20%C2%B7%20Amgen&badge=phase%202 Sensipar after Post Transplant Sensipar after Post Transplant · Amgen https://druglandscape.com/drug/sentoclone https://druglandscape.com/api/og?type=drug&title=SentoClone%C2%AE&subtitle=SentoClone%C2%AE%20%C2%B7%20SentoClone%20AB&badge=phase%202 SentoClone® SentoClone® · SentoClone AB https://druglandscape.com/drug/sep-363856-open-label https://druglandscape.com/api/og?type=drug&title=SEP-363856%20Open%20Label&subtitle=SEP-363856%20Open%20Label%20%C2%B7%20Otsuka%20Pharmaceutical%20Development%20%26%20Commercialization%2C%20Inc.&badge=phase%201 SEP-363856 Open Label SEP-363856 Open Label · Otsuka Pharmaceutical Development & Commercialization, Inc. https://druglandscape.com/drug/sep-631 https://druglandscape.com/api/og?type=drug&title=SEP-631&subtitle=SEP-631%20%C2%B7%20Septerna%2C%20Inc.&badge=phase%201 SEP-631 SEP-631 · Septerna, Inc. https://druglandscape.com/drug/seqeunce-3 https://druglandscape.com/api/og?type=drug&title=Seqeunce%203&subtitle=Seqeunce%203%20%C2%B7%20Samyang%20Biopharmaceuticals%20Corporation&badge=phase%201 Seqeunce 3 Seqeunce 3 · Samyang Biopharmaceuticals Corporation https://druglandscape.com/drug/sequence-1 https://druglandscape.com/api/og?type=drug&title=Sequence%201&subtitle=Sequence%201%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 Sequence 1 Sequence 1 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/sequence-1-pci-32765 https://druglandscape.com/api/og?type=drug&title=Sequence%201%3A%20PCI-32765&subtitle=Sequence%201%3A%20PCI-32765%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Sequence 1: PCI-32765 Sequence 1: PCI-32765 · Janssen Research & Development, LLC https://druglandscape.com/drug/sequence-2 https://druglandscape.com/api/og?type=drug&title=Sequence%202&subtitle=Sequence%202%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 Sequence 2 Sequence 2 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/sequence-2-pci-32765 https://druglandscape.com/api/og?type=drug&title=Sequence%202%3A%20PCI-32765&subtitle=Sequence%202%3A%20PCI-32765%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Sequence 2: PCI-32765 Sequence 2: PCI-32765 · Janssen Research & Development, LLC https://druglandscape.com/drug/sequence-3 https://druglandscape.com/api/og?type=drug&title=Sequence%203&subtitle=Sequence%203%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 Sequence 3 Sequence 3 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/sequence-3-pci-32765 https://druglandscape.com/api/og?type=drug&title=Sequence%203%3A%20PCI-32765&subtitle=Sequence%203%3A%20PCI-32765%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Sequence 3: PCI-32765 Sequence 3: PCI-32765 · Janssen Research & Development, LLC https://druglandscape.com/drug/sequence-4 https://druglandscape.com/api/og?type=drug&title=Sequence%204&subtitle=Sequence%204%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 Sequence 4 Sequence 4 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/sequence-4-pci-32765 https://druglandscape.com/api/og?type=drug&title=Sequence%204%3A%20PCI-32765&subtitle=Sequence%204%3A%20PCI-32765%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Sequence 4: PCI-32765 Sequence 4: PCI-32765 · Janssen Research & Development, LLC https://druglandscape.com/drug/sequence-5 https://druglandscape.com/api/og?type=drug&title=Sequence%205&subtitle=Sequence%205%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 Sequence 5 Sequence 5 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/sequence-5-pci-32765 https://druglandscape.com/api/og?type=drug&title=Sequence%205%3A%20PCI-32765&subtitle=Sequence%205%3A%20PCI-32765%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 Sequence 5: PCI-32765 Sequence 5: PCI-32765 · Janssen Research & Development, LLC https://druglandscape.com/drug/sequence-6 https://druglandscape.com/api/og?type=drug&title=Sequence%206&subtitle=Sequence%206%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 Sequence 6 Sequence 6 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/sequence-a-absk-011 https://druglandscape.com/api/og?type=drug&title=Sequence%20A%20ABSK-011&subtitle=Sequence%20A%20ABSK-011%20%C2%B7%20Abbisko%20Therapeutics%20Co%2C%20Ltd&badge=phase%201 Sequence A ABSK-011 Sequence A ABSK-011 · Abbisko Therapeutics Co, Ltd https://druglandscape.com/drug/sequence-b-r-t-r-t https://druglandscape.com/api/og?type=drug&title=Sequence%20B%20R-T-R-T&subtitle=Sequence%20B%20R-T-R-T%20%C2%B7%20Shenzhen%20Salubris%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 Sequence B R-T-R-T Sequence B R-T-R-T · Shenzhen Salubris Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/sequential-ctx https://druglandscape.com/api/og?type=drug&title=Sequential%20CTX&subtitle=Sequential%20CTX%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%202 Sequential CTX Sequential CTX · RemeGen Co., Ltd. https://druglandscape.com/drug/sequential-epirubicin https://druglandscape.com/api/og?type=drug&title=Sequential%20Epirubicin&subtitle=Sequential%20Epirubicin%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%202 Sequential Epirubicin Sequential Epirubicin · RemeGen Co., Ltd. https://druglandscape.com/drug/sequential-therapy-of-atorvastatin https://druglandscape.com/api/og?type=drug&title=Sequential%20therapy%20of%20atorvastatin&subtitle=Sequential%20therapy%20of%20atorvastatin%20%C2%B7%20Zhang%20Qi%2C%20MD&badge=phase%201 Sequential therapy of atorvastatin Sequential therapy of atorvastatin · Zhang Qi, MD https://druglandscape.com/drug/ser-155 https://druglandscape.com/api/og?type=drug&title=SER-155&subtitle=SER-155%20%C2%B7%20Seres%20Therapeutics%2C%20Inc.&badge=phase%201 SER-155 SER-155 · Seres Therapeutics, Inc. https://druglandscape.com/drug/ser-262 https://druglandscape.com/api/og?type=drug&title=SER-262&subtitle=SER-262%20%C2%B7%20Seres%20Therapeutics%2C%20Inc.&badge=phase%201 SER-262 SER-262 · Seres Therapeutics, Inc. https://druglandscape.com/drug/ser100 https://druglandscape.com/api/og?type=drug&title=SER100&subtitle=SER100%20%C2%B7%20Serodus%20AS&badge=phase%202 SER100 SER100 · Serodus AS https://druglandscape.com/drug/ser150 https://druglandscape.com/api/og?type=drug&title=SER150&subtitle=SER150%20%C2%B7%20Serodus%20AS&badge=phase%202 SER150 SER150 · Serodus AS https://druglandscape.com/drug/seretide-accuhaler https://druglandscape.com/api/og?type=drug&title=Seretide%E2%84%A2%20Accuhaler%E2%84%A2&subtitle=Seretide%E2%84%A2%20Accuhaler%E2%84%A2%20%C2%B7%20Mylan%20Pharma%20UK%20Ltd.&badge=phase%201 Seretide™ Accuhaler™ Seretide™ Accuhaler™ · Mylan Pharma UK Ltd. https://druglandscape.com/drug/seretide-diskus https://druglandscape.com/api/og?type=drug&title=Seretide%20Diskus&subtitle=Seretide%20Diskus%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 Seretide Diskus Seretide Diskus · Orion Corporation, Orion Pharma https://druglandscape.com/drug/seretide-rotacaps https://druglandscape.com/api/og?type=drug&title=SERETIDE%20Rotacaps&subtitle=SERETIDE%20Rotacaps%20%C2%B7%20GlaxoSmithKline&badge=phase%201 SERETIDE Rotacaps SERETIDE Rotacaps · GlaxoSmithKline https://druglandscape.com/drug/serine-proteinase-inhibitor-wx-671 https://druglandscape.com/api/og?type=drug&title=Serine%20Proteinase%20Inhibitor%20WX-671&subtitle=Serine%20Proteinase%20Inhibitor%20WX-671%20%C2%B7%20Heidelberg%20Pharma%20AG&badge=phase%202 Serine Proteinase Inhibitor WX-671 Serine Proteinase Inhibitor WX-671 · Heidelberg Pharma AG https://druglandscape.com/drug/serlopitant-high-dose https://druglandscape.com/api/og?type=drug&title=Serlopitant%20High%20Dose&subtitle=Serlopitant%20High%20Dose%20%C2%B7%20Vyne%20Therapeutics%20Inc.&badge=phase%202 Serlopitant High Dose Serlopitant High Dose · Vyne Therapeutics Inc. https://druglandscape.com/drug/serology-and-elispot-test https://druglandscape.com/api/og?type=drug&title=serology%20and%20ELISPOT%20test&subtitle=serology%20and%20ELISPOT%20test%20%C2%B7%20Centre%20Georges%20Francois%20Leclerc&badge=phase%201 serology and ELISPOT test serology and ELISPOT test · Centre Georges Francois Leclerc https://druglandscape.com/drug/serology-test https://druglandscape.com/api/og?type=drug&title=serology%20test&subtitle=serology%20test%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 serology test serology test · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/sertraline-or-venlafaxine https://druglandscape.com/api/og?type=drug&title=Sertraline%20or%20venlafaxine&subtitle=Sertraline%20or%20venlafaxine%20%C2%B7%20Kliniken%20Essen-Mitte&badge=phase%202 Sertraline or venlafaxine Sertraline or venlafaxine · Kliniken Essen-Mitte https://druglandscape.com/drug/sertraline-plus-telenzepine https://druglandscape.com/api/og?type=drug&title=Sertraline%20plus%20Telenzepine&subtitle=Sertraline%20plus%20Telenzepine%20%C2%B7%20Theracos&badge=phase%201 Sertraline plus Telenzepine Sertraline plus Telenzepine · Theracos https://druglandscape.com/drug/serum-and-plasma-samples https://druglandscape.com/api/og?type=drug&title=Serum%20and%20plasma%20samples&subtitle=Serum%20and%20plasma%20samples%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 Serum and plasma samples Serum and plasma samples · Hospices Civils de Lyon https://druglandscape.com/drug/serum-bank https://druglandscape.com/api/og?type=drug&title=Serum%20bank&subtitle=Serum%20bank%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Serum bank Serum bank · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/serum-collection https://druglandscape.com/api/og?type=drug&title=Serum%20collection&subtitle=Serum%20collection%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Serum collection Serum collection · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/serum-free-avonex https://druglandscape.com/api/og?type=drug&title=Serum%20Free%20Avonex&subtitle=Serum%20Free%20Avonex%20%C2%B7%20Biogen&badge=phase%201 Serum Free Avonex Serum Free Avonex · Biogen https://druglandscape.com/drug/serum-tube-collection https://druglandscape.com/api/og?type=drug&title=Serum%20tube%20collection&subtitle=Serum%20tube%20collection%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 Serum tube collection Serum tube collection · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/sevasemten-dose-1 https://druglandscape.com/api/og?type=drug&title=Sevasemten%20Dose%201&subtitle=Sevasemten%20Dose%201%20%C2%B7%20Edgewise%20Therapeutics%2C%20Inc.&badge=phase%202 Sevasemten Dose 1 Sevasemten Dose 1 · Edgewise Therapeutics, Inc. https://druglandscape.com/drug/sevelamer-carbonate-sevelamer-hydrochloride https://druglandscape.com/api/og?type=drug&title=sevelamer%20carbonate%2C%20sevelamer%20hydrochloride&subtitle=sevelamer%20carbonate%2C%20sevelamer%20hydrochloride%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%202 sevelamer carbonate, sevelamer hydrochloride sevelamer carbonate, sevelamer hydrochloride · Genzyme, a Sanofi Company https://druglandscape.com/drug/sevelamer-hydrochloride-sevelamer-carbonate https://druglandscape.com/api/og?type=drug&title=sevelamer%20hydrochloride%2C%20sevelamer%20carbonate&subtitle=sevelamer%20hydrochloride%2C%20sevelamer%20carbonate%20%C2%B7%20Genzyme%2C%20a%20Sanofi%20Company&badge=phase%202 sevelamer hydrochloride, sevelamer carbonate sevelamer hydrochloride, sevelamer carbonate · Genzyme, a Sanofi Company https://druglandscape.com/drug/sf-easyhaler https://druglandscape.com/api/og?type=drug&title=SF%20Easyhaler&subtitle=SF%20Easyhaler%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 SF Easyhaler SF Easyhaler · Orion Corporation, Orion Pharma https://druglandscape.com/drug/sfa002 https://druglandscape.com/api/og?type=drug&title=SFA002&subtitle=SFA002%20%C2%B7%20SFA%20Therapeutics&badge=phase%202 SFA002 SFA002 · SFA Therapeutics https://druglandscape.com/drug/sfg-02 https://druglandscape.com/api/og?type=drug&title=SFG-02&subtitle=SFG-02%20%C2%B7%20Juro%20Sciences%20Inc.&badge=phase%201 SFG-02 SFG-02 · Juro Sciences Inc. https://druglandscape.com/drug/sfp-control https://druglandscape.com/api/og?type=drug&title=SFP%20Control&subtitle=SFP%20Control%20%C2%B7%20Bayer&badge=phase%201 SFP Control SFP Control · Bayer https://druglandscape.com/drug/sg1906 https://druglandscape.com/api/og?type=drug&title=SG1906&subtitle=SG1906%20%C2%B7%20Hangzhou%20Sumgen%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 SG1906 SG1906 · Hangzhou Sumgen Biotech Co., Ltd. https://druglandscape.com/drug/sg2918 https://druglandscape.com/api/og?type=drug&title=SG2918&subtitle=SG2918%20%C2%B7%20Hangzhou%20Sumgen%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 SG2918 SG2918 · Hangzhou Sumgen Biotech Co., Ltd. https://druglandscape.com/drug/sgas https://druglandscape.com/api/og?type=drug&title=SGAs&subtitle=SGAs%20%C2%B7%20Calo%20Psychiatric%20Center&badge=phase%201 SGAs SGAs · Calo Psychiatric Center https://druglandscape.com/drug/sgb-3383 https://druglandscape.com/api/og?type=drug&title=SGB-3383&subtitle=SGB-3383%20%C2%B7%20Suzhou%20Sanegene%20Bio%20Inc.&badge=phase%201 SGB-3383 SGB-3383 · Suzhou Sanegene Bio Inc. https://druglandscape.com/drug/sgb-3908 https://druglandscape.com/api/og?type=drug&title=SGB-3908&subtitle=SGB-3908%20%C2%B7%20Suzhou%20Sanegene%20Bio%20Inc.&badge=phase%201 SGB-3908 SGB-3908 · Suzhou Sanegene Bio Inc. https://druglandscape.com/drug/sgb-7342 https://druglandscape.com/api/og?type=drug&title=SGB-7342&subtitle=SGB-7342%20%C2%B7%20Suzhou%20Sanegene%20Bio%20Inc.&badge=phase%201 SGB-7342 SGB-7342 · Suzhou Sanegene Bio Inc. https://druglandscape.com/drug/sgb-9768 https://druglandscape.com/api/og?type=drug&title=SGB-9768&subtitle=SGB-9768%20%C2%B7%20Suzhou%20Sanegene%20Bio%20Inc.&badge=phase%202 SGB-9768 SGB-9768 · Suzhou Sanegene Bio Inc. https://druglandscape.com/drug/sgc001 https://druglandscape.com/api/og?type=drug&title=SGC001&subtitle=SGC001%20%C2%B7%20Beijing%20Sungen%20Biomedical%20Technology%20Co.%2C%20Ltd&badge=phase%202 SGC001 SGC001 · Beijing Sungen Biomedical Technology Co., Ltd https://druglandscape.com/drug/sgi-110 https://druglandscape.com/api/og?type=drug&title=SGI-110&subtitle=SGI-110%20%C2%B7%20Otsuka%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 SGI-110 SGI-110 · Otsuka Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sgn-00101 https://druglandscape.com/api/og?type=drug&title=SGN-00101&subtitle=SGN-00101%20%C2%B7%20Nventa%20Biopharmaceuticals%20Corporation&badge=phase%202 SGN-00101 SGN-00101 · Nventa Biopharmaceuticals Corporation https://druglandscape.com/drug/sgn-15-docetaxel https://druglandscape.com/api/og?type=drug&title=SGN-15%2C%20Docetaxel&subtitle=SGN-15%2C%20Docetaxel%20%C2%B7%20Seagen%20Inc.&badge=phase%202 SGN-15, Docetaxel SGN-15, Docetaxel · Seagen Inc. https://druglandscape.com/drug/sgn-35 https://druglandscape.com/api/og?type=drug&title=SGN-35&subtitle=SGN-35%20%C2%B7%20Seagen%20Inc.&badge=phase%202 SGN-35 SGN-35 · Seagen Inc. https://druglandscape.com/drug/sgn-cd19a https://druglandscape.com/api/og?type=drug&title=SGN-CD19A&subtitle=SGN-CD19A%20%C2%B7%20Seagen%20Inc.&badge=phase%201 SGN-CD19A SGN-CD19A · Seagen Inc. https://druglandscape.com/drug/sgn-cd33a https://druglandscape.com/api/og?type=drug&title=SGN-CD33A&subtitle=SGN-CD33A%20%C2%B7%20Seagen%20Inc.&badge=phase%201 SGN-CD33A SGN-CD33A · Seagen Inc. https://druglandscape.com/drug/sgn1 https://druglandscape.com/api/og?type=drug&title=SGN1&subtitle=SGN1%20%C2%B7%20Guangzhou%20Sinogen%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 SGN1 SGN1 · Guangzhou Sinogen Pharmaceutical Co., Ltd https://druglandscape.com/drug/sgt-501 https://druglandscape.com/api/og?type=drug&title=SGT-501&subtitle=SGT-501%20%C2%B7%20Solid%20Biosciences%20Inc.&badge=phase%201 SGT-501 SGT-501 · Solid Biosciences Inc. https://druglandscape.com/drug/sh-1028 https://druglandscape.com/api/og?type=drug&title=SH-1028&subtitle=SH-1028%20%C2%B7%20Nanjing%20Sanhome%20Pharmaceutical%2C%20Co.%2C%20Ltd.&badge=phase%202 SH-1028 SH-1028 · Nanjing Sanhome Pharmaceutical, Co., Ltd. https://druglandscape.com/drug/sh-t00186df https://druglandscape.com/api/og?type=drug&title=SH%20T00186DF&subtitle=SH%20T00186DF%20%C2%B7%20Bayer&badge=phase%202 SH T00186DF SH T00186DF · Bayer https://druglandscape.com/drug/sh-t00268c https://druglandscape.com/api/og?type=drug&title=SH%20T00268C&subtitle=SH%20T00268C%20%C2%B7%20Bayer&badge=phase%202 SH T00268C SH T00268C · Bayer https://druglandscape.com/drug/sh-t04740b https://druglandscape.com/api/og?type=drug&title=SH%20T04740B&subtitle=SH%20T04740B%20%C2%B7%20Bayer&badge=phase%202 SH T04740B SH T04740B · Bayer https://druglandscape.com/drug/sh-t04740f https://druglandscape.com/api/og?type=drug&title=SH%20T04740F&subtitle=SH%20T04740F%20%C2%B7%20Bayer&badge=phase%202 SH T04740F SH T04740F · Bayer https://druglandscape.com/drug/sh006 https://druglandscape.com/api/og?type=drug&title=SH006&subtitle=SH006%20%C2%B7%20Nanjing%20Sanhome%20Pharmaceutical%2C%20Co.%2C%20Ltd.&badge=phase%202 SH006 SH006 · Nanjing Sanhome Pharmaceutical, Co., Ltd. https://druglandscape.com/drug/sh009 https://druglandscape.com/api/og?type=drug&title=SH009&subtitle=SH009%20%C2%B7%20Nanjing%20Sanhome%20Pharmaceutical%2C%20Co.%2C%20Ltd.&badge=phase%201 SH009 SH009 · Nanjing Sanhome Pharmaceutical, Co., Ltd. https://druglandscape.com/drug/sh1573-capsules https://druglandscape.com/api/og?type=drug&title=SH1573%20Capsules&subtitle=SH1573%20Capsules%20%C2%B7%20Nanjing%20Sanhome%20Pharmaceutical%2C%20Co.%2C%20Ltd.&badge=phase%201 SH1573 Capsules SH1573 Capsules · Nanjing Sanhome Pharmaceutical, Co., Ltd. https://druglandscape.com/drug/sh229 https://druglandscape.com/api/og?type=drug&title=SH229&subtitle=SH229%20%C2%B7%20Nanjing%20Sanhome%20Pharmaceutical%2C%20Co.%2C%20Ltd.&badge=phase%201 SH229 SH229 · Nanjing Sanhome Pharmaceutical, Co., Ltd. https://druglandscape.com/drug/sh229-tablets https://druglandscape.com/api/og?type=drug&title=SH229%20tablets&subtitle=SH229%20tablets%20%C2%B7%20Nanjing%20Sanhome%20Pharmaceutical%2C%20Co.%2C%20Ltd.&badge=phase%202 SH229 tablets SH229 tablets · Nanjing Sanhome Pharmaceutical, Co., Ltd. https://druglandscape.com/drug/sh3809-tablet https://druglandscape.com/api/og?type=drug&title=SH3809%20tablet&subtitle=SH3809%20tablet%20%C2%B7%20Nanjing%20Sanhome%20Pharmaceutical%2C%20Co.%2C%20Ltd.&badge=phase%201 SH3809 tablet SH3809 tablet · Nanjing Sanhome Pharmaceutical, Co., Ltd. https://druglandscape.com/drug/shape-gel https://druglandscape.com/api/og?type=drug&title=SHAPE%20Gel&subtitle=SHAPE%20Gel%20%C2%B7%20TetraLogic%20Pharmaceuticals&badge=phase%202 SHAPE Gel SHAPE Gel · TetraLogic Pharmaceuticals https://druglandscape.com/drug/shc014748m https://druglandscape.com/api/og?type=drug&title=SHC014748M&subtitle=SHC014748M%20%C2%B7%20Nanjing%20Sanhome%20Pharmaceutical%2C%20Co.%2C%20Ltd.&badge=phase%202 SHC014748M SHC014748M · Nanjing Sanhome Pharmaceutical, Co., Ltd. https://druglandscape.com/drug/shc014748m-treatment https://druglandscape.com/api/og?type=drug&title=SHC014748M%20treatment&subtitle=SHC014748M%20treatment%20%C2%B7%20Nanjing%20Sanhome%20Pharmaceutical%2C%20Co.%2C%20Ltd.&badge=phase%202 SHC014748M treatment SHC014748M treatment · Nanjing Sanhome Pharmaceutical, Co., Ltd. https://druglandscape.com/drug/shen211-tablets https://druglandscape.com/api/og?type=drug&title=SHEN211%20Tablets&subtitle=SHEN211%20Tablets%20%C2%B7%20JKT%20Biopharma%20Co.%2C%20Ltd.&badge=phase%202 SHEN211 Tablets SHEN211 Tablets · JKT Biopharma Co., Ltd. https://druglandscape.com/drug/shenbai-granules https://druglandscape.com/api/og?type=drug&title=Shenbai%20Granules&subtitle=Shenbai%20Granules%20%C2%B7%20Jiangsu%20Famous%20Medical%20Technology%20Co.%2C%20Ltd.&badge=phase%202 Shenbai Granules Shenbai Granules · Jiangsu Famous Medical Technology Co., Ltd. https://druglandscape.com/drug/shigella-4v https://druglandscape.com/api/og?type=drug&title=Shigella%204V&subtitle=Shigella%204V%20%C2%B7%20LimmaTech%20Biologics%20AG&badge=phase%201 Shigella 4V Shigella 4V · LimmaTech Biologics AG https://druglandscape.com/drug/shigella-flexneri-2a-2457t https://druglandscape.com/api/og?type=drug&title=Shigella%20flexneri%202a%202457T&subtitle=Shigella%20flexneri%202a%202457T%20%C2%B7%20PATH&badge=phase%201 Shigella flexneri 2a 2457T Shigella flexneri 2a 2457T · PATH https://druglandscape.com/drug/shigella-flexneri-2a-invaplex-50 https://druglandscape.com/api/og?type=drug&title=Shigella%20flexneri%202a%20Invaplex%2050&subtitle=Shigella%20flexneri%202a%20Invaplex%2050%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 Shigella flexneri 2a Invaplex 50 Shigella flexneri 2a Invaplex 50 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/shigella-flexneri-2a-invaplexar https://druglandscape.com/api/og?type=drug&title=Shigella%20flexneri%202a%20InvaplexAR&subtitle=Shigella%20flexneri%202a%20InvaplexAR%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 Shigella flexneri 2a InvaplexAR Shigella flexneri 2a InvaplexAR · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/shigella-vaccine https://druglandscape.com/api/og?type=drug&title=Shigella%20vaccine&subtitle=Shigella%20vaccine%20%C2%B7%20GlycoVaxyn%20AG&badge=phase%201 Shigella vaccine Shigella vaccine · GlycoVaxyn AG https://druglandscape.com/drug/shigetec-live-attenuated-oral-vaccine https://druglandscape.com/api/og?type=drug&title=ShigETEC%20live%2C%20attenuated%2C%20oral%20vaccine&subtitle=ShigETEC%20live%2C%20attenuated%2C%20oral%20vaccine%20%C2%B7%20Eveliqure%20Biotechnologies%20GmbH&badge=phase%201 ShigETEC live, attenuated, oral vaccine ShigETEC live, attenuated, oral vaccine · Eveliqure Biotechnologies GmbH https://druglandscape.com/drug/shigetec-vaccine https://druglandscape.com/api/og?type=drug&title=ShigETEC%20vaccine&subtitle=ShigETEC%20vaccine%20%C2%B7%20Eveliqure%20Biotechnologies%20GmbH&badge=phase%202 ShigETEC vaccine ShigETEC vaccine · Eveliqure Biotechnologies GmbH https://druglandscape.com/drug/shj-high-concentration https://druglandscape.com/api/og?type=drug&title=SHJ%20-%20High%20concentration&subtitle=SHJ%20-%20High%20concentration%20%C2%B7%20Sunhawk%20Vision%20Biotech%2C%20Inc.&badge=phase%201 SHJ - High concentration SHJ - High concentration · Sunhawk Vision Biotech, Inc. https://druglandscape.com/drug/shj-low-concentration https://druglandscape.com/api/og?type=drug&title=SHJ%20-%20Low%20concentration&subtitle=SHJ%20-%20Low%20concentration%20%C2%B7%20Sunhawk%20Vision%20Biotech%2C%20Inc.&badge=phase%201 SHJ - Low concentration SHJ - Low concentration · Sunhawk Vision Biotech, Inc. https://druglandscape.com/drug/shj-maximum-tolerated https://druglandscape.com/api/og?type=drug&title=SHJ%20-%20Maximum%20tolerated&subtitle=SHJ%20-%20Maximum%20tolerated%20%C2%B7%20Sunhawk%20Vision%20Biotech%2C%20Inc.&badge=phase%201 SHJ - Maximum tolerated SHJ - Maximum tolerated · Sunhawk Vision Biotech, Inc. https://druglandscape.com/drug/short-acting-2-agonist https://druglandscape.com/api/og?type=drug&title=short%20acting%20%CE%B22-%20agonist&subtitle=short%20acting%20%CE%B22-%20agonist%20%C2%B7%20Novartis&badge=phase%202 short acting β2- agonist short acting β2- agonist · Novartis https://druglandscape.com/drug/short-course-chemotherapy https://druglandscape.com/api/og?type=drug&title=short-course%20chemotherapy&subtitle=short-course%20chemotherapy%20%C2%B7%20Associazione%20Italiana%20per%20lo%20Studio%20del%20Pancreas&badge=phase%203 short-course chemotherapy short-course chemotherapy · Associazione Italiana per lo Studio del Pancreas https://druglandscape.com/drug/short-course-mdr-tb-treatment-regimen https://druglandscape.com/api/og?type=drug&title=Short%20course%20MDR-TB%20treatment%20regimen&subtitle=Short%20course%20MDR-TB%20treatment%20regimen%20%C2%B7%20Medecins%20Sans%20Frontieres%2C%20Netherlands&badge=phase%202 Short course MDR-TB treatment regimen Short course MDR-TB treatment regimen · Medecins Sans Frontieres, Netherlands https://druglandscape.com/drug/short-term-on-q https://druglandscape.com/api/og?type=drug&title=Short-term%20ON-Q&subtitle=Short-term%20ON-Q%20%C2%B7%20AdventHealth&badge=phase%201 Short-term ON-Q Short-term ON-Q · AdventHealth https://druglandscape.com/drug/short-tirofiban https://druglandscape.com/api/og?type=drug&title=Short%20Tirofiban&subtitle=Short%20Tirofiban%20%C2%B7%20Medicure&badge=phase%202 Short Tirofiban Short Tirofiban · Medicure https://druglandscape.com/drug/shortened-steroid-regimen https://druglandscape.com/api/og?type=drug&title=Shortened%20steroid%20regimen&subtitle=Shortened%20steroid%20regimen%20%C2%B7%20Centro%20de%20Investigaci%C3%B3n%20en.%20Enfermedades%20Infecciosas%2C%20Mexico&badge=phase%201 Shortened steroid regimen Shortened steroid regimen · Centro de Investigación en. Enfermedades Infecciosas, Mexico https://druglandscape.com/drug/shp611 https://druglandscape.com/api/og?type=drug&title=SHP611&subtitle=SHP611%20%C2%B7%20Shire&badge=phase%202 SHP611 SHP611 · Shire https://druglandscape.com/drug/shp623 https://druglandscape.com/api/og?type=drug&title=SHP623&subtitle=SHP623%20%C2%B7%20Shire&badge=phase%201 SHP623 SHP623 · Shire https://druglandscape.com/drug/shp643 https://druglandscape.com/api/og?type=drug&title=SHP643&subtitle=SHP643%20%C2%B7%20Shire&badge=phase%201 SHP643 SHP643 · Shire https://druglandscape.com/drug/shp655 https://druglandscape.com/api/og?type=drug&title=SHP655&subtitle=SHP655%20%C2%B7%20Shire&badge=phase%202 SHP655 SHP655 · Shire https://druglandscape.com/drug/shp681 https://druglandscape.com/api/og?type=drug&title=SHP681&subtitle=SHP681%20%C2%B7%20Shire&badge=phase%201 SHP681 SHP681 · Shire https://druglandscape.com/drug/shr-1020 https://druglandscape.com/api/og?type=drug&title=SHR-1020&subtitle=SHR-1020%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR-1020 SHR-1020 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr-1222 https://druglandscape.com/api/og?type=drug&title=SHR-1222&subtitle=SHR-1222%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR-1222 SHR-1222 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr-1316-and-shr-a1811 https://druglandscape.com/api/og?type=drug&title=SHR-1316%20and%20SHR-A1811&subtitle=SHR-1316%20and%20SHR-A1811%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 SHR-1316 and SHR-A1811 SHR-1316 and SHR-A1811 · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-1501-adebrelimab https://druglandscape.com/api/og?type=drug&title=SHR-1501%2C%20Adebrelimab&subtitle=SHR-1501%2C%20Adebrelimab%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SHR-1501, Adebrelimab SHR-1501, Adebrelimab · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-1681 https://druglandscape.com/api/og?type=drug&title=SHR-1681&subtitle=SHR-1681%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 SHR-1681 SHR-1681 · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-1707 https://druglandscape.com/api/og?type=drug&title=SHR-1707&subtitle=SHR-1707%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 SHR-1707 SHR-1707 · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-1826 https://druglandscape.com/api/og?type=drug&title=SHR-1826&subtitle=SHR-1826%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 SHR-1826 SHR-1826 · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-1901 https://druglandscape.com/api/og?type=drug&title=SHR-1901&subtitle=SHR-1901%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 SHR-1901 SHR-1901 · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-1906 https://druglandscape.com/api/og?type=drug&title=SHR-1906&subtitle=SHR-1906%20%C2%B7%20Guangdong%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 SHR-1906 SHR-1906 · Guangdong Hengrui Pharmaceutical Co., Ltd https://druglandscape.com/drug/shr-1921 https://druglandscape.com/api/og?type=drug&title=SHR-1921&subtitle=SHR-1921%20%C2%B7%20Atridia%20Pty%20Ltd.&badge=phase%202 SHR-1921 SHR-1921 · Atridia Pty Ltd. https://druglandscape.com/drug/shr-2002-and-shr-1316 https://druglandscape.com/api/og?type=drug&title=SHR-2002%20and%20SHR-1316&subtitle=SHR-2002%20and%20SHR-1316%20%C2%B7%20Atridia%20Pty%20Ltd.&badge=phase%201 SHR-2002 and SHR-1316 SHR-2002 and SHR-1316 · Atridia Pty Ltd. https://druglandscape.com/drug/shr-2005 https://druglandscape.com/api/og?type=drug&title=SHR-2005&subtitle=SHR-2005%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SHR-2005 SHR-2005 · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-2173 https://druglandscape.com/api/og?type=drug&title=SHR-2173&subtitle=SHR-2173%20%C2%B7%20Guangdong%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 SHR-2173 SHR-2173 · Guangdong Hengrui Pharmaceutical Co., Ltd https://druglandscape.com/drug/shr-3032 https://druglandscape.com/api/og?type=drug&title=SHR-3032&subtitle=SHR-3032%20%C2%B7%20Guangdong%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 SHR-3032 SHR-3032 · Guangdong Hengrui Pharmaceutical Co., Ltd https://druglandscape.com/drug/shr-3836-administered-as-multiple-doses https://druglandscape.com/api/og?type=drug&title=SHR-3836%20administered%20as%20multiple%20doses.&subtitle=SHR-3836%20administered%20as%20multiple%20doses.%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SHR-3836 administered as multiple doses. SHR-3836 administered as multiple doses. · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-4375 https://druglandscape.com/api/og?type=drug&title=SHR-4375&subtitle=SHR-4375%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 SHR-4375 SHR-4375 · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-4394 https://druglandscape.com/api/og?type=drug&title=SHR-4394&subtitle=SHR-4394%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR-4394 SHR-4394 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr-4597 https://druglandscape.com/api/og?type=drug&title=SHR-4597&subtitle=SHR-4597%20%C2%B7%20Guangdong%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 SHR-4597 SHR-4597 · Guangdong Hengrui Pharmaceutical Co., Ltd https://druglandscape.com/drug/shr-4602 https://druglandscape.com/api/og?type=drug&title=SHR-4602&subtitle=SHR-4602%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 SHR-4602 SHR-4602 · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-4642 https://druglandscape.com/api/og?type=drug&title=SHR-4642&subtitle=SHR-4642%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 SHR-4642 SHR-4642 · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-7367 https://druglandscape.com/api/og?type=drug&title=SHR-7367&subtitle=SHR-7367%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SHR-7367 SHR-7367 · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-7631 https://druglandscape.com/api/og?type=drug&title=SHR-7631&subtitle=SHR-7631%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 SHR-7631 SHR-7631 · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-8068-adebrelimab https://druglandscape.com/api/og?type=drug&title=SHR-8068%EF%BC%9BAdebrelimab&subtitle=SHR-8068%EF%BC%9BAdebrelimab%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 SHR-8068；Adebrelimab SHR-8068；Adebrelimab · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-8068-adebrelimab-bevacizumab https://druglandscape.com/api/og?type=drug&title=SHR-8068%EF%BC%9BAdebrelimab%20%EF%BC%9BBevacizumab&subtitle=SHR-8068%EF%BC%9BAdebrelimab%20%EF%BC%9BBevacizumab%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 SHR-8068；Adebrelimab ；Bevacizumab SHR-8068；Adebrelimab ；Bevacizumab · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-8068-adebrelimab-hs-10516 https://druglandscape.com/api/og?type=drug&title=SHR-8068%EF%BC%9BAdebrelimab%20%EF%BC%9BHS-10516&subtitle=SHR-8068%EF%BC%9BAdebrelimab%20%EF%BC%9BHS-10516%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 SHR-8068；Adebrelimab ；HS-10516 SHR-8068；Adebrelimab ；HS-10516 · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-9803 https://druglandscape.com/api/og?type=drug&title=SHR-9803&subtitle=SHR-9803%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR-9803 SHR-9803 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr-9839 https://druglandscape.com/api/og?type=drug&title=SHR-9839&subtitle=SHR-9839%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SHR-9839 SHR-9839 · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-9839-almonertinib https://druglandscape.com/api/og?type=drug&title=SHR-9839%20%EF%BC%9B%20Almonertinib&subtitle=SHR-9839%20%EF%BC%9B%20Almonertinib%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SHR-9839 ； Almonertinib SHR-9839 ； Almonertinib · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-9839-pemetrexed-carboplatin https://druglandscape.com/api/og?type=drug&title=SHR-9839%20%EF%BC%9B%20pemetrexed%20%EF%BC%9Bcarboplatin&subtitle=SHR-9839%20%EF%BC%9B%20pemetrexed%20%EF%BC%9Bcarboplatin%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SHR-9839 ； pemetrexed ；carboplatin SHR-9839 ； pemetrexed ；carboplatin · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-9839-shr-a1921 https://druglandscape.com/api/og?type=drug&title=SHR-9839%20%EF%BC%9B%20SHR-A1921&subtitle=SHR-9839%20%EF%BC%9B%20SHR-A1921%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SHR-9839 ； SHR-A1921 SHR-9839 ； SHR-A1921 · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-9839-shr-a2009 https://druglandscape.com/api/og?type=drug&title=SHR-9839%20%EF%BC%9BSHR-A2009&subtitle=SHR-9839%20%EF%BC%9BSHR-A2009%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SHR-9839 ；SHR-A2009 SHR-9839 ；SHR-A2009 · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-a1403 https://druglandscape.com/api/og?type=drug&title=SHR-A1403&subtitle=SHR-A1403%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR-A1403 SHR-A1403 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr-a181-shr-1701-and-capecitabine https://druglandscape.com/api/og?type=drug&title=SHR-A181%2C%20SHR-1701%2C%20and%20capecitabine&subtitle=SHR-A181%2C%20SHR-1701%2C%20and%20capecitabine%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 SHR-A181, SHR-1701, and capecitabine SHR-A181, SHR-1701, and capecitabine · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-a1811-albumin-paclitaxel https://druglandscape.com/api/og?type=drug&title=SHR-A1811%EF%BC%9BAlbumin%20paclitaxel&subtitle=SHR-A1811%EF%BC%9BAlbumin%20paclitaxel%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR-A1811；Albumin paclitaxel SHR-A1811；Albumin paclitaxel · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr-a1811-and-capecitabine https://druglandscape.com/api/og?type=drug&title=SHR-A1811%20and%20capecitabine&subtitle=SHR-A1811%20and%20capecitabine%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 SHR-A1811 and capecitabine SHR-A1811 and capecitabine · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-a1811-and-shr-1701 https://druglandscape.com/api/og?type=drug&title=SHR-A1811%20and%20SHR-1701&subtitle=SHR-A1811%20and%20SHR-1701%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 SHR-A1811 and SHR-1701 SHR-A1811 and SHR-1701 · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-a1811-combined-with-pyrotinib https://druglandscape.com/api/og?type=drug&title=SHR-A1811%20combined%20with%20Pyrotinib.&subtitle=SHR-A1811%20combined%20with%20Pyrotinib.%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR-A1811 combined with Pyrotinib. SHR-A1811 combined with Pyrotinib. · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr-a1811-dalpiciclib-isethionate-tablets https://druglandscape.com/api/og?type=drug&title=SHR-A1811%20%26%20Dalpiciclib%20Isethionate%20Tablets&subtitle=SHR-A1811%20%26%20Dalpiciclib%20Isethionate%20Tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR-A1811 & Dalpiciclib Isethionate Tablets SHR-A1811 & Dalpiciclib Isethionate Tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr-a1811-for-injection-capecitabine https://druglandscape.com/api/og?type=drug&title=SHR-A1811%20for%20injection%20%3B%20capecitabine&subtitle=SHR-A1811%20for%20injection%20%3B%20capecitabine%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 SHR-A1811 for injection ; capecitabine SHR-A1811 for injection ; capecitabine · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-a1811-pertuzumab https://druglandscape.com/api/og?type=drug&title=SHR-A1811%EF%BC%9BPertuzumab&subtitle=SHR-A1811%EF%BC%9BPertuzumab%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR-A1811；Pertuzumab SHR-A1811；Pertuzumab · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr-a1811-pyrotinib https://druglandscape.com/api/og?type=drug&title=SHR-A1811%EF%BC%9APyrotinib&subtitle=SHR-A1811%EF%BC%9APyrotinib%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR-A1811：Pyrotinib SHR-A1811：Pyrotinib · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr-a1811-shr-1316-and-5-fu https://druglandscape.com/api/og?type=drug&title=SHR-A1811%2C%20SHR-1316%2C%20and%205-FU&subtitle=SHR-A1811%2C%20SHR-1316%2C%20and%205-FU%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 SHR-A1811, SHR-1316, and 5-FU SHR-A1811, SHR-1316, and 5-FU · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-a1811-shr-1316-and-capecitabine https://druglandscape.com/api/og?type=drug&title=SHR-A1811%2C%20SHR-1316%2C%20and%20capecitabine&subtitle=SHR-A1811%2C%20SHR-1316%2C%20and%20capecitabine%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 SHR-A1811, SHR-1316, and capecitabine SHR-A1811, SHR-1316, and capecitabine · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-a1811and-5-fu https://druglandscape.com/api/og?type=drug&title=SHR-A1811and%205-FU&subtitle=SHR-A1811and%205-FU%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 SHR-A1811and 5-FU SHR-A1811and 5-FU · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-a1904-adebrelimab https://druglandscape.com/api/og?type=drug&title=SHR-A1904%3B%20Adebrelimab&subtitle=SHR-A1904%3B%20Adebrelimab%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SHR-A1904; Adebrelimab SHR-A1904; Adebrelimab · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-a1904-capox-adebrelimab https://druglandscape.com/api/og?type=drug&title=SHR-A1904%3B%20CAPOX%3B%20Adebrelimab&subtitle=SHR-A1904%3B%20CAPOX%3B%20Adebrelimab%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SHR-A1904; CAPOX; Adebrelimab SHR-A1904; CAPOX; Adebrelimab · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-a1912-r-chemo https://druglandscape.com/api/og?type=drug&title=SHR-A1912%3B%20R-Chemo&subtitle=SHR-A1912%3B%20R-Chemo%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SHR-A1912; R-Chemo SHR-A1912; R-Chemo · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-a2009-shr-1316 https://druglandscape.com/api/og?type=drug&title=SHR-A2009%3B%20SHR-1316&subtitle=SHR-A2009%3B%20SHR-1316%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR-A2009; SHR-1316 SHR-A2009; SHR-1316 · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/shr-a2102 https://druglandscape.com/api/og?type=drug&title=SHR-A2102&subtitle=SHR-A2102%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 SHR-A2102 SHR-A2102 · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr-a2102-adebrelimab https://druglandscape.com/api/og?type=drug&title=SHR-A2102%EF%BC%9BAdebrelimab&subtitle=SHR-A2102%EF%BC%9BAdebrelimab%20%C2%B7%20Suzhou%20Suncadia%20Biopharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 SHR-A2102；Adebrelimab SHR-A2102；Adebrelimab · Suzhou Suncadia Biopharmaceuticals Co., Ltd. https://druglandscape.com/drug/shr-a2102-adebrelimab-cisplatin https://druglandscape.com/api/og?type=drug&title=SHR-A2102%EF%BC%9BAdebrelimab%EF%BC%9BCisplatin&subtitle=SHR-A2102%EF%BC%9BAdebrelimab%EF%BC%9BCisplatin%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SHR-A2102；Adebrelimab；Cisplatin SHR-A2102；Adebrelimab；Cisplatin · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr0302-14c-shr0302 https://druglandscape.com/api/og?type=drug&title=SHR0302%E3%80%81%5B14C%5DSHR0302&subtitle=SHR0302%E3%80%81%5B14C%5DSHR0302%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR0302、[14C]SHR0302 SHR0302、[14C]SHR0302 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr0302-base-gel https://druglandscape.com/api/og?type=drug&title=SHR0302%20Base%20Gel&subtitle=SHR0302%20Base%20Gel%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR0302 Base Gel SHR0302 Base Gel · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr0302-quick-release-tablets https://druglandscape.com/api/og?type=drug&title=SHR0302%20quick%20release%20tablets&subtitle=SHR0302%20quick%20release%20tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR0302 quick release tablets SHR0302 quick release tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr0302base-gel https://druglandscape.com/api/og?type=drug&title=SHR0302Base%20gel&subtitle=SHR0302Base%20gel%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR0302Base gel SHR0302Base gel · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr0532 https://druglandscape.com/api/og?type=drug&title=SHR0532&subtitle=SHR0532%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR0532 SHR0532 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr117887 https://druglandscape.com/api/og?type=drug&title=SHR117887&subtitle=SHR117887%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR117887 SHR117887 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr1459 https://druglandscape.com/api/og?type=drug&title=SHR1459&subtitle=SHR1459%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR1459 SHR1459 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr1459-fasted-in-p1-high-fat-diet-in-p2 https://druglandscape.com/api/og?type=drug&title=SHR1459%20fasted%20in%20P1%2C%20high-fat%20diet%20in%20P2&subtitle=SHR1459%20fasted%20in%20P1%2C%20high-fat%20diet%20in%20P2%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR1459 fasted in P1, high-fat diet in P2 SHR1459 fasted in P1, high-fat diet in P2 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr1459-high-dose https://druglandscape.com/api/og?type=drug&title=SHR1459%20High%20Dose&subtitle=SHR1459%20High%20Dose%20%C2%B7%20Reistone%20Biopharma%20Company%20Limited&badge=phase%202 SHR1459 High Dose SHR1459 High Dose · Reistone Biopharma Company Limited https://druglandscape.com/drug/shr1459-low-dose https://druglandscape.com/api/og?type=drug&title=SHR1459%20Low%20Dose&subtitle=SHR1459%20Low%20Dose%20%C2%B7%20Reistone%20Biopharma%20Company%20Limited&badge=phase%202 SHR1459 Low Dose SHR1459 Low Dose · Reistone Biopharma Company Limited https://druglandscape.com/drug/shr1459-yy-20394 https://druglandscape.com/api/og?type=drug&title=SHR1459%20%EF%BC%9BYY-20394&subtitle=SHR1459%20%EF%BC%9BYY-20394%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR1459 ；YY-20394 SHR1459 ；YY-20394 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr1819 https://druglandscape.com/api/og?type=drug&title=SHR1819&subtitle=SHR1819%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 SHR1819 SHR1819 · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr2150-tablet-efavirenz https://druglandscape.com/api/og?type=drug&title=SHR2150%20tablet%E3%80%81efavirenz&subtitle=SHR2150%20tablet%E3%80%81efavirenz%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR2150 tablet、efavirenz SHR2150 tablet、efavirenz · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr2554-adabelimumab https://druglandscape.com/api/og?type=drug&title=SHR2554%3B%20Adabelimumab&subtitle=SHR2554%3B%20Adabelimumab%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR2554; Adabelimumab SHR2554; Adabelimumab · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr2554-and-itraconazole https://druglandscape.com/api/og?type=drug&title=SHR2554%20and%20Itraconazole&subtitle=SHR2554%20and%20Itraconazole%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR2554 and Itraconazole SHR2554 and Itraconazole · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr2554-shr-1701 https://druglandscape.com/api/og?type=drug&title=SHR2554%3B%20SHR-1701&subtitle=SHR2554%3B%20SHR-1701%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR2554; SHR-1701 SHR2554; SHR-1701 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr2554-shr-a2102 https://druglandscape.com/api/og?type=drug&title=SHR2554%3B%20SHR-A2102&subtitle=SHR2554%3B%20SHR-A2102%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR2554; SHR-A2102 SHR2554; SHR-A2102 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr2554-tablet-dosing https://druglandscape.com/api/og?type=drug&title=SHR2554%20tablet%20dosing&subtitle=SHR2554%20tablet%20dosing%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR2554 tablet dosing SHR2554 tablet dosing · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr3680-shr3162 https://druglandscape.com/api/og?type=drug&title=SHR3680%3B%20SHR3162&subtitle=SHR3680%3B%20SHR3162%20%C2%B7%20Atridia%20Pty%20Ltd.&badge=phase%201 SHR3680; SHR3162 SHR3680; SHR3162 · Atridia Pty Ltd. https://druglandscape.com/drug/shr3680-tablets https://druglandscape.com/api/og?type=drug&title=SHR3680%20tablets&subtitle=SHR3680%20tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR3680 tablets SHR3680 tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr3824-metformin https://druglandscape.com/api/og?type=drug&title=SHR3824%20metformin&subtitle=SHR3824%20metformin%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR3824 metformin SHR3824 metformin · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr3824-simvastatin https://druglandscape.com/api/og?type=drug&title=SHR3824%2C%20Simvastatin&subtitle=SHR3824%2C%20Simvastatin%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR3824, Simvastatin SHR3824, Simvastatin · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr3824-sp2086 https://druglandscape.com/api/og?type=drug&title=SHR3824%2C%20SP2086&subtitle=SHR3824%2C%20SP2086%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR3824, SP2086 SHR3824, SP2086 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr4394 https://druglandscape.com/api/og?type=drug&title=SHR4394&subtitle=SHR4394%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR4394 SHR4394 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr4597 https://druglandscape.com/api/og?type=drug&title=SHR4597&subtitle=SHR4597%20%C2%B7%20Guangdong%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 SHR4597 SHR4597 · Guangdong Hengrui Pharmaceutical Co., Ltd https://druglandscape.com/drug/shr4640-dose1-plus-febuxostat-dose1 https://druglandscape.com/api/og?type=drug&title=SHR4640%20dose1%20plus%20Febuxostat%20dose1&subtitle=SHR4640%20dose1%20plus%20Febuxostat%20dose1%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR4640 dose1 plus Febuxostat dose1 SHR4640 dose1 plus Febuxostat dose1 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr4640-febuxostat https://druglandscape.com/api/og?type=drug&title=SHR4640%20%3B%20Febuxostat&subtitle=SHR4640%20%3B%20Febuxostat%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR4640 ; Febuxostat SHR4640 ; Febuxostat · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr4640-tablets-and-furosemide-tablets https://druglandscape.com/api/og?type=drug&title=SHR4640%20tablets%20and%20furosemide%20tablets&subtitle=SHR4640%20tablets%20and%20furosemide%20tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR4640 tablets and furosemide tablets SHR4640 tablets and furosemide tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr6390-efavirenz https://druglandscape.com/api/og?type=drug&title=SHR6390%E3%80%81efavirenz&subtitle=SHR6390%E3%80%81efavirenz%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR6390、efavirenz SHR6390、efavirenz · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr6390-omeprazole https://druglandscape.com/api/og?type=drug&title=SHR6390%E3%80%81Omeprazole&subtitle=SHR6390%E3%80%81Omeprazole%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR6390、Omeprazole SHR6390、Omeprazole · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr6508 https://druglandscape.com/api/og?type=drug&title=SHR6508&subtitle=SHR6508%20%C2%B7%20Shanghai%20Hengrui%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 SHR6508 SHR6508 · Shanghai Hengrui Pharmaceutical Co., Ltd. https://druglandscape.com/drug/shr7280 https://druglandscape.com/api/og?type=drug&title=SHR7280&subtitle=SHR7280%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR7280 SHR7280 · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr7280-dry-suspension https://druglandscape.com/api/og?type=drug&title=SHR7280%20dry%20suspension&subtitle=SHR7280%20dry%20suspension%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR7280 dry suspension SHR7280 dry suspension · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr7280-tablets https://druglandscape.com/api/og?type=drug&title=SHR7280%20Tablets&subtitle=SHR7280%20Tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 SHR7280 Tablets SHR7280 Tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr8554-itraconazole https://druglandscape.com/api/og?type=drug&title=SHR8554%EF%BC%9BItraconazole&subtitle=SHR8554%EF%BC%9BItraconazole%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 SHR8554；Itraconazole SHR8554；Itraconazole · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/shr8735 https://druglandscape.com/api/og?type=drug&title=SHR8735&subtitle=SHR8735%20%C2%B7%20Atridia%20Pty%20Ltd.&badge=phase%201 SHR8735 SHR8735 · Atridia Pty Ltd. https://druglandscape.com/drug/shx-001-active-high-dose https://druglandscape.com/api/og?type=drug&title=SHX-001%20Active%20High%20dose&subtitle=SHX-001%20Active%20High%20dose%20%C2%B7%20Shenox%20Pharmaceuticals%2C%20LLC&badge=phase%201 SHX-001 Active High dose SHX-001 Active High dose · Shenox Pharmaceuticals, LLC https://druglandscape.com/drug/shz-qiv-0-5-ml-2-doses https://druglandscape.com/api/og?type=drug&title=Shz%20QIV%200.5%20mL%2C%202%20doses&subtitle=Shz%20QIV%200.5%20mL%2C%202%20doses%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Shz QIV 0.5 mL, 2 doses Shz QIV 0.5 mL, 2 doses · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/si-544 https://druglandscape.com/api/og?type=drug&title=si-544&subtitle=si-544%20%C2%B7%20selectION%20Therapeutics%20GmbH&badge=phase%201 si-544 si-544 · selectION Therapeutics GmbH https://druglandscape.com/drug/si-b003 https://druglandscape.com/api/og?type=drug&title=SI-B003&subtitle=SI-B003%20%C2%B7%20Sichuan%20Baili%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 SI-B003 SI-B003 · Sichuan Baili Pharmaceutical Co., Ltd. https://druglandscape.com/drug/si-f019 https://druglandscape.com/api/og?type=drug&title=SI-F019&subtitle=SI-F019%20%C2%B7%20Sichuan%20Baili%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SI-F019 SI-F019 · Sichuan Baili Pharmaceutical Co., Ltd. https://druglandscape.com/drug/si000413 https://druglandscape.com/api/og?type=drug&title=SI000413&subtitle=SI000413%20%C2%B7%20Dong-A%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 SI000413 SI000413 · Dong-A Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sialic-acid-extended-release https://druglandscape.com/api/og?type=drug&title=Sialic%20Acid-Extended%20Release&subtitle=Sialic%20Acid-Extended%20Release%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%202 Sialic Acid-Extended Release Sialic Acid-Extended Release · Hadassah Medical Organization https://druglandscape.com/drug/sibling-umbilical-cord-blood https://druglandscape.com/api/og?type=drug&title=sibling%20umbilical%20cord%20blood&subtitle=sibling%20umbilical%20cord%20blood%20%C2%B7%20Joanne%20Kurtzberg%2C%20MD&badge=phase%201 sibling umbilical cord blood sibling umbilical cord blood · Joanne Kurtzberg, MD https://druglandscape.com/drug/sid1903 https://druglandscape.com/api/og?type=drug&title=SID1903&subtitle=SID1903%20%C2%B7%20SK%20Chemicals%20Co.%2C%20Ltd.&badge=phase%201 SID1903 SID1903 · SK Chemicals Co., Ltd. https://druglandscape.com/drug/signature-cord-prime https://druglandscape.com/api/og?type=drug&title=Signature%20Cord%20Prime&subtitle=Signature%20Cord%20Prime%20%C2%B7%20Thomas%20Klootwyk%2C%20MD&badge=phase%201 Signature Cord Prime Signature Cord Prime · Thomas Klootwyk, MD https://druglandscape.com/drug/siilpcv10 https://druglandscape.com/api/og?type=drug&title=SIILPCV10&subtitle=SIILPCV10%20%C2%B7%20PATH&badge=phase%201 SIILPCV10 SIILPCV10 · PATH https://druglandscape.com/drug/siiv https://druglandscape.com/api/og?type=drug&title=SIIV&subtitle=SIIV%20%C2%B7%20Hipra%20Scientific%2C%20S.L.U&badge=phase%202 SIIV SIIV · Hipra Scientific, S.L.U https://druglandscape.com/drug/sildenafill-reference-product https://druglandscape.com/api/og?type=drug&title=Sildenafill-Reference%20product&subtitle=Sildenafill-Reference%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Sildenafill-Reference product Sildenafill-Reference product · Bio-innova Co., Ltd https://druglandscape.com/drug/sildenafill-test-product https://druglandscape.com/api/og?type=drug&title=Sildenafill-Test%20product&subtitle=Sildenafill-Test%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Sildenafill-Test product Sildenafill-Test product · Bio-innova Co., Ltd https://druglandscape.com/drug/silevertinib-in-combination-with-temozolomide https://druglandscape.com/api/og?type=drug&title=silevertinib%20in%20combination%20with%20temozolomide&subtitle=silevertinib%20in%20combination%20with%20temozolomide%20%C2%B7%20Black%20Diamond%20Therapeutics%2C%20Inc.&badge=phase%202 silevertinib in combination with temozolomide silevertinib in combination with temozolomide · Black Diamond Therapeutics, Inc. https://druglandscape.com/drug/silvadene-cream-1-silver-sulfadiazine https://druglandscape.com/api/og?type=drug&title=Silvadene%C2%AE%20Cream%201%25%20%5BSilver%20Sulfadiazine%5D&subtitle=Silvadene%C2%AE%20Cream%201%25%20%5BSilver%20Sulfadiazine%5D%20%C2%B7%20Skingenix%2C%20Inc.&badge=phase%202 Silvadene® Cream 1% [Silver Sulfadiazine] Silvadene® Cream 1% [Silver Sulfadiazine] · Skingenix, Inc. https://druglandscape.com/drug/silver-citrate-complex-and-acemannan https://druglandscape.com/api/og?type=drug&title=silver%20citrate%20complex%20and%20acemannan&subtitle=silver%20citrate%20complex%20and%20acemannan%20%C2%B7%20CelaCare%20Technologies%2C%20Inc.&badge=phase%201 silver citrate complex and acemannan silver citrate complex and acemannan · CelaCare Technologies, Inc. https://druglandscape.com/drug/silver-nanoparticles https://druglandscape.com/api/og?type=drug&title=Silver%20nanoparticles&subtitle=Silver%20nanoparticles%20%C2%B7%20Ahmed%20A.%20H.%20Abdellatif&badge=phase%201 Silver nanoparticles Silver nanoparticles · Ahmed A. H. Abdellatif https://druglandscape.com/drug/silver-nanoparticles-irrigation https://druglandscape.com/api/og?type=drug&title=Silver%20Nanoparticles%20Irrigation&subtitle=Silver%20Nanoparticles%20Irrigation%20%C2%B7%20Radwa%20fath%20Ahmed&badge=phase%201 Silver Nanoparticles Irrigation Silver Nanoparticles Irrigation · Radwa fath Ahmed https://druglandscape.com/drug/sim0348 https://druglandscape.com/api/og?type=drug&title=SIM0348&subtitle=SIM0348%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SIM0348 SIM0348 · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sim0417 https://druglandscape.com/api/og?type=drug&title=SIM0417&subtitle=SIM0417%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 SIM0417 SIM0417 · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sim0500 https://druglandscape.com/api/og?type=drug&title=SIM0500&subtitle=SIM0500%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SIM0500 SIM0500 · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sim0508-tablets https://druglandscape.com/api/og?type=drug&title=SIM0508%20Tablets&subtitle=SIM0508%20Tablets%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SIM0508 Tablets SIM0508 Tablets · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sim0686 https://druglandscape.com/api/og?type=drug&title=SIM0686&subtitle=SIM0686%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SIM0686 SIM0686 · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sim1803-1a https://druglandscape.com/api/og?type=drug&title=SIM1803-1A&subtitle=SIM1803-1A%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SIM1803-1A SIM1803-1A · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sim1811-03 https://druglandscape.com/api/og?type=drug&title=SIM1811-03&subtitle=SIM1811-03%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SIM1811-03 SIM1811-03 · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sim1910-09 https://druglandscape.com/api/og?type=drug&title=SIM1910-09&subtitle=SIM1910-09%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SIM1910-09 SIM1910-09 · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/simmitinib-plus-irinotecan-liposome https://druglandscape.com/api/og?type=drug&title=simmitinib%20plus%20irinotecan%20liposome&subtitle=simmitinib%20plus%20irinotecan%20liposome%20%C2%B7%20Shanghai%20Runshi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd&badge=phase%202 simmitinib plus irinotecan liposome simmitinib plus irinotecan liposome · Shanghai Runshi Pharmaceutical Technology Co., Ltd https://druglandscape.com/drug/simmitinib-tablets https://druglandscape.com/api/og?type=drug&title=Simmitinib%20tablets&subtitle=Simmitinib%20tablets%20%C2%B7%20Shanghai%20Runshi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd&badge=phase%201 Simmitinib tablets Simmitinib tablets · Shanghai Runshi Pharmaceutical Technology Co., Ltd https://druglandscape.com/drug/simotinib-hydrochloride https://druglandscape.com/api/og?type=drug&title=Simotinib%20Hydrochloride&subtitle=Simotinib%20Hydrochloride%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Simotinib Hydrochloride Simotinib Hydrochloride · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/simplified-lv5fu2 https://druglandscape.com/api/og?type=drug&title=simplified%20LV5FU2&subtitle=simplified%20LV5FU2%20%C2%B7%20GERCOR%20-%20Multidisciplinary%20Oncology%20Cooperative%20Group&badge=phase%202 simplified LV5FU2 simplified LV5FU2 · GERCOR - Multidisciplinary Oncology Cooperative Group https://druglandscape.com/drug/simvastatin-and-gdc-0853 https://druglandscape.com/api/og?type=drug&title=Simvastatin%20and%20GDC-0853&subtitle=Simvastatin%20and%20GDC-0853%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 Simvastatin and GDC-0853 Simvastatin and GDC-0853 · Genentech, Inc. https://druglandscape.com/drug/simvastatin-susp https://druglandscape.com/api/og?type=drug&title=Simvastatin%20Susp.&subtitle=Simvastatin%20Susp.%20%C2%B7%20Forbes%20Porter%2C%20M.D.&badge=phase%202 Simvastatin Susp. Simvastatin Susp. · Forbes Porter, M.D. https://druglandscape.com/drug/sinecatechins-15-ointment https://druglandscape.com/api/og?type=drug&title=Sinecatechins%2015%25%20Ointment&subtitle=Sinecatechins%2015%25%20Ointment%20%C2%B7%20Icahn%20School%20of%20Medicine%20at%20Mount%20Sinai&badge=phase%201 Sinecatechins 15% Ointment Sinecatechins 15% Ointment · Icahn School of Medicine at Mount Sinai https://druglandscape.com/drug/sinemet-25-100-oral-tablet https://druglandscape.com/api/og?type=drug&title=Sinemet%2025-100%20Oral%20Tablet&subtitle=Sinemet%2025-100%20Oral%20Tablet%20%C2%B7%20XenoPort%2C%20Inc.&badge=phase%201 Sinemet 25-100 Oral Tablet Sinemet 25-100 Oral Tablet · XenoPort, Inc. https://druglandscape.com/drug/sinemet-ir https://druglandscape.com/api/og?type=drug&title=Sinemet%20IR&subtitle=Sinemet%20IR%20%C2%B7%20Depomed&badge=phase%202 Sinemet IR Sinemet IR · Depomed https://druglandscape.com/drug/sing2016-m2sr-h3n2-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=Sing2016%20M2SR%20H3N2%20influenza%20vaccine&subtitle=Sing2016%20M2SR%20H3N2%20influenza%20vaccine%20%C2%B7%20FluGen%20Inc&badge=phase%201 Sing2016 M2SR H3N2 influenza vaccine Sing2016 M2SR H3N2 influenza vaccine · FluGen Inc https://druglandscape.com/drug/single-administration-cmg-dose-group https://druglandscape.com/api/og?type=drug&title=Single%20administration%20Cmg%20dose%20Group&subtitle=Single%20administration%20Cmg%20dose%20Group%20%C2%B7%20J2H%20Biotech&badge=phase%201 Single administration Cmg dose Group Single administration Cmg dose Group · J2H Biotech https://druglandscape.com/drug/single-administration-dmg-dose-group https://druglandscape.com/api/og?type=drug&title=Single%20administration%20Dmg%20dose%20Group&subtitle=Single%20administration%20Dmg%20dose%20Group%20%C2%B7%20J2H%20Biotech&badge=phase%201 Single administration Dmg dose Group Single administration Dmg dose Group · J2H Biotech https://druglandscape.com/drug/single-ascending-dose-of-sab-176 https://druglandscape.com/api/og?type=drug&title=Single%20Ascending%20Dose%20of%20SAB-176&subtitle=Single%20Ascending%20Dose%20of%20SAB-176%20%C2%B7%20SAb%20Biotherapeutics%2C%20Inc.&badge=phase%201 Single Ascending Dose of SAB-176 Single Ascending Dose of SAB-176 · SAb Biotherapeutics, Inc. https://druglandscape.com/drug/single-ascending-dose-of-x842 https://druglandscape.com/api/og?type=drug&title=Single%20ascending%20dose%20of%20X842&subtitle=Single%20ascending%20dose%20of%20X842%20%C2%B7%20Cinclus%20Pharma%20AG&badge=phase%201 Single ascending dose of X842 Single ascending dose of X842 · Cinclus Pharma AG https://druglandscape.com/drug/single-ascending-doses-sul-238 https://druglandscape.com/api/og?type=drug&title=Single%20ascending%20doses%20SUL-238&subtitle=Single%20ascending%20doses%20SUL-238%20%C2%B7%20GEN%20%C4%B0la%C3%A7%20ve%20Sa%C4%9Fl%C4%B1k%20%C3%9Cr%C3%BCnleri%20A.%C5%9E.&badge=phase%201 Single ascending doses SUL-238 Single ascending doses SUL-238 · GEN İlaç ve Sağlık Ürünleri A.Ş. https://druglandscape.com/drug/single-dose-azithromycin https://druglandscape.com/api/og?type=drug&title=Single-dose%20azithromycin&subtitle=Single-dose%20azithromycin%20%C2%B7%20FHI%20360&badge=phase%201 Single-dose azithromycin Single-dose azithromycin · FHI 360 https://druglandscape.com/drug/single-dose-c2n-8e12 https://druglandscape.com/api/og?type=drug&title=Single%20dose%20C2N-8E12&subtitle=Single%20dose%20C2N-8E12%20%C2%B7%20C2N%20Diagnostics&badge=phase%201 Single dose C2N-8E12 Single dose C2N-8E12 · C2N Diagnostics https://druglandscape.com/drug/single-dose-g1090n https://druglandscape.com/api/og?type=drug&title=Single%20Dose%20G1090N&subtitle=Single%20Dose%20G1090N%20%C2%B7%20Genfit&badge=phase%201 Single Dose G1090N Single Dose G1090N · Genfit https://druglandscape.com/drug/single-dose-of-uc-mscs https://druglandscape.com/api/og?type=drug&title=single%20dose%20of%20UC-MSCs&subtitle=single%20dose%20of%20UC-MSCs%20%C2%B7%20LiveKidney.Bio&badge=phase%201 single dose of UC-MSCs single dose of UC-MSCs · LiveKidney.Bio https://druglandscape.com/drug/single-dose-preoperative-antibiotic https://druglandscape.com/api/og?type=drug&title=single%20dose%20preoperative%20antibiotic&subtitle=single%20dose%20preoperative%20antibiotic%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 single dose preoperative antibiotic single dose preoperative antibiotic · Asan Medical Center https://druglandscape.com/drug/single-dose-sul-238 https://druglandscape.com/api/og?type=drug&title=Single%20dose%20SUL-238&subtitle=Single%20dose%20SUL-238%20%C2%B7%20GEN%20%C4%B0la%C3%A7%20ve%20Sa%C4%9Fl%C4%B1k%20%C3%9Cr%C3%BCnleri%20A.%C5%9E.&badge=phase%201 Single dose SUL-238 Single dose SUL-238 · GEN İlaç ve Sağlık Ürünleri A.Ş. https://druglandscape.com/drug/single-entity-oral-triptans https://druglandscape.com/api/og?type=drug&title=Single-entity%20oral%20triptans&subtitle=Single-entity%20oral%20triptans%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Single-entity oral triptans Single-entity oral triptans · GlaxoSmithKline https://druglandscape.com/drug/single-high-dose-vitamin-d https://druglandscape.com/api/og?type=drug&title=Single%20high%20dose%20vitamin%20D&subtitle=Single%20high%20dose%20vitamin%20D%20%C2%B7%20Prof.%20Dr.%20J%C3%B6rg%20Leuppi&badge=phase%201 Single high dose vitamin D Single high dose vitamin D · Prof. Dr. Jörg Leuppi https://druglandscape.com/drug/single-immediate-chemotherapy-instillation https://druglandscape.com/api/og?type=drug&title=single%20immediate%20chemotherapy%20instillation&subtitle=single%20immediate%20chemotherapy%20instillation%20%C2%B7%20Turku%20University%20Hospital&badge=phase%203 single immediate chemotherapy instillation single immediate chemotherapy instillation · Turku University Hospital https://druglandscape.com/drug/single-infusion-of-obinutuzumab https://druglandscape.com/api/og?type=drug&title=single%20infusion%20of%20Obinutuzumab&subtitle=single%20infusion%20of%20Obinutuzumab%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 single infusion of Obinutuzumab single infusion of Obinutuzumab · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/single-intravenous-doses-of-mrx-4 https://druglandscape.com/api/og?type=drug&title=Single%20intravenous%20doses%20of%20MRX-4&subtitle=Single%20intravenous%20doses%20of%20MRX-4%20%C2%B7%20MicuRx&badge=phase%201 Single intravenous doses of MRX-4 Single intravenous doses of MRX-4 · MicuRx https://druglandscape.com/drug/single-oral-dose-of-cobicistat https://druglandscape.com/api/og?type=drug&title=Single%20oral%20dose%20of%20cobicistat&subtitle=Single%20oral%20dose%20of%20cobicistat%20%C2%B7%20Medicines%20for%20Malaria%20Venture&badge=phase%201 Single oral dose of cobicistat Single oral dose of cobicistat · Medicines for Malaria Venture https://druglandscape.com/drug/single-person-sipv-control-vaccine https://druglandscape.com/api/og?type=drug&title=single-person%20sIPV%20control%20vaccine&subtitle=single-person%20sIPV%20control%20vaccine%20%C2%B7%20Sinovac%20Biotech%20Co.%2C%20Ltd&badge=phase%203 single-person sIPV control vaccine single-person sIPV control vaccine · Sinovac Biotech Co., Ltd https://druglandscape.com/drug/single-shot-antibiotic-prophylaxis https://druglandscape.com/api/og?type=drug&title=Single%20shot%20antibiotic%20prophylaxis&subtitle=Single%20shot%20antibiotic%20prophylaxis%20%C2%B7%20Onze%20Lieve%20Vrouwe%20Gasthuis&badge=phase%202 Single shot antibiotic prophylaxis Single shot antibiotic prophylaxis · Onze Lieve Vrouwe Gasthuis https://druglandscape.com/drug/single-shot-femoral-nerve-blocks https://druglandscape.com/api/og?type=drug&title=Single%20Shot%20Femoral%20Nerve%20Blocks&subtitle=Single%20Shot%20Femoral%20Nerve%20Blocks%20%C2%B7%20Eastern%20Maine%20Medical%20Center&badge=phase%201 Single Shot Femoral Nerve Blocks Single Shot Femoral Nerve Blocks · Eastern Maine Medical Center https://druglandscape.com/drug/singulair-and-xyzal https://druglandscape.com/api/og?type=drug&title=Singulair%20and%20Xyzal&subtitle=Singulair%20and%20Xyzal%20%C2%B7%20Hanmi%20Pharmaceutical%20Company%20Limited&badge=phase%201 Singulair and Xyzal Singulair and Xyzal · Hanmi Pharmaceutical Company Limited https://druglandscape.com/drug/sinovac-pcv24 https://druglandscape.com/api/og?type=drug&title=Sinovac%20PCV24&subtitle=Sinovac%20PCV24%20%C2%B7%20Sinovac%20Life%20Sciences%20Co.%2C%20Ltd.&badge=phase%202 Sinovac PCV24 Sinovac PCV24 · Sinovac Life Sciences Co., Ltd. https://druglandscape.com/drug/sintilimab-plus-platinum-based-chemotherapy https://druglandscape.com/api/og?type=drug&title=sintilimab%20plus%20platinum-based%20chemotherapy&subtitle=sintilimab%20plus%20platinum-based%20chemotherapy%20%C2%B7%20Tang-Du%20Hospital&badge=phase%203 sintilimab plus platinum-based chemotherapy sintilimab plus platinum-based chemotherapy · Tang-Du Hospital https://druglandscape.com/drug/sinupret-forte https://druglandscape.com/api/og?type=drug&title=Sinupret%20forte&subtitle=Sinupret%20forte%20%C2%B7%20Bitop%20AG&badge=phase%202 Sinupret forte Sinupret forte · Bitop AG https://druglandscape.com/drug/sion-109 https://druglandscape.com/api/og?type=drug&title=SION-109&subtitle=SION-109%20%C2%B7%20Sionna%20Therapeutics%20Inc.&badge=phase%201 SION-109 SION-109 · Sionna Therapeutics Inc. https://druglandscape.com/drug/sion-2222 https://druglandscape.com/api/og?type=drug&title=SION-2222&subtitle=SION-2222%20%C2%B7%20Sionna%20Therapeutics%20Inc.&badge=phase%201 SION-2222 SION-2222 · Sionna Therapeutics Inc. https://druglandscape.com/drug/sion-719 https://druglandscape.com/api/og?type=drug&title=SION-719&subtitle=SION-719%20%C2%B7%20Sionna%20Therapeutics%20Inc.&badge=phase%202 SION-719 SION-719 · Sionna Therapeutics Inc. https://druglandscape.com/drug/sips-2209-2-sips-2209-3 https://druglandscape.com/api/og?type=drug&title=SIPS-2209-2%2C%20SIPS-2209-3&subtitle=SIPS-2209-2%2C%20SIPS-2209-3%20%C2%B7%20Samik%20Pharmaceutical%20Co.%20Ltd.&badge=phase%201 SIPS-2209-2, SIPS-2209-3 SIPS-2209-2, SIPS-2209-3 · Samik Pharmaceutical Co. Ltd. https://druglandscape.com/drug/sipuleucel-t-with-booster https://druglandscape.com/api/og?type=drug&title=Sipuleucel-T%20with%20Booster&subtitle=Sipuleucel-T%20with%20Booster%20%C2%B7%20Dendreon&badge=phase%202 Sipuleucel-T with Booster Sipuleucel-T with Booster · Dendreon https://druglandscape.com/drug/sipuleucel-t-without-booster https://druglandscape.com/api/og?type=drug&title=Sipuleucel-T%20without%20Booster&subtitle=Sipuleucel-T%20without%20Booster%20%C2%B7%20Dendreon&badge=phase%202 Sipuleucel-T without Booster Sipuleucel-T without Booster · Dendreon https://druglandscape.com/drug/sipv-sipv-bopv-vaccination-schedule https://druglandscape.com/api/og?type=drug&title=sIPV-sIPV-bOPV%20vaccination%20schedule&subtitle=sIPV-sIPV-bOPV%20vaccination%20schedule%20%C2%B7%20Sinovac%20Biotech%20Co.%2C%20Ltd&badge=phase%203 sIPV-sIPV-bOPV vaccination schedule sIPV-sIPV-bOPV vaccination schedule · Sinovac Biotech Co., Ltd https://druglandscape.com/drug/sir1-365 https://druglandscape.com/api/og?type=drug&title=SIR1-365&subtitle=SIR1-365%20%C2%B7%20Sironax%20USA%2C%20Inc.&badge=phase%201 SIR1-365 SIR1-365 · Sironax USA, Inc. https://druglandscape.com/drug/sirpant-m https://druglandscape.com/api/og?type=drug&title=SIRPant-M&subtitle=SIRPant-M%20%C2%B7%20SIRPant%20Immunotherapeutics%2C%20Inc.&badge=phase%201 SIRPant-M SIRPant-M · SIRPant Immunotherapeutics, Inc. https://druglandscape.com/drug/sitagliptin-mitiglinide https://druglandscape.com/api/og?type=drug&title=Sitagliptin%2C%20Mitiglinide&subtitle=Sitagliptin%2C%20Mitiglinide%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%201 Sitagliptin, Mitiglinide Sitagliptin, Mitiglinide · Samsung Medical Center https://druglandscape.com/drug/sjp-223 https://druglandscape.com/api/og?type=drug&title=SJP-223&subtitle=SJP-223%20%C2%B7%20Sen-Jam%20Pharmaceutical&badge=phase%202 SJP-223 SJP-223 · Sen-Jam Pharmaceutical https://druglandscape.com/drug/sjp-304 https://druglandscape.com/api/og?type=drug&title=SJP-304&subtitle=SJP-304%20%C2%B7%20Sen-Jam%20Pharmaceutical&badge=phase%202 SJP-304 SJP-304 · Sen-Jam Pharmaceutical https://druglandscape.com/drug/sjp002 https://druglandscape.com/api/og?type=drug&title=SJP002&subtitle=SJP002%20%C2%B7%20Samjin%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SJP002 SJP002 · Samjin Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sjp002-qid https://druglandscape.com/api/og?type=drug&title=SJP002%20QID&subtitle=SJP002%20QID%20%C2%B7%20Samjin%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 SJP002 QID SJP002 QID · Samjin Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sk-08 https://druglandscape.com/api/og?type=drug&title=SK-08&subtitle=SK-08%20%C2%B7%20Consun%20Pharmaceutical%20Group&badge=phase%201 SK-08 SK-08 · Consun Pharmaceutical Group https://druglandscape.com/drug/sk-09 https://druglandscape.com/api/og?type=drug&title=SK-09&subtitle=SK-09%20%C2%B7%20Consun%20Pharmaceutical%20Group&badge=phase%201 SK-09 SK-09 · Consun Pharmaceutical Group https://druglandscape.com/drug/sk-1404 https://druglandscape.com/api/og?type=drug&title=SK-1404&subtitle=SK-1404%20%C2%B7%20Sanwa%20Kagaku%20Kenkyusho%20Co.%2C%20Ltd.&badge=phase%202 SK-1404 SK-1404 · Sanwa Kagaku Kenkyusho Co., Ltd. https://druglandscape.com/drug/sk-1405-high-dose https://druglandscape.com/api/og?type=drug&title=SK-1405%20high%20dose&subtitle=SK-1405%20high%20dose%20%C2%B7%20Sanwa%20Kagaku%20Kenkyusho%20Co.%2C%20Ltd.&badge=phase%202 SK-1405 high dose SK-1405 high dose · Sanwa Kagaku Kenkyusho Co., Ltd. https://druglandscape.com/drug/sk-1405-low-dose https://druglandscape.com/api/og?type=drug&title=SK-1405%20low%20dose&subtitle=SK-1405%20low%20dose%20%C2%B7%20Sanwa%20Kagaku%20Kenkyusho%20Co.%2C%20Ltd.&badge=phase%202 SK-1405 low dose SK-1405 low dose · Sanwa Kagaku Kenkyusho Co., Ltd. https://druglandscape.com/drug/sk-antithrombin-iii https://druglandscape.com/api/og?type=drug&title=SK%20Antithrombin%20III&subtitle=SK%20Antithrombin%20III%20%C2%B7%20SK%20Chemicals%20Co.%2C%20Ltd.&badge=phase%201 SK Antithrombin III SK Antithrombin III · SK Chemicals Co., Ltd. https://druglandscape.com/drug/sk10 https://druglandscape.com/api/og?type=drug&title=SK10&subtitle=SK10%20%C2%B7%20Guangzhou%20Zhiyi%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 SK10 SK10 · Guangzhou Zhiyi Biotechnology Co., Ltd. https://druglandscape.com/drug/skb103-for-injection-monotherapy https://druglandscape.com/api/og?type=drug&title=SKB103%20for%20injection%20monotherapy&subtitle=SKB103%20for%20injection%20monotherapy%20%C2%B7%20Sichuan%20Kelun-Biotech%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SKB103 for injection monotherapy SKB103 for injection monotherapy · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/skb105-for-injection-monotherapy https://druglandscape.com/api/og?type=drug&title=SKB105%20for%20injection%20Monotherapy&subtitle=SKB105%20for%20injection%20Monotherapy%20%C2%B7%20Sichuan%20Kelun-Biotech%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SKB105 for injection Monotherapy SKB105 for injection Monotherapy · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/skb518 https://druglandscape.com/api/og?type=drug&title=SKB518&subtitle=SKB518%20%C2%B7%20Sichuan%20Kelun-Biotech%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 SKB518 SKB518 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/skb571 https://druglandscape.com/api/og?type=drug&title=SKB571&subtitle=SKB571%20%C2%B7%20Sichuan%20Kelun-Biotech%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SKB571 SKB571 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/ski-606 https://druglandscape.com/api/og?type=drug&title=SKI-606&subtitle=SKI-606%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 SKI-606 SKI-606 · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/ski-g-801 https://druglandscape.com/api/og?type=drug&title=SKI-G-801&subtitle=SKI-G-801%20%C2%B7%20Oscotec%20Inc.&badge=phase%201 SKI-G-801 SKI-G-801 · Oscotec Inc. https://druglandscape.com/drug/ski-o-703 https://druglandscape.com/api/og?type=drug&title=SKI-O-703&subtitle=SKI-O-703%20%C2%B7%20Oscotec%20Inc.&badge=phase%202 SKI-O-703 SKI-O-703 · Oscotec Inc. https://druglandscape.com/drug/ski2670 https://druglandscape.com/api/og?type=drug&title=SKI2670&subtitle=SKI2670%20%C2%B7%20SK%20Chemicals%20Co.%2C%20Ltd.&badge=phase%201 SKI2670 SKI2670 · SK Chemicals Co., Ltd. https://druglandscape.com/drug/ski3246-low-dose https://druglandscape.com/api/og?type=drug&title=SKI3246%20Low%20Dose&subtitle=SKI3246%20Low%20Dose%20%C2%B7%20SK%20Chemicals%20Co.%2C%20Ltd.&badge=phase%202 SKI3246 Low Dose SKI3246 Low Dose · SK Chemicals Co., Ltd. https://druglandscape.com/drug/skin-auto-fluorescence https://druglandscape.com/api/og?type=drug&title=Skin%20auto-fluorescence&subtitle=Skin%20auto-fluorescence%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 Skin auto-fluorescence Skin auto-fluorescence · Hospices Civils de Lyon https://druglandscape.com/drug/skin-autograft https://druglandscape.com/api/og?type=drug&title=Skin%20Autograft&subtitle=Skin%20Autograft%20%C2%B7%20Andalusian%20Network%20for%20Design%20and%20Translation%20of%20Advanced%20Therapies&badge=phase%202 Skin Autograft Skin Autograft · Andalusian Network for Design and Translation of Advanced Therapies https://druglandscape.com/drug/skin-cell-dip https://druglandscape.com/api/og?type=drug&title=Skin%20Cell%20Dip&subtitle=Skin%20Cell%20Dip%20%C2%B7%20Truway%20Health%2C%20Inc.&badge=phase%202 Skin Cell Dip Skin Cell Dip · Truway Health, Inc. https://druglandscape.com/drug/skin-prick-test https://druglandscape.com/api/og?type=drug&title=Skin%20Prick%20Test&subtitle=Skin%20Prick%20Test%20%C2%B7%20Roxall%20Medicina%20Espa%C3%B1a%20S.A&badge=phase%201 Skin Prick Test Skin Prick Test · Roxall Medicina España S.A https://druglandscape.com/drug/skin-prick-test-allergic-subjects https://druglandscape.com/api/og?type=drug&title=Skin%20Prick%20Test%20-%20Allergic%20subjects&subtitle=Skin%20Prick%20Test%20-%20Allergic%20subjects%20%C2%B7%20Roxall%20Medicina%20Espa%C3%B1a%20S.A&badge=phase%202 Skin Prick Test - Allergic subjects Skin Prick Test - Allergic subjects · Roxall Medicina España S.A https://druglandscape.com/drug/skin-prick-test-atopic-subjects https://druglandscape.com/api/og?type=drug&title=Skin%20Prick%20Test%20-%20Atopic%20Subjects&subtitle=Skin%20Prick%20Test%20-%20Atopic%20Subjects%20%C2%B7%20Roxall%20Medicina%20Espa%C3%B1a%20S.A&badge=phase%202 Skin Prick Test - Atopic Subjects Skin Prick Test - Atopic Subjects · Roxall Medicina España S.A https://druglandscape.com/drug/skin-prick-test-no-atopic-subjects https://druglandscape.com/api/og?type=drug&title=Skin%20Prick%20Test%20-%20No%20Atopic%20Subjects&subtitle=Skin%20Prick%20Test%20-%20No%20Atopic%20Subjects%20%C2%B7%20Roxall%20Medicina%20Espa%C3%B1a%20S.A&badge=phase%201 Skin Prick Test - No Atopic Subjects Skin Prick Test - No Atopic Subjects · Roxall Medicina España S.A https://druglandscape.com/drug/skin-prick-test-non-atopic-subjects https://druglandscape.com/api/og?type=drug&title=Skin%20Prick%20Test%20-%20Non%20Atopic%20subjects&subtitle=Skin%20Prick%20Test%20-%20Non%20Atopic%20subjects%20%C2%B7%20Roxall%20Medicina%20Espa%C3%B1a%20S.A&badge=phase%202 Skin Prick Test - Non Atopic subjects Skin Prick Test - Non Atopic subjects · Roxall Medicina España S.A https://druglandscape.com/drug/skin-test-panel https://druglandscape.com/api/og?type=drug&title=Skin%20test%20panel&subtitle=Skin%20test%20panel%20%C2%B7%20EVE%20Medical%20Systems%20Ltd.&badge=phase%202 Skin test panel Skin test panel · EVE Medical Systems Ltd. https://druglandscape.com/drug/skin-test-panel-and-solvent https://druglandscape.com/api/og?type=drug&title=Skin%20test%20panel%20and%20solvent&subtitle=Skin%20test%20panel%20and%20solvent%20%C2%B7%20EVE%20Medical%20Systems%20Ltd.&badge=phase%202 Skin test panel and solvent Skin test panel and solvent · EVE Medical Systems Ltd. https://druglandscape.com/drug/skl11197 https://druglandscape.com/api/og?type=drug&title=SKL11197&subtitle=SKL11197%20%C2%B7%20SK%20Life%20Science%2C%20Inc.&badge=phase%202 SKL11197 SKL11197 · SK Life Science, Inc. https://druglandscape.com/drug/skl15508 https://druglandscape.com/api/og?type=drug&title=SKL15508&subtitle=SKL15508%20%C2%B7%20SK%20Life%20Science%2C%20Inc.&badge=phase%201 SKL15508 SKL15508 · SK Life Science, Inc. https://druglandscape.com/drug/skl24741 https://druglandscape.com/api/og?type=drug&title=SKL24741&subtitle=SKL24741%20%C2%B7%20SK%20Life%20Science%2C%20Inc.&badge=phase%201 SKL24741 SKL24741 · SK Life Science, Inc. https://druglandscape.com/drug/sklb1028-dose-escalation https://druglandscape.com/api/og?type=drug&title=SKLB1028%20Dose%20Escalation&subtitle=SKLB1028%20Dose%20Escalation%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 SKLB1028 Dose Escalation SKLB1028 Dose Escalation · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/sky-0515 https://druglandscape.com/api/og?type=drug&title=SKY-0515&subtitle=SKY-0515%20%C2%B7%20Skyhawk%20Therapeutics%2C%20Inc.&badge=phase%202 SKY-0515 SKY-0515 · Skyhawk Therapeutics, Inc. https://druglandscape.com/drug/sl-28 https://druglandscape.com/api/og?type=drug&title=SL-28.&subtitle=SL-28.%20%C2%B7%20Second%20Life%20Therapeutics&badge=phase%202 SL-28. SL-28. · Second Life Therapeutics https://druglandscape.com/drug/sl-325 https://druglandscape.com/api/og?type=drug&title=SL-325&subtitle=SL-325%20%C2%B7%20Shattuck%20Labs%2C%20Inc.&badge=phase%201 SL-325 SL-325 · Shattuck Labs, Inc. https://druglandscape.com/drug/sl-801 https://druglandscape.com/api/og?type=drug&title=SL-801&subtitle=SL-801%20%C2%B7%20Stemline%20Therapeutics%2C%20Inc.&badge=phase%201 SL-801 SL-801 · Stemline Therapeutics, Inc. https://druglandscape.com/drug/sl-apo https://druglandscape.com/api/og?type=drug&title=SL-APO&subtitle=SL-APO%20%C2%B7%20Bial%20-%20Portela%20C%20S.A.&badge=phase%202 SL-APO SL-APO · Bial - Portela C S.A. https://druglandscape.com/drug/sl-bup https://druglandscape.com/api/og?type=drug&title=SL-BUP&subtitle=SL-BUP%20%C2%B7%20NYU%20Langone%20Health&badge=phase%202 SL-BUP SL-BUP · NYU Langone Health https://druglandscape.com/drug/sl-film https://druglandscape.com/api/og?type=drug&title=SL%20film&subtitle=SL%20film%20%C2%B7%20INSYS%20Therapeutics%20Inc&badge=phase%201 SL film SL film · INSYS Therapeutics Inc https://druglandscape.com/drug/sl-t10 https://druglandscape.com/api/og?type=drug&title=SL-T10&subtitle=SL-T10%20%C2%B7%20SL%20VAXiGEN&badge=phase%201 SL-T10 SL-T10 · SL VAXiGEN https://druglandscape.com/drug/slc-3010 https://druglandscape.com/api/og?type=drug&title=SLC-3010&subtitle=SLC-3010%20%C2%B7%20Selecxine&badge=phase%201 SLC-3010 SLC-3010 · Selecxine https://druglandscape.com/drug/sleep-parameters https://druglandscape.com/api/og?type=drug&title=sleep%20parameters&subtitle=sleep%20parameters%20%C2%B7%20Monica%20Levy%20Andersen&badge=phase%201 sleep parameters sleep parameters · Monica Levy Andersen https://druglandscape.com/drug/sli-f06 https://druglandscape.com/api/og?type=drug&title=SLI-F06&subtitle=SLI-F06%20%C2%B7%20Scarless%20Laboratories%2C%20Inc.&badge=phase%202 SLI-F06 SLI-F06 · Scarless Laboratories, Inc. https://druglandscape.com/drug/sln12140 https://druglandscape.com/api/og?type=drug&title=SLN12140&subtitle=SLN12140%20%C2%B7%20Linno%20Pharmaceuticals%2C%20Inc.&badge=phase%202 SLN12140 SLN12140 · Linno Pharmaceuticals, Inc. https://druglandscape.com/drug/sln124 https://druglandscape.com/api/og?type=drug&title=SLN124&subtitle=SLN124%20%C2%B7%20Silence%20Therapeutics%20plc&badge=phase%201 SLN124 SLN124 · Silence Therapeutics plc https://druglandscape.com/drug/sln360 https://druglandscape.com/api/og?type=drug&title=SLN360&subtitle=SLN360%20%C2%B7%20Silence%20Therapeutics%20plc&badge=phase%202 SLN360 SLN360 · Silence Therapeutics plc https://druglandscape.com/drug/slog-chemotherapy https://druglandscape.com/api/og?type=drug&title=SLOG%20chemotherapy&subtitle=SLOG%20chemotherapy%20%C2%B7%20Medigen%20Biotechnology%20Corporation&badge=phase%201 SLOG chemotherapy SLOG chemotherapy · Medigen Biotechnology Corporation https://druglandscape.com/drug/sls-002 https://druglandscape.com/api/og?type=drug&title=SLS-002&subtitle=SLS-002%20%C2%B7%20Seelos%20Therapeutics%2C%20Inc.&badge=phase%202 SLS-002 SLS-002 · Seelos Therapeutics, Inc. https://druglandscape.com/drug/sls-005-trehalose https://druglandscape.com/api/og?type=drug&title=SLS-005%20Trehalose&subtitle=SLS-005%20Trehalose%20%C2%B7%20Merit%20E.%20Cudkowicz%2C%20MD&badge=phase%202 SLS-005 Trehalose SLS-005 Trehalose · Merit E. Cudkowicz, MD https://druglandscape.com/drug/sls009 https://druglandscape.com/api/og?type=drug&title=SLS009&subtitle=SLS009%20%C2%B7%20Sellas%20Life%20Sciences%20Group&badge=phase%201 SLS009 SLS009 · Sellas Life Sciences Group https://druglandscape.com/drug/slv354 https://druglandscape.com/api/og?type=drug&title=SLV354&subtitle=SLV354%20%C2%B7%20Abbott&badge=phase%201 SLV354 SLV354 · Abbott https://druglandscape.com/drug/sm-020 https://druglandscape.com/api/og?type=drug&title=SM-020&subtitle=SM-020%20%C2%B7%20DermBiont%2C%20Inc.&badge=phase%202 SM-020 SM-020 · DermBiont, Inc. https://druglandscape.com/drug/sm-020-1-gel https://druglandscape.com/api/og?type=drug&title=SM-020%201%25%20Gel&subtitle=SM-020%201%25%20Gel%20%C2%B7%20DermBiont%2C%20Inc.&badge=phase%202 SM-020 1% Gel SM-020 1% Gel · DermBiont, Inc. https://druglandscape.com/drug/sm-030-gel-0-08 https://druglandscape.com/api/og?type=drug&title=SM-030%20gel%200.08%25&subtitle=SM-030%20gel%200.08%25%20%C2%B7%20DermBiont%2C%20Inc.&badge=phase%202 SM-030 gel 0.08% SM-030 gel 0.08% · DermBiont, Inc. https://druglandscape.com/drug/sm04554 https://druglandscape.com/api/og?type=drug&title=SM04554&subtitle=SM04554%20%C2%B7%20Biosplice%20Therapeutics%2C%20Inc.&badge=phase%202 SM04554 SM04554 · Biosplice Therapeutics, Inc. https://druglandscape.com/drug/sm17 https://druglandscape.com/api/og?type=drug&title=SM17&subtitle=SM17%20%C2%B7%20SinoMab%20BioScience%20Ltd&badge=phase%201 SM17 SM17 · SinoMab BioScience Ltd https://druglandscape.com/drug/sm3321 https://druglandscape.com/api/og?type=drug&title=SM3321&subtitle=SM3321%20%C2%B7%20Beijing%20StarMab%20Biomed%20Technology%20Ltd&badge=phase%201 SM3321 SM3321 · Beijing StarMab Biomed Technology Ltd https://druglandscape.com/drug/smoking-of-cannabis https://druglandscape.com/api/og?type=drug&title=smoking%20of%20cannabis&subtitle=smoking%20of%20cannabis%20%C2%B7%20Meir%20Medical%20Center&badge=phase%201 smoking of cannabis smoking of cannabis · Meir Medical Center https://druglandscape.com/drug/smp-100 https://druglandscape.com/api/og?type=drug&title=SMP-100&subtitle=SMP-100%20%C2%B7%20Chengdu%20SciMount%20Pharmatech%20Co.%2C%20Ltd.&badge=phase%201 SMP-100 SMP-100 · Chengdu SciMount Pharmatech Co., Ltd. https://druglandscape.com/drug/smp-986 https://druglandscape.com/api/og?type=drug&title=SMP-986&subtitle=SMP-986%20%C2%B7%20Sumitomo%20Pharma%20America%2C%20Inc.&badge=phase%202 SMP-986 SMP-986 · Sumitomo Pharma America, Inc. https://druglandscape.com/drug/smp3124lp https://druglandscape.com/api/og?type=drug&title=SMP3124LP&subtitle=SMP3124LP%20%C2%B7%20Sumitomo%20Pharma%20America%2C%20Inc.&badge=phase%201 SMP3124LP SMP3124LP · Sumitomo Pharma America, Inc. https://druglandscape.com/drug/sms001 https://druglandscape.com/api/og?type=drug&title=SMS001&subtitle=SMS001%20%C2%B7%20ToLymph%20Inc.&badge=phase%202 SMS001 SMS001 · ToLymph Inc. https://druglandscape.com/drug/sn-38-liposome https://druglandscape.com/api/og?type=drug&title=SN-38%20liposome&subtitle=SN-38%20liposome%20%C2%B7%20Alliance%20for%20Clinical%20Trials%20in%20Oncology&badge=phase%202 SN-38 liposome SN-38 liposome · Alliance for Clinical Trials in Oncology https://druglandscape.com/drug/sn132d https://druglandscape.com/api/og?type=drug&title=SN132D&subtitle=SN132D%20%C2%B7%20Spago%20Nanomedical%20AB&badge=phase%202 SN132D SN132D · Spago Nanomedical AB https://druglandscape.com/drug/sn2001 https://druglandscape.com/api/og?type=drug&title=SN2001&subtitle=SN2001%20%C2%B7%20Chimivac%20INC&badge=phase%201 SN2001 SN2001 · Chimivac INC https://druglandscape.com/drug/sn2310-injectable-emulsion https://druglandscape.com/api/og?type=drug&title=SN2310%20Injectable%20Emulsion&subtitle=SN2310%20Injectable%20Emulsion%20%C2%B7%20Achieve%20Life%20Sciences&badge=phase%201 SN2310 Injectable Emulsion SN2310 Injectable Emulsion · Achieve Life Sciences https://druglandscape.com/drug/sna02-48 https://druglandscape.com/api/og?type=drug&title=SNA02-48&subtitle=SNA02-48%20%C2%B7%20Sinovac%20Life%20Sciences%20Co.%2C%20Ltd.&badge=phase%201 SNA02-48 SNA02-48 · Sinovac Life Sciences Co., Ltd. https://druglandscape.com/drug/snb-101 https://druglandscape.com/api/og?type=drug&title=SNB-101&subtitle=SNB-101%20%C2%B7%20SN%20BioScience&badge=phase%201 SNB-101 SNB-101 · SN BioScience https://druglandscape.com/drug/snc-109-car-t-cells https://druglandscape.com/api/og?type=drug&title=SNC-109%20CAR-T%20Cells&subtitle=SNC-109%20CAR-T%20Cells%20%C2%B7%20Shanghai%20Simnova%20Biotechnology%20Co.%2CLtd.&badge=phase%201 SNC-109 CAR-T Cells SNC-109 CAR-T Cells · Shanghai Simnova Biotechnology Co.,Ltd. https://druglandscape.com/drug/snc109 https://druglandscape.com/api/og?type=drug&title=SNC109&subtitle=SNC109%20%C2%B7%20Shanghai%20Simnova%20Biotechnology%20Co.%2CLtd.&badge=phase%201 SNC109 SNC109 · Shanghai Simnova Biotechnology Co.,Ltd. https://druglandscape.com/drug/sne-101 https://druglandscape.com/api/og?type=drug&title=SNE-101&subtitle=SNE-101%20%C2%B7%20S%26Ebio%20Co.%20Ltd.&badge=phase%201 SNE-101 SNE-101 · S&Ebio Co. Ltd. https://druglandscape.com/drug/snf472 https://druglandscape.com/api/og?type=drug&title=SNF472&subtitle=SNF472%20%C2%B7%20Sanifit%20Therapeutics%20S.%20A.&badge=phase%202 SNF472 SNF472 · Sanifit Therapeutics S. A. https://druglandscape.com/drug/sng100 https://druglandscape.com/api/og?type=drug&title=SNG100&subtitle=SNG100%20%C2%B7%20Seanergy%20Dermatology%20Ltd.&badge=phase%201 SNG100 SNG100 · Seanergy Dermatology Ltd. https://druglandscape.com/drug/snh-119014 https://druglandscape.com/api/og?type=drug&title=SNH-119014&subtitle=SNH-119014%20%C2%B7%20ScinnoHub%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SNH-119014 SNH-119014 · ScinnoHub Pharmaceutical Co., Ltd. https://druglandscape.com/drug/snk01 https://druglandscape.com/api/og?type=drug&title=SNK01&subtitle=SNK01%20%C2%B7%20NKGen%20Biotech%2C%20Inc.&badge=phase%202 SNK01 SNK01 · NKGen Biotech, Inc. https://druglandscape.com/drug/snk02 https://druglandscape.com/api/og?type=drug&title=SNK02&subtitle=SNK02%20%C2%B7%20NKGen%20Biotech%2C%20Inc.&badge=phase%201 SNK02 SNK02 · NKGen Biotech, Inc. https://druglandscape.com/drug/snp-610 https://druglandscape.com/api/og?type=drug&title=SNP-610&subtitle=SNP-610%20%C2%B7%20Sinew%20Pharma%20Inc.&badge=phase%202 SNP-610 SNP-610 · Sinew Pharma Inc. https://druglandscape.com/drug/snp318 https://druglandscape.com/api/og?type=drug&title=SNP318&subtitle=SNP318%20%C2%B7%20SciNeuro&badge=phase%202 SNP318 SNP318 · SciNeuro https://druglandscape.com/drug/sns01-t https://druglandscape.com/api/og?type=drug&title=SNS01-T&subtitle=SNS01-T%20%C2%B7%20Senesco%20Technologies%2C%20Inc.&badge=phase%201 SNS01-T SNS01-T · Senesco Technologies, Inc. https://druglandscape.com/drug/sns851 https://druglandscape.com/api/og?type=drug&title=SNS851&subtitle=SNS851%20%C2%B7%20Oneness%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 SNS851 SNS851 · Oneness Biotech Co., Ltd. https://druglandscape.com/drug/snx-001 https://druglandscape.com/api/og?type=drug&title=SNX-001&subtitle=SNX-001%20%C2%B7%20SeneXta%20Therapeutics%20SA&badge=phase%201 SNX-001 SNX-001 · SeneXta Therapeutics SA https://druglandscape.com/drug/snx-5422-mesylate-hsp90-inhibitor https://druglandscape.com/api/og?type=drug&title=SNX-5422%20Mesylate%20Hsp90%20inhibitor&subtitle=SNX-5422%20Mesylate%20Hsp90%20inhibitor%20%C2%B7%20Esanex%20Inc.&badge=phase%201 SNX-5422 Mesylate Hsp90 inhibitor SNX-5422 Mesylate Hsp90 inhibitor · Esanex Inc. https://druglandscape.com/drug/sob100 https://druglandscape.com/api/og?type=drug&title=SOB100&subtitle=SOB100%20%C2%B7%20Shine-On%20Biomedical%20Co.%2C%20Ltd.&badge=phase%201 SOB100 SOB100 · Shine-On Biomedical Co., Ltd. https://druglandscape.com/drug/soc-agent https://druglandscape.com/api/og?type=drug&title=SOC%20Agent&subtitle=SOC%20Agent%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 SOC Agent SOC Agent · Hoffmann-La Roche https://druglandscape.com/drug/soc-antibiotics https://druglandscape.com/api/og?type=drug&title=SOC%20Antibiotics&subtitle=SOC%20Antibiotics%20%C2%B7%20Osteal%20Therapeutics%2C%20Inc.&badge=phase%202 SOC Antibiotics SOC Antibiotics · Osteal Therapeutics, Inc. https://druglandscape.com/drug/soc-chemotherapies https://druglandscape.com/api/og?type=drug&title=SOC%20chemotherapies&subtitle=SOC%20chemotherapies%20%C2%B7%20iTeos%20Belgium%20SA&badge=phase%201 SOC chemotherapies SOC chemotherapies · iTeos Belgium SA https://druglandscape.com/drug/soc-chemotherapy-treatment-2 https://druglandscape.com/api/og?type=drug&title=SoC%20chemotherapy%20treatment%202&subtitle=SoC%20chemotherapy%20treatment%202%20%C2%B7%20BioNTech%20SE&badge=phase%201 SoC chemotherapy treatment 2 SoC chemotherapy treatment 2 · BioNTech SE https://druglandscape.com/drug/soc-insti-based-art https://druglandscape.com/api/og?type=drug&title=SOC%20INSTI-based%20ART&subtitle=SOC%20INSTI-based%20ART%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 SOC INSTI-based ART SOC INSTI-based ART · ViiV Healthcare https://druglandscape.com/drug/soc-temozolomide https://druglandscape.com/api/og?type=drug&title=SOC%3A%20Temozolomide&subtitle=SOC%3A%20Temozolomide%20%C2%B7%20Imvax&badge=phase%202 SOC: Temozolomide SOC: Temozolomide · Imvax https://druglandscape.com/drug/sodium-acetate-c11-pet-mri https://druglandscape.com/api/og?type=drug&title=Sodium%20Acetate%20C11%20PET%20MRI&subtitle=Sodium%20Acetate%20C11%20PET%20MRI%20%C2%B7%20Michael%20C%20Roarke%2C%20MD&badge=phase%202 Sodium Acetate C11 PET MRI Sodium Acetate C11 PET MRI · Michael C Roarke, MD https://druglandscape.com/drug/sodium-bicarbonate-and-sodium-fluoride https://druglandscape.com/api/og?type=drug&title=Sodium%20bicarbonate%20and%20sodium%20fluoride&subtitle=Sodium%20bicarbonate%20and%20sodium%20fluoride%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Sodium bicarbonate and sodium fluoride Sodium bicarbonate and sodium fluoride · GlaxoSmithKline https://druglandscape.com/drug/sodium-borocaptate https://druglandscape.com/api/og?type=drug&title=sodium%20borocaptate&subtitle=sodium%20borocaptate%20%C2%B7%20European%20Organisation%20for%20Research%20and%20Treatment%20of%20Cancer%20-%20EORTC&badge=phase%201 sodium borocaptate sodium borocaptate · European Organisation for Research and Treatment of Cancer - EORTC https://druglandscape.com/drug/sodium-chloride-0-9-inj-post-exposure https://druglandscape.com/api/og?type=drug&title=Sodium%20Chloride%200.9%25%20Inj%20post-exposure&subtitle=Sodium%20Chloride%200.9%25%20Inj%20post-exposure%20%C2%B7%20BioAegis%20Therapeutics%20Inc.&badge=phase%202 Sodium Chloride 0.9% Inj post-exposure Sodium Chloride 0.9% Inj post-exposure · BioAegis Therapeutics Inc. https://druglandscape.com/drug/sodium-chloride-0-9-inj-pre-exposure https://druglandscape.com/api/og?type=drug&title=Sodium%20Chloride%200.9%25%20Inj%20pre-exposure&subtitle=Sodium%20Chloride%200.9%25%20Inj%20pre-exposure%20%C2%B7%20BioAegis%20Therapeutics%20Inc.&badge=phase%202 Sodium Chloride 0.9% Inj pre-exposure Sodium Chloride 0.9% Inj pre-exposure · BioAegis Therapeutics Inc. https://druglandscape.com/drug/sodium-chloride-aguettant-0-9 https://druglandscape.com/api/og?type=drug&title=sodium%20chloride%20AGUETTANT%200.9%25&subtitle=sodium%20chloride%20AGUETTANT%200.9%25%20%C2%B7%20Association%20Athletes%20For%20Transparency&badge=phase%201 sodium chloride AGUETTANT 0.9% sodium chloride AGUETTANT 0.9% · Association Athletes For Transparency https://druglandscape.com/drug/sodium-copper-chlorophyllin https://druglandscape.com/api/og?type=drug&title=Sodium%20Copper%20Chlorophyllin&subtitle=Sodium%20Copper%20Chlorophyllin%20%C2%B7%20Tata%20Memorial%20Centre&badge=phase%202 Sodium Copper Chlorophyllin Sodium Copper Chlorophyllin · Tata Memorial Centre https://druglandscape.com/drug/sodium-fluoride-with-cpp-acp https://druglandscape.com/api/og?type=drug&title=Sodium%20Fluoride%20with%20CPP-ACP&subtitle=Sodium%20Fluoride%20with%20CPP-ACP%20%C2%B7%20Merve%20Erkmen%20Almaz&badge=phase%202 Sodium Fluoride with CPP-ACP Sodium Fluoride with CPP-ACP · Merve Erkmen Almaz https://druglandscape.com/drug/sodium-fluoride-with-cxp https://druglandscape.com/api/og?type=drug&title=Sodium%20Fluoride%20with%20CXP&subtitle=Sodium%20Fluoride%20with%20CXP%20%C2%B7%20Merve%20Erkmen%20Almaz&badge=phase%201 Sodium Fluoride with CXP Sodium Fluoride with CXP · Merve Erkmen Almaz https://druglandscape.com/drug/sodium-fluoride-with-tcp https://druglandscape.com/api/og?type=drug&title=Sodium%20Fluoride%20with%20TCP&subtitle=Sodium%20Fluoride%20with%20TCP%20%C2%B7%20Merve%20Erkmen%20Almaz&badge=phase%201 Sodium Fluoride with TCP Sodium Fluoride with TCP · Merve Erkmen Almaz https://druglandscape.com/drug/sodium-hypochlorite-5-irrigation https://druglandscape.com/api/og?type=drug&title=Sodium%20Hypochlorite%205%25%20Irrigation&subtitle=Sodium%20Hypochlorite%205%25%20Irrigation%20%C2%B7%20KEZBAN%20MELTEM%20%C3%87OLAK&badge=phase%201 Sodium Hypochlorite 5% Irrigation Sodium Hypochlorite 5% Irrigation · KEZBAN MELTEM ÇOLAK https://druglandscape.com/drug/sodium-laural-sulfate https://druglandscape.com/api/og?type=drug&title=Sodium%20Laural%20Sulfate&subtitle=Sodium%20Laural%20Sulfate%20%C2%B7%20Stiefel%2C%20a%20GSK%20Company&badge=phase%201 Sodium Laural Sulfate Sodium Laural Sulfate · Stiefel, a GSK Company https://druglandscape.com/drug/sodium-lauryl-sulfate-0-1 https://druglandscape.com/api/og?type=drug&title=Sodium%20lauryl%20sulfate%200.1%25&subtitle=Sodium%20lauryl%20sulfate%200.1%25%20%C2%B7%20Pfizer&badge=phase%201 Sodium lauryl sulfate 0.1% Sodium lauryl sulfate 0.1% · Pfizer https://druglandscape.com/drug/sodium-nitrite-inhalation-solution https://druglandscape.com/api/og?type=drug&title=Sodium%20Nitrite%20Inhalation%20Solution&subtitle=Sodium%20Nitrite%20Inhalation%20Solution%20%C2%B7%20Aires%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Sodium Nitrite Inhalation Solution Sodium Nitrite Inhalation Solution · Aires Pharmaceuticals, Inc. https://druglandscape.com/drug/sodium-polysulthionate https://druglandscape.com/api/og?type=drug&title=sodium%20polysulthionate&subtitle=sodium%20polysulthionate%20%C2%B7%20Sulfagenix%20Australia%20Pty%20Ltd.&badge=phase%201 sodium polysulthionate sodium polysulthionate · Sulfagenix Australia Pty Ltd. https://druglandscape.com/drug/sodium-pyruvate-nasal-spray https://druglandscape.com/api/og?type=drug&title=sodium%20pyruvate%20nasal%20spray&subtitle=sodium%20pyruvate%20nasal%20spray%20%C2%B7%20Cellular%20Sciences%2C%20inc.&badge=phase%202 sodium pyruvate nasal spray sodium pyruvate nasal spray · Cellular Sciences, inc. https://druglandscape.com/drug/sodium-st20 https://druglandscape.com/api/og?type=drug&title=Sodium%20ST20&subtitle=Sodium%20ST20%20%C2%B7%20HemaQuest%20Pharmaceuticals%20Inc.&badge=phase%201 Sodium ST20 Sodium ST20 · HemaQuest Pharmaceuticals Inc. https://druglandscape.com/drug/sodium-valporate https://druglandscape.com/api/og?type=drug&title=Sodium%20valporate&subtitle=Sodium%20valporate%20%C2%B7%20Sanofi&badge=phase%202 Sodium valporate Sodium valporate · Sanofi https://druglandscape.com/drug/sodium-valproate-bezafibrate-medroxyprogesterone https://druglandscape.com/api/og?type=drug&title=Sodium%20Valproate%2C%20Bezafibrate%2C%20Medroxyprogesterone&subtitle=Sodium%20Valproate%2C%20Bezafibrate%2C%20Medroxyprogesterone%20%C2%B7%20Prof.%20Janet%20Dunn&badge=phase%202 Sodium Valproate, Bezafibrate, Medroxyprogesterone Sodium Valproate, Bezafibrate, Medroxyprogesterone · Prof. Janet Dunn https://druglandscape.com/drug/sofosbuvir-tablet https://druglandscape.com/api/og?type=drug&title=Sofosbuvir%20Tablet&subtitle=Sofosbuvir%20Tablet%20%C2%B7%20Sunshine%20Lake%20Pharma%20Co.%2C%20Ltd.&badge=phase%202 Sofosbuvir Tablet Sofosbuvir Tablet · Sunshine Lake Pharma Co., Ltd. https://druglandscape.com/drug/sol-116 https://druglandscape.com/api/og?type=drug&title=SOL-116&subtitle=SOL-116%20%C2%B7%20Lipum%20AB&badge=phase%201 SOL-116 SOL-116 · Lipum AB https://druglandscape.com/drug/solid-tumor-and-ct-dna https://druglandscape.com/api/og?type=drug&title=Solid%20tumor%20and%20CT%20DNA&subtitle=Solid%20tumor%20and%20CT%20DNA%20%C2%B7%20Gustave%20Roussy%2C%20Cancer%20Campus%2C%20Grand%20Paris&badge=phase%201 Solid tumor and CT DNA Solid tumor and CT DNA · Gustave Roussy, Cancer Campus, Grand Paris https://druglandscape.com/drug/solifenacin-succinate-formulation-b https://druglandscape.com/api/og?type=drug&title=Solifenacin%20Succinate%20Formulation%20B&subtitle=Solifenacin%20Succinate%20Formulation%20B%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%201 Solifenacin Succinate Formulation B Solifenacin Succinate Formulation B · Astellas Pharma Inc https://druglandscape.com/drug/solo-1-group https://druglandscape.com/api/og?type=drug&title=Solo%201%20group&subtitle=Solo%201%20group%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Solo 1 group Solo 1 group · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/solo-3-group https://druglandscape.com/api/og?type=drug&title=Solo%203%20group&subtitle=Solo%203%20group%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%201 Solo 3 group Solo 3 group · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/solrikitug-high-dose https://druglandscape.com/api/og?type=drug&title=Solrikitug%20High%20Dose&subtitle=Solrikitug%20High%20Dose%20%C2%B7%20Uniquity%20One%20(UNI)&badge=phase%202 Solrikitug High Dose Solrikitug High Dose · Uniquity One (UNI) https://druglandscape.com/drug/solrikitug-low-dose https://druglandscape.com/api/og?type=drug&title=Solrikitug%20Low%20Dose&subtitle=Solrikitug%20Low%20Dose%20%C2%B7%20Uniquity%20One%20(UNI)&badge=phase%202 Solrikitug Low Dose Solrikitug Low Dose · Uniquity One (UNI) https://druglandscape.com/drug/solrikitug-mid-dose https://druglandscape.com/api/og?type=drug&title=Solrikitug%20Mid%20Dose&subtitle=Solrikitug%20Mid%20Dose%20%C2%B7%20Uniquity%20One%20(UNI)&badge=phase%202 Solrikitug Mid Dose Solrikitug Mid Dose · Uniquity One (UNI) https://druglandscape.com/drug/soluble-ferric-pyrophosphate https://druglandscape.com/api/og?type=drug&title=soluble%20ferric%20pyrophosphate&subtitle=soluble%20ferric%20pyrophosphate%20%C2%B7%20Rockwell%20Medical%20Technologies%2C%20Inc.&badge=phase%202 soluble ferric pyrophosphate soluble ferric pyrophosphate · Rockwell Medical Technologies, Inc. https://druglandscape.com/drug/som0226 https://druglandscape.com/api/og?type=drug&title=SOM0226&subtitle=SOM0226%20%C2%B7%20SOM%20Innovation%20Biotech%20SA&badge=phase%201 SOM0226 SOM0226 · SOM Innovation Biotech SA https://druglandscape.com/drug/som230-lar https://druglandscape.com/api/og?type=drug&title=SOM230%20LAR&subtitle=SOM230%20LAR%20%C2%B7%20Prof.%20Dr.%20Berthold%20Schalke&badge=phase%202 SOM230 LAR SOM230 LAR · Prof. Dr. Berthold Schalke https://druglandscape.com/drug/som230c https://druglandscape.com/api/og?type=drug&title=SOM230C&subtitle=SOM230C%20%C2%B7%20Patrick%20Y.%20Wen%2C%20MD&badge=phase%202 SOM230C SOM230C · Patrick Y. Wen, MD https://druglandscape.com/drug/somatostatin-intravenous-bolus https://druglandscape.com/api/og?type=drug&title=somatostatin%2C%20intravenous%20bolus&subtitle=somatostatin%2C%20intravenous%20bolus%20%C2%B7%20Fundaci%C3%B3%20Institut%20de%20Recerca%20de%20l'Hospital%20de%20la%20Santa%20Creu%20i%20Sant&badge=phase%203 somatostatin, intravenous bolus somatostatin, intravenous bolus · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau https://druglandscape.com/drug/somatropin-injection-low-dose-group https://druglandscape.com/api/og?type=drug&title=Somatropin%20Injection%20low%20dose%20group&subtitle=Somatropin%20Injection%20low%20dose%20group%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Somatropin Injection low dose group Somatropin Injection low dose group · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/somatropine-norditropine-simplexx https://druglandscape.com/api/og?type=drug&title=SOMATROPINE*%20%3A%20Norditropine%C2%AE%20simplexx%C2%AE&subtitle=SOMATROPINE*%20%3A%20Norditropine%C2%AE%20simplexx%C2%AE%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 SOMATROPINE* : Norditropine® simplexx® SOMATROPINE* : Norditropine® simplexx® · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/son-1010 https://druglandscape.com/api/og?type=drug&title=SON-1010&subtitle=SON-1010%20%C2%B7%20Sonnet%20BioTherapeutics&badge=phase%201 SON-1010 SON-1010 · Sonnet BioTherapeutics https://druglandscape.com/drug/son-dp https://druglandscape.com/api/og?type=drug&title=SON-DP&subtitle=SON-DP%20%C2%B7%20Qurgen%20Inc.&badge=phase%201 SON-DP SON-DP · Qurgen Inc. https://druglandscape.com/drug/sonovue-bracco https://druglandscape.com/api/og?type=drug&title=Sonovue%2C%20Bracco&subtitle=Sonovue%2C%20Bracco%20%C2%B7%20Rambam%20Health%20Care%20Campus&badge=phase%201 Sonovue, Bracco Sonovue, Bracco · Rambam Health Care Campus https://druglandscape.com/drug/sor007-ointment-1-0 https://druglandscape.com/api/og?type=drug&title=SOR007%20Ointment%201.0%25&subtitle=SOR007%20Ointment%201.0%25%20%C2%B7%20DFB%20Soria%2C%20LLC&badge=phase%201 SOR007 Ointment 1.0% SOR007 Ointment 1.0% · DFB Soria, LLC https://druglandscape.com/drug/sorafenib-period-1 https://druglandscape.com/api/og?type=drug&title=Sorafenib%20-%20Period%201&subtitle=Sorafenib%20-%20Period%201%20%C2%B7%20Xspray%20Pharma%20AB&badge=phase%201 Sorafenib - Period 1 Sorafenib - Period 1 · Xspray Pharma AB https://druglandscape.com/drug/sorafenib-period-2 https://druglandscape.com/api/og?type=drug&title=Sorafenib%20-%20Period%202&subtitle=Sorafenib%20-%20Period%202%20%C2%B7%20Xspray%20Pharma%20AB&badge=phase%201 Sorafenib - Period 2 Sorafenib - Period 2 · Xspray Pharma AB https://druglandscape.com/drug/sorafenib-period-3 https://druglandscape.com/api/og?type=drug&title=Sorafenib%20-%20Period%203&subtitle=Sorafenib%20-%20Period%203%20%C2%B7%20Xspray%20Pharma%20AB&badge=phase%201 Sorafenib - Period 3 Sorafenib - Period 3 · Xspray Pharma AB https://druglandscape.com/drug/sorafenib-ts-1 https://druglandscape.com/api/og?type=drug&title=sorafenib%2C%20TS-1&subtitle=sorafenib%2C%20TS-1%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%201 sorafenib, TS-1 sorafenib, TS-1 · Samsung Medical Center https://druglandscape.com/drug/sot201 https://druglandscape.com/api/og?type=drug&title=SOT201&subtitle=SOT201%20%C2%B7%20SOTIO%20Biotech%20AG&badge=phase%201 SOT201 SOT201 · SOTIO Biotech AG https://druglandscape.com/drug/sotatercept-autoinjector https://druglandscape.com/api/og?type=drug&title=Sotatercept%20Autoinjector&subtitle=Sotatercept%20Autoinjector%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Sotatercept Autoinjector Sotatercept Autoinjector · Merck Sharp & Dohme LLC https://druglandscape.com/drug/sotb07 https://druglandscape.com/api/og?type=drug&title=SOTB07&subtitle=SOTB07%20%C2%B7%20SK%20Chemicals%20Co.%2C%20Ltd.&badge=phase%202 SOTB07 SOTB07 · SK Chemicals Co., Ltd. https://druglandscape.com/drug/soy-protein-isolate https://druglandscape.com/api/og?type=drug&title=soy%20protein%20isolate&subtitle=soy%20protein%20isolate%20%C2%B7%20National%20Center%20for%20Research%20Resources%20(NCRR)&badge=phase%203 soy protein isolate soy protein isolate · National Center for Research Resources (NCRR) https://druglandscape.com/drug/soybean-oil-lipid-emulsion https://druglandscape.com/api/og?type=drug&title=Soybean%20oil%20lipid%20emulsion&subtitle=Soybean%20oil%20lipid%20emulsion%20%C2%B7%20Alexandra%20N.%20Carey&badge=phase%201 Soybean oil lipid emulsion Soybean oil lipid emulsion · Alexandra N. Carey https://druglandscape.com/drug/sp-002 https://druglandscape.com/api/og?type=drug&title=SP-002&subtitle=SP-002%20%C2%B7%20Stamford%20Pharmaceuticals%2C%20Inc.&badge=phase%202 SP-002 SP-002 · Stamford Pharmaceuticals, Inc. https://druglandscape.com/drug/sp-103 https://druglandscape.com/api/og?type=drug&title=SP-103&subtitle=SP-103%20%C2%B7%20Scilex%20Pharmaceuticals%2C%20Inc.&badge=phase%202 SP-103 SP-103 · Scilex Pharmaceuticals, Inc. https://druglandscape.com/drug/sp-104 https://druglandscape.com/api/og?type=drug&title=SP-104&subtitle=SP-104%20%C2%B7%20Scilex%20Pharmaceuticals%2C%20Inc.&badge=phase%201 SP-104 SP-104 · Scilex Pharmaceuticals, Inc. https://druglandscape.com/drug/sp-2577-seclidemstat https://druglandscape.com/api/og?type=drug&title=SP-2577%20Seclidemstat&subtitle=SP-2577%20Seclidemstat%20%C2%B7%20Salarius%20Pharmaceuticals%2C%20LLC&badge=phase%201 SP-2577 Seclidemstat SP-2577 Seclidemstat · Salarius Pharmaceuticals, LLC https://druglandscape.com/drug/sp-3164 https://druglandscape.com/api/og?type=drug&title=SP-3164&subtitle=SP-3164%20%C2%B7%20Salarius%20Pharmaceuticals%2C%20LLC&badge=phase%201 SP-3164 SP-3164 · Salarius Pharmaceuticals, LLC https://druglandscape.com/drug/sp-333 https://druglandscape.com/api/og?type=drug&title=SP-333&subtitle=SP-333%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%201 SP-333 SP-333 · Bausch Health Americas, Inc. https://druglandscape.com/drug/sp-624 https://druglandscape.com/api/og?type=drug&title=SP-624&subtitle=SP-624%20%C2%B7%20Sirtsei%20Pharmaceuticals%2C%20Inc.&badge=phase%202 SP-624 SP-624 · Sirtsei Pharmaceuticals, Inc. https://druglandscape.com/drug/sp-8008-prototype-capsule-b https://druglandscape.com/api/og?type=drug&title=SP-8008%20Prototype%20Capsule%20B&subtitle=SP-8008%20Prototype%20Capsule%20B%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%201 SP-8008 Prototype Capsule B SP-8008 Prototype Capsule B · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/sp-8203-high-dose https://druglandscape.com/api/og?type=drug&title=SP-8203%20High%20dose&subtitle=SP-8203%20High%20dose%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 SP-8203 High dose SP-8203 High dose · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/sp-8203-low-dose https://druglandscape.com/api/og?type=drug&title=SP-8203%20Low%20dose&subtitle=SP-8203%20Low%20dose%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 SP-8203 Low dose SP-8203 Low dose · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/sp-amodiaquine-piperaquine-dihdroartemisinin https://druglandscape.com/api/og?type=drug&title=SP%2C%20amodiaquine%2C%20piperaquine%2C%20dihdroartemisinin&subtitle=SP%2C%20amodiaquine%2C%20piperaquine%2C%20dihdroartemisinin%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%202 SP, amodiaquine, piperaquine, dihdroartemisinin SP, amodiaquine, piperaquine, dihdroartemisinin · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/sp-aq https://druglandscape.com/api/og?type=drug&title=SP-AQ&subtitle=SP-AQ%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%202 SP-AQ SP-AQ · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/sp01a https://druglandscape.com/api/og?type=drug&title=SP01A&subtitle=SP01A%20%C2%B7%20Samaritan%20Pharmaceuticals%2C%20Inc&badge=phase%202 SP01A SP01A · Samaritan Pharmaceuticals, Inc https://druglandscape.com/drug/sparc-08-038 https://druglandscape.com/api/og?type=drug&title=SPARC-08-038&subtitle=SPARC-08-038%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 SPARC-08-038 SPARC-08-038 · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/sparc001-type-ii https://druglandscape.com/api/og?type=drug&title=SPARC001%20type%20II&subtitle=SPARC001%20type%20II%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 SPARC001 type II SPARC001 type II · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/sparc001a https://druglandscape.com/api/og?type=drug&title=SPARC001A&subtitle=SPARC001A%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 SPARC001A SPARC001A · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/sparc001b https://druglandscape.com/api/og?type=drug&title=SPARC001B&subtitle=SPARC001B%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 SPARC001B SPARC001B · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/sparc1023-ii https://druglandscape.com/api/og?type=drug&title=SPARC1023%20II&subtitle=SPARC1023%20II%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 SPARC1023 II SPARC1023 II · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/sparc1102-i https://druglandscape.com/api/og?type=drug&title=SPARC1102%20I&subtitle=SPARC1102%20I%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%202 SPARC1102 I SPARC1102 I · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/sparc1102-ii https://druglandscape.com/api/og?type=drug&title=SPARC1102%20II&subtitle=SPARC1102%20II%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%202 SPARC1102 II SPARC1102 II · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/sparc1103-high-dose https://druglandscape.com/api/og?type=drug&title=SPARC1103%20high%20dose&subtitle=SPARC1103%20high%20dose%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%202 SPARC1103 high dose SPARC1103 high dose · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/sparc1103-low-dose https://druglandscape.com/api/og?type=drug&title=SPARC1103%20low%20dose&subtitle=SPARC1103%20low%20dose%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%202 SPARC1103 low dose SPARC1103 low dose · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/sparc1203 https://druglandscape.com/api/og?type=drug&title=SPARC1203&subtitle=SPARC1203%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%202 SPARC1203 SPARC1203 · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/sparc1310-i https://druglandscape.com/api/og?type=drug&title=SPARC1310%20I&subtitle=SPARC1310%20I%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%202 SPARC1310 I SPARC1310 I · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/sparc1310-iii https://druglandscape.com/api/og?type=drug&title=SPARC1310%20III&subtitle=SPARC1310%20III%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%202 SPARC1310 III SPARC1310 III · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/sparc1316-dose-1 https://druglandscape.com/api/og?type=drug&title=SPARC1316%20Dose%201&subtitle=SPARC1316%20Dose%201%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 SPARC1316 Dose 1 SPARC1316 Dose 1 · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/sparc147709 https://druglandscape.com/api/og?type=drug&title=SPARC147709&subtitle=SPARC147709%20%C2%B7%20Sun%20Pharma%20Advanced%20Research%20Company%20Limited&badge=phase%201 SPARC147709 SPARC147709 · Sun Pharma Advanced Research Company Limited https://druglandscape.com/drug/spc-1001-mid2 https://druglandscape.com/api/og?type=drug&title=SPC%201001%20Mid2&subtitle=SPC%201001%20Mid2%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 SPC 1001 Mid2 SPC 1001 Mid2 · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/spc-2004 https://druglandscape.com/api/og?type=drug&title=SPC%202004&subtitle=SPC%202004%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 SPC 2004 SPC 2004 · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/spc1001-low https://druglandscape.com/api/og?type=drug&title=SPC1001%20Low&subtitle=SPC1001%20Low%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 SPC1001 Low SPC1001 Low · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/spc1001-mid1 https://druglandscape.com/api/og?type=drug&title=SPC1001%20Mid1&subtitle=SPC1001%20Mid1%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 SPC1001 Mid1 SPC1001 Mid1 · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/spc1001-mid2 https://druglandscape.com/api/og?type=drug&title=SPC1001%20Mid2&subtitle=SPC1001%20Mid2%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 SPC1001 Mid2 SPC1001 Mid2 · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/spc2996 https://druglandscape.com/api/og?type=drug&title=SPC2996&subtitle=SPC2996%20%C2%B7%20Santaris%20Pharma%20A%2FS&badge=phase%201 SPC2996 SPC2996 · Santaris Pharma A/S https://druglandscape.com/drug/spc3001 https://druglandscape.com/api/og?type=drug&title=SPC3001&subtitle=SPC3001%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 SPC3001 SPC3001 · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/spc3649 https://druglandscape.com/api/og?type=drug&title=SPC3649&subtitle=SPC3649%20%C2%B7%20Santaris%20Pharma%20A%2FS&badge=phase%201 SPC3649 SPC3649 · Santaris Pharma A/S https://druglandscape.com/drug/spc4001 https://druglandscape.com/api/og?type=drug&title=SPC4001&subtitle=SPC4001%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 SPC4001 SPC4001 · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/spc4002 https://druglandscape.com/api/og?type=drug&title=SPC4002&subtitle=SPC4002%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 SPC4002 SPC4002 · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/spc4955 https://druglandscape.com/api/og?type=drug&title=SPC4955&subtitle=SPC4955%20%C2%B7%20Santaris%20Pharma%20A%2FS&badge=phase%201 SPC4955 SPC4955 · Santaris Pharma A/S https://druglandscape.com/drug/spc5002 https://druglandscape.com/api/og?type=drug&title=SPC5002&subtitle=SPC5002%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 SPC5002 SPC5002 · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/spc5003 https://druglandscape.com/api/og?type=drug&title=SPC5003&subtitle=SPC5003%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 SPC5003 SPC5003 · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/spc5004 https://druglandscape.com/api/og?type=drug&title=SPC5004&subtitle=SPC5004%20%C2%B7%20Shin%20Poong%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 SPC5004 SPC5004 · Shin Poong Pharmaceutical Co. Ltd. https://druglandscape.com/drug/spd422 https://druglandscape.com/api/og?type=drug&title=SPD422&subtitle=SPD422%20%C2%B7%20Shire&badge=phase%201 SPD422 SPD422 · Shire https://druglandscape.com/drug/spd503 https://druglandscape.com/api/og?type=drug&title=SPD503&subtitle=SPD503%20%C2%B7%20Shire&badge=phase%201 SPD503 SPD503 · Shire https://druglandscape.com/drug/spd544 https://druglandscape.com/api/og?type=drug&title=SPD544&subtitle=SPD544%20%C2%B7%20Shire&badge=phase%201 SPD544 SPD544 · Shire https://druglandscape.com/drug/spectrila https://druglandscape.com/api/og?type=drug&title=Spectrila%C2%AE&subtitle=Spectrila%C2%AE%20%C2%B7%20medac%20GmbH&badge=phase%202 Spectrila® Spectrila® · medac GmbH https://druglandscape.com/drug/sperm-capacitation https://druglandscape.com/api/og?type=drug&title=sperm%20capacitation&subtitle=sperm%20capacitation%20%C2%B7%20Assaf-Harofeh%20Medical%20Center&badge=phase%202 sperm capacitation sperm capacitation · Assaf-Harofeh Medical Center https://druglandscape.com/drug/spg302 https://druglandscape.com/api/og?type=drug&title=SPG302&subtitle=SPG302%20%C2%B7%20Spinogenix&badge=phase%202 SPG302 SPG302 · Spinogenix https://druglandscape.com/drug/spg601 https://druglandscape.com/api/og?type=drug&title=SPG601&subtitle=SPG601%20%C2%B7%20Spinogenix&badge=phase%202 SPG601 SPG601 · Spinogenix https://druglandscape.com/drug/spgl008 https://druglandscape.com/api/og?type=drug&title=SPGL008&subtitle=SPGL008%20%C2%B7%20Shenyang%20Sunshine%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%201 SPGL008 SPGL008 · Shenyang Sunshine Pharmaceutical Co., LTD. https://druglandscape.com/drug/sph-3348 https://druglandscape.com/api/og?type=drug&title=SPH%203348&subtitle=SPH%203348%20%C2%B7%20Shanghai%20Pharmaceuticals%20Holding%20Co.%2C%20Ltd&badge=phase%201 SPH 3348 SPH 3348 · Shanghai Pharmaceuticals Holding Co., Ltd https://druglandscape.com/drug/sph3127-tablets-with-dose-b https://druglandscape.com/api/og?type=drug&title=SPH3127%20Tablets%20with%20Dose%20B&subtitle=SPH3127%20Tablets%20with%20Dose%20B%20%C2%B7%20Shanghai%20Pharmaceuticals%20Holding%20Co.%2C%20Ltd&badge=phase%202 SPH3127 Tablets with Dose B SPH3127 Tablets with Dose B · Shanghai Pharmaceuticals Holding Co., Ltd https://druglandscape.com/drug/sph4336-tablets https://druglandscape.com/api/og?type=drug&title=SPH4336%20Tablets&subtitle=SPH4336%20Tablets%20%C2%B7%20Shanghai%20Pharmaceuticals%20Holding%20Co.%2C%20Ltd&badge=phase%202 SPH4336 Tablets SPH4336 Tablets · Shanghai Pharmaceuticals Holding Co., Ltd https://druglandscape.com/drug/sph5030 https://druglandscape.com/api/og?type=drug&title=SPH5030&subtitle=SPH5030%20%C2%B7%20Shanghai%20Pharmaceuticals%20Holding%20Co.%2C%20Ltd&badge=phase%202 SPH5030 SPH5030 · Shanghai Pharmaceuticals Holding Co., Ltd https://druglandscape.com/drug/sph5030-tablets https://druglandscape.com/api/og?type=drug&title=SPH5030%20tablets&subtitle=SPH5030%20tablets%20%C2%B7%20Shanghai%20Pharmaceuticals%20Holding%20Co.%2C%20Ltd&badge=phase%201 SPH5030 tablets SPH5030 tablets · Shanghai Pharmaceuticals Holding Co., Ltd https://druglandscape.com/drug/sph6516-tablets https://druglandscape.com/api/og?type=drug&title=SPH6516%20tablets&subtitle=SPH6516%20tablets%20%C2%B7%20Shanghai%20Pharmaceuticals%20Holding%20Co.%2C%20Ltd&badge=phase%201 SPH6516 tablets SPH6516 tablets · Shanghai Pharmaceuticals Holding Co., Ltd https://druglandscape.com/drug/sph7485 https://druglandscape.com/api/og?type=drug&title=SPH7485&subtitle=SPH7485%20%C2%B7%20Shanghai%20Pharmaceuticals%20Holding%20Co.%2C%20Ltd&badge=phase%201 SPH7485 SPH7485 · Shanghai Pharmaceuticals Holding Co., Ltd https://druglandscape.com/drug/sph7854 https://druglandscape.com/api/og?type=drug&title=SPH7854&subtitle=SPH7854%20%C2%B7%20Shanghai%20Pharmaceuticals%20Holding%20Co.%2C%20Ltd&badge=phase%201 SPH7854 SPH7854 · Shanghai Pharmaceuticals Holding Co., Ltd https://druglandscape.com/drug/sph9788 https://druglandscape.com/api/og?type=drug&title=SPH9788&subtitle=SPH9788%20%C2%B7%20Shanghai%20Pharmaceuticals%20Holding%20Co.%2C%20Ltd&badge=phase%201 SPH9788 SPH9788 · Shanghai Pharmaceuticals Holding Co., Ltd https://druglandscape.com/drug/sphingosine-kinase-2-inhibitor-abc294640 https://druglandscape.com/api/og?type=drug&title=sphingosine%20kinase-2%20inhibitor%20ABC294640&subtitle=sphingosine%20kinase-2%20inhibitor%20ABC294640%20%C2%B7%20RedHill%20Biopharma%20Limited&badge=phase%201 sphingosine kinase-2 inhibitor ABC294640 sphingosine kinase-2 inhibitor ABC294640 · RedHill Biopharma Limited https://druglandscape.com/drug/spi-1005-high-dose https://druglandscape.com/api/og?type=drug&title=SPI-1005%20High%20dose&subtitle=SPI-1005%20High%20dose%20%C2%B7%20Sound%20Pharmaceuticals%2C%20Incorporated&badge=phase%202 SPI-1005 High dose SPI-1005 High dose · Sound Pharmaceuticals, Incorporated https://druglandscape.com/drug/spi-1005-low-dose https://druglandscape.com/api/og?type=drug&title=SPI-1005%20Low%20dose&subtitle=SPI-1005%20Low%20dose%20%C2%B7%20Sound%20Pharmaceuticals%2C%20Incorporated&badge=phase%202 SPI-1005 Low dose SPI-1005 Low dose · Sound Pharmaceuticals, Incorporated https://druglandscape.com/drug/spi-1005-middle-dose https://druglandscape.com/api/og?type=drug&title=SPI-1005%20Middle%20dose&subtitle=SPI-1005%20Middle%20dose%20%C2%B7%20Sound%20Pharmaceuticals%2C%20Incorporated&badge=phase%202 SPI-1005 Middle dose SPI-1005 Middle dose · Sound Pharmaceuticals, Incorporated https://druglandscape.com/drug/spif https://druglandscape.com/api/og?type=drug&title=sPIF&subtitle=sPIF%20%C2%B7%20Christopher%20O'Brien%2C%20MD&badge=phase%201 sPIF sPIF · Christopher O'Brien, MD https://druglandscape.com/drug/spikevax-bivalent https://druglandscape.com/api/og?type=drug&title=SPIKEVAX%20Bivalent&subtitle=SPIKEVAX%20Bivalent%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%202 SPIKEVAX Bivalent SPIKEVAX Bivalent · ModernaTX, Inc. https://druglandscape.com/drug/spiriva-respimat-inhalation-spray https://druglandscape.com/api/og?type=drug&title=Spiriva%C2%AE%20Respimat%C2%AE%20inhalation%20spray&subtitle=Spiriva%C2%AE%20Respimat%C2%AE%20inhalation%20spray%20%C2%B7%20Glenmark%20Specialty%20S.A.&badge=phase%202 Spiriva® Respimat® inhalation spray Spiriva® Respimat® inhalation spray · Glenmark Specialty S.A. https://druglandscape.com/drug/spk-9001 https://druglandscape.com/api/og?type=drug&title=SPK-9001&subtitle=SPK-9001%20%C2%B7%20Pfizer&badge=phase%202 SPK-9001 SPK-9001 · Pfizer https://druglandscape.com/drug/spl-108 https://druglandscape.com/api/og?type=drug&title=SPL-108&subtitle=SPL-108%20%C2%B7%20Splash%20Pharmaceuticals%2C%20Inc.&badge=phase%201 SPL-108 SPL-108 · Splash Pharmaceuticals, Inc. https://druglandscape.com/drug/spl026-im https://druglandscape.com/api/og?type=drug&title=SPL026%20IM&subtitle=SPL026%20IM%20%C2%B7%20Small%20Pharma%20Ltd&badge=phase%201 SPL026 IM SPL026 IM · Small Pharma Ltd https://druglandscape.com/drug/spl026-iv https://druglandscape.com/api/og?type=drug&title=SPL026%20IV&subtitle=SPL026%20IV%20%C2%B7%20Small%20Pharma%20Ltd&badge=phase%201 SPL026 IV SPL026 IV · Small Pharma Ltd https://druglandscape.com/drug/spl84 https://druglandscape.com/api/og?type=drug&title=SPL84&subtitle=SPL84%20%C2%B7%20SpliSense%20Ltd.&badge=phase%202 SPL84 SPL84 · SpliSense Ltd. https://druglandscape.com/drug/split-abs https://druglandscape.com/api/og?type=drug&title=SPLIT%20Abs&subtitle=SPLIT%20Abs%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 SPLIT Abs SPLIT Abs · Hoffmann-La Roche https://druglandscape.com/drug/split-cisplatin https://druglandscape.com/api/og?type=drug&title=Split%20Cisplatin&subtitle=Split%20Cisplatin%20%C2%B7%20Groupe%20Oncologie%20Radiotherapie%20Tete%20et%20Cou&badge=phase%202 Split Cisplatin Split Cisplatin · Groupe Oncologie Radiotherapie Tete et Cou https://druglandscape.com/drug/split-virion-inactivated-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=Split%20virion%2C%20inactivated%20Influenza%20vaccine&subtitle=Split%20virion%2C%20inactivated%20Influenza%20vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%202 Split virion, inactivated Influenza vaccine Split virion, inactivated Influenza vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/spm-936 https://druglandscape.com/api/og?type=drug&title=SPM%20936&subtitle=SPM%20936%20%C2%B7%20UCB%20Pharma&badge=phase%202 SPM 936 SPM 936 · UCB Pharma https://druglandscape.com/drug/spn-804o https://druglandscape.com/api/og?type=drug&title=SPN-804O&subtitle=SPN-804O%20%C2%B7%20Supernus%20Pharmaceuticals%2C%20Inc.&badge=phase%201 SPN-804O SPN-804O · Supernus Pharmaceuticals, Inc. https://druglandscape.com/drug/spn-810m https://druglandscape.com/api/og?type=drug&title=SPN-810M&subtitle=SPN-810M%20%C2%B7%20Supernus%20Pharmaceuticals%2C%20Inc.&badge=phase%201 SPN-810M SPN-810M · Supernus Pharmaceuticals, Inc. https://druglandscape.com/drug/spn-817 https://druglandscape.com/api/og?type=drug&title=SPN-817&subtitle=SPN-817%20%C2%B7%20Supernus%20Pharmaceuticals%2C%20Inc.&badge=phase%202 SPN-817 SPN-817 · Supernus Pharmaceuticals, Inc. https://druglandscape.com/drug/spn-817-treatment-c https://druglandscape.com/api/og?type=drug&title=SPN-817%2C%20Treatment%20C&subtitle=SPN-817%2C%20Treatment%20C%20%C2%B7%20Supernus%20Pharmaceuticals%2C%20Inc.&badge=phase%201 SPN-817, Treatment C SPN-817, Treatment C · Supernus Pharmaceuticals, Inc. https://druglandscape.com/drug/spo1101 https://druglandscape.com/api/og?type=drug&title=SPO1101&subtitle=SPO1101%20%C2%B7%20Seoul%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 SPO1101 SPO1101 · Seoul Pharma Co., Ltd. https://druglandscape.com/drug/spo1101d https://druglandscape.com/api/og?type=drug&title=SPO1101D&subtitle=SPO1101D%20%C2%B7%20Seoul%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 SPO1101D SPO1101D · Seoul Pharma Co., Ltd. https://druglandscape.com/drug/spot-ala-2-hour-incubation https://druglandscape.com/api/og?type=drug&title=Spot%20ALA%202%20hour%20incubation&subtitle=Spot%20ALA%202%20hour%20incubation%20%C2%B7%20DUSA%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Spot ALA 2 hour incubation Spot ALA 2 hour incubation · DUSA Pharmaceuticals, Inc. https://druglandscape.com/drug/spot-mrna01 https://druglandscape.com/api/og?type=drug&title=SPOT-mRNA01&subtitle=SPOT-mRNA01%20%C2%B7%20SIPO%20Biotechnology%20Co.%20Ltd.&badge=phase%201 SPOT-mRNA01 SPOT-mRNA01 · SIPO Biotechnology Co. Ltd. https://druglandscape.com/drug/spp100 https://druglandscape.com/api/og?type=drug&title=SPP100&subtitle=SPP100%20%C2%B7%20Novartis&badge=phase%202 SPP100 SPP100 · Novartis https://druglandscape.com/drug/spp635 https://druglandscape.com/api/og?type=drug&title=SPP635&subtitle=SPP635%20%C2%B7%20Speedel%20Pharma%20Ltd.&badge=phase%202 SPP635 SPP635 · Speedel Pharma Ltd. https://druglandscape.com/drug/sprycel-dasatinib-tablet https://druglandscape.com/api/og?type=drug&title=Sprycel%20Dasatinib%20tablet&subtitle=Sprycel%20Dasatinib%20tablet%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 Sprycel Dasatinib tablet Sprycel Dasatinib tablet · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/spvn06 https://druglandscape.com/api/og?type=drug&title=SPVN06&subtitle=SPVN06%20%C2%B7%20SparingVision&badge=phase%201 SPVN06 SPVN06 · SparingVision https://druglandscape.com/drug/spy002 https://druglandscape.com/api/og?type=drug&title=SPY002&subtitle=SPY002%20%C2%B7%20Spyre%20Therapeutics%2C%20Inc.&badge=phase%202 SPY002 SPY002 · Spyre Therapeutics, Inc. https://druglandscape.com/drug/spy002-072 https://druglandscape.com/api/og?type=drug&title=SPY002-072&subtitle=SPY002-072%20%C2%B7%20Spyre%20Therapeutics%2C%20Inc.&badge=phase%202 SPY002-072 SPY002-072 · Spyre Therapeutics, Inc. https://druglandscape.com/drug/spy002-091 https://druglandscape.com/api/og?type=drug&title=SPY002-091&subtitle=SPY002-091%20%C2%B7%20Spyre%20Therapeutics%2C%20Inc.&badge=phase%201 SPY002-091 SPY002-091 · Spyre Therapeutics, Inc. https://druglandscape.com/drug/spy003 https://druglandscape.com/api/og?type=drug&title=SPY003&subtitle=SPY003%20%C2%B7%20Spyre%20Therapeutics%2C%20Inc.&badge=phase%202 SPY003 SPY003 · Spyre Therapeutics, Inc. https://druglandscape.com/drug/spy003-207 https://druglandscape.com/api/og?type=drug&title=SPY003-207&subtitle=SPY003-207%20%C2%B7%20Spyre%20Therapeutics%2C%20Inc.&badge=phase%201 SPY003-207 SPY003-207 · Spyre Therapeutics, Inc. https://druglandscape.com/drug/spyvac01 https://druglandscape.com/api/og?type=drug&title=SPYVAC01&subtitle=SPYVAC01%20%C2%B7%20SpyBiotech%20Limited&badge=phase%201 SPYVAC01 SPYVAC01 · SpyBiotech Limited https://druglandscape.com/drug/sqin-furosemide https://druglandscape.com/api/og?type=drug&title=SQIN-Furosemide&subtitle=SQIN-Furosemide%20%C2%B7%20SQ%20Innovation%2C%20Inc.&badge=phase%202 SQIN-Furosemide SQIN-Furosemide · SQ Innovation, Inc. https://druglandscape.com/drug/sqz-pbmc-hpv https://druglandscape.com/api/og?type=drug&title=SQZ-PBMC-HPV&subtitle=SQZ-PBMC-HPV%20%C2%B7%20SQZ%20Biotechnologies&badge=phase%201 SQZ-PBMC-HPV SQZ-PBMC-HPV · SQZ Biotechnologies https://druglandscape.com/drug/sr-878 https://druglandscape.com/api/og?type=drug&title=SR-878&subtitle=SR-878%20%C2%B7%20SciRhom%20GmbH&badge=phase%201 SR-878 SR-878 · SciRhom GmbH https://druglandscape.com/drug/sr-exenatide https://druglandscape.com/api/og?type=drug&title=SR-exenatide&subtitle=SR-exenatide%20%C2%B7%20Dong-A%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SR-exenatide SR-exenatide · Dong-A Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sr123781a https://druglandscape.com/api/og?type=drug&title=SR123781A&subtitle=SR123781A%20%C2%B7%20Sanofi&badge=phase%202 SR123781A SR123781A · Sanofi https://druglandscape.com/drug/sr1375 https://druglandscape.com/api/og?type=drug&title=SR1375&subtitle=SR1375%20%C2%B7%20Shanghai%20SIMR%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 SR1375 SR1375 · Shanghai SIMR Biotechnology Co., Ltd. https://druglandscape.com/drug/sr1375-capsules https://druglandscape.com/api/og?type=drug&title=SR1375%20capsules&subtitle=SR1375%20capsules%20%C2%B7%20Shanghai%20SIMR%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 SR1375 capsules SR1375 capsules · Shanghai SIMR Biotechnology Co., Ltd. https://druglandscape.com/drug/sr147778 https://druglandscape.com/api/og?type=drug&title=SR147778&subtitle=SR147778%20%C2%B7%20Sanofi&badge=phase%202 SR147778 SR147778 · Sanofi https://druglandscape.com/drug/sr31747a https://druglandscape.com/api/og?type=drug&title=SR31747A&subtitle=SR31747A%20%C2%B7%20Sanofi&badge=phase%202 SR31747A SR31747A · Sanofi https://druglandscape.com/drug/sr48692 https://druglandscape.com/api/og?type=drug&title=SR48692&subtitle=SR48692%20%C2%B7%20Sanofi&badge=phase%202 SR48692 SR48692 · Sanofi https://druglandscape.com/drug/sr57667b https://druglandscape.com/api/og?type=drug&title=SR57667B&subtitle=SR57667B%20%C2%B7%20Sanofi&badge=phase%202 SR57667B SR57667B · Sanofi https://druglandscape.com/drug/sr604 https://druglandscape.com/api/og?type=drug&title=SR604&subtitle=SR604%20%C2%B7%20Equilibra%20Bioscience%20LLC&badge=phase%201 SR604 SR604 · Equilibra Bioscience LLC https://druglandscape.com/drug/sr750-tablet https://druglandscape.com/api/og?type=drug&title=SR750%20tablet&subtitle=SR750%20tablet%20%C2%B7%20Shanghai%20SIMR%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%202 SR750 tablet SR750 tablet · Shanghai SIMR Biotechnology Co., Ltd. https://druglandscape.com/drug/sra-333 https://druglandscape.com/api/og?type=drug&title=SRA-333&subtitle=SRA-333%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%202 SRA-333 SRA-333 · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/sra-444 https://druglandscape.com/api/og?type=drug&title=SRA-444&subtitle=SRA-444%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%201 SRA-444 SRA-444 · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/sra737 https://druglandscape.com/api/og?type=drug&title=SRA737&subtitle=SRA737%20%C2%B7%20Sierra%20Oncology%20LLC%20-%20a%20GSK%20company&badge=phase%201 SRA737 SRA737 · Sierra Oncology LLC - a GSK company https://druglandscape.com/drug/sra737-gemcitabine https://druglandscape.com/api/og?type=drug&title=SRA737%2C%20gemcitabine&subtitle=SRA737%2C%20gemcitabine%20%C2%B7%20Sierra%20Oncology%20LLC%20-%20a%20GSK%20company&badge=phase%201 SRA737, gemcitabine SRA737, gemcitabine · Sierra Oncology LLC - a GSK company https://druglandscape.com/drug/sra737-gemcitabine-cisplatin https://druglandscape.com/api/og?type=drug&title=SRA737%2C%20gemcitabine%2C%20cisplatin&subtitle=SRA737%2C%20gemcitabine%2C%20cisplatin%20%C2%B7%20Sierra%20Oncology%20LLC%20-%20a%20GSK%20company&badge=phase%201 SRA737, gemcitabine, cisplatin SRA737, gemcitabine, cisplatin · Sierra Oncology LLC - a GSK company https://druglandscape.com/drug/srd-001 https://druglandscape.com/api/og?type=drug&title=SRD-001&subtitle=SRD-001%20%C2%B7%20Sardocor%20Corp.&badge=phase%201 SRD-001 SRD-001 · Sardocor Corp. https://druglandscape.com/drug/srd174-cream https://druglandscape.com/api/og?type=drug&title=SRD174%20Cream&subtitle=SRD174%20Cream%20%C2%B7%20Serentis%20Ltd.&badge=phase%202 SRD174 Cream SRD174 Cream · Serentis Ltd. https://druglandscape.com/drug/srf388 https://druglandscape.com/api/og?type=drug&title=SRF388&subtitle=SRF388%20%C2%B7%20Coherus%20Oncology%2C%20Inc.&badge=phase%202 SRF388 SRF388 · Coherus Oncology, Inc. https://druglandscape.com/drug/srg-514 https://druglandscape.com/api/og?type=drug&title=SRG-514&subtitle=SRG-514%20%C2%B7%20SURGE%20Therapeutics&badge=phase%201 SRG-514 SRG-514 · SURGE Therapeutics https://druglandscape.com/drug/srk-015 https://druglandscape.com/api/og?type=drug&title=SRK-015&subtitle=SRK-015%20%C2%B7%20Scholar%20Rock%2C%20Inc.&badge=phase%202 SRK-015 SRK-015 · Scholar Rock, Inc. https://druglandscape.com/drug/srk-439 https://druglandscape.com/api/og?type=drug&title=SRK-439&subtitle=SRK-439%20%C2%B7%20Scholar%20Rock%2C%20Inc.&badge=phase%201 SRK-439 SRK-439 · Scholar Rock, Inc. https://druglandscape.com/drug/srl-172 https://druglandscape.com/api/og?type=drug&title=SRL-172&subtitle=SRL-172%20%C2%B7%20Dartmouth-Hitchcock%20Medical%20Center&badge=phase%202 SRL-172 SRL-172 · Dartmouth-Hitchcock Medical Center https://druglandscape.com/drug/srn001 https://druglandscape.com/api/og?type=drug&title=SRN001&subtitle=SRN001%20%C2%B7%20siRNAgen%20Therapeutics%20Inc.&badge=phase%201 SRN001 SRN001 · siRNAgen Therapeutics Inc. https://druglandscape.com/drug/srp1020 https://druglandscape.com/api/og?type=drug&title=SRP1020&subtitle=SRP1020%20%C2%B7%20Shanghai%20SciBrunch%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 SRP1020 SRP1020 · Shanghai SciBrunch Therapeutics Co., Ltd. https://druglandscape.com/drug/srsd107 https://druglandscape.com/api/og?type=drug&title=SRSD107&subtitle=SRSD107%20%C2%B7%20Sirius%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%202 SRSD107 SRSD107 · Sirius Therapeutics Co., Ltd. https://druglandscape.com/drug/srt3025 https://druglandscape.com/api/og?type=drug&title=SRT3025&subtitle=SRT3025%20%C2%B7%20Sirtris%2C%20a%20GSK%20Company&badge=phase%201 SRT3025 SRT3025 · Sirtris, a GSK Company https://druglandscape.com/drug/srt501 https://druglandscape.com/api/og?type=drug&title=SRT501&subtitle=SRT501%20%C2%B7%20Sirtris%2C%20a%20GSK%20Company&badge=phase%201 SRT501 SRT501 · Sirtris, a GSK Company https://druglandscape.com/drug/ss-rbx https://druglandscape.com/api/og?type=drug&title=SS-RBX&subtitle=SS-RBX%20%C2%B7%20Pfizer&badge=phase%202 SS-RBX SS-RBX · Pfizer https://druglandscape.com/drug/ss109 https://druglandscape.com/api/og?type=drug&title=SS109&subtitle=SS109%20%C2%B7%20Jiangsu%20Gensciences%20lnc.&badge=phase%201 SS109 SS109 · Jiangsu Gensciences lnc. https://druglandscape.com/drug/ssd8432-dose-1-7-and-ritonavir https://druglandscape.com/api/og?type=drug&title=SSD8432%20dose%201~7%20and%20Ritonavir&subtitle=SSD8432%20dose%201~7%20and%20Ritonavir%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SSD8432 dose 1~7 and Ritonavir SSD8432 dose 1~7 and Ritonavir · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ssd8432-dose-13-and-ritonavir https://druglandscape.com/api/og?type=drug&title=SSD8432%20dose%2013%20and%20Ritonavir&subtitle=SSD8432%20dose%2013%20and%20Ritonavir%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SSD8432 dose 13 and Ritonavir SSD8432 dose 13 and Ritonavir · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ssd8432-dose-8-9 https://druglandscape.com/api/og?type=drug&title=SSD8432%20dose%208~9&subtitle=SSD8432%20dose%208~9%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SSD8432 dose 8~9 SSD8432 dose 8~9 · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ssgj-612 https://druglandscape.com/api/og?type=drug&title=SSGJ-612&subtitle=SSGJ-612%20%C2%B7%20Shenyang%20Sunshine%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%201 SSGJ-612 SSGJ-612 · Shenyang Sunshine Pharmaceutical Co., LTD. https://druglandscape.com/drug/ssgj-613 https://druglandscape.com/api/og?type=drug&title=SSGJ-613&subtitle=SSGJ-613%20%C2%B7%20Sunshine%20Guojian%20Pharmaceutical%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 SSGJ-613 SSGJ-613 · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. https://druglandscape.com/drug/ssgj-705 https://druglandscape.com/api/og?type=drug&title=SSGJ-705&subtitle=SSGJ-705%20%C2%B7%20Sunshine%20Guojian%20Pharmaceutical%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%202 SSGJ-705 SSGJ-705 · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. https://druglandscape.com/drug/ssgj-706 https://druglandscape.com/api/og?type=drug&title=SSGJ-706&subtitle=SSGJ-706%20%C2%B7%20Shenyang%20Sunshine%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%202 SSGJ-706 SSGJ-706 · Shenyang Sunshine Pharmaceutical Co., LTD. https://druglandscape.com/drug/ssp-002358 https://druglandscape.com/api/og?type=drug&title=SSP-002358&subtitle=SSP-002358%20%C2%B7%20Shire&badge=phase%201 SSP-002358 SSP-002358 · Shire https://druglandscape.com/drug/ssp-004184 https://druglandscape.com/api/og?type=drug&title=SSP-004184&subtitle=SSP-004184%20%C2%B7%20Shire&badge=phase%201 SSP-004184 SSP-004184 · Shire https://druglandscape.com/drug/ssp-004184ss https://druglandscape.com/api/og?type=drug&title=SSP-004184SS&subtitle=SSP-004184SS%20%C2%B7%20Shire&badge=phase%201 SSP-004184SS SSP-004184SS · Shire https://druglandscape.com/drug/ssr149415 https://druglandscape.com/api/og?type=drug&title=SSR149415&subtitle=SSR149415%20%C2%B7%20Sanofi&badge=phase%202 SSR149415 SSR149415 · Sanofi https://druglandscape.com/drug/ssr149744c https://druglandscape.com/api/og?type=drug&title=SSR149744C&subtitle=SSR149744C%20%C2%B7%20Sanofi&badge=phase%202 SSR149744C SSR149744C · Sanofi https://druglandscape.com/drug/ssr150106 https://druglandscape.com/api/og?type=drug&title=SSR150106&subtitle=SSR150106%20%C2%B7%20Sanofi&badge=phase%202 SSR150106 SSR150106 · Sanofi https://druglandscape.com/drug/ssri-active https://druglandscape.com/api/og?type=drug&title=SSRI%20Active&subtitle=SSRI%20Active%20%C2%B7%20Euthymics%20BioScience%2C%20Inc.&badge=phase%202 SSRI Active SSRI Active · Euthymics BioScience, Inc. https://druglandscape.com/drug/ssri-snri-tca https://druglandscape.com/api/og?type=drug&title=SSRI%3B%20SNRI%3B%20TCA&subtitle=SSRI%3B%20SNRI%3B%20TCA%20%C2%B7%20Tirat%20Carmel%20Mental%20Health%20Center&badge=phase%201 SSRI; SNRI; TCA SSRI; SNRI; TCA · Tirat Carmel Mental Health Center https://druglandscape.com/drug/sss06 https://druglandscape.com/api/og?type=drug&title=SSS06&subtitle=SSS06%20%C2%B7%20Shenyang%20Sunshine%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%202 SSS06 SSS06 · Shenyang Sunshine Pharmaceutical Co., LTD. https://druglandscape.com/drug/sss17 https://druglandscape.com/api/og?type=drug&title=SSS17&subtitle=SSS17%20%C2%B7%20Shenyang%20Sunshine%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%202 SSS17 SSS17 · Shenyang Sunshine Pharmaceutical Co., LTD. https://druglandscape.com/drug/sss39 https://druglandscape.com/api/og?type=drug&title=SSS39&subtitle=SSS39%20%C2%B7%20Shenyang%20Sunshine%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%201 SSS39 SSS39 · Shenyang Sunshine Pharmaceutical Co., LTD. https://druglandscape.com/drug/sss55 https://druglandscape.com/api/og?type=drug&title=SSS55&subtitle=SSS55%20%C2%B7%20Shenyang%20Sunshine%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%201 SSS55 SSS55 · Shenyang Sunshine Pharmaceutical Co., LTD. https://druglandscape.com/drug/sss59 https://druglandscape.com/api/og?type=drug&title=SSS59&subtitle=SSS59%20%C2%B7%20Shenyang%20Sunshine%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%201 SSS59 SSS59 · Shenyang Sunshine Pharmaceutical Co., LTD. https://druglandscape.com/drug/sst-6007 https://druglandscape.com/api/og?type=drug&title=SST-6007&subtitle=SST-6007%20%C2%B7%20Strategic%20Science%20%26%20Technologies%2C%20LLC&badge=phase%202 SST-6007 SST-6007 · Strategic Science & Technologies, LLC https://druglandscape.com/drug/st-01156 https://druglandscape.com/api/og?type=drug&title=ST-01156&subtitle=ST-01156%20%C2%B7%20SEED%20Therapeutics%2C%20Inc.&badge=phase%201 ST-01156 ST-01156 · SEED Therapeutics, Inc. https://druglandscape.com/drug/st-067 https://druglandscape.com/api/og?type=drug&title=ST-067&subtitle=ST-067%20%C2%B7%20Simcha%20IL-18%2C%20Inc.&badge=phase%201 ST-067 ST-067 · Simcha IL-18, Inc. https://druglandscape.com/drug/st-1891 https://druglandscape.com/api/og?type=drug&title=ST-1891&subtitle=ST-1891%20%C2%B7%20Sention%20Therapeutics%2C%20LLC&badge=phase%202 ST-1891 ST-1891 · Sention Therapeutics, LLC https://druglandscape.com/drug/st-246 https://druglandscape.com/api/og?type=drug&title=ST-246&subtitle=ST-246%20%C2%B7%20SIGA%20Technologies&badge=phase%201 ST-246 ST-246 · SIGA Technologies https://druglandscape.com/drug/st-246-days-11-13 https://druglandscape.com/api/og?type=drug&title=ST-246%20Days%2011%20-%2013&subtitle=ST-246%20Days%2011%20-%2013%20%C2%B7%20SIGA%20Technologies&badge=phase%201 ST-246 Days 11 - 13 ST-246 Days 11 - 13 · SIGA Technologies https://druglandscape.com/drug/st1968 https://druglandscape.com/api/og?type=drug&title=ST1968&subtitle=ST1968%20%C2%B7%20sigma-tau%20i.f.r.%20S.p.A.&badge=phase%201 ST1968 ST1968 · sigma-tau i.f.r. S.p.A. https://druglandscape.com/drug/st266 https://druglandscape.com/api/og?type=drug&title=ST266&subtitle=ST266%20%C2%B7%20Noveome%20Biotherapeutics%2C%20formerly%20Stemnion&badge=phase%202 ST266 ST266 · Noveome Biotherapeutics, formerly Stemnion https://druglandscape.com/drug/st266-immediate https://druglandscape.com/api/og?type=drug&title=ST266%20immediate&subtitle=ST266%20immediate%20%C2%B7%20Noveome%20Biotherapeutics%2C%20formerly%20Stemnion&badge=phase%202 ST266 immediate ST266 immediate · Noveome Biotherapeutics, formerly Stemnion https://druglandscape.com/drug/sta-1 https://druglandscape.com/api/og?type=drug&title=STA-1&subtitle=STA-1%20%C2%B7%20Sinphar%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 STA-1 STA-1 · Sinphar Pharmaceutical Co., Ltd https://druglandscape.com/drug/sta-2 https://druglandscape.com/api/og?type=drug&title=STA-2&subtitle=STA-2%20%C2%B7%20Sinphar%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 STA-2 STA-2 · Sinphar Pharmaceutical Co., Ltd https://druglandscape.com/drug/sta-5312 https://druglandscape.com/api/og?type=drug&title=STA-5312&subtitle=STA-5312%20%C2%B7%20Synta%20Pharmaceuticals%20Corp.&badge=phase%201 STA-5312 STA-5312 · Synta Pharmaceuticals Corp. https://druglandscape.com/drug/sta-5326-mesylate https://druglandscape.com/api/og?type=drug&title=STA%205326%20mesylate&subtitle=STA%205326%20mesylate%20%C2%B7%20Synta%20Pharmaceuticals%20Corp.&badge=phase%202 STA 5326 mesylate STA 5326 mesylate · Synta Pharmaceuticals Corp. https://druglandscape.com/drug/staccato-loxapine https://druglandscape.com/api/og?type=drug&title=Staccato%20Loxapine&subtitle=Staccato%20Loxapine%20%C2%B7%20Alexza%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Staccato Loxapine Staccato Loxapine · Alexza Pharmaceuticals, Inc. https://druglandscape.com/drug/stage-2-abiraterone-acetate https://druglandscape.com/api/og?type=drug&title=Stage%202%3A%20abiraterone%20acetate&subtitle=Stage%202%3A%20abiraterone%20acetate%20%C2%B7%20Cougar%20Biotechnology%2C%20Inc.&badge=phase%201 Stage 2: abiraterone acetate Stage 2: abiraterone acetate · Cougar Biotechnology, Inc. https://druglandscape.com/drug/stage-3-abiraterone-acetate https://druglandscape.com/api/og?type=drug&title=Stage%203%3A%20abiraterone%20acetate&subtitle=Stage%203%3A%20abiraterone%20acetate%20%C2%B7%20Cougar%20Biotechnology%2C%20Inc.&badge=phase%201 Stage 3: abiraterone acetate Stage 3: abiraterone acetate · Cougar Biotechnology, Inc. https://druglandscape.com/drug/stage-3-glucocorticoid https://druglandscape.com/api/og?type=drug&title=Stage%203%3A%20glucocorticoid&subtitle=Stage%203%3A%20glucocorticoid%20%C2%B7%20Cougar%20Biotechnology%2C%20Inc.&badge=phase%201 Stage 3: glucocorticoid Stage 3: glucocorticoid · Cougar Biotechnology, Inc. https://druglandscape.com/drug/stage-4-abiraterone-acetate https://druglandscape.com/api/og?type=drug&title=Stage%204%3A%20abiraterone%20acetate&subtitle=Stage%204%3A%20abiraterone%20acetate%20%C2%B7%20Cougar%20Biotechnology%2C%20Inc.&badge=phase%201 Stage 4: abiraterone acetate Stage 4: abiraterone acetate · Cougar Biotechnology, Inc. https://druglandscape.com/drug/stage-4-glucocorticoid https://druglandscape.com/api/og?type=drug&title=Stage%204%3A%20glucocorticoid&subtitle=Stage%204%3A%20glucocorticoid%20%C2%B7%20Cougar%20Biotechnology%2C%20Inc.&badge=phase%201 Stage 4: glucocorticoid Stage 4: glucocorticoid · Cougar Biotechnology, Inc. https://druglandscape.com/drug/stahist-ndc-58407-536-01 https://druglandscape.com/api/og?type=drug&title=STAHIST%20NDC%20%2358407-536-01&subtitle=STAHIST%20NDC%20%2358407-536-01%20%C2%B7%20Magna%20Pharmaceuticals%2C%20Inc.&badge=phase%201 STAHIST NDC #58407-536-01 STAHIST NDC #58407-536-01 · Magna Pharmaceuticals, Inc. https://druglandscape.com/drug/standardized-kudzu https://druglandscape.com/api/og?type=drug&title=Standardized%20kudzu&subtitle=Standardized%20kudzu%20%C2%B7%20Glenn-Milo%20Santos&badge=phase%202 Standardized kudzu Standardized kudzu · Glenn-Milo Santos https://druglandscape.com/drug/standardized-propofol-administration https://druglandscape.com/api/og?type=drug&title=Standardized%20Propofol%20Administration&subtitle=Standardized%20Propofol%20Administration%20%C2%B7%20Pontificia%20Universidad%20Catolica%20de%20Chile&badge=phase%202 Standardized Propofol Administration Standardized Propofol Administration · Pontificia Universidad Catolica de Chile https://druglandscape.com/drug/staphylococcal-investigational-vaccine-gsk2392019a https://druglandscape.com/api/og?type=drug&title=Staphylococcal%20investigational%20vaccine%20GSK2392019A&subtitle=Staphylococcal%20investigational%20vaccine%20GSK2392019A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Staphylococcal investigational vaccine GSK2392019A Staphylococcal investigational vaccine GSK2392019A · GlaxoSmithKline https://druglandscape.com/drug/star-0215 https://druglandscape.com/api/og?type=drug&title=STAR-0215&subtitle=STAR-0215%20%C2%B7%20Astria%20Therapeutics%2C%20Inc.&badge=phase%202 STAR-0215 STAR-0215 · Astria Therapeutics, Inc. https://druglandscape.com/drug/star-0310 https://druglandscape.com/api/og?type=drug&title=STAR-0310&subtitle=STAR-0310%20%C2%B7%20Astria%20Therapeutics%2C%20Inc.&badge=phase%201 STAR-0310 STAR-0310 · Astria Therapeutics, Inc. https://druglandscape.com/drug/star0602 https://druglandscape.com/api/og?type=drug&title=STAR0602&subtitle=STAR0602%20%C2%B7%20Marengo%20Therapeutics%2C%20Inc.&badge=phase%201 STAR0602 STAR0602 · Marengo Therapeutics, Inc. https://druglandscape.com/drug/statin-aspirin https://druglandscape.com/api/og?type=drug&title=Statin%2C%20aspirin&subtitle=Statin%2C%20aspirin%20%C2%B7%20Hillel%20Yaffe%20Medical%20Center&badge=phase%201 Statin, aspirin Statin, aspirin · Hillel Yaffe Medical Center https://druglandscape.com/drug/statin-stable-dose https://druglandscape.com/api/og?type=drug&title=statin%2C%20stable%20dose&subtitle=statin%2C%20stable%20dose%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 statin, stable dose statin, stable dose · Genentech, Inc. https://druglandscape.com/drug/stelara-pfs https://druglandscape.com/api/og?type=drug&title=Stelara%20PFS&subtitle=Stelara%20PFS%20%C2%B7%20Alvotech%20Swiss%20AG&badge=phase%201 Stelara PFS Stelara PFS · Alvotech Swiss AG https://druglandscape.com/drug/stem-cell-donation https://druglandscape.com/api/og?type=drug&title=Stem%20cell%20donation&subtitle=Stem%20cell%20donation%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 Stem cell donation Stem cell donation · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/stem-cell-therapy https://druglandscape.com/api/og?type=drug&title=stem%20cell%20therapy&subtitle=stem%20cell%20therapy%20%C2%B7%20Fondazione%20IRCCS%20Ca'%20Granda%2C%20Ospedale%20Maggiore%20Policlinico&badge=phase%202 stem cell therapy stem cell therapy · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico https://druglandscape.com/drug/stem-cells-from-human-exfoliated-teeth https://druglandscape.com/api/og?type=drug&title=Stem%20Cells%20From%20Human%20Exfoliated%20Teeth&subtitle=Stem%20Cells%20From%20Human%20Exfoliated%20Teeth%20%C2%B7%20CAR-T%20(Shanghai)%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 Stem Cells From Human Exfoliated Teeth Stem Cells From Human Exfoliated Teeth · CAR-T (Shanghai) Biotechnology Co., Ltd. https://druglandscape.com/drug/stem-oa https://druglandscape.com/api/og?type=drug&title=STEM-OA&subtitle=STEM-OA%20%C2%B7%20StemMedical%20A%2FS&badge=phase%201 STEM-OA STEM-OA · StemMedical A/S https://druglandscape.com/drug/stemchymal https://druglandscape.com/api/og?type=drug&title=Stemchymal%C2%AE&subtitle=Stemchymal%C2%AE%20%C2%B7%20Steminent%20Biotherapeutics%20Inc.&badge=phase%202 Stemchymal® Stemchymal® · Steminent Biotherapeutics Inc. https://druglandscape.com/drug/stemis https://druglandscape.com/api/og?type=drug&title=Stemis%E2%84%A2&subtitle=Stemis%E2%84%A2%20%C2%B7%20Ji%20Yan%20Biomedical%20Co.%2C%20Ltd.&badge=phase%201 Stemis™ Stemis™ · Ji Yan Biomedical Co., Ltd. https://druglandscape.com/drug/step-1-ts-142 https://druglandscape.com/api/og?type=drug&title=Step%201%3A%20TS-142&subtitle=Step%201%3A%20TS-142%20%C2%B7%20Taisho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Step 1: TS-142 Step 1: TS-142 · Taisho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/step-2-ts-142 https://druglandscape.com/api/og?type=drug&title=Step%202%3A%20TS-142&subtitle=Step%202%3A%20TS-142%20%C2%B7%20Taisho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Step 2: TS-142 Step 2: TS-142 · Taisho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/steroid-containing-mouthwash https://druglandscape.com/api/og?type=drug&title=Steroid%20Containing%20Mouthwash&subtitle=Steroid%20Containing%20Mouthwash%20%C2%B7%20Daiichi%20Sankyo%20Co.%2C%20Ltd.&badge=phase%201 Steroid Containing Mouthwash Steroid Containing Mouthwash · Daiichi Sankyo Co., Ltd. https://druglandscape.com/drug/steroid-therapy https://druglandscape.com/api/og?type=drug&title=steroid%20therapy&subtitle=steroid%20therapy%20%C2%B7%20China%20Medical%20University%20Hospital&badge=phase%203 steroid therapy steroid therapy · China Medical University Hospital https://druglandscape.com/drug/steroids-monoclonal-anti-il2r-antibody https://druglandscape.com/api/og?type=drug&title=steroids%2C%20monoclonal%20anti-IL2R%20antibody&subtitle=steroids%2C%20monoclonal%20anti-IL2R%20antibody%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%202 steroids, monoclonal anti-IL2R antibody steroids, monoclonal anti-IL2R antibody · Astellas Pharma Inc https://druglandscape.com/drug/steroids-switch https://druglandscape.com/api/og?type=drug&title=Steroids%20switch&subtitle=Steroids%20switch%20%C2%B7%20Centro%20Nacional%20de%20Investigaciones%20Oncologicas%20CARLOS%20III&badge=phase%202 Steroids switch Steroids switch · Centro Nacional de Investigaciones Oncologicas CARLOS III https://druglandscape.com/drug/sti-1386 https://druglandscape.com/api/og?type=drug&title=STI-1386&subtitle=STI-1386%20%C2%B7%20Sorrento%20Therapeutics%2C%20Inc.&badge=phase%201 STI-1386 STI-1386 · Sorrento Therapeutics, Inc. https://druglandscape.com/drug/sti-5656 https://druglandscape.com/api/og?type=drug&title=STI-5656&subtitle=STI-5656%20%C2%B7%20Sorrento%20Therapeutics%2C%20Inc.&badge=phase%202 STI-5656 STI-5656 · Sorrento Therapeutics, Inc. https://druglandscape.com/drug/sti-6129 https://druglandscape.com/api/og?type=drug&title=STI-6129&subtitle=STI-6129%20%C2%B7%20Sorrento%20Therapeutics%2C%20Inc.&badge=phase%201 STI-6129 STI-6129 · Sorrento Therapeutics, Inc. https://druglandscape.com/drug/sti-8591 https://druglandscape.com/api/og?type=drug&title=STI-8591&subtitle=STI-8591%20%C2%B7%20Zhejiang%20ACEA%20Pharmaceutical%20Co.%20Ltd.&badge=phase%201 STI-8591 STI-8591 · Zhejiang ACEA Pharmaceutical Co. Ltd. https://druglandscape.com/drug/stilnox-cr https://druglandscape.com/api/og?type=drug&title=Stilnox%20CR%C2%AE&subtitle=Stilnox%20CR%C2%AE%20%C2%B7%20Apsen%20Farmaceutica%20S.A.&badge=phase%202 Stilnox CR® Stilnox CR® · Apsen Farmaceutica S.A. https://druglandscape.com/drug/stimotimagene-copolymerplasmid https://druglandscape.com/api/og?type=drug&title=Stimotimagene%20copolymerplasmid&subtitle=Stimotimagene%20copolymerplasmid%20%C2%B7%20Gene%20Surgery%20LLC&badge=phase%201 Stimotimagene copolymerplasmid Stimotimagene copolymerplasmid · Gene Surgery LLC https://druglandscape.com/drug/stiripentol-oral-administration https://druglandscape.com/api/og?type=drug&title=STIRIPENTOL%20oral%20administration&subtitle=STIRIPENTOL%20oral%20administration%20%C2%B7%20Biocodex&badge=phase%201 STIRIPENTOL oral administration STIRIPENTOL oral administration · Biocodex https://druglandscape.com/drug/stk-009 https://druglandscape.com/api/og?type=drug&title=STK-009&subtitle=STK-009%20%C2%B7%20Synthekine&badge=phase%201 STK-009 STK-009 · Synthekine https://druglandscape.com/drug/stk-012 https://druglandscape.com/api/og?type=drug&title=STK-012&subtitle=STK-012%20%C2%B7%20Synthekine&badge=phase%201 STK-012 STK-012 · Synthekine https://druglandscape.com/drug/stlx-2012 https://druglandscape.com/api/og?type=drug&title=STLX-2012&subtitle=STLX-2012%20%C2%B7%20Stelexis%20BioSciences&badge=phase%201 STLX-2012 STLX-2012 · Stelexis BioSciences https://druglandscape.com/drug/stm-416 https://druglandscape.com/api/og?type=drug&title=STM-416&subtitle=STM-416%20%C2%B7%20SURGE%20Therapeutics&badge=phase%201 STM-416 STM-416 · SURGE Therapeutics https://druglandscape.com/drug/stm-416p https://druglandscape.com/api/og?type=drug&title=STM-416p&subtitle=STM-416p%20%C2%B7%20SURGE%20Therapeutics&badge=phase%201 STM-416p STM-416p · SURGE Therapeutics https://druglandscape.com/drug/stm-434 https://druglandscape.com/api/og?type=drug&title=STM%20434&subtitle=STM%20434%20%C2%B7%20Santa%20Maria%20Biotherapeutics&badge=phase%201 STM 434 STM 434 · Santa Maria Biotherapeutics https://druglandscape.com/drug/stmc-103h https://druglandscape.com/api/og?type=drug&title=STMC-103H&subtitle=STMC-103H%20%C2%B7%20Siolta%20Therapeutics%2C%20Inc.&badge=phase%201 STMC-103H STMC-103H · Siolta Therapeutics, Inc. https://druglandscape.com/drug/stn1010904-ophthalmic-suspension-0-1-bid https://druglandscape.com/api/og?type=drug&title=STN1010904%20ophthalmic%20suspension%200.1%25%20BID&subtitle=STN1010904%20ophthalmic%20suspension%200.1%25%20BID%20%C2%B7%20Santen%20Inc.&badge=phase%202 STN1010904 ophthalmic suspension 0.1% BID STN1010904 ophthalmic suspension 0.1% BID · Santen Inc. https://druglandscape.com/drug/stool-and-blood-samples https://druglandscape.com/api/og?type=drug&title=Stool%20and%20blood%20samples&subtitle=Stool%20and%20blood%20samples%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Stool and blood samples Stool and blood samples · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/stool-sample https://druglandscape.com/api/og?type=drug&title=Stool%20Sample&subtitle=Stool%20Sample%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 Stool Sample Stool Sample · Hospices Civils de Lyon https://druglandscape.com/drug/stool-sampling https://druglandscape.com/api/og?type=drug&title=Stool%20sampling&subtitle=Stool%20sampling%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Stool sampling Stool sampling · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/stop-aca https://druglandscape.com/api/og?type=drug&title=Stop%20ACA&subtitle=Stop%20ACA%20%C2%B7%20French%20Innovative%20Leukemia%20Organisation&badge=phase%202 Stop ACA Stop ACA · French Innovative Leukemia Organisation https://druglandscape.com/drug/stp1 https://druglandscape.com/api/og?type=drug&title=STP1&subtitle=STP1%20%C2%B7%20Stalicla%20SA&badge=phase%201 STP1 STP1 · Stalicla SA https://druglandscape.com/drug/stp1002 https://druglandscape.com/api/og?type=drug&title=STP1002&subtitle=STP1002%20%C2%B7%20ST%20Pharm%20Co.%2C%20Ltd.&badge=phase%201 STP1002 STP1002 · ST Pharm Co., Ltd. https://druglandscape.com/drug/stp206 https://druglandscape.com/api/og?type=drug&title=STP206&subtitle=STP206%20%C2%B7%20Leadiant%20Biosciences%2C%20Inc.&badge=phase%201 STP206 STP206 · Leadiant Biosciences, Inc. https://druglandscape.com/drug/stp705 https://druglandscape.com/api/og?type=drug&title=STP705&subtitle=STP705%20%C2%B7%20Sirnaomics&badge=phase%202 STP705 STP705 · Sirnaomics https://druglandscape.com/drug/stp707 https://druglandscape.com/api/og?type=drug&title=STP707&subtitle=STP707%20%C2%B7%20Sirnaomics&badge=phase%201 STP707 STP707 · Sirnaomics https://druglandscape.com/drug/stp938 https://druglandscape.com/api/og?type=drug&title=STP938&subtitle=STP938%20%C2%B7%20Step%20Pharma%2C%20SAS&badge=phase%201 STP938 STP938 · Step Pharma, SAS https://druglandscape.com/drug/str-324 https://druglandscape.com/api/og?type=drug&title=STR-324&subtitle=STR-324%20%C2%B7%20Alaxia%20SAS&badge=phase%202 STR-324 STR-324 · Alaxia SAS https://druglandscape.com/drug/strata-2-cxl-1020 https://druglandscape.com/api/og?type=drug&title=Strata%202%20CXL-1020&subtitle=Strata%202%20CXL-1020%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 Strata 2 CXL-1020 Strata 2 CXL-1020 · Bristol-Myers Squibb https://druglandscape.com/drug/strata-3-cxl-1020 https://druglandscape.com/api/og?type=drug&title=Strata%203%20CXL-1020&subtitle=Strata%203%20CXL-1020%20%C2%B7%20Bristol-Myers%20Squibb&badge=phase%202 Strata 3 CXL-1020 Strata 3 CXL-1020 · Bristol-Myers Squibb https://druglandscape.com/drug/stratamgt https://druglandscape.com/api/og?type=drug&title=StrataMGT&subtitle=StrataMGT%20%C2%B7%20Andrew%20T.%20Goldstein%2C%20MD&badge=phase%201 StrataMGT StrataMGT · Andrew T. Goldstein, MD https://druglandscape.com/drug/strength-a-sublingual-minoxidil https://druglandscape.com/api/og?type=drug&title=Strength%20A%20Sublingual%20Minoxidil&subtitle=Strength%20A%20Sublingual%20Minoxidil%20%C2%B7%20Samson%20Clinical%20Operations%20Pty%20Ltd&badge=phase%201 Strength A Sublingual Minoxidil Strength A Sublingual Minoxidil · Samson Clinical Operations Pty Ltd https://druglandscape.com/drug/strength-b-sublingual-minoxidil https://druglandscape.com/api/og?type=drug&title=Strength%20B%20Sublingual%20Minoxidil&subtitle=Strength%20B%20Sublingual%20Minoxidil%20%C2%B7%20Samson%20Clinical%20Operations%20Pty%20Ltd&badge=phase%201 Strength B Sublingual Minoxidil Strength B Sublingual Minoxidil · Samson Clinical Operations Pty Ltd https://druglandscape.com/drug/strepsils-anaesthetic-formula https://druglandscape.com/api/og?type=drug&title=Strepsils%20Anaesthetic%20Formula&subtitle=Strepsils%20Anaesthetic%20Formula%20%C2%B7%20Dr%20Sebastian%20Sundaraj&badge=phase%201 Strepsils Anaesthetic Formula Strepsils Anaesthetic Formula · Dr Sebastian Sundaraj https://druglandscape.com/drug/streptococcus-pneumoniae-inoculation https://druglandscape.com/api/og?type=drug&title=Streptococcus%20pneumoniae%20inoculation&subtitle=Streptococcus%20pneumoniae%20inoculation%20%C2%B7%20Genocea%20Biosciences%2C%20Inc.&badge=phase%202 Streptococcus pneumoniae inoculation Streptococcus pneumoniae inoculation · Genocea Biosciences, Inc. https://druglandscape.com/drug/stri-formula https://druglandscape.com/api/og?type=drug&title=STRI%20Formula&subtitle=STRI%20Formula%20%C2%B7%20Eyecheck%2C%20Inc.&badge=phase%202 STRI Formula STRI Formula · Eyecheck, Inc. https://druglandscape.com/drug/stro-002 https://druglandscape.com/api/og?type=drug&title=STRO-002&subtitle=STRO-002%20%C2%B7%20Tasly%20Pharmaceutical%20Group%20Co.%2C%20Ltd&badge=phase%201 STRO-002 STRO-002 · Tasly Pharmaceutical Group Co., Ltd https://druglandscape.com/drug/stro-004 https://druglandscape.com/api/og?type=drug&title=STRO-004&subtitle=STRO-004%20%C2%B7%20Sutro%20Biopharma%2C%20Inc.&badge=phase%201 STRO-004 STRO-004 · Sutro Biopharma, Inc. https://druglandscape.com/drug/stromaforte https://druglandscape.com/api/og?type=drug&title=StromaForte&subtitle=StromaForte%20%C2%B7%20Cellcolabs%20Clinical%20SPV%20Limited&badge=phase%201 StromaForte StromaForte · Cellcolabs Clinical SPV Limited https://druglandscape.com/drug/stromal-vasular-fraction https://druglandscape.com/api/og?type=drug&title=Stromal%20Vasular%20Fraction&subtitle=Stromal%20Vasular%20Fraction%20%C2%B7%20Antria&badge=phase%202 Stromal Vasular Fraction Stromal Vasular Fraction · Antria https://druglandscape.com/drug/stromectol-tablets https://druglandscape.com/api/og?type=drug&title=Stromectol%20%C2%AE%20tablets&subtitle=Stromectol%20%C2%AE%20tablets%20%C2%B7%20Humanis%20Sagl%C4%B1k%20Anonim%20Sirketi&badge=phase%201 Stromectol ® tablets Stromectol ® tablets · Humanis Saglık Anonim Sirketi https://druglandscape.com/drug/stromel https://druglandscape.com/api/og?type=drug&title=StroMel&subtitle=StroMel%20%C2%B7%20Akan%20Biosciences%2C%20LLC&badge=phase%201 StroMel StroMel · Akan Biosciences, LLC https://druglandscape.com/drug/strontium-malonate https://druglandscape.com/api/og?type=drug&title=Strontium%20malonate&subtitle=Strontium%20malonate%20%C2%B7%20Osteologix&badge=phase%202 Strontium malonate Strontium malonate · Osteologix https://druglandscape.com/drug/structured-treatment-interruption https://druglandscape.com/api/og?type=drug&title=Structured%20treatment%20interruption&subtitle=Structured%20treatment%20interruption%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%202 Structured treatment interruption Structured treatment interruption · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/stsg https://druglandscape.com/api/og?type=drug&title=STSG&subtitle=STSG%20%C2%B7%20CUTISS%20AG&badge=phase%202 STSG STSG · CUTISS AG https://druglandscape.com/drug/stud100 https://druglandscape.com/api/og?type=drug&title=STUD100&subtitle=STUD100%20%C2%B7%20Futura%20Medical%20Developments%20Ltd.&badge=phase%201 STUD100 STUD100 · Futura Medical Developments Ltd. https://druglandscape.com/drug/sturlimogene-erparepvec https://druglandscape.com/api/og?type=drug&title=Sturlimogene%20Erparepvec&subtitle=Sturlimogene%20Erparepvec%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%202 Sturlimogene Erparepvec Sturlimogene Erparepvec · City of Hope Medical Center https://druglandscape.com/drug/stx-001 https://druglandscape.com/api/og?type=drug&title=STX-001&subtitle=STX-001%20%C2%B7%20Strand%20Therapeutics%20Inc.&badge=phase%201 STX-001 STX-001 · Strand Therapeutics Inc. https://druglandscape.com/drug/stx-0712 https://druglandscape.com/api/og?type=drug&title=STX-0712&subtitle=STX-0712%20%C2%B7%20Solu%20Therapeutics%2C%20Inc&badge=phase%201 STX-0712 STX-0712 · Solu Therapeutics, Inc https://druglandscape.com/drug/stx209 https://druglandscape.com/api/og?type=drug&title=STX209&subtitle=STX209%20%C2%B7%20Seaside%20Therapeutics%2C%20Inc.&badge=phase%202 STX209 STX209 · Seaside Therapeutics, Inc. https://druglandscape.com/drug/su-011-248 https://druglandscape.com/api/og?type=drug&title=SU-011%2C248&subtitle=SU-011%2C248%20%C2%B7%20Pfizer&badge=phase%202 SU-011,248 SU-011,248 · Pfizer https://druglandscape.com/drug/su011248-capecitabine https://druglandscape.com/api/og?type=drug&title=SU011248%3B%20Capecitabine&subtitle=SU011248%3B%20Capecitabine%20%C2%B7%20Pfizer&badge=phase%201 SU011248; Capecitabine SU011248; Capecitabine · Pfizer https://druglandscape.com/drug/su014813 https://druglandscape.com/api/og?type=drug&title=SU014813&subtitle=SU014813%20%C2%B7%20Pfizer&badge=phase%202 SU014813 SU014813 · Pfizer https://druglandscape.com/drug/su5416 https://druglandscape.com/api/og?type=drug&title=SU5416&subtitle=SU5416%20%C2%B7%20SUGEN&badge=phase%202 SU5416 SU5416 · SUGEN https://druglandscape.com/drug/sub-q-gentamicin https://druglandscape.com/api/og?type=drug&title=sub-q%20gentamicin&subtitle=sub-q%20gentamicin%20%C2%B7%20Dallas%20VA%20Medical%20Center&badge=phase%201 sub-q gentamicin sub-q gentamicin · Dallas VA Medical Center https://druglandscape.com/drug/subcutaneous-abatacept https://druglandscape.com/api/og?type=drug&title=Subcutaneous%20Abatacept&subtitle=Subcutaneous%20Abatacept%20%C2%B7%20Orrin%20M%20Troum%2C%20M.D.%20and%20Medical%20Associates&badge=phase%202 Subcutaneous Abatacept Subcutaneous Abatacept · Orrin M Troum, M.D. and Medical Associates https://druglandscape.com/drug/subcutaneous-injection-of-cu-20401 https://druglandscape.com/api/og?type=drug&title=Subcutaneous%20injection%20of%20CU-20401&subtitle=Subcutaneous%20injection%20of%20CU-20401%20%C2%B7%20Cutia%20Therapeutics%EF%BC%88Wuxi%EF%BC%89Co.%2CLtd&badge=phase%202 Subcutaneous injection of CU-20401 Subcutaneous injection of CU-20401 · Cutia Therapeutics（Wuxi）Co.,Ltd https://druglandscape.com/drug/subcutaneous-interferon-gamma https://druglandscape.com/api/og?type=drug&title=Subcutaneous%20interferon-gamma&subtitle=Subcutaneous%20interferon-gamma%20%C2%B7%20NYU%20Langone%20Health&badge=phase%202 Subcutaneous interferon-gamma Subcutaneous interferon-gamma · NYU Langone Health https://druglandscape.com/drug/subcutaneous-nitroglycrin https://druglandscape.com/api/og?type=drug&title=Subcutaneous%20nitroglycrin&subtitle=Subcutaneous%20nitroglycrin%20%C2%B7%20AlRefaey%20Kandeel&badge=phase%201 Subcutaneous nitroglycrin Subcutaneous nitroglycrin · AlRefaey Kandeel https://druglandscape.com/drug/subcutaneous-rituximab https://druglandscape.com/api/og?type=drug&title=subcutaneous%20Rituximab&subtitle=subcutaneous%20Rituximab%20%C2%B7%20Grupo%20Espa%C3%B1ol%20de%20Linfomas%20y%20Transplante%20Aut%C3%B3logo%20de%20M%C3%A9dula%20%C3%93sea&badge=phase%202 subcutaneous Rituximab subcutaneous Rituximab · Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea https://druglandscape.com/drug/subcutaneous-single-and-mutiple-dose https://druglandscape.com/api/og?type=drug&title=Subcutaneous%20single%20and%20mutiple%20dose&subtitle=Subcutaneous%20single%20and%20mutiple%20dose%20%C2%B7%20Shanghai%20Minwei%20Biotechnology%20Co.%2C%20Ltd&badge=phase%201 Subcutaneous single and mutiple dose Subcutaneous single and mutiple dose · Shanghai Minwei Biotechnology Co., Ltd https://druglandscape.com/drug/subcutaneous-ustekinumab https://druglandscape.com/api/og?type=drug&title=Subcutaneous%20Ustekinumab&subtitle=Subcutaneous%20Ustekinumab%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Subcutaneous Ustekinumab Subcutaneous Ustekinumab · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/subcutaneous-vedolizumab https://druglandscape.com/api/og?type=drug&title=Subcutaneous%20vedolizumab&subtitle=Subcutaneous%20vedolizumab%20%C2%B7%20Groupe%20d'Etude%20Therapeutique%20des%20Affections%20Inflammatoires%20Digestives&badge=phase%202 Subcutaneous vedolizumab Subcutaneous vedolizumab · Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives https://druglandscape.com/drug/subcutanious-administration https://druglandscape.com/api/og?type=drug&title=subcutanious%20administration&subtitle=subcutanious%20administration%20%C2%B7%20GlaxoSmithKline&badge=phase%201 subcutanious administration subcutanious administration · GlaxoSmithKline https://druglandscape.com/drug/sublingual-aspirin https://druglandscape.com/api/og?type=drug&title=Sublingual%20aspirin&subtitle=Sublingual%20aspirin%20%C2%B7%20Vita%20Green%20Health%20Products%20Co.%20Ltd&badge=phase%201 Sublingual aspirin Sublingual aspirin · Vita Green Health Products Co. Ltd https://druglandscape.com/drug/sublingual-film-containing-dexmedetomidine https://druglandscape.com/api/og?type=drug&title=Sublingual%20film%20containing%20Dexmedetomidine&subtitle=Sublingual%20film%20containing%20Dexmedetomidine%20%C2%B7%20BioXcel%20Therapeutics%20Inc&badge=phase%201 Sublingual film containing Dexmedetomidine Sublingual film containing Dexmedetomidine · BioXcel Therapeutics Inc https://druglandscape.com/drug/sublingual-ketamine-wafers https://druglandscape.com/api/og?type=drug&title=Sublingual%20ketamine%20wafers&subtitle=Sublingual%20ketamine%20wafers%20%C2%B7%20iX%20Biopharma%20Ltd.&badge=phase%202 Sublingual ketamine wafers Sublingual ketamine wafers · iX Biopharma Ltd. https://druglandscape.com/drug/sublingual-tizanidine-hcl https://druglandscape.com/api/og?type=drug&title=Sublingual%20Tizanidine%20HCl&subtitle=Sublingual%20Tizanidine%20HCl%20%C2%B7%20Teva%20GTC&badge=phase%201 Sublingual Tizanidine HCl Sublingual Tizanidine HCl · Teva GTC https://druglandscape.com/drug/sublivac-fix-mite-mixture https://druglandscape.com/api/og?type=drug&title=SUBLIVAC%20FIX%20Mite%20mixture&subtitle=SUBLIVAC%20FIX%20Mite%20mixture%20%C2%B7%20HAL%20Allergy&badge=phase%201 SUBLIVAC FIX Mite mixture SUBLIVAC FIX Mite mixture · HAL Allergy https://druglandscape.com/drug/sublivac-fix-phleum-prat https://druglandscape.com/api/og?type=drug&title=SUBLIVAC%20FIX%20phleum%20prat.&subtitle=SUBLIVAC%20FIX%20phleum%20prat.%20%C2%B7%20HAL%20Allergy&badge=phase%202 SUBLIVAC FIX phleum prat. SUBLIVAC FIX phleum prat. · HAL Allergy https://druglandscape.com/drug/subretinally-injected-retinostat https://druglandscape.com/api/og?type=drug&title=Subretinally%20injected%20RetinoStat&subtitle=Subretinally%20injected%20RetinoStat%20%C2%B7%20Oxford%20BioMedica&badge=phase%201 Subretinally injected RetinoStat Subretinally injected RetinoStat · Oxford BioMedica https://druglandscape.com/drug/substance-like-alcohol-marijuana-etc https://druglandscape.com/api/og?type=drug&title=Substance%20like%20alcohol%2C%20marijuana%2C%20etc.&subtitle=Substance%20like%20alcohol%2C%20marijuana%2C%20etc.%20%C2%B7%20Singh%2C%20Ranjan%20Kumar%2C%20M.D.&badge=phase%202 Substance like alcohol, marijuana, etc. Substance like alcohol, marijuana, etc. · Singh, Ranjan Kumar, M.D. https://druglandscape.com/drug/subutinib-maleate-capsules https://druglandscape.com/api/og?type=drug&title=Subutinib%20Maleate%20capsules&subtitle=Subutinib%20Maleate%20capsules%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 Subutinib Maleate capsules Subutinib Maleate capsules · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/sufentanil-nanotab https://druglandscape.com/api/og?type=drug&title=Sufentanil%20NanoTab&subtitle=Sufentanil%20NanoTab%20%C2%B7%20Talphera%2C%20Inc&badge=phase%202 Sufentanil NanoTab Sufentanil NanoTab · Talphera, Inc https://druglandscape.com/drug/suglat https://druglandscape.com/api/og?type=drug&title=Suglat%C2%AE&subtitle=Suglat%C2%AE%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%202 Suglat® Suglat® · Astellas Pharma Inc https://druglandscape.com/drug/sulfadoxine-pyrimethamine-with-artesunate https://druglandscape.com/api/og?type=drug&title=sulfadoxine-pyrimethamine%20with%20artesunate&subtitle=sulfadoxine-pyrimethamine%20with%20artesunate%20%C2%B7%20Centers%20for%20Disease%20Control%20and%20Prevention&badge=phase%201 sulfadoxine-pyrimethamine with artesunate sulfadoxine-pyrimethamine with artesunate · Centers for Disease Control and Prevention https://druglandscape.com/drug/sulfatinib-t-capsule https://druglandscape.com/api/og?type=drug&title=Sulfatinib%20T%20capsule&subtitle=Sulfatinib%20T%20capsule%20%C2%B7%20Hutchison%20Medipharma%20Limited&badge=phase%201 Sulfatinib T capsule Sulfatinib T capsule · Hutchison Medipharma Limited https://druglandscape.com/drug/sulforaphane-nutraceutical https://druglandscape.com/api/og?type=drug&title=Sulforaphane%20Nutraceutical&subtitle=Sulforaphane%20Nutraceutical%20%C2%B7%20Sheppard%20Pratt%20Health%20System&badge=phase%202 Sulforaphane Nutraceutical Sulforaphane Nutraceutical · Sheppard Pratt Health System https://druglandscape.com/drug/sulphadoxine-pryrimethamine https://druglandscape.com/api/og?type=drug&title=Sulphadoxine-pryrimethamine&subtitle=Sulphadoxine-pryrimethamine%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%202 Sulphadoxine-pryrimethamine Sulphadoxine-pryrimethamine · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/sulphadoxine-pyrimethamine-and-amodiaquine https://druglandscape.com/api/og?type=drug&title=Sulphadoxine-pyrimethamine%20and%20Amodiaquine&subtitle=Sulphadoxine-pyrimethamine%20and%20Amodiaquine%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%201 Sulphadoxine-pyrimethamine and Amodiaquine Sulphadoxine-pyrimethamine and Amodiaquine · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/sult-allosteric-inhibition https://druglandscape.com/api/og?type=drug&title=SULT%20Allosteric%20Inhibition&subtitle=SULT%20Allosteric%20Inhibition%20%C2%B7%20Albert%20Einstein%20College%20of%20Medicine&badge=phase%201 SULT Allosteric Inhibition SULT Allosteric Inhibition · Albert Einstein College of Medicine https://druglandscape.com/drug/sum-101 https://druglandscape.com/api/og?type=drug&title=SUM-101&subtitle=SUM-101%20%C2%B7%20European%20Vaccine%20Initiative&badge=phase%201 SUM-101 SUM-101 · European Vaccine Initiative https://druglandscape.com/drug/sumatriptan-5 https://druglandscape.com/api/og?type=drug&title=Sumatriptan%205%25&subtitle=Sumatriptan%205%25%20%C2%B7%20Express%20Specialty%20Pharmacy&badge=phase%202 Sumatriptan 5% Sumatriptan 5% · Express Specialty Pharmacy https://druglandscape.com/drug/sunitinib-and-erlotinib https://druglandscape.com/api/og?type=drug&title=Sunitinib%20and%20Erlotinib&subtitle=Sunitinib%20and%20Erlotinib%20%C2%B7%20Clinical%20Research%20Management%2C%20Inc.&badge=phase%201 Sunitinib and Erlotinib Sunitinib and Erlotinib · Clinical Research Management, Inc. https://druglandscape.com/drug/sunitinib-malate-capsules-generic-product https://druglandscape.com/api/og?type=drug&title=Sunitinib%20malate%20capsules%20generic%20product&subtitle=Sunitinib%20malate%20capsules%20generic%20product%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 Sunitinib malate capsules generic product Sunitinib malate capsules generic product · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/sunitinib-malate-dose-escalation https://druglandscape.com/api/og?type=drug&title=sunitinib%20malate%20dose%20escalation&subtitle=sunitinib%20malate%20dose%20escalation%20%C2%B7%20Pfizer&badge=phase%202 sunitinib malate dose escalation sunitinib malate dose escalation · Pfizer https://druglandscape.com/drug/sunitinib-maleate https://druglandscape.com/api/og?type=drug&title=Sunitinib%20maleate&subtitle=Sunitinib%20maleate%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 Sunitinib maleate Sunitinib maleate · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/sunitinib-pemetrexed https://druglandscape.com/api/og?type=drug&title=Sunitinib%2C%20Pemetrexed&subtitle=Sunitinib%2C%20Pemetrexed%20%C2%B7%20Pfizer&badge=phase%201 Sunitinib, Pemetrexed Sunitinib, Pemetrexed · Pfizer https://druglandscape.com/drug/sunitinib-pemetrexed-cisplatin-carboplatin https://druglandscape.com/api/og?type=drug&title=Sunitinib%2C%20Pemetrexed%2C%20Cisplatin%2C%20Carboplatin&subtitle=Sunitinib%2C%20Pemetrexed%2C%20Cisplatin%2C%20Carboplatin%20%C2%B7%20Pfizer&badge=phase%201 Sunitinib, Pemetrexed, Cisplatin, Carboplatin Sunitinib, Pemetrexed, Cisplatin, Carboplatin · Pfizer https://druglandscape.com/drug/sunpg1623-i https://druglandscape.com/api/og?type=drug&title=SUNPG1623%20I&subtitle=SUNPG1623%20I%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%202 SUNPG1623 I SUNPG1623 I · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/sunpg1623-ii https://druglandscape.com/api/og?type=drug&title=SUNPG1623%20II&subtitle=SUNPG1623%20II%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%202 SUNPG1623 II SUNPG1623 II · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/sunpg1623-iii https://druglandscape.com/api/og?type=drug&title=SUNPG1623%20III&subtitle=SUNPG1623%20III%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%202 SUNPG1623 III SUNPG1623 III · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/sunscreen-fps-60 https://druglandscape.com/api/og?type=drug&title=Sunscreen%20FPS%2060&subtitle=Sunscreen%20FPS%2060%20%C2%B7%20Universidade%20Federal%20de%20Goias&badge=phase%202 Sunscreen FPS 60 Sunscreen FPS 60 · Universidade Federal de Goias https://druglandscape.com/drug/sunscreen-oil-with-6-bemotrizinol https://druglandscape.com/api/og?type=drug&title=Sunscreen%20oil%20with%206%25%20Bemotrizinol&subtitle=Sunscreen%20oil%20with%206%25%20Bemotrizinol%20%C2%B7%20dsm-firmenich%20Switzerland%20AG&badge=phase%202 Sunscreen oil with 6% Bemotrizinol Sunscreen oil with 6% Bemotrizinol · dsm-firmenich Switzerland AG https://druglandscape.com/drug/sunscreening-agents https://druglandscape.com/api/og?type=drug&title=Sunscreening%20Agents&subtitle=Sunscreening%20Agents%20%C2%B7%20Henry%20Ford%20Health%20System&badge=phase%202 Sunscreening Agents Sunscreening Agents · Henry Ford Health System https://druglandscape.com/drug/super-dc-vaccine https://druglandscape.com/api/og?type=drug&title=Super%20DC%20Vaccine&subtitle=Super%20DC%20Vaccine%20%C2%B7%20Shanghai%20Cell%20Therapy%20Group%20Co.%2CLtd&badge=phase%201 Super DC Vaccine Super DC Vaccine · Shanghai Cell Therapy Group Co.,Ltd https://druglandscape.com/drug/super1-tcr-t https://druglandscape.com/api/og?type=drug&title=Super1%20TCR-T&subtitle=Super1%20TCR-T%20%C2%B7%20Guangzhou%20FineImmune%20Biotechnology%20Co.%2C%20LTD.&badge=phase%201 Super1 TCR-T Super1 TCR-T · Guangzhou FineImmune Biotechnology Co., LTD. https://druglandscape.com/drug/superficial-skin-swabs https://druglandscape.com/api/og?type=drug&title=Superficial%20skin%20swabs&subtitle=Superficial%20skin%20swabs%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Superficial skin swabs Superficial skin swabs · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/superparamagnetic-iron-oxide https://druglandscape.com/api/og?type=drug&title=Superparamagnetic%20Iron%20Oxide&subtitle=Superparamagnetic%20Iron%20Oxide%20%C2%B7%20Vastra%20Gotaland%20Region&badge=phase%202 Superparamagnetic Iron Oxide Superparamagnetic Iron Oxide · Vastra Gotaland Region https://druglandscape.com/drug/suplexa https://druglandscape.com/api/og?type=drug&title=SUPLEXA&subtitle=SUPLEXA%20%C2%B7%20Alloplex%20Biotherapeutics%20Inc&badge=phase%201 SUPLEXA SUPLEXA · Alloplex Biotherapeutics Inc https://druglandscape.com/drug/supplementary-oxygen https://druglandscape.com/api/og?type=drug&title=supplementary%20oxygen&subtitle=supplementary%20oxygen%20%C2%B7%20LHL%20Helse&badge=phase%201 supplementary oxygen supplementary oxygen · LHL Helse https://druglandscape.com/drug/supra-therapeutic-dose https://druglandscape.com/api/og?type=drug&title=Supra-therapeutic%20Dose&subtitle=Supra-therapeutic%20Dose%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%201 Supra-therapeutic Dose Supra-therapeutic Dose · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/suramin-sodium https://druglandscape.com/api/og?type=drug&title=Suramin%20Sodium&subtitle=Suramin%20Sodium%20%C2%B7%20Paxmedica&badge=phase%202 Suramin Sodium Suramin Sodium · Paxmedica https://druglandscape.com/drug/surf-201 https://druglandscape.com/api/og?type=drug&title=SURF-201&subtitle=SURF-201%20%C2%B7%20Surface%20Ophthalmics%2C%20Inc.&badge=phase%202 SURF-201 SURF-201 · Surface Ophthalmics, Inc. https://druglandscape.com/drug/surfactant-administration https://druglandscape.com/api/og?type=drug&title=surfactant%20administration&subtitle=surfactant%20administration%20%C2%B7%20HaEmek%20Medical%20Center%2C%20Israel&badge=phase%201 surfactant administration surfactant administration · HaEmek Medical Center, Israel https://druglandscape.com/drug/surfolase-cr https://druglandscape.com/api/og?type=drug&title=Surfolase%20CR&subtitle=Surfolase%20CR%20%C2%B7%20Hyundai%20Pharmaceutical%20Co.%2C%20LTD.&badge=phase%201 Surfolase CR Surfolase CR · Hyundai Pharmaceutical Co., LTD. https://druglandscape.com/drug/surgical-tissue-samples https://druglandscape.com/api/og?type=drug&title=surgical%20tissue%20samples&subtitle=surgical%20tissue%20samples%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 surgical tissue samples surgical tissue samples · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/suspension-fed-state https://druglandscape.com/api/og?type=drug&title=Suspension%20Fed%20State&subtitle=Suspension%20Fed%20State%20%C2%B7%20KU%20Leuven&badge=phase%201 Suspension Fed State Suspension Fed State · KU Leuven https://druglandscape.com/drug/sustained-release-desvenlafaxine-hydrochloride https://druglandscape.com/api/og?type=drug&title=Sustained-Release%20Desvenlafaxine%20Hydrochloride&subtitle=Sustained-Release%20Desvenlafaxine%20Hydrochloride%20%C2%B7%20Jiangsu%20Hansoh%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Sustained-Release Desvenlafaxine Hydrochloride Sustained-Release Desvenlafaxine Hydrochloride · Jiangsu Hansoh Pharmaceutical Co., Ltd. https://druglandscape.com/drug/sustained-release-tablet https://druglandscape.com/api/og?type=drug&title=sustained%20release%20tablet&subtitle=sustained%20release%20tablet%20%C2%B7%20IlDong%20Pharmaceutical%20Co%20Ltd&badge=phase%201 sustained release tablet sustained release tablet · IlDong Pharmaceutical Co Ltd https://druglandscape.com/drug/sutetinib-maleate-capsule https://druglandscape.com/api/og?type=drug&title=Sutetinib%20Maleate%20Capsule&subtitle=Sutetinib%20Maleate%20Capsule%20%C2%B7%20Teligene%20US&badge=phase%202 Sutetinib Maleate Capsule Sutetinib Maleate Capsule · Teligene US https://druglandscape.com/drug/suvn-502 https://druglandscape.com/api/og?type=drug&title=SUVN-502&subtitle=SUVN-502%20%C2%B7%20Suven%20Life%20Sciences%20Limited&badge=phase%202 SUVN-502 SUVN-502 · Suven Life Sciences Limited https://druglandscape.com/drug/sv003 https://druglandscape.com/api/og?type=drug&title=SV003&subtitle=SV003%20%C2%B7%20Shanghai%20Synvida%20Biotechnology%20Co.%2CLtd.&badge=phase%201 SV003 SV003 · Shanghai Synvida Biotechnology Co.,Ltd. https://druglandscape.com/drug/svg103 https://druglandscape.com/api/og?type=drug&title=SVG103&subtitle=SVG103%20%C2%B7%20Sovargen&badge=phase%201 SVG103 SVG103 · Sovargen https://druglandscape.com/drug/svt-40776 https://druglandscape.com/api/og?type=drug&title=SVT-40776&subtitle=SVT-40776%20%C2%B7%20Salvat&badge=phase%202 SVT-40776 SVT-40776 · Salvat https://druglandscape.com/drug/sw-682 https://druglandscape.com/api/og?type=drug&title=SW-682&subtitle=SW-682%20%C2%B7%20SpringWorks%20Therapeutics%2C%20Inc.&badge=phase%201 SW-682 SW-682 · SpringWorks Therapeutics, Inc. https://druglandscape.com/drug/swa1211 https://druglandscape.com/api/og?type=drug&title=SWA1211&subtitle=SWA1211%20%C2%B7%20Beijing%20StoneWise%20Technology%20Co.%2C%20Ltd&badge=phase%201 SWA1211 SWA1211 · Beijing StoneWise Technology Co., Ltd https://druglandscape.com/drug/swallowed-fluticasone https://druglandscape.com/api/og?type=drug&title=Swallowed%20fluticasone&subtitle=Swallowed%20fluticasone%20%C2%B7%20Walter%20Reed%20Army%20Medical%20Center&badge=phase%201 Swallowed fluticasone Swallowed fluticasone · Walter Reed Army Medical Center https://druglandscape.com/drug/sxc-2023 https://druglandscape.com/api/og?type=drug&title=SXC-2023&subtitle=SXC-2023%20%C2%B7%20Promentis%20Pharmaceuticals%2C%20Inc.&badge=phase%202 SXC-2023 SXC-2023 · Promentis Pharmaceuticals, Inc. https://druglandscape.com/drug/sy-004 https://druglandscape.com/api/og?type=drug&title=SY-004&subtitle=SY-004%20%C2%B7%20Suzhou%20Yabao%20Pharmaceutical%20R%26D%20Co.%2C%20Ltd.&badge=phase%202 SY-004 SY-004 · Suzhou Yabao Pharmaceutical R&D Co., Ltd. https://druglandscape.com/drug/sy-005 https://druglandscape.com/api/og?type=drug&title=SY-005&subtitle=SY-005%20%C2%B7%20Suzhou%20Yabao%20Pharmaceutical%20R%26D%20Co.%2C%20Ltd.&badge=phase%202 SY-005 SY-005 · Suzhou Yabao Pharmaceutical R&D Co., Ltd. https://druglandscape.com/drug/sy-007 https://druglandscape.com/api/og?type=drug&title=SY-007&subtitle=SY-007%20%C2%B7%20Suzhou%20Yabao%20Pharmaceutical%20R%26D%20Co.%2C%20Ltd.&badge=phase%201 SY-007 SY-007 · Suzhou Yabao Pharmaceutical R&D Co., Ltd. https://druglandscape.com/drug/sy-008 https://druglandscape.com/api/og?type=drug&title=SY-008&subtitle=SY-008%20%C2%B7%20Suzhou%20Yabao%20Pharmaceutical%20R%26D%20Co.%2C%20Ltd.&badge=phase%201 SY-008 SY-008 · Suzhou Yabao Pharmaceutical R&D Co., Ltd. https://druglandscape.com/drug/sy-009-capsules https://druglandscape.com/api/og?type=drug&title=SY-009%20capsules&subtitle=SY-009%20capsules%20%C2%B7%20Suzhou%20Yabao%20Pharmaceutical%20R%26D%20Co.%2C%20Ltd.&badge=phase%202 SY-009 capsules SY-009 capsules · Suzhou Yabao Pharmaceutical R&D Co., Ltd. https://druglandscape.com/drug/sy-201-ophthalmic-solution-0-5 https://druglandscape.com/api/og?type=drug&title=SY-201%20Ophthalmic%20Solution%200.5%25&subtitle=SY-201%20Ophthalmic%20Solution%200.5%25%20%C2%B7%20Seinda%20Pharmaceutical%20Guangzhou%20Corporation&badge=phase%201 SY-201 Ophthalmic Solution 0.5% SY-201 Ophthalmic Solution 0.5% · Seinda Pharmaceutical Guangzhou Corporation https://druglandscape.com/drug/sy-201-ophthalmic-solution-1-0 https://druglandscape.com/api/og?type=drug&title=SY-201%20Ophthalmic%20Solution%201.0%25&subtitle=SY-201%20Ophthalmic%20Solution%201.0%25%20%C2%B7%20Seinda%20Pharmaceutical%20Guangzhou%20Corporation&badge=phase%201 SY-201 Ophthalmic Solution 1.0% SY-201 Ophthalmic Solution 1.0% · Seinda Pharmaceutical Guangzhou Corporation https://druglandscape.com/drug/sy-3505 https://druglandscape.com/api/og?type=drug&title=SY-3505&subtitle=SY-3505%20%C2%B7%20Shouyao%20Holdings%20(Beijing)%20Co.%20LTD&badge=phase%202 SY-3505 SY-3505 · Shouyao Holdings (Beijing) Co. LTD https://druglandscape.com/drug/sy-4835 https://druglandscape.com/api/og?type=drug&title=SY-4835&subtitle=SY-4835%20%C2%B7%20Shouyao%20Holdings%20(Beijing)%20Co.%20LTD&badge=phase%201 SY-4835 SY-4835 · Shouyao Holdings (Beijing) Co. LTD https://druglandscape.com/drug/sy-5933 https://druglandscape.com/api/og?type=drug&title=SY-5933&subtitle=SY-5933%20%C2%B7%20Shouyao%20Holdings%20(Beijing)%20Co.%20LTD&badge=phase%201 SY-5933 SY-5933 · Shouyao Holdings (Beijing) Co. LTD https://druglandscape.com/drug/sy-9453 https://druglandscape.com/api/og?type=drug&title=SY-9453&subtitle=SY-9453%20%C2%B7%20Shouyao%20Holdings%20(Beijing)%20Co.%20LTD&badge=phase%201 SY-9453 SY-9453 · Shouyao Holdings (Beijing) Co. LTD https://druglandscape.com/drug/sy001 https://druglandscape.com/api/og?type=drug&title=SY001&subtitle=SY001%20%C2%B7%20Cell%20Origin%20Biotech%20(Hangzhou)%20Co.%2C%20Ltd.&badge=phase%201 SY001 SY001 · Cell Origin Biotech (Hangzhou) Co., Ltd. https://druglandscape.com/drug/syb-c-0501 https://druglandscape.com/api/og?type=drug&title=SyB%20C-0501&subtitle=SyB%20C-0501%20%C2%B7%20SymBio%20Pharmaceuticals&badge=phase%201 SyB C-0501 SyB C-0501 · SymBio Pharmaceuticals https://druglandscape.com/drug/syb-d-0701 https://druglandscape.com/api/og?type=drug&title=SyB%20D-0701&subtitle=SyB%20D-0701%20%C2%B7%20SymBio%20Pharmaceuticals&badge=phase%202 SyB D-0701 SyB D-0701 · SymBio Pharmaceuticals https://druglandscape.com/drug/syb-l-1101 https://druglandscape.com/api/og?type=drug&title=SyB%20L-1101&subtitle=SyB%20L-1101%20%C2%B7%20SymBio%20Pharmaceuticals&badge=phase%201 SyB L-1101 SyB L-1101 · SymBio Pharmaceuticals https://druglandscape.com/drug/syb-v-1901 https://druglandscape.com/api/og?type=drug&title=SyB%20V-1901&subtitle=SyB%20V-1901%20%C2%B7%20SymBio%20Pharmaceuticals&badge=phase%201 SyB V-1901 SyB V-1901 · SymBio Pharmaceuticals https://druglandscape.com/drug/syd1875 https://druglandscape.com/api/og?type=drug&title=SYD1875&subtitle=SYD1875%20%C2%B7%20Byondis%20B.V.&badge=phase%201 SYD1875 SYD1875 · Byondis B.V. https://druglandscape.com/drug/syd985 https://druglandscape.com/api/og?type=drug&title=SYD985&subtitle=SYD985%20%C2%B7%20Byondis%20B.V.&badge=phase%202 SYD985 SYD985 · Byondis B.V. https://druglandscape.com/drug/syh2043 https://druglandscape.com/api/og?type=drug&title=SYH2043&subtitle=SYH2043%20%C2%B7%20CSPC%20Ouyi%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SYH2043 SYH2043 · CSPC Ouyi Pharmaceutical Co., Ltd. https://druglandscape.com/drug/syha1402-tablets https://druglandscape.com/api/og?type=drug&title=SYHA1402%20tablets&subtitle=SYHA1402%20tablets%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%202 SYHA1402 tablets SYHA1402 tablets · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/syha1805-tablets https://druglandscape.com/api/og?type=drug&title=SYHA1805%20tablets&subtitle=SYHA1805%20tablets%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 SYHA1805 tablets SYHA1805 tablets · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/syha1815 https://druglandscape.com/api/og?type=drug&title=SYHA1815&subtitle=SYHA1815%20%C2%B7%20Shanghai%20Runshi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd&badge=phase%201 SYHA1815 SYHA1815 · Shanghai Runshi Pharmaceutical Technology Co., Ltd https://druglandscape.com/drug/syhx1903 https://druglandscape.com/api/og?type=drug&title=SYHX1903&subtitle=SYHX1903%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 SYHX1903 SYHX1903 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/syhx2001 https://druglandscape.com/api/og?type=drug&title=SYHX2001&subtitle=SYHX2001%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 SYHX2001 SYHX2001 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/syhx2005 https://druglandscape.com/api/og?type=drug&title=SYHX2005&subtitle=SYHX2005%20%C2%B7%20CSPC%20Ouyi%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SYHX2005 SYHX2005 · CSPC Ouyi Pharmaceutical Co., Ltd. https://druglandscape.com/drug/syhx2011-and-abraxane https://druglandscape.com/api/og?type=drug&title=SYHX2011%20and%20Abraxane%C2%AE&subtitle=SYHX2011%20and%20Abraxane%C2%AE%20%C2%B7%20CSPC%20Ouyi%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 SYHX2011 and Abraxane® SYHX2011 and Abraxane® · CSPC Ouyi Pharmaceutical Co., Ltd. https://druglandscape.com/drug/syl040012 https://druglandscape.com/api/og?type=drug&title=SYL040012&subtitle=SYL040012%20%C2%B7%20Sylentis%2C%20S.A.&badge=phase%202 SYL040012 SYL040012 · Sylentis, S.A. https://druglandscape.com/drug/syl1001 https://druglandscape.com/api/og?type=drug&title=SYL1001&subtitle=SYL1001%20%C2%B7%20Sylentis%2C%20S.A.&badge=phase%202 SYL1001 SYL1001 · Sylentis, S.A. https://druglandscape.com/drug/syl18001-sodium-high-dose-b-i-d https://druglandscape.com/api/og?type=drug&title=SYL18001%20sodium%20High%20dose%20b.i.d&subtitle=SYL18001%20sodium%20High%20dose%20b.i.d%20%C2%B7%20Sylentis%2C%20S.A.&badge=phase%201 SYL18001 sodium High dose b.i.d SYL18001 sodium High dose b.i.d · Sylentis, S.A. https://druglandscape.com/drug/syl18001-sodium-high-dose-q-d https://druglandscape.com/api/og?type=drug&title=SYL18001%20sodium%20High%20dose%20q.d&subtitle=SYL18001%20sodium%20High%20dose%20q.d%20%C2%B7%20Sylentis%2C%20S.A.&badge=phase%201 SYL18001 sodium High dose q.d SYL18001 sodium High dose q.d · Sylentis, S.A. https://druglandscape.com/drug/syl18001-sodium-low-dose-q-d https://druglandscape.com/api/og?type=drug&title=SYL18001%20sodium%20Low%20dose%20q.d&subtitle=SYL18001%20sodium%20Low%20dose%20q.d%20%C2%B7%20Sylentis%2C%20S.A.&badge=phase%201 SYL18001 sodium Low dose q.d SYL18001 sodium Low dose q.d · Sylentis, S.A. https://druglandscape.com/drug/syl18001-sodium-middle-dose-q-d https://druglandscape.com/api/og?type=drug&title=SYL18001%20sodium%20Middle%20dose%20q.d&subtitle=SYL18001%20sodium%20Middle%20dose%20q.d%20%C2%B7%20Sylentis%2C%20S.A.&badge=phase%201 SYL18001 sodium Middle dose q.d SYL18001 sodium Middle dose q.d · Sylentis, S.A. https://druglandscape.com/drug/syl1801 https://druglandscape.com/api/og?type=drug&title=SYL1801&subtitle=SYL1801%20%C2%B7%20Sylentis%2C%20S.A.&badge=phase%202 SYL1801 SYL1801 · Sylentis, S.A. https://druglandscape.com/drug/sym001 https://druglandscape.com/api/og?type=drug&title=Sym001&subtitle=Sym001%20%C2%B7%20Symphogen%20A%2FS&badge=phase%202 Sym001 Sym001 · Symphogen A/S https://druglandscape.com/drug/sym015 https://druglandscape.com/api/og?type=drug&title=Sym015&subtitle=Sym015%20%C2%B7%20Symphogen%20A%2FS&badge=phase%201 Sym015 Sym015 · Symphogen A/S https://druglandscape.com/drug/sym021 https://druglandscape.com/api/og?type=drug&title=Sym021&subtitle=Sym021%20%C2%B7%20Symphogen%20A%2FS&badge=phase%201 Sym021 Sym021 · Symphogen A/S https://druglandscape.com/drug/sym022 https://druglandscape.com/api/og?type=drug&title=Sym022&subtitle=Sym022%20%C2%B7%20Symphogen%20A%2FS&badge=phase%201 Sym022 Sym022 · Symphogen A/S https://druglandscape.com/drug/sym023 https://druglandscape.com/api/og?type=drug&title=Sym023&subtitle=Sym023%20%C2%B7%20Symphogen%20A%2FS&badge=phase%201 Sym023 Sym023 · Symphogen A/S https://druglandscape.com/drug/sym024 https://druglandscape.com/api/og?type=drug&title=Sym024&subtitle=Sym024%20%C2%B7%20Symphogen%20A%2FS&badge=phase%201 Sym024 Sym024 · Symphogen A/S https://druglandscape.com/drug/symbicort-pmdi-without-spacer-device https://druglandscape.com/api/og?type=drug&title=Symbicort%20pMDI%20without%20spacer%20device&subtitle=Symbicort%20pMDI%20without%20spacer%20device%20%C2%B7%20AstraZeneca&badge=phase%201 Symbicort pMDI without spacer device Symbicort pMDI without spacer device · AstraZeneca https://druglandscape.com/drug/symlin-and-humulin https://druglandscape.com/api/og?type=drug&title=Symlin%C2%AE%20and%20Humulin%C2%AE&subtitle=Symlin%C2%AE%20and%20Humulin%C2%AE%20%C2%B7%20Adocia&badge=phase%201 Symlin® and Humulin® Symlin® and Humulin® · Adocia https://druglandscape.com/drug/syn-004 https://druglandscape.com/api/og?type=drug&title=SYN-004&subtitle=SYN-004%20%C2%B7%20Theriva%20Biologics%2C%20Inc.&badge=phase%202 SYN-004 SYN-004 · Theriva Biologics, Inc. https://druglandscape.com/drug/syn-010 https://druglandscape.com/api/og?type=drug&title=SYN-010&subtitle=SYN-010%20%C2%B7%20Theriva%20Biologics%2C%20Inc.&badge=phase%202 SYN-010 SYN-010 · Theriva Biologics, Inc. https://druglandscape.com/drug/syn-020-delayed-release-capsule https://druglandscape.com/api/og?type=drug&title=SYN-020%20Delayed%20Release%20Capsule&subtitle=SYN-020%20Delayed%20Release%20Capsule%20%C2%B7%20Theriva%20Biologics%2C%20Inc.&badge=phase%201 SYN-020 Delayed Release Capsule SYN-020 Delayed Release Capsule · Theriva Biologics, Inc. https://druglandscape.com/drug/syn060 https://druglandscape.com/api/og?type=drug&title=SYN060&subtitle=SYN060%20%C2%B7%20Synermore%20Biologics%20Co.%2C%20Ltd.&badge=phase%201 SYN060 SYN060 · Synermore Biologics Co., Ltd. https://druglandscape.com/drug/syn111 https://druglandscape.com/api/og?type=drug&title=SYN111&subtitle=SYN111%20%C2%B7%20Biotie%20Therapies%20Inc.&badge=phase%202 SYN111 SYN111 · Biotie Therapies Inc. https://druglandscape.com/drug/syn120 https://druglandscape.com/api/og?type=drug&title=SYN120&subtitle=SYN120%20%C2%B7%20Biotie%20Therapies%20Inc.&badge=phase%202 SYN120 SYN120 · Biotie Therapies Inc. https://druglandscape.com/drug/syn321 https://druglandscape.com/api/og?type=drug&title=SYN321&subtitle=SYN321%20%C2%B7%20Synartro%20AB&badge=phase%201 SYN321 SYN321 · Synartro AB https://druglandscape.com/drug/syn608 https://druglandscape.com/api/og?type=drug&title=SYN608&subtitle=SYN608%20%C2%B7%20Hangzhou%20SynRx%20Therapeutics%20Biomedical%20Technology%20Co.%2C%20Ltd&badge=phase%201 SYN608 SYN608 · Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd https://druglandscape.com/drug/syn818 https://druglandscape.com/api/og?type=drug&title=SYN818&subtitle=SYN818%20%C2%B7%20Hangzhou%20SynRx%20Therapeutics%20Biomedical%20Technology%20Co.%2C%20Ltd&badge=phase%201 SYN818 SYN818 · Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd https://druglandscape.com/drug/syn818-and-olaparib-will-be-administered https://druglandscape.com/api/og?type=drug&title=SYN818%20and%20Olaparib%20will%20be%20administered&subtitle=SYN818%20and%20Olaparib%20will%20be%20administered%20%C2%B7%20Hangzhou%20SynRx%20Therapeutics%20Biomedical%20Technology%20Co.%2C%20Lt&badge=phase%201 SYN818 and Olaparib will be administered SYN818 and Olaparib will be administered · Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd https://druglandscape.com/drug/synalar-ointment https://druglandscape.com/api/og?type=drug&title=Synalar%C2%AE%20ointment&subtitle=Synalar%C2%AE%20ointment%20%C2%B7%20LEO%20Pharma&badge=phase%201 Synalar® ointment Synalar® ointment · LEO Pharma https://druglandscape.com/drug/synb1934 https://druglandscape.com/api/og?type=drug&title=SYNB1934&subtitle=SYNB1934%20%C2%B7%20Synlogic&badge=phase%202 SYNB1934 SYNB1934 · Synlogic https://druglandscape.com/drug/synb8802 https://druglandscape.com/api/og?type=drug&title=SYNB8802&subtitle=SYNB8802%20%C2%B7%20Synlogic&badge=phase%201 SYNB8802 SYNB8802 · Synlogic https://druglandscape.com/drug/synb8802v1 https://druglandscape.com/api/og?type=drug&title=SYNB8802v1&subtitle=SYNB8802v1%20%C2%B7%20Synlogic&badge=phase%201 SYNB8802v1 SYNB8802v1 · Synlogic https://druglandscape.com/drug/synbiotic-supplement https://druglandscape.com/api/og?type=drug&title=Synbiotic%20Supplement&subtitle=Synbiotic%20Supplement%20%C2%B7%20Sheppard%20Pratt%20Health%20System&badge=phase%202 Synbiotic Supplement Synbiotic Supplement · Sheppard Pratt Health System https://druglandscape.com/drug/syncar-001 https://druglandscape.com/api/og?type=drug&title=SYNCAR-001&subtitle=SYNCAR-001%20%C2%B7%20Synthekine&badge=phase%201 SYNCAR-001 SYNCAR-001 · Synthekine https://druglandscape.com/drug/syngem https://druglandscape.com/api/og?type=drug&title=SynGEM&subtitle=SynGEM%20%C2%B7%20Mucosis%20BV&badge=phase%201 SynGEM SynGEM · Mucosis BV https://druglandscape.com/drug/synov1-1 https://druglandscape.com/api/og?type=drug&title=SynOV1.1&subtitle=SynOV1.1%20%C2%B7%20Beijing%20Syngentech%20Co.%2C%20Ltd.&badge=phase%201 SynOV1.1 SynOV1.1 · Beijing Syngentech Co., Ltd. https://druglandscape.com/drug/synt001 https://druglandscape.com/api/og?type=drug&title=SYNT001&subtitle=SYNT001%20%C2%B7%20Syntimmune%2C%20Inc.&badge=phase%201 SYNT001 SYNT001 · Syntimmune, Inc. https://druglandscape.com/drug/syo-1126 https://druglandscape.com/api/og?type=drug&title=SYO-1126&subtitle=SYO-1126%20%C2%B7%20Samyang%20Biopharmaceuticals%20Corporation&badge=phase%201 SYO-1126 SYO-1126 · Samyang Biopharmaceuticals Corporation https://druglandscape.com/drug/syo-1644 https://druglandscape.com/api/og?type=drug&title=SYO-1644&subtitle=SYO-1644%20%C2%B7%20Samyang%20Biopharmaceuticals%20Corporation&badge=phase%201 SYO-1644 SYO-1644 · Samyang Biopharmaceuticals Corporation https://druglandscape.com/drug/syp-1512 https://druglandscape.com/api/og?type=drug&title=SYP-1512&subtitle=SYP-1512%20%C2%B7%20Samyang%20Biopharmaceuticals%20Corporation&badge=phase%201 SYP-1512 SYP-1512 · Samyang Biopharmaceuticals Corporation https://druglandscape.com/drug/syr-322-4833-bl https://druglandscape.com/api/og?type=drug&title=SYR-322-4833%20BL&subtitle=SYR-322-4833%20BL%20%C2%B7%20Takeda&badge=phase%201 SYR-322-4833 BL SYR-322-4833 BL · Takeda https://druglandscape.com/drug/syr-322met https://druglandscape.com/api/og?type=drug&title=SYR-322MET&subtitle=SYR-322MET%20%C2%B7%20Takeda&badge=phase%201 SYR-322MET SYR-322MET · Takeda https://druglandscape.com/drug/syringe-with-exenatide-suspension https://druglandscape.com/api/og?type=drug&title=Syringe%20with%20exenatide%20suspension&subtitle=Syringe%20with%20exenatide%20suspension%20%C2%B7%20AstraZeneca&badge=phase%201 Syringe with exenatide suspension Syringe with exenatide suspension · AstraZeneca https://druglandscape.com/drug/syrup-hydryllin https://druglandscape.com/api/og?type=drug&title=Syrup%20Hydryllin&subtitle=Syrup%20Hydryllin%20%C2%B7%20The%20Searle%20Company%20Limited%20Pakistan&badge=phase%202 Syrup Hydryllin Syrup Hydryllin · The Searle Company Limited Pakistan https://druglandscape.com/drug/sys6005 https://druglandscape.com/api/og?type=drug&title=SYS6005&subtitle=SYS6005%20%C2%B7%20CSPC%20Megalith%20Biopharmaceutical%20Co.%2CLtd.&badge=phase%201 SYS6005 SYS6005 · CSPC Megalith Biopharmaceutical Co.,Ltd. https://druglandscape.com/drug/sys6010-jnjection https://druglandscape.com/api/og?type=drug&title=SYS6010%20jnjection&subtitle=SYS6010%20jnjection%20%C2%B7%20CSPC%20Megalith%20Biopharmaceutical%20Co.%2CLtd.&badge=phase%201 SYS6010 jnjection SYS6010 jnjection · CSPC Megalith Biopharmaceutical Co.,Ltd. https://druglandscape.com/drug/sys6020 https://druglandscape.com/api/og?type=drug&title=SYS6020&subtitle=SYS6020%20%C2%B7%20CSPC%20ZhongQi%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 SYS6020 SYS6020 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/sys6023 https://druglandscape.com/api/og?type=drug&title=SYS6023&subtitle=SYS6023%20%C2%B7%20CSPC%20Megalith%20Biopharmaceutical%20Co.%2CLtd.&badge=phase%201 SYS6023 SYS6023 · CSPC Megalith Biopharmaceutical Co.,Ltd. https://druglandscape.com/drug/sys6043 https://druglandscape.com/api/og?type=drug&title=SYS6043&subtitle=SYS6043%20%C2%B7%20Conjupro%20Biotherapeutics%2C%20Inc.&badge=phase%201 SYS6043 SYS6043 · Conjupro Biotherapeutics, Inc. https://druglandscape.com/drug/sys6045 https://druglandscape.com/api/og?type=drug&title=SYS6045&subtitle=SYS6045%20%C2%B7%20CSPC%20Megalith%20Biopharmaceutical%20Co.%2CLtd.&badge=phase%201 SYS6045 SYS6045 · CSPC Megalith Biopharmaceutical Co.,Ltd. https://druglandscape.com/drug/sys6055 https://druglandscape.com/api/og?type=drug&title=SYS6055&subtitle=SYS6055%20%C2%B7%20Beijing%20Kangchuanglian%20Biopharmaceutical%20Technology%20Research%20Co.%2C%20Ltd&badge=phase%201 SYS6055 SYS6055 · Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd https://druglandscape.com/drug/systematic-therapy https://druglandscape.com/api/og?type=drug&title=systematic%20therapy&subtitle=systematic%20therapy%20%C2%B7%20Jian%20Zhang%2CMD&badge=phase%202 systematic therapy systematic therapy · Jian Zhang,MD https://druglandscape.com/drug/systemic-amg-108 https://druglandscape.com/api/og?type=drug&title=Systemic%20AMG%20108&subtitle=Systemic%20AMG%20108%20%C2%B7%20Amgen&badge=phase%202 Systemic AMG 108 Systemic AMG 108 · Amgen https://druglandscape.com/drug/systemic-chemotherapy-alone https://druglandscape.com/api/og?type=drug&title=Systemic%20chemotherapy%20alone&subtitle=Systemic%20chemotherapy%20alone%20%C2%B7%20Association%20Francaise%20de%20Chirurgie&badge=phase%202 Systemic chemotherapy alone Systemic chemotherapy alone · Association Francaise de Chirurgie https://druglandscape.com/drug/systemic-clarithromycin https://druglandscape.com/api/og?type=drug&title=systemic%20clarithromycin&subtitle=systemic%20clarithromycin%20%C2%B7%20Universidade%20Estadual%20Paulista%20J%C3%BAlio%20de%20Mesquita%20Filho&badge=phase%201 systemic clarithromycin systemic clarithromycin · Universidade Estadual Paulista Júlio de Mesquita Filho https://druglandscape.com/drug/systemic-cyclosporine https://druglandscape.com/api/og?type=drug&title=Systemic%20cyclosporine&subtitle=Systemic%20cyclosporine%20%C2%B7%20Erasmus%20Medical%20Center&badge=phase%201 Systemic cyclosporine Systemic cyclosporine · Erasmus Medical Center https://druglandscape.com/drug/systemic-oncological-treatment https://druglandscape.com/api/og?type=drug&title=Systemic%20oncological%20treatment&subtitle=Systemic%20oncological%20treatment%20%C2%B7%20Fundaci%C3%B3n%20GECP&badge=phase%202 Systemic oncological treatment Systemic oncological treatment · Fundación GECP https://druglandscape.com/drug/systemic-opioids https://druglandscape.com/api/og?type=drug&title=Systemic%20opioids&subtitle=Systemic%20opioids%20%C2%B7%20Salmaniya%20Medical%20Complex&badge=phase%202 Systemic opioids Systemic opioids · Salmaniya Medical Complex https://druglandscape.com/drug/syt-510 https://druglandscape.com/api/og?type=drug&title=SYT-510&subtitle=SYT-510%20%C2%B7%20Synendos%20Therapeutics%20AG&badge=phase%202 SYT-510 SYT-510 · Synendos Therapeutics AG https://druglandscape.com/drug/t-1301-capsules https://druglandscape.com/api/og?type=drug&title=T-1301%20Capsules&subtitle=T-1301%20Capsules%20%C2%B7%20Taivex%20Therapeutics%20Corporation&badge=phase%201 T-1301 Capsules T-1301 Capsules · Taivex Therapeutics Corporation https://druglandscape.com/drug/t-817ma https://druglandscape.com/api/og?type=drug&title=T-817MA&subtitle=T-817MA%20%C2%B7%20FUJIFILM%20Toyama%20Chemical%20Co.%2C%20Ltd.&badge=phase%202 T-817MA T-817MA · FUJIFILM Toyama Chemical Co., Ltd. https://druglandscape.com/drug/t-817ma-h https://druglandscape.com/api/og?type=drug&title=T-817MA-H&subtitle=T-817MA-H%20%C2%B7%20FUJIFILM%20Toyama%20Chemical%20Co.%2C%20Ltd.&badge=phase%202 T-817MA-H T-817MA-H · FUJIFILM Toyama Chemical Co., Ltd. https://druglandscape.com/drug/t-817ma-l https://druglandscape.com/api/og?type=drug&title=T-817MA-L&subtitle=T-817MA-L%20%C2%B7%20FUJIFILM%20Toyama%20Chemical%20Co.%2C%20Ltd.&badge=phase%202 T-817MA-L T-817MA-L · FUJIFILM Toyama Chemical Co., Ltd. https://druglandscape.com/drug/t-ace-oil https://druglandscape.com/api/og?type=drug&title=T-ACE%20Oil&subtitle=T-ACE%20Oil%20%C2%B7%20T-ACE%20Medical%20Co.%2C%20Ltd&badge=phase%201 T-ACE Oil T-ACE Oil · T-ACE Medical Co., Ltd https://druglandscape.com/drug/t-allo10-cells-addback https://druglandscape.com/api/og?type=drug&title=T-allo10%20cells%20addback&subtitle=T-allo10%20cells%20addback%20%C2%B7%20Porteus%2C%20Matthew%2C%20MD&badge=phase%201 T-allo10 cells addback T-allo10 cells addback · Porteus, Matthew, MD https://druglandscape.com/drug/t-cell-infusion-agent https://druglandscape.com/api/og?type=drug&title=%CE%B3%CE%B4T%20Cell%20infusion%20agent&subtitle=%CE%B3%CE%B4T%20Cell%20infusion%20agent%20%C2%B7%20PersonGen%20BioTherapeutics%20(Suzhou)%20Co.%2C%20Ltd.&badge=phase%201 γδT Cell infusion agent γδT Cell infusion agent · PersonGen BioTherapeutics (Suzhou) Co., Ltd. https://druglandscape.com/drug/t-cell-infusion-dose-level-2 https://druglandscape.com/api/og?type=drug&title=T-Cell%20Infusion%20Dose%20Level%202&subtitle=T-Cell%20Infusion%20Dose%20Level%202%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 T-Cell Infusion Dose Level 2 T-Cell Infusion Dose Level 2 · Baylor College of Medicine https://druglandscape.com/drug/t-cell-infusion-dose-level-4 https://druglandscape.com/api/og?type=drug&title=T-Cell%20Infusion-%20Dose%20Level%204&subtitle=T-Cell%20Infusion-%20Dose%20Level%204%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 T-Cell Infusion- Dose Level 4 T-Cell Infusion- Dose Level 4 · Baylor College of Medicine https://druglandscape.com/drug/t-den-f-19 https://druglandscape.com/api/og?type=drug&title=T-DEN%20F-19&subtitle=T-DEN%20F-19%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%202 T-DEN F-19 T-DEN F-19 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/t-den-f17 https://druglandscape.com/api/og?type=drug&title=T-DEN%20F17&subtitle=T-DEN%20F17%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%202 T-DEN F17 T-DEN F17 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/t-den-post-transfection-f17 https://druglandscape.com/api/og?type=drug&title=T-DEN-Post-Transfection%20F17&subtitle=T-DEN-Post-Transfection%20F17%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%202 T-DEN-Post-Transfection F17 T-DEN-Post-Transfection F17 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/t-den-post-transfection-f19 https://druglandscape.com/api/og?type=drug&title=T-DEN-Post-Transfection%20F19&subtitle=T-DEN-Post-Transfection%20F19%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%202 T-DEN-Post-Transfection F19 T-DEN-Post-Transfection F19 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/t-dm1-and-pertuzumab https://druglandscape.com/api/og?type=drug&title=T-DM1%20and%20Pertuzumab&subtitle=T-DM1%20and%20Pertuzumab%20%C2%B7%20QuantumLeap%20Healthcare%20Collaborative&badge=phase%202 T-DM1 and Pertuzumab T-DM1 and Pertuzumab · QuantumLeap Healthcare Collaborative https://druglandscape.com/drug/t-reg-depleted-dli https://druglandscape.com/api/og?type=drug&title=T-reg%20depleted%20DLI&subtitle=T-reg%20depleted%20DLI%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 T-reg depleted DLI T-reg depleted DLI · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/t-va https://druglandscape.com/api/og?type=drug&title=t%C4%B1va&subtitle=t%C4%B1va%20%C2%B7%20dilara%20gocmen&badge=phase%201 tıva tıva · dilara gocmen https://druglandscape.com/drug/t0903131-besylate https://druglandscape.com/api/og?type=drug&title=T0903131%20Besylate&subtitle=T0903131%20Besylate%20%C2%B7%20InteKrin%20Therapeutics%2C%20Inc.&badge=phase%202 T0903131 Besylate T0903131 Besylate · InteKrin Therapeutics, Inc. https://druglandscape.com/drug/t101-group https://druglandscape.com/api/og?type=drug&title=T101%20Group&subtitle=T101%20Group%20%C2%B7%20Tasly%20Tianjin%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 T101 Group T101 Group · Tasly Tianjin Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/t121 https://druglandscape.com/api/og?type=drug&title=T121&subtitle=T121%20%C2%B7%20Thar%20Pharmaceuticals%2C%20Inc&badge=phase%201 T121 T121 · Thar Pharmaceuticals, Inc https://druglandscape.com/drug/t2026 https://druglandscape.com/api/og?type=drug&title=T2026&subtitle=T2026%20%C2%B7%20Sciwind%20Biosciences%20APAC%20CO%20Pty.%20Ltd.&badge=phase%201 T2026 T2026 · Sciwind Biosciences APAC CO Pty. Ltd. https://druglandscape.com/drug/t3011-high-dose https://druglandscape.com/api/og?type=drug&title=T3011%20high%20dose&subtitle=T3011%20high%20dose%20%C2%B7%20Shanghai%20Pharmaceuticals%20Holding%20Co.%2C%20Ltd&badge=phase%201 T3011 high dose T3011 high dose · Shanghai Pharmaceuticals Holding Co., Ltd https://druglandscape.com/drug/t3011-middle-dose https://druglandscape.com/api/og?type=drug&title=T3011%20middle%20dose&subtitle=T3011%20middle%20dose%20%C2%B7%20Shanghai%20Pharmaceuticals%20Holding%20Co.%2C%20Ltd&badge=phase%201 T3011 middle dose T3011 middle dose · Shanghai Pharmaceuticals Holding Co., Ltd https://druglandscape.com/drug/t3d-959 https://druglandscape.com/api/og?type=drug&title=T3D-959&subtitle=T3D-959%20%C2%B7%20T3D%20Therapeutics%2C%20Inc.&badge=phase%202 T3D-959 T3D-959 · T3D Therapeutics, Inc. https://druglandscape.com/drug/t4p1010-administration https://druglandscape.com/api/og?type=drug&title=T4P1010%20administration&subtitle=T4P1010%20administration%20%C2%B7%20Tools4Patient&badge=phase%201 T4P1010 administration T4P1010 administration · Tools4Patient https://druglandscape.com/drug/t601 https://druglandscape.com/api/og?type=drug&title=T601&subtitle=T601%20%C2%B7%20Tasly%20Tianjin%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 T601 T601 · Tasly Tianjin Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/t89-group-c https://druglandscape.com/api/og?type=drug&title=T89%20Group%20C&subtitle=T89%20Group%20C%20%C2%B7%20Tasly%20Pharmaceuticals%2C%20Inc.&badge=phase%201 T89 Group C T89 Group C · Tasly Pharmaceuticals, Inc. https://druglandscape.com/drug/ta-1790 https://druglandscape.com/api/og?type=drug&title=TA-1790&subtitle=TA-1790%20%C2%B7%20VIVUS%20LLC&badge=phase%201 TA-1790 TA-1790 · VIVUS LLC https://druglandscape.com/drug/ta-46 https://druglandscape.com/api/og?type=drug&title=TA-46&subtitle=TA-46%20%C2%B7%20Pfizer&badge=phase%201 TA-46 TA-46 · Pfizer https://druglandscape.com/drug/ta-7284 https://druglandscape.com/api/og?type=drug&title=TA-7284&subtitle=TA-7284%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%201 TA-7284 TA-7284 · Tanabe Pharma Corporation https://druglandscape.com/drug/ta-7284-low-middle https://druglandscape.com/api/og?type=drug&title=TA-7284-Low-middle&subtitle=TA-7284-Low-middle%20%C2%B7%20Tanabe%20Pharma%20Corporation&badge=phase%202 TA-7284-Low-middle TA-7284-Low-middle · Tanabe Pharma Corporation https://druglandscape.com/drug/ta-cd-vaccination https://druglandscape.com/api/og?type=drug&title=TA-CD%20Vaccination&subtitle=TA-CD%20Vaccination%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%202 TA-CD Vaccination TA-CD Vaccination · Baylor College of Medicine https://druglandscape.com/drug/ta-nic https://druglandscape.com/api/og?type=drug&title=TA-NIC&subtitle=TA-NIC%20%C2%B7%20Celtic%20Pharma%20Development%20Services&badge=phase%202 TA-NIC TA-NIC · Celtic Pharma Development Services https://druglandscape.com/drug/taa-specific-ctls https://druglandscape.com/api/og?type=drug&title=TAA-Specific%20CTLs&subtitle=TAA-Specific%20CTLs%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%202 TAA-Specific CTLs TAA-Specific CTLs · Baylor College of Medicine https://druglandscape.com/drug/taa-specific-ctls-fixed-dose https://druglandscape.com/api/og?type=drug&title=TAA-specific%20CTLs-%20fixed%20dose&subtitle=TAA-specific%20CTLs-%20fixed%20dose%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 TAA-specific CTLs- fixed dose TAA-specific CTLs- fixed dose · Baylor College of Medicine https://druglandscape.com/drug/tab-srt2104-intermediate-release https://druglandscape.com/api/og?type=drug&title=Tab%20SRT2104%20intermediate%20release&subtitle=Tab%20SRT2104%20intermediate%20release%20%C2%B7%20Sirtris%2C%20a%20GSK%20Company&badge=phase%201 Tab SRT2104 intermediate release Tab SRT2104 intermediate release · Sirtris, a GSK Company https://druglandscape.com/drug/tab014 https://druglandscape.com/api/og?type=drug&title=TAB014&subtitle=TAB014%20%C2%B7%20Lee's%20Pharmaceutical%20Limited&badge=phase%201 TAB014 TAB014 · Lee's Pharmaceutical Limited https://druglandscape.com/drug/tablet-amitriptyline-10-milligrams https://druglandscape.com/api/og?type=drug&title=Tablet%20Amitriptyline%2010%20milligrams&subtitle=Tablet%20Amitriptyline%2010%20milligrams%20%C2%B7%20Md.%20Moktadirul%20Hoque%20Shuvo&badge=phase%202 Tablet Amitriptyline 10 milligrams Tablet Amitriptyline 10 milligrams · Md. Moktadirul Hoque Shuvo https://druglandscape.com/drug/tablet-dispersible https://druglandscape.com/api/og?type=drug&title=Tablet%2C%20Dispersible&subtitle=Tablet%2C%20Dispersible%20%C2%B7%20ALK-Abell%C3%B3%20A%2FS&badge=phase%202 Tablet, Dispersible Tablet, Dispersible · ALK-Abelló A/S https://druglandscape.com/drug/tabp-eic https://druglandscape.com/api/og?type=drug&title=TABP%20EIC&subtitle=TABP%20EIC%20%C2%B7%20Allife%20Medical%20Science%20and%20Technology%20Co.%2C%20Ltd.&badge=phase%201 TABP EIC TABP EIC · Allife Medical Science and Technology Co., Ltd. https://druglandscape.com/drug/tach101 https://druglandscape.com/api/og?type=drug&title=TACH101&subtitle=TACH101%20%C2%B7%20Tachyon%20Therapeutics%2C%20Inc.&badge=phase%201 TACH101 TACH101 · Tachyon Therapeutics, Inc. https://druglandscape.com/drug/tacrolimus-inhalation-aerosol https://druglandscape.com/api/og?type=drug&title=Tacrolimus%20Inhalation%20Aerosol&subtitle=Tacrolimus%20Inhalation%20Aerosol%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%202 Tacrolimus Inhalation Aerosol Tacrolimus Inhalation Aerosol · Astellas Pharma Inc https://druglandscape.com/drug/tacrolimus-lipid-suspension-for-enema https://druglandscape.com/api/og?type=drug&title=Tacrolimus%20Lipid%20Suspension%20for%20enema&subtitle=Tacrolimus%20Lipid%20Suspension%20for%20enema%20%C2%B7%20Jina%20Pharmaceuticals%20Inc.&badge=phase%202 Tacrolimus Lipid Suspension for enema Tacrolimus Lipid Suspension for enema · Jina Pharmaceuticals Inc. https://druglandscape.com/drug/tacrolimus-prolonged-release https://druglandscape.com/api/og?type=drug&title=Tacrolimus%20prolonged%20release&subtitle=Tacrolimus%20prolonged%20release%20%C2%B7%20Astellas%20Pharma%20Europe%20Ltd.&badge=phase%202 Tacrolimus prolonged release Tacrolimus prolonged release · Astellas Pharma Europe Ltd. https://druglandscape.com/drug/tadalafil-and-acetazolamide https://druglandscape.com/api/og?type=drug&title=Tadalafil%20and%20acetazolamide&subtitle=Tadalafil%20and%20acetazolamide%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%201 Tadalafil and acetazolamide Tadalafil and acetazolamide · Sheba Medical Center https://druglandscape.com/drug/tadalafil-and-sildenafil https://druglandscape.com/api/og?type=drug&title=Tadalafil%20and%20Sildenafil&subtitle=Tadalafil%20and%20Sildenafil%20%C2%B7%20Cedars-Sinai%20Medical%20Center&badge=phase%201 Tadalafil and Sildenafil Tadalafil and Sildenafil · Cedars-Sinai Medical Center https://druglandscape.com/drug/tadalafil-and-vaccination https://druglandscape.com/api/og?type=drug&title=tadalafil%20and%20vaccination&subtitle=tadalafil%20and%20vaccination%20%C2%B7%20Providence%20Health%20%26%20Services&badge=phase%201 tadalafil and vaccination tadalafil and vaccination · Providence Health & Services https://druglandscape.com/drug/tadalafil-tablet-or-oral-suspension https://druglandscape.com/api/og?type=drug&title=Tadalafil-%20Tablet%20or%20Oral%20suspension&subtitle=Tadalafil-%20Tablet%20or%20Oral%20suspension%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Tadalafil- Tablet or Oral suspension Tadalafil- Tablet or Oral suspension · Eli Lilly and Company https://druglandscape.com/drug/tae-plus-p53-gene https://druglandscape.com/api/og?type=drug&title=TAE%20plus%20P53%20gene&subtitle=TAE%20plus%20P53%20gene%20%C2%B7%20Shenzhen%20SiBiono%20GeneTech%20Co.%2CLtd&badge=phase%202 TAE plus P53 gene TAE plus P53 gene · Shenzhen SiBiono GeneTech Co.,Ltd https://druglandscape.com/drug/tafamidis-free-acid-tablet https://druglandscape.com/api/og?type=drug&title=Tafamidis%20free%20acid%20tablet&subtitle=Tafamidis%20free%20acid%20tablet%20%C2%B7%20Pfizer&badge=phase%201 Tafamidis free acid tablet Tafamidis free acid tablet · Pfizer https://druglandscape.com/drug/tafamidis-meglumine-capsule https://druglandscape.com/api/og?type=drug&title=Tafamidis%20meglumine%20capsule&subtitle=Tafamidis%20meglumine%20capsule%20%C2%B7%20Pfizer&badge=phase%201 Tafamidis meglumine capsule Tafamidis meglumine capsule · Pfizer https://druglandscape.com/drug/tafasitamab-and-lenalidomide https://druglandscape.com/api/og?type=drug&title=Tafasitamab%20and%20Lenalidomide&subtitle=Tafasitamab%20and%20Lenalidomide%20%C2%B7%20Beijing%20InnoCare%20Pharma%20Tech%20Co.%2C%20Ltd.&badge=phase%202 Tafasitamab and Lenalidomide Tafasitamab and Lenalidomide · Beijing InnoCare Pharma Tech Co., Ltd. https://druglandscape.com/drug/tafasitamab-plus-lenalidomide https://druglandscape.com/api/og?type=drug&title=Tafasitamab%20plus%20lenalidomide&subtitle=Tafasitamab%20plus%20lenalidomide%20%C2%B7%20MorphoSys%20AG&badge=phase%201 Tafasitamab plus lenalidomide Tafasitamab plus lenalidomide · MorphoSys AG https://druglandscape.com/drug/tafenoquine-control https://druglandscape.com/api/og?type=drug&title=Tafenoquine%20Control&subtitle=Tafenoquine%20Control%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Tafenoquine Control Tafenoquine Control · GlaxoSmithKline https://druglandscape.com/drug/tafenoquine-sil https://druglandscape.com/api/og?type=drug&title=Tafenoquine%20SIL&subtitle=Tafenoquine%20SIL%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Tafenoquine SIL Tafenoquine SIL · GlaxoSmithKline https://druglandscape.com/drug/tafluprost-timolol-maleate https://druglandscape.com/api/og?type=drug&title=Tafluprost%2C%20timolol%20maleate&subtitle=Tafluprost%2C%20timolol%20maleate%20%C2%B7%20Santen%20Pharmaceutical%20(Taiwan)%20Co.%2C%20LTD&badge=phase%202 Tafluprost, timolol maleate Tafluprost, timolol maleate · Santen Pharmaceutical (Taiwan) Co., LTD https://druglandscape.com/drug/tahp-and-ahp https://druglandscape.com/api/og?type=drug&title=TAHP%20and%20AHP&subtitle=TAHP%20and%20AHP%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%201 TAHP and AHP TAHP and AHP · Samsung Medical Center https://druglandscape.com/drug/tai-gpc3-cart-cells https://druglandscape.com/api/og?type=drug&title=TAI-GPC3-CART%20cells&subtitle=TAI-GPC3-CART%20cells%20%C2%B7%20Shanghai%20GeneChem%20Co.%2C%20Ltd.&badge=phase%201 TAI-GPC3-CART cells TAI-GPC3-CART cells · Shanghai GeneChem Co., Ltd. https://druglandscape.com/drug/tak-007 https://druglandscape.com/api/og?type=drug&title=TAK-007&subtitle=TAK-007%20%C2%B7%20Takeda&badge=phase%202 TAK-007 TAK-007 · Takeda https://druglandscape.com/drug/tak-020-captisol-oral-solution https://druglandscape.com/api/og?type=drug&title=TAK-020%20Captisol%20Oral%20Solution&subtitle=TAK-020%20Captisol%20Oral%20Solution%20%C2%B7%20Takeda&badge=phase%201 TAK-020 Captisol Oral Solution TAK-020 Captisol Oral Solution · Takeda https://druglandscape.com/drug/tak-020-irt https://druglandscape.com/api/og?type=drug&title=TAK-020%20IRT&subtitle=TAK-020%20IRT%20%C2%B7%20Takeda&badge=phase%201 TAK-020 IRT TAK-020 IRT · Takeda https://druglandscape.com/drug/tak-020-sdt https://druglandscape.com/api/og?type=drug&title=TAK-020%20SDT&subtitle=TAK-020%20SDT%20%C2%B7%20Takeda&badge=phase%201 TAK-020 SDT TAK-020 SDT · Takeda https://druglandscape.com/drug/tak-063 https://druglandscape.com/api/og?type=drug&title=TAK-063&subtitle=TAK-063%20%C2%B7%20Takeda&badge=phase%201 TAK-063 TAK-063 · Takeda https://druglandscape.com/drug/tak-079 https://druglandscape.com/api/og?type=drug&title=TAK-079&subtitle=TAK-079%20%C2%B7%20Takeda&badge=phase%202 TAK-079 TAK-079 · Takeda https://druglandscape.com/drug/tak-101 https://druglandscape.com/api/og?type=drug&title=TAK-101&subtitle=TAK-101%20%C2%B7%20Takeda&badge=phase%202 TAK-101 TAK-101 · Takeda https://druglandscape.com/drug/tak-123 https://druglandscape.com/api/og?type=drug&title=TAK-123&subtitle=TAK-123%20%C2%B7%20Takeda&badge=phase%201 TAK-123 TAK-123 · Takeda https://druglandscape.com/drug/tak-165 https://druglandscape.com/api/og?type=drug&title=TAK-165&subtitle=TAK-165%20%C2%B7%20Takeda&badge=phase%201 TAK-165 TAK-165 · Takeda https://druglandscape.com/drug/tak-188 https://druglandscape.com/api/og?type=drug&title=TAK-188&subtitle=TAK-188%20%C2%B7%20Takeda&badge=phase%201 TAK-188 TAK-188 · Takeda https://druglandscape.com/drug/tak-226 https://druglandscape.com/api/og?type=drug&title=TAK-226&subtitle=TAK-226%20%C2%B7%20Takeda&badge=phase%202 TAK-226 TAK-226 · Takeda https://druglandscape.com/drug/tak-227 https://druglandscape.com/api/og?type=drug&title=TAK-227&subtitle=TAK-227%20%C2%B7%20Takeda&badge=phase%201 TAK-227 TAK-227 · Takeda https://druglandscape.com/drug/tak-228-tak-117 https://druglandscape.com/api/og?type=drug&title=Tak-228%20%26%20Tak-117&subtitle=Tak-228%20%26%20Tak-117%20%C2%B7%20Joyce%20O'Shaughnessy&badge=phase%202 Tak-228 & Tak-117 Tak-228 & Tak-117 · Joyce O'Shaughnessy https://druglandscape.com/drug/tak-233 https://druglandscape.com/api/og?type=drug&title=TAK-233&subtitle=TAK-233%20%C2%B7%20Takeda&badge=phase%201 TAK-233 TAK-233 · Takeda https://druglandscape.com/drug/tak-272 https://druglandscape.com/api/og?type=drug&title=TAK-272&subtitle=TAK-272%20%C2%B7%20Takeda&badge=phase%202 TAK-272 TAK-272 · Takeda https://druglandscape.com/drug/tak-285-dose-escalation-cohorts https://druglandscape.com/api/og?type=drug&title=TAK-285%20Dose%20Escalation%20Cohorts&subtitle=TAK-285%20Dose%20Escalation%20Cohorts%20%C2%B7%20Millennium%20Pharmaceuticals%2C%20Inc.&badge=phase%201 TAK-285 Dose Escalation Cohorts TAK-285 Dose Escalation Cohorts · Millennium Pharmaceuticals, Inc. https://druglandscape.com/drug/tak-329 https://druglandscape.com/api/og?type=drug&title=TAK-329&subtitle=TAK-329%20%C2%B7%20Takeda&badge=phase%201 TAK-329 TAK-329 · Takeda https://druglandscape.com/drug/tak-341 https://druglandscape.com/api/og?type=drug&title=TAK-341&subtitle=TAK-341%20%C2%B7%20Takeda&badge=phase%202 TAK-341 TAK-341 · Takeda https://druglandscape.com/drug/tak-360 https://druglandscape.com/api/og?type=drug&title=TAK-360&subtitle=TAK-360%20%C2%B7%20Takeda&badge=phase%202 TAK-360 TAK-360 · Takeda https://druglandscape.com/drug/tak-385-t2-formulation https://druglandscape.com/api/og?type=drug&title=TAK-385%20T2%20Formulation&subtitle=TAK-385%20T2%20Formulation%20%C2%B7%20Takeda&badge=phase%201 TAK-385 T2 Formulation TAK-385 T2 Formulation · Takeda https://druglandscape.com/drug/tak-385-t4-formulation-c https://druglandscape.com/api/og?type=drug&title=TAK-385%20T4%20Formulation%20C&subtitle=TAK-385%20T4%20Formulation%20C%20%C2%B7%20Takeda&badge=phase%201 TAK-385 T4 Formulation C TAK-385 T4 Formulation C · Takeda https://druglandscape.com/drug/tak-385-tablets https://druglandscape.com/api/og?type=drug&title=TAK-385%20Tablets&subtitle=TAK-385%20Tablets%20%C2%B7%20Takeda&badge=phase%201 TAK-385 Tablets TAK-385 Tablets · Takeda https://druglandscape.com/drug/tak-411 https://druglandscape.com/api/og?type=drug&title=TAK-411&subtitle=TAK-411%20%C2%B7%20Takeda&badge=phase%202 TAK-411 TAK-411 · Takeda https://druglandscape.com/drug/tak-438-od https://druglandscape.com/api/og?type=drug&title=TAK-438%20OD&subtitle=TAK-438%20OD%20%C2%B7%20Takeda&badge=phase%201 TAK-438 OD TAK-438 OD · Takeda https://druglandscape.com/drug/tak-438asa https://druglandscape.com/api/og?type=drug&title=TAK-438ASA&subtitle=TAK-438ASA%20%C2%B7%20Takeda&badge=phase%201 TAK-438ASA TAK-438ASA · Takeda https://druglandscape.com/drug/tak-491 https://druglandscape.com/api/og?type=drug&title=TAK-491&subtitle=TAK-491%20%C2%B7%20Takeda&badge=phase%201 TAK-491 TAK-491 · Takeda https://druglandscape.com/drug/tak-505 https://druglandscape.com/api/og?type=drug&title=TAK-505&subtitle=TAK-505%20%C2%B7%20Takeda&badge=phase%201 TAK-505 TAK-505 · Takeda https://druglandscape.com/drug/tak-510 https://druglandscape.com/api/og?type=drug&title=TAK-510&subtitle=TAK-510%20%C2%B7%20Takeda&badge=phase%201 TAK-510 TAK-510 · Takeda https://druglandscape.com/drug/tak-536-ganule-formulation https://druglandscape.com/api/og?type=drug&title=TAK-536%20Ganule%20Formulation&subtitle=TAK-536%20Ganule%20Formulation%20%C2%B7%20Takeda&badge=phase%201 TAK-536 Ganule Formulation TAK-536 Ganule Formulation · Takeda https://druglandscape.com/drug/tak-577 https://druglandscape.com/api/og?type=drug&title=TAK-577&subtitle=TAK-577%20%C2%B7%20Takeda&badge=phase%202 TAK-577 TAK-577 · Takeda https://druglandscape.com/drug/tak-583 https://druglandscape.com/api/og?type=drug&title=TAK-583&subtitle=TAK-583%20%C2%B7%20Takeda&badge=phase%202 TAK-583 TAK-583 · Takeda https://druglandscape.com/drug/tak-662 https://druglandscape.com/api/og?type=drug&title=TAK-662&subtitle=TAK-662%20%C2%B7%20Takeda&badge=phase%201 TAK-662 TAK-662 · Takeda https://druglandscape.com/drug/tak-783-and-methotrexate https://druglandscape.com/api/og?type=drug&title=TAK-783%20and%20methotrexate&subtitle=TAK-783%20and%20methotrexate%20%C2%B7%20Takeda&badge=phase%202 TAK-783 and methotrexate TAK-783 and methotrexate · Takeda https://druglandscape.com/drug/tak-875-and-sitagliptin https://druglandscape.com/api/og?type=drug&title=TAK-875%20and%20Sitagliptin&subtitle=TAK-875%20and%20Sitagliptin%20%C2%B7%20Takeda&badge=phase%202 TAK-875 and Sitagliptin TAK-875 and Sitagliptin · Takeda https://druglandscape.com/drug/tak-915-suspension https://druglandscape.com/api/og?type=drug&title=TAK-915%20suspension&subtitle=TAK-915%20suspension%20%C2%B7%20Takeda&badge=phase%201 TAK-915 suspension TAK-915 suspension · Takeda https://druglandscape.com/drug/tak-919 https://druglandscape.com/api/og?type=drug&title=TAK-919&subtitle=TAK-919%20%C2%B7%20Takeda&badge=phase%201 TAK-919 TAK-919 · Takeda https://druglandscape.com/drug/tak-925 https://druglandscape.com/api/og?type=drug&title=TAK-925&subtitle=TAK-925%20%C2%B7%20Takeda&badge=phase%201 TAK-925 TAK-925 · Takeda https://druglandscape.com/drug/tak-931-pic https://druglandscape.com/api/og?type=drug&title=TAK-931%20PIC&subtitle=TAK-931%20PIC%20%C2%B7%20Millennium%20Pharmaceuticals%2C%20Inc.&badge=phase%201 TAK-931 PIC TAK-931 PIC · Millennium Pharmaceuticals, Inc. https://druglandscape.com/drug/tak-931-tablet https://druglandscape.com/api/og?type=drug&title=TAK-931%20Tablet&subtitle=TAK-931%20Tablet%20%C2%B7%20Millennium%20Pharmaceuticals%2C%20Inc.&badge=phase%202 TAK-931 Tablet TAK-931 Tablet · Millennium Pharmaceuticals, Inc. https://druglandscape.com/drug/tak-935 https://druglandscape.com/api/og?type=drug&title=TAK-935&subtitle=TAK-935%20%C2%B7%20Takeda&badge=phase%202 TAK-935 TAK-935 · Takeda https://druglandscape.com/drug/taking-drug-tamsulosin https://druglandscape.com/api/og?type=drug&title=Taking%20drug%20Tamsulosin&subtitle=Taking%20drug%20Tamsulosin%20%C2%B7%20Joint-Stock%20Company%20North-West%20Center%20for%20Evidence-Based%20Medicine%2C%20Russian%20&badge=phase%201 Taking drug Tamsulosin Taking drug Tamsulosin · Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation https://druglandscape.com/drug/taking-of-urines https://druglandscape.com/api/og?type=drug&title=Taking%20of%20urines&subtitle=Taking%20of%20urines%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 Taking of urines Taking of urines · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/talazoparib-plus-irinotecan https://druglandscape.com/api/og?type=drug&title=Talazoparib%20plus%20Irinotecan&subtitle=Talazoparib%20plus%20Irinotecan%20%C2%B7%20QuantumLeap%20Healthcare%20Collaborative&badge=phase%202 Talazoparib plus Irinotecan Talazoparib plus Irinotecan · QuantumLeap Healthcare Collaborative https://druglandscape.com/drug/talcum-powder https://druglandscape.com/api/og?type=drug&title=Talcum%20powder&subtitle=Talcum%20powder%20%C2%B7%20Center%20Trials%20%26%20Treatment%20Europe&badge=phase%201 Talcum powder Talcum powder · Center Trials & Treatment Europe https://druglandscape.com/drug/tamoxifen-dose-adjustment https://druglandscape.com/api/og?type=drug&title=Tamoxifen%20dose%20adjustment&subtitle=Tamoxifen%20dose%20adjustment%20%C2%B7%20Nalagenetics%20Pte%20Ltd&badge=phase%201 Tamoxifen dose adjustment Tamoxifen dose adjustment · Nalagenetics Pte Ltd https://druglandscape.com/drug/tamsulosin-1-week https://druglandscape.com/api/og?type=drug&title=Tamsulosin%20-%201%20week&subtitle=Tamsulosin%20-%201%20week%20%C2%B7%20Hackensack%20Meridian%20Health&badge=phase%201 Tamsulosin - 1 week Tamsulosin - 1 week · Hackensack Meridian Health https://druglandscape.com/drug/tamsulosin-and-avanafil https://druglandscape.com/api/og?type=drug&title=Tamsulosin%20and%20avanafil&subtitle=Tamsulosin%20and%20avanafil%20%C2%B7%20VIVUS%20LLC&badge=phase%201 Tamsulosin and avanafil Tamsulosin and avanafil · VIVUS LLC https://druglandscape.com/drug/tamsulosin-formulation-b https://druglandscape.com/api/og?type=drug&title=Tamsulosin%20formulation-B&subtitle=Tamsulosin%20formulation-B%20%C2%B7%20Astellas%20Pharma%20China%2C%20Inc.&badge=phase%201 Tamsulosin formulation-B Tamsulosin formulation-B · Astellas Pharma China, Inc. https://druglandscape.com/drug/tangning-tongluo-capsule https://druglandscape.com/api/og?type=drug&title=Tangning%20Tongluo%20Capsule&subtitle=Tangning%20Tongluo%20Capsule%20%C2%B7%20Guizhou%20Bailing%20Group%20Pharmaceutical%20Co%20Ltd&badge=phase%202 Tangning Tongluo Capsule Tangning Tongluo Capsule · Guizhou Bailing Group Pharmaceutical Co Ltd https://druglandscape.com/drug/tangningtongluo-tablets https://druglandscape.com/api/og?type=drug&title=Tangningtongluo%20tablets&subtitle=Tangningtongluo%20tablets%20%C2%B7%20Guizhou%20Bailing%20Group%20Pharmaceutical%20Co%20Ltd&badge=phase%202 Tangningtongluo tablets Tangningtongluo tablets · Guizhou Bailing Group Pharmaceutical Co Ltd https://druglandscape.com/drug/tanhuo-decoction https://druglandscape.com/api/og?type=drug&title=Tanhuo%20decoction&subtitle=Tanhuo%20decoction%20%C2%B7%20Jinggang%20Xia%2C%20MD&badge=phase%201 Tanhuo decoction Tanhuo decoction · Jinggang Xia, MD https://druglandscape.com/drug/tap-block-bupivacaine https://druglandscape.com/api/og?type=drug&title=Tap%20Block%20-%20Bupivacaine&subtitle=Tap%20Block%20-%20Bupivacaine%20%C2%B7%20Royal%20College%20of%20Surgeons%2C%20Ireland&badge=phase%201 Tap Block - Bupivacaine Tap Block - Bupivacaine · Royal College of Surgeons, Ireland https://druglandscape.com/drug/tapentadol-er-250-mg-pr2-tablet https://druglandscape.com/api/og?type=drug&title=Tapentadol%20ER%20250-mg%20PR2%20tablet&subtitle=Tapentadol%20ER%20250-mg%20PR2%20tablet%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 Tapentadol ER 250-mg PR2 tablet Tapentadol ER 250-mg PR2 tablet · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/tapentadol-ir https://druglandscape.com/api/og?type=drug&title=tapentadol%20IR&subtitle=tapentadol%20IR%20%C2%B7%20Ortho-McNeil%20Janssen%20Scientific%20Affairs%2C%20LLC&badge=phase%203 tapentadol IR tapentadol IR · Ortho-McNeil Janssen Scientific Affairs, LLC https://druglandscape.com/drug/tapentadol-prolonged-release-reference-product https://druglandscape.com/api/og?type=drug&title=Tapentadol%20Prolonged-release%20Reference%20Product&subtitle=Tapentadol%20Prolonged-release%20Reference%20Product%20%C2%B7%20Gr%C3%BCnenthal%20GmbH&badge=phase%201 Tapentadol Prolonged-release Reference Product Tapentadol Prolonged-release Reference Product · Grünenthal GmbH https://druglandscape.com/drug/tapentadol-test-product-1 https://druglandscape.com/api/og?type=drug&title=Tapentadol%20Test%20Product%201&subtitle=Tapentadol%20Test%20Product%201%20%C2%B7%20Gr%C3%BCnenthal%20GmbH&badge=phase%201 Tapentadol Test Product 1 Tapentadol Test Product 1 · Grünenthal GmbH https://druglandscape.com/drug/tapentadol-test-product-2 https://druglandscape.com/api/og?type=drug&title=Tapentadol%20Test%20Product%202&subtitle=Tapentadol%20Test%20Product%202%20%C2%B7%20Gr%C3%BCnenthal%20GmbH&badge=phase%201 Tapentadol Test Product 2 Tapentadol Test Product 2 · Grünenthal GmbH https://druglandscape.com/drug/tarceva-erlotinib-osi-774 https://druglandscape.com/api/og?type=drug&title=Tarceva%2C%20erlotinib%2C%20OSI-774&subtitle=Tarceva%2C%20erlotinib%2C%20OSI-774%20%C2%B7%20OSI%20Pharmaceuticals&badge=phase%201 Tarceva, erlotinib, OSI-774 Tarceva, erlotinib, OSI-774 · OSI Pharmaceuticals https://druglandscape.com/drug/targeted-therapy-tailored-treatment https://druglandscape.com/api/og?type=drug&title=Targeted%20Therapy%20Tailored%20Treatment&subtitle=Targeted%20Therapy%20Tailored%20Treatment%20%C2%B7%20Sofia%20Perea%2C%20Director%20Clinical%20Trials%20Unit.&badge=phase%202 Targeted Therapy Tailored Treatment Targeted Therapy Tailored Treatment · Sofia Perea, Director Clinical Trials Unit. https://druglandscape.com/drug/targeting-cd276-car-t-cells https://druglandscape.com/api/og?type=drug&title=Targeting%20CD276%20CAR%20T%20cells&subtitle=Targeting%20CD276%20CAR%20T%20cells%20%C2%B7%20PersonGen%20BioTherapeutics%20(Suzhou)%20Co.%2C%20Ltd.&badge=phase%201 Targeting CD276 CAR T cells Targeting CD276 CAR T cells · PersonGen BioTherapeutics (Suzhou) Co., Ltd. https://druglandscape.com/drug/tas-102-pill https://druglandscape.com/api/og?type=drug&title=TAS-102%20pill&subtitle=TAS-102%20pill%20%C2%B7%20Teclison%20Ltd.&badge=phase%202 TAS-102 pill TAS-102 pill · Teclison Ltd. https://druglandscape.com/drug/tas-102-tablets https://druglandscape.com/api/og?type=drug&title=TAS-102%20tablets&subtitle=TAS-102%20tablets%20%C2%B7%20Taiho%20Oncology%2C%20Inc.&badge=phase%201 TAS-102 tablets TAS-102 tablets · Taiho Oncology, Inc. https://druglandscape.com/drug/tas-205 https://druglandscape.com/api/og?type=drug&title=TAS-205&subtitle=TAS-205%20%C2%B7%20Taiho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 TAS-205 TAS-205 · Taiho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/tas-205-14c-tas-205 https://druglandscape.com/api/og?type=drug&title=TAS-205%2C%20%5B14C%5DTAS-205&subtitle=TAS-205%2C%20%5B14C%5DTAS-205%20%C2%B7%20Taiho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 TAS-205, [14C]TAS-205 TAS-205, [14C]TAS-205 · Taiho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/tas-303-14c-tas-303 https://druglandscape.com/api/og?type=drug&title=TAS-303%2C%20%5B14C%5DTAS-303&subtitle=TAS-303%2C%20%5B14C%5DTAS-303%20%C2%B7%20Taiho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 TAS-303, [14C]TAS-303 TAS-303, [14C]TAS-303 · Taiho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/tas3681 https://druglandscape.com/api/og?type=drug&title=TAS3681&subtitle=TAS3681%20%C2%B7%20Taiho%20Oncology%2C%20Inc.&badge=phase%201 TAS3681 TAS3681 · Taiho Oncology, Inc. https://druglandscape.com/drug/tas5315-dose-1 https://druglandscape.com/api/og?type=drug&title=TAS5315%20Dose%201&subtitle=TAS5315%20Dose%201%20%C2%B7%20Taiho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 TAS5315 Dose 1 TAS5315 Dose 1 · Taiho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/tas5315-high-dose https://druglandscape.com/api/og?type=drug&title=TAS5315%20high%20dose&subtitle=TAS5315%20high%20dose%20%C2%B7%20Taiho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 TAS5315 high dose TAS5315 high dose · Taiho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/tas5315-low-dose https://druglandscape.com/api/og?type=drug&title=TAS5315%20low%20dose&subtitle=TAS5315%20low%20dose%20%C2%B7%20Taiho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 TAS5315 low dose TAS5315 low dose · Taiho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/tat-oyi https://druglandscape.com/api/og?type=drug&title=Tat%20Oyi&subtitle=Tat%20Oyi%20%C2%B7%20BIOSANTECH&badge=phase%201 Tat Oyi Tat Oyi · BIOSANTECH https://druglandscape.com/drug/tat-protein https://druglandscape.com/api/og?type=drug&title=Tat%20protein&subtitle=Tat%20protein%20%C2%B7%20Barbara%20Ensoli%2C%20MD&badge=phase%202 Tat protein Tat protein · Barbara Ensoli, MD https://druglandscape.com/drug/tat4-gel https://druglandscape.com/api/og?type=drug&title=TAT4%20Gel&subtitle=TAT4%20Gel%20%C2%B7%20Topokine%20Therapeutics%2C%20Inc.&badge=phase%202 TAT4 Gel TAT4 Gel · Topokine Therapeutics, Inc. https://druglandscape.com/drug/tat4-gel-concentration-a https://druglandscape.com/api/og?type=drug&title=TAT4%20Gel%20concentration%20A&subtitle=TAT4%20Gel%20concentration%20A%20%C2%B7%20Topokine%20Therapeutics%2C%20Inc.&badge=phase%201 TAT4 Gel concentration A TAT4 Gel concentration A · Topokine Therapeutics, Inc. https://druglandscape.com/drug/tate-and-pembrolizumab https://druglandscape.com/api/og?type=drug&title=TATE%20and%20pembrolizumab&subtitle=TATE%20and%20pembrolizumab%20%C2%B7%20Teclison%20Ltd.&badge=phase%202 TATE and pembrolizumab TATE and pembrolizumab · Teclison Ltd. https://druglandscape.com/drug/tau2 https://druglandscape.com/api/og?type=drug&title=Tau2&subtitle=Tau2%20%C2%B7%20Paul%20S.%20Aisen&badge=phase%202 Tau2 Tau2 · Paul S. Aisen https://druglandscape.com/drug/tavapadon-14c-suspension https://druglandscape.com/api/og?type=drug&title=Tavapadon%20%5B14C%5D%20suspension&subtitle=Tavapadon%20%5B14C%5D%20suspension%20%C2%B7%20Cerevel%20Therapeutics%2C%20LLC&badge=phase%201 Tavapadon [14C] suspension Tavapadon [14C] suspension · Cerevel Therapeutics, LLC https://druglandscape.com/drug/taxane-drug https://druglandscape.com/api/og?type=drug&title=taxane%20drug&subtitle=taxane%20drug%20%C2%B7%20Sun%20Yat-Sen%20Memorial%20Hospital%20of%20Sun%20Yat-Sen%20University&badge=phase%203 taxane drug taxane drug · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University https://druglandscape.com/drug/taxol-plus-everolimus https://druglandscape.com/api/og?type=drug&title=taxol%20plus%20everolimus&subtitle=taxol%20plus%20everolimus%20%C2%B7%20Samsung%20Medical%20Center&badge=phase%201 taxol plus everolimus taxol plus everolimus · Samsung Medical Center https://druglandscape.com/drug/tazaroc-gel https://druglandscape.com/api/og?type=drug&title=Tazaroc%20Gel&subtitle=Tazaroc%20Gel%20%C2%B7%20Stiefel%2C%20a%20GSK%20Company&badge=phase%201 Tazaroc Gel Tazaroc Gel · Stiefel, a GSK Company https://druglandscape.com/drug/tazarotene-cream https://druglandscape.com/api/og?type=drug&title=Tazarotene%20cream&subtitle=Tazarotene%20cream%20%C2%B7%20Stiefel%2C%20a%20GSK%20Company&badge=phase%202 Tazarotene cream Tazarotene cream · Stiefel, a GSK Company https://druglandscape.com/drug/tazarotene-foam-without-irradiation https://druglandscape.com/api/og?type=drug&title=Tazarotene%20Foam%20without%20irradiation&subtitle=Tazarotene%20Foam%20without%20irradiation%20%C2%B7%20Stiefel%2C%20a%20GSK%20Company&badge=phase%201 Tazarotene Foam without irradiation Tazarotene Foam without irradiation · Stiefel, a GSK Company https://druglandscape.com/drug/tazemetostat-and-14c-tazemetostat https://druglandscape.com/api/og?type=drug&title=Tazemetostat%20and%20%5B14C%5D%20Tazemetostat&subtitle=Tazemetostat%20and%20%5B14C%5D%20Tazemetostat%20%C2%B7%20Epizyme%2C%20Inc.&badge=phase%201 Tazemetostat and [14C] Tazemetostat Tazemetostat and [14C] Tazemetostat · Epizyme, Inc. https://druglandscape.com/drug/tb001 https://druglandscape.com/api/og?type=drug&title=TB001&subtitle=TB001%20%C2%B7%20Shenzhen%20Turier%20Biotech%20Co.%2C%20Ltd&badge=phase%201 TB001 TB001 · Shenzhen Turier Biotech Co., Ltd https://druglandscape.com/drug/tb511 https://druglandscape.com/api/og?type=drug&title=TB511&subtitle=TB511%20%C2%B7%20Twinpig%20Biolab%2C%20Inc.&badge=phase%201 TB511 TB511 · Twinpig Biolab, Inc. https://druglandscape.com/drug/tbaj-876-suspension https://druglandscape.com/api/og?type=drug&title=TBAJ-876%20suspension&subtitle=TBAJ-876%20suspension%20%C2%B7%20Global%20Alliance%20for%20TB%20Drug%20Development&badge=phase%201 TBAJ-876 suspension TBAJ-876 suspension · Global Alliance for TB Drug Development https://druglandscape.com/drug/tbi-223-enteric-capsule https://druglandscape.com/api/og?type=drug&title=TBI-223%20enteric%20capsule&subtitle=TBI-223%20enteric%20capsule%20%C2%B7%20Global%20Alliance%20for%20TB%20Drug%20Development&badge=phase%201 TBI-223 enteric capsule TBI-223 enteric capsule · Global Alliance for TB Drug Development https://druglandscape.com/drug/tbi-223-sr-tablet-prototype-2 https://druglandscape.com/api/og?type=drug&title=TBI-223%20SR%20Tablet%20Prototype%202&subtitle=TBI-223%20SR%20Tablet%20Prototype%202%20%C2%B7%20Global%20Alliance%20for%20TB%20Drug%20Development&badge=phase%201 TBI-223 SR Tablet Prototype 2 TBI-223 SR Tablet Prototype 2 · Global Alliance for TB Drug Development https://druglandscape.com/drug/tbi-223-sr-tablet-prototype-3 https://druglandscape.com/api/og?type=drug&title=TBI-223%20SR%20Tablet%20Prototype%203&subtitle=TBI-223%20SR%20Tablet%20Prototype%203%20%C2%B7%20Global%20Alliance%20for%20TB%20Drug%20Development&badge=phase%201 TBI-223 SR Tablet Prototype 3 TBI-223 SR Tablet Prototype 3 · Global Alliance for TB Drug Development https://druglandscape.com/drug/tbr-652 https://druglandscape.com/api/og?type=drug&title=TBR-652&subtitle=TBR-652%20%C2%B7%20Tobira%20Therapeutics%2C%20Inc.&badge=phase%201 TBR-652 TBR-652 · Tobira Therapeutics, Inc. https://druglandscape.com/drug/tbx-2400 https://druglandscape.com/api/og?type=drug&title=TBX-2400&subtitle=TBX-2400%20%C2%B7%20Taiga%20Biotechnologies%2C%20Inc.&badge=phase%201 TBX-2400 TBX-2400 · Taiga Biotechnologies, Inc. https://druglandscape.com/drug/tbx-3400 https://druglandscape.com/api/og?type=drug&title=TBX-3400&subtitle=TBX-3400%20%C2%B7%20Taiga%20Biotechnologies%2C%20Inc.&badge=phase%201 TBX-3400 TBX-3400 · Taiga Biotechnologies, Inc. https://druglandscape.com/drug/tc-510 https://druglandscape.com/api/og?type=drug&title=TC-510&subtitle=TC-510%20%C2%B7%20TCR2%20Therapeutics&badge=phase%201 TC-510 TC-510 · TCR2 Therapeutics https://druglandscape.com/drug/tc-5619 https://druglandscape.com/api/og?type=drug&title=TC-5619&subtitle=TC-5619%20%C2%B7%20Targacept%20Inc.&badge=phase%202 TC-5619 TC-5619 · Targacept Inc. https://druglandscape.com/drug/tc-5619-238 https://druglandscape.com/api/og?type=drug&title=TC-5619-238&subtitle=TC-5619-238%20%C2%B7%20Targacept%20Inc.&badge=phase%202 TC-5619-238 TC-5619-238 · Targacept Inc. https://druglandscape.com/drug/tc-6499 https://druglandscape.com/api/og?type=drug&title=TC-6499&subtitle=TC-6499%20%C2%B7%20Targacept%20Inc.&badge=phase%202 TC-6499 TC-6499 · Targacept Inc. https://druglandscape.com/drug/tc-99m-ec20 https://druglandscape.com/api/og?type=drug&title=Tc%2099m%20EC20&subtitle=Tc%2099m%20EC20%20%C2%B7%20Endocyte&badge=phase%202 Tc 99m EC20 Tc 99m EC20 · Endocyte https://druglandscape.com/drug/tc-d101-car-t https://druglandscape.com/api/og?type=drug&title=TC-D101%20CAR-T&subtitle=TC-D101%20CAR-T%20%C2%B7%20TCRCure%20Biopharma%20Ltd.&badge=phase%201 TC-D101 CAR-T TC-D101 CAR-T · TCRCure Biopharma Ltd. https://druglandscape.com/drug/tc011 https://druglandscape.com/api/og?type=drug&title=TC011&subtitle=TC011%20%C2%B7%20TICAROS%20Co.%2C%20Ltd.&badge=phase%201 TC011 TC011 · TICAROS Co., Ltd. https://druglandscape.com/drug/tc011-single-arm https://druglandscape.com/api/og?type=drug&title=TC011%20single-arm&subtitle=TC011%20single-arm%20%C2%B7%20TICAROS%20Co.%2C%20Ltd.&badge=phase%202 TC011 single-arm TC011 single-arm · TICAROS Co., Ltd. https://druglandscape.com/drug/tca-ir https://druglandscape.com/api/og?type=drug&title=TCA%20IR&subtitle=TCA%20IR%20%C2%B7%20Pacira%20Pharmaceuticals%2C%20Inc&badge=phase%202 TCA IR TCA IR · Pacira Pharmaceuticals, Inc https://druglandscape.com/drug/tcc1727-tablet-1 https://druglandscape.com/api/og?type=drug&title=TCC1727%20tablet%EF%BC%881%EF%BC%89&subtitle=TCC1727%20tablet%EF%BC%881%EF%BC%89%20%C2%B7%20Beijing%20Tide%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 TCC1727 tablet（1） TCC1727 tablet（1） · Beijing Tide Pharmaceutical Co., Ltd https://druglandscape.com/drug/tcc1727-tablet-2 https://druglandscape.com/api/og?type=drug&title=TCC1727%20tablet%EF%BC%882%EF%BC%89&subtitle=TCC1727%20tablet%EF%BC%882%EF%BC%89%20%C2%B7%20Beijing%20Tide%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 TCC1727 tablet（2） TCC1727 tablet（2） · Beijing Tide Pharmaceutical Co., Ltd https://druglandscape.com/drug/tcd-717 https://druglandscape.com/api/og?type=drug&title=TCD-717&subtitle=TCD-717%20%C2%B7%20Traslational%20Cancer%20Drugs%20Pharma%2C%20SL&badge=phase%201 TCD-717 TCD-717 · Traslational Cancer Drugs Pharma, SL https://druglandscape.com/drug/tcd601 https://druglandscape.com/api/og?type=drug&title=TCD601&subtitle=TCD601%20%C2%B7%20ITB-Med%20LLC&badge=phase%202 TCD601 TCD601 · ITB-Med LLC https://druglandscape.com/drug/tciv https://druglandscape.com/api/og?type=drug&title=TCiv&subtitle=TCiv%20%C2%B7%20Shanghai%20Gynecologic%20Oncology%20Group&badge=phase%202 TCiv TCiv · Shanghai Gynecologic Oncology Group https://druglandscape.com/drug/tcm-herbal-therapy https://druglandscape.com/api/og?type=drug&title=TCM%20Herbal%20Therapy&subtitle=TCM%20Herbal%20Therapy%20%C2%B7%20Chia-Ying%20Chuang&badge=phase%202 TCM Herbal Therapy TCM Herbal Therapy · Chia-Ying Chuang https://druglandscape.com/drug/tcm-prescriptions https://druglandscape.com/api/og?type=drug&title=TCM%20prescriptions&subtitle=TCM%20prescriptions%20%C2%B7%20Jiangsu%20Famous%20Medical%20Technology%20Co.%2C%20Ltd.&badge=phase%202 TCM prescriptions TCM prescriptions · Jiangsu Famous Medical Technology Co., Ltd. https://druglandscape.com/drug/tcp-25-gel https://druglandscape.com/api/og?type=drug&title=TCP-25%20gel&subtitle=TCP-25%20gel%20%C2%B7%20Xinnate%20AB&badge=phase%202 TCP-25 gel TCP-25 gel · Xinnate AB https://druglandscape.com/drug/tcr-t-cells https://druglandscape.com/api/og?type=drug&title=TCR%20T-cells&subtitle=TCR%20T-cells%20%C2%B7%20Beijing%20Geekgene%20Technology%20Co.%2C%20LTD&badge=phase%202 TCR T-cells TCR T-cells · Beijing Geekgene Technology Co., LTD https://druglandscape.com/drug/tcr1672-tablet https://druglandscape.com/api/og?type=drug&title=TCR1672%20tablet&subtitle=TCR1672%20tablet%20%C2%B7%20Beijing%20Tide%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 TCR1672 tablet TCR1672 tablet · Beijing Tide Pharmaceutical Co., Ltd https://druglandscape.com/drug/td001 https://druglandscape.com/api/og?type=drug&title=TD001&subtitle=TD001%20%C2%B7%20T.O.A.D.%20Oncology%20SA&badge=phase%201 TD001 TD001 · T.O.A.D. Oncology SA https://druglandscape.com/drug/td0015 https://druglandscape.com/api/og?type=drug&title=TD0015&subtitle=TD0015%20%C2%B7%20Sao%20Thai%20Duong%20Joint%20Stock%20Company&badge=phase%202 TD0015 TD0015 · Sao Thai Duong Joint Stock Company https://druglandscape.com/drug/td0019-oral-capsule https://druglandscape.com/api/og?type=drug&title=TD0019%20oral%20capsule&subtitle=TD0019%20oral%20capsule%20%C2%B7%20Sao%20Thai%20Duong%20Joint%20Stock%20Company&badge=phase%202 TD0019 oral capsule TD0019 oral capsule · Sao Thai Duong Joint Stock Company https://druglandscape.com/drug/td0025 https://druglandscape.com/api/og?type=drug&title=TD0025&subtitle=TD0025%20%C2%B7%20Vietstar%20Biomedical%20Research&badge=phase%202 TD0025 TD0025 · Vietstar Biomedical Research https://druglandscape.com/drug/td101 https://druglandscape.com/api/og?type=drug&title=TD101&subtitle=TD101%20%C2%B7%20Pachyonychia%20Congenita%20Project&badge=phase%201 TD101 TD101 · Pachyonychia Congenita Project https://druglandscape.com/drug/td1414-2-cream https://druglandscape.com/api/og?type=drug&title=TD1414%202%25%20cream&subtitle=TD1414%202%25%20cream%20%C2%B7%20LEO%20Pharma&badge=phase%202 TD1414 2% cream TD1414 2% cream · LEO Pharma https://druglandscape.com/drug/tdcp https://druglandscape.com/api/og?type=drug&title=Tdcp&subtitle=Tdcp%20%C2%B7%20CanSino%20Biologics%20Inc.&badge=phase%202 Tdcp Tdcp · CanSino Biologics Inc. https://druglandscape.com/drug/tdcs https://druglandscape.com/api/og?type=drug&title=tDCS&subtitle=tDCS%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 tDCS tDCS · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/tdenv-lav-f17 https://druglandscape.com/api/og?type=drug&title=TDENV-LAV%20F17&subtitle=TDENV-LAV%20F17%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 TDENV-LAV F17 TDENV-LAV F17 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/tdm-105795-0-02 https://druglandscape.com/api/og?type=drug&title=TDM-105795%2C%200.02%25&subtitle=TDM-105795%2C%200.02%25%20%C2%B7%20Technoderma%20Medicines%20Inc.&badge=phase%202 TDM-105795, 0.02% TDM-105795, 0.02% · Technoderma Medicines Inc. https://druglandscape.com/drug/tdm-180935 https://druglandscape.com/api/og?type=drug&title=TDM-180935&subtitle=TDM-180935%20%C2%B7%20Technoderma%20Medicines%20Inc.&badge=phase%201 TDM-180935 TDM-180935 · Technoderma Medicines Inc. https://druglandscape.com/drug/tdm-180935-topical-ointment-1-0 https://druglandscape.com/api/og?type=drug&title=TDM-180935%20topical%20ointment%201.0%25&subtitle=TDM-180935%20topical%20ointment%201.0%25%20%C2%B7%20Technoderma%20Medicines%20Inc.&badge=phase%202 TDM-180935 topical ointment 1.0% TDM-180935 topical ointment 1.0% · Technoderma Medicines Inc. https://druglandscape.com/drug/tdm-180935-topical-ointment-2-0 https://druglandscape.com/api/og?type=drug&title=TDM-180935%20topical%20ointment%202.0%25&subtitle=TDM-180935%20topical%20ointment%202.0%25%20%C2%B7%20Technoderma%20Medicines%20Inc.&badge=phase%202 TDM-180935 topical ointment 2.0% TDM-180935 topical ointment 2.0% · Technoderma Medicines Inc. https://druglandscape.com/drug/tdm1 https://druglandscape.com/api/og?type=drug&title=TDM1&subtitle=TDM1%20%C2%B7%20David%20Garcia%20Cinca&badge=phase%202 TDM1 TDM1 · David Garcia Cinca https://druglandscape.com/drug/tdmards https://druglandscape.com/api/og?type=drug&title=tDMARDs&subtitle=tDMARDs%20%C2%B7%20Pfizer&badge=phase%202 tDMARDs tDMARDs · Pfizer https://druglandscape.com/drug/tdt067-and-lamisil https://druglandscape.com/api/og?type=drug&title=TDT067%20and%20Lamisil&subtitle=TDT067%20and%20Lamisil%20%C2%B7%20Celtic%20Pharma%20Development%20Services&badge=phase%202 TDT067 and Lamisil TDT067 and Lamisil · Celtic Pharma Development Services https://druglandscape.com/drug/tdv-high-dose https://druglandscape.com/api/og?type=drug&title=TDV%20-%20High%20Dose&subtitle=TDV%20-%20High%20Dose%20%C2%B7%20Inviragen%20Inc.&badge=phase%201 TDV - High Dose TDV - High Dose · Inviragen Inc. https://druglandscape.com/drug/tdv-idt-lyophilized https://druglandscape.com/api/og?type=drug&title=TDV%20IDT%20Lyophilized&subtitle=TDV%20IDT%20Lyophilized%20%C2%B7%20Takeda&badge=phase%202 TDV IDT Lyophilized TDV IDT Lyophilized · Takeda https://druglandscape.com/drug/tdv-low-dose https://druglandscape.com/api/og?type=drug&title=TDV%20-%20Low%20Dose&subtitle=TDV%20-%20Low%20Dose%20%C2%B7%20Inviragen%20Inc.&badge=phase%201 TDV - Low Dose TDV - Low Dose · Inviragen Inc. https://druglandscape.com/drug/te-8214-sad https://druglandscape.com/api/og?type=drug&title=TE-8214%20-%20SAD&subtitle=TE-8214%20-%20SAD%20%C2%B7%20Immunwork%2C%20Inc.&badge=phase%201 TE-8214 - SAD TE-8214 - SAD · Immunwork, Inc. https://druglandscape.com/drug/tea-extracts https://druglandscape.com/api/og?type=drug&title=tea%20extracts&subtitle=tea%20extracts%20%C2%B7%20NatureGen&badge=phase%201 tea extracts tea extracts · NatureGen https://druglandscape.com/drug/tea-tree-oil-topical-application-oil https://druglandscape.com/api/og?type=drug&title=Tea%20Tree%20Oil%20Topical%20Application%20Oil&subtitle=Tea%20Tree%20Oil%20Topical%20Application%20Oil%20%C2%B7%20Ehab%20Mohamed%20Elsayed%20Mohamed%20Saad&badge=phase%201 Tea Tree Oil Topical Application Oil Tea Tree Oil Topical Application Oil · Ehab Mohamed Elsayed Mohamed Saad https://druglandscape.com/drug/tears-again https://druglandscape.com/api/og?type=drug&title=Tears%20Again&subtitle=Tears%20Again%20%C2%B7%20Trima%2C%20Israel%20Pharmaceutical%20Products&badge=phase%201 Tears Again Tears Again · Trima, Israel Pharmaceutical Products https://druglandscape.com/drug/tearx https://druglandscape.com/api/og?type=drug&title=TeaRx&subtitle=TeaRx%20%C2%B7%20TeaRx%20LLC&badge=phase%202 TeaRx TeaRx · TeaRx LLC https://druglandscape.com/drug/technetium-tc-99m-ec20 https://druglandscape.com/api/og?type=drug&title=Technetium%20Tc%2099m%20EC20&subtitle=Technetium%20Tc%2099m%20EC20%20%C2%B7%20Endocyte&badge=phase%202 Technetium Tc 99m EC20 Technetium Tc 99m EC20 · Endocyte https://druglandscape.com/drug/teclistamab-monotherapy https://druglandscape.com/api/og?type=drug&title=Teclistamab%20Monotherapy&subtitle=Teclistamab%20Monotherapy%20%C2%B7%20Multiple%20Myeloma%20Research%20Consortium&badge=phase%202 Teclistamab Monotherapy Teclistamab Monotherapy · Multiple Myeloma Research Consortium https://druglandscape.com/drug/teduglutide-0-05 https://druglandscape.com/api/og?type=drug&title=teduglutide%200.05&subtitle=teduglutide%200.05%20%C2%B7%20Shire&badge=phase%202 teduglutide 0.05 teduglutide 0.05 · Shire https://druglandscape.com/drug/teg002 https://druglandscape.com/api/og?type=drug&title=TEG002&subtitle=TEG002%20%C2%B7%20Gadeta%20B.V.&badge=phase%201 TEG002 TEG002 · Gadeta B.V. https://druglandscape.com/drug/tegafur-gimeracil-oteracil-potassium https://druglandscape.com/api/og?type=drug&title=tegafur-gimeracil-oteracil%20potassium&subtitle=tegafur-gimeracil-oteracil%20potassium%20%C2%B7%20Fukushima%20Medical%20University%20Hospital&badge=phase%203 tegafur-gimeracil-oteracil potassium tegafur-gimeracil-oteracil potassium · Fukushima Medical University Hospital https://druglandscape.com/drug/tegafur-gimeracil-oteracil-potassium-capsule https://druglandscape.com/api/og?type=drug&title=Tegafur%20gimeracil%20oteracil%20potassium%20capsule&subtitle=Tegafur%20gimeracil%20oteracil%20potassium%20capsule%20%C2%B7%20Yu%20jiren&badge=phase%202 Tegafur gimeracil oteracil potassium capsule Tegafur gimeracil oteracil potassium capsule · Yu jiren https://druglandscape.com/drug/tegileridine-fumarate-lnjection https://druglandscape.com/api/og?type=drug&title=Tegileridine%20Fumarate%20lnjection&subtitle=Tegileridine%20Fumarate%20lnjection%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 Tegileridine Fumarate lnjection Tegileridine Fumarate lnjection · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/tegoprazan-tablet https://druglandscape.com/api/og?type=drug&title=Tegoprazan%20tablet&subtitle=Tegoprazan%20tablet%20%C2%B7%20Shandong%20Luoxin%20Pharmaceutical%20Group%20Stock%20Co.%2C%20Ltd.&badge=phase%201 Tegoprazan tablet Tegoprazan tablet · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. https://druglandscape.com/drug/telaprevir-formulation-b https://druglandscape.com/api/og?type=drug&title=telaprevir%20Formulation%20B&subtitle=telaprevir%20Formulation%20B%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 telaprevir Formulation B telaprevir Formulation B · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/telaprevir-formulation-c https://druglandscape.com/api/og?type=drug&title=telaprevir%20Formulation%20C&subtitle=telaprevir%20Formulation%20C%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 telaprevir Formulation C telaprevir Formulation C · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/telaprevir-formulation-d https://druglandscape.com/api/og?type=drug&title=telaprevir%20Formulation%20D&subtitle=telaprevir%20Formulation%20D%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 telaprevir Formulation D telaprevir Formulation D · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/telatinib-mesylate https://druglandscape.com/api/og?type=drug&title=Telatinib%20Mesylate&subtitle=Telatinib%20Mesylate%20%C2%B7%20Taizhou%20EOC%20Pharma%20Co.%2C%20Ltd.&badge=phase%201 Telatinib Mesylate Telatinib Mesylate · Taizhou EOC Pharma Co., Ltd. https://druglandscape.com/drug/temcap https://druglandscape.com/api/og?type=drug&title=TEMCAP&subtitle=TEMCAP%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 TEMCAP TEMCAP · Asan Medical Center https://druglandscape.com/drug/temiri https://druglandscape.com/api/og?type=drug&title=TEMIRI&subtitle=TEMIRI%20%C2%B7%20Italian%20Sarcoma%20Group&badge=phase%202 TEMIRI TEMIRI · Italian Sarcoma Group https://druglandscape.com/drug/temodal-or-dacarbazine-medac https://druglandscape.com/api/og?type=drug&title=Temodal%C2%AE%20or%20Dacarbazine%20Medac%C2%AE&subtitle=Temodal%C2%AE%20or%20Dacarbazine%20Medac%C2%AE%20%C2%B7%20SentoClone%20AB&badge=phase%202 Temodal® or Dacarbazine Medac® Temodal® or Dacarbazine Medac® · SentoClone AB https://druglandscape.com/drug/temozolamide-irinotecan https://druglandscape.com/api/og?type=drug&title=Temozolamide%2C%20irinotecan&subtitle=Temozolamide%2C%20irinotecan%20%C2%B7%20Grupo%20Espa%C3%B1ol%20de%20Investigaci%C3%B3n%20en%20Neurooncolog%C3%ADa&badge=phase%202 Temozolamide, irinotecan Temozolamide, irinotecan · Grupo Español de Investigación en Neurooncología https://druglandscape.com/drug/temozolomide-cisplatinum https://druglandscape.com/api/og?type=drug&title=Temozolomide%2C%20Cisplatinum&subtitle=Temozolomide%2C%20Cisplatinum%20%C2%B7%20Gustave%20Roussy%2C%20Cancer%20Campus%2C%20Grand%20Paris&badge=phase%202 Temozolomide, Cisplatinum Temozolomide, Cisplatinum · Gustave Roussy, Cancer Campus, Grand Paris https://druglandscape.com/drug/temozolomide-in-both-arms https://druglandscape.com/api/og?type=drug&title=Temozolomide%20in%20both%20arms&subtitle=Temozolomide%20in%20both%20arms%20%C2%B7%20Prof.%20Dr.%20Wolfgang%20Wick&badge=phase%202 Temozolomide in both arms Temozolomide in both arms · Prof. Dr. Wolfgang Wick https://druglandscape.com/drug/temozolomide-radiation-therapy https://druglandscape.com/api/og?type=drug&title=Temozolomide%20%26%20Radiation%20Therapy&subtitle=Temozolomide%20%26%20Radiation%20Therapy%20%C2%B7%20Myrexis%20Inc.&badge=phase%202 Temozolomide & Radiation Therapy Temozolomide & Radiation Therapy · Myrexis Inc. https://druglandscape.com/drug/teneligliptin-and-empagliflozin https://druglandscape.com/api/og?type=drug&title=Teneligliptin%20and%20Empagliflozin&subtitle=Teneligliptin%20and%20Empagliflozin%20%C2%B7%20Handok%20Inc.&badge=phase%201 Teneligliptin and Empagliflozin Teneligliptin and Empagliflozin · Handok Inc. https://druglandscape.com/drug/tenofovir-film https://druglandscape.com/api/og?type=drug&title=Tenofovir%20Film&subtitle=Tenofovir%20Film%20%C2%B7%20CONRAD&badge=phase%201 Tenofovir Film Tenofovir Film · CONRAD https://druglandscape.com/drug/tenofovir-intravaginal-ring https://druglandscape.com/api/og?type=drug&title=Tenofovir%20intravaginal%20ring&subtitle=Tenofovir%20intravaginal%20ring%20%C2%B7%20CONRAD&badge=phase%201 Tenofovir intravaginal ring Tenofovir intravaginal ring · CONRAD https://druglandscape.com/drug/tenofovir-monotherapy https://druglandscape.com/api/og?type=drug&title=tenofovir%20monotherapy&subtitle=tenofovir%20monotherapy%20%C2%B7%20Uijeongbu%20St.%20Mary%20Hospital&badge=phase%203 tenofovir monotherapy tenofovir monotherapy · Uijeongbu St. Mary Hospital https://druglandscape.com/drug/tepotinib-tf2 https://druglandscape.com/api/og?type=drug&title=Tepotinib%20TF2&subtitle=Tepotinib%20TF2%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 Tepotinib TF2 Tepotinib TF2 · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/tepotinib-tf3 https://druglandscape.com/api/og?type=drug&title=Tepotinib%20TF3&subtitle=Tepotinib%20TF3%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 Tepotinib TF3 Tepotinib TF3 · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/ter-101 https://druglandscape.com/api/og?type=drug&title=TER-101&subtitle=TER-101%20%C2%B7%20Teres%20Bio%2C%20Inc.&badge=phase%202 TER-101 TER-101 · Teres Bio, Inc. https://druglandscape.com/drug/ter-1754 https://druglandscape.com/api/og?type=drug&title=TER-1754&subtitle=TER-1754%20%C2%B7%20Terremoto%20Biosciences%20Inc.&badge=phase%201 TER-1754 TER-1754 · Terremoto Biosciences Inc. https://druglandscape.com/drug/ter-2013 https://druglandscape.com/api/og?type=drug&title=TER-2013&subtitle=TER-2013%20%C2%B7%20Terremoto%20Biosciences%20Inc.&badge=phase%201 TER-2013 TER-2013 · Terremoto Biosciences Inc. https://druglandscape.com/drug/terazol-vaginal-suppository https://druglandscape.com/api/og?type=drug&title=Terazol%20Vaginal%20Suppository&subtitle=Terazol%20Vaginal%20Suppository%20%C2%B7%20Padagis%20LLC&badge=phase%201 Terazol Vaginal Suppository Terazol Vaginal Suppository · Padagis LLC https://druglandscape.com/drug/terazosin-therapy https://druglandscape.com/api/og?type=drug&title=Terazosin%20therapy&subtitle=Terazosin%20therapy%20%C2%B7%20Cedars-Sinai%20Medical%20Center&badge=phase%202 Terazosin therapy Terazosin therapy · Cedars-Sinai Medical Center https://druglandscape.com/drug/terbutaline-sulphate-delivered-dose https://druglandscape.com/api/og?type=drug&title=terbutaline%20sulphate%20delivered%20dose&subtitle=terbutaline%20sulphate%20delivered%20dose%20%C2%B7%20AstraZeneca&badge=phase%201 terbutaline sulphate delivered dose terbutaline sulphate delivered dose · AstraZeneca https://druglandscape.com/drug/terbutaline-sulphate-metered-dose https://druglandscape.com/api/og?type=drug&title=terbutaline%20sulphate%20metered%20dose&subtitle=terbutaline%20sulphate%20metered%20dose%20%C2%B7%20AstraZeneca&badge=phase%201 terbutaline sulphate metered dose terbutaline sulphate metered dose · AstraZeneca https://druglandscape.com/drug/teribone-inj https://druglandscape.com/api/og?type=drug&title=Teribone%20Inj.&subtitle=Teribone%20Inj.%20%C2%B7%20QuadMedicine&badge=phase%201 Teribone Inj. Teribone Inj. · QuadMedicine https://druglandscape.com/drug/teriq-patch https://druglandscape.com/api/og?type=drug&title=TeriQ%20Patch&subtitle=TeriQ%20Patch%20%C2%B7%20QuadMedicine&badge=phase%201 TeriQ Patch TeriQ Patch · QuadMedicine https://druglandscape.com/drug/tern-501 https://druglandscape.com/api/og?type=drug&title=TERN-501&subtitle=TERN-501%20%C2%B7%20Terns%2C%20Inc.&badge=phase%202 TERN-501 TERN-501 · Terns, Inc. https://druglandscape.com/drug/tern-701 https://druglandscape.com/api/og?type=drug&title=TERN-701&subtitle=TERN-701%20%C2%B7%20Terns%2C%20Inc.&badge=phase%201 TERN-701 TERN-701 · Terns, Inc. https://druglandscape.com/drug/terpenes-enriched-cbd-predominant-oil https://druglandscape.com/api/og?type=drug&title=Terpenes-Enriched%20CBD-Predominant%20Oil&subtitle=Terpenes-Enriched%20CBD-Predominant%20Oil%20%C2%B7%20Bazelet%20Nehushtan%20LtD.&badge=phase%202 Terpenes-Enriched CBD-Predominant Oil Terpenes-Enriched CBD-Predominant Oil · Bazelet Nehushtan LtD. https://druglandscape.com/drug/terpinen-4-ol https://druglandscape.com/api/og?type=drug&title=Terpinen-4-ol&subtitle=Terpinen-4-ol%20%C2%B7%20BioTissue%20Holdings%2C%20Inc&badge=phase%201 Terpinen-4-ol Terpinen-4-ol · BioTissue Holdings, Inc https://druglandscape.com/drug/test-dentifrice https://druglandscape.com/api/og?type=drug&title=Test%20Dentifrice&subtitle=Test%20Dentifrice%20%C2%B7%20HALEON&badge=phase%201 Test Dentifrice Test Dentifrice · HALEON https://druglandscape.com/drug/test-drug-1 https://druglandscape.com/api/og?type=drug&title=Test%20drug%201&subtitle=Test%20drug%201%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 Test drug 1 Test drug 1 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/test-drug-2 https://druglandscape.com/api/og?type=drug&title=Test%20drug%202&subtitle=Test%20drug%202%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 Test drug 2 Test drug 2 · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/test-eutirox https://druglandscape.com/api/og?type=drug&title=Test%20Eutirox%C2%AE&subtitle=Test%20Eutirox%C2%AE%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmstadt%2C%20Ge&badge=phase%201 Test Eutirox® Test Eutirox® · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/test-fluoride-toothpaste https://druglandscape.com/api/og?type=drug&title=Test%20Fluoride%20Toothpaste&subtitle=Test%20Fluoride%20Toothpaste%20%C2%B7%20HALEON&badge=phase%201 Test Fluoride Toothpaste Test Fluoride Toothpaste · HALEON https://druglandscape.com/drug/test-formulation-a https://druglandscape.com/api/og?type=drug&title=Test%20formulation%20A&subtitle=Test%20formulation%20A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Test formulation A Test formulation A · GlaxoSmithKline https://druglandscape.com/drug/test-formulation-administered-with-water https://druglandscape.com/api/og?type=drug&title=Test%20formulation%20administered%20with%20water&subtitle=Test%20formulation%20administered%20with%20water%20%C2%B7%20Pfizer&badge=phase%201 Test formulation administered with water Test formulation administered with water · Pfizer https://druglandscape.com/drug/test-formulation-d1 https://druglandscape.com/api/og?type=drug&title=Test%20formulation%20D1&subtitle=Test%20formulation%20D1%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%201 Test formulation D1 Test formulation D1 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/test-formulation-d2 https://druglandscape.com/api/og?type=drug&title=Test%20formulation%20D2&subtitle=Test%20formulation%20D2%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%201 Test formulation D2 Test formulation D2 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/test-formulation-of-hrs-1893-tablet https://druglandscape.com/api/og?type=drug&title=Test%20formulation%20of%20HRS-1893%20tablet&subtitle=Test%20formulation%20of%20HRS-1893%20tablet%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Test formulation of HRS-1893 tablet Test formulation of HRS-1893 tablet · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/test-gir https://druglandscape.com/api/og?type=drug&title=Test%20GIR&subtitle=Test%20GIR%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 Test GIR Test GIR · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/test-glucophage-xr https://druglandscape.com/api/og?type=drug&title=Test%20Glucophage%C2%AE%20XR&subtitle=Test%20Glucophage%C2%AE%20XR%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20Merck%20KGaA%2C%20Darmsta&badge=phase%201 Test Glucophage® XR Test Glucophage® XR · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/test-gxr https://druglandscape.com/api/og?type=drug&title=Test%20GXR&subtitle=Test%20GXR%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 Test GXR Test GXR · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/test-meal-ceaprove-wafer https://druglandscape.com/api/og?type=drug&title=Test%20Meal%3A%20Ceaprove%20wafer&subtitle=Test%20Meal%3A%20Ceaprove%20wafer%20%C2%B7%20Glycaemic%20Index%20Testing%2C%20Inc.&badge=phase%201 Test Meal: Ceaprove wafer Test Meal: Ceaprove wafer · Glycaemic Index Testing, Inc. https://druglandscape.com/drug/test-montelukast https://druglandscape.com/api/og?type=drug&title=Test%20Montelukast&subtitle=Test%20Montelukast%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Test Montelukast Test Montelukast · GlaxoSmithKline https://druglandscape.com/drug/test-of-biological-samples https://druglandscape.com/api/og?type=drug&title=Test%20of%20biological%20samples&subtitle=Test%20of%20biological%20samples%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 Test of biological samples Test of biological samples · Hospices Civils de Lyon https://druglandscape.com/drug/test-product-10156 https://druglandscape.com/api/og?type=drug&title=Test%20Product%2010156&subtitle=Test%20Product%2010156%20%C2%B7%20Medicis%20Global%20Service%20Corporation&badge=phase%202 Test Product 10156 Test Product 10156 · Medicis Global Service Corporation https://druglandscape.com/drug/test-product-hy07121 https://druglandscape.com/api/og?type=drug&title=Test%20Product%20HY07121&subtitle=Test%20Product%20HY07121%20%C2%B7%20Sichuan%20Huiyu%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 Test Product HY07121 Test Product HY07121 · Sichuan Huiyu Pharmaceutical Co., Ltd https://druglandscape.com/drug/test-product-hyp-2090ptsa https://druglandscape.com/api/og?type=drug&title=Test%20product%3A%20HYP-2090PTSA&subtitle=Test%20product%3A%20HYP-2090PTSA%20%C2%B7%20Sichuan%20Huiyu%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 Test product: HYP-2090PTSA Test product: HYP-2090PTSA · Sichuan Huiyu Pharmaceutical Co., Ltd https://druglandscape.com/drug/test-product-hyp-6589 https://druglandscape.com/api/og?type=drug&title=Test%20Product%20HYP-6589&subtitle=Test%20Product%20HYP-6589%20%C2%B7%20Sichuan%20Huiyu%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 Test Product HYP-6589 Test Product HYP-6589 · Sichuan Huiyu Pharmaceutical Co., Ltd https://druglandscape.com/drug/test-shr3680-tablets https://druglandscape.com/api/og?type=drug&title=test%20SHR3680%20tablets&subtitle=test%20SHR3680%20tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 test SHR3680 tablets test SHR3680 tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/test-toothpaste-1 https://druglandscape.com/api/og?type=drug&title=Test%20Toothpaste%201&subtitle=Test%20Toothpaste%201%20%C2%B7%20HALEON&badge=phase%201 Test Toothpaste 1 Test Toothpaste 1 · HALEON https://druglandscape.com/drug/test-toothpaste-2 https://druglandscape.com/api/og?type=drug&title=Test%20Toothpaste%202&subtitle=Test%20Toothpaste%202%20%C2%B7%20HALEON&badge=phase%201 Test Toothpaste 2 Test Toothpaste 2 · HALEON https://druglandscape.com/drug/test-treatment-v0116-transdermal-patch https://druglandscape.com/api/og?type=drug&title=Test%20treatment%20%3A%20V0116%20transdermal%20patch&subtitle=Test%20treatment%20%3A%20V0116%20transdermal%20patch%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%201 Test treatment : V0116 transdermal patch Test treatment : V0116 transdermal patch · Pierre Fabre Medicament https://druglandscape.com/drug/test-varnish https://druglandscape.com/api/og?type=drug&title=Test%20varnish&subtitle=Test%20varnish%20%C2%B7%20Advantage%20Silver%20Dental%20Arrest%2C%20LLC&badge=phase%202 Test varnish Test varnish · Advantage Silver Dental Arrest, LLC https://druglandscape.com/drug/testosterone-anastrozole https://druglandscape.com/api/og?type=drug&title=testosterone%20anastrozole&subtitle=testosterone%20anastrozole%20%C2%B7%20Havah%20Therapeutics%20Pty%20Ltd&badge=phase%201 testosterone anastrozole testosterone anastrozole · Havah Therapeutics Pty Ltd https://druglandscape.com/drug/testosterone-cyclopentylpropionate https://druglandscape.com/api/og?type=drug&title=Testosterone%20cyclopentylpropionate&subtitle=Testosterone%20cyclopentylpropionate%20%C2%B7%20Parc%20de%20Salut%20Mar&badge=phase%201 Testosterone cyclopentylpropionate Testosterone cyclopentylpropionate · Parc de Salut Mar https://druglandscape.com/drug/testosterone-pellets https://druglandscape.com/api/og?type=drug&title=Testosterone%20Pellets&subtitle=Testosterone%20Pellets%20%C2%B7%20Men's%20Health%20Boston&badge=phase%201 Testosterone Pellets Testosterone Pellets · Men's Health Boston https://druglandscape.com/drug/tetanus-day-29 https://druglandscape.com/api/og?type=drug&title=Tetanus%20Day%2029&subtitle=Tetanus%20Day%2029%20%C2%B7%20Providence%20Health%20%26%20Services&badge=phase%201 Tetanus Day 29 Tetanus Day 29 · Providence Health & Services https://druglandscape.com/drug/tetracthib https://druglandscape.com/api/og?type=drug&title=TETRActHib%E2%84%A2&subtitle=TETRActHib%E2%84%A2%20%C2%B7%20GlaxoSmithKline&badge=phase%202 TETRActHib™ TETRActHib™ · GlaxoSmithKline https://druglandscape.com/drug/tetralens-bandage-contact-lens https://druglandscape.com/api/og?type=drug&title=TetraLens%20bandage%20contact%20lens&subtitle=TetraLens%20bandage%20contact%20lens%20%C2%B7%20Vance%20Thompson%20Vision&badge=phase%201 TetraLens bandage contact lens TetraLens bandage contact lens · Vance Thompson Vision https://druglandscape.com/drug/tetralite https://druglandscape.com/api/og?type=drug&title=TETRALITE&subtitle=TETRALITE%20%C2%B7%20LiteVax%20BV&badge=phase%201 TETRALITE TETRALITE · LiteVax BV https://druglandscape.com/drug/tetravisc-0-5-gel https://druglandscape.com/api/og?type=drug&title=Tetravisc%200.5%25%20Gel&subtitle=Tetravisc%200.5%25%20Gel%20%C2%B7%20Retina%20Vitreous%20Associates%20of%20Florida&badge=phase%201 Tetravisc 0.5% Gel Tetravisc 0.5% Gel · Retina Vitreous Associates of Florida https://druglandscape.com/drug/tev-48125-1 https://druglandscape.com/api/og?type=drug&title=TEV-48125%20-%201&subtitle=TEV-48125%20-%201%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%201 TEV-48125 - 1 TEV-48125 - 1 · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/tev-48125-2 https://druglandscape.com/api/og?type=drug&title=TEV-48125%20-%202&subtitle=TEV-48125%20-%202%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%201 TEV-48125 - 2 TEV-48125 - 2 · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/tev-48574-dose-regiment-b https://druglandscape.com/api/og?type=drug&title=TEV-48574%20Dose%20Regiment%20B&subtitle=TEV-48574%20Dose%20Regiment%20B%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%20LLC&badge=phase%202 TEV-48574 Dose Regiment B TEV-48574 Dose Regiment B · Teva Branded Pharmaceutical Products R&D LLC https://druglandscape.com/drug/tev-53408 https://druglandscape.com/api/og?type=drug&title=TEV-53408&subtitle=TEV-53408%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%20LLC&badge=phase%202 TEV-53408 TEV-53408 · Teva Branded Pharmaceutical Products R&D LLC https://druglandscape.com/drug/tev-56278 https://druglandscape.com/api/og?type=drug&title=TEV-56278&subtitle=TEV-56278%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%201 TEV-56278 TEV-56278 · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/tev-56286 https://druglandscape.com/api/og?type=drug&title=TEV-56286&subtitle=TEV-56286%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%202 TEV-56286 TEV-56286 · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/tev-56286-reference https://druglandscape.com/api/og?type=drug&title=TEV-56286%20Reference&subtitle=TEV-56286%20Reference%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%20LLC&badge=phase%201 TEV-56286 Reference TEV-56286 Reference · Teva Branded Pharmaceutical Products R&D LLC https://druglandscape.com/drug/tev-56286-test https://druglandscape.com/api/og?type=drug&title=TEV-56286%20Test&subtitle=TEV-56286%20Test%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%20LLC&badge=phase%201 TEV-56286 Test TEV-56286 Test · Teva Branded Pharmaceutical Products R&D LLC https://druglandscape.com/drug/tevagastrim https://druglandscape.com/api/og?type=drug&title=TevaGastrim&subtitle=TevaGastrim%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%202 TevaGastrim TevaGastrim · Sheba Medical Center https://druglandscape.com/drug/teverelix-tfa https://druglandscape.com/api/og?type=drug&title=teverelix%20TFA&subtitle=teverelix%20TFA%20%C2%B7%20Antev%20Ltd.&badge=phase%201 teverelix TFA teverelix TFA · Antev Ltd. https://druglandscape.com/drug/tezepelumab-dose-1 https://druglandscape.com/api/og?type=drug&title=Tezepelumab%20Dose%201&subtitle=Tezepelumab%20Dose%201%20%C2%B7%20Amgen&badge=phase%202 Tezepelumab Dose 1 Tezepelumab Dose 1 · Amgen https://druglandscape.com/drug/tf-002 https://druglandscape.com/api/og?type=drug&title=TF%20002&subtitle=TF%20002%20%C2%B7%20JADO%20Technologies%20GmbH&badge=phase%202 TF 002 TF 002 · JADO Technologies GmbH https://druglandscape.com/drug/tfv-ivr https://druglandscape.com/api/og?type=drug&title=TFV%20IVR&subtitle=TFV%20IVR%20%C2%B7%20CONRAD&badge=phase%202 TFV IVR TFV IVR · CONRAD https://druglandscape.com/drug/tfx05-01 https://druglandscape.com/api/og?type=drug&title=TFX05-01&subtitle=TFX05-01%20%C2%B7%20Zhejiang%20Yangli%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 TFX05-01 TFX05-01 · Zhejiang Yangli Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/tfx06-tablet https://druglandscape.com/api/og?type=drug&title=TFX06%20tablet&subtitle=TFX06%20tablet%20%C2%B7%20Zhejiang%20Yangli%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 TFX06 tablet TFX06 tablet · Zhejiang Yangli Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/tg-0054 https://druglandscape.com/api/og?type=drug&title=TG-0054&subtitle=TG-0054%20%C2%B7%20GPCR%20Therapeutics%2C%20Inc.&badge=phase%202 TG-0054 TG-0054 · GPCR Therapeutics, Inc. https://druglandscape.com/drug/tg-1000 https://druglandscape.com/api/og?type=drug&title=TG-1000&subtitle=TG-1000%20%C2%B7%20TaiGen%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%202 TG-1000 TG-1000 · TaiGen Biotechnology Co., Ltd. https://druglandscape.com/drug/tg-1501 https://druglandscape.com/api/og?type=drug&title=TG-1501&subtitle=TG-1501%20%C2%B7%20TG%20Therapeutics%2C%20Inc.&badge=phase%201 TG-1501 TG-1501 · TG Therapeutics, Inc. https://druglandscape.com/drug/tg-2349-as-a-new-capsule-formulation https://druglandscape.com/api/og?type=drug&title=TG-2349%20as%20a%20new%20capsule%20formulation&subtitle=TG-2349%20as%20a%20new%20capsule%20formulation%20%C2%B7%20TaiGen%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 TG-2349 as a new capsule formulation TG-2349 as a new capsule formulation · TaiGen Biotechnology Co., Ltd. https://druglandscape.com/drug/tg-c-low-dose https://druglandscape.com/api/og?type=drug&title=TG-C%20Low%20Dose&subtitle=TG-C%20Low%20Dose%20%C2%B7%20Kolon%20TissueGene%2C%20Inc.&badge=phase%201 TG-C Low Dose TG-C Low Dose · Kolon TissueGene, Inc. https://druglandscape.com/drug/tg-c-mid-dose https://druglandscape.com/api/og?type=drug&title=TG-C%20Mid%20Dose&subtitle=TG-C%20Mid%20Dose%20%C2%B7%20Kolon%20TissueGene%2C%20Inc.&badge=phase%201 TG-C Mid Dose TG-C Mid Dose · Kolon TissueGene, Inc. https://druglandscape.com/drug/tg01 https://druglandscape.com/api/og?type=drug&title=TG01&subtitle=TG01%20%C2%B7%20Tragara%20Pharmaceuticals%2C%20Inc.&badge=phase%201 TG01 TG01 · Tragara Pharmaceuticals, Inc. https://druglandscape.com/drug/tg101348 https://druglandscape.com/api/og?type=drug&title=TG101348&subtitle=TG101348%20%C2%B7%20TargeGen&badge=phase%201 TG101348 TG101348 · TargeGen https://druglandscape.com/drug/tg103-q2w https://druglandscape.com/api/og?type=drug&title=TG103%2CQ2W&subtitle=TG103%2CQ2W%20%C2%B7%20CSPC%20Baike%20(Shandong)%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 TG103,Q2W TG103,Q2W · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/tg103-qw https://druglandscape.com/api/og?type=drug&title=TG103%2CQW&subtitle=TG103%2CQW%20%C2%B7%20CSPC%20Baike%20(Shandong)%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 TG103,QW TG103,QW · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/tg1050 https://druglandscape.com/api/og?type=drug&title=TG1050&subtitle=TG1050%20%C2%B7%20Transgene&badge=phase%201 TG1050 TG1050 · Transgene https://druglandscape.com/drug/tg4050 https://druglandscape.com/api/og?type=drug&title=TG4050&subtitle=TG4050%20%C2%B7%20Transgene&badge=phase%201 TG4050 TG4050 · Transgene https://druglandscape.com/drug/tgf-2-antisense-oligonucleotide https://druglandscape.com/api/og?type=drug&title=TGF-%CE%B22%20antisense%20oligonucleotide&subtitle=TGF-%CE%B22%20antisense%20oligonucleotide%20%C2%B7%20Isarna%20Therapeutics%20GmbH&badge=phase%201 TGF-β2 antisense oligonucleotide TGF-β2 antisense oligonucleotide · Isarna Therapeutics GmbH https://druglandscape.com/drug/tgf-b-15-peptide https://druglandscape.com/api/og?type=drug&title=TGF%CE%B2-B-15%20peptide&subtitle=TGF%CE%B2-B-15%20peptide%20%C2%B7%20Inna%20Chen%2C%20MD&badge=phase%201 TGFβ-B-15 peptide TGFβ-B-15 peptide · Inna Chen, MD https://druglandscape.com/drug/tgfbeta-resistant-lmp-specific-ctls https://druglandscape.com/api/og?type=drug&title=TGFbeta%20resistant%20LMP-specific%20CTLs&subtitle=TGFbeta%20resistant%20LMP-specific%20CTLs%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 TGFbeta resistant LMP-specific CTLs TGFbeta resistant LMP-specific CTLs · Baylor College of Medicine https://druglandscape.com/drug/tgfbr2 https://druglandscape.com/api/og?type=drug&title=TGFBR2&subtitle=TGFBR2%20%C2%B7%20French%20Cardiology%20Society&badge=phase%202 TGFBR2 TGFBR2 · French Cardiology Society https://druglandscape.com/drug/tgi-5 https://druglandscape.com/api/og?type=drug&title=TGI-5&subtitle=TGI-5%20%C2%B7%20Hefei%20TG%20ImmunoPharma%20Co.%2C%20Ltd.&badge=phase%201 TGI-5 TGI-5 · Hefei TG ImmunoPharma Co., Ltd. https://druglandscape.com/drug/tgm-312-sc01 https://druglandscape.com/api/og?type=drug&title=TGM-312-SC01&subtitle=TGM-312-SC01%20%C2%B7%20Tangram%20Therapeutics%20Plc&badge=phase%201 TGM-312-SC01 TGM-312-SC01 · Tangram Therapeutics Plc https://druglandscape.com/drug/tgn-s11 https://druglandscape.com/api/og?type=drug&title=TGN-S11&subtitle=TGN-S11%20%C2%B7%20Toragen%2C%20Inc.&badge=phase%201 TGN-S11 TGN-S11 · Toragen, Inc. https://druglandscape.com/drug/tgrx-1942 https://druglandscape.com/api/og?type=drug&title=TGRX-1942&subtitle=TGRX-1942%20%C2%B7%20Shenzhen%20TargetRx%20Co.%2C%20Ltd.&badge=phase%201 TGRX-1942 TGRX-1942 · Shenzhen TargetRx Co., Ltd. https://druglandscape.com/drug/tgrx-814 https://druglandscape.com/api/og?type=drug&title=TGRX-814&subtitle=TGRX-814%20%C2%B7%20Shenzhen%20TargetRx%20Co.%2C%20Ltd.&badge=phase%201 TGRX-814 TGRX-814 · Shenzhen TargetRx Co., Ltd. https://druglandscape.com/drug/tgw101 https://druglandscape.com/api/og?type=drug&title=TGW101&subtitle=TGW101%20%C2%B7%20Tagworks%20Pharmaceuticals%20BV&badge=phase%201 TGW101 TGW101 · Tagworks Pharmaceuticals BV https://druglandscape.com/drug/tgx-007 https://druglandscape.com/api/og?type=drug&title=TGX-007&subtitle=TGX-007%20%C2%B7%20Trogenix%20ltd&badge=phase%201 TGX-007 TGX-007 · Trogenix ltd https://druglandscape.com/drug/th1902 https://druglandscape.com/api/og?type=drug&title=TH1902&subtitle=TH1902%20%C2%B7%20Theratechnologies&badge=phase%201 TH1902 TH1902 · Theratechnologies https://druglandscape.com/drug/thalidomide-celgene https://druglandscape.com/api/og?type=drug&title=Thalidomide%20Celgene%E2%84%A2&subtitle=Thalidomide%20Celgene%E2%84%A2%20%C2%B7%20Celgene&badge=phase%201 Thalidomide Celgene™ Thalidomide Celgene™ · Celgene https://druglandscape.com/drug/thb335-multiple-dose https://druglandscape.com/api/og?type=drug&title=THB335%20multiple%20dose&subtitle=THB335%20multiple%20dose%20%C2%B7%20Third%20Harmonic%20Bio%2C%20Inc.&badge=phase%201 THB335 multiple dose THB335 multiple dose · Third Harmonic Bio, Inc. https://druglandscape.com/drug/thb335-single-dose https://druglandscape.com/api/og?type=drug&title=THB335%20single%20dose&subtitle=THB335%20single%20dose%20%C2%B7%20Third%20Harmonic%20Bio%2C%20Inc.&badge=phase%201 THB335 single dose THB335 single dose · Third Harmonic Bio, Inc. https://druglandscape.com/drug/thc-free-cbd-oil https://druglandscape.com/api/og?type=drug&title=THC-free%20CBD%20Oil&subtitle=THC-free%20CBD%20Oil%20%C2%B7%20Eastern%20Virginia%20Medical%20School&badge=phase%202 THC-free CBD Oil THC-free CBD Oil · Eastern Virginia Medical School https://druglandscape.com/drug/the-experimental-group-received-nivolumab https://druglandscape.com/api/og?type=drug&title=The%20experimental%20group%20received%20Nivolumab&subtitle=The%20experimental%20group%20received%20Nivolumab%20%C2%B7%20xiaohua%20li&badge=phase%202 The experimental group received Nivolumab The experimental group received Nivolumab · xiaohua li https://druglandscape.com/drug/the-extract-of-green-tea https://druglandscape.com/api/og?type=drug&title=the%20extract%20of%20green%20tea&subtitle=the%20extract%20of%20green%20tea%20%C2%B7%20Taipei%20City%20Hospital&badge=phase%203 the extract of green tea the extract of green tea · Taipei City Hospital https://druglandscape.com/drug/the-fec75-and-95-regimen https://druglandscape.com/api/og?type=drug&title=the%20FEC75%20and%2095%20regimen&subtitle=the%20FEC75%20and%2095%20regimen%20%C2%B7%20Central%20European%20Cooperative%20Oncology%20Group&badge=phase%202 the FEC75 and 95 regimen the FEC75 and 95 regimen · Central European Cooperative Oncology Group https://druglandscape.com/drug/the-first-donor-s-stem-cell https://druglandscape.com/api/og?type=drug&title=the%20first%20donor's%20stem%20cell&subtitle=the%20first%20donor's%20stem%20cell%20%C2%B7%20huishengai&badge=phase%202 the first donor's stem cell the first donor's stem cell · huishengai https://druglandscape.com/drug/the-fourth-dose https://druglandscape.com/api/og?type=drug&title=The%20fourth%20dose&subtitle=The%20fourth%20dose%20%C2%B7%20BioSyngen%20Pte%20Ltd&badge=phase%201 The fourth dose The fourth dose · BioSyngen Pte Ltd https://druglandscape.com/drug/the-ginsenoside-rg3 https://druglandscape.com/api/og?type=drug&title=the%20ginsenoside%20Rg3&subtitle=the%20ginsenoside%20Rg3%20%C2%B7%20ShenFeng&badge=phase%201 the ginsenoside Rg3 the ginsenoside Rg3 · ShenFeng https://druglandscape.com/drug/the-infiltration-group https://druglandscape.com/api/og?type=drug&title=the%20infiltration%20group&subtitle=the%20infiltration%20group%20%C2%B7%20Alaa%20Mazy%20Mazy&badge=phase%201 the infiltration group the infiltration group · Alaa Mazy Mazy https://druglandscape.com/drug/the-injectable-tqd3606 https://druglandscape.com/api/og?type=drug&title=The%20injectable%20TQD3606&subtitle=The%20injectable%20TQD3606%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 The injectable TQD3606 The injectable TQD3606 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/the-reference-octreotide-microsphere https://druglandscape.com/api/og?type=drug&title=The%20reference%20octreotide%20microsphere&subtitle=The%20reference%20octreotide%20microsphere%20%C2%B7%20Qilu%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 The reference octreotide microsphere The reference octreotide microsphere · Qilu Pharmaceutical Co., Ltd. https://druglandscape.com/drug/the-second-donor-s-stem-cell https://druglandscape.com/api/og?type=drug&title=the%20second%20donor's%20stem%20cell&subtitle=the%20second%20donor's%20stem%20cell%20%C2%B7%20huishengai&badge=phase%202 the second donor's stem cell the second donor's stem cell · huishengai https://druglandscape.com/drug/the-usual-treatment https://druglandscape.com/api/og?type=drug&title=The%20usual%20treatment&subtitle=The%20usual%20treatment%20%C2%B7%20Mohammad%20Sadegh%20Bagheri%20Baghdasht&badge=phase%201 The usual treatment The usual treatment · Mohammad Sadegh Bagheri Baghdasht https://druglandscape.com/drug/theophylline-and-bambuterol https://druglandscape.com/api/og?type=drug&title=Theophylline%20and%20Bambuterol&subtitle=Theophylline%20and%20Bambuterol%20%C2%B7%20Norwegian%20Armed%20Forces%20Medical%20Service&badge=phase%201 Theophylline and Bambuterol Theophylline and Bambuterol · Norwegian Armed Forces Medical Service https://druglandscape.com/drug/theracurmin-hp https://druglandscape.com/api/og?type=drug&title=Theracurmin%20HP&subtitle=Theracurmin%20HP%20%C2%B7%20Richard%20Bedlack%2C%20M.D.%2C%20Ph.D.&badge=phase%202 Theracurmin HP Theracurmin HP · Richard Bedlack, M.D., Ph.D. https://druglandscape.com/drug/theraflex-bay-874017 https://druglandscape.com/api/og?type=drug&title=Theraflex%2C%20BAY%20874017&subtitle=Theraflex%2C%20BAY%20874017%20%C2%B7%20Bayer&badge=phase%202 Theraflex, BAY 874017 Theraflex, BAY 874017 · Bayer https://druglandscape.com/drug/therapeutic-autologous-lymphocytes https://druglandscape.com/api/og?type=drug&title=therapeutic%20autologous%20lymphocytes&subtitle=therapeutic%20autologous%20lymphocytes%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%202 therapeutic autologous lymphocytes therapeutic autologous lymphocytes · City of Hope Medical Center https://druglandscape.com/drug/therapeutic-dose-1 https://druglandscape.com/api/og?type=drug&title=Therapeutic%20Dose%201&subtitle=Therapeutic%20Dose%201%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%201 Therapeutic Dose 1 Therapeutic Dose 1 · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/therapeutic-melatonin https://druglandscape.com/api/og?type=drug&title=therapeutic%20melatonin&subtitle=therapeutic%20melatonin%20%C2%B7%20Radiation%20Therapy%20Oncology%20Group&badge=phase%202 therapeutic melatonin therapeutic melatonin · Radiation Therapy Oncology Group https://druglandscape.com/drug/theratope-vaccine https://druglandscape.com/api/og?type=drug&title=THERATOPE%C2%AE%20vaccine&subtitle=THERATOPE%C2%AE%20vaccine%20%C2%B7%20Oncothyreon%20Canada%20Inc.&badge=phase%202 THERATOPE® vaccine THERATOPE® vaccine · Oncothyreon Canada Inc. https://druglandscape.com/drug/thiotepa-melphalan https://druglandscape.com/api/og?type=drug&title=thiotepa%20melphalan&subtitle=thiotepa%20melphalan%20%C2%B7%20Rabin%20Medical%20Center&badge=phase%201 thiotepa melphalan thiotepa melphalan · Rabin Medical Center https://druglandscape.com/drug/thiscart19-cells https://druglandscape.com/api/og?type=drug&title=ThisCART19%20cells&subtitle=ThisCART19%20cells%20%C2%B7%20Fundamenta%20Therapeutics%2C%20Ltd.&badge=phase%201 ThisCART19 cells ThisCART19 cells · Fundamenta Therapeutics, Ltd. https://druglandscape.com/drug/thiscart7-cells https://druglandscape.com/api/og?type=drug&title=ThisCART7%20cells&subtitle=ThisCART7%20cells%20%C2%B7%20Fundamenta%20Therapeutics%2C%20Ltd.&badge=phase%201 ThisCART7 cells ThisCART7 cells · Fundamenta Therapeutics, Ltd. https://druglandscape.com/drug/thn-201 https://druglandscape.com/api/og?type=drug&title=THN%20201&subtitle=THN%20201%20%C2%B7%20Theranexus&badge=phase%201 THN 201 THN 201 · Theranexus https://druglandscape.com/drug/thn102 https://druglandscape.com/api/og?type=drug&title=THN102&subtitle=THN102%20%C2%B7%20Theranexus&badge=phase%201 THN102 THN102 · Theranexus https://druglandscape.com/drug/thn102-dosage-a https://druglandscape.com/api/og?type=drug&title=THN102%20Dosage%20A&subtitle=THN102%20Dosage%20A%20%C2%B7%20Theranexus&badge=phase%202 THN102 Dosage A THN102 Dosage A · Theranexus https://druglandscape.com/drug/thn102-dosage-b https://druglandscape.com/api/og?type=drug&title=THN102%20Dosage%20B&subtitle=THN102%20Dosage%20B%20%C2%B7%20Theranexus&badge=phase%202 THN102 Dosage B THN102 Dosage B · Theranexus https://druglandscape.com/drug/thn102-dosage-c https://druglandscape.com/api/og?type=drug&title=THN102%20Dosage%20C&subtitle=THN102%20Dosage%20C%20%C2%B7%20Theranexus&badge=phase%202 THN102 Dosage C THN102 Dosage C · Theranexus https://druglandscape.com/drug/thn391 https://druglandscape.com/api/og?type=drug&title=THN391&subtitle=THN391%20%C2%B7%20Therini%20Bio%2C%20Inc.&badge=phase%201 THN391 THN391 · Therini Bio, Inc. https://druglandscape.com/drug/thr-149-dose-level-1 https://druglandscape.com/api/og?type=drug&title=THR-149%20dose%20level%201&subtitle=THR-149%20dose%20level%201%20%C2%B7%20Oxurion&badge=phase%202 THR-149 dose level 1 THR-149 dose level 1 · Oxurion https://druglandscape.com/drug/thr-149-dose-level-2 https://druglandscape.com/api/og?type=drug&title=THR-149%20dose%20level%202&subtitle=THR-149%20dose%20level%202%20%C2%B7%20Oxurion&badge=phase%202 THR-149 dose level 2 THR-149 dose level 2 · Oxurion https://druglandscape.com/drug/thr-4109 https://druglandscape.com/api/og?type=drug&title=THR-4109&subtitle=THR-4109%20%C2%B7%20Theracos&badge=phase%202 THR-4109 THR-4109 · Theracos https://druglandscape.com/drug/thr-687-dose-level-3 https://druglandscape.com/api/og?type=drug&title=THR-687%20dose%20level%203&subtitle=THR-687%20dose%20level%203%20%C2%B7%20ThromboGenics&badge=phase%201 THR-687 dose level 3 THR-687 dose level 3 · ThromboGenics https://druglandscape.com/drug/threolone-ointment https://druglandscape.com/api/og?type=drug&title=Threolone%20ointment&subtitle=Threolone%20ointment%20%C2%B7%20Rabin%20Medical%20Center&badge=phase%202 Threolone ointment Threolone ointment · Rabin Medical Center https://druglandscape.com/drug/thrombolytic-agent https://druglandscape.com/api/og?type=drug&title=Thrombolytic%20Agent&subtitle=Thrombolytic%20Agent%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%202 Thrombolytic Agent Thrombolytic Agent · Baylor College of Medicine https://druglandscape.com/drug/thrv-1268 https://druglandscape.com/api/og?type=drug&title=THRV-1268&subtitle=THRV-1268%20%C2%B7%20Thryv%20Therapeutics%2C%20Inc.&badge=phase%202 THRV-1268 THRV-1268 · Thryv Therapeutics, Inc. https://druglandscape.com/drug/thv01-1 https://druglandscape.com/api/og?type=drug&title=THV01-1&subtitle=THV01-1%20%C2%B7%20Theravectys%20S.A.&badge=phase%201 THV01-1 THV01-1 · Theravectys S.A. https://druglandscape.com/drug/thv01-2 https://druglandscape.com/api/og?type=drug&title=THV01-2&subtitle=THV01-2%20%C2%B7%20Theravectys%20S.A.&badge=phase%201 THV01-2 THV01-2 · Theravectys S.A. https://druglandscape.com/drug/thx-110 https://druglandscape.com/api/og?type=drug&title=THX-110&subtitle=THX-110%20%C2%B7%20Neurothera%20Labs%20Inc.&badge=phase%202 THX-110 THX-110 · Neurothera Labs Inc. https://druglandscape.com/drug/thymic-peptides https://druglandscape.com/api/og?type=drug&title=Thymic%20peptides&subtitle=Thymic%20peptides%20%C2%B7%20Universidad%20Cat%C3%B3lica%20de%20Honduras&badge=phase%202 Thymic peptides Thymic peptides · Universidad Católica de Honduras https://druglandscape.com/drug/thymus-tissue-for-transplantation https://druglandscape.com/api/og?type=drug&title=Thymus%20Tissue%20for%20Transplantation&subtitle=Thymus%20Tissue%20for%20Transplantation%20%C2%B7%20Sumitomo%20Pharma%20Switzerland%20GmbH&badge=phase%201 Thymus Tissue for Transplantation Thymus Tissue for Transplantation · Sumitomo Pharma Switzerland GmbH https://druglandscape.com/drug/thyroid-hormone-replacement-therapy https://druglandscape.com/api/og?type=drug&title=thyroid%20hormone%20replacement%20therapy&subtitle=thyroid%20hormone%20replacement%20therapy%20%C2%B7%20Nabil%20Mahmoud%20Ismail%20Abdel-Aal&badge=phase%201 thyroid hormone replacement therapy thyroid hormone replacement therapy · Nabil Mahmoud Ismail Abdel-Aal https://druglandscape.com/drug/tibulizumab-dose-a https://druglandscape.com/api/og?type=drug&title=Tibulizumab%20Dose%20A&subtitle=Tibulizumab%20Dose%20A%20%C2%B7%20Zura%20Bio%20Inc&badge=phase%202 Tibulizumab Dose A Tibulizumab Dose A · Zura Bio Inc https://druglandscape.com/drug/tibulizumab-dose-b https://druglandscape.com/api/og?type=drug&title=Tibulizumab%20Dose%20B&subtitle=Tibulizumab%20Dose%20B%20%C2%B7%20Zura%20Bio%20Inc&badge=phase%202 Tibulizumab Dose B Tibulizumab Dose B · Zura Bio Inc https://druglandscape.com/drug/ticagrelor-granule https://druglandscape.com/api/og?type=drug&title=Ticagrelor%20granule&subtitle=Ticagrelor%20granule%20%C2%B7%20AstraZeneca&badge=phase%201 Ticagrelor granule Ticagrelor granule · AstraZeneca https://druglandscape.com/drug/ticagrelor-reference-product https://druglandscape.com/api/og?type=drug&title=Ticagrelor-Reference%20product&subtitle=Ticagrelor-Reference%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Ticagrelor-Reference product Ticagrelor-Reference product · Bio-innova Co., Ltd https://druglandscape.com/drug/ticagrelor-tablets https://druglandscape.com/api/og?type=drug&title=Ticagrelor%20Tablets&subtitle=Ticagrelor%20Tablets%20%C2%B7%20Advenchen%20Laboratories%20Nanjing%20Ltd.&badge=phase%202 Ticagrelor Tablets Ticagrelor Tablets · Advenchen Laboratories Nanjing Ltd. https://druglandscape.com/drug/ticagrelor-test-product https://druglandscape.com/api/og?type=drug&title=Ticagrelor-Test%20product&subtitle=Ticagrelor-Test%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Ticagrelor-Test product Ticagrelor-Test product · Bio-innova Co., Ltd https://druglandscape.com/drug/ticagrelor-vs-clopidogrel https://druglandscape.com/api/og?type=drug&title=Ticagrelor%20vs%20Clopidogrel&subtitle=Ticagrelor%20vs%20Clopidogrel%20%C2%B7%20Fundaci%C3%B3n%20Investigaci%C3%B3n%20Sanitaria%20en%20Le%C3%B3n&badge=phase%201 Ticagrelor vs Clopidogrel Ticagrelor vs Clopidogrel · Fundación Investigación Sanitaria en León https://druglandscape.com/drug/tid-hydrocortisone https://druglandscape.com/api/og?type=drug&title=TID%20Hydrocortisone&subtitle=TID%20Hydrocortisone%20%C2%B7%20Vastra%20Gotaland%20Region&badge=phase%201 TID Hydrocortisone TID Hydrocortisone · Vastra Gotaland Region https://druglandscape.com/drug/tight-blood-pressure-management https://druglandscape.com/api/og?type=drug&title=Tight%20blood%20pressure%20management&subtitle=Tight%20blood%20pressure%20management%20%C2%B7%20Miodrag%20Filipovic%2C%20Prof.%20Dr.%20med.&badge=phase%201 Tight blood pressure management Tight blood pressure management · Miodrag Filipovic, Prof. Dr. med. https://druglandscape.com/drug/til-administration https://druglandscape.com/api/og?type=drug&title=TIL%20administration&subtitle=TIL%20administration%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%202 TIL administration TIL administration · Sheba Medical Center https://druglandscape.com/drug/tilt-123 https://druglandscape.com/api/og?type=drug&title=TILT-123&subtitle=TILT-123%20%C2%B7%20TILT%20Biotherapeutics%20Ltd.&badge=phase%201 TILT-123 TILT-123 · TILT Biotherapeutics Ltd. https://druglandscape.com/drug/timod-implant https://druglandscape.com/api/og?type=drug&title=TimoD%20implant&subtitle=TimoD%20implant%20%C2%B7%20EyeD%20Pharma&badge=phase%201 TimoD implant TimoD implant · EyeD Pharma https://druglandscape.com/drug/timolol-maleate-0-5-oph-soln https://druglandscape.com/api/og?type=drug&title=Timolol%20Maleate%200.5%25%20Oph%20Soln&subtitle=Timolol%20Maleate%200.5%25%20Oph%20Soln%20%C2%B7%20XiaoXi%20Lin&badge=phase%202 Timolol Maleate 0.5% Oph Soln Timolol Maleate 0.5% Oph Soln · XiaoXi Lin https://druglandscape.com/drug/timolol-nasal-spray https://druglandscape.com/api/og?type=drug&title=Timolol%20nasal%20spray&subtitle=Timolol%20nasal%20spray%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 Timolol nasal spray Timolol nasal spray · Hospices Civils de Lyon https://druglandscape.com/drug/timolol-trusopt https://druglandscape.com/api/og?type=drug&title=Timolol-trusopt&subtitle=Timolol-trusopt%20%C2%B7%20Zahra%20Rabbani%20Khah&badge=phase%202 Timolol-trusopt Timolol-trusopt · Zahra Rabbani Khah https://druglandscape.com/drug/tinidazole-and-albendazole https://druglandscape.com/api/og?type=drug&title=Tinidazole%20and%20Albendazole&subtitle=Tinidazole%20and%20Albendazole%20%C2%B7%20Sheba%20Medical%20Center&badge=phase%201 Tinidazole and Albendazole Tinidazole and Albendazole · Sheba Medical Center https://druglandscape.com/drug/tinzaparin-high-dose-prophylactic-anticoagulation https://druglandscape.com/api/og?type=drug&title=Tinzaparin%2C%20High%20dose%20prophylactic%20anticoagulation&subtitle=Tinzaparin%2C%20High%20dose%20prophylactic%20anticoagulation%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Tinzaparin, High dose prophylactic anticoagulation Tinzaparin, High dose prophylactic anticoagulation · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/tinzaparin-therapeutic-anticoagulation https://druglandscape.com/api/og?type=drug&title=Tinzaparin%2CTherapeutic%20anticoagulation&subtitle=Tinzaparin%2CTherapeutic%20anticoagulation%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Tinzaparin,Therapeutic anticoagulation Tinzaparin,Therapeutic anticoagulation · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/tiotropium-pmdi https://druglandscape.com/api/og?type=drug&title=tiotropium%20pMDI&subtitle=tiotropium%20pMDI%20%C2%B7%20Solventum%20US%20LLC&badge=phase%201 tiotropium pMDI tiotropium pMDI · Solventum US LLC https://druglandscape.com/drug/tip-chemotherapy https://druglandscape.com/api/og?type=drug&title=TIP%20chemotherapy&subtitle=TIP%20chemotherapy%20%C2%B7%20Dragonboat%20Biopharmaceutical%20Company%20Limited&badge=phase%201 TIP chemotherapy TIP chemotherapy · Dragonboat Biopharmaceutical Company Limited https://druglandscape.com/drug/tirosin-kinase-inhibitors https://druglandscape.com/api/og?type=drug&title=Tirosin%20Kinase%20Inhibitors&subtitle=Tirosin%20Kinase%20Inhibitors%20%C2%B7%20Spanish%20Lung%20Cancer%20Group&badge=phase%202 Tirosin Kinase Inhibitors Tirosin Kinase Inhibitors · Spanish Lung Cancer Group https://druglandscape.com/drug/tisa-818-inj https://druglandscape.com/api/og?type=drug&title=TISA-818-Inj&subtitle=TISA-818-Inj%20%C2%B7%20EnliTISA%20(Shanghai)%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 TISA-818-Inj TISA-818-Inj · EnliTISA (Shanghai) Pharmaceutical Co., Ltd. https://druglandscape.com/drug/tislelizumab-alone https://druglandscape.com/api/og?type=drug&title=Tislelizumab%20alone&subtitle=Tislelizumab%20alone%20%C2%B7%20Jiangsu%20Yahong%20Meditech%20Co.%2C%20Ltd%20aka%20Asieris&badge=phase%201 Tislelizumab alone Tislelizumab alone · Jiangsu Yahong Meditech Co., Ltd aka Asieris https://druglandscape.com/drug/tislelizumab-atezolizumab-or-trastuzumab https://druglandscape.com/api/og?type=drug&title=Tislelizumab%EF%BC%8Catezolizumab%20or%20Trastuzumab&subtitle=Tislelizumab%EF%BC%8Catezolizumab%20or%20Trastuzumab%20%C2%B7%20Base%20Therapeutics%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 Tislelizumab，atezolizumab or Trastuzumab Tislelizumab，atezolizumab or Trastuzumab · Base Therapeutics (Shanghai) Co., Ltd. https://druglandscape.com/drug/tislelizumab-iv https://druglandscape.com/api/og?type=drug&title=Tislelizumab%20IV&subtitle=Tislelizumab%20IV%20%C2%B7%20BeiGene&badge=phase%201 Tislelizumab IV Tislelizumab IV · BeiGene https://druglandscape.com/drug/tislelizumab-sc https://druglandscape.com/api/og?type=drug&title=Tislelizumab%20SC&subtitle=Tislelizumab%20SC%20%C2%B7%20BeiGene&badge=phase%201 Tislelizumab SC Tislelizumab SC · BeiGene https://druglandscape.com/drug/tissue-culture-media https://druglandscape.com/api/og?type=drug&title=tissue%20culture%20media&subtitle=tissue%20culture%20media%20%C2%B7%20The%20Egyptian%20IVF-ET%20Center&badge=phase%201 tissue culture media tissue culture media · The Egyptian IVF-ET Center https://druglandscape.com/drug/tiv-ha-formulation-2-at-high-dose https://druglandscape.com/api/og?type=drug&title=TIV-HA%20formulation%202%20at%20high%20dose&subtitle=TIV-HA%20formulation%202%20at%20high%20dose%20%C2%B7%20Sanofi&badge=phase%201 TIV-HA formulation 2 at high dose TIV-HA formulation 2 at high dose · Sanofi https://druglandscape.com/drug/tiv-mrna-ha-vaccine-2 https://druglandscape.com/api/og?type=drug&title=TIV%20mRNA-HA%20Vaccine%202&subtitle=TIV%20mRNA-HA%20Vaccine%202%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 TIV mRNA-HA Vaccine 2 TIV mRNA-HA Vaccine 2 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/tizanidine-0-1 https://druglandscape.com/api/og?type=drug&title=Tizanidine%200.1%25&subtitle=Tizanidine%200.1%25%20%C2%B7%20Express%20Specialty%20Pharmacy&badge=phase%202 Tizanidine 0.1% Tizanidine 0.1% · Express Specialty Pharmacy https://druglandscape.com/drug/tj004309 https://druglandscape.com/api/og?type=drug&title=TJ004309&subtitle=TJ004309%20%C2%B7%20I-Mab%20Biopharma%20US%20Limited&badge=phase%202 TJ004309 TJ004309 · I-Mab Biopharma US Limited https://druglandscape.com/drug/tj011133 https://druglandscape.com/api/og?type=drug&title=TJ011133&subtitle=TJ011133%20%C2%B7%20I-Mab%20Biopharma%20US%20Limited&badge=phase%201 TJ011133 TJ011133 · I-Mab Biopharma US Limited https://druglandscape.com/drug/tj0113 https://druglandscape.com/api/og?type=drug&title=TJ0113&subtitle=TJ0113%20%C2%B7%20Hangzhou%20PhecdaMed%20Co.%2C%20Ltd.&badge=phase%202 TJ0113 TJ0113 · Hangzhou PhecdaMed Co., Ltd. https://druglandscape.com/drug/tj101-injection-test-product https://druglandscape.com/api/og?type=drug&title=TJ101%20injection%20Test%20Product&subtitle=TJ101%20injection%20Test%20Product%20%C2%B7%20TJ%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 TJ101 injection Test Product TJ101 injection Test Product · TJ Biopharma Co., Ltd. https://druglandscape.com/drug/tj107 https://druglandscape.com/api/og?type=drug&title=TJ107&subtitle=TJ107%20%C2%B7%20TJ%20Biopharma%20Co.%2C%20Ltd.&badge=phase%202 TJ107 TJ107 · TJ Biopharma Co., Ltd. https://druglandscape.com/drug/tk006 https://druglandscape.com/api/og?type=drug&title=TK006&subtitle=TK006%20%C2%B7%20Jiangsu%20T-Mab%20Biopharma%20Co.%2CLtd&badge=phase%201 TK006 TK006 · Jiangsu T-Mab Biopharma Co.,Ltd https://druglandscape.com/drug/tkcell https://druglandscape.com/api/og?type=drug&title=TKCell&subtitle=TKCell%20%C2%B7%20Binex&badge=phase%201 TKCell TKCell · Binex https://druglandscape.com/drug/tki-based-therapy https://druglandscape.com/api/og?type=drug&title=TKI-Based%20Therapy&subtitle=TKI-Based%20Therapy%20%C2%B7%20Changchun%20GeneScience%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 TKI-Based Therapy TKI-Based Therapy · Changchun GeneScience Pharmaceutical Co., Ltd. https://druglandscape.com/drug/tki-sutent-nexavar-or-votrient https://druglandscape.com/api/og?type=drug&title=TKI%3A%20Sutent%2C%20Nexavar%20or%20Votrient&subtitle=TKI%3A%20Sutent%2C%20Nexavar%20or%20Votrient%20%C2%B7%20Central%20European%20Society%20for%20Anticancer%20Drug%20Research&badge=phase%202 TKI: Sutent, Nexavar or Votrient TKI: Sutent, Nexavar or Votrient · Central European Society for Anticancer Drug Research https://druglandscape.com/drug/tl-001 https://druglandscape.com/api/og?type=drug&title=TL-001&subtitle=TL-001%20%C2%B7%20TrueLab%20Biopharmaceutical%20Co.%2C%20Ltd&badge=phase%201 TL-001 TL-001 · TrueLab Biopharmaceutical Co., Ltd https://druglandscape.com/drug/tl-118 https://druglandscape.com/api/og?type=drug&title=TL-118&subtitle=TL-118%20%C2%B7%20Tiltan%20Pharma%20Ltd.&badge=phase%202 TL-118 TL-118 · Tiltan Pharma Ltd. https://druglandscape.com/drug/tl-895 https://druglandscape.com/api/og?type=drug&title=TL-895&subtitle=TL-895%20%C2%B7%20Telios%20Pharma%2C%20Inc.&badge=phase%202 TL-895 TL-895 · Telios Pharma, Inc. https://druglandscape.com/drug/tl-925 https://druglandscape.com/api/og?type=drug&title=TL-925&subtitle=TL-925%20%C2%B7%20Telios%20Pharma%2C%20Inc.&badge=phase%202 TL-925 TL-925 · Telios Pharma, Inc. https://druglandscape.com/drug/tl011 https://druglandscape.com/api/og?type=drug&title=TL011&subtitle=TL011%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%201 TL011 TL011 · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/tl117 https://druglandscape.com/api/og?type=drug&title=TL117&subtitle=TL117%20%C2%B7%20Suzhou%20Junde%20Biotechnology%20Co.%2C%20Ltd&badge=phase%201 TL117 TL117 · Suzhou Junde Biotechnology Co., Ltd https://druglandscape.com/drug/tl118-capsule https://druglandscape.com/api/og?type=drug&title=TL118%20Capsule&subtitle=TL118%20Capsule%20%C2%B7%20Teligene%20US&badge=phase%202 TL118 Capsule TL118 Capsule · Teligene US https://druglandscape.com/drug/tlc-2716-dose-1 https://druglandscape.com/api/og?type=drug&title=TLC-2716%20Dose%201&subtitle=TLC-2716%20Dose%201%20%C2%B7%20OrsoBio%2C%20Inc&badge=phase%202 TLC-2716 Dose 1 TLC-2716 Dose 1 · OrsoBio, Inc https://druglandscape.com/drug/tlc-3595-dose-1 https://druglandscape.com/api/og?type=drug&title=TLC-3595%20Dose%201&subtitle=TLC-3595%20Dose%201%20%C2%B7%20OrsoBio%2C%20Inc&badge=phase%202 TLC-3595 Dose 1 TLC-3595 Dose 1 · OrsoBio, Inc https://druglandscape.com/drug/tlc-6740-oral-solution https://druglandscape.com/api/og?type=drug&title=TLC-6740%20Oral%20Solution&subtitle=TLC-6740%20Oral%20Solution%20%C2%B7%20OrsoBio%2C%20Inc&badge=phase%201 TLC-6740 Oral Solution TLC-6740 Oral Solution · OrsoBio, Inc https://druglandscape.com/drug/tlc178 https://druglandscape.com/api/og?type=drug&title=TLC178&subtitle=TLC178%20%C2%B7%20Taiwan%20Liposome%20Company&badge=phase%201 TLC178 TLC178 · Taiwan Liposome Company https://druglandscape.com/drug/tlc19 https://druglandscape.com/api/og?type=drug&title=TLC19&subtitle=TLC19%20%C2%B7%20Taiwan%20Liposome%20Company&badge=phase%201 TLC19 TLC19 · Taiwan Liposome Company https://druglandscape.com/drug/tlc399 https://druglandscape.com/api/og?type=drug&title=TLC399&subtitle=TLC399%20%C2%B7%20Taiwan%20Liposome%20Company&badge=phase%201 TLC399 TLC399 · Taiwan Liposome Company https://druglandscape.com/drug/tlc599-hd-group https://druglandscape.com/api/og?type=drug&title=TLC599%20HD%20group&subtitle=TLC599%20HD%20group%20%C2%B7%20Taiwan%20Liposome%20Company&badge=phase%202 TLC599 HD group TLC599 HD group · Taiwan Liposome Company https://druglandscape.com/drug/tlk286 https://druglandscape.com/api/og?type=drug&title=TLK286&subtitle=TLK286%20%C2%B7%20Telik&badge=phase%202 TLK286 TLK286 · Telik https://druglandscape.com/drug/tlk286-cisplatin https://druglandscape.com/api/og?type=drug&title=TLK286%2C%20cisplatin&subtitle=TLK286%2C%20cisplatin%20%C2%B7%20Telik&badge=phase%201 TLK286, cisplatin TLK286, cisplatin · Telik https://druglandscape.com/drug/tll018-tablets https://druglandscape.com/api/og?type=drug&title=TLL018%20tablets&subtitle=TLL018%20tablets%20%C2%B7%20Hangzhou%20Highlightll%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 TLL018 tablets TLL018 tablets · Hangzhou Highlightll Pharmaceutical Co., Ltd https://druglandscape.com/drug/tln-121 https://druglandscape.com/api/og?type=drug&title=TLN-121&subtitle=TLN-121%20%C2%B7%20Treeline%20Biosciences%2C%20Inc.&badge=phase%201 TLN-121 TLN-121 · Treeline Biosciences, Inc. https://druglandscape.com/drug/tln-254 https://druglandscape.com/api/og?type=drug&title=TLN-254&subtitle=TLN-254%20%C2%B7%20Treeline%20Biosciences%2C%20Inc.&badge=phase%201 TLN-254 TLN-254 · Treeline Biosciences, Inc. https://druglandscape.com/drug/tln-372 https://druglandscape.com/api/og?type=drug&title=TLN-372&subtitle=TLN-372%20%C2%B7%20Treeline%20Biosciences%2C%20Inc.&badge=phase%201 TLN-372 TLN-372 · Treeline Biosciences, Inc. https://druglandscape.com/drug/tlpldc-vaccine https://druglandscape.com/api/og?type=drug&title=TLPLDC%20Vaccine&subtitle=TLPLDC%20Vaccine%20%C2%B7%20Elios%20Therapeutics%2C%20LLC&badge=phase%201 TLPLDC Vaccine TLPLDC Vaccine · Elios Therapeutics, LLC https://druglandscape.com/drug/tm-601 https://druglandscape.com/api/og?type=drug&title=TM-601&subtitle=TM-601%20%C2%B7%20TransMolecular&badge=phase%201 TM-601 TM-601 · TransMolecular https://druglandscape.com/drug/tmb-380 https://druglandscape.com/api/og?type=drug&title=TMB-380&subtitle=TMB-380%20%C2%B7%20TaiMed%20Biologics%20Inc.&badge=phase%202 TMB-380 TMB-380 · TaiMed Biologics Inc. https://druglandscape.com/drug/tmc114-tmc41629 https://druglandscape.com/api/og?type=drug&title=TMC114%3B%20TMC41629&subtitle=TMC114%3B%20TMC41629%20%C2%B7%20Tibotec%20Pharmaceuticals%2C%20Ireland&badge=phase%201 TMC114; TMC41629 TMC114; TMC41629 · Tibotec Pharmaceuticals, Ireland https://druglandscape.com/drug/tmc125-once-daily https://druglandscape.com/api/og?type=drug&title=TMC125%20once%20daily&subtitle=TMC125%20once%20daily%20%C2%B7%20St%20Stephens%20Aids%20Trust&badge=phase%201 TMC125 once daily TMC125 once daily · St Stephens Aids Trust https://druglandscape.com/drug/tmc207-nevirapine https://druglandscape.com/api/og?type=drug&title=TMC207%3B%20nevirapine&subtitle=TMC207%3B%20nevirapine%20%C2%B7%20Tibotec%20BVBA&badge=phase%201 TMC207; nevirapine TMC207; nevirapine · Tibotec BVBA https://druglandscape.com/drug/tmc278-moxifloxacin-efavirenz https://druglandscape.com/api/og?type=drug&title=TMC278%3B%20Moxifloxacin%3B%20Efavirenz&subtitle=TMC278%3B%20Moxifloxacin%3B%20Efavirenz%20%C2%B7%20Tibotec%20Pharmaceuticals%2C%20Ireland&badge=phase%201 TMC278; Moxifloxacin; Efavirenz TMC278; Moxifloxacin; Efavirenz · Tibotec Pharmaceuticals, Ireland https://druglandscape.com/drug/tmc278-omeprazole https://druglandscape.com/api/og?type=drug&title=TMC278%3B%20Omeprazole&subtitle=TMC278%3B%20Omeprazole%20%C2%B7%20Tibotec%20Pharmaceuticals%2C%20Ireland&badge=phase%201 TMC278; Omeprazole TMC278; Omeprazole · Tibotec Pharmaceuticals, Ireland https://druglandscape.com/drug/tmc647055 https://druglandscape.com/api/og?type=drug&title=TMC647055&subtitle=TMC647055%20%C2%B7%20Janssen%20R%26D%20Ireland&badge=phase%202 TMC647055 TMC647055 · Janssen R&D Ireland https://druglandscape.com/drug/tmp001 https://druglandscape.com/api/og?type=drug&title=TMP001&subtitle=TMP001%20%C2%B7%20Dr.%20Frank%20Behrens&badge=phase%202 TMP001 TMP001 · Dr. Frank Behrens https://druglandscape.com/drug/tmx-049 https://druglandscape.com/api/og?type=drug&title=TMX-049&subtitle=TMX-049%20%C2%B7%20Teijin%20America%2C%20Inc.&badge=phase%202 TMX-049 TMX-049 · Teijin America, Inc. https://druglandscape.com/drug/tmx-101 https://druglandscape.com/api/og?type=drug&title=TMX-101&subtitle=TMX-101%20%C2%B7%20Telormedix%20SA&badge=phase%202 TMX-101 TMX-101 · Telormedix SA https://druglandscape.com/drug/tmx-67 https://druglandscape.com/api/og?type=drug&title=TMX-67&subtitle=TMX-67%20%C2%B7%20SK%20Chemicals%20Co.%2C%20Ltd.&badge=phase%201 TMX-67 TMX-67 · SK Chemicals Co., Ltd. https://druglandscape.com/drug/tmz-maintenance https://druglandscape.com/api/og?type=drug&title=TMZ%20Maintenance&subtitle=TMZ%20Maintenance%20%C2%B7%20EpicentRx%2C%20Inc.&badge=phase%201 TMZ Maintenance TMZ Maintenance · EpicentRx, Inc. https://druglandscape.com/drug/tnb-383b https://druglandscape.com/api/og?type=drug&title=TNB-383B&subtitle=TNB-383B%20%C2%B7%20AbbVie&badge=phase%202 TNB-383B TNB-383B · AbbVie https://druglandscape.com/drug/tnb-738 https://druglandscape.com/api/og?type=drug&title=TNB-738&subtitle=TNB-738%20%C2%B7%20TeneoFour%20Inc.&badge=phase%201 TNB-738 TNB-738 · TeneoFour Inc. https://druglandscape.com/drug/tnf-inhibitor-or-jak-inhibitor https://druglandscape.com/api/og?type=drug&title=TNF-%CE%B1%20inhibitor%20OR%20JAK%20inhibitor&subtitle=TNF-%CE%B1%20inhibitor%20OR%20JAK%20inhibitor%20%C2%B7%20Vastra%20Gotaland%20Region&badge=phase%201 TNF-α inhibitor OR JAK inhibitor TNF-α inhibitor OR JAK inhibitor · Vastra Gotaland Region https://druglandscape.com/drug/tnf-kinoid https://druglandscape.com/api/og?type=drug&title=TNF%20kinoid&subtitle=TNF%20kinoid%20%C2%B7%20Neovacs&badge=phase%202 TNF kinoid TNF kinoid · Neovacs https://druglandscape.com/drug/tnfa-kinoid https://druglandscape.com/api/og?type=drug&title=TNFa%20Kinoid&subtitle=TNFa%20Kinoid%20%C2%B7%20Neovacs&badge=phase%202 TNFa Kinoid TNFa Kinoid · Neovacs https://druglandscape.com/drug/tnferade https://druglandscape.com/api/og?type=drug&title=TNFerade%E2%84%A2&subtitle=TNFerade%E2%84%A2%20%C2%B7%20GenVec&badge=phase%202 TNFerade™ TNFerade™ · GenVec https://druglandscape.com/drug/tnferade-biologic https://druglandscape.com/api/og?type=drug&title=TNFerade%20biologic&subtitle=TNFerade%20biologic%20%C2%B7%20GenVec&badge=phase%201 TNFerade biologic TNFerade biologic · GenVec https://druglandscape.com/drug/tnfi https://druglandscape.com/api/og?type=drug&title=TNFi&subtitle=TNFi%20%C2%B7%20Marie%20Hudson%2C%20MD&badge=phase%201 TNFi TNFi · Marie Hudson, MD https://druglandscape.com/drug/tng260 https://druglandscape.com/api/og?type=drug&title=TNG260&subtitle=TNG260%20%C2%B7%20Tango%20Therapeutics%2C%20Inc.&badge=phase%201 TNG260 TNG260 · Tango Therapeutics, Inc. https://druglandscape.com/drug/tng456 https://druglandscape.com/api/og?type=drug&title=TNG456&subtitle=TNG456%20%C2%B7%20Tango%20Therapeutics%2C%20Inc.&badge=phase%201 TNG456 TNG456 · Tango Therapeutics, Inc. https://druglandscape.com/drug/tng462 https://druglandscape.com/api/og?type=drug&title=TNG462&subtitle=TNG462%20%C2%B7%20Tango%20Therapeutics%2C%20Inc.&badge=phase%201 TNG462 TNG462 · Tango Therapeutics, Inc. https://druglandscape.com/drug/tniv-vaccine https://druglandscape.com/api/og?type=drug&title=tNIV%20Vaccine&subtitle=tNIV%20Vaccine%20%C2%B7%20Novavax&badge=phase%203 tNIV Vaccine tNIV Vaccine · Novavax https://druglandscape.com/drug/tnm005 https://druglandscape.com/api/og?type=drug&title=TNM005&subtitle=TNM005%20%C2%B7%20Zhuhai%20Trinomab%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 TNM005 TNM005 · Zhuhai Trinomab Pharmaceutical Co., Ltd. https://druglandscape.com/drug/tnp-2092 https://druglandscape.com/api/og?type=drug&title=TNP-2092&subtitle=TNP-2092%20%C2%B7%20TenNor%20Therapeutics%20Limited&badge=phase%202 TNP-2092 TNP-2092 · TenNor Therapeutics Limited https://druglandscape.com/drug/tnp-2198 https://druglandscape.com/api/og?type=drug&title=TNP-2198&subtitle=TNP-2198%20%C2%B7%20TenNor%20Therapeutics%20(Suzhou)%20Limited&badge=phase%202 TNP-2198 TNP-2198 · TenNor Therapeutics (Suzhou) Limited https://druglandscape.com/drug/tnx-1900 https://druglandscape.com/api/og?type=drug&title=TNX-1900&subtitle=TNX-1900%20%C2%B7%20Tonix%20Pharmaceuticals%2C%20Inc.&badge=phase%202 TNX-1900 TNX-1900 · Tonix Pharmaceuticals, Inc. https://druglandscape.com/drug/tnx-201 https://druglandscape.com/api/og?type=drug&title=TNX-201&subtitle=TNX-201%20%C2%B7%20Tonix%20Pharmaceuticals%2C%20Inc.&badge=phase%202 TNX-201 TNX-201 · Tonix Pharmaceuticals, Inc. https://druglandscape.com/drug/tnx-355 https://druglandscape.com/api/og?type=drug&title=TNX-355&subtitle=TNX-355%20%C2%B7%20Tanox&badge=phase%202 TNX-355 TNX-355 · Tanox https://druglandscape.com/drug/tnx-832 https://druglandscape.com/api/og?type=drug&title=TNX-832&subtitle=TNX-832%20%C2%B7%20Altor%20BioScience&badge=phase%201 TNX-832 TNX-832 · Altor BioScience https://druglandscape.com/drug/to-be-given-as-a-treatment https://druglandscape.com/api/og?type=drug&title=to%20be%20given%20as%20a%20treatment&subtitle=to%20be%20given%20as%20a%20treatment%20%C2%B7%20Salmaniya%20Medical%20Complex&badge=phase%203 to be given as a treatment to be given as a treatment · Salmaniya Medical Complex https://druglandscape.com/drug/to-o-1001 https://druglandscape.com/api/og?type=drug&title=TO-O-1001&subtitle=TO-O-1001%20%C2%B7%20Theratocular%20Biotek%20Co.&badge=phase%201 TO-O-1001 TO-O-1001 · Theratocular Biotek Co. https://druglandscape.com/drug/tobacco-cessation-pharmacotherapy https://druglandscape.com/api/og?type=drug&title=Tobacco%20cessation%20pharmacotherapy&subtitle=Tobacco%20cessation%20pharmacotherapy%20%C2%B7%20Iowa%20City%20Veterans%20Affairs%20Medical%20Center&badge=phase%202 Tobacco cessation pharmacotherapy Tobacco cessation pharmacotherapy · Iowa City Veterans Affairs Medical Center https://druglandscape.com/drug/tobi-nebcinal https://druglandscape.com/api/og?type=drug&title=Tobi%20Nebcinal&subtitle=Tobi%20Nebcinal%20%C2%B7%20Erempharma&badge=phase%201 Tobi Nebcinal Tobi Nebcinal · Erempharma https://druglandscape.com/drug/tocilizumab-iv https://druglandscape.com/api/og?type=drug&title=tocilizumab%20IV&subtitle=tocilizumab%20IV%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%203 tocilizumab IV tocilizumab IV · Hoffmann-La Roche https://druglandscape.com/drug/tok-001 https://druglandscape.com/api/og?type=drug&title=TOK-001&subtitle=TOK-001%20%C2%B7%20LTN%20PHARMACEUTICALS%2C%20INC.&badge=phase%201 TOK-001 TOK-001 · LTN PHARMACEUTICALS, INC. https://druglandscape.com/drug/tol-3021 https://druglandscape.com/api/og?type=drug&title=TOL-3021&subtitle=TOL-3021%20%C2%B7%20Tolerion%2C%20Inc.&badge=phase%202 TOL-3021 TOL-3021 · Tolerion, Inc. https://druglandscape.com/drug/tolasure-topical-gel https://druglandscape.com/api/og?type=drug&title=TolaSure%20Topical%20Gel&subtitle=TolaSure%20Topical%20Gel%20%C2%B7%20BioMendics%2C%20LLC&badge=phase%202 TolaSure Topical Gel TolaSure Topical Gel · BioMendics, LLC https://druglandscape.com/drug/tolerogenic-fibroblasts https://druglandscape.com/api/og?type=drug&title=Tolerogenic%20Fibroblasts&subtitle=Tolerogenic%20Fibroblasts%20%C2%B7%20FibroBiologics&badge=phase%201 Tolerogenic Fibroblasts Tolerogenic Fibroblasts · FibroBiologics https://druglandscape.com/drug/tolododekin-alfa https://druglandscape.com/api/og?type=drug&title=tolododekin%20alfa&subtitle=tolododekin%20alfa%20%C2%B7%20Ankyra%20Therapeutics%2C%20Inc&badge=phase%201 tolododekin alfa tolododekin alfa · Ankyra Therapeutics, Inc https://druglandscape.com/drug/tolterodine-pr https://druglandscape.com/api/og?type=drug&title=tolterodine%20PR&subtitle=tolterodine%20PR%20%C2%B7%20Pfizer&badge=phase%203 tolterodine PR tolterodine PR · Pfizer https://druglandscape.com/drug/tolterodine-pregabalin https://druglandscape.com/api/og?type=drug&title=Tolterodine%20%26%20Pregabalin&subtitle=Tolterodine%20%26%20Pregabalin%20%C2%B7%20Pfizer&badge=phase%202 Tolterodine & Pregabalin Tolterodine & Pregabalin · Pfizer https://druglandscape.com/drug/toludivenlafaxine-hydrochloride-sustained-release-tablets https://druglandscape.com/api/og?type=drug&title=Toludivenlafaxine%20hydrochloride%20sustained-release%20tablets&subtitle=Toludivenlafaxine%20hydrochloride%20sustained-release%20tablets%20%C2%B7%20Shanghai%20Mental%20Health%20Center&badge=phase%201 Toludivenlafaxine hydrochloride sustained-release tablets Toludivenlafaxine hydrochloride sustained-release tablets · Shanghai Mental Health Center https://druglandscape.com/drug/tolvaptan-ir https://druglandscape.com/api/og?type=drug&title=Tolvaptan%20IR&subtitle=Tolvaptan%20IR%20%C2%B7%20Otsuka%20Pharmaceutical%20Development%20%26%20Commercialization%2C%20Inc.&badge=phase%202 Tolvaptan IR Tolvaptan IR · Otsuka Pharmaceutical Development & Commercialization, Inc. https://druglandscape.com/drug/toms-of-maine-0-ppm-fluoride-dentifrice https://druglandscape.com/api/og?type=drug&title=Toms%20of%20Maine%200%20ppm%20Fluoride%20Dentifrice&subtitle=Toms%20of%20Maine%200%20ppm%20Fluoride%20Dentifrice%20%C2%B7%20Procter%20and%20Gamble&badge=phase%201 Toms of Maine 0 ppm Fluoride Dentifrice Toms of Maine 0 ppm Fluoride Dentifrice · Procter and Gamble https://druglandscape.com/drug/top-n53 https://druglandscape.com/api/og?type=drug&title=TOP-N53&subtitle=TOP-N53%20%C2%B7%20Topadur%20Pharma%20AG&badge=phase%202 TOP-N53 TOP-N53 · Topadur Pharma AG https://druglandscape.com/drug/top1288 https://druglandscape.com/api/og?type=drug&title=TOP1288&subtitle=TOP1288%20%C2%B7%20Topivert%20Pharma%20Ltd&badge=phase%202 TOP1288 TOP1288 · Topivert Pharma Ltd https://druglandscape.com/drug/top1630-0-1-ophthalmic-solution-tid-ou https://druglandscape.com/api/og?type=drug&title=TOP1630%200.1%25%20Ophthalmic%20Solution%20TID%20OU&subtitle=TOP1630%200.1%25%20Ophthalmic%20Solution%20TID%20OU%20%C2%B7%20Topivert%20Pharma%20Ltd&badge=phase%202 TOP1630 0.1% Ophthalmic Solution TID OU TOP1630 0.1% Ophthalmic Solution TID OU · Topivert Pharma Ltd https://druglandscape.com/drug/topamax-coated-tablet https://druglandscape.com/api/og?type=drug&title=Topamax%C2%AE%20coated%20tablet&subtitle=Topamax%C2%AE%20coated%20tablet%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Topamax® coated tablet Topamax® coated tablet · GlaxoSmithKline https://druglandscape.com/drug/topamax-tablets https://druglandscape.com/api/og?type=drug&title=Topamax%C2%AE%20Tablets&subtitle=Topamax%C2%AE%20Tablets%20%C2%B7%20Teva%20Pharmaceuticals%20USA&badge=phase%201 Topamax® Tablets Topamax® Tablets · Teva Pharmaceuticals USA https://druglandscape.com/drug/topiramate-2-5 https://druglandscape.com/api/og?type=drug&title=Topiramate%202.5%25&subtitle=Topiramate%202.5%25%20%C2%B7%20Express%20Specialty%20Pharmacy&badge=phase%202 Topiramate 2.5% Topiramate 2.5% · Express Specialty Pharmacy https://druglandscape.com/drug/topiramate-and-n-acetyl-cysteine https://druglandscape.com/api/og?type=drug&title=Topiramate%20and%20N-Acetyl%20Cysteine&subtitle=Topiramate%20and%20N-Acetyl%20Cysteine%20%C2%B7%20Nassima%20Ait-Daoud%20Tiouririne&badge=phase%201 Topiramate and N-Acetyl Cysteine Topiramate and N-Acetyl Cysteine · Nassima Ait-Daoud Tiouririne https://druglandscape.com/drug/topiramate-er https://druglandscape.com/api/og?type=drug&title=Topiramate%20ER&subtitle=Topiramate%20ER%20%C2%B7%20Supernus%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Topiramate ER Topiramate ER · Supernus Pharmaceuticals, Inc. https://druglandscape.com/drug/topiramate-flunarizine https://druglandscape.com/api/og?type=drug&title=Topiramate%3B%20flunarizine&subtitle=Topiramate%3B%20flunarizine%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%201 Topiramate; flunarizine Topiramate; flunarizine · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/topiramate-ir https://druglandscape.com/api/og?type=drug&title=Topiramate%20IR&subtitle=Topiramate%20IR%20%C2%B7%20Supernus%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Topiramate IR Topiramate IR · Supernus Pharmaceuticals, Inc. https://druglandscape.com/drug/topotecan-and-pegylated-doxorubicin https://druglandscape.com/api/og?type=drug&title=Topotecan%20and%20pegylated%20doxorubicin&subtitle=Topotecan%20and%20pegylated%20doxorubicin%20%C2%B7%20Christiana%20Care%20Health%20Services&badge=phase%201 Topotecan and pegylated doxorubicin Topotecan and pegylated doxorubicin · Christiana Care Health Services https://druglandscape.com/drug/topotecan-and-taxotere https://druglandscape.com/api/og?type=drug&title=Topotecan%20and%20Taxotere&subtitle=Topotecan%20and%20Taxotere%20%C2%B7%20Montefiore%20Medical%20Center&badge=phase%202 Topotecan and Taxotere Topotecan and Taxotere · Montefiore Medical Center https://druglandscape.com/drug/topotecan-and-vp16 https://druglandscape.com/api/og?type=drug&title=Topotecan%20and%20VP16&subtitle=Topotecan%20and%20VP16%20%C2%B7%20New%20Mexico%20Cancer%20Research%20Alliance&badge=phase%201 Topotecan and VP16 Topotecan and VP16 · New Mexico Cancer Research Alliance https://druglandscape.com/drug/topotecan-it https://druglandscape.com/api/og?type=drug&title=Topotecan%20IT&subtitle=Topotecan%20IT%20%C2%B7%20C17%20Council&badge=phase%201 Topotecan IT Topotecan IT · C17 Council https://druglandscape.com/drug/topotecan-usual https://druglandscape.com/api/og?type=drug&title=Topotecan%20-%20usual&subtitle=Topotecan%20-%20usual%20%C2%B7%20Han%20Xu%2C%20M.D.%2C%20Ph.D.%2C%20FAPCR%2C%20Sponsor-Investigator%2C%20IRB%20Chair&badge=phase%202 Topotecan - usual Topotecan - usual · Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair https://druglandscape.com/drug/topv-commercial-batch https://druglandscape.com/api/og?type=drug&title=tOPV%20commercial%20batch&subtitle=tOPV%20commercial%20batch%20%C2%B7%20PT%20Bio%20Farma&badge=phase%202 tOPV commercial batch tOPV commercial batch · PT Bio Farma https://druglandscape.com/drug/topv-pilot-batch https://druglandscape.com/api/og?type=drug&title=tOPV%20pilot%20batch&subtitle=tOPV%20pilot%20batch%20%C2%B7%20PT%20Bio%20Farma&badge=phase%202 tOPV pilot batch tOPV pilot batch · PT Bio Farma https://druglandscape.com/drug/torasemide-tablets https://druglandscape.com/api/og?type=drug&title=Torasemide%20tablets&subtitle=Torasemide%20tablets%20%C2%B7%20Jemincare&badge=phase%202 Torasemide tablets Torasemide tablets · Jemincare https://druglandscape.com/drug/toripalimab-12weeks https://druglandscape.com/api/og?type=drug&title=Toripalimab%20%EF%BC%8812weeks%EF%BC%89&subtitle=Toripalimab%20%EF%BC%8812weeks%EF%BC%89%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%202 Toripalimab （12weeks） Toripalimab （12weeks） · RemeGen Co., Ltd. https://druglandscape.com/drug/toripalimab-18weeks https://druglandscape.com/api/og?type=drug&title=Toripalimab%20%EF%BC%8818weeks%EF%BC%89&subtitle=Toripalimab%20%EF%BC%8818weeks%EF%BC%89%20%C2%B7%20RemeGen%20Co.%2C%20Ltd.&badge=phase%202 Toripalimab （18weeks） Toripalimab （18weeks） · RemeGen Co., Ltd. https://druglandscape.com/drug/torl-1-23 https://druglandscape.com/api/og?type=drug&title=TORL-1-23&subtitle=TORL-1-23%20%C2%B7%20TORL%20Biotherapeutics%2C%20LLC&badge=phase%202 TORL-1-23 TORL-1-23 · TORL Biotherapeutics, LLC https://druglandscape.com/drug/torl-2-307-adc https://druglandscape.com/api/og?type=drug&title=TORL-2-307-ADC&subtitle=TORL-2-307-ADC%20%C2%B7%20TORL%20Biotherapeutics%2C%20LLC&badge=phase%201 TORL-2-307-ADC TORL-2-307-ADC · TORL Biotherapeutics, LLC https://druglandscape.com/drug/torl-2-307-mab https://druglandscape.com/api/og?type=drug&title=TORL-2-307-MAB&subtitle=TORL-2-307-MAB%20%C2%B7%20TORL%20Biotherapeutics%2C%20LLC&badge=phase%201 TORL-2-307-MAB TORL-2-307-MAB · TORL Biotherapeutics, LLC https://druglandscape.com/drug/torl-3-600 https://druglandscape.com/api/og?type=drug&title=TORL-3-600&subtitle=TORL-3-600%20%C2%B7%20TORL%20Biotherapeutics%2C%20LLC&badge=phase%201 TORL-3-600 TORL-3-600 · TORL Biotherapeutics, LLC https://druglandscape.com/drug/torl-4-500 https://druglandscape.com/api/og?type=drug&title=TORL-4-500&subtitle=TORL-4-500%20%C2%B7%20TORL%20Biotherapeutics%2C%20LLC&badge=phase%201 TORL-4-500 TORL-4-500 · TORL Biotherapeutics, LLC https://druglandscape.com/drug/torl-5-700 https://druglandscape.com/api/og?type=drug&title=TORL-5-700&subtitle=TORL-5-700%20%C2%B7%20TORL%20Biotherapeutics%2C%20LLC&badge=phase%201 TORL-5-700 TORL-5-700 · TORL Biotherapeutics, LLC https://druglandscape.com/drug/torrent-s-fluoxetine-tablets https://druglandscape.com/api/og?type=drug&title=Torrent's%20Fluoxetine%20Tablets&subtitle=Torrent's%20Fluoxetine%20Tablets%20%C2%B7%20Torrent%20Pharmaceuticals%20Limited&badge=phase%201 Torrent's Fluoxetine Tablets Torrent's Fluoxetine Tablets · Torrent Pharmaceuticals Limited https://druglandscape.com/drug/torrent-s-nebivolol-tablets https://druglandscape.com/api/og?type=drug&title=Torrent's%20Nebivolol%20Tablets&subtitle=Torrent's%20Nebivolol%20Tablets%20%C2%B7%20Torrent%20Pharmaceuticals%20Limited&badge=phase%201 Torrent's Nebivolol Tablets Torrent's Nebivolol Tablets · Torrent Pharmaceuticals Limited https://druglandscape.com/drug/torrent-s-pioglitazone https://druglandscape.com/api/og?type=drug&title=Torrent's%20Pioglitazone&subtitle=Torrent's%20Pioglitazone%20%C2%B7%20Torrent%20Pharmaceuticals%20Limited&badge=phase%201 Torrent's Pioglitazone Torrent's Pioglitazone · Torrent Pharmaceuticals Limited https://druglandscape.com/drug/torrent-s-quetiapine-fumarate-tablets https://druglandscape.com/api/og?type=drug&title=Torrent's%20Quetiapine%20Fumarate%20Tablets&subtitle=Torrent's%20Quetiapine%20Fumarate%20Tablets%20%C2%B7%20Torrent%20Pharmaceuticals%20Limited&badge=phase%201 Torrent's Quetiapine Fumarate Tablets Torrent's Quetiapine Fumarate Tablets · Torrent Pharmaceuticals Limited https://druglandscape.com/drug/total-intravenous-plus-block-group https://druglandscape.com/api/og?type=drug&title=Total%20intravenous%20plus%20block%20group&subtitle=Total%20intravenous%20plus%20block%20group%20%C2%B7%20Alaa%20Mazy%20Mazy&badge=phase%201 Total intravenous plus block group Total intravenous plus block group · Alaa Mazy Mazy https://druglandscape.com/drug/tozadenant-tablet https://druglandscape.com/api/og?type=drug&title=tozadenant%20tablet&subtitle=tozadenant%20tablet%20%C2%B7%20Biotie%20Therapies%20Inc.&badge=phase%201 tozadenant tablet tozadenant tablet · Biotie Therapies Inc. https://druglandscape.com/drug/tp-03-0-25 https://druglandscape.com/api/og?type=drug&title=TP-03%2C%200.25%25&subtitle=TP-03%2C%200.25%25%20%C2%B7%20Tarsus%20Pharmaceuticals%2C%20Inc.&badge=phase%202 TP-03, 0.25% TP-03, 0.25% · Tarsus Pharmaceuticals, Inc. https://druglandscape.com/drug/tp-102 https://druglandscape.com/api/og?type=drug&title=TP-102&subtitle=TP-102%20%C2%B7%20Technophage%2C%20SA&badge=phase%202 TP-102 TP-102 · Technophage, SA https://druglandscape.com/drug/tp-122a https://druglandscape.com/api/og?type=drug&title=TP-122A&subtitle=TP-122A%20%C2%B7%20Technophage%2C%20SA&badge=phase%201 TP-122A TP-122A · Technophage, SA https://druglandscape.com/drug/tp-1454-monotherapy https://druglandscape.com/api/og?type=drug&title=TP-1454%20monotherapy&subtitle=TP-1454%20monotherapy%20%C2%B7%20Sumitomo%20Pharma%20America%2C%20Inc.&badge=phase%201 TP-1454 monotherapy TP-1454 monotherapy · Sumitomo Pharma America, Inc. https://druglandscape.com/drug/tp-3654 https://druglandscape.com/api/og?type=drug&title=TP%203654&subtitle=TP%203654%20%C2%B7%20Sumitomo%20Pharma%20America%2C%20Inc.&badge=phase%201 TP 3654 TP 3654 · Sumitomo Pharma America, Inc. https://druglandscape.com/drug/tp-38 https://druglandscape.com/api/og?type=drug&title=TP-38&subtitle=TP-38%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%202 TP-38 TP-38 · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/tp-434 https://druglandscape.com/api/og?type=drug&title=TP-434&subtitle=TP-434%20%C2%B7%20Tetraphase%20Pharmaceuticals%2C%20Inc&badge=phase%202 TP-434 TP-434 · Tetraphase Pharmaceuticals, Inc https://druglandscape.com/drug/tp05-coating-a https://druglandscape.com/api/og?type=drug&title=TP05%20Coating%20A&subtitle=TP05%20Coating%20A%20%C2%B7%20Tillotts%20Pharma%20AG&badge=phase%201 TP05 Coating A TP05 Coating A · Tillotts Pharma AG https://druglandscape.com/drug/tp05-coating-b https://druglandscape.com/api/og?type=drug&title=TP05%20Coating%20B&subtitle=TP05%20Coating%20B%20%C2%B7%20Tillotts%20Pharma%20AG&badge=phase%201 TP05 Coating B TP05 Coating B · Tillotts Pharma AG https://druglandscape.com/drug/tp05-coating-d https://druglandscape.com/api/og?type=drug&title=TP05%20Coating%20D&subtitle=TP05%20Coating%20D%20%C2%B7%20Tillotts%20Pharma%20AG&badge=phase%201 TP05 Coating D TP05 Coating D · Tillotts Pharma AG https://druglandscape.com/drug/tp05-coating-e https://druglandscape.com/api/og?type=drug&title=TP05%20Coating%20E&subtitle=TP05%20Coating%20E%20%C2%B7%20Tillotts%20Pharma%20AG&badge=phase%201 TP05 Coating E TP05 Coating E · Tillotts Pharma AG https://druglandscape.com/drug/tp05-coating-h https://druglandscape.com/api/og?type=drug&title=TP05%20Coating%20H&subtitle=TP05%20Coating%20H%20%C2%B7%20Tillotts%20Pharma%20AG&badge=phase%201 TP05 Coating H TP05 Coating H · Tillotts Pharma AG https://druglandscape.com/drug/tp38 https://druglandscape.com/api/og?type=drug&title=TP38&subtitle=TP38%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%202 TP38 TP38 · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/tpm502 https://druglandscape.com/api/og?type=drug&title=TPM502&subtitle=TPM502%20%C2%B7%20Topas%20Therapeutics%20GmbH&badge=phase%202 TPM502 TPM502 · Topas Therapeutics GmbH https://druglandscape.com/drug/tpn-101 https://druglandscape.com/api/og?type=drug&title=TPN-101&subtitle=TPN-101%20%C2%B7%20Transposon%20Therapeutics%2C%20Inc.&badge=phase%202 TPN-101 TPN-101 · Transposon Therapeutics, Inc. https://druglandscape.com/drug/tpn-672 https://druglandscape.com/api/og?type=drug&title=TPN-672&subtitle=TPN-672%20%C2%B7%20Jiangsu%20Kanion%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 TPN-672 TPN-672 · Jiangsu Kanion Pharmaceutical Co., Ltd https://druglandscape.com/drug/tpn171h-single-dose https://druglandscape.com/api/og?type=drug&title=TPN171H%20single%20dose&subtitle=TPN171H%20single%20dose%20%C2%B7%20Vigonvita%20Life%20Sciences&badge=phase%201 TPN171H single dose TPN171H single dose · Vigonvita Life Sciences https://druglandscape.com/drug/tpx-115 https://druglandscape.com/api/og?type=drug&title=TPX-115&subtitle=TPX-115%20%C2%B7%20Tego%20Science%2C%20Inc.&badge=phase%202 TPX-115 TPX-115 · Tego Science, Inc. https://druglandscape.com/drug/tq-a3326 https://druglandscape.com/api/og?type=drug&title=TQ-A3326&subtitle=TQ-A3326%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQ-A3326 TQ-A3326 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tq-b3101 https://druglandscape.com/api/og?type=drug&title=TQ-B3101&subtitle=TQ-B3101%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 TQ-B3101 TQ-B3101 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tq-b3139-capsules https://druglandscape.com/api/og?type=drug&title=TQ-B3139%20capsules&subtitle=TQ-B3139%20capsules%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQ-B3139 capsules TQ-B3139 capsules · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tq-b3203 https://druglandscape.com/api/og?type=drug&title=TQ-B3203&subtitle=TQ-B3203%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQ-B3203 TQ-B3203 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tq05105 https://druglandscape.com/api/og?type=drug&title=TQ05105&subtitle=TQ05105%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQ05105 TQ05105 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tq05105-tablets https://druglandscape.com/api/og?type=drug&title=TQ05105%20Tablets&subtitle=TQ05105%20Tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 TQ05105 Tablets TQ05105 Tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqa3334-tablet https://druglandscape.com/api/og?type=drug&title=TQA3334%20Tablet&subtitle=TQA3334%20Tablet%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 TQA3334 Tablet TQA3334 Tablet · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqa3605-tablets-plus-nas https://druglandscape.com/api/og?type=drug&title=TQA3605%20tablets%20plus%20NAs&subtitle=TQA3605%20tablets%20plus%20NAs%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 TQA3605 tablets plus NAs TQA3605 tablets plus NAs · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb2922-injection-tas-102-tablets https://druglandscape.com/api/og?type=drug&title=TQB2922%20injection%20%C2%B1%20TAS-102%20tablets&subtitle=TQB2922%20injection%20%C2%B1%20TAS-102%20tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Nanjing%20Shunxin%20Pharmac&badge=phase%201 TQB2922 injection ± TAS-102 tablets TQB2922 injection ± TAS-102 tablets · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. https://druglandscape.com/drug/tqb3006-tablets https://druglandscape.com/api/og?type=drug&title=TQB3006%20tablets&subtitle=TQB3006%20tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3006 tablets TQB3006 tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3019-capsules https://druglandscape.com/api/og?type=drug&title=TQB3019%20capsules&subtitle=TQB3019%20capsules%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3019 capsules TQB3019 capsules · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3107-tablets https://druglandscape.com/api/og?type=drug&title=TQB3107%20Tablets&subtitle=TQB3107%20Tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3107 Tablets TQB3107 Tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3117-tablets https://druglandscape.com/api/og?type=drug&title=TQB3117%20tablets&subtitle=TQB3117%20tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3117 tablets TQB3117 tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3122-capsules https://druglandscape.com/api/og?type=drug&title=TQB3122%20Capsules&subtitle=TQB3122%20Capsules%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3122 Capsules TQB3122 Capsules · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3201-tablets https://druglandscape.com/api/og?type=drug&title=TQB3201%20tablets&subtitle=TQB3201%20tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3201 tablets TQB3201 tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3205-capsules https://druglandscape.com/api/og?type=drug&title=TQB3205%20capsules&subtitle=TQB3205%20capsules%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3205 capsules TQB3205 capsules · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3217tablets https://druglandscape.com/api/og?type=drug&title=TQB3217Tablets&subtitle=TQB3217Tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3217Tablets TQB3217Tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3303 https://druglandscape.com/api/og?type=drug&title=TQB3303&subtitle=TQB3303%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3303 TQB3303 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3454 https://druglandscape.com/api/og?type=drug&title=TQB3454&subtitle=TQB3454%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3454 TQB3454 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3455 https://druglandscape.com/api/og?type=drug&title=TQB3455&subtitle=TQB3455%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3455 TQB3455 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3558 https://druglandscape.com/api/og?type=drug&title=TQB3558&subtitle=TQB3558%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3558 TQB3558 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3602 https://druglandscape.com/api/og?type=drug&title=TQB3602&subtitle=TQB3602%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3602 TQB3602 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3617 https://druglandscape.com/api/og?type=drug&title=TQB3617&subtitle=TQB3617%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3617 TQB3617 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3617-capsules https://druglandscape.com/api/og?type=drug&title=TQB3617%20Capsules&subtitle=TQB3617%20Capsules%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3617 Capsules TQB3617 Capsules · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3702-tablets https://druglandscape.com/api/og?type=drug&title=TQB3702%20tablets&subtitle=TQB3702%20tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 TQB3702 tablets TQB3702 tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3728 https://druglandscape.com/api/og?type=drug&title=TQB3728&subtitle=TQB3728%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3728 TQB3728 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3804 https://druglandscape.com/api/og?type=drug&title=TQB3804&subtitle=TQB3804%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3804 TQB3804 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3811 https://druglandscape.com/api/og?type=drug&title=TQB3811&subtitle=TQB3811%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3811 TQB3811 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3820-tablets https://druglandscape.com/api/og?type=drug&title=TQB3820%20tablets&subtitle=TQB3820%20tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3820 tablets TQB3820 tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3824-tablets https://druglandscape.com/api/og?type=drug&title=TQB3824%20tablets&subtitle=TQB3824%20tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3824 tablets TQB3824 tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3909-tablet https://druglandscape.com/api/og?type=drug&title=TQB3909%20tablet&subtitle=TQB3909%20tablet%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3909 tablet TQB3909 tablet · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3909-tablets https://druglandscape.com/api/og?type=drug&title=TQB3909%20tablets&subtitle=TQB3909%20tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3909 tablets TQB3909 tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqb3915-tablets https://druglandscape.com/api/og?type=drug&title=TQB3915%20tablets&subtitle=TQB3915%20tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQB3915 tablets TQB3915 tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqc3302-inhalation-spray https://druglandscape.com/api/og?type=drug&title=TQC3302%20inhalation%20spray&subtitle=TQC3302%20inhalation%20spray%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20(Guangzhou)%20Co.%2C%20Ltd.&badge=phase%201 TQC3302 inhalation spray TQC3302 inhalation spray · Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd. https://druglandscape.com/drug/tqc3721-inhalation-powder https://druglandscape.com/api/og?type=drug&title=TQC3721%20inhalation%20powder&subtitle=TQC3721%20inhalation%20powder%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 TQC3721 inhalation powder TQC3721 inhalation powder · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqd3606 https://druglandscape.com/api/og?type=drug&title=TQD3606&subtitle=TQD3606%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQD3606 TQD3606 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqh2929-injections https://druglandscape.com/api/og?type=drug&title=TQH2929%20Injections&subtitle=TQH2929%20Injections%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%202 TQH2929 Injections TQH2929 Injections · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqh3821-tablets https://druglandscape.com/api/og?type=drug&title=TQH3821%20tablets&subtitle=TQH3821%20tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TQH3821 tablets TQH3821 tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tqh3906-capsule https://druglandscape.com/api/og?type=drug&title=TQH3906%20Capsule&subtitle=TQH3906%20Capsule%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Nanjing%20Shunxin%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 TQH3906 Capsule TQH3906 Capsule · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. https://druglandscape.com/drug/tr-01-xrs https://druglandscape.com/api/og?type=drug&title=TR-01-XRS&subtitle=TR-01-XRS%20%C2%B7%20Terran%20Biosciences%20Australia%20Pty%20Ltd&badge=phase%201 TR-01-XRS TR-01-XRS · Terran Biosciences Australia Pty Ltd https://druglandscape.com/drug/tr-012001 https://druglandscape.com/api/og?type=drug&title=TR-012001&subtitle=TR-012001%20%C2%B7%20SNLD%2C%20Ltd.&badge=phase%202 TR-012001 TR-012001 · SNLD, Ltd. https://druglandscape.com/drug/tr-701 https://druglandscape.com/api/og?type=drug&title=TR-701&subtitle=TR-701%20%C2%B7%20Trius%20Therapeutics%20LLC%2C%20a%20subsidiary%20of%20Merck%20%26%20Co.%2C%20Inc.%20(Rahway%2C%20New%20Jersey%20USA)&badge=phase%201 TR-701 TR-701 · Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) https://druglandscape.com/drug/tr115 https://druglandscape.com/api/og?type=drug&title=TR115&subtitle=TR115%20%C2%B7%20Tarapeutics%20Science%20Inc.&badge=phase%201 TR115 TR115 · Tarapeutics Science Inc. https://druglandscape.com/drug/tr128 https://druglandscape.com/api/og?type=drug&title=TR128&subtitle=TR128%20%C2%B7%20Tarapeutics%20Science%20Inc.&badge=phase%201 TR128 TR128 · Tarapeutics Science Inc. https://druglandscape.com/drug/tr64 https://druglandscape.com/api/og?type=drug&title=TR64&subtitle=TR64%20%C2%B7%20Tarapeutics%20Science%20Inc.&badge=phase%201 TR64 TR64 · Tarapeutics Science Inc. https://druglandscape.com/drug/trabectedin-and-pegylated-liposomal-doxorubicin https://druglandscape.com/api/og?type=drug&title=Trabectedin%20and%20Pegylated%20Liposomal%20Doxorubicin&subtitle=Trabectedin%20and%20Pegylated%20Liposomal%20Doxorubicin%20%C2%B7%20Grupo%20Espa%C3%B1ol%20de%20Investigaci%C3%B3n%20en%20C%C3%A1ncer%20de%20Ovario&badge=phase%202 Trabectedin and Pegylated Liposomal Doxorubicin Trabectedin and Pegylated Liposomal Doxorubicin · Grupo Español de Investigación en Cáncer de Ovario https://druglandscape.com/drug/trabectedin-and-pld https://druglandscape.com/api/og?type=drug&title=Trabectedin%20and%20PLD&subtitle=Trabectedin%20and%20PLD%20%C2%B7%20Grupo%20Espa%C3%B1ol%20de%20Investigaci%C3%B3n%20en%20C%C3%A1ncer%20de%20Ovario&badge=phase%202 Trabectedin and PLD Trabectedin and PLD · Grupo Español de Investigación en Cáncer de Ovario https://druglandscape.com/drug/traditional-chinese-medicine-jitai https://druglandscape.com/api/og?type=drug&title=Traditional%20Chinese%20Medicine%20JITAI&subtitle=Traditional%20Chinese%20Medicine%20JITAI%20%C2%B7%20Shanghai%20Mental%20Health%20Center&badge=phase%201 Traditional Chinese Medicine JITAI Traditional Chinese Medicine JITAI · Shanghai Mental Health Center https://druglandscape.com/drug/traditional-letrozole-therapy https://druglandscape.com/api/og?type=drug&title=Traditional%20Letrozole%20Therapy&subtitle=Traditional%20Letrozole%20Therapy%20%C2%B7%20GABRIEL%20MONTEIRO%20PINHEIRO&badge=phase%201 Traditional Letrozole Therapy Traditional Letrozole Therapy · GABRIEL MONTEIRO PINHEIRO https://druglandscape.com/drug/tralokinumab-300-mg-q2w https://druglandscape.com/api/og?type=drug&title=Tralokinumab%20300%20mg%2C%20Q2W&subtitle=Tralokinumab%20300%20mg%2C%20Q2W%20%C2%B7%20MedImmune%20LLC&badge=phase%202 Tralokinumab 300 mg, Q2W Tralokinumab 300 mg, Q2W · MedImmune LLC https://druglandscape.com/drug/tramadol-and-flurbiprofen https://druglandscape.com/api/og?type=drug&title=tramadol%20and%20flurbiprofen&subtitle=tramadol%20and%20flurbiprofen%20%C2%B7%20Chinese%20Medical%20Association&badge=phase%201 tramadol and flurbiprofen tramadol and flurbiprofen · Chinese Medical Association https://druglandscape.com/drug/tramadol-apap https://druglandscape.com/api/og?type=drug&title=Tramadol%20APAP&subtitle=Tramadol%20APAP%20%C2%B7%20Par%20Pharmaceutical%2C%20Inc.&badge=phase%201 Tramadol APAP Tramadol APAP · Par Pharmaceutical, Inc. https://druglandscape.com/drug/tramadol-contramid-oad https://druglandscape.com/api/og?type=drug&title=Tramadol%20Contramid%20OAD&subtitle=Tramadol%20Contramid%20OAD%20%C2%B7%20Labopharm%20Inc.&badge=phase%201 Tramadol Contramid OAD Tramadol Contramid OAD · Labopharm Inc. https://druglandscape.com/drug/tramadol-hydrochloride-jns013 https://druglandscape.com/api/og?type=drug&title=Tramadol%20Hydrochloride%3B%20JNS013&subtitle=Tramadol%20Hydrochloride%3B%20JNS013%20%C2%B7%20Janssen%20Pharmaceutical%20K.K.&badge=phase%202 Tramadol Hydrochloride; JNS013 Tramadol Hydrochloride; JNS013 · Janssen Pharmaceutical K.K. https://druglandscape.com/drug/tramadol-hydrochloride-sr-tablets https://druglandscape.com/api/og?type=drug&title=Tramadol%20Hydrochloride%20SR%20Tablets&subtitle=Tramadol%20Hydrochloride%20SR%20Tablets%20%C2%B7%20Shandong%20Suncadia%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 Tramadol Hydrochloride SR Tablets Tramadol Hydrochloride SR Tablets · Shandong Suncadia Medicine Co., Ltd. https://druglandscape.com/drug/trametinib-pediatric-formulation https://druglandscape.com/api/og?type=drug&title=Trametinib%20pediatric%20formulation&subtitle=Trametinib%20pediatric%20formulation%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Trametinib pediatric formulation Trametinib pediatric formulation · GlaxoSmithKline https://druglandscape.com/drug/tranexamic-1-gram https://druglandscape.com/api/og?type=drug&title=Tranexamic%201%20gram&subtitle=Tranexamic%201%20gram%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%201 Tranexamic 1 gram Tranexamic 1 gram · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/tranexamic-acid-1-gram-intramuscular https://druglandscape.com/api/og?type=drug&title=Tranexamic%20acid%201%20gram%20intramuscular&subtitle=Tranexamic%20acid%201%20gram%20intramuscular%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%201 Tranexamic acid 1 gram intramuscular Tranexamic acid 1 gram intramuscular · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/tranexamic-acid-2-grams-oral-solution https://druglandscape.com/api/og?type=drug&title=Tranexamic%20acid%202%20grams%20oral%20solution&subtitle=Tranexamic%20acid%202%20grams%20oral%20solution%20%C2%B7%20London%20School%20of%20Hygiene%20and%20Tropical%20Medicine&badge=phase%201 Tranexamic acid 2 grams oral solution Tranexamic acid 2 grams oral solution · London School of Hygiene and Tropical Medicine https://druglandscape.com/drug/trans-catheter-embolization https://druglandscape.com/api/og?type=drug&title=Trans-catheter%20embolization&subtitle=Trans-catheter%20embolization%20%C2%B7%20Shenzhen%20SiBiono%20GeneTech%20Co.%2CLtd&badge=phase%202 Trans-catheter embolization Trans-catheter embolization · Shenzhen SiBiono GeneTech Co.,Ltd https://druglandscape.com/drug/transabdominal-plane-block https://druglandscape.com/api/og?type=drug&title=Transabdominal%20Plane%20Block&subtitle=Transabdominal%20Plane%20Block%20%C2%B7%20Icahn%20School%20of%20Medicine%20at%20Mount%20Sinai&badge=phase%202 Transabdominal Plane Block Transabdominal Plane Block · Icahn School of Medicine at Mount Sinai https://druglandscape.com/drug/transcon-cnp https://druglandscape.com/api/og?type=drug&title=TransCon%20CNP&subtitle=TransCon%20CNP%20%C2%B7%20Ascendis%20Pharma%20Growth%20Disorders%20A%2FS&badge=phase%202 TransCon CNP TransCon CNP · Ascendis Pharma Growth Disorders A/S https://druglandscape.com/drug/transcriptomic-analysis https://druglandscape.com/api/og?type=drug&title=transcriptomic%20analysis&subtitle=transcriptomic%20analysis%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 transcriptomic analysis transcriptomic analysis · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/transcutaneous-mode-of-administration https://druglandscape.com/api/og?type=drug&title=Transcutaneous%20mode%20of%20administration&subtitle=Transcutaneous%20mode%20of%20administration%20%C2%B7%20Objectif%20Recherche%20Vaccins%20SIDA&badge=phase%201 Transcutaneous mode of administration Transcutaneous mode of administration · Objectif Recherche Vaccins SIDA https://druglandscape.com/drug/transdermal-contraceptive-system https://druglandscape.com/api/og?type=drug&title=Transdermal%20Contraceptive%20System&subtitle=Transdermal%20Contraceptive%20System%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%202 Transdermal Contraceptive System Transdermal Contraceptive System · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/transdermal-ketoprofen-patch-with-chadd https://druglandscape.com/api/og?type=drug&title=Transdermal%20Ketoprofen%20Patch%20with%20CHADD&subtitle=Transdermal%20Ketoprofen%20Patch%20with%20CHADD%20%C2%B7%20ZARS%20Pharma%20Inc.&badge=phase%202 Transdermal Ketoprofen Patch with CHADD Transdermal Ketoprofen Patch with CHADD · ZARS Pharma Inc. https://druglandscape.com/drug/transdermal-neostigmine-and-glycopyrrolate https://druglandscape.com/api/og?type=drug&title=Transdermal%20Neostigmine%20and%20Glycopyrrolate&subtitle=Transdermal%20Neostigmine%20and%20Glycopyrrolate%20%C2%B7%20James%20J.%20Peters%20Veterans%20Affairs%20Medical%20Center&badge=phase%201 Transdermal Neostigmine and Glycopyrrolate Transdermal Neostigmine and Glycopyrrolate · James J. Peters Veterans Affairs Medical Center https://druglandscape.com/drug/transdermal-oestradiol https://druglandscape.com/api/og?type=drug&title=Transdermal%20Oestradiol&subtitle=Transdermal%20Oestradiol%20%C2%B7%20Medical%20Research%20Council&badge=phase%202 Transdermal Oestradiol Transdermal Oestradiol · Medical Research Council https://druglandscape.com/drug/transdermal-patch-and-nicotine-inhaler https://druglandscape.com/api/og?type=drug&title=transdermal%20patch%20and%20nicotine%20inhaler&subtitle=transdermal%20patch%20and%20nicotine%20inhaler%20%C2%B7%20US%20Department%20of%20Veterans%20Affairs&badge=phase%203 transdermal patch and nicotine inhaler transdermal patch and nicotine inhaler · US Department of Veterans Affairs https://druglandscape.com/drug/transdermal-teriparatide https://druglandscape.com/api/og?type=drug&title=Transdermal%20Teriparatide&subtitle=Transdermal%20Teriparatide%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%202 Transdermal Teriparatide Transdermal Teriparatide · Eli Lilly and Company https://druglandscape.com/drug/transforaminal-epidural-steroid-injections https://druglandscape.com/api/og?type=drug&title=Transforaminal%20Epidural%20Steroid%20Injections&subtitle=Transforaminal%20Epidural%20Steroid%20Injections%20%C2%B7%20Muhammad%20Aamir%20Latif&badge=phase%201 Transforaminal Epidural Steroid Injections Transforaminal Epidural Steroid Injections · Muhammad Aamir Latif https://druglandscape.com/drug/transfused-biotin-rbcs-adults-phase-i https://druglandscape.com/api/og?type=drug&title=Transfused%20Biotin%20RBCs%20-%20Adults%20Phase%20I&subtitle=Transfused%20Biotin%20RBCs%20-%20Adults%20Phase%20I%20%C2%B7%20John%20A%20Widness&badge=phase%202 Transfused Biotin RBCs - Adults Phase I Transfused Biotin RBCs - Adults Phase I · John A Widness https://druglandscape.com/drug/transfused-biotin-rbcs-infants-phase-ii https://druglandscape.com/api/og?type=drug&title=Transfused%20Biotin%20RBCs%20-%20Infants%20Phase%20II&subtitle=Transfused%20Biotin%20RBCs%20-%20Infants%20Phase%20II%20%C2%B7%20John%20A%20Widness&badge=phase%202 Transfused Biotin RBCs - Infants Phase II Transfused Biotin RBCs - Infants Phase II · John A Widness https://druglandscape.com/drug/transfused-biotin-rbcs-infants-phase-iii https://druglandscape.com/api/og?type=drug&title=Transfused%20Biotin%20RBCs%20-%20Infants%20Phase%20III&subtitle=Transfused%20Biotin%20RBCs%20-%20Infants%20Phase%20III%20%C2%B7%20John%20A%20Widness&badge=phase%202 Transfused Biotin RBCs - Infants Phase III Transfused Biotin RBCs - Infants Phase III · John A Widness https://druglandscape.com/drug/transfusion-graft https://druglandscape.com/api/og?type=drug&title=Transfusion%20graft&subtitle=Transfusion%20graft%20%C2%B7%20Association%20for%20Training%2C%20Education%2C%20and%20Research%20in%20Hematology%2C%20Immunology%2C%20and&badge=phase%201 Transfusion graft Transfusion graft · Association for Training, Education, and Research in Hematology, Immunology, and Transplantation https://druglandscape.com/drug/trasgex https://druglandscape.com/api/og?type=drug&title=TrasGEX%E2%84%A2&subtitle=TrasGEX%E2%84%A2%20%C2%B7%20Glycotope%20GmbH&badge=phase%201 TrasGEX™ TrasGEX™ · Glycotope GmbH https://druglandscape.com/drug/trastuzumab-biosimilar-abp-980 https://druglandscape.com/api/og?type=drug&title=Trastuzumab%20Biosimilar%20ABP%20980&subtitle=Trastuzumab%20Biosimilar%20ABP%20980%20%C2%B7%20West%20German%20Study%20Group&badge=phase%202 Trastuzumab Biosimilar ABP 980 Trastuzumab Biosimilar ABP 980 · West German Study Group https://druglandscape.com/drug/trastuzumab-capecitabine-and-cisplatin https://druglandscape.com/api/og?type=drug&title=Trastuzumab%2C%20Capecitabine%20and%20Cisplatin&subtitle=Trastuzumab%2C%20Capecitabine%20and%20Cisplatin%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 Trastuzumab, Capecitabine and Cisplatin Trastuzumab, Capecitabine and Cisplatin · Asan Medical Center https://druglandscape.com/drug/trastuzumab-derxutecan https://druglandscape.com/api/og?type=drug&title=trastuzumab%20derxutecan&subtitle=trastuzumab%20derxutecan%20%C2%B7%20UNICANCER&badge=phase%202 trastuzumab derxutecan trastuzumab derxutecan · UNICANCER https://druglandscape.com/drug/trastuzumab-docetaxel https://druglandscape.com/api/og?type=drug&title=Trastuzumab%2C%20Docetaxel&subtitle=Trastuzumab%2C%20Docetaxel%20%C2%B7%20Austrian%20Breast%20%26%20Colorectal%20Cancer%20Study%20Group&badge=phase%202 Trastuzumab, Docetaxel Trastuzumab, Docetaxel · Austrian Breast & Colorectal Cancer Study Group https://druglandscape.com/drug/trastuzumab-docetaxel-bevacizumab https://druglandscape.com/api/og?type=drug&title=Trastuzumab%2C%20Docetaxel%2C%20Bevacizumab&subtitle=Trastuzumab%2C%20Docetaxel%2C%20Bevacizumab%20%C2%B7%20Austrian%20Breast%20%26%20Colorectal%20Cancer%20Study%20Group&badge=phase%202 Trastuzumab, Docetaxel, Bevacizumab Trastuzumab, Docetaxel, Bevacizumab · Austrian Breast & Colorectal Cancer Study Group https://druglandscape.com/drug/trastuzumab-emtansine-kadcyla https://druglandscape.com/api/og?type=drug&title=trastuzumab%20emtansine%20%5BKadcyla%5D&subtitle=trastuzumab%20emtansine%20%5BKadcyla%5D%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 trastuzumab emtansine [Kadcyla] trastuzumab emtansine [Kadcyla] · Genentech, Inc. https://druglandscape.com/drug/trastuzumab-lapatinib https://druglandscape.com/api/og?type=drug&title=Trastuzumab%2C%20Lapatinib&subtitle=Trastuzumab%2C%20Lapatinib%20%C2%B7%20Fondazione%20del%20Piemonte%20per%20l'Oncologia&badge=phase%202 Trastuzumab, Lapatinib Trastuzumab, Lapatinib · Fondazione del Piemonte per l'Oncologia https://druglandscape.com/drug/trastuzumab-mcc-dm1 https://druglandscape.com/api/og?type=drug&title=trastuzumab-MCC-DM1&subtitle=trastuzumab-MCC-DM1%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%202 trastuzumab-MCC-DM1 trastuzumab-MCC-DM1 · Genentech, Inc. https://druglandscape.com/drug/trastuzumab-or-lapatinib https://druglandscape.com/api/og?type=drug&title=Trastuzumab%20or%20Lapatinib&subtitle=Trastuzumab%20or%20Lapatinib%20%C2%B7%20Azienda%20Ospedaliera%20Ordine%20Mauriziano%20di%20Torino&badge=phase%202 Trastuzumab or Lapatinib Trastuzumab or Lapatinib · Azienda Ospedaliera Ordine Mauriziano di Torino https://druglandscape.com/drug/trazodone-hydrochloride-prolonged-release-tablet https://druglandscape.com/api/og?type=drug&title=trazodone%20hydrochloride%20prolonged-release%20tablet&subtitle=trazodone%20hydrochloride%20prolonged-release%20tablet%20%C2%B7%20Lee's%20Pharmaceutical%20Limited&badge=phase%201 trazodone hydrochloride prolonged-release tablet trazodone hydrochloride prolonged-release tablet · Lee's Pharmaceutical Limited https://druglandscape.com/drug/trazodone-hydrochloride-prolonged-release-tablets https://druglandscape.com/api/og?type=drug&title=Trazodone%20Hydrochloride%20prolonged-release%20tablets&subtitle=Trazodone%20Hydrochloride%20prolonged-release%20tablets%20%C2%B7%20Lee's%20Pharmaceutical%20Limited&badge=phase%201 Trazodone Hydrochloride prolonged-release tablets Trazodone Hydrochloride prolonged-release tablets · Lee's Pharmaceutical Limited https://druglandscape.com/drug/trb-061 https://druglandscape.com/api/og?type=drug&title=TRB-061&subtitle=TRB-061%20%C2%B7%20TRex%20Bio%2C%20Inc.&badge=phase%201 TRB-061 TRB-061 · TRex Bio, Inc. https://druglandscape.com/drug/trc105-and-pazopanib https://druglandscape.com/api/og?type=drug&title=TRC105%20and%20Pazopanib&subtitle=TRC105%20and%20Pazopanib%20%C2%B7%20Tracon%20Pharmaceuticals%20Inc.&badge=phase%201 TRC105 and Pazopanib TRC105 and Pazopanib · Tracon Pharmaceuticals Inc. https://druglandscape.com/drug/trd205 https://druglandscape.com/api/og?type=drug&title=TRD205&subtitle=TRD205%20%C2%B7%20Beijing%20Tide%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 TRD205 TRD205 · Beijing Tide Pharmaceutical Co., Ltd https://druglandscape.com/drug/trd205-tablets https://druglandscape.com/api/og?type=drug&title=TRD205%20tablets&subtitle=TRD205%20tablets%20%C2%B7%20Beijing%20Tide%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%202 TRD205 tablets TRD205 tablets · Beijing Tide Pharmaceutical Co., Ltd https://druglandscape.com/drug/treamid-once-a-day https://druglandscape.com/api/og?type=drug&title=Treamid%20once%20a%20day&subtitle=Treamid%20once%20a%20day%20%C2%B7%20PHARMENTERPRISES%20LLC&badge=phase%202 Treamid once a day Treamid once a day · PHARMENTERPRISES LLC https://druglandscape.com/drug/treamid-twice-a-day https://druglandscape.com/api/og?type=drug&title=Treamid%20twice%20a%20day&subtitle=Treamid%20twice%20a%20day%20%C2%B7%20PHARMENTERPRISES%20LLC&badge=phase%202 Treamid twice a day Treamid twice a day · PHARMENTERPRISES LLC https://druglandscape.com/drug/trehalose-for-iv-infusion https://druglandscape.com/api/og?type=drug&title=Trehalose%20for%20IV%20Infusion&subtitle=Trehalose%20for%20IV%20Infusion%20%C2%B7%20Bioblast%20Pharma%20Ltd.&badge=phase%201 Trehalose for IV Infusion Trehalose for IV Infusion · Bioblast Pharma Ltd. https://druglandscape.com/drug/tremelimumab-immunotherapy https://druglandscape.com/api/og?type=drug&title=Tremelimumab%20immunotherapy&subtitle=Tremelimumab%20immunotherapy%20%C2%B7%20Boston%20Scientific%20Corporation&badge=phase%202 Tremelimumab immunotherapy Tremelimumab immunotherapy · Boston Scientific Corporation https://druglandscape.com/drug/tremelimumab-monotherapy https://druglandscape.com/api/og?type=drug&title=Tremelimumab%20monotherapy&subtitle=Tremelimumab%20monotherapy%20%C2%B7%20AstraZeneca&badge=phase%202 Tremelimumab monotherapy Tremelimumab monotherapy · AstraZeneca https://druglandscape.com/drug/treosulfan-iv https://druglandscape.com/api/og?type=drug&title=Treosulfan%20IV&subtitle=Treosulfan%20IV%20%C2%B7%20IRCCS%20San%20Raffaele&badge=phase%202 Treosulfan IV Treosulfan IV · IRCCS San Raffaele https://druglandscape.com/drug/trephination-with-platelet-rich-plasma https://druglandscape.com/api/og?type=drug&title=trephination%20with%20platelet%20rich%20plasma&subtitle=trephination%20with%20platelet%20rich%20plasma%20%C2%B7%20Centre%20of%20Postgraduate%20Medical%20Education&badge=phase%202 trephination with platelet rich plasma trephination with platelet rich plasma · Centre of Postgraduate Medical Education https://druglandscape.com/drug/treprostinil-dienthanolmine-sustained-release https://druglandscape.com/api/og?type=drug&title=treprostinil%20dienthanolmine%20sustained%20release&subtitle=treprostinil%20dienthanolmine%20sustained%20release%20%C2%B7%20Ochsner%20Health%20System&badge=phase%202 treprostinil dienthanolmine sustained release treprostinil dienthanolmine sustained release · Ochsner Health System https://druglandscape.com/drug/tretinoin-0-05-cream https://druglandscape.com/api/og?type=drug&title=Tretinoin%200%2C05%25%20cream&subtitle=Tretinoin%200%2C05%25%20cream%20%C2%B7%20Universidade%20Federal%20de%20Goias&badge=phase%202 Tretinoin 0,05% cream Tretinoin 0,05% cream · Universidade Federal de Goias https://druglandscape.com/drug/tretinoin-and-pioglitazone-hcl https://druglandscape.com/api/og?type=drug&title=Tretinoin%20and%20Pioglitazone%20HCL&subtitle=Tretinoin%20and%20Pioglitazone%20HCL%20%C2%B7%20Phoenix%20Neurological%20Associates%2C%20LTD&badge=phase%201 Tretinoin and Pioglitazone HCL Tretinoin and Pioglitazone HCL · Phoenix Neurological Associates, LTD https://druglandscape.com/drug/tretinoin-cream-0-1 https://druglandscape.com/api/og?type=drug&title=Tretinoin%20cream%200.1%25&subtitle=Tretinoin%20cream%200.1%25%20%C2%B7%20Sun%20Pharmaceutical%20Industries%2C%20Inc.&badge=phase%202 Tretinoin cream 0.1% Tretinoin cream 0.1% · Sun Pharmaceutical Industries, Inc. https://druglandscape.com/drug/tretinoin-gel-microsphere-0-04 https://druglandscape.com/api/og?type=drug&title=Tretinoin%20Gel%20Microsphere%2C%200.04%25&subtitle=Tretinoin%20Gel%20Microsphere%2C%200.04%25%20%C2%B7%20Sun%20Pharmaceutical%20Industries%2C%20Inc.&badge=phase%201 Tretinoin Gel Microsphere, 0.04% Tretinoin Gel Microsphere, 0.04% · Sun Pharmaceutical Industries, Inc. https://druglandscape.com/drug/tretinoin-gel-microsphere-0-1 https://druglandscape.com/api/og?type=drug&title=Tretinoin%20Gel%20Microsphere%2C%200.1%25&subtitle=Tretinoin%20Gel%20Microsphere%2C%200.1%25%20%C2%B7%20Sun%20Pharmaceutical%20Industries%2C%20Inc.&badge=phase%201 Tretinoin Gel Microsphere, 0.1% Tretinoin Gel Microsphere, 0.1% · Sun Pharmaceutical Industries, Inc. https://druglandscape.com/drug/trg-200-kit https://druglandscape.com/api/og?type=drug&title=TRG-200%20KIT&subtitle=TRG-200%20KIT%20%C2%B7%20Trigone%20Pharma%20Ltd.&badge=phase%202 TRG-200 KIT TRG-200 KIT · Trigone Pharma Ltd. https://druglandscape.com/drug/tri-611 https://druglandscape.com/api/og?type=drug&title=TRI-611&subtitle=TRI-611%20%C2%B7%20TRIANA%20Biomedicines%2C%20Inc.&badge=phase%201 TRI-611 TRI-611 · TRIANA Biomedicines, Inc. https://druglandscape.com/drug/tri-weekly-cisplatin https://druglandscape.com/api/og?type=drug&title=tri-weekly%20cisplatin&subtitle=tri-weekly%20cisplatin%20%C2%B7%20Korea%20Cancer%20Center%20Hospital&badge=phase%203 tri-weekly cisplatin tri-weekly cisplatin · Korea Cancer Center Hospital https://druglandscape.com/drug/triamcinolone-acetonide-oral-paste https://druglandscape.com/api/og?type=drug&title=triamcinolone%20acetonide%20Oral%20paste&subtitle=triamcinolone%20acetonide%20Oral%20paste%20%C2%B7%20Hams%20Hamed%20Abdelrahman&badge=phase%201 triamcinolone acetonide Oral paste triamcinolone acetonide Oral paste · Hams Hamed Abdelrahman https://druglandscape.com/drug/triamcinolone-and-bevacizumab https://druglandscape.com/api/og?type=drug&title=triamcinolone%20and%20bevacizumab&subtitle=triamcinolone%20and%20bevacizumab%20%C2%B7%20Johann%20Wolfgang%20Goethe%20University%20Hospital&badge=phase%203 triamcinolone and bevacizumab triamcinolone and bevacizumab · Johann Wolfgang Goethe University Hospital https://druglandscape.com/drug/triamcinolone-in-orabase https://druglandscape.com/api/og?type=drug&title=triamcinolone%20in%20orabase&subtitle=triamcinolone%20in%20orabase%20%C2%B7%20Mona%20Taha%20Mohammed%20MD&badge=phase%201 triamcinolone in orabase triamcinolone in orabase · Mona Taha Mohammed MD https://druglandscape.com/drug/triazolam-and-ts-172 https://druglandscape.com/api/og?type=drug&title=Triazolam%20and%20TS-172&subtitle=Triazolam%20and%20TS-172%20%C2%B7%20Taisho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Triazolam and TS-172 Triazolam and TS-172 · Taisho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/tribenzor-of-daichi-sankyo-inc-usa https://druglandscape.com/api/og?type=drug&title=Tribenzor%20of%20Daichi%20Sankyo%20Inc.%20USA&subtitle=Tribenzor%20of%20Daichi%20Sankyo%20Inc.%20USA%20%C2%B7%20Torrent%20Pharmaceuticals%20Limited&badge=phase%201 Tribenzor of Daichi Sankyo Inc. USA Tribenzor of Daichi Sankyo Inc. USA · Torrent Pharmaceuticals Limited https://druglandscape.com/drug/tricar-t-cd19 https://druglandscape.com/api/og?type=drug&title=TriCAR-T-CD19&subtitle=TriCAR-T-CD19%20%C2%B7%20Timmune%20Biotech%20Inc.&badge=phase%201 TriCAR-T-CD19 TriCAR-T-CD19 · Timmune Biotech Inc. https://druglandscape.com/drug/tricyclic-antidepressants https://druglandscape.com/api/og?type=drug&title=Tricyclic%20antidepressants&subtitle=Tricyclic%20antidepressants%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Tricyclic antidepressants Tricyclic antidepressants · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/trifarotene-cream-0-005 https://druglandscape.com/api/og?type=drug&title=Trifarotene%20Cream%200.005%25&subtitle=Trifarotene%20Cream%200.005%25%20%C2%B7%20Sun%20Pharmaceutical%20Industries%2C%20Inc.&badge=phase%201 Trifarotene Cream 0.005% Trifarotene Cream 0.005% · Sun Pharmaceutical Industries, Inc. https://druglandscape.com/drug/trifluridine-and-tipiracil-tablets https://druglandscape.com/api/og?type=drug&title=Trifluridine%20and%20Tipiracil%20Tablets&subtitle=Trifluridine%20and%20Tipiracil%20Tablets%20%C2%B7%20Chia%20Tai%20Tianqing%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 Trifluridine and Tipiracil Tablets Trifluridine and Tipiracil Tablets · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/trifluridine-tipiracil-plus-bevacizumab-alone https://druglandscape.com/api/og?type=drug&title=Trifluridine-tipiracil%20plus%20Bevacizumab%20Alone&subtitle=Trifluridine-tipiracil%20plus%20Bevacizumab%20Alone%20%C2%B7%20Delcath%20Systems%20Inc.&badge=phase%202 Trifluridine-tipiracil plus Bevacizumab Alone Trifluridine-tipiracil plus Bevacizumab Alone · Delcath Systems Inc. https://druglandscape.com/drug/trimedat https://druglandscape.com/api/og?type=drug&title=Trimedat%C2%AE&subtitle=Trimedat%C2%AE%20%C2%B7%20Valenta%20Pharm%20JSC&badge=phase%201 Trimedat® Trimedat® · Valenta Pharm JSC https://druglandscape.com/drug/trimix-300 https://druglandscape.com/api/og?type=drug&title=TriMix_300&subtitle=TriMix_300%20%C2%B7%20Judit%20Pich%20Mart%C3%ADnez&badge=phase%201 TriMix_300 TriMix_300 · Judit Pich Martínez https://druglandscape.com/drug/trin2755 https://druglandscape.com/api/og?type=drug&title=TRIN2755&subtitle=TRIN2755%20%C2%B7%20Trin%20Therapeutics%20GmbH&badge=phase%201 TRIN2755 TRIN2755 · Trin Therapeutics GmbH https://druglandscape.com/drug/trinity-evolution https://druglandscape.com/api/og?type=drug&title=Trinity%20Evolution&subtitle=Trinity%20Evolution%20%C2%B7%20Orthofix%20Inc.&badge=phase%202 Trinity Evolution Trinity Evolution · Orthofix Inc. https://druglandscape.com/drug/trip-2d https://druglandscape.com/api/og?type=drug&title=TrIP-2D&subtitle=TrIP-2D%20%C2%B7%20Alkermes%2C%20Inc.&badge=phase%202 TrIP-2D TrIP-2D · Alkermes, Inc. https://druglandscape.com/drug/trip-2ss https://druglandscape.com/api/og?type=drug&title=TrIP-2SS&subtitle=TrIP-2SS%20%C2%B7%20Alkermes%2C%20Inc.&badge=phase%202 TrIP-2SS TrIP-2SS · Alkermes, Inc. https://druglandscape.com/drug/triple-antibiotic-ointment-neosporin https://druglandscape.com/api/og?type=drug&title=Triple%20Antibiotic%20Ointment%20Neosporin&subtitle=Triple%20Antibiotic%20Ointment%20Neosporin%20%C2%B7%20Next%20Science%20TM&badge=phase%201 Triple Antibiotic Ointment Neosporin Triple Antibiotic Ointment Neosporin · Next Science TM https://druglandscape.com/drug/triple-drug-regimen https://druglandscape.com/api/og?type=drug&title=Triple%20drug%20regimen&subtitle=Triple%20drug%20regimen%20%C2%B7%20Akil%20Al%20Islam&badge=phase%201 Triple drug regimen Triple drug regimen · Akil Al Islam https://druglandscape.com/drug/triple-it-therapy https://druglandscape.com/api/og?type=drug&title=Triple%20IT%20Therapy&subtitle=Triple%20IT%20Therapy%20%C2%B7%20Therapeutic%20Advances%20in%20Childhood%20Leukemia%20Consortium&badge=phase%201 Triple IT Therapy Triple IT Therapy · Therapeutic Advances in Childhood Leukemia Consortium https://druglandscape.com/drug/triple-targeted-car-t-therapy https://druglandscape.com/api/og?type=drug&title=Triple-targeted%20CAR-T%20Therapy&subtitle=Triple-targeted%20CAR-T%20Therapy%20%C2%B7%20Shanghai%20Unicar-Therapy%20Bio-medicine%20Technology%20Co.%2CLtd&badge=phase%201 Triple-targeted CAR-T Therapy Triple-targeted CAR-T Therapy · Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd https://druglandscape.com/drug/tripotassium-bismuth-dicitrate https://druglandscape.com/api/og?type=drug&title=Tripotassium%20bismuth%20dicitrate&subtitle=Tripotassium%20bismuth%20dicitrate%20%C2%B7%20Takeda&badge=phase%201 Tripotassium bismuth dicitrate Tripotassium bismuth dicitrate · Takeda https://druglandscape.com/drug/tripril-car-t-cells https://druglandscape.com/api/og?type=drug&title=TriPRIL%20CAR%20T%20Cells&subtitle=TriPRIL%20CAR%20T%20Cells%20%C2%B7%20Marcela%20V.%20Maus%2C%20M.D.%2CPh.D.&badge=phase%201 TriPRIL CAR T Cells TriPRIL CAR T Cells · Marcela V. Maus, M.D.,Ph.D. https://druglandscape.com/drug/triptan-monotherapy https://druglandscape.com/api/og?type=drug&title=Triptan%20monotherapy&subtitle=Triptan%20monotherapy%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Triptan monotherapy Triptan monotherapy · GlaxoSmithKline https://druglandscape.com/drug/triptolide-analog https://druglandscape.com/api/og?type=drug&title=Triptolide%20Analog&subtitle=Triptolide%20Analog%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%201 Triptolide Analog Triptolide Analog · City of Hope Medical Center https://druglandscape.com/drug/triptorelin-acetate-depot https://druglandscape.com/api/og?type=drug&title=Triptorelin%20acetate%20depot&subtitle=Triptorelin%20acetate%20depot%20%C2%B7%20Immune%20System%20Regulation%20AB&badge=phase%202 Triptorelin acetate depot Triptorelin acetate depot · Immune System Regulation AB https://druglandscape.com/drug/trivalent-darwin-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=Trivalent-Darwin%20influenza%20vaccine&subtitle=Trivalent-Darwin%20influenza%20vaccine%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Trivalent-Darwin influenza vaccine Trivalent-Darwin influenza vaccine · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/trivalent-ganglioside-vaccine https://druglandscape.com/api/og?type=drug&title=Trivalent%20ganglioside%20vaccine&subtitle=Trivalent%20ganglioside%20vaccine%20%C2%B7%20MabVax%20Therapeutics%2C%20Inc.&badge=phase%202 Trivalent ganglioside vaccine Trivalent ganglioside vaccine · MabVax Therapeutics, Inc. https://druglandscape.com/drug/trivalent-influenza-vaccine-gsk-138842a https://druglandscape.com/api/og?type=drug&title=Trivalent%20influenza%20vaccine%20GSK%20138842A&subtitle=Trivalent%20influenza%20vaccine%20GSK%20138842A%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Trivalent influenza vaccine GSK 138842A Trivalent influenza vaccine GSK 138842A · GlaxoSmithKline https://druglandscape.com/drug/trivalent-influenza-vaccine-intradermal-dose https://druglandscape.com/api/og?type=drug&title=Trivalent%20Influenza%20Vaccine%20intradermal%20dose&subtitle=Trivalent%20Influenza%20Vaccine%20intradermal%20dose%20%C2%B7%20Seqirus&badge=phase%201 Trivalent Influenza Vaccine intradermal dose Trivalent Influenza Vaccine intradermal dose · Seqirus https://druglandscape.com/drug/trivalent-influenza-vaccine-licensed https://druglandscape.com/api/og?type=drug&title=Trivalent%20influenza%20vaccine-licensed&subtitle=Trivalent%20influenza%20vaccine-licensed%20%C2%B7%20Seqirus&badge=phase%201 Trivalent influenza vaccine-licensed Trivalent influenza vaccine-licensed · Seqirus https://druglandscape.com/drug/trivalent-p2-vp8 https://druglandscape.com/api/og?type=drug&title=Trivalent%20P2-VP8&subtitle=Trivalent%20P2-VP8%20%C2%B7%20PATH&badge=phase%202 Trivalent P2-VP8 Trivalent P2-VP8 · PATH https://druglandscape.com/drug/trivalent-p2-vp8-booster-dose https://druglandscape.com/api/og?type=drug&title=Trivalent%20P2-VP8%20Booster%20dose&subtitle=Trivalent%20P2-VP8%20Booster%20dose%20%C2%B7%20PATH&badge=phase%202 Trivalent P2-VP8 Booster dose Trivalent P2-VP8 Booster dose · PATH https://druglandscape.com/drug/trivalent-vaccine https://druglandscape.com/api/og?type=drug&title=Trivalent%20Vaccine&subtitle=Trivalent%20Vaccine%20%C2%B7%20Pontificia%20Universidad%20Catolica%20de%20Chile&badge=phase%202 Trivalent Vaccine Trivalent Vaccine · Pontificia Universidad Catolica de Chile https://druglandscape.com/drug/trivirus-specific-ctls https://druglandscape.com/api/og?type=drug&title=Trivirus-Specific%20CTLs&subtitle=Trivirus-Specific%20CTLs%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%202 Trivirus-Specific CTLs Trivirus-Specific CTLs · Baylor College of Medicine https://druglandscape.com/drug/trk-100stp https://druglandscape.com/api/og?type=drug&title=TRK-100STP&subtitle=TRK-100STP%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%201 TRK-100STP TRK-100STP · Astellas Pharma Inc https://druglandscape.com/drug/trk-100stp-high-dose https://druglandscape.com/api/og?type=drug&title=TRK-100STP%20high%20dose&subtitle=TRK-100STP%20high%20dose%20%C2%B7%20Toray%20Industries%2C%20Inc&badge=phase%202 TRK-100STP high dose TRK-100STP high dose · Toray Industries, Inc https://druglandscape.com/drug/trk-100stp-low-dose https://druglandscape.com/api/og?type=drug&title=TRK-100STP%20low%20dose&subtitle=TRK-100STP%20low%20dose%20%C2%B7%20Toray%20Industries%2C%20Inc&badge=phase%202 TRK-100STP low dose TRK-100STP low dose · Toray Industries, Inc https://druglandscape.com/drug/trk-170 https://druglandscape.com/api/og?type=drug&title=TRK-170&subtitle=TRK-170%20%C2%B7%20Toray%20Industries%2C%20Inc&badge=phase%202 TRK-170 TRK-170 · Toray Industries, Inc https://druglandscape.com/drug/trk-250 https://druglandscape.com/api/og?type=drug&title=TRK-250&subtitle=TRK-250%20%C2%B7%20Toray%20Industries%2C%20Inc&badge=phase%201 TRK-250 TRK-250 · Toray Industries, Inc https://druglandscape.com/drug/trk-700 https://druglandscape.com/api/og?type=drug&title=TRK-700&subtitle=TRK-700%20%C2%B7%20Toray%20Industries%2C%20Inc&badge=phase%202 TRK-700 TRK-700 · Toray Industries, Inc https://druglandscape.com/drug/trk-820 https://druglandscape.com/api/og?type=drug&title=TRK-820&subtitle=TRK-820%20%C2%B7%20Toray%20Industries%2C%20Inc&badge=phase%201 TRK-820 TRK-820 · Toray Industries, Inc https://druglandscape.com/drug/trl1068 https://druglandscape.com/api/og?type=drug&title=TRL1068&subtitle=TRL1068%20%C2%B7%20Trellis%20Bioscience%20LLC&badge=phase%201 TRL1068 TRL1068 · Trellis Bioscience LLC https://druglandscape.com/drug/trl1068-a-human-monoclonal-antibody https://druglandscape.com/api/og?type=drug&title=TRL1068%2C%20a%20human%20monoclonal%20antibody&subtitle=TRL1068%2C%20a%20human%20monoclonal%20antibody%20%C2%B7%20Trellis%20Bioscience%20LLC&badge=phase%201 TRL1068, a human monoclonal antibody TRL1068, a human monoclonal antibody · Trellis Bioscience LLC https://druglandscape.com/drug/trl345-a-human-monoclonal-antibody https://druglandscape.com/api/og?type=drug&title=TRL345%2C%20a%20human%20monoclonal%20antibody&subtitle=TRL345%2C%20a%20human%20monoclonal%20antibody%20%C2%B7%20Trellis%20Bioscience%20LLC&badge=phase%201 TRL345, a human monoclonal antibody TRL345, a human monoclonal antibody · Trellis Bioscience LLC https://druglandscape.com/drug/trn-157 https://druglandscape.com/api/og?type=drug&title=TRN-157&subtitle=TRN-157%20%C2%B7%20Theron%20Pharmaceuticals%2C%20Inc.&badge=phase%202 TRN-157 TRN-157 · Theron Pharmaceuticals, Inc. https://druglandscape.com/drug/trn501-dose-1 https://druglandscape.com/api/og?type=drug&title=TRN501%20-%20Dose%201&subtitle=TRN501%20-%20Dose%201%20%C2%B7%20SNLD%2C%20Ltd.&badge=phase%201 TRN501 - Dose 1 TRN501 - Dose 1 · SNLD, Ltd. https://druglandscape.com/drug/tro19622 https://druglandscape.com/api/og?type=drug&title=TRO19622&subtitle=TRO19622%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 TRO19622 TRO19622 · Hoffmann-La Roche https://druglandscape.com/drug/tro40303 https://druglandscape.com/api/og?type=drug&title=TRO40303&subtitle=TRO40303%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 TRO40303 TRO40303 · Hoffmann-La Roche https://druglandscape.com/drug/trobalt https://druglandscape.com/api/og?type=drug&title=Trobalt%E2%84%A2&subtitle=Trobalt%E2%84%A2%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Trobalt™ Trobalt™ · GlaxoSmithKline https://druglandscape.com/drug/troponin-t-blood-level https://druglandscape.com/api/og?type=drug&title=Troponin%20T%20blood%20level&subtitle=Troponin%20T%20blood%20level%20%C2%B7%20H%C3%B4pital%20NOVO&badge=phase%202 Troponin T blood level Troponin T blood level · Hôpital NOVO https://druglandscape.com/drug/trs005 https://druglandscape.com/api/og?type=drug&title=TRS005&subtitle=TRS005%20%C2%B7%20Zhejiang%20Teruisi%20Pharmaceutical%20Inc.&badge=phase%202 TRS005 TRS005 · Zhejiang Teruisi Pharmaceutical Inc. https://druglandscape.com/drug/trv027 https://druglandscape.com/api/og?type=drug&title=TRV027&subtitle=TRV027%20%C2%B7%20Imperial%20College%20London&badge=phase%202 TRV027 TRV027 · Imperial College London https://druglandscape.com/drug/trv027-dose-2 https://druglandscape.com/api/og?type=drug&title=TRV027%20Dose%20%232&subtitle=TRV027%20Dose%20%232%20%C2%B7%20Trevena%20Inc.&badge=phase%202 TRV027 Dose #2 TRV027 Dose #2 · Trevena Inc. https://druglandscape.com/drug/trv120027 https://druglandscape.com/api/og?type=drug&title=TRV120027&subtitle=TRV120027%20%C2%B7%20Trevena%20Inc.&badge=phase%201 TRV120027 TRV120027 · Trevena Inc. https://druglandscape.com/drug/trv130a https://druglandscape.com/api/og?type=drug&title=TRV130A&subtitle=TRV130A%20%C2%B7%20Trevena%20Inc.&badge=phase%201 TRV130A TRV130A · Trevena Inc. https://druglandscape.com/drug/trv734-blinded https://druglandscape.com/api/og?type=drug&title=TRV734%20blinded&subtitle=TRV734%20blinded%20%C2%B7%20Trevena%20Inc.&badge=phase%201 TRV734 blinded TRV734 blinded · Trevena Inc. https://druglandscape.com/drug/trx-100 https://druglandscape.com/api/og?type=drug&title=TRX-100&subtitle=TRX-100%20%C2%B7%20Traws%20Pharma%2C%20Inc.&badge=phase%202 TRX-100 TRX-100 · Traws Pharma, Inc. https://druglandscape.com/drug/trx-221 https://druglandscape.com/api/og?type=drug&title=TRX-221&subtitle=TRX-221%20%C2%B7%20Therapex%20Co.%2C%20Ltd&badge=phase%201 TRX-221 TRX-221 · Therapex Co., Ltd https://druglandscape.com/drug/trx0014 https://druglandscape.com/api/og?type=drug&title=TRx0014&subtitle=TRx0014%20%C2%B7%20TauRx%20Therapeutics%20Ltd&badge=phase%202 TRx0014 TRx0014 · TauRx Therapeutics Ltd https://druglandscape.com/drug/trx0037 https://druglandscape.com/api/og?type=drug&title=TRx0037&subtitle=TRx0037%20%C2%B7%20TauRx%20Therapeutics%20Ltd&badge=phase%201 TRx0037 TRx0037 · TauRx Therapeutics Ltd https://druglandscape.com/drug/trx103 https://druglandscape.com/api/og?type=drug&title=TRX103&subtitle=TRX103%20%C2%B7%20Tr1X%2C%20Inc.&badge=phase%201 TRX103 TRX103 · Tr1X, Inc. https://druglandscape.com/drug/trx319 https://druglandscape.com/api/og?type=drug&title=TRX319&subtitle=TRX319%20%C2%B7%20Tr1X%2C%20Inc.&badge=phase%201 TRX319 TRX319 · Tr1X, Inc. https://druglandscape.com/drug/trx518-with-nivolumab https://druglandscape.com/api/og?type=drug&title=TRX518%20with%20nivolumab&subtitle=TRX518%20with%20nivolumab%20%C2%B7%20Leap%20Therapeutics%2C%20Inc.&badge=phase%201 TRX518 with nivolumab TRX518 with nivolumab · Leap Therapeutics, Inc. https://druglandscape.com/drug/trx518-with-pembrolizumab https://druglandscape.com/api/og?type=drug&title=TRX518%20with%20pembrolizumab&subtitle=TRX518%20with%20pembrolizumab%20%C2%B7%20Leap%20Therapeutics%2C%20Inc.&badge=phase%201 TRX518 with pembrolizumab TRX518 with pembrolizumab · Leap Therapeutics, Inc. https://druglandscape.com/drug/tryp-0082 https://druglandscape.com/api/og?type=drug&title=TRYP-0082&subtitle=TRYP-0082%20%C2%B7%20TRYP%20Therapeutics&badge=phase%202 TRYP-0082 TRYP-0082 · TRYP Therapeutics https://druglandscape.com/drug/ts-091 https://druglandscape.com/api/og?type=drug&title=TS-091&subtitle=TS-091%20%C2%B7%20Taisho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 TS-091 TS-091 · Taisho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ts-142 https://druglandscape.com/api/og?type=drug&title=TS-142&subtitle=TS-142%20%C2%B7%20Taisho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 TS-142 TS-142 · Taisho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ts-143 https://druglandscape.com/api/og?type=drug&title=TS-143&subtitle=TS-143%20%C2%B7%20Taisho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 TS-143 TS-143 · Taisho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ts-172-and-itraconazole https://druglandscape.com/api/og?type=drug&title=TS-172%20and%20itraconazole&subtitle=TS-172%20and%20itraconazole%20%C2%B7%20Taisho%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 TS-172 and itraconazole TS-172 and itraconazole · Taisho Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ts022 https://druglandscape.com/api/og?type=drug&title=TS022&subtitle=TS022%20%C2%B7%20Taisho%20Pharmaceutical%20R%26D%20Inc.&badge=phase%202 TS022 TS022 · Taisho Pharmaceutical R&D Inc. https://druglandscape.com/drug/ts23 https://druglandscape.com/api/og?type=drug&title=TS23&subtitle=TS23%20%C2%B7%20Translational%20Sciences%2C%20Inc.&badge=phase%202 TS23 TS23 · Translational Sciences, Inc. https://druglandscape.com/drug/tsa-ctl https://druglandscape.com/api/og?type=drug&title=TSA-CTL&subtitle=TSA-CTL%20%C2%B7%20BGI%2C%20China&badge=phase%201 TSA-CTL TSA-CTL · BGI, China https://druglandscape.com/drug/tsc-201-b0702 https://druglandscape.com/api/og?type=drug&title=TSC-201-B0702&subtitle=TSC-201-B0702%20%C2%B7%20TScan%20Therapeutics%2C%20Inc.&badge=phase%201 TSC-201-B0702 TSC-201-B0702 · TScan Therapeutics, Inc. https://druglandscape.com/drug/tsc-202-a0201 https://druglandscape.com/api/og?type=drug&title=TSC-202-A0201&subtitle=TSC-202-A0201%20%C2%B7%20TScan%20Therapeutics%2C%20Inc.&badge=phase%201 TSC-202-A0201 TSC-202-A0201 · TScan Therapeutics, Inc. https://druglandscape.com/drug/tsc-203-a0201 https://druglandscape.com/api/og?type=drug&title=TSC-203-A0201&subtitle=TSC-203-A0201%20%C2%B7%20TScan%20Therapeutics%2C%20Inc.&badge=phase%201 TSC-203-A0201 TSC-203-A0201 · TScan Therapeutics, Inc. https://druglandscape.com/drug/tsc-204-a0101 https://druglandscape.com/api/og?type=drug&title=TSC-204-A0101&subtitle=TSC-204-A0101%20%C2%B7%20TScan%20Therapeutics%2C%20Inc.&badge=phase%201 TSC-204-A0101 TSC-204-A0101 · TScan Therapeutics, Inc. https://druglandscape.com/drug/tsc-204-a0201 https://druglandscape.com/api/og?type=drug&title=TSC-204-A0201&subtitle=TSC-204-A0201%20%C2%B7%20TScan%20Therapeutics%2C%20Inc.&badge=phase%201 TSC-204-A0201 TSC-204-A0201 · TScan Therapeutics, Inc. https://druglandscape.com/drug/tsc-204-c0702 https://druglandscape.com/api/og?type=drug&title=TSC-204-C0702&subtitle=TSC-204-C0702%20%C2%B7%20TScan%20Therapeutics%2C%20Inc.&badge=phase%201 TSC-204-C0702 TSC-204-C0702 · TScan Therapeutics, Inc. https://druglandscape.com/drug/tsd-001 https://druglandscape.com/api/og?type=drug&title=TSD-001&subtitle=TSD-001%20%C2%B7%20Lipac%20Oncology%20LLC&badge=phase%201 TSD-001 TSD-001 · Lipac Oncology LLC https://druglandscape.com/drug/tsha-101 https://druglandscape.com/api/og?type=drug&title=TSHA-101&subtitle=TSHA-101%20%C2%B7%20Dr.%20Anupam%20Sehgal&badge=phase%201 TSHA-101 TSHA-101 · Dr. Anupam Sehgal https://druglandscape.com/drug/tsi-gsd-200-rvf-vaccine https://druglandscape.com/api/og?type=drug&title=TSI-GSD%20200%20RVF%20Vaccine&subtitle=TSI-GSD%20200%20RVF%20Vaccine%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%202 TSI-GSD 200 RVF Vaccine TSI-GSD 200 RVF Vaccine · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/tsn084 https://druglandscape.com/api/og?type=drug&title=TSN084&subtitle=TSN084%20%C2%B7%20Tyligand%20Bioscience%20(Shanghai)%20Limited&badge=phase%201 TSN084 TSN084 · Tyligand Bioscience (Shanghai) Limited https://druglandscape.com/drug/tsn1611 https://druglandscape.com/api/og?type=drug&title=TSN1611&subtitle=TSN1611%20%C2%B7%20Tyligand%20Pharmaceuticals%20(Suzhou)%20Limited&badge=phase%201 TSN1611 TSN1611 · Tyligand Pharmaceuticals (Suzhou) Limited https://druglandscape.com/drug/tsr-011 https://druglandscape.com/api/og?type=drug&title=TSR-011&subtitle=TSR-011%20%C2%B7%20Tesaro%2C%20Inc.&badge=phase%201 TSR-011 TSR-011 · Tesaro, Inc. https://druglandscape.com/drug/tsr-033 https://druglandscape.com/api/og?type=drug&title=TSR-033&subtitle=TSR-033%20%C2%B7%20Tesaro%2C%20Inc.&badge=phase%201 TSR-033 TSR-033 · Tesaro, Inc. https://druglandscape.com/drug/tsr-042 https://druglandscape.com/api/og?type=drug&title=TSR-042&subtitle=TSR-042%20%C2%B7%20Tesaro%2C%20Inc.&badge=phase%202 TSR-042 TSR-042 · Tesaro, Inc. https://druglandscape.com/drug/tsra-196 https://druglandscape.com/api/og?type=drug&title=TSRA-196&subtitle=TSRA-196%20%C2%B7%20Tessera%20Therapeutics%2C%20Inc.&badge=phase%201 TSRA-196 TSRA-196 · Tessera Therapeutics, Inc. https://druglandscape.com/drug/tst001 https://druglandscape.com/api/og?type=drug&title=TST001&subtitle=TST001%20%C2%B7%20Suzhou%20Transcenta%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%202 TST001 TST001 · Suzhou Transcenta Therapeutics Co., Ltd. https://druglandscape.com/drug/tst003 https://druglandscape.com/api/og?type=drug&title=TST003&subtitle=TST003%20%C2%B7%20Suzhou%20Transcenta%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 TST003 TST003 · Suzhou Transcenta Therapeutics Co., Ltd. https://druglandscape.com/drug/tsx-002 https://druglandscape.com/api/og?type=drug&title=TSX-002&subtitle=TSX-002%20%C2%B7%20TesoRx%20Pharma%2C%20LLC&badge=phase%202 TSX-002 TSX-002 · TesoRx Pharma, LLC https://druglandscape.com/drug/tt-00420-capsule https://druglandscape.com/api/og?type=drug&title=TT-00420%20Capsule&subtitle=TT-00420%20Capsule%20%C2%B7%20TransThera%20Sciences%20(Nanjing)%2C%20Inc.&badge=phase%202 TT-00420 Capsule TT-00420 Capsule · TransThera Sciences (Nanjing), Inc. https://druglandscape.com/drug/tt-00434 https://druglandscape.com/api/og?type=drug&title=TT-00434&subtitle=TT-00434%20%C2%B7%20TransThera%20Sciences%20(Nanjing)%2C%20Inc.&badge=phase%201 TT-00434 TT-00434 · TransThera Sciences (Nanjing), Inc. https://druglandscape.com/drug/tt-00920 https://druglandscape.com/api/og?type=drug&title=TT-00920&subtitle=TT-00920%20%C2%B7%20TransThera%20Sciences%20(Nanjing)%2C%20Inc.&badge=phase%201 TT-00920 TT-00920 · TransThera Sciences (Nanjing), Inc. https://druglandscape.com/drug/tt-00973-ms-tablets-treatment https://druglandscape.com/api/og?type=drug&title=TT-00973-MS%20tablets%20treatment&subtitle=TT-00973-MS%20tablets%20treatment%20%C2%B7%20TransThera%20Sciences%20(Nanjing)%2C%20Inc.&badge=phase%201 TT-00973-MS tablets treatment TT-00973-MS tablets treatment · TransThera Sciences (Nanjing), Inc. https://druglandscape.com/drug/tt-01025-cl https://druglandscape.com/api/og?type=drug&title=TT-01025-CL&subtitle=TT-01025-CL%20%C2%B7%20LG%20Chem&badge=phase%201 TT-01025-CL TT-01025-CL · LG Chem https://druglandscape.com/drug/tt-01488 https://druglandscape.com/api/og?type=drug&title=TT-01488&subtitle=TT-01488%20%C2%B7%20TransThera%20Sciences%20(Nanjing)%2C%20Inc.&badge=phase%201 TT-01488 TT-01488 · TransThera Sciences (Nanjing), Inc. https://druglandscape.com/drug/tt-01488-tablets https://druglandscape.com/api/og?type=drug&title=TT-01488%20Tablets&subtitle=TT-01488%20Tablets%20%C2%B7%20TransThera%20Sciences%20(Nanjing)%2C%20Inc.&badge=phase%201 TT-01488 Tablets TT-01488 Tablets · TransThera Sciences (Nanjing), Inc. https://druglandscape.com/drug/tt-034 https://druglandscape.com/api/og?type=drug&title=TT-034&subtitle=TT-034%20%C2%B7%20Tacere%20Therapeutics%2C%20Inc.&badge=phase%201 TT-034 TT-034 · Tacere Therapeutics, Inc. https://druglandscape.com/drug/tt-173 https://druglandscape.com/api/og?type=drug&title=TT-173&subtitle=TT-173%20%C2%B7%20Thrombotargets%20Europe%20S.L&badge=phase%202 TT-173 TT-173 · Thrombotargets Europe S.L https://druglandscape.com/drug/tt-4 https://druglandscape.com/api/og?type=drug&title=TT-4&subtitle=TT-4%20%C2%B7%20Tarus%20Therapeutics%2C%20Inc.&badge=phase%201 TT-4 TT-4 · Tarus Therapeutics, Inc. https://druglandscape.com/drug/tt-702 https://druglandscape.com/api/og?type=drug&title=TT-702&subtitle=TT-702%20%C2%B7%20Cancer%20Research%20UK&badge=phase%201 TT-702 TT-702 · Cancer Research UK https://druglandscape.com/drug/tt125-802 https://druglandscape.com/api/og?type=drug&title=TT125-802&subtitle=TT125-802%20%C2%B7%20TOLREMO%20therapeutics%20AG&badge=phase%201 TT125-802 TT125-802 · TOLREMO therapeutics AG https://druglandscape.com/drug/tt223 https://druglandscape.com/api/og?type=drug&title=TT223&subtitle=TT223%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 TT223 TT223 · Eli Lilly and Company https://druglandscape.com/drug/tt301 https://druglandscape.com/api/og?type=drug&title=TT301&subtitle=TT301%20%C2%B7%20OPKO%20Health%2C%20Inc.&badge=phase%201 TT301 TT301 · OPKO Health, Inc. https://druglandscape.com/drug/ttf-ngr https://druglandscape.com/api/og?type=drug&title=tTF-NGR&subtitle=tTF-NGR%20%C2%B7%20Universit%C3%A4t%20M%C3%BCnster&badge=phase%203 tTF-NGR tTF-NGR · Universität Münster https://druglandscape.com/drug/tthx1114 https://druglandscape.com/api/og?type=drug&title=TTHX1114&subtitle=TTHX1114%20%C2%B7%20Trefoil%20Therapeutics%2C%20Inc.&badge=phase%202 TTHX1114 TTHX1114 · Trefoil Therapeutics, Inc. https://druglandscape.com/drug/tti-0102 https://druglandscape.com/api/og?type=drug&title=TTI-0102&subtitle=TTI-0102%20%C2%B7%20VA%20Office%20of%20Research%20and%20Development&badge=phase%202 TTI-0102 TTI-0102 · VA Office of Research and Development https://druglandscape.com/drug/ttp054 https://druglandscape.com/api/og?type=drug&title=TTP054&subtitle=TTP054%20%C2%B7%20vTv%20Therapeutics&badge=phase%202 TTP054 TTP054 · vTv Therapeutics https://druglandscape.com/drug/ttp273 https://druglandscape.com/api/og?type=drug&title=TTP273&subtitle=TTP273%20%C2%B7%20vTv%20Therapeutics&badge=phase%202 TTP273 TTP273 · vTv Therapeutics https://druglandscape.com/drug/ttp399 https://druglandscape.com/api/og?type=drug&title=TTP399&subtitle=TTP399%20%C2%B7%20vTv%20Therapeutics&badge=phase%201 TTP399 TTP399 · vTv Therapeutics https://druglandscape.com/drug/ttp4000 https://druglandscape.com/api/og?type=drug&title=TTP4000&subtitle=TTP4000%20%C2%B7%20vTv%20Therapeutics&badge=phase%201 TTP4000 TTP4000 · vTv Therapeutics https://druglandscape.com/drug/ttp435 https://druglandscape.com/api/og?type=drug&title=TTP435&subtitle=TTP435%20%C2%B7%20vTv%20Therapeutics&badge=phase%202 TTP435 TTP435 · vTv Therapeutics https://druglandscape.com/drug/ttv-dnaemia https://druglandscape.com/api/og?type=drug&title=TTV%20DNAemia&subtitle=TTV%20DNAemia%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 TTV DNAemia TTV DNAemia · Hospices Civils de Lyon https://druglandscape.com/drug/ttx-030 https://druglandscape.com/api/og?type=drug&title=TTX-030&subtitle=TTX-030%20%C2%B7%20Trishula%20Therapeutics%2C%20Inc.&badge=phase%201 TTX-030 TTX-030 · Trishula Therapeutics, Inc. https://druglandscape.com/drug/ttx-080 https://druglandscape.com/api/og?type=drug&title=TTX-080&subtitle=TTX-080%20%C2%B7%20Tizona%20Therapeutics%2C%20Inc&badge=phase%201 TTX-080 TTX-080 · Tizona Therapeutics, Inc https://druglandscape.com/drug/ttx-mc138 https://druglandscape.com/api/og?type=drug&title=TTX-MC138&subtitle=TTX-MC138%20%C2%B7%20TransCode%20Therapeutics&badge=phase%201 TTX-MC138 TTX-MC138 · TransCode Therapeutics https://druglandscape.com/drug/ttyp01 https://druglandscape.com/api/og?type=drug&title=TTYP01&subtitle=TTYP01%20%C2%B7%20Shanghai%20Auzone%20Biological%20Technology%20Co.%2C%20Ltd.&badge=phase%201 TTYP01 TTYP01 · Shanghai Auzone Biological Technology Co., Ltd. https://druglandscape.com/drug/tu7710 https://druglandscape.com/api/og?type=drug&title=TU7710&subtitle=TU7710%20%C2%B7%20TiumBio%20Co.%2C%20Ltd.&badge=phase%201 TU7710 TU7710 · TiumBio Co., Ltd. https://druglandscape.com/drug/tub-030 https://druglandscape.com/api/og?type=drug&title=TUB-030&subtitle=TUB-030%20%C2%B7%20Tubulis%20GmbH&badge=phase%201 TUB-030 TUB-030 · Tubulis GmbH https://druglandscape.com/drug/tubes-3-5tablet-qd https://druglandscape.com/api/og?type=drug&title=Tubes%203~5Tablet%2C%20QD&subtitle=Tubes%203~5Tablet%2C%20QD%20%C2%B7%20LigaChem%20Biosciences%2C%20Inc.&badge=phase%202 Tubes 3~5Tablet, QD Tubes 3~5Tablet, QD · LigaChem Biosciences, Inc. https://druglandscape.com/drug/tucatinib-oral-tablet https://druglandscape.com/api/og?type=drug&title=Tucatinib%20Oral%20Tablet&subtitle=Tucatinib%20Oral%20Tablet%20%C2%B7%20UNICANCER&badge=phase%202 Tucatinib Oral Tablet Tucatinib Oral Tablet · UNICANCER https://druglandscape.com/drug/tucatinib-plus-trastuzumab-and-pertuzumab https://druglandscape.com/api/og?type=drug&title=Tucatinib%20plus%20trastuzumab%20and%20pertuzumab&subtitle=Tucatinib%20plus%20trastuzumab%20and%20pertuzumab%20%C2%B7%20QuantumLeap%20Healthcare%20Collaborative&badge=phase%202 Tucatinib plus trastuzumab and pertuzumab Tucatinib plus trastuzumab and pertuzumab · QuantumLeap Healthcare Collaborative https://druglandscape.com/drug/tulisokibart-form-1 https://druglandscape.com/api/og?type=drug&title=Tulisokibart%20Form%201&subtitle=Tulisokibart%20Form%201%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Tulisokibart Form 1 Tulisokibart Form 1 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/tulisokibart-form-2 https://druglandscape.com/api/og?type=drug&title=Tulisokibart%20Form%202&subtitle=Tulisokibart%20Form%202%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Tulisokibart Form 2 Tulisokibart Form 2 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/tum012 https://druglandscape.com/api/og?type=drug&title=TUM012&subtitle=TUM012%20%C2%B7%20iCoat%20Medical%20AB&badge=phase%201 TUM012 TUM012 · iCoat Medical AB https://druglandscape.com/drug/tumescent-lidocaine-infiltration https://druglandscape.com/api/og?type=drug&title=tumescent%20lidocaine%20infiltration&subtitle=tumescent%20lidocaine%20infiltration%20%C2%B7%20Klein%2C%20Jeffrey%20A.%2C%20M.D.&badge=phase%201 tumescent lidocaine infiltration tumescent lidocaine infiltration · Klein, Jeffrey A., M.D. https://druglandscape.com/drug/tumescent-local-anesthesia https://druglandscape.com/api/og?type=drug&title=Tumescent%20local%20anesthesia&subtitle=Tumescent%20local%20anesthesia%20%C2%B7%20Op%C4%87a%20%C5%BEupanijska%20bolnica%20Po%C5%BEega&badge=phase%201 Tumescent local anesthesia Tumescent local anesthesia · Opća županijska bolnica Požega https://druglandscape.com/drug/tumor-infiltrating-lymphocyte https://druglandscape.com/api/og?type=drug&title=Tumor%20Infiltrating%20Lymphocyte&subtitle=Tumor%20Infiltrating%20Lymphocyte%20%C2%B7%20Shanghai%20Juncell%20Therapeutics&badge=phase%201 Tumor Infiltrating Lymphocyte Tumor Infiltrating Lymphocyte · Shanghai Juncell Therapeutics https://druglandscape.com/drug/tumor-necrosis-factor-alpha https://druglandscape.com/api/og?type=drug&title=Tumor%20necrosis%20factor%20alpha&subtitle=Tumor%20necrosis%20factor%20alpha%20%C2%B7%20OncoCareClinic%20308%20Ltd&badge=phase%202 Tumor necrosis factor alpha Tumor necrosis factor alpha · OncoCareClinic 308 Ltd https://druglandscape.com/drug/tumor-peptide-vaccine https://druglandscape.com/api/og?type=drug&title=tumor%20peptide%20vaccine&subtitle=tumor%20peptide%20vaccine%20%C2%B7%20Michael%20Morse%2C%20MD&badge=phase%201 tumor peptide vaccine tumor peptide vaccine · Michael Morse, MD https://druglandscape.com/drug/tumor-sample https://druglandscape.com/api/og?type=drug&title=Tumor%20sample&subtitle=Tumor%20sample%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 Tumor sample Tumor sample · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/tumor-specific-tcr-t-cells https://druglandscape.com/api/og?type=drug&title=tumor-specific%20TCR-T%20cells&subtitle=tumor-specific%20TCR-T%20cells%20%C2%B7%20Guangzhou%20FineImmune%20Biotechnology%20Co.%2C%20LTD.&badge=phase%201 tumor-specific TCR-T cells tumor-specific TCR-T cells · Guangzhou FineImmune Biotechnology Co., LTD. https://druglandscape.com/drug/tums-ultra-strength https://druglandscape.com/api/og?type=drug&title=TUMS%C2%AE%20Ultra%20Strength&subtitle=TUMS%C2%AE%20Ultra%20Strength%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 TUMS® Ultra Strength TUMS® Ultra Strength · Merck Sharp & Dohme LLC https://druglandscape.com/drug/tunodafil-hydrochloride-tablets https://druglandscape.com/api/og?type=drug&title=Tunodafil%20Hydrochloride%20Tablets&subtitle=Tunodafil%20Hydrochloride%20Tablets%20%C2%B7%20Yangtze%20River%20Pharmaceutical%20Group%20Co.%2C%20Ltd.&badge=phase%201 Tunodafil Hydrochloride Tablets Tunodafil Hydrochloride Tablets · Yangtze River Pharmaceutical Group Co., Ltd. https://druglandscape.com/drug/tuvusertib-14c-tuvusertib-microtracer https://druglandscape.com/api/og?type=drug&title=Tuvusertib%20%5B14C%5DTuvusertib%20microtracer&subtitle=Tuvusertib%20%5B14C%5DTuvusertib%20microtracer%20%C2%B7%20Merck%20Healthcare%20KGaA%2C%20Darmstadt%2C%20Germany%2C%20an%20affiliate%20of%20&badge=phase%201 Tuvusertib [14C]Tuvusertib microtracer Tuvusertib [14C]Tuvusertib microtracer · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/tv-45070 https://druglandscape.com/api/og?type=drug&title=TV-45070&subtitle=TV-45070%20%C2%B7%20Teva%20Branded%20Pharmaceutical%20Products%20R%26D%2C%20Inc.&badge=phase%202 TV-45070 TV-45070 · Teva Branded Pharmaceutical Products R&D, Inc. https://druglandscape.com/drug/tvb-3567 https://druglandscape.com/api/og?type=drug&title=TVB-3567&subtitle=TVB-3567%20%C2%B7%20Sagimet%20Biosciences%20Inc.&badge=phase%201 TVB-3567 TVB-3567 · Sagimet Biosciences Inc. https://druglandscape.com/drug/tvgv-1 https://druglandscape.com/api/og?type=drug&title=TVGV-1&subtitle=TVGV-1%20%C2%B7%20THEVAX%20Genetics%20Vaccine&badge=phase%202 TVGV-1 TVGV-1 · THEVAX Genetics Vaccine https://druglandscape.com/drug/tvi-brain-1 https://druglandscape.com/api/og?type=drug&title=TVI-Brain%201&subtitle=TVI-Brain%201%20%C2%B7%20TVAX%20Biomedical&badge=phase%202 TVI-Brain 1 TVI-Brain 1 · TVAX Biomedical https://druglandscape.com/drug/tw001 https://druglandscape.com/api/og?type=drug&title=TW001&subtitle=TW001%20%C2%B7%20Treeway%20B.V.&badge=phase%202 TW001 TW001 · Treeway B.V. https://druglandscape.com/drug/twb-103 https://druglandscape.com/api/og?type=drug&title=TWB-103&subtitle=TWB-103%20%C2%B7%20Transwell%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 TWB-103 TWB-103 · Transwell Biotech Co., Ltd. https://druglandscape.com/drug/two-doses-of-pentamidine https://druglandscape.com/api/og?type=drug&title=Two%20doses%20of%20Pentamidine&subtitle=Two%20doses%20of%20Pentamidine%20%C2%B7%20Funda%C3%A7%C3%A3o%20de%20Medicina%20Tropical%20Dr.%20Heitor%20Vieira%20Dourado&badge=phase%202 Two doses of Pentamidine Two doses of Pentamidine · Fundação de Medicina Tropical Dr. Heitor Vieira Dourado https://druglandscape.com/drug/two-im-injections-lenti-hpv-07 https://druglandscape.com/api/og?type=drug&title=Two%20IM%20injections%20Lenti-HPV-07&subtitle=Two%20IM%20injections%20Lenti-HPV-07%20%C2%B7%20Theravectys%20S.A.&badge=phase%201 Two IM injections Lenti-HPV-07 Two IM injections Lenti-HPV-07 · Theravectys S.A. https://druglandscape.com/drug/twp-101 https://druglandscape.com/api/og?type=drug&title=TWP-101&subtitle=TWP-101%20%C2%B7%20Shandong%20TheraWisdom%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 TWP-101 TWP-101 · Shandong TheraWisdom Biopharma Co., Ltd. https://druglandscape.com/drug/twp-201 https://druglandscape.com/api/og?type=drug&title=TWP-201&subtitle=TWP-201%20%C2%B7%20Shandong%20TheraWisdom%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 TWP-201 TWP-201 · Shandong TheraWisdom Biopharma Co., Ltd. https://druglandscape.com/drug/tx000045 https://druglandscape.com/api/og?type=drug&title=TX000045&subtitle=TX000045%20%C2%B7%20Tectonic%20Operating%20Company%2C%20Inc.&badge=phase%202 TX000045 TX000045 · Tectonic Operating Company, Inc. https://druglandscape.com/drug/txn10128 https://druglandscape.com/api/og?type=drug&title=TXN10128&subtitle=TXN10128%20%C2%B7%20Txinno%20Bioscience%20Inc.&badge=phase%201 TXN10128 TXN10128 · Txinno Bioscience Inc. https://druglandscape.com/drug/ty-1091 https://druglandscape.com/api/og?type=drug&title=TY-1091&subtitle=TY-1091%20%C2%B7%20TYK%20Medicines%2C%20Inc&badge=phase%201 TY-1091 TY-1091 · TYK Medicines, Inc https://druglandscape.com/drug/ty-2136b https://druglandscape.com/api/og?type=drug&title=TY-2136b&subtitle=TY-2136b%20%C2%B7%20TYK%20Medicines%2C%20Inc&badge=phase%201 TY-2136b TY-2136b · TYK Medicines, Inc https://druglandscape.com/drug/ty-2699a https://druglandscape.com/api/og?type=drug&title=TY-2699a&subtitle=TY-2699a%20%C2%B7%20TYK%20Medicines%2C%20Inc&badge=phase%201 TY-2699a TY-2699a · TYK Medicines, Inc https://druglandscape.com/drug/ty-302 https://druglandscape.com/api/og?type=drug&title=TY-302&subtitle=TY-302%20%C2%B7%20TYK%20Medicines%2C%20Inc&badge=phase%201 TY-302 TY-302 · TYK Medicines, Inc https://druglandscape.com/drug/ty014 https://druglandscape.com/api/og?type=drug&title=TY014&subtitle=TY014%20%C2%B7%20Tysana%20Pte%20Ltd&badge=phase%201 TY014 TY014 · Tysana Pte Ltd https://druglandscape.com/drug/ty101 https://druglandscape.com/api/og?type=drug&title=TY101&subtitle=TY101%20%C2%B7%20Tayu%20Huaxia%20Biotech%20Medical%20Group%20Co.%2C%20Ltd.&badge=phase%201 TY101 TY101 · Tayu Huaxia Biotech Medical Group Co., Ltd. https://druglandscape.com/drug/tyk-00540 https://druglandscape.com/api/og?type=drug&title=TYK-00540&subtitle=TYK-00540%20%C2%B7%20TYK%20Medicines%2C%20Inc&badge=phase%201 TYK-00540 TYK-00540 · TYK Medicines, Inc https://druglandscape.com/drug/tyk2-inhibitor https://druglandscape.com/api/og?type=drug&title=Tyk2%20inhibitor&subtitle=Tyk2%20inhibitor%20%C2%B7%20Usynova%20Pharmaceuticals%20Ltd.&badge=phase%201 Tyk2 inhibitor Tyk2 inhibitor · Usynova Pharmaceuticals Ltd. https://druglandscape.com/drug/tykerb-tablets https://druglandscape.com/api/og?type=drug&title=TYKERB%C2%AE%20tablets&subtitle=TYKERB%C2%AE%20tablets%20%C2%B7%20GlaxoSmithKline&badge=phase%202 TYKERB® tablets TYKERB® tablets · GlaxoSmithKline https://druglandscape.com/drug/tylenol-caplets https://druglandscape.com/api/og?type=drug&title=Tylenol%C2%AE%20Caplets&subtitle=Tylenol%C2%AE%20Caplets%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Tylenol® Caplets Tylenol® Caplets · GlaxoSmithKline https://druglandscape.com/drug/tynadote https://druglandscape.com/api/og?type=drug&title=TYNADOTE&subtitle=TYNADOTE%20%C2%B7%20Sinew%20Pharma%20Inc.&badge=phase%202 TYNADOTE TYNADOTE · Sinew Pharma Inc. https://druglandscape.com/drug/type-2-dm-drugs https://druglandscape.com/api/og?type=drug&title=Type%202%20DM%20drugs&subtitle=Type%202%20DM%20drugs%20%C2%B7%20Bayer&badge=phase%202 Type 2 DM drugs Type 2 DM drugs · Bayer https://druglandscape.com/drug/typhibev https://druglandscape.com/api/og?type=drug&title=TYPHIBEV&subtitle=TYPHIBEV%20%C2%B7%20GlaxoSmithKline&badge=phase%202 TYPHIBEV TYPHIBEV · GlaxoSmithKline https://druglandscape.com/drug/typical-antipsychotics https://druglandscape.com/api/og?type=drug&title=typical%20antipsychotics&subtitle=typical%20antipsychotics%20%C2%B7%20Canadian%20Network%20for%20Observational%20Drug%20Effect%20Studies%2C%20CNODES&badge=phase%202 typical antipsychotics typical antipsychotics · Canadian Network for Observational Drug Effect Studies, CNODES https://druglandscape.com/drug/tyra-300 https://druglandscape.com/api/og?type=drug&title=TYRA-300&subtitle=TYRA-300%20%C2%B7%20Tyra%20Biosciences%2C%20Inc&badge=phase%201 TYRA-300 TYRA-300 · Tyra Biosciences, Inc https://druglandscape.com/drug/tyra-300-b01 https://druglandscape.com/api/og?type=drug&title=TYRA-300-B01&subtitle=TYRA-300-B01%20%C2%B7%20Tyra%20Biosciences%2C%20Inc&badge=phase%201 TYRA-300-B01 TYRA-300-B01 · Tyra Biosciences, Inc https://druglandscape.com/drug/tyra-300-dose-tbd https://druglandscape.com/api/og?type=drug&title=TYRA-300%20Dose%20TBD&subtitle=TYRA-300%20Dose%20TBD%20%C2%B7%20Tyra%20Biosciences%2C%20Inc&badge=phase%202 TYRA-300 Dose TBD TYRA-300 Dose TBD · Tyra Biosciences, Inc https://druglandscape.com/drug/tyrosine-kinase-inhibitors https://druglandscape.com/api/og?type=drug&title=Tyrosine%20kinase%20inhibitors&subtitle=Tyrosine%20kinase%20inhibitors%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Tyrosine kinase inhibitors Tyrosine kinase inhibitors · GlaxoSmithKline https://druglandscape.com/drug/u-14c-wx-081 https://druglandscape.com/api/og?type=drug&title=%5BU-14C%5D%20WX-081&subtitle=%5BU-14C%5D%20WX-081%20%C2%B7%20Shanghai%20Jiatan%20Pharmatech%20Co.%2C%20Ltd&badge=phase%201 [U-14C] WX-081 [U-14C] WX-081 · Shanghai Jiatan Pharmatech Co., Ltd https://druglandscape.com/drug/u-hcg https://druglandscape.com/api/og?type=drug&title=u-hCG&subtitle=u-hCG%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%202 u-hCG u-hCG · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/u-s-approved-neupogen https://druglandscape.com/api/og?type=drug&title=U.S.-approved%20Neupogen%C2%AE&subtitle=U.S.-approved%20Neupogen%C2%AE%20%C2%B7%20Pfizer&badge=phase%201 U.S.-approved Neupogen® U.S.-approved Neupogen® · Pfizer https://druglandscape.com/drug/u-s-commercial-dupixent https://druglandscape.com/api/og?type=drug&title=U.S.%20commercial%20Dupixent%C2%AE&subtitle=U.S.%20commercial%20Dupixent%C2%AE%20%C2%B7%20Jiangsu%20Genscend%20Biopharmaceutical%20Co.%2C%20Ltd&badge=phase%201 U.S. commercial Dupixent® U.S. commercial Dupixent® · Jiangsu Genscend Biopharmaceutical Co., Ltd https://druglandscape.com/drug/u3-1402 https://druglandscape.com/api/og?type=drug&title=U3-1402&subtitle=U3-1402%20%C2%B7%20SCRI%20Development%20Innovations%2C%20LLC&badge=phase%202 U3-1402 U3-1402 · SCRI Development Innovations, LLC https://druglandscape.com/drug/u32-car-t https://druglandscape.com/api/og?type=drug&title=U32%20CAR-T&subtitle=U32%20CAR-T%20%C2%B7%20Shanghai%20Unicar-Therapy%20Bio-medicine%20Technology%20Co.%2CLtd&badge=phase%201 U32 CAR-T U32 CAR-T · Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd https://druglandscape.com/drug/u87-car-t https://druglandscape.com/api/og?type=drug&title=U87%20CAR-T&subtitle=U87%20CAR-T%20%C2%B7%20Shanghai%20Unicar-Therapy%20Bio-medicine%20Technology%20Co.%2CLtd&badge=phase%201 U87 CAR-T U87 CAR-T · Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd https://druglandscape.com/drug/ua026 https://druglandscape.com/api/og?type=drug&title=UA026&subtitle=UA026%20%C2%B7%20Usynova%20Pharmaceuticals%20Ltd.&badge=phase%201 UA026 UA026 · Usynova Pharmaceuticals Ltd. https://druglandscape.com/drug/ub-312 https://druglandscape.com/api/og?type=drug&title=UB-312&subtitle=UB-312%20%C2%B7%20United%20Neuroscience%20Ltd.&badge=phase%201 UB-312 UB-312 · United Neuroscience Ltd. https://druglandscape.com/drug/ub-313 https://druglandscape.com/api/og?type=drug&title=UB-313&subtitle=UB-313%20%C2%B7%20Vaxxinity%2C%20Inc.&badge=phase%201 UB-313 UB-313 · Vaxxinity, Inc. https://druglandscape.com/drug/ub-421-sc https://druglandscape.com/api/og?type=drug&title=UB-421%20SC&subtitle=UB-421%20SC%20%C2%B7%20United%20BioPharma&badge=phase%201 UB-421 SC UB-421 SC · United BioPharma https://druglandscape.com/drug/ub-621-high-dose https://druglandscape.com/api/og?type=drug&title=UB-621%20high-dose&subtitle=UB-621%20high-dose%20%C2%B7%20UBP%20Greater%20China%20(Shanghai)%20Co.%2C%20Ltd&badge=phase%202 UB-621 high-dose UB-621 high-dose · UBP Greater China (Shanghai) Co., Ltd https://druglandscape.com/drug/ub-621-low-dose https://druglandscape.com/api/og?type=drug&title=UB-621%20low-dose&subtitle=UB-621%20low-dose%20%C2%B7%20UBP%20Greater%20China%20(Shanghai)%20Co.%2C%20Ltd&badge=phase%202 UB-621 low-dose UB-621 low-dose · UBP Greater China (Shanghai) Co., Ltd https://druglandscape.com/drug/ub-921 https://druglandscape.com/api/og?type=drug&title=UB-921&subtitle=UB-921%20%C2%B7%20United%20BioPharma&badge=phase%201 UB-921 UB-921 · United BioPharma https://druglandscape.com/drug/ub-vv410 https://druglandscape.com/api/og?type=drug&title=UB-VV410&subtitle=UB-VV410%20%C2%B7%20Nanjing%20IASO%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 UB-VV410 UB-VV410 · Nanjing IASO Biotechnology Co., Ltd. https://druglandscape.com/drug/ubx0101 https://druglandscape.com/api/og?type=drug&title=UBX0101&subtitle=UBX0101%20%C2%B7%20Unity%20Biotechnology%2C%20Inc.&badge=phase%202 UBX0101 UBX0101 · Unity Biotechnology, Inc. https://druglandscape.com/drug/ubx1325-injection-50-l https://druglandscape.com/api/og?type=drug&title=UBX1325%20injection%2050%20%CE%BCL&subtitle=UBX1325%20injection%2050%20%CE%BCL%20%C2%B7%20Unity%20Biotechnology%2C%20Inc.&badge=phase%202 UBX1325 injection 50 μL UBX1325 injection 50 μL · Unity Biotechnology, Inc. https://druglandscape.com/drug/uc-msc-infusion https://druglandscape.com/api/og?type=drug&title=UC-MSC%20infusion&subtitle=UC-MSC%20infusion%20%C2%B7%20Asia%20Stem%20Cell%20Regenerative%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 UC-MSC infusion UC-MSC infusion · Asia Stem Cell Regenerative Pharmaceutical Co., Ltd. https://druglandscape.com/drug/uc-msc-sev https://druglandscape.com/api/og?type=drug&title=UC-MSC%20sEV&subtitle=UC-MSC%20sEV%20%C2%B7%20Universidad%20de%20los%20Andes%2C%20Chile&badge=phase%201 UC-MSC sEV UC-MSC sEV · Universidad de los Andes, Chile https://druglandscape.com/drug/uc1010 https://druglandscape.com/api/og?type=drug&title=UC1010&subtitle=UC1010%20%C2%B7%20Umecrine%20Mood%20AB&badge=phase%201 UC1010 UC1010 · Umecrine Mood AB https://druglandscape.com/drug/ucart20x22 https://druglandscape.com/api/og?type=drug&title=UCART20x22&subtitle=UCART20x22%20%C2%B7%20Cellectis%20S.A.&badge=phase%201 UCART20x22 UCART20x22 · Cellectis S.A. https://druglandscape.com/drug/ucart22 https://druglandscape.com/api/og?type=drug&title=UCART22&subtitle=UCART22%20%C2%B7%20Cellectis%20S.A.&badge=phase%201 UCART22 UCART22 · Cellectis S.A. https://druglandscape.com/drug/ucb0022 https://druglandscape.com/api/og?type=drug&title=UCB0022&subtitle=UCB0022%20%C2%B7%20UCB%20Biopharma%20SRL&badge=phase%202 UCB0022 UCB0022 · UCB Biopharma SRL https://druglandscape.com/drug/ucb0107 https://druglandscape.com/api/og?type=drug&title=UCB0107&subtitle=UCB0107%20%C2%B7%20UCB%20Biopharma%20S.P.R.L.&badge=phase%201 UCB0107 UCB0107 · UCB Biopharma S.P.R.L. https://druglandscape.com/drug/ucb0599 https://druglandscape.com/api/og?type=drug&title=UCB0599&subtitle=UCB0599%20%C2%B7%20UCB%20Biopharma%20S.P.R.L.&badge=phase%202 UCB0599 UCB0599 · UCB Biopharma S.P.R.L. https://druglandscape.com/drug/ucb1381 https://druglandscape.com/api/og?type=drug&title=UCB1381&subtitle=UCB1381%20%C2%B7%20UCB%20Biopharma%20SRL&badge=phase%201 UCB1381 UCB1381 · UCB Biopharma SRL https://druglandscape.com/drug/ucb4594 https://druglandscape.com/api/og?type=drug&title=UCB4594&subtitle=UCB4594%20%C2%B7%20Cancer%20Research%20UK&badge=phase%201 UCB4594 UCB4594 · Cancer Research UK https://druglandscape.com/drug/ucb4940 https://druglandscape.com/api/og?type=drug&title=UCB4940&subtitle=UCB4940%20%C2%B7%20UCB%20Celltech&badge=phase%201 UCB4940 UCB4940 · UCB Celltech https://druglandscape.com/drug/ucb5285 https://druglandscape.com/api/og?type=drug&title=UCB5285&subtitle=UCB5285%20%C2%B7%20UCB%20Biopharma%20SRL&badge=phase%201 UCB5285 UCB5285 · UCB Biopharma SRL https://druglandscape.com/drug/ucb7665 https://druglandscape.com/api/og?type=drug&title=UCB7665&subtitle=UCB7665%20%C2%B7%20UCB%20Biopharma%20S.P.R.L.&badge=phase%202 UCB7665 UCB7665 · UCB Biopharma S.P.R.L. https://druglandscape.com/drug/ucb7665-intravenous-1 https://druglandscape.com/api/og?type=drug&title=UCB7665%20Intravenous%201&subtitle=UCB7665%20Intravenous%201%20%C2%B7%20UCB%20Celltech&badge=phase%201 UCB7665 Intravenous 1 UCB7665 Intravenous 1 · UCB Celltech https://druglandscape.com/drug/ucb7665-intravenous-2 https://druglandscape.com/api/og?type=drug&title=UCB7665%20Intravenous%202&subtitle=UCB7665%20Intravenous%202%20%C2%B7%20UCB%20Celltech&badge=phase%201 UCB7665 Intravenous 2 UCB7665 Intravenous 2 · UCB Celltech https://druglandscape.com/drug/ucb7665-intravenous-4 https://druglandscape.com/api/og?type=drug&title=UCB7665%20Intravenous%204&subtitle=UCB7665%20Intravenous%204%20%C2%B7%20UCB%20Celltech&badge=phase%201 UCB7665 Intravenous 4 UCB7665 Intravenous 4 · UCB Celltech https://druglandscape.com/drug/ucb7665-intravenous-5 https://druglandscape.com/api/og?type=drug&title=UCB7665%20Intravenous%205&subtitle=UCB7665%20Intravenous%205%20%C2%B7%20UCB%20Celltech&badge=phase%201 UCB7665 Intravenous 5 UCB7665 Intravenous 5 · UCB Celltech https://druglandscape.com/drug/ucb7665-subcutaneous-1 https://druglandscape.com/api/og?type=drug&title=UCB7665%20Subcutaneous%201&subtitle=UCB7665%20Subcutaneous%201%20%C2%B7%20UCB%20Celltech&badge=phase%201 UCB7665 Subcutaneous 1 UCB7665 Subcutaneous 1 · UCB Celltech https://druglandscape.com/drug/ucb7665-subcutaneous-2 https://druglandscape.com/api/og?type=drug&title=UCB7665%20Subcutaneous%202&subtitle=UCB7665%20Subcutaneous%202%20%C2%B7%20UCB%20Celltech&badge=phase%201 UCB7665 Subcutaneous 2 UCB7665 Subcutaneous 2 · UCB Celltech https://druglandscape.com/drug/ucb7853 https://druglandscape.com/api/og?type=drug&title=UCB7853&subtitle=UCB7853%20%C2%B7%20UCB%20Biopharma%20SRL&badge=phase%201 UCB7853 UCB7853 · UCB Biopharma SRL https://druglandscape.com/drug/ucb7858 https://druglandscape.com/api/og?type=drug&title=UCB7858&subtitle=UCB7858%20%C2%B7%20UCB%20Biopharma%20S.P.R.L.&badge=phase%201 UCB7858 UCB7858 · UCB Biopharma S.P.R.L. https://druglandscape.com/drug/ucb9741 https://druglandscape.com/api/og?type=drug&title=UCB9741&subtitle=UCB9741%20%C2%B7%20UCB%20Biopharma%20SRL&badge=phase%201 UCB9741 UCB9741 · UCB Biopharma SRL https://druglandscape.com/drug/ucmscs https://druglandscape.com/api/og?type=drug&title=UCMSCs&subtitle=UCMSCs%20%C2%B7%20Joshua%20M%20Hare&badge=phase%201 UCMSCs UCMSCs · Joshua M Hare https://druglandscape.com/drug/uct-03-008 https://druglandscape.com/api/og?type=drug&title=UCT-03-008&subtitle=UCT-03-008%20%C2%B7%201200%20Pharma%2C%20LLC&badge=phase%201 UCT-03-008 UCT-03-008 · 1200 Pharma, LLC https://druglandscape.com/drug/udi-001 https://druglandscape.com/api/og?type=drug&title=UDI-001&subtitle=UDI-001%20%C2%B7%20Rohto%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 UDI-001 UDI-001 · Rohto Pharmaceutical Co., Ltd. https://druglandscape.com/drug/udp-003 https://druglandscape.com/api/og?type=drug&title=UDP-003&subtitle=UDP-003%20%C2%B7%20Cyclarity%20Therapeutics%2C%20Inc.&badge=phase%201 UDP-003 UDP-003 · Cyclarity Therapeutics, Inc. https://druglandscape.com/drug/ugn-301 https://druglandscape.com/api/og?type=drug&title=UGN-301&subtitle=UGN-301%20%C2%B7%20UroGen%20Pharma%20Ltd.&badge=phase%201 UGN-301 UGN-301 · UroGen Pharma Ltd. https://druglandscape.com/drug/ugt1a1-victim-drug https://druglandscape.com/api/og?type=drug&title=UGT1A1%20victim%20drug&subtitle=UGT1A1%20victim%20drug%20%C2%B7%20Kadmon%2C%20a%20Sanofi%20Company&badge=phase%201 UGT1A1 victim drug UGT1A1 victim drug · Kadmon, a Sanofi Company https://druglandscape.com/drug/uhe-101-cream https://druglandscape.com/api/og?type=drug&title=UHE-101%20Cream&subtitle=UHE-101%20Cream%20%C2%B7%20Therapeutics%2C%20Inc.&badge=phase%202 UHE-101 Cream UHE-101 Cream · Therapeutics, Inc. https://druglandscape.com/drug/uhe-103-cream https://druglandscape.com/api/og?type=drug&title=UHE-103%20Cream&subtitle=UHE-103%20Cream%20%C2%B7%20Therapeutics%2C%20Inc.&badge=phase%201 UHE-103 Cream UHE-103 Cream · Therapeutics, Inc. https://druglandscape.com/drug/uhe-103a1-cream https://druglandscape.com/api/og?type=drug&title=UHE-103A1%20cream&subtitle=UHE-103A1%20cream%20%C2%B7%20Therapeutics%2C%20Inc.&badge=phase%202 UHE-103A1 cream UHE-103A1 cream · Therapeutics, Inc. https://druglandscape.com/drug/uhe-103a1b-cream https://druglandscape.com/api/og?type=drug&title=UHE-103A1B%20cream&subtitle=UHE-103A1B%20cream%20%C2%B7%20Therapeutics%2C%20Inc.&badge=phase%202 UHE-103A1B cream UHE-103A1B cream · Therapeutics, Inc. https://druglandscape.com/drug/uhe-103a2b-cream https://druglandscape.com/api/og?type=drug&title=UHE-103A2B%20cream&subtitle=UHE-103A2B%20cream%20%C2%B7%20Therapeutics%2C%20Inc.&badge=phase%202 UHE-103A2B cream UHE-103A2B cream · Therapeutics, Inc. https://druglandscape.com/drug/uhe-103b-cream https://druglandscape.com/api/og?type=drug&title=UHE-103B%20cream&subtitle=UHE-103B%20cream%20%C2%B7%20Therapeutics%2C%20Inc.&badge=phase%202 UHE-103B cream UHE-103B cream · Therapeutics, Inc. https://druglandscape.com/drug/ui009 https://druglandscape.com/api/og?type=drug&title=UI009&subtitle=UI009%20%C2%B7%20Korea%20United%20Pharm.%20Inc.&badge=phase%201 UI009 UI009 · Korea United Pharm. Inc. https://druglandscape.com/drug/ui030 https://druglandscape.com/api/og?type=drug&title=UI030&subtitle=UI030%20%C2%B7%20Korea%20United%20Pharm.%20Inc.&badge=phase%202 UI030 UI030 · Korea United Pharm. Inc. https://druglandscape.com/drug/ui03spg300ct https://druglandscape.com/api/og?type=drug&title=UI03SPG300CT&subtitle=UI03SPG300CT%20%C2%B7%20Korea%20United%20Pharm.%20Inc.&badge=phase%201 UI03SPG300CT UI03SPG300CT · Korea United Pharm. Inc. https://druglandscape.com/drug/ui059 https://druglandscape.com/api/og?type=drug&title=UI059&subtitle=UI059%20%C2%B7%20Korea%20United%20Pharm.%20Inc.&badge=phase%201 UI059 UI059 · Korea United Pharm. Inc. https://druglandscape.com/drug/ui15aml055mt https://druglandscape.com/api/og?type=drug&title=UI15AML055MT&subtitle=UI15AML055MT%20%C2%B7%20Korea%20United%20Pharm.%20Inc.&badge=phase%201 UI15AML055MT UI15AML055MT · Korea United Pharm. Inc. https://druglandscape.com/drug/uic202201 https://druglandscape.com/api/og?type=drug&title=UIC202201&subtitle=UIC202201%20%C2%B7%20Korea%20United%20Pharm.%20Inc.&badge=phase%201 UIC202201 UIC202201 · Korea United Pharm. Inc. https://druglandscape.com/drug/uish001 https://druglandscape.com/api/og?type=drug&title=UISH001&subtitle=UISH001%20%C2%B7%20Beech%20Tree%20Labs%2C%20Inc.&badge=phase%201 UISH001 UISH001 · Beech Tree Labs, Inc. https://druglandscape.com/drug/uk-369-003 https://druglandscape.com/api/og?type=drug&title=UK-369%2C003&subtitle=UK-369%2C003%20%C2%B7%20Pfizer&badge=phase%202 UK-369,003 UK-369,003 · Pfizer https://druglandscape.com/drug/uk-390-957 https://druglandscape.com/api/og?type=drug&title=UK-390%2C957&subtitle=UK-390%2C957%20%C2%B7%20Pfizer&badge=phase%202 UK-390,957 UK-390,957 · Pfizer https://druglandscape.com/drug/uk-396-082 https://druglandscape.com/api/og?type=drug&title=UK-396%2C082&subtitle=UK-396%2C082%20%C2%B7%20Pfizer&badge=phase%201 UK-396,082 UK-396,082 · Pfizer https://druglandscape.com/drug/uk-453-061 https://druglandscape.com/api/og?type=drug&title=UK-453%2C%20061&subtitle=UK-453%2C%20061%20%C2%B7%20Pfizer&badge=phase%202 UK-453, 061 UK-453, 061 · Pfizer https://druglandscape.com/drug/uk0369-003 https://druglandscape.com/api/og?type=drug&title=UK0369%2C003&subtitle=UK0369%2C003%20%C2%B7%20Pfizer&badge=phase%202 UK0369,003 UK0369,003 · Pfizer https://druglandscape.com/drug/uk369-003 https://druglandscape.com/api/og?type=drug&title=UK369%2C003&subtitle=UK369%2C003%20%C2%B7%20Pfizer&badge=phase%201 UK369,003 UK369,003 · Pfizer https://druglandscape.com/drug/ulsc https://druglandscape.com/api/og?type=drug&title=ULSC&subtitle=ULSC%20%C2%B7%20Restem%2C%20LLC.&badge=phase%201 ULSC ULSC · Restem, LLC. https://druglandscape.com/drug/ulthera-system-treatment https://druglandscape.com/api/og?type=drug&title=Ulthera%20System%20Treatment&subtitle=Ulthera%20System%20Treatment%20%C2%B7%20Ulthera%2C%20Inc&badge=phase%201 Ulthera System Treatment Ulthera System Treatment · Ulthera, Inc https://druglandscape.com/drug/ultibro-breezhaler-with-oral-charcoal https://druglandscape.com/api/og?type=drug&title=Ultibro%20Breezhaler%20with%20oral%20charcoal&subtitle=Ultibro%20Breezhaler%20with%20oral%20charcoal%20%C2%B7%20Orion%20Corporation%2C%20Orion%20Pharma&badge=phase%201 Ultibro Breezhaler with oral charcoal Ultibro Breezhaler with oral charcoal · Orion Corporation, Orion Pharma https://druglandscape.com/drug/ultimaster-tansei-stents https://druglandscape.com/api/og?type=drug&title=Ultimaster%E2%84%A2%20Tansei%E2%84%A2%20stents&subtitle=Ultimaster%E2%84%A2%20Tansei%E2%84%A2%20stents%20%C2%B7%20Duk-Woo%20Park%2C%20MD&badge=phase%202 Ultimaster™ Tansei™ stents Ultimaster™ Tansei™ stents · Duk-Woo Park, MD https://druglandscape.com/drug/ultrafiltrate-sampling https://druglandscape.com/api/og?type=drug&title=Ultrafiltrate%20sampling&subtitle=Ultrafiltrate%20sampling%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 Ultrafiltrate sampling Ultrafiltrate sampling · Hospices Civils de Lyon https://druglandscape.com/drug/ultrasound-erector-spinae-plane-block https://druglandscape.com/api/og?type=drug&title=Ultrasound%20erector%20spinae%20plane%20block&subtitle=Ultrasound%20erector%20spinae%20plane%20block%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 Ultrasound erector spinae plane block Ultrasound erector spinae plane block · Asan Medical Center https://druglandscape.com/drug/ultrasound-guided-rectus-sheath-block https://druglandscape.com/api/og?type=drug&title=Ultrasound%20guided%20Rectus%20sheath%20block&subtitle=Ultrasound%20guided%20Rectus%20sheath%20block%20%C2%B7%20Asan%20Medical%20Center&badge=phase%201 Ultrasound guided Rectus sheath block Ultrasound guided Rectus sheath block · Asan Medical Center https://druglandscape.com/drug/ultratrace-iobenguane-i131 https://druglandscape.com/api/og?type=drug&title=Ultratrace%20Iobenguane%20I131&subtitle=Ultratrace%20Iobenguane%20I131%20%C2%B7%20Molecular%20Insight%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Ultratrace Iobenguane I131 Ultratrace Iobenguane I131 · Molecular Insight Pharmaceuticals, Inc. https://druglandscape.com/drug/ultratracetm-iobenguane-i-131-imaging https://druglandscape.com/api/og?type=drug&title=UltratraceTM%20Iobenguane%20I%20131%20Imaging&subtitle=UltratraceTM%20Iobenguane%20I%20131%20Imaging%20%C2%B7%20Molecular%20Insight%20Pharmaceuticals%2C%20Inc.&badge=phase%202 UltratraceTM Iobenguane I 131 Imaging UltratraceTM Iobenguane I 131 Imaging · Molecular Insight Pharmaceuticals, Inc. https://druglandscape.com/drug/ultratracetm-iobenguane-i-131-therapy https://druglandscape.com/api/og?type=drug&title=UltratraceTM%20Iobenguane%20I%20131%20Therapy&subtitle=UltratraceTM%20Iobenguane%20I%20131%20Therapy%20%C2%B7%20Molecular%20Insight%20Pharmaceuticals%2C%20Inc.&badge=phase%202 UltratraceTM Iobenguane I 131 Therapy UltratraceTM Iobenguane I 131 Therapy · Molecular Insight Pharmaceuticals, Inc. https://druglandscape.com/drug/ultravate-cream https://druglandscape.com/api/og?type=drug&title=Ultravate%20Cream&subtitle=Ultravate%20Cream%20%C2%B7%20Bausch%20Health%20Americas%2C%20Inc.&badge=phase%202 Ultravate Cream Ultravate Cream · Bausch Health Americas, Inc. https://druglandscape.com/drug/umbilical-cord-blood-administration https://druglandscape.com/api/og?type=drug&title=Umbilical%20Cord%20Blood%20administration&subtitle=Umbilical%20Cord%20Blood%20administration%20%C2%B7%20MinYoung%20Kim%2C%20M.D.&badge=phase%201 Umbilical Cord Blood administration Umbilical Cord Blood administration · MinYoung Kim, M.D. https://druglandscape.com/drug/umbilical-cord-blood-mononuclear-cells https://druglandscape.com/api/og?type=drug&title=umbilical%20cord%20blood%20mononuclear%20cells&subtitle=umbilical%20cord%20blood%20mononuclear%20cells%20%C2%B7%20Shandong%20Qilu%20Stem%20Cells%20Engineering%20Co.%2C%20Ltd.&badge=phase%201 umbilical cord blood mononuclear cells umbilical cord blood mononuclear cells · Shandong Qilu Stem Cells Engineering Co., Ltd. https://druglandscape.com/drug/umbilical-cord-derived-wharton-s-jelly https://druglandscape.com/api/og?type=drug&title=Umbilical%20Cord-derived%20Wharton's%20Jelly&subtitle=Umbilical%20Cord-derived%20Wharton's%20Jelly%20%C2%B7%20BioIntegrate&badge=phase%201 Umbilical Cord-derived Wharton's Jelly Umbilical Cord-derived Wharton's Jelly · BioIntegrate https://druglandscape.com/drug/umbilical-cord-mesenchymal-stromal-cells https://druglandscape.com/api/og?type=drug&title=umbilical-cord%20mesenchymal%20stromal%20cells&subtitle=umbilical-cord%20mesenchymal%20stromal%20cells%20%C2%B7%20Francisco%20Espinoza%2C%20MD&badge=phase%201 umbilical-cord mesenchymal stromal cells umbilical-cord mesenchymal stromal cells · Francisco Espinoza, MD https://druglandscape.com/drug/umc119-06 https://druglandscape.com/api/og?type=drug&title=UMC119-06&subtitle=UMC119-06%20%C2%B7%20Meridigen%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 UMC119-06 UMC119-06 · Meridigen Biotech Co., Ltd. https://druglandscape.com/drug/umc119-06-05 https://druglandscape.com/api/og?type=drug&title=UMC119-06-05&subtitle=UMC119-06-05%20%C2%B7%20Meridigen%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 UMC119-06-05 UMC119-06-05 · Meridigen Biotech Co., Ltd. https://druglandscape.com/drug/umn-0501 https://druglandscape.com/api/og?type=drug&title=UMN-0501&subtitle=UMN-0501%20%C2%B7%20UMN%20Pharma%20Inc.&badge=phase%202 UMN-0501 UMN-0501 · UMN Pharma Inc. https://druglandscape.com/drug/umsc01 https://druglandscape.com/api/og?type=drug&title=UMSC01&subtitle=UMSC01%20%C2%B7%20Ever%20Supreme%20Bio%20Technology%20Co.%2C%20Ltd.&badge=phase%201 UMSC01 UMSC01 · Ever Supreme Bio Technology Co., Ltd. https://druglandscape.com/drug/unadjuvanted-panblok-dose-3 https://druglandscape.com/api/og?type=drug&title=Unadjuvanted%20Panblok%20Dose%203&subtitle=Unadjuvanted%20Panblok%20Dose%203%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%201 Unadjuvanted Panblok Dose 3 Unadjuvanted Panblok Dose 3 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/unconjugated-belantamab-antibody https://druglandscape.com/api/og?type=drug&title=Unconjugated%20belantamab%20antibody&subtitle=Unconjugated%20belantamab%20antibody%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Unconjugated belantamab antibody Unconjugated belantamab antibody · GlaxoSmithKline https://druglandscape.com/drug/uncoupled-rbcs https://druglandscape.com/api/og?type=drug&title=uncoupled%20RBCs&subtitle=uncoupled%20RBCs%20%C2%B7%20Cellerys%20AG&badge=phase%201 uncoupled RBCs uncoupled RBCs · Cellerys AG https://druglandscape.com/drug/undiluted-intravenous-da-5217 https://druglandscape.com/api/og?type=drug&title=Undiluted%20Intravenous%20DA-5217&subtitle=Undiluted%20Intravenous%20DA-5217%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 Undiluted Intravenous DA-5217 Undiluted Intravenous DA-5217 · Dong-A ST Co., Ltd. https://druglandscape.com/drug/unicar02-t-ppsma https://druglandscape.com/api/og?type=drug&title=UniCAR02-T-pPSMA&subtitle=UniCAR02-T-pPSMA%20%C2%B7%20AvenCell%20Therapeutics%2C%20Inc.&badge=phase%202 UniCAR02-T-pPSMA UniCAR02-T-pPSMA · AvenCell Therapeutics, Inc. https://druglandscape.com/drug/unlabeled-ertugliflozin-for-oral-use https://druglandscape.com/api/og?type=drug&title=Unlabeled%20ertugliflozin%20for%20oral%20use&subtitle=Unlabeled%20ertugliflozin%20for%20oral%20use%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 Unlabeled ertugliflozin for oral use Unlabeled ertugliflozin for oral use · Merck Sharp & Dohme LLC https://druglandscape.com/drug/unlabeled-th-302 https://druglandscape.com/api/og?type=drug&title=Unlabeled%20TH-302&subtitle=Unlabeled%20TH-302%20%C2%B7%20Merck%20KGaA%2C%20Darmstadt%2C%20Germany&badge=phase%201 Unlabeled TH-302 Unlabeled TH-302 · Merck KGaA, Darmstadt, Germany https://druglandscape.com/drug/unlicensed-cbu https://druglandscape.com/api/og?type=drug&title=unlicensed%20CBU&subtitle=unlicensed%20CBU%20%C2%B7%20New%20York%20Blood%20Center&badge=phase%202 unlicensed CBU unlicensed CBU · New York Blood Center https://druglandscape.com/drug/unstimulated-saliva-sampling https://druglandscape.com/api/og?type=drug&title=Unstimulated%20saliva%20sampling&subtitle=Unstimulated%20saliva%20sampling%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Unstimulated saliva sampling Unstimulated saliva sampling · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/untreated-whole-blood https://druglandscape.com/api/og?type=drug&title=Untreated%20Whole%20Blood&subtitle=Untreated%20Whole%20Blood%20%C2%B7%20Terumo%20BCTbio&badge=phase%201 Untreated Whole Blood Untreated Whole Blood · Terumo BCTbio https://druglandscape.com/drug/up-to-900-micrograms-nexvax2 https://druglandscape.com/api/og?type=drug&title=Up%20to%20900%20micrograms%20Nexvax2&subtitle=Up%20to%20900%20micrograms%20Nexvax2%20%C2%B7%20Nexpep%20Pty%20Ltd&badge=phase%201 Up to 900 micrograms Nexvax2 Up to 900 micrograms Nexvax2 · Nexpep Pty Ltd https://druglandscape.com/drug/up421 https://druglandscape.com/api/og?type=drug&title=UP421&subtitle=UP421%20%C2%B7%20Per-Ola%20Carlsson&badge=phase%201 UP421 UP421 · Per-Ola Carlsson https://druglandscape.com/drug/upb-101 https://druglandscape.com/api/og?type=drug&title=UPB-101&subtitle=UPB-101%20%C2%B7%20Upstream%20Bio%20Inc.&badge=phase%201 UPB-101 UPB-101 · Upstream Bio Inc. https://druglandscape.com/drug/uptravi-film-coated-tablets https://druglandscape.com/api/og?type=drug&title=Uptravi%C2%AE%20Film%20Coated%20Tablets&subtitle=Uptravi%C2%AE%20Film%20Coated%20Tablets%20%C2%B7%20Humanis%20Sagl%C4%B1k%20Anonim%20Sirketi&badge=phase%201 Uptravi® Film Coated Tablets Uptravi® Film Coated Tablets · Humanis Saglık Anonim Sirketi https://druglandscape.com/drug/urc102 https://druglandscape.com/api/og?type=drug&title=URC102&subtitle=URC102%20%C2%B7%20JW%20Pharmaceutical&badge=phase%202 URC102 URC102 · JW Pharmaceutical https://druglandscape.com/drug/urea-based-cream https://druglandscape.com/api/og?type=drug&title=urea-based%20cream&subtitle=urea-based%20cream%20%C2%B7%20Chinese%20Anti-Cancer%20Association&badge=phase%202 urea-based cream urea-based cream · Chinese Anti-Cancer Association https://druglandscape.com/drug/uricase-peg-20 https://druglandscape.com/api/og?type=drug&title=Uricase-PEG%2020&subtitle=Uricase-PEG%2020%20%C2%B7%20EnzymeRx&badge=phase%201 Uricase-PEG 20 Uricase-PEG 20 · EnzymeRx https://druglandscape.com/drug/urinary-cotinine-assesment https://druglandscape.com/api/og?type=drug&title=urinary%20cotinine%20assesment&subtitle=urinary%20cotinine%20assesment%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 urinary cotinine assesment urinary cotinine assesment · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/urinary-dosage https://druglandscape.com/api/og?type=drug&title=Urinary%20dosage&subtitle=Urinary%20dosage%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 Urinary dosage Urinary dosage · Hospices Civils de Lyon https://druglandscape.com/drug/urinary-nnn-assesement https://druglandscape.com/api/og?type=drug&title=Urinary%20NNN%20assesement&subtitle=Urinary%20NNN%20assesement%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Urinary NNN assesement Urinary NNN assesement · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/urine-and-blood-samples https://druglandscape.com/api/og?type=drug&title=Urine%20and%20blood%20samples&subtitle=Urine%20and%20blood%20samples%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 Urine and blood samples Urine and blood samples · Hospices Civils de Lyon https://druglandscape.com/drug/urine-and-stoll-samples https://druglandscape.com/api/og?type=drug&title=Urine%20and%20stoll%20samples&subtitle=Urine%20and%20stoll%20samples%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Urine and stoll samples Urine and stoll samples · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/urine-collection https://druglandscape.com/api/og?type=drug&title=urine%20collection&subtitle=urine%20collection%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%202 urine collection urine collection · Hospices Civils de Lyon https://druglandscape.com/drug/urine-sample-collection https://druglandscape.com/api/og?type=drug&title=Urine%20sample%20collection&subtitle=Urine%20sample%20collection%20%C2%B7%20Unity%20Health%20Toronto&badge=phase%201 Urine sample collection Urine sample collection · Unity Health Toronto https://druglandscape.com/drug/urine-specimens https://druglandscape.com/api/og?type=drug&title=urine%20specimens&subtitle=urine%20specimens%20%C2%B7%20Hospices%20Civils%20de%20Lyon&badge=phase%201 urine specimens urine specimens · Hospices Civils de Lyon https://druglandscape.com/drug/uro-902 https://druglandscape.com/api/og?type=drug&title=URO-902&subtitle=URO-902%20%C2%B7%20Urovant%20Sciences%20GmbH&badge=phase%202 URO-902 URO-902 · Urovant Sciences GmbH https://druglandscape.com/drug/urokinase-and-dornase-alfa https://druglandscape.com/api/og?type=drug&title=Urokinase%20and%20Dornase%20alfa&subtitle=Urokinase%20and%20Dornase%20alfa%20%C2%B7%20Azienda%20Ospedaliera%20di%20Padova&badge=phase%202 Urokinase and Dornase alfa Urokinase and Dornase alfa · Azienda Ospedaliera di Padova https://druglandscape.com/drug/urokinase-derived-peptide-a6 https://druglandscape.com/api/og?type=drug&title=Urokinase-Derived%20Peptide%20A6&subtitle=Urokinase-Derived%20Peptide%20A6%20%C2%B7%20Gynecologic%20Oncology%20Group&badge=phase%202 Urokinase-Derived Peptide A6 Urokinase-Derived Peptide A6 · Gynecologic Oncology Group https://druglandscape.com/drug/us-approved-neulasta https://druglandscape.com/api/og?type=drug&title=US-approved%20Neulasta&subtitle=US-approved%20Neulasta%20%C2%B7%20Pfizer&badge=phase%201 US-approved Neulasta US-approved Neulasta · Pfizer https://druglandscape.com/drug/us-approved-neupogen https://druglandscape.com/api/og?type=drug&title=US-approved%20Neupogen%C2%AE&subtitle=US-approved%20Neupogen%C2%AE%20%C2%B7%20Pfizer&badge=phase%201 US-approved Neupogen® US-approved Neupogen® · Pfizer https://druglandscape.com/drug/us-darzalex-faspro-rd https://druglandscape.com/api/og?type=drug&title=US-DARZALEX%20FASPRO%C2%AE-Rd&subtitle=US-DARZALEX%20FASPRO%C2%AE-Rd%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 US-DARZALEX FASPRO®-Rd US-DARZALEX FASPRO®-Rd · Shanghai Henlius Biotech https://druglandscape.com/drug/us-dupixent https://druglandscape.com/api/og?type=drug&title=US-Dupixent&subtitle=US-Dupixent%20%C2%B7%20Chong%20Kun%20Dang%20Pharmaceutical&badge=phase%201 US-Dupixent US-Dupixent · Chong Kun Dang Pharmaceutical https://druglandscape.com/drug/us-gonal-f https://druglandscape.com/api/og?type=drug&title=US%20Gonal-f%C2%AE&subtitle=US%20Gonal-f%C2%AE%20%C2%B7%20Fertility%20Biotech%20AG&badge=phase%201 US Gonal-f® US Gonal-f® · Fertility Biotech AG https://druglandscape.com/drug/us-herceptin https://druglandscape.com/api/og?type=drug&title=US-Herceptin&subtitle=US-Herceptin%20%C2%B7%20Prestige%20Biopharma%20Limited&badge=phase%201 US-Herceptin US-Herceptin · Prestige Biopharma Limited https://druglandscape.com/drug/us-humalog https://druglandscape.com/api/og?type=drug&title=US-Humalog%C2%AE&subtitle=US-Humalog%C2%AE%20%C2%B7%20Xentria%2C%20Inc.&badge=phase%201 US-Humalog® US-Humalog® · Xentria, Inc. https://druglandscape.com/drug/us-humira https://druglandscape.com/api/og?type=drug&title=US-Humira&subtitle=US-Humira%20%C2%B7%20Mylan%20Inc.&badge=phase%201 US-Humira US-Humira · Mylan Inc. https://druglandscape.com/drug/us-lantus https://druglandscape.com/api/og?type=drug&title=US-Lantus%C2%AE&subtitle=US-Lantus%C2%AE%20%C2%B7%20Xentria%2C%20Inc.&badge=phase%201 US-Lantus® US-Lantus® · Xentria, Inc. https://druglandscape.com/drug/us-license-enbrel https://druglandscape.com/api/og?type=drug&title=US%20License%20Enbrel&subtitle=US%20License%20Enbrel%20%C2%B7%20mAbxience%20Research%20S.L.&badge=phase%201 US License Enbrel US License Enbrel · mAbxience Research S.L. https://druglandscape.com/drug/us-licensed-avastin https://druglandscape.com/api/og?type=drug&title=US-licensed%20Avastin&subtitle=US-licensed%20Avastin%20%C2%B7%20Zhejiang%20Teruisi%20Pharmaceutical%20Inc.&badge=phase%201 US-licensed Avastin US-licensed Avastin · Zhejiang Teruisi Pharmaceutical Inc. https://druglandscape.com/drug/us-licensed-cosentyx https://druglandscape.com/api/og?type=drug&title=US-licensed%20Cosentyx&subtitle=US-licensed%20Cosentyx%20%C2%B7%20Celltrion&badge=phase%201 US-licensed Cosentyx US-licensed Cosentyx · Celltrion https://druglandscape.com/drug/us-licensed-herceptin https://druglandscape.com/api/og?type=drug&title=US-licensed%20Herceptin&subtitle=US-licensed%20Herceptin%20%C2%B7%20Alteogen%2C%20Inc.&badge=phase%201 US-licensed Herceptin US-licensed Herceptin · Alteogen, Inc. https://druglandscape.com/drug/us-licensed-stelara https://druglandscape.com/api/og?type=drug&title=US-licensed%20Stelara&subtitle=US-licensed%20Stelara%20%C2%B7%20Celltrion&badge=phase%201 US-licensed Stelara US-licensed Stelara · Celltrion https://druglandscape.com/drug/us-novolog https://druglandscape.com/api/og?type=drug&title=US-NovoLog%C2%AE&subtitle=US-NovoLog%C2%AE%20%C2%B7%20Xentria%2C%20Inc.&badge=phase%201 US-NovoLog® US-NovoLog® · Xentria, Inc. https://druglandscape.com/drug/us-prolia https://druglandscape.com/api/og?type=drug&title=US-Prolia%C2%AE&subtitle=US-Prolia%C2%AE%20%C2%B7%20Xentria%2C%20Inc.&badge=phase%201 US-Prolia® US-Prolia® · Xentria, Inc. https://druglandscape.com/drug/us-remicade https://druglandscape.com/api/og?type=drug&title=US%20Remicade&subtitle=US%20Remicade%20%C2%B7%20Samsung%20Bioepis%20Co.%2C%20Ltd.&badge=phase%201 US Remicade US Remicade · Samsung Bioepis Co., Ltd. https://druglandscape.com/drug/us-sourced-avastin https://druglandscape.com/api/og?type=drug&title=US%20Sourced%20Avastin%C2%AE&subtitle=US%20Sourced%20Avastin%C2%AE%20%C2%B7%20Cipla%20BioTec%20Pvt.%20Ltd.&badge=phase%201 US Sourced Avastin® US Sourced Avastin® · Cipla BioTec Pvt. Ltd. https://druglandscape.com/drug/us-sourced-darzalex https://druglandscape.com/api/og?type=drug&title=US-sourced%20DARZALEX%C2%AE&subtitle=US-sourced%20DARZALEX%C2%AE%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 US-sourced DARZALEX® US-sourced DARZALEX® · Shanghai Henlius Biotech https://druglandscape.com/drug/us-sourced-enbrel https://druglandscape.com/api/og?type=drug&title=US%20sourced%20Enbrel&subtitle=US%20sourced%20Enbrel%20%C2%B7%20Samsung%20Bioepis%20Co.%2C%20Ltd.&badge=phase%201 US sourced Enbrel US sourced Enbrel · Samsung Bioepis Co., Ltd. https://druglandscape.com/drug/us-sourced-herceptin https://druglandscape.com/api/og?type=drug&title=US%20sourced%20Herceptin%C2%AE&subtitle=US%20sourced%20Herceptin%C2%AE%20%C2%B7%20Samsung%20Bioepis%20Co.%2C%20Ltd.&badge=phase%201 US sourced Herceptin® US sourced Herceptin® · Samsung Bioepis Co., Ltd. https://druglandscape.com/drug/us-sourced-ipilimumab-group https://druglandscape.com/api/og?type=drug&title=US-sourced%20ipilimumab%20group&subtitle=US-sourced%20ipilimumab%20group%20%C2%B7%20Shanghai%20Henlius%20Biotech&badge=phase%201 US-sourced ipilimumab group US-sourced ipilimumab group · Shanghai Henlius Biotech https://druglandscape.com/drug/us-sourced-prolia https://druglandscape.com/api/og?type=drug&title=US%20Sourced%20Prolia&subtitle=US%20Sourced%20Prolia%20%C2%B7%20Enzene%20Biosciences%20Ltd.&badge=phase%201 US Sourced Prolia US Sourced Prolia · Enzene Biosciences Ltd. https://druglandscape.com/drug/us-sourced-xgeva https://druglandscape.com/api/og?type=drug&title=US-sourced%20Xgeva&subtitle=US-sourced%20Xgeva%20%C2%B7%20mAbxience%20Research%20S.L.&badge=phase%201 US-sourced Xgeva US-sourced Xgeva · mAbxience Research S.L. https://druglandscape.com/drug/us-stelara https://druglandscape.com/api/og?type=drug&title=US-STELARA%C2%AE&subtitle=US-STELARA%C2%AE%20%C2%B7%20BioFactura%20Australia%20Pty%20Ltd.&badge=phase%201 US-STELARA® US-STELARA® · BioFactura Australia Pty Ltd. https://druglandscape.com/drug/us-synagis https://druglandscape.com/api/og?type=drug&title=US-Synagis%C2%AE&subtitle=US-Synagis%C2%AE%20%C2%B7%20mAbxience%20Research%20S.L.&badge=phase%201 US-Synagis® US-Synagis® · mAbxience Research S.L. https://druglandscape.com/drug/use-of-cannabis-oil https://druglandscape.com/api/og?type=drug&title=Use%20of%20cannabis%20oil&subtitle=Use%20of%20cannabis%20oil%20%C2%B7%20Azienda%20Ospedaliera%20SS.%20Antonio%20e%20Biagio%20e%20Cesare%20Arrigo%20di%20Alessandria&badge=phase%202 Use of cannabis oil Use of cannabis oil · Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria https://druglandscape.com/drug/use-of-fentanyl-patch-that-was-halved https://druglandscape.com/api/og?type=drug&title=use%20of%20fentanyl%20patch%20that%20was%20halved&subtitle=use%20of%20fentanyl%20patch%20that%20was%20halved%20%C2%B7%20Meir%20Medical%20Center&badge=phase%201 use of fentanyl patch that was halved use of fentanyl patch that was halved · Meir Medical Center https://druglandscape.com/drug/use-of-gabaergic-drugs https://druglandscape.com/api/og?type=drug&title=use%20of%20GABAergic-drugs&subtitle=use%20of%20GABAergic-drugs%20%C2%B7%20Ente%20Ospedaliero%20Ospedali%20Galliera&badge=phase%201 use of GABAergic-drugs use of GABAergic-drugs · Ente Ospedaliero Ospedali Galliera https://druglandscape.com/drug/use-of-mitomycin-c-in-trabeculectomy https://druglandscape.com/api/og?type=drug&title=Use%20of%20Mitomycin-C%20in%20trabeculectomy&subtitle=Use%20of%20Mitomycin-C%20in%20trabeculectomy%20%C2%B7%20Aeon%20Astron%20Europe%20B.V.&badge=phase%201 Use of Mitomycin-C in trabeculectomy Use of Mitomycin-C in trabeculectomy · Aeon Astron Europe B.V. https://druglandscape.com/drug/use-of-teicoplanin-three-times-a-week https://druglandscape.com/api/og?type=drug&title=Use%20of%20teicoplanin%20three%20times%20a%20week&subtitle=Use%20of%20teicoplanin%20three%20times%20a%20week%20%C2%B7%20Azienda%20Ospedaliera%20di%20Lecco&badge=phase%202 Use of teicoplanin three times a week Use of teicoplanin three times a week · Azienda Ospedaliera di Lecco https://druglandscape.com/drug/utidelone-combined-with-bevacizumab https://druglandscape.com/api/og?type=drug&title=Utidelone%20combined%20with%20Bevacizumab&subtitle=Utidelone%20combined%20with%20Bevacizumab%20%C2%B7%20Beijing%20Biostar%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%202 Utidelone combined with Bevacizumab Utidelone combined with Bevacizumab · Beijing Biostar Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/utidelone-injection-capecitabine https://druglandscape.com/api/og?type=drug&title=Utidelone%20Injection%3B%20capecitabine&subtitle=Utidelone%20Injection%3B%20capecitabine%20%C2%B7%20Beijing%20Biostar%20Pharmaceuticals%20Co.%2C%20Ltd.&badge=phase%201 Utidelone Injection; capecitabine Utidelone Injection; capecitabine · Beijing Biostar Pharmaceuticals Co., Ltd. https://druglandscape.com/drug/uv-endonuclease-from-micrococcus-luteus https://druglandscape.com/api/og?type=drug&title=UV%20endonuclease%20from%20Micrococcus%20luteus&subtitle=UV%20endonuclease%20from%20Micrococcus%20luteus%20%C2%B7%20Moy-Fincher-Chipps%20Facial%20Plastics%20and%20Dermatology&badge=phase%201 UV endonuclease from Micrococcus luteus UV endonuclease from Micrococcus luteus · Moy-Fincher-Chipps Facial Plastics and Dermatology https://druglandscape.com/drug/uv1-synthetic-peptide-vaccine-and-gm-csf https://druglandscape.com/api/og?type=drug&title=UV1%20synthetic%20peptide%20vaccine%20and%20GM-CSF&subtitle=UV1%20synthetic%20peptide%20vaccine%20and%20GM-CSF%20%C2%B7%20Ultimovacs%20ASA&badge=phase%201 UV1 synthetic peptide vaccine and GM-CSF UV1 synthetic peptide vaccine and GM-CSF · Ultimovacs ASA https://druglandscape.com/drug/uv1-vaccine https://druglandscape.com/api/og?type=drug&title=UV1%20vaccine&subtitle=UV1%20vaccine%20%C2%B7%20Ultimovacs%20ASA&badge=phase%201 UV1 vaccine UV1 vaccine · Ultimovacs ASA https://druglandscape.com/drug/ux-da001 https://druglandscape.com/api/og?type=drug&title=UX-DA001&subtitle=UX-DA001%20%C2%B7%20Shanghai%20UniXell%20Biotechnology%20Co.%2C%20Ltd&badge=phase%201 UX-DA001 UX-DA001 · Shanghai UniXell Biotechnology Co., Ltd https://druglandscape.com/drug/ux111 https://druglandscape.com/api/og?type=drug&title=UX111&subtitle=UX111%20%C2%B7%20Ultragenyx%20Pharmaceutical%20Inc&badge=phase%202 UX111 UX111 · Ultragenyx Pharmaceutical Inc https://druglandscape.com/drug/v-01 https://druglandscape.com/api/og?type=drug&title=V-01&subtitle=V-01%20%C2%B7%20Livzon%20Pharmaceutical%20Group%20Inc.&badge=phase%201 V-01 V-01 · Livzon Pharmaceutical Group Inc. https://druglandscape.com/drug/v-01d-351 https://druglandscape.com/api/og?type=drug&title=V-01D-351&subtitle=V-01D-351%20%C2%B7%20Livzon%20Pharmaceutical%20Group%20Inc.&badge=phase%201 V-01D-351 V-01D-351 · Livzon Pharmaceutical Group Inc. https://druglandscape.com/drug/v-101 https://druglandscape.com/api/og?type=drug&title=V-101&subtitle=V-101%20%C2%B7%20Vicept%20Therapeutics%2C%20Inc.&badge=phase%202 V-101 V-101 · Vicept Therapeutics, Inc. https://druglandscape.com/drug/v-5-immunitor https://druglandscape.com/api/og?type=drug&title=V-5%20immunitor&subtitle=V-5%20immunitor%20%C2%B7%20Lisichansk%20Regional%20Tuberculosis%20Dispensary&badge=phase%202 V-5 immunitor V-5 immunitor · Lisichansk Regional Tuberculosis Dispensary https://druglandscape.com/drug/v-boost https://druglandscape.com/api/og?type=drug&title=V-Boost&subtitle=V-Boost%20%C2%B7%20Immunitor%20LLC&badge=phase%202 V-Boost V-Boost · Immunitor LLC https://druglandscape.com/drug/v-endo https://druglandscape.com/api/og?type=drug&title=V-Endo&subtitle=V-Endo%20%C2%B7%20Immunitor%20LLC&badge=phase%202 V-Endo V-Endo · Immunitor LLC https://druglandscape.com/drug/v-sars https://druglandscape.com/api/og?type=drug&title=V-SARS&subtitle=V-SARS%20%C2%B7%20Immunitor%20LLC&badge=phase%201 V-SARS V-SARS · Immunitor LLC https://druglandscape.com/drug/v0018 https://druglandscape.com/api/og?type=drug&title=V0018&subtitle=V0018%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%202 V0018 V0018 · Pierre Fabre Medicament https://druglandscape.com/drug/v0018-b-mg https://druglandscape.com/api/og?type=drug&title=V0018%20-%20B%20mg&subtitle=V0018%20-%20B%20mg%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%201 V0018 - B mg V0018 - B mg · Pierre Fabre Medicament https://druglandscape.com/drug/v0057-a-mg https://druglandscape.com/api/og?type=drug&title=V0057%20-%20A%20mg&subtitle=V0057%20-%20A%20mg%20%C2%B7%20Pierre%20Fabre%20Dermatology&badge=phase%201 V0057 - A mg V0057 - A mg · Pierre Fabre Dermatology https://druglandscape.com/drug/v0116-transdermal-patch https://druglandscape.com/api/og?type=drug&title=V0116%20transdermal%20patch&subtitle=V0116%20transdermal%20patch%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%202 V0116 transdermal patch V0116 transdermal patch · Pierre Fabre Medicament https://druglandscape.com/drug/v0162 https://druglandscape.com/api/og?type=drug&title=V0162&subtitle=V0162%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%202 V0162 V0162 · Pierre Fabre Medicament https://druglandscape.com/drug/v0251 https://druglandscape.com/api/og?type=drug&title=V0251&subtitle=V0251%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%202 V0251 V0251 · Pierre Fabre Medicament https://druglandscape.com/drug/v0474-a-mg https://druglandscape.com/api/og?type=drug&title=V0474%20-%20A%20mg&subtitle=V0474%20-%20A%20mg%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%201 V0474 - A mg V0474 - A mg · Pierre Fabre Medicament https://druglandscape.com/drug/v0474-b-mg https://druglandscape.com/api/og?type=drug&title=V0474%20-%20B%20mg&subtitle=V0474%20-%20B%20mg%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%201 V0474 - B mg V0474 - B mg · Pierre Fabre Medicament https://druglandscape.com/drug/v0474-c-mg https://druglandscape.com/api/og?type=drug&title=V0474%20-%20C%20mg&subtitle=V0474%20-%20C%20mg%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%201 V0474 - C mg V0474 - C mg · Pierre Fabre Medicament https://druglandscape.com/drug/v0498-a-mg https://druglandscape.com/api/og?type=drug&title=V0498%20-%20A%20mg&subtitle=V0498%20-%20A%20mg%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%201 V0498 - A mg V0498 - A mg · Pierre Fabre Medicament https://druglandscape.com/drug/v10153 https://druglandscape.com/api/og?type=drug&title=V10153&subtitle=V10153%20%C2%B7%20Vernalis%20(R%26D)%20Ltd&badge=phase%202 V10153 V10153 · Vernalis (R&D) Ltd https://druglandscape.com/drug/v114-0-5x-0-5x-2x https://druglandscape.com/api/og?type=drug&title=V114%200.5x%3A0.5x%3A2x&subtitle=V114%200.5x%3A0.5x%3A2x%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V114 0.5x:0.5x:2x V114 0.5x:0.5x:2x · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v114-1x-1x-1x https://druglandscape.com/api/og?type=drug&title=V114%201x%3A1x%3A1x&subtitle=V114%201x%3A1x%3A1x%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V114 1x:1x:1x V114 1x:1x:1x · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v114-1x-1x-2x https://druglandscape.com/api/og?type=drug&title=V114%201x%3A1x%3A2x&subtitle=V114%201x%3A1x%3A2x%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V114 1x:1x:2x V114 1x:1x:2x · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v114-2x-2x-2x https://druglandscape.com/api/og?type=drug&title=V114%202x%3A2x%3A2x&subtitle=V114%202x%3A2x%3A2x%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V114 2x:2x:2x V114 2x:2x:2x · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v114-a https://druglandscape.com/api/og?type=drug&title=V114-A&subtitle=V114-A%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 V114-A V114-A · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v114-aluminum-adjuvanted https://druglandscape.com/api/og?type=drug&title=V114%20Aluminum-adjuvanted&subtitle=V114%20Aluminum-adjuvanted%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 V114 Aluminum-adjuvanted V114 Aluminum-adjuvanted · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v114-b https://druglandscape.com/api/og?type=drug&title=V114-B&subtitle=V114-B%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 V114-B V114-B · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v114-high-dose https://druglandscape.com/api/og?type=drug&title=V114%20High%20Dose&subtitle=V114%20High%20Dose%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V114 High Dose V114 High Dose · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v114-lot-1 https://druglandscape.com/api/og?type=drug&title=V114%20Lot%201&subtitle=V114%20Lot%201%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 V114 Lot 1 V114 Lot 1 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v114-lot-2 https://druglandscape.com/api/og?type=drug&title=V114%20Lot%202&subtitle=V114%20Lot%202%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 V114 Lot 2 V114 Lot 2 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v114-non-adjuvanted https://druglandscape.com/api/og?type=drug&title=V114%20Non-adjuvanted&subtitle=V114%20Non-adjuvanted%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 V114 Non-adjuvanted V114 Non-adjuvanted · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v116517-50-mg-tablets https://druglandscape.com/api/og?type=drug&title=V116517%2050-mg%20tablets&subtitle=V116517%2050-mg%20tablets%20%C2%B7%20Purdue%20Pharma%20LP&badge=phase%202 V116517 50-mg tablets V116517 50-mg tablets · Purdue Pharma LP https://druglandscape.com/drug/v116517-aqueous-suspension https://druglandscape.com/api/og?type=drug&title=V116517%20aqueous%20suspension&subtitle=V116517%20aqueous%20suspension%20%C2%B7%20Purdue%20Pharma%20LP&badge=phase%201 V116517 aqueous suspension V116517 aqueous suspension · Purdue Pharma LP https://druglandscape.com/drug/v118 https://druglandscape.com/api/og?type=drug&title=V118&subtitle=V118%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V118 V118 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v118c https://druglandscape.com/api/og?type=drug&title=V118C&subtitle=V118C%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V118C V118C · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v118e https://druglandscape.com/api/og?type=drug&title=V118E&subtitle=V118E%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V118E V118E · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v120083 https://druglandscape.com/api/og?type=drug&title=V120083&subtitle=V120083%20%C2%B7%20Purdue%20Pharma%20LP&badge=phase%202 V120083 V120083 · Purdue Pharma LP https://druglandscape.com/drug/v1512 https://druglandscape.com/api/og?type=drug&title=V1512&subtitle=V1512%20%C2%B7%20Vernalis%20(R%26D)%20Ltd&badge=phase%201 V1512 V1512 · Vernalis (R&D) Ltd https://druglandscape.com/drug/v1512-and-entacapone https://druglandscape.com/api/og?type=drug&title=V1512%20and%20Entacapone&subtitle=V1512%20and%20Entacapone%20%C2%B7%20Vernalis%20(R%26D)%20Ltd&badge=phase%201 V1512 and Entacapone V1512 and Entacapone · Vernalis (R&D) Ltd https://druglandscape.com/drug/v158866 https://druglandscape.com/api/og?type=drug&title=V158866&subtitle=V158866%20%C2%B7%20Vernalis%20(R%26D)%20Ltd&badge=phase%202 V158866 V158866 · Vernalis (R&D) Ltd https://druglandscape.com/drug/v160 https://druglandscape.com/api/og?type=drug&title=V160&subtitle=V160%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 V160 V160 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v160-low-dose-im https://druglandscape.com/api/og?type=drug&title=V160%20Low%20Dose%20IM&subtitle=V160%20Low%20Dose%20IM%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V160 Low Dose IM V160 Low Dose IM · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v160-medium-dose-id https://druglandscape.com/api/og?type=drug&title=V160%20Medium%20Dose%20ID&subtitle=V160%20Medium%20Dose%20ID%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V160 Medium Dose ID V160 Medium Dose ID · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v160-medium-dose-im https://druglandscape.com/api/og?type=drug&title=V160%20Medium%20Dose%20IM&subtitle=V160%20Medium%20Dose%20IM%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V160 Medium Dose IM V160 Medium Dose IM · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v181-high-potency-level https://druglandscape.com/api/og?type=drug&title=V181%20High-Potency%20Level&subtitle=V181%20High-Potency%20Level%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 V181 High-Potency Level V181 High-Potency Level · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v181-low-potency-level https://druglandscape.com/api/og?type=drug&title=V181%20Low-Potency%20Level&subtitle=V181%20Low-Potency%20Level%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 V181 Low-Potency Level V181 Low-Potency Level · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v181-mid-potency-level https://druglandscape.com/api/og?type=drug&title=V181%20Mid-Potency%20Level&subtitle=V181%20Mid-Potency%20Level%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 V181 Mid-Potency Level V181 Mid-Potency Level · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v184 https://druglandscape.com/api/og?type=drug&title=V184&subtitle=V184%20%C2%B7%20Themis%20Bioscience%20GmbH&badge=phase%202 V184 V184 · Themis Bioscience GmbH https://druglandscape.com/drug/v24343 https://druglandscape.com/api/og?type=drug&title=V24343&subtitle=V24343%20%C2%B7%20Vernalis%20(R%26D)%20Ltd&badge=phase%201 V24343 V24343 · Vernalis (R&D) Ltd https://druglandscape.com/drug/v3-mommo https://druglandscape.com/api/og?type=drug&title=V3-MOMMO&subtitle=V3-MOMMO%20%C2%B7%20Immunitor%20LLC&badge=phase%202 V3-MOMMO V3-MOMMO · Immunitor LLC https://druglandscape.com/drug/v3-p https://druglandscape.com/api/og?type=drug&title=V3-P&subtitle=V3-P%20%C2%B7%20Immunitor%20LLC&badge=phase%201 V3-P V3-P · Immunitor LLC https://druglandscape.com/drug/v330 https://druglandscape.com/api/og?type=drug&title=V330&subtitle=V330%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V330 V330 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v3381 https://druglandscape.com/api/og?type=drug&title=V3381&subtitle=V3381%20%C2%B7%20Vernalis%20(R%26D)%20Ltd&badge=phase%202 V3381 V3381 · Vernalis (R&D) Ltd https://druglandscape.com/drug/v350b https://druglandscape.com/api/og?type=drug&title=V350B&subtitle=V350B%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V350B V350B · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v4020 https://druglandscape.com/api/og?type=drug&title=V4020&subtitle=V4020%20%C2%B7%20Medigen%2C%20Inc.&badge=phase%201 V4020 V4020 · Medigen, Inc. https://druglandscape.com/drug/v526 https://druglandscape.com/api/og?type=drug&title=V526&subtitle=V526%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V526 V526 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v540a-2 https://druglandscape.com/api/og?type=drug&title=V540A-2&subtitle=V540A-2%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 V540A-2 V540A-2 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v540a-3 https://druglandscape.com/api/og?type=drug&title=V540A-3&subtitle=V540A-3%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 V540A-3 V540A-3 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v540b https://druglandscape.com/api/og?type=drug&title=V540B&subtitle=V540B%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V540B V540B · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v540d https://druglandscape.com/api/og?type=drug&title=V540D&subtitle=V540D%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V540D V540D · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v565 https://druglandscape.com/api/og?type=drug&title=V565&subtitle=V565%20%C2%B7%20VHsquared%20Ltd.&badge=phase%202 V565 V565 · VHsquared Ltd. https://druglandscape.com/drug/v81444 https://druglandscape.com/api/og?type=drug&title=V81444&subtitle=V81444%20%C2%B7%20Vernalis%20(R%26D)%20Ltd&badge=phase%201 V81444 V81444 · Vernalis (R&D) Ltd https://druglandscape.com/drug/v920 https://druglandscape.com/api/og?type=drug&title=V920&subtitle=V920%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V920 V920 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v920-vaccine https://druglandscape.com/api/og?type=drug&title=V920%20Vaccine&subtitle=V920%20Vaccine%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V920 Vaccine V920 Vaccine · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v930 https://druglandscape.com/api/og?type=drug&title=V930&subtitle=V930%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V930 V930 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v932 https://druglandscape.com/api/og?type=drug&title=V932&subtitle=V932%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V932 V932 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v940 https://druglandscape.com/api/og?type=drug&title=V940&subtitle=V940%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 V940 V940 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/v950 https://druglandscape.com/api/og?type=drug&title=V950&subtitle=V950%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 V950 V950 · Merck Sharp & Dohme LLC https://druglandscape.com/drug/va2914 https://druglandscape.com/api/og?type=drug&title=VA2914&subtitle=VA2914%20%C2%B7%20HRA%20Pharma&badge=phase%202 VA2914 VA2914 · HRA Pharma https://druglandscape.com/drug/vac-3s https://druglandscape.com/api/og?type=drug&title=VAC-3S&subtitle=VAC-3S%20%C2%B7%20InnaVirVax&badge=phase%202 VAC-3S VAC-3S · InnaVirVax https://druglandscape.com/drug/vac85135 https://druglandscape.com/api/og?type=drug&title=VAC85135&subtitle=VAC85135%20%C2%B7%20Janssen%20Research%20%26%20Development%2C%20LLC&badge=phase%201 VAC85135 VAC85135 · Janssen Research & Development, LLC https://druglandscape.com/drug/vacc-4x https://druglandscape.com/api/og?type=drug&title=Vacc-4x&subtitle=Vacc-4x%20%C2%B7%20Bionor%20Immuno%20AS&badge=phase%202 Vacc-4x Vacc-4x · Bionor Immuno AS https://druglandscape.com/drug/vaccination-against-tbe https://druglandscape.com/api/og?type=drug&title=Vaccination%20against%20TBE&subtitle=Vaccination%20against%20TBE%20%C2%B7%20Sormland%20County%20Council%2C%20Sweden&badge=phase%202 Vaccination against TBE Vaccination against TBE · Sormland County Council, Sweden https://druglandscape.com/drug/vaccination-ppv23 https://druglandscape.com/api/og?type=drug&title=vaccination%20PPV23&subtitle=vaccination%20PPV23%20%C2%B7%20Walvax%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%203 vaccination PPV23 vaccination PPV23 · Walvax Biotechnology Co., Ltd. https://druglandscape.com/drug/vaccination-with-fab-6011 https://druglandscape.com/api/og?type=drug&title=Vaccination%20with%20FAB-6011&subtitle=Vaccination%20with%20FAB-6011%20%C2%B7%20Fluart%20Innovative%20Vaccine%20Ltd%2C%20Hungary&badge=phase%201 Vaccination with FAB-6011 Vaccination with FAB-6011 · Fluart Innovative Vaccine Ltd, Hungary https://druglandscape.com/drug/vaccination-with-fab-9011 https://druglandscape.com/api/og?type=drug&title=Vaccination%20with%20FAB-9011&subtitle=Vaccination%20with%20FAB-9011%20%C2%B7%20Fluart%20Innovative%20Vaccine%20Ltd%2C%20Hungary&badge=phase%201 Vaccination with FAB-9011 Vaccination with FAB-9011 · Fluart Innovative Vaccine Ltd, Hungary https://druglandscape.com/drug/vaccination-with-fluval-ab https://druglandscape.com/api/og?type=drug&title=Vaccination%20with%20Fluval%20AB&subtitle=Vaccination%20with%20Fluval%20AB%20%C2%B7%20Fluart%20Innovative%20Vaccine%20Ltd%2C%20Hungary&badge=phase%201 Vaccination with Fluval AB Vaccination with Fluval AB · Fluart Innovative Vaccine Ltd, Hungary https://druglandscape.com/drug/vaccination-with-fluval-p https://druglandscape.com/api/og?type=drug&title=Vaccination%20with%20FLUVAL%20P&subtitle=Vaccination%20with%20FLUVAL%20P%20%C2%B7%20Fluart%20Innovative%20Vaccine%20Ltd%2C%20Hungary&badge=phase%201 Vaccination with FLUVAL P Vaccination with FLUVAL P · Fluart Innovative Vaccine Ltd, Hungary https://druglandscape.com/drug/vaccination-with-inactivated-polio-vaccine https://druglandscape.com/api/og?type=drug&title=Vaccination%20with%20inactivated%20polio%20vaccine&subtitle=Vaccination%20with%20inactivated%20polio%20vaccine%20%C2%B7%20Centers%20for%20Disease%20Control%20and%20Prevention&badge=phase%201 Vaccination with inactivated polio vaccine Vaccination with inactivated polio vaccine · Centers for Disease Control and Prevention https://druglandscape.com/drug/vaccine-anapn1 https://druglandscape.com/api/og?type=drug&title=Vaccine%20AnAPN1&subtitle=Vaccine%20AnAPN1%20%C2%B7%20Centre%20de%20Recherche%20M%C3%A9dicale%20de%20Lambar%C3%A9n%C3%A9&badge=phase%201 Vaccine AnAPN1 Vaccine AnAPN1 · Centre de Recherche Médicale de Lambaréné https://druglandscape.com/drug/vaccine-enhancement-patch https://druglandscape.com/api/og?type=drug&title=Vaccine%20Enhancement%20Patch&subtitle=Vaccine%20Enhancement%20Patch%20%C2%B7%20Intercell%20USA%2C%20Inc.&badge=phase%201 Vaccine Enhancement Patch Vaccine Enhancement Patch · Intercell USA, Inc. https://druglandscape.com/drug/vaccine-fp-01-1 https://druglandscape.com/api/og?type=drug&title=Vaccine%20FP-01.1&subtitle=Vaccine%20FP-01.1%20%C2%B7%20Immune%20Targeting%20Systems%20Ltd&badge=phase%201 Vaccine FP-01.1 Vaccine FP-01.1 · Immune Targeting Systems Ltd https://druglandscape.com/drug/vaccine-prophylaxis https://druglandscape.com/api/og?type=drug&title=vaccine%20prophylaxis&subtitle=vaccine%20prophylaxis%20%C2%B7%20Fondazione%20IRCCS%20Policlinico%20San%20Matteo%20di%20Pavia&badge=phase%202 vaccine prophylaxis vaccine prophylaxis · Fondazione IRCCS Policlinico San Matteo di Pavia https://druglandscape.com/drug/vad044-part-i https://druglandscape.com/api/og?type=drug&title=VAD044%20Part%20I&subtitle=VAD044%20Part%20I%20%C2%B7%20Vaderis%20Therapeutics%20AG&badge=phase%201 VAD044 Part I VAD044 Part I · Vaderis Therapeutics AG https://druglandscape.com/drug/vad044-part-ii https://druglandscape.com/api/og?type=drug&title=VAD044%20Part%20II&subtitle=VAD044%20Part%20II%20%C2%B7%20Vaderis%20Therapeutics%20AG&badge=phase%201 VAD044 Part II VAD044 Part II · Vaderis Therapeutics AG https://druglandscape.com/drug/vaginal-progesterone-suppositories https://druglandscape.com/api/og?type=drug&title=vaginal%20progesterone%20suppositories&subtitle=vaginal%20progesterone%20suppositories%20%C2%B7%20Toronto%20Centre%20for%20Advanced%20Reproductive%20Technology&badge=phase%201 vaginal progesterone suppositories vaginal progesterone suppositories · Toronto Centre for Advanced Reproductive Technology https://druglandscape.com/drug/vaginal-swab https://druglandscape.com/api/og?type=drug&title=Vaginal%20swab&subtitle=Vaginal%20swab%20%C2%B7%20ANRS%2C%20Emerging%20Infectious%20Diseases&badge=phase%202 Vaginal swab Vaginal swab · ANRS, Emerging Infectious Diseases https://druglandscape.com/drug/vaginal-tablet-endometrin-twice-a-day https://druglandscape.com/api/og?type=drug&title=Vaginal%20tablet%20Endometrin%20twice%20a%20day&subtitle=Vaginal%20tablet%20Endometrin%20twice%20a%20day%20%C2%B7%20Wolfson%20Medical%20Center&badge=phase%201 Vaginal tablet Endometrin twice a day Vaginal tablet Endometrin twice a day · Wolfson Medical Center https://druglandscape.com/drug/val-083 https://druglandscape.com/api/og?type=drug&title=VAL-083&subtitle=VAL-083%20%C2%B7%20Kintara%20Therapeutics%2C%20Inc.&badge=phase%202 VAL-083 VAL-083 · Kintara Therapeutics, Inc. https://druglandscape.com/drug/val-1221 https://druglandscape.com/api/og?type=drug&title=VAL-1221&subtitle=VAL-1221%20%C2%B7%20Parasail%2C%20LLC&badge=phase%202 VAL-1221 VAL-1221 · Parasail, LLC https://druglandscape.com/drug/val-181388 https://druglandscape.com/api/og?type=drug&title=VAL-181388&subtitle=VAL-181388%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 VAL-181388 VAL-181388 · ModernaTX, Inc. https://druglandscape.com/drug/val-339851 https://druglandscape.com/api/og?type=drug&title=VAL-339851&subtitle=VAL-339851%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 VAL-339851 VAL-339851 · ModernaTX, Inc. https://druglandscape.com/drug/val-413 https://druglandscape.com/api/og?type=drug&title=VAL-413&subtitle=VAL-413%20%C2%B7%20Valent%20Technologies%2C%20LLC&badge=phase%201 VAL-413 VAL-413 · Valent Technologies, LLC https://druglandscape.com/drug/val-506440 https://druglandscape.com/api/og?type=drug&title=VAL-506440&subtitle=VAL-506440%20%C2%B7%20ModernaTX%2C%20Inc.&badge=phase%201 VAL-506440 VAL-506440 · ModernaTX, Inc. https://druglandscape.com/drug/val-cel-and-met-xr-high https://druglandscape.com/api/og?type=drug&title=Val%2C%20Cel%20and%20Met%20XR%20High&subtitle=Val%2C%20Cel%20and%20Met%20XR%20High%20%C2%B7%20ARKAY%20Therapeutics&badge=phase%201 Val, Cel and Met XR High Val, Cel and Met XR High · ARKAY Therapeutics https://druglandscape.com/drug/val-cel-and-met-xr-low https://druglandscape.com/api/og?type=drug&title=Val%2C%20Cel%20and%20Met%20XR%20Low&subtitle=Val%2C%20Cel%20and%20Met%20XR%20Low%20%C2%B7%20ARKAY%20Therapeutics&badge=phase%201 Val, Cel and Met XR Low Val, Cel and Met XR Low · ARKAY Therapeutics https://druglandscape.com/drug/val-mcyd https://druglandscape.com/api/og?type=drug&title=val-mCyd&subtitle=val-mCyd%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%201 val-mCyd val-mCyd · Merck Sharp & Dohme LLC https://druglandscape.com/drug/val201 https://druglandscape.com/api/og?type=drug&title=VAL201&subtitle=VAL201%20%C2%B7%20ValiRx%20Plc&badge=phase%201 VAL201 VAL201 · ValiRx Plc https://druglandscape.com/drug/val401 https://druglandscape.com/api/og?type=drug&title=VAL401&subtitle=VAL401%20%C2%B7%20ValiSeek%20Limited&badge=phase%202 VAL401 VAL401 · ValiSeek Limited https://druglandscape.com/drug/valaciclovir-hydrochloride https://druglandscape.com/api/og?type=drug&title=Valaciclovir%20Hydrochloride.&subtitle=Valaciclovir%20Hydrochloride.%20%C2%B7%20GlaxoSmithKline&badge=phase%202 Valaciclovir Hydrochloride. Valaciclovir Hydrochloride. · GlaxoSmithKline https://druglandscape.com/drug/valacyclovir-celecoxib-dose-1 https://druglandscape.com/api/og?type=drug&title=Valacyclovir%20celecoxib%20dose%201&subtitle=Valacyclovir%20celecoxib%20dose%201%20%C2%B7%20Bateman%20Horne%20Center&badge=phase%202 Valacyclovir celecoxib dose 1 Valacyclovir celecoxib dose 1 · Bateman Horne Center https://druglandscape.com/drug/valchlor-0-016-topical-gel https://druglandscape.com/api/og?type=drug&title=Valchlor%200.016%20%25%20Topical%20Gel&subtitle=Valchlor%200.016%20%25%20Topical%20Gel%20%C2%B7%20Rochester%20Skin%20Lymphoma%20Medical%20Group%2C%20PLLC&badge=phase%202 Valchlor 0.016 % Topical Gel Valchlor 0.016 % Topical Gel · Rochester Skin Lymphoma Medical Group, PLLC https://druglandscape.com/drug/valganciclovir-tablets https://druglandscape.com/api/og?type=drug&title=Valganciclovir%20Tablets&subtitle=Valganciclovir%20Tablets%20%C2%B7%20Cecilia%20Soderberg-Naucler&badge=phase%202 Valganciclovir Tablets Valganciclovir Tablets · Cecilia Soderberg-Naucler https://druglandscape.com/drug/valortim-and-selected-components https://druglandscape.com/api/og?type=drug&title=Valortim%20and%20selected%20Components&subtitle=Valortim%20and%20selected%20Components%20%C2%B7%20PharmAthene%2C%20Inc.&badge=phase%201 Valortim and selected Components Valortim and selected Components · PharmAthene, Inc. https://druglandscape.com/drug/vamifeport-irf https://druglandscape.com/api/og?type=drug&title=Vamifeport%20IRF&subtitle=Vamifeport%20IRF%20%C2%B7%20CSL%20Behring&badge=phase%201 Vamifeport IRF Vamifeport IRF · CSL Behring https://druglandscape.com/drug/vancomycin-pre-treat https://druglandscape.com/api/og?type=drug&title=Vancomycin%20Pre-Treat&subtitle=Vancomycin%20Pre-Treat%20%C2%B7%20Seres%20Therapeutics%2C%20Inc.&badge=phase%201 Vancomycin Pre-Treat Vancomycin Pre-Treat · Seres Therapeutics, Inc. https://druglandscape.com/drug/vancomycin-resistant-enterococci-and-esbl https://druglandscape.com/api/og?type=drug&title=vancomycin-resistant%20enterococci%20and%20ESBL&subtitle=vancomycin-resistant%20enterococci%20and%20ESBL%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%202 vancomycin-resistant enterococci and ESBL vancomycin-resistant enterococci and ESBL · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/vancomycin-teicoplanin-or-daptomycin https://druglandscape.com/api/og?type=drug&title=vancomycin%2C%20teicoplanin%20or%20daptomycin&subtitle=vancomycin%2C%20teicoplanin%20or%20daptomycin%20%C2%B7%20Aziende%20Chimiche%20Riunite%20Angelini%20Francesco%20S.p.A&badge=phase%202 vancomycin, teicoplanin or daptomycin vancomycin, teicoplanin or daptomycin · Aziende Chimiche Riunite Angelini Francesco S.p.A https://druglandscape.com/drug/vancomycin-traditional-dosing https://druglandscape.com/api/og?type=drug&title=Vancomycin-traditional%20dosing&subtitle=Vancomycin-traditional%20dosing%20%C2%B7%20Hamad%20Medical%20Corporation&badge=phase%201 Vancomycin-traditional dosing Vancomycin-traditional dosing · Hamad Medical Corporation https://druglandscape.com/drug/vancomycin-trough-only-based-dosing https://druglandscape.com/api/og?type=drug&title=Vancomycin-%20Trough-only%20based%20dosing&subtitle=Vancomycin-%20Trough-only%20based%20dosing%20%C2%B7%20Hamad%20Medical%20Corporation&badge=phase%201 Vancomycin- Trough-only based dosing Vancomycin- Trough-only based dosing · Hamad Medical Corporation https://druglandscape.com/drug/vancomycin-with-aztreonam https://druglandscape.com/api/og?type=drug&title=vancomycin%20with%20aztreonam&subtitle=vancomycin%20with%20aztreonam%20%C2%B7%20Wyeth%20is%20now%20a%20wholly%20owned%20subsidiary%20of%20Pfizer&badge=phase%203 vancomycin with aztreonam vancomycin with aztreonam · Wyeth is now a wholly owned subsidiary of Pfizer https://druglandscape.com/drug/vandetanib-induction https://druglandscape.com/api/og?type=drug&title=vandetanib%20induction&subtitle=vandetanib%20induction%20%C2%B7%20PrECOG%2C%20LLC.&badge=phase%202 vandetanib induction vandetanib induction · PrECOG, LLC. https://druglandscape.com/drug/vandetanib-maintenance https://druglandscape.com/api/og?type=drug&title=Vandetanib%20maintenance&subtitle=Vandetanib%20maintenance%20%C2%B7%20PrECOG%2C%20LLC.&badge=phase%202 Vandetanib maintenance Vandetanib maintenance · PrECOG, LLC. https://druglandscape.com/drug/vandetanib-selumetinib https://druglandscape.com/api/og?type=drug&title=Vandetanib%2C%20Selumetinib&subtitle=Vandetanib%2C%20Selumetinib%20%C2%B7%20Cancer%20Research%20UK&badge=phase%201 Vandetanib, Selumetinib Vandetanib, Selumetinib · Cancer Research UK https://druglandscape.com/drug/vardenafil-oral-tablet https://druglandscape.com/api/og?type=drug&title=Vardenafil%20Oral%20Tablet&subtitle=Vardenafil%20Oral%20Tablet%20%C2%B7%20Respira%20Therapeutics%2C%20Inc.&badge=phase%201 Vardenafil Oral Tablet Vardenafil Oral Tablet · Respira Therapeutics, Inc. https://druglandscape.com/drug/varenicline-free-base-solution https://druglandscape.com/api/og?type=drug&title=Varenicline%20free%20base%20solution&subtitle=Varenicline%20free%20base%20solution%20%C2%B7%20Pfizer&badge=phase%201 Varenicline free base solution Varenicline free base solution · Pfizer https://druglandscape.com/drug/varenicline-tartrate-controlled-release https://druglandscape.com/api/og?type=drug&title=Varenicline%20Tartrate%20Controlled%20Release&subtitle=Varenicline%20Tartrate%20Controlled%20Release%20%C2%B7%20Pfizer&badge=phase%201 Varenicline Tartrate Controlled Release Varenicline Tartrate Controlled Release · Pfizer https://druglandscape.com/drug/varespladib-intravenous-form https://druglandscape.com/api/og?type=drug&title=Varespladib%20intravenous%20form&subtitle=Varespladib%20intravenous%20form%20%C2%B7%20Ophirex%2C%20Inc.&badge=phase%202 Varespladib intravenous form Varespladib intravenous form · Ophirex, Inc. https://druglandscape.com/drug/varespladib-methyl-oral-form https://druglandscape.com/api/og?type=drug&title=varespladib-methyl-%20oral%20form&subtitle=varespladib-methyl-%20oral%20form%20%C2%B7%20Ophirex%2C%20Inc.&badge=phase%202 varespladib-methyl- oral form varespladib-methyl- oral form · Ophirex, Inc. https://druglandscape.com/drug/vari-fast https://druglandscape.com/api/og?type=drug&title=Vari-Fast&subtitle=Vari-Fast%20%C2%B7%20Pfizer&badge=phase%201 Vari-Fast Vari-Fast · Pfizer https://druglandscape.com/drug/variability-based-lenvatinib-regimen https://druglandscape.com/api/og?type=drug&title=variability-based%20lenvatinib%20regimen&subtitle=variability-based%20lenvatinib%20regimen%20%C2%B7%20Hadassah%20Medical%20Organization&badge=phase%201 variability-based lenvatinib regimen variability-based lenvatinib regimen · Hadassah Medical Organization https://druglandscape.com/drug/variable-treatment-duration https://druglandscape.com/api/og?type=drug&title=Variable%20treatment%20duration&subtitle=Variable%20treatment%20duration%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Variable treatment duration Variable treatment duration · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/vasopressin-v2-receptor-antagonist https://druglandscape.com/api/og?type=drug&title=Vasopressin%20V2%20Receptor%20Antagonist&subtitle=Vasopressin%20V2%20Receptor%20Antagonist%20%C2%B7%20Sanofi&badge=phase%202 Vasopressin V2 Receptor Antagonist Vasopressin V2 Receptor Antagonist · Sanofi https://druglandscape.com/drug/vax102 https://druglandscape.com/api/og?type=drug&title=VAX102&subtitle=VAX102%20%C2%B7%20VaxInnate%20Corporation&badge=phase%201 VAX102 VAX102 · VaxInnate Corporation https://druglandscape.com/drug/vax102-flagellin-hum2e https://druglandscape.com/api/og?type=drug&title=VAX102%20%5BFlagellin.HuM2e%5D&subtitle=VAX102%20%5BFlagellin.HuM2e%5D%20%C2%B7%20VaxInnate%20Corporation&badge=phase%201 VAX102 [Flagellin.HuM2e] VAX102 [Flagellin.HuM2e] · VaxInnate Corporation https://druglandscape.com/drug/vax125 https://druglandscape.com/api/og?type=drug&title=VAX125&subtitle=VAX125%20%C2%B7%20VaxInnate%20Corporation&badge=phase%202 VAX125 VAX125 · VaxInnate Corporation https://druglandscape.com/drug/vax128 https://druglandscape.com/api/og?type=drug&title=VAX128&subtitle=VAX128%20%C2%B7%20VaxInnate%20Corporation&badge=phase%201 VAX128 VAX128 · VaxInnate Corporation https://druglandscape.com/drug/vax161-stf2-ha5-h5n1 https://druglandscape.com/api/og?type=drug&title=VAX161%20%5BSTF2.HA5%20H5N1%5D&subtitle=VAX161%20%5BSTF2.HA5%20H5N1%5D%20%C2%B7%20VaxInnate%20Corporation&badge=phase%201 VAX161 [STF2.HA5 H5N1] VAX161 [STF2.HA5 H5N1] · VaxInnate Corporation https://druglandscape.com/drug/vax161c-vaccine https://druglandscape.com/api/og?type=drug&title=VAX161C%20vaccine&subtitle=VAX161C%20vaccine%20%C2%B7%20VaxInnate%20Corporation&badge=phase%201 VAX161C vaccine VAX161C vaccine · VaxInnate Corporation https://druglandscape.com/drug/vax2012q https://druglandscape.com/api/og?type=drug&title=VAX2012Q&subtitle=VAX2012Q%20%C2%B7%20VaxInnate%20Corporation&badge=phase%202 VAX2012Q VAX2012Q · VaxInnate Corporation https://druglandscape.com/drug/vb-111 https://druglandscape.com/api/og?type=drug&title=VB-111&subtitle=VB-111%20%C2%B7%20Vascular%20Biogenics%20Ltd.%20operating%20as%20VBL%20Therapeutics&badge=phase%202 VB-111 VB-111 · Vascular Biogenics Ltd. operating as VBL Therapeutics https://druglandscape.com/drug/vb-1953-2 https://druglandscape.com/api/og?type=drug&title=VB-1953%20-%202%25&subtitle=VB-1953%20-%202%25%20%C2%B7%20Vyome%20Therapeutics%20Inc.&badge=phase%202 VB-1953 - 2% VB-1953 - 2% · Vyome Therapeutics Inc. https://druglandscape.com/drug/vb10-16 https://druglandscape.com/api/og?type=drug&title=VB10.16&subtitle=VB10.16%20%C2%B7%20Nykode%20Therapeutics%20ASA&badge=phase%202 VB10.16 VB10.16 · Nykode Therapeutics ASA https://druglandscape.com/drug/vb10-2129 https://druglandscape.com/api/og?type=drug&title=VB10.2129&subtitle=VB10.2129%20%C2%B7%20Nykode%20Therapeutics%20ASA&badge=phase%201 VB10.2129 VB10.2129 · Nykode Therapeutics ASA https://druglandscape.com/drug/vb10-2210 https://druglandscape.com/api/og?type=drug&title=VB10.2210&subtitle=VB10.2210%20%C2%B7%20Nykode%20Therapeutics%20ASA&badge=phase%201 VB10.2210 VB10.2210 · Nykode Therapeutics ASA https://druglandscape.com/drug/vb10-neo https://druglandscape.com/api/og?type=drug&title=VB10.NEO&subtitle=VB10.NEO%20%C2%B7%20Nykode%20Therapeutics%20ASA&badge=phase%201 VB10.NEO VB10.NEO · Nykode Therapeutics ASA https://druglandscape.com/drug/vb15010 https://druglandscape.com/api/og?type=drug&title=VB15010&subtitle=VB15010%20%C2%B7%20Zhejiang%20Yangli%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 VB15010 VB15010 · Zhejiang Yangli Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/vb19055 https://druglandscape.com/api/og?type=drug&title=VB19055&subtitle=VB19055%20%C2%B7%20Zhejiang%20Yangli%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 VB19055 VB19055 · Zhejiang Yangli Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/vbc101 https://druglandscape.com/api/og?type=drug&title=VBC101&subtitle=VBC101%20%C2%B7%20VelaVigo%20Bio%20Inc&badge=phase%201 VBC101 VBC101 · VelaVigo Bio Inc https://druglandscape.com/drug/vbc103 https://druglandscape.com/api/og?type=drug&title=VBC103&subtitle=VBC103%20%C2%B7%20VelaVigo%20Bio%20Inc&badge=phase%201 VBC103 VBC103 · VelaVigo Bio Inc https://druglandscape.com/drug/vbi-1901 https://druglandscape.com/api/og?type=drug&title=VBI-1901&subtitle=VBI-1901%20%C2%B7%20VBI%20Vaccines%20Inc.&badge=phase%201 VBI-1901 VBI-1901 · VBI Vaccines Inc. https://druglandscape.com/drug/vbi-2901a https://druglandscape.com/api/og?type=drug&title=VBI-2901a&subtitle=VBI-2901a%20%C2%B7%20VBI%20Vaccines%20Inc.&badge=phase%201 VBI-2901a VBI-2901a · VBI Vaccines Inc. https://druglandscape.com/drug/vbi-2902a https://druglandscape.com/api/og?type=drug&title=VBI-2902a&subtitle=VBI-2902a%20%C2%B7%20VBI%20Vaccines%20Inc.&badge=phase%201 VBI-2902a VBI-2902a · VBI Vaccines Inc. https://druglandscape.com/drug/vbi-2905a https://druglandscape.com/api/og?type=drug&title=VBI-2905a&subtitle=VBI-2905a%20%C2%B7%20VBI%20Vaccines%20Inc.&badge=phase%201 VBI-2905a VBI-2905a · VBI Vaccines Inc. https://druglandscape.com/drug/vbp-245 https://druglandscape.com/api/og?type=drug&title=VBP-245&subtitle=VBP-245%20%C2%B7%20Veloce%20BioPharma%20LLC&badge=phase%202 VBP-245 VBP-245 · Veloce BioPharma LLC https://druglandscape.com/drug/vbp-245-topical-gel https://druglandscape.com/api/og?type=drug&title=VBP-245%20Topical%20Gel&subtitle=VBP-245%20Topical%20Gel%20%C2%B7%20Veloce%20BioPharma%20LLC&badge=phase%202 VBP-245 Topical Gel VBP-245 Topical Gel · Veloce BioPharma LLC https://druglandscape.com/drug/vbp-926 https://druglandscape.com/api/og?type=drug&title=VBP-926&subtitle=VBP-926%20%C2%B7%20Veloce%20BioPharma%20LLC&badge=phase%202 VBP-926 VBP-926 · Veloce BioPharma LLC https://druglandscape.com/drug/vbp15 https://druglandscape.com/api/og?type=drug&title=VBP15&subtitle=VBP15%20%C2%B7%20ReveraGen%20BioPharma%2C%20Inc.&badge=phase%201 VBP15 VBP15 · ReveraGen BioPharma, Inc. https://druglandscape.com/drug/vby-036 https://druglandscape.com/api/og?type=drug&title=VBY-036&subtitle=VBY-036%20%C2%B7%20Virobay%20Inc.&badge=phase%201 VBY-036 VBY-036 · Virobay Inc. https://druglandscape.com/drug/vby-376 https://druglandscape.com/api/og?type=drug&title=VBY%20376&subtitle=VBY%20376%20%C2%B7%20Virobay%20Inc.&badge=phase%201 VBY 376 VBY 376 · Virobay Inc. https://druglandscape.com/drug/vby-891 https://druglandscape.com/api/og?type=drug&title=VBY-891&subtitle=VBY-891%20%C2%B7%20Virobay%20Inc.&badge=phase%201 VBY-891 VBY-891 · Virobay Inc. https://druglandscape.com/drug/vc004 https://druglandscape.com/api/og?type=drug&title=VC004&subtitle=VC004%20%C2%B7%20Jiangsu%20vcare%20pharmaceutical%20technology%20co.%2C%20LTD&badge=phase%201 VC004 VC004 · Jiangsu vcare pharmaceutical technology co., LTD https://druglandscape.com/drug/vc004-and-itraconazole https://druglandscape.com/api/og?type=drug&title=VC004%20and%20Itraconazole&subtitle=VC004%20and%20Itraconazole%20%C2%B7%20Jiangsu%20vcare%20pharmaceutical%20technology%20co.%2C%20LTD&badge=phase%201 VC004 and Itraconazole VC004 and Itraconazole · Jiangsu vcare pharmaceutical technology co., LTD https://druglandscape.com/drug/vc004-and-rifampicin https://druglandscape.com/api/og?type=drug&title=VC004%20and%20rifampicin&subtitle=VC004%20and%20rifampicin%20%C2%B7%20Jiangsu%20vcare%20pharmaceutical%20technology%20co.%2C%20LTD&badge=phase%201 VC004 and rifampicin VC004 and rifampicin · Jiangsu vcare pharmaceutical technology co., LTD https://druglandscape.com/drug/vc005-groups https://druglandscape.com/api/og?type=drug&title=VC005%20groups&subtitle=VC005%20groups%20%C2%B7%20Jiangsu%20vcare%20pharmaceutical%20technology%20co.%2C%20LTD&badge=phase%202 VC005 groups VC005 groups · Jiangsu vcare pharmaceutical technology co., LTD https://druglandscape.com/drug/vc005-tablets-food-effects-group https://druglandscape.com/api/og?type=drug&title=VC005%20Tablets%20food%20effects%20group&subtitle=VC005%20Tablets%20food%20effects%20group%20%C2%B7%20Jiangsu%20vcare%20pharmaceutical%20technology%20co.%2C%20LTD&badge=phase%201 VC005 Tablets food effects group VC005 Tablets food effects group · Jiangsu vcare pharmaceutical technology co., LTD https://druglandscape.com/drug/vch-222 https://druglandscape.com/api/og?type=drug&title=VCH-222&subtitle=VCH-222%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 VCH-222 VCH-222 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vch-916 https://druglandscape.com/api/og?type=drug&title=VCH%20916&subtitle=VCH%20916%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 VCH 916 VCH 916 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vcl-cb01 https://druglandscape.com/api/og?type=drug&title=VCL-CB01&subtitle=VCL-CB01%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%202 VCL-CB01 VCL-CB01 · Astellas Pharma Inc https://druglandscape.com/drug/vcl-hb01 https://druglandscape.com/api/og?type=drug&title=VCL-HB01&subtitle=VCL-HB01%20%C2%B7%20Vical&badge=phase%202 VCL-HB01 VCL-HB01 · Vical https://druglandscape.com/drug/vcl-hm01 https://druglandscape.com/api/og?type=drug&title=VCL-HM01&subtitle=VCL-HM01%20%C2%B7%20Vical&badge=phase%201 VCL-HM01 VCL-HM01 · Vical https://druglandscape.com/drug/vcl-ipm1 https://druglandscape.com/api/og?type=drug&title=VCL-IPM1&subtitle=VCL-IPM1%20%C2%B7%20Vical&badge=phase%201 VCL-IPM1 VCL-IPM1 · Vical https://druglandscape.com/drug/vcl-ipt1 https://druglandscape.com/api/og?type=drug&title=VCL-IPT1&subtitle=VCL-IPT1%20%C2%B7%20Vical&badge=phase%201 VCL-IPT1 VCL-IPT1 · Vical https://druglandscape.com/drug/vdmn-21-patch-high-dose https://druglandscape.com/api/og?type=drug&title=VDMN-21%20Patch%20High%20Dose&subtitle=VDMN-21%20Patch%20High%20Dose%20%C2%B7%20Veradermics%2C%20Inc.&badge=phase%202 VDMN-21 Patch High Dose VDMN-21 Patch High Dose · Veradermics, Inc. https://druglandscape.com/drug/vdo-gel https://druglandscape.com/api/og?type=drug&title=VDO%20gel&subtitle=VDO%20gel%20%C2%B7%20Yung%20Shin%20Pharm.%20Ind.%20Co.%2C%20Ltd.&badge=phase%202 VDO gel VDO gel · Yung Shin Pharm. Ind. Co., Ltd. https://druglandscape.com/drug/vedolizumab-ustekinumab-or-tofacitinib https://druglandscape.com/api/og?type=drug&title=Vedolizumab%2C%20Ustekinumab%2C%20or%20Tofacitinib&subtitle=Vedolizumab%2C%20Ustekinumab%2C%20or%20Tofacitinib%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 Vedolizumab, Ustekinumab, or Tofacitinib Vedolizumab, Ustekinumab, or Tofacitinib · Asan Medical Center https://druglandscape.com/drug/vee-tc-83 https://druglandscape.com/api/og?type=drug&title=VEE%20TC-83&subtitle=VEE%20TC-83%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%202 VEE TC-83 VEE TC-83 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/vee-vaccine https://druglandscape.com/api/og?type=drug&title=VEE%20Vaccine&subtitle=VEE%20Vaccine%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%202 VEE Vaccine VEE Vaccine · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/vegf https://druglandscape.com/api/og?type=drug&title=VEGF&subtitle=VEGF%20%C2%B7%20Losordo%2C%20Douglas%2C%20M.D.&badge=phase%201 VEGF VEGF · Losordo, Douglas, M.D. https://druglandscape.com/drug/vegf-tki https://druglandscape.com/api/og?type=drug&title=VEGF-TKI&subtitle=VEGF-TKI%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%201 VEGF-TKI VEGF-TKI · City of Hope Medical Center https://druglandscape.com/drug/vegfr-tki https://druglandscape.com/api/og?type=drug&title=VEGFR%20TKI&subtitle=VEGFR%20TKI%20%C2%B7%20AbbVie&badge=phase%201 VEGFR TKI VEGFR TKI · AbbVie https://druglandscape.com/drug/velbe-bleomycin-cisplatin https://druglandscape.com/api/og?type=drug&title=Velbe-Bleomycin-Cisplatin&subtitle=Velbe-Bleomycin-Cisplatin%20%C2%B7%20Centre%20Leon%20Berard&badge=phase%202 Velbe-Bleomycin-Cisplatin Velbe-Bleomycin-Cisplatin · Centre Leon Berard https://druglandscape.com/drug/velcade-and-rituximab https://druglandscape.com/api/og?type=drug&title=VELCADE%20and%20rituximab&subtitle=VELCADE%20and%20rituximab%20%C2%B7%20Millennium%20Pharmaceuticals%2C%20Inc.&badge=phase%202 VELCADE and rituximab VELCADE and rituximab · Millennium Pharmaceuticals, Inc. https://druglandscape.com/drug/velcade-cyclophosphamide-prednisone https://druglandscape.com/api/og?type=drug&title=velcade%20cyclophosphamide%20prednisone&subtitle=velcade%20cyclophosphamide%20prednisone%20%C2%B7%20European%20Myeloma%20Network%20B.V.&badge=phase%202 velcade cyclophosphamide prednisone velcade cyclophosphamide prednisone · European Myeloma Network B.V. https://druglandscape.com/drug/velcade-prednisone https://druglandscape.com/api/og?type=drug&title=velcade%20prednisone&subtitle=velcade%20prednisone%20%C2%B7%20European%20Myeloma%20Network%20B.V.&badge=phase%202 velcade prednisone velcade prednisone · European Myeloma Network B.V. https://druglandscape.com/drug/velcade-subcutaneous-melphalan-prednisone https://druglandscape.com/api/og?type=drug&title=velcade%20subcutaneous%20melphalan%20prednisone&subtitle=velcade%20subcutaneous%20melphalan%20prednisone%20%C2%B7%20European%20Myeloma%20Network%20B.V.&badge=phase%202 velcade subcutaneous melphalan prednisone velcade subcutaneous melphalan prednisone · European Myeloma Network B.V. https://druglandscape.com/drug/vemlidy-film-coated-tablets https://druglandscape.com/api/og?type=drug&title=Vemlidy%C2%AE%20film-coated%20tablets&subtitle=Vemlidy%C2%AE%20film-coated%20tablets%20%C2%B7%20Humanis%20Sagl%C4%B1k%20Anonim%20Sirketi&badge=phase%201 Vemlidy® film-coated tablets Vemlidy® film-coated tablets · Humanis Saglık Anonim Sirketi https://druglandscape.com/drug/vemlidy-tab https://druglandscape.com/api/og?type=drug&title=Vemlidy%20Tab&subtitle=Vemlidy%20Tab%20%C2%B7%20Dong-A%20ST%20Co.%2C%20Ltd.&badge=phase%201 Vemlidy Tab Vemlidy Tab · Dong-A ST Co., Ltd. https://druglandscape.com/drug/vemurafenib-in-combination-with-cobimetinib https://druglandscape.com/api/og?type=drug&title=Vemurafenib%20in%20combination%20with%20cobimetinib&subtitle=Vemurafenib%20in%20combination%20with%20cobimetinib%20%C2%B7%20Cancer%20Research%20UK&badge=phase%202 Vemurafenib in combination with cobimetinib Vemurafenib in combination with cobimetinib · Cancer Research UK https://druglandscape.com/drug/vena-punction https://druglandscape.com/api/og?type=drug&title=vena%20punction&subtitle=vena%20punction%20%C2%B7%20Erasmus%20Medical%20Center&badge=phase%202 vena punction vena punction · Erasmus Medical Center https://druglandscape.com/drug/venetoclax-dexamethasone-ixazomib-pomalidomide https://druglandscape.com/api/og?type=drug&title=Venetoclax%2C%20dexamethasone%2C%20ixazomib%2C%20pomalidomide&subtitle=Venetoclax%2C%20dexamethasone%2C%20ixazomib%2C%20pomalidomide%20%C2%B7%20Multiple%20Myeloma%20Research%20Consortium&badge=phase%201 Venetoclax, dexamethasone, ixazomib, pomalidomide Venetoclax, dexamethasone, ixazomib, pomalidomide · Multiple Myeloma Research Consortium https://druglandscape.com/drug/venetoclax-oral-product https://druglandscape.com/api/og?type=drug&title=Venetoclax%20Oral%20Product&subtitle=Venetoclax%20Oral%20Product%20%C2%B7%20The%20Lymphoma%20Academic%20Research%20Organisation&badge=phase%202 Venetoclax Oral Product Venetoclax Oral Product · The Lymphoma Academic Research Organisation https://druglandscape.com/drug/venetoclax-oral-tablet https://druglandscape.com/api/og?type=drug&title=Venetoclax%20Oral%20Tablet&subtitle=Venetoclax%20Oral%20Tablet%20%C2%B7%20Montefiore%20Medical%20Center&badge=phase%202 Venetoclax Oral Tablet Venetoclax Oral Tablet · Montefiore Medical Center https://druglandscape.com/drug/venetoclax-plus-hma https://druglandscape.com/api/og?type=drug&title=Venetoclax%20plus%20HMA&subtitle=Venetoclax%20plus%20HMA%20%C2%B7%20Gruppo%20Italiano%20Malattie%20EMatologiche%20dell'Adulto&badge=phase%202 Venetoclax plus HMA Venetoclax plus HMA · Gruppo Italiano Malattie EMatologiche dell'Adulto https://druglandscape.com/drug/venetoclax-plus-ric https://druglandscape.com/api/og?type=drug&title=Venetoclax%20plus%20RIC&subtitle=Venetoclax%20plus%20RIC%20%C2%B7%20Xianmin%20Song%2C%20MD&badge=phase%202 Venetoclax plus RIC Venetoclax plus RIC · Xianmin Song, MD https://druglandscape.com/drug/venous-blood-sample https://druglandscape.com/api/og?type=drug&title=Venous%20blood%20sample&subtitle=Venous%20blood%20sample%20%C2%B7%20Assistance%20Publique%20Hopitaux%20De%20Marseille&badge=phase%201 Venous blood sample Venous blood sample · Assistance Publique Hopitaux De Marseille https://druglandscape.com/drug/venox https://druglandscape.com/api/og?type=drug&title=VENOX&subtitle=VENOX%20%C2%B7%20Inmunotek%20S.L.&badge=phase%202 VENOX VENOX · Inmunotek S.L. https://druglandscape.com/drug/vent-03 https://druglandscape.com/api/og?type=drug&title=VENT-03&subtitle=VENT-03%20%C2%B7%20Ventus%20Therapeutics%20U.S.%2C%20Inc.&badge=phase%202 VENT-03 VENT-03 · Ventus Therapeutics U.S., Inc. https://druglandscape.com/drug/ventrigel https://druglandscape.com/api/og?type=drug&title=VentriGel&subtitle=VentriGel%20%C2%B7%20Ventrix%2C%20Inc.&badge=phase%201 VentriGel VentriGel · Ventrix, Inc. https://druglandscape.com/drug/vepeside-ifosfamide-cisplatin https://druglandscape.com/api/og?type=drug&title=Vepeside-ifosfamide-Cisplatin&subtitle=Vepeside-ifosfamide-Cisplatin%20%C2%B7%20Centre%20Leon%20Berard&badge=phase%202 Vepeside-ifosfamide-Cisplatin Vepeside-ifosfamide-Cisplatin · Centre Leon Berard https://druglandscape.com/drug/vericiguat-tablet https://druglandscape.com/api/og?type=drug&title=Vericiguat%20tablet&subtitle=Vericiguat%20tablet%20%C2%B7%20Khawaja%20Danish%20Ali&badge=phase%202 Vericiguat tablet Vericiguat tablet · Khawaja Danish Ali https://druglandscape.com/drug/verinurad-prolonged-release-gelatin-capsule https://druglandscape.com/api/og?type=drug&title=Verinurad%20prolonged%20release%20gelatin%20Capsule&subtitle=Verinurad%20prolonged%20release%20gelatin%20Capsule%20%C2%B7%20AstraZeneca&badge=phase%201 Verinurad prolonged release gelatin Capsule Verinurad prolonged release gelatin Capsule · AstraZeneca https://druglandscape.com/drug/verinurad-prolonged-release-hpmc-capsule https://druglandscape.com/api/og?type=drug&title=Verinurad%20prolonged%20release%20HPMC%20capsule&subtitle=Verinurad%20prolonged%20release%20HPMC%20capsule%20%C2%B7%20AstraZeneca&badge=phase%201 Verinurad prolonged release HPMC capsule Verinurad prolonged release HPMC capsule · AstraZeneca https://druglandscape.com/drug/vero-cell-derived-influenza-vaccine https://druglandscape.com/api/og?type=drug&title=Vero%20Cell-derived%20Influenza%20Vaccine&subtitle=Vero%20Cell-derived%20Influenza%20Vaccine%20%C2%B7%20Alachua%20Government%20Services%2C%20Inc.&badge=phase%202 Vero Cell-derived Influenza Vaccine Vero Cell-derived Influenza Vaccine · Alachua Government Services, Inc. https://druglandscape.com/drug/verorab-vaccine https://druglandscape.com/api/og?type=drug&title=Verorab%20vaccine&subtitle=Verorab%20vaccine%20%C2%B7%20African%20Malaria%20Network%20Trust&badge=phase%202 Verorab vaccine Verorab vaccine · African Malaria Network Trust https://druglandscape.com/drug/vert-002 https://druglandscape.com/api/og?type=drug&title=VERT-002&subtitle=VERT-002%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%201 VERT-002 VERT-002 · Pierre Fabre Medicament https://druglandscape.com/drug/veru-944 https://druglandscape.com/api/og?type=drug&title=Veru-944&subtitle=Veru-944%20%C2%B7%20Veru%20Inc.&badge=phase%202 Veru-944 Veru-944 · Veru Inc. https://druglandscape.com/drug/verve-102 https://druglandscape.com/api/og?type=drug&title=VERVE-102&subtitle=VERVE-102%20%C2%B7%20Verve%20Therapeutics%2C%20Inc.&badge=phase%201 VERVE-102 VERVE-102 · Verve Therapeutics, Inc. https://druglandscape.com/drug/verve-201 https://druglandscape.com/api/og?type=drug&title=VERVE-201&subtitle=VERVE-201%20%C2%B7%20Verve%20Therapeutics%2C%20Inc.&badge=phase%201 VERVE-201 VERVE-201 · Verve Therapeutics, Inc. https://druglandscape.com/drug/very-low-nicotine-cigarette https://druglandscape.com/api/og?type=drug&title=Very%20Low%20Nicotine%20Cigarette&subtitle=Very%20Low%20Nicotine%20Cigarette%20%C2%B7%20Mikhail%20N%20Koffarnus&badge=phase%201 Very Low Nicotine Cigarette Very Low Nicotine Cigarette · Mikhail N Koffarnus https://druglandscape.com/drug/ves001 https://druglandscape.com/api/og?type=drug&title=VES001&subtitle=VES001%20%C2%B7%20Vesper%20Biotechnologies%20ApS&badge=phase%201 VES001 VES001 · Vesper Biotechnologies ApS https://druglandscape.com/drug/vet3-tgi https://druglandscape.com/api/og?type=drug&title=VET3-TGI&subtitle=VET3-TGI%20%C2%B7%20KaliVir%20Immunotherapeutics&badge=phase%201 VET3-TGI VET3-TGI · KaliVir Immunotherapeutics https://druglandscape.com/drug/veverimer-daily https://druglandscape.com/api/og?type=drug&title=veverimer%20daily&subtitle=veverimer%20daily%20%C2%B7%20Tufts%20Medical%20Center&badge=phase%201 veverimer daily veverimer daily · Tufts Medical Center https://druglandscape.com/drug/veverimer-every-other-day https://druglandscape.com/api/og?type=drug&title=veverimer%20every%20other%20day&subtitle=veverimer%20every%20other%20day%20%C2%B7%20Tufts%20Medical%20Center&badge=phase%201 veverimer every other day veverimer every other day · Tufts Medical Center https://druglandscape.com/drug/vf001-dp-hd https://druglandscape.com/api/og?type=drug&title=VF001-DP%20HD&subtitle=VF001-DP%20HD%20%C2%B7%20Factor%20Therapeutics%20Ltd.&badge=phase%202 VF001-DP HD VF001-DP HD · Factor Therapeutics Ltd. https://druglandscape.com/drug/vf001-dp-ld https://druglandscape.com/api/og?type=drug&title=VF001-DP%20LD&subtitle=VF001-DP%20LD%20%C2%B7%20Factor%20Therapeutics%20Ltd.&badge=phase%202 VF001-DP LD VF001-DP LD · Factor Therapeutics Ltd. https://druglandscape.com/drug/vg161 https://druglandscape.com/api/og?type=drug&title=VG161&subtitle=VG161%20%C2%B7%20Virogin%20Biotech%20Canada%20Ltd&badge=phase%202 VG161 VG161 · Virogin Biotech Canada Ltd https://druglandscape.com/drug/vg290131 https://druglandscape.com/api/og?type=drug&title=VG290131&subtitle=VG290131%20%C2%B7%20Zhejiang%20Vimgreen%20Pharmaceuticals%2C%20Ltd.&badge=phase%201 VG290131 VG290131 · Zhejiang Vimgreen Pharmaceuticals, Ltd. https://druglandscape.com/drug/vg801 https://druglandscape.com/api/og?type=drug&title=VG801&subtitle=VG801%20%C2%B7%20VeonGen%20Therapeutics%20GmbH&badge=phase%201 VG801 VG801 · VeonGen Therapeutics GmbH https://druglandscape.com/drug/vg901 https://druglandscape.com/api/og?type=drug&title=VG901&subtitle=VG901%20%C2%B7%20VeonGen%20Therapeutics%20GmbH&badge=phase%201 VG901 VG901 · VeonGen Therapeutics GmbH https://druglandscape.com/drug/vgn-r08b-1-68-10-14-vg https://druglandscape.com/api/og?type=drug&title=VGN-R08b%201.68%C3%9710%5E14%20vg&subtitle=VGN-R08b%201.68%C3%9710%5E14%20vg%20%C2%B7%20Shanghai%20Vitalgen%20BioPharma%20Co.%2C%20Ltd.&badge=phase%201 VGN-R08b 1.68×10^14 vg VGN-R08b 1.68×10^14 vg · Shanghai Vitalgen BioPharma Co., Ltd. https://druglandscape.com/drug/vgn-r08b-4-2-10-13-vg https://druglandscape.com/api/og?type=drug&title=VGN-R08b%204.2%C3%9710%5E13%20vg&subtitle=VGN-R08b%204.2%C3%9710%5E13%20vg%20%C2%B7%20Shanghai%20Vitalgen%20BioPharma%20Co.%2C%20Ltd.&badge=phase%201 VGN-R08b 4.2×10^13 vg VGN-R08b 4.2×10^13 vg · Shanghai Vitalgen BioPharma Co., Ltd. https://druglandscape.com/drug/vgx-3400 https://druglandscape.com/api/og?type=drug&title=VGX-3400&subtitle=VGX-3400%20%C2%B7%20GeneOne%20Life%20Science%2C%20Inc.&badge=phase%201 VGX-3400 VGX-3400 · GeneOne Life Science, Inc. https://druglandscape.com/drug/vgx-6150 https://druglandscape.com/api/og?type=drug&title=VGX-6150&subtitle=VGX-6150%20%C2%B7%20GeneOne%20Life%20Science%2C%20Inc.&badge=phase%201 VGX-6150 VGX-6150 · GeneOne Life Science, Inc. https://druglandscape.com/drug/vh4004280 https://druglandscape.com/api/og?type=drug&title=VH4004280&subtitle=VH4004280%20%C2%B7%20ViiV%20Healthcare&badge=phase%202 VH4004280 VH4004280 · ViiV Healthcare https://druglandscape.com/drug/vh4004280-formulation-a https://druglandscape.com/api/og?type=drug&title=VH4004280%20Formulation%20A&subtitle=VH4004280%20Formulation%20A%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 VH4004280 Formulation A VH4004280 Formulation A · ViiV Healthcare https://druglandscape.com/drug/vh4004280-formulation-c https://druglandscape.com/api/og?type=drug&title=VH4004280%20Formulation%20C&subtitle=VH4004280%20Formulation%20C%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 VH4004280 Formulation C VH4004280 Formulation C · ViiV Healthcare https://druglandscape.com/drug/vh4004280-formulation-d https://druglandscape.com/api/og?type=drug&title=VH4004280%20Formulation%20D&subtitle=VH4004280%20Formulation%20D%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 VH4004280 Formulation D VH4004280 Formulation D · ViiV Healthcare https://druglandscape.com/drug/vh4004280-formulation-e https://druglandscape.com/api/og?type=drug&title=VH4004280%20Formulation%20E&subtitle=VH4004280%20Formulation%20E%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 VH4004280 Formulation E VH4004280 Formulation E · ViiV Healthcare https://druglandscape.com/drug/vh4011499 https://druglandscape.com/api/og?type=drug&title=VH4011499&subtitle=VH4011499%20%C2%B7%20ViiV%20Healthcare&badge=phase%202 VH4011499 VH4011499 · ViiV Healthcare https://druglandscape.com/drug/vh4011499-dose-a https://druglandscape.com/api/og?type=drug&title=VH4011499%20Dose%20A&subtitle=VH4011499%20Dose%20A%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 VH4011499 Dose A VH4011499 Dose A · ViiV Healthcare https://druglandscape.com/drug/vh4011499-dose-b https://druglandscape.com/api/og?type=drug&title=VH4011499%20Dose%20B&subtitle=VH4011499%20Dose%20B%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 VH4011499 Dose B VH4011499 Dose B · ViiV Healthcare https://druglandscape.com/drug/vh4524184 https://druglandscape.com/api/og?type=drug&title=VH4524184&subtitle=VH4524184%20%C2%B7%20ViiV%20Healthcare&badge=phase%202 VH4524184 VH4524184 · ViiV Healthcare https://druglandscape.com/drug/vh4524184-formulation-a-im https://druglandscape.com/api/og?type=drug&title=VH4524184%20Formulation%20A%20IM&subtitle=VH4524184%20Formulation%20A%20IM%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 VH4524184 Formulation A IM VH4524184 Formulation A IM · ViiV Healthcare https://druglandscape.com/drug/vh4524184-formulation-a-sc https://druglandscape.com/api/og?type=drug&title=VH4524184%20Formulation%20A%20SC&subtitle=VH4524184%20Formulation%20A%20SC%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 VH4524184 Formulation A SC VH4524184 Formulation A SC · ViiV Healthcare https://druglandscape.com/drug/vh4527079 https://druglandscape.com/api/og?type=drug&title=VH4527079&subtitle=VH4527079%20%C2%B7%20ViiV%20Healthcare&badge=phase%201 VH4527079 VH4527079 · ViiV Healthcare https://druglandscape.com/drug/vi-0609 https://druglandscape.com/api/og?type=drug&title=VI-0609&subtitle=VI-0609%20%C2%B7%20VIVUS%20LLC&badge=phase%202 VI-0609 VI-0609 · VIVUS LLC https://druglandscape.com/drug/vi-1121 https://druglandscape.com/api/og?type=drug&title=VI-1121&subtitle=VI-1121%20%C2%B7%20VIVUS%20LLC&badge=phase%202 VI-1121 VI-1121 · VIVUS LLC https://druglandscape.com/drug/vi-crm197-vaccine https://druglandscape.com/api/og?type=drug&title=Vi-CRM197%20vaccine&subtitle=Vi-CRM197%20vaccine%20%C2%B7%20Novartis&badge=phase%202 Vi-CRM197 vaccine Vi-CRM197 vaccine · Novartis https://druglandscape.com/drug/via-3196 https://druglandscape.com/api/og?type=drug&title=VIA-3196&subtitle=VIA-3196%20%C2%B7%20Madrigal%20Pharmaceuticals%2C%20Inc.&badge=phase%201 VIA-3196 VIA-3196 · Madrigal Pharmaceuticals, Inc. https://druglandscape.com/drug/viaject-50 https://druglandscape.com/api/og?type=drug&title=VIAject%2050%25&subtitle=VIAject%2050%25%20%C2%B7%20Biodel&badge=phase%202 VIAject 50% VIAject 50% · Biodel https://druglandscape.com/drug/viaject25 https://druglandscape.com/api/og?type=drug&title=VIAject%C2%AE25&subtitle=VIAject%C2%AE25%20%C2%B7%20Biodel&badge=phase%201 VIAject®25 VIAject®25 · Biodel https://druglandscape.com/drug/viaject7 https://druglandscape.com/api/og?type=drug&title=VIAject%C2%AE7&subtitle=VIAject%C2%AE7%20%C2%B7%20Biodel&badge=phase%201 VIAject®7 VIAject®7 · Biodel https://druglandscape.com/drug/viaskin-peanut https://druglandscape.com/api/og?type=drug&title=Viaskin%20Peanut&subtitle=Viaskin%20Peanut%20%C2%B7%20DBV%20Technologies&badge=phase%202 Viaskin Peanut Viaskin Peanut · DBV Technologies https://druglandscape.com/drug/vib4920 https://druglandscape.com/api/og?type=drug&title=VIB4920&subtitle=VIB4920%20%C2%B7%20Amgen&badge=phase%202 VIB4920 VIB4920 · Amgen https://druglandscape.com/drug/vicks-cough-syrup-for-chesty-coughs https://druglandscape.com/api/og?type=drug&title=Vicks%20Cough%20Syrup%20for%20Chesty%20Coughs&subtitle=Vicks%20Cough%20Syrup%20for%20Chesty%20Coughs%20%C2%B7%20Reckitt%20Benckiser%20Inc.&badge=phase%201 Vicks Cough Syrup for Chesty Coughs Vicks Cough Syrup for Chesty Coughs · Reckitt Benckiser Inc. https://druglandscape.com/drug/vigadexa https://druglandscape.com/api/og?type=drug&title=Vigadexa%C2%AE&subtitle=Vigadexa%C2%AE%20%C2%B7%20EMS&badge=phase%202 Vigadexa® Vigadexa® · EMS https://druglandscape.com/drug/vigiv https://druglandscape.com/api/og?type=drug&title=VIGIV&subtitle=VIGIV%20%C2%B7%20Emergent%20BioSolutions&badge=phase%202 VIGIV VIGIV · Emergent BioSolutions https://druglandscape.com/drug/vildagliptin-and-metformin-reference-product https://druglandscape.com/api/og?type=drug&title=Vildagliptin%20and%20Metformin-Reference%20product&subtitle=Vildagliptin%20and%20Metformin-Reference%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Vildagliptin and Metformin-Reference product Vildagliptin and Metformin-Reference product · Bio-innova Co., Ltd https://druglandscape.com/drug/vildagliptin-and-metformin-test-product https://druglandscape.com/api/og?type=drug&title=Vildagliptin%20and%20Metformin-Test%20product&subtitle=Vildagliptin%20and%20Metformin-Test%20product%20%C2%B7%20Bio-innova%20Co.%2C%20Ltd&badge=phase%201 Vildagliptin and Metformin-Test product Vildagliptin and Metformin-Test product · Bio-innova Co., Ltd https://druglandscape.com/drug/vincristine-cyclophosphamide-and-doxorubicin https://druglandscape.com/api/og?type=drug&title=vincristine%2C%20cyclophosphamide%2C%20and%20doxorubicin&subtitle=vincristine%2C%20cyclophosphamide%2C%20and%20doxorubicin%20%C2%B7%20St.%20Jude%20Children's%20Research%20Hospital&badge=phase%203 vincristine, cyclophosphamide, and doxorubicin vincristine, cyclophosphamide, and doxorubicin · St. Jude Children's Research Hospital https://druglandscape.com/drug/vincristine-irinotecan https://druglandscape.com/api/og?type=drug&title=Vincristine%2C%20Irinotecan&subtitle=Vincristine%2C%20Irinotecan%20%C2%B7%20Centre%20Oscar%20Lambret&badge=phase%202 Vincristine, Irinotecan Vincristine, Irinotecan · Centre Oscar Lambret https://druglandscape.com/drug/vinflunine-carboplatin https://druglandscape.com/api/og?type=drug&title=Vinflunine%2C%20Carboplatin&subtitle=Vinflunine%2C%20Carboplatin%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%202 Vinflunine, Carboplatin Vinflunine, Carboplatin · Pierre Fabre Medicament https://druglandscape.com/drug/vinorebine-everolimus https://druglandscape.com/api/og?type=drug&title=Vinorebine%2C%20Everolimus&subtitle=Vinorebine%2C%20Everolimus%20%C2%B7%20AIO-Studien-gGmbH&badge=phase%202 Vinorebine, Everolimus Vinorebine, Everolimus · AIO-Studien-gGmbH https://druglandscape.com/drug/vinorelbine-and-carboplatin https://druglandscape.com/api/og?type=drug&title=Vinorelbine%20and%20Carboplatin&subtitle=Vinorelbine%20and%20Carboplatin%20%C2%B7%20LungenClinic%20Grosshansdorf&badge=phase%202 Vinorelbine and Carboplatin Vinorelbine and Carboplatin · LungenClinic Grosshansdorf https://druglandscape.com/drug/vinorelbine-cisplatin-radiotherapy https://druglandscape.com/api/og?type=drug&title=Vinorelbine%20cisplatin%20radiotherapy&subtitle=Vinorelbine%20cisplatin%20radiotherapy%20%C2%B7%20Pierre%20Fabre%20Medicament&badge=phase%202 Vinorelbine cisplatin radiotherapy Vinorelbine cisplatin radiotherapy · Pierre Fabre Medicament https://druglandscape.com/drug/vinorelbine-cyclofosfamide https://druglandscape.com/api/og?type=drug&title=Vinorelbine%2C%20cyclofosfamide&subtitle=Vinorelbine%2C%20cyclofosfamide%20%C2%B7%20Gustave%20Roussy%2C%20Cancer%20Campus%2C%20Grand%20Paris&badge=phase%202 Vinorelbine, cyclofosfamide Vinorelbine, cyclofosfamide · Gustave Roussy, Cancer Campus, Grand Paris https://druglandscape.com/drug/vinorelbine-plus-cisplatin https://druglandscape.com/api/og?type=drug&title=vinorelbine%20plus%20cisplatin&subtitle=vinorelbine%20plus%20cisplatin%20%C2%B7%20Seoul%20National%20University%20Hospital&badge=phase%203 vinorelbine plus cisplatin vinorelbine plus cisplatin · Seoul National University Hospital https://druglandscape.com/drug/vintafolide-iv-bolus https://druglandscape.com/api/og?type=drug&title=Vintafolide%20IV%20Bolus&subtitle=Vintafolide%20IV%20Bolus%20%C2%B7%20Endocyte&badge=phase%201 Vintafolide IV Bolus Vintafolide IV Bolus · Endocyte https://druglandscape.com/drug/vintafolide-iv-infusion https://druglandscape.com/api/og?type=drug&title=Vintafolide%20IV%20Infusion&subtitle=Vintafolide%20IV%20Infusion%20%C2%B7%20Endocyte&badge=phase%201 Vintafolide IV Infusion Vintafolide IV Infusion · Endocyte https://druglandscape.com/drug/vir-2218 https://druglandscape.com/api/og?type=drug&title=VIR-2218&subtitle=VIR-2218%20%C2%B7%20Brii%20Biosciences%20Limited&badge=phase%202 VIR-2218 VIR-2218 · Brii Biosciences Limited https://druglandscape.com/drug/vir-3434 https://druglandscape.com/api/og?type=drug&title=VIR-3434&subtitle=VIR-3434%20%C2%B7%20Vir%20Biotechnology%2C%20Inc.&badge=phase%202 VIR-3434 VIR-3434 · Vir Biotechnology, Inc. https://druglandscape.com/drug/vir-5500 https://druglandscape.com/api/og?type=drug&title=VIR-5500&subtitle=VIR-5500%20%C2%B7%20Vir%20Biotechnology%2C%20Inc.&badge=phase%201 VIR-5500 VIR-5500 · Vir Biotechnology, Inc. https://druglandscape.com/drug/vir-5818 https://druglandscape.com/api/og?type=drug&title=VIR-5818&subtitle=VIR-5818%20%C2%B7%20Vir%20Biotechnology%2C%20Inc.&badge=phase%201 VIR-5818 VIR-5818 · Vir Biotechnology, Inc. https://druglandscape.com/drug/viral-vector-vaccine-booster https://druglandscape.com/api/og?type=drug&title=Viral%20vector%20vaccine%20booster&subtitle=Viral%20vector%20vaccine%20booster%20%C2%B7%20Universidad%20del%20Desarrollo&badge=phase%202 Viral vector vaccine booster Viral vector vaccine booster · Universidad del Desarrollo https://druglandscape.com/drug/viralym-c https://druglandscape.com/api/og?type=drug&title=Viralym-C&subtitle=Viralym-C%20%C2%B7%20AlloVir&badge=phase%201 Viralym-C Viralym-C · AlloVir https://druglandscape.com/drug/vis171 https://druglandscape.com/api/og?type=drug&title=VIS171&subtitle=VIS171%20%C2%B7%20Otsuka%20Pharmaceutical%20Development%20%26%20Commercialization%2C%20Inc.&badge=phase%201 VIS171 VIS171 · Otsuka Pharmaceutical Development & Commercialization, Inc. https://druglandscape.com/drug/vis410 https://druglandscape.com/api/og?type=drug&title=VIS410&subtitle=VIS410%20%C2%B7%20Visterra%2C%20Inc.&badge=phase%202 VIS410 VIS410 · Visterra, Inc. https://druglandscape.com/drug/vis410-high-dose https://druglandscape.com/api/og?type=drug&title=VIS410%20high%20dose&subtitle=VIS410%20high%20dose%20%C2%B7%20Visterra%2C%20Inc.&badge=phase%202 VIS410 high dose VIS410 high dose · Visterra, Inc. https://druglandscape.com/drug/vis410-low-dose https://druglandscape.com/api/og?type=drug&title=VIS410%20low%20dose&subtitle=VIS410%20low%20dose%20%C2%B7%20Visterra%2C%20Inc.&badge=phase%202 VIS410 low dose VIS410 low dose · Visterra, Inc. https://druglandscape.com/drug/vis649 https://druglandscape.com/api/og?type=drug&title=VIS649&subtitle=VIS649%20%C2%B7%20Visterra%2C%20Inc.&badge=phase%201 VIS649 VIS649 · Visterra, Inc. https://druglandscape.com/drug/vis954 https://druglandscape.com/api/og?type=drug&title=VIS954&subtitle=VIS954%20%C2%B7%20Visterra%2C%20Inc.&badge=phase%201 VIS954 VIS954 · Visterra, Inc. https://druglandscape.com/drug/vision5-product https://druglandscape.com/api/og?type=drug&title=VISION5%20Product&subtitle=VISION5%20Product%20%C2%B7%20ForSight%20Vision5%2C%20Inc.&badge=phase%201 VISION5 Product VISION5 Product · ForSight Vision5, Inc. https://druglandscape.com/drug/visonac-pdt https://druglandscape.com/api/og?type=drug&title=Visonac%20PDT&subtitle=Visonac%20PDT%20%C2%B7%20Photocure&badge=phase%202 Visonac PDT Visonac PDT · Photocure https://druglandscape.com/drug/visonac-wiped-off-after-one-hour https://druglandscape.com/api/og?type=drug&title=Visonac%20wiped%20off%20after%20one%20hour&subtitle=Visonac%20wiped%20off%20after%20one%20hour%20%C2%B7%20Photocure&badge=phase%202 Visonac wiped off after one hour Visonac wiped off after one hour · Photocure https://druglandscape.com/drug/visuxl https://druglandscape.com/api/og?type=drug&title=VisuXL%C2%AE&subtitle=VisuXL%C2%AE%20%C2%B7%20Adolfo%20Daniel%20Rodriguez-Carrizalez&badge=phase%202 VisuXL® VisuXL® · Adolfo Daniel Rodriguez-Carrizalez https://druglandscape.com/drug/vita-6 https://druglandscape.com/api/og?type=drug&title=Vita%206&subtitle=Vita%206%20%C2%B7%20Muhammad%20Aamir%20Latif&badge=phase%201 Vita 6 Vita 6 · Muhammad Aamir Latif https://druglandscape.com/drug/vitamin-b12-b9-b6-c-supplementation https://druglandscape.com/api/og?type=drug&title=Vitamin%20B12%2C%20B9%2C%20B6%2C%20C%20supplementation&subtitle=Vitamin%20B12%2C%20B9%2C%20B6%2C%20C%20supplementation%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%201 Vitamin B12, B9, B6, C supplementation Vitamin B12, B9, B6, C supplementation · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/vitamin-b12b https://druglandscape.com/api/og?type=drug&title=Vitamin%20B12B&subtitle=Vitamin%20B12B%20%C2%B7%20General%20Oncology%2C%20Inc.&badge=phase%201 Vitamin B12B Vitamin B12B · General Oncology, Inc. https://druglandscape.com/drug/vitamin-b2-streuli https://druglandscape.com/api/og?type=drug&title=Vitamin%20B2%20Streuli%C2%AE&subtitle=Vitamin%20B2%20Streuli%C2%AE%20%C2%B7%20Castillo%2C%20Jos%C3%A9%2C%20M.D.&badge=phase%202 Vitamin B2 Streuli® Vitamin B2 Streuli® · Castillo, José, M.D. https://druglandscape.com/drug/vitamin-c-vitamin-b1-hydrocortisone https://druglandscape.com/api/og?type=drug&title=vitamin%20C%2C%20vitamin%20B1%2C%20hydrocortisone&subtitle=vitamin%20C%2C%20vitamin%20B1%2C%20hydrocortisone%20%C2%B7%20Beth%20Israel%20Deaconess%20Medical%20Center&badge=phase%202 vitamin C, vitamin B1, hydrocortisone vitamin C, vitamin B1, hydrocortisone · Beth Israel Deaconess Medical Center https://druglandscape.com/drug/vitamin-e-softgel https://druglandscape.com/api/og?type=drug&title=Vitamin%20E%20softgel&subtitle=Vitamin%20E%20softgel%20%C2%B7%20Zhejiang%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Vitamin E softgel Vitamin E softgel · Zhejiang Medicine Co., Ltd. https://druglandscape.com/drug/vitamin-k-antagonist-at-inr-2-3 https://druglandscape.com/api/og?type=drug&title=Vitamin-K%20antagonist%20at%20INR%202-3&subtitle=Vitamin-K%20antagonist%20at%20INR%202-3%20%C2%B7%20AstraZeneca&badge=phase%202 Vitamin-K antagonist at INR 2-3 Vitamin-K antagonist at INR 2-3 · AstraZeneca https://druglandscape.com/drug/vitamin-k1-tablets https://druglandscape.com/api/og?type=drug&title=Vitamin%20K1%20Tablets&subtitle=Vitamin%20K1%20Tablets%20%C2%B7%20Jiangsu%20HengRui%20Medicine%20Co.%2C%20Ltd.&badge=phase%201 Vitamin K1 Tablets Vitamin K1 Tablets · Jiangsu HengRui Medicine Co., Ltd. https://druglandscape.com/drug/vitamine-c-and-e https://druglandscape.com/api/og?type=drug&title=vitamine%20C%20and%20E&subtitle=vitamine%20C%20and%20E%20%C2%B7%20Erzincan%20Military%20Hospital&badge=phase%203 vitamine C and E vitamine C and E · Erzincan Military Hospital https://druglandscape.com/drug/vitis-xtra-forte https://druglandscape.com/api/og?type=drug&title=Vitis%20Xtra%20Forte%C2%A9&subtitle=Vitis%20Xtra%20Forte%C2%A9%20%C2%B7%20Fundaci%C3%B3n%20para%20el%20Fomento%20de%20la%20Investigaci%C3%B3n%20Sanitaria%20y%20Biom%C3%A9dica%20de%20la%20Comuni&badge=phase%201 Vitis Xtra Forte© Vitis Xtra Forte© · Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana https://druglandscape.com/drug/vitreoscilla-filiformis-cream https://druglandscape.com/api/og?type=drug&title=vitreoscilla%20filiformis%20cream&subtitle=vitreoscilla%20filiformis%20cream%20%C2%B7%20L'Oreal&badge=phase%201 vitreoscilla filiformis cream vitreoscilla filiformis cream · L'Oreal https://druglandscape.com/drug/vix001 https://druglandscape.com/api/og?type=drug&title=VIX001&subtitle=VIX001%20%C2%B7%20Neobiosis%2C%20LLC&badge=phase%201 VIX001 VIX001 · Neobiosis, LLC https://druglandscape.com/drug/vk0214 https://druglandscape.com/api/og?type=drug&title=VK0214&subtitle=VK0214%20%C2%B7%20Viking%20Therapeutics%2C%20Inc.&badge=phase%201 VK0214 VK0214 · Viking Therapeutics, Inc. https://druglandscape.com/drug/vk2735-drug https://druglandscape.com/api/og?type=drug&title=VK2735%20Drug&subtitle=VK2735%20Drug%20%C2%B7%20Viking%20Therapeutics%2C%20Inc.&badge=phase%201 VK2735 Drug VK2735 Drug · Viking Therapeutics, Inc. https://druglandscape.com/drug/vk2809 https://druglandscape.com/api/og?type=drug&title=VK2809&subtitle=VK2809%20%C2%B7%20Viking%20Therapeutics%2C%20Inc.&badge=phase%202 VK2809 VK2809 · Viking Therapeutics, Inc. https://druglandscape.com/drug/vka-inr-2-3 https://druglandscape.com/api/og?type=drug&title=VKA%20INR%202-3&subtitle=VKA%20INR%202-3%20%C2%B7%20AstraZeneca&badge=phase%202 VKA INR 2-3 VKA INR 2-3 · AstraZeneca https://druglandscape.com/drug/vla15-without-alum https://druglandscape.com/api/og?type=drug&title=VLA15%20without%20Alum&subtitle=VLA15%20without%20Alum%20%C2%B7%20Pfizer&badge=phase%201 VLA15 without Alum VLA15 without Alum · Pfizer https://druglandscape.com/drug/vla1553-full-dose https://druglandscape.com/api/og?type=drug&title=VLA1553%20full%20dose&subtitle=VLA1553%20full%20dose%20%C2%B7%20Valneva%20Austria%20GmbH&badge=phase%202 VLA1553 full dose VLA1553 full dose · Valneva Austria GmbH https://druglandscape.com/drug/vla1553-half-dose https://druglandscape.com/api/og?type=drug&title=VLA1553%20half%20dose&subtitle=VLA1553%20half%20dose%20%C2%B7%20Valneva%20Austria%20GmbH&badge=phase%202 VLA1553 half dose VLA1553 half dose · Valneva Austria GmbH https://druglandscape.com/drug/vla1701 https://druglandscape.com/api/og?type=drug&title=VLA1701&subtitle=VLA1701%20%C2%B7%20Valneva%20Austria%20GmbH&badge=phase%202 VLA1701 VLA1701 · Valneva Austria GmbH https://druglandscape.com/drug/vla84 https://druglandscape.com/api/og?type=drug&title=VLA84&subtitle=VLA84%20%C2%B7%20Valneva%20Austria%20GmbH&badge=phase%202 VLA84 VLA84 · Valneva Austria GmbH https://druglandscape.com/drug/vlp-polio https://druglandscape.com/api/og?type=drug&title=VLP-Polio&subtitle=VLP-Polio%20%C2%B7%20CanSino%20Biologics%20Inc.&badge=phase%201 VLP-Polio VLP-Polio · CanSino Biologics Inc. https://druglandscape.com/drug/vlp-polio-high-dose https://druglandscape.com/api/og?type=drug&title=VLP-Polio%20high%20dose&subtitle=VLP-Polio%20high%20dose%20%C2%B7%20CanSino%20Biologics%20Inc.&badge=phase%201 VLP-Polio high dose VLP-Polio high dose · CanSino Biologics Inc. https://druglandscape.com/drug/vlp-polio-medium-dose https://druglandscape.com/api/og?type=drug&title=VLP-Polio%20medium%20dose&subtitle=VLP-Polio%20medium%20dose%20%C2%B7%20CanSino%20Biologics%20Inc.&badge=phase%201 VLP-Polio medium dose VLP-Polio medium dose · CanSino Biologics Inc. https://druglandscape.com/drug/vls-1488 https://druglandscape.com/api/og?type=drug&title=VLS-1488&subtitle=VLS-1488%20%C2%B7%20Volastra%20Therapeutics%2C%20Inc.&badge=phase%201 VLS-1488 VLS-1488 · Volastra Therapeutics, Inc. https://druglandscape.com/drug/vlt-015 https://druglandscape.com/api/og?type=drug&title=VLT-015&subtitle=VLT-015%20%C2%B7%20CF%20Pharma%2C%20LLC&badge=phase%201 VLT-015 VLT-015 · CF Pharma, LLC https://druglandscape.com/drug/vlts-934 https://druglandscape.com/api/og?type=drug&title=VLTS-934&subtitle=VLTS-934%20%C2%B7%20Valentis&badge=phase%202 VLTS-934 VLTS-934 · Valentis https://druglandscape.com/drug/vm-1500 https://druglandscape.com/api/og?type=drug&title=VM-1500&subtitle=VM-1500%20%C2%B7%20Viriom&badge=phase%202 VM-1500 VM-1500 · Viriom https://druglandscape.com/drug/vm-1500a-lai https://druglandscape.com/api/og?type=drug&title=VM-1500A-LAI&subtitle=VM-1500A-LAI%20%C2%B7%20Viriom&badge=phase%202 VM-1500A-LAI VM-1500A-LAI · Viriom https://druglandscape.com/drug/vm-1500fdc https://druglandscape.com/api/og?type=drug&title=VM-1500FDC&subtitle=VM-1500FDC%20%C2%B7%20Viriom&badge=phase%201 VM-1500FDC VM-1500FDC · Viriom https://druglandscape.com/drug/vm206ad https://druglandscape.com/api/og?type=drug&title=VM206Ad&subtitle=VM206Ad%20%C2%B7%20Reyon%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 VM206Ad VM206Ad · Reyon Pharmaceutical Co., Ltd. https://druglandscape.com/drug/vmd-3866-gel https://druglandscape.com/api/og?type=drug&title=VMD-3866%20Gel&subtitle=VMD-3866%20Gel%20%C2%B7%20VM%20Therapeutics%20LLC&badge=phase%202 VMD-3866 Gel VMD-3866 Gel · VM Therapeutics LLC https://druglandscape.com/drug/vmp001 https://druglandscape.com/api/og?type=drug&title=VMP001&subtitle=VMP001%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 VMP001 VMP001 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/vnrx-5022 https://druglandscape.com/api/og?type=drug&title=VNRX-5022&subtitle=VNRX-5022%20%C2%B7%20Venatorx%20Pharmaceuticals%2C%20Inc.&badge=phase%201 VNRX-5022 VNRX-5022 · Venatorx Pharmaceuticals, Inc. https://druglandscape.com/drug/vnrx-5133 https://druglandscape.com/api/og?type=drug&title=VNRX-5133&subtitle=VNRX-5133%20%C2%B7%20Venatorx%20Pharmaceuticals%2C%20Inc.&badge=phase%201 VNRX-5133 VNRX-5133 · Venatorx Pharmaceuticals, Inc. https://druglandscape.com/drug/vnrx-5133-and-vnrx-5022 https://druglandscape.com/api/og?type=drug&title=VNRX-5133%20and%20VNRX-5022&subtitle=VNRX-5133%20and%20VNRX-5022%20%C2%B7%20Venatorx%20Pharmaceuticals%2C%20Inc.&badge=phase%201 VNRX-5133 and VNRX-5022 VNRX-5133 and VNRX-5022 · Venatorx Pharmaceuticals, Inc. https://druglandscape.com/drug/vnx001 https://druglandscape.com/api/og?type=drug&title=VNX001&subtitle=VNX001%20%C2%B7%20Vaneltix%20Pharma%2C%20Inc.&badge=phase%202 VNX001 VNX001 · Vaneltix Pharma, Inc. https://druglandscape.com/drug/vo659 https://druglandscape.com/api/og?type=drug&title=VO659&subtitle=VO659%20%C2%B7%20Vico%20Therapeutics%20B.%20V.&badge=phase%201 VO659 VO659 · Vico Therapeutics B. V. https://druglandscape.com/drug/voclosporin-high-dose https://druglandscape.com/api/og?type=drug&title=Voclosporin%20High%20Dose&subtitle=Voclosporin%20High%20Dose%20%C2%B7%20Aurinia%20Pharmaceuticals%20Inc.&badge=phase%202 Voclosporin High Dose Voclosporin High Dose · Aurinia Pharmaceuticals Inc. https://druglandscape.com/drug/voclosporin-low-dose https://druglandscape.com/api/og?type=drug&title=Voclosporin%20Low%20Dose&subtitle=Voclosporin%20Low%20Dose%20%C2%B7%20Aurinia%20Pharmaceuticals%20Inc.&badge=phase%202 Voclosporin Low Dose Voclosporin Low Dose · Aurinia Pharmaceuticals Inc. https://druglandscape.com/drug/volcolon-sugar-free https://druglandscape.com/api/og?type=drug&title=Volcolon%20sugar%20free&subtitle=Volcolon%20sugar%20free%20%C2%B7%20Amsterdam%20UMC%2C%20location%20VUmc&badge=phase%201 Volcolon sugar free Volcolon sugar free · Amsterdam UMC, location VUmc https://druglandscape.com/drug/voltaren-ophtha-0-1 https://druglandscape.com/api/og?type=drug&title=Voltaren%20ophtha%200.1%25&subtitle=Voltaren%20ophtha%200.1%25%20%C2%B7%20Wolfson%20Medical%20Center&badge=phase%202 Voltaren ophtha 0.1% Voltaren ophtha 0.1% · Wolfson Medical Center https://druglandscape.com/drug/von-willebrand-factor-concentrates https://druglandscape.com/api/og?type=drug&title=Von%20Willebrand%20Factor%20Concentrates&subtitle=Von%20Willebrand%20Factor%20Concentrates%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%202 Von Willebrand Factor Concentrates Von Willebrand Factor Concentrates · Hoffmann-La Roche https://druglandscape.com/drug/von-willebrand-factor-containing-product https://druglandscape.com/api/og?type=drug&title=Von%20Willebrand%20Factor-Containing%20Product&subtitle=Von%20Willebrand%20Factor-Containing%20Product%20%C2%B7%20Octapharma&badge=phase%202 Von Willebrand Factor-Containing Product Von Willebrand Factor-Containing Product · Octapharma https://druglandscape.com/drug/vonoprazan-odt-1-or-odt-2-with-water https://druglandscape.com/api/og?type=drug&title=Vonoprazan%20ODT-1%20or%20ODT-2%20with%20Water&subtitle=Vonoprazan%20ODT-1%20or%20ODT-2%20with%20Water%20%C2%B7%20Phathom%20Pharmaceuticals%2C%20Inc.&badge=phase%201 Vonoprazan ODT-1 or ODT-2 with Water Vonoprazan ODT-1 or ODT-2 with Water · Phathom Pharmaceuticals, Inc. https://druglandscape.com/drug/voquezna-tablets https://druglandscape.com/api/og?type=drug&title=VOQUEZNA%C2%AE%20Tablets&subtitle=VOQUEZNA%C2%AE%20Tablets%20%C2%B7%20Humanis%20Sagl%C4%B1k%20Anonim%20Sirketi&badge=phase%201 VOQUEZNA® Tablets VOQUEZNA® Tablets · Humanis Saglık Anonim Sirketi https://druglandscape.com/drug/voriconazole-inhalation-powder https://druglandscape.com/api/og?type=drug&title=Voriconazole%20Inhalation%20Powder&subtitle=Voriconazole%20Inhalation%20Powder%20%C2%B7%20TFF%20Pharmaceuticals%2C%20Inc.&badge=phase%202 Voriconazole Inhalation Powder Voriconazole Inhalation Powder · TFF Pharmaceuticals, Inc. https://druglandscape.com/drug/voriconazole-inhaled https://druglandscape.com/api/og?type=drug&title=Voriconazole%20inhaled&subtitle=Voriconazole%20inhaled%20%C2%B7%20Zambon%20SpA&badge=phase%201 Voriconazole inhaled Voriconazole inhaled · Zambon SpA https://druglandscape.com/drug/voriconazole-or-posaconazole https://druglandscape.com/api/og?type=drug&title=Voriconazole%20or%20posaconazole&subtitle=Voriconazole%20or%20posaconazole%20%C2%B7%20Universidade%20Federal%20do%20Rio%20de%20Janeiro&badge=phase%201 Voriconazole or posaconazole Voriconazole or posaconazole · Universidade Federal do Rio de Janeiro https://druglandscape.com/drug/voriconazole-tablet https://druglandscape.com/api/og?type=drug&title=voriconazole%20tablet&subtitle=voriconazole%20tablet%20%C2%B7%20Pfizer&badge=phase%202 voriconazole tablet voriconazole tablet · Pfizer https://druglandscape.com/drug/vorinostat-lenalidomide-carfilzomib-dexamethasone https://druglandscape.com/api/og?type=drug&title=Vorinostat%2C%20Lenalidomide%2C%20Carfilzomib%2C%20Dexamethasone&subtitle=Vorinostat%2C%20Lenalidomide%2C%20Carfilzomib%2C%20Dexamethasone%20%C2%B7%20Hackensack%20Meridian%20Health&badge=phase%201 Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone · Hackensack Meridian Health https://druglandscape.com/drug/vorinostat-lenalinomide-and-dexamethasone https://druglandscape.com/api/og?type=drug&title=Vorinostat%2C%20Lenalinomide%20and%20Dexamethasone&subtitle=Vorinostat%2C%20Lenalinomide%20and%20Dexamethasone%20%C2%B7%20Hackensack%20Meridian%20Health&badge=phase%201 Vorinostat, Lenalinomide and Dexamethasone Vorinostat, Lenalinomide and Dexamethasone · Hackensack Meridian Health https://druglandscape.com/drug/vortioxetine-hydrobromide-tablets https://druglandscape.com/api/og?type=drug&title=Vortioxetine%20Hydrobromide%20Tablets&subtitle=Vortioxetine%20Hydrobromide%20Tablets%20%C2%B7%20Seasons%20Biotechnology%20(Taizhou)%20Co.%2C%20Ltd.&badge=phase%201 Vortioxetine Hydrobromide Tablets Vortioxetine Hydrobromide Tablets · Seasons Biotechnology (Taizhou) Co., Ltd. https://druglandscape.com/drug/vortioxetine-iv https://druglandscape.com/api/og?type=drug&title=Vortioxetine%20IV&subtitle=Vortioxetine%20IV%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%202 Vortioxetine IV Vortioxetine IV · H. Lundbeck A/S https://druglandscape.com/drug/vortioxetine-sla https://druglandscape.com/api/og?type=drug&title=Vortioxetine%20SLA&subtitle=Vortioxetine%20SLA%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Vortioxetine SLA Vortioxetine SLA · H. Lundbeck A/S https://druglandscape.com/drug/vortioxetine-slb https://druglandscape.com/api/og?type=drug&title=Vortioxetine%20SLB&subtitle=Vortioxetine%20SLB%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Vortioxetine SLB Vortioxetine SLB · H. Lundbeck A/S https://druglandscape.com/drug/vortioxetine-slc https://druglandscape.com/api/og?type=drug&title=Vortioxetine%20SLC&subtitle=Vortioxetine%20SLC%20%C2%B7%20H.%20Lundbeck%20A%2FS&badge=phase%201 Vortioxetine SLC Vortioxetine SLC · H. Lundbeck A/S https://druglandscape.com/drug/vosoritide-injection-voxzogo https://druglandscape.com/api/og?type=drug&title=Vosoritide%20Injection%20%5BVoxzogo%5D&subtitle=Vosoritide%20Injection%20%5BVoxzogo%5D%20%C2%B7%20BioMarin%20Pharmaceutical&badge=phase%202 Vosoritide Injection [Voxzogo] Vosoritide Injection [Voxzogo] · BioMarin Pharmaceutical https://druglandscape.com/drug/vp-001 https://druglandscape.com/api/og?type=drug&title=VP-001&subtitle=VP-001%20%C2%B7%20PYC%20Therapeutics&badge=phase%201 VP-001 VP-001 · PYC Therapeutics https://druglandscape.com/drug/vp20621 https://druglandscape.com/api/og?type=drug&title=VP20621&subtitle=VP20621%20%C2%B7%20Shire&badge=phase%202 VP20621 VP20621 · Shire https://druglandscape.com/drug/vpd-737 https://druglandscape.com/api/og?type=drug&title=VPD-737&subtitle=VPD-737%20%C2%B7%20Vyne%20Therapeutics%20Inc.&badge=phase%202 VPD-737 VPD-737 · Vyne Therapeutics Inc. https://druglandscape.com/drug/vpi-2690b-high-dose https://druglandscape.com/api/og?type=drug&title=VPI-2690B%20high%20dose&subtitle=VPI-2690B%20high%20dose%20%C2%B7%20Vascular%20Pharmaceuticals%2C%20Inc.&badge=phase%202 VPI-2690B high dose VPI-2690B high dose · Vascular Pharmaceuticals, Inc. https://druglandscape.com/drug/vpi-2690b-low-dose https://druglandscape.com/api/og?type=drug&title=VPI-2690B%20low%20dose&subtitle=VPI-2690B%20low%20dose%20%C2%B7%20Vascular%20Pharmaceuticals%2C%20Inc.&badge=phase%202 VPI-2690B low dose VPI-2690B low dose · Vascular Pharmaceuticals, Inc. https://druglandscape.com/drug/vpi-2690b-medium-dose https://druglandscape.com/api/og?type=drug&title=VPI-2690B%20medium%20dose&subtitle=VPI-2690B%20medium%20dose%20%C2%B7%20Vascular%20Pharmaceuticals%2C%20Inc.&badge=phase%202 VPI-2690B medium dose VPI-2690B medium dose · Vascular Pharmaceuticals, Inc. https://druglandscape.com/drug/vpm1002-live-vaccine https://druglandscape.com/api/og?type=drug&title=VPM1002%20live%20vaccine&subtitle=VPM1002%20live%20vaccine%20%C2%B7%20Serum%20Life%20Science%20Europe%20GmbH&badge=phase%201 VPM1002 live vaccine VPM1002 live vaccine · Serum Life Science Europe GmbH https://druglandscape.com/drug/vr-ad-1005 https://druglandscape.com/api/og?type=drug&title=VR-AD-1005&subtitle=VR-AD-1005%20%C2%B7%20Hunazine%20Biotech%20S.L.&badge=phase%202 VR-AD-1005 VR-AD-1005 · Hunazine Biotech S.L. https://druglandscape.com/drug/vrb-101 https://druglandscape.com/api/og?type=drug&title=VRB-101&subtitle=VRB-101%20%C2%B7%20Verdiva%20Bio%20Dev%20Limited&badge=phase%202 VRB-101 VRB-101 · Verdiva Bio Dev Limited https://druglandscape.com/drug/vrelysin https://druglandscape.com/api/og?type=drug&title=VRELysin%E2%84%A2&subtitle=VRELysin%E2%84%A2%20%C2%B7%20Intralytix%2C%20Inc.&badge=phase%201 VRELysin™ VRELysin™ · Intralytix, Inc. https://druglandscape.com/drug/vrn101099 https://druglandscape.com/api/og?type=drug&title=VRN101099&subtitle=VRN101099%20%C2%B7%20Voronoi%2C%20Inc&badge=phase%201 VRN101099 VRN101099 · Voronoi, Inc https://druglandscape.com/drug/vrn110755 https://druglandscape.com/api/og?type=drug&title=VRN110755&subtitle=VRN110755%20%C2%B7%20Voronoi%2C%20Inc&badge=phase%201 VRN110755 VRN110755 · Voronoi, Inc https://druglandscape.com/drug/vrvg-1 https://druglandscape.com/api/og?type=drug&title=VRVg%201&subtitle=VRVg%201%20%C2%B7%20Sanofi%20Pasteur%2C%20a%20Sanofi%20Company&badge=phase%202 VRVg 1 VRVg 1 · Sanofi Pasteur, a Sanofi Company https://druglandscape.com/drug/vs-101 https://druglandscape.com/api/og?type=drug&title=VS-101&subtitle=VS-101%20%C2%B7%20VSPharmTech%20Co.%2CLtd.&badge=phase%202 VS-101 VS-101 · VSPharmTech Co.,Ltd. https://druglandscape.com/drug/vs-505 https://druglandscape.com/api/og?type=drug&title=VS-505&subtitle=VS-505%20%C2%B7%20Shanghai%20Alebund%20Pharmaceuticals%20Limited&badge=phase%202 VS-505 VS-505 · Shanghai Alebund Pharmaceuticals Limited https://druglandscape.com/drug/vs-6063 https://druglandscape.com/api/og?type=drug&title=VS-6063&subtitle=VS-6063%20%C2%B7%20Verastem%2C%20Inc.&badge=phase%202 VS-6063 VS-6063 · Verastem, Inc. https://druglandscape.com/drug/vs-7375 https://druglandscape.com/api/og?type=drug&title=VS-7375&subtitle=VS-7375%20%C2%B7%20Verastem%2C%20Inc.&badge=phase%201 VS-7375 VS-7375 · Verastem, Inc. https://druglandscape.com/drug/vs101-insert-dose-a https://druglandscape.com/api/og?type=drug&title=VS101%20Insert%20Dose%20A&subtitle=VS101%20Insert%20Dose%20A%20%C2%B7%20ViSci%20Ltd.&badge=phase%201 VS101 Insert Dose A VS101 Insert Dose A · ViSci Ltd. https://druglandscape.com/drug/vs101-insert-dose-b https://druglandscape.com/api/og?type=drug&title=VS101%20Insert%20Dose%20B&subtitle=VS101%20Insert%20Dose%20B%20%C2%B7%20ViSci%20Ltd.&badge=phase%201 VS101 Insert Dose B VS101 Insert Dose B · ViSci Ltd. https://druglandscape.com/drug/vs101-insert-dose-c https://druglandscape.com/api/og?type=drug&title=VS101%20Insert%20Dose%20C&subtitle=VS101%20Insert%20Dose%20C%20%C2%B7%20ViSci%20Ltd.&badge=phase%201 VS101 Insert Dose C VS101 Insert Dose C · ViSci Ltd. https://druglandscape.com/drug/vsa006 https://druglandscape.com/api/og?type=drug&title=VSA006&subtitle=VSA006%20%C2%B7%20Visirna%20Therapeutics%20HK%20Limited&badge=phase%202 VSA006 VSA006 · Visirna Therapeutics HK Limited https://druglandscape.com/drug/vsa012 https://druglandscape.com/api/og?type=drug&title=VSA012&subtitle=VSA012%20%C2%B7%20Visirna%20Therapeutics%20HK%20Limited&badge=phase%201 VSA012 VSA012 · Visirna Therapeutics HK Limited https://druglandscape.com/drug/vsn16r https://druglandscape.com/api/og?type=drug&title=VSN16R&subtitle=VSN16R%20%C2%B7%20Canbex%20Therapeutics%20Ltd&badge=phase%202 VSN16R VSN16R · Canbex Therapeutics Ltd https://druglandscape.com/drug/vsv-ifn-nis https://druglandscape.com/api/og?type=drug&title=VSV-IFN%CE%B2-NIS&subtitle=VSV-IFN%CE%B2-NIS%20%C2%B7%20Vyriad%2C%20Inc.&badge=phase%201 VSV-IFNβ-NIS VSV-IFNβ-NIS · Vyriad, Inc. https://druglandscape.com/drug/vsv-ifn-nis-and-avelumab https://druglandscape.com/api/og?type=drug&title=VSV-IFN%CE%B2-NIS%20and%20avelumab&subtitle=VSV-IFN%CE%B2-NIS%20and%20avelumab%20%C2%B7%20Vyriad%2C%20Inc.&badge=phase%201 VSV-IFNβ-NIS and avelumab VSV-IFNβ-NIS and avelumab · Vyriad, Inc. https://druglandscape.com/drug/vt-1161 https://druglandscape.com/api/og?type=drug&title=VT-1161&subtitle=VT-1161%20%C2%B7%20Viamet&badge=phase%202 VT-1161 VT-1161 · Viamet https://druglandscape.com/drug/vt-ebv-n https://druglandscape.com/api/og?type=drug&title=VT-EBV-N&subtitle=VT-EBV-N%20%C2%B7%20ViGenCell%20Inc.&badge=phase%202 VT-EBV-N VT-EBV-N · ViGenCell Inc. https://druglandscape.com/drug/vt301 https://druglandscape.com/api/og?type=drug&title=VT301&subtitle=VT301%20%C2%B7%20VTBIO%20Co.%20LTD&badge=phase%201 VT301 VT301 · VTBIO Co. LTD https://druglandscape.com/drug/vt3989 https://druglandscape.com/api/og?type=drug&title=VT3989&subtitle=VT3989%20%C2%B7%20Vivace%20Therapeutics%2C%20Inc&badge=phase%201 VT3989 VT3989 · Vivace Therapeutics, Inc https://druglandscape.com/drug/vtp-38543 https://druglandscape.com/api/og?type=drug&title=VTP-38543&subtitle=VTP-38543%20%C2%B7%20Vitae%20Pharmaceuticals%2C%20Inc.&badge=phase%201 VTP-38543 VTP-38543 · Vitae Pharmaceuticals, Inc. https://druglandscape.com/drug/vtp-43742 https://druglandscape.com/api/og?type=drug&title=VTP-43742&subtitle=VTP-43742%20%C2%B7%20Vitae%20Pharmaceuticals%20Inc.%2C%20an%20Allergan%20affiliate&badge=phase%201 VTP-43742 VTP-43742 · Vitae Pharmaceuticals Inc., an Allergan affiliate https://druglandscape.com/drug/vtp195183 https://druglandscape.com/api/og?type=drug&title=VTP195183&subtitle=VTP195183%20%C2%B7%20Peter%20MacCallum%20Cancer%20Centre%2C%20Australia&badge=phase%201 VTP195183 VTP195183 · Peter MacCallum Cancer Centre, Australia https://druglandscape.com/drug/vtx002 https://druglandscape.com/api/og?type=drug&title=VTX002&subtitle=VTX002%20%C2%B7%20Oppilan%20Pharma%20Ltd&badge=phase%202 VTX002 VTX002 · Oppilan Pharma Ltd https://druglandscape.com/drug/vtx2735 https://druglandscape.com/api/og?type=drug&title=VTX2735&subtitle=VTX2735%20%C2%B7%20Zomagen%20Biosciences%20Ltd.&badge=phase%202 VTX2735 VTX2735 · Zomagen Biosciences Ltd. https://druglandscape.com/drug/vtx3232 https://druglandscape.com/api/og?type=drug&title=VTX3232&subtitle=VTX3232%20%C2%B7%20Zomagen%20Biosciences%20Ltd.&badge=phase%202 VTX3232 VTX3232 · Zomagen Biosciences Ltd. https://druglandscape.com/drug/vtx3232-dose-a https://druglandscape.com/api/og?type=drug&title=VTX3232%20Dose%20A&subtitle=VTX3232%20Dose%20A%20%C2%B7%20Zomagen%20Biosciences%20Ltd.&badge=phase%202 VTX3232 Dose A VTX3232 Dose A · Zomagen Biosciences Ltd. https://druglandscape.com/drug/vudalimab-monotherapy https://druglandscape.com/api/og?type=drug&title=vudalimab%20monotherapy&subtitle=vudalimab%20monotherapy%20%C2%B7%20Xencor%2C%20Inc.&badge=phase%202 vudalimab monotherapy vudalimab monotherapy · Xencor, Inc. https://druglandscape.com/drug/vv116 https://druglandscape.com/api/og?type=drug&title=VV116&subtitle=VV116%20%C2%B7%20Vigonvita%20Life%20Sciences&badge=phase%201 VV116 VV116 · Vigonvita Life Sciences https://druglandscape.com/drug/vvd-101 https://druglandscape.com/api/og?type=drug&title=VVD-101&subtitle=VVD-101%20%C2%B7%20Cady%2C%20Roger%2C%20M.D.&badge=phase%202 VVD-101 VVD-101 · Cady, Roger, M.D. https://druglandscape.com/drug/vvd-130037 https://druglandscape.com/api/og?type=drug&title=VVD-130037&subtitle=VVD-130037%20%C2%B7%20Vividion%20Therapeutics%2C%20Inc.&badge=phase%201 VVD-130037 VVD-130037 · Vividion Therapeutics, Inc. https://druglandscape.com/drug/vvd-159642 https://druglandscape.com/api/og?type=drug&title=VVD-159642&subtitle=VVD-159642%20%C2%B7%20Vividion%20Therapeutics%2C%20Inc.&badge=phase%201 VVD-159642 VVD-159642 · Vividion Therapeutics, Inc. https://druglandscape.com/drug/vvn001-ophthalmic-solution-1 https://druglandscape.com/api/og?type=drug&title=VVN001%20Ophthalmic%20Solution%201%25&subtitle=VVN001%20Ophthalmic%20Solution%201%25%20%C2%B7%20VivaVision%20Biotech%2C%20Inc&badge=phase%202 VVN001 Ophthalmic Solution 1% VVN001 Ophthalmic Solution 1% · VivaVision Biotech, Inc https://druglandscape.com/drug/vvn461-ophthalmic-solution-0-5 https://druglandscape.com/api/og?type=drug&title=VVN461%20Ophthalmic%20Solution%200.5%25&subtitle=VVN461%20Ophthalmic%20Solution%200.5%25%20%C2%B7%20VivaVision%20Biotech%2C%20Inc&badge=phase%202 VVN461 Ophthalmic Solution 0.5% VVN461 Ophthalmic Solution 0.5% · VivaVision Biotech, Inc https://druglandscape.com/drug/vvn539-ophthalmic-solution-0-02 https://druglandscape.com/api/og?type=drug&title=VVN539%20Ophthalmic%20Solution%200.02%25&subtitle=VVN539%20Ophthalmic%20Solution%200.02%25%20%C2%B7%20VivaVision%20Biotech%2C%20Inc&badge=phase%202 VVN539 Ophthalmic Solution 0.02% VVN539 Ophthalmic Solution 0.02% · VivaVision Biotech, Inc https://druglandscape.com/drug/vvn539-ophthalmic-solution-0-04 https://druglandscape.com/api/og?type=drug&title=VVN539%20Ophthalmic%20Solution%200.04%25&subtitle=VVN539%20Ophthalmic%20Solution%200.04%25%20%C2%B7%20VivaVision%20Biotech%2C%20Inc&badge=phase%202 VVN539 Ophthalmic Solution 0.04% VVN539 Ophthalmic Solution 0.04% · VivaVision Biotech, Inc https://druglandscape.com/drug/vvx001 https://druglandscape.com/api/og?type=drug&title=VVX001&subtitle=VVX001%20%C2%B7%20Viravaxx%20AG&badge=phase%202 VVX001 VVX001 · Viravaxx AG https://druglandscape.com/drug/vx-01 https://druglandscape.com/api/og?type=drug&title=VX-01&subtitle=VX-01%20%C2%B7%20Vantage%20Biosciences%20Ltd&badge=phase%202 VX-01 VX-01 · Vantage Biosciences Ltd https://druglandscape.com/drug/vx-118 https://druglandscape.com/api/og?type=drug&title=VX-118&subtitle=VX-118%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 VX-118 VX-118 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-147 https://druglandscape.com/api/og?type=drug&title=VX-147&subtitle=VX-147%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%202 VX-147 VX-147 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-150 https://druglandscape.com/api/og?type=drug&title=VX-150&subtitle=VX-150%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%202 VX-150 VX-150 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-152 https://druglandscape.com/api/og?type=drug&title=VX-152&subtitle=VX-152%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%202 VX-152 VX-152 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-264 https://druglandscape.com/api/og?type=drug&title=VX-264&subtitle=VX-264%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 VX-264 VX-264 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-272 https://druglandscape.com/api/og?type=drug&title=VX-272&subtitle=VX-272%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 VX-272 VX-272 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-407 https://druglandscape.com/api/og?type=drug&title=VX-407&subtitle=VX-407%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%202 VX-407 VX-407 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-440 https://druglandscape.com/api/og?type=drug&title=VX-440&subtitle=VX-440%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%202 VX-440 VX-440 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-445 https://druglandscape.com/api/og?type=drug&title=VX-445&subtitle=VX-445%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 VX-445 VX-445 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-509 https://druglandscape.com/api/og?type=drug&title=VX-509&subtitle=VX-509%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%202 VX-509 VX-509 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-548 https://druglandscape.com/api/og?type=drug&title=VX-548&subtitle=VX-548%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%202 VX-548 VX-548 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-581 https://druglandscape.com/api/og?type=drug&title=VX-581&subtitle=VX-581%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 VX-581 VX-581 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-634 https://druglandscape.com/api/og?type=drug&title=VX-634&subtitle=VX-634%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 VX-634 VX-634 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-659 https://druglandscape.com/api/og?type=drug&title=VX-659&subtitle=VX-659%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%202 VX-659 VX-659 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-668 https://druglandscape.com/api/og?type=drug&title=VX-668&subtitle=VX-668%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 VX-668 VX-668 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-670 https://druglandscape.com/api/og?type=drug&title=VX-670&subtitle=VX-670%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%202 VX-670 VX-670 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-708 https://druglandscape.com/api/og?type=drug&title=VX-708&subtitle=VX-708%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 VX-708 VX-708 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-765 https://druglandscape.com/api/og?type=drug&title=VX-765&subtitle=VX-765%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%202 VX-765 VX-765 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-787 https://druglandscape.com/api/og?type=drug&title=VX-787&subtitle=VX-787%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%202 VX-787 VX-787 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-809-vx-770 https://druglandscape.com/api/og?type=drug&title=VX-809%20%26%20VX-770&subtitle=VX-809%20%26%20VX-770%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 VX-809 & VX-770 VX-809 & VX-770 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-840 https://druglandscape.com/api/og?type=drug&title=VX-840&subtitle=VX-840%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 VX-840 VX-840 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-950 https://druglandscape.com/api/og?type=drug&title=VX-950&subtitle=VX-950%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%202 VX-950 VX-950 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-973 https://druglandscape.com/api/og?type=drug&title=VX-973&subtitle=VX-973%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%201 VX-973 VX-973 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vx-993 https://druglandscape.com/api/og?type=drug&title=VX-993&subtitle=VX-993%20%C2%B7%20Vertex%20Pharmaceuticals%20Incorporated&badge=phase%202 VX-993 VX-993 · Vertex Pharmaceuticals Incorporated https://druglandscape.com/drug/vxa-a1-1 https://druglandscape.com/api/og?type=drug&title=VXA-A1.1&subtitle=VXA-A1.1%20%C2%B7%20Vaxart&badge=phase%202 VXA-A1.1 VXA-A1.1 · Vaxart https://druglandscape.com/drug/vxa-cov2-1 https://druglandscape.com/api/og?type=drug&title=VXA-CoV2-1&subtitle=VXA-CoV2-1%20%C2%B7%20Vaxart&badge=phase%201 VXA-CoV2-1 VXA-CoV2-1 · Vaxart https://druglandscape.com/drug/vxa-cov2-3-3 https://druglandscape.com/api/og?type=drug&title=VXA-CoV2-3.3&subtitle=VXA-CoV2-3.3%20%C2%B7%20Vaxart&badge=phase%202 VXA-CoV2-3.3 VXA-CoV2-3.3 · Vaxart https://druglandscape.com/drug/vxa-g1-1-nn https://druglandscape.com/api/og?type=drug&title=VXA-G1.1-NN&subtitle=VXA-G1.1-NN%20%C2%B7%20Vaxart&badge=phase%201 VXA-G1.1-NN VXA-G1.1-NN · Vaxart https://druglandscape.com/drug/vxa-g2-4-ns https://druglandscape.com/api/og?type=drug&title=VXA-G2.4-NS&subtitle=VXA-G2.4-NS%20%C2%B7%20Vaxart&badge=phase%201 VXA-G2.4-NS VXA-G2.4-NS · Vaxart https://druglandscape.com/drug/vxa-g2-4-ns-t https://druglandscape.com/api/og?type=drug&title=VXA%20G2.4%20NS-T&subtitle=VXA%20G2.4%20NS-T%20%C2%B7%20Vaxart&badge=phase%201 VXA G2.4 NS-T VXA G2.4 NS-T · Vaxart https://druglandscape.com/drug/vxa-gi-1-nn https://druglandscape.com/api/og?type=drug&title=VXA-GI.1.NN&subtitle=VXA-GI.1.NN%20%C2%B7%20Vaxart&badge=phase%201 VXA-GI.1.NN VXA-GI.1.NN · Vaxart https://druglandscape.com/drug/vxco-100 https://druglandscape.com/api/og?type=drug&title=VXCO-100&subtitle=VXCO-100%20%C2%B7%20Vaccine%20Company%2C%20Inc.&badge=phase%201 VXCO-100 VXCO-100 · Vaccine Company, Inc. https://druglandscape.com/drug/vxm01 https://druglandscape.com/api/og?type=drug&title=VXM01&subtitle=VXM01%20%C2%B7%20Vaximm%20GmbH&badge=phase%201 VXM01 VXM01 · Vaximm GmbH https://druglandscape.com/drug/vxx-401 https://druglandscape.com/api/og?type=drug&title=VXX-401&subtitle=VXX-401%20%C2%B7%20Vaxxinity%2C%20Inc.&badge=phase%201 VXX-401 VXX-401 · Vaxxinity, Inc. https://druglandscape.com/drug/vycavert-taken-first https://druglandscape.com/api/og?type=drug&title=Vycavert%20taken%20first&subtitle=Vycavert%20taken%20first%20%C2%B7%20Acura%20Pharmaceuticals%20Inc.&badge=phase%202 Vycavert taken first Vycavert taken first · Acura Pharmaceuticals Inc. https://druglandscape.com/drug/vyd222 https://druglandscape.com/api/og?type=drug&title=VYD222&subtitle=VYD222%20%C2%B7%20Invivyd%2C%20Inc.&badge=phase%202 VYD222 VYD222 · Invivyd, Inc. https://druglandscape.com/drug/vyd2311 https://druglandscape.com/api/og?type=drug&title=VYD2311&subtitle=VYD2311%20%C2%B7%20Invivyd%2C%20Inc.&badge=phase%201 VYD2311 VYD2311 · Invivyd, Inc. https://druglandscape.com/drug/vyn201-gel https://druglandscape.com/api/og?type=drug&title=VYN201%20Gel&subtitle=VYN201%20Gel%20%C2%B7%20Vyne%20Therapeutics%20Inc.&badge=phase%202 VYN201 Gel VYN201 Gel · Vyne Therapeutics Inc. https://druglandscape.com/drug/vzv-vaccine https://druglandscape.com/api/og?type=drug&title=VZV%20vaccine&subtitle=VZV%20vaccine%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 VZV vaccine VZV vaccine · Baylor College of Medicine https://druglandscape.com/drug/w0027 https://druglandscape.com/api/og?type=drug&title=W0027&subtitle=W0027%20%C2%B7%20Stiefel%2C%20a%20GSK%20Company&badge=phase%201 W0027 W0027 · Stiefel, a GSK Company https://druglandscape.com/drug/warfarin-pill https://druglandscape.com/api/og?type=drug&title=Warfarin%20Pill&subtitle=Warfarin%20Pill%20%C2%B7%20SK%20Life%20Science%2C%20Inc.&badge=phase%201 Warfarin Pill Warfarin Pill · SK Life Science, Inc. https://druglandscape.com/drug/warfarin-plus-albiglutide https://druglandscape.com/api/og?type=drug&title=warfarin%20plus%20albiglutide&subtitle=warfarin%20plus%20albiglutide%20%C2%B7%20GlaxoSmithKline&badge=phase%201 warfarin plus albiglutide warfarin plus albiglutide · GlaxoSmithKline https://druglandscape.com/drug/warfarin-plus-fesoterodine https://druglandscape.com/api/og?type=drug&title=Warfarin%20plus%20Fesoterodine&subtitle=Warfarin%20plus%20Fesoterodine%20%C2%B7%20Pfizer&badge=phase%201 Warfarin plus Fesoterodine Warfarin plus Fesoterodine · Pfizer https://druglandscape.com/drug/warner-chilcott-llc-s-sarafem-tablet https://druglandscape.com/api/og?type=drug&title=Warner%20Chilcott%20LLC's%20Sarafem%20Tablet&subtitle=Warner%20Chilcott%20LLC's%20Sarafem%20Tablet%20%C2%B7%20Torrent%20Pharmaceuticals%20Limited&badge=phase%201 Warner Chilcott LLC's Sarafem Tablet Warner Chilcott LLC's Sarafem Tablet · Torrent Pharmaceuticals Limited https://druglandscape.com/drug/wb007-0-15 https://druglandscape.com/api/og?type=drug&title=WB007%200.15%25&subtitle=WB007%200.15%25%20%C2%B7%20Bausch%20%26%20Lomb%20Incorporated&badge=phase%201 WB007 0.15% WB007 0.15% · Bausch & Lomb Incorporated https://druglandscape.com/drug/wb007-0-4 https://druglandscape.com/api/og?type=drug&title=WB007%200.4%25&subtitle=WB007%200.4%25%20%C2%B7%20Bausch%20%26%20Lomb%20Incorporated&badge=phase%201 WB007 0.4% WB007 0.4% · Bausch & Lomb Incorporated https://druglandscape.com/drug/wck-2349-oral https://druglandscape.com/api/og?type=drug&title=WCK%202349%20Oral&subtitle=WCK%202349%20Oral%20%C2%B7%20Wockhardt&badge=phase%201 WCK 2349 Oral WCK 2349 Oral · Wockhardt https://druglandscape.com/drug/wck-4873 https://druglandscape.com/api/og?type=drug&title=WCK%204873&subtitle=WCK%204873%20%C2%B7%20Wockhardt&badge=phase%201 WCK 4873 WCK 4873 · Wockhardt https://druglandscape.com/drug/wck-5222 https://druglandscape.com/api/og?type=drug&title=WCK%205222&subtitle=WCK%205222%20%C2%B7%20Wockhardt&badge=phase%201 WCK 5222 WCK 5222 · Wockhardt https://druglandscape.com/drug/wd-1602 https://druglandscape.com/api/og?type=drug&title=WD-1602&subtitle=WD-1602%20%C2%B7%20Hong%20Kong%20WD%20Pharmaceutical%20Co.%2C%20Limited&badge=phase%201 WD-1602 WD-1602 · Hong Kong WD Pharmaceutical Co., Limited https://druglandscape.com/drug/wd-1603 https://druglandscape.com/api/og?type=drug&title=WD-1603&subtitle=WD-1603%20%C2%B7%20Hong%20Kong%20WD%20Pharmaceutical%20Co.%2C%20Limited&badge=phase%201 WD-1603 WD-1603 · Hong Kong WD Pharmaceutical Co., Limited https://druglandscape.com/drug/wd-890-tablet https://druglandscape.com/api/og?type=drug&title=WD-890%20tablet&subtitle=WD-890%20tablet%20%C2%B7%20Zhejiang%20Wenda%20Pharma%20Technology%20LTD.&badge=phase%202 WD-890 tablet WD-890 tablet · Zhejiang Wenda Pharma Technology LTD. https://druglandscape.com/drug/wd-910-tablet https://druglandscape.com/api/og?type=drug&title=WD-910%20tablet&subtitle=WD-910%20tablet%20%C2%B7%20Zhejiang%20Wenda%20Pharma%20Technology%20LTD.&badge=phase%201 WD-910 tablet WD-910 tablet · Zhejiang Wenda Pharma Technology LTD. https://druglandscape.com/drug/wee-1-kinase-inhibitor-azd1775 https://druglandscape.com/api/og?type=drug&title=Wee-1%20kinase%20inhibitor%20AZD1775&subtitle=Wee-1%20kinase%20inhibitor%20AZD1775%20%C2%B7%20AstraZeneca&badge=phase%201 Wee-1 kinase inhibitor AZD1775 Wee-1 kinase inhibitor AZD1775 · AstraZeneca https://druglandscape.com/drug/week-24 https://druglandscape.com/api/og?type=drug&title=week%2024&subtitle=week%2024%20%C2%B7%20University%20Hospital%2C%20Ghent&badge=phase%203 week 24 week 24 · University Hospital, Ghent https://druglandscape.com/drug/weekly-cabazitaxel https://druglandscape.com/api/og?type=drug&title=weekly%20cabazitaxel&subtitle=weekly%20cabazitaxel%20%C2%B7%20Jeffrey%20Yachnin%20M.D.%2C%20PhD.&badge=phase%202 weekly cabazitaxel weekly cabazitaxel · Jeffrey Yachnin M.D., PhD. https://druglandscape.com/drug/wef-001 https://druglandscape.com/api/og?type=drug&title=WEF-001&subtitle=WEF-001%20%C2%B7%20Auricula%20Biosciences%20Inc.&badge=phase%201 WEF-001 WEF-001 · Auricula Biosciences Inc. https://druglandscape.com/drug/weight-reduction https://druglandscape.com/api/og?type=drug&title=Weight%20reduction&subtitle=Weight%20reduction%20%C2%B7%20Assaf-Harofeh%20Medical%20Center&badge=phase%201 Weight reduction Weight reduction · Assaf-Harofeh Medical Center https://druglandscape.com/drug/wellbutrinxl https://druglandscape.com/api/og?type=drug&title=WellbutrinXL&subtitle=WellbutrinXL%20%C2%B7%20GlaxoSmithKline&badge=phase%201 WellbutrinXL WellbutrinXL · GlaxoSmithKline https://druglandscape.com/drug/western-equine-encephalitis-vaccine https://druglandscape.com/api/og?type=drug&title=Western%20Equine%20Encephalitis%20Vaccine&subtitle=Western%20Equine%20Encephalitis%20Vaccine%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 Western Equine Encephalitis Vaccine Western Equine Encephalitis Vaccine · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/wh-1-ointment https://druglandscape.com/api/og?type=drug&title=WH-1%20ointment&subtitle=WH-1%20ointment%20%C2%B7%20Oneness%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 WH-1 ointment WH-1 ointment · Oneness Biotech Co., Ltd. https://druglandscape.com/drug/wheat-oit https://druglandscape.com/api/og?type=drug&title=Wheat%20OIT&subtitle=Wheat%20OIT%20%C2%B7%20Hugh%20A%20Sampson%2C%20MD&badge=phase%201 Wheat OIT Wheat OIT · Hugh A Sampson, MD https://druglandscape.com/drug/white-button-mushroom-extract https://druglandscape.com/api/og?type=drug&title=White%20Button%20Mushroom%20Extract&subtitle=White%20Button%20Mushroom%20Extract%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%202 White Button Mushroom Extract White Button Mushroom Extract · City of Hope Medical Center https://druglandscape.com/drug/who-recommended-2011-influenza-vacccine https://druglandscape.com/api/og?type=drug&title=WHO%20recommended%202011%20Influenza%20vacccine&subtitle=WHO%20recommended%202011%20Influenza%20vacccine%20%C2%B7%20Tel-Aviv%20Sourasky%20Medical%20Center&badge=phase%201 WHO recommended 2011 Influenza vacccine WHO recommended 2011 Influenza vacccine · Tel-Aviv Sourasky Medical Center https://druglandscape.com/drug/whole-blood-donation https://druglandscape.com/api/og?type=drug&title=Whole%20blood%20donation&subtitle=Whole%20blood%20donation%20%C2%B7%20Etablissement%20Fran%C3%A7ais%20du%20Sang&badge=phase%201 Whole blood donation Whole blood donation · Etablissement Français du Sang https://druglandscape.com/drug/whole-blood-sample https://druglandscape.com/api/og?type=drug&title=Whole%20blood%20sample&subtitle=Whole%20blood%20sample%20%C2%B7%20Assistance%20Publique%20-%20H%C3%B4pitaux%20de%20Paris&badge=phase%202 Whole blood sample Whole blood sample · Assistance Publique - Hôpitaux de Paris https://druglandscape.com/drug/wid-clz18 https://druglandscape.com/api/og?type=drug&title=WID-CLZ18&subtitle=WID-CLZ18%20%C2%B7%20Whanin%20Pharmaceutical%20Company&badge=phase%201 WID-CLZ18 WID-CLZ18 · Whanin Pharmaceutical Company https://druglandscape.com/drug/wide-spectrum-nutritional-supplement https://druglandscape.com/api/og?type=drug&title=Wide-spectrum%20nutritional%20supplement&subtitle=Wide-spectrum%20nutritional%20supplement%20%C2%B7%20Rossignol%20Medical%20Center&badge=phase%202 Wide-spectrum nutritional supplement Wide-spectrum nutritional supplement · Rossignol Medical Center https://druglandscape.com/drug/win-901x-dose-level-1 https://druglandscape.com/api/og?type=drug&title=WIN-901X%20dose%20level%201&subtitle=WIN-901X%20dose%20level%201%20%C2%B7%20Whanin%20Pharmaceutical%20Company&badge=phase%202 WIN-901X dose level 1 WIN-901X dose level 1 · Whanin Pharmaceutical Company https://druglandscape.com/drug/win-901x-dose-level-3 https://druglandscape.com/api/og?type=drug&title=WIN-901X%20dose%20level%203&subtitle=WIN-901X%20dose%20level%203%20%C2%B7%20Whanin%20Pharmaceutical%20Company&badge=phase%202 WIN-901X dose level 3 WIN-901X dose level 3 · Whanin Pharmaceutical Company https://druglandscape.com/drug/wj-mscs https://druglandscape.com/api/og?type=drug&title=WJ-MSCs&subtitle=WJ-MSCs%20%C2%B7%20Stem%20Cells%20Arabia&badge=phase%201 WJ-MSCs WJ-MSCs · Stem Cells Arabia https://druglandscape.com/drug/wj47156 https://druglandscape.com/api/og?type=drug&title=WJ47156&subtitle=WJ47156%20%C2%B7%20Shanghai%20Junshi%20Bioscience%20Co.%2C%20Ltd.&badge=phase%201 WJ47156 WJ47156 · Shanghai Junshi Bioscience Co., Ltd. https://druglandscape.com/drug/wjb001 https://druglandscape.com/api/og?type=drug&title=WJB001&subtitle=WJB001%20%C2%B7%20Wigen%20Biomedicine%20Technology%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 WJB001 WJB001 · Wigen Biomedicine Technology (Shanghai) Co., Ltd. https://druglandscape.com/drug/wo3979 https://druglandscape.com/api/og?type=drug&title=WO3979&subtitle=WO3979%20%C2%B7%20Dr.%20August%20Wolff%20GmbH%20%26%20Co.%20KG%20Arzneimittel&badge=phase%201 WO3979 WO3979 · Dr. August Wolff GmbH & Co. KG Arzneimittel https://druglandscape.com/drug/wo3992 https://druglandscape.com/api/og?type=drug&title=WO3992&subtitle=WO3992%20%C2%B7%20Dr.%20August%20Wolff%20GmbH%20%26%20Co.%20KG%20Arzneimittel&badge=phase%201 WO3992 WO3992 · Dr. August Wolff GmbH & Co. KG Arzneimittel https://druglandscape.com/drug/wobenzym https://druglandscape.com/api/og?type=drug&title=Wobenzym%C2%AE&subtitle=Wobenzym%C2%AE%20%C2%B7%20Mucos%20Pharma%20GmbH%20%26%20Co.%20KG&badge=phase%201 Wobenzym® Wobenzym® · Mucos Pharma GmbH & Co. KG https://druglandscape.com/drug/wosulin-r https://druglandscape.com/api/og?type=drug&title=Wosulin%20R&subtitle=Wosulin%20R%20%C2%B7%20Wockhardt&badge=phase%201 Wosulin R Wosulin R · Wockhardt https://druglandscape.com/drug/wp1220 https://druglandscape.com/api/og?type=drug&title=WP1220&subtitle=WP1220%20%C2%B7%20Moleculin%20Biotech%2C%20Inc.&badge=phase%201 WP1220 WP1220 · Moleculin Biotech, Inc. https://druglandscape.com/drug/wpp-201-bacteriophage https://druglandscape.com/api/og?type=drug&title=WPP-201%20Bacteriophage&subtitle=WPP-201%20Bacteriophage%20%C2%B7%20Southwest%20Regional%20Wound%20Care%20Center&badge=phase%201 WPP-201 Bacteriophage WPP-201 Bacteriophage · Southwest Regional Wound Care Center https://druglandscape.com/drug/wpv01-dose-13-15-and-ritonavir https://druglandscape.com/api/og?type=drug&title=WPV01%20Dose%2013-15%20and%20Ritonavir&subtitle=WPV01%20Dose%2013-15%20and%20Ritonavir%20%C2%B7%20Westlake%20Pharmaceuticals%20(Hangzhou)%20Co.%2C%20Ltd.&badge=phase%201 WPV01 Dose 13-15 and Ritonavir WPV01 Dose 13-15 and Ritonavir · Westlake Pharmaceuticals (Hangzhou) Co., Ltd. https://druglandscape.com/drug/wpv01-dose-9-12 https://druglandscape.com/api/og?type=drug&title=WPV01%20Dose%209-12&subtitle=WPV01%20Dose%209-12%20%C2%B7%20Westlake%20Pharmaceuticals%20(Hangzhou)%20Co.%2C%20Ltd.&badge=phase%201 WPV01 Dose 9-12 WPV01 Dose 9-12 · Westlake Pharmaceuticals (Hangzhou) Co., Ltd. https://druglandscape.com/drug/wr-279396 https://druglandscape.com/api/og?type=drug&title=WR%20279396&subtitle=WR%20279396%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 WR 279396 WR 279396 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/wr826647 https://druglandscape.com/api/og?type=drug&title=WR826647&subtitle=WR826647%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 WR826647 WR826647 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/wr909390 https://druglandscape.com/api/og?type=drug&title=WR909390&subtitle=WR909390%20%C2%B7%20U.S.%20Army%20Medical%20Research%20and%20Development%20Command&badge=phase%201 WR909390 WR909390 · U.S. Army Medical Research and Development Command https://druglandscape.com/drug/wsd0922-fu https://druglandscape.com/api/og?type=drug&title=WSD0922-FU&subtitle=WSD0922-FU%20%C2%B7%20Wayshine%20Biopharm%2C%20Inc.&badge=phase%201 WSD0922-FU WSD0922-FU · Wayshine Biopharm, Inc. https://druglandscape.com/drug/wsd0922-fu-tablets-dose-level-b https://druglandscape.com/api/og?type=drug&title=WSD0922-FU%20Tablets%2C%20Dose%20level%20B&subtitle=WSD0922-FU%20Tablets%2C%20Dose%20level%20B%20%C2%B7%20Wayshine%20Biopharm%2C%20Inc.&badge=phase%202 WSD0922-FU Tablets, Dose level B WSD0922-FU Tablets, Dose level B · Wayshine Biopharm, Inc. https://druglandscape.com/drug/wsk-im02 https://druglandscape.com/api/og?type=drug&title=WSK-IM02&subtitle=WSK-IM02%20%C2%B7%20WestVac%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 WSK-IM02 WSK-IM02 · WestVac Biopharma Co., Ltd. https://druglandscape.com/drug/wsp-vaccine https://druglandscape.com/api/og?type=drug&title=wSp%20vaccine&subtitle=wSp%20vaccine%20%C2%B7%20Serum%20Life%20Science%20Europe%20GmbH&badge=phase%202 wSp vaccine wSp vaccine · Serum Life Science Europe GmbH https://druglandscape.com/drug/wst-057-active https://druglandscape.com/api/og?type=drug&title=WST-057%20Active&subtitle=WST-057%20Active%20%C2%B7%20WinSanTor%2C%20Inc&badge=phase%202 WST-057 Active WST-057 Active · WinSanTor, Inc https://druglandscape.com/drug/wst09 https://druglandscape.com/api/og?type=drug&title=WST09&subtitle=WST09%20%C2%B7%20STEBA%20France&badge=phase%202 WST09 WST09 · STEBA France https://druglandscape.com/drug/wtx-124 https://druglandscape.com/api/og?type=drug&title=WTX-124&subtitle=WTX-124%20%C2%B7%20Werewolf%20Therapeutics%2C%20Inc.&badge=phase%201 WTX-124 WTX-124 · Werewolf Therapeutics, Inc. https://druglandscape.com/drug/wtx-330 https://druglandscape.com/api/og?type=drug&title=WTX-330&subtitle=WTX-330%20%C2%B7%20Werewolf%20Therapeutics%2C%20Inc.&badge=phase%201 WTX-330 WTX-330 · Werewolf Therapeutics, Inc. https://druglandscape.com/drug/wu-cart-007 https://druglandscape.com/api/og?type=drug&title=WU-CART-007&subtitle=WU-CART-007%20%C2%B7%20Wugen%2C%20Inc.&badge=phase%202 WU-CART-007 WU-CART-007 · Wugen, Inc. https://druglandscape.com/drug/wu-nk-101-cohort-expansion https://druglandscape.com/api/og?type=drug&title=WU-NK-101%20-%20Cohort%20Expansion&subtitle=WU-NK-101%20-%20Cohort%20Expansion%20%C2%B7%20Wugen%2C%20Inc.&badge=phase%201 WU-NK-101 - Cohort Expansion WU-NK-101 - Cohort Expansion · Wugen, Inc. https://druglandscape.com/drug/wve-006 https://druglandscape.com/api/og?type=drug&title=WVE-006&subtitle=WVE-006%20%C2%B7%20Wave%20Life%20Sciences%20Ltd.&badge=phase%201 WVE-006 WVE-006 · Wave Life Sciences Ltd. https://druglandscape.com/drug/wx390 https://druglandscape.com/api/og?type=drug&title=WX390&subtitle=WX390%20%C2%B7%20Shanghai%20Jiatan%20Pharmatech%20Co.%2C%20Ltd&badge=phase%202 WX390 WX390 · Shanghai Jiatan Pharmatech Co., Ltd https://druglandscape.com/drug/wxfl10030390 https://druglandscape.com/api/og?type=drug&title=WXFL10030390&subtitle=WXFL10030390%20%C2%B7%20Shanghai%20Jiatan%20Pharmatech%20Co.%2C%20Ltd&badge=phase%201 WXFL10030390 WXFL10030390 · Shanghai Jiatan Pharmatech Co., Ltd https://druglandscape.com/drug/x-22-smoking-cessation-product https://druglandscape.com/api/og?type=drug&title=X-22%20Smoking%20Cessation%20Product&subtitle=X-22%20Smoking%20Cessation%20Product%20%C2%B7%2022nd%20Century%20Limited%2C%20LLC&badge=phase%202 X-22 Smoking Cessation Product X-22 Smoking Cessation Product · 22nd Century Limited, LLC https://druglandscape.com/drug/xaf5-concentration-b https://druglandscape.com/api/og?type=drug&title=XAF5%2C%20concentration%20B&subtitle=XAF5%2C%20concentration%20B%20%C2%B7%20Topokine%20Therapeutics%2C%20Inc.&badge=phase%201 XAF5, concentration B XAF5, concentration B · Topokine Therapeutics, Inc. https://druglandscape.com/drug/xb002 https://druglandscape.com/api/og?type=drug&title=XB002&subtitle=XB002%20%C2%B7%20Exelixis&badge=phase%201 XB002 XB002 · Exelixis https://druglandscape.com/drug/xb010 https://druglandscape.com/api/og?type=drug&title=XB010&subtitle=XB010%20%C2%B7%20Exelixis&badge=phase%201 XB010 XB010 · Exelixis https://druglandscape.com/drug/xb371 https://druglandscape.com/api/og?type=drug&title=XB371&subtitle=XB371%20%C2%B7%20Exelixis&badge=phase%201 XB371 XB371 · Exelixis https://druglandscape.com/drug/xb628 https://druglandscape.com/api/og?type=drug&title=XB628&subtitle=XB628%20%C2%B7%20Exelixis&badge=phase%201 XB628 XB628 · Exelixis https://druglandscape.com/drug/xbd173 https://druglandscape.com/api/og?type=drug&title=XBD173&subtitle=XBD173%20%C2%B7%20Imperial%20College%20London&badge=phase%202 XBD173 XBD173 · Imperial College London https://druglandscape.com/drug/xbi-302 https://druglandscape.com/api/og?type=drug&title=XBI-302&subtitle=XBI-302%20%C2%B7%20Shenzhen%20Xbiome%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 XBI-302 XBI-302 · Shenzhen Xbiome Biotech Co., Ltd. https://druglandscape.com/drug/xcel-mc-alpha https://druglandscape.com/api/og?type=drug&title=XCEL-MC-ALPHA&subtitle=XCEL-MC-ALPHA%20%C2%B7%20Banc%20de%20Sang%20i%20Teixits&badge=phase%201 XCEL-MC-ALPHA XCEL-MC-ALPHA · Banc de Sang i Teixits https://druglandscape.com/drug/xcel-mt-osteo-alpha https://druglandscape.com/api/og?type=drug&title=XCEL-MT-OSTEO-ALPHA&subtitle=XCEL-MT-OSTEO-ALPHA%20%C2%B7%20Banc%20de%20Sang%20i%20Teixits&badge=phase%201 XCEL-MT-OSTEO-ALPHA XCEL-MT-OSTEO-ALPHA · Banc de Sang i Teixits https://druglandscape.com/drug/xcel-umc-beta https://druglandscape.com/api/og?type=drug&title=XCEL-UMC-BETA&subtitle=XCEL-UMC-BETA%20%C2%B7%20Banc%20de%20Sang%20i%20Teixits&badge=phase%201 XCEL-UMC-BETA XCEL-UMC-BETA · Banc de Sang i Teixits https://druglandscape.com/drug/xcell-amnio-matrix https://druglandscape.com/api/og?type=drug&title=Xcell%20Amnio%20Matrix&subtitle=Xcell%20Amnio%20Matrix%20%C2%B7%20New%20Horizon%20Medical%20Solutions&badge=phase%201 Xcell Amnio Matrix Xcell Amnio Matrix · New Horizon Medical Solutions https://druglandscape.com/drug/xelox-regimes https://druglandscape.com/api/og?type=drug&title=Xelox%20regimes&subtitle=Xelox%20regimes%20%C2%B7%20Jiangsu%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 Xelox regimes Xelox regimes · Jiangsu Simcere Pharmaceutical Co., Ltd. https://druglandscape.com/drug/xen901 https://druglandscape.com/api/og?type=drug&title=XEN901&subtitle=XEN901%20%C2%B7%20Xenon%20Pharmaceuticals%20Inc.&badge=phase%201 XEN901 XEN901 · Xenon Pharmaceuticals Inc. https://druglandscape.com/drug/xenical-vs-emp-22 https://druglandscape.com/api/og?type=drug&title=Xenical%C2%AE%20vs%20EMP%2022&subtitle=Xenical%C2%AE%20vs%20EMP%2022%20%C2%B7%20Empros%20Pharma%20AB&badge=phase%201 Xenical® vs EMP 22 Xenical® vs EMP 22 · Empros Pharma AB https://druglandscape.com/drug/xenon-gas-inhalation https://druglandscape.com/api/og?type=drug&title=Xenon%20gas%20inhalation&subtitle=Xenon%20gas%20inhalation%20%C2%B7%20General%20Biophysics%20LLC&badge=phase%201 Xenon gas inhalation Xenon gas inhalation · General Biophysics LLC https://druglandscape.com/drug/xerecept-1-0 https://druglandscape.com/api/og?type=drug&title=Xerecept%201.0&subtitle=Xerecept%201.0%20%C2%B7%20Celtic%20Pharma%20Development%20Services&badge=phase%201 Xerecept 1.0 Xerecept 1.0 · Celtic Pharma Development Services https://druglandscape.com/drug/xerecept-2-0 https://druglandscape.com/api/og?type=drug&title=Xerecept%202.0&subtitle=Xerecept%202.0%20%C2%B7%20Celtic%20Pharma%20Development%20Services&badge=phase%201 Xerecept 2.0 Xerecept 2.0 · Celtic Pharma Development Services https://druglandscape.com/drug/xerecept-3-0 https://druglandscape.com/api/og?type=drug&title=Xerecept%203.0&subtitle=Xerecept%203.0%20%C2%B7%20Celtic%20Pharma%20Development%20Services&badge=phase%201 Xerecept 3.0 Xerecept 3.0 · Celtic Pharma Development Services https://druglandscape.com/drug/xeris-glucagon https://druglandscape.com/api/og?type=drug&title=Xeris%20glucagon&subtitle=Xeris%20glucagon%20%C2%B7%20Steven%20J.%20Russell%2C%20MD%2C%20PhD&badge=phase%202 Xeris glucagon Xeris glucagon · Steven J. Russell, MD, PhD https://druglandscape.com/drug/xeruborbactam-oral-prodrug https://druglandscape.com/api/og?type=drug&title=Xeruborbactam%20Oral%20Prodrug&subtitle=Xeruborbactam%20Oral%20Prodrug%20%C2%B7%20Qpex%20Biopharma%2C%20Inc.&badge=phase%201 Xeruborbactam Oral Prodrug Xeruborbactam Oral Prodrug · Qpex Biopharma, Inc. https://druglandscape.com/drug/xf-73 https://druglandscape.com/api/og?type=drug&title=XF-73&subtitle=XF-73%20%C2%B7%20Destiny%20Pharma%20Plc&badge=phase%202 XF-73 XF-73 · Destiny Pharma Plc https://druglandscape.com/drug/xf-73-nasal-gel https://druglandscape.com/api/og?type=drug&title=XF-73%20nasal%20gel&subtitle=XF-73%20nasal%20gel%20%C2%B7%20Destiny%20Pharma%20Plc&badge=phase%201 XF-73 nasal gel XF-73 nasal gel · Destiny Pharma Plc https://druglandscape.com/drug/xfb19 https://druglandscape.com/api/og?type=drug&title=XFB19&subtitle=XFB19%20%C2%B7%20Xfibra%2C%20Inc.&badge=phase%201 XFB19 XFB19 · Xfibra, Inc. https://druglandscape.com/drug/xg005 https://druglandscape.com/api/og?type=drug&title=XG005&subtitle=XG005%20%C2%B7%20Xgene%20Pharmaceutical%20Group&badge=phase%202 XG005 XG005 · Xgene Pharmaceutical Group https://druglandscape.com/drug/xg005-03 https://druglandscape.com/api/og?type=drug&title=XG005-03&subtitle=XG005-03%20%C2%B7%20Xgene%20Pharmaceutical%20Group&badge=phase%201 XG005-03 XG005-03 · Xgene Pharmaceutical Group https://druglandscape.com/drug/xh-s002-a https://druglandscape.com/api/og?type=drug&title=XH-S002%20%EF%BC%88A%EF%BC%89&subtitle=XH-S002%20%EF%BC%88A%EF%BC%89%20%C2%B7%20S-INFINITY%20Pharmaceuticals%20Co.%2C%20Ltd&badge=phase%201 XH-S002 （A） XH-S002 （A） · S-INFINITY Pharmaceuticals Co., Ltd https://druglandscape.com/drug/xh-s004-tablet https://druglandscape.com/api/og?type=drug&title=XH-S004%20tablet&subtitle=XH-S004%20tablet%20%C2%B7%20S-INFINITY%20Pharmaceuticals%20Co.%2C%20Ltd&badge=phase%201 XH-S004 tablet XH-S004 tablet · S-INFINITY Pharmaceuticals Co., Ltd https://druglandscape.com/drug/xilonix-plus-onivyde-and-5fu https://druglandscape.com/api/og?type=drug&title=Xilonix%20plus%20Onivyde%20and%205FU&subtitle=Xilonix%20plus%20Onivyde%20and%205FU%20%C2%B7%20Andrew%20Hendifar%2C%20MD&badge=phase%201 Xilonix plus Onivyde and 5FU Xilonix plus Onivyde and 5FU · Andrew Hendifar, MD https://druglandscape.com/drug/xingbaiji-formula https://druglandscape.com/api/og?type=drug&title=Xingbaiji%20Formula&subtitle=Xingbaiji%20Formula%20%C2%B7%20Jiangxi%20Provincial%20People's%20Hopital&badge=phase%201 Xingbaiji Formula Xingbaiji Formula · Jiangxi Provincial People's Hopital https://druglandscape.com/drug/xiongdan-wan https://druglandscape.com/api/og?type=drug&title=Xiongdan%20Wan&subtitle=Xiongdan%20Wan%20%C2%B7%20Shanghai%20Mental%20Health%20Center&badge=phase%202 Xiongdan Wan Xiongdan Wan · Shanghai Mental Health Center https://druglandscape.com/drug/xjn010-nasal-spray https://druglandscape.com/api/og?type=drug&title=XJN010%20Nasal%20Spray&subtitle=XJN010%20Nasal%20Spray%20%C2%B7%20Guangzhou%20Novaken%20Pharm%20Co.%2C%20Ltd.&badge=phase%202 XJN010 Nasal Spray XJN010 Nasal Spray · Guangzhou Novaken Pharm Co., Ltd. https://druglandscape.com/drug/xkdct293 https://druglandscape.com/api/og?type=drug&title=XKDCT293&subtitle=XKDCT293%20%C2%B7%20Shenzhen%20Celconta%20Life%20Science%20Co.%2C%20Ltd.&badge=phase%201 XKDCT293 XKDCT293 · Shenzhen Celconta Life Science Co., Ltd. https://druglandscape.com/drug/xl281 https://druglandscape.com/api/og?type=drug&title=XL281&subtitle=XL281%20%C2%B7%20Exelixis&badge=phase%201 XL281 XL281 · Exelixis https://druglandscape.com/drug/xl309 https://druglandscape.com/api/og?type=drug&title=XL309&subtitle=XL309%20%C2%B7%20Exelixis&badge=phase%201 XL309 XL309 · Exelixis https://druglandscape.com/drug/xl784 https://druglandscape.com/api/og?type=drug&title=XL784&subtitle=XL784%20%C2%B7%20Symphony%20Evolution%2C%20Inc.&badge=phase%202 XL784 XL784 · Symphony Evolution, Inc. https://druglandscape.com/drug/xl820 https://druglandscape.com/api/og?type=drug&title=XL820&subtitle=XL820%20%C2%B7%20Exelixis&badge=phase%202 XL820 XL820 · Exelixis https://druglandscape.com/drug/xl888 https://druglandscape.com/api/og?type=drug&title=XL888&subtitle=XL888%20%C2%B7%20Exelixis&badge=phase%201 XL888 XL888 · Exelixis https://druglandscape.com/drug/xm17 https://druglandscape.com/api/og?type=drug&title=XM17&subtitle=XM17%20%C2%B7%20Merckle%20GmbH&badge=phase%201 XM17 XM17 · Merckle GmbH https://druglandscape.com/drug/xmab13676 https://druglandscape.com/api/og?type=drug&title=XmAb13676&subtitle=XmAb13676%20%C2%B7%20Xencor%2C%20Inc.&badge=phase%201 XmAb13676 XmAb13676 · Xencor, Inc. https://druglandscape.com/drug/xmab14045 https://druglandscape.com/api/og?type=drug&title=XmAb14045&subtitle=XmAb14045%20%C2%B7%20Xencor%2C%20Inc.&badge=phase%201 XmAb14045 XmAb14045 · Xencor, Inc. https://druglandscape.com/drug/xmab24306 https://druglandscape.com/api/og?type=drug&title=XmAb24306&subtitle=XmAb24306%20%C2%B7%20Genentech%2C%20Inc.&badge=phase%201 XmAb24306 XmAb24306 · Genentech, Inc. https://druglandscape.com/drug/xmab2513 https://druglandscape.com/api/og?type=drug&title=XmAb2513&subtitle=XmAb2513%20%C2%B7%20Xencor%2C%20Inc.&badge=phase%201 XmAb2513 XmAb2513 · Xencor, Inc. https://druglandscape.com/drug/xmab541 https://druglandscape.com/api/og?type=drug&title=XmAb541&subtitle=XmAb541%20%C2%B7%20Xencor%2C%20Inc.&badge=phase%201 XmAb541 XmAb541 · Xencor, Inc. https://druglandscape.com/drug/xmab5574 https://druglandscape.com/api/og?type=drug&title=XmAb5574&subtitle=XmAb5574%20%C2%B7%20Xencor%2C%20Inc.&badge=phase%201 XmAb5574 XmAb5574 · Xencor, Inc. https://druglandscape.com/drug/xmab7195 https://druglandscape.com/api/og?type=drug&title=XmAb7195&subtitle=XmAb7195%20%C2%B7%20Xencor%2C%20Inc.&badge=phase%201 XmAb7195 XmAb7195 · Xencor, Inc. https://druglandscape.com/drug/xmab808 https://druglandscape.com/api/og?type=drug&title=XmAb%C2%AE808&subtitle=XmAb%C2%AE808%20%C2%B7%20Xencor%2C%20Inc.&badge=phase%201 XmAb®808 XmAb®808 · Xencor, Inc. https://druglandscape.com/drug/xmab819 https://druglandscape.com/api/og?type=drug&title=XmAb819&subtitle=XmAb819%20%C2%B7%20Xencor%2C%20Inc.&badge=phase%201 XmAb819 XmAb819 · Xencor, Inc. https://druglandscape.com/drug/xmab942 https://druglandscape.com/api/og?type=drug&title=XmAb942&subtitle=XmAb942%20%C2%B7%20Xencor%2C%20Inc.&badge=phase%201 XmAb942 XmAb942 · Xencor, Inc. https://druglandscape.com/drug/xnw3009 https://druglandscape.com/api/og?type=drug&title=XNW3009&subtitle=XNW3009%20%C2%B7%20Evopoint%20Biosciences%20Inc.&badge=phase%201 XNW3009 XNW3009 · Evopoint Biosciences Inc. https://druglandscape.com/drug/xnw4107 https://druglandscape.com/api/og?type=drug&title=XNW4107&subtitle=XNW4107%20%C2%B7%20Evopoint%20Biosciences%20Inc.&badge=phase%201 XNW4107 XNW4107 · Evopoint Biosciences Inc. https://druglandscape.com/drug/xnw5004 https://druglandscape.com/api/og?type=drug&title=XNW5004&subtitle=XNW5004%20%C2%B7%20Evopoint%20Biosciences%20Inc.&badge=phase%201 XNW5004 XNW5004 · Evopoint Biosciences Inc. https://druglandscape.com/drug/xnw5004-tablets https://druglandscape.com/api/og?type=drug&title=XNW5004%20tablets&subtitle=XNW5004%20tablets%20%C2%B7%20Evopoint%20Biosciences%20Inc.&badge=phase%202 XNW5004 tablets XNW5004 tablets · Evopoint Biosciences Inc. https://druglandscape.com/drug/xoma-358-single-dose-level-a https://druglandscape.com/api/og?type=drug&title=XOMA%20358%20single%20dose%20level%20A&subtitle=XOMA%20358%20single%20dose%20level%20A%20%C2%B7%20XOMA%20(US)%20LLC&badge=phase%202 XOMA 358 single dose level A XOMA 358 single dose level A · XOMA (US) LLC https://druglandscape.com/drug/xon7 https://druglandscape.com/api/og?type=drug&title=XON7&subtitle=XON7%20%C2%B7%20Xenothera%20SAS&badge=phase%201 XON7 XON7 · Xenothera SAS https://druglandscape.com/drug/xoph5-ointment https://druglandscape.com/api/og?type=drug&title=XOPH5%20Ointment&subtitle=XOPH5%20Ointment%20%C2%B7%20Topokine%20Therapeutics%2C%20Inc.&badge=phase%202 XOPH5 Ointment XOPH5 Ointment · Topokine Therapeutics, Inc. https://druglandscape.com/drug/xp13512 https://druglandscape.com/api/og?type=drug&title=XP13512&subtitle=XP13512%20%C2%B7%20XenoPort%2C%20Inc.&badge=phase%202 XP13512 XP13512 · XenoPort, Inc. https://druglandscape.com/drug/xp21279 https://druglandscape.com/api/og?type=drug&title=XP21279&subtitle=XP21279%20%C2%B7%20XenoPort%2C%20Inc.&badge=phase%201 XP21279 XP21279 · XenoPort, Inc. https://druglandscape.com/drug/xpf-001 https://druglandscape.com/api/og?type=drug&title=XPF-001&subtitle=XPF-001%20%C2%B7%20Xenon%20Pharmaceuticals%20Inc.&badge=phase%202 XPF-001 XPF-001 · Xenon Pharmaceuticals Inc. https://druglandscape.com/drug/xpf-002 https://druglandscape.com/api/og?type=drug&title=XPF-002&subtitle=XPF-002%20%C2%B7%20Xenon%20Pharmaceuticals%20Inc.&badge=phase%202 XPF-002 XPF-002 · Xenon Pharmaceuticals Inc. https://druglandscape.com/drug/xpf-005 https://druglandscape.com/api/og?type=drug&title=XPF-005&subtitle=XPF-005%20%C2%B7%20Xenon%20Pharmaceuticals%20Inc.&badge=phase%201 XPF-005 XPF-005 · Xenon Pharmaceuticals Inc. https://druglandscape.com/drug/xpf-008 https://druglandscape.com/api/og?type=drug&title=XPF-008&subtitle=XPF-008%20%C2%B7%20Xenon%20Pharmaceuticals%20Inc.&badge=phase%201 XPF-008 XPF-008 · Xenon Pharmaceuticals Inc. https://druglandscape.com/drug/xpf-010 https://druglandscape.com/api/og?type=drug&title=XPF-010&subtitle=XPF-010%20%C2%B7%20Xenon%20Pharmaceuticals%20Inc.&badge=phase%201 XPF-010 XPF-010 · Xenon Pharmaceuticals Inc. https://druglandscape.com/drug/xr-bup https://druglandscape.com/api/og?type=drug&title=XR-BUP&subtitle=XR-BUP%20%C2%B7%20NYU%20Langone%20Health&badge=phase%202 XR-BUP XR-BUP · NYU Langone Health https://druglandscape.com/drug/xrd-0394 https://druglandscape.com/api/og?type=drug&title=XRD-0394&subtitle=XRD-0394%20%C2%B7%20XRad%20Therapeutics%20Inc&badge=phase%201 XRD-0394 XRD-0394 · XRad Therapeutics Inc https://druglandscape.com/drug/xrp6976 https://druglandscape.com/api/og?type=drug&title=XRP6976&subtitle=XRP6976%20%C2%B7%20Sanofi&badge=phase%202 XRP6976 XRP6976 · Sanofi https://druglandscape.com/drug/xrp9881 https://druglandscape.com/api/og?type=drug&title=XRP9881&subtitle=XRP9881%20%C2%B7%20Sanofi&badge=phase%202 XRP9881 XRP9881 · Sanofi https://druglandscape.com/drug/xs-04-tablet https://druglandscape.com/api/og?type=drug&title=XS-04%20tablet&subtitle=XS-04%20tablet%20%C2%B7%20NovaOnco%20Therapeutics%20Co.%2C%20Ltd.&badge=phase%201 XS-04 tablet XS-04 tablet · NovaOnco Therapeutics Co., Ltd. https://druglandscape.com/drug/xs003 https://druglandscape.com/api/og?type=drug&title=XS003&subtitle=XS003%20%C2%B7%20XSpray%20Microparticles&badge=phase%201 XS003 XS003 · XSpray Microparticles https://druglandscape.com/drug/xs005-sorafenib-tablet-a-period-3 https://druglandscape.com/api/og?type=drug&title=XS005%20Sorafenib%20Tablet%20A%20-%20Period%203&subtitle=XS005%20Sorafenib%20Tablet%20A%20-%20Period%203%20%C2%B7%20Xspray%20Pharma%20AB&badge=phase%201 XS005 Sorafenib Tablet A - Period 3 XS005 Sorafenib Tablet A - Period 3 · Xspray Pharma AB https://druglandscape.com/drug/xstem-oa https://druglandscape.com/api/og?type=drug&title=XSTEM-OA&subtitle=XSTEM-OA%20%C2%B7%20Xindu%20Pty%20Ltd&badge=phase%201 XSTEM-OA XSTEM-OA · Xindu Pty Ltd https://druglandscape.com/drug/xstem-vlu https://druglandscape.com/api/og?type=drug&title=XSTEM-VLU&subtitle=XSTEM-VLU%20%C2%B7%20Xintela%20AB&badge=phase%201 XSTEM-VLU XSTEM-VLU · Xintela AB https://druglandscape.com/drug/xt-0528 https://druglandscape.com/api/og?type=drug&title=XT-0528&subtitle=XT-0528%20%C2%B7%20Xenthera%2C%20Inc.&badge=phase%201 XT-0528 XT-0528 · Xenthera, Inc. https://druglandscape.com/drug/xt-150 https://druglandscape.com/api/og?type=drug&title=XT-150&subtitle=XT-150%20%C2%B7%20Xalud%20Therapeutics%2C%20Inc.&badge=phase%202 XT-150 XT-150 · Xalud Therapeutics, Inc. https://druglandscape.com/drug/xtl6001 https://druglandscape.com/api/og?type=drug&title=XTL6001&subtitle=XTL6001%20%C2%B7%20Shanghai%20Xitaili%20Biomedicine%20Technology%20co.%2C%20Ltd.&badge=phase%201 XTL6001 XTL6001 · Shanghai Xitaili Biomedicine Technology co., Ltd. https://druglandscape.com/drug/xtmab-16 https://druglandscape.com/api/og?type=drug&title=XTMAB-16&subtitle=XTMAB-16%20%C2%B7%20Xentria%2C%20Inc.&badge=phase%202 XTMAB-16 XTMAB-16 · Xentria, Inc. https://druglandscape.com/drug/xtr003 https://druglandscape.com/api/og?type=drug&title=XTR003&subtitle=XTR003%20%C2%B7%20Sinotau%20Pharmaceutical%20Group&badge=phase%202 XTR003 XTR003 · Sinotau Pharmaceutical Group https://druglandscape.com/drug/xtx301 https://druglandscape.com/api/og?type=drug&title=XTX301&subtitle=XTX301%20%C2%B7%20Xilio%20Development%2C%20Inc.&badge=phase%201 XTX301 XTX301 · Xilio Development, Inc. https://druglandscape.com/drug/xw014 https://druglandscape.com/api/og?type=drug&title=XW014&subtitle=XW014%20%C2%B7%20Sciwind%20Biosciences%20USA%20Co.%2C%20Ltd.&badge=phase%201 XW014 XW014 · Sciwind Biosciences USA Co., Ltd. https://druglandscape.com/drug/xw10172 https://druglandscape.com/api/og?type=drug&title=XW10172&subtitle=XW10172%20%C2%B7%20XWPharma&badge=phase%201 XW10172 XW10172 · XWPharma https://druglandscape.com/drug/xw10508 https://druglandscape.com/api/og?type=drug&title=XW10508&subtitle=XW10508%20%C2%B7%20XWPharma&badge=phase%201 XW10508 XW10508 · XWPharma https://druglandscape.com/drug/xy03-ea https://druglandscape.com/api/og?type=drug&title=XY03-EA&subtitle=XY03-EA%20%C2%B7%20Shijiazhuang%20Yiling%20Pharmaceutical%20Co.%20Ltd&badge=phase%202 XY03-EA XY03-EA · Shijiazhuang Yiling Pharmaceutical Co. Ltd https://druglandscape.com/drug/xylometazoline-hcl-0-05 https://druglandscape.com/api/og?type=drug&title=xylometazoline%20HCL%200.05%25&subtitle=xylometazoline%20HCL%200.05%25%20%C2%B7%20Schneider%20Children's%20Medical%20Center%2C%20Israel&badge=phase%201 xylometazoline HCL 0.05% xylometazoline HCL 0.05% · Schneider Children's Medical Center, Israel https://druglandscape.com/drug/xylometazoline-nasal https://druglandscape.com/api/og?type=drug&title=Xylometazoline%20Nasal&subtitle=Xylometazoline%20Nasal%20%C2%B7%20Anabio%20R%26D&badge=phase%202 Xylometazoline Nasal Xylometazoline Nasal · Anabio R&D https://druglandscape.com/drug/xzb-0004 https://druglandscape.com/api/og?type=drug&title=XZB-0004&subtitle=XZB-0004%20%C2%B7%20Xuanzhu%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 XZB-0004 XZB-0004 · Xuanzhu Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/xzp-3287 https://druglandscape.com/api/og?type=drug&title=XZP-3287&subtitle=XZP-3287%20%C2%B7%20Sihuan%20Pharmaceutical%20Holdings%20Group%20Ltd.&badge=phase%201 XZP-3287 XZP-3287 · Sihuan Pharmaceutical Holdings Group Ltd. https://druglandscape.com/drug/xzp-3287-combined-with-clarithromycin https://druglandscape.com/api/og?type=drug&title=XZP-3287%20combined%20with%20clarithromycin&subtitle=XZP-3287%20combined%20with%20clarithromycin%20%C2%B7%20Xuanzhu%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 XZP-3287 combined with clarithromycin XZP-3287 combined with clarithromycin · Xuanzhu Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/xzp-3287-letrozole-anastrozole-fulvestrant https://druglandscape.com/api/og?type=drug&title=XZP-3287%3BLetrozole%3BAnastrozole%3BFulvestrant&subtitle=XZP-3287%3BLetrozole%3BAnastrozole%3BFulvestrant%20%C2%B7%20Sihuan%20Pharmaceutical%20Holdings%20Group%20Ltd.&badge=phase%201 XZP-3287;Letrozole;Anastrozole;Fulvestrant XZP-3287;Letrozole;Anastrozole;Fulvestrant · Sihuan Pharmaceutical Holdings Group Ltd. https://druglandscape.com/drug/xzp-6019-tablet https://druglandscape.com/api/og?type=drug&title=XZP-6019%20tablet&subtitle=XZP-6019%20tablet%20%C2%B7%20Xuanzhu%20Biopharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 XZP-6019 tablet XZP-6019 tablet · Xuanzhu Biopharmaceutical Co., Ltd. https://druglandscape.com/drug/y-2-sublingual-tablet https://druglandscape.com/api/og?type=drug&title=Y-2%20Sublingual%20Tablet&subtitle=Y-2%20Sublingual%20Tablet%20%C2%B7%20Simcere%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 Y-2 Sublingual Tablet Y-2 Sublingual Tablet · Simcere Pharmaceutical Co., Ltd https://druglandscape.com/drug/y-3-for-injection-40mg https://druglandscape.com/api/og?type=drug&title=Y-3%20for%20injection%EF%BC%8840mg%EF%BC%89&subtitle=Y-3%20for%20injection%EF%BC%8840mg%EF%BC%89%20%C2%B7%20Neurodawn%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 Y-3 for injection（40mg） Y-3 for injection（40mg） · Neurodawn Pharmaceutical Co., Ltd. https://druglandscape.com/drug/y-90-ibritumomab-tiuxetan https://druglandscape.com/api/og?type=drug&title=Y-90%20Ibritumomab%20tiuxetan&subtitle=Y-90%20Ibritumomab%20tiuxetan%20%C2%B7%20CABYC&badge=phase%202 Y-90 Ibritumomab tiuxetan Y-90 Ibritumomab tiuxetan · CABYC https://druglandscape.com/drug/y101d https://druglandscape.com/api/og?type=drug&title=Y101D&subtitle=Y101D%20%C2%B7%20Wuhan%20YZY%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 Y101D Y101D · Wuhan YZY Biopharma Co., Ltd. https://druglandscape.com/drug/y150 https://druglandscape.com/api/og?type=drug&title=Y150&subtitle=Y150%20%C2%B7%20Wuhan%20YZY%20Biopharma%20Co.%2C%20Ltd.&badge=phase%201 Y150 Y150 · Wuhan YZY Biopharma Co., Ltd. https://druglandscape.com/drug/y242 https://druglandscape.com/api/og?type=drug&title=Y242&subtitle=Y242%20%C2%B7%20Imperial%20College%20London&badge=phase%201 Y242 Y242 · Imperial College London https://druglandscape.com/drug/y90-ibritumomab-tiuxetan https://druglandscape.com/api/og?type=drug&title=Y90%20Ibritumomab%20Tiuxetan&subtitle=Y90%20Ibritumomab%20Tiuxetan%20%C2%B7%20Grupo%20Oncol%C3%B3gico%20para%20el%20Tratamiento%20y%20el%20Estudio%20de%20los%20Linfomas&badge=phase%202 Y90 Ibritumomab Tiuxetan Y90 Ibritumomab Tiuxetan · Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas https://druglandscape.com/drug/ya-101 https://druglandscape.com/api/og?type=drug&title=YA-101&subtitle=YA-101%20%C2%B7%20Yoda%20Therapeutics%20Inc.&badge=phase%202 YA-101 YA-101 · Yoda Therapeutics Inc. https://druglandscape.com/drug/yallaferon https://druglandscape.com/api/og?type=drug&title=Yallaferon%C2%AE&subtitle=Yallaferon%C2%AE%20%C2%B7%20Lee's%20Pharmaceutical%20Limited&badge=phase%202 Yallaferon® Yallaferon® · Lee's Pharmaceutical Limited https://druglandscape.com/drug/yangyinfang https://druglandscape.com/api/og?type=drug&title=YangYinFang&subtitle=YangYinFang%20%C2%B7%20Shanghai%20University%20of%20Traditional%20Chinese%20Medicine&badge=phase%203 YangYinFang YangYinFang · Shanghai University of Traditional Chinese Medicine https://druglandscape.com/drug/yaso-gel https://druglandscape.com/api/og?type=drug&title=YASO%20GEL&subtitle=YASO%20GEL%20%C2%B7%20Yaso%20Therapeutics%20Corporation&badge=phase%201 YASO GEL YASO GEL · Yaso Therapeutics Corporation https://druglandscape.com/drug/yb-1113 https://druglandscape.com/api/og?type=drug&title=YB-1113&subtitle=YB-1113%20%C2%B7%20Bright%20Cell%2C%20Inc.&badge=phase%201 YB-1113 YB-1113 · Bright Cell, Inc. https://druglandscape.com/drug/ybl-006 https://druglandscape.com/api/og?type=drug&title=YBL-006&subtitle=YBL-006%20%C2%B7%20Y%20Biologics%20Inc.&badge=phase%201 YBL-006 YBL-006 · Y Biologics Inc. https://druglandscape.com/drug/yd0743 https://druglandscape.com/api/og?type=drug&title=YD0743&subtitle=YD0743%20%C2%B7%20Shanghai%20Yidian%20Pharmaceutical%20Technology%20Development%20Co.%2C%20Ltd.&badge=phase%202 YD0743 YD0743 · Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. https://druglandscape.com/drug/yervoy-injectable-product https://druglandscape.com/api/og?type=drug&title=Yervoy%20Injectable%20Product&subtitle=Yervoy%20Injectable%20Product%20%C2%B7%20ImmunSYS%2C%20LLC&badge=phase%202 Yervoy Injectable Product Yervoy Injectable Product · ImmunSYS, LLC https://druglandscape.com/drug/yg1699 https://druglandscape.com/api/og?type=drug&title=YG1699&subtitle=YG1699%20%C2%B7%20Youngene%20Therapeutics%20Inc.%2C%20Ltd.&badge=phase%202 YG1699 YG1699 · Youngene Therapeutics Inc., Ltd. https://druglandscape.com/drug/yh002 https://druglandscape.com/api/og?type=drug&title=YH002&subtitle=YH002%20%C2%B7%20Eucure%20(Beijing)%20Biopharma%20Co.%2C%20Ltd&badge=phase%201 YH002 YH002 · Eucure (Beijing) Biopharma Co., Ltd https://druglandscape.com/drug/yjp-14 https://druglandscape.com/api/og?type=drug&title=YJP-14&subtitle=YJP-14%20%C2%B7%20Han%20Wha%20Pharma%20Co.%2C%20Ltd.&badge=phase%202 YJP-14 YJP-14 · Han Wha Pharma Co., Ltd. https://druglandscape.com/drug/yk-029a https://druglandscape.com/api/og?type=drug&title=YK-029A&subtitle=YK-029A%20%C2%B7%20Suzhou%20Puhe%20Pharmaceutical%20Technology%20Co.%2C%20LTD&badge=phase%201 YK-029A YK-029A · Suzhou Puhe Pharmaceutical Technology Co., LTD https://druglandscape.com/drug/yk012 https://druglandscape.com/api/og?type=drug&title=YK012&subtitle=YK012%20%C2%B7%20Excyte%20Biopharma%20Ltd&badge=phase%201 YK012 YK012 · Excyte Biopharma Ltd https://druglandscape.com/drug/ykp10811 https://druglandscape.com/api/og?type=drug&title=YKP10811&subtitle=YKP10811%20%C2%B7%20SK%20Life%20Science%2C%20Inc.&badge=phase%202 YKP10811 YKP10811 · SK Life Science, Inc. https://druglandscape.com/drug/ykp10811-drug-product-capsule https://druglandscape.com/api/og?type=drug&title=YKP10811%20Drug%20Product%20Capsule&subtitle=YKP10811%20Drug%20Product%20Capsule%20%C2%B7%20SK%20Life%20Science%2C%20Inc.&badge=phase%202 YKP10811 Drug Product Capsule YKP10811 Drug Product Capsule · SK Life Science, Inc. https://druglandscape.com/drug/ykp3089 https://druglandscape.com/api/og?type=drug&title=YKP3089&subtitle=YKP3089%20%C2%B7%20SK%20Life%20Science%2C%20Inc.&badge=phase%203 YKP3089 YKP3089 · SK Life Science, Inc. https://druglandscape.com/drug/yl-13027-sintilimab https://druglandscape.com/api/og?type=drug&title=YL-13027%EF%BC%8CSintilimab&subtitle=YL-13027%EF%BC%8CSintilimab%20%C2%B7%20Shanghai%20YingLi%20Pharmaceutical%20Co.%20Ltd.&badge=phase%201 YL-13027，Sintilimab YL-13027，Sintilimab · Shanghai YingLi Pharmaceutical Co. Ltd. https://druglandscape.com/drug/yl-15293 https://druglandscape.com/api/og?type=drug&title=YL-15293&subtitle=YL-15293%20%C2%B7%20Shanghai%20YingLi%20Pharmaceutical%20Co.%20Ltd.&badge=phase%201 YL-15293 YL-15293 · Shanghai YingLi Pharmaceutical Co. Ltd. https://druglandscape.com/drug/yl211 https://druglandscape.com/api/og?type=drug&title=YL211&subtitle=YL211%20%C2%B7%20MediLink%20Therapeutics%20(Suzhou)%20Co.%2C%20Ltd.&badge=phase%201 YL211 YL211 · MediLink Therapeutics (Suzhou) Co., Ltd. https://druglandscape.com/drug/yl217 https://druglandscape.com/api/og?type=drug&title=YL217&subtitle=YL217%20%C2%B7%20MediLink%20Therapeutics%20(Suzhou)%20Co.%2C%20Ltd.&badge=phase%201 YL217 YL217 · MediLink Therapeutics (Suzhou) Co., Ltd. https://druglandscape.com/drug/yl242 https://druglandscape.com/api/og?type=drug&title=YL242&subtitle=YL242%20%C2%B7%20MediLink%20Therapeutics%20(Suzhou)%20Co.%2C%20Ltd.&badge=phase%201 YL242 YL242 · MediLink Therapeutics (Suzhou) Co., Ltd. https://druglandscape.com/drug/yl242-5-fu-lv https://druglandscape.com/api/og?type=drug&title=YL242%3B%205-FU%3B%20LV&subtitle=YL242%3B%205-FU%3B%20LV%20%C2%B7%20MediLink%20Therapeutics%20(Suzhou)%20Co.%2C%20Ltd.&badge=phase%201 YL242; 5-FU; LV YL242; 5-FU; LV · MediLink Therapeutics (Suzhou) Co., Ltd. https://druglandscape.com/drug/yl242-pembrolizumab https://druglandscape.com/api/og?type=drug&title=YL242%3B%20Pembrolizumab&subtitle=YL242%3B%20Pembrolizumab%20%C2%B7%20MediLink%20Therapeutics%20(Suzhou)%20Co.%2C%20Ltd.&badge=phase%201 YL242; Pembrolizumab YL242; Pembrolizumab · MediLink Therapeutics (Suzhou) Co., Ltd. https://druglandscape.com/drug/yl242-pembrolizumab-5-fu https://druglandscape.com/api/og?type=drug&title=YL242%3B%20Pembrolizumab%3B%205-FU&subtitle=YL242%3B%20Pembrolizumab%3B%205-FU%20%C2%B7%20MediLink%20Therapeutics%20(Suzhou)%20Co.%2C%20Ltd.&badge=phase%201 YL242; Pembrolizumab; 5-FU YL242; Pembrolizumab; 5-FU · MediLink Therapeutics (Suzhou) Co., Ltd. https://druglandscape.com/drug/ym-155 https://druglandscape.com/api/og?type=drug&title=YM%20155&subtitle=YM%20155%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%201 YM 155 YM 155 · Astellas Pharma Inc https://druglandscape.com/drug/ym178-ocas https://druglandscape.com/api/og?type=drug&title=YM178%20OCAS&subtitle=YM178%20OCAS%20%C2%B7%20Astellas%20Pharma%20Europe%20B.V.&badge=phase%201 YM178 OCAS YM178 OCAS · Astellas Pharma Europe B.V. https://druglandscape.com/drug/ym543 https://druglandscape.com/api/og?type=drug&title=YM543&subtitle=YM543%20%C2%B7%20Astellas%20Pharma%20Inc&badge=phase%202 YM543 YM543 · Astellas Pharma Inc https://druglandscape.com/drug/yn001 https://druglandscape.com/api/og?type=drug&title=YN001&subtitle=YN001%20%C2%B7%20Beijing%20Inno%20Medicine%20Co.%2C%20Ltd.&badge=phase%202 YN001 YN001 · Beijing Inno Medicine Co., Ltd. https://druglandscape.com/drug/yolt-203 https://druglandscape.com/api/og?type=drug&title=YOLT-203&subtitle=YOLT-203%20%C2%B7%20Guangzhou%20Women%20and%20Children's%20Medical%20Center&badge=phase%201 YOLT-203 YOLT-203 · Guangzhou Women and Children's Medical Center https://druglandscape.com/drug/yondelis-caelyx https://druglandscape.com/api/og?type=drug&title=Yondelis%C2%AE-Caelyx%C2%AE&subtitle=Yondelis%C2%AE-Caelyx%C2%AE%20%C2%B7%20ARCAGY%2F%20GINECO%20GROUP&badge=phase%202 Yondelis®-Caelyx® Yondelis®-Caelyx® · ARCAGY/ GINECO GROUP https://druglandscape.com/drug/yp05002 https://druglandscape.com/api/og?type=drug&title=YP05002&subtitle=YP05002%20%C2%B7%20Yaopharma%20Co.%2C%20Ltd.&badge=phase%201 YP05002 YP05002 · Yaopharma Co., Ltd. https://druglandscape.com/drug/ypeg-rhepo https://druglandscape.com/api/og?type=drug&title=YPEG-rhEPO&subtitle=YPEG-rhEPO%20%C2%B7%20Xiamen%20Amoytop%20Biotech%20Co.%2C%20Ltd.&badge=phase%202 YPEG-rhEPO YPEG-rhEPO · Xiamen Amoytop Biotech Co., Ltd. https://druglandscape.com/drug/ypeg-rhgh https://druglandscape.com/api/og?type=drug&title=YPEG-rhGH&subtitle=YPEG-rhGH%20%C2%B7%20Xiamen%20Amoytop%20Biotech%20Co.%2C%20Ltd.&badge=phase%202 YPEG-rhGH YPEG-rhGH · Xiamen Amoytop Biotech Co., Ltd. https://druglandscape.com/drug/ypeg-somatropin https://druglandscape.com/api/og?type=drug&title=YPEG-Somatropin&subtitle=YPEG-Somatropin%20%C2%B7%20Xiamen%20Amoytop%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 YPEG-Somatropin YPEG-Somatropin · Xiamen Amoytop Biotech Co., Ltd. https://druglandscape.com/drug/yr001-dose-a-on-high-body-surface-area https://druglandscape.com/api/og?type=drug&title=YR001%20Dose%20A%20on%20high%20body%20surface%20area&subtitle=YR001%20Dose%20A%20on%20high%20body%20surface%20area%20%C2%B7%20Hangzhou%20Yirui%20Pharmaceutical%20Technology%20Co.%2C%20Ltd&badge=phase%201 YR001 Dose A on high body surface area YR001 Dose A on high body surface area · Hangzhou Yirui Pharmaceutical Technology Co., Ltd https://druglandscape.com/drug/yr001-dose-b-on-high-body-surface-area https://druglandscape.com/api/og?type=drug&title=YR001%20Dose%20B%20on%20high%20body%20surface%20area&subtitle=YR001%20Dose%20B%20on%20high%20body%20surface%20area%20%C2%B7%20Hangzhou%20Yirui%20Pharmaceutical%20Technology%20Co.%2C%20Ltd&badge=phase%201 YR001 Dose B on high body surface area YR001 Dose B on high body surface area · Hangzhou Yirui Pharmaceutical Technology Co., Ltd https://druglandscape.com/drug/yr001-dose-b-on-low-body-surface-area https://druglandscape.com/api/og?type=drug&title=YR001%20Dose%20B%20on%20low%20body%20surface%20area&subtitle=YR001%20Dose%20B%20on%20low%20body%20surface%20area%20%C2%B7%20Hangzhou%20Yirui%20Pharmaceutical%20Technology%20Co.%2C%20Ltd&badge=phase%201 YR001 Dose B on low body surface area YR001 Dose B on low body surface area · Hangzhou Yirui Pharmaceutical Technology Co., Ltd https://druglandscape.com/drug/yr001-ointment https://druglandscape.com/api/og?type=drug&title=YR001%20ointment&subtitle=YR001%20ointment%20%C2%B7%20Hangzhou%20Yirui%20Pharmaceutical%20Technology%20Co.%2C%20Ltd&badge=phase%202 YR001 ointment YR001 ointment · Hangzhou Yirui Pharmaceutical Technology Co., Ltd https://druglandscape.com/drug/yra-1909-high-dose https://druglandscape.com/api/og?type=drug&title=YRA-1909%20high%20dose&subtitle=YRA-1909%20high%20dose%20%C2%B7%20Yungjin%20Pharm.%20Co.%2C%20Ltd.&badge=phase%202 YRA-1909 high dose YRA-1909 high dose · Yungjin Pharm. Co., Ltd. https://druglandscape.com/drug/yra-1909-mid-dose https://druglandscape.com/api/og?type=drug&title=YRA-1909%20mid%20dose&subtitle=YRA-1909%20mid%20dose%20%C2%B7%20Yungjin%20Pharm.%20Co.%2C%20Ltd.&badge=phase%202 YRA-1909 mid dose YRA-1909 mid dose · Yungjin Pharm. Co., Ltd. https://druglandscape.com/drug/ys-0n-001 https://druglandscape.com/api/og?type=drug&title=YS-0N-001&subtitle=YS-0N-001%20%C2%B7%20Yisheng%20Biopharma%20(Singapore)%20Pte.%20Ltd.&badge=phase%201 YS-0N-001 YS-0N-001 · Yisheng Biopharma (Singapore) Pte. Ltd. https://druglandscape.com/drug/ys110 https://druglandscape.com/api/og?type=drug&title=YS110&subtitle=YS110%20%C2%B7%20Kissei%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 YS110 YS110 · Kissei Pharmaceutical Co., Ltd. https://druglandscape.com/drug/ys5-antibody https://druglandscape.com/api/og?type=drug&title=YS5%20antibody&subtitle=YS5%20antibody%20%C2%B7%20Robert%20Flavell%2C%20MD%2C%20PhD&badge=phase%201 YS5 antibody YS5 antibody · Robert Flavell, MD, PhD https://druglandscape.com/drug/yts109-cell https://druglandscape.com/api/og?type=drug&title=YTS109%20cell&subtitle=YTS109%20cell%20%C2%B7%20China%20Immunotech%20(Beijing)%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 YTS109 cell YTS109 cell · China Immunotech (Beijing) Biotechnology Co., Ltd. https://druglandscape.com/drug/yttrium-y-90-basiliximab https://druglandscape.com/api/og?type=drug&title=Yttrium%20Y%2090%20Basiliximab&subtitle=Yttrium%20Y%2090%20Basiliximab%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%202 Yttrium Y 90 Basiliximab Yttrium Y 90 Basiliximab · City of Hope Medical Center https://druglandscape.com/drug/yttrium-y-90-labeled-basiliximab https://druglandscape.com/api/og?type=drug&title=yttrium%20Y%2090-labeled%20basiliximab&subtitle=yttrium%20Y%2090-labeled%20basiliximab%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%201 yttrium Y 90-labeled basiliximab yttrium Y 90-labeled basiliximab · City of Hope Medical Center https://druglandscape.com/drug/yupingfeng-powder-granules https://druglandscape.com/api/og?type=drug&title=Yupingfeng%20Powder%20granules&subtitle=Yupingfeng%20Powder%20granules%20%C2%B7%20Prof.%20Lin%20Zhixiu&badge=phase%202 Yupingfeng Powder granules Yupingfeng Powder granules · Prof. Lin Zhixiu https://druglandscape.com/drug/yy-201 https://druglandscape.com/api/og?type=drug&title=YY-201&subtitle=YY-201%20%C2%B7%20Yuyu%20Pharma%2C%20Inc.&badge=phase%201 YY-201 YY-201 · Yuyu Pharma, Inc. https://druglandscape.com/drug/yy-20394 https://druglandscape.com/api/og?type=drug&title=YY-20394&subtitle=YY-20394%20%C2%B7%20Shanghai%20YingLi%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 YY-20394 YY-20394 · Shanghai YingLi Pharmaceutical Co. Ltd. https://druglandscape.com/drug/yy-20394-treatment https://druglandscape.com/api/og?type=drug&title=YY-20394%20treatment&subtitle=YY-20394%20treatment%20%C2%B7%20Shanghai%20YingLi%20Pharmaceutical%20Co.%20Ltd.&badge=phase%202 YY-20394 treatment YY-20394 treatment · Shanghai YingLi Pharmaceutical Co. Ltd. https://druglandscape.com/drug/yy-351 https://druglandscape.com/api/og?type=drug&title=YY-351&subtitle=YY-351%20%C2%B7%20Yuyu%20Pharma%2C%20Inc.&badge=phase%202 YY-351 YY-351 · Yuyu Pharma, Inc. https://druglandscape.com/drug/yy001 https://druglandscape.com/api/og?type=drug&title=YY001&subtitle=YY001%20%C2%B7%20Chongqing%20Claruvis%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 YY001 YY001 · Chongqing Claruvis Pharmaceutical Co., Ltd. https://druglandscape.com/drug/yy003 https://druglandscape.com/api/og?type=drug&title=YY003&subtitle=YY003%20%C2%B7%20Chongqing%20Claruvis%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%202 YY003 YY003 · Chongqing Claruvis Pharmaceutical Co., Ltd. https://druglandscape.com/drug/yy201 https://druglandscape.com/api/og?type=drug&title=YY201&subtitle=YY201%20%C2%B7%20Shanghai%20Yuyao%20Biotech%20Co.%2C%20Ltd.&badge=phase%201 YY201 YY201 · Shanghai Yuyao Biotech Co., Ltd. https://druglandscape.com/drug/yy2201 https://druglandscape.com/api/og?type=drug&title=YY2201&subtitle=YY2201%20%C2%B7%20Jiangsu%20YaYao%20Biotechnology%20Co.%2C%20Ltd.&badge=phase%201 YY2201 YY2201 · Jiangsu YaYao Biotechnology Co., Ltd. https://druglandscape.com/drug/yyb-103 https://druglandscape.com/api/og?type=drug&title=YYB-103&subtitle=YYB-103%20%C2%B7%20CellabMED&badge=phase%201 YYB-103 YYB-103 · CellabMED https://druglandscape.com/drug/yyb101 https://druglandscape.com/api/og?type=drug&title=YYB101&subtitle=YYB101%20%C2%B7%20CellabMED&badge=phase%201 YYB101 YYB101 · CellabMED https://druglandscape.com/drug/yyc506-a https://druglandscape.com/api/og?type=drug&title=YYC506-A&subtitle=YYC506-A%20%C2%B7%20Yooyoung%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 YYC506-A YYC506-A · Yooyoung Pharmaceutical Co., Ltd. https://druglandscape.com/drug/yyc506-t https://druglandscape.com/api/og?type=drug&title=YYC506-T&subtitle=YYC506-T%20%C2%B7%20Yooyoung%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 YYC506-T YYC506-T · Yooyoung Pharmaceutical Co., Ltd. https://druglandscape.com/drug/yyd601-1 https://druglandscape.com/api/og?type=drug&title=YYD601%201&subtitle=YYD601%201%20%C2%B7%20Yooyoung%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 YYD601 1 YYD601 1 · Yooyoung Pharmaceutical Co., Ltd. https://druglandscape.com/drug/yyd601-2 https://druglandscape.com/api/og?type=drug&title=YYD601%202&subtitle=YYD601%202%20%C2%B7%20Yooyoung%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 YYD601 2 YYD601 2 · Yooyoung Pharmaceutical Co., Ltd. https://druglandscape.com/drug/yyd601-3 https://druglandscape.com/api/og?type=drug&title=YYD601%203&subtitle=YYD601%203%20%C2%B7%20Yooyoung%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 YYD601 3 YYD601 3 · Yooyoung Pharmaceutical Co., Ltd. https://druglandscape.com/drug/yzj-1139-simulated-tablets https://druglandscape.com/api/og?type=drug&title=YZJ-1139%20simulated%20tablets&subtitle=YZJ-1139%20simulated%20tablets%20%C2%B7%20Shanghai%20Haiyan%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 YZJ-1139 simulated tablets YZJ-1139 simulated tablets · Shanghai Haiyan Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/yzj-1139-tablets https://druglandscape.com/api/og?type=drug&title=YZJ-1139%20tablets&subtitle=YZJ-1139%20tablets%20%C2%B7%20Shanghai%20Haiyan%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%201 YZJ-1139 tablets YZJ-1139 tablets · Shanghai Haiyan Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/yzj-4729 https://druglandscape.com/api/og?type=drug&title=YZJ-4729&subtitle=YZJ-4729%20%C2%B7%20Shanghai%20Haiyan%20Pharmaceutical%20Technology%20Co.%2C%20Ltd.&badge=phase%202 YZJ-4729 YZJ-4729 · Shanghai Haiyan Pharmaceutical Technology Co., Ltd. https://druglandscape.com/drug/z-1018 https://druglandscape.com/api/og?type=drug&title=Z-1018&subtitle=Z-1018%20%C2%B7%20Dynavax%20Technologies%20Corporation&badge=phase%201 Z-1018 Z-1018 · Dynavax Technologies Corporation https://druglandscape.com/drug/z0063 https://druglandscape.com/api/og?type=drug&title=Z0063&subtitle=Z0063%20%C2%B7%20Sanofi&badge=phase%201 Z0063 Z0063 · Sanofi https://druglandscape.com/drug/z102 https://druglandscape.com/api/og?type=drug&title=Z102&subtitle=Z102%20%C2%B7%20Zalicus&badge=phase%202 Z102 Z102 · Zalicus https://druglandscape.com/drug/z7200 https://druglandscape.com/api/og?type=drug&title=Z7200&subtitle=Z7200%20%C2%B7%20Zambon%20SpA&badge=phase%202 Z7200 Z7200 · Zambon SpA https://druglandscape.com/drug/z7200-without-oral-activated-charcoal https://druglandscape.com/api/og?type=drug&title=Z7200%20without%20oral%20activated%20charcoal&subtitle=Z7200%20without%20oral%20activated%20charcoal%20%C2%B7%20Zambon%20SpA&badge=phase%201 Z7200 without oral activated charcoal Z7200 without oral activated charcoal · Zambon SpA https://druglandscape.com/drug/zabdeno-booster https://druglandscape.com/api/og?type=drug&title=Zabdeno%C2%AE%20booster&subtitle=Zabdeno%C2%AE%20booster%20%C2%B7%20Institute%20of%20Tropical%20Medicine%2C%20Belgium&badge=phase%203 Zabdeno® booster Zabdeno® booster · Institute of Tropical Medicine, Belgium https://druglandscape.com/drug/zaleplon-ap-formulation https://druglandscape.com/api/og?type=drug&title=Zaleplon%20AP%20formulation&subtitle=Zaleplon%20AP%20formulation%20%C2%B7%20Intec%20Pharma%20Ltd.&badge=phase%202 Zaleplon AP formulation Zaleplon AP formulation · Intec Pharma Ltd. https://druglandscape.com/drug/zanubrutinib-oral-capsule https://druglandscape.com/api/og?type=drug&title=Zanubrutinib%20Oral%20Capsule&subtitle=Zanubrutinib%20Oral%20Capsule%20%C2%B7%20Stichting%20Hemato-Oncologie%20voor%20Volwassenen%20Nederland&badge=phase%202 Zanubrutinib Oral Capsule Zanubrutinib Oral Capsule · Stichting Hemato-Oncologie voor Volwassenen Nederland https://druglandscape.com/drug/zanubrutinib-oral-product https://druglandscape.com/api/og?type=drug&title=Zanubrutinib%20Oral%20Product&subtitle=Zanubrutinib%20Oral%20Product%20%C2%B7%20UMC%20Utrecht&badge=phase%202 Zanubrutinib Oral Product Zanubrutinib Oral Product · UMC Utrecht https://druglandscape.com/drug/zarnestra-tipifarnib-r115777 https://druglandscape.com/api/og?type=drug&title=ZARNESTRA%2C%20tipifarnib%2C%20R115777&subtitle=ZARNESTRA%2C%20tipifarnib%2C%20R115777%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%202 ZARNESTRA, tipifarnib, R115777 ZARNESTRA, tipifarnib, R115777 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/zb002 https://druglandscape.com/api/og?type=drug&title=ZB002&subtitle=ZB002%20%C2%B7%20Zenas%20BioPharma%20(USA)%2C%20LLC&badge=phase%201 ZB002 ZB002 · Zenas BioPharma (USA), LLC https://druglandscape.com/drug/zb004 https://druglandscape.com/api/og?type=drug&title=ZB004&subtitle=ZB004%20%C2%B7%20Zenas%20BioPharma%20(USA)%2C%20LLC&badge=phase%201 ZB004 ZB004 · Zenas BioPharma (USA), LLC https://druglandscape.com/drug/zb131 https://druglandscape.com/api/og?type=drug&title=ZB131&subtitle=ZB131%20%C2%B7%20ZielBio%2C%20Inc.&badge=phase%201 ZB131 ZB131 · ZielBio, Inc. https://druglandscape.com/drug/zb716 https://druglandscape.com/api/og?type=drug&title=ZB716&subtitle=ZB716%20%C2%B7%20EnhancedBio%20USA%20Inc.&badge=phase%201 ZB716 ZB716 · EnhancedBio USA Inc. https://druglandscape.com/drug/ze-117 https://druglandscape.com/api/og?type=drug&title=Ze%20117&subtitle=Ze%20117%20%C2%B7%20Max%20Zeller%20Soehne%20AG&badge=phase%201 Ze 117 Ze 117 · Max Zeller Soehne AG https://druglandscape.com/drug/ze-50-0134 https://druglandscape.com/api/og?type=drug&title=ZE%2050-0134&subtitle=ZE%2050-0134%20%C2%B7%20Lomond%20Therapeutics%20Holdings%2C%20Inc.&badge=phase%201 ZE 50-0134 ZE 50-0134 · Lomond Therapeutics Holdings, Inc. https://druglandscape.com/drug/ze46-0134 https://druglandscape.com/api/og?type=drug&title=ZE46-0134&subtitle=ZE46-0134%20%C2%B7%20Lomond%20Therapeutics%20Holdings%2C%20Inc.&badge=phase%201 ZE46-0134 ZE46-0134 · Lomond Therapeutics Holdings, Inc. https://druglandscape.com/drug/ze50-0134 https://druglandscape.com/api/og?type=drug&title=ZE50-0134&subtitle=ZE50-0134%20%C2%B7%20Lomond%20Therapeutics%20Holdings%2C%20Inc.&badge=phase%201 ZE50-0134 ZE50-0134 · Lomond Therapeutics Holdings, Inc. https://druglandscape.com/drug/zed1227 https://druglandscape.com/api/og?type=drug&title=ZED1227&subtitle=ZED1227%20%C2%B7%20Dr.%20Falk%20Pharma%20GmbH&badge=phase%202 ZED1227 ZED1227 · Dr. Falk Pharma GmbH https://druglandscape.com/drug/zemuron https://druglandscape.com/api/og?type=drug&title=Zemuron%C2%AE&subtitle=Zemuron%C2%AE%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%202 Zemuron® Zemuron® · Merck Sharp & Dohme LLC https://druglandscape.com/drug/zep-3na-0-1 https://druglandscape.com/api/og?type=drug&title=ZEP-3Na%200.1%25&subtitle=ZEP-3Na%200.1%25%20%C2%B7%20Shulov%20Innovate%20for%20Science%20Ltd.%202012&badge=phase%202 ZEP-3Na 0.1% ZEP-3Na 0.1% · Shulov Innovate for Science Ltd. 2012 https://druglandscape.com/drug/zep-3na-1 https://druglandscape.com/api/og?type=drug&title=ZEP-3Na%201%25&subtitle=ZEP-3Na%201%25%20%C2%B7%20Shulov%20Innovate%20for%20Science%20Ltd.%202012&badge=phase%202 ZEP-3Na 1% ZEP-3Na 1% · Shulov Innovate for Science Ltd. 2012 https://druglandscape.com/drug/zetomipzomib-in-open-label-extension https://druglandscape.com/api/og?type=drug&title=zetomipzomib%20in%20open-label%20extension&subtitle=zetomipzomib%20in%20open-label%20extension%20%C2%B7%20Kezar%20Life%20Sciences%2C%20Inc.&badge=phase%202 zetomipzomib in open-label extension zetomipzomib in open-label extension · Kezar Life Sciences, Inc. https://druglandscape.com/drug/zevalin-bucye https://druglandscape.com/api/og?type=drug&title=Zevalin-BuCyE&subtitle=Zevalin-BuCyE%20%C2%B7%20Asan%20Medical%20Center&badge=phase%202 Zevalin-BuCyE Zevalin-BuCyE · Asan Medical Center https://druglandscape.com/drug/zevalin-plus-beam https://druglandscape.com/api/og?type=drug&title=Zevalin%20plus%20BEAM&subtitle=Zevalin%20plus%20BEAM%20%C2%B7%20Lymphoma%20Study%20Association&badge=phase%202 Zevalin plus BEAM Zevalin plus BEAM · Lymphoma Study Association https://druglandscape.com/drug/zg005 https://druglandscape.com/api/og?type=drug&title=ZG005&subtitle=ZG005%20%C2%B7%20Suzhou%20Zelgen%20Biopharmaceuticals%20Co.%2CLtd&badge=phase%202 ZG005 ZG005 · Suzhou Zelgen Biopharmaceuticals Co.,Ltd https://druglandscape.com/drug/zgn-1061 https://druglandscape.com/api/og?type=drug&title=ZGN-1061&subtitle=ZGN-1061%20%C2%B7%20Zafgen%2C%20Inc.&badge=phase%202 ZGN-1061 ZGN-1061 · Zafgen, Inc. https://druglandscape.com/drug/zgn-440-sterile-diluent https://druglandscape.com/api/og?type=drug&title=ZGN-440%20sterile%20diluent&subtitle=ZGN-440%20sterile%20diluent%20%C2%B7%20Zafgen%2C%20Inc.&badge=phase%202 ZGN-440 sterile diluent ZGN-440 sterile diluent · Zafgen, Inc. https://druglandscape.com/drug/zhi-byed-11 https://druglandscape.com/api/og?type=drug&title=Zhi%20Byed%2011&subtitle=Zhi%20Byed%2011%20%C2%B7%20NICHD%20Global%20Network%20for%20Women's%20and%20Children's%20Health&badge=phase%201 Zhi Byed 11 Zhi Byed 11 · NICHD Global Network for Women's and Children's Health https://druglandscape.com/drug/zhibitai-capsule https://druglandscape.com/api/og?type=drug&title=zhibitai%20capsule&subtitle=zhibitai%20capsule%20%C2%B7%20Chengdu%20Diao%20Jiuhong%20Pharmaceutical%20Factory&badge=phase%202 zhibitai capsule zhibitai capsule · Chengdu Diao Jiuhong Pharmaceutical Factory https://druglandscape.com/drug/ziconotide-prialt https://druglandscape.com/api/og?type=drug&title=Ziconotide%20%5BPrialt%5D&subtitle=Ziconotide%20%5BPrialt%5D%20%C2%B7%20ESTEVE%20Pharmaceuticals%20SAS&badge=phase%202 Ziconotide [Prialt] Ziconotide [Prialt] · ESTEVE Pharmaceuticals SAS https://druglandscape.com/drug/zidebactam-cefepime https://druglandscape.com/api/og?type=drug&title=Zidebactam-Cefepime&subtitle=Zidebactam-Cefepime%20%C2%B7%20Wockhardt&badge=phase%201 Zidebactam-Cefepime Zidebactam-Cefepime · Wockhardt https://druglandscape.com/drug/ziltivekimab-d https://druglandscape.com/api/og?type=drug&title=Ziltivekimab%20D&subtitle=Ziltivekimab%20D%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%201 Ziltivekimab D Ziltivekimab D · Novo Nordisk A/S https://druglandscape.com/drug/zinc-64-aspartate https://druglandscape.com/api/og?type=drug&title=Zinc-64%20Aspartate&subtitle=Zinc-64%20Aspartate%20%C2%B7%20Vector%20Vitale%20LLC&badge=phase%201 Zinc-64 Aspartate Zinc-64 Aspartate · Vector Vitale LLC https://druglandscape.com/drug/zinc-b-toothpaste https://druglandscape.com/api/og?type=drug&title=Zinc-B%20toothpaste&subtitle=Zinc-B%20toothpaste%20%C2%B7%20GlaxoSmithKline&badge=phase%201 Zinc-B toothpaste Zinc-B toothpaste · GlaxoSmithKline https://druglandscape.com/drug/zinc-oxide-cream-40 https://druglandscape.com/api/og?type=drug&title=Zinc%20oxide%20cream%20%2540&subtitle=Zinc%20oxide%20cream%20%2540%20%C2%B7%20Gozde%20AKSUCU&badge=phase%201 Zinc oxide cream %40 Zinc oxide cream %40 · Gozde AKSUCU https://druglandscape.com/drug/zinc-supplementation-plus-standard-treatment https://druglandscape.com/api/og?type=drug&title=Zinc%20supplementation%20plus%20standard%20treatment&subtitle=Zinc%20supplementation%20plus%20standard%20treatment%20%C2%B7%20Muhammad%20Aamir%20Latif&badge=phase%201 Zinc supplementation plus standard treatment Zinc supplementation plus standard treatment · Muhammad Aamir Latif https://druglandscape.com/drug/zirconium-89-labeled-ro5479599 https://druglandscape.com/api/og?type=drug&title=zirconium-89-labeled%20RO5479599&subtitle=zirconium-89-labeled%20RO5479599%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 zirconium-89-labeled RO5479599 zirconium-89-labeled RO5479599 · Hoffmann-La Roche https://druglandscape.com/drug/zirconium-zr-89-df-crefmirlimab https://druglandscape.com/api/og?type=drug&title=Zirconium%20Zr%2089-Df-Crefmirlimab&subtitle=Zirconium%20Zr%2089-Df-Crefmirlimab%20%C2%B7%20City%20of%20Hope%20Medical%20Center&badge=phase%201 Zirconium Zr 89-Df-Crefmirlimab Zirconium Zr 89-Df-Crefmirlimab · City of Hope Medical Center https://druglandscape.com/drug/zirconium-zr-89-dfo-ys5 https://druglandscape.com/api/og?type=drug&title=Zirconium%20Zr%2089-DFO-YS5&subtitle=Zirconium%20Zr%2089-DFO-YS5%20%C2%B7%20Robert%20Flavell%2C%20MD%2C%20PhD&badge=phase%201 Zirconium Zr 89-DFO-YS5 Zirconium Zr 89-DFO-YS5 · Robert Flavell, MD, PhD https://druglandscape.com/drug/zk-219477 https://druglandscape.com/api/og?type=drug&title=ZK%20219477&subtitle=ZK%20219477%20%C2%B7%20Fondazione%20I.R.C.C.S.%20Istituto%20Neurologico%20Carlo%20Besta&badge=phase%202 ZK 219477 ZK 219477 · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta https://druglandscape.com/drug/zk-245186 https://druglandscape.com/api/og?type=drug&title=ZK%20245186&subtitle=ZK%20245186%20%C2%B7%20Bayer&badge=phase%202 ZK 245186 ZK 245186 · Bayer https://druglandscape.com/drug/zk245186 https://druglandscape.com/api/og?type=drug&title=ZK245186&subtitle=ZK245186%20%C2%B7%20Bayer&badge=phase%202 ZK245186 ZK245186 · Bayer https://druglandscape.com/drug/zkab001-monotherapy https://druglandscape.com/api/og?type=drug&title=ZKAB001%20monotherapy&subtitle=ZKAB001%20monotherapy%20%C2%B7%20Lee's%20Pharmaceutical%20Limited&badge=phase%201 ZKAB001 monotherapy ZKAB001 monotherapy · Lee's Pharmaceutical Limited https://druglandscape.com/drug/zl-1503 https://druglandscape.com/api/og?type=drug&title=ZL-1503&subtitle=ZL-1503%20%C2%B7%20Zai%20Lab%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 ZL-1503 ZL-1503 · Zai Lab (Shanghai) Co., Ltd. https://druglandscape.com/drug/zl-2102 https://druglandscape.com/api/og?type=drug&title=ZL-2102&subtitle=ZL-2102%20%C2%B7%20Zai%20Lab%20Pty.%20Ltd.&badge=phase%201 ZL-2102 ZL-2102 · Zai Lab Pty. Ltd. https://druglandscape.com/drug/zl-3101 https://druglandscape.com/api/og?type=drug&title=ZL-3101&subtitle=ZL-3101%20%C2%B7%20Zai%20Lab%20Pty.%20Ltd.&badge=phase%202 ZL-3101 ZL-3101 · Zai Lab Pty. Ltd. https://druglandscape.com/drug/zl-6201 https://druglandscape.com/api/og?type=drug&title=ZL-6201&subtitle=ZL-6201%20%C2%B7%20Zai%20Lab%20(Shanghai)%20Co.%2C%20Ltd.&badge=phase%201 ZL-6201 ZL-6201 · Zai Lab (Shanghai) Co., Ltd. https://druglandscape.com/drug/zl-82 https://druglandscape.com/api/og?type=drug&title=ZL-82&subtitle=ZL-82%20%C2%B7%20Chengdu%20Zenitar%20Biomedical%20Technology%20Co.%2C%20Ltd&badge=phase%201 ZL-82 ZL-82 · Chengdu Zenitar Biomedical Technology Co., Ltd https://druglandscape.com/drug/zl-85fa-tablets https://druglandscape.com/api/og?type=drug&title=ZL-85FA%20tablets&subtitle=ZL-85FA%20tablets%20%C2%B7%20Chengdu%20Zenitar%20Biomedical%20Technology%20Co.%2C%20Ltd&badge=phase%201 ZL-85FA tablets ZL-85FA tablets · Chengdu Zenitar Biomedical Technology Co., Ltd https://druglandscape.com/drug/zm-h1505r https://druglandscape.com/api/og?type=drug&title=ZM-H1505R&subtitle=ZM-H1505R%20%C2%B7%20Shanghai%20Zhimeng%20Biopharma%2C%20Inc.&badge=phase%202 ZM-H1505R ZM-H1505R · Shanghai Zhimeng Biopharma, Inc. https://druglandscape.com/drug/zm008 https://druglandscape.com/api/og?type=drug&title=ZM008&subtitle=ZM008%20%C2%B7%20Zumutor%20Biologics%20Inc.&badge=phase%201 ZM008 ZM008 · Zumutor Biologics Inc. https://druglandscape.com/drug/zn-a-1041 https://druglandscape.com/api/og?type=drug&title=ZN-A-1041&subtitle=ZN-A-1041%20%C2%B7%20Hoffmann-La%20Roche&badge=phase%201 ZN-A-1041 ZN-A-1041 · Hoffmann-La Roche https://druglandscape.com/drug/zn-c5 https://druglandscape.com/api/og?type=drug&title=ZN-c5&subtitle=ZN-c5%20%C2%B7%20Zeno%20Alpha%20Inc.&badge=phase%201 ZN-c5 ZN-c5 · Zeno Alpha Inc. https://druglandscape.com/drug/zn-e4 https://druglandscape.com/api/og?type=drug&title=ZN-e4&subtitle=ZN-e4%20%C2%B7%20Zeno%20Pharmaceuticals%2C%20Inc.&badge=phase%201 ZN-e4 ZN-e4 · Zeno Pharmaceuticals, Inc. https://druglandscape.com/drug/zoenasa-1-4 https://druglandscape.com/api/og?type=drug&title=Zoenasa-1%3A4&subtitle=Zoenasa-1%3A4%20%C2%B7%20Altheus%20Therapeutics%2C%20Inc.&badge=phase%202 Zoenasa-1:4 Zoenasa-1:4 · Altheus Therapeutics, Inc. https://druglandscape.com/drug/zoladex-la https://druglandscape.com/api/og?type=drug&title=Zoladex%20LA&subtitle=Zoladex%20LA%20%C2%B7%20Cancer%20Research%20Antwerp&badge=phase%202 Zoladex LA Zoladex LA · Cancer Research Antwerp https://druglandscape.com/drug/zolendric-acid https://druglandscape.com/api/og?type=drug&title=Zolendric%20acid&subtitle=Zolendric%20acid%20%C2%B7%20Baylor%20College%20of%20Medicine&badge=phase%201 Zolendric acid Zolendric acid · Baylor College of Medicine https://druglandscape.com/drug/zolmitriptan-oral https://druglandscape.com/api/og?type=drug&title=Zolmitriptan%20oral.&subtitle=Zolmitriptan%20oral.%20%C2%B7%20Parc%20de%20Salut%20Mar&badge=phase%201 Zolmitriptan oral. Zolmitriptan oral. · Parc de Salut Mar https://druglandscape.com/drug/zolpidem-tablets https://druglandscape.com/api/og?type=drug&title=Zolpidem%20-%20Tablets&subtitle=Zolpidem%20-%20Tablets%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%201 Zolpidem - Tablets Zolpidem - Tablets · Eli Lilly and Company https://druglandscape.com/drug/zonisamide-cr-and-bupropion-sr https://druglandscape.com/api/og?type=drug&title=Zonisamide%20CR%20and%20Bupropion%20SR&subtitle=Zonisamide%20CR%20and%20Bupropion%20SR%20%C2%B7%20Orexigen%20Therapeutics%2C%20Inc&badge=phase%202 Zonisamide CR and Bupropion SR Zonisamide CR and Bupropion SR · Orexigen Therapeutics, Inc https://druglandscape.com/drug/zonisamide-tablets https://druglandscape.com/api/og?type=drug&title=Zonisamide%20tablets&subtitle=Zonisamide%20tablets%20%C2%B7%20Eisai%20Inc.&badge=phase%202 Zonisamide tablets Zonisamide tablets · Eisai Inc. https://druglandscape.com/drug/zorifertinib-and-osimertinib-combination-therapy https://druglandscape.com/api/og?type=drug&title=Zorifertinib%20and%20Osimertinib%20Combination%20Therapy&subtitle=Zorifertinib%20and%20Osimertinib%20Combination%20Therapy%20%C2%B7%20Alpha%20Biopharma%20(Jiangsu)%20Co.%2C%20Ltd.&badge=phase%201 Zorifertinib and Osimertinib Combination Therapy Zorifertinib and Osimertinib Combination Therapy · Alpha Biopharma (Jiangsu) Co., Ltd. https://druglandscape.com/drug/zovirax-cream https://druglandscape.com/api/og?type=drug&title=Zovirax%C2%AE%20cream&subtitle=Zovirax%C2%AE%20cream%20%C2%B7%20AiCuris%20Anti-infective%20Cures%20AG&badge=phase%202 Zovirax® cream Zovirax® cream · AiCuris Anti-infective Cures AG https://druglandscape.com/drug/zp-pth https://druglandscape.com/api/og?type=drug&title=ZP-PTH&subtitle=ZP-PTH%20%C2%B7%20Zosano%20Pharma%20Corporation&badge=phase%201 ZP-PTH ZP-PTH · Zosano Pharma Corporation https://druglandscape.com/drug/zp-zolmitriptan https://druglandscape.com/api/og?type=drug&title=ZP-Zolmitriptan&subtitle=ZP-Zolmitriptan%20%C2%B7%20Zosano%20Pharma%20Corporation&badge=phase%202 ZP-Zolmitriptan ZP-Zolmitriptan · Zosano Pharma Corporation https://druglandscape.com/drug/zr-202-cov https://druglandscape.com/api/og?type=drug&title=ZR-202-CoV&subtitle=ZR-202-CoV%20%C2%B7%20Shanghai%20Zerun%20Biotechnology%20Co.%2CLtd&badge=phase%201 ZR-202-CoV ZR-202-CoV · Shanghai Zerun Biotechnology Co.,Ltd https://druglandscape.com/drug/zr-df-iab22m2c-infusion https://druglandscape.com/api/og?type=drug&title=%E2%81%B8%E2%81%B9Zr-Df-IAB22M2C%20Infusion&subtitle=%E2%81%B8%E2%81%B9Zr-Df-IAB22M2C%20Infusion%20%C2%B7%20ImaginAb%2C%20Inc.&badge=phase%201 ⁸⁹Zr-Df-IAB22M2C Infusion ⁸⁹Zr-Df-IAB22M2C Infusion · ImaginAb, Inc. https://druglandscape.com/drug/zr202-cov https://druglandscape.com/api/og?type=drug&title=ZR202-CoV&subtitle=ZR202-CoV%20%C2%B7%20Shanghai%20Zerun%20Biotechnology%20Co.%2CLtd&badge=phase%201 ZR202-CoV ZR202-CoV · Shanghai Zerun Biotechnology Co.,Ltd https://druglandscape.com/drug/zsp0678 https://druglandscape.com/api/og?type=drug&title=ZSP0678&subtitle=ZSP0678%20%C2%B7%20Guangdong%20Raynovent%20Biotech%20Co.%2C%20Ltd&badge=phase%201 ZSP0678 ZSP0678 · Guangdong Raynovent Biotech Co., Ltd https://druglandscape.com/drug/zsp0678-dose-1 https://druglandscape.com/api/og?type=drug&title=ZSP0678-Dose%201&subtitle=ZSP0678-Dose%201%20%C2%B7%20Guangdong%20Raynovent%20Biotech%20Co.%2C%20Ltd&badge=phase%201 ZSP0678-Dose 1 ZSP0678-Dose 1 · Guangdong Raynovent Biotech Co., Ltd https://druglandscape.com/drug/zsp1273-low-dose https://druglandscape.com/api/og?type=drug&title=ZSP1273%20Low%20Dose&subtitle=ZSP1273%20Low%20Dose%20%C2%B7%20Guangdong%20Zhongsheng%20Pharmaceutical%20Co.%2C%20Ltd.&badge=phase%201 ZSP1273 Low Dose ZSP1273 Low Dose · Guangdong Zhongsheng Pharmaceutical Co., Ltd. https://druglandscape.com/drug/zsp1601 https://druglandscape.com/api/og?type=drug&title=ZSP1601&subtitle=ZSP1601%20%C2%B7%20Guangdong%20Raynovent%20Biotech%20Co.%2C%20Ltd&badge=phase%202 ZSP1601 ZSP1601 · Guangdong Raynovent Biotech Co., Ltd https://druglandscape.com/drug/zstk474 https://druglandscape.com/api/og?type=drug&title=ZSTK474&subtitle=ZSTK474%20%C2%B7%20Zenyaku%20Kogyo%20Co.%2C%20Ltd.&badge=phase%201 ZSTK474 ZSTK474 · Zenyaku Kogyo Co., Ltd. https://druglandscape.com/drug/zt003 https://druglandscape.com/api/og?type=drug&title=ZT003&subtitle=ZT003%20%C2%B7%20Beijing%20QL%20Biopharmaceutical%20Co.%2CLtd&badge=phase%201 ZT003 ZT003 · Beijing QL Biopharmaceutical Co.,Ltd https://druglandscape.com/drug/zt006 https://druglandscape.com/api/og?type=drug&title=ZT006&subtitle=ZT006%20%C2%B7%20Beijing%20QL%20Biopharmaceutical%20Co.%2CLtd&badge=phase%202 ZT006 ZT006 · Beijing QL Biopharmaceutical Co.,Ltd https://druglandscape.com/drug/zti-01 https://druglandscape.com/api/og?type=drug&title=ZTI-01&subtitle=ZTI-01%20%C2%B7%20Nabriva%20Therapeutics%20AG&badge=phase%202 ZTI-01 ZTI-01 · Nabriva Therapeutics AG https://druglandscape.com/drug/zw251 https://druglandscape.com/api/og?type=drug&title=ZW251&subtitle=ZW251%20%C2%B7%20Zymeworks%20BC%20Inc.&badge=phase%201 ZW251 ZW251 · Zymeworks BC Inc. https://druglandscape.com/drug/zw49 https://druglandscape.com/api/og?type=drug&title=ZW49&subtitle=ZW49%20%C2%B7%20Zymeworks%20BC%20Inc.&badge=phase%201 ZW49 ZW49 · Zymeworks BC Inc. https://druglandscape.com/drug/zx-4081 https://druglandscape.com/api/og?type=drug&title=ZX-4081&subtitle=ZX-4081%20%C2%B7%20Nanjing%20Zenshine%20Pharmaceuticals&badge=phase%201 ZX-4081 ZX-4081 · Nanjing Zenshine Pharmaceuticals https://druglandscape.com/drug/zx-8177 https://druglandscape.com/api/og?type=drug&title=ZX-8177&subtitle=ZX-8177%20%C2%B7%20Nanjing%20Zenshine%20Pharmaceuticals&badge=phase%201 ZX-8177 ZX-8177 · Nanjing Zenshine Pharmaceuticals https://druglandscape.com/drug/zy19489-capsule https://druglandscape.com/api/og?type=drug&title=ZY19489%20Capsule&subtitle=ZY19489%20Capsule%20%C2%B7%20Zydus%20Lifesciences%20Limited&badge=phase%201 ZY19489 Capsule ZY19489 Capsule · Zydus Lifesciences Limited https://druglandscape.com/drug/zyd1 https://druglandscape.com/api/og?type=drug&title=ZYD1&subtitle=ZYD1%20%C2%B7%20Zydus%20Lifesciences%20Limited&badge=phase%201 ZYD1 ZYD1 · Zydus Lifesciences Limited https://druglandscape.com/drug/zyg24002-0-75 https://druglandscape.com/api/og?type=drug&title=ZYG24002%200.75%25&subtitle=ZYG24002%200.75%25%20%C2%B7%20Sinomune%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 ZYG24002 0.75% ZYG24002 0.75% · Sinomune Pharmaceutical Co., Ltd https://druglandscape.com/drug/zyg24002-1 https://druglandscape.com/api/og?type=drug&title=ZYG24002%201%25&subtitle=ZYG24002%201%25%20%C2%B7%20Sinomune%20Pharmaceutical%20Co.%2C%20Ltd&badge=phase%201 ZYG24002 1% ZYG24002 1% · Sinomune Pharmaceutical Co., Ltd https://druglandscape.com/drug/zyil1-capsule https://druglandscape.com/api/og?type=drug&title=ZYIL1%20capsule&subtitle=ZYIL1%20capsule%20%C2%B7%20Zydus%20Lifesciences%20Limited&badge=phase%202 ZYIL1 capsule ZYIL1 capsule · Zydus Lifesciences Limited https://druglandscape.com/drug/zyn002 https://druglandscape.com/api/og?type=drug&title=ZYN002&subtitle=ZYN002%20%C2%B7%20Harmony%20Biosciences%20Management%2C%20Inc.&badge=phase%202 ZYN002 ZYN002 · Harmony Biosciences Management, Inc. https://druglandscape.com/drug/zz06 https://druglandscape.com/api/og?type=drug&title=ZZ06&subtitle=ZZ06%20%C2%B7%20Changchun%20Intellicrown%20Pharmaceutical%20Co.%20LTD&badge=phase%201 ZZ06 ZZ06 · Changchun Intellicrown Pharmaceutical Co. LTD https://druglandscape.com/drug/tadalafil-once-a-day-t-oad https://druglandscape.com/api/og?type=drug&title=tadalafil%20once%20a%20day%20%5BT(OaD)%5D&subtitle=tadalafil%20once%20a%20day%20%5BT(OaD)%5D%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%203 tadalafil once a day [T(OaD)] tadalafil once a day [T(OaD)] · Eli Lilly and Company https://druglandscape.com/drug/estrace-cream-reference https://druglandscape.com/api/og?type=drug&title=estrace%20cream%20(Reference)&subtitle=estrace%20cream%20(Reference)%20%C2%B7%20Padagis%20LLC&badge=phase%203 estrace cream (Reference) estrace cream (Reference) · Padagis LLC https://druglandscape.com/drug/vehicle-of-otx-101 https://druglandscape.com/api/og?type=drug&title=vehicle%20of%20OTX-101&subtitle=vehicle%20of%20OTX-101%20%C2%B7%20Sun%20Pharmaceutical%20Industries%20Limited&badge=phase%203 vehicle of OTX-101 vehicle of OTX-101 · Sun Pharmaceutical Industries Limited https://druglandscape.com/drug/zolpidem-mr-sl800750 https://druglandscape.com/api/og?type=drug&title=zolpidem-MR%20(SL800750)&subtitle=zolpidem-MR%20(SL800750)%20%C2%B7%20Sanofi&badge=phase%203 zolpidem-MR (SL800750) zolpidem-MR (SL800750) · Sanofi https://druglandscape.com/drug/acarbose-vildagliptin https://druglandscape.com/api/og?type=drug&title=acarbose%20%2B%20vildagliptin&subtitle=acarbose%20%2B%20vildagliptin%20%C2%B7%20Radboud%20University%20Medical%20Center&badge=phase%203 acarbose + vildagliptin acarbose + vildagliptin · Radboud University Medical Center https://druglandscape.com/drug/amoxicillin-or-moxifloxacin-rifampicin https://druglandscape.com/api/og?type=drug&title=amoxicillin%20or%20moxifloxacin%20%2B%20rifampicin&subtitle=amoxicillin%20or%20moxifloxacin%20%2B%20rifampicin%20%C2%B7%20Centre%20Hospitalier%20Universitaire%20de%20Nice&badge=phase%203 amoxicillin or moxifloxacin + rifampicin amoxicillin or moxifloxacin + rifampicin · Centre Hospitalier Universitaire de Nice https://druglandscape.com/drug/bimatoprost-timolol-fixed-combination https://druglandscape.com/api/og?type=drug&title=bimatoprost%2Ftimolol%20fixed%20combination&subtitle=bimatoprost%2Ftimolol%20fixed%20combination%20%C2%B7%20Allergan&badge=phase%203 bimatoprost/timolol fixed combination bimatoprost/timolol fixed combination · Allergan https://druglandscape.com/drug/boceprevir-sch-503034 https://druglandscape.com/api/og?type=drug&title=boceprevir%20(SCH%20503034)&subtitle=boceprevir%20(SCH%20503034)%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%203 boceprevir (SCH 503034) boceprevir (SCH 503034) · Merck Sharp & Dohme LLC https://druglandscape.com/drug/brimonidine-timolol-fixed-combination https://druglandscape.com/api/og?type=drug&title=brimonidine%2Ftimolol%20fixed%20combination&subtitle=brimonidine%2Ftimolol%20fixed%20combination%20%C2%B7%20Allergan&badge=phase%203 brimonidine/timolol fixed combination brimonidine/timolol fixed combination · Allergan https://druglandscape.com/drug/camrelizumab-apatinib https://druglandscape.com/api/og?type=drug&title=camrelizumab%2Bapatinib&subtitle=camrelizumab%2Bapatinib%20%C2%B7%20Peking%20University%20Cancer%20Hospital%20%26%20Institute&badge=phase%203 camrelizumab+apatinib camrelizumab+apatinib · Peking University Cancer Hospital & Institute https://druglandscape.com/drug/carboplatin-paclitaxel-cp https://druglandscape.com/api/og?type=drug&title=carboplatin%2Fpaclitaxel%20(CP)&subtitle=carboplatin%2Fpaclitaxel%20(CP)%20%C2%B7%20Sanofi&badge=phase%203 carboplatin/paclitaxel (CP) carboplatin/paclitaxel (CP) · Sanofi https://druglandscape.com/drug/cisplatin-docetaxel-enoxaparin https://druglandscape.com/api/og?type=drug&title=cisplatin%20%2B%20docetaxel%20%2B%20enoxaparin&subtitle=cisplatin%20%2B%20docetaxel%20%2B%20enoxaparin%20%C2%B7%20University%20Hospital%2C%20Antwerp&badge=phase%203 cisplatin + docetaxel + enoxaparin cisplatin + docetaxel + enoxaparin · University Hospital, Antwerp https://druglandscape.com/drug/doxorubicine-docetaxel-combined https://druglandscape.com/api/og?type=drug&title=doxorubicine%20%2B%20docetaxel%20combined&subtitle=doxorubicine%20%2B%20docetaxel%20combined%20%C2%B7%20Sanofi&badge=phase%203 doxorubicine + docetaxel combined doxorubicine + docetaxel combined · Sanofi https://druglandscape.com/drug/drug-ascs-fibrin-glue https://druglandscape.com/api/og?type=drug&title=%E2%97%A6Drug%3A%20ASCs.%20%2B%20fibrin%20glue&subtitle=%E2%97%A6Drug%3A%20ASCs.%20%2B%20fibrin%20glue%20%C2%B7%20Instituto%20de%20Investigaci%C3%B3n%20Sanitaria%20de%20la%20Fundaci%C3%B3n%20Jim%C3%A9nez%20D%C3%ADaz&badge=phase%203 ◦Drug: ASCs. + fibrin glue ◦Drug: ASCs. + fibrin glue · Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz https://druglandscape.com/drug/epirubicin-cisplatin-capecitabine https://druglandscape.com/api/og?type=drug&title=epirubicin%2Bcisplatin%2Bcapecitabine&subtitle=epirubicin%2Bcisplatin%2Bcapecitabine%20%C2%B7%20Dutch%20Colorectal%20Cancer%20Group&badge=phase%203 epirubicin+cisplatin+capecitabine epirubicin+cisplatin+capecitabine · Dutch Colorectal Cancer Group https://druglandscape.com/drug/erapa-encapsulated-rapamycin https://druglandscape.com/api/og?type=drug&title=eRapa%20(encapsulated%20rapamycin)&subtitle=eRapa%20(encapsulated%20rapamycin)%20%C2%B7%20Rapamycin%20Holdings%2C%20Inc.%20dba%20Emtora%20Biosciences&badge=phase%203 eRapa (encapsulated rapamycin) eRapa (encapsulated rapamycin) · Rapamycin Holdings, Inc. dba Emtora Biosciences https://druglandscape.com/drug/estrace-cream-perrigo https://druglandscape.com/api/og?type=drug&title=estrace%20cream%20(Perrigo)&subtitle=estrace%20cream%20(Perrigo)%20%C2%B7%20Padagis%20LLC&badge=phase%203 estrace cream (Perrigo) estrace cream (Perrigo) · Padagis LLC https://druglandscape.com/drug/etoricoxib-mk0663 https://druglandscape.com/api/og?type=drug&title=etoricoxib%20(MK0663)&subtitle=etoricoxib%20(MK0663)%20%C2%B7%20Organon%20and%20Co&badge=phase%203 etoricoxib (MK0663) etoricoxib (MK0663) · Organon and Co https://druglandscape.com/drug/everolimus-mycophenolate-mofetil https://druglandscape.com/api/og?type=drug&title=everolimus%20%2B%20mycophenolate%20mofetil&subtitle=everolimus%20%2B%20mycophenolate%20mofetil%20%C2%B7%20Centre%20Hospitalier%20Universitaire%2C%20Amiens&badge=phase%203 everolimus + mycophenolate mofetil everolimus + mycophenolate mofetil · Centre Hospitalier Universitaire, Amiens https://druglandscape.com/drug/exenatide-insulin-glargine https://druglandscape.com/api/og?type=drug&title=exenatide%2Finsulin%20glargine&subtitle=exenatide%2Finsulin%20glargine%20%C2%B7%20AstraZeneca&badge=phase%203 exenatide/insulin glargine exenatide/insulin glargine · AstraZeneca https://druglandscape.com/drug/favezelimab-pembrolizumab https://druglandscape.com/api/og?type=drug&title=favezelimab%2Fpembrolizumab&subtitle=favezelimab%2Fpembrolizumab%20%C2%B7%20Merck%20Sharp%20%26%20Dohme%20LLC&badge=phase%203 favezelimab/pembrolizumab favezelimab/pembrolizumab · Merck Sharp & Dohme LLC https://druglandscape.com/drug/generic-single-tablet-taf-ftc-dtg https://druglandscape.com/api/og?type=drug&title=generic%20single%20tablet%20TAF%2FFTC%2FDTG&subtitle=generic%20single%20tablet%20TAF%2FFTC%2FDTG%20%C2%B7%20The%20HIV%20Netherlands%20Australia%20Thailand%20Research%20Collaboration&badge=phase%203 generic single tablet TAF/FTC/DTG generic single tablet TAF/FTC/DTG · The HIV Netherlands Australia Thailand Research Collaboration https://druglandscape.com/drug/insulin-degludec-insulin-aspart https://druglandscape.com/api/og?type=drug&title=insulin%20degludec%2Finsulin%20aspart&subtitle=insulin%20degludec%2Finsulin%20aspart%20%C2%B7%20Novo%20Nordisk%20A%2FS&badge=phase%203 insulin degludec/insulin aspart insulin degludec/insulin aspart · Novo Nordisk A/S https://druglandscape.com/drug/insulin-glargine-preprandial-lispro-insulin https://druglandscape.com/api/og?type=drug&title=insulin%20glargine%20%2B%20preprandial%20lispro%20insulin&subtitle=insulin%20glargine%20%2B%20preprandial%20lispro%20insulin%20%C2%B7%20GlaxoSmithKline&badge=phase%203 insulin glargine + preprandial lispro insulin insulin glargine + preprandial lispro insulin · GlaxoSmithKline https://druglandscape.com/drug/irinotecan-based-chemo-bevacizumab https://druglandscape.com/api/og?type=drug&title=irinotecan-based%20chemo%20%2B%20bevacizumab&subtitle=irinotecan-based%20chemo%20%2B%20bevacizumab%20%C2%B7%20GERCOR%20-%20Multidisciplinary%20Oncology%20Cooperative%20Group&badge=phase%203 irinotecan-based chemo + bevacizumab irinotecan-based chemo + bevacizumab · GERCOR - Multidisciplinary Oncology Cooperative Group https://druglandscape.com/drug/levofloxacin-imipenem-cilastitin https://druglandscape.com/api/og?type=drug&title=levofloxacin%3B%20imipenem%2Fcilastitin&subtitle=levofloxacin%3B%20imipenem%2Fcilastitin%20%C2%B7%20Johnson%20%26%20Johnson%20Pharmaceutical%20Research%20%26%20Development%2C%20L.L.C.&badge=phase%203 levofloxacin; imipenem/cilastitin levofloxacin; imipenem/cilastitin · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. https://druglandscape.com/drug/lidoca-ne-priloca-ne-5 https://druglandscape.com/api/og?type=drug&title=lidoca%C3%AFne%2Fpriloca%C3%AFne%205%25&subtitle=lidoca%C3%AFne%2Fpriloca%C3%AFne%205%25%20%C2%B7%20University%20Hospital%2C%20Brest&badge=phase%203 lidocaïne/prilocaïne 5% lidocaïne/prilocaïne 5% · University Hospital, Brest https://druglandscape.com/drug/lithium-mood-stabilizer https://druglandscape.com/api/og?type=drug&title=lithium%20(mood%20stabilizer)&subtitle=lithium%20(mood%20stabilizer)%20%C2%B7%20AstraZeneca&badge=phase%203 lithium (mood stabilizer) lithium (mood stabilizer) · AstraZeneca https://druglandscape.com/drug/losartan-duration-of-treatment-6-weeks https://druglandscape.com/api/og?type=drug&title=losartan%20%2F%20Duration%20of%20Treatment%3A%206%20weeks&subtitle=losartan%20%2F%20Duration%20of%20Treatment%3A%206%20weeks%20%C2%B7%20Organon%20and%20Co&badge=phase%203 losartan / Duration of Treatment: 6 weeks losartan / Duration of Treatment: 6 weeks · Organon and Co https://druglandscape.com/drug/lurbinectedin-pm01183 https://druglandscape.com/api/og?type=drug&title=lurbinectedin%20(PM01183)&subtitle=lurbinectedin%20(PM01183)%20%C2%B7%20PharmaMar&badge=phase%203 lurbinectedin (PM01183) lurbinectedin (PM01183) · PharmaMar https://druglandscape.com/drug/matching-placebo-of-emodepside https://druglandscape.com/api/og?type=drug&title=matching%20placebo%20of%20emodepside&subtitle=matching%20placebo%20of%20emodepside%20%C2%B7%20Drugs%20for%20Neglected%20Diseases&badge=phase%203 matching placebo of emodepside matching placebo of emodepside · Drugs for Neglected Diseases https://druglandscape.com/drug/niacin-extended-release-ner https://druglandscape.com/api/og?type=drug&title=niacin%20extended-release%20(NER)&subtitle=niacin%20extended-release%20(NER)%20%C2%B7%20Abbott&badge=phase%203 niacin extended-release (NER) niacin extended-release (NER) · Abbott https://druglandscape.com/drug/nitrendipine-hydrochlorothiazide-if-necessary https://druglandscape.com/api/og?type=drug&title=nitrendipine%20%2B%20hydrochlorothiazide%2C%20if%20necessary&subtitle=nitrendipine%20%2B%20hydrochlorothiazide%2C%20if%20necessary%20%C2%B7%20Daiichi%20Sankyo%20Europe%2C%20GmbH%2C%20a%20Daiichi%20Sankyo%20Com&badge=phase%203 nitrendipine + hydrochlorothiazide, if necessary nitrendipine + hydrochlorothiazide, if necessary · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company https://druglandscape.com/drug/ofatumumab-dhap https://druglandscape.com/api/og?type=drug&title=ofatumumab%20%2B%20DHAP&subtitle=ofatumumab%20%2B%20DHAP%20%C2%B7%20GlaxoSmithKline&badge=phase%203 ofatumumab + DHAP ofatumumab + DHAP · GlaxoSmithKline https://druglandscape.com/drug/ombitasvir-paritaprevir-ritonavir-dasabuvir https://druglandscape.com/api/og?type=drug&title=ombitasvir%2Fparitaprevir%2Fritonavir%2C%20dasabuvir&subtitle=ombitasvir%2Fparitaprevir%2Fritonavir%2C%20dasabuvir%20%C2%B7%20AbbVie&badge=phase%203 ombitasvir/paritaprevir/ritonavir, dasabuvir ombitasvir/paritaprevir/ritonavir, dasabuvir · AbbVie https://druglandscape.com/drug/palonosetron-dexamethasone https://druglandscape.com/api/og?type=drug&title=palonosetron%2Bdexamethasone&subtitle=palonosetron%2Bdexamethasone%20%C2%B7%20Union%20Hospital%2C%20Tongji%20Medical%20College%2C%20Huazhong%20University%20of%20Science%20&badge=phase%203 palonosetron+dexamethasone palonosetron+dexamethasone · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology https://druglandscape.com/drug/pembrolizumab-200-mg https://druglandscape.com/api/og?type=drug&title=pembrolizumab%20(200%20mg)&subtitle=pembrolizumab%20(200%20mg)%20%C2%B7%20Eisai%20Co.%2C%20Ltd.&badge=phase%203 pembrolizumab (200 mg) pembrolizumab (200 mg) · Eisai Co., Ltd. https://druglandscape.com/drug/pemetrexed-alimta https://druglandscape.com/api/og?type=drug&title=pemetrexed%20(Alimta)&subtitle=pemetrexed%20(Alimta)%20%C2%B7%20National%20Cheng-Kung%20University%20Hospital&badge=phase%203 pemetrexed (Alimta) pemetrexed (Alimta) · National Cheng-Kung University Hospital https://druglandscape.com/drug/photosensitizer-photofrin https://druglandscape.com/api/og?type=drug&title=photosensitizer(photofrin)&subtitle=photosensitizer(photofrin)%20%C2%B7%20The%20First%20Affiliated%20Hospital%20of%20Henan%20University%20of%20Science%20and%20Techno&badge=phase%203 photosensitizer(photofrin) photosensitizer(photofrin) · The First Affiliated Hospital of Henan University of Science and Technology https://druglandscape.com/drug/sarilumab-sar153191-regn88 https://druglandscape.com/api/og?type=drug&title=sarilumab%20SAR153191%20(REGN88)&subtitle=sarilumab%20SAR153191%20(REGN88)%20%C2%B7%20Sanofi&badge=phase%203 sarilumab SAR153191 (REGN88) sarilumab SAR153191 (REGN88) · Sanofi https://druglandscape.com/drug/sildenafil-citrate-uk-92-480 https://druglandscape.com/api/og?type=drug&title=sildenafil%20citrate%20(UK-92%2C480)&subtitle=sildenafil%20citrate%20(UK-92%2C480)%20%C2%B7%20Pfizer's%20Upjohn%20has%20merged%20with%20Mylan%20to%20form%20Viatris%20Inc.&badge=phase%203 sildenafil citrate (UK-92,480) sildenafil citrate (UK-92,480) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. https://druglandscape.com/drug/surfactant-vitamin-a https://druglandscape.com/api/og?type=drug&title=surfactant%2Bvitamin%20A&subtitle=surfactant%2Bvitamin%20A%20%C2%B7%20Third%20Military%20Medical%20University&badge=phase%203 surfactant+vitamin A surfactant+vitamin A · Third Military Medical University https://druglandscape.com/drug/sutimlimab-bivv009 https://druglandscape.com/api/og?type=drug&title=sutimlimab%20(BIVV009)&subtitle=sutimlimab%20(BIVV009)%20%C2%B7%20Bioverativ%2C%20a%20Sanofi%20company&badge=phase%203 sutimlimab (BIVV009) sutimlimab (BIVV009) · Bioverativ, a Sanofi company https://druglandscape.com/drug/tadalafil-as-needed-t-prn https://druglandscape.com/api/og?type=drug&title=tadalafil%20as%20needed%20%5BT(PRN)%5D&subtitle=tadalafil%20as%20needed%20%5BT(PRN)%5D%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%203 tadalafil as needed [T(PRN)] tadalafil as needed [T(PRN)] · Eli Lilly and Company https://druglandscape.com/drug/teriparatide-20-micrograms-day-subcutaneous https://druglandscape.com/api/og?type=drug&title=teriparatide%2020%20micrograms%2Fday%20subcutaneous&subtitle=teriparatide%2020%20micrograms%2Fday%20subcutaneous%20%C2%B7%20Eli%20Lilly%20and%20Company&badge=phase%203 teriparatide 20 micrograms/day subcutaneous teriparatide 20 micrograms/day subcutaneous · Eli Lilly and Company https://druglandscape.com/drug/tirapazamine-sr259075 https://druglandscape.com/api/og?type=drug&title=tirapazamine%20(SR259075)&subtitle=tirapazamine%20(SR259075)%20%C2%B7%20Sanofi&badge=phase%203 tirapazamine (SR259075) tirapazamine (SR259075) · Sanofi https://druglandscape.com/drug/tobramycin-bramitob https://druglandscape.com/api/og?type=drug&title=tobramycin%20%2F%20Bramitob&subtitle=tobramycin%20%2F%20Bramitob%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%203 tobramycin / Bramitob tobramycin / Bramitob · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/tobramycin-tobi https://druglandscape.com/api/og?type=drug&title=tobramycin%20%2F%20TOBI&subtitle=tobramycin%20%2F%20TOBI%20%C2%B7%20Chiesi%20Farmaceutici%20S.p.A.&badge=phase%203 tobramycin / TOBI tobramycin / TOBI · Chiesi Farmaceutici S.p.A. https://druglandscape.com/drug/triptorelin-embonate-inn https://druglandscape.com/api/og?type=drug&title=triptorelin%20embonate%20(INN)&subtitle=triptorelin%20embonate%20(INN)%20%C2%B7%20Debiopharm%20International%20SA&badge=phase%203 triptorelin embonate (INN) triptorelin embonate (INN) · Debiopharm International SA https://druglandscape.com/drug/urea-lactic-acid-based-topical-cream https://druglandscape.com/api/og?type=drug&title=urea%2Flactic%20acid-based%20topical%20cream&subtitle=urea%2Flactic%20acid-based%20topical%20cream%20%C2%B7%20Alliance%20for%20Clinical%20Trials%20in%20Oncology&badge=phase%203 urea/lactic acid-based topical cream urea/lactic acid-based topical cream · Alliance for Clinical Trials in Oncology https://druglandscape.com/drug/valsartan-amlodipine-combination-valsartan-amlodipine https://druglandscape.com/api/og?type=drug&title=valsartan%2Bamlodipine%20combination%2C%20valsartan%2C%20amlodipine&subtitle=valsartan%2Bamlodipine%20combination%2C%20valsartan%2C%20amlodipine%20%C2%B7%20Novartis&badge=phase%203 valsartan+amlodipine combination, valsartan, amlodipine valsartan+amlodipine combination, valsartan, amlodipine · Novartis https://druglandscape.com/drug/varenicline-cp-526-555 https://druglandscape.com/api/og?type=drug&title=varenicline%20(CP-526%2C555)&subtitle=varenicline%20(CP-526%2C555)%20%C2%B7%20Pfizer&badge=phase%203 varenicline (CP-526,555) varenicline (CP-526,555) · Pfizer https://druglandscape.com/drug/vehicle-of-p-3058-10 https://druglandscape.com/api/og?type=drug&title=vehicle%20of%20P-3058%2010%25&subtitle=vehicle%20of%20P-3058%2010%25%20%C2%B7%20Polichem%20S.A.&badge=phase%203 vehicle of P-3058 10% vehicle of P-3058 10% · Polichem S.A. https://druglandscape.com/drug/verapamil-trandolapril https://druglandscape.com/api/og?type=drug&title=verapamil%2Ftrandolapril&subtitle=verapamil%2Ftrandolapril%20%C2%B7%20Abbott&badge=phase%203 verapamil/trandolapril verapamil/trandolapril · Abbott https://druglandscape.com/drug/xp13512-gen https://druglandscape.com/api/og?type=drug&title=XP13512%20(GEn)&subtitle=XP13512%20(GEn)%20%C2%B7%20XenoPort%2C%20Inc.&badge=phase%203 XP13512 (GEn) XP13512 (GEn) · XenoPort, Inc. https://druglandscape.com/drug/zatolmilast-bpn14770 https://druglandscape.com/api/og?type=drug&title=Zatolmilast%2F%20BPN14770&subtitle=Zatolmilast%2F%20BPN14770%20%C2%B7%20Tetra%20Discovery%20Partners&badge=phase%203 Zatolmilast/ BPN14770 Zatolmilast/ BPN14770 · Tetra Discovery Partners https://druglandscape.com/drug/zavesca-miglustat https://druglandscape.com/api/og?type=drug&title=Zavesca%20(Miglustat)&subtitle=Zavesca%20(Miglustat)%20%C2%B7%20Children's%20National%20Research%20Institute&badge=phase%203 Zavesca (Miglustat) Zavesca (Miglustat) · Children's National Research Institute https://druglandscape.com/drug/zicam-ionic-zinc https://druglandscape.com/api/og?type=drug&title=Zicam%20(Ionic%20zinc)&subtitle=Zicam%20(Ionic%20zinc)%20%C2%B7%20Integrative%20Medicine%20Institute&badge=phase%203 Zicam (Ionic zinc) Zicam (Ionic zinc) · Integrative Medicine Institute https://druglandscape.com/drug/zidovudine-zdv https://druglandscape.com/api/og?type=drug&title=Zidovudine%20(ZDV)&subtitle=Zidovudine%20(ZDV)%20%C2%B7%20National%20Institute%20of%20Allergy%20and%20Infectious%20Diseases%20(NIAID)&badge=phase%203 Zidovudine (ZDV) Zidovudine (ZDV) · National Institute of Allergy and Infectious Diseases (NIAID) https://druglandscape.com/drug/zodin-drug https://druglandscape.com/api/og?type=drug&title=Zodin%20(drug)&subtitle=Zodin%20(drug)%20%C2%B7%20Stiftung%20Institut%20fuer%20Herzinfarktforschung&badge=phase%203 Zodin (drug) Zodin (drug) · Stiftung Institut fuer Herzinfarktforschung https://druglandscape.com/drug/zoledronic-acid-aclasta https://druglandscape.com/api/og?type=drug&title=zoledronic%20acid%20(aclasta)&subtitle=zoledronic%20acid%20(aclasta)%20%C2%B7%20Seoul%20National%20University%20Bundang%20Hospital&badge=phase%203 zoledronic acid (aclasta) zoledronic acid (aclasta) · Seoul National University Bundang Hospital https://druglandscape.com/drug/zoledronic-acide-aclasta https://druglandscape.com/api/og?type=drug&title=Zoledronic%20acide%20(Aclasta)&subtitle=Zoledronic%20acide%20(Aclasta)%20%C2%B7%20Prince%20of%20Wales%20Hospital%2C%20Shatin%2C%20Hong%20Kong&badge=phase%203 Zoledronic acide (Aclasta) Zoledronic acide (Aclasta) · Prince of Wales Hospital, Shatin, Hong Kong https://druglandscape.com/drug/zolpidem-mr-modified-release https://druglandscape.com/api/og?type=drug&title=zolpidem-MR%20(modified%20release)&subtitle=zolpidem-MR%20(modified%20release)%20%C2%B7%20Sanofi&badge=phase%203 zolpidem-MR (modified release) zolpidem-MR (modified release) · Sanofi